PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Hollingsworth, K; Callaway, L; Duhig, M; Matheson, S; Scott, J				Hollingsworth, Katharine; Callaway, Leonie; Duhig, Michael; Matheson, Sally; Scott, James			The Association between Maltreatment in Childhood and Pre-Pregnancy Obesity in Women Attending an Antenatal Clinic in Australia	PLOS ONE			English	Article							BODY-MASS INDEX; MATERNAL OBESITY; PREGNANCY; HEALTH; WEIGHT; LIFE; ABUSE; RISK; TERM; CONSEQUENCES	Introduction: Obesity in pregnancy is associated with increased risk of complications and adverse outcomes in mother and child. Childhood adverse experiences are known to have numerous negative physical and emotional sequelae. We aimed to examine if exposure to abuse and/or neglect in childhood increased the likelihood of pre-pregnancy obesity. Methods: Demographic and clinical data including weight, height, mental health as measured by the General Health Questionnaire and exposure to childhood trauma as measured by the childhood trauma questionnaire was collected from 239 women attending antenatal care at an Australian tertiary hospital. Results: More than one quarter of women were obese prior to pregnancy and approximately 20% of women self reported experiencing moderate to severe physical, sexual or emotional abuse. Almost 60% of women scored in the clinical range on the GHQ. Pre-pregnancy obesity in women attending antenatal care was associated with a self-reported history of emotional or physical abuse with those exposed to moderate or severe emotional or physical abuse having increased odds of being obese prior to pregnancy (O.R. and 95% CI: 2.40; 1.19-4.84 and 2.38; 1.18-4.79 respectively). There was no significant association between other forms of childhood maltreatment, demographic or current mental health status and pre-pregnancy obesity. Conclusions: The high rates of obesity, mental health problems and self reported childhood maltreatment in the Australian antenatal population are serious public health concerns due to the extra health risks conferred on mother and offspring. Exposure to physical or emotional abuse during childhood increases the likelihood of obesity in women attending antenatal care. Further research is required to determine reasons for this association.	[Callaway, Leonie; Scott, James] Royal Brisbane & Womens Hosp Herston, Dept Med, Herston, Qld, Australia; [Callaway, Leonie] Univ Queensland, Sch Med, Herston, Qld, Australia; [Duhig, Michael; Scott, James] Pk Ctr Mental Hlth, Queensland Ctr Mental Hlth Res, Wacol, Australia; [Scott, James] Univ Queensland, Clin Res Ctr, Herston, Qld, Australia	Royal Brisbane & Women's Hospital; University of Queensland; Queensland Centre for Mental Health Research; University of Queensland	Scott, J (corresponding author), Royal Brisbane & Womens Hosp Herston, Dept Med, Herston, Qld, Australia.	James_g_scott@health.qld.gov.au	Scott, James G/D-5900-2012	Scott, James G/0000-0002-0744-0688; Duhig, Michael/0000-0003-3880-4760; Callaway, Leonie/0000-0002-0137-9935	Royal Brisbane and Women's Hospital Foundation; Royal Brisbane and Women's Hospital; RBWH Foundation	Royal Brisbane and Women's Hospital Foundation; Royal Brisbane and Women's Hospital; RBWH Foundation	The study was undertaken by the first author (KH) whilst doing her honours degree during her medical studies. The publication fee was paid by The Royal Brisbane and Women's Hospital Foundation. There was no external funding for the project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the women who participated in this study, the staff of the Royal Brisbane and Women's Hospital and the RBWH Foundation who supported the publication of this manuscript.	ABS, 2011, OV OB AD AUSTR SNAPS; ABS, 2005, PERS SAF SURV; Austin MP, 2000, AUST NZ J OBSTET GYN, V40, P331, DOI 10.1111/j.1479-828X.2000.tb03344.x; Bardone-Cone AM, 2008, INT J EAT DISORDER, V41, P697, DOI 10.1002/eat.20567; Barlow J, 2004, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD002020.PUB2; Batten SV, 2004, J CLIN PSYCHIAT, V65, P249; Baxter S, 2011, HEALTH EDUC RES, V26, P265, DOI 10.1093/her/cyq092; Begum KS, 2011, CLIN EXP OBSTET GYN, V38, P14; Bernstein DP, 1998, CHILDHOOD TRAUMA QUE; Burton NW, 2010, AUST NZ J PUBL HEAL, V34, P620, DOI 10.1111/j.1753-6405.2010.00618.x; Callaway LK, 2006, MED J AUSTRALIA, V184, P56, DOI 10.5694/j.1326-5377.2006.tb00115.x; Catalano PM, 2006, BJOG-INT J OBSTET GY, V113, P1126, DOI 10.1111/j.1471-0528.2006.00989.x; Ching HL, 2007, CLIN ENDOCRINOL, V66, P373, DOI 10.1111/j.1365-2265.2007.02742.x; Cohen RA, 2006, INT J PSYCHIAT MED, V36, P35, DOI 10.2190/5R62-9PQY-0NEL-TLPA; Coverdale JH, 1996, AUST NZ J OBSTET GYN, V36, P424, DOI 10.1111/j.1479-828X.1996.tb02185.x; D'Argenio A, 2009, PHYSIOL BEHAV, V98, P543, DOI 10.1016/j.physbeh.2009.08.010; DELLAFEMINA D, 1990, CHILD ABUSE NEGLECT, V14, P227; Ehrenberg HM, 2002, AM J OBSTET GYNECOL, V187, P1189, DOI 10.1067/mob.2002.127125; Elfhag K, 2005, OBES REV, V6, P67, DOI 10.1111/j.1467-789X.2005.00170.x; FELITTI VJ, 1991, SOUTHERN MED J, V84, P328, DOI 10.1097/00007611-199103000-00008; Fraser JA, 2000, CHILD ABUSE NEGLECT, V24, P1399, DOI 10.1016/S0145-2134(00)00193-9; Gao Fei, 2004, Health Qual Life Outcomes, V2, P63, DOI 10.1186/1477-7525-2-63; Gartland D, 2010, AUST NZ J OBSTET GYN, V50, P413, DOI 10.1111/j.1479-828X.2010.01204.x; Goldberg DP, 1997, PSYCHOL MED, V27, P191, DOI 10.1017/S0033291796004242; Goodwin A, 2000, AUST NZ J OBSTET GYN, V40, P442, DOI 10.1111/j.1479-828X.2000.tb01178.x; Gunstad J, 2006, PSYCHIAT RES, V142, P31, DOI 10.1016/j.psychres.2005.11.007; Gustafson T B, 2004, Obes Rev, V5, P129, DOI 10.1111/j.1467-789X.2004.00145.x; Hinkle SN, 2011, MATERNAL CHILD HLTH; Howard KS, 2009, FUTURE CHILD, V19, P119, DOI 10.1353/foc.0.0032; Johnson DB, 2006, J AM DIET ASSOC, V106, P97, DOI 10.1016/j.jada.2005.09.048; Johnson JG, 2002, AM J PSYCHIAT, V159, P394, DOI 10.1176/appi.ajp.159.3.394; Kessler RC, 2010, BRIT J PSYCHIAT, V197, P378, DOI 10.1192/bjp.bp.110.080499; LISSAU I, 1994, LANCET, V343, P324, DOI 10.1016/S0140-6736(94)91163-0; Lois K, 2011, OCCUPATIONAL MED; Maughan B, 1997, J PERS DISORD, V11, P19, DOI 10.1521/pedi.1997.11.1.19; McEwen BS, 2000, NEUROPSYCHOPHARMACOL, V22, P108, DOI 10.1016/S0893-133X(99)00129-3; Melhuish E, 2010, ARCH DIS CHILD, V95, P159, DOI 10.1136/adc.2009.161018; Nemeroff CB Charles B, 2004, Psychopharmacol Bull, V38, P14; Price-Robertson R, FAMILY MATT IN PRESS; Rooney K, 2011, INT J OBESITY, V35, P883, DOI 10.1038/ijo.2011.96; Rosenman S, 2004, SOC PSYCH PSYCH EPID, V39, P695, DOI 10.1007/s00127-004-0802-0; Scher CD, 2001, J TRAUMA STRESS, V14, P843, DOI 10.1023/A:1013058625719; Scott J, 2010, ARCH GEN PSYCHIAT, V67, P111, DOI 10.1001/archgenpsychiatry.2009.188; Skagerstrom J, 2011, J WOMENS HEALTH, V20, P901, DOI 10.1089/jwh.2010.2216; Taylor AW, 2000, AUST NZ J PUBL HEAL, V24, P29, DOI 10.1111/j.1467-842X.2000.tb00719.x; Teixeira PJ, 2005, OBES REV, V6, P43, DOI 10.1111/j.1467-789X.2005.00166.x; Thomas R, 2007, J ABNORM CHILD PSYCH, V35, P475, DOI 10.1007/s10802-007-9104-9; Tsoi E, 2010, POSTGRAD MED J, V86, P617, DOI 10.1136/pgmj.2010.098186; Van Eerden P, 2011, S DAKOTA MED J S DAK; Wane S, 2010, J WOMENS HEALTH, V19, P1327, DOI 10.1089/jwh.2009.1738; WHITWELL D, 1990, BRIT J HOSP MED, V43, P346; Wiederman MW, 1999, WOMEN HEALTH, V29, P89, DOI 10.1300/J013v29n01_07; ZUCKERMAN B, 1989, AM J OBSTET GYNECOL, V160, P1107, DOI 10.1016/0002-9378(89)90170-1	53	22	22	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e51868	10.1371/journal.pone.0051868	http://dx.doi.org/10.1371/journal.pone.0051868			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	075GO	23300572	Green Published, gold, Green Submitted			2022-12-27	WOS:000313872600010
J	Yang, XW; Yang, J; Li, L; Man, XB; Zhang, BH; Shen, F; Wu, MC				Yang, Xin-wei; Yang, Jue; Li, Liang; Man, Xiao-bo; Zhang, Bao-hua; Shen, Feng; Wu, Meng-chao			Analysis of the Relationships between Clinicopathologic Factors and Survival in Gallbladder Cancer following Surgical Resection with Curative Intent	PLOS ONE			English	Article							GALL-BLADDER CANCER; RADICAL RESECTION; BILE-DUCT; CARCINOMA; JAUNDICE; MORTALITY; HEPATECTOMY; PREDICTOR; OUTCOMES; T2	Background: This study elucidated the relationships between various clinicopathologic factors and the outcome of patients with gallbladder cancer (GBC) treated by surgical resection with curative intent. Methods: Between January 2003 and January 2011, 76 patients with GBC underwent surgical resection with curative intent at our department. We then conducted a retrospective analysis of clinicopathologic data. Fourteen clinicopathological variables were selected for univariate and multivariate analysis to evaluate their influence on the outcome. Results: The actuarial 1-, 3-, and 5-year survival rates in the 76 resected cases were 56.6%, 32.7%, and 23.8%, respectively. The univariate analysis revealed that curative resection (P<0.001), lymph node metastasis (P<0.001), AJCC stage (P = 0.030), tumor location (P = 0.008), histologic differentiation (P = 0.028), intraoperative blood loss (P = 0.011), and preoperative jaundice (P = 0.012) were significant risk factors for survival. Multivariate analysis revealed that noncurative resection and tumor location on gallbladder neck were significant risk factors for poor outcome. Among jaundiced patients, we discovered that gallbladder carcinoma with tumor thrombus in common bile duct (CBD) was very rare but with relatively special clinical manifestation and characteristic radiography manifestation. The prognosis of gallbladder carcinoma with tumor thrombus in CBD after surgical procedure was apparently better than gallbladder carcinoma with invasion of hilar tissues. Conclusions: Curative surgical resection remains the only effective approach to the treatment of GBC. This series confirm that jaundice is a poor prognostic factor. However, the presence of jaundice does not preclude resection, especially in highly selected patients (when R0 resection is achievable). Gallbladder carcinoma with tumor thrombus in CBD has special clinical characteristics, which need to be awared by radiologists and clinicians.	[Yang, Xin-wei; Yang, Jue; Li, Liang; Man, Xiao-bo; Zhang, Bao-hua; Shen, Feng; Wu, Meng-chao] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Shanghai, Peoples R China	Naval Medical University	Zhang, BH (corresponding author), Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Shanghai, Peoples R China.	weicelia@163.com; shenfengdfgd@yahoo.com.cn	Li, Liang/AAY-9298-2020; Shen, Feng/GSD-2508-2022	Li, Liang/0000-0002-9410-6513; 				Agarwal AK, 2007, ANN SURG ONCOL, V14, P2831, DOI 10.1245/s10434-007-9456-y; Balzan S, 2005, ANN SURG, V242, P824, DOI 10.1097/01.sla.0000189131.90876.9e; Choi SB, 2010, J GASTROINTEST SURG, V14, P668, DOI 10.1007/s11605-009-1132-z; D'Angelica M, 2009, ANN SURG ONCOL, V16, P806, DOI 10.1245/s10434-008-0189-3; Dixon E, 2005, ANN SURG, V241, P385, DOI 10.1097/01.sla.0000154118.07704.ef; Dutta U, 2012, J GASTROEN HEPATOL, V27, P642, DOI 10.1111/j.1440-1746.2011.07048.x; Goetze TO, 2008, ANN SURG, V247, P104, DOI 10.1097/SLA.0b013e318154bf5d; Hawkins WG, 2004, ANN SURG ONCOL, V11, P310, DOI 10.1245/ASO.2004.03.011; International Union Against Cancer, 2009, TNM CLASSIFICATION M; Jayaraman S, 2010, GASTROENTEROL CLIN N, V39, P331, DOI 10.1016/j.gtc.2010.02.006; Kim WS, 2010, J GASTROINTEST SURG, V14, P679, DOI 10.1007/s11605-009-1140-z; Kobayashi A, 2012, WORLD J SURG, V36, P645, DOI 10.1007/s00268-011-1413-z; Kokudo N, 2003, ARCH SURG-CHICAGO, V138, P741, DOI 10.1001/archsurg.138.7.741; Kondo S, 2003, WORLD J SURG, V27, P272, DOI 10.1007/s00268-002-6654-4; Kondo S, DIG SURG, V28, P148; Midorikawa Y, 2000, SURGERY, V127, P473, DOI 10.1067/msy.2000.102421; Miura F, 2010, SURGERY, V148, P271, DOI 10.1016/j.surg.2010.04.022; Nishio H, 2000, BRIT J SURG, V87, P1656, DOI 10.1046/j.1365-2168.2000.01590.x; Nishio H, 2011, ANN SURG, V253, P953, DOI 10.1097/SLA.0b013e318216f5f3; Pilgrim C, 2009, EJSO-EUR J SURG ONC, V35, P903, DOI 10.1016/j.ejso.2009.02.005; Pilgrim CHC, 2009, EJSO-EUR J SURG ONC, V35, P1131, DOI 10.1016/j.ejso.2009.02.006; Regimbeau JM, 2011, EJSO-EUR J SURG ONC, V37, P505, DOI 10.1016/j.ejso.2011.03.135; Sano T, 2006, ANN SURG, V244, P240, DOI 10.1097/01.sla.0000217605.66519.38; Shih SP, 2007, ANN SURG, V245, P893, DOI 10.1097/SLA.0b013e31806beec2; Shimada K, 2011, BRIT J SURG, V98, P117, DOI 10.1002/bjs.7262; Varma V, 2009, DIGEST SURG, V26, P306, DOI 10.1159/000231880; Wakai T, 2008, WORLD J SURG, V32, P1067, DOI 10.1007/s00268-007-9393-8; Wakai T, 2010, AM J SURG PATHOL, V34, P65, DOI 10.1097/PAS.0b013e3181c467d4; Yagi H, 2006, J HEPATO-BILIARY-PAN, V13, P530, DOI 10.1007/s00534-006-1104-6	29	23	27	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e51513	10.1371/journal.pone.0051513	http://dx.doi.org/10.1371/journal.pone.0051513			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300551	Green Published, gold, Green Submitted			2022-12-27	WOS:000313872600006
J	De Souza, VC; Rabilloud, M; Cochat, P; Selistre, L; Hadj-Aissa, A; Kassai, B; Ranchin, B; Berg, U; Herthelius, M; Dubourg, L				De Souza, Vandrea Carla; Rabilloud, Muriel; Cochat, Pierre; Selistre, Luciano; Hadj-Aissa, Aoumeur; Kassai, Behrouz; Ranchin, Bruno; Berg, Ulla; Herthelius, Maria; Dubourg, Laurence			Schwartz Formula: Is One k-Coefficient Adequate for All Children?	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; CHRONIC KIDNEY-DISEASE; WORKING GROUP; CREATININE; PROGRESSION	Background/Objective: Plasma-creatinine-based equations to estimate the glomerular filtration rate are recommended by several clinical guidelines. In 2009, Schwartz et al. adapted the traditional Schwartz equation to children and adolescents but did not find different k-coefficients between children and adolescents (k = 36.5 for all patients). We reevaluated the coefficient of the 2009-Schwartz formula according to sex and age in a pediatric population. Patients/Methods: We used linear mixed-effects models to reestimate the 2009-Schwartz k-coefficient in 360 consecutive French subjects aged 1 to 18 years referred to a single centre between July 2003 and July 2010 (965 measurements). We assessed the agreement between the estimated glomerular filtration rate obtained with the new formula (called Schwartz-Lyon) and the rate measured by inulin clearance. We then compared this agreement to the one between the measured glomerular filtration rate and 2009-Schwartz formula, first in the French then in a Swedish cohort. Results: In Schwartz-Lyon formula, k was estimated at 32.5 in boys <13 years and all girls and at 36.5 in boys aged >= 13 years. The performance of this formula was higher than that of 2009-Schwartz formula in children <13 years. This was first supported by a statistically significant reduction of the overestimation of the measured glomerular filtration rate in both cohorts, by better 10% and 30% accuracies, and by a better concordance correlation coefficient. Conclusions: The performance and simplicity of Schwartz formula are strong arguments for its routine use in children and adolescents. The specific coefficient for children aged <13 years further improves this performance.	[De Souza, Vandrea Carla; Cochat, Pierre; Ranchin, Bruno; Dubourg, Laurence] Hosp Civils Lyon, Ctr Reference Malad Renales Rares, Serv Nephrol & Rhumatol Pediat, Lyon, France; [De Souza, Vandrea Carla; Selistre, Luciano; Hadj-Aissa, Aoumeur; Dubourg, Laurence] Hosp Civils Lyon, Grp Hosp Edouard Herriot, Lyon, France; [Cochat, Pierre; Dubourg, Laurence] Univ Lyon 1, CNRS, FRE 3310, F-69365 Lyon, France; [De Souza, Vandrea Carla; Selistre, Luciano] Univ Caxias do Sul, Ctr Ciencias Saude, Caxias Do Sul, Brazil; [Rabilloud, Muriel] Hosp Civils Lyon, Serv Biostat, Lyon, France; [Rabilloud, Muriel] CNRS, UMR5558, Lab Biometrie & Biol Evolut, Equipe Biostat Sante, Villeurbanne, France; [Selistre, Luciano] Pontificia Univ Catolica Rio Grande do Sul, Dept Nefrol, Porto Alegre, RS, Brazil; [Cochat, Pierre; Kassai, Behrouz] INSERM, CIC 201, EPICIME, UMR 5558,Serv Pharmacol Clin, F-69008 Lyon, France; [Berg, Ulla; Herthelius, Maria] Karolinska Inst, Karolinska Univ Hosp Huddinge, Dept Clin Sci Intervent & Technol, Div Pediat, Stockholm, Sweden	CHU Lyon; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universidade de Caxias do Sul; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); VetAgro Sup; Pontificia Universidade Catolica Do Rio Grande Do Sul; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut National de la Sante et de la Recherche Medicale (Inserm); VetAgro Sup; Karolinska Institutet; Karolinska University Hospital	De Souza, VC (corresponding author), Hosp Civils Lyon, Ctr Reference Malad Renales Rares, Serv Nephrol & Rhumatol Pediat, Lyon, France.	vandreasouza@gmail.com	de Souza, Vandrea Carla/N-1778-2013; SELISTRE, LUCIANO/AAJ-6346-2020; Dubourg, Laurence/F-8299-2016; SELISTRE, LUCIANO/L-5077-2013	de Souza, Vandrea Carla/0000-0001-7306-5639; SELISTRE, LUCIANO/0000-0002-0152-0636; SELISTRE, LUCIANO/0000-0002-0152-0636; Kassai, Behrouz/0000-0002-1712-120X	Hospices Civils de Lyon	Hospices Civils de Lyon	The work was supported by Hospices Civils de Lyon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacchetta J, 2010, CLIN J AM SOC NEPHRO; Berg UB, 2011, AM J KIDNEY DIS, V57, P55, DOI 10.1053/j.ajkd.2010.07.013; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Buron F, 2011, TRANSPLANTATION; Centers for Disease Control and Prevention [CDC], 2011, CONSTR SURV QUEST; Chavers BM, 2011, CLIN J AM SOC NEPHRO, V6, P1956, DOI 10.2215/CJN.10311110; Crawford SB, 2007, COMPUT METH PROG BIO, V88, P62, DOI 10.1016/j.cmpb.2007.07.003; Delanaye P, 2010, ANN BIOL CLIN-PARIS, V68, P531, DOI 10.1684/abc.2010.0479; Delanghe JR, 2011, CLIN CHEM LAB MED, V49, P977, DOI 10.1515/CCLM.2011.167; Du Bois D, 1916, ARCH INTERN MED, V17, P863, DOI 10.1001/archinte.1916.00080130010002; Dubourg L, 2002, KIDNEY INT, V62, P1454, DOI 10.1111/j.1523-1755.2002.kid576.x; Dubourg L, 2006, PEDIATR NEPHROL, P1526; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Everitt BS, 2010, HANDBOOK OF STATISTICAL ANALYSES USING R, 2ND EDITION, P1; Fadrowski JJ, 2011, CLIN J AM SOC NEPHRO; King TS, 2007, STAT MED, V26, P3095, DOI 10.1002/sim.2778; Krouwer JS, 2008, STAT MED, V27, P778, DOI 10.1002/sim.3086; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; LEVEY AS, 1990, KIDNEY INT, V38, P167, DOI 10.1038/ki.1990.182; Myers GL, 2006, CLIN CHEM, V52, P5, DOI 10.1373/clinchem.2005.0525144; Peralta CA, 2011, JAMA-J AM MED ASSOC, V305, P1545, DOI 10.1001/jama.2011.468; Pinheiro J. C., 2000, MIXED EFFECTS MODELS, P57, DOI [DOI 10.1198/JASA.2001.S411, 10.1007/0- 387-22747-4]; Pottel H, 2010, PEDIATR NEPHROL, V25, P927, DOI 10.1007/s00467-009-1389-1; Schwartz GJ, 2009, J AM SOC NEPHROL, V20, P629, DOI 10.1681/ASN.2008030287; SCHWARTZ GJ, 1987, PEDIATR CLIN N AM, V34, P571; SCHWARTZ GJ, 1976, PEDIATRICS, V58, P259; Staples A, 2010, PEDIATR NEPHROL, V25, P2321, DOI 10.1007/s00467-010-1598-7; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; Wright JT, 2002, JAMA-J AM MED ASSOC, V288, P2421, DOI 10.1001/jama.288.19.2421	29	65	68	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53439	10.1371/journal.pone.0053439	http://dx.doi.org/10.1371/journal.pone.0053439			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285295	Green Submitted, Green Published, gold			2022-12-27	WOS:000313051500150
J	Varghese, S; Whipple, R; Martin, SS; Alexander, HR				Varghese, Sheelu; Whipple, Rebecca; Martin, Stuart S.; Alexander, H. Richard			Multipotent Cancer Stem Cells Derived from Human Malignant Peritoneal Mesothelioma Promote Tumorigenesis	PLOS ONE			English	Article							VASCULAR ENDOTHELIAL-CELLS; STEM/PROGENITOR CELLS; COLORECTAL-CANCER; INITIATING CELLS; NEURAL CREST; DIFFERENTIATION; MYC; GENERATION; STATE; RISE	During the progression of malignant peritoneal mesothelioma (MPeM), tumor nodules propagate diffusely within the abdomen and tumors are characterized by distinct phenotypic sub-types. Recent studies in solid organ cancers have shown that cancer stem cells (CSCs) play a pivotal role in the initiation and progression of tumors. However, it is not known whether tumorigenic stem cells exist and whether they promote tumor growth in MPeM. In this study, we developed and characterized a CSC model for MPeM using stably expandable tumorigenic stem cells derived from patient tumors. We found morphologically distinct populations of CSCs that divide asymmetrically or symmetrically in MPeM in vitro cell culture. The MPeM stem cells (MPeMSCs) express stem cell markers c-MYC, NES and VEGFR2 and in the presence of matrix components cells form colony spheres. MPeMSCs are multipotent, differentiate into neuronal, vascular and adipose progeny upon defined induction and the differentiating cells express lineage-specific markers such as TUBB3, an early neuronal marker; vWF, VEGFA, VEGFC and IL-8, endothelial markers; and PPAR gamma and FABP4, adipose markers. Xenotransplantation experiments using MPeMSCs demonstrated early tumor growth compared with parental cells. Limiting dilution experiments using MPeMSCs and endothelial lineage-induced cells derived from a single MPeMSC resulted in early tumor growth in the latter group indicating that endothelial differentiation of MPeMSCs is important for MPeM tumor initiation. Our observation that the MPeM tumors contain stem cells with tumorigenic potential has important implications for understanding the cells of origin and tumor progression in MPeM and hence targeting CSCs may be a useful strategy to inhibit malignant progression.	[Varghese, Sheelu; Alexander, H. Richard] Univ Maryland, Sch Med, Dept Surg, Div Gen & Surg Oncol, Baltimore, MD 21201 USA; [Varghese, Sheelu; Whipple, Rebecca; Martin, Stuart S.] Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Varghese, S (corresponding author), Univ Maryland, Sch Med, Dept Surg, Div Gen & Surg Oncol, Baltimore, MD 21201 USA.	Svarghese@som.umaryland.edu			NATIONAL CANCER INSTITUTE [P30CA134274] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA134274] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Araki R, 2011, STEM CELLS, V29, P1362, DOI 10.1002/stem.685; Beck B, 2011, NATURE, V478, P399, DOI 10.1038/nature10525; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Billon N, 2007, DEVELOPMENT, V134, P2283, DOI 10.1242/dev.002642; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Chaffer CL, 2011, P NATL ACAD SCI USA, V108, P7950, DOI 10.1073/pnas.1102454108; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Gregorian C, 2009, J NEUROSCI, V29, P1874, DOI 10.1523/JNEUROSCI.3095-08.2009; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Hartl M, 2009, P NATL ACAD SCI USA, V106, P5604, DOI 10.1073/pnas.0812101106; Hill RP, 2007, JNCI-J NATL CANCER I, V99, P1435, DOI 10.1093/jnci/djm136; Kelly RJ, 2012, MOL CANCER THER, V11, P517, DOI 10.1158/1535-7163.MCT-11-0454; Leung ELH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014062; Liu H, 2005, CELL CYCLE, V4, P646, DOI 10.4161/cc.4.5.1674; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Medici D, 2010, NAT MED, V16, P1400, DOI 10.1038/nm.2252; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Pang R, 2010, CELL STEM CELL, V6, P603, DOI 10.1016/j.stem.2010.04.001; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Pine SR, 2010, P NATL ACAD SCI USA, V107, P2195, DOI 10.1073/pnas.0909390107; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; Salero E, 2012, CELL STEM CELL, V10, P88, DOI 10.1016/j.stem.2011.11.018; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Smith KN, 2010, CELL STEM CELL, V7, P343, DOI 10.1016/j.stem.2010.06.023; Soda Y, 2011, P NATL ACAD SCI USA, V108, P4274, DOI 10.1073/pnas.1016030108; Sousa-Nunes R, 2011, NATURE, V471, P508, DOI 10.1038/nature09867; Varghese S, 2011, CANCER-AM CANCER SOC, V117, P361, DOI 10.1002/cncr.25555; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624; Wurmser AE, 2004, NATURE, V430, P350, DOI 10.1038/nature02604; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568; Yamazaki H, 2012, BIOCHEM BIOPH RES CO, V419, P529, DOI 10.1016/j.bbrc.2012.02.054; Yeung TM, 2010, P NATL ACAD SCI USA, V107, P3722, DOI 10.1073/pnas.0915135107	36	22	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52825	10.1371/journal.pone.0052825	http://dx.doi.org/10.1371/journal.pone.0052825			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285196	gold, Green Submitted, Green Published			2022-12-27	WOS:000313051500067
J	Elhanati, Y; Brenner, N				Elhanati, Yuval; Brenner, Naama			Metabolic Variability in Micro-Populations	PLOS ONE			English	Article							STOCHASTIC GENE-EXPRESSION; CELL; GROWTH; DIVERSITY; SURVIVAL; CHANCE; NOISE; YIELD	Biological cells in a population are variable in practically every property. Much is known about how variability of single cells is reflected in the statistical properties of infinitely large populations; however, many biologically relevant situations entail finite times and intermediate-sized populations. The statistical properties of an ensemble of finite populations then come into focus, raising questions concerning inter-population variability and dependence on initial conditions. Recent technologies of microfluidic and microdroplet-based population growth realize these situations and make them immediately relevant for experiments and biotechnological application. We here study the statistical properties, arising from metabolic variability of single cells, in an ensemble of micro-populations grown to saturation in a finite environment such as a micro-droplet. We develop a discrete stochastic model for this growth process, describing the possible histories as a random walk in a phenotypic space with an absorbing boundary. Using a mapping to Polya's Urn, a classic problem of probability theory, we find that distributions approach a limiting inoculum-dependent form after a large number of divisions. Thus, population size and structure are random variables whose mean, variance and in general their distribution can reflect initial conditions after many generations of growth. Implications of our results to experiments and to biotechnology are discussed.	[Brenner, Naama] Technion Israel Inst Technol, Dept Chem Engn, IL-32000 Haifa, Israel; [Elhanati, Yuval] Technion Israel Inst Technol, Dept Phys, IL-32000 Haifa, Israel; [Elhanati, Yuval; Brenner, Naama] Technion Israel Inst Technol, Network Biol Res Lab, Haifa, Israel	Technion Israel Institute of Technology; Technion Israel Institute of Technology; Technion Israel Institute of Technology	Brenner, N (corresponding author), Technion Israel Inst Technol, Dept Chem Engn, IL-32000 Haifa, Israel.	nbrenner@technion.ac.il	Elhanati, Yuval/AAF-8601-2021	Elhanati, Yuval/0000-0002-4354-8864	Israeli Science Foundation	Israeli Science Foundation(Israel Science Foundation)	Funding provided by Israeli Science Foundation personal grant 2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avery SV, 2006, NAT REV MICROBIOL, V4, P577, DOI 10.1038/nrmicro1460; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Baraban L, 2011, LAB CHIP, V11, P4057, DOI 10.1039/c1lc20545e; Beardmore RE, 2011, NATURE, V472, P342, DOI 10.1038/nature09905; Booth IR, 2002, INT J FOOD MICROBIOL, V78, P19, DOI 10.1016/S0168-1605(02)00239-8; BOYCE MS, 1984, ANNU REV ECOL SYST, V15, P427, DOI 10.1146/annurev.es.15.110184.002235; Brenner N, 2006, PHYS BIOL, V3, P172, DOI 10.1088/1478-3975/3/3/002; Dewan A, 2012, BIOTECHNOL BIOENG, V109, P2987, DOI 10.1002/bit.24568; Dhar N, 2007, CURR OPIN MICROBIOL, V10, P30, DOI 10.1016/j.mib.2006.12.007; Elhanati Y, 2011, THEOR POPUL BIOL, V80, P49, DOI 10.1016/j.tpb.2011.03.005; Feller W., 1971, WILEY SERIES PROBABI; Filiba E, 2012, THEOR POPUL BIOL, V82, P187, DOI 10.1016/j.tpb.2012.06.004; Fraser D, 2009, MOL MICROBIOL, V71, P1333, DOI 10.1111/j.1365-2958.2009.06605.x; Friedlander T, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.018104; Huh D, 2011, P NATL ACAD SCI USA, V108, P15004, DOI 10.1073/pnas.1013171108; Janson S, 2006, PROBAB THEORY REL, V134, P417, DOI 10.1007/s00440-005-0442-7; Johnson N., 1977, URN MODELS THEIR APP; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Lachmann M, 1996, J THEOR BIOL, V181, P1, DOI 10.1006/jtbi.1996.0109; Lennon JT, 2011, NAT REV MICROBIOL, V9, P119, DOI 10.1038/nrmicro2504; Lu T, 2007, P NATL ACAD SCI USA, V104, P18982, DOI 10.1073/pnas.0706115104; MAC ARTHUR ROBERT H., 1967; MacLean R, 2008, HEREDITY, V100, P471, DOI 10.1038/sj.hdy.6801073x; Maharjan RP, 2007, J BACTERIOL, V189, P2350, DOI 10.1128/JB.01414-06; Mahmoud H, 2008, TEXTS STAT SCI, V76; Marcoux PR, 2011, COLLOID SURFACE A, V377, P54, DOI 10.1016/j.colsurfa.2010.12.013; Novak M, 2006, AM NAT, V168, P242, DOI 10.1086/506527; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Pfeiffer T, 2001, SCIENCE, V292, P504, DOI 10.1126/science.1058079; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Salman H, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.238105; Schauble S, 2011, METHOD ENZYMOL, V500, P437, DOI 10.1016/B978-0-12-385118-5.00022-0; Shahrezaei V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.31; Stelling J, 2002, NATURE, V420, P190, DOI 10.1038/nature01166; Stolovicki E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020530; Thattai M, 2004, GENETICS, V167, P523, DOI 10.1534/genetics.167.1.523; Theberge AB, 2010, ANGEW CHEM INT EDIT, V49, P5846, DOI 10.1002/anie.200906653; Trinh CT, 2009, APPL MICROBIOL BIOT, V81, P813, DOI 10.1007/s00253-008-1770-1; Tsuru S, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/3/036015; Um E, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3500980; Veening JW, 2008, ANNU REV MICROBIOL, V62, P193, DOI 10.1146/annurev.micro.62.081307.163002	42	2	2	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52105	10.1371/journal.pone.0052105	http://dx.doi.org/10.1371/journal.pone.0052105			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300596	Green Submitted, Green Published, gold			2022-12-27	WOS:000312829100020
J	Yu, MA; Kiang, A; Wang-Rodriguez, J; Rahimy, E; Haas, M; Yu, V; Ellies, LG; Chen, J; Fan, JB; Brumund, KT; Weisman, RA; Ongkeko, WM				Yu, Michael Andrew; Kiang, Alan; Wang-Rodriguez, Jessica; Rahimy, Elham; Haas, Martin; Yu, Vicky; Ellies, Lesley G.; Chen, Jing; Fan, Jian-Bing; Brumund, Kevin T.; Weisman, Robert A.; Ongkeko, Weg M.			Nicotine Promotes Acquisition of Stem Cell and Epithelial-to-Mesenchymal Properties in Head and Neck Squamous Cell Carcinoma	PLOS ONE			English	Article							E-CADHERIN; CANCER METASTASIS; DNA METHYLATION; TUMOR PROMOTION; IN-VIVO; TRANSITION; EXPRESSION; IDENTIFICATION; PROLIFERATION; TUMORIGENESIS	The ability of nicotine to enhance the malignancy of cancer cells is known; however, the possibility that nicotine could regulate a cancer stem cell phenotype remains to be well-established. In this study we sought to determine whether long-term exposure to nicotine could promote cancer stem cell-like properties in two head and neck squamous cell carcinoma cell lines, UMSCC-10B and HN-1. Nicotine treatment induced epithelial-to-mesenchymal transition (EMT) in both cell lines by repressing E-cadherin expression, and led to the induction of stem cell markers Oct-4, Nanog, CD44 and BMI-1, which was reversed upon ectopic re-expression of E-cadherin. Nicotine-treated cells formed spheres at a higher efficiency than non-treated cells, formed larger tumors when injected into mice, and formed tumors with 4-fold greater efficiency compared to control cells when injected at limiting doses. Consistent with previous literature, nicotine-treated cells demonstrated a greater capacity for survival and also a higher tendency to invade. Comparison of microRNA profiles between nicotine and control cells revealed the upregulation of miR-9, a repressor of E-cadherin, and the downregulation of miR-101, a repressor of EZH2. Taken together, these results suggest that nicotine may play a critical role in the development of tobacco-induced cancers by regulating cancer stem cell characteristics, and that these effects are likely mediated through EMT-promoting, microRNA-mediated pathways. Further characterization of such pathways remains a promising avenue for the understanding and treatment of tobacco-related cancers.	[Yu, Michael Andrew; Kiang, Alan; Rahimy, Elham; Yu, Vicky; Brumund, Kevin T.; Weisman, Robert A.; Ongkeko, Weg M.] Univ Calif San Diego, Dept Surg, Div Otolaryngol Head & Neck Surg, La Jolla, CA 92093 USA; [Wang-Rodriguez, Jessica; Ellies, Lesley G.] Univ Calif San Diego, Vet Adm Med Ctr, La Jolla, CA 92093 USA; [Wang-Rodriguez, Jessica; Ellies, Lesley G.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Haas, Martin] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Chen, Jing; Fan, Jian-Bing] Illumina Inc, San Diego, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Diego; University of California System; University of California San Diego; Illumina	Ongkeko, WM (corresponding author), Univ Calif San Diego, Dept Surg, Div Otolaryngol Head & Neck Surg, La Jolla, CA 92093 USA.	wongkeko@ucsd.edu		Rahimy, Elham/0000-0001-7356-3996	American Academy of Otolaryngology-Head and Neck Surgery Young Investigator Award; Department of Defense/CDMRP [ARMY/41482]	American Academy of Otolaryngology-Head and Neck Surgery Young Investigator Award; Department of Defense/CDMRP(United States Department of Defense)	This work was supported by the American Academy of Otolaryngology-Head and Neck Surgery Young Investigator Award (to WMO); ARMY/41482, Department of Defense/CDMRP (to WMO). The corresponding author had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benton G, 2009, FASEB J, V23, P3884, DOI 10.1096/fj.08-128702; Besancon R, 2009, CURR MED CHEM, V16, P394, DOI 10.2174/092986709787315531; Chen J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn387; Crowley-Weber CL, 2003, CHEM-BIOL INTERACT, V145, P53, DOI 10.1016/S0009-2797(02)00162-X; Dasgupta P, 2009, INT J CANCER, V124, P36, DOI 10.1002/ijc.23894; Delaloy C, 2010, CELL STEM CELL, V6, P323, DOI 10.1016/j.stem.2010.02.015; Dontu G, 2005, J MAMMARY GLAND BIOL, V10, P75, DOI 10.1007/s10911-005-2542-5; Dumont N, 2008, P NATL ACAD SCI USA, V105, P14867, DOI 10.1073/pnas.0807146105; Friedman JM, 2009, CANCER RES, V69, P2623, DOI 10.1158/0008-5472.CAN-08-3114; Gemenetzidis E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004849; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Hirata N, 2010, BIOCHEM BIOPH RES CO, V403, P138, DOI 10.1016/j.bbrc.2010.10.134; Hirsch HA, 2009, CANCER RES, V69, P7507, DOI 10.1158/0008-5472.CAN-09-2994; Hombach-Klonisch S, 2008, ARCH IMMUNOL THER EX, V56, P165, DOI 10.1007/s00005-008-0023-4; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Lau PP, 2006, ARTERIOSCL THROM VAS, V26, P143, DOI 10.1161/01.ATV.0000193510.19000.10; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Martin JW, 2009, EXP DERMATOL, V18, P497, DOI 10.1111/j.1600-0625.2009.00854.x; Nagel R, 2008, CANCER RES, V68, P5795, DOI 10.1158/0008-5472.CAN-08-0951; Nakao S, 2009, ARCH ORAL BIOL, V54, P251, DOI 10.1016/j.archoralbio.2008.11.006; Okamoto A, 2008, ORAL ONCOL; Pineau P, 2010, P NATL ACAD SCI USA, V107, P264, DOI 10.1073/pnas.0907904107; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Saika S, 2004, LAB INVEST, V84, P1245, DOI 10.1038/labinvest.3700156; Santisteban M, 2009, CANCER RES, V69, P2887, DOI 10.1158/0008-5472.CAN-08-3343; SCHWACHOFER JHM, 1990, ANTICANCER RES, V10, P805; Shen TJ, 2010, AM J RHINOL ALLERGY, V24, pE73, DOI 10.2500/ajra.2010.24.3456; Shieh YS, 2005, CANCER-AM CANCER SOC, V104, P1013, DOI 10.1002/cncr.21278; Sturgis EM, 2007, CANCER-AM CANCER SOC, V110, P1429, DOI 10.1002/cncr.22963; Takahashi H, 2010, CANCER CELL, V17, P89, DOI 10.1016/j.ccr.2009.12.008; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Trosko JE, 2006, ANN NY ACAD SCI, V1089, P36, DOI 10.1196/annals.1386.018; Tryndyak VP, 2010, INT J CANCER, V126, P2575, DOI 10.1002/ijc.24972; von Burstin J, 2009, GASTROENTEROLOGY, V137, P361, DOI 10.1053/j.gastro.2009.04.004; Vrba L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008697; WRIGHT SC, 1993, FASEB J, V7, P1045, DOI 10.1096/fasebj.7.11.8370474; Wu WG, 2002, CLIN EXP METASTAS, V19, P319, DOI 10.1023/A:1015515119300; Zhou XD, 2009, J INT MED RES, V37, P503, DOI 10.1177/147323000903700226; Zhu JH, 2009, CYTOTHERAPY, V11, P485, DOI 10.1080/14653240902887267	44	42	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e51967	10.1371/journal.pone.0051967	http://dx.doi.org/10.1371/journal.pone.0051967			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300583	Green Submitted, Green Published, gold			2022-12-27	WOS:000313618800041
J	Huarte, N; Araujo, A; Arranz, R; Lorizate, M; Quendler, H; Kunert, R; Valpuesta, JM; Nieva, JL				Huarte, Nerea; Araujo, Aitziber; Arranz, Rocio; Lorizate, Maier; Quendler, Heribert; Kunert, Renate; Valpuesta, Jose M.; Nieva, Jose L.			Recognition of Membrane-Bound Fusion-Peptide/MPER Complexes by the HIV-1 Neutralizing 2F5 Antibody: Implications for Anti-2F5 Immunogenicity	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PROXIMAL EXTERNAL REGION; LARGE UNILAMELLAR VESICLES; HUMAN MONOCLONAL-ANTIBODY; COMPLEMENTARITY-DETERMINING REGION; VACCINE DESIGN; ENVELOPE GLYCOPROTEIN; GP41 ECTODOMAIN; CONFORMATIONAL CONSTRAINTS; ANTI-HIV-1 ANTIBODIES	The membrane proximal external region (MPER) of the fusogenic HIV-1 glycoprotein-41 harbors the epitope sequence recognized by 2F5, a broadly neutralizing antibody isolated from an infected individual. Structural mimicry of the conserved MPER 2F5 epitope constitutes a pursued goal in the field of anti-HIV vaccine development. It has been proposed that 2F5 epitope folding into its native state is attained in the vicinity of the membrane interface and might involve interactions with other viral structures. Here we present results indicating that oligomeric complexes established between MPER and the conserved amino-terminal fusion peptide (FP) can partition into lipid vesicles and be specifically bound by the 2F5 antibody at their surfaces. Cryo-transmission electron microscopy of liposomes doped with MPER: FP peptide mixtures provided the structural grounds for complex recognition by antibody at lipid bilayer surfaces. Supporting the immunogenicity of the membrane-bound complex, these MPER: FP peptide-vesicle formulations could trigger cross-reactive anti-MPER antibodies in rabbits. Thus, our observations suggest that contacts with N-terminal regions of gp41 may stabilize the 2F5 epitope as a membrane-surface antigen.	[Huarte, Nerea; Araujo, Aitziber; Lorizate, Maier; Nieva, Jose L.] Univ Basque Country UPV EHU, Biophys Unit CSIC UPV EHU, Bilbao, Spain; [Huarte, Nerea; Araujo, Aitziber; Lorizate, Maier; Nieva, Jose L.] Univ Basque Country UPV EHU, Dept Biochem & Mol Biol, Bilbao, Spain; [Arranz, Rocio; Valpuesta, Jose M.] Natl Ctr Biotechnol CNB CSIC, Dept Macromol Struct, Madrid, Spain; [Quendler, Heribert; Kunert, Renate] Univ Nat Resources & Life Sci, Inst Appl Microbiol, Vienna, Austria	Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Basque Country; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); University of Natural Resources & Life Sciences, Vienna	Nieva, JL (corresponding author), Univ Basque Country UPV EHU, Biophys Unit CSIC UPV EHU, Bilbao, Spain.	gbpniesj@lg.ehu.es	Valpuesta, Jose M/AAA-6002-2019; Nieva, Jose L/Q-2063-2019; Kunert, Renate E/B-9185-2018; Valpuesta, José M/T-1977-2017; Lorizate, Maier/S-1151-2018	Nieva, Jose L/0000-0001-6446-5649; Kunert, Renate E/0000-0002-3397-3621; Valpuesta, José M/0000-0001-7468-8053; Lorizate, Maier/0000-0001-8173-2788; HUARTE ARRAYAGO, NEREA/0000-0002-6675-4150; Arranz, Rocio/0000-0001-5321-0915	Ministerio de Ciencia e Innovacion (Spanish MICINN) [BIO2011-29792]; Basque Government [GIU-06/42]; Ministerio de Ciencia e Innovacion (MICINN) [BFU2010-15703/BMC]; CAM (community of Madrid) [S2009MAT-1507]	Ministerio de Ciencia e Innovacion (Spanish MICINN); Basque Government(Basque Government); Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CAM (community of Madrid)	J.L.N. is supported by grants BIO2011-29792 and GIU-06/42 from The Ministerio de Ciencia e Innovacion (Spanish MICINN) and the Basque Government, respectively. J.M.V. is supported by The Ministerio de Ciencia e Innovacion (MICINN) grant BFU2010-15703/BMC and CAM (community of Madrid) grant S2009MAT-1507. A. A. received a pre-doctoral fellowship from the Basque Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agirre A, 2000, BBA-BIOMEMBRANES, V1467, P153, DOI 10.1016/S0005-2736(00)00214-5; Ahmed Z, 2006, BIOCHEMISTRY-US, V45, P9068, DOI 10.1021/bi060858m; Alam SM, 2009, P NATL ACAD SCI USA, V106, P20234, DOI 10.1073/pnas.0908713106; Alving CR, 2008, AIDS, V22, P649, DOI 10.1097/QAD.0b013e3282f51922; Barbato G, 2003, J MOL BIOL, V330, P1101, DOI 10.1016/S0022-2836(03)00611-9; Biron Z, 2005, BIOCHEMISTRY-US, V44, P13602, DOI 10.1021/bi0509245; Biron Z, 2002, BIOCHEMISTRY-US, V41, P12687, DOI 10.1021/bi026261y; Breden F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016857; Bryson S, 2009, J VIROL, V83, P11862, DOI 10.1128/JVI.01604-09; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; Burton DR, 2010, P NATL ACAD SCI USA, V107, P17859, DOI 10.1073/pnas.1012923107; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Coeffier E, 2000, VACCINE, V19, P684, DOI 10.1016/S0264-410X(00)00267-X; de la Arada I, 2009, J PHYS CHEM B, V113, P13626, DOI 10.1021/jp905965h; Dennison SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027824; Dennison SM, 2009, J VIROL, V83, P10211, DOI 10.1128/JVI.00571-09; Dimitrov AS, 2007, BIOCHEMISTRY-US, V46, P1398, DOI 10.1021/bi062245f; DREESMAN GR, 1982, NATURE, V295, P158, DOI 10.1038/295158a0; Gray ES, 2009, J VIROL, V83, P11265, DOI 10.1128/JVI.01359-09; Guenaga J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002806; Guenaga J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016074; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Hedestam GBK, 2008, NAT REV MICROBIOL, V6, P143, DOI 10.1038/nrmicro1819; Hessell AJ, 2010, J VIROL, V84, P1302, DOI 10.1128/JVI.01272-09; Ho J, 2005, VACCINE, V23, P1559, DOI 10.1016/j.vaccine.2004.09.037; HOPE MJ, 1985, BIOCHIM BIOPHYS ACTA, V812, P55, DOI 10.1016/0005-2736(85)90521-8; Huarte N, 2008, J VIROL, V82, P8986, DOI 10.1128/JVI.00846-08; Joyce JG, 2002, J BIOL CHEM, V277, P45811, DOI 10.1074/jbc.M205862200; Joyner AS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002234; Julien JP, 2010, J VIROL, V84, P4136, DOI 10.1128/JVI.02357-09; Julien JP, 2008, J MOL BIOL; Kim M, 2011, NAT STRUCT MOL BIOL, V18, P1235, DOI 10.1038/nsmb.2154; Kunert R, 2000, BIOTECHNOL BIOENG, V67, P97, DOI 10.1002/(SICI)1097-0290(20000105)67:1<97::AID-BIT11>3.0.CO;2-2; Li YL, 2007, BIOPHYS J, V93, P876, DOI 10.1529/biophysj.106.102335; Li YX, 2009, J VIROL, V83, P1045, DOI 10.1128/JVI.01992-08; Lingwood D, 2012, NATURE, V489, P566, DOI 10.1038/nature11371; Lorizate M, 2008, BBA-BIOMEMBRANES, V1778, P1624, DOI 10.1016/j.bbamem.2007.12.018; Lorizate M, 2006, BIOCHEMISTRY-US, V45, P14337, DOI 10.1021/bi0612521; Lorizate M, 2006, J MOL BIOL, V360, P45, DOI 10.1016/j.jmb.2006.04.056; Lorizate M, 2006, J BIOL CHEM, V281, P39598, DOI 10.1074/jbc.M605998200; Maeso R, 2011, AIDS RES HUM RETROV, V27, P863, DOI [10.1089/AID.2010.0265, 10.1089/aid.2010.0265]; Mao YD, 2012, NAT STRUCT MOL BIOL, V19, P893, DOI 10.1038/nsmb.2351; Matyas GR, 2009, AIDS, V23, P2069, DOI 10.1097/QAD.0b013e32832faea5; Matyas GR, 2009, BBA-BIOMEMBRANES, V1788, P660, DOI 10.1016/j.bbamem.2008.11.015; McGaughey GB, 2003, BIOCHEMISTRY-US, V42, P3214, DOI 10.1021/bi026952u; Montero M, 2008, MICROBIOL MOL BIOL R, V72, P54, DOI 10.1128/MMBR.00020-07; Montero M, 2012, J VIROL, V86, P2930, DOI 10.1128/JVI.06349-11; MUI BLS, 1995, BIOPHYS J, V69, P930, DOI 10.1016/S0006-3495(95)79967-2; MUSTER T, 1994, J VIROL, V68, P4031, DOI 10.1128/JVI.68.6.4031-4034.1994; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; Ofek G, 2010, P NATL ACAD SCI USA, V107, P17880, DOI 10.1073/pnas.1004728107; Ofek G, 2010, J VIROL, V84, P2955, DOI 10.1128/JVI.02257-09; Pai E, 2000, FAB EPITOPE COMPLEX; Parker CE, 2001, J VIROL, V75, P10906, DOI 10.1128/JVI.75.22.10906-10911.2001; Pereira FB, 1997, BIOPHYS J, V73, P1977, DOI 10.1016/S0006-3495(97)78228-6; PURTSCHER M, 1994, AIDS RES HUM RETROV, V10, P1651, DOI 10.1089/aid.1994.10.1651; Salzwedel K, 1999, J VIROL, V73, P2469, DOI 10.1128/JVI.73.3.2469-2480.1999; Sather DN, 2010, VACCINE, V28, pB8, DOI 10.1016/j.vaccine.2009.07.085; Scherer EM, 2007, AIDS, V21, P2131, DOI 10.1097/QAD.0b013e3282a4a632; Scherer EM, 2010, P NATL ACAD SCI USA, V107, P1529, DOI 10.1073/pnas.0909680107; Shen XY, 2009, J VIROL, V83, P3617, DOI 10.1128/JVI.02631-08; Singh H, 2011, AIDS, V25, P1247, DOI 10.1097/QAD.0b013e32834785cf; Song LK, 2009, P NATL ACAD SCI USA, V106, P9057, DOI 10.1073/pnas.0901474106; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Stiegler G, 2003, J ANTIMICROB CHEMOTH, V51, P757, DOI 10.1093/jac/dkg172; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; Suarez T, 2000, J VIROL, V74, P8038, DOI 10.1128/JVI.74.17.8038-8047.2000; Sun ZYJ, 2008, IMMUNITY, V28, P52, DOI 10.1016/j.immuni.2007.11.018; Tian Y, 2002, J PEPT RES, V59, P264, DOI 10.1034/j.1399-3011.2002.02988.x; Toukam DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038068; Vcelar B, 2007, AIDS, V21, P2161, DOI 10.1097/QAD.0b013e328285da15; Vishwanathan SA, 2008, J VIROL, V82, P5118, DOI 10.1128/JVI.00305-08; Xiao XD, 2009, VIRUSES-BASEL, V1, P802, DOI 10.3390/v1030802; Xu HY, 2010, J VIROL, V84, P1076, DOI 10.1128/JVI.02113-09; Ye L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014813; Zhou MK, 2012, VACCINE, V30, P1911, DOI 10.1016/j.vaccine.2012.01.026; Zhu ZY, 2011, J VIROL, V85, P11401, DOI 10.1128/JVI.05312-11; Zwick MB, 2005, J VIROL, V79, P1252, DOI 10.1128/JVI.79.2.1252-1261.2005; Zwick MB, 2004, J VIROL, V78, P3155, DOI 10.1128/JVI.78.6.3155-3161.2004; Zwick MB, 2005, AIDS, V19, P1725, DOI 10.1097/01.aids.0000189850.83322.41	81	8	10	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52740	10.1371/journal.pone.0052740	http://dx.doi.org/10.1371/journal.pone.0052740			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285173	gold, Green Submitted, Green Published			2022-12-27	WOS:000313158800093
J	Huson, MG; Church, JS; Poole, JM; Weisman, S; Sriskantha, A; Warden, AC; Campbell, PM; Ramshaw, JAM; Sutherland, TD				Huson, Mickey G.; Church, Jeffrey S.; Poole, Jacinta M.; Weisman, Sarah; Sriskantha, Alagacone; Warden, Andrew C.; Campbell, Peter M.; Ramshaw, John A. M.; Sutherland, Tara D.			Controlling the Molecular Structure and Physical Properties of Artificial Honeybee Silk by Heating or by Immersion in Solvents	PLOS ONE			English	Article							CROSS-LINKING; PROTEINS; FIBROIN; CONFORMATION; COLLAGEN; FIBERS; QUANTIFICATION; IDENTIFICATION; SPECTROSCOPY; SAMPLES	Honeybee larvae produce silken cocoons that provide mechanical stability to the hive. The silk proteins are small and non-repetitive and therefore can be produced at large scale by fermentation in E. coli. The recombinant proteins can be fabricated into a range of forms; however the resultant material is soluble in water and requires a post production stabilizing treatment. In this study, we describe the structural and mechanical properties of sponges fabricated from artificial honeybee silk proteins that have been stabilized in aqueous methanol baths or by dry heating. Aqueous methanol treatment induces formation of beta-sheets, with the amount of beta-sheet dictated by methanol concentration. Formation of beta-sheets renders sponges insoluble in water and generates a reversibly compressible material. Dry heat treatments at 190 degrees C produce a water insoluble material, that is stiffer than the methanol treated equivalent but without significant secondary structural changes. Honeybee silk proteins are particularly high in Lys, Ser, Thr, Glu and Asp. The properties of the heat treated material are attributed to generation of lysinoalanine, amide (isopeptide) and/or ester covalent cross-links. The unique ability to stabilize material by controlling secondary structure rearrangement and covalent cross-linking allows us to design recombinant silk materials with a wide range of properties.	[Huson, Mickey G.; Church, Jeffrey S.] CSIRO, Mat Sci & Engn, Geelong, Vic, Australia; [Poole, Jacinta M.; Ramshaw, John A. M.] CSIRO, Mat Sci & Engn, Melbourne, Vic, Australia; [Weisman, Sarah; Sriskantha, Alagacone; Warden, Andrew C.; Campbell, Peter M.; Sutherland, Tara D.] CSIRO, Ecosyst Sci, Canberra, ACT, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Huson, MG (corresponding author), CSIRO, Mat Sci & Engn, Geelong, Vic, Australia.	Mickey.Huson@csiro.au	Campbell, Peter M/B-7232-2008; Sriskantha, Alagacone/M-5989-2017; Warden, Andrew C/C-1484-2008; Sutherland, Tara/B-5635-2009; Weisman, Sarah/B-5091-2009	Warden, Andrew C/0000-0003-2683-9798; Sutherland, Tara/0000-0001-5211-4593; Ramshaw, John A.M./0000-0002-2131-3685	CSIRO (The Commonwealth Scientific and Industrial Research Organisation); AFOSR (Air Force Office of Scientific Research) [FA9550-09-1-0332]; Australian Government's National Collaborative Research Infrastructure Strategy (NCRIS)	CSIRO (The Commonwealth Scientific and Industrial Research Organisation); AFOSR (Air Force Office of Scientific Research)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Australian Government's National Collaborative Research Infrastructure Strategy (NCRIS)(Australian GovernmentDepartment of Industry, Innovation and Science)	This material is based upon work supported by CSIRO (The Commonwealth Scientific and Industrial Research Organisation) and the AFOSR (Air Force Office of Scientific Research) (Award No. FA9550-09-1-0332). This study was facilitated by access to the Australian Proteome Analysis Facility supported under the Australian Government's National Collaborative Research Infrastructure Strategy (NCRIS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman JF, 1990, US Patent, Patent No. 4980403; Church JS, 1998, J MOL STRUCT, V440, P15, DOI 10.1016/S0022-2860(97)00227-5; CHURCH JS, 1994, APPL SPECTROSC, V48, P813, DOI 10.1366/0003702944029938; Dollish F. R., 1974, CHARACTERISTIC RAMAN; Dzwolak W, 2005, BIOCHEMISTRY-US, V44, P8948, DOI 10.1021/bi050281t; Friedman M, 1999, Adv Exp Med Biol, V459, P145; Frushour B.G., 1975, ADV INFRARED RAMAN S, V1, P35; GORHAM SD, 1992, INT J BIOL MACROMOL, V14, P129, DOI 10.1016/S0141-8130(05)80002-9; Huson MG, 2006, POLYM TEST, V25, P2, DOI 10.1016/j.polymertesting.2005.09.014; Hwang S, 2011, J PHYS CHEM B, V115, P6653, DOI 10.1021/jp111448a; Kameda T, 2010, BIOMACROMOLECULES, V11, P1009, DOI 10.1021/bm901472a; Kendrick BS, 1996, J PHARM SCI, V85, P155, DOI 10.1021/js950332f; Kweon H, 2001, J APPL POLYM SCI, V81, P2271, DOI 10.1002/app.1667; Lefevre T, 2012, BIOPOLYMERS, V97, P322, DOI 10.1002/bip.21712; MAGOSHI J, 1977, J POLYM SCI POL PHYS, V15, P1675, DOI 10.1002/pol.1977.180150915; MAGOSHI J, 1974, KOBUNSHI RONBUNSHU, V31, P765; MILLER EJ, 1982, METHOD ENZYMOL, V82, P33; Mohammed ZH, 2000, J FOOD SCI, V65, P221, DOI 10.1111/j.1365-2621.2000.tb15983.x; Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e; RAMSHAW JAM, 1984, ANAL BIOCHEM, V141, P361, DOI 10.1016/0003-2697(84)90056-3; Rudall K.M., 1962, COMP BIOCHEM PHYSIOL, V4, P397; Rusconi F, 2001, ANAL BIOCHEM, V295, P31, DOI 10.1006/abio.2001.5164; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Schafer C, 2005, J AGR FOOD CHEM, V53, P2830, DOI 10.1021/jf048190a; Shi JH, 2008, BIOMATERIALS, V29, P2820, DOI 10.1016/j.biomaterials.2008.03.020; SUSI H, 1988, APPL SPECTROSC, V42, P819, DOI 10.1366/0003702884428905; Sutherland TD, 2006, GENOME RES, V16, P1414, DOI 10.1101/gr.5052606; Sutherland TD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016489; TSUKADA M, 1994, J POLYM SCI POL PHYS, V32, P961, DOI 10.1002/polb.1994.090320519; WEADOCK KS, 1995, J BIOMED MATER RES, V29, P1373, DOI 10.1002/jbm.820291108; WEDER JKP, 1981, Z LEBENSM UNTERS FOR, V172, P9, DOI 10.1007/BF01255454; Weisman S, 2010, BIOMATERIALS, V31, P2695, DOI 10.1016/j.biomaterials.2009.12.021; Wittmer CR, 2011, ACTA BIOMATER, V7, P3789, DOI 10.1016/j.actbio.2011.06.001; YANNAS AV, 1967, NATURE, V215, P509, DOI 10.1038/215509b0	34	25	26	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52308	10.1371/journal.pone.0052308	http://dx.doi.org/10.1371/journal.pone.0052308			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23300639	Green Published, gold, Green Submitted			2022-12-27	WOS:000313158800044
J	Lee, TTY; Tsai, CF; Hsieh, TH; Chen, JJJ; Wang, YC; Kao, MC; Wu, RM; Singh, S; Tsai, EM; Lee, JN				Lee, Tony Tung-Yin; Tsai, Cheng-Fang; Hsieh, Tsung-Hsun; Chen, Jia-Jin Jason; Wang, Yu-Chih; Kao, Mi-Chun; Wu, Ruey-Meei; Singh, Sher; Tsai, Eing-Mei; Lee, Jau-Nan			Ectopic Pregnancy-Derived Human Trophoblastic Stem Cells Regenerate Dopaminergic Nigrostriatal Pathway to Treat Parkinsonian Rats	PLOS ONE			English	Article							LEUKEMIA INHIBITORY FACTOR; INTERNAL RIBOSOME ENTRY; RETINOIC ACID; SELF-RENEWAL; DIFFERENTIATION; EXPRESSION; NEURONS; DISEASE; TRANSPLANTATION; TROPHECTODERM	Background: Stem cell therapy is a potential strategy to treat patients with Parkinson's disease (PD); however, several practical limitations remain. As such, finding the appropriate stem cell remains the primary issue in regenerative medicine today. We isolated a pre-placental pluripotent stem cell from the chorionic villi of women with early tubal ectopic pregnancies. Our objectives in this study were (i) to identify the characteristics of hTS cells as a potential cell source for therapy; and (ii) to test if hTS cells can be used as a potential therapeutic strategy for PD. Methods and Findings: hTS cells expressed gene markers of both the trophectoderm (TE) and the inner cell mass (ICM). hTS cells exhibited genetic and biological characteristics similar to that of hES cells, yet genetically distinct from placenta-derived mesenchymal stem cells. All-trans retinoic acid (RA) efficiently induced hTS cells into trophoblast neural stem cells (tNSCs) in 1-day. Overexpression of transcription factor Nanog was possibly achieved through a RA-induced non-genomic c-Src/Stat3/Nanog signaling pathway mediated by the subcellular c-Src mRNA localization for the maintenance of pluripotency in tNSCs. tNSC transplantation into the lesioned striatum of acute and chronic PD rats not only improved behavioral deficits but also regenerated dopaminergic neurons in the nigrostriatal pathway, evidenced by immunofluorescent and immunohistological analyses at 18-weeks. Furthermore, tNSCs showed immunological advantages for the application in regenerative medicine. Conclusions: We successfully isolated and characterized the unique ectopic pregnancy-derived hTS cells. hTS cells are pluripotent stem cells that can be efficiently induced to tNSCs with positive results in PD rat models. Our data suggest that the hTS cell is a dynamic stem cell platform that is potentially suitable for use in disease models, drug discovery, and cell therapy such as PD.	[Lee, Tony Tung-Yin; Wang, Yu-Chih; Kao, Mi-Chun; Tsai, Eing-Mei; Lee, Jau-Nan] Kaohsiung Med Univ Hosp, Dept Obstet & Gynecol, Kaohsiung, Taiwan; [Lee, Tony Tung-Yin; Wang, Yu-Chih; Kao, Mi-Chun; Tsai, Eing-Mei; Lee, Jau-Nan] Kaohsiung Med Univ Hosp, Ctr Excellence Environm Med, Kaohsiung, Taiwan; [Tsai, Cheng-Fang; Tsai, Eing-Mei] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan; [Hsieh, Tsung-Hsun; Chen, Jia-Jin Jason] Natl Cheng Kung Univ, Inst Biomed Engn, Tainan 70101, Taiwan; [Wu, Ruey-Meei] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan; [Singh, Sher] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; National Cheng Kung University; National Taiwan University; National Taiwan University Hospital; National Taiwan Normal University	Tsai, EM (corresponding author), Kaohsiung Med Univ Hosp, Dept Obstet & Gynecol, Kaohsiung, Taiwan.	tsaieing@yahoo.com; jaunanlee@hotmail.com	Hsieh, Tung-Hsun/AAZ-5010-2020; Wang, Yu-Chih/S-4805-2019	Hsieh, Tung-Hsun/0000-0002-1794-7941; Wang, Yu-Chih/0000-0003-0144-1388; Wu, Ruey-Meei/0000-0002-4947-5467	 [KMUH99-9I04];  [NSC 99-2628-B-037-009-MY3]	; 	This work was partly supported by grants of KMUH99-9I04 and NSC 99-2628-B-037-009-MY3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allam H, 2010, J BIOL CHEM, V285, P5713, DOI 10.1074/jbc.M109.029462; Anneren C, 2004, J BIOL CHEM, V279, P31590, DOI 10.1074/jbc.M403547200; Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Ben-Hur T, 2004, STEM CELLS, V22, P1246, DOI 10.1634/stemcells.2004-0094; Cai JL, 2009, STEM CELLS, V27, P220, DOI 10.1634/stemcells.2008-0734; CARTWRIGHT CA, 1988, P NATL ACAD SCI USA, V85, P3348, DOI 10.1073/pnas.85.10.3348; Casper KB, 2006, MOL CELL NEUROSCI, V31, P676, DOI 10.1016/j.mcn.2005.12.006; Cavaleri F, 2003, CELL, V113, P551, DOI 10.1016/S0092-8674(03)00394-5; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen HF, 2004, HUM REPROD, V19, P1647, DOI 10.1093/humrep/deh193; Chen L, 2008, STEM CELLS, V26, P1858, DOI 10.1634/stemcells.2008-0050; Dunnett SB, 2001, NAT REV NEUROSCI, V2, P365, DOI 10.1038/35072572; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Gilbert WV, 2010, J BIOL CHEM, V285, P29033, DOI 10.1074/jbc.R110.150532; Hansis C, 2000, MOL HUM REPROD, V6, P999, DOI 10.1093/molehr/6.11.999; He SY, 2008, STEM CELLS, V26, P842, DOI 10.1634/stemcells.2007-0356; Hellen CUT, 2009, BBA-GENE REGUL MECH, V1789, P558, DOI 10.1016/j.bbagrm.2009.06.001; Hentze H, 2009, STEM CELL RES, V2, P198, DOI 10.1016/j.scr.2009.02.002; Hori J, 2007, OCUL IMMUNOL INFLAMM, V15, P261, DOI 10.1080/09273940701382242; Hsieh TH, 2011, BEHAV BRAIN RES, V222, P1, DOI 10.1016/j.bbr.2011.03.031; Kane MA, 2005, BIOCHEM J, V388, P363, DOI 10.1042/BJ20041867; Kirchhof N, 2000, BIOL REPROD, V63, P1698, DOI 10.1095/biolreprod63.6.1698; Li L, 2004, STEM CELLS, V22, P448, DOI 10.1634/stemcells.22-4-448; Li RH, 1996, HUM REPROD, V11, P1328; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; Marabelle A, 2011, PEDIATR BLOOD CANCER, V56, P134, DOI 10.1002/pbc.22840; Martin-Ibanez R, 2007, J NEUROSCI RES, V85, P2686, DOI 10.1002/jnr.21228; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Ochs K, 2002, J VIROL, V76, P2113, DOI 10.1128/JVI.76.5.2113-2122.2002; Olanow CW, 2003, ANN NEUROL, V54, P403, DOI 10.1002/ana.10720; Panicker MM, 2001, COLD SPRING HARBOR M, P399; Park CH, 2005, J NEUROCHEM, V92, P1265, DOI 10.1111/j.1471-4159.2004.03006.x; Parolini O, 2008, STEM CELLS, V26, P300, DOI 10.1634/stemcells.2007-0594; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Taguchi A, 2004, J CLIN INVEST, V114, P330, DOI 10.1172/jci200420622; Wang KH, 2010, BIOL CELL, V102, P159, DOI 10.1042/BC20090132; Wang LL, 2009, J ALZHEIMERS DIS, V17, P295, DOI 10.3233/JAD-2009-1048; Wanggren K, 2007, MOL HUM REPROD, V13, P391, DOI 10.1093/molehr/gam013; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Yamanaka Y, 2006, DEV DYNAM, V235, P2301, DOI 10.1002/dvdy.20844; Yan JL, 2001, DEV BIOL, V235, P422, DOI 10.1006/dbio.2001.0300; Ying M, 2011, ONCOGENE, V30, P3454, DOI 10.1038/onc.2011.58	45	5	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52491	10.1371/journal.pone.0052491	http://dx.doi.org/10.1371/journal.pone.0052491			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285066	Green Published, gold, Green Submitted			2022-12-27	WOS:000313158800073
J	Cianciolo, GJ; Pizzo, SV				Cianciolo, George J.; Pizzo, Salvatore V.			Anti-Inflammatory and Vasoprotective Activity of a Retroviral-Derived Peptide, Homologous to Human Endogenous Retroviruses: Endothelial Cell Effects	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; PLACENTAL SYNCYTIN EXPRESSION; MESSENGER-RNA EXPRESSION; VASCULAR SMOOTH-MUSCLE; NF-KAPPA-B; ENVELOPE PROTEIN; GENE-EXPRESSION; TNF-ALPHA; LYMPHOCYTE-PROLIFERATION; MACROPHAGE ACCUMULATION	Malignant and inflammatory tissues sometimes express endogenous retroviruses or their proteins. A highly-conserved sequence from retroviral transmembrane (TM) proteins, termed the "immunosuppressive domain (ID)", is associated with inhibition of immune and inflammatory functions. An octadecapeptide (MN10021) from the ID of retroviral TM protein p15E inhibits in vitro release of pro-inflammatory cytokines and increases synthesis of anti-inflammatory IL-10. We sought to determine if MN10021 has significant in vivo effects. MN10021, prepared by solid-phase synthesis, was dimerized through a naturally-occurring, carboxy-terminal cysteine. In vivo anti-inflammatory activity was determined using a murine model of sodium periodate (NalO(4))-induced peritonitis. In vivo vasoprotective effects were determined using: (1) a carrageenan-induced model of disseminated intravascular coagulation (DIC) in mice; (2) a reverse passive Arthus model in guinea pigs; and (3) vasoregulatory effects in spontaneously hypertensive rats (SHR). In vitro studies included: (1) binding/uptake of MN10021 using human monocytes, cultured fibroblasts, and vascular endothelial cells (VEC); (2) gene expression by RT-PCR of MN10021-treated VEC; and (3) apoptosis of MN10021-treated VEC exposed to staurosporine or TNF-alpha. One-tenth nmol MN10021 inhibits 50 percent of the inflammatory response in the mouse peritonitis model. Furthermore, 73 nmol MN10021 completely protects mice in a lethal model of carrageenan-induced DIC and inhibits vascular leak in both the mouse DIC model and a guinea pig reverse passive Arthus reaction. MN10021 binds to and is taken up in a specific manner by both human monocytes and VEC but not by cultured human fibroblasts. Surprisingly, orally-administered MN10021 lowers blood pressure in SHR rats by 10-15% within 1 h suggesting a direct or indirect effect on the vascular endothelium. MN10021 and derived octapeptides induce iNOS (inducible nitric oxide synthase) mRNA in VEC and nitrate in VEC cell culture supernatants and protect VEC from induced apoptosis or necrosis. However, pretreatment of VEC with nitro-L-arginine methyl ester (L-NAME), while inhibiting the release of nitrate, does not block the anti-apoptotic effect of MN10021 and derived octapeptides suggesting that their potent vasoprotective and anti-inflammatory activity is not nitric oxide dependent.	[Cianciolo, George J.; Pizzo, Salvatore V.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA	Duke University	Cianciolo, GJ (corresponding author), Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA.	cianc002@mc.duke.edu						Andersson AC, 2002, VIROLOGY, V297, P220, DOI 10.1006/viro.2002.1428; Andersson AC, 1998, INT J ONCOL, V12, P309; BouchierHayes D, 1997, BRIT J SURG, V84, P540; Brown KM, 2003, J AM COLL SURGEONS, V197, P261, DOI 10.1016/S1072-7515(03)00386-7; Buchwalow IB, 2002, FASEB J, V16, P500, DOI 10.1096/fj.01-0842com; Ceneviva GD, 1998, AM J PHYSIOL-LUNG C, V275, pL717, DOI 10.1152/ajplung.1998.275.4.L717; Cerinic MM, 2002, RHEUMATOLOGY, V41, P843; Cerwinka WH, 2002, AM J PHYSIOL-HEART C, V282, pH1111, DOI 10.1152/ajpheart.00391.2001; CIANCIOLO G, 1981, J CLIN INVEST, V68, P831, DOI 10.1172/JCI110338; CIANCIOLO GJ, 1985, SCIENCE, V230, P453, DOI 10.1126/science.2996136; CIANCIOLO GJ, 1984, J EXP MED, V159, P964, DOI 10.1084/jem.159.3.964; CIANCIOLO GJ, 1980, J NATL CANCER I, V65, P829, DOI 10.1093/jnci/65.4.829; CIANCIOLO GJ, 1980, J IMMUNOL, V124, P2900; CIANCIOLO GJ, 1984, NATURE, V311, P515, DOI 10.1038/311515a0; COHEN M, 1985, VIROLOGY, V147, P449, DOI 10.1016/0042-6822(85)90147-3; COHEN M, 1988, J CELL BIOCHEM, V36, P121, DOI 10.1002/jcb.240360203; Cooke JP, 1997, ANNU REV MED, V48, P489, DOI 10.1146/annurev.med.48.1.489; Dash PR, 2003, EXP CELL RES, V287, P314, DOI 10.1016/S0014-4827(03)00156-3; Dash PR, 2003, HUM REPROD, V18, P959, DOI 10.1093/humrep/deg211; Dimmeler S, 1999, ARTERIOSCL THROM VAS, V19, P656, DOI 10.1161/01.ATV.19.3.656; Dimmeler S, 1997, CIRC RES, V81, P970; Farghali H, 2003, INT IMMUNOPHARMACOL, V3, P1627, DOI 10.1016/S1567-5769(03)00185-1; Fiorucci S, 1999, ALIMENT PHARM THER, V13, P421; FOULDS S, 1993, BRIT J CANCER, V68, P610, DOI 10.1038/bjc.1993.395; Freedman JE, 1997, J CLIN INVEST, V100, P350, DOI 10.1172/JCI119540; GENARO AM, 1995, J CLIN INVEST, V95, P1884, DOI 10.1172/JCI117869; Gidday JM, 1998, STROKE, V29, P1423, DOI 10.1161/01.STR.29.7.1423; GOTTLIEB RA, 1989, J IMMUNOL, V142, P4321; HARAGUCHI S, 1995, P NATL ACAD SCI USA, V92, P3611, DOI 10.1073/pnas.92.8.3611; HARAGUCHI S, 1992, J LEUKOCYTE BIOL, V52, P469, DOI 10.1002/jlb.52.4.469; HARAGUCHI S, 1993, J IMMUNOL, V151, P2733; HARAGUCHI S, 1995, P NATL ACAD SCI USA, V92, P5568, DOI 10.1073/pnas.92.12.5568; HARRELL RA, 1986, J IMMUNOL, V136, P3517; HARRIS DT, 1987, J IMMUNOL, V138, P889; Hatano E, 2001, GASTROENTEROLOGY, V120, P1251, DOI 10.1053/gast.2001.23239; Hickey MJ, 2001, CLIN SCI, V100, P1, DOI 10.1042/CS20000135; Hoffmann J, 2001, CIRC RES, V89, P709, DOI 10.1161/hh2001.097796; Ialenti A, 2000, INFLAMM RES, V49, P411, DOI 10.1007/s000110050609; Ignarro LJ, 2001, P NATL ACAD SCI USA, V98, P4202, DOI 10.1073/pnas.071054698; Jourdan KB, 1999, AM J RESP CELL MOL, V21, P105, DOI 10.1165/ajrcmb.21.1.3502; Kajiume T, 2000, J HEMATOTH STEM CELL, V9, P215, DOI 10.1089/152581600319423; KANNAN P, 1991, J VIROL, V65, P6343, DOI 10.1128/JVI.65.11.6343-6348.1991; Katsumata K, 1999, CLIN IMMUNOL, V93, P75, DOI 10.1006/clim.1999.4762; Keith JC, 2002, AM J OBSTET GYNECOL, V187, P1122, DOI 10.1067/mob.2002.128512; Kermarrec N, 1998, AM J RESP CRIT CARE, V158, P833, DOI 10.1164/ajrccm.158.3.9709097; Khan BV, 1996, P NATL ACAD SCI USA, V93, P9114, DOI 10.1073/pnas.93.17.9114; Knerr I, 2002, AM J OBSTET GYNECOL, V186, P210, DOI 10.1067/mob.2002.119636; Kolb H, 1998, IMMUNOL TODAY, V19, P556, DOI 10.1016/S0167-5699(98)01366-8; Kupatt C, 1996, J MOL CELL CARDIOL, V28, P643, DOI 10.1006/jmcc.1996.0060; Kupatt C, 1997, J MOL CELL CARDIOL, V29, P2599, DOI 10.1006/jmcc.1997.0439; KUROSE I, 1994, CIRC RES, V74, P376, DOI 10.1161/01.RES.74.3.376; Larrson E, 1997, LEUKEMIA, V11, P142; Lee X, 2001, PLACENTA, V22, P808, DOI 10.1053/plac.2001.0722; Lefer AM, 1996, CARDIOVASC RES, V32, P743, DOI 10.1016/0008-6363(96)00073-9; Luangwedchakarn V, 2003, PEPTIDES, V24, P631, DOI 10.1016/S0196-9781(03)00137-2; MANNICK JB, 1994, CELL, V79, P1137, DOI 10.1016/0092-8674(94)90005-1; Mehrotra S, 2003, PEPTIDES, V24, P979, DOI 10.1016/S0196-9781(03)00189-X; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; MITANI M, 1987, P NATL ACAD SCI USA, V84, P237, DOI 10.1073/pnas.84.1.237; NELSON M, 1990, CANCER IMMUNOL IMMUN, V30, P331, DOI 10.1007/BF01786882; NELSON M, 1989, CANCER IMMUNOL IMMUN, V30, P113, DOI 10.1007/BF01665962; OCONNELL C, 1984, VIROLOGY, V138, P225, DOI 10.1016/0042-6822(84)90347-7; OGASAWARA M, 1990, J IMMUNOL, V145, P456; OGASAWARA M, 1988, J IMMUNOL, V141, P614; Oostendorp R, 1992, DELAYED TYPE HYPERSE, P89; OOSTENDORP RAJ, 1992, J IMMUNOL, V149, P1010; OOSTENDORP RAJ, 1992, EUR J IMMUNOL, V22, P1505, DOI 10.1002/eji.1830220624; Paul-Clark MJ, 2001, J IMMUNOL, V166, P1169, DOI 10.4049/jimmunol.166.2.1169; Perrotta C, 2004, CANCER RES, V64, P3767, DOI 10.1158/0008-5472.CAN-04-0668; POSS WB, 1995, J APPL PHYSIOL, V79, P886, DOI 10.1152/jappl.1995.79.3.886; Rossig L, 1999, J BIOL CHEM, V274, P6823, DOI 10.1074/jbc.274.11.6823; RUEGG CL, 1989, J VIROL, V63, P3250, DOI 10.1128/JVI.63.8.3250-3256.1989; Sibata Masahiko, 1997, Leukemia (Basingstoke), V11, P145; Sprague RS, 1998, J PHARMACOL EXP THER, V284, P443; STOGER H, 1993, CLIN EXP IMMUNOL, V93, P437, DOI 10.1111/j.1365-2249.1993.tb08197.x; Takahashi A, 2001, J IMMUNOL, V166, P6771, DOI 10.4049/jimmunol.166.11.6771; TAKEUCHI K, 1995, CLIN EXP IMMUNOL, V99, P338; TAN IB, 1990, EUR ARCH OTO-RHINO-L, V247, P387; TAS MPR, 1993, CLIN OTOLARYNGOL, V18, P324, DOI 10.1111/j.1365-2273.1993.tb00857.x; Taylor BS, 1998, BIOCHEMISTRY-MOSCOW+, V63, P766; Tzeng E, 1998, SURGERY, V124, P278, DOI 10.1067/msy.1998.90569; VENABLES PJW, 1995, VIROLOGY, V211, P589, DOI 10.1006/viro.1995.1442; Walford G, 2003, J THROMB HAEMOST, V1, P2112, DOI 10.1046/j.1538-7836.2003.00345.x; WANG JM, 1989, J IMMUNOL, V142, P2012; WEINBERG JB, 1981, J NATL CANCER I, V66, P529	85	5	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52693	10.1371/journal.pone.0052693	http://dx.doi.org/10.1371/journal.pone.0052693			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285152	Green Published, gold, Green Submitted			2022-12-27	WOS:000312794500232
J	Donnenberg, AD; Zimmerlin, L; Landreneau, RJ; Luketich, JD; Donnenberg, VS				Donnenberg, Albert D.; Zimmerlin, Ludovic; Landreneau, Rodney J.; Luketich, James D.; Donnenberg, Vera S.			KIT (CD117) Expression in a Subset of Non-Small Cell Lung Carcinoma (NSCLC) Patients	PLOS ONE			English	Article							CANCER STEM-CELLS; GASTROINTESTINAL STROMAL TUMORS; C-KIT; IMATINIB MESYLATE; PHASE-II; BREAST-CANCER; MUTATIONS; RECEPTOR; STI571; IDENTIFICATION	We have previously described the expression of CD44, CD90, CD117 and CD133 in NSCLC tumors, adjacent normal lung, and malignant pleural effusions (MPE). Here we describe the unique subset of tumors expressing CD117 (KIT), a potential therapeutic target. Tumor and adjacent tissue were collected from 58 patients. Six MPE were obtained before therapy. Tissue was paraffin embedded for immunofluorescent microscopy, disaggregated and stained for flow cytometry or cryopreserved for later culture. The effect of imatinib on CD117(high)/KIT+ tumors was determined on first passage cells; absolute cell counts and flow cytometry were readouts for drug sensitivity of cell subsets. Primary tumors divided into KITneg and KIT+ by immunofluorescence. By more sensitive flow cytometric analysis, CD117+ cytokeratin+ cells were detected in all tissues (1.1% of cytokeratin+ cells in normal lung, 1.29% in KIT "negative" tumors, 40.7% in KIT+ tumors, and 0.4% in MPE). In KIT+/CD117(high), but not KIT+/CD117(low) tumors, CD117 was overexpressed 3.1-fold compared to normal lung. Primary cultures of CD117(high) tumors were sensitive to imatinib (5 mu M) in short term culture. We conclude that NSCLC tumors divide into CD117(low) and CD117(high). Overexpression of CD117 in CD117(high) NSCLC supports exploring KIT as a therapeutic target in this subset of patients. Citation: Donnenberg AD, Zimmerlin L, Landreneau RJ, Luketich JD, Donnenberg VS (2012) KIT (CD117) Expression in a Subset of Non-Small Cell Lung Carcinoma (NSCLC) Patients. PLoS ONE 7(12): e52885. doi:10.1371/journal.pone.0052885	[Donnenberg, Albert D.; Donnenberg, Vera S.] Univ Pittsburgh, Inst Canc, Hillman Canc Ctr, Pittsburgh, PA 15260 USA; [Donnenberg, Albert D.] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA USA; [Zimmerlin, Ludovic; Landreneau, Rodney J.; Luketich, James D.; Donnenberg, Vera S.] Univ Pittsburgh, Sch Med, Dept Cardiothorac Surg, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Donnenberg, AD (corresponding author), Univ Pittsburgh, Inst Canc, Hillman Canc Ctr, Pittsburgh, PA 15260 USA.	donnenbergad@upmc.edu; donnenbergvs@upmc.edu	luketich, james/AAY-6230-2020		Department of Defense [BC032981, BC044784]; Hillman Foundation; Glimmer of Hope Foundation; Cancer Center [P30CA047904]; NATIONAL CANCER INSTITUTE [P30CA047904] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); Hillman Foundation; Glimmer of Hope Foundation; Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants BC032981 and BC044784 from the Department of Defense, the Hillman Foundation and the Glimmer of Hope Foundation. Flow cytometry was performed at the UPCI Cytometry Facility and was partially supported by Cancer Center Support Grant P30CA047904. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Albanell J, 1999, DRUGS TODAY, V35, P931; Bumming P, 2003, BRIT J CANCER, V89, P460, DOI 10.1038/sj.bjc.6600965; Campioni D, 2008, CYTOMETRY B; Corless CL, 2005, J CLIN ONCOL, V23, P5357, DOI 10.1200/JCO.2005.14.068; de Silva MV, 2003, PATHOL ONCOL RES, V9, P13, DOI 10.1007/BF03033708; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Donnenberg VS, 2007, ERNST SCHERING FOUND, V5, P245, DOI 10.1007/2789_2007_054; Donnenberg VS, 2007, J CONTROL RELEASE, V122, P385, DOI 10.1016/j.jconrel.2007.05.005; Donnenberg VS, 2010, CYTOM PART B-CLIN CY, V78B, P287, DOI 10.1002/cyto.b.20530; Donnenberg VS, 2009, METHODS MOL BIOL, V568, P261, DOI 10.1007/978-1-59745-280-9_17; Donnenberg VS, 2012, CYTOMETRY A; Dy GK, 2005, ANN ONCOL, V16, P1811, DOI 10.1093/annonc/mdi365; Edling CE, 2007, INT J BIOCHEM CELL B, V39, P1995, DOI 10.1016/j.biocel.2006.12.005; Edwards ST, 2005, J PATHOL, V206, P279, DOI 10.1002/path.1780; Fabarius A, 2005, LEUKEMIA, V19, P1573, DOI 10.1038/sj.leu.2403861; Fischer T, 2002, LEUKEMIA, V16, P1220, DOI 10.1038/sj.leu.2402565; Han WD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018691; Heinrich MC, 2003, J CLIN ONCOL, V21, P4342, DOI 10.1200/JCO.2003.04.190; Herpel E, 2011, ANTICANCER RES, V31, P4491; Hochhaus A, 2009, LEUKEMIA, V23, P1054, DOI 10.1038/leu.2009.38; Humphrey RW, 2011, J NATL CANC I; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Johnson BE, 2003, CLIN CANCER RES, V9, P5880; Johnson FM, 2005, CLIN CANCER RES, V11, P6924, DOI 10.1158/1078-0432.CCR-05-0757; Kajstura J, 2011, NEW ENGL J MED, V364, P1795, DOI 10.1056/NEJMoa1101324; Kornblith P, 2003, ANTICANCER RES, V23, P3405; Krug LM, 2005, CANCER, V103, P2128, DOI 10.1002/cncr.21000; Krystal GW, 2001, CANCER RES, V61, P3660; Krystal GW, 2000, CLIN CANCER RES, V6, P3319; Levina V, 2010, CANCER RES, V70, P338, DOI 10.1158/0008-5472.CAN-09-1102; Mauro MJ, 2001, ONCOLOGIST, V6, P233, DOI 10.1634/theoncologist.6-3-233; Micke P, 2004, TUMOR BIOL, V25, P235, DOI 10.1159/000081386; Miettinen M, 2005, APPL IMMUNOHISTO M M, V13, P205, DOI 10.1097/01.pai.0000173054.83414.22; Mountain CF, 1997, CHEST, V111, P1710, DOI 10.1378/chest.111.6.1710; O'Brien SG, 2003, NEW ENGL J MED, V348, P994, DOI 10.1056/NEJMoa022457; Pandiella A, 2003, BRIT J HAEMATOL, V123, P858, DOI 10.1046/j.1365-2141.2003.04706.x; Pelosi G, 2004, MODERN PATHOL, V17, P711, DOI 10.1038/modpathol.3800110; Ross J. A., 2000, Tissue Antigens, V55, P65; Saglio G, 2004, J BIOL REG HOMEOS AG, V18, P246; Tamborini E, 2004, CLIN CANCER RES, V10, P8214, DOI 10.1158/1078-0432.CCR-04-1013; Yang ZF, 2008, HEPATOLOGY, V47, P919, DOI 10.1002/hep.22082; Yang ZF, 2008, CANCER CELL, V13, P153, DOI 10.1016/j.ccr.2008.01.013; Zermati Y, 2003, ONCOGENE, V22, P660, DOI 10.1038/sj.onc.1206120; Zhang Peilin, 2003, Mol Cancer, V2, P1; Zhu H, 2006, STEM CELLS, V24, P928, DOI 10.1634/stemcells.2005-0186; Zimmerlin L, 2011, FLOW CYTOMETRY PROTO	47	15	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52885	10.1371/journal.pone.0052885	http://dx.doi.org/10.1371/journal.pone.0052885			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285214	Green Submitted, Green Published, gold			2022-12-27	WOS:000312794500254
J	Micale, V; Campo, S; D'Ascola, A; Guerrera, MC; Levanti, MB; Germana, A; Muglia, U				Micale, Valeria; Campo, Salvatore; D'Ascola, Angela; Guerrera, M. Cristina; Levanti, M. Beatrice; Germana, Antonino; Muglia, Ugo			Cholecystokinin in White Sea Bream: Molecular Cloning, Regional Expression, and Immunohistochemical Localization in the Gut after Feeding and Fasting	PLOS ONE			English	Article							YELLOWTAIL SERIOLA-QUINQUERADIATA; DIGESTIVE-TRACT; IMMUNOREACTIVE CELLS; ENDOCRINE-CELLS; RAINBOW-TROUT; NEUROENDOCRINE SYSTEM; JAPANESE FLOUNDER; MESSENGER-RNAS; PEPTIDE-Y; ATLANTIC	Background: The peptide hormone cholecystokinin (CCK), secreted by the midgut, plays a key role in digestive physiology of vertebrates including teleosts, by stimulating pancreatic secretion, gut motility, and gallbladder contraction, as well as by delaying gastric emptying. Moreover, CCK is involved in the regulation of food intake and satiation. Secretion of CCK by the hindgut is controversial, and its biological activity remains to be elucidated. The present paper addresses the regional distribution of intestinal CCK in the white sea bream, Diplodus sargus, as well as the possible involvement of hindgut CCK in digestive processes. Methodology/Principal Findings: Full-lengths mRNAs encoding two CCK isoforms (CCK-1 and CCK-2) were sequenced and phylogenetically analyzed. CCK gene and protein expression levels in the different gut segments were measured 3 h and 72 h after feeding, by quantitative real-time RT-PCR and Western blot, respectively. Moreover, endocrine CCK cells were immunoistochemically detected. Fasting induced a significant decrease in CCK-2 in all intestinal segments, including the hindgut. On the other hand, no significant difference was induced by fasting on hindgut CCK-1. Conclusions/Significance: The results demonstrated two CCK isoforms in the hindgut of D. sargus, one of which (CCK-2) may be involved in the feedback control of uncompleted digestive processes. On the other hand, a functional role alternative to regulation of digestive processes may be inferred for D. sargus CCK-1, since its expression was unaffected by feeding or fasting.	[Micale, Valeria] CNR, Ist Ambiente Marino Costiero, Messina, Italy; [Campo, Salvatore; D'Ascola, Angela] Univ Messina, Sch Med, Med Chem Sect, Dept Biochem Physiol & Nutr Sci, Messina, Italy; [Guerrera, M. Cristina; Levanti, M. Beatrice; Germana, Antonino; Muglia, Ugo] Univ Messina, Fac Vet Med, Dept Morphol Biochem Physiol & Anim Prod, Messina, Italy; [Muglia, Ugo] Consorzio Interuniv INBB Ist Nazl Biostrutture &, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); L'Istituto per l'Ambiente Marino Costiero (IAMC-CNR); University of Messina; University of Messina	Micale, V (corresponding author), CNR, Ist Ambiente Marino Costiero, Messina, Italy.	valeria.micale@iamc.cnr.it	Germana, Antonino/AAH-2505-2020	Germana, Antonino/0000-0003-0934-3619; d'ascola, angela/0000-0001-7530-1316; CAMPO, Salvatore/0000-0002-7955-8917				ABAD ME, 1987, GEN COMP ENDOCR, V66, P123, DOI 10.1016/0016-6480(87)90357-1; Abellan E, 1999, MARINE FINFISH SPECI; ALDMAN G, 1992, GEN COMP ENDOCR, V86, P20, DOI 10.1016/0016-6480(92)90121-Y; Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Bermudez R, 2007, FISH SHELLFISH IMMUN, V22, P252, DOI 10.1016/j.fsi.2006.05.006; Bosi G, 2004, GEN COMP ENDOCR, V138, P166, DOI 10.1016/j.ygcen.2004.06.003; Chandra Rashmi, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P63, DOI 10.1097/MED.0b013e3280122850; Chandra R, 2011, CURR OPIN GASTROEN, V27, P439, DOI 10.1097/MOG.0b013e328349e2e1; Chaudhri O, 2006, PHILOS T R SOC B, V361, P1187, DOI 10.1098/rstb.2006.1856; Einarsson S, 1997, COMP BIOCHEM PHYS C, V117, P63, DOI 10.1016/S0742-8413(96)00226-5; ELBAL MT, 1986, GEN COMP ENDOCR, V64, P339, DOI 10.1016/0016-6480(86)90067-5; Forgan LG, 2007, COMP BIOCHEM PHYS C, V146, P343, DOI 10.1016/j.cbpc.2007.04.007; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hartviksen MB, 2009, J FISH BIOL, V75, P834, DOI 10.1111/j.1095-8649.2009.02325.x; HERNANDEZ MPG, 1994, CELL TISSUE RES, V277, P373, DOI 10.1007/BF00327785; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Jensen H, 2001, BBA-GENE STRUCT EXPR, V1517, P190, DOI 10.1016/S0167-4781(00)00263-3; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kamisaka Y, 2003, GEN COMP ENDOCR, V134, P116, DOI 10.1016/S0016-6480(03)00242-9; Kamisaka Y, 2002, SARSIA, V87, P258, DOI 10.1080/00364820260294888; Kamisaka Y, 2001, GEN COMP ENDOCR, V123, P31, DOI 10.1006/gcen.2001.7653; Kurokawa T, 2000, GEN COMP ENDOCR, V120, P8, DOI 10.1006/gcen.2000.7512; Kurokawa T, 2003, PEPTIDES, V24, P227, DOI 10.1016/S0196-9781(03)00034-2; Lee JH, 2004, J FISH BIOL, V65, P170, DOI 10.1111/j.0022-1112.2004.00442.x; MARUYAMA K, 1994, GENE, V138, P171; Micale V, 2010, GEN COMP ENDOCR, V169, P23, DOI 10.1016/j.ygcen.2010.07.001; Moran TH, 2009, INT J OBESITY, V33, pS7, DOI 10.1038/ijo.2009.9; Murashita K, 2006, GEN COMP ENDOCR, V145, P287, DOI 10.1016/j.ygcen.2005.09.008; Murashita K, 2007, COMP BIOCHEM PHYS B, V146, P318, DOI 10.1016/j.cbpb.2006.11.009; Murashita K, 2009, GEN COMP ENDOCR, V160, P223, DOI 10.1016/j.ygcen.2008.11.024; Olsson C, 1999, J EXP BIOL, V202, P161; Quemener L, 2002, AQUAT LIVING RESOUR, V15, P293, DOI 10.1016/S0990-7440(02)01187-7; Raybould HE, 2007, CURR OPIN PHARMACOL, V7, P570, DOI 10.1016/j.coph.2007.09.006; Reinecke M, 1997, ANAT EMBRYOL, V195, P87; Ronnestad I, 2007, AQUACULTURE, V268, P82, DOI 10.1016/j.aquaculture.2007.04.031; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHAEFER BC, 1995, ANAL BIOCHEM, V227, P255, DOI 10.1006/abio.1995.1279; Suzuki T, 1999, FISH PHYSIOL BIOCHEM, V21, P73, DOI 10.1023/A:1007703422249; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Volkoff H, 2006, ZEBRAFISH, V3, P131, DOI 10.1089/zeb.2006.3.131; Wang BJ, 2007, AM J PHYSIOL-REG I, V292, pR666, DOI 10.1152/ajpregu.00131.2006; Webb KA, 2010, GEN COMP ENDOCR, V166, P152, DOI 10.1016/j.ygcen.2009.10.010	42	20	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52428	10.1371/journal.pone.0052428	http://dx.doi.org/10.1371/journal.pone.0052428			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285038	Green Submitted, gold, Green Published			2022-12-27	WOS:000312794500165
J	Ogiwara, H; Kohno, T				Ogiwara, Hideaki; Kohno, Takashi			CBP and p300 Histone Acetyltransferases Contribute to Homologous Recombination by Transcriptionally Activating the BRCA1 and RAD51 Genes	PLOS ONE			English	Article							STRAND BREAK REPAIR; DNA END RESECTION; CELL-CYCLE; ACETYLATION; CHROMATIN; PROLIFERATION; NUCLEOSOMES; CHECKPOINT; EXPRESSION; PROTEINS	Histone acetylation at DNA double-strand break (DSB) sites by CBP and p300 histone acetyltransferases (HATs) is critical for the recruitment of DSB repair proteins to chromatin. Here, we show that CBP and p300 HATs also function in DSB repair by transcriptionally activating the BRCA1 and RAD51 genes, which are involved in homologous recombination (HR), a major DSB repair system. siRNA-mediated depletion of CBP and p300 impaired HR activity and downregulated BRCA1 and RAD51 at the protein and mRNA levels. Chromatin immunoprecipitation assays showed that CBP and p300 bind to the promoter regions of the BRCA1 and RAD51 genes, and that depletion of CBP and/or p300 reduces H3 and H4 acetylation and inhibits binding of the transcription factor E2F1 to these promoters. Depletion of CBP and p300 impaired DNA damage-induced phosphorylation and chromatin binding of the single-strand DNA-binding protein RPA following BRCA1-mediated DNA end resection. Consistent with this, subsequent phosphorylation of CHK1 and activation of the G2/M damage checkpoint were also impaired. These results indicate that the HATs CBP and p300 play multiple roles in the activation of the cellular response to DSBs. Citation: Ogiwara H, Kohno T (2012) CBP and p300 Histone Acetyltransferases Contribute to Homologous Recombination by Transcriptionally Activating the BRCA1 and RAD51 Genes. PLoS ONE 7(12): e52810. doi:10.1371/journal.pone.0052810	[Ogiwara, Hideaki; Kohno, Takashi] Natl Canc Ctr, Res Inst, Div Genome Biol, Chuo Ku, Tokyo 104, Japan	National Cancer Center - Japan	Kohno, T (corresponding author), Natl Canc Ctr, Res Inst, Div Genome Biol, Chuo Ku, Tokyo 104, Japan.	tkkohno@ncc.go.jp		Ogiwara, Hideaki/0000-0003-0860-1807	Ministry of Education, Culture, Sports, Science, and Technology of Japan for Scientific Research on Innovative Areas [22131006]; Japan Society for the Promotion of Science for Young Scientists (B) KAKENHI [23701110]; National Cancer Center Research and Development Fund	Ministry of Education, Culture, Sports, Science, and Technology of Japan for Scientific Research on Innovative Areas; Japan Society for the Promotion of Science for Young Scientists (B) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); National Cancer Center Research and Development Fund(National Cancer Center - Japan)	This work was supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan for Scientific Research on Innovative Areas(22131006); from the Japan Society for the Promotion of Science for Young Scientists (B) KAKENHI (23701110); and from the National Cancer Center Research and Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Si-Ali S, 2000, ONCOGENE, V19, P2430, DOI 10.1038/sj.onc.1203562; Bedford DC, 2010, EPIGENETICS-US, V5, P9, DOI 10.4161/epi.5.1.10449; Bindra RS, 2007, ONCOGENE, V26, P2048, DOI 10.1038/sj.onc.1210001; Bird AW, 2002, NATURE, V419, P411, DOI 10.1038/nature01035; Chen LC, 2008, J BIOL CHEM, V283, P7713, DOI 10.1074/jbc.M710245200; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Flygare J, 1996, BBA-MOL CELL RES, V1312, P231, DOI 10.1016/0167-4889(96)00040-7; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Horwitz GA, 2008, SCIENCE, V321, P1084, DOI 10.1126/science.1155544; Karamouzis MV, 2007, CELL RES, V17, P324, DOI 10.1038/cr.2007.10; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Morishima K, 2007, BIOCHEM BIOPH RES CO, V362, P872, DOI 10.1016/j.bbrc.2007.08.086; Murr R, 2006, NAT CELL BIOL, V8, P91, DOI 10.1038/ncb1343; Nimonkar AV, 2011, GENE DEV, V25, P350, DOI 10.1101/gad.2003811; Ogiwara H, 2011, ONCOGENE, V30, P2135, DOI [10.1038/onc.2010.592, 10.1038/onc.2010.592;]; Osley MA, 2006, TRENDS GENET, V22, P671, DOI 10.1016/j.tig.2006.09.007; Park EJ, 2003, NUCLEIC ACIDS RES, V31, P6819, DOI 10.1093/nar/gkg921; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Rajan JV, 1996, P NATL ACAD SCI USA, V93, P13078, DOI 10.1073/pnas.93.23.13078; Rando OJ, 2009, ANNU REV BIOCHEM, V78, P245, DOI 10.1146/annurev.biochem.78.071107.134639; Roy R, 2012, NAT REV CANCER, V12, P68, DOI 10.1038/nrc3181; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Schiltz RL, 1999, J BIOL CHEM, V274, P1189, DOI 10.1074/jbc.274.3.1189; Schlegel BP, 2006, CANCER RES, V66, P5181, DOI 10.1158/0008-5472.CAN-05-3209; Sorensen CS, 2005, NAT CELL BIOL, V7, P195, DOI 10.1038/ncb1212; Stauffer D, 2007, J BIOL CHEM, V282, P9678, DOI 10.1074/jbc.M609261200; Tamburini BA, 2005, MOL CELL BIOL, V25, P4903, DOI 10.1128/MCB.25.12.4903-4913.2005; van den Heuvel S, 2008, NAT REV MOL CELL BIO, V9, P713, DOI 10.1038/nrm2469; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4	34	37	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52810	10.1371/journal.pone.0052810	http://dx.doi.org/10.1371/journal.pone.0052810			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285190	Green Published, Green Submitted, gold			2022-12-27	WOS:000312794500248
J	Rensen, SS; Bieghs, V; Xanthoulea, S; Arfianti, E; Bakker, JA; Shiri-Sverdlov, R; Hofker, MH; Greve, JW; Buurman, WA				Rensen, Sander S.; Bieghs, Veerle; Xanthoulea, Sofia; Arfianti, Evi; Bakker, Jaap A.; Shiri-Sverdlov, Ronit; Hofker, Marten H.; Greve, Jan Willem; Buurman, Wim A.			Neutrophil-Derived Myeloperoxidase Aggravates Non-Alcoholic Steatohepatitis in Low-Density Lipoprotein Receptor-Deficient Mice	PLOS ONE			English	Article							FATTY LIVER-DISEASE; INSULIN-RESISTANCE; HYPOCHLOROUS ACID; OXIDATIVE STRESS; ATHEROSCLEROTIC LESIONS; SCAVENGER RECEPTORS; ACTIVATION; INFLAMMATION; MATRIX; IMPACT	Background: Chronic inflammation and oxidative stress play fundamental roles in the pathogenesis of non-alcoholic steatohepatitis (NASH). Previously, we reported that myeloperoxidase (MPO), an aggressive oxidant-generating neutrophil enzyme, is associated with NASH severity in man. We now investigated the hypothesis that MPO contributes to the development and progression of NASH. Methodology: Low-density lipoprotein receptor-deficient mice with an MPO-deficient hematopoietic system (LDLR-/-/MPO-/-tp mice) were generated and compared with LDLR-/-/MPO+/+tp mice after induction of NASH by high-fat feeding. Results: High-fat feeding caused a similar to 4-fold induction of liver MPO in LDLR-/-/MPO+/+ mice which was associated with hepatic sequestration of MPO-positive neutrophils and high levels of nitrotyrosine, a marker of MPO activity. Importantly, LDLR-/-/MPO-/-tp mice displayed markedly reduced hepatic neutrophil and T-lymphocyte infiltration (p<0.05), and strong down regulation of pro-inflammatory genes such as TNF-alpha and IL-6 (p<0.05, p<0.01) in comparison with LDLR-/-/MPO+/+tp mice. Next to the generalized reduction of inflammation, liver cholesterol accumulation was significantly diminished in LDLR-/-/MPO-/-tp mice (p = 0.01). Moreover, MPO deficiency appeared to attenuate the development of hepatic fibrosis as evident from reduced hydroxyproline levels (p, 0.01). Interestingly, visceral adipose tissue inflammation was markedly reduced in LDLR-/-/MPO-/-tp mice, with a complete lack of macrophage crown-like structures. In conclusion, MPO deficiency attenuates the development of NASH and diminishes adipose tissue inflammation in response to a high fat diet, supporting an important role for neutrophils in the pathogenesis of metabolic disease.	[Rensen, Sander S.; Xanthoulea, Sofia; Arfianti, Evi; Greve, Jan Willem; Buurman, Wim A.] Maastricht Univ Med Ctr, NUTRIM Sch Nutr Toxicol & Metab, Dept Surg, Maastricht, Netherlands; [Bieghs, Veerle; Shiri-Sverdlov, Ronit] Maastricht Univ Med Ctr, NUTRIM Sch Nutr Toxicol & Metab, Dept Genet & Cell Biol, Maastricht, Netherlands; [Bakker, Jaap A.] Maastricht Univ Med Ctr, NUTRIM Sch Nutr Toxicol & Metab, Dept Clin Genet, Maastricht, Netherlands; [Hofker, Marten H.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Med Biol Sect, Groningen, Netherlands; [Greve, Jan Willem] Atrium Med Ctr Parkstad, Dept Surg, Heerlen, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); University of Groningen; Atrium Medical Center	Rensen, SS (corresponding author), Maastricht Univ Med Ctr, NUTRIM Sch Nutr Toxicol & Metab, Dept Surg, Maastricht, Netherlands.	s.rensen@maastrichtuniversity.nl	Bakker, J. A./H-7910-2019; Arfianti, Arfianti/GPT-4310-2022; Shiri-Sverdlov, Ronit/X-2642-2019; Rensen, Sander/J-3224-2019; Shiri-Sverdlov, Ronit/E-5571-2017	Arfianti, Arfianti/0000-0003-3331-5044; Shiri-Sverdlov, Ronit/0000-0002-6736-7814; Rensen, Sander/0000-0001-5054-8400; Shiri-Sverdlov, Ronit/0000-0002-6736-7814; Bakker, Jaap A./0000-0002-2918-7361; xanthoulea, sofia/0000-0003-4700-3404	Senter Novem Innovation Oriented Research Program on Genomics [IGE05012]; Transnational University Limburg grant; Dutch Digestive Foundation [WO 09-46]; VENI grant from the Netherlands Organization for Scientific Research [916.76.070]	Senter Novem Innovation Oriented Research Program on Genomics; Transnational University Limburg grant; Dutch Digestive Foundation; VENI grant from the Netherlands Organization for Scientific Research	Supported by the Senter Novem Innovation Oriented Research Program on Genomics, grant IGE05012 (MH/JWG/WB), a Transnational University Limburg grant and a Dutch Digestive Foundation project grant (WO 09-46) to SR, and VENI grant 916.76.070 from the Netherlands Organization for Scientific Research (RS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aratani Y, 1999, INFECT IMMUN, V67, P1828; Baffy G, 2009, J HEPATOL, V51, P212, DOI 10.1016/j.jhep.2009.03.008; Bieghs V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030668; Bieghs V, 2010, GASTROENTEROLOGY, V138, P2477, DOI 10.1053/j.gastro.2010.02.051; Boxio R, 2004, J LEUKOCYTE BIOL, V75, P604, DOI 10.1189/jlb.0703340; Brennan ML, 2001, J CLIN INVEST, V107, P419, DOI 10.1172/JCI8797; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Collins AR, 2009, CIRC RES, V104, pe42, DOI 10.1161/CIRCRESAHA.108.188771; Elgazar-Carmon V, 2008, J LIPID RES, V49, P1894, DOI 10.1194/jlr.M800132-JLR200; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fu XY, 2003, J BIOL CHEM, V278, P28403, DOI 10.1074/jbc.M304739200; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Gaut JP, 2002, J CLIN INVEST, V109, P1311, DOI 10.1172/JCI200215021; Gupte AA, 2010, HEPATOLOGY, V52, P2001, DOI 10.1002/hep.23941; HAMILTON TA, 1995, J CLIN INVEST, V95, P2020, DOI 10.1172/JCI117887; Hazell LJ, 1996, J CLIN INVEST, V97, P1535, DOI 10.1172/JCI118576; Hofnagel O, 2007, BBA-MOL CELL BIOL L, V1771, P1117, DOI 10.1016/j.bbalip.2007.06.003; Ikura Y, 2006, HEPATOLOGY, V43, P506, DOI 10.1002/hep.21070; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; Lau D, 2005, P NATL ACAD SCI USA, V102, P431, DOI 10.1073/pnas.0405193102; Leclercq IA, 2000, J CLIN INVEST, V105, P1067, DOI 10.1172/JCI8814; LEE KS, 1995, J CLIN INVEST, V96, P2461, DOI 10.1172/JCI118304; LEFKOWITZ DL, 1993, IMMUNOL LETT, V36, P43, DOI 10.1016/0165-2478(93)90067-C; Malle E, 2007, BRIT J PHARMACOL, V152, P838, DOI 10.1038/sj.bjp.0707358; Mari M, 2006, CELL METAB, V4, P185, DOI 10.1016/j.cmet.2006.07.006; Marra F, 2008, TRENDS MOL MED, V14, P72, DOI 10.1016/j.molmed.2007.12.003; Moore KJ, 2006, ARTERIOSCL THROM VAS, V26, P1702, DOI 10.1161/01.ATV.0000229218.97976.43; Podrez EA, 1999, J CLIN INVEST, V103, P1547, DOI 10.1172/JCI5549; Ra HJ, 2007, MATRIX BIOL, V26, P587, DOI 10.1016/j.matbio.2007.07.001; Rensen SS, 2009, HEPATOLOGY, V50, P1809, DOI 10.1002/hep.23228; Rensen SS, 2009, AM J PATHOL, V175, P1473, DOI 10.2353/ajpath.2009.080999; Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256; Schoonbroodt S, 1997, BIOCHEM J, V321, P777, DOI 10.1042/bj3210777; Seki S, 2002, J HEPATOL, V37, P56, DOI 10.1016/S0168-8278(02)00073-9; Shen ZZ, 2000, BIOCHEMISTRY-US, V39, P5474, DOI 10.1021/bi992809y; Tilg H, 2006, GASTROENTEROLOGY, V131, P934, DOI 10.1053/j.gastro.2006.05.054; Tsochatzis E, 2006, AM J GASTROENTEROL, V101, P2629, DOI 10.1111/j.1572-0241.2006.00848.x; van der Veen BS, 2009, ANTIOXID REDOX SIGN, V11, P2899, DOI [10.1089/ars.2009.2538, 10.1089/ARS.2009.2538]; van Leeuwen M, 2008, ARTERIOSCL THROM VAS, V28, P84, DOI 10.1161/ATVBAHA.107.154807; Videla LA, 2006, TRENDS MOL MED, V12, P555, DOI 10.1016/j.molmed.2006.10.001; Wang Y, 2007, J BIOL CHEM, V282, P31826, DOI 10.1074/jbc.M704894200; Waterval WAH, 2009, CLIN CHIM ACTA, V407, P36, DOI 10.1016/j.cca.2009.06.023; Woods AA, 2003, BIOCHEM J, V376, P219, DOI 10.1042/BJ20030715; Wouters K, 2008, HEPATOLOGY, V48, P474, DOI 10.1002/hep.22363; Zheng LM, 2004, J CLIN INVEST, V114, P529, DOI 10.1172/JCI200421109	46	81	82	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52411	10.1371/journal.pone.0052411	http://dx.doi.org/10.1371/journal.pone.0052411			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285030	gold, Green Published, Green Submitted			2022-12-27	WOS:000312794500160
J	Wang, H; Yang, YB; Shen, HM; Gu, J; Li, T; Li, XM				Wang, Huan; Yang, Yue-Bo; Shen, Hui-Min; Gu, Jian; Li, Tian; Li, Xiao-Mao			ABT-737 Induces Bim Expression via JNK Signaling Pathway and Its Effect on the Radiation Sensitivity of HeLa Cells	PLOS ONE			English	Article							TERMINAL KINASE JNK; C-JUN; CANCER-THERAPY; APOPTOSIS; ACTIVATION; BCL-2; INHIBITION; PHOSPHORYLATION; DEXAMETHASONE; INDUCTION	ABT-737 is a BH3 mimetic small molecule inhibitor that can effectively inhibit the activity of antiapoptotic Bcl-2 family proteins including Bcl2, Bcl-xL and Bcl-w, and further enhances the effect of apoptosis by activating the proapoptotic proteins (t-Bid, Bad, Bim). In this study, we demonstrate that ABT-737 improved the radiation sensitivity of cervical cancer HeLa cells and thereby provoked cell apoptosis. Our results show that ABT-737 inhibited HeLa cell proliferation and activated JNK and its downstream target c-Jun, which caused the up-regulation of Bim expression. Blockade of JNK/c-Jun signaling pathway resulted in significant down-regulation of ABT-737-induced Bim mRNA and protein expression level. Also, ABT-737 could evoke the Bim promoter activity, and enhance the radiation sensitivity of HeLa cells via JNK/c-Jun and Bim signaling pathway. Our data imply that combination of ABT-737 and conventional radiation therapy might represent a highly effective therapeutic approach for future treatment of cervical cancer. Citation: Wang H, Yang Y-B, Shen H-M, Gu J, Li T, et al. (2012) ABT-737 Induces Bim Expression via JNK Signaling Pathway and Its Effect on the Radiation Sensitivity of HeLa Cells. PLoS ONE 7(12): e52483. doi:10.1371/journal.pone.0052483	[Wang, Huan; Yang, Yue-Bo; Shen, Hui-Min; Gu, Jian; Li, Tian; Li, Xiao-Mao] Sun Yat Sen Univ, Dept Gynecol, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Li, XM (corresponding author), Sun Yat Sen Univ, Dept Gynecol, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China.	tigerlee777@163.com			Guangdong province science and technology department project [2010B031600033]	Guangdong province science and technology department project	The study was supported by a grant from Guangdong province science and technology department project (2010B031600033) (:http://pro.gdstc.gov.cn/stms/main.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Azmi AS, 2011, EXPERT OPIN EMERG DR, V16, P59, DOI 10.1517/14728214.2010.515210; Chen YR, 1996, J BIOL CHEM, V271, P31929, DOI 10.1074/jbc.271.50.31929; Dasmahapatra G, 2009, CANCER BIOL THER, V8, P808, DOI 10.4161/cbt.8.9.8131; Howard AN, 2009, CANCER CHEMOTH PHARM, V65, P41, DOI 10.1007/s00280-009-1001-1; Kang MH, 2007, BLOOD, V110, P2057, DOI 10.1182/blood-2007-03-080325; Kang MH, 2009, CLIN CANCER RES, V15, P1126, DOI 10.1158/1078-0432.CCR-08-0144; KERR JFR, 1994, CANCER-AM CANCER SOC, V73, P2013, DOI 10.1002/1097-0142(19940415)73:8<2013::AID-CNCR2820730802>3.0.CO;2-J; Keuling AM, 2010, PIGM CELL MELANOMA R, V23, P430, DOI 10.1111/j.1755-148X.2010.00698.x; Konopleva M, 2011, THEOR APPL GENET, V122, P1517; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Li DD, 2009, ONCOGENE, V28, P886, DOI 10.1038/onc.2008.441; Liu J, 2005, CELL RES, V15, P36, DOI 10.1038/sj.cr.7290262; Moore VD, 2007, J CLIN INVEST, V117, P112, DOI 10.1172/JCI28281; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Petros AM, 2006, J MED CHEM, V49, P656, DOI 10.1021/jm0507532; Pollack M, 2001, J GERONTOL A-BIOL, V56, pB475, DOI 10.1093/gerona/56.11.B475; SLUSS HK, 1994, MOL CELL BIOL, V14, P8376, DOI 10.1128/MCB.14.12.8376; Srivastava RK, 1999, MOL CELL BIOL, V19, P5659; Subramanian SL, 2012, DIABETOLOGIA, V55, P166, DOI 10.1007/s00125-011-2338-7; Tahir SK, 2007, CANCER RES, V67, P1176, DOI 10.1158/0008-5472.CAN-06-2203; Trudel S, 2007, CLIN CANCER RES, V13, P621, DOI 10.1158/1078-0432.CCR-06-1526; van der Sanden MHM, 2004, J BIOL CHEM, V279, P52007, DOI 10.1074/jbc.M405577200; Watson A, 1998, J NEUROSCI, V18, P751; Will B, 2010, BLOOD, V115, P2901, DOI 10.1182/blood-2009-03-209544; Yao HP, 2007, CELL RES, V17, P565, DOI 10.1038/cr.2007.6; Yoon S, 2006, NEUROSCI LETT, V394, P190, DOI 10.1016/j.neulet.2005.10.034	27	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52483	10.1371/journal.pone.0052483	http://dx.doi.org/10.1371/journal.pone.0052483			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285061	gold, Green Published, Green Submitted			2022-12-27	WOS:000312794500181
J	Windey, K; De Preter, V; Louat, T; Schuit, F; Herman, J; Vansant, G; Verbeke, K				Windey, Karen; De Preter, Vicky; Louat, Thierry; Schuit, Frans; Herman, Jean; Vansant, Greet; Verbeke, Kristin			Modulation of Protein Fermentation Does Not Affect Fecal Water Toxicity: A Randomized Cross-Over Study in Healthy Subjects	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; RED MEAT; COLORECTAL-CANCER; COLON-CANCER; DNA-DAMAGE; HYDROGEN-SULFIDE; RESISTANT STARCH; DIETARY-PROTEIN; DISTAL COLON; BILE-ACIDS	Objective: Protein fermentation results in production of metabolites such as ammonia, amines and indolic, phenolic and sulfur-containing compounds. In vitro studies suggest that these metabolites might be toxic. However, human and animal studies do not consistently support these findings. We modified protein fermentation in healthy subjects to assess the effects on colonic metabolism and parameters of gut health, and to identify metabolites associated with toxicity. Design: After a 2-week run-in period with normal protein intake (NP), 20 healthy subjects followed an isocaloric high protein (HP) and low protein (LP) diet for 2 weeks in a cross-over design. Protein fermentation was estimated from urinary p-cresol excretion. Fecal metabolite profiles were analyzed using GC-MS and compared using cluster analysis. DGGE was used to analyze microbiota composition. Fecal water genotoxicity and cytotoxicity were determined using the Comet assay and the WST-1-assay, respectively, and were related to the metabolite profiles. Results: Dietary protein intake was significantly higher during the HP diet compared to the NP and LP diet. Urinary p-cresol excretion correlated positively with protein intake. Fecal water cytotoxicity correlated negatively with protein fermentation, while fecal water genotoxicity was not correlated with protein fermentation. Heptanal, 3-methyl-2-butanone, dimethyl disulfide and 2-propenyl ester of acetic acid are associated with genotoxicity and indole, 1-octanol, heptanal, 2,4-dithiapentane, allyl-isothiocyanate, 1-methyl-4-(1-methylethenyl)-benzene, propionic acid, octanoic acid, nonanoic acid and decanoic acid with cytotoxicity. Conclusion: This study does not support a role of protein fermentation in gut toxicity. The identified metabolites can provide new insight into colonic health.	[Windey, Karen; De Preter, Vicky; Verbeke, Kristin] KU Leven, Univ Hosp Gasthuisberg, Translat Res Ctr Gastrointestinal Disorders, Louvain, Belgium; [Windey, Karen; De Preter, Vicky; Verbeke, Kristin] KU Leven, Univ Hosp Gasthuisberg, Leuven Food Sci & Nutr Res Ctr, Louvain, Belgium; [Vansant, Greet] KU Leven, Dept Nutr Publ Hlth Med, Leuven Food Sci & Nutr Res Ctr, Louvain, Belgium; [Schuit, Frans] KU Leven, Dept Mol Cell Biol, Gene Express Unit, Louvain, Belgium	KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven	Verbeke, K (corresponding author), KU Leven, Univ Hosp Gasthuisberg, Translat Res Ctr Gastrointestinal Disorders, Louvain, Belgium.	Kristin.Verbeke@med.kuleuven.be	De Preter, Vicky/P-6131-2019; LOUAT, Thierry/F-6789-2018	LOUAT, Thierry/0000-0002-3920-2916; Verbeke, Kristin/0000-0002-5352-7565; Vansant, Greet (Margareta)/0000-0002-5781-8482	Fund for Scientific Research-Flanders (FWO Vlaanderen) Belgium (FWO) [G.0674.10]	Fund for Scientific Research-Flanders (FWO Vlaanderen) Belgium (FWO)(FWO)	Sources of support are Fund for Scientific Research-Flanders (FWO Vlaanderen) Belgium (FWO project G.0674.10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DD, 2009, AM J CLIN NUTR, V89, P1402, DOI 10.3945/ajcn.2008.26838; Arafa MA, 2011, ASIAN PAC J CANCER P, V12, P1931; Attene-Ramos MS, 2007, MOL CANCER RES, V5, P455, DOI 10.1158/1541-7786.MCR-06-0439; Attene-Ramos MS, 2006, MOL CANCER RES, V4, P9, DOI 10.1158/1541-7786.MCR-05-0126; Auerbach SS, 2008, TOXICOLOGY, V253, P79, DOI 10.1016/j.tox.2008.08.014; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; Bastide NM, 2011, CANCER PREV RES, V4, P177, DOI 10.1158/1940-6207.CAPR-10-0113; Bedani R, 2010, J SCI FOOD AGR, V90, P233, DOI 10.1002/jsfa.3800; Benassi-Evans B, 2010, MUTAT RES-GEN TOX EN, V703, P130, DOI 10.1016/j.mrgentox.2010.08.009; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernstein C, 2011, ARCH TOXICOL, V85, P863, DOI 10.1007/s00204-011-0648-7; Blachier F, 2007, AMINO ACIDS, V33, P547, DOI 10.1007/s00726-006-0477-9; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bokhof B, 2010, PUBLIC HEALTH NUTR, V13, P826, DOI 10.1017/S136898000999317X; CORPET DE, 1995, NUTR CANCER, V23, P271, DOI 10.1080/01635589509514381; de Loor H, 2005, CLIN CHEM, V51, P1535, DOI 10.1373/clinchem.2005.050781; De Preter V, 2006, ALIMENT PHARM THER, V23, P963, DOI 10.1111/j.1365-2036.2006.02834.x; De Preter V, 2012, INFLAMM BOWEL DIS; De Preter V, 2011, MOL NUTR FOOD RES, V55, P714, DOI 10.1002/mnfr.201000442; De Preter V, 2009, J CHROMATOGR A, V1216, P1476, DOI 10.1016/j.chroma.2008.12.095; Evenepoel P, 1999, AM J PHYSIOL-GASTR L, V277, pG935, DOI 10.1152/ajpgi.1999.277.5.G935; FLORIN T, 1991, GUT, V32, P766, DOI 10.1136/gut.32.7.766; Geboes KP, 2005, AM J PHYSIOL-GASTR L, V288, pG994, DOI 10.1152/ajpgi.00408.2004; Gezondheidsraad H, 2005, MATEN GEWICHTEN HAND, P2; Glinghammar B, 1997, AM J CLIN NUTR, V66, P1277, DOI 10.1093/ajcn/66.5.1277; Hofmann E, 1930, BIOCHEM Z, V243, P416; Hou JK, 2011, AM J GASTROENTEROL, V106, P563, DOI 10.1038/ajg.2011.44; Hughes R, 2008, NUTR CANCER, V60, P259, DOI 10.1080/01635580701649644; Ichikawa H, 1998, J NUTR, V128, P843, DOI 10.1093/jn/128.5.843; Joossens M, 2011, GUT, V60, P631, DOI 10.1136/gut.2010.223263; KNUIMAN JT, 1986, HUM NUTR-CLIN NUTR, V40C, P229; KRAG E, 1975, SCAND J GASTROENTERO, V10, P105; Magee EA, 2000, AM J CLIN NUTR, V72, P1488; Matsumoto M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00233; Norat T, 2005, J NATL CANCER I, V97, P906, DOI 10.1093/jnci/dji164; Ou JH, 2012, NUTR CANCER, V64, P34, DOI 10.1080/01635581.2012.630164; Pedersen G, 2002, SCAND J GASTROENTERO, V37, P74, DOI 10.1080/003655202753387392; Volp ACP, 2011, NUTR HOSP, V26, P430, DOI [10.3305/nh.2011.26.3.5181, 10.1590/S0212-16112011000300002]; ROEDIGER WEW, 1993, CLIN SCI, V85, P623, DOI 10.1042/cs0850623; Sakurazawa T, 2005, J GASTROENTEROL, V40, P600, DOI 10.1007/s00535-005-1594-z; Schoorl N, 1903, RECL TRAV CH PAYS-BA, V22, P31; Shen Q, 2010, ANAEROBE; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Toden S, 2007, CARCINOGENESIS, V28, P2355, DOI 10.1093/carcin/bgm216; Toden S, 2007, CANCER BIOL THER, V6, P253, DOI 10.4161/cbt.6.2.3627; Toden S, 2006, CANCER BIOL THER, V5, P267, DOI 10.4161/cbt.5.3.2382; Vanhoutte T, 2004, FEMS MICROBIOL ECOL, V48, P437, DOI 10.1016/j.femsec.2004.03.001; Watanabe R, 2004, J NUTR SCI VITAMINOL, V50, P184, DOI 10.3177/jnsv.50.184; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; WELBERG JWM, 1993, EUR J CLIN INVEST, V23, P63, DOI 10.1111/j.1365-2362.1993.tb00719.x; WILLETT WC, 1990, NEW ENGL J MED, V323, P1664, DOI 10.1056/NEJM199012133232404; Williams CD, 2010, NUTR CANCER, V62, P701, DOI 10.1080/01635581003605938; Windey K, 2012, MOL NUTR FOOD RES, V56, P184, DOI 10.1002/mnfr.201100542; Wong JMW, 2006, J CLIN GASTROENTEROL, V40, P235, DOI 10.1097/00004836-200603000-00015; YOUNG TB, 1988, INT J CANCER, V42, P167, DOI 10.1002/ijc.2910420205; ZENTEK J, 1995, J ANIM PHYSIOL AN N, V74, P43, DOI 10.1111/j.1439-0396.1995.tb00435.x; Zheng W, 2009, NUTR CANCER, V61, P437, DOI 10.1080/01635580802710741	57	52	54	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52387	10.1371/journal.pone.0052387	http://dx.doi.org/10.1371/journal.pone.0052387			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285019	Green Published, Green Submitted, gold			2022-12-27	WOS:000312794500155
J	Izawa, T; Kondo, T; Kurosawa, M; Oura, R; Matsumoto, K; Tanaka, E; Yamada, A; Arakaki, R; Kudo, Y; Hayashi, Y; Ishimaru, N				Izawa, Takashi; Kondo, Tomoyuki; Kurosawa, Mie; Oura, Ritsuko; Matsumoto, Kazuma; Tanaka, Eiji; Yamada, Akiko; Arakaki, Rieko; Kudo, Yasusei; Hayashi, Yoshio; Ishimaru, Naozumi			Fas-Independent T-Cell Apoptosis by Dendritic Cells Controls Autoimmune Arthritis in MRL/lpr Mice	PLOS ONE			English	Article							OSTEOCLAST DIFFERENTIATION FACTOR; SYSTEMIC-LUPUS-ERYTHEMATOSUS; TRAIL-INDUCED APOPTOSIS; RHEUMATOID-ARTHRITIS; OSTEOPROTEGERIN-LIGAND; DECOY RECEPTOR; INTERLEUKIN-10; ACTIVATION; DISEASE; EXPRESSION	Background: Although autoimmunity in MRL/lpr mice occurs due to a defect in Fas-mediated cell death of T cells, the role of Fas-independent apoptosis in pathogenesis has rarely been investigated. We have recently reported that receptor activator of nuclear factor (NF)-kappa B ligand (RANKL)-activated dendritic cells (DCs) play a key role in the pathogenesis of rheumatoid arthritis (RA) in MRL/lpr mice. We here attempted to establish a new therapeutic strategy with RANKL-activated DCs in RA by controlling apoptosis of peripheral T cells. Repeated transfer of RANKL-activated DCs into MRL/lpr mice was tested to determine whether this had a therapeutic effect on autoimmunity. Methods and Finding: Cellular and molecular mechanisms of Fas-independent apoptosis of T cells induced by the DCs were investigated by in vitro and in vivo analyses. We demonstrated that repeated transfers of RANKL-activated DCs into MRL/lpr mice resulted in therapeutic effects on RA lesions and lymphoproliferation due to declines of CD4(+) T, B, and CD4(-)CD8(-) double negative (DN) T cells. We also found that the Fas-independent T-cell apoptosis was induced by a direct interaction between tumor necrosis factor (TNF)-related apoptosis-inducing ligand-receptor 2 (TRAIL-R2) on T cells and TRAIL on Fas-deficient DCs in MRL/lpr mice. Conclusion: These results strongly suggest that a novel Fas-independent apoptosis pathway in T cells maintains peripheral tolerance and thus controls autoimmunity in MRL/lpr mice.	[Izawa, Takashi; Kondo, Tomoyuki; Kurosawa, Mie; Oura, Ritsuko; Yamada, Akiko; Arakaki, Rieko; Kudo, Yasusei; Hayashi, Yoshio; Ishimaru, Naozumi] Univ Tokushima, Grad Sch, Dept Oral Mol Pathol, Inst Hlth Biosci, Tokushima 770, Japan; [Izawa, Takashi; Matsumoto, Kazuma; Tanaka, Eiji] Univ Tokushima, Grad Sch, Dept Orthodont & Dentofacial Orthoped, Inst Hlth Biosci, Tokushima 770, Japan	Tokushima University; Tokushima University	Ishimaru, N (corresponding author), Univ Tokushima, Grad Sch, Dept Oral Mol Pathol, Inst Hlth Biosci, Tokushima 770, Japan.	ishimaru@dent.tokushima-u.ac.jp	Tanaka, Eiji/E-7105-2015	Tanaka, Eiji/0000-0002-2707-1613; Kudo, Yasusei/0000-0002-0392-7720	Funding Program for Next Generation World-Leading Researchers in Japan [LS090]; Ministry of Education, Culture, Sports, Science and Technology of Japan [21249090, 23390429, 23659879]; Grants-in-Aid for Scientific Research [23390429, 23659966] Funding Source: KAKEN	Funding Program for Next Generation World-Leading Researchers in Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The study was supported by Funding Program for Next Generation World-Leading Researchers in Japan (LS090) and a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (no. 21249090, no. 23390429, no. 23659879). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; ANDREWS BS, 1978, J EXP MED, V148, P1198, DOI 10.1084/jem.148.5.1198; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bodmer JL, 2000, NAT CELL BIOL, V2, P241, DOI 10.1038/35008667; Bonardelle D, 2001, J RHEUMATOL, V28, P956; CAUX C, 1994, J EXP MED, V180, P1263, DOI 10.1084/jem.180.4.1263; Edwards CK, 1996, J IMMUNOL, V157, P1758; ELLIOTT MJ, 1993, ARTHRITIS RHEUM, V36, P1681, DOI 10.1002/art.23362; Fanger NA, 1999, J EXP MED, V190, P1155, DOI 10.1084/jem.190.8.1155; Fata JE, 2000, CELL, V103, P41, DOI 10.1016/S0092-8674(00)00103-3; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; HANG L, 1982, J EXP MED, V155, P1690, DOI 10.1084/jem.155.6.1690; Hersey P, 2001, NAT REV CANCER, V1, P142, DOI 10.1038/35101078; HOUSSIAU FA, 1995, LUPUS, V4, P393, DOI 10.1177/096120339500400510; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Izawa T, 2007, BLOOD, V110, P242, DOI 10.1182/blood-2006-11-059980; Jeremias I, 1998, EUR J IMMUNOL, V28, P143, DOI 10.1002/(SICI)1521-4141(199801)28:01<143::AID-IMMU143>3.0.CO;2-3; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Krammer PH, 2007, NAT REV IMMUNOL, V7, P532, DOI 10.1038/nri2115; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lamhamedi-Cherradi SE, 2003, NAT IMMUNOL, V4, P255, DOI 10.1038/ni894; Liu ZG, 2003, J CLIN INVEST, V112, P1332, DOI 10.1172/JCI200319209; LLORENTE L, 1995, J EXP MED, V181, P839, DOI 10.1084/jem.181.3.839; Lopatin U, 2001, BLOOD, V97, P3161, DOI 10.1182/blood.V97.10.3161; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; Menges M, 2002, J EXP MED, V195, P15, DOI 10.1084/jem.20011341; Merad M, 2009, BLOOD, V113, P3418, DOI 10.1182/blood-2008-12-180646; MORSE HC, 1982, J IMMUNOL, V129, P2612; OSULLIVAN FX, 1985, ARTHRITIS RHEUM, V28, P529, DOI 10.1002/art.1780280511; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Plows D, 1999, J IMMUNOL, V162, P1018; PRUDHOMME GJ, 1995, MOL IMMUNOL, V32, P495, DOI 10.1016/0161-5890(95)00024-9; Rescigno M, 1998, J EXP MED, V188, P2175, DOI 10.1084/jem.188.11.2175; Russell JH, 2002, ANNU REV IMMUNOL, V20, P323, DOI 10.1146/annurev.immunol.20.100201.131730; Sarkar S, 2005, FRONT BIOSCI-LANDMRK, V10, P656, DOI 10.2741/1560; Schneider P, 1997, FEBS LETT, V416, P329, DOI 10.1016/S0014-5793(97)01231-3; Shalhoub V, 2000, BRIT J HAEMATOL, V111, P501, DOI 10.1046/j.1365-2141.2000.02379.x; Sheikh MS, 1999, ONCOGENE, V18, P4153, DOI 10.1038/sj.onc.1202763; Sheridan JP, 1997, SCIENCE, V277, P818, DOI 10.1126/science.277.5327.818; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Sprick MR, 2002, EMBO J, V21, P4520, DOI 10.1093/emboj/cdf441; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; TARKOWSKI A, 1987, ARTHRITIS RHEUM-US, V30, P75, DOI 10.1002/art.1780300110; van Duivenvoorde LM, 2006, IMMUNOBIOLOGY, V211, P627, DOI 10.1016/j.imbio.2006.05.014; VanGool SW, 1996, IMMUNOL REV, V153, P47; vanKooten C, 1997, CURR OPIN IMMUNOL, V9, P330, DOI 10.1016/S0952-7915(97)80078-7; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; Wenink M H, 2009, Handb Exp Pharmacol, P81, DOI 10.1007/978-3-540-71029-5_4; Wong BR, 1999, J LEUKOCYTE BIOL, V65, P715, DOI 10.1002/jlb.65.6.715; Wu XJ, 2005, J BONE MINER RES, V20, P107, DOI 10.1359/JBMR.041022; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Zhang XR, 2003, CELL DEATH DIFFER, V10, P203, DOI 10.1038/sj.cdd.4401138	53	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e48798	10.1371/journal.pone.0048798	http://dx.doi.org/10.1371/journal.pone.0048798			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23300516	Green Submitted, gold, Green Published			2022-12-27	WOS:000313236200009
J	Gadelha, A; Ota, VK; Cano, JP; Melaragno, MI; Smith, MAC; Mari, JD; Bressan, RA; Belangero, SI; Breen, G				Gadelha, Ary; Ota, Vanessa Kiyomi; Cano, Jose Paya; Melaragno, Maria Isabel; Smith, Marilia A. C.; Mari, Jair de Jesus; Bressan, Rodrigo A.; Belangero, Sintia Iole; Breen, Gerome			Linkage Replication for Chromosomal Region 13q32 in Schizophrenia: Evidence from a Brazilian Pilot Study on Early Onset Schizophrenia Families	PLOS ONE			English	Article							GENOME-WIDE LINKAGE; BIPOLAR DISORDER; PSYCHOTIC DISORDERS; METAANALYSIS; ASSOCIATION; VALIDITY; ALLELE; LOCUS; MOOD	We report analyses of a Brazilian study of early onset schizophrenia (BEOS) families. We genotyped 22 members of 4 families on a linkage SNP array and report here non-parametric linkage analyses using MERLIN (R) software. We found suggestive evidence for linkage on two chromosomal regions, 13q32 and 11p15.4. A LOD score of 2.71 was observed at 13q32 with a one LOD interval extending from 60.63-92.35 cM. From simulations, this LOD score gave a genome-wide empirical corrected p = 0.33, after accounting for all markers tested. Similarly 11p15.4 showed the same maximum LOD of 2.71 and a narrower one LOD interval of 4-14 cM. Of these, 13q32 has been reported to be linked to schizophrenia by multiple different studies. Thus, our study provides additional supporting evidence for an aetiological role of variants at 13q32 in schizophrenia.	[Gadelha, Ary; Ota, Vanessa Kiyomi; Mari, Jair de Jesus; Bressan, Rodrigo A.; Belangero, Sintia Iole] Univ Fed Sao Paulo UNIFESP, Dept Psychiat, Interdisciplinary Lab Clin Neurosci LiNC, Sao Paulo, Brazil; [Gadelha, Ary; Ota, Vanessa Kiyomi; Mari, Jair de Jesus; Bressan, Rodrigo A.; Belangero, Sintia Iole] Univ Fed Sao Paulo UNIFESP, Dept Psychiat, Schizophrenia Program PROESQ, Sao Paulo, Brazil; [Ota, Vanessa Kiyomi; Melaragno, Maria Isabel; Smith, Marilia A. C.; Belangero, Sintia Iole] Univ Fed Sao Paulo UNIFESP, Morphol & Genet Dept, Sao Paulo, Brazil; [Cano, Jose Paya; Breen, Gerome] Kings Coll London, Inst Psychiat, MRC, Social Genet & Dev Psychiat Ctr, London WC2R 2LS, England; [Breen, Gerome] Kings Coll London, Inst Psychiat, Natl Inst Hlth Res Biomed Res, Ctr Mental Hlth, London WC2R 2LS, England	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); University of London; King's College London; University of London; King's College London	Gadelha, A (corresponding author), Univ Fed Sao Paulo UNIFESP, Dept Psychiat, Interdisciplinary Lab Clin Neurosci LiNC, Sao Paulo, Brazil.	aryararipe@yahoo.com.br	de A. C. Smith, Marilia/C-4397-2012; de Jesus Mari, Jair/A-7309-2008; Ota, Vanessa/J-6442-2012; Belangero, Sintia I/A-6818-2009; Melaragno, Maria I/F-9013-2012; Melaragno, Maria Isabel/W-8714-2019; Psiquiatria, Inct/I-1060-2013; Breen, Gerome/Y-2706-2019; Breen, Gerome D/A-5540-2010; Bressan, Rodrigo A/E-9178-2010	de A. C. Smith, Marilia/0000-0002-1441-1033; de Jesus Mari, Jair/0000-0002-5403-0112; Ota, Vanessa/0000-0003-0129-6360; Belangero, Sintia I/0000-0002-2419-4351; Breen, Gerome/0000-0003-2053-1792; Breen, Gerome D/0000-0003-2053-1792; Bressan, Rodrigo A/0000-0002-0868-4449; Gadelha de Alencar Araripe Neto, Ary/0000-0002-0993-8017	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2011/00030-1]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (grant number 2011/00030-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2005, AM J HUM GENET, V77, P754, DOI 10.1086/497345; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; Blouin JL, 1998, NAT GENET, V20, P70, DOI 10.1038/1734; Brasil HHA, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-83; Bressan RA, 1998, SCHIZOPHR RES, V32, P41; Brzustowicz LM, 2000, SCIENCE, V288, P678, DOI 10.1126/science.288.5466.678; Brzustowicz LM, 1999, AM J HUM GENET, V65, P1096, DOI 10.1086/302579; Cardno AG, 1999, ARCH GEN PSYCHIAT, V56, P162, DOI 10.1001/archpsyc.56.2.162; Craddock N, 1999, AM J MED GENET, V88, P244, DOI 10.1002/(SICI)1096-8628(19990618)88:3<244::AID-AJMG7>3.0.CO;2-1; Cui YH, 2010, METHODS MOL BIOL, V620, P219, DOI 10.1007/978-1-60761-580-4_6; de Lima MS, 2007, REV BRAS PSIQUIATR, V29, P246, DOI 10.1590/S1516-44462007000300010; Detera-Wadleigh SD, 2006, BIOL PSYCHIAT, V60, P106, DOI 10.1016/j.biopsych.2006.01.019; Faraone SV, 2002, AM J MED GENET, V114, P598, DOI 10.1002/ajmg.10601; Goes FS, 2007, AM J PSYCHIAT, V164, P236, DOI 10.1176/appi.ajp.164.2.236; Gornick MC, 2007, AM J MED GENET B, V144B, P379, DOI 10.1002/ajmg.b.30460; Huang J, 2010, AM J PSYCHIAT, V167, P1254, DOI 10.1176/appi.ajp.2010.09091335; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Levinson DF, 2000, AM J HUM GENET, V67, P652, DOI 10.1086/303041; Lewis CM, 2003, AM J HUM GENET, V73, P34, DOI 10.1086/376549; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Lin MW, 1995, PSYCHIATR GENET, V5, P117, DOI 10.1097/00041444-199505030-00004; Liu XQ, 2008, BIOL PSYCHIAT, V64, P561, DOI 10.1016/j.biopsych.2008.05.023; Maziade M, 2009, EUR J HUM GENET, V17, P1034, DOI 10.1038/ejhg.2008.268; Mortensen PB, 1999, NEW ENGL J MED, V340, P603, DOI 10.1056/NEJM199902253400803; Mulle JG, 2005, MOL PSYCHIATR, V10, P429, DOI 10.1038/sj.mp.4001639; Ng MYM, 2009, MOL PSYCHIATR, V14, P774, DOI 10.1038/mp.2008.135; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Saha S, 2005, PLOS MED, V2, P413, DOI 10.1371/journal.pmed.0020141; Sullivan PF, 2005, PLOS MED, V2, P614, DOI 10.1371/journal.pmed.0020212; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Swartz MS, 2007, AM J PSYCHIAT, V164, P428, DOI 10.1176/appi.ajp.164.3.428; WHITTEMORE AS, 1994, BIOMETRICS, V50, P118, DOI 10.2307/2533202	35	3	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e52262	10.1371/journal.pone.0052262	http://dx.doi.org/10.1371/journal.pone.0052262			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300629	Green Published, Green Submitted, gold			2022-12-27	WOS:000313872600012
J	Partow, S; Siewers, V; Daviet, L; Schalk, M; Nielsen, J				Partow, Siavash; Siewers, Verena; Daviet, Laurent; Schalk, Michel; Nielsen, Jens			Reconstruction and Evaluation of the Synthetic Bacterial MEP Pathway in Saccharomyces cerevisiae	PLOS ONE			English	Article							DEOXYXYLULOSE PHOSPHATE-PATHWAY; ISOPRENOID BIOSYNTHETIC-PATHWAY; ESCHERICHIA-COLI; ISPH PROTEIN; ARABIDOPSIS-THALIANA; 4FE-4S PROTEIN; GENE SYNTHESIS; TRANSFER-RNAS; STEROL LEVELS; IN-VIVO	Isoprenoids, which are a large group of natural and chemical compounds with a variety of applications as e.g. fragrances, pharmaceuticals and potential biofuels, are produced via two different metabolic pathways, the mevalonate (MVA) pathway and the 2-C-methyl-D-erythritol 4-phosphate (MEP) pathway. Here, we attempted to replace the endogenous MVA pathway in Saccharomyces cerevisiae by a synthetic bacterial MEP pathway integrated into the genome to benefit from its superior properties in terms of energy consumption and productivity at defined growth conditions. It was shown that the growth of a MVA pathway deficient S. cerevisiae strain could not be restored by the heterologous MEP pathway even when accompanied by the co-expression of genes erpA, hISCA1 and CpIscA involved in the Fe-S trafficking routes leading to maturation of IspG and IspH and E. coli genes fldA and fpr encoding flavodoxin and flavodoxin reductase believed to be responsible for electron transfer to IspG and IspH.	[Partow, Siavash; Siewers, Verena; Nielsen, Jens] Chalmers Univ Technol, Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden; [Daviet, Laurent; Schalk, Michel] Firmenich Co, Corp R&D Div, Geneva, Switzerland	Chalmers University of Technology; Firmenich	Nielsen, J (corresponding author), Chalmers Univ Technol, Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden.	nielsenj@chalmers.se	Siewers, Verena/AAV-4902-2020; Nielsen, Jens/Q-1347-2017	Siewers, Verena/0000-0002-9502-9804; Nielsen, Jens/0000-0002-9955-6003	Knut and Alice Wallenberg Foundation; Chalmers Foundation; Firmenich AG	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Chalmers Foundation; Firmenich AG	The Knut and Alice Wallenberg Foundation, the Chalmers Foundation and Firmenich AG have financially supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghany SE, 2005, PLANT PHYSIOL, V138, P161, DOI 10.1104/pp.104.058602; Adam P, 2002, P NATL ACAD SCI USA, V99, P12108, DOI 10.1073/pnas.182412599; Ajikumar PK, 2010, SCIENCE, V330, P70, DOI 10.1126/science.1191652; ALBERTS AW, 1980, P NATL ACAD SCI-BIOL, V77, P3957, DOI 10.1073/pnas.77.7.3957; Altincicek B, 2002, FEBS LETT, V532, P437, DOI 10.1016/S0014-5793(02)03726-2; Arigoni D, 1997, P NATL ACAD SCI USA, V94, P10600, DOI 10.1073/pnas.94.20.10600; Asadollahi MA, 2009, METAB ENG, V11, P328, DOI 10.1016/j.ymben.2009.07.001; Berges T, 1997, J BACTERIOL, V179, P4664, DOI 10.1128/jb.179.15.4664-4670.1997; Boguta M, 1997, GENE, V185, P291, DOI 10.1016/S0378-1119(96)00669-5; Chen Y, 2012, FEMS YEAST RES, P1; Culotta VC, 2000, J BIOL CHEM, V20, P3918; DeJong JM, 2006, BIOTECHNOL BIOENG, V93, P212, DOI 10.1002/bit.20694; DIHANICH ME, 1987, MOL CELL BIOL, V7, P177, DOI 10.1128/MCB.7.1.177; DimsterDenk D, 1996, MOL CELL BIOL, V16, P3981; Dugar D, 2011, NAT BIOTECHNOL, V29, P1074, DOI 10.1038/nbt.2055; Erdeniz N, 1997, GENOME RES, V7, P1174, DOI 10.1101/gr.7.12.1174; Flagfeldt DB, 2009, YEAST, V26, P545, DOI 10.1002/yea.1705; Formenti LR, 2011, THESIS DTU DENMARK; Forster J, 2003, GENOME RES, V13, P244, DOI 10.1101/gr.234503; Gerber J, 2004, MOL CELL BIOL, V24, P4848, DOI 10.1128/MCB.24.11.4848-4857.2004; Geu-Flores F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm106; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Grawert T, 2010, P NATL ACAD SCI USA, V107, P1077, DOI 10.1073/pnas.0913045107; Grawert T, 2004, J AM CHEM SOC, V126, P12847, DOI 10.1021/ja0471727; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Gustafsson C, 2004, TRENDS BIOTECHNOL, V22, P346, DOI 10.1016/j.tibtech.2004.04.006; Herz S, 2000, P NATL ACAD SCI USA, V97, P2486, DOI 10.1073/pnas.040554697; IKEMURA T, 1981, J MOL BIOL, V151, P389, DOI 10.1016/0022-2836(81)90003-6; JENKINS CM, 1994, J BIOL CHEM, V269, P27401; JENNINGS SM, 1991, P NATL ACAD SCI USA, V88, P6038, DOI 10.1073/pnas.88.14.6038; Kaminska J, 2002, FEMS YEAST RES, V2, P31, DOI 10.1111/j.1567-1364.2002.tb00066.x; Kosuri S, 2010, NAT BIOTECHNOL, V28, P1295, DOI 10.1038/nbt.1716; Kuranda K, 2010, FEMS YEAST RES, V10, P14, DOI 10.1111/j.1567-1364.2009.00560.x; Kuranda K, 2009, FEMS YEAST RES, V9, P381, DOI 10.1111/j.1567-1364.2009.00485.x; Lill R, 2005, TRENDS BIOCHEM SCI, V30, P133, DOI 10.1016/j.tibs.2005.01.006; LIOCHEV SI, 1994, FREE RADICAL BIO MED, V16, P29, DOI 10.1016/0891-5849(94)90239-9; Loiseau L, 2007, P NATL ACAD SCI USA, V104, P13626, DOI 10.1073/pnas.0705829104; LORENZ RT, 1990, ANTIMICROB AGENTS CH, V34, P1660, DOI 10.1128/AAC.34.9.1660; Luttgen H, 2000, P NATL ACAD SCI USA, V97, P1062, DOI 10.1073/pnas.97.3.1062; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; Matzas M, 2010, NAT BIOTECHNOL, V28, P1291, DOI 10.1038/nbt.1710; Maury J, 2005, ADV BIOCHEM ENG BIOT, V100, P19, DOI 10.1007/b136410; Maury J, 2008, FEBS LETT, V582, P4032, DOI 10.1016/j.febslet.2008.10.045; Muhlenhoff U, 2002, J BIOL CHEM, V277, P29810, DOI 10.1074/jbc.M204675200; Muhlenhoff U, 2011, J BIOL CHEM, P1; Nookaew I, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-71; Nour-Eldin HH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl635; PANTOPOULOS K, 1995, EMBO J, V14, P2917, DOI 10.1002/j.1460-2075.1995.tb07291.x; Partow S, 2010, YEAST, V27, P955, DOI 10.1002/yea.1806; Piddocke MP, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-27; Pinske C, 2012, J BACTERIOL, V194, P346, DOI 10.1128/JB.06024-11; Puan KJ, 2005, FEBS LETT, V579, P3802, DOI 10.1016/j.febslet.2005.05.047; Querol J, 2002, FEBS LETT, V514, P343, DOI 10.1016/S0014-5793(02)02402-X; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Rohdich F, 2003, P NATL ACAD SCI USA, V100, P1586, DOI 10.1073/pnas.0337742100; Rohdich F, 1999, P NATL ACAD SCI USA, V96, P11758, DOI 10.1073/pnas.96.21.11758; ROHMER M, 1993, BIOCHEM J, V295, P517, DOI 10.1042/bj2950517; Seemann M, 2006, FEBS LETT, V580, P1547, DOI 10.1016/j.febslet.2006.01.082; Seemann M, 2005, J BIOL INORG CHEM, V10, P131, DOI 10.1007/s00775-004-0619-z; SERVOUSE M, 1984, BIOCHEM BIOPH RES CO, V123, P424, DOI 10.1016/0006-291X(84)90247-X; Shao ZY, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn991; Sharma AK, 2010, J BIOL CHEM, V285, P26745, DOI 10.1074/jbc.R110.122218; Song DS, 2009, J BIOL CHEM, V284, P35297, DOI 10.1074/jbc.M109.040014; Sprenger GA, 1997, P NATL ACAD SCI USA, V94, P12857, DOI 10.1073/pnas.94.24.12857; Szczebara FM, 2003, NAT BIOTECHNOL, V21, P143, DOI 10.1038/nbt775; Takahashi S, 1998, PSYCHIAT CLIN NEUROS, V52, P1; Tan GQ, 2009, BIOCHEM J, V420, P463, DOI 10.1042/BJ20090206; TSAY YH, 1991, MOL CELL BIOL, V11, P620, DOI 10.1128/MCB.11.2.620; VERDUYN C, 1992, YEAST, V8, P501, DOI 10.1002/yea.320080703; Vinella D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000497; Wingler LM, 2011, P NATL ACAD SCI USA, V108, P15135, DOI 10.1073/pnas.1100507108; Wolff M, 2003, FEBS LETT, V541, P115, DOI 10.1016/S0014-5793(03)00317-X; Xiao YL, 2008, J AM CHEM SOC, V130, P2164, DOI 10.1021/ja710245d; Xiao YL, 2009, J AM CHEM SOC, V131, P9931, DOI 10.1021/ja903778d; Yan YJ, 2005, APPL ENVIRON MICROB, V71, P5610, DOI 10.1128/AEM.71.9.5610-5613.2005	75	37	38	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52498	10.1371/journal.pone.0052498	http://dx.doi.org/10.1371/journal.pone.0052498			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285068	Green Published, gold, Green Submitted			2022-12-27	WOS:000313051500031
J	Popovich, I; Windsor, B; Jordan, V; Showell, M; Shea, B; Farquhar, CM				Popovich, Ivor; Windsor, Bethany; Jordan, Vanessa; Showell, Marian; Shea, Bev; Farquhar, Cynthia M.			Methodological Quality of Systematic Reviews in Subfertility: A Comparison of Two Different Approaches	PLOS ONE			English	Review								Background: Systematic reviews are used widely to guide health care decisions. Several tools have been created to assess systematic review quality. The measurement tool for assessing the methodological quality of systematic reviews known as the AMSTAR tool applies a yes/no score to eleven relevant domains of review methodology. This tool has been reworked so that each domain is scored based on a four point scale, producing R-AMSTAR. Methods and Findings: We aimed to compare the AMSTAR and R-AMSTAR tools in assessing systematic reviews in the field of assisted reproduction for subfertility. All published systematic reviews on assisted reproductive technology, with the latest search for studies taking place from 2007-2011, were considered. Reviews that contained no included studies or considered diagnostic outcomes were excluded. Thirty each of Cochrane and non-Cochrane reviews were randomly selected from a search of relevant databases. Both tools were then applied to all sixty reviews. The results were converted to percentage scores and all reviews graded and ranked based on this. AMSTAR produced a much wider variation in percentage scores and achieved higher inter-rater reliability than R-AMSTAR according to kappa statistics. The average rating for Cochrane reviews was consistent between the two tools (88.3% for R-AMSTAR versus 83.6% for AMSTAR) but inconsistent for non-Cochrane reviews (63.9% R-AMSTAR vs. 38.5% AMSTAR). In comparing the rankings generated between the two tools Cochrane reviews changed an average of 4.2 places, compared to 2.9 for non-Cochrane. Conclusion: R-AMSTAR provided greater guidance in the assessment of domains and produced quantitative results. However, there were many problems with the construction of its criteria and AMSTAR was much easier to apply consistently. We recommend that AMSTAR incorporates the findings of this study and produces additional guidance for its application in order to improve its reliability and usefulness.	[Showell, Marian; Farquhar, Cynthia M.] Univ Auckland, Dept Obstet & Gynaecol, Cochrane Menstrual Disorders & Subfertil Grp, Auckland 1, New Zealand; [Popovich, Ivor; Windsor, Bethany] Univ Auckland, Fac Med & Hlth Sci, Auckland 1, New Zealand; [Shea, Bev] Univ Ottawa, Community Informat Epidemiol Communities, Ottawa, ON, Canada	University of Auckland; University of Auckland; University of Ottawa	Farquhar, CM (corresponding author), Univ Auckland, Dept Obstet & Gynaecol, Cochrane Menstrual Disorders & Subfertil Grp, Auckland 1, New Zealand.	c.farquhar@auckland.ac.nz		Farquhar, Cynthia/0000-0002-3685-3553; Jordan, Vanessa/0000-0002-9079-6457	University of Auckland Summer Studentship Programme	University of Auckland Summer Studentship Programme	Ivor Popovich and Bethany Windsor were funded to take part by the University of Auckland Summer Studentship Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; Fleiss J. L., 1981, STAT METHODS RATES P, V2; Green S, 2011, COCHRANE HDB SYSTEMA, P6; Kung Jason, 2010, Open Dent J, V4, P84, DOI 10.2174/1874210601004020084; Moher D, 2007, PLOS MED, V4, P447, DOI 10.1371/journal.pmed.0040078; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10	7	31	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e50403	10.1371/journal.pone.0050403	http://dx.doi.org/10.1371/journal.pone.0050403			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23300526	gold, Green Submitted, Green Published			2022-12-27	WOS:000313051500004
J	Schultz, A; Koch, S; Fuss, M; Mazzotta, AS; Sarzotti-Kelsoe, M; Ozaki, DA; Montefiori, DC; von Briesen, H; Zimmermann, H; Meyerhans, A				Schultz, Anke; Koch, Stefanie; Fuss, Martina; Mazzotta, Angela S.; Sarzotti-Kelsoe, Marcella; Ozaki, Daniel A.; Montefiori, David C.; von Briesen, Hagen; Zimmermann, Heiko; Meyerhans, Andreas			An Automated HIV-1 Env-Pseudotyped Virus Production for Global HIV Vaccine Trials	PLOS ONE			English	Article							FUSION INHIBITOR T-20; NEUTRALIZING ANTIBODIES; V3 LOOP; TYPE-1; CULTURE; CLONES; INFECTIONS; LINEAGE; PROTEIN; DESIGN	Background: Infections with HIV still represent a major human health problem worldwide and a vaccine is the only long-term option to fight efficiently against this virus. Standardized assessments of HIV-specific immune responses in vaccine trials are essential for prioritizing vaccine candidates in preclinical and clinical stages of development. With respect to neutralizing antibodies, assays with HIV-1 Env-pseudotyped viruses are a high priority. To cover the increasing demands of HIV pseudoviruses, a complete cell culture and transfection automation system has been developed. Methodology/Principal Findings: The automation system for HIV pseudovirus production comprises a modified Tecan-based Cellerity system. It covers an area of 5x3 meters and includes a robot platform, a cell counting machine, a CO2 incubator for cell cultivation and a media refrigerator. The processes for cell handling, transfection and pseudovirus production have been implemented according to manual standard operating procedures and are controlled and scheduled autonomously by the system. The system is housed in a biosafety level II cabinet that guarantees protection of personnel, environment and the product. HIV pseudovirus stocks in a scale from 140 ml to 1000 ml have been produced on the automated system. Parallel manual production of HIV pseudoviruses and comparisons (bridging assays) confirmed that the automated produced pseudoviruses were of equivalent quality as those produced manually. In addition, the automated method was fully validated according to Good Clinical Laboratory Practice (GCLP) guidelines, including the validation parameters accuracy, precision, robustness and specificity. Conclusions: An automated HIV pseudovirus production system has been successfully established. It allows the high quality production of HIV pseudoviruses under GCLP conditions. In its present form, the installed module enables the production of 1000 ml of virus-containing cell culture supernatant per week. Thus, this novel automation facilitates standardized large-scale productions of HIV pseudoviruses for ongoing and upcoming HIV vaccine trials.	[Koch, Stefanie; Fuss, Martina; Meyerhans, Andreas] Univ Saarland, Dept Virol, D-6650 Homburg, Germany; [Schultz, Anke; Mazzotta, Angela S.; von Briesen, Hagen; Zimmermann, Heiko] Fraunhofer Inst Biomed Engn, St Ingbert, Germany; [Sarzotti-Kelsoe, Marcella; Ozaki, Daniel A.; Montefiori, David C.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Meyerhans, Andreas] Univ Pompeu Fabra, Dept Expt & Hlth Sci, ICREA Infect Biol Lab, Barcelona, Spain	Saarland University; Fraunhofer Gesellschaft; Duke University; ICREA; Pompeu Fabra University	Meyerhans, A (corresponding author), Univ Saarland, Dept Virol, D-6650 Homburg, Germany.	andreas.meyerhans@upf.edu	Meyerhans, Andreas/D-3382-2014; Meyerhans, Andreas/S-2559-2019	Meyerhans, Andreas/0000-0003-0620-5317; Meyerhans, Andreas/0000-0003-0620-5317; Zimmermann, Heiko/0000-0001-8595-1304	Bill and Melinda Gates Foundation [OPP38580_01]; Fraunhofer Society, Germany; ICREA Funding Source: Custom	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Fraunhofer Society, Germany; ICREA(ICREA)	This article derived from a collaboration of the Fraunhofer Institute for Biomedical Engineering, the "Global HIV Vaccine Research Cryorepository Consortium" (principal investigator: HVB) and the "Comprehensive Antibody Vaccine Immune Monitoring Consortium" (principal investigator: DM) within the "Collaboration for AIDS Vaccine Discovery", funded by the Bill and Melinda Gates Foundation (#OPP38580_01). Automation of cell culture and HIV pseudovirus production was established in exclusive cooperation with TECAN funded as a strategic investment by the Fraunhofer Society, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barouch DH, 2008, NATURE, V455, P613, DOI 10.1038/nature07352; Beuselinck K, 2005, J CLIN MICROBIOL, V43, P5541, DOI 10.1128/JCM.43.11.5541-5546.2005; Bonsignori M, 2012, J VIROL, V86, P4688, DOI 10.1128/JVI.07163-11; Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; ChengMayer C, 1997, J VIROL, V71, P1657, DOI 10.1128/JVI.71.2.1657-1661.1997; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Edmonds TG, 2010, VIROLOGY, V408, P1, DOI 10.1016/j.virol.2010.08.028; Ezzelle J, 2008, J PHARMACEUT BIOMED, V46, P18, DOI 10.1016/j.jpba.2007.10.010; Fenyo EM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004505; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Gao F, 1998, J VIROL, V72, P5680, DOI 10.1128/JVI.72.7.5680-5698.1998; Haynes BF, 2012, NAT BIOTECHNOL, V30, P423, DOI 10.1038/nbt.2197; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Huang LC, 2010, BIOLOGICALS, V38, P393, DOI 10.1016/j.biologicals.2010.01.009; Johnson V.A., 1990, TECHNIQUES HIV RES, P71; Johnson Victoria A, 2008, Top HIV Med, V16, P138; Kato R, 2010, TISSUE ENG PART C-ME, V16, P947, DOI [10.1089/ten.tec.2009.0305, 10.1089/ten.TEC.2009.0305]; KORBER BTM, 1993, P NATL ACAD SCI USA, V90, P7176, DOI 10.1073/pnas.90.15.7176; Kowalski MP, 2012, J BIOMOL SCREEN; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li M, 2006, J VIROL, V80, P11776, DOI 10.1128/JVI.01730-06; Liu Y, 2010, J TISSUE ENG REGEN M, V4, P45, DOI 10.1002/term.217; Mascola JR, 2005, J VIROL, V79, P10103, DOI 10.1128/JVI.79.16.10103-10107.2005; Montefiori DC, 2012, J INFECT DIS, V206, P431, DOI 10.1093/infdis/jis367; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; Ozaki DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030963; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Sarzotti-Kelsoe M, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000067; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Shi SP, 2011, JOVE-J VIS EXP, DOI 10.3791/3010; Stamatatos L, 1998, AIDS RES HUM RETROV, V14, P1129, DOI 10.1089/aid.1998.14.1129; Stevens W, 2003, Qual Assur, V10, P83; STILES T, 2003, GOOD CLIN LAB PRACTI, P1; Terstegge S, 2007, BIOTECHNOL BIOENG, V96, P195, DOI 10.1002/bit.21061; Thomas RJ, 2009, BIOTECHNOL BIOENG, V102, P1636, DOI 10.1002/bit.22187; Thomas R, 2012, METHODS MOL BIOL, V806, P393, DOI 10.1007/978-1-61779-367-7_26; Todd CA, 2012, J IMMUNOL METHODS, V375, P57, DOI 10.1016/j.jim.2011.09.007; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Zhao YG, 2011, J STRUCT BIOL, V175, P209, DOI 10.1016/j.jsb.2011.04.017	44	11	15	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e51715	10.1371/journal.pone.0051715	http://dx.doi.org/10.1371/journal.pone.0051715			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300558	gold, Green Published			2022-12-27	WOS:000312829100012
J	Batsukh, T; Schulz, Y; Wolf, S; Rabe, TI; Oellerich, T; Urlaub, H; Schaefer, IM; Pauli, S				Batsukh, Tserendulam; Schulz, Yvonne; Wolf, Stephan; Rabe, Tamara I.; Oellerich, Thomas; Urlaub, Henning; Schaefer, Inga-Marie; Pauli, Silke			Identification and Characterization of FAM124B as a Novel Component of a CHD7 and CHD8 Containing Complex	PLOS ONE			English	Article							CHROMATIN REMODELING FACTOR; CHARGE SYNDROME; PHENOTYPIC SPECTRUM; MUTATIONS; EXPRESSION; RNA; INTERACTS; PROTEINS; DEFECTS; MICE	Background: Mutations in the chromodomain helicase DNA binding protein 7 gene (CHD7) lead to CHARGE syndrome, an autosomal dominant multiple malformation disorder. Proteins involved in chromatin remodeling typically act in multiprotein complexes. We previously demonstrated that a part of human CHD7 interacts with a part of human CHD8, another chromodomain helicase DNA binding protein presumably being involved in the pathogenesis of neurodevelopmental (NDD) and autism spectrum disorders (ASD). Because identification of novel CHD7 and CHD8 interacting partners will provide further insights into the pathogenesis of CHARGE syndrome and ASD/NDD, we searched for additional associated polypeptides using the method of stable isotope labeling by amino acids in cell culture (SILAC) in combination with mass spectrometry. Principle findings: The hitherto uncharacterized FAM124B (Family with sequence similarity 124B) was identified as a potential interaction partner of both CHD7 and CHD8. We confirmed the result by co-immunoprecipitation studies and showed a direct binding to the CHD8 part by direct yeast two hybrid experiments. Furthermore, we characterized FAM124B as a mainly nuclear localized protein with a widespread expression in embryonic and adult mouse tissues. Conclusion: Our results demonstrate that FAM124B is a potential interacting partner of a CHD7 and CHD8 containing complex. From the overlapping expression pattern between Chd7 and Fam124B at murine embryonic day E12.5 and the high expression of Fam124B in the developing mouse brain, we conclude that Fam124B is a novel protein possibly involved in the pathogenesis of CHARGE syndrome and neurodevelopmental disorders.	[Batsukh, Tserendulam; Schulz, Yvonne; Wolf, Stephan; Pauli, Silke] Univ Med Ctr, Inst Human Genet, Gottingen, Germany; [Rabe, Tamara I.] Max Planck Inst Biophys Chem, Dept Mol Cell Biol, D-37077 Gottingen, Germany; [Oellerich, Thomas; Urlaub, Henning] Max Planck Inst Biophys Chem, Bioanalyt Mass Spectrometry Grp, D-37077 Gottingen, Germany; [Urlaub, Henning] Univ Med Ctr, Dept Clin Chem, Gottingen, Germany; [Schaefer, Inga-Marie] Univ Med Ctr, Dept Pathol, Gottingen, Germany	University of Gottingen; Max Planck Society; Max Planck Society; University of Gottingen; University of Gottingen	Pauli, S (corresponding author), Univ Med Ctr, Inst Human Genet, Gottingen, Germany.	spauli@gwdg.de	Schaefer, Inga-Marie/ABA-3951-2020	Schaefer, Inga-Marie/0000-0001-9710-5500; Batsukh, Tserendulam/0000-0002-8409-0968	Deutsche Forschungsgemeinschaft (DFG) [PA 2030/1-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) (www.dfg.de) (PA 2030/1-1) to SP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aramaki M, 2006, J PEDIATR-US, V148, P410, DOI 10.1016/j.jpeds.2005.10.044; Bajpai R, 2010, NATURE, V463, P958, DOI 10.1038/nature08733; Batsukh T, 2010, HUM MOL GENET, V19, P2858, DOI 10.1093/hmg/ddq189; Bergman JEH, 2010, EUR J HUM GENET, V18, P171, DOI 10.1038/ejhg.2009.158; Betancur C, 2011, BRAIN RES, V1380, P42, DOI 10.1016/j.brainres.2010.11.078; Bosman EA, 2005, HUM MOL GENET, V14, P3463, DOI 10.1093/hmg/ddi375; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Hurd EA, 2007, MAMM GENOME, V18, P94, DOI 10.1007/s00335-006-0107-6; Ishihara K, 2006, MOL CELL, V23, P733, DOI 10.1016/j.molcel.2006.08.008; Janssen N, 2012, HUM MUTAT, V33, P1149, DOI 10.1002/humu.22086; Jongmans MCJ, 2006, J MED GENET, V43, P306, DOI 10.1136/jmg.2005.036061; Lalani SR, 2006, AM J HUM GENET, V78, P303, DOI 10.1086/500273; Layman WS, 2009, HUM MOL GENET, V18, P1909, DOI 10.1093/hmg/ddp112; Moorman AFM, 2001, J HISTOCHEM CYTOCHEM, V49, P1, DOI 10.1177/002215540104900101; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Nikolov M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.005371; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Oellerich T, 2011, EMBO J, V30, P3620, DOI 10.1038/emboj.2011.251; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Rodriguez-Paredes M, 2009, NUCLEIC ACIDS RES, V37, P2449, DOI 10.1093/nar/gkp101; Sanlaville D, 2006, J MED GENET, V43, P211, DOI 10.1136/jmg.2005.036160; Schnetz MP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001023; Schnetz MP, 2009, GENOME RES, V19, P590, DOI 10.1101/gr.086983.108; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Srinivasan S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000217; Takada I, 2007, NAT CELL BIOL, V9, P1273, DOI 10.1038/ncb1647; Talkowski ME, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.028; Thompson BA, 2008, MOL CELL BIOL, V28, P3894, DOI 10.1128/MCB.00322-08; Vissers LELM, 2004, NAT GENET, V36, P955, DOI 10.1038/ng1407; Wincent J, 2008, CLIN GENET, V74, P31, DOI 10.1111/j.1399-0004.2008.01014.x; Yokoyama A, 2008, CANCER CELL, V14, P36, DOI 10.1016/j.ccr.2008.05.003; Zahir F, 2007, J MED GENET, V44, DOI 10.1136/jmg.2007.050823; Zentner GE, 2010, HUM MOL GENET, V19, P3491, DOI 10.1093/hmg/ddq265	33	15	19	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52640	10.1371/journal.pone.0052640	http://dx.doi.org/10.1371/journal.pone.0052640			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285124	Green Published, Green Submitted, gold			2022-12-27	WOS:000313158800084
J	Kedenko, L; Lamina, C; Kiesslich, T; Kapur, K; Bergmann, S; Waterworth, D; Heid, IM; Wichmann, HE; Kedenko, I; Kronenberg, F; Paulweber, B				Kedenko, Lyudmyla; Lamina, Claudia; Kiesslich, Tobias; Kapur, Karen; Bergmann, Sven; Waterworth, Dawn; Heid, Iris M.; Wichmann, H. -Erich; Kedenko, Igor; Kronenberg, Florian; Paulweber, Bernhard			Genetic Polymorphisms of the Main Transcription Factors for Adiponectin Gene Promoter in Regulation of Adiponectin Levels: Association Analysis in Three European Cohorts	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; TYPE-2 DIABETES-MELLITUS; ACTIVATED-RECEPTOR-GAMMA; PLASMA ADIPONECTIN; METABOLIC SYNDROME; PRO12ALA POLYMORPHISM; SERUM ADIPONECTIN; ADIPOSE-TISSUE; JAPANESE POPULATION; PPAR-GAMMA-2 GENE	Adiponectin serum concentrations are an important biomarker in cardiovascular epidemiology with heritability etimates of 30-70%. However, known genetic variants in the adiponectin gene locus (ADIPOQ) account for only 2%-8% of its variance. As transcription factors are thought to play an under-acknowledged role in carrying functional variants, we hypothesized that genetic polymorphisms in genes coding for the main transcription factors for the ADIPOQ promoter influence adiponectin levels. Single nucleotide polymorphisms (SNPs) at these genes were selected based on the haplotype block structure and previously published evidence to be associated with adiponectin levels. We performed association analyses of the 24 selected SNPs at forkhead box O1 (FOXO1), sterol-regulatory-element-binding transcription factor 1 (SREBF1), sirtuin 1 (SIRT1), peroxisome-proliferator-activated receptor gamma (PPARG) and transcription factor activating enhancer binding protein 2 beta (TFAP2B) gene loci with adiponectin levels in three different European cohorts: SAPHIR (n = 1742), KORA F3 (n = 1636) and CoLaus (n = 5355). In each study population, the association of SNPs with adiponectin levels on log-scale was tested using linear regression adjusted for age, sex and body mass index, applying both an additive and a recessive genetic model. A pooled effect size was obtained by meta-analysis assuming a fixed effects model. We applied a significance threshold of 0.0033 accounting for the multiple testing situation. A significant association was only found for variants within SREBF1 applying an additive genetic model (smallest p-value for rs1889018 on log(adiponectin) = 0.002, beta on original scale = -0.217 mu g/ml), explaining similar to 0.4% of variation of adiponectin levels. Recessive genetic models or haplotype analyses of the FOXO1, SREBF1, SIRT1, TFAPB2B genes or sex-stratified analyses did not reveal additional information on the regulation of adiponectin levels. The role of genetic variations at the SREBF1 gene in regulating adiponectin needs further investigation by functional studies.	[Kedenko, Lyudmyla; Kiesslich, Tobias; Kedenko, Igor; Paulweber, Bernhard] Paracelsus Med Univ Salzburg, Univ Clin Internal Med 1, Salzburg, Austria; [Lamina, Claudia] Med Univ Innsbruck, Div Genet Epidemiol, A-6020 Innsbruck, Austria; [Kapur, Karen; Bergmann, Sven] Univ Lausanne, Dept Med Genet, CH-1015 Lausanne, Switzerland; [Kapur, Karen; Bergmann, Sven] Swiss Inst Bioinformat, Lausanne, Switzerland; [Waterworth, Dawn] GlaxoSmithKline, Genet, Philadelphia, PA USA; [Heid, Iris M.] Univ Regensburg, Med Ctr, Dept Epidemiol & Prevent Med, D-93053 Regensburg, Germany; [Heid, Iris M.; Wichmann, H. -Erich] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Inst Epidemiol 1, Neuherberg, Germany; [Wichmann, H. -Erich] Univ Munich, Chair Epidemiol, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Wichmann, H. -Erich] Univ Munich, Klinikum Grosshadern, D-80539 Munich, Germany	Paracelsus Private Medical University; Medical University of Innsbruck; University of Lausanne; Swiss Institute of Bioinformatics; GlaxoSmithKline; University of Regensburg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich	Kedenko, L (corresponding author), Paracelsus Med Univ Salzburg, Univ Clin Internal Med 1, Salzburg, Austria.	l.kedenko@salk.at; Florian.Kronenberg@i-med.ac.at	Colaus, PsyColaus/K-6607-2013; Wichmann, Heinz Erich/AAA-5695-2022; Lamina, Claudia/F-7608-2010; Kronenberg, Florian/B-1736-2008	Lamina, Claudia/0000-0002-5398-5806; Kronenberg, Florian/0000-0003-2229-1120; Bergmann, Sven/0000-0002-6785-9034; Kiesslich, Tobias/0000-0001-5403-9478	Kamilo-Eisner Stiftung; Salzburger Forschungsgesellschaft; OeNB [13339]; FFF-PMU [E-09/09/055-PAU]; Austrian Genome Research Program GEN-AU; GlaxoSmithKline; Swiss National Science Foundation [33CSCO-122661]; Faculty of Biology and Medicine of Lausanne	Kamilo-Eisner Stiftung; Salzburger Forschungsgesellschaft; OeNB; FFF-PMU; Austrian Genome Research Program GEN-AU; GlaxoSmithKline(GlaxoSmithKline); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Faculty of Biology and Medicine of Lausanne	The SAPHIR population was supported by: Kamilo-Eisner Stiftung, Salzburger Forschungsgesellschaft, OeNB Nr.13339 and FFF-PMU Nr. E-09/09/055-PAU. The KORA study was supported by: "Austrian Genome Research Program GEN-AU" for the project "Genomics of Lipid-associated Disorders - GOLD." The CoLaus study was supported by: grants from GlaxoSmithKline, the Swiss National Science Foundation (Grant 33CSCO-122661) and the Faculty of Biology and Medicine of Lausanne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjorntorp P, 1996, INT J OBESITY, V20, P291; Blaak E, 2001, CURR OPIN CLIN NUTR, V4, P499, DOI 10.1097/00075197-200111000-00006; Bowden DW, 2010, HUM MOL GENET, V19, P4112, DOI 10.1093/hmg/ddq327; Brochu-Gaudreau K, 2010, ENDOCRINE, V37, P11, DOI 10.1007/s12020-009-9278-8; Chuang LM, 2004, J CLIN ENDOCR METAB, V89, P5772, DOI 10.1210/jc.2004-0640; Chung CM, 2011, DIABETES, V60, P2417, DOI 10.2337/db10-1321; Comuzzie AG, 2001, J CLIN ENDOCR METAB, V86, P4321, DOI 10.1210/jc.86.9.4321; Dastani Z, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002607; de Courten BV, 2005, DIABETES, V54, P284, DOI 10.2337/diabetes.54.1.284; Felder TK, 2007, INT J OBESITY, V31, P1099, DOI 10.1038/sj.ijo.0803505; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; Galic S, 2010, MOL CELL ENDOCRINOL, V316, P129, DOI 10.1016/j.mce.2009.08.018; Gouda HN, 2010, AM J EPIDEMIOL, V171, P645, DOI 10.1093/aje/kwp450; Guo XQ, 2006, DIABETES, V55, P1723, DOI 10.2337/db05-0428; Harding AH, 2006, DIABETOLOGIA, V49, P2642, DOI 10.1007/s00125-006-0430-1; Heid IM, 2006, DIABETES, V55, P375, DOI 10.2337/diabetes.55.02.06.db05-0747; Heid IM, 2010, ATHEROSCLEROSIS, V208, P412, DOI 10.1016/j.atherosclerosis.2009.11.035; Heikkinen S, 2009, CELL METAB, V9, P88, DOI 10.1016/j.cmet.2008.11.007; Helisalmi S, 2008, J NEUROL, V255, P668, DOI 10.1007/s00415-008-0774-1; Henneman P, 2010, DIABETES CARE, V33, P908, DOI 10.2337/dc09-1385; Hicks C, 2007, OBESITY, V15, P1207, DOI 10.1038/oby.2007.142; Hivert MF, 2008, DIABETES, V57, P3353, DOI 10.2337/db08-0700; Ikeda K, 2006, J BIOL CHEM, V281, P31245, DOI 10.1074/jbc.M605132200; Iwaki M, 2003, DIABETES, V52, P1655, DOI 10.2337/diabetes.52.7.1655; Jee SH, 2010, AM J HUM GENET, V87, P545, DOI 10.1016/j.ajhg.2010.09.004; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kawada T, 2008, ASIA PAC J CLIN NUTR, V17, P126; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Kita A, 2005, BIOCHEM BIOPH RES CO, V331, P484, DOI 10.1016/j.bbrc.2005.03.205; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Lindsay RS, 2003, DIABETES, V52, P2419, DOI 10.2337/diabetes.52.9.2419; Ling H, 2009, OBESITY, V17, P737, DOI 10.1038/oby.2008.625; Liu ML, 2010, BIOCHEM J, V425, P41, DOI 10.1042/BJ20091045; Maeda S, 2005, J HUM GENET, V50, P283, DOI 10.1007/s10038-005-0253-9; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Morisaki H, 2012, HUM MUTAT, V33, P402, DOI 10.1002/humu.21652; Mousavinasab F, 2005, ENDOCRINE, V27, P307, DOI 10.1385/ENDO:27:3:307; Nishida M, 2007, MED MOL MORPHOL, V40, P55, DOI 10.1007/s00795-007-0366-7; Qiao LP, 2006, J BIOL CHEM, V281, P39915, DOI 10.1074/jbc.M607215200; Qiao LP, 2005, DIABETES, V54, P1744, DOI 10.2337/diabetes.54.6.1744; Rangwala SM, 2004, TRENDS PHARMACOL SCI, V25, P331, DOI 10.1016/j.tips.2004.03.012; Rasmussen-Torvik LJ, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-39; Richards JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000768; Ruchat SM, 2008, J HUM GENET, V53, P629, DOI 10.1007/s10038-008-0291-1; Sanchez JLG, 2002, EUR J ENDOCRINOL, V147, P495, DOI 10.1530/eje.0.1470495; Sandhu MS, 2008, LANCET, V371, P483, DOI 10.1016/S0140-6736(08)60208-1; Schaffler A, 1998, BBA-GENE STRUCT EXPR, V1399, P187, DOI 10.1016/S0167-4781(98)00106-7; Segawa K, 2009, J ENDOCRINOL, V200, P107, DOI 10.1677/JOE-08-0376; Sharma AM, 2007, J CLIN ENDOCR METAB, V92, P386, DOI 10.1210/jc.2006-1268; Sinnwell JP, 2009, HAPLO STATS STAT ANA; Smith SR, 2001, METABOLISM, V50, P425, DOI 10.1053/meta.2001.21693; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; Stumvoll M, 2002, DIABETES, V51, P2341, DOI 10.2337/diabetes.51.8.2341; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Vasseur F, 2002, HUM MOL GENET, V11, P2607, DOI 10.1093/hmg/11.21.2607; Vidal H, 2001, ANN MED, V33, P547, DOI 10.3109/07853890108995965; VidalPuig AJ, 1997, J CLIN INVEST, V99, P2416, DOI 10.1172/JCI119424; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; Wu Y, 2010, HUM MOL GENET, V19, P4955, DOI 10.1093/hmg/ddq423; Yamamoto Y, 2002, METABOLISM, V51, P1407, DOI 10.1053/meta.2002.35586; Yeung E, 2011, INT J MOL EPIDEMIOL, V2, P138	62	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52497	10.1371/journal.pone.0052497	http://dx.doi.org/10.1371/journal.pone.0052497			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285067	Green Submitted, Green Published, gold			2022-12-27	WOS:000313158800074
J	Merabishvili, M; De Vos, D; Verbeken, G; Kropinski, AM; Vandenheuvel, D; Lavigne, R; Wattiau, P; Mast, J; Ragimbeau, C; Mossong, J; Scheres, J; Chanishvili, N; Vaneechoutte, M; Pirnay, JP				Merabishvili, Maia; De Vos, Daniel; Verbeken, Gilbert; Kropinski, Andrew M.; Vandenheuvel, Dieter; Lavigne, Rob; Wattiau, Pierre; Mast, Jan; Ragimbeau, Catherine; Mossong, Joel; Scheres, Jacques; Chanishvili, Nina; Vaneechoutte, Mario; Pirnay, Jean-Paul			Selection and Characterization of a Candidate Therapeutic Bacteriophage That Lyses the Escherichia coli O104:H4 Strain from the 2011 Outbreak in Germany	PLOS ONE			English	Article								In 2011, a novel strain of O104:H4 Escherichia coli caused a serious outbreak of foodborne hemolytic uremic syndrome and bloody diarrhea in Germany. Antibiotics were of questionable use and 54 deaths occurred. Candidate therapeutic bacteriophages that efficiently lyse the E. coli O104:H4 outbreak strain could be selected rather easily from a phage bank or isolated from the environment. It is argued that phage therapy should be more considered as a potential armament against the growing threat of (resistant) bacterial infections.	[Merabishvili, Maia; De Vos, Daniel; Verbeken, Gilbert; Pirnay, Jean-Paul] Queen Astrid Mil Hosp, Lab Mol & Cellular Technol, Brussels, Belgium; [Merabishvili, Maia; Chanishvili, Nina] Eliava Inst Bacteriophage Microbiol & Virol, Tbilisi, Georgia; [Merabishvili, Maia; Vaneechoutte, Mario] Univ Ghent, Lab Bacteriol Res, B-9000 Ghent, Belgium; [Kropinski, Andrew M.] Publ Hlth Agcy Canada, Lab Foodborne Zoonoses, Toronto, ON, Canada; [Kropinski, Andrew M.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Vandenheuvel, Dieter; Lavigne, Rob] Katholieke Univ Leuven, Lab Gene Technol, Heverlee, Belgium; [Wattiau, Pierre] Vet & Agrochem Res Ctr, Unit Highly Pathogen & Foodborne Zoonoses, Brussels, Belgium; [Mast, Jan] Vet & Agrochem 8 Res Ctr, Electron Microscopy Unit, Brussels, Belgium; [Ragimbeau, Catherine; Mossong, Joel] Lab Natl Sante, Luxembourg, Luxembourg; [Scheres, Jacques] Maastricht Univ, Med Ctr, Maastricht, Netherlands; [Scheres, Jacques] European Ctr Dis Prevent & Control, Stockholm, Sweden	Queen Astrid Military Hospital; Ghent University; Public Health Agency of Canada; University of Guelph; KU Leuven; Maastricht University; European Centre for Disease Prevention & Control	Pirnay, JP (corresponding author), Queen Astrid Mil Hosp, Lab Mol & Cellular Technol, Brussels, Belgium.	jean-paul.pirnay@mil.be	Chanishvili, Nina/CAG-5114-2022; Merabishvili, Maia/GLU-4387-2022; Mossong, Joël/D-4998-2009; Vaneechoutte, Mario/A-6189-2009; Kropinski, Andrew M/H-7130-2016	Chanishvili, Nina/0000-0002-7859-3032; Merabishvili, Maia/0000-0002-2566-0772; Mossong, Joël/0000-0003-0717-9835; Vaneechoutte, Mario/0000-0002-4586-203X; Kropinski, Andrew M/0000-0002-6871-6799; Lavigne, Rob/0000-0001-7377-1314; Pirnay, Jean-Paul/0000-0002-6863-5219; Mast, Jan/0000-0002-4879-3367; Vandenheuvel, Dieter/0000-0002-4398-1916; Ragimbeau, Catherine/0000-0001-7399-2379	Royal Higher Institute for Defense [MED 12]; FWO Vlaanderen [WO.022.09]	Royal Higher Institute for Defense; FWO Vlaanderen(FWO)	This work was suported by the Royal Higher Institute for Defense (grant MED 12). The authors would like to acknowledge the Research community "Phagebiotics" (WO.022.09) grant from the FWO Vlaanderen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann M, 2011, EMERG INFECT DIS, V17, P1906, DOI 10.3201/eid1710.111027; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arbiol C, 2010, GENOME BIOL EVOL, V2, P140, DOI 10.1093/gbe/evq006; Bezuidt O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025702; Bielaszewska M, 2011, LANCET INFECT DIS, V11, P671, DOI 10.1016/S1473-3099(11)70165-7; Brussow H, 2012, VIROLOGY; Bruttin A, 2005, ANTIMICROB AGENTS CH, V49, P2874, DOI 10.1128/AAC.49.7.2874-2878.2005; Buchholz U, 2011, NEW ENGL J MED, V365, P1763, DOI 10.1056/NEJMoa1106482; Casey Pat G, 2011, Bioeng Bugs, V2, P189, DOI 10.4161/bbug.2.4.16961; Edgell DR, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-290; Faruque SM, 2005, P NATL ACAD SCI USA, V102, P1702, DOI 10.1073/pnas.0408992102; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Friedrich AW, 2011, EUROSURVEILLANCE, V16, P2; Goodridge Lawrence D, 2011, Bacteriophage, V1, P130; Imberechts H, 1996, MICROB PATHOGENESIS, V21, P183, DOI 10.1006/mpat.1996.0053; Kimmitt PT, 2000, EMERG INFECT DIS, V6, P458, DOI 10.3201/eid0605.000503; Kropinski AM, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-102; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Maura D, 2012, ENVIRON MICROBIOL, V14, P1844, DOI 10.1111/j.1462-2920.2011.02644.x; Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751; Merabishvili M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004944; Michael M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003595.pub2; Muniesa M, 2012, APPL ENVIRON MICROB, V78, P4065, DOI 10.1128/AEM.00217-12; MYERS EW, 1988, COMPUT APPL BIOSCI, V4, P11, DOI 10.1093/bioinformatics/4.1.11; Pirnay JP, 2012, FUTURE VIROL, V7, P379, DOI 10.2217/FVL.12.24; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Struelens MJ, 2011, EUROSURVEILLANCE, V16, P2; Vandersteegen K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024418	28	36	37	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52709	10.1371/journal.pone.0052709	http://dx.doi.org/10.1371/journal.pone.0052709			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285164	Green Published, Green Submitted, gold			2022-12-27	WOS:000313158800092
J	Morley, SA; Martin, SM; Day, RW; Ericson, J; Lai, CH; Lamare, M; Tan, KS; Thorne, MAS; Peck, LS				Morley, Simon A.; Martin, Stephanie M.; Day, Robert W.; Ericson, Jess; Lai, Chien-Houng; Lamare, Miles; Tan, Koh-Siang; Thorne, Michael A. S.; Peck, Lloyd S.			Thermal Reaction Norms and the Scale of Temperature Variation: Latitudinal Vulnerability of Intertidal Nacellid Limpets to Climate Change	PLOS ONE			English	Article							TOLERANCE; LIMITS; TENACITY; IMPACTS; ECOLOGY; VARIABILITY; SENSITIVITY; PERFORMANCE; STRATEGIES; ECTOTHERMS	The thermal reaction norms of 4 closely related intertidal Nacellid limpets, Antarctic (Nacella concinna), New Zealand (Cellana ornata), Australia (C. tramoserica) and Singapore (C. radiata), were compared across environments with different temperature magnitude, variability and predictability, to test their relative vulnerability to different scales of climate warming. Lethal limits were measured alongside a newly developed metric of "duration tenacity", which was tested at different temperatures to calculate the thermal reaction norm of limpet adductor muscle fatigue. Except in C. tramoserica which had a wide optimum range with two break points, duration tenacity did not follow a typical aerobic capacity curve but was best described by a single break point at an optimum temperature. Thermal reaction norms were shifted to warmer temperatures in warmer environments; the optimum temperature for tenacity (T-opt) increased from 1.0 degrees C (N. concinna) to 14.3 degrees C (C. ornata) to 18.0 degrees C (an average for the optimum range of C. tramoserica) to 27.6 degrees C (C. radiata). The temperature limits for duration tenacity of the 4 species were most consistently correlated with both maximum sea surface temperature and summer maximum in situ habitat logger temperature. Tropical C. radiata, which lives in the least variable and most predictable environment, generally had the lowest warming tolerance and thermal safety margin (WT and TSM; respectively the thermal buffer of CTmax and T-opt over habitat temperature). However, the two temperate species, C. ornata and C. tramoserica, which live in a variable and seasonally unpredictable microhabitat, had the lowest TSM relative to in situ logger temperature. N. concinna which lives in the most variable, but seasonally predictable microhabitat, generally had the highest TSMs. Intertidal animals live at the highly variable interface between terrestrial and marine biomes and even small changes in the magnitude and predictability of their environment could markedly influence their future distributions.	[Morley, Simon A.; Thorne, Michael A. S.; Peck, Lloyd S.] British Antarctic Survey, Nat Environm Res Council, Cambridge, England; [Day, Robert W.] Univ Melbourne, Dept Zool, Parkville, Vic 3052, Australia; [Ericson, Jess; Lamare, Miles] Univ Otago, Dept Marine Sci, Dunedin, New Zealand; [Lai, Chien-Houng; Tan, Koh-Siang] Natl Univ Singapore, Trop Marine Sci Inst, Singapore 117548, Singapore	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; University of Melbourne; University of Otago; National University of Singapore	Morley, SA (corresponding author), British Antarctic Survey, Nat Environm Res Council, Cambridge, England.	smor@bas.ac.uk	Tan, Koh Siang/GOH-0321-2022; Ericson, Jessica/B-1696-2016; Lamare, Miles M/A-7020-2010; Ericson, Jessica/AAP-1976-2020; Day, Robert William/K-6052-2012	Tan, Koh Siang/0000-0002-4599-9482; Ericson, Jessica/0000-0001-5220-8493; Ericson, Jessica/0000-0001-5220-8493; Day, Robert William/0000-0001-5913-2292; Lamare, Miles/0000-0001-8656-7240; Thorne, Michael/0000-0001-7759-612X	Natural environment research council (United Kingdom) [0821010024]; University of Otago Research Committee; Trans-Antarctic Association [TAA05/08]; Rothera marine team; NERC Scientific Diving Facility; NERC [bas0100025, dml011000] Funding Source: UKRI; Natural Environment Research Council [dml011000, bas0100025] Funding Source: researchfish	Natural environment research council (United Kingdom)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); University of Otago Research Committee; Trans-Antarctic Association; Rothera marine team; NERC Scientific Diving Facility(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This project was funded by the Natural environment research council (United Kingdom) core funding to BAS, A*Star proposal (SERC project no. 0821010024), the University of Otago Research Committee and the Trans-Antarctic Association (TAA05/08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; All experiments conform to the current laws of the country in which they were undertaken. We thank Amanda Bates for intellectual input and Mike Barker for limpet identification in New Zealand. Diving in the Antarctic was supported by the Rothera marine team and the NERC Scientific Diving Facility.	BENNETT AF, 1985, J EXP BIOL, V115, P333; BRANCH GM, 1978, J EXP MAR BIOL ECOL, V34, P111, DOI 10.1016/0022-0981(78)90035-7; Brierley AS, 2009, CURR BIOL, V19, pR602, DOI 10.1016/j.cub.2009.05.046; Brown CJ, 2010, GLOBAL CHANGE BIOL, V16, P1194, DOI 10.1111/j.1365-2486.2009.02046.x; Clarke A, 2008, DEEP-SEA RES PT II, V55, P1988, DOI 10.1016/j.dsr2.2008.04.035; Clarke A, 2006, P ROY SOC B-BIOL SCI, V273, P2257, DOI 10.1098/rspb.2006.3545; Clusella-Trullas S, 2011, AM NAT, V177, P738, DOI 10.1086/660021; Compton TJ, 2007, J EXP MAR BIOL ECOL, V352, P200, DOI 10.1016/j.jembe.2007.07.010; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Donelson JM, 2012, NAT CLIM CHANGE, V2, P30, DOI 10.1038/NCLIMATE1323; Finke GR, 2007, MAR ECOL PROG SER, V343, P57, DOI 10.3354/meps06918; Gaston KJ, 2009, AM NAT, V174, P595, DOI 10.1086/605982; GRENON JF, 1981, J EXP MAR BIOL ECOL, V54, P277, DOI 10.1016/0022-0981(81)90162-3; Guderley H, 2004, COMP BIOCHEM PHYS B, V139, P371, DOI 10.1016/j.cbpc.2004.04.001; Guderley H, 2010, CAN J ZOOL, V88, P753, DOI 10.1139/Z10-039; Guppy M, 1999, BIOL REV, V74, P1, DOI 10.1017/S0006323198005258; Hansen J, 2010, REV GEOPHYS, V48, DOI 10.1029/2010RG000345; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Helmuth B, 2002, SCIENCE, V298, P1015, DOI 10.1126/science.1076814; Helmuth B, 2002, INTEGR COMP BIOL, V42, P837, DOI 10.1093/icb/42.4.837; Helmuth B, 2006, ECOL MONOGR, V76, P461, DOI 10.1890/0012-9615(2006)076[0461:MPOTSI]2.0.CO;2; Helmuth B, 2009, J EXP BIOL, V212, P753, DOI 10.1242/jeb.023861; Hochachka P. W., 2002, BIOCH ADAPTATION MEC, DOI 10.1002/bmb.2002.494030030071; HUEY RB, 1989, TRENDS ECOL EVOL, V4, P131, DOI 10.1016/0169-5347(89)90211-5; Lima FP, 2009, LIMNOL OCEANOGR-METH, V7, P347, DOI 10.4319/lom.2009.7.347; Miyazawa K, 2004, ANN BOT-LONDON, V94, P635, DOI 10.1093/aob/mch184; Morley SA, 2011, J EXP MAR BIOL ECOL, V399, P39, DOI 10.1016/j.jembe.2011.01.013; Morley SA, 2010, J EXP MAR BIOL ECOL, V390, P1, DOI 10.1016/j.jembe.2010.04.040; Morley SA, 2009, COMP BIOCHEM PHYS A, V153, P154, DOI 10.1016/j.cbpa.2009.02.001; Munkvik M, 2009, AM J PHYSIOL-REG I, V297, pR900, DOI 10.1152/ajpregu.91043.2008; Nguyen KDT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029340; Obermuller BE, 2011, J EXP MAR BIOL ECOL, V403, P39, DOI 10.1016/j.jembe.2011.04.003; Peck LS, 2008, MAR ECOL PROG SER, V358, P181, DOI 10.3354/meps07336; Peck LS, 2009, FUNCT ECOL, V23, P248, DOI 10.1111/j.1365-2435.2008.01537.x; Peck LS, 2006, BIOL REV, V81, P75, DOI 10.1017/S1464793105006871; Peck LS, 2004, FUNCT ECOL, V18, P625, DOI 10.1111/j.0269-8463.2004.00903.x; Poloczanska ES, 2008, ECOLOGY, V89, P3138, DOI 10.1890/07-1169.1; Portner HO, 2002, COMP BIOCHEM PHYS A, V132, P739, DOI 10.1016/S1095-6433(02)00045-4; Prosser C.L., 1973, COMP ANIMAL PHYSL, VThird; Richard J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034655; ROCKSTEIN M, 1971, BIOL BULL-US, V141, P167, DOI 10.2307/1540001; Sinclair ELE, 2006, J EXP MAR BIOL ECOL, V335, P131, DOI 10.1016/j.jembe.2006.03.010; STEVENS GC, 1989, AM NAT, V133, P240, DOI 10.1086/284913; Stillman JH, 2002, INTEGR COMP BIOL, V42, P790, DOI 10.1093/icb/42.4.790; Sunday JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022881; Sunday JM, 2011, P ROY SOC B-BIOL SCI, V278, P1823, DOI 10.1098/rspb.2010.1295; Tewksbury JJ, 2008, SCIENCE, V320, P1296, DOI 10.1126/science.1159328; Waller CL, 2006, POLAR BIOL, V29, P1077, DOI 10.1007/s00300-006-0152-3; Westerblad H, 2002, NEWS PHYSIOL SCI, V17, P17; WIDDOWS J, 1976, J COMP PHYSIOL, V105, P115, DOI 10.1007/BF00691115; Zeileis A., 2002, J STAT SOFTW, V7, P1, DOI [DOI 10.18637/JSS.V007.I02, 10.18637/jss.v007.i02]	51	20	20	1	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52818	10.1371/journal.pone.0052818	http://dx.doi.org/10.1371/journal.pone.0052818			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285194	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000313158800097
J	Salame, TM; Knop, D; Levinson, D; Mabjeesh, SJ; Yarden, O; Hadar, Y				Salame, Tomer M.; Knop, Doriv; Levinson, Dana; Mabjeesh, Sameer J.; Yarden, Oded; Hadar, Yitzhak			Release of Pleurotus ostreatus Versatile-Peroxidase from Mn2+ Repression Enhances Anthropogenic and Natural Substrate Degradation	PLOS ONE			English	Article							LACCASE MULTIGENE FAMILY; SOLID-STATE FERMENTATION; MANGANESE PEROXIDASE; BIOTECHNOLOGICAL APPLICATIONS; CERIPORIOPSIS-SUBVERMISPORA; PHANEROCHAETE-CHRYSOSPORIUM; HOMOLOGOUS EXPRESSION; LIGNIN DEGRADATION; HEME PEROXIDASES; GENE-EXPRESSION	The versatile-peroxidase (VP) encoded by mnp4 is one of the nine members of the manganese-peroxidase (MnP) gene family that constitutes part of the ligninolytic system of the white-rot basidiomycete Pleurotus ostreatus (oyster mushroom). VP enzymes exhibit dual activity on a wide range of substrates. As Mn2+ supplement to P. ostreatus cultures results in enhanced degradation of recalcitrant compounds and lignin, we examined the effect of Mn2+ on the expression profile of the MnP gene family. In P. ostreatus (monokaryon PC9), mnp4 was found to be the predominantly expressed mnp in Mn2+-deficient media, whereas strongly repressed (to approximately 1%) in Mn2+-supplemented media. Accordingly, in-vitro Mn2+-independent activity was found to be negligible. We tested whether release of mnp4 from Mn2+ repression alters the activity of the ligninolytic system. A transformant over-expressing mnp4 (designated OEmnp4) under the control of the beta-tubulin promoter was produced. Now, despite the presence of Mn2+ in the medium, OEmnp4 produced mnp4 transcript as well as VP activity as early as 4 days after inoculation. The level of expression was constant throughout 10 days of incubation (about 0.4-fold relative to beta-tubulin) and the activity was comparable to the typical activity of PC9 in Mn2+-deficient media. In-vivo decolorization of the azo dyes Orange II, Reactive Black 5, and Amaranth by OEmnp4 preceded that of PC9. OEmnp4 and PC9 were grown for 2 weeks under solid-state fermentation conditions on cotton stalks as a lignocellulosic substrate. [C-14]-lignin mineralization, in-vitro dry matter digestibility, and neutral detergent fiber digestibility were found to be significantly higher (about 25%) in OEmnp4-fermented substrate, relative to PC9. We conclude that releasing Mn2+ suppression of VP4 by over-expression of the mnp4 gene in P. ostreatus improved its ligninolytic functionality.	[Salame, Tomer M.; Knop, Doriv; Levinson, Dana; Yarden, Oded; Hadar, Yitzhak] Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Dept Plant Pathol & Microbiol, Jerusalem, Israel; [Mabjeesh, Sameer J.] Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Dept Anim Sci, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Hadar, Y (corresponding author), Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Dept Plant Pathol & Microbiol, Jerusalem, Israel.	hadar@agri.huji.ac.il	Yarden, Oded/J-5988-2012		Ministry of Science and Technology, Israel; U.S.-Israel Binational Science Foundation (BSF) [2011505]	Ministry of Science and Technology, Israel; U.S.-Israel Binational Science Foundation (BSF)(US-Israel Binational Science Foundation)	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This research was partially supported by the Ministry of Science and Technology, Israel, and by grant No. 2011505 from the U.S.-Israel Binational Science Foundation (BSF). No additional external funding received for this study.	BONNARME P, 1990, APPL ENVIRON MICROB, V56, P210, DOI 10.1128/AEM.56.1.210-217.1990; Chen M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025647; Cohen R, 2002, APPL ENVIRON MICROB, V68, P3156, DOI 10.1128/AEM.68.6.3156-3158.2002; Cohen R, 2002, APPL MICROBIOL BIOT, V58, P582, DOI 10.1007/s00253-002-0930-y; Cohen R, 2002, APPL BIOCHEM BIOTECH, V102, P415, DOI 10.1385/ABAB:102-103:1-6:415; Cohen R, 2001, ENVIRON MICROBIOL, V3, P312, DOI 10.1046/j.1462-2920.2001.00197.x; Collins PJ, 1999, APPL ENVIRON MICROB, V65, P1343; Courty PE, 2009, NEW PHYTOL, V182, P736, DOI 10.1111/j.1469-8137.2009.02774.x; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; Garcia-Ruiz E, 2012, BIOCHEM J, V441, P487, DOI 10.1042/BJ20111199; Gettemy JM, 1998, APPL ENVIRON MICROB, V64, P569; Golan-Rozen N, 2011, ENVIRON SCI TECHNOL, V45, P6800, DOI 10.1021/es200298t; Gutierrez M, 2008, CURR GENET, V54, P163, DOI 10.1007/s00294-008-0209-7; Hammel KE, 2008, CURR OPIN PLANT BIOL, V11, P349, DOI 10.1016/j.pbi.2008.02.003; Hofrichter M, 2010, APPL MICROBIOL BIOT, V87, P871, DOI 10.1007/s00253-010-2633-0; Honda Y, 2000, CURR GENET, V37, P209, DOI 10.1007/s002940050521; Irie T, 2001, APPL MICROBIOL BIOT, V55, P566, DOI 10.1007/s002530000540; Irie T, 2001, APPL MICROBIOL BIOT, V55, P563, DOI 10.1007/s002530000535; Kamitsuji H, 2004, APPL MICROBIOL BIOT, V65, P287, DOI 10.1007/s00253-003-1543-9; KEREM Z, 1995, APPL ENVIRON MICROB, V61, P3057, DOI 10.1128/AEM.61.8.3057-3062.1995; KEREM Z, 1993, APPL ENVIRON MICROB, V59, P4115, DOI 10.1128/AEM.59.12.4115-4120.1993; Kersten P, 2007, FUNGAL GENET BIOL, V44, P77, DOI 10.1016/j.fgb.2006.07.007; Kilaru S, 2006, CURR GENET, V50, P45, DOI 10.1007/s00294-006-0074-1; Larraya LM, 1999, APPL ENVIRON MICROB, V65, P3413; MacDonald J, 2012, APPL MICROBIOL BIOT, V94, P339, DOI 10.1007/s00253-012-3937-z; Martinez AT, 2005, INT MICROBIOL, V8, P195; Martinez MJ, 1996, EUR J BIOCHEM, V237, P424, DOI 10.1111/j.1432-1033.1996.0424k.x; Morgenstern I, 2008, J MOL EVOL, V66, P243, DOI 10.1007/s00239-008-9079-3; Ninomiya Y, 2004, P NATL ACAD SCI USA, V101, P12248, DOI 10.1073/pnas.0402780101; Pezzella C, 2009, CURR GENET, V55, P45, DOI 10.1007/s00294-008-0221-y; Ruiz-Duenas FJ, 2011, CR BIOL, V334, P795, DOI 10.1016/j.crvi.2011.06.004; Salame TM, 2012, APPL ENVIRON MICROB, V78, P5341, DOI 10.1128/AEM.01234-12; Salame TM, 2011, APPL MICROBIOL BIOT, V89, P501, DOI 10.1007/s00253-010-2928-1; Salame TM, 2010, MICROB BIOTECHNOL, V3, P93, DOI 10.1111/j.1751-7915.2009.00154.x; Sambrook J., 2002, MOL CLONING LAB MANU; Sanchez C, 2010, APPL MICROBIOL BIOT, V85, P1321, DOI 10.1007/s00253-009-2343-7; Stajic M, 2009, CRIT REV BIOTECHNOL, V29, P55, DOI 10.1080/07388550802688821; TILLEY J. M. A., 1963, JOUR BRIT GRASSLAND SOC, V18, P104; Tsukihara T, 2006, APPL MICROBIOL BIOT, V71, P114, DOI 10.1007/s00253-005-0136-1; URZUA U, 1995, FEBS LETT, V371, P132, DOI 10.1016/0014-5793(95)00874-9; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Wymelenberg AV, 2011, APPL ENVIRON MICROB, V77, P4499, DOI 10.1128/AEM.00508-11; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001	43	28	30	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52446	10.1371/journal.pone.0052446	http://dx.doi.org/10.1371/journal.pone.0052446			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285046	gold, Green Published, Green Submitted			2022-12-27	WOS:000313158800067
J	Wijgerde, T; Jurriaans, S; Hoofd, M; Verreth, JAJ; Osinga, R				Wijgerde, Tim; Jurriaans, Saskia; Hoofd, Marleen; Verreth, Johan A. J.; Osinga, Ronald			Oxygen and Heterotrophy Affect Calcification of the Scleractinian Coral Galaxea fascicularis	PLOS ONE			English	Article							STYLOPHORA-PISTILLATA; SKELETAL GROWTH; ARTEMIA-SALINA; PHOTOSYNTHESIS; ZOOXANTHELLAE; REEF; RESPIRATION; LIGHT; WATER; STARVATION	Heterotrophy is known to stimulate calcification of scleractinian corals, possibly through enhanced organic matrix synthesis and photosynthesis, and increased supply of metabolic DIC. In contrast to the positive long-term effects of heterotrophy, inhibition of calcification has been observed during feeding, which may be explained by a temporal oxygen limitation in coral tissue. To test this hypothesis, we measured the short-term effects of zooplankton feeding on light and dark calcification rates of the scleractinian coral Galaxea fascicularis (n = 4) at oxygen saturation levels ranging from 13 to 280%. Significant main and interactive effects of oxygen, heterotrophy and light on calcification rates were found (three-way factorial repeated measures ANOVA, p < 0.05). Light and dark calcification rates of unfed corals were severely affected by hypoxia and hyperoxia, with optimal rates at 110% saturation. Light calcification rates of fed corals exhibited a similar trend, with highest rates at 150% saturation. In contrast, dark calcification rates of fed corals were close to zero under all oxygen saturations. We conclude that oxygen exerts a strong control over light and dark calcification rates of corals, and propose that in situ calcification rates are highly dynamic. Nevertheless, the inhibitory effect of heterotrophy on dark calcification appears to be oxygen-independent. We hypothesize that dark calcification is impaired during zooplankton feeding by a temporal decrease of the pH and aragonite saturation state of the calcifying medium, caused by increased respiration rates. This may invoke a transient reallocation of metabolic energy to soft tissue growth and organic matrix synthesis. These insights enhance our understanding of how oxygen and heterotrophy affect coral calcification, both in situ as well as in aquaculture.	[Wijgerde, Tim; Jurriaans, Saskia; Hoofd, Marleen; Verreth, Johan A. J.; Osinga, Ronald] Wageningen Univ, Univ Wageningen & Res Ctr, Dept Anim Sci, Aquaculture & Fisheries Grp, NL-6700 AP Wageningen, Netherlands	Wageningen University & Research	Wijgerde, T (corresponding author), Wageningen Univ, Univ Wageningen & Res Ctr, Dept Anim Sci, Aquaculture & Fisheries Grp, NL-6700 AP Wageningen, Netherlands.	tim.wijgerde@wur.nl	Verreth, Johan/ABD-7198-2020	Verreth, Johan/0000-0001-7277-5129; Jurriaans, Saskia/0000-0003-1534-8301	EU [244161]	EU(European Commission)	This study was funded by the EU Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 244161 (FORCE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Horani FA, 2007, CORAL REEFS, V26, P531, DOI 10.1007/s00338-007-0250-x; Al-Horani FA, 2003, MAR BIOL, V142, P419, DOI 10.1007/s00227-002-0981-8; Allemand D, 1998, J EXP BIOL, V201, P2001; BABCOCK GT, 1992, NATURE, V356, P301, DOI 10.1038/356301a0; BREWER PG, 1976, LIMNOL OCEANOGR, V21, P108, DOI 10.4319/lo.1976.21.1.0108; CHALKER BE, 1975, PROC R SOC SER B-BIO, V190, P323, DOI 10.1098/rspb.1975.0096; CHISHOLM JRM, 1991, LIMNOL OCEANOGR, V36, P1232, DOI 10.4319/lo.1991.36.6.1232; Colombo-Pallotta MF, 2010, CORAL REEFS, V29, P899, DOI 10.1007/s00338-010-0638-x; DUBINSKY Z, 1990, PROC R SOC SER B-BIO, V239, P231, DOI 10.1098/rspb.1990.0015; Ferrier-Pages C, 2003, CORAL REEFS, V22, P229, DOI 10.1007/s00338-003-0312-7; FRIDOVICH I, 1977, BIOSCIENCE, V27, P462, DOI 10.2307/1297527; Furla P, 2000, J EXP BIOL, V203, P3445; Hii YS, 2009, AQUACULT INT, V17, P363, DOI 10.1007/s10499-008-9208-4; Houlbreque F, 2004, J EXP BIOL, V207, P1461, DOI 10.1242/jeb.00911; Houlbreque F, 2003, J EXP MAR BIOL ECOL, V296, P145; Houlbreque F, 2009, BIOL REV, V84, P1, DOI 10.1111/j.1469-185X.2008.00058.x; IP YK, 1991, MAR BIOL, V111, P191, DOI 10.1007/BF01319700; Kawaguti S., 1948, Bulletin of the Oceanographical Institute of Taiwan, VNo. 4, P65; KINSEY DW, 1967, AUST J MAR FRESH RES, V18, P23, DOI 10.1071/MF9670023; Kraines S, 1996, LIMNOL OCEANOGR, V41, P1790, DOI 10.4319/lo.1996.41.8.1790; KUHL M, 1995, MAR ECOL PROG SER, V117, P159, DOI 10.3354/meps117159; LESSER MP, 1989, J EXP MAR BIOL ECOL, V134, P129, DOI 10.1016/0022-0981(90)90105-L; Marshall AT, 2002, J EXP BIOL, V205, P2107; Marubini F, 1999, LIMNOL OCEANOGR, V44, P716, DOI 10.4319/lo.1999.44.3.0716; Mass T, 2010, P NATL ACAD SCI USA, V107, P2527, DOI 10.1073/pnas.0912348107; MATTA JL, 1991, SYMBIOSIS, V11, P31; Osinga R, 2011, MAR BIOTECHNOL, V13, P658, DOI 10.1007/s10126-011-9382-7; RINKEVICH B, 1984, MAR BIOL, V80, P1, DOI 10.1007/BF00393120; SHASHAR N, 1993, BIOL BULL, V185, P455, DOI 10.2307/1542485; SHASHAR N, 1992, J EXP MAR BIOL ECOL, V163, P277, DOI 10.1016/0022-0981(92)90055-F; SHICK JM, 1985, OECOLOGIA, V66, P33, DOI 10.1007/BF00378549; SZMANTFROELICH A, 1984, MAR BIOL, V81, P153, DOI 10.1007/BF00393114; Titlyanov E, 2000, MAR BIOL, V137, P463, DOI 10.1007/s002270000370; Titlyanov EA, 2000, SYMBIOSIS, V28, P303; Titlyanov EA, 2001, J EXP MAR BIOL ECOL, V257, P163, DOI 10.1016/S0022-0981(00)00308-7; Wangpraseurt D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031192; Wijgerde T, 2011, J EXP BIOL, V214, P3351, DOI 10.1242/jeb.058354	37	21	21	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52702	10.1371/journal.pone.0052702	http://dx.doi.org/10.1371/journal.pone.0052702			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285159	gold, Green Published, Green Submitted			2022-12-27	WOS:000313158800091
J	Guo, SZ; Zhou, YM; Xing, CH; Lok, J; Som, AT; Ning, MM; Ji, XM; Lo, EH				Guo, Shuzhen; Zhou, Yiming; Xing, Changhong; Lok, Josephine; Som, Angel T.; Ning, MingMing; Ji, Xunming; Lo, Eng H.			The Vasculome of the Mouse Brain	PLOS ONE			English	Article							CEREBRAL ENDOTHELIAL-CELLS; UCH37 DEUBIQUITINATING ENZYME; SPINOCEREBELLAR ATAXIA TYPE-1; PSORIASIS SUSCEPTIBILITY GENE; ENDOPLASMIC-RETICULUM STRESS; CHROMATIN-REMODELING COMPLEX; LONG-TERM POTENTIATION; NITRIC-OXIDE SYNTHASE; 20-LIKE KINASE-3 MST3; C FAMILY-MEMBERS	The blood vessel is no longer viewed as passive plumbing for the brain. Increasingly, experimental and clinical findings suggest that cerebral endothelium may possess endocrine and paracrine properties - actively releasing signals into and receiving signals from the neuronal parenchyma. Hence, metabolically perturbed microvessels may contribute to central nervous system (CNS) injury and disease. Furthermore, cerebral endothelium can serve as sensors and integrators of CNS dysfunction, releasing measurable biomarkers into the circulating bloodstream. Here, we define and analyze the concept of a brain vasculome, i.e. a database of gene expression patterns in cerebral endothelium that can be linked to other databases and systems of CNS mediators and markers. Endothelial cells were purified from mouse brain, heart and kidney glomeruli. Total RNA were extracted and profiled on Affymetrix mouse 430 2.0 micro-arrays. Gene expression analysis confirmed that these brain, heart and glomerular preparations were not contaminated by brain cells (astrocytes, oligodendrocytes, or neurons), cardiomyocytes or kidney tubular cells respectively. Comparison of the vasculome between brain, heart and kidney glomeruli showed that endothelial gene expression patterns were highly organ-dependent. Analysis of the brain vasculome demonstrated that many functionally active networks were present, including cell adhesion, transporter activity, plasma membrane, leukocyte transmigration, Wnt signaling pathways and angiogenesis. Analysis of representative genome-wide-association-studies showed that genes linked with Alzheimer's disease, Parkinson's disease and stroke were detected in the brain vasculome. Finally, comparison of our mouse brain vasculome with representative plasma protein databases demonstrated significant overlap, suggesting that the vasculome may be an important source of circulating signals in blood. Perturbations in cerebral endothelial function may profoundly affect CNS homeostasis. Mapping and dissecting the vasculome of the brain in health and disease may provide a novel database for investigating disease mechanisms, assessing therapeutic targets and exploring new biomarkers for the CNS.	[Guo, Shuzhen; Zhou, Yiming; Xing, Changhong; Lok, Josephine; Som, Angel T.; Ning, MingMing; Lo, Eng H.] Harvard Univ, Sch Med, Dept Radiol, Neuroprotect Res Lab,Massachusetts Gen Hosp, Boston, MA 02115 USA; [Guo, Shuzhen; Zhou, Yiming; Xing, Changhong; Lok, Josephine; Som, Angel T.; Ning, MingMing; Lo, Eng H.] Harvard Univ, Sch Med, Dept Neurol, Neuroprotect Res Lab,Massachusetts Gen Hosp, Boston, MA 02115 USA; [Zhou, Yiming] Broad Inst Massachusetts Inst Technol & Harvard M, Boston, MA USA; [Lok, Josephine] Harvard Univ, Sch Med, Dept Pediat, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Ning, MingMing; Lo, Eng H.] Harvard Univ, Sch Med, Dept Neurol, Clin Prote Res Ctr,Massachusetts Gen Hosp, Boston, MA 02115 USA; [Ji, Xunming] Capital Med Univ, Cerebrovasc Res Ctr, XuanWu Hosp, Beijing, Peoples R China	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Capital Medical University	Guo, SZ (corresponding author), Harvard Univ, Sch Med, Dept Radiol, Neuroprotect Res Lab,Massachusetts Gen Hosp, Boston, MA 02115 USA.	sguo@partners.org; Lo@helix.mgh.harvard.edu	Ji, Xunming/AAN-3370-2021		NIH [RC2-NS69335, R37-NS37074, R01-NS76694, P01-NS55104]; Claflin award from Massachusetts General Hospital; Phyliss and Jerome Lyle Rappaport MGH Research Scholar award; Beijing Natural Science Foundation; China National Basic Research 973 Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS055104, RC2NS069335, K08NS057339, R37NS037074, R01NS076694, R01NS067139] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Claflin award from Massachusetts General Hospital; Phyliss and Jerome Lyle Rappaport MGH Research Scholar award; Beijing Natural Science Foundation(Beijing Natural Science Foundation); China National Basic Research 973 Program(National Basic Research Program of China); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by studies funded in part by grants from the NIH (RC2-NS69335, R37-NS37074, R01-NS76694, P01-NS55104), the Claflin award from Massachusetts General Hospital, the Phyliss and Jerome Lyle Rappaport MGH Research Scholar award, the Beijing Natural Science Foundation, and the China National Basic Research 973 Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aase K, 2007, GENE DEV, V21, P2055, DOI 10.1101/gad.432007; Abbott NJ, 2002, J ANAT, V200, P629, DOI 10.1046/j.1469-7580.2002.00064.x; Acevedo L, 2004, NAT MED, V10, P382, DOI 10.1038/nm1020; Al-Ramahi I, 2006, J BIOL CHEM, V281, P26714, DOI 10.1074/jbc.M601603200; Andras IE, 2007, J CEREBR BLOOD F MET, V27, P1431, DOI 10.1038/sj.jcbfm.9600445; Anveden A, 2012, OBESITY, V20, P708, DOI 10.1038/oby.2011.268; Arese M, 2011, INT J DEV BIOL, V55, P439, DOI 10.1387/ijdb.103242ma; Askarova S, 2011, NEUROSCIENCE, V199, P375, DOI 10.1016/j.neuroscience.2011.09.038; Asrar S, 2009, NEUROPHARMACOLOGY, V56, P73, DOI 10.1016/j.neuropharm.2008.06.055; Aston C, 2005, MOL PSYCHIATR, V10, P309, DOI 10.1038/sj.mp.4001565; Aston C, 2004, J NEUROSCI RES, V77, P858, DOI 10.1002/jnr.20208; Astorga J, 2007, DEVELOPMENT, V134, P3753, DOI 10.1242/dev.004432; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Baird JW, 1999, J BIOL CHEM, V274, P33496, DOI 10.1074/jbc.274.47.33496; Banu N, 2006, FASEB J, V20, P2150, DOI 10.1096/fj.05-5698fje; Beard RS, 2011, BLOOD, V118, P2007, DOI 10.1182/blood-2011-02-338269; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Bergaya S, 2011, HYPERTENSION, V58, P439, DOI 10.1161/HYPERTENSIONAHA.111.172429; Bijlmakers MJ, 2011, HUM MOL GENET, V20, P3129, DOI 10.1093/hmg/ddr215; Blais V, 2001, J NEUROPATH EXP NEUR, V60, P893, DOI 10.1093/jnen/60.9.893; Bokoch GM, 1998, CELL DEATH DIFFER, V5, P637, DOI 10.1038/sj.cdd.4400405; Bost F, 1998, EUR J BIOCHEM, V252, P339, DOI 10.1046/j.1432-1327.1998.2520339.x; Bottos A, 2009, P NATL ACAD SCI USA, V106, P20782, DOI 10.1073/pnas.0809510106; Bratt A, 2005, J BIOL CHEM, V280, P34859, DOI 10.1074/jbc.M503915200; Buchner DA, 2007, P NATL ACAD SCI USA, V104, P13996, DOI 10.1073/pnas.0700947104; Capon F, 2008, HUM MOL GENET, V17, P1938, DOI 10.1093/hmg/ddn091; Cappuzzello C, 2007, CARDIOVASC RES, V75, P608, DOI 10.1016/j.cardiores.2007.04.020; Causeret F, 2009, CEREB CORTEX, V19, P861, DOI 10.1093/cercor/bhn133; Chen SY, 2011, P NATL ACAD SCI USA, V108, P5861, DOI 10.1073/pnas.1018128108; Chong ZZ, 2007, CURR NEUROVASC RES, V4, P194; Chrissobolis S, 2008, TRENDS MOL MED, V14, P495, DOI 10.1016/j.molmed.2008.09.003; Chui R, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-1; Collard CD, 2002, J BIOL CHEM, V277, P14801, DOI 10.1074/jbc.M110557200; Conrotto P, 2005, BLOOD, V105, P4321, DOI 10.1182/blood-2004-07-2885; Crack PJ, 2006, J NEURAL TRANSM, V113, P645, DOI 10.1007/s00702-005-0352-y; D'Arcy P, 2011, NAT MED, V17, P1636, DOI 10.1038/nm.2536; Daneman R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013741; Daneman R, 2009, P NATL ACAD SCI USA, V106, P641, DOI 10.1073/pnas.0805165106; de la Torre-Ubieta L, 2010, GENE DEV, V24, P799, DOI 10.1101/gad.1880510; DEHAAN JB, 1995, BIOCHEM MOL BIOL INT, V35, P1281; DELI MA, 1993, J NEUROCHEM, V60, P1960, DOI 10.1111/j.1471-4159.1993.tb13429.x; Demyanenko GP, 2010, NEUROSCIENCE, V165, P107, DOI 10.1016/j.neuroscience.2009.09.077; Demyanenko GP, 2011, J NEUROSCI, V31, P1545, DOI 10.1523/JNEUROSCI.4467-10.2011; Di Lorenzo A, 2011, BLOOD, V117, P2284, DOI 10.1182/blood-2010-04-281956; Diep DB, 2004, DEV BRAIN RES, V153, P261, DOI 10.1016/j.devbrainres.2004.09.008; Dougherty JD, 2010, NUCLEIC ACIDS RES, V38, P4218, DOI 10.1093/nar/gkq130; Doupnik CA, 1997, P NATL ACAD SCI USA, V94, P10461, DOI 10.1073/pnas.94.19.10461; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Dugas JC, 2008, J NEUROSCI, V28, P8294, DOI 10.1523/JNEUROSCI.2010-08.2008; Dukhanina EA, 2008, B EXP BIOL MED+, V145, P191, DOI 10.1007/s10517-008-0047-0; Enerson BE, 2006, J CEREBR BLOOD F MET, V26, P959, DOI 10.1038/sj.jcbfm.9600249; Ernkvist M, 2006, FEBS J, V273, P2000, DOI 10.1111/j.1742-4658.2006.05216.x; Ernkvist M, 2008, BBA-MOL CELL RES, V1783, P429, DOI 10.1016/j.bbamcr.2007.11.018; Falk S, 2008, CELL STEM CELL, V2, P472, DOI 10.1016/j.stem.2008.03.006; Fancy SPJ, 2011, NAT NEUROSCI, V14, P1009, DOI 10.1038/nn.2855; FISCHER I, 1991, J NEUROSCI RES, V28, P81, DOI 10.1002/jnr.490280108; Flatman PW, 2008, CURR OPIN NEPHROL HY, V17, P186, DOI 10.1097/MNH.0b013e3282f5244e; Fleegal MA, 2005, AM J PHYSIOL-HEART C, V289, pH2012, DOI 10.1152/ajpheart.00495.2005; Frey RS, 2009, ANTIOXID REDOX SIGN, V11, P791, DOI [10.1089/ars.2008.2220, 10.1089/ARS.2008.2220]; Galasso G, 2006, CIRC RES, V98, P254, DOI 10.1161/01.RES.0000200740.57764.52; Gandhi S, 2010, NAT NEUROSCI, V13, P789, DOI 10.1038/nn.2584; Garbuzova-Davis S, 2011, BRAIN RES, V1398, P113, DOI 10.1016/j.brainres.2011.04.049; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Glienke J, 2000, EUR J BIOCHEM, V267, P2820, DOI 10.1046/j.1432-1327.2000.01325.x; Goeckeler ZM, 2000, J BIOL CHEM, V275, P18366, DOI 10.1074/jbc.M001339200; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a; Greenberg DA, 2005, NATURE, V438, P954, DOI 10.1038/nature04481; Guo SZ, 2008, P NATL ACAD SCI USA, V105, P7582, DOI 10.1073/pnas.0801105105; Guo SZ, 2012, J NEUROCHEM, V123, P58, DOI 10.1111/j.1471-4159.2012.07944.x; Guo SZ, 2009, STROKE, V40, pS4, DOI 10.1161/STROKEAHA.108.534388; Hamm A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-25; Han J, 2006, NEURON, V51, P575, DOI 10.1016/j.neuron.2006.07.012; Hayashi ML, 2007, P NATL ACAD SCI USA, V104, P11489, DOI 10.1073/pnas.0705003104; Helms HC, 2012, GLIA, V60, P882, DOI 10.1002/glia.22321; Holton M, 2010, CARDIOVASC RES, V87, P440, DOI 10.1093/cvr/cvq077; Homey B, 2002, NAT MED, V8, P157, DOI 10.1038/nm0202-157; Huang CYF, 2002, J BIOL CHEM, V277, P34367, DOI 10.1074/jbc.M202468200; Hutchison RM, 2009, HIPPOCAMPUS, V19, P687, DOI 10.1002/hipo.20582; Irwin N, 2006, P NATL ACAD SCI USA, V103, P18320, DOI 10.1073/pnas.0605135103; Ishibashi N, 2002, J IMMUNOL, V168, P1926, DOI 10.4049/jimmunol.168.4.1926; Ishibashi N, 2002, MOL BRAIN RES, V109, P34, DOI 10.1016/S0169-328X(02)00459-X; Jukkola T, 2004, GENE EXPR PATTERNS, V4, P755, DOI 10.1016/j.modgep.2004.03.006; Jung BP, 2002, NEUROSCIENCE, V115, P515, DOI 10.1016/S0306-4522(02)00383-4; Kalani MYS, 2008, P NATL ACAD SCI USA, V105, P16970, DOI 10.1073/pnas.0808616105; Kalin TV, 2008, AM J RESP CELL MOL, V39, P390, DOI 10.1165/rcmb.2008-0044OC; Kammermeier PJ, 1999, NEURON, V22, P819, DOI 10.1016/S0896-6273(00)80740-0; Kanda S, 2004, CELL SIGNAL, V16, P1273, DOI 10.1016/j.cellsig.2004.03.010; Kang P, 2012, NEURON, V74, P79, DOI 10.1016/j.neuron.2012.01.024; Ke Y, 2007, CAN J PHYSIOL PHARM, V85, P281, DOI 10.1139/Y06-100; Klein IK, 2009, J BIOL CHEM, V284, P25953, DOI 10.1074/jbc.M109.035071; Koga M, 2009, HUM MOL GENET, V18, P2483, DOI 10.1093/hmg/ddp166; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; KRIZBAI I, 1995, J NEUROCHEM, V65, P459; Krizbai IA, 1998, J NEUROSCI RES, V54, P814; Kruger RR, 2005, NAT REV MOL CELL BIO, V6, P789, DOI 10.1038/nrm1740; Kukalev A, 2005, NAT STRUCT MOL BIOL, V12, P238, DOI 10.1038/nsmb904; Laflamme N, 1999, J NEUROCHEM, V73, P309, DOI 10.1046/j.1471-4159.1999.0730309.x; Lam YC, 2006, CELL, V127, P1335, DOI 10.1016/j.cell.2006.11.038; Lanzani C, 2005, J HYPERTENS, V23, P543, DOI 10.1097/01.hjh.0000160210.48479.78; Lecrux C, 2011, ACTA PHYSIOL, V203, P47, DOI 10.1111/j.1748-1716.2011.02256.x; Leventhal C, 1999, MOL CELL NEUROSCI, V13, P450, DOI 10.1006/mcne.1999.0762; Li C, 2000, AM J PHYSIOL-RENAL, V279, pF785, DOI 10.1152/ajprenal.2000.279.4.F785; Li WQ, 2004, J BIOL CHEM, V279, P32824, DOI 10.1074/jbc.M401878200; Liebner S, 2008, J CELL BIOL, V183, P409, DOI 10.1083/jcb.200806024; Lifschytz T, 2011, INT J NEUROPSYCHOPH, P1; Lim YC, 2006, METH MOL B, V341, P141; Liu C, 2000, J BIOL CHEM, V275, P24490, DOI 10.1074/jbc.M001239200; Liu T, 2005, J PROTEOME RES, V4, P2070, DOI 10.1021/pr0502065; Liu T, 2006, MOL CELL PROTEOMICS, V5, P1899, DOI 10.1074/mcp.M600068-MCP200; Lorber B, 2009, NAT NEUROSCI, V12, P1407, DOI 10.1038/nn.2414; Lu TJ, 2006, J BIOL CHEM, V281, P38405, DOI 10.1074/jbc.M605035200; Malin D, 2007, MOL CELL BIOL, V27, P2486, DOI 10.1128/MCB.01736-06; Manunta P, 2008, HYPERTENSION, V52, P366, DOI 10.1161/HYPERTENSIONAHA.108.113977; Manunta P, 2007, PHARMACOGENOMICS, V8, P465, DOI 10.2217/14622416.8.5.465; Matilla-Duenas A, 2008, CEREBELLUM, V7, P106, DOI 10.1007/s12311-008-0009-0; Mayo JN, 2012, J CEREBR BLOOD F MET, V32, P825, DOI 10.1038/jcbfm.2011.185; Mazumdar T, 2010, P NATL ACAD SCI USA, V107, P13854, DOI 10.1073/pnas.0913495107; McCormick JA, 2011, PHYSIOL REV, V91, P177, DOI 10.1152/physrev.00017.2010; Miller AD, 2008, J VIROL, V82, P6862, DOI 10.1128/JVI.00397-08; Morrison AC, 2002, HYPERTENSION, V39, P1053, DOI 10.1161/01.HYP.0000019128.94483.3A; Moy SS, 2009, BEHAV BRAIN RES, V205, P123, DOI 10.1016/j.bbr.2009.06.021; Muthusamy B, 2005, PROTEOMICS, V5, P3531, DOI 10.1002/pmic.200401335; Nadadur SS, 2009, TOXICOL IN VITRO, V23, P67, DOI 10.1016/j.tiv.2008.10.004; Navaratna D, 2011, DIABETES, V60, P1789, DOI 10.2337/db10-1371; Neuwelt EA, 2011, NAT REV NEUROSCI, V12, P169, DOI 10.1038/nrn2995; Nguyen HL, 2011, LAB INVEST, V91, P1554, DOI 10.1038/labinvest.2011.124; Nibbs RJB, 2003, EXPERT OPIN BIOL TH, V3, P15, DOI 10.1517/14712598.3.1.15; Ning MM, 2011, STROKE, V42, P37, DOI 10.1161/STROKEAHA.110.585703; Omenn GS, 2005, PROTEOMICS, V5, P3226, DOI 10.1002/pmic.200500358; Ormestad M, 2006, DEVELOPMENT, V133, P833, DOI 10.1242/dev.02252; Osei-Owusu P, 2012, J BIOL CHEM, V287, P12541, DOI 10.1074/jbc.M111.332130; Pardridge WM, 2007, STROKE, V38, P686, DOI 10.1161/01.STR.0000247887.61831.74; Parfenova H, 2003, J CEREBR BLOOD F MET, V23, P190, DOI 10.1097/01.WCB.000004823561824.C4; Park M, 2012, EMBO J, V31, P2697, DOI 10.1038/emboj.2012.145; Pasterkamp RJ, 2009, CURR OPIN NEUROBIOL, V19, P263, DOI 10.1016/j.conb.2009.06.001; Perticone F, 2007, J HYPERTENS, V25, P2234, DOI 10.1097/HJH.0b013e3282ef3a50; Phng LK, 2009, DEV CELL, V16, P70, DOI 10.1016/j.devcel.2008.12.009; Pi XC, 2009, P NATL ACAD SCI USA, V106, P5675, DOI 10.1073/pnas.0809568106; Ping PP, 2005, PROTEOMICS, V5, P3506, DOI 10.1002/pmic.200500140; Planutiene M, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-28; Qian WJ, 2008, MOL CELL PROTEOMICS, V7, P1963, DOI 10.1074/mcp.M800008-MCP200; Rao XQ, 2011, CIRCULATION, V123, P2964, DOI 10.1161/CIRCULATIONAHA.110.966408; Rehman A, 2001, CYTOKINE, V13, P8, DOI 10.1006/cyto.2000.0800; Reisman DN, 2005, APPL IMMUNOHISTO M M, V13, P66, DOI 10.1097/00129039-200503000-00011; Robson A, 2010, DEV DYNAM, V239, P2435, DOI 10.1002/dvdy.22376; Ronaldson PT, 2012, CURR PHARM DESIGN, V18, P3624; Roudier E, 2009, J PHYSIOL-LONDON, V587, P4105, DOI 10.1113/jphysiol.2009.175554; Rudrabhatla RS, 2006, MICROBES INFECT, V8, P460, DOI 10.1016/j.micinf.2005.07.012; Rudrabhatla RS, 2003, INFECT IMMUN, V71, P2787, DOI 10.1128/IAI.71.5.2787-2797.2003; Rzymski T, 2012, ONCOGENE, V31, P3621, DOI 10.1038/onc.2011.522; Sakurai A, 2012, CELL RES, V22, P23, DOI 10.1038/cr.2011.198; Sakurai T, 2012, MOL CELL NEUROSCI, V49, P351, DOI 10.1016/j.mcn.2011.12.002; Salminen A, 2010, MOL MED, V16, P535, DOI 10.2119/molmed.2010.00070; Sarzani R, 2006, J HYPERTENS, V24, P697, DOI 10.1097/01.hjh.0000217852.89745.dc; Schmid RS, 2004, NEUROREPORT, V15, P2791; Seifert M, 2007, ONCOL REP, V17, P1207; Sharp FR, 2006, ARCH NEUROL-CHICAGO, V63, P1529, DOI 10.1001/archneur.63.11.1529; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Shimomura Y, 2010, NATURE, V464, P1043, DOI 10.1038/nature08875; Smoller JW, 2008, ARCH GEN PSYCHIAT, V65, P298, DOI 10.1001/archgenpsychiatry.2007.48; Stegert MR, 2005, MOL CELL BIOL, V25, P11019, DOI 10.1128/MCB.25.24.11019-11029.2005; Stenman JM, 2008, SCIENCE, V322, P1247, DOI 10.1126/science.1164594; Stockton R, 2007, MOL BIOL CELL, V18, P2346, DOI 10.1091/mbc.E06-07-0584; Street VA, 1998, NAT GENET, V19, P390, DOI 10.1038/1284; Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977; Tajima M, 2009, EUR J PHARMACOL, V606, P45, DOI 10.1016/j.ejphar.2009.01.026; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Tam SJ, 2012, DEV CELL, V22, P403, DOI 10.1016/j.devcel.2011.11.018; Tong X, 2011, EMBO REP, V12, P428, DOI 10.1038/embor.2011.49; Tossidou I, 2007, J BIOL CHEM, V282, P7457, DOI 10.1074/jbc.M608519200; Tripathy D, 2007, J ALZHEIMERS DIS, V11, P447; Troyanovsky B, 2001, J CELL BIOL, V152, P1247, DOI 10.1083/jcb.152.6.1247; Tsai CC, 2004, P NATL ACAD SCI USA, V101, P4047, DOI 10.1073/pnas.0400615101; Tsang Sharon, 2010, Front Biosci (Schol Ed), V2, P547; Tsyba L, 2011, GENE, V473, P67, DOI 10.1016/j.gene.2010.11.016; Tudor EL, 2005, J BIOL CHEM, V280, P34735, DOI 10.1074/jbc.M506216200; van Rijn MJE, 2006, STROKE, V37, P2930, DOI 10.1161/01.STR.0000248760.67039.2b; Varela-Nallar L, 2010, P NATL ACAD SCI USA, V107, P21164, DOI 10.1073/pnas.1010011107; Veeck J, 2008, ONCOGENE, V27, P865, DOI 10.1038/sj.onc.1210669; Wallgard E, 2008, ARTERIOSCL THROM VAS, V28, P1469, DOI 10.1161/ATVBAHA.108.165738; Wang F, 2004, J BIOL CHEM, V279, P46733, DOI 10.1074/jbc.M409002200; Wicks SJ, 2005, ONCOGENE, V24, P8080, DOI 10.1038/sj.onc.1208944; Wong CHY, 2008, J NEUROCHEM, V107, P241, DOI 10.1111/j.1471-4159.2008.05605.x; Xiao R, 2012, MOL CELL, V45, P656, DOI 10.1016/j.molcel.2012.01.009; Xie J, 2009, AM J PATHOL, V175, P1315, DOI 10.2353/ajpath.2009.090094; Xiong Ye, 2004, J Stroke Cerebrovasc Dis, V13, P129, DOI 10.1016/j.jstrokecerebrovasdis.2004.05.001; Yang TZ, 2006, PHARM RES-DORDR, V23, P291, DOI 10.1007/s11095-005-9143-2; Yao T, 2008, MOL CELL, V31, P909, DOI 10.1016/j.molcel.2008.08.027; Yao TT, 2006, NAT CELL BIOL, V8, P994, DOI 10.1038/ncb1460; Yashin DV, 2011, J BIOL CHEM, V286, P10258, DOI 10.1074/jbc.M110.163436; Yoshikawa T, 2011, CURR EYE RES, V36, P1153, DOI 10.3109/02713683.2011.606592; Yu J, 2009, P NATL ACAD SCI USA, V106, P17511, DOI 10.1073/pnas.0907359106; Zacchigna S, 2008, CURR TOP DEV BIOL, V80, P1, DOI 10.1016/S0070-2153(07)80001-9; Zach S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013191; Zechner D, 2003, DEV BIOL, V258, P406, DOI 10.1016/S0012-1606(03)00123-4; Zeng Q, 2000, J CELL SCI, V113, P471; Zhang C, 2010, J BIOL CHEM, V285, P8515, DOI 10.1074/jbc.M109.079079; Zhang HY, 2005, J NEUROSCI, V25, P3379, DOI 10.1523/JNEUROSCI.3553-04.2005; Zhang ZH, 2009, J BIOL CHEM, V284, P15717, DOI 10.1074/jbc.M808751200; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111; Zhao W, 2012, J IMMUNOL, V188, P3179, DOI 10.4049/jimmunol.1101175; Zheng XJ, 2010, J CLIN INVEST, V120, P2795, DOI 10.1172/JCI39679; Zirn B, 2006, GENE CHROMOSOME CANC, V45, P565, DOI 10.1002/gcc.20319; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114; Zoghbi HY, 2009, J BIOL CHEM, V284, P7425, DOI 10.1074/jbc.R800041200	208	32	32	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52665	10.1371/journal.pone.0052665	http://dx.doi.org/10.1371/journal.pone.0052665			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285140	Green Published, Green Submitted, gold			2022-12-27	WOS:000312794500225
J	Munoz-Ruiz, MA; Hartikainen, P; Koikkalainen, J; Wolz, R; Julkunen, V; Niskanen, E; Herukka, SK; Kivipelto, M; Vanninen, R; Rueckert, D; Liu, YW; Lotjonen, J; Soininen, H				Munoz-Ruiz, Miguel Angel; Hartikainen, Paivi; Koikkalainen, Juha; Wolz, Robin; Julkunen, Valtteri; Niskanen, Eini; Herukka, Sanna-Kaisa; Kivipelto, Miia; Vanninen, Ritva; Rueckert, Daniel; Liu, Yawu; Lotjonen, Jyrki; Soininen, Hilkka			Structural MRI in Frontotemporal Dementia: Comparisons between Hippocampal Volumetry, Tensor-Based Morphometry and Voxel-Based Morphometry	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; GRAY-MATTER LOSS; ALZHEIMERS-DISEASE; LOBAR DEGENERATION; BRAIN ATROPHY; BEHAVIORAL VARIANT; CORTICAL THICKNESS; ENTORHINAL CORTEX; GREY-MATTER; PATTERNS	Background: MRI is an important clinical tool for diagnosing dementia-like diseases such as Frontemporal Dementia (FTD). However there is a need to develop more accurate and standardized MRI analysis methods. Objective: To compare FTD with Alzheimer's Disease (AD) and Mild Cognitive Impairment (MCI) with three automatic MRI analysis methods - Hippocampal Volumetry (HV), Tensor-based Morphometry (TBM) and Voxel-based Morphometry (VBM), in specific regions of interest in order to determine the highest classification accuracy. Methods: Thirty-seven patients with FTD, 46 patients with AD, 26 control subjects, 16 patients with progressive MCI (PMCI) and 48 patients with stable MCI (SMCI) were examined with HV, TBM for shape change, and VBM for gray matter density. We calculated the Correct Classification Rate (CCR), sensitivity (SS) and specificity (SP) between the study groups. Results: We found unequivocal results differentiating controls from FTD with HV (hippocampus left side) (CCR = 0.83; SS = 0.84; SP = 0.80), with TBM (hippocampus and amygdala (CCR = 0.80/SS = 0.71/SP = 0.94), and with VBM (all the regions studied, especially in lateral ventricle frontal horn, central part and occipital horn) (CCR = 0.87/SS = 0.81/SP = 0.96). VBM achieved the highest accuracy in differentiating AD and FTD (CCR = 0.72/SS = 0.67/SP = 0.76), particularly in lateral ventricle (frontal horn, central part and occipital horn) (CCR = 0.73), whereas TBM in superior frontal gyrus also achieved a high accuracy (CCR = 0.71/SS = 0.68/SP = 0.73). TBM resulted in low accuracy (CCR = 0.62) in the differentiation of AD from FTD using all regions of interest, with similar results for HV (CCR = 0.55). Conclusion: Hippocampal atrophy is present not only in AD but also in FTD. Of the methods used, VBM achieved the highest accuracy in its ability to differentiate between FTD and AD.	[Munoz-Ruiz, Miguel Angel; Hartikainen, Paivi; Julkunen, Valtteri; Herukka, Sanna-Kaisa; Kivipelto, Miia; Liu, Yawu; Soininen, Hilkka] Univ Eastern Finland, Inst Clin Med, Kuopio, Finland; [Hartikainen, Paivi; Julkunen, Valtteri; Soininen, Hilkka] Kuopio Univ Hosp, Dept Neurol, SF-70210 Kuopio, Finland; [Koikkalainen, Juha; Lotjonen, Jyrki] VTT Tech Res Ctr Finland, Knowledge Intens Serv, Tampere, Finland; [Wolz, Robin; Rueckert, Daniel] Univ London Imperial Coll Sci Technol & Med, Dept Comp, Biomed Image Anal Grp, London, England; [Niskanen, Eini; Vanninen, Ritva; Liu, Yawu] Kuopio Univ Hosp, Dept Clin Radiol, SF-70210 Kuopio, Finland; [Kivipelto, Miia] Karolinska Inst, Aging Res Ctr, Stockholm, Sweden	University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; VTT Technical Research Center Finland; Imperial College London; Kuopio University Hospital; University of Eastern Finland; Karolinska Institutet	Soininen, H (corresponding author), Univ Eastern Finland, Inst Clin Med, Kuopio, Finland.	hilkka.soininen@uef.fi	Rueckert, Daniel/C-4393-2008; Kivipelto, Miia/AAS-3557-2021	Munoz Ruiz, Miguel/0000-0003-3604-3064; Julkunen, Valtteri/0000-0002-8727-8536; Kivipelto, Miia/0000-0003-0992-3875; Rueckert, Daniel/0000-0002-5683-5889	European Union; PredictAD; From Patient Data to Personalised Healthcare in Alzheimer's Disease; Finnish Cultural Foundation/North Savo Regional fund [65101997]; Orion Farmos Research Fund; Health Research Council of Academy of Finland; EVO from Kuopio University Hospital; University of Eastern Finland; Novo Nordisk Fonden [NNF12OC1016402, NNF11OC1014884] Funding Source: researchfish	European Union(European Commission); PredictAD; From Patient Data to Personalised Healthcare in Alzheimer's Disease; Finnish Cultural Foundation/North Savo Regional fund(Finnish Cultural Foundation); Orion Farmos Research Fund; Health Research Council of Academy of Finland; EVO from Kuopio University Hospital; University of Eastern Finland; Novo Nordisk Fonden(Novo Nordisk Foundation)	This study was partly funded by the European Union 7th Framework Program, PredictAD, From Patient Data to Personalised Healthcare in Alzheimer's Disease, grant number 65101997 from the Finnish Cultural Foundation/North Savo Regional fund (VJ), Orion Farmos Research Fund (VJ), Health Research Council of Academy of Finland (HS), EVO grant from Kuopio University Hospital (HS) and Strategic funding for UEFBRAIN from University of Eastern Finland (HS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta F, 2012, CORTEX, V48, P389, DOI 10.1016/j.cortex.2011.04.012; Apostolova LG, 2012, ALZ DIS ASSOC DIS, V26, P17, DOI 10.1097/WAD.0b013e3182163b62; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 1998, HUM BRAIN MAPP, V6, P348, DOI 10.1002/(SICI)1097-0193(1998)6:5/6<348::AID-HBM4>3.0.CO;2-P; Avants B, 2005, ALZ DIS ASSOC DIS, V19, pS25, DOI 10.1097/01.wad.0000183083.14939.82; Baron JC, 2001, NEUROIMAGE, V14, P298, DOI 10.1006/nimg.2001.0848; Boccardi M, 2005, NEUROBIOL AGING, V26, P37, DOI 10.1016/j.neurobiolaging.2004.02.019; Boccardi M, 2003, NEUROBIOL AGING, V24, P95, DOI 10.1016/S0197-4580(02)00045-3; Borroni B, 2007, ARCH NEUROL-CHICAGO, V64, P246, DOI 10.1001/archneur.64.2.246; Borroni B, 2010, J ALZHEIMERS DIS, V19, P111, DOI 10.3233/JAD-2010-1208; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Brambati SM, 2007, NEUROIMAGE, V35, P998, DOI 10.1016/j.neuroimage.2007.01.028; Broe M, 2003, NEUROLOGY, V60, P1005, DOI 10.1212/01.WNL.0000052685.09194.39; Brun CC, 2009, NEUROIMAGE, V48, P37, DOI 10.1016/j.neuroimage.2009.05.022; Chan D, 2001, NEUROLOGY, V57, P1756, DOI 10.1212/WNL.57.10.1756; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Chetelat G, 2005, NEUROIMAGE, V27, P934, DOI 10.1016/j.neuroimage.2005.05.015; Chung MK, 2001, NEUROIMAGE, V14, P595, DOI 10.1006/nimg.2001.0862; Convit A, 2000, NEUROBIOL AGING, V21, P19, DOI 10.1016/S0197-4580(99)00107-4; Davatzikos C, 2008, NEUROIMAGE, V41, P1220, DOI 10.1016/j.neuroimage.2008.03.050; Davies RR, 2009, NEURORADIOLOGY, V51, P491, DOI 10.1007/s00234-009-0521-z; Du AT, 2007, BRAIN, V130, P1159, DOI 10.1093/brain/awm016; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Dukart J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022193; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fox NC, 2001, LANCET, V358, P201, DOI 10.1016/S0140-6736(01)05408-3; Freeborough PA, 1996, J COMPUT ASSIST TOMO, V20, P1012, DOI 10.1097/00004728-199611000-00030; Frisoni GB, 1999, NEUROLOGY, V52, P91, DOI 10.1212/WNL.52.1.91; Frisoni GB, 2002, J NEUROL NEUROSUR PS, V73, P657, DOI 10.1136/jnnp.73.6.657; Garibotto V, 2011, NEUROBIOL AGING, V32, P875, DOI 10.1016/j.neurobiolaging.2009.05.004; Gee J, 2003, ACAD RADIOL, V10, P1392, DOI 10.1016/S1076-6332(03)00543-9; Gislason TB, 2003, J NEUROL NEUROSUR PS, V74, P867, DOI 10.1136/jnnp.74.7.867; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Good CD, 2002, NEUROIMAGE, V17, P29, DOI 10.1006/nimg.2002.1202; Gorno-Tempini ML, 2004, ANN NEUROL, V55, P335, DOI 10.1002/ana.10825; Hanninen T, 2002, ACTA NEUROL SCAND, V106, P148, DOI 10.1034/j.1600-0404.2002.01225.x; Harvey RJ, 2003, J NEUROL NEUROSUR PS, V74, P1206, DOI 10.1136/jnnp.74.9.1206; HELKALA EL, 1988, ANN NEUROL, V24, P214, DOI 10.1002/ana.410240207; Hirata Y, 2005, NEUROSCI LETT, V382, P269, DOI 10.1016/j.neulet.2005.03.038; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Julkunen V, 2010, J ALZHEIMERS DIS, V21, P1141, DOI 10.3233/JAD-2010-100114; Julkunen V, 2009, DEMENT GERIATR COGN, V28, P404, DOI 10.1159/000256274; Kanda T, 2008, EUR J NUCL MED MOL I, V35, P2227, DOI 10.1007/s00259-008-0871-5; Killiany RJ, 2000, ANN NEUROL, V47, P430, DOI 10.1002/1531-8249(200004)47:4<430::AID-ANA5>3.0.CO;2-I; Kipps CM, 2005, J NEUROL NEUROSUR PS, V76, P650, DOI 10.1136/jnnp.2004.047993; Kivipelto M, 2001, BMJ-BRIT MED J, V322, P1447, DOI 10.1136/bmj.322.7300.1447; Koikkalainen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031112; Koikkalainen J, 2011, NEUROIMAGE, V56, P1134, DOI 10.1016/j.neuroimage.2011.03.029; Laakso MP, 2000, BIOL PSYCHIAT, V47, P1056, DOI 10.1016/S0006-3223(99)00306-6; Liu YW, 2011, NEUROBIOL AGING, V32, P1198, DOI 10.1016/j.neurobiolaging.2009.07.008; Lotjonen J, 2011, NEUROIMAGE, V56, P185, DOI 10.1016/j.neuroimage.2011.01.062; Lotjonen JMP, 2010, NEUROIMAGE, V49, P2352, DOI 10.1016/j.neuroimage.2009.10.026; NEARY D, 1988, J NEUROL NEUROSUR PS, V51, P353, DOI 10.1136/jnnp.51.3.353; Pennanen C, 2005, J NEUROL NEUROSUR PS, V76, P11, DOI 10.1136/jnnp.2004.035600; Petersen R C, 1997, Int Psychogeriatr, V9 Suppl 1, P65, DOI 10.1017/S1041610297004717; PETERSEN RC, 1995, JAMA-J AM MED ASSOC, V273, P1274, DOI 10.1001/jama.273.16.1274; Piguet O, 2011, ANN NEUROL, V69, P312, DOI 10.1002/ana.22244; Rabinovici G D, 2007, Am J Alzheimers Dis Other Demen, V22, P474, DOI 10.1177/1533317507308779; Ratnavalli E, 2002, NEUROLOGY, V58, P1615, DOI 10.1212/WNL.58.11.1615; Rosen HJ, 2002, NEUROLOGY, V58, P198, DOI 10.1212/WNL.58.2.198; Seelaar H, 2011, J NEUROL NEUROSUR PS, V82, P476, DOI 10.1136/jnnp.2010.212225; Seeley WW, 2008, ARCH NEUROL-CHICAGO, V65, P249, DOI 10.1001/archneurol.2007.38; Shen Qian, 2011, Alzheimers Dement, V7, pe101, DOI 10.1016/j.jalz.2010.07.002; Stonnington CM, 2008, NEUROIMAGE, V39, P1180, DOI 10.1016/j.neuroimage.2007.09.066; Thompson PM, 2007, ANN NY ACAD SCI, V1097, P183, DOI 10.1196/annals.1379.017; van De Pol LA, 2006, J NEUROL NEUROSUR PS, V77, P439, DOI 10.1136/jnnp.2005.075341; Van Leemput K, 1999, IEEE T MED IMAGING, V18, P897, DOI 10.1109/42.811270; Vemuri P, 2011, NEUROIMAGE, V55, P522, DOI 10.1016/j.neuroimage.2010.12.073; Westman E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022506; Whitwell JL, 2008, NEUROLOGY, V70, P512, DOI 10.1212/01.wnl.0000280575.77437.a2; Whitwell JL, 2007, ARCH NEUROL-CHICAGO, V64, P371, DOI 10.1001/archneur.64.3.371; Whitwell JL, 2012, BRAIN, V135, P794, DOI 10.1093/brain/aws001; Whitwell JL, 2009, BRAIN, V132, P2932, DOI 10.1093/brain/awp232; Williams GB, 2005, NEUROIMAGE, V24, P1042, DOI 10.1016/j.neuroimage.2004.10.023; Wolz R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025446; Wolz R, 2010, NEUROIMAGE, V49, P1316, DOI 10.1016/j.neuroimage.2009.09.069	77	41	41	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52531	10.1371/journal.pone.0052531	http://dx.doi.org/10.1371/journal.pone.0052531			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285078	gold, Green Published, Green Submitted			2022-12-27	WOS:000312794500191
J	Crumling, MA; Liu, LQ; Thomas, PV; Benson, J; Kanicki, A; Kabara, L; Halsey, K; Dolan, D; Duncan, RK				Crumling, Mark A.; Liu, Liqian; Thomas, Paul V.; Benson, Jennifer; Kanicki, Ariane; Kabara, Lisa; Haelsey, Karin; Dolan, David; Duncan, R. Keith			Hearing Loss and Hair Cell Death in Mice Given the Cholesterol-Chelating Agent Hydroxypropyl-beta-Cyclodextrin	PLOS ONE			English	Article							EVERY ORGAN; THRESHOLD; PRESTIN; MOUSE; EXPRESSION; PROTEIN; MOTOR	Cyclodextrins are sugar compounds that are increasingly finding medicinal uses due to their ability to complex with hydrophobic molecules. One cyclodextrin in particular, 2-hydroxypropyl- beta-cyclodextrin (HPbCD), is used as a carrier to solubilize lipophilic drugs and is itself being considered as a therapeutic agent for treatment of Niemann-Pick Type C disease, due to its ability to mobilize cholesterol. Results from toxicological studies suggest that HP beta CD is generally safe, but a recent study has found that it causes hearing loss in cats. Whether the hearing loss occurred via death of cochlear hair cells, rendering it permanent, was unexplored. In the present study, we examined peripheral auditory function and cochlear histology in mice after subcutaneous injection of HP beta CD to test for hearing loss and correlate any observed auditory deficits with histological findings. On average, auditory brainstem response thresholds were elevated at 4, 16, and 32 kHz in mice one week after treatment with 8,000 mg/kg. In severely affected mice all outer hair cells were missing in the basal half of the cochlea. In many cases, surviving hair cells in the cochlear apex exhibited abnormal punctate distribution of the motor protein prestin, suggesting long term changes to membrane composition and integrity. Mice given a lower dose of 4,000 mg/kg exhibited hearing loss only after repeated doses, but these threshold shifts were temporary. Therefore, cyclodextrin-induced hearing loss was complex, involving cell death and other more subtle influences on cochlear physiology.	[Crumling, Mark A.; Liu, Liqian; Thomas, Paul V.; Benson, Jennifer; Kanicki, Ariane; Kabara, Lisa; Haelsey, Karin; Dolan, David; Duncan, R. Keith] Univ Michigan, Kresge Hearing Res Inst, Dept Otolaryngol Head & Neck Surg, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Duncan, RK (corresponding author), Univ Michigan, Kresge Hearing Res Inst, Dept Otolaryngol Head & Neck Surg, 1301 E Ann St, Ann Arbor, MI 48109 USA.	rkduncan@umich.edu		Duncan, Robert/0000-0002-8949-8727	United States National Institutes of Health [NIDCD R01 DC007432, ARRA R01, DC007432-04S1, P30 DC005188]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007432, P30DC005188] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants from the United States National Institutes of Health (NIDCD R01 DC007432, ARRA R01 supplement DC007432-04S1, and P30 DC005188). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashmore J, 2008, PHYSIOL REV, V88, P173, DOI 10.1152/physrev.00044.2006; Brownell WE, 2011, PFLUG ARCH EUR J PHY, V461, P677, DOI 10.1007/s00424-011-0942-5; Cheatham MA, 2004, J PHYSIOL-LONDON, V560, P821, DOI 10.1113/jphysiol.2004.069559; Davidson CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006951; Di Berardino F, 2007, INT J PEDIAT OTOR EX, V2, P169, DOI 10.1016/j.pedex.2007.05.002; Gimpl G, 2010, SUBCELL BIOCHEM, V51, P1, DOI 10.1007/978-90-481-8622-8_1; Gould S, 2005, FOOD CHEM TOXICOL, V43, P1451, DOI 10.1016/j.fct.2005.03.007; KALINEC F, 1992, P NATL ACAD SCI USA, V89, P8671, DOI 10.1073/pnas.89.18.8671; Karolyi IJ, 2007, MAMM GENOME, V18, P596, DOI 10.1007/s00335-007-9038-0; Kharkovets T, 2006, EMBO J, V25, P642, DOI 10.1038/sj.emboj.7600951; Levic S, 2011, J BIOL CHEM, V286, P5768, DOI 10.1074/jbc.M110.186486; Levitan I, 2010, SUBCELL BIOCHEM, V51, P509, DOI 10.1007/978-90-481-8622-8_19; Liu B, 2010, J LIPID RES, V51, P933, DOI 10.1194/jlr.M000257; Loftsson T, 2010, J PHARM PHARMACOL, V62, P1607, DOI 10.1111/j.2042-7158.2010.01030.x; Maxfield FR, 2010, CURR OPIN CELL BIOL, V22, P422, DOI 10.1016/j.ceb.2010.05.004; Mhatre AN, 2010, HEARING RES, V269, P180, DOI 10.1016/j.heares.2010.06.012; Muller M, 2005, HEARING RES, V202, P63, DOI 10.1016/j.heares.2004.08.011; Muralidhar A, 2011, MOL GENET METAB, V103, P142, DOI 10.1016/j.ymgme.2011.03.001; Nguyen TVN, 1998, OTOLARYNG HEAD NECK, V119, P14, DOI 10.1016/S0194-5998(98)70167-6; Oesterle EC, 2008, JARO-J ASSOC RES OTO, V9, P65, DOI 10.1007/s10162-007-0106-7; OHTANI Y, 1989, EUR J BIOCHEM, V186, P17, DOI 10.1111/j.1432-1033.1989.tb15171.x; Purcell EK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026289; Rajagopalan L, 2007, J BIOL CHEM, V282, P36659, DOI 10.1074/jbc.M705078200; Ramirez CM, 2010, PEDIATR RES, V68, P309, DOI 10.1203/00006450-201011001-00604; Santos-Sacchi J, 1998, NEUROSCI LETT, V256, P155, DOI 10.1016/S0304-3940(98)00788-5; Ward S, 2010, PEDIATR RES, V68, P52, DOI [10.1203/PDR.0b013e3181df4623, 10.1203/00006450-201011001-00099]; Wu XD, 2004, MOL BRAIN RES, V126, P30, DOI 10.1016/j.molbrainres.2004.03.020; Yanjanin NM, 2010, AM J MED GENET B, V153B, P132, DOI 10.1002/ajmg.b.30969; Zheng J, 2003, MAMM GENOME, V14, P87, DOI 10.1007/s00335-002-2227-y; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9	30	64	67	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53280	10.1371/journal.pone.0053280	http://dx.doi.org/10.1371/journal.pone.0053280			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285273	Green Published, gold, Green Submitted			2022-12-27	WOS:000313051500127
J	Feng, X; Wang, H; Ye, SC; Guan, JX; Tan, WK; Cheng, S; Wei, GL; Wu, WY; Wu, F; Zhou, Y				Feng, Xiao; Wang, Hao; Ye, Shicai; Guan, Jiaxi; Tan, Wenkai; Cheng, Si; Wei, Guoli; Wu, Weiyun; Wu, Feng; Zhou, Yu			Up-Regulation of microRNA-126 May Contribute to Pathogenesis of Ulcerative Colitis via Regulating NF-kappaB Inhibitor I kappa B alpha	PLOS ONE			English	Article							EXPRESSION PROFILES; CROHNS-DISEASE; SUSCEPTIBILITY; ASSOCIATION; CELLS; SUPPRESSES; ACTIVATION; CARCINOMA; PLAYERS; KINASE	Background: MicroRNAs (miRNAs) are important post-transcriptional regulators. Altered expression of miRNAs has recently demonstrated association with human ulcerative colitis (UC). In this study, we attempted to elucidate the roles of miR-126 in the pathogenesis of UC. Methods: Expression of miR-126, miR-21, miR-375 and the potential targets NF-kappa B inhibitor alpha (I kappa B alpha, IKBA or NFKBIA), Polo-like kinase 2 (PLK2) and v-Crk sarcoma virus CT10 oncogene homolog (CRK) were assessed in 52 colonic biopsies from patients with active UC, inactive UC, irritable bowel syndrome (IBS) and from healthy subjects by quantitative RT-PCR and immunofluorescence analyses. Regulation of gene expression by miR-126 was assessed using luciferase reporter construct assays and specific miRNA mimic transfection. Results: We found that the expression of miR-126 and miR-21 were significantly increased in active UC group compared to the inactive UC, IBS and healthy control groups (P< 0.05). In contrast, the expression of IKBA mRNA and protein was remarkably decreased in the active UC group compared with the other three groups (P<0.05). The expression of miR-126 and IKBA mRNA were inversely correlated in active UC patients (P<0.05). However the expression of miR-375, PLK2 and CRK showed no difference between each group. Furthermore, we demonstrate that endogenous miR-126 and exogenous miR-126 mimic can inhibit I kappa B alpha expression. Finally, mutating the miR-126 binding site of the IKBA 39-UTR reporter construct restored reporter gene expression. Conclusion: miR-126 may play roles in UC inflammatory activity by down-regulating the expression of IKBA, an important inhibitor of NF-kappa B signaling pathway.	[Feng, Xiao; Wang, Hao; Ye, Shicai; Guan, Jiaxi; Tan, Wenkai; Cheng, Si; Wei, Guoli; Wu, Weiyun; Zhou, Yu] Guangdong Med Coll, Affiliated Hosp, Dept Gastroenterol, Zhanjiang, Guangdong, Peoples R China; [Wu, Feng] Univ Chicago, Dept Med, Chicago, IL 60637 USA	Guangdong Medical University; University of Chicago	Zhou, Y (corresponding author), Guangdong Med Coll, Affiliated Hosp, Dept Gastroenterol, Zhanjiang, Guangdong, Peoples R China.	ahdg2005@126.com			National Natural Science Foundation of China [30971350]; Planned Science and Technology Project of Guangdong Province, China [2009B030801332]; Affiliated Hospital of Guangdong Medical College	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Planned Science and Technology Project of Guangdong Province, China; Affiliated Hospital of Guangdong Medical College	This study was supported by National Natural Science Foundation of China (grant number 30971350 to Yu Zhou) and the Planned Science and Technology Project of Guangdong Province, China (grant number 2009B030801332 to Yu Zhou). This research was also supported by the fund at The Affiliated Hospital of Guangdong Medical College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Farid E., 2009, Cancer Genomics & Proteomics, V6, P281; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bian Z, 2011, J PATHOL, V225, P544, DOI 10.1002/path.2907; Carthew RW, 2006, CURR OPIN GENET DEV, V16, P203, DOI 10.1016/j.gde.2006.02.012; Costello CM, 2005, PLOS MED, V2, P771, DOI 10.1371/journal.pmed.0020199; Crawford M, 2008, BIOCHEM BIOPH RES CO, V373, P607, DOI 10.1016/j.bbrc.2008.06.090; Dalal Sushila R, 2010, Gastroenterol Hepatol (N Y), V6, P714; Dijkstra G, 2002, SCAND J GASTROENTERO, V37, P37, DOI 10.1080/003655202320621436; Fasseu M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013160; Feng RH, 2010, CANCER LETT, V298, P50, DOI 10.1016/j.canlet.2010.06.004; Gu S, 2009, NAT STRUCT MOL BIOL, V16, P144, DOI 10.1038/nsmb.1552; Harris TA, 2008, P NATL ACAD SCI USA, V105, P1516, DOI 10.1073/pnas.0707493105; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Jiang XL, 2002, WORLD J GASTROENTERO, V8, P158, DOI 10.3748/wjg.v8.i1.158; Lawrance IC, 2001, HUM MOL GENET, V10, P445, DOI 10.1093/hmg/10.5.445; Lederhuber H, 2011, NEONATOLOGY, V99, P51, DOI 10.1159/000301938; Li XF, 2009, ONCOGENE, V28, P3937, DOI 10.1038/onc.2009.245; Li ZJ, 2008, P NATL ACAD SCI USA, V105, P15535, DOI 10.1073/pnas.0808266105; Mahabeleshwar GH, 2003, J BIOL CHEM, V278, P6209, DOI 10.1074/jbc.M208905200; Mattes J, 2009, P NATL ACAD SCI USA, V106, P18704, DOI 10.1073/pnas.0905063106; McGovern DPB, 2010, NAT GENET, V42, P332, DOI 10.1038/ng.549; Murakami Y, 2006, ONCOGENE, V25, P2537, DOI 10.1038/sj.onc.1209283; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Olaru AV, 2011, INFLAMM BOWEL DIS, V17, P221, DOI 10.1002/ibd.21359; Sato T, 2010, AM J RESP CRIT CARE, V182, P1020, DOI 10.1164/rccm.201001-0055OC; Sonkoly E, 2008, SEMIN CANCER BIOL, V18, P131, DOI 10.1016/j.semcancer.2008.01.005; STEVENS C, 1992, DIGEST DIS SCI, V37, P818, DOI 10.1007/BF01300378; SUTHERLAND LR, 1987, GASTROENTEROLOGY, V92, P1894, DOI 10.1016/0016-5085(87)90621-4; Szamosi T, 2009, DIGEST DIS SCI, V54, P351, DOI 10.1007/s10620-008-0351-6; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Takagi T, 2010, J GASTROEN HEPATOL, V25, pS129, DOI 10.1111/j.1440-1746.2009.06216.x; Toedter G, 2011, AM J GASTROENTEROL, V106, P1272, DOI 10.1038/ajg.2011.83; Ukil A, 2006, BRIT J PHARMACOL, V149, P121, DOI 10.1038/sj.bjp.0706847; Visekruna A, 2006, J CLIN INVEST, V116, P3195, DOI 10.1172/JCI28804; Wei B, 2010, CELL MOL IMMUNOL, V7, P175, DOI 10.1038/cmi.2010.19; Williams AE, 2008, BIOCHEM SOC T, V36, P1211, DOI 10.1042/BST0361211; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Wu F, 2008, GASTROENTEROLOGY, V135, P1624, DOI 10.1053/j.gastro.2008.07.068; Wu F, 2007, INFLAMM BOWEL DIS, V13, P807, DOI 10.1002/ibd.20110; Wu F, 2011, INFLAMM BOWEL DIS, V17, P241, DOI 10.1002/ibd.21450; Wu F, 2010, INFLAMM BOWEL DIS, V16, P1729, DOI 10.1002/ibd.21267; Zhou BY, 2007, P NATL ACAD SCI USA, V104, P7080, DOI 10.1073/pnas.0702409104	44	89	99	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52782	10.1371/journal.pone.0052782	http://dx.doi.org/10.1371/journal.pone.0052782			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285182	Green Published, Green Submitted, gold			2022-12-27	WOS:000313051500061
J	Lee, KS; Zhou, WB; Scott-McKean, JJ; Emmerling, KL; Cai, GY; Krah, DL; Costa, AC; Freed, CR; Levin, MJ				Lee, Katherine S.; Zhou, Wenbo; Scott-McKean, Jonah J.; Emmerling, Kaitlin L.; Cai, Guang-yun; Krah, David L.; Costa, Alberto C.; Freed, Curt R.; Levin, Myron J.			Human Sensory Neurons Derived from Induced Pluripotent Stem Cells Support Varicella-Zoster Virus Infection	PLOS ONE			English	Article							NEURAL CREST CELLS; DORSAL-ROOT GANGLIA; FAMILIAL DYSAUTONOMIA; MANNOSE 6-PHOSPHATE; MEDIATED-IMMUNITY; HUMAN FIBROBLASTS; GENE-EXPRESSION; IN-VIVO; DIFFERENTIATION; PRECURSORS	After primary infection, varicella-zoster virus (VZV) establishes latency in neurons of the dorsal root and trigeminal ganglia. Many questions concerning the mechanism of VZV pathogenesis remain unanswered, due in part to the strict host tropism and inconsistent availability of human tissue obtained from autopsies and abortions. The recent development of induced pluripotent stem (iPS) cells provides great potential for the study of many diseases. We previously generated human iPS cells from skin fibroblasts by introducing four reprogramming genes with non-integrating adenovirus. In this study, we developed a novel protocol to generate sensory neurons from iPS cells. Human iPS cells were exposed to small molecule inhibitors for 10 days, which efficiently converted pluripotent cells into neural progenitor cells (NPCs). The NPCs were then exposed for two weeks to growth factors required for their conversion to sensory neurons. The iPS cell-derived sensory neurons were characterized by immunocytochemistry, flow cytometry, RT-qPCR, and electrophysiology. After differentiation, approximately 80% of the total cell population expressed the neuron-specific protein, beta III-tubulin. Importantly, 15% of the total cell population co-expressed the markers Brn3a and peripherin, indicating that these cells are sensory neurons. These sensory neurons could be infected by both VZV and herpes simplex virus (HSV), a related alphaherpesvirus. Since limited neuronal populations are capable of supporting the entire VZV and HSV life cycles, our iPS-derived sensory neuron model may prove useful for studying alphaherpesvirus latency and reactivation.	[Lee, Katherine S.; Emmerling, Kaitlin L.; Cai, Guang-yun; Levin, Myron J.] Univ Colorado, Dept Pediat, Infect Dis Sect, Aurora, CO USA; [Zhou, Wenbo; Scott-McKean, Jonah J.; Costa, Alberto C.; Freed, Curt R.] Univ Colorado, Dept Med, Neurosci Training Program, Div Clin Pharmacol & Toxicol, Aurora, CO USA; [Krah, David L.] Merck Sharp & Dohme Corp, West Point, PA USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Merck & Company	Lee, KS (corresponding author), Univ Colorado, Dept Pediat, Infect Dis Sect, Aurora, CO USA.	Katherine.S.Lee@ucdenver.edu		Scott-McKean, Jonah/0000-0002-2604-6635; Costa, Alberto/0000-0002-7855-1190	NIH/NCATS Colorado CTSI Grant [KL2 TR000156, UL1 TR000154]; Brain Research Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001080, KL2TR000156, UL1TR000154] Funding Source: NIH RePORTER	NIH/NCATS Colorado CTSI Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Brain Research Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was supported by NIH/NCATS Colorado CTSI Grant Number KL2 TR000156 (K.S.L.), NIH/NCATS Colorado CTSI Grant Number UL1 TR000154 (W.Z.), and the Brain Research Foundation (C.R.F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARVIN AM, 1992, J INFECT DIS, V166, pS35, DOI 10.1093/infdis/166.Supplement_1.S35; Arvin AM, 1996, ADV VIRUS RES, V46, P263, DOI 10.1016/S0065-3527(08)60074-3; Baiker A, 2004, P NATL ACAD SCI USA, V101, P10792, DOI 10.1073/pnas.0404016101; Barberi T, 2003, NAT BIOTECHNOL, V21, P1200, DOI 10.1038/nbt870; Bez A, 2003, BRAIN RES, V993, P18, DOI 10.1016/j.brainres.2003.08.061; Brokhman I, 2008, DIFFERENTIATION, V76, P145, DOI 10.1111/j.1432-0436.2007.00196.x; Chambers SM, 2012, NAT BIOTECHNOL, V30, P715, DOI 10.1038/nbt.2249; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chen JJ, 2011, J NEUROVIROL, V17, P578, DOI 10.1007/s13365-011-0070-1; Chen Jason J., 2003, Journal of Medical Virology, V70, pS71, DOI 10.1002/jmv.10325; Chen JJ, 2004, CELL, V119, P915, DOI 10.1016/j.cell.2004.11.007; Christensen J, 2011, J VIROL, V85, P8436, DOI 10.1128/JVI.00515-11; Cohen JI, 2010, CURR TOP MICROBIOL, V342, P277, DOI 10.1007/82_2010_11; Dasgupta G, 2011, VACCINE, V29, P5824, DOI 10.1016/j.vaccine.2011.06.083; Dukhovny A, 2012, J VIROL, V86, P3211, DOI 10.1128/JVI.06810-11; Dworkin RH, 2007, J AM GERIATR SOC, V55, P1168, DOI 10.1111/j.1532-5415.2007.01231.x; Dykes IM, 2011, J NEUROSCI, V31, P9789, DOI 10.1523/JNEUROSCI.0901-11.2011; Eng SR, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-3; FEDTSOVA NG, 1995, MECH DEVELOP, V53, P291, DOI 10.1016/0925-4773(95)00435-1; Fradette J, 2005, MOL THERAPY, V11, pS62; Gershon AA, 2008, J INFECT DIS, V197, pS61, DOI 10.1086/522149; Gowrishankar K, 2007, J VIROL, V81, P6752, DOI 10.1128/JVI.02793-06; Hood C, 2003, J VIROL, V77, P12852, DOI 10.1128/JVI.77.23.12852-12864.2003; Huang EJ, 1999, DEVELOPMENT, V126, P2869; Jang J, 2012, EXP MOL MED, V44, P202, DOI DOI 10.3858/EMM.2012.44.3.015; Jung YW, 2012, CURR OPIN NEUROL, V25, P125, DOI 10.1097/WCO.0b013e3283518226; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Kitajima H, 2005, J NEUROSCI RES, V80, P467, DOI 10.1002/jnr.20469; Lange C, 2011, NEUROSCI LETT, V488, P36, DOI 10.1016/j.neulet.2010.10.076; Lanier J, 2007, DEV BIOL, V302, P703, DOI 10.1016/j.ydbio.2006.10.050; Lee G, 2011, PHILOS T R SOC B, V366, P2286, DOI 10.1098/rstb.2011.0026; Lee G, 2010, NAT PROTOC, V5, P688, DOI 10.1038/nprot.2010.35; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Li QX, 2006, CELL, V127, P305, DOI 10.1016/j.cell.2006.08.046; Li WL, 2011, P NATL ACAD SCI USA, V108, P8299, DOI 10.1073/pnas.1014041108; Manceur AP, 2011, EXP CELL RES, V317, P2086, DOI 10.1016/j.yexcr.2011.06.004; Markus A, 2011, J VIROL, V85, P6220, DOI 10.1128/JVI.02396-10; Marmigere F, 2007, NAT REV NEUROSCI, V8, P114, DOI 10.1038/nrn2057; Menendez L, 2011, P NATL ACAD SCI USA, V108, P19240, DOI 10.1073/pnas.1113746108; Messaoudi I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000657; Meyer C, 2011, J NEUROVIROL, V17, P600, DOI 10.1007/s13365-011-0057-y; MOFFAT JF, 1995, J VIROL, V69, P5236, DOI 10.1128/JVI.69.9.5236-5242.1995; Nelson BR, 2006, DEV NEUROSCI-BASEL, V28, P128, DOI 10.1159/000090759; Oxman MN, 2009, J AM OSTEOPATH ASSOC, V109, pS13; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Pavan WJ, 2012, DEV BIOL, V366, P55, DOI 10.1016/j.ydbio.2012.02.038; Pomp O, 2008, BRAIN RES, V1230, P50, DOI 10.1016/j.brainres.2008.07.029; Pugazhenthi S, 2011, J VIROL, V85, P6678, DOI 10.1128/JVI.00445-11; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SOMEKH E, 1992, PEDIATR RES, V32, P699, DOI 10.1203/00006450-199212000-00016; Spear PG, 2004, CELL MICROBIOL, V6, P401, DOI 10.1111/j.1462-5822.2004.00389.x; Sun YF, 2008, NAT NEUROSCI, V11, P1283, DOI 10.1038/nn.2209; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tojo M, 2005, CANCER SCI, V96, P791, DOI 10.1111/j.1349-7006.2005.00103.x; Valensi-Kurtz M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009290; Weinberg A, 2010, CURR TOP MICROBIOL, V342, P341, DOI 10.1007/82_2010_31; Yu PB, 2008, NAT MED, V14, P1363, DOI 10.1038/nm.1888; Zerboni L, 2005, P NATL ACAD SCI USA, V102, P6490, DOI 10.1073/pnas.0501045102; Zhou WB, 2009, STEM CELLS, V27, P2667, DOI 10.1002/stem.201; ZHU ZL, 1995, P NATL ACAD SCI USA, V92, P3546, DOI 10.1073/pnas.92.8.3546	61	51	55	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53010	10.1371/journal.pone.0053010	http://dx.doi.org/10.1371/journal.pone.0053010			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285249	gold, Green Published, Green Submitted			2022-12-27	WOS:000313051500100
J	Tsunada, J; Sawaguchi, T				Tsunada, Joji; Sawaguchi, Toshiyuki			Neuronal Categorization and Discrimination of Social Behaviors in Primate Prefrontal Cortex	PLOS ONE			English	Article							NEURAL REPRESENTATION; VISUAL CATEGORIZATION; FACIAL EXPRESSIONS; RHESUS MACAQUES; PARIETAL; ATTENTION; RESPONSES; IDENTITY; AMYGDALA; MONKEYS	It has been implied that primates have an ability to categorize social behaviors between other individuals for the execution of adequate social-interactions. Since the lateral prefrontal cortex (LPFC) is involved in both the categorization and the processing of social information, the primate LPFC may be involved in the categorization of social behaviors. To test this hypothesis, we examined neuronal activity in the LPFC of monkeys during presentations of two types of movies of social behaviors (grooming, mounting) and movies of plural monkeys without any eye- or body-contacts between them (no-contacts movies). Although the monkeys were not required to categorize and discriminate the movies in this task, a subset of neurons sampled from the LPFC showed a significantly different activity during the presentation of a specific type of social behaviors in comparison with the others. These neurons categorized social behaviors at the population level and, at the individual neuron level, the majority of the neurons discriminated each movie within the same category of social behaviors. Our findings suggest that a fraction of LPFC neurons process categorical and discriminative information of social behaviors, thereby contributing to the adaptation to social environments.	[Tsunada, Joji; Sawaguchi, Toshiyuki] Hokkaido Univ, Grad Sch Med, Lab Cognit Neurobiol, Sapporo, Hokkaido, Japan; [Tsunada, Joji; Sawaguchi, Toshiyuki] Human Neurosci Inst, Sapporo, Hokkaido, Japan; [Sawaguchi, Toshiyuki] Musashino Gakuin Univ, Sayama, Saitama, Japan	Hokkaido University	Tsunada, J (corresponding author), Univ Penn, Sch Med, Dept Otorhinolaryngol, Philadelphia, PA 19104 USA.	tsunada@mail.med.upenn.edu	Tsunada, Joji/N-8759-2018	Tsunada, Joji/0000-0002-9125-7578	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Science and Technology Agency	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan to T. Sawaguchi, and the Japan Science and Technology Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amemori K, 2006, EUR J NEUROSCI, V23, P1895, DOI 10.1111/j.1460-9568.2006.04702.x; Amemori K, 2006, CEREB CORTEX, V16, P1002, DOI 10.1093/cercor/bhj042; Arnsten AFT, 2005, BIOL PSYCHIAT, V57, P1377, DOI 10.1016/j.biopsych.2004.08.019; Aureli F., 2000, NATURAL CONFLICT RES; Bergman TJ, 2003, SCIENCE, V302, P1234, DOI 10.1126/science.1087513; Bernstein IS, 1999, AM J PRIMATOL, V48, P283, DOI 10.1002/(SICI)1098-2345(1999)48:4<283::AID-AJP3>3.0.CO;2-4; BRODY EB, 1952, PSYCHOSOM MED, V14, P406, DOI 10.1097/00006842-195209000-00007; BRUCE CJ, 1985, J NEUROPHYSIOL, V54, P714, DOI 10.1152/jn.1985.54.3.714; Byrne R., 1988, MACHIAVELLIAN INTELL; Caruana F, 2011, CURR BIOL, V21, P195, DOI 10.1016/j.cub.2010.12.042; Castles DL, 1996, ANIM BEHAV, V52, P389, DOI 10.1006/anbe.1996.0183; Cheney D.L., 1990, MONKEYS SEE WORLD IN, DOI [10.7208/chicago/9780226218526.001.0001, DOI 10.7208/CHICAGO/9780226218526.001.0001]; Cheney Dorothy L., 2007, BABOON METAPHYSICS; Cohen YE, 2007, J NEUROPHYSIOL, V97, P1470, DOI 10.1152/jn.00769.2006; Cohen YE, 2006, BIOL LETTERS, V2, P261, DOI 10.1098/rsbl.2005.0436; de Waal F. B. M, 1982, CHIMPANZEE POLITICS; Deaner RO, 2005, CURR BIOL, V15, P543, DOI 10.1016/j.cub.2005.01.044; DEBRUIN JPC, 1990, PROG BRAIN RES, V85, P485; DUNBAR RIM, 1983, ANIM BEHAV, V31, P565, DOI 10.1016/S0003-3472(83)80080-3; Everling S, 2002, NAT NEUROSCI, V5, P671, DOI 10.1038/nn874; Fitch WT, 2006, J ACOUST SOC AM, V120, P2132, DOI 10.1121/1.2258499; Freedman DJ, 2008, NEUROSCI BIOBEHAV R, V32, P311, DOI 10.1016/j.neubiorev.2007.07.011; Freedman DJ, 2011, NAT NEUROSCI, V14, P143, DOI 10.1038/nn.2740; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; Freedman DJ, 2002, J NEUROPHYSIOL, V88, P929, DOI 10.1152/jn.2002.88.2.929; Freedman DJ, 2003, J NEUROSCI, V23, P5235; Fujii N, 2009, SOC NEUROSCI-UK, V4, P73, DOI 10.1080/17470910802046230; Fujii N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000397; Funahashi S, 2001, NEUROSCI RES, V39, P147, DOI 10.1016/S0168-0102(00)00224-8; Ghazanfar AA, 2003, NATURE, V423, P937, DOI 10.1038/423937a; Ghazanfar AA, 2007, CURR BIOL, V17, P425, DOI 10.1016/j.cub.2007.01.029; Gifford GW, 2005, J COGNITIVE NEUROSCI, V17, P1471, DOI 10.1162/0898929054985464; Gifford GW, 2003, BRAIN BEHAV EVOLUT, V61, P213, DOI 10.1159/000070704; Gothard KM, 2007, J NEUROPHYSIOL, V97, P1671, DOI 10.1152/jn.00714.2006; Hauser MD, 1998, ANIM BEHAV, V55, P1647, DOI 10.1006/anbe.1997.0712; Hosokawa T, 2012, J NEUROSCI, V32, P7662, DOI 10.1523/JNEUROSCI.6479-11.2012; Iacoboni M, 2004, NEUROIMAGE, V21, P1167, DOI 10.1016/j.neuroimage.2003.11.013; Jordan KE, 2005, CURR BIOL, V15, P1034, DOI 10.1016/j.cub.2005.04.056; Kobayashi S, 2006, NEURON, V51, P861, DOI 10.1016/j.neuron.2006.08.031; Kuraoka K, 2006, NEUROREPORT, V17, P9, DOI 10.1097/01.wnr.0000194383.02999.c5; Kuraoka K, 2007, J NEUROPHYSIOL, V97, P1379, DOI 10.1152/jn.00464.2006; Kutsukake N, 2005, INT J PRIMATOL, V26, P775, DOI 10.1007/s10764-005-5308-4; Lebedev MA, 2004, PLOS BIOL, V2, P1919, DOI 10.1371/journal.pbio.0020365; Mah L, 2004, AM J PSYCHIAT, V161, P1247, DOI 10.1176/appi.ajp.161.7.1247; MASS R, 1975, Primates, V16, P239, DOI 10.1007/BF02381552; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MYERS RE, 1973, BRAIN RES, V64, P257, DOI 10.1016/0006-8993(73)90182-0; Nieder A, 2002, SCIENCE, V297, P1708, DOI 10.1126/science.1072493; O Scalaidhe SP, 1999, CEREB CORTEX, V9, P459, DOI 10.1093/cercor/9.5.459; OScalaidhe SP, 1997, SCIENCE, V278, P1135, DOI 10.1126/science.278.5340.1135; PERRETT DI, 1982, EXP BRAIN RES, V47, P329; Perry S, 1998, PRIMATES, V39, P51, DOI 10.1007/BF02557743; Petrides M, 2002, EUR J NEUROSCI, V16, P291, DOI 10.1046/j.1460-9568.2001.02090.x; Romanski LM, 2007, CEREB CORTEX, V17, pI61, DOI 10.1093/cercor/bhm099; Romanski LM, 2009, ANNU REV NEUROSCI, V32, P315, DOI 10.1146/annurev.neuro.051508.135431; Romanski LM, 1999, NAT NEUROSCI, V2, P1131, DOI 10.1038/16056; Romanski LM, 2005, J NEUROPHYSIOL, V93, P734, DOI 10.1152/jn.00675.2004; Romanski LM, 2002, NAT NEUROSCI, V5, P15, DOI 10.1038/nn781; Romanski LM, 1999, J COMP NEUROL, V403, P141, DOI 10.1002/(SICI)1096-9861(19990111)403:2<141::AID-CNE1>3.0.CO;2-V; Rudebeck PH, 2006, SCIENCE, V313, P1310, DOI 10.1126/science.1128197; Russ BE, 2008, J NEUROPHYSIOL, V99, P87, DOI 10.1152/jn.01069.2007; Sallet J, 2011, SCIENCE, V334, P697, DOI 10.1126/science.1210027; SCHINO G, 1988, AM J PRIMATOL, V16, P43, DOI 10.1002/ajp.1350160106; Schino G, 2006, ANIM BEHAV, V71, P1069, DOI 10.1016/j.anbehav.2005.07.019; SEYFARTH RM, 1984, NATURE, V308, P541, DOI 10.1038/308541a0; Shaw P, 2005, J COGNITIVE NEUROSCI, V17, P1410, DOI 10.1162/0898929054985491; Shepherd SV, 2009, P NATL ACAD SCI USA, V106, P9489, DOI 10.1073/pnas.0900419106; Shepherd SV, 2006, CURR BIOL, V16, pR119, DOI 10.1016/j.cub.2006.02.013; SILK JB, 1982, BEHAVIOUR, V79, P162, DOI 10.1163/156853982X00238; SILK JB, 1994, BEHAVIOUR, V130, P271, DOI 10.1163/156853994X00569; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Smuts B. B., 1987, PRIMATE SOC; Smuts B.B., 1985, SEX FRIENDSHIP BABOO; Sugihara T, 2006, J NEUROSCI, V26, P11138, DOI 10.1523/JNEUROSCI.3550-06.2006; TANAKA I, 1993, ANTHROPOL SCI, V101, P187, DOI 10.1537/ase.101.187; Tanji J, 2008, PHYSIOL REV, V88, P37, DOI 10.1152/physrev.00014.2007; Tokuda K., 1964, Primates, V3, P1, DOI 10.1007/BF01795094; Tsao DY, 2008, NAT NEUROSCI, V11, P877, DOI 10.1038/nn.2158; Tsujimoto S, 2004, CEREB CORTEX, V14, P47, DOI 10.1093/cercor/bhg090; Watanabe M, 1996, NATURE, V382, P629, DOI 10.1038/382629a0; WEBSTER MJ, 1994, CEREB CORTEX, V4, P470, DOI 10.1093/cercor/4.5.470; WOLFE L, 1978, ARCH SEX BEHAV, V7, P55, DOI 10.1007/BF01541898; Yoshida K, 2011, CURR BIOL, V21, P249, DOI 10.1016/j.cub.2011.01.004	83	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52610	10.1371/journal.pone.0052610	http://dx.doi.org/10.1371/journal.pone.0052610			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285110	Green Submitted, Green Published, gold			2022-12-27	WOS:000313051500039
J	Zhang, XZ; Ma, HL; Huang, JR; Dai, Y				Zhang, Xinzhou; Ma, Hualin; Huang, Jianrong; Dai, Yong			Characterization of the Phosphoproteome in SLE Patients	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; PROTEIN-PHOSPHORYLATION; RHEUMATOID-ARTHRITIS; MASS-SPECTROMETRY; MAP KINASE; QUANTITATIVE PROTEOMICS; T-CELLS; DISEASE; IDENTIFICATION; PATHOGENESIS	Protein phosphorylation is a complex regulatory event that is involved in the signaling networks that affect virtually every cellular process. The protein phosphorylation may be a novel source for discovering biomarkers and drug targets. However, a systematic analysis of the phosphoproteome in patients with SLE has not been performed. To clarify the pathogenesis of systemic lupus erythematosus (SLE), we compared phosphoprotein expression in PBMCs from SLE patients and normal subjects using proteomics analyses. Phosphopeptides were enriched using TiO2 from PBMCs isolated from 15 SLE patients and 15 healthy subjects and then analyzed by automated LC-MS/MS analysis. Phosphorylation sites were identified and quantitated by MASCOT and MaxQuant. A total of 1035 phosphorylation sites corresponding to 618 NCBI-annotated genes were identified in SLE patients compared with normal subjects. Differentially expressed proteins, peptides and phosphorylation sites were then subjected to bioinformatics analyses. Gene ontology(GO) and pathway analyses showed that nucleic acid metabolism, cellular component organization, transport and multicellular organismal development pathways made up the largest proportions of the differentially expressed genes. Pathway analyses showed that the mitogen-activated protein kinase (MAPK) signaling pathway and actin cytoskeleton regulators made up the largest proportions of the metabolic pathways. Network analysis showed that rous sarcoma oncogene (SRC), v-rel reticuloendotheliosis viral oncogene homolog A (RELA), histone deacetylase (HDA1C) and protein kinase C, delta (PRKCD) play important roles in the stability of the network. These data suggest that aberrant protein phosphorylation may contribute to SLE pathogenesis.	[Dai, Yong] Jinan Univ, Clin Med Coll 2, Shenzhen Peoples Hosp, Clin Med Res Ctr, Shenzhen, Peoples R China; [Zhang, Xinzhou; Ma, Hualin; Huang, Jianrong] Jinan Univ, Clin Med Coll 2, Shenzhen Peoples Hosp, Dept Nephrol, Shenzhen, Peoples R China	Jinan University; Jinan University	Dai, Y (corresponding author), Jinan Univ, Clin Med Coll 2, Shenzhen Peoples Hosp, Clin Med Res Ctr, Shenzhen, Peoples R China.	daiyong22@yahoo.com.cn		Dai, Yong/0000-0002-6840-9158	National Nature Science Foundation of China [30972741\C080701]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was financially supported by National Nature Science Foundation of China (grant number 30972741\C080701). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chien KY, 2011, J PROTEOME RES, V10, P4041, DOI 10.1021/pr2002403; Collins MO, 2007, PROTEOMICS, V7, P2751, DOI 10.1002/pmic.200700145; Cox J, 2009, NAT PROTOC, V4, P698, DOI 10.1038/nprot.2009.36; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; De Luca A, 2012, EXPERT OPIN THER TAR, V16, pS17, DOI 10.1517/14728222.2011.639361; Di Domenico F, 2011, J PROTEOMICS, V74, P1091, DOI 10.1016/j.jprot.2011.03.033; Fernbach NV, 2009, J PROTEOME RES, V8, P4753, DOI 10.1021/pr900455x; Gafken PR, 2006, CELL COMMUN ADHES, V13, P249, DOI 10.1080/15419060601077917; Ge F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013095; Giorgianni F, 2007, ELECTROPHORESIS, V28, P2027, DOI 10.1002/elps.200600782; Hoffert JD, 2008, ANAL BIOCHEM, V375, P1, DOI 10.1016/j.ab.2007.11.023; Hoffman RW, 2004, CLIN IMMUNOL, V113, P4, DOI 10.1016/j.clim.2004.05.001; Kanbe K, 2011, CLIN RHEUMATOL, V30, P1407, DOI 10.1007/s10067-011-1833-z; Kline CLB, 2009, CLIN EXP METASTAS, V26, P77, DOI 10.1007/s10585-008-9215-x; Kyttaris VC, 2004, CURR OPIN RHEUMATOL, V16, P548, DOI 10.1097/01.bor.0000132646.55056.e0; La Cava A, 2009, LUPUS, V18, P196, DOI 10.1177/0961203308098191; Li X, 2011, RAPID COMMUN MASS SP, V25, P2439, DOI 10.1002/rcm.5123; Lin SY, 2012, AUTOPHAGY, V8, P1385, DOI 10.4161/auto.20959; Lopez-Santalla M, 2011, ARTHRITIS RHEUM-US, V63, P1833, DOI 10.1002/art.30375; Melo-Braga MN, 2012, MOL CELL PROTEOMICS, V11, P945, DOI 10.1074/mcp.M112.020214; Niu XF, 2012, EUR J PHARMACOL, V689, P262, DOI 10.1016/j.ejphar.2012.05.039; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Popova TG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013805; Raggiaschi R, 2005, BIOSCIENCE REP, V25, P33, DOI 10.1007/s10540-005-2846-0; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; Thiel MJ, 2007, ARTHRITIS RHEUM-US, V56, P3347, DOI 10.1002/art.22869; Wu HY, 2007, J PROTEOME RES, V6, P1812, DOI 10.1021/pr060631d; Wu HY, 2010, J PROTEOME RES, V9, P4102, DOI 10.1021/pr1006153; Xiang YJ, 2009, RHEUMATOL INT, V29, P481, DOI 10.1007/s00296-008-0809-z; Yang F, 2006, J PROTEOME RES, V5, P1252, DOI 10.1021/pr060028v; Zahid S, 2012, J NEUROCHEM, V121, P954, DOI 10.1111/j.1471-4159.2012.07737.x	32	4	4	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53129	10.1371/journal.pone.0053129	http://dx.doi.org/10.1371/journal.pone.0053129			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285258	gold, Green Published, Green Submitted			2022-12-27	WOS:000313051500110
J	Loutfy, MR; Logie, CH; Zhang, YM; Blitz, SL; Margolese, SL; Tharao, WE; Rourke, SB; Rueda, S; Raboud, JM				Loutfy, Mona R.; Logie, Carmen H.; Zhang, Yimeng; Blitz, Sandra L.; Margolese, Shari L.; Tharao, Wangari E.; Rourke, Sean B.; Rueda, Sergio; Raboud, Janet M.			Gender and Ethnicity Differences in HIV-related Stigma Experienced by People Living with HIV in Ontario, Canada	PLOS ONE			English	Article							AIDS-RELATED STIGMA; HIV/AIDS STIGMA; POSITIVE MEN; MEDICATION ADHERENCE; YOUNGER ADULTS; UNITED-STATES; BLACK-WOMEN; CAPE-TOWN; HEALTH; DISCRIMINATION	This study aimed to understand gender and ethnicity differences in HIV-related stigma experienced by 1026 HIV-positive individuals living in Ontario, Canada that were enrolled in the OHTN Cohort Study. Total and subscale HIV-related stigma scores were measured using the revised HIV-related Stigma Scale. Correlates of total stigma scores were assessed in univariate and multivariate linear regression. Women had significantly higher total and subscale stigma scores than men (total, median = 56.0 vs. 48.0, p<0.0001). Among men and women, Black individuals had the highest, Aboriginal and Asian/Latin-American/Unspecified people intermediate, and White individuals the lowest total stigma scores. The gender-ethnicity interaction term was significant in multivariate analysis: Black women and Asian/Latin-American/Unspecified men reported the highest HIV-related stigma scores. Gender and ethnicity differences in HIV-related stigma were identified in our cohort. Findings suggest differing approaches may be required to address HIV-related stigma based on gender and ethnicity; and such strategies should challenge racist and sexist stereotypes.	[Loutfy, Mona R.; Logie, Carmen H.; Margolese, Shari L.] Womens Coll Hosp, Womens Coll Res Inst, Dept Med, Toronto, ON M5S 1B2, Canada; [Loutfy, Mona R.; Zhang, Yimeng] Univ Toronto, Fac Med, Toronto, ON, Canada; [Blitz, Sandra L.; Raboud, Janet M.] Univ Hlth Network, Dept Med, Toronto, ON, Canada; [Tharao, Wangari E.] Womens Hands Community Hlth Ctr, Womens Hlth, Toronto, ON, Canada; [Rourke, Sean B.] St Michaels Hosp, Dept Psychiat, Toronto, ON M5B 1W8, Canada	University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Loutfy, MR (corresponding author), Womens Coll Hosp, Womens Coll Res Inst, Dept Med, Toronto, ON M5S 1B2, Canada.	mona.loutfy@wchospital.ca			AIDS Bureau - Ontario Ministry of Health and Long-Term Care; Ontario Ministry of Health and Long-Term Care; Canadian Institutes of Health Research; Ontario HIV Treatment Network	AIDS Bureau - Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario HIV Treatment Network	We gratefully acknowledge all of the people living with HIV who volunteered to participate in the OHTN Cohort Study and the work and support of the past and present members of the OCS Governance Committee: Darien Taylor, Dr. Evan Collins, Dr. Greg Robinson, Shari Margolese, Patrick Cupido, Tony Di Pede, Rick Kennedy, Michael Hamilton, Ken King, Brian Finch, Lori Stoltz, Dr. Ahmed Bayoumi, Dr. Clemon George, Dr. Curtis Cooper, Dr. Troy Grennan, Adrian Betts, Tracey Conway, and Colleen Price. We thank all the interviewers, data collectors, research associates and coordinators, nurses and physicians who provide support for data collection and extraction. The authors wish to thank the OHTN staff and their teams for data management and IT support ( Mark Fisher, Director, IT), and OCS project coordination (Samantha Robinson, Project Coordinator). The OHTN Cohort Study is supported by the Ontario Ministry of Health and Long-Term Care.; The OHTN Cohort Study is supported by the AIDS Bureau - Ontario Ministry of Health and Long-Term Care. Three investigators are also the recipients of salary support from the Canadian Institutes of Health Research (MRL, CHL) and the Ontario HIV Treatment Network (JMR).	Abell N, 2007, AIDS CARE, V19, P242, DOI 10.1080/09540120600774297; Amaro H, 2000, SEX ROLES, V42, P723, DOI 10.1023/A:1007059708789; Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Baral S, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-36; Berger BE, 2001, RES NURS HEALTH, V24, P518, DOI 10.1002/nur.10011; Bradford JB, 2007, AIDS PATIENT CARE ST, V21, pS49, DOI 10.1089/apc.2007.9987; Brondolo E, 2009, J BEHAV MED, V32, P1, DOI 10.1007/s10865-008-9190-3; Brown L, 2003, AIDS EDUC PREV, V15, P49, DOI 10.1521/aeap.15.1.49.23844; Buseh AG, 2006, WOMEN HEALTH, V44, P1, DOI 10.1300/J013v44n03_01; Campbell C, 2006, J COMMUNITY APPL SOC, V16, P411, DOI 10.1002/casp.901; Cloete A, 2008, AIDS CARE, V20, P1105, DOI 10.1080/09540120701842720; Collins P. H., 1991, BLACK FEMINIST THOUG; Collins P.H., 2000, BLACK FEMINIST THOUG; Collins PY, 2008, SOC SCI MED, V67, P389, DOI 10.1016/j.socscimed.2008.03.013; Courtenay-Quirk C, 2006, AIDS EDUC PREV, V18, P56, DOI 10.1521/aeap.2006.18.1.56; Crandall CS, 1997, J APPL SOC PSYCHOL, V27, P95, DOI 10.1111/j.1559-1816.1997.tb00625.x; Crenshaw K., 1989, UNIV CHICAGO LEG FOR, V1989, P139; Deacon H, 2006, J COMMUNITY APPL SOC, V16, P418, DOI 10.1002/casp.900; Doyal L, 2009, CULT HEALTH SEX, V11, P173, DOI 10.1080/13691050802560336; Emlet C, 2005, RES SOCIAL WORK PRAC, V15, P291, DOI 10.1177/1049731504273250; Emlet CA, 2006, AIDS PATIENT CARE ST, V20, P350, DOI 10.1089/apc.2006.20.350; Farmer P.E, 2001, INFECT INEQUALITIES; Gibson K, 2009, SOCIOBEHAVIOURAL VAR; Gilman Sander, 1988, DIS REPRESENTATION I; Goffman E. M., 1963, BEHAV PUBLIC PLACES; GREEN G, 1996, SOC AS AIDS, P46; Heckman TG, 2004, HEALTH PSYCHOL, V23, P94, DOI 10.1037/0278-6133.23.1.94; HEREK GM, 1988, AM PSYCHOL, V43, P886, DOI 10.1037/0003-066X.43.11.886; Herek GM, 2003, HEALTH PSYCHOL, V22, P533, DOI 10.1037/0278-6133.22.5.533; Herek GM, 2002, AM J PUBLIC HEALTH, V92, P371, DOI 10.2105/AJPH.92.3.371; Herek GM, 1999, AM BEHAV SCI, V42, P1130, DOI 10.1177/0002764299042007006; Herek GM, 1999, AM BEHAV SCI, V42, P1106, DOI 10.1177/00027649921954787; Herek GM, 2007, ANNU REV CLIN PSYCHO, V3, P353, DOI 10.1146/annurev.clinpsy.3.022806.091510; Ingram D, 2000, QUAL HEALTH RES, V10, P117, DOI 10.1177/104973200129118282; [Joint United Nations Program on HIV/AIDS (UNAIDS) World Health Organization (WHO)], 2007, AIDS EP UPD 2007; Kalichman SC, 2009, AIDS CARE, V21, P87, DOI 10.1080/09540120802032627; Katz S, 2005, AIDS PATIENT CARE ST, V19, P110, DOI 10.1089/apc.2005.19.110; Konkle-Parker DJ, 2008, J ASSOC NURSE AIDS C, V19, P98, DOI 10.1016/j.jana.2007.09.005; Kylma J, 2005, J ADV NURS, V52, P620, DOI 10.1111/j.1365-2648.2005.03633.x; Lawless S, 1996, SOC SCI MED, V43, P1371, DOI 10.1016/0277-9536(96)00017-2; Lee RS, 2002, AIDS BEHAV, V6, P309, DOI DOI 10.1023/A:1021144511957; Lekas HM, 2006, QUAL HEALTH RES, V16, P1165, DOI 10.1177/1049732306292284; Link BG, 2001, ANNU REV SOCIOL, V27, P363, DOI 10.1146/annurev.soc.27.1.363; Logie C, 2009, AIDS CARE, V21, P742, DOI 10.1080/09540120802511877; Logie CH, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001124; Mahajan AP, 2008, AIDS, V22, pS67, DOI 10.1097/01.aids.0000327438.13291.62; Mak WWS, 2007, SOC SCI MED, V65, P245, DOI 10.1016/j.socscimed.2007.03.015; Margulies Peter, 1994, Georget Immgr Law J, V8, P521; Meyer IH, 2003, PSYCHOL BULL, V129, P674, DOI 10.1037/0033-2909.129.5.674; Naar-King S, 2007, AIDS PATIENT CARE ST, V21, pS40, DOI 10.1089/apc.2007.9988; Newman PA, 2012, GLOB PUBLIC HEALTH, V7, P87, DOI 10.1080/17441692.2010.549139; Newman PA, 2008, J HEALTH CARE POOR U, V19, P829, DOI 10.1353/hpu.0.0043; Nyblade Laura C, 2006, Psychol Health Med, V11, P335, DOI 10.1080/13548500600595178; Parker R, 2003, SOC SCI MED, V57, P13, DOI 10.1016/S0277-9536(02)00304-0; Patton Cindy, 2002, GLOBALIZING AIDS; Public Health Agency of Canada (PHAC), 2009, HIV AIDS CAN; Purdie-Vaughns V, 2008, SEX ROLES, V59, P377, DOI 10.1007/s11199-008-9424-4; Raboud J, 2010, P OHTN RES C TOR ONT; Rao D, 2007, AIDS CARE, V19, P28, DOI 10.1080/09540120600652303; Reidpath DD, 2005, AIDS CARE, V17, P425, DOI 10.1080/09540120412331319769; Reif S, 2005, AIDS CARE, V17, P558, DOI 10.1080/09540120412331319750; Rintamaki LS, 2006, AIDS PATIENT CARE ST, V20, P359, DOI 10.1089/apc.2006.20.359; Rourke SB, 2012, INT J EPIDEMIOL; Rueda S, 2011, AIDS BEHAV, V16, P660; Sandelowski M, 2004, J NURS SCHOLARSHIP, V36, P122, DOI 10.1111/j.1547-5069.2004.04024.x; Schuster MA, 2005, J GEN INTERN MED, V20, P807, DOI 10.1111/j.1525-1497.2005.05049.x; Schwartz JP, 2009, J PRIM PREV, V30, P27, DOI 10.1007/s10935-008-0162-8; Scott-Sheldon LAJ, 2008, HEALTH PSYCHOL, V27, P129, DOI 10.1037/0278-6133.27.2.129; Sengupta S, 2011, AIDS BEHAV, V15, P1075, DOI 10.1007/s10461-010-9847-0; Shields SA, 2008, SEX ROLES, V59, P301, DOI 10.1007/s11199-008-9501-8; Simbayi LC, 2007, SOC SCI MED, V64, P1823, DOI 10.1016/j.socscimed.2007.01.006; Sowell RL, 1997, PUBLIC HEALTH NURS, V14, P302, DOI 10.1111/j.1525-1446.1997.tb00379.x; Stephenson J, 2000, JAMA-J AM MED ASSOC, V284, P167, DOI 10.1001/jama.284.2.167; Steward WT, 2008, SOC SCI MED, V67, P1225, DOI 10.1016/j.socscimed.2008.05.032; Sumartojo E, 2000, AIDS, V14, pS3, DOI 10.1097/00002030-200006001-00002; Swendeman D, 2006, HEALTH PSYCHOL, V25, P501, DOI 10.1037/0278-6133.25.4.501; Tharao E, 2006, SILENT VOICES HIV AI; UNAIDS, 2010, UNAIDS REP GLOB AIDS; UNAIDS, 2005, HIV REL STIGM DISCR; Van Brakel Wim H, 2006, Psychol Health Med, V11, P307, DOI 10.1080/13548500600595160; Vanable PA, 2006, AIDS BEHAV, V10, P473, DOI 10.1007/s10461-006-9099-1; Ware NC, 2006, AIDS CARE, V18, P904, DOI 10.1080/09540120500330554; White RC, 2005, CULT HEALTH SEX, V7, P347, DOI 10.1080/13691050500100799; Williams CC, 2009, SOC SCI MED, V68, P12, DOI 10.1016/j.socscimed.2008.09.043; Wolffers I, 2000, B WORLD HEALTH ORGAN, V78, P267; Wright K, 2007, J ADOLESCENT HEALTH, V40, P96, DOI 10.1016/j.jadohealth.2006.08.001	86	73	80	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e48168	10.1371/journal.pone.0048168	http://dx.doi.org/10.1371/journal.pone.0048168			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	061EA	23300514	gold, Green Submitted, Green Published			2022-12-27	WOS:000312829100002
J	Chen, G; Li, SC; Dong, XX; Bai, Y; Chen, AL; Yang, SM; Fang, MY; Zamaratskaia, G; Doran, O				Chen, Gang; Li, Sicong; Dong, Xinxing; Bai, Ying; Chen, Ailiang; Yang, Shuming; Fang, Meiying; Zamaratskaia, Galia; Doran, Olena			Investigation of Testosterone, Androstenone, and Estradiol Metabolism in HepG2 Cells and Primary Culture Pig Hepatocytes and Their Effects on 17 beta HSD7 Gene Expression	PLOS ONE			English	Article							3-BETA-HYDROXYSTEROID DEHYDROGENASE; 17-BETA-HYDROXYSTEROID DEHYDROGENASES; MASS-SPECTROMETRY; BOAR; SULFOCONJUGATION; LOCALIZATION; TAINT; FAT	Steroid metabolism is important in various species. The accumulation of androgen metabolite, androstenone, in pig adipose tissue is negatively associated with pork flavor, odour and makes the meat unfit for human consumption. The 17 beta-hydroxysteroid dehydrogenase type 7 (17 beta HSD7) expressed abundantly in porcine liver, and it was previously suggested to be associated with androstenone levels. Understanding the enzymes and metabolic pathways responsible for androstenone as well as other steroids metabolism is important for improving the meat quality. At the same time, metabolism of steroids is known to be species- and tissue-specific. Therefore it is important to investigate between-species variations in the hepatic steroid metabolism and to elucidate the role of 17 beta HSD7 in this process. Here we used an effective methodological approach, liquid chromatography coupled with mass spectrometry, to investigate species- specific metabolism of androstenone, testosterone and beta-estradiol in HepG2 cell line, and pig cultured hepatocytes. Species- and concentration-depended effect of steroids on 17 beta HSD7 gene expression was also investigated. It was demonstrated that the investigated steroids can regulate the 17 beta HSD7 gene expression in HepG2 and primary cultured porcine hepatocytes in a concentration-dependent and species- dependent pattern. Investigation of steroid metabolites demonstrated that androstenone formed a 3'-hydroxy compound 3 beta-hydroxy-5 alpha-androst-16-ene. Testosterone was metabolized to 4-and-rostene-3,17-dione. Estrone was found as the metabolite for beta-estradiol. Inhibition study with 17 beta HSD inhibitor apigenin showed that apigenin didn't affect androstenone metabolism. Apigenin at high concentration (50 mu M) tends to inhibit testosterone metabolism but this inhibition effect was negligible. Beta-estradiol metabolism was notably inhibited with apigenin at high concentration. The study also established that the level of testosterone and b-estradiol metabolites was markedly increased after Co-incubation with high concentration of apigenin. This study established that 17bHSD7 is not the key enzyme responsible for androstenone and testosterone metabolism in porcine liver cells.	[Chen, Gang; Li, Sicong; Chen, Ailiang; Yang, Shuming] Chinese Acad Agr Sci, Key Lab Agroprod Qual & Safety, Inst Qual Stand & Testing Technol Agroprod, Beijing 100193, Peoples R China; [Dong, Xinxing; Bai, Ying; Fang, Meiying] China Agr Univ, Coll Anim Sci & Technol, Beijing 100094, Peoples R China; [Zamaratskaia, Galia] Swedish Univ Agr Sci SLU, Dept Food Sci, Uppsala, Sweden; [Doran, Olena] Univ W England, Ctr Res Biosci, Fac Hlth & Life Sci, Bristol BS16 1QY, Avon, England	Chinese Academy of Agricultural Sciences; Institute of Quality Standards & Testing Technology for Agro-Products, CAAS; China Agricultural University; Swedish University of Agricultural Sciences; University of West England	Fang, MY (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Beijing 100094, Peoples R China.	meiying@cau.edu.cn	Zamaratskaia, Galia/I-6155-2016; Chen, Ailiang/AAA-6470-2022	Zamaratskaia, Galia/0000-0003-0926-4849; 	Natural Science Foundation of China (NSFC) [31171691, 31072002]; Special Fund for Agro-Scientific Research in the Public Interest [201203046]; International Science & Technology Cooperation Program of China [2012DFA31140]; National High Technology and Science Development Plan of China [2011AA100302]; Biotechnology and Biological Sciences Research Council (BBSRC) UK-China Partnering Award [BB/H531435/1]; BBSRC [BB/H531435/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C506072/1, BB/H531435/1] Funding Source: researchfish	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-Scientific Research in the Public Interest; International Science & Technology Cooperation Program of China; National High Technology and Science Development Plan of China(National High Technology Research and Development Program of China); Biotechnology and Biological Sciences Research Council (BBSRC) UK-China Partnering Award(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Natural Science Foundation of China (NSFC, Grant Nos. 31171691, and 31072002), Special Fund for Agro-Scientific Research in the Public Interest (201203046), International Science & Technology Cooperation Program of China (2012DFA31140), National High Technology and Science Development Plan of China (2011AA100302), and Biotechnology and Biological Sciences Research Council (BBSRC) UK-China Partnering Award (BB/H531435/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker ME, 2001, MOL CELL ENDOCRINOL, V171, P211, DOI 10.1016/S0303-7207(00)00414-7; BOOTH WD, 1988, J ENDOCRINOL, V118, P47, DOI 10.1677/joe.0.1180047; Brittany D, 2010, J LIPID RES, V51, P262; BROOKS RI, 1986, J ANIM SCI, V62, P632, DOI 10.2527/jas1986.623632x; Chen G, 2007, J ANIM SCI, V85, P2457, DOI 10.2527/jas.2007-0087; CLAUS R, 1994, MEAT SCI, V38, P289, DOI 10.1016/0309-1740(94)90118-X; Day JM, 2008, ENDOCR-RELAT CANCER, V15, P665, DOI 10.1677/ERC-08-0042; De Brabander HF, 2007, J MASS SPECTROM, V42, P983, DOI 10.1002/jms.1272; Dong XX, 2012, GENE, V499, P186, DOI 10.1016/j.gene.2012.02.039; Doran E, 2004, CHEM-BIOL INTERACT, V147, P141, DOI 10.1016/j.cbi.2003.12.002; Forman BM, 1998, NATURE, V395, P612, DOI 10.1038/26996; GEISSLER WM, 1994, NAT GENET, V7, P34, DOI 10.1038/ng0594-34; GOLDSTEIN JA, 1993, ENVIRON HEALTH PERSP, V100, P169, DOI 10.2307/3431523; Hansen LL, 2006, ANIM SCI, V82, P359, DOI 10.1079/ASC200648; Krazeisen A, 1999, FEBS LETT, V460, P373, DOI 10.1016/S0014-5793(99)01366-6; Kushnir MM, 2011, CLIN BIOCHEM, V44, P77, DOI 10.1016/j.clinbiochem.2010.07.008; Larionov A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-62; Mareck U, 2008, J MASS SPECTROM, V43, P877, DOI 10.1002/jms.1457; Nicolau-Solano SI, 2006, J ANIM SCI, V84, P2809, DOI 10.2527/jas.2005-595; Nokelainen P, 2000, ENDOCRINOLOGY, V141, P772, DOI 10.1210/en.141.2.772; PATTERSON RL, 1968, J SCI FOOD AGR, V19, P31, DOI 10.1002/jsfa.2740190107; Payne AH, 2004, ENDOCR REV, V25, P947, DOI 10.1210/er.2003-0030; Rauh M, 2006, STEROIDS, V71, P450, DOI 10.1016/j.steroids.2006.01.015; Simard J, 2005, ENDOCR REV, V26, P525, DOI 10.1210/er.2002-0050; Sinclair PA, 2006, J MOL ENDOCRINOL, V36, P301, DOI 10.1677/jme.1.01847; Sinclair PA, 2005, J ANIM SCI, V83, P358; Valsamakis G, 2004, J CLIN ENDOCR METAB, V89, P4755, DOI 10.1210/jc.2003-032240	27	9	10	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52255	10.1371/journal.pone.0052255	http://dx.doi.org/10.1371/journal.pone.0052255			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300627	Green Published, Green Submitted, gold			2022-12-27	WOS:000313618800061
J	Fabiansson, EC; Denson, TF				Fabiansson, Emma C.; Denson, Thomas F.			The Effects of Intrapersonal Anger and Its Regulation in Economic Bargaining	PLOS ONE			English	Article							EMOTION REGULATION; CARDIOVASCULAR RECOVERY; ANALYTICAL RUMINATION; ANGRY RUMINATION; DECISION-MAKING; COGNITIVE COSTS; DISTRACTION; REAPPRAISAL; NEGOTIATION; EXPRESSION	Anger is a common cause of strained negotiations. This research investigated the effects of experiencing anger (Experiment 1) and regulating anger (Experiment 2) on ultimatum bargaining. Experiment 1 showed that relative to a control condition, angered participants proposed less fair offers and rejected more offers when bargaining with the person who angered them. Experiment 2 replicated Experiment 1, and additionally showed that regulating anger via reappraisal and distraction both reduced anger. However, only reappraisal effectively reduced anger for the duration of the negotiation. Participants who reappraised proposed fairer offers than those in the distraction condition, but did not differ in offers accepted. This research may have implications for what emotion regulation strategy should be employed in economic bargaining. However, future research is required to determine the most effective timing and components of reappraisal for promoting beneficial outcomes in bargaining contexts.	[Fabiansson, Emma C.; Denson, Thomas F.] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia	University of New South Wales Sydney	Fabiansson, EC (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW, Australia.	efabiansson@psy.unsw.edu.au	Denson, Thomas F./J-7840-2019	Denson, Thomas F./0000-0002-9620-4280	Australian Postgraduate Award; Australian Research Council [DP0985413]	Australian Postgraduate Award(Australian Government); Australian Research Council(Australian Research Council)	This research was supported by an Australian Postgraduate Award to EF and a Australian Research Council Discovery Project DP0985413 to TD, http://www.arc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler RS, 1998, NEGOTIATION J, V14, P161, DOI 10.1023/A:1024657321423; Allred KG, 1997, ORGAN BEHAV HUM DEC, V70, P175, DOI 10.1006/obhd.1997.2705; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Ben-Shakhar G, 2007, J ECON PSYCHOL, V28, P314, DOI 10.1016/j.joep.2007.02.005; Berkowitz L, 2004, EMOTION, V4, P107, DOI 10.1037/1528-3542.4.2.107; Berkowitz L., 1993, AGGRESSION ITS CAUSE, DOI 3.0.CO;2-9; BODENHAUSEN GV, 1994, EUR J SOC PSYCHOL, V24, P45, DOI 10.1002/ejsp.2420240104; Bushman BJ, 2002, PERS SOC PSYCHOL B, V28, P724, DOI 10.1177/0146167202289002; Bushman BJ, 1999, J PERS SOC PSYCHOL, V76, P367, DOI 10.1037/0022-3514.76.3.367; Butt AN, 2005, J ORGAN BEHAV, V26, P681, DOI 10.1002/job.328; CAMERER C, 1995, J ECON PERSPECT, V9, P209, DOI 10.1257/jep.9.2.209; Carver CS, 2009, PSYCHOL BULL, V135, P183, DOI 10.1037/a0013965; Denson TF, 2012, BEHAV THER, V43, P355, DOI 10.1016/j.beth.2011.08.001; Denson TF, 2011, MOTIV EMOTION, V35, P14, DOI 10.1007/s11031-011-9201-5; Denson TF, 2010, J EXP SOC PSYCHOL, V46, P1023, DOI 10.1016/j.jesp.2010.05.023; Denson TF, 2009, J RES PERS, V43, P673, DOI 10.1016/j.jrp.2009.04.003; Denson TF, 2009, J COGNITIVE NEUROSCI, V21, P734, DOI 10.1162/jocn.2009.21051; Fabiansson EC, 2012, NEUROIMAGE, V59, P2974, DOI 10.1016/j.neuroimage.2011.09.078; Fisher R., 1991, GETTING YES NEGOTIAT; Frank R. H., 1988, PASSIONS REASON STRA; Frijda N. H., 1986, EMOTIONS STUDIES EMO; Goldin PR, 2008, BIOL PSYCHIAT, V63, P577, DOI 10.1016/j.biopsych.2007.05.031; Gross JJ, 1998, J PERS SOC PSYCHOL, V74, P224, DOI 10.1037/0022-3514.74.1.224; Gross JJ, 2001, CURR DIR PSYCHOL SCI, V10, P214, DOI 10.1111/1467-8721.00152; Gross JJ., 1998, REV GEN PSYCHOL, V2, P271, DOI 10.1037/1089-2680.2.3.271; GUTH W, 1982, J ECON BEHAV ORGAN, V3, P367, DOI 10.1016/0167-2681(82)90011-7; Harle KM, 2007, EMOTION, V7, P876, DOI 10.1037/1528-3542.7.4.876; Kahneman D., 1986, J BUS, V59, P285, DOI DOI 10.1086/296367; Koenigs M, 2007, J NEUROSCI, V27, P951, DOI 10.1523/JNEUROSCI.4606-06.2007; Larsen BA, 2011, BIOL PSYCHOL, V86, P143, DOI 10.1016/j.biopsycho.2010.02.011; Leliveld MC, 2008, PERS SOC PSYCHOL B, V34, P1214, DOI 10.1177/0146167208318600; Lerner JS, 2006, J BEHAV DECIS MAKING, V19, P115, DOI 10.1002/bdm.515; Lerner JS, 2001, J PERS SOC PSYCHOL, V81, P146, DOI 10.1037//0022-3514.81.1.146; Levy BJ, 2011, ANN NY ACAD SCI, V1224, P40, DOI 10.1111/j.1749-6632.2011.05958.x; Lieberman MD, 2007, ANNU REV PSYCHOL, V58, P259, DOI 10.1146/annurev.psych.58.110405.085654; Liu M, 2009, HUM COMMUN RES, V35, P148, DOI 10.1111/j.1468-2958.2008.01342.x; Mauss IB, 2007, INT J PSYCHOPHYSIOL, V66, P116, DOI 10.1016/j.ijpsycho.2007.03.017; Memedovic S, 2010, J RES PERS, V44, P540, DOI 10.1016/j.jrp.2010.05.002; Miller N, 2003, PERS SOC PSYCHOL REV, V7, P75, DOI 10.1207/S15327957PSPR0701_5; Moons WG, 2007, PERS SOC PSYCHOL B, V33, P706, DOI 10.1177/0146167206298566; Moore DA, 1999, ORGAN BEHAV HUM DEC, V77, P22, DOI 10.1006/obhd.1998.2814; Morris M, 2002, GROUP DYN-THEOR RES, V6, P89, DOI 10.1037//1089-2699.6.1.89; Morris MW, 2000, RES ORGAN BEHAV, V22, P1, DOI 10.1016/S0191-3085(00)22002-9; Neumann SA, 2004, HEALTH PSYCHOL, V23, P631, DOI 10.1037/0278-6133.23.6.631; NOLENHOEKSEMA S, 1991, J ABNORM PSYCHOL, V100, P569, DOI 10.1037/0021-843X.100.4.569; Nowlis V., 1965, AFFECT COGNITION PER, P352; Overbeck JR, 2010, ORGAN BEHAV HUM DEC, V112, P126, DOI 10.1016/j.obhdp.2010.02.004; Pedersen WC, 2011, BRIT J SOC PSYCHOL, V50, P281, DOI 10.1348/014466610X515696; Pennebaker J. W., 2007, LIWC MANUAL DEV PSYC; Pennebaker JW, 2007, LINGUISTIC INQUIRY W; Pillutla MM, 1996, ORGAN BEHAV HUM DEC, V68, P208, DOI 10.1006/obhd.1996.0100; Ray RD, 2008, J PERS SOC PSYCHOL, V94, P133, DOI 10.1037/0022-3514.94.1.133; Richards JM, 2000, J PERS SOC PSYCHOL, V79, P410, DOI 10.1037//0022-3514.79.3.410; Rusting CL, 1998, J PERS SOC PSYCHOL, V74, P790, DOI 10.1037/0022-3514.74.3.790; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Sheppes G, 2007, PERS SOC PSYCHOL B, V33, P1518, DOI 10.1177/0146167207305537; Sheppes G, 2011, PERS SOC PSYCHOL REV, V15, P319, DOI 10.1177/1088868310395778; Sheppes G, 2008, EMOTION, V8, P870, DOI 10.1037/a0013711; Sinaceur M, 2006, J EXP SOC PSYCHOL, V42, P314, DOI 10.1016/j.jesp.2005.05.002; Tabibnia G, 2008, PSYCHOL SCI, V19, P339, DOI 10.1111/j.1467-9280.2008.02091.x; Tausczik YR, 2010, J LANG SOC PSYCHOL, V29, P24, DOI 10.1177/0261927X09351676; Tiedens LZ, 2001, J PERS SOC PSYCHOL, V81, P973, DOI 10.1037//0022-3514.81.6.973; van Dijk E, 2008, J PERS SOC PSYCHOL, V94, P600, DOI 10.1037/0022-3514.94.4.600; Van Kleef GA, 2004, J PERS SOC PSYCHOL, V87, P510, DOI 10.1037/0022-3514.87.4.510; Van Kleef GA, 2008, GROUP DECIS NEGOT, V17, P13, DOI 10.1007/s10726-007-9092-8; Van Kleef GA, 2007, J APPL PSYCHOL, V92, P1557, DOI 10.1037/0021-9010.92.6.1557; Wang CS, 2011, ORGAN BEHAV HUM DEC, V116, P46, DOI 10.1016/j.obhdp.2011.05.007; Watkins E, 2004, BEHAV RES THER, V42, P1037, DOI 10.1016/j.brat.2004.01.009; Zillmann D., 1983, AGGRESSION THEORETIC, V1, P75	69	21	21	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e51595	10.1371/journal.pone.0051595	http://dx.doi.org/10.1371/journal.pone.0051595			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	071TV	23300553	Green Published, Green Submitted, gold			2022-12-27	WOS:000313618800021
J	Hu, W; Li, LN; Sharma, S; Wang, J; McHardy, I; Lux, R; Yang, Z; He, XS; Gimzewski, JK; Li, YZ; Shi, WY				Hu, Wei; Li, Lina; Sharma, Shivani; Wang, Jing; McHardy, Ian; Lux, Renate; Yang, Zhe; He, Xuesong; Gimzewski, James K.; Li, Yuezhong; Shi, Wenyuan			DNA Builds and Strengthens the Extracellular Matrix in Myxococcus xanthus Biofilms by Interacting with Exopolysaccharides	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA BIOFILMS; STAPHYLOCOCCUS-EPIDERMIDIS; MULTICELLULAR STRUCTURES; COLOCALIZATION ANALYSIS; NEISSERIA-GONORRHOEAE; CHEMOTAXIS HOMOLOGS; MEMBRANE-VESICLES; CHROMOSOMAL DNA; SOCIAL MOTILITY; POLYSACCHARIDE	One intriguing discovery in modern microbiology is the extensive presence of extracellular DNA (eDNA) within biofilms of various bacterial species. Although several biological functions have been suggested for eDNA, including involvement in biofilm formation, the detailed mechanism of eDNA integration into biofilm architecture is still poorly understood. In the biofilms formed by Myxococcus xanthus, a Gram-negative soil bacterium with complex morphogenesis and social behaviors, DNA was found within both extracted and native extracellular matrices (ECM). Further examination revealed that these eDNA molecules formed well organized structures that were similar in appearance to the organization of exopolysaccharides (EPS) in ECM. Biochemical and image analyses confirmed that eDNA bound to and colocalized with EPS within the ECM of starvation biofilms and fruiting bodies. In addition, ECM containing eDNA exhibited greater physical strength and biological stress resistance compared to DNase I treated ECM. Taken together, these findings demonstrate that DNA interacts with EPS and strengthens biofilm structures in M. xanthus.	[Hu, Wei; Wang, Jing; Li, Yuezhong] Shandong Univ, Sch Life Sci, State Key Lab Microbial Technol, Jinan, Shandong, Peoples R China; [Hu, Wei; Li, Lina; Wang, Jing; McHardy, Ian; Lux, Renate; Yang, Zhe; He, Xuesong; Shi, Wenyuan] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90024 USA; [Hu, Wei; Li, Lina; Wang, Jing; McHardy, Ian; Lux, Renate; Yang, Zhe; He, Xuesong; Shi, Wenyuan] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Sharma, Shivani; Gimzewski, James K.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA; [Sharma, Shivani; Gimzewski, James K.] Univ Calif Los Angeles, Calif NanoSyst Inst CNSI, Los Angeles, CA 90024 USA; [Gimzewski, James K.] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton Satellite MANA, Tsukuba, Ibaraki, Japan	Shandong University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; National Institute for Materials Science	Shi, WY (corresponding author), Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90024 USA.	wenyuan@ucla.edu	He, Xuesong/GXN-2297-2022; SHI, wen/GPW-9531-2022; Li, Yuezhong/ACN-5179-2022	gimzewski, james/0000-0003-4333-6957; McHardy, Ian/0000-0002-2121-5460; Li, Yuezhong/0000-0001-8336-6638	United States National Institutes of Health Grant [GM54666]; Chinese Natural Science Foundation Grant [30870020]; Shandong Natural Science Foundation Grant [ZR2012CM003]; SDU Innovation Grant [2012TS007]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054666] Funding Source: NIH RePORTER	United States National Institutes of Health Grant; Chinese Natural Science Foundation Grant; Shandong Natural Science Foundation Grant; SDU Innovation Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by United States National Institutes of Health Grant GM54666 (to W.S.), Chinese Natural Science Foundation Grant 30870020 (to W.H.), Shandong Natural Science Foundation Grant ZR2012CM003 (to W.H.) and SDU Innovation Grant 2012TS007 (to W.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allesen-Holm M, 2006, MOL MICROBIOL, V59, P1114, DOI 10.1111/j.1365-2958.2005.05008.x; Andersson S, 2009, APPL MICROBIOL BIOT, V82, P535, DOI 10.1007/s00253-008-1817-3; AVERY L, 1983, MOL GEN GENET, V191, P110, DOI 10.1007/BF00330897; Barken KB, 2008, ENVIRON MICROBIOL, V10, P2331, DOI 10.1111/j.1462-2920.2008.01658.x; BEHMLANDER RM, 1994, J BACTERIOL, V176, P6295, DOI 10.1128/jb.176.20.6295-6303.1994; Berne C, 2010, MOL MICROBIOL, V77, P815, DOI 10.1111/j.1365-2958.2010.07267.x; Bhinu VS, 2005, J MOL MICROB BIOTECH, V10, P15, DOI 10.1159/000090344; Black WP, 2004, J BACTERIOL, V186, P1001, DOI 10.1128/JB.186.4.1001-1008.2004; Bockelmann U, 2006, FEMS MICROBIOL LETT, V262, P31, DOI 10.1111/j.1574-6968.2006.00361.x; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; CAMPOS JM, 1978, J MOL BIOL, V119, P167, DOI 10.1016/0022-2836(78)90431-X; Cao WD, 2006, ANAL CHEM, V78, P7222, DOI 10.1021/ac060391l; CHANG BY, 1994, J BACTERIOL, V176, P7190, DOI 10.1128/JB.176.23.7190-7196.1994; COHEN GH, 1964, J BACTERIOL, V88, P329, DOI 10.1128/JB.88.2.329-338.1964; Dell'Anno A, 2005, SCIENCE, V309, P2179, DOI 10.1126/science.1117475; Dickschat JS, 2010, NAT PROD REP, V27, P343, DOI 10.1039/b804469b; Dillard JP, 2001, MOL MICROBIOL, V41, P263, DOI 10.1046/j.1365-2958.2001.02520.x; Diodati ME, 2007, MYXOBACTERIA: MULTICELLULARITY AND DIFFERENTIATION, P43; Dworkin M, 1993, MYXOBACTERIA, P63; Finkel SE, 2001, J BACTERIOL, V183, P6288, DOI 10.1128/JB.183.21.6288-6293.2001; Hall-Stoodley L, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-173; Hamilton HL, 2005, MOL MICROBIOL, V55, P1704, DOI 10.1111/j.1365-2958.2005.04521.x; HARA T, 1981, AGR BIOL CHEM TOKYO, V45, P2457, DOI 10.1080/00021369.1981.10864927; Izano EA, 2008, APPL ENVIRON MICROB, V74, P470, DOI 10.1128/AEM.02073-07; Jurcisek JA, 2007, J BACTERIOL, V189, P3868, DOI 10.1128/JB.01935-06; KAISER D, 1979, P NATL ACAD SCI USA, V76, P5952, DOI 10.1073/pnas.76.11.5952; Kaiser D, 2003, NAT REV MICROBIOL, V1, P45, DOI 10.1038/nrmicro733; Kaplan JB, 2010, J DENT RES, V89, P205, DOI 10.1177/0022034509359403; Klausen M, 2003, MOL MICROBIOL, V50, P61, DOI 10.1046/j.1365-2958.2003.03677.x; Kolenbrander PE, 2007, MYXOBACTERIA: MULTICELLULARITY AND DIFFERENTIATION, P453; KUNER JM, 1982, J BACTERIOL, V151, P458, DOI 10.1128/JB.151.1.458-461.1982; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Lux R., 2004, BIOFILMS, V1, P293; Ma LM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000354; Mayer C, 1999, INT J BIOL MACROMOL, V26, P3, DOI 10.1016/S0141-8130(99)00057-4; Merroun ML, 2003, CHEMOSPHERE, V52, P113, DOI 10.1016/S0045-6535(03)00220-0; Mignot T, 2007, SCIENCE, V315, P853, DOI 10.1126/science.1137223; Mulcahy H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000213; Nariya H, 2008, CELL, V132, P55, DOI 10.1016/j.cell.2007.11.044; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; OCONNOR KA, 1988, J BACTERIOL, V170, P4103, DOI 10.1128/jb.170.9.4103-4112.1988; PALMEN R, 1995, CURR MICROBIOL, V30, P7, DOI 10.1007/BF00294516; Pelling AE, 2005, P NATL ACAD SCI USA, V102, P6484, DOI 10.1073/pnas.0501207102; Qin ZQ, 2007, MICROBIOL-SGM, V153, P2083, DOI 10.1099/mic.0.2007/006031-0; Rasband W., 2006, IMAGEJ; Renelli M, 2004, MICROBIOL-SGM, V150, P2161, DOI 10.1099/mic.0.26841-0; ROE JH, 1966, ANAL BIOCHEM, V15, P245, DOI 10.1016/0003-2697(66)90028-5; ROSENBLUH A, 1993, MYXOBACTERIA, V2, P213; Schooling SR, 2006, J BACTERIOL, V188, P5945, DOI 10.1128/JB.00257-06; SHIMKETS LJ, 1986, J BACTERIOL, V166, P842, DOI 10.1128/jb.166.3.842-848.1986; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; Sutherland IW, 2001, MICROBIOL-UK, V147, P3, DOI 10.1099/00221287-147-1-3; Vilain S, 2009, APPL ENVIRON MICROB, V75, P2861, DOI 10.1128/AEM.01317-08; Vlassov VV, 2007, BIOESSAYS, V29, P654, DOI 10.1002/bies.20604; Wang J, 2011, J BACTERIOL, V193, P2122, DOI 10.1128/JB.00041-11; Welch R, 2001, P NATL ACAD SCI USA, V98, P14907, DOI 10.1073/pnas.261574598; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Yang ZM, 1998, MOL MICROBIOL, V30, P1123, DOI 10.1046/j.1365-2958.1998.01160.x; Zinchuk V, 2007, ACTA HISTOCHEM CYTOC, V40, P101, DOI 10.1267/ahc.07002	61	40	44	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e51905	10.1371/journal.pone.0051905	http://dx.doi.org/10.1371/journal.pone.0051905			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300576	Green Published, Green Submitted, gold			2022-12-27	WOS:000313618800035
J	Layous, K; Nelson, SK; Oberle, E; Schonert-Reichl, KA; Lyubomirsky, S				Layous, Kristin; Nelson, S. Katherine; Oberle, Eva; Schonert-Reichl, Kimberly A.; Lyubomirsky, Sonja			Kindness Counts: Prompting Prosocial Behavior in Preadolescents Boosts Peer Acceptance and Well-Being	PLOS ONE			English	Article							EARLY ADOLESCENTS; POSITIVE AFFECT; HAPPINESS; CHILDREN; POPULARITY; TEMPERAMENT; GRATITUDE; BENEFITS	At the top of parents' many wishes is for their children to be happy, to be good, and to be well-liked. Our findings suggest that these goals may not only be compatible but also reciprocal. In a longitudinal experiment conducted in 19 classrooms in Vancouver, 9- to 11-year olds were instructed to perform three acts of kindness (versus visit three places) per week over the course of 4 weeks. Students in both conditions improved in well-being, but students who performed kind acts experienced significantly bigger increases in peer acceptance (or sociometric popularity) than students who visited places. Increasing peer acceptance is a critical goal, as it is related to a variety of important academic and social outcomes, including reduced likelihood of being bullied. Teachers and interventionists can build on this study by introducing intentional prosocial activities into classrooms and recommending that such activities be performed regularly and purposefully.	[Layous, Kristin; Nelson, S. Katherine; Lyubomirsky, Sonja] Univ Calif Riverside, Dept Psychol, Riverside, CA 92521 USA; [Oberle, Eva; Schonert-Reichl, Kimberly A.] Univ British Columbia, Dept Educ & Counseling Psychol & Special Educ, Vancouver, BC V5Z 1M9, Canada	University of California System; University of California Riverside; University of British Columbia	Layous, K (corresponding author), Univ Calif Riverside, Dept Psychol, Riverside, CA 92521 USA.	klayo001@ucr.edu		Nelson-Coffey, S. Katherine/0000-0002-9958-6819; Layous, Kristin/0000-0003-0524-2802				Aknin LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039211; Aknin LB, 2012, J HAPPINESS STUD, V13, P347, DOI 10.1007/s10902-011-9267-5; Caprara GV, 2000, PSYCHOL SCI, V11, P302, DOI 10.1111/1467-9280.00260; Cillessen AHN, 2005, CURR DIR PSYCHOL SCI, V14, P102, DOI 10.1111/j.0963-7214.2005.00343.x; de Bruyn EH, 2005, SOC DEV, V14, P555, DOI 10.1111/j.1467-9507.2005.00317.x; Diener ML, 2004, J CROSS CULT PSYCHOL, V35, P525, DOI 10.1177/0022022104268387; Dunn EW, 2008, SCIENCE, V319, P1687, DOI 10.1126/science.1150952; Fowler JH, 2010, P NATL ACAD SCI USA, V107, P5334, DOI 10.1073/pnas.0913149107; Froh JJ, 2008, J SCHOOL PSYCHOL, V46, P213, DOI 10.1016/j.jsp.2007.03.005; Froh JJ, 2009, J POSIT PSYCHOL, V4, P408, DOI 10.1080/17439760902992464; Gadermann AM, 2010, SOC INDIC RES, V96, P229, DOI 10.1007/s11205-009-9474-1; GROSS JJ, 1995, COGNITION EMOTION, V9, P87, DOI 10.1080/02699939508408966; Holder MD, 2008, J HAPPINESS STUD, V9, P279, DOI 10.1007/s10902-007-9052-7; Holder MD, 2010, J HAPPINESS STUD, V11, P419, DOI 10.1007/s10902-009-9149-2; Krueger RF, 2001, PSYCHOL SCI, V12, P397, DOI 10.1111/1467-9280.00373; Laurent J, 1999, PSYCHOL ASSESSMENT, V11, P326, DOI 10.1037/1040-3590.11.3.326; Lyubomirsky S, 2005, PSYCHOL BULL, V131, P803, DOI 10.1037/0033-2909.131.6.803; Lyubomirsky S, 2005, REV GEN PSYCHOL, V9, P111, DOI 10.1037/1089-2680.9.2.111; Lyubomirsky S, 2006, SOC INDIC RES, V78, P363, DOI 10.1007/s11205-005-0213-y; Ostberg V, 2003, SOC SCI MED, V56, P17, DOI 10.1016/S0277-9536(02)00006-0; Richards M, 2011, J POSIT PSYCHOL, V6, P75, DOI 10.1080/17439760.2011.536655; Sandstrom MJ, 2006, INT J BEHAV DEV, V30, P305, DOI 10.1177/0165025406072789; Sin NL, 2009, J CLIN PSYCHOL, V65, P467, DOI 10.1002/jclp.20593; Suldo S, 2011, J POSIT PSYCHOL, V6, P17, DOI 10.1080/17439760.2010.536774; Van Dillen LF, 2007, EMOTION, V7, P715, DOI 10.1037/1528-3542.7.4.715; Wang SY, 2003, J CROSS CULT PSYCHOL, V34, P629, DOI 10.1177/0022022103255498; Warneken F, 2006, SCIENCE, V311, P1301, DOI 10.1126/science.1121448; Weinstein N, 2010, J PERS SOC PSYCHOL, V98, P222, DOI 10.1037/a0016984; Wentzel, 2009, HDB POSITIVE PSYCHOL, P229; Wentzel K.R., 2005, HDB COMPETENCE MOTIV, P279	30	170	172	6	118	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e51380	10.1371/journal.pone.0051380	http://dx.doi.org/10.1371/journal.pone.0051380			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	071TV	23300546	gold, Green Published			2022-12-27	WOS:000313618800018
J	Ose, D; Rochon, J; Campbell, SM; Wensing, M; van Lieshout, J; Uhlmann, L; Freund, T; Szecsenyi, J; Ludt, S				Ose, Dominik; Rochon, Justine; Campbell, Stephen M.; Wensing, Michel; van Lieshout, Jan; Uhlmann, Lorenz; Freund, Tobias; Szecsenyi, Joachim; Ludt, Sabine			Secondary Prevention in Patients with Coronary Heart Diseases: What Factors Are Associated with Health Status in Usual Primary Care?	PLOS ONE			English	Article							QUALITY-OF-LIFE; CARDIOVASCULAR-DISEASE; STRUCTURAL CAPABILITIES; CLINICAL-PRACTICE; GUIDED CARE; MANAGEMENT; RISK; BURDEN; TRIAL; INDICATORS	Background: For patients with coronary heart diseases a substantial part of secondary prevention is delivered in primary care. Along with the growing importance of prevention, health-related quality of life (HRQoL) is an indicator of patient-centered care that has gained increased attention. Different approaches for reorganization in primary care have been associated with improvements in HRQoL. However, these are often results of complex interventions. Evidence on aspects concerning usual primary care that actually have an impact on HRQoL remains scarce. Therefore, this observational study aimed to identify factors which are associated with HRQoL in usual primary care at practice and patient-level. Methods: This observational study was conducted in eight European countries. We were able to match data from survey instruments for 3505 patients with coronary heart disease (CHD) in 228 practices. A multilevel analysis was performed to identify associations of EQ-5D scores at patient and practice-level. Results: After dropping patients with missing information, our cohort consisted of 2656 patients. In this sample, 30.5% were female and the mean age was 67.5 years (SD 10.1). The final model included a total set of 14 potential explanatory variables. At practice-level no variable was associated with EQ-5D. At patient-level, lower education (r = -0.0381, p < 0.0001), female gender (r = -0.0543, p < 0.0001) and a higher number of other conditions (r = -0.0340, p < 0.0001), had a strong negative effect on HRQoL. Strong positive associations with HRQoL were found for a good medication adherence (Morisky) (r = 0.0195, p < 0.0001) and more positive evaluations of physicians' clinical behavior (r = 0.0282, p = 0.002). In terms of HRQoL no differences between single-handed and group practices exist. Conclusion: The results of our study suggest that a better patient-physician relationship rather than organization of CHD care is associated with higher HRQOL in the primary care setting. The results may imply that interventions to improve HRQoL require a strong patient-centered approach.	[Ose, Dominik; Campbell, Stephen M.; Wensing, Michel; Freund, Tobias; Szecsenyi, Joachim; Ludt, Sabine] Univ Heidelberg Hosp, Dept Gen Practice & Hlth Serv, Heidelberg, Germany; [Wensing, Michel; van Lieshout, Jan] Radboud Univ Nijmegen, Med Ctr, Sci Inst Qual Healthcare, Nijmegen, Netherlands; [Rochon, Justine; Uhlmann, Lorenz] Heidelberg Univ, Inst Med Biometry & Informat, Heidelberg, Germany; [Campbell, Stephen M.] Univ Manchester, Hlth Sci Primary Care Grp, Manchester, Lancs, England	Ruprecht Karls University Heidelberg; Radboud University Nijmegen; Ruprecht Karls University Heidelberg; University of Manchester	Ose, D (corresponding author), Univ Heidelberg Hosp, Dept Gen Practice & Hlth Serv, Heidelberg, Germany.	dominik.ose@med.uni-heidelberg.de	Uhlmann, Lorenz/AAL-9839-2020; Ose, Dominik J/F-7691-2013; Wensing, Michel/H-8113-2014; Ose, Dominik/L-4250-2019; Van Lieshout, J./L-4490-2015	Ose, Dominik J/0000-0002-5079-2152; Wensing, Michel/0000-0001-6569-8137; Ose, Dominik/0000-0002-5079-2152; Campbell, Stephen/0000-0002-2328-4136	Bertelsmann Foundation (Gutersloh, Germany); IQ Healthcare of the Radboud University Nijmegen (The Netherlands)	Bertelsmann Foundation (Gutersloh, Germany); IQ Healthcare of the Radboud University Nijmegen (The Netherlands)	The Bertelsmann Foundation (Gutersloh, Germany) initiated, coordinated, and funded the EPA Cardio project, in collaboration with IQ Healthcare of the Radboud University Nijmegen (The Netherlands). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell RJ, 2007, CLIN ENDOCRINOL, V66, P548, DOI 10.1111/j.1365-2265.2007.02771.x; Bielaszka-DuVernay C, 2011, HEALTH AFFAIR, V30, P431, DOI 10.1377/hlthaff.2011.0043; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1775, DOI 10.1001/jama.288.14.1775; Boyd CM, 2007, GERONTOLOGIST, V47, P697, DOI 10.1093/geront/47.5.697; Boyd CM, 2010, J GEN INTERN MED, V25, P235, DOI 10.1007/s11606-009-1192-5; Brown JR, 2010, NEW ENGL J MED, V362, P2150, DOI 10.1056/NEJMp1003880; Byrne M, 2005, J PSYCHOSOM RES, V58, P403, DOI 10.1016/j.jpsychores.2004.11.010; Campbell SM, 2008, EUR J CARDIOV PREV R, V15, P509, DOI 10.1097/HJR.0b013e328302f44d; Counsell SR, 2007, JAMA-J AM MED ASSOC, V298, P2623, DOI 10.1001/jama.298.22.2623; Davis PD, 1995, SURV METHODOL, V21, P99; Dyer MTD, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-13; Engels Y, 2006, FAM PRACT, V23, P137, DOI 10.1093/fampra/cmi091; Eriksson MK, 2010, ARCH INTERN MED, V170, P1470, DOI 10.1001/archinternmed.2010.301; Ford ES, 2008, J WOMENS HEALTH, V17, P757, DOI 10.1089/jwh.2007.0468; Friedberg MW, 2009, ANN INTERN MED, V151, P456, DOI 10.7326/0003-4819-151-7-200910060-00006; Friedberg MW, 2009, J GEN INTERN MED, V24, P162, DOI 10.1007/s11606-008-0856-x; Frieden TR, 2011, NEW ENGL J MED, V365, DOI [10.1056/NEJMp1110421, 10.1056/NEJMP1110421]; Friedman SM, 2005, GERONTOLOGIST, V45, P157, DOI 10.1093/geront/45.2.157; Garster NC, 2009, QUAL LIFE RES, V18, P1239, DOI 10.1007/s11136-009-9533-8; Graham I, 2007, EUR HEART J, V28, P2375, DOI 10.1093/eurheartj/ehm316; Greiner Wolfgang, 2003, Eur J Health Econ, V4, P222, DOI 10.1007/s10198-003-0182-5; Koertge J, 2003, AM J CARDIOL, V91, P1316, DOI 10.1016/S0002-9149(03)00320-5; Leal J, 2006, EUR HEART J, V27, P1610, DOI 10.1093/eurheartj/ehi733; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Ludt S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029334; Mensah GA, 2007, HEALTH AFFAIR, V26, P38, DOI 10.1377/hlthaff.26.1.38; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; Nadash P, 2004, GERONTOLOGIST, V44, P644, DOI 10.1093/geront/44.5.644; Ose D, 2009, DIABETES CARE, V32, P1594, DOI 10.2337/dc08-2223; Parker RM, 1999, JAMA-J AM MED ASSOC, V281, P552; Piette JD, 2005, ARCH INTERN MED, V165, P1749, DOI 10.1001/archinte.165.15.1749; Rasbash J, 2011, MLWIN VERSION 2 24; Raudenbusch S. W., 2002, HIERARCHICAL LINEAR; REDELMEIER DA, 1993, JAMA-J AM MED ASSOC, V270, P72, DOI 10.1001/jama.270.1.72; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Rumsfeld JS, 2002, CIRCULATION, V106, P5, DOI 10.1161/01.CIR.0000020805.31531.48; Simons-Morton DG, 2001, JAMA-J AM MED ASSOC, V286, P677; Street RL, 2009, PATIENT EDUC COUNS, V74, P295, DOI 10.1016/j.pec.2008.11.015; Takach M, 2010, STRENGTHENING PRIMAR; Tsai AC, 2005, AM J MANAG CARE, V11, P478; van Dam RM, 2009, CIRCULATION, V120, P1171, DOI 10.1161/CIRCULATIONAHA.109.891507; van Lieshout J, 2009, AM J MANAG CARE, V15, P255; Vargas RB, 2007, J GEN INTERN MED, V22, P215, DOI 10.1007/s11606-006-0072-5; Wadden TA, 2011, NEW ENGL J MED, V365, P1969, DOI 10.1056/NEJMoa1109220; Wang WR, 2012, HEART LUNG, V41, P15, DOI 10.1016/j.hrtlng.2011.05.005; Wensing M, 2000, EUROPEAN J GEN PRACT, V6, P82, DOI DOI 10.3109/13814780009069953; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wroth TH, 2006, J AM BOARD FAM MED, V19, P478, DOI 10.3122/jabfm.19.5.478; Xie JP, 2008, CIRCULATION, V118, P491, DOI 10.1161/CIRCULATIONAHA.107.752006; Yusuf S, 2001, CIRCULATION, V104, P2855, DOI 10.1161/hc4701.099488	50	12	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e51726	10.1371/journal.pone.0051726	http://dx.doi.org/10.1371/journal.pone.0051726			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	071TV	23300560	gold, Green Published, Green Submitted			2022-12-27	WOS:000313618800024
J	Schuepp, C; Rittiner, S; Entling, MH				Schueepp, Christof; Rittiner, Sarah; Entling, Martin H.			High Bee and Wasp Diversity in a Heterogeneous Tropical Farming System Compared to Protected Forest	PLOS ONE			English	Article							FLOWER-VISITING INSECTS; BETA-DIVERSITY; SPECIES RICHNESS; HABITAT FRAGMENTATION; HUMAN DISTURBANCE; CROP POLLINATION; RAIN-FORESTS; BIODIVERSITY; CONSERVATION; COMMUNITIES	It is a globally important challenge to meet increasing demands for resources and, at the same time, protect biodiversity and ecosystem services. Farming is usually regarded as a major threat to biodiversity due to its expansion into natural areas. We compared biodiversity of bees and wasps between heterogeneous small-scale farming areas and protected forest in northern coastal Belize, Central America. Malaise traps operated for three months during the transition from wet to dry season. Farming areas consisted of a mosaic of mixed crop types, open habitat, secondary forest, and agroforestry. Mean species richness per site (alpha diversity), as well as spatial and temporal community variation (beta diversity) of bees and wasps were equal or higher in farming areas compared to protected forest. The higher species richness and community variation in farmland was due to additional species that did not occur in the forest, whereas most species trapped in forest were also found in farming areas. The overall regional species richness (gamma diversity) increased by 70% with the inclusion of farming areas. Our results suggest that small-scale farming systems adjacent to protected forest may not only conserve, but even favour, biodiversity of some taxonomic groups. We can, however, not exclude possible declines of bee and wasp diversity in more intensified farmland or in landscapes completely covered by heterogeneous farming systems.	[Schueepp, Christof; Rittiner, Sarah] Univ Bern, Inst Ecol & Evolut, Bern, Switzerland; [Schueepp, Christof; Entling, Martin H.] Univ Koblenz Landau, Landau, Germany	University of Bern; University of Koblenz & Landau	Schuepp, C (corresponding author), Univ Bern, Inst Ecol & Evolut, Bern, Switzerland.	christof.schueepp@iee.unibe.ch	Entling, Martin H/C-6953-2008		International Tropical Conservation Foundation ITCF, Kerzers, Switzerland; Natural History Museum of Bern, Switzerland (Naturhistorisches Museum der Burgergemeinde Bern)	International Tropical Conservation Foundation ITCF, Kerzers, Switzerland; Natural History Museum of Bern, Switzerland (Naturhistorisches Museum der Burgergemeinde Bern)	This research project was funded by the International Tropical Conservation Foundation ITCF, Kerzers, Switzerland (www.shipstern.org) and the Natural History Museum of Bern, Switzerland (Naturhistorisches Museum der Burgergemeinde Bern, www.nmbe.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, except for the requirement of ITCF that at least a part of the research project takes place at Shipstern Nature Reserve.	Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; Axmacher JC, 2011, BIOL CONSERV, V144, P2362, DOI 10.1016/j.biocon.2011.06.016; Bailey D, 2010, J APPL ECOL, V47, P1003, DOI 10.1111/j.1365-2664.2010.01858.x; Barlow J, 2007, P NATL ACAD SCI USA, V104, P18555, DOI 10.1073/pnas.0703333104; Basset Y, 2008, CONSERV BIOL, V22, P1552, DOI 10.1111/j.1523-1739.2008.01017.x; Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; Bijleveld CFA, 1998, VEGETATION SHIPSTERN; Brosi BJ, 2008, J APPL ECOL, V45, P773, DOI 10.1111/j.1365-2664.2007.01412.x; Brown KS, 1997, J INSECT CONSERV, V1, P25, DOI 10.1023/A:1018422807610; Bruggisser OT, 2010, BIOL CONSERV, V143, P1521, DOI 10.1016/j.biocon.2010.03.034; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; Cagnolo L, 2009, CONSERV BIOL, V23, P1167, DOI 10.1111/j.1523-1739.2009.01214.x; Cardoso P, 2011, BIOL CONSERV, V144, P2647, DOI 10.1016/j.biocon.2011.07.024; Chacoff NP, 2006, J APPL ECOL, V43, P18, DOI 10.1111/j.1365-2664.2005.01116.x; Chazdon RL, 2009, CONSERV BIOL, V23, P1406, DOI 10.1111/j.1523-1739.2009.01338.x; Coad L., 2009, ECOLOGICAL REPRESENT; COLWELL R. K, 2009, ESTIMATES STAT ESTIM; Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Davies KF, 2000, ECOLOGY, V81, P1450, DOI 10.2307/177221; Dormann CF, 2007, GLOBAL ECOL BIOGEOGR, V16, P774, DOI 10.1111/j.1466-8238.2007.00344.x; Duivenvoorden JF, 2002, SCIENCE, V295, P636, DOI 10.1126/science.295.5555.636; EHRLICH PR, 1992, AMBIO, V21, P219; Eltz T, 2002, OECOLOGIA, V131, P27, DOI 10.1007/s00442-001-0848-6; Fox JW, 2013, TRENDS ECOL EVOL, V28, P86, DOI 10.1016/j.tree.2012.08.014; Gardner TA, 2009, ECOL LETT, V12, P561, DOI 10.1111/j.1461-0248.2009.01294.x; Gascon C, 1999, BIOL CONSERV, V91, P223, DOI 10.1016/S0006-3207(99)00080-4; Gauld ID, 1995, HYMENOPTERA COSTA RI, P185; Godfray HCJ, 2011, SCIENCE, V333, P1231, DOI 10.1126/science.1211815; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Google, 2011, GOOGL EARTH 6 1 0 50; Hagen M, 2010, BIOL CONSERV, V143, P1654, DOI 10.1016/j.biocon.2010.03.036; Hoehn P, 2010, BIODIVERS CONSERV, V19, P2189, DOI 10.1007/s10531-010-9831-z; Jha S, 2010, BIOL CONSERV, V143, P1423, DOI 10.1016/j.biocon.2010.03.017; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Karp DS, 2012, ECOL LETT, V15, P963, DOI 10.1111/j.1461-0248.2012.01815.x; Kessler M, 2009, ECOL APPL, V19, P2142, DOI 10.1890/08-1074.1; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Klein AM, 2003, P ROY SOC B-BIOL SCI, V270, P955, DOI 10.1098/rspb.2002.2306; Kremen C, 2002, P NATL ACAD SCI USA, V99, P16812, DOI 10.1073/pnas.262413599; Kremen C., 2008, BEE POLLINATION AGR; Kremen C, 2007, ECOL LETT, V10, P299, DOI 10.1111/j.1461-0248.2007.01018.x; Lande R, 1996, OIKOS, V76, P5, DOI 10.2307/3545743; Lewis OT, 2001, CONSERV BIOL, V15, P389, DOI 10.1046/j.1523-1739.2001.015002389.x; Magurran AE, 2007, MEASURING BIOL DIVER, V5; Meerman J. C., 2010, BIODIVERSITY ENV RES; Calvillo LM, 2010, J INSECT CONSERV, V14, P323, DOI 10.1007/s10841-010-9262-x; Michener C.D., 2007, BEES WORLD, Vsecond; Missa O, 2009, J INSECT CONSERV, V13, P103, DOI 10.1007/s10841-007-9130-5; Molino JF, 2001, SCIENCE, V294, P1702, DOI 10.1126/science.1060284; Oksanen J., 2022, VEGAN COMMUNITY ECOL; Pardini R, 2009, BIOL CONSERV, V142, P1178, DOI 10.1016/j.biocon.2009.02.010; Pinheiro JC, 2012, NLME LINEAR NONLINEA, P1; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ricketts TH, 2008, ECOL LETT, V11, P499, DOI 10.1111/j.1461-0248.2008.01157.x; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Roubik D. W., 2004, ORCHID BEES TROPICAL; Samejima H, 2004, BIOL CONSERV, V120, P577, DOI 10.1016/j.biocon.2004.03.030; Scales BR, 2008, ENVIRON CONSERV, V35, P160, DOI 10.1017/S0376892908004840; Schleuning M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027785; Schuepp C, 2011, OECOLOGIA, V165, P713, DOI 10.1007/s00442-010-1746-6; Smith B, 1996, OIKOS, V76, P70, DOI 10.2307/3545749; Soule ME, 1998, SCIENCE, V279, P2060, DOI 10.1126/science.279.5359.2060; Summerville KS, 2005, BIODIVERS CONSERV, V14, P3393, DOI 10.1007/s10531-004-0546-x; Svensson JR, 2007, ECOLOGY, V88, P830, DOI 10.1890/06-0976; Tilman D, 1999, P NATL ACAD SCI USA, V96, P5995, DOI 10.1073/pnas.96.11.5995; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Tscharntke T, 2002, ECOL RES, V17, P229, DOI 10.1046/j.1440-1703.2002.00482.x; Tscharntke T, 2012, BIOL REV, V87, P661, DOI 10.1111/j.1469-185X.2011.00216.x; Tuomisto H, 2003, J ECOL, V91, P743, DOI 10.1046/j.1365-2745.2003.00802.x; Tylianakis JM, 2006, J BIOGEOGR, V33, P1295, DOI 10.1111/j.1365-2699.2006.01493.x; Tylianakis JM, 2005, ECOLOGY, V86, P3296, DOI 10.1890/05-0371; Vellend M, 2007, J ECOL, V95, P565, DOI 10.1111/j.1365-2745.2007.01233.x; Vulliamy B, 2006, OIKOS, V114, P529, DOI 10.1111/j.2006.0030-1299.14004.x; Warren MS, 2001, NATURE, V414, P65, DOI 10.1038/35102054; Winfree R, 2007, CONSERV BIOL, V21, P213, DOI 10.1111/j.1523-1739.2006.00574.x; Wittemyer G, 2008, SCIENCE, V321, P123, DOI 10.1126/science.1158900; Zuur Alain F., 2009, P1	81	22	23	2	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52109	10.1371/journal.pone.0052109	http://dx.doi.org/10.1371/journal.pone.0052109			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300598	Green Published, gold, Green Submitted			2022-12-27	WOS:000313618800049
J	Gupta, K; Thakur, VS; Bhaskaran, N; Nawab, A; Babcook, MA; Jackson, MW; Gupta, S				Gupta, Karishma; Thakur, Vijay S.; Bhaskaran, Natarajan; Nawab, Akbar; Babcook, Melissa A.; Jackson, Mark W.; Gupta, Sanjay			Green Tea Polyphenols Induce p53-Dependent and p53-Independent Apoptosis in Prostate Cancer Cells through Two Distinct Mechanisms	PLOS ONE			English	Article							NF-KAPPA-B; IN-VITRO; CONSTITUTIVE ACTIVATION; MEDIATED APOPTOSIS; GROWTH ARREST; RICH EXTRACT; CYCLE ARREST; P53 PROTEIN; PATHWAY; AKT	Inactivation of the tumor suppressor gene p53 is commonly observed in human prostate cancer and is associated with therapeutic resistance. We have previously demonstrated that green tea polyphenols (GTP) induce apoptosis in prostate cancer cells irrespective of p53 status. However, the molecular mechanisms underlying these observations remain elusive. Here we investigated the mechanisms of GTP-induced apoptosis in human prostate cancer LNCaP cells stably-transfected with short hairpin-RNA against p53 (LNCaPshp53) and control vector (LNCaPshV). GTP treatment induced p53 stabilization and activation of downstream targets p21/waf1 and Bax in a dose-dependent manner specifically in LNCaPshV cells. However, GTP-induced FAS upregulation through activation of c-jun-N-terminal kinase resulted in FADD phosphorylation, caspase-8 activation and truncation of BID, leading to apoptosis in both LNCaPshV and LNCaPshp53 cells. In parallel, treatment of cells with GTP resulted in inhibition of survival pathway, mediated by Akt deactivation and loss of BAD phosphorylation more prominently in LNCaPshp53 cells. These distinct routes of cell death converged to a common pathway, leading to loss of mitochondrial transmembrane potential, cytochrome c release and activation of terminal caspases, resulting in PARP-cleavage. GTP-induced apoptosis was attenuated with JNK inhibitor, SP600125 in both cell lines; whereas PI3K-Akt inhibitor, LY294002 resulted in increased cell death prominently in LNCaPshp53 cells, establishing the role of two distinct pathways of GTP-mediated apoptosis. Furthermore, GTP exposure resulted in inhibition of class I HDAC protein, accumulation of acetylated histone-H3 in total cellular chromatin, resulting in increased accessibility of transcription factors to bind with the promoter sequences of p21/waf1 and Bax, regardless of the p53 status of cells, consistent with effects elicited by an HDAC inhibitor, trichostatin A. These results demonstrate that GTP induces prostate cancer cell death by two distinct mechanisms regardless of p53 status, thus identifying specific well-defined molecular mechanisms that may be targeted by chemopreventive and/or therapeutic strategies.	[Gupta, Karishma; Thakur, Vijay S.; Bhaskaran, Natarajan; Nawab, Akbar; Babcook, Melissa A.; Gupta, Sanjay] Case Western Reserve Univ, Dept Urol, Cleveland, OH 44106 USA; [Babcook, Melissa A.; Gupta, Sanjay] Case Western Reserve Univ, Dept Nutr, Cleveland, OH 44106 USA; [Jackson, Mark W.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Thakur, Vijay S.; Bhaskaran, Natarajan; Nawab, Akbar; Babcook, Melissa A.; Gupta, Sanjay] Univ Hosp Case Med Ctr, Cleveland, OH USA; [Gupta, Sanjay] Case Comprehens Canc Ctr, Cleveland, OH USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; Case Western Reserve University	Gupta, S (corresponding author), Case Western Reserve Univ, Dept Urol, Cleveland, OH 44106 USA.	sanjay.gupta@case.edu	Bhaskaran, Natarajan/AAE-8445-2019	Gupta, Karishma/0000-0002-1501-032X; Gupta, Sanjay/0000-0002-9492-3249	United States Public Health Service [RO1 CA115491, RO1 CA108512, RO1 AT002709, R21 CA109424]; NATIONAL CANCER INSTITUTE [R01CA108512, R21CA109424, R01CA115491] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT002709] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	The research work is supported by United States Public Health Service Grants RO1 CA115491, RO1 CA108512, RO1 AT002709, and R21 CA109424 and Endowment funds to SG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundson SA, 1998, ONCOGENE, V17, P3287, DOI 10.1038/sj.onc.1202576; Asensi M, 2011, CRIT REV CL LAB SCI, V48, P197, DOI 10.3109/10408363.2011.631268; Blagosklonny MV, 1996, INT J CANCER, V67, P386, DOI 10.1002/(SICI)1097-0215(19960729)67:3<386::AID-IJC13>3.0.CO;2-6; Brady CA, 2010, J CELL SCI, V123, P2527, DOI 10.1242/jcs.064501; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Bush JA, 2001, EXP CELL RES, V271, P305, DOI 10.1006/excr.2001.5381; Carden CP, 2012, MOL CANCER THER, V11, P1609, DOI 10.1158/1535-7163.MCT-11-0996; Chang F, 2003, LEUKEMIA, V17, P590, DOI 10.1038/sj.leu.2402824; Chen WJ, 2010, MOL PHARMACOL, V77, P416, DOI 10.1124/mol.109.061226; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Davies MA, 2011, J CLIN ONCOL, V29, P4715, DOI 10.1200/JCO.2011.37.4751; Delcuve GP, 2012, CLIN EPIGENETICS, V4, DOI 10.1186/1868-7083-4-5; Ecke TH, 2007, ANTICANCER RES, V27, P4143; Feng LJ, 2005, MOL CELL BIOL, V25, P5389, DOI 10.1128/MCB.25.13.5389-5395.2005; Griewe GL, 2003, PROSTATE CANCER P D, V6, P281, DOI 10.1038/sj.pcan.4500665; Grignon DJ, 1997, JNCI-J NATL CANCER I, V89, P158, DOI 10.1093/jnci/89.2.158; Hastak K, 2005, FASEB J, V19, P789, DOI 10.1096/fj.04-2226fje; Hastak K, 2003, ONCOGENE, V22, P4851, DOI 10.1038/sj.onc.1206708; Henning SM, 2006, J NUTR, V136, P1839, DOI 10.1093/jn/136.7.1839; Huo C., 2008, Inflammopharmacology, V16, P248, DOI 10.1007/s10787-008-8031-x; Kaur P, 2008, CARCINOGENESIS, V29, P2210, DOI 10.1093/carcin/bgn201; Keshelava N, 2000, MED PEDIATR ONCOL, V35, P563, DOI 10.1002/1096-911X(20001201)35:6<563::AID-MPO15>3.0.CO;2-J; Ko YC, 2011, CANCER LETT, V309, P46, DOI 10.1016/j.canlet.2011.05.014; Kraus AC, 2002, ONCOGENE, V21, P8683, DOI 10.1038/sj.onc.1205939; Lahiry L, 2010, CARCINOGENESIS, V31, P259, DOI 10.1093/carcin/bgp240; Lee DH, 2008, BIOCHEM PHARMACOL, V75, P2345, DOI 10.1016/j.bcp.2008.03.013; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Lin HH, 2005, MOL CARCINOGEN, V43, P86, DOI 10.1002/mc.20103; Loriot Y, 2012, ANN ONCOL, V23, P1085, DOI 10.1093/annonc/mdr573; McCormack E, 2012, LEUKEMIA, V26, P910, DOI 10.1038/leu.2011.315; Mukhtar H, 2000, AM J CLIN NUTR, V71, p1698S, DOI 10.1093/ajcn/71.6.1698S; Nargi Jennifer L., 1999, Neoplasia (New York), V1, P544; NAVONE NM, 1993, J NATL CANCER I, V85, P1657, DOI 10.1093/jnci/85.20.1657; Nawab A, 2012, INT J MOL MED, V29, P277, DOI 10.3892/ijmm.2011.835; Oz Helieh S, 2010, J Cancer Ther, V1, P105; Pandey M, 2010, INT J CANCER, V126, P2520, DOI 10.1002/ijc.24988; Pastorino JG, 1999, J BIOL CHEM, V274, P19411, DOI 10.1074/jbc.274.27.19411; Pesche S, 1998, ONCOGENE, V16, P2879, DOI 10.1038/sj.onc.1202081; Philips BJ, 2009, BIOMED RES-TOKYO, V30, P207, DOI 10.2220/biomedres.30.207; Pommier Y, 2004, ONCOGENE, V23, P2934, DOI 10.1038/sj.onc.1207515; Shimada K, 2004, CARCINOGENESIS, V25, P1089, DOI 10.1093/carcin/bgh130; Shimura T, 2011, INT J RADIAT ONCOL, V80, P540, DOI 10.1016/j.ijrobp.2010.12.065; Shukla S, 2005, PROSTATE, V64, P224, DOI 10.1002/pros.20217; Srivastava RK, 2001, NEOPLASIA, V3, P535, DOI 10.1038/sj.neo.7900203; Thakur VS, 2012, INT J ONCOL, V41, P353, DOI 10.3892/ijo.2012.1449; Thakur VS, 2012, CARCINOGENESIS, V33, P377, DOI 10.1093/carcin/bgr277; Thakur VS, 2010, CANCER LETT, V296, P225, DOI 10.1016/j.canlet.2010.04.012; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Whang YE, 1998, P NATL ACAD SCI USA, V95, P5246, DOI 10.1073/pnas.95.9.5246; Wirth MP, 2007, EUR UROL, V51, P306, DOI 10.1016/j.eururo.2006.08.043; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Yang GY, 1998, CARCINOGENESIS, V19, P611, DOI 10.1093/carcin/19.4.611; Yang XK, 2006, CANCER RES, V66, P3126, DOI 10.1158/0008-5472.CAN-05-0425; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zeng CW, 2012, MOL PHARMACOL, V81, P578, DOI 10.1124/mol.111.076794; Zhao S, 2004, LEUKEMIA, V18, P267, DOI 10.1038/sj.leu.2403220; Zheng L, 2004, CELL RES, V14, P497, DOI 10.1038/sj.cr.7290253	58	35	36	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52572	10.1371/journal.pone.0052572	http://dx.doi.org/10.1371/journal.pone.0052572			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285096	Green Published, gold, Green Submitted			2022-12-27	WOS:000312794500201
J	Qian, S; Dean, R; Urban, VS; Chaudhuri, BN				Qian, Shuo; Dean, Rebecca; Urban, Volker S.; Chaudhuri, Barnali N.			The Internal Organization of Mycobacterial Partition Assembly: Does the DNA Wrap a Protein Core?	PLOS ONE			English	Article							BACTERIAL CHROMOSOME SEGREGATION; SMALL-ANGLE SCATTERING; X-RAY-SCATTERING; NEUTRON-SCATTERING; PLASMID PARTITION; STRUCTURAL BIOLOGY; PARB; COMPLEX; SITES; CAULOBACTER	Before cell division in many bacteria, the ParBs spread on a large segment of DNA encompassing the origin-proximal parS site(s) to form the partition assembly that participates in chromosome segregation. Little is known about the structural organization of chromosomal partition assembly. We report solution X-ray and neutron scattering data characterizing the size parameters and internal organization of a nucleoprotein assembly formed by the mycobacterial chromosomal ParB and a 120-meric DNA containing a parS-encompassing region from the mycobacterial genome. The cross-sectional radii of gyration and linear mass density describing the rod-like ParB-DNA assembly were determined from solution scattering. A "DNA outside, protein inside" mode of partition assembly organization consistent with the neutron scattering hydrogen/deuterium contrast variation data is discussed. In this organization, the high scattering DNA is positioned towards the outer region of the partition assembly. The new results presented here provide a basis for understanding how ParBs organize the parS-proximal chromosome, thus setting the stage for further interactions with the DNA condensins, the origin tethering factors and the ParA.	[Qian, Shuo; Urban, Volker S.] Oak Ridge Natl Lab, Ctr Struct Mol Biol, Biol & Soft Matter Div, Oak Ridge, TN USA; [Dean, Rebecca; Chaudhuri, Barnali N.] Hauptman Woodward Inst, Buffalo, NY USA; [Chaudhuri, Barnali N.] SUNY Buffalo, Dept Biol Struct, Buffalo, NY 14260 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; Hauptman Woodward Medical Research Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Chaudhuri, BN (corresponding author), S Asian Univ, Fac Life Sci & Biotechnol, New Delhi, India.	barnalichaudhuri1@gmail.com	Qian, Shuo/AAU-1770-2020; Urban, Volker S/N-5361-2015	Qian, Shuo/0000-0002-4842-828X; Urban, Volker S/0000-0002-7962-3408	John R. Oishei Foundation; Department of Energy, Office of Biological and Environmental Research; National Institutes of Health, National Center for Research Resources, Biomedical Technology Program; Scientific User Facilities Division, Office of Basic Energy Sciences, U.S. Department of Energy	John R. Oishei Foundation; Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Center for Research Resources, Biomedical Technology Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Scientific User Facilities Division, Office of Basic Energy Sciences, U.S. Department of Energy(United States Department of Energy (DOE))	Funding was provided by The John R. Oishei Foundation. Work at the Stanford Synchrotron Radiation Laboratory was supported by the Department of Energy, Office of Biological and Environmental Research, and by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program. SANS research at Oak Ridge National Laboratory's Center for Structural Molecular Biology was supported by the Office of Biological and Environmental Research, using ORNL's High Flux Isotope Reactor, sponsored by the Scientific User Facilities Division, Office of Basic Energy Sciences, U.S. Department of Energy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aylett CHS, 2012, P NATL ACAD SCI USA, V109, P16522, DOI 10.1073/pnas.1210899109; Banigan EJ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002145; Bowman GR, 2008, CELL, V134, P945, DOI 10.1016/j.cell.2008.07.015; Breier AM, 2007, MOL MICROBIOL, V64, P703, DOI 10.1111/j.1365-2958.2007.05690.x; Chaudhuri BN, 2011, J MOL BIOL, V413, P901, DOI 10.1016/j.jmb.2011.08.002; Chaudhuri BN, 2011, BIOCHEMISTRY-US, V50, P1799, DOI 10.1021/bi1016759; DICAPUA E, 1989, BIOCHEMISTRY-US, V28, P3287, DOI 10.1021/bi00434a025; Donovan C, 2012, MOL MICROBIOL, V84, P105, DOI 10.1111/j.1365-2958.2012.08011.x; Fogel MA, 2006, GENE DEV, V20, P3269, DOI 10.1101/gad.1496506; GERCHMAN SE, 1987, P NATL ACAD SCI USA, V84, P7802, DOI 10.1073/pnas.84.22.7802; Gerdes K, 2000, MOL MICROBIOL, V37, P455, DOI 10.1046/j.1365-2958.2000.01975.x; Gerdes K, 2010, CELL, V141, P927, DOI 10.1016/j.cell.2010.05.033; GLATTER O, 1980, J APPL CRYSTALLOGR, V13, P577, DOI 10.1107/S0021889880012794; GRAZIANO V, 1994, NATURE, V368, P351, DOI 10.1038/368351a0; Gruber S, 2009, CELL, V137, P685, DOI 10.1016/j.cell.2009.02.035; Hayes F, 2006, NAT REV MICROBIOL, V4, P133, DOI 10.1038/nrmicro1342; HJELM RP, 1977, CELL, V10, P139, DOI 10.1016/0092-8674(77)90148-9; IBEL K, 1975, J MOL BIOL, V93, P255, DOI 10.1016/0022-2836(75)90131-X; Ingerson-Mahar M, 2012, FEMS MICROBIOL REV, V36, P256, DOI 10.1111/j.1574-6976.2011.00316.x; Inoko Y, 1992, J BIOCH, V111, P3106; Jakimowicz D, 2007, MICROBIOL-SGM, V153, P4050, DOI 10.1099/mic.0.2007/011619-0; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kusiak M, 2011, J BACTERIOL, V193, P3342, DOI 10.1128/JB.00328-11; Livny J, 2007, J BACTERIOL, V189, P8693, DOI 10.1128/JB.01239-07; Lutkenhaus J, 2012, TRENDS MICROBIOL, V20, P411, DOI 10.1016/j.tim.2012.05.002; Lynn GW, 2006, PHYSICA B, V385-86, P880, DOI 10.1016/j.physb.2006.05.133; Maloney E, 2009, TUBERCULOSIS, V89, pS65, DOI 10.1016/S1472-9792(09)70015-0; Minnen A, 2011, MOL MICROBIOL, V81, P676, DOI 10.1111/j.1365-2958.2011.07722.x; Moller-Jensen J, 2007, EMBO J, V26, P4413, DOI 10.1038/sj.emboj.7601864; Murray H, 2006, MOL MICROBIOL, V61, P1352, DOI 10.1111/j.1365-2958.2006.05316.x; Nisa S, 2010, J ANTIMICROB CHEMOTH, V65, P2347, DOI 10.1093/jac/dkq311; PERKINS SJ, 1988, BIOCHEM J, V254, P313, DOI 10.1042/bj2540313; Ptacin JL, 2010, NAT CELL BIOL, V12, P791, DOI 10.1038/ncb2083; Schofield WB, 2010, EMBO J, V29, P3068, DOI 10.1038/emboj.2010.207; Schumacher MA, 2008, BIOCHEM J, V412, P1, DOI 10.1042/BJ20080359; Schumacher MA, 2007, NATURE, V450, P1268, DOI 10.1038/nature06392; Schumacher MA, 2010, NUCLEIC ACIDS RES, V38, P4514, DOI 10.1093/nar/gkq161; Shebelut CW, 2010, P NATL ACAD SCI USA, V107, P14194, DOI 10.1073/pnas.1005274107; Smolsky IL, 2007, J APPL CRYSTALLOGR, V40, pS453, DOI 10.1107/S0021889807009624; Sullivan NL, 2009, CELL, V137, P697, DOI 10.1016/j.cell.2009.04.044; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Szardenings F, 2011, CURR OPIN MICROBIOL, V14, P712, DOI 10.1016/j.mib.2011.09.008; Thanbichler M, 2006, CELL, V126, P147, DOI 10.1016/j.cell.2006.05.038; Thiyagarajan P, 2000, J APPL CRYSTALLOGR, V33, P535, DOI 10.1107/S0021889899014387; Tsuruta H, 1998, J APPL CRYSTALLOGR, V31, P672, DOI 10.1107/S0021889898002702; Umbarger MA, 2011, MOL CELL, V44, P252, DOI 10.1016/j.molcel.2011.09.010; Vecchiarelli AG, 2012, MOL MICROBIOL, V86, P513, DOI 10.1111/mmi.12017; Vecchiarelli AG, 2010, MOL MICROBIOL, V78, P78, DOI 10.1111/j.1365-2958.2010.07314.x; Whitten AE, 2008, J APPL CRYSTALLOGR, V41, P222, DOI 10.1107/S0021889807055136; Whitten AE, 2008, P NATL ACAD SCI USA, V105, P18360, DOI 10.1073/pnas.0808903105	51	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52690	10.1371/journal.pone.0052690	http://dx.doi.org/10.1371/journal.pone.0052690			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285150	Green Published, Green Submitted, gold			2022-12-27	WOS:000312794500230
J	Uddin, MH; Bae, YM; Choi, MH; Hong, ST				Uddin, Md. Hafiz; Bae, Young Mee; Choi, Min-Ho; Hong, Sung-Tae			Production and Deformation of Clonorchis sinensis Eggs during In Vitro Maintenance	PLOS ONE			English	Article							ECHINOSTOMA-CAPRONI; LIGHT; WORMS	Clonorchis sinensis is a carcinogenic human liver fluke. The present study monitored eggs produced by long-term maintained adult worms of C. sinensis to confirm their egg productivity in vitro. The worms from infected rabbits were incubated in vitro in 1xLocke's solution and broth media (RPMI-1640, DMEM and IMDM). Numbers of expelled eggs were counted sequentially and their morphological changes were monitored by microscopy after 1, 30, 60, and 90 days of cultivation. On the 1-3 days of cultivation, the eggs counted maximum 4,7566202 eggs/worm/day in IMDM medium. The number of eggs gradually decreased less than 1,000 at 7-14 days and below 100 at 21days but continued to pass eggs after 56 days in all media. Length of the eggs were reduced about 1 mm at 30 days, and the length/width ratio was maintained around 1.8 at 30 days but decreased to 1.7 at 60 days and 1.5 at 90 days. Faust-Meleney index (FMI) decreased as the cultivation duration increased and lowest FMI (5662.9 +/- 974.7) observed in IMDM media at day 90 (P=0.001). Microscopic findings of the eggs recognized the miracidium in most of eggs at 60 days but not in those at 90 days. Instead, the eggs contained dark granules or vacuoles in the deformed shell at 90 days. Scanning electron microscopy revealed partial loss of wrinkles on the deformed egg surface and prominent abopercular knob. Eggs viability decreased as the cultivation progressed and showed significant positive correlation with FMI and length/width ratio. In conclusion, the cultivated worms pass only the eggs which are preformed in their uterus before cultivation. One gravid C. sinensis contains about 37,000 eggs in its uterus and produces about 4,000 eggs every day. The deformed eggs with FMI less than 7,000 and length/width ratio lower than 1.7 are non-viable.	[Uddin, Md. Hafiz; Bae, Young Mee; Choi, Min-Ho; Hong, Sung-Tae] Seoul Natl Univ, Coll Med, Dept Parasitol & Trop Med, Seoul, South Korea	Seoul National University (SNU)	Hong, ST (corresponding author), Seoul Natl Univ, Coll Med, Dept Parasitol & Trop Med, Seoul, South Korea.	hst@snu.ac.kr		Uddin, Md. Hafiz/0000-0002-0188-6857; Hong, Sung-Tae/0000-0002-0300-1944	Seoul National University Hospital [21-2005-0330]	Seoul National University Hospital	The present study was supported by a research grant from Seoul National University Hospital (21-2005-0330). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beer SA, 1991, MED PARAZITOL MOSK, V6, P32; DITRICH O, 1992, FOLIA PARASIT, V39, P123; Hong ST., 2005, ASIAN PARASITOL, V1, P35; Hong ST, 2012, PARASITOL INT, V61, P17, DOI 10.1016/j.parint.2011.06.007; Khampoosa P, 2012, PARASITOL RES, V110, P799, DOI 10.1007/s00436-011-2557-3; Kim JH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001339; KREJCI KG, 1994, PARASITOL RES, V80, P42, DOI 10.1007/BF00932622; Li Shunyu, 2004, Korean Journal of Parasitology, V42, P169, DOI 10.3347/kjp.2004.42.4.169; Peoples RC, 2009, PARASITOL RES, V104, P471, DOI 10.1007/s00436-008-1209-8; Salikhova ChR, 1989, MED PARAZITOL MOSK, V5, P60; Smyth JD, 1990, IN VITRO CULTIVATION; Uddin MH, 2012, KOREAN J PARASITOL, V50, P309, DOI 10.3347/kjp.2012.50.4.309; WELLS KE, 1991, EXP PARASITOL, V73, P295, DOI 10.1016/0014-4894(91)90101-2	13	3	3	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52676	10.1371/journal.pone.0052676	http://dx.doi.org/10.1371/journal.pone.0052676			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285144	Green Submitted, Green Published, gold			2022-12-27	WOS:000312794500228
J	Zhu, HT; Dong, QZ; Sheng, YY; Wei, JW; Wang, G; Zhou, HJ; Ren, N; Jia, HL; Ye, QH; Qin, LX				Zhu, Hai-Tao; Dong, Qiong-Zhu; Sheng, Yuan-Yuan; Wei, Jin-Wang; Wang, Guan; Zhou, Hai-Jun; Ren, Ning; Jia, Hu-Liang; Ye, Qing-Hai; Qin, Lun-Xiu			MicroRNA-29a-5p Is a Novel Predictor for Early Recurrence of Hepatitis B Virus-Related Hepatocellular Carcinoma after Surgical Resection	PLOS ONE			English	Article							INTRAHEPATIC RECURRENCE; EXPRESSION PROFILES; CURATIVE RESECTION; GENE-EXPRESSION; CELL-MIGRATION; TISSUES; RISK; IDENTIFICATION; METASTASIS; APOPTOSIS	It is still difficult to predict the probability of tumor recurrence after resection of hepatocellular carcinoma (HCC). In this study, we set out to identify specific microRNA (miRNA) in microdissected hepatitis B virus (HBV)-related HCC tissue from formalin-fixed paraffin-embedded (FFPE) samples which might be used in predicting early recurrence after HCC resection. Taqman low density arrays were used to detect the 667 miRNA profiles in both the microdissected tumorous and adjacent non-tumorous liver tissues from 20 HCC patients (discovery set) including 10 patients with early tumor recurrence and 10 without early tumor recurrence and to identify the differentially expressed miRNAs related to HCC recurrence. Then quantitative real-time PCR (qRT-PCR) was used to verify the findings in 106 patients (training set), and to develop a predictive assay. The identified miRNAs were further validated in an independent cohort of 112 patients (validation set). Thirty seven miRNAs were identified from 20 HCC patients and validated in 106 HCC patients using qRT-PCR. A significant association was found between miR-29a-5p level in HCC tissues and early tumor recurrence (P = 0.0002). This association was further confirmed in the independent validation set of 112 patients (P = 0.0154). MiR-29a-5p level was significantly associated with both time to tumor recurrence (TTR) (P = 0.0015) and overall survival (OS) (P = 0.0079) in validation set. In the multivariate analyses, miR-29a-5p was identified as an independent factor for TTR, particularly for those patients with early stage of HCC. The sensitivity and specificity of miR-29a-5p for the prediction of early HCC recurrence of BCLC 0/A stage HCC were 74.2% and 68.2%, respectively. These suggest that miR-29a-5p might be a useful marker for the prediction of early tumor recurrence after HCC resection, especially in BCLC 0/A stage HCCs.	[Qin, Lun-Xiu] Fudan Univ, Liver Canc Inst, Shanghai 200433, Peoples R China; Fudan Univ, Inst Biomed Sci, Zhongshan Hosp, Shanghai 200433, Peoples R China; Minist Educ Res, Key Lab Carcinogenesis & Canc Invas, Shanghai, Peoples R China	Fudan University; Fudan University	Qin, LX (corresponding author), Fudan Univ, Liver Canc Inst, Shanghai 200433, Peoples R China.	qin.lunxiu@zs-hospital.sh.cn		Zhu, Haitao/0000-0003-1435-9607; Ren, Ning/0000-0001-9776-2471	National Key Projects for Infectious Disease of China [2008ZX10002-021, 2012ZX10002-012]; Program of Shanghai Chief Scientist [08XD14008]; Program for Outstanding Medical Academic Leader [LJ10010]; Major International Joint Research Project [81120108016]; Regular Project of the Natural Science Foundation of China (NSFC), the Research Fund for New Teachers of Fudan University [30600589]	National Key Projects for Infectious Disease of China; Program of Shanghai Chief Scientist; Program for Outstanding Medical Academic Leader; Major International Joint Research Project(National Natural Science Foundation of China (NSFC)); Regular Project of the Natural Science Foundation of China (NSFC), the Research Fund for New Teachers of Fudan University	This article was supported by the National Key Projects for Infectious Disease of China (2008ZX10002-021, 2012ZX10002-012), Program of Shanghai Chief Scientist (08XD14008), Program for Outstanding Medical Academic Leader(LJ10010), Major International Joint Research Project (81120108016) and the Regular Project (30600589) of the Natural Science Foundation of China (NSFC), the Research Fund for New Teachers of Fudan University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braconi C, 2011, ONCOGENE, V30, P4750, DOI 10.1038/onc.2011.193; Bruix J, 2009, LANCET, V373, P614, DOI 10.1016/S0140-6736(09)60381-0; Budhu A, 2008, HEPATOLOGY, V47, P897, DOI 10.1002/hep.22160; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chung GE, 2010, ONCOL REP, V23, P113, DOI 10.3892/or_00000612; Ding J, 2010, NAT CELL BIOL, V12, P390, DOI 10.1038/ncb2039; Du ZM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019137; Duncavage E, 2010, J THORAC ONCOL, V5, P1755, DOI 10.1097/JTO.0b013e3181f3909d; EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fornari F, 2010, CANCER RES, V70, P5184, DOI 10.1158/0008-5472.CAN-10-0145; Haller F, 2004, ANAL BIOCHEM, V335, P1, DOI 10.1016/j.ab.2004.08.024; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Hudson RS, 2012, NUCLEIC ACIDS RES, V40, P3689, DOI 10.1093/nar/gkr1222; Iizuka N, 2003, LANCET, V361, P923, DOI 10.1016/S0140-6736(03)12775-4; Imamura H, 2003, J HEPATOL, V38, P200, DOI 10.1016/S0168-8278(02)00360-4; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Ji JF, 2010, J HEPATOL, V52, P690, DOI 10.1016/j.jhep.2009.12.025; Kong GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019518; Kurokawa Y, 2004, J HEPATOL, V41, P284, DOI 10.1016/j.jhep.2004.04.031; Lan FF, 2010, INT J CANC; Lee JS, 2004, HEPATOLOGY, V40, P667, DOI 10.1002/hep.20375; Livraghi T, 2011, SCAND J SURG, V100, P22, DOI 10.1177/145749691110000105; Llovet JM, 2005, SEMIN LIVER DIS, V25, P181, DOI 10.1055/s-2005-871198; Llovet JM, 2008, JNCI-J NATL CANCER I, V100, P698, DOI 10.1093/jnci/djn134; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Nakashima Y, 2003, HEPATOL RES, V26, P142, DOI 10.1016/S1386-6346(03)00007-X; Patnaik SK, 2010, CANCER RES, V70, P36, DOI 10.1158/0008-5472.CAN-09-3153; Patterson Erin E, 2011, Cancer, V117, P1630, DOI 10.1002/cncr.25724; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Plaisier CL, 2012, GENOME RES, V22, P2302, DOI 10.1101/gr.133991.111; Portolani N, 2006, ANN SURG, V243, P229, DOI 10.1097/01.sla.0000197706.21803.a1; Sherman M, 2008, NEW ENGL J MED, V359, P2045, DOI 10.1056/NEJMe0807581; Siebolts U, 2009, J CLIN PATHOL, V62, P84, DOI 10.1136/jcp.2008.058339; Spahn M, 2010, INT J CANCER, V127, P394, DOI 10.1002/ijc.24715; Sun HC, 2007, J HEPATOL, V47, P684, DOI 10.1016/j.jhep.2007.06.019; Toyoda H, 2005, AM J GASTROENTEROL, V100, P1764, DOI 10.1111/j.1572-0241.2005.41943.x; Ura S, 2009, HEPATOLOGY, V49, P1098, DOI 10.1002/hep.22749; Van Deusen MA, 2005, EXPERT REV MOL DIAGN, V5, P377, DOI 10.1586/14737159.5.3.377; Villanueva Augusto, 2011, Gastroenterology, V140, P1501, DOI 10.1053/j.gastro.2011.02.006; Wang LG, 2012, CANCER EPIDEMIOL, V36, pE61, DOI 10.1016/j.canep.2011.05.002; Wang Y, 2008, J BIOL CHEM, V283, P13205, DOI 10.1074/jbc.M707629200; Xi YG, 2007, RNA, V13, P1668, DOI 10.1261/rna.642907; Xiong YJ, 2010, HEPATOLOGY, V51, P836, DOI 10.1002/hep.23380; Yip L, 2011, ANN SURG ONCOL, V18, P2035, DOI 10.1245/s10434-011-1733-0; Yoon SO, 2011, HUM PATHOL, V42, P1391, DOI 10.1016/j.humpath.2010.12.010; Zhou HJ, 2010, GUT, V59, P1699, DOI 10.1136/gut.2010.218404	48	69	73	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52393	10.1371/journal.pone.0052393	http://dx.doi.org/10.1371/journal.pone.0052393			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285022	Green Submitted, Green Published, gold			2022-12-27	WOS:000312794500157
J	Zhou, CC; Chu, J; Liu, JA; Tobe, RG; Gen, H; Wang, XZ; Zheng, WG; Xu, LZ				Zhou, Chengchao; Chu, Jie; Liu, Jinan; Tobe, Ruoyan Gai; Gen, Hong; Wang, Xingzhou; Zheng, Wengui; Xu, Lingzhong			Adherence to Tuberculosis Treatment among Migrant Pulmonary Tuberculosis Patients in Shandong, China: A Quantitative Survey Study	PLOS ONE			English	Article							BARRIERS; POPULATION; ETHIOPIA; IMPACT; CARE	Adherence to TB treatment is the most important requirement for efficient TB control. Migrant TB patients' "migratory" nature affects the adherence negatively, which presents an important barrier for National TB Control Program in China. Therefore, TB control among migrants is of high importance. The aim of this study is to describe adherence to TB treatment among migrant TB patients and to identify factors associated with adherence. A total of 12 counties/districts of Shandong Province, China were selected as study sites. 314 confirmed smear positive TB patients were enrolled between August 2(nd) 2008 and October 17(th) 2008, 16% of whom were non-adherent to TB therapy. Risk factors for non-adherence were: the divorced or bereft of spouse, patients not receiving TB-related health education before chemotherapy, weak incentives for treatment adherence, and self supervision on treatment. Based on the risk factors identified, measures are recommended such as implementing health education for all migrant patients before chemotherapy and encouraging primary care workers to supervise patients.	[Zhou, Chengchao; Tobe, Ruoyan Gai; Wang, Xingzhou; Zheng, Wengui; Xu, Lingzhong] Shandong Univ, Sch Publ Hlth, Inst Social Med & Hlth Serv Management, Jinan 250100, Peoples R China; [Chu, Jie] Shandong Ctr Dis Control & Prevent, Jinan, Peoples R China; [Liu, Jinan] HealthCore Inc, Wilmington, DE USA; [Gen, Hong] Shandong Ctr TB Prevent & Control, Jinan, Peoples R China	Shandong University; HealthCore, Inc	Xu, LZ (corresponding author), Shandong Univ, Sch Publ Hlth, Inst Social Med & Hlth Serv Management, Jinan 250100, Peoples R China.	lzxu@sdu.edu.cn			Department of Science and Technology of Shandong Province [BS2012SF010]; China Center for Disease Prevention and Control [TB08-004]	Department of Science and Technology of Shandong Province; China Center for Disease Prevention and Control	This study was supported by Department of Science and Technology of Shandong Province (BS2012SF010) and the Global Fund (TB08-004, China Center for Disease Prevention and Control). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	China Global Fund Project Office, 2006, IMPL FLOAT POP TB CO; General Office of the State Council of PRC, 2010, NAT TUB CONTR PROGR; Haiju D, 2007, CHINESE PREVENTIVE M, V8, P568; Hand CH, 1996, J ASTHMA, V33, P331, DOI 10.3109/02770909609055374; Hoeppner VH, 2007, CANADIAN TUBERCULOSI, P114; Jaiswal A, 2003, TROP MED INT HEALTH, V8, P625, DOI 10.1046/j.1365-3156.2003.01061.x; Li XX, 2010, J IMMIGR MINOR HEALT, V12, P811, DOI 10.1007/s10903-010-9336-6; Liam CK, 1999, INT J TUBERC LUNG D, V3, P300; Liefooghe R, 1999, INT J TUBERC LUNG D, V3, P1073; Lipsitch M, 1998, INT J TUBERC LUNG D, V2, P187; Ministry of Health of PRC, 2009, NAT TB CONTR PROGR I; Munro SA, 2007, PLOS MED, V4, P1230, DOI 10.1371/journal.pmed.0040238; National Population and Family Planning Commission China, 2010, REP NAT DEV MIGR CHI; Orr P, 2011, INT J CIRCUMPOL HEAL, V70, P113, DOI 10.3402/ijch.v70i2.17809; Pope DS, 2003, INT J TUBERC LUNG D, V7, P611; Sagbakken M, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-11; Sockrider M, 1996, J RESP DIS, V17, P204; Tekle B, 2002, INT J TUBERC LUNG D, V6, P573; Tobe RG, 2011, BIOSCI TRENDS, V5, P226, DOI 10.5582/bst.2011.v5.6.226; Wang HB, 2008, CHIN J HLTH ED, V24, P468; Wares DF, 2003, INT J TUBERC LUNG D, V7, P327; Wei XL, 2009, TROP MED INT HEALTH, V14, P754, DOI 10.1111/j.1365-3156.2009.02286.x; *WHO, 2002, COMM DIS; *WHO, 2005, WHOHTMTB2005349; Xu L, 2010, INT J TUBERC LUNG D, V14, P440; Xu WG, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-169; Yancheng Z, 2010, THESIS SHANDONG U CH; Yongming L, 2006, CHINESE J PUBLIC HLT, V22, P1468; Zhang LX, 2006, INT J TUBERC LUNG D, V10, P959; Zhao R, 2007, PRACT PREV MED, V14, P322	30	20	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e52334	10.1371/journal.pone.0052334	http://dx.doi.org/10.1371/journal.pone.0052334			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284993	Green Submitted, Green Published, gold			2022-12-27	WOS:000312435900089
J	Zhu, J; Siclari, VA; Liu, F; Spatz, JM; Chandra, A; Pajevic, PD; Qin, L				Zhu, Ji; Siclari, Valerie A.; Liu, Fei; Spatz, Jordan M.; Chandra, Abhishek; Pajevic, Paola Divieti; Qin, Ling			Amphiregulin-EGFR Signaling Mediates the Migration of Bone Marrow Mesenchymal Progenitors toward PTH-Stimulated Osteoblasts and Osteocytes	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; INTERMITTENT PARATHYROID-HORMONE; IN-VIVO; OSTEOPROGENITOR CELLS; PTH/PTHRP RECEPTOR; ANABOLIC ACTIONS; EXPRESSION; DIFFERENTIATION; MECHANISMS; MICROARRAY	Intermittent administration of parathyroid hormone (PTH) dramatically increases bone mass and currently is one of the most effective treatments for osteoporosis. However, the detailed mechanisms are still largely unknown. Here we demonstrate that conditioned media from PTH-treated osteoblastic and osteocytic cells contain soluble chemotactic factors for bone marrow mesenchymal progenitors, which express a low amount of PTH receptor (PTH1R) and do not respond to PTH stimulation by increasing cAMP production or migrating toward PTH alone. Conditioned media from PTH-treated osteoblasts elevated phosphorylated Akt and p38MAPK amounts in mesenchymal progenitors and inhibition of these pathways blocked the migration of these progenitors toward conditioned media. Our previous and current studies revealed that PTH stimulates the expression of amphiregulin, an epidermal growth factor (EGF)-like ligand that signals through the EGF receptor (EGFR), in both osteoblasts and osteocytes. Interestingly, conditioned media from PTH-treated osteoblasts increased EGFR phosphorylation in mesenchymal progenitors. Using several different approaches, including inhibitor, neutralizing antibody, and siRNA, we demonstrate that PTH increases the release of amphiregulin from osteoblastic cells, which acts on the EGFRs expressed on mesenchymal progenitors to stimulate the Akt and p38MAPK pathways and subsequently promote their migration in vitro. Furthermore, inactivation of EGFR signaling specifically in osteoprogenitors/osteoblasts attenuated the anabolic actions of PTH on bone formation. Taken together, these results suggest a novel mechanism for the therapeutic effect of PTH on osteoporosis and an important role of EGFR signaling in mediating PTH's anabolic actions on bone.	[Zhu, Ji; Siclari, Valerie A.; Liu, Fei; Chandra, Abhishek; Qin, Ling] Univ Penn, Perelman Sch Med, Dept Orthopaed Surg, McKay Orthopaed Res Lab, Philadelphia, PA 19104 USA; [Liu, Fei] Shanghai Ninth Peoples Hosp, Dept Plast & Reconstruct Surg, Shanghai, Peoples R China; [Spatz, Jordan M.; Pajevic, Paola Divieti] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; [Spatz, Jordan M.; Pajevic, Paola Divieti] Harvard Univ, Sch Med, Boston, MA USA	University of Pennsylvania; Pennsylvania Medicine; Shanghai Jiao Tong University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Qin, L (corresponding author), Univ Penn, Perelman Sch Med, Dept Orthopaed Surg, McKay Orthopaed Res Lab, Philadelphia, PA 19104 USA.	qinling@mail.med.upenn.edu	Pajevic, Paola Divieti/M-3236-2019; Chandra, Abhishek/AAG-8781-2020	Chandra, Abhishek/0000-0001-9423-9669; Divieti Pajevic, Paola/0000-0001-9853-9837; Spatz, Jordan/0000-0002-6732-7353	National Institutes of Health [K01-DK071988, UH2-AR059655]; New Jersey Stem Cell Research Grant; National Osteoporosis Foundation; National Cancer Institute [R25 CA101871-07]; NATIONAL CANCER INSTITUTE [R25CA101871] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [UH2AR059655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK071988] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Jersey Stem Cell Research Grant; National Osteoporosis Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This publication was made possible by support from the National Institutes of Health K01 grants K01-DK071988 (to LQ), UH2-AR059655 (to PDP), New Jersey Stem Cell Research Grant (to LQ), National Osteoporosis Foundation (to LQ), and grant R25 CA101871-07 from the National Cancer Institute (to VS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr S, 2008, CLIN EXP METASTAS, V25, P685, DOI 10.1007/s10585-007-9121-7; Bianco P, 2011, J CELL BIOCHEM, V112, P1713, DOI 10.1002/jcb.23103; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Compston JE, 2007, BONE, V40, P1447, DOI 10.1016/j.bone.2006.09.008; Davies J, 2004, J ENDOCRINOL, V180, P505, DOI 10.1677/joe.0.1800505; DEMPSTER DW, 1993, ENDOCR REV, V14, P690, DOI 10.1210/er.14.6.690; FERMOR B, 1995, J BONE MINER RES, V10, P1935; Frey MR, 2004, J BIOL CHEM, V279, P44513, DOI 10.1074/jbc.M406253200; Gallacher SJ, 2010, CALCIFIED TISSUE INT, V87, P469, DOI 10.1007/s00223-010-9420-x; Jilka RL, 2007, BONE, V40, P1434, DOI 10.1016/j.bone.2007.03.017; Kalajzic I, 2005, J BIOL CHEM, V280, P24618, DOI 10.1074/jbc.M413834200; Kalajzic I, 2002, J BONE MINER RES, V17, P15, DOI 10.1359/jbmr.2002.17.1.15; Knopp E, 2005, ENDOCRINOLOGY, V146, P1983, DOI 10.1210/en.2004-0770; Kostenuik PJ, 1999, J BONE MINER RES, V14, P21, DOI 10.1359/jbmr.1999.14.1.21; Kramer I, 2010, TRENDS ENDOCRIN MET, V21, P237, DOI 10.1016/j.tem.2009.12.002; Krampera M, 2005, BLOOD, V106, P59, DOI 10.1182/blood-2004-09-3645; Lee D, 2004, MAMM GENOME, V15, P525, DOI 10.1007/s00335-004-2384-2; LEE K, 1994, ENDOCRINOLOGY, V134, P441, DOI 10.1210/en.134.1.441; Li X, 2007, J BIOL CHEM, V282, P33086, DOI 10.1074/jbc.M705194200; Liu F, 2004, INT J DEV BIOL, V48, P645, DOI 10.1387/ijdb.041816fl; Liu Y, 2007, MOL MEMBR BIOL, V24, P91, DOI 10.1080/10929080600990500; Meirelles LD, 2008, STEM CELLS, V26, P2287, DOI 10.1634/stemcells.2007-1122; NISHIDA S, 1994, BONE, V15, P717, DOI 10.1016/8756-3282(94)90322-0; Polk DB, 1998, GASTROENTEROLOGY, V114, P493, DOI 10.1016/S0016-5085(98)70532-3; Powell WF, 2011, J ENDOCRINOL, V209, P21, DOI 10.1530/JOE-10-0308; Prisby R, 2011, J BONE MINER RES, V26, P2583, DOI 10.1002/jbmr.459; Qin L, 2003, J BIOL CHEM, V278, P19723, DOI 10.1074/jbc.M212226200; Qin L, 2005, J BIOL CHEM, V280, P3974, DOI 10.1074/jbc.M409807200; Qin L, 2004, TRENDS ENDOCRIN MET, V15, P60, DOI 10.1016/j.tem.2004.01.006; Reiss K, 2009, SEMIN CELL DEV BIOL, V20, P126, DOI 10.1016/j.semcdb.2008.11.002; Rhee Y, 2011, J BONE MINER RES, V26, P1035, DOI 10.1002/jbmr.304; ROULEAU MF, 1988, ENDOCRINOLOGY, V123, P187, DOI 10.1210/endo-123-1-187; Ryan MA, 2010, NAT MED, V16, P1141, DOI 10.1038/nm.2217; Sakai A, 1999, J BONE MINER RES, V14, P1691, DOI 10.1359/jbmr.1999.14.10.1691; Sanderson MP, 2006, GROWTH FACTORS, V24, P121, DOI 10.1080/08977190600634373; Schipani E, 2009, ADULT MESENCHYMAL ST; Schneider MR, 2009, TRENDS ENDOCRIN MET, V20, P517, DOI 10.1016/j.tem.2009.06.008; Schneider MR, 2012, BONE, V50, P237, DOI 10.1016/j.bone.2011.10.019; Schneider MR, 2009, J BONE MINER RES, V24, P455, DOI 10.1359/JBMR.081202; Shinoda Y, 2010, J CELL BIOCHEM, V109, P755, DOI 10.1002/jcb.22454; TAM CS, 1982, ENDOCRINOLOGY, V110, P506, DOI 10.1210/endo-110-2-506; Tamama K, 2006, STEM CELLS, V24, P686, DOI 10.1634/stemcells.2005-0176; Wang YM, 2007, J BONE MINER RES, V22, P1329, DOI 10.1359/JBMR.070517; Wu J, 2010, INVEST NEW DRUG, V28, P268, DOI 10.1007/s10637-009-9242-8; Wu XW, 2010, CELL STEM CELL, V7, P571, DOI 10.1016/j.stem.2010.09.012; Yamaoka T, 2011, AM J PHYSIOL-GASTR L, V301, pG368, DOI 10.1152/ajpgi.00327.2010; Zhang XR, 2011, J BONE MINER RES, V26, P1022, DOI 10.1002/jbmr.295; Zhu J, 2011, J CELL BIOCHEM, V112, P1749, DOI 10.1002/jcb.23094	50	47	51	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e50099	10.1371/journal.pone.0050099	http://dx.doi.org/10.1371/journal.pone.0050099			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300521	Green Published, gold, Green Submitted			2022-12-27	WOS:000313872600001
J	Li, H; Wang, YY; Zhang, HQ; Jia, BY; Wang, DA; Li, HM; Lu, DX; Qi, RB; Yan, YX; Wang, HD				Li, Hui; Wang, Yiyang; Zhang, Haoqing; Jia, Baoyin; Wang, Daan; Li, Hongmei; Lu, Daxiang; Qi, Renbin; Yan, Yuxia; Wang, Huadong			Yohimbine Enhances Protection of Berberine against LPS-Induced Mouse Lethality through Multiple Mechanisms	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; MOLECULAR-MECHANISMS; GENE-EXPRESSION; ENDOTOXIN-SHOCK; MICE LACKING; LIPOPOLYSACCHARIDE; SEPSIS; PATHOGENESIS; MACROPHAGES; INJURY	Sepsis remains a major cause of mortality in intensive care units, better therapies are urgently needed. Gram-negative bacterial lipopolysaccharide (LPS) is an important trigger of sepsis. We have demonstrated that berberine (Ber) protects against lethality induced by LPS, which is enhanced by yohimbine (Y) pretreatment, and Ber combined with Y also improves survival in septic mice. However, the precise mechanisms by which Y enhances protection of Ber against LPS - induced lethality remain unclear. The present study confirmed that simultaneously administered Y also enhanced protection of Ber against LPS-induced lethality. Ber or/and Y attenuated liver injury, but not renal injury in LPS-challenged mice. Ber or/and Y all inhibited LPS-stimulated I kappa B alpha, JNK and ERK phosphorylation, NF-kappa B activation as well as TNF-alpha production. Ber also increased IL-10 production in LPS-challenged mice, which was enhanced by Y. Furthermore, Ber or/and Y all suppressed LPS-induced IRF3, TyK2 and STAT1 phosphorylation, as well as IFN-beta and IP-10 mRNA expression in spleen of mice at 1 h after LPS challenge. Especially, Y enhanced the inhibitory effect of Ber on LPS-induced IP-10 mRNA expression. In vitro experiments further demonstrated that Y significantly enhanced the inhibitory effect of Ber on TNF-alpha production in LPS-treated peritoneal macrophages, Ber combined with Y promoted LPS-induced IL-10 production and LPS-stimulated I kappa B alpha, JNK, ERK and IRF3 phosphorylation and NF-kappa B activation were also suppressed by Ber or/and Y pretreatment in peritoneal macrophages. Taken together, these results demonstrate that Y enhances the protection of Ber against LPS-induced lethality in mice via attenuating liver injury, upregulating IL-10 production and suppressing I kappa B alpha, JNK, ERK and IRF3 phosphorylation. Ber combined with Y may be an effective immunomodulator agent for the prevention of sepsis.	[Wang, Yiyang; Jia, Baoyin; Wang, Daan; Li, Hongmei; Lu, Daxiang; Qi, Renbin; Wang, Huadong] Jinan Univ, Sch Med, Key Lab State Adm Tradit Chinese Med Peoples Repu, Dept Pathophysiol, Guangzhou, Guangdong, Peoples R China; [Li, Hui] Jinan Univ, Sch Med, Guangzhou Overseas Chinese Hosp, Dept Otolaryngol, Guangzhou, Guangdong, Peoples R China; [Yan, Yuxia] Jinan Univ, Sch Med, Dept Biochem, Guangzhou, Guangdong, Peoples R China; [Zhang, Haoqing] Chenzhou 1 Peoples Hosp, Ctr Prenatal Diag, Chenzhou, Hunan, Peoples R China	Jinan University; Jinan University; Jinan University	Wang, HD (corresponding author), Jinan Univ, Sch Med, Key Lab State Adm Tradit Chinese Med Peoples Repu, Dept Pathophysiol, Guangzhou, Guangdong, Peoples R China.	owanghd@jnu.edu.cn		wang, yiyang/0000-0002-0318-6715	National Natural Science Foundation of China [30670826, 30971191]; Science and Technology Foundation from Ministry of Education of the People's Republic of China [207140]; Guangzhou Science and Technology Projects [12C22071599]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Foundation from Ministry of Education of the People's Republic of China; Guangzhou Science and Technology Projects	This work was supported by grants from the National Natural Science Foundation of China (grant no. 30670826, 30971191), the Science and Technology Foundation from Ministry of Education of the People's Republic of China (grant no. 207140) and the Guangzhou Science and Technology Projects (grant no. 12C22071599). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anas AA, 2010, NETH J MED, V68, P147; Ando H, 2000, J PHARMACOL EXP THER, V294, P1043; Delsesto D, 2011, CONTRIB MICROBIOL, V17, P137, DOI 10.1159/000324030; Dombrovskiy VY, 2007, CRIT CARE MED, V35, P1244, DOI 10.1097/01.CCM.0000261890.41311.E9; Fantuzzi G, 1996, J IMMUNOL, V157, P291; Fujihara M, 2003, PHARMACOL THERAPEUT, V100, P171, DOI 10.1016/j.pharmthera.2003.08.003; Goldsmith M, 2009, MOL IMMUNOL, V46, P1979, DOI 10.1016/j.molimm.2009.03.009; Guarda G, 2010, IMMUNOLOGY, V130, P329, DOI 10.1111/j.1365-2567.2010.03283.x; Hochholzer P, 2000, INFECT IMMUN, V68, P3502, DOI 10.1128/IAI.68.6.3502-3508.2000; HOWARD M, 1993, J EXP MED, V177, P1205, DOI 10.1084/jem.177.4.1205; Kamezaki K, 2004, INT IMMUNOL, V16, P1173, DOI 10.1093/intimm/dxh118; Kang BY, 2002, BIOCHEM PHARMACOL, V63, P1901, DOI 10.1016/S0006-2952(02)00982-6; Karaghiosoff M, 2003, NAT IMMUNOL, V4, P471, DOI 10.1038/ni910; Karima R, 1999, MOL MED TODAY, V5, P123, DOI 10.1016/S1357-4310(98)01430-0; LAUBACH VE, 1995, P NATL ACAD SCI USA, V92, P10688, DOI 10.1073/pnas.92.23.10688; Li F, 2006, ACTA PHARMACOL SIN, V27, P1199, DOI 10.1111/j.1745-7254.2006.00368.x; Li HM, 2011, ACTA PHARMACOL SIN, V32, P1364, DOI 10.1038/aps.2011.102; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Marshall JC, 2010, CONTRIB NEPHROL, V167, P1, DOI 10.1159/000315914; Miksa M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005504; Moore LJ, 2010, ARCH SURG-CHICAGO, V145, P695, DOI 10.1001/archsurg.2010.107; Negishi M, 2011, AM J REPROD IMMUNOL, V65, P20, DOI 10.1111/j.1600-0897.2010.00856.x; O'Sullivan JB, 2010, J NEUROIMMUNOL, V220, P34, DOI 10.1016/j.jneuroim.2009.12.007; Ponte CB, 2012, INT IMMUNOPHARMACOL, V13, P114, DOI 10.1016/j.intimp.2012.03.016; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; Sakaguchi S, 2003, BIOCHEM BIOPH RES CO, V306, P860, DOI 10.1016/S0006-291X(03)01049-0; STANDIFORD TJ, 1995, J IMMUNOL, V155, P2222; Tateda K, 1996, INFECT IMMUN, V64, P769, DOI 10.1128/IAI.64.3.769-774.1996; Toshchakov V, 2002, NAT IMMUNOL, V3, P392, DOI 10.1038/ni774; Wang YY, 2011, SHOCK, V35, P322, DOI 10.1097/SHK.0b013e3181facf73; Zhang HQ, 2008, SHOCK, V29, P617, DOI 10.1097/SHK.0b013e318157ea14	32	15	18	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52863	10.1371/journal.pone.0052863	http://dx.doi.org/10.1371/journal.pone.0052863			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285207	Green Published, Green Submitted, gold			2022-12-27	WOS:000313051500072
J	Wang, K; Han, GC; Dou, Y; Wang, Y; Liu, GJ; Wang, RX; Xiao, H; Li, XY; Hou, CM; Shen, BF; Guo, RF; Li, Y; Shi, YC; Chen, GJ				Wang, Ke; Han, Gencheng; Dou, Yan; Wang, Yi; Liu, Guijun; Wang, Renxi; Xiao, He; Li, Xinying; Hou, Chunmei; Shen, Beifen; Guo, Renfeng; Li, Yan; Shi, Yanchun; Chen, Guojiang			Opposite Role of Tumor Necrosis Factor Receptors in Dextran Sulfate Sodium-Induced Colitis in Mice	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; INTESTINAL INFLAMMATION; TNF RECEPTORS; ACTIVATION; EXPRESSION; NEUTROPHILS; CYTOKINES; IMMUNITY; THERAPY; MODELS	Tumor necrosis factor-alpha (TNF-alpha) is a key factor for the pathogenesis of inflammatory bowel diseases (IBD), whose function is known to be mediated by TNF receptor 1 (TNFR1) or 2. However, the precise role of the two receptors in IBD remains poorly understood. Herein, acute colitis was induced by dextran sulfate sodium (DSS) instillation in TNFR1 or 2-/- mice. TNFR1 ablation led to exacerbation of signs of colitis, including more weight loss, increased mortality, colon shortening and oedema, severe intestinal damage, and higher levels of myeloperoxidase compared to wild-type counterparts. While, TNFR2 deficiency had opposite effects. This discrepancy was reflected by alteration of proinflammatory cytokine and chemokine production in the colons. Importantly, TNFR1 ablation rendered enhanced apoptosis of colonic epithelial cells and TNFR2 deficiency conferred pro-apoptotic effects of lamina propria (LP)-immune cells, as shown by the decreased ratio of Bcl-2/Bax and enhanced nuclear factor (NF)-kappa B activity.	[Liu, Guijun; Shi, Yanchun] Inner Mongolia Med Coll, Ctr Mol Biol, Hohhot, Peoples R China; [Guo, Renfeng] InflaRx GmbH, Jena, Germany; [Wang, Ke] Cent S Univ, Sch Basic Med Sci, Dept Immunol, Changsha, Hunan, Peoples R China; [Wang, Ke; Han, Gencheng; Wang, Yi; Wang, Renxi; Xiao, He; Li, Xinying; Hou, Chunmei; Shen, Beifen; Li, Yan; Chen, Guojiang] Inst Basic Med Sci, Dept Immunol, Beijing 100730, Peoples R China; [Dou, Yan] Gen Hosp PLA, Dept Gastroenterol, Beijing, Peoples R China	Inner Mongolia Medical University; Central South University; Chinese People's Liberation Army General Hospital	Shi, YC (corresponding author), Inner Mongolia Med Coll, Ctr Mol Biol, Hohhot, Peoples R China.	ycshi5388@yahoo.com.cn; guogangch@yahoo.com	Wang, Ke/GXM-9831-2022; Ke, Wang/AAI-4120-2020; Wang, Renxi/AAM-1326-2020; li, xin/HHS-9461-2022	Wang, Renxi/0000-0003-4130-3334	National Key Basic Research Program of China [2007CB512406, 2009CB522408]; National Natural Science Foundation of China [30801029, 81072475, 81172800]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Key Basic Research Program of China (2007CB512406; 2009CB522408) and the National Natural Science Foundation of China (30801029, 81072475 and 81172800). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspalter RM, 2003, J LEUKOCYTE BIOL, V74, P572, DOI 10.1189/jlb.0303112; Blam ME, 2001, AM J GASTROENTEROL, V96, P1977, DOI 10.1016/S0002-9270(01)02494-7; Ebach DR, 2005, INFLAMM BOWEL DIS, V11, P533, DOI 10.1097/01.MIB.0000163698.34592.30; Ellerin T, 2003, ARTHRITIS RHEUM-US, V48, P3013, DOI 10.1002/art.11301; GRISHAM MB, 1992, ANN NY ACAD SCI, V664, P103, DOI 10.1111/j.1749-6632.1992.tb39753.x; Hehlgans T, 2005, IMMUNOLOGY, V182, P1281; Holtmann MH, 2002, EUR J IMMUNOL, V32, P3142, DOI 10.1002/1521-4141(200211)32:11<3142::AID-IMMU3142>3.0.CO;2-4; Jacobs M, 2000, PATHOBIOLOGY, V68, P68, DOI 10.1159/000028116; Kobayashi Y, 2008, FRONT BIOSCI-LANDMRK, V13, P2400, DOI 10.2741/2853; Kollias G, 1999, IMMUNOL REV, V169, P175, DOI 10.1111/j.1600-065X.1999.tb01315.x; KRAWISZ JE, 1984, GASTROENTEROLOGY, V87, P1344; Lai CF, 2012, ENDOCRINOLOGY, V153, P3897, DOI 10.1210/en.2012-1216; Legrand-Poels S, 2000, BIOCHEM J, V349, P765, DOI 10.1042/bj3490765; Lochman I, 2011, AUTOIMMUN REV, V10, P295, DOI 10.1016/j.autrev.2010.11.003; MacEwan DJ, 2002, CELL SIGNAL, V14, P477, DOI 10.1016/S0898-6568(01)00262-5; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Mizoguchi E, 2002, GASTROENTEROLOGY, V122, P134, DOI 10.1053/gast.2002.30347; Montecucco F, 2008, CELL SIGNAL, V20, P557, DOI 10.1016/j.cellsig.2007.11.008; Nakai M, 2005, DIGEST DIS SCI, V50, P1669, DOI 10.1007/s10620-005-2913-1; Paland N, 2008, J BIOL CHEM, V283, P6438, DOI 10.1074/jbc.M708422200; Papadakis KA, 2000, ANNU REV MED, V51, P289, DOI 10.1146/annurev.med.51.1.289; Pimentel-Muinos FX, 1999, IMMUNITY, V11, P783, DOI 10.1016/S1074-7613(00)80152-1; RACHMILEWITZ D, 1989, GASTROENTEROLOGY, V97, P326, DOI 10.1016/0016-5085(89)90068-1; Sashio H, 2002, IMMUNOGENETICS, V53, P1020, DOI 10.1007/s00251-001-0423-7; Schneider JD, 2009, EUR J IMMUNOL, V39, P1743, DOI 10.1002/eji.200839132; Stillie R, 2009, INFLAMM BOWEL DIS, V15, P1515, DOI 10.1002/ibd.20951; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Sydora BC, 2012, DIGEST DIS SCI, V57, P345, DOI 10.1007/s10620-011-1878-5; Weisman MH, 2002, J RHEUMATOL, V29, P33; Westbrook AM, 2010, CANCER RES, V70, P1875, DOI 10.1158/0008-5472.CAN-09-2584; Xu J, 2007, BLOOD, V109, P3333, DOI 10.1182/blood-2006-06-026385; Yang Y, 2011, CLIN EXP IMMUNOL, V165, P372, DOI 10.1111/j.1365-2249.2011.04413.x; Zhao XQ, 2007, CANCER RES, V67, P4443, DOI 10.1158/0008-5472.CAN-07-0185; Zhou ZG, 2007, CELL SIGNAL, V19, P1238, DOI 10.1016/j.cellsig.2006.12.013	34	29	30	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52924	10.1371/journal.pone.0052924	http://dx.doi.org/10.1371/journal.pone.0052924			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285227	Green Published, gold, Green Submitted			2022-12-27	WOS:000313051500082
J	Frazer, HA; Ellis, M; Huveneers, C				Frazer, Holly A.; Ellis, Megan; Huveneers, Charlie			Can a Threshold Value Be Used to Classify Chondrichthyan Reproductive Modes: Systematic Review and Validation Using an Oviparous Species	PLOS ONE			English	Review							SCYLIORHINUS-CANICULA; SHARK; PLACENTA; BIOLOGY; SQUATINIDAE; EXTINCTION; VIVIPARITY; MORPHOLOGY	The maternal-embryonic nutritional relationship in chondrichthyans has been poorly explored. Consequently, accurately discerning between their different reproductive modes is difficult; especially lecithotrophy and incipient histotrophy. This present study is the first to assess changes in mass throughout embryonic development of an oviparous chondrichthyan other than Scyliorhinus canicula. Heterodontus portusjacksoni egg cases were collected and used to quantify the gain or loss of wet mass, dry mass, water content, inorganic and organic matter from freshly deposited eggs (without macroscopically visible embryos) to near full-term embryos. A loss in organic mass of similar to 40% found from this study is approximately double the values previously obtained for S. canicula. This raises concerns for the validity of the current threshold value used to discern between lecithotrophic and matrotrophic species. Accordingly, 26 studies published in the primary literature between 1932 and 2012 addressing the maternal-embryonic nutritional relationship in sharks were reviewed. Values for changes in mass reported for over 20 different shark species were synthesised and recalculated, revealing multiple typographical, transcribing, calculation and rounding errors across many papers. These results suggest that the current threshold value of -20% established by previous studies is invalid and should be avoided to ascertain the reproductive mode of aplacental viviparous species.	[Frazer, Holly A.; Huveneers, Charlie] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia; [Ellis, Megan] Gladstone Ports Corp, Safety Environm & Risk Dept, Gladstone, Qld, Australia; [Ellis, Megan] Univ Kwazulu Natal, Fac Hlth Sci, Biomed Resources Unit, Kwa Zulu, South Africa; [Huveneers, Charlie] SARDI Aquat Sci, Threatened Endangered & Protected Species Subprog, Adelaide, SA, Australia	Flinders University South Australia; University of Kwazulu Natal	Frazer, HA (corresponding author), Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia.	fraz0018@flinders.edu.au		Huveneers, Charlie/0000-0001-8937-1358	Flinders University; SARDI (South Australian Research and Development Institute)	Flinders University; SARDI (South Australian Research and Development Institute)	This work was supported by Flinders University and SARDI (South Australian Research and Development Institute). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIRCHARD GF, 1995, PHYSIOL ZOOL, V68, P622, DOI 10.1086/physzool.68.4.30166348; BLACKBURN DG, 1994, COPEIA, P925; Braccini JM, 2007, MAR BIOL, V150, P727, DOI 10.1007/s00227-006-0393-2; Capape C, 1999, CYBIUM, V23, P259; CAPAPE C, 1990, J FISH BIOL, V37, P347, DOI 10.1111/j.1095-8649.1990.tb05865.x; Capape C, 2002, J MAR BIOL ASSOC UK, V82, P635, DOI 10.1017/S0025315402005994; DELHAYE E, 1992, B SOC ZOOL FR, V117, P149; Garcia VB, 2008, P ROY SOC B-BIOL SCI, V275, P83, DOI 10.1098/rspb.2007.1295; GILBERT PW, 1966, COPEIA, P451; Guallart J, 2001, ENVIRON BIOL FISH, V61, P135, DOI 10.1023/A:1011080429625; Hamlett W., 1999, Placenta, V20; Hamlett WC, 1999, SHARKS, SKATES, AND RAYS, P398; HAMLETT WC, 1985, J ULTRA MOL STRUCT R, V91, P192, DOI 10.1016/S0022-5320(85)80013-7; Hamlett WC, 2001, ENCY LIFE SCI, P1; Hamlett William C., 2005, P301; Heming T.A., 1988, P407; HISAW FL, 1947, BIOL BULL-US, V92, P187, DOI 10.2307/1538305; Huveneers C, 2011, J FISH BIOL, V78, P1375, DOI 10.1111/j.1095-8649.2011.02938.x; Isaac NJB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000296; LECHENAULT H, 1993, ENVIRON BIOL FISH, V38, P241, DOI 10.1007/BF00842920; Mellinger J., 1986, INDO PACIFIC FISH BI, P310; Mooers AO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003700; Moura T, 2011, MAR BIOL, V158, P401, DOI 10.1007/s00227-010-1568-4; Needham J., 1942, BIOCH MORPHOGENESIS; O'Gower A.K., 1978, P529; OTAKE T, 1985, JPN J ICHTHYOL, V32, P52; Paiva RB, 2012, J MAR BIOL ASSOC UK, V92, P387, DOI 10.1017/S0025315411001743; Powter DM, 2010, MAR FRESHWATER RES, V61, P74, DOI 10.1071/MF09021; Ranzi S, 1936, NATURWISSENSCHAFTEN, V24, P642, DOI 10.1007/BF01475802; Ranzi S., 1932, PUBBL STAZ ZOOL NAPO, V13, P209; Ranzi S, 1934, PUBBL STAZ ZOOL NAPO, V13, P332; Rodda KR, 2008, J FISH BIOL, V72, P961, DOI 10.1111/j.1095-8649.2007.01777.x; Steel M, 2007, EVOL BIOINFORM, V3, P237; Storrie M, 2009, THESIS DEAKIN U VICT; Stribling MC, 1980, P SO CAROL ACAD SCI, V42, P111; Summers AP, 2004, J MORPHOL, V260, P1, DOI 10.1002/jmor.10141; Todd PA, 2007, OIKOS, V116, P1599, DOI 10.1111/j.2007.0030-1299.15992.x; Todd PA, 2010, MAR ECOL PROG SER, V408, P299, DOI 10.3354/meps08587; Wourms J.P., 1988, P1; WOURMS JP, 1993, ENVIRON BIOL FISH, V38, P269, DOI 10.1007/BF00842922; WOURMS JP, 1981, AM ZOOL, V21, P473; WOURMS JP, 1977, AM ZOOL, V17, P379; YANO K, 1992, COPEIA, P460, DOI 10.2307/1446205	43	9	9	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e50196	10.1371/journal.pone.0050196	http://dx.doi.org/10.1371/journal.pone.0050196			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300523	gold, Green Published, Green Submitted			2022-12-27	WOS:000312829100004
J	Jung, C; Colombel, JF; Lemann, M; Beaugerie, L; Allez, M; Cosnes, J; Vernier-Massouille, G; Gornet, JM; Gendre, JP; Cezard, JP; Ruemmele, FM; Turck, D; Merlin, F; Zouali, H; Libersa, C; Dieude, P; Soufir, N; Thomas, G; Hugot, JP				Jung, Camille; Colombel, Jean-Frederic; Lemann, Marc; Beaugerie, Laurent; Allez, Matthieu; Cosnes, Jacques; Vernier-Massouille, Gwenola; Gornet, Jean-Marc; Gendre, Jean-Pierre; Cezard, Jean-Pierre; Ruemmele, Frank M.; Turck, Dominique; Merlin, Francoise; Zouali, Habib; Libersa, Christian; Dieude, Philippe; Soufir, Nadem; Thomas, Gilles; Hugot, Jean-Pierre			Genotype/Phenotype Analyses for 53 Crohn's Disease Associated Genetic Polymorphisms	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; DELETION POLYMORPHISM; ATG16L1 T300A; VARIANTS; IL23R; POPULATION; ONSET; RISK	Background & Aims: Recent studies reported a role for more than 70 genes or loci in the susceptibility to Crohn's disease (CD). However, the impact of these associations in clinical practice remains to be defined. The aim of the study was to analyse the relationship between genotypes and phenotypes for the main 53 CD-associated polymorphisms. Method: A cohort of 798 CD patients with a median follow up of 7 years was recruited by tertiary adult and paediatric gastroenterological centres. A detailed phenotypic description of the disease was recorded, including clinical presentation, response to treatments and complications. The participants were genotyped for 53 CD-associated variants previously reported in the literature and correlations with clinical sub-phenotypes were searched for. A replication cohort consisting of 722 CD patients was used to further explore the putative associations. Results: The NOD2 rare variants were associated with an earlier age at diagnosis (p = 0.0001) and an ileal involvement (OR = 2.25[1.49-3.41] and 2.77 [1.71-4.50] for rs2066844 and rs2066847, respectively). Colonic lesions were positively associated with the risk alleles of IL23R rs11209026 (OR = 2.25 [1.13-4.51]) and 6q21 rs7746082 (OR = 1.60 [1.10-2.34] and negatively associated with the risk alleles of IRGM rs13361189 (OR = 0.29 [0.11-0.74]) and DEFB1 rs11362 (OR = 0.50 [0.30-0.80]). The ATG16L1 and IRGM variants were associated with a non-inflammatory behaviour (OR = 1.75 [1.22-2.53] and OR = 1.50 [1.04-2.16] respectively). However, these associations lost significance after multiple testing corrections. The protective effect of the IRGM risk allele on colonic lesions was the only association replicated in the second cohort (p = 0.03). Conclusions: It is not recommended to genotype the studied polymorphisms in routine practice.	[Jung, Camille; Merlin, Francoise; Hugot, Jean-Pierre] Univ Paris Diderot, UMR843, Paris, France; [Jung, Camille; Merlin, Francoise; Hugot, Jean-Pierre] INSERM, UMR843, Paris, France; [Jung, Camille; Cezard, Jean-Pierre; Hugot, Jean-Pierre] Hop Robert Debre, APHP, Serv Gastroenterol Pediat, F-75019 Paris, France; [Colombel, Jean-Frederic; Vernier-Massouille, Gwenola] Univ Lille, Hop Claude Huriez, Serv Gastroenterol, Lille, France; [Lemann, Marc; Allez, Matthieu; Gornet, Jean-Marc] Univ Paris Diderot, Hop St Louis, AP HP, Serv Gastroenterol, Paris, France; [Beaugerie, Laurent; Cosnes, Jacques; Gendre, Jean-Pierre] Univ Paris 06, Paris, France; [Beaugerie, Laurent; Cosnes, Jacques; Gendre, Jean-Pierre] Hop St Antoine, AP HP, Dept Gastroenterol, F-75571 Paris, France; [Ruemmele, Frank M.] Univ Paris 05, Serv Gastroenterol Pediat, Hop Necker Enfants Malad, APHP, Paris, France; [Turck, Dominique] Univ Lille 2, Hop Jean de Flandre, Serv Gastroenterol Pediat, Lille, France; [Zouali, Habib; Thomas, Gilles] CEPH Fdn Jean Dausset, Paris, France; [Libersa, Christian] Hop Cardiol, INSERM, Ctr Invest Clin 9301, F-59037 Lille, France; [Dieude, Philippe] Hop Bichat Claude Bernard, Serv Rhumatol, F-75877 Paris, France; [Soufir, Nadem] Hop Bichat Claude Bernard, Serv Biochim Genet, F-75877 Paris, France	UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Hugot, JP (corresponding author), Univ Paris Diderot, UMR843, Paris, France.	jean-pierre.hugot@rdb.aphp.fr	Turck, Dominique/S-2382-2018	Turck, Dominique/0000-0003-1370-4667; Allez, Matthieu/0000-0002-2012-7522; Hugot, Jean-Pierre/0000-0002-8446-6056; JUNG, Camille/0000-0001-8486-8939; Dieude, Philippe/0000-0002-4814-0307	Ministere de la Sante (PHRC) [P010904]; Assistance-Publique Hopitaux de Paris APHP; Institut National de la Recherche Scientifique (INSERM); Universites Paris Denis-Diderot; Paris Pierre et Marie-Curie; Paris Rene-Descartes and Lille 2 droit et sante; Agence Nationale de la Recherche (ANR); fondation Jean Dausset/CEPH; Centre National de Genotypage (CNG); Societe Nationale Francaise de Gastroenterologie; Fondation pour la Recherche Medicale; Association Francois Aupetit	Ministere de la Sante (PHRC); Assistance-Publique Hopitaux de Paris APHP; Institut National de la Recherche Scientifique (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universites Paris Denis-Diderot; Paris Pierre et Marie-Curie; Paris Rene-Descartes and Lille 2 droit et sante; Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); fondation Jean Dausset/CEPH; Centre National de Genotypage (CNG); Societe Nationale Francaise de Gastroenterologie; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Association Francois Aupetit	This work was financially supported by the Ministere de la Sante (PHRC noP010904), Assistance-Publique Hopitaux de Paris APHP, Institut National de la Recherche Scientifique (INSERM), Universites Paris Denis-Diderot, Paris Pierre et Marie-Curie, Paris Rene-Descartes and Lille 2 droit et sante, Agence Nationale de la Recherche (ANR), fondation Jean Dausset/CEPH, the Centre National de Genotypage (CNG), Societe Nationale Francaise de Gastroenterologie, Fondation pour la Recherche Medicale and the Association Francois Aupetit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler J, 2011, AM J GASTROENTEROL, V106, P699, DOI 10.1038/ajg.2011.19; Baldassano RN, 2007, GUT, V56, P1171, DOI 10.1136/gut.2007.122747; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Beaugerie L, 2006, GASTROENTEROLOGY, V130, P650, DOI 10.1053/j.gastro.2005.12.019; Cooney R, 2009, INFLAMM BOWEL DIS, V15, P1014, DOI 10.1002/ibd.20885; Cummings JRF, 2007, INFLAMM BOWEL DIS, V13, P941, DOI 10.1002/ibd.20162; Dideberg V, 2007, HUM MOL GENET, V16, P3008, DOI 10.1093/hmg/ddm259; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Duraes C, 2012, INFLAMM BOWEL DIS; Faubion WA, 2001, GASTROENTEROLOGY, V121, P255, DOI 10.1053/gast.2001.26279; Fowler EV, 2008, AM J GASTROENTEROL, V103, P2519, DOI 10.1111/j.1572-0241.2008.02023.x; Franke A, 2008, NAT GENET, V40, P713, DOI 10.1038/ng.148; Franke A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000691; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Guedj M, 2008, HUM MUTAT, V29, P1154, DOI 10.1002/humu.20823; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hancock L, 2008, INFLAMM BOWEL DIS, V14, P1667, DOI 10.1002/ibd.20517; Henckaerts L, 2009, CLIN GASTROENTEROL H, V7, P972, DOI 10.1016/j.cgh.2009.05.001; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kocsis AK, 2008, SCAND J GASTROENTERO, V43, P299, DOI 10.1080/00365520701682615; Koslowski MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004496; Kugathasan S, 2008, NAT GENET, V40, P1211, DOI 10.1038/ng.203; Lappalainen M, 2008, INFLAMM BOWEL DIS, V14, P1118, DOI 10.1002/ibd.20431; Latiano A, 2009, AM J GASTROENTEROL, V104, P110, DOI 10.1038/ajg.2008.3; Latiano A, 2008, WORLD J GASTROENTERO, V14, P4643, DOI 10.3748/wjg.14.4643; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Lesage S, 2002, AM J HUM GENET, V70, P845, DOI 10.1086/339432; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Marquez A, 2008, INFLAMM BOWEL DIS, V14, P1192, DOI 10.1002/ibd.20463; Mascheretti S, 2005, AM J PHARMACOGENOMIC, V5, P213, DOI 10.2165/00129785-200505040-00002; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; McGovern DPB, 2009, INFLAMM BOWEL DIS, V15, P75, DOI 10.1002/ibd.20611; Momozawa Y, 2011, NAT GENET, V43, P43, DOI 10.1038/ng.733; Palomino-Morales RJ, 2009, GENES IMMUN, V10, P356, DOI 10.1038/gene.2009.25; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Peltekova VD, 2004, NAT GENET, V36, P471, DOI 10.1038/ng1339; Peyrin-Biroulet L, 2010, AM J GASTROENTEROL, V105, P289, DOI 10.1038/ajg.2009.579; Peyrin-Biroulet Laurent, 2008, Gastroenterology, V135, P1420, DOI 10.1053/j.gastro.2008.08.017; Prescott NJ, 2007, GASTROENTEROLOGY, V132, P1665, DOI 10.1053/j.gastro.2007.03.034; Radford-Smith G, 2006, WORLD J GASTROENTERO, V12, P7097, DOI 10.3748/wjg.v12.i44.7097; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Roberts RL, 2007, AM J GASTROENTEROL, V102, P2754, DOI 10.1111/j.1572-0241.2007.01525.x; Seiderer J, 2006, SCAND J GASTROENTERO, V41, P1421, DOI 10.1080/00365520600703900; Stoll M, 2004, NAT GENET, V36, P476, DOI 10.1038/ng1345; Tremelling M, 2007, GASTROENTEROLOGY, V132, P1657, DOI 10.1053/j.gastro.2007.02.051; Van Assche G, 2010, J CROHNS COLITIS, V4, P7, DOI 10.1016/j.crohns.2009.12.003; Van Limbergen J, 2008, INFLAMM BOWEL DIS, V14, P338, DOI 10.1002/ibd.20340; Limbergen J, 2007, GUT, V56, P1173, DOI 10.1136/gut.2007.122069; Villani AC, 2009, NAT GENET, V41, P71, DOI 10.1038/ng.285; Waterman M, 2011, INFLAMM BOWEL DIS, V17, P1936, DOI 10.1002/ibd.21579; Weersma RK, 2008, AM J GASTROENTEROL, V103, P621, DOI 10.1111/j.1572-0241.2007.01660.x	53	36	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52223	10.1371/journal.pone.0052223	http://dx.doi.org/10.1371/journal.pone.0052223			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300620	Green Published, gold, Green Submitted			2022-12-27	WOS:000312829100031
J	Korkut, A; Hendrickson, WA				Korkut, Anil; Hendrickson, Wayne A.			Structural Plasticity and Conformational Transitions of HIV Envelope Glycoprotein gp120	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PROTEIN SECONDARY STRUCTURE; ATOM MOLECULAR-MECHANICS; RECEPTOR-BINDING; FORCE-FIELD; NORMAL-MODE; FLUCTUATION DYNAMICS; CD4-BOUND STATE; CD4 RECEPTOR; CCR5 BINDING	HIV envelope glycoproteins undergo large-scale conformational changes as they interact with cellular receptors to cause the fusion of viral and cellular membranes that permits viral entry to infect targeted cells. Conformational dynamics in HIV gp120 are also important in masking conserved receptor epitopes from being detected for effective neutralization by the human immune system. Crystal structures of HIV gp120 and its complexes with receptors and antibody fragments provide high-resolution pictures of selected conformational states accessible to gp120. Here we describe systematic computational analyses of HIV gp120 plasticity in such complexes with CD4 binding fragments, CD4 mimetic proteins, and various antibody fragments. We used three computational approaches: an isotropic elastic network analysis of conformational plasticity, a full atomic normal mode analysis, and simulation of conformational transitions with our coarse-grained virtual atom molecular mechanics (VAMM) potential function. We observe collective sub-domain motions about hinge points that coordinate those motions, correlated local fluctuations at the interfacial cavity formed when gp120 binds to CD4, and concerted changes in structural elements that form at the CD4 interface during large-scale conformational transitions to the CD4-bound state from the deformed states of gp120 in certain antibody complexes.	[Korkut, Anil; Hendrickson, Wayne A.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10027 USA; [Hendrickson, Wayne A.] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY USA; [Hendrickson, Wayne A.] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute	Hendrickson, WA (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10027 USA.	wayne@xtl.cumc.columbia.edu			National Institutes of Health [GM56550]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM056550] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM56550 (to WAH) and by the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; Bahar I, 1997, FOLD DES, V2, P173, DOI 10.1016/S1359-0278(97)00024-2; Berkower I, 2008, VIROLOGY, V377, P330, DOI 10.1016/j.virol.2008.03.040; BROOKS B, 1985, P NATL ACAD SCI USA, V82, P4995, DOI 10.1073/pnas.82.15.4995; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; Chen L, 2009, SCIENCE, V326, P1123, DOI 10.1126/science.1175868; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; de Bakker PIW, 2003, PROTEINS, V51, P21, DOI 10.1002/prot.10235; Dey B, 2007, J VIROL, V81, P5579, DOI 10.1128/JVI.02500-06; Diskin R, 2011, SCIENCE, V334, P1289, DOI 10.1126/science.1213782; Do Kwon Y, 2012, P NATL ACAD SCI USA, V109, P5663, DOI 10.1073/pnas.1112391109; Haliloglu T, 1997, PHYS REV LETT, V79, P3090, DOI 10.1103/PhysRevLett.79.3090; Haliloglu T, 1999, PROTEINS, V37, P654, DOI 10.1002/(SICI)1097-0134(19991201)37:4<654::AID-PROT15>3.0.CO;2-J; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; Huang CC, 2005, STRUCTURE, V13, P755, DOI 10.1016/j.str.2005.03.006; ICHIYE T, 1991, PROTEINS, V11, P205, DOI 10.1002/prot.340110305; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Korkut A, 2009, P NATL ACAD SCI USA, V106, P15673, DOI 10.1073/pnas.0907684106; Korkut A, 2009, P NATL ACAD SCI USA, V106, P15667, DOI 10.1073/pnas.0907674106; Krol M, 2004, J COMPUT AID MOL DES, V18, P41, DOI 10.1023/B:JCAM.0000022562.76762.f0; Kwong PD, 2000, STRUCTURE, V8, P1329, DOI 10.1016/S0969-2126(00)00547-5; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Ma JP, 1997, J MOL BIOL, V274, P114, DOI 10.1006/jmbi.1997.1313; Madani N, 2004, J VIROL, V78, P3742, DOI 10.1128/JVI.78.7.3742-3752.2004; MADDON PJ, 1986, CELL, V47, P333, DOI 10.1016/0092-8674(86)90590-8; Mechulam A, 2005, J MOL MED, V83, P542, DOI 10.1007/s00109-005-0673-1; Miller DW, 1999, J MOL BIOL, V286, P267, DOI 10.1006/jmbi.1998.2445; MOUAWAD L, 1993, BIOPOLYMERS, V33, P599, DOI 10.1002/bip.360330409; Myszka DG, 2000, P NATL ACAD SCI USA, V97, P9026, DOI 10.1073/pnas.97.16.9026; OLSHEVSKY U, 1990, J VIROL, V64, P5701, DOI 10.1128/JVI.64.12.5701-5707.1990; Pan YP, 2005, J MOL BIOL, V350, P514, DOI 10.1016/j.jmb.2005.05.009; Pan YP, 2004, J BIOL CHEM, V279, P30523, DOI 10.1074/jbc.M404364200; Pancera M, 2010, P NATL ACAD SCI USA, V107, P1166, DOI 10.1073/pnas.0911004107; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Poignard P, 2001, ANNU REV IMMUNOL, V19, P253, DOI 10.1146/annurev.immunol.19.1.253; Rizzuto CD, 1998, SCIENCE, V280, P1949, DOI 10.1126/science.280.5371.1949; ROST B, 1994, COMPUT APPL BIOSCI, V10, P53; Sanchez R, 2000, METH MOL B, V143, P97; Shrivastava I, 2011, BIOCHEMISTRY-US, V50, P4173, DOI 10.1021/bi2002218; Shrivastava I, 2010, PROTEINS, V78, P2935, DOI 10.1002/prot.22816; Tan HP, 2009, PROTEINS, V74, P881, DOI 10.1002/prot.22196; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Xiang SH, 2002, J VIROL, V76, P9888, DOI 10.1128/JVI.76.19.9888-9899.2002; Yang XZ, 2004, J VIROL, V78, P12975, DOI 10.1128/JVI.78.23.12975-12986.2004; Yang XZ, 2003, VIROLOGY, V313, P117, DOI 10.1016/S0042-6822(03)00273-3; Yuan W, 2006, J VIROL, V80, P6725, DOI 10.1128/JVI.00118-06; Zhang WT, 1999, BIOCHEMISTRY-US, V38, P9405, DOI 10.1021/bi990654o; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	54	17	17	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52170	10.1371/journal.pone.0052170	http://dx.doi.org/10.1371/journal.pone.0052170			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300605	Green Published, Green Submitted, gold			2022-12-27	WOS:000312829100025
J	Tey, NP; Yew, SY; Low, WY; Su'ut, L; Renjhen, P; Huang, MSL; Tong, WT; Lai, SL				Tey, Nai-peng; Yew, Siew-yong; Low, Wah-yun; Su'ut, Lela; Renjhen, Prachi; Huang, M. S. L.; Tong, Wen-ting; Lai, Siow-li			Medical Students' Attitudes toward Abortion Education: Malaysian Perspective	PLOS ONE			English	Article							CONTRACEPTION; CARE; CURRICULUM; FERTILITY	Background: Abortion is a serious public health issue, and it poses high risks to the health and life of women. Yet safe abortion services are not readily available because few doctors are trained to provide such services. Many doctors are unaware of laws pertaining to abortion. This article reports survey findings on Malaysian medical students' attitudes toward abortion education and presents a case for including abortion education in medical schools. Methods and Results: A survey on knowledge of and attitudes toward abortion among medical students was conducted in two public universities and a private university in Malaysia in 2011. A total of 1,060 students returned the completed questionnaires. The survey covered about 90% of medical students in Years 1, 3, and 5 in the three universities. About 90% of the students wanted more training on the general knowledge and legal aspects of abortion, and pre- and post-abortion counseling. Overall, 75.9% and 81.0% of the students were in favor of including in medical education the training on surgical abortion techniques and medical abortion, respectively. Only 2.4% and 1.7% were opposed to the inclusion of training of these two methods in the curriculum. The remaining respondents were neutral in their stand. Desire for more abortion education was associated with students' pro-choice index, their intention to provide abortion services in future practice, and year of study. However, students' attitudes toward abortion were not significantly associated with gender, type of university, or ethnicity. Conclusions: Most students wanted more training on abortion. Some students also expressed their intention to provide abortion counseling and services in their future practice. Their desire for more training on abortion should be taken into account in the new curriculum. Abortion education is an important step towards making available safe abortion services to enable women to exercise their reproductive rights.	[Tey, Nai-peng; Yew, Siew-yong; Lai, Siow-li] Univ Malaya, Fac Econ & Adm, Kuala Lumpur, Malaysia; [Low, Wah-yun; Tong, Wen-ting] Univ Malaya, Fac Med, Kuala Lumpur, Malaysia; [Su'ut, Lela] Univ Malaysia Sarawak, Fac Med & Hlth Sci, Sarawak, Malaysia; [Renjhen, Prachi] Melaka Manipal Med Coll, Dept Obstet & Gynaecol, Melaka, Malaysia; [Huang, M. S. L.] Univ Putra Malaysia, Fac Med & Hlth Sci, Serdang, Malaysia	Universiti Malaya; Universiti Malaya; University of Malaysia Sarawak; Manipal Academy of Higher Education (MAHE); Universiti Putra Malaysia	Tey, NP (corresponding author), Univ Malaya, Fac Econ & Adm, Kuala Lumpur, Malaysia.	teynp@um.edu.my	Tong, Wen Ting/G-8106-2012; Tong, Wen Ting/Q-4993-2017; Lai, Siow Li/O-7135-2016; Low, Wah-Yun/B-1775-2009; TEY, NAI PENG/B-5270-2010	Lai, Siow Li/0000-0001-9945-9986; Low, Wah-Yun/0000-0003-4409-1509; TEY, NAI PENG/0000-0003-3707-5033	World Health Organization (WHO), Malaysia	World Health Organization (WHO), Malaysia	The authors thank the World Health Organization (WHO), Malaysia for funding the survey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed FA, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-110; Baggaley RF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013260; Berer M, 2002, REPROD HEALTH MATTER, V10, P31, DOI 10.1016/S0968-8080(02)00021-6; Bongaarts J, 2000, STUD FAMILY PLANN, V31, P193, DOI 10.1111/j.1728-4465.2000.00193.x; Cessford TA, 2011, J OBSTET GYNAECOL CA, V33, P38, DOI 10.1016/S1701-2163(16)34771-5; Daher AM, 2010, BMC MED EDUC, V10, DOI 10.1186/1472-6920-10-34; Dalvie S, 2012, STUDY KNOWLEDGE ATTI; Department of Economic and Social Information and Policy Analysis UNPD, 2003, AB POL GLOB REV; Department of Statistics, 2010, POP HOUS CENS MAL PO; Espey E, 2005, AM J OBSTET GYNECOL, V192, P640, DOI 10.1016/j.ajog.2004.09.013; Espey E, 2004, ACAD MED, V79, P96, DOI 10.1097/00001888-200401000-00020; Espey E, 2008, CONTRACEPTION, V77, P205, DOI 10.1016/j.contraception.2007.11.011; Field A, 2013, DISCOVERING STAT USI; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Leeman L, 2005, CONTRACEPTION, V71, P84, DOI 10.1016/j.contraception.2004.07.017; Marston C, 2003, INT FAM PLAN PERSPEC, V29, P6, DOI 10.2307/3180995; Ministry of Higher Education Malaysia, 2010, STAT HIGH ED MAL; Peng Tey Nai, 2007, ASIAN POPULATION STU, V3, P243, DOI DOI 10.1080/17441730701746391; Rahman A, 1998, INT FAM PLAN PERSPEC, V24, P56, DOI 10.2307/2991926; Sedgh G, 2011, INT PERSPECT SEX R H, V37, P84, DOI 10.1363/3708411; Shotorbani S, 2004, PERSPECT SEX REPRO H, V36, P58, DOI 10.1111/j.1931-2393.2004.tb00009.x; Singh S, 1997, INT FAM PLAN PERSPEC, V23, P59, DOI 10.2307/2950825; Singh S, 1997, INT FAM PLAN PERSPEC, V23, P4, DOI 10.2307/2950780; SINGH Susheela, 2009, ABORTION WORLDWIDE D; Tey NP, 2012, ASIA-PAC J PUBLIC HE, V24, P495, DOI 10.1177/1010539511401374; United Nations Statistics Division, 2012, DEM SOC STAT; WHO, 2011, UNS AB GLOB REG EST, VSix	27	12	12	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52116	10.1371/journal.pone.0052116	http://dx.doi.org/10.1371/journal.pone.0052116			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	061EA	23300600	Green Published, gold, Green Submitted			2022-12-27	WOS:000312829100022
J	Wei, Q; Zhang, DJ; Yao, AN; Mai, LY; Zhang, ZW; Zhou, QB				Wei, Qiong; Zhang, Dejun; Yao, Anna; Mai, Liyi; Zhang, Zhiwei; Zhou, Qibing			Design, Synthesis, and In Vitro and In Vivo Biological Studies of a 3 '-Deoxythymidine Conjugate that Potentially Kills Cancer Cells Selectively	PLOS ONE			English	Article							ADVANCED HEPATOCELLULAR-CARCINOMA; THYMIDINE KINASE 1; NUCLEOSIDE ANALOGS; HEPATITIS-B; MECHANISM; TOXICITY; 3'-AZIDO-3'-DEOXYTHYMIDINE; 5-FLUOROURACIL; CYTOTOXICITY; DOXORUBICIN	Thymidine kinases (TKs) have been considered one of the potential targets for anticancer therapeutic because of their elevated expressions in cancer cells. However, nucleobase analogs targeting TKs have shown poor selective cytotoxicity in cancer cells despite effective antiviral activity. 3'-Deoxythymidine phenylquinoxaline conjugate (dT-QX) was designed as a novel nucleobase analog to target TKs in cancer cells and block cell replication via conjugated DNA intercalating quinoxaline moiety. In vitro cell screening showed that dT-QX selectively kills a variety of cancer cells including liver carcinoma, breast adenocarcinoma and brain glioma cells; whereas it had a low cytotoxicity in normal cells such as normal human liver cells. The anticancer activity of dT-QX was attributed to its selective inhibition of DNA synthesis resulting in extensive mitochondrial superoxide stress in cancer cells. We demonstrate that covalent linkage with 3'-deoxythymidine uniquely directed cytotoxic phenylquinoxaline moiety more toward cancer cells than normal cells. Preliminary mouse study with subcutaneous liver tumor model showed that dT-QX effectively inhibited the growth of tumors. dT-QX is the first molecule of its kind with highly amendable constituents that exhibits this selective cytotoxicity in cancer cells.	[Wei, Qiong; Zhang, Dejun; Yao, Anna; Mai, Liyi; Zhou, Qibing] Huazhong Univ Sci & Technol, Inst Mat Med, Coll Life Sci & Technol, Wuhan 430074, Hubei, Peoples R China; [Zhang, Zhiwei] Huazhong Univ Sci & Technol, Hepat Surg Ctr, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China; [Zhou, Qibing] Virginia Commonwealth Univ, Dept Med Chem, Richmond, VA 23298 USA	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Virginia Commonwealth University	Zhou, QB (corresponding author), Huazhong Univ Sci & Technol, Inst Mat Med, Coll Life Sci & Technol, Wuhan 430074, Hubei, Peoples R China.	qibingzhou@hust.edu.cn			National Basic Research Program of China [2011CB933100]; Fundamental Research Funds for the Central Universities [HUST: 2010ZD023]; Important National Science & Technology Specific Projects [2009ZX09301-014]	National Basic Research Program of China(National Basic Research Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Important National Science & Technology Specific Projects	This work is supported by National Basic Research Program of China (2011CB933100), the Fundamental Research Funds for the Central Universities (HUST: 2010ZD023), and the Important National Science & Technology Specific Projects (2009ZX09301-014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNER ESJ, 1995, PHARMACOL THERAPEUT, V67, P155, DOI 10.1016/0163-7258(95)00015-9; Barth RF, 2008, P NATL ACAD SCI USA, V105, P17493, DOI 10.1073/pnas.0809569105; Chen YL, 2010, J BIOL CHEM, V285, P27327, DOI 10.1074/jbc.M110.137042; ELION GB, 1982, AM J MED, V73, P7, DOI 10.1016/0002-9343(82)90055-9; Feng YX, 2010, HEPATOLOGY, V51, P535, DOI 10.1002/hep.23313; FURMAN PA, 1986, P NATL ACAD SCI USA, V83, P8333, DOI 10.1073/pnas.83.21.8333; He QM, 2004, INT J ONCOL, V25, P945; HENGSTSCHLAGER M, 1994, J BIOL CHEM, V269, P13836; KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960; Kong DH, 2005, CANCER RES, V65, P9047, DOI 10.1158/0008-5472.CAN-05-1235; Li XQ, 2011, CANCER LETT, V301, P212, DOI 10.1016/j.canlet.2010.12.004; Lin J, 2010, BIOORGAN MED CHEM, V18, P3261, DOI 10.1016/j.bmc.2010.03.023; Llovet JM, 2008, HEPATOLOGY, V48, P1312, DOI 10.1002/hep.22506; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Lund KC, 2007, ANTIMICROB AGENTS CH, V51, P2531, DOI 10.1128/AAC.00039-07; Miltenburger H G, 1987, Dev Biol Stand, V66, P91; Morgenroth A, 2008, CLIN CANCER RES, V14, P7311, DOI 10.1158/1078-0432.CCR-08-0907; MUNCHPETERSEN B, 1995, ADV ENZYME REGUL, V35, P69, DOI 10.1016/0065-2571(94)00014-T; Pan-Zhou XR, 2000, ANTIMICROB AGENTS CH, V44, P496, DOI 10.1128/AAC.44.3.496-503.2000; PATT YZ, 1994, J CLIN ONCOL, V12, P1204, DOI 10.1200/JCO.1994.12.6.1204; Perez MJ, 2002, FREE RADICAL BIO MED, V33, P111, DOI 10.1016/S0891-5849(02)00865-1; Sangro B, 2010, CANCER GENE THER, V17, P837, DOI 10.1038/cgt.2010.40; Shen YC, 2010, J GASTROENTEROL, V45, P794, DOI 10.1007/s00535-010-0270-0; SHERLEY JL, 1988, J BIOL CHEM, V263, P8350; Slamenova D, 2006, MUTAT RES-FUND MOL M, V593, P97, DOI 10.1016/j.mrfmmm.2005.06.029; Van Poecke S, 2010, J MED CHEM, V53, P2902, DOI 10.1021/jm901532h; Yuan JN, 2008, MED ONCOL, V25, P201, DOI 10.1007/s12032-007-9013-3; YUSA T, 1988, CANCER RES, V48, P5001; Zhou Q, 2008, CHEM RES TOXICOL, V21, P732, DOI 10.1021/tx700363s	29	15	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52199	10.1371/journal.pone.0052199	http://dx.doi.org/10.1371/journal.pone.0052199			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300611	Green Published, Green Submitted, gold			2022-12-27	WOS:000313618800054
J	Zhang, YD; Baker, SS; Baker, RD; Zhu, RX; Zhu, LX				Zhang, Yida; Baker, Susan S.; Baker, Robert D.; Zhu, Ruixin; Zhu, Lixin			Systematic Analysis of the Gene Expression in the Livers of Nonalcoholic Steatohepatitis: Implications on Potential Biomarkers and Molecular Pathological Mechanism	PLOS ONE			English	Article							ALCOHOL-DEHYDROGENASE; ETHANOL-PRODUCTION; ACID-METABOLISM; FOLLOW-UP; DISEASE; ASSOCIATION; VALIDATION; SIMILARITY; DIFFERENCE; DIAGNOSIS	Non-alcoholic steatohepatitis (NASH) is a severe form of non-alcoholic fatty liver disease (NAFLD). The molecular pathological mechanism of NASH is poorly understood. Recently, high throughput data such as microarray data together with bioinformatics methods have become a powerful way to identify biomarkers and to investigate pathogenesis of diseases. Taking advantage of well characterized microarray datasets of NASH livers, we performed a systematic analysis of potential biomarkers and possible pathological mechanism of NASH from a bioinformatics perspective. CodeLink Human Whole Genome Bioarrays were analyzed to find differentially expressed genes (DEGs) between controls and NASH patients. Four methods were used to identify DEGs and the intersection of DEGs identified by these methods was subsequently used for both biomarker prediction and molecular pathological mechanism analysis. For biomarker prediction, rank aggregation was used to rank DEGs identified by all these methods according to their significance of different expression. Alcohol dehydrogenase 4 (ADH4) exhibited the highest rank suggesting the most significant differential expression between normal and disease condition. Together with the previous report demonstrating the association between ADH4 and the pathogenesis of NASH, our data suggest that ADH4 could be a potential biomarker for NASH. For molecular pathological mechanism analysis, two clusters of highly correlated annotation terms and genes in these terms were identified based on the intersection of DEGs. Then, pathways enriched with these genes were identified to construct the network. Using this network, both for the first time, amino acid catabolism is implicated to play a pivotal role and urea cycle is implicated to be involved in the development of NASH. The results of our study identified potential biomarkers and suggested possible molecular pathological mechanism of NASH. These findings provide a comprehensive and systematic understanding of the pathogenesis of NASH and may facilitate the diagnosis, prevention and treatment of NASH.	[Zhang, Yida; Zhu, Ruixin] Tongji Univ, Dept Bioinformat, Shanghai 200092, Peoples R China; [Baker, Susan S.; Baker, Robert D.; Zhu, Lixin] SUNY Buffalo, Digest Dis & Nutr Ctr, Dept Pediat, Buffalo, NY 14260 USA	Tongji University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Zhu, RX (corresponding author), Tongji Univ, Dept Bioinformat, Shanghai 200092, Peoples R China.	rxzhu@tongji.edu.cn; lixinzhu@buffalo.edu	, 金石为开/AFU-9737-2022; Zhang, Yida/ABB-6924-2021	Zhu, Lixin/0000-0001-7904-1769; Zhu, Ruixin/0000-0002-5070-6453	Peter and Tommy Fund, Inc., Buffalo, NY; National Natural Science Foundation of China [31200986, 30976611]; Research Fund for the Doctoral Program of Higher Education of China [20100072120050]	Peter and Tommy Fund, Inc., Buffalo, NY; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by an unrestricted grant from the Peter and Tommy Fund, Inc., Buffalo, NY, http://thepeterandtommyfund.org (to SSB), a departmental start-up fund (to LZ), National Natural Science Foundation of China 31200986, 30976611(to RZ), and Research Fund for the Doctoral Program of Higher Education of China 20100072120050 (to RZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Baker SS, 2010, PLOS ONE, V5, pA82, DOI 10.1371/journal.pone.0009570; Banasch M, 2011, EUR J MED RES, V16, P258, DOI 10.1186/2047-783X-16-6-258; Baranova A, 2008, HEPATOLOGY, V47, P373, DOI 10.1002/hep.22140; BARAONA E, 1986, GASTROENTEROLOGY, V90, P103, DOI 10.1016/0016-5085(86)90081-8; Bertola A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013577; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Caldwell SH, 1999, J HEPATOL, V31, P430, DOI 10.1016/S0168-8278(99)80033-6; Chitturi S, 2001, ETIOPATHOGENESIS NON, P23; Chu G., 2002, SAM SIGNIFICANCE ANA; Chuaqui RF, 2002, NAT GENET, V32, P509, DOI 10.1038/ng1034; Connor SC, 2010, MOL BIOSYST, V6, P909, DOI 10.1039/b914182k; Cope K, 2000, GASTROENTEROLOGY, V119, P1340, DOI 10.1053/gast.2000.19267; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; de Alwis NMW, 2008, J HEPATOL, V48, pS104, DOI 10.1016/j.jhep.2008.01.009; DIEHL AM, 1988, GASTROENTEROLOGY, V95, P1056, DOI 10.1016/0016-5085(88)90183-7; Dowman JK, 2011, ALIMENT PHARM THER, V33, P525, DOI 10.1111/j.1365-2036.2010.04556.x; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; Erickson SK, 2009, J LIPID RES, V50, pS412, DOI 10.1194/jlr.R800089-JLR200; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Fiehn O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015234; FREUND HR, 1978, ANN SURG, V188, P423, DOI 10.1097/00000658-197809000-00017; Galli A, 1999, HEPATOLOGY, V29, P1164, DOI 10.1002/hep.510290420; Hashimoto E, 2009, J GASTROEN HEPATOL, V24, P501, DOI 10.1111/j.1440-1746.2009.05806.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kadota K, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-227; Kadota K, 2008, ALGORITHM MOL BIOL, V3, DOI 10.1186/1748-7188-3-8; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kang H, 2012, J CHEM INF MODEL, V52, P834, DOI 10.1021/ci200481c; Kaur I, 2012, PROTEOMICS, V12, P2036, DOI 10.1002/pmic.201100105; Kojima H, 2005, ALCOHOL CLIN EXP RES, V29, p259S, DOI 10.1097/01.alc.0000191776.37626.30; LIEBER CS, 1961, J CLIN INVEST, V40, P394, DOI 10.1172/JCI104266; Lindinger W, 1997, ALCOHOL CLIN EXP RES, V21, P939; Liu WS, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0024363, 10.1371/journal.pone.0024406]; LUDWIG J, 1980, MAYO CLIN PROC, V55, P434; Ma Xiong, 2006, Chin J Dig Dis, V7, P7, DOI 10.1111/j.1443-9573.2006.00237.x; Ma Y, 2005, INT J IMMUNOPATH PH, V18, P173, DOI 10.1177/039463200501800118; Marchesini G, 1999, AM J MED, V107, P450, DOI 10.1016/S0002-9343(99)00271-5; Martel C, 2012, CURR PHARM BIOTECHNO, V13, P726, DOI 10.2174/138920112799857558; Masotti A, 2012, J GASTROEN HEPATOL, V27, P187, DOI 10.1111/j.1440-1746.2011.07032.x; McCullough AJ, 2006, J CLIN GASTROENTEROL, V40, pS17; Medicinenet, ALC NUTR; Miller MH, 2011, LIVER INT, V31, P461, DOI 10.1111/j.1478-3231.2011.02451.x; Nosova T, 1996, ALCOHOL ALCOHOLISM, V31, P555; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Parola M, 2001, J HEPATOL, V35, P297, DOI 10.1016/S0168-8278(01)00142-8; Perez-Carreras M, 2003, HEPATOLOGY, V38, P999, DOI 10.1053/jhep.2003.50398; Pihur V, 2007, BIOINFORMATICS, V23, P1607, DOI 10.1093/bioinformatics/btm158; Pihur V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-62; Valdecantos MP, 2011, BIOMARKERS, V16, P670, DOI 10.3109/1354750X.2011.625504; POZEFSKY T, 1976, J CLIN INVEST, V57, P444, DOI 10.1172/JCI108295; Raychaudhuri S, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P286; Rhoads JM, 2009, AMINO ACIDS, V37, P111, DOI 10.1007/s00726-008-0225-4; Riviere L, 2009, P NATL ACAD SCI USA, V106, P12694, DOI 10.1073/pnas.0903355106; Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256; SARIN SK, 1988, DIGEST DIS SCI, V33, P443, DOI 10.1007/BF01536029; SOFER W, 1987, ANNU REV GENET, V21, P203, DOI 10.1146/annurev.genet.21.1.203; Stokkeland K, 2010, ALCOHOL CLIN EXP RES, V34, P1993, DOI 10.1111/j.1530-0277.2010.01289.x; Sunny NE, 2011, CELL METAB, V14, P804, DOI 10.1016/j.cmet.2011.11.004; Tamimi TIAR, 2011, J HEPATOL, V54, P1224, DOI 10.1016/j.jhep.2010.08.023; Troyanskaya OG, 2002, BIOINFORMATICS, V18, P1454, DOI 10.1093/bioinformatics/18.11.1454; Tsodikov A, 2002, BIOINFORMATICS, V18, P251, DOI 10.1093/bioinformatics/18.2.251; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vuppalanchi R, 2009, HEPATOLOGY, V49, P306, DOI 10.1002/hep.22603; Wei YZ, 2008, WORLD J GASTROENTERO, V14, P193, DOI 10.3748/wjg.14.193; Wu GY, 2009, AMINO ACIDS, V37, P1, DOI 10.1007/s00726-009-0269-0; Yilmaz Y, 2009, WORLD J GASTROENTERO, V15, P4387, DOI 10.3748/wjg.15.4387; Zhu LX, 2011, METABOLISM, V60, P1001, DOI 10.1016/j.metabol.2010.10.003	70	11	11	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e51131	10.1371/journal.pone.0051131	http://dx.doi.org/10.1371/journal.pone.0051131			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300535	Green Published, gold, Green Submitted			2022-12-27	WOS:000313618800011
J	Lin, JF; Pan, HC; Ma, LP; Shen, YQ; Schachner, M				Lin, Jin-Fei; Pan, Hong-Chao; Ma, Li-Ping; Shen, Yan-Qin; Schachner, Melitta			The Cell Neural Adhesion Molecule Contactin-2 (TAG-1) Is Beneficial for Functional Recovery after Spinal Cord Injury in Adult Zebrafish	PLOS ONE			English	Article							SECRETED PROTEIN AXONIN-1; RETINAL GANGLION-CELLS; NEURITE OUTGROWTH; NERVOUS-SYSTEM; EXPRESSION; REGENERATION; AXONS; PATHWAY; GROWTH; NEUROGENESIS	The cell neural adhesion molecule contactin-2 plays a key role in axon extension and guidance, fasciculation, and myelination during development. We thus asked, whether contactin-2 is also important in nervous system regeneration after trauma. In this study, we used an adult zebrafish spinal cord transection model to test the functions of contactin-2 in spinal cord regeneration. The expression patterns of contactin-2 at different time points after spinal cord injury were studied at the mRNA level by qPCR and in situ hybridization, and contactin-2 protein levels and immunohistological localization were detected by Western blot and immunofluorescence analyses, respectively. Contactin-2 mRNA and protein levels were increased along the central canal at 6 days and 11 days after spinal cord injury, suggesting a requirement for contactin-2 in spinal cord regeneration. Co-localization of contactin-2 and islet-1 (a motoneuron marker) was observed in spinal cords before and after injury. To further explore the functions of contactin-2 in regeneration, an anti-sense morpholino was used to knock down the expression of contactin-2 protein by application at the time of injury. Motion analysis showed that inhibition of contactin-2 retarded the recovery of swimming functions when compared to standard control morpholino. Anterograde and retrograde tracing at 6 weeks after injury showed that knock down of contactin-2 inhibited axonal regrowth from NMLF neurons beyond lesion site. The combined observations indicate that contactin-2 contributes to locomotor recovery and successful regrowth of axons after spinal cord injury in adult zebrafish.	[Lin, Jin-Fei; Pan, Hong-Chao; Shen, Yan-Qin; Schachner, Melitta] Shantou Univ, Coll Med, Ctr Neurosci, Shantou, Peoples R China; [Ma, Li-Ping; Schachner, Melitta] Rutgers State Univ, Keck Ctr Collaborat Neurosci, Piscataway, NJ USA; [Ma, Li-Ping; Schachner, Melitta] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ USA	Shantou University; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Shen, YQ (corresponding author), Shantou Univ, Coll Med, Ctr Neurosci, Shantou, Peoples R China.	yqshen@stu.edu.cn; schachner@stu.edu.cn			Li Ka Shing Foundation; NSFC [81072622, 31271580]; NSF of Guangdong [S2012010009480]	Li Ka Shing Foundation; NSFC(National Natural Science Foundation of China (NSFC)); NSF of Guangdong(National Natural Science Foundation of Guangdong Province)	This work was supported by Li Ka Shing Foundation to M. Schachner and NSFC (81072622 and 31271580), NSF of Guangdong (S2012010009480) to Y.Q. Shen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeriswyl T, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-7; Becker CG, 2008, RESTOR NEUROL NEUROS, V26, P71; Becker CG, 2004, J NEUROSCI, V24, P7837, DOI 10.1523/JNEUROSCI.2420-04.2004; Becker T, 1997, J COMP NEUROL, V377, P577, DOI 10.1002/(SICI)1096-9861(19970127)377:4<577::AID-CNE8>3.0.CO;2-#; Bernhardt RR, 1996, J COMP NEUROL, V376, P253, DOI 10.1002/(SICI)1096-9861(19961209)376:2<253::AID-CNE7>3.0.CO;2-2; Chatzopoulou E, 2008, J NEUROSCI, V28, P7624, DOI 10.1523/JNEUROSCI.1103-08.2008; Denaxa M, 2001, DEVELOPMENT, V128, P4635; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; FELSENFELD DP, 1994, NEURON, V12, P675, DOI 10.1016/0896-6273(94)90222-4; FURLEY AJ, 1990, CELL, V61, P157, DOI 10.1016/0092-8674(90)90223-2; Goff LA, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-76; Guo Y, 2011, NEUROSCIENCE, V172, P329, DOI 10.1016/j.neuroscience.2010.10.026; HALFTER W, 1994, DEV BRAIN RES, V78, P87, DOI 10.1016/0165-3806(94)90013-2; Hui SP, 2010, DEV DYNAM, V239, P2962, DOI 10.1002/dvdy.22438; Jung M, 1997, MOL CELL NEUROSCI, V9, P116, DOI 10.1006/mcne.1997.0611; Karagogeos D, 1997, J COMP NEUROL, V379, P415, DOI 10.1002/(SICI)1096-9861(19970317)379:3<415::AID-CNE7>3.0.CO;2-6; Kroehne V, 2011, DEVELOPMENT, V138, P4831, DOI 10.1242/dev.072587; KUHN TB, 1991, J CELL BIOL, V115, P1113, DOI 10.1083/jcb.115.4.1113; Lang DM, 2001, MOL CELL NEUROSCI, V17, P398, DOI 10.1006/mcne.2000.0936; Ma LP, 2012, EUR J NEUROSCI, V35, P353, DOI 10.1111/j.1460-9568.2011.07958.x; Ma QH, 2008, NAT CELL BIOL, V10, P283, DOI 10.1038/ncb1690; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Pei DS, 2007, ANAL BIOCHEM, V363, P291, DOI 10.1016/j.ab.2006.12.005; Reimer MM, 2008, J NEUROSCI, V28, P8510, DOI 10.1523/JNEUROSCI.1189-08.2008; RUEGG MA, 1989, J CELL BIOL, V109, P2363, DOI 10.1083/jcb.109.5.2363; RUEGG MA, 1989, EMBO J, V8, P55, DOI 10.1002/j.1460-2075.1989.tb03348.x; Savvaki M, 2010, J NEUROSCI, V30, P13943, DOI 10.1523/JNEUROSCI.2574-10.2010; Soares S, 2005, EUR J NEUROSCI, V21, P1169, DOI 10.1111/j.1460-9568.2005.03961.x; STOECKLI ET, 1991, J CELL BIOL, V112, P449, DOI 10.1083/jcb.112.3.449; Summerton J, 1997, ANTISENSE NUCLEIC A, V7, P187, DOI 10.1089/oli.1.1997.7.187; Traka M, 2002, J NEUROSCI, V22, P3016, DOI 10.1523/JNEUROSCI.22-08-03016.2002; Wolfer DP, 1998, ANAT EMBRYOL, V197, P177, DOI 10.1007/s004290050129; Wolman MA, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-6; Yu YM, 2011, NEUROSCIENCE, V183, P238, DOI 10.1016/j.neuroscience.2011.03.043; ZUELLIG RA, 1992, EUR J BIOCHEM, V204, P453, DOI 10.1111/j.1432-1033.1992.tb16655.x	35	24	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52376	10.1371/journal.pone.0052376	http://dx.doi.org/10.1371/journal.pone.0052376			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285014	Green Published, gold, Green Submitted			2022-12-27	WOS:000313158800056
J	Yu, F; Li, BY; Li, XL; Cai, Q; Zhang, Z; Cheng, M; Yin, M; Wang, JF; Zhang, JH; Lu, WD; Zhou, RH; Gao, HQ				Yu, Fei; Li, Bao-ying; Li, Xiao-li; Cai, Qian; Zhang, Zhen; Cheng, Mei; Yin, Mei; Wang, Jun-fu; Zhang, Jian-hua; Lu, Wei-da; Zhou, Rui-hai; Gao, Hai-qing			Proteomic Analysis of Aorta and Protective Effects of Grape Seed Procyanidin B2 in db/db Mice Reveal a Critical Role of Milk Fat Globule Epidermal Growth Factor-8 in Diabetic Arterial Damage	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; NF-KAPPA-B; MUSCLE-CELL PROLIFERATION; PROANTHOCYANIDIN EXTRACTS; OXIDATIVE STRESS; ENDOTHELIAL-CELLS; SIGNALING PATHWAY; ANGIOTENSIN-II; ACTIVATION; EXPRESSION	Background: Atherosclerosis is one of the major complications of type 2 diabetic patients (T2DM), leading to morbidity and mortality. Grape seed procyanidin B2 (GSPB2) has demonstrated protective effect against atherosclerosis, which is believed to be, at least in part, a result of its antioxidative effects. The aim of this study is to identify the target protein of GSPB2 responsible for the protective effect against atherosclerosis in patients with DM. Methods and Results: GSPB2 (30 mg/kg body weight/day) were administrated to db/db mice for 10 weeks. Proteomics of the aorta extracts by iTRAQ analysis was obtained from db/db mice. The results showed that expression of 557 proteins were either up-or down-regulated in the aorta of diabetic mice. Among those proteins, 139 proteins were normalized by GSPB2 to the levels comparable to those in control mice. Among the proteins regulated by GSPB2, the milk fat globule epidermal growth factor-8 (MFG-E8) was found to be increased in serum level in T2DM patients; the serum level of MFG-E8 was positively correlated with carotid-femoral pulse wave velocity (CF-PWV). Inhibition of MFG-E8 by RNA interference significantly suppressed whereas exogenous recombinant MFG-E8 administration exacerbated atherogenesis the db/db mice. To gain more insights into the mechanism of action of MFG-E8, we investigated the effects of MFG-E8 on the signal pathway involving the extracellular signal-regulated kinase (ERK) and monocyte chemoattractant protein-1 (MCP-1). Treatment with recombinant MFG-E8 led to increased whereas inhibition of MFG-E8 to decreased expression of MCP-1 and phosphorylation of ERK1/2. Conclusion: Our data suggests that MFG-E8 plays an important role in atherogenesis in diabetes through both ERK and MCP-1 signaling pathways. GSPB2, a well-studied antioxidant, significantly inhibited the arterial wall changes favoring atherogenesis in db/db mice by down-regulating MFG-E8 expression in aorta and its serum level. Measuring MFG-E8 serum level could be a useful clinical surrogate prognosticating atherogenesis in DM patients.	[Yu, Fei; Li, Bao-ying; Li, Xiao-li; Cai, Qian; Zhang, Zhen; Cheng, Mei; Yin, Mei; Lu, Wei-da; Gao, Hai-qing] Shandong Univ, Qi Lu Hosp, Dept Geriatr, Key Lab Cardiovasc Prote Shandong Prov, Jinan 250100, Peoples R China; [Wang, Jun-fu; Zhang, Jian-hua] Med Sci Acad Shandong, Inst Basic Sci, Jinan, Peoples R China; [Zhou, Rui-hai] Univ N Carolina, Div Cardiol, Chapel Hill, NC USA	Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; University of North Carolina; University of North Carolina Chapel Hill	Gao, HQ (corresponding author), Shandong Univ, Qi Lu Hosp, Dept Geriatr, Key Lab Cardiovasc Prote Shandong Prov, Jinan 250100, Peoples R China.	gaohaiqingdr@yahoo.com.cn			National Natural Science Foundation of China [30873145, 81000340, 81100595]; Outstanding Young Scientist Research Award Fund of Shandong Province [BS2009YY046]; China Postdoctoral Science Foundation [20100471520, 2011M500748]; Natural Science Foundation of Shandong Province [Y2008C100, ZR2010HQ067]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Outstanding Young Scientist Research Award Fund of Shandong Province; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This work was supported by National Natural Science Foundation of China (30873145, 81000340 and 81100595), Outstanding Young Scientist Research Award Fund of Shandong Province (BS2009YY046), China Postdoctoral Science Foundation (20100471520, 2011M500748) and Natural Science Foundation of Shandong Province (Y2008C100, ZR2010HQ067). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki N, 2007, ENDOCRINOLOGY, V148, P3850, DOI 10.1210/en.2006-1479; Bayraktutan U, 2002, DIABETES OBES METAB, V4, P224, DOI 10.1046/j.1463-1326.2002.00184.x; Cai K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019559; Cai Q, 2011, BIOSCI BIOTECH BIOCH, V75, P1692, DOI 10.1271/bbb.110194; Calabro P, 2004, CIRCULATION, V110, P3335, DOI 10.1161/01.CIR.0000147825.97879.E7; Casagrande V, 2012, ARTERIOSCL THROM VAS, V32, P74, DOI 10.1161/ATVBAHA.111.238402; Castrillejo VM, 2011, NUTRITION, V27, P1172, DOI 10.1016/j.nut.2010.12.010; Chen DM, 2006, J CARDIOVASC PHARM, V48, P54, DOI 10.1097/01.fjc.0000242052.60502.21; Chen JL, 2011, J ETHNOPHARMACOL, V136, P217, DOI 10.1016/j.jep.2011.04.052; Cheng M, 2012, DIABETES RES CLIN PR, V95, P125, DOI 10.1016/j.diabres.2011.09.030; Cheng SL, 2010, CIRC RES, V107, P271, DOI 10.1161/CIRCRESAHA.110.219899; Cu XP, 2008, J NUTR SCI VITAMINOL, V54, P321; Devi SA, 2011, EXP GERONTOL, V46, P958, DOI 10.1016/j.exger.2011.08.006; Doney ASF, 2005, CIRCULATION, V111, P2927, DOI 10.1161/CIRCULATIONAHA.104.509224; Fens MHAM, 2012, HAEMATOL-HEMATOL J, V97, P500, DOI 10.3324/haematol.2011.048694; Fu ZM, 2009, CIRC RES, V104, P1337, DOI 10.1161/CIRCRESAHA.108.187088; Henry RMA, 2003, CIRCULATION, V107, P2089, DOI 10.1161/01.CIR.0000065222.34933.FC; Houde V, 2006, J PERIODONTOL, V77, P1371, DOI 10.1902/jop.2006.050419; Jay D, 2006, FREE RADICAL BIO MED, V40, P183, DOI 10.1016/j.freeradbiomed.2005.06.018; Jia ZY, 2011, MOL VIS, V17, P210; Khanna S, 2002, FREE RADICAL BIO MED, V33, P1089, DOI 10.1016/S0891-5849(02)00999-1; King GL, 1996, DIABETES, V45, pS105, DOI 10.2337/diab.45.3.S105; Koyama H, 1998, CIRC RES, V82, P713, DOI 10.1161/01.RES.82.6.713; Kushwaha S, 2011, MUTAT RES-GEN TOX EN, V726, P242, DOI 10.1016/j.mrgentox.2011.10.004; Lee Yong-Ho, 2005, Curr Diab Rep, V5, P70; Lee YA, 2008, J AGR FOOD CHEM, V56, P7781, DOI 10.1021/jf800639m; Li BY, 2008, J CELL BIOCHEM, V104, P668, DOI 10.1002/jcb.21658; Li BY, 2011, APOPTOSIS, V16, P732, DOI 10.1007/s10495-011-0602-4; Li BY, 2011, CELL BIOL INT, V35, P663, DOI 10.1042/CBI20100656; Li XL, 2010, INT J MOL MED, V25, P237, DOI 10.3892/ijmm_00000336; Lilly B, 2010, ARTERIOSCL THROM VAS, V30, P694, DOI 10.1161/ATVBAHA.109.200741; Lin JG, 2012, LAB INVEST, V92, P827, DOI 10.1038/labinvest.2012.53; Lu M, 2010, J NUTR SCI VITAMINOL, V56, P87, DOI 10.3177/jnsv.56.87; Ma L, 2007, J CARDIOVASC PHARM, V49, P293, DOI 10.1097/FJC.0b013e31803c5616; Mackenzie GG, 2008, BIOCHEM PHARMACOL, V75, P1461, DOI 10.1016/j.bcp.2007.12.013; Miura T, 2008, CARCINOGENESIS, V29, P585, DOI 10.1093/carcin/bgm198; Okudan N, 2011, J MED FOOD, V14, P1298, DOI 10.1089/jmf.2010.0030; Silvestre JS, 2005, NAT MED, V11, P499, DOI 10.1038/nm1233; Stenina OI, 2003, CIRCULATION, V107, P3209, DOI 10.1161/01.CIR.0000074223.56882.97; Taniyama Y, 2003, HYPERTENSION, V42, P1075, DOI 10.1161/01.HYP.0000100443.09293.4F; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Terrisse AD, 2010, J THROMB HAEMOST, V8, P2810, DOI 10.1111/j.1538-7836.2010.04088.x; Terry JG, 2003, CIRCULATION, V107, P1146, DOI 10.1161/01.CIR.0000051461.92839.F7; Vayalil PK, 2004, CARCINOGENESIS, V25, P987, DOI 10.1093/carcin/bgh095; Wakabayashi I, 2010, EUR J PHARMACOL, V629, P1, DOI 10.1016/j.ejphar.2009.11.054; Wang MY, 2010, CURR HYPERTENS REV, V6, P266, DOI 10.2174/157340210793611668; Werle M, 2002, CARDIOVASC RES, V56, P284, DOI 10.1016/S0008-6363(02)00600-4; Yokozawa T, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/623879; Zhang FL, 2006, J CARDIOVASC PHARM, V48, P47, DOI 10.1097/01.fjc.0000242058.72471.0c; ZHANG YJ, 1995, MOL CELL BIOL, V15, P4851; Zunino SJ, 2009, J NUTR, V139, p1794S, DOI 10.3945/jn.109.107631	51	36	37	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52541	10.1371/journal.pone.0052541	http://dx.doi.org/10.1371/journal.pone.0052541			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285083	Green Published, gold, Green Submitted			2022-12-27	WOS:000313158800076
J	Gao, P; Ma, HY; Luan, FS; Song, HB				Gao, Peng; Ma, Hongyan; Luan, Feishi; Song, Haibin			DNA Fingerprinting of Chinese Melon Provides Evidentiary Support of Seed Quality Appraisal	PLOS ONE			English	Article							SIMPLE-SEQUENCE REPEATS; GENETIC DIVERSITY; MOLECULAR MARKERS; LINKAGE MAP; PCR MARKERS; L.; SSR; TRAITS; BARLEY; RAPD	Melon, Cucumis melo L. is an important vegetable crop worldwide. At present, there are phenomena of homonyms and synonyms present in the melon seed markets of China, which could cause variety authenticity issues influencing the process of melon breeding, production, marketing and other aspects. Molecular markers, especially microsatellites or simple sequence repeats (SSRs) are playing increasingly important roles for cultivar identification. The aim of this study was to construct a DNA fingerprinting database of major melon cultivars, which could provide a possibility for the establishment of a technical standard system for purity and authenticity identification of melon seeds. In this study, to develop the core set SSR markers, 470 polymorphic SSRs were selected as the candidate markers from 1219 SSRs using 20 representative melon varieties (lines). Eighteen SSR markers, evenly distributed across the genome and with the highest contents of polymorphism information (PIC) were identified as the core marker set for melon DNA fingerprinting analysis. Fingerprint codes for 471 melon varieties (lines) were established. There were 51 materials which were classified into17 groups based on sharing the same fingerprint code, while field traits survey results showed that these plants in the same group were synonyms because of the same or similar field characters. Furthermore, DNA fingerprinting quick response (QR) codes of 471 melon varieties (lines) were constructed. Due to its fast readability and large storage capacity, QR coding melon DNA fingerprinting is in favor of read convenience and commercial applications.	[Gao, Peng; Ma, Hongyan; Luan, Feishi; Song, Haibin] NE Agr Univ, Coll Hort, Harbin, Heilongjiang Pr, Peoples R China	Northeast Agricultural University - China	Luan, FS (corresponding author), NE Agr Univ, Coll Hort, Harbin, Heilongjiang Pr, Peoples R China.	luanfeishi@sina.com			China Agriculture Research System, Ministry of Agriculture, People's Republic of China [CARS-26-02]	China Agriculture Research System, Ministry of Agriculture, People's Republic of China	This work was funded by China Agriculture Research System (CARS-26-02), Ministry of Agriculture, People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtar S, 2010, Genetika, V46, P1500; Arif IA, 2010, INT J MOL SCI, V11, P2079, DOI 10.3390/ijms11052079; Ashfaq M, 2012, Genetika, V48, P62; Baek HJ, 2003, THEOR APPL GENET, V106, P397, DOI 10.1007/s00122-002-1029-7; Bornet B, 2002, GENOME, V45, P481, DOI 10.1139/G02-002; Danin-Poleg Y, 2000, GENOME, V43, P963, DOI 10.1139/gen-43-6-963; Danin-Poleg Y, 2001, THEOR APPL GENET, V102, P61, DOI 10.1007/s001220051618; Deleu W, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-90; Diaz A, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-111; Ding CM, 2009, METHODS MOL BIOL, V578, P245, DOI 10.1007/978-1-60327-411-1_16; Fazio G, 2002, J AM SOC HORTIC SCI, V127, P545, DOI 10.21273/JASHS.127.4.545; Fernandez-Silva I, 2008, THEOR APPL GENET, V118, P139, DOI 10.1007/s00122-008-0883-3; Gao MeiLing, 2011, Acta Horticulturae Sinica, V38, P1308; Garcia-Mas J, 2000, THEOR APPL GENET, V101, P860, DOI 10.1007/s001220051553; Garcia-Mas J, 2012, P NATL ACAD SCI USA, V109, P11872, DOI 10.1073/pnas.1205415109; Gonzalo MJ, 2005, THEOR APPL GENET, V110, P802, DOI 10.1007/s00122-004-1814-6; Joobeur T, 2006, THEOR APPL GENET, V112, P1553, DOI 10.1007/s00122-006-0258-6; Katzir N, 1996, THEOR APPL GENET, V93, P1282, DOI 10.1007/BF00223461; Kirst M, 2005, J HERED, V96, P161, DOI 10.1093/jhered/esi023; Krishna GK, 2004, CELL MOL BIOL LETT, V9, P685; Luan F, 2008, EUPHYTICA, V164, P445, DOI 10.1007/s10681-008-9699-0; Luan FS, 2010, EUPHYTICA, V173, P1, DOI 10.1007/s10681-009-0110-6; Ma HB, 2010, FUJIAN J AGR SCI, V25, P33; Maestri E, 2002, MOL GENET GENOMICS, V267, P186, DOI 10.1007/s00438-002-0650-0; Matus IA, 2002, GENOME, V45, P1095, DOI 10.1139/G02-071; Monforte AJ, 2003, PLANT BREEDING, V122, P153, DOI 10.1046/j.1439-0523.2003.00848.x; Mujaju C, 2010, HEREDITAS, V147, P142, DOI 10.1111/j.1601-5223.2010.02165.x; Naito Y, 2008, BREEDING SCI, V58, P293, DOI 10.1270/jsbbs.58.293; NEI M, 1977, ANN HUM GENET, V41, P225, DOI 10.1111/j.1469-1809.1977.tb01918.x; Ng'uni D, 2011, HEREDITAS, V148, P52, DOI 10.1111/j.1601-5223.2011.02208.x; Nunez-Palenius HG, 2008, CRIT REV BIOTECHNOL, V28, P13, DOI [10.1080/07388550801891111, 10.1080/07388550801891111 ]; Pavlicek A, 1999, FOLIA BIOL-PRAGUE, V45, P97; Reif J, 2006, THEOR APPL GENET, V113, P177, DOI 10.1007/s00122-006-0283-5; Silberstein L, 2003, GENOME, V46, P761, DOI [10.1139/g03-060, 10.1139/G03-060]; Staub J. E., 2001, Cucurbit Genetics Cooperative, P29; Staub JE, 2000, EUPHYTICA, V115, P225, DOI 10.1023/A:1004054014174; Stepansky A, 1999, PLANT SYST EVOL, V217, P313, DOI 10.1007/BF00984373; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wang JingYi, 2009, Journal of Fruit Science, V26, P733; Yu RH, 2012, GENET MOL RES, V11, P254, DOI 10.4238/2012.February.3.5; Zalapa JE, 2007, THEOR APPL GENET, V114, P1185, DOI 10.1007/s00122-007-0510-8; Zhang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027565; Zhu ZiCheng, 2011, Acta Horticulturae Sinica, V38, P1753	43	16	19	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52431	10.1371/journal.pone.0052431	http://dx.doi.org/10.1371/journal.pone.0052431			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285039	Green Submitted, Green Published, gold			2022-12-27	WOS:000312794500166
J	Gunne, M; Urlacher, VB				Gunne, Matthias; Urlacher, Vlada B.			Characterization of the Alkaline Laccase Ssl1 from Streptomyces sviceus with Unusual Properties Discovered by Genome Mining	PLOS ONE			English	Article							FUNGAL LACCASES; BACILLUS-SUBTILIS; BACTERIAL LACCASE; ESCHERICHIA-COLI; COPPER TOLERANCE; PHENOL OXIDASE; COELICOLOR; INHIBITION; EXPRESSION; STABILITY	Fungal laccases are well investigated enzymes with high potential in diverse applications like bleaching of waste waters and textiles, cellulose delignification, and organic synthesis. However, they are limited to acidic reaction conditions and require eukaryotic expression systems. This raises a demand for novel laccases without these constraints. We have taken advantage of the laccase engineering database LccED derived from genome mining to identify and clone the laccase Ssl1 from Streptomyces sviceus which can circumvent the limitations of fungal laccases. Ssl1 belongs to the family of small laccases that contains only few characterized enzymes. After removal of the twin-arginine signal peptide Ssl1 was readily expressed in E. coli. Ssl1 is a small laccase with 32.5 kDa, consists of only two cupredoxin-like domains, and forms trimers in solution. Ssl1 oxidizes 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) (ABTS) and phenolic substrates like 2,6-dimethoxy phenol, guaiacol, and syringaldazine. The k(cat) value for ABTS oxidation was at least 20 times higher than for other substrates. The optimal pH for oxidation reactions is substrate dependent: for phenolic substrates the highest activities were detected at alkaline conditions (pH 9.0 for 2,6-dimethoxy phenol and guaiacol and pH 8.0 for syringaldazine), while the highest reaction rates with ABTS were observed at pH 4.0. Though originating from a mesophilic organism, Ssl demonstrates remarkable stability at elevated temperatures (T-1/2,T-60 degrees C = 88 min) and in a wide pH range (pH 5.0 to 11.0). Notably, the enzyme retained 80% residual activity after 5 days of incubation at pH 11. Detergents and organic co-solvents do not affect Ssl1 stability. The described robustness makes Ssl1 a potential candidate for industrial applications, preferably in processes that require alkaline reaction conditions.	[Gunne, Matthias; Urlacher, Vlada B.] Univ Dusseldorf, Inst Biochem, Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Urlacher, VB (corresponding author), Univ Dusseldorf, Inst Biochem, Univ Str 1, Dusseldorf, Germany.	Vlada.Urlacher@uni-duesseldorf.de	Urlacher, Vlada B./AAV-5999-2021	Urlacher, Vlada B./0000-0003-1312-4574	Heinrich-Heine-University Dusseldorf	Heinrich-Heine-University Dusseldorf	This work was funded by the Heinrich-Heine-University Dusseldorf. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcalde M, 2007, IND ENZYM STRUCT FUN, P461, DOI [10.1007/1-4020-5377-0-26, DOI 10.1007/1-4020-5377-0, DOI 10.1007/1-4020-5377-0_26]; Ausec L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025724; Baldrian P, 2006, FEMS MICROBIOL REV, V30, P215, DOI 10.1111/j.1574-4976.2005.00010.x; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; BOLLAG JM, 1984, APPL ENVIRON MICROB, V48, P849, DOI 10.1128/AEM.48.4.849-854.1984; Dube E, 2008, APPL MICROBIOL BIOT, V79, P597, DOI 10.1007/s00253-008-1475-5; Durao P, 2006, J BIOL INORG CHEM, V11, P514, DOI 10.1007/s00775-006-0102-0; Eiben S, 2007, APPL MICROBIOL BIOT, V75, P1055, DOI 10.1007/s00253-007-0922-z; Endo K, 2003, J BIOCHEM, V133, P671, DOI 10.1093/jb/mvg086; Endo K, 2002, MICROBIOL-SGM, V148, P1767, DOI 10.1099/00221287-148-6-1767; Festa G, 2008, PROTEINS, V72, P25, DOI 10.1002/prot.21889; Grass G, 2001, BIOCHEM BIOPH RES CO, V286, P902, DOI 10.1006/bbrc.2001.5474; Hakulinen N, 2002, NAT STRUCT BIOL, V9, P601, DOI 10.1038/nsb823; HANKA LJ, 1973, ANTIMICROB AGENTS CH, V3, P425, DOI 10.1128/AAC.3.3.425; Heinzkill M, 1998, APPL ENVIRON MICROB, V64, P1601; Hullo MF, 2001, J BACTERIOL, V183, P5426, DOI 10.1128/JB.183.18.5426-5430.2001; Johannes C, 2000, J BIOTECHNOL, V78, P193, DOI 10.1016/S0168-1656(00)00208-X; Kellner H, 2008, SOIL BIOL BIOCHEM, V40, P638, DOI 10.1016/j.soilbio.2007.09.013; Koschorreck K, 2008, APPL MICROBIOL BIOT, V79, P217, DOI 10.1007/s00253-008-1417-2; Kurniawati S, 2007, ENZYME MICROB TECH, V41, P353, DOI 10.1016/j.enzmictec.2007.03.003; Machczynski MC, 2004, PROTEIN SCI, V13, P2388, DOI 10.1110/ps.04759104; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Martins LO, 2002, J BIOL CHEM, V277, P18849, DOI 10.1074/jbc.M200827200; Miyazaki K, 2005, EXTREMOPHILES, V9, P415, DOI 10.1007/s00792-005-0458-z; Molina-Guijarro JM, 2009, INT MICROBIOL, V12, P13, DOI 10.2436/20.1501.01.77; Outten FW, 2001, J BIOL CHEM, V276, P30670, DOI 10.1074/jbc.M104122200; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Ruijssenaars HJ, 2004, APPL MICROBIOL BIOT, V65, P177, DOI 10.1007/s00253-004-1571-0; Santhanam N, 2011, TRENDS BIOTECHNOL, V29, P480, DOI 10.1016/j.tibtech.2011.04.005; Schelder S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022143; Sirim D., 2011, DATABASE, V2011; Skalova T, 2009, J MOL BIOL, V385, P1165, DOI 10.1016/j.jmb.2008.11.024; Solomon EI, 2008, DALTON T, P3921, DOI 10.1039/b800799c; Xu F, 1996, BIOCHEMISTRY-US, V35, P7608, DOI 10.1021/bi952971a; Xu F, 1997, J BIOL CHEM, V272, P924, DOI 10.1074/jbc.272.2.924	35	68	71	5	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52360	10.1371/journal.pone.0052360	http://dx.doi.org/10.1371/journal.pone.0052360			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285009	Green Published, gold, Green Submitted			2022-12-27	WOS:000312794500153
J	Conde, J; Scotece, M; Lopez, V; Gomez, R; Lago, F; Pino, J; Gomez-Reino, J; Gualillo, O				Conde, Javier; Scotece, Morena; Lopez, Veronica; Gomez, Rodolfo; Lago, Francisca; Pino, Jesus; Gomez-Reino, Jesus; Gualillo, Oreste			Adiponectin and Leptin Induce VCAM-1 Expression in Human and Murine Chondrocytes	PLOS ONE			English	Article							CELL-ADHESION MOLECULE-1; SYNTHASE TYPE-II; RHEUMATOID-ARTHRITIS; INTEGRIN VLA-4; OSTEOARTHRITIS; INFLAMMATION; LEUKOCYTE; INTERVENTION; ACTIVATION; CYTOKINES	Background: Osteoarthritis (OA) and rheumatoid arthritis (RA), the most common rheumatic diseases, are characterized by irreversible degeneration of the joint tissues. There are several factors involved in the pathogenesis of these diseases including pro-inflammatory cytokines, adipokines and adhesion molecules. Objective: Up to now, the relationship between adipokines and adhesion molecules at cartilage level was not explored. Thus, the aim of this article was to study the effect of leptin and adiponectin on the expression of VCAM-1 in human and murine chondrocytes. For completeness, intracellular signal transduction pathway was also explored. Methods: VCAM-1 expression was assessed by quantitative RT-PCR and western blot analysis upon treatment with leptin, adiponectin and other pertinent reagents in cultured human primary chondrocytes. Signal transduction pathways have been explored by using specific pharmacological inhibitors in the adipokine-stimulated human primary chondrocytes and ATDC5 murine chondrocyte cell line. Results: Herein, we demonstrate, for the first time, that leptin and adiponectin increase VCAM-1 expression in human and murine chondrocytes. In addition, both adipokines have additive effect with IL-1 beta. Finally, we demonstrate that several kinases, including JAK2, PI3K and AMPK are at a play in the intracellular signalling of VCAM-1 induction. Conclusions: Taken together, our results suggest that leptin and adiponectin could perpetuate cartilage-degrading processes by inducing also factors responsible of leukocyte and monocyte infiltration at inflamed joints.	[Conde, Javier; Scotece, Morena; Lopez, Veronica; Gomez-Reino, Jesus; Gualillo, Oreste] Univ Santiago, Clin Hosp, Inst Med Res IDIS, NEIRID Lab,SERGAS, Santiago De Compostela, Spain; [Gomez, Rodolfo] Fdn Jimenez Diaz, Div Rheumatol, Madrid, Spain; [Lago, Francisca] Univ Santiago, Clin Hosp, Inst Med Res IDIS, Res Lab Mol & Cellular Cardiol 7,SERGAS, Santiago De Compostela, Spain; [Pino, Jesus] Univ Santiago, Clin Hosp, Inst Med Res IDIS, Div Orthopaed Surg & Traumatol,SERGAS, Santiago De Compostela, Spain	Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela	Gualillo, O (corresponding author), Univ Santiago, Clin Hosp, Inst Med Res IDIS, NEIRID Lab,SERGAS, Santiago De Compostela, Spain.	oreste.gualillo@sergas.es	Scotece, Morena/ABI-6561-2020; Gualillo, Oreste/B-8223-2008; Gomez, Rodolfo/B-4642-2012; Aranda, Javier Conde/P-5537-2015	Scotece, Morena/0000-0002-1150-2933; Gualillo, Oreste/0000-0002-7154-1328; Gomez, Rodolfo/0000-0002-1309-1023; Aranda, Javier Conde/0000-0002-2187-479X; Gomez-Reino, Juan/0000-0001-5229-6294; Pino, Jesus/0000-0002-1847-1199	Instituto de Salud Carlos III; Xunta de Galicia (SERGAS); Xunta de Galicia; Instituto de Salud Carlos III (ISCIII) [RD08/0075]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Xunta de Galicia (SERGAS)(Xunta de Galicia); Xunta de Galicia(Xunta de GaliciaEuropean Commission); Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission)	The work of O.G. and F.L. is funded by the Instituto de Salud Carlos III and the Xunta de Galicia (SERGAS) through a research-staff stabilization contract. O.G. is supported by Instituto de Salud Carlos III and Xunta de Galicia. This work was also partially supported by RETICS Program, RD08/0075 (RIER) from Instituto de Salud Carlos III (ISCIII), within the VI NP of R+D+I 2008-2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBELDA SM, 1991, AM J RESP CELL MOL, V4, P195, DOI 10.1165/ajrcmb/4.3.195; Conde J, 2011, ANN RHEUM DIS, V70, P551, DOI 10.1136/ard.2010.132399; ELICES MJ, 1990, CELL, V60, P577, DOI 10.1016/0092-8674(90)90661-W; Felson DT, 2005, J RHEUMATOL, V32, P1133; Francin PJ, 2011, J CELL PHYSIOL, V226, P2790, DOI 10.1002/jcp.22627; Golias C, 2007, IN VIVO, V21, P757; Gomez R, 2009, ARTHRITIS RHEUM-US, V60, P1704, DOI 10.1002/art.24522; Heinegard D, 2011, NAT REV RHEUMATOL, V7, P50, DOI 10.1038/nrrheum.2010.198; Iliopoulos D, 2007, ANN RHEUM DIS, V66, P1616, DOI 10.1136/ard.2007.069377; Kalichman L, 2011, CLIN EXP RHEUMATOL, V29, P544; Kienzle G, 1998, ARTHRITIS RHEUM-US, V41, P1296, DOI 10.1002/1529-0131(199807)41:7<1296::AID-ART21>3.0.CO;2-8; Kluger Martin S, 2004, Adv Dermatol, V20, P163; Koskinen A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3512; KRIEGSMANN J, 1995, LAB INVEST, V72, P209; Lago F, 2007, NAT CLIN PRACT RHEUM, V3, P716, DOI 10.1038/ncprheum0674; Lago R, 2008, OSTEOARTHR CARTILAGE, V16, P1101, DOI 10.1016/j.joca.2007.12.008; Martel-Pelletier Johanne, 2004, Osteoarthritis Cartilage, V12 Suppl A, pS31; Martin JA, 2002, BIOGERONTOLOGY, V3, P257, DOI 10.1023/A:1020185404126; MORALESDUCRET J, 1992, J IMMUNOL, V149, P1424; Otero M, 2005, ARTHRITIS RES THER, V7, pR581, DOI 10.1186/ar1708; Otero M, 2006, ANN RHEUM DIS, V65, P1198, DOI 10.1136/ard.2005.046540; Salmi M, 2001, J IMMUNOL, V166, P4650, DOI 10.4049/jimmunol.166.7.4650; Schett G, 2009, ARTHRITIS RHEUM-US, V60, P2381, DOI 10.1002/art.24757; Smith MD, 1997, J RHEUMATOL, V24, P365; Sommaggio R, 2009, CELL TRANSPLANT, V18, P1381, DOI 10.3727/096368909X474249; TAK PP, 1995, CLIN IMMUNOL IMMUNOP, V77, P236, DOI 10.1006/clin.1995.1149; Thomas DP, 2000, J CELL SCI, V113, P439; Tokuhira M, 2000, ARTHRITIS RHEUM, V43, P1122, DOI 10.1002/1529-0131(200005)43:5<1122::AID-ANR23>3.0.CO;2-7	28	75	77	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e52533	10.1371/journal.pone.0052533	http://dx.doi.org/10.1371/journal.pone.0052533			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23285079	gold, Green Published, Green Submitted			2022-12-27	WOS:000312694300090
J	Berglund, ED; Li, CY; Ayala, JE; McGuinness, OP; Wasserman, DH				Berglund, Eric D.; Li, Candice Y.; Ayala, Julio E.; McGuinness, Owen P.; Wasserman, David H.			Regulation of Endogenous Glucose Production in Glucose Transporter 4 Over-Expressing Mice	PLOS ONE			English	Article							TRANSGENIC MICE; CONSCIOUS MOUSE; GLUT4; TRANSPORTER; PROTEIN; GENE; METABOLISM; TOLERANCE	Strategies to amplify whole-body glucose disposal are key therapies to treat type 2 diabetes. Mice that over-express glucose transporter 4 (Glut4) in skeletal muscle, heart, and adipose tissue (G4Tg) exhibit increased fasting glucose disposal and thus lowered blood glucose. Intriguingly, G4Tg mice also exhibit improved insulin-stimulated suppression of endogenous glucose production even though Glut4 is not present in the liver. It is unclear, however, if hepatic gluco-regulation is altered in G4Tg mice in the basal, non-insulin-stimulated state. The current studies were performed to examine fasting hepatic glucose metabolism in G4Tg mice and to determine whether gluco-regulatory adaptations exist in the non-insulin-stimulated condition. To test this question, phloridzin-glucose clamps were used to match blood glucose and pancreatic hormone levels while tracer dilution techniques were used to measure glucose flux. These techniques were performed in chronically-catheterized, conscious, and un-stressed 5h-fasted G4Tg and wild-type (WT) littermates. Results show reduced blood glucose, hepatic glycogen content, and hepatic glucokinase (GK) activity/expression as well as higher endogenous glucose production, glucose disposal, arterial glucagon, and hepatic glucose-6-phosphatase (G6Pase) activity/expression in G4Tg mice versus WT controls. Clamping blood glucose for 90 min at,115 mg/dLin G4Tg and WT mice normalized nearly all variables. Notably, however, net hepatic glycogen synthetic rates were disproportionately elevated compared to changes in blood glucose. In conclusion, these studies demonstrate that basal improvements in glucose tolerance due to increased uptake in extra-hepatic sites provoke important gluco-regulatory adaptations in the liver. Although changes in blood glucose underlie the majority of these adaptations, net hepatic glycogen synthesis is sensitized. These data emphasize that anti-diabetic therapies that target skeletal muscle, heart, and/or adipose tissue likely positively impact the liver.	[Berglund, Eric D.; Li, Candice Y.; Ayala, Julio E.; McGuinness, Owen P.; Wasserman, David H.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA; [Ayala, Julio E.; McGuinness, Owen P.; Wasserman, David H.] Vanderbilt Univ, Sch Med, Mouse Metab Phenotyping Ctr, Nashville, TN 37212 USA	Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Vanderbilt University	Berglund, ED (corresponding author), Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA.	berglunde@gmail.com			NIH [DK050277, DK059637]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK050277, U2CDK059637, R01DK050277, T32DK007563, U24DK059637] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by NIH DK050277 and DK059637 (awarded to DHW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayala JE, 2006, DIABETES, V55, P390, DOI 10.2337/diabetes.55.02.06.db05-0686; Balcombe JP, 2004, CONTEMP TOP LAB ANIM, V43, P42; Berglund ED, 2009, ENDOCRINOLOGY; CHAN TM, 1976, ANAL BIOCHEM, V71, P96, DOI 10.1016/0003-2697(76)90014-2; CHARRON MJ, 1989, P NATL ACAD SCI USA, V86, P2535, DOI 10.1073/pnas.86.8.2535; Ehrenkranz JRL, 2005, DIABETES-METAB RES, V21, P31, DOI 10.1002/dmrr.532; Fueger PT, 2007, J PHYSIOL-LONDON, V582, P801, DOI 10.1113/jphysiol.2007.132902; Fueger PT, 2004, J BIOL CHEM, V279, P50956, DOI 10.1074/jbc.M408312200; HANSEN PA, 1995, J BIOL CHEM, V270, P1679; LIU ML, 1993, P NATL ACAD SCI USA, V90, P11346, DOI 10.1073/pnas.90.23.11346; Marshall BA, 1999, AM J PHYSIOL-ENDOC M, V276, pE390, DOI 10.1152/ajpendo.1999.276.2.E390; MORGAN CR, 1962, P SOC EXP BIOL MED, V110, P29; Niswender KD, 1997, J BIOL CHEM, V272, P22570, DOI 10.1074/jbc.272.36.22570; OLSON AL, 1993, J BIOL CHEM, V268, P9839; REN JM, 1995, J CLIN INVEST, V95, P429, DOI 10.1172/JCI117673; TREADWAY JL, 1994, J BIOL CHEM, V269, P29956; Wasserman DH, 2009, AM J PHYSIOL-ENDOC M, V296, pE11, DOI 10.1152/ajpendo.90563.2008	17	5	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e52355	10.1371/journal.pone.0052355	http://dx.doi.org/10.1371/journal.pone.0052355			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23285006	Green Published, Green Submitted, gold			2022-12-27	WOS:000312435900091
J	Abuhammad, A; Fullam, E; Lowe, ED; Staunton, D; Kawamura, A; Westwood, IM; Bhakta, S; Garner, AC; Wilson, DL; Seden, PT; Davies, SG; Russell, AJ; Garman, EF; Sim, E				Abuhammad, Areej; Fullam, Elizabeth; Lowe, Edward D.; Staunton, David; Kawamura, Akane; Westwood, Isaac M.; Bhakta, Sanjib; Garner, Alun Christopher; Wilson, David L.; Seden, Peter T.; Davies, Stephen G.; Russell, Angela J.; Garman, Elspeth F.; Sim, Edith			Piperidinols That Show Anti-Tubercular Activity as Inhibitors of Arylamine N-Acetyltransferase: An Essential Enzyme for Mycobacterial Survival Inside Macrophages	PLOS ONE			English	Article							CHOLESTEROL CATABOLISM; RESISTANT TUBERCULOSIS; LATENT TUBERCULOSIS; MAXIMUM-LIKELIHOOD; DRUG DISCOVERY; ACIDS; EXPRESSION; MECHANISM; TARGET; SPECIFICITY	Latent M. tuberculosis infection presents one of the major obstacles in the global eradication of tuberculosis (TB). Cholesterol plays a critical role in the persistence of M. tuberculosis within the macrophage during latent infection. Catabolism of cholesterol contributes to the pool of propionyl-CoA, a precursor that is incorporated into cell-wall lipids. Arylamine N-acetyltransferase (NAT) is encoded within a gene cluster that is involved in the cholesterol sterol-ring degradation and is essential for intracellular survival. The ability of the NAT from M. tuberculosis (TBNAT) to utilise propionyl-CoA links it to the cholesterol-catabolism pathway. Deleting the nat gene or inhibiting the NAT enzyme prevents intracellular survival and results in depletion of cell-wall lipids. TBNAT has been investigated as a potential target for TB therapies. From a previous high-throughput screen, 3-benzoyl-4-phenyl-1-methylpiperidinol was identified as a selective inhibitor of prokaryotic NAT that exhibited antimycobacterial activity. The compound resulted in time-dependent irreversible inhibition of the NAT activity when tested against NAT from M. marinum (MMNAT). To further evaluate the antimycobacterial activity and the NAT inhibition of this compound, four piperidinol analogues were tested. All five compounds exert potent antimycobacterial activity against M. tuberculosis with MIC values of 2.3-16.9 mu M. Treatment of the MMNAT enzyme with this set of inhibitors resulted in an irreversible time-dependent inhibition of NAT activity. Here we investigate the mechanism of NAT inhibition by studying protein-ligand interactions using mass spectrometry in combination with enzyme analysis and structure determination. We propose a covalent mechanism of NAT inhibition that involves the formation of a reactive intermediate and selective cysteine residue modification. These piperidinols present a unique class of antimycobacterial compounds that have a novel mode of action different from known anti-tubercular drugs.	[Abuhammad, Areej; Fullam, Elizabeth; Kawamura, Akane; Westwood, Isaac M.; Bhakta, Sanjib; Russell, Angela J.; Sim, Edith] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; [Abuhammad, Areej] Univ Jordan, Fac Pharm, Amman, Jordan; [Abuhammad, Areej; Lowe, Edward D.; Staunton, David; Garman, Elspeth F.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Fullam, Elizabeth; Kawamura, Akane; Westwood, Isaac M.; Garner, Alun Christopher; Wilson, David L.; Seden, Peter T.; Davies, Stephen G.; Russell, Angela J.] Univ Oxford, Dept Chem, Oxford, England; [Sim, Edith] Kingston Univ, Fac Sci Engn & Comp, Kingston upon Thames, Surrey, England	University of Oxford; University of Jordan; University of Oxford; University of Oxford; Kingston University	Sim, E (corresponding author), Univ Oxford, Dept Pharmacol, S Parks Rd, Oxford OX1 3QT, England.	E.Sim@kingston.ac.uk	Abuhammad, Areej/C-3492-2015; Kawamura, Akane/I-4047-2018; Lowe, Edward/AAP-5381-2021	Abuhammad, Areej/0000-0003-4978-5059; Kawamura, Akane/0000-0003-1169-5082; Lowe, Edward/0000-0002-1757-0208; Garman, Elspeth/0000-0001-8329-5665; Russell, Angela/0000-0003-3610-9369	Wellcome Trust; Medical Research Council; University of Jordan	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Jordan	The authors thank the Wellcome Trust and the Medical Research Council for financial support. The authors are also grateful to the University of Jordan for a studentship (A.A.). E.S. and S.B. are members of the MRC UK TB Drug Discovery consortium, TBD-UK (http://www.tbd-uk.org.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuhammad A, 2011, PROTEIN EXPRES PURIF, V80, P246, DOI 10.1016/j.pep.2011.06.021; Accelrys LLC, 2010, DS VISUALIZER ACTIVE, V3, P1; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Astarie-Dequeker C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000289; Bhakta S, 2004, J EXP MED, V199, P1191, DOI 10.1084/jem.20031956; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Brooke EW, 2003, BIOORGAN MED CHEM, V11, P1227, DOI 10.1016/S0968-0896(02)00642-9; COHEN SA, 1993, ANAL BIOCHEM, V211, P279, DOI 10.1006/abio.1993.1270; Copeland R. A., 2005, EVALUATION ENZYME IN; Cwik A, 2004, J MOL CATAL A-CHEM, V219, P377, DOI 10.1016/j.molcata.2004.06.002; Davioud-Charvet E, 2003, BIOCHEMISTRY-US, V42, P13319, DOI 10.1021/bi0353629; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Diacon AH, 2009, NEW ENGL J MED, V360, P2397, DOI 10.1056/NEJMoa0808427; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Espinoza-Fonseca LM, 2006, BIOORGAN MED CHEM, V14, P896, DOI 10.1016/j.bmc.2005.09.011; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fullam E, 2008, J MOL BIOL, V375, P178, DOI 10.1016/j.jmb.2007.10.019; Gideon HP, 2011, IMMUNOL RES, V50, P202, DOI 10.1007/s12026-011-8229-7; Ginsberg A, 2011, FUTURE MED CHEM, V3, P1247, DOI [10.4155/fmc.11.82, 10.4155/FMC.11.82]; Gul M, 2005, ARZNEIMITTELFORSCH, V55, P332; Huang HH, 2005, J AM SOC MASS SPECTR, V16, P324, DOI 10.1016/j.jasms.2004.11.016; JENEY E, 1956, Zentralbl Bakteriol Orig, V167, P55; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaneko T, 2011, FUTURE MED CHEM, V3, P1373, DOI [10.4155/fmc.11.115, 10.4155/FMC.11.115]; Kaul D, 2004, MOL CELL BIOCHEM, V258, P219, DOI 10.1023/B:MCBI.0000012851.42642.be; Kawamura A, 2005, BIOCHEM PHARMACOL, V69, P347, DOI 10.1016/j.bcp.2004.09.014; KELLY SL, 1991, HUM EXP TOXICOL, V10, P33, DOI 10.1177/096032719101000106; Kendall SL, 2007, MOL MICROBIOL, V65, P684, DOI 10.1111/j.1365-2958.2007.05827.x; Kendall SL, 2010, MICROBIOL-SGM, V156, P1362, DOI 10.1099/mic.0.034538-0; KITZ R, 1962, J BIOL CHEM, V237, P3245; Koul A, 2011, NATURE, V469, P483, DOI 10.1038/nature09657; Lack NA, 2009, BIOCHEM J, V418, P369, DOI 10.1042/BJ20082011; Laurieri N, 2010, J AM CHEM SOC, V132, P3238, DOI 10.1021/ja909165u; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGovern SL, 2002, J MED CHEM, V45, P1712, DOI 10.1021/jm010533y; Mishra AK, 2011, FEMS MICROBIOL REV, V35, P1126, DOI 10.1111/j.1574-6976.2011.00276.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ndungu JM, 2005, ORG LETT, V7, P5845, DOI 10.1021/ol052382p; Ouellet H, 2011, TRENDS MICROBIOL, V19, P530, DOI 10.1016/j.tim.2011.07.009; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Payton M, 1999, J BACTERIOL, V181, P1343, DOI 10.1128/JB.181.4.1343-1347.1999; Plati JT, 1951, TETRAHYDROPYRIDINES; Rengarajan J, 2005, P NATL ACAD SCI USA, V102, P8327, DOI 10.1073/pnas.0503272102; Russell AJ, 2009, BIOORGAN MED CHEM, V17, P905, DOI 10.1016/j.bmc.2008.11.032; Sarkar S, 2011, J PHARM PHARM SCI, V14, P148, DOI 10.18433/J33591; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Savvi S, 2008, J BACTERIOL, V190, P3886, DOI 10.1128/JB.01767-07; Schrodinger L., 2020, PYMOL; Shenoi S, 2009, ANNU REV MED, V60, P307, DOI 10.1146/annurev.med.60.053107.103955; Sim E, 2008, DRUG METAB REV, V40, P479, DOI [10.1080/03602530802186603, 10.1080/03602530802186603 ]; Sim E, 2008, CURR DRUG METAB, V9, P510, DOI 10.2174/138920008784892100; Sinclair JC, 2000, NAT STRUCT BIOL, V7, P560; Singh J, 2011, NAT REV DRUG DISCOV, V10, P307, DOI 10.1038/nrd3410; Thomas ST, 2011, J BIOL CHEM, V286, P43668, DOI 10.1074/jbc.M111.313643; Van der Geize R, 2007, P NATL ACAD SCI USA, V104, P1947, DOI 10.1073/pnas.0605728104; Vilcheze C, 2005, ANTIMICROB AGENTS CH, V49, P708, DOI 10.1128/AAC.49.2.708-720.2005; Wang HQ, 2005, BIOCHEMISTRY-US, V44, P11295, DOI 10.1021/bi047564q; Wang W, 2005, P NATL ACAD SCI USA, V102, P7505, DOI 10.1073/pnas.0409482102; Westwood I, 2005, STRUCTURE ACTIVITY A; Westwood IM, 2011, COMB CHEM HIGH T SCR, V14, P117; Westwood IM, 2010, PROTEIN CELL, V1, P82, DOI 10.1007/s13238-010-0006-1; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; World Health Organization, 2019, GLOB TUB REP; Wu H, 2007, J BIOL CHEM, V282, P30189, DOI 10.1074/jbc.M704138200; Yam KC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000344; Yang XX, 2009, BIOCHEMISTRY-US, V48, P3819, DOI 10.1021/bi9005418; Young DB, 2009, TRENDS MICROBIOL, V17, P183, DOI 10.1016/j.tim.2009.02.005	67	22	24	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52790	10.1371/journal.pone.0052790	http://dx.doi.org/10.1371/journal.pone.0052790			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285185	gold, Green Published, Green Submitted			2022-12-27	WOS:000313051500063
J	Cartana, T; Saftoiu, A; Gruionu, LG; Gheonea, DI; Pirici, D; Georgescu, CV; Ciocalteu, A; Gruionu, G				Cartana, Tatiana; Saftoiu, Adrian; Gruionu, Lucian Gheorghe; Gheonea, Dan Ionut; Pirici, Daniel; Georgescu, Claudia Valentina; Ciocalteu, Adriana; Gruionu, Gabriel			Confocal Laser Endomicroscopy for the Morphometric Evaluation of Microvessels in Human Colorectal Cancer Using Targeted Anti-CD31 Antibodies	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; IN-VIVO; TUMOR ANGIOGENESIS	Introduction: Numerous anti-angiogenic agents are currently developed to limit tumor growth and metastasis. While these drugs offer hope for cancer patients, their transient effect on tumor vasculature is difficult to assess in clinical settings. Confocal laser endomicroscopy (CLE) is a novel endoscopic imaging technology that enables histological examination of the gastrointestinal mucosa. The aim of the present study was to evaluate the feasibility of using CLE to image the vascular network in fresh biopsies of human colorectal tissue. For this purpose we have imaged normal and malignant biopsy tissue samples and compared the vascular network parameters obtained with CLE with established histopathology techniques. Materials and Methods: Fresh non-fixed biopsy samples of both normal and malignant colorectal mucosa were stained with fluorescently labeled anti-CD31 antibodies and imaged by CLE using a dedicated endomicroscopy system. Corresponding biopsy samples underwent immunohistochemical staining for CD31, assessing the microvessel density (MVD) and vascular areas for comparison with CLE data, which were measured offline using specific software. Results: The vessels were imaged by CLE in both normal and tumor samples. The average diameter of normal vessels was 8.5 +/- 0.9 mu m whereas in tumor samples it was 13.5 +/- 0.7 mu m (p = 0.0049). Vascular density was 188.7 +/- 24.9 vessels/mm(2) in the normal tissue vs. 242.4 +/- 16.1 vessels/mm(2) in the colorectal cancer samples (p = 0.1201). In the immunohistochemistry samples, the MVD was 211.2 +/- 42.9/mm(2) and 351.3 +/- 39.6/mm(2) for normal and malignant mucosa, respectively. The vascular area was 2.9 +/- 0.5% of total tissue area for the normal mucosa and 8.5 +/- 2.1% for primary colorectal cancer tissue. Conclusion: Selective imaging of blood vessels with CLE is feasible in normal and tumor colorectal tissue by using fluorescently labeled antibodies targeted against an endothelial marker. The method could be translated into the clinical setting for monitoring of anti-angiogenic therapy.	[Cartana, Tatiana; Saftoiu, Adrian; Gruionu, Lucian Gheorghe; Gheonea, Dan Ionut; Ciocalteu, Adriana; Gruionu, Gabriel] Univ Med & Pharm Craiova, Res Ctr Gastroenterol & Hepatol, Craiova, Romania; [Gruionu, Lucian Gheorghe] Univ Craiova, Dept Mech Engn, Craiova, Romania; [Pirici, Daniel] Univ Med & Pharm Craiova, Dept Histol, Craiova, Romania; [Georgescu, Claudia Valentina] Emergency Cty Hosp, Dept Pathol, Craiova, Romania; [Gruionu, Gabriel] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Steele Lab Tumor Biol,Dept Radiat Oncol, Boston, MA USA	University of Medicine & Pharmacy of Craiova; University of Craiova; University of Medicine & Pharmacy of Craiova; Harvard University; Harvard Medical School; Massachusetts General Hospital	Saftoiu, A (corresponding author), Univ Med & Pharm Craiova, Res Ctr Gastroenterol & Hepatol, Craiova, Romania.	adrian.saftoiu@webmail.umfcv.ro	Saftoiu, Adrian/C-2792-2011; Gheonea, Dan Ionut/C-3578-2012; GRUIONU, Lucian Gheorghe/F-6121-2011; Ciocalteu, Adriana/AAF-8592-2021; Gruionu, Gabriel/C-5152-2011; Pirici, Daniel/C-5760-2012	Saftoiu, Adrian/0000-0001-7993-8269; GRUIONU, Lucian Gheorghe/0000-0002-4526-0864; Pirici, Daniel/0000-0001-9192-7319; Ciocalteu, Adriana/0000-0002-8668-4946; Pirici, Daniel/0000-0002-0196-0949	National Research Council (CNCS), Romania [PN-II-ID-PCE-2011-3-0664]	National Research Council (CNCS), Romania	This work was supported from the research grant entitled "Clinical and Biomathematical Modeling of Vascular Changes Following Anti-Angiogenic Therapy in Advanced Colorectal Carcinoma", funded by the National Research Council (CNCS), Romania, contract number PN-II-ID-PCE-2011-3-0664. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown AP, 2008, CANCER METAST REV, V27, P415, DOI 10.1007/s10555-008-9143-x; DeLisser H, 2010, P NATL ACAD SCI USA, V107, P18616, DOI 10.1073/pnas.1004654107; Foersch S, 2010, GUT, V59, P1046, DOI 10.1136/gut.2009.202986; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Fukumura D, 2008, APMIS, V116, P695, DOI 10.1111/j.1600-0463.2008.01148.x; Gheonea DI, 2011, WORLD J GASTROENTERO, V17, P21, DOI 10.3748/wjg.v17.i1.21; Goetz M, 2010, AM J PHYSIOL-GASTR L, V298, pG797, DOI 10.1152/ajpgi.00027.2010; Goetz M, 2010, GASTROENTEROLOGY, V138, P435, DOI 10.1053/j.gastro.2009.10.032; Hasan J, 2002, BRIT J CANCER, V86, P1566, DOI 10.1038/sj.bjc.6600315; Jain RK, 2008, SCI AM, V298, P56, DOI 10.1038/scientificamerican0108-56; Kachlik D, 2010, J ANAT, V216, P335, DOI 10.1111/j.1469-7580.2009.01199.x; Kiesslich R, 2004, GASTROENTEROLOGY, V127, P706, DOI 10.1053/j.gastro.2004.06.050; Kiesslich R, 2007, GASTROINTEST ENDOSC, V66, P150, DOI 10.1016/j.gie.2006.12.031; Kiesslich R, 2006, CLIN GASTROENTEROL H, V4, P979, DOI 10.1016/j.cgh.2006.05.010; Konerding MA, 2001, BRIT J CANCER, V84, P1354, DOI 10.1054/bjoc.2001.1809; Meining A, 2008, GASTROENTEROLOGY, V134, P915, DOI 10.1053/j.gastro.2008.02.049; Mizuno K, 2011, DIGEST DIS SCI, V56, P1811, DOI 10.1007/s10620-010-1519-4; Nakai Y, 2012, J PHYSIOL PHARMACOL, V63, P303; Polglase AL, 2005, GASTROINTEST ENDOSC, V62, P686, DOI 10.1016/j.gie.2005.05.021; Rmali KA, 2007, COLORECTAL DIS, V9, P3, DOI 10.1111/j.1463-1318.2006.01089.x; Sanduleanu S, 2010, CLIN GASTROENTEROL H, V8, P371, DOI 10.1016/j.cgh.2009.08.006; Wallace M, 2011, ENDOSCOPY, V43, P882, DOI 10.1055/s-0030-1256632; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101	23	14	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52815	10.1371/journal.pone.0052815	http://dx.doi.org/10.1371/journal.pone.0052815			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285192	Green Published, Green Submitted, gold			2022-12-27	WOS:000313051500065
J	Gupta, S; Marcel, N; Sarin, A; Shivashankar, GV				Gupta, Soumya; Marcel, Nimi; Sarin, Apurva; Shivashankar, G. V.			Role of Actin Dependent Nuclear Deformation in Regulating Early Gene Expression	PLOS ONE			English	Article							T-CELL-ACTIVATION; SHAPE; MECHANOTRANSDUCTION; KINASE; MODULATION; INDUCTION; MECHANICS; MATRIX	The nucleus of a living cell is constantly undergoing changes in shape and size as a result of various mechanical forces in physiology. These changes correlate with alterations in gene expression, however it is unclear whether nuclear deformation alone is sufficient to elicit these alterations. We used T-cell activation as a model system to test the coupling between nuclear deformation (elongation) and gene expression. Naive T-cell activation with surrogate antigens resulted in actin dependent nuclear elongation. This was accompanied with Erk and NF-kappa B signaling to the nucleus to induce CD69 expression. Importantly, inhibiting actin polymerization abolished both nuclear elongation and CD69 expression, while inhibiting Erk, NF-kappa B or microtubule depolymerization only abolished expression but not elongation. Immobilization of antigen-coated beads, under conditions where actin polymerization was inhibited, rescued both nuclear elongation and CD69 expression. In addition, fibroblast cells plated on fibronectin micropatterns of different sizes showed correlation between nuclear shape index and tenascin C expression. Upon inhibiting the signaling intermediate Erk, tenascin C expression was down regulated although the nuclear shape index remained unaltered. Our results highlight the importance of specific signaling intermediates accompanied with nuclear deformation in the modulation of cellular genomic programs.	[Gupta, Soumya; Marcel, Nimi; Sarin, Apurva; Shivashankar, G. V.] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India; [Marcel, Nimi] Manipal Univ, Dept Hlth Sci, Manipal, Karnataka, India; [Gupta, Soumya; Shivashankar, G. V.] Natl Univ Singapore, MechanoBiol Inst, Singapore 117548, Singapore; [Gupta, Soumya; Shivashankar, G. V.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Manipal Academy of Higher Education (MAHE); National University of Singapore; National University of Singapore	Shivashankar, GV (corresponding author), Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India.	dbsgvs@nus.edu.sg			Nanoscience Initiative and Swarnajayanti Grant (Department of Science and Technology, India); Nanoscience Initiative and Swarnajayanti Grant MechanoBiology Institute, Singapore	Nanoscience Initiative and Swarnajayanti Grant (Department of Science and Technology, India); Nanoscience Initiative and Swarnajayanti Grant MechanoBiology Institute, Singapore	Funding was obtained from Nanoscience Initiative and Swarnajayanti Grants (Department of Science and Technology, India), and MechanoBiology Institute, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babich A, 2012, J CELL BIOL, V197, P775, DOI 10.1083/jcb.201201018; Billadeau DD, 2007, NAT REV IMMUNOL, V7, P131, DOI 10.1038/nri2021; Brandt A, 2006, CURR BIOL, V16, P543, DOI 10.1016/j.cub.2006.01.051; Dahl KN, 2008, CIRC RES, V102, P1307, DOI 10.1161/CIRCRESAHA.108.173989; Judokusumo E, 2012, BIOPHYS J, V102, pL5, DOI 10.1016/j.bpj.2011.12.011; Khatau SB, 2009, P NATL ACAD SCI USA, V106, P19017, DOI 10.1073/pnas.0908686106; Krummel MF, 2006, NAT IMMUNOL, V7, P1143, DOI 10.1038/ni1404; Lammerding J, 2005, J CELL BIOL, V170, P781, DOI 10.1083/jcb.200502148; Lammerding J, 2004, J CLIN INVEST, V113, P370, DOI 10.1172/JCI200419670; Li Y, 2011, BIOPHYS J, V100, P1902, DOI 10.1016/j.bpj.2011.03.008; LOPEZCABRERA M, 1995, J BIOL CHEM, V270, P21545, DOI 10.1074/jbc.270.37.21545; Maier S, 2008, BBA-MOL CELL RES, V1783, P1150, DOI 10.1016/j.bbamcr.2008.01.013; Maschler S, 2004, ONCOGENE, V23, P3622, DOI 10.1038/sj.onc.1207403; Mazumder A, 2010, J R SOC INTERFACE, V7, pS321, DOI 10.1098/rsif.2010.0039.focus; Olins AL, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-30; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; Roca-Cusachs P, 2008, BIOPHYS J, V94, P4984, DOI 10.1529/biophysj.107.116863; Sancho D, 2005, TRENDS IMMUNOL, V26, P136, DOI 10.1016/j.it.2004.12.006; Sawada Y, 2006, CELL, V127, P1015, DOI 10.1016/j.cell.2006.09.044; Schuh K, 1998, J EXP MED, V188, P1369, DOI 10.1084/jem.188.7.1369; Shen K, 2008, P NATL ACAD SCI USA, V105, P7791, DOI 10.1073/pnas.0710295105; Shivashankar GV, 2011, ANNU REV BIOPHYS, V40, P361, DOI 10.1146/annurev-biophys-042910-155319; TESTI R, 1989, J IMMUNOL, V142, P1854; Thomas CH, 2002, P NATL ACAD SCI USA, V99, P1972, DOI 10.1073/pnas.032668799; Versaevel M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1668; Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594	26	35	35	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53031	10.1371/journal.pone.0053031	http://dx.doi.org/10.1371/journal.pone.0053031			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285252	Green Submitted, gold, Green Published			2022-12-27	WOS:000313051500103
J	Harris, RS; Fujii-Rios, H; Winkler, T; Musch, G; Melo, MFV; Venegas, JG				Harris, R. Scott; Fujii-Rios, Hanae; Winkler, Tilo; Musch, Guido; Melo, Marcos F. Vidal; Venegas, Jose G.			Ventilation Defect Formation in Healthy and Asthma Subjects Is Determined by Lung Inflation	PLOS ONE			English	Article							HE-3 MAGNETIC-RESONANCE; REGIONAL VENTILATION; PULMONARY PERFUSION; BRONCHOCONSTRICTION; METHACHOLINE; PET; DYSFUNCTION; HISTAMINE; RESPONSES; PATCHY	Background: Imaging studies have demonstrated that ventilation during bronchoconstriction in subjects with asthma is patchy with large ventilation defective areas (Vdefs). Based on a theoretical model, we postulated that during bronchoconstriction, as smooth muscle force activation increases, a patchy distribution of ventilation should emerge, even in the presence of minimal heterogeneity the lung. We therefore theorized that in normal lungs, Vdefs should also emerge in regions of the lung with reduced expansion. Objective: We studied 12 healthy subjects to evaluate whether Vdefs formed during bronchoconstriction, and compared their Vdefs with those observed in 9 subjects with mild asthma. Methods: Spirometry, low frequency (0.15 Hz) lung elastance and resistance, and regional ventilation by intravenous (NN)-N-13-saline positron emission tomography were measured before and after a challenge with nebulized methacholine. Vdefs were defined as regions with elevated residual (NN)-N-13 after a period of washout. The average location, ventilation, volume, and fractional gas content of the Vdefs, relative to those of the rest of the lung, were calculated for both groups. Results: Consistent with the predictions of the theoretical model, both healthy subjects and those with asthma developed Vdefs. These Vdefs tended to form in regions that, at baseline, had a lower degree of lung inflation and, in healthy subjects, tended to occur in more dependent locations than in subjects with asthma. Conclusion: The formation of Vdefs is determined by the state of inflation prior to bronchoconstriction.	[Harris, R. Scott; Fujii-Rios, Hanae] Massachusetts Gen Hosp, Dept Med, Pulm & Crit Care Unit, Boston, MA 02114 USA; [Harris, R. Scott; Fujii-Rios, Hanae; Winkler, Tilo; Musch, Guido; Melo, Marcos F. Vidal; Venegas, Jose G.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Harris, RS (corresponding author), Massachusetts Gen Hosp, Dept Med, Pulm & Crit Care Unit, Boston, MA 02114 USA.	rsharris@mgh.harvard.edu	Melo, Marcos F Vidal/C-3452-2013; Melo, Marcos Vidal/AAN-7219-2020; Winkler, Tilo/B-5337-2009	Winkler, Tilo/0000-0002-7276-5550	National Institutes of Health [HL-68011, HL-04501]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068011, K08HL004501] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Institutes of Health: HL-68011 to JGV and HL-04501 to RSH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altes TA, 2001, J MAGN RESON IMAGING, V13, P378, DOI 10.1002/jmri.1054; Bayat S, 2009, J APPL PHYSIOL, V106, P1949, DOI 10.1152/japplphysiol.90550.2008; Busk M, 2012, EUR RESP J; CARTIER A, 1983, J APPL PHYSIOL, V54, P821, DOI 10.1152/jappl.1983.54.3.821; Ciftci TU, 2005, RESP MED, V99, P529, DOI 10.1016/j.rmed.2004.10.011; de Lange EE, 2007, J ALLERGY CLIN IMMUN, V119, P1072, DOI 10.1016/j.jaci.2006.12.659; de Lange EE, 2006, CHEST, V130, P1055, DOI 10.1378/chest.130.4.1055; Froese AB, 2006, ANESTHESIOLOGY, V104, P193, DOI 10.1097/00000542-200601000-00026; Harris RS, 2006, AM J RESP CRIT CARE, V174, P245, DOI 10.1164/rccm.200510-1634OC; Harris RS, 2009, J APPL PHYSIOL, V107, P266, DOI 10.1152/japplphysiol.91386.2008; Kraft M, 2001, AM J RESP CRIT CARE, V163, P1551, DOI 10.1164/ajrccm.163.7.2008013; Lafond C, 2007, EUR RESPIR J, V29, P307, DOI 10.1183/09031936.00059706; Melo MFV, 2005, AM J RESP CRIT CARE, V171, P714, DOI 10.1164/rccm.200409-1296OC; Melo MFV, 2003, J NUCL MED, V44, P1982; MUNKNER T, 1986, EUR J RESPIR DIS, V68, P62; Musch G, 2002, J APPL PHYSIOL, V93, P1841, DOI 10.1152/japplphysiol.00223.2002; National Asthma Education and Prevention Program, 2007, J Allergy Clin Immunol, V120, pS94; Samee S, 2003, J ALLERGY CLIN IMMUN, V111, P1205, DOI 10.1067/mai.2003.1544; SHARDONOFSKY FR, 1992, AM REV RESPIR DIS, V145, P750, DOI 10.1164/ajrccm/145.4_Pt_1.750; Tgavalekos NT, 2007, EUR RESPIR J, V29, P1174, DOI 10.1183/09031936.00113606; Tgavalekos NT, 2005, J APPL PHYSIOL, V99, P2388, DOI 10.1152/japplphysiol.00391.2005; Tgavalekos NT, 2003, ANN BIOMED ENG, V31, P363, DOI 10.1114/1.1557972; Tzeng YS, 2009, J APPL PHYSIOL, V106, P813, DOI 10.1152/japplphysiol.01133.2007; Venegas JG, 2005, RESP PHYSIOL NEUROBI, V148, P57, DOI 10.1016/j.resp.2005.05.023; Venegas JG, 2005, NATURE, V434, P777, DOI 10.1038/nature03490; Winkler T, 2007, J APPL PHYSIOL, V103, P655, DOI 10.1152/japplphysiol.00041.2007	26	19	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53216	10.1371/journal.pone.0053216	http://dx.doi.org/10.1371/journal.pone.0053216			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285270	gold, Green Published, Green Submitted			2022-12-27	WOS:000313051500124
J	Jayaratne, YSN; Deutsch, CK; McGrath, CPJ; Zwahlen, RA				Jayaratne, Yasas S. N.; Deutsch, Curtis K.; McGrath, Colman P. J.; Zwahlen, Roger A.			Are Neoclassical Canons Valid for Southern Chinese Faces?	PLOS ONE			English	Article							FACIAL CANONS; PHOTOGRAMMETRIC IMAGES; POPULATIONS; ATTRACTIVENESS; PRECISION; REVISION	Background: Proportions derived from neoclassical canons, initially described by Renaissance sculptors and painters, are still being employed as aesthetic guidelines during the clinical assessment of the facial morphology. Objective: 1. to determine the applicability of neoclassical canons for Southern Chinese faces and 2. to explore gender differences in relation to the applicability of the neoclassical canons and their variants. Methodology: 3-D photographs acquired from 103 young adults (51 males and 52 females) without facial dysmorphology were used to test applicability of four neoclassical canons. Standard anthropometric measurements that determine the facial canons were made on these 3-D images. The validity of the canons as well as their different variants were quantified. Principal Findings: The neoclassical cannons seldom applied to these individuals, and facial three-section and orbital canons did not apply at all. The orbitonasal canon was most frequently applicable, with a frequency of 19%. Significant sexual dimorphism was found relative to the prevalence of the variants of facial three-section and orbitonasal canons. Conclusion: The neoclassical canons did not appear to apply to our sample when rigorous quantitative measurements were employed. Thus, they should not be used as esthetic goals for craniofacial surgical interventions.	[Jayaratne, Yasas S. N.; Zwahlen, Roger A.] Univ Hong Kong, Fac Dent, Discipline Oral & Maxillofacial Surg, Sai Ying Pun, Hong Kong, Peoples R China; [Deutsch, Curtis K.] Univ Massachusetts, Sch Med, Eunice Kennedy Shriver Ctr, Waltham, MA USA; [Deutsch, Curtis K.] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [McGrath, Colman P. J.] Univ Hong Kong, Fac Dent, Discipline Periodontol & Publ Hlth, Sai Ying Pun, Hong Kong, Peoples R China	University of Hong Kong; University of Massachusetts System; Harvard University; Harvard Medical School; University of Hong Kong	Zwahlen, RA (corresponding author), Univ Hong Kong, Fac Dent, Discipline Oral & Maxillofacial Surg, Sai Ying Pun, Hong Kong, Peoples R China.	zwahlen@hku.hk		Jayaratne, Yasas/0000-0002-4813-648X; McGrath, Colman Patrick Joseph/0000-0001-9379-0889; ZWAHLEN, Roger Arthur/0000-0003-4666-7567				Aldridge K, 2005, AM J MED GENET A, V138A, P247, DOI 10.1002/ajmg.a.30959; Bashour M, 2006, PLAST RECONSTR SURG, V118, P741, DOI 10.1097/01.prs.0000233051.61512.65; Borman H, 1999, ANN PLAS SURG, V42, P280, DOI 10.1097/00000637-199903000-00009; Buggio L, 2012, GYNECOL ENDOCRINOL, V28, P753, DOI 10.3109/09513590.2012.662545; Choe Kyle S, 2004, Arch Facial Plast Surg, V6, P244, DOI 10.1001/archfaci.6.4.244; Edler R J, 2001, J Orthod, V28, P159, DOI 10.1093/ortho/28.2.159; Farkas L G, 1987, ANTHROPOMETRIC FACIA; Farkas LG, 2000, AESTHET PLAST SURG, V24, P179, DOI 10.1007/s002660010029; FARKAS LG, 1985, PLAST RECONSTR SURG, V75, P328, DOI 10.1097/00006534-198503000-00005; Gill DS, 2008, DENT UPDATE, V35, P164; Hubbe M, 2009, ANAT REC, V292, P1720, DOI 10.1002/ar.20976; Jayaratne YSN, 2012, PLAST RECONSTR SURG, V129, p164E, DOI 10.1097/PRS.0b013e3182362e3f; JEFFRIES JM, 1995, ANN PLAS SURG, V34, P318, DOI 10.1097/00000637-199503000-00016; Kolar JC., 1997, CRANIOFACIAL ANTHROP; Le TT, 2002, AESTHET PLAST SURG, V26, P64, DOI 10.1007/s00266-001-0033-7; Lieberman DE, 2008, EVOL ANTHROPOL, V17, P55, DOI 10.1002/evan.20154; Naini Farhad B, 2008, Dent Update, V35, P102; Naini Farhad B, 2008, Dent Update, V35, P159; Naini FB, 2008, DENT UPDATE, V35, P106; Naini FB, 2008, DENT UPDATE, V35, P169; Noback ML, 2011, AM J PHYS ANTHROPOL, V145, P599, DOI 10.1002/ajpa.21523; Okazaki K, 2011, ANTHROPOL SCI, V119, P49, DOI 10.1537/ase.100202; Porter J P, 2001, Arch Facial Plast Surg, V3, P191; Swennen GRJ, 2005, 3 DIMENSIONAL CEPHAL; Wang DW, 1997, AESTHET PLAST SURG, V21, P265; Weinberg SM, 2006, J CRANIOFAC SURG, V17, P477, DOI 10.1097/00001665-200605000-00015; Wong JY, 2008, CLEFT PALATE-CRAN J, V45, P232, DOI 10.1597/06-175; Wu XJ, 2007, CHINESE SCI BULL, V52, P1661, DOI 10.1007/s11434-007-0227-8	29	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52593	10.1371/journal.pone.0052593	http://dx.doi.org/10.1371/journal.pone.0052593			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285105	Green Submitted, Green Published, gold			2022-12-27	WOS:000313051500037
J	Sandeu, MM; Moussiliou, A; Moiroux, N; Padonou, GG; Massougbodji, A; Corbel, V; Ndam, NT				Sandeu, Maurice Marcel; Moussiliou, Azizath; Moiroux, Nicolas; Padonou, Gilles G.; Massougbodji, Achille; Corbel, Vincent; Ndam, Nicaise Tuikue			Optimized Pan-species and Speciation Duplex Real-time PCR Assays for Plasmodium Parasites Detection in Malaria Vectors	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; LINKED IMMUNOSORBENT-ASSAY; CIRCUMSPOROZOITE PROTEIN; ANOPHELES-GAMBIAE; FALCIPARUM; ELISA; SPOROZOITES; MOSQUITOS; SENSITIVITY; BLOOD	Background: An accurate method for detecting malaria parasites in the mosquito's vector remains an essential component in the vector control. The Enzyme linked immunosorbent assay specific for circumsporozoite protein (ELISA-CSP) is the gold standard method for the detection of malaria parasites in the vector even if it presents some limitations. Here, we optimized multiplex real-time PCR assays to accurately detect minor populations in mixed infection with multiple Plasmodium species in the African malaria vectors Anopheles gambiae and Anopheles funestus. Methods: Complementary TaqMan-based real-time PCR assays that detect Plasmodium species using specific primers and probes were first evaluated on artificial mixtures of different targets inserted in plasmid constructs. The assays were further validated in comparison with the ELISA-CSP on 200 field caught Anopheles gambiae and Anopheles funestus mosquitoes collected in two localities in southern Benin. Results: The validation of the duplex real-time PCR assays on the plasmid mixtures demonstrated robust specificity and sensitivity for detecting distinct targets. Using a panel of mosquito specimen, the real-time PCR showed a relatively high sensitivity (88.6%) and specificity (98%), compared to ELISA-CSP as the referent standard. The agreement between both methods was "excellent'' (k = 0.8, P < 0.05). The relative quantification of Plasmodium DNA between the two Anopheles species analyzed showed no significant difference (P = 0, 2). All infected mosquito samples contained Plasmodium falciparum DNA and mixed infections with P. malariae and/or P. ovale were observed in 18.6% and 13.6% of An. gambiae and An. funestus respectively. Plasmodium vivax was found in none of the mosquito samples analyzed. Conclusion: This study presents an optimized method for detecting the four Plasmodium species in the African malaria vectors. The study highlights substantial discordance with traditional ELISA-CSP pointing out the utility of employing an accurate molecular diagnostic tool for detecting malaria parasites in field mosquito populations.	[Sandeu, Maurice Marcel; Moussiliou, Azizath; Massougbodji, Achille; Ndam, Nicaise Tuikue] FSS, CERPAGE, Cotonou, Benin; [Sandeu, Maurice Marcel; Moiroux, Nicolas; Padonou, Gilles G.; Corbel, Vincent] Univ Abomey Calavi, CREC, Cotonou, Benin; [Sandeu, Maurice Marcel; Moiroux, Nicolas; Corbel, Vincent] Inst Rech Dev IRD 224, Cotonou, Benin; [Moussiliou, Azizath; Ndam, Nicaise Tuikue] Inst Rech Dev IRD 216, Cotonou, Benin; [Ndam, Nicaise Tuikue] Univ Paris 05, Fac Pharm, PRES Sorbonne Paris Cite, Paris, France	Entomological Research Center of Cotonou (CREC); University of Abomey Calavi; UDICE-French Research Universities; Universite Paris Cite	Ndam, NT (corresponding author), FSS, CERPAGE, Cotonou, Benin.	nicaise.ndam@ird.fr	Corbel, VIncent/G-9576-2016; Moiroux, Nicolas/AFT-2925-2022	Moiroux, Nicolas/0000-0001-6755-6167; PADONOU, Germain Gil/0000-0002-3802-6439; Tuikue Ndam, Nicaise/0000-0003-2646-2513; corbel, vincent/0000-0003-0995-3257	LMI LLIP "Laboratoire de lutte integree contre le paludisme: Institut de recherche pour le developpement; Institut des sciences biomedicales - ISBA (Cotonou, BENIN); Faculte des sciences de la sante - FSS (Cotonou, BENIN); Centre de Recherche Entomologique de Cotonou - CREC (Cotonou, BENIN) -(USAID); DPF/IRD	LMI LLIP "Laboratoire de lutte integree contre le paludisme: Institut de recherche pour le developpement; Institut des sciences biomedicales - ISBA (Cotonou, BENIN); Faculte des sciences de la sante - FSS (Cotonou, BENIN); Centre de Recherche Entomologique de Cotonou - CREC (Cotonou, BENIN) -(USAID)(United States Agency for International Development (USAID)); DPF/IRD	The current study was financially supported by the LMI LLIP "Laboratoire de lutte integree contre le paludisme: Institut de recherche pour le developpement, Institut des sciences biomedicales - ISBA (Cotonou, BENIN), Faculte des sciences de la sante - FSS (Cotonou, BENIN), Centre de Recherche Entomologique de Cotonou - CREC (Cotonou, BENIN) -(USAID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Plasmodium genomic DNAs of P. vivax, P. malariae or P. ovale and plasmids containing insert of the 18S gene of each of those species were kindly provided by Dr Stephanie Yanow at the Provincial Laboratory for Public Health, Edmonton, Alberta, Canada. We thank all the inhabitants of the districts (Adjarra, Adjohoun, Dangbo, Misserete, and Seme) who agreed to participate in the study. We are very grateful to the mosquito collectors staff. MS was supported by PhD studentships from DPF/IRD.	Amexo M, 2004, LANCET, V364, P1896, DOI 10.1016/S0140-6736(04)17446-1; [Anonymous], 1987, SUPPLEMENT ANOPHELIN; [Anonymous], 1968, ANOPHELINAE AFR S SA; Arez AP, 2000, EXP PARASITOL, V94, P269, DOI 10.1006/expr.2000.4496; BEIER JC, 1991, MED VET ENTOMOL, V5, P81, DOI 10.1111/j.1365-2915.1991.tb00524.x; Bigoga JD, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-5; BURKOT TR, 1984, AM J TROP MED HYG, V33, P783, DOI 10.4269/ajtmh.1984.33.783; COLLINS FH, 1988, AM J TROP MED HYG, V38, P283, DOI 10.4269/ajtmh.1988.38.283; Damien GB, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-380; Dana AN, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-5; de Monbrison F, 2003, J MICROBIOL METH, V54, P391, DOI 10.1016/s0167-7012(03)00086-1; Diallo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031100; Dicko A, 2011, LANCET INFECT DIS, V11, P722, DOI 10.1016/S1473-3099(11)70186-4; Durnez L, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-195; Edwards FR, 1941, BRIT MED J, V1941, P901, DOI 10.1136/bmj.2.4225.901; Figtree M, 2010, EMERG INFECT DIS, V16, P672, DOI 10.3201/eid1604.091624; Koekemoer LL, 2002, AM J TROP MED HYG, V66, P804, DOI 10.4269/ajtmh.2002.66.804; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lochouarn L, 1999, T ROY SOC TROP MED H, V93, P101, DOI 10.1016/S0035-9203(99)90198-0; Moiroux N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030558; Mouatcho JC, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-30; POSTHUMA G, 1989, EUR J CELL BIOL, V49, P66; Rougemont M, 2004, J CLIN MICROBIOL, V42, P5636, DOI 10.1128/JCM.42.12.5636-5643.2004; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; Shokoples SE, 2009, J CLIN MICROBIOL, V47, P975, DOI 10.1128/JCM.01858-08; SNIGS, 2010, RAPP ACT 2010 IRD BE; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B; SNOUNOU G, 1993, T ROY SOC TROP MED H, V87, P649, DOI 10.1016/0035-9203(93)90274-T; SOMBOON P, 1993, T ROY SOC TROP MED H, V87, P322, DOI 10.1016/0035-9203(93)90148-J; Sylla EHK, 2000, T ROY SOC TROP MED H, V94, P652, DOI 10.1016/S0035-9203(00)90219-0; TASSANAKAJON A, 1993, T ROY SOC TROP MED H, V87, P273, DOI 10.1016/0035-9203(93)90124-9; Vo TKD, 2007, T ROY SOC TROP MED H, V101, P422, DOI 10.1016/j.trstmh.2006.09.004; WHO, 2011, WORLD MALARIA REPORT 2011, P1; *WHO UN CHILDR FUN, 2005, WORLD MAL REP 2005; WIRTZ RA, 1987, B WORLD HEALTH ORGAN, V65, P39	35	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52719	10.1371/journal.pone.0052719	http://dx.doi.org/10.1371/journal.pone.0052719			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285168	Green Published, gold			2022-12-27	WOS:000313051500052
J	Wang, YM; Qu, RB; Hu, SF; Xiao, Y; Jiang, XH; Xu, GY				Wang, Yongmeng; Qu, Ruobing; Hu, Shufen; Xiao, Ying; Jiang, Xinghong; Xu, Guang-Yin			Upregulation of Cystathionine beta-Synthetase Expression Contributes to Visceral Hyperalgesia Induced by Heterotypic Intermittent Stress in Rats	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; DORSAL-ROOT GANGLIA; ENDOGENOUS HYDROGEN-SULFIDE; K-ATP CHANNELS; GASTROINTESTINAL-TRACT; ESCHERICHIA-COLI; SODIUM CURRENTS; ION CHANNELS; SMALL-CELLS; GUINEA-PIG	Background: Hydrogen sulfide (H2S) functions as a neuromodulator, but whether it modulates visceral pain is not well known. This study was designed to determine the role for the endogenous H2S producing enzyme cystathionine beta-synthetase (CBS) and cystathionine gamma-lyase (CSE) in a validated rat model of visceral hyperalgesia (VH). Methods: VH was induced by nine-day heterotypic intermittent stress (HIS). Abdominal withdrawal reflex (AWR) scores were determined by measuring the visceromoter responses to colorectal distension (CRD). Dorsal root ganglia (DRG) neurons innervating the colon were labeled by injection of DiI (1,1'-dioleyl-3,3,3',3-tetramethylindocarbocyanine methanesulfonate) into the colon wall. Patch clamp recording techniques were employed to examine excitability and sodium channel currents of colon specific DRG neurons. Tissues from colon related thoracolumbar DRGs were analyzed for CBS, CSE and sodium channel expression. Results: HIS significantly increased the visceromotor responses to CRD in association with an upregulated expression of CBS not CSE proteins in colon related DRGs. Administration of O-(Carboxymethyl)hydroxylamine hemihydrochloride (AOAA), an inhibitor of CBS, attenuated the AWR scores in HIS-treated rats, in a dose dependent fashion. In contrast, AOAA did not produce any effect on AWR scores in healthy control rats. AOAA reversed the potentiation of sodium channel current densities of colon specific DRG neurons of HIS rats. To further confirm the role for CBS-H2S signaling, NaHS was used to mimic the production of H2S by CBS. Application of NaHS significantly enhanced neuronal excitability and potentiated sodium channel current densities of colon DRG neurons from healthy control rats. Furthermore, AOAA reversed the upregulation of Na(V)1.7 and Na(V)1.8 in colon related DRGs of HIS rats. Conclusion: Our results suggest that upregulation of CBS expression might play an important role in developing VH via sensitization of sodium channels in peripheral nociceptors, thus identifying a specific neurobiological target for the treatment of VH in functional bowel syndromes.	[Wang, Yongmeng; Qu, Ruobing; Hu, Shufen; Xiao, Ying; Jiang, Xinghong; Xu, Guang-Yin] Soochow Univ, Dept Neurobiol, Key Lab Pain Basic Res & Clin Therapy, Inst Neurosci, Suzhou, Peoples R China	Soochow University - China	Xu, GY (corresponding author), Soochow Univ, Dept Neurobiol, Key Lab Pain Basic Res & Clin Therapy, Inst Neurosci, Suzhou, Peoples R China.	guangyinxu@suda.edu.cn			National Natural Science Foundation of China [81070884, 81230024]; Jiangsu Distinguished Professor Program of Jiangsu Province [SR21500111]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Distinguished Professor Program of Jiangsu Province	This work was supported by grants from National Natural Science Foundation of China (81070884; 81230024) and from Jiangsu Distinguished Professor Program of Jiangsu Province (SR21500111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Chaer ED, 2000, GASTROENTEROLOGY, V119, P1276, DOI 10.1053/gast.2000.19576; Azpiroz F, 2007, NEUROGASTROENT MOTIL, V19, P62, DOI 10.1111/j.1365-2982.2006.00875.x; Bennett EJ, 1998, GUT, V43, P256, DOI 10.1136/gut.43.2.256; Beyak MJ, 2005, NEUROGASTROENT MOTIL, V17, P175, DOI 10.1111/j.1365-2982.2004.00596.x; BUKOVSKA G, 1994, PROTEIN EXPRES PURIF, V5, P442, DOI 10.1006/prep.1994.1063; Distrutti E, 2006, J PHARMACOL EXP THER, V316, P325, DOI 10.1124/jpet.105.091595; Distrutti E, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-36; DROSSMAN DA, 1995, ANN INTERN MED, V123, P782, DOI 10.7326/0003-4819-123-10-199511150-00007; DROSSMAN DA, 1995, SCAND J GASTROENTERO, V30, P90, DOI 10.3109/00365529509107768; Drossman DA, 1997, GASTROENTEROLOGY, V112, P2120, DOI 10.1053/gast.1997.v112.agast972120; ELLIOTT AA, 1993, J PHYSIOL-LONDON, V463, P39, DOI 10.1113/jphysiol.1993.sp019583; ERICKSON PF, 1990, BIOCHEM J, V269, P335, DOI 10.1042/bj2690335; Eto K, 2002, J BIOL CHEM, V277, P42680, DOI 10.1074/jbc.M205835200; Fiorucci S, 2006, GASTROENTEROLOGY, V131, P259, DOI 10.1053/j.gastro.2006.02.033; Julian D, 2002, COMP BIOCHEM PHYS A, V133, P105, DOI 10.1016/S1095-6433(02)00122-8; Kataoka H, 2002, BIOL PHARM BULL, V25, P1436, DOI 10.1248/bpb.25.1436; Kawabata A, 2007, PAIN, V132, P74, DOI 10.1016/j.pain.2007.01.026; Lai J, 2002, PAIN, V95, P143, DOI 10.1016/S0304-3959(01)00391-8; Lembo T, 1997, DIGEST DIS SCI, V42, P1112, DOI 10.1023/A:1018817132213; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Lowicka E, 2007, PHARMACOL REP, V59, P4; Maeda Y, 2009, PAIN, V142, P127, DOI 10.1016/j.pain.2008.12.021; Matsunami M, 2009, GUT, V58, P751, DOI 10.1136/gut.2007.144543; Mayer EA, 2001, AM J PHYSIOL-GASTR L, V280, pG519, DOI 10.1152/ajpgi.2001.280.4.G519; McLaughlin JP, 2003, J NEUROSCI, V23, P5674, DOI 10.1523/jneurosci.23-13-05674.2003; Rush AM, 1998, J PHYSIOL-LONDON, V511, P771, DOI 10.1111/j.1469-7793.1998.771bg.x; Schicho R, 2006, GASTROENTEROLOGY, V131, P1542, DOI 10.1053/j.gastro.2006.08.035; Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI [10.1089/ars.2008.2253, 10.1089/ARS.2008.2253]; Stewart T, 2003, J PHYSIOL-LONDON, V552, P797, DOI 10.1113/jphysiol.2003.046409; Streng T, 2008, EUR UROL, V53, P391, DOI 10.1016/j.eururo.2007.10.024; Strickland IT, 2008, EUR J PAIN, V12, P564, DOI 10.1016/j.ejpain.2007.09.001; Tache Y, 2007, J CLIN INVEST, V117, P33, DOI 10.1172/JCI30085; TALLEY NJ, 1994, GASTROENTEROLOGY, V107, P1040, DOI 10.1016/0016-5085(94)90228-3; Tang GH, 2005, MOL PHARMACOL, V68, P1757, DOI 10.1124/mol.105.017467; Tang GH, 2010, CLIN EXP PHARMACOL P, V37, P753, DOI 10.1111/j.1440-1681.2010.05351.x; Trevisani M, 2005, BRIT J PHARMACOL, V145, P1123, DOI 10.1038/sj.bjp.0706277; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; Winston J, 2007, GASTROENTEROLOGY, V132, P615, DOI 10.1053/j.gastro.2006.11.014; Winston JH, 2010, GASTROENTEROLOGY, V138, P294, DOI 10.1053/j.gastro.2009.09.054; Xu GY, 2008, GUT, V57, P1230, DOI 10.1136/gut.2007.134221; Xu GY, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-44; Yonezawa D, 2007, TOXICOLOGY, V241, P11, DOI 10.1016/j.tox.2007.07.020; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008	43	28	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53165	10.1371/journal.pone.0053165	http://dx.doi.org/10.1371/journal.pone.0053165			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285261	Green Published, Green Submitted, gold			2022-12-27	WOS:000313051500113
J	Chan, KH; Lam, KSL; Cheng, OY; Kwan, JSC; Ho, PWL; Cheng, KKY; Chung, SK; Ho, JWM; Guo, VY; Xu, A				Chan, Koon-Ho; Lam, Karen Siu-Ling; Cheng, On-Yin; Kwan, Jason Shing-Cheong; Ho, Philip Wing-Lok; Cheng, Kenneth King-Yip; Chung, Sookja Kim; Ho, Jessica Wing-Man; Guo, Vivian Yawei; Xu, Almin			Adiponectin is Protective against Oxidative Stress Induced Cytotoxicity in Amyloid-Beta Neurotoxicity	PLOS ONE			English	Article							NF-KAPPA-B; ACTIVATED PROTEIN-KINASE; NEUROBLASTOMA SH-SY5Y CELLS; GROWTH-FACTOR EXPRESSION; ALZHEIMERS-DISEASE; NEURODEGENERATIVE DISEASE; METABOLIC SYNDROME; PRECURSOR PROTEIN; GENE-EXPRESSION; MOUSE MODEL	Beta-amyloid (A beta) neurotoxicity is important in Alzheimer's disease (AD) pathogenesis. Ab neurotoxicity causes oxidative stress, inflammation and mitochondrial damage resulting in neuronal degeneration and death. Oxidative stress, inflammation and mitochondrial failure are also pathophysiological mechanisms of type 2 diabetes (T2DM) which is characterized by insulin resistance. Interestingly, T2DM increases risk to develop AD which is associated with reduced neuronal insulin sensitivity (central insulin resistance). We studied the potential protective effect of adiponectin (an adipokine with insulin-sensitizing, anti-inflammatory and anti-oxidant properties) against A beta neurotoxicity in human neuroblastoma cells (SH-SY5Y) transfected with the Swedish amyloid precursor protein (Sw-APP) mutant, which overproduced A beta with abnormal intracellular A beta accumulation. Cytotoxicity was measured by assay for lactate dehydrogenase (LDH) released upon cell death and lysis. Our results revealed that Sw-APP transfected SH-SY5Y cells expressed both adiponectin receptor 1 and 2, and had increased AMP-activated protein kinase (AMPK) activation and enhanced nuclear factor-kappa B (NF-kappa B) activation compared to control empty-vector transfected SH-SY5Y cells. Importantly, adiponectin at physiological concentration of 10 mu g/ml protected Sw-APP transfected SH-SY5Y cells against cytotoxicity under oxidative stress induced by hydrogen peroxide. This neuroprotective action of adiponectin against A beta neurotoxicity-induced cytotoxicity under oxidative stress involved 1) AMPK activation mediated via the endosomal adaptor protein APPL1 (adaptor protein with phosphotyrosine binding, pleckstrin homology domains and leucine zipper motif) and possibly 2) suppression of NF-kappa B activation. This raises the possibility of novel therapies for AD such as adiponectin receptor agonists.	[Chan, Koon-Ho; Lam, Karen Siu-Ling; Cheng, On-Yin; Kwan, Jason Shing-Cheong; Ho, Philip Wing-Lok; Cheng, Kenneth King-Yip; Ho, Jessica Wing-Man; Guo, Vivian Yawei; Xu, Almin] Univ Hong Kong, LKS Fac Med, Univ Dept Med, Hong Kong, Hong Kong, Peoples R China; [Chan, Koon-Ho; Lam, Karen Siu-Ling; Ho, Philip Wing-Lok; Cheng, Kenneth King-Yip; Xu, Almin] Univ Hong Kong, LKS Fac Med, Res Ctr Heart Brain Hormone & Hlth Aging, Hong Kong, Hong Kong, Peoples R China; [Chan, Koon-Ho; Lam, Karen Siu-Ling; Chung, Sookja Kim] Univ Hong Kong, LKS Fac Med, Hong Kong Univ Alzheimers Dis Res Network, Hong Kong, Hong Kong, Peoples R China; [Chan, Koon-Ho; Cheng, On-Yin; Kwan, Jason Shing-Cheong] Univ Hong Kong, LKS Fac Med, Neuroimmunol & Neuroinflammat Res Lab, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong	Chan, KH (corresponding author), Univ Hong Kong, LKS Fac Med, Univ Dept Med, Hong Kong, Hong Kong, Peoples R China.	koonho@hkucc.hku.hk	Guo, Vivian/ABB-5803-2022; Xu, Aimin/D-3291-2013; Ho, Philip Wing-Lok/K-5814-2013; /C-4315-2009	Xu, Aimin/0000-0002-0668-033X; Ho, Philip Wing-Lok/0000-0001-7794-0146; /0000-0003-4665-2576; Guo, Vivian Yawei/0000-0001-9399-1808; Cheng, Kenneth King Yip/0000-0002-7274-0839; /0000-0001-5757-541X	Hong Kong University Alzheimer's Disease Research Network; LKS Faculty of Medicine of the University of Hong Kong	Hong Kong University Alzheimer's Disease Research Network; LKS Faculty of Medicine of the University of Hong Kong	This study is supported by funding from the Hong Kong University Alzheimer's Disease Research Network and Seed Funding for Basic Research from the LKS Faculty of Medicine of the University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzheimer A., 1907, Z GESAMTE NEUROL PSY, V18, P177; ARISPE N, 1993, P NATL ACAD SCI USA, V90, P567, DOI 10.1073/pnas.90.2.567; Boissiere F, 1997, NEUROREPORT, V8, P2849, DOI 10.1097/00001756-199709080-00009; Bonda DJ, 2010, NEUROPHARMACOLOGY, V59, P290, DOI 10.1016/j.neuropharm.2010.04.005; Bossu P, 2008, BRAIN BEHAV IMMUN, V22, P487, DOI 10.1016/j.bbi.2007.10.001; Britschgi M, 2007, NAT MED, V13, P408, DOI 10.1038/nm0407-408; CAI XD, 1993, SCIENCE, V259, P514, DOI 10.1126/science.8424174; Ceddia RB, 2005, DIABETOLOGIA, V48, P132, DOI 10.1007/s00125-004-1609-y; Chandrasekar B, 2008, J BIOL CHEM, V283, P24889, DOI 10.1074/jbc.M804236200; Chen B, 2009, BRAIN RES, V1273, P129, DOI 10.1016/j.brainres.2009.04.002; Cheng KKY, 2007, DIABETES, V56, P1387, DOI 10.2337/db06-1580; Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Craft S, 2004, LANCET NEUROL, V3, P169, DOI 10.1016/S1474-4422(04)00681-7; Crouch PJ, 2005, J NEUROSCI, V25, P672, DOI 10.1523/JNEUROSCI.4276-04.2005; Culmsee C, 2001, J MOL NEUROSCI, V17, P45, DOI 10.1385/JMN:17:1:45; Dasgupta B, 2007, P NATL ACAD SCI USA, V104, P7217, DOI 10.1073/pnas.0610068104; de la Monte SM, 2006, J ALZHEIMERS DIS, V10, P89; de la Monte SM, 2009, BMB REP, V42, P475, DOI 10.5483/BMBRep.2009.42.8.475; Deepa SS, 2009, AM J PHYSIOL-ENDOC M, V296, pE22, DOI 10.1152/ajpendo.90731.2008; Granic I, 2009, J ALZHEIMERS DIS, V16, P809, DOI 10.3233/JAD-2009-0976; Greco SJ, 2010, J ALZHEIMERS DIS, V19, P1155, DOI 10.3233/JAD-2010-1308; Greco SJ, 2009, BIOCHEM BIOPH RES CO, V380, P98, DOI 10.1016/j.bbrc.2009.01.041; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hoyer S, 1994, J Neural Transm Suppl, V44, P259; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Jeon BT, 2009, BRAIN RES REV, V61, P81, DOI 10.1016/j.brainresrev.2009.05.002; Jones A, 2009, J ALZHEIMERS DIS, V16, P787, DOI 10.3233/JAD-2009-0973; Jung TW, 2006, BIOCHEM PHARMACOL, V72, P616, DOI 10.1016/j.bcp.2006.05.013; Jung TW, 2006, BIOCHEM BIOPH RES CO, V343, P564, DOI 10.1016/j.bbrc.2006.02.186; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kaltschmidt B, 1997, P NATL ACAD SCI USA, V94, P2642, DOI 10.1073/pnas.94.6.2642; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lam Karen S L, 2005, Curr Diab Rep, V5, P254, DOI 10.1007/s11892-005-0019-y; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lee YM, 2010, ARCH PHARM RES, V33, P231, DOI 10.1007/s12272-010-0207-4; Lukiw WJ, 1998, J NEUROSCI RES, V53, P583, DOI 10.1002/(SICI)1097-4547(19980901)53:5<583::AID-JNR8>3.3.CO;2-B; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; Marques CA, 2003, J BIOL CHEM, V278, P28294, DOI 10.1074/jbc.M212265200; MARTIN BL, 1995, J BIOL CHEM, V270, P26727, DOI 10.1074/jbc.270.45.26727; McGeer EG, 2010, J ALZHEIMERS DIS, V19, P355, DOI 10.3233/JAD-2010-1219; McGeer PL, 2006, J ALZHEIMERS DIS, V9, P271; Moreira PI, 2009, J ALZHEIMERS DIS, V16, P741, DOI 10.3233/JAD-2009-0972; Mrak RE, 2009, J ALZHEIMERS DIS, V18, P473, DOI 10.3233/JAD-2009-1158; Nunomura A, 2001, J NEUROPATH EXP NEUR, V60, P759, DOI 10.1093/jnen/60.8.759; Oh DK, 2007, DIABETES OBES METAB, V9, P282, DOI 10.1111/j.1463-1326.2006.00610.x; Ojala J, 2007, NEUROBIOL AGING, V30, P198; Ott A, 1999, NEUROLOGY, V53, P1937, DOI 10.1212/WNL.53.9.1937; Pratico D, 2001, J NEUROSCI, V21, P4183, DOI 10.1523/JNEUROSCI.21-12-04183.2001; Pratico D, 2008, TRENDS PHARMACOL SCI, V29, P609, DOI 10.1016/j.tips.2008.09.001; Psilopanagioti A, 2009, NEUROENDOCRINOLOGY, V89, P38, DOI 10.1159/000151396; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Reger MA, 2008, NEUROLOGY, V70, P440, DOI 10.1212/01.WNL.0000265401.62434.36; Rivera EJ, 2005, J ALZHEIMERS DIS, V8, P247; Roselli F, 2005, J NEUROSCI, V25, P11061, DOI 10.1523/JNEUROSCI.3034-05.2005; Schnabel R, 2008, EUR HEART J, V29, P649, DOI 10.1093/eurheartj/ehn009; Selkoe DJ, 2003, ANNU REV PHARMACOL, V43, P545, DOI 10.1146/annurev.pharmtox.43.100901.140248; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Spasic MR, 2009, NEUROSCIENTIST, V15, P309, DOI 10.1177/1073858408327805; Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107; Takeda S, 2010, P NATL ACAD SCI USA, V107, P7036, DOI 10.1073/pnas.1000645107; Terai K, 1996, BRAIN RES, V735, P159; Thornton C, 2011, BIOCHEM J, V434, P503, DOI 10.1042/BJ20101485; Une K, 2011, EUR J NEUROL, V18, P1006, DOI 10.1111/j.1468-1331.2010.03194.x; van Himbergen TM, 2012, ARCH NEUROL-CHICAGO, V69, P594, DOI 10.1001/archneurol.2011.670; Vingtdeux V, 2011, ACTA NEUROPATHOL, V121, P337, DOI 10.1007/s00401-010-0759-x; VITEK MP, 1994, P NATL ACAD SCI USA, V91, P4766, DOI 10.1073/pnas.91.11.4766; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang Y, 2008, BIOCHEM J, V409, P623, DOI 10.1042/BJ20071492; Xu AM, 2004, ENDOCRINOLOGY, V145, P487, DOI 10.1210/en.2003-1140; Yaffe K, 2004, JAMA-J AM MED ASSOC, V292, P2237, DOI 10.1001/jama.292.18.2237; Yaffe K, 2007, J AM GERIATR SOC, V55, P758, DOI 10.1111/j.1532-5415.2007.01139.x; YAN SD, 1995, NAT MED, V1, P693, DOI 10.1038/nm0795-693; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Zhao WQ, 1999, J BIOL CHEM, V274, P34893, DOI 10.1074/jbc.274.49.34893; ZHONG ZY, 1994, J BIOL CHEM, V269, P12179; Zhou L, 2012, BIOCHEM BIOPH RES CO, V423, P697, DOI 10.1016/j.bbrc.2012.06.017	85	98	105	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52354	10.1371/journal.pone.0052354	http://dx.doi.org/10.1371/journal.pone.0052354			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300647	Green Submitted, Green Published, gold			2022-12-27	WOS:000312829100044
J	Tamura, Y; Nakajima, Y; Ozeki, Y; Ono, T; Takei, M; Yamamoto, T; Fukuda, K				Tamura, Yuichi; Nakajima, Yasuo; Ozeki, Yasushi; Ono, Tomohiko; Takei, Makoto; Yamamoto, Tsunehisa; Fukuda, Keiichi			Temperature Variations around Medication Cassette and Carry Bag in Routine Use of Epoprostenol Administration in Healthy Volunteers	PLOS ONE			English	Article							PULMONARY ARTERIAL-HYPERTENSION; PROSTACYCLIN; DIAGNOSIS; THERAPY; TIME	Background: According to several treatment guidelines, epoprostenol is an important treatment option for pulmonary arterial hypertension. However, the pharmacokinetic characteristics and poor stability of epoprostenol at room temperature make its administration challenging. We therefore studied temperature fluctuations between the drug administration cassette and atmosphere to promote the safe use of epoprostenol. Methods and Findings: Five healthy volunteers carried a portable intravenous infusion pump attached to a medication cassette containing saline in a bag during their ordinary activities over 16 days during which the mean atmospheric temperature was 29.6 +/- 1.5 degrees C. The temperature around the medication cassette was not less than 25 degrees C on any occasion, and the mean period over 24 h during which the temperature around the cassette exceeded 35 degrees C and 40 degrees C was 96.9 +/- 156.4 min and 24.4 +/- 77.3 min, respectively. Significant correlations were observed between the temperatures outside the bag and around the cassette, as well as between temperatures around the cassette and of the saline solution in the cassette (r = 0.9258 and 0.8276, respectively). There were no differences in the temperatures outside the bag or around the cassette with respect to the bag material. Conclusions: Temperatures around a medication cassette and outside the bag containing the medication increase with sunlight exposure. The temperature around cassettes used for administering epoprostenol must therefore be kept low for as long as possible during hot summer conditions to maintain the drug stability.	[Tamura, Yuichi; Ono, Tomohiko; Takei, Makoto; Yamamoto, Tsunehisa; Fukuda, Keiichi] Keio Univ, Sch Med, Dept Cardiol, Shinjuku Ku, Tokyo, Japan; [Nakajima, Yasuo; Ozeki, Yasushi] GlaxoSmithKline KK, Dev & Med Affairs Div, Shibuya Ku, Tokyo, Japan	Keio University; GlaxoSmithKline	Tamura, Y (corresponding author), Keio Univ, Sch Med, Dept Cardiol, Shinjuku Ku, Tokyo, Japan.	u1@ta-mu.net	Fukuda, Keiichi/L-3777-2013; Yamamoto, Tsunehisa/O-2014-2013; Tamura, Yuichi/B-5991-2014	Tamura, Yuichi/0000-0002-4437-8019; Yamamoto, Tsunehisa/0000-0002-5241-9482	GlaxoSmithKline KK	GlaxoSmithKline KK(GlaxoSmithKline)	This study was sponsored by GlaxoSmithKline KK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi S, 2010, CIRC J, V74, P2200, DOI 10.1253/circj.CJ-10-0190; Al-Qudah AA, 2007, J DENT, V35, P238, DOI 10.1016/j.jdent.2006.07.012; Barst RJ, 1986, NEW ENGL J MED, V334, P296; Benza RL, 2012, CHEST, V142, P448, DOI 10.1378/chest.11-1460; Flolan [package insert], 2011, FLOL PACK INS; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; Marty W, 2001, AM J FOREN MED PATH, V22, P215, DOI 10.1097/00000433-200109000-00001; RUBIN LJ, 1982, CIRCULATION, V66, P334, DOI 10.1161/01.CIR.66.2.334	8	1	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52216	10.1371/journal.pone.0052216	http://dx.doi.org/10.1371/journal.pone.0052216			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300618	Green Published, gold, Green Submitted			2022-12-27	WOS:000312829100030
J	Miramon, P; Dunker, C; Windecker, H; Bohovych, IM; Brown, AJP; Kurzai, O; Hube, B				Miramon, Pedro; Dunker, Christine; Windecker, Hanna; Bohovych, Iryna M.; Brown, Alistair J. P.; Kurzai, Oliver; Hube, Bernhard			Cellular Responses of Candida albicans to Phagocytosis and the Extracellular Activities of Neutrophils Are Critical to Counteract Carbohydrate Starvation, Oxidative and Nitrosative Stress	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; NITRIC-OXIDE; TRANSCRIPTIONAL RESPONSE; PATHOGEN; GENE; INDUCTION; VIRULENCE; PATHWAYS	Neutrophils are key players during Candida albicans infection. However, the relative contributions of neutrophil activities to fungal clearance and the relative importance of the fungal responses that counteract these activities remain unclear. We studied the contributions of the intra- and extracellular antifungal activities of human neutrophils using diagnostic Green Fluorescent Protein (GFP)-marked C. albicans strains. We found that a carbohydrate starvation response, as indicated by up-regulation of glyoxylate cycle genes, was only induced upon phagocytosis of the fungus. Similarly, the nitrosative stress response was only observed in internalised fungal cells. In contrast, the response to oxidative stress was observed in both phagocytosed and non-phagocytosed fungal cells, indicating that oxidative stress is imposed both intra- and extracellularly. We assessed the contributions of carbohydrate starvation, oxidative and nitrosative stress as antifungal activities by analysing the resistance to neutrophil killing of C. albicans mutants lacking key glyoxylate cycle, oxidative and nitrosative stress genes. We found that the glyoxylate cycle plays a crucial role in fungal resistance against neutrophils. The inability to respond to oxidative stress (in cells lacking superoxide dismutase 5 or glutathione reductase 2) renders C. albicans susceptible to neutrophil killing, due to the accumulation of reactive oxygen species (ROS). We also show that neutrophil-derived nitric oxide is crucial for the killing of C. albicans: a yhb1 Delta/Delta mutant, unable to detoxify NO center dot, was more susceptible to neutrophils, and this phenotype was rescued by the nitric oxide scavenger carboxy-PTIO. The stress responses of C. albicans to neutrophils are partially regulated via the stress regulator Hog1 since a hog1 Delta/Delta mutant was clearly less resistant to neutrophils and unable to respond properly to neutrophil-derived attack. Our data indicate that an appropriate fungal response to all three antifungal activities, carbohydrate starvation, nitrosative stress and oxidative stress, is essential for full wild type resistance to neutrophils.	[Miramon, Pedro; Dunker, Christine; Hube, Bernhard] Hans Knoell Inst, Leibniz Inst Nat Product Res & Infect Biol, Dept Microbial Pathogen Mech, Jena, Germany; [Windecker, Hanna; Kurzai, Oliver] Univ Jena, Sept Res Ctr, Jena, Germany; [Bohovych, Iryna M.; Brown, Alistair J. P.] Univ Aberdeen, Inst Med Sci, Aberdeen Fungal Grp, Aberdeen, Scotland; [Hube, Bernhard] Univ Klinikum Jena, Ctr Sepsis Control & Care, Jena, Germany	Hans Knoll Institute (HKI); Friedrich Schiller University of Jena; University of Aberdeen; Friedrich Schiller University of Jena	Hube, B (corresponding author), Hans Knoell Inst, Leibniz Inst Nat Product Res & Infect Biol, Dept Microbial Pathogen Mech, Jena, Germany.	Bernhard.Hube@hki-jena.de	Brown, Alistair J.P./B-6627-2014	Miramon, Pedro/0000-0002-6867-7697; Kurzai, Oliver/0000-0002-7277-2646; Hube, Bernhard/0000-0002-6028-0425; Brown, Alistair JP/0000-0003-1406-4251	European Commission [PITN-GA-2008-214004, ERC-2009-AdG-249793]; UK Biotechnology and Biological Research Council [BB/F00513X/1]; Wellcome Trust [080088]; BBSRC [BB/F00513X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/B/06679, BB/F00513X/1] Funding Source: researchfish	European Commission(European CommissionEuropean Commission Joint Research Centre); UK Biotechnology and Biological Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The European Commission funded the FINSysB Marie Curie Initial Training Network (PITN-GA-2008-214004). AJPB is also supported by funding from the European Commission (STRIFE, ERC-2009-AdG-249793), the UK Biotechnology and Biological Research Council (BB/F00513X/1), and from the Wellcome Trust (080088). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Monge R, 1999, J BACTERIOL, V181, P3058, DOI 10.1128/JB.181.10.3058-3068.1999; Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; Arana DM, 2007, CELL MICROBIOL, V9, P1647, DOI 10.1111/j.1462-5822.2007.00898.x; Barelle CJ, 2006, CELL MICROBIOL, V8, P961, DOI 10.1111/j.1462-5822.2005.00676.x; Barelle CJ, 2004, YEAST, V21, P333, DOI 10.1002/yea.1099; BELLAMY W, 1993, MED MICROBIOL IMMUN, V182, P97, DOI 10.1007/BF00189377; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Calderone RA, 2001, TRENDS MICROBIOL, V9, P327, DOI 10.1016/S0966-842X(01)02094-7; Cederlund A, 2010, J INNATE IMMUN, V2, P508, DOI 10.1159/000317665; Chaves GM, 2007, GENET MOL RES, V6, P1051; Cheetham J, 2011, J BIOL CHEM, V286, P42002, DOI 10.1074/jbc.M111.265231; Cheng SC, 2011, J LEUKOCYTE BIOL, V90, P357, DOI 10.1189/jlb.1210702; Chiranand W, 2008, EUKARYOT CELL, V7, P268, DOI 10.1128/EC.00240-07; Dantas AD, 2010, MOL CELL BIOL, V30, P4550, DOI 10.1128/MCB.00313-10; de Jesus-Berrios M, 2003, CURR BIOL, V13, P1963, DOI 10.1016/j.cub.2003.10.029; Enjalbert B, 2006, MOL BIOL CELL, V17, P1018, DOI 10.1091/mbc.E05-06-0501; Enjalbert B, 2007, INFECT IMMUN, V75, P2143, DOI 10.1128/IAI.01680-06; Fang FC, 2004, NAT REV MICROBIOL, V2, P820, DOI 10.1038/nrmicro1004; Fradin C, 2005, MOL MICROBIOL, V56, P397, DOI 10.1111/j.1365-2958.2005.04557.x; Frohner IE, 2009, MOL MICROBIOL, V71, P240, DOI 10.1111/j.1365-2958.2008.06528.x; Heilmann CJ, 2011, MICROBIOL-SGM, V157, P2297, DOI 10.1099/mic.0.049395-0; Hromatka BS, 2005, MOL BIOL CELL, V16, P4814, DOI 10.1091/mbc.E05-05-0435; Hube B, 2004, CURR OPIN MICROBIOL, V7, P336, DOI 10.1016/j.mib.2004.06.003; Hube B, 2009, CURR OPIN MICROBIOL, V12, P347, DOI 10.1016/j.mib.2009.06.009; Jacobsen ID, 2012, EXPERT REV ANTI-INFE, V10, P85, DOI [10.1586/eri.11.152, 10.1586/ERI.11.152]; Kaloriti D, 2012, MED MYCOL; LEHRER RI, 1990, BLOOD, V76, P2169; Lorenz MC, 2004, EUKARYOT CELL, V3, P1076, DOI 10.1128/EC.3.5.1076-1087.2004; Lorenz MC, 2001, NATURE, V412, P83, DOI 10.1038/35083594; Martchenko M, 2004, MOL BIOL CELL, V15, P456, DOI 10.1091/mbc.E03-03-0179; Moyes DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026580; Moyes DL, 2010, CELL HOST MICROBE, V8, P225, DOI 10.1016/j.chom.2010.08.002; Netea MG, 2008, NAT REV MICROBIOL, V6, P67, DOI 10.1038/nrmicro1815; Nordenfelt P, 2011, J LEUKOCYTE BIOL, V90, P271, DOI 10.1189/jlb.0810457; Odds FC., 1988, CANDIDA CANDIDOSIS; Pathania R, 2002, MOL MICROBIOL, V45, P1303, DOI 10.1046/j.1365-2958.2002.03095.x; Rubin-Bejerano I, 2003, P NATL ACAD SCI USA, V100, P11007, DOI 10.1073/pnas.1834481100; Smith DA, 2004, MOL BIOL CELL, V15, P4179, DOI 10.1091/mbc.E04-03-0181; Stevanin TM, 2007, GENE, V398, P62, DOI 10.1016/j.gene.2007.03.021; Stevanin TM, 2002, INFECT IMMUN, V70, P4399, DOI 10.1128/IAI.70.8.4399-4405.2002; Ullmann BD, 2004, EUKARYOT CELL, V3, P715, DOI 10.1128/EC.3.3.715-723.2004; Wheeler MA, 1997, J CLIN INVEST, V99, P110, DOI 10.1172/JCI119121; Wilson D, 2009, FEMS YEAST RES, V9, P688, DOI 10.1111/j.1567-1364.2009.00524.x; Wozniok I, 2008, CELL MICROBIOL, V10, P807, DOI 10.1111/j.1462-5822.2007.01086.x; Wysong DR, 1998, INFECT IMMUN, V66, P1953, DOI 10.1128/IAI.66.5.1953-1961.1998; Youseff BH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002713	46	80	90	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52850	10.1371/journal.pone.0052850	http://dx.doi.org/10.1371/journal.pone.0052850			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285201	Green Published, gold			2022-12-27	WOS:000313158800101
J	Pany, S; Majhi, A; Das, J				Pany, Satyabrata; Majhi, Anjoy; Das, Joydip			PKC Activation by Resveratrol Derivatives with Unsaturated Aliphatic Chain	PLOS ONE			English	Article							PROTEIN-KINASE-C; ALCOHOL-BINDING-SITE; FATTY-ACIDS; PLATELET-AGGREGATION; MOLECULAR-BASIS; LINOLEIC-ACID; RED WINE; IN-VITRO; APOPTOSIS; ALPHA	Resveratrol (1) is a naturally occurring phytoalexin that affects a variety of human disease models, including cardio- and neuroprotection, immune regulation, and cancer chemoprevention. One of the possible mechanisms by which resveratrol affects these disease states is by affecting the cellular signaling network involving protein kinase C (PKC). PKC is the family of serine/threonine kinases, whose activity is inhibited by resveratrol. To develop PKC isotype selective molecules on the resveratrol scaffold, several analogs (2-5) of resveratrol with a long aliphatic chain varying with number of unsaturated doubled bonds have been synthesized, their cytotoxic effects on CHO-K1 cells are measured and their effects on the membrane translocation properties of PKC alpha and PKC epsilon have been determined. The analogs showed less cytotoxic effects on CHO-K1 cells. Analog 4 with three unsaturated double bonds in its aliphatic chain activated PKC alpha, but not PKC epsilon. Analog 4 also activated ERK1/2, the downstream proteins in the PKC signaling pathway. Resveratrol analogs 2-5, however, did not show any inhibition of the phorbol ester-induced membrane translocation for either PKC alpha or PKC epsilon. Molecular docking of 4 into the activator binding site of PKC alpha revealed that the resveratrol moiety formed hydrogen bonds with the activator binding residues and the aliphatic chain capped the activator binding loops making its surface hydrophobic to facilitate its interaction with the plasma membrane. The present study shows that subtle changes in the resveratrol structure can have profound impact on the translocation properties of PKCs. Therefore, resveratrol scaffold can be used to develop PKC selective modulators for regulating associated disease states.	[Pany, Satyabrata; Majhi, Anjoy; Das, Joydip] Univ Houston, Coll Pharm, Dept Pharmacol & Pharmaceut Sci, Houston, TX 77030 USA	University of Houston System; University of Houston	Das, J (corresponding author), Univ Houston, Coll Pharm, Dept Pharmacol & Pharmaceut Sci, Houston, TX 77030 USA.	jdas@uh.edu		MAJHI, ANJOY/0000-0003-0142-4940				Aires V, 2007, MOL PHARMACOL, V72, P1545, DOI 10.1124/mol.107.039792; Alkon DL, 2007, TRENDS PHARMACOL SCI, V28, P51, DOI 10.1016/j.tips.2006.12.002; Ananthanarayanan B, 2003, J BIOL CHEM, V278, P46886, DOI 10.1074/jbc.M307853200; Atten MJ, 2005, INVEST NEW DRUG, V23, P111, DOI 10.1007/s10637-005-5855-8; Babich H, 2000, TOXICOL LETT, V114, P143, DOI 10.1016/S0378-4274(99)00288-X; Banci L, 2002, J BIOL CHEM, V277, P12988, DOI 10.1074/jbc.M106875200; Battaini F, 2007, PHARMACOL RES, V55, P461, DOI 10.1016/j.phrs.2007.05.005; Belguendouz L, 1997, BIOCHEM PHARMACOL, V53, P1347, DOI 10.1016/S0006-2952(96)00820-9; Braz JC, 2004, NAT MED, V10, P248, DOI 10.1038/nm1000; Bright R, 2005, STROKE, V36, P2781, DOI 10.1161/01.STR.0000189996.71237.f7; Chen CK, 1996, GEN PHARMACOL-VASC S, V27, P363; Chou WH, 2005, TRENDS CARDIOVAS MED, V15, P47, DOI 10.1016/j.tcm.2005.01.003; Das Evcimen N, 2007, PHARMACOL RES, V55, P498, DOI 10.1016/j.phrs.2007.04.016; Das J, 2004, J BIOL CHEM, V279, P37964, DOI 10.1074/jbc.M405137200; Das J, 2006, PROTEIN SCI, V15, P2107, DOI 10.1110/ps.062237606; Das J, 2011, BIOORGAN MED CHEM, V19, P5321, DOI 10.1016/j.bmc.2011.08.008; Das J, 2009, BIOCHEM J, V421, P405, DOI 10.1042/BJ20082271; Endo Y, 2000, BIOORG MED CHEM LETT, V10, P63, DOI 10.1016/S0960-894X(99)00580-6; Ferrero ME, 1998, AM J CLIN NUTR, V68, P1208, DOI 10.1093/ajcn/68.6.1208; Fremont L, 2000, LIFE SCI, V66, P663, DOI 10.1016/S0024-3205(99)00410-5; Geczy T, 2012, J BIOL CHEM, V287, P13137, DOI 10.1074/jbc.M111.320010; Gehm BD, 1997, P NATL ACAD SCI USA, V94, P14138, DOI 10.1073/pnas.94.25.14138; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Gupta SC, 2011, ANN NY ACAD SCI, V1215, P150, DOI 10.1111/j.1749-6632.2010.05852.x; Gusman J, 2001, CARCINOGENESIS, V22, P1111, DOI 10.1093/carcin/22.8.1111; Hofmann J, 2004, CURR CANCER DRUG TAR, V4, P125, DOI 10.2174/1568009043481579; Hsieh TC, 1999, EXP CELL RES, V249, P109, DOI 10.1006/excr.1999.4471; Irie K, 1998, J AM CHEM SOC, V120, P9159, DOI 10.1021/ja981087f; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Joe AK, 2002, CLIN CANCER RES, V8, P893; Kanno T, 2006, J LIPID RES, V47, P1146, DOI 10.1194/jlr.M500329-JLR200; Kim HFS, 2001, MOL PSYCHIATR, V6, P246, DOI 10.1038/sj.mp.4000837; KIMURA Y, 1985, BIOCHIM BIOPHYS ACTA, V834, P275; Koivunen J, 2006, CANCER LETT, V235, P1, DOI 10.1016/j.canlet.2005.03.033; Konopatskaya O, 2010, TRENDS PHARMACOL SCI, V31, P8, DOI 10.1016/j.tips.2009.10.006; Kuo PL, 2002, LIFE SCI, V72, P23, DOI 10.1016/S0024-3205(02)02177-X; Liu QH, 2011, J MOL CELL CARDIOL, V51, P474, DOI 10.1016/j.yjmcc.2010.10.004; Maccarrone M, 1999, EUR J BIOCHEM, V265, P27, DOI 10.1046/j.1432-1327.1999.00630.x; Majhi A, 2010, BIOORGAN MED CHEM, V18, P1591, DOI 10.1016/j.bmc.2009.12.075; Mgbonyebi OP, 1998, INT J ONCOL, V12, P865; Morris GZ, 2002, PROSTATE, V52, P319, DOI 10.1002/pros.10122; MURAKAMI K, 1986, J BIOL CHEM, V261, P5424; Nakashima S, 2002, J BIOCHEM, V132, P669, DOI 10.1093/oxfordjournals.jbchem.a003272; Nelson TJ, 2009, J BIOL CHEM, V284, P34514, DOI 10.1074/jbc.M109.016683; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; PACEASCIAK CR, 1995, CLIN CHIM ACTA, V235, P207, DOI 10.1016/0009-8981(95)06045-1; PaceAsciak CR, 1996, CLIN CHIM ACTA, V246, P163, DOI 10.1016/0009-8981(96)06236-5; Patel KR, 2011, ANN NY ACAD SCI, V1215, P161, DOI 10.1111/j.1749-6632.2010.05853.x; Pervaiz S, 2003, FASEB J, V17, P1975, DOI 10.1096/fj.03-0168rev; Pervaiz S, 2009, ANTIOXID REDOX SIGN, V11, P2851, DOI [10.1089/ars.2008.2412, 10.1089/ARS.2008.2412]; Petrovski G, 2011, ANN NY ACAD SCI, V1215, P22, DOI 10.1111/j.1749-6632.2010.05843.x; Pi YQ, 2000, AM J PHYSIOL-HEART C, V279, pH26, DOI 10.1152/ajpheart.2000.279.1.H26; Pirola L, 2008, IUBMB LIFE, V60, P323, DOI 10.1002/iub.47; Prades J, 2003, J LIPID RES, V44, P1720, DOI 10.1194/jlr.M300092-JLR200; Ratan HL, 2002, UROL ONCOL, V7, P223, DOI 10.1016/S1078-1439(02)00194-1; Rawicz W, 2000, BIOPHYS J, V79, P328, DOI 10.1016/S0006-3495(00)76295-3; Richard T, 2011, ANN NY ACAD SCI, V1215, P103, DOI 10.1111/j.1749-6632.2010.05865.x; Sabri A, 2003, MOL CELL BIOCHEM, V251, P97, DOI 10.1023/A:1025490017780; Schneider Y, 2000, CANCER LETT, V158, P85, DOI 10.1016/S0304-3835(00)00511-5; Schwedhelm E, 2003, CLIN PHARMACOKINET, V42, P437, DOI 10.2165/00003088-200342050-00003; SHINOMURA T, 1991, P NATL ACAD SCI USA, V88, P5149, DOI 10.1073/pnas.88.12.5149; Shirai Y, 1998, J CELL BIOL, V143, P511, DOI 10.1083/jcb.143.2.511; Shukla Y, 2011, ANN NY ACAD SCI, V1215, P1, DOI 10.1111/j.1749-6632.2010.05870.x; Slater SJ, 2003, BBA-MOL BASIS DIS, V1637, P59, DOI 10.1016/S0925-4439(02)00214-4; Sodeoka M, 1998, J AM CHEM SOC, V120, P457, DOI 10.1021/ja971270t; Stahelin RV, 2005, J BIOL CHEM, V280, P19784, DOI 10.1074/jbc.M411285200; Stewart JR, 1999, BIOCHEMISTRY-US, V38, P13244, DOI 10.1021/bi990875u; Stewart JR, 2004, INVEST NEW DRUG, V22, P107, DOI 10.1023/B:DRUG.0000011787.75522.ec; Subbaramaiah K, 1998, J BIOL CHEM, V273, P21875, DOI 10.1074/jbc.273.34.21875; Surh YJ, 1999, CANCER LETT, V140, P1, DOI 10.1016/S0304-3835(99)00039-7; Szekeres T, 2011, ANN NY ACAD SCI, V1215, P89, DOI 10.1111/j.1749-6632.2010.05864.x; Teicher BA, 2006, CLIN CANCER RES, V12, P5336, DOI 10.1158/1078-0432.CCR-06-0945; Wada R, 2002, J AM CHEM SOC, V124, P10658, DOI 10.1021/ja027048s; Wang Y, 2002, J AGR FOOD CHEM, V50, P431, DOI 10.1021/jf010812u; WOOTEN MW, 1988, BIOCHEM BIOPH RES CO, V153, P67, DOI 10.1016/S0006-291X(88)81190-2; Wu JM, 2011, ANN NY ACAD SCI, V1215, P16, DOI 10.1111/j.1749-6632.2010.05854.x; Yaguchi T, 2005, MOL BRAIN RES, V133, P320, DOI 10.1016/j.molbrainres.2004.10.031; Yamatsugu K, 2006, CHEM-ASIAN J, V1, P314, DOI 10.1002/asia.200600185; Yang YM, 2008, AM J CHINESE MED, V36, P603, DOI 10.1142/S0192415X08006016	80	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52888	10.1371/journal.pone.0052888	http://dx.doi.org/10.1371/journal.pone.0052888			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285216	Green Published, gold, Green Submitted			2022-12-27	WOS:000313158800105
J	Sachse, D; Sletner, L; Morkrid, K; Jenum, AK; Birkeland, KI; Rise, F; Piehler, AP; Berg, JP				Sachse, Daniel; Sletner, Line; Morkrid, Kjersti; Jenum, Anne Karen; Birkeland, Kare I.; Rise, Frode; Piehler, Armin P.; Berg, Jens Petter			Metabolic Changes in Urine during and after Pregnancy in a Large, Multiethnic Population-Based Cohort Study of Gestational Diabetes	PLOS ONE			English	Article							NMR-BASED METABONOMICS; ANALYTICAL REPRODUCIBILITY; MAGNETIC-RESONANCE; MATERNAL URINE; INBORN-ERRORS; BLOOD-PLASMA; OUTCOME HAPO; SPECTROSCOPY; PREECLAMPSIA; BIOMARKERS	This study aims to identify novel markers for gestational diabetes (GDM) in the biochemical profile of maternal urine using NMR metabolomics. It also catalogs the general effects of pregnancy and delivery on the urine profile. Urine samples were collected at three time points (visit V1: gestational week 8-20; V2: week 28 +/- 62; V3: 10-16 weeks post partum) from participants in the STORK Groruddalen program, a prospective, multiethnic cohort study of 823 healthy, pregnant women in Oslo, Norway, and analyzed using H-1-NMR spectroscopy. Metabolites were identified and quantified where possible. PCA, PLS-DA and univariate statistics were applied and found substantial differences between the time points, dominated by a steady increase of urinary lactose concentrations, and an increase during pregnancy and subsequent dramatic reduction of several unidentified NMR signals between 0.5 and 1.1 ppm. Multivariate methods could not reliably identify GDM cases based on the WHO or graded criteria based on IADPSG definitions, indicating that the pattern of urinary metabolites above micromolar concentrations is not influenced strongly and consistently enough by the disease. However, univariate analysis suggests elevated mean citrate concentrations with increasing hyperglycemia. Multivariate classification with respect to ethnic background produced weak but statistically significant models. These results suggest that although NMR-based metabolomics can monitor changes in the urinary excretion profile of pregnant women, it may not be a prudent choice for the study of GDM.	[Sachse, Daniel; Berg, Jens Petter] Univ Oslo, Dept Med Biochem, Oslo, Norway; [Sachse, Daniel; Piehler, Armin P.; Berg, Jens Petter] Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway; [Sachse, Daniel; Rise, Frode] Univ Oslo, Dept Chem, Oslo, Norway; [Sletner, Line; Morkrid, Kjersti; Birkeland, Kare I.] Oslo Univ Hosp, Dept Endocrinol Morbid Obes & Prevent Med, Oslo, Norway; [Sletner, Line] Akershus Univ Hosp, Dept Child & Adolescents Med, Lorenskog, Norway; [Sletner, Line; Morkrid, Kjersti; Birkeland, Kare I.] Univ Oslo, Dept Endocrinol Morbid Obes & Prevent Med, Oslo, Norway; [Jenum, Anne Karen] Univ Oslo, Dept Gen Practice, Oslo, Norway; [Jenum, Anne Karen] Oslo & Akershus Univ, Coll Appl Sci, Oslo, Norway; [Piehler, Armin P.] Furst Med Lab, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; Oslo Metropolitan University (OsloMet)	Sachse, D (corresponding author), Univ Oslo, Dept Med Biochem, Oslo, Norway.	daniel.sachse@medisin.uio.no	Berg, Jens P/G-1455-2012; Birkeland, Kåre I/E-9750-2010	Berg, Jens P/0000-0003-0157-5888; Sachse, Daniel/0000-0002-3121-1236; Rise, Frode/0000-0002-7871-3962	University of Oslo; Oslo Diabetes Research Centre	University of Oslo; Oslo Diabetes Research Centre	The study was supported by grants from the University of Oslo and the Oslo Diabetes Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; [Anonymous], 2010, R LANG ENV STAT COMP; Ashwood ER, 2006, TIETZ TXB CLIN CHEM, P2153; Banfi D, 2008, CHIMIA, V62, P280, DOI 10.2533/chimia.2008.280; Barkauskas DA, 2009, FTICRMS PROGR AN FOU; Barkauskas DA, 2010, ANAL CHIM ACTA, V657, P191, DOI 10.1016/j.aca.2009.10.043; Beaglehole R, 2012, LANCET, V379, P1873, DOI 10.1016/S0140-6736(12)60800-9; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; BELL JD, 1988, CHEM BRIT, V24, P1021; Buchanan TA, 2012, NAT REV ENDOCRINOL, V8, P639, DOI 10.1038/nrendo.2012.96; Carraro S, 2007, AM J RESP CRIT CARE, V175, P986, DOI 10.1164/rccm.200606-769OC; Castillo AM, 2011, J MAGN RESON, V209, P123, DOI 10.1016/j.jmr.2010.12.008; Constantinou MA, 2005, ANAL CHIM ACTA, V542, P169, DOI 10.1016/j.aca.2005.03.059; Contreras M, 2002, INT J GYNECOL OBSTET, V78, P69; Cox DB, 1999, EXP PHYSIOL, V84, P421, DOI 10.1017/S0958067099018072; Crowther CA, 2005, NEW ENGL J MED, V352, P2477, DOI 10.1056/NEJMoa042973; DATE JW, 1964, SCAND J CLIN LAB INV, V16, P589, DOI 10.3109/00365516409055221; Diaz SO, 2011, J PROTEOME RES, V10, P3732, DOI 10.1021/pr200352m; Dumas ME, 2006, ANAL CHEM, V78, P2199, DOI 10.1021/ac0517085; Dunn WB, 2011, BIOANALYSIS, V3, P2205, DOI [10.4155/BIO.11.223, 10.4155/bio.11.223]; Eaton J.W., 2002, GNU OCTAVE MANUAL; Ferrara A, 2007, DIABETES CARE, V30, pS141, DOI 10.2337/dc07-s206; Gallery EDM, 1996, HYPERTENS PREGNANCY, V15, P257, DOI 10.3109/10641959609015709; Graca G, 2012, MOL BIOSYST, V8, P1243, DOI 10.1039/c2mb05424h; Hadden DR, 2009, SEMIN FETAL NEONAT M, V14, P66, DOI 10.1016/j.siny.2008.09.004; HAMMAR ML, 1987, SCAND J UROL NEPHROL, V21, P51, DOI 10.3109/00365598709180291; Holmes E, 1997, J PHARMACEUT BIOMED, V15, P1647, DOI 10.1016/S0731-7085(97)00066-6; Holmes E, 2011, TRENDS MICROBIOL, V19, P349, DOI 10.1016/j.tim.2011.05.006; Horgan RP, 2009, BJOG-INT J OBSTET GY, V116, P173, DOI 10.1111/j.1471-0528.2008.01997.x; Horgan RP, 2011, J PROTEOME RES, V10, P3660, DOI 10.1021/pr2002897; International Diabetes Federation, 2011, IDF DIAB ATL; Ishikawa H, 1999, J LIPID RES, V40, P1920; Jenum AK, 2012, EUR J ENDOCRINOL, V166, P317, DOI 10.1530/EJE-11-0866; Jenum AK, 2010, SCAND J PUBLIC HEALT, V38, P60, DOI 10.1177/1403494810378921; Kenny LC, 2008, REPROD SCI, V15, P591, DOI 10.1177/1933719108316908; Kenny LC, 2010, HYPERTENSION, V56, P741, DOI 10.1161/HYPERTENSIONAHA.110.157297; Keun HC, 2002, CHEM RES TOXICOL, V15, P1380, DOI 10.1021/tx0255774; Kim C, 2002, DIABETES CARE, V25, P1862, DOI 10.2337/diacare.25.10.1862; Lain KY, 2007, CLIN OBSTET GYNECOL, V50, P938, DOI 10.1097/GRF.0b013e31815a5494; Lind T, 1980, ADV CLIN CHEM, P1; Maher AD, 2007, ANAL CHEM, V79, P5204, DOI 10.1021/ac070212f; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; Metzger BE, 2009, DIABETES, V58, P453, DOI 10.2337/db08-1112; Mevik B.H., 2011, PLS PARTIAL LEAST SQ; Morkrid K, 2012, EUR J ENDOCRINOL, V167, P579, DOI 10.1530/EJE-12-0452; Naismith DJ, 2003, ENCY FOOD SCI NUTR, P4723, DOI DOI 10.1016/B0-12-227055-X/00961-5; Nicholson G, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.57; Nicholson JK, 2008, NATURE, V455, P1054, DOI 10.1038/4551054a; NICHOLSON JK, 1995, ANAL CHEM, V67, P793, DOI 10.1021/ac00101a004; PETRARULO M, 1995, CLIN CHEM, V41, P1518; Psihogios NG, 2008, NMR BIOMED, V21, P195, DOI 10.1002/nbm.1176; Ratner RE, 2008, J CLIN ENDOCR METAB, V93, P4774, DOI 10.1210/jc.2008-0772; Reynolds WF, 2002, J NAT PROD, V65, P221, DOI 10.1021/np010444o; Risberg A, 2004, SCAND J CLIN LAB INV, V64, P17, DOI 10.1080/00365510410003714; Salek RM, 2007, PHYSIOL GENOMICS, V29, P99, DOI 10.1152/physiolgenomics.00194.2006; Saude EJ, 2007, METABOLOMICS, V3, P439, DOI 10.1007/s11306-007-0091-1; Schlotterbeck G, 2006, PHARMACOGENOMICS, V7, P1055, DOI 10.2217/14622416.7.7.1055; Spratlin JL, 2009, CLIN CANCER RES, V15, P431, DOI 10.1158/1078-0432.CCR-08-1059; Stacklies W, 2007, BIOINFORMATICS, V23, P1164, DOI 10.1093/bioinformatics/btm069; Trump S, 2006, MAGN RESON MATER PHY, V19, P305, DOI 10.1007/s10334-006-0058-7; Turner E, 2007, HYPERTENS PREGNANCY, V26, P329, DOI 10.1080/10641950701436073; Westerhuis JA, 2008, METABOLOMICS, V4, P81, DOI 10.1007/s11306-007-0099-6; Wishart DS, 2009, BIOANALYSIS, V1, P1579, DOI 10.4155/BIO.09.138; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Zhang XY, 2009, J PROTEOME RES, V8, P5188, DOI 10.1021/pr900524z; Zhao XJ, 2010, METABOLOMICS, V6, P362, DOI 10.1007/s11306-010-0203-1	67	59	60	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52399	10.1371/journal.pone.0052399	http://dx.doi.org/10.1371/journal.pone.0052399			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285025	Green Published, gold, Green Submitted			2022-12-27	WOS:000313158800063
J	Baitaluk, M; Kozhenkov, S; Ponomarenko, J				Baitaluk, Michael; Kozhenkov, Sergey; Ponomarenko, Julia			An Integrative Approach to Inferring Gene Regulatory Module Networks	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; SYSTEMS-BIOLOGY; EXPRESSION DATA; DNA-BINDING; GENOME; DATABASE; BIOLOGICALNETWORKS; PLURIPOTENCY; ASTHMA; MOUSE	Background: Gene regulatory networks (GRNs) provide insight into the mechanisms of differential gene expression at a system level. However, the methods for inference, functional analysis and visualization of gene regulatory modules and GRNs require the user to collect heterogeneous data from many sources using numerous bioinformatics tools. This makes the analysis expensive and time-consuming. Results: In this work, the BiologicalNetworks application-the data integration and network based research environment-was extended with tools for inference and analysis of gene regulatory modules and networks. The backend database of the application integrates public data on gene expression, pathways, transcription factor binding sites, gene and protein sequences, and functional annotations. Thus, all data essential for the gene regulation analysis can be mined publicly. In addition, the user's data can either be integrated in the database and become public, or kept private within the application. The capabilities to analyze multiple gene expression experiments are also provided. Conclusion: The generated modular networks, regulatory modules and binding sites can be visualized and further analyzed within this same application. The developed tools were applied to the mouse model of asthma and the OCT4 regulatory network in embryonic stem cells. Developed methods and data are available through the Java application from BiologicalNetworks program at http://www.biologicalnetworks.org. Citation: Baitaluk M, Kozhenkov S, Ponomarenko J (2012) An Integrative Approach to Inferring Gene Regulatory Module Networks. PLoS ONE 7(12): e52836. doi:10.1371/journal.pone.0052836	[Baitaluk, Michael; Kozhenkov, Sergey; Ponomarenko, Julia] Univ Calif San Diego, San Diego Supercomp Ctr, La Jolla, CA 92093 USA; [Ponomarenko, Julia] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Ponomarenko, J (corresponding author), Univ Calif San Diego, San Diego Supercomp Ctr, La Jolla, CA 92093 USA.	jpon@sdsc.edu	Gallardo, Julie/H-8878-2013; Ponomarenko, Julia/K-8105-2015	Ponomarenko, Julia/0000-0002-1477-9444	National Institute of Health [R01GM084881, R01GM085325]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084881, R01GM085325] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of Health grants R01GM084881 to MB, and R01GM085325 to JP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r139; Baitaluk M, 2006, NUCLEIC ACIDS RES, V34, pW466, DOI 10.1093/nar/gkl308; Baitaluk M, 2010, BIOINFORMATICS, V26, P1651, DOI 10.1093/bioinformatics/btq231; Bar-Joseph Z, 2003, NAT BIOTECHNOL, V21, P1337, DOI 10.1038/nbt890; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Bonneau R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r36; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Cochrane GR, 2010, NUCLEIC ACIDS RES, V38, pD1, DOI 10.1093/nar/gkp1077; D'haeseleer P, 2000, BIOINFORMATICS, V16, P707, DOI 10.1093/bioinformatics/16.8.707; De Smet R, 2010, NAT REV MICROBIOL, V8, P717, DOI 10.1038/nrmicro2419; Fisher R. A., 1921, METRON             4, V1, P3, DOI DOI 10.1093/BIOMET/9.1-2.22; Garcia E, 2011, METAANALYSIS INFOR 1; Griffith OL, 2008, NUCLEIC ACIDS RES, V36, pD107, DOI 10.1093/nar/gkm967; Huttenhower C, 2009, BIOINFORMATICS, V25, P3267, DOI 10.1093/bioinformatics/btp588; Ihmels J, 2002, NAT GENET, V31, P370, DOI 10.1038/ng941; Jegga AG, 2007, NUCLEIC ACIDS RES, V35, pD116, DOI 10.1093/nar/gkl1011; Joshi A, 2009, BIOINFORMATICS, V25, P490, DOI 10.1093/bioinformatics/btn658; Jung M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010709; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kozhenkov S, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-7; Kozhenkov S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-610; Lemmens K, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r27; Liu A, TEASE TREE EASE METH; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Loots G, 2007, BIOINFORMATICS, V23, P122, DOI 10.1093/bioinformatics/btl546; Matoba R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000026; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; McCord RP, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100140; Melen E, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-86; Ng HH, 2011, NAT CELL BIOL, V13, P490, DOI 10.1038/ncb0511-490; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Novershtern N, 2011, BIOINFORMATICS, V27, pI177, DOI 10.1093/bioinformatics/btr222; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Noverstern N, 2008, AM J RESP CELL MOL, V38, P324, DOI 10.1165/rcmb.2007-0151OC; Parkinson H, 2011, NUCLEIC ACIDS RES, V39, pD1002, DOI 10.1093/nar/gkq1040; Pattaro C, 2006, ALLERGY, V61, P239, DOI 10.1111/j.1398-9995.2006.00988.x; Pilpel Y, 2001, NAT GENET, V29, P153, DOI 10.1038/ng724; Romero P, 2005, GENOME BIOL, V6; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; SCHOLER HR, 1989, EMBO J, V8, P2551, DOI 10.1002/j.1460-2075.1989.tb08393.x; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Segal E, 2008, NATURE, V451, P535, DOI 10.1038/nature06496; Sharov AA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-269; Walker E, 2007, CELL STEM CELL, V1, P71, DOI 10.1016/j.stem.2007.04.002; Wilczynski B, 2010, DEV BIOL, V340, P161, DOI 10.1016/j.ydbio.2009.10.032; Zhu C, 2009, GENOME RES, V19, P556, DOI 10.1101/gr.090233.108; Zwir I, 2005, BIOINFORMATICS, V21, P4073, DOI 10.1093/bioinformatics/bti672	49	4	4	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52836	10.1371/journal.pone.0052836	http://dx.doi.org/10.1371/journal.pone.0052836			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285197	Green Published, gold			2022-12-27	WOS:000312794500250
J	Eba, H; Murasawa, Y; Iohara, K; Isogai, Z; Nakamura, H; Nakamura, H; Nakashima, M				Eba, Hisanori; Murasawa, Yusuke; Iohara, Koichiro; Isogai, Zenzo; Nakamura, Hiroshi; Nakamura, Hiroyuki; Nakashima, Misako			The Anti-Inflammatory Effects of Matrix Metalloproteinase-3 on Irreversible Pulpitis of Mature Erupted Teeth	PLOS ONE			English	Article							ALPHA-TRYPSIN INHIBITOR; HYALURONAN; CELLS; MICROLEAKAGE; ACTIVATION; COMPLEX; PROTEIN; CANCER; TH1	Matrix metalloproteinases (MMPs) are involved in extracellular matrix degradation and the modulation of cell behavior. These proteinases have also been implicated in tissue repair and regeneration. Our previous studies have demonstrated that MMP-3 elicits stimulatory effects on the proliferation and the migration of endothelial cells as well as anti-apoptotic effects on these cells in vitro. In addition, we found that MMP-3 enhanced the regeneration of lost pulp tissue in a rat incisor pulp injury model. However, continuously erupting rodent incisors exhibit significantly different pulp organization compared with mature erupted teeth. Therefore, we have further extended these studies using a canine irreversible pulpitis model to investigate the effects of MMP-3. In this study, the crowns of the canine mature premolars were removed and the pulp tissues were amputated. The amputated pulp tissues remained exposed for 24 or 72 hours to induce mild or severe irreversible pulpitis, respectively, followed by sealing of the cavities. In both models, the whole pulp tissues became necrotic by day 14. In this mild pulpitis model, the regeneration of pulp tissue with vasculature and nerves was observed until 14 days after sealing with MMP-3, followed by extracellular matrix formation in the regenerated pulp tissues until day 28. The treatment with MMP-3 resulted in a decrease in the number of macrophage and antigen-presenting cells and a significant inhibition of IL-6 expression on day 3. The inhibition of MMP-3 activity abolished these anti-inflammatory effects. Immunofluorescence staining demonstrated that MMP-3 was involved in the modification of serum-derived hyaluronan-associated proteins and hyaluronan (SHAP-HA) complexes possibly through the degradation of versican. These results demonstrate that MMP-3 can act as an anti-inflammatory agent and suggest that MMP-3 might represent a useful therapy for the treatment of mild irreversible pulpitis.	[Eba, Hisanori; Iohara, Koichiro; Nakamura, Hiroyuki; Nakashima, Misako] Natl Ctr Geriatr & Gerontol, Ctr Adv Med Dent & Oral Dis, Dept Dent Regenerat Med, Obu, Aichi, Japan; [Murasawa, Yusuke; Isogai, Zenzo] Natl Ctr Geriatr & Gerontol, Dept Adv Med, Obu, Aichi, Japan; [Eba, Hisanori; Nakamura, Hiroshi] Aichi Gakuin Univ, Dept Endodont, Sch Dent, Nagoya, Aichi 464, Japan	National Center for Geriatrics & Gerontology; National Center for Geriatrics & Gerontology; Aichi Gakuin University	Nakamura, H (corresponding author), Natl Ctr Geriatr & Gerontol, Ctr Adv Med Dent & Oral Dis, Dept Dent Regenerat Med, Obu, Aichi, Japan.	hnak@me.com	nakamura, hiroyuki/A-2953-2013; Isogai, Zenzo/AAD-3690-2022	nakamura, hiroyuki/0000-0002-2524-3063; 	Japan Science and Technology Agency (JST) [AS232Z01229F]; Ministry of Education, Science, Sports and Culture, Japan [20390504, 21390512, 22592030]; Ministry of Health, Labour, and Welfare [21A-7]; Grants-in-Aid for Scientific Research [22592030] Funding Source: KAKEN	Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Ministry of Education, Science, Sports and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Adaptable and Seamless Technology transfer Program through target-driven R&D (A-STEP) by Japan Science and Technology Agency (JST) (AS232Z01229F to Hiroyuki N), a grant-in-aid for Scientific Research from the Ministry of Education, Science, Sports and Culture, Japan (#20390504 to MN, #21390512 to Hiroshi Nakamura, #22592030 to Hiroyuki Nakamura), and by the Research Grant for Longevity Sciences (21A-7) from the Ministry of Health, Labour, and Welfare (MN). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Byers MR, 1999, CRIT REV ORAL BIOL M, V10, P4, DOI 10.1177/10454411990100010101; BYERS MR, 1984, INT REV NEUROBIOL, V25, P39, DOI 10.1016/S0074-7742(08)60677-7; Caplan DJ, 2005, J PUBLIC HEALTH DENT, V65, P90, DOI 10.1111/j.1752-7325.2005.tb02792.x; de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X; Demirel F, 2005, INT J PERIODONT REST, V25, P73; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Eriksen GV, 1999, BIOCHEM J, V340, P613, DOI 10.1042/0264-6021:3400613; Hahn CL, 2007, J ENDODONT, V33, P643, DOI 10.1016/j.joen.2007.01.001; IMAI M, 1993, J ORAL PATHOL MED, V22, P411, DOI 10.1111/j.1600-0714.1993.tb00132.x; Katoh S, 2011, EUR J IMMUNOL, V41, P3198, DOI 10.1002/eji.201141521; Kimura A, 2011, INT IMMUNOPHARMACOL, V11, P319, DOI 10.1016/j.intimp.2010.10.004; Kobayashi N, 2010, CANCER RES, V70, P7073, DOI 10.1158/0008-5472.CAN-09-4687; Koyama H, 2007, AM J PATHOL, V170, P1086, DOI 10.2353/ajpath.2007.060793; Le NTV, 2007, FRONT BIOSCI, V12, P1475, DOI 10.2741/2161; Milner Jennifer M., 2005, Current Drug Targets - Inflammation and Allergy, V4, P363, DOI 10.2174/1568010054022141; NAGASE H, 1994, J BIOL CHEM, V269, P20952; Nakamura H, 1998, EUR J BIOCHEM, V253, P67, DOI 10.1046/j.1432-1327.1998.2530067.x; Overall CM, 2002, NAT REV CANCER, V2, P657, DOI 10.1038/nrc884; Pappen AF, 2005, J PROSTHET DENT, V94, P214, DOI 10.1016/j.prosdent.2005.05.022; Pashley DH, 1996, CRIT REV ORAL BIOL M, V7, P104, DOI 10.1177/10454411960070020101; PERIDES G, 1995, BIOCHEM J, V312, P377, DOI 10.1042/bj3120377; Piwowarczyk A, 2005, DENT MATER, V21, P445, DOI 10.1016/j.dental.2004.07.009; ROMAGNANI S, 1994, ANNU REV IMMUNOL, V12, P227, DOI 10.1146/annurev.iy.12.040194.001303; Selbi W, 2006, KIDNEY INT, V70, P1287, DOI 10.1038/sj.ki.5001760; Sjolander A, 1998, J IMMUNOL, V160, P3949; Staquet M-J, 2011, Adv Dent Res, V23, P296, DOI 10.1177/0022034511405390; Torabinejad M, 2008, ENDODNTICS PRINCIPLE; Zero Domenick T, 2011, Dent Clin North Am, V55, P29, DOI 10.1016/j.cden.2010.08.010; Zheng L, 2009, AM J PATHOL, V175, P1905, DOI 10.2353/ajpath.2009.080705; Zhuo LS, 2006, J BIOL CHEM, V281, P20303, DOI 10.1074/jbc.M506703200; Zhuo LS, 2004, J BIOL CHEM, V279, P38079, DOI 10.1074/jbc.R300039200	32	43	44	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52523	10.1371/journal.pone.0052523	http://dx.doi.org/10.1371/journal.pone.0052523			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285075	Green Published, Green Submitted, gold			2022-12-27	WOS:000312794500188
J	Mani, J; Makarevic, J; Juengel, E; Ackermann, H; Nelson, K; Haferkamp, A; Blaheta, RA				Mani, Jens; Makarevic, Jasmina; Juengel, Eva; Ackermann, Hanns; Nelson, Karen; Haferkamp, Axel; Blaheta, Roman A.			Publication of Original Research in Urologic Journals - A Neglected Orphan?	PLOS ONE			English	Article							SCIENCE	The pathophysiologic mechanisms behind urologic disease are increasingly being elucidated. The object of this investigation was to evaluate the publication policies of urologic journals during a period of progressively better understanding and management of urologic disease. Based on the ISI Web of Knowledge Journal Citation Reports and the PubMed database, the number and percentage of original experimental, original clinical, review or commentarial articles published between 2002-2010 in six leading urologic journals were analyzed. "British Journal of Urology International", "European Urology", "Urologic Oncology-Seminars and Original Investigations" ("Urologic Oncology"), "Urology", "The Journal of Urology", and "World Journal of Urology" were chosen, because these journals publish articles in all four categories. The publication policies of the six journals were very heterogeneous during the time period from 2002 to 2010. The percentage of original experimental and original clinical articles, related to all categories, remained the same in "British Journal of Urology International", "Urologic Oncology", "Urology" and "The Journal of Urology". The percentage of experimental reports in "World Journal of Urology" between 2002-2010 significantly increased from 10 to 20%. A distinct elevation in the percentage of commentarial articles accompanied by a reduction of clinical articles became evident in "European Urology" which significantly correlated with a large increase in the journal's impact factor. No clearly superior policy could be identified with regard to a general increase in the impact factors from all the journals. The publication policy of urologic journals does not expressly reflect the increase in scientific knowledge, which has occurred over the period 2002-2010. One way of increasing the exposure of urologists to research and expand the interface between experimental and clinical research, would be to enlarge the percentage of experimental articles published. There is no indication that such policy would be detrimental to a journal's impact factor.	[Mani, Jens; Makarevic, Jasmina; Juengel, Eva; Haferkamp, Axel; Blaheta, Roman A.] Goethe Univ Frankfurt, Dept Urol, Frankfurt, Germany; [Ackermann, Hanns] Goethe Univ Frankfurt, Inst Biostat, Frankfurt, Germany; [Nelson, Karen] Goethe Univ Frankfurt, Dept Vasc & Endovasc Surg, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt	Blaheta, RA (corresponding author), Goethe Univ Frankfurt, Dept Urol, Frankfurt, Germany.	Blaheta@em.uni-frankfurt.de						Eberli D, 2009, INDIAN J UROL, V25, P217, DOI 10.4103/0970-1591.52924; Jung K, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-87; Labanaris AP, 2007, UROL INT, V78, P299, DOI 10.1159/000100831; Olumi AF, 2009, UROL ONCOL-SEMIN ORI, V27, P205, DOI 10.1016/j.urolonc.2008.07.027; Zinner DE, 2009, JAMA-J AM MED ASSOC, V302, P969, DOI 10.1001/jama.2009.1265	5	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e52420	10.1371/journal.pone.0052420	http://dx.doi.org/10.1371/journal.pone.0052420			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23285032	Green Published, gold, Green Submitted			2022-12-27	WOS:000312694300089
J	Barreda, VD; Cuneo, NR; Wilf, P; Currano, ED; Scasso, RA; Brinkhuis, H				Barreda, Viviana D.; Cuneo, Nestor R.; Wilf, Peter; Currano, Ellen D.; Scasso, Roberto A.; Brinkhuis, Henk			Cretaceous/Paleogene Floral Turnover in Patagonia: Drop in Diversity, Low Extinction, and a Classopollis Spike	PLOS ONE			English	Article							TERTIARY BOUNDARY; MASS EXTINCTION; END; VEGETATION; SEDIMENTS; ECOSYSTEM; POLLEN; RECORD	Nearly all data regarding land-plant turnover across the Cretaceous/Paleogene boundary come from western North America, relatively close to the Chicxulub, Mexico impact site. Here, we present a palynological analysis of a section in Patagonia that shows a marked fall in diversity and abundance of nearly all plant groups across the K/Pg interval. Minimum diversity occurs during the earliest Danian, but only a few palynomorphs show true extinctions. The low extinction rate is similar to previous observations from New Zealand. The differing responses between the Southern and Northern hemispheres could be related to the attenuation of damage with increased distance from the impact site, to hemispheric differences in extinction severity, or to both effects. Legacy effects of the terminal Cretaceous event also provide a plausible, partial explanation for the fact that Paleocene and Eocene macrofloras from Patagonia are among the most diverse known globally. Also of great interest, earliest Danian assemblages are dominated by the gymnosperm palynomorphs Classopollis of the extinct Mesozoic conifer family Cheirolepidiaceae. The expansion of Classopollis after the boundary in Patagonia is another example of typically Mesozoic plant lineages surviving into the Cenozoic in southern Gondwanan areas, and this greatly supports previous hypotheses of high latitude southern regions as biodiversity refugia during the end-Cretaceous global crisis.	[Barreda, Viviana D.] Consejo Nacl Invest Cient & Tecn, Museo Argentino Ciencias Nat Bernardino Rivadavia, Div Paleobot, RA-1033 Buenos Aires, DF, Argentina; [Cuneo, Nestor R.] Consejo Nacl Invest Cient & Tecn, Museo Paleontol Egidio Feruglio, Trelew, Chubut, Argentina; [Wilf, Peter] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Currano, Ellen D.] Miami Univ, Dept Geol & Environm Earth Sci, Oxford, OH 45056 USA; [Scasso, Roberto A.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Geol, Buenos Aires, DF, Argentina; [Brinkhuis, Henk] Univ Utrecht, Fac Sci, Inst Environm Biol, Utrecht, Netherlands	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Museo Argentino de Ciencias Naturales Bernardino Rivadavia (MACN); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University System of Ohio; Miami University; University of Buenos Aires; Utrecht University	Barreda, VD (corresponding author), Consejo Nacl Invest Cient & Tecn, Museo Argentino Ciencias Nat Bernardino Rivadavia, Div Paleobot, RA-1033 Buenos Aires, DF, Argentina.	vbarreda@macn.gov.ar		Brinkhuis, Henk/0000-0003-0253-6610; Barreda, Viviana Dora/0000-0002-1560-1277	National Science Foundation [DEB-0919071]; Consejo Nacional de Investigaciones Cientificas y Tecnicas; Direct For Biological Sciences [0919071] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Support was provided through National Science Foundation grant DEB-0919071 and the Consejo Nacional de Investigaciones Cientificas y Tecnicas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZ LW, 1980, SCIENCE, V208, P1095, DOI 10.1126/science.208.4448.1095; ALVIN KL, 1982, REV PALAEOBOT PALYNO, V37, P71, DOI 10.1016/0034-6667(82)90038-0; [Anonymous], 1991, EXTINCTION BAD GENES; ARCHANGELSKY S, 1973, Ameghiniana, V10, P339; Askin R.A., 1988, GEOLOGICAL SOC AM ME, V169, P155, DOI 10.1130/mem169-p155; Baldoni Alicia M., 1992, Palynology, V16, P117; Baldoni Alicia M., 1993, Palynology, V17, P241; Barreda V., 2004, 10 REUN ARG SED, P185; BERRY EDWARD W., 1935, TORREYA, V35, P11; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; CASE J A, 1986, Palaios, V1, P413, DOI 10.2307/3514478; Cuneo N. R., 2010, BOT SOC AM ANN M PRO; Gelfo Javier N., 2001, Geodiversitas, V23, P369; Grimm E, 2004, TILIA SOFTWARE 2 0 2; Hill RS, 1999, AUST J BOT, V47, P717, DOI 10.1071/BT98018; Hotton CL, 2002, GEOL S AM S, P473; Iglesias A, 2007, GEOLOGY, V35, P947, DOI 10.1130/G23889A.1; Jiang SJ, 2010, NAT GEOSCI, V3, P280, DOI 10.1038/NGEO775; Kunzmann L, 2007, ZOOL ANZ, V246, P257, DOI 10.1016/j.jcz.2007.08.001; Macphail MK, 1994, PALAEOAUSTRAL, V1, P9; McLoughlin S, 2008, AM J BOT, V95, P465, DOI 10.3732/ajb.95.4.465; McLoughlin S, 2011, INT J PLANT SCI, V172, P574, DOI 10.1086/658920; Medina FA, 1994, RAGA, V48, P100; Medina FA., 1990, 5 C ARG PAL BIOESTR, P137; Nichols DJ, 2008, PLANTS AND THE K-T BOUNDARY, P1, DOI 10.1017/CBO9780511535536; ORTH CJ, 1981, SCIENCE, V214, P1341, DOI 10.1126/science.214.4527.1341; Panti C, 2012, ALCHERINGA, V36, P1, DOI 10.1080/03115518.2011.564562; Punt W, 2007, REV PALAEOBOT PALYNO, V143, P1, DOI 10.1016/j.revpalbo.2006.06.008; Quattrocchio, 1997, REV ESP MICROPALEONT, V29, P115; Scasso RA, 2012, CRETACEOUS RES, V36, P37, DOI 10.1016/j.cretres.2012.02.002; Schulte P, 2010, SCIENCE, V327, P1214, DOI 10.1126/science.1177265; Sokal RR, 1995, BIOMETRY; SRIVASTAVA SK, 1976, LETHAIA, V9, P437, DOI 10.1111/j.1502-3931.1976.tb00985.x; TSCHUDY RH, 1984, SCIENCE, V225, P1030, DOI 10.1126/science.225.4666.1030; Vajda V, 2004, SCIENCE, V303, P1489, DOI 10.1126/science.1093807; Vajda V, 2003, NEW ZEAL J GEOL GEOP, V46, P255, DOI 10.1080/00288306.2003.9515008; Vajda V, 2001, SCIENCE, V294, P1700, DOI 10.1126/science.1064706; Vajda V, 2007, REV PALAEOBOT PALYNO, V144, P99, DOI 10.1016/j.revpalbo.2005.09.007; Volkheimer W., 2007, REV ESPA NOLA MICROP, V39, P117; Wappler T, 2009, P ROY SOC B-BIOL SCI, V276, P4271, DOI 10.1098/rspb.2009.1255; Watson J., 1988, ORIGIN EVOLUTION GYM, P382; Wilf P, 2005, AM NAT, V165, P634, DOI 10.1086/430055; Wilf P, 2004, PALEOBIOLOGY, V30, P347, DOI 10.1666/0094-8373(2004)030<0347:LPEATE>2.0.CO;2; Wing SL, 2009, P NATL ACAD SCI USA, V106, P18627, DOI 10.1073/pnas.0905130106; WOLFE JA, 1986, NATURE, V324, P148, DOI 10.1038/324148a0	45	92	100	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e52455	10.1371/journal.pone.0052455	http://dx.doi.org/10.1371/journal.pone.0052455			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23285049	Green Published, gold, Green Submitted			2022-12-27	WOS:000312435900094
J	Isin, B; Estiu, G; Wiest, O; Oltvai, ZN				Isin, Basak; Estiu, Guillermina; Wiest, Olaf; Oltvai, Zoltan N.			Identifying Ligand Binding Conformations of the beta 2-Adrenergic Receptor by Using Its Agonists as Computational Probes	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; BETA(2) ADRENERGIC-RECEPTOR; CONSERVED NPXXY MOTIF; BETA(2)-ADRENERGIC RECEPTOR; CRYSTAL-STRUCTURE; MOLECULAR-DYNAMICS; ACTIVE STATE; ACTIVATION; RHODOPSIN; IDENTIFICATION	Recently available G-protein coupled receptor (GPCR) structures and biophysical studies suggest that the difference between the effects of various agonists and antagonists cannot be explained by single structures alone, but rather that the conformational ensembles of the proteins need to be considered. Here we use an elastic network model-guided molecular dynamics simulation protocol to generate an ensemble of conformers of a prototypical GPCR, beta(2)-adrenergic receptor (beta(2)AR). The resulting conformers are clustered into groups based on the conformations of the ligand binding site, and distinct conformers from each group are assessed for their binding to known agonists of beta(2)AR. We show that the select ligands bind preferentially to different predicted conformers of beta(2)AR, and identify a role of beta(2)AR extracellular region as an allosteric binding site for larger drugs such as salmeterol. Thus, drugs and ligands can be used as "computational probes" to systematically identify protein conformers with likely biological significance.	[Isin, Basak; Oltvai, Zoltan N.] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15260 USA; [Estiu, Guillermina; Wiest, Olaf] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Estiu, Guillermina; Wiest, Olaf] Univ Notre Dame, Ctr Rare & Neglected Dis, Notre Dame, IN 46556 USA; [Wiest, Olaf] Peking Univ, Shenzhen Grad Sch, Lab Chem Genom, Lab Computat Chem & Drug Design, Shenzhen, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Notre Dame; University of Notre Dame; Peking University; University Town of Shenzhen	Isin, B (corresponding author), Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15260 USA.	bai2@pitt.edu; oltvai@pitt.edu			NIAID [U01-0700499]	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by NIAID U01-0700499 to OW and ZNO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja S, 2009, TRENDS PHARMACOL SCI, V30, P494, DOI 10.1016/j.tips.2009.06.003; Arakawa M, 2010, PROTEIN SCI, V19, P85, DOI 10.1002/pro.285; Azzi M, 2003, P NATL ACAD SCI USA, V100, P11406, DOI 10.1073/pnas.1936664100; Bahar I, 1997, FOLD DES, V2, P173, DOI 10.1016/S1359-0278(97)00024-2; BARAK LS, 1994, J BIOL CHEM, V269, P2790; Bhattacharya S, 2008, BIOPHYS J, V94, P2027, DOI 10.1529/biophysj.107.117648; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; Bowers K.J., 2006, P 2006 ACM IEEE C SU, P43, DOI DOI 10.1109/SC.2006.54; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; CHUNG FZ, 1988, J BIOL CHEM, V263, P4052; Deupi X, 2007, ADV PROTEIN CHEM, V74, P137, DOI 10.1016/S0065-3231(07)74004-4; Dror RO, 2009, P NATL ACAD SCI USA, V106, P4689, DOI 10.1073/pnas.0811065106; FARRENS DL, 1995, J BIOL CHEM, V270, P5073, DOI 10.1074/jbc.270.10.5073; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Fritze O, 2003, P NATL ACAD SCI USA, V100, P2290, DOI 10.1073/pnas.0435715100; Gales C, 2000, J BIOL CHEM, V275, P17321, DOI 10.1074/jbc.M909801199; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; Ghanouni P, 2001, J BIOL CHEM, V276, P24433, DOI 10.1074/jbc.C100162200; Green SA, 1996, J BIOL CHEM, V271, P24029, DOI 10.1074/jbc.271.39.24029; Han DS, 2008, BIOCHEMISTRY-US, V47, P7317, DOI 10.1021/bi800442g; Isin B, 2002, BIOPHYS J, V82, P569, DOI 10.1016/S0006-3495(02)75422-2; Isin B, 2008, BIOPHYS J, V95, P789, DOI 10.1529/biophysj.107.120691; Isin B, 2006, PROTEINS, V65, P970, DOI 10.1002/prot.21158; Javitch JA, 1998, BIOCHEMISTRY-US, V37, P998, DOI 10.1021/bi972241y; Johnson MS, 2006, CELL SIGNAL, V18, P1793, DOI 10.1016/j.cellsig.2006.02.002; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Kobilka BK, 2007, BBA-BIOMEMBRANES, V1768, P794, DOI 10.1016/j.bbamem.2006.10.021; Lei S, 2002, J BIOL CHEM, V277, P40989, DOI 10.1074/jbc.M206801200; Liapakis G, 2000, J BIOL CHEM, V275, P37779, DOI 10.1074/jbc.M002092200; Liapakis G, 2004, MOL PHARMACOL, V65, P1181, DOI 10.1124/mol.65.5.1181; Liu JJ, 2012, SCIENCE, V335, P1106, DOI 10.1126/science.1215802; Ludeke S, 2005, J MOL BIOL, V353, P345, DOI 10.1016/j.jmb.2005.08.039; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; OLSSON JE, 1992, NEURON, V9, P815, DOI 10.1016/0896-6273(92)90236-7; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Palanche T, 2001, J BIOL CHEM, V276, P34853, DOI 10.1074/jbc.M104363200; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Paolini GV, 2006, NAT BIOTECHNOL, V24, P805, DOI 10.1038/nbt1228; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Reynolds KA, 2009, J COMPUT AIDED MOL D; Romo TD, 2010, BIOPHYS J, V98, P76, DOI 10.1016/j.bpj.2009.09.046; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Seifert R, 2001, J PHARMACOL EXP THER, V297, P1218; Shenkin PS, 1994, CLUSTER ANAL MOL CON, V15, P899; STRADER CD, 1988, J BIOL CHEM, V263, P10267; STRADER CD, 1989, J BIOL CHEM, V264, P13572; STRADER CD, 1989, J BIOL CHEM, V264, P16470; Strange PG, 1999, BIOCHEM PHARMACOL, V58, P1081; Swaminath G, 2004, J BIOL CHEM, V279, P686, DOI 10.1074/jbc.M310888200; Swaminath G, 2005, J BIOL CHEM, V280, P22165, DOI 10.1074/jbc.M502352200; Wieland K, 1996, P NATL ACAD SCI USA, V93, P9276, DOI 10.1073/pnas.93.17.9276; Yao XJ, 2006, NAT CHEM BIOL, V2, P417, DOI 10.1038/nchembio801; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338; Zhang X, 2010, ANAL CHEM, V82, P1100, DOI 10.1021/ac902484p	62	17	17	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e50186	10.1371/journal.pone.0050186	http://dx.doi.org/10.1371/journal.pone.0050186			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300522	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000313872600002
J	Schayowitz, A; Bertenshaw, G; Jeffries, E; Schatz, T; Cotton, J; Villanueva, J; Herlyn, M; Krepler, C; Vultur, A; Xu, W; Yu, GH; Schuchter, L; Clark, DP				Schayowitz, Adam; Bertenshaw, Greg; Jeffries, Emiko; Schatz, Timothy; Cotton, James; Villanueva, Jessie; Herlyn, Meenhard; Krepler, Clemens; Vultur, Adina; Xu, Wei; Yu, Gordon H.; Schuchter, Lynn; Clark, Douglas P.			Functional Profiling of Live Melanoma Samples Using a Novel Automated Platform	PLOS ONE			English	Article							RAF INHIBITOR RESISTANCE; TARGETED CANCER-THERAPY; ACQUIRED-RESISTANCE; IMPROVED SURVIVAL; OPEN-LABEL; BRAF; KINASE; MEK; BRAF(V600E); VEMURAFENIB	Aims: This proof-of-concept study was designed to determine if functional, pharmacodynamic profiles relevant to targeted therapy could be derived from live human melanoma samples using a novel automated platform. Methods: A series of 13 melanoma cell lines was briefly exposed to a BRAF inhibitor (PLX-4720) on a platform employing automated fluidics for sample processing. Levels of the phosphoprotein p-ERK in the mitogen-activated protein kinase (MAPK) pathway from treated and untreated sample aliquots were determined using a bead-based immunoassay. Comparison of these levels provided a determination of the pharmacodynamic effect of the drug on the MAPK pathway. A similar ex vivo analysis was performed on fine needle aspiration (FNA) biopsy samples from four murine xenograft models of metastatic melanoma, as well as 12 FNA samples from patients with metastatic melanoma. Results: Melanoma cell lines with known sensitivity to BRAF inhibitors displayed marked suppression of the MAPK pathway in this system, while most BRAF inhibitor-resistant cell lines showed intact MAPK pathway activity despite exposure to a BRAF inhibitor (PLX-4720). FNA samples from melanoma xenografts showed comparable ex vivo MAPK activity as their respective cell lines in this system. FNA samples from patients with metastatic melanoma successfully yielded three categories of functional profiles including: MAPK pathway suppression; MAPK pathway reactivation; MAPK pathway stimulation. These profiles correlated with the anticipated MAPK activity, based on the known BRAF mutation status, as well as observed clinical responses to BRAF inhibitor therapy. Conclusion: Pharmacodynamic information regarding the ex vivo effect of BRAF inhibitors on the MAPK pathway in live human melanoma samples can be reproducibly determined using a novel automated platform. Such information may be useful in preclinical and clinical drug development, as well as predicting response to targeted therapy in individual patients.	[Schayowitz, Adam; Bertenshaw, Greg; Jeffries, Emiko; Schatz, Timothy; Cotton, James; Clark, Douglas P.] BioMarker Strategies, Baltimore, MD USA; [Villanueva, Jessie; Herlyn, Meenhard; Krepler, Clemens; Vultur, Adina] Wistar Inst Anat & Biol, Melanoma Res Ctr, Philadelphia, PA 19104 USA; [Xu, Wei; Schuchter, Lynn] Univ Penn, Sch Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Yu, Gordon H.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	The Wistar Institute; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Clark, DP (corresponding author), BioMarker Strategies, Baltimore, MD USA.	dpclark@biomarkerstrategies.com		Vultur, Adina/0000-0003-0068-9496	National Cancer Institute (SBIR) [HHSN261200900075C, HHSN261201100112C]; NIH [PO1 CA114046]; Abramson Cancer Center Helbert Institute [461505]; NATIONAL CANCER INSTITUTE [P01CA114046, P30CA016520] Funding Source: NIH RePORTER	National Cancer Institute (SBIR); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Abramson Cancer Center Helbert Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Authors DPC, AS, GB, EJ, TS, JC and the SnapPath (TM) platform are supported by the National Cancer Institute (SBIR Contract ID: HHSN261200900075C and HHSN261201100112C). Authors JV, AV, CK, WX, LS and MH are supported by NIH PO1 CA114046 - Targeted Therapies in Melanoma. Authors LS, WX and GHY are supported by Abramson Cancer Center Helbert Institute fund (#461505) and Gift & Endowment funds within the Abramson Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avraham R, 2011, NAT REV MOL CELL BIO, V12, P104, DOI 10.1038/nrm3048; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Clark DP, 2009, EXPERT REV MOL DIAGN, V9, P787, DOI 10.1586/ERM.09.62; Clark DP, 2009, CANCER CYTOPATHOL, V117, P289, DOI 10.1002/cncy.20045; Corcoran RB, 2012, CANCER DISCOV, V2, P227, DOI 10.1158/2159-8290.CD-11-0341; Emery CM, 2009, P NATL ACAD SCI USA, V106, P20411, DOI 10.1073/pnas.0905833106; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Flaherty KT, 2012, NAT REV CANCER, V12, P349, DOI 10.1038/nrc3218; Fojo T, 2010, CLIN CANCER RES, V16, P5972, DOI 10.1158/1078-0432.CCR-10-1277; Greger JG, 2012, MOL CANCER THER, V11, P909, DOI 10.1158/1535-7163.MCT-11-0989; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Hauschild A, 2012, LANCET, V380, P358, DOI 10.1016/S0140-6736(12)60868-X; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Herlyn M, 2010, J INVEST DERMATOL, V130, P911, DOI 10.1038/jid.2009.441; Irish JM, 2006, NAT REV CANCER, V6, P146, DOI 10.1038/nrc1804; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Kaplan FM, 2011, ONCOGENE, V30, P366, DOI 10.1038/onc.2010.408; Kirkwood JM, 2012, CLIN CANCER RES, V18, P555, DOI 10.1158/1078-0432.CCR-11-1491; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Paraiso KHT, 2011, CANCER RES, V71, P2750, DOI 10.1158/0008-5472.CAN-10-2954; Parkinson DR, 2009, CURR OPIN MOL THER, V11, P252; Poste G, 2011, NATURE, V469, P156, DOI 10.1038/469156a; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Sawyers CL, 2008, NATURE, V452, P548, DOI 10.1038/nature06913; Shi HB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1727; Shi HB, 2011, CANCER RES, V71, P5067, DOI 10.1158/0008-5472.CAN-11-0140; Sikorski R, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001087; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Yang H, 2010, CANCER RES, V70, P5518, DOI 10.1158/0008-5472.CAN-10-0646	34	6	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52760	10.1371/journal.pone.0052760	http://dx.doi.org/10.1371/journal.pone.0052760			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285177	Green Published, gold			2022-12-27	WOS:000313051500057
J	Goncalves, R; Pedrozo, AL; Coutinho, ESF; Figueira, I; Ventura, P				Goncalves, Raquel; Pedrozo, Ana Lucia; Freire Coutinho, Evandro Silva; Figueira, Ivan; Ventura, Paula			Efficacy of Virtual Reality Exposure Therapy in the Treatment of PTSD: A Systematic Review	PLOS ONE			English	Review							POSTTRAUMATIC-STRESS-DISORDER; ANXIETY DISORDERS; VIETNAM VETERANS; METAANALYSIS; SEPTEMBER-11; AFGHANISTAN; TRIALS; IRAQ; CARE	The use of Information and Communication Technologies, such as virtual reality, has been employed in the treatment of anxiety disorders with the goal of augmenting exposure treatment, which is already considered to be the first-line treatment for Post-traumatic Stress Disorder (PTSD). To evaluate the efficacy of virtual reality exposure therapy (VRET) in the treatment of PTSD, we performed a systematic review of published articles using the following electronic databases: Web of Science, PubMed, PsycINFO, and PILOTS. Eligibility criteria included the use of patients diagnosed with PTSD according to DSM-IV, the use of cognitive behavioral therapy (CBT) and the use of virtual reality for performing exposure. 10 articles were selected, seven of which showed that VRET produced statistically significant results in comparison to the waiting list. However, no difference was found between VRET and exposure treatment. Of these 10, four were randomized, two were controlled but not randomized and four were non-controlled. The majority of the articles used head-mounted display virtual reality (VR) equipment and VR systems specific for the population that was being treated. Dropout rates do not seem to be lower than in traditional exposure treatment. However, there are a few limitations. Because this is a new field of research, there are few studies in the literature. There is also a need to standardize the number of sessions used. The randomized studies were analyzed to assess the quality of the methodology, and important deficiencies were noted, such as the non-use of intent-to-treat-analysis and the absence of description of possible concomitant treatments and comorbidities. Preliminary data suggest that VRET is as efficacious as traditional exposure treatment and can be especially useful in the treatment of patients who are resistant to traditional exposure.	[Goncalves, Raquel; Pedrozo, Ana Lucia] Univ Fed Rio de Janeiro, Inst Pschol, Rio De Janeiro, Brazil; [Freire Coutinho, Evandro Silva] Escola Nacl Saude Publ ENSP FIOCRUZ, Dept Epidemiol, Rio De Janeiro, Brazil; [Figueira, Ivan; Ventura, Paula] Univ Fed Rio de Janeiro, Inst Psychiat, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro	Goncalves, R (corresponding author), Univ Fed Rio de Janeiro, Inst Pschol, Rio De Janeiro, Brazil.	mgoncalves.raquel@gmail.com	Gonçalves, Raquel M/M-2423-2018	Coutinho, Evandro/0000-0002-4649-7353	CNPq (Brazilian Research Council)	CNPq (Brazilian Research Council)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The study was partially supported by CNPq (Brazilian Research Council). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banos RM, 2011, INT J HUM-COMPUT ST, V69, P602, DOI 10.1016/j.ijhcs.2011.06.002; Botella C, 2010, CYBERPSYCH BEH SOC N, V13, P67, DOI 10.1089/cyber.2009.0353; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Brewin CR, 1996, PSYCHOL REV, V103, P670, DOI 10.1037/0033-295X.103.4.670; Conner BT, 2010, CLIN PSYCHOL-SCI PR, V17, P52, DOI 10.1111/j.1468-2850.2009.01193.x; Difede J, 2002, PSYCHIAT SERV, V53, P1083, DOI 10.1176/appi.ps.53.9.1083; Difede J, 2007, J CLIN PSYCHIAT, V68, P1639, DOI 10.4088/JCP.v68n1102; Erbes CR, 2009, PSYCHOL SERV, V6, P175, DOI 10.1037/a0016662; Foa E.B., 2019, PROLONGED EXPOSURE T, V2, DOI [10.1093/med-psych/9780190926939.001.0001/med-9780190926939, DOI 10.1093/MED-PSYCH/9780190926939.001.0001/MED-9780190926939]; FOA EB, 1986, PSYCHOL BULL, V99, P20, DOI 10.1037/0033-2909.99.1.20; Gamito P, 2010, CYBERPSYCH BEH SOC N, V13, P43, DOI 10.1089/cyber.2009.0237; Hembree EA, 2003, J TRAUMA STRESS, V16, P555, DOI 10.1023/B:JOTS.0000004078.93012.7d; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Kocsis JH, 2009, COMPR PSYCHIAT, V51, P319; McLay RN, 2011, CYBERPSYCH BEH SOC N, V14, P223, DOI 10.1089/cyber.2011.0003; McLay RN, 2010, CYBERPSYCH BEH SOC N, V13, P37, DOI 10.1089/cyber.2009.0346; Meyerbroker K, 2010, DEPRESS ANXIETY, V27, P933, DOI 10.1002/da.20734; Opris D, 2012, DEPRESS ANXIETY, V29, P85, DOI 10.1002/da.20910; Parsons TD, 2008, J BEHAV THER EXP PSY, V39, P250, DOI 10.1016/j.jbtep.2007.07.007; Pollack S., 2006, J AGGRESS MALTREAT T, V12, P199, DOI [10.1300/J146v12n01_11, DOI 10.1300/J146V12N01_]; Powers MB, 2008, J ANXIETY DISORD, V22, P561, DOI 10.1016/j.janxdis.2007.04.006; Ready DJ, 2010, CYBERPSYCH BEH SOC N, V13, P49, DOI 10.1089/cyber.2009.0239; Rizzo A, 2010, ANN NY ACAD SCI, V1208, P114, DOI 10.1111/j.1749-6632.2010.05755.x; Rothbaum BO, 2009, DEPRESS ANXIETY, V26, P209, DOI 10.1002/da.20556; Rothbaum BO, 2001, J CLIN PSYCHIAT, V62, P617, DOI 10.4088/JCP.v62n0808; Roy MJ, 2010, ANN NY ACAD SCI, V1208, P142, DOI 10.1111/j.1749-6632.2010.05689.x; Schottenbauer MA, 2008, PSYCHIATRY, V71, P134, DOI 10.1521/psyc.2008.71.2.134; Seal KH, 2010, J TRAUMA STRESS, V23, P5, DOI 10.1002/jts.20493; Shearer-Underhill C, 2010, CLIN PSYCHOL-SCI PR, V17, P41, DOI 10.1111/j.1468-2850.2009.01191.x; The Cochrane Collaboration, 2011, COCHRANE HDB SYSTEMA, DOI DOI 10.1002/9780470712184.CH9; Wald J, 2004, BEHAV THER, V35, P621, DOI 10.1016/S0005-7894(04)80035-2; Wood DP, 2009, STUD HEALTH TECHNOL, V144, P223, DOI 10.3233/978-1-60750-017-9-223	32	116	118	7	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e48469	10.1371/journal.pone.0048469	http://dx.doi.org/10.1371/journal.pone.0048469			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	061EA	23300515	Green Published, gold, Green Submitted			2022-12-27	WOS:000312829100003
J	He, CF; Li, YX; Zhang, GX; Gu, ZG; Yang, R; Li, J; Lu, ZJ; Zhou, ZH; Zhang, CY; Wang, J				He, Chenfeng; Li, Ying-Xin; Zhang, Guangxin; Gu, Zuguang; Yang, Rong; Li, Jie; Lu, Zhi John; Zhou, Zhi-Hua; Zhang, Chenyu; Wang, Jin			MiRmat: Mature microRNA Sequence Prediction	PLOS ONE			English	Article							NUCLEAR EXPORT; REGULATORY MOTIFS; RNA INTERFERENCE; DROSHA; IDENTIFICATION; BIOGENESIS; PRECURSORS	Background: MicroRNAs are known to be generated from primary transcripts mainly through the sequential cleavages by two enzymes, Drosha and Dicer. The sequence of a mature microRNA, especially the 'seeding sequence', largely determines its binding ability and specificity to target mRNAs. Therefore, methods that predict mature microRNA sequences with high accuracy will benefit the identification and characterization of novel microRNAs and their targets, and contribute to inferring the post-transcriptional regulation network at a genome scale. Methodology/Principal Findings: We have developed a method, MiRmat, to predict the mature microRNA sequence. MiRmat is essentially composed of two parts: the prediction of Drosha processing site and the identification of Dicer processing site. Based on the analysis of microRNAs from 12 species, we found that the patterns of free energy profiles are conserved among vertebrate microRNA hairpins. Therefore, we introduced in our method the free energy distribution pattern of the downstream part of pri-microRNA secondary structure and Random Forest algorithm to predict the mature microRNA sequence. Based on the evaluation on an independent test dataset from 10 vertebrates, MiRmat was shown to identify 77.8% of the Drosha processing sites and 92.8% of the Dicer sites within a deviation of 2 nt. In a more stringent evaluation by excluding the microRNAs sharing the same family between the training set and test set, MiRmat kept a rather well performance of 71.9% and 87.2% of the identification rate on the Drosha and Dicer site respectively, which represents the ability to deal with the novel microRNA family. MiRmat outperforms other state-of-the-art methods and has a high degree of efficacy for the prediction of mature microRNA sequences of vertebrates. Conclusion: MiRmat was developed for identifying microRNA mature sequence(s) by introducing the free energy distribution of RNA stem-loop structure and the Random Forest algorithm. We prove that MiRmat has better performance than the existing tools and is applicable among vertebrates. MiRmat is freely available at http://mcube.nju.edu.cn/jwang/lab/soft/MiRmat/.	[Li, Ying-Xin; Zhou, Zhi-Hua] Nanjing Univ, Natl Key Lab Novel Software Technol, Nanjing, Jiangsu, Peoples R China; [He, Chenfeng; Zhang, Guangxin; Gu, Zuguang; Li, Jie; Zhang, Chenyu; Wang, Jin] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China; [He, Chenfeng; Zhang, Guangxin; Gu, Zuguang; Li, Jie; Zhang, Chenyu; Wang, Jin] Nanjing Univ, Jiangsu Engn Res Ctr MicroRNA Biol & Biotechnol, Sch Life Sci, Nanjing, Jiangsu, Peoples R China; [Li, Ying-Xin] Beijing Jingwei Text Machinery New Technol Co Ltd, Inst Machine Vis & Machine Intelligence, Beijing, Peoples R China; [Yang, Rong] Nanjing Univ, Sch Phys, Inst Biophys, Nanjing, Jiangsu, Peoples R China; [Lu, Zhi John] Tsinghua Univ, Minist Educ, Key Lab Bioinformat & Syst Biol, Sch Life Sci, Beijing 100084, Peoples R China	Nanjing University; Nanjing University; Nanjing University; Nanjing University; Tsinghua University	Zhou, ZH (corresponding author), Nanjing Univ, Natl Key Lab Novel Software Technol, Nanjing, Jiangsu, Peoples R China.	zhouzh@nju.edu.cn; cyzhang@nju.edu.cn; jwang@nju.edu.cn	Gu, Zuguang/C-5914-2009; He, Chenfeng/W-9330-2019	He, Chenfeng/0000-0002-9171-3879; Gu, Zuguang/0000-0002-7395-8709	National Natural Science Foundation of China [30890044, 31071232, 61021062, 61173068]; National Basic Research Program [2007CB814806, 2010CB327903]; Postdoctoral Science Foundation of China [20090461086]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program(National Basic Research Program of China); Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation)	This work was supported by grants from the National Natural Science Foundation of China (30890044, 31071232, 61021062, 61173068), the National Basic Research Program (2007CB814806, 2010CB327903) and the Postdoctoral Science Foundation of China (20090461086). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bohnsack MT, 2004, RNA, V10, P185, DOI 10.1261/rna.5167604; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Dostie J, 2003, RNA, V9, P180, DOI 10.1261/rna.2141503; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Frank E, 2004, BIOINFORMATICS, V20, P2479, DOI 10.1093/bioinformatics/bth261; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Gkirtzou K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011843; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Han J, 2009, CELL, V136, P75, DOI 10.1016/j.cell.2008.10.053; Helvik SA, 2007, BIOINFORMATICS, V23, P142, DOI 10.1093/bioinformatics/btl570; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Lui WO, 2007, CANCER RES, V67, P6031, DOI 10.1158/0008-5472.CAN-06-0561; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Mathews David H, 2006, Curr Protoc Bioinformatics, VChapter 12, DOI [10.1002/0471250953.bi1206s46, 10.1002/0471250953.bi1206s13]; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Mignone F, 2005, NUCLEIC ACIDS RES, V33, pD141, DOI 10.1093/nar/gki021; Murchison EP, 2004, CURR OPIN CELL BIOL, V16, P223, DOI 10.1016/j.ceb.2004.04.003; Nam JW, 2005, NUCLEIC ACIDS RES, V33, P3570, DOI 10.1093/nar/gki668; Park JE, 2011, NATURE, V475, P201, DOI 10.1038/nature10198; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Saini HK, 2007, P NATL ACAD SCI USA, V104, P17719, DOI 10.1073/pnas.0703890104; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Sinha S, 2009, J PROTEOM BIOINFORM, V2, P336; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Soifer HS, 2008, NUCLEIC ACIDS RES, V36, P6511, DOI 10.1093/nar/gkn687; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Tiscornia G, 2010, GENE DEV, V24, P2732, DOI 10.1101/gad.1982910; Warren WC, 2008, NATURE, V453, P175, DOI 10.1038/nature06936; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Xuan P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027422; Xue CH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-310; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Yousef M, 2006, BIOINFORMATICS, V22, P1325, DOI 10.1093/bioinformatics/btl094; Zhou Z.-H., 2009, ENCY BIOMETRICS, P270, DOI DOI 10.1007/978-0-387-73003-5_293; Zimmerman AL, 2011, CANCER LETT, V300, P10, DOI 10.1016/j.canlet.2010.09.019	52	20	21	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e51673	10.1371/journal.pone.0051673	http://dx.doi.org/10.1371/journal.pone.0051673			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300555	Green Published, gold			2022-12-27	WOS:000312829100011
J	Bevacqua, D; Genard, M; Lescourret, F				Bevacqua, Daniele; Genard, Michel; Lescourret, Francoise			A Simple Model to Predict the Probability of a Peach (Prunus persicae) Tree Bud to Develop as a Long or Short Shoot as a Consequence of Winter Pruning Intensity and Previous Year Growth	PLOS ONE			English	Article							RESPONSES; HERBIVORY; LOAD	In many woody plants, shoots emerging from buds can develop as short or long shoots. The probability of a bud to develop as a long or short shoot relies upon genetic, environmental and management factors and controlling it is an important issue in commercial orchard. We use peach (Prunus persicae) trees, subjected to different winter pruning levels and monitored for two years, to develop and calibrate a model linking the probability of a bud to develop as a long shoot to winter pruning intensity and previous year vegetative growth. Eventually we show how our model can be used to adjust pruning intensity to obtain a desired proportion of long and short shoots.	[Bevacqua, Daniele; Genard, Michel; Lescourret, Francoise] INRA, PSH UR1115, Avignon, France	INRAE	Bevacqua, D (corresponding author), INRA, PSH UR1115, Avignon, France.	daniele.bevacqua@avignon.inra.fr	Bevacqua, Daniele/ABA-7173-2021; Bevacqua, Daniele/D-9421-2012	Bevacqua, Daniele/0000-0002-3341-1696; Lescourret, Francoise/0000-0002-6576-8067				BELSKY AJ, 1986, AM NAT, V127, P870, DOI 10.1086/284531; Bussi C, 2011, SCI HORTIC-AMSTERDAM, V130, P725, DOI 10.1016/j.scienta.2011.08.026; DAVIDSON RL, 1969, ANN BOT-LONDON, V33, P561, DOI 10.1093/oxfordjournals.aob.a084308; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; ELFVING DC, 1976, J AM SOC HORTIC SCI, V101, P290; Faust M., 1989, PHYSL TEMPERATE ZONE; Fournier D, 1998, ACTA HORTIC, P557, DOI 10.17660/ActaHortic.1998.465.69; GIAUQUE P, 2003, CONDUITE VERGER PECH; Gordon D, 2007, ANN BOT-LONDON, V99, P323, DOI 10.1093/aob/mcl262; Grechi I, 2008, ENTOMOL EXP APPL, V128, P369, DOI 10.1111/j.1570-7458.2008.00720.x; Grechi I, 2010, ECOL MODEL, V221, P2363, DOI 10.1016/j.ecolmodel.2010.06.015; Greenwood MS, 2010, TREE PHYSIOL, V30, P459, DOI 10.1093/treephys/tpq004; Lakso A, 1984, GRAT LAKES FRUIT GRO, V23, P50; MASCHINSKI J, 1989, AM NAT, V134, P1, DOI 10.1086/284962; MCNAUGHTON SJ, 1984, AM NAT, V124, P863, DOI 10.1086/284321; ROM CR, 1985, J AM SOC HORTIC SCI, V110, P455; Stephan J, 2007, ANN BOT-LONDON, V99, P1055, DOI 10.1093/aob/mcm049; Thornley J. H. M., 2000, PLANT CROP MODELING; WEBSTER AD, 1984, J HORTIC SCI, V59, P175, DOI 10.1080/00221589.1984.11515185; Wilson B. F., 1966, DEV SHOOT SYSTEM ACE; Zimmermann M.H., 1971, TREES-STRUCT FUNCT, P307, DOI 10.1007/978-3-642-88528-0_7	21	7	7	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52185	10.1371/journal.pone.0052185	http://dx.doi.org/10.1371/journal.pone.0052185			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300609	Green Submitted, Green Published, gold			2022-12-27	WOS:000313618800053
J	Hernandez-Baltazar, D; Martinez-Fong, D; Trudeau, LE				Hernandez-Baltazar, Daniel; Martinez-Fong, Daniel; Trudeau, Louis-Eric			Optimizing NTS-Polyplex as a Tool for Gene Transfer to Cultured Dopamine Neurons	PLOS ONE			English	Article							RAT SUBSTANTIA-NIGRA; PARKINSONS-DISEASE; NEUROTENSIN POLYPLEX; NEUROTROPHIC FACTOR; NONVIRAL VECTOR; GROWTH-FACTOR; DELIVERY; EXPRESSION; THERAPY; LOCALIZATION	The study of signal transduction in dopamine (DA)-containing neurons as well as the development of new therapeutic approaches for Parkinson's disease requires the selective expression of transgenes in such neurons. Here we describe optimization of the use of the NTS-polyplex, a gene carrier system taking advantage of neurotensin receptor internalization, to transfect mouse DA neurons in primary culture. The plasmids DsRed2 (4.7 kbp) and VGLUT2-Venus (11 kbp) were used to compare the ability of this carrier system to transfect plasmids of different sizes. We examined the impact of age of the neurons (1, 3, 5 and 8 days after seeding), of culture media used during the transfection (Neurobasal with B27 vs. conditioned medium) and of three molar ratios of plasmid DNA to carrier. While the NTS-polyplex successfully transfected both plasmids in a control N1E-115 cell line, only the pDsRed2 plasmid could be transfected in primary cultured DA neurons. We achieved 20% transfection efficiency of pDsRed2 in DA neurons, with 80% cell viability. The transfection was demonstrated pharmacologically to be dependent on activation of neurotensin receptors and to be selective for DA neurons. The presence of conditioned medium for transfection was found to be required to insure cell viability. Highest transfection efficiency was achieved in the most mature neurons. In contrast, transfection with the VGLUT2-Venus plasmid produced cell damage, most likely due to the high molar ratios required, as evidenced by a 15% cell viability of DA neurons at the three molar ratios tested (1: 36, 1: 39 and 1: 42). We conclude that, when used at molar ratios lower than 1: 33, the NTS-polyplex can selectively transfect mature cultured DA neurons with only low levels of toxicity. Our results provide evidence that the NTS-polyplex has good potential for targeted gene delivery in cultured DA neurons, an in vitro system of great use for the screening of new therapeutic approaches for Parkinson's disease.	[Hernandez-Baltazar, Daniel; Martinez-Fong, Daniel] Ctr Invest & Estudios Avanzados Inst Politecn Nac, Dept Fisiol Biofis & Neurociencias, Mexico City, DF, Mexico; [Trudeau, Louis-Eric] Univ Montreal, Fac Med, Dept Pharmacol, Grp Rech Syst Nerveux Cent, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Trudeau, LE (corresponding author), Univ Montreal, Fac Med, Dept Pharmacol, Grp Rech Syst Nerveux Cent, Montreal, PQ H3C 3J7, Canada.	louis-eric.trudeau@umontreal.ca	BALTAZAR, DANIEL HERNANDEZ/S-9655-2019; Trudeau, Louis-Eric/AAE-4782-2020	BALTAZAR, DANIEL HERNANDEZ/0000-0002-3658-4808; Trudeau, Louis-Eric/0000-0003-4684-1377	Quebec Ministry of International Relations - CONACTY Mexico [B330.521]; Canadian Institutes of Health Research [MOP-106556]; Brain Canada Foundation; Krembil Foundation; CONACYT [206727/203652]	Quebec Ministry of International Relations - CONACTY Mexico; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Brain Canada Foundation; Krembil Foundation; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by a Quebec-Mexico bilateral cooperation grant # B330.521 (Quebec Ministry of International Relations - CONACTY Mexico) to L.-E.T. and D.-M.F., and in part by research grants from the Canadian Institutes of Health Research (MOP-106556) and from the Brain Canada Foundation and Krembil Foundation (to L.-E.T). D. H.-B. was the recipient of scholarship from CONACYT (206727/203652). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Maya I, 2001, MOL MED, V7, P186, DOI 10.1007/BF03401952; Arango-Rodriguez ML, 2006, BBA-GEN SUBJECTS, V1760, P1009, DOI 10.1016/j.bbagen.2006.02.021; Bauer M, 2000, HUM GENE THER, V11, P1529, DOI 10.1089/10430340050083261; BECK KD, 1993, NEUROSCIENCE, V52, P855, DOI 10.1016/0306-4522(93)90534-M; Bourque MJ, 2000, EUR J NEUROSCI, V12, P3172, DOI 10.1046/j.1460-9568.2000.00219.x; Burke RE, 1998, J NEUROCHEM, V71, P517; CARDOZO DL, 1993, NEUROSCIENCE, V56, P409, DOI 10.1016/0306-4522(93)90342-D; CUSACK B, 1991, EUR J PHARM-MOLEC PH, V206, P339, DOI 10.1016/0922-4106(91)90119-3; Dal Bo G, 2004, J NEUROCHEM, V88, P1398, DOI 10.1046/j.1471-4159.2003.02277.x; Fasano Caroline, 2008, Curr Protoc Neurosci, VChapter 3, DOI 10.1002/0471142301.ns0321s44; Gonzalez-Barrios JA, 2006, MOL THER, V14, P857, DOI 10.1016/j.ymthe.2006.09.001; Howe SJ, 2008, J CLIN INVEST, V118, P3143, DOI 10.1172/JCI35798; Imaoka T, 1998, HUM GENE THER, V9, P1093, DOI 10.1089/hum.1998.9.7-1093; Jomphe C, 2005, J NEUROSCI METH, V146, P1, DOI 10.1016/j.jneumeth.2005.01.014; Lim KI, 2012, BMB REP, V45, P207, DOI 10.5483/BMBRep.2012.45.4.207; Mandel RJ, 2008, EXP NEUROL, V209, P58, DOI 10.1016/j.expneurol.2007.08.008; Marks WJ, 2010, LANCET NEUROL, V9, P1164, DOI 10.1016/S1474-4422(10)70254-4; Martinez-Fong D, 2000, BRAIN RES PROTOC, V6, P13, DOI 10.1016/S1385-299X(00)00032-5; Martinez-Fong D, 1999, MOL BRAIN RES, V69, P249, DOI 10.1016/S0169-328X(99)00114-X; Martinez-Fong D, 2012, NANOMED-NANOTECHNOL, V8, P1052, DOI 10.1016/j.nano.2012.02.009; Martres MP, 1998, EUR J NEUROSCI, V10, P3607, DOI 10.1046/j.1460-9568.1998.00366.x; Navarro-Quiroga I, 2002, MOL BRAIN RES, V105, P86, DOI 10.1016/S0169-328X(02)00396-0; Nihira T, 2011, J NEUROSCI METH, V201, P55, DOI 10.1016/j.jneumeth.2011.07.010; Orozco-Barrios CE, 2009, PLOS ONE, V4, pe8268; QUIRION R, 1985, BRAIN RES, V327, P385, DOI 10.1016/0006-8993(85)91542-2; RAYPORT S, 1992, J NEUROSCI, V12, P4264; Rubio-Zapata HA, 2009, CANCER GENE THER, V16, P573, DOI 10.1038/cgt.2009.1; Sakurai H, 2008, INT J PHARMACEUT, V354, P9, DOI 10.1016/j.ijpharm.2007.06.012; St-Gelais F, 2004, J NEUROSCI, V24, P2566, DOI 10.1523/JNEUROSCI.5376-03.2004; Sulzer D, 1998, J NEUROSCI, V18, P4588, DOI 10.1523/jneurosci.18-12-04588.1998; SZIGETHY E, 1989, J COMP NEUROL, V279, P128, DOI 10.1002/cne.902790111; TAKESHIMA T, 1994, J NEUROSCI, V14, P4769; Takeshima T, 1996, J NEUROSCI METH, V67, P27, DOI 10.1016/S0165-0270(96)00002-7; Toulorge D, 2011, FASEB J, V25, P2563, DOI 10.1096/fj.11-182824; Toy-Miou-Leong M, 2004, J HISTOCHEM CYTOCHEM, V52, P335, DOI 10.1177/002215540405200304; Ulusoy A, 2011, THER DELIV, V2, P37, DOI 10.4155/TDE.10.95; Yu LY, 2008, J NEUROSCI METH, V169, P8, DOI 10.1016/j.jneumeth.2007.11.018; Zhu JG, 2009, J CLIN INVEST, V119, P2388, DOI 10.1172/JCI37607	38	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e51341	10.1371/journal.pone.0051341	http://dx.doi.org/10.1371/journal.pone.0051341			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300540	gold, Green Published, Green Submitted			2022-12-27	WOS:000313618800014
J	Jeckel, KM; Veeramachaneni, DNR; Chicco, AJ; Chapman, PL; Mulligan, CM; Hegarty, JR; Pagliassotti, MJ; Ferguson, LA; Bouma, GJ; Frye, MA				Jeckel, Kimberly M.; Veeramachaneni, D. N. Rao; Chicco, Adam J.; Chapman, Phillip L.; Mulligan, Christopher M.; Hegarty, Jennifer R.; Pagliassotti, Michael J.; Ferguson, Lindsay A.; Bouma, Gerrit J.; Frye, Melinda A.			Docosahexaenoic Acid Supplementation Does Not Improve Western Diet-Induced Cardiomyopathy in Rats	PLOS ONE			English	Article							HIGH-FAT DIET; LEFT-VENTRICULAR MASS; CARDIAC-HYPERTROPHY; HEART-FAILURE; CONTRACTILE DYSFUNCTION; LIPID-ACCUMULATION; INSULIN-RESISTANCE; SYSTOLIC FUNCTION; GENE-EXPRESSION; OBESITY	Obesity increases risk for cardiomyopathy in the absence of hypertension, diabetes or ischemia. The fatty acid milieu, modulated by diet, may modify myocardial structure and function, lending partial explanation for the array of cardiomyopathic phenotypy. We sought to identify gross, cellular and ultrastructural myocardial changes associated with Western diet intake, and subsequent modification with docosahexaenoic acid (DHA) supplementation. Wistar and Sprague-Dawley (SD) rats received 1 of 3 diets: control (CON); Western (WES); Western + DHA (WES+DHA). After 12 weeks of treatment, echocardiography was performed and myocardial adiponectin, fatty acids, collagen, area occupied by lipid and myocytes, and ultrastructure were determined. Strain effects included higher serum adiponectin in Wistar rats, and differences in myocardial fatty acid composition. Diet effects were evident in that both WES and WES+DHA feeding were associated with similarly increased left ventricular (LV) diastolic cranial wall thickness (LVWcr/d) and decreased diastolic internal diameter (LVIDd), compared to CON. Unexpectedly, WES+DHA feeding was associated additionally with increased thickness of the LV cranial wall during systole (LVWcr/s) and the caudal wall during diastole (LVWca/d) compared to CON; this was observed concomitantly with increased serum and myocardial adiponectin. Diastolic dysfunction was present in WES+DHA rats compared to both WES and CON. Myocyte cross sectional area (CSA) was greater in WES compared to CON rats. In both fat-fed groups, transmission electron microscopy (TEM) revealed myofibril degeneration, disorganized mitochondrial cristae, lipid inclusions and vacuolation. In the absence of hypertension and whole body insulin resistance, WES+DHA intake was associated with more global LV thickening and with diastolic dysfunction, compared to WES feeding alone. Myocyte hypertrophy, possibly related to subcellular injury, is an early change that may contribute to gross hypertrophy. Strain differences in adipokines and myocardial fatty acid accretion may underlie heterogeneous data from rodent studies.	[Jeckel, Kimberly M.; Veeramachaneni, D. N. Rao; Chicco, Adam J.; Bouma, Gerrit J.; Frye, Melinda A.] Colorado State Univ, Dept Biomed Sci, Coll Vet Med & Biomed Sci, Ft Collins, CO 80523 USA; [Chicco, Adam J.] Colorado State Univ, Dept Hlth & Exercise Sci, Coll Appl Human Sci, Ft Collins, CO 80523 USA; [Chapman, Phillip L.] Colorado State Univ, Coll Nat Sci, Dept Stat, Ft Collins, CO 80523 USA; [Chicco, Adam J.; Mulligan, Christopher M.; Pagliassotti, Michael J.] Colorado State Univ, Coll Appl Human Sci, Dept Food Sci & Human Nutr, Ft Collins, CO 80523 USA; [Hegarty, Jennifer R.] Colorado State Univ, Coll Engn, Dept Chem & Biol Engn, Ft Collins, CO 80523 USA; [Ferguson, Lindsay A.] Creighton Univ, Sch Med, Omaha, NE USA; [Frye, Melinda A.] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Clin Sci, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University; Colorado State University; Colorado State University; Colorado State University; Creighton University; Colorado State University	Frye, MA (corresponding author), Colorado State Univ, Dept Biomed Sci, Coll Vet Med & Biomed Sci, Ft Collins, CO 80523 USA.	melinda.frye@colostate.edu	Bouma, Gerrit/AAT-4644-2020; Pagliassotti, Michael/AAV-8238-2021	Bouma, Gerrit/0000-0003-2433-5086; 	National Institutes of Health, National Center for Research Resources [SERCA K01]; Colorado State University College Research Council; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K01OD010971] Funding Source: NIH RePORTER	National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Colorado State University College Research Council; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding for this project was contributed by the National Institutes of Health, National Center for Research Resources (SERCA K01) and the Colorado State University College Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akki A, 2009, CARDIOVASC RES, V81, P610, DOI 10.1093/cvr/cvn316; AMAD KH, 1965, CIRCULATION, V32, P740, DOI 10.1161/01.CIR.32.5.740; Amin RH, 2010, AM J PHYSIOL-HEART C, V299, pH690, DOI 10.1152/ajpheart.01032.2009; Arterburn LM, 2000, FOOD CHEM TOXICOL, V38, P35, DOI 10.1016/S0278-6915(99)00119-2; Ayalew-Pervanchon A, 2007, AM J PHYSIOL-HEART C, V293, pH2296, DOI 10.1152/ajpheart.00194.2007; Bartels ED, 2010, ENDOCRINOLOGY, V151, P5218, DOI 10.1210/en.2010-0355; Berkalp B, 1995, INT J CARDIOL, V52, P23, DOI 10.1016/0167-5273(95)02431-U; Bordoni A, 2007, FEBS LETT, V581, P923, DOI 10.1016/j.febslet.2007.01.070; Chicco AJ, 2008, HYPERTENSION, V52, P549, DOI 10.1161/HYPERTENSIONAHA.108.114264; Dong F, 2007, DIABETES, V56, P2201, DOI 10.2337/db06-1596; Drazner MH, 2004, J AM COLL CARDIOL, V43, P2207, DOI 10.1016/j.jacc.2003.11.064; du Toit EF, 2005, BASIC RES CARDIOL, V100, P346, DOI 10.1007/s00395-005-0528-5; Duda MK, 2009, CARDIOVASC RES, V81, P319, DOI 10.1093/cvr/cvn310; Esmaillzadeh A, 2007, AM J CLIN NUTR, V85, P910, DOI 10.1093/ajcn/85.3.910; Essick EE, 2011, AM J PHYSIOL-HEART C, V301, pH984, DOI 10.1152/ajpheart.00428.2011; Fang Y, 2011, FUND CLIN PHARMACOL, V25, P323, DOI 10.1111/j.1472-8206.2010.00839.x; Foppa Murilo, 2005, Cardiovasc Ultrasound, V3, P17, DOI 10.1186/1476-7120-3-17; Fujita M, 2011, BIOL PHARM BULL, V34, P87, DOI 10.1248/bpb.34.87; GALAN X, 1994, LIPIDS, V29, P333, DOI 10.1007/BF02537186; Gardin JM, 2001, AM J CARDIOL, V87, P1051, DOI 10.1016/S0002-9149(01)01460-6; Ge F, 2012, J OBES, V2012, DOI 10.1155/2012/205648; Glenn DJ, 2011, HYPERTENSION, V57, P216, DOI 10.1161/HYPERTENSIONAHA.110.160655; Gruber C, 2012, CARDIOVASC PATHOL, V21, P346, DOI 10.1016/j.carpath.2011.11.003; Guo ZX, 2012, EUR J PHARMACOL, V685, P116, DOI 10.1016/j.ejphar.2012.04.010; Halade GV, 2011, PHARMACOL RES, V63, P300, DOI 10.1016/j.phrs.2010.12.012; Higashino H., 1995, Clinical and Experimental Pharmacology and Physiology, V22, pS292, DOI 10.1111/j.1440-1681.1995.tb02923.x; Iyer A, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep090; Jalili T, 2003, J NUTR, V133, P358, DOI 10.1093/jn/133.2.358; Jeckel KM, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-92; Jude S, 2007, BRIT J NUTR, V98, P1143, DOI 10.1017/S0007114507798914; Kardys I, 2009, INT J CARDIOL, V133, P198, DOI 10.1016/j.ijcard.2007.12.031; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Kong SW, 2005, PHYSIOL GENOMICS, V21, P34, DOI 10.1152/physiolgenomics.00226.2004; Kortelainen ML, 2011, AM J FOREN MED PATH, V32, P372, DOI 10.1097/PAF.0b013e318219cd89; Kris-Etherton PM, 2003, ARTERIOSCL THROM VAS, V23, P151, DOI 10.1161/01.ATV.0000057393.97337.AE; KUWAHARA M, 1991, EXP ANIM TOKYO, V40, P331, DOI 10.1538/expanim1978.40.3_331; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Li YQ, 2009, J MOL CELL CARDIOL, V47, P536, DOI 10.1016/j.yjmcc.2009.07.001; Lien EL, 2009, PROSTAG LEUKOTR ESS, V81, P125, DOI 10.1016/j.plefa.2009.05.004; Lind L, 2011, ARTERIOSCL THROM VAS, V31, pE27, DOI 10.1161/ATVBAHA.110.221572; Loh MY, 1998, P SOC EXP BIOL MED, V218, P38, DOI 10.3181/00379727-218-44265; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; McLennan PL, 2012, BRIT J NUTR, V108, P645, DOI 10.1017/S0007114511005915; McManus DD, 2012, OBESITY, V20, P1882, DOI 10.1038/oby.2011.32; Mullen KL, 2007, AM J PHYSIOL-ENDOC M, V293, pE83, DOI 10.1152/ajpendo.00545.2006; Murtaugh MA, 2007, J AM DIET ASSOC, V107, P1311, DOI 10.1016/j.jada.2007.05.008; O'Shea KM, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-95; Okere IC, 2006, HYPERTENSION, V48, P1116, DOI 10.1161/01.HYP.0000248430.26229.0f; Okere IC, 2006, AM J PHYSIOL-HEART C, V291, pH38, DOI 10.1152/ajpheart.01295.2005; Oliveira SA, 2010, MED SCI MONITOR, V16, pBR367; Oliveira SA, 2009, ARQ BRAS CARDIOL, V93, P487, DOI 10.1590/S0066-782X2009001100014; Ouwens DM, 2005, DIABETOLOGIA, V48, P1229, DOI 10.1007/s00125-005-1755-x; Park J, 2011, J HYPERTENS, V29, P1765, DOI 10.1097/HJH.0b013e32834a50f3; Perona JS, 2005, AM J HYPERTENS, V18, P72, DOI 10.1016/j.amjhyper.2004.11.012; Poudyal H, 2012, J NUTR BIOCHEM, V23, P153, DOI 10.1016/j.jnutbio.2010.11.011; Poudyal H, 2010, J NUTR, V140, P946, DOI 10.3945/jn.109.117812; Powell BD, 2006, AM J CARDIOL, V98, P116, DOI 10.1016/j.amjcard.2006.01.063; Pulakat L, 2011, AM J PHYSIOL-REG I, V301, pR885, DOI 10.1152/ajpregu.00316.2011; Qin YW, 2010, ACTA PHARMACOL SIN, V31, P1350, DOI 10.1038/aps.2010.109; Rider OJ, 2011, HEART, V97, P203, DOI 10.1136/hrt.2009.185009; Riquelme CA, 2011, SCIENCE, V334, P528, DOI 10.1126/science.1210558; RUSTAN AC, 1992, BIOCHEM J, V283, P333, DOI 10.1042/bj2830333; Schaub MC, 1997, J MOL MED, V75, P901, DOI 10.1007/s001090050182; SCHEMMEL R, 1970, J NUTR, V100, P1041; Sergiel JP, 1998, CAN J PHYSIOL PHARM, V76, P728, DOI 10.1139/cjpp-76-7-8-728; Sharma S, 2004, FASEB J, V18, P1692, DOI 10.1096/fj.04-2263com; Slee EL, 2010, J LIPID RES, V51, P1841, DOI 10.1194/jlr.M004069; STORLIEN LH, 1991, DIABETES, V40, P280, DOI 10.2337/diabetes.40.2.280; SWITZER BR, 1971, ANAL BIOCHEM, V39, P487, DOI 10.1016/0003-2697(71)90438-6; Szczepaniak LS, 2003, MAGN RESON MED, V49, P417, DOI 10.1002/mrm.10372; Tumuklu MM, 2007, ECHOCARDIOGR-J CARD, V24, P802, DOI 10.1111/j.1540-8175.2007.00484.x; Turdi S, 2011, J MOL CELL CARDIOL, V50, P712, DOI 10.1016/j.yjmcc.2010.12.007; WEST DB, 1995, AM J PHYSIOL-REG I, V268, pR658, DOI 10.1152/ajpregu.1995.268.3.R658; Wilson CR, 2007, BIOCHEM J, V406, P457, DOI 10.1042/BJ20070392; Wong CY, 2004, CIRCULATION, V110, P3081, DOI 10.1161/01.CIR.0000147184.13872.0F; Xu FP, 2004, CIRCULATION, V110, P1269, DOI 10.1161/01.CIR.0000140766.52771.6D; Yi W, 2011, ANTIOXID REDOX SIGN, V15, P1779, DOI 10.1089/ars.2010.3722	77	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e51994	10.1371/journal.pone.0051994	http://dx.doi.org/10.1371/journal.pone.0051994			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300587	Green Submitted, Green Published, gold			2022-12-27	WOS:000313618800043
J	Lou, CJ; Zhang, FY; Yang, M; Zhao, J; Zeng, WF; Fang, XC; Zhang, YQ; Zhang, CL; Liang, W				Lou, Changjie; Zhang, Fayun; Yang, Ming; Zhao, Juan; Zeng, Wenfeng; Fang, Xiaocui; Zhang, Yanqiao; Zhang, Chunling; Liang, Wei			Naringenin Decreases Invasiveness and Metastasis by Inhibiting TGF-beta-Induced Epithelial to Mesenchymal Transition in Pancreatic Cancer Cells	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; RECEPTOR KINASE; GROWTH; EXPRESSION; TGF-BETA-1; TRANSDIFFERENTIATION; PROLIFERATION; RESISTANCE	Epithelial to mesenchymal transition (EMT) promotes cellular motility, invasiveness and metastasis during embryonic development and tumorigenesis. Transforming growth factor-beta (TGF-beta) signaling pathway is a key regulator of EMT. A lot of evidences suggest that this process is Smad3-dependent. Herein we showed that exposure of aspc-1 and panc-1 pancreatic cancer cells to TGF-beta 1 resulted in characteristic morphological alterations of EMT, and enhancement of cell motility and gemcitabine (Gem) resistance along with an up-regulation of EMT markers genes such as vimentin, N-cadherin, MMP2 and MMP9. Naringenin (Nar) down-regulated EMT markers expression in both mRNA and protein levels by inhibiting TGF-beta 1/Smad3 signal pathway in the pancreatic cancer cells. Consequently, Nar suppressed the cells migration and invasion and reversed their resistance to Gem.	[Lou, Changjie; Yang, Ming; Zhao, Juan; Zhang, Yanqiao] Harbin Med Univ, Inst Prevent & Treatment Canc Heilongjiang Prov, Dept Gastrointestinal Med Oncol, Affiliated Hosp 3, Harbin, Peoples R China; [Lou, Changjie; Zhang, Fayun; Zeng, Wenfeng; Fang, Xiaocui; Zhang, Chunling; Liang, Wei] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Prot & Peptide Pharmaceut Lab, Beijing 100080, Peoples R China	Harbin Medical University; Chinese Academy of Sciences; Institute of Biophysics, CAS	Zhang, YQ (corresponding author), Harbin Med Univ, Inst Prevent & Treatment Canc Heilongjiang Prov, Dept Gastrointestinal Med Oncol, Affiliated Hosp 3, Harbin, Peoples R China.	yanqiaozhang@126.com; zhangcl@moon.ibp.ac.cn			National Nature Sciences Foundation of China [81173633]; State Key Development Plan Project [2011CB707705]; Research Foundation of Department of Health of Heilongjiang Province [2010-107]; startup Fund of The Affiliated Third Hospital of Harbin Medical University [JJ2010-15]	National Nature Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Development Plan Project; Research Foundation of Department of Health of Heilongjiang Province; startup Fund of The Affiliated Third Hospital of Harbin Medical University	This work was supported by the National Nature Sciences Foundation of China (81173633), grants from State Key Development Plan Project (2011CB707705), the Research Foundation of Department of Health of Heilongjiang Province(2010-107) and the startup Fund of The Affiliated Third Hospital of Harbin Medical University (JJ2010-15). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumugam T, 2009, CANCER RES, V69, P5820, DOI 10.1158/0008-5472.CAN-08-2819; Banerjee S, 2011, INT J CANCER, V128, P1240, DOI 10.1002/ijc.25658; Callahan JF, 2002, J MED CHEM, V45, P999, DOI 10.1021/jm010493y; Du GJ, 2009, CANCER RES, V69, P3205, DOI 10.1158/0008-5472.CAN-08-3393; Duarte N, 2010, PLANTA MED, V76, P975, DOI 10.1055/s-0029-1240892; Ellenrieder V, 2001, INT J CANCER, V93, P204, DOI 10.1002/ijc.1330; Ellenrieder V, 2001, CANCER RES, V61, P4222; Fakhrai H, 2006, CANCER GENE THER, V13, P1052, DOI 10.1038/sj.cgt.7700975; Flavell RA, 2010, NAT REV IMMUNOL, V10, P554, DOI 10.1038/nri2808; Furukawa H, 1996, CANCER, V78, P986, DOI 10.1002/(SICI)1097-0142(19960901)78:5<986::AID-CNCR7>3.0.CO;2-A; Halder SK, 2005, NEOPLASIA, V7, P509, DOI 10.1593/neo.04640; Hau P, 2007, OLIGONUCLEOTIDES, V17, P201, DOI 10.1089/oli.2006.0053; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jeong JH, 2009, J CELL BIOCHEM, V106, P73, DOI 10.1002/jcb.21977; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Labbe E, 1998, MOL CELL, V2, P109, DOI 10.1016/S1097-2765(00)80119-7; Laping NJ, 2002, MOL PHARMACOL, V62, P58, DOI 10.1124/mol.62.1.58; Levy L, 2006, CYTOKINE GROWTH F R, V17, P41, DOI 10.1016/j.cytogfr.2005.09.009; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Lim H, 2011, J PHARMACOL SCI, V116, P221, DOI 10.1254/jphs.11014FP; Liu XJ, 2006, PHARM RES-DORDR, V23, P82, DOI 10.1007/s11095-005-9043-5; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nakajima S, 2004, CLIN CANCER RES, V10, P4125, DOI 10.1158/1078-0432.CCR-0578-03; Oft M, 1996, GENE DEV, V10, P2462, DOI 10.1101/gad.10.19.2462; Qin L, 2011, PROTEIN CELL, V2, P507, DOI 10.1007/s13238-011-1056-8; Shin JA, 2011, J CELL BIOCHEM, V112, P179, DOI 10.1002/jcb.22929; Tang LY, 2011, EMBO J, V30, P4777, DOI 10.1038/emboj.2011.393; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thomas Hilary, 2003, Cancer Control, V10, P159; Valcourt U, 2005, MOL BIOL CELL, V16, P1987, DOI 10.1091/mbc.e04-08-0658; Vandewalle C, 2005, NUCLEIC ACIDS RES, V33, P6566, DOI 10.1093/nar/gki965; Varadhachary GR, 2006, ANN SURG ONCOL, V13, P1035, DOI 10.1245/ASO.2006.08.011; Wang ZW, 2011, NAT REV GASTRO HEPAT, V8, P27, DOI 10.1038/nrgastro.2010.188; Yang Y, 2011, CHEM COMMUN, V47, P5440, DOI 10.1039/c1cc10778j; Yin Tao, 2006, J Huazhong Univ Sci Technolog Med Sci, V26, P700, DOI 10.1007/s11596-006-0619-z; Yingling JM, 2004, NAT REV DRUG DISCOV, V3, P1011, DOI 10.1038/nrd1580; Zhang FY, 2009, PHARM RES-DORDR, V26, P914, DOI 10.1007/s11095-008-9793-y	37	86	92	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e50956	10.1371/journal.pone.0050956	http://dx.doi.org/10.1371/journal.pone.0050956			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300530	Green Published, gold, Green Submitted			2022-12-27	WOS:000313618800008
J	Qin, SM; Verkasalo, H; Mohtaschemi, M; Hartonen, T; Alava, M				Qin, Shao-Meng; Verkasalo, Hannu; Mohtaschemi, Mikael; Hartonen, Tuomo; Alava, Mikko			Patterns, Entropy, and Predictability of Human Mobility and Life	PLOS ONE			English	Article								Cellular phones are now offering an ubiquitous means for scientists to observe life: how people act, move and respond to external influences. They can be utilized as measurement devices of individual persons and for groups of people of the social context and the related interactions. The picture of human life that emerges shows complexity, which is manifested in such data in properties of the spatiotemporal tracks of individuals. We extract from smartphone-based data for a set of persons important locations such as "home", "work" and so forth over fixed length time-slots covering the days in the dataset (see also [1,2]). This set of typical places is heavy-tailed, a power-law distribution with an exponent close to -1.7. To analyze the regularities and stochastic features present, the days are classified for each person into regular, personal patterns. To this are superimposed fluctuations for each day. This randomness is measured by "life" entropy, computed both before and after finding the clustering so as to subtract the contribution of a number of patterns. The main issue that we then address is how predictable individuals are in their mobility. The patterns and entropy are reflected in the predictability of the mobility of the life both individually and on average. We explore the simple approaches to guess the location from the typical behavior, and of exploiting the transition probabilities with time from location or activity A to B. The patterns allow an enhanced predictability, at least up to a few hours into the future from the current location. Such fixed habits are most clearly visible in the working-day length.	[Qin, Shao-Meng; Mohtaschemi, Mikael; Hartonen, Tuomo; Alava, Mikko] Aalto Univ, Dept Appl Phys, Espoo, Finland; [Verkasalo, Hannu] WR WIRELESS Res Ltd, Espoo, Finland; [Verkasalo, Hannu] Zokem Ltd, Espoo, Finland	Aalto University	Alava, M (corresponding author), Aalto Univ, Dept Appl Phys, Espoo, Finland.	mikko.alava@aalto.fi	Alava, Mikko/G-2202-2013	Alava, Mikko/0000-0001-9249-5079	Finnish Funding Agency for Technology and Innovation; National Agency for Technology; Academy of Finland's Center of Excellence program	Finnish Funding Agency for Technology and Innovation(Finnish Funding Agency for Technology & Innovation (TEKES)); National Agency for Technology; Academy of Finland's Center of Excellence program	The study has been financed by the Finnish Funding Agency for Technology and Innovation, the National Agency for Technology and the Academy of Finland's Center of Excellence program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad U, 2007, P 6 INT C MOB UB MUL, P55; [Anonymous], 2007, STAT PHYS PARTICLES; Blondel V. D., 2012, ARXIV12100137; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Candia J, 2008, J PHYS A-MATH THEOR, V41, DOI 10.1088/1751-8113/41/22/224015; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Chon Y, 2012, INT CONF PERVAS COMP, P206, DOI 10.1109/PerCom.2012.6199868; De Domenico M, 2012, NOK MOB DAT CHALL 20; Duch J, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.027104; Eagle N, 2006, PERS UBIQUIT COMPUT, V10, P255, DOI 10.1007/s00779-005-0046-3; Eagle N, 2009, P NATL ACAD SCI USA, V106, P15274, DOI 10.1073/pnas.0900282106; Etter V, 2012, NOK MOB DAT CHALL 20; Farrahi K, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1889681.1889684; Farrahi K, 2008, TWELFTH IEEE INTERNATIONAL SYMPOSIUM ON WEARABLE COMPUTERS, PROCEEDINGS, P29, DOI 10.1109/ISWC.2008.4911580; Gambs S, 2012, 1 WORKSH MEAS PRIV M; Gambs S, 2011, 1 INT WORKSH DYN OPO; Gao H., 2012, P NOK MOB DAT CHALL, V41, P1; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Huang CM, 2012, NOK MOB DAT CHALL 20; Isaacman S, 2011, LECT NOTES COMPUT SC, V6696, P133, DOI 10.1007/978-3-642-21726-5_9; Kim DH, 2009, UBICOMP'09: PROCEEDINGS OF THE 11TH ACM INTERNATIONAL CONFERENCE ON UBIQUITOUS COMPUTING, P21; Kirmse A., 2011, P 19 ACM SIGSPATIAL, P397, DOI DOI 10.1145/2093973.2094032; Kiukkonen N., 2010, P ICPS, V68, P1; Laasonen K, 2009, THESIS U HELSINKI; Lu Z, 2012, NOK MOB DAT CHALL 20; McGrath R, 2012, NOK MOB DAT CHALL 20; McInerney J, 2012, NOK MOB DAT CHALL 20; Mitchell TM, 2009, SCIENCE, V326, P1644, DOI 10.1126/science.1174459; Montoliu R., 2012, P NOK MOB DAT CHALL, V1, P1; Nguyen L, 2012, NOK MOB DAT CHALL 20; Nurmi P., 2009, THESIS U HELSINKI; Raento M, 2005, IEEE PERVAS COMPUT, V4, P51, DOI 10.1109/MPRV.2005.29; Raento M, 2009, SOCIOL METHOD RES, V37, P426, DOI 10.1177/0049124108330005; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Szell M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00457; Vespignani A, 2009, SCIENCE, V325, P425, DOI 10.1126/science.1171990; Wang J, 2012, NOK MOB DAT CHALL 20; Zhu Y, 2012, NOK MOB DAT CHALL 20	41	34	36	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e51353	10.1371/journal.pone.0051353	http://dx.doi.org/10.1371/journal.pone.0051353			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300542	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000313618800015
J	Tervo, OM; Christoffersen, MF; Simon, M; Miller, LA; Jensen, FH; Parks, SE; Madsen, PT				Tervo, Outi M.; Christoffersen, Mads F.; Simon, Malene; Miller, Lee A.; Jensen, Frants H.; Parks, Susan E.; Madsen, Peter T.			High Source Levels and Small Active Space of High-Pitched Song in Bowhead Whales (Balaena mysticetus)	PLOS ONE			English	Article							UNDERWATER SOUNDS; HUMPBACK WHALES; FIN WHALES; COMMUNICATION; BEHAVIOR; RANGE; SIGNALS; NOISE; MIGRATION; WHISTLES	The low-frequency, powerful vocalizations of blue and fin whales may potentially be detected by conspecifics across entire ocean basins. In contrast, humpback and bowhead whales produce equally powerful, but more complex broadband vocalizations composed of higher frequencies that suffer from higher attenuation. Here we evaluate the active space of high frequency song notes of bowhead whales (Balaena mysticetus) in Western Greenland using measurements of song source levels and ambient noise. Four independent, GPS-synchronized hydrophones were deployed through holes in the ice to localize vocalizing bowhead whales, estimate source levels and measure ambient noise. The song had a mean apparent source level of 185 +/- 2 dB rms re 1 mu Pa @ 1 m and a high mean centroid frequency of 444 +/- 48 Hz. Using measured ambient noise levels in the area and Arctic sound spreading models, the estimated active space of these song notes is between 40 and 130 km, an order of magnitude smaller than the estimated active space of low frequency blue and fin whale songs produced at similar source levels and for similar noise conditions. We propose that bowhead whales spatially compensate for their smaller communication range through mating aggregations that co-evolved with broadband song to form a complex and dynamic acoustically mediated sexual display.	[Tervo, Outi M.; Christoffersen, Mads F.] Univ Copenhagen, Arctic Stn, Qeqertarsuaq, Greenland; [Simon, Malene] Greenland Inst Nat Resources, Greenland Climate Res Ctr, Nuuk, Greenland; [Miller, Lee A.] Univ So Denmark, Inst Biol, Odense M, Denmark; [Jensen, Frants H.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Parks, Susan E.] Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA; [Madsen, Peter T.] Aarhus Univ, Dept Biosci, DK-8000 Aarhus C, Denmark	Greenland Institute of Natural Resources; University of Southern Denmark; Woods Hole Oceanographic Institution; Syracuse University; Aarhus University	Tervo, OM (corresponding author), Univ Copenhagen, Arctic Stn, Qeqertarsuaq, Greenland.	outiter@gmail.com	Jensen, Frants H/G-3438-2013; Madsen, Peter T/K-5832-2013; Parks, Susan E/D-2675-2014	Jensen, Frants H/0000-0001-8776-3606; Madsen, Peter T/0000-0002-5208-5259; Parks, Susan E/0000-0001-6663-627X; Miller, Lee A./0000-0002-6004-1950	Oticon Foundation [08-3469]; AP Moller og Hustru Chastine Mc-Kinney Mollers Fond til almene Formaal; Danish Council for Independent Research, Natural Sciences post-doctoral grant; U.S. Office of Naval Research; Danish Natural Science Research Council	Oticon Foundation; AP Moller og Hustru Chastine Mc-Kinney Mollers Fond til almene Formaal; Danish Council for Independent Research, Natural Sciences post-doctoral grant; U.S. Office of Naval Research(Office of Naval Research); Danish Natural Science Research Council(Danish Natural Science Research Council)	This work was funded by the Oticon Foundation (grant # 08-3469 to Arctic Station, OT). OT and MC were additionally funded by AP Moller og Hustru Chastine Mc-Kinney Mollers Fond til almene Formaal, MS by a PhD scholarship from the Oticon Foundation, FHJ by a Danish Council for Independent Research, Natural Sciences post-doctoral grant, SEP by a grant from the U.S. Office of Naval Research, and PTM by frame grants from the Danish Natural Science Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1986, BRUEL KJAER POCKET H, P51; Au W. W., 1993, SONAR DOLPHINS; Au WWL, 2006, J ACOUST SOC AM, V120, P1103, DOI 10.1121/1.2211547; Blackwell SB, 2007, ARCTIC, V60, P255; Blackwell SB, 2012, MAR MAMMAL SCI, V28, P200, DOI 10.1111/j.1748-7692.2011.00464.x; Bradbury Jack W., 1998, pi; BRENOWITZ EA, 1982, BEHAV ECOL SOCIOBIOL, V10, P29, DOI 10.1007/BF00296393; BRENOWITZ EA, 1982, J COMP PHYSIOL, V147, P511, DOI 10.1007/BF00612017; Brownell RL, 1986, REPORTS INT WHALING, V8, P110; CATCHPOLE CK, 1980, BEHAVIOUR, V74, P149, DOI 10.1163/156853980X00366; Catchpole CK, 1995, BIRD SONG BIOL THEME; Cerchio S, 2001, ANIM BEHAV, V62, P313, DOI 10.1006/anbe.2001.1747; Clark CW, 2009, MAR ECOL PROG SER, V395, P201, DOI 10.3354/meps08402; CLARK CW, 1990, NATO ADV SCI I A-LIF, V196, P571; CLARK CW, 1984, CAN J ZOOL, V62, P1436, DOI 10.1139/z84-206; Clark CW, 1995, REPORT INT WHALING C, V45, P210; Clark CW, 1986, REP FROM MARINE ACOU; Clark CW, 2004, ECHOLOCATION BATS DO, P565; Connor RC, 2000, CETACEAN SOCIETIES, P247; Croll DA, 2002, NATURE, V417, P809, DOI 10.1038/417809a; Cummings W. C., 1994, J ACOUST SOC AM, V95, P2853, DOI DOI 10.1121/1.409514; CUMMINGS WC, 1987, J ACOUST SOC AM, V82, P814, DOI 10.1121/1.395279; CUMMINGS WC, 1971, J ACOUST SOC AM, V50, P1193, DOI 10.1121/1.1912752; DABELSTEEN T, 1993, J ACOUST SOC AM, V93, P2206, DOI 10.1121/1.406682; Delarue J, 2009, J ACOUST SOC AM, V126, P3319, DOI 10.1121/1.3257201; Draganoiu TI, 2002, P ROY SOC B-BIOL SCI, V269, P2525, DOI 10.1098/rspb.2002.2192; Eschricht DF, 1861, OM NORDHVALEN BALAEN; Evans PGH, 1987, THE NATURAL HISTORY; Fletcher NH, 2004, J ACOUST SOC AM, V115, P2334, DOI 10.1121/1.1694997; GERHARDT HC, 1988, ANIM BEHAV, V36, P1247, DOI 10.1016/S0003-3472(88)80090-3; Gillooly JF, 2010, P ROY SOC B-BIOL SCI, V277, P1325, DOI 10.1098/rspb.2009.2134; Heide-Jorgensen M. P., 2010, Endangered Species Research, V13, P73, DOI 10.3354/esr00315; Heide-Jorgensen MP, 2007, BIOL LETTERS, V3, P577, DOI 10.1098/rsbl.2007.0310; Janik VM, 2000, J COMP PHYSIOL A, V186, P673, DOI 10.1007/s003590000120; Jensen FH, 2012, J ACOUST SOC AM, V131, P582, DOI 10.1121/1.3662067; Kinsler, 1999, FUNDAMENTALS ACOUSTI; Laidre KL, 2007, MAR ECOL PROG SER, V346, P285, DOI 10.3354/meps06995; LJUNGBLAD DK, 1982, J ACOUST SOC AM, V71, P477, DOI 10.1121/1.387419; Madsen PT, 2007, DEEP-SEA RES PT I, V54, P1421, DOI 10.1016/j.dsr.2007.04.020; MARTEN K, 1977, BEHAV ECOL SOCIOBIOL, V2, P271, DOI 10.1007/BF00299740; Mathevon N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001580; Medwin H., 1998, FUNDAMENTALS ACOUSTI; Mellinger DK, 2000, MAR MAMMAL SCI, V16, P739, DOI 10.1111/j.1748-7692.2000.tb00969.x; Mohl B, 2001, J ACOUST SOC AM, V109, P434, DOI 10.1121/1.1323462; Nakano R, 2009, J EXP BIOL, V212, P4072, DOI 10.1242/jeb.032466; PAYNE K, 1985, Z TIERPSYCHOL, V68, P89; PAYNE R, 1971, ANN NY ACAD SCI, V188, P110, DOI 10.1111/j.1749-6632.1971.tb13093.x; PAYNE RS, 1971, SCIENCE, V173, P585, DOI 10.1126/science.173.3997.585; POOLE JH, 1988, BEHAV ECOL SOCIOBIOL, V22, P385, DOI 10.1007/BF00294975; PRESTWICH KN, 1989, J EXP BIOL, V144, P53; Richardson WJ, 1995, MARINE MAMMALS NOISE; Simon M, 2010, J ACOUST SOC AM, V128, P3200, DOI 10.1121/1.3495946; Simon M, 2009, P ROY SOC B-BIOL SCI, V276, P3819, DOI 10.1098/rspb.2009.1135; Sirovic A, 2007, J ACOUST SOC AM, V122, P1208, DOI 10.1121/1.2749452; SPIESBERGER JL, 1990, AM NAT, V135, P107, DOI 10.1086/285035; Stafford KM, 2008, J ACOUST SOC AM, V124, P3315, DOI 10.1121/1.2980443; Taylor AM, 2010, J ZOOL, V280, P221, DOI 10.1111/j.1469-7998.2009.00661.x; Tervo OM, 2011, J ACOUST SOC AM, V130, P2257, DOI 10.1121/1.3628327; Tervo OM, 2011, MAR MAMMAL SCI, V27, pE241, DOI 10.1111/j.1748-7692.2010.00451.x; Tervo OM, 2009, J ACOUST SOC AM, V126, P1570, DOI 10.1121/1.3158941; Tyack PL, 2000, SPR HDB AUD, V12, P156; Tyack PL, 2000, CETACEAN SOCIETIES, P270; Urick RJ., 1983, PRINCIPLES UNDERWATE, V3; Wahlberg M, 2001, J ACOUST SOC AM, V109, P397, DOI 10.1121/1.1329619; WATKINS WA, 1987, J ACOUST SOC AM, V82, P1901, DOI 10.1121/1.395685; WENZ GM, 1961, J ACOUST SOC AM, V33, P64, DOI 10.1121/1.1908406; WHITEHEAD H, 1985, SCI AM, V252, P84, DOI 10.1038/scientificamerican0385-84; Wursig Bernd, 1993, Society for Marine Mammalogy Special Publication, V2, P157	68	14	14	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52072	10.1371/journal.pone.0052072	http://dx.doi.org/10.1371/journal.pone.0052072			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300591	Green Published, gold			2022-12-27	WOS:000313618800045
J	Vannier, J				Vannier, Jean			Gut Contents as Direct Indicators for Trophic Relationships in the Cambrian Marine Ecosystem	PLOS ONE			English	Article							PHYLLOPOD BED COMMUNITY; BURGESS SHALE; PRIAPULUS-CAUDATUS; ANOMALOCARIS; WORMS; ARTHROPOD; ORIGIN; LAGERSTATTE; PREDATORS; BEHAVIOR	Present-day ecosystems host a huge variety of organisms that interact and transfer mass and energy via a cascade of trophic levels. When and how this complex machinery was established remains largely unknown. Although exceptionally preserved biotas clearly show that Early Cambrian animals had already acquired functionalities that enabled them to exploit a wide range of food resources, there is scant direct evidence concerning their diet and exact trophic relationships. Here I describe the gut contents of Ottoia prolifica, an abundant priapulid worm from the middle Cambrian (Stage 5) Burgess Shale biota. I identify the undigested exoskeletal remains of a wide range of small invertebrates that lived at or near the water sediment interface such as hyolithids, brachiopods, different types of arthropods, polychaetes and wiwaxiids. This set of direct fossil evidence allows the first detailed reconstruction of the diet of a 505-million-year-old animal. Ottoia was a dietary generalist and had no strict feeding regime. It fed on both living individuals and decaying organic matter present in its habitat. The feeding behavior of Ottoia was remarkably simple, reduced to the transit of food through an eversible pharynx and a tubular gut with limited physical breakdown and no storage. The recognition of generalist feeding strategies, exemplified by Ottoia, reveals key-aspects of modern-style trophic complexity in the immediate aftermath of the Cambrian explosion. It also shows that the middle Cambrian ecosystem was already too complex to be understood in terms of simple linear dynamics and unique pathways.	Univ Lyon 1, Lab Geol Lyon Terre, F-69622 Villeurbanne, France	Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Vannier, J (corresponding author), Univ Lyon 1, Lab Geol Lyon Terre, F-69622 Villeurbanne, France.	jean.vannier@univ-lyon1.fr			ANR (Agence Nationale de la Recherche) grant (ORECO); European Assemble Project (Sven Loven Centre for Marine Sciences at Kristineberg, Sweden); ANR (Agence Nationale de la Recherche) grant (RALI)	ANR (Agence Nationale de la Recherche) grant (ORECO)(French National Research Agency (ANR)); European Assemble Project (Sven Loven Centre for Marine Sciences at Kristineberg, Sweden); ANR (Agence Nationale de la Recherche) grant (RALI)(French National Research Agency (ANR))	The author's research is supported by ANR (Agence Nationale de la Recherche) grants (ORECO and RALI) and by the European Assemble Project (2010, Sven Loven Centre for Marine Sciences at Kristineberg, Sweden). ANR website at: www.agence-nationale-recherche.fr, ASSEMBLE (Association of European Marine Biological Laboratories): www.assemblemarine.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANKAR S, 1981, OPHELIA, V20, P45, DOI 10.1080/00785236.1981.10426561; BABCOCK L E, 1988, University of Kansas Paleontological Contributions Paper, P1; Babcock LE, 2002, PREDATOR PREY INTERA, P317; Briggs D.E.G., 1994, FOSSILS BURGESS SHAL; Brusca RC, 2003, INVERTEBRATES; BRUTON DL, 1983, PHILOS T R SOC B, V300, P553, DOI 10.1098/rstb.1983.0020; Bruton DL, 2001, LETHAIA, V34, P163, DOI 10.1080/00241160152418456; BUDD G, 1993, NATURE, V364, P709, DOI 10.1038/364709a0; Butterfield N.J., 2001, P40, DOI 10.1002/9780470999295.ch7; Butterfield NJ, 2007, PALAEONTOLOGY, V50, P537, DOI 10.1111/j.1475-4983.2007.00656.x; Caron J-B, 2009, ICCE 2009; Caron JB, 2008, PALAEOGEOGR PALAEOCL, V258, P222, DOI 10.1016/j.palaeo.2007.05.023; Caron JB, 2006, PALAIOS, V21, P451, DOI 10.2110/palo.2003.P05-070R; Caron JB, 2006, NATURE, V442, P159, DOI 10.1038/nature04894; CHEN J. Y., 2004, DAWN ANIMAL WORLD; Chen JY, 2004, LETHAIA, V37, P3, DOI 10.1080/00241160410004764; Conway Morris S., 1977, SPEC PAP PALAEONTOL, V20, P1; Cutler E. B, 1994, SIPUNCULA THEIR SYST; Daley AC, 2012, NATURWISSENSCHAFTEN, V99, P501, DOI 10.1007/s00114-012-0910-8; Daley AC, 2009, SCIENCE, V323, P1597, DOI 10.1126/science.1169514; Dunne JA, 2008, PLOS BIOL, V6, P693, DOI 10.1371/journal.pbio.0060102; Fletcher TP, 2003, CAN J EARTH SCI, V40, P1823, DOI 10.1139/E03-057; Fletcher TP, 1998, CAN J EARTH SCI, V35, P413, DOI 10.1139/e97-120; Gaines RR, 2012, P NATL ACAD SCI USA, V109, P5180, DOI 10.1073/pnas.1111784109; Gehling JG, 2011, AUST J EARTH SCI, V58, P243, DOI 10.1080/08120099.2011.555487; Hagadorn JW, 2009, GEOLOGICAL SOC AM AB, V41, P162; Hagadorn JW, 2009, WALC 2009 INT C CAMB, P33; Harvey THP, 2008, NATURE, V452, P868, DOI 10.1038/nature06724; Hou X. -G., 2004, CAMBRIAN FOSSILS CHE; Hou XG, 2008, SCIENCE, V322, P224, DOI 10.1126/science.1162794; Hu SX, 2007, PALAEOGEOGR PALAEOCL, V254, P307, DOI 10.1016/j.palaeo.2007.03.044; Huang DY, 2004, P ROY SOC B-BIOL SCI, V271, P1671, DOI 10.1098/rspb.2004.2774; JENSEN S, 1990, LETHAIA, V23, P29, DOI 10.1111/j.1502-3931.1990.tb01779.x; Laflamme M, 2009, P NATL ACAD SCI USA, V106, P14438, DOI 10.1073/pnas.0904836106; Land J. van der, 1970, ZOOL VERHANDL, V112, P1; LANG KARL, 1948, ARKIV ZOOL, V41B, P1; Lee MSY, 2011, NATURE, V474, P631, DOI 10.1038/nature10097; Leighton LR, 2003, PREDATOR PREY INTERA, P317; Macdonald TA, 2012, MAR ECOL PROG SER, V445, P129, DOI 10.3354/meps09478; Minter NJ, 2012, P ROY SOC B-BIOL SCI, V279, P1613, DOI 10.1098/rspb.2011.1986; Moore JC, 2004, ECOL LETT, V7, P584, DOI 10.1111/j.1461-0248.2004.00606.x; MORRIS SC, 1986, PALAEONTOLOGY, V29, P423; MORRIS SC, 1985, PHILOS T R SOC B, V307, P507, DOI 10.1098/rstb.1985.0005; MORRIS SC, 1979, PHILOS T R SOC B, V285, P227, DOI 10.1098/rstb.1979.0006; MORRIS SC, 1987, NATURE, V326, P181, DOI 10.1038/326181a0; Narbonne GM, 2005, ANNU REV EARTH PL SC, V33, P421, DOI 10.1146/annurev.earth.33.092203.122519; Nedin C, 1999, GEOLOGY, V27, P987, DOI 10.1130/0091-7613(1999)027<0987:APONAM>2.3.CO;2; O'Brien LL, 2012, PLOS ONE, V7, pe2923; Paterson JR, 2011, NATURE, V480, P237, DOI 10.1038/nature10689; Peng SC, 2011, B GEOSCI, V86, P391, DOI 10.3140/bull.geosci.1273; RASETTI FRANCO, 1951, SMITHSONIAN MISC COLL, V116, P1; Rigby J.K., 1986, PALAEONTOGR CAN, V2, P1; Rigby J.K., 2004, ROYAL ONTARIO MUSEUM, V1, P1; Siveter David J., 1997, Special Papers in Palaeontology, V57, P1; Smith MR, 2010, NATURE, V465, P469, DOI 10.1038/nature09068; Stein M, 2010, LETHAIA, V43, P258, DOI 10.1111/j.1502-3931.2009.00189.x; STORCH V, 1994, J MORPHOL, V220, P281, DOI 10.1002/jmor.1052200307; Storch V, 1991, MICROSCOPIC ANATOMY, V4; Trott TJ, 1998, MAR FRESHW BEHAV PHY, V31, P251, DOI 10.1080/10236249809387076; Vannier J, 2007, P ROY SOC B-BIOL SCI, V274, P627, DOI 10.1098/rspb.2006.3761; Vannier J, 2005, PALAIOS, V20, P3, DOI 10.2110/palo.2003.p03-40; Vannier J, 2009, P ROY SOC B-BIOL SCI, V276, P2567, DOI 10.1098/rspb.2009.0361; Vannier J, 2010, GEOLOGY, V38, P711, DOI 10.1130/G30829.1; Vannier J, 2009, CR PALEVOL, V8, P133, DOI 10.1016/j.crpv.2008.10.006; Walcott C. D., 1924, Smithsonian Miscellaneous Collections, V67, P477; Walcott C.D, 1912, GEOL SURV US MONOGR, V2, P1; Waloszek D, 2007, PALAEOGEOGR PALAEOCL, V254, P273, DOI 10.1016/j.palaeo.2007.03.027; WHITTINGTON HB, 1985, PHILOS T R SOC B, V309, P569, DOI 10.1098/rstb.1985.0096; Wilson LA, 2006, THESIS CAMBRIDGE; Zhang XL, 2007, J PALEONTOL, V81, P1, DOI 10.1666/06-082.1; Zhao FC, 2012, PALAEOGEOGR PALAEOCL, V346, P54, DOI 10.1016/j.palaeo.2012.05.021; Zhao FC, 2009, PALAIOS, V24, P826, DOI 10.2110/palo.2009.p09-004r; Zhu MY, 2004, P ROY SOC B-BIOL SCI, V271, pS277, DOI 10.1098/rsbl.2004.0194	73	74	76	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52200	10.1371/journal.pone.0052200	http://dx.doi.org/10.1371/journal.pone.0052200			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300612	Green Published, Green Submitted, gold			2022-12-27	WOS:000313618800055
J	Long, SY; Yang, XL; Liu, XJ; Yang, P				Long, Shuyu; Yang, Xingliang; Liu, Xiaojiao; Yang, Pei			Methylenetetrahydrofolate Reductase (MTHFR) Polymorphisms and Susceptibility for Cervical Lesions: A Meta-Analysis	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS; COLORECTAL-CANCER; NATURAL-HISTORY; COMMON MUTATION; FOLATE; RISK; ASSOCIATION; C677T; GENE; CARCINOGENESIS	Background: The association between the methylenetetrahydrofolate reductase (MTHFR) C677T/A1298C polymorphisms and the susceptibility to cervical lesions was unclear. This study was designed to investigate their precise association using a large-scale meta-analysis. Methods: The previous 16 studies were identified by searching PubMed, Embase and CBM databases. The crude odds ratios and their corresponding 95% confidence intervals (CIs) were used to estimate the association between the MTHFR C677T/A1298C polymorphisms and the susceptibility to the cervical lesions. The subgroup analyses were made on the following: pathological history, geographic region, ethnicity, source of controls and source of DNA for genotyping. Results: Neither of the polymorphisms had a significant association with the susceptibility to the cervical lesions in all genetic models. Similar results were found in the subgroup analyses. No association was found between the MTHFR C677T polymorphism and the cervical lesions in the Asia or the America populations though a significant inverse association was found in the Europe population (additive model: P = 0.006, OR = 0.83, 95% CI = 0.72-0.95; CT vs. CC: P = 0.05, OR = 0.83, 95% CI = 0.69-1.00; TT vs. CC: P = 0.05, OR = 0.73, 95% CI = 0.53-1.00). Interestingly, women with the MTHFR A1298C polymorphisms had a marginally increased susceptibility to invasive cancer (ICC) when compared with no carriers but no statistically significant difference in the dominant model (P = 0.06, OR = 1.21, 95% CI = 0.99-1.49) and AC vs. AA (P = 0.09, OR = 1.21, 95% CI = 0.97-1.51). Conclusions: The MTHFR C677T and A1298C polymorphisms may not increase the susceptibility to cervical lesions. However, the meta-analysis reveals a negative association between the MTHFR C677T polymorphisms and the cervical lesions, especially in the European populations. The marginal association between the MTHFR A1298C polymorphisms and the susceptibility to cervical cancer requires a further study.	[Long, Shuyu; Liu, Xiaojiao; Yang, Pei] Sichuan Univ, W China Hosp 2, Dept Gynecol & Obstet, Chengdu 610064, Sichuan, Peoples R China; [Yang, Xingliang] Third Mil Med Univ, Affiliated Hosp 2, Dept Urol, Chongqing, Peoples R China	Sichuan University; Army Medical University	Yang, P (corresponding author), Sichuan Univ, W China Hosp 2, Dept Gynecol & Obstet, Chengdu 610064, Sichuan, Peoples R China.	YangP790@126.com						Agodi A, 2010, INT J GYNECOL CANCER, V20, P141, DOI 10.1111/IGC.0b013e3181c20842; Ashfield-Watt PAL, 2002, AM J CLIN NUTR, V76, P180, DOI 10.1093/ajcn/76.1.180; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Blount BC, 1997, P NATL ACAD SCI USA, V94, P3290, DOI 10.1073/pnas.94.7.3290; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; BUTTERWORTH CE, 1992, JAMA-J AM MED ASSOC, V267, P528, DOI 10.1001/jama.267.4.528; Castellsague X, 2002, VIRUS RES, V89, P191, DOI 10.1016/S0168-1702(02)00188-0; Castellsague Xavier, 2003, J Natl Cancer Inst Monogr, P20; Collin SM, 2009, CANCER EPIDEM BIOMAR, V18, P2528, DOI 10.1158/1055-9965.EPI-09-0223; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Elfgren K, 2000, AM J OBSTET GYNECOL, V183, P561, DOI 10.1067/mob.2000.106749; Garcia-Closas R, 2005, INT J CANCER, V117, P629, DOI 10.1002/ijc.21193; Goodman MT, 2001, CANCER EPIDEM BIOMAR, V10, P1275; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Huang Y, 2007, J HUM GENET, V52, P73, DOI 10.1007/s10038-006-0082-5; Hubner RA, 2007, INT J CANCER, V120, P1027, DOI 10.1002/ijc.22440; Insinga RP, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-119; Jacques PF, 1996, CIRCULATION, V93, P7, DOI 10.1161/01.CIR.93.1.7; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kang S, 2005, GYNECOL ONCOL, V96, P173, DOI 10.1016/j.ygyno.2004.09.031; Kohaar I, 2010, BIOMARKERS, V15, P61, DOI 10.3109/13547500903295881; Lambropoulos AF, 2003, CANCER LETT, V191, P187, DOI 10.1016/S0304-3835(02)00675-4; Langevin SM, 2009, TOXICOL LETT, V184, P73, DOI 10.1016/j.toxlet.2008.09.003; Larsson SC, 2006, GASTROENTEROLOGY, V131, P1271, DOI 10.1053/j.gastro.2006.08.010; Ma X, 2006, CHINA PUBLIC HLTH, V22, P1247; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Mostowska A, 2011, CLIN BIOCHEM, V44, P596, DOI 10.1016/j.clinbiochem.2011.02.007; Nandan Naveen Kumar, 2008, Drug Metab Lett, V2, P18; Pillai MR, 2003, J CLIN PATHOL, V56, P569, DOI 10.1136/jcp.56.8.569; Piyathilake CJ, 2007, NUTRITION, V23, P229, DOI 10.1016/j.nut.2006.12.006; Piyathilake CJ, 2004, CANCER RES, V64, P8788, DOI 10.1158/0008-5472.CAN-04-2402; Piyathilake CJ, 2000, ANTICANCER RES, V20, P1751; POTISCHMAN N, 1991, CANCER RES, V51, P4785; Prasad VVTS, 2011, ONKOLOGIE, V34, P422, DOI 10.1159/000331131; Sedjo RL, 2002, CANCER EPIDEM BIOMAR, V11, P353; Shekari M, 2008, ARCH GYNECOL OBSTET, V278, P517, DOI 10.1007/s00404-008-0623-6; Sull JW, 2004, GYNECOL ONCOL, V95, P557, DOI 10.1016/j.ygyno.2004.08.008; Tong SY, 2011, CANCER CAUSE CONTROL, V22, P63, DOI 10.1007/s10552-010-9675-6; van der Put NMJ, 1998, AM J HUM GENET, V62, P1044, DOI 10.1086/301825; VANEENWYK J, 1992, CANCER EPIDEM BIOMAR, V1, P119; VANNIEKERK WA, 1966, ACTA CYTOL, V10, P67; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; WHITEHEAD N, 1973, JAMA-J AM MED ASSOC, V226, P1421, DOI 10.1001/jama.226.12.1421; Yamada K, 2001, P NATL ACAD SCI USA, V98, P14853, DOI 10.1073/pnas.261469998; Yang F, 2010, J CHINA MATERNAL CHI, V23, P4122; Zacho J, 2011, INT J CANCER, V128, P644, DOI 10.1002/ijc.25375; Zintzaras E, 2006, J HUM GENET, V51, P618, DOI 10.1007/s10038-006-0405-6; Zoodsma M, 2005, HUM GENET, V116, P247, DOI 10.1007/s00439-004-1233-4	49	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52381	10.1371/journal.pone.0052381	http://dx.doi.org/10.1371/journal.pone.0052381			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285018	Green Published, Green Submitted, gold			2022-12-27	WOS:000313158800059
J	Prado, JRM; Chen, X; Fuller, MT				Prado, Jose Rafael Morillo; Chen, Xin; Fuller, Margaret T.			Polycomb Group Genes Psc and Su(z)2 Maintain Somatic Stem Cell Identity and Activity in Drosophila	PLOS ONE			English	Article							POSTERIOR SEX COMBS; SELF-RENEWAL; BITHORAX COMPLEX; GROUP PROTEIN; SPATIAL EXPRESSION; TUMOR-SUPPRESSOR; ABDOMINAL-B; BMI-1; MEL-18; ENCODES	Adult stem cells are essential for the proper function of many tissues, yet the mechanisms that maintain the proper identity and regulate proliferative capacity in stem cell lineages are not well understood. Polycomb group (PcG) proteins are transcriptional repressors that have recently emerged as important regulators of stem cell maintenance and differentiation. Here we describe the role of Polycomb Repressive Complex 1 (PRC1) genes Posterior sex combs (Psc) and Suppressor of zeste two (Su(z)2) in restricting the proliferation and maintaining the identity of the Cyst Stem Cell (CySC) lineage in the Drosophila testis. In contrast, Psc and Su(z)2 seem to be dispensable for both germline stem cell (GSC) maintenance and germ cell development. We show that loss of Psc and Su(z)2 function in the CySC lineage results in the formation of aggregates of mutant cells that proliferate abnormally, and display abnormal somatic identity correlated with derepression of the Hox gene Abdominal-B. Furthermore, we show that tumorigenesis in the CySC lineage interferes non-cell autonomously with maintenance of GSCs most likely by displacing them from their niche.	[Prado, Jose Rafael Morillo; Fuller, Margaret T.] Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA; [Chen, Xin] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA	Stanford University; Johns Hopkins University	Fuller, MT (corresponding author), Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA.	mtfuller@stanford.edu		Fuller, Margaret T/0000-0002-3804-4987	NIH [GM61986, K-99/R00 HD055052]; NSF; Stanford University DARE; Reed-Hodgson Professorship in Human Biology; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K99HD055052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061986] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Stanford University DARE; Reed-Hodgson Professorship in Human Biology; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant GM61986 to M. T. F. J.R.M.P. was supported by an NSF Graduate Research Fellowship and a Stanford University DARE Doctoral Fellowship. X. C. was supported by NIH K-99/R00 HD055052 award. M. T. F. gratefully acknowledges the Reed-Hodgson Professorship in Human Biology, which partially supported this work. [http://www.nih.gov/, http://www.nsfgrfp.org/, http://vpge.stanford.edu/fellowships/dare.html]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beuchle D, 2001, DEVELOPMENT, V128, P993; BONINI NM, 1993, CELL, V72, P379, DOI 10.1016/0092-8674(93)90115-7; BOYLE M, 1995, DEVELOPMENT, V121, P1815; BRUNK BP, 1991, NATURE, V353, P351, DOI 10.1038/353351a0; CELNIKER SE, 1990, EMBO J, V9, P4277, DOI 10.1002/j.1460-2075.1990.tb07876.x; CELNIKER SE, 1993, P NATL ACAD SCI USA, V90, P1566, DOI 10.1073/pnas.90.4.1566; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Classen AK, 2009, NAT GENET, V41, P1150, DOI 10.1038/ng.445; DeFalco T, 2004, MECH DEVELOP, V121, P1323, DOI 10.1016/j.mod.2004.07.001; DeFalco TJ, 2003, DEV CELL, V5, P205, DOI 10.1016/S1534-5807(03)00204-1; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; DiNardo S, 2011, DEVELOPMENT, V138, P1687, DOI 10.1242/dev.057364; Fabrizio JJ, 2003, DEV BIOL, V258, P117, DOI 10.1016/S0012-1606(03)00127-1; Fuller MT, 2007, SCIENCE, V316, P402, DOI 10.1126/science.1140861; GOEBL MG, 1991, CELL, V66, P623, DOI 10.1016/0092-8674(91)90106-9; GOLIC KG, 1991, SCIENCE, V252, P958, DOI 10.1126/science.2035025; Guo WJ, 2007, CANCER RES, V67, P5083, DOI 10.1158/0008-5472.CAN-06-4368; Guo WJ, 2007, MOL BIOL CELL, V18, P536, DOI 10.1091/mbc.E06-05-0447; HAUPT Y, 1993, ONCOGENE, V8, P3161; IRMINGERFINGER I, 1995, GENE, V163, P203, DOI 10.1016/0378-1119(95)00326-2; Iwai Y, 1997, NEURON, V19, P77, DOI 10.1016/S0896-6273(00)80349-9; Iwama A, 2004, IMMUNITY, V21, P843, DOI 10.1016/j.immuni.2004.11.004; JURGENS G, 1985, NATURE, V316, P153, DOI 10.1038/316153a0; Kajiume T, 2004, EXP HEMATOL, V32, P571, DOI 10.1016/j.exphem.2004.03.001; KANNO M, 1995, EMBO J, V14, P5672, DOI 10.1002/j.1460-2075.1995.tb00254.x; Kennison JA, 1995, ANNU REV GENET, V29, P289, DOI 10.1146/annurev.ge.29.120195.001445; Kiger AA, 2000, NATURE, V407, P750, DOI 10.1038/35037606; Kim JH, 2004, BREAST, V13, P383, DOI 10.1016/j.breast.2004.02.010; Kyba M, 1998, MOL CELL BIOL, V18, P2712, DOI 10.1128/MCB.18.5.2712; LAWRENCE PA, 1983, CELL, V35, P27, DOI 10.1016/0092-8674(83)90204-0; Le Bras S, 2006, DEV BIOL, V294, P92, DOI 10.1016/j.ydbio.2006.02.030; Leatherman JL, 2008, CELL STEM CELL, V3, P44, DOI 10.1016/j.stem.2008.05.001; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Li MA, 2003, NAT CELL BIOL, V5, P994, DOI 10.1038/ncb1058; Li XH, 2010, GENE DEV, V24, P933, DOI 10.1101/gad.1901510; Lovato TL, 2002, DEVELOPMENT, V129, P5019; Lovegrove B, 2006, CURR BIOL, V16, P2206, DOI 10.1016/j.cub.2006.09.029; MARTIN EC, 1993, DEVELOPMENT, V117, P641; Martinez AM, 2006, GENE DEV, V20, P501, DOI 10.1101/gad.357106; McGuire Sean E, 2004, Sci STKE, V2004, ppl6, DOI 10.1126/stke.2202004pl6; Nanda S, 2009, SEX DEV, V3, P26, DOI 10.1159/000200079; ODA H, 1994, DEV BIOL, V165, P716, DOI 10.1006/dbio.1994.1287; Orlando V, 2003, CELL, V112, P599, DOI 10.1016/S0092-8674(03)00157-0; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; RIGGLEMAN B, 1990, CELL, V63, P549, DOI 10.1016/0092-8674(90)90451-J; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; Shiozawa Y, 2011, J CLIN INVEST, V121, P1298, DOI 10.1172/JCI43414; SOTO MC, 1995, GENETICS, V140, P231; Strutt H, 1997, MOL CELL BIOL, V17, P6773, DOI 10.1128/MCB.17.12.6773; Tran J, 2000, NATURE, V407, P754, DOI 10.1038/35037613; VANLOHUIZEN M, 1991, NATURE, V353, P353, DOI 10.1038/353353a0; Xie T, 2005, DEV DYNAM, V232, P775, DOI 10.1002/dvdy.20317; XU T, 1993, DEVELOPMENT, V117, P1223; Yamashita YM, 2005, J CELL SCI, V118, P665, DOI 10.1242/jcs.01680	55	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52892	10.1371/journal.pone.0052892	http://dx.doi.org/10.1371/journal.pone.0052892			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285219	Green Published, Green Submitted, gold			2022-12-27	WOS:000313158800106
J	Wang, JM; Bai, ZK; Yang, PL				Wang, Jinman; Bai, Zhongke; Yang, Peiling			Sodic Soil Properties and Sunflower Growth as Affected by Byproducts of Flue Gas Desulfurization	PLOS ONE			English	Article							GYPSUM; RECLAMATION; RESTORATION	The main component of the byproducts of flue gas desulfurization (BFGD) is CaSO4, which can be used to improve sodic soils. The effects of BFGD on sodic soil properties and sunflower growth were studied in a pot experiment. The experiment consisted of eight treatments, at four BFGD rates (0, 7.5, 15 and 22.5 t ha(-1)) and two leaching levels (750 and 1200 m(3) ha(-1)). The germination rate and yield of the sunflower increased, and the exchangeable sodium percentage (ESP), pH and total dissolved salts (TDS) in the soils decreased after the byproducts were applied. Excessive BFGD also affected sunflower germination and growth, and leaching improved reclamation efficiency. The physical and chemical properties of the reclaimed soils were best when the byproducts were applied at 7.5 t ha(-1) and water was supplied at 1200 m(3).ha(-1). Under these conditions, the soil pH, ESP, and TDS decreased from 9.2, 63.5 and 0.65% to 7.8, 2.8 and 0.06%, and the germination rate and yield per sunflower reached 90% and 36.4 g, respectively. Salinity should be controlled by leaching when sodic soils are reclaimed with BFGD as sunflower growth is very sensitive to salinity during its seedling stage.	[Wang, Jinman; Bai, Zhongke] China Univ Geosci, Coll Land Sci & Technol, Beijing, Peoples R China; [Wang, Jinman; Bai, Zhongke] Minist Land & Resources, Key Lab Land Consolidat & Land Rehabil, Beijing, Peoples R China; [Yang, Peiling] China Agr Univ, Coll Hydraul & Civil Engn, Beijing 100094, Peoples R China	China University of Geosciences; Ministry of Natural Resources of the People's Republic of China; China Agricultural University	Wang, JM (corresponding author), China Univ Geosci, Coll Land Sci & Technol, Beijing, Peoples R China.	wangjinman2002@163.com		Wang, Jinman/0000-0002-8140-997X	Fundamental Research Funds for the Central Universities of China; National Natural Science Foundation of China [50749032]	Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the Fundamental Research Funds for the Central Universities of China, and the National Natural Science Foundation of China (50749032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CARLSON CL, 1993, J ENVIRON QUAL, V22, P227, DOI 10.2134/jeq1993.00472425002200020002x; Carter M. R., 1989, Arid Soil Research and Rehabilitation, V3, P1, DOI 10.1080/15324988909381184; Chen LM, 2009, FUEL, V88, P1167, DOI 10.1016/j.fuel.2008.07.015; Chorom M, 1994, AUSTR J SOIL RES, V32, P1152; Chun S, 2001, ENVIRON POLLUT, V114, P453, DOI 10.1016/S0269-7491(00)00226-8; Clark RB, 2001, FUEL, V80, P821, DOI 10.1016/S0016-2361(00)00162-9; FRENKEL H, 1989, J SOIL SCI, V40, P599, DOI 10.1111/j.1365-2389.1989.tb01301.x; Ilyas M, 1997, SOIL TECHNOL, V10, P247, DOI 10.1016/S0933-3630(96)00121-3; Katerji N, 1997, AGR WATER MANAGE, V34, P57, DOI 10.1016/S0378-3774(96)01294-2; Ministry of Agriculture and fisheries, 1984, GB428484 MIN AGR FIS; Ministry of Agriculture and fisheries, 1987, GB817387 MIN AGR FIS; OSTER JD, 1980, SOIL SCI SOC AM J, V44, P41, DOI 10.2136/sssaj1980.03615995004400010010x; Pandey V. C., 2011, Ecological Restoration, V29, P322, DOI 10.3368/er.29.4.322; Rhoades J. D., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P149; Sakai Y, 2004, SOIL SEDIMENT CONTAM, V13, P65, DOI 10.1080/10588330490269840; Shannon MC, 1997, ADV AGRON, V60, P75, DOI 10.1016/S0065-2113(08)60601-X; Singh K, 2012, CATENA, V96, P57, DOI 10.1016/j.catena.2012.04.007; Sloan JJ, 1999, FUEL, V78, P169, DOI 10.1016/S0016-2361(98)00135-5; Stuczynski TI, 1998, SOIL SCI, V163, P952, DOI 10.1097/00010694-199812000-00005; Truman CC, 2010, CATENA, V81, P234, DOI 10.1016/j.catena.2010.04.003; Wang JinMan, 2005, Acta Pedologica Sinica, V42, P98; Wang JM, 2004, Land and Water Management: Decision Tools and Practices, Vols 1 and 2, P1015; Wang SJ, 2008, ENVIRON POLLUT, V151, P200, DOI 10.1016/j.envpol.2007.02.014	23	11	12	7	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52437	10.1371/journal.pone.0052437	http://dx.doi.org/10.1371/journal.pone.0052437			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285042	Green Submitted, Green Published, gold			2022-12-27	WOS:000313158800066
J	Finn, TP; Stewart, BT; Reid, HL; Petty, N; Sabasio, A; Oguttu, D; Lado, M; Brooker, SJ; Kolaczinski, JH				Finn, Timothy P.; Stewart, Barclay T.; Reid, Heidi L.; Petty, Nora; Sabasio, Anthony; Oguttu, David; Lado, Mounir; Brooker, Simon J.; Kolaczinski, Jan H.			Integrated Rapid Mapping of Neglected Tropical Diseases in Three States of South Sudan: Survey Findings and Treatment Needs	PLOS ONE			English	Article							URINARY SCHISTOSOMIASIS; EPIDEMIOLOGY; FILARIASIS	Background: Integrated rapid mapping to target interventions for schistosomiasis, soil-transmitted helminthiasis (STH) and lymphatic filariasis (LF) is ongoing in South Sudan. From May to September 2010, three states - Unity, Eastern Equatoria and Central Equatoria - were surveyed with the aim of identifying which administrative areas are eligible for mass drug administration (MDA) of preventive chemotherapy (PCT). Methods and Principal Findings: Payams (third administrative tier) were surveyed for Schistosoma mansoni, S. haematobium and STH infections while counties (second administrative tier) were surveyed for LF. Overall, 12,742 children from 193 sites were tested for schistosome and STH infection and, at a subset of 50 sites, 3,980 adults were tested for LF. Either S. mansoni or S. haematobium or both species were endemic throughout Unity State and occurred in foci in Central and Eastern Equatoria. STH infection was endemic throughout Central Equatoria and the western counties of Eastern Equatoria, while LF was endemic over most of Central- and Eastern Equatoria, but only in selected foci in Unity. All areas identified as STH endemic were co-endemic for schistosomiasis and/or LF. Conclusions: The distribution and prevalence of major NTDs, particularly schistosomiasis, varies considerably throughout South Sudan. Rapid mapping is therefore important in identifying (co)-endemic areas. The present survey established that across the three surveyed states between 1.2 and 1.4 million individuals are estimated to be eligible for regular MDA with PCT to treat STH and schistosomiasis, respectively, while approximately 1.3 million individuals residing in Central- and Eastern Equatoria are estimated to require MDA for LF. Citation: Finn TP, Stewart BT, Reid HL, Petty N, Sabasio A, et al. (2012) Integrated Rapid Mapping of Neglected Tropical Diseases in Three States of South Sudan: Survey Findings and Treatment Needs. PLoS ONE 7(12): e52789. doi:10.1371/journal.pone.0052789	[Stewart, Barclay T.; Brooker, Simon J.; Kolaczinski, Jan H.] London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England; [Finn, Timothy P.; Stewart, Barclay T.; Reid, Heidi L.; Petty, Nora; Sabasio, Anthony] S Sudan Country Off, Malaria Consortium, Juba, Sudan; [Stewart, Barclay T.] Med Univ S Carolina, Charleston, SC 29425 USA; [Reid, Heidi L.] Univ Queensland, Sch Populat Hlth, Herston, Qld, Australia; [Oguttu, David] Minist Hlth, Vector Control Div, Kampala, Uganda; [Lado, Mounir] Minist Hlth, Juba, Sudan; [Brooker, Simon J.] Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Nairobi, Kenya; [Kolaczinski, Jan H.] Africa Reg Off, Malaria Consortium, Kampala, Uganda	University of London; London School of Hygiene & Tropical Medicine; Medical University of South Carolina; University of Queensland; Kenya Medical Research Institute	Kolaczinski, JH (corresponding author), London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England.	jan_kolaczinski@mac.com			USAID through RTI International; Wellcome Trust through a Research Career Development Fellowship [081673]	USAID through RTI International(United States Agency for International Development (USAID)); Wellcome Trust through a Research Career Development Fellowship(Wellcome Trust)	The work presented in this publication was made possible by the generous support of the American people through the United States Agency for International Development (USAID). The contents are the responsibility of the authors and do not necessarily reflect the views of USAID or the United States Government. USAID funding was provided through RTI International to Malaria Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. SB is supported by the Wellcome Trust through a Research Career Development Fellowship (081673).	Brooker S, 2004, EPIDEMIOL INFECT, V132, P1065, DOI 10.1017/S0950268804003024; Brooker S, 2007, T ROY SOC TROP MED H, V101, P1, DOI 10.1016/j.trstmh.2006.08.004; Ekpo UF, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-74; KIRK R, 1957, Bull World Health Organ, V16, P593; Kolaczinski JH, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000745; Mectizan Expert Committee, 2006, REC MECT EXP COMM MA; *MOH GOSS, 2008, NEGL TROP DIS SO SUD; MORE SJ, 1990, TROP MED PARASITOL, V41, P403; Ngondi J, 2009, B WORLD HEALTH ORGAN, V87, P143, DOI 10.2471/BLT.07.046326; Rumunu J, 2009, TRENDS PARASITOL, V25, P301, DOI 10.1016/j.pt.2009.03.011; Simoonga C, 2008, GEOSPATIAL HEALTH, V3, P57, DOI 10.4081/gh.2008.232; Srividya A, 2002, AM J TROP MED HYG, V67, P480, DOI 10.4269/ajtmh.2002.67.480; Sturrock HJW, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000537; TDR, 2002, GUID RAP LOA LOA; WHO, 2006, PREV CHEM HUM HELM; WOODMAN H. M., 1941, TRANS ROY SOC TROP MED AND HYG, V35, P77, DOI 10.1016/S0035-9203(41)90014-7	16	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52789	10.1371/journal.pone.0052789	http://dx.doi.org/10.1371/journal.pone.0052789			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285184	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000312794500245
J	Gellert, A; Salanki, K; Tombacz, K; Tuboly, T; Balazs, E				Gellert, Akos; Salanki, Katalin; Tombacz, Kata; Tuboly, Tamas; Balazs, Ervin			A Cucumber Mosaic Virus Based Expression System for the Production of Porcine Circovirus Specific Vaccines	PLOS ONE			English	Article							B SURFACE-ANTIGEN; CAPSID PROTEIN; TRANSGENIC PLANTS; DISEASE VIRUS; I-TASSER; TYPE-2; IMMUNOGENICITY; IDENTIFICATION; RECOGNITION; PARTICLES	Potential porcine circovirus type 2 (PCV2) capsid protein epitopes, suitable for expression on the surface of cucumber mosaic virus (CMV) particles were determined by a thorough analysis of the predicted PCV capsid protein structure. The ab initio protein structure prediction was carried out with fold recognition and threading methods. The putative PCV epitopes were selected on the basis of PCV virion models and integrated into the plant virus coat protein, after amino acid position 131. The recombinants were tested for infectivity and stability on different Nicotiana species and stable recombinant virus particles were purified. The particles were tested for their ability to bind to PCV induced porcine antibodies and used for specific antibody induction in mice and pigs. The results showed that PCV epitopes expressed on the CMV surface were recognized by the porcine antibodies and they were also able to induce PCV specific antibody response. Challenge experiment with PCV2 carried out in immunized pigs showed partial protection against the infection. Based on these results it was concluded that specific antiviral vaccine production for the given pathogen was feasible, offering an inexpensive way for the mass production of such vaccines.	[Gellert, Akos; Balazs, Ervin] Hungarian Acad Sci, Dept Appl Genom, Inst Agr, Agr Res Ctr, H-2462 Martonvasar, Brunszvik, Hungary; [Salanki, Katalin] Agr Biotechnol Ctr, H-2100 Godollo, Szent Gyorgyi, Hungary; [Tombacz, Kata; Tuboly, Tamas] Szent Istvan Univ, Dept Microbiol & Infect Dis, Fac Vet Sci, Budapest, Hungary	Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Hungarian University of Agriculture & Life Sciences	Balazs, E (corresponding author), Hungarian Acad Sci, Dept Appl Genom, Inst Agr, Agr Res Ctr, H-2462 Martonvasar, Brunszvik, Hungary.	balazs.ervin@agrar.mta.hu	Salanki, Katalin/AAY-1834-2021	Salanki, Katalin/0000-0002-0128-4338; Tombacz, Kata/0000-0003-4062-1664	consortial Hungarian research grant OTKA-NKTH [78317, 78675, 78608]	consortial Hungarian research grant OTKA-NKTH(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	The research in this paper was financed by the consortial Hungarian research grant OTKA-NKTH 78317, 78675, 78608. (http://www.otka.hu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brun A, 2011, VIRUS RES, V157, P1, DOI 10.1016/j.virusres.2011.02.006; Carrillo C, 1998, J VIROL, V72, P1688, DOI 10.1128/JVI.72.2.1688-1690.1998; Csagola A, 2009, EPIDEMIOLOGICAL EXAM; Gellert A, 2006, J MOL GRAPH MODEL, V24, P319, DOI 10.1016/j.jmgm.2005.09.015; Gil F, 2006, PLANT BIOTECHNOL J, V4, P135, DOI 10.1111/j.1467-7652.2005.00172.x; Gilpin DF, 2003, VET IMMUNOL IMMUNOP, V94, P149, DOI 10.1016/S0165-2427(03)00087-4; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Khayat R, 2011, J VIROL, V85, P7856, DOI 10.1128/JVI.00737-11; Kristensen CS, 2011, PREV VET MED, V98, P250, DOI 10.1016/j.prevetmed.2010.11.015; Lekcharoensuk P, 2004, J VIROL, V78, P8135, DOI 10.1128/JVI.78.15.8135-8145.2004; Llamas S, 2006, J GEN VIROL, V87, P2085, DOI 10.1099/vir.0.81871-0; LOT H, 1972, Annales de Phytopathologie, V4, P25; Loza-Rubio E, 2010, ACTA VET HUNG, V58, P511, DOI 10.1556/AVet.58.2010.4.11; Mahe D, 2000, J GEN VIROL, V81, P1815, DOI 10.1099/0022-1317-81-7-1815; MASON HS, 1992, P NATL ACAD SCI USA, V89, P11745, DOI 10.1073/pnas.89.24.11745; Mason HS, 1996, P NATL ACAD SCI USA, V93, P5335, DOI 10.1073/pnas.93.11.5335; Pacios LF, 2006, J GEN VIROL, V87, P2073, DOI 10.1099/vir.0.81621-0; Patterson AR, 2011, VET MICROBIOL, V149, P91, DOI 10.1016/j.vetmic.2010.10.020; PEDEN KWC, 1973, VIROLOGY, V53, P487, DOI 10.1016/0042-6822(73)90232-8; Richter LJ, 2000, NAT BIOTECHNOL, V18, P1167, DOI 10.1038/81153; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Salanki K, 1997, J VIROL, V71, P3597; Salanki K, 2011, ARCH VIROL, V156, P2279, DOI 10.1007/s00705-011-1104-y; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schneidman-Duhovny D, 2005, PROTEINS, V60, P224, DOI 10.1002/prot.20562; Segales Joaquim, 2005, Animal Health Research Reviews, V6, P119, DOI 10.1079/AHR2005106; Segales J, 2012, VIRUS RES, V164, P10, DOI 10.1016/j.virusres.2011.10.007; Shang SB, 2009, RES VET SCI, V84, P150; SHANKARAPPA B, 1992, BIOTECHNIQUES, V12, P882; Streatfield SJ, 2001, VACCINE, V19, P2742, DOI 10.1016/S0264-410X(00)00512-0; Thompson JR, 2006, J VIROL, V80, P7740, DOI 10.1128/JVI.00436-06; TISCHER I, 1974, ZBL BAKT-INT J MED M, V226, P153; Truong C, 2011, ARCH VIROL, V46, P1197; Tuboly T, 2000, VACCINE, V18, P2023, DOI 10.1016/S0264-410X(99)00525-3; Vitti A, 2010, J VIROL METHODS, V169, P332, DOI 10.1016/j.jviromet.2010.07.039; WHITE JL, 1989, J VIROL METHODS, V23, P83, DOI 10.1016/0166-0934(89)90122-5; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	37	16	20	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52688	10.1371/journal.pone.0052688	http://dx.doi.org/10.1371/journal.pone.0052688			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285149	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000312794500229
J	Lin, CW; Song, H; Huang, C; Yao, E; Gacayan, R; Xu, SM; Chuang, PT				Lin, Chuwen; Song, Hai; Huang, Cecilia; Yao, Erica; Gacayan, Rhodora; Xu, Shan-Mei; Chuang, Pao-Tien			Alveolar Type II Cells Possess the Capability of Initiating Lung Tumor Development	PLOS ONE			English	Article							MOUSE MODELS; K-RAS; CRE RECOMBINASE; EGFR MUTATIONS; CANCER MODELS; MICE; ADENOCARCINOMA; P53; PROGRESSION; EXPRESSION	Identifying cells of tumor origin is a fundamental question in tumor biology. Answers to this central question will not only advance our understanding of tumor initiation and progression but also have important therapeutic implications. In this study, we aimed to uncover the cells of origin of lung adenocarcinoma, a major subtype of non-small cell lung cancer. To this end, we developed new mouse models of lung adenocarcinoma that enabled selective manipulation of gene activity in surfactant associated protein C (SPC)-expressing cells, including alveolar type II cells and bronchioalveolar stem cells (BASCs) that reside at the bronchioalveolar duct junction (BADJ). Our findings showed that activation of oncogenic Kras alone or in combination with the removal of the tumor suppressor p53 in SPC+ cells resulted in development of alveolar tumors. Similarly, sustained EGF signaling in SPC+ cells led to alveolar tumors. By contrast, BASCs failed to proliferate or produce tumors under these conditions. Importantly, in a mouse strain in which Kras/p53 activity was selectively altered in type II cells but not BASCs, alveolar tumors developed while BADJs retained normal architecture. These results confirm and extend previous findings and support a model in which lung adenocarcinoma can initiate in alveolar type II cells. Our results establish the foundation for elucidating the molecular mechanisms by which lung cancer initiates and progresses in a specific lung cell type. Citation: Lin C, Song H, Huang C, Yao E, Gacayan R, et al. (2012) Alveolar Type II Cells Possess the Capability of Initiating Lung Tumor Development. PLoS ONE 7(12): e53817. doi:10.1371/journal.pone.0053817	[Lin, Chuwen; Song, Hai; Huang, Cecilia; Yao, Erica; Gacayan, Rhodora; Xu, Shan-Mei; Chuang, Pao-Tien] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Chuang, PT (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA.	pao-tien.chuang@ucsf.edu	Lin, Chuwen/I-3287-2018					Andreeva AV, 2007, AM J PHYSIOL-LUNG C, V293, pL259, DOI 10.1152/ajplung.00112.2007; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Chapman HA, 2011, J CLIN INVEST, V121, P2855, DOI 10.1172/JCI57673; Cheng L, 2012, MOD PATHOL; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; de Seranno S, 2010, EUR RESPIR J, V35, P426, DOI 10.1183/09031936.00124709; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Eliasz S, 2010, ONCOGENE, V29, P2488, DOI 10.1038/onc.2010.7; Frese KK, 2007, NAT REV CANCER, V7, P645, DOI 10.1038/nrc2192; Gazdar AF, 2010, JNCI-J NATL CANCER I, V102, P1310, DOI 10.1093/jnci/djq279; Glasser SW, 2001, P NATL ACAD SCI USA, V98, P6366, DOI 10.1073/pnas.101500298; Greulich Heidi, 2010, Genes Cancer, V1, P1200, DOI 10.1177/1947601911407324; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Joyner AL, 2000, GENE TARGETING PRACT; Kadara H, 2012, RESPIROLOGY, V17, P50, DOI 10.1111/j.1440-1843.2011.02095.x; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kitamura H, 1997, VIRCHOWS ARCH, V431, P415, DOI 10.1007/s004280050118; Kwak I, 2004, ANNU REV PHYSIOL, V66, P647, DOI 10.1146/annurev.physiol.66.032102.134301; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; McErlean A, 2011, SEMIN ROENTGENOL, V46, P173, DOI 10.1053/j.ro.2011.02.002; Meuwissen R, 2005, GENE DEV, V19, P643, DOI 10.1101/gad.1284505; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Murala Sanjay, 2010, J Thorac Dis, V2, P237, DOI 10.3978/j.issn.2072-1439.2010.11.6; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nagy A., 2003, MANIPULATING MOUSE E; Nikitin AY, 2004, CANCER RES, V64, P2307, DOI 10.1158/0008-5472.CAN-03-3376; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2011, LANCET ONCOL, V12, P175, DOI 10.1016/S1470-2045(10)70087-5; Pao W, 2010, NAT REV CANCER, V10, P760, DOI 10.1038/nrc2947; Politi K, 2006, GENE DEV, V20, P1496, DOI 10.1101/gad.1417406; Politi K, 2011, J CLIN ONCOL, V29, P2273, DOI 10.1200/JCO.2010.30.8304; Ramalingam SS, 2011, CA-CANCER J CLIN, V61, P91, DOI 10.3322/caac.20102; Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002; Regales L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000810; Reungwetwattana T, 2011, CLIN LUNG CANC; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Santos GD, 2011, ANNU REV PATHOL-MECH, V6, P49, DOI 10.1146/annurev-pathol-011110-130206; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Sutherland KD, 2010, MOL ONCOL, V4, P397, DOI 10.1016/j.molonc.2010.05.002; Vahakangas KH, 2001, CANCER RES, V61, P4350; Vallieres E, 2011, THORAX; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Winslow MM, 2011, NATURE, V473, P101, DOI 10.1038/nature09881; Xu X, 2012, P NATL ACAD SCI USA, V109, P4910, DOI 10.1073/pnas.1112499109; Yang YN, 2011, J CLIN INVEST, V121, P1373, DOI 10.1172/JCI42579	47	65	69	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e53817	10.1371/journal.pone.0053817	http://dx.doi.org/10.1371/journal.pone.0053817			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285300	Green Published, gold, Green Submitted			2022-12-27	WOS:000312794500259
J	Morrison, BJ; Hastie, ML; Grewal, YS; Bruce, ZC; Schmidt, C; Reynolds, BA; Gorman, JJ; Lopez, JA				Morrison, Brian J.; Hastie, Marcus L.; Grewal, Yadveer S.; Bruce, Zara C.; Schmidt, Chris; Reynolds, Brent A.; Gorman, Jeffrey J.; Lopez, J. Alejandro			Proteomic Comparison of MCF-7 Tumoursphere and Monolayer Cultures	PLOS ONE			English	Article							CARCINOMA-ASSOCIATED PROTEIN; MODIFIED CITRUS PECTIN; IN-VITRO PROPAGATION; BREAST-CANCER CELLS; CARCINOEMBRYONIC ANTIGEN; STEM-CELLS; STEM/PROGENITOR CELLS; MOLECULAR-BIOLOGY; CYCLE ARREST; GALECTIN-3	Breast cancer is a heterogenous disease, composed of tumour cells with differing gene expressions and phenotypes. Very few antigens have been identified and a better understanding of tumour initiating-cells as targets for therapy is critically needed. Recently, a rare subpopulation of cells within tumours has been described with the ability to: (i) initiate and sustain tumour growth; (ii) resist traditional therapies and allow for secondary tumour dissemination; and (iii) display some of the characteristics of stem cells such as self-renewal. These cells are termed tumour-initiating cells or cancer stem cells, or alternatively, in the case of breast cancer, breast cancer stem cells. Previous studies have demonstrated that breast cancer stem cells can be enriched for in "tumoursphere" culture. Proteomics represents a novel way to investigate protein expression between cells. We hypothesise that characterisation of the proteome of the breast cancer line MCF-7 tumourspheres compared to adherent/differentiated cells identifies proteins of novel interest for further isolating or targeting breast cancer stem cells. We present evidence that: (i) the proteome of adherent cells is different to the proteome of cells grown in sphere medium from either early passage (passage 2) or late passage (passage 5) spheres; (ii) that spheres are enriched in expression of a variety of tumour-relevant proteins (including MUC1 and Galectin-3); and (iii) that targeting of one of these identified proteins (galectin-3) using an inhibitor (N-acetyllactosamine) decreases sphere formation/self-renewal of MCF-7 cancer stem cells in vitro and tumourigenicity in vivo. Hence, proteomic analysis of tumourspheres may find use in identifying novel targets for future therapy. The therapeutic targeting of breast cancer stem cells, a highly clinically relevant sub-population of tumour cells, has the potential to eliminate residual disease and may become an important component of a multi-modality treatment of cancer.	[Morrison, Brian J.; Bruce, Zara C.; Lopez, J. Alejandro] Griffith Univ, Sch Biomol & Phys Sci, Brisbane, Qld 4111, Australia; [Morrison, Brian J.; Hastie, Marcus L.; Grewal, Yadveer S.; Bruce, Zara C.; Schmidt, Chris; Gorman, Jeffrey J.; Lopez, J. Alejandro] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Reynolds, Brent A.] Univ Florida, McKnight Brain Inst, Gainesville, FL USA	Griffith University; QIMR Berghofer Medical Research Institute; State University System of Florida; University of Florida	Lopez, JA (corresponding author), Griffith Univ, Sch Biomol & Phys Sci, Brisbane, Qld 4111, Australia.	a.lopez@griffith.edu.au	Lopez, J. Alejandro/P-4129-2019; Hastie, Marcus L/L-4366-2016; Lopez, J. Alejandro/B-9290-2008; Schmidt, Christopher/A-4353-2009	Lopez, J. Alejandro/0000-0001-9370-1516; Hastie, Marcus L/0000-0002-8386-5549; Lopez, J. Alejandro/0000-0001-9370-1516; Schmidt, Christopher/0000-0002-3955-5076; Grewal, Yadveer/0000-0003-3621-2753	Australian Government National Collaborative Infrastructure Scheme via Bioplatforms Australia; Queensland State Government; Cancer Council Queensland; National Breast Cancer Foundation; NATIONAL CANCER INSTITUTE [T32CA117846] Funding Source: NIH RePORTER	Australian Government National Collaborative Infrastructure Scheme via Bioplatforms Australia(Australian Government); Queensland State Government; Cancer Council Queensland(Cancer Council Queensland); National Breast Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Access to proteomic infrastructure funding was made possible through funds from the Australian Government National Collaborative Infrastructure Scheme provided via Bioplatforms Australia and the Queensland State Government. Funding for this research was obtained from the Cancer Council Queensland and the National Breast Cancer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE M, 1989, CANCER RES, V49, P2834; Agrawal B, 1998, MOL MED TODAY, V4, P397, DOI 10.1016/S1357-4310(98)01322-7; Ahn SM, 2008, PROTEOMICS, V8, P4946, DOI 10.1002/pmic.200800312; Aka JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031532; Akahani S, 1997, CANCER RES, V57, P5272; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Ao A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018810; Aplander K, 2006, CARBOHYD RES, V341, P1363, DOI 10.1016/j.carres.2006.04.027; Beatson RE, 2010, IMMUNOTHERAPY-UK, V2, P305, DOI 10.2217/IMT.10.17; Blumenthal RD, 2005, CANCER RES, V65, P8809, DOI 10.1158/0008-5472.CAN-05-0420; Burchell JM, 2001, J MAMMARY GLAND BIOL, V6, P355, DOI 10.1023/A:1011331809881; Cariati M, 2008, INT J CANCER, V122, P298, DOI 10.1002/ijc.23103; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; CROKER AK, 2008, J CELL MOL MED; Deleyrolle LP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015844; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Duxbury MS, 2004, ONCOGENE, V23, P1539, DOI 10.1038/sj.onc.1207272; Elgaaen BV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013837; Engelmann K, 2008, CANCER RES, V68, P2419, DOI 10.1158/0008-5472.CAN-07-2249; Fessler SP, 2009, BREAST CANCER RES TR, V118, P113, DOI 10.1007/s10549-009-0412-3; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; GENDLER SJ, 1990, J BIOL CHEM, V265, P15286; Gilewski T, 2000, CLIN CANCER RES, V6, P1693; Goydos JS, 1996, J SURG RES, V63, P298, DOI 10.1006/jsre.1996.0264; Grkovic S, 2012, ONCOGENE; Hammarstrom S, 1999, SEMIN CANCER BIOL, V9, P67, DOI 10.1006/scbi.1998.0119; Hastie ML, 2012, MOL CELL PROTEOMICS, V11, P108, DOI 10.1074/mcp.M111.015909; Hikita ST, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003312; Hondermarck H, 2002, J MAMMARY GLAND BIOL, V7, P395, DOI 10.1023/A:1024086015542; Hubner NC, 2008, PROTEOMICS, V8, P4862, DOI 10.1002/pmic.200800351; Hughes RC, 2001, BIOCHIMIE, V83, P667; INOHARA H, 1995, CANCER RES, V55, P3267; Kanojia D, 2012, PROTEOMICS; Kim HRC, 1999, CANCER RES, V59, P4148; Kim JC, 2012, BREAST CANCER RES TR, V133, P909, DOI 10.1007/s10549-011-1868-5; Korkaya H, 2008, ONCOGENE, V27, P6120, DOI 10.1038/onc.2008.207; Korkaya H, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000121; LeMarer N, 1996, J CELL PHYSIOL, V168, P51, DOI 10.1002/(SICI)1097-4652(199607)168:1<51::AID-JCP7>3.0.CO;2-7; Li YQ, 2003, ONCOGENE, V22, P6107, DOI 10.1038/sj.onc.1206732; Magnifico A, 2009, CLIN CANCER RES, V15, P2010, DOI 10.1158/1078-0432.CCR-08-1327; Mahanta S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002054; McPherson K, 2000, BMJ-BRIT MED J, V321, P624, DOI 10.1136/bmj.321.7261.624; Moiseeva EV, 2005, BREAST CANCER RES TR, V91, P227, DOI 10.1007/s10549-005-0289-8; Morrison BJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2111; Nangia-Makker P, 2002, JNCI-J NATL CANCER I, V94, P1854, DOI 10.1093/jnci/94.24.1854; Nangia-Makker P, 2000, AM J PATHOL, V156, P899, DOI 10.1016/S0002-9440(10)64959-0; Nangia-Makker P, 2008, CANCER MICROENVIRON, V1, P43, DOI 10.1007/s12307-008-0003-6; Ordonez C, 2000, CANCER RES, V60, P3419; Patterson RJ, 2002, GLYCOCONJUGATE J, V19, P499, DOI 10.1023/B:GLYC.0000014079.87862.c7; PERILLO NL, 1995, NATURE, V378, P736, DOI 10.1038/378736a0; PIENTA KJ, 1995, J NATL CANCER I, V87, P348, DOI 10.1093/jnci/87.5.348; PLATT D, 1992, J NATL CANCER I, V84, P438, DOI 10.1093/jnci/84.6.438; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; RAZ A, 1987, CANCER METAST REV, V6, P433, DOI 10.1007/BF00144274; Ren J, 2004, CANCER CELL, V5, P163, DOI 10.1016/S1535-6108(04)00020-0; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Scott Ken, 2004, Glycoconjugate Journal, V19, P467; Shekhar MPV, 2004, AM J PATHOL, V165, P1931, DOI 10.1016/S0002-9440(10)63245-2; SHIVELY JE, 1985, CRC CR REV ONCOL-HEM, V2, P355, DOI 10.1016/S1040-8428(85)80008-1; Song YK, 2002, AM J PATHOL, V160, P1069, DOI 10.1016/S0002-9440(10)64927-9; Suzuki HI, 2011, MOL CELL, V44, P424, DOI 10.1016/j.molcel.2011.09.012; Takenaka Y, 2002, GLYCOCONJUGATE J, V19, P543, DOI 10.1023/B:GLYC.0000014084.01324.15; Thijssen VLJL, 2006, P NATL ACAD SCI USA, V103, P15975, DOI 10.1073/pnas.0603883103; THOMPSON JA, 1991, J CLIN LAB ANAL, V5, P344, DOI 10.1002/jcla.1860050510; Tsutsumida H, 2006, CLIN CANCER RES, V12, P2976, DOI 10.1158/1078-0432.CCR-05-1197; Tyers M, 2003, NATURE, V422, P193, DOI 10.1038/nature01510; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Wilkins MR, 1996, BIO-TECHNOL, V14, P61, DOI 10.1038/nbt0196-61; Yoshii T, 2002, J BIOL CHEM, V277, P6852, DOI 10.1074/jbc.M107668200; Zotter S, 1988, CANCER REV, P11	72	17	17	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52692	10.1371/journal.pone.0052692	http://dx.doi.org/10.1371/journal.pone.0052692			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285151	Green Published, gold, Green Submitted			2022-12-27	WOS:000312794500231
J	Shields, RK; Clancy, CJ; Gillis, LM; Kwak, EJ; Silveira, FP; Massih, RCA; Eschenauer, GA; Potoski, BA; Nguyen, MH				Shields, Ryan K.; Clancy, Cornelius J.; Gillis, Louise M.; Kwak, Eun J.; Silveira, Fernanda P.; Massih, Rima C. Abdel; Eschenauer, Gregory A.; Potoski, Brian A.; Nguyen, M. Hong			Epidemiology, Clinical Characteristics and Outcomes of Extensively Drug-Resistant Acinetobacter baumannii Infections among Solid Organ Transplant Recipients	PLOS ONE			English	Article							IN-VITRO ACTIVITIES; POLYMYXIN-B; COMBINATION THERAPY; VS. COLISTIN; TIGECYCLINE; RIFAMPICIN; MORTALITY; SYNERGY; LUNG; MEROPENEM	Background: Extensively drug-resistant Acinetobacter baumannii (XDR-Ab) has emerged as a major nosocomial pathogen, but optimal treatment regimens are unknown. Although solid organ transplant (SOT) recipients are particularly susceptible to XDR-Ab infections, studies in this population are limited. Our objectives were to determine the epidemiology, clinical characteristics and outcomes of XDR-Ab infections among SOT patients. Methods: A retrospective study of SOT recipients at our center who were colonized or infected with XDR-Ab between November 2006 and December 2011 was conducted. Among infected patients, the primary outcome was survival at 28 days. Secondary outcomes included survival at 90 days and clinical success at 28 days, and XDR-Ab infection recurrence. Results: XDR-Ab was isolated from 69 SOT patients, of whom 41% (28) and 59% (41) were colonized and infected, respectively. Infections were significantly more common among cardiothoracic than abdominal transplant recipients (p = 0.0004). Ninety-eight percent (40/41) of patients had respiratory tract infections, most commonly ventilator-associated pneumonia (VAP; 88% [36/41]). Survival rates at 28 and 90 days were 54% (22/41) and 46% (19/41), respectively. Treatment with a colistin-carbapenem regimen was an independent predictor of 28-day survival (p = 0.01; odds ratio = 7.88 [95% CI: 1.60-38.76]). Clinical success at 28 days was achieved in 49% (18/37) of patients who received antimicrobial therapy, but 44% (8/18) of successes were associated with infection recurrence within 3 months. Colistin resistance emerged in 18% (2/11) and 100% (3/3) of patients treated with colistin-carbapenem and colistin-tigecycline, respectively (p = 0.03). Conclusions: XDR-Ab causes VAP and other respiratory infections following SOT that are associated with significant recurrence and mortality rates. Cardiothoracic transplant recipients are at greatest risk. Results from this retrospective study suggest that colistin-carbapenem combinations may result in improved clinical responses and survival compared to other regimens and may also limit the emergence of colistin resistance.	[Shields, Ryan K.; Clancy, Cornelius J.; Kwak, Eun J.; Silveira, Fernanda P.; Massih, Rima C. Abdel; Potoski, Brian A.; Nguyen, M. Hong] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15260 USA; [Shields, Ryan K.; Gillis, Louise M.; Kwak, Eun J.; Massih, Rima C. Abdel; Eschenauer, Gregory A.; Potoski, Brian A.; Nguyen, M. Hong] Univ Pittsburgh, Med Ctr, Antibiot Management Program, Pittsburgh, PA USA; [Clancy, Cornelius J.] VA Healthcare Syst Pittsburgh, Pittsburgh, PA USA; [Gillis, Louise M.; Potoski, Brian A.] Univ Pittsburgh, Dept Pharm & Therapeut, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Clancy, CJ (corresponding author), Univ Pittsburgh, Dept Med, Pittsburgh, PA 15260 USA.	cjc76@pitt.edu	Silveira, Fernanda/K-4465-2012; Eschenauer, Gregory/O-9008-2019	Eschenauer, Gregory/0000-0001-5971-0531	National Center for Advancing Translational Sciences of the National Institutes of Health [KL2 RR024154, KL2TR000146]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000146] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024154] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The project described was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award numbers KL2 RR024154 and KL2TR000146 to R. K. S. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams-Haduch JM, 2008, ANTIMICROB AGENTS CH, V52, P3837, DOI 10.1128/AAC.00570-08; American Thoracic Society, 2003, MMWR Recomm Rep, V52, P1; Arroyo LA, 2009, ANTIMICROB AGENTS CH, V53, P1295, DOI 10.1128/AAC.01097-08; Bassetti M, 2008, J ANTIMICROB CHEMOTH, V61, P417, DOI 10.1093/jac/dkm509; Benden C, 2011, J HEART LUNG TRANSPL, V30, P1123, DOI 10.1016/j.healun.2011.08.011; Betrosian AP, 2008, J INFECTION, V56, P432, DOI 10.1016/j.jinf.2008.04.002; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Cai Y, 2012, J ANTIMICROB CHEMOTH, V67, P1607, DOI 10.1093/jac/dks084; Choi JY, 2004, CLIN MICROBIOL INFEC, V10, P1098, DOI 10.1111/j.1469-0691.2004.00987.x; Clinical and Laboratory Standards Institute, 2009, M07A8 CLSI; Deris ZZ, 2012, ANTIMICROB AGENTS CH; Duarte AG, 2011, LUNG; Esterly JS, 2011, ANTIMICROB AGENTS CH, V55, P4844, DOI 10.1128/AAC.01728-10; Falagas ME, 2008, EPIDEMIOL INFECT, V136, P1009, DOI 10.1017/S0950268807009478; Falagas ME, 2006, CLIN MICROBIOL INFEC, V12, P1227, DOI 10.1111/j.1469-0691.2006.01559.x; Falagas ME, 2008, INT J ANTIMICROB AG, V32, P450, DOI 10.1016/j.ijantimicag.2008.05.016; Giamarellos-Bourboulis EJ, 2001, DIAGN MICR INFEC DIS, V40, P117, DOI 10.1016/S0732-8893(01)00258-9; Giamarellou H, 2008, INT J ANTIMICROB AG, V32, P106, DOI 10.1016/j.ijantimicag.2008.02.013; Haddad FA, 2005, EUR J CLIN MICROBIOL, V24, P577, DOI 10.1007/s10096-005-1366-y; Ho J, 2010, CURR OPIN INFECT DIS, V23, P546, DOI 10.1097/QCO.0b013e32833f0d3e; Hogg GM, 1998, J ANTIMICROB CHEMOTH, V41, P494, DOI 10.1093/jac/41.4.494; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Husain S, 2011, J HEART LUNG TRANSPL, V30, P361, DOI 10.1016/j.healun.2011.01.701; Kalin G, 2012, J INFECT CHEMOTHER; Kempf M, 2012, INT J ANTIMICROB AG, V39, P180, DOI 10.1016/j.ijantimicag.2011.10.001; Kiffer CRV, 2005, DIAGN MICR INFEC DIS, V52, P317, DOI 10.1016/j.diagmicrobio.2005.03.003; Kim YJ, 2011, TRANSPL P, V43, P2397, DOI 10.1016/j.transproceed.2011.06.011; Ku K, 2012, AM J INFECT CONTROL; Lee HW, 2008, CLIN MICROBIOL INFEC, V14, P49, DOI 10.1111/j.1469-0691.2007.01842.x; Lee JC, 2006, RES MICROBIOL, V157, P360, DOI 10.1016/j.resmic.2005.09.011; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Mak JK, 2009, J ANTIMICROB CHEMOTH, V63, P47, DOI 10.1093/jac/dkn454; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; Mortensen BL, 2012, CELL MICROBIOL; Motaouakkil S, 2006, J INFECTION, V53, P274, DOI 10.1016/j.jinf.2005.11.019; Mouton JW, 1999, INFECTION, V27, pS24, DOI 10.1007/BF02561666; Nunley DR, 2010, LUNG, V188, P381, DOI 10.1007/s00408-010-9250-7; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Pankey GA, 2009, DIAGN MICR INFEC DIS, V63, P228, DOI 10.1016/j.diagmicrobio.2008.11.002; Peleg AY, 2007, J ANTIMICROB CHEMOTH, V59, P128, DOI 10.1093/jac/dkl441; Principe L, 2009, ANN CLIN MICROB ANTI, V8, DOI 10.1186/1476-0711-8-18; Reddy P, 2010, TRANSPL INFECT DIS, V12, P87, DOI 10.1111/j.1399-3062.2009.00445.x; Roca I, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00148; Sands M, 2007, EUR J CLIN MICROBIOL, V26, P521, DOI 10.1007/s10096-007-0330-4; Saner FH, 2008, TRANSPLANTATION, V85, P1564, DOI 10.1097/TP.0b013e31816f61a6; Scheetz MH, 2007, ANTIMICROB AGENTS CH, V51, P1621, DOI 10.1128/AAC.01099-06; Shields RK, 2011, DIAGN MICR INFEC DIS, V70, P246, DOI 10.1016/j.diagmicrobio.2010.12.023; Shyu S, 2011, J HEART LUNG TRANSPL, V30, P743, DOI 10.1016/j.healun.2011.01.714; Siempos II, 2010, SHOCK, V33, P590, DOI 10.1097/SHK.0b013e3181cc0418; Song JY, 2007, J ANTIMICROB CHEMOTH, V60, P317, DOI 10.1093/jac/dkm136; Sopirala MM, 2008, J HEART LUNG TRANSPL, V27, P804, DOI 10.1016/j.healun.2008.03.023; Sopirala MM, 2010, ANTIMICROB AGENTS CH, V54, P4678, DOI 10.1128/AAC.00497-10; Tascini C, 1998, J ANTIMICROB CHEMOTH, V42, P270, DOI 10.1093/jac/42.2.270; Tripodi MF, 2007, INT J ANTIMICROB AG, V30, P537, DOI 10.1016/j.ijantimicag.2007.07.007; Vittinghoff E, 1999, J INFECT DIS, V179, P717, DOI 10.1086/314623; Yoon J, 2004, ANTIMICROB AGENTS CH, V48, P753, DOI 10.1128/AAC.48.3.753-757.2004	56	96	98	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52349	10.1371/journal.pone.0052349	http://dx.doi.org/10.1371/journal.pone.0052349			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285002	Green Published, gold, Green Submitted			2022-12-27	WOS:000312794500149
J	Arhzaouy, K; Ramezani-Rad, M				Arhzaouy, Khalid; Ramezani-Rad, Massoud			Nuclear Import of UBL-Domain Protein Mdy2 Is Required for Heat-Induced Stress Response in Saccharomyces cerevisiae	PLOS ONE			English	Article							MESSENGER-RNA; CYTOPLASMIC GRANULES; MEMBRANE INSERTION; UBIQUITIN; IDENTIFICATION; COMPLEX; YEAST; SGT2; LOCALIZATION; TRANSPORT	Ubiquitin (Ub) and ubiquitin-like (UBL) proteins regulate a diverse array of cellular pathways through covalent as well as non-covalent interactions with target proteins. Yeast protein Mdy2 (Get5) and its human homolog GdX (Ubl4a) belong to the class of UBL proteins which do not form conjugates with other proteins. Mdy2 is required for cell survival under heat stress and for efficient mating. As part of a complex with Sgt2 and Get4 it has been implicated in the biogenesis of tail-anchored proteins. Interestingly, in response to heat stress, Mdy2 protein that is predominantly localized in the nucleus co-localized with poly(A)-binding protein Pab1 to cytoplasmic stress granules suggesting that nucleocytoplasmic shuttling is of functional importance. Here we investigate the nuclear import of Mdy2, a process that is independent of the Get4/Sgt2 complex but required for stress response. Nuclear import is mediated by an N-terminal nuclear localization signal (NLS) and this process is essential for the heat stress response. In contrast, cells expressing Mdy2 lacking a nuclear export signal (NES) behave like wild type. Importantly, both Mdy2 and Mdy2-Delta NES, but not Mdy2-Delta NLS, physically interact with Pab1 and this interaction correlates with the accumulation in cytoplasmic stress granules. Thus, the nuclear history of the UBL Mdy2 appears to be essential for its function in cytoplasmic stress granules during the rapid cellular response to heat stress.	[Arhzaouy, Khalid; Ramezani-Rad, Massoud] Univ Dusseldorf, Inst Microbiol, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Ramezani-Rad, M (corresponding author), Univ Dusseldorf, Inst Microbiol, D-40225 Dusseldorf, Germany.	ramezani@uni-duesseldorf.de						Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791; Battle A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.27; Bozkurt G, 2009, P NATL ACAD SCI USA, V106, P21131, DOI 10.1073/pnas.0910223106; Brengues M, 2007, MOL BIOL CELL, V18, P2592, DOI 10.1091/mbc.E06-12-1149; Brune C, 2005, RNA, V11, P517, DOI 10.1261/rna.7291205; Buchan JR, 2011, J CELL SCI, V124, P228, DOI 10.1242/jcs.078444; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Chang YW, 2010, J BIOL CHEM, V285, P9962, DOI 10.1074/jbc.M109.087098; Chartron JW, 2012, J BIOL CHEM, V287, P8310, DOI 10.1074/jbc.M111.333252; Chartron JW, 2011, J BIOL CHEM, V286, P34325, DOI 10.1074/jbc.M111.277798; Chartron JW, 2010, P NATL ACAD SCI USA, V107, P12127, DOI 10.1073/pnas.1006036107; Chook YM, 2001, CURR OPIN STRUC BIOL, V11, P703, DOI 10.1016/S0959-440X(01)00264-0; Cohnen A, 2010, CYTOSKELETON, V67, P635, DOI 10.1002/cm.20477; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; Dong XH, 2009, NATURE, V458, P1136, DOI 10.1038/nature07975; Fleischer TC, 2006, GENE DEV, V20, P1294, DOI 10.1101/gad.1422006; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Grousl T, 2009, J CELL SCI, V122, P2078, DOI 10.1242/jcs.045104; Hegde RS, 2011, NAT REV MOL CELL BIO, V12, P787, DOI 10.1038/nrm3226; Hoyle NP, 2007, J CELL BIOL, V179, P65, DOI 10.1083/jcb.200707010; Hu Z, 2006, J CELL SCI, V119, P326, DOI 10.1242/jcs.02754; Iwanejko L, 1999, YEAST, V15, P1529, DOI 10.1002/(SICI)1097-0061(199910)15:14<1529::AID-YEA457>3.3.CO;2-P; Jansen G, 2005, GENE, V344, P43, DOI 10.1016/j.gene.2004.10.016; Jentsch S, 2000, TRENDS CELL BIOL, V10, P335, DOI 10.1016/S0962-8924(00)01785-2; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; KALDERON D, 1984, NATURE, V311, P33, DOI 10.1038/311033a0; Kedersha N, 2002, MOL BIOL CELL, V13, P195, DOI 10.1091/mbc.01-05-0221; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Lange A, 2008, J BIOL CHEM, V283, P12926, DOI 10.1074/jbc.M800898200; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Liou ST, 2007, CELL STRESS CHAPERON, V12, P59, DOI 10.1379/CSC-220R.1; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Saeki Y, 2002, BIOCHEM BIOPH RES CO, V293, P986, DOI 10.1016/S0006-291X(02)00340-6; Simpson PJ, 2010, STRUCTURE, V18, P897, DOI 10.1016/j.str.2010.07.003; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; TONIOLO D, 1988, EMBO J, V7, P401, DOI 10.1002/j.1460-2075.1988.tb02827.x; Tran EJ, 2007, CELL, V131, DOI 10.1016/j.cell.2007.10.015; Wang F, 2010, MOL CELL, V40, P159, DOI 10.1016/j.molcel.2010.08.038; Wang QY, 2011, MOL CELL, V42, P758, DOI 10.1016/j.molcel.2011.05.010	43	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52956	10.1371/journal.pone.0052956	http://dx.doi.org/10.1371/journal.pone.0052956			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285234	Green Submitted, gold, Green Published			2022-12-27	WOS:000313051500089
J	Holm, I; Lavazec, C; Garnier, T; Mitri, C; Riehle, MM; Bischoff, E; Brito-Fravallo, E; Takashima, E; Thiery, I; Zettor, A; Petres, S; Bourgouin, C; Vernick, KD; Eiglmeier, K				Holm, Inge; Lavazec, Catherine; Garnier, Thierry; Mitri, Christian; Riehle, Michelle M.; Bischoff, Emmanuel; Brito-Fravallo, Emma; Takashima, Eizo; Thiery, Isabelle; Zettor, Agnes; Petres, Stephane; Bourgouin, Catherine; Vernick, Kenneth D.; Eiglmeier, Karin			Diverged Alleles of the Anopheles gambiae Leucine-Rich Repeat Gene APL1A Display Distinct Protective Profiles against Plasmodium falciparum	PLOS ONE			English	Article							MALARIA PARASITES; PROTEINS; COMPLEMENT; RESISTANCE; INFECTION; IMMUNITY; SYSTEM; GENOME; REGION	Functional studies have demonstrated a role for the Anopheles gambiae APL1A gene in resistance against the human malaria parasite, Plasmodium falciparum. Here, we exhaustively characterize the structure of the APL1 locus and show that three structurally different APL1A alleles segregate in the Ngousso colony. Genetic association combined with RNAi-mediated gene silencing revealed that APL1A alleles display distinct protective profiles against P. falciparum. One APL1A allele is sufficient to explain the protective phenotype of APL1A observed in silencing experiments. Epitope-tagged APL1A isoforms expressed in an in vitro hemocyte-like cell system showed that under assay conditions, the most protective APL1A isoform (APL1A(2)) localizes within large cytoplasmic vesicles, is not constitutively secreted, and forms only one protein complex, while a less protective isoform (APL1A(1)) is constitutively secreted in at least two protein complexes. The tested alleles are identical to natural variants in the wild A. gambiae population, suggesting that APL1A genetic variation could be a factor underlying natural heterogeneity of vector susceptibility to P. falciparum.	[Holm, Inge; Lavazec, Catherine; Garnier, Thierry; Mitri, Christian; Bischoff, Emmanuel; Brito-Fravallo, Emma; Takashima, Eizo; Vernick, Kenneth D.; Eiglmeier, Karin] Inst Pasteur, Dept Parasitol & Mycol, Unit Hosts Vectors & Infect Agents URA3012, Unit Insect Vector Genet & Genom,CNRS, Paris, France; [Riehle, Michelle M.; Vernick, Kenneth D.] Univ Minnesota, Dept Microbiol, St Paul, MN USA; [Thiery, Isabelle; Zettor, Agnes; Bourgouin, Catherine] Inst Pasteur, Ctr Prod & Infect Anopheles CEPIA, Paris, France; [Petres, Stephane] Inst Pasteur, Ctr Prod Prot Recombinantes & Anticorps, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Minnesota System; University of Minnesota Twin Cities; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Eiglmeier, K (corresponding author), Inst Pasteur, Dept Parasitol & Mycol, Unit Hosts Vectors & Infect Agents URA3012, Unit Insect Vector Genet & Genom,CNRS, Paris, France.	kei@pasteur.fr	Lavazec, Catherine/AAD-9206-2020; Bischoff, Emmanuel/F-1197-2011; Lavazec, Catherine/A-4285-2016; Bourgouin, Catherine/F-1253-2014	Lavazec, Catherine/0000-0003-1533-7282; Bischoff, Emmanuel/0000-0003-4655-4247; Lavazec, Catherine/0000-0003-1533-7282; Bourgouin, Catherine/0000-0002-9209-845X; petres, stephane/0000-0002-4716-565X; Mitri, Christian/0000-0003-3882-2029; Takashima, Eizo/0000-0001-9070-8499	NIAID/NIH [AI042361, AI073685]; Ile de France DIM (Domain d'Interet Majeur Maladies Infectieuses, Parasitaires et Nocosomiales Emergentes); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073685, R01AI042361] Funding Source: NIH RePORTER	NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Ile de France DIM (Domain d'Interet Majeur Maladies Infectieuses, Parasitaires et Nocosomiales Emergentes); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by NIAID/NIH AI042361 and AI073685 to KDV, and by Ile de France DIM (Domain d'Interet Majeur Maladies Infectieuses, Parasitaires et Nocosomiales Emergentes) to CL. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1932, STAT METHODS RES WOR; Baxter RHG, 2007, P NATL ACAD SCI USA, V104, P11615, DOI 10.1073/pnas.0704967104; Baxter RHG, 2010, P NATL ACAD SCI USA, V107, P16817, DOI 10.1073/pnas.1010575107; Blandin SA, 2009, SCIENCE, V326, P147, DOI 10.1126/science.1175241; Crawford JE, 2012, GENES GENOM IN PRESS; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; Dong YM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002458; Dong YM, 2009, J BIOL CHEM, V284, P9835, DOI 10.1074/jbc.M807084200; Fraiture M, 2009, CELL HOST MICROBE, V5, P273, DOI 10.1016/j.chom.2009.01.005; Garver LS, 2008, DEV COMP IMMUNOL, V32, P519, DOI 10.1016/j.dci.2007.09.007; Gupta L, 2009, CELL HOST MICROBE, V5, P498, DOI 10.1016/j.chom.2009.04.003; Harris C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001112; Harris C, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-81; Hurd H, 2005, EVOLUTION, V59, P2560, DOI 10.1111/j.0014-3820.2005.tb00969.x; Kumar S, 2010, SCIENCE, V327, P1644, DOI 10.1126/science.1184008; Meister S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000542; Mendes AM, 2011, INFECT IMMUN, V79, P4708, DOI 10.1128/IAI.05647-11; Menge DM, 2006, GENETICS, V173, P235, DOI 10.1534/genetics.105.055129; Mitri C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000576; Muller HM, 1999, J BIOL CHEM, V274, P11727, DOI 10.1074/jbc.274.17.11727; Niare O, 2002, SCIENCE, V298, P213, DOI 10.1126/science.1073420; PONNUDURAI T, 1982, T ROY SOC TROP MED H, V76, P812, DOI 10.1016/0035-9203(82)90116-X; Povelones M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002023; Povelones M, 2009, SCIENCE, V324, P258, DOI 10.1126/science.1171400; Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967; Riehle MM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003672; Riehle MM, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-87; Riehle MM, 2006, SCIENCE, V312, P577, DOI 10.1126/science.1124153; Rottschaefer SM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000600; TDR/WHO, 2012, MAL; Waterhouse RM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-531; Wilding CS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-320	32	9	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52684	10.1371/journal.pone.0052684	http://dx.doi.org/10.1371/journal.pone.0052684			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285147	Green Published, gold, Green Submitted			2022-12-27	WOS:000313051500047
J	Lu, W; Chen, C; Shao, Y; Shi, JY; Zhong, CQ; Yang, DD; Song, HH; Li, GL; Ding, XY; Peng, H; Zhu, LY; Zhou, Y; Zhu, LM				Lu, Wei; Chen, Cheng; Shao, Yan; Shi, Jinyan; Zhong, Chongqiao; Yang, Dandan; Song, Honghuan; Li, Guoli; Ding, Xiaoyan; Peng, Hong; Zhu, Linyang; Zhou, Yang; Zhu, Limei			Evaluation of Biochip System in Determining Isoniazid and Rifampicin Resistances of Mycobacterium Tuberculosis in Sputum Samples	PLOS ONE			English	Article							GENOTYPE MTBDRPLUS; CLINICAL SPECIMENS; IDENTIFICATION; CHINA; ASSAY; MICROARRAY; RPOB	Objective: To evaluate a biochip system in determining isoniazid and rifampicin resistances of Mycobacterium tuberculosis in sputum samples in a Chinese population. Methods: We assembled 907 sputum smeared positive specimens of tuberculosis patients in total. Each sample would be separated into two parts for culture and biochip assay simultaneously. And those cultured positive and having full drug resistance results would be used as reference. The McNemar chi(2) test was adopted for evaluating the paired 262 table. Results: Compared with drug sensitivity test, the agreement rates of the two methods in detecting rifampicin and isoniazid resistances were 93.37% and 94.49%, respectively. The sensitivity and specificity of biochip in detecting isoniazid were 74.31% and 96.92%, respectively. Meanwhile, the sensitivity and specificity for rifampicin were 79.76% and 96.53%, respectively. For multi-drug resistance, the sensitivity and specificity were 64.62% and 97.75%, respectively. Conclusions: The biochip system is a rapid and accurate method for drug resistant tuberculosis diagnosis using sputum samples directly, especially for rifampicin resistance detection.	[Lu, Wei; Chen, Cheng; Shao, Yan; Yang, Dandan; Song, Honghuan; Li, Guoli; Ding, Xiaoyan; Peng, Hong; Zhou, Yang; Zhu, Limei] Ctr Dis Control & Prevent Jiangsu Prov, Dept Chron Communicable Dis, Nanjing, Jiangsu, Peoples R China; [Zhong, Chongqiao; Zhu, Linyang] Ctr Dis Control & Prevent Lianyungang, Dept Chron Communicable Dis, Lianyungang, Jiangsu, Peoples R China; [Shi, Jinyan] Fourth Peoples Hosp Lianyungang City, Lab TB, Lianyungang, Jiangsu, Peoples R China	Jiangsu Provincial Center for Disease Control & Prevention	Zhu, LM (corresponding author), Ctr Dis Control & Prevent Jiangsu Prov, Dept Chron Communicable Dis, Nanjing, Jiangsu, Peoples R China.	jsjkmck@163.com	YANG, Dan/HHD-2733-2022		provincial department of public health of Jiangsu [Y201030]; key medical disciplines of Jiangsu Province [XK201150]; training projects of center for disease control and prevention of Jiangsu province [JKRC2011005]	provincial department of public health of Jiangsu; key medical disciplines of Jiangsu Province; training projects of center for disease control and prevention of Jiangsu province	This work was supported in part by provincial department of public health of Jiangsu (Y201030), the key medical disciplines of Jiangsu Province (XK201150) and the training projects of center for disease control and prevention of Jiangsu province (JKRC2011005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, LANCET INFECT DIS, V11, P333, DOI 10.1016/S1473-3099(11)70105-0; [Anonymous], 2009, GUID SURV DRUG RES T; Campbell PJ, 2011, ANTIMICROB AGENTS CH, V55, P2032, DOI 10.1128/AAC.01550-10; Chang HJ, 2010, CLIN MICROBIOL INFEC, V16, P1090, DOI 10.1111/j.1469-0691.2009.03045.x; Giampaglia CMS, 2007, INT J TUBERC LUNG D, V11, P803; Guo Y, 2009, INT J TUBERC LUNG D, V13, P914; Hillemann D, 2007, J CLIN MICROBIOL, V45, P2635, DOI 10.1128/JCM.00521-07; Jia ZW, 2012, LANCET, V379, P2149, DOI 10.1016/S0140-6736(12)60942-8; Maschmann RD, 2011, MEM I OSWALDO CRUZ, V106, P139, DOI 10.1590/S0074-02762011000200004; Miotto P, 2008, J CLIN MICROBIOL, V46, P393, DOI 10.1128/JCM.01066-07; Mironova S, 2012, EUR J CLIN MICROBIOL, V31, P1381, DOI 10.1007/s10096-011-1453-1; Mokrousov I, 2006, EUR J CLIN MICROBIOL, V25, P703, DOI 10.1007/s10096-006-0215-y; MUSSER JM, 1995, CLIN MICROBIOL REV, V8, P496, DOI 10.1128/CMR.8.4.496; Ramaswamy S., 1998, Tubercle and Lung Disease, V79, P3, DOI 10.1054/tuld.1998.0002; Shao Y, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-110; Song EJ, 2007, J MICROBIOL METH, V68, P430, DOI 10.1016/j.mimet.2006.09.005; Volokhov Dmitriy V., 2008, V465, P395, DOI 10.1007/978-1-59745-207-6_26; WHO, 2011, WHO GLOBAL TUBERCULO; Yang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020343; Yao C, 2010, CLIN MICROBIOL INFEC, V16, P1639, DOI 10.1111/j.1469-0691.2010.03267.x; Zazueta-Beltran J, 2011, INT J INFECT DIS, V15, pE272, DOI 10.1016/j.ijid.2011.01.001; Zhao YL, 2012, NEW ENGL J MED, V366, P2161, DOI 10.1056/NEJMoa1108789; Zhu LX, 2007, J CLIN MICROBIOL, V45, P3514, DOI 10.1128/JCM.02340-06; Zhu LX, 2010, J CLIN MICROBIOL, V48, P3654, DOI 10.1128/JCM.00158-10	24	3	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52953	10.1371/journal.pone.0052953	http://dx.doi.org/10.1371/journal.pone.0052953			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285233	Green Submitted, Green Published, gold			2022-12-27	WOS:000313051500088
J	Ma, XQ; Yao, YW; Yuan, DM; Liu, HB; Wang, SJ; Zhou, CS; Song, Y				Ma, Xingqun; Yao, Yanwen; Yuan, Dongmei; Liu, Hongbing; Wang, Shouju; Zhou, Changsheng; Song, Yong			Recombinant Human Endostatin Endostar Suppresses Angiogenesis and Lymphangiogenesis of Malignant Pleural Effusion in Mice	PLOS ONE			English	Article							LYMPH-NODE METASTASIS; I CLINICAL-TRIAL; GROWTH-FACTOR-C; INHIBITS LYMPHANGIOGENESIS; DOWN-REGULATION; TUMOR-CELLS; THERAPY; CANCER; MANAGEMENT; VEGF	Background: Malignant pleural effusion (MPE) is a common complication of lung cancer. One widely used treatment for MPE is Endostar, a recombined humanized endostatin based treatment. However, the mechanism of this treatment is still unclear. The aim of this study was to investigate the effects of Endostar in mice with MPE. Methods and Materials: Lewis lung carcinoma (LLC) cell line expressing enhanced green fluorescent protein (EGFP) was injected into pleural cavity to establish MPE mice model. Mice were randomly divided into four groups. High dose of Endostar (30 mg/kg), low dose of Endostar (8 mg/kg), normal saline, or Bevacizumab (5 mg/kg) was respectively injected into pleural cavity three times with 3-day interval in each group. Transverse computed tomography (CT) was performed to observe pleural fluid formation 14 days after LLC cells injection. Mice were anesthetized and sacrificed 3 days after final administration. The volume of pleural effusion n was measured using 1 ml syringe. Micro blood vessel density (MVD), Lymphatic micro vessel density (LMVD), the expression level of vascular endothelial growth factor A (VEGF-A) and VEGF-C were observed by immunohistochemistry (IHC) staining. Results: The volume of pleural effusion as well as the number of pleural tumor foci, MVD and the expression of VEGF- A were significantly reduced in high dose of Endostar treat group. More importantly, LMVD and the expression of VEGF-C were markedly lower in treat group than those in the other three control groups. Conclusion: Our work demonstrated that Endostar played an efficient anti-cancer role in MPE through its suppressive effect on angiogenesis and lymphangiogenesis, which provided a certain theoretical basis for the effectiveness of Endostar on the MPE treatment.	[Ma, Xingqun; Yao, Yanwen; Yuan, Dongmei; Liu, Hongbing; Song, Yong] Nanjing Univ, Sch Med, Dept Resp Med, Jinling Hosp, Nanjing, Jiangsu, Peoples R China; [Wang, Shouju; Zhou, Changsheng] Nanjing Univ, Sch Med, Dept Med Imaging, Jinling Hosp, Nanjing, Jiangsu, Peoples R China	Nanjing University; Nanjing University	Song, Y (corresponding author), Nanjing Univ, Sch Med, Dept Resp Med, Jinling Hosp, Nanjing, Jiangsu, Peoples R China.	yong_song6310@yahoo.com	Liu, Hongbing/F-5980-2015	Liu, Hongbing/0000-0003-1404-0647; Wang, Shouju/0000-0001-9213-6818	Natural Science Fund of Jiangsu Province [BK2011658]	Natural Science Fund of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This research was supported by the Natural Science Fund of Jiangsu Province (BK2011658) to Song Yong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avraamides CJ, 2008, NAT REV CANCER, V8, P604, DOI 10.1038/nrc2353; Bose D, 2010, LANCET ONCOL, V11, P373, DOI 10.1016/S1470-2045(09)70341-9; Brideau G, 2007, CANCER RES, V67, P11528, DOI 10.1158/0008-5472.CAN-07-1458; CHERNOW B, 1977, AM J MED, V63, P695, DOI 10.1016/0002-9343(77)90154-1; Dong X, 2011, THORAC CARDIOV SURG, V59, P133, DOI 10.1055/s-0030-1250152; Eder JP, 2002, J CLIN ONCOL, V20, P3772, DOI 10.1200/JCO.2002.02.082; Fang F, 2009, J CANCER RES CLIN, V135, P1149, DOI 10.1007/s00432-009-0555-y; Fukumoto S, 2005, CLIN EXP METASTAS, V22, P31, DOI 10.1007/s10585-005-3973-5; Gerber HP, 2005, CANCER RES, V65, P671; Hajitou A, 2002, FASEB J, V16, P1802, DOI 10.1096/fj.02-0109fje; Jantz MA, 2008, RESPIRATION, V75, P121, DOI 10.1159/000113629; Juttner S, 2006, J CLIN ONCOL, V24, P228, DOI 10.1200/JCO.2004.00.3467; Kaifi JT, 2012, J SURG ONCOL, V105, P731, DOI 10.1002/jso.22100; Kobold S, 2009, ONCOLOGIST, V14, P1242, DOI 10.1634/theoncologist.2009-0109; Lee YCG, 2004, RESPIROLOGY, V9, P148, DOI 10.1111/j.1440-1843.2004.00566.x; Ling Y, 2007, BIOCHEM BIOPH RES CO, V361, P79, DOI 10.1016/j.bbrc.2007.06.155; Lohela M, 2009, CURR OPIN CELL BIOL, V21, P154, DOI 10.1016/j.ceb.2008.12.012; LYNCH TJ, 1993, CHEST, V103, pS385; Ma X, 2012, ZHONGGUO FEI AI ZA Z, V15, P317; Mohammed RAA, 2007, BRIT J CANCER, V96, P1092, DOI 10.1038/sj.bjc.6603678; Mundhenke C, 2001, CLIN CANCER RES, V7, P3366; Nagahashi M, 2010, WORLD J GASTROENTERO, V16, P4003, DOI 10.3748/wjg.v16.i32.4003; Najmunnisa N, 2007, EUR RESPIR J, V29, P761, DOI 10.1183/09031936.00061606; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Presta LG, 1997, CANCER RES, V57, P4593; Reck M, 2009, LUNG CANCER, V63, P1, DOI 10.1016/j.lungcan.2008.05.015; Rolny C, 2011, CANCER CELL, V19, P31, DOI 10.1016/j.ccr.2010.11.009; Shibuya M, 2006, EXP CELL RES, V312, P549, DOI 10.1016/j.yexcr.2005.11.012; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Stathopoulos GT, 2007, CANCER RES, V67, P9825, DOI 10.1158/0008-5472.CAN-07-1064; Stathopoulos GT, 2006, AM J RESP CELL MOL, V34, P142, DOI 10.1165/rcmb.2005-0130OC; Wei Hong-mei, 2010, Nan Fang Yi Ke Da Xue Xue Bao, V30, P1509; Wei Shuzhen, 2010, Zhongguo Fei Ai Za Zhi, V13, P670, DOI 10.3779/j.issn.1009-3419.2010.07.03	33	31	40	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53449	10.1371/journal.pone.0053449	http://dx.doi.org/10.1371/journal.pone.0053449			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285296	Green Published, Green Submitted, gold			2022-12-27	WOS:000313051500151
J	Nausch, H; Mischofsky, H; Koslowski, R; Meyer, U; Broer, I; Huckauf, J				Nausch, Henrik; Mischofsky, Heike; Koslowski, Roswitha; Meyer, Udo; Broer, Inge; Huckauf, Jana			Expression and Subcellular Targeting of Human Complement Factor C5a in Nicotiana species	PLOS ONE			English	Article							PLANT-MADE PHARMACEUTICALS; HIGH-YIELD PRODUCTION; HETEROLOGOUS PROTEINS; ENDOPLASMIC-RETICULUM; MONOCLONAL-ANTIBODY; GENE-EXPRESSION; N-GLYCOSYLATION; SEVERE SEPSIS; TOBACCO; STRATEGIES	We evaluated transgenic tobacco plants as an alternative to Escherichia coli for the production of recombinant human complement factor 5a (C5a). C5a has not been expressed in plants before and is highly unstable in vivo in its native form, so it was necessary to establish the most suitable subcellular targeting strategy. We used the strong and constitutive CaMV 35S promoter to drive transgene expression and compared three different subcellular compartments. The yields of C5a in the T-0 transgenic plants were low in terms of the proportion of total soluble protein (TSP) when targeted to the apoplast (0.0002% TSP) or endoplasmic reticulum (0.0003% TSP) but was one order of magnitude higher when targeted to the vacuole (0.001% TSP). The yields could be increased by conventional breeding (up to 0.014% TSP in the T-2 generation). C5a accumulated to the same level in seeds and leaves when targeted to the apoplast but was up to 1.7-fold more abundant in the seeds when targeted to the ER or vacuole, although this difference was less striking in the better-performing lines. When yields were calculated as an amount per gram fresh weight of transgenic plant tissue, the vacuole targeting strategy was clearly more efficient in seeds, reaching 35.8 mu g C5a per gram of fresh seed weight compared to 10.62 mu g C5a per gram fresh weight of leaves. Transient expression of C5aER and C5aVac in N. benthamiana, using MagnICON vectors, reached up to 0.2% and 0.7% of TSP, respectively, but was accompanied by cytotoxic effects and induced leaf senescence. Western blot of the plant extracts revealed a band matching the corresponding glycosylated native protein and the bioassay demonstrated that recombinant C5a was biologically active.	[Nausch, Henrik; Mischofsky, Heike; Broer, Inge; Huckauf, Jana] Univ Rostock, Agr & Environm Fac, Dept Agrobiotechnol, Rostock, Germany; [Koslowski, Roswitha; Meyer, Udo] Bioserv GmbH, Rostock, Germany	University of Rostock	Broer, I (corresponding author), Univ Rostock, Agr & Environm Fac, Dept Agrobiotechnol, Rostock, Germany.	inge.broer@uni-rostock.de		Nausch, Henrik/0000-0001-5393-3267	doctorate program of the University of Rostock	doctorate program of the University of Rostock	The first author appreciated the grant from the doctorate program of the University of Rostock. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.; This work was supported by the doctorate program of the University of Rostock. The authors thank Dr. Anatoli Giritch and Prof. Dr. Juri Gleba for providing the MagnICON vectors for research purposes.	ALI H, 1993, J BIOL CHEM, V268, P24247; Avesani L, 2010, EXPERT REV VACCINES, V9, P957, DOI [10.1586/erv.10.82, 10.1586/ERV.10.82]; Benchabane M, 2008, PLANT BIOTECHNOL J, V6, P633, DOI 10.1111/j.1467-7652.2008.00344.x; Bendandi M, 2010, ANN ONCOL, V21, P2420, DOI 10.1093/annonc/mdq256; Boehm R, 2007, ANN NY ACAD SCI, V1102, P121, DOI 10.1196/annals.1408.009; Boothe J, 2010, PLANT BIOTECHNOL J, V8, P588, DOI 10.1111/j.1467-7652.2010.00511.x; Christie M, 2011, PLANT J, V68, P159, DOI 10.1111/j.1365-313X.2011.04676.x; Cohen J, 2009, CLIN MICROBIOL INFEC, V15, P302, DOI 10.1111/j.1469-0691.2009.02753.x; Conrad U, 1998, PLANT MOL BIOL, V38, P101, DOI 10.1023/A:1006029617949; Czermak BJ, 1999, NAT MED, V5, P788, DOI 10.1038/10512; Davies HM, 2010, PLANT BIOTECHNOL J, V8, P845, DOI 10.1111/j.1467-7652.2010.00550.x; DENECKE J, 1992, EMBO J, V11, P2345, DOI 10.1002/j.1460-2075.1992.tb05294.x; Dombrovskiy VY, 2007, CRIT CARE MED, V35, P1244, DOI 10.1097/01.CCM.0000261890.41311.E9; Doran PM, 2006, TRENDS BIOTECHNOL, V24, P426, DOI 10.1016/j.tibtech.2006.06.012; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; FERNANDEZ HN, 1978, J BIOL CHEM, V253, P6955; Fischer R, 2012, BIOTECHNOL ADV, V30, P434, DOI 10.1016/j.biotechadv.2011.08.007; Flierl MA, 2009, CRITICAL CARE, P13; FRANKE AE, 1988, METHOD ENZYMOL, V162, P653; FREGA N, 1991, J AM OIL CHEM SOC, V68, P29, DOI 10.1007/BF02660305; Frigerio L, 2001, J PLANT PHYSIOL, V158, P499, DOI 10.1078/0176-1617-00362; GALLIE DR, 1987, NUCLEIC ACIDS RES, V15, P3257, DOI 10.1093/nar/15.8.3257; Giritch A, 2006, P NATL ACAD SCI USA, V103, P14701, DOI 10.1073/pnas.0606631103; GOLDSTEI.IM, 1974, J IMMUNOL, V113, P1583; Goulet C, 2012, PLANT BIOTECHNOL J, V10, P83, DOI 10.1111/j.1467-7652.2011.00643.x; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; Hausmann L, 1999, VORT PFLANZENZUCHTG, V45, P155; Hehle VK, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-128; HERRERAESTRELLA L, 1983, EMBO J, V2, P987, DOI 10.1002/j.1460-2075.1983.tb01532.x; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Huang CJ, 2012, J IND MICROBIOL BIOT, V39, P383, DOI 10.1007/s10295-011-1082-9; Huang Z, 2006, VACCINE, V24, P2506, DOI 10.1016/j.vaccine.2005.12.024; Huang Z, 2008, PLANT BIOTECHNOL J, V6, P202, DOI 10.1111/j.1467-7652.2007.00316.x; Huber-Lang MS, 2002, J IMMUNOL, V169, P3223, DOI 10.4049/jimmunol.169.6.3223; Huhns M, 2009, PLANT BIOTECHNOL J, V7, P883, DOI 10.1111/j.1467-7652.2009.00451.x; HUGLI TE, 1984, SPRINGER SEMIN IMMUN, V7, P193; Jacobs PP, 2009, CURR MOL MED, V9, P774, DOI 10.2174/156652409789105552; Khan I, 2012, J BIOTECHNOL; Khanuja SPS, 1999, PLANT MOL BIOL REP, V17, P74, DOI 10.1023/A:1007528101452; Komarova TV, 2010, EXPERT REV VACCINES, V9, P859, DOI [10.1586/erv.10.85, 10.1586/ERV.10.85]; Lau OS, 2009, BIOTECHNOL ADV, V27, P1015, DOI 10.1016/j.biotechadv.2009.05.005; Liu JZ, 2005, PLANT PHYSIOL, V138, P1853, DOI 10.1104/pp.105.065722; MANDECKI W, 1986, GENE, V43, P131, DOI 10.1016/0378-1119(86)90016-8; Marillonnet S, 2004, P NATL ACAD SCI USA, V101, P6852, DOI 10.1073/pnas.0400149101; Mikschofsky H, 2012, TRANSGENIC RES, V21, P715, DOI 10.1007/s11248-011-9573-z; Mikschofsky H, 2009, PLANT BIOTECHNOL J, V7, P537, DOI 10.1111/j.1467-7652.2009.00422.x; MOLLISON KW, 1987, AGENTS ACTIONS, V21, P366, DOI 10.1007/BF01966518; MOLLISON KW, 1991, AGENT ACTION SUPPL, V35, P17; Morandini F, 2011, PLANT BIOTECHNOL J, V9, P911, DOI 10.1111/j.1467-7652.2011.00605.x; Nagels B, 2012, CRIT REV PLANT SCI, V31, P148, DOI 10.1080/07352689.2011.616075; Nausch H, 2012, AFRICAN J BIOT UNPUB; Nausch H, 2012, PLOS ONE UNPUB; Niederbichler AD, 2006, J EXP MED, V203, P53, DOI 10.1084/jem.20051207; Obembe OO, 2011, BIOTECHNOL ADV, V29, P210, DOI 10.1016/j.biotechadv.2010.11.004; ODELL JT, 1985, NATURE, V313, P810, DOI 10.1038/313810a0; Pagny S, 2003, PLANT CELL PHYSIOL, V44, P173, DOI 10.1093/pcp/pcg027; Parrish WR, 2008, ANN NY ACAD SCI, V1144, P210, DOI 10.1196/annals.1418.011; Paul M, 2011, BIOTECHNOL APPL BIOC, V58, P58, DOI 10.1002/bab.6; Petruccelli S, 2006, PLANT BIOTECHNOL J, V4, P511, DOI 10.1111/j.1467-7652.2006.00200.x; Pinkhasov J, 2011, PLANT BIOTECHNOL J, V9, P991, DOI 10.1111/j.1467-7652.2011.00614.x; Riedemann NC, 2003, NAT MED, V9, P517, DOI 10.1038/nm0503-517; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Sawant SV, 2001, PLANT PHYSIOL, V126, P1630, DOI 10.1104/pp.126.4.1630; Schillberg S, 1999, TRANSGENIC RES, V8, P255, DOI 10.1023/A:1008937011213; Sharp JM, 2001, BIOTECHNOL BIOENG, V73, P338, DOI 10.1002/bit.1067; Thomas DR, 2011, INT J MOL SCI, V12, P3220, DOI 10.3390/ijms12053220; Tiwari S, 2009, PLANT CELL REP, V28, P1827, DOI 10.1007/s00299-009-0782-3; Torikaiu K, 2005, FOOD CHEM TOXICOL, V43, P559, DOI 10.1016/j.fct.2004.12.011; Tremblay R, 2010, BIOTECHNOL ADV, V28, P214, DOI 10.1016/j.biotechadv.2009.11.008; Tripathi NK, 2009, DEFENCE SCI J, V59, P137, DOI 10.14429/dsj.59.1501; Twyman RM, 2012, CURRENT PHA IN PRESS; Vitale A, 2005, MOL INTERV, V5, P216, DOI 10.1124/mi.5.4.5; Ward PA, 2008, J LEUKOCYTE BIOL, V83, P467, DOI 10.1189/jlb.0607376; Webster DE, 2012, BIOTECHNOL ADV, V30, P410, DOI 10.1016/j.biotechadv.2011.07.015; Yang SJ, 2004, P NATL ACAD SCI USA, V101, P6297, DOI 10.1073/pnas.0304346101	75	18	22	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53023	10.1371/journal.pone.0053023	http://dx.doi.org/10.1371/journal.pone.0053023			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285250	Green Published, gold, Green Submitted			2022-12-27	WOS:000313051500101
J	Roddy, P; Howard, N; Van Kerkhove, MD; Lutwama, J; Wamala, J; Yoti, Z; Colebunders, R; Palma, PP; Sterk, E; Jeffs, B; Van Herp, M; Borchert, M				Roddy, Paul; Howard, Natasha; Van Kerkhove, Maria D.; Lutwama, Julius; Wamala, Joseph; Yoti, Zabulon; Colebunders, Robert; Palma, Pedro Pablo; Sterk, Esther; Jeffs, Benjamin; Van Herp, Michel; Borchert, Matthias			Clinical Manifestations and Case Management of Ebola Haemorrhagic Fever Caused by a Newly Identified Virus Strain, Bundibugyo, Uganda, 2007-2008	PLOS ONE			English	Article							SUBTYPE RESTON VIRUS; RISK-FACTORS; FILOVIRUS INFECTIONS; MARBURG; DISEASE; EPIDEMIC; KIKWIT; CONGO; TRANSMISSION; OUTBREAK	A confirmed Ebola haemorrhagic fever (EHF) outbreak in Bundibugyo, Uganda, November 2007-February 2008, was caused by a putative new species (Bundibugyo ebolavirus). It included 93 putative cases, 56 laboratory-confirmed cases, and 37 deaths (CFR = 25%). Study objectives are to describe clinical manifestations and case management for 26 hospitalised laboratory-confirmed EHF patients. Clinical findings are congruous with previously reported EHF infections. The most frequently experienced symptoms were non-bloody diarrhoea (81%), severe headache (81%), and asthenia (77%). Seven patients reported or were observed with haemorrhagic symptoms, six of whom died. Ebola care remains difficult due to the resource-poor setting of outbreaks and the infection-control procedures required. However, quality data collection is essential to evaluate case definitions and therapeutic interventions, and needs improvement in future epidemics. Organizations usually involved in EHF case management have a particular responsibility in this respect.	[Roddy, Paul; Palma, Pedro Pablo; Jeffs, Benjamin] Med Dept Med Sans Frontieres, Barcelona, Spain; [Sterk, Esther] Med Dept Med Sans Frontieres, Geneva, Switzerland; [Van Herp, Michel] Med Dept Med Sans Frontieres, Brussels, Belgium; [Howard, Natasha] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1, England; [Van Kerkhove, Maria D.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, Med Res Council Ctr Outbreak Anal & Modelling, London, England; [Lutwama, Julius] Uganda Virus Res Inst, Dept Arbovirol Emerging & Re Emerging Viral Infec, Entebbe, Uganda; [Wamala, Joseph] Uganda Minist Hlth, Natl Dis Control, Kampala, Uganda; [Yoti, Zabulon] World Hlth Org Reg Off Africa, Kampala, Uganda; [Colebunders, Robert] Univ Antwerp, Dept Clin Sci, Inst Trop Med Antwerp, B-2020 Antwerp, Belgium; [Colebunders, Robert] Univ Antwerp, Dept Epidemiol & Social Med, B-2020 Antwerp, Belgium; [Borchert, Matthias] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England; [Borchert, Matthias] Charite, Inst Trop Med & Int Hlth, D-13353 Berlin, Germany	Doctors Without Borders; Doctors Without Borders; Doctors Without Borders; University of London; London School of Hygiene & Tropical Medicine; Imperial College London; Uganda Virus Research Institute; World Health Organization; Institute of Tropical Medicine (ITM); University of Antwerp; University of Antwerp; University of London; London School of Hygiene & Tropical Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Roddy, P (corresponding author), Med Dept Med Sans Frontieres, Barcelona, Spain.	roddypd@gmail.com		Howard, Natasha/0000-0003-4174-7349; Van Kerkhove, Maria/0000-0002-6135-0018	Medical Research Council UK; Bill and Melinda Gates Foundation; Medical Research Council [G0600719B] Funding Source: researchfish	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	MDVK acknowledges funding from the Medical Research Council UK and the Bill and Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baert B, 2001, EBOLA OUTBREAK PREPA; BARON RC, 1983, B WORLD HEALTH ORGAN, V61, P997; Bausch DG, 2008, ANTIVIR RES, V78, P150, DOI 10.1016/j.antiviral.2008.01.152; Bausch DG, 2007, J INFECT DIS, V196, pS142, DOI 10.1086/520545; Bausch DG, 2007, J INFECT DIS, V196, pS136, DOI 10.1086/520542; Bausch DG, 2006, NEW ENGL J MED, V355, P909, DOI 10.1056/NEJMoa051465; Bausch DG, 2003, EMERG INFECT DIS, V9, P1531, DOI 10.3201/eid0912.030355; BECKER S, 1992, MED MICROBIOL IMMUN, V181, P43, DOI 10.1007/BF00193395; Bonnet MJ, 1998, EMERG INFECT DIS, V4, P508, DOI 10.3201/eid0403.980349; Borchert M, 2002, TROP MED INT HEALTH, V7, P902, DOI 10.1046/j.1365-3156.2002.00945.x; Bray M, 2003, J INFECT DIS, V188, P1613, DOI 10.1086/379727; Bray M, 2007, J INFECT DIS, V196, pS438, DOI 10.1086/520552; Buhler S, 2008, THESIS LONDON SCH HY; Burke J, 1978, B WORLD HEALTH ORGAN, V56, P271; Bwaka MA, 1999, J INFECT DIS, V179, pS1, DOI 10.1086/514308; Casillas Adrian M, 2003, Biol Res Nurs, V4, P268, DOI 10.1177/1099800403252603; CDC, 2007, EB HEM FEV OUTBR UG; CDC, 2010, KNOWN CAS OUTBR EB H; Colebunders R, 2007, J INFECT DIS, V196, pS148, DOI 10.1086/520543; CONRAD JL, 1978, AM J TROP MED HYG, V27, P1210, DOI 10.4269/ajtmh.1978.27.1210; Davis KJ, 1997, ARCH PATHOL LAB MED, V121, P805; Deng IM, 1978, B WORLD HEALTH ORGAN, V56, P247; Dowell SF, 1996, PEDIATR INFECT DIS J, V15, P189, DOI 10.1097/00006454-199603000-00002; Egbring R, 1971, MARBURG VIRUS DIS, P42; EMOND RTD, 1977, BMJ-BRIT MED J, V2, P541, DOI 10.1136/bmj.2.6086.541; Feldmann H., 2004, VIRUS TAXONOMY 8 REP, P645; FISHERHOCH SP, 1992, J INFECT DIS, V166, P753, DOI 10.1093/infdis/166.4.753; Formenty P, 1999, J INFECT DIS, V179, pS48, DOI 10.1086/514285; Formenty P, 2003, Med Trop (Mars), V63, P291; Francesconi P, 2003, EMERG INFECT DIS, V9, P1430, DOI 10.3201/eid0911.030339; Fujita N., 2009, Morbidity and Mortality Weekly Report, V58, P1377; GEAR JSS, 1975, BRIT MED J, V4, P489, DOI 10.1136/bmj.4.5995.489; Georges AJ, 1999, J INFECT DIS, V179, pS65, DOI 10.1086/514290; Grolla A, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001183; Hewlett BS, 2003, EMERG INFECT DIS, V9, P1242; HEYMANN DL, 1980, J INFECT DIS, V142, P372, DOI 10.1093/infdis/142.3.372; Isaacson M, 1978, EBOLA VIRUS HAEMORRH, P15; Jaax NK, 1996, ARCH PATHOL LAB MED, V120, P140; Jeffs B, 2007, J INFECT DIS, V196, pS154, DOI 10.1086/520548; Johnson ED, 1996, ARCH VIROL, P101; Kalongi Y, 1999, J INFECT DIS, V179, pS15, DOI 10.1086/514301; Kibadi K, 1999, J INFECT DIS, V179, pS13, DOI 10.1086/514288; Kuhn JH, 2008, FILOVIRUSES COMPENDI; LEGUENNO B, 1995, LANCET, V345, P1271, DOI 10.1016/S0140-6736(95)90925-7; Leroy EM, 2004, SCIENCE, V303, P387, DOI 10.1126/science.1092528; Leroy EM, 2002, LANCET, V359, P712, DOI 10.1016/S0140-6736(02)07796-6; MacNeil A, 2010, EMERG INFECT DIS, V16, P1969, DOI 10.3201/eid1612.100627; Martini G A, 1968, Ger Med Mon, V13, P457; MARTINI G A, 1971, P1; MARTINI GA, 1969, T ROY SOC TROP MED H, V63, P295, DOI 10.1016/0035-9203(69)90001-7; Miranda ME, 1999, J INFECT DIS, V179, pS115, DOI 10.1086/514314; Mupapa K, 1999, J INFECT DIS, V179, pS18, DOI 10.1086/514298; Mupapa K, 1999, J INFECT DIS, V179, pS11, DOI 10.1086/514289; Mupere E, 2001, Afr Health Sci, V1, P60; Ndambi R, 1999, J INFECT DIS, V179, pS8, DOI 10.1086/514297; Nikiforov V V, 1994, Zh Mikrobiol Epidemiol Immunobiol, P104; Piot P, 1978, EBOLA VIRUS HAEMORRH, P7; Roddy P, J INFECT DIS UNPUB; Roddy P, 2010, J INFECT DIS, V201, P1909, DOI 10.1086/652748; Roels TH, 1999, J INFECT DIS, V179, pS92, DOI 10.1086/514286; Rollin PE, 1999, J INFECT DIS, V179, pS108, DOI 10.1086/514303; SIEGERT R, 1967, DEUT MED WOCHENSCHR, V92, P2341, DOI 10.1055/s-0028-1106144; SMITH DH, 1982, LANCET, V1, P816; Sterk E, 2008, FILOVIRUS HAEMORRHAG; STILLE W, 1971, P10; Stroher U, 2006, EXPERT OPIN INV DRUG, V15, P1523, DOI 10.1517/13543784.15.12.1523; SUREAU PH, 1989, REV INFECT DIS, V11, pS790; TODOROVITCH K, 1971, P19; Towner JS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000212; Tuffs A, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1223; *WHO, 2007, EB HAEM FEV UG; WHO, 2008, END EB OUTBR DEM REP; WHO, 2005, MARB HAEM FEV ANG, P25; WHO, 2008, EB HAEM FEV DEM REP; WHO, 2008, EB OUTBR CONT UG; WHO, 1995, WEEKLY EPIDEMIOLOGIC, V70, P137; WHO, 2011, EB UG; WHO, 2007, END EB OUTBR UG; WHO, 2004, WHO ANN END EB OUTBR; WHO, 2008, CAS MARB HAEM FEV IM; WHO CDC, 1998, INF CONTR VIR HAEM F; Zaki SR, 1999, CURR TOP MICROBIOL, V235, P97	82	51	53	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52986	10.1371/journal.pone.0052986	http://dx.doi.org/10.1371/journal.pone.0052986			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285243	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000313051500095
J	Trevillion, K; Oram, S; Feder, G; Howard, LM				Trevillion, Kylee; Oram, Sian; Feder, Gene; Howard, Louise M.			Experiences of Domestic Violence and Mental Disorders: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							INTIMATE PARTNER VIOLENCE; POSTTRAUMATIC-STRESS-DISORDER; PSYCHIATRIC-DISORDERS; HEALTH; WOMEN; PREVALENCE; GENDER; RISK; COMMUNITY; ADULT	Background: Little is known about the extent to which being a victim of domestic violence is associated with different mental disorders in men and women. We aimed to estimate the prevalence and odds of being a victim of domestic violence by diagnostic category and sex. Methods: Study design: Systematic review and meta-analysis. Data Sources: Eighteen biomedical and social sciences databases (including MEDLINE, EMBASE, PsycINFO); journal hand searches; scrutiny of references and citation tracking of included articles; expert recommendations, and an update of a systematic review on victimisation and mental disorder. Inclusion criteria: observational and intervention studies reporting prevalence or odds of being a victim of domestic violence in men and women (aged >= 16 years), using validated diagnostic measures of mental disorder. Procedure: Data were extracted and study quality independently appraised by two reviewers. Analysis: Random effects meta-analyses were used to pool estimates of prevalence and odds. Results: Forty-one studies were included. There is a higher risk of experiencing adult lifetime partner violence among women with depressive disorders (OR 2.77 (95% CI 1.96-3.92), anxiety disorders (OR 4.08 (95% CI 2.39-6.97), and PTSD (OR 7.34 95% CI 4.50-11.98), compared to women without mental disorders. Insufficient data were available to calculate pooled odds for other mental disorders, family violence (i.e. violence perpetrated by a non-partner), or violence experienced by men. Individual studies reported increased odds for women and men for all diagnostic categories, including psychoses, with a higher prevalence reported for women. Few longitudinal studies were found so the direction of causality could not be investigated. Conclusions: There is a high prevalence and increased likelihood of being a victim of domestic violence in men and women across all diagnostic categories, compared to people without disorders. Longitudinal studies are needed to identify pathways to being a victim of domestic violence to optimise healthcare responses.	[Trevillion, Kylee; Oram, Sian; Howard, Louise M.] Kings Coll London, Sect Womens Mental Hlth, Hlth Serv & Populat Res Dept, Inst Psychiat, London WC2R 2LS, England; [Feder, Gene] Univ Bristol, Ctr Acad Primary Care, Sch Social & Community Med, Bristol, Avon, England	University of London; King's College London; University of Bristol	Howard, LM (corresponding author), Kings Coll London, Sect Womens Mental Hlth, Hlth Serv & Populat Res Dept, Inst Psychiat, London WC2R 2LS, England.	louise.howard@kcl.ac.uk	Oram, Sian/G-3342-2013; Howard, Louise/E-3495-2010	Howard, Louise/0000-0001-9942-744X; Feder, Gene/0000-0002-7890-3926; Oram, Sian/0000-0001-8704-0379; Trevillion, Kylee/0000-0001-5865-4726	NIHR Programme Grants for Applied Research scheme [RP-PG-0108-10084]; National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London; Maudsley NHS Foundation Trust; King's College London; National Institute for Health Research (NIHR) under its Programme Grants for Applied Research scheme [RP-PG-0108-10084]; National Institute for Health Research [RP-PG-0108-10084] Funding Source: researchfish	NIHR Programme Grants for Applied Research scheme; National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London(National Institute for Health Research (NIHR)); Maudsley NHS Foundation Trust; King's College London(General Electric); National Institute for Health Research (NIHR) under its Programme Grants for Applied Research scheme(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	The authors receive support from the NIHR Programme Grants for Applied Research scheme (RP-PG-0108-10084). Louise Howard also receives salary support from the National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London. This paper presents independent research funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research scheme (RP-PG-0108-10084). The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. The funder had no role in study design, data collection, data analysis, decision to publish, or preparation of the manuscript.	Afifi TO, 2009, J INTERPERS VIOLENCE, V24, P1398, DOI 10.1177/0886260508322192; ANDREWS B, 1988, BRIT J PSYCHIAT, V153, P305, DOI 10.1192/bjp.153.3.305; Ayub M, 2009, SOC PSYCH PSYCH EPID, V44, P953, DOI 10.1007/s00127-009-0016-6; Baker CK, 2005, SOC PSYCH PSYCH EPID, V40, P519, DOI 10.1007/s00127-005-0921-2; Bardone AM, 1996, DEV PSYCHOPATHOL, V8, P811, DOI 10.1017/S0954579400007446; BROWN GW, 1994, BRIT J PSYCHIAT, V165, P457, DOI 10.1192/bjp.165.4.457; Campbell JC, 2002, LANCET, V359, P1331, DOI 10.1016/S0140-6736(02)08336-8; CASCARDI M, 1995, J CONSULT CLIN PSYCH, V63, P616, DOI 10.1037/0022-006X.63.4.616; Center for Disease Control, 2003, COSTS INTIMATE PARTN; Cerulli C, 2011, J WOMENS HEALTH, V0, P1; Chang DF, 2009, INT J LAW PSYCHIAT, V32, P167, DOI 10.1016/j.ijlp.2009.02.004; Contreras-Pezzotti L, 2011, REV COLOMB PSIQUIAT, V39, P85; Critical Appraisal Skills Programme, 2012, CRIT APPR SKILLS PRO; Danielson KK, 1998, AM J PSYCHIAT, V155, P131, DOI 10.1176/ajp.155.1.131; DeKlyen M, 2006, AM J PUBLIC HEALTH, V96, P1836, DOI 10.2105/AJPH.2004.049296; Dennis MF, 2009, VIOLENCE AGAINST WOM, V15, P618, DOI 10.1177/1077801209331410; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Deyessa Negussie, 2009, Clin Pract Epidemiol Ment Health, V5, P8, DOI 10.1186/1745-0179-5-8; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Duran B, 2009, AM INDIAN ALASKA NAT, V16, P11; Egger M, 1998, BMJ-BRIT MED J, V316, P61, DOI 10.1136/bmj.316.7124.61; Feder G, 2009, HLTH TECHNOLOGY ASSE, V13, piii; Feder G, 2011, LANCET, V11, P1; Fergusson DM, 2005, J MARRIAGE FAM, V67, P1103, DOI 10.1111/j.1741-3737.2005.00202.x; Fisher J, 2010, B WORLD HEALTH ORGAN, V88, P737, DOI 10.2471/BLT.09.067066; Friedman SH, 2011, COMMUNITY MENT HLT J, V47, P156, DOI 10.1007/s10597-009-9270-z; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Gass JD, 2011, J INTERPERS VIOLENCE, V26, P2764, DOI 10.1177/0886260510390960; Golding JM, 1999, J FAM VIOLENCE, V14, P99, DOI 10.1023/A:1022079418229; Grant BF, 2011, J ANXIETY DIORD, V25, P456; Greenland S, 2001, Biostatistics, V2, P463, DOI 10.1093/biostatistics/2.4.463; Hammen C, 2002, J AFFECT DISORDERS, V72, P145, DOI 10.1016/S0165-0327(01)00455-4; Friedman SH, 2007, J WOMENS HEALTH, V16, P471, DOI 10.1089/jwh.2006.0115; Hicks MHR, 2003, J NERV MENT DIS, V191, P722, DOI 10.1097/01.nmd.0000095124.05023.e1; Home Office, 2005, DOM VIOL NAT REP; Howard LM, 2010, PSYCHOL MED, V40, P881, DOI 10.1017/S0033291709991589; Hughes K, 2012, LANCET, V379, P1621, DOI 10.1016/S0140-6736(11)61851-5; Iverson KM, 2011, J CONSULT CLIN PSYCH, V79, P193, DOI 10.1037/a0022512; Jirapramukpitak T, 2011, SOC PSYCH PSYCH EPID, V46, P825, DOI 10.1007/s00127-010-0252-9; Jonas S, INTIMATE PARTN UNPUB; Kaminer D, 2008, SOC SCI MED, V67, P1589, DOI 10.1016/j.socscimed.2008.07.023; Khalifeh H, 2010, INT REV PSYCHIATR, V22, P535, DOI 10.3109/09540261.2010.506185; Lejoyeux M, 2002, EUR PSYCHIAT, V17, P479, DOI 10.1016/S0924-9338(02)00712-5; Loney P. L., 2000, CHRONIC DIS CANADA, V19, P170; Loseke D. R., 2005, CURRENT CONTROVERSIE, P79; MacMillan HL, 2006, JAMA-J AM MED ASSOC, V296, P530, DOI 10.1001/jama.296.5.530; Maniglio R, 2009, ACTA PSYCHIAT SCAND, V119, P180, DOI 10.1111/j.1600-0447.2008.01300.x; McClennen JC, 2005, J INTERPERS VIOLENCE, V20, P149, DOI 10.1177/0886260504268762; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1136/bmj.b2535, 10.1186/2046-4053-4-1]; Najavits LM, 2004, ADDICT BEHAV, V29, P707, DOI 10.1016/j.addbeh.2004.01.003; NICE, 2008, GUID MAN; O'Leary KD, 2008, SOC PSYCH PSYCH EPID, V43, P619, DOI 10.1007/s00127-008-0339-8; Patel V, 2006, ARCH GEN PSYCHIAT, V63, P404, DOI 10.1001/archpsyc.63.4.404; Ramsay J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005043.pub2; Rivara FP, 2007, PEDIATRICS, V120, P1270, DOI 10.1542/peds.2007-1148; Roberts GL, 1998, AUST NZ J PUBL HEAL, V22, P796, DOI 10.1111/j.1467-842X.1998.tb01496.x; Saha S, 2005, PLOS MED, V2, P413, DOI 10.1371/journal.pmed.0020141; Saliou V, 2005, GEN HOSP PSYCHIAT, V27, P263, DOI 10.1016/j.genhosppsych.2005.03.009; Schumacher JA, 2010, VIOLENCE VICTIMS, V25, P588, DOI 10.1891/0886-6708.25.5.588; Simsek Z, 2008, J PUBLIC HLTH; StataCorp LP, 2009, STATA STAT SOFTW REL; Straus MA, 1996, J FAM ISSUES, V17, P283, DOI 10.1177/019251396017003001; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Thurston WE, 2006, CAN J RURAL MED, V11, P259; Tolman RM, 2001, VIOLENCE AGAINST WOM, V7, P141, DOI 10.1177/10778010122182361; Trevillion K, PILOT STUDY DO UNPUB; Tuten M, 2004, ADDICT BEHAV, V29, P1029, DOI 10.1016/j.addbeh.2004.02.055; Vahip I, 2006, TURK PSIKIYATR DERG, V17, P107; Van Dorn R, 2011, P 7 EUR C VIOL CLIN; Van Dorn R, 2012, SOC PSYCH PSYCH EPID, V47, P487, DOI 10.1007/s00127-011-0356-x; Walby S., 2009, COST DOMESTIC VIOLEN; Weizmann-Henelius G, 2004, INT J FORENSIC MENT, V3, P185, DOI DOI 10.1080/14999013.2004.10471206; *WHO, 1997, COMP INT DIAGN INT C; Wing J., 1994, SCHEDULES CLIN ASSES; Wong SPY, 2009, SUICIDE LIFE-THREAT, V39, P648, DOI 10.1521/suli.2009.39.6.648; World Health Organization, GUID DEV GR IN PRESS; Yasan A, 2009, J TRAUMA STRESS, V22, P663, DOI 10.1002/jts.20459; Zanarini MC, 1999, J NERV MENT DIS, V187, P65, DOI 10.1097/00005053-199902000-00001	78	327	328	4	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e51740	10.1371/journal.pone.0051740	http://dx.doi.org/10.1371/journal.pone.0051740			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	071TV	23300562	Green Published, Green Submitted, gold			2022-12-27	WOS:000313618800026
J	Jiang, WM; Liu, S; Hou, GY; Li, JP; Zhuang, QY; Wang, SC; Zhang, P; Chen, JM				Jiang, Wenming; Liu, Shuo; Hou, Guangyu; Li, Jinping; Zhuang, Qingye; Wang, Suchun; Zhang, Peng; Chen, Jiming			Chinese and Global Distribution of H9 Subtype Avian Influenza Viruses	PLOS ONE			English	Article							LIVE-POULTRY MARKETS; WILD BIRDS; A VIRUS; HEMAGGLUTININ; INFECTION; LINEAGE; SURVEILLANCE; TRANSMISSION; REPLICATION; EVOLUTION	H9 subtype avian influenza viruses (AIVs) are of significance in poultry and public health, but epidemiological studies about the viruses are scarce. In this study, phylogenetic relationships of the viruses were analyzed based on 1233 previously reported sequences and 745 novel sequences of the viral hemagglutinin gene. The novel sequences were obtained through large-scale surveys conducted in 2008-2011 in China. The results revealed distinct distributions of H9 subtype AIVs in different hosts, sites and regions in China and in the world: (1) the dominant lineage of H9 subtype AIVs in China in recent years is lineage h9.4.2.5 represented by A/chicken/Guangxi/55/2005; (2) the newly emerging lineage h9.4.2.6, represented by A/chicken/Guangdong/FZH/2011, has also become prevalent in China; (3) lineages h9.3.3, h9.4.1 and h9.4.2, represented by A/duck/Hokkaido/26/99, A/quail/Hong Kong/G1/97 and A/chicken/Hong Kong/G9/97, respectively, have become globally dominant in recent years; (4) lineages h9.4.1 and h9.4.2 are likely of more risk to public health than others; (5) different lineages have different transmission features and host tropisms. This study also provided novel experimental data which indicated that the Leu-234 (H9 numbering) motif in the viral hemagglutinin gene is an important but not unique determinant in receptor-binding preference. This report provides a detailed and updated panoramic view of the epidemiological distributions of H9 subtype AIVs globally and in China, and sheds new insights for the prevention of infection in poultry and preparedness for a potential pandemic caused by the viruses.	[Jiang, Wenming; Liu, Shuo; Hou, Guangyu; Li, Jinping; Zhuang, Qingye; Wang, Suchun; Zhang, Peng; Chen, Jiming] China Anim Hlth & Epidemiol Ctr, Lab Avian Dis Surveillance, Qingdao, Peoples R China	China Animal Health & Epidemiology Center	Chen, JM (corresponding author), China Anim Hlth & Epidemiol Ctr, Lab Avian Dis Surveillance, Qingdao, Peoples R China.	jmchen66@yahoo.cn	Chen, Ji-Ming/AHD-7398-2022; Chen, Jiming/AAA-3575-2020	Chen, Jiming/0000-0003-3155-3145; Chen, Jiming/0000-0002-0404-0830	Ministry of Science and Technology [SQ2012FY3260033]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work is supported by the Sci-tech Basic Work Project of Ministry of Science and Technology (SQ2012FY3260033). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abolnik C, 2010, AVIAN DIS, V54, P313, DOI 10.1637/8781-040109-Reg.1; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P93; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P457; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Baumer A, 2010, AVIAN DIS, V54, P875, DOI 10.1637/9119-110209-Reg.1; Butt KM, 2005, J CLIN MICROBIOL, V43, P5760, DOI 10.1128/JCM.43.11.5760-5767.2005; Chen JM, 2007, ARCH VIROL, V152, P415, DOI 10.1007/s00705-006-0852-6; Chen JM, 2007, AM J INFECT CONTROL, V35, P351, DOI 10.1016/j.ajic.2006.07.016; Chu YC, 2011, INFLUENZA OTHER RESP, V5, P68; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fusaro A, 2011, J VIROL, V85, P8413, DOI 10.1128/JVI.00219-11; Ge FF, 2009, J CLIN MICROBIOL, V47, P3294, DOI 10.1128/JCM.00355-09; Guo Y, 1999, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V13, P105; Guo Y, 1997, INFLUENZA VIRUSES RE, P65; Ha Y, 2002, EMBO J, V21, P865, DOI 10.1093/emboj/21.5.865; Hansbro PM, 2010, EMERG INFECT DIS, V16, P1896, DOI 10.3201/eid1612.100776; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Ji K, 2010, J VIROL METHODS, V163, P186, DOI 10.1016/j.jviromet.2009.09.013; Kang HM, 2010, J WILDLIFE DIS, V46, P878, DOI 10.7589/0090-3558-46.3.878; Krauss S, 2007, PLOS PATHOG, V3, P1684, DOI 10.1371/journal.ppat.0030167; Lee DH, 2011, INFECT GENET EVOL, V11, P232, DOI 10.1016/j.meegid.2010.09.012; Li CJ, 2005, VIROLOGY, V340, P70, DOI 10.1016/j.virol.2005.06.025; Li W.H., 1997, MOL EVOLUTION, P149, DOI [10.1371/journal.pone.0052671, DOI 10.1371/JOURNAL.PONE.0052671]; Liu S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005022; Liu YH, 2009, AVIAN PATHOL, V38, P263, DOI 10.1080/03079450903055363; Martin V, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001308; Matrosovich MN, 2001, VIROLOGY, V281, P156, DOI 10.1006/viro.2000.0799; Moon HJ, 2010, ARCH VIROL, V155, P229, DOI 10.1007/s00705-009-0577-4; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Nagarajan S, 2009, VET MICROBIOL, V133, P154, DOI 10.1016/j.vetmic.2008.06.013; Negovetich NJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019311; Ramey AM, 2010, VIROLOGY, V406, P352, DOI 10.1016/j.virol.2010.07.031; Roussan DA, 2009, PREV VET MED, V88, P77, DOI 10.1016/j.prevetmed.2008.06.021; Saito T, 2001, VACCINE, V20, P125, DOI 10.1016/S0264-410X(01)00279-1; Senne DA, 2007, AVIAN DIS, V51, P167, DOI 10.1637/7621-042606R1.1; Smith GJD, 2012, INFLUENZA OTHER RESP, V6, P1, DOI 10.1111/j.1750-2659.2011.00298.x; Sorrell EM, 2009, P NATL ACAD SCI USA, V106, P7565, DOI 10.1073/pnas.0900877106; Sun YP, 2011, P NATL ACAD SCI USA, V108, P4164, DOI 10.1073/pnas.1019109108; Suptawiwat O, 2008, J CLIN VIROL, V42, P186, DOI 10.1016/j.jcv.2008.01.014; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; Wan H, 2007, J VIROL, V81, P5181, DOI 10.1128/JVI.02827-06; Wan HQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002923; Wan XF, 2011, J VIROL, V85, P13432, DOI 10.1128/JVI.05266-11; Wang Q, 2010, INFLUENZA MOL VIROLO, P69; World Organization for Animal Health, 2011, TERR AN HLTH COD 201; Xu CT, 2004, MICROBES INFECT, V6, P919, DOI 10.1016/j.micinf.2004.04.015; Xu KM, 2007, J VIROL, V81, P10389, DOI 10.1128/JVI.00979-07	48	46	57	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52671	10.1371/journal.pone.0052671	http://dx.doi.org/10.1371/journal.pone.0052671			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285143	Green Published, gold, Green Submitted			2022-12-27	WOS:000313158800089
J	Klutsch, CFC; Manseau, M; Wilson, PJ				Kluetsch, Cornelya F. C.; Manseau, Micheline; Wilson, Paul J.			Phylogeographical Analysis of mtDNA Data Indicates Postglacial Expansion from Multiple Glacial Refugia in Woodland Caribou (Rangifer tarandus caribou)	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; POPULATION-GROWTH; TIME DEPENDENCY; MODEL SELECTION; ICE; EXTIRPATION; PERSISTENCE; PHYLOGENIES; NEUTRALITY; RESPONSES	Glacial refugia considerably shaped the phylogeographical structure of species and may influence intra-specific morphological, genetic, and adaptive differentiation. However, the impact of the Quaternary ice ages on the phylogeographical structure of North American temperate mammalian species is not well-studied. Here, we surveyed similar to 1600 individuals of the widely distributed woodland caribou (Rangifer tarandus caribou) using mtDNA control region sequences to investigate if glacial refugia contributed to the phylogeographical structure in this subspecies. Phylogenetic tree reconstruction, a median-joining network, and mismatch distributions supported postglacial expansions of woodland caribou from three glacial refugia dating back to 13544-22005 years. These three lineages consisted almost exclusively of woodland caribou mtDNA haplotypes, indicating that phylogeographical structure was mainly shaped by postglacial expansions. The putative centres of these lineages are geographically separated; indicating disconnected glacial refugia in the Rocky Mountains, east of the Mississippi, and the Appalachian Mountains. This is in congruence with the fossil record that caribou were distributed in these areas during the Pleistocene. Our results suggest that the last glacial maximum substantially shaped the phylogeographical structure of this large mammalian North American species that will be affected by climatic change. Therefore, the presented results will be essential for future conservation planning in woodland caribou.	[Kluetsch, Cornelya F. C.; Wilson, Paul J.] Trent Univ, Dept Biol, Peterborough, ON K9J 7B8, Canada; [Manseau, Micheline] Pk Canada, No & Western Serv Ctr, Winnipeg, MB, Canada; [Manseau, Micheline] Univ Manitoba, Nat Resources Inst, Winnipeg, MB, Canada	Trent University; University of Manitoba	Wilson, PJ (corresponding author), Trent Univ, Dept Biol, Peterborough, ON K9J 7B8, Canada.	pawilson@trentu.ca	Klutsch, Cornelya/G-8944-2019	Klutsch, Cornelya/0000-0001-8238-2484	NSERC; Parks Canada; Manitoba Conservation; Manitoba Hydro; Prince Albert Model Forest; Saskatchewan Environment; Ontario Ministry of Natural Resources; Species at Risk Recovery Fund	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Parks Canada; Manitoba Conservation; Manitoba Hydro; Prince Albert Model Forest; Saskatchewan Environment; Ontario Ministry of Natural Resources; Species at Risk Recovery Fund	Funding for this study was provided by NSERC through the Collaborative, Strategic and Discovery Programs. Additional funding and in-kind support was provided by Parks Canada, Manitoba Conservation, Manitoba Hydro, Prince Albert Model Forest, Saskatchewan Environment, Ontario Ministry of Natural Resources, and the Species at Risk Recovery Fund. The funders contributed to the field work but had no role in study design, lab and data analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Arsenault A. Alan, 2011, Rangifer, V31, P33; Ball MC, 2010, CONSERV GENET, V11, P2131, DOI 10.1007/s10592-010-0099-3; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Banfield, 1961, NATL MUSEUM CANADA B, V177; Beheregaray LB, 2008, MOL ECOL, V17, P3754, DOI 10.1111/j.1365-294X.2008.03857.x; Bergerud A. T., 2008, RETURN CARIBOU UNGAV; Brant SV, 2003, MOL ECOL, V12, P1435, DOI 10.1046/j.1365-294X.2003.01789.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; CHURCHER CS, 1989, CAN J ZOOL, V67, P1210, DOI 10.1139/z89-175; Clark PU, 2009, SCIENCE, V325, P710, DOI 10.1126/science.1172873; COSEWIC, 2011, DES UN CAR RANG TAR; Cronin MRA, 2005, J MAMMAL, V86, P495, DOI 10.1644/1545-1542(2005)86[495:VIMDAM]2.0.CO;2; CSARDI G., 2006, INTERJOURNAL COMPLEX, V1695; Delcourt P.A., 1981, GEOBOTANY, P123; DEVOS A, 1951, J MAMMAL, V32, P329, DOI 10.2307/1375665; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dueck GS, 1998, THESIS U ALBERTA CAN; Dyke AS, 2003, 1574 GEOL SURV CAN; Eger JL, 2009, P CAR GEN REL WORKSH, P45; ELLSWORTH DL, 1994, EVOLUTION, V48, P122, DOI 10.1111/j.1558-5646.1994.tb01299.x; Erixon P, 2003, SYST BIOL, V52, P665, DOI 10.1080/10635150390235485; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Festa-Bianchet M, 2011, CAN J ZOOL, V89, P419, DOI [10.1139/z11-025, 10.1139/Z11-025]; Flagstad O, 2003, EVOLUTION, V57, P658; Fu YX, 1997, GENETICS, V147, P915; Geist V., 1998, DEER WORLD THEIR EVO; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Harding LE, 2003, CAR GEN REL WORKSH M, P6; Harington C.R., 2003, ANNOTATED BIBLIO QUA; HARPENDING HC, 1994, HUM BIOL, V66, P591; Hebblewhite Mark, 2007, Rangifer, P79; Hettinga PN, 2012, J WILDLIFE MANAGE, V76, P1153, DOI 10.1002/jwmg.380; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hins C, 2009, FOREST ECOL MANAG, V257, P636, DOI 10.1016/j.foreco.2008.09.049; Ho SYW, 2008, BIOL LETTERS, V4, P370, DOI 10.1098/rsbl.2008.0073; Ho SYW, 2007, SYST BIOL, V56, P515, DOI 10.1080/10635150701435401; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Hofreiter M, 2009, CURR BIOL, V19, pR584, DOI 10.1016/j.cub.2009.06.030; Hopkins M. L, 1969, Tebiwa, V12, P1; Keppel G, 2012, GLOBAL ECOL BIOGEOGR, V21, P393, DOI 10.1111/j.1466-8238.2011.00686.x; Kuhn TS, 2010, MOL ECOL, V19, P1312, DOI 10.1111/j.1365-294X.2010.04565.x; Kurten B., 1980, PLEISTOCENE MAMMALS; Latch EK, 2009, MOL ECOL, V18, P1730, DOI 10.1111/j.1365-294X.2009.04153.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lister AM, 2004, PHILOS T R SOC B, V359, P221, DOI 10.1098/rstb.2003.1436; Lorenzen ED, 2011, NATURE, V479, P359, DOI 10.1038/nature10574; McDevitt AD, 2009, MOL ECOL, V18, P665, DOI 10.1111/j.1365-294X.2008.04050.x; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Post E, 2008, PHILOS T R SOC B, V363, P2369, DOI 10.1098/rstb.2007.2207; Provan J, 2008, TRENDS ECOL EVOL, V23, P564, DOI 10.1016/j.tree.2008.06.010; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Roed Knut H., 2005, Rangifer, V25, P19; Rowe KC, 2004, P NATL ACAD SCI USA, V101, P10355, DOI 10.1073/pnas.0401338101; Schaefer JA, 2003, CONSERV BIOL, V17, P1435, DOI 10.1046/j.1523-1739.2003.02288.x; Shafer ABA, 2010, MOL ECOL, V19, P4589, DOI 10.1111/j.1365-294X.2010.04828.x; Soltis DE, 2006, MOL ECOL, V15, P4261, DOI 10.1111/j.1365-294X.2006.03061.x; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; Sullivan J, 2005, ANNU REV ECOL EVOL S, V36, P445, DOI 10.1146/annurev.ecolsys.36.102003.152633; Swenson NG, 2005, AM NAT, V166, P581, DOI 10.1086/491688; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thompson Mark D., 2005, P205, DOI 10.1007/3-540-26604-6_8; Vors LS, 2007, J WILDLIFE MANAGE, V71, P1249, DOI 10.2193/2006-263; Vors LS, 2009, GLOBAL CHANGE BIOL, V15, P2626, DOI 10.1111/j.1365-2486.2009.01974.x; Weckworth BV, 2012, MOL ECOL, V21, P3610, DOI 10.1111/j.1365-294X.2012.05621.x; Wittmer HU, 2007, J ANIM ECOL, V76, P568, DOI 10.1111/j.1365-2656.2007.01220.x; Wittmer HU, 2010, BIOL CONSERV, V143, P86, DOI 10.1016/j.biocon.2009.09.007; Wittmer HU, 2005, OECOLOGIA, V144, P257, DOI 10.1007/s00442-005-0055-y; Woolley SM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001913	73	34	36	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52661	10.1371/journal.pone.0052661	http://dx.doi.org/10.1371/journal.pone.0052661			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285137	Green Published, gold, Green Submitted			2022-12-27	WOS:000313158800087
J	Liu, X; Wang, SY; Xia, XW; Chen, YS; Zhou, Y; Wu, XM; Zhang, JB; He, S; Tan, YF; Qiang, FL; Roe, OD; Li, G; Zhou, JW				Liu, Xin; Wang, Shouyu; Xia, Xiaowei; Chen, Yansu; Zhou, Yan; Wu, Xuming; Zhang, Jianbing; He, Song; Tan, Yongfei; Qiang, Fulin; Roe, Oluf Dimitri; Li, Gang; Zhou, Jianwei			Synergistic Role between p53 and JWA: Prognostic and Predictive Biomarkers in Gastric Cancer	PLOS ONE			English	Article							MUTANT P53; BREAST-CANCER; TARGETED THERAPIES; POOR-PROGNOSIS; WILD-TYPE; CELLS; CHEMOTHERAPY; EXPRESSION; STRESS; METASTASIS	Expression of p53 appears to be correlated to prognosis in patients with malignancy, but its role in gastric carcinoma has remained controversial. Recently we reported that JWA, an ADP-ribosylation-like factor 6 interacting protein 5 (ARL6ip5), was both prognostic for overall survival and predictive for platinum-based treatment of gastric cancer. In this study, we aimed to investigate p53 expression as a prognostic and predictive marker in resectable gastric cancer, alone and in combination with JWA. Expression of p53 was examined in three large patient cohorts (total n = 1155) of gastric cancer. High expression of p53 was significantly correlated with unfavorable clinicopathologic parameters and decreased overall patient survival. Furthermore, patients with high p53 expression in tumors acquired remarkable survival benefit from adjuvant first-line platinum-based-chemotherapy. The synergy between p53 and JWA in predicting patient outcome was demonstrated, while no significantly elevated predictive value concerning chemotherapy was observed. Thus, p53 expression is a potent prognostic and predictive factor for resectable gastric cancer with adjuvant platinum-based chemotherapy. A combined effect of p53 with JWA as efficient prognostic indicators was found for the first time.	[Liu, Xin; Wang, Shouyu; Xia, Xiaowei; Chen, Yansu; Wu, Xuming; Zhang, Jianbing; Zhou, Jianwei] Nanjing Med Univ, Sch Publ Hlth, Prevent & Treatment Canc Ctr, Dept Mol Cell Biol & Toxicol,Jiangsu Key Lab Canc, Nanjing, Jiangsu, Peoples R China; [Zhou, Yan; Tan, Yongfei] Yixing Hosp, Dept Oncol, Yixing, Jiangsu, Peoples R China; [Wu, Xuming; Zhang, Jianbing; He, Song; Qiang, Fulin] Nantong Canc Hosp, Dept Pathol, Nantong, Jiangsu, Peoples R China; [Roe, Oluf Dimitri] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway; [Li, Gang] Univ British Columbia, Vancouver Coastal Hlth Res Inst, Jack Bell Res Ctr, Dept Dermatol & Skin Sci, Vancouver, BC V5Z 1M9, Canada	Nanjing Medical University; Norwegian University of Science & Technology (NTNU); University of British Columbia; Vancouver Coastal Health Research Institute	Zhou, JW (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Prevent & Treatment Canc Ctr, Dept Mol Cell Biol & Toxicol,Jiangsu Key Lab Canc, Nanjing, Jiangsu, Peoples R China.	jwzhou@njmu.edu.cn		Roe, Oluf Dimitri/0000-0002-4870-5822; Liu, Xin/0000-0003-4094-1211	Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions; National Natural Science Foundation of China [30930080, 81110027]; Foundation of Cancer Center of Nanjing Medical University [08ZLKF08]	Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Cancer Center of Nanjing Medical University	This study was supported in part by the project funded by the Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions (http://jsycw.ec.js.edu.cn); the National Natural Science Foundation of China (30930080 and 81110027) (http://www.nsfc.gov.cn); the Foundation of Cancer Center of Nanjing Medical University (08ZLKF08) (http://202.195.178.127/zlsys). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiko Takashi, 1998, Gastric Cancer, V1, P25, DOI 10.1007/s101200050052; Allum WH, 2011, GUT, V60, P1449, DOI 10.1136/gut.2010.228254; Alsner J, 2008, ACTA ONCOL, V47, P600, DOI 10.1080/02841860802047411; Avkin S, 2006, MOL CELL, V22, P407, DOI 10.1016/j.molcel.2006.03.022; Bai J, 2010, ONCOGENE, V29, P1227, DOI 10.1038/onc.2009.408; Bartek J, 2007, CELL CYCLE, V6, P2344, DOI 10.4161/cc.6.19.4754; Bourdon JC, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2811; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Chang FL, 2000, ANTICANCER RES, V20, P329; Chen HR, 2007, CELL SIGNAL, V19, P1315, DOI 10.1016/j.cellsig.2007.01.007; Chen R, 2007, FREE RADICAL BIO MED, V42, P1704, DOI 10.1016/j.freeradbiomed.2007.02.018; Cheok CF, 2011, NAT REV CLIN ONCOL, V8, P25, DOI 10.1038/nrclinonc.2010.174; Coutant C, 2011, CLIN CANCER RES, V17, P2591, DOI 10.1158/1078-0432.CCR-10-1045; Cunningham D, 2007, NEW ENGL J MED, V357, P1863, DOI 10.1056/NEJMe078182; Ferreira CG, 1999, ANN ONCOL, V10, P1011, DOI 10.1023/A:1008361818480; Gamboa-Dominguez A, 2007, J CLIN PATHOL, V60, P756, DOI 10.1136/jcp.2006.038976; Goh AM, 2011, J PATHOL, V223, P116, DOI 10.1002/path.2784; Goldstein I, 2011, CANCER GENE THER, V18, P2, DOI 10.1038/cgt.2010.63; Hanel W, 2012, J CELL BIOCHEM, V113, P433, DOI 10.1002/jcb.23400; Huang S, 2006, BIOCHEM BIOPH RES CO, V341, P440, DOI 10.1016/j.bbrc.2005.12.197; Huang YP, 2012, CELL CYCLE, V11, P2367, DOI 10.4161/cc.20863; Issaeva N, 2003, P NATL ACAD SCI USA, V100, P13303, DOI 10.1073/pnas.1835733100; Jackson JG, 2012, CANCER CELL, V21, P793, DOI 10.1016/j.ccr.2012.04.027; Li X., 2011, ONCOGENE; Liu XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029670; Machado-Silva A, 2010, SEMIN CANCER BIOL, V20, P57, DOI 10.1016/j.semcancer.2010.02.005; Maehara Y, 1999, BRIT J CANCER, V79, P1255, DOI 10.1038/sj.bjc.6690201; Mallette FA, 2007, CELL CYCLE, V6, P1831, DOI 10.4161/cc.6.15.4516; Maslon MM, 2010, TRENDS CELL BIOL, V20, P542, DOI 10.1016/j.tcb.2010.06.005; Melino G, 2011, CELL DEATH DIFFER, V18, P1487, DOI 10.1038/cdd.2011.81; Muller PAJ, 2011, J CELL BIOL, V192, P209, DOI 10.1083/jcb.201009059; Sakamoto H, 2008, NAT GENET, V40, P730, DOI 10.1038/ng.152; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sumiyoshi Y, 2006, CLIN CANCER RES, V12, P5112, DOI 10.1158/1078-0432.CCR-05-2382; Tang WY, 2007, J TOXICOL ENV HEAL A, V70, P885, DOI 10.1080/15287390701285915; Ueno Y, 2006, CANCER LETT, V241, P289, DOI 10.1016/j.canlet.2005.10.035; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wagner AD, 2009, CURR OPIN ONCOL, V21, P381, DOI 10.1097/CCO.0b013e32832c42e0; Wang SY, 2012, CLIN CANCER RES, V18, P2987, DOI 10.1158/1078-0432.CCR-11-2863; Wang SY, 2009, NUCLEIC ACIDS RES, V37, P1936, DOI 10.1093/nar/gkp054; Wang YX, 2011, J CLIN INVEST, V121, P893, DOI 10.1172/JCI44504; Weichert W, 2008, LANCET ONCOL, V9, P139, DOI 10.1016/S1470-2045(08)70004-4; Wu AW, 2008, JNCI-J NATL CANCER I, V100, P376, DOI 10.1093/jnci/djn055; Wu CW, 1999, BRIT J CANCER, V80, P483, DOI 10.1038/sj.bjc.6690382; Yang H, 2006, INT J CANCER, V119, P2304, DOI 10.1002/ijc.22154; Yokobori T, 2009, CANCER RES, V69, P3788, DOI 10.1158/0008-5472.CAN-08-2846; Zhang J, 2010, J INT MED RES, V38, P423, DOI 10.1177/147323001003800205; Zurer I, 2004, CARCINOGENESIS, V25, P11, DOI 10.1093/carcin/bgg186	48	13	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52348	10.1371/journal.pone.0052348	http://dx.doi.org/10.1371/journal.pone.0052348			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285001	Green Published, gold, Green Submitted			2022-12-27	WOS:000313158800052
J	Matulis, SM; Morales, AA; Yehiayan, L; Lee, KP; Cai, Y; Boise, LH				Matulis, Shannon M.; Morales, Alejo A.; Yehiayan, Lucy; Lee, Kelvin P.; Cai, Yong; Boise, Lawrence H.			Alterations in Glutathione Levels and Apoptotic Regulators Are Associated with Acquisition of Arsenic Trioxide Resistance in Multiple Myeloma	PLOS ONE			English	Article							CELL-CYCLE ARREST; ASCORBIC-ACID; COMBINATION THERAPY; SIGNALING PATHWAYS; LINES; MELPHALAN; CYTOTOXICITY; ACTIVATION; MECHANISMS; EXPRESSION	Arsenic trioxide (ATO) has been tested in relapsed/refractory multiple myeloma with limited success. In order to better understand drug mechanism and resistance pathways in myeloma we generated an ATO-resistant cell line, 8226/S-ATOR05, with an IC50 that is 2-3-fold higher than control cell lines and significantly higher than clinically achievable concentrations. Interestingly we found two parallel pathways governing resistance to ATO in 8226/S-ATOR05, and the relevance of these pathways appears to be linked to the concentration of ATO used. We found changes in the expression of Bcl-2 family proteins Bfl-1 and Noxa as well as an increase in cellular glutathione (GSH) levels. At low, clinically achievable concentrations, resistance was primarily associated with an increase in expression of the anti-apoptotic protein Bfl-1 and a decrease in expression of the pro-apoptotic protein Noxa. However, as the concentration of ATO increased, elevated levels of intracellular GSH in 8226/S-ATOR05 became the primary mechanism of ATO resistance. Removal of arsenic selection resulted in a loss of the resistance phenotype, with cells becoming sensitive to high concentrations of ATO within 7 days following drug removal, indicating changes associated with high level resistance (elevated GSH) are dependent upon the presence of arsenic. Conversely, not until 50 days without arsenic did cells once again become sensitive to clinically relevant doses of ATO, coinciding with a decrease in the expression of Bfl-1. In addition we found cross-resistance to melphalan and doxorubicin in 8226/S-ATOR05, suggesting ATO-resistance pathways may also be involved in resistance to other chemotherapeutic agents used in the treatment of multiple myeloma.	[Matulis, Shannon M.; Boise, Lawrence H.] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [Matulis, Shannon M.; Boise, Lawrence H.] Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA USA; [Matulis, Shannon M.; Boise, Lawrence H.] Winship Canc Inst, Atlanta, GA USA; [Morales, Alejo A.] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA; [Yehiayan, Lucy; Cai, Yong] Florida Int Univ, Dept Chem & Biochem, Miami, FL 33199 USA; [Lee, Kelvin P.] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA; [Lee, Kelvin P.] Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA	Emory University; Emory University; University of Miami; State University System of Florida; Florida International University; Roswell Park Cancer Institute; Roswell Park Cancer Institute	Boise, LH (corresponding author), Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA.	lboise@emory.edu	Boise, Lawrence/AAD-2314-2019; Cai, Yong/K-9868-2015	Cai, Yong/0000-0002-2811-4638; Boise, Lawrence/0000-0001-9436-8815	National Institutes of Health [NIH R01 CA129986, NIH R01 CA97243]; T. J. Martell Foundation; Georgia Cancer Coalition; NATIONAL CANCER INSTITUTE [R01CA129968, R01CA097243] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); T. J. Martell Foundation; Georgia Cancer Coalition; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by the National Institutes of Health, NIH R01 CA129986 and NIH R01 CA97243, the T. J. Martell Foundation, and the Georgia Cancer Coalition. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Jawde RM, 2006, MED ONCOL, V23, P263, DOI 10.1385/MO:23:2:263; Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Akay C, 2003, CELL CYCLE, V2, P358, DOI 10.4161/cc.2.4.417; Anderson KC, 2002, CANCER J, V8, P12, DOI 10.1097/00130404-200201000-00003; Bahlis NJ, 2002, CLIN CANCER RES, V8, P3658; BELLAMY WT, 1988, CANCER RES, V48, P6360; Berenson JR, 2006, BRIT J HAEMATOL, V135, P174, DOI 10.1111/j.1365-2141.2006.06280.x; BOISE LH, 1995, IMMUNITY, V3, P87, DOI 10.1016/1074-7613(95)90161-2; Chen SJ, 2011, BLOOD, V117, P6425, DOI 10.1182/blood-2010-11-283598; Chen Z, 2002, SEMIN HEMATOL, V39, P22, DOI 10.1053/shem.2002.33611; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Chonghaile TN, 2008, ONCOGENE, V27, pS149, DOI 10.1038/onc.2009.52; Davison K, 2003, LEUKEMIA, V17, P931, DOI 10.1038/sj.leu.2402876; Gartenhaus RB, 2002, CLIN CANCER RES, V8, P566; Ge F, 2009, J PROTEOME RES, V8, P3006, DOI 10.1021/pr9001004; Grad JM, 2001, BLOOD, V98, P805, DOI 10.1182/blood.V98.3.805; Hazlehurst LA, 2003, CANCER RES, V63, P7900; Kircelli F, 2007, INT J ONCOL, V30, P993; Lallemand-Breitenbach V, 2012, TRENDS MOL MED, V18, P36, DOI 10.1016/j.molmed.2011.10.001; Liu Q, 2003, BLOOD, V101, P4078, DOI 10.1182/blood-2002-10-3231; Lu SC, 2009, MOL ASPECTS MED, V30, P42, DOI 10.1016/j.mam.2008.05.005; Lunghi P, 2008, BLOOD, V112, P2450, DOI 10.1182/blood-2007-10-114348; Matulis SM, 2009, MOL CANCER THER, V8, P1197, DOI 10.1158/1535-7163.MCT-08-1072; MAZARS GR, 1992, ONCOGENE, V7, P1015; McCafferty-Grad J, 2003, MOL CANCER THER, V2, P1155; Miller WH, 2002, ONCOLOGIST, V7, P14; Miller WH, 2002, CANCER RES, V62, P3893; Morales AA, 2005, INT J CANCER, V113, P730, DOI 10.1002/ijc.20614; Morales AA, 2008, BLOOD, V111, P5152, DOI 10.1182/blood-2007-10-116889; Morales AA, 2009, J BIOL CHEM, V284, P12886, DOI 10.1074/jbc.M806546200; MULCAHY RT, 1994, CANCER CHEMOTH PHARM, V34, P67, DOI 10.1007/s002800050105; Munshi NC, 2002, LEUKEMIA, V16, P1835, DOI 10.1038/sj.leu.2402599; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Park WH, 2000, CANCER RES, V60, P3065; Rousselot P, 2004, LEUKEMIA, V18, P1518, DOI 10.1038/sj.leu.2403424; Rousselot P, 1999, CANCER RES, V59, P1041; UOTILA L, 1974, J BIOL CHEM, V249, P7653; Vogler M, 2012, CELL DEATH DIFFER, V19, P67, DOI 10.1038/cdd.2011.158; Watts GS, 2001, J PHARMACOL EXP THER, V299, P434; Waxman S, 2001, ONCOLOGIST, V6, P3, DOI 10.1634/theoncologist.6-suppl_2-3; Yecies D, 2010, BLOOD, V115, P3304, DOI 10.1182/blood-2009-07-233304; Zhang XW, 2010, SCIENCE, V328, P240, DOI 10.1126/science.1183424	42	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52662	10.1371/journal.pone.0052662	http://dx.doi.org/10.1371/journal.pone.0052662			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285138	Green Submitted, Green Published, gold			2022-12-27	WOS:000313158800088
J	Rojas, M; Farr, GW; Fernandez, CF; Lauden, L; McCormack, JC; Wolin, SL				Rojas, Marta; Farr, George W.; Fernandez, Cesar F.; Lauden, Laura; McCormack, John C.; Wolin, Sandra L.			Yeast Gis2 and Its Human Ortholog CNBP Are Novel Components of Stress-Induced RNP Granules	PLOS ONE			English	Article							ACID-BINDING-PROTEIN; TANDEM AFFINITY PURIFICATION; EUKARYOTIC MESSENGER-RNAS; ZINC-FINGER PROTEIN; P-BODIES; SACCHAROMYCES-CEREVISIAE; TRANSLATION INITIATION; PROCESSING BODIES; MASS-SPECTROMETRY; C-MYC	Although a CCTG expansion in the gene encoding the zinc knuckle protein CNBP causes a common form of muscular dystrophy, the function of both human CNBP and its putative budding yeast ortholog Gis2 remain poorly understood. Here we report the protein interactions of Gis2 and the subcellular locations of both Gis2 and CNBP. We found that Gis2 exhibits RNA-dependent interactions with two proteins involved in mRNA recognition, the poly(A) binding protein and the translation initiation factor eIF4G. We show that Gis2 is a component of two large RNA-protein granules, processing bodies and stress granules, which contain translationally repressed mRNAs. Consistent with a functional ortholog, CNBP also associates with the poly(A) binding protein and accumulates in stress granules during arsenite treatment of human cells. These results implicate both Gis2 and CNBP in mRNA handling during stress.	[Rojas, Marta; Fernandez, Cesar F.; Lauden, Laura; McCormack, John C.; Wolin, Sandra L.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [Farr, George W.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Farr, George W.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA	Yale University; Yale University; Howard Hughes Medical Institute; Yale University	Wolin, SL (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA.	sandra.wolin@yale.edu	Wolin, Sandra/H-2333-2016	Wolin, Sandra/0000-0001-6730-0399	National Institutes of Health (NIH) [R01-GM048410, R01-GM073863]; NIH [F32-ES017387]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F32ES017387] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073863, R01GM048410] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding provided by National Institutes of Health (NIH) Grants R01-GM048410 and R01-GM073863 to SLW, NIH Postdoctoral fellowship F32-ES017387 to JCM and Howard Hughes Medical Institute (GWF). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ALTMANN M, 1985, BIOCHEMISTRY-US, V24, P6085, DOI 10.1021/bi00343a009; ANDERSON JT, 1993, MOL CELL BIOL, V13, P6102, DOI 10.1128/MCB.13.10.6102; Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; Arribere JA, 2011, MOL CELL, V44, P745, DOI 10.1016/j.molcel.2011.09.019; Ashe MP, 2000, MOL BIOL CELL, V11, P833, DOI 10.1091/mbc.11.3.833; Ausubel FM, 1998, CURRENT PROTOCOLS MO; Balagopal V, 2009, CURR OPIN CELL BIOL, V21, P403, DOI 10.1016/j.ceb.2009.03.005; Balagopal V, 2009, GENETICS, V181, P93, DOI 10.1534/genetics.108.092601; Balciunas D, 1999, MOL GEN GENET, V262, P589; Borgognone M, 2010, BIOCHEM J, V428, P491, DOI 10.1042/BJ20100038; Botta A, 2006, BBA-MOL BASIS DIS, V1762, P329, DOI 10.1016/j.bbadis.2005.11.004; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Brengues M, 2007, MOL BIOL CELL, V18, P2592, DOI 10.1091/mbc.E06-12-1149; Buchan JR, 2008, J CELL BIOL, V183, P441, DOI 10.1083/jcb.200807043; Buchan JR, 2010, METHOD ENZYMOL, V470, P619, DOI 10.1016/S0076-6879(10)70025-2; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Calcaterra NB, 2010, IUBMB LIFE, V62, P707, DOI 10.1002/iub.379; Chen W, 2003, DEVELOPMENT, V130, P1367, DOI 10.1242/dev.00349; Chen W, 2007, J MOL BIOL, V368, P8, DOI 10.1016/j.jmb.2007.01.088; Clarkson BK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009114; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; Coller J, 2008, METHOD ENZYMOL, V448, P267, DOI 10.1016/S0076-6879(08)02614-1; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; D'Souza V, 2004, NATURE, V431, P586, DOI 10.1038/nature02944; Damgaard CK, 2011, GENE DEV, V25, P2057, DOI 10.1101/gad.17355911; Gallois-Montbrun S, 2007, J VIROL, V81, P2165, DOI 10.1128/JVI.02287-06; Gelbart ME, 2001, MOL CELL BIOL, V21, P2098, DOI 10.1128/MCB.21.6.2098-2106.2001; Gerbasi VR, 2007, MOL CELL PROTEOMICS, V6, P1049, DOI 10.1074/mcp.M600384-MCP200; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gobeil LA, 2008, FRONT BIOSCI-LANDMRK, V13, P2203, DOI 10.2741/2835; Hamill S, 2010, P NATL ACAD SCI USA, V107, P15045, DOI 10.1073/pnas.1003505107; Hatfield L, 1996, MOL CELL BIOL, V16, P5830; Hilliker A, 2011, MOL CELL, V43, P962, DOI 10.1016/j.molcel.2011.08.008; Holmes LEA, 2004, MOL CELL BIOL, V24, P2998, DOI 10.1128/MCB.24.7.2998-3010.2004; Hoyle NP, 2007, J CELL BIOL, V179, P65, DOI 10.1083/jcb.200707010; HSU CL, 1993, MOL CELL BIOL, V13, P4826, DOI 10.1128/MCB.13.8.4826; Huichalaf C, 2009, J NEUROSCI, V29, P9042, DOI 10.1523/JNEUROSCI.1983-09.2009; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Konicek BW, 1998, DNA CELL BIOL, V17, P799, DOI 10.1089/dna.1998.17.799; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Lee JE, 2009, BIOCHEM SOC T, V37, P1281, DOI 10.1042/BST0371281; Liu MF, 1998, VIRUS RES, V58, P73, DOI 10.1016/S0168-1702(98)00108-7; Lukong KE, 2008, TRENDS GENET, V24, P416, DOI 10.1016/j.tig.2008.05.004; Margolis JM, 2006, HUM MOL GENET, V15, P1808, DOI 10.1093/hmg/ddl103; MICHELOTTI EF, 1995, J BIOL CHEM, V270, P9494, DOI 10.1074/jbc.270.16.9494; Mollet S, 2008, MOL BIOL CELL, V19, P4469, DOI 10.1091/mbc.E08-05-0499; Muhlrad D, 2005, EMBO J, V24, P1033, DOI 10.1038/sj.emboj.7600560; Niedowicz DM, 2010, NEUROSCI LETT, V482, P57, DOI 10.1016/j.neulet.2010.07.006; Nottrott S, 2006, NAT STRUCT MOL BIOL, V13, P1108, DOI 10.1038/nsmb1173; Ohn T, 2008, NAT CELL BIOL, V10, P1224, DOI 10.1038/ncb1783; Park EH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-68; Pellizzoni L, 1997, J MOL BIOL, V267, P264, DOI 10.1006/jmbi.1996.0888; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Raheem O, 2010, AM J PATHOL, V177, P3025, DOI 10.2353/ajpath.2010.100179; RAJAVASHISTH TB, 1989, SCIENCE, V245, P640, DOI 10.1126/science.2562787; Sammons MA, 2011, BIOCHEM BIOPH RES CO, V406, P13, DOI 10.1016/j.bbrc.2011.01.086; Sammons MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009301; Scherrer T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r3; Segal SP, 2006, MOL CELL BIOL, V26, P5120, DOI 10.1128/MCB.01913-05; Shevchenko A, 2002, MOL CELL PROTEOMICS, V1, P204, DOI 10.1074/mcp.M200005-MCP200; Sim S, 2012, RNA, V18, P100, DOI 10.1261/rna.029207.111; Sobel SG, 1999, MOL BIOL CELL, V10, P3849, DOI 10.1091/mbc.10.11.3849; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; TARN WY, 1995, RNA, V1, P644; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; Windgassen M, 2004, MOL CELL BIOL, V24, P10479, DOI 10.1128/MCB.24.23.10479-10491.2004; XU HP, 1992, MOL BIOL CELL, V3, P721, DOI 10.1091/mbc.3.7.721; Yasuda J, 1995, DNA Res, V2, P45, DOI 10.1093/dnares/2.1.45; Yates JR, 2009, ANNU REV BIOMED ENG, V11, P49, DOI 10.1146/annurev-bioeng-061008-124934; YOO CJ, 1994, MOL CELL BIOL, V14, P5412, DOI 10.1128/MCB.14.8.5412	73	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52824	10.1371/journal.pone.0052824	http://dx.doi.org/10.1371/journal.pone.0052824			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285195	gold, Green Published			2022-12-27	WOS:000313158800098
J	Chung, MH; Severynen, AO; Hals, MP; Harrington, RD; Spach, DH; Kim, HN				Chung, Michael H.; Severynen, Anneleen O.; Hals, Matthew P.; Harrington, Robert D.; Spach, David H.; Kim, H. Nina			Offering an American Graduate Medical HIV Course to Health Care Workers in Resource-Limited Settings via the Internet	PLOS ONE			English	Article							ANTIRETROVIRAL TREATMENT; PUBLIC-HEALTH; EDUCATION; HIV/AIDS	Background: Western accredited medical universities can offer graduate-level academic courses to health care workers (HCWs) in resource-limited settings through the internet. It is not known whether HCWs are interested in these online courses, whether they can perform as well as matriculated students, or whether such courses are educationally or practically relevant. Methods and Findings: In 2011, the University of Washington (UW) Schools of Medicine and Nursing offered the graduate course, "Clinical Management of HIV", to HCWs that included a demographic survey, knowledge assessment, and course evaluation. UW faculty delivered HIV clinical topics through ten 2-hour weekly sessions from the perspectives of practicing HIV medicine in developed and developing settings. HCWs viewed lectures through Adobe Acrobat Connect Pro (Adobe Systems, San Jose, CA), and completed online homework on HIV Web Study (http://depts.washington.edu/hivaids/) and online quizzes. HCWs, who met the same passing requirements as UW students by attending 80% lectures, completing >= 90% homework, and achieving a cumulative >= 70% grade on quizzes, were awarded a certificate. 369 HCWs at 33 sites in 21 countries joined the course in 2011, a >15-fold increase since the course was first offered in 2007. The majority of HCWs came from Africa (72%), and most were physicians (41%), nurses (22%), or midlevel practitioners (20%). 298 HCWs (81%) passed all requirements and earned a certificate. In a paired analysis of pre- and post-course HIV knowledge assessments, 56% of HCWs improved their post-course score (p<0.0001) with 27% improving by at least 30%. In the course evaluation, most HCWs rated the course as excellent (53%) or very good (39%). Conclusions: This online HIV course demonstrated that opening a Western graduate medical and nursing curriculum to HCWs in resource-limited settings is feasible, popular, and valuable, and may address logistic and economic barriers to the provision of high quality education in these settings.	[Chung, Michael H.; Hals, Matthew P.; Kim, H. Nina] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Chung, Michael H.; Severynen, Anneleen O.; Harrington, Robert D.; Spach, David H.; Kim, H. Nina] Univ Washington, Dept Med, Seattle, WA USA; [Chung, Michael H.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Chung, MH (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.	mhchung@uw.edu			Health Resources and Services Administration (HRSA), U.S. Department of Health and Human Services [H4AHA00051]	Health Resources and Services Administration (HRSA), U.S. Department of Health and Human Services(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA))	HIV Web Study is supported with funding through the Health Resources and Services Administration (HRSA), U.S. Department of Health and Human Services (Grant No. H4AHA00051). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnighausen T, 2007, AIDS PATIENT CARE ST, V21, P799, DOI 10.1089/apc.2007.0193; Brigley S, 2009, MED TEACH, V31, pE169, DOI 10.1080/01421590802590546; Cohen J, 2004, AIDS, V18, P2105, DOI 10.1097/00002030-200410210-00024; Coomarasamy A, 2004, BMJ-BRIT MED J, V329, P1017, DOI 10.1136/bmj.329.7473.1017; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Heller RF, 2007, B WORLD HEALTH ORGAN, V85, P930, DOI 10.2471/BLT.07.044388; Kiviat AD, 2007, J INFECT DIS, V196, pS512, DOI 10.1086/521117; Knapp H, 2011, TELEMED E-HEALTH, V17, P335, DOI 10.1089/tmj.2010.0187; Kober K, 2004, LANCET, V364, P103, DOI 10.1016/S0140-6736(04)16597-5; Marchal B, 2005, TROP MED INT HEALTH, V10, P300, DOI 10.1111/j.1365-3156.2005.01397.x; McCarthy EA, 2006, PLOS MED, V3, P989, DOI 10.1371/journal.pmed.0030304	11	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52663	10.1371/journal.pone.0052663	http://dx.doi.org/10.1371/journal.pone.0052663			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285139	Green Published, gold, Green Submitted			2022-12-27	WOS:000312794500224
J	Dave, H; Anver, MR; Butcher, DO; Brown, P; Khan, J; Wayne, AS; Baskar, S; Rader, C				Dave, Hema; Anver, Miriam R.; Butcher, Donna O.; Brown, Patrick; Khan, Javed; Wayne, Alan S.; Baskar, Sivasubramanian; Rader, Christoph			Restricted Cell Surface Expression of Receptor Tyrosine Kinase ROR1 in Pediatric B-Lineage Acute Lymphoblastic Leukemia Suggests Targetability with Therapeutic Monoclonal Antibodies	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; MOUSE DEVELOPMENT; RNAI SCREEN; BLINATUMOMAB; PHENOTYPE; CHILDREN; SURVIVAL; DISEASE; TARGET; CLL	Background: Despite high cure rates for pediatric B-lineage acute lymphoblastic leukemia (B-ALL), short-term and long-term toxicities and chemoresistance are shortcomings of standard chemotherapy. Immunotherapy and chemoimmunotherapy based on monoclonal antibodies (mAbs) that target cell surface antigens with restricted expression in pediatric B-ALL may offer the potential to reduce toxicities and prevent or overcome chemoresistance. The receptor tyrosine kinase ROR1 has emerged as a candidate for mAb targeting in select B-cell malignancies. Methodology and Principal Findings: Using flow cytometry, Western blotting, immunohistochemistry, and confocal immunofluorescence microscopy, we analyzed the cell surface expression of ROR1 across major pediatric ALL subtypes represented by 14 cell lines and 56 primary blasts at diagnosis or relapse as well as in normal adult and pediatric tissues. Cell surface ROR1 expression was found in 45% of pediatric ALL patients, all of which were B-ALL, and was not limited to any particular genotype. All cell lines and primary blasts with E2A-PBX1 translocation and a portion of patients with other high risk genotypes, such as MLL rearrangement, expressed cell surface ROR1. Importantly, cell surface ROR1 expression was found in many of the pediatric B-ALL patients with multiply relapsed and refractory disease and normal karyotype or low risk cytogenetics, such as hyperdiploidy. Notably, cell surface ROR1 was virtually absent in normal adult and pediatric tissues. Conclusions and Significance: Collectively, this study suggests that ROR1 merits preclinical and clinical investigations as a novel target for mAb-based therapies in pediatric B-ALL. We propose cell surface expression of ROR1 detected by flow cytometry as primary inclusion criterion for pediatric B-ALL patients in future clinical trials of ROR1-targeted therapies.	[Dave, Hema; Wayne, Alan S.; Baskar, Sivasubramanian; Rader, Christoph] NCI, Expt Transplantat & Immunol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Dave, Hema; Khan, Javed; Wayne, Alan S.] NCI, Pediat Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Anver, Miriam R.; Butcher, Donna O.] NCI, Pathol Histotechnol Lab, Sci Applicat Int Corp Frederick, Frederick Natl Lab Canc Res,NIH, Frederick, MD 21701 USA; [Brown, Patrick] Johns Hopkins Univ Hosp, Dept Oncol & Pediat, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21287 USA; [Rader, Christoph] Scripps Res Inst, Dept Canc Biol, Jupiter, FL USA; [Rader, Christoph] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); Johns Hopkins University; Johns Hopkins Medicine; Scripps Research Institute; Scripps Research Institute	Rader, C (corresponding author), NCI, Expt Transplantat & Immunol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	crader@scripps.edu		Rader, Christoph/0000-0001-9955-3454; Dave, Hema/0000-0001-5530-0201	Intramural Research Program of the Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health (NIH); NCI; NIH [HHSN261200800001E]	Intramural Research Program of the Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health (NIH); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was funded by the Intramural Research Program of the Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health (NIH), and in part with federal funds from the NCI and NIH under Contract No. HHSN261200800001E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shawi R, 2001, DEV GENES EVOL, V211, P161, DOI 10.1007/s004270100140; Ariffin Hany, 2003, SMJ Singapore Medical Journal, V44, P517; Barna G, 2011, HEMATOL ONCOL, V29, P17, DOI 10.1002/hon.948; Barth M, 2012, BRIT J HAEMATOL, V159, P3, DOI 10.1111/bjh.12002; Baskar S, 2008, CLIN CANCER RES, V14, P396, DOI 10.1158/1078-0432.CCR-07-1823; Baskar S, 2012, MABS-AUSTIN, V4, P349, DOI 10.4161/mabs.19870; Broome HE, 2011, LEUKEMIA RES, V35, P1390, DOI 10.1016/j.leukres.2011.06.021; Carroll William L, 2003, Hematology Am Soc Hematol Educ Program, P102; CRIST WM, 1990, BLOOD, V76, P117; DaneshManesh AH, 2008, INT J CANCER, V123, P1190, DOI 10.1002/ijc.23587; de Vries JF, 2011, LEUKEMIA; DiJoseph JF, 2007, LEUKEMIA, V21, P2240, DOI 10.1038/sj.leu.2404866; Fukuda T, 2008, P NATL ACAD SCI USA, V105, P3047, DOI 10.1073/pnas.0712148105; Gashaw I, 2011, DRUG DISCOVERY TODAY, V00; Gentile A, 2011, CANCER RES, V71, P3132, DOI 10.1158/0008-5472.CAN-10-2662; Handgretinger R, 2011, LEUKEMIA, V25, P181, DOI 10.1038/leu.2010.239; Hudecek M, 2010, BLOOD, V116, P4532, DOI 10.1182/blood-2010-05-283309; Klein U, 2001, J EXP MED, V194, P1625, DOI 10.1084/jem.194.11.1625; Lapalombella R, 2010, BLOOD, V115, P2619, DOI 10.1182/blood-2009-09-242438; MacKeigan JP, 2005, NAT CELL BIOL, V7, P591, DOI 10.1038/ncb1258; MASIAKOWSKI P, 1992, J BIOL CHEM, V267, P26181; Oishi I, 1999, GENES CELLS, V4, P41, DOI 10.1046/j.1365-2443.1999.00234.x; Pui C, 2004, NEW ENGL J MED, V350, P1535, DOI 10.1056/NEJMra023001; Raetz EA, 2008, J CLIN ONCOL, V26, P3756, DOI 10.1200/JCO.2007.15.3528; Rebagay G, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00034; Rosenwald A, 2001, J EXP MED, V194, P1639, DOI 10.1084/jem.194.11.1639; Ross ME, 2003, BLOOD, V102, P2951, DOI 10.1182/blood-2003-01-0338; Sanchez-Solana B, 2012, MOL ENDOCRINOL, V26, P110, DOI 10.1210/me.2011-1027; Shabani M, 2008, LEUKEMIA LYMPHOMA, V49, P1360, DOI 10.1080/10428190802124000; Topp MS, 2011, J CLIN ONCOL, V29, P2493, DOI 10.1200/JCO.2010.32.7270; Tyner JW, 2009, P NATL ACAD SCI USA, V106, P8695, DOI 10.1073/pnas.0903233106; Wayne AS, 2010, CLIN CANCER RES, V16, P1894, DOI 10.1158/1078-0432.CCR-09-2980; Yamaguchi T, 2012, CANCER CELL, V21, P348, DOI 10.1016/j.ccr.2012.02.008; Yang JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021018; Zhang SP, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031127, 10.1371/journal.pone.0046853]; ZHOU MX, 1994, LEUKEMIA, V8, P659	36	36	44	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52655	10.1371/journal.pone.0052655	http://dx.doi.org/10.1371/journal.pone.0052655			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285131	Green Submitted, Green Published, gold			2022-12-27	WOS:000312794500220
J	Gu, JM; Qian, H; Shen, L; Zhang, X; Zhu, W; Huang, L; Yan, YM; Mao, F; Zhao, CH; Shi, YY; Xu, WR				Gu, Jianmei; Qian, Hui; Shen, Li; Zhang, Xu; Zhu, Wei; Huang, Ling; Yan, Yongmin; Mao, Fei; Zhao, Chonghui; Shi, Yunyan; Xu, Wenrong			Gastric Cancer Exosomes Trigger Differentiation of Umbilical Cord Derived Mesenchymal Stem Cells to Carcinoma-Associated Fibroblasts through TGF-beta/Smad Pathway	PLOS ONE			English	Article							PROMOTE TUMOR-GROWTH; TRANSITION	Background: Mesenchymal stem cells (MSCs) promote tumor growth by differentiating into carcinoma-associated fibroblasts (CAFs) and composing the tumor microenvironment. However, the mechanisms responsible for the transition of MSCs to CAFs are not well understood. Exosomes regulate cellular activities by mediating cell-cell communication. In this study, we aimed to investigate whether cancer cell-derived exosomes were involved in regulating the differentiation of human umbilical cord-derived MSCs (hucMSCs) to CAFs. Methodology/Principal Findings: We first showed that gastric cancer cell-derived exosomes induced the expression of CAF markers in hucMSCs. We then demonstrated that gastric cancer cell-derived exosomes stimulated the phosphorylation of Smad-2 in hucMSCs. We further confirmed that TGF-beta receptor 1 kinase inhibitor attenuated Smad-2 phosphorylation and CAF marker expression in hucMSCs after exposure to gastric cancer cell-derived exosomes. Conclusion/Significance: Our results suggest that gastric cancer cells triggered the differentiation of hucMSCs to CAFs by exosomes-mediated TGF-beta transfer and TGF-beta/Smad pathway activation, which may represent a novel mechanism for MSCs to CAFs transition in cancer.	[Gu, Jianmei; Qian, Hui; Shen, Li; Zhang, Xu; Zhu, Wei; Huang, Ling; Yan, Yongmin; Mao, Fei; Zhao, Chonghui; Shi, Yunyan; Xu, Wenrong] Jiangsu Univ, Sch Med Sci & Lab Med, Zhenjiang, Jiangsu, Peoples R China; [Xu, Wenrong] Jiangsu Univ, Affiliated Hosp, Dept Clin Lab Med, Zhenjiang, Jiangsu, Peoples R China	Jiangsu University; Jiangsu University	Qian, H (corresponding author), Jiangsu Univ, Sch Med Sci & Lab Med, Zhenjiang, Jiangsu, Peoples R China.	lstmmmlst@163.com; icls@ujs.edu.cn		Zhao, Chonghui/0000-0002-6837-8902	Major Research Plan of the National Natural Science Foundation of China [91129718]; National Natural Science Foundation of China [81071421, 31140063]; Jiangsu Province's Scientific and Technological Supporting Program [BE2010703]; 333 Project of Jiangsu Province [2009055]; Sci-Tech Innovation Team and Talents of Jiangsu University [2008-018-02]	Major Research Plan of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province's Scientific and Technological Supporting Program; 333 Project of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Sci-Tech Innovation Team and Talents of Jiangsu University	This work was supported by the Major Research Plan of the National Natural Science Foundation of China (Grant no. 91129718), the National Natural Science Foundation of China (Grant no. 81071421, 31140063), Jiangsu Province's Scientific and Technological Supporting Program (Grant no. BE2010703), 333 Project of Jiangsu Province (Grant no. 2009055) and the Sci-Tech Innovation Team and Talents of Jiangsu University (Grant no. 2008-018-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albarenque SM, 2011, STEM CELL RES, V7, P163, DOI 10.1016/j.scr.2011.05.002; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Cao HL, 2009, CANCER LETT, V274, P61, DOI 10.1016/j.canlet.2008.08.036; Cat B, 2006, J CELL SCI, V119, P2727, DOI 10.1242/jcs.03011; Cho JA, 2012, INT J ONCOL, V40, P130, DOI 10.3892/ijo.2011.1193; Cho JA, 2011, GYNECOL ONCOL, V123, P379, DOI 10.1016/j.ygyno.2011.08.005; Clayton A, 2007, CANCER RES, V67, P7458, DOI 10.1158/0008-5472.CAN-06-3456; De Bruyn C, 2011, STEM CELLS DEV, V20, P547, DOI 10.1089/scd.2010.0260; Egeblad M, 2010, DEV CELL, V18, P884, DOI 10.1016/j.devcel.2010.05.012; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Gang EJ, 2004, STEM CELLS, V22, P617, DOI 10.1634/stemcells.22-4-617; Giannoni E, 2010, CANCER RES, V70, P6945, DOI 10.1158/0008-5472.CAN-10-0785; Gibbings DJ, 2009, NAT CELL BIOL, V11, P1143, DOI 10.1038/ncb1929; Hao S., 2006, Experimental Oncology, V28, P126; Haubeiss S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-168; Hu M, 2008, CURR OPIN GENET DEV, V18, P27, DOI 10.1016/j.gde.2007.12.006; Joyce JA, 2005, CANCER CELL, V7, P513, DOI 10.1016/j.ccr.2005.05.024; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Lamparski HG, 2002, J IMMUNOL METHODS, V270, P211, DOI 10.1016/S0022-1759(02)00330-7; Liechty KW, 2000, NAT MED, V6, P1282, DOI 10.1038/81395; Liu CR, 2006, J IMMUNOL, V176, P1375, DOI 10.4049/jimmunol.176.3.1375; Mineo M, 2012, ANGIOGENESIS, V15, P33, DOI 10.1007/s10456-011-9241-1; Mishra L, 2005, SCIENCE, V310, P68, DOI 10.1126/science.1118389; Mishra PJ, 2009, CANCER RES, V69, P1255, DOI 10.1158/0008-5472.CAN-08-3562; Ogawa M, 2006, BLOOD, V108, P2893, DOI 10.1182/blood-2006-04-016600; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Qian H, 2008, INT J MOL MED, V22, P325, DOI 10.3892/ijmm_00000026; Qiao C, 2008, CELL BIOL INT, V32, P8, DOI 10.1016/j.cellbi.2007.08.002; Quante M, 2011, CANCER CELL, V19, P257, DOI 10.1016/j.ccr.2011.01.020; Spaeth EL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004992; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Valenti R, 2007, CANCER RES, V67, P2912, DOI 10.1158/0008-5472.CAN-07-0520; Wang GJ, 2008, J IMMUNOL, V181, P5242, DOI 10.4049/jimmunol.181.8.5242; Webber J, 2010, CANCER RES, V70, P9621, DOI 10.1158/0008-5472.CAN-10-1722; Wolfers J, 2001, NAT MED, V7, P297, DOI 10.1038/85438; Yu SH, 2007, J IMMUNOL, V178, P6867, DOI 10.4049/jimmunol.178.11.6867; Zhu W, 2011, CELL CYCLE, V10, DOI 10.4161/cc.10.18.17638; Zhu W, 2012, CANCER LETT, V315, P28, DOI 10.1016/j.canlet.2011.10.002	39	73	86	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52465	10.1371/journal.pone.0052465	http://dx.doi.org/10.1371/journal.pone.0052465			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285052	Green Published, gold, Green Submitted			2022-12-27	WOS:000312794500176
J	Fang, KN; Jiang, YF; Shia, BC; Ma, SG				Fang, Kuangnan; Jiang, Yefei; Shia, BenChang; Ma, Shuangge			Impact of Illness and Medical Expenditure on Household Consumptions: A Survey in Western China	PLOS ONE			English	Article							OUT-OF-POCKET; HEALTH-INSURANCE; CHRONIC DISEASE; CARE	Background: The main goal of this study is to examine the associations between illness conditions and out-of-pocket medical expenditure with other types of household consumptions. In November and December of 2011, a survey was conducted in three cities in western China, namely Lan Zhou, Gui Lin and Xi An, and their surrounding rural areas. Results: Information on demographics, income and consumption was collected on 2,899 households. Data analysis suggested that the presence of household members with chronic diseases was not associated with characteristics of households or household heads. The presence of inpatient treatments was significantly associated with the age of household head (p-value 0.03). The level of per capita medical expense was significantly associated with household size, presence of members younger than 18, older than 65, basic health insurance coverage, per capita income, and household head occupation. Adjusting for confounding effects, the presence of chronic diseases was negatively associated with the amount of basic consumption (p-value 0.02) and the percentage of basic consumption (p-value 0.01), but positively associated with the percentage of insurance expense (p-value 0.02). Medical expenditure was positively associated with all other types of consumptions, including basic, education, saving and investment, entertainment, insurance, durable goods, and alcohol/tobacco. It was negatively associated with the percentage of basic consumption, saving and investment, and insurance. Conclusions: Early studies conducted in other Asian countries and rural China found negative associations between illness conditions and medical expenditure with other types of consumptions. This study was conducted in three major cities and surrounding areas in western China, which had not been well investigated in published literature. The observed consumption patterns were different from those in early studies, and the negative associations were not observed. This study may complement the existing rural studies and provide useful information on western Chinese cities.	[Ma, Shuangge] Yale Univ, Sch Publ Hlth, New Haven, CT 06520 USA; [Fang, Kuangnan; Jiang, Yefei; Shia, BenChang] Xiamen Univ, Dept Stat, Sch Econ, Xiamen, Peoples R China; [Shia, BenChang] FuJen Catholic Univ, Dept Stat & Informat Sci, New Taipei City, Peoples R China	Yale University; Xiamen University	Ma, SG (corresponding author), Yale Univ, Sch Publ Hlth, New Haven, CT 06520 USA.	shuangge.ma@yale.edu	Jiang, Yefei/T-6145-2017		National Natural Science Foundation of China [71201139]; Bureau of Statistics of China [2011LD002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Bureau of Statistics of China	This study was partially supported by the National Natural Science Foundation of China (Grant No. 71201139) and the Bureau of Statistics of China (Grant No. 2011LD002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen Wen-Xian, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P243; Fang KN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039157; Flores G, 2008, HEALTH ECON, V17, P1393, DOI 10.1002/hec.1338; FOSTER AD, 1994, AM ECON REV, V84, P216; Freedman D, 1999, STAT SCI, V14, P243, DOI 10.1214/ss/1009212409; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Jian WY, 2010, HEALTH AFFAIR, V29, P2189, DOI 10.1377/hlthaff.2009.0989; Kabir M, 2000, J INT DEV, V12, P707, DOI DOI 10.1002/1099-1328(200007)12:5<707::AID-JID703>3.0.CO;2-G; Nguyen KT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047423; Kopecky KA, 2010, 201019 FED RES BANK; Lu CL, 2009, B WORLD HEALTH ORGAN, V87, P238, DOI 10.2471/BLT.08.054379; Morrison J, 2008, FIELD NOTE PERSPECTI, V10, P141; NBS GDP DATA, 2012, NBS GDP DATA REVISIO; Setboonsarng S, 2008, 129 ADB I; Sun Q, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-42; Van Doorslaer E, 2007, HEALTH ECON, V16, P1159, DOI 10.1002/hec.1209; Wagstaff A, 2007, J HEALTH ECON, V26, P82, DOI 10.1016/j.jhealeco.2006.07.001; WAKSBERG J, 1978, J AM STAT ASSOC, V73, P40, DOI 10.2307/2286513; Wang H, 2006, HEALTH POLICY, V78, P167, DOI 10.1016/j.healthpol.2005.09.008; Xiao SB, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-695; You X, 2011, APPL HEALTH ECON HEA, V9, P39, DOI 10.2165/11530730-000000000-00000	21	12	12	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52928	10.1371/journal.pone.0052928	http://dx.doi.org/10.1371/journal.pone.0052928			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	064DQ	23285229	Green Published, gold			2022-12-27	WOS:000313051500084
J	Gonzalez, D; Rojas, A; Herrera, MB; Conlan, RS				Gonzalez, Deyarina; Rojas, Armando; Herrera, Maria Beatriz; Conlan, R. Steven			iNOS Activation Regulates beta-catenin Association with Its Partners in Endothelial Cells	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; COLON-CANCER CELLS; NO-DONATING ASPIRIN; TYROSINE PHOSPHORYLATION; KAPPA-B; CADHERIN COMPLEX; TIGHT JUNCTIONS; EXPRESSION; GROWTH; P120-CATENIN	Background: Signals that disrupt beta-catenin association to cadherins may influence the translocation of beta-catenin to the nucleus to regulate transcription. Post-translational modification of proteins is a signalling event that may lead to changes in structural conformation, association or function of the target proteins. NO and its derivatives induce nitration of proteins during inflammation. It has been described that animals treated with NO donors showed increased permeability due to modulation of VE-cadherin/catenin complex. We, therefore, aim to evaluate the effect of iNOS activation on the expression, nuclear localisation and function of beta-catenin in endothelial cells. Methodology/Principal Findings: Expression, nuclear localisation, post-translational modifications and function of beta-catenin was analysed by cell fractionation, immunoprecipitation, immunoblots, QRT-PCR and permeability assays in murine endothelial cells (H5V). Influence of macrophage activation on expression of VE-cadherin/p120-catenin/beta-catenin complex in co-cultured H5V cells was also assessed. Activation of macrophages to produce NO provoked a decrease in VE-cadherin/ p120-catenin/beta-catenin expression in H5V cells. Phosphorylation of beta-catenin, p120-catenin and VE-cadherin, and reduction in the barrier properties of the cell monolayer was associated with iNOS induction. Moreover, high NO levels provoked nitration of beta-catenin, and induced its translocation to the nucleus. In the nucleus of NOS activated cells, nitration levels of beta-catenin influenced its association with TCF4 and p65 proteins. High levels of NO altered beta-catenin mediated gene expression of NFkB and Wnt target genes without affecting cell viability. Conclusions: NOS activity modulates beta-catenin post-translational modifications, function and its association with different partners to promote endothelial cell survival. Therapeutic manipulation of iNOS levels may remove a critical cytoprotective mechanism of importance in tumour angiogenesis.	[Gonzalez, Deyarina; Conlan, R. Steven] Swansea Univ, Coll Med, Ctr NanoHlth, Swansea, W Glam, Wales; [Rojas, Armando] Catholic Univ Maule, Sch Med, Biomed Res Lab, Talca, Chile; [Herrera, Maria Beatriz] Univ Turin, Dept Internal Med, Res Ctr Expt Med, Turin, Italy	Swansea University; Universidad Catolica del Maule; University of Turin	Gonzalez, D (corresponding author), Swansea Univ, Coll Med, Ctr NanoHlth, Swansea, W Glam, Wales.	d.gonzalez@swansea.ac.uk	Rojas, Armando/D-2647-2014	Gonzalez, Deyarina/0000-0002-1838-6752; Conlan, Robert/0000-0002-2562-3461; Rojas, Armando/0000-0001-9911-7142	Royal Society, UK [2005/R4]; Fondo de Desarrollo Cientifico y Tecnologico (FONDECYT), Chile [1090340]; Welsh Asembly Government	Royal Society, UK(Royal Society of London); Fondo de Desarrollo Cientifico y Tecnologico (FONDECYT), Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Welsh Asembly Government	This work was supported in part by grants from Royal Society, UK (grant 2005/R4) and Fondo de Desarrollo Cientifico y Tecnologico (FONDECYT), Chile (grant 1090340). DG and RSC are supported by the Welsh Asembly Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Alema S, 2007, BBA-MOL CELL RES, V1773, P47, DOI 10.1016/j.bbamcr.2006.06.001; Andriopoulou P, 1999, ARTERIOSCL THROM VAS, V19, P2286, DOI 10.1161/01.ATV.19.10.2286; BALLIGAND JL, 1995, AM J PHYSIOL-HEART C, V268, pH1293, DOI 10.1152/ajpheart.1995.268.3.H1293; Beckers CML, 2008, CARDIOVASC RES, V79, P679, DOI 10.1093/cvr/cvn127; Chang K, 2004, EXP MOL MED, V36, P311, DOI 10.1038/emm.2004.42; Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004; Deng JO, 2002, CANCER CELL, V2, P323, DOI 10.1016/S1535-6108(02)00154-X; Dighiero P, 1997, INVEST OPHTH VIS SCI, V38, P2045; Du Q, 2009, CANCER RES, V69, P3764, DOI 10.1158/0008-5472.CAN-09-0014; Esser S, 1998, J CELL SCI, V111, P1853; GARLANDA C, 1994, P NATL ACAD SCI USA, V91, P7291, DOI 10.1073/pnas.91.15.7291; Gonzalez D, 2004, J BIOL CHEM, V279, P43345, DOI 10.1074/jbc.M401889200; Gonzalez D, 2003, BIOCHEM BIOPH RES CO, V304, P113, DOI 10.1016/S0006-291X(03)00546-1; Gow AJ, 2004, AM J PHYSIOL-LUNG C, V287, pL262, DOI 10.1152/ajplung.00295.2003; Harris TJC, 2005, TRENDS CELL BIOL, V15, P234, DOI 10.1016/j.tcb.2005.03.002; Hatanaka K, 2011, AM J PHYSIOL-HEART C, V300, pH162, DOI 10.1152/ajpheart.00650.2010; Huber P, 1996, GENOMICS, V32, P21, DOI 10.1006/geno.1996.0072; Illi B, 2009, PHARMACOL THERAPEUT, V123, P344, DOI 10.1016/j.pharmthera.2009.05.003; Kanwar JR, 2009, CURR MED CHEM, V16, P2373, DOI 10.2174/092986709788682155; Kibbe M, 1999, CARDIOVASC RES, V43, P650, DOI 10.1016/S0008-6363(99)00130-3; Kimura H, 2000, BLOOD, V95, P189, DOI 10.1182/blood.V95.1.189.001k05_189_197; Knepler JL, 2001, AM J PHYSIOL-CELL PH, V281, pC1064, DOI 10.1152/ajpcell.2001.281.3.C1064; KRIKOS A, 1992, J BIOL CHEM, V267, P17971; Lilien J, 2005, CURR OPIN CELL BIOL, V17, P459, DOI 10.1016/j.ceb.2005.08.009; Lin JZ, 2010, CLIN CANCER RES, V16, P77, DOI 10.1158/1078-0432.CCR-08-2362; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Mariner DJ, 2004, J CELL SCI, V117, P1339, DOI 10.1242/jcs.01001; Monteiro HP, 2005, METHOD ENZYMOL, V396, P350, DOI 10.1016/S0076-6879(05)96029-1; Nath N, 2005, BIOCHEM BIOPH RES CO, V326, P93, DOI 10.1016/j.bbrc.2004.11.009; Nath N, 2003, P NATL ACAD SCI USA, V100, P12584, DOI 10.1073/pnas.2134840100; NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6; Navarro P, 1995, J BIOL CHEM, V270, P30965, DOI 10.1074/jbc.270.52.30965; Otero K, 2001, BIOCHEM J, V359, P567, DOI 10.1042/0264-6021:3590567; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; PALMER RMJ, 1988, BIOCHEM BIOPH RES CO, V153, P1251, DOI 10.1016/S0006-291X(88)81362-7; Piedra J, 2001, J BIOL CHEM, V276, P20436, DOI 10.1074/jbc.M100194200; Prandini MH, 2005, ONCOGENE, V24, P2992, DOI 10.1038/sj.onc.1208483; Prevotat L, 2006, GASTROENTEROLOGY, V131, P1142, DOI 10.1053/j.gastro.2006.07.017; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Sossa Rojas A, 2010, CURRENT ENZYME INHIB, V6, P34, DOI [DOI 10.2174/157340810790712050, 10.2174/157340810790712050]; Taddei A, 2008, NAT CELL BIOL, V10, P923, DOI 10.1038/ncb1752; Thoreson MA, 2000, J CELL BIOL, V148, P189, DOI 10.1083/jcb.148.1.189; Udhayakumar G, 2011, MOL CELL BIOCHEM, V357, P283, DOI 10.1007/s11010-011-0899-x; van Veelen W, 2011, GUT, V60, P1204, DOI 10.1136/gut.2010.233460; VANE JR, 1994, P NATL ACAD SCI USA, V91, P2046, DOI 10.1073/pnas.91.6.2046; Wallez Y, 2008, BBA-BIOMEMBRANES, V1778, P794, DOI 10.1016/j.bbamem.2007.09.003; Wang XH, 2002, CIRC RES, V90, P340, DOI 10.1161/hh0302.104466; Weis SM, 2005, NATURE, V437, P497, DOI 10.1038/nature03987; Williams JL, 2011, EXP CELL RES, V317, P1359, DOI 10.1016/j.yexcr.2011.03.001; Wright M, 1999, BIOCHEM BIOPH RES CO, V263, P384, DOI 10.1006/bbrc.1999.1344; Xiao KY, 2005, MOL BIOL CELL, V16, P5141, DOI 10.1091/mbc.E05-05-0440; XIE QW, 1994, J BIOL CHEM, V269, P4705; Zhu HX, 2010, CANCER SCI, V101, P1156, DOI 10.1111/j.1349-7006.2010.01528.x	54	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52964	10.1371/journal.pone.0052964	http://dx.doi.org/10.1371/journal.pone.0052964			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285236	Green Published, Green Submitted, gold			2022-12-27	WOS:000313051500090
J	Hua, N; Wei, XL; Liu, XY; Ma, XY; He, XH; Zhuo, RG; Zhao, Z; Wang, LY; Yan, HT; Zhong, BH; Zheng, JQ				Hua, Nan; Wei, Xiaoli; Liu, Xiaoyan; Ma, Xiaoyun; He, Xinhua; Zhuo, Rengong; Zhao, Zhe; Wang, Liyun; Yan, Haitao; Zhong, Bohua; Zheng, Jianquan			A Novel Muscarinic Antagonist R2HBJJ Inhibits Non-Small Cell Lung Cancer Cell Growth and Arrests the Cell Cycle in G0/G1	PLOS ONE			English	Article							BRONCHIAL EPITHELIAL-CELLS; ALPHA-7-NICOTINIC ACETYLCHOLINE-RECEPTOR; ACTIVATED PROTEIN-KINASE; PROLIFERATION; CARCINOMA; AUTOCRINE; HYDROCHLORIDE; SYNTHESIZE; APOPTOSIS; PATHWAY	Lung cancers express the cholinergic autocrine loop, which facilitates the progression of cancer cells. The antagonists of mAChRs have been demonstrated to depress the growth of small cell lung cancers (SCLCs). In this study we intended to investigate the growth inhibitory effect of R2HBJJ, a novel muscarinic antagonist, on non-small cell lung cancer (NSCLC) cells and the possible mechanisms. The competitive binding assay revealed that R2HBJJ had a high affinity to M3 and M1 AChRs. R2HBJJ presented a strong anticholinergic activity on carbachol-induced contraction of guinea-pig trachea. R2HBJJ markedly suppressed the growth of NSCLC cells, such as H1299, H460 and H157. In H1299 cells, both R2HBJJ and its leading compound R2-PHC displayed significant anti-proliferative activity as M3 receptor antagonist darifenacin. Exogenous replenish of ACh could attenuate R2HBJJ-induced growth inhibition. Silencing M3 receptor or ChAT by specific-siRNAs resulted in a growth inhibition of 55.5% and 37.9% on H1299 cells 96 h post transfection, respectively. Further studies revealed that treatment with R2HBJJ arrested the cell cycle in G0/G1 by down-regulation of cyclin D1-CDK4/6-Rb. Therefore, the current study reveals that NSCLC cells express an autocrine and paracrine cholinergic system which stimulates the growth of NSCLC cells. R2HBJJ, as a novel mAChRs antagonist, can block the local cholinergic loop by antagonizing predominantly M3 receptors and inhibit NSCLC cell growth, which suggest that M3 receptor antagonist might be a potential chemotherapeutic regimen for NSCLC.	[Hua, Nan; Wei, Xiaoli; Liu, Xiaoyan; Ma, Xiaoyun; He, Xinhua; Zhuo, Rengong; Zhao, Zhe; Wang, Liyun; Yan, Haitao; Zhong, Bohua; Zheng, Jianquan] Beijing Inst Pharmacol & Toxicol, Beijing, Peoples R China	Academy of Military Medical Sciences - China	Zheng, JQ (corresponding author), Beijing Inst Pharmacol & Toxicol, Beijing, Peoples R China.	zhengjq@bmi.ac.cn		He, Xinhua/0000-0001-7826-2973				Betticher DC, 1997, INT J CANCER, V74, P556, DOI 10.1002/(SICI)1097-0215(19971021)74:5<556::AID-IJC14>3.0.CO;2-4; Calleja-Macias IE, 2009, INT J CANCER, V124, P1090, DOI 10.1002/ijc.24053; Catassi A, 2008, EUR J CANCER, V44, P2296, DOI 10.1016/j.ejca.2008.06.045; Chen CS, 2011, BREAST CANCER RES TR, V125, P73, DOI 10.1007/s10549-010-0821-3; Chen RJ, 2008, TOXICOL SCI, V104, P283, DOI 10.1093/toxsci/kfn086; Cheng KR, 2008, AM J PHYSIOL-GASTR L, V295, pG591, DOI 10.1152/ajpgi.00055.2008; Egleton RD, 2008, TRENDS PHARMACOL SCI, V29, P151, DOI 10.1016/j.tips.2007.12.006; GRANDO SA, 1993, J INVEST DERMATOL, V101, P32, DOI 10.1111/1523-1747.ep12358588; Haberberger RV, 2000, HISTOCHEM CELL BIOL, V113, P379; Harbour JW, 2000, NAT CELL BIOL, V2, pE65, DOI 10.1038/35008695; Hei TK, 1997, ENVIRON HEALTH PERSP, V105, P1085, DOI 10.2307/3433513; HUNTER T, 1994, CELL, V79, P573, DOI 10.1016/0092-8674(94)90543-6; Kim ES, 2011, CANCER PREV RES, V4, P779, DOI 10.1158/1940-6207.CAPR-11-0143; Klapproth H, 1997, N-S ARCH PHARMACOL, V355, P515, DOI 10.1007/PL00004977; Knudsen ES, 1996, J BIOL CHEM, V271, P8313, DOI 10.1074/jbc.271.14.8313; LIN CH, 1994, BRIT J PHARMACOL, V113, P275, DOI 10.1111/j.1476-5381.1994.tb16205.x; Martinez-Moreno P, 2006, CARCINOGENESIS, V27, P429, DOI 10.1093/carcin/bgi250; NIU WZ, 1990, ARCH INT PHARMACOD T, V304, P64; Oppitz M, 2002, GYNECOL ONCOL, V85, P159, DOI 10.1006/gyno.2002.6597; Ortega S, 2002, BBA-REV CANCER, V1602, P73, DOI 10.1016/S0304-419X(02)00037-9; Paleari L, 2008, CELL PROLIFERAT, V41, P936, DOI 10.1111/j.1365-2184.2008.00566.x; Proskocil BJ, 2004, ENDOCRINOLOGY, V145, P2498, DOI 10.1210/en.2003-1728; Ramalingam SS, 2011, CA-CANCER J CLIN, V61, P91, DOI 10.3322/caac.20102; Rayford W, 1997, PROSTATE, V30, P160, DOI 10.1002/(SICI)1097-0045(19970215)30:3<160::AID-PROS3>3.0.CO;2-Q; RUBINSTEIN LV, 1990, J NATL CANCER I, V82, P1113, DOI 10.1093/jnci/82.13.1113; Shah N, 2009, AM J PHYSIOL-CELL PH, V296, pC221, DOI 10.1152/ajpcell.00514.2008; Shen WF, 2009, PHARMACOL RES, V60, P296, DOI 10.1016/j.phrs.2009.04.007; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Song PF, 2003, CANCER RES, V63, P214; Song PF, 2008, CANCER RES, V68, P4693, DOI 10.1158/0008-5472.CAN-08-0183; Song P, 2007, CANCER RES, V67, P3936, DOI 10.1158/0008-5472.CAN-06-2484; Wang YA, 2005, LIFE SCI, V78, P210, DOI 10.1016/j.lfs.2005.04.071; Wessler I, 1997, N-S ARCH PHARMACOL, V356, P694, DOI 10.1007/PL00005107; Wessler I, 1998, PHARMACOL THERAPEUT, V77, P9; WILLEY JC, 1991, CANCER RES, V51, P5370; Wong HPS, 2007, TOXICOL APPL PHARM, V221, P261, DOI 10.1016/j.taap.2007.04.002; Yagle K, 2001, GLIA, V35, P111, DOI 10.1002/glia.1076	37	18	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53170	10.1371/journal.pone.0053170	http://dx.doi.org/10.1371/journal.pone.0053170			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285263	Green Published, gold, Green Submitted			2022-12-27	WOS:000313051500116
J	Liu, M; Lin, LS; Gao, TX; Yanagimoto, T; Sakurai, Y; Grant, WS				Liu, Ming; Lin, Longshan; Gao, Tianxiang; Yanagimoto, Takashi; Sakurai, Yasunori; Grant, W. Stewart			What Maintains the Central North Pacific Genetic Discontinuity in Pacific Herring?	PLOS ONE			English	Article							POPULATION-STRUCTURE; CLUPEA-PALLASII; MITOCHONDRIAL-DNA; CONTROL REGION; PLEISTOCENE; DIVERSITY; DIVERGENCE; SOFTWARE; SEA; DISPERSAL	Pacific herring show an abrupt genetic discontinuity in the central North Pacific that represents secondary contact between refuge populations previously isolated during Pleistocene glaciations. Paradoxically, high levels of gene flow produce genetic homogeneity among ocean-type populations within each group. Here, we surveyed variability in mtDNA control-region sequences (463 bp) and nine microsatellite loci in Pacific herring from sites across the North Pacific to further explore the nature of the genetic discontinuity around the Alaska Peninsula. Consistent with previous studies, little divergence (Phi(ST) = 0.011) was detected between ocean-type populations of Pacific herring in the North West Pacific, except for a population in the Yellow Sea (Phi(ST) = 0.065). A moderate reduction in genetic diversity for both mtDNA and microsatellites in the Yellow Sea likely reflects founder effects during the last colonization of this sea. Reciprocal monophyly between divergent mtDNA lineages (Phi(ST) = 0.391) across the Alaska Peninsula defines the discontinuity across the North Pacific. However, microsatellites did not show a strong break, as eastern Bering Sea (EBS) herring were more closely related to NE Pacific than to NW Pacific herring. This discordance between mtDNA and microsatellites may be due to microsatellite allelic convergence or to sex-biased dispersal across the secondary contact zone. The sharp discontinuity between Pacific herring populations may be maintained by high-density blocking, competitive exclusion or hybrid inferiority.	[Liu, Ming; Lin, Longshan; Gao, Tianxiang] Ocean Univ China, Inst Evolut & Marine Biodivers, Qingdao, Shandong, Peoples R China; [Yanagimoto, Takashi] Fisheries Res Agcy, Natl Res Inst Fisheries Sci, Yokohama, Kanagawa, Japan; [Sakurai, Yasunori] Hokkaido Univ, Grad Sch Fisheries Sci, Hakodate, Hokkaido, Japan; [Grant, W. Stewart] Alaska Dept Fish & Game, Anchorage, AK 99518 USA	Ocean University of China; Japan Fisheries Research & Education Agency (FRA); Hokkaido University; Alaska Department of Fish & Game	Gao, TX (corresponding author), Ocean Univ China, Inst Evolut & Marine Biodivers, Qingdao, Shandong, Peoples R China.	gaozhang@ouc.edu.cn	Liu, Ming/ABC-8369-2020	Liu, Ming/0000-0002-6454-7297	Special Fund for Agro-scientific Research in the Public Interest [200903005]; National Natural Science Foundation of China [31061160187]; Open Foundation from Ocean Fishery Science and Technology in the Most Important Subjects of Zhejiang	Special Fund for Agro-scientific Research in the Public Interest; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Foundation from Ocean Fishery Science and Technology in the Most Important Subjects of Zhejiang	This work was supported by the Special Fund for Agro-scientific Research in the Public Interest (No. 200903005), the National Natural Science Foundation of China (31061160187), and the Open Foundation from Ocean Fishery Science and Technology in the Most Important Subjects of Zhejiang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike Shoichi, 2010, Scientific Reports of Hokkaido Fisheries Experimental Station, V77, P29; [Anonymous], 1999, POPGENE VERSION 1 3; BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Beacham TD, 2008, T AM FISH SOC, V137, P1795, DOI 10.1577/T08-033.1; Binks RM, 2012, EVOLUTION, V66, P3545, DOI 10.1111/j.1558-5646.2012.01700.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2004, MOL ECOL, V13, P853, DOI 10.1046/j.1365-294X.2003.02004.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fu YX, 1997, GENETICS, V147, P915; Galindo HM, 2006, CURR BIOL, V16, P1622, DOI 10.1016/j.cub.2006.06.052; Gorbarenko SA, 2000, PALAEOGEOGR PALAEOCL, V156, P177, DOI 10.1016/S0031-0182(99)00137-6; Grant WS, 2012, MOL PHYLOGENET EVOL, V65, P203, DOI 10.1016/j.ympev.2012.06.006; GRANT WS, 1984, CAN J FISH AQUAT SCI, V41, P856, DOI 10.1139/f84-102; Harrison PJ, 1999, PROG OCEANOGR, V43, P205, DOI 10.1016/S0079-6611(99)00015-4; Hay DE, 2008, PROG OCEANOGR, V77, P233, DOI 10.1016/j.pocean.2008.03.015; HAY DE, 1985, CAN J FISH AQUAT SCI, V42, P111; Hotta T, 1999, NIPPON SUISAN GAKK, V65, P655; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Jiang X, 2008, J APPL ICHTHYOL, V24, P180, DOI 10.1111/j.1439-0426.2007.01016.x; Johannesson K, 2006, MOL ECOL, V15, P2013, DOI 10.1111/j.1365-294X.2006.02919.x; Jorgensen HBH, 2005, MOL ECOL, V14, P3219, DOI 10.1111/j.1365-294X.2005.02658.x; Kanno Y., 1989, Bulletin of the Japanese Society of Scientific Fisheries, V55, P431; Kobayashi Tokimasa, 1993, Bulletin of the National Research Institute of Far Seas Fisheries, V30, P1; Liu JX, 2007, MOL ECOL, V16, P275, DOI 10.1111/j.1365-294X.2006.03140.x; Liu JX, 2011, MOL ECOL, V20, P3879, DOI 10.1111/j.1365-294X.2011.05213.x; Liu M, 2011, CHIN J OCEANOL LIMN, V29, P317, DOI 10.1007/s00343-011-0008-8; Maggs CA, 2008, ECOLOGY, V89, pS108, DOI 10.1890/08-0257.1; MANN DH, 1995, QUATERNARY SCI REV, V14, P449, DOI 10.1016/0277-3791(95)00016-I; Mantua NJ, 2002, J OCEANOGR, V58, P35, DOI 10.1023/A:1015820616384; Nagasawa K, 2001, PROG OCEANOGR, V49, P551, DOI 10.1016/S0079-6611(01)00040-4; Neiva J, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-78; O'Connell M, 1998, J FISH BIOL, V53, P150; Olsen JB, 2002, MOL ECOL NOTES, V2, P101, DOI 10.1046/j.1471-8286.2002.00160.x; Patarnello T, 2007, MOL ECOL, V16, P4426, DOI 10.1111/j.1365-294X.2007.03477.x; Payne MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030105; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pritchard JK, 2000, GENETICS, V155, P945; Ray N, 2003, MOL BIOL EVOL, V20, P76, DOI 10.1093/molbev/msg009; REEB CA, 1990, GENETICS, V124, P397; Riginos C, 2001, MOL ECOL, V10, P1439, DOI 10.1046/j.1365-294X.2001.01294.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Roman J, 2004, MOL ECOL, V13, P2891, DOI 10.1111/j.1365-294X.2004.02255.x; Rousset F, 1997, GENETICS, V145, P1219; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Ryman N, 2006, MOL ECOL, V15, P2031, DOI 10.1111/j.1365-294X.2006.02839.x; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SANCETTA C, 1983, DEEP-SEA RES, V30, P851, DOI 10.1016/0198-0149(83)90004-3; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; Small MP, 2005, T AM FISH SOC, V134, P1329, DOI 10.1577/T05-050.1; Springer SA, 2007, EVOLUTION, V61, P772, DOI 10.1111/j.1558-5646.2007.00073.x; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Toews DPL, 2012, MOL ECOL, V21, P3907, DOI 10.1111/j.1365-294X.2012.05664.x; Tojo N, 2007, DEEP-SEA RES PT II, V54, P2832, DOI 10.1016/j.dsr2.2007.07.032; Waters JM, 2011, MOL ECOL, V20, P4388, DOI 10.1111/j.1365-294X.2011.05286.x; Wildes SL, 2011, FISH B-NOAA, V109, P382; Yamane K, 2010, AQUAT BIOL, V10, P283, DOI 10.3354/ab00291; Zarraonaindia I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042201; Zebdi Abdelkrim, 1995, Canadian Special Publication of Fisheries and Aquatic Sciences, V121, P277	63	24	25	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e50340	10.1371/journal.pone.0050340	http://dx.doi.org/10.1371/journal.pone.0050340			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23300525	Green Published, Green Submitted, gold			2022-12-27	WOS:000313051500003
J	Qin, XY; Sone, H; Kojima, Y; Mizuno, K; Ueoka, K; Muroya, K; Miyado, M; Hisada, A; Zaha, H; Fukuda, T; Yoshinaga, J; Yonemoto, J; Kohri, K; Hayashi, Y; Fukami, M; Ogata, T				Qin, Xian-Yang; Sone, Hideko; Kojima, Yoshiyuki; Mizuno, Kentaro; Ueoka, Katsuhiko; Muroya, Koji; Miyado, Mami; Hisada, Aya; Zaha, Hiroko; Fukuda, Tomokazu; Yoshinaga, Jun; Yonemoto, Junzo; Kohri, Kenjiro; Hayashi, Yutaro; Fukami, Maki; Ogata, Tsutomu			Individual Variation of the Genetic Response to Bisphenol A in Human Foreskin Fibroblast Cells Derived from Cryptorchidism and Hypospadias Patients	PLOS ONE			English	Article							TESTICULAR DYSGENESIS SYNDROME; NUCLEAR TRANSLOCATOR ARNT; BREAST-CANCER CELLS; ANDROGEN RECEPTOR; EXPRESSION; ABNORMALITIES; POPULATION; METABOLISM; EXPOSURE; HYPOXIA	Background/Purpose: We hypothesized that polymorphic differences among individuals might cause variations in the effect that environmental endocrine disruptors (EEDs) have on male genital malformations (MGMs). In this study, individual variation in the genetic response to low-dose bisphenol A (BPA) was investigated in human foreskin fibroblast cells (hFFCs) derived from child cryptorchidism (CO) and hypospadias (HS) patients. Methodology/Principal Findings: hFFCs were collected from control children without MGMs (n = 5) and child CO and HS patients (n = 8 and 21, respectively). BPA exposure (10 nM) was found to inhibit matrix metalloproteinase-11 (MMP11) expression in the HS group (0.74-fold, P = 0.0034) but not in the control group (0.93- fold, P = 0.84) and CO group (0.94-fold, P = 0.70). Significantly lower levels of MMP11 expression were observed in the HS group compared with the control group (0.80-fold, P = 0.0088) and CO group (0.79-fold, P = 0.039) in response to 10 nM BPA. The effect of single-nucleotide polymorphism rs5000770 (G. A), located within the aryl hydrocarbon receptor nuclear translocator 2 (ARNT2) locus, on individual sensitivity to low-dose BPA was investigated in the HS group. A significant difference in neurotensin receptor 1 (NTSR1) expression in response to 10 nM BPA was observed between AA and AG/GG groups (n = 6 and 15, respectively. P = 0.031). However, no significant difference in ARNT2 expression was observed (P = 0.18). Conclusions/Significance: This study advances our understanding of the specificity of low-dose BPA effects on human reproductive health. Our results suggest that genetic variability among individuals affects susceptibility to the effects of EEDs exposure as a potential cause of HS.	[Qin, Xian-Yang; Sone, Hideko; Zaha, Hiroko; Yonemoto, Junzo] Natl Inst Environm Studies, Res Ctr Environm Risk, Hlth Risk Res Sect, Tsukuba, Ibaraki, Japan; [Qin, Xian-Yang; Hisada, Aya; Yoshinaga, Jun] Univ Tokyo, Grad Sch Frontier Sci, Dept Environm Studies, Kashiwa, Chiba, Japan; [Kojima, Yoshiyuki] Fukushima Med Univ, Sch Med, Dept Urol, Fukushima, Japan; [Mizuno, Kentaro; Kohri, Kenjiro; Hayashi, Yutaro] Nagoya City Univ, Grad Sch Med Sci, Dept Nephrourol, Nagoya, Aichi, Japan; [Ueoka, Katsuhiko] Natl Res Ctr Child Hlth & Dev, Dept Surg Subspecialties, Tokyo, Japan; [Muroya, Koji] Kanagawa Childrens Med Ctr, Div Endocrinol & Metab, Yokohama, Kanagawa, Japan; [Miyado, Mami; Fukami, Maki] Natl Res Inst Child Hlth & Dev, Dept Endocrinol & Metab, Tokyo, Japan; [Fukuda, Tomokazu] Tohoku Univ, Grad Sch Agr Sci, Dept Anim Prod Sci, Sendai, Miyagi 980, Japan; [Ogata, Tsutomu] Hamamatsu Univ Sch Med, Univ Hosp, Dept Pediat, Hamamatsu, Shizuoka 4313192, Japan	National Institute for Environmental Studies - Japan; University of Tokyo; Fukushima Medical University; Nagoya City University; National Center for Child Health & Development - Japan; National Center for Child Health & Development - Japan; Tohoku University; Hamamatsu University School of Medicine	Sone, H (corresponding author), Natl Inst Environm Studies, Res Ctr Environm Risk, Hlth Risk Res Sect, Tsukuba, Ibaraki, Japan.	hsone@nies.go.jp	Muroya, Koji/J-1304-2016; Fukami, Maki/ABE-4694-2020; Qin, Xian-Yang/AAB-5628-2020; Mizuno, Kentaro/H-8950-2019; Fukuda, Tomokazu/O-1257-2018	Muroya, Koji/0000-0002-1810-9894; Fukami, Maki/0000-0001-9971-4035; Mizuno, Kentaro/0000-0002-9624-2009; Fukuda, Tomokazu/0000-0001-8456-0483; Ogata, Tsutomu/0000-0001-7178-9991	Environmental Technology Development Fund from the Ministry of the Environment, Japan	Environmental Technology Development Fund from the Ministry of the Environment, Japan	This study was supported by the Environmental Technology Development Fund from the Ministry of the Environment, Japan. The funding agency had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alifano M, 2010, CLIN CANCER RES, V16, P4401, DOI 10.1158/1078-0432.CCR-10-0659; Andrieux J, 2009, AM J MED GENET A, V149A, P2813, DOI 10.1002/ajmg.a.33097; Barrow LL, 2002, TERATOLOGY, V66, P85, DOI 10.1002/tera.10062; Baskin LS, 2001, CELL TISSUE RES, V305, P379, DOI 10.1007/s004410000345; Calafat AM, 2005, ENVIRON HEALTH PERSP, V113, P391, DOI 10.1289/ehp.7534; Carbone P, 2007, INT J ANDROL, V30, P3, DOI 10.1111/j.1365-2605.2006.00703.x; Dupouy S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004223; Hankinson O, 2008, TOXICOL SCI, V103, P1, DOI 10.1093/toxsci/kfn032; Hill AJ, 2009, ZEBRAFISH, V6, P79, DOI 10.1089/zeb.2008.0536; Hirose K, 1996, MOL CELL BIOL, V16, P1706; Hsu HJ, 2001, BIOCHEM BIOPH RES CO, V282, P487, DOI 10.1006/bbrc.2001.4525; Klopocki E, 2008, EUR J PEDIATR, V167, P903, DOI 10.1007/s00431-007-0616-7; Knorr E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004751; Maltepe E, 2000, BIOCHEM BIOPH RES CO, V273, P231, DOI 10.1006/bbrc.2000.2928; Martin OV, 2008, ENVIRON HEALTH PERSP, V116, P149, DOI 10.1289/ehp.10545; McInnes LA, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-5; Peruzzi D, 2009, CLIN CANCER RES, V15, P4104, DOI 10.1158/1078-0432.CCR-08-3226; Qiao L, 2012, PEDIATR RES, V71, P393, DOI 10.1038/pr.2011.49; Qin XY, 2012, J HUM GENET, V57, P434, DOI 10.1038/jhg.2012.48; Qin XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036711; Qin XY, 2011, FEBS LETT, V585, P3310, DOI 10.1016/j.febslet.2011.09.017; Qin XY, 2011, TOXICOL LETT, V206, P152, DOI 10.1016/j.toxlet.2011.07.007; Sekine H, 2006, J BIOL CHEM, V281, P37507, DOI 10.1074/jbc.M606910200; Toppari J, 2010, BIRTH DEFECTS RES A, V88, P910, DOI 10.1002/bdra.20707; Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010; Vandenberg LN, 2009, ENDOCR REV, V30, P75, DOI 10.1210/er.2008-0021; Vidaeff AC, 2005, REPROD TOXICOL, V20, P5, DOI 10.1016/j.reprotox.2004.12.015; Virtanen HE, 2007, ACTA PAEDIATR, V96, P611, DOI 10.1111/j.1651-2227.2007.00241.x; Vottero A, 2011, J CLIN ENDOCR METAB, V96, pE1953, DOI 10.1210/jc.2011-0511; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; Watanabe M, 2007, HUM REPROD, V22, P1279, DOI 10.1093/humrep/del513; Wetherill YB, 2007, REPROD TOXICOL, V24, P178, DOI 10.1016/j.reprotox.2007.05.010	32	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52756	10.1371/journal.pone.0052756	http://dx.doi.org/10.1371/journal.pone.0052756			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285176	Green Published, Green Submitted, gold			2022-12-27	WOS:000313051500056
J	Stepto, NK; Benziane, B; Wadley, GD; Chibalin, AV; Canny, BJ; Eynon, N; McConell, GK				Stepto, Nigel K.; Benziane, Boubacar; Wadley, Glenn D.; Chibalin, Alexander V.; Canny, Benedict J.; Eynon, Nir; McConell, Glenn K.			Short-Term Intensified Cycle Training Alters Acute and Chronic Responses of PGC1 alpha and Cytochrome C Oxidase IV to Exercise in Human Skeletal Muscle	PLOS ONE			English	Article							PGC-1-ALPHA MESSENGER-RNA; INDUCED MITOCHONDRIAL BIOGENESIS; GENE-EXPRESSION; NUCLEAR ABUNDANCE; SPRINT INTERVAL; INCREASES; ACTIVATION; PROTEIN; RIP140; AMPK	Reduced activation of exercise responsive signalling pathways have been reported in response to acute exercise after training; however little is known about the adaptive responses of the mitochondria. Accordingly, we investigated changes in mitochondrial gene expression and protein abundance in response to the same acute exercise before and after 10-d of intensive cycle training. Nine untrained, healthy participants (mean +/- SD; VO2peak 44.1 +/- 17.6 ml/kg/min) performed a 60 min bout of cycling exercise at 164 +/- 18 W (72% of pre-training VO2peak). Muscle biopsies were obtained from the vastus lateralis muscle at rest, immediately and 3 h after exercise. The participants then underwent 10-d of cycle training which included four high-intensity interval training sessions (6x5 min; 90-100% VO2peak) and six prolonged moderate-intensity sessions (45-90 min; 75% VO2peak). Participants repeated the pre-training exercise trial at the same absolute work load (64% of pre-training VO2peak). Muscle PGC1-alpha mRNA expression was attenuated as it increased by 11- and 4- fold (P<0.001) after exercise pre- and post-training, respectively. PGC1-alpha protein expression increased 1.5 fold (P<0.05) in response to exercise pre-training with no further increases after the post-training exercise bout. RIP140 protein abundance was responsive to acute exercise only (P<0.01). COXIV mRNA (1.6 fold; P<0.01) and COXIV protein expression (1.5 fold; P<0.05) were increased by training but COXIV protein expression was decreased (20%; P<0.01) by acute exercise pre- and post-training. These findings demonstrate that short-term intensified training promotes increased mitochondrial gene expression and protein abundance. Furthermore, acute indicators of exercise-induced mitochondrial adaptation appear to be blunted in response to exercise at the same absolute intensity following short-term training.	[Stepto, Nigel K.; Eynon, Nir; McConell, Glenn K.] Victoria Univ, Inst Sport Exercise & Act Living, Footscray, Vic, Australia; [Stepto, Nigel K.; Eynon, Nir] Victoria Univ, Sch Sport & Exercise Sci, Footscray, Vic, Australia; [Benziane, Boubacar] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Wadley, Glenn D.] Deakin Univ, Sch Exercise & Nutr Sci, Ctr Phys Act & Nutr Res, Burwood, Vic, Australia; [Chibalin, Alexander V.] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Canny, Benedict J.] Monash Univ, Dept Physiol, Clayton, Vic 3168, Australia; [McConell, Glenn K.] Victoria Univ, Sch Biomed & Hlth Sci, Footscray, Vic, Australia	Victoria University; Victoria University; Karolinska Institutet; Deakin University; Karolinska Institutet; Monash University; Victoria University	Stepto, NK (corresponding author), Victoria Univ, Inst Sport Exercise & Act Living, Footscray, Vic, Australia.	Nigel.Stepto@vu.edu.au		Wadley, Glenn/0000-0002-6617-4359; McConell, Glenn/0000-0002-8572-9065; Stepto, Nigel/0000-0002-0875-6836; Chibalin, Alexander/0000-0002-6339-6271; Eynon, Nir/0000-0003-4046-8276	Swedish Research Council; Novo-Nordisk Foundation; commission of the European Communities [LSHM-CT-2004-512013, LSHM-CT-2004-005272]; Australian Government Collaborative Research Network Scheme	Swedish Research Council(Swedish Research CouncilEuropean Commission); Novo-Nordisk Foundation(Novo Nordisk Foundation); commission of the European Communities(European Commission); Australian Government Collaborative Research Network Scheme(Australian GovernmentDepartment of Industry, Innovation and Science)	This work was supported by grants from the Swedish Research Council, the Novo-Nordisk Foundation, and the commission of the European Communities (Contract number LSHM-CT-2004-512013 EUGENEHEART and Contract No. LSHM-CT-2004-005272 EXGENESIS)to AVC. NKS is supported by the Australian Government Collaborative Research Network Scheme. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Akimoto T, 2005, J BIOL CHEM, V280, P19587, DOI 10.1074/jbc.M408862200; Arany Z, 2007, CELL METAB, V5, P35, DOI 10.1016/j.cmet.2006.12.003; Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com; Barres R, 2011, AM J CLIN NUTR, V93, p897S, DOI 10.3945/ajcn.110.001933; Barres R, 2012, CELL METAB, V15, P405, DOI 10.1016/j.cmet.2012.01.001; Bartlett JD, 2012, J APPL PHYSIOL, V112, P1135, DOI 10.1152/japplphysiol.01040.2011; Benziane B, 2008, AM J PHYSIOL-ENDOC M, V295, pE1427, DOI 10.1152/ajpendo.90428.2008; Bergman BC, 1999, AM J PHYSIOL-ENDOC M, V277, pE81, DOI 10.1152/ajpendo.1999.277.1.E81; BOOTH FW, 1977, J BIOL CHEM, V252, P416; Burgomaster KA, 2007, AM J PHYSIOL-REG I, V292, pR1970, DOI 10.1152/ajpregu.00503.2006; Chesley A, 1996, AM J PHYSIOL-ENDOC M, V270, pE328, DOI 10.1152/ajpendo.1996.270.2.E328; Choksi KB, 2004, BBA-MOL BASIS DIS, V1688, P95, DOI 10.1016/j.bbadis.2003.11.007; Coffey VG, 2007, SPORTS MED, V37, P737, DOI 10.2165/00007256-200737090-00001; Coffey VG, 2009, AM J PHYSIOL-REG I, V297, pR1441, DOI 10.1152/ajpregu.00351.2009; COYLE EF, 1985, J APPL PHYSIOL, V59, P853, DOI 10.1152/jappl.1985.59.3.853; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; D'Antona G, 2010, CELL METAB, V12, P362, DOI 10.1016/j.cmet.2010.08.016; D'souza D, 2012, AM J PHYSIOL-REG I, V303, pR408, DOI 10.1152/ajpregu.00085.2012; Daussin FN, 2012, MED SCI SPORT EXER, V44, P217, DOI 10.1249/MSS.0b013e31822b0bd4; Egan B, 2010, J PHYSIOL-LONDON, V588, P1779, DOI 10.1113/jphysiol.2010.188011; Feng ZH, 2011, FREE RADICAL BIO MED, V50, P1437, DOI 10.1016/j.freeradbiomed.2011.03.001; Fluck M, 2006, J EXP BIOL, V209, P2239, DOI 10.1242/jeb.02149; Fluck M, 2003, REV PHYSIOL BIOCH P, V146, P159, DOI 10.1007/s10254-002-0004-7; Frier BC, 2011, J APPL PHYSIOL, V111, P688, DOI 10.1152/japplphysiol.00279.2011; Fritah A, 2010, AM J PHYSIOL-ENDOC M, V299, pE335, DOI 10.1152/ajpendo.00243.2010; Gibala MJ, 2006, J PHYSIOL-LONDON, V575, P901, DOI 10.1113/jphysiol.2006.112094; Gibala MJ, 2009, J APPL PHYSIOL, V106, P929, DOI 10.1152/japplphysiol.90880.2008; GOLLNICK PD, 1973, J APPL PHYSIOL, V34, P107, DOI 10.1152/jappl.1973.34.1.107; Green HJ, 2008, J APPL PHYSIOL, V104, P931, DOI 10.1152/japplphysiol.01151.2007; Gupta P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002658; Hallberg M, 2008, MOL CELL BIOL, V28, P6785, DOI 10.1128/MCB.00504-08; Holloszy JO, 2008, J PHYSIOL PHARMACOL, V59, P5; Holloszy J O, 1977, Ann N Y Acad Sci, V301, P440, DOI 10.1111/j.1749-6632.1977.tb38220.x; Hood DA, 2001, J APPL PHYSIOL, V90, P1137, DOI 10.1152/jappl.2001.90.3.1137; Hood MS, 2011, MED SCI SPORT EXER, V43, P1849, DOI 10.1249/MSS.0b013e3182199834; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Joseph AM, 2006, ESSAYS BIOCHEM, V42, P13, DOI 10.1042/bse0420013; Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185; Leek BT, 2001, AM J PHYSIOL-REG I, V280, pR441, DOI 10.1152/ajpregu.2001.280.2.R441; Little JP, 2011, AM J PHYSIOL-REG I, V300, pR1303, DOI 10.1152/ajpregu.00538.2010; Little JP, 2010, AM J PHYSIOL-REG I, V298, pR912, DOI 10.1152/ajpregu.00409.2009; Lundby C, 2005, EUR J APPL PHYSIOL, V95, P351, DOI 10.1007/s00421-005-0022-7; Mathai AS, 2008, J APPL PHYSIOL, V105, P1098, DOI 10.1152/japplphysiol.00847.2007; McConell GK, 2005, J PHYSIOL-LONDON, V568, P665, DOI 10.1113/jphysiol.2005.089839; Mecleiros DM, 2008, METHODS, V46, P288, DOI 10.1016/j.ymeth.2008.09.026; Miller BF, 2012, AM J PHYSIOL-ENDOC M, V302, pE496, DOI 10.1152/ajpendo.00578.2011; Mortensen OH, 2007, J APPL PHYSIOL, V103, P1536, DOI 10.1152/japplphysiol.00575.2007; Nordsborg NB, 2010, MED SCI SPORT EXER, V42, P1477, DOI 10.1249/MSS.0b013e3181d2d21c; Norrbom J, 2004, J APPL PHYSIOL, V96, P189, DOI 10.1152/japplphysiol.00765.2003; Perry CGR, 2010, J PHYSIOL-LONDON, V588, P4795, DOI 10.1113/jphysiol.2010.199448; Pilegaard H, 2003, J PHYSIOL-LONDON, V546, P851, DOI 10.1113/jphysiol.2002.034850; Pilegaard H, 2000, AM J PHYSIOL-ENDOC M, V279, pE806; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Rhinn H, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-62; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; Roth SM, 2011, J APPL PHYSIOL, V110, P301, DOI 10.1152/japplphysiol.01330.2010; Russell AP, 2005, FASEB J, V19, P986, DOI 10.1096/fj.04-3168fje; Scarpulla RC, 2008, ANN NY ACAD SCI, V1147, P321, DOI 10.1196/annals.1427.006; Serpiello FR, 2012, MED SCI SPORT EXER, V44, P827, DOI 10.1249/MSS.0b013e318240067e; Spina RJ, 1996, J APPL PHYSIOL, V80, P2250, DOI 10.1152/jappl.1996.80.6.2250; Stepto NK, 2009, MED SCI SPORT EXER, V41, P546, DOI 10.1249/MSS.0b013e31818c6be9; Wadley GD, 2010, J APPL PHYSIOL, V108, P1719, DOI 10.1152/japplphysiol.00127.2010; WIBOM R, 1992, J APPL PHYSIOL, V73, P2004, DOI 10.1152/jappl.1992.73.5.2004; Wright DC, 2007, J BIOL CHEM, V282, P18793, DOI 10.1074/jbc.M611252200; Wright DC, 2007, J BIOL CHEM, V282, P194, DOI 10.1074/jbc.M606116200; Yu M, 2003, J PHYSIOL-LONDON, V546, P327, DOI 10.1113/jphysiol.2002.034223	67	44	44	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53080	10.1371/journal.pone.0053080	http://dx.doi.org/10.1371/journal.pone.0053080			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285255	Green Published, gold, Green Accepted			2022-12-27	WOS:000313051500107
J	Deogan, C; Ferguson, J; Stenberg, K				Deogan, Charlotte; Ferguson, Jane; Stenberg, Karin			Resource Needs for Adolescent Friendly Health Services: Estimates for 74 Low- and Middle-Income Countries	PLOS ONE			English	Article							YOUNG-PEOPLE; INJECT DRUGS; MORTALITY; DISEASE; HIV	Background: In order to achieve Millennium Development Goals 4, 5 and 6, it is essential to address adolescents' health. Objective: To estimate the additional resources required to scale up adolescent friendly health service interventions with the objective to reduce mortality and morbidity among individuals aged 10 to 19 years in 74 low-and middle-income countries. Methods: A costing model was developed to estimate the financial resources needed to scale-up delivery of a set of interventions including contraception, maternity care, management of sexually transmitted infections, HIV testing and counseling, safe abortion services, HIV harm reduction, HIV care and treatment and care of injuries due to intimate partner physical and sexual violence. Financial costs were estimated for each intervention, country and year using a bottom-up ingredients approach, defining costs at different levels of delivery (i.e., community, health centre, and hospital level). Programme activity costs to improve quality of care were also estimated, including activities undertaken at national-, district-and facility level in order to improve adolescents' use of health services (i.e., to render health services adolescent friendly). Results: Costs of achieving universal coverage are estimated at an additional US$ 15.41 billion for the period 2011-2015, increasing from US$ 1.86 billion in 2011 to US$ 4,31 billion in 2015. This corresponds to approximately US$ 1.02 per adolescent in 2011, increasing to 4.70 in 2015. On average, for all 74 countries, an annual additional expenditure per capita ranging from of US$ 0.38 in 2011 to US$ 0.82 in 2015, would be required to support the scale-up of key adolescent friendly health services. Conclusion: The estimated costs show a substantial investment gap and are indicative of the additional investments required to scale up health service delivery to adolescents towards universal coverage by 2015.	[Deogan, Charlotte] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Ferguson, Jane] WHO, Dept Maternal Newborn Child & Adolescent Hlth, CH-1211 Geneva, Switzerland; [Stenberg, Karin] WHO, Dept Hlth Syst Financing, CH-1211 Geneva, Switzerland	Karolinska Institutet; World Health Organization; World Health Organization	Deogan, C (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden.	charlotte.deogan@ki.se						Brown C., 2002, COST EFFECTIVENESS E, P139; Dumitru A., 2022, CONNECTING NATURE GU; Ebbeler J, 2009, FINANCIAL REQUIREMEN; Gore FM, 2011, LANCET, V377, P2093, DOI 10.1016/S0140-6736(11)60512-6; Haller DM, 2012, J ADOLESCENT HEALTH, V51, P422, DOI 10.1016/j.jadohealth.2012.01.019; Inst Med, 2009, ADOLESCENT HEALTH SERVICES: MISSING OPPORTUNITIES, P1; Johns Benjamin, 2003, Cost Eff Resour Alloc, V1, P1, DOI 10.1186/1478-7547-1-1; Management Sciences for Health, 2004, INT DRUG PRIC GUID; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; Mathers BM, 2010, LANCET, V375, P1014, DOI 10.1016/S0140-6736(10)60232-2; Neal S, 2012, ACTA OBSTET GYN SCAN, V91, P1114, DOI 10.1111/j.1600-0412.2012.01467.x; Patton GC, 2009, LANCET, V374, P881, DOI 10.1016/S0140-6736(09)60741-8; Ross D. A., 2006, WHO Technical Report Series; Sawyer SM, 2012, LANCET, V379, P1630, DOI 10.1016/S0140-6736(12)60072-5; Shah L, 2004, REPROD HEALTH MATTER, V12, P9, DOI 10.1016/S0968-8080(04)24002-2; Stenberg K, 2007, B WORLD HEALTH ORGAN, V85, P305, DOI 10.2471/BLT.06.032052; Stenberg K, 2012, GLOB HEART, V7, P52, DOI 10.1016/j.gheart.2012.02.001; Taskforce-on-Innovative-International-Financing-for-Health-Systems, 2009, HIGH LEV TASKF INT I; Temin M., 2009, START GIRL NEW AGEND; UN Millennium Project, 2005, INV DEV PRACT PLAN A; UN Population Division, 2009, WORLD POP PROSP 2008; UNAIDS, 2007, FIN RES REQ ACH UN A; UNICEF, 2011, OPP CRIS PREV HIV EA; United Nations Secretary General, 2010, GLOB STRAT WOM CHILD; USAID UNAIDS WHO UNICEF, 2004, COV SEL SERV HIV AID; Viner RM, 2011, LANCET, V377, P1162, DOI 10.1016/S0140-6736(11)60106-2; WHO, 2012, PREL RES MNCAH SURV; WHO, 2012, WHO ESTIMATES UNSAFE; WHO, 2008, OP GUID MAN OP DEP S; WHO, 2012, COUNTR SPEC EST OUTP; WHO, 2012, EST COSTS SCAL UP AD; WHO, 2012, MAK HLTH SERV AD FRI; WHO, 2011, GUID PREV PREGN POOR; WHO, 2004, SCAL ANT THER RES LI; WHO, 2011, YOUTH HLTH RISKS WHO; WHO, 2009, STRENGTHENING HLTH S; WHO, 2005, EST COST SCAL UP MAT; WHO Department of Child and Adolescent Health and Development, 2002, WHOFCHCAH0218 DEP CH; WHO UNICEF, 2010, COUNTD 2015 MAT NEWB; World Health Organization, 2010, ANT THER HIV INF AD; World Health Organization, 2006, CONS GUID US ANT DRU; World Health Organization, 2009, TECHN GUID COUNTR SE; World Health Organization, 2011, PREV INC SEL SEX TRA; World Health Organization, 2021, ANT DRUGS TREAT PREG; World Health Organization (WHO), 2012, WHO CHOICE	45	15	15	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e51420	10.1371/journal.pone.0051420	http://dx.doi.org/10.1371/journal.pone.0051420			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300548	gold, Green Submitted, Green Published			2022-12-27	WOS:000312829100008
J	Guo, YF; Fan, Y; Qiu, JX; Liu, Y; Gao, JW; Guo, F				Guo, Yifeng; Fan, Yu; Qiu, Jianxin; Liu, Yong; Gao, Junwei; Guo, Fang			Polymorphisms in CTLA4 Influence Incidence of Drug-Induced Liver Injury after Renal Transplantation in Chinese Recipients	PLOS ONE			English	Article							ACUTE REJECTION; KIDNEY-TRANSPLANTATION; ANTIGEN-4 INFLUENCE; GENE POLYMORPHISMS; PROMOTER REGION; ASSOCIATION; DISEASE; SUSCEPTIBILITY; DETERMINANT; GENOTYPE	Genetic polymorphisms in cytotoxic T lymphocyte-associated antigen 4 (CTLA4) play an influential role in graft rejection and the long-term clinical outcome of organ transplantation. We investigated the association of 5 CTLA4 single-nucleotide polymorphisms (SNPs) (rs733618 C/T, rs4553808 A/G, rs5742909 C/T, rs231775 A/G, and rs3087243 G/A) with drug-induced liver injury (DILI) in Chinese renal transplantation (RT) recipients. Each recipient underwent a 24-month follow-up observation for drug-induced liver damage. The CTLA4 SNPs were genotyped in 864 renal transplantation recipients. A significant association was found between the rs231775 genotype and an early onset of DILI in the recipients. Multivariate analyses revealed that a risk factor, recipient rs231775 genotype (p = 0.040), was associated with DILI. Five haplotypes were estimated for 4 SNPs (excluding rs733618); the frequency of haplotype ACGG was significantly higher in the DILI group (68.9%) than in the non-DILI group (61.1%) (p = 0.041). In conclusion, CTLA4 haplotype ACGG was partially associated with the development of DILI in Chinese kidney transplant recipients. The rs231775 GG genotype may be a risk factor for immunosuppressive drug-induced liver damage.	[Guo, Yifeng; Fan, Yu; Qiu, Jianxin; Liu, Yong] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Organ Transplantat Ctr, Shanghai 200030, Peoples R China; [Gao, Junwei] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Sch Med, Dept Pharm, Shanghai 200030, Peoples R China; [Guo, Fang] Chinese Acad Sci, Shanghai Adv Res Inst, Ctr Nanomed & Translat Med, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Advanced Research Institute, CAS	Guo, YF (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Organ Transplantat Ctr, Shanghai 200030, Peoples R China.	gyfslm@gmail.com; guof@sari.ac.cn	Qiu, Jason/B-3502-2012	Qiu, Jason/0000-0003-1067-3199	National Natural Science Foundation of China [30971137, 31171308]; Chinese Postdoctoral Science Foundation [2003033271]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	The project was supported by the National Natural Science Foundation of China (30971137 and 31171308) and grants from the Chinese Postdoctoral Science Foundation (2003033271). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegre ML, 2001, NAT REV IMMUNOL, V1, P220, DOI 10.1038/35105024; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bouqbis L, 2003, GENES IMMUN, V4, P132, DOI 10.1038/sj.gene.6363933; Daly AK, 2009, SEMIN LIVER DIS, V29, P400, DOI 10.1055/s-0029-1240009; Daly AK, 2009, NAT GENET, V41, P816, DOI 10.1038/ng.379; de Reuver P, 2003, AM J TRANSPLANT, V3, P1587, DOI 10.1046/j.1600-6135.2003.00261.x; Engels EA, 2011, JAMA-J AM MED ASSOC, V306, P1891, DOI 10.1001/jama.2011.1592; Fountain FF, 2005, CHEST, V128, P116, DOI 10.1378/chest.128.1.116; Gao JW, 2012, TRANSPL IMMUNOL, V26, P207, DOI 10.1016/j.trim.2012.02.005; Gorgi Y, 2006, TRANSPLANT P, V38, P2303, DOI 10.1016/j.transproceed.2006.06.132; Grohmann U, 2002, NAT IMMUNOL, V3, P1097, DOI 10.1038/ni846; Hudson LL, 2002, HUM GENET, V111, P452, DOI 10.1007/s00439-002-0807-2; Hurst FP, 2011, TRANSPLANTATION, V92, P36, DOI 10.1097/TP.0b013e31821c1e70; Lucena MI, 2009, HEPATOLOGY, V49, P2001, DOI 10.1002/hep.22895; Kanno Yukiko, 2006, Fukushima J Med Sci, V52, P79; Kouki T, 2000, J IMMUNOL, V165, P6606, DOI 10.4049/jimmunol.165.11.6606; Kulak CA, 2012, OSTEOPOROSIS TRANSPL, V10, P48; Kupeli E, 2011, TRANSPL P, V43, P551, DOI 10.1016/j.transproceed.2011.01.063; Kusztal M, 2010, TRANSPL IMMUNOL, V23, P121, DOI 10.1016/j.trim.2010.05.002; Lee CS, 2003, CLIN RHEUMATOL, V22, P221, DOI 10.1007/s10067-003-0720-7; Lee WM, 2008, HEPATOLOGY, V47, P1401, DOI 10.1002/hep.22177; Maddrey WC, 2005, J CLIN GASTROENTEROL, V39, pS83, DOI 10.1097/01.mcg.0000155548.91524.6e; Maria VAJ, 1997, HEPATOLOGY, V26, P664, DOI 10.1053/jhep.1997.v26.pm0009303497; Navarro V, 2010, HEPATIC ADVERSE EVEN; Pauli-Magnus C, 2006, HEPATOLOGY, V44, P778, DOI 10.1002/hep.21359; Racusen LC, 2003, AM J TRANSPLANT, V3, P708, DOI 10.1034/j.1600-6143.2003.00072.x; Rezzani R, 2004, PROG HISTOCHEM CYTO, V39, P85, DOI 10.1016/j.proghi.2004.04.001; Tapirdamaz O, 2006, GUT, V55, P863, DOI 10.1136/gut.2005.080937; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Valenti L, 2004, ALCOHOL ALCOHOLISM, V39, P276, DOI 10.1093/alcalc/agh047; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Wu J, 2009, CLIN CHIM ACTA, V403, P229, DOI 10.1016/j.cca.2009.03.037	32	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e51723	10.1371/journal.pone.0051723	http://dx.doi.org/10.1371/journal.pone.0051723			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23300559	Green Published, Green Submitted, gold			2022-12-27	WOS:000313158800014
J	Lun, SWM; Cheung, ST; Cheung, PFY; To, KF; Woo, JKS; Choy, KW; Chow, C; Cheung, CCM; Chung, GTY; Cheng, ASH; Ko, CW; Tsao, SW; Busson, P; Ng, MHL; Lo, KW				Lun, Samantha Wei-Man; Cheung, Siu Tim; Cheung, Phyllis Fung Yi; To, Ka-Fai; Woo, John Kong-Sang; Choy, Kwong-Wai; Chow, Chit; Cheung, Chartia Ching-Mei; Chung, Grace Tin-Yun; Cheng, Alice Suk-Hang; Ko, Chun-Wai; Tsao, Sai-Wah; Busson, Pierre; Ng, Margaret Heung-Ling; Lo, Kwok-Wai			CD44+Cancer Stem-Like Cells in EBV-Associated Nasopharyngeal Carcinoma	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; EPITHELIAL-MESENCHYMAL TRANSITION; OVARIAN-CANCER; CONFERS RESISTANCE; INITIATING CELLS; ABC TRANSPORTERS; IDENTIFICATION; LINE; POPULATION; EXPRESSION	Nasopharyngeal carcinoma (NPC) is a unique EBV-associated epithelial malignancy, showing highly invasive and metastatic phenotype. Despite increasing evidence demonstrating the critical role of cancer stem-like cells (CSCs) in the maintenance and progression of tumors in a variety of malignancies, the existence and properties of CSC in EBV-associated NPC are largely unknown. Our study aims to elucidate the presence and role of CSCs in the pathogenesis of this malignant disease. Sphere-forming cells were isolated from an EBV-positive NPC cell line C666-1 and its tumor-initiating properties were confirmed by in vitro and in vivo assays. In these spheroids, up-regulation of multiple stem cell markers were found. By flow cytometry, we demonstrated that both CD44 and SOX2 were overexpressed in a majority of sphere-forming C666-1 cells. The CD44+SOX2+ cells was detected in a minor population in EBV-positive xenografts and primary tumors and considered as potential CSC in NPC. Notably, the isolated CD44+ NPC cells were resistant to chemotherapeutic agents and with higher spheroid formation efficiency, showing CSC properties. On the other hand, microarray analysis has revealed a number of differentially expressed genes involved in transcription regulation (e. g. FOXN4, GLI1), immune response (CCR7, IL8) and transmembrane transport (e. g. ABCC3, ABCC11) in the spheroids. Among these genes, increased expression of CCR7 in CD44+ CSCs was confirmed in NPC xenografts and primary tumors. Importantly, blocking of CCR7 abolished the sphere-forming ability of C666-1 in vitro. Expression of CCR7 was associated with recurrent disease and distant metastasis. The current study defined the specific properties of a CSC subpopulation in EBV-associated NPC. Our findings provided new insights into developing effective therapies targeting on CSCs, thereby potentiating treatment efficacy for NPC patients.	[Lun, Samantha Wei-Man; To, Ka-Fai; Chow, Chit; Cheung, Chartia Ching-Mei; Chung, Grace Tin-Yun; Cheng, Alice Suk-Hang; Ko, Chun-Wai; Ng, Margaret Heung-Ling; Lo, Kwok-Wai] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Anat & Cellular Pathol, State Key Lab Oncol S China, Hong Kong, Hong Kong, Peoples R China; [Lun, Samantha Wei-Man; To, Ka-Fai; Chung, Grace Tin-Yun; Ng, Margaret Heung-Ling; Lo, Kwok-Wai] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Cheung, Siu Tim; Cheung, Phyllis Fung Yi] Univ Hong Kong, Dept Surg, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China; [Woo, John Kong-Sang] Chinese Univ Hong Kong, Dept Otorhinolaryngol Head & Neck Surg, Hong Kong, Hong Kong, Peoples R China; [Choy, Kwong-Wai] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China; [Tsao, Sai-Wah] Univ Hong Kong, Dept Anat, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China; [Busson, Pierre] Univ Paris 11, CNRS UMR 8126, Villejuif, France; [Busson, Pierre] Inst Cancerol Gustave Roussy, Villejuif, France	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Prince of Wales Hospital; University of Hong Kong; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy	Lo, KW (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Anat & Cellular Pathol, State Key Lab Oncol S China, Hong Kong, Hong Kong, Peoples R China.	kwlo@cuhk.edu.hk	Choy, Richard/AAW-8230-2020; Cheung, Siu-Tim/C-4238-2009	Choy, Richard/0000-0002-3616-6200; Cheung, Siu-Tim/0000-0003-2147-315X; Busson, Pierre/0000-0003-1027-3400; Lo, Kwok Wai/0000-0002-3488-6124	Research Grants Council of Hong Kong (GRF) [470321, 471610, 471211, 471709, CUHK8/CRF/11R, AoE/M-06/08]; Research Grant Council [GRF776608M, GRF777809M]	Research Grants Council of Hong Kong (GRF)(Hong Kong Research Grants Council); Research Grant Council(Hong Kong Research Grants Council)	The study was supported by the Research Grants Council of Hong Kong (GRF: Grant No. 470321, 471610, 471211, 471709; GRF: Grant No. CUHK8/CRF/11R; AoE/M-06/08) and Research Grant Council (GRF776608M; GRF777809M). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auner V, 2010, GYNECOL ONCOL, V117, P198, DOI 10.1016/j.ygyno.2009.10.077; Bussolati B, 2008, FASEB J, V22, P3696, DOI 10.1096/fj.08-102590; BUSSON P, 1988, INT J CANCER, V42, P599, DOI 10.1002/ijc.2910420422; Chan ATC, 2011, EUR J CANCER, V47, pS302, DOI 10.1016/S0959-8049(11)70179-4; Cheung ST, 1999, INT J CANCER, V83, P121, DOI 10.1002/(SICI)1097-0215(19990924)83:1<121::AID-IJC21>3.0.CO;2-F; Chia MC, 2008, CLIN CANCER RES, V14, P984, DOI 10.1158/1078-0432.CCR-07-0828; Curley MD, 2009, STEM CELLS, V27, P2875, DOI 10.1002/stem.236; Dean M, 2009, J MAMMARY GLAND BIOL, V14, P3, DOI 10.1007/s10911-009-9109-9; Driessens G, 2011, CELL STEM CELL, V9, P283, DOI 10.1016/j.stem.2011.09.007; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Garvalov BK, 2011, J MOL MED, V89, P95, DOI 10.1007/s00109-010-0685-3; Ho FCH, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-98; Horikawa T, 2011, BRIT J CANCER, V104, P1160, DOI 10.1038/bjc.2011.38; Horikawa T, 2007, CANCER RES, V67, P1970, DOI 10.1158/0008-5472.CAN-06-3933; HUANG DP, 1989, INT J CANCER, V43, P936, DOI 10.1002/ijc.2910430535; Hui ABY, 1998, CANCER GENET CYTOGEN, V101, P83, DOI 10.1016/S0165-4608(97)00231-8; Joshua B, 2012, HEAD NECK-J SCI SPEC, V34, P42, DOI 10.1002/hed.21699; Kang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033919; Kondo S, 2011, J VIROL, V85, P11255, DOI 10.1128/JVI.00188-11; Leung ELH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014062; Li J, 2011, DIGEST LIVER DIS, V43, P40, DOI 10.1016/j.dld.2010.05.013; Liu JC, 2007, CANCER RES, V67, P8671, DOI 10.1158/0008-5472.CAN-07-1486; Lo KW, 2004, CANCER CELL, V5, P423, DOI 10.1016/S1535-6108(04)00119-9; Lou H, 2007, ONCOGENE, V26, P1357, DOI 10.1038/sj.onc.1210200; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mine T, 2010, ONCOL REP, V23, P1537, DOI 10.3892/or_00000793; O'Brien CA, 2009, SEMIN RADIAT ONCOL, V19, P71, DOI 10.1016/j.semradonc.2008.11.001; Oguri T, 2007, MOL CANCER THER, V6, P122, DOI 10.1158/1535-7163.MCT-06-0529; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; PATHMANATHAN R, 1995, AM J PATHOL, V146, P1355; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Su J, 2011, ARCH MED RES, V42, P15, DOI 10.1016/j.arcmed.2011.01.007; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; Wang J, 2007, CANCER RES, V67, P3716, DOI 10.1158/0008-5472.CAN-06-4343; Wong HL, 2005, MOL CARCINOGEN, V44, P92, DOI 10.1002/mc.20133; Young LC, 2001, CLIN CANCER RES, V7, P1798; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364; Zhang Y, 2010, J OTOLARYNGOL-HEAD N, V39, P157, DOI 10.2310/7070.2009.090150	38	64	70	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52426	10.1371/journal.pone.0052426	http://dx.doi.org/10.1371/journal.pone.0052426			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285037	Green Submitted, Green Published, gold			2022-12-27	WOS:000313158800065
J	Brines, R; Maicas, N; Ferrandiz, ML; Loboda, A; Jozkowicz, A; Dulak, J; Alcaraz, MJ				Brines, Rita; Maicas, Nuria; Luisa Ferrandiz, Maria; Loboda, Agnieszka; Jozkowicz, Alicja; Dulak, Jozef; Jose Alcaraz, Maria			Heme Oxygenase-1 Regulates the Progression of K/BxN Serum Transfer Arthritis	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; TUMOR-NECROSIS-FACTOR; RHEUMATOID-ARTHRITIS; CARBON-MONOXIDE; INFLAMMATORY RESPONSES; MURINE MODEL; T-CELLS; EXPRESSION; INDUCTION; DISEASE	Background: Heme oxygenase-1 (HO-1) is induced in many cell types as a defense mechanism against stress. We have investigated the possible role of endogenous HO-1 in the effector phase of arthritis using the K/BxN serum transfer model of arthritis in HO-1 heterozygous and homozygous knock-out mice. Methodology/Principal Findings: Arthritis was induced in C57/Black-6 xFVB (HO-1(+/+), HO-1(+/-) and HO-1(-/-)) mice by intraperitoneal injection of 150 mu l serum from arthritic K/BxN mice at days 0 and 2. Blood was collected and animals were sacrificed at day 10. Histological analysis was performed in ankle sections. The levels of inflammatory mediators were measured in serum and paw homogenates by enzyme-linked immunosorbent assay or Multiplex technology. The incidence of arthritis was higher in HO-1(+/-) and HO-1(-/-) groups compared with HO-1(+/+). The inflammatory response was aggravated in HO-1(+/-) mice as shown by arthritic score and the migration of inflammatory cells that could be related to the enhancement of CXCL-1 production. In addition, the HO-1(+/-) group showed proteoglycan depletion significantly higher than HO-1(+/+) mice. Serum levels of matrix metalloproteinase-3, monocyte chemotactic protein-1, plasminogen activator inhibitor-1, E-selectin and intercellular adhesion molecule-1 were increased in arthritic HO-1(-/-) mice, whereas vascular endothelial growth factor and some cytokines such as interferon-gamma showed a reduction compared to HO-1(+/+) or HO-1(+/-) mice. In addition, down-regulated gene expression of ferritin, glutathione S-reductase A1 and superoxide dismutase-2 was observed in the livers of arthritic HO-1(+/-) animals. Conclusion/Significance: Endogenous HO-1 regulates the production of systemic and local inflammatory mediators and plays a protective role in K/BxN serum transfer arthritis.	[Brines, Rita; Maicas, Nuria; Luisa Ferrandiz, Maria; Jose Alcaraz, Maria] Univ Valencia, Dept Pharmacol, Valencia, Spain; [Brines, Rita; Maicas, Nuria; Luisa Ferrandiz, Maria; Jose Alcaraz, Maria] Univ Valencia, IDM, Valencia, Spain; [Loboda, Agnieszka; Jozkowicz, Alicja; Dulak, Jozef] Jagiellonian Univ, Dept Med Biotechnol, Fac Biochem Biophys & Biotechnol, Krakow, Poland	University of Valencia; University of Valencia; Jagiellonian University	Alcaraz, MJ (corresponding author), Univ Valencia, Dept Pharmacol, Valencia, Spain.	maria.j.alcaraz@uv.es	Alcaraz, Maria Jose/D-8195-2018; Ferrandiz/K-9323-2017	Ferrandiz/0000-0003-4059-0175	Ministerio de Ciencia e Innovacion, ISCIII, FEDER [SAF2010-22048, RETICEF RD06/0013/2001]; Generalitat Valenciana [Prometeo2010-047]; Foundation for Polish Science - Parent-Bridge Programme; European Union within European Regional Development Fund; European Union; Polish Ministry of Science and Higher Education [POIG.02.01.00-12 064/08, POIG.02.02.00-014/08]	Ministerio de Ciencia e Innovacion, ISCIII, FEDER(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Foundation for Polish Science - Parent-Bridge Programme; European Union within European Regional Development Fund; European Union(European Commission); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was funded by grants SAF2010-22048, RETICEF RD06/0013/2001 (Ministerio de Ciencia e Innovacion, ISCIII, FEDER), and Prometeo2010-047 (Generalitat Valenciana). AL is supported by the Foundation for Polish Science - Parent-Bridge Programme co-financed by the European Union within European Regional Development Fund. The Faculty of Biochemistry, Biophysics and Biotechnology of the Jagiellonian University is a beneficiary of the structural funds from the European Union and the Polish Ministry of Science and Higher Education (grants no: POIG.02.01.00-12 064/08 and POIG.02.02.00-014/08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALLA G, 1992, J BIOL CHEM, V267, P18148; Benallaoua M, 2007, ARTHRITIS RHEUM, V56, P2585, DOI 10.1002/art.22749; Choi BM, 2005, BIOCHEM BIOPH RES CO, V327, P1066, DOI 10.1016/j.bbrc.2004.12.106; Devesa I, 2005, ARTHRITIS RHEUM-US, V52, P3230, DOI 10.1002/art.21356; Elliott ER, 2011, J IMMUNOL, V187, P4319, DOI 10.4049/jimmunol.1100341; Ferrandiz ML, 2008, ANN RHEUM DIS, V67, P1211, DOI 10.1136/ard.2007.082412; George JF, 2008, AM J PATHOL, V173, P154, DOI 10.2353/ajpath.2008.070963; Grundemar L, 1997, TRENDS PHARMACOL SCI, V18, P193, DOI 10.1016/S0165-6147(97)90622-2; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Jacobs JP, 2010, ARTHRITIS RHEUM-US, V62, P1921, DOI 10.1002/art.27470; Ji H, 2002, J EXP MED, V196, P77, DOI 10.1084/jem.20020439; Jozkowicz A, 2003, ACTA BIOCHIM POL, V50, P69, DOI 10.18388/abp.2003_3715; Kaieda S, 2007, ARTHRITIS RHEUM, V56, P1836, DOI 10.1002/art.22714; Kapturczak MH, 2004, AM J PATHOL, V165, P1045, DOI 10.1016/S0002-9440(10)63365-2; Kirino Y, 2005, ARTHRITIS RES THER, V7, pR616, DOI 10.1186/ar1721; Kirino Y, 2007, ARTHRITIS RHEUM-US, V56, P464, DOI 10.1002/art.22370; Kitamura A, 2011, MOD RHEUMATOL, V21, P150, DOI 10.1007/s10165-010-0372-9; Kobayashi H, 2006, ARTHRITIS RHEUM-US, V54, P1132, DOI 10.1002/art.21754; Lin HH, 2009, J THROMB HAEMOST, V7, P1401, DOI 10.1111/j.1538-7836.2009.03478.x; Maicas N, 2010, EUR J PHARMACOL, V634, P184, DOI 10.1016/j.ejphar.2010.02.028; Matsumoto H, 2006, MOL CELL BIOCHEM, V291, P21, DOI 10.1007/s11010-006-9190-y; Matsumoto I, 2002, NAT IMMUNOL, V3, P360, DOI 10.1038/ni772; Motterlini R, 2010, NAT REV DRUG DISCOV, V9, P728, DOI 10.1038/nrd3228; Paya M, 1996, BRIT J PHARMACOL, V117, P1773, DOI 10.1111/j.1476-5381.1996.tb15353.x; Pham CG, 2004, CELL, V119, P529, DOI 10.1016/j.cell.2004.10.017; Pittock ST, 2005, KIDNEY INT, V68, P611, DOI 10.1111/j.1523-1755.2005.00439.x; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10919, DOI 10.1073/pnas.94.20.10919; Remy S, 2009, J IMMUNOL, V182, P1877, DOI 10.4049/jimmunol.0802436; Rueda B, 2007, ARTHRITIS RHEUM-US, V56, P3953, DOI 10.1002/art.23048; Shah D, 2011, IMMUNOBIOLOGY, V216, P1010, DOI 10.1016/j.imbio.2011.04.001; Soares MP, 2004, J IMMUNOL, V172, P3553, DOI 10.4049/jimmunol.172.6.3553; Solomon S, 2005, EUR J IMMUNOL, V35, P3064, DOI 10.1002/eji.200526167; Tzima S, 2009, J EXP MED, V206, P1167, DOI 10.1084/jem.20081582; Vachharajani TJ, 2000, AM J PHYSIOL-HEART C, V278, pH1613, DOI 10.1152/ajpheart.2000.278.5.H1613; Wagener FADTG, 2008, ARTHRITIS RHEUM, V58, P3388, DOI 10.1002/art.23970; Was H, 2011, FREE RADICAL BIO MED, V51, P1717, DOI 10.1016/j.freeradbiomed.2011.07.025; Wipke BT, 2001, J IMMUNOL, V167, P1601, DOI 10.4049/jimmunol.167.3.1601	37	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52435	10.1371/journal.pone.0052435	http://dx.doi.org/10.1371/journal.pone.0052435			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285041	Green Published, gold			2022-12-27	WOS:000312794500168
J	Chakrabarti, S; Davidge, ST				Chakrabarti, Subhadeep; Davidge, Sandra T.			G-Protein Coupled Receptor 30 (GPR30): A Novel Regulator of Endothelial Inflammation	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; ESTROGEN-RECEPTOR; TNF-ALPHA; ADHESION MOLECULES; VCAM-1 EXPRESSION; INDUCED APOPTOSIS; E-SELECTIN; ESTRADIOL; CELLS; 17-BETA-ESTRADIOL	Estrogen, the female sex hormone, is known to exert anti-inflammatory and anti-atherogenic effects. Traditionally, estrogen effects were believed to be largely mediated through the classical estrogen receptors (ERs). However, there is increasing evidence that G-protein coupled receptor 30 (GPR30), a novel estrogen receptor, can mediate many estrogenic effects on the vasculature. Despite this, the localization and functional significance of GPR30 in the human vascular endothelium remains poorly understood. Given this background, we examined the subcellular location and potential anti-inflammatory roles of GPR30 using human umbilical vein endothelial cells as a model system. Inflammatory changes were induced by treatment with tumor necrosis factor (TNF), a pro-inflammatory cytokine involved in atherogenesis and many other inflammatory conditions. We found that GPR30 was located predominantly in the endothelial cell nuclei. Treatment with the selective GPR30 agonist G-1 partially attenuated the TNF induced upregulation of pro-inflammatory proteins such as intercellular cell adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1). This effect was completely abolished by the selective GPR30 antagonist G-15, suggesting that it was indeed mediated in a GPR30 dependent manner. Interestingly, estrogen alone had no effects on TNF-treated endothelium. Concomitant activation of the classical ERs blocked the anti-inflammatory effects of G-1, indicating opposing effects of GPR30 and the classical ERs. Our findings demonstrate that endothelial GPR30 is a novel regulator of the inflammatory response which could be a potential therapeutic target against atherosclerosis and other inflammatory diseases.	[Chakrabarti, Subhadeep; Davidge, Sandra T.] Univ Alberta, Dept Obstet & Gynecol, Edmonton, AB, Canada; [Chakrabarti, Subhadeep; Davidge, Sandra T.] Univ Alberta, Women & Childrens Hlth Res Inst, Edmonton, AB, Canada; [Chakrabarti, Subhadeep; Davidge, Sandra T.] Univ Alberta, Cardiovasc Res Ctr, Edmonton, AB, Canada; [Davidge, Sandra T.] Univ Alberta, Dept Physiol, Edmonton, AB, Canada; [Chakrabarti, Subhadeep; Davidge, Sandra T.] Mazankowski Alberta Heart Inst, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta	Davidge, ST (corresponding author), Univ Alberta, Dept Obstet & Gynecol, Edmonton, AB, Canada.	sandra.davidge@ualberta.ca	Chakrabarti, Subhadeep/AAD-1078-2022	Davidge, Sandra/0000-0002-5559-4905	Heart and Stroke Foundation of Alberta, Northwest Territories Nunavut; Canadian Institutes for Health Research (CIHR); Alberta Innovates - Health Solutions (AIHS)	Heart and Stroke Foundation of Alberta, Northwest Territories Nunavut; Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alberta Innovates - Health Solutions (AIHS)	The study was supported by grants from the Heart and Stroke Foundation of Alberta, Northwest Territories & Nunavut and the Canadian Institutes for Health Research (CIHR). S. Chakrabarti is supported by a CIHR fellowship. S. Davidge is a Canada Research Chair (CRC) in Women's Cardiovascular Health and is funded by Alberta Innovates - Health Solutions (AIHS) as an Alberta Heritage Foundation for Medical Research (AHFMR) Scientist. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajayi AA, 2004, EUR J CLIN INVEST, V34, P349, DOI 10.1111/j.1365-2362.2004.01339.x; Arenas IA, 2004, AM J PHYSIOL-CELL PH, V286, pC779, DOI 10.1152/ajpcell.00398.2003; Arnal JF, 2007, CURR OPIN LIPIDOL, V18, P554, DOI 10.1097/MOL.0b013e3282ef3bca; Aziz KE, 1996, CELL IMMUNOL, V167, P79, DOI 10.1006/cimm.1996.0010; Ba ZF, 2008, AM J PHYSIOL-HEART C, V295, pH2061, DOI 10.1152/ajpheart.00707.2008; Balhuizen A, 2010, MOL CELL ENDOCRINOL, V320, P16, DOI 10.1016/j.mce.2010.01.030; Barton M, 2012, STEROIDS, V77, P935, DOI 10.1016/j.steroids.2012.04.001; Blankenberg S, 2003, ATHEROSCLEROSIS, V170, P191, DOI 10.1016/S0021-9150(03)00097-2; Blasko E, 2009, J NEUROIMMUNOL, V214, P67, DOI 10.1016/j.jneuroim.2009.06.023; Brouchet L, 2001, CIRCULATION, V103, P423; Broughton BRS, 2010, AM J PHYSIOL-HEART C, V298, pH1055, DOI 10.1152/ajpheart.00878.2009; Carmeci C, 1997, GENOMICS, V45, P607, DOI 10.1006/geno.1997.4972; Chakrabarti S, 2009, J STEROID BIOCH MOL; Chakrabarti S, 2013, J VASC RES, V50, P21, DOI 10.1159/000342736; Chakrabarti S, 2012, J LEUKOCYTE BIOL, V91, P947, DOI 10.1189/jlb.1011513; Chakrabarti S, 2010, CARDIOVASC RES, V85, P796, DOI 10.1093/cvr/cvp368; Coma M, 2005, BRAIN, V128, P1613, DOI 10.1093/brain/awh492; Dean SA, 2005, AM J PHYSIOL-REG I, V288, pR759, DOI 10.1152/ajpregu.00595.2004; Ding QM, 2009, AM J PHYSIOL-CELL PH, V297, pC1178, DOI 10.1152/ajpcell.00185.2009; Filardo EJ, 2012, ENDOCRINOLOGY, V153, P2953, DOI 10.1210/en.2012-1061; Filardo EJ, 2005, TRENDS ENDOCRIN MET, V16, P362, DOI 10.1016/j.tem.2005.08.005; Florian M, 2008, STEROIDS, V73, P47, DOI 10.1016/j.steroids.2007.08.010; Foster CA, 1996, J ALLERGY CLIN IMMUN, V98, pS270, DOI 10.1016/S0091-6749(96)70075-1; Gao F, 2011, ENDOCRINOLOGY, V152, P1434, DOI 10.1210/en.2010-1368; Gonzalez-Gay MA, 2006, CLIN EXP RHEUMATOL, V24, P373; Hinojosa-Laborde C, 2004, HYPERTENSION, V44, P405, DOI 10.1161/01.HYP.0000142893.08655.96; Holm A, 2011, J VASC RES, V48, P327, DOI 10.1159/000322578; Huang NL, 2009, INT J CARDIOL, V134, P169, DOI 10.1016/j.ijcard.2008.04.010; Ihionkhan CE, 2002, CIRC RES, V91, P814, DOI 10.1161/01.RES.0000038304.62046.4C; KORPELAINEN EI, 1993, P NATL ACAD SCI USA, V90, P11137, DOI 10.1073/pnas.90.23.11137; Li ZL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038787; Madeo A, 2010, CANCER RES, V70, P6036, DOI 10.1158/0008-5472.CAN-10-0408; Merchant SJ, 2004, HYPERTENS PREGNANCY, V23, P47, DOI 10.1081/PRG-120028281; Miller AP, 2007, MENOPAUSE, V14, P251, DOI 10.1097/01.gme.0000235366.39726.f6; Mori M, 2004, LIFE SCI, V75, P599, DOI 10.1016/j.lfs.2003.12.023; Mukherjee TK, 2005, BBA-MOL CELL RES, V1745, P300, DOI 10.1016/j.bbamcr.2005.03.012; Narumiya H, 2001, HYPERTENS PREGNANCY, V20, P185, DOI 10.1081/PRG-100106968; Nilsson BO, 2011, BRIT J PHARMACOL, V163, P1131, DOI 10.1111/j.1476-5381.2011.01235.x; Pare G, 2002, CIRC RES, V90, P1087, DOI 10.1161/01.RES.0000021114.92282.FA; Popa C, 2007, J LIPID RES, V48, P751, DOI 10.1194/jlr.R600021-JLR200; Qiao XY, 2008, GENDER MED, V5, pS46, DOI 10.1016/j.genm.2008.03.006; Rahman A, 2008, ANTIOXID REDOX SIGNA; Regitz-Zagrosek V, 2006, NAT REV DRUG DISCOV, V5, P425, DOI 10.1038/nrd2032; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Rowlands DJ, 2011, HYPERTENSION, V57, P833, DOI 10.1161/HYPERTENSIONAHA.110.162198; Sanchez AM, 2011, MOL HUM REPROD, V17, P219, DOI 10.1093/molehr/gaq097; Sankaralingam S, 2009, HYPERTENSION, V53, P270, DOI 10.1161/HYPERTENSIONAHA.108.122630; Seok YM, 2012, NAUNYN SCHMIEDEBERGS; Sherwood A, 2007, ARTERIOSCL THROM VAS, V27, P1782, DOI 10.1161/ATVBAHA.107.145383; Somjen D, 2004, J STEROID BIOCHEM, V88, P101, DOI 10.1016/j.jsbmb.2003.11.002; Stork S, 2004, TRENDS ENDOCRIN MET, V15, P66, DOI 10.1016/j.tem.2004.01.005; Taylor PC, 2000, ARTHRITIS RHEUM-US, V43, P38, DOI 10.1002/1529-0131(200001)43:1<38::AID-ANR6>3.0.CO;2-L; Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064; Weil BR, 2010, SURGERY, V148, P436, DOI 10.1016/j.surg.2010.03.011; Wollin M, 2009, TRANSPL INT, V22, P342, DOI 10.1111/j.1432-2277.2008.00802.x; Yang L, 2005, BLOOD, V106, P584, DOI 10.1182/blood-2004-12-4942; Yates MA, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-20; Zhang B, 2010, J IMMUNOL, V184, P4087, DOI 10.4049/jimmunol.0902339; Zhang X, 2002, METHOD FIND EXP CLIN, V24, P125, DOI 10.1358/mf.2002.24.3.802295; Zhang X, 2002, LIFE SCI, V71, P15, DOI 10.1016/S0024-3205(02)01567-9; Zhou ZG, 2007, CELL SIGNAL, V19, P1238, DOI 10.1016/j.cellsig.2006.12.013	61	90	96	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52357	10.1371/journal.pone.0052357	http://dx.doi.org/10.1371/journal.pone.0052357			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285008	Green Submitted, Green Published, gold			2022-12-27	WOS:000312794500152
J	Lim, H; Kim, YU; Drouin, SM; Mueller-Ortiz, S; Yun, K; Morschl, E; Wetsel, RA; Chung, Y				Lim, Hoyong; Kim, Young Uk; Drouin, Scott M.; Mueller-Ortiz, Stacey; Yun, Kyoungah; Morschl, Eva; Wetsel, Rick A.; Chung, Yeonseok			Negative Regulation of Pulmonary Th17 Responses by C3a Anaphylatoxin during Allergic Inflammation in Mice	PLOS ONE			English	Article							ANTI-INTERLEUKIN-17 MONOCLONAL-ANTIBODY; BRONCHOALVEOLAR LAVAGE FLUID; T-HELPER-CELLS; GAMMA-DELTA-T; AIRWAY INFLAMMATION; COMPLEMENT C3A; NEUTROPHIL RECRUITMENT; RHEUMATOID-ARTHRITIS; LUNG INFLAMMATION; DENDRITIC CELLS	Activation of complement is one of the earliest immune responses to exogenous threats, resulting in various cleavage products including anaphylatoxin C3a. In addition to its contribution to host defense, C3a has been shown to mediate Th2 responses in animal models of asthma. However, the role of C3a on pulmonary Th17 responses during allergic inflammation remains unclear. Here, we show that mice deficient in C3a receptor (C3aR) exhibited (i) higher percentages of endogenous IL-17-producing CD4(+) T cells in the lungs, (ii) higher amounts of IL-17 in the bronchoalveolar lavage fluid, and (iii) more neutrophils in the lungs than wild-type mice when challenged with intranasal allergens. Moreover, adoptive transfer experiments showed that the frequencies of antigen-specific IL-17-producing CD4+ T cells were significantly higher in the lungs and bronchial lymph nodes of C3aR-deficient recipients than those of wild-types recipients. Bone-marrow reconstitution study indicated that C3aR-deficiency on hematopoietic cells was required for the increased Th17 responses. Furthermore, C3aR-deficient mice exhibited increased percentages of Foxp3(+) regulatory T cells; however, depletion of these cells minimally affected the induction of antigen-specific Th17 cell population in the lungs. Neutralization of IL-17 significantly reduced the number of neutrophils in bronchoalveolar lavage fluid of C3aR-deficient mice. Our findings demonstrate that C3a signals negatively regulate antigen-specific Th17 responses during allergic lung inflammation and the size of Foxp3(+) regulatory T cell population in the periphery.	[Lim, Hoyong; Kim, Young Uk; Drouin, Scott M.; Mueller-Ortiz, Stacey; Yun, Kyoungah; Morschl, Eva; Wetsel, Rick A.; Chung, Yeonseok] Univ Texas Med Sch Houston, Ctr Immunol & Autoimmune Dis, Inst Mol Med, Houston, TX 77030 USA; [Kim, Young Uk; Drouin, Scott M.; Wetsel, Rick A.; Chung, Yeonseok] Univ Texas Hlth Sci Ctr, Grad Sch Biomed Sci, Houston, TX USA; [Yun, Kyoungah] Daejon Hlth Sci Coll, Taejon, South Korea	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Chung, Y (corresponding author), Univ Texas Med Sch Houston, Ctr Immunol & Autoimmune Dis, Inst Mol Med, Houston, TX 77030 USA.	Yeonseok.Chung@uth.tmc.edu		Chung, Yeonseok/0000-0001-5780-4841; Kim, Young Uk/0000-0002-2518-0189	American Heart Association [10SDG3860046]; National Institutes of Health [R01 HL081398, 5 R01 AI025011-17]; Cancer Prevention and Research Institute of Texas (CPRIT) [RP 110776]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081398] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI025011] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas (CPRIT); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work is supported by research grant 10SDG3860046 from the American Heart Association (to Y.C.), R01 HL081398 (to S. D.) and 5 R01 AI025011-17 (to R.A.W.) from National Institutes of Health. The Flow Cytometry Core Facility is supported in part by the shared instrumentation grant (RP 110776) from the Cancer Prevention and Research Institute of Texas (CPRIT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcorn JF, 2010, ANNU REV PHYSIOL, V72, P495, DOI 10.1146/annurev-physiol-021909-135926; Angkasekwinai P, 2007, J EXP MED, V204, P1509, DOI 10.1084/jem.20061675; Angkasekwinai P, 2010, NAT IMMUNOL, V11, P250, DOI 10.1038/ni.1846; Baelder R, 2005, J IMMUNOL, V174, P783, DOI 10.4049/jimmunol.174.2.783; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bosmann M, 2012, FASEB J, V26, P1640, DOI 10.1096/fj.11-199216; Bullens DMA, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-135; Chen Y, 2011, IMMUNITY, V34, P409, DOI 10.1016/j.immuni.2011.02.011; Chung Y, 2005, J LEUKOCYTE BIOL, V77, P906, DOI 10.1189/jlb.1004599; Chung Y, 2002, IMMUNOBIOLOGY, V206, P408, DOI 10.1078/0171-2985-00190; Chung Y, 2008, J IMMUNOL, V180, P2276, DOI 10.4049/jimmunol.180.4.2276; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Corry David B, 2002, Am J Respir Med, V1, P185; Dillard P, 2007, AM J RESP CRIT CARE, V175, P1250, DOI 10.1164/rccm.200701-049OC; Douwes J, 2002, THORAX, V57, P643, DOI 10.1136/thorax.57.7.643; Drouin SM, 2002, J IMMUNOL, V169, P5926, DOI 10.4049/jimmunol.169.10.5926; Drouin SM, 2001, J IMMUNOL, V166, P2025, DOI 10.4049/jimmunol.166.3.2025; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Dunkelberger JR, 2010, MOL IMMUNOL, V47, P2176, DOI 10.1016/j.molimm.2010.05.008; Eustace A, 2011, CHEST, V139, P1089, DOI 10.1378/chest.10-0779; Fang CY, 2009, BLOOD, V114, P1005, DOI 10.1182/blood-2009-01-198283; Finkelman FD, 2010, J IMMUNOL, V184, P1663, DOI 10.4049/jimmunol.0902185; Genovese MC, 2010, ARTHRITIS RHEUM-US, V62, P929, DOI 10.1002/art.27334; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; Gutzmer R, 2004, IMMUNOLOGY, V111, P435, DOI 10.1111/j.1365-2567.2004.01829.x; Hamid Q, 2009, ANNU REV PHYSIOL, V71, P489, DOI 10.1146/annurev.physiol.010908.163200; HANSCH GM, 1984, J IMMUNOL, V133, P2145; HARTUNG HP, 1983, J IMMUNOL, V130, P1345; Hashimoto M, 2010, J EXP MED, V207, P1135, DOI 10.1084/jem.20092301; Hellings PW, 2003, AM J RESP CELL MOL, V28, P42, DOI 10.1165/rcmb.4832; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Hueber W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001107; Humbles AA, 2000, NATURE, V406, P998, DOI 10.1038/35023175; Ishizu T, 2005, BRAIN, V128, P988, DOI 10.1093/brain/awh453; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kheradmand F, 2002, J IMMUNOL, V169, P5904, DOI 10.4049/jimmunol.169.10.5904; Kildsgaard J, 2000, J IMMUNOL, V165, P5406, DOI 10.4049/jimmunol.165.10.5406; Kiss A, 2007, J ALLERGY CLIN IMMUN, V120, P334, DOI 10.1016/j.jaci.2007.04.025; Kohl J, 2006, IMMUNOL RES, V34, P157, DOI 10.1385/IR:34:2:157; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Krueger GG, 2007, NEW ENGL J MED, V356, P580, DOI 10.1056/NEJMoa062382; Krug N, 2001, AM J RESP CRIT CARE, V164, P1841, DOI 10.1164/ajrccm.164.10.2010096; Kudo M, 2012, NAT MED, V18, P547, DOI 10.1038/nm.2684; Laan M, 1999, J IMMUNOL, V162, P2347; Lajoie S, 2010, NAT IMMUNOL, V11, P928, DOI 10.1038/ni.1926; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Larche M, 2006, CURR OPIN IMMUNOL, V18, P745, DOI 10.1016/j.coi.2006.09.013; Lee SH, 2004, J ALLERGY CLIN IMMUN, V113, P72, DOI 10.1016/j.jaci.2003.09.039; Leonardi C, 2012, NEW ENGL J MED, V366, P1190, DOI 10.1056/NEJMoa1109997; Lloyd CM, 2010, NAT REV IMMUNOL, V10, P838, DOI 10.1038/nri2870; Lo Re S, 2010, J IMMUNOL, V184, P6367, DOI 10.4049/jimmunol.0900459; Louis R, 2000, AM J RESP CRIT CARE, V161, P9, DOI 10.1164/ajrccm.161.1.9802048; Martin U, 1997, J EXP MED, V186, P199, DOI 10.1084/jem.186.2.199; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; McKinley L, 2008, J IMMUNOL, V181, P4089, DOI 10.4049/jimmunol.181.6.4089; Mizutani N, 2009, J IMMUNOL, V183, P4039, DOI 10.4049/jimmunol.0901468; Molet S, 2001, J ALLERGY CLIN IMMUN, V108, P430, DOI 10.1067/mai.2001.117929; Monsinjon T, 2003, FASEB J, V17, P1003, DOI 10.1096/fj.02-0737com; Monsinjon T, 2001, FEBS LETT, V487, P339, DOI 10.1016/S0014-5793(00)02320-6; Mucida D, 2009, J ALLERGY CLIN IMMUN, V123, P997, DOI 10.1016/j.jaci.2009.03.016; Murdoch JR, 2010, AM J RESP CRIT CARE, V182, P464, DOI 10.1164/rccm.200911-1775OC; Reca R, 2003, BLOOD, V101, P3784, DOI 10.1182/blood-2002-10-3233; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Sarma VJ, 2006, AUTOIMMUNITY, V39, P387, DOI 10.1080/08916930600739456; Schnyder-Candrian S, 2006, J EXP MED, V203, P2715, DOI 10.1084/jem.20061401; Sheerin NS, 2008, FASEB J, V22, P1065, DOI 10.1096/fj.07-8719com; Souwer Y, 2010, CURR OPIN IMMUNOL, V22, P821, DOI 10.1016/j.coi.2010.10.013; Valdez PA, 2012, IMMUNITY, V36, P668, DOI 10.1016/j.immuni.2012.02.013; VANDEGRAAF EA, 1992, J IMMUNOL METHODS, V147, P241, DOI 10.1016/S0022-1759(12)80014-7; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Wang YH, 2010, J EXP MED, V207, P2479, DOI 10.1084/jem.20101376; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Weaver DJ, 2010, EUR J IMMUNOL, V40, P710, DOI 10.1002/eji.200939333; Werfel T, 2000, J IMMUNOL, V165, P6599, DOI 10.4049/jimmunol.165.11.6599; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Woodruff PG, 2001, J ALLERGY CLIN IMMUN, V108, P753, DOI 10.1067/mai.2001.119411; Wu Q, 2007, MICROBES INFECT, V9, P78, DOI 10.1016/j.micinf.2006.10.012; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yu SH, 2011, J IMMUNOL, V187, P4907, DOI 10.4049/jimmunol.1101519	82	21	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52666	10.1371/journal.pone.0052666	http://dx.doi.org/10.1371/journal.pone.0052666			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285141	Green Published, Green Submitted, gold			2022-12-27	WOS:000312794500226
J	Wang, J; Wang, BC; Zhao, WP; Guo, Y; Chen, H; Chu, HL; Liang, XJ; Bi, JW				Wang, Jun; Wang, Baocheng; Zhao, Weipeng; Guo, Yan; Chen, Hong; Chu, Huili; Liang, Xiuju; Bi, Jingwang			Clinical Significance and Role of Lymphatic Vessel Invasion as a Major Prognostic Implication in Non-Small Cell Lung Cancer: A Meta-Analysis	PLOS ONE			English	Article							PLEURAL LAVAGE CYTOLOGY; BLOOD-VESSEL; VASCULAR INVASION; TNM-STAGE; INCREASED EXPRESSION; MONOCLONAL-ANTIBODY; SURGICAL RESECTION; CIGARETTE-SMOKING; LATE RECURRENCE; CARCINOMA	Background: Lymphatic vessel invasion (LVI) exerts an important process in the progression and local spread of cancer cells. However, LVI as a prognostic factor for survival in non-small cell lung cancer (NSCLC) remains controversial. Methodology/Principal Findings: A meta-analysis of published studies from PubMed and EMBASE electronic databases was performed to quantity the effects of LVI on both relapse-free survival and overall survival for patients with NSCLC. Hazard ratios (HRs) with 95% confidence intervals (95% CIs) were used to assess the strength of these effects. This meta-analysis included 18,442 NSCLC patients from 53 eligible studies. LVI appeared in 32.1% (median; range, 2.8% to 70.9%) of tumor samples. In all, patients with LVI were 2.48 times more likely to relapse by univariate analysis (95% CI: 1.92-3.22) and 1.73 times by multivariate analysis (95% CI: 1.24-2.41) compared with those without LVI. For the analyses of LVI and overall survival, the pooled HR estimate was 1.97 (95% CI: 1.75-2.21) by univariate analysis and 1.59 (95% CI: 1.41-1.79) by multivariate analysis. Multivariate analysis showed a risk was 91% higher for recurrence (HR = 1.91, 95% CI: 1.14-2.91) and 70% higher for mortality (HR = 1.70, 95% CI: 1.38-2.10) in LVI-positive I stage patients compared with LVI-negative I stage patients. Subgroup analyses showed similar significant adjusted risks for recurrence and death in adenocarcinomas, and a significant adjusted risk for death in studies that utilized elastic staining with or without immunohistochemistry in defining LVI. Conclusions/Significance: The present study indicates that LVI appears to be an independent poor prognosticator in surgically managed NSCLC. NSCLC patients with LVI would require a more aggressive treatment strategy after surgery. However, large, well-designed prospective studies with clinically relevant modeling and standard methodology to assess LVI are required to address some of these important issues.	[Wang, Jun; Wang, Baocheng; Chu, Huili; Liang, Xiuju; Bi, Jingwang] Jinan Command Peoples Liberat Army, Dept Oncol, Gen Hosp, Jinan, Peoples R China; [Zhao, Weipeng] Tianjin Med Univ, Tianjin Canc Hosp & Inst, Tianjin, Peoples R China; [Guo, Yan] Mil Command Shandong Prov, Dept Outpatient, Jinan, Peoples R China; [Chen, Hong] N Sichuan Med Coll, Dept Chinese Med, Affiliated Hosp, Nanchong, Peoples R China	Tianjin Medical University; North Sichuan Medical University	Wang, J (corresponding author), Jinan Command Peoples Liberat Army, Dept Oncol, Gen Hosp, Jinan, Peoples R China.	ggjun2005@126.com	Wang, Jun/AAZ-2098-2020		National Nature Science Foundation of China [30901788, 81272619]; Shandong Provincial Nature Science Foundation [ZR2010HQ038, ZR2010HM059]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Provincial Nature Science Foundation	This study was funded in part by the National Nature Science Foundation of China (No. 30901788 and No. 81272619) and the Shandong Provincial Nature Science Foundation (No. ZR2010HQ038 and No. ZR2010HM059). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki K, 2011, GEN THORAC CARDIOVAS, V59, P605, DOI 10.1007/s11748-011-0782-4; Arigami T, 2005, BRIT J CANCER, V93, P688, DOI 10.1038/sj.bjc.6602739; Bodendorf MO, 2009, LUNG CANCER, V64, P71, DOI 10.1016/j.lungcan.2008.07.011; Brechot JM, 1996, CANCER-AM CANCER SOC, V78, P2111, DOI 10.1002/(SICI)1097-0142(19961115)78:10<2111::AID-CNCR11>3.3.CO;2-N; Brundage MD, 2002, CHEST, V122, P1037, DOI 10.1378/chest.122.3.1037; Chansky K, 2009, J THORAC ONCOL, V4, P792, DOI 10.1097/JTO.0b013e3181a7716e; Cho S, 2008, LUNG, V186, P411, DOI 10.1007/s00408-008-9116-4; Duarte IG, 1998, J THORAC CARDIOV SUR, V115, P652, DOI 10.1016/S0022-5223(98)70331-9; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fu X, 2001, Zhongguo Fei Ai Za Zhi, V4, P459, DOI 10.3779/j.issn.1009-3419.2001.06.18; Fu XL, 1999, LUNG CANCER-J IASLC, V23, P143, DOI 10.1016/S0169-5002(99)00009-4; FUJISAWA T, 1995, CANCER, V76, P2464, DOI 10.1002/1097-0142(19951215)76:12<2464::AID-CNCR2820761210>3.0.CO;2-U; Funai K, 2011, ANN SURG ONCOL, V18, P2968, DOI 10.1245/s10434-011-1729-9; Gabor S, 2004, EUR J CARDIO-THORAC, V25, P439, DOI 10.1016/j.ejcts.2003.11.033; Hanagiri T, 2011, EUR SURG RES, V47, P211, DOI 10.1159/000333367; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harada M, 2011, J THORAC ONCOL, V6, P48, DOI 10.1097/JTO.0b013e3181f8a1f1; HARPOLE DH, 1995, CANCER-AM CANCER SOC, V76, P787, DOI 10.1002/1097-0142(19950901)76:5<787::AID-CNCR2820760512>3.0.CO;2-Q; Hashizume S, 2009, LUNG CANCER, V65, P363, DOI 10.1016/j.lungcan.2008.12.014; Hashizume T, 2008, CHEST, V133, P441, DOI 10.1378/chest.07-1533; Higashiyama M, 2009, EUR J CARDIO-THORAC, V35, P337, DOI 10.1016/j.ejcts.2008.10.013; Hirata T, 1998, CANCER RES, V58, P1108; ICHINOSE Y, 1995, J THORAC CARDIOV SUR, V110, P601, DOI 10.1016/S0022-5223(95)70090-0; ICHINOSE Y, 1993, J THORAC CARDIOV SUR, V106, P90, DOI 10.1016/S0022-5223(19)33744-4; ICHINOSE Y, 1994, J THORAC CARDIOV SUR, V108, P684; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kahn HJ, 2002, LAB INVEST, V82, P1255, DOI 10.1097/01.LAB.0000028824.03032.AB; Kaiserling E, 2004, PATHOLOGE, V25, P362, DOI 10.1007/s00292-004-0693-6; Kawachi R, 2009, THORAC CARDIOV SURG, V57, P472, DOI 10.1055/s-0029-1185734; Kawachi Riken, 2009, Interact Cardiovasc Thorac Surg, V9, P265, DOI 10.1510/icvts.2009.202010; Kawata Y, 2012, MED PHYS, V39, P988, DOI 10.1118/1.3679017; MACCHIARINI P, 1993, J THORAC CARDIOV SUR, V106, P80, DOI 10.1016/S0022-5223(19)33743-2; Maeda R, 2012, ANN THORAC SURG, V93, P1626, DOI 10.1016/j.athoracsur.2012.01.005; Maeda R, 2011, J THORAC ONCOL, V6, P743, DOI 10.1097/JTO.0b013e3182103714; Maeda R, 2011, CHEST, V139, P855, DOI 10.1378/chest.10-1535; Maeda R, 2010, THORAX, V65, P1092, DOI 10.1136/thx.2010.141861; Maeda R, 2010, J THORAC ONCOL, V5, P1246, DOI 10.1097/JTO.0b013e3181e2f247; Maeda R, 2010, CHEST, V138, P145, DOI 10.1378/chest.09-2361; Maeshima AM, 2002, CANCER, V95, P2546, DOI 10.1002/cncr.11006; Martin B, 2003, BRIT J CANCER, V89, P55, DOI 10.1038/sj.bjc.6601095; Matsuguma H, 2008, J THORAC CARDIOV SUR, V135, P44, DOI 10.1016/j.jtcvs.2007.09.032; Meert AP, 2002, EUR RESPIR J, V20, P975, DOI 10.1183/09031936.02.00296502; Mizuno T, 2008, LUNG CANCER, V62, P302, DOI 10.1016/j.lungcan.2008.03.032; Moriya Y, 2001, CANCER, V91, P1129, DOI 10.1002/1097-0142(20010315)91:6<1129::AID-CNCR1109>3.0.CO;2-C; OGAWA J, 1994, CANCER, V73, P1177, DOI 10.1002/1097-0142(19940215)73:4<1177::AID-CNCR2820730409>3.0.CO;2-0; Okada M, 2003, J THORAC CARDIOV SUR, V126, P1911, DOI 10.1016/S0022-5223(03)00715-3; Okada M, 2003, ANN THORAC SURG, V76, P1828, DOI 10.1016/S0003-4975(03)01077-4; Okada M, 2003, CANCER, V98, P535, DOI 10.1002/cncr.11530; Ordonez NG, 2005, HUM PATHOL, V36, P372, DOI 10.1016/j.humpath.2005.01.019; Padera TP, 2002, SCIENCE, V296, P1883, DOI 10.1126/science.1071420; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Poleri C, 2003, CHEST, V123, P1858, DOI 10.1378/chest.123.6.1858; Rigau V, 2002, LUNG CANCER-J IASLC, V38, P169, DOI 10.1016/S0169-5002(02)00213-1; ROBERTS TE, 1992, J CLIN PATHOL, V45, P591, DOI 10.1136/jcp.45.7.591; Roma AA, 2006, MODERN PATHOL, V19, P392, DOI 10.1038/modpathol.3800546; Rouzaut A, 2007, J THORAC ONCOL, V2, P384, DOI 10.1097/01.JTO.0000268670.72249.ad; Ryuge S, 2011, CHEST, V139, P862, DOI 10.1378/chest.10-1121; Saijo T, 2007, LUNG CANCER, V55, P61, DOI 10.1016/j.lungcan.2006.09.027; Saito Makoto, 2002, Jpn J Thorac Cardiovasc Surg, V50, P413; Sakai Y, 2011, LUNG CANCER, V73, P89, DOI 10.1016/j.lungcan.2010.11.002; Sayar A, 2004, ANN THORAC SURG, V77, P421, DOI 10.1016/S0003-4975(03)01645-X; Shimada Y, 2010, J THORAC ONCOL, V5, P970, DOI 10.1097/JTO.0b013e3181dd1803; Shimizu K, 2005, J THORAC CARDIOV SUR, V130, P160, DOI 10.1016/j.jtcvs.2004.11.021; Shoji F, 2010, ANN THORAC SURG, V89, P864, DOI 10.1016/j.athoracsur.2009.09.047; Steels E, 2001, EUR RESPIR J, V18, P705, DOI 10.1183/09031936.01.00062201; Sun JG, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-21; Suzuki H, 2002, CANCER LETT, V187, P215, DOI 10.1016/S0304-3835(02)00400-7; Suzuki K, 1999, CANCER-AM CANCER SOC, V86, P1976, DOI 10.1002/(SICI)1097-0142(19991115)86:10<1976::AID-CNCR14>3.0.CO;2-I; Takanami I, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-1; Takanami I, 2005, ONCOL REP, V13, P727; Thomas P, 2002, ANN THORAC SURG, V73, P1065, DOI 10.1016/S0003-4975(01)03595-0; Van den Eynden GG, 2006, BRIT J CANCER, V94, P1643, DOI 10.1038/sj.bjc.6603152; Wang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028844; Wang J, 2011, CARCINOGENESIS, V32, P411, DOI 10.1093/carcin/bgq266; Wang XL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-299; WHITEHEAD A, 1991, STAT MED, V10, P1665, DOI 10.1002/sim.4780101105; Yamaguchi Y, 2010, J THORAC ONCOL, V5, P1361, DOI 10.1097/JTO.0b013e3181eaf2f3; Yamamoto S, 2004, ANN SURG ONCOL, V11, P697, DOI 10.1245/ASO.2004.10.018; Yokose T, 2000, LUNG CANCER, V29, P179, DOI 10.1016/S0169-5002(00)00103-3; Yoshida T, 2004, ANN ONCOL, V15, P252, DOI 10.1093/annonc/mdh073; Zhou QJ, 2010, INTERACT CARDIOV TH, V10, P53, DOI 10.1510/icvts.2009.216119	81	17	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52704	10.1371/journal.pone.0052704	http://dx.doi.org/10.1371/journal.pone.0052704			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285161	Green Published, gold, Green Submitted			2022-12-27	WOS:000312794500236
J	Zhao, ZY; Worthylake, D; LeCour, L; Maresh, GA; Pincus, SH				Zhao, Zhiyu; Worthylake, David; LeCour, Louis, Jr.; Maresh, Grace A.; Pincus, Seth H.			Crystal Structure and Computational Modeling of the Fab Fragment from a Protective Anti-Ricin Monoclonal Antibody	PLOS ONE			English	Article							3-DIMENSIONAL STRUCTURES; STRUCTURE VALIDATION; CANONICAL STRUCTURES; PROTEINS; ERRORS; IMMUNOGLOBULINS; CRYSTALLOGRAPHY; RECOGNITION; MOLPROBITY; ACCURACY	Background: Many antibody crystal structures have been solved. Structural modeling programs have been developed that utilize this information to predict 3-D structures of an antibody based upon its sequence. Because of the problem of self-reference, the accuracy and utility of these predictions can only be tested when a new structure has not yet been deposited in the Protein Data Bank. Methods: We have solved the crystal structure of the Fab fragment of RAC18, a protective anti-ricin mAb, to 1.9 angstrom resolution. We have also modeled the Fv structure of RAC18 using publicly available Ab modeling tools Prediction of Immunoglobulin Structures (PIGS), RosettaAntibody, and Web Antibody Modeling (WAM). The model structures underwent energy minimization. We compared results to the crystal structure on the basis of root-mean-square deviation (RMSD), template modeling score (TM-score), Z-score, and MolProbity analysis. Findings: The crystal structure showed a pocket formed mainly by AA residues in each of the heavy chain complementarity determining regions (CDRs). There were differences between the crystal structure and structures predicted by the modeling tools, particularly in the CDRs. There were also differences among the predicted models, although the differences were small and within experimental error. No one modeling program was clearly superior to the others. In some cases, choosing structures based only on sequence homology to the crystallized Ab yielded RMSDs comparable to the models. Conclusions: Molecular modeling programs accurately predict the structure of most regions of antibody variable domains of RAC18. The hypervariable CDRs proved most difficult to model, particularly H chain CDR3. Because CDR3 is most often involved in contact with antigen, this defect must be considered when using models to identify potential contacts between antibody and antigen. Because this study represents only a single case, the results cannot be generalized. Rather they highlight the utility and limitations of modeling programs.	[Zhao, Zhiyu; Maresh, Grace A.; Pincus, Seth H.] Childrens Hosp, Res Inst Children, New Orleans, LA USA; [Zhao, Zhiyu] Louisiana Opt Network Initiat Inst, Baton Rouge, LA USA; [Zhao, Zhiyu] Univ New Orleans, Dept Comp Sci, New Orleans, LA 70148 USA; [Worthylake, David; LeCour, Louis, Jr.] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, New Orleans, LA USA; [Pincus, Seth H.] Louisiana State Univ, Hlth Sci Ctr, Dept Pediat, New Orleans, LA USA; [Pincus, Seth H.] Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol Immunol & Parasitol, New Orleans, LA USA	Children's Hospital of New Orleans; University of Louisiana System; University of New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Pincus, SH (corresponding author), Childrens Hosp, Res Inst Children, New Orleans, LA USA.	spincus@chnola-research.org			LONI Institute; Research Institute for Children at Children's Hospital New Orleans; National Institutes of Health from National Institute of Allergy and Infectious Diseases [AI059376]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059376] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084072] Funding Source: NIH RePORTER	LONI Institute; Research Institute for Children at Children's Hospital New Orleans; National Institutes of Health from National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	These studies were funded by the LONI Institute (http://institute.loni.org/), Research Institute for Children at Children's Hospital New Orleans (chnola-research.org) and National Institutes of Health grant AI059376 from National Institute of Allergy and Infectious Diseases (niaid.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accelrys, 2011, ANT DEV DISC STUD; Akdis CA, 2009, J ALLERGY CLIN IMMUN, V123, P735, DOI 10.1016/j.jaci.2009.02.030; AlLazikani B, 1997, J MOL BIOL, V273, P927, DOI 10.1006/jmbi.1997.1354; Almagro JC, 2011, PROTEINS, V79, P3050, DOI 10.1002/prot.23130; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chemical Computing Group, 2012, PROT ANT MOD; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CHOTHIA C, 1987, J MOL BIOL, V196, P901, DOI 10.1016/0022-2836(87)90412-8; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Keedy DA, 2009, PROTEINS, V77, P29, DOI 10.1002/prot.22551; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Maddaloni M, 2004, J IMMUNOL, V172, P6221, DOI 10.4049/jimmunol.172.10.6221; Marcatili P, 2008, BIOINFORMATICS, V24, P1953, DOI 10.1093/bioinformatics/btn341; MARTINI A, 2001, POSITIVE HLTH PREVEN, P33; RUTENBER E, 1991, PROTEINS, V10, P240, DOI 10.1002/prot.340100308; Schrodinger LLC, 2010, PYMOL MOL GRAPH SYST; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Sircar A, 2009, NUCLEIC ACIDS RES, V37, pW474, DOI 10.1093/nar/gkp387; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Whitelegg NRJ, 2000, PROTEIN ENG, V13, P819, DOI 10.1093/protein/13.12.819; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264	25	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e52613	10.1371/journal.pone.0052613	http://dx.doi.org/10.1371/journal.pone.0052613			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23285112	Green Submitted, gold, Green Published			2022-12-27	WOS:000312694300094
J	Chappell, JM; Iqbal, A; Iannella, N; Abbott, D				Chappell, James M.; Iqbal, Azhar; Iannella, Nicolangelo; Abbott, Derek			Revisiting Special Relativity: A Natural Algebraic Alternative to Minkowski Spacetime	PLOS ONE			English	Article							ELECTRON-STRUCTURE; PHYSICS; ZITTERBEWEGUNG; LIGHT; MODEL; TIME	Minkowski famously introduced the concept of a space-time continuum in 1908, merging the three dimensions of space with an imaginary time dimension ict, with the unit imaginary producing the correct spacetime distance x(2) - c(2)t(2), and the results of Einstein's then recently developed theory of special relativity, thus providing an explanation for Einstein's theory in terms of the structure of space and time. As an alternative to a planar Minkowski space-time of two space dimensions and one time dimension, we replace the unit imaginary i =root 1,with the Clifford bivector i=e(1)e(2) for the plane that also squares to minus one, but which can be included without the addition of an extra dimension, as it is an integral part of the real Cartesian plane with the orthonormal basis e(1) and e(2). We find that with this model of planar spacetime, using a two-dimensional Clifford multivector, the spacetime metric and the Lorentz transformations follow immediately as properties of the algebra. This also leads to momentum and energy being represented as components of a multivector and we give a new efficient derivation of Compton's scattering formula, and a simple formulation of Dirac's and Maxwell's equations. Based on the mathematical structure of the multivector, we produce a semi-classical model of massive particles, which can then be viewed as the origin of the Minkowski spacetime structure and thus a deeper explanation for relativistic effects. We also find a new perspective on the nature of time, which is now given a precise mathematical definition as the bivector of the plane.	[Chappell, James M.; Iqbal, Azhar; Iannella, Nicolangelo; Abbott, Derek] Univ Adelaide, Sch Elect & Elect Engn, Adelaide, SA, Australia	University of Adelaide	Chappell, JM (corresponding author), Univ Adelaide, Sch Elect & Elect Engn, Adelaide, SA, Australia.	james.m.chappell@adelaide.edu.au	Iannella, Nicolangelo/A-1026-2009; Iqbal, Azhar/E-8749-2011; Abbott, Derek/E-8352-2011	Iannella, Nicolangelo/0000-0002-1983-9071; Iqbal, Azhar/0000-0002-5221-9384; Abbott, Derek/0000-0002-0945-2674				Augustine, 1972, CITY GOD; Baylis WE, 2004, CAN J PHYS, V82, P853, DOI 10.1139/P04-058; Boudet R, 2009, SPRINGER SER ATOM OP, V52; Catillon P, 2008, FOUND PHYS, V38, P659, DOI 10.1007/s10701-008-9225-1; COLE EAB, 1980, PHYS LETT A, V76, P371, DOI 10.1016/0375-9601(80)90734-3; Doran C., 2003, GEOMETRIC ALGEBRA PH, DOI DOI 10.1017/CBO9780511807497; Eckle P, 2008, NAT PHYS, V4, P565, DOI 10.1038/nphys982; Einstein A, 1905, ANN PHYS-BERLIN, V17, P891; Einstein A., 1952, PRINCIPLE RELATIVITY; Einstein A., 1934, PHILOS SCI, V2, P163, DOI DOI 10.1086/286316; Einstein Albert, 1921, RELATIVITY SPECIAL G; Ernst A, 2001, CHINESE J PHYS, V39, P211; French A P, 1987, SPECIAL RELATIVITY; Gerritsma R, 2010, NATURE, V463, P68, DOI 10.1038/nature08688; Goenner H., 1999, EXPANDING WORLDS GEN; GOLDBERG S, 1967, AM J PHYS, V35, P934, DOI 10.1119/1.1973643; Goldstein H., 2001, CLASSICAL MECH; Hestenes D, 2003, AM J PHYS, V71, P691, DOI 10.1119/1.1571836; Hestenes D., 2003, Annales de la Fondation Louis de Broglie, V28, P367; HESTENES D, 1990, FOUND PHYS, V20, P1213, DOI 10.1007/BF01889466; HESTENES D, 1984, CLIFFORD ALGEBRA GEO, V5; Hestenes D., 1999, NEW FDN CLASSICAL ME, VSecond; Krausz F, 2009, REV MOD PHYS, V81, P163, DOI 10.1103/RevModPhys.81.163; Lehto A., 1990, Chinese Journal of Physics, V28, P215; Leveugle J, 2004, RELATIVE POINCARE EI; Logunov AA, 2004, PHYSICS0408077 ARXIV; Lorentz HA, 1904, P K AKAD WET-AMSTERD, V6, P809; Matolcsi T, 1984, MODELS SPACE TIME CO; Minkowski H, 1909, RAUM ZEIT VORTR GEH; Misner C. W., 1973, GRAVITATION; Murguia G, 2011, PLANAR DIRAC FERMION; Newton I, 1686, PRINCIPIA; PAVSIC M, 1993, PHYS LETT B, V318, P481, DOI 10.1016/0370-2693(93)91543-V; Pavsic M, 2004, HEPTH0411053 ARXIV; Pfeiffer AN, 2011, NAT PHYS, V7, P428, DOI [10.1038/nphys1946, 10.1038/NPHYS1946]; Poincare M, 1906, RENDICONTI CIRCOLO M, V21, P129, DOI DOI 10.1007/BF03013466;; Poincare M, 1905, CR HEBD ACAD SCI, V140, P1504; Rodrigues Jr W.A., 2007, MANY FACES MAXWELL D, V722; RODRIGUES WA, 1993, PHYS LETT B, V318, P623, DOI 10.1016/0370-2693(93)90464-S; Rowe DE, 2009, MATH INTELL, V31, P27, DOI 10.1007/s00283-009-9027-0; Schrodinger Erwin, 1930, SITZ PREUSS AKAD WIS, V24, P418; Sexl RU., 2001, RELATIVITY GROUPS PA, DOI [10.1007/978-3-7091-6234-7, DOI 10.1007/978-3-7091-6234-7]; Taylor EF., 1966, SPACETIME PHYS; Tifft WG, 1996, ASTROPHYS SPACE SCI, V244, P187, DOI 10.1007/BF00642291; Ueda K, 2011, NAT PHYS, V7, P371, DOI 10.1038/nphys1985; VAZ J, 1995, PHYS LETT B, V345, P448, DOI 10.1016/0370-2693(94)01630-U; VAZ J, 1995, PHYS LETT B, V344, P149, DOI 10.1016/0370-2693(94)01548-Q; VAZ J, 1993, PHYS LETT B, V319, P203, DOI 10.1016/0370-2693(93)90803-P; Voigt W, 1887, NACHR GES WISS, P41; WEINBERG NN, 1980, PHYS LETT A, V80, P102, DOI 10.1016/0375-9601(80)90195-4; Wunderlich C, 2010, NATURE, V463, P37, DOI 10.1038/463037a; Zawadzki W, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/14/143201; ZEEMAN EC, 1964, J MATH PHYS, V5, P490, DOI 10.1063/1.1704140; ZENI JR, 1992, INT J MOD PHYS A, V7, P1793, DOI 10.1142/S0217751X92000776	55	5	5	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e51756	10.1371/journal.pone.0051756	http://dx.doi.org/10.1371/journal.pone.0051756			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300566	Green Submitted, Green Published, gold			2022-12-27	WOS:000313872600008
J	Hoh, RA; Stowe, TR; Turk, E; Stearns, T				Hoh, Ramona A.; Stowe, Timothy R.; Turk, Erin; Stearns, Tim			Transcriptional Program of Ciliated Epithelial Cells Reveals New Cilium and Centrosome Components and Links to Human Disease	PLOS ONE			English	Article							BARDET-BIEDL-SYNDROME; PROTEOMIC ANALYSIS; MOLECULAR CHARACTERIZATION; CENTRIOLE BIOGENESIS; FUNCTIONAL GENOMICS; EXPRESSION; DIFFERENTIATION; CILIOGENESIS; FLAGELLAR; PROTEINS	Defects in the centrosome and cilium are associated with a set of human diseases having diverse phenotypes. To further characterize the components that define the function of these organelles we determined the transcriptional profile of multiciliated tracheal epithelial cells. Cultures of mouse tracheal epithelial cells undergoing differentiation in vitro were derived from mice expressing GFP from the ciliated-cell specific FOXJ1 promoter (FOXJ1: GFP). The transcriptional profile of ciliating GFP+ cells from these cultures was defined at an early and a late time point during differentiation and was refined by subtraction of the profile of the non-ciliated GFP-cells. We identified 649 genes upregulated early, when most cells were forming basal bodies, and 73 genes genes upregulated late, when most cells were fully ciliated. Most, but not all, of known centrosome proteins are transcriptionally upregulated early, particularly Plk4, a master regulator of centriole formation. We found that three genes associated with human disease states, Mdm1, Mlf1, and Dyx1c1, are upregulated during ciliogenesis and localize to centrioles and cilia. This transcriptome for mammalian multiciliated epithelial cells identifies new candidate centrosome and cilia proteins, highlights similarities between components of motile and primary cilia, and identifies new links between cilia proteins and human disease.	[Hoh, Ramona A.; Stowe, Timothy R.; Turk, Erin; Stearns, Tim] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Stearns, Tim] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University	Stearns, T (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	stearns@stanford.edu		Piazza, Erin/0000-0002-3263-5946; Stearns, Tim/0000-0002-0671-6582	NSF; Gabilan Stanford Graduate Fellowship; United States National Institutes of Health [GM52022]; NATIONAL CANCER INSTITUTE [T32CA009302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052022] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); Gabilan Stanford Graduate Fellowship; United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by an NSF graduate research fellowship to T. R. S., the Gabilan Stanford Graduate Fellowship to E. T., and United States National Institutes of Health grant GM52022 to T. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Anitha A, 2009, AM J MED GENET B, V150B, P967, DOI 10.1002/ajmg.b.30926; Avidor-Reiss T, 2004, CELL, V117, P527, DOI 10.1016/S0092-8674(04)00412-X; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Barbe L, 2008, MOL CELL PROTEOMICS, V7, P499, DOI 10.1074/mcp.M700325-MCP200; Baron DM, 2007, J CELL SCI, V120, P478, DOI 10.1242/jcs.03352; Basto R, 2006, CELL, V125, P1375, DOI 10.1016/j.cell.2006.05.025; Berbari NF, 2009, CURR BIOL, V19, pR526, DOI 10.1016/j.cub.2009.05.025; Bettencourt-Dias M, 2005, CURR BIOL, V15, P2199, DOI 10.1016/j.cub.2005.11.042; Bettencourt-Dias M, 2011, TRENDS GENET, V27, P307, DOI 10.1016/j.tig.2011.05.004; Bettencourt-Dias M, 2009, CELL, V136, P188, DOI 10.1016/j.cell.2008.12.035; Blacque OE, 2005, CURR BIOL, V15, P935, DOI 10.1016/j.cub.2005.04.059; BLOODGOOD RA, 1990, J CELL SCI, V96, P27; Bloodgood RA, 2010, J CELL SCI, V123, P505, DOI 10.1242/jcs.066308; Broadhead R, 2006, NATURE, V440, P224, DOI 10.1038/nature04541; Chang B, 2008, HUM MOL GENET, V17, P3929, DOI 10.1093/hmg/ddn295; Chen NS, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r126; Christensen ST, 2003, CURR BIOL, V13, pR50, DOI 10.1016/S0960-9822(02)01425-2; Cizmecioglu O, 2010, J CELL BIOL, V191, P731, DOI 10.1083/jcb.201007107; Dawe HR, 2007, J CELL SCI, V120, P7, DOI 10.1242/jcs.03305; Deng CX, 2002, ONCOGENE, V21, P6222, DOI 10.1038/sj.onc.1205713; DIRKSEN ER, 1991, BIOL CELL, V72, P31, DOI 10.1016/0248-4900(91)90075-X; Dutertre S, 2002, ONCOGENE, V21, P6175, DOI 10.1038/sj.onc.1205775; Dzhindzhev NS, 2010, NATURE, V467, P714, DOI 10.1038/nature09445; Efimenko E, 2005, DEVELOPMENT, V132, P1923, DOI 10.1242/dev.01775; Engelender S, 1997, HUM MOL GENET, V6, P2205, DOI 10.1093/hmg/6.13.2205; Fisch C, 2011, BIOL CELL, V103, P249, DOI 10.1042/BC20100139; Gabel LA, 2010, NEUROBIOL DIS, V38, P173, DOI 10.1016/j.nbd.2009.06.019; Gherman A, 2006, NAT GENET, V38, P961, DOI 10.1038/ng0906-961; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Graser S, 2007, J CELL SCI, V120, P4321, DOI 10.1242/jcs.020248; Guarguaglini G, 2005, MOL BIOL CELL, V16, P1095, DOI 10.1091/mbc.E04-10-0939; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; Hagiwara H, 2004, INT REV CYTOL, V234, P101, DOI 10.1016/S0074-7696(04)34003-9; Hatch EM, 2010, J CELL BIOL, V191, P721, DOI 10.1083/jcb.201006049; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Inglis PN, 2006, TRENDS GENET, V22, P491, DOI 10.1016/j.tig.2006.07.006; Ivliev AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035618; Jacquet BV, 2009, DEVELOPMENT, V136, P4021, DOI 10.1242/dev.041129; Jakobsen L, 2011, EMBO J, V30, P1520, DOI 10.1038/emboj.2011.63; Keller LC, 2005, CURR BIOL, V15, P1090, DOI 10.1016/j.cub.2005.05.024; Kim JC, 2004, NAT GENET, V36, P462, DOI 10.1038/ng1352; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Kubo A, 1999, J CELL BIOL, V147, P969, DOI 10.1083/jcb.147.5.969; Lacey KR, 1999, P NATL ACAD SCI USA, V96, P2817, DOI 10.1073/pnas.96.6.2817; Lawo S, 2009, CURR BIOL, V19, P816, DOI 10.1016/j.cub.2009.04.033; Leidel S, 2005, NAT CELL BIOL, V7, P115, DOI 10.1038/ncb1220; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Liu Q, 2007, MOL CELL PROTEOMICS, V6, P1299, DOI 10.1074/mcp.M700054-MCP200; Liu Q, 2010, ADV EXP MED BIOL, V664, P223, DOI 10.1007/978-1-4419-1399-9_26; Lorenzo IM, 2008, P NATL ACAD SCI USA, V105, P12611, DOI 10.1073/pnas.0803970105; Ma L, 2011, J CELL SCI, V124, P2622, DOI 10.1242/jcs.084798; Mahjoub MR, 2010, J CELL BIOL, V191, P331, DOI 10.1083/jcb.201003009; Marshall WF, 2009, CURR OPIN CELL BIOL, V21, P14, DOI 10.1016/j.ceb.2009.01.008; Martin-Lanneree S, 2006, GENES CELLS, V11, P1317, DOI 10.1111/j.1365-2443.2006.01023.x; Massinen S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020580; Matsumoto N, 2000, LEUKEMIA, V14, P1757, DOI 10.1038/sj.leu.2401897; Mayor T, 2000, J CELL BIOL, V151, P837, DOI 10.1083/jcb.151.4.837; McClintock TS, 2008, PHYSIOL GENOMICS, V32, P198, DOI 10.1152/physiolgenomics.00128.2007; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; MORITZ M, 1995, NATURE, V378, P638, DOI 10.1038/378638a0; Nigg EA, 2011, NAT CELL BIOL, V13, P1154, DOI 10.1038/ncb2345; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Oshimori N, 2009, EMBO J, V28, P2066, DOI 10.1038/emboj.2009.161; Ostrowski LE, 2003, MOL THER, V8, P637, DOI 10.1016/S1525-0016(03)00221-1; Ostrowski LE, 2002, MOL CELL PROTEOMICS, V1, P451, DOI 10.1074/mcp.M200037-MCP200; Pan JM, 2000, J BIOL CHEM, V275, P24106, DOI 10.1074/jbc.M002686200; Paracchini S, 2006, HUM MOL GENET, V15, P1659, DOI 10.1093/hmg/ddl089; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; Pezzulo AA, 2011, AM J PHYSIOL-LUNG C, V300, pL25, DOI 10.1152/ajplung.00256.2010; Poelmans G, 2009, AM J MED GENET B, V150B, P140, DOI 10.1002/ajmg.b.30787; Prasad TSK, 2009, METHODS MOL BIOL, V577, P67, DOI 10.1007/978-1-60761-232-2_6; Rodrigues-Martins A, 2007, CURR BIOL, V17, P1465, DOI 10.1016/j.cub.2007.07.034; Ross AJ, 2007, AM J RESP CELL MOL, V37, P169, DOI 10.1165/rcmb.2006-0466OC; Schulz Irene, 2006, V346, P479; Shah AS, 2008, P NATL ACAD SCI USA, V105, P3380, DOI 10.1073/pnas.0712327105; Shah AS, 2009, SCIENCE; Smith E, 2009, NAT CELL BIOL, V11, P278, DOI 10.1038/ncb1835; Staples CJ, 2012, J CELL SCI; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stolc V, 2005, P NATL ACAD SCI USA, V102, P3703, DOI 10.1073/pnas.0408358102; Stubbs JL, 2008, NAT GENET, V40, P1454, DOI 10.1038/ng.267; Taipale M, 2003, P NATL ACAD SCI USA, V100, P11553, DOI 10.1073/pnas.1833911100; Tammimies K, 2012, BIOL PSYCHIAT; Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011; Threlkeld SW, 2007, BRAIN RES BULL, V71, P508, DOI 10.1016/j.brainresbull.2006.11.005; Tobin JL, 2009, GENET MED, V11, P386, DOI 10.1097/GIM.0b013e3181a02882; Tsou MFB, 2006, CURR OPIN CELL BIOL, V18, P74, DOI 10.1016/j.ceb.2005.12.008; Uehara R, 2009, P NATL ACAD SCI USA, V106, P6998, DOI 10.1073/pnas.0901587106; Uetake Y, 2007, J CELL BIOL, V176, P173, DOI 10.1083/jcb.200607073; Vincensini L, 2011, BIOL CELL, V103, P109, DOI 10.1042/BC20100104; Vladar EK, 2007, J CELL BIOL, V178, P31, DOI 10.1083/jcb.200703064; Wang Q, 2006, CELL, V125, P549, DOI 10.1016/j.cell.2006.02.044; Wang Y, 2006, NEUROSCIENCE, V143, P515, DOI 10.1016/j.neuroscience.2006.08.022; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Wilkinson CJ, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-17; Williams J, 2006, EUR J HUM GENET, V14, P681, DOI 10.1038/sj.ejhg.5201575; Wilson CW, 2009, NATURE, V459, P98, DOI 10.1038/nature07883; Yang PF, 2006, J CELL SCI, V119, P1165, DOI 10.1242/jcs.02811; Yoneda-Kato N, 2008, MOL CELL BIOL, V28, P422, DOI 10.1128/MCB.02335-06; You YJ, 2002, AM J PHYSIOL-LUNG C, V283, pL1315, DOI 10.1152/ajplung.00169.2002; You YJ, 2004, AM J PHYSIOL-LUNG C, V286, pL650, DOI 10.1152/ajplung.00170.2003; Yu XW, 2008, NAT GENET, V40, P1445, DOI 10.1038/ng.263; Zaghloul NA, 2009, J CLIN INVEST, V119, P428, DOI 10.1172/JCI37041; ZHENG YX, 1995, NATURE, V378, P578, DOI 10.1038/378578a0; Zhu F, 2008, CURR BIOL, V18, P136, DOI 10.1016/j.cub.2007.12.055	108	86	87	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e52166	10.1371/journal.pone.0052166	http://dx.doi.org/10.1371/journal.pone.0052166			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300604	gold, Green Published, Green Submitted			2022-12-27	WOS:000313872600011
J	Ye, SD; Xiao, Y; Jin, CR; Cassell, H; Blevins, M; Sun, JP; Vermund, SH; Qian, HZ				Ye, Shaodong; Xiao, Yan; Jin, Canrui; Cassell, Holly; Blevins, Meridith; Sun, Jiangping; Vermund, Sten H.; Qian, Han-Zhu			Effectiveness of Integrated HIV Prevention Interventions among Chinese Men Who Have Sex with Men: Evaluation of a 16-City Public Health Program	PLOS ONE			English	Article							ANTIRETROVIRAL TREATMENT PROGRAM; SYPHILIS INFECTIONS; PREVALENCE; MUNICIPALITY; SURVEILLANCE	To examine the impacts of a multi-city HIV prevention public health program (China Global Fund Round 5 Project) on condom use and HIV infection, we analyzed four yearly cross-sectional surveys from 2006 through 2009 among 20,843 men who have sex with men (MSM) in 16 Chinese cities. Self-reported condom use at last sex with a male partner increased from 58% in 2006 to 81% in 2009 (trend test, P<0.001). HIV prevalence increased from 2.3% in 2006 to 5.3% in 2009 (P<0.001). Multivariable logistic regression analysis showed that self-reported receipt of interventions was an independent predictor of increased condom use at last sex with a male partner over time (adjusted odds ratio [aOR], 1.63 in 2006 to 2.33 in 2009; P<0.001), and lower HIV prevalence (aOR, 1.08 in 2006 to 0.45 in 2009; P<0.001). HIV prevalence increased from 2006-2009 for participants with no self-reported receipt of interventions (2.1% in 2006 to 10.3% in 2009) and less so for those with interventions (2.4% to 4.7%). This Chinese public health program had positive impacts on both behaviors and disease rate among MSM population. Escalation of the coverage and intensity of effective interventions is needed for further increasing condom use and for reversing the rising trend of HIV epidemic.	[Ye, Shaodong; Cassell, Holly; Vermund, Sten H.; Qian, Han-Zhu] Vanderbilt Univ, Vanderbilt Inst Global Hlth, Nashville, TN 37212 USA; [Ye, Shaodong; Xiao, Yan; Jin, Canrui; Sun, Jiangping] China Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Blevins, Meridith] Vanderbilt Univ, Dept Biostat, Nashville, TN USA	Vanderbilt University; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Vanderbilt University	Qian, HZ (corresponding author), Vanderbilt Univ, Vanderbilt Inst Global Hlth, Nashville, TN 37212 USA.	han-zhu.qian@vanderbilt.edu	Vermund, Sten/AAD-3592-2020	Vermund, Sten/0000-0001-7289-8698; Cassell, Holly/0000-0003-3754-7328; Blevins, Meridith/0000-0002-3861-9859	China Global Fund Round Five Project [CHN-506-G06-H]; US NIH [5 D43 TW001035-12]; FOGARTY INTERNATIONAL CENTER [D43TW001035] Funding Source: NIH RePORTER	China Global Fund Round Five Project; US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	China Global Fund Round Five Project (Grant # CHN-506-G06-H) and US NIH grant (Grant # 5 D43 TW001035-12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, HIV US; Chow EPF, 2011, SEX TRANSM DIS, V38, P845, DOI 10.1097/OLQ.0b013e31821a4f43; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Dou ZH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013737; Feng LG, 2009, JAIDS-J ACQ IMM DEF, V52, P79, DOI 10.1097/QAI.0b013e3181a4f53e; Lai L, 2009, LEGAL SYSTEM SOC, V22, P198; Li HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023431; Liu B, 2007, AIDS, V21, pS123, DOI 10.1097/01.aids.0000304707.56670.cf; Liu H, 2006, SEX TRANSM DIS, V33, P68, DOI 10.1097/01.olq.0000187266.29927.11; Magnani R, 2005, AIDS, V19, pS67, DOI 10.1097/01.aids.0000172879.20628.e1; Malekinejad M, 2008, AIDS BEHAV, V12, pS105, DOI 10.1007/s10461-008-9421-1; Ministry of Health of the People's Republic of China UNAIDS and WHO, 2011, NAT REP HIV AIDS EST; Qian HZ, 2008, J SUBST ABUSE TREAT, V34, P391, DOI 10.1016/j.jsat.2007.07.002; Qian HZ, 2012, J AIDS CLIN RES S, VS4, pe001, DOI [10.4172/2155-6113.S4-e001, DOI 10.4172/2155-6113.S4-E001]; Rogowska-Szadkowska Dorota, 2011, Przegl Epidemiol, V65, P515; State Council AIDS Working Committee Office and Un Theme Group on HIV/AIDS in China, 2008, JOINT ASS HIV AIDS P; UNAIDS, 2010, REP GLOB AIDS EP; United Nations Population Fund, 2012, HIV PREV NOW PROGR B; World Health Organization Regional Office for Europe, 2010, HIV AIDS SURV EUR; World Health Organization Regional Office for South-East Asia, 2009, HIV AIDS SE AS REG 2; Wu ZY, 2007, LANCET, V369, P679, DOI 10.1016/S0140-6736(07)60315-8; Xiao Y, 2010, JAIDS-J ACQ IMM DEF, V53, pS66, DOI 10.1097/QAI.0b013e3181c7db43; Xiao Y, 2009, SEX TRANSM DIS, V36, P647, DOI 10.1097/OLQ.0b013e3181aac23d; Zhang FJ, 2007, AIDS, V21, pS143, DOI 10.1097/01.aids.0000304710.10036.2b; Zhang FJ, 2009, ANN INTERN MED, V151, P241, DOI 10.7326/0003-4819-151-4-200908180-00006	25	21	23	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e50873	10.1371/journal.pone.0050873	http://dx.doi.org/10.1371/journal.pone.0050873			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300528	Green Published, Green Submitted, gold			2022-12-27	WOS:000313872600003
J	Altenburg, TM; Hofsteenge, GH; Weijs, PJM; Delemarre-van de Waal, HA; Chinapaw, MJM				Altenburg, Teatske M.; Hofsteenge, Geesje H.; Weijs, Peter J. M.; Delemarre-van de Waal, Henriette A.; Chinapaw, Mai J. M.			Self-Reported Screen Time and Cardiometabolic Risk in Obese Dutch Adolescents	PLOS ONE			English	Article							SEDENTARY BEHAVIOR; PHYSICAL-ACTIVITY; CHILDHOOD OVERWEIGHT; HEALTH CONSEQUENCES; CARDIOVASCULAR RISK; METABOLIC SYNDROME; CHILDREN; YOUTH; RELIABILITY; WORLDWIDE	Background: It is not clear whether the association between sedentary time and cardiometabolic risk exists among obese adolescents. We examined the association between screen time (TV and computer time) and cardiometabolic risk in obese Dutch adolescents. Methods and Findings: For the current cross-sectional study, baseline data of 125 Dutch overweight and obese adolescents (12-18 years) participating in the Go4it study were included. Self-reported screen time (Activity Questionnaire for Adolescents and Adults) and clustered and individual cardiometabolic risk (i.e. body composition, systolic and diastolic blood pressure, low-density (LDL-C), high-density (HDL-C) and total cholesterol (TC), triglycerides, glucose and insulin) were assessed in all participants. Multiple linear regression analyses were used to assess the association between screen time and cardiometabolic risk, adjusting for age, gender, pubertal stage, ethnicity and moderate-to-vigorous physical activity. We found no significant relationship between self-reported total screen time and clustered cardiometabolic risk or individual risk factors in overweight and obese adolescents. Unexpectedly, self-reported computer time, but not TV time, was slightly but significantly inversely associated with TC (B = -0.002; CI = [-0.003; -0.000]) and LDL-C (B = -0.002; CI = [-0.001; 0.000]). Conclusions: In obese adolescents we could not confirm the hypothesised positive association between screen time and cardiometabolic risk. Future studies should consider computer use as a separate class of screen behaviour, thereby also discriminating between active video gaming and other computer activities.	[Altenburg, Teatske M.; Chinapaw, Mai J. M.] Vrije Univ Amsterdam, EMGO Inst Hlth & Care Res, Dept Publ & Occupat Hlth, Med Ctr, Amsterdam, Netherlands; [Hofsteenge, Geesje H.; Weijs, Peter J. M.] Vrije Univ Amsterdam, EMGO Inst Hlth & Care Res, Dept Nutr & Dietet, Med Ctr, Amsterdam, Netherlands; [Delemarre-van de Waal, Henriette A.] Leiden Univ, Med Ctr, Dept Pediat, Leiden, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Altenburg, TM (corresponding author), Vrije Univ Amsterdam, EMGO Inst Hlth & Care Res, Dept Publ & Occupat Hlth, Med Ctr, Amsterdam, Netherlands.	t.altenburg@vumc.nl	Paw, Mai Chin A/N-1665-2019; Altenburg, Teatske/S-2059-2016	Paw, Mai Chin A/0000-0001-6259-2441; Altenburg, Teatske/0000-0002-8764-5631; Weijs, Peter/0000-0001-8281-0426	ZONMW [50-50110-98-255]	ZONMW(Netherlands Organization for Health Research and Development)	This study was funded by ZONMW (no: 50-50110-98-255). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen LB, 2006, LANCET, V368, P299, DOI 10.1016/S0140-6736(06)69075-2; Bao WH, 1996, ARCH INTERN MED, V156, P1315, DOI 10.1001/archinte.156.12.1315; Carson V, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-274; Chinapaw MJM, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-58; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Daniels SR, 2006, FUTURE CHILD, V16, P47, DOI 10.1353/foc.2006.0004; Dietz WH, 1998, PEDIATRICS, V101, P518; Ekelund U, 2006, PLOS MED, V3, P2449, DOI 10.1371/journal.pmed.0030488; Goldfield Gary S, 2011, PLoS One, V6, pe26643, DOI 10.1371/journal.pone.0026643; Hofsteenge GH, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-410; Lambert M, 2008, CAN J CARDIOL, V24, P575, DOI 10.1016/S0828-282X(08)70639-1; MAFFEIS C, 1994, J PEDIATR-US, V124, P348, DOI 10.1016/S0022-3476(94)70355-8; Mark AE, 2008, J PUBLIC HEALTH-UK, V30, P153, DOI 10.1093/pubmed/fdn022; Martinez-Gomez D, 2010, REV ESP CARDIOL, V63, P277, DOI 10.1016/S0300-8932(10)70086-5; Martinez-Gomez D, 2009, ARCH PEDIAT ADOL MED, V163, P724, DOI 10.1001/archpediatrics.2009.90; MUST A, 1992, NEW ENGL J MED, V327, P1350, DOI 10.1056/NEJM199211053271904; Nathan BM, 2008, CURR OPIN ENDOCRINOL, V15, P21, DOI 10.1097/MED.0b013e3282f43d19; Pardee PE, 2007, AM J PREV MED, V33, P439, DOI 10.1016/j.amepre.2007.07.036; Reilly JJ, 2005, BEST PRACT RES CL EN, V19, P327, DOI 10.1016/j.beem.2005.04.002; Sardinha LB, 2008, DIABETES CARE, V31, P569, DOI 10.2337/dc07-1286; Slootmaker SM, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-17; Tanner JM, 1962, GROWTH ADOLESCENCE, V2nd; Twisk JWR, 1997, AM J EPIDEMIOL, V145, P888, DOI 10.1093/oxfordjournals.aje.a009048; Wang XW, 2006, ARCH PEDIAT ADOL MED, V160, P411, DOI 10.1001/archpedi.160.4.411; Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747; Zimmet P, 2007, PEDIATR DIABETES, V8, P299, DOI 10.1111/j.1399-5448.2007.00271.x	26	12	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53333	10.1371/journal.pone.0053333	http://dx.doi.org/10.1371/journal.pone.0053333			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285284	Green Published, gold			2022-12-27	WOS:000313051500138
J	Azrad, M; Zhang, K; Vollmer, RT; Madden, J; Polascik, TJ; Snyder, DC; Ruffin, MT; Moul, JW; Brenner, D; Hardy, RW; Demark-Wahnefried, W				Azrad, Maria; Zhang, Kui; Vollmer, Robin T.; Madden, John; Polascik, Thomas J.; Snyder, Denise C.; Ruffin, Mack T.; Moul, Judd W.; Brenner, Dean; Hardy, Robert W.; Demark-Wahnefried, Wendy			Prostatic Alpha-Linolenic Acid (ALA) Is Positively Associated with Aggressive Prostate Cancer: A Relationship Which May Depend on Genetic Variation in ALA Metabolism	PLOS ONE			English	Article							FATTY-ACIDS; RISK; DIET; MEN; METAANALYSIS; EXPRESSION; VARIANTS; RECEPTOR; SUPPLEMENTATION; DESATURASE	Previous observational studies have reported associations between prostate cancer and alpha-linolenic acid (ALA). However, few investigations have been able to study this relationship prospectively and in well-controlled settings. Moreover, no studies have determined whether single nucleotide polymorphisms (SNPs) that influence ALA metabolism are associated with this common cancer. The purpose of this study was to explore associations between prostatic levels of ALA, SNPs and prostate cancer-specific biomarkers in samples collected from a previous randomized clinical trial conducted using a presurgical model and which tested the effects of flaxseed supplementation, a rich source of ALA, prior to prostatectomy (n = 134). Serum prostate-specific antigen (PSA) was determined and immunohistochemistry was used to assess tumor proliferation rate (Ki67). Prostatic ALA was determined with gas chromatography. Seven previously identified SNPs associated with delta-6 desaturase activity (rs99780, rs174537, rs174545, rs174572, rs498793, rs3834458 and rs968567) were tested for associations with prostatic ALA, PSA and Ki67. Despite consuming seven times more ALA per day, men in the flaxseed arm had similar amounts of prostatic ALA relative to men not consuming flaxseed. In unadjusted analysis, there were significant positive associations between prostatic ALA and PSA (rho = 0.191, p = 0.028) and Ki67 (rho = 0.186, p = 0.037). After adjusting for covariates (flaxseed, age, race, BMI and statin-use) the association between ALA and PSA remained (p = 0.004) but was slightly attenuated for Ki67 (p = 0.051). We did not observe associations between any of the SNPs studied and prostatic ALA; however, in models for PSA there was a significant interaction between rs498793 and ALA and for Ki67 there were significant interactions with ALA and rs99780 and rs174545. Independent and inverse associations were observed between rs174572 and Ki67. This study provides evidence that prostatic ALA, independent of the amount of ALA consumed, is positively associated with biomarkers of aggressive prostate cancer and that genetic variation may modify this relationship.	[Azrad, Maria; Hardy, Robert W.; Demark-Wahnefried, Wendy] Univ Alabama Birmingham, Dept Nutr Sci, Birmingham, AL 35294 USA; [Zhang, Kui; Vollmer, Robin T.; Madden, John] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Vollmer, Robin T.] Durham Vet Affair Med Ctr, Dept Surg Pathol & Cytopathol, Durham, NC USA; [Polascik, Thomas J.; Moul, Judd W.] Duke Univ, Med Ctr, Dept Surg, Duke Canc Inst, Durham, NC 27710 USA; [Polascik, Thomas J.; Moul, Judd W.] Duke Univ, Med Ctr, Duke Canc Inst, Duke Prostate Ctr, Durham, NC USA; [Snyder, Denise C.] Duke Univ, Med Ctr, Dept Clin Res, Durham, NC USA; [Ruffin, Mack T.; Brenner, Dean] Univ Michigan, Dept Family Med, Ann Arbor, MI 48109 USA; [Brenner, Dean] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Hardy, Robert W.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; Duke University; Duke University; Duke University; Duke University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Alabama System; University of Alabama Birmingham	Azrad, M (corresponding author), Univ Alabama Birmingham, Dept Nutr Sci, Birmingham, AL 35294 USA.	maria123@uab.edu		Ruffin, Mack/0000-0001-8336-478X	National Institutes of Health [CA85740, CA07464830, M01-RR-30]; NATIONAL CANCER INSTITUTE [R25CA047888, R01CA085740] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000030] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding for this study was provided by the National Institutes of Health (CA85740, CA07464830, and M01-RR-30). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronson WJ, 2011, CANCER PREV RES, V4, P2062, DOI 10.1158/1940-6207.CAPR-11-0298; Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brouwer IA, 2004, J NUTR, V134, P919, DOI 10.1093/jn/134.4.919; Burdge GC, 2006, NUTR RES REV, V19, P26, DOI 10.1079/NRR2005113; Carayol M, 2010, CANCER CAUSE CONTROL, V21, P347, DOI 10.1007/s10552-009-9465-1; Carey AM, 2007, INT J CANCER, V121, P520, DOI 10.1002/ijc.22715; Chan JM, 2005, J CLIN ONCOL, V23, P8152, DOI 10.1200/JCO.2005.03.1492; Chen YF, 2001, INT J CANCER, V91, P41, DOI 10.1002/1097-0215(20010101)91:1<41::AID-IJC1009>3.0.CO;2-2; Cho HP, 1999, J BIOL CHEM, V274, P471, DOI 10.1074/jbc.274.1.471; Cho HP, 1999, J BIOL CHEM, V274, P37335, DOI 10.1074/jbc.274.52.37335; Christensen JH, 2006, BJU INT, V97, P270, DOI 10.1111/j.1464-410X.2006.05951.x; Chung CC, 2012, PROSTATE, V72, P476, DOI 10.1002/pros.21450; Chung CC, 2011, HUM MOL GENET, V20, P2869, DOI 10.1093/hmg/ddr189; Demark-Wahnefried W, 2008, CANCER EPIDEM BIOMAR, V17, P3577, DOI 10.1158/1055-9965.EPI-08-0008; Demark-Wahnefried W, 2008, CLIN TRIALS, V5, P262, DOI 10.1177/1740774508091676; Farmer KC, 1999, CLIN THER, V21, P1074, DOI 10.1016/S0149-2918(99)80026-5; Goyens PL, 2006, AM J CLIN NUTR, V84, P44, DOI 10.1093/ajcn/84.1.44; Harnack K, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-8; Heinzen EL, 2008, PLOS BIOL, V6, P2869, DOI 10.1371/journal.pbio.1000001; Heymach JV, 2011, CANCER PREV RES, V4, P1590, DOI 10.1158/1940-6207.CAPR-10-0136; LAMMIE GA, 1991, CANCER CELL-MON REV, V3, P413; Lattka E, 2010, CURR OPIN LIPIDOL, V21, P64, DOI 10.1097/MOL.0b013e3283327ca8; Lemaitre RN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002193; Merino DM, 2011, MOL GENET METAB, V103, P171, DOI 10.1016/j.ymgme.2011.02.012; NIENDORF A, 1995, INT J CANCER, V61, P461, DOI 10.1002/ijc.2910610405; POMFRET EA, 1989, ANAL BIOCHEM, V180, P85, DOI 10.1016/0003-2697(89)90091-2; Schaeffer L, 2006, HUM MOL GENET, V15, P1745, DOI 10.1093/hmg/ddl117; Simon JA, 2009, AM J CLIN NUTR, V89, pS1558, DOI 10.3945/ajcn.2009.26736E; Simopoulos AP, 2010, EXP BIOL MED, V235, P785, DOI 10.1258/ebm.2010.009298; Sonn GA, 2005, PROSTATE CANCER P D, V8, P304, DOI 10.1038/sj.pcan.4500825; STASSEWOLTHUIS M, 1979, AM J CLIN NUTR, V32, P1881, DOI 10.1093/ajcn/32.9.1881; Subar AF, 2001, AM J EPIDEMIOL, V154, P1089, DOI 10.1093/aje/154.12.1089; Tanaka T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000338	34	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53104	10.1371/journal.pone.0053104	http://dx.doi.org/10.1371/journal.pone.0053104			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285256	gold, Green Submitted, Green Published			2022-12-27	WOS:000313051500108
J	Larkin, JR; Zhang, F; Godfrey, L; Molostvov, G; Zehnder, D; Rabbani, N; Thornalley, PJ				Larkin, James R.; Zhang, Fang; Godfrey, Lisa; Molostvov, Guerman; Zehnder, Daniel; Rabbani, Naila; Thornalley, Paul J.			Glucose-Induced Down Regulation of Thiamine Transporters in the Kidney Proximal Tubular Epithelium Produces Thiamine Insufficiency in Diabetes	PLOS ONE			English	Article							HIGH-DOSE THIAMINE; PHOSPHATE-ESTERS; VASCULAR-DISEASE; HUMAN INTESTINE; IN-VITRO; EXPRESSION; PLASMA; FAMILY; MICROALBUMINURIA; ABSORPTION	Increased renal clearance of thiamine (vitamin B-1) occurs in experimental and clinical diabetes producing thiamine insufficiency mediated by impaired tubular re-uptake and linked to the development of diabetic nephropathy. We studied the mechanism of impaired renal re-uptake of thiamine in diabetes. Expression of thiamine transporter proteins THTR-1 and THTR-2 in normal human kidney sections examined by immunohistochemistry showed intense polarised staining of the apical, luminal membranes in proximal tubules for THTR-1 and THTR-2 of the cortex and uniform, diffuse staining throughout cells of the collecting duct for THTR-1 and THTR-2 of the medulla. Human primary proximal tubule epithelial cells were incubated with low and high glucose concentration, 5 and 26 mmol/l, respectively. In high glucose concentration there was decreased expression of THTR-1 and THTR-2 (transporter mRNA: -76% and -53% respectively, p<0.001; transporter protein -77% and -83% respectively, p<0.05), concomitant with decreased expression of transcription factor specificity protein-1. High glucose concentration also produced a 37% decrease in apical to basolateral transport of thiamine transport across cell monolayers. Intensification of glycemic control corrected increased fractional excretion of thiamine in experimental diabetes. We conclude that glucose-induced decreased expression of thiamine transporters in the tubular epithelium may mediate renal mishandling of thiamine in diabetes. This is a novel mechanism of thiamine insufficiency linked to diabetic nephropathy.	[Larkin, James R.; Zhang, Fang; Godfrey, Lisa; Molostvov, Guerman; Zehnder, Daniel; Rabbani, Naila; Thornalley, Paul J.] Univ Warwick, Univ Hosp, Clin Sci Res Labs, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England	University of Warwick	Thornalley, PJ (corresponding author), Univ Warwick, Univ Hosp, Clin Sci Res Labs, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England.	P.J.Thornalley@warwick.ac.uk		Larkin, James/0000-0002-4169-8447; Rabbani, Naila/0000-0002-5819-2506; Thornalley, Paul/0000-0001-7659-443X	Diabetes UK; University of Warwick; British Heart Foundation	Diabetes UK(Diabetes UK); University of Warwick; British Heart Foundation(British Heart Foundation)	This study was funded by a grant from Diabetes UK to NR and PJT which provided a PhD studentship to FZ. JRL thanks the University of Warwick for a PhD studentship. It was also supported by a grant from British Heart Foundation to NR and PJT supporting a postdoctoral fellowship to LG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adaikalakoteswari A, 2008, DIABETOLOGIA, V51, pS98; Adaikalakoteswari A, 2012, DIABETES RES CLIN PR, V95, P415, DOI 10.1016/j.diabres.2011.10.042; Ashokkumar B, 2006, AM J PHYSIOL-RENAL, V291, pF796, DOI 10.1152/ajprenal.00078.2006; Babaei-Jadidi R, 2003, DIABETES, V52, P2110, DOI 10.2337/diabetes.52.8.2110; Boulware MJ, 2003, BIOCHEM J, V376, P43, DOI 10.1042/BJ20031220; Chamberlain BR, 1996, ANN CLIN BIOCHEM, V33, P352, DOI 10.1177/000456329603300413; Dutta B, 1999, J BIOL CHEM, V274, P31925, DOI 10.1074/jbc.274.45.31925; Eudy JD, 2000, MOL GENET METAB, V71, P581, DOI 10.1006/mgme.2000.3112; Gastaldi G, 2000, KIDNEY INT, V57, P2043, DOI 10.1046/j.1523-1755.2000.00053.x; Hubatsch I, 2007, NAT PROTOC, V2, P2111, DOI 10.1038/nprot.2007.303; LUM H, 1996, J PHYSIOL PHARMACOL, V74, P787; Makino A, 2008, AM J PHYSIOL-CELL PH, V295, pC221, DOI 10.1152/ajpcell.00433.2007; Nabokina SM, 2004, AM J PHYSIOL-GASTR L, V287, pG822, DOI 10.1152/ajpgi.00234.2004; Page GLJ, 2011, INT J CLIN PRACT, V65, P684, DOI 10.1111/j.1742-1241.2011.02680.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Phillips Aled O, 2003, Curr Diab Rep, V3, P491, DOI 10.1007/s11892-003-0013-1; Rabbani N, 2009, DIABETOLOGIA, V52, P208, DOI 10.1007/s00125-008-1224-4; Rabbani N, 2011, DIABETES OBES METAB, V13, P577, DOI 10.1111/j.1463-1326.2011.01384.x; Reidling JC, 2010, GASTROENTEROLOGY, V138, P1802, DOI 10.1053/j.gastro.2009.10.042; Reidling JC, 2003, AM J PHYSIOL-CELL PH, V285, pC633, DOI 10.1152/ajpcell.00076.2003; Reidling JC, 2002, BBA-BIOMEMBRANES, V1561, P180, DOI 10.1016/S0005-2736(02)00341-3; Rieck J, 1999, J LAB CLIN MED, V134, P238, DOI 10.1016/S0022-2143(99)90203-2; ROBINSON KA, 1995, DIABETES, V44, P1438, DOI 10.2337/diabetes.44.12.1438; RYAN MJ, 1994, KIDNEY INT, V45, P48, DOI 10.1038/ki.1994.6; Said HM, 2004, AM J PHYSIOL-GASTR L, V286, pG491, DOI 10.1152/ajpgi.00361.2003; SANDER S, 1991, J CHROMATOGR, V558, P115, DOI 10.1016/0021-9673(91)80116-X; Schleicher ED, 2000, KIDNEY INT, V58, pS13, DOI 10.1046/j.1523-1755.2000.07703.x; Sihag B, 2010, DIABETES OBES METAB, V12, P87; Smithline Howard A, 2012, BMC Clin Pharmacol, V12, P4, DOI 10.1186/1472-6904-12-4; Subramanian VS, 2010, AM J PHYSIOL-RENAL, V299, pF28, DOI 10.1152/ajprenal.00140.2010; Takahashi N, 2007, KIDNEY INT, V71, P266, DOI 10.1038/sj.ki.5002033; TALLAKSEN CME, 1993, EUR J CLIN PHARMACOL, V44, P73, DOI 10.1007/BF00315284; Tasevska N, 2008, EUR J CLIN NUTR, V62, P1139, DOI 10.1038/sj.ejcn.1602829; Thornalley PJ, 2007, DIABETOLOGIA, V50, P2164, DOI 10.1007/s00125-007-0771-4; Thornalley PJ, 2011, OXID STRESS APPL BAS, P93, DOI 10.1007/978-1-60761-857-7_5; TURANO A, 1982, ANN NY ACAD SCI, V378, P91, DOI 10.1111/j.1749-6632.1982.tb31188.x	36	35	40	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53175	10.1371/journal.pone.0053175	http://dx.doi.org/10.1371/journal.pone.0053175			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285265	Green Published, gold, Green Submitted			2022-12-27	WOS:000313051500118
J	Mutka, SC; Green, LH; Verderber, EL; Richards, JP; Looker, DL; Chlipala, EA; Rosenthal, GJ				Mutka, Sarah C.; Green, Lucia H.; Verderber, Evie L.; Richards, Jane P.; Looker, Doug L.; Chlipala, Elizabeth A.; Rosenthal, Gary J.			ADH IB Expression, but Not ADH III, Is Decreased in Human Lung Cancer	PLOS ONE			English	Article							S-NITROSOGLUTATHIONE REDUCTASE; ASTHMA; GSNOR	Endogenous S-nitrosothiols, including S-nitrosoglutathione (GSNO), mediate nitric oxide (NO)-based signaling, inflammatory responses, and smooth muscle function. Reduced GSNO levels have been implicated in several respiratory diseases, and inhibition of GSNO reductase, (GSNOR) the primary enzyme that metabolizes GSNO, represents a novel approach to treating inflammatory lung diseases. Recently, an association between decreased GSNOR expression and human lung cancer risk was proposed in part based on immunohistochemical staining using a polyclonal GSNOR antibody. GSNOR is an isozyme of the alcohol dehydrogenase (ADH) family, and we demonstrate that the antibody used in those studies cross reacts substantially with other ADH proteins and may not be an appropriate reagent. We evaluated human lung cancer tissue arrays using monoclonal antibodies highly specific for human GSNOR with minimal cross reactivity to other ADH proteins. We verified the presence of GSNOR in >= 85% of specimens examined, and extensive analysis of these samples demonstrated no difference in GSNOR protein expression between cancerous and normal lung tissues. Additionally, GSNOR and other ADH mRNA levels were evaluated quantitatively in lung cancer cDNA arrays by qPCR. Consistent with our immunohistochemical findings, GSNOR mRNA levels were not changed in lung cancer tissues, however the expression levels of other ADH genes were decreased. ADH IB mRNA levels were reduced (>10-fold) in 65% of the lung cancer cDNA specimens. We conclude that the previously reported results showed an incorrect association of GSNOR and human lung cancer risk, and a decrease in ADH IB, rather than GSNOR, correlates with human lung cancer.	[Mutka, Sarah C.; Green, Lucia H.; Verderber, Evie L.; Richards, Jane P.; Looker, Doug L.; Rosenthal, Gary J.] N30 Pharmaceut Inc, Boulder, CO USA; [Chlipala, Elizabeth A.] Premier Lab LLC, Longmont, CO USA		Mutka, SC (corresponding author), N30 Pharmaceut Inc, Boulder, CO USA.	sarah.mutka@n30pharma.com		Mutka, Sarah/0000-0002-9744-8439	N30 Pharmaceuticals	N30 Pharmaceuticals	All authors except Elizabeth Chlipala are or were employees of N30 Pharmaceuticals, the funder of this study. Elizabeth Chlipala (Premier Laboratory) was paid to perform the immunohistochemistry work reported in this manuscript. N30 Pharma is developing a novel class of disease modifying therapies that preserve intracellular GSNO (Snitrosoglutathione), a key regulator of organ repair, regeneration, and healing. There are no further patents, products in development or marketed products relevant to this paper to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	DANIELSSON O, 1992, P NATL ACAD SCI USA, V89, P9247, DOI 10.1073/pnas.89.19.9247; Green LS, 2012, BIOCHEMISTRY-US, V51, P2157, DOI 10.1021/bi201785u; Hoog JO, 2001, J BIOMED SCI, V8, P71, DOI 10.1159/000054015; Lee SP, 2006, ALCOHOL, V39, P13, DOI 10.1016/j.alcohol.2006.06.012; Marozkina NV, 2012, AM J RESP CELL MOL, V46, P63, DOI 10.1165/rcmb.2011-0147OC; Que LG, 2005, SCIENCE, V308, P1618, DOI 10.1126/science.1108228; Snyder AH, 2002, AM J RESP CRIT CARE, V165, P922, DOI 10.1164/ajrccm.165.7.2105032; Straub AC, 2011, ARTERIOSCL THROM VAS, V31, P399, DOI 10.1161/ATVBAHA.110.215939; Sun XC, 2012, BIOORG MED CHEM LETT, V22, P2338, DOI 10.1016/j.bmcl.2012.01.047; Sun XC, 2011, BIOORG MED CHEM LETT, V21, P5849, DOI 10.1016/j.bmcl.2011.07.103; Sun XC, 2011, BIOORG MED CHEM LETT, V21, P3671, DOI 10.1016/j.bmcl.2011.04.086; Wang LS, 2010, NUCLEIC ACIDS RES, V38, pD665, DOI 10.1093/nar/gkp945; Wei W, 2011, CARCINOGENESIS, V32, P973, DOI 10.1093/carcin/bgr041; Wu H, 2007, J ALLERGY CLIN IMMUN, V120, P322, DOI 10.1016/j.jaci.2007.04.022; Wu XL, 2010, J PHARMACOL SCI, V113, P32, DOI 10.1254/jphs.09279FP; Yang SJ, 2010, WORLD J GASTROENTERO, V16, P4210, DOI 10.3748/wjg.v16.i33.4210	16	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52995	10.1371/journal.pone.0052995	http://dx.doi.org/10.1371/journal.pone.0052995			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285246	gold, Green Submitted, Green Published			2022-12-27	WOS:000313051500098
J	Rowse, AL; Naves, R; Cashman, KS; McGuire, DJ; Mbana, T; Raman, C; De Sarno, P				Rowse, Amber L.; Naves, Rodrigo; Cashman, Kevin S.; McGuire, Donald J.; Mbana, Tethia; Raman, Chander; De Sarno, Patrizia			Lithium Controls Central Nervous System Autoimmunity through Modulation of IFN-gamma Signaling	PLOS ONE			English	Article							INTERFERON-GAMMA; TH17 CELLS; DIFFERENTIAL REGULATION; EFFECTOR PHASE; T-CELLS; T(H)17; BETA; PATHWAYS; IL-17; RECEPTOR	Inhibitors of glycogen synthase kinase 3 (GSK3) are being explored as therapy for chronic inflammatory diseases. We previously demonstrated that the GSK inhibitor lithium is beneficial in experimental autoimmune encephalomyelitis (EAE), the mouse model of multiple sclerosis. In this study we report that lithium suppresses EAE induced by encephalitogenic interferon-gamma (IFN-gamma)-producing T helper (Th1) cells but not by interleukin (IL)-17-producing T helper (Th17) cells. The therapeutic activity of lithium required functional IFN-gamma-signaling, but not the receptor for type I IFN (IFNAR). Inhibitor/s of GSK3 attenuated IFN-gamma dependent activation of the transcription factor STAT1 in naive T cells as well as in encephalitogenic T cells and Th1 cells. The inhibition of STAT1 activation was associated with reduced IFN-gamma production and decreased expansion of encephalitogenic Th1 cells. Furthermore, lithium treatment induced Il27 expression within the spinal cords of mice with EAE. In contrast, such treatment of Ifngr(-)/(-) mice did not induce Il27 and was associated with lack of therapeutic response. Our study reveals a novel mechanism for the efficacy of GSK3 targeting in EAE, through the IFN-gamma-STAT1 axis that is independent IFNAR-STAT1 axis. Overall our findings set the framework for the use of GSK3 inhibitors as therapeutic agents in autoimmune neuroinflammation.	[De Sarno, Patrizia] Univ Alabama Birmingham, Dept Psychiat & Behav Neurobiol, Birmingham, AL 35294 USA; [Rowse, Amber L.; Cashman, Kevin S.; McGuire, Donald J.; Raman, Chander] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Naves, Rodrigo; Mbana, Tethia; Raman, Chander] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	De Sarno, P (corresponding author), Univ Alabama Birmingham, Dept Psychiat & Behav Neurobiol, Birmingham, AL 35294 USA.	desarno@uab.edu	Naves, Rodrigo/H-4829-2014	Naves, Rodrigo/0000-0002-1203-3593; McGuire, Donald/0000-0002-3742-9594	National Institutes of Health [NS064261, AI1076562]; National Multiple Sclerosis Society Collaborative Research Center Trainee Award; UAB Animal Resources Program [G20 RR025858, G20 RR022807-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [G20RR022807, G20RR025858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076562, T32AI007051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064261] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society Collaborative Research Center Trainee Award; UAB Animal Resources Program; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by National Institutes of Health Grants NS064261 (to PD), AI1076562 (to CR) and, National Multiple Sclerosis Society Collaborative Research Center Trainee Award (to ALR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Robin Lorenz for Stat1<SUP>-</SUP>/<SUP>-</SUP> mice, Dr. John D. Mountz for Ifnar1<SUP>-</SUP>/<SUP>-</SUP> mice, Dr. Casey Weaver for IL-17F-Thy1.1 mice, and KyungHee Hong for her help. We acknowledge the UAB CAMAC Comprehensive Flow Cytometry Core (P30 AR48311) and the UAB Animal Resources Program (G20 RR025858 and G20 RR022807-01).	Axtell RC, 2010, NAT MED, V16, P406, DOI 10.1038/nm.2110; Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; Beeton Christine, 2007, J Vis Exp, P527, DOI 10.3791/527; Berenson LS, 2004, IMMUNOL REV, V202, P157, DOI 10.1111/j.0105-2896.2004.00208.x; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Beurel E, 2008, J BIOL CHEM, V283, P21934, DOI 10.1074/jbc.M802481200; Beurel E, 2011, J IMMUNOL, V186, P1391, DOI 10.4049/jimmunol.1003511; Beurel E, 2009, CELL SIGNAL, V21, P978, DOI 10.1016/j.cellsig.2009.02.019; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Dardalhon V, 2008, J AUTOIMMUN, V31, P252, DOI 10.1016/j.jaut.2008.04.017; De Sarno P, 2008, J IMMUNOL, V181, P338, DOI 10.4049/jimmunol.181.1.338; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; El-behi M, 2010, J NEUROIMMUNE PHARM, V5, P189, DOI 10.1007/s11481-009-9188-9; Fitzgerald DC, 2007, J IMMUNOL, V179, P3268, DOI 10.4049/jimmunol.179.5.3268; Guo BC, 2008, J CLIN INVEST, V118, P1680, DOI 10.1172/JCI33342; Haak S, 2009, IMMUNOTHERAPY-UK, V1, P199, DOI 10.2217/1750743X.1.2.199; Hu XY, 2007, J LEUKOCYTE BIOL, V82, P237, DOI 10.1189/jlb.1206763; Hu XY, 2009, IMMUNITY, V31, P539, DOI 10.1016/j.immuni.2009.09.002; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kroenke MA, 2008, J EXP MED, V205, P1535, DOI 10.1084/jem.20080159; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Maldonado RA, 2004, NATURE, V431, P527, DOI 10.1038/nature02916; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Martin-Saavedra FM, 2008, MOL IMMUNOL, V45, P4008, DOI 10.1016/j.molimm.2008.06.006; Mayo L, 2012, IMMUNOL REV, V248, P170, DOI 10.1111/j.1600-065X.2012.01135.x; Murugaiyan G, 2009, J IMMUNOL, V183, P2435, DOI 10.4049/jimmunol.0900568; Nylander A, 2012, J CLIN INVEST, V122, P1180, DOI 10.1172/JCI58649; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Prinz M, 2010, TRENDS MOL MED, V16, P379, DOI 10.1016/j.molmed.2010.06.001; Ramgolam VS, 2009, J IMMUNOL, V183, P5418, DOI 10.4049/jimmunol.0803227; Schulz EG, 2009, IMMUNITY, V30, P673, DOI 10.1016/j.immuni.2009.03.013; Shen F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000066; Steinman L, 2008, J EXP MED, V205, P1517, DOI 10.1084/jem.20072066; Stromnes IM, 2008, NAT MED, V14, P337, DOI 10.1038/nm1715; Tsai CJ, 2009, J NANOPART RES, V11, P1, DOI 10.1007/s11051-008-9474-0; Wang HZ, 2011, CYTOKINE, V53, P130, DOI 10.1016/j.cyto.2010.10.009; Zhang LJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0028432, 10.1371/journal.pone.0020963, 10.1371/journal.pone.0026129, 10.1371/journal.pone.0028953]	37	31	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52658	10.1371/journal.pone.0052658	http://dx.doi.org/10.1371/journal.pone.0052658			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285134	Green Published, gold, Green Submitted			2022-12-27	WOS:000313051500044
J	Kahan, J; Mancini, L; Urner, M; Friston, KJ; Hariz, M; Holl, E; White, M; Ruge, D; Jahanshahi, M; Boertien, T; Yousry, T; Thornton, JS; Limousin, P; Zrinzo, L; Foltynie, T				Kahan, Josh; Mancini, Laura; Urner, Maren; Friston, Karl J.; Hariz, Marwan; Holl, Etienne; White, Mark; Ruge, Diane; Jahanshahi, Marjan; Boertien, Tessel; Yousry, Tarek; Thornton, John S.; Limousin, Patricia; Zrinzo, Ludvic; Foltynie, Tom			Therapeutic Subthalamic Nucleus Deep Brain Stimulation Reverses Cortico-Thalamic Coupling during Voluntary Movements in Parkinson's Disease	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; EFFECTIVE CONNECTIVITY; FUNCTIONAL MRI; ACTIVATION; MOTOR; ASSOCIATION; MODELS; DISORDERS; PATTERN; SAFETY	Deep brain stimulation of the subthalamic nucleus (STN DBS) has become an accepted treatment for patients experiencing the motor complications of Parkinson's disease (PD). While its successes are becoming increasingly apparent, the mechanisms underlying its action remain unclear. Multiple studies using radiotracer-based imaging have investigated DBS-induced regional changes in neural activity. However, little is known about the effect of DBS on connectivity within neural networks; in other words, whether DBS impacts upon functional integration of specialized regions of cortex. In this work, we report the first findings of fMRI in 10 subjects with PD and fully implanted DBS hardware receiving efficacious stimulation. Despite the technical demands associated with the safe acquisition of fMRI data from patients with implanted hardware, robust activation changes were identified in the insula cortex and thalamus in response to therapeutic STN DBS. We then quantified the neuromodulatory effects of DBS and compared sixteen dynamic causal models of effective connectivity between the two identified nodes. Using Bayesian model comparison, we found unequivocal evidence for the modulation of extrinsic (between region), i.e. cortico-thalamic and thalamo-cortical connections. Using Bayesian model parameter averaging we found that during voluntary movements, DBS reversed the effective connectivity between regions of the cortex and thalamus. This casts the therapeutic effects of DBS in a fundamentally new light, emphasising a role in changing distributed cortico-subcortical interactions. We conclude that STN DBS does impact upon the effective connectivity between the cortex and thalamus by changing their sensitivities to extrinsic afferents. Furthermore, we confirm that fMRI is both feasible and is tolerated well by these patients provided strict safety measures are adhered to.	[Kahan, Josh; Hariz, Marwan; Ruge, Diane; Jahanshahi, Marjan; Boertien, Tessel; Limousin, Patricia; Zrinzo, Ludvic; Foltynie, Tom] UCL Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London, England; [Mancini, Laura; White, Mark; Yousry, Tarek; Thornton, John S.] Natl Hosp Neurol & Neurosurg UCLH NHS Fdn Trust, Lysholm Dept Neuroradiol, London, England; [Mancini, Laura; White, Mark; Thornton, John S.] UCL Inst Neurol, Neuroradiol Acad Unit, Dept Brain Repair & Rehabil, London, England; [Zrinzo, Ludvic] Natl Hosp Neurol & Neurosurg UCLH NHS Fdn Trust, Victor Horsley Dept Neurosurg, London, England; [Urner, Maren; Friston, Karl J.] UCL Inst Neurol, Wellcome Trust Ctr Neuroimaging, London, England; [Urner, Maren] UCL, UCL Inst Cognit Neurosci, London, England; [Holl, Etienne] Med Univ Graz, Dept Neurosurg, Graz, Austria	University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; Medical University of Graz	Kahan, J (corresponding author), UCL Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London, England.	joshua.kahan@ucl.ac.uk	Kahan, Joshua/AAO-2239-2020; Friston, Karl/D-9230-2011	Friston, Karl/0000-0001-7984-8909; Zrinzo, Ludvic/0000-0002-6013-4946; Kahan, Joshua/0000-0002-1443-9837; Thornton, John/0000-0003-3248-8437	Brain Research trust; Astor Foundation; Rosetrees Trust; MHMS General Charitable Trust; Wellcome Trust; Parkinson's Appeal; Monument trust; UK Department of Health's NIHR Biomedical Research Centres funding scheme	Brain Research trust; Astor Foundation; Rosetrees Trust(Rosetrees Trust); MHMS General Charitable Trust; Wellcome Trust(Wellcome TrustEuropean Commission); Parkinson's Appeal(Parkinson's UK); Monument trust; UK Department of Health's NIHR Biomedical Research Centres funding scheme(National Institute for Health Research (NIHR))	This study was funded by the Brain Research trust (www.brt.org.uk). Josh Kahan receives funding from The Astor Foundation, The Rosetrees Trust, and the MHMS General Charitable Trust. Karl Friston receives funding from the Wellcome Trust. The Unit of Functional Neurosurgery is funded by the Parkinson's Appeal and the Monument trust. The work was undertaken by UCL/UCLH, who receive a proportion of funding from the UK Department of Health's NIHR Biomedical Research Centres funding scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Allen P, 2010, NEUROIMAGE, V49, P947, DOI 10.1016/j.neuroimage.2009.08.038; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Ballanger B, 2009, J CEREBR BLOOD F MET, V29, P1743, DOI 10.1038/jcbfm.2009.111; Benabid AL, 1996, J NEUROSURG, V84, P203, DOI 10.3171/jns.1996.84.2.0203; Benazzouz A, 2000, NEUROSCIENCE, V99, P289, DOI 10.1016/S0306-4522(00)00199-8; Boertien T, 2011, MOVEMENT DISORDERS O; Buxton RB, 1998, MAGNET RESON MED, V39, P855, DOI 10.1002/mrm.1910390602; Carmichael DW, 2007, NEUROIMAGE, V37, P508, DOI 10.1016/j.neuroimage.2007.04.058; Cauda F, 2011, NEUROIMAGE, V55, P8, DOI 10.1016/j.neuroimage.2010.11.049; Ceballos-Baumann AO, 1999, ARCH NEUROL-CHICAGO, V56, P997, DOI 10.1001/archneur.56.8.997; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; Dima D, 2011, J NEUROSCI, V31, P14378, DOI 10.1523/JNEUROSCI.2400-11.2011; Dorval AD, 2008, J NEUROPHYSIOL, V100, P2807, DOI 10.1152/jn.90763.2008; Dorval AD, 2010, J NEUROPHYSIOL, V104, P911, DOI 10.1152/jn.00103.2010; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Etgen T, 2003, J NEUROL, V250, P226, DOI 10.1007/s00415-003-0984-5; Fasano A, 2010, BRAIN, V133, P2664, DOI 10.1093/brain/awq221; Foltynie T, 2011, J NEUROL NEUROSUR PS, V82, P358, DOI 10.1136/jnnp.2010.205542; Foltynie T, 2010, EXPERT REV NEUROTHER, V10, P903, DOI 10.1586/ERN.10.68; Friston KJ, 2009, PLOS BIOL, V7, P220, DOI 10.1371/journal.pbio.1000033; Friston KJ, 2005, ANNU REV PSYCHOL, V56, P57, DOI 10.1146/annurev.psych.56.091103.070311; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Grafton ST, 2006, NEUROLOGY, V66, P1192, DOI 10.1212/01.wnl.0000214237.58321.c3; Guo YX, 2008, J NEUROPHYSIOL, V99, P1477, DOI 10.1152/jn.01080.2007; Hammond C, 2007, TRENDS NEUROSCI, V30, P357, DOI 10.1016/j.tins.2007.05.004; Hammond C, 2008, MOVEMENT DISORD, V23, P2111, DOI 10.1002/mds.22120; Hesselmann V, 2004, EUR RADIOL, V14, P686, DOI 10.1007/s00330-003-2051-0; Holl EM, 2010, NEUROSURGERY, V67, DOI 10.1227/NEU.0b013e3181f7422a; JAHANSHAHI M, 1995, BRAIN, V118, P913, DOI 10.1093/brain/118.4.913; Jech R, 2001, MOVEMENT DISORD, V16, P1126, DOI 10.1002/mds.1217; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Krack P, 2003, NEW ENGL J MED, V349, P1925, DOI 10.1056/NEJMoa035275; Lambert C, 2011, NEUROIMAGE; Li S, 2007, J NEUROPHYSIOL, V98, P3525, DOI 10.1152/jn.00808.2007; Ligot N, 2011, J CEREBR BLOOD F MET, V31, P41, DOI 10.1038/jcbfm.2010.186; Limousin P, 1997, ANN NEUROL, V42, P283, DOI 10.1002/ana.410420303; Litvak V, 2011, BRAIN, V134, P359, DOI 10.1093/brain/awq332; McIntyre CC, 2010, NEUROBIOL DIS, V38, P329, DOI 10.1016/j.nbd.2009.09.022; McIntyre CC, 2004, CLIN NEUROPHYSIOL, V115, P1239, DOI 10.1016/j.clinph.2003.12.024; Moran RJ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002124; Mutschler I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000259; Payoux P, 2004, ARCH NEUROL-CHICAGO, V61, P1307, DOI 10.1001/archneur.61.8.1307; Penny WD, 2004, NEUROIMAGE, V22, P1157, DOI 10.1016/j.neuroimage.2004.03.026; Phillips MD, 2006, RADIOLOGY, V239, P209, DOI 10.1148/radiol.2391041990; Rehme AK, 2011, NEUROIMAGE, V55, P1147, DOI 10.1016/j.neuroimage.2011.01.014; Rowe JB, 2010, NEUROIMAGE, V52, P1015, DOI 10.1016/j.neuroimage.2009.12.080; Seghier ML, 2010, FRONT SYST NEUROSCI, V4, DOI [10.3389/fnsys.2010.001422007, 10.3389/fnsys.2010.00142]; Smith GS, 2012, NEUROPSYCHOPHARMACOL, V37, P1, DOI 10.1038/npp.2011.233; Stephan KE, 2010, NEUROIMAGE, V49, P3099, DOI 10.1016/j.neuroimage.2009.11.015; Strafella AP, 2003, NEUROLOGY, V60, P1039, DOI 10.1212/01.WNL.0000052691.48076.92; Thobois S, 2002, J NEUROL, V249, P1689, DOI 10.1007/s00415-002-0906-y; Vulliemoz S, 2011, NEUROIMAGE, V54, P182, DOI 10.1016/j.neuroimage.2010.08.004; Xu WD, 2008, J NEUROSCI, V28, P11916, DOI 10.1523/JNEUROSCI.2027-08.2008; Zrinzo L, 2011, WORLD NEUROSURG, V76, P164, DOI 10.1016/j.wneu.2011.02.029	56	52	53	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e50270	10.1371/journal.pone.0050270	http://dx.doi.org/10.1371/journal.pone.0050270			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300524	Green Published, gold, Green Submitted			2022-12-27	WOS:000313618800006
J	MacLeod, AK; Davies, G; Payton, A; Tenesa, A; Harris, SE; Liewald, D; Ke, XY; Luciano, M; Lopez, LM; Gow, AJ; Corley, J; Redmond, P; McNeill, G; Pickles, A; Ollier, W; Horan, M; Starr, JM; Pendleton, N; Thomson, PA; Porteous, DJ; Deary, IJ				MacLeod, Andrew K.; Davies, Gail; Payton, Antony; Tenesa, Albert; Harris, Sarah E.; Liewald, David; Ke, Xiayi; Luciano, Michelle; Lopez, Lorna M.; Gow, Alan J.; Corley, Janie; Redmond, Paul; McNeill, Geraldine; Pickles, Andrew; Ollier, William; Horan, Michael; Starr, John M.; Pendleton, Neil; Thomson, Pippa A.; Porteous, David J.; Deary, Ian J.			Genetic Copy Number Variation and General Cognitive Ability	PLOS ONE			English	Article							RARE CHROMOSOMAL DELETIONS; HIDDEN-MARKOV MODEL; GENOME-WIDE; MISSING HERITABILITY; STRUCTURAL VARIATION; MENTAL-RETARDATION; HUMAN INTELLIGENCE; INCREASE RISK; COMMON SNPS; AUTISM	Differences in genomic structure between individuals are ubiquitous features of human genetic variation. Specific copy number variants (CNVs) have been associated with susceptibility to numerous complex psychiatric disorders, including attention-deficit-hyperactivity disorder, autism-spectrum disorders and schizophrenia. These disorders often display comorbidity with low intelligence. Rare chromosomal deletions and duplications are associated with these disorders, so it has been suggested that these deletions or duplications may be associated with differences in intelligence. Here we investigate associations between large (>= 500kb), rare (< 1% population frequency) CNVs and both fluid and crystallized intelligence in community-dwelling older people. We observe no significant associations between intelligence and total CNV load. Examining individual CNV regions previously implicated in neuropsychological disorders, we find suggestive evidence that CNV regions around SHANK3 are associated with fluid intelligence as derived from a battery of cognitive tests. This is the first study to examine the effects of rare CNVs as called by multiple algorithms on cognition in a large non-clinical sample, and finds no effects of such variants on general cognitive ability.	[MacLeod, Andrew K.; Harris, Sarah E.; Liewald, David; Luciano, Michelle; Lopez, Lorna M.; Gow, Alan J.; Starr, John M.; Thomson, Pippa A.; Porteous, David J.; Deary, Ian J.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [MacLeod, Andrew K.; Harris, Sarah E.; Thomson, Pippa A.; Porteous, David J.] Univ Edinburgh, Inst Genet & Mol Med, Med Genet Sect, Ctr Mol Med, Edinburgh, Midlothian, Scotland; [Davies, Gail; Liewald, David; Luciano, Michelle; Lopez, Lorna M.; Gow, Alan J.; Corley, Janie; Redmond, Paul; Deary, Ian J.] Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland; [Payton, Antony; Ollier, William] Univ Manchester, Ctr Integrated Genom Med Res, Manchester, Lancs, England; [Tenesa, Albert] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin Inst, Edinburgh EH9 1QH, Midlothian, Scotland; [Tenesa, Albert] Univ Edinburgh, Human Genet Unit, MRC, Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland; [Ke, Xiayi] UCL, Inst Child Hlth, MRC, Ctr Epidemiol Child Hlth, London, England; [McNeill, Geraldine] Univ Aberdeen, Inst Appl Hlth Sci, Aberdeen, Scotland; [Pickles, Andrew] Univ Manchester, Dept Med, Sch Epidemiol & Hlth Sci, Manchester M13 9PL, Lancs, England; [Horan, Michael; Pendleton, Neil] Univ Manchester, Neurodegenerat Res Grp, Sch Community Based Med, Manchester, Lancs, England; [Starr, John M.] Univ Edinburgh, Geriatr Med Unit, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Manchester; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; University of London; University College London; University of Aberdeen; University of Manchester; University of Manchester; University of Edinburgh	MacLeod, AK (corresponding author), Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland.	andrew.macleod@ed.ac.uk; i.deary@ed.ac.uk	Porteous, David J/C-7289-2013; Deary, Ian J/C-6297-2009; Pickles, Andrew/A-9625-2011; Lopez, Lorna/AAR-4912-2020; Pendleton, Neil/F-2333-2015; Gow, Alan J/A-6070-2009; Luciano, Michelle/F-7277-2010; Porteous, David/AAA-3446-2021; MacLeod, Andrew/Q-8655-2016	Porteous, David J/0000-0003-1249-6106; Deary, Ian J/0000-0002-1733-263X; Pickles, Andrew/0000-0003-1283-0346; Lopez, Lorna/0000-0002-0241-9783; Pendleton, Neil/0000-0003-0794-2386; Gow, Alan J/0000-0002-3320-4531; Luciano, Michelle/0000-0003-0935-7682; Porteous, David/0000-0003-1249-6106; MacLeod, Andrew/0000-0003-3298-5193; Tenesa, Albert/0000-0003-4884-4475; McNeill, Geraldine/0000-0003-0373-650X; Payton, Antony/0000-0003-0335-152X	UK's Biotechnology and Biological Sciences Research Council (BBSRC); RCUK Fellowship; AXA research fund; BBSRC [BB/F022441/1, BB/F019394/1] Funding Source: UKRI; MRC [G1001375, G0700704] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F019394/1, BB/F022441/1] Funding Source: researchfish; Medical Research Council [G0700704, G1001375] Funding Source: researchfish	UK's Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); RCUK Fellowship(UK Research & Innovation (UKRI)); AXA research fund(AXA Research Fund); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Genotyping and analyses of the cohorts conducted here were supported by the UK's Biotechnology and Biological Sciences Research Council (BBSRC). ML is a Royal Society of Edinburgh/Lloyds TSB Foundation for Scotland Personal Research Fellow. PAT is partially funded by an RCUK Fellowship. LML is funded by the AXA research fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckmann JS, 2007, NAT REV GENET, V8, P639, DOI 10.1038/nrg2149; Bijlsma EK, 2009, EUR J MED GENET, V52, P77, DOI 10.1016/j.ejmg.2009.03.006; Blauw HM, 2010, HUM MOL GENET, V19, P4091, DOI 10.1093/hmg/ddq323; Blcuw HM, 2008, LANCET NEUROL, V7, P319, DOI 10.1016/S1474-4422(08)70048-6; Bochukova EG, 2010, NATURE, V463, P666, DOI 10.1038/nature08689; Carroll J. B., 1993, HUMAN COGNITIVE ABIL, DOI DOI 1017/CBO9780511571312; Carter NP, 2007, NAT GENET, V39, pS16, DOI 10.1038/ng2028; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Davies G, 2011, MOL PSYCHIATR, V16, P996, DOI 10.1038/mp.2011.85; Deary I.J., 2009, LIFETIME INTELLIGENC; Deary I, 2008, NATURE, V456, P175, DOI 10.1038/456175a; Deary IJ, 2010, NAT REV NEUROSCI, V11, P201, DOI 10.1038/nrn2793; Deary IJ, 2009, HUM GENET, V126, P215, DOI 10.1007/s00439-009-0655-4; Deary IJ, 2004, J PERS SOC PSYCHOL, V86, P130, DOI 10.1037/0022-3514.86.1.130; Deary IJ, 2007, BMC GERIATRICS, V7; Dellinger AE, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq040; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Edelmann L, 2009, ANN NY ACAD SCI, V1151, P157, DOI 10.1111/j.1749-6632.2008.03610.x; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Frank B, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-83; Gauthier J, 2011, HUM GENET, V130, P563, DOI 10.1007/s00439-011-0975-z; Glessner JT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015463; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Helbig I, 2009, NAT GENET, V41, P160, DOI 10.1038/ng.292; Hill SK, 2004, AM J PSYCHIAT, V161, P996, DOI 10.1176/appi.ajp.161.6.996; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Houlihan LM, 2009, GENES BRAIN BEHAV, V8, P238, DOI 10.1111/j.1601-183X.2008.00470.x; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Ingason A, 2009, MOL PSYCHIAT; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Johnson W, 2004, INTELLIGENCE, V32, P95, DOI 10.1016/S0160-2896(03)00062-X; Johnson W, 2008, INTELLIGENCE, V36, P81, DOI 10.1016/j.intell.2007.06.001; Kalscheuer VM, 2007, HUM GENET, V121, P501, DOI 10.1007/s00439-006-0284-0; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Kumar RA, 2008, HUM MOL GENET, V17, P628, DOI 10.1093/hmg/ddm376; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474; McKinney C, 2008, ANN RHEUM DIS, V67, P409, DOI 10.1136/ard.2007.075028; McMullan DJ, 2009, HUM MUTAT, V30, P1082, DOI 10.1002/humu.21015; Merikangas AK, 2009, TRENDS GENET, V25, P536, DOI 10.1016/j.tig.2009.10.006; Mitchell KJ, 2010, SCHIZOPHR RES, V117, P222, DOI 10.1016/j.schres.2010.02.318; Moessner R, 2007, AM J HUM GENET, V81, P1289, DOI 10.1086/522590; Morrow EM, 2010, J AM ACAD CHILD PSY, V49, P1091, DOI 10.1016/j.jaac.2010.08.009; Need AC, 2009, HUM MOL GENET, V18, P4650, DOI 10.1093/hmg/ddp413; Nelson H., 1991, NATL ADULT READING T; Payton A, 2009, NEUROPSYCHOL REV, V19, P451, DOI 10.1007/s11065-009-9116-z; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Rabbitt PMA, 2004, AGING NEUROPSYCHOL C, V11, P245, DOI 10.1080/13825580490511116; Raven JC, 1977, MANUAL RAVENS PROGR; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Roohi J, 2009, J MED GENET, V46, P176, DOI 10.1136/jmg.2008.057505; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Salthouse TA, 2004, INTELLIGENCE, V32, P541, DOI 10.1016/j.intell.2004.07.003; Saus E, 2010, J PSYCHIATR RES, V44, P971, DOI 10.1016/j.jpsychires.2010.03.007; Schrider DR, 2010, P ROY SOC B-BIOL SCI, V277, P3213, DOI 10.1098/rspb.2010.1180; Scottish Council for Research in Education, 1933, INT SCOTT CHILDR NAT; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Slatkin M, 2009, GENETICS, V182, P845, DOI 10.1534/genetics.109.102798; Spearman C, 1904, AM J PSYCHOL, V15, P201, DOI 10.2307/1412107; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Visscher PM, 2008, NAT GENET, V40, P489, DOI 10.1038/ng0508-489; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Wechsler D, 2008, WAIS 3 WECHSLER ADUL, VFourth; Wechsler D, 1998, WAIS 3 UK ADM SCORIN; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Williams NM, 2010, LANCET, V376, P1401, DOI 10.1016/S0140-6736(10)61109-9; Wilson HL, 2003, J MED GENET, V40, P575, DOI 10.1136/jmg.40.8.575; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yang Y, 2007, MOL IMMUNOL, V44, P261, DOI 10.1016/j.molimm.2006.07.268; Yeo RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016339; Zhang D, 2011, PLOS ONE	83	15	15	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e37385	10.1371/journal.pone.0037385	http://dx.doi.org/10.1371/journal.pone.0037385			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300510	Green Published, gold, Green Submitted			2022-12-27	WOS:000313618800001
J	Guo, SC; Li, YQ; Tong, Q; Gu, F; Zhu, TH; Fu, L; Yang, S				Guo, Shaocong; Li, Yaqing; Tong, Qi; Gu, Feng; Zhu, Tianhui; Fu, Li; Yang, Shuang			delta EF1 Down-Regulates ER-alpha Expression and Confers Tamoxifen Resistance in Breast Cancer	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; ENDOCRINE THERAPY RESISTANCE; TRANSCRIPTION FACTOR ZEB1; E-CADHERIN; MESENCHYMAL TRANSITION; PROTEIN DELTA-EF1; ZINC-FINGER; CELLS; GENE; MECHANISMS	Resistance to tamoxifen therapy represents a major barrier to the successful treatment of breast cancer, where a loss of or reduced ER-alpha level is considered a primary mechanism. Understanding how ER-alpha expression is regulated would provide insights into new intervention points to overcome tamoxifen resistance. In this study, we report that the expression of delta EF1 is up-regulated by 17 beta-estradiol (E2) in MCF-7 cells in an ER-alpha-dependent manner, through either PI3K or NF-kappa B pathway. Ectopic expression of delta EF1 in turn repressed ER-alpha transcription by binding to the E-2-box on the ER-alpha promoter. At the tissue level of breast cancer, there is a strong and inverse correlation between the expression levels of delta EF1 and ER-alpha. In MCF-7 cells, an elevated expression of delta EF1 made the cells less sensitive to tamoxifen treatment, whereas overexpression of ER-alpha compromised the effects of delta EF1 and restored the sensitivity. Also, depletion of delta EF1 by RNA interference in MDA-MB-231 cells restored the expression of ER-alpha and tamoxifen sensitivity. In conclusion, we have identified an important role of delta EF1 in the development of tamoxifen resistance in breast cancer. Inhibiting delta EF1 to restore ER-alpha expression might represent a potential therapeutic strategy for overcoming endocrine resistance in breast cancer.	[Guo, Shaocong; Tong, Qi; Zhu, Tianhui; Yang, Shuang] Nankai Univ, Coll Med, Tianjin 300071, Peoples R China; [Li, Yaqing; Gu, Feng; Fu, Li] Tianjin Med Univ, Canc Inst & Hosp, Tianjin, Peoples R China	Nankai University; Tianjin Medical University	Yang, S (corresponding author), Nankai Univ, Coll Med, Tianjin 300071, Peoples R China.	yangshuang@nankai.edu.cn			China National Nature Science Foundation [81072153, 81272184]; New Century Excellent Talents Supporting Program [NCET-11-0260]; China National Basic Research Program [2009CB521705]; Yangtze Scholar and Innovative Team Development Program [IRT0743]; Tianjin Natural Science Foundation [11JCYBJC12400]	China National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); New Century Excellent Talents Supporting Program; China National Basic Research Program(National Basic Research Program of China); Yangtze Scholar and Innovative Team Development Program; Tianjin Natural Science Foundation(Natural Science Foundation of Tianjin)	This work is supported by grants from the China National Nature Science Foundation (No. 81072153, No. 81272184), the New Century Excellent Talents Supporting Program (No. NCET-11-0260), the China National Basic Research Program (No. 2009CB521705), the Yangtze Scholar and Innovative Team Development Program (No. IRT0743), and the Tianjin Natural Science Foundation (11JCYBJC12400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner K, 2007, ONCOGENE, V26, P6979, DOI 10.1038/sj.onc.1210508; Barone I, 2010, CLIN CANCER RES, V16, P2702, DOI 10.1158/1078-0432.CCR-09-1753; Bellon E, 2009, J CELL BIOL, V187, P685, DOI 10.1083/jcb.200904034; Darling DS, 2003, GENE EXPR PATTERNS, V3, P709, DOI 10.1016/S1567-133X(03)00147-9; Dillner NB, 2002, MOL CELL ENDOCRINOL, V192, P85, DOI 10.1016/S0303-7207(02)00088-6; Dillner NB, 2002, J BIOL CHEM, V277, P33890, DOI 10.1074/jbc.M204399200; Du J, 2009, CELL RES, V19, P487, DOI 10.1038/cr.2009.34; Eger A, 2005, ONCOGENE, V24, P2375, DOI 10.1038/sj.onc.1208429; Ellison-Zelski SJ, 2009, MOL CELL BIOL, V29, P4949, DOI 10.1128/MCB.00383-09; Frasor J, 2009, CANCER RES, V69, P8918, DOI 10.1158/0008-5472.CAN-09-2608; FUNAHASHI J, 1991, NUCLEIC ACIDS RES, V19, P3543, DOI 10.1093/nar/19.13.3543; FUNAHASHI J, 1993, DEVELOPMENT, V119, P433; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gururaj AE, 2006, CLIN CANCER RES, V12, p1001S, DOI 10.1158/1078-0432.CCR-05-2110; Haddad Y, 2009, CLIN CANCER RES, V15, P532, DOI 10.1158/1078-0432.CCR-08-1733; Higashi Y, 1997, J EXP MED, V185, P1467, DOI 10.1084/jem.185.8.1467; Higgins MJ, 2011, ANNU REV MED, V62, P281, DOI 10.1146/annurev-med-070909-182545; Hu F, 2011, BBA-GENE REGUL MECH, V1809, P200, DOI 10.1016/j.bbagrm.2011.01.003; Hu F, 2010, BBA-MOL BASIS DIS, V1802, P301, DOI 10.1016/j.bbadis.2009.12.002; Kansra S, 2005, MOL CELL ENDOCRINOL, V239, P27, DOI 10.1016/j.mce.2005.04.008; Kuske B, 2006, ENDOCR-RELAT CANCER, V13, P1121, DOI 10.1677/erc.1.01257; Lapidus RG, 1998, CANCER RES, V58, P2515; Lorenzatti G, 2011, J CELL SCI, V124, P1752, DOI 10.1242/jcs.084194; Michalides R, 2004, CANCER CELL, V5, P597, DOI 10.1016/j.ccr.2004.05.016; Nishimura G, 2006, DEV CELL, V11, P93, DOI 10.1016/j.devcel.2006.05.011; Osborne CK, 2011, ANNU REV MED, V62, P233, DOI 10.1146/annurev-med-070909-182917; Osborne CK, 2005, CLIN CANCER RES, V11, p865S; Park SH, 2008, MOL ENDOCRINOL, V22, P2085, DOI 10.1210/me.2007-0512; Ponticos M, 2004, MOL CELL BIOL, V24, P6151, DOI 10.1128/MCB.24.14.6151-6161.2004; Rachagani S, 2011, BRIT J CANCER, V104, P1038, DOI 10.1038/bjc.2011.31; Ring A, 2004, ENDOCR-RELAT CANCER, V11, P643, DOI 10.1677/erc.1.00776; Sanchez CG, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2833; Spoelstra NS, 2006, CANCER RES, V66, P3893, DOI 10.1158/0008-5472.CAN-05-2881; Takagi T, 1998, DEVELOPMENT, V125, P21; Terraz C, 2001, J BIOL CHEM, V276, P37011, DOI 10.1074/jbc.M104185200; Vesuna F, 2012, ONCOGENE, V31, P3223, DOI 10.1038/onc.2011.483; Yamamoto H, 2011, BIOL PHARM BULL, V34, P324, DOI 10.1248/bpb.34.324; Yamashita H, 2008, INT J CLIN ONCOL, V13, P380, DOI 10.1007/s10147-008-0818-7; Yang S, 2007, J BIOMED SCI, V14, P663, DOI 10.1007/s11373-007-9155-5; Yang S, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-211; Yang XW, 2001, CANCER RES, V61, P7025	41	15	16	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52380	10.1371/journal.pone.0052380	http://dx.doi.org/10.1371/journal.pone.0052380			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285017	Green Published, gold, Green Submitted			2022-12-27	WOS:000313158800058
J	Buschard, K; Mansson, JE; Roep, BO; Nikolic, T				Buschard, Karsten; Mansson, Jan-Eric; Roep, Bart O.; Nikolic, Tatjana			Self-Glycolipids Modulate Dendritic Cells Changing the Cytokine Profiles of Committed Autoreactive T Cells	PLOS ONE			English	Article							DEPENDENT DIABETES-MELLITUS; II NKT CELLS; BETA-CELLS; INSULIN EPITOPE; NOD MICE; SULFATIDE; GALACTOSYLCERAMIDE; PREVENTS; AUTOIMMUNITY; PATHOGENESIS	The impact of glycolipids of non-mammalian origin on autoimmune inflammation has become widely recognized. Here we report that the naturally occurring mammalian glycolipids, sulfatide and beta-GalCer, affect the differentiation and the quality of antigen presentation by monocyte-derived dendritic cells (DCs). In response to sulfatide and beta-GalCer, monocytes develop into immature DCs with higher expression of HLA-DR and CD86 but lower expression of CD80, CD40 and CD1a and lower production of IL-12 compared to non-modulated DCs. Self-glycolipid-modulated DCs responded to lipopolysaccharide (LPS) by changing phenotype but preserved low IL-12 production. Sulfatide, in particular, reduced the capacity of DCs to stimulate autoreactive Glutamic Acid Decarboxylase (GAD65) - specific T cell response and promoted IL-10 production by the GAD65-specific clone. Since sulfatide and beta-GalCer induced toll-like receptor (TLR)-mediated signaling, we hypothesize that self-glycolipids deliver a (tolerogenic) polarizing signal to differentiating DCs, facilitating the maintenance of self-tolerance under proinflammatory conditions.	[Buschard, Karsten] Rigshosp, Bartholin Inst, DK-2100 Copenhagen, Denmark; [Mansson, Jan-Eric] Univ Gothenburg, Inst Neurosci & Physiol, Sahlgrenska Acad, Gothenburg, Sweden; [Roep, Bart O.; Nikolic, Tatjana] Leiden Univ, Dept Immunohematol & Blood Transfus, Med Ctr, Leiden, Netherlands	Rigshospitalet; University of Copenhagen; University of Gothenburg; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Buschard, K (corresponding author), Rigshosp, Bartholin Inst, DK-2100 Copenhagen, Denmark.	buschard@dadlnet.dk	NIkolic, Tatjana/I-2162-2012; Roep, Bart/AAD-7609-2021	Buschard, Karsten/0000-0002-0126-7423	Dutch Diabetes Research Foundation (Expert Center) [2008.40.001]; Juvenile Diabetes Research Foundation; Netherlands Organization for Scientific Research (NWO-VICI) [918.86.611]; European Union (FP7-NAIMIT) [241447]; Lundbeck Foundation; Danish Council for Independent Research \ Medical Sciences [271-06-0424]	Dutch Diabetes Research Foundation (Expert Center); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Netherlands Organization for Scientific Research (NWO-VICI)(Netherlands Organization for Scientific Research (NWO)); European Union (FP7-NAIMIT); Lundbeck Foundation(Lundbeckfonden); Danish Council for Independent Research \ Medical Sciences(Det Frie Forskningsrad (DFF))	This work has been supported by the Dutch Diabetes Research Foundation (Expert Center Grant 2008.40.001), the Juvenile Diabetes Research Foundation, the Netherlands Organization for Scientific Research (NWO-VICI, 918.86.611), the European Union (FP7-NAIMIT, number 241447), the Lundbeck Foundation, and the Danish Council for Independent Research vertical bar Medical Sciences (number 271-06-0424). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrenberg P, 2011, GASTROENTEROLOGY, V140, P646, DOI 10.1053/j.gastro.2010.10.003; Arrenberg P, 2010, P NATL ACAD SCI USA, V107, P10984, DOI 10.1073/pnas.1000576107; BEEKMAN EM, 1994, NATURE, V372, P691, DOI 10.1038/372691a0; Blomqvist M, 2009, EUR J IMMUNOL, V39, P1726, DOI 10.1002/eji.200839001; BUSCHARD K, 1991, AUTOIMMUNITY, V10, P65, DOI 10.3109/08916939108997149; BUSCHARD K, 1993, LANCET, V342, P840, DOI 10.1016/0140-6736(93)92697-R; Buschard K, 1996, APMIS, V104, P938, DOI 10.1111/j.1699-0463.1996.tb04962.x; BUSCHARD K, 1994, DIABETOLOGIA, V37, P1000; Buschard K, 2001, AUTOIMMUNITY, V34, P9, DOI 10.3109/08916930108994121; Buschard K, 1999, DIABETOLOGIA, V42, P1212, DOI 10.1007/s001250051294; Cook DN, 2004, NAT IMMUNOL, V5, P975, DOI 10.1038/ni1116; Coppieters KT, 2012, J EXP MED, V209, P51, DOI 10.1084/jem.20111187; de Jong EC, 2002, J IMMUNOL, V168, P1704, DOI 10.4049/jimmunol.168.4.1704; Fredman P, 2000, GLYCOBIOLOGY, V10, P39, DOI 10.1093/glycob/10.1.39; Hiemstra HS, 2001, P NATL ACAD SCI USA, V98, P3988, DOI 10.1073/pnas.071050898; HOLLANDER PH, 1982, DIABETES, V31, P149, DOI 10.2337/diabetes.31.2.149; Hong S, 2001, NAT MED, V7, P1052, DOI 10.1038/nm0901-1052; Jahng A, 2004, J EXP MED, V199, P947, DOI 10.1084/jem.20031389; Jahng AW, 2001, J EXP MED, V194, P1789, DOI 10.1084/jem.194.12.1789; Kent SC, 2005, NATURE, V435, P224, DOI 10.1038/nature03625; Kinjo Y, 2011, NAT IMMUNOL, V12, P966, DOI 10.1038/ni.2096; Kleijwegt FS, 2010, J IMMUNOL, V185, P1412, DOI 10.4049/jimmunol.1000560; Lutz MB, 2002, TRENDS IMMUNOL, V23, P445, DOI 10.1016/S1471-4906(02)02281-0; Mahnke K, 2002, IMMUNOL CELL BIOL, V80, P477, DOI 10.1046/j.1440-1711.2002.01115.x; Nakayama M, 2005, NATURE, V435, P220, DOI 10.1038/nature03523; NORTON WT, 1966, J NEUROCHEM, V13, P213, DOI 10.1111/j.1471-4159.1966.tb06794.x; Osterbye T, 2001, GLYCOBIOLOGY, V11, P473, DOI 10.1093/glycob/11.6.473; Osterbye T, 2010, DIABETES-METAB RES, V26, P656, DOI 10.1002/dmrr.1134; Roeske-Nielsen A, 2004, IMMUNOL LETT, V91, P205, DOI 10.1016/j.imlet.2003.12.010; Roeske-Nielsen A, 2010, DIABETES-METAB RES, V26, P631, DOI 10.1002/dmrr.1130; Schloot NC, 1999, J AUTOIMMUN, V12, P289, DOI 10.1006/jaut.1999.0280; Shamshiev A, 1999, EUR J IMMUNOL, V29, P1667, DOI 10.1002/(SICI)1521-4141(199905)29:05<1667::AID-IMMU1667>3.0.CO;2-U; Sharif S, 2001, NAT MED, V7, P1057, DOI 10.1038/nm0901-1057; Shimada A, 1996, J AUTOIMMUN, V9, P263, DOI 10.1006/jaut.1996.0033; Subramanian L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037771; SVENNERHOLM L, 1992, BIOCHIM BIOPHYS ACTA, V1128, P1, DOI 10.1016/0005-2760(92)90250-Y; van der Kleij D, 2002, J BIOL CHEM, V277, P48122, DOI 10.1074/jbc.M206941200; van Halteren AGS, 2002, DIABETES, V51, P2119, DOI 10.2337/diabetes.51.7.2119; Wu D, 2005, P NATL ACAD SCI USA, V102, P1351, DOI 10.1073/pnas.0408696102; ZUCKERFRANKLIN D, 1983, P NATL ACAD SCI-BIOL, V80, P6977, DOI 10.1073/pnas.80.22.6977	40	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52639	10.1371/journal.pone.0052639	http://dx.doi.org/10.1371/journal.pone.0052639			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285123	gold, Green Submitted, Green Published			2022-12-27	WOS:000312794500216
J	Chen, CY; Wei, RX; Qiao, RM; Ren, J; Yang, H; Liu, CL; Huang, LS				Chen, Congying; Wei, Rongxing; Qiao, Ruimin; Ren, Jun; Yang, Hui; Liu, Chenlong; Huang, Lusheng			A Genome-Wide Investigation of Expression Characteristics of Natural Antisense Transcripts in Liver and Muscle Samples of Pigs	PLOS ONE			English	Article							GENE-EXPRESSION; RNA; SENSE; IDENTIFICATION; INTERFERENCE; METHYLATION; LOCUS; MAP	Natural antisense transcripts are endogenous transcripts that are complementary to the sense-strand of DNA. These transcripts have been identified in various eukaryotic species and are involved in a broad range of regulatory events and biological processes. However, their general biological functions, expression characteristics and regulatory mechanisms are still unclear. In this study, 497 liver and 586 muscle samples were harvested from a White DurocxErhualian F-2 resource population. The expression profiles of sense and antisense transcripts were determined by tag-based RNA sequencing. We identified 33.7% and 20.4% of transcripts having both sense and antisense expression, and 12.5% and 6.1% of transcripts only expressing antisense transcripts in liver and muscle, respectively. More than 32.2% of imprinting or predicted imprinting genes in the geneimprint database were detected with both sense and antisense expression. The correlations between sense and antisense expression in sense-antisense pairs were diverse in both liver and muscle, showing positive, negative or absent correlation. Antisense expression increases gene expression variability. More interestingly, compared to eQTL mapping of sense transcripts in which more than one eQTL was mapped for a transcript, only one eQTL was identified for each antisense transcript, and the percentage of cis-eQTL in antisense eQTL was higher than that in sense eQTL. This suggests that the expressions of antisense transcripts tend to be cis-regulated by a single genomic locus. To our knowledge, this study is the first systematical investigation of antisense transcription in pigs. The findings improve our understanding of the complexity of porcine transcriptome.	[Chen, Congying; Wei, Rongxing; Qiao, Ruimin; Ren, Jun; Yang, Hui; Liu, Chenlong; Huang, Lusheng] Jiangxi Agr Univ, Key Lab Anim Biotechnol Jiangxi Prov, Nanchang, Peoples R China; [Chen, Congying; Wei, Rongxing; Qiao, Ruimin; Ren, Jun; Yang, Hui; Liu, Chenlong; Huang, Lusheng] Jiangxi Agr Univ, Minist Agr China, Nanchang, Peoples R China; [Wei, Rongxing] Nanchang Working Canine Base, Nanchang, Peoples R China	Jiangxi Agricultural University; Jiangxi Agricultural University; Ministry of Agriculture & Rural Affairs	Huang, LS (corresponding author), Jiangxi Agr Univ, Key Lab Anim Biotechnol Jiangxi Prov, Nanchang, Peoples R China.	Lushenghuang@hotmail.com	Ren, Jun/H-9793-2019; Chen, Congying/AFU-8515-2022; Chen, Congying/ABB-7384-2021		National Natural Science Foundation of China [31160225]; Ministry of Education of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China)	This subject was supported by the National Natural Science Foundation of China (31160225), the Jiangxi Project for Cultivating Young Scientists and Key Project for Scientific Research from the Ministry of Education of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airavaara M, 2011, J BIOL CHEM, V286, P45093, DOI 10.1074/jbc.M111.310250; Asmann YW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-531; BARRELL BG, 1976, NATURE, V264, P34, DOI 10.1038/264034a0; Bosher JM, 2000, NAT CELL BIOL, V2, pE31, DOI 10.1038/35000102; Braunschweig MH, 2004, GENOMICS, V84, P1021, DOI 10.1016/j.ygeno.2004.09.006; Chen JJ, 2004, NUCLEIC ACIDS RES, V32, P4812, DOI 10.1093/nar/gkh818; Chen JJ, 2005, TRENDS GENET, V21, P326, DOI 10.1016/j.tig.2005.04.006; Faghihi MA, 2009, NAT REV MOL CELL BIO, V10, P637, DOI 10.1038/nrm2738; Guo Y, 2009, ANIM GENET, V40, P47, DOI 10.1111/j.1365-2052.2008.01802.x; Gyorffy A, 2007, J GENET, V86, P103, DOI 10.1007/s12041-007-0015-x; Haddad F, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-21; Hastings ML, 2000, J BIOL CHEM, V275, P11507, DOI 10.1074/jbc.275.15.11507; Hayward BE, 2000, HUM MOL GENET, V9, P835, DOI 10.1093/hmg/9.5.835; He YP, 2008, SCIENCE, V322, P1855, DOI 10.1126/science.1163853; Holmes R, 2003, GENOME RES, V13, P1410, DOI 10.1101/gr.955503; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kelley RL, 2000, CELL, V103, P9, DOI 10.1016/S0092-8674(00)00099-4; Kerin T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003479; Khalil AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001486; Knee R, 1997, NEUROCHEM INT, V31, P379, DOI 10.1016/S0197-0186(96)00108-8; Lavorgna G, 2004, TRENDS BIOCHEM SCI, V29, P88, DOI 10.1016/j.tibs.2003.12.002; Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734; Li AW, 2000, MOL CELL ENDOCRINOL, V170, P231, DOI 10.1016/S0303-7207(00)00440-8; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li YY, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-18; Mazo A, 2007, J CELL SCI, V120, P2755, DOI 10.1242/jcs.007633; MISRA S, 2002, GENOME BIOL, V3, P83, DOI [DOI 10.1186/GB-2002-3-12-RESEARCH0083, 10.1186/gb-2002-3-12-research0083]; Moore T, 1997, P NATL ACAD SCI USA, V94, P12509, DOI 10.1073/pnas.94.23.12509; Morrissy AS, 2011, GENOME RES, V21, P1203, DOI 10.1101/gr.113431.110; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Nezer C, 1999, NAT GENET, V21, P155, DOI 10.1038/5935; Okada Y, 2008, HUM MOL GENET, V17, P1631, DOI 10.1093/hmg/ddn051; OKANO H, 1991, J NEUROCHEM, V56, P560, DOI 10.1111/j.1471-4159.1991.tb08186.x; Osato N, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2003-5-1-r5; Peters NT, 2003, RNA, V9, P698, DOI 10.1261/rna.2120703; Poole RL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-475; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Seitz A, 2005, HUM MOL GENET, V14, P2661, DOI 10.1093/hmg/ddi296; Sleutels F, 2000, CURR OPIN GENET DEV, V10, P229, DOI 10.1016/S0959-437X(00)00062-9; Span PN, 2011, ENDOCR-RELAT CANCER, V18, P323, DOI 10.1530/ERC-10-0184; Sun M, 2006, GENOME RES, V16, P922, DOI 10.1101/gr.5210006; Tufarelli C, 2003, NAT GENET, V34, P157, DOI 10.1038/ng1157; Vanhee-Brossollet C, 1998, GENE, V211, P1, DOI 10.1016/S0378-1119(98)00093-6; Wutz A, 1997, NATURE, V389, P745, DOI 10.1038/39631; Xu ZY, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.1; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Yelin R, 2003, NAT BIOTECHNOL, V21, P379, DOI 10.1038/nbt808; Zhang Y, 2006, NUCLEIC ACIDS RES, V34, P3465, DOI 10.1093/nar/gkl473; ZHOU BS, 1992, CANCER RES, V52, P4280	50	17	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52433	10.1371/journal.pone.0052433	http://dx.doi.org/10.1371/journal.pone.0052433			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285040	Green Submitted, gold, Green Published			2022-12-27	WOS:000312794500167
J	Jo, YK; Kim, SC; Park, IJ; Park, SJ; Jin, DH; Hong, SW; Cho, DH; Kim, JC				Jo, Yoon Kyung; Kim, Seung Cheol; Park, In Ja; Park, So Jung; Jin, Dong-Hoon; Hong, Seung-Woo; Cho, Dong-Hyung; Kim, Jin Cheon			Increased Expression of ATG10 in Colorectal Cancer Is Associated with Lymphovascular Invasion and Lymph Node Metastasis	PLOS ONE			English	Article							UBIQUITIN-CONJUGATING ENZYME; METABOLIC STRESS; GASTRIC-CANCER; BREAST-CANCER; CELL-SURVIVAL; RECTAL-CANCER; AUTOPHAGY; TUMORIGENESIS; MACROAUTOPHAGY; DISEASE	Background: Autophagy has paradoxical and complex functions in cancer development, and autophagy-related genes (ATG) are key regulators in autophagy. Until now, more than 30 different ATG proteins have been identified in yeast, and their mammalian counterparts also have been reported. Although the roles of a few ATG proteins in cancer have been characterized, the role of ATG10 is almost completely unknown. Methodology/Principal Findings: To investigate the clinicopathological role of ATG10 in colorectal cancer, we analyzed ATG10 expression in colorectal cancer tissues and cell lines. Protein expression analysis showed that ATG10 is highly increased in colorectal cancer (tissue - 18/37 cases, 48%; cell line - 8/12 cell lines, 66%). Immunohistochemical analysis with clinicopathological features indicated a strong association of the up-regulation of ATG10 with tumor lymph node metastasis (p = 0.005) and invasion (p<0.001). Moreover, both 5-year disease free survival and overall survival rates of patients bearing tumors that did not express ATG10 were significantly higher than those of patients bearing ATG10-expressing tumors (p = 0.012). Conclusion/Significance: Increased expression of ATG10 in colorectal cancer is associated with lymphovascular invasion and lymph node metastasis indicating that ATG10 may be a potential prognostic maker in colorectal cancer.	[Jo, Yoon Kyung; Park, So Jung; Cho, Dong-Hyung] Kyung Hee Univ, Grad Sch EW Med Sci, Gyeonggi Do, South Korea; [Jo, Yoon Kyung; Kim, Seung Cheol; Jin, Dong-Hoon; Hong, Seung-Woo; Kim, Jin Cheon] Asan Med Ctr, Inst Innovat Canc Res, Seoul, South Korea; [Kim, Seung Cheol; Park, In Ja; Kim, Jin Cheon] Univ Ulsan, Dept Surg, Coll Med, Seoul, South Korea; [Jin, Dong-Hoon; Hong, Seung-Woo] Univ Ulsan, Dept Oncol, Coll Med, Seoul, South Korea	Kyung Hee University; University of Ulsan; Asan Medical Center; University of Ulsan; University of Ulsan	Cho, DH (corresponding author), Kyung Hee Univ, Grad Sch EW Med Sci, Gyeonggi Do, South Korea.	dhcho@khu.ac.kr; jckim@amc.seoul.kr	Park, In Ja/U-2371-2019	Park, In Ja/0000-0001-5355-3969	Center for Development and Commercialization of Anti-Cancer Therapeutics; Korean Health 21 RD Project [A062254, A102059]; Ministry of Health, Welfare and Family Affairs, Korea; Asan Institute for Life Sciences [2011-069]; Basic Science Research Program (the National Research Foundation, Korea) [2010-0009164]	Center for Development and Commercialization of Anti-Cancer Therapeutics; Korean Health 21 RD Project; Ministry of Health, Welfare and Family Affairs, Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Asan Institute for Life Sciences; Basic Science Research Program (the National Research Foundation, Korea)	This work was supported by the Center for Development and Commercialization of Anti-Cancer Therapeutics and the Korean Health 21 R&D Project (A062254 and A102059, Ministry of Health, Welfare and Family Affairs, Korea), the Asan Institute for Life Sciences (2011-069), and the Basic Science Research Program (2010-0009164, the National Research Foundation, Korea). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedin MJ, 2007, CELL DEATH DIFFER, V14, P500, DOI 10.1038/sj.cdd.4402039; Brech A, 2009, MOL ONCOL, V3, P366, DOI 10.1016/j.molonc.2009.05.007; Cho DH, 2010, MOL MED, V16, P271, DOI 10.2119/molmed.2009.00187; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Fung C, 2008, MOL BIOL CELL, V19, P797, DOI 10.1091/mbc.E07-10-1092; Geng JF, 2008, EMBO REP, V9, P859, DOI 10.1038/embor.2008.163; Huang JJ, 2010, AUTOPHAGY, V6, P777, DOI 10.4161/auto.6.6.12784; Jin SK, 2007, AUTOPHAGY, V3, P28, DOI 10.4161/auto.3269; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; Kenific CM, 2010, CURR OPIN CELL BIOL, V22, P241, DOI 10.1016/j.ceb.2009.10.008; Lee WS, 2012, HEPATO-GASTROENTEROL, V59, P1313, DOI 10.5754/hge11610; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li ZD, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-98; Lock R, 2008, CURR OPIN CELL BIOL, V20, P583, DOI 10.1016/j.ceb.2008.05.002; Mantripragada KK, 2009, GENE CHROMOSOME CANC, V48, P897, DOI 10.1002/gcc.20695; Mehrpour M, 2010, CELL RES, V20, P748, DOI 10.1038/cr.2010.82; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Morselli E, 2009, BBA-MOL CELL RES, V1793, P1524, DOI 10.1016/j.bbamcr.2009.01.006; Moschos SJ, 2010, HUM PATHOL, V41, P1286, DOI 10.1016/j.humpath.2010.02.007; Nagtegaal ID, 2008, J CLIN ONCOL, V26, P303, DOI 10.1200/JCO.2007.12.7027; Nalepa G, 2006, NAT REV DRUG DISCOV, V5, P596, DOI 10.1038/nrd2056; Oga A, 2001, CYTOMETRY, V46, P57, DOI 10.1002/1097-0320(20010215)46:1<57::AID-CYTO1038>3.3.CO;2-X; Okamoto Y, 2003, CANCER RES, V63, P4167; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Ramus SJ, 2003, CANCER RES, V63, P417; Shiraishi K, 2001, ONCOLOGY-BASEL, V60, P151, DOI 10.1159/000055313; Tedesco D, 2007, NEOPLASIA, V9, P601, DOI 10.1593/neo.07385; Tilney HS, 2007, DIS COLON RECTUM, V50, P29, DOI 10.1007/s10350-006-0744-6	30	53	58	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52705	10.1371/journal.pone.0052705	http://dx.doi.org/10.1371/journal.pone.0052705			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285162	Green Published, gold, Green Submitted			2022-12-27	WOS:000312794500237
J	Sanchez-Barrena, MJ; Vallis, Y; Clatworthy, MR; Doherty, GJ; Veprintsev, DB; Evans, PR; McMahon, HT				Jose Sanchez-Barrena, Maria; Vallis, Yvonne; Clatworthy, Menna R.; Doherty, Gary J.; Veprintsev, Dmitry B.; Evans, Philip R.; McMahon, Harvey T.			Bin2 Is a Membrane Sculpting N-BAR Protein That Influences Leucocyte Podosomes, Motility and Phagocytosis	PLOS ONE			English	Article							ACTIN CYTOSKELETON; MOLECULAR-GRAPHICS; ALPHA-PIX; DOMAIN; CURVATURE; DEGRADATION; INVADOPODIA; ADHESIONS; PAK	Cell motility, adhesion and phagocytosis are controlled by actin and membrane remodelling processes. Bridging integrator-2 (Bin2) also called Breast cancer-associated protein 1 (BRAP1) is a predicted N-BAR domain containing protein with unknown function that is highly expressed in leucocytic cells. In the present study we solved the structure of Bin2 BAR domain and studied its membrane binding and bending properties in vitro and in vivo. Live-cell imaging experiments showed that Bin2 is associated with actin rich structures on the plasma membrane, where it was targeted through its N-BAR domain. Pull-down experiments and immunoprecipitations showed that Bin2 C-terminus bound SH3 domain containing proteins such as Endophilin A2 and alpha-PIX. siRNA of endogenous protein led to decreased cell migration, increased phagocytosis and reduced podosome density and dynamics. In contrast, overexpression of Bin2 led to decreased phagocytosis and increased podosome density and dynamics. We conclude that Bin2 is a membrane-sculpting protein that influences podosome formation, motility and phagocytosis in leucocytes. Further understanding of this protein may be key to understand the behaviour of leucocytes under physiological and pathological conditions.	[Jose Sanchez-Barrena, Maria; Vallis, Yvonne; Doherty, Gary J.; Veprintsev, Dmitry B.; Evans, Philip R.; McMahon, Harvey T.] MRC Lab Mol Biol, Cambridge, England; [Clatworthy, Menna R.] Univ Cambridge Sch Clin Med, Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge, England	MRC Laboratory Molecular Biology; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	McMahon, HT (corresponding author), MRC Lab Mol Biol, Cambridge, England.	xmjose@iqfr.csic.es; hmm@mrc-lmb.cam.ac.uk	Veprintsev, Dmitry B/H-2228-2012; Sanchez-Barrena, Maria Jose/E-6842-2015	Veprintsev, Dmitry B/0000-0002-3583-5409; Sanchez-Barrena, Maria Jose/0000-0002-5986-1804; Doherty, Gary/0000-0002-8158-8111	FEBS; "Ramon y Cajal" contract in Spain; Medical Research Council UK [U105178795, U105178845]; Wellcome Trust Intermediate Fellowship [WT081020]; Medical Research Council [MC_U105178795, MC_U105178845] Funding Source: researchfish; MRC [MC_U105178845, MC_U105178795] Funding Source: UKRI	FEBS; "Ramon y Cajal" contract in Spain; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Intermediate Fellowship(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	MJS-B was funded by a FEBS postdoctoral fellowship during her stay in Cambridge (UK) and by a "Ramon y Cajal" contract in Spain. HMM, GD, and YV were funded by the Medical Research Council UK (grant number U105178795), PRE was funded by the Medical Research Council UK (grant number U105178845). MRC was funded by a Wellcome Trust Intermediate Fellowship (WT081020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Boucrot E, 2012, CELL, V149, P124, DOI 10.1016/j.cell.2012.01.047; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Calle Y, 2006, EUR J CELL BIOL, V85, P151, DOI 10.1016/j.ejcb.2005.09.003; Casal E, 2006, BIOCHEMISTRY-US, V45, P12917, DOI 10.1021/bi060717k; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Clatworthy MR, 2004, J EXP MED, V199, P717, DOI 10.1084/jem.20032197; Dovas A, 2011, CELL SIGNAL, V23, P1225, DOI 10.1016/j.cellsig.2011.02.004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Frost A, 2009, CELL, V137, P191, DOI 10.1016/j.cell.2009.04.010; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Ge K, 2000, GENOMICS, V67, P210, DOI 10.1006/geno.2000.6216; Gringel A, 2006, J CELL PHYSIOL, V209, P568, DOI 10.1002/jcp.20777; Henne WM, 2007, STRUCTURE, V15, P839, DOI 10.1016/j.str.2007.05.002; Jaffer ZM, 2002, INT J BIOCHEM CELL B, V34, P713, DOI 10.1016/S1357-2725(01)00158-3; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Linder S, 2005, J CELL SCI, V118, P2079, DOI 10.1242/jcs.02390; Linder S, 2007, TRENDS CELL BIOL, V17, P107, DOI 10.1016/j.tcb.2007.01.002; Masuda M, 2006, EMBO J, V25, P2889, DOI 10.1038/sj.emboj.7601176; Mazaki Y, 2006, NAT IMMUNOL, V7, P724, DOI 10.1038/ni1349; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Millard TH, 2005, EMBO J, V24, P240, DOI 10.1038/sj.emboj.7600535; MORGAN C, 1987, J CELL PHYSIOL, V130, P420, DOI 10.1002/jcp.1041300316; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ochoa GC, 2000, J CELL BIOL, V150, P377, DOI 10.1083/jcb.150.2.377; Oikawa T, 2009, CELL ADHES MIGR, V3, P195, DOI 10.4161/cam.3.2.7510; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Rosenberger G, 2006, EUR J CELL BIOL, V85, P265, DOI 10.1016/j.ejcb.2005.10.007; Saarikangas J, 2010, PHYSIOL REV, V90, P259, DOI 10.1152/physrev.00036.2009; Webb BA, 2005, AM J PHYSIOL-CELL PH, V289, pC898, DOI 10.1152/ajpcell.00095.2005; Wernimont SA, 2008, EUR J CELL BIOL, V87, P507, DOI 10.1016/j.ejcb.2008.01.011; West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153; Wu XY, 2005, DEV CELL, V9, P185, DOI 10.1016/j.devcel.2005.06.006	36	29	39	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52401	10.1371/journal.pone.0052401	http://dx.doi.org/10.1371/journal.pone.0052401			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285027	Green Published, gold, Green Submitted			2022-12-27	WOS:000312794500159
J	Knies, K; Schuster, B; Ameziane, N; Rooimans, M; Bettecken, T; de Winter, J; Schindler, D				Knies, Kerstin; Schuster, Beatrice; Ameziane, Najim; Rooimans, Martin; Bettecken, Thomas; de Winter, Johan; Schindler, Detlev			Genotyping of Fanconi Anemia Patients by Whole Exome Sequencing: Advantages and Challenges	PLOS ONE			English	Article							MUTATIONS; DIAGNOSIS; CANCER; GENE; LEUKEMIA; FANCD2	Fanconi anemia (FA) is a rare genomic instability syndrome. Disease-causing are biallelic mutations in any one of at least 15 genes encoding members of the FA/BRCA pathway of DNA-interstrand crosslink repair. Patients are diagnosed based upon phenotypical manifestationsand the diagnosis of FA is confirmed by the hypersensitivity of cells to DNA interstrand crosslinking agents. Customary molecular diagnostics has become increasingly cumbersome, time-consuming and expensive the more FA genes have been identified. We performed Whole Exome Sequencing (WES) in four FA patients in order to investigate the potential of this method for FA genotyping. In search of an optimal WES methodology we explored different enrichment and sequencing techniques. In each case we were able to identify the pathogenic mutations so that WES provided both, complementation group assignment and mutation detection in a single approach. The mutations included homozygous and heterozygous single base pair substitutions and a two-base-pair duplication in FANCJ, -D1, or -D2. Different WES strategies had no critical influence on the individual outcome. However, database errors and in particular pseudogenes impose obstacles that may prevent correct data perception and interpretation, and thus cause pitfalls. With these difficulties in mind, our results show that WES is a valuable tool for the molecular diagnosis of FA and a sufficiently safe technique, capable of engaging increasingly in competition with classical genetic approaches.	[Knies, Kerstin; Schuster, Beatrice; Schindler, Detlev] Univ Wurzburg, Dept Human Genet, D-8700 Wurzburg, Germany; [Ameziane, Najim; Rooimans, Martin; de Winter, Johan] Vrije Univ, Dept Clin Genet, Med Ctr, Amsterdam, Netherlands; [Bettecken, Thomas] Max Planck Inst Psychiat, Ctr Appl Genotyping Munic, D-80804 Munich, Germany	University of Wurzburg; Vrije Universiteit Amsterdam; Max Planck Society	Knies, K (corresponding author), Univ Wurzburg, Dept Human Genet, D-8700 Wurzburg, Germany.	kerstin.knies@uni-wuerzburg.de; beatrice.schuster@biozentrum.uni-wuerzburg.de			German Research Foundation (DFG); University of Wuerzburg	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter B. P., 1993, GENEREVIEWS; Ameziane N, 2012, ANEMIA, V2012, DOI 10.1155/2012/132856; AUERBACH AD, 1993, EXP HEMATOL, V21, P731; Auerbach AD, 2009, MUTAT RES-FUND MOL M, V668, P4, DOI 10.1016/j.mrfmmm.2009.01.013; Carr IM, 2006, HUM MUTAT, V27, P1041, DOI 10.1002/humu.20383; CERVENKA J, 1981, PEDIATRICS, V67, P119; Clark MJ, 2011, NAT BIOTECHNOL, V29, P908, DOI 10.1038/nbt.1975; Deans AJ, 2011, NAT REV CANCER, V11, P467, DOI 10.1038/nrc3088; Hirsch B, 2004, BLOOD, V103, P2554, DOI 10.1182/blood-2003-06-1970; Kalb R, 2007, AM J HUM GENET, V80, P895, DOI 10.1086/517616; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Rosenberg PS, 2003, BLOOD, V101, P822, DOI 10.1182/blood-2002-05-1498; SCHINDLER D, 1987, AM J PEDIAT HEMATOL, V9, P172; SCHINDLER D, 2007, FANCONI ANEMIA PARAD, P110; SCHROEDER TM, 1964, HUMANGENETIK, V1, P194, DOI 10.1007/BF00389636; Seif AE, 2011, CANCER GENET-NY, V204, P227, DOI 10.1016/j.cancergen.2011.04.005; SEYSCHAB H, 1995, BLOOD, V85, P2233, DOI 10.1182/blood.V85.8.2233.bloodjournal8582233; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Timmers C, 2001, MOL CELL, V7, P241, DOI 10.1016/S1097-2765(01)00172-1; Vaz F, 2010, NAT GENET, V42, P406, DOI 10.1038/ng.570; Vuorela M, 2011, BREAST CANCER RES TR, V130, P1003, DOI 10.1007/s10549-011-1677-x; Wagner JE, 2004, BLOOD, V103, P3226, DOI 10.1182/blood-2003-09-3138; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603	25	27	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52648	10.1371/journal.pone.0052648	http://dx.doi.org/10.1371/journal.pone.0052648			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285130	Green Published, gold, Green Submitted			2022-12-27	WOS:000312794500219
J	Yuan, XG; Zhang, JY; Zhang, SL; Yu, GQ; Wang, Y				Yuan, Xiguo; Zhang, Junying; Zhang, Shengli; Yu, Guoqiang; Wang, Yue			Comparative Analysis of Methods for Identifying Recurrent Copy Number Alterations in Cancer	PLOS ONE			English	Article							CIRCULAR BINARY SEGMENTATION; SQUAMOUS-CELL CARCINOMA; ARRAY CGH DATA; LUNG-CANCER; GENETIC-VARIANTS; STEM-CELLS; ABERRATIONS; GLIOMA; IDENTIFICATION; GENOME	Recurrent copy number alterations (CNAs) play an important role in cancer genesis. While a number of computational methods have been proposed for identifying such CNAs, their relative merits remain largely unknown in practice since very few efforts have been focused on comparative analysis of the methods. To facilitate studies of recurrent CNA identification in cancer genome, it is imperative to conduct a comprehensive comparison of performance and limitations among existing methods. In this paper, six representative methods proposed in the latest six years are compared. These include one-stage and two-stage approaches, working with raw intensity ratio data and discretized data respectively. They are based on various techniques such as kernel regression, correlation matrix diagonal segmentation, semi-parametric permutation and cyclic permutation schemes. We explore multiple criteria including type I error rate, detection power, Receiver Operating Characteristics (ROC) curve and the area under curve (AUC), and computational complexity, to evaluate performance of the methods under multiple simulation scenarios. We also characterize their abilities on applications to two real datasets obtained from cancers with lung adenocarcinoma and glioblastoma. This comparison study reveals general characteristics of the existing methods for identifying recurrent CNAs, and further provides new insights into their strengths and weaknesses. It is believed helpful to accelerate the development of novel and improved methods.	[Yuan, Xiguo; Zhang, Junying] Xidian Univ, Sch Comp Sci & Technol, Xian, Peoples R China; Virginia Polytech Inst & State Univ, Bradley Dept Elect & Comp Engn, Arlington, VA 22203 USA; [Zhang, Shengli] Xidian Univ, Dept Math, Xian, Peoples R China	Xidian University; Virginia Polytechnic Institute & State University; Xidian University	Wang, Y (corresponding author), Virginia Polytech Inst & State Univ, Bradley Dept Elect & Comp Engn, Arlington, VA 22203 USA.	yuewang@vt.edu			Natural Science Foundation of China [61201312, 61070137, 61202175, 91130006]; United States National Institutes of Health [CA160036, CA149147, GM085665]; Natural Science Basic Research Plan in Shaanxi Province of China [2012JQ8027, 2012JQ1010]; Fundamental Research Funds for the Central Universities [K50511030002, K50511030001, K5051270012]; NATIONAL CANCER INSTITUTE [U54CA149147, U24CA160036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM085665] Funding Source: NIH RePORTER	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Science Basic Research Plan in Shaanxi Province of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Natural Science Foundation of China under grants 61201312, 61070137, 61202175, and 91130006; the United States National Institutes of Health under grants CA160036, CA149147, and GM085665; and the Project Supported by Natural Science Basic Research Plan in Shaanxi Province of China (program number 2012JQ8027, 2012JQ1010); and the Fundamental Research Funds for the Central Universities (K50511030002, K50511030001, and K5051270012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Broet P, 2011, CLIN CANCER RES, V17, P3542, DOI 10.1158/1078-0432.CCR-10-2185; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Chen HY, 2011, AM J EPIDEMIOL, V173, P915, DOI 10.1093/aje/kwq457; Chen L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-344; Coe BR, 2006, GENE CHROMOSOME CANC, V45, P11, DOI 10.1002/gcc.20260; Dallol A, 2003, ONCOGENE, V22, P4611, DOI 10.1038/sj.onc.1206687; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Diskin SJ, 2006, GENOME RES, V16, P1149, DOI 10.1101/gr.5076506; Dobbins SE, 2011, NAT GENET, V43, P825, DOI 10.1038/ng.879; Duncan CD, 2010, ADVANCED CRIME SCENE PHOTOGRAPHY, P1; Enfield KSS, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/474632; Fu JC, 2012, J STAT PLAN INFER, V142, P473, DOI 10.1016/j.jspi.2011.08.005; Gamez-Pozo A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007731; Guttman M, 2007, PLOS GENET, V3, P1464, DOI 10.1371/journal.pgen.0030143; Hong KM, 2007, INT J CANCER, V120, P2353, DOI 10.1002/ijc.22577; Hsu L, 2005, BIOSTATISTICS, V6, P211, DOI 10.1093/biostatistics/kxi004; Hu ZB, 2011, NAT GENET, V43, P792, DOI 10.1038/ng.875; Hupe P, 2004, BIOINFORMATICS, V20, P3413, DOI 10.1093/bioinformatics/bth418; Junes-Gill KS, 2011, J NEURO-ONCOL, V102, P197, DOI 10.1007/s11060-010-0314-6; Kang JU, 2010, INT J ONCOL, V37, P327, DOI 10.3892/ijo_00000681; Kang JU, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-237; Kanteti R, 2009, J ENVIRON PATHOL TOX, V28, P89, DOI 10.1615/JEnvironPatholToxicolOncol.v28.i2.10; Kim YH, 2010, ONCOGENE, V29, P1421, DOI 10.1038/onc.2009.437; Klijn C, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1143; Kuhn E, 2012, J NATL CANC I; Kuo KT, 2009, CANCER RES, V69, P4036, DOI 10.1158/0008-5472.CAN-08-3913; Lachance DH, 2011, AM J EPIDEMIOL, V174, P574, DOI 10.1093/aje/kwr124; Lai WR, 2005, BIOINFORMATICS, V21, P3763, DOI 10.1093/bioinformatics/bti611; Li CG, 2012, J THORAC ONCOL, V7, P85, DOI 10.1097/JTO.0b013e318234f0a2; Li YF, 2010, LANCET ONCOL, V11, P321, DOI 10.1016/S1470-2045(10)70042-5; Liu WN, 2009, NAT MED, V15, P559, DOI 10.1038/nm.1944; Liu YH, 2012, HUM GENET, V131, P1507, DOI 10.1007/s00439-012-1187-x; Loo LWM, 2011, BREAST CANCER RES TR, V127, P297, DOI 10.1007/s10549-010-1297-x; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Micke P, 2011, J THORAC ONCOL, V6, P1833, DOI 10.1097/JTO.0b013e3182295917; Mollenhauer J, 1997, NAT GENET, V17, P32, DOI 10.1038/ng0997-32; Morganella S, 2011, BIOINFORMATICS, V27, P2949, DOI 10.1093/bioinformatics/btr488; Morganella S, 2010, BIOINFORMATICS, V26, P3020, DOI 10.1093/bioinformatics/btq586; Motomura K, 2012, J NEUROPATH EXP NEUR, V71, P702, DOI 10.1097/NEN.0b013e31825f2e5d; Nakanishi H, 2009, CANCER RES, V69, P1615, DOI 10.1158/0008-5472.CAN-08-3218; Nasarre P, 2010, CELL ADHES MIGR, V4, P130, DOI 10.4161/cam.4.1.10882; Naylor TL, 2005, BREAST CANCER RES, V7, pR1186, DOI 10.1186/bcr1356; Newton MA, 1998, STAT MED, V17, P1425, DOI 10.1002/(SICI)1097-0258(19980715)17:13<1425::AID-SIM861>3.0.CO;2-V; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Roversi G, 2006, ONCOGENE, V25, P1571, DOI 10.1038/sj.onc.1209177; Rueda OM, 2010, CURR BIOINFORM, V5, P1; Rueda OM, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-308; Sanchez-Garcia F, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-189; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Shah SP, 2007, BIOINFORMATICS, V23, pI450, DOI 10.1093/bioinformatics/btm221; Taylor BS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003179; Van Loo P, 2012, NAT BIOTECHNOL, V30, P620, DOI 10.1038/nbt.2293; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Vital AL, 2010, NEURO-ONCOLOGY, V12, P991, DOI 10.1093/neuonc/noq050; Wakimoto H, 2012, NEURO-ONCOLOGY, V14, P132, DOI 10.1093/neuonc/nor195; Walter V, 2011, BIOINFORMATICS, V27, P678, DOI 10.1093/bioinformatics/btq717; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Westfall P.H., 1993, RESAMPLING BASED MUL, V279; Westfall PH, 1997, AM STAT, V51, P3, DOI 10.2307/2684683; Wilkerson MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036530; Willenbrock H, 2005, BIOINFORMATICS, V21, P4084, DOI 10.1093/bioinformatics/bti677; Wu C, 2009, CANCER RES, V69, P5065, DOI 10.1158/0008-5472.CAN-09-0081; Wu LY, 2009, BIOINFORMATICS, V25, P1669, DOI 10.1093/bioinformatics/btp270; Xiao YY, 2012, CLIN CANCER RES, V18, P3154, DOI 10.1158/1078-0432.CCR-11-2778; Yadav AK, 2009, JAMA-J AM MED ASSOC, V302, P276, DOI 10.1001/jama.2009.1022; Yang TH, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-63; Yin D, 2009, MOL CANCER RES, V7, P665, DOI 10.1158/1541-7786.MCR-08-0270; Yu GQ, 2011, BIOINFORMATICS, V27, P1473, DOI 10.1093/bioinformatics/btr183; Yuan XG, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-342; Yuan XG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041082; Yuan XG, 2012, J COMPUT BIOL, V19, P42, DOI 10.1089/cmb.2010.0188; Yuan XG, 2011, BIOCHEM GENET, V49, P395, DOI 10.1007/s10528-011-9416-x; Zhang QY, 2010, BIOINFORMATICS, V26, P464, DOI 10.1093/bioinformatics/btp708; Zheng HW, 2010, CANCER CELL, V17, P497, DOI 10.1016/j.ccr.2010.03.020	81	11	11	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52516	10.1371/journal.pone.0052516	http://dx.doi.org/10.1371/journal.pone.0052516			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285074	Green Published, Green Submitted, gold			2022-12-27	WOS:000312794500187
J	Della Gaspera, B; Armand, AS; Lecolle, S; Charbonnier, F; Chanoine, C				Della Gaspera, Bruno; Armand, Anne-Sophie; Lecolle, Sylvie; Charbonnier, Frederic; Chanoine, Christophe			Mef2d Acts Upstream of Muscle Identity Genes and Couples Lateral Myogenesis to Dermomyotome Formation in Xenopus laevis	PLOS ONE			English	Article							TRANSCRIPTION FACTOR MEF2C; NEURAL-TUBE CLOSURE; CONVERGENT EXTENSION; MOUSE EMBRYOGENESIS; PARAXIAL MESODERM; SOMITE FORMATION; EXPRESSION; DIFFERENTIATION; MYOD; CELLS	Xenopus myotome is formed by a first medial and lateral myogenesis directly arising from the presomitic mesoderm followed by a second myogenic wave emanating from the dermomyotome. Here, by a series of gain and loss of function experiments, we showed that Mef2d, a member of the Mef2 family of MADS-box transcription factors, appeared as an upstream regulator of lateral myogenesis, and as an inducer of dermomyotome formation at the beginning of neurulation. In the lateral presomitic cells, we showed that Mef2d transactivates Myod expression which is necessary for lateral myogenesis. In the most lateral cells of the presomitic mesoderm, we showed that Mef2d and Paraxis (Tcf15), a member of the Twist family of transcription factors, were co-localized and activate directly the expression of Meox2, which acts upstream of Pax3 expression during dermomyotome formation. Cell tracing experiments confirm that the most lateral Meox2 expressing cells of the presomitic mesoderm correspond to the dermomyotome progenitors since they give rise to the most dorsal cells of the somitic mesoderm. Thus, Xenopus Mef2d couples lateral myogenesis to dermomyotome formation before somite segmentation. These results together with our previous works reveal striking similarities between dermomyotome and tendon formation in Xenopus: both develop in association with myogenic cells and both involve a gene transactivation pathway where one member of the Mef2 family, Mef2d or Mef2c, cooperates with a bHLH protein of the Twist family, Paraxis or Scx (Scleraxis) respectively. We propose that these shared characteristics in Xenopus laevis reflect the existence of a vertebrate ancestral mechanism which has coupled the development of the myogenic cells to the formation of associated tissues during somite compartmentalization.	[Della Gaspera, Bruno; Armand, Anne-Sophie; Lecolle, Sylvie; Charbonnier, Frederic; Chanoine, Christophe] Univ Paris 05, Ctr Univ St Peres, Ctr Etud Sensori Motricite, UMR 8194,CNRS, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Della Gaspera, B (corresponding author), Univ Paris 05, Ctr Univ St Peres, Ctr Etud Sensori Motricite, UMR 8194,CNRS, Paris, France.	bruno.della-gaspera@parisdescartes.fr		chanoine, christophe/0000-0001-8155-2357; Armand, Anne-Sophie/0000-0002-0291-6421; Charbonnier, Frederic/0000-0003-4341-3246; della gaspera, bruno/0000-0002-0652-1822	CNRS; AFM (Association Francaise contre les Myopathies)	CNRS(Centre National de la Recherche Scientifique (CNRS)); AFM (Association Francaise contre les Myopathies)(Association Francaise contre les Myopathies)	This work was supported by grants from CNRS and AFM (Association Francaise contre les Myopathies). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRES V, 1995, MOL CELL BIOL, V15, P4272; Barnes RM, 2009, INT J DEV BIOL, V53, P909, DOI 10.1387/ijdb.082747rb; Becker C, 2003, DEV DYNAM, V227, P445, DOI 10.1002/dvdy.10318; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Blais A, 2005, GENE DEV, V19, P553, DOI 10.1101/gad.1281105; Buckingham M, 2009, CURR OPIN GENET DEV, V19, P444, DOI 10.1016/j.gde.2009.08.001; CANDIA AF, 1995, MECH DEVELOP, V52, P27, DOI 10.1016/0925-4773(95)00384-D; Carpio R, 2004, DEV DYNAM, V231, P609, DOI 10.1002/dvdy.20147; Charbonnier F, 2002, J BIOL CHEM, V277, P1139, DOI 10.1074/jbc.M107018200; Chen Y, 2006, DEVELOPMENT, V133, P2303, DOI 10.1242/dev.02397; Colas A, 2008, DEV BIOL, V320, P351, DOI 10.1016/j.ydbio.2008.05.547; Daughters RS, 2011, DEVELOPMENT, V138, P821, DOI 10.1242/dev.056481; Davidson LA, 1999, DEVELOPMENT, V126, P4547; Della Gaspera B, 2006, DEV DYNAM, V235, P524, DOI 10.1002/dvdy.20628; Della Gaspera B, 2012, DEV DYNAM, V241, P995, DOI 10.1002/dvdy.23780; della Gaspera B, 2009, DEV BIOL, V328, P392, DOI 10.1016/j.ydbio.2009.01.039; Delling U, 2000, MOL CELL BIOL, V20, P6600, DOI 10.1128/MCB.20.17.6600-6611.2000; Devoto SH, 1996, DEVELOPMENT, V122, P3371; Dorey K, 2010, DEVELOPMENT, V137, P3731, DOI 10.1242/dev.037689; EDMONDSON DG, 1994, DEVELOPMENT, V120, P1251; Fisher ME, 2002, DEVELOPMENT, V129, P1307; Fletcher RB, 2006, DEVELOPMENT, V133, P1703, DOI 10.1242/dev.02342; FRANK D, 1991, DEVELOPMENT, V113, P1387; Freitas R, 2006, NATURE, V442, P1033, DOI 10.1038/nature04984; Geiser M, 2001, BIOTECHNIQUES, V31, P88, DOI 10.2144/01311st05; Gensch N, 2008, DEVELOPMENT, V135, P1597, DOI 10.1242/dev.019331; Grimaldi A, 2004, DEVELOPMENT, V131, P3249, DOI 10.1242/dev.01194; Gros J, 2005, NATURE, V435, P954, DOI 10.1038/nature03572; Groves JA, 2005, DEVELOPMENT, V132, P4211, DOI 10.1242/dev.01958; Haldar M, 2008, DEV CELL, V14, P437, DOI 10.1016/j.devcel.2008.01.002; HARVEY RP, 1990, DEVELOPMENT, V108, P669; Hinits Y, 2007, DEVELOPMENT, V134, P2511, DOI 10.1242/dev.007088; Hinits Y, 2009, DEVELOPMENT, V136, P403, DOI 10.1242/dev.028019; Hollway GE, 2007, DEV CELL, V12, P207, DOI 10.1016/j.devcel.2007.01.001; HOPWOOD ND, 1991, DEVELOPMENT, V111, P551; HOPWOOD ND, 1989, EMBO J, V8, P3409, DOI 10.1002/j.1460-2075.1989.tb08505.x; ISAACS HV, 1994, EMBO J, V13, P4469, DOI 10.1002/j.1460-2075.1994.tb06769.x; JENNINGS CGB, 1992, DEV BIOL, V150, P121, DOI 10.1016/0012-1606(92)90012-6; Kassar-Duchossoy L, 2004, NATURE, V431, P466, DOI 10.1038/nature02876; Keren A, 2005, DEV BIOL, V288, P73, DOI 10.1016/j.ydbio.2005.09.020; Khokha MK, 2005, DEV CELL, V8, P401, DOI 10.1016/j.devcel.2005.01.013; Kim SH, 2000, CURR BIOL, V10, P821, DOI 10.1016/S0960-9822(00)00580-7; Kroll KL, 1996, DEVELOPMENT, V122, P3173; Kusakabe R, 2007, DEV DYNAM, V236, P2410, DOI 10.1002/dvdy.21177; LEIBHAM D, 1994, MOL CELL BIOL, V14, P686, DOI 10.1128/MCB.14.1.686; Leise WF, 2004, DEVELOPMENT, V131, P1703, DOI 10.1242/dev.01054; Lin Q, 1998, DEVELOPMENT, V125, P4565; Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; Linker C, 2005, DEVELOPMENT, V132, P3895, DOI 10.1242/dev.01961; Mankoo BS, 2003, DEVELOPMENT, V130, P4655, DOI 10.1242/dev.00687; Mariani FV, 2001, DEV CELL, V1, P115, DOI 10.1016/S1534-5807(01)00018-1; Martin BL, 2001, DEV BIOL, V239, P270, DOI 10.1006/dbio.2001.0434; Meadows SM, 2008, P NATL ACAD SCI USA, V105, P1545, DOI 10.1073/pnas.0703918105; Mokalled MH, 2012, GENE DEV, V26, P190, DOI 10.1101/gad.179663.111; Monsoro-Burq AH, 2003, DEVELOPMENT, V130, P3111, DOI 10.1242/dev.00531; Naya FJ, 1999, CURR OPIN CELL BIOL, V11, P683, DOI 10.1016/S0955-0674(99)00036-8; Nentwich O, 2009, DEV BIOL, V336, P313, DOI 10.1016/j.ydbio.2009.09.039; Paris J, 2004, PHYSIOL GENOMICS, V20, P143, DOI 10.1152/physiolgenomics.00149.2004; Penn BH, 2004, GENE DEV, V18, P2348, DOI 10.1101/gad.1234304; Potthoff MJ, 2007, MOL CELL BIOL, V27, P8143, DOI 10.1128/MCB.01187-07; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Potthoff MJ, 2007, J CLIN INVEST, V117, P2459, DOI 10.1172/JCI31960; Rampalli S, 2007, NAT STRUCT MOL BIOL, V14, P1150, DOI 10.1038/nsmb1316; Reijntjes S, 2007, INT J DEV BIOL, V51, P753, DOI 10.1387/ijdb.072332sr; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Rolo A, 2009, DEV BIOL, V327, P327, DOI 10.1016/j.ydbio.2008.12.009; Sambasivan R, 2009, DEV CELL, V16, P810, DOI 10.1016/j.devcel.2009.05.008; Sandmann T, 2007, GENE DEV, V21, P436, DOI 10.1101/gad.1509007; Sandmann T, 2006, DEV CELL, V10, P797, DOI 10.1016/j.devcel.2006.04.009; SCALES JB, 1990, MOL CELL BIOL, V10, P1516, DOI 10.1128/MCB.10.4.1516; Steinbach OC, 1998, DEV BIOL, V202, P280, DOI 10.1006/dbio.1998.8993; Tajbakhsh S, 2009, J INTERN MED, V266, P372, DOI 10.1111/j.1365-2796.2009.02158.x; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; Wilson-Rawls J, 1999, DEVELOPMENT, V126, P5217; WONG MW, 1994, DEV BIOL, V166, P683, DOI 10.1006/dbio.1994.1347; Yusuf F, 2006, ANAT EMBRYOL, V211, pS21, DOI 10.1007/s00429-006-0119-8	76	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e52359	10.1371/journal.pone.0052359	http://dx.doi.org/10.1371/journal.pone.0052359			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300648	gold, Green Published, Green Submitted			2022-12-27	WOS:000313872600015
J	Chambers, KT; Chen, ZJ; Crawford, PA; Fu, XR; Burgess, SC; Lai, L; Leone, TC; Kelly, DP; Finck, BN				Chambers, Kari T.; Chen, Zhouji; Crawford, Peter A.; Fu, Xiaorong; Burgess, Shawn C.; Lai, Ling; Leone, Teresa C.; Kelly, Daniel P.; Finck, Brian N.			Liver-Specific PGC-1beta Deficiency Leads to Impaired Mitochondrial Function and Lipogenic Response to Fasting-Refeeding	PLOS ONE			English	Article							FATTY-ACID OXIDATION; TRANSCRIPTIONAL COACTIVATOR; HEPATIC GLUCONEOGENESIS; INSULIN-RESISTANCE; ADAPTIVE THERMOGENESIS; INDUCIBLE COACTIVATOR; ENERGY-METABOLISM; LIPID-METABOLISM; RECEPTOR-ALPHA; MICE	PGC-1 beta plays pleiotropic roles in regulating intermediary metabolism and has been shown to regulate both catabolic and anabolic processes in liver. We sought to evaluate the effects of PGC-1 beta on liver energy metabolism by generating mice with postnatal, liver-specific deletion of PGC-1 beta (LS-PGC-1 beta(-)/(-) mice). LS-PGC-1 beta(-)/(-) mice were outwardly normal, but exhibited a significant increase in hepatic triglyceride content at 6 weeks of age. Hepatic steatosis was due, at least in part, to impaired capacity for fatty acid oxidation and marked mitochondrial dysfunction. Mitochondrial DNA content and the expression of genes encoding multiple steps in mitochondrial fatty acid oxidation and oxidative phosphorylation pathways were significantly diminished in LS-PGC-1 beta(-/-) mice. Liquid chromatography mass spectrometry-based analyses also revealed that acetylcarnitine and butyrylcarnitine levels were depleted whereas palmitoylcarnitine content was increased in LS-PGC-1 beta(-/-) liver, which is consistent with attenuated rates of fatty acid oxidation. Interestingly, loss of PGC-1 beta also significantly impaired inducible expression of glycolytic and lipogenic enzymes that occurs with high carbohydrate diet refeeding after a prolonged fast. These results suggest that PGC-1 beta plays dual roles in regulating hepatic fatty acid metabolism by controlling the expression of programs of genes involved in both fatty acid oxidation and de novo fatty acid synthesis.	[Chambers, Kari T.; Chen, Zhouji; Crawford, Peter A.; Finck, Brian N.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Fu, Xiaorong; Burgess, Shawn C.] Univ Texas SW Med Ctr Dallas, Adv Imaging Res Ctr, Dallas, TX 75390 USA; [Fu, Xiaorong; Burgess, Shawn C.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Lai, Ling; Leone, Teresa C.; Kelly, Daniel P.] Sanford Burnham Med Res Inst Lake Nona, Orlando, FL USA	Washington University (WUSTL); University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Sanford Burnham Prebys Medical Discovery Institute	Finck, BN (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.	bfinck@dom.wustl.edu	Kelly, Daniel/ABG-2056-2021	Crawford, Peter/0000-0001-8597-4426; Finck, Brian/0000-0001-5411-3674	American Liver Foundation; NIH [R01 DK078187, R01 DK078184, R01 HL058493]; Digestive Diseases Research Core [P30 DK52574]; Nutrition Obesity Research Center [P30 DK56341]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002584] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078187, P30DK052574, R01DK045416, P30DK056341, P30DK020579, R01DK091538, R01DK078184] Funding Source: NIH RePORTER	American Liver Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Digestive Diseases Research Core; Nutrition Obesity Research Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding was provided by the American Liver Foundation (www.liverfoundation.org); NIH R01 DK078187, R01 DK078184, R01 HL058493; Digestive Diseases Research Core P30 DK52574; Nutrition Obesity Research Center P30 DK56341. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLARD MF, 1994, AM J PHYSIOL, V267, pH742, DOI 10.1152/ajpheart.1994.267.2.H742; Andersson U, 2001, MOL CELL BIOL, V21, P3738, DOI 10.1128/MCB.21.11.3738-3749.2001; Boehm EA, 2001, AM J PHYSIOL-HEART C, V280, pH977, DOI 10.1152/ajpheart.2001.280.3.H977; Burgess SC, 2006, J BIOL CHEM, V281, P19000, DOI 10.1074/jbc.M600050200; Chen ZJ, 2008, ARTERIOSCL THROM VAS, V28, P1738, DOI 10.1161/ATVBAHA.108.171538; Chen ZJ, 2000, J BIOL CHEM, V275, P32807, DOI 10.1074/jbc.M004913200; Djouadi F, 2003, MOL GENET METAB, V78, P112, DOI 10.1016/S1096-7192(03)00017-9; ESSER V, 1993, J BIOL CHEM, V268, P5810; Estall JL, 2009, DIABETES, V58, P1499, DOI 10.2337/db08-1571; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Kumar A, 2010, DIABETES, V59, P1397, DOI 10.2337/db09-1061; Lai L, 2008, GENE DEV, V22, P1948, DOI 10.1101/gad.1661708; Lehman JJ, 2008, AM J PHYSIOL-HEART C, V295, pH185, DOI 10.1152/ajpheart.00081.2008; Lelliott CJ, 2006, PLOS BIOL, V4, P2042, DOI 10.1371/journal.pbio.0040369; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Leone TC, 1999, P NATL ACAD SCI USA, V96, P7473, DOI 10.1073/pnas.96.13.7473; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043; Lin JD, 2002, J BIOL CHEM, V277, P1645, DOI 10.1074/jbc.C100631200; Lin X, 2002, ARTERIOSCL THROM VAS, V22, P476, DOI 10.1161/hq0302.105271; Makowski L, 2009, FASEB J, V23, P586, DOI 10.1096/fj.08-119420; MILLINGTON DS, 1990, J INHERIT METAB DIS, V13, P321, DOI 10.1007/BF01799385; Nagai Y, 2009, CELL METAB, V9, P252, DOI 10.1016/j.cmet.2009.01.011; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Sonoda J, 2007, P NATL ACAD SCI USA, V104, P5223, DOI 10.1073/pnas.0611623104; Sunny NE, 2010, AM J PHYSIOL-ENDOC M, V298, pE1226, DOI 10.1152/ajpendo.00033.2010; Vega RB, 1997, J BIOL CHEM, V272, P31693, DOI 10.1074/jbc.272.50.31693; Vianna CR, 2006, CELL METAB, V4, P453, DOI 10.1016/j.cmet.2006.11.003; Wueest S, 2010, J CLIN INVEST, V120, P191, DOI 10.1172/JCI38388; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050	36	25	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52645	10.1371/journal.pone.0052645	http://dx.doi.org/10.1371/journal.pone.0052645			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285128	Green Published, Green Submitted, gold			2022-12-27	WOS:000313051500043
J	Morner, A; Brave, A; Kling, AM; Kuhlmann-Berenzon, S; Krook, K; Hedenskog, M; Silhammar, I; Ljungman, M; Ortqvist, A; Andersson, S; Brytting, M; Thorstensson, R; Linde, A				Morner, Andreas; Brave, Andreas; Kling, Anna-Maria; Kuhlmann-Berenzon, Sharon; Krook, Katarina; Hedenskog, Mona; Silhammar, Irene; Ljungman, Margaretha; Ortqvist, Ake; Andersson, Soren; Brytting, Maria; Thorstensson, Rigmor; Linde, Annika			Pandemic Influenza A(H1N1)pdm09 Seroprevalence in Sweden before and after the Pandemic and the Vaccination Campaign in 2009	PLOS ONE			English	Article							IMMUNE-RESPONSE; ANTIBODY-RESPONSE; ELDERLY-PEOPLE; INFECTION	The immunity to pandemic influenza A(H1N1)pdm09 in Sweden before and after the outbreaks in 2009 and 2010 was investigated in a seroepidemiological study. Serum samples were collected at four time points: during 2007 (n = 1968), in October 2009 (n = 2218), in May 2010 (n = 2638) and in May 2011 (n = 2513) and were tested for hemagglutination inhibition (HI) antibodies. In 2007, 4.9% of the population had pre-existing HI titres >= 40, with the highest prevalence (20.0%) in 15-24 year-olds, followed by >= 80 year-olds (9.3%). The overall prevalence of HI titres >= 40 had not changed significantly in October 2009. In May 2010 the prevalence had increased to 48.6% with the highest percentages in 5-14 year-olds (76.2%) andlowest in 75-79 year-olds (18.3%). One year later the prevalence of HI titres >= 40 had increased further to 52.2%. Children 5-14 years had the highest incidence of infection and vaccine uptake as well as the highest post-pandemic protective antibody levels. In contrast, the elderly had high vaccine uptake and low attack rate but low levels of protective antibodies, underlining that factors other than HI antibodies are involved in protection against influenza A(H1N1) pdm09. However, for all age-groups the seroprevalence was stable or increasing between 2010 and 2011, indicating that both vaccine- and infection-induced antibodies were long-lived.	[Morner, Andreas; Krook, Katarina; Hedenskog, Mona; Silhammar, Irene; Ljungman, Margaretha; Andersson, Soren; Brytting, Maria; Thorstensson, Rigmor] Swedish Inst Communicable Dis Control, Dept Diagnost & Vaccinol, Solna, Sweden; [Brave, Andreas] Swedish Inst Communicable Dis Control, Dept Preparedness, Solna, Sweden; [Kling, Anna-Maria; Kuhlmann-Berenzon, Sharon; Linde, Annika] Swedish Inst Communicable Dis Control, Dept Anal & Prevent, Solna, Sweden; [Ortqvist, Ake] Karolinska Inst, Dept Med, Infect Dis Unit, Stockholm, Sweden	Swedish Institute for Infectious Disease Control; Swedish Institute for Infectious Disease Control; Swedish Institute for Infectious Disease Control; Karolinska Institutet	Morner, A (corresponding author), Swedish Inst Communicable Dis Control, Dept Diagnost & Vaccinol, Solna, Sweden.	andreas.morner@smi.se	Kühlmann-Berenzon, Sharon/J-1554-2019	Kühlmann-Berenzon, Sharon/0000-0002-8138-1196; Morner, Andreas/0000-0002-3654-1728	Swedish Civil Contingencies Agency [2:4]	Swedish Civil Contingencies Agency	This study was funded by grant 2:4 from the Swedish Civil Contingencies Agency (www.msb.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson WE, 2011, J CLIN VIROL, V52, P300, DOI 10.1016/j.jcv.2011.08.019; Adamson WE, 2011, EUROSURVEILLANCE, V16, P5; Brown F, 2003, LAB CORRELATES IMMUN; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; de Jong J C, 2003, Dev Biol (Basel), V115, P63; Dudareva S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021340; [(EMEA) TEAftEoMP Unit HME], 1997, NOT GUID HARM REQ IN; Garcia-Sicilia J, 2011, VACCINE; Goodwin K, 2006, VACCINE, V24, P1159, DOI 10.1016/j.vaccine.2005.08.105; GOVAERT TME, 1994, VACCINE, V12, P1185, DOI 10.1016/0264-410X(94)90241-0; GOVAERT TME, 1994, JAMA-J AM MED ASSOC, V272, P1661, DOI 10.1001/jama.272.21.1661; Hallander HO, 2009, APMIS, V117, P912, DOI 10.1111/j.1600-0463.2009.02554.x; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; Ikonen N, 2010, EUROSURVEILLANCE, V15, P16; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; KENDAL AP, 1982, CONCEPTS PROCEDURES, pB17; Khurana S, 2012, J INFECT DIS, V205, P610, DOI 10.1093/infdis/jir791; Linde A, 2009, EUROSURVEILLANCE, V14, P2; Liu W, 2012, VACCINE, V30, P4785, DOI 10.1016/j.vaccine.2012.05.030; Maltezou HC, 2011, VACCINE, V29, P6664, DOI 10.1016/j.vaccine.2011.06.098; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; POTTER CW, 1979, BRIT MED BULL, V35, P69, DOI 10.1093/oxfordjournals.bmb.a071545; Reinheimer C, 2012, EUR J CLIN MICROBIOL, V31, P1467, DOI 10.1007/s10096-011-1465-x; Remarque EJ, 1998, J MED VIROL, V55, P82, DOI 10.1002/(SICI)1096-9071(199805)55:1&lt;82::AID-JMV13&gt;3.0.CO;2-1; Verma N, 2012, J VIROL; Walker WT, 2010, EXPERT REV VACCINES, V9, P1385, DOI [10.1586/erv.10.141, 10.1586/ERV.10.141]; [No title captured]	28	11	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53511	10.1371/journal.pone.0053511	http://dx.doi.org/10.1371/journal.pone.0053511			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285299	Green Submitted, gold, Green Published			2022-12-27	WOS:000313051500154
J	Nadai, M; Palu, G; Palumbo, M; Richter, SN				Nadai, Matteo; Palu, Giorgio; Palumbo, Manlio; Richter, Sara N.			Differential Targeting of Unpaired Bases within Duplex DNA by the Natural Compound Clerocidin: A Valuable Tool to Dissect DNA Secondary Structure	PLOS ONE			English	Article							CONTAINING DEOXYTRIDECANUCLEOTIDE DUPLEXES; CONFORMATIONAL TRANSITIONS; BULGE; RECOGNITION; MISMATCH; SEQUENCE; BINDING; LOOPS; TEMPERATURE; REACTIVITY	Non-canonical DNA structures have been postulated to mediate protein-nucleic acid interactions and to function as intermediates in the generation of frame-shift mutations when errors in DNA replication occur, which result in a variety of diseases and cancers. Compounds capable of binding to non-canonical DNA conformations may thus have significant diagnostic and therapeutic potential. Clerocidin is a natural diterpenoid which has been shown to selectively react with single-stranded bases without targeting the double helix. Here we performed a comprehensive analysis on several non-canonical DNA secondary structures, namely mismatches, nicks, bulges, hairpins, with sequence variations in both the single-stranded region and the double-stranded flanking segment. By analysis of clerocidin reactivity, we were able to identify the exposed reactive residues which provided information on both the secondary structure and the accessibility of the non-paired sites. Mismatches longer than 1 base were necessary to be reached by clerocidin reactive groups, while 1-base nicks were promptly targeted by clerocidin; in hairpins, clerocidin reactivity increased with the length of the hairpin loop, while, interestingly, reactivity towards bulges reached a maximum in 3-base-long bulges and declined in longer bulges. Electrophoretic mobility shift analysis demonstrated that bulges longer than 3 bases (i.e. 5- and 7-bases) folded or stacked on the duplex region therefore being less accessible by the compound. Clerocidin thus represents a new valuable diagnostic tool to dissect DNA secondary structures.	[Nadai, Matteo; Palu, Giorgio; Richter, Sara N.] Univ Padua, Dept Mol Med, Padua, Italy; [Palumbo, Manlio] Univ Padua, Dept Pharmaceut & Pharmacol Sci, Padua, Italy	University of Padua; University of Padua	Richter, SN (corresponding author), Univ Padua, Dept Mol Med, Padua, Italy.	sara.richter@unipd.it	Richter, Sara/A-5578-2012	Richter, Sara/0000-0002-5446-9029; Palumbo, Manlio/0000-0002-3163-1564	Italian Ministry of University and Research [FIRB-Ideas] [RBID082ATK_001]; University of Padua	Italian Ministry of University and Research [FIRB-Ideas]; University of Padua	This work was supported by the Italian Ministry of University and Research [FIRB-Ideas RBID082ATK_001] and by the University of Padua. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN NR, 1984, TETRAHEDRON LETT, V25, P469, DOI 10.1016/S0040-4039(00)99913-1; ANDERSEN NR, 1983, J ANTIBIOT, V36, P753, DOI 10.7164/antibiotics.36.753; ANDERSEN NR, 1984, TETRAHEDRON LETT, V25, P465, DOI 10.1016/S0040-4039(00)99912-X; Baase WA, 2009, NUCLEIC ACIDS RES, V37, P1682, DOI 10.1093/nar/gkn1042; Bahr M, 2008, NUCLEIC ACIDS RES, V36, P5000, DOI 10.1093/nar/gkn392; Belmont P, 2001, CHEM SOC REV, V30, P70, DOI 10.1039/a904630e; Dohno C, 2012, NUCLEIC ACIDS RES, V40, P2771, DOI 10.1093/nar/gkr1148; Dornberger U, 1999, BIOCHEMISTRY-US, V38, P12860, DOI 10.1021/bi9906874; Granzhan A, 2010, CHEM-EUR J, V16, P878, DOI 10.1002/chem.200901989; Hong CF, 2011, ANGEW CHEM INT EDIT, V50, P4390, DOI 10.1002/anie.201100075; Jones GB, 2008, CURR TOP MED CHEM, V8, P436, DOI 10.2174/156802608783955692; Jourdan M, 2012, NUCLEIC ACIDS RES, V40, P5115, DOI 10.1093/nar/gks067; KALNIK MW, 1989, BIOCHEMISTRY-US, V28, P294, DOI 10.1021/bi00427a040; KALNIK MW, 1990, J BIOL CHEM, V265, P636; Kamashev D, 2008, NUCLEIC ACIDS RES, V36, P1026, DOI 10.1093/nar/gkm667; Maxam A M, 1980, Methods Enzymol, V65, P499; MORDEN KM, 1990, BIOCHEMISTRY-US, V29, P8835, DOI 10.1021/bi00489a047; Nakatani K, 2001, J AM CHEM SOC, V123, P12650, DOI 10.1021/ja0109186; Nakatani K, 1999, ANGEW CHEM INT EDIT, V38, P3378, DOI 10.1002/(SICI)1521-3773(19991115)38:22<3378::AID-ANIE3378>3.3.CO;2-D; NIKONOWICZ E, 1989, BIOCHEMISTRY-US, V28, P8714, DOI 10.1021/bi00448a007; NIKONOWICZ EP, 1990, BIOCHEMISTRY-US, V29, P4193, DOI 10.1021/bi00469a024; Ong HC, 2009, CHEM COMMUN, P668, DOI 10.1039/b817733n; PATEL DJ, 1982, BIOCHEMISTRY-US, V21, P445, DOI 10.1021/bi00532a004; Peng T, 2005, ANGEW CHEM INT EDIT, V44, P7280, DOI 10.1002/anie.200502282; Pierre VC, 2007, P NATL ACAD SCI USA, V104, P429, DOI 10.1073/pnas.0610170104; Richter S, 2004, CHEM RES TOXICOL, V17, P492, DOI 10.1021/tx034210b; Richter S, 2003, NUCLEIC ACIDS RES, V31, P5149, DOI 10.1093/nar/gkg696; Richter SN, 2009, ORG BIOMOL CHEM, V7, P976, DOI 10.1039/b819049f; Richter SN, 2004, NUCLEIC ACIDS RES, V32, P5658, DOI 10.1093/nar/gkh898; ROSEN MA, 1992, BIOCHEMISTRY-US, V31, P4004, DOI 10.1021/bi00131a016; Smith GR, 2008, GENE DEV, V22, P2612, DOI 10.1101/gad.1724708; STREISINGER G, 1966, COLD SPRING HARB SYM, V31, P77, DOI 10.1101/SQB.1966.031.01.014; Svozil D, 2008, NUCLEIC ACIDS RES, V36, P3690, DOI 10.1093/nar/gkn260; Tippin B, 2004, J BIOL CHEM, V279, P45360, DOI 10.1074/jbc.M408600200; VANDENHOOGEN YT, 1988, NUCLEIC ACIDS RES, V16, P5013, DOI 10.1093/nar/16.11.5013; WOODSON SA, 1988, BIOCHEMISTRY-US, V27, P436, DOI 10.1021/bi00401a065; Xiang AX, 1998, J ORG CHEM, V63, P6774, DOI 10.1021/jo981331l	37	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52994	10.1371/journal.pone.0052994	http://dx.doi.org/10.1371/journal.pone.0052994			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285245	Green Published, gold, Green Submitted			2022-12-27	WOS:000313051500097
J	Tsai, D; Chen, S; Protti, DA; Morley, JW; Suaning, GJ; Lovell, NH				Tsai, David; Chen, Spencer; Protti, Dario A.; Morley, John W.; Suaning, Gregg J.; Lovell, Nigel H.			Responses of Retinal Ganglion Cells to Extracellular Electrical Stimulation, from Single Cell to Population: Model-Based Analysis	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; PHYSIOLOGICAL-PROPERTIES; ACTION-POTENTIALS; CORTICAL-NEURONS; ACTIVATION; MECHANISMS; MORPHOLOGY; MIDGET; MICROSTIMULATION; PROSTHESIS	Retinal ganglion cells (RGCs), which survive in large numbers following neurodegenerative diseases, could be stimulated with extracellular electric pulses to elicit artificial percepts. How do the RGCs respond to electrical stimulation at the subcellular level under different stimulus configurations, and how does this influence the whole-cell response? At the population level, why have experiments yielded conflicting evidence regarding the extent of passing axon activation? We addressed these questions through simulations of morphologically and biophysically detailed computational RGC models on high performance computing clusters. We conducted the analyses on both large-field RGCs and small-field midget RGCs. The latter neurons are unique to primates. We found that at the single cell level the electric potential gradient in conjunction with neuronal element excitability, rather than the electrode center location per se, determined the response threshold and latency. In addition, stimulus positioning strongly influenced the location of RGC response initiation and subsequent activity propagation through the cellular structure. These findings were robust with respect to inhomogeneous tissue resistivity perpendicular to the electrode plane. At the population level, RGC cellular structures gave rise to low threshold hotspots, which limited axonal and multi-cell activation with threshold stimuli. Finally, due to variations in neuronal element excitability over space, following supra-threshold stimulation some locations favored localized activation of multiple cells, while others favored axonal activation of cells over extended space.	[Tsai, David; Chen, Spencer; Suaning, Gregg J.; Lovell, Nigel H.] Univ New S Wales, Grad Sch Biomed Engn, Sydney, NSW, Australia; [Tsai, David] Columbia Univ, Dept Biol Sci, Howard Hughes Med Inst, New York, NY 10027 USA; [Tsai, David] Columbia Univ, Dept Elect Engn, Bioelect Syst Lab, New York, NY 10027 USA; [Protti, Dario A.] Univ Sydney, Discipline Physiol, Sydney, NSW 2006, Australia; [Protti, Dario A.] Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia; [Morley, John W.] Univ Western Sydney, Sch Med, Sydney, NSW, Australia	University of New South Wales Sydney; Columbia University; Howard Hughes Medical Institute; Columbia University; University of Sydney; University of Sydney; Western Sydney University	Lovell, NH (corresponding author), Univ New S Wales, Grad Sch Biomed Engn, Sydney, NSW, Australia.	n.lovell@unsw.edu.au	Lovell, Nigel H/AGF-6679-2022	Lovell, Nigel H/0000-0003-1637-1079; Suaning, Gregg/0000-0003-1918-3313	Australian Research Council Special Research Initiative in Bionic Vision Technologies	Australian Research Council Special Research Initiative in Bionic Vision Technologies(Australian Research Council)	This research was supported in part by an Australian Research Council (www.arc.gov.au) Special Research Initiative in Bionic Vision Technologies to Bionic Vision Australia. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja AK, 2008, IEEE T BIO-MED ENG, V55, P1744, DOI 10.1109/TBME.2008.919126; Barbeau H, 1999, BRAIN RES REV, V30, P27, DOI 10.1016/S0165-0173(99)00008-9; Behrend MR, 2009, J NEUROSCI METH, V179, P166, DOI 10.1016/j.jneumeth.2009.01.019; Butterwick A, 2009, EXP EYE RES, V88, P22, DOI 10.1016/j.exer.2008.09.018; Carnevale NT, 2006, NEURON BOOK; Chan LLH, 2011, J NEUROPHYSIOL, V105, P2687, DOI 10.1152/jn.00619.2010; DACEY DM, 1992, P NATL ACAD SCI USA, V89, P9666, DOI 10.1073/pnas.89.20.9666; DACEY DM, 1993, J NEUROSCI, V13, P5334, DOI 10.1523/JNEUROSCI.13-12-05334.1993; Eickenscheidt M, 2012, J NEUROPHYSIOL, V107, P2742, DOI 10.1152/jn.00909.2011; Fohlmeister JF, 1997, J NEUROPHYSIOL, V78, P1948, DOI 10.1152/jn.1997.78.4.1948; Fried SI, 2009, J NEUROPHYSIOL, V101, P1972, DOI 10.1152/jn.91081.2008; Fried SI, 2006, J NEUROPHYSIO; Fujikado T, 2007, GRAEF ARCH CLIN EXP, V245, P1411, DOI 10.1007/s00417-007-0563-z; Ghosh KK, 1996, J COMP NEUROL, V366, P76, DOI 10.1002/(SICI)1096-9861(19960226)366:1<76::AID-CNE6>3.0.CO;2-H; Greenberg RJ, 1999, IEEE T BIO-MED ENG, V46, P505, DOI 10.1109/10.759051; Hines ML, 2008, J NEUROSCI METH, V169, P425, DOI 10.1016/j.jneumeth.2007.09.010; Histed MH, 2009, NEURON, V63, P508, DOI 10.1016/j.neuron.2009.07.016; Holt GR, 1999, J COMPUT NEUROSCI, V6, P169, DOI 10.1023/A:1008832702585; Horsager A, 2009, INVEST OPHTH VIS SCI, V50, P1483, DOI 10.1167/iovs.08-2595; Jeng J, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/036022; Jensen RJ, 2005, J NEURAL ENG, V2, pS16, DOI 10.1088/1741-2560/2/1/003; Jensen RJ, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/3/035004; Jensen RJ, 2003, INVEST OPHTH VIS SCI, V44, P3533, DOI 10.1167/iovs.02-1041; Karwoski CJ, 1999, VISUAL NEUROSCI, V16, P369, DOI 10.1017/S0952523899162163; Kong JH, 2005, J COMP NEUROL, V489, P293, DOI 10.1002/cne.20631; Lin B, 2004, NEURON, V43, P475, DOI 10.1016/j.neuron.2004.08.002; Logothetis NK, 2007, NEURON, V55, P809, DOI 10.1016/j.neuron.2007.07.027; Lopez-Aguado L, 2001, NEUROSCIENCE, V108, P249, DOI 10.1016/S0306-4522(01)00417-1; Margolis DJ, 2008, J NEUROSCI, V28, P6526, DOI 10.1523/JNEUROSCI.1533-08.2008; Margolis DJ, 2007, J NEUROSCI, V27, P5994, DOI 10.1523/JNEUROSCI.0130-07.2007; Mazzoni F, 2008, J NEUROSCI, V28, P14282, DOI 10.1523/JNEUROSCI.4968-08.2008; McIntyre CC, 1999, BIOPHYS J, V76, P878, DOI 10.1016/S0006-3495(99)77251-6; McIntyre CC, 2000, ANN BIOMED ENG, V28, P219, DOI 10.1114/1.262; McIntyre CC, 2002, J NEUROPHYSIOL, V88, P1592, DOI 10.1152/jn.2002.88.4.1592; Migliore M, 2006, J COMPUT NEUROSCI, V21, P119, DOI 10.1007/s10827-006-7949-5; Moore DR, 2009, NAT NEUROSCI, V12, P686, DOI 10.1038/nn.2326; MURASUGI CM, 1993, J NEUROSCI, V13, P1719; Nanduri D, 2008, 30 ANN INT IEEE EMBS; Nowak LG, 1998, EXP BRAIN RES, V118, P477, DOI 10.1007/s002210050304; O'Brien BJ, 2002, J PHYSIOL-LONDON, V538, P787, DOI 10.1113/jphysiol.2001.013009; Oesch N, 2005, NEURON, V47, P739, DOI 10.1016/j.neuron.2005.06.036; Plonsey R., 2007, BIOELECTRICITY QUANT; RANCK JB, 1975, BRAIN RES, V98, P417, DOI 10.1016/0006-8993(75)90364-9; Rattay F, 2003, NEUROMODULATION, V6, P42, DOI 10.1046/j.1525-1403.2003.03006.x; RATTAY F, 1986, IEEE T BIO-MED ENG, V33, P974, DOI 10.1109/TBME.1986.325670; Rizzo JF, 2003, INVEST OPHTH VIS SCI, V44, P5362, DOI 10.1167/iovs.02-0817; Rodieck R.W., 1998, 1 STEPS SEEING; Schachter MJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000899; Segev I, 2000, SCIENCE, V290, P744, DOI 10.1126/science.290.5492.744; Sekirnjak C, 2008, J NEUROSCI, V28, P4446, DOI 10.1523/JNEUROSCI.5138-07.2008; Sekirnjak C, 2006, J NEUROPHYSIOL, V95, P3311, DOI 10.1152/jn.01168.2005; Sekirnjak C, 2011, J NEUROPHYSIOL, V105, P2560, DOI 10.1152/jn.01061.2010; Sekirnjak C, 2009, J NEUROPHYSIOL, V102, P3260, DOI 10.1152/jn.00663.2009; Sheasby BW, 1999, J NEUROPHYSIOL, V81, P1685, DOI 10.1152/jn.1999.81.4.1685; Stett A, 2000, VISION RES, V40, P1785, DOI 10.1016/S0042-6989(00)00005-5; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Stuart G, 2008, DENDRITES; Tehovnik EJ, 2006, J NEUROPHYSIOL, V96, P512, DOI 10.1152/jn.00126.2006; Traub RD, 2005, J NEUROPHYSIOL, V93, P2194, DOI 10.1152/jn.00983.2004; Velte TJ, 1999, J NEUROPHYSIOL, V81, P1412, DOI 10.1152/jn.1999.81.3.1412; WASSLE H, 1991, PHYSIOL REV, V71, P447, DOI 10.1152/physrev.1991.71.2.447; WATANABE M, 1989, J COMP NEUROL, V289, P434, DOI 10.1002/cne.902890308; Wei XFF, 2005, J NEURAL ENG, V2, P139, DOI 10.1088/1741-2560/2/4/010; Zhou JA, 2008, J BIOMED BIOTECHNOL, DOI 10.1155/2008/547428; Zrenner E, 2011, P ROY SOC B-BIOL SCI, V278, P1489, DOI 10.1098/rspb.2010.1747	65	39	40	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53357	10.1371/journal.pone.0053357	http://dx.doi.org/10.1371/journal.pone.0053357			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285287	Green Published, Green Submitted, gold			2022-12-27	WOS:000313051500142
J	Xie, P; Zhang, WW; Yuan, ST; Chen, ZQ; Yang, Q; Yuan, DQ; Wang, F; Liu, QH				Xie, Ping; Zhang, WeiWei; Yuan, Songtao; Chen, Zhiqiang; Yang, Qin; Yuan, DongQing; Wang, Feng; Liu, QingHuai			Suppression of Experimental Choroidal Neovascularization by Curcumin in Mice	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; RETINAL-PIGMENT EPITHELIUM; TNF-ALPHA; ADHESION MOLECULES; MACROPHAGE INFILTRATION; INFLAMMATORY RESPONSES; MACULAR DEGENERATION; MCP-1 SECRETION; DOWN-REGULATION; EXPRESSION	Purpose: To investigate the effects of curcumin on the development of experimental choroidal neovascularization (CNV) with underlying cellular and molecular mechanisms. Methods: C57BL/6N mice were pretreated with intraperitoneal injections of curcumin daily for 3 days prior to laser-induced CNV, and the drug treatments were continued until the end of the study. The CNV area was analyzed by fluorescein-labeled dextran angiography of retinal pigment epithelium (RPE)-choroid flat mounts on day 7 and 14, and CNV leakage was evaluated by fluorescein angiography (FA) on day 14 after laser photocoagulation. The infiltration of F4/80 positive macrophages and GR-1 positive granulocytes were evaluated by immunohistochemistry on RPE-choroid flat mounts on day 3. Their expression in RPE-choroid complex was quantified by real-time PCR (F4/80) and Western blotting (GR-1) on day 3. RPE-choroid levels of vascular endothelial growth factor (VEGF), tumor necrosis factor (TNF)-alpha, monocyte chemotactic protein (MCP)-1, and intercellular adhesion molecule (ICAM)-1 were examined by ELISA on day 3. Double immunostaining of F4/80 and VEGF was performed on cryo-sections of CNV lesions on day 3. The expression of nuclear factor (NF)-kappa B and hypoxia-inducible factor (HIF)-1 alpha in the RPE-choroid was determined by Western blotting. Results: Curcumin-treated mice had significantly less CNV area (P<0.05) and CNV leakage (P<0.001) than vehicle-treated mice. Curcumin treatment led to significant inhibition of F4/80 positive macrophages (P<0.05) and GR-1 positive granulocytes infiltration (P<0.05). VEGF mainly expressed in F4/80 positive macrophages in laser injury sites, which was suppressed by curcumin treatment (P<0.01). Curcumin inhibited the RPE-choroid levels of TNF-alpha (P<0.05), MCP-1 (P<0.05) and ICAM-1 (P<0.05), and suppressed the activation of NF-kappa B in nuclear extracts (P<0.05) and the activation of HIF-1 alpha (P<0.05). Conclusion: Curcumin treatment led to the suppression of CNV development together with inflammatory and angiogenic processes including NF-kappa B and HIF-1 alpha activation, the up-regulation of inflammatory and angiogenic cytokines, and infiltrating macrophages and granulocytes. This provides molecular and cellular evidence of the validity of curcumin supplementation as a therapeutic strategy for the suppression of age-related macular degeneration(AMD)-associated CNV.	[Xie, Ping; Zhang, WeiWei; Yuan, Songtao; Yang, Qin; Yuan, DongQing; Wang, Feng; Liu, QingHuai] Nanjing Med Univ, Affiliated Hosp 1, Dept Ophthalmol, Nanjing, Jiangsu, Peoples R China; [Chen, Zhiqiang] JiangSu Prov Official Hosp, Dept Ophthalmol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Liu, QH (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Ophthalmol, Nanjing, Jiangsu, Peoples R China.	liuqh@njmu.edu.cn		Xie, Ping/0000-0003-4257-8970; Liu, Qinghuai/0000-0003-1605-1964	National Basic Research Program of China (973 Program) [2011CB510200]; National Natural Science Foundation of China [81170855, 30973257]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is supported by National Basic Research Program of China (973 Program, No. 2011CB510200 http://www.973.gov.cn/English/Index.aspx) and National Natural Science Foundation of China (No. 81170855 and No. 30973257 http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegri P, 2010, CLIN OPHTHALMOL, V4, P1201, DOI 10.2147/OPTH.S13271; Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Bae MK, 2006, ONCOL REP, V15, P1557; Benny O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012515; Bian ZM, 1999, CURR EYE RES, V18, P349, DOI 10.1076/ceyr.18.5.349.5353; Bian ZM, 2001, INVEST OPHTH VIS SCI, V42, P1660; Caicedo A, 2005, EXP EYE RES, V81, P38, DOI 10.1016/j.exer.2005.01.013; Chen D, 2008, PHARMACOLOGY, V82, P264, DOI 10.1159/000161127; Chen HY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002339; Chen WH, 2005, CHINESE MED J-PEKING, V118, P2052; Curry JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003405; DEODHAR SD, 1980, INDIAN J MED RES, V71, P632; ELNER SG, 1991, LAB INVEST, V64, P819; ELNER SG, 1992, LAB INVEST, V66, P200; Espinosa-Heidmann DG, 2005, EXP EYE RES, V80, P413, DOI 10.1016/j.exer.2004.10.008; Espinosa-Heidmann DG, 2003, INVEST OPHTH VIS SCI, V44, P3586, DOI 10.1167/iovs.03-0038; FERRARA N, 1992, ENDOCR REV, V13, P18, DOI 10.1210/er.13.1.18; Fine SL, 2000, NEW ENGL J MED, V342, P483, DOI 10.1056/NEJM200002173420707; FURIE MB, 1995, AM J PATHOL, V146, P1287; Grossniklaus HE, 2002, MOL VIS, V8, P119; Gukovsky I, 2003, AM J PHYSIOL-GASTR L, V284, pG85, DOI 10.1152/ajpgi.00138.2002; Gupta SK, 2011, J OCUL PHARMACOL TH, V27, P123, DOI 10.1089/jop.2010.0123; Hanai H, 2006, CLIN GASTROENTEROL H, V4, P1502, DOI 10.1016/j.cgh.2006.08.008; Hangai M, 2006, J NEUROIMMUNOL, V171, P45, DOI 10.1016/j.jneuroim.2005.09.018; Hara R, 2010, CURR EYE RES, V35, P1012, DOI 10.3109/02713683.2010.500112; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Heng MCY, 2000, BRIT J DERMATOL, V143, P937, DOI 10.1046/j.1365-2133.2000.03767.x; Holt PR, 2005, DIGEST DIS SCI, V50, P2191, DOI 10.1007/s10620-005-3032-8; Inoue Y, 2007, BRIT J OPHTHALMOL, V91, P1720, DOI 10.1136/bjo.2006.111583; Ishibashi T, 1997, GRAEF ARCH CLIN EXP, V235, P159, DOI 10.1007/BF00941723; Itaya M, 2007, INVEST OPHTH VIS SCI, V48, P5677, DOI 10.1167/iovs.07-0156; Izumi-Nagai K, 2007, ARTERIOSCL THROM VAS, V27, P2555, DOI 10.1161/ATVBAHA.107.151431; Jackson JK, 2006, INFLAMM RES, V55, P168, DOI 10.1007/s00011-006-0067-z; Jain SK, 2009, ANTIOXID REDOX SIGN, V11, P241, DOI 10.1089/ars.2008.2140; Jung HJ, 2010, J BIOL CHEM, V285, P25867, DOI 10.1074/jbc.M110.135632; Kent D, 2003, MOL VIS, V9, P747; Kim JS, 2010, CURR EYE RES, V35, P274, DOI 10.3109/02713680903528345; Kim YS, 2007, J CARDIOVASC PHARM, V50, P41, DOI 10.1097/FJC.0b013e31805559b9; Kowluru RA, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-8; Krzystolik MG, 2002, ARCH OPHTHALMOL-CHIC, V120, P338; Kulkarni AD, 2005, ADV DRUG DELIVER REV, V57, P1994, DOI 10.1016/j.addr.2005.09.003; Kumar A, 1998, BIOCHEM PHARMACOL, V55, P775, DOI 10.1016/S0006-2952(97)00557-1; Kunnumakkara AB, 2008, CANCER LETT, V269, P199, DOI 10.1016/j.canlet.2008.03.009; Kuwabara N, 2006, UROLOGY, V67, P440, DOI 10.1016/j.urology.2005.09.028; Lal B, 2000, PHYTOTHER RES, V14, P443, DOI 10.1002/1099-1573(200009)14:6&lt;443::AID-PTR619&gt;3.0.CO;2-V; Lal B, 1999, PHYTOTHER RES, V13, P318, DOI 10.1002/(SICI)1099-1573(199906)13:4&lt;318::AID-PTR445&gt;3.0.CO;2-7; Larmonier CB, 2011, INFLAMM BOWEL DIS, V17, P503, DOI 10.1002/ibd.21391; Lichtlen P, 2010, INVEST OPHTH VIS SCI, V51, P4738, DOI 10.1167/iovs.09-4890; Lin MK, 2012, INVEST OPHTH VIS SCI, V53, P6197, DOI 10.1167/iovs.11-8936; Luhmann UFO, 2009, INVEST OPHTH VIS SCI, V50, P5934, DOI 10.1167/iovs.09-3462; Madan B, 2003, SHOCK, V19, P91, DOI 10.1097/00024382-200301000-00017; Markomichelakis NN, 2005, AM J OPHTHALMOL, V139, P537, DOI 10.1016/j.ajo.2004.09.058; Moghaddam SJ, 2009, CARCINOGENESIS, V30, P1949, DOI 10.1093/carcin/bgp229; Mrudula T, 2007, BIOCHEM BIOPH RES CO, V361, P528, DOI 10.1016/j.bbrc.2007.07.059; Nagai N, 2006, ARTERIOSCL THROM VAS, V26, P2252, DOI 10.1161/01.ATV.0000240050.15321.fe; Oh H, 1999, INVEST OPHTH VIS SCI, V40, P1891; Olson JL, 2007, ARCH OPHTHALMOL-CHIC, V125, P1221, DOI 10.1001/archopht.125.9.1221; Pan Y, 2012, BRIT J PHARMACOL, V166, P1169, DOI 10.1111/j.1476-5381.2012.01854.x; Regatieri CV, 2009, INVEST OPHTH VIS SCI, V50, P5487, DOI 10.1167/iovs.08-3171; Sakurai E, 2003, INVEST OPHTH VIS SCI, V44, P2743, DOI 10.1167/iovs.02-1246; Sakurai E, 2003, INVEST OPHTH VIS SCI, V44, P3578, DOI 10.1167/iovs.03-0097; Sawatpanich Tarinee, 2010, J Med Assoc Thai, V93 Suppl 2, pS1; Shen WY, 1998, BRIT J OPHTHALMOL, V82, P1063, DOI 10.1136/bjo.82.9.1063; Sheridan CM, 2009, GRAEF ARCH CLIN EXP, V247, P1361, DOI 10.1007/s00417-009-1133-3; Shi X, 2006, EXP EYE RES, V83, P1325, DOI 10.1016/j.exer.2006.07.007; Shoskes D, 2005, TRANSPLANTATION, V80, P1556, DOI 10.1097/01.tp.0000183290.64309.21; Sikora E, 2010, Immun Ageing, V7, P1, DOI 10.1186/1742-4933-7-1; Singh S, 2007, CELL, V130, P765, DOI 10.1016/j.cell.2007.08.024; Soetikno V, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-35; Song SJ, 2008, OPHTHALMIC RES, V40, P35, DOI 10.1159/000111157; Sugimoto H, 1997, DIABETES, V46, P2075, DOI 10.2337/diabetes.46.12.2075; Takahashi M, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/10767; Takehana Y, 1999, INVEST OPHTH VIS SCI, V40, P459; Theodossiadis PG, 2009, AM J OPHTHALMOL, V147, P825, DOI 10.1016/j.ajo.2008.12.004; Tsutsumi C, 2003, J LEUKOCYTE BIOL, V74, P25, DOI 10.1189/jlb.0902436; Woo HM, 2007, LIFE SCI, V80, P926, DOI 10.1016/j.lfs.2006.11.030; Xiong M, 1998, AM J PATHOL, V153, P587, DOI 10.1016/S0002-9440(10)65601-5; Yamada K, 2007, INVEST OPHTH VIS SCI, V48, P1839, DOI 10.1167/iovs.06-1085; Yeh DC, 2004, INVEST OPHTH VIS SCI, V45, P2368, DOI 10.1167/iovs.03-0981; Yoshida T, 2010, FASEB J, V24, P1759, DOI 10.1096/fj.09-145664; Zhang Y, 2011, INT J MOL MED, V27, P87, DOI 10.3892/ijmm.2010.552; Zhong F, 2011, BIOL PHARM BULL, V34, P226, DOI 10.1248/bpb.34.226; Zhou HY, 2011, CURR DRUG TARGETS, V12, P332, DOI 10.2174/138945011794815356; Zhou JH, 2005, MOL VIS, V11, P414	85	25	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53329	10.1371/journal.pone.0053329	http://dx.doi.org/10.1371/journal.pone.0053329			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285282	gold, Green Published, Green Submitted			2022-12-27	WOS:000313051500136
J	Liu, T; Zhou, Y; Chen, L; Chen, W; Liu, L; Shen, X; Zhang, WQ; Zhang, JZ; Yang, Q				Liu, Tian; Zhou, Yong; Chen, Lei; Chen, Wei; Liu, Lin; Shen, Xu; Zhang, Wenqing; Zhang, Jianzhen; Yang, Qing			Structural Insights into Cellulolytic and Chitinolytic Enzymes Revealing Crucial Residues of Insect beta-N-acetyl-D-hexosaminidase	PLOS ONE			English	Article							CATALYTIC MECHANISM; OSTRINIA-FURNACALIS; D-GLUCOSIDASE; PURIFICATION; SEQUENCE; CHITOBIASE; BINDING; GENOME	The chemical similarity of cellulose and chitin supports the idea that their corresponding hydrolytic enzymes would bind beta-1,4-linked glucose residues in a similar manner. A structural and mutational analysis was performed for the plant cellulolytic enzyme BGlu1 from Oryza sativa and the insect chitinolytic enzyme OfHex1 from Ostrinia furnacalis. Although BGlu1 shows little amino-acid sequence or topological similarity with OfHex1, three residues (Trp(490), Glu(328), Val(327) in OfHex1, and Trp(358), Tyr(131) and Ile(179) in BGlu1) were identified as being conserved in the +1 sugar binding site. OfHex1 Glu(328) together with Trp(490) was confirmed to be necessary for substrate binding. The mutant E328A exhibited a 8-fold increment in K-m for (GlcNAc) 2 and a 42-fold increment in K-i for TMG-chitotriomycin. A crystal structure of E328A in complex with TMG-chitotriomycin was resolved at 2.5 angstrom, revealing the obvious conformational changes of the catalytic residues (Glu(368) and Asp(367)) and the absence of the hydrogen bond between E328A and the C3-OH of the +1 sugar. V327G exhibited the same activity as the wild-type, but acquired the ability to efficiently hydrolyse beta-1,2-linked GlcNAc in contrast to the wild-type. Thus, Glu(328) and Val(327) were identified as important for substrate-binding and as glycosidic-bond determinants. A structure-based sequence alignment confirmed the spatial conservation of these three residues in most plant cellulolytic, insect and bacterial chitinolytic enzymes.	[Liu, Tian; Chen, Lei; Chen, Wei; Liu, Lin; Yang, Qing] Dalian Univ Technol, Sch Life Sci & Biotechnol, Dalian, Peoples R China; [Zhou, Yong] Dalian Univ Technol, Sch Software Technol, Dalian, Peoples R China; [Shen, Xu] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 200031, Peoples R China; [Zhang, Wenqing] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Jianzhen] Shanxi Univ, Res Inst Appl Biol, Taiyuan, Peoples R China	Dalian University of Technology; Dalian University of Technology; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Sun Yat Sen University; Shanxi University	Yang, Q (corresponding author), Dalian Univ Technol, Sch Life Sci & Biotechnol, Dalian, Peoples R China.	qingyang@dlut.edu.cn	zhang, wenqing/GYA-0786-2022; Liu, Tian/E-2481-2012; Yang, Qing/GZK-2526-2022	Liu, Tian/0000-0001-9768-5496; Yang, Qing/0000-0001-8623-7532; liu, lin/0000-0002-4248-7377	National Key Project for Basic Research [2010CB126100]; National Natural Science Foundation of China [31070715, 31101671]; National High Technology Research and Development Program of China [2011AA10A204]; National Key Technology RD Program [2011BAE06B05]; Fundamental Research Funds for the Central Universities [DUT11ZD113, DUT11RC(3)73]	National Key Project for Basic Research(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Key Technology RD Program(National Key Technology R&D Program); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The authors acknowledge the financial support provided by the National Key Project for Basic Research (2010CB126100), the National Natural Science Foundation of China (31070715, 31101671), the National High Technology Research and Development Program of China (2011AA10A204), the National Key Technology R&D Program (2011BAE06B05), and the Fundamental Research Funds for the Central Universities (DUT11ZD113, DUT11RC(3)73). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEGUIN P, 1990, ANNU REV MICROBIOL, V44, P219, DOI 10.1146/annurev.mi.44.100190.001251; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cairns JRK, 2010, CELL MOL LIFE SCI, V67, P3389, DOI 10.1007/s00018-010-0399-2; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chuenchor W, 2008, J MOL BIOL, V377, P1200, DOI 10.1016/j.jmb.2008.01.076; Chuenchor W, 2011, J STRUCT BIOL, V173, P169, DOI 10.1016/j.jsb.2010.09.021; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hrmova M, 1996, J BIOL CHEM, V271, P5277, DOI 10.1074/jbc.271.9.5277; Hrmova M, 1998, J BIOL CHEM, V273, P11134, DOI 10.1074/jbc.273.18.11134; Jiang YL, 2011, J BIOL CHEM, V286, P43004, DOI 10.1074/jbc.M111.256578; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Kuntothom T, 2009, ARCH BIOCHEM BIOPHYS, V491, P85, DOI 10.1016/j.abb.2009.09.004; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEAH R, 1995, J BIOL CHEM, V270, P15789, DOI 10.1074/jbc.270.26.15789; Liu JL, 2012, INT J MOL SCI, V13, P4545, DOI 10.3390/ijms13044545; Liu T, 2011, BIOCHEM J, V438, P467, DOI 10.1042/BJ20110390; Liu TA, 2011, J BIOL CHEM, V286, P4049, DOI 10.1074/jbc.M110.184796; Liu T, 2009, PROTEIN EXPRES PURIF, V68, P99, DOI 10.1016/j.pep.2009.06.004; Mark BL, 2001, J BIOL CHEM, V276, P10330, DOI 10.1074/jbc.M011067200; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Opassiri R, 2004, BIOCHEM J, V379, P125, DOI 10.1042/BJ20031485; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Pluvinage B, 2011, STRUCTURE, V19, P1603, DOI 10.1016/j.str.2011.08.011; Sumida T, 2012, ORG BIOMOL CHEM, V10, P2607, DOI 10.1039/c2ob06636j; Tews I, 1996, GENE, V170, P63, DOI 10.1016/0378-1119(95)00848-9; Tews I, 1996, NAT STRUCT BIOL, V3, P638, DOI 10.1038/nsb0796-638; Usuki H, 2011, ORG BIOMOL CHEM, V9, P2943, DOI 10.1039/c0ob01090a; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wang YL, 2012, CHEM BIOL DRUG DES, V79, P572, DOI 10.1111/j.1747-0285.2011.01301.x; Yang Q, 2008, FEBS J, V275, P5690, DOI 10.1111/j.1742-4658.2008.06695.x; Yang Y, 2011, CHEMBIOCHEM, V12, P457, DOI 10.1002/cbic.201000561	37	14	16	1	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52225	10.1371/journal.pone.0052225	http://dx.doi.org/10.1371/journal.pone.0052225			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300622	Green Published, gold, Green Submitted			2022-12-27	WOS:000312829100032
J	Mongraw-Chaffin, ML; Matsushita, K; Brancati, FL; Astor, BC; Coresh, J; Crawford, SO; Schmidt, MI; Hoogeveen, RC; Ballantyne, CM; Young, JH				Mongraw-Chaffin, Morgana L.; Matsushita, Kunihiro; Brancati, Frederick L.; Astor, Brad C.; Coresh, Josef; Crawford, Stephen O.; Schmidt, Maria Ines; Hoogeveen, Ron C.; Ballantyne, Christie M.; Young, Jeffery Hunter			Diabetes Medication Use and Blood Lactate Level among Participants with Type 2 Diabetes: The Atherosclerosis Risk in Communities Carotid MRI Study	PLOS ONE			English	Article							MITOCHONDRIAL DYSFUNCTION; INSULIN-RESISTANCE; PHYSICAL-ACTIVITY; HYPOXIA	Background: The objective of this study is to compare lactate levels between users and non-users of diabetes medications under the hypothesis that the level of lactate is a marker of oxidative capacity. Methods: The cross-sectional data of 493 participants aged 61-84 with type 2 diabetes who participated in the Atherosclerosis Risk in Communities Carotid MRI study were analyzed using survey weighted linear regression. Results: Median plasma lactate level was 8.58 (95% CI: 8.23, 8.87) mg/dl. Comparing users of diabetic medications with non-users, thiazolidinedione use was significantly associated with lower lactate level (7.57 (6.95-8.25) mg/dL vs. 8.78 (8.43-9.14) mg/dL), metformin use with a slightly higher lactate level (9.02 (8.51-9.58) mg/dL vs. 8.36 (7.96-8.77) mg/dL), and sulfonylurea and insulin use were not associated with lactate level. After adjustment for demographic and lifestyle factors, the plasma lactate level for thiazolidinedione users was 15.78% lower than that for non-users (p < 0.001). Considering use of each medication separately and in combination did not change the results. Conclusion: In conclusion, thiazolidinedione use was associated with lower plasma lactate level compared to non-use and metformin use was only marginally associated with a slightly higher lactate level. These results are consistent with the previously demonstrated effects of diabetes medications on oxidative metabolism. Further investigation of the role that diabetes medications play in improvement of oxidative metabolism is warranted.	[Mongraw-Chaffin, Morgana L.; Matsushita, Kunihiro; Brancati, Frederick L.; Astor, Brad C.; Coresh, Josef; Crawford, Stephen O.; Young, Jeffery Hunter] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Brancati, Frederick L.; Coresh, Josef; Young, Jeffery Hunter] Johns Hopkins Med Inst, Dept Med, Baltimore, MD 21205 USA; [Astor, Brad C.] Univ Wisconsin Sch Med & Publ Hlth, Dept Med, Madison, WI USA; [Crawford, Stephen O.] Davita Clin Res Inc, Minneapolis, MN USA; [Schmidt, Maria Ines] Univ Fed Rio Grande do Sul, Sch Med, Porto Alegre, RS, Brazil; [Schmidt, Maria Ines] Univ N Carolina, Dept Epidemiol, Sch Publ Hlth Chapel Hill, Chapel Hill, NC USA; [Hoogeveen, Ron C.; Ballantyne, Christie M.] Baylor Coll Med, Dept Med, Sect Atherosclerosis & Vasc Med, Houston, TX 77030 USA; [Hoogeveen, Ron C.; Ballantyne, Christie M.] Methodist DeBakey Heart Ctr, Ctr Cardiovasc Dis Prevent, Houston, TX USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; University of Wisconsin System; DaVita; Universidade Federal do Rio Grande do Sul; University of North Carolina; University of North Carolina Chapel Hill; Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; Methodist DeBakey Heart & Vascular Center	Mongraw-Chaffin, ML (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA.	mmongraw@jhsph.edu	Schmidt, Maria/V-3196-2019; Iats, Inct/K-2300-2013; Matsushita, Kunihiro/AAJ-5817-2020; Matsushita, Kunihiro/B-1021-2018; Schmidt, Maria Inês/AGP-6441-2022; Ballantyne, Christie/A-6599-2008; Schmidt, Maria Inês/AGT-5691-2022	Matsushita, Kunihiro/0000-0002-7179-718X; Matsushita, Kunihiro/0000-0002-7179-718X; Schmidt, Maria Inês/0000-0002-3837-0731; Hoogeveen, Ron/0000-0003-2399-4653; Ballantyne, Christie/0000-0002-6432-1730; Mongraw-Chaffin, Morgana/0000-0001-6541-7198	National Heart, Lung, and Blood Institute [5T32HL007024, HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C]; National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK 085458]; ARIC [U01HL075572-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL075572, T32HL007024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085458, P30DK079637] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); ARIC; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Heart, Lung, and Blood Institute grant 5T32HL007024 to MMC. The measurement of lactate were supported by National Institute of Diabetes and Digestive and Kidney Diseases grant R01 DK 085458 to JHY. The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts [HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C] with the ARIC carotid MRI examination funded by U01HL075572-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani MA, 2008, CURR DIABETES REP, V8, P173, DOI 10.1007/s11892-008-0030-1; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; Bakerman S., 1984, ABCS INTERPRETIVE LA; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Crawford SO, 2010, INT J EPIDEMIOL, V39, P1647, DOI 10.1093/ije/dyq126; DiGirolamo M, 1989, INT J OBESITY, V13, P394; Dumas JF, 2009, DIABETES METAB, V35, P159, DOI 10.1016/j.diabet.2009.02.002; Hoeks J, 2010, DIABETES, V59, P2117, DOI 10.2337/db10-0519; Holloszy JO, 2009, AM J CLIN NUTR, V89, p463S, DOI 10.3945/ajcn.2008.26717C; Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911; Hsueh WA, 2004, AM J MED, V117, P109, DOI 10.1016/j.amjmed.2004.02.042; Jansen TC, 2009, CRIT CARE MED, V37, P2827, DOI 10.1097/CCM.0b013e3181a98899; JANSSON PA, 1990, DIABETOLOGIA, V33, P253, DOI 10.1007/BF00404805; Li L, 2011, DIABETES, V60, P157, DOI 10.2337/db10-0331; Martens FMAC, 2002, DRUGS, V62, P1463, DOI 10.2165/00003495-200262100-00004; Regazzetti C, 2009, DIABETES, V58, P95, DOI 10.2337/db08-0457; Regensteiner JG, 2005, DIABETES CARE, V28, P2877, DOI 10.2337/diacare.28.12.2877; Reusch JEB, 2003, AM J MED, V115, P69, DOI 10.1016/j.amjmed.2003.09.012; Sabatine MS, 2005, CIRCULATION, V112, P3868, DOI 10.1161/CIRCULATIONAHA.105.569137; Salpeter SR, 2010, COCHRANE DATABASE SY, DOI 10.1002/14651858.00002967.pub4; StataCorp, 2009, STAT STAT SOFTW REL; Stolar MW, 2008, J MANAGE CARE PHARM, V14, pS2; Wasserman BA, 2010, J MAGN RESON IMAGING, V31, P406, DOI 10.1002/jmri.22043; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184	24	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e51237	10.1371/journal.pone.0051237	http://dx.doi.org/10.1371/journal.pone.0051237			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300538	Green Published, gold			2022-12-27	WOS:000313618800013
J	Antonenko, YN; Horner, A; Pohl, P				Antonenko, Yuri N.; Horner, Andreas; Pohl, Peter			Electrostatically Induced Recruitment of Membrane Peptides into Clusters Requires Ligand Binding at Both Interfaces	PLOS ONE			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; GRAMICIDIN CHANNELS; LIPID-BILAYERS; DIFFUSION-COEFFICIENTS; RECEPTOR ACTIVATION; ION CHANNELS; KINETICS; INACTIVATION; ENERGETICS; PHOTOINACTIVATION	Protein recruitment to specific membrane locations may be governed or facilitated by electrostatic attraction, which originates from a multivalent ligand. Here we explored the energetics of a model system in which this simple electrostatic recruitment mechanism failed. That is, basic poly-L-lysine binding to one leaflet of a planar lipid bilayer did not recruit the triply-charged peptide (O-Pyromellitylgramicidin). Clustering was only observed in cases where PLL was bound to both channel ends. Clustering was indicated (i) by the decreased diffusional PLL mobility D-PLL and (ii) by an increased lifetime tau(PLL) of the clustered channels. In contrast, if PLL was bound to only one leaflet, neither D-PLL nor tau(P) changed. Simple calculations suggest that electrostatic repulsion of the unbound ends prevented neighboring OPg dimers from approaching each other. We believe that a similar mechanism may also operate in cell signaling and that it may e. g. contribute to the controversial results obtained for the ligand driven dimerization of G protein-coupled receptors.	[Antonenko, Yuri N.] Moscow MV Lomonosov State Univ, Belozersky Inst Physicochem Biol, Moscow, Russia; [Horner, Andreas; Pohl, Peter] Johannes Kepler Univ Linz, Inst Biophys, A-4040 Linz, Austria	Lomonosov Moscow State University; Johannes Kepler University Linz	Pohl, P (corresponding author), Johannes Kepler Univ Linz, Inst Biophys, A-4040 Linz, Austria.	peter.pohl@jku.at	Horner, Andreas/F-6427-2013; Antonenko, Yuri N/K-1323-2013; Pohl, Peter/A-5361-2008	Horner, Andreas/0000-0002-5328-1745; Pohl, Peter/0000-0002-1792-2314	Upper Austrian government; Austrian Science Fund [W1201]; Russian Foundation for Basic Research [09-04-00890]; Russian-Austria exchange program of the OAAD [15/2006]; Johannes Kepler University	Upper Austrian government; Austrian Science Fund(Austrian Science Fund (FWF)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian-Austria exchange program of the OAAD; Johannes Kepler University	This work was supported by the Upper Austrian government, by the Austrian Science Fund (W1201 to PP), by the Russian Foundation for Basic Research (09-04-00890 to YNA), by the Russian-Austria exchange program of the OAAD (15/2006), and a research fellowship from the Johannes Kepler University to YA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Momani L, 2005, BIOCHEM BIOPH RES CO, V328, P342, DOI 10.1016/j.bbrc.2004.12.170; Andersen OS, 1999, NAT STRUCT BIOL, V6, P609, DOI 10.1038/10648; BAMBERG E, 1974, BIOCHIM BIOPHYS ACTA, V367, P127, DOI 10.1016/0005-2736(74)90037-6; BAMBERG E, 1973, J MEMBRANE BIOL, V11, P177, DOI 10.1007/BF01869820; Benda A, 2003, LANGMUIR, V19, P4120, DOI 10.1021/la0270136; Borisenko V, 2003, BIOPHYS J, V84, P612, DOI 10.1016/S0006-3495(03)74881-4; Carlton JG, 2005, TRENDS CELL BIOL, V15, P540, DOI 10.1016/j.tcb.2005.08.005; CEVC G, 1990, BIOCHIM BIOPHYS ACTA, V1031, P311, DOI 10.1016/0304-4157(90)90015-5; Cornea A, 2001, J BIOL CHEM, V276, P2153, DOI 10.1074/jbc.M007850200; Ehrenberg B, 1998, PHOTOCHEM PHOTOBIOL, V68, P135, DOI 10.1111/j.1751-1097.1998.tb02479.x; Gambhir A, 2004, BIOPHYS J, V86, P2188, DOI 10.1016/S0006-3495(04)74278-2; Gambin Y, 2006, P NATL ACAD SCI USA, V103, P2098, DOI 10.1073/pnas.0511026103; Goforth RL, 2003, J GEN PHYSIOL, V121, P477, DOI 10.1085/jgp.200308797; Golebiewska U, 2006, BIOPHYS J, V91, P588, DOI 10.1529/biophysj.106.081562; Goulian M, 1998, BIOPHYS J, V74, P328, DOI 10.1016/S0006-3495(98)77790-2; Hawtin SR, 2006, J BIOL CHEM, V281, P38478, DOI 10.1074/jbc.M607639200; Horner A, 2012, J BIOL CHEM IN PRESS; Horner A, 2009, BIOPHYS J, V96, P2689, DOI 10.1016/j.bpj.2008.12.3931; Kota Z, 2004, BIOPHYS J, V86, P1521, DOI 10.1016/S0006-3495(04)74220-4; Krylov AV, 1998, FEBS LETT, V440, P235, DOI 10.1016/S0014-5793(98)01462-8; Krylov AV, 2002, J MEMBRANE BIOL, V189, P119, DOI 10.1007/s00232-002-1007-7; Krylov AV, 2000, BBA-BIOMEMBRANES, V1509, P373, DOI 10.1016/S0005-2736(00)00320-5; KUNZ L, 1995, BIOCHEMISTRY-US, V34, P11895, DOI 10.1021/bi00037a030; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Lougheed T, 2001, BIOCONJUGATE CHEM, V12, P594, DOI 10.1021/bc010006t; Lundbaek JA, 2010, J R SOC INTERFACE, V7, P373, DOI 10.1098/rsif.2009.0443; Maier B, 1999, PHYS REV LETT, V82, P1911, DOI 10.1103/PhysRevLett.82.1911; Martinac B, 2002, P NATL ACAD SCI USA, V99, P4308, DOI 10.1073/pnas.072632899; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; Milligan G, 2004, MOL PHARMACOL, V66, P1, DOI 10.1124/mol.104.000497.; Missner A, 2008, BBA-BIOMEMBRANES, V1778, P2154, DOI 10.1016/j.bbamem.2008.05.001; Nielsen C, 1998, BIOPHYS J, V74, P1966, DOI 10.1016/S0006-3495(98)77904-4; Petrasek Z, 2008, BIOPHYS J, V94, P1437, DOI 10.1529/biophysj.107.108811; Przybylo M, 2006, LANGMUIR, V22, P9096, DOI 10.1021/la061934p; Rokitskaya TI, 2000, BIOPHYS J, V78, P2572, DOI 10.1016/S0006-3495(00)76801-9; Rokitskaya TI, 1996, BBA-BIOENERGETICS, V1275, P221, DOI 10.1016/0005-2728(96)00025-4; Rokitskaya TI, 2003, J GEN PHYSIOL, V121, P463, DOI 10.1085/jgp.200208780; Sackmann E, 2012, LEHRBUCH BIOPHYSIK; SAFFMAN PG, 1975, P NATL ACAD SCI USA, V72, P3111, DOI 10.1073/pnas.72.8.3111; Serowy S, 2003, BIOPHYS J, V84, P1031, DOI 10.1016/S0006-3495(03)74919-4; Sokolov VS, 2009, BIOPHYS J, V96, P77, DOI 10.1529/biophysj.108.135145; Tian AW, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.208102; Wess J, 1997, FASEB J, V11, P346, DOI 10.1096/fasebj.11.5.9141501; Woolf TB, 1996, PROTEINS, V24, P92	44	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52839	10.1371/journal.pone.0052839	http://dx.doi.org/10.1371/journal.pone.0052839			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285199	Green Published, Green Submitted, gold			2022-12-27	WOS:000313158800099
J	Bygrave, H; Mtangirwa, J; Ncube, K; Ford, N; Kranzer, K; Munyaradzi, D				Bygrave, Helen; Mtangirwa, Judith; Ncube, Kwenzakwenkosi; Ford, Nathan; Kranzer, Katharina; Munyaradzi, Dhodho			Antiretroviral Therapy Outcomes among Adolescents and Youth in Rural Zimbabwe	PLOS ONE			English	Article							YOUNG-ADULTS; ADHERENCE; CARE	Around 2 million adolescents and 3 million youth are estimated to be living with HIV worldwide. Antiretroviral outcomes for this group appear to be worse compared to adults. We report antiretroviral therapy outcomes from a rural setting in Zimbabwe among patients aged 10-30 years who were initiated on ART between 2005 and 2008. The cohort was stratified into four age groups: 10-15 (young adolescents) 15.1-19 years (adolescents), 19.1-24 years (young adults) and 24.1-29.9 years (older adults). Survival analysis was used to estimate rates of deaths and loss to follow-up stratified by age group. Endpoints were time from ART initiation to death or loss to follow-up. Follow-up of patients on continuous therapy was censored at date of transfer, or study end (31 December 2008). Sex-adjusted Cox proportional hazards models were used to estimate hazard ratios for different age groups. 898 patients were included in the analysis; median duration on ART was 468 days. The risk of death were highest in adults compared to young adolescents (aHR 2.25, 95% CI 1.17-4.35). Young adults and adolescents had a 2-3 times higher risk of loss to follow-up compared to young adolescents. When estimating the risk of attrition combining loss to follow-up and death, young adults had the highest risk (aHR 2.70, 95% CI 1.62-4.52). This study highlights the need for adapted adherence support and service delivery models for both adolescents and young adults. Citation: Bygrave H, Mtangirwa J, Ncube K, Ford N, Kranzer K, et al. (2012) Antiretroviral Therapy Outcomes among Adolescents and Youth in Rural Zimbabwe. PLoS ONE 7(12): e52856. doi:10.1371/journal.pone.0052856	[Bygrave, Helen; Mtangirwa, Judith; Ford, Nathan] Medecins Sans Frontieres, So Africa Med Unit, Cape Town, South Africa; [Ncube, Kwenzakwenkosi] Minist Hlth & Child Welf Zimbabwe, Buhera Dist, Zimbabwe; [Ford, Nathan] Univ Cape Town, Ctr Infect Dis Epidemiol & Res, ZA-7925 Cape Town, South Africa; [Kranzer, Katharina] London Sch Hyg & Trop Med, Clin Res Unit, London WC1, England; [Munyaradzi, Dhodho] Medecins Sans Frontieres, Med Unit, Harare, Zimbabwe	University of Cape Town; University of London; London School of Hygiene & Tropical Medicine	Bygrave, H (corresponding author), Medecins Sans Frontieres, So Africa Med Unit, Cape Town, South Africa.	Helen.bygrave@joburg.msf.org	Kranzer, Katharina/O-8845-2014	Kranzer, Katharina/0000-0001-5691-7270	M�decins Sans Fronti�res [OCA_pilot_00_Bygrave] Funding Source: researchfish	M�decins Sans Fronti�res		[Anonymous], 2011, OPPORTUNITY CRISIS P; Arrive E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033690; Bakanda C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019261; Belzer ME, 1999, J ADOLESCENT HEALTH, V25, P316, DOI 10.1016/S1054-139X(99)00052-X; Charles M, 2008, B WORLD HEALTH ORGAN, V86, P970, DOI 10.2471/BLT.07.050120; Cremin I, 2009, SEX TRANSM INFECT, V85, pI34, DOI 10.1136/sti.2008.033431; Demissie S, 2003, STAT MED, V22, P545, DOI 10.1002/sim.1340; Flynn PM, 2007, AIDS RES HUM RETROV, V23, P1208, DOI 10.1089/aid.2006.0290; Greenland S, 1995, AM J EPIDEMIOL, V142, P1255, DOI 10.1093/oxfordjournals.aje.a117592; Khan M, 2009, ARCH DIS CHILD, V94, P970, DOI 10.1136/adc.2008.156232; Knol MJ, 2010, J CLIN EPIDEMIOL, V63, P728, DOI 10.1016/j.jclinepi.2009.08.028; Maturo D, 2011, J PEDIATR HEALTH CAR, V25, P16, DOI 10.1016/j.pedhc.2009.12.005; Moodley K, 2006, SAMJ S AFR MED J, V96, pA201; Nachega JB, 2011, PATIENT PREFER ADHER, V5, P357, DOI 10.2147/PPA.S22771; Nachega JB, 2009, JAIDS-J ACQ IMM DEF, V51, P65, DOI 10.1097/QAI.0b013e318199072e; Report G., 2010, UNAIDS REPORT GLOBAL; Ryscavage PA, 2011, JAIDS-J ACQ IMM DEF, V58, P193, DOI [10.1097/QAI.0B013E31822D7564, 10.1097/QAI.0b013e31822d7564]; Van Cutsem G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014684	18	59	59	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52856	10.1371/journal.pone.0052856	http://dx.doi.org/10.1371/journal.pone.0052856			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285204	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000312794500251
J	Magen, S; Magnani, R; Haziza, S; Hershkovitz, E; Houtz, R; Cambi, F; Parvari, R				Magen, Sophia; Magnani, Roberta; Haziza, Sitvanit; Hershkovitz, Eli; Houtz, Robert; Cambi, Franca; Parvari, Ruti			Human Calmodulin Methyltransferase: Expression, Activity on Calmodulin, and Hsp90 Dependence	PLOS ONE			English	Article							MOLECULAR CHAPERONE; MITOCHONDRIAL DISEASE; KINASE ACTIVATION; METHYLATION; BINDING; PURIFICATION; DELETION; COMPLEX; CLIENT; CANCER	Deletion of the first exon of calmodulin-lysine N-methyltransferase (CaM KMT, previously C2orf34) has been reported in two multigene deletion syndromes, but additional studies on the gene have not been reported. Here we show that in the cells from 2p21 deletion patients the loss of CaM KMT expression results in accumulation of hypomethylated calmodulin compared to normal controls, suggesting that CaM KMT is essential for calmodulin methylation and there are no compensatory mechanisms for CaM methylation in humans. We have further studied the expression of this gene at the transcript and protein levels. We have identified 2 additional transcripts in cells of the 2p21 deletion syndrome patients that start from alternative exons positioned outside the deletion region. One of them starts in the 2nd known exon, the other in a novel exon. The transcript starting from the novel exon was also identified in a variety of tissues from normal individuals. These new transcripts are not expected to produce proteins. Immunofluorescent localization of tagged CaM KMT in HeLa cells indicates that it is present in both the cytoplasm and nucleus of cells whereas the short isoform is localized to the Golgi apparatus. Using Western blot analysis we show that the CaM KMT protein is broadly expressed in mouse tissues. Finally we demonstrate that the CaM KMT interacts with the middle portion of the Hsp90 molecular chaperon and is probably a client protein since it is degraded upon treatment of cells with the Hsp90 inhibitor geldanamycin. These findings suggest that the CaM KMT is the major, possibly the single, methyltransferase of calmodulin in human cells with a wide tissue distribution and is a novel Hsp90 client protein. Thus our data provides basic information for a gene potentially contributing to the patient phenotype of two contiguous gene deletion syndromes.	[Magen, Sophia; Haziza, Sitvanit; Parvari, Ruti] Ben Gurion Univ Negev, Fac Hlth Sci, Shraga Segal Dept Microbiol Virol & Genet, Beer Sheva, Israel; [Magnani, Roberta; Houtz, Robert] Univ Kentucky, Dept Hort, Lexington, KY 40546 USA; [Hershkovitz, Eli] Soroka Med Ctr, Pediat Endocrinol & Metab Unit, IL-84101 Beer Sheva, Israel; [Cambi, Franca] Univ Kentucky, Dept Neurol, Lexington, KY 40536 USA; [Parvari, Ruti] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel	Ben Gurion University; University of Kentucky; Ben Gurion University; Soroka Medical Center; University of Kentucky; Ben Gurion University	Parvari, R (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Shraga Segal Dept Microbiol Virol & Genet, Beer Sheva, Israel.	ruthi@bgu.ac.il	Herskowitz, eli/F-1922-2012	Herskowitz, eli/0000-0003-1624-1960	Israel Science Foundation [787/05]	Israel Science Foundation(Israel Science Foundation)	This study was supported by Grant 787/05 of the Israel Science Foundation to RP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BarPeled M, 1996, ANAL BIOCHEM, V241, P140, DOI 10.1006/abio.1996.0390; Buchner J, 1999, TRENDS BIOCHEM SCI, V24, P136, DOI 10.1016/S0968-0004(99)01373-0; Catlett MG, 2006, J BIOL CHEM, V281, P33739, DOI 10.1074/jbc.M603847200; Chabrol B, 2008, J MED GENET, V45, P314, DOI 10.1136/jmg.2007.055475; Chin HG, 2007, NUCLEIC ACIDS RES, V35, P7313, DOI 10.1093/nar/gkm726; Faas GC, 2011, NAT NEUROSCI, V14, P301, DOI 10.1038/nn.2746; de Barreda EG, 2011, BIOCHEM BIOPH RES CO, V408, P500, DOI 10.1016/j.bbrc.2011.04.082; GOPALAKRISHNA R, 1982, BIOCHEM BIOPH RES CO, V104, P830, DOI 10.1016/0006-291X(82)90712-4; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; Hawle P, 2006, MOL CELL BIOL, V26, P8385, DOI 10.1128/MCB.02188-05; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kozak M, 1996, MAMM GENOME, V7, P563, DOI 10.1007/s003359900171; Lai DZ, 2009, P NATL ACAD SCI USA, V106, P1169, DOI 10.1073/pnas.0811274106; Magnani R, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1044; MOLLA A, 1981, J BIOL CHEM, V256, P15; OH SH, 1990, PLANT PHYSIOL, V93, P880, DOI 10.1104/pp.93.3.880; OH SH, 1992, ARCH BIOCHEM BIOPHYS, V297, P28, DOI 10.1016/0003-9861(92)90636-B; Panina S, 2012, J BIOL CHEM, V287, P18173, DOI 10.1074/jbc.M112.339382; Parvari R, 2005, GENOMICS, V86, P195, DOI 10.1016/j.ygeno.2005.04.001; Parvari R, 2001, AM J HUM GENET, V69, P869, DOI 10.1086/323624; Parvari R, 2007, EUR J HUM GENET, V15, P997, DOI 10.1038/sj.ejhg.5201894; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; ROBERTS DM, 1986, J BIOL CHEM, V261, P1491; ROWE PM, 1986, J BIOL CHEM, V261, P7060; Sampath SC, 2007, MOL CELL, V27, P596, DOI 10.1016/j.molcel.2007.06.026; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Shames DS, 2008, P NATL ACAD SCI USA, V105, P1389, DOI 10.1073/pnas.0711993105; Sharp S, 2006, ADV CANCER RES, V95, P323, DOI 10.1016/S0065-230X(06)95009-X; Siddique A, 2011, FEBS J, V278, P2055, DOI 10.1111/j.1742-4658.2011.08121.x; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; Sugiana C, 2008, AM J HUM GENET, V83, P468, DOI 10.1016/j.ajhg.2008.09.009; Sutherland BW, 2008, J MASS SPECTROM, V43, P699, DOI 10.1002/jms.1415; SZILAK L, 1994, NUCLEIC ACIDS RES, V22, P2876, DOI 10.1093/nar/22.15.2876; Taherian A, 2008, BIOCHEM CELL BIOL, V86, P37, DOI [10.1139/O07-154, 10.1139/o07-154]; Takemori N, 2007, PROTEOMICS, V7, P2651, DOI 10.1002/pmic.200700343; Tian GL, 2006, P NATL ACAD SCI USA, V103, P13491, DOI 10.1073/pnas.0602798103; Vaughan CK, 2010, NAT STRUCT MOL BIOL, V17, P1400, DOI 10.1038/nsmb1210-1400; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Williamson EA, 2008, NUCLEIC ACIDS RES, V36, P5822, DOI 10.1093/nar/gkn560; Zhang MH, 2006, MOL CELL BIOCHEM, V281, P111, DOI 10.1007/s11010-006-0638-x	41	8	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52425	10.1371/journal.pone.0052425	http://dx.doi.org/10.1371/journal.pone.0052425			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285036	Green Submitted, Green Published, gold			2022-12-27	WOS:000312794500164
J	Cao, MH; Li, YY; Xu, J; Feng, YJ; Lin, XH; Li, K; Han, T; Chen, CJ				Cao, Ming-Hua; Li, Yong-yu; Xu, Jing; Feng, Ya-jing; Lin, Xu-hong; Li, Kun; Han, Tong; Chen, Chang-Jie			Cannabinoid HU210 Protects Isolated Rat Stomach against Impairment Caused by Serum of Rats with Experimental Acute Pancreatitis	PLOS ONE			English	Article							ASCITIC FLUID; ENDOCANNABINOID SYSTEM; ACINAR-CELLS; INFLAMMATION; NECROSIS; DISEASE; INJURY; PATHOPHYSIOLOGY; SOMATOSTATIN; INHIBITION	Acute pancreatitis (AP), especially severe acute pancreatitis often causes extra-pancreatic complications, such as acute gastrointestinal mucosal lesion (AGML) which is accompanied by a considerably high mortality, yet the pathogenesis of AP-induced AGML is still not fully understood. In this report, we investigated the alterations of serum components and gastric endocrine and exocrine functions in rats with experimental acute pancreatitis, and studied the possible contributions of these alterations in the pathogenesis of AGML. In addition, we explored the intervention effects of cannabinoid receptor agonist HU210 and antagonist AM251 on isolated and serum-perfused rat stomach. Our results showed that the AGML occurred after 5 h of AP replication, and the body homeostasis was disturbed in AP rat, with increased levels of pancreatic enzymes, lipopolysaccharide (LPS), proinflammtory cytokines and chemokines in the blood, and an imbalance of the gastric secretion function. Perfusing the isolated rat stomach with the AP rat serum caused morphological changes in the stomach, accompanied with a significant increment of pepsin and [H+] release, and increased gastrin and decreased somatostatin secretion. HU210 reversed the AP-serum-induced rat pathological alterations, including the reversal of transformation of the gastric morphology to certain degree. The results from this study prove that the inflammatory responses and the imbalance of the gastric secretion during the development of AP are responsible for the pathogenesis of AGML, and suggest the therapeutic potential of HU210 for AGML associated with acute pancreatitis.	[Cao, Ming-Hua; Li, Yong-yu; Xu, Jing; Feng, Ya-jing; Lin, Xu-hong; Li, Kun; Han, Tong; Chen, Chang-Jie] Tongji Univ, Inst Digest Dis, Dept Pathophysiol, Sch Med, Shanghai 200092, Peoples R China	Tongji University	Li, YY (corresponding author), Tongji Univ, Inst Digest Dis, Dept Pathophysiol, Sch Med, Shanghai 200092, Peoples R China.	liyongyu@tongji.edu.cn	xu, jing/GRR-8698-2022		National Natural Science Foundation of China [81270477, 81141050]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant No. 81270477 and 81141050 to Dr. Yong-yu Li). http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adami M, 2002, BRIT J PHARMACOL, V135, P1598, DOI 10.1038/sj.bjp.0704625; AHO HJ, 1983, EUR SURG RES, V15, P28, DOI 10.1159/000128330; Alhamoruni A, 2012, BRIT J PHARMACOL, V165, P2598, DOI 10.1111/j.1476-5381.2011.01589.x; Andican G, 2005, WORLD J GASTROENTERO, V11, P2340, DOI 10.3748/wjg.v11.i15.2340; Banks PA, 2006, AM J GASTROENTEROL, V101, P2379, DOI 10.1111/j.1572-0241.2006.00856.x; Browne GW, 2006, WORLD J GASTROENTERO, V12, P7087, DOI 10.3748/wjg.v12.i44.7087; Chen TA, 2007, J CLIN GASTROENTEROL, V41, P630, DOI 10.1097/01.mcg.0000225638.37533.8c; Coruzzi G, 1999, N-S ARCH PHARMACOL, V360, P715, DOI 10.1007/s002109900135; Dembinski A, 2006, J PHYSIOL PHARMACOL, V57, P137; Di Marzo V, 2009, PHARMACOL RES, V60, P77, DOI 10.1016/j.phrs.2009.02.010; Frossard JL, 2008, LANCET, V371, P143, DOI 10.1016/S0140-6736(08)60107-5; Germano MP, 2001, N-S ARCH PHARMACOL, V363, P241, DOI 10.1007/s002100000360; Lee KM, 2011, WORLD J GASTROENTERO, V17, P1058, DOI 10.3748/wjg.v17.i8.1058; Li XL, 2009, CELL STRESS CHAPERON, V14, P199, DOI 10.1007/s12192-008-0074-9; Li YY, 2010, CELL STRESS CHAPERON, V15, P583, DOI 10.1007/s12192-010-0170-5; Li YY, 2009, J GASTROEN HEPATOL, V24, P155, DOI 10.1111/j.1440-1746.2008.05592.x; Li YY, 2003, WORLD J GASTROENTERO, V9, P129, DOI 10.3748/wjg.v9.i1.129; Lin XH, 2011, NEUROGASTROENT MOTIL, V23, P862, DOI 10.1111/j.1365-2982.2011.01742.x; Masamune A, 1999, PANCREAS, V18, P141, DOI 10.1097/00006676-199903000-00005; Massa F, 2004, J CLIN INVEST, V113, P1202, DOI 10.1172/JCI200419465; Massa F, 2005, J MOL MED, V83, P944, DOI 10.1007/s00109-005-0698-5; Michalski CW, 2007, GASTROENTEROLOGY, V132, P1968, DOI 10.1053/j.gastro.2007.02.035; Muddana V, 2009, AM J GASTROENTEROL, V104, P164, DOI 10.1038/ajg.2008.66; Nathan JD, 2002, AM J PHYSIOL-GASTR L, V283, pG938, DOI 10.1152/ajpgi.00105.2002; Pacher P, 2008, BRIT J PHARMACOL, V153, P252, DOI 10.1038/sj.bjp.0707582; Pagotto U, 2006, ENDOCR REV, V27, P73, DOI 10.1210/er.2005-0009; Ramudo L, 2005, CRIT CARE MED, V33, P143, DOI 10.1097/01.CCM.0000150654.13653.5B; Sathyanarayan G, 2007, J GASTROEN HEPATOL, V22, P550, DOI 10.1111/j.1440-1746.2006.04752.x; Seerden TC, 2005, NEUROGASTROENT MOTIL, V17, P671, DOI 10.1111/j.1365-2982.2005.00689.x; Storr MA, 2007, CURR OPIN PHARMACOL, V7, P575, DOI 10.1016/j.coph.2007.08.008; Sun FP, 2002, WORLD J GASTROENTERO, V8, P375; Tyler K, 2000, EUR J PHARMACOL, V409, P207, DOI 10.1016/S0014-2999(00)00843-8; Ueda T, 2002, SURGERY, V131, P66, DOI 10.1067/msy.2002.118317; Yang J, 2003, J GASTROINTEST SURG, V7, P200, DOI 10.1016/S1091-255X(02)00134-8	34	5	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52921	10.1371/journal.pone.0052921	http://dx.doi.org/10.1371/journal.pone.0052921			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285225	Green Submitted, Green Published, gold			2022-12-27	WOS:000313051500080
J	Forrester, HB; Li, J; Hovan, D; Ivashkevich, AN; Sprung, CN				Forrester, Helen B.; Li, Jason; Hovan, Daniel; Ivashkevich, Alesia N.; Sprung, Carl N.			DNA Repair Genes: Alternative Transcription and Gene Expression at the Exon Level in Response to the DNA Damaging Agent, Ionizing Radiation	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; RIBONUCLEOTIDE REDUCTASE GENE; HUMAN LYMPHOBLASTOID-CELLS; DOUBLE-STRAND BREAKS; XERODERMA-PIGMENTOSUM; TARGETED DISRUPTION; HUMAN FIBROBLASTS; CANCER-PATIENTS; EMBRYONIC MICE; COLON-CANCER	DNA repair is an essential cellular process required to maintain genomic stability. Every cell is subjected to thousands of DNA lesions daily under normal physiological conditions. Ionizing radiation (IR) is a major DNA damaging agent that can be produced by both natural and man-made sources. A common source of radiation exposure is through its use in medical diagnostics or treatments such as for cancer radiotherapy where relatively high doses are received by patients. To understand the detailed DNA repair gene transcription response to high dose IR, gene expression exon array studies have been performed and the response to radiation in two divergent cell types, lymphoblastoid cell lines and primary fibroblasts, has been examined. These exon arrays detect expression levels across the entire gene, and have the advantage of high sensitivity and the ability to identify alternative transcripts. We found a selection of DNA repair genes, including some not previously reported, that are modulated in response to radiation. Detailed dose and time course kinetics of DNA repair transcription was conducted and results have been validated utilizing PCR methods. Alternative transcription products in response to IR were identified in several DNA repair genes including RRM2B and XPC where alternative initiation sites were found. These investigations have advanced the knowledge about the transcriptional response of DNA repair.	[Forrester, Helen B.; Hovan, Daniel; Ivashkevich, Alesia N.; Sprung, Carl N.] Monash Univ, Ctr Innate Immun & Infect Dis, Monash Inst Med Res, Clayton, Vic, Australia; [Li, Jason] Peter MacCallum Canc Ctr, Div Res, Melbourne, Vic, Australia	Monash University; Peter Maccallum Cancer Center	Sprung, CN (corresponding author), Monash Univ, Ctr Innate Immun & Infect Dis, Monash Inst Med Res, Clayton, Vic, Australia.	Carl.Sprung@med.monash.edu.au		Li, Jason/0000-0002-1150-3549	Collaborative Cancer Research Scheme [1002743]; Australian Government Department of Health and Ageing; Cancer Australia; Australian National Health and Medical Research Council [145780, 288713]; Australian National Breast Cancer Foundation [PG-08-06]; National Institutes of Health [5U19AI067773-07]; Victorian Government's Operational Infrastructure Support Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067773] Funding Source: NIH RePORTER	Collaborative Cancer Research Scheme; Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); Cancer Australia; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian National Breast Cancer Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Victorian Government's Operational Infrastructure Support Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was supported through the 2010 round of the priority-driven Collaborative Cancer Research Scheme (grant 1002743) and funded by the Australian Government Department of Health and Ageing with the assistance of Cancer Australia. Also, this work was supported by the Australian National Health and Medical Research Council (grant numbers 145780, 288713; http://www.nhmrc.gov.au/); the Australian National Breast Cancer Foundation (grant PG-08-06; http://www.nbcf.org.au/); and the National Institutes of Health (grant 5U19AI067773-07). Support was also provided by the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbaszadeh F, 2010, J MED GENET, V47, P176, DOI 10.1136/jmg.2009.068866; Amundson SA, 2000, RADIAT RES, V154, P342, DOI 10.1667/0033-7587(2000)154[0342:IOPMBI]2.0.CO;2; Amundson SA, 2002, CANCER BIOL THER, V1, P145, DOI 10.4161/cbt.59; BARAK Y, 1994, GENE DEV, V8, P1739, DOI 10.1101/gad.8.15.1739; Barnes DE, 1998, CURR BIOL, V8, P1395, DOI 10.1016/S0960-9822(98)00021-9; Batty D, 2000, J MOL BIOL, V300, P275, DOI 10.1006/jmbi.2000.3857; Berneburg M, 2001, ADV GENET, V43, P71, DOI 10.1016/S0065-2660(01)43004-5; Bernstein C, 2002, MUTAT RES-REV MUTAT, V511, P145, DOI 10.1016/S1383-5742(02)00009-1; Bohr VA, 1999, BIOCHIMIE, V81, P155, DOI 10.1016/S0300-9084(99)80048-0; Bunick CG, 2006, BIOCHEMISTRY-US, V45, P14965, DOI 10.1021/bi061370o; Buterin T, 2005, CHEM BIOL, V12, P913, DOI 10.1016/j.chembiol.2005.06.011; Cleaver JE, 2009, NAT REV GENET, V10, P756, DOI 10.1038/nrg2663; D'Andrea AD, 2010, NEW ENGL J MED, V362, P1909, DOI 10.1056/NEJMra0809889; Ding LH, 2005, RADIAT RES, V164, P523, DOI 10.1667/RR3350.1; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; Fousteri M, 2008, CELL RES, V18, P73, DOI 10.1038/cr.2008.6; GONDA DK, 1989, J BIOL CHEM, V264, P16700; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Jen KY, 2003, GENOME RES, V13, P2092, DOI 10.1101/gr.1240103; Kimura T, 2003, CANCER SCI, V94, P431, DOI 10.1111/j.1349-7006.2003.tb01460.x; Kis E, 2006, INT J RADIAT ONCOL, V66, P1506, DOI 10.1016/j.ijrobp.2006.08.004; Lee TI, 2000, ANNU REV GENET, V34, P77, DOI 10.1146/annurev.genet.34.1.77; LEGERSKI R, 1992, NATURE, V359, P70, DOI 10.1038/359070a0; Lehmann AR, 2003, BIOCHIMIE, V85, P1101, DOI 10.1016/j.biochi.2003.09.010; Leong T, 2000, INT J RADIAT ONCOL, V48, P959, DOI 10.1016/S0360-3016(00)00728-8; Liu G, 2006, MOL CELL BIOL, V26, P1398, DOI 10.1128/MCB.26.4.1398-1413.2006; Long XH, 2007, INT J MOL MED, V19, P607; Nakano K, 2000, ONCOGENE, V19, P4283, DOI 10.1038/sj.onc.1203774; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; Paul S, 2008, INT J RADIAT ONCOL, V71, P1236, DOI 10.1016/j.ijrobp.2008.03.043; Pierce AJ, 2001, TRENDS CELL BIOL, V11, pS52, DOI 10.1016/S0962-8924(01)02149-3; Radhakrishnan SK, 2006, ONCOGENE, V25, P1812, DOI 10.1038/sj.onc.1209195; Riballo E, 1999, CURR BIOL, V9, P699, DOI 10.1016/S0960-9822(99)80311-X; Riches LC, 2008, MUTAGENESIS, V23, P331, DOI 10.1093/mutage/gen039; Rieger KE, 2004, NUCLEIC ACIDS RES, V32, P4786, DOI 10.1093/nar/gkh783; RILEY PA, 1994, INT J RADIAT BIOL, V65, P27, DOI 10.1080/09553009414550041; Severin DM, 2001, INT J RADIAT ONCOL, V50, P1323, DOI 10.1016/S0360-3016(01)01608-X; Sprung CN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025758; Tachiiri S, 2006, INT J RADIAT ONCOL, V64, P272, DOI 10.1016/j.ijrobp.2005.08.030; Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506; Thut CJ, 1997, GENE DEV, V11, P1974, DOI 10.1101/gad.11.15.1974; Tsai MH, 2006, ONCOGENE, V25, P622, DOI 10.1038/sj.onc.1209082; Tsuzuki T, 1996, P NATL ACAD SCI USA, V93, P6236, DOI 10.1073/pnas.93.13.6236; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang QE, 2012, CANCER RES, V72, P666, DOI 10.1158/0008-5472.CAN-11-2774; Wood RD, 2005, MUTAT RES-FUND MOL M, V577, P275, DOI 10.1016/j.mrfmmm.2005.03.007; Wood RD, 2001, SCIENCE, V291, P1284, DOI 10.1126/science.1056154; Xu J, 1999, MOL CELL BIOL, V19, P12; Xue LJ, 2007, CANCER RES, V67, P16, DOI 10.1158/0008-5472.CAN-06-3200; ZAUBERMAN A, 1995, NUCLEIC ACIDS RES, V23, P2584, DOI 10.1093/nar/23.14.2584	51	24	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53358	10.1371/journal.pone.0053358	http://dx.doi.org/10.1371/journal.pone.0053358			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285288	Green Submitted, gold, Green Published			2022-12-27	WOS:000313051500143
J	Jung, CH; Lee, WJ; Hwang, JY; Lee, MJ; Seol, SM; Kim, YM; La Lee, Y; Kim, HS; Kim, MS; Park, JY				Jung, Chang Hee; Lee, Woo Je; Hwang, Jenie Yoonoo; Lee, Min Jung; Seol, So Mi; Kim, Yun Mi; La Lee, Yoo; Kim, Hyun Sik; Kim, Min-Seon; Park, Joong-Yeol			Vaspin Increases Nitric Oxide Bioavailability through the Reduction of Asymmetric Dimethylarginine in Vascular Endothelial Cells	PLOS ONE			English	Article							NF-KAPPA-B; INSULIN SENSITIVITY; STAT3; DYSFUNCTION; MIGRATION; GENE; PHOSPHORYLATION; ADIPOCYTOKINE; MACROPHAGES; RESISTANCE	Vaspin is an adipocytokine recently identified in the visceral adipose tissue of diabetic rats and having anti-diabetic effects. We have recently shown that vaspin has anti-atherogenic effect through Akt-mediated inhibition of endothelial cell apoptosis. Decreased activity of endothelial nitric oxide synthase (eNOS) plays an important role in the pathogenesis of atherosclerosis. Asymmetric dimethylarginine (ADMA) is a well-known endogenous competitive inhibitor of eNOS and risk factor of cardiovascular diseases. The aim of this study was to examine whether vaspin might protect against atherosclerosis through its beneficial effects on the ADMA-eNOS system. Treatment of vaspin significantly increased NO secretion from endothelial cells and isolated aorta from Sprague-Dawley (SD) rats. Furthermore, treatment of vaspin prevented fatty acid-induced decrease in endothelium-dependent vasorelaxation in isolated aorta of SD rat. For the mechanism of vaspin-induced NO biosynthesis, vaspin activated the STAT3 signaling pathway and stimulated eNOS phosphorylation (Ser 1177), a marker of eNOS activation, through STAT3-dependent mechanism. Furthermore, vaspin treatment increased the expression of dimethylarginine dimethylaminohydrolase (DDAH) II, the responsible enzyme for the degradation of ADMA, leading to a reduction in ADMA levels. Vaspin-induced increase in DDAH II gene expression was through STAT3-mediated stimulation of DDAH II promoter activity. These results suggest that vaspin increases eNOS activity by reducing ADMA level through STAT3-mediated regulation of DDAH II expression. Our findings provide a novel molecular mechanism of antiatherogenic actions of vaspin.	[Jung, Chang Hee; Lee, Woo Je; Hwang, Jenie Yoonoo; Lee, Min Jung; Kim, Min-Seon; Park, Joong-Yeol] Univ Ulsan, Coll Med, Dept Internal Med, Seoul, South Korea; [Seol, So Mi; Kim, Yun Mi; La Lee, Yoo; Kim, Hyun Sik] Univ Ulsan, Coll Med, Asan Inst Life Sci, Seoul, South Korea	University of Ulsan; University of Ulsan	Park, JY (corresponding author), Univ Ulsan, Coll Med, Dept Internal Med, Seoul, South Korea.	jypark@amc.seoul.kr	Jung, Chang Hee/AAU-7897-2020	Jung, Chang Hee/0000-0003-4043-2396	Asan Institute of Life Sciences, Republic of Korea [2011-122, 2012-122]	Asan Institute of Life Sciences, Republic of Korea	This work was supported by grants (2011-122, 2012-122) from the Asan Institute of Life Sciences, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achan V, 2002, CIRC RES, V90, P764, DOI 10.1161/01.RES.0000014450.40853.2B; Andrew PJ, 1999, CARDIOVASC RES, V43, P521, DOI 10.1016/S0008-6363(99)00115-7; Boger RH, 1998, CIRCULATION, V98, P1842, DOI 10.1161/01.CIR.98.18.1842; Boger RH, 2003, CLIN CHEM LAB MED, V41, P1467, DOI 10.1515/CCLM.2003.225; Burdelya L, 2005, J IMMUNOL, V174, P3925, DOI 10.4049/jimmunol.174.7.3925; Chan NN, 2002, DIABETOLOGIA, V45, P1609, DOI 10.1007/s00125-002-0975-6; Cho JK, 2010, EUR J APPL PHYSIOL, V108, P347, DOI 10.1007/s00421-009-1238-8; Choi SH, 2011, CLIN ENDOCRINOL OXF; Dudzinski DM, 2007, CARDIOVASC RES, V75, P247, DOI 10.1016/j.cardiores.2007.03.023; Fu XY, 2006, CELL RES, V16, P214, DOI 10.1038/sj.cr.7310029; Hegyi K, 2004, CELL BIOL INT, V28, P159, DOI 10.1016/j.cellbi.2003.12.003; Hida K, 2005, P NATL ACAD SCI USA, V102, P10610, DOI 10.1073/pnas.0504703102; Inoue H, 2004, NAT MED, V10, P168, DOI 10.1038/nm980; Ito A, 1999, CIRCULATION, V99, P3092, DOI 10.1161/01.CIR.99.24.3092; Jung CH, 2011, BIOCHEM BIOPH RES CO, V413, P264, DOI 10.1016/j.bbrc.2011.08.083; Kadoglou NPE, 2011, CLIN CHIM ACTA, V412, P48, DOI 10.1016/j.cca.2010.09.012; Kajimoto H, 2012, KIDNEY INT, V81, P762, DOI 10.1038/ki.2011.476; Kano A, 2003, J EXP MED, V198, P1517, DOI 10.1084/jem.20030077; Kawashima S, 2004, ARTERIOSCL THROM VAS, V24, P998, DOI 10.1161/01.ATV.0000125114.88079.96; Kira M, 2002, J BIOL CHEM, V277, P12931, DOI 10.1074/jbc.M110795200; Koiou E, 2011, ENDOCR J, V58, P237, DOI 10.1507/endocrj.K10E-330; Lee WJ, 2005, BIOCHEM BIOPH RES CO, V332, P885, DOI 10.1016/j.bbrc.2005.05.035; Lee WJ, 2010, BIOCHEM BIOPH RES CO, V398, P653, DOI 10.1016/j.bbrc.2010.06.127; Leiper JM, 1999, BIOCHEM J, V343, P209, DOI 10.1042/0264-6021:3430209; Lin KY, 2002, CIRCULATION, V106, P987, DOI 10.1161/01.CIR.0000027109.14149.67; MacAllister RJ, 1996, BRIT J PHARMACOL, V119, P1533, DOI 10.1111/j.1476-5381.1996.tb16069.x; Malin DH, 1998, PSYCHOPHARMACOLOGY, V140, P371, DOI 10.1007/s002130050778; Matsukawa A, 2005, J IMMUNOL, V175, P3354, DOI 10.4049/jimmunol.175.5.3354; Naseem Khalid M., 2005, Molecular Aspects of Medicine, V26, P33, DOI 10.1016/j.mam.2004.09.003; Oelze M, 2000, CIRC RES, V87, P999, DOI 10.1161/01.RES.87.11.999; Paiva H, 2002, J AM COLL CARDIOL, V40, P1241, DOI 10.1016/S0735-1097(02)02174-5; Phalitakul S, 2012, BIOCHEM BIOPH RES CO, V423, P844, DOI 10.1016/j.bbrc.2012.06.052; Phalitakul S, 2011, PHARMACOL RES, V64, P493, DOI 10.1016/j.phrs.2011.06.001; Sherman CT, 2001, MOL ENDOCRINOL, V15, P441, DOI 10.1210/me.15.3.441; Steinberg HO, 1997, J CLIN INVEST, V100, P1230, DOI 10.1172/JCI119636; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Tan BK, 2008, DIABETES, V57, P1501, DOI 10.2337/db08-0127; Tan B, 2007, VASC PHARMACOL, V46, P338, DOI 10.1016/j.vph.2006.11.006; Teshigawara S, 2012, J CLIN ENDOCR METAB, V97, pE1202, DOI 10.1210/jc.2011-3297; Tran CTL, 2003, ATHEROSCLEROSIS SUPP, V4, P33, DOI 10.1016/S1567-5688(03)00032-1; Wada J, 2008, EXPERT OPIN INV DRUG, V17, P327, DOI 10.1517/13543784.17.3.327 ; Wadham C, 2009, EXPERT OPIN DRUG MET, V5, P303, DOI [10.1517/17425250902785172 , 10.1517/17425250902785172]; Wang MJ, 2007, AM J PHYSIOL-HEART C, V293, pH2101, DOI 10.1152/ajpheart.00125.2007; Won JC, 2010, ARTERIOSCL THROM VAS, V30, P290, DOI 10.1161/ATVBAHA.109.198721; Yang TL, 2005, N-S ARCH PHARMACOL, V371, P401, DOI 10.1007/s00210-005-1060-8; Yin QF, 2005, J CARDIOVASC PHARM, V45, P525, DOI 10.1097/01.fjc.0000159642.44523.7f; You BS, 2008, DIABETES, V57, P372, DOI 10.2337/db07-1045; YU CL, 1995, SCIENCE, V269, P81, DOI 10.1126/science.7541555; Zanetti M, 2001, AM J PHYSIOL-HEART C, V280, pH2516, DOI 10.1152/ajpheart.2001.280.6.H2516; Zhang XC, 2006, FASEB J, V20, P2156, DOI 10.1096/fj.06-5668fje	51	47	52	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52346	10.1371/journal.pone.0052346	http://dx.doi.org/10.1371/journal.pone.0052346			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23284999	gold, Green Published, Green Submitted			2022-12-27	WOS:000313051500028
J	Launay, O; Krivine, A; Charlier, C; Truster, V; Tsatsaris, V; Lepercq, J; Ville, Y; Avenell, C; Andrieu, T; Rozenberg, F; Artiguebielle, F; Treluyer, JM; Goffinet, F				Launay, Odile; Krivine, Anne; Charlier, Caroline; Truster, Van; Tsatsaris, Vassilis; Lepercq, Jacques; Ville, Yves; Avenell, Carolyn; Andrieu, Thibaut; Rozenberg, Flore; Artiguebielle, Florence; Treluyer, Jean-Marc; Goffinet, Francois		Inserm COFLUPREG Study Grp	Low Rate of Pandemic A/H1N1 2009 Influenza Infection and Lack of Severe Complication of Vaccination in Pregnant Women: A Prospective Cohort Study	PLOS ONE			English	Article							RESPIRATORY ILLNESS; H1N1 INFLUENZA; IMMUNIZATION; HOSPITALIZATIONS; HEALTH; OUTCOMES; MOTHERS; SAFETY	Background: In 2009, pregnant women were specifically targeted by a national vaccination campaign against pandemic A/H1N1 influenza virus. The objectives of the COFLUPREG study, initially set up to assess the incidence of serious forms of A/H1N1 influenza, were to assess the consequences of maternal vaccination on pregnancy outcomes and maternal seroprotection at delivery. Methods: Pregnant women, between 12 and 35 weeks of gestation, non vaccinated against A/H1N1 2009 influenza were randomly selected to be included in a prospective cohort study conducted in three maternity centers in Paris (France) during pandemic period. Blood samples were planned to assess hemagglutination inhibition (HI) antibody against A/H1N1 2009 influenza at inclusion and at delivery. Results: Among the 877 pregnant women included in the study, 678 (77.3%) had serum samples both at inclusion and delivery, and 320 (36.5%) received pandemic A/H1N1 2009 influenza vaccine with a median interval between vaccination and delivery of 92 days (95% CI 48-134). At delivery, the proportion of women with seroprotection (HI antibodies titers against A/H1N1 2009 influenza of 1: 40 or greater) was 69.9% in vaccinated women. Of the 422 non-vaccinated women with serological data, 11 (2.6%; 95% CI: 1.3-4.6) had laboratory documented A/H1N1 2009 influenza (1 with positive PCR and 10 with serological seroconversion). None of the 877 study's women was hospitalized for flu. No difference on pregnancy outcomes was evidenced between vaccinated women, non-vaccinated women without seroconversion and non-vaccinated women with flu. Conclusion: Despite low vaccine coverage, incidence of pandemic flu was low in this cohort of pregnant women. No effect on pregnancy and delivery outcomes was evidenced after vaccination.	[Launay, Odile; Charlier, Caroline; Tsatsaris, Vassilis; Lepercq, Jacques; Ville, Yves; Rozenberg, Flore; Treluyer, Jean-Marc; Goffinet, Francois] Univ Paris 05, Paris, France; [Launay, Odile; Truster, Van] INSERM, CIC BT505, Paris, France; [Launay, Odile] Hop Cochin, AP HP, CIC Vaccinol Cochin Pasteur, F-75674 Paris, France; [Krivine, Anne; Rozenberg, Flore] Hop Cochin, AP HP, Serv Virol, F-75674 Paris, France; [Charlier, Caroline; Ville, Yves] Hop Necker Enfants Malad, AP HP, Paris, France; [Avenell, Carolyn; Andrieu, Thibaut; Goffinet, Francois] Univ Paris 06, Inserm U953, Paris, France; [Artiguebielle, Florence; Treluyer, Jean-Marc; Goffinet, Francois] INSERM, CIC P0901, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Launay, O (corresponding author), Univ Paris 05, Paris, France.	odile.launay@cch.aphp.fr	Rozenberg, Flore/O-8854-2017; Lecuit, Marc/M-4126-2019; Charlier, Caroline/AAH-8547-2020; Batteux, Frederic/O-7889-2017; Lecuit, Marc/J-4073-2013; treluyer, Jean-Marc/F-8036-2010	Lecuit, Marc/0000-0002-4491-1063; Charlier, Caroline/0000-0002-9375-3620; Batteux, Frederic/0000-0002-1265-7996; Lecuit, Marc/0000-0002-4491-1063; GOFFINET, Francois/0000-0001-9643-0299; Le Ray, Camille/0000-0003-0891-1063; van der WERF, Sylvie/0000-0002-1148-4456	French National Institut for Health and Medical Research, (Inserm, Paris, France); programme derecherches H1N1 Aviesan - Institut de Microbiologie et Maladies Infectieuses	French National Institut for Health and Medical Research, (Inserm, Paris, France); programme derecherches H1N1 Aviesan - Institut de Microbiologie et Maladies Infectieuses	The French National Institut for Health and Medical Research, (Inserm, Paris, France) sponsored the trial. The trial was supported by a grant from the programme derecherches H1N1 Aviesan - Institut de Microbiologie et Maladies Infectieuses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black SB, 2004, AM J PERINAT, V21, P333, DOI 10.1055/s-2004-831888; Blondel B, 2012, J GYNECOL OBST BIO R, V41, P151, DOI 10.1016/j.jgyn.2011.11.008; Centers for Disease Control and Prevention (CDC), 2009, WHAT SHOULD PREGN WO; Cox S, 2006, OBSTET GYNECOL, V107, P1315, DOI 10.1097/01.AOG.0000218702.92005.bb; Creanga AA, 2010, OBSTET GYNECOL, V115, P717, DOI 10.1097/AOG.0b013e3181d57947; DEINARD AS, 1981, AM J OBSTET GYNECOL, V140, P240, DOI 10.1016/0002-9378(81)90267-2; Dubar G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013112; *ECDC, 2009, US SPEC PAND INFL VA; Englund JA, 2003, VACCINE, V21, P3460, DOI 10.1016/S0264-410X(03)00351-7; European Commission Health Security Committee (HSC)/Early Warning and Response System (EWRS, 2009, EHC EWRS STAT INFL H; European Committee for Proprietary Medicinal Products, 2007, GUIDE INFL VACC PREP; European Committee for Proprietary Medicinal Products, 2004, GUID DOSS STRUCT CON; *FDA GUID IND, 2007, CLIN DAT NEED SUPP L; Freund R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020900; Haut Conseil de la sante publique, 2009, ACT AV REL REC UT VA; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Kendal AP, 1982, CONCEPTS PROCEDURES; Louie JK, 2010, NEW ENGL J MED, V362, P27, DOI 10.1056/NEJMoa0910444; Mak TK, 2008, LANCET INFECT DIS, V8, P44, DOI 10.1016/S1473-3099(07)70311-0; Munoz FM, 2005, AM J OBSTET GYNECOL, V192, P1098, DOI 10.1016/j.ajog.2004.12.019; Neuzil KM, 1998, AM J EPIDEMIOL, V148, P1094, DOI 10.1093/oxfordjournals.aje.a009587; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Pasternak B, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2794; Pelat C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019621; Pierce M, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3214; Steinhoff MC, 2010, NEW ENGL J MED, V362, P1644, DOI 10.1056/NEJMc0912599; SUMAYA CV, 1979, J INFECT DIS, V140, P141, DOI 10.1093/infdis/140.2.141; Tavares F, 2011, VACCINE, V29, P6358, DOI 10.1016/j.vaccine.2011.04.114; Tsatsaris V, 2011, ANN INTERN MED; WOOD JM, 1994, VACCINE, V12, P167, DOI 10.1016/0264-410X(94)90056-6; World Health Organization, 2010, PREGN PAND INFL H1N1; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373; Yeager DP, 1999, AM J PERINAT, V16, P283, DOI 10.1055/s-2007-993873; Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630; Zarocostas J, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2425	35	19	19	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52303	10.1371/journal.pone.0052303	http://dx.doi.org/10.1371/journal.pone.0052303			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300637	Green Submitted, Green Published, gold			2022-12-27	WOS:000312829100038
J	Lee, SL; Nekouzadeh, A; Butler, B; Pryse, KM; McConnaughey, WB; Nathan, AC; Legant, WR; Schaefer, PM; Pless, RB; Elliot, LE; Genin, GM				Lee, Sheng-Lin; Nekouzadeh, Ali; Butler, Boyd; Pryse, Kenneth M.; McConnaughey, William B.; Nathan, Adam C.; Legant, Wesley R.; Schaefer, Pascal M.; Pless, Robert B.; Elson, Elliot L.; Genin, Guy M.			Physically-Induced Cytoskeleton Remodeling of Cells in Three-Dimensional Culture	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; AIRWAY HYPERRESPONSIVENESS; CONTRACTILE FIBROBLASTS; BIOPHYSICAL BASIS; FOCAL ADHESIONS; STRESS FIBERS; SMOOTH-MUSCLE; LIVING CELL; STRETCH; ACTIN	Characterizing how cells in three-dimensional (3D) environments or natural tissues respond to biophysical stimuli is a longstanding challenge in biology and tissue engineering. We demonstrate a strategy to monitor morphological and mechanical responses of contractile fibroblasts in a 3D environment. Cells responded to stretch through specific, cell-wide mechanisms involving staged retraction and reinforcement. Retraction responses occurred for all orientations of stress fibers and cellular protrusions relative to the stretch direction, while reinforcement responses, including extension of cellular processes and stress fiber formation, occurred predominantly in the stretch direction. A previously unreported role of F-actin clumps was observed, with clumps possibly acting as F-actin reservoirs for retraction and reinforcement responses during stretch. Responses were consistent with a model of cellular sensitivity to local physical cues. These findings suggest mechanisms for global actin cytoskeleton remodeling in non-muscle cells and provide insight into cellular responses important in pathologies such as fibrosis and hypertension.	[Lee, Sheng-Lin; Nathan, Adam C.; Genin, Guy M.] Washington Univ, Dept Mech Engn & Mat Sci, St Louis, MO 63130 USA; [Nekouzadeh, Ali; Legant, Wesley R.] Washington Univ, Dept Biomed Engn, St Louis, MO USA; [Butler, Boyd] Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA; [Pryse, Kenneth M.; McConnaughey, William B.; Elson, Elliot L.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Schaefer, Pascal M.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Pless, Robert B.] Washington Univ, Dept Comp Sci & Engn, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Texas Tech University System; Texas Tech University; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Genin, GM (corresponding author), Washington Univ, Dept Mech Engn & Mat Sci, St Louis, MO 63130 USA.	genin@wustl.edu	Pless, Robert B/I-4698-2013	Lee, Sheng-Lin/0000-0001-5180-682X	NIH [K25-HL079165, R01-HL109505]; Johanna D. Bemis Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K25HL079165, R01HL109505] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johanna D. Bemis Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by the NIH through grants K25-HL079165 and R01-HL109505, and by the Johanna D. Bemis Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SS, 2007, CAN J PHYSIOL PHARM, V85, P700, DOI 10.1139/Y07-059; BYERS HR, 1982, J CELL BIOL, V93, P804, DOI 10.1083/jcb.93.3.804; Chen C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012035; De RM, 2010, METHOD CELL BIOL, V98, P143, DOI 10.1016/S0091-679X(10)98007-2; De R, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.031923; Deshpande VS, 2006, P NATL ACAD SCI USA, V103, P14015, DOI 10.1073/pnas.0605837103; Discher D, 2009, ANN BIOMED ENG, V37, P847, DOI 10.1007/s10439-009-9661-x; Fabry Ben, 2007, Drug Discov Today Dis Models, V4, P131, DOI 10.1016/j.ddmod.2007.12.003; FELDER S, 1990, J CELL BIOL, V111, P2513, DOI 10.1083/jcb.111.6.2513; FORSCHER P, 1988, J CELL BIOL, V107, P1505, DOI 10.1083/jcb.107.4.1505; Fredberg JJ, 2004, RESP RES, V5, DOI 10.1186/1465-9921-5-2; Fredberg JJ, 2002, AM J PHYSIOL-LUNG C, V283, pL1179, DOI 10.1152/ajplung.00190.2002; Friedrich BM, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002544; Friedrich BM, 2011, BIOPHYS J, V100, P2706, DOI 10.1016/j.bpj.2011.04.050; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Haviv L, 2008, EUR BIOPHYS J BIOPHY, V37, P447, DOI 10.1007/s00249-007-0236-1; Hsu HJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012470; Hsu HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004853; Kaunas R, 2005, P NATL ACAD SCI USA, V102, P15895, DOI 10.1073/pnas.0506041102; Kaunas R, 2006, CELL SIGNAL, V18, P1924, DOI 10.1016/j.cellsig.2006.02.008; Kaunas R, 2009, J THEOR BIOL, V257, P320, DOI 10.1016/j.jtbi.2008.11.024; Krishnan R, 2012, AM J PHYSL CELL PHYS; Krishnan R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005486; Lee CF, 2010, BIOCHEM BIOPH RES CO, V401, P344, DOI 10.1016/j.bbrc.2010.09.046; Lee S-L, 2011, THESIS WASH U; Legant WR, 2010, NAT METHODS, V7, P969, DOI 10.1038/NMETH.1531; Lenormand G, 2006, BIORHEOLOGY, V43, P1; Marquez JP, 2010, PHILOS T R SOC A, V368, P635, DOI 10.1098/rsta.2009.0240; McGarry JP, 2009, ANN BIOMED ENG, V37, P2317, DOI 10.1007/s10439-009-9772-4; Nekouzadeh A, 2008, J BIOMECH, V41, P2964, DOI 10.1016/j.jbiomech.2008.07.033; Nekouzadeh A, 2011, P ROY SOC A-MATH PHY, V467, P2310, DOI 10.1098/rspa.2010.0623; Nguyen Trang T B, 2008, Proc Am Thorac Soc, V5, P58, DOI 10.1513/pats.200705-055VS; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Rohr S, 2009, HEART RHYTHM, V6, P848, DOI 10.1016/j.hrthm.2009.02.038; Shore SA, 2005, J ALLERGY CLIN IMMUN, V115, P925, DOI 10.1016/j.jaci.2005.01.064; Small JV, 1998, BBA-MOL CELL RES, V1404, P271, DOI 10.1016/S0167-4889(98)00080-9; Taber LA, 2009, PHILOS T R SOC A, V367, P3555, DOI 10.1098/rsta.2009.0100; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Totsukawa G, 2000, J CELL BIOL, V150, P797, DOI 10.1083/jcb.150.4.797; Trepat X, 2007, NATURE, V447, P592, DOI 10.1038/nature05824; Verkhovsky AB, 1999, BIOCHEM SOC SYMP, V65, P207; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Wakatsuki T, 2000, BIOPHYS J, V79, P2353, DOI 10.1016/S0006-3495(00)76481-2; Waters CM, 2002, AM J PHYSIOL-LUNG C, V283, pL503, DOI 10.1152/ajplung.00141.2002; Wight TN, 2011, AM J PHYSIOL-GASTR L, V301, pG950, DOI 10.1152/ajpgi.00132.2011; Wolfenson H, 2009, CELL MOTIL CYTOSKEL, V66, P1017, DOI 10.1002/cm.20410; Zahalak GI, 2000, BIOPHYS J, V79, P2369, DOI 10.1016/S0006-3495(00)76482-4; Zemel A, 2010, NAT PHYS, V6, P468, DOI 10.1038/NPHYS1613; Zemel A, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194110; Zemel A, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.021905	52	82	85	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e45512	10.1371/journal.pone.0045512	http://dx.doi.org/10.1371/journal.pone.0045512			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300512	Green Published, Green Submitted, gold			2022-12-27	WOS:000312829100001
J	Liang, JW; Gao, P; Wang, ZN; Song, YX; Xu, YY; Wang, MX; Dong, YL; Xu, HM				Liang, Ji-wang; Gao, Peng; Wang, Zhen-ning; Song, Yong-xi; Xu, Ying-ying; Wang, Mei-xian; Dong, Yu-lan; Xu, Hui-mian			The Integration of Macroscopic Tumor Invasion of Adjacent Organs into TNM Staging System for Colorectal Cancer	PLOS ONE			English	Article							SURVIVAL; ADENOCARCINOMAS; DEPOSITS; NUMBER; COLON	Objective: In addition to pathological TNM (pTNM) staging, the macroscopic staging (surgical TNM, sTNM) is another method used to stage and assess tumors, and it also potentially influences patient treatment guidelines. However, for the same patient, surgeons and pathologists might assess tumor depth differently. We aimed to evaluate the prognosis of patients who exhibit unconformity of intraoperative and postoperative results and propose a revised pT category (r-pT category) to predict survival in colorectal cancer. Methods and Results: In our study, 948 colorectal cancer patients were reviewed. We proposed a novel r-pT category in which surgical macroscopic T4b (sT4b) is incorporated into the pT category, namely, patients in the pT3 category with sT4b cancers are reclassified as being in the r-pT4a category; patients in the pT4a category with sT4b cancers are reclassified as being in the r-pT4b category. Cancer-specific survival according to the r-pT category was analyzed using Kaplan-Meier survival curves. A two-step multivariate analysis was used to determine correlations between the r-pT category and the prognosis. Harrell's C statistic was utilized to test the predictive capacity. There were significant prognostic differences among the r-pT subcategories. We substituted the r-pT category for the pT category in current TNM staging in a 2-step multivariate analysis. The Harrell's C statistical analysis results demonstrated that the r-pT category had superior predictive capacity compared to the pT category (Harrell' C: 0.668 vs. 0.636; P = 0.002). Conclusions: Patients in the pT3 category with sT4b cancers, and patients in the pT4a category with sT4b cancers, are potentially under-staged, reclassification into higher categories could potentially benefit these patients. The results indicate that the r-pT category we proposed is potentially superior to the pT category in the assessment of prognosis for colorectal cancer.	[Liang, Ji-wang; Gao, Peng; Wang, Zhen-ning; Song, Yong-xi; Xu, Ying-ying; Xu, Hui-mian] China Med Univ, Dept Surg Oncol & Gen Surg, Hosp 1, Shenyang, Peoples R China; [Wang, Mei-xian; Dong, Yu-lan] China Med Univ, Dept Tumor Pathol & Surg Oncol, Hosp 1, Shenyang, Peoples R China	China Medical University; China Medical University	Wang, ZN (corresponding author), China Med Univ, Dept Surg Oncol & Gen Surg, Hosp 1, Shenyang, Peoples R China.	josieon826@yahoo.com.cn	Xu, Yingying/E-3884-2018; wang, zhen ning/E-1878-2011; Gao, Peng/B-8031-2013	Xu, Yingying/0000-0003-4924-9379; wang, zhen ning/0000-0003-0557-3097; 	National Science Foundation of China [30972879, 81172370]; Program of Scientific and Technological Department of Liaoning Province [2010225032]; Program of Education Department of Liaoning Province [L2011137]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Scientific and Technological Department of Liaoning Province; Program of Education Department of Liaoning Province	This work was supported by National Science Foundation of China (30972879 and 81172370), the Program of Scientific and Technological Department of Liaoning Province (2010225032) and the Program of Education Department of Liaoning Province (L2011137). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHEN J, 1986, Journal of Fujian Agricultural College, V15, P347; Chen YG, 2011, CELL BIOCHEM BIOPHYS, V59, P1, DOI 10.1007/s12013-010-9106-z; Chok KSH, 2007, WORLD J SURG, V31, P1485, DOI 10.1007/s00268-007-9089-0; Compton CC, 2004, CA-CANCER J CLIN, V54, P295, DOI 10.3322/canjclin.54.6.295; Gajra A, 2003, J CLIN ONCOL, V21, P1029, DOI 10.1200/JCO.2003.07.010; Goldstein NS, 2000, CANCER-AM CANCER SOC, V88, P2228, DOI 10.1002/(SICI)1097-0142(20000515)88:10<2228::AID-CNCR5>3.0.CO;2-1; Greene FL, 2009, J SURG ONCOL, V99, P269, DOI 10.1002/jso.21237; Harisi R, 2008, HEPATO-GASTROENTEROL, V55, P66; HARRELL FE, 1984, STAT MED, V3, P143, DOI 10.1002/sim.4780030207; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hemminki K, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-688; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; MADDEN MV, 1987, BRIT J SURG, V74, P119, DOI 10.1002/bjs.1800740217; Markman Maurie, 2003, Curr Oncol Rep, V5, P437, DOI 10.1007/s11912-003-0001-2; Nagtegaal ID, 2007, HISTOPATHOLOGY, V51, P141, DOI 10.1111/j.1365-2559.2007.02720.x; Ostadi MA, 2007, SURG ENDOSC, V21, P2142, DOI 10.1007/s00464-007-9414-6; Sobin LH., 2009, TNM CLASSIFICATION M, V7th edition; Sun Z, 2009, ANN SURG, V249, P768, DOI 10.1097/SLA.0b013e3181a3df77; Tong LL, 2012, ANN SURG, V255, P208, DOI 10.1097/SLA.0b013e31821ad8a2; Tong LL, 2011, ANN SURG ONCOL, V18, P2453, DOI 10.1245/s10434-011-1687-2; Tong LL, 2011, ANN SURG ONCOL, V18, P1389, DOI 10.1245/s10434-010-1440-2; Xu HM, 1995, J CHINA MED U, V24, P352	22	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52269	10.1371/journal.pone.0052269	http://dx.doi.org/10.1371/journal.pone.0052269			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300631	gold, Green Submitted, Green Published			2022-12-27	WOS:000313618800064
J	White, EJ; Genesee, F; Steinhauer, K				White, Erin Jacquelyn; Genesee, Fred; Steinhauer, Karsten			Brain Responses before and after Intensive Second Language Learning: Proficiency Based Changes and First Language Background Effects in Adult Learners	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; TIME-COURSE; ACQUISITION; ERP; ACTIVATION; EXPLICIT; IMPLICIT; CHINESE; AGE; MORPHOLOGY	This longitudinal study tracked the neuro-cognitive changes associated with second language (L2) grammar learning in adults in order to investigate how L2 processing is shaped by a learner's first language (L1) background and L2 proficiency. Previous studies using event-related potentials (ERPs) have argued that late L2 learners cannot elicit a P600 in response to L2 grammatical structures that do not exist in the L1 or that are different in the L1 and L2. We tested whether the neuro-cognitive processes underlying this component become available after intensive L2 instruction. Korean- and Chinese late-L2- learners of English were tested at the beginning and end of a 9-week intensive English-L2 course. ERPs were recorded while participants read English sentences containing violations of regular past tense (a grammatical structure that operates differently in Korean and does not exist in Chinese). Whereas no P600 effects were present at the start of instruction, by the end of instruction, significant P600s were observed for both L1 groups. Latency differences in the P600 exhibited by Chinese and Korean speakers may be attributed to differences in L1-L2 reading strategies. Across all participants, larger P600 effects at session 2 were associated with: 1) higher levels of behavioural performance on an online grammaticality judgment task; and 2) with correct, rather than incorrect, behavioural responses. These findings suggest that the neuro-cognitive processes underlying the P600 (e.g., "grammaticalization'') are modulated by individual levels of L2 behavioural performance and learning.	[White, Erin Jacquelyn; Genesee, Fred; Steinhauer, Karsten] Ctr Res Brain Language & Mus, Montreal, PQ, Canada; [White, Erin Jacquelyn; Genesee, Fred] McGill Univ, Dept Psychol, Montreal, PQ, Canada; [Steinhauer, Karsten] McGill Univ, Sch Commun Sci & Disorders, Montreal, PQ, Canada	McGill University; McGill University	White, EJ (corresponding author), Ctr Res Brain Language & Mus, Montreal, PQ, Canada.	erin.white@mail.mcgill.ca; karsten.steinhauer@mcgill.ca	Steinhauer, Karsten/B-2863-2008		Natural Sciences and Engineering Research Council of Canada (NSERC) Postgraduate Scholarship (PGS) [PGS D3 - 347964 - 2007]; Canada Research Chair program; Canada Foundation for Innovation (CRC/CFI) [201876]; Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPGP 312835]; Center for Research on Brain, Language and Music [CRLMB 214404]; Social Sciences and Humanities Research Council of Canada SSHRC [232345]; Fonds de Recherche Societe et Culture FQRSC [2010-SE-103727]	Natural Sciences and Engineering Research Council of Canada (NSERC) Postgraduate Scholarship (PGS)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair program(Canada Research Chairs); Canada Foundation for Innovation (CRC/CFI)(Canada Foundation for Innovation); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Center for Research on Brain, Language and Music; Social Sciences and Humanities Research Council of Canada SSHRC(Social Sciences and Humanities Research Council of Canada (SSHRC)CGIAR); Fonds de Recherche Societe et Culture FQRSC	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) Postgraduate Scholarship (PGS), Application No: PGS D3 - 347964 - 2007 (http://www.nserc-crsng.gc.ca/index_eng.asp); Canada Research Chair program; Canada Foundation for Innovation (CRC/CFI; project # 201876, http://www.chairs.gc.ca/); Natural Sciences and Engineering Research Council of Canada (NSERC; #RGPGP 312835, http://www.nserc-crsng.gc.ca/index_eng.asp); Center for Research on Brain, Language and Music (CRLMB 214404, http://www.crblm.ca/); Social Sciences and Humanities Research Council of Canada SSHRC (grant no: 232345, http://www.sshrc-crsh.gc.ca/Default.aspx); Fonds de Recherche Societe et Culture FQRSC (#2010-SE-103727, http://www.fqrsc.gouv.qc.ca/fr/accueil.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birdsong D, 2006, LANG LEARN, V56, P9, DOI 10.1111/j.1467-9922.2006.00353.x; Chen L, 2007, BILING-LANG COGN, V10, P161, DOI 10.1017/S136672890700291X; Drury J, 2007, J COGNITIVE NEUROS S, P249; Ellis R., 1994, STUDY 2 LANGUAGE ACQ; Franceschina F., 2005, FOSSILIZED 2 LANGUAG; Friederici AD, 2002, TRENDS COGN SCI, V6, P78, DOI 10.1016/S1364-6613(00)01839-8; FRIEDERICI AD, 1995, BRAIN LANG, V50, P259, DOI 10.1006/brln.1995.1048; Dowens MG, 2011, NEUROPSYCHOLOGIA, V49, P1651, DOI 10.1016/j.neuropsychologia.2011.02.034; Dowens MG, 2010, J COGNITIVE NEUROSCI, V22, P1870, DOI 10.1162/jocn.2009.21304; Goad H, 2008, LINGUA, V118, P577, DOI 10.1016/j.lingua.2007.01.008; Gouvea AC, 2010, LANG COGNITIVE PROC, V25, P149, DOI 10.1080/01690960902965951; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Gunter TC, 1997, PSYCHOPHYSIOLOGY, V34, P660, DOI 10.1111/j.1469-8986.1997.tb02142.x; HAGOORT P, 1993, LANG COGNITIVE PROC, V8, P439, DOI 10.1080/01690969308407585; Hahne A, 2006, J COGNITIVE NEUROSCI, V18, P121, DOI 10.1162/089892906775250067; Hahne A, 1999, J COGNITIVE NEUROSCI, V11, P194, DOI 10.1162/089892999563328; Hahne A, 2001, J PSYCHOLINGUIST RES, V30, P251, DOI 10.1023/A:1010490917575; Hernandez AE, 2007, PSYCHOL BULL, V133, P638, DOI 10.1037/0033-2909.133.4.638; Inoue K., BILINGUALIS IN PRESS; Jia G, 2007, J SPEECH LANG HEAR R, V50, P1280, DOI 10.1044/1092-4388(2007/090); Kaan E, 2000, LANG COGNITIVE PROC, V15, P159, DOI 10.1080/016909600386084; Kotz SA, 2009, BRAIN LANG, V109, P68, DOI 10.1016/j.bandl.2008.06.002; Kuperberg GR, 2007, BRAIN RES, V1146, P23, DOI 10.1016/j.brainres.2006.12.063; Kuperberg GR, 2003, J COGNITIVE NEUROSCI, V15, P272, DOI 10.1162/089892903321208204; Li P, 2007, BILING-LANG COGN, V10, P117, DOI 10.1017/S1366728907002878; Macmillan NA, 2005, DETECTION THEORY USE; MacWhinney B., 2005, HDB BILINGUALISM PSY, P49, DOI DOI 10.1075/TILAR.22.15MAC; MCCARTHY G, 1985, ELECTROEN CLIN NEURO, V62, P203, DOI 10.1016/0168-5597(85)90015-2; McLaughlin J, 2004, NAT NEUROSCI, V7, P703, DOI 10.1038/nn1264; McLaughlin J, 2010, LANG LEARN, V60, P123, DOI 10.1111/j.1467-9922.2010.00604.x; Morgan-Short K, 2012, J COGNITIVE NEUROSCI, V24, P933, DOI 10.1162/jocn_a_00119; Morgan-Short K, 2010, LANG LEARN, V60, P154, DOI 10.1111/j.1467-9922.2009.00554.x; NEVILLE H, 1991, J COGNITIVE NEUROSCI, V3, P151, DOI 10.1162/jocn.1991.3.2.151; Ojima S, 2005, J COGNITIVE NEUROSCI, V17, P1212, DOI 10.1162/0898929055002436; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Osterhout L, 2004, ON-LINE STUDY OF SENTENCE COMPREHENSION, P271; OSTERHOUT L, 1992, J MEM LANG, V31, P785, DOI 10.1016/0749-596X(92)90039-Z; Osterhout L, 1995, J MEM LANG, V34, P739, DOI 10.1006/jmla.1995.1033; Osterhout L, 2006, LANG LEARN, V56, P199, DOI 10.1111/j.1467-9922.2006.00361.x; Osterhout L, 2008, J NEUROLINGUIST, V21, P509, DOI 10.1016/j.jneuroling.2008.01.001; Pakulak E, 2011, J COGNITIVE NEUROSCI, V23, P2752, DOI 10.1162/jocn.2010.21586; Perfetti CA, 2005, PSYCHOL REV, V112, P43, DOI 10.1037/0033-295X.112.1.43; Perfetti CA, 1998, J EXP PSYCHOL LEARN, V24, P101, DOI 10.1037/0278-7393.24.1.101; Perfetti CA, 2010, NEURAL BASIS READING, P147; Rossi S, 2006, J COGNITIVE NEUROSCI, V18, P2030, DOI 10.1162/jocn.2006.18.12.2030; Sabourin L, 2006, SECOND LANG RES, V22, P1, DOI 10.1191/0267658306sr259oa; Sabourin L, 2008, SECOND LANG RES, V24, P397, DOI 10.1177/0267658308090186; Steinhauer K, 2006, J COGNITIVE NEUROS S, P99; Steinhauer K, 2012, BRAIN LANG, V120, P135, DOI 10.1016/j.bandl.2011.07.001; Steinhauer K, 2009, SECOND LANG RES, V25, P13, DOI 10.1177/0267658308098995; Tan LH, 2003, HUM BRAIN MAPP, V18, P158, DOI 10.1002/hbm.10089; Tan LH, 2005, HONG KONG J PAEDIATR, V10, P131; Tanner D, 2009, PROC ANN BUCLD, P528; Tokowicz N, 2005, STUD SECOND LANG ACQ, V27, P173, DOI 10.1017/S0272263105050102; Tremblay K, 1998, NEUROREPORT, V9, P3557, DOI 10.1097/00001756-199811160-00003; Wang M, 2003, COGNITION, V87, P129, DOI 10.1016/S0010-0277(02)00232-9; WeberFox CM, 1996, J COGNITIVE NEUROSCI, V8, P231, DOI 10.1162/jocn.1996.8.3.231; White L., 2003, 2 LANGUAGE ACQUISITI	58	44	44	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52318	10.1371/journal.pone.0052318	http://dx.doi.org/10.1371/journal.pone.0052318			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	071TV	23300641	Green Submitted, gold, Green Published			2022-12-27	WOS:000313618800068
J	Gillmaier, N; Gotz, A; Schulz, A; Eisenreich, W; Goebel, W				Gillmaier, Nadine; Goetz, Andreas; Schulz, Anette; Eisenreich, Wolfgang; Goebel, Werner			Metabolic Responses of Primary and Transformed Cells to Intracellular Listeria monocytogenes	PLOS ONE			English	Article							CARBON METABOLISM; GLUTAMINE-METABOLISM; PYRUVATE-CARBOXYLASE; ENERGY-METABOLISM; INTERFERON-GAMMA; GENE-EXPRESSION; NITRIC-OXIDE; IFN-GAMMA; MYC; ACTIVATION	The metabolic response of host cells, in particular of primary mammalian cells, to bacterial infections is poorly understood. Here, we compare the carbon metabolism of primary mouse macrophages and of established J774A.1 cells upon Listeria monocytogenes infection using C-13-labelled glucose or glutamine as carbon tracers. The C-13-profiles of protein-derived amino acids from labelled host cells and intracellular L. monocytogenes identified active metabolic pathways in the different cell types. In the primary cells, infection with live L. monocytogenes increased glycolytic activity and enhanced flux of pyruvate into the TCA cycle via pyruvate dehydrogenase and pyruvate carboxylase, while in J774A.1 cells the already high glycolytic and glutaminolytic activities hardly changed upon infection. The carbon metabolism of intracellular L. monocytogenes was similar in both host cells. Taken together, the data suggest that efficient listerial replication in the cytosol of the host cells mainly depends on the glycolytic activity of the hosts.	[Gillmaier, Nadine; Eisenreich, Wolfgang] Tech Univ Munich, Lehrstuhl Biochem, Garching, Germany; [Goetz, Andreas; Schulz, Anette; Goebel, Werner] Univ Munich, Max von Pettenkofer Inst, Munich, Germany	Technical University of Munich; University of Munich	Eisenreich, W (corresponding author), Tech Univ Munich, Lehrstuhl Biochem, Garching, Germany.	wolfgang.eisenreich@mytum.de; goebel@biozentrum.uni-wuerzburg.de	Eisenreich, Wolfgang/A-1258-2013	Eisenreich, Wolfgang/0000-0002-9832-8279; Goebel, Werner/0000-0003-4851-2083	German Research Foundation (DFG) [Go168/28-1, EI 384/5-2 (SPP1316)]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the grants Go168/28-1 and EI 384/5-2 (SPP1316) from the German Research Foundation (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2004, INT MICROBIOL, V7, P181; Beiting DP, 2011, IMMUNOL REV, V240, P117, DOI 10.1111/j.1600-065X.2010.00998.x; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Boldrick JC, 2002, P NATL ACAD SCI USA, V99, P972, DOI 10.1073/pnas.231625398; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P8674, DOI 10.1073/pnas.1016627108; Dang CV, 2009, CLIN CANCER RES, V15, P6479, DOI 10.1158/1078-0432.CCR-09-0889; Daye D, 2012, SEMIN CELL DEV BIOL, V23, P362, DOI 10.1016/j.semcdb.2012.02.002; De Stefano D, 2006, J MOL MED, V84, P65, DOI 10.1007/s00109-005-0713-x; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; DeBerardinis RJ, 2012, CELL, V148, P1132, DOI 10.1016/j.cell.2012.02.032; Dunlop EA, 2009, CELL SIGNAL, V21, P827, DOI 10.1016/j.cellsig.2009.01.012; Eisenreich W, 2006, P NATL ACAD SCI USA, V103, P2040, DOI 10.1073/pnas.0507580103; Eisenreich W, 2010, NAT REV MICROBIOL, V8, P401, DOI 10.1038/nrmicro2351; Eylert E, 2008, MOL MICROBIOL, V69, P1008, DOI 10.1111/j.1365-2958.2008.06337.x; FAN K, 1993, J CELL PHYSIOL, V154, P535, DOI 10.1002/jcp.1041540312; Feron O, 2009, RADIOTHER ONCOL, V92, P329, DOI 10.1016/j.radonc.2009.06.025; Fuchs TM, 2012, FEMS MICROBIOL REV, V36, P435, DOI 10.1111/j.1574-6976.2011.00301.x; Gao D, 2009, BIOCHEM BIOPH RES CO, V388, P278, DOI 10.1016/j.bbrc.2009.07.160; Gotz A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010586; Gordan JD, 2007, CANCER CELL, V12, P108, DOI 10.1016/j.ccr.2007.07.006; Hartmann H, 2008, GASTROENTEROLOGY, V134, P756, DOI 10.1053/j.gastro.2007.12.008; Holleran AL, 1995, MOL CELL BIOCHEM, V152, P95, DOI 10.1007/BF01076071; Holsbeeks I, 2004, TRENDS BIOCHEM SCI, V29, P556, DOI 10.1016/j.tibs.2004.08.010; Hyde R, 2007, J BIOL CHEM, V282, P19788, DOI 10.1074/jbc.M611520200; Jarasch N, 2005, VIRAL IMMUNOL, V18, P355, DOI 10.1089/vim.2005.18.355; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kim JW, 2004, MOL CELL BIOL, V24, P5923, DOI 10.1128/MCB.24.13.5923-5936.2004; Kumar Y, 2009, CELL HOST MICROBE, V5, P593, DOI 10.1016/j.chom.2009.05.014; LEE WNP, 1991, BIOL MASS SPECTROM, V20, P451, DOI 10.1002/bms.1200200804; Maddocks ODK, 2011, J MOL MED, V89, P237, DOI 10.1007/s00109-011-0735-5; MATEO RB, 1995, AM J PHYSIOL-CELL PH, V268, pC669, DOI 10.1152/ajpcell.1995.268.3.C669; Moreno-Sanchez R, 2007, FEBS J, V274, P1393, DOI 10.1111/j.1742-4658.2007.05686.x; Munoz-Elias EJ, 2006, CELL MICROBIOL, V8, P10, DOI 10.1111/j.1462-5822.2005.00648.x; Nau GJ, 2002, P NATL ACAD SCI USA, V99, P1503, DOI 10.1073/pnas.022649799; Osthus RC, 2000, J BIOL CHEM, V275, P21797, DOI 10.1074/jbc.C000023200; Patiar S, 2006, ENDOCR-RELAT CANCER, V13, pS61, DOI 10.1677/erc.1.01290; Pfeiffer T, 2001, SCIENCE, V292, P504, DOI 10.1126/science.1058079; PICKUP JF, 1976, ANAL CHEM, V48, P1885, DOI 10.1021/ac50007a019; Poncet S, 2009, CONTRIB MICROBIOL, V16, P88, DOI 10.1159/000219374; Puzio-Kuter Anna M, 2011, Genes Cancer, V2, P385, DOI 10.1177/1947601911409738; RALPH P, 1975, NATURE, V257, P393, DOI 10.1038/257393a0; Schar J, 2010, J BACTERIOL, V192, P1774, DOI 10.1128/JB.01132-09; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Schroder K, 2006, IMMUNOBIOLOGY, V211, P511, DOI 10.1016/j.imbio.2006.05.007; Stavru F, 2011, P NATL ACAD SCI USA, V108, P3612, DOI 10.1073/pnas.1100126108; WARBURG O, 1956, SCIENCE, V124, P269; Wellen KE, 2010, MOL CELL, V40, P323, DOI 10.1016/j.molcel.2010.10.004; Werth N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011576; Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Yin CQ, 2012, CRIT REV EUKAR GENE, V22, P17, DOI 10.1615/CritRevEukarGeneExpr.v22.i1.20; Zamboni N, 2009, CURR OPIN MICROBIOL, V12, P553, DOI 10.1016/j.mib.2009.08.003	52	31	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52378	10.1371/journal.pone.0052378	http://dx.doi.org/10.1371/journal.pone.0052378			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285016	Green Published, gold, Green Submitted			2022-12-27	WOS:000313158800057
J	Gupta, V; Dawood, FS; Muangchana, C; Lan, PT; Xeuatvongsa, A; Sovann, L; Olveda, R; Cutter, J; Oo, KY; Ratih, TSD; Kheong, CC; Kapella, BK; Kitsutani, P; Corwin, A; Olsen, SJ				Gupta, Vinay; Dawood, Fatimah S.; Muangchana, Charung; Lan, Phan Trong; Xeuatvongsa, Anonh; Sovann, Ly; Olveda, Remigio; Cutter, Jeffery; Oo, Khin Yi; Ratih, Theresia Sandra Diah; Kheong, Chong Chee; Kapella, Bryan K.; Kitsutani, Paul; Corwin, Andrew; Olsen, Sonja J.			Influenza Vaccination Guidelines and Vaccine Sales in Southeast Asia: 2008-2011	PLOS ONE			English	Article							PRODUCTION CAPACITY; IMMUNIZATION; THAILAND	Background: Southeast Asia is a region with great potential for the emergence of a pandemic influenza virus. Global efforts to improve influenza surveillance in this region have documented the burden and seasonality of influenza viruses and have informed influenza prevention strategies, but little information exists about influenza vaccination guidelines and vaccine sales. Methods: To ascertain the existence of influenza vaccine guidelines and define the scope of vaccine sales, we sent a standard three-page questionnaire to the ten member nations of the Association of Southeast Asian Nations. We also surveyed three multinational manufacturers who supply influenza vaccines in the region. Results: Vaccine sales in the private sector were,1000 per 100,000 population in the 10 countries. Five countries reported purchasing vaccine for use in the public sector. In 2011, Thailand had the highest combined reported rate of vaccine sales (10,333 per 100,000). In the 10 countries combined, the rate of private sector sales during 2010-2011 (after the A(H1N1)2009pdm pandemic) exceeded 2008 pre-pandemic levels. Five countries (Indonesia, Malaysia, Singapore, Thailand and Vietnam) had guidelines for influenza vaccination but only two were consistent with global guidelines. Four recommended vaccination for health care workers, four for elderly persons, three for young children, three for persons with underlying disease, and two for pregnant women. Conclusions: The rate of vaccine sales in Southeast Asia remains low, but there was a positive impact in sales after the A(H1N1) 2009pdm pandemic. Low adherence to global vaccine guidelines suggests that more work is needed in the policy arena.	[Gupta, Vinay] Columbia Univ, Coll Phys & Surg, New York, NY USA; [Gupta, Vinay; Olsen, Sonja J.] US CDC Collaborat, Thailand Minist Publ Hlth, Nonthaburi, Thailand; [Dawood, Fatimah S.; Kapella, Bryan K.; Kitsutani, Paul; Corwin, Andrew; Olsen, Sonja J.] Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA; [Muangchana, Charung] Minist Publ Hlth, Dept Dis Control, Natl Vaccine Comm Off, Nonthaburi, Thailand; [Lan, Phan Trong] Minist Hlth, Gen Dept Prevent Med, Hanoi, Vietnam; [Xeuatvongsa, Anonh] Minist Publ Hlth, Expanded Program Immunizat, Viangchan, Laos; [Sovann, Ly] Minist Publ Hlth, CDC Dept, Phnom Penh, Cambodia; [Olveda, Remigio] Res Inst Trop Med, Dept Hlth, Muntinlupa, Philippines; [Cutter, Jeffery] Minist Hlth, Communicable Dis Div, Singapore, Singapore; [Oo, Khin Yi] Minist Hlth, Natl Hlth Lab, Nay Pyi Taw, Myanmar; [Ratih, Theresia Sandra Diah] Minist Publ Hlth, Expanded Program Immunizat, Jakarta, Indonesia; [Kheong, Chong Chee] Minist Hlth, Dis Control Div, Kuala Lumpur, Malaysia	Columbia University; Ministry of Public Health - Thailand; Centers for Disease Control & Prevention - USA; Ministry of Public Health - Thailand; Philippine Department Health; Research Institute for Tropical Medicine - Philippines; Ministry of Health-Singapore; Kementerian Kesihatan Malaysia	Olsen, SJ (corresponding author), US CDC Collaborat, Thailand Minist Publ Hlth, Nonthaburi, Thailand.	Solsen@cdc.gov		Trong Phan, Lan/0000-0003-4756-3655	U.S. Centers for Disease Control and Prevention	U.S. Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by the U.S. Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, Wkly Epidemiol Rec, V87, P201; [Bureau USC USDo Commerce], 2011, STAT ABSTR US 2012; CDC, 2012, LAO PEOPL DEM REP LA; Collin N, 2009, VACCINE, V27, P5184, DOI 10.1016/j.vaccine.2009.06.034; Friede M, 2011, VACCINE, V29, pA2, DOI 10.1016/j.vaccine.2011.02.079; Furlow Carolyn, 2011, Morbidity and Mortality Weekly Report, V60, P737; Hanshaoworakul W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006051; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Katz MA, 2007, VACCINE, V25, P3827, DOI 10.1016/j.vaccine.2007.01.109; Mereckiene J, 2010, EUROSURVEILLANCE; Music T, 2012, INT NURS REV, V59, P161, DOI 10.1111/j.1466-7657.2011.00961.x; Palache A, 2011, VACCINE, V29, P9459, DOI 10.1016/j.vaccine.2011.10.030; Salaam-Blyther T, 2009, GLOBAL HLTH USAID PR, P1; Suhardono M, 2011, VACCINE, V29, pA22, DOI 10.1016/j.vaccine.2011.04.123; United Nations, 2011, WORLD POP PROSP 2010; United Nations, 2010, WORLD URB PROSP 2009; WHO, 2009, INFL SEAS; World Health Organization, 2012, REP WHO PAND INFL AH; World Health Organization, 2006, GLOB PAND INFL ACT P; Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630	21	31	32	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52842	10.1371/journal.pone.0052842	http://dx.doi.org/10.1371/journal.pone.0052842			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285200	Green Published, Green Submitted, gold			2022-12-27	WOS:000313158800100
J	Lopez-Piriz, R; Sola-Linares, E; Granizo, JJ; Diaz-Guemes, I; Enciso, S; Bartolome, JF; Cabal, B; Esteban-Tejeda, L; Torrecillas, R; Moya, JS				Lopez-Piriz, Roberto; Sola-Linares, Eva; Granizo, Juan J.; Diaz-Gueemes, Idohia; Enciso, Silvia; Bartolome, Jose F.; Cabal, Belen; Esteban-Tejeda, Leticia; Torrecillas, Ramon; Moya, Jose S.			Radiologic Evaluation of Bone Loss at Implants with Biocide Coated Titanium Abutments: A Study in the Dog	PLOS ONE			English	Article							PERI-IMPLANT; SILVER NANOPARTICLES; PREVALENCE; BREAKDOWN	The objective of the present study is to evaluate bone loss at implant abutments coated with a soda-lime glass containing silver nanoparticles subjected to experimental peri-implantitis. Five beagle dogs were used in the experiments, 3 implants were installed in each quadrant of the mandibles. Glass/n-Ag coted abutments were connected to implant platform. Cotton floss ligatures were placed in a submarginal position around the abutment necks and the animals were subject to a diet which allowed plaque accumulation, and after 15 weeks the dogs were sacrificed. Radiographs of all implant sites were obtained at the beginning and at the end of the experimentally induced peri-implantitis. The radiographic examination indicated that significant amounts of additional bone loss occurred in implants without biocide coating, considering both absolute and relative values of bone loss. Percentages of additional bone loss observed in implants dressed with a biocide coated abutment were about 3 times lower (p < 0.006 distal aspect; and p < 0.031 at mesial aspect) than the control ones. Within the limits of the present study it seems promising the use of soda-lime glass/nAg coatings on abutments to prevent peri-implant diseases.	[Lopez-Piriz, Roberto; Cabal, Belen; Torrecillas, Ramon] Univ Oviedo, CSIC, Nanomat & Nanotechnol Res Ctr, Llanera, Spain; [Sola-Linares, Eva; Granizo, Juan J.] Adv Oral Surg Inst, Madrid, Spain; [Diaz-Gueemes, Idohia; Enciso, Silvia] Minimally Invas Surg Ctr Jesus Uson, Caceres, Spain; [Bartolome, Jose F.; Esteban-Tejeda, Leticia; Moya, Jose S.] CSIC, Inst Ciencia Mat Madrid, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion en Nanomateriales y Nanotecnologia (CINN); University of Oviedo; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencia de Materiales de Madrid (ICMM)	Bartolome, JF (corresponding author), CSIC, Inst Ciencia Mat Madrid, Madrid, Spain.	jbartolo@icmm.csic.es	López-Píriz, Roberto/W-8146-2019; Bartolomé, José/B-1977-2010; Moya, Jose/I-5841-2013; Cabal, Belén/G-2694-2019; Torrecillas, Ramón/G-7851-2011	López-Píriz, Roberto/0000-0003-2431-6950; Bartolomé, José/0000-0002-7515-4202; Cabal, Belén/0000-0002-4102-3810; Torrecillas, Ramón/0000-0003-3856-0217; Diaz-Guemes, Idoia/0000-0001-6047-2489; Enciso, Silvia/0000-0001-5004-6734	Spanish Ministry of Science and Innovation [MAT2009-14542-C02-01]; Nanoker Research SL.; Consejo Superior de Investigaciones Cientificas JAE-Doc Program	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Nanoker Research SL.; Consejo Superior de Investigaciones Cientificas JAE-Doc Program	This work was supported by the Spanish Ministry of Science and Innovation under the project MAT2009-14542-C02-01 and Nanoker Research SL. BC thanks the Consejo Superior de Investigaciones Cientificas JAE-Doc Program for a postdoctoral contract. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsson I, 1998, CLIN ORAL IMPLAN RES, V9, P73; Berglundh T, 2002, J CLIN PERIODONTOL, V29, P197, DOI 10.1034/j.1600-051X.29.s3.12.x; Berglundh T, 2007, CLIN ORAL IMPLAN RES, V18, P655, DOI 10.1111/j.1600-0501.2007.01397.x; Cabal B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042393; Cao HL, 2010, WIRES NANOMED NANOBI, V2, P670, DOI 10.1002/wnan.113; ERICSSON I, 1975, SCAND J DENT RES, V83, P189; Esteban-Tejeda L, 2012, J EUR CERAM SOC, V32, P2723, DOI 10.1016/j.jeurceramsoc.2012.02.053; Esteban-Tejeda L, 2010, ADV ENG MATER, V12, pB292, DOI 10.1002/adem.200980077; Fransson C, 2005, CLIN ORAL IMPLAN RES, V16, P440, DOI 10.1111/j.1600-0501.2005.01137.x; Lindhe J, 1992, Clin Oral Implants Res, V3, P9, DOI 10.1034/j.1600-0501.1992.030102.x; Mir-Mari J, 2012, J CLIN PERIODONTOL, V39, P490, DOI 10.1111/j.1600-051X.2012.01872.x; Pye AD, 2009, J HOSP INFECT, V72, P104, DOI 10.1016/j.jhin.2009.02.010; Roos-Jansaker AM, 2006, J CLIN PERIODONTOL, V33, P290, DOI 10.1111/j.1600-051X.2006.00906.x; Schou S, 1993, Clin Oral Implants Res, V4, P12; Schrand AM, 2012, ADV EXP MED BIOL, V745, P58, DOI 10.1007/978-1-4614-3055-1_5; Sreenivasan P, 2002, J CLIN PERIODONTOL, V29, P965, DOI 10.1034/j.1600-051X.2002.291101.x	16	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52861	10.1371/journal.pone.0052861	http://dx.doi.org/10.1371/journal.pone.0052861			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285206	gold, Green Published, Green Submitted			2022-12-27	WOS:000313158800102
J	Moodley, A; Rae, W; Bhigjee, A; Connolly, C; Devparsad, N; Michowicz, A; Harrison, T; Loyse, A				Moodley, Anand; Rae, William; Bhigjee, Ahmed; Connolly, Cathy; Devparsad, Natasha; Michowicz, Andrew; Harrison, Thomas; Loyse, Angela			Early Clinical and Subclinical Visual Evoked Potential and Humphrey's Visual Field Defects in Cryptococcal Meningitis	PLOS ONE			English	Article							VAR GATTII MENINGITIS; AIDS PATIENTS; OPTIC-NERVE; SUDDEN BLINDNESS; SOUTH-AFRICA; INFECTION; PRESSURE; PATIENT	Cryptococcal induced visual loss is a devastating complication in survivors of cryptococcal meningitis (CM). Early detection is paramount in prevention and treatment. Subclinical optic nerve dysfunction in CM has not hitherto been investigated by electrophysiological means. We undertook a prospective study on 90 HIV sero-positive patients with culture confirmed CM. Seventy-four patients underwent visual evoked potential (VEP) testing and 47 patients underwent Humphrey's visual field (HVF) testing. Decreased best corrected visual acuity (BCVA) was detected in 46.5% of patients. VEP was abnormal in 51/74 (68.9%) right eyes and 50/74 (67.6%) left eyes. VEP P100 latency was the main abnormality with mean latency values of 118.9 (+/-16.5) ms and 119.8 (+/-15.7) ms for the right and left eyes respectively, mildly prolonged when compared to our laboratory references of 104 (+/-10) ms (p<0.001). Subclinical VEP abnormality was detected in 56.5% of normal eyes and constituted mostly latency abnormality. VEP amplitude was also significantly reduced in this cohort but minimally so in the visually unimpaired. HVF was abnormal in 36/47 (76.6%) right eyes and 32/45 (71.1%) left eyes. The predominant field defect was peripheral constriction with an enlarged blind spot suggesting the greater impact by raised intracranial pressure over that of optic neuritis. Whether this was due to papilloedema or a compartment syndrome is open to further investigation. Subclinical HVF abnormalities were minimal and therefore a poor screening test for early optic nerve dysfunction. However, early optic nerve dysfunction can be detected by testing of VEP P100 latency, which may precede the onset of visual loss in CM.	[Moodley, Anand; Devparsad, Natasha] Greys Hosp, Dept Neurol, Pietermaritzburg, South Africa; [Rae, William] Univ Free State, Dept Med Phys, Bloemfontein, South Africa; [Moodley, Anand; Bhigjee, Ahmed] Univ KwaZulu Natal, Dept Neurol, Durban, South Africa; [Connolly, Cathy] MRC, Biostat Unit, Durban, South Africa; [Michowicz, Andrew] Edendale Hosp, Dept Med, Pietermaritzburg, South Africa; [Harrison, Thomas; Loyse, Angela] St Georges Univ London, Div Clin Sci, Res Ctr Infect & Immun, Cryptococcal Meningitis Grp, London, England	University of the Free State; University of Kwazulu Natal; St Georges University London	Moodley, A (corresponding author), Greys Hosp, Dept Neurol, Pietermaritzburg, South Africa.	anand.moodley@kznhealth.gov.za		Loyse, Angela/0000-0001-7853-1344; Moodley, Anand/0000-0002-8205-9342; Harrison, Thomas/0000-0003-3619-4348	Medical Research Council [RN 2721]	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was partly sponsored by the Medical Research Council, grant number RN 2721. No additional external funding received for this study. Sponsorship was for technical and statistical costs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Claus JJ, 1998, CLIN NEUROL NEUROSUR, V100, P51, DOI 10.1016/S0303-8467(97)00119-4; COHEN DB, 1993, OPHTHALMOLOGY, V100, P1689, DOI 10.1016/S0161-6420(93)31416-8; Corti M, 2010, REV IBEROAM MICOL, V27, P207, DOI 10.1016/j.riam.2010.09.002; De Schacht C, 2005, ACTA CLIN BELG, V60, P10, DOI 10.1179/acb.2005.003; Ferreira RC, 1997, AM J OPHTHALMOL, V124, P558, DOI 10.1016/S0002-9394(14)70877-3; Jabs D A, 1995, Trans Am Ophthalmol Soc, V93, P623; JOHNSTON SRD, 1992, J INFECTION, V24, P185, DOI 10.1016/0163-4453(92)92954-H; Kestelyn P, 1997, T ROY SOC TROP MED H, V91, P727, DOI 10.1016/S0035-9203(97)90542-3; Killer HE, 2011, ACTA OPHTHALMOL, V89, pE472, DOI 10.1111/j.1755-3768.2011.02182.x; Lightowler JVJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008630; LIPSON BK, 1989, AM J OPHTHALMOL, V107, P523, DOI 10.1016/0002-9394(89)90498-4; MALESSA R, 1995, J NEUROL SCI, V130, P82, DOI 10.1016/0022-510X(95)00002-J; Milman T, 2008, CLIN OPHTHALMOL, V2, P637; Moodley A, 2012, NEURO-OPHTHALMOLOGY, V36, P186, DOI 10.3109/01658107.2012.715716; Moosa MYS, 1997, CLIN INFECT DIS, V24, P131, DOI 10.1093/clinids/24.2.131; Mwanza JC, 2004, BRIT J OPHTHALMOL, V88, P1455, DOI 10.1136/bjo.2004.044289; Ng C. W., 2000, SMJ, V41, P80; Odom JV, 2010, DOC OPHTHALMOL, V120, P111, DOI 10.1007/s10633-009-9195-4; Orem J, 2005, TROP DOCT, V35, P19, DOI 10.1258/0049475053001967; REX JH, 1993, MEDICINE, V72, P207, DOI 10.1097/00005792-199307000-00001; Seaton RA, 1997, T ROY SOC TROP MED H, V91, P50, DOI 10.1016/S0035-9203(97)90393-X; Seaton RA, 1997, T ROY SOC TROP MED H, V91, P44, DOI 10.1016/S0035-9203(97)90391-6; Torres OH, 1999, AIDS, V13, P530, DOI 10.1097/00002030-199903110-00018	23	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52895	10.1371/journal.pone.0052895	http://dx.doi.org/10.1371/journal.pone.0052895			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285220	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000313158800107
J	Pascual, G; Sotomayor, S; Rodriguez, M; Perez-Kohler, R; Bellon, JM				Pascual, Gemma; Sotomayor, Sandra; Rodriguez, Marta; Perez-Koehler, Rarbara; Bellon, Juan M.			Repair of Abdominal Wall Defects with Biodegradable Laminar Prostheses: Polymeric or Biological?	PLOS ONE			English	Article							HERNIA REPAIR; CROSS-LINKING; TISSUE; MESHES; ACTIVATION; MODEL	Introduction: Biological and synthetic laminar absorbable prostheses are available for the repair of hernia defects in the abdominal wall. They share the important feature of being gradually degraded in the host, resulting in place the formation of a neotissue. This study was designed to assess the host tissue's incorporation of collagen bioprostheses and a synthetic absorbable prosthesis. Methods: Partial defects were created in the abdominal walls of 72 New Zealand rabbits and repaired using collagen bioprostheses Tutomesh (R) and Strattice (R) or a synthetic prosthesis Bio-A (R). Specimens were collected for light microscopy, collagens gene and protein expression, macrophage response and biomechanical resistance at 14, 30, 90 and 180 days post-implantation. Results: Tutomesh (R) and Bio-A (R) were gradually infiltrated by the host tissue and almost completely degraded by 180 days post-implantation. In contrast, Strattice (R) exhibited material encapsulation, no prosthetic degradation and low cell infiltration at earlier timepoints, whereas at later study time, collagen deposition could be observed within the mesh. In the short term, Bio-A (R) exhibited higher level of collagen 1 and 3 mRNA expression compared with the two other biological prostheses, which exhibited two peaks of higher expression at 14 and 90 days. The expression of collagen III was homogeneous throughout the study and collagen I deposition was more evident in Strattice (R). Macrophage response decreased over time in biomeshes. However, in the synthetic mesh remained high and homogeneous until 90 days. The biomechanical analysis demonstrated the progressively increasing tensile strength of all biomaterials. Conclusions: The tissue infiltration of laminar absorbable prostheses is affected by the structure and composition of the mesh. The synthetic prosthesis exhibited a distinct pattern of tissue incorporation and a greater macrophage response than did the biological prostheses. Of all of the laminar, absorbable biomaterials that were tested in this study, StratticeH demonstrated the optimal levels of integration and degradation.	[Rodriguez, Marta; Bellon, Juan M.] Alcala Univ, Fac Med, Networking Res Ctr Bioengn Biomat & Nanomed CIBER, Dept Surg, Madrid, Spain; [Pascual, Gemma; Sotomayor, Sandra; Perez-Koehler, Rarbara] Alcala Univ, Fac Med, Networking Res Ctr Bioengn Biomat & Nanomed CIBER, Dept Med Specialties, Madrid, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Universidad de Alcala; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Universidad de Alcala	Bellon, JM (corresponding author), Alcala Univ, Fac Med, Networking Res Ctr Bioengn Biomat & Nanomed CIBER, Dept Surg, Madrid, Spain.	juanm.bellon@uah.es	Köhler, Bárbara Pérez/M-1858-2019; PASCUAL, GEMMA/M-6564-2016	Köhler, Bárbara Pérez/0000-0002-5061-1526; BELLON, JUAN M./0000-0002-6071-5011; PASCUAL, GEMMA/0000-0002-1623-4384; Sotomayor Nunez, Sandra/0000-0003-4998-762X	Fundacion Mutua Madrilena, Madrid, Spain [FMM08]; Spanish Ministry of Science and Technology [DPI2011-27939-C02-02]	Fundacion Mutua Madrilena, Madrid, Spain; Spanish Ministry of Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This study was supported by a grant from the Fundacion Mutua Madrilena 2008 (FMM08), Madrid, Spain, and by the Spanish Ministry of Science and Technology through the research project DPI2011-27939-C02-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellows CF, 2012, AM J SURG, V3; Bellows CF, 2007, AM J SURG, V194, P192, DOI 10.1016/j.amjsurg.2006.11.012; Buchberg B, 2010, AM SURGEON, V76, P1150; Burgess PL, 2011, J SURG EDUC, V68, P62, DOI 10.1016/j.jsurg.2010.09.006; Butler CE, 2010, J AM COLL SURGEONS, V211, P368, DOI 10.1016/j.jamcollsurg.2010.04.024; Campbell KT, 2011, PLAST RECONSTR SURG, V127, P2321, DOI 10.1097/PRS.0b013e318213a053; Cavallaro A, 2010, WORLD J GASTROENTERO, V16, P1928, DOI 10.3748/wjg.v16.i15.1928; Connor J, 2009, REGEN MED, V4, P185, DOI 10.2217/17460751.4.2.185; Efthimiou M, 2011, HERNIA, V15, P181, DOI 10.1007/s10029-010-0765-x; Gupta A, 2006, Hernia, V10, P419, DOI 10.1007/s10029-006-0130-2; Harth KC, 2009, SURG INNOV, V16, P324, DOI 10.1177/1553350609353609; Hiles M, 2009, SURG INNOV, V16, P26, DOI 10.1177/1553350609331397; Jenkins ED, 2010, J AM COLL SURGEONS, V210, P402, DOI 10.1016/j.jamcollsurg.2009.12.001; Kapan S, 2003, Hernia, V7, P39; Liang HC, 2004, BIOMATERIALS, V25, P3541, DOI 10.1016/j.biomaterials.2003.09.109; Limpert JN, 2009, AM J SURG, V198, P60; Losanoff J E, 2002, Hernia, V6, P144; Ngo MD, 2011, CELL TISSUE BANK, V12, P135, DOI 10.1007/s10561-011-9245-5; Mulier KE, 2011, HERNIA, V15, P315, DOI 10.1007/s10029-010-0777-6; Orenstein SB, 2010, HERNIA, V14, P401, DOI 10.1007/s10029-010-0634-7; Orenstein SB, 2010, SURG ENDOSC, V24, P805, DOI 10.1007/s00464-009-0664-3; Pascual G, 2012, WOUND REPAIR REGEN, V20, P402, DOI 10.1111/j.1524-475X.2012.00781.x; Petter-Puchner AH, 2008, J SURG RES, V145, P105, DOI 10.1016/j.jss.2007.03.090; Ratto C, 2012, COLORECTAL DIS, V14, pe264, DOI 10.1111/j.1463-1318.2012.02964.x; Sandor M, 2008, TISSUE ENG PT A, V14, P2021, DOI 10.1089/ten.tea.2007.0317	25	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52628	10.1371/journal.pone.0052628	http://dx.doi.org/10.1371/journal.pone.0052628			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285119	gold, Green Published, Green Submitted			2022-12-27	WOS:000313158800083
J	Klenke, C; Janowski, S; Borck, D; Widera, D; Ebmeyer, J; Kalinowski, J; Leichtle, A; Hofestadt, R; Upile, T; Kaltschmidt, C; Kaltschmidt, B; Sudhoff, H				Klenke, Christin; Janowski, Sebastian; Borck, Daniela; Widera, Darius; Ebmeyer, Joerg; Kalinowski, Joern; Leichtle, Anke; Hofestaedt, Ralf; Upile, Tahwinder; Kaltschmidt, Christian; Kaltschmidt, Barbara; Sudhoff, Holger			Identification of Novel Cholesteatoma-Related Gene Expression Signatures Using Full-Genome Microarrays	PLOS ONE			English	Article							MOLECULAR INTERACTION DATABASE; GROWTH; EPITHELIUM; INHIBITOR; REGULATOR; PATTERNS; PROLIFERATION; INFLAMMATION; LAMININ-5; MIGRATION	Background: Cholesteatoma is a gradually expanding destructive epithelial lesion within the middle ear. It can cause extensive local tissue destruction in the temporal bone and can initially lead to the development of conductive hearing loss via ossicular erosion. As the disease progresses, sensorineural hearing loss, vertigo or facial palsy may occur. Cholesteatoma may promote the spread of infection through the tegmen of the middle ear and cause meningitis or intracranial infections with abscess formation. It must, therefore, be considered as a potentially life-threatening middle ear disease. Methods and Findings: In this study, we investigated differentially expressed genes in human cholesteatomas in comparison to regular auditory canal skin using Whole Human Genome Microarrays containing 19,596 human genes. In addition to already described up-regulated mRNAs in cholesteatoma, such as MMP9, DEFB2 and KRT19, we identified 3558 new cholesteatoma-related transcripts. 811 genes appear to be significantly differentially up-regulated in cholesteatoma. 334 genes were down-regulated more than 2-fold. Significantly regulated genes with protein metabolism activity include matrix metalloproteinases as well as PI3, SERPINB3 and SERPINB4. Genes like SPP1, KRT6B, PRPH, SPRR1B and LAMC2 are known as genes with cell growth and/or maintenance activity. Transport activity genes and signal transduction genes are LCN2, GJB2 and CEACAM6. Three cell communication genes were identified; one CDH19 and two from the S100 family. Conclusions: This study demonstrates that the expression profile of cholesteatoma is similar to a metastatic tumour and chronically inflamed tissue. Based on the investigated profiles we present novel protein-protein interaction and signal transduction networks, which include cholesteatoma-regulated transcripts and may be of great value for drug targeting and therapy development.	[Klenke, Christin; Ebmeyer, Joerg; Leichtle, Anke; Sudhoff, Holger] Klinikum Bielefeld, Dept Otolaryngol & Head & Neck Surg, Bielefeld, Germany; [Janowski, Sebastian; Borck, Daniela; Hofestaedt, Ralf] Univ Bielefeld, Bioinformat Dept, D-33615 Bielefeld, Germany; [Upile, Tahwinder] Univ Coll London Hosp, Dept Otolaryngol & Head & Neck Surg, London, England; [Kalinowski, Joern] Univ Bielefeld, Ctr Biotechnol, D-33615 Bielefeld, Germany	University of Bielefeld; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of Bielefeld	Klenke, C (corresponding author), Klinikum Bielefeld, Dept Otolaryngol & Head & Neck Surg, Bielefeld, Germany.	christin.zander@klinikumbielefeld.de	Leichtle, Anke/AAA-3505-2020; Sudhoff, Holger/AAV-9741-2020; Widera, Darius/J-4237-2012; Leichtle, Anke/GPW-7895-2022	Sudhoff, Holger/0000-0002-9274-5645; Widera, Darius/0000-0003-1686-130X; 	Klosterfrau Healthcare Group, Cassella-med GmbH & Co. KG, Cologne, Germany	Klosterfrau Healthcare Group, Cassella-med GmbH & Co. KG, Cologne, Germany	This study was sponsored by Klosterfrau Healthcare Group, Cassella-med GmbH & Co. KG, Cologne, Germany. The study sponsor did not participate in study design and data analysis. Cassella-med had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam H, 2011, MOL BIOL CELL, V22, P4068, DOI 10.1091/mbc.E10-08-0703; Alam SR, 2012, BIOCHEM PHARMACOL, V83, P695, DOI 10.1016/j.bcp.2011.11.003; Blake J, 2003, HISTOL HISTOPATHOL, V18, P529, DOI 10.14670/HH-18.529; Blons H, 2002, ONCOGENE, V21, P5016, DOI 10.1038/sj.onc.1205626; Carey JPW, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-173; CARTER WG, 1991, CELL, V65, P599, DOI 10.1016/0092-8674(91)90092-D; Chan ASW, 2003, ONCOGENE, V22, P6946, DOI 10.1038/sj.onc.1206799; Chen SS, 2011, BLOOD, V117, P862, DOI 10.1182/blood-2010-05-284638; Dornelles Cristina, 2006, Braz J Otorhinolaryngol, V72, P641; Dremmen MHG, 2012, AM J NEURORADIOL, V33, P439, DOI 10.3174/ajnr.A2824; Duxbury MS, 2004, BRIT J CANCER, V91, P1384, DOI 10.1038/sj.bjc.6602113; Elek J, 2000, IN VIVO, V14, P173; Giannelli G, 2005, GASTROENTEROLOGY, V129, P1375, DOI 10.1053/j.gastro.2005.09.055; Hajra KM, 2002, GENE CHROMOSOME CANC, V34, P255, DOI 10.1002/gcc.10083; Himoudi N, 2007, CANCER IMMUNOL IMMUN, V56, P1381, DOI 10.1007/s00262-007-0294-3; Huisman MA, 2008, LARYNGOSCOPE, V118, P94, DOI 10.1097/MLG.0b013e31814faafa; Janowski Sebastian, 2011, Stud Health Technol Inform, V162, P182; Jean D, 1998, J BIOL CHEM, V273, P16501, DOI 10.1074/jbc.273.26.16501; Kerrien S, 2012, NUCLEIC ACIDS RES, V40, pD841, DOI 10.1093/nar/gkr1088; Kim HJ, 2002, J KOREAN MED SCI, V17, P381, DOI 10.3346/jkms.2002.17.3.381; Kim HJ, 2002, OTOL NEUROTOL, V23, P840, DOI 10.1097/00129492-200211000-00005; Kojima H, 1999, ARCH OTOLARYNGOL, V125, P738, DOI 10.1001/archotol.125.7.738; Kwon KH, 2006, ACTA OTO-LARYNGOL, V126, P691, DOI 10.1080/00016480500475633; Lee HM, 2004, J PERIODONTOL, V75, P453, DOI 10.1902/jop.2004.75.3.453; LEE RJ, 1994, CLIN OTOLARYNGOL, V19, P516, DOI 10.1111/j.1365-2273.1994.tb01280.x; Li C, 2011, CYTOKINE, V56, P435, DOI 10.1016/j.cyto.2011.07.021; Li S, 2008, INVEST OPHTH VIS SCI, V49, P34, DOI 10.1167/iovs.07-0685; Licata L, 2012, NUCLEIC ACIDS RES, V40, pD857, DOI 10.1093/nar/gkr930; LIM DJ, 1972, ANN OTO RHINOL LARYN, V81, P2, DOI 10.1177/000348947208100102; Makiishi-Shimobayashi C, 2004, AURIS NASUS LARYNX, V31, P3, DOI 10.1016/j.anl.2003.11.010; Masui T, 2003, CLIN CANCER RES, V9, P1779; Medic S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009977; Nunes LMA, 2010, INT ARCH OTORHINOLAR; Oh J, 2001, CELL, V107, P789, DOI 10.1016/S0092-8674(01)00597-9; Oka T, 2009, WORLD J GASTROENTERO, V15, P3865, DOI 10.3748/wjg.15.3865; Olszewska E, 2007, HISTOL HISTOPATHOL, V22, P37, DOI 10.14670/HH-22.37; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Shunyu NB, 2011, OTOLARYNG HEAD NECK, V145, P628, DOI 10.1177/0194599811409303; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Sudhoff H, 2000, AM J OTOL, V21, P793; Sudhoff H, 1999, LARYNGO RHINO OTOL, V78, P63, DOI 10.1055/s-2007-996832; Sudhoff H, 2007, EUR ARCH OTO-RHINO-L, V264, P1137, DOI 10.1007/s00405-007-0340-y; Wei HF, 2012, GYNECOL ONCOL, V125, P727, DOI 10.1016/j.ygyno.2012.03.018; WELLS MD, 1991, J LARYNGOL OTOL, V105, P261, DOI 10.1017/S0022215100115567; Xu JD, 2010, J ORTHOP RES, V28, P1621, DOI 10.1002/jor.21178; Yoshikawa M, 2006, ARCH OTOLARYNGOL, V132, P734, DOI 10.1001/archotol.132.7.734; Zhang JH, 2008, MOL ENDOCRINOL, V22, P1416, DOI 10.1210/me.2007-0420	50	29	33	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52718	10.1371/journal.pone.0052718	http://dx.doi.org/10.1371/journal.pone.0052718			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285167	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000312794500240
J	Mehra, D; Geraghty, PM; Hardigan, AA; Foronjy, R				Mehra, Divya; Geraghty, Patrick M.; Hardigan, Andrew A.; Foronjy, Robert			A Comparison of the Inflammatory and Proteolytic Effects of Dung Biomass and Cigarette Smoke Exposure in the Lung	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; INDOOR AIR-POLLUTION; ACTIVATED PROTEIN-KINASE; MATRIX METALLOPROTEINASES; ALVEOLAR MACROPHAGES; OXIDATIVE STRESS; EMPHYSEMA; COPD; COMBUSTION; WOMEN	Rationale: Biomass is the energy source for cooking and heating for billions of people worldwide. Despite their prevalent use and their potential impact on global health, the effects of these fuels on lung biology and function remain poorly understood. Methods: We exposed human small airway epithelial cells and C57BL/6 mice to dung biomass smoke or cigarette smoke to compare how these exposures impacted lung signaling and inflammatory and proteolytic responses that have been linked with disease pathogenesis. Results: The in vitro exposure and siRNA studies demonstrated that biomass and cigarette smoke activated ERK to up regulate IL-8 and MMP-1 expression in human airway epithelial cells. In contrast to cigarette smoke, biomass also activated p38 and JNK within these lung cells and lowered the expression of tissue inhibitor of matrix metalloproteinase-1 (TIMP-1). Similarly, in the lungs of mice, both biomass and cigarette smoke exposure increased macrophages, activated ERK and p38 and up regulated MMP-9 and MMP-12 expression. The main differences seen in the exposure studies was that mice exposed to biomass exhibited more perivascular inflammation and had higher G-CSF and GM-CSF lavage fluid levels than mice exposed identically to cigarette smoke. Conclusion: Biomass activates similar pathogenic processes seen in cigarette smoke exposure that are known to result in the disruption of lung structure. These findings provide biological evidence that public health interventions are needed to address the harm associated with the use of this fuel source. Citation: Mehra D, Geraghty PM, Hardigan AA, Foronjy R (2012) A Comparison of the Inflammatory and Proteolytic Effects of Dung Biomass and Cigarette Smoke Exposure in the Lung. PLoS ONE 7(12): e52889. doi:10.1371/journal.pone.0052889	[Geraghty, Patrick M.; Hardigan, Andrew A.; Foronjy, Robert] Columbia Univ, St Lukes Roosevelt Hosp Ctr, Div Pulm & Crit Care Med, New York, NY 10027 USA; [Mehra, Divya] Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA	Columbia University; Mount Sinai St. Luke's; Mount Sinai West; Columbia University	Foronjy, R (corresponding author), Columbia Univ, St Lukes Roosevelt Hosp Ctr, Div Pulm & Crit Care Med, New York, NY 10027 USA.	rforonjy@chpnet.org		Geraghty, Patrick/0000-0003-1647-5505	National Institute of Health [HL086936-04, HL0998528-04]; Flight Attendant Medical Research Institute [074047]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086936, R01HL098528] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flight Attendant Medical Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institute of Health (HL086936-04, HL0998528-04) and the Flight Attendant Medical Research Institute (Clinical Innovator Award 074047). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud RT, 2008, INT J TUBERC LUNG D, V12, P361; Balakrishnan K, 2002, ENVIRON HEALTH PERSP, V110, P1069, DOI 10.1289/ehp.021101069; Banerjee A, 2012, INFLAMMATION, V35, P671, DOI 10.1007/s10753-011-9360-2; BEHERA D, 1994, RESPIRATION, V61, P89; Belvisi MG, 2003, INFLAMM RES, V52, P95, DOI 10.1007/s000110300020; Chung KF, 2001, EUR RESPIR J, V18, p50S, DOI 10.1183/09031936.01.00229701; Chung KF, 2011, CHEST, V139, P1470, DOI 10.1378/chest.10-1914; Churg A, 2008, AM J PHYSIOL-LUNG C, V294, pL612, DOI 10.1152/ajplung.00390.2007; Cuttica MJ, 2011, AM J RESP CELL MOL, V45, P62, DOI 10.1165/rcmb.2009-0365OC; D'Armiento J, 2007, CANCER RES, V67, P1902, DOI 10.1158/0008-5472.CAN-06-1122; Desai M, 2004, SERIES WEBOD; Dutta A, 2012, INT J HYG ENV HLTH; Dutta A, 2012, TOXICOL APPL PHARM, V261, P255, DOI 10.1016/j.taap.2012.04.004; Ezzati M, 2001, LANCET, V358, P619, DOI 10.1016/S0140-6736(01)05777-4; da Silva LFF, 2012, ENVIRON RES, V112, P111, DOI 10.1016/j.envres.2011.10.012; Ford JG, 2001, J IMMUNOL, V167, P1769, DOI 10.4049/jimmunol.167.3.1769; Foronjy RF, 2006, AM J RESP CRIT CARE, V173, P623, DOI 10.1164/rccm.200506-850OC; Foronjy R, 2008, AM J PHYSIOL-LUNG C, V294, pL1149, DOI 10.1152/ajplung.00481.2007; Geraghty P, 2011, J BIOL CHEM, V286, P30211, DOI 10.1074/jbc.M111.238824; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; Hogg JC, 2004, LANCET, V364, P709, DOI 10.1016/S0140-6736(04)16900-6; Johnson P, 2011, GLOBAL HEALTH ACTION, V4, DOI 10.3402/gha.v4i0.7226; Kurmi OP, 2012, EUR RESPIR J, V40, P239, DOI 10.1183/09031936.00190211; Lal K, 2011, ECOTOX ENVIRON SAFE, V74, P2126, DOI 10.1016/j.ecoenv.2011.06.006; Laniado-Laborin R, 2011, INT J TUBERC LUNG D, V15, P818, DOI 10.5588/ijtld.10.0546; Linden A, 2005, EUR RESPIR J, V25, P159, DOI 10.1183/09031936.04.00032904; Mercer BA, 2004, J BIOL CHEM, V279, P17690, DOI 10.1074/jbc.M313842200; Mocchegiani E, 2011, CURR OPIN PULM MED, V17, pS11, DOI 10.1097/01.mcp.0000410743.98087.12; (Organization) WWH, 1997, HLTH ENV SUST DEV; Podowski M, 2012, J CLIN INVEST, V122, P229, DOI 10.1172/JCI46215; Rahman I, 1998, THORAX, V53, P601, DOI 10.1136/thx.53.7.601; SANDOVAL J, 1993, CHEST, V103, P12, DOI 10.1378/chest.103.1.12; Semple S, 2010, ENVIRON HEALTH PERSP, V118, P988, DOI 10.1289/ehp.0901605; Sertogullarindan B, 2012, INT J MED SCI, V9, P406, DOI 10.7150/ijms.4715; Shankavaram UT, 1998, J LEUKOCYTE BIOL, V64, P221, DOI 10.1002/jlb.64.2.221; Syrkina OL, 2007, AM J PHYSIOL-LUNG C, V292, pL984, DOI 10.1152/ajplung.00248.2006; THOMASSEN MJ, 1992, AM J RESP CELL MOL, V7, P257, DOI 10.1165/ajrcmb/7.3.257; Vlahos R, 2010, AM J RESP CRIT CARE, V182, P34, DOI 10.1164/rccm.200912-1794OC; Voelkel NF, 2003, EUR RESPIR J, V22, p28S, DOI 10.1183/09031936.03.00000503; Wallace AM, 2012, TOXICOL SCI, V126, P589, DOI 10.1093/toxsci/kfr351; World Health Organization, 2002, WORLD HLTH REP; Yoshida M, 2001, J IMMUNOL, V166, P7514, DOI 10.4049/jimmunol.166.12.7514	42	46	46	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52889	10.1371/journal.pone.0052889	http://dx.doi.org/10.1371/journal.pone.0052889			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285217	gold, Green Submitted, Green Published			2022-12-27	WOS:000312794500255
J	Ruffing, U; Akulenko, R; Bischoff, M; Helms, V; Herrmann, M; von Muller, L				Ruffing, Ulla; Akulenko, Ruslan; Bischoff, Markus; Helms, Volkhard; Herrmann, Mathias; von Mueller, Lutz			Matched-Cohort DNA Microarray Diversity Analysis of Methicillin Sensitive and Methicillin Resistant Staphylococcus aureus Isolates from Hospital Admission Patients	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; CATABOLIC MOBILE ELEMENT; LOCUS VARIABLE-NUMBER; MULTIPLE-LOCUS; CLONAL COMPLEXES; SEQUENCE; MRSA; ASSIGNMENT; VIRULENCE; STRAINS	As genotyping of S. aureus is important for epidemiologic research and for hygiene management, methods are required for standardized fast and easily applicable evaluation of closely related epidemic strains with high prevalence in hospitals. In this single centre matched control study we compared a new commercially available DNA microarray (IdentiBAC) with standard spa-typing for S. aureus genotyping. Included in the study was a subgroup of 46 MRSA and matched 46 MSSA nasal isolates of the Saarland University Medical Center collected during a state-wide admission prevalence screening. Microarray (MA) and also spa-typing could easily differentiate the genetically diverse MSSA group. However, due to the predominance of CC5/t003 in the MRSA group a sufficient subtyping required analysis of more complex genetic profiles as was shown here by the MA comprising a total number of 334 different hybridization probes. The genetic repertoire of the MRSA group was characterized by more virulence genes as compared to the MSSA group. The standard evaluation of MA results by the original software into CCs, agr-, SCCmec- and capsule-types was substituted in the present study by implementation of multivariate subtyping of closely related CC5 isolates using three different bioinformatic methods (splits graph, cluster dendrogram, and principal component analysis). Each method used was applicable for standardized and highly discriminative subtyping with high concordance. We propose that the identified S. aureus subtypes with characteristic virulence gene profiles are presumably associated also with virulence and pathogenicity in vivo; however, this remains to be analyzed in future studies. MA was superior to spa-typing for epidemiologic and presumably also provide functional respectively virulence associated characterization of S. aureus isolates. This is of specific importance for the hospital setting. In future, MA could become a new standard test for S. aureus typing in combination with multivariate bioinformatic analysis. Citation: Ruffing U, Akulenko R, Bischoff M, Helms V, Herrmann M, et al. (2012) Matched-Cohort DNA Microarray Diversity Analysis of Methicillin Sensitive and Methicillin Resistant Staphylococcus aureus Isolates from Hospital Admission Patients. PLoS ONE 7(12): e52487. doi:10.1371/journal.pone.0052487	[Ruffing, Ulla; Bischoff, Markus; Herrmann, Mathias; von Mueller, Lutz] Univ Saarland, Inst Med Microbiol & Hyg, Med Ctr, D-6650 Homburg, Germany; [Akulenko, Ruslan; Helms, Volkhard] Univ Saarland, Ctr Bioinformat, D-6600 Saarbrucken, Germany	Saarland University; Saarland University	von Muller, L (corresponding author), Univ Saarland, Inst Med Microbiol & Hyg, Med Ctr, D-6650 Homburg, Germany.	lutz.mueller@uks.eu	Bischoff, Markus/D-2130-2014; Herrmann, Mathias/B-6475-2013	Bischoff, Markus/0000-0001-6734-2732; Herrmann, Mathias/0000-0003-2638-2257; von Muller, Lutz/0000-0001-9013-4245; Helms, Volkhard/0000-0002-2180-9154	Deutsche Forschungsgemeinschaft [1850/9-1]; Federal Ministry for Education and Science (BMBF grant) [01KI1014B]; State of Saarland; German Ministry of Health [IIA5-2509NIK008/321-4532-04/21]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Federal Ministry for Education and Science (BMBF grant); State of Saarland; German Ministry of Health	This study was supported by the Deutsche Forschungsgemeinschaft (He 1850/9-1 to M.H.) and the Federal Ministry for Education and Science (BMBF grant #01KI1014B to MH and MB). Alere Inc. contributed to the study by supplying the IdentiBAC ArrayMateTM Reader and the imaging software Iconoclust. The isolates were collected in the context of the admission prevalence screening carried out by the MRSA Network Saarland (www.mrsaar.net) funded by the State of Saarland and the German Ministry of Health (IIA5-2509NIK008/321-4532-04/21). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028189; Beiko RG, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-34; Degnan JH, 2006, PLOS GENET, V2, P762, DOI 10.1371/journal.pgen.0020068; Deurenberg RH, 2009, DIAGN MICR INFEC DIS, V65, P116, DOI 10.1016/j.diagmicrobio.2009.07.007; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Diep BA, 2008, J INFECT DIS, V197, P1523, DOI 10.1086/587907; Dunman PM, 2004, J CLIN MICROBIOL, V42, P4275, DOI 10.1128/JCM.42.9.4275-4283.2004; Francois P, 2005, J CLIN MICROBIOL, V43, P3346, DOI 10.1128/JCM.43.7.3346-3355.2005; Friedrich A W, 2008, Euro Surveill, V13; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gill SR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018673; Goering RV, 2007, J CLIN MICROBIOL, V45, P1981, DOI 10.1128/JCM.00273-07; Gorwitz RJ, 2008, PEDIATR INFECT DIS J, V27, P1, DOI 10.1097/INF.0b013e31815819bb; Grundmann H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000215; HACKBARTH CJ, 1993, ANTIMICROB AGENTS CH, V37, P1144, DOI 10.1128/AAC.37.5.1144; Haenni M, 2012, J ANTIMICROB CHEMOTH, V67, P326, DOI 10.1093/jac/dkr499; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Holmes A, 2010, J CLIN MICROBIOL, V48, P3600, DOI 10.1128/JCM.01039-10; Horvath A, 2012, EUR J CLIN MICROBIOL, V31, P2029, DOI 10.1007/s10096-011-1536-z; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jarraud S, 2002, INFECT IMMUN, V70, P631, DOI 10.1128/IAI.70.2.631-641.2002; Kawaguchiya M, 2011, MICROB DRUG RESIST, V17, P241, DOI 10.1089/mdr.2010.0136; Kock R, 2011, J HOSP INFECT, V79, P292, DOI 10.1016/j.jhin.2011.08.011; Kock R, 2010, EUROSURVEILLANCE, V15, P12, DOI 10.2807/ese.15.41.19688-en; Koser CU, 2012, NEW ENGL J MED, V366, P2267, DOI 10.1056/NEJMoa1109910; Koreen L, 2004, J CLIN MICROBIOL, V42, P792, DOI 10.1128/JCM.42.2.792-799.2004; Lamy B, 2012, EUR J CLIN MICROBIOL, V31, P1279, DOI 10.1007/s10096-011-1441-5; Lina G, 2004, J INFECT DIS, V189, P2334, DOI 10.1086/420852; Lindsay JA, 2006, J BACTERIOL, V188, P669, DOI 10.1128/JB.188.2.669-676.2006; Loffler B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000715; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Milheirico C, 2007, ANTIMICROB AGENTS CH, V51, P3374, DOI 10.1128/AAC.00275-07; Monecke S, 2008, CLIN MICROBIOL INFEC, V14, P534, DOI 10.1111/j.1469-0691.2008.01986.x; Monecke S, 2005, CLIN MICROBIOL INFEC, V11, P825, DOI 10.1111/j.1469-0691.2005.01243.x; Monecke S, 2009, EUR J CLIN MICROBIOL, V28, P1383, DOI 10.1007/s10096-009-0796-3; Monecke S, 2008, FEMS IMMUNOL MED MIC, V53, P237, DOI 10.1111/j.1574-695X.2008.00426.x; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; Monecke S, 2011, VET MICROBIOL, V150, P309, DOI 10.1016/j.vetmic.2011.02.001; Moore PCL, 2001, J CLIN MICROBIOL, V39, P2760, DOI 10.1128/JCM.39.8.2760-2767.2001; Nienaber JJC, 2011, J INFECT DIS, V204, P704, DOI 10.1093/infdis/jir389; Novembre J, 2008, NAT GENET, V40, P646, DOI 10.1038/ng.139; Nuebel U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032698; Peacock SJ, 2002, INFECT IMMUN, V70, P4987, DOI 10.1128/IAI.70.9.4987-4996.2002; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pryer JA, 2001, J EPIDEMIOL COMMUN H, V55, P29, DOI 10.1136/jech.55.1.29; Quackenbush J, 2001, NAT REV GENET, V2, P418, DOI 10.1038/35076576; Robinson DA, 2005, J BACTERIOL, V187, P8312, DOI 10.1128/JB.187.24.8312-8321.2005; Sakwinska O, 2009, APPL ENVIRON MICROB, V75, P175, DOI 10.1128/AEM.01860-08; Schouls LM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005082; Strommenger B, 2008, J CLIN MICROBIOL, V46, P574, DOI 10.1128/JCM.01599-07; Strommenger B, 2006, J CLIN MICROBIOL, V44, P2533, DOI 10.1128/JCM.00420-06; Vu-Thien H, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-24; Xue T, 2011, INFECT IMMUN, V79, P2154, DOI 10.1128/IAI.01180-10; Young BC, 2012, P NATL ACAD SCI USA, V109, P4550, DOI 10.1073/pnas.1113219109; Zhang MH, 2000, CRIT CARE MED, V28, pN60, DOI 10.1097/00003246-200004001-00007	56	24	24	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52487	10.1371/journal.pone.0052487	http://dx.doi.org/10.1371/journal.pone.0052487			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285062	Green Published, Green Submitted, gold			2022-12-27	WOS:000312794500182
J	Staniszewska, AD; Pensa, S; Caffarel, MM; Anderson, LH; Poli, V; Watson, CJ				Staniszewska, Anna D.; Pensa, Sara; Caffarel, Maria M.; Anderson, Lisa H.; Poli, Valeria; Watson, Christine J.			Stat3 Is Required to Maintain the Full Differentiation Potential of Mammary Stem Cells and the Proliferative Potential of Mammary Luminal Progenitors	PLOS ONE			English	Article							LEUKEMIA INHIBITORY FACTOR; SERIAL TRANSPLANTATION; GLAND INVOLUTION; EPITHELIAL-CELLS; TRANSGENIC MICE; SELF-RENEWAL; LIFE SPAN; IN-VIVO; ACTIVATION; GENE	Stat3 has a defined role in mammary gland where it is a critical mediator of cell death during post-lactational regression. On the other hand, Stat3 is required for the self-renewal of embryonic stem cells and is sufficient for the induction of a naive pluripotent state in epiblast stem cells. Mammary stem cells (MaSCs) have a high capacity for self-renewal and can grow robustly in transplantation experiments in vivo. However, a role for Stat3 in MaSCs has not been investigated. Here we show that depletion of Stat3 from basal cells results in reduced primary transplantation efficiency and diminishes the potential to generate ductal, but not alveolar, outgrowths. In addition, Stat3 is required for maximal proliferation of luminal progenitors.	[Staniszewska, Anna D.; Pensa, Sara; Caffarel, Maria M.; Anderson, Lisa H.; Watson, Christine J.] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Poli, Valeria] Univ Turin, Ctr Mol Biotechnol, Dept Genet Biol & Biochem, Turin, Italy	University of Cambridge; University of Turin	Watson, CJ (corresponding author), Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England.	cjw53@cam.ac.uk	Poli, Valeria/A-9215-2012	Poli, Valeria/0000-0002-3739-3966; Staniszewska, Anna/0000-0003-1328-1959; Caffarel, Maria/0000-0002-7442-6827; Anderson, Lisa/0000-0001-9541-1950	Breast Cancer Campaign; Marie Curie Intra-European fellowship FP7-PEOPLE-IEF; MRC [G0900980] Funding Source: UKRI; Medical Research Council [G0900980] Funding Source: researchfish	Breast Cancer Campaign; Marie Curie Intra-European fellowship FP7-PEOPLE-IEF; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a PhD studentship grant from the Breast Cancer Campaign to A. D. S. and C.J.W. S. P. is the recipient of a Marie Curie Intra-European fellowship FP7-PEOPLE-2010-IEF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonzi T, 2001, MOL CELL BIOL, V21, P1621, DOI 10.1128/MCB.21.5.1621-1632.2001; Asselin-Labat ML, 2008, COLD SH Q B, V73, P469, DOI 10.1101/sqb.2008.73.020; Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Boulanger CA, 2005, ONCOGENE, V24, P552, DOI 10.1038/sj.onc.1208185; Chapman RS, 1999, GENE DEV, V13, P2604, DOI 10.1101/gad.13.19.2604; Cui Y, 2004, MOL CELL BIOL, V24, P8037, DOI 10.1128/MCB.24.18.8037-8047.2004; DANIEL CW, 1968, P NATL ACAD SCI USA, V61, P53, DOI 10.1073/pnas.61.1.53; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Hennighausen L, 2005, NAT REV MOL CELL BIO, V6, P715, DOI 10.1038/nrm1714; Hirai H, 2011, BIOCHEM J, V438, P11, DOI 10.1042/BJ20102152; HOSHINO K, 1967, NATURE, V213, P193, DOI 10.1038/213193a0; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Humphreys RC, 2002, ENDOCRINOLOGY, V143, P3641, DOI 10.1210/en.2002-220224; Iavnilovitch E, 2002, MOL CANCER RES, V1, P32; Kordon EC, 1998, DEVELOPMENT, V125, P1921; Kreuzaler PA, 2011, NAT CELL BIOL, V13, P303, DOI 10.1038/ncb2171; Liu XW, 1997, GENE DEV, V11, P179, DOI 10.1101/gad.11.2.179; LIU XW, 1995, P NATL ACAD SCI USA, V92, P8831, DOI 10.1073/pnas.92.19.8831; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Matthews JR, 2011, CELL DEATH DIFFER, V18, P1934, DOI 10.1038/cdd.2011.77; Matulka LA, 2007, DEV BIOL, V303, P29, DOI 10.1016/j.ydbio.2006.12.017; Molyneux G, 2010, CELL STEM CELL, V7, P403, DOI 10.1016/j.stem.2010.07.010; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Oh IH, 2002, ONCOGENE, V21, P4778, DOI 10.1038/sj.onc.1205592; Selbert S, 1998, TRANSGENIC RES, V7, P387, DOI 10.1023/A:1008848304391; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Sleeman KE, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1371; Smith GH, 1996, BREAST CANCER RES TR, V39, P21, DOI 10.1007/BF01806075; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Turkson J, 2000, ONCOGENE, V19, P6613, DOI 10.1038/sj.onc.1204086; Van Keymeulen A, 2011, NATURE; Wagner KU, 2002, DEVELOPMENT, V129, P1377; WARLEY A, 1995, DIABETOLOGIA, V38, P413, DOI 10.1007/s001250050300; WHITELAW CBA, 1992, BIOCHEM J, V286, P31, DOI 10.1042/bj2860031; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Yamaji D, 2009, GENE DEV, V23, P2382, DOI 10.1101/gad.1840109	37	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52608	10.1371/journal.pone.0052608	http://dx.doi.org/10.1371/journal.pone.0052608			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285109	Green Published, Green Submitted, gold			2022-12-27	WOS:000312794500209
J	Tan, J; Lim, PE; Phang, SM; Hong, DD; Sunarpi, H; Hurtado, AQ				Tan, Ji; Lim, Phaik-Eem; Phang, Siew-Moi; Dang Diem Hong; Sunarpi, H.; Hurtado, Anicia Q.			Assessment of Four Molecular Markers as Potential DNA Barcodes for Red Algae Kappaphycus Doty and Eucheuma J. Agardh (Solieriaceae, Rhodophyta)	PLOS ONE			English	Article							CANADIAN WATERS; GIGARTINALES; RBCL; SYSTEMATICS; GELIDIALES; MORPHOLOGY; PHYLOGENY; SEQUENCE; PHAEOPHYCEAE; DIVERSITY	DNA barcoding has been a major advancement in the field of taxonomy, seeing much effort put into the barcoding of wide taxa of organisms, macro and microalgae included. The mitochondrial-encoded cox1 and plastid-encoded rbcL has been proposed as potential DNA barcodes for rhodophytes, but are yet to be tested on the commercially important carrageenophytes Kappaphycus and Eucheuma. This study gauges the effectiveness of four markers, namely the mitochondrial cox1, cox2, cox2-3 spacer and the plastid rbcL in DNA barcoding on selected Kappaphycus and Eucheuma from Southeast Asia. Marker assessments were performed using established distance and tree-based identification criteria from earlier studies. Barcoding patterns on a larger scale were simulated by empirically testing on the commonly used cox2-3 spacer. The phylogeny of these rhodophytes was also briefly described. In this study, the cox2 marker which satisfies the prerequisites of DNA barcodes was found to exhibit moderately high interspecific divergences with no intraspecific variations, thus a promising marker for the DNA barcoding of Kappaphycus and Eucheuma. However, the already extensively used cox2-3 spacer was deemed to be in overall more appropriate as a DNA barcode for these two genera. On a wider scale, cox1 and rbcL were still better DNA barcodes across the rhodophyte taxa when practicality and cost-efficiency were taken into account. The phylogeny of Kappaphycus and Eucheuma were generally similar to those earlier reported. Still, the application of DNA barcoding has demonstrated our relatively poor taxonomic comprehension of these seaweeds, thus suggesting more in-depth efforts in taxonomic restructuring as well as establishment. Citation: Tan J, Lim P-E, Phang S-M, Hong DD, Sunarpi H, et al. (2012) Assessment of Four Molecular Markers as Potential DNA Barcodes for Red Algae Kappaphycus Doty and Eucheuma J. Agardh (Solieriaceae, Rhodophyta). PLoS ONE 7(12): e52905. doi:10.1371/journal.pone.0052905	[Tan, Ji; Lim, Phaik-Eem; Phang, Siew-Moi] Univ Malaya, Inst Biol Sci, Kuala Lumpur, Malaysia; [Tan, Ji; Lim, Phaik-Eem; Phang, Siew-Moi] Univ Malaya, IOES, Kuala Lumpur, Malaysia; [Dang Diem Hong] Vietnamese Acad Sci & Technol, Inst Biotechnol, Hanoi, Vietnam; [Sunarpi, H.] Mataram Univ, Fac Sci & Math, Mataram, Lombok, Indonesia; [Hurtado, Anicia Q.] Integrated Serv Dev Aquaculture & Fisheries, Iliolo City, Philippines	Universiti Malaya; Universiti Malaya; Vietnam Academy of Science & Technology (VAST); Universitas Mataram	Lim, PE (corresponding author), Univ Malaya, Inst Biol Sci, Kuala Lumpur, Malaysia.	phaikeem@um.edu.my	Tan, Ji/J-1653-2017; LIM, Phaik Eem/B-5331-2010; Phang, Siew Moi/A-7653-2008	LIM, Phaik Eem/0000-0001-9186-1487; Tan, Ji/0000-0002-1264-5442	E-Science Fund [14-02-03-4027]; Department of Fisheries Malaysia [53-02-03-1062]; University of Malaya Malaya, PPP [PV014/2011A]	E-Science Fund; Department of Fisheries Malaysia; University of Malaya Malaya, PPP	Project funding is by the E-Science Fund, Project No. 14-02-03-4027, Department of Fisheries Malaysia (53-02-03-1062) and University of Malaya Malaya, PPP (Phylogenetic analysis of Kappaphycus spp. and Eucheuma spp. with the application of various molecular markers; grant number: PV014/2011A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bindu MS, 2010, J APPL PHYCOLOGY; Bixler HJ, 2011, J APPL PHYCOL, V23, P321, DOI 10.1007/s10811-010-9529-3; Clarkston BE, 2010, BOTANY, V88, P119, DOI 10.1139/B09-101; Conklin KY, 2009, J APPL PHYCOL, V21, P691, DOI 10.1007/s10811-009-9404-2; de Paula EJ, 1999, J APPL PHYCOL, V11, P111, DOI 10.1023/A:1008085614360; DeSalle R, 2012, PLOS ONE, V7; Doty MS, 1985, TAXONOMY EC SEAWEEDS, P37; Fredericq S, 1999, HYDROBIOLOGIA, V399, P25; Freshwater DW, 2010, CRYPTOGAMIE ALGOL, V31, P435; FRESHWATER DW, 1994, PHYCOLOGIA, V33, P187, DOI 10.2216/i0031-8884-33-3-187.1; Ganzon-Fortes ET, 2012, J APPL PHYCOL, V24, P1107, DOI 10.1007/s10811-011-9740-x; Gavio B, 2002, EUR J PHYCOL, V37, P349, DOI 10.1017/S0967026202003839; Geraldino Paul John L., 2006, Algae, V21, P417; Geraldino PJL, 2009, TAXON, V58, P606, DOI 10.1002/tax.582023; Gompert Z, 2006, MOL ECOL, V15, P1759, DOI 10.1111/j.1365-294X.2006.02905.x; Halling C, 2012, J APPL PHYC IN PRESS; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Jinbo U, 2011, ENTOMOL SCI, V14, P107, DOI 10.1111/j.1479-8298.2011.00449.x; Kim MS, 2010, CRYPTOGAMIE ALGOL, V31, P387; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Kucera H, 2008, BOTANY, V86, P1065, DOI 10.1139/B08-056; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Le Gall L, 2010, J PHYCOL, V46, P374, DOI 10.1111/j.1529-8817.2010.00807.x; LEBLANC C, 1995, J MOL BIOL, V250, P484, DOI 10.1006/jmbi.1995.0392; McDevit DC, 2010, PHYCOLOGIA, V49, P235, DOI 10.2216/PH09-36.1; Meier R, 2008, SYST BIOL, V57, P809, DOI 10.1080/10635150802406343; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Meyer CP, 2004, MALACOLOGIA, V46, P127; Phang SM, 2010, MALAYSIAN J SCI, V29, P214, DOI DOI 10.22452/mjs.vol29no3.4; Pickering TD, 2007, BOT MAR, V50, P338, DOI 10.1515/BOT.2007.039; Rambaut A, 2010, FIGTREE V131; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Robba L, 2006, AM J BOT, V93, P1101, DOI 10.3732/ajb.93.8.1101; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sarkar IN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014689; Saunders GW, 2008, BOTANY, V86, P773, DOI 10.1139/B08-001; Saunders GW, 2009, MOL ECOL RESOUR, V9, P140, DOI 10.1111/j.1755-0998.2009.02639.x; Saunders GW, 2005, PHILOS T R SOC B, V360, P1879, DOI 10.1098/rstb.2005.1719; Sherwood AR, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-258; Silvestro D., 2011, ORG DIVERS EVOL, V12, P335, DOI [10.1007/sI3127-011-0056-0, DOI 10.1007/S13127-011-0056-0]; Swofford DL., 2003, PAUP PHYLOGENETIC AN; Tan J, 2013, J APPL PHYCOL, V25, P13, DOI 10.1007/s10811-012-9833-1; Tanabe AS, 2011, MOL ECOL RESOUR, V11, P914, DOI 10.1111/j.1755-0998.2011.03021.x; van Velzen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030490; Virgilio M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-206; Wiriyadamrikul J, 2010, BOT MAR, V53, P343, DOI 10.1515/BOT.2010.037; Yang EC, 2008, J APPL PHYCOL, V20, P161, DOI 10.1007/s10811-007-9201-8; Zhao SF, 2011, CHIN J OCEANOL LIMN, V29, P1287, DOI 10.1007/s00343-011-1032-4; Zhou XH, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016733, 10.1371/journal.pone.0017812]; Zuccarello GC, 2006, PHYCOLOGIA, V45, P24, DOI 10.2216/05-07.1; Zuccarello GC, 1999, MOL ECOL, V8, P1443, DOI 10.1046/j.1365-294x.1999.00710.x; Zuccarello GC, 2006, J APPL PHYCOL, V18, P643, DOI 10.1007/s10811-006-9066-2	57	36	38	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52905	10.1371/journal.pone.0052905	http://dx.doi.org/10.1371/journal.pone.0052905			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285223	Green Published, Green Submitted, gold			2022-12-27	WOS:000312794500256
J	Atkinson, PJ; Wise, AK; Flynn, BO; Nayagam, BA; Hume, CR; O'Leary, SJ; Shepherd, RK; Richardson, RT				Atkinson, Patrick J.; Wise, Andrew K.; Flynn, Brianna O.; Nayagam, Bryony A.; Hume, Clifford R.; O'Leary, Stephen J.; Shepherd, Robert K.; Richardson, Rachael T.			Neurotrophin Gene Therapy for Sustained Neural Preservation after Deafness	PLOS ONE			English	Article							SPIRAL GANGLION NEURONS; SENSORINEURAL HEARING-LOSS; GUINEA-PIG COCHLEA; ELECTRICAL-STIMULATION; AUDITORY NEURONS; SURVIVAL; EXPRESSION; ADENOVIRUS; RECEPTOR; CELLS	The cochlear implant provides auditory cues to profoundly deaf patients by electrically stimulating the residual spiral ganglion neurons. These neurons, however, undergo progressive degeneration after hearing loss, marked initially by peripheral fibre retraction and ultimately culminating in cell death. This research aims to use gene therapy techniques to both hold and reverse this degeneration by providing a sustained and localised source of neurotrophins to the deafened cochlea. Adenoviral vectors containing green fluorescent protein, with or without neurotrophin-3 and brain derived neurotrophic factor, were injected into the lower basal turn of scala media of guinea pigs ototoxically deafened one week prior to intervention. This single injection resulted in localised and sustained gene expression, principally in the supporting cells within the organ of Corti. Guinea pigs treated with adenoviral neurotrophin-gene therapy had greater neuronal survival compared to contralateral non-treated cochleae when examined at 7 and 11 weeks post injection. Moreover; there was evidence of directed peripheral fibre regrowth towards cells expressing neurotrophin genes after both treatment periods. These data suggest that neurotrophin-gene therapy can provide sustained protection of spiral ganglion neurons and peripheral fibres after hearing loss.	[Atkinson, Patrick J.; Wise, Andrew K.; Flynn, Brianna O.; Nayagam, Bryony A.; O'Leary, Stephen J.; Shepherd, Robert K.; Richardson, Rachael T.] Bion Inst, Melbourne, Vic, Australia; [Atkinson, Patrick J.; Wise, Andrew K.; Nayagam, Bryony A.; O'Leary, Stephen J.; Shepherd, Robert K.; Richardson, Rachael T.] Univ Melbourne, Dept Otolaryngol, Melbourne, Vic, Australia; [Wise, Andrew K.; Shepherd, Robert K.; Richardson, Rachael T.] Univ Melbourne, Dept Med Bion, Melbourne, Vic, Australia; [Hume, Clifford R.] Univ Washington, Dept Otolaryngol Head & Neck Surg, Seattle, WA 98195 USA	Bionics Institute; University of Melbourne; University of Melbourne; University of Washington; University of Washington Seattle	Richardson, RT (corresponding author), Bion Inst, Melbourne, Vic, Australia.	rrichardson@bionicsinstitute.org	Shepherd, Robert/I-6276-2012; Shepherd, Robert/G-1332-2013; Wise, Andrew/B-5943-2014	Wise, Andrew/0000-0001-9715-8784; Richardson, Rachael/0000-0002-2412-8354; O'Leary, Stephen/0000-0001-6926-2103; Nayagam, Bryony/0000-0003-1069-6059; Shepherd, Robert/0000-0002-4239-3362	Action on Hearing Loss; Garnett Passe and Rodney Williams Memorial Foundation; National Institutes of Health [NIDCD HHS-N-263-2007-00053-c, NIDCD DC-006437, NIDCD P30 DC-04661, NICHHD P30 HD-02774]; University Of Melbourne Department Of Otolaryngology; Royal Victorian Eye and Ear Hospital; Hearing Regeneration Initiative; Veterans' Hospital Administration; State Government of Victoria's Operational Infrastructure Program; RNID [G39] Funding Source: researchfish; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K08DC006437, P30DC004661] Funding Source: NIH RePORTER	Action on Hearing Loss; Garnett Passe and Rodney Williams Memorial Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University Of Melbourne Department Of Otolaryngology; Royal Victorian Eye and Ear Hospital; Hearing Regeneration Initiative; Veterans' Hospital Administration; State Government of Victoria's Operational Infrastructure Program; RNID; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Action on Hearing Loss (http://www.actiononhearingloss.org.uk/, The Garnett Passe and Rodney Williams Memorial Foundation, The National Institutes of Health (http://www.nih.gov/)(NIDCD HHS-N-263-2007-00053-c, NIDCD DC-006437, NIDCD P30 DC-04661, NICHHD P30 HD-02774), The University Of Melbourne Department Of Otolaryngology (http://www.unimelb.edu.au/), The Royal Victorian Eye and Ear Hospital (http://www.eyeandear.org.au/), The Hearing Regeneration Initiative (http://www.hearingregeneration.com/), The Veterans' Hospital Administration, The State Government of Victoria's Operational Infrastructure Program (http://www.business.vic.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agterberg MJH, 2008, HEARING RES, V244, P25, DOI 10.1016/j.heares.2008.07.004; Agterberg MJH, 2009, JARO-J ASSOC RES OTO, V10, P355, DOI 10.1007/s10162-009-0170-2; Amalfitano A, 1998, J VIROL, V72, P926, DOI 10.1128/JVI.72.2.926-933.1998; Backhouse S, 2008, EXP NEUROL, V214, P193, DOI 10.1016/j.expneurol.2008.08.002; BICHLER E, 1983, ARCH OTO-RHINO-LARYN, V237, P201, DOI 10.1007/BF00453725; Chikar JA, 2008, HEARING RES, V245, P24, DOI 10.1016/j.heares.2008.08.005; Clark GM, 2003, AIP SER MOD AC SIG, P160; Coyne CB, 2005, ADV DRUG DELIVER REV, V57, P869, DOI 10.1016/j.addr.2005.01.007; Dalkara D, 2011, MOL THER, V19, P1602, DOI 10.1038/mt.2011.62; Davis A C, 1990, Acta Otolaryngol Suppl, V476, P23; Dodson HC, 2000, J NEUROCYTOL, V29, P525, DOI 10.1023/A:1007201913730; Eberling JL, 2009, HUM GENE THER, V20, P511, DOI 10.1089/hum.2008.201; ERNFORS P, 1992, EUR J NEUROSCI, V4, P1140, DOI 10.1111/j.1460-9568.1992.tb00141.x; Ernfors P, 1996, NAT MED, V2, P463, DOI 10.1038/nm0496-463; Farinas I, 2001, J NEUROSCI, V21, P6170, DOI 10.1523/JNEUROSCI.21-16-06170.2001; Feghali J G, 1998, Ear Nose Throat J, V77, P282; Feghali JG, 1998, ENT-EAR NOSE THROAT, V77, P282; Feghali JG, 1998, ENT-EAR NOSE THROAT, V77, P280; Fritzsch B, 1998, INT J DEV NEUROSCI, V16, P493, DOI 10.1016/S0736-5748(98)00043-4; Fritzsch B, 1997, TRENDS NEUROSCI, V20, P159, DOI 10.1016/S0166-2236(96)01007-7; Gillespie LN, 2003, J NEUROSCI RES, V71, P785, DOI 10.1002/jnr.10542; Glueckert R, 2008, J COMP NEUROL, V507, P1602, DOI 10.1002/cne.21619; Hardie NA, 1999, HEARING RES, V128, P147, DOI 10.1016/S0378-5955(98)00209-3; James DP, 2008, AUDIOL NEURO-OTOL, V13, P86, DOI 10.1159/000111780; Keithley EM, 1996, LARYNGOSCOPE, V106, P341, DOI 10.1097/00005537-199603000-00019; KOITCHEV K, 1982, ACTA OTO-LARYNGOL, V94, P431, DOI 10.3109/00016488209128931; Landry TG, 2011, THESIS U MELBOURNE M; LEAKE PA, 1988, HEARING RES, V33, P11, DOI 10.1016/0378-5955(88)90018-4; Leake PA, 2011, J COMP NEUROL, V519, P1526, DOI 10.1002/cne.22582; Lin DW, 1997, OTOLARYNG HEAD NECK, V117, P530, DOI 10.1016/S0194-5998(97)70026-3; NADOL JB, 1989, ANN OTO RHINOL LARYN, V98, P411, DOI 10.1177/000348948909800602; Nakaizumi T, 2004, AUDIOL NEURO-OTOL, V9, P135, DOI 10.1159/000077264; RAPHAEL Y, 1991, CELL MOTIL CYTOSKEL, V18, P215, DOI 10.1002/cm.970180307; Richardson RT, 2009, BIOMATERIALS, V30, P2614, DOI 10.1016/j.biomaterials.2009.01.015; Richardson RT, 2004, HEARING RES, V198, P25, DOI 10.1016/j.heares.2004.02.012; Sellick P, 2008, J NEUROSCI METH, V167, P237, DOI 10.1016/j.jneumeth.2007.08.026; SHEPHERD RK, 1985, HEARING RES, V18, P105, DOI 10.1016/0378-5955(85)90001-2; SHEPHERD RK, 1993, HEARING RES, V66, P108, DOI 10.1016/0378-5955(93)90265-3; Shibata SB, 2010, EXP NEUROL, V223, P464, DOI 10.1016/j.expneurol.2010.01.011; Slevin JT, 2007, J NEUROSURG, V106, P614, DOI 10.3171/jns.2007.106.4.614; SPOENDLIN H, 1975, ACTA OTO-LARYNGOL, V79, P266, DOI 10.3109/00016487509124683; Stankovic K, 2004, J NEUROSCI, V24, P8651, DOI 10.1523/JNEUROSCI.0733-04.2004; Taylor RR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030577; Tuinstra HM, 2012, BIOMATERIALS, V33, P1618, DOI 10.1016/j.biomaterials.2011.11.002; van den Honert C, 2007, J ACOUST SOC AM, V121, P3703, DOI 10.1121/1.2722047; Venail F, 2007, GENE THER, V14, P30, DOI 10.1038/sj.gt.3302826; Versnel H, 2007, HEARING RES, V231, P1, DOI 10.1016/j.heares.2007.03.003; Waehler R, 2007, NAT REV GENET, V8, P573, DOI 10.1038/nrg2141; Wilson DH, 1999, INT J EPIDEMIOL, V28, P247, DOI 10.1093/ije/28.2.247; Wise AK, 2005, J COMP NEUROL, V487, P147, DOI 10.1002/cne.20563; Wise AK, 2011, HEARING RES, V278, P69, DOI 10.1016/j.heares.2011.04.010; Wise AK, 2010, MOL THER, V18, P1111, DOI 10.1038/mt.2010.28; YLIKOSKI J, 1993, HEARING RES, V65, P69, DOI 10.1016/0378-5955(93)90202-C	53	40	41	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e52338	10.1371/journal.pone.0052338	http://dx.doi.org/10.1371/journal.pone.0052338			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284995	gold, Green Published, Green Submitted			2022-12-27	WOS:000312435900090
J	Griesser, M; Schneider, NA; Collis, MA; Overs, A; Guppy, M; Guppy, S; Takeuchi, N; Collins, P; Peters, A; Hall, ML				Griesser, Michael; Schneider, Nicole A.; Collis, Mary-Anne; Overs, Anthony; Guppy, Michael; Guppy, Sarah; Takeuchi, Naoko; Collins, Pete; Peters, Anne; Hall, Michelle L.			Causes of Ring-Related Leg Injuries in Birds - Evidence and Recommendations from Four Field Studies	PLOS ONE			English	Article							AUSTRALIAN PASSERINE; SIBERIAN JAY; FOOT LOSS; BANDS; FLYCATCHERS; MORTALITY; PREDATION; BEHAVIOR; PLOVERS; HISTORY	One of the main techniques for recognizing individuals in avian field research is marking birds with plastic and metal leg rings. However, in some species individuals may react negatively to rings, causing leg injuries and, in extreme cases, the loss of a foot or limb. Here, we report problems that arise from ringing and illustrate solutions based on field data from Brown Thornbills (Acanthiza pusilla) (2 populations), Siberian Jays (Perisoreus infaustus) and Purple-crowned Fairy-wrens (Malurus coronatus). We encountered three problems caused by plastic rings: inflammations triggered by material accumulating under the ring (Purple-crowned Fairy-wrens), contact inflammations as a consequence of plastic rings touching the foot or tibio-tarsal joint (Brown Thornbills), and toes or the foot getting trapped in partly unwrapped flat-band colour rings (Siberian Jays). Metal rings caused two problems: the edges of aluminium rings bent inwards if mounted on top of each other (Brown Thornbills), and too small a ring size led to inflammation (Purple-crowned Fairy-wrens). We overcame these problems by changing the ringing technique (using different ring types or larger rings), or using different adhesive. Additionally, we developed and tested a novel, simple technique of gluing plastic rings onto metal rings in Brown Thornbills. A review of studies reporting ring injuries (N = 23) showed that small birds (<55 g body weight) are more prone to leg infections while larger birds (>35 g) tend to get rings stuck over their feet. We give methodological advice on how these problems can be avoided, and suggest a ringing hazard index to compare the impact of ringing in terms of injury on different bird species. Finally, to facilitate improvements in ringing techniques, we encourage online deposition of information regarding ringing injuries of birds at a website hosted by the European Union for Bird Ringing (EURING).	[Griesser, Michael] Univ Bern, Dept Biol, Inst Ecol & Evolut, Bern, Switzerland; [Griesser, Michael; Schneider, Nicole A.] Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden; [Griesser, Michael] Univ Zurich, Anthropol Inst & Museum, Zurich, Switzerland; [Schneider, Nicole A.] Univ Tasmania, Sch Zool, Hobart, Tas, Australia; [Peters, Anne] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia; [Hall, Michelle L.] Univ Melbourne, Dept Zool, Melbourne, Vic, Australia	University of Bern; Swedish University of Agricultural Sciences; University of Zurich; University of Tasmania; Monash University; University of Melbourne	Griesser, M (corresponding author), Univ Bern, Dept Biol, Inst Ecol & Evolut, Bern, Switzerland.	michael.griesser@uzh.ch	Hall, Michelle L/A-1904-2010; Griesser, Michael/J-4542-2012; Peters, Anne/A-1821-2010	Hall, Michelle L/0000-0002-1263-8314; Griesser, Michael/0000-0002-2220-2637; Peters, Anne/0000-0001-8071-0560	Swedish Research Council [621-2008-5349]; Swiss National Science Foundation [PPOOP3-123520]; Stiftelsen Lars Hiertas Minne [FO2010-0041]; Max Planck Society (Minerva Program)	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Stiftelsen Lars Hiertas Minne; Max Planck Society (Minerva Program)	The different project were made possible from funding from the Swedish Research Council (621-2008-5349; to MGR), the Swiss National Science Foundation (PPOOP3-123520; to MGR), Stiftelsen Lars Hiertas Minne (FO2010-0041; to NAS), and the Max Planck Society (Minerva Program; to AP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amat JA, 1999, J FIELD ORNITHOL, V70, P555; Amirault DL, 2006, J FIELD ORNITHOL, V77, P18, DOI 10.1111/j.1557-9263.2006.00002.x; Armstrong DP, 1999, BIOL CONSERV, V89, P329, DOI 10.1016/S0006-3207(99)00012-9; Berggren A, 2004, WILDLIFE RES, V31, P535, DOI 10.1071/WR03058; Blake C. H., 1954, Bird-Banding, V25, P11; Boland CRJ, 2002, EMU, V102, P9, DOI 10.1071/MU01039; Brown J.L., 1987, HELPING COMMUNAL BRE; Calvo B., 1992, Ringing and Migration, V13, P129; Cresswell W, 2007, J AVIAN BIOL, V38, P309, DOI 10.1111/j.0908-8857.2007.03925.x; Dettmann B, 1999, FLIGHTLINES, P3; Eggers S, 2005, OIKOS, V111, P150, DOI 10.1111/j.0030-1299.2005.13802.x; Ekman J, 2001, J ANIM ECOL, V70, P317, DOI 10.1046/j.1365-2656.2001.00490.x; GRATTOTREVOR CL, 1994, J FIELD ORNITHOL, V65, P133; Green DJ, 2001, J ANIM ECOL, V70, P505, DOI 10.1046/j.1365-2656.2001.00503.x; Green DJ, 1999, AUST J ZOOL, V47, P633, DOI 10.1071/ZO99052; Griesser M, 2012, FOREST ECOL MANAG, V271, P58, DOI 10.1016/j.foreco.2012.01.037; Griesser M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023438; Guppy M, AUSTR ZOOLO IN PRESS; Gustafson M. E., 1997, N AM BIRD BANDING MA; Hall ML, 2008, ANIM BEHAV, V76, P65, DOI 10.1016/j.anbehav.2008.01.010; Hartley I, 2011, RINGING NEWS, V12, P8; Higgins P. J., 2002, HDB AUSTR NZ ANTARCT, V6; KEAST A, 1970, Biotropica, V2, P61, DOI 10.2307/2989764; Kingma SA, 2011, AM NAT, V177, P486, DOI 10.1086/658989; Koronkiewicz TJ, 2005, J FIELD ORNITHOL, V76, P94, DOI 10.1648/0273-8570-76.1.94; Marchant S, 1992, EUROBODALLA NATURAL, V1, P1; Newton I., 1998, POPULATION LIMITATIO; Nice M.M., 1937, T LINNAEAN SOC NEW Y, V4, P1; NISBET ICT, 1991, N AM BIRD BANDER, V16, P61; Nystrand M, 2010, J ANIM ECOL, V79, P266, DOI 10.1111/j.1365-2656.2009.01627.x; Pekins CE, 2002, GOLDEN CHEEKED WARBL; Pierce Andrew J., 2007, Ringing & Migration, V23, P205; REED JM, 1993, J FIELD ORNITHOL, V64, P145; Reed P. C., 1953, Bird-Banding, V24, P65; Roff Derek A., 1992; Saraux C, 2011, NATURE, V469, P203, DOI 10.1038/nature09630; Schneider NA, 2012, GETTING INFORM RISKY; Schneider NA, 2013, BEHAV ECOL, V24, P47, DOI 10.1093/beheco/ars134; Sedgwick JA, 1997, J FIELD ORNITHOL, V68, P622; Splittgerber K, 2006, J FIELD ORNITHOL, V77, P195, DOI 10.1111/j.1557-9263.2006.00041.x; Stacey P.B., 1990, COOPERATIVE BREEDING; SWEENEY TM, 1985, J FIELD ORNITHOL, V56, P251	42	19	22	5	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e51891	10.1371/journal.pone.0051891	http://dx.doi.org/10.1371/journal.pone.0051891			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300574	Green Published, gold, Green Accepted			2022-12-27	WOS:000313618800033
J	Roescher, N; Vosters, JL; Lai, ZA; Uede, T; Tak, PP; Chiorini, JA				Roescher, Nienke; Vosters, Jelle L.; Lai, Zhenan; Uede, Toshimitsu; Tak, Paul P.; Chiorini, John A.			Local Administration of Soluble CD40:Fc to the Salivary Glands of Non-Obese Diabetic Mice Does Not Ameliorate Autoimmune Inflammation	PLOS ONE			English	Article							NF-KAPPA-B; GENE-EXPRESSION; SJOGRENS-SYNDROME; PATHWAYS; THERAPY; CD40IG; LACTOFERRIN; ACTIVATION; INDUCTION; BACTERIA	Objective: CD40-CD154 (CD40 ligand) interaction in the co-stimulatory pathway is involved in many (auto) immune processes and both molecules are upregulated in salivary glands of Sjogren's syndrome (SS) patients. Interference within the CD40 pathway has ameliorated (auto) inflammation in a number of disease models. To test the potential role of the CD40 pathway in loss of gland function and inflammation in SS, an inhibitor of CD40-CD154 interaction was overexpressed in the salivary glands (SGs) of a spontaneous murine model of SS; the Non-Obese Diabetic (NOD) mouse. Materials and Methods: At different disease stages an adeno associated viral vector encoding CD40 coupled to a human Fc domain (CD40: Fc) was injected locally into the SGs of NOD mice. Delivery was confirmed by PCR. The overall effect on local inflammation was determined by assessment of the focus score (FS), quantification of infiltrating cell types, immunoglobulin levels, and microarray analysis. The effect on SG function was determined by measuring stimulated salivary flow. Results: CD40: Fc was stably expressed in the SG of NOD mice, and the protein was secreted into the blood stream. Microarray analysis revealed that expression of CD40: Fc affected the expression of many genes involved in regulation of the immune response. However, FS, infiltrating cell types, immunoglobulin levels, and salivary gland output were similar for treated and control mice. Discussion: Although endogenous CD40 is expressed in SG inflammatory foci in the SG of NOD mice, the expression of soluble CD40: Fc did not lead to reduced overall inflammation and/or improved salivary gland function. These data indicate possible redundancy of the CD40 pathway in the SG and suggests that targeting CD40 alone may not be sufficient to alter the disease phenotype.	[Roescher, Nienke; Vosters, Jelle L.; Lai, Zhenan; Chiorini, John A.] Natl Inst Dent & Craniofacial Res, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD USA; [Roescher, Nienke; Vosters, Jelle L.; Tak, Paul P.] Univ Amsterdam, Acad Med Ctr, Div Clin Immunol & Rheumatol, NL-1105 AZ Amsterdam, Netherlands; [Tak, Paul P.] GlaxoSmithKline, London, England; [Uede, Toshimitsu] Hokkaido Univ, Inst Med Genet, Div Mol Immunol, Sapporo, Hokkaido, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of Amsterdam; Academic Medical Center Amsterdam; GlaxoSmithKline; Hokkaido University	Chiorini, JA (corresponding author), Natl Inst Dent & Craniofacial Res, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD USA.	jchiorini@dir.nidcr.nih.gov			United States National Institutes of Health; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000695] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The study was funded by a United States National Institutes of Health intramural grant to JAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsura M, 2003, ONCOGENE, V22, P412, DOI 10.1038/sj.onc.1206132; Balasa B, 1997, J IMMUNOL, V159, P4620; Cha S, 2002, CRIT REV ORAL BIOL M, V13, P5, DOI 10.1177/154411130201300103; Chang GJ, 2002, SURGERY, V132, P149, DOI 10.1067/msy.2002.125169; Curran CS, 2006, CELL IMMUNOL, V242, P23, DOI 10.1016/j.cellimm.2006.08.006; Dadgostar H, 2002, P NATL ACAD SCI USA, V99, P1497, DOI 10.1073/pnas.032665099; Dimitriou ID, 2002, CLIN EXP IMMUNOL, V127, P386, DOI 10.1046/j.1365-2249.2002.01752.x; Gingery A, 2008, EXP CELL RES, V314, P2725, DOI 10.1016/j.yexcr.2008.06.006; Girvin AM, 2002, J AUTOIMMUN, V18, P83, DOI 10.1006/jaut.2001.0573; GREENSPAN JS, 1974, ORAL SURG ORAL MED O, V37, P217, DOI 10.1016/0030-4220(74)90417-4; Grimm D, 1998, HUM GENE THER, V9, P2745, DOI 10.1089/hum.1998.9.18-2745; Haxhinasto SA, 2002, J IMMUNOL, V169, P1145, DOI 10.4049/jimmunol.169.3.1145; HU YF, 1992, AM J PHYSIOL, V263, pE607, DOI 10.1152/ajpendo.1992.263.4.E607; Inwald DP, 2003, CIRC RES, V92, P1041, DOI 10.1161/01.RES.0000070111.98158.6C; Ishinaga H, 2007, EMBO J, V26, P1150, DOI 10.1038/sj.emboj.7601546; Kaludov N, 2001, J VIROL, V75, P6884, DOI 10.1128/JVI.75.15.6884-6893.2001; Kanaya K, 2003, TRANSPLANTATION, V75, P275, DOI 10.1097/01.TP.0000046966.35399.75; KARMANN K, 1995, P NATL ACAD SCI USA, V92, P4342, DOI 10.1073/pnas.92.10.4342; Kelly JA, 2011, ACR 2011; Kirk AD, 1997, P NATL ACAD SCI USA, V94, P8789, DOI 10.1073/pnas.94.16.8789; Kok MR, 2005, J GENE MED, V7, P432, DOI 10.1002/jgm.678; Livolsi A, 2001, EUR J BIOCHEM, V268, P1508, DOI 10.1046/j.1432-1327.2001.02028.x; LONNERDAL B, 1995, ANNU REV NUTR, V15, P93, DOI 10.1146/annurev.nu.15.070195.000521; Madsen J, 2003, EUR J IMMUNOL, V33, P2327, DOI 10.1002/eji.200323972; MAIA AL, 1995, MOL ENDOCRINOL, V9, P969, DOI 10.1210/me.9.8.969; Mauri C, 2000, NAT MED, V6, P673, DOI 10.1038/76251; Munroe ME, 2007, J IMMUNOL, V178, P671, DOI 10.4049/jimmunol.178.2.671; Najafian N, 2003, EXPERT OPIN BIOL TH, V3, P227, DOI 10.1517/14712598.3.2.227; Nguyen VT, 1998, EUR J IMMUNOL, V28, P2537, DOI 10.1002/(SICI)1521-4141(199808)28:08<2537::AID-IMMU2537>3.0.CO;2-1; Nomura M, 2002, TRANSPLANTATION, V73, P1403, DOI 10.1097/00007890-200205150-00008; Ohlsson M, 2002, SCAND J IMMUNOL, V56, P561, DOI 10.1046/j.1365-3083.2002.01168.x; Qian YC, 2002, P NATL ACAD SCI USA, V99, P9386, DOI 10.1073/pnas.142294499; Roescher N, 2011, ORAL DIS; Roescher N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019962; Saito Miwako, 2007, Mod Rheumatol, V17, P45, DOI 10.1007/s10165-006-0538-7; Schonbeck U, 2001, CELL MOL LIFE SCI, V58, P4, DOI 10.1007/PL00000776; Sidiropoulos PI, 2004, LUPUS, V13, P391, DOI 10.1191/0961203304lu1032oa; Van Kooten Cees, 1997, Frontiers in Bioscience (online), V2, pD1; VANHAASTEREN GAC, 1994, ENDOCRINOLOGY, V135, P1336, DOI 10.1210/en.135.4.1336; Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76	40	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e51375	10.1371/journal.pone.0051375	http://dx.doi.org/10.1371/journal.pone.0051375			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300544	Green Submitted, gold, Green Published			2022-12-27	WOS:000313618800016
J	Borges, R; Johnson, WE; O'Brien, SJ; Vasconcelos, V; Antunes, A				Borges, Rui; Johnson, Warren E.; O'Brien, Stephen J.; Vasconcelos, Vitor; Antunes, Agostinho			The Role of Gene Duplication and Unconstrained Selective Pressures in the Melanopsin Gene Family Evolution and Vertebrate Circadian Rhythm Regulation	PLOS ONE			English	Article							DETECTING POSITIVE SELECTION; RETINAL GANGLION-CELLS; FUNCTIONAL DIVERGENCE; MOLECULAR ADAPTATION; CRYSTAL-STRUCTURE; PHOTOTRANSDUCTION; EXPRESSION; PHYLOGENIES; INFERENCE; RHODOPSIN	Melanopsin is a photosensitive cell protein involved in regulating circadian rhythms and other non-visual responses to light. The melanopsin gene family is represented by two paralogs, OPN4x and OPN4m, which originated through gene duplication early in the emergence of vertebrates. Here we studied the melanopsin gene family using an integrated gene/protein evolutionary approach, which revealed that the rhabdomeric urbilaterian ancestor had the same amino acid patterns (DRY motif and the Y and E conterions) as extant vertebrate species, suggesting that the mechanism for light detection and regulation is similar to rhabdomeric rhodopsins. Both OPN4m and OPN4x paralogs are found in vertebrate genomic paralogons, suggesting that they diverged following this duplication event about 600 million years ago, when the complex eye emerged in the vertebrate ancestor. Melanopsins generally evolved under negative selection (omega = 0.171) with some minor episodes of positive selection (proportion of sites = 25%) and functional divergence (theta(I) = 0.349 and theta(II) = 0.126). The OPN4m and OPN4x melanopsin paralogs show evidence of spectral divergence at sites likely involved in melanopsin light absorbance (200F, 273S and 276A). Also, following the teleost lineage-specific whole genome duplication (3R) that prompted the teleost fish radiation, type I divergence (theta(I) = 0.181) and positive selection (affecting 11% of sites) contributed to amino acid variability that we related with the photo-activation stability of melanopsin. The melanopsin intracellular regions had unexpectedly high variability in their coupling specificity of G-proteins and we propose that Gq/11 and Gi/o are the two G-proteins most-likely to mediate the melanopsin phototransduction pathway. The selection signatures were mainly observed on retinal-related sites and the third and second intracellular loops, demonstrating the physiological plasticity of the melanopsin protein group. Our results provide new insights on the phototransduction process and additional tools for disentangling and understanding the links between melanopsin gene evolution and the specializations observed in vertebrates, especially in teleost fish.	[Borges, Rui; Vasconcelos, Vitor; Antunes, Agostinho] Univ Porto, CIMAR CIIMAR, Ctr Interdisciplinar Invest Marinha & Ambiental, P-4100 Oporto, Portugal; [Borges, Rui; Vasconcelos, Vitor; Antunes, Agostinho] Univ Porto, Dept Biol, Fac Ciencias, P-4100 Oporto, Portugal; [Johnson, Warren E.; O'Brien, Stephen J.; Antunes, Agostinho] NCI, Lab Genom Divers, Frederick, MD 21701 USA; [O'Brien, Stephen J.] St Petersburg State Univ, Theodosius Dobzhansky Ctr Genome Bioinformat, St Petersburg, Russia	Universidade do Porto; Universidade do Porto; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Saint Petersburg State University	Antunes, A (corresponding author), Univ Porto, CIMAR CIIMAR, Ctr Interdisciplinar Invest Marinha & Ambiental, Rua Bragas, P-4100 Oporto, Portugal.	aantunes@ciimar.up.pt	Vasconcelos, Vitor/A-8933-2008; OBRIEN, STEPHEN/ABD-1346-2020; Borges, Rui/H-5873-2016; Johnson, Warren/D-4149-2016	Vasconcelos, Vitor/0000-0003-3585-2417; Borges, Rui/0000-0002-5905-3778; Johnson, Warren/0000-0002-5954-186X; Antunes, Agostinho/0000-0002-1328-1732; O'Brien, Stephen J./0000-0001-7353-8301; Borges, Rui/0000-0003-3931-9476; OBRIEN, STEPHEN/0000-0001-7857-0757	Portuguese Foundation for Science and Technology (FCT) [SFRH/BD/79850/2011, PTDC/AAC-AMB/104983/2008 (FCOMP-01-0124-FEDER-008610), PTDC/AAC-AMB/121301/2010 (FCOMP-01-0124-FEDER-019490)]; Intramural Research Program of the National Institutes of Health, National Cancer Institute	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); Intramural Research Program of the National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors acknowledge the Portuguese Foundation for Science and Technology (FCT) for financial support to RB (SFRH/BD/79850/2011) and the projects PTDC/AAC-AMB/104983/2008 (FCOMP-01-0124-FEDER-008610) and PTDC/AAC-AMB/121301/2010 (FCOMP-01-0124-FEDER-019490) to AA. This research received support by the Intramural Research Program of the National Institutes of Health, National Cancer Institute to WEJ and SJO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angueyra JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029813; Anisimova M, 2001, MOL BIOL EVOL, V18, P1585, DOI 10.1093/oxfordjournals.molbev.a003945; Arendt D, 2003, INT J DEV BIOL, V47, P563; Arendt D, 2001, PHILOS T R SOC B, V356, P1545, DOI 10.1098/rstb.2001.0971; Arendt D, 2008, NAT REV GENET, V9, P868, DOI 10.1038/nrg2416; Bellingham J, 2006, PLOS BIOL, V4, P1334, DOI 10.1371/journal.pbio.0040254; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Bowmaker JK, 2006, CURR BIOL, V16, pR484, DOI 10.1016/j.cub.2006.06.016; Chaurasia SS, 2005, J NEUROCHEM, V92, P158, DOI 10.1111/j.1471-4159.2004.02874.x; Collin SP, 2009, PHILOS T R SOC B, V364, P2925, DOI 10.1098/rstb.2009.0099; Davies WL, 2010, PHOTOCH PHOTOBIO SCI, V9, P1444, DOI 10.1039/c0pp00203h; Davies WIL, 2011, CELLULAR MOL LIFE SC; Davies WL, 2010, EXPT EYE RES, P110; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Dong C, 2011, BIOCH GENETICS; Doron-Faigenboim A, 2005, BIOINFORMATICS, V21, P2101, DOI 10.1093/bioinformatics/bti259; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Frigato E, 2006, NATURWISSENSCHAFTEN, V93, P379, DOI 10.1007/s00114-006-0119-9; Fritze O, 2003, P NATL ACAD SCI USA, V100, P2290, DOI 10.1073/pnas.0435715100; Gojobori J, 2009, TRENDS GENET, V25, P198, DOI 10.1016/j.tig.2009.03.008; Graham DM, 2008, J NEUROPHYSIOL, V99, P2522, DOI 10.1152/jn.01066.2007; Gu X, 1999, MOL BIOL EVOL, V16, P1664, DOI 10.1093/oxfordjournals.molbev.a026080; Gu X, 2002, BIOINFORMATICS, V18, P500, DOI 10.1093/bioinformatics/18.3.500; Gu X, 2001, MOL BIOL EVOL, V18, P453, DOI 10.1093/oxfordjournals.molbev.a003824; Gu X, 2006, MOL BIOL EVOL, V23, P1937, DOI 10.1093/molbev/msl056; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hankins MW, 2002, CURR BIOL, V12, P191, DOI 10.1016/S0960-9822(02)00659-0; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Heesy CP, 2010, BRAIN BEHAV EVOLUT, V75, P195, DOI 10.1159/000314278; HOLLAND PWH, 1994, DEVELOPMENT, P125; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; Isoldi MC, 2005, P NATL ACAD SCI USA, V102, P1217, DOI 10.1073/pnas.0409252102; Jacobs GH, 2009, PHILOS T R SOC B, V364, P2957, DOI 10.1098/rstb.2009.0039; KONIG B, 1989, P NATL ACAD SCI USA, V86, P6878, DOI 10.1073/pnas.86.18.6878; Koyanagi M, 2005, CURR BIOL, V15, P1065, DOI 10.1016/j.cub.2005.04.063; Kusakabe T, 2001, FEBS LETT, V506, P69, DOI 10.1016/S0014-5793(01)02877-0; Kusakabe T, 2003, PHOTOCHEM PHOTOBIOL, V83, P248; Lamb TD, 2007, NAT REV NEUROSCI, V8, P960, DOI 10.1038/nrn2283; Lamb Trevor D., 2008, Evolution Education and Outreach, V1, P415, DOI 10.1007/s12052-008-0091-2; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Larhammar D, 2009, PHILOS T R SOC B, V364, P2867, DOI 10.1098/rstb.2009.0077; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Lucas RJ, 1999, SCIENCE, V284, P505, DOI 10.1126/science.284.5413.505; McClellan DA, 2005, MOL BIOL EVOL, V22, P437, DOI 10.1093/molbev/msi028; Melyan Z, 2005, NATURE, V433, P741, DOI 10.1038/nature03344; Muffato M, 2010, BIOINFORMATICS, V26, P1119, DOI 10.1093/bioinformatics/btq079; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Panda S, 2005, SCIENCE, V307, P600, DOI 10.1126/science.1105121; Peirson S, 2006, NEURON, V49, P331, DOI 10.1016/j.neuron.2006.01.006; Peirson SN, 2004, MOL BRAIN RES, V123, P132, DOI 10.1016/j.molbrainres.2004.01.007; Peirson SN, 2009, PHILOS T R SOC B, V364, P2849, DOI 10.1098/rstb.2009.0050; Pires SS, 2007, P R SOC B, V274, P2791, DOI 10.1098/rspb.2007.0976; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Qiu XD, 2005, NATURE, V433, P745, DOI 10.1038/nature03345; Rennison DJ, 2012, MOL PHYLOGENET EVOL, V62, P986, DOI 10.1016/j.ympev.2011.11.030; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schmidt TM, 2011, TRENDS NEUROSCI, V34, P572, DOI 10.1016/j.tins.2011.07.001; Schrodinger L., PYMOL MOL GRAPHICS S; Sgourakis NG, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-104; Shimamura T, 2008, J BIOL CHEM, V283, P17753, DOI 10.1074/jbc.C800040200; Spagnuolo A, 2003, GENE, V309, P71, DOI 10.1016/S0378-1119(03)00488-8; Swanson WJ, 2003, MOL BIOL EVOL, V20, P18, DOI 10.1093/oxfordjournals.molbev.a004233; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Terakita A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-213; Torii M, 2007, FEBS LETT, V581, P5327, DOI 10.1016/j.febslet.2007.10.019; Tsukamoto H, 2010, PHOTOCH PHOTOBIO SCI, V9, P1435, DOI 10.1039/c0pp00168f; Vandepoele K, 2004, P NATL ACAD SCI USA, V101, P1638, DOI 10.1073/pnas.0307968100; Vopalensky P, 2009, PHILOS T R SOC B, V364, P2819, DOI 10.1098/rstb.2009.0079; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Woolley S, 2003, BIOINFORMATICS, V19, P671, DOI 10.1093/bioinformatics/btg043; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8	82	18	18	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52413	10.1371/journal.pone.0052413	http://dx.doi.org/10.1371/journal.pone.0052413			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285031	Green Published, gold, Green Submitted			2022-12-27	WOS:000313158800064
J	Lee, H; Kim, HJ; Lee, YJ; Lee, MY; Choi, H; Lee, H; Kim, JW				Lee, Haemi; Kim, Hyo Jung; Lee, Yoo Jeong; Lee, Min-Young; Choi, Hyeonjin; Lee, Hyemin; Kim, Jae-Woo			Kruppel-Like Factor KLF8 Plays a Critical Role in Adipocyte Differentiation	PLOS ONE			English	Article							MITOTIC CLONAL EXPANSION; BINDING PROTEIN-BETA; C/EBP-ALPHA GENE; TRANSCRIPTIONAL REGULATION; 3T3-L1 PREADIPOCYTES; ADIPOGENESIS; CELLS; ACTIVATION; EXPRESSION; PHOSPHORYLATION	KLF8 (Kruppel-like factor 8) is a zinc-finger transcription factor known to play an essential role in the regulation of the cell cycle, apoptosis, and differentiation. However, its physiological roles and functions in adipogenesis remain unclear. In the present study, we show that KLF8 acts as a key regulator controlling adipocyte differentiation. In 3T3-L1 preadipocytes, we found that KLF8 expression was induced during differentiation, which was followed by expression of peroxisome proliferator-activated receptor gamma (PPAR gamma) and CCAAT/enhancer-binding protein alpha (C/EBP alpha). Adipocyte differentiation was significantly attenuated by the addition of siRNA against KLF8, whereas overexpression of KLF8 resulted in enhanced differentiation. Furthermore, luciferase reporter assays demonstrated that overexpression of KLF8 induced PPAR gamma 2 and C/EBP alpha promoter activity, suggesting that KLF8 is an upstream regulator of PPAR gamma and C/EBP alpha. The KLF8 binding sites were localized by site mutation analysis to -191 region in C/EBP alpha promoter and -303 region in PPAR gamma promoter, respectively. Taken together, these data reveal that KLF8 is a key component of the transcription factor network that controls terminal differentiation during adipogenesis.	[Lee, Haemi; Kim, Hyo Jung; Lee, Yoo Jeong; Lee, Min-Young; Choi, Hyeonjin; Lee, Hyemin; Kim, Jae-Woo] Yonsei Univ, Coll Med, Inst Genet Sci, Dept Biochem & Mol Biol,Integrated Genom Res Ctr, Seoul, South Korea; [Lee, Haemi; Lee, Yoo Jeong; Lee, Min-Young; Choi, Hyeonjin; Kim, Jae-Woo] Yonsei Univ, Brain Korea Project Med Sci 21, Seoul, South Korea; [Lee, Hyemin; Kim, Jae-Woo] Yonsei Univ, Grad Sch, WCU Program, Dept Integrated OMICS Biomed Sci, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University	Kim, JW (corresponding author), Yonsei Univ, Coll Med, Inst Genet Sci, Dept Biochem & Mol Biol,Integrated Genom Res Ctr, Seoul, South Korea.	japol13@yuhs.ac		Choi, Hyeonjin/0000-0002-5055-5093; Kim, Jae-woo/0000-0001-5456-9495; KIM, HYO JUNG/0000-0002-3514-1247	Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A100475]	Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This work was supported by a grant from the Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A100475). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bieker JJ, 2001, J BIOL CHEM, V276, P34355, DOI 10.1074/jbc.R100043200; Birsoy K, 2008, CELL METAB, V7, P339, DOI 10.1016/j.cmet.2008.02.001; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; CHRISTY RJ, 1991, P NATL ACAD SCI USA, V88, P2593, DOI 10.1073/pnas.88.6.2593; Crossley M, 1996, MOL CELL BIOL, V16, P1695; Eaton SA, 2008, J BIOL CHEM, V283, P26937, DOI 10.1074/jbc.M804831200; FREYTAG SO, 1994, GENE DEV, V8, P1654, DOI 10.1101/gad.8.14.1654; Kim J, 2007, P NATL ACAD SCI USA, V104, P1800, DOI 10.1073/pnas.0611137104; Kim JW, 2007, BIOCHEM BIOPH RES CO, V354, P517, DOI 10.1016/j.bbrc.2007.01.008; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Lee H, 2009, J BIOL CHEM, V284, P10601, DOI 10.1074/jbc.M808742200; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; Morrison RF, 2000, J NUTR, V130, p3116S, DOI 10.1093/jn/130.12.3116S; Oishi Y, 2005, CELL METAB, V1, P27, DOI 10.1016/j.cmet.2004.11.005; Otto TC, 2005, CRIT REV BIOCHEM MOL, V40, P229, DOI 10.1080/10409230591008189; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Siersbaek R, 2012, TRENDS ENDOCRIN MET, V23, P56, DOI 10.1016/j.tem.2011.10.001; Sue N, 2008, MOL CELL BIOL, V28, P3967, DOI 10.1128/MCB.01942-07; Sugii S, 2010, P NATL ACAD SCI USA, V107, P3558, DOI 10.1073/pnas.0910172106; Tang QQ, 2005, P NATL ACAD SCI USA, V102, P9766, DOI 10.1073/pnas.0503891102; Tang QQ, 1999, MOL CELL BIOL, V19, P4855; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P44, DOI 10.1073/pnas.0137044100; Tang QQ, 1999, GENE DEV, V13, P2231, DOI 10.1101/gad.13.17.2231; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Urvalek AM, 2010, CELL CYCLE, V9, P601, DOI 10.4161/cc.9.3.10606; Wei HJ, 2006, J BIOL CHEM, V281, P16664, DOI 10.1074/jbc.M513135200	31	12	19	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52474	10.1371/journal.pone.0052474	http://dx.doi.org/10.1371/journal.pone.0052474			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285057	gold, Green Published, Green Submitted			2022-12-27	WOS:000313158800069
J	Remedio, L; Carvalho, T; Caiado, F; Bastos-Carvalho, A; Martins, D; Duarte, A; Yagita, H; Dias, S				Remedio, Leonor; Carvalho, Tania; Caiado, Francisco; Bastos-Carvalho, Ana; Martins, Diana; Duarte, Antonio; Yagita, Hideo; Dias, Sergio			Context- and Cell-Dependent Effects of Delta-Like 4 Targeting in the Bone Marrow Microenvironment	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELL; INHIBITS TUMOR-GROWTH; ENDOTHELIAL-CELLS; NOTCH LIGAND; PROGENITOR CELLS; VASCULAR NICHE; SELF-RENEWAL; INDUCED MOBILIZATION; IN-VITRO; DIFFERENTIATION	Delta-like 4 (Dll4) is a ligand of the Notch pathway family which has been widely studied in the context of tumor angiogenesis, its blockade shown to result in non-productive angiogenesis and halted tumor growth. As Dll4 inhibitors enter the clinic, there is an emerging need to understand their side effects, namely the systemic consequences of Dll4: Notch blockade in tissues other than tumors. The present study focused on the effects of systemic anti-Dll4 targeting in the bone marrow (BM) microenvironment. Here we show that Dll4 blockade with monoclonal antibodies perturbs the BM vascular niche of sub-lethally irradiated mice, resulting in increased CD31(+), VE-Cadherin(+) and c-kit(+) vessel density, and also increased megakaryocytes, whereas CD105(+), VEGFR3(+), SMA(+) and lectin(+) vessel density remained unaltered. We investigated also the expression of angiocrine genes upon Dll4 treatment in vivo, and demonstrate that IGFbp2, IGFbp3, Angpt2, Dll4, DHH and VEGF-A are upregulated, while FGF1 and CSF2 are reduced. In vitro treatment of endothelial cells with anti-Dll4 reduced Akt phosphorylation while maintaining similar levels of Erk 1/2 phosphorylation. Besides its effects in the BM vascular niche, anti-Dll4 treatment perturbed hematopoiesis, as evidenced by increased myeloid (CD11b(+)), decreased B (B220(+)) and T (CD3(+)) lymphoid BM content of treated mice, with a corresponding increase in myeloid circulating cells. Moreover, anti-Dll4 treatment also increased the number of CFU-M and -G colonies in methylcellulose assays, independently of Notch1. Finally, anti-Dll4 treatment of donor BM improved the hematopoietic recovery of lethally irradiated recipients in a transplant setting. Together, our data reveals the hematopoietic (BM) effects of systemic anti-Dll4 treatment result from qualitative vascular changes and also direct hematopoietic cell modulation, which may be favorable in a transplant setting.	[Remedio, Leonor; Carvalho, Tania; Caiado, Francisco; Bastos-Carvalho, Ana; Dias, Sergio] Portuguese Inst Oncol, IPOLFG, EPE, Angiogenesis Lab,CIPM, Lisbon, Portugal; [Yagita, Hideo] Juntendo Univ, Sch Med, Dept Immunol, Tokyo 113, Japan; [Duarte, Antonio] Univ Tecn Lisboa, Fac Med Vet, CIISA, Lisbon, Portugal; [Remedio, Leonor; Carvalho, Tania; Caiado, Francisco; Bastos-Carvalho, Ana; Dias, Sergio] Univ Nova Lisboa, CEDOC, FCM, P-1200 Lisbon, Portugal; [Remedio, Leonor; Carvalho, Tania; Caiado, Francisco; Dias, Sergio] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Bastos-Carvalho, Ana] Ctr Hosp Lisboa Norte, Programme Adv Med Educ, Lisbon, Portugal; [Bastos-Carvalho, Ana] Fac Med Lisbon, Lisbon, Portugal; [Bastos-Carvalho, Ana] Ctr Hosp Lisboa Norte, Dept Ophthalmol, Lisbon, Portugal; [Martins, Diana] Hosp Santa Maria, Dept Obstet & Gynecol, Lisbon, Portugal	Universidade de Coimbra; Juntendo University; Universidade de Lisboa; Universidade Nova de Lisboa; Instituto Gulbenkian de Ciencia; Universidade de Lisboa; Universidade de Lisboa; Universidade de Lisboa; Universidade de Lisboa; Hospital Santa Maria	Dias, S (corresponding author), Univ Lisbon, Fac Med, Inst Mol Med, Neovascularizat Unit, P-1699 Lisbon, Portugal.	sergiodias@fm.ul.pt	Carvalho, Tânia/GNM-6203-2022; Carvalho, Tânia/X-2873-2019; Dias, Sergio/L-1250-2014; Duarte, Antonio/V-1178-2018	Carvalho, Tânia/0000-0002-5283-5013; Dias, Sergio/0000-0002-7603-4616; Duarte, Antonio/0000-0002-9255-3635; Caiado, Francisco/0000-0003-4096-4448	FCT [PTDC/SAU-ORG/113617/2009]; Fundacao Calouste Gulbenkian; Fundacao Champalimaud; Ministerio da Saude; Fundacao para a Ciencia e Tecnologia, Portugal; Fundação para a Ciência e a Tecnologia [PTDC/SAU-ORG/113617/2009] Funding Source: FCT	FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundacao Calouste Gulbenkian(European Commission); Fundacao Champalimaud; Ministerio da Saude; Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Fundação para a Ciência e a Tecnologia	This work was supported by FCT PTDC/SAU-ORG/113617/2009 (www.fct.pt). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank other members of the Angiogenesis Lab for their input and suggestions. The Program for Advanced Medical Education is sponsored by Fundacao Calouste Gulbenkian, Fundacao Champalimaud, Ministerio da Saude and Fundacao para a Ciencia e Tecnologia, Portugal.	Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Avecilla ST, 2004, NAT MED, V10, P64, DOI 10.1038/nm973; Bassil R, 2011, J IMMUNOL, V187, P2322, DOI 10.4049/jimmunol.1100725; Bautch VL, 2011, NAT MED, V17, P1437, DOI 10.1038/nm.2539; Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180; Bird IN, 1999, J CELL SCI, V112, P1989; Broxmeyer HE, 2011, BLOOD, V117, P4773, DOI 10.1182/blood-2011-01-330514; Butler JM, 2010, CELL STEM CELL, V6, P251, DOI 10.1016/j.stem.2010.02.001; Candal FJ, 1996, MICROVASC RES, V52, P221, DOI 10.1006/mvre.1996.0060; Cao GY, 2002, AM J PHYSIOL-CELL PH, V282, pC1181, DOI 10.1152/ajpcell.00524.2001; Chang KH, 2007, P NATL ACAD SCI USA, V104, P10595, DOI 10.1073/pnas.0702072104; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Chute JP, 2007, BLOOD, V109, P2365, DOI 10.1182/blood-2006-05-022640; COFFMAN RL, 1981, NATURE, V289, P681, DOI 10.1038/289681a0; Dando JS, 2005, STEM CELLS, V23, P550, DOI 10.1634/stemcells.2004-0205; de La Coste A, 2005, J IMMUNOL, V174, P2730, DOI 10.4049/jimmunol.174.5.2730; Dhanjal TS, 2007, BLOOD, V109, P4237, DOI 10.1182/blood-2006-10-050740; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Dorsch M, 2002, BLOOD, V100, P2046, DOI 10.1182/blood.V100.6.2046.h81802002046_2046_2055; Fragoso R, 2008, EXP HEMATOL, V36, P1329, DOI 10.1016/j.exphem.2008.04.023; GALMICHE MC, 1993, BLOOD, V82, P66, DOI 10.1182/blood.V82.1.66.bloodjournal82166; Harrington LS, 2008, MICROVASC RES, V75, P144, DOI 10.1016/j.mvr.2007.06.006; Heemskerk VH, 1999, CYTOKINE GROWTH F R, V10, P5, DOI 10.1016/S1359-6101(98)00022-7; Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006; Hozumi K, 2008, J EXP MED, V205, P2507, DOI 10.1084/jem.20080134; Huang YH, 2007, BLOOD, V110, P624, DOI 10.1182/blood-2007-01-065714; Ishida W, 2011, INVEST OPHTH VIS SCI, V52, P8224, DOI 10.1167/iovs.11-7756; Itoi M, 2007, INT IMMUNOL, V19, P127, DOI 10.1093/intimm/dxl129; Karanu FN, 2001, BLOOD, V97, P1960, DOI 10.1182/blood.V97.7.1960; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kimura Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026918; Kobayashi H, 2010, NAT CELL BIOL, V12, P1046, DOI 10.1038/ncb2108; Koch U, 2008, J EXP MED, V205, P2515, DOI 10.1084/jem.20080829; Kopp HG, 2005, PHYSIOLOGY, V20, P349, DOI 10.1152/physiol.00025.2005; Kopp HG, 2005, BLOOD, V106, P505, DOI 10.1182/blood-2004-11-4269; Kostyak JC, 2012, BLOOD, V119, P838, DOI 10.1182/blood-2011-04-346098; Lahmar M, 2008, STEM CELLS, V26, P621, DOI 10.1634/stemcells.2007-0428; Lamorte S, 2009, HEMATOL REP, V1, P80, DOI 10.4081/hr.2009.e14; Lau CI, 2012, BLOOD, V119, P4741, DOI 10.1182/blood-2011-10-387266; Lauret E, 2004, LEUKEMIA, V18, P788, DOI 10.1038/sj.leu.2403288; Li XM, 2009, CIRCULATION, V120, P1910, DOI 10.1161/CIRCULATIONAHA.109.871574; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Lofqvist C, 2007, P NATL ACAD SCI USA, V104, P10589, DOI 10.1073/pnas.0702031104; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Mohtashami M, 2010, J IMMUNOL, V185, P867, DOI 10.4049/jimmunol.1000782; NAKAHATA T, 1982, P NATL ACAD SCI-BIOL, V79, P3843, DOI 10.1073/pnas.79.12.3843; Nakamura-Ishizu A, 2008, J MOL HISTOL, V39, P471, DOI 10.1007/s10735-008-9186-x; Nelson CM, 2003, J CELL SCI, V116, P3571, DOI 10.1242/jcs.00680; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Ohm JE, 2003, BLOOD, V101, P4878, DOI 10.1182/blood-2002-07-1956; Patel NS, 2005, CANCER RES, V65, P8690, DOI 10.1158/0008-5472.CAN-05-1208; PIALI L, 1995, J CELL BIOL, V130, P451, DOI 10.1083/jcb.130.2.451; Pitchford SC, 2012, BLOOD, V120, P2787, DOI 10.1182/blood-2011-09-378174; Poirault-Chassac S, 2010, BLOOD, V116, P5670, DOI 10.1182/blood-2010-05-285957; RAFII S, 1995, BLOOD, V86, P3353, DOI 10.1182/blood.V86.9.3353.bloodjournal8693353; Real C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018323; REINHERZ EL, 1980, P NATL ACAD SCI-BIOL, V77, P1588, DOI 10.1073/pnas.77.3.1588; Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313; Ross EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002338; Salter AB, 2009, BLOOD, V113, P2104, DOI 10.1182/blood-2008-06-162941; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Sekine C, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3758; Shutter JR, 2000, GENE DEV, V14, P1313; SKALLI O, 1989, J HISTOCHEM CYTOCHEM, V37, P315, DOI 10.1177/37.3.2918221; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Sunamura M, 2008, NEUTRALIZING MONOCLO; Sunamura M, 2008, UK Patent Application, Patent No. [1-85, 185]; Takagi S, 2012, BLOOD, V119, P2768, DOI 10.1182/blood-2011-05-353201; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Tian ZG, 1998, STEM CELLS, V16, P193, DOI 10.1002/stem.160193; TODD RF, 1981, J IMMUNOL, V126, P1435; VAINCHENKER W, 1982, BLOOD, V59, P514; van Buul JD, 2002, J IMMUNOL, V168, P588, DOI 10.4049/jimmunol.168.2.588; VAPORCIYAN AA, 1993, SCIENCE, V262, P1580, DOI 10.1126/science.8248808; Wang JW, 2012, CELL, V148, P1001, DOI 10.1016/j.cell.2012.01.040; Wheat LA, 2011, ARTERIOSCL THROM VAS, V31, P1598, DOI 10.1161/ATVBAHA.111.227124; Wu Y, 2007, BLOOD, V110, P851, DOI 10.1182/blood-2006-05-022087; Xie YC, 2009, NATURE, V457, P97, DOI 10.1038/nature07639; Yan MH, 2010, NATURE, V463, pE6, DOI 10.1038/nature08751; Yan XQ, 2001, BLOOD, V98, P3793, DOI 10.1182/blood.V98.13.3793; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	82	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52450	10.1371/journal.pone.0052450	http://dx.doi.org/10.1371/journal.pone.0052450			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285048	Green Published, gold, Green Submitted			2022-12-27	WOS:000312794500173
J	Satizabal, P; Mignucci-Giannoni, AA; Duchene, S; Caicedo-Herrera, D; Perea-Sicchar, CM; Garcia-Davila, CR; Trujillo, F; Caballero, SJ				Satizabal, Paula; Mignucci-Giannoni, Antonio A.; Duchene, Sebastian; Caicedo-Herrera, Dalila; Perea-Sicchar, Carlos M.; Garcia-Davila, Carmen R.; Trujillo, Fernando; Caballero, Susana J.			Phylogeography and Sex-Biased Dispersal across Riverine Manatee Populations (Trichechus inunguis and Trichechus manatus) in South America	PLOS ONE			English	Article							WEST-INDIAN MANATEE; MICROSATELLITE DNA MARKERS; FLORIDA MANATEE; MITOCHONDRIAL-DNA; GENETIC-ANALYSIS; COALESCENT; MIGRATION; DIFFERENTIATION; CHROMOSOME; SEQUENCES	Phylogeographic patterns and sex-biased dispersal were studied in riverine populations of West Indian (Trichechus manatus) and Amazonian manatees (T. inunguis) in South America, using 410bp D-loop (Control Region, Mitochondrial DNA) sequences and 15 nuclear microsatellite loci. This multi-locus approach was key to disentangle complex patterns of gene flow among populations. D-loop analyses revealed population structuring among all Colombian rivers for T. manatus, while microsatellite data suggested no structure. Two main populations of T. inunguis separating the Colombian and Peruvian Amazon were supported by analysis of the D-loop and microsatellite data. Overall, we provide molecular evidence for differences in dispersal patterns between sexes, demonstrating male-biased gene flow dispersal in riverine manatees. These results are in contrast with previously reported levels of population structure shown by microsatellite data in marine manatee populations, revealing low habitat restrictions to gene flow in riverine habitats, and more significant dispersal limitations for males in marine environments.	[Satizabal, Paula; Duchene, Sebastian; Caballero, Susana J.] Univ Los Andes, Dept Ciencias Biol, Lab Ecol Mol Vertebrados Acuat LEMVA, Bogota, Colombia; [Mignucci-Giannoni, Antonio A.] Inter Amer Univ Puerto Rico, Puerto Rico Manatee Conservat Ctr, Bayamon, PR USA; [Duchene, Sebastian] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Caicedo-Herrera, Dalila; Trujillo, Fernando] Fdn Omacha, Bogota, Cundinamarca, Colombia; [Perea-Sicchar, Carlos M.] Direcc Reg Prod Loreto, Iquitos, Peru; [Garcia-Davila, Carmen R.] Inst Invest Amazonia Peruana, LBGM, Iquitos, Peru	Universidad de los Andes (Colombia); Inter American University of Puerto Rico-San German; University of Sydney	Satizabal, P (corresponding author), Univ Los Andes, Dept Ciencias Biol, Lab Ecol Mol Vertebrados Acuat LEMVA, Bogota, Colombia.	paula.satizabal@gmail.com		Satizabal, Paula/0000-0003-0284-3573; Duchene, Sebastian/0000-0002-2863-0907; Garcia-Davila, Carmen/0000-0003-4125-5563; Mignucci-Giannoni, Antonio A./0000-0003-1443-4873	Programa de Jovenes Investigadores de Colciencias, Virginia Gutierrez de Pineda; Proyecto Semilla-Universidad de los Andes; Proyecto Profesor Asistente-Universidad de los Andes	Programa de Jovenes Investigadores de Colciencias, Virginia Gutierrez de Pineda; Proyecto Semilla-Universidad de los Andes; Proyecto Profesor Asistente-Universidad de los Andes	Funders: Programa de Jovenes Investigadores de Colciencias, Virginia Gutierrez de Pineda (2010), the Proyecto Semilla-Universidad de los Andes, and the Proyecto Profesor Asistente-Universidad de los Andes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson Paul K., 2002, Journal of Mammalian Evolution, V9, P55, DOI 10.1023/A:1021383827946; [Anonymous], 2010, LATIN AM J AQUAT MAM, DOI DOI 10.5597/lajam00155; Arraut EM, 2010, J ZOOL, V280, P247, DOI 10.1111/j.1469-7998.2009.00655.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beerli P, 1999, GENETICS, V152, P763; Beerli P, 2010, GENETICS, V185, P313, DOI 10.1534/genetics.109.112532; Bengtson JL, 1981, ECOLOGY MANATEES; Best R.C., 1984, Monographiae Biologicae, V56, P371; BEST RC, 1983, BIOTROPICA, V15, P61, DOI 10.2307/2388000; Bossart GD, 1999, J AM VET MED ASSOC, V214, P1178; Cantanhede AM, 2005, MOL ECOL, V14, P401, DOI 10.1111/j.1365-294X.2004.02413.x; Cassens I, 2005, MOL ECOL, V14, P107, DOI 10.1111/j.1365-294X.2004.02407.x; Deutsch C. J., 2008, TRICHECHUS MANATUS I; Deutsch CJ, 2003, WILDLIFE MONOGR, P1; DeWoody JA, 2006, MOL ECOL NOTES, V6, P951, DOI 10.1111/j.1471-8286.2006.01449.x; DOBSON FS, 1982, ANIM BEHAV, V30, P1183; DOMNING DP, 1986, MAR MAMMAL SCI, V2, P87, DOI 10.1111/j.1748-7692.1986.tb00034.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Earl DA, 2011, CONSERV GENET RESOUR, V4, P359, DOI DOI 10.1007/S12686-011-9548-7; Escorza-Trevino S, 2000, MOL ECOL, V9, P1049, DOI 10.1046/j.1365-294x.2000.00959.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Felsenstein J, 2006, MOL BIOL EVOL, V23, P691, DOI 10.1093/molbev/msj079; Garcia-Rodriguez AI, 2000, MOL ECOL, V9, P2161, DOI 10.1046/j.1365-294X.2000.10534.x; Garcia-Rodriguez AI, 1998, MOL ECOL, V7, P1137, DOI 10.1046/j.1365-294x.1998.00430.x; Goudet J, 2002, MOL ECOL, V11, P1103, DOI 10.1046/j.1365-294X.2002.01496.x; Handley LJL, 2007, MOL ECOL, V16, P1559, DOI 10.1111/j.1365-294X.2006.03152.x; Hartman DS, 1979, SPECIAL PUBLICATION, P28; Heled J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-289; Hellborg L, 2003, MOL ECOL, V12, P283, DOI 10.1046/j.1365-294X.2003.01702.x; Hollatz C, 2011, BIOL J LINN SOC, V102, P812, DOI 10.1111/j.1095-8312.2011.01616.x; Hrbek T, 2005, ANIM CONSERV, V8, P297, DOI 10.1017/S1367943005002210; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Hunter M, 2012, CONSERVATIO IN PRESS; Hunter ME, 2010, ANIM CONSERV, V13, P592, DOI 10.1111/j.1469-1795.2010.00383.x; Hurles ME, 2001, MOL ECOL, V10, P1599, DOI 10.1046/j.0962-1083.2001.01314.x; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Junk WJ, 1989, CANADIAN SPECIAL PUB, V106, P110, DOI DOI 10.1016/J.MATCHEMPHYS.2012.10.032; Kalinowski ST, 2005, HEREDITY, V94, P33, DOI 10.1038/sj.hdy.6800548; Kellogg ME, 2008, SIRENIAN CONSERVATIO; Lartillot N, 2006, SYST BIOL, V55, P195, DOI 10.1080/10635150500433722; Lyrholm T, 1999, P ROY SOC B-BIOL SCI, V266, P347, DOI 10.1098/rspb.1999.0644; MADDISON DR, 2000, MACCLADE 4; Marmontel M, 2008, TRICHECHUS INUNGUIS; Montoya-Ospina RA, 2001, BIOL CONSERV, V102, P117, DOI 10.1016/S0006-3207(00)00062-8; Muschett G, 2009, MAR MAMMAL SCI, V25, P955, DOI 10.1111/j.1748-7692.2009.00310.x; Naranjo LG, 1992, WATERFOWL WETLAND CO, P132; Nei M., 1987, MOL EVOLUTIONARY GEN; Nourisson C, 2011, GENETICA, V139, P833, DOI 10.1007/s10709-011-9583-z; Oksanen J., 2007, COMMUN ECOL PACK, P631; Oosterhout C, 2003, MICROCHECKER VERSION; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pause KC, 2007, MOL ECOL NOTES, V7, P1073, DOI 10.1111/j.1471-8286.2007.01781.x; Peters JL, 2012, MOL ECOL, V21, P3562, DOI 10.1111/j.1365-294X.2012.05612.x; Pritchard JK, 2000, GENETICS, V155, P945; Prugnolle F, 2002, HEREDITY, V88, P161, DOI 10.1038/sj.hdy.6800060; Rambaut A, 2010, FIGTREE V131; RAMBAUT A, 2003, TRACER PROGRAM ANAL; Rathbun GB, 1995, REPROD FREE RANGING; REYNOLDS JE, 1981, MAMMALIA, V45, P431; ROSAS FCW, 1994, MAMMAL REV, V24, P49, DOI 10.1111/j.1365-2907.1994.tb00134.x; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sambrook J., 2001, MOL CLONING LAB MANU; Santos MCF, 2007, J FISH BIOL, V71, P33, DOI 10.1111/j.1095-8649.2007.01514.x; Self-Sullivan Caryn, 2003, Aquatic Mammals, V29, P342, DOI 10.1578/01675420360736514; Thornback J, 1982, IUCN MAMMAL RED DA 1; Tringali MD, 2008, MAR MAMMAL SCI, V24, P218, DOI 10.1111/j.1748-7692.2007.00147.x; Tringali MD, 2008, MOL ECOL RESOUR, V8, P328, DOI 10.1111/j.1471-8286.2007.01944.x; Vasconcelos WR, 2006, GENET MOL BIOL, V29, P220, DOI 10.1590/S1415-47572006000200006; Vianna JA, 2006, MOL ECOL, V15, P433, DOI 10.1111/j.1365-294X.2005.02771.x; Wu CH, 2011, GENETICS, V188, P151, DOI 10.1534/genetics.110.125260	73	20	20	1	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52468	10.1371/journal.pone.0052468	http://dx.doi.org/10.1371/journal.pone.0052468			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285054	gold, Green Published			2022-12-27	WOS:000312794500177
J	Allam, AB; Brown, MB; Reyes, L				Allam, Ayman B.; Brown, Mary B.; Reyes, Leticia			Disruption of the S41 Peptidase Gene in Mycoplasma mycoides capri Impacts Proteome Profile, H2O2 Production, and Sensitivity to Heat Shock	PLOS ONE			English	Article							PENICILLIN-BINDING PROTEIN-3; CARBOXYL-TERMINAL PROTEASE; LARGE-COLONY TYPE; SUBSP-MYCOIDES; STREPTOCOCCUS-PNEUMONIAE; ESCHERICHIA-COLI; SERINE PROTEASES; HYDROGEN-PEROXIDE; MOLLICUTES; VIRULENCE	Members of the Mycoplasma mycoides cluster are among the most virulent of the mycoplasmas, causing worldwide economically significant diseases of cattle and goats. A distinguishing phenotype among the members of the cluster is the ability to degrade casein. The MMCAP2_0241 gene, an S41 peptidase, confers the proteolytic phenotype in Mycoplasma mycoides subsp. capri GM12. In order to determine the impact of disruption of the gene, we used differential proteome profiling to compare the M. mycoides subsp. capri wild type with a mutant lacking the proteolytic phenotype. Disruption of MMCAP2_0241 resulted in altered phenotypes reminiscent of M. mycoides subsp. mycoides SC and had significant impacts on the proteome profile of the microbe. The mutant exhibited increased production of hydrogen peroxide, decreased lactate dehydrogenase activity, and increased sensitivity to heat shock.	[Allam, Ayman B.; Brown, Mary B.; Reyes, Leticia] Univ Florida, Coll Vet Med, Dept Infect Dis & Pathol, Gainesville, FL 32603 USA	State University System of Florida; University of Florida	Brown, MB (corresponding author), Univ Florida, Coll Vet Med, Dept Infect Dis & Pathol, Gainesville, FL 32603 USA.	mbbrown@ufl.edu	Reyes, Leticia/H-7338-2019; Allam, Ayman/AAJ-7852-2020	Allam, Ayman/0000-0002-6726-089X	USDA CSREES grant [99-35204-8367]; University of South Florida Center for Biological Defense [6415-100607, W911SR-06-C-0023]; Public Health Service grant from the National Institute of Diabetes and Digestive and Kidney Diseases [5K08DK07651]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007651] Funding Source: NIH RePORTER	USDA CSREES grant(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); University of South Florida Center for Biological Defense; Public Health Service grant from the National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The majority of the work was funded by USDA CSREES grant 99-35204-8367 to M. B. B. and subcontract 6415-100607 to M. B. B. from the University of South Florida Center for Biological Defense (contract W911SR-06-C-0023). L. R. was supported by Public Health Service grant 5K08DK07651 from the National Institute of Diabetes and Digestive and Kidney Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUGROUN EAM, 1994, MICROBIOL-UK, V140, P2033, DOI 10.1099/13500872-140-8-2033; Allam AB, 2010, APPL ENVIRON MICROB, V76, P6951, DOI 10.1128/AEM.00056-10; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Bandara AB, 2005, J BACTERIOL, V187, P5767, DOI 10.1128/JB.187.16.5767-5775.2005; Bandara AB, 2008, MICROB PATHOGENESIS, V45, P207, DOI 10.1016/j.micpath.2008.05.005; Barre A, 2004, NUCLEIC ACIDS RES, V32, pD307, DOI 10.1093/nar/gkh114; BAUMLER AJ, 1994, INFECT IMMUN, V62, P1623; BenMenachem G, 1997, MICROBIOL-SGM, V143, P1933, DOI 10.1099/00221287-143-6-1933; Bischof DF, 2008, INFECT IMMUN, V76, P263, DOI 10.1128/IAI.00938-07; Chattoraj P, 2010, J BACTERIOL, V192, P1312, DOI 10.1128/JB.01350-09; COTTEW GS, 1978, AUST VET J, V54, P293, DOI 10.1111/j.1751-0813.1978.tb02462.x; COTTEW GS, 1987, ISRAEL J MED SCI, V23, P632; DAMASSA AJ, 1983, AM J VET RES, V44, P322; Dimmer EC, 2012, NUCLEIC ACIDS RES, V40, pD565, DOI 10.1093/nar/gkr1048; DINER BA, 1988, J BIOL CHEM, V263, P8972; Djordjevic SP, 2003, MICROBIOL-SGM, V149, P195, DOI 10.1099/mic.0.25742-0; Ekici OD, 2008, PROTEIN SCI, V17, P2023, DOI 10.1110/ps.035436.108; Frees D, 2007, MOL MICROBIOL, V63, P1285, DOI 10.1111/j.1365-2958.2007.05598.x; Gilbert KB, 2007, FEMS MICROBIOL LETT, V272, P65, DOI 10.1111/j.1574-6968.2007.00735.x; Gorg A, 2004, PROTEOMICS, V4, P3665, DOI 10.1002/pmic.200401031; Halbedel S, 2007, J MOL MICROB BIOTECH, V12, P147, DOI 10.1159/000096470; Hames C, 2009, J BACTERIOL, V191, P747, DOI 10.1128/JB.01103-08; HARA H, 1991, J BACTERIOL, V173, P4799, DOI 10.1128/jb.173.15.4799-4813.1991; Kannan TR, 2000, INFECT IMMUN, V68, P6419, DOI 10.1128/IAI.68.11.6419-6422.2000; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Khan LA, 2005, VET RES COMMUN, V29, P181, DOI 10.1023/B:VERC.0000047506.04096.06; Kwon HY, 2003, INFECT IMMUN, V71, P3757, DOI 10.1128/IAI.71.7.3757-3765.2003; Lad SP, 2007, J BACTERIOL, V189, P6619, DOI 10.1128/JB.00429-07; Liao DI, 2000, NAT STRUCT BIOL, V7, P749, DOI 10.1038/78973; Lilley KS, 2004, EXPERT REV PROTEOMIC, V1, P401, DOI 10.1586/14789450.1.4.401; Madsen ML, 2006, INFECT IMMUN, V74, P160, DOI 10.1128/IAI.74.1.160-166.2006; Manso-Silvan L, 2009, INT J SYST EVOL MICR, V59, P1353, DOI 10.1099/ijs.0.005546-0; Manso-Silvan L, 2007, INT J SYST EVOL MICR, V57, P2247, DOI 10.1099/ijs.0.64918-0; MAURIZI MR, 1990, J BIOL CHEM, V265, P12546; MILES RJ, 1992, J GEN MICROBIOL, V138, P1773, DOI 10.1099/00221287-138-9-1773; Mishra S, 2012, ARCH BIOCHEM BIOPHYS, V525, P145, DOI 10.1016/j.abb.2012.04.014; NAGASAWA H, 1989, J BACTERIOL, V171, P5890, DOI 10.1128/jb.171.11.5890-5893.1989; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Niang M, 1998, J VET MED A, V45, P29, DOI 10.1111/j.1439-0442.1998.tb00798.x; Ostberg Y, 2004, J BACTERIOL, V186, P2074, DOI 10.1128/JB.186.7.2074-2084.2004; Paetzel M, 1997, TRENDS BIOCHEM SCI, V22, P28, DOI 10.1016/S0968-0004(96)10065-7; Pilo P, 2005, J BACTERIOL, V187, P6824, DOI 10.1128/JB.187.19.6824-6831.2005; Pollack JD, 1997, CRIT REV MICROBIOL, V23, P269, DOI 10.3109/10408419709115140; POLLACK JD, 1981, J BACTERIOL, V146, P907, DOI 10.1128/JB.146.3.907-913.1981; Reyes L, 2009, INFECT IMMUN, V77, P4265, DOI 10.1128/IAI.00458-09; Robertson GT, 2002, J BACTERIOL, V184, P3508, DOI 10.1128/JB.184.13.3508-3520.2002; Rodriguez JL, 1995, J VET MED B, V42, P587, DOI 10.1111/j.1439-0450.1995.tb00752.x; Schmidl SR, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002263; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; SILBER KR, 1994, MOL GEN GENET, V242, P237, DOI 10.1007/BF00391018; Thiaucourt F, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-114; Thon JN, 2008, TRANSFUSION, V48, P425, DOI 10.1111/j.1537-2995.2007.01546.x; Vilei EM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-31; Vilei EM, 2000, MICROBIOL-UK, V146, P477, DOI 10.1099/00221287-146-2-477; Vilei EM, 2001, CLIN DIAGN LAB IMMUN, V8, P85, DOI 10.1128/CDLI.8.1.85-92.2001; Weiner J, 2003, NUCLEIC ACIDS RES, V31, P6306, DOI 10.1093/nar/gkg841; Zhang Q, 2012, CURR MICROBIOL, V64, P294, DOI 10.1007/s00284-011-0060-9; Zhong GM, 2001, J EXP MED, V193, P935, DOI 10.1084/jem.193.8.935	59	11	12	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e51345	10.1371/journal.pone.0051345	http://dx.doi.org/10.1371/journal.pone.0051345			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300541	gold, Green Published, Green Submitted			2022-12-27	WOS:000313872600005
J	Armstrong, AW; Schupp, C; Wu, JL; Bebo, B				Armstrong, April W.; Schupp, Clayton; Wu, Julie; Bebo, Bruce			Quality of Life and Work Productivity Impairment among Psoriasis Patients: Findings from the National Psoriasis Foundation Survey Data 2003-2011	PLOS ONE			English	Article							EXPERIENCE; SEVERITY; MODERATE	Objective: To ascertain impairment in quality of life and work productivity among patients with psoriasis and psoriatic arthritis. Design: From 2003 through 2011, the National Psoriasis Foundation collected survey data from patients with psoriasis and psoriatic arthritis via email and telephone correspondences. Setting: Survey data were collected from psoriasis and psoriatic arthritis patients in the general community in the U.S. Main Outcome Measures: Quality of life focusing on emotional impact (anger, frustration, helplessness, etc.) and physical impact (pain, pruritus, physical irritation, etc.); employment status. Patients: The surveys were performed through random sampling of participants from a database of over 75,000 patients. Results: From 2003 to 2011, 5,604 patients completed the surveys. Psoriasis and psoriatic arthritis affected overall emotional wellbeing in 88% of patients, and they interfered with enjoyment of life in 82%. Most patients reported experiencing anger (89%), frustration (89%), helplessness (87%), embarrassment (87%), and self-consciousness (89%). Many patients also actively concealed physical manifestations of their diseases (83%), and experienced pain (83%) and pruritus (93%) regularly. Of note, 12% of patients were unemployed, and 11% worked part-time. Among unemployed patients, 92% cited psoriasis and/or psoriatic arthritis as the sole reasons for not working. Among working patients, 49% missed work days regularly due to psoriasis. Compared to patients with mild psoriasis, patients with severe psoriasis have 1.8 times greater odds to be unemployed after adjusting for age and gender (Adjusted OR = 1.7, 95% CI 1.4-2.3). Conclusion: Patients with psoriasis and psoriatic arthritis continue to experience significant impairment of quality of life and work productivity.	[Armstrong, April W.; Schupp, Clayton; Wu, Julie] Univ Calif Davis, Dept Dermatol, Sacramento, CA 95817 USA; [Bebo, Bruce] Natl Psoriasis Fdn, Portland, OR USA	University of California System; University of California Davis	Armstrong, AW (corresponding author), Univ Calif Davis, Dept Dermatol, Sacramento, CA 95817 USA.	aprilarmstrong@post.harvard.edu			Abbott; Amgen; Janssen	Abbott(Abbott Laboratories); Amgen(Amgen); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc)	AWA has received research grants and/or consultant honoraria from Abbott, Amgen, and Janssen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bronsard V, 2010, J EUR ACAD DERMATOL, V24, P17, DOI 10.1111/j.1468-3083.2009.03563.x; Feldman SR, 2005, J AM ACAD DERMATOL, V53, P101, DOI 10.1016/j.jaad.2005.03.050; Gupta MA, 1998, CUTIS, V61, P339; Horn EJ, 2007, J AM ACAD DERMATOL, V57, P957, DOI 10.1016/j.jaad.2007.06.042; Horn EJ, 2007, J AM ACAD DERMATOL, V57, P963, DOI 10.1016/j.jaad.2007.07.023; Kimball Alexa Boer, 2012, J Am Acad Dermatol, V66, pe67, DOI 10.1016/j.jaad.2010.10.020; Ortonne JP, 2009, J EUR ACAD DERMATOL, V23, P919, DOI 10.1111/j.1468-3083.2009.03221.x; Palotai T, 2010, ACTA DERMATOVENER CR, V18, P151; Pariser DM, 2007, ARCH DERMATOL, V143, P239, DOI 10.1001/archderm.143.2.239; Pearce DJ, 2006, J DERMATOL TREAT, V17, P24, DOI 10.1080/09546630500482886; Reich K, 2008, ARCH DERMATOL RES, V300, P537, DOI 10.1007/s00403-008-0885-7; Revicki DA, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-75; Saad AA, 2010, ARTHRIT CARE RES, V62, P345, DOI 10.1002/acr.20104; SchmidOtt G, 1996, DERMATOLOGY, V193, P304, DOI 10.1159/000246275; Spandonaro F, 2011, GIORN ITAL DERMAT V, V146, P169; Stern RS, 2004, J INVEST DERM SYMP P, V9, P136, DOI 10.1046/j.1087-0024.2003.09102.x	16	172	180	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52935	10.1371/journal.pone.0052935	http://dx.doi.org/10.1371/journal.pone.0052935			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285231	Green Published, Green Submitted, gold			2022-12-27	WOS:000313051500086
J	Firdessa, R; Tschopp, R; Wubete, A; Sombo, M; Hailu, E; Erenso, G; Kiros, T; Yamuah, L; Vordermeier, M; Hewinson, RG; Young, D; Gordon, SV; Sahile, M; Aseffa, A; Berg, S				Firdessa, Rebuma; Tschopp, Rea; Wubete, Alehegne; Sombo, Melaku; Hailu, Elena; Erenso, Girume; Kiros, Teklu; Yamuah, Lawrence; Vordermeier, Martin; Hewinson, R. Glyn; Young, Douglas; Gordon, Stephen V.; Sahile, Mesfin; Aseffa, Abraham; Berg, Stefan			High Prevalence of Bovine Tuberculosis in Dairy Cattle in Central Ethiopia: Implications for the Dairy Industry and Public Health	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS; PATHOLOGY; INFECTION; HUSBANDRY; LIVESTOCK; DISEASE	Background: Ethiopia has the largest cattle population in Africa. The vast majority of the national herd is of indigenous zebu cattle maintained in rural areas under extensive husbandry systems. However, in response to the increasing demand for milk products and the Ethiopian government's efforts to improve productivity in the livestock sector, recent years have seen increased intensive husbandry settings holding exotic and cross breeds. This drive for increased productivity is however threatened by animal diseases that thrive under intensive settings, such as bovine tuberculosis (BTB), a disease that is already endemic in Ethiopia. Methodology/Principal Findings: An extensive study was conducted to: estimate the prevalence of BTB in intensive dairy farms in central Ethiopia; identify associated risk factors; and characterize circulating strains of the causative agent, Mycobacterium bovis. The comparative intradermal tuberculin test (CIDT), questionnaire survey, post-mortem examination, bacteriology, and molecular typing were used to get a better understanding of the BTB prevalence among dairy farms in the study area. Based on the CIDT, our findings showed that around 30% of 2956 tested dairy cattle from 88 herds were positive for BTB while the herd prevalence was over 50%. Post-mortem examination revealed gross tuberculous lesions in 34/36 CIDT positive cattle and acid-fast bacilli were recovered from 31 animals. Molecular typing identified all isolates as M. bovis and further characterization by spoligotyping and MIRU-VNTR typing indicated low strain diversity within the study area. Conclusions/Significance: This study showed an overall BTB herd prevalence of 50% in intensive dairy farms in Addis Ababa and surroundings, signalling an urgent need for intervention to control the disease and prevent zoonotic transmission of M. bovis to human populations consuming dairy products coming from these farms. It is suggested that government and policy makers should work together with stakeholders to design methods for the control of BTB in intensive farms in Ethiopia.	[Vordermeier, Martin; Hewinson, R. Glyn; Berg, Stefan] Anim Hlth & Vet Labs Agcy, Dept Bovine TB, Weybridge, Surrey, England; [Firdessa, Rebuma; Tschopp, Rea; Hailu, Elena; Erenso, Girume; Kiros, Teklu; Yamuah, Lawrence; Aseffa, Abraham] Armauer Hansen Res Inst, Addis Ababa, Ethiopia; [Wubete, Alehegne; Sombo, Melaku; Sahile, Mesfin] Natl Anim Hlth Diagnost & Invest Ctr, Addis Ababa, Ethiopia; [Gordon, Stephen V.] Univ Coll Dublin, Sch Vet Med, Dublin 2, Ireland; [Tschopp, Rea; Young, Douglas] Univ London Imperial Coll Sci Technol & Med, Ctr Mol Microbiol & Infect, London, England; [Tschopp, Rea] Swiss Trop & Publ Hlth, Basel, Switzerland	Veterinary Laboratories Agency; University College Dublin; Imperial College London; University of Basel; Swiss Tropical & Public Health Institute	Berg, S (corresponding author), Anim Hlth & Vet Labs Agcy, Dept Bovine TB, Weybridge, Surrey, England.	Stefan.berg@ahvla.gsi.gov.uk	Aseffa, Abraham/J-3248-2016; Berg, Stefan/AAU-6463-2020; Berg, Stefan O/D-3847-2011; Firdessa, Rebuma/P-6238-2019; Hewinson, Glyn/AAA-2364-2019; Vordermeier, H Martin/C-6936-2011; Yirsaw, Alehegne/AGG-9696-2022; Hewinson, Glyn/J-1902-2014	Aseffa, Abraham/0000-0002-8028-1150; Berg, Stefan/0000-0002-3470-7579; Firdessa, Rebuma/0000-0003-2523-165X; Gordon, Stephen/0000-0002-4833-5542; Hewinson, Glyn/0000-0002-5517-4281	Wellcome Trust (UK) under their "Animal health in the developing world initiative" [075833/A/04/Z]; Schweizerische Stiftung fur Medizinisch-Biologische Stipendien (SSMBS); Swiss National Science Foundation (SNSF); MRC [MC_U117581288] Funding Source: UKRI; Medical Research Council [MC_U117581288] Funding Source: researchfish	Wellcome Trust (UK) under their "Animal health in the developing world initiative"; Schweizerische Stiftung fur Medizinisch-Biologische Stipendien (SSMBS); Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was sponsored by the Wellcome Trust (UK) under their "Animal health in the developing world initiative" (grant number 075833/A/04/Z). The authors acknowledge the Schweizerische Stiftung fur Medizinisch-Biologische Stipendien (SSMBS) and the Swiss National Science Foundation (SNSF) for their financial support of Rea Tschopp during the analysis and writing phase. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreha T, 2006, REG WORKSH ORG ASARE; Allix-Beguec C, 2008, EUR RESPIR J, V31, P1077, DOI 10.1183/09031936.00053307; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P1398, DOI 10.1128/JCM.02089-07; Ameni G, 2007, CLIN VACCINE IMMUNOL, V14, P1356, DOI 10.1128/CVI.00205-07; Ameni G, 2006, CLIN VACCINE IMMUNOL, V13, P1030, DOI 10.1128/CVI.00134-06; Ameni G, 2011, VET J, V188, P359, DOI 10.1016/j.tvjl.2010.05.005; Ayele WY, 2004, INT J TUBERC LUNG D, V8, P924; Berg S, 2011, J BACTERIOL, V193, P670, DOI 10.1128/JB.00750-10; Berg S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005068; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Bureau PR, 2010, WORLD POPULATION DAT; CARMICHAEL J., 1939, JOUR COMP PATH AND THERAP, V52, P322, DOI 10.1016/S0368-1742(39)80029-7; Cosivi O, 1998, EMERG INFECT DIS, V4, P59, DOI 10.3201/eid0401.980108; CSA, 2011, REP LIV LIV CHAR AGR; CSA, 2007, REP LIV LIV CHAR AGR; de la Rua-Domenech R, 2006, TUBERCULOSIS, V86, P77, DOI 10.1016/j.tube.2005.05.002; Demelash B, 2009, TROP ANIM HEALTH PRO, V41, P755, DOI 10.1007/s11250-008-9248-9; Elias K, 2008, REV SCI TECH OIE, V27, P915, DOI 10.20506/rst.27.3.1850; Firdessa R, 2013, EMERGING IN IN PRESS; GALLAGHER J, 1977, J HYG-CAMBRIDGE, V79, P155, DOI 10.1017/S0022172400052943; Grange JM, 2001, TUBERCULOSIS, V81, P71, DOI 10.1054/tube.2000.0263; Gumi B, 2012, ECOHEALTH, V9, P139, DOI 10.1007/s10393-012-0754-x; Gumi B, 2011, TROP ANIM HEALTH PRO, V43, P1081, DOI 10.1007/s11250-010-9777-x; Halderman M, 2004, POLITICAL EC PRO POO, P1; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Le Fleche P, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-37; Liebana E, 2008, VET J, V176, P354, DOI 10.1016/j.tvjl.2007.07.001; Meisinger G, 1970, Monatsh Veterinarmed, V25, P7; OIE, 2009, BOV TUB TERR MAN; Pennell WT, 2011, TECHNICAL CHALLENGES OF MULTIPOLLUTANT AIR QUALITY MANAGEMENT, P1, DOI 10.1007/978-94-007-0304-9_1; Phillips CJC, 2003, RES VET SCI, V74, P1, DOI 10.1016/S0034-5288(02)00145-5; SNV, 2008, DAIR INV OPP ETH, P1; Supply P, 2003, MOL MICROBIOL, V47, P529, DOI 10.1046/j.1365-2958.2003.03315.x; Tegegne A, 2002, SCOPING STUDY URBA 1; Thoen C., 1995, MYCOBACTERIUM BOVIS; Thoen CO., 1995, MYCOBACTERIUM BOVIS, P3; Tschopp R, 2010, VET REC, V167, P250, DOI 10.1136/vr.c3381; Tschopp R, 2013, CURR TOP MICROBIOL, V365, P249, DOI 10.1007/82_2012_245; Tschopp R, 2010, MT RES DEV, V30, P381, DOI 10.1659/MRD-JOURNAL-D-09-00072.1; Tschopp R, 2009, PREV VET MED, V89, P205, DOI 10.1016/j.prevetmed.2009.02.006; Tsegaye W, 2010, INT J APPL RES VET M, V8, P143; Vordermeier HM, 2002, INFECT IMMUN, V70, P3026, DOI 10.1128/IAI.70.6.3026-3032.2002	42	59	64	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52851	10.1371/journal.pone.0052851	http://dx.doi.org/10.1371/journal.pone.0052851			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285202	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000313051500069
J	Gandolfi, B; Gruffydd-Jones, TJ; Malik, R; Cortes, A; Jones, BR; Helps, CR; Prinzenberg, EM; Erhardt, G; Lyons, LA				Gandolfi, Barbara; Gruffydd-Jones, Timothy J.; Malik, Richard; Cortes, Alejandro; Jones, Boyd R.; Helps, Chris R.; Prinzenberg, Eva M.; Erhardt, George; Lyons, Leslie A.			First WNK4-Hypokalemia Animal Model Identified by Genome-Wide Association in Burmese Cats	PLOS ONE			English	Article							HYPERKALEMIC PERIODIC PARALYSIS; DISTAL CONVOLUTED TUBULE; CHANNEL ALPHA-SUBUNIT; NA-CL COTRANSPORTER; HYPOKALEMIC POLYMYOPATHY; POTASSIUM-DEPLETION; GITELMANS-SYNDROME; MUSCLE WEAKNESS; FELIS-CATUS; WNK KINASES	Burmese is an old and popular cat breed, however, several health concerns, such as hypokalemia and a craniofacial defect, are prevalent, endangering the general health of the breed. Hypokalemia, a subnormal serum potassium ion concentration ([K+]), most often occurs as a secondary problem but can occur as a primary problem, such as hypokalaemic periodic paralysis in humans, and as feline hypokalaemic periodic polymyopathy primarily in Burmese. The most characteristic clinical sign of hypokalemia in Burmese is a skeletal muscle weakness that is frequently episodic in nature, either generalized, or sometimes localized to the cervical and thoracic limb girdle muscles. Burmese hypokalemia is suspected to be a single locus autosomal recessive trait. A genome wide case-control study using the illumina Infinium Feline 63K iSelect DNA array was performed using 35 cases and 25 controls from the Burmese breed that identified a locus on chromosome E1 associated with hypokalemia. Within approximately 1.2 Mb of the highest associated SNP, two candidate genes were identified, KCNH4 and WNK4. Direct sequencing of the genes revealed a nonsense mutation, producing a premature stop codon within WNK4 (c.2899C>T), leading to a truncated protein that lacks the C-terminal coiled-coil domain and the highly conserved Akt1/SGK phosphorylation site. All cases were homozygous for the mutation. Although the exact mechanism causing hypokalemia has not been determined, extrapolation from the homologous human and mouse genes suggests the mechanism may involve a potassium-losing nephropathy. A genetic test to screen for the genetic defect within the active breeding population has been developed, which should lead to eradication of the mutation and improved general health within the breed. Moreover, the identified mutation may help clarify the role of the protein in K+ regulation and the cat represents the first animal model for WNK4-associated hypokalemia.	[Gandolfi, Barbara; Cortes, Alejandro; Lyons, Leslie A.] Univ Calif Davis, Dept Populat Hlth & Reprod, Davis, CA 95616 USA; [Gruffydd-Jones, Timothy J.] Univ Bristol, Feline Ctr, Bristol, Avon, England; [Malik, Richard] Univ Sydney, Ctr Vet Educ, Sydney, NSW 2006, Australia; [Jones, Boyd R.] Massey Univ, Inst Vet Anim & Biomed Sci, Palmerston North, New Zealand; [Helps, Chris R.] Univ Bristol, Mol Diagnost Unit, Bristol, Avon, England; [Prinzenberg, Eva M.; Erhardt, George] Univ Giessen, Inst Anim Breeding & Genet, Giessen, Germany	University of California System; University of California Davis; University of Bristol; University of Sydney; Massey University; University of Bristol; Justus Liebig University Giessen	Lyons, LA (corresponding author), Univ Calif Davis, Dept Populat Hlth & Reprod, Davis, CA 95616 USA.	lalyons@ucdavis.edu	Malik, Richard/I-2009-2019	Helps, Chris/0000-0003-3405-4843; Lyons, Leslie/0000-0002-1628-7726	National Center for Research Resources [R24 RR016094]; Office of Research Infrastructure Programs/OD [R24OD010928]; Cat Health Network grant [D12FE-508]; Center for Companion Animal Health, School of Veterinary Medicine, University of California, Davis; Valentine Charlton Bequest from the University of Sydney; Morris Animal Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR016094] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD010928] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs/OD; Cat Health Network grant; Center for Companion Animal Health, School of Veterinary Medicine, University of California, Davis(University of California System); Valentine Charlton Bequest from the University of Sydney; Morris Animal Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by funding from the National Center for Research Resources R24 RR016094 and is currently supported by the Office of Research Infrastructure Programs/OD R24OD010928, the Cat Health Network grant D12FE-508, and the Center for Companion Animal Health, School of Veterinary Medicine, University of California, Davis. Richard Malik is supported by the Valentine Charlton Bequest from the University of Sydney. Support for the development of the Illumina Infinium Feline 63K iSelect DNA array was provided by the Morris Animal Foundation (http://www.morrisanimalfoundation.org) via a donation from Hill's Pet Food, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman M, 2008, NEUROMUSCULAR DISORD, V18, P277, DOI 10.1016/j.nmd.2008.01.001; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bighignoli B, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-27; BLAXTER A, 1986, VET REC, V118, P619, DOI 10.1136/vr.118.22.619; BRADLEY WG, 1990, ARCH NEUROL-CHICAGO, V47, P1013, DOI 10.1001/archneur.1990.00530090091018; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; Cox JH, 1986, P ANN CONV AM ASS EQ, P383; DOW SW, 1987, J AM VET MED ASSOC, V191, P1563; DOW SW, 1989, J AM VET MED ASSOC, V194, P1604; DOW SW, 1987, J AM VET MED ASSOC, V191, P1569; FETTMAN MJ, 1989, VET CLIN N AM-SMALL, V19, P415, DOI 10.1016/S0195-5616(89)50053-6; Finsterer J, 2008, ACTA NEUROL SCAND, V117, P145, DOI 10.1111/j.1600-0404.2007.00963.x; FONTAINE B, 1990, SCIENCE, V250, P1000, DOI 10.1126/science.2173143; Gabow PA, 1986, DISORDERS POTASSIUM, P207; GAMSTORP I, 1957, Acta Genet Stat Med, V7, P325; Golbang AP, 2005, HYPERTENSION, V46, P295, DOI 10.1161/01.HYP.0000174326.96918.d6; Harrington ML, 1996, PROG VET NEUROL, V7, P130; Heath S, 2001, VET REC, V149, P660; Helps CR, 2007, MOL CELL PROBE, V21, P31, DOI 10.1016/j.mcp.2006.07.003; HO K, 1993, NATURE, V362, P31, DOI 10.1038/362031a0; Holtzapple GE, 1905, J AMER MED ASSOC, V45, P1224; HOPKINS AL, 1989, VET REC, V125, P17, DOI 10.1136/vr.125.1.17; Hubner CA, 2002, HUM MOL GENET, V11, P2435, DOI 10.1093/hmg/11.20.2435; JONES BR, 1988, NEW ZEAL VET J, V36, P150, DOI 10.1080/00480169.1988.35514; JONES BR, 1990, CORNELL VET, V80, P13; Kahle KT, 2004, P NATL ACAD SCI USA, V101, P2064, DOI 10.1073/pnas.0308434100; Kahle KT, 2003, NAT GENET, V35, P372, DOI 10.1038/ng1271; Lalioti MD, 2006, NAT GENET, V38, P1124, DOI 10.1038/ng1877; Lantinga E, 1998, TIJDSCHR DIERGENEESK, V123, P435; LAYZER RB, 1982, ANN NEUROL, V11, P547, DOI 10.1002/ana.410110602; Lehmann-Horn F, 1999, PHYSIOL REV, V79, P1317, DOI 10.1152/physrev.1999.79.4.1317; LEVITT LP, 1972, NEW ENGL J MED, V286, P253, DOI 10.1056/NEJM197202032860507; Lipinski MJ, 2007, ANIM GENET, V38, P371, DOI 10.1111/j.1365-2052.2007.01632.x; Lipinski MJ, 2008, GENOMICS, V91, P12, DOI 10.1016/j.ygeno.2007.10.009; Loffing J, 2004, J AM SOC NEPHROL, V15, P2276, DOI 10.1097/01.ASN.0000138234.18569.63; LUTZ TA, 1995, VET CLIN N AM-SMALL, V25, P527, DOI 10.1016/S0195-5616(95)50051-8; MASON KV, 1988, J AM ANIM HOSP ASSOC, V24, P481; Mayan H, 2004, J CLIN ENDOCR METAB, V89, P4025, DOI 10.1210/jc.2004-0037; McCormick JA, 2011, PHYSIOL REV, V91, P177, DOI 10.1152/physrev.00017.2010; NAYLOR JM, 1994, CAN VET J, V35, P279; NODEN DM, 1986, J CRAN GENET DEV BIO, P249; OBrien SJ, 1997, J HERED, V88, P408, DOI 10.1093/oxfordjournals.jhered.a023127; OBrien SJ, 1997, TRENDS GENET, V13, P393, DOI 10.1016/S0168-9525(97)01297-3; PAVER WK, 1964, MED J AUSTRALIA, V35, P305; Proctor G, 2006, AM J KIDNEY DIS, V48, P674, DOI 10.1053/j.ajkd.2006.06.014; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ring AM, 2007, P NATL ACAD SCI USA, V104, P4025, DOI 10.1073/pnas.0611728104; ROCHE GM, 1994, VET REC, V134, P360, DOI 10.1136/vr.134.14.360-a; ROJAS CV, 1991, NATURE, V354, P387, DOI 10.1038/354387a0; RUDOLPH JA, 1992, NAT GENET, V2, P144, DOI 10.1038/ng1092-144; Schaefer TJ, 2005, EMERG MED CLIN N AM, V23, P723, DOI 10.1016/j.emc.2005.03.016; SCHAER M, 1982, VET CLIN N AM-SMALL, V12, P399, DOI 10.1016/S0195-5616(82)50052-6; Schultheis PJ, 1998, J BIOL CHEM, V273, P29150, DOI 10.1074/jbc.273.44.29150; SCHUNK KL, 1984, P 2 ANN FOR AM COLL, P197; Sielman ES, 1997, J AM VET MED ASSOC, V210, P240; Simon DB, 1996, NAT GENET, V12, P24, DOI 10.1038/ng0196-24; SMITH SG, 1950, ARCH PATHOL, V49, P185; SPIER SJ, 1990, J AM VET MED ASSOC, V197, P1009; STEISS JE, 1986, CAN VET J, V27, P332; STERNS RH, 1981, MEDICINE, V60, P339, DOI 10.1097/00005792-198109000-00002; Stolze M, 2001, KLEINTIERPRAXIS, V46, P517; Sturgess CP, 1997, VET REC, V141, P566, DOI 10.1136/vr.141.22.566; Talbott JH, 1941, MEDICINE, V20, P85, DOI 10.1097/00005792-194102000-00002; THIER SO, 1986, AM J MED, V80, P3, DOI 10.1016/0002-9343(86)90334-7; Venance SL, 2006, BRAIN, V129, P8, DOI 10.1093/brain/awh639; Wang ZH, 2004, BIOCHEM BIOPH RES CO, V317, P939, DOI 10.1016/j.bbrc.2004.03.132; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Wilson FH, 2003, P NATL ACAD SCI USA, V100, P680, DOI 10.1073/pnas.242735399; Yang CL, 2003, J CLIN INVEST, V111, P1039, DOI 10.1172/JCI200317443	69	35	35	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53173	10.1371/journal.pone.0053173	http://dx.doi.org/10.1371/journal.pone.0053173			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285264	gold, Green Published, Green Submitted			2022-12-27	WOS:000313051500117
J	Mary, C; Duek, P; Salleron, L; Tienz, P; Bumann, D; Bairoch, A; Lane, L				Mary, Camille; Duek, Paula; Salleron, Lisa; Tienz, Petra; Bumann, Dirk; Bairoch, Amos; Lane, Lydie			Functional Identification of APIP as Human mtnB, a Key Enzyme in the Methionine Salvage Pathway	PLOS ONE			English	Article							ESCHERICHIA-COLI; METHYLTHIOADENOSINE PHOSPHORYLASE; ORNITHINE-DECARBOXYLASE; L-RIBULOSE-5-PHOSPHATE 4-EPIMERASE; CELL-LINES; BACILLUS-SUBTILIS; ABC TRANSPORTER; CANCER-CELLS; GENE; DEPENDENCY	The methionine salvage pathway is widely distributed among some eubacteria, yeast, plants and animals and recycles the sulfur-containing metabolite 5-methylthioadenosine (MTA) to methionine. In eukaryotic cells, the methionine salvage pathway takes place in the cytosol and usually involves six enzymatic activities: MTA phosphorylase (MTAP, EC 2.4.2.28), 5'-methylthioribose-1-phosphate isomerase (mtnA, EC 5.3.1.23), 5'-methylthioribulose-1-phosphate dehydratase (mtnB, EC: 4.2.1.109), 2,3-dioxomethiopentane-1-phosphate enolase/phosphatase (mtnC, EC 3.1.3.77), aci-reductone dioxygenase (mtnD, EC 1.13.11.54) and 4-methylthio-2-oxo-butanoate (MTOB) transaminase (EC 2.6.1.-). The aim of this study was to complete the available information on the methionine salvage pathway in human by identifying the enzyme responsible for the dehydratase step. Using a bioinformatics approach, we propose that a protein called APIP could perform this role. The involvement of this protein in the methionine salvage pathway was investigated directly in HeLa cells by transient and stable short hairpin RNA interference. We show that APIP depletion specifically impaired the capacity of cells to grow in media where methionine is replaced by MTA. Using a Shigella mutant auxotroph for methionine, we confirm that the knockdown of APIP specifically affects the recycling of methionine. We also show that mutation of three potential phosphorylation sites does not affect APIP activity whereas mutation of the potential zinc binding site completely abrogates it. Finally, we show that the N-terminal region of APIP that is missing in the short isoform is required for activity. Together, these results confirm the involvement of APIP in the methionine salvage pathway, which plays a key role in many biological functions like cancer, apoptosis, microbial proliferation and inflammation.	[Mary, Camille; Duek, Paula; Bairoch, Amos; Lane, Lydie] Univ Geneva, SIB, CALIPHO Grp, Geneva, Switzerland; [Salleron, Lisa; Bairoch, Amos; Lane, Lydie] Univ Geneva, Dept Human Prot Sci, Geneva, Switzerland; [Tienz, Petra; Bumann, Dirk] Univ Basel, Biozentrum, Basel, Switzerland	Swiss Institute of Bioinformatics; University of Geneva; University of Geneva; University of Basel	Mary, C (corresponding author), Univ Geneva, SIB, CALIPHO Grp, Geneva, Switzerland.	camille.mary@isb-sib.ch	Duek, Paula/AAV-2308-2020; Bairoch, Amos/X-7411-2019; Lane, Lydie/AAQ-4896-2021	Bairoch, Amos/0000-0003-2826-6444; Lane, Lydie/0000-0002-9818-3030; Duek Roggli, Paula/0000-0002-0819-0473	Swiss SystemsX.ch initiative (BattleX)	Swiss SystemsX.ch initiative (BattleX)	This project was financed with a grant from the Swiss SystemsX.ch initiative (BattleX), evaluated by the Swiss National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akana J, 2006, BIOCHEMISTRY-US, V45, P2493, DOI 10.1021/bi052474m; Albers E, 2009, IUBMB LIFE, V61, P1132, DOI 10.1002/iub.278; Anderson ME, 1998, CHEM-BIOL INTERACT, V112, P1; [Anonymous], INT J ONCOLOGY, V40, P2111; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Ashida H, 2008, BIOSCI BIOTECH BIOCH, V72, P959, DOI 10.1271/bbb.70651; BACKLUND PS, 1982, J BIOL CHEM, V257, P4196; Basu I, 2007, J BIOL CHEM, V282, P21477, DOI 10.1074/jbc.M702287200; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Behrmann I, 2003, AM J PATHOL, V163, P683, DOI 10.1016/S0002-9440(10)63695-4; Cavuoto P, 2012, CANCER TREAT REV, V38, P726, DOI 10.1016/j.ctrv.2012.01.004; Cellarier E, 2003, CANCER TREAT REV, V29, P489, DOI 10.1016/S0305-7372(03)00118-X; Chattopadhyay MK, 2005, P NATL ACAD SCI USA, V102, P16158, DOI 10.1073/pnas.0507299102; Cho DH, 2007, ONCOGENE, V26, P2809, DOI 10.1038/sj.onc.1210080; Cho DH, 2004, J BIOL CHEM, V279, P39942, DOI 10.1074/jbc.M405747200; Chow WA, 2006, CANCER GENET CYTOGEN, V166, P95, DOI 10.1016/j.cancergencyto.2005.10.009; Collins CC, 2012, MOL CANCER THER, V11, P775, DOI 10.1158/1535-7163.MCT-11-0826; Cooper AJL, 2004, NEUROCHEM INT, V44, P557, DOI 10.1016/j.neuint.2003.12.002; Cooper AJL, 2012, COMP BIOCHEM PHYS B, V163, P108, DOI 10.1016/j.cbpb.2012.05.010; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DellaRagione F, 1996, BIOCHEM BIOPH RES CO, V223, P514, DOI 10.1006/bbrc.1996.0926; DELLARAGIONE F, 1992, BIOCHEM J, V281, P533, DOI 10.1042/bj2810533; DREYER MK, 1993, J MOL BIOL, V231, P549, DOI 10.1006/jmbi.1993.1307; Durando X, 2008, B CANCER, V95, P69, DOI 10.1684/bdc.2008.0550; Gal J, 2002, J BACTERIOL, V184, P4930, DOI 10.1128/JB.184.17.4930-4932.2002; Hirano W, 2005, GENES CELLS, V10, P565, DOI 10.1111/j.1365-2443.2005.00859.x; Jarvinen AK, 2008, GENE CHROMOSOME CANC, V47, P500, DOI 10.1002/gcc.20551; Johnson AE, 1998, BIOCHEMISTRY-US, V37, P5746, DOI 10.1021/bi972984j; Kabuyama Y, 2009, MOL CELL PROTEOMICS, V8, P2308, DOI 10.1074/mcp.M900178-MCP200; KADNER RJ, 1974, J BACTERIOL, V119, P401, DOI 10.1128/JB.119.2.401-409.1974; Ko DC, 2012, P NATL ACAD SCI US; Komatsu A, 2008, INT J ONCOL, V33, P261, DOI 10.3892/ijo_00000005; KREIS W, 1991, J NATL CANCER I, V83, P725, DOI 10.1093/jnci/83.10.725; Kroemer M, 2003, BIOCHEMISTRY-US, V42, P10560, DOI 10.1021/bi0349266; Lee LV, 2000, BIOCHEMISTRY-US, V39, P4821, DOI 10.1021/bi9928952; Lima T, 2009, NUCLEIC ACIDS RES, V37, pD471, DOI 10.1093/nar/gkn661; Luo Y, 2001, BIOCHEMISTRY-US, V40, P14763, DOI 10.1021/bi0112513; Mantis N, 1996, INFECT IMMUN, V64, P2474, DOI 10.1128/IAI.64.7.2474-2482.1996; MECHAM JO, 1983, BIOCHEM BIOPH RES CO, V117, P429, DOI 10.1016/0006-291X(83)91218-4; Merlin C, 2002, J BACTERIOL, V184, P5513, DOI 10.1128/JB.184.19.5513-5517.2002; Miki K, 2000, CANCER RES, V60, P2696; Murphy KC, 2003, BMC MOL BIOL, V4, DOI 10.1186/1471-2199-4-11; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Pirkov I, 2008, FEBS J, V275, P4111, DOI 10.1111/j.1742-4658.2008.06552.x; Rigbolt KTG, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001570; Salim HMW, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000701; Sekowska A, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-9; Sekowska A, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-8; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SODA K, 1987, METHOD ENZYMOL, V143, P453; Steinhauer J, 1999, MOL MICROBIOL, V32, P367, DOI 10.1046/j.1365-2958.1999.01356.x; Subhi AL, 2004, CLIN CANCER RES, V10, P7290, DOI 10.1158/1078-0432.CCR-04-0972; Subhi AL, 2003, J BIOL CHEM, V278, P49868, DOI 10.1074/jbc.M308451200; Tang BQ, 2006, BIOCHEM PHARMACOL, V72, P806, DOI 10.1016/j.bcp.2006.06.018; Tang BQ, 2000, CANCER RES, V60, P5543; Thivat E, ANTICANCER RES, V27, P2779; TRACKMAN PC, 1983, J BIOL CHEM, V258, P6717; Wang H, 2005, J MOL BIOL, V348, P917, DOI 10.1016/j.jmb.2005.01.072; Wright FA, 2011, NAT GENET, V43, P539, DOI 10.1038/ng.838; Zhang ZG, 2003, ARCH MICROBIOL, V180, P88, DOI 10.1007/s00203-003-0561-4	60	22	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52877	10.1371/journal.pone.0052877	http://dx.doi.org/10.1371/journal.pone.0052877			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285211	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000313051500075
J	Ortega-Hernandez, J; Brena, C				Ortega-Hernandez, Javier; Brena, Carlo			Ancestral Patterning of Tergite Formation in a Centipede Suggests Derived Mode of Trunk Segmentation in Trilobites	PLOS ONE			English	Article							MILLIPEDE GLOMERIS-MARGINATA; SIRIUS PASSET FAUNA; GENE-EXPRESSION; ENGRAILED EXPRESSION; BOUNDARY FORMATION; DROSOPHILA; ARTHROPOD; EVOLUTION; ORGANIZATION; COMPARTMENT	Trilobites have a rich and abundant fossil record, but little is known about the intrinsic mechanisms that orchestrate their body organization. To date, there is disagreement regarding the correspondence, or lack thereof, of the segmental units that constitute the trilobite trunk and their associated exoskeletal elements. The phylogenetic position of trilobites within total-group Euarthropoda, however, allows inferences about the underlying organization in these extinct taxa to be made, as some of the fundamental genetic processes for constructing the trunk segments are remarkably conserved among living arthropods. One example is the expression of the segment polarity gene engrailed, which at embryonic and early postembryonic stages is expressed in extant panarthropods (i.e. tardigrades, onychophorans, euarthropods) as transverse stripes that define the posteriormost region of each trunk segment. Due to its conservative morphology and allegedly primitive trunk tagmosis, we have utilized the centipede Strigamia maritima to study the correspondence between the expression of engrailed during late embryonic to postembryonic stages, and the development of the dorsal exoskeletal plates (i.e. tergites). The results corroborate the close correlation between the formation of the tergite borders and the dorsal expression of engrailed, and suggest that this association represents a symplesiomorphy within Euarthropoda. This correspondence between the genetic and phenetic levels enables making accurate inferences about the dorsoventral expression domains of engrailed in the trunk of exceptionally preserved trilobites and their close relatives, and is suggestive of the widespread occurrence of a distinct type of genetic segmental mismatch in these extinct arthropods. The metameric organization of the digestive tract in trilobites provides further support to this new interpretation. The wider evolutionary implications of these findings suggest the presence of a derived morphogenetic patterning mechanism responsible for the reiterated occurrence of different types of trunk dorsoventral segmental mismatch in several phylogenetically distant, extinct and extant, arthropod groups.	[Ortega-Hernandez, Javier] Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; [Brena, Carlo] Univ Cambridge, Dept Zool, Cambridge CB2 3EQ, England	University of Cambridge; University of Cambridge	Ortega-Hernandez, J (corresponding author), Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England.	jo314@cam.ac.uk			Consejo Nacional de Ciencia y Tecnologia, Mexico (CONACYT); University of Cambridge Trusts (UK); Darwin College (UK); University of Cambridge	Consejo Nacional de Ciencia y Tecnologia, Mexico (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); University of Cambridge Trusts (UK); Darwin College (UK); University of Cambridge(University of Cambridge)	JOH is funded by Consejo Nacional de Ciencia y Tecnologia, Mexico (CONACYT), the University of Cambridge Trusts (UK) and Darwin College (UK). This study was supported by the University of Cambridge funding to Michael Akam. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; [Anonymous], 1991, HETEROCHRONY EVOLUTI; Becker S, 1997, DEVELOPMENT, V124, P2615; Bergstrom J., 1973, Fossils Strata, V2, P1; BERGSTROM J, 1973, Acta Geologica Polonica, V23, P207; BERGSTROM J, 1984, LETHAIA, V17, P67, DOI 10.1111/j.1502-3931.1984.tb00668.x; Bergstrom J, 2008, GFF, V130, P189; Bonato L, 2010, ZOOKEYS, P17, DOI 10.3897/zookeys.69.737; Bortolin F, 2011, DEV GENES EVOL, V221, P105, DOI 10.1007/s00427-011-0359-3; Brena C, 2012, DEV BIOL, V363, P290, DOI 10.1016/j.ydbio.2011.11.006; BROADIE KS, 1991, DEVELOPMENT, V113, P103; Bruton David L., 1997, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V245, P1; Bruton David L., 1999, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V253, P29; BRUTON DL, 2003, SP PALAEONT, P331; Budd GE, 2001, EVOL DEV, V3, P332, DOI 10.1046/j.1525-142X.2001.01041.x; Budd GE, 2011, J SYST PALAEONTOL, V9, P217, DOI 10.1080/14772019.2010.492644; Budd GE, 2009, NATURE, V457, P812, DOI 10.1038/nature07890; CAMPBELL GL, 1989, DEVELOPMENT, V106, P727; Chen Jun-Yuan, 1997, Records of the Australian Museum, V49, P1; Chen JY, 2007, PALAEOGEOGR PALAEOCL, V254, P250, DOI 10.1016/j.palaeo.2007.03.018; Chipman AD, 2004, EVOL DEV, V6, P78, DOI 10.1111/j.1525-142X.2004.04016.x; CISNE J L, 1975, Fossils and Strata, V4, P45; Cotton TJ, 2004, T ROY SOC EDIN-EARTH, V94, P169, DOI 10.1017/S0263593300000596; Cronier C, 2010, HIST BIOL, V22, P341, DOI 10.1080/08912960903548712; CURRIE DA, 1991, DEVELOPMENT, V113, P91; Damen WGM, 2002, DEVELOPMENT, V129, P1239; Deutsch JS, 2004, BIOESSAYS, V26, P1117, DOI 10.1002/bies.20111; Edgecombe GD, 1999, J PALEONTOL, V73, P263, DOI 10.1017/S0022336000027761; Eriksson BJ, 2009, DEV GENES EVOL, V219, P249, DOI 10.1007/s00427-009-0287-7; Fusco G, 2004, AM NAT, V163, P167, DOI 10.1086/381042; Fusco G, 2012, EVOLUTION, V66, P314, DOI 10.1111/j.1558-5646.2011.01447.x; Gabriel WN, 2007, DEV GENES EVOL, V217, P421, DOI 10.1007/s00427-007-0152-5; HAMA C, 1990, GENE DEV, V4, P1079, DOI 10.1101/gad.4.7.1079; Haug JT, 2010, EARTH ENV SCI T R SO, V100, P311, DOI 10.1017/S1755691010008145; Hertzler PL, 2009, ARTHROPOD STRUCT DEV, V38, P235, DOI 10.1016/j.asd.2008.12.003; HESSLER RR, 1962, J PALEONTOL, V36, P1305; Hou X. -G., 2004, CAMBRIAN FOSSILS CHE; Hou Xianguang, 1997, Fossils and Strata, V45, P1; Hughes NC, 2005, EVOLVING FORM AND FUNCTION: FOSSILS AND DEVELOPMENT, P139; Hughes NC, 2003, INTEGR COMP BIOL, V43, P185, DOI 10.1093/icb/43.1.185; Hughes NC, 1999, EVOL DEV, V1, P24, DOI 10.1046/j.1525-142x.1999.99005.x; Hughes NC, 2003, BIOESSAYS, V25, P386, DOI 10.1002/bies.10270; HUGHES NC, 1991, GEOLOGY, V19, P913, DOI 10.1130/0091-7613(1991)019<0913:MPAGFI>2.3.CO;2; Hughes NC, 2007, ANNU REV EARTH PL SC, V35, P401, DOI 10.1146/annurev.earth.35.031306.140258; Hughes NC, 2006, PALEOBIOLOGY, V32, P602, DOI 10.1666/06017.1; Jacobs DK, 2000, EVOL DEV, V2, P340, DOI 10.1046/j.1525-142x.2000.00077.x; Janssen R, 2004, DEV BIOL, V268, P89, DOI 10.1016/j.ydbio.2003.12.021; Janssen R, 2008, DEV GENES EVOL, V218, P361, DOI 10.1007/s00427-008-0231-2; Janssen R, 2011, EVOL DEV, V13, P477, DOI 10.1111/j.1525-142X.2011.00504.x; Janssen R, 2011, EVODEVO, V2, DOI 10.1186/2041-9139-2-5; Kettle C, 2003, EVOL DEV, V5, P198, DOI 10.1046/j.1525-142X.2003.03027.x; KORNBERG T, 1981, DEV BIOL, V86, P363, DOI 10.1016/0012-1606(81)90194-9; KORNBERG T, 1981, P NATL ACAD SCI-BIOL, V78, P1095, DOI 10.1073/pnas.78.2.1095; Krzemien J, 2012, DEVELOPMENT, V139, P75, DOI 10.1242/dev.073692; Lagebro L, 2009, J PALEONTOL, V83, P820, DOI 10.1666/09-011.1; Larsen CW, 2003, DEVELOPMENT, V130, P5625, DOI 10.1242/dev.00867; Lawrence PA, 2002, DEVELOPMENT, V129, P2749; Lerosey-Aubril R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032934; Linder F., 1952, Proceedings of the United States National Museum, V102, P1; McNamara K.J., 1983, Special Papers in Palaeontology, P59; McNamara KJ, 2011, J PALEONTOL, V85, P106, DOI 10.1666/10-049.1; Mittmann B, 2012, DEV GENES EVOL, V222, P189, DOI 10.1007/s00427-012-0401-0; Nielsen C, 2003, DEV GENES EVOL, V213, P149, DOI 10.1007/s00427-003-0301-4; Nulsen C, 1999, DEV GENES EVOL, V209, P340, DOI 10.1007/s004270050262; Ortega-Hernandez J, 2013, CLADISTICS, V29, P15, DOI 10.1111/j.1096-0031.2012.00413.x; PALMER AR, 1957, J PALEONTOL, V31, P105; RAW FRANK, 1953, JOUR PALEONTOL, V27, P82; Rogers BT, 1996, DEVELOPMENT, V122, P3419; Shen J, 2005, DEV BIOL, V279, P31, DOI 10.1016/j.ydbio.2004.11.033; Snodgrass RE, 1935, PRINCIPLES INSECT MO; Stein M, 2010, ZOOL J LINN SOC-LOND, V158, P477, DOI 10.1111/j.1096-3642.2009.00562.x; Stormer L., 1942, NORSK GEOLOGISK TIDD, V21, P50; Struhl G, 1997, DEVELOPMENT, V124, P2143; Sturmer W., 1973, Palaeontologische Z, V47, P104; Svensson ME, 2004, DEV GENES EVOL, V214, P418, DOI 10.1007/s00427-004-0416-2; Vedel V, 2008, EVOL DEV, V10, P487, DOI 10.1111/j.1525-142X.2008.00259.x; VOLK T, 1994, DEVELOPMENT, V120, P59; WALOSSEK D, 1990, LETHAIA, V23, P409, DOI 10.1111/j.1502-3931.1990.tb01373.x; Walossek D, 1987, FOSSILS STRATA, V19, P1; Warnock RCM, 2012, BIOL LETTERS, V8, P156, DOI 10.1098/rsbl.2011.0710; Webster M, 2007, SCIENCE, V317, P499, DOI 10.1126/science.1142964; WHITTINGTON H B, 1975, Fossils and Strata, V4, P97; WHITTINGTON HB, 1993, PHILOS T ROY SOC B, V339, P109, DOI 10.1098/rstb.1993.0008; WHITTINGTON HB, 1957, BIOL REV, V32, P421, DOI 10.1111/j.1469-185X.1957.tb00779.x; WHITTINGTON HB, 1987, PHILOS T ROY SOC B, V317, P1, DOI 10.1098/rstb.1987.0046; Zhang XL, 2007, J PALEONTOL, V81, P1, DOI 10.1666/06-082.1; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3; ZRZAVY J, 1995, Q REV BIOL, V70, P279, DOI 10.1086/419072	88	30	30	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52623	10.1371/journal.pone.0052623	http://dx.doi.org/10.1371/journal.pone.0052623			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285116	Green Published, gold, Green Submitted			2022-12-27	WOS:000313051500041
J	Pan, XH; Zhang, QJ; Yan, WG; Jia, M; Jackson, A; Li, XB; Jia, LM; Huang, BH; Xu, PZ; Correa-Victoria, F; Li, SG				Pan, Xuhao; Zhang, Qijun; Yan, Wengui; Jia, Melissa; Jackson, Aaron; Li, Xiaobai; Jia, Limeng; Huang, Bihu; Xu, Peizhou; Correa-Victoria, Fernando; Li, Shigui			Development of Genetic Markers Linked to Straighthead Resistance through Fine Mapping in Rice (Oryza sativa L.)	PLOS ONE			English	Article							CULTIVARS; DIVERSITY; GENOTYPE; MINERALS; LOCUS; QTL	Straighthead, a physiological disorder characterized by sterile florets and distorted spikelets, causes significant yield losses in rice, and occurs in many countries. The current control method of draining paddies early in the season stresses plants, is costly, and wastes water. Development of resistant cultivar is regarded as the most efficient way for its control. We mapped a QTL for straighthead resistance using two recombinant inbred line (RIL) F-9 populations that were phenotyped over two years using monosodium methanearsonate (MSMA) to induce the symptoms. One population of 170 RILs was genotyped with 136 SSRs and the other population of 91 RILs was genotyped with 159 SSRs. A major QTL qSH-8 was identified in an overlapping region in both populations, and explained 46% of total variation in one and 67% in another population for straighthead resistance. qSH-8 was fine mapped from 1.0 Mbp to 340 kb using 7 SSR markers and further mapped to 290 kb in a population between RM22573 and InDel 27 using 4 InDel markers. SSR AP3858-1 and InDel 11 were within the fine mapped region, and co-segregated with straighthead resistance in both RIL populations, as well as in a collection of diverse global accessions. These results demonstrate that AP3858-1 and InDel 11 can be used for marker-assisted selection (MAS) for straighthead resistant cultivars, which is especially important because there is no effective way to directly evaluate straighthead resistance.	[Pan, Xuhao; Yan, Wengui; Jia, Melissa; Jackson, Aaron; Li, Shigui] ARS, USDA, Dale Bumpers Natl Rice Res Ctr, Stuttgart, AR USA; [Pan, Xuhao; Xu, Peizhou] Sichuan Agr Univ, Rice Res Inst, Chengdu, Peoples R China; [Pan, Xuhao] Univ Arkansas, Rice Res & Extens Ctr, Stuttgart, AR USA; [Zhang, Qijun] Jiangsu Acad Agr Sci, Inst Food Crops, Nanjing, Jiangsu, Peoples R China; [Li, Xiaobai] Zhejiang Univ, Inst Nucl Agr Sci, State Key Lab Rice Biol, Hangzhou 310003, Zhejiang, Peoples R China; [Jia, Limeng] Zhejiang Acad Agr Sci, Inst Virol & Biotechnol, Hangzhou, Zhejiang, Peoples R China; [Huang, Bihu] Univ Arkansas, Pine Bluff, AR USA; [Correa-Victoria, Fernando] RiceTec Inc, Alvin, TX USA	United States Department of Agriculture (USDA); Sichuan Agricultural University; University of Arkansas System; University of Arkansas Fayetteville; Jiangsu Academy of Agricultural Sciences; Zhejiang University; Zhejiang Academy of Agricultural Sciences; University of Arkansas System; University of Arkansas Fayetteville	Yan, WG (corresponding author), ARS, USDA, Dale Bumpers Natl Rice Res Ctr, Stuttgart, AR USA.	Wengui.Yan@ars.usda.gov; lishigui_sc@263.net	Li, Xiaobai/AAB-7604-2021	Li, Xiaobai/0000-0001-9615-3543; Jackson, Aaron/0000-0002-5540-9255	USDA; National Natural Science Foundation of China [31025017, 30971763]; RiceTec, Inc.	USDA(United States Department of Agriculture (USDA)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); RiceTec, Inc.	This work was supported by USDA in-house funds and partially by a grant from the National Natural Science Foundation of China (No. 31025017 and 30971763) and by RiceTec, Inc. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair CR, 1973, USDA289 AGR HDB, V289, P47; Agrama HA, 2009, PLANT BREEDING, V128, P551, DOI 10.1111/j.1439-0523.2009.01631.x; Agrama HA, 2010, PLANT BREEDING, V129, P304, DOI 10.1111/j.1439-0523.2009.01688.x; Andaya VC, 2006, THEOR APPL GENET, V113, P467, DOI 10.1007/s00122-006-0311-5; ATKINS J. G., 1957, International Rice Commission Newsletter, V6, P12; BABA I, 1954, PHYSL DIS RICE PLANT; Belefant-Miller H, 2007, AGRON J, V99, P1675, DOI 10.2134/agronj2007.0032N; Collier JS, 1912, 156 EXP STN, P19; CUNHA J. M. DE ARRIAGA E., 1958, AGRON LUSITANA, V20, P17; Dunn BW, 2006, AUST J EXP AGR, V46, P1077, DOI 10.1071/EA05004; FRANS R, 1988, ARKANSAS AES REP SER, V302, P1; HORTON DK, 1983, WEED SCI, V31, P648, DOI 10.1017/S0043174500070120; Hua B, 2011, ENV ENG SCI, V28; Hua W, 2009, THEOR APPL GENET, V119, P223, DOI 10.1007/s00122-009-1031-4; HULBERT SH, 1991, MOL GEN GENET, V226, P377, DOI 10.1007/BF00260649; Jones JW, 1938, USDA FARMERS B, V1808; Kim MY, 2004, EUPHYTICA, V135, P169, DOI 10.1023/B:EUPH.0000014909.40136.20; Linscombe SD, 2000, CROP SCI, V40, P294, DOI 10.2135/cropsci2000.0007rcv; Liu XH, 2010, AFR J BIOTECHNOL, V9, P950; Mackill DJ, 2002, W CROP SCI, P87; McCord PH, 2011, CROP SCI, V51, P771, DOI 10.2135/cropsci2010.02.0108; Nelson JC, 1997, MOL BREEDING, V3, P239, DOI 10.1023/A:1009604312050; Norton GJ, 2010, ENVIRON SCI TECHNOL, V44, P1471, DOI 10.1021/es902992d; PATERSON AH, 1990, GENETICS, V124, P735; Pillai TR, 2010, CROP SCI, V50, P2065, DOI 10.2135/cropsci2009.10.0568; RASAMIVELONA A, 1995, CROP SCI, V35, P1365, DOI 10.2135/cropsci1995.0011183X003500050017x; Slaton N. A., 2000, Research Series - Arkansas Agricultural Experiment Station, P313; Somenahally AC, 2011, ENVIRON SCI TECHNOL, V45, P8328, DOI 10.1021/es2012403; Somenahally AC, 2011, SOIL BIOL BIOCHEM, V43, P1220, DOI 10.1016/j.soilbio.2011.02.011; TAKEOKA Y, 1990, JPN J CROP SCI, V59, P785, DOI 10.1626/jcs.59.785; USEPA, 2009, 0037 USEPA; Weerapat P., 1979, International Rice Research Newsletter, V4, P6; WELLS BR, 1977, AGRON J, V69, P451, DOI 10.2134/agronj1977.00021962006900030029x; Wilson C. E. Jr., 2001, Research Series - Arkansas Agricultural Experiment Station, P428; Wilson Jr C. E., 2010, BR WELLS RICE RES ST, V581, P11; Wilson Jr. CE, 2010, MY RICE FIELD IS NO; Wilson Jr. CE, 2010, MANAGING STRAIGHTHEA; Wilson Jr CE, 2008, ARKANSAS AGR EXP STA, P11; Yan W. G., 2002, Research Series - Arkansas Agricultural Experiment Station, P359; Yan W. G., 2010, P 33 RIC TECHN WORK; Yan WG, 2010, CROP SCI, V50, P2406, DOI 10.2135/cropsci2010.02.0096; Yan WG, 2008, AGRON J, V100, P1655, DOI 10.2134/agronj2008.0108; Yan WG, 2005, CROP SCI, V45, P1223, DOI 10.2135/cropsci2004.0348	44	7	7	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52540	10.1371/journal.pone.0052540	http://dx.doi.org/10.1371/journal.pone.0052540			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285082	Green Published, gold, Green Submitted			2022-12-27	WOS:000313051500034
J	Patillon, B; Luisi, P; Blanche, H; Patin, E; Cann, HM; Genin, E; Sabbagh, A				Patillon, Blandine; Luisi, Pierre; Blanche, Helene; Patin, Etienne; Cann, Howard M.; Genin, Emmanuelle; Sabbagh, Audrey			Positive Selection in the Chromosome 16 VKORC1 Genomic Region Has Contributed to the Variability of Anticoagulant Response in Humans	PLOS ONE			English	Article							VITAMIN-K; NATURAL-SELECTION; POPULATION DIFFERENTIATION; GENETIC-DETERMINANTS; WARFARIN-RESISTANCE; WIDE ASSOCIATION; POLYMORPHISMS; HAPLOTYPES; DIVERSITY; SWEEPS	VKORC1 (vitamin K epoxide reductase complex subunit 1, 16p11.2) is the main genetic determinant of human response to oral anticoagulants of antivitamin K type (AVK). This gene was recently suggested to be a putative target of positive selection in East Asian populations. In this study, we genotyped the HGDP-CEPH Panel for six VKORC1 SNPs and downloaded chromosome 16 genotypes from the HGDP-CEPH database in order to characterize the geographic distribution of footprints of positive selection within and around this locus. A unique VKORC1 haplotype carrying the promoter mutation associated with AVK sensitivity showed especially high frequencies in all the 17 HGDP-CEPH East Asian population samples. VKORC1 and 24 neighboring genes were found to lie in a 505 kb region of strong linkage disequilibrium in these populations. Patterns of allele frequency differentiation and haplotype structure suggest that this genomic region has been submitted to a near complete selective sweep in all East Asian populations and only in this geographic area. The most extreme scores of the different selection tests are found within a smaller 45 kb region that contains VKORC1 and three other genes (BCKDK, MYST1 (KAT8), and PRSS8) with different functions. Because of the strong linkage disequilibrium, it is not possible to determine if VKORC1 or one of the three other genes is the target of this strong positive selection that could explain present-day differences among human populations in AVK dose requirement. Our results show that the extended region surrounding a presumable single target of positive selection should be analyzed for genetic variation in a wide range of genetically diverse populations in order to account for other neighboring and confounding selective events and the hitchhiking effect.	[Patillon, Blandine; Sabbagh, Audrey] Univ Paris Diderot, Inst Univ Hematol, UMRS 946, INSERM, Paris, France; [Patillon, Blandine] Univ Paris 11, Le Kremlin Bicetre, France; [Luisi, Pierre] CEXS UPF PRBB, Inst Evolutionary Biol, Barcelona, Spain; [Blanche, Helene; Cann, Howard M.] Fdn Jean Dausset CEPH, Paris, France; [Patin, Etienne] Inst Pasteur, CNRS, URA3012, Paris, France; [Sabbagh, Audrey] Univ Paris Diderot, UMR IRD 216, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay; Pompeu Fabra University; Foundation Jean Dausset-CEPH; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite	Patillon, B (corresponding author), Univ Paris Diderot, Inst Univ Hematol, UMRS 946, INSERM, Paris, France.	blandine.patillon@inserm.fr	Genin, Emmanuelle/C-4974-2013	Genin, Emmanuelle/0000-0003-4117-2813; Patin, Etienne/0000-0002-9911-4459; SABBAGH, Audrey/0000-0003-0283-8803	Spanish National Institute for Bioinformatics; "Accion Estrategica de Salud, en el Marco del Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica'' from Instituto de Salud Carlos III; doctoral program in Public Health from Paris Sud University [ED420]	Spanish National Institute for Bioinformatics; "Accion Estrategica de Salud, en el Marco del Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica'' from Instituto de Salud Carlos III; doctoral program in Public Health from Paris Sud University	This work was supported by the Spanish National Institute for Bioinformatics (www.inab.org). PL is supported by a PhD fellowship from "Accion Estrategica de Salud, en el Marco del Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica 2008-2011'' from Instituto de Salud Carlos III. BP is supported by a PhD fellowship from the doctoral program in Public Health (ED420: www.ed-sante-publique.u-psud.fr) from Paris Sud University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey JM, 2009, GENOME RES, V19, P711, DOI 10.1101/gr.086652.108; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bardowel SA, 2010, J NUTR, V140, P1901, DOI 10.3945/jn.110.128579; Barreiro LB, 2008, NAT GENET, V40, P340, DOI 10.1038/ng.78; Barreiro LB, 2010, NAT REV GENET, V11, P17, DOI 10.1038/nrg2698; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Beavan SR, 2005, EUR J CLIN NUTR, V59, P72, DOI 10.1038/sj.ejcn.1602037; Bodin L, 2005, BLOOD, V106, P135, DOI 10.1182/blood-2005-01-0341; Cann HM, 1998, CR ACAD SCI III-VIE, V321, P443, DOI 10.1016/S0764-4469(98)80774-9; Cann HM, 2002, SCIENCE, V296, P261; Carlson CS, 2005, GENOME RES, V15, P1553, DOI 10.1101/gr.4326505; Cha PC, 2010, HUM MOL GENET, V19, P4735, DOI 10.1093/hmg/ddq389; Chen H, 2010, GENOME RES, V20, P393, DOI 10.1101/gr.100545.109; Clark AG, 2005, GENOME RES, V15, P1496, DOI 10.1101/gr.4107905; Coop G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000500; Cooper GM, 2008, BLOOD, V112, P1022, DOI 10.1182/blood-2008-01-134247; D'Andrea G, 2008, BLOOD REV, V22, P127, DOI 10.1016/j.blre.2007.11.004; Diaz JC, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-43; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fujita Y, 2011, OSTEOPOROS INT; Gardner M, 2008, AM J MED GENET B, V147B, P1070, DOI 10.1002/ajmg.b.30717; Geisen C, 2005, THROMB HAEMOSTASIS, V94, P773, DOI 10.1160/TH05-04-0290; Genin E, 2004, J MED GENET, V41, P445, DOI 10.1136/jmg.2003.017962; GOLDSTEIN JA, 1994, PHARMACOGENETICS, V4, P285, DOI 10.1097/00008571-199412000-00001; Hernandez RD, 2011, SCIENCE, V331, P920, DOI 10.1126/science.1198878; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Hirsh J, 1998, CHEST, V114, p445S, DOI 10.1378/chest.114.5_Supplement.445S; Hofer T, 2009, ANN HUM GENET, V73, P95, DOI 10.1111/j.1469-1809.2008.00489.x; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Hyers TM, 1998, CHEST, V114, p561S, DOI 10.1378/chest.114.5_Supplement.561S; Jarvinen TM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014212; Kaneki M, 2001, NUTRITION, V17, P315, DOI 10.1016/S0899-9007(00)00554-2; Kohn MH, 2003, GENETICS, V164, P1055; Kohn MH, 2000, P NATL ACAD SCI USA, V97, P7911, DOI 10.1073/pnas.97.14.7911; LEWONTIN RC, 1964, GENETICS, V49, P49; Li J, 2011, HUM MOL GENET, V20, P528, DOI 10.1093/hmg/ddq498; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Li T, 2004, NATURE, V427, P541, DOI 10.1038/nature02254; Limdi NA, 2008, PHARMACOGENOMICS, V9, P1445, DOI 10.2217/14622416.9.10.1445; Limdi NA, 2010, BLOOD, V115, P3827, DOI 10.1182/blood-2009-12-255992; Luna A, 2007, BIOINFORMATICS, V23, P774, DOI 10.1093/bioinformatics/btl657; Marsh S, 2006, J THROMB HAEMOST, V4, P473, DOI 10.1111/j.1538-7836.2006.01759.x; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; MUELLER RL, 1994, CIRCULATION, V89, P432, DOI 10.1161/01.CIR.89.1.432; Nath SK, 2008, NAT GENET, V40, P152, DOI 10.1038/ng.71; Oldenburg J, 2008, VITAM HORM, V78, P35, DOI 10.1016/S0083-6729(07)00003-9; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Pritchard JK, 2010, NAT REV GENET, V11, P665, DOI 10.1038/nrg2880; Pritchard JK, 2010, CURR BIOL, V20, pR208, DOI 10.1016/j.cub.2009.11.055; Rieder MJ, 2005, NEW ENGL J MED, V352, P2285, DOI 10.1056/NEJMoa044503; Rosenberg NA, 2006, ANN HUM GENET, V70, P841, DOI 10.1111/j.1469-1809.2006.00285.x; Ross KA, 2010, J HUM GENET, V55, P582, DOI 10.1038/jhg.2010.73; Rost S, 2004, NATURE, V427, P537, DOI 10.1038/nature02214; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Scheinfeldt Laura B., 2011, Frontiers in Genetics, V2, P50, DOI 10.3389/fgene.2011.00050; Schwarz UI, 2008, NEW ENGL J MED, V358, P999, DOI 10.1056/NEJMoa0708078; Shriver Mark D, 2004, Hum Genomics, V1, P274; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Song Y, 2011, CURR BIOL, V21, P1296, DOI 10.1016/j.cub.2011.06.043; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Stec DE, 2007, PHYSIOL GENOMICS, V30, P74, DOI 10.1152/physiolgenomics.00003.2007; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Storz JF, 2004, MOL BIOL EVOL, V21, P1800, DOI 10.1093/molbev/msh192; SUTTIE JW, 1985, ANNU REV BIOCHEM, V54, P459, DOI 10.1146/annurev.bi.54.070185.002331; TAJIMA F, 1989, GENETICS, V123, P585; Takeuchi F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000433; Teichert M, 2009, HUM MOL GENET, V18, P3758, DOI 10.1093/hmg/ddp309; Teo YY, 2009, GENOME RES, V19, P2154, DOI 10.1101/gr.095000.109; Vermeer C, 2004, EUR J NUTR, V43, P325, DOI 10.1007/s00394-004-0480-4; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang ET, 2006, P NATL ACAD SCI USA, V103, P135, DOI 10.1073/pnas.0509691102; Wardrop D, 2008, BRIT J HAEMATOL, V141, P757, DOI 10.1111/j.1365-2141.2008.07119.x; Weir BS, 2002, ANNU REV GENET, V36, P721, DOI 10.1146/annurev.genet.36.050802.093940; Winckler W, 2005, SCIENCE, V308, P107, DOI 10.1126/science.1105322; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Wu AHB, 2008, PHARMACOGENOMICS, V9, P169, DOI 10.2217/14622416.9.2.169; Xue YL, 2009, GENETICS, V183, P1065, DOI 10.1534/genetics.109.107722; Yan LY, 2004, BRIT J NUTR, V92, P939, DOI 10.1079/BJN20041261; Yang LM, 2010, THROMB RES, V125, pE159, DOI 10.1016/j.thromres.2009.10.017	84	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53049	10.1371/journal.pone.0053049	http://dx.doi.org/10.1371/journal.pone.0053049			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285254	Green Published, gold, Green Submitted			2022-12-27	WOS:000313051500105
J	Song, HO; Kim, JH; Ryu, HS; Lee, DH; Kim, SJ; Kim, DJ; Suh, IB; Choi, DY; In, KH; Kim, SW; Park, H				Song, Hyun-Ok; Kim, Je-Hyoung; Ryu, Ho-Sun; Lee, Dong-Hoon; Kim, Sun-Jin; Kim, Deog-Joong; Suh, In Bum; Choi, Du Young; In, Kwang-Ho; Kim, Sung-Woo; Park, Hyun			Polymeric LabChip Real-Time PCR as a Point-of-Care-Potential Diagnostic Tool for Rapid Detection of Influenza A/H1N1 Virus in Human Clinical Specimens	PLOS ONE			English	Article							A H1N1 VIRUS; SWINE-ORIGIN 2009; NUCLEIC-ACID AMPLIFICATION; RT-PCR; MICROFLUIDIC DEVICES; SENSITIVITY; TESTS; TRANSMISSION; PATHOGENESIS; PERFORMANCE	It is clinically important to be able to detect influenza A/H1N1 virus using a fast, portable, and accurate system that has high specificity and sensitivity. To achieve this goal, it is necessary to develop a highly specific primer set that recognizes only influenza A viral genes and a rapid real-time PCR system that can detect even a single copy of the viral gene. In this study, we developed and validated a novel fluidic chip-type real-time PCR (LabChip real-time PCR) system that is sensitive and specific for the detection of influenza A/H1N1, including the pandemic influenza strain A/H1N1 of 2009. This LabChip real-time PCR system has several remarkable features: (1) It allows rapid quantitative analysis, requiring only 15 min to perform 30 cycles of real-time PCR. (2) It is portable, with a weight of only 5.5 kg. (3) The reaction cost is low, since it uses disposable plastic chips. (4) Its high efficiency is equivalent to that of commercially available tube-type real-time PCR systems. The developed disposable LabChip is an economic, heat-transferable, light-transparent, and easy-to-fabricate polymeric chip compared to conventional silicon- or glass-based labchip. In addition, our LabChip has large surface-to-volume ratios in micro channels that are required for overcoming time consumed for temperature control during real-time PCR. The efficiency of the LabChip real-time PCR system was confirmed using novel primer sets specifically targeted to the hemagglutinin (HA) gene of influenza A/H1N1 and clinical specimens. Eighty-five human clinical swab samples were tested using the LabChip real-time PCR. The results demonstrated 100% sensitivity and specificity, showing 72 positive and 13 negative cases. These results were identical to those from a tube-type real-time PCR system. This indicates that the novel LabChip real-time PCR may be an ultra-fast, quantitative, point-of-care-potential diagnostic tool for influenza A/H1N1 with a high sensitivity and specificity.	[Ryu, Ho-Sun; Lee, Dong-Hoon; Kim, Sun-Jin; Kim, Deog-Joong; Kim, Sung-Woo] NanoBioSys Inc, Seoul, South Korea; [Song, Hyun-Ok; Kim, Je-Hyoung; Park, Hyun] Wonkwang Univ, Sch Med, Zoonosis Res Ctr, Dept Infect Biol, Iksan, Jeonbuk, South Korea; [Suh, In Bum] Kangwon Natl Univ, Sch Med, Dept Lab Med, Chunchon, Kangwon Do, South Korea; [Choi, Du Young] Wonkwang Univ, Sch Med, Dept Pediat, Iksan, Jeonbuk, South Korea; [In, Kwang-Ho] Korea Univ, Dept Med, Sch Med, Seoul, South Korea	Wonkwang University; Kangwon National University; Wonkwang University; Korea University; Korea University Medicine (KU Medicine)	Kim, SW (corresponding author), NanoBioSys Inc, Seoul, South Korea.	swkim58a@nanobiosys.co.kr; hyunpk@wonkwang.ac.kr		Suh, In Bum/0000-0001-7012-0305	Public Welfare & Safety Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2011-0020967]	Public Welfare & Safety Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by the Public Welfare & Safety Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2011-0020967). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andresen DN, 2010, J CLIN MICROBIOL, V48, P2658, DOI 10.1128/JCM.00229-10; [Anonymous], 2009, MMWR MORB MORTAL WKL, V58, P1029; [Anonymous], 2009, MMWR MORB MORTAL WKL, V58, P826; Becker H, 2002, TALANTA, V56, P267, DOI 10.1016/S0039-9140(01)00594-X; Carr MJ, 2009, J CLIN VIROL, V45, P196, DOI 10.1016/j.jcv.2009.06.001; Chan KH, 2009, J CLIN VIROL, V45, P205, DOI 10.1016/j.jcv.2009.05.034; Chen ZY, 2007, ANN NY ACAD SCI, V1098, P429, DOI 10.1196/annals.1384.024; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Faix DJ, 2009, NEW ENGL J MED, V361, P728, DOI 10.1056/NEJMc0904264; Fouchier RAM, 2000, J CLIN MICROBIOL, V38, P4096, DOI 10.1128/JCM.38.11.4096-4101.2000; Frey O, 2007, BIOMED MICRODEVICES, V9, P711, DOI 10.1007/s10544-007-9080-4; Hagan KA, 2011, LAB CHIP, V11, P957, DOI 10.1039/c01c00136h; Hall Richard J., 2009, V3, P47, DOI 10.1007/978-3-540-73835-0_4; Hawkes M, 2010, PEDIATRICS, V125, pE639, DOI 10.1542/peds.2009-2669; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Horimoto T, 2001, CLIN MICROBIOL REV, V14, P129, DOI 10.1128/CMR.14.1.129-149.2001; Hurt AC, 2009, INFLUENZA OTHER RESP, V3, P171, DOI 10.1111/j.1750-2659.2009.00086.x; Jiang T, 2010, J VIROL METHODS, V163, P470, DOI 10.1016/j.jviromet.2009.09.021; Kawai Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030236; Kok J, 2010, J CLIN MICROBIOL, V48, P290, DOI 10.1128/JCM.01465-09; Landry ML, 2011, CURR OPIN PEDIATR, V23, P91, DOI 10.1097/MOP.0b013e328341ebd9; Mackay IM, 2002, NUCLEIC ACIDS RES, V30, P1292, DOI 10.1093/nar/30.6.1292; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Mair DA, 2006, LAB CHIP, V6, P1346, DOI 10.1039/b605911b; Munchow G, 2005, EXPERT REV MOL DIAGN, V5, P613, DOI 10.1586/14737159.5.4.613; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; Pabbaraju K, 2009, J CLIN MICROBIOL, V47, P3454, DOI 10.1128/JCM.01103-09; Sun Y, 2011, LAB CHIP, V11, P1457, DOI 10.1039/c0lc00528b; Teo J, 2011, ARCH VIROL, V156, P1371, DOI 10.1007/s00705-011-0999-7; Uyeki Tim, 2009, N Engl J Med, V361, pe114, DOI 10.1056/NEJMopv0911052; Wang RX, 2009, J CLIN MICROBIOL, V47, P2675, DOI 10.1128/JCM.01087-09; Whiley DM, 2009, J CLIN VIROL, V45, P203, DOI 10.1016/j.jcv.2009.05.032; Yang YW, 2010, J VIROL METHODS, V167, P37, DOI 10.1016/j.jviromet.2010.03.007; Zhang CS, 2007, NUCLEIC ACIDS RES, V35, P4223, DOI 10.1093/nar/gkm389; Zhang CS, 2006, BIOTECHNOL ADV, V24, P243, DOI 10.1016/j.biotechadv.2005.10.002	35	22	25	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53325	10.1371/journal.pone.0053325	http://dx.doi.org/10.1371/journal.pone.0053325			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285281	Green Published, Green Submitted, gold			2022-12-27	WOS:000313051500135
J	Spear, G; Rothaeulser, K; Fritts, L; Gillevet, PM; Miller, CJ				Spear, Gregory; Rothaeulser, Kristina; Fritts, Linda; Gillevet, Patrick M.; Miller, Christopher J.			In Captive Rhesus Macaques, Cervicovaginal Inflammation Is Common but Not Associated with the Stable Polymicrobial Microbiome	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; HERPES-SIMPLEX-VIRUS; BACTERIAL VAGINOSIS; VAGINAL FLORA; INTRAVAGINAL INOCULATION; LYMPHOID-TISSUES; ANIMAL-MODEL; HIV; TRANSMISSION; INFECTION	Vaginal inoculation of rhesus macaques (RM) with simian immunodeficiency virus (SIV) has been used to study the biology of HIV transmission. Although the results of vaginal SIV transmission experiments could be affected by vaginal inflammation, studies to date have been conducted without regard to levels of pre-existing genital inflammation present in RM. We collected cevicovaginal secretions (CVS) from 33-36 RM during the mid menstrual cycle (day 10-20) at 2 time points approximately 8 months apart and characterized the mRNA and protein levels of inflammatory cytokines, chemokines and interferon-stimulated genes. There was extreme variability in the levels of inflammatory mediators (IFN-alpha, IFN-gamma, IL-6, TNF, IL-1b, IP-10, MIG, IL-12 and IL-17). In most animals, the mRNA levels of the inflammatory mediators were similar in the 2 CVS samples collected 8 months apart, suggesting that genital inflammation is stable in a subset of captive female RM. At both time points the cervicovaginal microbiota had low levels of Lactobacillus and was relatively diverse with an average of 13 genera in the samples from the first time point (median 13, range 7-21) and an average of 11.5 genera in the samples from the second time point (median 11, range 5-20). Many of the macaques had similar microbiota in the samples collected 8 months apart. However, we found no correlation between specific bacterial genera and the mRNA or protein levels of the inflammatory mediators in the genital tract of RM in this study. It seems likely that results of published vaginal SIV transmission experiments in RM have been influenced by pre-existing inflammation in the animals used for the experiments.	[Rothaeulser, Kristina; Fritts, Linda; Miller, Christopher J.] Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA; [Spear, Gregory] Rush Univ, Dept Immunol Microbiol, Med Ctr, Chicago, IL 60612 USA; [Rothaeulser, Kristina; Fritts, Linda; Miller, Christopher J.] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA; [Gillevet, Patrick M.] George Mason Univ, Microbiome Anal Ctr, Manassas, VA USA; [Gillevet, Patrick M.] George Mason Univ, Dept Environm Sci & Policy, Manassas, VA USA	University of California System; University of California Davis; Rush University; University of California System; University of California Davis; George Mason University; George Mason University	Miller, CJ (corresponding author), Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA.	cjmiller@ucdavis.edu			Public Health Service grant from the National Center for Research Resources [P51RR00169]; National Institute of Allergy and Infectious Disease [AI076981]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI076981, P30AI082151] Funding Source: NIH RePORTER	Public Health Service grant from the National Center for Research Resources; National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Service grant P51RR00169 from the National Center for Research Resources and grant AI076981 from the National Institute of Allergy and Infectious Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel K, 2004, J VIROL, V78, P841, DOI 10.1128/JVI.78.2.841-854.2004; Abel K, 2003, J VIROL, V77, P3099, DOI 10.1128/JVI.77.5.3099-3118.2003; Abel K, 2001, CYTOKINE, V16, P191, DOI 10.1006/cyto.2001.0961; Abel K, 2002, J VIROL, V76, P8433, DOI 10.1128/JVI.76.16.8433-8445.2002; Atashili J, 2008, AIDS, V22, P1493, DOI 10.1097/QAD.0b013e3283021a37; COHEN CR, 1995, AIDS, V9, P1093, DOI 10.1097/00002030-199509000-00017; Conaway CH, 1964, J MAMMAL, V45, P577; Corey L, 2007, J INFECT DIS, V195, P1242, DOI 10.1086/513570; Corey L, 2007, NEW ENGL J MED, V356, P854, DOI 10.1056/NEJMe068302; Du YH, 2010, J AM ASSOC LAB ANIM, V49, P289; Gajer P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003605; GORDON TP, 1981, AM ZOOL, V21, P185; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Hu JJ, 2000, J VIROL, V74, P6087, DOI 10.1128/JVI.74.13.6087-6095.2000; Johnson KE, 2011, J INFECT DIS, V203, P602, DOI 10.1093/infdis/jiq091; Kaul R, 2008, J REPROD IMMUNOL, V77, P32, DOI 10.1016/j.jri.2007.02.002; Kyongo JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043951; Li QS, 2009, NATURE, V458, P1034, DOI 10.1038/nature07831; LIAO F, 1995, J EXP MED, V182, P1301, DOI 10.1084/jem.182.5.1301; Mares D, 2008, J REPROD IMMUNOL, V77, P91, DOI 10.1016/j.jri.2007.04.004; Martin HL, 1999, J INFECT DIS, V180, P1863, DOI 10.1086/315127; MILLER CJ, 1994, J VIROL, V68, P6391, DOI 10.1128/JVI.68.10.6391-6400.1994; Miller CJ, 1998, J VIROL, V72, P3248, DOI 10.1128/JVI.72.4.3248-3258.1998; MILLER CJ, 1989, J VIROL, V63, P4277, DOI 10.1128/JVI.63.10.4277-4284.1989; Miller CJ, 2005, J VIROL, V79, P9217, DOI 10.1128/JVI.79.14.9217-9227.2005; Mirmonsef P, 2012, AIDS RES HUM RETROV, V28, P76, DOI [10.1089/AID.2011.0071, 10.1089/aid.2011.0071]; Mirmonsef P, 2012, CURR HIV RES, V10, P202, DOI 10.2174/157016212800618165; Rebbapragada A, 2007, AIDS, V21, P589, DOI 10.1097/QAD.0b013e328012b896; Sewankambo N, 1997, LANCET, V350, P546, DOI 10.1016/S0140-6736(97)01063-5; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sheffield JS, 2007, J INFECT DIS, V196, P1509, DOI 10.1086/522518; Spear GT, 2012, AIDS RES HUM RETROV, V28, P1244, DOI 10.1089/aid.2011.0382; Spear GT, 2010, AIDS RES HUM RETROV, V26, P193, DOI 10.1089/aid.2009.0166; Stone M, 2010, J VIROL, V84, P7083, DOI 10.1128/JVI.00481-10; Stone M, 2009, VIROLOGY, V392, P260, DOI 10.1016/j.virol.2009.06.052; Taha TE, 1999, J ACQ IMMUN DEF SYND, V20, P52, DOI 10.1097/00042560-199901010-00008; Taha TE, 1998, AIDS, V12, P1699, DOI 10.1097/00002030-199813000-00019; Thurman AR, 2011, AM J REPROD IMMUNOL, V65, P89, DOI 10.1111/j.1600-0897.2010.00902.x; VALERIO DA, 1969, ANN NY ACAD SCI, V162, P282, DOI 10.1111/j.1749-6632.1969.tb56375.x; Van de Perre P, 2008, LANCET INFECT DIS, V8, P490, DOI 10.1016/S1473-3099(08)70181-6; WALKER ML, 1983, BIOL REPROD, V29, P841, DOI 10.1095/biolreprod29.4.841; Zhu J, 2009, NAT MED, V15, P886, DOI 10.1038/nm.2006	43	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52992	10.1371/journal.pone.0052992	http://dx.doi.org/10.1371/journal.pone.0052992			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285244	gold, Green Submitted, Green Published			2022-12-27	WOS:000313051500096
J	van de Wolfshaar, KE; Schellekens, T; Poos, JJ; van Kooten, T				van de Wolfshaar, Karen E.; Schellekens, Tim; Poos, Jan-Jaap; van Kooten, Tobias			Interspecific Resource Competition Effects on Fisheries Revenue	PLOS ONE			English	Article							STAGE-SPECIFIC BIOMASS; NORTH-SEA; CONVERSION FACTORS; MORTALITY; GROWTH; PLAICE; REPRODUCTION; ECOSYSTEMS; MANAGEMENT; WEIGHT	In many fisheries multiple species are simultaneously caught while stock assessments and fishing quota are defined at species level. Yet species caught together often share habitat and resources, resulting in interspecific resource competition. The consequences of resource competition on population dynamics and revenue of simultaneously harvested species has received little attention due to the historical single stock approach in fisheries management. Here we present the results of a modelling study on the interaction between resource competition of sole (Solea solea) and slaice (Pleuronectus platessa) and simultaneous harvesting of these species, using a stage-structured population model. Three resources were included of which one is shared with a varied competition intensity. We find that plaice is the better competitor of the two species and adult plaice are more abundant than adult sole. When competition is high sole population biomass increases with increasing fishing effort prior to plaice extinction. As a result of this increase in the sole population, the revenue of the stocks combined as function of effort becomes bimodal with increasing resource competition. When considering a single stock quota for sole, its recovery with increasing effort may result in even more fishing effort that would drive the plaice population to extinction. When sole and plaice compete for resources the highest revenue is obtained at effort levels at which plaice is extinct. Ignoring resource competition promotes overfishing due to increasing stock of one species prior to extinction of the other species. Consequently, efforts to mitigate the decline in one species will not be effective if increased stock in the other species leads to increased quota. If a species is to be protected against extinction, management should not only be directed at this one species, but all species that compete with it for resource as well.	[van de Wolfshaar, Karen E.; Poos, Jan-Jaap; van Kooten, Tobias] Wageningen UR IJmuiden, Dept Fish, Inst Marine Resource & Ecosyst Studies IMARES, Wageningen, Netherlands; [Schellekens, Tim] Wageningen UR, Dept Delta, Inst Marine Resource & Ecosyst Studies IMARES, Yerseke, Netherlands	Wageningen University & Research; Wageningen University & Research	van de Wolfshaar, KE (corresponding author), Wageningen UR IJmuiden, Dept Fish, Inst Marine Resource & Ecosyst Studies IMARES, Wageningen, Netherlands.	Karen.vandewolfshaar@wur.nl	van de Wolfshaar, Karen E./AAM-9875-2020; Poos, Jan Jaap/B-9940-2009; van de Wolfshaar, Karen E./B-7508-2008	van de Wolfshaar, Karen E./0000-0003-4190-6717; Poos, Jan Jaap/0000-0002-8507-5751; van de Wolfshaar, Karen E./0000-0003-4190-6717	KBWOT [2011 4301900330]	KBWOT	This research was financed by KBWOT 2011 4301900330. IMARES (Institute for Marine Resources and Ecosystem Studies), made available by the Dutch Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen KH, 2010, P ROY SOC B-BIOL SCI, V277, P795, DOI 10.1098/rspb.2009.1512; BERGMAN MJN, 1992, ICES J MAR SCI, V49, P5, DOI 10.1093/icesjms/49.1.5; BREY T, 1988, J EXP MAR BIOL ECOL, V117, P271, DOI 10.1016/0022-0981(88)90062-7; Chase JM, 2002, ECOL LETT, V5, P302, DOI 10.1046/j.1461-0248.2002.00315.x; Christensen V, 2004, ECOL MODEL, V172, P109, DOI 10.1016/j.ecolmodel.2003.09.003; Daan N, 1997, J SEA RES, V37, P321, DOI 10.1016/S1385-1101(97)00026-9; Davis MW, 2002, CAN J FISH AQUAT SCI, V59, P1834, DOI 10.1139/F02-139; De Roos AM, 2008, THEOR POPUL BIOL, V73, P47, DOI 10.1016/j.tpb.2007.09.004; de Roos AM, 2007, AM NAT, V170, pE59, DOI 10.1086/520119; Dhooge A, 2003, ACM T MATH SOFTWARE, V29, P141, DOI 10.1145/779359.779362; Eichinger M, 2010, J SEA RES, V64, P373, DOI 10.1016/j.seares.2010.05.005; FONDS M, 1979, MAR ECOL PROG SER, V1, P91, DOI 10.3354/meps001091; Geffen AJ, 2011, J EXP MAR BIOL ECOL, V400, P108, DOI 10.1016/j.jembe.2011.02.030; Gillis DM, 2008, CAN J FISH AQUAT SCI, V65, P27, DOI 10.1139/F07-147; Hiddink JG, 2006, ICES J MAR SCI, V63, P822, DOI 10.1016/j.icesjms.2006.02.006; HOLT RD, 1994, AM NAT, V144, P741, DOI 10.1086/285705; ICES, 2011, 2011AC3713 ICEM CM, V13; Link JS, 2012, MAR ECOL PROG SER, V459, P293, DOI 10.3354/meps09829; Mackinson S, 2009, CAN J FISH AQUAT SCI, V66, P1107, DOI 10.1139/F09-057; MCCLANAHAN TR, 1995, ECOL MODEL, V80, P21, DOI 10.1016/0304-3800(94)00035-G; Nilsson KA, 2010, J ANIM ECOL, V79, P871, DOI 10.1111/j.1365-2656.2010.01679.x; Poos JJ, 2010, ICES J MAR SCI, V67, P323, DOI 10.1093/icesjms/fsp241; Ricciardi A, 1998, MAR ECOL PROG SER, V163, P245, DOI 10.3354/meps163245; RIJNSDORP AD, 1989, J FISH BIOL, V35, P401, DOI 10.1111/j.1095-8649.1989.tb02992.x; Rijnsdorp AD, 2001, J SEA RES, V45, P219, DOI 10.1016/S1385-1101(01)00047-8; SaLM Kooijman, 2000, DYNAMIC ENERGY MASS, DOI 10.1017/CBO9780511565403; Taal C, 2010, VISSERIJ CIJFERS 201; van de Wolfshaar KE, 2011, MAR ECOL PROG SER, V438, P175, DOI 10.3354/meps09304; van der Veer HW, 2001, J SEA RES, V45, P303, DOI 10.1016/S1385-1101(01)00061-2; Van Keeken O, 2004, 04024 CTR FISH RES; Van Leeuwen A, 2008, J SEA RES, V60, P89, DOI 10.1016/j.seares.2008.02.008; VANBEEK FA, 1990, NETH J SEA RES, V26, P151, DOI 10.1016/0077-7579(90)90064-N	32	2	2	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53352	10.1371/journal.pone.0053352	http://dx.doi.org/10.1371/journal.pone.0053352			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285285	Green Published, Green Submitted, gold			2022-12-27	WOS:000313051500140
J	West, SD; Goldberg, D; Ziegler, A; Krencicki, M; Du Clos, TW; Mold, C				West, Sonlee D.; Goldberg, Daniel; Ziegler, Anna; Krencicki, Michael; Du Clos, Terry W.; Mold, Carolyn			Transforming Growth Factor-beta, Macrophage Colony-Stimulating Factor and C-Reactive Protein Levels Correlate with CD14(high)CD16(+) Monocyte Induction and Activation in Trauma Patients	PLOS ONE			English	Article							SCAVENGER RECEPTOR CD163; DENDRITIC CELLS; IN-VITRO; EXPRESSION; INHIBITOR; RESPONSES; FAILURE; SEPSIS; INNATE; ALPHA	Severe injury remains a leading cause of death and morbidity in patients under 40, with the number of annual trauma-related deaths approaching 160,000 in the United States. Patients who survive the initial trauma and post-traumatic resuscitation are at risk for immune dysregulation, which contributes to late mortality and accounts for approximately 20% of deaths after traumatic injury. This post-traumatic immunosuppressed state has been attributed to over-expression of anti-inflammatory mediators in an effort to restore host homeostasis. We measured a panel of monocyte markers and cytokines in 50 severely injured trauma patients for 3 days following admission. We made the novel observation that the subpopulation of monocytes expressing high levels of CD14 and CD16 was expanded in the majority of patients. These cells also expressed CD163 consistent with differentiation into alternatively activated macrophages with potential regulatory or wound-healing activity. We examined factors in trauma plasma that may contribute to the generation and activation of these cells. The percentage of CD14(high)CD16(+) monocytes after trauma correlated strongly with plasma C-reactive protein (CRP) transforming growth factor-beta (TGF-beta), and macrophage colony-stimulating factor (M-CSF) levels. We demonstrate a role for TGF-beta and M-CSF, but not CRP in generating these cells using monocytes from healthy volunteers incubated with plasma from trauma patients. CD16 is a receptor for CRP and IgG, and we showed that monocytes differentiated to the CD14(high)CD16(+) phenotype produced anti-inflammatory cytokines in response to acute phase concentrations of CRP. The role of these cells in immunosuppression following trauma is an area of ongoing investigation.	[West, Sonlee D.; Ziegler, Anna; Krencicki, Michael] Univ New Mexico, Hlth Sci Ctr, Dept Surg, Albuquerque, NM 87131 USA; [Goldberg, Daniel; Mold, Carolyn] Univ New Mexico, Hlth Sci Ctr, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA; [Du Clos, Terry W.] Univ New Mexico, Hlth Sci Ctr, Dept Internal Med, Albuquerque, NM 87131 USA; [Du Clos, Terry W.] Univ New Mexico, Hlth Sci Ctr, VA Med Ctr, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center	West, SD (corresponding author), Univ New Mexico, Hlth Sci Ctr, Dept Surg, Albuquerque, NM 87131 USA.	sowest@salud.unm.edu			National Center for Research Resources; National Center for Advancing Translational Sciences of the National Institutes of Health [KL2TR000041]; DHHS/NIH/NCRR [UL1TR000041]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000089, UL1TR000041] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); DHHS/NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This project was supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health through Grant Number KL2TR000041. Orrin Myers provided statistical assistance through DHHS/NIH/NCRR Grant Number UL1TR000041, and The University of New Mexico Clinical and Translational Science Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambarus CA, 2012, J IMMUNOL METHODS, V375, P196, DOI 10.1016/j.jim.2011.10.013; Belge KU, 2002, J IMMUNOL, V168, P3536, DOI 10.4049/jimmunol.168.7.3536; Buechler C, 2000, J LEUKOCYTE BIOL, V67, P97, DOI 10.1002/jlb.67.1.97; Chen Y, 2008, J LEUKOCYTE BIOL, V83, P1165, DOI 10.1189/jlb.0807521; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Brunialti MKC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037393; De AK, 2003, J IMMUNOL, V170, P6355, DOI 10.4049/jimmunol.170.12.6355; Devaraj S, 2009, J LEUKOCYTE BIOL, V85, P262, DOI 10.1189/jlb.0808458; Feng AL, 2011, CLIN EXP IMMUNOL, V164, P57, DOI 10.1111/j.1365-2249.2011.04321.x; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Kampalath B, 2003, ARCH PATHOL LAB MED, V127, P1580; Kumpf O, 2010, J INNATE IMMUN, V2, P381, DOI 10.1159/000314269; Laping NJ, 2002, MOL PHARMACOL, V62, P58, DOI 10.1124/mol.62.1.58; Lekkou A, 2004, CLIN DIAGN LAB IMMUN, V11, P161, DOI 10.1128/CDLI.11.1.161-167.2004; Lobo SMA, 2003, CHEST, V123, P2043, DOI 10.1378/chest.123.6.2043; Lu JH, 2008, NATURE, V456, P989, DOI 10.1038/nature07468; Martin C, 1997, CRIT CARE MED, V25, P1813, DOI 10.1097/00003246-199711000-00018; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Mokart D, 2002, BRIT J SURG, V89, P1450, DOI 10.1046/j.1365-2168.2002.02218.x; Mold C, 2002, J IMMUNOL, V169, P7019, DOI 10.4049/jimmunol.169.12.7019; Moniuszko M, 2009, CLIN IMMUNOL, V130, P338, DOI 10.1016/j.clim.2008.09.011; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Munn DH, 1996, BLOOD, V88, P1215, DOI 10.1182/blood.V88.4.1215.bloodjournal8841215; Oberholzer A, 2001, SHOCK, V16, P83, DOI 10.1097/00024382-200116020-00001; Ohno H, 2006, MOL CANCER THER, V5, P2634, DOI 10.1158/1535-7163.MCT-05-0313; Philippidis P, 2004, CIRC RES, V94, P119, DOI 10.1161/01.RES.0000109414.78907.F9; Roach JP, 2009, SHOCK, V31, P251, DOI 10.1097/SHK.0b013e3181834115; Skrzeczynska J, 2002, SCAND J IMMUNOL, V55, P629, DOI 10.1046/j.1365-3083.2002.01092.x; Skrzeczynska-Moncznik J, 2008, SCAND J IMMUNOL, V67, P152, DOI 10.1111/j.1365-3083.2007.02051.x; Sutterwala FS, 1998, J EXP MED, V188, P217, DOI 10.1084/jem.188.1.217; Van Gorp H, 2010, MOL IMMUNOL, V47, P1650, DOI 10.1016/j.molimm.2010.02.008; WELCH GR, 1990, J IMMUNOL, V144, P3444; West SD, 2012, J SURG RES, V172, P5, DOI 10.1016/j.jss.2011.04.016; Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354; Zhang JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017484; Ziegler-Heitbrock L, 2007, J LEUKOCYTE BIOL, V81, P584, DOI 10.1189/jlb.0806510; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	38	29	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52406	10.1371/journal.pone.0052406	http://dx.doi.org/10.1371/journal.pone.0052406			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285029	Green Published, gold, Green Submitted			2022-12-27	WOS:000313051500030
J	Boeck, L; Tamm, M; Grendelmeier, P; Stolz, D				Boeck, Lucas; Tamm, Michael; Grendelmeier, Peter; Stolz, Daiana			Acute Effects of Aerosolized Iloprost in COPD Related Pulmonary Hypertension - A Randomized Controlled Crossover Trial	PLOS ONE			English	Article							INHALED NITRIC-OXIDE; GAS-EXCHANGE; PROSTACYCLIN SYNTHASE; EXERCISE; DISEASE; SILDENAFIL; VASOCONSTRICTION; NIFEDIPINE; INHALATION; DIAGNOSIS	Background: Inhaled iloprost potentially improves hemodynamics and gas exchange in patients with chronic obstructive pulmonary disease (COPD) and secondary pulmonary hypertension (PH). Objectives: To evaluate acute effects of aerosolized iloprost in patients with COPD-associated PH. Methods: A randomized, double blind, crossover study was conducted in 16 COPD patients with invasively confirmed PH in a single tertiary care center. Each patient received a single dose of 10 mu g iloprost (low dose), 20 mu g iloprost (high dose) and placebo during distinct study-visits. The primary end-point of the study was exercise capacity as assessed by the six minute walking distance. Results: Both iloprost doses failed to improve six-minute walking distance (p = 0.36). Low dose iloprost (estimated difference of the means -1.0%, p = 0.035) as well as high dose iloprost (-2.2%, p<0.001) significantly impaired oxygenation at rest. Peak oxygen consumption and carbon dioxide production differed significantly over the three study days (p = 0.002 and p = 0.003, accordingly). As compared to placebo, low dose iloprost was associated with reduced peak oxygen consumption (-76 ml/min, p = 0.002), elevated partial pressure of carbon dioxide (0.27 kPa, p = 0.040) and impaired ventilation during exercise (-3.0l/min, p<0.001). Conclusions: Improvement of the exercise capacity after iloprost inhalation in patients with COPD-associated mild to moderate PH is very unlikely.	[Boeck, Lucas; Tamm, Michael; Grendelmeier, Peter; Stolz, Daiana] Univ Basel Hosp, Clin Pulm Med & Resp Cell Res, CH-4031 Basel, Switzerland	University of Basel	Stolz, D (corresponding author), Univ Basel Hosp, Clin Pulm Med & Resp Cell Res, CH-4031 Basel, Switzerland.	dstolz@uhbs.ch		Stolz, Daiana/0000-0003-0099-882X; Boeck, Lucas/0000-0002-1442-9073	Swiss National Foundation [PP00P3_128412/1]; Bayer Schering; Clinic of Pulmonary Medicine, University Hospital Basel, Switzerland	Swiss National Foundation(Swiss National Science Foundation (SNSF)); Bayer Schering(Bayer AG); Clinic of Pulmonary Medicine, University Hospital Basel, Switzerland	DS was supported by a grant from the Swiss National Foundation (PP00P3_128412/1). The trial was supported by an unrestricted grant from Bayer Schering. Additional funding was granted by the Clinic of Pulmonary Medicine, University Hospital Basel, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADNOT S, 1993, AM REV RESPIR DIS, V148, P310, DOI 10.1164/ajrccm/148.2.310; AGUSTI AGN, 1990, CHEST, V97, P268, DOI 10.1378/chest.97.2.268; Aliverti A, 2008, J APPL PHYSIOL, V105, P763, DOI 10.1152/japplphysiol.90745.2008; Alp S, 2006, PULM PHARMACOL THER, V19, P386, DOI 10.1016/j.pupt.2005.09.006; Attinger A, 2006, SWISS MED WKLY, V136, P13; Barr RG, 2010, NEW ENGL J MED, V362, P217, DOI 10.1056/NEJMoa0808836; Blanco I, 2010, AM J RESP CRIT CARE, V181, P270, DOI 10.1164/rccm.200907-0988OC; Boerrigter BG, 2012, CHEST; Bogaard HJ, 1998, EUR RESPIR J, V12, P374, DOI 10.1183/09031936.98.12020374; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Dernaika TA, 2010, RESPIRATION, V79, P377, DOI 10.1159/000242498; Galie N, 2009, EUR RESPIR J, V34, P1219, DOI 10.1183/09031936.00139009; Gessler T, 2001, EUR RESPIR J, V17, P14, DOI 10.1183/09031936.01.17100140; Halpern SD, 2009, CHEST, V136, P37, DOI 10.1378/chest.08-2784; KALRA L, 1993, AM J MED, V94, P419, DOI 10.1016/0002-9343(93)90154-H; Kessler R, 1999, AM J RESP CRIT CARE, V159, P158, DOI 10.1164/ajrccm.159.1.9803117; Lee JD, 2005, CHEST, V128, p575S, DOI 10.1016/S0012-3692(15)30992-2; Mannino DM, 2002, CHEST, V121, p121S, DOI 10.1378/chest.121.5_suppl.121S; MELOT C, 1984, AM REV RESPIR DIS, V130, P612; Nana-Sinkam S Patrick, 2006, Proc Am Thorac Soc, V3, P517, DOI 10.1513/pats.200603-074MS; Olschewski H, 1999, AM J RESP CRIT CARE, V160, P600, DOI 10.1164/ajrccm.160.2.9810008; OSWALDMAMMOSSER M, 1995, CHEST, V107, P1193, DOI 10.1378/chest.107.5.1193; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Rietema H, 2008, EUR RESPIR J, V31, P759, DOI 10.1183/09031936.00114207; Roger N, 1997, AM J RESP CRIT CARE, V156, P800, DOI 10.1164/ajrccm.156.3.9611051; Rosengarten B, 2006, CEREBROVASC DIS, V21, P194, DOI 10.1159/000090555; Sabit R, 2010, RESP MED, V104, P1171, DOI 10.1016/j.rmed.2010.01.020; SIMONNEAU G, 1981, NEW ENGL J MED, V304, P1582, DOI 10.1056/NEJM198106253042606; Sims MW, 2009, CHEST, V136, P412, DOI 10.1378/chest.08-2739; Stolz D, 2008, EUR RESPIR J, V32, P619, DOI 10.1183/09031936.00011308; Tueller C, 2010, RESPIRATION, V80, P410, DOI 10.1159/000319834; Vonbank K, 2003, THORAX, V58, P289, DOI 10.1136/thorax.58.4.289; Walmrath D, 1996, AM J RESP CRIT CARE, V153, P991, DOI 10.1164/ajrccm.153.3.8630585; Zwissler B, 1996, AM J RESP CRIT CARE, V154, P1671, DOI 10.1164/ajrccm.154.6.8970353	35	37	37	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52248	10.1371/journal.pone.0052248	http://dx.doi.org/10.1371/journal.pone.0052248			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300624	gold, Green Published, Green Submitted			2022-12-27	WOS:000312829100034
J	Ahlering, MA; Eggert, LS; Western, D; Estes, A; Munishi, L; Fleischer, R; Roberts, M; Maldonado, JE				Ahlering, Marissa A.; Eggert, Lori S.; Western, David; Estes, Anna; Munishi, Linus; Fleischer, Robert; Roberts, Melissa; Maldonado, Jesus E.			Identifying Source Populations and Genetic Structure for Savannah Elephants in Human-Dominated Landscapes and Protected Areas in the Kenya-Tanzania Borderlands	PLOS ONE			English	Article							CYTONUCLEAR GENOMIC DISSOCIATION; AFRICAN ELEPHANT; MICROSATELLITE LOCI; LOXODONTA-AFRICANA; PATERNITY SUCCESS; DNA; PHYLOGEOGRAPHY; MITOCHONDRIAL; SOFTWARE; CONSERVATION	We investigated the genetic metapopulation structure of elephants across the trans Rift Valley region of Kenya and Tanzania, one of the remaining strongholds for savannah elephants (Loxodonata africana) in East Africa, using microsatellite and mitochondrial DNA (mtDNA) markers. We then examined this population structure to determine the source population for a recent colonization event of savannah elephants on community-owned land within the trans rift valley region. Four of the five sampled populations showed significant genetic differentiation (p<0.05) as measured with both mtDNA haplotypes and microsatellites. Only the samples from the adjacent Maasai Mara and Serengeti ecosystems showed no significant differentiation. A phylogenetic neighbour-joining tree constructed from mtDNA haplotypes detected four clades. Clade four corresponds to the F clade of previous mtDNA studies that reported to have originated in forest elephants (Loxodonta cyclotis) but to also be present in some savannah elephant populations. The split between clade four and the other three clades corresponded strongly to the geographic distribution of mtDNA haplotypes across the rift valley in the study area. Clade four was the dominant clade detected on the west side of the rift valley with rare occurrences on the east side. Finally, the strong patterns of population differentiation clearly indicated that the recent colonists to the community-owned land in Kenya came from the west side of the rift valley. Our results indicate strong female philopatry within the isolated populations of the trans rift valley region, with gene flow primarily mediated via male movements. The recent colonization event from Maasai Mara or Serengeti suggests there is hope for maintaining connectivity and population viability outside formal protected areas in the region.	[Ahlering, Marissa A.; Eggert, Lori S.] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA; [Ahlering, Marissa A.; Fleischer, Robert; Roberts, Melissa; Maldonado, Jesus E.] Smithsonian Conservat Biol Inst, Ctr Conservat & Evolutionary Genet, Washington, DC USA; [Ahlering, Marissa A.; Western, David] African Conservat Ctr, Nairobi, Kenya; [Estes, Anna] Univ Virginia, Dept Environm Sci, Charlottesville, VA 22903 USA; [Munishi, Linus] Wildlife Conservat Soc, Tarangire Elephant Project, Arusha, Tanzania; [Roberts, Melissa; Maldonado, Jesus E.] Smithsonian Inst, Dept Vertebrate Zool, Natl Museum Nat Hist, Washington, DC 20560 USA	University of Missouri System; University of Missouri Columbia; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; University of Virginia; Smithsonian Institution; Smithsonian National Museum of Natural History	Ahlering, MA (corresponding author), Nature Conservancy, Grand Forks, ND USA.	mahlering@tnc.org	Maldonado, Jesus/AIE-8664-2022	Maldonado, Jesus/0000-0002-4282-1072	University of Missouri Research Board; Center for Conservation and Evolutionary Genetics at the Smithsonian Conservation Biology Institute; Smithsonian Postdoctoral Fellowship Program, Friends of the National Zoo; American Philosophical Society; Liz Claiborne and Art Ortenberg Foundation	University of Missouri Research Board; Center for Conservation and Evolutionary Genetics at the Smithsonian Conservation Biology Institute; Smithsonian Postdoctoral Fellowship Program, Friends of the National Zoo; American Philosophical Society; Liz Claiborne and Art Ortenberg Foundation	This study was supported by the University of Missouri Research Board, the Center for Conservation and Evolutionary Genetics at the Smithsonian Conservation Biology Institute, the Smithsonian Postdoctoral Fellowship Program, Friends of the National Zoo, the American Philosophical Society and the Liz Claiborne and Art Ortenberg Foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlering MA, 2012, DIVERS DISTRIB, V18, P952, DOI 10.1111/j.1472-4642.2012.00896.x; Ahlering MA, 2011, MOL ECOL RESOUR, V11, P831, DOI 10.1111/j.1755-0998.2011.03030.x; AMOS W, 1992, MAR MAMMAL SCI, V8, P275, DOI 10.1111/j.1748-7692.1992.tb00409.x; Archie EA, 2003, MOL ECOL NOTES, V3, P244, DOI 10.1046/j.1471-8286.2003.00412.x; Arctander P, 1999, MOL BIOL EVOL, V16, P1724, DOI 10.1093/oxfordjournals.molbev.a026085; ARMBRUSTER P, 1993, CONSERV BIOL, V7, P602, DOI 10.1046/j.1523-1739.1993.07030602.x; Barnes R., 1999, AFRICAN ELEPHANT DAT; Blanc J. J., 2007, OCCASIONAL PAPER SER, V33; Brandt AL, 2012, MOL ECOL, V21, P1175, DOI 10.1111/j.1365-294X.2012.05461.x; Comstock KE, 2000, MOL ECOL, V9, P1004, DOI 10.1046/j.1365-294x.2000.00939-8.x; Comstock KE, 2002, MOL ECOL, V11, P2489, DOI 10.1046/j.1365-294X.2002.01615.x; Debruyne R, 2005, CLADISTICS, V21, P31, DOI 10.1111/j.1096-0031.2004.00044.x; Douglas-Hamilton I., 1987, Oryx, V6, P11; Drummond A., 2011, GENEIOUS V 5 5; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Eggert LS, 2005, METHOD ENZYMOL, V395, P73, DOI 10.1016/S0076-6879(05)95006-4; Eggert LS, 2002, P ROY SOC B-BIOL SCI, V269, P1993, DOI 10.1098/rspb.2002.2070; Eggert LS, 2000, MOL ECOL, V9, P2223, DOI 10.1046/j.1365-294X.2000.105336.x; EGGERT LS, 2007, P 2007 INT EL CONS R, P157; Enk J, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r51; Estes AB, 2012, BIOL CONSERV, V147, P255, DOI 10.1016/j.biocon.2012.01.010; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Evans BJ, 2011, MOL ECOL, V20, P4216, DOI 10.1111/j.1365-294X.2011.05262.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fernando P, 2000, BEHAV ECOL SOCIOBIOL, V48, P84, DOI 10.1007/s002650000218; GEORGIADIS N, 1994, J HERED, V85, P100, DOI 10.1093/oxfordjournals.jhered.a111405; Guajardo JCR, 2010, MOL ECOL, V19, P5126, DOI 10.1111/j.1365-294X.2010.04833.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Heller R, 2010, MOL ECOL, V19, P1324, DOI 10.1111/j.1365-294X.2010.04589.x; Hollister-Smith JA, 2007, ANIM BEHAV, V74, P287, DOI 10.1016/j.anbehav.2006.12.008; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Ishida Y, 2012, EVOLUTIONARY APPL ON; Ishida Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020642; Kebede M, 2007, MOL ECOL, V16, P1233, DOI 10.1111/j.1365-294X.2007.03232.x; Lei R, 2008, J ZOOL, V275, P252, DOI 10.1111/j.1469-7998.2008.00437.x; Lei R, 2012, J ZOOL, V286, P38, DOI 10.1111/j.1469-7998.2011.00851.x; Lei RH, 2009, J HERED, V100, P675, DOI 10.1093/jhered/esp069; Miller CR, 2002, GENETICS, V160, P357; Mills LS, 2000, ECOL APPL, V10, P283, DOI 10.2307/2641002; Munshi-South J, 2008, DIVERS DISTRIB, V14, P995, DOI 10.1111/j.1472-4642.2008.00509.x; Nyakaana S, 1999, MOL ECOL, V8, P1105, DOI 10.1046/j.1365-294x.1999.00661.x; Nyakaana S, 1998, MOL ECOL, V7, P1436; Okello JBA, 2008, J HERED, V99, P443, DOI 10.1093/jhered/esn028; Park SDE, 2001, THESIS U DUBLIN; Petit RJ, 2009, TRENDS ECOL EVOL, V24, P386, DOI 10.1016/j.tree.2009.02.011; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pritchard JK, 2000, GENETICS, V155, P945; Rasmussen HB, 2008, BEHAV ECOL, V19, P9, DOI 10.1093/beheco/arm093; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Roca AL, 2001, SCIENCE, V293, P1473, DOI 10.1126/science.1059936; Roca AL, 2005, NAT GENET, V37, P96, DOI 10.1038/ng1485; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Scribner KT, 2005, J WILDLIFE MANAGE, V69, P1434, DOI 10.2193/0022-541X(2005)69[1434:GGCFAE]2.0.CO;2; Sitati NW, 2006, ORYX, V40, P279, DOI 10.1017/S0030605306000834; Taberlet P, 1996, NUCLEIC ACIDS RES, V24, P3189, DOI 10.1093/nar/24.16.3189; Waits LP, 2001, MOL ECOL, V10, P249, DOI 10.1046/j.1365-294X.2001.01185.x; Wasser SK, 2004, P NATL ACAD SCI USA, V101, P14847, DOI 10.1073/pnas.0403170101	57	18	18	0	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52288	10.1371/journal.pone.0052288	http://dx.doi.org/10.1371/journal.pone.0052288			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300634	gold, Green Submitted, Green Published			2022-12-27	WOS:000313618800065
J	Chou, CY; Dong, Y; Hung, YK; Kao, YJ; Wang, WC; Kao, CM; Chen, CT				Chou, Cheng-Ying; Dong, Yun; Hung, Yukai; Kao, Yu-Jiun; Wang, Weichung; Kao, Chien-Min; Chen, Chin-Tu			Accelerating Image Reconstruction in Dual-Head PET System by GPU and Symmetry Properties	PLOS ONE			English	Article							SMALL-ANIMAL PET; ITERATIVE RECONSTRUCTION; DETECTOR; DEPTH; PERFORMANCE; RESOLUTION; DESIGN; SCANNER; MATRIX	Positron emission tomography (PET) is an important imaging modality in both clinical usage and research studies. We have developed a compact high-sensitivity PET system that consisted of two large-area panel PET detector heads, which produce more than 224 million lines of response and thus request dramatic computational demands. In this work, we employed a state-of-the-art graphics processing unit (GPU), NVIDIA Tesla C2070, to yield an efficient reconstruction process. Our approaches ingeniously integrate the distinguished features of the symmetry properties of the imaging system and GPU architectures, including block/warp/thread assignments and effective memory usage, to accelerate the computations for ordered subset expectation maximization (OSEM) image reconstruction. The OSEM reconstruction algorithms were implemented employing both CPU-based and GPU-based codes, and their computational performance was quantitatively analyzed and compared. The results showed that the GPU-accelerated scheme can drastically reduce the reconstruction time and thus can largely expand the applicability of the dual-head PET system.	[Chou, Cheng-Ying; Kao, Yu-Jiun] Natl Taiwan Univ, Dept Bioind Mechatron Engn, Taipei 10764, Taiwan; [Dong, Yun] IIT, Dept Biomed Engn, Chicago, IL 60616 USA; [Hung, Yukai; Wang, Weichung] Natl Taiwan Univ, Dept Math, Taipei 10764, Taiwan; [Kao, Chien-Min; Chen, Chin-Tu] Univ Chicago, Dept Radiol, Chicago, IL 60637 USA	National Taiwan University; Illinois Institute of Technology; National Taiwan University; University of Chicago	Wang, WC (corresponding author), Natl Taiwan Univ, Dept Math, Taipei 10764, Taiwan.	wwang@ntu.edu.tw	Kao, Chien-Min/CAI-0648-2022; Chen, Chin-Tu/K-3393-2014	Kao, Chien-Min/0000-0002-8785-5225; CHOU, CHENG-YING/0000-0002-5737-6960; Wang, Weichung/0000-0002-6154-7750	National Science Council [NSC 99-2221-E-002-043-MY3, NSC 100-2628-M-002-011-MY4]; Taida Institute of Mathematical Sciences, Center for Advanced Study in Theoretical Sciences; National Center for Theoretical Sciences (Taipei Office)	National Science Council(Ministry of Science and Technology, Taiwan); Taida Institute of Mathematical Sciences, Center for Advanced Study in Theoretical Sciences; National Center for Theoretical Sciences (Taipei Office)	This work was supported in part by the National Science Council under grant No. NSC 99-2221-E-002-043-MY3 and NSC 100-2628-M-002-011-MY4, the Taida Institute of Mathematical Sciences, Center for Advanced Study in Theoretical Sciences, and the National Center for Theoretical Sciences (Taipei Office). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexoff DL, 2011, NUCL MED BIOL, V38, P191, DOI 10.1016/j.nucmedbio.2010.08.004; Astakhov V, 2003, IEEE T NUCL SCI, V50, P1373, DOI 10.1109/TNS.2003.817944; BARTZAKOS P, 1991, PHYS MED BIOL, V36, P735, DOI 10.1088/0031-9155/36/6/003; Boning G, 2001, IEEE T NUCL SCI, V48, P805, DOI 10.1109/23.940167; Chatziioannou AF, 2002, EUR J NUCL MED, V29, P98, DOI 10.1007/s00259-001-0683-3; Chou CY, 2011, MED PHYS, V38, P4052, DOI 10.1118/1.3591994; de Jong HWAM, 2007, PHYS MED BIOL, V52, P1505, DOI 10.1088/0031-9155/52/5/019; Dong Y, 2006, IEEE NUCL SCI CONF R, P2864; Gambhir SS, 2002, NAT REV CANCER, V2, P683, DOI 10.1038/nrc882; Herholz K, 2002, NEUROIMAGE, V17, P302, DOI 10.1006/nimg.2002.1208; Herraiz JL, 2006, PHYS MED BIOL, V51, P4547, DOI 10.1088/0031-9155/51/18/007; HUDSON HM, 1994, IEEE T MED IMAGING, V13, P601, DOI 10.1109/42.363108; Hwu W.W., 2011, GPU COMPUTING GEMS E; Jan S, 2004, PHYS MED BIOL, V49, P4543, DOI 10.1088/0031-9155/49/19/007; Kao C, 2002, NUCL SCI IEEE T, V47, P1551; Kao CM, 2007, IEEE NUCL SCI CONF R, P3046, DOI 10.1109/NSSMIC.2007.4436773; Kao CM, 2005, IEEE NUCL SCI CONF R, P2081; Kao CM, 2009, IEEE T NUCL SCI, V56, P2678, DOI 10.1109/TNS.2009.2026647; Kao CM, 2002, IEEE T NUCL SCI, V49, P208, DOI 10.1109/TNS.2002.998753; Kao CN, 2004, IEEE NUCL SCI CONF R, P2072; Kawachi N, 2011, IEEE T NUCL SCI, V58, P395, DOI 10.1109/TNS.2011.2113192; Kwon SI, 2011, J NUCL MED, V52, P572, DOI 10.2967/jnumed.110.079707; Lecomte R, 2004, NUCL INSTRUM METH A, V527, P157, DOI 10.1016/j.nima.2004.03.113; Miyaoka RS, 1998, IEEE T NUCL SCI, V45, P1069, DOI 10.1109/23.681980; Moehrs S, 2006, PHYS MED BIOL, V51, P1113, DOI 10.1088/0031-9155/51/5/004; Moisan C, 1996, IEEE T NUCL SCI, V43, P1926, DOI 10.1109/23.507248; Morrish PK, 1996, BRAIN, V119, P585, DOI 10.1093/brain/119.2.585; MOSES WW, 1994, IEEE T NUCL SCI, V41, P1441, DOI 10.1109/23.322929; Mumcuoglu E, 2002, NUCL SCI S 1996 C RE, V3, P1569; Murayama H, 1998, IEEE T NUCL SCI, V45, P1152, DOI 10.1109/23.681994; Murphy M, 2010, P ISMRM SCI M EXH, P4854; Nestle U, 2009, PHYS MED BIOL, V54, pR1, DOI 10.1088/0031-9155/54/1/R01; Nvidia C, 2007, COMP UN DEV ARCH PRO; NVIDIA Corporation, 2008, NVIDIA CUDA CUBLAS L; Okitsu Y, 2010, PARALLEL COMPUT, V36, P129, DOI 10.1016/j.parco.2010.01.004; Pratx G, 2011, PHYS MED BIOL, V56, P4023, DOI 10.1088/0031-9155/56/13/018; Qi JY, 1998, PHYS MED BIOL, V43, P1001, DOI 10.1088/0031-9155/43/4/027; Rafecas M, 2004, IEEE T NUCL SCI, V51, P2597, DOI 10.1109/TNS.2004.834827; Rogers JG, 1996, IEEE T NUCL SCI, V43, P3240, DOI 10.1109/23.552726; Rohren EM, 2004, RADIOLOGY, V231, P305, DOI 10.1148/radiol.2312021185; Sanders J., 2010, CUDA EXAMPLE; Tai YC, 2005, ANNU REV BIOMED ENG, V7, P255, DOI 10.1146/annurev.bioeng.6.040803.140021; Uchida H, 2004, NUCL INSTRUM METH A, V516, P564, DOI 10.1016/j.nima.2003.08.165; Wang ZG, 2005, IEEE T NUCL SCI, V52, P1274, DOI 10.1109/TNS.2005.858231; Weisenberger AG, 2009, IEEE NUCL SCI CONF R, P2323, DOI 10.1109/NSSMIC.2009.5402259; Wuest F, 2005, AMINO ACIDS, V29, P323, DOI 10.1007/s00726-005-0201-1; Yamamoto S, 1998, IEEE T NUCL SCI, V45, P1078, DOI 10.1109/23.681982; Zhou J, 2011, PHYS MED BIOL, V56, P6739, DOI 10.1088/0031-9155/56/20/015	48	8	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e50540	10.1371/journal.pone.0050540	http://dx.doi.org/10.1371/journal.pone.0050540			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300527	gold, Green Submitted, Green Published			2022-12-27	WOS:000313618800007
J	Hall, J; Philip, RCM; Marwick, K; Whalley, HC; Romaniuk, L; McIntosh, AM; Santos, I; Sprengelmeyer, R; Johnstone, EC; Stanfield, AC; Young, AW; Lawrie, SM				Hall, Jeremy; Philip, Ruth C. M.; Marwick, Katie; Whalley, Heather C.; Romaniuk, Liana; McIntosh, Andrew M.; Santos, Isabel; Sprengelmeyer, Reiner; Johnstone, Eve C.; Stanfield, Andrew C.; Young, Andy W.; Lawrie, Stephen M.			Social Cognition, the Male Brain and the Autism Spectrum	PLOS ONE			English	Article							HIGH-FUNCTIONING AUTISM; MIRROR-NEURON SYSTEM; SEX-DIFFERENCES; CORTICAL THICKNESS; ASPERGER-SYNDROME; HEALTHY-INDIVIDUALS; GENDER-DIFFERENCES; MATTER VOLUME; GRAY-MATTER; CHILDREN	Behavioral studies have shown that, at a population level, women perform better on tests of social cognition and empathy than men. Furthermore Autism Spectrum Disorders (ASDs), which are characterized by impairments in social functioning and empathy, occur more commonly in males than females. These findings have led to the hypothesis that differences in the functioning of the social brain between males and females contribute to the greater vulnerability of males to ASD and the suggestion that ASD may represent an extreme form of the male brain. Here we sought to investigate this hypothesis by determining: (i) whether males and females differ in social brain function, and (ii) whether any sex differences in social brain function are exaggerated in individuals with ASD. Using fMRI we show that males and females differ markedly in social brain function when making social decisions from faces (compared to simple sex judgements) especially when making decisions of an affective nature, with the greatest sex differences in social brain activation being in the inferior frontal cortex (IFC). We also demonstrate that this difference is exaggerated in individuals with ASD, who show an extreme male pattern of IFC function. These results show that males and females differ significantly in social brain function and support the view that sex differences in the social brain contribute to the greater vulnerability of males to ASDs.	[Hall, Jeremy; Philip, Ruth C. M.; Marwick, Katie; Whalley, Heather C.; Romaniuk, Liana; McIntosh, Andrew M.; Johnstone, Eve C.; Stanfield, Andrew C.; Lawrie, Stephen M.] Univ Edinburgh, Div Psychiat, Edinburgh, Midlothian, Scotland; [Santos, Isabel] Univ Aveiro, Dept Educ Sci, Aveiro, Portugal; [Sprengelmeyer, Reiner] Univ St Andrews, Dept Psychol, St Andrews, Fife, Scotland; [Young, Andy W.] Univ York, York Neuroimaging Ctr, York YO10 5DD, N Yorkshire, England	University of Edinburgh; Universidade de Aveiro; University of St Andrews; University of York - UK	Hall, J (corresponding author), Univ Edinburgh, Div Psychiat, Edinburgh, Midlothian, Scotland.	jeremy.hall@ed.ac.uk	Santos, Isabel M/K-6092-2013; Whalley, Heather C/N-1886-2019; Young, Andy/G-2189-2011; Lawrie, Stephen MacGregor/AAD-1607-2021; Stanfield, Andrew/AFQ-1896-2022; McIntosh, Andrew M/B-9379-2008	Santos, Isabel M/0000-0003-2404-4035; Whalley, Heather C/0000-0002-4505-8869; Young, Andy/0000-0002-1202-6297; Lawrie, Stephen MacGregor/0000-0002-2444-5675; McIntosh, Andrew M/0000-0002-0198-4588; Stanfield, Andrew/0000-0003-2459-1434; Hall, Jeremy/0000-0002-0403-3278; Sprengelmeyer, Reiner Heinrich/0000-0002-3083-5995; Marwick, Katie/0000-0003-1753-4626	Scottish Senior Clinical Fellowships; Royal Society Dorothy Hodgkin Fellowship; Mortimer and Theresa Sackler Foundation; MRC [G0600429] Funding Source: UKRI; Medical Research Council [G0600429, G0801418B] Funding Source: researchfish	Scottish Senior Clinical Fellowships; Royal Society Dorothy Hodgkin Fellowship(Royal Society of London); Mortimer and Theresa Sackler Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was funded by the Mortimer and Theresa Sackler Foundation. J.H. and A.McI. are supported by Scottish Senior Clinical Fellowships. H. C. W. is supported by a Royal Society Dorothy Hodgkin Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell F, 1999, NEUROREPORT, V10, P1647, DOI 10.1097/00001756-199906030-00005; Alaerts K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020989; Aleman A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003622; Baron-Cohen S, 2003, PHILOS T ROY SOC B, V358, P361, DOI 10.1098/rstb.2002.1206; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S, 1999, EUR J NEUROSCI, V11, P1891, DOI 10.1046/j.1460-9568.1999.00621.x; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Baron-Cohen S, 2006, BRAIN COGNITION, V61, P122, DOI 10.1016/j.bandc.2005.12.011; Baron-Cohen S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001081; BaronCohen S, 1997, VIS COGN, V4, P311, DOI 10.1080/713756761; Callicott JH, 2003, AM J PSYCHIAT, V160, P2209, DOI 10.1176/appi.ajp.160.12.2209; Chen XH, 2007, NEUROIMAGE, V36, P691, DOI 10.1016/j.neuroimage.2007.03.063; Cheng Y, 2009, NEUROSCIENCE, V158, P713, DOI 10.1016/j.neuroscience.2008.10.026; Courchesne E, 2011, BRAIN RES, V1380, P138, DOI 10.1016/j.brainres.2010.09.101; Dapretto M, 2006, NAT NEUROSCI, V9, P28, DOI 10.1038/nn1611; Davis M. H., 1980, JSAS CATALOG SELECTE, V10, P1, DOI DOI 10.1037/0022-3514.44.1.113; Derntl B, 2010, PSYCHONEUROENDOCRINO, V35, P67, DOI 10.1016/j.psyneuen.2009.10.006; EISENBERG N, 1983, PSYCHOL BULL, V94, P100, DOI 10.1037/0033-2909.94.1.100; Fombonne E, 2003, J AUTISM DEV DISORD, V33, P365, DOI 10.1023/A:1025054610557; Goldstein JM, 2001, CEREB CORTEX, V11, P490, DOI 10.1093/cercor/11.6.490; Good CD, 2001, NEUROIMAGE, V14, P685, DOI 10.1006/nimg.2001.0857; Hadjikhani N, 2006, CEREB CORTEX, V16, P1276, DOI 10.1093/cercor/bh069; Hall J, 2010, PSYCHOL MED, V40, P1183, DOI 10.1017/S0033291709991395; HALL JA, 1978, PSYCHOL BULL, V85, P845, DOI 10.1037/0033-2909.85.4.845; Hoffmann H, 2010, ACTA PSYCHOL, V135, P278, DOI 10.1016/j.actpsy.2010.07.012; Iacoboni M, 2009, ANNU REV PSYCHOL, V60, P653, DOI 10.1146/annurev.psych.60.110707.163604; Im K, 2006, NEUROIMAGE, V31, P31, DOI 10.1016/j.neuroimage.2005.11.042; Ino T, 2010, BRAIN IMAGING BEHAV, V4, P55, DOI 10.1007/s11682-009-9085-0; Lenroot RK, 2007, NEUROIMAGE, V36, P1065, DOI 10.1016/j.neuroimage.2007.03.053; Luders E, 2006, HUM BRAIN MAPP, V27, P314, DOI 10.1002/hbm.20187; Luders E, 2004, NAT NEUROSCI, V7, P799, DOI 10.1038/nn1277; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; McAlonan GM, 2005, BRAIN, V128, P268, DOI 10.1093/brain/awh332; McClure EB, 2000, PSYCHOL BULL, V126, P424, DOI 10.1037/0033-2909.126.3.424; Mosconi MW, 2009, ARCH GEN PSYCHIAT, V66, P509, DOI 10.1001/archgenpsychiatry.2009.19; Philip RCM, 2010, PSYCHOL MED, V40, P1919, DOI 10.1017/S0033291709992364; Platek SM, 2005, NEUROIMAGE, V25, P1336, DOI 10.1016/j.neuroimage.2004.12.037; Rizzolatti G, 2010, NAT REV NEUROSCI, V11, P264, DOI 10.1038/nrn2805; Russell TA, 2000, AM J PSYCHIAT, V157, P2040, DOI 10.1176/appi.ajp.157.12.2040; Santos IM, 2008, PERCEPTION, V37, P1061, DOI 10.1068/p5278; Schulte-Ruther M, 2008, NEUROIMAGE, V42, P393, DOI 10.1016/j.neuroimage.2008.04.180; Shamay-Tsoory SG, 2009, BRAIN, V132, P617, DOI 10.1093/brain/awn279; Sowell ER, 2007, CEREB CORTEX, V17, P1550, DOI 10.1093/cercor/bhl066; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wang AT, 2006, BRAIN, V129, P932, DOI 10.1093/brain/awl032; Wilke M, 2007, EXP BRAIN RES, V178, P296, DOI 10.1007/s00221-006-0732-z; Yamasaki S, 2010, BIOL PSYCHIAT, V68, P1141, DOI 10.1016/j.biopsych.2010.07.012; Yamasue H, 2008, CEREB CORTEX, V18, P2331, DOI 10.1093/cercor/bhm254	48	19	20	0	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e49033	10.1371/journal.pone.0049033	http://dx.doi.org/10.1371/journal.pone.0049033			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	071TV	23300517	Green Published, gold, Green Submitted			2022-12-27	WOS:000313618800003
J	Lin, CC; Zhou, JP; Liu, YP; Liu, JJ; Yang, XN; Jazag, A; Zhang, ZP; Guleng, B; Ren, JL				Lin, Chan-Chan; Zhou, Jing-Ping; Liu, Yun-Peng; Liu, Jing-Jing; Yang, Xiao-Ning; Jazag, Amarsanaa; Zhang, Zhi-Ping; Guleng, Bayasi; Ren, Jian-Lin			The Silencing of Pokemon Attenuates the Proliferation of Hepatocellular Carcinoma Cells In Vitro and In Vivo by Inhibiting the PI3K/Akt Pathway	PLOS ONE			English	Article							REPRESSES TRANSCRIPTION; NUCLEAR-LOCALIZATION; POOR-PROGNOSIS; FBI-1; ACTIVATION; GENE; EXPRESSION; GROWTH; ERK; MIGRATION	Pokemon (POK erythroid myeloid ontogenic factor), which belongs to the POK protein family, is also called LRF, OCZF and FBI-1. As a transcriptional repressor, Pokemon assumes a critical function in cellular differentiation and oncogenesis. Our study identified an oncogenic role for Pokemon in human hepatocellular carcinoma (HCC). We successfully established human HepG2 and Huh-7 cell lines in which Pokemon was stably knocked down. We demonstrated that Pokemon silencing inhibited cell proliferation and migration. Pokemon knockdown inhibited the PI3K/Akt and c-Raf/MEK/ERK pathways and modulated the expression of various cell cycle regulators in HepG2 and Huh-7 cells. Therefore, Pokemon may also be involved in cell cycle progression in these cells. We confirmed that Pokemon silencing suppresses hepatocellular carcinoma growth in tumor xenograft mice. These results suggest that Pokemon promotes cell proliferation and migration in hepatocellular carcinoma and accelerates tumor development in an Akt- and ERK-signaling-dependent manner.	[Lin, Chan-Chan; Zhou, Jing-Ping; Liu, Yun-Peng; Liu, Jing-Jing; Yang, Xiao-Ning; Zhang, Zhi-Ping; Guleng, Bayasi; Ren, Jian-Lin] Xiamen Univ, Zhongshan Hosp, Dept Gastroenterol, Xiamen, Peoples R China; [Guleng, Bayasi] Xiamen Univ, Coll Med, Fac Clin Med, Xiamen, Peoples R China; [Jazag, Amarsanaa] 3rd Gen Hosp, Natl Inst Med Res, Ulaanbaatar, Mongolia	Xiamen University; Xiamen University	Guleng, B (corresponding author), Xiamen Univ, Zhongshan Hosp, Dept Gastroenterol, Xiamen, Peoples R China.	bayasi8@gmail.com; renjianl@xmu.edu.cn		zhou, jingping/0000-0002-3703-2204	Youth Innovation Fund of Fujian Province [2006F3127]; National Natural Science Foundation of China [30971362, 81072013]; Fundamental Research Funds for the Central Universities in China [2010111082]	Youth Innovation Fund of Fujian Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities in China	This work was supported by Youth Innovation Fund of Fujian Province (2006F3127), National Natural Science Foundation of China (No. 30971362 & 81072013) and Fundamental Research Funds for the Central Universities in China (No. 2010111082). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal A, 2010, EXP MOL PATHOL, V89, P140, DOI 10.1016/j.yexmp.2010.05.002; Agrawal A, 2006, EXP MOL PATHOL, V81, P115, DOI 10.1016/j.yexmp.2006.07.001; Brugarolas J, 1999, P NATL ACAD SCI USA, V96, P1002, DOI 10.1073/pnas.96.3.1002; Buendia MA, 2000, SEMIN CANCER BIOL, V10, P185; Chang CJ, 2008, MOL CELL BIOL, V28, P3281, DOI 10.1128/MCB.00310-08; Choi WI, 2009, J BIOL CHEM, V284, P12633, DOI 10.1074/jbc.M809794200; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Guleng B, 2005, CANCER RES, V65, P5864, DOI 10.1158/0008-5472.CAN-04-3833; Horn S, 2004, LEUKEMIA, V18, P1839, DOI 10.1038/sj.leu.2403529; Huynh H, 2003, BMC GASTROENTEROL, V3, DOI 10.1186/1471-230X-3-19; Jeon BN, 2008, J BIOL CHEM, V283, P33199, DOI 10.1074/jbc.M802935200; Lee DK, 2005, J BIOL CHEM, V280, P27783, DOI 10.1074/jbc.M504909200; Lee DK, 2002, J BIOL CHEM, V277, P26761, DOI 10.1074/jbc.M202078200; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Merle P, 2009, VIRUSES-BASEL, V1, P852, DOI 10.3390/v1030852; Miyagishi M, 2002, NAT BIOTECHNOL, V20, P497, DOI 10.1038/nbt0502-497; Morrison DJ, 1999, NUCLEIC ACIDS RES, V27, P1251, DOI 10.1093/nar/27.5.1251; Nakanishi K, 2005, CANCER-AM CANCER SOC, V103, P307, DOI 10.1002/cncr.20774; Roy Sanjit K, 2010, J Mol Signal, V5, P10, DOI 10.1186/1750-2187-5-10; Saxena NK, 2007, CANCER RES, V67, P2497, DOI 10.1158/0008-5472.CAN-06-3075; Schmitz KJ, 2008, J HEPATOL, V48, P83, DOI 10.1016/j.jhep.2007.08.018; Suzuki A, 2000, HEPATOLOGY, V32, P796, DOI 10.1053/jhep.2000.17738; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Wiesenauer CA, 2004, J AM COLL SURGEONS, V198, P410, DOI 10.1016/j.jamcollsurg.2003.10.004; Zhang QL, 2011, ONKOLOGIE, V34, P526, DOI 10.1159/000332141	26	29	34	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e51916	10.1371/journal.pone.0051916	http://dx.doi.org/10.1371/journal.pone.0051916			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300578	Green Submitted, Green Published, gold			2022-12-27	WOS:000313618800037
J	Martin-Ordas, G; Schumacher, L; Call, J				Martin-Ordas, Gema; Schumacher, Lena; Call, Josep			Sequential Tool Use in Great Apes	PLOS ONE			English	Article							CALEDONIAN CROWS; TASK; SELECTIVITY; MONKEYS; GORILLA; SOLVE	Sequential tool use is defined as using a tool to obtain another non-food object which subsequently itself will serve as a tool to act upon a further ( sub) goal. Previous studies have shown that birds and great apes succeed in such tasks. However, the inclusion of a training phase for each of the sequential steps and the low cost associated with retrieving the longest tools limits the scope of the conclusions. The goal of the experiments presented here was, first to replicate a previous study on sequential tool use conducted on New Caledonian crows and, second, extend this work by increasing the cost of retrieving a tool in order to test tool selectivity of apes. In Experiment 1, we presented chimpanzees, orangutans and bonobos with an out-of-reach reward, two tools that were available but too short to reach the food and four out-of-reach tools differing in functionality. Similar to crows, apes spontaneously used up to 3 tools in sequence to get the reward and also showed a strong preference for the longest out-of reach tool independently of the distance of the food. In Experiment 2, we increased the cost of reaching for the longest out-of reach tool. Now apes used up to 5 tools in sequence to get the reward and became more selective in their choice of the longest tool as the costs of its retrieval increased. The findings of the studies presented here contribute to the growing body of comparative research on tool use.	[Martin-Ordas, Gema; Schumacher, Lena; Call, Josep] Max Planck Inst Evolutionary Anthropol, Leipzig, Germany; [Martin-Ordas, Gema] Ctr Autobiog Memory Res, Aarhus, Denmark	Max Planck Society	Martin-Ordas, G (corresponding author), Max Planck Inst Evolutionary Anthropol, Leipzig, Germany.	ordas@psy.au.dk		Call Balaguer, Josep/0000-0002-8597-8336	"Programa de Ayuda a la Movilidad del Ministerio de Ciencia e Innovacion (Micinn)", Spain; Danish National Research Foundation	"Programa de Ayuda a la Movilidad del Ministerio de Ciencia e Innovacion (Micinn)", Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Danish National Research Foundation(Danmarks Grundforskningsfond)	Gema Martin-Ordas was supported by a post-doctoral fellowship of the "Programa de Ayuda a la Movilidad del Ministerio de Ciencia e Innovacion (Micinn)", Spain. Also parts of the first author's contributions were supported by the Danish National Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck B. B., 1980, ANIMAL TOOL BEHAV US; Birch HG, 1945, J COMP PSYCHOL, V38, P295, DOI 10.1037/h0059937; Bird CD, 2009, CURR BIOL, V19, P1410, DOI 10.1016/j.cub.2009.07.033; BYRNE RW, 1993, AM J PRIMATOL, V31, P241, DOI 10.1002/ajp.1350310402; Byrne RW, 1998, BEHAV BRAIN SCI, V21, P667, DOI 10.1017/S0140525X98001745; Chappell J, 2002, ANIM COGN, V5, P71, DOI 10.1007/s10071-002-0130-2; Emery NJ, 2004, SCIENCE, V306, P1903, DOI 10.1126/science.1098410; EPSTEIN R, 1984, NATURE, V308, P61, DOI 10.1038/308061a0; Girndt A, 2008, J EXP PSYCHOL ANIM B, V34, P54, DOI 10.1037/0097-7403.34.1.54; Hihara S, 2003, PHYSIOL BEHAV, V78, P427, DOI 10.1016/S0031-9384(02)01006-5; Hunt GR, 2002, EMU, V102, P349, DOI 10.1071/MU01056; Koehler W., 1925, MENTALITY APES; McGrew WC, 2010, SCIENCE, V328, P579, DOI 10.1126/science.1187921; Mulcahy NJ, 2006, ANIM COGN, V9, P193, DOI 10.1007/s10071-006-0019-6; Mulcahy NJ, 2005, J COMP PSYCHOL, V119, P23, DOI 10.1037/0735-7036.119.1.23; Ottoni EB, 2008, EVOL ANTHROPOL, V17, P171, DOI 10.1002/evan.20185; Rensch B., 1968, Zeitschrift fuer Tierpsychologie, V25, P216; Santos LR, 2005, ANIM COGN, V8, P236, DOI 10.1007/s10071-004-0246-7; Seed AM, 2009, J EXP PSYCHOL ANIM B, V35, P23, DOI 10.1037/a0012925; Shumaker R. W., 2011, ANIMAL TOOL BEHAV US; Silva FJ, 2012, LEARN BEHAV, V40, P494, DOI 10.3758/s13420-012-0069-3; Silva FJ, 2010, LEARN BEHAV, V38, P87, DOI 10.3758/LB.38.1.87; Taylor AH, 2007, CURR BIOL, V17, P1504, DOI 10.1016/j.cub.2007.07.057; Taylor AH, 2010, P ROY SOC B-BIOL SCI, V277, P2637, DOI 10.1098/rspb.2010.0285; Warden CJ, 1940, PEDAGOG SEMIN J GEN, V56, P297; Wimpenny JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006471	26	20	21	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52074	10.1371/journal.pone.0052074	http://dx.doi.org/10.1371/journal.pone.0052074			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300592	Green Published, Green Submitted, gold			2022-12-27	WOS:000313618800046
J	Neff, MW; Beck, JS; Koeman, JM; Boguslawski, E; Kefene, L; Borgman, A; Ruhe, AL				Neff, Mark W.; Beck, John S.; Koeman, Julie M.; Boguslawski, Elissa; Kefene, Lisa; Borgman, Andrew; Ruhe, Alison L.			Partial Deletion of the Sulfate Transporter SLC13A1 Is Associated with an Osteochondrodysplasia in the Miniature Poodle Breed	PLOS ONE			English	Article							MULTIPLE EPIPHYSEAL DYSPLASIA; DIASTROPHIC DYSPLASIA; INORGANIC SULFATE; CLUB FOOT; NULL MICE; GENE; MUTATIONS; ACHONDROPLASIA; GENOME; MOUSE	A crippling dwarfism was first described in the Miniature Poodle in Great Britain in 1956. Here, we resolve the genetic basis of this recessively inherited disorder. A case-control analysis (8:8) of genotype data from 173 k SNPs revealed a single associated locus on CFA14 (P-raw <10(-8)). All affected dogs were homozygous for an ancestral haplotype consistent with a founder effect and an identical-by-descent mutation. Systematic failure of nine, nearly contiguous SNPs, was observed solely in affected dogs, suggesting a deletion was the causal mutation. A 130-kb deletion was confirmed both by fluorescence in situ hybridization (FISH) analysis and by cloning the physical breakpoints. The mutation was perfectly associated in all cases and obligate heterozygotes. The deletion ablated all but the first exon of SLC13A1, a sodium/sulfate symporter responsible for regulating serum levels of inorganic sulfate. Our results corroborate earlier findings from an Slc13a1 mouse knockout, which resulted in hyposulfatemia and syndromic defects. Interestingly, the metabolic disorder in Miniature Poodles appears to share more clinical signs with a spectrum of human disorders caused by SLC26A2 than with the mouse Slc13a1 model. SLC26A2 is the primary sodium-independent sulfate transporter in cartilage and bone and is important for the sulfation of proteoglycans such as aggregan. We propose that disruption of SLC13A1 in the dog similarly causes undersulfation of proteoglycans in the extracellular matrix (ECM), which impacts the conversion of cartilage to bone. A co-dominant DNA test of the deletion was developed to enable breeders to avoid producing affected dogs and to selectively eliminate the mutation from the gene pool.	[Neff, Mark W.; Beck, John S.; Koeman, Julie M.; Boguslawski, Elissa; Kefene, Lisa; Borgman, Andrew; Ruhe, Alison L.] Van Andel Res Inst, Lab Neurogenet & Canine Behav, Grand Rapids, MI USA; [Ruhe, Alison L.] Translat Genom Res Inst, Program Canine Hlth & Performance, Phoenix, AZ USA	Van Andel Institute; Translational Genomics Research Institute	Neff, MW (corresponding author), Van Andel Res Inst, Lab Neurogenet & Canine Behav, Grand Rapids, MI USA.	mark.neff@vai.org						ALMLOEF J, 1961, ZBL VETERINARMEDIZIN, V8, P43; BRUNO WJ, 1977, J AM VET MED ASSOC, V170, P1097; Cho YR, 2004, BIOCHEM BIOPH RES CO, V323, P769, DOI 10.1016/j.bbrc.2004.08.173; COTCHIN E., 1956, Veterinary Record, V68, P427; Dawson PA, 2009, GUT, V58, P910, DOI 10.1136/gut.2007.147595; Dawson PA, 2005, BEHAV BRAIN RES, V159, P15, DOI 10.1016/j.bbr.2004.09.020; Dawson PA, 2004, BEHAV BRAIN RES, V154, P457, DOI 10.1016/j.bbr.2004.03.013; Dawson PA, 2003, P NATL ACAD SCI USA, V100, P13704, DOI 10.1073/pnas.2231298100; GARDNER DL, 1959, J PATHOL BACTERIOL, V77, P243, DOI 10.1002/path.1700770123; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; Huber C, 2001, J MED GENET, V38, P191, DOI 10.1136/jmg.38.3.191; Jackson GC, 2012, HUM MUTAT, V33, P144, DOI 10.1002/humu.21611; JACKSON SG, 1978, ANAL BIOCHEM, V90, P802, DOI 10.1016/0003-2697(78)90171-9; KRUSKAL WILLIAM H., 1952, JOUR AMER STATIST ASSOC, V47, P583, DOI 10.2307/2280779; Lee A, 2000, GENOMICS, V70, P354, DOI 10.1006/geno.2000.6404; Lee S, 2007, NEUROREPORT, V18, P1981, DOI 10.1097/WNR.0b013e3282f22998; LODGE D, 1966, VET REC, V79, P136; LUNDQUIST P, 1980, CLIN CHEM, V26, P1178; Markovich D, 2011, EXP GERONTOL, V46, P833, DOI 10.1016/j.exger.2011.05.008; Oberbauer AM, 2003, VET RES COMMUN, V27, P27, DOI 10.1023/A:1022006606796; Ohana E, 2009, J PHYSIOL-LONDON, V587, P2179, DOI 10.1113/jphysiol.2008.164863; Purcell S, 2007, AM J HUM GENET, P81; Riser W, 1962, RADIOLOGIC DIAGNOSES, P122; RISER WH, 1980, J AM VET MED ASSOC, V176, P335; Rossi A, 1996, HUM GENET, V98, P657, DOI 10.1007/s004390050279; Satoh H, 1998, J BIOL CHEM, V273, P12307, DOI 10.1074/jbc.273.20.12307; Stevens J W, 1999, Iowa Orthop J, V19, P53; Superti-Furga A, 1999, J MED GENET, V36, P621; SupertiFurga A, 1996, NAT GENET, V12, P100, DOI 10.1038/ng0196-100; VanBrocklin MW, 2009, PIGM CELL MELANOMA R, V22, P454, DOI 10.1111/j.1755-148X.2009.00576.x; Wong AK, 2010, GENETICS, V184, P595, DOI 10.1534/genetics.109.106831	31	18	18	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e51917	10.1371/journal.pone.0051917	http://dx.doi.org/10.1371/journal.pone.0051917			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300579	Green Published, gold, Green Submitted			2022-12-27	WOS:000313618800038
J	Chen, JC; Krasnow, MA				Chen, Jichao; Krasnow, Mark A.			Integrin Beta 1 Suppresses Multilayering of a Simple Epithelium	PLOS ONE			English	Article							LUNG BRANCHING MORPHOGENESIS; EPIDERMAL MORPHOGENESIS; EXPRESSION; SKIN; BETA-1-INTEGRIN; STRATIFICATION; MOUSE; P63; DIFFERENTIATION; PROLIFERATION	Epithelia are classified as either simple, a single cell layer thick, or stratified (multilayered). Stratified epithelia arise from simple epithelia during development, and transcription factor p63 functions as a key positive regulator of epidermal stratification. Here we show that deletion of integrin beta 1 (Itgb1) in the developing mouse airway epithelium abrogates airway branching and converts this monolayer epithelium into a multilayer epithelium with more than 10 extra layers. Mutant lung epithelial cells change mitotic spindle orientation to seed outer layers, and cells in different layers become molecularly and functionally distinct, hallmarks of normal stratification. However, mutant lung epithelial cells do not activate p63 and do not switch to the stratified keratin profile of epidermal cells. These data, together with previous data implicating Itgb1 in regulation of epidermal stratification, suggest that the simple-versus-stratified developmental decision may involve not only stratification inducers like p63 but suppressors like Itgb1 that prevent simple epithelia from inappropriately activating key steps in the stratification program.	Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; Stanford Univ, Sch Med, HHMI, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University	Chen, JC (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pulm Med, Houston, TX 77030 USA.	jchen16@mdanderson.org; krasnow@stanford.edu			Jane Coffin Childs Memorial Fund for Medical Research; Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099999, U01HL099995] Funding Source: NIH RePORTER	Jane Coffin Childs Memorial Fund for Medical Research; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Jane Coffin Childs Memorial Fund for Medical Research (J.C.) (http://www.jccfund.org/) and the Howard Hughes Medical Institute (M.A.K.) (http://www.hhmi.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Magdalena P, 2009, P NATL ACAD SCI USA, V106, P2859, DOI 10.1073/pnas.0812666106; Bragulla HH, 2009, J ANAT, V214, P516, DOI 10.1111/j.1469-7580.2009.01066.x; Brakebusch C, 2000, EMBO J, V19, P3990, DOI 10.1093/emboj/19.15.3990; Chen J, 2007, DEV CELL, V13, P325, DOI 10.1016/j.devcel.2007.07.011; Coraux C, 1998, J HISTOCHEM CYTOCHEM, V46, P803, DOI 10.1177/002215549804600703; De Arcangelis A, 1999, DEVELOPMENT, V126, P3957; FASSLER R, 1995, GENE DEV, V9, P1896, DOI 10.1101/gad.9.15.1896; Fernandez-Minan A, 2007, CURR BIOL, V17, P683, DOI 10.1016/j.cub.2007.02.052; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Harris KS, 2006, P NATL ACAD SCI USA, V103, P2208, DOI 10.1073/pnas.0510839103; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Koster MI, 2007, ANNU REV CELL DEV BI, V23, P93, DOI 10.1146/annurev.cellbio.23.090506.123357; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Pozzi A, 2011, CURR OPIN CELL BIOL; Raghavan S, 2000, J CELL BIOL, V150, P1149, DOI 10.1083/jcb.150.5.1149; Ray S, 2011, CELL DIV, V6, DOI 10.1186/1747-1028-6-12; ROMAN J, 1991, DEVELOPMENT, V112, P551; Sauer FC, 1935, J COMP NEUROL, V62, P377, DOI 10.1002/cne.900620207; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Simpson CL, 2011, NAT REV MOL CELL BIO, V12, P565, DOI 10.1038/nrm3175; STEPHENS LE, 1995, GENE DEV, V9, P1883, DOI 10.1101/gad.9.15.1883; Tang SHE, 2002, GENESIS, V32, P199, DOI 10.1002/gene.10030; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Williams SE, 2011, NATURE, V470, P353, DOI 10.1038/nature09793; Winklbauer R, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/4/045001; Wu JE, 1996, DEV DYNAM, V206, P169, DOI 10.1002/(SICI)1097-0177(199606)206:2<169::AID-AJA6>3.0.CO;2-G; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Zovein AC, 2010, DEV CELL, V18, P39, DOI 10.1016/j.devcel.2009.12.006	32	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52886	10.1371/journal.pone.0052886	http://dx.doi.org/10.1371/journal.pone.0052886			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285215	Green Published, gold			2022-12-27	WOS:000313158800104
J	Imam, JS; Plyler, JR; Bansal, H; Prajapati, S; Bansal, S; Rebeles, J; Chen, HIH; Chang, YF; Panneerdoss, S; Zoghi, B; Buddavarapu, KC; Broaddus, R; Hornsby, P; Tomlinson, G; Dome, J; Vadlamudi, RK; Pertsemlidis, A; Chen, YD; Rao, MK				Imam, J. Saadi; Plyler, Jason R.; Bansal, Hima; Prajapati, Suresh; Bansal, Sanjay; Rebeles, Jennifer; Chen, Hung-I Harry; Chang, Yao-Fu; Panneerdoss, Subbarayalu; Zoghi, Behyar; Buddavarapu, Kalyan C.; Broaddus, Russell; Hornsby, Peter; Tomlinson, Gail; Dome, Jeffrey; Vadlamudi, Ratna K.; Pertsemlidis, Alexander; Chen, Yidong; Rao, Manjeet K.			Genomic Loss of Tumor Suppressor miRNA-204 Promotes Cancer Cell Migration and Invasion by Activating AKT/mTOR/Rac1 Signaling and Actin Reorganization	PLOS ONE			English	Article							OVARIAN-CANCER; IN-VITRO; EXPRESSION; MICRORNAS; MOTILITY; TARGET; GROWTH; TRKB; EZRIN; RAC1	Increasing evidence suggests that chromosomal regions containing microRNAs are functionally important in cancers. Here, we show that genomic loci encoding miR-204 are frequently lost in multiple cancers, including ovarian cancers, pediatric renal tumors, and breast cancers. MiR-204 shows drastically reduced expression in several cancers and acts as a potent tumor suppressor, inhibiting tumor metastasis in vivo when systemically delivered. We demonstrated that miR-204 exerts its function by targeting genes involved in tumorigenesis including brain-derived neurotrophic factor (BDNF), a neurotrophin family member which is known to promote tumor angiogenesis and invasiveness. Analysis of primary tumors shows that increased expression of BDNF or its receptor tropomyosin-related kinase B (TrkB) parallel a markedly reduced expression of miR-204. Our results reveal that loss of miR-204 results in BDNF overexpression and subsequent activation of the small GTPase Rac1 and actin reorganization through the AKT/mTOR signaling pathway leading to cancer cell migration and invasion. These results suggest that microdeletion of genomic loci containing miR-204 is directly linked with the deregulation of key oncogenic pathways that provide crucial stimulus for tumor growth and metastasis. Our findings provide a strong rationale for manipulating miR-204 levels therapeutically to suppress tumor metastasis.	[Imam, J. Saadi; Plyler, Jason R.; Bansal, Hima; Prajapati, Suresh; Bansal, Sanjay; Rebeles, Jennifer; Chen, Hung-I Harry; Chang, Yao-Fu; Panneerdoss, Subbarayalu; Buddavarapu, Kalyan C.; Tomlinson, Gail; Pertsemlidis, Alexander; Chen, Yidong; Rao, Manjeet K.] Univ Texas Hlth Sci Ctr San Antonio, Greehey Childrens Canc Res Inst, San Antonio, TX 78229 USA; [Plyler, Jason R.; Chang, Yao-Fu; Rao, Manjeet K.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Zoghi, Behyar] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Hornsby, Peter] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA; [Vadlamudi, Ratna K.] Univ Texas Hlth Sci Ctr San Antonio, Dept Obstet & Gynecol, San Antonio, TX 78229 USA; [Chen, Yidong] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostatist, San Antonio, TX 78229 USA; [Broaddus, Russell] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Dome, Jeffrey] Childrens Natl Med Ctr, Ctr Canc & Immunol Res, Washington, DC 20010 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; UTMD Anderson Cancer Center; Children's National Health System	Rao, MK (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Greehey Childrens Canc Res Inst, San Antonio, TX 78229 USA.	raom@uthscsa.edu	Pertsemlidis, Alexander/Q-7899-2017; Dome, Jeffrey/AAH-7825-2019	Pertsemlidis, Alexander/0000-0003-1624-9372; Imam, J Saadi/0000-0003-3463-838X	William and Ella Medical Research Foundation; GCCRI start up fund; CPRIT fellowship; National Institutes of Health (NIH); NIH/National Cancer Institute cancer center [P30 CA054174-17]; NATIONAL CANCER INSTITUTE [T32CA148724, P30CA054174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007686] Funding Source: NIH RePORTER	William and Ella Medical Research Foundation; GCCRI start up fund; CPRIT fellowship; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Cancer Institute cancer center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported by The William and Ella Medical Research Foundation grant (MKR), GCCRI start up fund (MKR), CPRIT fellowship (BZ), National Institutes of Health (NIH) T32 training grant (YFC), and NIH/National Cancer Institute cancer center grant (P30 CA054174-17). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alami J, 2003, J CLIN PATHOL-MOL PA, V56, P218, DOI 10.1136/mp.56.4.218; Albertson DG, 2003, HUM MOL GENET, V12, pR145, DOI 10.1093/hmg/ddg261; Au CWH, 2009, CANCER LETT, V281, P151, DOI 10.1016/j.canlet.2009.02.025; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bartels CL, 2009, CLIN CHEM, V55, P623, DOI 10.1373/clinchem.2008.112805; Bayani J, 2007, SEMIN CANCER BIOL, V17, P5, DOI 10.1016/j.semcancer.2006.10.006; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chung TKH, 2012, INT J CANCER, V130, P1036, DOI 10.1002/ijc.26060; Cui RR, 2012, CARDIOVASC RES, V96, P320, DOI 10.1093/cvr/cvs258; Du LQ, 2009, MOL CANCER RES, V7, P1234, DOI 10.1158/1541-7786.MCR-08-0507; Edsjo A, 2003, LAB INVEST, V83, P813, DOI 10.1097/01.LAB.0000074895.48776.D8; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Gong M, 2012, NEURO-ONCOLOGY, V14, P1007, DOI 10.1093/neuonc/nos124; Grille SJ, 2003, CANCER RES, V63, P2172; Gulhati P, 2011, CANCER RES, V71, P3246, DOI 10.1158/0008-5472.CAN-10-4058; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Higuchi M, 2001, CURR BIOL, V11, P1958, DOI 10.1016/S0960-9822(01)00599-1; Imam JS, 2010, ONCOGENE, V29, P4971, DOI 10.1038/onc.2010.233; Kim EK, 2011, ONCOGENE, V30, P2954, DOI 10.1038/onc.2011.22; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krishnan K, 2006, CLIN EXP METASTAS, V23, P227, DOI 10.1007/s10585-006-9033-y; Lewin GR, 1996, PHILOS T ROY SOC B, V351, P405, DOI 10.1098/rstb.1996.0035; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li GR, 2011, INVEST OPHTH VIS SCI, V52, P2999, DOI 10.1167/iovs.10-6708; Liu H, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S3-S12; Miyamoto Y, 2006, P NATL ACAD SCI USA, V103, P10444, DOI 10.1073/pnas.0603914103; NAKAGAWARA A, 1994, MOL CELL BIOL, V14, P759, DOI 10.1128/MCB.14.1.759; Qiu LH, 2006, INT J ONCOL, V29, P1003; Saci A, 2011, MOL CELL, V42, P50, DOI 10.1016/j.molcel.2011.03.017; Segal RA, 1996, J BIOL CHEM, V271, P20175, DOI 10.1074/jbc.271.33.20175; Shen C, 2008, BIOLOGICALS, V36, P263, DOI 10.1016/j.biologicals.2008.02.002; Siu MKY, 2009, EXPERT OPIN THER TAR, V13, P1169, DOI 10.1517/14728220903196787; Tang SJ, 2002, P NATL ACAD SCI USA, V99, P467, DOI 10.1073/pnas.012605299; Troca-Marin JA, 2010, MOL CELL NEUROSCI, V43, P308, DOI 10.1016/j.mcn.2009.12.004; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Wan XL, 2005, CANCER RES, V65, P2406, DOI 10.1158/0008-5472.CAN-04-3135; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449; Yu YL, 2004, NAT MED, V10, P175, DOI 10.1038/nm966; Yue D, 2010, ACM INT C BIOINF COM; Zadran S, 2010, J NEUROSCI, V30, P1086, DOI 10.1523/JNEUROSCI.5120-09.2010	43	122	130	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52397	10.1371/journal.pone.0052397	http://dx.doi.org/10.1371/journal.pone.0052397			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285024	Green Submitted, Green Published, gold			2022-12-27	WOS:000313158800062
J	Liao, Y; Zhang, JS; Huang, ZP; Xi, YB; Zhang, QR; Zhu, TL; Liu, XF				Liao, Yang; Zhang, Jinsong; Huang, Zhiping; Xi, Yibin; Zhang, Qianru; Zhu, Tianli; Liu, Xufeng			Altered Baseline Brain Activity with 72 h of Simulated Microgravity - Initial Evidence from Resting-State fMRI	PLOS ONE			English	Article							HEAD-DOWN TILT; MEDIODORSAL NUCLEUS; MENTAL PERFORMANCE; SCHIZOPHRENIA; OSCILLATIONS; FLUCTUATION; AMPLITUDE; CONTRAST; CHILDREN; GRAVITY	To provide the basis and reference to further insights into the neural activity of the human brain in a microgravity environment, we discuss the amplitude changes of low-frequency brain activity fluctuations using a simulated microgravity model. Twelve male participants between 24 and 31 years old received resting-state fMRI scans in both a normal condition and after 72 hours in a -6 degrees head down tilt (HDT). A paired sample t-test was used to test the amplitude differences of low-frequency brain activity fluctuations between these two conditions. With 72 hours in a -6 degrees HDT, the participants showed a decreased amplitude of low-frequency fluctuations in the left thalamus compared with the normal condition (a combined threshold of P<0.005 and a minimum cluster size of 351 mm(3) (13 voxels), which corresponded with the corrected threshold of P<0.05 determined by AlphaSim). Our findings indicate that a gravity change-induced redistribution of body fluid may disrupt the function of the left thalamus in the resting state, which may contribute to reduced motor control abilities and multiple executive functions in astronauts in a microgravity environment.	[Liao, Yang; Huang, Zhiping; Zhang, Qianru; Zhu, Tianli; Liu, Xufeng] Fourth Mil Med Univ, Sch Aerosp Med, Dept Psychol, Xian 710032, Shaanxi, Peoples R China; [Zhang, Jinsong; Xi, Yibin] Fourth Mil Med Univ, Xijing Hosp, Dept Radiol, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Liu, XF (corresponding author), Fourth Mil Med Univ, Sch Aerosp Med, Dept Psychol, Xian 710032, Shaanxi, Peoples R China.	lllfmmu@fmmu.edu.cn	Liao, Yang/A-6479-2016; zhang, jinsong/G-4215-2015	Liao, Yang/0000-0003-0969-235X; 	National Science Foundation of China [81071616, 81272174]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Science Foundation of China, Grant No. 81071616 and No.81272174. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANNETT M, 1970, BRIT J PSYCHOL, V61, P303, DOI 10.1111/j.2044-8295.1970.tb01248.x; BAGIAN JP, 1991, J CLIN PHARMACOL, V31, P1036, DOI 10.1002/j.1552-4604.1991.tb03668.x; BAISCH F, 1992, ACTA PHYSIOL SCAND, V144, P1; Berger M, 1997, AVIAT SPACE ENVIR MD, V68, P781; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bock O, 2001, AVIAT SPACE ENVIR MD, V72, P877; Buchsbaum MS, 1998, SCHIZOPHRENIA BULL, V24, P343, DOI 10.1093/oxfordjournals.schbul.a033331; Caprihan A, 1999, EUR J APPL PHYSIOL O, V79, P367, DOI 10.1007/s004210050522; Cheron G, 2006, BRAIN RES, V1121, P104, DOI 10.1016/j.brainres.2006.08.098; Eddy DR, 1998, ACTA ASTRONAUT, V43, P193, DOI 10.1016/S0094-5765(98)00154-4; FISK J, 1993, J NEUROPHYSIOL, V69, P504, DOI 10.1152/jn.1993.69.2.504; GIGUERE M, 1988, J COMP NEUROL, V277, P195, DOI 10.1002/cne.902770204; GOLDMANRAKIC PS, 1985, J COMP NEUROL, V242, P535, DOI 10.1002/cne.902420406; Haber SN, 2009, BRAIN RES BULL, V78, P69, DOI 10.1016/j.brainresbull.2008.09.013; Han XE, 2000, J GRAVIT PHYSL, V7, P95; Hazlett EA, 2008, NEUROIMAGE, V42, P1164, DOI 10.1016/j.neuroimage.2008.05.039; Hirayanagi K, 2009, ACTA ASTRONAUT, V64, P1298, DOI 10.1016/j.actaastro.2009.01.003; Hoptman MJ, 2010, SCHIZOPHR RES, V117, P13, DOI 10.1016/j.schres.2009.09.030; Huang XQ, 2010, NEUROIMAGE, V49, P2901, DOI 10.1016/j.neuroimage.2009.11.072; Inoue M, 2012, CLIN NEUROPHYSIOLOGY; Ishizaki Y, 2002, ACTA ASTRONAUT, V50, P453, DOI 10.1016/S0094-5765(01)00189-8; Karemaker JM, 2009, RESP PHYSIOL NEUROBI, V169, pS55, DOI 10.1016/j.resp.2009.05.006; KAWAI Y, 1993, J APPL PHYSIOL, V74, P3046, DOI 10.1152/jappl.1993.74.6.3046; Kawai Yasuaki, 2003, Yonago Acta Medica, V46, P1; Kiviniemi V, 2000, MAGN RESON MED, V44, P373, DOI 10.1002/1522-2594(200009)44:3<373::AID-MRM5>3.0.CO;2-P; Liu Y, 2011, EUR J RADIOL, V80, P407, DOI 10.1016/j.ejrad.2010.05.002; Lukhanina EP, 1994, NEUROPHYSIOLOGY+, V26, P378, DOI 10.1007/BF01053582; Mallol R, 2007, BRAIN RES, V1147, P265, DOI 10.1016/j.brainres.2007.02.046; MANZEY D, 1993, CLIN INVESTIGATOR, V71, P725; Manzey D, 1998, ERGONOMICS, V41, P537, DOI 10.1080/001401398186991; Manzey D, 2000, AVIAT SPACE ENVIR MD, V71, pA69; Newman DJ, 1999, IEEE T SYST MAN CY C, V29, P387, DOI 10.1109/5326.777074; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; OGAWA S, 1990, MAGNET RESON MED, V14, P68, DOI 10.1002/mrm.1910140108; Pletser V, 2003, ACTA ASTRONAUT, V52, P581, DOI 10.1016/S0094-5765(02)00124-8; Raeva S, 1999, NEUROSCIENCE, V88, P377, DOI 10.1016/S0306-4522(98)00230-9; Sangals J, 1999, EXP BRAIN RES, V129, P378, DOI 10.1007/s002210050906; Schneider S, 2008, NEUROIMAGE, V42, P1316, DOI 10.1016/j.neuroimage.2008.06.010; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Talairach J., 1988, COPLANAR STEREOTAXIC; Tononi Giulio, 2004, BMC Neurosci, V5, P42, DOI 10.1186/1471-2202-5-42; Watt DGD, 1997, AVIAT SPACE ENVIR MD, V68, P99; Wise RG, 2004, NEUROIMAGE, V21, P1652, DOI 10.1016/j.neuroimage.2003.11.025; Yang H, 2007, NEUROIMAGE, V36, P144, DOI 10.1016/j.neuroimage.2007.01.054; Yang H, 2011, NEUROSCI LETT, V502, P89, DOI 10.1016/j.neulet.2011.07.028; Yin Y, 2011, NEUROSCI LETT, V498, P185, DOI 10.1016/j.neulet.2011.02.069; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zoppelt D, 2003, NEUROPSYCHOLOGIA, V41, P1160, DOI 10.1016/S0028-3932(03)00019-8; Zou Q, 2012, HUMAN BRAIN MAPPING	49	21	24	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52558	10.1371/journal.pone.0052558	http://dx.doi.org/10.1371/journal.pone.0052558			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285086	Green Published, gold, Green Submitted			2022-12-27	WOS:000313158800077
J	Fang, CL; Hseu, YC; Lin, YF; Hung, ST; Tai, C; Uen, YH; Lin, KY				Fang, Chia-Lang; Hseu, You-Cheng; Lin, Yi-Feng; Hung, Shih-Ting; Tai, Chein; Uen, Yih-Huei; Lin, Kai-Yuan			Clinical and Prognostic Association of Transcription Factor SOX4 in Gastric Cancer	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR INVASION; EXPRESSION; GENES; OVEREXPRESSION; CARCINOMA; PREDICTORS; MICRORNAS; APOPTOSIS; SURVIVAL	Gastric cancer (GC) is one of the most common malignant cancers worldwide. However, little is known about the molecular process by which this disease develops and progresses. This study investigated correlations between the expression of nuclear transcription factor SOX4 and various clinicopathologic parameters as well as patients' survival. Expression levels of nuclear SOX4 were analyzed by immunohistochemistry; the data comprised gastric tissues from 168 patients with GC. Paired t tests were used to analyze the differences in nuclear SOX4 expression between tumor and non-tumor tissues from each patient. Two-tailed X-2 tests were performed to determine whether the differences in nuclear SOX4 expression and clinicopathologic parameters were significant. Time-to-event endpoints for clinicopathologic parameters were plotted using the Kaplan-Meier method, and statistical significance was determined using univariate log-rank tests. Cox proportional hazard model was used for multivariate analysis to determine the independence of prognostic effects of nuclear SOX4 expression. Overexpression of nuclear SOX4 was significantly correlated with depth of invasion (P<0.0001), nodal status (P=0.0055), distant metastasis (P=0.0195), stage (P=0.0003), and vascular invasion (P=0.0383). Patients who displayed high expression levels of nuclear SOX4 achieved a significantly poorer disease-free survival rate, compared with patients with low SOX4 expression levels (P=0.003). Univariate Cox regression analysis showed that overexpression of nuclear SOX4 was a clear prognostic marker for GC (P=0.004). Overexpression of nuclear SOX4 can be used as a marker to predict the outcome of patients with GC. Citation: Fang C-L, Hseu Y-C, Lin Y-F, Hung S-T, Tai C, et al. (2012) Clinical and Prognostic Association of Transcription Factor SOX4 in Gastric Cancer. PLoS ONE 7(12): e52804. doi:10.1371/journal.pone.0052804	[Hung, Shih-Ting; Uen, Yih-Huei; Lin, Kai-Yuan] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Fang, Chia-Lang] Taipei Med Univ, Coll Med, Sch Med, Dept Pathol, Taipei, Taiwan; [Fang, Chia-Lang] Taipei Med Univ, Wan Fang Hosp, Dept Pathol, Taipei, Taiwan; [Hseu, You-Cheng] China Med Univ, Dept Cosmeceut, Taichung, Taiwan; [Lin, Yi-Feng] Chi Mei Hosp Chiali, Dept Surg, Div Gen Surg, Tainan, Taiwan; [Lin, Yi-Feng; Uen, Yih-Huei] Chi Mei Med Ctr, Dept Surg, Div Gen Surg, Tainan, Taiwan; [Tai, Chein] So Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan; [Uen, Yih-Huei] Chi Mei Hosp Chiali, Superintendents Off, Tainan, Taiwan; [Uen, Yih-Huei] So Taiwan Univ Sci & Technol, Inst Biomed Engn, Tainan, Taiwan; [Lin, Kai-Yuan] Chia Nan Univ Pharm & Sci, Dept Biotechnol, Tainan, Taiwan	Chi Mei Hospital; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; China Medical University Taiwan; Chi Mei Hospital; Southern Taiwan University of Science & Technology; Southern Taiwan University of Science & Technology; Chia Nan University of Pharmacy & Science	Lin, KY (corresponding author), Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan.	d84306@yahoo.com.tw			Chi Mei Medical Center [CMFHR10020, CMFHR10064]	Chi Mei Medical Center	This work was supported by two grants (CMFHR10020 and CMFHR10064) from Chi Mei Medical Center (www.chimei.org.tw). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaboe M, 2006, CANCER RES, V66, P3434, DOI 10.1158/0008-5472.CAN-05-3456; Andersen CL, 2009, BRIT J CANCER, V100, P511, DOI 10.1038/sj.bjc.6604884; Baba K, 2012, J SURG ONCOL, V105, P195, DOI 10.1002/jso.22024; Becker KF, 2000, SURG ONCOL, V9, P5, DOI 10.1016/S0960-7404(00)00016-5; Begnami MD, 2011, J CLIN ONCOL, V29, P3030, DOI 10.1200/JCO.2010.33.6313; Catalano V, 2009, CRIT REV ONCOL HEMAT, V71, P127, DOI 10.1016/j.critrevonc.2009.01.004; de Bont JM, 2008, NEURO-ONCOLOGY, V10, P648, DOI 10.1215/15228517-2008-032; Dicken BJ, 2004, ANN SURG ONCOL, V11, P629, DOI 10.1245/ASO.2004.09.002; Eastham AM, 2007, CANCER RES, V67, P11254, DOI 10.1158/0008-5472.CAN-07-2253; FUCHS CS, 1995, NEW ENGL J MED, V333, P32, DOI 10.1056/NEJM199507063330107; Guarino M, 2007, INT J BIOCHEM CELL B, V39, P2153, DOI 10.1016/j.biocel.2007.07.011; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Huang YW, 2009, CANCER RES, V69, P9038, DOI 10.1158/0008-5472.CAN-09-1499; Hundahl SA, 2000, CANCER-AM CANCER SOC, V88, P921, DOI 10.1002/(SICI)1097-0142(20000215)88:4<921::AID-CNCR24>3.3.CO;2-J; Hur W, 2010, CARCINOGENESIS, V31, P1298, DOI 10.1093/carcin/bgq072; Jafarnejad SM, 2010, AM J PATHOL, V177, P2741, DOI 10.2353/ajpath.2010.100377; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Lin KY, 2008, J SURG ONCOL, V97, P538, DOI 10.1002/jso.20997; Lin KY, 2012, MOL CANCER RES, V10, P750, DOI 10.1158/1541-7786.MCR-11-0598-T; Lin KY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017193; Lin KY, 2010, ANN SURG ONCOL, V17, P1695, DOI 10.1245/s10434-010-0911-9; Liu PB, 2006, CANCER RES, V66, P4011, DOI 10.1158/0008-5472.CAN-05-3055; Lund AH, 2002, NAT GENET, V32, P160, DOI 10.1038/ng956; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Medina PP, 2009, HUM MOL GENET, V18, P1343, DOI 10.1093/hmg/ddp034; Oliveira Fernando Jose, 1998, Gastric Cancer, V1, P51, DOI 10.1007/s101200050054; Pan X, 2009, P NATL ACAD SCI USA, V106, P3788, DOI 10.1073/pnas.0810147106; Pramoonjago P, 2006, ONCOGENE, V25, P5626, DOI 10.1038/sj.onc.1209566; Schepers GE, 2002, DEV CELL, V3, P167, DOI 10.1016/S1534-5807(02)00223-X; Schilham MW, 1996, NATURE, V380, P711, DOI 10.1038/380711a0; Shen RZ, 2010, BIOCHEM BIOPH RES CO, V394, P1047, DOI 10.1016/j.bbrc.2010.03.121; Shin MS, 2004, CANCER RES, V64, P4419, DOI 10.1158/0008-5472.CAN-03-3885; Suzuki T, 2002, NAT GENET, V32, P166, DOI 10.1038/ng949; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; VANDEWETERING M, 1993, EMBO J, V12, P3847, DOI 10.1002/j.1460-2075.1993.tb06063.x; Voulgari A, 2009, BIOCHIM BIOPHYS ACTA, V1796, P5; Wang CG, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-41; Wilson M, 2002, CURR OPIN GENET DEV, V12, P441, DOI 10.1016/S0959-437X(02)00323-4; Ya J, 1998, CIRC RES, V83, P986, DOI 10.1161/01.RES.83.10.986; Zhang JC, 2012, CANCER RES, V72, P4597, DOI 10.1158/0008-5472.CAN-12-1045	41	40	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52804	10.1371/journal.pone.0052804	http://dx.doi.org/10.1371/journal.pone.0052804			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285187	Green Published, gold, Green Submitted			2022-12-27	WOS:000312794500247
J	Hosokawa, M; Arai, T; Masuda-Suzukake, M; Nonaka, T; Yamashita, M; Akiyama, H; Hasegawa, M				Hosokawa, Masato; Arai, Tetsuaki; Masuda-Suzukake, Masami; Nonaka, Takashi; Yamashita, Makiko; Akiyama, Haruhiko; Hasegawa, Masato			Methylene Blue Reduced Abnormal Tau Accumulation in P301L Tau Transgenic Mice	PLOS ONE			English	Article							SEPTIC SHOCK; INHIBITION; PROTEIN; PHENOTHIAZINES; AGGREGATION; DRUGS; RATS; DYES	In neurodegenerative disorders, abnormally hyperphosphorylated and aggregated tau accumulates intracellularly, a mechanism which is thought to induce neuronal cell death. Methylene blue, a type of phenothiazine, has been reported to inhibit tau aggregation in vitro. However, the effect of methylene blue in vivo has remained unknown. Therefore, we examined whether methylene blue suppresses abnormal tau accumulation using P301L tau transgenic mice. At 8 to 11 months of age, these mice were orally administered methylene blue for 5 months. Subsequent results of Western blotting analysis revealed that this agent reduced detergent-insoluble phospho-tau. Methylene blue may have potential as a drug candidate for the treatment of tauopathy.	[Hosokawa, Masato; Arai, Tetsuaki; Akiyama, Haruhiko] Tokyo Metropolitan Inst Med Sci, Dept Dementia & Higher Brain Funct, Tokyo 113, Japan; [Masuda-Suzukake, Masami; Nonaka, Takashi; Yamashita, Makiko; Hasegawa, Masato] Tokyo Metropolitan Inst Med Sci, Dept Pathol & Cell Biol, Tokyo 113, Japan; [Arai, Tetsuaki] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Psychiat, Tsukuba, Ibaraki, Japan	Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute of Medical Science; University of Tsukuba	Akiyama, H (corresponding author), Tokyo Metropolitan Inst Med Sci, Dept Dementia & Higher Brain Funct, Bunkyo Ku, Tokyo 113, Japan.	akiyama-hr@igakuken.or.jp	Nonaka, Takashi/L-8572-2017	Nonaka, Takashi/0000-0002-0830-9403; Hosokawa, Masato/0000-0003-2377-9232	Japan Society for the Promotion of Science [21591536, 24591738]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was partially supported by the Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research (C), grant number 21591536 to HA and 24591738 to M. Hosokawa. The additional part of the funding of the authors' study has come from institute budget. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atamna H, 2008, FASEB J, V22, P703, DOI 10.1096/fj.07-9610com; Chies AB, 2003, POL J PHARMACOL, V55, P573; Congdon EE, 2012, AUTOPHAGY, V8, P609, DOI 10.4161/auto.19048; Gonzalez-Lima F, 2004, LEARN MEMORY, V11, P633, DOI 10.1101/lm.82404; Gravitz L, 2011, NATURE, V475, pS9, DOI 10.1038/475S9a; GREENBERG SG, 1990, P NATL ACAD SCI USA, V87, P5827, DOI 10.1073/pnas.87.15.5827; Harrington C., 2008, ALZHEIMERS DEMENT, V4, pT120, DOI DOI 10.1016/J.JALZ.2008.05.259; Heiberg IL, 2002, BEHAV BRAIN RES, V134, P479, DOI 10.1016/S0166-4328(02)00084-0; KRISTIANSEN JE, 1989, DAN MED BULL, V36, P178; Kucukkilinc T, 2007, ARCH BIOCHEM BIOPHYS, V461, P294, DOI 10.1016/j.abb.2007.02.029; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; MANSOURI A, 1993, AM J HEMATOL, V42, P7, DOI 10.1002/ajh.2830420104; Medina DX, 2011, BRAIN PATHOL, V21, P140, DOI 10.1111/j.1750-3639.2010.00430.x; Necula M, 2007, BIOCHEMISTRY-US, V46, P8850, DOI 10.1021/bi700411k; PREISER JC, 1995, CRIT CARE MED, V23, P259, DOI 10.1097/00003246-199502000-00010; Rengelshausen J, 2004, EUR J CLIN PHARMACOL, V60, P709, DOI 10.1007/s00228-004-0818-0; Schirmer RH, 2003, REDOX REP, V8, P272, DOI 10.1179/135100003225002899; SCHNEIDER F, 1992, INTENS CARE MED, V18, P309, DOI 10.1007/BF01706481; Taniguchi S, 2005, J BIOL CHEM, V280, P7614, DOI 10.1074/jbc.M408714200; van Bebber F, 2010, NEUROBIOL DIS, V39, P265, DOI 10.1016/j.nbd.2010.03.023; Visarius TM, 1997, FEBS LETT, V412, P157, DOI 10.1016/S0014-5793(97)00767-9; Wischik CM, 1996, P NATL ACAD SCI USA, V93, P11213, DOI 10.1073/pnas.93.20.11213; Wischik CM, 2008, ALZHEIMERS DEMENT, V8, pT167; WOLOZIN B, 1987, ANN NEUROL, V22, P521, DOI 10.1002/ana.410220412; Wrubel KM, 2007, PHARMACOL BIOCHEM BE, V86, P712, DOI 10.1016/j.pbb.2007.02.018; Yamashita M, 2009, FEBS LETT, V583, P2419, DOI 10.1016/j.febslet.2009.06.042	26	68	72	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52389	10.1371/journal.pone.0052389	http://dx.doi.org/10.1371/journal.pone.0052389			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285020	Green Published, gold, Green Submitted			2022-12-27	WOS:000312794500156
J	Lemaitre, N; Ricard, I; Pradel, E; Foligne, B; Courcol, R; Simonet, M; Sebbane, F				Lemaitre, Nadine; Ricard, Isabelle; Pradel, Elizabeth; Foligne, Benoit; Courcol, Rene; Simonet, Michel; Sebbane, Florent			Efficacy of Ciprofloxacin-Gentamicin Combination Therapy in Murine Bubonic Plague	PLOS ONE			English	Article							YERSINIA-PESTIS INFECTION; PNEUMONIC PLAGUE; PSEUDOMONAS-AERUGINOSA; ESCHERICHIA-COLI; PHARMACOKINETICS; AMINOGLYCOSIDES; ANTIBIOTICS; STRAINS; MODEL	Potential benefits of combination antibiotic therapy for the treatment of plague have never been evaluated. We compared the efficacy of a ciprofloxacin (CIN) and gentamicin (GEN) combination therapy with that of each antibiotic administered alone (i) against Yersinia pestis in vitro and (ii) in a mouse model of bubonic plague in which animals were intravenously injected with antibiotics for five days, starting at two different times after infection (44 h and 56 h). In vitro, the CIN+GEN combination was synergistic at 0.5x the individual drugs' MICs and indifferent at 1x- or 2x MIC. In vivo, the survival rate for mice treated with CIN+GEN was similar to that observed with CIN alone and slightly higher than that observed for GEN alone 100, 100 and 85%, respectively when treatment was started 44 h post challenge, 100% of survivors were recorded in the CIN+GEN group vs 86 and 83% in the CIN and GEN groups, respectively when treatment was delayed to 56 h post-challenge. However, these differences were not statistically significant. Five days after the end of treatment, Y. pestis were observed in lymph nodes draining the inoculation site (but not in the spleen) in surviving mice in each of the three groups. The median lymph node log(10) CFU recovered from persistently infected lymph nodes was significantly higher with GEN than with CIN (5.8 vs. 3.2, p = 0.04) or CIN+GEN (5.8 vs. 2.8, p = 0.01). Taken as the whole, our data show that CIN+GEN combination is as effective as CIN alone but, regimens containing CIN are more effective to eradicate Y. pestis from the draining lymph node than the recommended GEN monotherapy. Moreover, draining lymph nodes may serve as a reservoir for the continued release of Y. pestis into the blood - even after five days of intravenous antibiotic treatment. Citation: Lemaitre N, Ricard I, Pradel E, Foligne B, Courcol R, et al. (2012) Efficacy of Ciprofloxacin-Gentamicin Combination Therapy in Murine Bubonic Plague. PLoS ONE 7(12): e52503. doi:10.1371/journal.pone.0052503	[Lemaitre, Nadine; Courcol, Rene; Simonet, Michel] CHU Lille, Lab Bacteriol Hyg, F-59037 Lille, France; [Lemaitre, Nadine; Ricard, Isabelle; Pradel, Elizabeth; Foligne, Benoit; Courcol, Rene; Simonet, Michel; Sebbane, Florent] Univ Lille Nord France, Lille, France; [Lemaitre, Nadine; Ricard, Isabelle; Pradel, Elizabeth; Foligne, Benoit; Courcol, Rene; Simonet, Michel; Sebbane, Florent] Univ Lille 2, Lille, France; [Lemaitre, Nadine; Ricard, Isabelle; Pradel, Elizabeth; Foligne, Benoit; Courcol, Rene; Simonet, Michel; Sebbane, Florent] INSERM, U1019, F-59045 Lille, France; [Lemaitre, Nadine; Ricard, Isabelle; Pradel, Elizabeth; Foligne, Benoit; Courcol, Rene; Simonet, Michel; Sebbane, Florent] Ctr Natl Rech Sci, UMR8204, Lille, France; [Lemaitre, Nadine; Ricard, Isabelle; Pradel, Elizabeth; Foligne, Benoit; Courcol, Rene; Simonet, Michel; Sebbane, Florent] Inst Pasteur, F-59019 Lille, France	Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille	Lemaitre, N (corresponding author), CHU Lille, Lab Bacteriol Hyg, F-59037 Lille, France.	nadine.lemaitre@chru-lille.fr	Sebbane, Florent/D-4213-2009; Pradel, Elizabeth/R-5026-2018; Sebbane, Florent/ABA-2213-2020; Foligne, Benoit/B-2754-2014	Pradel, Elizabeth/0000-0003-3563-9325; Sebbane, Florent/0000-0003-3811-9691; Foligne, Benoit/0000-0001-9263-9706; Ricard, Isabelle/0000-0002-2142-6807; Lemaitre, Nadine/0000-0002-0011-3596	Institut National de la Sante et de la Recherche Medicale; Centre National de la Recherche Scientifique; Universite Lille Nord de France; Institut Pasteur de Lille	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite Lille Nord de France; Institut Pasteur de Lille	This work was supported by Institut National de la Sante et de la Recherche Medicale, Centre National de la Recherche Scientifique, Universite Lille Nord de France and Institut Pasteur de Lille. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGAN T, 1986, EUR J CLIN MICROBIOL, V5, P458, DOI 10.1007/BF02075709; BONACORSI SP, 1994, ANTIMICROB AGENTS CH, V38, P481, DOI 10.1128/AAC.38.3.481; BORNER K, 1986, EUR J CLIN MICROBIOL, V5, P179, DOI 10.1007/BF02013983; BUTLER T, 1994, CLIN INFECT DIS, V19, P655, DOI 10.1093/clinids/19.4.655; Byrne WR, 1998, ANTIMICROB AGENTS CH, V42, P675, DOI 10.1128/AAC.42.3.675; CHALKLEY LJ, 1985, ANTIMICROB AGENTS CH, V28, P331, DOI 10.1128/AAC.28.2.331; Craig WA, 2011, CRIT CARE CLIN, V27, P107, DOI 10.1016/j.ccc.2010.11.006; Demczar DJ, 1997, ANTIMICROB AGENTS CH, V41, P1115, DOI 10.1128/AAC.41.5.1115; EASMON CSF, 1985, J CLIN PATHOL, V38, P442, DOI 10.1136/jcp.38.4.442; HALLER I, 1985, ANTIMICROB AGENTS CH, V28, P663, DOI 10.1128/AAC.28.5.663; Heine HS, 2007, J INFECT DIS, V196, P782, DOI 10.1086/520547; Inglesby TV, 2000, JAMA-J AM MED ASSOC, V283, P2281, DOI 10.1001/jama.283.17.2281; JOLLEY ME, 1981, CLIN CHEM, V27, P1190; Kumar A, 2010, CRIT CARE MED, V38, P1773, DOI 10.1097/CCM.0b013e3181eb3ccd; KUSSER WC, 1988, ANTIMICROB AGENTS CH, V32, P1247, DOI 10.1128/AAC.32.8.1247; Lorange EA, 2005, J INFECT DIS, V191, P1907, DOI 10.1086/429931; Mandal S, 2003, JPN J INFECT DIS, V56, P156; National Committee for Clinical and Laboratory Standards Institute, 2006, M7A7 NCCLS I; Nham T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034714; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; PEARSON RD, 1980, ANTIMICROB AGENTS CH, V18, P699, DOI 10.1128/AAC.18.5.699; Pujol U, 2005, CLIN IMMUNOL, V114, P216, DOI 10.1016/j.clim.2004.07.013; REYNOLDS AV, 1976, LANCET, V1, P447; Russell P, 1998, J ANTIMICROB CHEMOTH, V41, P301, DOI 10.1093/jac/41.2.301; Sebbane F, 2005, AM J PATHOL, V166, P1427, DOI 10.1016/S0002-9440(10)62360-7; SMITH MD, 1995, ANTIMICROB AGENTS CH, V39, P2153, DOI 10.1128/AAC.39.9.2153; Wang H, 2011, CLIN INFECT DIS, V52, P185, DOI 10.1093/cid/ciq107; WEBER A, 1985, ANTIMICROB AGENTS CH, V27, P531, DOI 10.1128/AAC.27.4.531; World Health Organization, 2008, WHOHSEEPR20083; ZEILER HJ, 1984, EUR J CLIN MICROBIOL, V3, P339, DOI 10.1007/BF01977490	30	11	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52503	10.1371/journal.pone.0052503	http://dx.doi.org/10.1371/journal.pone.0052503			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285069	Green Published, gold, Green Submitted			2022-12-27	WOS:000312794500184
J	Sun, HJ; Li, P; Chen, WW; Xiong, XQ; Han, Y				Sun, Hai-Jian; Li, Peng; Chen, Wei-Wei; Xiong, Xiao-Qing; Han, Ying			Angiotensin II and Angiotensin-(1-7) in Paraventricular Nucleus Modulate Cardiac Sympathetic Afferent Reflex in Renovascular Hypertensive Rats	PLOS ONE			English	Article							ROSTRAL VENTROLATERAL MEDULLA; NITRIC-OXIDE SYNTHASE; SUPEROXIDE ANIONS; BLOOD-PRESSURE; HEART-FAILURE; BRAIN; ACTIVATION; RECEPTORS; LOCALIZATION; PATHOGENESIS	Background: The enhanced cardiac sympathetic afferent reflex (CSAR) is involved in the sympathetic activation that contributes to the pathogenesis and progression of hypertension. Activation of AT(1) receptors by angiotension (Ang) II in the paraventricular nucleus (PVN) augments the enhanced CSAR and sympathetic outflow in hypertension. The present study is designed to determine whether Ang-(1-7) in PVN plays the similar roles as Ang II and the interaction between Ang-(1-7) and Ang II on CSAR in renovascular hypertension. Methodology/Principal Findings: The two-kidney, one-clip (2K1C) method was used to induce renovascular hypertension. The CSAR was evaluated by the renal sympathetic nerve activity (RSNA) and mean arterial pressure (MAP) responses to epicardial application of capsaicin in sinoaortic-denervated and cervical-vagotomized rats with urethane and alpha-chloralose anesthesia. Either Ang II or Ang-(1-7) in PVN caused greater increases in RSNA and MAP, and enhancement in CSAR in 2K1C rats than in sham-operated (Sham) rats. Mas receptor antagonist A-779 and AT(1) receptor antagonist losartan induced opposite effects to Ang-(1-7) or Ang II respectively in 2K1C rats, but losartan had no effects in Sham rats. Losartan but not the A-779 abolished the effects of Ang II, while A-779 but not the losartan blocked the effects of Ang-(1-7). PVN pretreatment with Ang-(1-7) dose-dependently augmented the RSNA, MAP, and CSAR responses to the Ang II in 2K1C rats. Ang II level, AT(1) receptor and Mas receptor protein expression in PVN increased in 2K1C rats compared with Sham rats but Ang-(1-7) level did not. Conclusions: Ang-(1-7) in PVN is as effective as Ang II in enhancing the CSAR and increasing sympathetic outflow and both endogenous Ang-(1-7) and Ang II in PVN contribute to the enhanced CSAR and sympathetic outflow in renovascular hypertension. Ang-(1-7) in PVN potentiates the effects of Ang II in renovascular hypertension.	[Sun, Hai-Jian; Li, Peng; Chen, Wei-Wei; Xiong, Xiao-Qing; Han, Ying] Nanjing Med Univ, Dept Physiol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Han, Y (corresponding author), Nanjing Med Univ, Dept Physiol, Nanjing, Jiangsu, Peoples R China.	yhancn@njmu.edu.cn		Han, Ying/0000-0001-8591-7894	Chinese National Natural Science Fund [81100182]; Natural Science Foundation from Department of Education of Jiangsu Province [11KJB310002]; Science and Technology Foundation from Nanjing Medical University [2010NJMUZ23]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	Chinese National Natural Science Fund(National Natural Science Foundation of China (NSFC)); Natural Science Foundation from Department of Education of Jiangsu Province; Science and Technology Foundation from Nanjing Medical University; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the Chinese National Natural Science Fund (81100182), Natural Science Foundation from Department of Education of Jiangsu Province (11KJB310002), Science and Technology Foundation from Nanjing Medical University (2010NJMUZ23), and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AM, 2000, AM J HYPERTENS, V13, p31S, DOI 10.1016/S0895-7061(99)00249-6; Alzamora AC, 2006, AM J PHYSIOL-REG I, V290, pR1027, DOI 10.1152/ajpregu.00852.2004; Badoer E, 2001, CLIN EXP PHARMACOL P, V28, P95, DOI 10.1046/j.1440-1681.2001.03413.x; Becker LK, 2007, AM J PHYSIOL-HEART C, V293, pH1416, DOI 10.1152/ajpheart.00141.2007; BLOCK CH, 1988, PEPTIDES, V9, P1395, DOI 10.1016/0196-9781(88)90208-2; Campese VM, 2002, HYPERTENSION, V39, P519, DOI 10.1161/hy0202.102815; Capettini LSA, 2012, CURR PHARM DESIGN, V18, P963; Cassis P, 2010, PFLUG ARCH EUR J PHY, V459, P325, DOI 10.1007/s00424-009-0725-4; Cato MJ, 2005, J NEUROPHYSIOL, V93, P403, DOI 10.1152/jn.01055.2003; CHAPPELL MC, 1989, J BIOL CHEM, V264, P16518; Chen AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040748; Chen AD, 2011, EXP PHYSIOL, V96, P94, DOI 10.1113/expphysiol.2010.054353; COHN JN, 1977, MED CLIN N AM, V61, P581, DOI 10.1016/S0025-7125(16)31318-9; da Silva AQG, 2005, HYPERTENSION, V46, P341, DOI 10.1161/01.HYP.0000179216.04357.49; Del Colle S, 2007, J CARDIOVASC PHARM, V50, P487; Dilauro M, 2010, AM J PHYSIOL-RENAL, V298, pF1523, DOI 10.1152/ajprenal.00426.2009; Du YH, 2007, J APPL PHYSIOL, V102, P9, DOI 10.1152/japplphysiol.01032.2006; Ehlers PI, 2011, LIFE SCI, V88, P206, DOI 10.1016/j.lfs.2010.11.001; Esler M, 2010, J APPL PHYSIOL, V109, P1996, DOI 10.1152/japplphysiol.00182.2010; Fan ZD, 2012, GENE THER, V19, P810, DOI 10.1038/gt.2011.145; Ferreira PM, 2008, NEUROSCIENCE, V151, P1208, DOI 10.1016/j.neuroscience.2007.11.042; Fisher JP, 2010, EXP PHYSIOL, V95, P572, DOI 10.1113/expphysiol.2009.047332; FONTES MAP, 1994, BRAIN RES, V665, P175, DOI 10.1016/0006-8993(94)91171-1; Fujita M, 2007, HYPERTENSION, V50, P360, DOI 10.1161/HYPERTENSIONAHA.107.091009; Gan XB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025784; da Silva AQG, 2012, BRAIN RES, V1448, P101, DOI 10.1016/j.brainres.2012.02.021; da Silva AQG, 2011, BRAIN RES, V1368, P231, DOI 10.1016/j.brainres.2010.10.087; Grassi G, 2010, EXP PHYSIOL, V95, P581, DOI 10.1113/expphysiol.2009.047381; Gwathmey TM, 2012, AM J PHYSIOL-REG I, V302, pR518, DOI 10.1152/ajpregu.00525.2011; Han Y, 2007, EUR J HEART FAIL, V9, P967, DOI 10.1016/j.ejheart.2007.07.004; Han Y, 2011, J APPL PHYSIOL, V110, P646, DOI 10.1152/japplphysiol.00908.2010; Han Y, 2011, PFLUG ARCH EUR J PHY, V461, P437, DOI 10.1007/s00424-011-0932-7; Hogarth AJ, 2007, J HUM HYPERTENS, V21, P239, DOI 10.1038/sj.jhh.1002132; KATHOLI RE, 1982, HYPERTENSION, V4, P166, DOI 10.1161/01.HYP.4.3_Pt_2.166; Krob HA, 1998, BRAIN RES, V798, P36, DOI 10.1016/S0006-8993(98)00384-9; Li DP, 2007, J PHARMACOL EXP THER, V320, P615, DOI 10.1124/jpet.106.109538; Li P, 2012, NEUROSCIENCE, V223, P388, DOI 10.1016/j.neuroscience.2012.07.048; Li YF, 2006, AM J PHYSIOL-REG I, V290, pR1035, DOI 10.1152/ajpregu.00338.2004; Li YF, 2003, ACTA PHYSIOL SCAND, V177, P17, DOI 10.1046/j.1365-201X.2003.01043.x; Malliani A, 2002, HYPERTENSION, V39, P63, DOI 10.1161/hy0102.099200; Mancia G, 1999, HYPERTENSION, V34, P724, DOI 10.1161/01.HYP.34.4.724; Morise T, 2000, J HUM HYPERTENS, V14, P807, DOI 10.1038/sj.jhh.1001114; Neumann J, 2007, HYPERTENSION, V49, P506, DOI 10.1161/01.HYP.0000256530.39695.a3; Nie WC, 2009, MOL IMMUNOL, V46, P355, DOI 10.1016/j.molimm.2008.10.022; Qi YF, 2011, EXP PHYSIOL, V96, P863, DOI 10.1113/expphysiol.2011.056994; Rahn KH, 1999, J HYPERTENS, V17, pS11; Remuzzi G, 1999, NEW ENGL J MED, V340, P1360, DOI 10.1056/NEJM199904293401711; Rossi NF, 2010, EXP PHYSIOL, V95, P845, DOI 10.1113/expphysiol.2009.051789; Santos RAS, 2003, P NATL ACAD SCI USA, V100, P8258, DOI 10.1073/pnas.1432869100; Santos RAS, 2003, HYPERTENSION, V41, P737, DOI 10.1161/01.HYP.0000052947.60363.24; Shi Z, 2009, PFLUG ARCH EUR J PHY, V458, P247, DOI 10.1007/s00424-008-0627-x; Silva-Barcellos NM, 2001, HYPERTENSION, V38, P1266, DOI 10.1161/hy1201.096056; Wang ZV, 2010, J BIOL CHEM, V285, P8509, DOI 10.1074/jbc.R109.025023; Xu P, 2011, AM J PHYSIOL-REG I, V300, pR804, DOI 10.1152/ajpregu.00222.2010; Zhong MK, 2008, EXP PHYSIOL, V93, P746, DOI 10.1113/expphysiol.2007.041632; Zhou LM, 2010, PFLUG ARCH EUR J PHY, V459, P681, DOI 10.1007/s00424-010-0793-5; Zhu GQ, 2004, J APPL PHYSIOL, V97, P1746, DOI 10.1152/japplphysiol.00573.2004; Zhu GQ, 2009, EXP PHYSIOL, V94, P785, DOI 10.1113/expphysiol.2008.046565; Zimmerman MC, 2011, CURR OPIN PHARMACOL, V11, P138, DOI 10.1016/j.coph.2011.01.001	59	14	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52557	10.1371/journal.pone.0052557	http://dx.doi.org/10.1371/journal.pone.0052557			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285085	gold, Green Submitted, Green Published			2022-12-27	WOS:000312794500194
J	Waltz, X; Pichon, A; Lemonne, N; Mougenel, D; Lalanne-Mistrih, ML; Lamarre, Y; Tarer, V; Tressieres, B; Etienne-Julan, M; Hardy-Dessources, MD; Hue, O; Connes, P				Waltz, Xavier; Pichon, Aurelien; Lemonne, Nathalie; Mougenel, Daniele; Lalanne-Mistrih, Marie-Laure; Lamarre, Yann; Tarer, Vanessa; Tressieres, Benoit; Etienne-Julan, Maryse; Hardy-Dessources, Marie-Dominique; Hue, Olivier; Connes, Philippe			Normal Muscle Oxygen Consumption and Fatigability in Sickle Cell Patients Despite Reduced Microvascular Oxygenation and Hemorheological Abnormalities	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; BLOOD-FLOW; IN-VIVO; WAVELET ANALYSIS; OSCILLATIONS; EXERCISE; AGGREGATION; FLOWMOTION; VASOMOTION; TURNOVER	Background/Aim: Although it has been hypothesized that muscle metabolism and fatigability could be impaired in sickle cell patients, no study has addressed this issue. Methods: We compared muscle metabolism and function (muscle microvascular oxygenation, microvascular blood flow, muscle oxygen consumption and muscle microvascular oxygenation variability, which reflects vasomotion activity, maximal muscle force and local muscle fatigability) and the hemorheological profile at rest between 16 healthy subjects (AA), 20 sickle cell-hemoglobin C disease (SC) patients and 16 sickle cell anemia (SS) patients. Results: Muscle microvascular oxygenation was reduced in SS patients compared to the SC and AA groups and this reduction was not related to hemorhelogical abnormalities. No difference was observed between the three groups for oxygen consumption and vasomotion activity. Muscle microvascular blood flow was higher in SS patients compared to the AA group, and tended to be higher compared to the SC group. Multivariate analysis revealed that muscle oxygen consumption was independently associated with muscle microvascular blood flow in the two sickle cell groups (SC and SS). Finally, despite reduced muscle force in sickle cell patients, their local muscle fatigability was similar to that of the healthy subjects. Conclusions: Sickle cell patients have normal resting muscle oxygen consumption and fatigability despite hemorheological alterations and, for SS patients only, reduced muscle microvascular oxygenation and increased microvascular blood flow. Two alternative mechanisms can be proposed for SS patients: 1) the increased muscle microvascular blood flow is a way to compensate for the lower muscle microvascular oxygenation to maintain muscle oxygen consumption to normal values or 2) the reduced microvascular oxygenation coupled with a normal resting muscle oxygen consumption could indicate that there is slight hypoxia within the muscle which is not sufficient to limit mitochondrial respiration but increases muscle microvascular blood flow.	[Waltz, Xavier; Lalanne-Mistrih, Marie-Laure; Lamarre, Yann; Hardy-Dessources, Marie-Dominique; Connes, Philippe] Univ Antilles Guyane, Inserm 665, Pointe A Pitre, Guadeloupe, France; [Waltz, Xavier; Pichon, Aurelien; Lamarre, Yann; Hardy-Dessources, Marie-Dominique; Connes, Philippe] PRES, Lab Excellence GR Ex Red Cell Genesis Death, Paris, France; [Waltz, Xavier; Hue, Olivier; Connes, Philippe] Univ Antilles Guyane, Lab ACTES, Dept Physiol, EA 3596, Pointe A Pitre, Guadeloupe, France; [Pichon, Aurelien] Univ Paris 13, PRES, EA2363, Lab Reponses Cellulaires & Fonct Hypoxie, Bobigny, France; [Lemonne, Nathalie; Mougenel, Daniele; Etienne-Julan, Maryse] Ctr Hosp & Univ, Unite Transversale Drepanocytose, Pointe A Pitre, Guadeloupe, France; [Lalanne-Mistrih, Marie-Laure; Tressieres, Benoit] Ctr Hosp & Univ, CIC EC Inserm 802, Pointe A Pitre, Guadeloupe, France; [Tarer, Vanessa] Ctr Hosp & Univ, Ctr Reference Malad Rares Drepanocytose Antilles, Pointe A Pitre, Guadeloupe, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite des Antilles; Universite des Antilles; Universite Paris 13; CHU Guadeloupe; CHU Guadeloupe; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Guadeloupe	Connes, P (corresponding author), Univ Antilles Guyane, Inserm 665, Pointe A Pitre, Guadeloupe, France.	pconnes@yahoo.fr	Pichon, Aurélien/AAD-3320-2021; , Hardy-dessources/K-9189-2017; Connes, Philippe/J-7835-2019; TRESSIERES, Benoit/ABH-1085-2020; WALTZ, Xavier/M-3606-2016; Lamarre, Yann/ABC-2074-2020	, Hardy-dessources/0000-0003-0861-3648; Connes, Philippe/0000-0002-9232-0268; WALTZ, Xavier/0000-0002-0838-290X; Lamarre, Yann/0000-0003-0669-793X; Philippe, Connes/0000-0001-8449-7998; Hue, Olivier/0000-0002-2155-0816; ETIENNE-JULAN, Maryse/0000-0003-1339-6545	Academic Hospital of Pointe-a-Pitre (PHRC CHU de Pointe a Pitre); association "Ensemble contre la drepanocytose"; regional council of Guadeloupe	Academic Hospital of Pointe-a-Pitre (PHRC CHU de Pointe a Pitre); association "Ensemble contre la drepanocytose"; regional council of Guadeloupe	This work was supported by local grants from the Academic Hospital of Pointe-a-Pitre (PHRC CHU de Pointe a Pitre). PhD funding of X. W. was supported by the association "Ensemble contre la drepanocytose" and by the regional council of Guadeloupe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalkjaer C, 2011, ACTA PHYSIOL, V202, P253, DOI 10.1111/j.1748-1716.2011.02320.x; BADALOO A, 1989, CLIN SCI, V77, P93, DOI 10.1042/cs0770093; Balayssac-Siransy E, 2011, BRIT J HAEMATOL, V154, P398, DOI 10.1111/j.1365-2141.2011.08728.x; BALLAS SK, 1992, BLOOD, V79, P2154, DOI 10.1182/blood.V79.8.2154.2154; Baskurt OK, 2007, INDIAN J EXP BIOL, V45, P25; Baskurt OK, 2009, CLIN HEMORHEOL MICRO, V42, P75, DOI 10.3233/CH-2009-1202; Baskurt O, 2008, MICROCIRCULATION, V15, P585, DOI 10.1080/10739680802107447; BROWN MM, 1985, BRAIN, V108, P81, DOI 10.1093/brain/108.1.81; Buchowski MS, 2001, AM J PHYSIOL-ENDOC M, V280, pE518, DOI 10.1152/ajpendo.2001.280.3.E518; Buison AM, 2005, PEDIATRICS, V116, P943, DOI 10.1542/peds.2004-2582; Callahan LA, 2002, AM J RESP CRIT CARE, V165, P1309, DOI 10.1164/rccm.2002036; Connes P, C R BIOL IN PRESS; Connes P, 2011, CLIN HEMORHEOL MICRO, V49, P151, DOI 10.3233/CH-2011-1465; De Luca CJ, 1997, J APPL BIOMECH, V13, P135, DOI 10.1123/jab.13.2.135; Dougherty KA, 2011, J PEDIAT HEMATOL ONC, V33, P93, DOI 10.1097/MPH.0b013e318200ef49; Ellsworth ML, 2009, PHYSIOLOGY, V24, P107, DOI 10.1152/physiol.00038.2008; Ferrari M, 2004, CAN J APPL PHYSIOL, V29, P463, DOI 10.1139/h04-031; Hamaoka T, 2003, ADV EXP MED BIOL, V530, P475; Hardeman MR, 2001, CLIN HEMORHEOL MICRO, V25, P1; Kaul DK, 2004, MICROCIRCULATION, V11, P153, DOI 10.1080/10739680490278457; Kislukhin VV, 2010, THEOR BIOL MED MODEL, V7, DOI 10.1186/1742-4682-7-29; Kvandal P, 2003, MICROVASC RES, V65, P160, DOI 10.1016/S0026-2862(03)00006-2; Kvernmo HD, 1999, MICROVASC RES, V57, P298, DOI 10.1006/mvre.1998.2139; Lamarre Y., HAEMATOLOGI IN PRESS; Li ZY, 2006, ARCH PHYS MED REHAB, V87, P1207, DOI 10.1016/j.apmr.2006.05.025; Nahavandi M, 2004, EUR J CLIN INVEST, V34, P143, DOI 10.1111/j.1365-2362.2004.01307.x; Nahavandi M, 2009, HEMATOLOGY, V14, P46, DOI 10.1179/102453309X385133; Nebor D, 2011, HAEMATOL-HEMATOL J, V96, P1589, DOI 10.3324/haematol.2011.047365; Parthasarathi K, 1999, AM J PHYSIOL-HEART C, V277, pH2145, DOI 10.1152/ajpheart.1999.277.6.H2145; Perrey S, 2008, METHODS, V45, P289, DOI 10.1016/j.ymeth.2008.04.005; Pittman RN, 2011, INTEGRATED SYSTEMS P; Raj A, 2004, J PEDIAT HEMATOL ONC, V26, P279, DOI 10.1097/00043426-200405000-00004; RODGERS GP, 1984, NEW ENGL J MED, V311, P1534, DOI 10.1056/NEJM198412133112403; Rossi M, 2006, BIOMED PHARMACOTHER, V60, P437, DOI 10.1016/j.biopha.2006.07.012; SEAKINS M, 1973, J CLIN INVEST, V52, P422, DOI 10.1172/JCI107199; Soderstrom T, 2003, AM J PHYSIOL-HEART C, V284, pH1638, DOI 10.1152/ajpheart.00826.2000; Stefanovska A, 1999, IEEE T BIO-MED ENG, V46, P1230, DOI 10.1109/10.790500; Tavakkoli F, 2005, CLIN THER, V27, P1083, DOI 10.1016/j.clinthera.2005.07.002; Thorn CE, 2011, AM J PHYSIOL-HEART C, V301, pH442, DOI 10.1152/ajpheart.01316.2010; Tripette J, 2009, HAEMATOL-HEMATOL J, V94, P1060, DOI 10.3324/haematol.2008.005371; TSAI AG, 1993, INT J MICROCIRC, V12, P75; van Beekvelt MCP, 2001, CLIN SCI, V101, P21, DOI 10.1042/CS20000247; van Beekvelt MCP, 2001, J APPL PHYSIOL, V90, P511, DOI 10.1152/jappl.2001.90.2.511; Waltz X., CLIN HEMORH IN PRESS; Waypa GB, 2010, RESP PHYSIOL NEUROBI, V174, P201, DOI 10.1016/j.resp.2010.08.007	45	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52471	10.1371/journal.pone.0052471	http://dx.doi.org/10.1371/journal.pone.0052471			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285055	Green Submitted, Green Published, gold			2022-12-27	WOS:000312794500178
J	Hinder, MR; Fujiyama, H; Summers, JJ				Hinder, Mark R.; Fujiyama, Hakuei; Summers, Jeffery J.			Premotor-Motor Interhemispheric Inhibition Is Released during Movement Initiation in Older but Not Young Adults	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; AGE-RELATED DIFFERENCES; CROSS-LIMB TRANSFER; DORSAL PREMOTOR; CORTICOSPINAL EXCITABILITY; PERFORMANCE GAINS; CORTEX; TASK; BRAIN; CONNECTIVITY	Neural interactions between contralateral motor regions are thought to be instrumental in the successful preparation, and execution, of volitional movements. Here we investigated whether healthy ageing is associated with a change in functional connectivity, as indicated by the ability to modulate interhemispheric interactions during movement preparation in a manner that assists rapid movement responses. Thirteen young (mean age 22.2 years) and thirteen older (68.5 years) adults rapidly abducted their left index finger as soon as possible in response to a visual imperative signal, presented 500 ms after a visual warning signal. Interactions between left dorsal premotor cortex (LPMd) and right primary motor cortex (RM1) and between left primary motor cortex (LM1) and RM1 were investigated at six time points between the warning signal and the volitional response using paired-pulse transcranial magnetic stimulation. Relative to the inhibitory interactions measured at rest, both young and older adults released LM1-RM1 inhibition beginning 250 ms after the warning signal, with no significant differences between groups. LPMd-RM1 interactions became facilitatory (from the onset of the imperative signal onwards) in the older, but not the young, group. Regression analyses revealed that for the older adults, modulation of LPMd-RM1 interactions early in the preparation period was associated with faster responses, suggesting that specifically timed modulation of these pathways may be a compensatory mechanism to offset, at least in part, slowing of motor responses. The results suggest a greater reliance on premotor regions during the preparation of simple motor actions with advancing age.	[Hinder, Mark R.; Fujiyama, Hakuei; Summers, Jeffery J.] Univ Tasmania, Sch Psychol, Motor Control Lab, Hobart, Tas 7001, Australia	University of Tasmania	Hinder, MR (corresponding author), Univ Tasmania, Sch Psychol, Motor Control Lab, Hobart, Tas 7001, Australia.	Mark.Hinder@utas.edu.au	Fujiyama, Hakuei/O-4025-2019	Hinder, Mark/0000-0002-5240-4790; Fujiyama, Hakuei/0000-0002-7546-6636	Australian Research Council [DP0770568, DE120100729]	Australian Research Council(Australian Research Council)	Funding provided by the Australian Research Council Discovery Project DP0770568 and Discovery Early Career Researcher Award Fellowship DE120100729. www.arc.gov.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeumer T, 2006, J PHYSIOL-LONDON, V572, P857, DOI 10.1113/jphysiol.2006.104901; Baliz Y, 2005, J INT NEUROPSYCH SOC, V11, P855, DOI 10.1017/S1355617705051003; Bodwell JA, 2003, J AM GERIATR SOC, V51, P1735, DOI 10.1046/j.1532-5415.2003.51557.x; Cabeza R, 2002, NEUROIMAGE, V17, P1394, DOI 10.1006/nimg.2002.1280; Carroll TJ, 2008, J APPL PHYSIOL, V104, P1656, DOI 10.1152/japplphysiol.01351.2007; Carson RG, 2005, BRAIN RES REV, V49, P641, DOI 10.1016/j.brainresrev.2005.03.005; Chen R, 2004, EXP BRAIN RES, V154, P1, DOI 10.1007/s00221-003-1684-1; Chen R, 2003, J NEUROPHYSIOL, V89, P1256, DOI 10.1152/jn.00950.2002; Cisek P, 2003, J NEUROPHYSIOL, V89, P922, DOI 10.1152/jn.00607.2002; Civardi C, 2001, NEUROIMAGE, V14, P1444, DOI 10.1006/nimg.2001.0918; Crammond DJ, 1996, EXP BRAIN RES, V108, P45; Daskalakis ZJ, 2002, J PHYSIOL-LONDON, V543, P317, DOI 10.1113/jphysiol.2002.017673; Davranche K, 2007, EUR J NEUROSCI, V25, P3766, DOI 10.1111/j.1460-9568.2007.05588.x; Di Lazzaro V, 1999, EXP BRAIN RES, V124, P520, DOI 10.1007/s002210050648; Duque J, 2007, J COGNITIVE NEUROSCI, V19, P204, DOI 10.1162/jocn.2007.19.2.204; Duque J, 2009, CEREB CORTEX, V19, P2013, DOI 10.1093/cercor/bhn230; FERBERT A, 1992, J PHYSIOL-LONDON, V453, P525, DOI 10.1113/jphysiol.1992.sp019243; Fujiyama H, 2012, J COGNITIVE NEUROSCI, V24, P1253, DOI 10.1162/jocn_a_00201; Fujiyama H, 2011, PSYCHOPHYSIOLOGY, V48, P1448, DOI 10.1111/j.1469-8986.2011.01201.x; Fujiyama H, 2010, PSYCHOPHYSIOLOGY, V47, P501, DOI 10.1111/j.1469-8986.2009.00954.x; Garry MI, 2005, EXP BRAIN RES, V163, P118, DOI 10.1007/s00221-005-2226-9; Gazzaniga MS, 2005, NAT REV NEUROSCI, V6, P653, DOI 10.1038/nrn1723; Gerloff C, 1998, J PHYSIOL-LONDON, V510, P249, DOI 10.1111/j.1469-7793.1998.249bz.x; Heuninckx S, 2005, J NEUROSCI, V25, P6787, DOI 10.1523/JNEUROSCI.1263-05.2005; Heuninckx S, 2008, J NEUROSCI, V28, P91, DOI 10.1523/JNEUROSCI.3300-07.2008; Hinder MR, 2012, J NEUROPHYSIOL, V107, P1791, DOI 10.1152/jn.00822.2011; Hinder MR, 2011, J APPL PHYSIOL, V110, P166, DOI 10.1152/japplphysiol.00958.2010; Hinder MR, 2010, EXP BRAIN RES, V205, P423, DOI 10.1007/s00221-010-2379-z; Hinder MR, 2010, EXP BRAIN RES, V201, P229, DOI 10.1007/s00221-009-2029-5; Hoy KE, 2004, BRAIN RES REV, V46, P315, DOI 10.1016/j.brainresrev.2004.07.013; Jung P, 2012, J NEUROSCI, V32, P5667, DOI 10.1523/JNEUROSCI.5957-11.2012; Koch G, 2006, J NEUROSCI, V26, P7452, DOI 10.1523/JNEUROSCI.1158-06.2006; Kroeger J, 2010, EUR J NEUROSCI, V32, P1771, DOI 10.1111/j.1460-9568.2010.07442.x; Kukaswadia S, 2005, J PHYSIOL-LONDON, V563, P915, DOI 10.1113/jphysiol.2004.080010; Lee H, 2007, J PHYSIOL-LONDON, V580, P1021, DOI 10.1113/jphysiol.2006.126011; Lee M, 2010, J PHYSIOL-LONDON, V588, P201, DOI 10.1113/jphysiol.2009.183855; Levin O, 2011, NEUROSCI LETT, V487, P53, DOI 10.1016/j.neulet.2010.09.072; Liuzzi G, 2011, J NEUROSCI, V31, P9111, DOI 10.1523/JNEUROSCI.0046-11.2011; Liuzzi G, 2010, CEREB CORTEX, V20, P1323, DOI 10.1093/cercor/bhp196; Meyer-Lindenberg A, 2002, P NATL ACAD SCI USA, V99, P10948, DOI 10.1073/pnas.162114799; Mochizuki H, 2005, EXP BRAIN RES, V167, P414, DOI 10.1007/s00221-005-0047-5; Ni Z, 2009, CEREB CORTEX, V19, P1654, DOI 10.1093/cercor/bhn201; O'Shea J, 2007, EUR J NEUROSCI, V26, P2085, DOI 10.1111/j.1460-9568.2007.05795.x; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Perez MA, 2008, J NEUROSCI, V28, P5631, DOI 10.1523/JNEUROSCI.0093-08.2008; RIEHLE A, 1989, J NEUROPHYSIOL, V61, P534, DOI 10.1152/jn.1989.61.3.534; Rogasch NC, 2009, J APPL PHYSIOL, V107, P1874, DOI 10.1152/japplphysiol.00443.2009; Schambra HM, 2003, CLIN NEUROPHYSIOL, V114, P130, DOI 10.1016/S1388-2457(02)00342-5; Schluter ND, 1998, BRAIN, V121, P785, DOI 10.1093/brain/121.5.785; Sinclair C, 2008, EXP BRAIN RES, V186, P385, DOI 10.1007/s00221-007-1241-4; Talelli P, 2008, EXP BRAIN RES, V186, P59, DOI 10.1007/s00221-007-1205-8; Tandonnet C, 2010, BIOL PSYCHOL, V85, P481, DOI 10.1016/j.biopsycho.2010.08.016; Vercauteren K, 2008, NEUROSCI LETT, V445, P209, DOI 10.1016/j.neulet.2008.09.013; Ward NS, 2008, NEUROBIOL AGING, V29, P1434, DOI 10.1016/j.neurobiolaging.2007.04.017	54	36	37	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e52573	10.1371/journal.pone.0052573	http://dx.doi.org/10.1371/journal.pone.0052573			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23285097	Green Submitted, Green Published, gold			2022-12-27	WOS:000312694300093
J	Rong, X; Lu, L; Wang, JZ; Xiong, HP; Huang, JT; Chen, JY; Huang, K; Xu, R; Wang, M; Zhang, XM; Guo, T; Liu, YY; Gao, GQ; Fu, YS; Nelson, KE				Rong, Xia; Lu, Ling; Wang, Junzhi; Xiong, Huaping; Huang, Jieting; Chen, Jinyan; Huang, Ke; Xu, Ru; Wang, Min; Zhang, Xuemei; Guo, Tai; Liu, Yueyue; Gao, Guoquan; Fu, Yongshui; Nelson, Kenrad E.			Correlation of Viral Loads with HCV Genotypes: Higher Levels of Virus Were Revealed among Blood Donors Infected with 6a Strains	PLOS ONE			English	Article							HEPATITIS-C VIRUS; PEGYLATED INTERFERON; ESTROGEN-RECEPTOR; RISK-FACTORS; TRANSMISSION; PREVALENCE; CHINA; RIBAVIRIN; SEQUENCE; THERAPY	Background: Both HCV genotypes and viral loads are predictors of therapeutic outcomes among patients treated with alpha-interferon plus ribavirin; however, such correlation has only been studied for genotypes 1, 2, and 3 but not for genotype 6. Methodology/Findings: 299 voluntary blood donors were recruited who were HCV viremic. Their mean age was 31.8; the male/female ratio was 3.82 (225/59). The viral loads of HCV were measured using the COBAS AmpliPrep/COBAS TaqMan test (CAP/CTM) while HCV genotypes were determined by direct sequencing the partial NS5B region. HCV genotypes 1, 2, 3, and 6 were determined in 48.9%, 8.7%, 12.3%, and 30.1% of the donors, respectively, and the levels of mean viral loads in genotype 1 and 6 significantly higher than that of 2 and 3 (P < 0.001). As a whole, the viral loads in male donors were higher than in female (P = 0.006). Moreover, the donors' gender and HCV genotypes are independently correlated with the measured viral loads. Conclusion: HCV genotype 1 and 6 had significantly higher viral loads than genotype 2 and 3.	[Rong, Xia; Xiong, Huaping; Huang, Jieting; Chen, Jinyan; Huang, Ke; Xu, Ru; Wang, Min; Fu, Yongshui] Guangzhou Blood Ctr, Guangzhou, Guangdong, Peoples R China; [Rong, Xia; Zhang, Xuemei; Gao, Guoquan] Sun Yat Sen Univ, Coll Med, Dept Biochem, Guangzhou 510275, Guangdong, Peoples R China; [Lu, Ling] Univ Kansas, Med Ctr, Ctr Viral Oncol, Kansas City, KS 66103 USA; [Wang, Junzhi; Guo, Tai; Liu, Yueyue] Natl Inst Food & Drug Control, Beijing, Peoples R China; [Nelson, Kenrad E.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA	Guangzhou Blood Center; Sun Yat Sen University; University of Kansas; University of Kansas Medical Center; National Institute of Food & Drug Control - China; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Fu, YS (corresponding author), Guangzhou Blood Ctr, Guangzhou, Guangdong, Peoples R China.	fuyongshui1969@yahoo.com		Xu, Ru/0000-0001-5926-9213; Chen, Jinyan/0000-0003-4103-7056	National Institute of Allergy and Infectious Diseases [5 R01 AI080734-03A]; Science and Technology Bureau, Guangzhou Municipality, China [2010UI-E00661]; 12th Five-year National Science & Technology Major Project [2012ZX10004702]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080734] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Science and Technology Bureau, Guangzhou Municipality, China; 12th Five-year National Science & Technology Major Project; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from The National Institute of Allergy and Infectious Diseases (5 R01 AI080734-03A), a grant from The Science and Technology Bureau, Guangzhou Municipality, China (No. 2010UI-E00661, Dr YF) (http://www.gzsi.gov.cn/) and a grant from The 12th Five-year National Science & Technology Major Project (No. 2012ZX10004702) (http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad W, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-293; Ali L, 2010, J GEN VIROL, V91, P1931, DOI 10.1099/vir.0.018119-0; [Anonymous], 1999, Wkly Epidemiol Rec, V74, P425; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Berger A, 1996, J MED VIROL, V48, P339, DOI 10.1002/(SICI)1096-9071(199604)48:4&lt;339::AID-JMV7&gt;3.0.CO;2-8; Chamberlain RW, 1997, J GEN VIROL, V78, P1341, DOI 10.1099/0022-1317-78-6-1341; Chevaliez S, 2007, HEPATOLOGY, V46, P22, DOI 10.1002/hep.21656; Craxi A, 2011, J HEPATOL, V55, P245, DOI 10.1016/j.jhep.2011.02.023; Davis GL, 1997, HEPATOLOGY, V26, pS122, DOI 10.1002/hep.510260721; Ponde RAD, 2011, MED MICROBIOL IMMUN, V200, P7, DOI 10.1007/s00430-010-0159-9; Dev AT, 2002, HEPATOLOGY, V36, P1259, DOI 10.1053/jhep.2002.36781; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Fu Y, 2011, J VIRAL HEPATITIS, V18, P42, DOI 10.1111/j.1365-2893.2010.01280.x; Fu YS, 2010, TRANSFUSION, V50, P1505, DOI 10.1111/j.1537-2995.2010.02616.x; Fu YSH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047324, 10.1371/journal.pone.0028006]; Fung J, 2008, J INFECT DIS, V198, P808, DOI 10.1086/591252; Hayashida K, 2010, MICROBIOL IMMUNOL, V54, P684, DOI 10.1111/j.1348-0421.2010.00268.x; Hillung J, 2012, J GEN VIROL, V93, P780, DOI 10.1099/vir.0.039396-0; Hubschen JM, 2011, CLIN MICROBIOL INFEC, V17, pE30, DOI 10.1111/j.1469-0691.2011.03665.x; Hui CK, 2003, J INFECT DIS, V187, P1071, DOI 10.1086/368217; Kuiken C, 2008, NUCLEIC ACIDS RES, V36, pD512, DOI 10.1093/nar/gkm962; Lu L, 2005, J MED VIROL, V75, P538, DOI 10.1002/jmv.20307; MAHANEY K, 1994, HEPATOLOGY, V20, P1405, DOI 10.1002/hep.1840200605; Marongiu A, 2012, SEX TRANSM INFECT; Mauss S, 2012, Z GASTROENTEROL, V50, P441, DOI 10.1055/s-0031-1282072; Mellor J, 1999, J CLIN MICROBIOL, V37, P2525, DOI 10.1128/JCM.37.8.2525-2532.1999; Nguyen M. H., 2005, CLIN LIVER DIS, V9, pvi; Nguyen Mindie H, 2005, Clin Liver Dis, V9, P411, DOI 10.1016/j.cld.2005.05.010; Nguyen NH, 2010, J VIRAL HEPATITIS, V17, P691, DOI 10.1111/j.1365-2893.2009.01226.x; Nguyen NH, 2010, HEPATOL INT, V4, P523, DOI 10.1007/s12072-010-9181-7; Pham VH, 2011, JPN J INFECT DIS, V64, P537; Poynard T, 2001, J HEPATOL, V34, P730, DOI 10.1016/S0168-8278(00)00097-0; Prati D, 2006, J HEPATOL, V45, P607, DOI 10.1016/j.jhep.2006.07.003; Pybus OG, 2007, INT J PARASITOL, V37, P839, DOI 10.1016/j.ijpara.2007.04.009; Pybus OG, 2009, J VIROL, V83, P1071, DOI 10.1128/JVI.01501-08; Rao HY, 2012, J VIRAL HEPATITIS, V19, P173, DOI 10.1111/j.1365-2893.2011.01497.x; Sarrazin C, 2006, J CLIN MICROBIOL, V44, P729, DOI 10.1128/JCM.44.3.729-737.2006; Scott JD, 2007, JAMA-J AM MED ASSOC, V297, P724, DOI 10.1001/jama.297.7.724; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; SMUTS HM, 1995, J CLIN MICROBIOL, V33, P1679, DOI 10.1128/JCM.33.6.1679-1681.1995; Soriano V, 2008, J INFECT DIS, V198, P1337, DOI 10.1086/592171; Sulkowski MS, 2002, JAMA-J AM MED ASSOC, V287, P2406, DOI 10.1001/jama.287.18.2406; Tohme RA, 2010, HEPATOLOGY, V52, P1497, DOI 10.1002/hep.23808; Uccellini L, 2012, HEPATOLOGY; Wang CC, 2007, J INFECT DIS, V196, P1474, DOI 10.1086/522608; Watashi K, 2007, J BIOL CHEM, V282, P32765, DOI 10.1074/jbc.M704418200; World Health Organization, 2011, HEP C FACT SHEET; Xia X, 2008, PUBLIC HEALTH, V122, P990, DOI 10.1016/j.puhe.2008.01.014; YAMADA G, 1995, HEPATOLOGY, V22, P1351, DOI 10.1002/hep.1840220502; Yeung LTF, 2001, HEPATOLOGY, V34, P223, DOI 10.1053/jhep.2001.25885	50	17	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e52467	10.1371/journal.pone.0052467	http://dx.doi.org/10.1371/journal.pone.0052467			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23285053	gold, Green Published, Green Submitted			2022-12-27	WOS:000312435900095
J	Gast, KB; Tjeerdema, N; Stijnen, T; Smit, JWA; Dekkers, OM				Gast, Karin B.; Tjeerdema, Nathanja; Stijnen, Theo; Smit, Johannes W. A.; Dekkers, Olaf M.			Insulin Resistance and Risk of Incident Cardiovascular Events in Adults without Diabetes: Meta-Analysis	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; MYOCARDIAL-INFARCTION; PROSPECTIVE COHORT; CASE-FATALITY; GLUCOSE; MEN; STROKE; WOMEN; MELLITUS; HEALTH	Background: Glucose, insulin and Homeostasis Model Assessment Insulin Resistance (HOMA-IR) are markers of insulin resistance. The objective of this study is to compare fasting glucose, fasting insulin concentrations and HOMA-IR in strength of association with incident cardiovascular disease. Methods: We searched the PubMed, MEDLINE, EMBASE, Web of Science, ScienceDirect and Cochrane Library databases from inception to March, 2011, and screened reference lists. Cohort studies or nested case-control studies that investigated the association between fasting glucose, fasting insulin or HOMA-IR and incident cardiovascular disease, were eligible. Two investigators independently performed the article selection, data extraction and risk of bias assessment. Cardiovascular endpoints were coronary heart disease (CHD), stroke or combined cardiovascular disease. We used fixed and random-effect meta-analyses to calculate the pooled relative risk for CHD, stroke and combined cardiovascular disease, comparing high to low concentrations of glucose, insulin or HOMA-IR. Study heterogeneity was calculated with the I-2 statistic. To enable a comparison between cardiovascular disease risks for glucose, insulin and HOMA-IR, we calculated pooled relative risks per increase of one standard deviation. Results: We included 65 studies (involving 516,325 participants) in this meta-analysis. In a random-effect meta-analysis the pooled relative risk of CHD (95% CI; I-2) comparing high to low concentrations was 1.52 (1.31, 1.76; 62.4%) for glucose, 1.12 (0.92, 1.37; 41.0%) for insulin and 1.64 (1.35, 2.00; 0%) for HOMA-IR. The pooled relative risk of CHD per one standard deviation increase was 1.21 (1.13, 1.30; 64.9%) for glucose, 1.04 (0.96, 1.12; 43.0%) for insulin and 1.46 (1.26, 1.69; 0.0%) for HOMA-IR. Conclusions: The relative risk of cardiovascular disease was higher for an increase of one standard deviation in HOMA-IR compared to an increase of one standard deviation in fasting glucose or fasting insulin concentration. It may be useful to add HOMA-IR to a cardiovascular risk prediction model.	[Gast, Karin B.; Tjeerdema, Nathanja] Leiden Univ, Med Ctr, Dept Internal Med, Leiden, Netherlands; [Gast, Karin B.; Dekkers, Olaf M.] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands; [Stijnen, Theo] Leiden Univ, Med Ctr, Dept Med Stat & Bioinformat, Leiden, Netherlands; [Smit, Johannes W. A.; Dekkers, Olaf M.] Leiden Univ, Med Ctr, Dept Endocrinol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Gast, KB (corresponding author), Leiden Univ, Med Ctr, Dept Internal Med, Leiden, Netherlands.	k.b.gast@lumc.nl	Smit, J.W.A./H-8091-2014	Smit, J.W.A./0000-0003-1052-9314; Dekkers, Olaf/0000-0002-1333-7580				Almdal T, 2004, ARCH INTERN MED, V164, P1422, DOI 10.1001/archinte.164.13.1422; Ammar KA, 2004, AM HEART J, V148, P277, DOI 10.1016/j.ahj.2004.03.019; Avendano M, 2006, LANCET, V368, P1631, DOI 10.1016/S0140-6736(06)69675-X; Blaak E, 2008, CURR OPIN CLIN NUTR, V11, P500, DOI 10.1097/MCO.0b013e32830467d3; Bornfeldt KE, 2011, CELL METAB, V14, P575, DOI 10.1016/j.cmet.2011.07.015; Brunner EJ, 2010, DIABETIC MED, V27, P550, DOI 10.1111/j.1464-5491.2010.02921.x; Burns EM, 2012, J PUBLIC HEALTH-UK, V34, P138, DOI 10.1093/pubmed/fdr054; Cordoba G, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3920; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Faerch K, 2009, DIABETES CARE, V32, P439, DOI 10.2337/dc08-1195; Ford ES, 2010, J AM COLL CARDIOL, V55, P1310, DOI 10.1016/j.jacc.2009.10.060; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; HARMSEN P, 1990, STROKE, V21, P223, DOI 10.1161/01.STR.21.2.223; Hartemink N, 2006, AM J EPIDEMIOL, V163, P1042, DOI 10.1093/aje/kwj141; Hutcheon JA, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2289; Huxley R, 2006, BMJ-BRIT MED J, V332, P73, DOI 10.1136/bmj.38678.389583.7C; Kanaya AM, 2002, ARCH INTERN MED, V162, P1737, DOI 10.1001/archinte.162.15.1737; Kim SH, 2008, DIABETES CARE, V31, P347, DOI 10.2337/dc07-1574; Levitan EB, 2004, ARCH INTERN MED, V164, P2147, DOI 10.1001/archinte.164.19.2147; Mendis S, 2011, INT J EPIDEMIOL, V40, P139, DOI 10.1093/ije/dyq165; Nissinen A, 2004, DIABETOLOGIA, V47, P1245, DOI 10.1007/s00125-004-1433-4; Nybo M, 2005, CLIN CHEM, V51, P1563, DOI 10.1373/clinchem.2005.051789; Qizilbash N, 1995, LANCET, V346, P1647; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Sarwar N, 2007, EUR HEART J, V28, P2491, DOI 10.1093/eurheartj/ehm115; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Wannamethee SG, 2012, DIABETOLOGIA, V55, P80, DOI 10.1007/s00125-011-2284-4; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Wilhelmsen L, 2005, EUR HEART J, V26, P1916, DOI 10.1093/eurheartj/ehi412; Yu QJ, 2011, CARDIOVASC RES, V89, P516, DOI 10.1093/cvr/cvq349	32	174	179	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52036	10.1371/journal.pone.0052036	http://dx.doi.org/10.1371/journal.pone.0052036			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23300589	Green Submitted, Green Published, gold			2022-12-27	WOS:000313051500021
J	Griffiths, KM; Mackinnon, AJ; Crisp, DA; Christensen, H; Bennett, K; Farrer, L				Griffiths, Kathleen M.; Mackinnon, Andrew J.; Crisp, Dimity A.; Christensen, Helen; Bennett, Kylie; Farrer, Louise			The Effectiveness of an Online Support Group for Members of the Community with Depression: A Randomised Controlled Trial	PLOS ONE			English	Article							INTERNET INTERVENTIONS; ANXIETY	Background: Internet support groups (ISGs) are popular, particularly among people with depression, but there is little high quality evidence concerning their effectiveness. Aim: The study aimed to evaluate the efficacy of an ISG for reducing depressive symptoms among community members when used alone and in combination with an automated Internet-based psychotherapy training program. Method: Volunteers with elevated psychological distress were identified using a community-based screening postal survey. Participants were randomised to one of four 12-week conditions: depression Internet Support Group (ISG), automated depression Internet Training Program (ITP), combination of the two (ITP+ISG), or a control website with delayed access to e-couch at 6 months. Assessments were conducted at baseline, post-intervention, 6 and 12 months. Results: There was no change in depressive symptoms relative to control after 3 months of exposure to the ISG. However, both the ISG alone and the combined ISG+ITP group showed significantly greater reduction in depressive symptoms at 6 and 12 months follow-up than the control group. The ITP program was effective relative to control at post-intervention but not at 6 months. Conclusions: ISGs for depression are promising and warrant further empirical investigation.	[Griffiths, Kathleen M.; Christensen, Helen; Bennett, Kylie; Farrer, Louise] Australian Natl Univ, Mental Hlth Res Ctr, Canberra, ACT, Australia; [Mackinnon, Andrew J.] Univ Melbourne, Orygen Youth Hlth Res Ctr, Biostat Unit, Melbourne, Vic, Australia; [Crisp, Dimity A.] Australian Natl Univ, Ctr Res Ageing Hlth & Wellbeing, Canberra, ACT, Australia	Australian National University; Orygen, The National Centre of Excellence in Youth Mental Health; University of Melbourne; Australian National University	Griffiths, KM (corresponding author), Australian Natl Univ, Mental Hlth Res Ctr, Canberra, ACT, Australia.	Kathy.Griffiths@anu.edu.au	Bennett, Kylie/R-7618-2019; Christensen, Helen/F-5053-2012	Bennett, Kylie/0000-0003-4160-492X; Christensen, Helen/0000-0003-0435-2065; Mackinnon, Andrew/0000-0003-0831-9801; Crisp, Dimity/0000-0003-0241-1121	National Health and Medical Research Council [471435]; NHMRC Fellowship [525413];  [525411]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Fellowship(National Health and Medical Research Council (NHMRC) of Australia); 	The trial was funded by a National Health and Medical Research Council Project Grant 471435. KG is supported by NHMRC Fellowship No. 525413 and HC is supported by Fellowship No. 525411. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson G, 2005, BRIT J PSYCHIAT, V187, P456, DOI 10.1192/bjp.187.5.456; Andrews G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013196; [Anonymous], CLIN PSYCHOL PSYCHOT; [Anonymous], 2001, ONLINE COMMUNITIES N; [Anonymous], DEPR TREATM MAN DEPR; [Anonymous], [No title captured]; Bender R, 2001, CONTROL CLIN TRIALS, V22, P102, DOI 10.1016/S0197-2456(00)00134-3; Berger M, 2005, SOC SCI MED, V61, P1821, DOI 10.1016/j.socscimed.2005.03.025; Christensen H, 2004, BRIT MED J, V328, P265, DOI 10.1136/bmj.37945.566632.EE; Christensen H, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1194; Davison KP, 2000, AM PSYCHOL, V55, P205, DOI 10.1037/0003-066X.55.2.205; DiMatteo MR, 2004, HEALTH PSYCHOL, V23, P207, DOI 10.1037/0278-6133.23.2.207; Eaton WW, 2004, USE PSYCHOL TESTING, V3, P363; Eysenbach G, 2005, J MED INTERNET RES, V7, DOI 10.2196/jmir.7.1.e11; Griffiths KM, 2010, MED J AUSTRALIA, V192, pS4, DOI 10.5694/j.1326-5377.2010.tb03685.x; Griffiths KM, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-20; Griffiths KM, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1303; Houston TK, 2002, AM J PSYCHIAT, V159, P2062, DOI 10.1176/appi.ajp.159.12.2062; Jones S., 2009, GENERATIONS ONLINE 2; Malhi GS, 2009, ACTA PSYCHIAT SCAND, V119, P8, DOI 10.1111/j.1600-0447.2009.01382.x; Pfeiffer PN, 2011, GEN HOSP PSYCHIAT, V33, P29, DOI 10.1016/j.genhosppsych.2010.10.002; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; World Health Organization, 2008, The global burden of disease: 2004 update	23	63	63	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53244	10.1371/journal.pone.0053244	http://dx.doi.org/10.1371/journal.pone.0053244			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	064DQ	23285271	Green Published, gold			2022-12-27	WOS:000313051500125
J	Hawley, DF; Morch, K; Christie, BR; Leasure, JL				Hawley, Darby F.; Morch, Kristin; Christie, Brian R.; Leasure, J. Leigh			Differential Response of Hippocampal Subregions to Stress and Learning	PLOS ONE			English	Article							SPATIAL WORKING-MEMORY; LONG-TERM POTENTIATION; DENTATE GYRUS; NEUROTROPHIC FACTOR; ADULT NEUROGENESIS; RATS; MAZE; ANXIETY; LESIONS; DORSAL	The hippocampus has two functionally distinct subregions-the dorsal portion, primarily associated with spatial navigation, and the ventral portion, primarily associated with anxiety. In a prior study of chronic unpredictable stress (CUS) in rodents, we found that it selectively enhanced cellular plasticity in the dorsal hippocampal subregion while negatively impacting it in the ventral. In the present study, we determined whether this adaptive plasticity in the dorsal subregion would confer CUS rats an advantage in a spatial task-the radial arm water maze (RAWM). RAWM exposure is both stressful and requires spatial navigation, and therefore places demands simultaneously upon both hippocampal subregions. Therefore, we used Western blotting to investigate differential expression of plasticity-associated proteins (brain derived neurotrophic factor [BDNF], proBDNF and postsynaptic density-95 [PSD-95]) in the dorsal and ventral subregions following RAWM exposure. Lastly, we used unbiased stereology to compare the effects of CUS on proliferation, survival and neuronal differentiation of cells in the dorsal and ventral hippocampal subregions. We found that CUS and exposure to the RAWM both increased corticosterone, indicating that both are stressful; nevertheless, CUS animals had significantly better long-term spatial memory. We also observed a subregion-specific pattern of protein expression following RAWM, with proBDNF increased in the dorsal and decreased in the ventral subregion, while PSD-95 was selectively upregulated in the ventral. Finally, consistent with our previous study, we found that CUS most negatively affected neurogenesis in the ventral (compared to the dorsal) subregion. Taken together, our data support a dual role for the hippocampus in stressful experiences, with the more resilient dorsal portion undergoing adaptive plasticity (perhaps to facilitate escape from or neutralization of the stressor), and the ventral portion involved in affective responses.	[Hawley, Darby F.; Leasure, J. Leigh] Univ Houston, Dept Psychol, Houston, TX 77004 USA; [Morch, Kristin; Christie, Brian R.] Univ Victoria, Div Med Sci, Victoria, BC, Canada; [Christie, Brian R.] Univ British Columbia, Isl Med Program, Victoria, BC, Canada; [Leasure, J. Leigh] Univ Houston, Dept Biol & Biochem, Houston, TX USA	University of Houston System; University of Houston; University of Victoria; University of British Columbia; University of Houston System; University of Houston	Leasure, JL (corresponding author), Univ Houston, Dept Psychol, Houston, TX 77004 USA.	jlleasure@uh.edu	Christie, Brian Ross/AAF-3766-2019	Christie, Brian Ross/0000-0002-6830-0160; Leasure, J. Leigh/0000-0002-9014-2525	University of Houston Department of Psychology; Canadian Institutes for Health Research; Natural Sciences and Engineering Research Council	University of Houston Department of Psychology; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was funded by the University of Houston Department of Psychology, the Canadian Institutes for Health Research and the Natural Sciences and Engineering Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleisa AM, 2011, HIPPOCAMPUS, V21, P899, DOI 10.1002/hipo.20806; Alessio HM, 2005, PHYSIOL BEHAV, V84, P65, DOI 10.1016/j.physbeh.2004.10.010; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Bannerman DM, 2003, BEHAV BRAIN RES, V139, P197, DOI 10.1016/S0166-4328(02)00268-1; Bannerman DM, 2002, BEHAV NEUROSCI, V116, P884, DOI 10.1037//0735-7044.116.5.884; Bekinschtein P, 2007, NEURON, V53, P261, DOI 10.1016/j.neuron.2006.11.025; BURESOVA O, 1985, PHYSIOL BEHAV, V34, P1003, DOI 10.1016/0031-9384(85)90028-9; Callaghan CK, 2012, HIPPOCAMPUS; Cavigellil SA, 2005, J ENDOCRINOL, V184, P153, DOI 10.1677/joe.1.05935; Diamond DM, 1999, HIPPOCAMPUS, V9, P542, DOI 10.1002/(SICI)1098-1063(1999)9:5<542::AID-HIPO8>3.3.CO;2-E; Duman Ronald S, 2009, Dialogues Clin Neurosci, V11, P239; Eadie BD, 2009, NEUROBIOL DIS, V36, P361, DOI 10.1016/j.nbd.2009.08.001; Gomez-Pinilla F, 2001, BRAIN RES, V904, P13, DOI 10.1016/S0006-8993(01)02394-0; Hattiangady B, 2005, EXP NEUROL, V195, P353, DOI 10.1016/j.expneurol.2005.05.014; Hawley DF, 2012, HIPPOCAMPUS, V22, P1338, DOI 10.1002/hipo.20970; Hawley DF, 2010, STRESS, V13, P172, DOI 10.3109/10253890903144621; Ho YC, 2010, NEUROSCIENCE, V171, P153, DOI 10.1016/j.neuroscience.2010.08.062; Hock BJ, 1998, J NEUROSCI, V18, P7027; Hu XD, 2011, J NEUROSCI, V31, P15597, DOI 10.1523/JNEUROSCI.2445-11.2011; Hunt CA, 1996, J NEUROSCI, V16, P1380; KANT GJ, 1988, PHARMACOL BIOCHEM BE, V31, P487, DOI 10.1016/0091-3057(88)90378-4; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; Maggio N, 2007, J NEUROSCI, V27, P5757, DOI 10.1523/JNEUROSCI.0155-07.2007; Maurer AP, 2005, HIPPOCAMPUS, V15, P841, DOI 10.1002/hipo.20114; Mirescu C, 2006, HIPPOCAMPUS, V16, P233, DOI 10.1002/hipo.20155; Mizuno M, 2000, J NEUROSCI, V20, P7116, DOI 10.1523/JNEUROSCI.20-18-07116.2000; MOSER E, 1993, J NEUROSCI, V13, P3916; Moser MB, 1998, HIPPOCAMPUS, V8, P608, DOI 10.1002/(SICI)1098-1063(1998)8:6<608::AID-HIPO3>3.0.CO;2-7; Rao MS, 2005, EUR J NEUROSCI, V21, P464, DOI 10.1111/j.1460-9568.2005.03853.x; Rao MS, 2004, EUR J NEUROSCI, V19, P234, DOI 10.1111/j.0953-816X.2003.03123.x; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Shors TJ, 2004, LEARN MEMORY, V11, P137, DOI 10.1101/lm.66604; Snyder JS, 2009, HIPPOCAMPUS, V19, P360, DOI 10.1002/hipo.20525; Thanos PK, 2009, PHYSIOL RES, V58, P219, DOI 10.33549/physiolres.931434; Tran TT, 2010, NEUROBIOL DIS, V37, P756, DOI 10.1016/j.nbd.2009.12.016; Vega CJ, 2005, NAT METHODS, V2, P167, DOI 10.1038/NMETH741; von Bohlen und Halbach O, 2006, BIOL PSYCHIAT, V59, P793, DOI 10.1016/j.biopsych.2005.08.025; Watt MJ, 2009, BEHAV NEUROSCI, V123, P564, DOI 10.1037/a0015752; Wibrand K, 2006, EUR J NEUROSCI, V23, P1501, DOI 10.1111/j.1460-9568.2006.04687.x; Wolf OT, 2002, BRAIN RES PROTOC, V10, P41; Woo NH, 2005, NAT NEUROSCI, V8, P1069, DOI 10.1038/nn1510; Zoladz PR, 2012, HIPPOCAMPUS, V22, P577, DOI 10.1002/hipo.20922	42	38	41	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53126	10.1371/journal.pone.0053126	http://dx.doi.org/10.1371/journal.pone.0053126			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285257	Green Published, Green Submitted, gold			2022-12-27	WOS:000313051500109
J	Jiang, D; Nelson, ML; Gally, F; Smith, S; Wu, Q; Minor, M; Case, S; Thaikoottathil, J; Chu, HW				Jiang, Di; Nelson, Mark L.; Gally, Fabienne; Smith, Sean; Wu, Qun; Minor, Maisha; Case, Stephanie; Thaikoottathil, Jyoti; Chu, Hong Wei			Airway Epithelial NF-kappa B Activation Promotes Mycoplasma pneumoniae Clearance in Mice	PLOS ONE			English	Article							IN-VITRO ACTIVITY; LUNG INFLAMMATION; ALLERGIC INFLAMMATION; MURINE MODEL; INFECTION; DOXYCYCLINE; HYPERRESPONSIVENESS; ASTHMA; EXPRESSION; DEFENSE	Background/Objective: Respiratory infections including atypical bacteria Mycoplasma pneumoniae (Mp) contribute to the pathobiology of asthma and chronic obstructive pulmonary disease (COPD). Mp infection mainly targets airway epithelium and activates various signaling pathways such as nuclear factor kappa B (NF-kappa B). We have shown that short palate, lung, and nasal epithelium clone 1 (SPLUNC1) serves as a novel host defense protein and is up-regulated upon Mp infection through NF-kappa B activation in cultured human and mouse primary airway epithelial cells. However, the in vivo role of airway epithelial NF-kappa B activation in host defense against Mp infection has not been investigated. In the current study, we investigated the effects of in vivo airway epithelial NF-kappa B activation on lung Mp clearance and its association with airway epithelial SPLUNC1 expression. Methodology/Main Results: Non-antimicrobial tetracycline analog 9-t-butyl doxycycline (9-TB) was initially optimized in mouse primary tracheal epithelial cell culture, and then utilized to induce in vivo airway epithelial specific NF-kappa B activation in conditional NF-kappa B transgenic mice (CC10-CAIKK beta) with or without Mp infection. Lung Mp load and inflammation were evaluated, and airway epithelial SPLUNC1 protein was examined by immunohistochemistry. We found that 9-TB treatment in NF-kappa B transgene positive (Tg+), but not transgene negative (Tg-) mice significantly reduced lung Mp load. Moreover, 9-TB increased airway epithelial SPLUNC1 protein expression in NF-kappa B Tg+ mice. Conclusion: By using the non-antimicrobial 9-TB, our study demonstrates that in vivo airway epithelial NF-kappa B activation promotes lung bacterial clearance, which is accompanied by increased epithelial SPLUNC1 expression.	[Jiang, Di; Gally, Fabienne; Smith, Sean; Wu, Qun; Minor, Maisha; Case, Stephanie; Thaikoottathil, Jyoti; Chu, Hong Wei] Natl Jewish Hlth, Dept Med, Denver, CO USA; [Jiang, Di; Nelson, Mark L.; Gally, Fabienne; Smith, Sean; Wu, Qun; Minor, Maisha; Case, Stephanie; Thaikoottathil, Jyoti; Chu, Hong Wei] Univ Colorado, Denver, CO 80202 USA; [Nelson, Mark L.] Natl Jewish Hlth, Dept Immunol, Denver, CO USA; [Chu, Hong Wei] Echelon Biosci Inc, Business & Sci Dev, Salt Lake City, UT USA	National Jewish Health; University of Colorado System; University of Colorado Denver; National Jewish Health	Chu, HW (corresponding author), Natl Jewish Hlth, Dept Med, Denver, CO USA.	chuhw@njhealth.org		Gally, Fabienne/0000-0003-0503-7411	National Institutes of Health/National Heart, Lung and Blood Institute (NIH/NHLBI) [R01HL088264]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088264] Funding Source: NIH RePORTER	National Institutes of Health/National Heart, Lung and Blood Institute (NIH/NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by the National Institutes of Health/National Heart, Lung and Blood Institute (NIH/NHLBI) R01HL088264. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkawash M, 1999, J ANTIMICROB CHEMOTH, V44, P385, DOI 10.1093/jac/44.3.385; Alvarez JI, 2009, AM J PATHOL, V175, P685, DOI 10.2353/ajpath.2009.081073; Ather JL, 2011, AM J RESP CELL MOL, V44, P631, DOI 10.1165/rcmb.2010-0106OC; BEBEAR C, 1985, PATHOL BIOL, V33, P577; Bebear CM, 2000, ANTIMICROB AGENTS CH, V44, P2557, DOI 10.1128/AAC.44.9.2557-2560.2000; Bouchillon SK, 2005, DIAGN MICR INFEC DIS, V51, P291, DOI 10.1016/j.diagmicrobio.2004.11.006; Chen SM, 2008, CLIN EXP IMMUNOL, V153, P420, DOI 10.1111/j.1365-2249.2008.03707.x; Cheng DS, 2007, J IMMUNOL, V178, P6504, DOI 10.4049/jimmunol.178.10.6504; Chu HW, 2007, J IMMUNOL, V179, P3995, DOI 10.4049/jimmunol.179.6.3995; Chu HW, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-155; Chu HW, 1998, AM J RESP CRIT CARE, V158, P1936, DOI 10.1164/ajrccm.158.6.9712073; Chu HW, 2003, INFECT IMMUN, V71, P1520, DOI 10.1128/IAI.71.3.1520-1526.2003; COHEN MA, 1991, DIAGN MICR INFEC DIS, V14, P245, DOI 10.1016/0732-8893(91)90039-I; Esposito S, 2002, PEDIATR PULM, V34, P122, DOI 10.1002/ppul.10139; Gally F, 2011, J INNATE IMMUN; Gally F, 2011, AM J PATHOL, V178, P2159, DOI 10.1016/j.ajpath.2011.01.026; Halterman MW, 2011, J BIOMOL SCREEN, V16, P332, DOI 10.1177/1087057110397355; Hannan PCT, 2000, J ANTIMICROB CHEMOTH, V45, P367, DOI 10.1093/jac/45.3.367; Hardy RD, 2002, INFECT IMMUN, V70, P649, DOI 10.1128/IAI.70.2.649-654.2002; Heine HS, 2007, ANTIMICROB AGENTS CH, V51, P1373, DOI 10.1128/AAC.01050-06; Kraft M, 2008, EUR RESPIR J, V31, P43, DOI 10.1183/09031936.00103307; Kraft M, 1998, AM J RESP CRIT CARE, V158, P998, DOI 10.1164/ajrccm.158.3.9711092; MALINVERNI R, 1995, ANTIMICROB AGENTS CH, V39, P45, DOI 10.1128/AAC.39.1.45; Pantano C, 2008, AM J RESP CRIT CARE, V177, P959, DOI 10.1164/rccm.200707-1096OC; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Poynter ME, 2004, J IMMUNOL, V173, P7003, DOI 10.4049/jimmunol.173.11.7003; Poynter ME, 2003, J IMMUNOL, V170, P6257, DOI 10.4049/jimmunol.170.12.6257; Poynter ME, 2002, AM J PATHOL, V160, P1325, DOI 10.1016/S0002-9440(10)62559-X; Prall AK, 2002, J VASC SURG, V35, P923, DOI 10.1067/mva.2002.123757; Sheller JR, 2009, EXP LUNG RES, V35, P883, DOI 10.3109/01902140903019710; Thaikoottathil J, 2011, MOL IMMUNOL, V49, P415, DOI 10.1016/j.molimm.2011.08.005; Vieira RP, 2011, RESP PHYSIOL NEUROBI, V175, P383, DOI 10.1016/j.resp.2011.01.002; Wu Q, 2011, AM J PHYSL LUNG CELL; Wu Q, 2008, AM J RESP CRIT CARE, V177, P720, DOI 10.1164/rccm.200709-1387OC; Wu Q, 2007, AM J PHYSIOL-LUNG C, V292, pL1064, DOI 10.1152/ajplung.00301.2006; Zhu PX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000533	36	10	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52969	10.1371/journal.pone.0052969	http://dx.doi.org/10.1371/journal.pone.0052969			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285237	Green Submitted, Green Published, gold			2022-12-27	WOS:000313051500091
J	Park, S; Oh, S; van Nocker, S				Park, Sunchung; Oh, Sookyung; van Nocker, Steve			Genomic and Gene-Level Distribution of Histone H3 Dimethyl Lysine-27 (H3K27me2) in Arabidopsis	PLOS ONE			English	Article							DNA METHYLATION; ACTIVE GENES; MODIFICATION PATTERNS; IN-VIVO; CHROMATIN; THALIANA; TRIMETHYLATION; MAP; REPLICATION; ACETYLATION	Histone lysine methylation patterns underlie much of the functional diversity of nucleosomes in eukaryotes, and an interesting aspect of histone methylation is the potential functional specificity for different methylation states on a given lysine. Trimethylation of histone H3 (H3K27me3) is intimately related to developmental gene silencing through the so-called Polycomb Group (PcG) mechanism. How this modification becomes established at PcG-repressed loci is generally not known, but it has been suggested that it may be facilitated by prior occupancy by H3K27me2. In this study we mapped the genomic and gene-level distribution of H3K27me2 in Arabidopsis thaliana using ChIP and a high-density tiling microarray, and integrated this with previous maps of other chromatin features and gene expression data. At the genome level, H3K27me2 enrichment sites were sparsely distributed across chromosomes, within an average size expected for a single nucleosome, and contrasted with the longer domains seen for H3K27me3. In both heterochromatic and euchromatic segments of the genome, H3K27me2 enrichment was often localized within transposon-related genes, with the longest genomic stretches of this modification corresponding to retroelements. However, H3K27me2 was more frequently found within protein-coding genes. These genes generally also showed moderate enrichment for H3K27me3, but H3K27me2 was strongly depleted within those genes most enriched in H3K27me3. H3K27me2 within highly transcribed genes was at highest levels at transcriptional starts and was strongly depleted throughout the transcribed regions, and reached higher levels at active than at silent promoters.	[van Nocker, Steve] Michigan State Univ, Dept Hort, E Lansing, MI 48824 USA; [Park, Sunchung; Oh, Sookyung] Michigan State Univ, Plant Res Lab, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	van Nocker, S (corresponding author), Michigan State Univ, Dept Hort, E Lansing, MI 48824 USA.	vannocke@msu.edu		Park, Sunchung/0000-0002-7398-9476	National Science Foundation (NSF) [IOS-0922447]	National Science Foundation (NSF)(National Science Foundation (NSF))	This work was supported by the National Science Foundation (NSF) through a grant (IOS-0922447) to SVN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Bannister AJ, 2005, J BIOL CHEM, V280, P17732, DOI 10.1074/jbc.M500796200; Bastow R, 2004, NATURE, V427, P164, DOI 10.1038/nature02269; Baumbusch LO, 2001, NUCLEIC ACIDS RES, V29, P4319, DOI 10.1093/nar/29.21.4319; Bernatavichute YV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003156; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Fischer A, 2006, J PLANT PHYSIOL, V163, P358, DOI 10.1016/j.jplph.2005.10.015; Jacob Y, 2010, NATURE, V466, P987, DOI 10.1038/nature09290; Jacob Y, 2009, NAT STRUCT MOL BIOL, V16, P763, DOI 10.1038/nsmb.1611; Ji HK, 2005, BIOINFORMATICS, V21, P3629, DOI 10.1093/bioinformatics/bti593; Johnson L, 2004, NUCLEIC ACIDS RES, V32, P6511, DOI 10.1093/nar/gkh992; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krichevsky A, 2007, DEV BIOL, V303, P259, DOI 10.1016/j.ydbio.2006.11.012; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Li GH, 2011, CURR OPIN GENET DEV, V21, P175, DOI 10.1016/j.gde.2011.01.022; Li H, 2007, PLANT CELL, V19, P2403, DOI 10.1105/tpc.107.053579; Li XY, 2008, PLANT CELL, V20, P259, DOI 10.1105/tpc.107.056879; Lindroth AM, 2004, EMBO J, V23, P4146, DOI 10.1038/sj.emboj.7600430; Lu FL, 2011, NAT GENET, V43, P715, DOI 10.1038/ng.854; MALUSZYNSKA J, 1991, PLANT J, V1, P159, DOI 10.1111/j.1365-313X.1991.00159.x; Mathieu O, 2005, EMBO J, V24, P2783, DOI 10.1038/sj.emboj.7600743; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Naumann K, 2005, EMBO J, V24, P1418, DOI 10.1038/sj.emboj.7600604; Nekrasov M, 2007, EMBO J, V26, P4078, DOI 10.1038/sj.emboj.7601837; Oh SY, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000077; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Reynolds N, 2012, EMBO J, V31, P593, DOI 10.1038/emboj.2011.431; Roudier F, 2011, EMBO J, V30, P1928, DOI 10.1038/emboj.2011.103; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Sarma K, 2008, MOL CELL BIOL, V28, P2718, DOI 10.1128/MCB.02017-07; Schatz DG, 2011, NAT REV IMMUNOL, V11, P251, DOI 10.1038/nri2941; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schubert D, 2006, EMBO J, V25, P4638, DOI 10.1038/sj.emboj.7601311; Schug J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r33; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Shi JH, 2006, GENETICS, V173, P1571, DOI 10.1534/genetics.106.056853; Snowden AW, 2002, CURR BIOL, V12, P2159, DOI 10.1016/S0960-9822(02)01391-X; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Talbert PB, 2010, NAT REV MOL CELL BIO, V11, P264, DOI 10.1038/nrm2861; Tie F, 2009, DEVELOPMENT, V136, P3131, DOI 10.1242/dev.037127; Turck F, 2007, PLOS GENET, V3, P855, DOI 10.1371/journal.pgen.0030086; Vakoc CR, 2006, MOL CELL BIOL, V26, P9185, DOI 10.1128/MCB.01529-06; van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001; Yanowitz J, 2010, CURR OPIN CELL BIOL, V22, P744, DOI 10.1016/j.ceb.2010.08.016; Zhang KL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001210; Zhang XY, 2007, PLOS BIOL, V5, P1026, DOI 10.1371/journal.pbio.0050129; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003	48	6	6	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52855	10.1371/journal.pone.0052855	http://dx.doi.org/10.1371/journal.pone.0052855			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285203	gold, Green Published, Green Submitted			2022-12-27	WOS:000313051500070
J	Reed, AJ; Thatje, S; Linse, K				Reed, Adam J.; Thatje, Sven; Linse, Katrin			Shifting Baselines in Antarctic Ecosystems; Ecophysiological Response to Warming in Lissarca miliaris at Signy Island, Antarctica	PLOS ONE			English	Article							CLIMATE-CHANGE; ANTHROPOGENIC IMPACTS; THERMAL TOLERANCE; MARINE ECOSYSTEMS; SHELL; GROWTH; TEMPERATURE; PENINSULA; SEA; PHILOBRYIDAE	The Antarctic Peninsula has experienced a rapid increase in atmospheric temperature over the last 50 years. Whether or not marine organisms thriving in this cold stenothermal environment are able to cope with warming is of concern. Here, we present changes to the growth and shell characteristics of the ecologically important, small and short lived brooding bivalve Lissarca miliaris from Signy Island, Antarctica. Using material collected from the 1970's to the present day, we show an increase in growth rate and adult shell deterioration accompanied by a decrease in offspring size, associated with an increase in annual average temperatures. Critical changes to the bivalve's ecology seen today evidence the problem of a shift in baseline since the onset of warming recorded in Antarctica. These small bivalves are demonstrating ecophysiological responses to subtle warming that, provided warming continues, could soon surpass a physiological tipping point, adding to warming associated threats such as increased predatory pressure and ocean acidification.	[Reed, Adam J.; Thatje, Sven] Univ Southampton, Natl Oceanog Ctr Southampton, Southampton, Hants, England; [Linse, Katrin] British Antarctic Survey, Nat Environm Res Council, Cambridge CB3 0ET, England	NERC National Oceanography Centre; University of Southampton; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Reed, AJ (corresponding author), Univ Southampton, Natl Oceanog Ctr Southampton, Southampton, Hants, England.	ajr04@soton.ac.uk	; Reed, Adam/Q-7276-2017	Linse, Katrin/0000-0003-3477-3047; Reed, Adam/0000-0003-2200-5067	Natural Environment Research Council PhD studentship; NERC [bas0100026] Funding Source: UKRI; Natural Environment Research Council [bas0100026] Funding Source: researchfish	Natural Environment Research Council PhD studentship(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	AJR was supported through a Natural Environment Research Council PhD studentship. This study is part of the British Antarctic Survey Polar Science for Planet Earth Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPELDOORN RS, 1983, FISH B-NOAA, V81, P75; Arntz Wolf E., 2003, Berichte zur Polar- und Meeresforschung, V462, P1; Aronson RB, 2007, ANNU REV ECOL EVOL S, V38, P129, DOI 10.1146/annurev.ecolsys.38.091206.095525; Aronson RB, 2011, ANN NY ACAD SCI, V1223, P82, DOI 10.1111/j.1749-6632.2010.05926.x; BREY T, 1992, MAR ECOL PROG SER, V82, P219, DOI 10.3354/meps082219; Brey T, 1999, ADV MAR BIOL, V35, P153, DOI 10.1016/S0065-2881(08)60005-X; Brey T, 2011, J MARINE SYST, V88, P542, DOI 10.1016/j.jmarsys.2011.07.004; Cerrano C, 2001, POLAR BIOL, V24, P790, DOI 10.1007/s003000100294; Clarke A, 1996, LIMNOL OCEANOGR, V41, P1281, DOI 10.4319/lo.1996.41.6.1281; CLARKE A, 1988, BRIT ANTARCT SURV B, P65; Cook AJ, 2005, SCIENCE, V308, P541, DOI 10.1126/science.1104235; Cramer KL, 2012, ECOL LETT, V15, P561, DOI 10.1111/j.1461-0248.2012.01768.x; DEVILLIERS S, 1995, SCIENCE, V269, P1247, DOI 10.1126/science.269.5228.1247; Fabry VJ, 2009, OCEANOGRAPHY, V22, P160, DOI 10.5670/oceanog.2009.105; Fraser WR, 2003, MAR ECOL PROG SER, V265, P1, DOI 10.3354/meps265001; GELLER JB, 1990, J EXP MAR BIOL ECOL, V136, P77, DOI 10.1016/0022-0981(90)90101-H; GOODSELL JG, 1992, NAUTILUS, V106, P119; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Harper EM, 2000, J ZOOL, V251, P179, DOI 10.1111/j.1469-7998.2000.tb00602.x; Heilmayer O, 2004, FUNCT ECOL, V18, P641, DOI 10.1111/j.0269-8463.2004.00905.x; Higgs ND, 2009, MAR BIOL, V156, P1073, DOI 10.1007/s00227-009-1154-9; Huber M, 2010, LISSARCA MILIARIS PH; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Kaehler S, 1999, MAR BIOL, V135, P505, DOI 10.1007/s002270050651; Kaehler S, 1999, MAR BIOL, V135, P497, DOI 10.1007/s002270050650; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; McClintock JB, 2009, ANTARCT SCI, V21, P449, DOI 10.1017/S0954102009990198; Meredith MP, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024042; NICOL DAVID, 1967, J PALEONTOL, V41, P1330; NOLAN CP, 1991, J MOLLUS STUD, V57, P225, DOI 10.1093/mollus/57.2.225; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Pinnegar JK, 2008, REV FISH BIOL FISHER, V18, P1, DOI 10.1007/s11160-007-9058-6; Portner HO, 2010, J EXP BIOL, V213, P881, DOI 10.1242/jeb.037523; Portner HO, 2001, NATURWISSENSCHAFTEN, V88, P137; Reed AJ, 2013, POLAR BIOL, V36, P1, DOI 10.1007/s00300-012-1233-0; Richardson M.G., 1979, BR ANTARCTIC SURVEY, V49, P91; Rosenheim BE, 2004, GEOLOGY, V32, P145, DOI 10.1130/G20117.1; Roy K, 2003, ECOL LETT, V6, P205, DOI 10.1046/j.1461-0248.2003.00419.x; Schofield O, 2010, SCIENCE, V328, P1520, DOI 10.1126/science.1185779; Schone BR, 2005, PALAEOGEOGR PALAEOCL, V228, P130, DOI 10.1016/j.palaeo.2005.03.049; Sosdian S, 2006, GEOCHEM GEOPHY GEOSY, V7, P1; Stammerjohn SE, 2008, DEEP-SEA RES PT II, V55, P2041, DOI 10.1016/j.dsr2.2008.04.026; Taskinen J, 1999, J PARASITOL, V85, P588, DOI 10.2307/3285806; Turner J, 2005, INT J CLIMATOL, V25, P279, DOI 10.1002/joc.1130; Vaughan DG, 2003, CLIMATIC CHANGE, V60, P243, DOI 10.1023/A:1026021217991; Villas A, 2011, ECOL APPL, V21, P2172, DOI 10.1890/10-1473.1; Watson EB, 2004, GEOCHIM COSMOCHIM AC, V68, P1473, DOI 10.1016/j.gca.2003.10.003; WEBB SC, 1994, J SHELLFISH RES, V13, P11	48	3	3	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53477	10.1371/journal.pone.0053477	http://dx.doi.org/10.1371/journal.pone.0053477			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285298	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000313051500153
J	Zhang, XY; Chen, DC; Xiu, MH; Luo, XG; Zuo, LJ; Haile, CN; Kosten, TA; Kosten, TR				Zhang, Xiang Yang; Chen, Da Chun; Xiu, Mei Hong; Luo, Xingguang; Zuo, Lingjun; Haile, Colin N.; Kosten, Therese A.; Kosten, Thomas R.			BDNF Val66Met Variant and Smoking in a Chinese Population	PLOS ONE			English	Article							ACTIVITY-DEPENDENT SECRETION; GENOME-WIDE METAANALYSES; NEUROTROPHIC FACTOR BDNF; ANTEROGRADE TRANSPORT; NICOTINE DEPENDENCE; MALE SMOKERS; ASSOCIATION; BRAIN; POLYMORPHISM; BEHAVIOR	Several recent studies have supported the hypothesis that brain-derived neurotrophic factor (BDNF), a member of the neurotrophic factor family, might be associated with nicotine addiction. Association studies have also suggested that the BDNF gene might play a role in the susceptibility to nicotine dependence but results appear contradictory. The present work was therefore undertaken to examine the association of smoking with the BDNF Val66Met gene polymorphism in Chinese population. The BDNF Val66Met gene polymorphism was examined in 628 healthy male volunteers including 322 smokers and 306 non-smokers. Also, the BDNF serum levels were measured in 136 smokers and 97 nonsmokers. Our results showed no significant association between the BDNF Val66Met polymorphism or serum levels among smokers and nonsmokers. Smokers with the Met allele however started smoking significantly earlier than those with the Val/Val genotype (mean age at smoking initiation of 17.4, 17.9 and 21.2 years for Met/Met, Met/Val, and Val/Val, respectively; both p<0.05). No other significant differences between other variables such as number of cigarettes per day, smoking severity as measured by the Fagerstrom Test for Nicotine Dependence (FTND) score and carbon monoxide (CO) levels (all p>0.05). In addition, there was no main effect of genotype on serum BDNF levels. Our findings suggest that the BDNF Val66Met polymorphism may not be involved in susceptibility to smoking among the Chinese male population, but may influence the age at which smoking is initiated. However, the findings must be interpreted with caution because of the relatively small sample size for an association study. Results should be confirmed in a larger cohort.	[Zhang, Xiang Yang; Haile, Colin N.; Kosten, Therese A.; Kosten, Thomas R.] Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Houston, TX 77030 USA; [Zhang, Xiang Yang; Chen, Da Chun; Xiu, Mei Hong; Kosten, Thomas R.] Peking Univ, Beijing Hui Long Guan Hosp, Psychiat Res Ctr, Beijing 100871, Peoples R China; [Luo, Xingguang; Zuo, Lingjun] Yale Univ, Dept Psychiat, New Haven, CT 06520 USA	Baylor College of Medicine; Peking University; Yale University	Zhang, XY (corresponding author), Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Houston, TX 77030 USA.	xyzhang@bcm.edu; kosten@bcm.edu	KOSTEN, Therese/R-2506-2019; Kosten, Thomas/AAI-5998-2021	Haile, Colin/0000-0001-8293-7291	National Natural Science Foundation of China [81000509]; Beijing Municipal Excellent Talents Foundation [2010D003034000032]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Excellent Talents Foundation	This study was funded by National Natural Science Foundation of China (81000509) and Beijing Municipal Excellent Talents Foundation (2010D003034000032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altar CA, 1997, NATURE, V389, P856, DOI 10.1038/39885; Altar CA, 1998, TRENDS NEUROSCI, V21, P433, DOI 10.1016/S0166-2236(98)01273-9; Beuten J, 2005, AM J MED GENET B, V139B, P73, DOI 10.1002/ajmg.b.30231; Bhang SY, 2010, NEUROSCI LETT, V468, P7, DOI 10.1016/j.neulet.2009.10.046; Breetvelt EJ, 2012, PSYCHIAT GENET, V22, P96, DOI 10.1097/YPG.0b013e32834c0c75; Chen ZY, 2004, J NEUROSCI, V24, P4401, DOI 10.1523/JNEUROSCI.0348-04.2004; David SP, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.41; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; FAGERSTROM KO, 1978, ADDICT BEHAV, V3, P235, DOI 10.1016/0306-4603(78)90024-2; Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571; Gauderman WJ, 2002, AM J EPIDEMIOL, V155, P478, DOI 10.1093/aje/155.5.478; Ghitza UE, 2010, NEUROSCI BIOBEHAV R, V35, P157, DOI 10.1016/j.neubiorev.2009.11.009; Gratacos M, 2007, BIOL PSYCHIAT, V61, P911, DOI 10.1016/j.biopsych.2006.08.025; Guillin O, 2001, NATURE, V411, P86, DOI 10.1038/35075076; Guo S, 2007, PSYCHOPHARMACOLOGY, V190, P449, DOI 10.1007/s00213-006-0628-4; HYMAN C, 1991, NATURE, V350, P230, DOI 10.1038/350230a0; Kenny PJ, 2000, MOL BRAIN RES, V85, P234, DOI 10.1016/S0169-328X(00)00246-1; Lang UE, 2007, PSYCHOPHARMACOLOGY, V190, P433, DOI 10.1007/s00213-006-0647-1; Lee S, 2009, ADDICT BEHAV, V34, P969, DOI 10.1016/j.addbeh.2009.05.005; Lerman C, 2003, AM J MED GENET B, V118B, P48, DOI 10.1002/ajmg.b.10003; Li MD, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-S1-S103; Liu JZ, 2010, NAT GENET, V42, P436, DOI 10.1038/ng.572; Montag C, 2008, NEUROSCI LETT, V442, P30, DOI 10.1016/j.neulet.2008.06.064; Montag C, 2010, NEUROPSYCHOPHARMACOL, V35, P1860, DOI 10.1038/npp.2010.55; Nestler EJ, 2005, NAT NEUROSCI, V8, P1445, DOI 10.1038/nn1578; Nishio T, 1998, NEUROREPORT, V9, P2847, DOI 10.1097/00001756-199808240-00030; Pontieri FE, 1996, NATURE, V382, P255, DOI 10.1038/382255a0; Seidah NG, 1996, FEBS LETT, V379, P247, DOI 10.1016/0014-5793(95)01520-5; Suchanek R, 2012, J MOL NEUROSCI, V46, P217, DOI 10.1007/s12031-011-9582-7; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Thorgeirsson TE, 2010, NAT GENET, V42, P448, DOI 10.1038/ng.573; Uhl GR, 2001, AM J HUM GENET, V69, P1290, DOI 10.1086/324467; Xiu MH, 2009, PROG NEURO-PSYCHOPH, V33, P1508, DOI 10.1016/j.pnpbp.2009.08.011; Zhang XY, 2008, NEUROPSYCHOPHARMACOL, V33, P2200, DOI 10.1038/sj.npp.1301619	36	11	11	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53295	10.1371/journal.pone.0053295	http://dx.doi.org/10.1371/journal.pone.0053295			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285275	Green Submitted, gold, Green Published			2022-12-27	WOS:000313051500129
J	Downes, JC; Birsoy, B; Chipman, KC; Rothman, JH				Downes, Joanna C.; Birsoy, Bilge; Chipman, Kyle C.; Rothman, Joel H.			Handedness of a Motor Program in C. elegans Is Independent of Left-Right Body Asymmetry	PLOS ONE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; OLFACTORY NEURON FATES; MATING-BEHAVIOR; EMBRYONIC-DEVELOPMENT; ISOGENIC POPULATIONS; CELL LINEAGES; CHEMOTAXIS; EVOLUTION; GENETICS; PROTEIN	Complex animals display bilaterally asymmetric motor behavior, or "motor handedness," often revealed by preferential use of limbs on one side. For example, use of right limbs is dominant in a strong majority of humans. While the mechanisms that establish bilateral asymmetry in motor function are unknown in humans, they appear to be distinct from those for other handedness asymmetries, including bilateral visceral organ asymmetry, brain laterality, and ocular dominance. We report here that a simple, genetically homogeneous animal comprised of only similar to 1000 somatic cells, the nematode C. elegans, also shows a distinct motor handedness preference: on a population basis, males show a pronounced right-hand turning bias during mating. The handedness bias persists through much of adult lifespan, suggesting that, as in more complex animals, it is an intrinsic trait of each individual, which can differ from the population mean. Our observations imply that the laterality of motor handedness preference in C. elegans is driven by epigenetic factors rather than by genetic variation. The preference for right-hand turns is also seen in animals with mirror-reversed anatomical handedness and is not attributable to stochastic asymmetric loss of male sensory rays that occurs by programmed cell death. As with C. elegans, we also observed a substantial handedness bias, though not necessarily the same preference in direction, in several gonochoristic Caenorhabditis species. These findings indicate that the independence of bilaterally asymmetric motor dominance from overall anatomical asymmetry, and a population-level tendency away from ambidexterity, occur even in simple invertebrates, suggesting that these may be common features of bilaterian metazoans.	[Rothman, Joel H.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Rothman, JH (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.	joel.rothman@lifesci.ucsb.edu		Bairzin, Joanna/0000-0001-7628-0684; Birsoy, Bilge/0000-0003-4337-4582	National Institutes of Health (NIH) [GM87137, HD062922]; University of California Santa Barbara CCS Summer Undergraduate Research Fellowship; NIH National Center for Research Resources; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087137] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California Santa Barbara CCS Summer Undergraduate Research Fellowship; NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants GM87137 and HD062922 from the National Institutes of Health (NIH) to JHR. BB was supported by an NIH Ruth Kirschstein Fellowship and a Harvey Karp Discovery Award. JCD was supported in part by a University of California Santa Barbara CCS Summer Undergraduate Research Fellowship. The Caenorhabditis Genetics Center is funded by the NIH National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asami T, 1998, AM NAT, V152, P225, DOI 10.1086/286163; Bergmann DC, 2003, DEVELOPMENT, V130, P5731, DOI 10.1242/dev.00839; BRENNER S, 1974, GENETICS, V77, P71; Byrne RA, 2002, ANIM BEHAV, V64, P461, DOI 10.1006/anbe.2002.3089; Chen J, 2001, EXP GERONTOL, V36, P431, DOI 10.1016/S0531-5565(00)00225-4; Corballis MC, 1997, PSYCHOL REV, V104, P714, DOI 10.1037/0033-295X.104.4.714; Croll N. A., 1977, Biology of nematodes.; Davison A, 2009, BIOL LETTERS, V5, P20, DOI 10.1098/rsbl.2008.0528; GENDREAU SB, 1994, DEV BIOL, V166, P770, DOI 10.1006/dbio.1994.1355; Hall SE, 2010, CURR BIOL, V20, P149, DOI 10.1016/j.cub.2009.11.035; HARDYCK C, 1977, PSYCHOL BULL, V84, P385, DOI 10.1037/0033-2909.84.3.385; Hermann GJ, 2000, DEVELOPMENT, V127, P3429; HODGKIN J, 1983, GENETICS, V103, P43; HUTTER H, 1995, DEVELOPMENT, V121, P3417; HUTTER H, 1994, DEVELOPMENT, V120, P2051; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; Kight SL, 2008, BEHAV PROCESS, V79, P66, DOI 10.1016/j.beproc.2008.04.001; LIU KS, 1995, NEURON, V14, P79, DOI 10.1016/0896-6273(95)90242-2; MCCULLAGH P, 1989, GEN LINEAR MODELS, pR19; McGrew WC, 1999, PRIMATES, V40, P509, DOI 10.1007/BF02557586; Mevorach C, 2005, NAT NEUROSCI, V8, P276, DOI 10.1038/nn1400; MOSKOWITZ IPG, 1994, DEVELOPMENT, V120, P3325; Nance J, 1999, GENETICS, V152, P209; Palopoli MF, 2008, NATURE, V454, P1019, DOI 10.1038/nature07171; Pierce-Shimomura JT, 2001, NATURE, V410, P694, DOI 10.1038/35070575; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Pohl Christian, 2011, Commun Integr Biol, V4, P34, DOI 10.4161/cib.4.1.14144; Poole RJ, 2006, CURR BIOL, V16, P2279, DOI 10.1016/j.cub.2006.09.041; Rea SL, 2005, NAT GENET, V37, P894, DOI 10.1038/ng1608; Sagasti A, 1999, GENE DEV, V13, P1794, DOI 10.1101/gad.13.14.1794; Sagasti A, 2001, CELL, V105, P221, DOI 10.1016/S0092-8674(01)00313-0; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; SULSTON JE, 1983, COLD SPRING HARB SYM, V48, P443, DOI 10.1101/SQB.1983.048.01.049; SULSTON JE, 1980, DEV BIOL, V78, P542, DOI 10.1016/0012-1606(80)90352-8; Suzuki H, 2008, NATURE, V454, P114, DOI 10.1038/nature06927; Troemel ER, 1999, CELL, V99, P387, DOI 10.1016/S0092-8674(00)81525-1; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; WOOD WB, 1991, NATURE, V349, P536, DOI 10.1038/349536a0	39	8	8	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52138	10.1371/journal.pone.0052138	http://dx.doi.org/10.1371/journal.pone.0052138			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300601	Green Published, Green Submitted, gold			2022-12-27	WOS:000312829100023
J	Almlof, JC; Lundmark, P; Lundmark, A; Ge, B; Maouche, S; Goring, HHH; Liljedahl, U; Enstrom, C; Brocheton, J; Proust, C; Godefroy, T; Sambrook, JG; Jolley, J; Crisp-Hihn, A; Foad, N; Lloyd-Jones, H; Stephens, J; Gwilliam, R; Rice, CM; Hengstenberg, C; Samani, NJ; Erdmann, J; Schunkert, H; Pastinen, T; Deloukas, P; Goodall, AH; Ouwehand, WH; Cambien, F; Syvanen, AC				Almlof, Jonas Carlsson; Lundmark, Per; Lundmark, Anders; Ge, Bing; Maouche, Seraya; Goering, Harald H. H.; Liljedahl, Ulrika; Enstrom, Camilla; Brocheton, Jessy; Proust, Carole; Godefroy, Tiphaine; Sambrook, Jennifer G.; Jolley, Jennifer; Crisp-Hihn, Abigail; Foad, Nicola; Lloyd-Jones, Heather; Stephens, Jonathan; Gwilliam, Rhian; Rice, Catherine M.; Hengstenberg, Christian; Samani, Nilesh J.; Erdmann, Jeanette; Schunkert, Heribert; Pastinen, Tomi; Deloukas, Panos; Goodall, Alison H.; Ouwehand, Willem H.; Cambien, Francois; Syvanen, Ann-Christine		CARDIOGENICS Consortium; CARDIOGENICS Consortium; CARDIOGENICS Consortium; CARDIOGENICS Consortium	Powerful Identification of Cis-regulatory SNPs in Human Primary Monocytes Using Allele-Specific Gene Expression	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DISCOVERY	A large number of genome-wide association studies have been performed during the past five years to identify associations between SNPs and human complex diseases and traits. The assignment of a functional role for the identified disease-associated SNP is not straight-forward. Genome-wide expression quantitative trait locus (eQTL) analysis is frequently used as the initial step to define a function while allele-specific gene expression (ASE) analysis has not yet gained a wide-spread use in disease mapping studies. We compared the power to identify cis-acting regulatory SNPs (cis-rSNPs) by genome-wide allele-specific gene expression (ASE) analysis with that of traditional expression quantitative trait locus (eQTL) mapping. Our study included 395 healthy blood donors for whom global gene expression profiles in circulating monocytes were determined by Illumina BeadArrays. ASE was assessed in a subset of these monocytes from 188 donors by quantitative genotyping of mRNA using a genome-wide panel of SNP markers. The performance of the two methods for detecting cis-rSNPs was evaluated by comparing associations between SNP genotypes and gene expression levels in sample sets of varying size. We found that up to 8-fold more samples are required for eQTL mapping to reach the same statistical power as that obtained by ASE analysis for the same rSNPs. The performance of ASE is insensitive to SNPs with low minor allele frequencies and detects a larger number of significantly associated rSNPs using the same sample size as eQTL mapping. An unequivocal conclusion from our comparison is that ASE analysis is more sensitive for detecting cis-rSNPs than standard eQTL mapping. Our study shows the potential of ASE mapping in tissue samples and primary cells which are difficult to obtain in large numbers.	[Almlof, Jonas Carlsson; Lundmark, Per; Lundmark, Anders; Liljedahl, Ulrika; Enstrom, Camilla; Syvanen, Ann-Christine] Uppsala Univ, Dept Med Sci, Mol Med & Sci Life Lab, Uppsala, Sweden; [Ge, Bing; Pastinen, Tomi] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Maouche, Seraya; Brocheton, Jessy; Proust, Carole; Godefroy, Tiphaine; Cambien, Francois] Univ Paris 06, INSERM, UMRS 937, Paris, France; [Maouche, Seraya; Brocheton, Jessy; Proust, Carole; Godefroy, Tiphaine; Cambien, Francois] Sch Med, Paris, France; [Goering, Harald H. H.] Texas Biomed Res Inst, Dept Genet, San Antonio, TX USA; [Sambrook, Jennifer G.; Lloyd-Jones, Heather; Stephens, Jonathan; Ouwehand, Willem H.] Univ Cambridge, Dept Haematol, Cambridge, England; [Sambrook, Jennifer G.; Jolley, Jennifer; Crisp-Hihn, Abigail; Foad, Nicola; Lloyd-Jones, Heather; Stephens, Jonathan; Ouwehand, Willem H.] Cambridge Ctr, Natl Hlth Serv Blood & Transplant, Cambridge, England; [Gwilliam, Rhian; Rice, Catherine M.; Deloukas, Panos] Wellcome Trust Sanger Inst, Cambridge, England; [Hengstenberg, Christian] Univ Regensburg, Klin & Poliklin Innere Med 2, D-93053 Regensburg, Germany; [Samani, Nilesh J.; Goodall, Alison H.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Samani, Nilesh J.; Goodall, Alison H.] Glenfield Gen Hosp, Leicester NIHR Biomed Res Unit Cardiovasc Dis, Leicester LE3 9QP, Leics, England; [Erdmann, Jeanette; Schunkert, Heribert] Med Univ Lubeck, Med Klin 2, D-23538 Lubeck, Germany	Uppsala University; McGill University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite de Franche-Comte; Texas Biomedical Research Institute; University of Cambridge; NHS Blood & Transplant (NHSBT); Wellcome Trust Sanger Institute; University of Regensburg; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Lubeck	Syvanen, AC (corresponding author), Uppsala Univ, Dept Med Sci, Mol Med & Sci Life Lab, Uppsala, Sweden.	Ann-Christine.Syvanen@medsci.uu.se	Erdmann, Jeanette/A-4417-2009; Erdmann, Jeanette/P-7513-2014; Hengstenberg, Christian/U-5485-2019; Cambien, Francois/AAP-9751-2020; Almlöf, Jonas/E-1608-2017	Erdmann, Jeanette/0000-0002-4486-6231; Almlöf, Jonas/0000-0002-1211-9821; Stephens, Jonathan/0000-0003-2020-9330; Goodall, Alison/0000-0002-7883-9645; Maouche, Seraya/0000-0001-8186-1635; Ouwehand, Willem/0000-0002-7744-1790	Cardiogenics EU FP6 project [LSHM-CT-2006-037593]; European Sequencing and Genotyping Infrastructure (ESGI) EU FP7 [262055]; GEUVADIS EU FP7 project [261123]; Swedish Research Council for Science and Technology [90559401]; Knut and Alice Wallenberg Foundation [KAW 2011.0073]; National Institute for Health Research (NIHR) [RP-PG-0310-1002]; National Institute of Health (NIH) [RR017515]; Canadian Institutes of Health Research; Swedish Research Council; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR017515] Funding Source: NIH RePORTER	Cardiogenics EU FP6 project; European Sequencing and Genotyping Infrastructure (ESGI) EU FP7; GEUVADIS EU FP7 project; Swedish Research Council for Science and Technology(Swedish Research Council); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Swedish Research Council(Swedish Research CouncilEuropean Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the Cardiogenics EU FP6 project (grant number LSHM-CT-2006-037593); the European Sequencing and Genotyping Infrastructure (ESGI) EU FP7 (grant number 262055); the GEUVADIS EU FP7 project (grant number 261123); the Swedish Research Council for Science and Technology (grant number 90559401 to ACS); the Knut and Alice Wallenberg Foundation (KAW 2011.0073 to ACS); the National Institute for Health Research (NIHR) (RP-PG-0310-1002 to HG); and the National Institute of Health (NIH) (RR017515 to HG). TP holds a Canada Research Chair and his work is supported by the Canadian Institutes of Health Research. Funding for open access charge was granted by the Swedish Research Council. The project made use of volunteers from the Cambridge BioResource.(http://www.cambridgebioresource.org.uk/). This local resource for genotype-phenotype association studies is supported by a grant from the National Institute for Health Research (NIHR) to the Cambridge Biomedical Research Centre (to JS and JJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Ge B, 2009, NAT GENET, V41, P1216, DOI 10.1038/ng.473; Hindorff LA, 2011, CATALOG PUBLISHED GE; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Lerner-Ellis JP, 2009, HUM MUTAT, V30, P1072, DOI 10.1002/humu.21001; Milani L, 2009, GENOME RES, V19, P1, DOI 10.1101/gr.083931.108; Murphy A, 2010, HUM MOL GENET, V19, P4745, DOI 10.1093/hmg/ddq392; Pastinen T, 2010, NAT REV GENET, V11, P533, DOI 10.1038/nrg2815; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Rotival M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002367; SHAFFER JP, 1995, ANNU REV PSYCHOL, V46, P561, DOI 10.1146/annurev.ps.46.020195.003021; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Teo YY, 2007, BIOINFORMATICS, V23, P2741, DOI 10.1093/bioinformatics/btm443; Verlaan DJ, 2009, GENOME RES, V19, P118, DOI 10.1101/gr.084798.108; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693	18	27	27	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52260	10.1371/journal.pone.0052260	http://dx.doi.org/10.1371/journal.pone.0052260			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300628	Green Published, Green Submitted, gold			2022-12-27	WOS:000313618800062
J	Dayyani, F; Parikh, NU; Varkaris, AS; Song, JH; Moorthy, S; Chatterji, T; Maity, SN; Wolfe, AR; Carboni, JM; Gottardis, MM; Logothetis, CJ; Gallick, GE				Dayyani, Farshid; Parikh, Nila U.; Varkaris, Andreas S.; Song, Jian H.; Moorthy, Shhyam; Chatterji, Tanushree; Maity, Sankar N.; Wolfe, Adam R.; Carboni, Joan M.; Gottardis, Marco M.; Logothetis, Christopher J.; Gallick, Gary E.			Combined Inhibition of IGF-1R/IR and Src Family Kinases Enhances Antitumor Effects in Prostate Cancer by Decreasing Activated Survival Pathways	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; LYMPH-NODE METASTASES; POTENT INHIBITOR; TUMOR-GROWTH; DASATINIB; EXPRESSION; CELLS; BONE; PROGRESSION; ANTIBODY	Background: Treatment of metastatic prostate cancer (PCa) with single agents has shown only modest efficacy. We hypothesized dual inhibition of different pathways in PCa results in improved tumor inhibition. The Src family kinases (SFK) and insulin-like growth factor-1 (IGF-1) signaling axes are aberrantly activated in both primary PCa and bone metastases and regulate distinct and overlapping functions in PCa progression. We examined the antitumor effects of combined inhibition of these pathways. Materials and Methods: Src andIGF-1 receptor (IGF-1R) inhibition was achieved in vitro by short hairpin (sh) RNA and in vitro and in vivo by small molecule inhibitors (dasatinib and BMS-754807, against SFK and IGF-1R/Insulin Receptor(IR), respectively). Results: In vitro, inhibition of IGF-1 signaling affected cell survival and proliferation. SFK blockade alone had modest effects on proliferation, but significantly enhanced the IGF-1R blockade. These findings correlated with a robust inhibition of IGF-1-induced Akt1 phophorylation by dasatinib, whereas Akt2 phosphorylation was SFK independent and only inhibited by BMS-754807. Thus, complete inhibition of both Akt genes, not seen by either drug alone, is likely a major mechanism for the decreased survival of PCa cells. Furthermore, dasatinib and BMS-754807 inhibited in vivo growth of the primary human xenograft MDA PCa 133, with corresponding inhibition of Akt in tumors. Also, both orthotopic and intratibial tumor growth of PC-3 cells were more potently inhibited by dual SFK and IGF-1R/IR blockade compared to either pathway alone, with a corresponding decrease in bone turnover markers. Conclusions: Dual IGF-1R/IR and SFK inhibition may be a rational therapeutic approach in PCa by blocking both independent and complementary processes critical to tumor growth.	[Dayyani, Farshid; Parikh, Nila U.; Varkaris, Andreas S.; Song, Jian H.; Moorthy, Shhyam; Chatterji, Tanushree; Maity, Sankar N.; Wolfe, Adam R.; Logothetis, Christopher J.; Gallick, Gary E.] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA; [Dayyani, Farshid; Parikh, Nila U.; Varkaris, Andreas S.; Song, Jian H.; Moorthy, Shhyam; Chatterji, Tanushree; Maity, Sankar N.; Wolfe, Adam R.; Logothetis, Christopher J.; Gallick, Gary E.] Univ Texas MD Anderson Canc Ctr, David H Koch Ctr Appl Res Genitourinary Canc, Houston, TX 77030 USA; [Chatterji, Tanushree; Gallick, Gary E.] Univ Texas Grad Sch Biomed Sci Houston, Program Canc Metastasis, Houston, TX USA; [Carboni, Joan M.; Gottardis, Marco M.] Bristol Myers Squibb Co, Dept Pharmaceut Candidate Org, Princeton, NJ USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Bristol-Myers Squibb	Gallick, GE (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA.	ggallick@mdanderson.org	varkaris, andreas/AAS-4833-2020; Varkaris, Andreas/AAU-3262-2020; Dayyani, Farshid/CAF-8867-2022; Wolfe, Adam/AAF-1213-2019	Dayyani, Farshid/0000-0002-4970-5189; Wolfe, Adam/0000-0002-0123-7371; Maity, Sankar/0000-0002-2387-6545; Moorthy, Shhyam/0000-0003-3169-2719	United States National Institutes of Health [T32 CA009666, 1 P50 CA140388-01]; Prostate Cancer Foundation; NIH through MD Anderson's Cancer Center Support Grant [5 P30 CA016672-35]; Prostate Cancer Research Program grant at UTMDACC; NATIONAL CANCER INSTITUTE [P50CA140388, P30CA016672, T32CA009666] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Prostate Cancer Foundation; NIH through MD Anderson's Cancer Center Support Grant; Prostate Cancer Research Program grant at UTMDACC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	F.D. was supported by United States National Institutes of Health grant T32 CA009666; F.D., G.E.G., J.C.A., and C.J.L. were supported by 1 P50 CA140388-01; F.D., G.E.G., and C.J.L. were also supported from a grant by the Prostate Cancer Foundation. This work was also supported by the NIH through MD Anderson's Cancer Center Support Grant, 5 P30 CA016672-35. S.N.M. was supported by a Prostate Cancer Research Program grant at UTMDACC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo JC, 2012, CANCER-AM CANCER SOC, V118, P63, DOI 10.1002/cncr.26204; Brownlow N, 2009, LEUKEMIA, V23, P590, DOI 10.1038/leu.2008.237; Carboni JM, 2009, MOL CANCER THER, V8, P3341, DOI 10.1158/1535-7163.MCT-09-0499; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Darash-Yahana M, 2004, FASEB J, V18, P1240, DOI 10.1096/fj.03-0935fje; Davies MA, 2002, CLIN CANCER RES, V8, P1904; Dayyani F, 2011, JNCI-J NATL CANCER I, V103, P1665, DOI 10.1093/jnci/djr362; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; de Bono JS, 2010, LANCET, V376, P1147, DOI 10.1016/S0140-6736(10)61389-X; Desai J, 2010, J CLIN ONCOL S, V28, p15s, DOI DOI 10.1200/jco.2010.28.15_suppl.3104; Fagan DH, 2012, CANCER RES, V72, P3372, DOI 10.1158/0008-5472.CAN-12-0684; Fizazi K, 2007, ANN ONCOL, V18, P1765, DOI 10.1093/annonc/mdm086; Gills JJ, 2009, CURR ONCOL REP, V11, P102, DOI 10.1007/s11912-009-0016-4; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Kim SJ, 2003, CLIN CANCER RES, V9, P5161; Kim SJ, 2006, JNCI-J NATL CANCER I, V98, P783, DOI 10.1093/jnci/djj211; Kimura T, 2010, CLIN CANCER RES, V16, P121, DOI 10.1158/1078-0432.CCR-09-0982; Kopetz S, 2009, CANCER RES, V69, P3842, DOI 10.1158/0008-5472.CAN-08-2246; Krueckl SL, 2004, CANCER RES, V64, P8620, DOI 10.1158/0008-5472.CAN-04-2446; Landen CN, 2006, J NATL CANCER I, V98, P1558, DOI 10.1093/jnci/djj414; Larsson O, 2005, BRIT J CANCER, V92, P2097, DOI 10.1038/sj.bjc.6602627; Lee YC, 2010, ONCOGENE, V29, P3196, DOI 10.1038/onc.2010.73; Lee YC, 2011, CANCER RES, V71, P5194, DOI 10.1158/0008-5472.CAN-10-4374; Ligresti G, 2009, CELL CYCLE, V8, P1352, DOI 10.4161/cc.8.9.8255; Logothetis CJ, 2005, NAT REV CANCER, V5, P21, DOI 10.1038/nrc1528; Lombardo LJ, 2004, J MED CHEM, V47, P6658, DOI 10.1021/jm049486a; Maloney EK, 2003, CANCER RES, V63, P5073; Miyake H, 2000, ENDOCRINOLOGY, V141, P2257, DOI 10.1210/en.141.6.2257; MOHAN S, 1991, CLIN ORTHOP RELAT R, P30; Nam S, 2005, CANCER RES, V65, P9185, DOI 10.1158/0008-5472.CAN-05-1731; Ngo TH, 2003, ENDOCRINOLOGY, V144, P2319, DOI 10.1210/en.2003-221028; Paccez JD, 2013, ONCOGENE, V32, P689, DOI 10.1038/onc.2012.89; Papageorgiou E, 2008, MOL MED, V14, P403, DOI 10.2119/2008-00021.Papageorgiou; Park SI, 2008, CANCER RES, V68, P3323, DOI 10.1158/0008-5472.CAN-07-2997; Park Serk In, 2010, Curr Protoc Pharmacol, VChapter 14, DOI 10.1002/0471141755.ph1415s51; Pollak MN, 2004, NAT REV CANCER, V4, P505, DOI 10.1038/nrc1387; Rabbani SA, MOL CANC THER, V9, P1147; Saad F, 2009, BJU INT, V103, P434, DOI 10.1111/j.1464-410X.2008.08249.x; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Su AI, 2001, CANCER RES, V61, P7388; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Tai S, 2011, PROSTATE, V71, P1668, DOI 10.1002/pros.21383; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Tao Y, 2007, NAT CLIN PRACT ONCOL, V4, P591, DOI 10.1038/ncponc0934; Vandyke K, 2010, J BONE MINER RES, V25, P1759, DOI 10.1002/jbmr.85; Varkaris A, 2011, EXPERT OPIN INV DRUG, V20, P1677, DOI 10.1517/13543784.2011.631523; Wahdan-Alaswad RS, 2010, CANCER RES, V70, P9106, DOI 10.1158/0008-5472.CAN-10-1119; Windham TC, 2002, ONCOGENE, V21, P7797, DOI 10.1038/sj.onc.1205989; Wu JD, 2005, CLIN CANCER RES, V11, P3065, DOI 10.1158/1078-0432.CCR-04-1586; Wu Zhaoju, 2010, Genes Cancer, V1, P40, DOI 10.1177/1947601909358324; Yap TA, 2011, EXPERT OPIN INV DRUG, V20, P1293, DOI 10.1517/13543784.2011.602630; Yu EY, 2009, CLIN CANCER RES, V15, P7421, DOI 10.1158/1078-0432.CCR-09-1691; Zhang J, 2007, J CLIN INVEST, V117, P2962, DOI 10.1172/JCI30710	54	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e51189	10.1371/journal.pone.0051189	http://dx.doi.org/10.1371/journal.pone.0051189			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300537	gold, Green Submitted, Green Published			2022-12-27	WOS:000313618800012
J	Roopin, M; Levy, O				Roopin, Modi; Levy, Oren			Melatonin Distribution Reveals Clues to Its Biological Significance in Basal Metazoans	PLOS ONE			English	Article							CLASS-LEVEL RELATIONSHIPS; PINEAL MELATONIN; OXIDATIVE STRESS; PHYLUM CNIDARIA; NERVOUS-SYSTEM; HORMONE; IDENTIFICATION; CHROMATOGRAPHY; NEUROPEPTIDES; ANTIOXIDANT	Although nearly ubiquitous in nature, the precise biological significance of endogenous melatonin is poorly understood in phylogenetically basal taxa. In the present work, we describe insights into the functional role of melatonin at the most "basal" level of metazoan evolution. Hitherto unknown morphological determinants of melatonin distribution were evaluated in Nematostella vectensis by detecting melatonin immunoreactivity and examining the spatial gene expression patterns of putative melatonin biosynthetic and receptor elements that are located at opposing ends of the melatonin signaling pathway. Immuno-melatonin profiling indicated an elaborate interaction with reproductive tissues, reinforcing previous conjectures of a melatonin-responsive component in anthozoan reproduction. In situ hybridization (ISH) to putative melatonin receptor elements highlighted the possibility that the bioregulatory effects of melatonin in anthozoan reproduction may be mediated by interactions with membrane receptors, as in higher vertebrates. Another intriguing finding of the present study pertains to the prevalence of melatonin in centralized nervous structures. This pattern may be of great significance given that it 1) identifies an ancestral association between melatonin and key neuronal components and 2) potentially implies that certain effects of melatonin in basal species may be spread widely by regionalized nerve centers.	[Roopin, Modi; Levy, Oren] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel	Bar Ilan University	Roopin, M (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel.	modiroopin@gmail.com			PADI Foundation [159]; Israeli Science Foundation [243/10]	PADI Foundation; Israeli Science Foundation(Israel Science Foundation)	This study was funded by a PADI Foundation grant to MR, Req No. 159 (2009), and an Israeli Science Foundation (No. 243/10) grant to OL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anctil M, 2009, COMP BIOCHEM PHYS D, V4, P268, DOI 10.1016/j.cbd.2009.07.001; Antolin I, 1997, J PINEAL RES, V23, P182, DOI 10.1111/j.1600-079X.1997.tb00353.x; BRAINARD GC, 1982, NEUROENDOCRINOLOGY, V35, P342, DOI 10.1159/000123405; BRIDGE D, 1995, MOL BIOL EVOL, V12, P679; BRIDGE D, 1992, P NATL ACAD SCI USA, V89, P8750, DOI 10.1073/pnas.89.18.8750; Cary GA, 2012, COMP BIOCHEM PHYS A, V161, P355, DOI 10.1016/j.cbpa.2011.12.005; Collin F, 2009, J MASS SPECTROM, V44, P318, DOI 10.1002/jms.1508; Collins AG, 2006, SYST BIOL, V55, P97, DOI 10.1080/10635150500433615; Dubocovich ML, 2005, ENDOCRINE, V27, P101, DOI 10.1385/ENDO:27:2:101; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Fritzenwanker JH, 2002, DEV GENES EVOL, V212, P99, DOI 10.1007/s00427-002-0214-7; Galano A, 2011, J PINEAL RES, V51, P1, DOI 10.1111/j.1600-079X.2011.00916.x; Garm A, 2007, CELL TISSUE RES, V329, P147, DOI 10.1007/s00441-007-0393-7; GRIMMELIKHUIJZEN CJP, 1983, HISTOCHEMISTRY, V78, P361, DOI 10.1007/BF00496623; Grimmelikhuijzen CJP, 2002, CAN J ZOOL, V80, P1690, DOI 10.1139/Z02-137; GRIMMELIKHUIJZEN CJP, 1991, HYDROBIOLOGIA, V216, P555, DOI 10.1007/BF00026513; Hardeland R, 1999, REPROD NUTR DEV, V39, P399, DOI 10.1051/rnd:19990311; Hardeland R, 2003, J PINEAL RES, V34, P233, DOI 10.1034/j.1600-079X.2003.00040.x; Hardeland R, 2008, CELL MOL LIFE SCI, V65, P2001, DOI 10.1007/s00018-008-8001-x; Hardeland R, 1996, TREND COMPAR BIOCHEM, V2, P25; Hardeland R., 2008, OPEN PHYSL J, V1, P1, DOI DOI 10.2174/1874360900901010001; Hardeland R., 2007, FUNCT PLANT SCI BIOT, V1, P32; Hardeland R, 2011, PROG NEUROBIOL, V93, P350, DOI 10.1016/j.pneurobio.2010.12.004; Klein DC, 2007, J BIOL CHEM, V282, P4233, DOI 10.1074/jbc.R600036200; Koizumi O, 2007, BRAIN BEHAV EVOLUT, V69, P151, DOI 10.1159/000095204; LEROITH D, 1986, RECENT PROG HORM RES, V42, P549; Luchetti F, 2010, FASEB J, V24, P3603, DOI 10.1096/fj.10-154450; Mackie GO, 2004, NEUROSIGNALS, V13, P5, DOI 10.1159/000076155; Marlow HQ, 2009, DEV NEUROBIOL, V69, P235, DOI 10.1002/dneu.20698; Mechawar N, 1997, J COMP NEUROL, V387, P243; Odorico DM, 1997, P ROY SOC B-BIOL SCI, V264, P77, DOI 10.1098/rspb.1997.0011; PANTIN CFA, 1952, PROC R SOC SER B-BIO, V140, P147, DOI 10.1098/rspb.1952.0052; Pape C, 1999, STUDIES ANTIOXIDANTS, P28; Parker GH, 1919, ELEMENTARY NERVOUS S, P1; Pernet V, 2004, J COMP NEUROL, V472, P208, DOI 10.1002/cne.20108; Pevet P, 2006, CHRONOBIOL INT, V23, P39, DOI 10.1080/07420520500482074; Reiter RJ, 2007, ADV MED SCI-POLAND, V52, P11; REITER RJ, 1991, ENDOCR REV, V12, P151, DOI 10.1210/edrv-12-2-151; REITER RJ, 1993, EXPERIENTIA, V49, P654, DOI 10.1007/BF01923947; REITER RJ, 1974, CHRONOBIOLOGIA, V1, P365; Reiter RJ, 2009, BIOL REPROD, V81, P445, DOI 10.1095/biolreprod.108.075655; ROLLAG MD, 1980, P SOC EXP BIOL MED, V165, P330, DOI 10.3181/00379727-165-40981; Roopin M, 2012, J PINEAL RES, V53, P259, DOI 10.1111/j.1600-079X.2012.00994.x; Sato S, 2008, J PHYSIOL SCI, V58, P317, DOI 10.2170/physiolsci.RP006208; Tan DX, 2007, J PINEAL RES, V42, P28, DOI 10.1111/j.1600-079X.2006.00407.x; Tan DX, 2010, BIOL REV, V85, P607, DOI 10.1111/j.1469-185X.2009.00118.x; Tan DX, 2003, J PINEAL RES, V34, P75, DOI 10.1034/j.1600-079X.2003.02111.x; Gomez FJV, 2012, J PINEAL RES, V52, P349, DOI 10.1111/j.1600-079X.2011.00949.x; VIVIENROELS B, 1993, EXPERIENTIA, V49, P642, DOI 10.1007/BF01923945; VIVIENROELS B, 1984, NEUROSCI LETT, V49, P153, DOI 10.1016/0304-3940(84)90152-6; Watanabe H, 2009, DEV GROWTH DIFFER, V51, P167, DOI 10.1111/j.1440-169X.2009.01103.x; Wurtman R J, 1968, Adv Pharmacol, V6, P141; Yang SM, 2002, J PHARMACEUT BIOMED, V30, P781, DOI 10.1016/S0731-7085(02)00387-4; Yasuo S, 2009, INTEGR COMP BIOL, V49, P507, DOI 10.1093/icb/icp011	54	3	3	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52266	10.1371/journal.pone.0052266	http://dx.doi.org/10.1371/journal.pone.0052266			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300630	Green Published, gold, Green Submitted			2022-12-27	WOS:000313618800063
J	Suchodolski, JS; Markel, ME; Garcia-Mazcorro, JF; Unterer, S; Heilmann, RM; Dowd, SE; Kachroo, P; Ivanov, I; Minamoto, Y; Dillman, EM; Steiner, JM; Cook, AK; Toresson, L				Suchodolski, Jan S.; Markel, Melissa E.; Garcia-Mazcorro, Jose F.; Unterer, Stefan; Heilmann, Romy M.; Dowd, Scot E.; Kachroo, Priyanka; Ivanov, Ivan; Minamoto, Yasushi; Dillman, Enricka M.; Steiner, Joerg M.; Cook, Audrey K.; Toresson, Linda			The Fecal Microbiome in Dogs with Acute Diarrhea and Idiopathic Inflammatory Bowel Disease	PLOS ONE			English	Article							MOLECULAR-PHYLOGENETIC CHARACTERIZATION; RNA GENE ANALYSIS; REAL-TIME PCR; SMALL-INTESTINE; HEALTHY DOGS; CLOSTRIDIUM-PERFRINGENS; GASTROINTESTINAL-TRACT; CHRONIC ENTEROPATHIES; BACTERIAL MICROBIOTA; RAPID DETECTION	Background: Recent molecular studies have revealed a highly complex bacterial assembly in the canine intestinal tract. There is mounting evidence that microbes play an important role in the pathogenesis of acute and chronic enteropathies of dogs, including idiopathic inflammatory bowel disease (IBD). The aim of this study was to characterize the bacterial microbiota in dogs with various gastrointestinal disorders. Methodology/Principal Findings: Fecal samples from healthy dogs (n = 32), dogs with acute non-hemorrhagic diarrhea (NHD; n = 12), dogs with acute hemorrhagic diarrhea (AHD; n = 13), and dogs with active (n = 9) and therapeutically controlled idiopathic IBD (n = 10) were analyzed by 454-pyrosequencing of the 16S rRNA gene and qPCR assays. Dogs with acute diarrhea, especially those with AHD, had the most profound alterations in their microbiome, as significant separations were observed on PCoA plots of unweighted Unifrac distances. Dogs with AHD had significant decreases in Blautia, Ruminococcaceae including Faecalibacterium, and Turicibacter spp., and significant increases in genus Sutterella and Clostridium perfringens when compared to healthy dogs. No significant separation on PCoA plots was observed for the dogs with IBD. Faecalibacterium spp. and Fusobacteria were, however, decreased in the dogs with clinically active IBD, but increased during time periods of clinically insignificant IBD, as defined by a clinical IBD activity index (CIBDAI). Conclusions: Results of this study revealed a bacterial dysbiosis in fecal samples of dogs with various GI disorders. The observed changes in the microbiome differed between acute and chronic disease states. The bacterial groups that were commonly decreased during diarrhea are considered to be important short-chain fatty acid producers and may be important for canine intestinal health. Future studies should correlate these observed phylogenetic differences with functional changes in the intestinal microbiome of dogs with defined disease phenotypes.	[Suchodolski, Jan S.; Markel, Melissa E.; Heilmann, Romy M.; Minamoto, Yasushi; Steiner, Joerg M.] Texas A&M Univ, Gastrointestinal Lab, Coll Vet Med & Biomed Sci, College Stn, TX 77843 USA; [Garcia-Mazcorro, Jose F.] Univ Autonoma Nuevo Leon Gral Escobedo, Fac Med Vet, Nuevo Leon, Mexico; [Unterer, Stefan] Univ Munich, Clin Small Anim Med, Munich, Germany; [Dowd, Scot E.] Mol Res DNA Lab, Shallowater, TX USA; [Toresson, Linda] Helsingborg Referral Anim Hosp, Helsingborg, Sweden	Texas A&M University System; Texas A&M University College Station; University of Munich	Suchodolski, JS (corresponding author), Texas A&M Univ, Gastrointestinal Lab, Coll Vet Med & Biomed Sci, College Stn, TX 77843 USA.	jsuchodolski@cvm.tamu.edu	Garcia-Mazcorro, Jose F/O-5799-2018; Dowd, Scot E/M-5386-2017	Garcia-Mazcorro, Jose F/0000-0001-6047-4361; Dowd, Scot E/0000-0002-6296-1427; Suchodolski, Jan/0000-0002-2176-6932; Cook, Audrey/0000-0002-2840-6497; Unterer, Stefan/0000-0003-0447-3174				Allenspach K, 2010, VET MICROBIOL, V146, P326, DOI 10.1016/j.vetmic.2010.05.025; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Bansal T, 2010, P NATL ACAD SCI USA, V107, P228, DOI 10.1073/pnas.0906112107; Bell J. A., 2008, INTERDISCIP PERSPECT, DOI [10.1155/2008/149694, DOI 10.1155/2008/149694.PMID:19282974]; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chaban B, 2012, MICROB ECOL, V63, P348, DOI 10.1007/s00248-011-9931-7; Chapkin RS, 2010, AM J PHYSIOL-GASTR L, V298, pG582, DOI 10.1152/ajpgi.00004.2010; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Fukuda S, 2012, GUT MICROBES, V3, P449, DOI [10.4161.gmic.21214, 10.4161/gmic.21214]; Garcia-Mazcorro JF, 2012, MICROBIOLOGYOPEN, V1, P340, DOI 10.1002/mbo3.36; Garcia-Mazcorro JF, 2012, FEMS MICROBIOL ECOL, V80, P624, DOI 10.1111/j.1574-6941.2012.01331.x; Gontcharova Viktoria, 2010, Open Microbiol J, V4, P47, DOI 10.2174/1874285801004010047; Gurjar AA, 2008, MOL CELL PROBE, V22, P90, DOI 10.1016/j.mcp.2007.08.001; Handl S, 2011, FEMS MICROBIOL ECOL, V76, P301, DOI 10.1111/j.1574-6941.2011.01058.x; Houser BA, 2010, FOODBORNE PATHOG DIS, V7, P719, DOI 10.1089/fpd.2009.0483; Jergens AE, 2003, J VET INTERN MED, V17, P291, DOI 10.1892/0891-6640(2003)017&lt;0291:ASIFDA&gt;2.3.CO;2; Jia J, 2010, FEMS MICROBIOL ECOL, V71, P304, DOI 10.1111/j.1574-6941.2009.00812.x; Kachroo P, 2011, DIGEST DIS SCI, V56, P2595, DOI 10.1007/s10620-011-1652-8; Kempf C, 2010, TIERAERZTL PRAX K H, V38, P79; Lubbs DC, 2009, J ANIM PHYSIOL AN N, V93, P113, DOI 10.1111/j.1439-0396.2007.00788.x; Malinen E, 2005, AM J GASTROENTEROL, V100, P373, DOI 10.1111/j.1572-0241.2005.40312.x; Marks SL, 2011, J VET INTERN MED, V25, P1195, DOI 10.1111/j.1939-1676.2011.00821.x; Muhling M, 2008, ISME J, V2, P379, DOI 10.1038/ismej.2007.97; Packey CD, 2009, CURR OPIN INFECT DIS, V22, P292, DOI 10.1097/QCO.0b013e32832a8a5d; Pryde SE, 2002, FEMS MICROBIOL LETT, V217, P133, DOI 10.1016/S0378-1097(02)01106-0; Ritchie LE, 2008, FEMS MICROBIOL ECOL, V66, P590, DOI 10.1111/j.1574-6941.2008.00609.x; Ritchie LE, 2010, VET MICROBIOL, V144, P140, DOI 10.1016/j.vetmic.2009.12.045; Sima C, 2011, BIOINFORMATICS, V27, P3056, DOI 10.1093/bioinformatics/btr518; Simpson KW, 2011, VET CLIN N AM-SMALL, V41, P381, DOI 10.1016/j.cvsm.2011.02.003; Sokol H, 2009, INFLAMM BOWEL DIS, V15, P1183, DOI 10.1002/ibd.20903; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Suchodolski JS, 2011, J ANIM SCI, V89, P1520, DOI 10.2527/jas.2010-3377; Suchodolski JS, 2008, FEMS MICROBIOL ECOL, V66, P567, DOI 10.1111/j.1574-6941.2008.00521.x; Suchodolski JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039333; Suchodolski JS, 2010, VET MICROBIOL, V142, P394, DOI 10.1016/j.vetmic.2009.11.002; Suchodolski JS, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-210; Suchodolski JS, 2008, VET MICROBIOL, V132, P379, DOI 10.1016/j.vetmic.2008.05.017; Unterer S, 2011, J VET INTERN MED, V25, P973, DOI 10.1111/j.1939-1676.2011.00765.x; Weese JS, 2011, VET CLIN N AM-SMALL, V41, P287, DOI 10.1016/j.cvsm.2010.12.005; Wise MG, 2005, APPL ENVIRON MICROB, V71, P3911, DOI 10.1128/AEM.71.7.3911-3916.2005; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Xenoulis PG, 2008, FEMS MICROBIOL ECOL, V66, P579, DOI 10.1111/j.1574-6941.2008.00556.x	43	255	264	3	130	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e51907	10.1371/journal.pone.0051907	http://dx.doi.org/10.1371/journal.pone.0051907			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300577	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000313618800036
J	Xu, B; Sathitsuksanoh, N; Tang, YH; Udvardi, MK; Zhang, JY; Shen, ZX; Balota, M; Harich, K; Zhang, PYH; Zhao, BY				Xu, Bin; Sathitsuksanoh, Noppadon; Tang, Yuhong; Udvardi, Michael K.; Zhang, Ji-Yi; Shen, Zhengxing; Balota, Maria; Harich, Kim; Zhang, Percival Y-H; Zhao, Bingyu			Overexpression of AtLOV1 in Switchgrass Alters Plant Architecture, Lignin Content, and Flowering Time	PLOS ONE			English	Article							FERMENTABLE SUGAR YIELDS; ZINC-FINGER PROTEIN; TRANSCRIPTION-FACTOR; TRANSLATIONAL GENOMICS; PANICUM-VIRGATUM; GENE ENCODES; BIOENERGY PRODUCTION; BIOMASS YIELD; ARABIDOPSIS; BIOSYNTHESIS	Background: Switchgrass (Panicum virgatum L.) is a prime candidate crop for biofuel feedstock production in the United States. As it is a self-incompatible polyploid perennial species, breeding elite and stable switchgrass cultivars with traditional breeding methods is very challenging. Translational genomics may contribute significantly to the genetic improvement of switchgrass, especially for the incorporation of elite traits that are absent in natural switchgrass populations. Methodology/Principal Findings: In this study, we constitutively expressed an Arabidopsis NAC transcriptional factor gene, LONG VEGETATIVE PHASE ONE (AtLOV1), in switchgrass. Overexpression of AtLOV1 in switchgrass caused the plants to have a smaller leaf angle by changing the morphology and organization of epidermal cells in the leaf collar region. Also, overexpression of AtLOV1 altered the lignin content and the monolignol composition of cell walls, and caused delayed flowering time. Global gene-expression analysis of the transgenic plants revealed an array of responding genes with predicted functions in plant development, cell wall biosynthesis, and flowering. Conclusions/Significance: To our knowledge, this is the first report of a single ectopically expressed transcription factor altering the leaf angle, cell wall composition, and flowering time of switchgrass, therefore demonstrating the potential advantage of translational genomics for the genetic improvement of this crop.	[Xu, Bin; Shen, Zhengxing; Zhao, Bingyu] Virginia Tech, Dept Hort, Blacksburg, VA 24061 USA; [Sathitsuksanoh, Noppadon; Zhang, Percival Y-H] Virginia Tech, Dept Biol Syst Engn, Blacksburg, VA USA; [Tang, Yuhong; Udvardi, Michael K.; Zhang, Ji-Yi] Samuel Roberts Noble Fdn Inc, Div Plant Biol, Ardmore, OK USA; [Balota, Maria] Virginia Tech, Dept Plant Pathol Plant Physiol & Weed Sci, Blacksburg, VA USA; [Harich, Kim] Virginia Tech, Dept Biochem, Blacksburg, VA USA; [Tang, Yuhong; Udvardi, Michael K.; Zhang, Ji-Yi] US DOE, BESC BioEnergy Sci Ctr, Ardmore, OK USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Noble Research Institute; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; United States Department of Energy (DOE); Oak Ridge National Laboratory; BioEnergy Science Center (BESC)	Zhao, BY (corresponding author), Virginia Tech, Dept Hort, Blacksburg, VA 24061 USA.	bzhao07@vt.edu	sathitsuksanoh, noppadon/O-6305-2014; Udvardi, Michael/GPX-4653-2022	sathitsuksanoh, noppadon/0000-0003-1521-9155; Udvardi, Michael/0000-0001-9850-0828; Tang, Yuhong/0000-0003-2967-778X	Department of Energy [DE-FG02-08ER64629]; Institute for Critical Technology and Applied Science at Virginia Tech; Biodesign and Bioprocessing Research Center of the College of Agriculture and Life Sciences at Virginia Tech; Virginia Agricultural Experimental Station [VA135872]; College of Agriculture and Life Sciences at Virginia Tech; Department of Energy through the BioEnergy Science Center	Department of Energy(United States Department of Energy (DOE)); Institute for Critical Technology and Applied Science at Virginia Tech; Biodesign and Bioprocessing Research Center of the College of Agriculture and Life Sciences at Virginia Tech; Virginia Agricultural Experimental Station; College of Agriculture and Life Sciences at Virginia Tech; Department of Energy through the BioEnergy Science Center(United States Department of Energy (DOE))	This work was supported by grants from the Department of Energy (DE-FG02-08ER64629), the Institute for Critical Technology and Applied Science at Virginia Tech, the Biodesign and Bioprocessing Research Center of the College of Agriculture and Life Sciences at Virginia Tech, the Virginia Agricultural Experimental Station (VA135872). This activity was funded, in part, with an integrated, internal competitive grant from the College of Agriculture and Life Sciences at Virginia Tech. It was also supported by Department of Energy through the BioEnergy Science Center to M. Udvardi, Y. Tang and J.-Y. Zhang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H., 2007, ENCY MEASUREMENT STA, V3, P103; Aharoni A, 2004, PLANT CELL, V16, P2463, DOI 10.1105/tpc.104.022897; Ambavaram MMR, 2011, PLANT PHYSIOL, V155, P916, DOI 10.1104/pp.110.168641; Boateng AA, 2008, IND ENG CHEM RES, V47, P4115, DOI 10.1021/ie800096g; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Bush DR, 2007, PLANT CELL, V19, P2971, DOI 10.1105/tpc.107.191040; Candela H, 2008, PLANT CELL, V20, P2073, DOI 10.1105/tpc.108.059709; Casler MD, 2007, CROP SCI, V47, P2249, DOI 10.2135/cropsci2006.12.0780; Casler MD, 2004, CROP SCI, V44, P293, DOI 10.2135/cropsci2004.2930; Century K, 2008, PLANT PHYSIOL, V147, P20, DOI 10.1104/pp.108.117887; Chen F, 2007, NAT BIOTECHNOL, V25, P759, DOI 10.1038/nbt1316; Chiang VL, 2006, ENVIRON CHEM LETT, V4, P143, DOI 10.1007/s10311-006-0067-9; Christensen AH, 1996, TRANSGENIC RES, V5, P213, DOI 10.1007/BF01969712; Colasanti J, 1998, CELL, V93, P593, DOI 10.1016/S0092-8674(00)81188-5; Demura T, 2010, CURR OPIN PLANT BIOL, V13, P299, DOI 10.1016/j.pbi.2010.03.002; Dence CW, 1992, METHODS LIGNIN CHEM, P33, DOI DOI 10.1007/978-3-642-74065-7_3; Dozmorov I, 2003, BIOINFORMATICS, V19, P204, DOI 10.1093/bioinformatics/19.2.204; Eckardt NA, 2010, PLANT CELL, V22, P2103, DOI 10.1105/tpc.110.220710; Emery JF, 2003, CURR BIOL, V13, P1768, DOI 10.1016/j.cub.2003.09.035; Eshed Y, 2004, DEVELOPMENT, V131, P2997, DOI 10.1242/dev.01186; Fu CX, 2012, PLANT BIOTECHNOL J, V10, P443, DOI 10.1111/j.1467-7652.2011.00677.x; Fu CX, 2011, P NATL ACAD SCI USA, V108, P3803, DOI 10.1073/pnas.1100310108; Fu CX, 2011, BIOENERG RES, V4, P153, DOI 10.1007/s12155-010-9109-z; Hong Z, 2002, PLANT J, V32, P495, DOI 10.1046/j.1365-313X.2002.01438.x; Hu HH, 2006, P NATL ACAD SCI USA, V103, P12987, DOI 10.1073/pnas.0604882103; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jedlicka P, 1997, EMBO J, V16, P2452, DOI 10.1093/emboj/16.9.2452; Jensen MK, 2010, BIOCHEM J, V426, P183, DOI 10.1042/BJ20091234; Jensen MK, 2010, PLANT SIGNAL BEHAV, V5, P907, DOI 10.4161/psb.5.7.12099; Kang Y, 2011, PLANT J; Keskiaho K, 2007, PLANT CELL, V19, P256, DOI 10.1105/tpc.106.042739; Lawrence CJ, 2007, PLANT CELL, V19, P2091, DOI 10.1105/tpc.107.053660; Lemus R, 2002, BIOMASS BIOENERG, V23, P433, DOI 10.1016/S0961-9534(02)00073-9; Madakadze IC, 1998, BIOMASS BIOENERG, V15, P475, DOI 10.1016/S0961-9534(98)00060-9; Masle J, 2005, NATURE, V436, P866, DOI 10.1038/nature03835; McLaughlin SB, 2005, BIOMASS BIOENERG, V28, P515, DOI 10.1016/j.biombioe.2004.05.006; Meng X, 2011, PLANT CELL, V23, P942, DOI 10.1105/tpc.110.081406; Morinaka Y, 2006, PLANT PHYSIOL, V141, P924, DOI 10.1104/pp.106.077081; Mosesson Y, 2009, DEV CELL, V16, P687, DOI 10.1016/j.devcel.2009.03.015; Ooka H, 2003, DNA RES, V10, P239, DOI 10.1093/dnares/10.6.239; Parrish DJ, 2005, CRIT REV PLANT SCI, V24, P423, DOI 10.1080/07352680500316433; Rastogi S, 2008, PLANT SCI, V174, P264, DOI 10.1016/j.plantsci.2007.11.014; Reguera M, 2011, BIOCH BIOPHYS ACTA; Robinson AR, 2009, PLANT J, V58, P706, DOI 10.1111/j.1365-313X.2009.03808.x; Saathoff AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016416; Sakamoto T, 2006, NAT BIOTECHNOL, V24, P105, DOI 10.1038/nbt1173; Salentijn EMJ, 2007, MOL BREEDING, V20, P1, DOI 10.1007/s11032-006-9069-3; Shi ZY, 2007, PLANTA, V226, P99, DOI 10.1007/s00425-006-0472-0; Simmons BA, 2010, CURR OPIN PLANT BIOL, V13, P313, DOI 10.1016/j.pbi.2010.03.001; Sinclair TR, 1999, SCIENCE, V283, P1456; Sluiter A, 2004, DETERMINATION STRUCT; Takeda S, 2008, NAT REV GENET, V9, P444, DOI 10.1038/nrg2342; Tamaki S, 2007, SCIENCE, V316, P1033, DOI 10.1126/science.1141753; Tesso T, 2011, FIELD CROP RES, V120, P271, DOI 10.1016/j.fcr.2010.10.015; Tobias CM, 2005, THEOR APPL GENET, V111, P956, DOI 10.1007/s00122-005-0030-3; Torii KU, 1996, PLANT CELL, V8, P735, DOI 10.1105/tpc.8.4.735; Van Esbroeck GA, 1998, CROP SCI, V38, P342, DOI 10.2135/cropsci1998.0011183X003800020010x; VanEsbroeck GA, 1997, CROP SCI, V37, P864, DOI 10.2135/cropsci1997.0011183X003700030028x; Vogel KP, 2008, CROP SCI, V48, P2159, DOI 10.2135/cropsci2008.02.0117; Wang L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003521; Xu B, 2011, NEW PHYTOL, V192, P611, DOI 10.1111/j.1469-8137.2011.03830.x; Xu B, 2011, SCI HORTIC-AMSTERDAM, V129, P854, DOI 10.1016/j.scienta.2011.05.016; Xue GP, 2011, MOL PLANT, V4, P697, DOI 10.1093/mp/ssr013; Yamamuro C, 2000, PLANT CELL, V12, P1591, DOI 10.1105/tpc.12.9.1591; Yang XC, 2008, HEREDITY, V101, P396, DOI 10.1038/hdy.2008.90; Yoo SY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000642; Zhang GH, 2009, PLANT CELL, V21, P719, DOI 10.1105/tpc.108.061457; Zhao Q, 2011, TRENDS PLANT SCI, V16, P227, DOI 10.1016/j.tplants.2010.12.005; Zhao QA, 2010, PLANT J, V63, P100, DOI 10.1111/j.1365-313X.2010.04223.x; Zhou JL, 2009, PLANT CELL, V21, P248, DOI 10.1105/tpc.108.063321	70	35	36	3	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e47399	10.1371/journal.pone.0047399	http://dx.doi.org/10.1371/journal.pone.0047399			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300513	Green Published, gold			2022-12-27	WOS:000313618800002
J	Yin, J; Shine, L; Raycroft, F; Deeti, S; Reynolds, A; Ackerman, KM; Glaviano, A; O'Farrell, S; O'Leary, O; Kilty, C; Kennedy, C; McLoughlin, S; Rice, M; Russell, E; Higgins, DG; Hyde, DR; Kennedy, BN				Yin, Jun; Shine, Lisa; Raycroft, Francis; Deeti, Sudhakar; Reynolds, Alison; Ackerman, Kristin M.; Glaviano, Antonino; O'Farrell, Sean; O'Leary, Olivia; Kilty, Claire; Kennedy, Ciaran; McLoughlin, Sarah; Rice, Megan; Russell, Eileen; Higgins, Desmond G.; Hyde, David R.; Kennedy, Breandan N.			Inhibition of the Pim1 Oncogene Results in Diminished Visual Function	PLOS ONE			English	Article							CILIARY NEUROTROPHIC FACTOR; GENE-EXPRESSION; PROTOONCOGENE PIM-1; JAK/STAT PATHWAY; SWISS-MODEL; C-MYC; ZEBRAFISH; MUTATIONS; KINASE; ROLES	Our objective was to profile genetic pathways whose differential expression correlates with maturation of visual function in zebrafish. Bioinformatic analysis of transcriptomic data revealed Jak-Stat signalling as the pathway most enriched in the eye, as visual function develops. Real-time PCR, western blotting, immunohistochemistry and in situ hybridization data confirm that multiple Jak-Stat pathway genes are up-regulated in the zebrafish eye between 3-5 days post-fertilisation, times associated with significant maturation of vision. One of the most up-regulated Jak-Stat genes is the proto-oncogene Pim1 kinase, previously associated with haematological malignancies and cancer. Loss of function experiments using Pim1 morpholinos or Pim1 inhibitors result in significant diminishment of visual behaviour and function. In summary, we have identified that enhanced expression of Jak-Stat pathway genes correlates with maturation of visual function and that the Pim1 oncogene is required for normal visual function.	[Yin, Jun; Higgins, Desmond G.] Natl Univ Ireland Univ Coll Dublin, UCD Sch Med & Med Sci, UCD Conway Inst, Dublin 4, Ireland; [Shine, Lisa; Deeti, Sudhakar; Reynolds, Alison; Glaviano, Antonino; O'Farrell, Sean; O'Leary, Olivia; Kilty, Claire; Kennedy, Ciaran; McLoughlin, Sarah; Rice, Megan; Russell, Eileen; Kennedy, Breandan N.] Natl Univ Ireland Univ Coll Dublin, UCD Sch Biomol & Biomed Sci, UCD Conway Inst, Dublin 4, Ireland; [Raycroft, Francis; Ackerman, Kristin M.; Hyde, David R.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Raycroft, Francis; Ackerman, Kristin M.; Hyde, David R.] Univ Notre Dame, Ctr Zebrafish Res, Notre Dame, IN 46556 USA	University College Dublin; University College Dublin; University of Notre Dame; University of Notre Dame	Kennedy, BN (corresponding author), Natl Univ Ireland Univ Coll Dublin, UCD Sch Biomol & Biomed Sci, UCD Conway Inst, Dublin 4, Ireland.	brendan.kennedy@ucd.ie	kennedy, Breandan/H-5643-2019; Yin, Jun/A-7502-2010	kennedy, Breandan/0000-0001-7991-4689; Yin, Jun/0000-0003-4543-1229; Kennedy, Ciaran/0000-0003-1967-8754; wang, jun/0000-0002-0926-4761; Reynolds, Alison/0000-0002-3147-0094; Higgins, Des/0000-0002-3952-3285	Irish Research Council for Science Engineering and Technology (IRCSET) Graduate Education Programme (GREP); Science Foundation Ireland (SFI) [SFI 04/IN3/B559, SFI 06/RFP/BIM052]	Irish Research Council for Science Engineering and Technology (IRCSET) Graduate Education Programme (GREP); Science Foundation Ireland (SFI)(Science Foundation Ireland)	The authors thank the Irish Research Council for Science Engineering and Technology (IRCSET) Graduate Education Programme (GREP), and Science Foundation Ireland (SFI) SFI 04/IN3/B559 (BK), and SFI 06/RFP/BIM052 (BK) for funding support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman KM, 2009, DEV DYNAM, V238, P980, DOI 10.1002/dvdy.21912; Adachi M, 1998, LEUKEMIA LYMPHOMA, V30, P483, DOI 10.3109/10428199809057561; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alvarez Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007867; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Arshavsky VY, 2002, TRENDS NEUROSCI, V25, P124, DOI 10.1016/S0166-2236(00)02094-4; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Babel I, 2009, MOL CELL PROTEOMICS, V8, P2382, DOI 10.1074/mcp.M800596-MCP200; Bachmann M, 2005, INT J BIOCHEM CELL B, V37, P726, DOI 10.1016/j.biocel.2004.11.005; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Betz A, 2001, P NATL ACAD SCI USA, V98, P9563, DOI 10.1073/pnas.171302098; Bilotta J, 2001, DEV DYNAM, V222, P564, DOI 10.1002/dvdy.1188; Blanco-Aparicio C, 2010, CANC LETT; BRANCHEK T, 1984, J COMP NEUROL, V224, P116, DOI 10.1002/cne.902240110; Brockerhoff SE, 2006, NAT PROTOC, V1, P2448, DOI 10.1038/nprot.2006.255; Chen XP, 2002, P NATL ACAD SCI USA, V99, P2175, DOI 10.1073/pnas.042035699; Chiang WF, 2006, INT J ORAL MAX SURG, V35, P740, DOI 10.1016/j.ijom.2006.01.027; Daiger S., 1998, INVESTIG OPHTHALMOL, V39; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Ding C, 2011, MOL MICROBIOL; Dryja TP, 1997, INVEST OPHTH VIS SCI, V38, P1972; Easter SS, 1996, DEV BIOL, V180, P646; Easter SS, 1997, DEV PSYCHOBIOL, V31, P267, DOI 10.1002/(SICI)1098-2302(199712)31:4<267::AID-DEV4>3.0.CO;2-P; Ebong S, 2004, MOL VIS, V10, P122; Eichmann A, 2000, ONCOGENE, V19, P1215, DOI 10.1038/sj.onc.1203355; EMRAN F, 2008, J VIS EXP; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Griffith AJ, 2000, ARCH OTOLARYNGOL, V126, P891, DOI 10.1001/archotol.126.7.891; Grosdidier A, 2011, NUCL ACIDS RES; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Haider S, 2009, NUCLEIC ACIDS RES, V37, pW23, DOI 10.1093/nar/gkp265; Heidelberger R, 2005, PROG RETIN EYE RES, V24, P682, DOI 10.1016/j.preteyeres.2005.04.002; Houlden H, 2003, NEUROLOGY, V61, P1423, DOI 10.1212/01.WNL.0000094120.09977.92; HUANG SH, 1995, NAT GENET, V11, P468, DOI 10.1038/ng1295-468; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kassen SC, 2007, DEV NEUROBIOL, V67, P1009, DOI 10.1002/dneu.20362; Kisseleva T, 2002, GENE, V285, P1, DOI 10.1016/S0378-1119(02)00398-0; Kovanen PE, 2003, J BIOL CHEM, V278, P5205, DOI 10.1074/jbc.M209015200; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Long AA, 2010, J CELL SCI, V123, P3303, DOI 10.1242/jcs.069468; Losman J, 1999, COLD SPRING HARB SYM, V64, P405, DOI 10.1101/sqb.1999.64.405; Luo H, 2001, BIOESSAYS, V23, P1138, DOI 10.1002/bies.10016; McAlinden A, 2008, HUM MUTAT, V29, P83, DOI 10.1002/humu.20603; Merkel Anna Lena, 2012, Expert Opin Investig Drugs, V21, P425, DOI 10.1517/13543784.2012.668527; Ozawa Y, 2007, DEV BIOL, V303, P591, DOI 10.1016/j.ydbio.2006.11.032; Payne AM, 2001, J MED GENET, V38, P611, DOI 10.1136/jmg.38.9.611; Peltola KJ, 2004, BLOOD, V103, P3744, DOI 10.1182/blood-2003-09-3126; PERRIMON N, 1986, DEV BIOL, V118, P28, DOI 10.1016/0012-1606(86)90070-9; Peterson WM, 2000, J NEUROSCI, V20, P4081; Rajan P, 1996, J NEUROSCI RES, V43, P403, DOI 10.1002/(SICI)1097-4547(19960215)43:4<403::AID-JNR2>3.0.CO;2-J; Reiser-Erkan C, 2008, CANCER BIOL THER, V7, P1352, DOI 10.4161/cbt.7.9.6418; Rhee KD, 2003, MOL VIS, V9, P715; Saszik S, 1999, VISUAL NEUROSCI, V16, P881, DOI 10.1017/S0952523899165076; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Schmitt EA, 1999, J COMP NEUROL, V404, P515; Shirogane T, 1999, IMMUNITY, V11, P709, DOI 10.1016/S1074-7613(00)80145-4; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sprague J, 2008, NUCLEIC ACIDS RES, V36, pD768, DOI 10.1093/nar/gkm956; STAHL N, 1994, J NEUROBIOL, V25, P1454, DOI 10.1002/neu.480251111; Stout BA, 2004, J IMMUNOL, V173, P6409, DOI 10.4049/jimmunol.173.10.6409; VANLOHUIZEN M, 1989, CELL, V56, P673, DOI 10.1016/0092-8674(89)90589-8; Veldman MB, 2007, DEV BIOL, V312, P596, DOI 10.1016/j.ydbio.2007.09.019; Vihtelic TS, 1999, VISUAL NEUROSCI, V16, P571, DOI 10.1017/S0952523899163168; Westbrook J, 2003, NUCLEIC ACIDS RES, V31, P489, DOI 10.1093/nar/gkg068; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yin J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-50; Zeidler MP, 2000, ONCOGENE, V19, P2598, DOI 10.1038/sj.onc.1203482; Zippo A, 2007, NAT CELL BIOL, V9, P932, DOI 10.1038/ncb1618	72	23	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52177	10.1371/journal.pone.0052177	http://dx.doi.org/10.1371/journal.pone.0052177			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300608	Green Published, Green Submitted, gold			2022-12-27	WOS:000313618800052
J	Lalwani, MK; Sharma, M; Singh, AR; Chauhan, RK; Patowary, A; Singh, N; Scaria, V; Sivasubbu, S				Lalwani, Mukesh Kumar; Sharma, Meenakshi; Singh, Angom Ramcharan; Chauhan, Rajendra Kumar; Patowary, Ashok; Singh, Naresh; Scaria, Vinod; Sivasubbu, Sridhar			Reverse Genetics Screen in Zebrafish Identifies a Role of miR-142a-3p in Vascular Development and Integrity	PLOS ONE			English	Article							VE-CADHERIN; IN-VIVO; CELL JUNCTIONS; MICRORNA EXPRESSION; LMO2; ANGIOGENESIS; MATURATION	MicroRNAs are a well-studied class of non-coding RNA and are known to regulate developmental processes in eukaryotes. Their role in key biological processes such as vasculature development has attracted interest. However, a comprehensive understanding of molecular regulation of angiogenesis and vascular integrity during development remains less explored. Here we identified miRNAs involved in the development and maintenance of vasculature in zebrafish embryos using a reverse genetics approach. Using a combination of bioinformatics predictions and literature based evidences we mined over 701 Human and 329 Zebrafish miRNAs to derive a list of 29 miRNAs targeting vascular specific genes in zebrafish. We shortlisted eight miRNAs and investigated their potential role in regulating vascular development in zebrafish transgenic model. In this screen we identified three miRNAs, namely miR-1, miR-144 and miR-142a-3p that have the potential to influence vascular development in zebrafish. We show that miR-142a-3p mediates vascular integrity and developmental angiogenesis in vivo. Overexpression of miR-142a-3p results in loss of vascular integrity, hemorrhage and vascular remodeling during zebrafish embryonic development, while loss of function of miR-142a-3p causes abnormal vascular remodeling. MiR-142a-3p functions in part by directly repressing cdh5 (VE-cadherin). The vascular abnormalities that results from modulation of miR-142a-3p are reminiscent of cdh5 perturbation in zebrafish embryos. We also demonstrate that the action of miR-142a on cdh5 is potentially regulated by Lmo2, an important transcription factor, known for its role in vasculature development. The miR142a-3p mediated control of cdh5 constitutes an additional layer of regulation for maintaining vascular integrity and developmental angiogenesis. These findings have implications in development, wound repair and tumor growth.	[Sharma, Meenakshi; Scaria, Vinod] CSIR Inst Genom & Integrat Biol, GN Ramachandran Knowledge Ctr Genome Informat, Delhi, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Scaria, V (corresponding author), CSIR Inst Genom & Integrat Biol, GN Ramachandran Knowledge Ctr Genome Informat, Delhi, India.	vinods@igib.res.in; s.sivasubbu@igib.res.in	Patowary, Ashok/AAT-5305-2020; Scaria, Vinod/B-2819-2008; Scaria, Vinod/AAS-3151-2021	Patowary, Ashok/0000-0001-7507-3907; Scaria, Vinod/0000-0001-7644-7181; Chauhan, Rajendra Kumar/0000-0002-3904-5332	Council of Scientific and Industrial Research (CSIR), India [NWP0036, FAC002]; CSIR, India	Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); CSIR, India(Council of Scientific & Industrial Research (CSIR) - India)	The authors acknowledge funding from the Council of Scientific and Industrial Research (CSIR), India through the NWP0036 and FAC002 Grant. MKL acknowledges senior research fellowships from CSIR, India. The funding organization had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bahary N, 2007, BLOOD, V110, P3627, DOI 10.1182/blood-2006-04-016378; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; Bendoraite A, 2010, GYNECOL ONCOL, V116, P117, DOI 10.1016/j.ygyno.2009.08.009; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Corada M, 2002, BLOOD, V100, P905, DOI 10.1182/blood.V100.3.905; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004; Deleuze V, 2007, MOL CELL BIOL, V27, P2687, DOI 10.1128/MCB.00493-06; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; Fu YF, 2009, BLOOD, V113, P1340, DOI 10.1182/blood-2008-08-174854; Garzon R, 2008, CURR OPIN HEMATOL, V15, P352, DOI 10.1097/MOH.0b013e328303e15d; Garzon R, 2010, NAT REV DRUG DISCOV, V9, P775, DOI 10.1038/nrd3179; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Gory-Faure S, 1999, DEVELOPMENT, V126, P2093; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Harris ES, 2010, CURR OPIN CELL BIOL, V22, P651, DOI 10.1016/j.ceb.2010.07.006; Hyatt TM, 1999, METHOD CELL BIOL, V59, P117; Isogai S, 2001, DEV BIOL, V230, P278, DOI 10.1006/dbio.2000.9995; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li HQ, 2010, J NEUROSCI, V30, P3254, DOI 10.1523/JNEUROSCI.4948-09.2010; Mishima Y, 2009, GENE DEV, V23, P619, DOI 10.1101/gad.1760209; Mitchell IC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008807; Montero-Balaguer M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005772; Nicoli S, 2007, CANCER RES, V67, P2927, DOI 10.1158/0008-5472.CAN-06-4268; Nishiyama T, 2012, BIOCHEM BIOPH RES CO, V425, P755, DOI 10.1016/j.bbrc.2012.07.148; Nyqvist D, 2008, EMBO REP, V9, P742, DOI 10.1038/embor.2008.123; Pase Luke, 2009, V546, P227, DOI 10.1007/978-1-60327-977-2_14; Pase L, 2009, BLOOD, V113, P1794, DOI 10.1182/blood-2008-05-155812; Patterson LJ, 2007, BLOOD, V109, P2389, DOI 10.1182/blood-2006-02-003087; Shi R, 2005, BIOTECHNIQUES, V39, P519, DOI 10.2144/000112010; Sivasubbu S, 2006, MECH DEVELOP, V123, P513, DOI 10.1016/j.mod.2006.06.002; Sprague J, 2008, NUCLEIC ACIDS RES, V36, pD768, DOI 10.1093/nar/gkm956; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Wu LF, 2011, FEBS LETT, V585, P1322, DOI 10.1016/j.febslet.2011.03.067; Yang WJ, 2005, J BIOL CHEM, V280, P9330, DOI 10.1074/jbc.M413394200; Yuan W, 2008, LEUKEMIA, V22, P1067, DOI 10.1038/sj.leu.2405001; Zeng L, 2009, P NATL ACAD SCI USA, V106, P17793, DOI 10.1073/pnas.0903693106; Zou J, 2011, CIRC RES, V108, P201, DOI 10.1161/CIRCRESAHA.110.225045	48	33	36	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52588	10.1371/journal.pone.0052588	http://dx.doi.org/10.1371/journal.pone.0052588			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285103	Green Published, gold, Green Submitted			2022-12-27	WOS:000313158800078
J	Padmanabhan, PK; Dumas, C; Samant, M; Rochette, A; Simard, MJ; Papadopoulou, B				Padmanabhan, Prasad K.; Dumas, Carole; Samant, Mukesh; Rochette, Annie; Simard, Martin J.; Papadopoulou, Barbara			Novel Features of a PIWI-Like Protein Homolog in the Parasitic Protozoan Leishmania	PLOS ONE			English	Article							RNA INTERFERENCE RNAI; APOPTOSIS-LIKE DEATH; PIRNA PATHWAY; ARGONAUTE PROTEINS; GENE-EXPRESSION; MESSENGER-RNAS; LOCALIZATION; TRANSLATION; DEFENSE; GENOME	In contrast to nearly all eukaryotes, the Old World Leishmania species L. infantum and L. major lack the bona fide RNAi machinery genes. Interestingly, both Leishmania genomes code for an atypical Argonaute-like protein that possesses a PIWI domain but lacks the PAZ domain found in Argonautes from RNAi proficient organisms. Using sub-cellular fractionation and confocal fluorescence microscopy, we show that unlike other eukaryotes, the PIWI-like protein is mainly localized in the single mitochondrion in Leishmania. To predict PIWI function, we generated a knockout mutant for the PIWI gene in both L. infantum (Lin) and L. major species by double-targeted gene replacement. Depletion of PIWI has no effect on the viability of insect promastigote forms but leads to an important growth defect of the mammalian amastigote lifestage in vitro and significantly delays disease pathology in mice, consistent with a higher expression of the PIWI transcript in amastigotes. Moreover, amastigotes lacking PIWI display a higher sensitivity to apoptosis inducing agents than wild type parasites, suggesting that PIWI may be a sensor for apoptotic stimuli. Furthermore, a whole-genome DNA microarray analysis revealed that loss of LinPIWI in Leishmania amastigotes affects mostly the expression of specific subsets of developmentally regulated genes. Several transcripts encoding surface and membrane-bound proteins were found downregulated in the LinPIWI ((-/-)) mutant whereas all histone transcripts were upregulated in the null mutant, supporting the possibility that PIWI plays a direct or indirect role in the stability of these transcripts. Although our data suggest that PIWI is not involved in the biogenesis or the stability of small noncoding RNAs, additional studies are required to gain further insights into the role of this protein on RNA regulation and amastigote development in Leishmania.	[Padmanabhan, Prasad K.; Dumas, Carole; Samant, Mukesh; Papadopoulou, Barbara] Univ Laval, Fac Med, Res Ctr Infect Dis, CHUL Res Ctr CHUQ, Quebec City, PQ G1K 7P4, Canada; [Padmanabhan, Prasad K.; Dumas, Carole; Samant, Mukesh; Papadopoulou, Barbara] Univ Laval, Fac Med, Dept Microbiol & Immunol, Quebec City, PQ G1K 7P4, Canada; [Rochette, Annie] INRS Inst Armand Frappier, Laval, PQ, Canada; [Simard, Martin J.] Univ Laval, Canc Res Ctr, Hotel Dieu Quebec CHUQ, Quebec City, PQ, Canada	Laval University; Laval University; University of Quebec; Institut national de la recherche scientifique (INRS); Laval University	Papadopoulou, B (corresponding author), Univ Laval, Fac Med, Res Ctr Infect Dis, CHUL Res Ctr CHUQ, Quebec City, PQ G1K 7P4, Canada.	barbara.papadopoulou@crchul.ulaval.ca		Simard, Martin/0000-0002-3189-9309	CIHR [MOP-12182]; Canadian Institutes of Health Research (CIHR) [STP-53924]; Centre for Host-Parasite Interactions (CHPI)	CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Centre for Host-Parasite Interactions (CHPI)	This work was supported by CIHR operating grant MOP-12182 awarded to BP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are thankful to Dr Osvaldo de Melo Neto for providing us with an antibody against the mitochondrial HSP70 protein. PP was a recipient of a postdoctoral fellowship from the Canadian Institutes of Health Research (CIHR) Strategic Training Program STP-53924 and the Centre for Host-Parasite Interactions (CHPI). M.J.S. is a Fonds de Recherche du Quebec-Sante Junior 2 Scholar supported by CIHR. BP is a member of the Centre for Host-Parasite Interactions 'Programme Regroupements Strategiques' of the Fonds de Quebec pour la Recherche sur la Nature et les Technologies.	Aravin AA, 2008, MOL CELL, V31, P785, DOI 10.1016/j.molcel.2008.09.003; Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Aravin AA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000764; Bagijn MP, 2012, SCIENCE, V337, P574, DOI 10.1126/science.1220952; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Bringaud F, 2007, PLOS PATHOG, V3, P1291, DOI 10.1371/journal.ppat.0030136; Brower-Toland B, 2007, GENE DEV, V21, P2300, DOI 10.1101/gad.1564307; Campos RM, 2008, MOL BIOCHEM PARASIT, V160, P157, DOI 10.1016/j.molbiopara.2008.04.013; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Chung WJ, 2008, CURR BIOL, V18, P795, DOI 10.1016/j.cub.2008.05.006; Cox DN, 2000, DEVELOPMENT, V127, P503; Darlyuk I, 2009, J BIOL CHEM, V284, P19800, DOI 10.1074/jbc.M901066200; DaRocha WD, 2004, MOL BIOCHEM PARASIT, V133, P175, DOI 10.1016/j.molbiopara.2003.10.005; Das M, 2001, J CELL SCI, V114, P2461; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Dumas C, 2006, EUKARYOT CELL, V5, P2033, DOI 10.1128/EC.00147-06; Foucher AL, 2006, J PROTEOME RES, V5, P1741, DOI 10.1021/pr060081j; Silva MRG, 2010, GENE, V466, P26, DOI 10.1016/j.gene.2010.06.012; GENSKE JE, 1991, MOL CELL BIOL, V11, P240, DOI 10.1128/MCB.11.1.240; Girard A, 2008, TRENDS CELL BIOL, V18, P136, DOI 10.1016/j.tcb.2008.01.004; Grivna ST, 2006, P NATL ACAD SCI USA, V103, P13415, DOI 10.1073/pnas.0605506103; GueirosFilho FJ, 1996, MOL CELL BIOL, V16, P5655; Haile S, 2007, CURR OPIN MICROBIOL, V10, P569, DOI 10.1016/j.mib.2007.10.001; HAJDUK SL, 1993, FASEB J, V7, P54, DOI 10.1096/fasebj.7.1.8422975; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hock J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-210; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Kolev NG, 2011, EUKARYOT CELL, V10, P1156, DOI 10.1128/EC.05114-11; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Lee JH, 2006, HUM MOL GENET, V15, P201, DOI 10.1093/hmg/ddi430; Lim AK, 2009, J CELL BIOL, V186, P333, DOI 10.1083/jcb.200904063; Lingel A, 2003, NATURE, V426, P465, DOI 10.1038/nature02123; Liu BY, 2005, TRENDS PARASITOL, V21, P363, DOI 10.1016/j.pt.2005.06.008; Lye LF, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001161; Makarova KS, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-29; McNicoll F, 2005, J BIOL CHEM, V280, P35238, DOI 10.1074/jbc.M507511200; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Muller M, 2010, NUCLEIC ACIDS RES, V38, P5867, DOI 10.1093/nar/gkq349; Noll TM, 1997, MOL BIOCHEM PARASIT, V84, P215, DOI 10.1016/S0166-6851(96)02801-0; Nowotny M, 2005, CELL, V121, P1005, DOI 10.1016/j.cell.2005.04.024; Ohrt T, 2012, CURR TOP MED CHEM, V12, P79, DOI 10.2174/156802612798919132; Olivier M, 2012, MICROBES INFECT; Padmanabhan PK, 2012, CELL DEATH DIFFER, V19, P1972, DOI 10.1038/cdd.2012.85; PAPADOPOULOU B, 1994, MOL BIOCHEM PARASIT, V65, P39, DOI 10.1016/0166-6851(94)90113-9; Paris C, 2004, ANTIMICROB AGENTS CH, V48, P852, DOI 10.1128/AAC.48.3.852-859.2004; Parker JS, 2006, TRENDS BIOCHEM SCI, V31, P622, DOI 10.1016/j.tibs.2006.09.010; Parker JS, 2004, EMBO J, V23, P4727, DOI 10.1038/sj.emboj.7600488; Peacock CS, 2007, NAT GENET, V39, P839, DOI 10.1038/ng2053; Robinson KA, 2003, MOL BIOCHEM PARASIT, V128, P217, DOI 10.1016/S0166-6851(03)00079-3; Rochette Annie, 2008, BMC Genomics, V9, P255, DOI 10.1186/1471-2164-9-255; Rochette A, 2009, MOL BIOCHEM PARASIT, V165, P32, DOI 10.1016/j.molbiopara.2008.12.012; Rodriguez-Contreras D, 2007, MOL BIOCHEM PARASIT, V153, P9, DOI 10.1016/j.molbiopara.2007.01.010; Rodriguez-Contreras D, 2006, J BIOL CHEM, V281, P20068, DOI 10.1074/jbc.M603265200; Rouget C, 2010, NATURE, V467, P1128, DOI 10.1038/nature09465; Sambrook J., 2001, MOL CLONING LAB MANU; Sereno D, 2001, ANTIMICROB AGENTS CH, V45, P1168, DOI 10.1128/AAC.45.4.1168-1173.2001; Sereno D, 2001, ANTIMICROB AGENTS CH, V45, P2064, DOI 10.1128/AAC.45.7.2064-2069.2001; SHAW JM, 1989, P NATL ACAD SCI USA, V86, P6220, DOI 10.1073/pnas.86.16.6220; Simonelig M, 2011, RNA BIOL, V8; Soto M, 2003, PARASITOLOGY, V127, P95, DOI 10.1017/S0031182003003445; Soto M, 1997, MOL BIOCHEM PARASIT, V90, P439, DOI 10.1016/S0166-6851(97)00178-3; Soto M, 1996, BIOCHEM J, V318, P813, DOI 10.1042/bj3180813; Thomson T, 2009, ANNU REV CELL DEV BI, V25, P355, DOI 10.1146/annurev.cellbio.24.110707.175327; Tolia NH, 2007, NAT CHEM BIOL, V3, P36, DOI 10.1038/nchembio848; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wanasen N, 2007, INFECT IMMUN, V75, P2802, DOI 10.1128/IAI.00026-07; Wei KF, 2012, J CELL BIOCHEM, V113, P2576, DOI 10.1002/jcb.24133; Yin H, 2007, NATURE, V450, P304, DOI 10.1038/nature06263; ZAMZAMI N, 1995, J EXP MED, V182, P367, DOI 10.1084/jem.182.2.367	74	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52612	10.1371/journal.pone.0052612	http://dx.doi.org/10.1371/journal.pone.0052612			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285111	Green Published, Green Submitted, gold			2022-12-27	WOS:000313158800081
J	Sanchez-Chavez, G; Pena-Rangel, MT; Riesgo-Escovar, JR; Martinez-Martinez, A; Salceda, R				Sanchez-Chavez, Gustavo; Teresa Pena-Rangel, Ma.; Riesgo-Escovar, Juan R.; Martinez-Martinez, Alejandro; Salceda, Rocio			Insulin Stimulated-Glucose Transporter Glut 4 Is Expressed in the Retina	PLOS ONE			English	Article							RECEPTOR BETA-SUBUNIT; IN-VIVO REGULATION; PLASMA-MEMBRANE; OUTER SEGMENTS; GROWTH-FACTORS; RAT RETINA; HUMAN EYE; PIGMENT EPITHELIUM; DIABETIC-RATS; MOUSE-BRAIN	The vertebrate retina is a very metabolically active tissue whose energy demands are normally met through the uptake of glucose and oxygen. Glucose metabolism in this tissue relies upon adequate glucose delivery from the systemic circulation. Therefore, glucose transport depends on the expression of glucose transporters. Here, we show retinal expression of the Glut 4 glucose transporter in frog and rat retinas. Immunohistochemistry and in situ hybridization studies showed Glut 4 expression in the three nuclear layers of the retina: the photoreceptor, inner nuclear and ganglionar cell layers. In the rat retina immunoprecipitation and Western blot analysis revealed a protein with an apparent molecular mass of 45 kDa. C-14-glucose accumulation by isolated rat retinas was significantly enhanced by physiological concentrations of insulin, an effect blocked by inhibitors of phosphatidyl-inositol 3-kinase (PI3K), a key enzyme in the insulin-signaling pathway in other tissues. Also, we observed an increase in 3(H)-cytochalasin binding sites in the presence of insulin, suggesting an increase in transporter recruitment at the cell surface. Besides, insulin induced phosphorylation of Akt, an effect also blocked by PI3K inhibition. Expression of Glut 4 was not modified in retinas of a type 1 diabetic rat model. To our knowledge, our results provide the first evidence of Glut4 expression in the retina, suggesting it as an insulin-responsive tissue.	[Sanchez-Chavez, Gustavo; Salceda, Rocio] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Div Neurociencias, Mexico City 04510, DF, Mexico; [Teresa Pena-Rangel, Ma.; Riesgo-Escovar, Juan R.] Univ Nacl Autonoma Mexico, Inst Neurobiol, Dept Neurobiol Desarrollo & Neurofisiol, Queretaro, Mexico; [Martinez-Martinez, Alejandro] Univ Autonoma Ciudad Juarez, Juarez, Chihuahua, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Autonoma de Ciudad Juarez	Salceda, R (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Div Neurociencias, Mexico City 04510, DF, Mexico.	rsalceda@ifc.unam.mx	Martinez-Martinez, Alejandro/N-1161-2018	Martinez-Martinez, Alejandro/0000-0003-3448-910X; Sanchez-Chavez, Gustavo/0000-0002-1331-9358	Direccion General de Asuntos del Personal Academico/Programa de Apoyo a Proyectos de Investigacione Innovacion Tecnologica UNAM/DGAPA/PAPIIT [IN207810-3]; Consejo Nacional de Ciencia y Tecnologia CONACYT [81864]	Direccion General de Asuntos del Personal Academico/Programa de Apoyo a Proyectos de Investigacione Innovacion Tecnologica UNAM/DGAPA/PAPIIT; Consejo Nacional de Ciencia y Tecnologia CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was partially supported by a grant from the Direccion General de Asuntos del Personal Academico/Programa de Apoyo a Proyectos de Investigacione Innovacion Tecnologica UNAM/DGAPA/PAPIIT (IN207810-3) to Rocio Salceda; and from Consejo Nacional de Ciencia y Tecnologia CONACYT protect # 81864 to Juan Rafael Riesgo-Escovar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Velazquez-Flores MA, 2011, SYNAPSE, V65, P1231, DOI 10.1002/syn.20963; BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O; Barrett D, 2003, J NEUROSCI, V23, P5740; Benomar Y, 2006, ENDOCRINOLOGY, V147, P2550, DOI 10.1210/en.2005-1464; BETZ AL, 1983, EXP EYE RES, V36, P269, DOI 10.1016/0014-4835(83)90011-8; Bugner V, 2011, DEV DYNAM, V240, P1705, DOI 10.1002/dvdy.22659; Choeiri C, 2006, BEHAV BRAIN RES, V172, P233, DOI 10.1016/j.bbr.2006.05.005; Choeiri C, 2002, NEUROSCIENCE, V111, P19, DOI 10.1016/S0306-4522(01)00619-4; CUSHMAN SW, 1980, J BIOL CHEM, V255, P4758; DEPABLO F, 1995, TRENDS NEUROSCI, V18, P143, DOI 10.1016/0166-2236(95)93892-2; Diaz B, 2000, DEVELOPMENT, V127, P1641; Diggs-Andrews KA, 2010, DIABETES, V59, P2271, DOI 10.2337/db10-0401; Emery M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021586; FRANK RN, 1995, PROG RETIN EYE RES, V14, P361, DOI 10.1016/1350-9462(94)00011-4; Gomez O, 2010, J ANAT, V217, P616, DOI 10.1111/j.1469-7580.2010.01291.x; Graymore C., 1970, BIOCH RETINA; Grillo CA, 2009, BRAIN RES, V1296, P35, DOI 10.1016/j.brainres.2009.08.005; HARDIN DS, 1993, METABOLISM, V42, P1310, DOI 10.1016/0026-0495(93)90130-G; HAYES KC, 1975, SCIENCE, V188, P949, DOI 10.1126/science.1138364; HSU SC, 1991, J BIOL CHEM, V266, P21745; Im SS, 2007, IUBMB LIFE, V59, P134, DOI 10.1080/15216540701313788; Ishiki M, 2005, ENDOCRINOLOGY, V146, P5071, DOI 10.1210/en.2005-0850; Khan MI, 2011, VISION RES, V51, P1623, DOI 10.1016/j.visres.2011.05.003; KING GL, 1985, J CLIN INVEST, V75, P1028, DOI 10.1172/JCI111764; KOIVISTO VA, 1993, J APPL PHYSIOL, V74, P1755, DOI 10.1152/jappl.1993.74.4.1755; KUMAGAI AK, 1994, INVEST OPHTH VIS SCI, V35, P2887; LI XB, 1994, EXP EYE RES, V59, P351, DOI 10.1006/exer.1994.1117; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MANTYCH GJ, 1993, ENDOCRINOLOGY, V133, P600, DOI 10.1210/en.133.2.600; MARETTE A, 1992, AM J PHYSIOL, V263, pC443, DOI 10.1152/ajpcell.1992.263.2.C443; McNamara CR, 2011, FUTURE MED CHEM, V3, P549, DOI [10.4155/fmc.11.12, 10.4155/FMC.11.12]; Piroli GG, 2007, NEUROENDOCRINOLOGY, V85, P71, DOI 10.1159/000101694; Rajala RVS, 2002, J BIOL CHEM, V277, P43319, DOI 10.1074/jbc.M206355200; Rajala RVS, 2001, INVEST OPHTH VIS SCI, V42, P3110; ROSENZWEIG SA, 1990, J BIOL CHEM, V265, P18030; Salceda R, 1998, NEUROCHEM RES, V23, P893, DOI 10.1023/A:1022467230259; Salceda R, 1999, NEUROCHEM INT, V35, P301, DOI 10.1016/S0197-0186(99)00072-8; Saltiel AR, 2002, TRENDS CELL BIOL, V12, P65, DOI 10.1016/S0962-8924(01)02207-3; Sanchez-Chavez G, 2008, NEUROCHEM RES, V33, P1301, DOI 10.1007/s11064-007-9583-7; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; TAKATA K, 1990, BIOCHEM BIOPH RES CO, V173, P67, DOI 10.1016/S0006-291X(05)81022-8; Pena-Rangel MT, 2008, NEUROREPORT, V19, P1295, DOI 10.1097/WNR.0b013e32830a9618; Thorens B, 2010, AM J PHYSIOL-ENDOC M, V298, pE141, DOI 10.1152/ajpendo.00712.2009; Umino Y, 2006, P NATL ACAD SCI USA, V103, P19541, DOI 10.1073/pnas.0604478104; Vilchis C, 1996, NEUROCHEM INT, V28, P213, DOI 10.1016/0197-0186(95)00068-2; WALDBILLIG RJ, 1987, EXP EYE RES, V45, P837, DOI 10.1016/S0014-4835(87)80100-8; WATANABE T, 1994, BRAIN RES, V655, P128, DOI 10.1016/0006-8993(94)91606-3	47	18	18	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52959	10.1371/journal.pone.0052959	http://dx.doi.org/10.1371/journal.pone.0052959			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285235	Green Published, gold, Green Submitted			2022-12-27	WOS:000313158800109
J	Abella, V; Valladares, M; Rodriguez, T; Haz, M; Blanco, M; Tarrio, N; Iglesias, P; Aparicio, LA; Figueroa, A				Abella, Vanessa; Valladares, Manuel; Rodriguez, Teresa; Haz, Mar; Blanco, Moises; Tarrio, Nuria; Iglesias, Pilar; Aparicio, Luis A.; Figueroa, Angelica			miR-203 Regulates Cell Proliferation through Its Influence on Hakai Expression	PLOS ONE			English	Article							MOLECULE E-CADHERIN; MICRORNA TARGETS; BLADDER-CANCER; ADHESION; PROTEIN; MIRNA; RNA; INVASIVENESS; INHIBITION; MECHANISM	Gene expression is potently regulated through the action of microRNAs (miRNAs). Here, we present evidence of a miRNA regulating Hakai protein. Hakai was discovered as an E3 ubiquitin-ligase that mediates the posttranslational downregulation of E-cadherin, a major component of adherens junctions in epithelial cells and a potent tumour suppressor. Recent data have provided evidence that Hakai affects cell proliferation in an E-cadherin-independent manner, thus revealing a role for Hakai in the early stages of tumour progression. Furthermore, Hakai is highly up-regulated in human colon adenocarcinomas compared to normal tissues. However, the molecular mechanisms that regulate Hakai abundance are unknown. We identified two putative sites of miR-203 interaction on the Hakai mRNA, in its 3'-untranslated region (UTR). In several human carcinoma cell lines tested, overexpression of a miR-203 precursor (Pre-miR-203) reduced Hakai abundance, while inhibiting miR-203 by using an antisense RNA (Anti-miR-203) elevated Hakai levels. The repressive influence of miR-203 on the Hakai 3'-UTR was confirmed using heterologous reporter constructs. In keeping with Hakai's proliferative influence, Anti-miR-203 significantly increased cell number and BrdU incorporation, while Pre-miR-203 reduced these parameters. Importantly, the growth-promoting effects of anti-miR-203 required the presence of Hakai, because downregulation of Hakai by siRNA suppressed its proliferative action. Finally, in situ hybridization showed that miR-203 expression is attenuated in colon tumour tissues compared to normal colon tissues, suggesting that miR-203 could be a potential new prognostic marker and therapeutic target to explore in colon cancer. In conclusion, our findings reveal, for the first time, a post-transcriptional regulator of Hakai expression. Furthermore, by lowering Hakai abundance, miR-203 also reduces Hakai-regulated-cell division.	[Abella, Vanessa; Valladares, Manuel; Rodriguez, Teresa; Haz, Mar; Blanco, Moises; Aparicio, Luis A.; Figueroa, Angelica] Complexo Hosp Univ A Coruna CHUAC SERGAS, Inst Invest Biomed A Coruna INIBIC, Translat Canc Res Grp, La Coruna, Spain; [Valladares, Manuel; Aparicio, Luis A.] CHUAC SERGAS, Med Oncol Unit, La Coruna, Spain; [Tarrio, Nuria] Hosp Univ Marques de Valdecilla, Clin Trials Serv, Santander, Cantabria, Spain; [Iglesias, Pilar] CHUAC SERGAS, Dept Pathol, La Coruna, Spain	Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Instituto de Investigacion Biomedica de A Coruna (INIBIC); Complejo Hospitalario Universitario A Coruna; Hospital Universitario Marques de Valdecilla (HUMV); Complejo Hospitalario Universitario A Coruna	Figueroa, A (corresponding author), Complexo Hosp Univ A Coruna CHUAC SERGAS, Inst Invest Biomed A Coruna INIBIC, Translat Canc Res Grp, La Coruna, Spain.	angelica.figueroa.conde-valvis@sergas.es	Figueroa, Angelica/ABD-7705-2020; Martín, Teresa Rodríguez/GZL-1938-2022; Blanco-Calvo, Moisés/F-5476-2013; Valladares-Ayerbes, Manuel/K-8986-2014	Figueroa, Angelica/0000-0001-5530-5213; Blanco-Calvo, Moisés/0000-0001-9153-6895; Valladares-Ayerbes, Manuel/0000-0002-7950-9584; Abella Cajigal, Vanessa/0000-0002-3658-7208	Conselleria de Sanidade from Xunta de Galicia, Spain [PS09/24]; Secretaria Xeral I+D+I from Xunta de Galicia, Spain [10CSA916023PR]; Rede Galega de Investigacion sobre Cancro Colorrectal (REGICC), Xunta de Galicia, Spain; Instituto de Salud Carlos III, Spain [CA09/00116]; Secretaria Xeral I+D+I, Xunta de Galicia, Spain [IPP.08-07]	Conselleria de Sanidade from Xunta de Galicia, Spain; Secretaria Xeral I+D+I from Xunta de Galicia, Spain; Rede Galega de Investigacion sobre Cancro Colorrectal (REGICC), Xunta de Galicia, Spain; Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III); Secretaria Xeral I+D+I, Xunta de Galicia, Spain(Xunta de Galicia)	This work is supported by a grant from Conselleria de Sanidade (PS09/24) and from Secretaria Xeral I+D+I, (10CSA916023PR), both from Xunta de Galicia, Spain. V.A. is the recipient of a grant from Secretaria Xeral I+D+I, Xunta de Galicia, Spain (10CSA916023PR). T. R. was the recipient of a grant from Rede Galega de Investigacion sobre Cancro Colorrectal (REGICC), Xunta de Galicia, Spain. M. H. is supported by Instituto de Salud Carlos III, Spain (CA09/00116). A. F. is the recipient of a grant from Secretaria Xeral I+D+I, Xunta de Galicia, Spain (IPP.08-07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2008, P NATL ACAD SCI USA, V105, P20297, DOI 10.1073/pnas.0809376106; Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Aparicio LA, 2012, CANC METASTASIS REV; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berx G., 2009, COLD SPRING HARB PER, V1; BIRCHMEIER W, 1994, BBA-REV CANCER, V1198, P11, DOI 10.1016/0304-419X(94)90003-5; Bo JJ, 2011, FEBS J, V278, P786, DOI 10.1111/j.1742-4658.2010.07997.x; Bueno MJ, 2008, CANCER CELL, V13, P496, DOI 10.1016/j.ccr.2008.04.018; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Christofori G, 1999, TRENDS BIOCHEM SCI, V24, P73, DOI 10.1016/S0968-0004(98)01343-7; Croce CM, 2008, NEW ENGL J MED, V358, P502, DOI 10.1056/NEJMra072367; Deng S, 2008, CELL CYCLE, V7, P2643, DOI 10.4161/cc.7.17.6597; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; Fan SJ, 2001, ONCOGENE, V20, P77, DOI 10.1038/sj.onc.1204073; Figueroa A, 2009, CELL CYCLE, V8, P3648, DOI 10.4161/cc.8.22.9909; Figueroa A, 2009, MOL BIOL CELL, V20, P3533, DOI 10.1091/mbc.E08-08-0845; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Furuta M, 2010, CARCINOGENESIS, V31, P766, DOI 10.1093/carcin/bgp250; Gennarino VA, 2009, GENOME RES, V19, P481, DOI 10.1101/gr.084129.108; Gong E, 2010, CANC SCI; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hartsock A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037476; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Johnsen SA, 2009, CANCER RES, V69, P128, DOI 10.1158/0008-5472.CAN-08-1630; Kaido M, 2009, GENES CELLS, V14, P1067, DOI 10.1111/j.1365-2443.2009.01335.x; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lena AM, 2008, CELL DEATH DIFFER, V15, P1187, DOI 10.1038/cdd.2008.69; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li JA, 2011, CANCER LETT, V304, P52, DOI 10.1016/j.canlet.2011.02.003; Meltzer PS, 2005, NATURE, V435, P745, DOI 10.1038/435745a; Mukherjee M., 2012, EMBO J, DOI emboj2011496; Palacios F, 2005, MOL CELL BIOL, V25, P389, DOI 10.1128/MCB.25.1.389-402.2005; Papadopoulos GL, 2009, NUCLEIC ACIDS RES, V37, pD155, DOI 10.1093/nar/gkn809; Reczko M, 2012, BIOINFORMATICS, V28, P771, DOI 10.1093/bioinformatics/bts043; Rodriguez-Rigueiro T, 2011, PROTEOMICS; Rodriguez-Rigueiro T, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-474; Saini S, 2011, CANCER PREV RES, V4, P1698, DOI 10.1158/1940-6207.CAPR-11-0267; Saini S, 2011, CLIN CANCER RES, V17, P5287, DOI 10.1158/1078-0432.CCR-10-2619; van Roy F, 2008, CELL MOL LIFE SCI, V65, P3756, DOI 10.1007/s00018-008-8281-1; Vergoulis T, 2012, NUCLEIC ACIDS RES, V40, pD222, DOI 10.1093/nar/gkr1161; Viticchie G, 2011, CELL CYCLE, V10, P1121, DOI 10.4161/cc.10.7.15180; Yang JY, 2006, MOL CELL BIOL, V26, P7269, DOI 10.1128/MCB.00172-06; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642	48	31	33	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52568	10.1371/journal.pone.0052568	http://dx.doi.org/10.1371/journal.pone.0052568			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285092	Green Submitted, gold, Green Published			2022-12-27	WOS:000312794500198
J	Chan, DW; Hui, WWY; Cai, PCH; Liu, MX; Yung, MMH; Mak, CSL; Leung, THY; Chan, KKL; Ngan, HYS				Chan, David W.; Hui, Winnie W. Y.; Cai, Patty C. H.; Liu, Michelle X.; Yung, Mingo M. H.; Mak, Celia S. L.; Leung, Thomas H. Y.; Chan, Karen K. L.; Ngan, Hextan Y. S.			Targeting GRB7/ERK/FOXM1 Signaling Pathway Impairs Aggressiveness of Ovarian Cancer Cells	PLOS ONE			English	Article							CYCLIC PEPTIDE INHIBITOR; GROWTH-FACTOR RECEPTOR; RAF-MEK-ERK; TRANSCRIPTION FACTOR; TRANSDUCTION PROTEIN; ESOPHAGEAL-CARCINOMA; GRB7 FAMILY; SH2 DOMAIN; LOW-GRADE; IN-VITRO	Ovarian cancer is a highly lethal disease with poor prognosis and especially in high-grade tumor. Emerging evidence has reported that aberrant upregulation and activation of GRB7, ERK as well as FOXM1 are closely associated with aggresivenesss of human cancers. However, the interplay between these factors in the pathogenesis of human cancers still remains unclear. In this study, we found that GRB7 (P<0.0001), ERK phosphorylation (P<0.0001) and FOXM1 (P = 0.001) were frequently increased and associated with high-grade tumors, as well as a high tendency in association with advanced stage ovarian cancer by immunohistochemical analysis. Intriguingly, the expressions of GRB7 (P<0.0001), ERK phosphorylation (P<0.001) and FOXM1 (P<0.001) showed a significant stepwise increase pattern along Grade 1 to Grade 3 ovarian cancers. Biochemical studies using western blot analysis demonstrated that enforced expression or knockdown of GRB7 showed GRB7 could elevate the levels of ERK phosphorylation and FOXM1, whereas enforced expression of FOXM1 could not alter levels of GRB7 and ERK phosphorylation. But inhibition of ERK signaling by U0126 or PD98059 could reduce the level of FOXM1 in GRB7-overexpressing ovarian cancer cells, suggesting that GRB7, ERK and FOXM1 are regulated orderly. Moreover, inhibition of ERK activity by U0126 or PD98059, or decreased FOXM1 expression by Thiostrepton significantly inhibited cell migration/invasion, tumor growth in vitro and in vivo. Collectively, our findings confer that targeting GRB7/ERK/FOXM1 signaling cascade may be a promising molecular therapeutic choice in combating ovarian cancer.	[Chan, David W.; Hui, Winnie W. Y.; Cai, Patty C. H.; Liu, Michelle X.; Yung, Mingo M. H.; Mak, Celia S. L.; Leung, Thomas H. Y.; Chan, Karen K. L.; Ngan, Hextan Y. S.] Univ Hong Kong, Dept Obstet & Gynaecol, LKS Fac Med, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Chan, DW (corresponding author), Univ Hong Kong, Dept Obstet & Gynaecol, LKS Fac Med, Hong Kong, Hong Kong, Peoples R China.	dwchan@hku.hk; hysngan@hku.hk	Chan, David/O-9896-2018; YUNG, Mingo Ming Ho/AHB-5775-2022; Chan, Karen/E-4041-2015	Chan, David/0000-0002-6951-3467; YUNG, Mingo Ming Ho/0000-0003-0903-1164; Chan, Karen/0000-0001-9947-4713; Ngan, Hextan Y S/0000-0003-3945-159X	Wong Check She Charitable Foundation	Wong Check She Charitable Foundation	This study was supported by the Wong Check She Charitable Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambaye ND, 2011, J MOL BIOL, V412, P397, DOI 10.1016/j.jmb.2011.07.030; Ambaye ND, 2011, BIOORGAN MED CHEM, V19, P693, DOI 10.1016/j.bmc.2010.10.030; Bai T, 2008, CARCINOGENESIS, V29, P473, DOI 10.1093/carcin/bgm221; Bessard A, 2008, ONCOGENE, V27, P5315, DOI 10.1038/onc.2008.163; Bristow RE, 2010, GYNECOL ONCOL, V118, P262, DOI 10.1016/j.ygyno.2010.05.025; Calvo F, 2010, BIOESSAYS, V32, P412, DOI 10.1002/bies.200900155; Chan DW, 2008, J PATHOL, V215, P245, DOI 10.1002/path.2355; Chan DW, 2008, CARCINOGENESIS, V29, P1742, DOI 10.1093/carcin/bgn167; CY Koo, 2011, BIOCH BIOPHYS ACTA; D'Alo D, 2010, EUR J GYNAECOL ONCOL, V31, P174; Daly RJ, 1998, CELL SIGNAL, V10, P613, DOI 10.1016/S0898-6568(98)00022-9; Giricz O, 2011, BREAST CANC RES TREA; Gunzburg MJ, 2012, J MOL RECOGNIT, V25, P57, DOI 10.1002/jmr.2148; Han DC, 2001, ONCOGENE, V20, P6315, DOI 10.1038/sj.onc.1204775; Johnson TR, 2008, MOL CANCER RES, V6, P1639, DOI 10.1158/1541-7786.MCR-08-0052; Karst AM, 2010, J ONCOL, V2010, DOI 10.1155/2010/932371; Kohno M, 2006, ANN MED, V38, P200, DOI 10.1080/07853890600551037; Koo CY, 2012, BBA-GENE REGUL MECH, V1819, P28, DOI 10.1016/j.bbagrm.2011.09.004; Lo HW, 2010, CURR CANCER DRUG TAR, V10, P840, DOI 10.2174/156800910793357970; Lok GTM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023790; Malpica A, 2004, AM J SURG PATHOL, V28, P496, DOI 10.1097/00000478-200404000-00009; McCubrey JA, 2010, EXPERT OPIN EMERG DR, V15, P203, DOI 10.1517/14728210903282760; Mebratu Y, 2009, CELL CYCLE, V8, P1168, DOI 10.4161/cc.8.8.8147; Montagut C, 2009, CANCER LETT, V283, P125, DOI 10.1016/j.canlet.2009.01.022; O'Neill CJ, 2005, AM J SURG PATHOL, V29, P1034; Pero SC, 2007, BRIT J CANCER, V96, P1520, DOI 10.1038/sj.bjc.6603732; Pero SC, 2002, J BIOL CHEM, V277, P11918, DOI 10.1074/jbc.M111816200; Pero Stephanie C, 2003, Expert Rev Mol Med, V5, P1, DOI 10.1017/S1462399403006227; Porter CJ, 2007, BIOPOLYMERS, V88, P174, DOI 10.1002/bip.20667; Porter CJ, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-58; Priller M, 2011, CLIN CANCER RES, V17, P6791, DOI 10.1158/1078-0432.CCR-11-1214; Ramsey B, 2011, BREAST CANCER RES TR, V127, P659, DOI 10.1007/s10549-010-1010-0; Raychaudhuri P, 2011, CANCER RES, V71, P4329, DOI 10.1158/0008-5472.CAN-11-0640; Saad Antonio F., 2010, Hormones & Cancer, V1, P277, DOI 10.1007/s12672-010-0054-2; Schneiderman D, 1999, APOPTOSIS, V4, P271, DOI 10.1023/A:1008186323178; Steelman LS, 2011, AGING-US, V3, P192, DOI 10.18632/aging.100296; Tanaka S, 2000, J CELL PHYSIOL, V183, P411, DOI 10.1002/(SICI)1097-4652(200006)183:3<411::AID-JCP14>3.0.CO;2-Z; Tanaka S, 2006, JNCI-J NATL CANCER I, V98, P491, DOI 10.1093/jnci/djj105; Tanaka S, 1997, CANCER RES, V57, P28; Trujillo JI, 2011, EXPERT OPIN THER PAT, V21, P1045, DOI 10.1517/13543776.2011.577068; Vang R, 2009, ADV ANAT PATHOL, V16, P267, DOI 10.1097/PAP.0b013e3181b4fffa; Walch A, 2004, INT J CANCER, V112, P747, DOI 10.1002/ijc.20411; Wang YJ, 2010, CLIN CANCER RES, V16, P2529, DOI 10.1158/1078-0432.CCR-10-0018; Wang ZW, 2010, CANCER TREAT REV, V36, P151, DOI 10.1016/j.ctrv.2009.11.006; Wierstra I, 2007, BIOL CHEM, V388, P1257, DOI 10.1515/BC.2007.159; Wu QF, 2010, ACTA PHARMACOL SIN, V31, P361, DOI 10.1038/aps.2010.4; Yokote K, 1996, J BIOL CHEM, V271, P30942, DOI 10.1074/jbc.271.48.30942; Zebisch A, 2007, CURR MED CHEM, V14, P601, DOI 10.2174/092986707780059670; Zhang D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029902; ZYLBERBERG B, 1991, PRESSE MED, V20, P1320	50	41	45	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52578	10.1371/journal.pone.0052578	http://dx.doi.org/10.1371/journal.pone.0052578			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285101	Green Submitted, gold, Green Published			2022-12-27	WOS:000312794500205
J	Hobson, KA; Anderson, RC; Soto, DX; Wassenaar, LI				Hobson, Keith A.; Anderson, R. Charles; Soto, David X.; Wassenaar, Leonard I.			Isotopic Evidence That Dragonflies (Pantala flavescens) Migrating through the Maldives Come from the Northern Indian Subcontinent	PLOS ONE			English	Article							HYDROGEN	Large numbers of the Globe Skimmer dragonfly (Pantala flavescens) appear in the Maldives every October-December. Since they cannot breed on these largely waterless islands, it has recently been suggested that they are "falling out" during a trans-oceanic flight from India to East Africa. In addition, it has been suggested that this trans-oceanic crossing is just one leg of a multi-generational migratory circuit covering about 14,000-18,000 km. The dragonflies are presumed to accomplish this remarkable feat by riding high-altitude winds associated with the Inter-tropical Convergence Zone (ITCZ). While there is considerable evidence for this migratory circuit, much of that evidence is circumstantial. Recent developments in the application of stable isotope analyses to track migratory dragonflies include the establishment of direct associations between dragonfly wing chitin delta H-2 values with those derived from long-term delta H-2 precipitation isoscapes. We applied this approach by measuring wing chitin delta H-2 values in 49 individual Pantala flavescens from the November-December migration through the Maldives. Using a previously established spatial calibration algorithm for dragonflies, the mean wing delta H-2 value of -117 +/- 16 parts per thousand corresponded to a predicted mean natal ambient water source of -81 parts per thousand, which resulted in a probabilistic origin of northern India, and possibly further north and east. This strongly suggests that the migratory circuit of this species in this region is longer than previously suspected, and could possibly involve a remarkable trans-Himalayan high-altitude traverse.	[Hobson, Keith A.; Soto, David X.; Wassenaar, Leonard I.] Environm Canada, Saskatoon, SK, Canada; [Anderson, R. Charles] Manta Marine Pvt Ltd, Male, Maldives; [Soto, David X.] Univ New Brunswick, Canadian Rivers Inst, Fredericton, NB, Canada; [Soto, David X.] Univ New Brunswick, Dept Biol, Fredericton, NB, Canada	Environment & Climate Change Canada; University of New Brunswick; University of New Brunswick	Hobson, KA (corresponding author), Environm Canada, Saskatoon, SK, Canada.	Keith.Hobson@ec.gc.ca	Hobson, Keith/Q-9306-2019; Soto, David X./B-2017-2018; Wassenaar, Leonard/AAY-7081-2020	Soto, David X./0000-0003-4210-293X; Wassenaar, Leonard/0000-0001-5532-0771	Environment Canada	Environment Canada(CGIAR)	The work was supported by Environment Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RC, 2009, J TROP ECOL, V25, P347, DOI 10.1017/S0266467409006087; Bowen GJ, 2005, OECOLOGIA, V143, P337, DOI 10.1007/s00442-004-1813-y; Corbet PS, 2004, DRAGONFLIES BEHAVIOR; Fein JS, 1987, MONSOON; Hobson KA, 2008, TERR ECOL SER, V2, P1; Hobson KA, 2008, TERR ECOL SER, V2, P1, DOI 10.1016/S1936-7961(07)00001-2; Hobson KA, 2012, METHODS ECOL EVOL, V3, P766, DOI 10.1111/j.2041-210X.2012.00202.x; Kumar A., 1984, Annals of Entomology (Dehra Dun), V2, P43; Solensky MJ, 2004, MONARCH BUTTERFLY BIOLOGY AND CONSERVATION, P79; Suhling F, 2004, HYDROBIOLOGIA, V528, P75, DOI 10.1007/s10750-004-3047-8; Vick G.S., 1989, Opuscula Zoologica Fluminensia, P1; Wassenaar LI, 2003, ISOT ENVIRON HEALT S, V39, P211, DOI 10.1080/1025601031000096781; Wikelski M, 2006, BIOL LETTERS, V2, P325, DOI 10.1098/rsbl.2006.0487; WOJTUSIAK J, 1974, Odonatologica, V3, P137	14	53	60	2	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52594	10.1371/journal.pone.0052594	http://dx.doi.org/10.1371/journal.pone.0052594			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285106	Green Submitted, Green Published, gold			2022-12-27	WOS:000312794500207
J	Latasa, MU; Salis, F; Urtasun, R; Garcia-Irigoyen, O; Elizalde, M; Uriarte, I; Santamaria, M; Feo, F; Pascale, RM; Prieto, J; Berasain, C; Avila, MA				Latasa, Maria U.; Salis, Fabiana; Urtasun, Raquel; Garcia-Irigoyen, Oihane; Elizalde, Maria; Uriarte, Iker; Santamaria, Monica; Feo, Francesco; Pascale, Rosa M.; Prieto, Jesus; Berasain, Carmen; Avila, Matias A.			Regulation of Amphiregulin Gene Expression by beta-Catenin Signaling in Human Hepatocellular Carcinoma Cells: A Novel Crosstalk between FGF19 and the EGFR System	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; LIGAND AMPHIREGULIN; LIVER-CANCER; TUMOR-GROWTH; PATHWAY; TARGET; PROLIFERATION; THERAPIES; TRANSACTIVATION; OVEREXPRESSION	Hepatocellular carcinoma (HCC) is the most prevalent liver tumor and a deadly disease with limited therapeutic options. Dysregulation of cell signaling pathways is a common denominator in tumorigenesis, including hepatocarcinogenesis. The epidermal growth factor receptor (EGFR) signaling system is commonly activated in HCC, and is currently being evaluated as a therapeutic target in combination therapies. We and others have identified a central role for the EGFR ligand amphiregulin (AR) in the proliferation, survival and drug resistance of HCC cells. AR expression is frequently up-regulated in HCC tissues and cells through mechanisms not completely known. Here we identify the beta-catenin signaling pathway as a novel mechanism leading to transcriptional activation of the AR gene in human HCC cells. Activation of beta-catenin signaling, or expression of the T41A beta-catenin active mutant, led to the induction of AR expression involving three specific beta-catenin-Tcf responsive elements in its proximal promoter. We demonstrate that HCC cells expressing the T41A b-catenin active mutant show enhanced proliferation that is dependent in part on AR expression and EGFR signaling. We also demonstrate here a novel cross-talk of the EGFR system with fibroblast growth factor 19 (FGF19). FGF19 is a recently identified driver gene in hepatocarcinogenesis and an activator of b-catenin signaling in HCC and colon cancer cells. We show that FGF19 induced AR gene expression through the beta-catenin pathway in human HCC cells. Importantly, AR up-regulation and EGFR signaling participated in the induction of cyclin D1 and cell proliferation elicited by FGF19. Finally, we demonstrate a positive correlation between FGF19 and AR expression in human HCC tissues, therefore supporting in clinical samples our experimental observations. These findings identify the AR/EGFR system as a key mediator of FGF19 responses in HCC cells involving beta-catenin signaling, and suggest that combined targeting of FGF19 and AR/ EGFR may enhance therapeutic efficacy.	[Latasa, Maria U.; Urtasun, Raquel; Garcia-Irigoyen, Oihane; Elizalde, Maria; Santamaria, Monica; Prieto, Jesus; Berasain, Carmen; Avila, Matias A.] Univ Navarra, Div Hepatol & Gene Therapy, Ctr Appl Med Res, E-31080 Pamplona, Spain; [Salis, Fabiana; Feo, Francesco; Pascale, Rosa M.] Univ Sassari, Div Expt Pathol & Oncol, Dept Clin & Expt Med & Oncol, I-07100 Sassari, Italy; [Uriarte, Iker; Prieto, Jesus; Berasain, Carmen; Avila, Matias A.] Univ Navarra, Ctr Invest Biomed Red el Area Temat Enfermedades, Univ Clin, E-31080 Pamplona, Spain	University of Navarra; University of Sassari; University of Navarra	Berasain, C (corresponding author), Univ Navarra, Div Hepatol & Gene Therapy, Ctr Appl Med Res, E-31080 Pamplona, Spain.	cberasain@unav.es; maavila@unav.es	Uriarte, Iker/AFP-1513-2022; URIARTE, IKER/Z-2161-2019; Garcia-Irigoyen, Oihane/HDM-3461-2022; Latasa, Maria Ujue/Z-2178-2019; M., Elizalde/Z-2691-2019; Santamaria, Monica/H-4737-2013; URTASUN, RAQUEL/AAD-1590-2021; Uriarte, Iker/AFP-1514-2022; Avila, Matias A/Y-6342-2019; Berasain, Carmen/E-4139-2016	URIARTE, IKER/0000-0001-5237-7799; Garcia-Irigoyen, Oihane/0000-0002-9964-3940; Latasa, Maria Ujue/0000-0002-0878-1337; M., Elizalde/0000-0002-7636-1836; Avila, Matias A/0000-0001-6570-3557; Berasain, Carmen/0000-0001-7075-2476; URTASUN, RAQUEL/0000-0003-2332-5361; Prieto, Jesus/0000-0002-1091-9593	Fundacion para la Investigacion Medica Aplicada; UTE project Centro de Investigacion Medica Aplicada; Fondo para la Investigacion Sanitaria (FIS) from Instituto de Salud Carlos III [PI070392, PI070402, PI10/00038, PI10/02642]; Ministerio de Educacion; Instituto de Salud Carlos III, FIS [CP04/00123]; Erasmus Program (European Union); Ministerio de Educacion, Cultura y Deporte, Spain	Fundacion para la Investigacion Medica Aplicada; UTE project Centro de Investigacion Medica Aplicada; Fondo para la Investigacion Sanitaria (FIS) from Instituto de Salud Carlos III; Ministerio de Educacion; Instituto de Salud Carlos III, FIS(Instituto de Salud Carlos IIIEuropean Commission); Erasmus Program (European Union); Ministerio de Educacion, Cultura y Deporte, Spain(Spanish Government)	Work in the authors' laboratory is supported by the agreement between Fundacion para la Investigacion Medica Aplicada and the "UTE project Centro de Investigacion Medica Aplicada". Red Tematica de Investigacion Cooperativa en Cancer RD06 00200061 (CB and MAA), Centro de Investigacion Biomedica en Red en el Area tematica de Enfermedades Hepaticas y Digestivas (JP), Fundacion Echebano, Fundacion Barriede la Maza y Condesa de Fenosa, and grants Fondo para la Investigacion Sanitaria (FIS) PI070392, PI070402, PI10/00038 and PI10/02642 from Instituto de Salud Carlos III. MUL and RU were supported by a "Ramon y Cajal" and a "Torres Quevedo" contract from Ministerio de Educacion, respectively. MS was supported by a contract (CP04/00123) from Instituto de Salud Carlos III, FIS. FS was supported by the Erasmus Program (European Union). ME was supported by a fellowship from Gobierno de Navarra. OGI was supported by a Formacion del Profesorado Universitario fellowship from Ministerio de Educacion, Cultura y Deporte, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Avila MA, 2006, ONCOGENE, V25, P3866, DOI 10.1038/sj.onc.1209550; Bade LK, 2011, J CELL SCI, V124, P3106, DOI 10.1242/jcs.082651; Baffy G, 2012, J HEPATOL, V56, P1384, DOI 10.1016/j.jhep.2011.10.027; Baillo A, 2011, J CELL PHYSIOL, V226, P2691, DOI 10.1002/jcp.22620; Bengochea A, 2008, BRIT J CANCER, V99, P143, DOI 10.1038/sj.bjc.6604422; Berasain C, 2007, CANCER LETT, V254, P30, DOI 10.1016/j.canlet.2007.01.015; Berasain C, 2004, BBA-MOL BASIS DIS, V1690, P276, DOI 10.1016/j.bbadis.2004.08.002; Berasain C, 2007, LIVER INT, V27, P174, DOI 10.1111/j.1478-3231.2006.01424.x; Berasain Carmen, 2011, Cancers (Basel), V3, P2444, DOI 10.3390/cancers3022444; Blivet-Van Eggelpoel MJ, 2012, J HEPATOL, V57, P108, DOI 10.1016/j.jhep.2012.02.019; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Breuhahn K, 2010, PROG MOL BIOL TRANSL, V97, P251, DOI 10.1016/B978-0-12-385233-5.00009-X; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Busser B, 2011, BBA-REV CANCER, V1816, P119, DOI 10.1016/j.bbcan.2011.05.003; Calvisi DF, 2012, BBA-REV CANCER, V1826, P215, DOI 10.1016/j.bbcan.2012.04.003; Castillo J, 2006, CANCER RES, V66, P6129, DOI 10.1158/0008-5472.CAN-06-0404; Castillo J, 2009, GASTROENTEROLOGY, V137, P1805, DOI 10.1053/j.gastro.2009.07.065; Civenni G, 2003, EMBO REP, V4, P166, DOI 10.1038/sj.embor.embor735; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; Dahmani R, 2011, CLIN RES HEPATOL GAS, V35, P709, DOI 10.1016/j.clinre.2011.05.010; Desbois-Mouthon C, 2001, ONCOGENE, V20, P252, DOI 10.1038/sj.onc.1204064; Desbois-Mouthon C, 2006, INT J CANCER, V119, P2557, DOI 10.1002/ijc.22221; Desnoyers L, 2008, ONCOGENE, V27, P85, DOI 10.1038/sj.onc.1210623; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; El-Serag HB, 2004, GASTROENTEROLOGY, V127, pS27, DOI 10.1053/j.gastro.2004.09.013; Ezzoukhry Z, 2012, INT J CANC; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; French DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036713; Gauglhofer C, 2011, HEPATOLOGY, V53, P854, DOI 10.1002/hep.24099; Gschwind A, 2003, EMBO J, V22, P2411, DOI 10.1093/emboj/cdg231; Hoshida Y, 2010, SEMIN LIVER DIS, V30, P35, DOI 10.1055/s-0030-1247131; Hoshida Y, 2009, CANCER RES, V69, P7385, DOI 10.1158/0008-5472.CAN-09-1089; Hu TH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-236; Jia HL, 2007, CLIN CANCER RES, V13, P1133, DOI 10.1158/1078-0432.CCR-06-1025; Katoh Y, 2006, INT J MOL MED, V17, P1163; Lee JS, 2006, ONCOGENE, V25, P3801, DOI 10.1038/sj.onc.1209561; Lee JS, 2006, NAT MED, V12, P410, DOI 10.1038/nm1377; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Merle P, 2004, GASTROENTEROLOGY, V127, P1110, DOI 10.1053/j.gastro.2004.07.009; Miura S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-56; Miyamoto S, 2009, ANTICANCER RES, V29, P823; Monga SPS, 2002, CANCER RES, V62, P2064; Nault JC, 2011, SEMIN LIVER DIS, V31, P173, DOI 10.1055/s-0031-1276646; Nejak-Bowen KN, 2011, SEMIN CANCER BIOL, V21, P44, DOI 10.1016/j.semcancer.2010.12.010; Pai R, 2008, CANCER RES, V68, P5086, DOI 10.1158/0008-5472.CAN-07-2325; Pardo-Saganta A, 2009, J HEPATOL, V51, P1010, DOI 10.1016/j.jhep.2009.06.030; Perugorria MJ, 2008, HEPATOLOGY, V48, P1251, DOI 10.1002/hep.22437; PLOWMAN GD, 1990, MOL CELL BIOL, V10, P1969, DOI 10.1128/MCB.10.5.1969; Poh WJ, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-14; Renard CA, 2007, CANCER RES, V67, P901, DOI 10.1158/0008-5472.CAN-06-2344; Sawey ET, 2011, CANCER CELL, V19, P347, DOI 10.1016/j.ccr.2011.01.040; Schlange T, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1769; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Tan XP, 2005, GASTROENTEROLOGY, V129, P285, DOI 10.1053/j.gastro.2005.04.013; Torre C, 2011, J HEPATOL, V55, P86, DOI 10.1016/j.jhep.2010.10.021; Urtasun R, 2011, HEPATOLOGY, V54, P2149, DOI 10.1002/hep.24587; Villanueva A, 2012, CLIN CANCER RES, V18, P1824, DOI 10.1158/1078-0432.CCR-12-0151; Villanueva A, 2011, GASTROENTEROLOGY, V140, P1410, DOI 10.1053/j.gastro.2011.03.006; Vivanco I, 2010, CURR OPIN ONCOL, V22, P573, DOI 10.1097/CCO.0b013e32833edbdf; Wege H, 2011, MOL CANCER RES, V9, P1222, DOI 10.1158/1541-7786.MCR-10-0474; Wei Y, 2000, ONCOGENE, V19, P498, DOI 10.1038/sj.onc.1203356; White BD, 2012, GASTROENTEROLOGY, V142, P219, DOI 10.1053/j.gastro.2011.12.001; Whittaker S, 2010, ONCOGENE, V29, P4989, DOI 10.1038/onc.2010.236; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598; Yuzugullu H, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-90; Zeng G, 2007, NEOPLASIA, V9, P951, DOI 10.1593/neo.07469	69	43	46	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52711	10.1371/journal.pone.0052711	http://dx.doi.org/10.1371/journal.pone.0052711			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285165	Green Published, gold, Green Submitted			2022-12-27	WOS:000312794500238
J	Mueller, JE; Yaro, S; Ouedraogo, MS; Levina, N; Njanpop-Lafourcade, BM; Tall, H; Idohou, RS; Sanou, O; Kroman, SS; Drabo, A; Nacro, B; Millogo, A; van der Linden, M; Gessner, BD				Mueller, Judith E.; Yaro, Seydou; Ouedraogo, Macaire S.; Levina, Natalia; Njanpop-Lafourcade, Berthe-Marie; Tall, Haoua; Idohou, Regina S.; Sanou, Oumarou; Kroman, Sita S.; Drabo, Aly; Nacro, Boubacar; Millogo, Athanase; van der Linden, Mark; Gessner, Bradford D.			Pneumococci in the African Meningitis Belt: Meningitis Incidence and Carriage Prevalence in Children and Adults	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; BURKINA-FASO; SEROTYPE-1; NASOPHARYNGEAL; SURVEILLANCE; OUTBREAK; AGE	Background: The development of optimal vaccination strategies for pneumococcal conjugate vaccines requires serotype-specific data on disease incidence and carriage prevalence. This information is lacking for the African meningitis belt. Methods: We conducted hospital-based surveillance of acute bacterial meningitis in an urban and rural population of Burkina Faso during 2007-09. Cerebrospinal fluid was evaluated by polymerase chain reaction for species and serotype. In 2008, nasopharyngeal swabs were obtained from a representative population sample (1 month to 39 years; N = 519) and additional oropharyngeal swabs from 145 participants. Swabs were evaluated by culture. Results: Annual pneumococcal meningitis incidence rates were highest among <6-month-old (58/100,000) and 15- to 19-year-old persons (15/100,000). Annual serotype 1 incidence was around 5/100,000 in all age groups. Pneumococcal carriage prevalence in nasopharyngeal swabs was 63% among <5-year-old children and 22% among >= 5-year-old persons, but adding oropharyngeal to nasopharyngeal swabs increased the estimated carriage prevalence by 60%. Serotype 1 showed high propensity for invasive disease, particularly among persons aged >= 5 years. Conclusions: Serotype 1 causes the majority of cases with a relatively constant age-specific incidence. Pneumococcal carriage is common in all age groups including adults. Vaccination programs in this region may need to include older target age groups for optimal impact on disease burden.	[Mueller, Judith E.; Njanpop-Lafourcade, Berthe-Marie; Tall, Haoua; Idohou, Regina S.; Sanou, Oumarou; Kroman, Sita S.; Gessner, Bradford D.] Agence Med Prevent, Paris, France; [Yaro, Seydou; Drabo, Aly] Ctr Muraz, Bobo Dioulasso, Burkina Faso; [Ouedraogo, Macaire S.; Nacro, Boubacar; Millogo, Athanase] Ctr Hosp Univ Sourou Sanou, Bobo Dioulasso, Burkina Faso; [Levina, Natalia; van der Linden, Mark] GNRC Streptococci, Aachen, Germany	Agence de Medecine Preventive; Centre Muraz	Gessner, BD (corresponding author), Agence Med Prevent, Paris, France.	bgessner@aamp.org	van der Linden, Mark/B-9305-2009	van der Linden, Mark/0000-0002-6574-4313	PneumoADIP; UK Medical Research Council; Sanofi Pasteur; GSK; Merck; Pfizer; Crucell; MSD	PneumoADIP; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Sanofi Pasteur; GSK(GlaxoSmithKline); Merck(Merck & Company); Pfizer(Pfizer); Crucell; MSD	The meningitis surveillance was supported by Sanofi Pasteur, Hib Initiative, PneumoADIP and the French Ministry of Foreign Affairs. The carriage study was supported by PneumoADIP and made possible through synergies with a seroprevalence study funded by the UK Medical Research Council (to Dr Caroline Trotter, Bristol University). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; JEM, HT, BMNL, RSI, and BDG work for AMP which receives unrestricted support from Sanofi Pasteur and grant specific support from Sanofi Pasteur, GSK, Merck, Pfizer, and Crucell. MVDL received research grants and honoraria from Pfizer, GSK, Sanofi Pasteur, and MSD. No other conflicts exist. For members of AMP, this relation was (and is) indirect via unrestricted funding from Sanofi Pasteur to AMP and specific project funding; no AMP authors have individual conflicts of interest (employment, consultancy, patents, products in development or marketed products etc). MVDL received consultancy and project funding, but not employment, patents, products in development or marketed products. At no time was the funder involved in analyses, interpretation of the results or manuscript writing. Altogether, these relations do not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Brueggemann AB, 2003, J INFECT DIS, V187, P1424, DOI 10.1086/374624; Campagne G, 1999, B WORLD HEALTH ORGAN, V77, P499; Campbell JD, 2004, PEDIATR INFECT DIS J, V23, P642, DOI 10.1097/01.inf.0000130951.85974.79; Carvalho MD, 2010, J CLIN MICROBIOL, V48, P1611, DOI 10.1128/JCM.02243-09; Cisse M F, 1989, Med Trop (Mars), V49, P265; Dagan R, 2000, CLIN INFECT DIS, V30, P319, DOI 10.1086/313645; Darboe MK, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-195; du Chatelet IP, 2005, CLIN INFECT DIS, V40, P17, DOI 10.1086/426436; Fine PEM, 2008, VACCINES, P1573; GARCIA P, 1986, GENE, V43, P265, DOI 10.1016/0378-1119(86)90215-5; Gessner BD, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-22; Hill PC, 2010, CLIN INFECT DIS, V50, P1468, DOI 10.1086/652443; Kaltoft MS, 2008, J MICROBIOL METH, V75, P540, DOI 10.1016/j.mimet.2008.08.010; Lafourcade BMN, 2010, J CLIN MICROBIOL, V48, P612, DOI 10.1128/JCM.01402-09; Lagos R, 2008, J INFECT DIS, V198, P1809, DOI 10.1086/593334; LAPEYSSONNIE L, 1963, Bull World Health Organ, V28 Suppl, P1; Leimkugel J, 2005, J INFECT DIS, V192, P192, DOI 10.1086/431151; Lepoutre A., 2007, Bulletin Epidemiologique Hebdomadaire, P37; Mueller JE, 2010, INT J INFECT DIS, V14, pE553, DOI 10.1016/j.ijid.2009.08.013; Neufeld F, 1902, Z HYG INFEKTIONSKR, V40, P54; O'Brien KL, 2003, PEDIATR INFECT DIS J, V22, P133, DOI [10.1097/00006454-200302000-00009, 10.1097/00006454-200302000-00010]; Rapola S, 1997, J CLIN MICROBIOL, V35, P1077, DOI 10.1128/JCM.35.5.1077-1079.1997; Sjolinder H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014034; Taha MK, 2002, J CLIN MICROBIOL, V40, P1083, DOI 10.1128/JCM.40.3.1083-1084.2002; Tall H, 2012, 8 INT S PNEUM PNEUM; Traore Y, 2009, CLIN INFECT DIS, V48, pS181, DOI 10.1086/596498; Watt JP, 2004, J CLIN MICROBIOL, V42, P4974, DOI 10.1128/JCM.42.11.4974-4976.2004; WHO-AFRO, 2009, STANDARD OPERATING P; . World Health Organization, CHILD GROWTH STAND W; Yaro S, 2008, 6 INT S PNEUM PNEUM, P288	30	44	46	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52464	10.1371/journal.pone.0052464	http://dx.doi.org/10.1371/journal.pone.0052464			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285051	gold, Green Submitted, Green Published			2022-12-27	WOS:000312794500175
J	VanDusen, BM; Fegley, SR; Peterson, CH				VanDusen, Beth M.; Fegley, Stephen R.; Peterson, Charles H.			Prey Distribution, Physical Habitat Features, and Guild Traits Interact to Produce Contrasting Shorebird Assemblages among Foraging Patches	PLOS ONE			English	Article							DUNLINS CALIDRIS-ALPINA; IDEAL FREE DISTRIBUTION; TIDAL CYCLE; DENSITY; WADERS; SELECTION; BEHAVIOR; CHOICE; COMMUNITIES; MANAGEMENT	Worldwide declines in shorebird populations, driven largely by habitat loss and degradation, motivate environmental managers to preserve and restore the critical coastal habitats on which these birds depend. Effective habitat management requires an understanding of the factors that determine habitat use and value to shorebirds, extending from individuals to the entire community. While investigating the factors that influenced shorebird foraging distributions among neighboring intertidal sand flats, we built upon species-level understandings of individual-based, small-scale foraging decisions to develop more comprehensive guild-and community-level insights. We found that densities and community composition of foraging shorebirds varied substantially among elevations within some tidal flats and among five flats despite their proximity (all located within a 400-m stretch of natural, unmodified inlet shoreline). Non-dimensional multivariate analyses revealed that the changing composition of the shorebird community among flats and tidal elevations correlated significantly (rho(s) = 0.56) with the spatial structure of the benthic invertebrate prey community. Sediment grain-sizes affected shorebird community spatial patterns indirectly by influencing benthic macroinvertebrate community compositions. Furthermore, combining sediment and macroinvertebrate information produced a 27% increase in correlation (rho(s) = 0.71) with shorebird assemblage patterns over the correlation of the bird community with the macroinvertebrate community alone. Beyond its indirect effects acting through prey distributions, granulometry of the flats influenced shorebird foraging directly by modifying prey availability. Our study highlights the importance of habitat heterogeneity, showing that no single patch type was ideal for the entire shorebird community. Generally, shorebird density and diversity were greatest at lower elevations on flats when they became exposed; these areas are at risk from human intervention by inlet sand mining, construction of groins and jetties that divert sediments from flats, and installation of seawalls on inlet shorelines that induce erosion of flats.	[VanDusen, Beth M.; Fegley, Stephen R.; Peterson, Charles H.] Univ N Carolina Chapel Hill, Inst Marine Sci, Morehead City, NC 28557 USA; [VanDusen, Beth M.; Peterson, Charles H.] Univ N Carolina, Curriculum Environm & Ecol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	VanDusen, BM (corresponding author), Univ N Carolina Chapel Hill, Inst Marine Sci, Morehead City, NC 28557 USA.	vandusen@unc.edu			Strategic Environmental Research and Development Program [W912HQ-07-C-0002]	Strategic Environmental Research and Development Program	This work was supported by the Strategic Environmental Research and Development Program (contract number W912HQ-07-C-0002), and conducted under the Defense Coastal/Estuarine Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Views, opinions, and/or findings contained in this document are those of the authors and should not be construed as an official United States Department of Defense position or decision unless so designated by other official documentation.	ABRAHAMS MV, 1986, BEHAV ECOL SOCIOBIOL, V19, P409, DOI 10.1007/BF00300543; Anderson M.J., 2008, PERMANOVA PRIMER GUI; BAKER MC, 1979, OIKOS, V33, P121, DOI 10.2307/3544520; BROOME SW, 1988, AQUAT BOT, V32, P1, DOI 10.1016/0304-3770(88)90085-X; Brown JS, 2004, ECOL LETT, V7, P999, DOI 10.1111/j.1461-0248.2004.00661.x; Brusati ED, 2001, WATERBIRDS, V24, P371, DOI 10.2307/1522067; Bryant DM, 1979, EST COAST MAR SCI, V9, P363; BURGER J, 1977, AUK, V94, P743, DOI 10.2307/4085271; Bush D.M., 2004, LIVING FLORIDAS ATLA; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Clarke KR, 1998, OECOLOGIA, V113, P278, DOI 10.1007/s004420050379; Clarke KR, 2006, J EXP MAR BIOL ECOL, V330, P55, DOI 10.1016/j.jembe.2005.12.017; Cohen JB, 2009, WILDLIFE MONOGR, P1, DOI 10.2193/2007-553; COLWELL MA, 1993, CONDOR, V95, P94, DOI 10.2307/1369390; Dekker D, 2004, CONDOR, V106, P415, DOI 10.1650/7364; Finn PG, 2008, ESTUAR COAST SHELF S, V80, P381, DOI 10.1016/j.ecss.2008.09.001; French P.W., 2001, COASTAL DEFENSES PRO; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Gorley C.K., 2006, GETTING STARTED PRIM; GOSSCUSTARD JD, 1992, J APPL ECOL, V29, P330, DOI 10.2307/2404502; GOSSCUSTARD JD, 1970, J ANIM ECOL, V39, P91, DOI 10.2307/2891; GOSSCUSTARD JD, 1977, ESTUAR COAST MAR SCI, V5, P497, DOI 10.1016/0302-3524(77)90097-4; Grabowski JH, 2005, ECOLOGY, V86, P1926, DOI 10.1890/04-0690; Granadeiro JP, 2006, ACTA OECOL, V29, P293, DOI 10.1016/j.actao.2005.11.008; HOLLAND AF, 1977, CHESAPEAKE SCI, V18, P58, DOI 10.2307/1350364; Karpanty SM, 2006, J WILDLIFE MANAGE, V70, P1704, DOI 10.2193/0022-541X(2006)70[1704:HCEDRK]2.0.CO;2; KENNEDY M, 1993, OIKOS, V68, P158, DOI 10.2307/3545322; LEBER KM, 1982, MAR ECOL PROG SER, V7, P297, DOI 10.3354/meps007297; Mangel M., 1988, DYNAMIC MODELING BEH; Mazerolle MJ, 1999, ECOSCIENCE, V6, P117, DOI 10.1080/11956860.1999.11952204; METCALFE NB, 1987, IBIS, V129, P553, DOI 10.1111/j.1474-919X.1987.tb08243.x; MOURITSEN KN, 1992, MAR ECOL PROG SER, V85, P1, DOI 10.3354/meps085001; NEHLS G, 1993, NETH J SEA RES, V31, P375, DOI 10.1016/0077-7579(93)90054-V; NOL E, 1999, BIRDS N AM; Peterson CH, 2006, J EXP MAR BIOL ECOL, V338, P205, DOI 10.1016/j.jembe.2006.06.021; PIENKOWSKI MW, 1983, MAR ECOL PROG SER, V11, P141, DOI 10.3354/meps011141; QUAMMEN ML, 1982, MAR BIOL, V71, P339, DOI 10.1007/BF00397050; Quinn G.P., 2002, EXPT DESIGNS DATA AN; Reed DJ, 2012, J COASTAL RES, P51, DOI 10.2112/SI_60_6; Ribeiro PD, 2004, IBIS, V146, P672, DOI 10.1111/j.1474-919x.2004.00301.x; Rosa S, 2007, J EXP MAR BIOL ECOL, V353, P35, DOI 10.1016/j.jembe.2007.08.019; Safran RJ, 2000, CONDOR, V102, P211, DOI 10.1650/0010-5422(2000)102[0211:FSSBNW]2.0.CO;2; Sanders MD, 2000, J APPL ECOL, V37, P66, DOI 10.1046/j.1365-2664.2000.00469.x; Santos CD, 2010, J AVIAN BIOL, V41, P18, DOI 10.1111/j.1600-048X.2009.04860.x; Smart J, 2006, J APPL ECOL, V43, P454, DOI 10.1111/j.1365-2664.2006.01166.x; STINSON CH, 1980, OIKOS, V34, P35, DOI 10.2307/3544547; Vader W, 1964, NETH J SEA RES, V2, P189; Walters JR, 1984, WADER STUD GROUP B, V40, P27; Warnock N., 1996, BIRDS N AM; Watkinson AR, 2004, IBIS, V146, P4, DOI 10.1111/j.1474-919X.2004.00321.x; Watzin MC, 1984, THESIS U N CAROLINA; YATES MG, 1993, J APPL ECOL, V30, P599, DOI 10.2307/2404240	52	16	18	0	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52694	10.1371/journal.pone.0052694	http://dx.doi.org/10.1371/journal.pone.0052694			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285153	Green Published, gold, Green Submitted			2022-12-27	WOS:000312794500233
J	Dukic-Stefanovic, S; Walther, J; Wosch, S; Zimmermann, G; Wiedemann, P; Alexander, H; Claudepierre, T				Dukic-Stefanovic, Sladjana; Walther, Jan; Wosch, Sebastian; Zimmermann, Gerolf; Wiedemann, Peter; Alexander, Henry; Claudepierre, Thomas			Chorionic Gonadotropin and Its Receptor Are Both Expressed in Human Retina, Possible Implications in Normal and Pathological Conditions	PLOS ONE			English	Article							DECREASES INTRAOCULAR-PRESSURE; HORMONE-RELEASING HORMONE; LUTEINIZING-HORMONE; PITUITARY APOPLEXY; CHILDREN BORN; HCG; RETINOBLASTOMA; CELLS; RAT; LOCALIZATION	Extra-gonadal role of gonadotropins has been re-evaluated over the last 20 years. In addition to pituitary secretion of luteinizing hormone (LH) and follicle stimulating hormone (FSH), the CNS has been clearly identified as a source of hCG acting locally to influence behaviour. Here we demonstrated that human retina is producing this gonadotropin that acts as a neuroactive molecule. Muller glial and retinal pigmented epithelial (RPE) cells are producing hCG that may affects neighbour cells expressing its receptor, namely cone photoreceptors. It was previously described that amacrine and retinal ganglion (RGC) cells are targets of the gonadotropin releasing hormone that control the secretion of all gonadotropins. Therefore our findings suggest that a complex neuroendocrine circuit exists in the retina, involving hCG secreting cells (glial and RPE), hCG targets (photoreceptors) and hCG-release controlling cells (amacrine and RGC). The exact physiological functions of this circuit have still to be identified, but the proliferation of photoreceptor-derived tumor induced by hCG demonstrated the need to control this neuroendocrine loop.	[Dukic-Stefanovic, Sladjana; Walther, Jan; Wosch, Sebastian; Wiedemann, Peter; Claudepierre, Thomas] Univ Leipzig, Fac Med, Dept Ophthalmol, Leipzig, Germany; [Zimmermann, Gerolf; Alexander, Henry] Univ Leipzig, Dept Obstet & Gynecol, Div Human Reprod & Endocrinol, Leipzig, Germany	Leipzig University; Leipzig University	Claudepierre, T (corresponding author), Univ Leipzig, Fac Med, Dept Ophthalmol, Leipzig, Germany.	thomas.claudepierre@medizin.uni-leipzig.de		Claudepierre, Thomas/0000-0001-6968-8518	German foundation "Stifterverband fur die Deutsche Wissenschaft"	German foundation "Stifterverband fur die Deutsche Wissenschaft"	This work was supported by the German foundation "Stifterverband fur die Deutsche Wissenschaft" (to TC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson DH, 2004, RETINA-J RET VIT DIS, V24, P828, DOI 10.1097/00006982-200412000-00002; AlHader AA, 1997, BIOL REPROD, V56, P501, DOI 10.1095/biolreprod56.2.501; AlHader AA, 1997, BIOL REPROD, V56, P1071, DOI 10.1095/biolreprod56.5.1071; Anteby I, 2001, ARCH OPHTHALMOL-CHIC, V119, P1525; Apaja PM, 2004, J BIOL CHEM, V279, P1899, DOI 10.1074/jbc.M311395200; Archer S, 1995, P ROY SOC B-BIOL SCI, V262, P289, DOI 10.1098/rspb.1995.0208; Ascoli M, 2002, ENDOCR REV, V23, P141, DOI 10.1210/er.23.2.141; Banerjee P, 2011, REV ENDOCR METAB DIS, V12, P323, DOI 10.1007/s11154-011-9193-1; BELLISARIO R, 1973, J BIOL CHEM, V248, P6796; Berndt S, 2009, J CLIN ENDOCR METAB, V94, P4567, DOI 10.1210/jc.2009-0443; Birken S, 1996, ENDOCRINOLOGY, V137, P1402, DOI 10.1210/en.137.4.1402; Boime I, 1999, RECENT PROG HORM RES, V54, P271; Botul JB, 2002, ZYCIE SEKSUALNE IMMA; BOWEN DJ, 1992, APPETITE, V19, P233, DOI 10.1016/0195-6663(92)90164-2; Bukovsky Antonin, 2003, Reprod Biol Endocrinol, V1, P46, DOI 10.1186/1477-7827-1-46; CARMICHAEL DN, 1995, DIABETOLOGIA, V38, pA275; Chen HF, 1999, J CLIN ENDOCR METAB, V84, P743, DOI 10.1210/jc.84.2.743; Cole LA, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-24; Cole LA, 2012, AM J CANCER RES, V2, P22; Cole LA, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-102; Dinc H, 1998, ACTA RADIOL, V39, P64, DOI 10.3109/02841859809172152; Efe YK, 2012, CAN J OPHTHALMOL, V47, P150, DOI 10.1016/j.jcjo.2012.01.004; ELMAN J, 1987, INVEST OPHTH VIS SCI, V28, P197; EMANUELE NV, 1991, NEUROENDOCRINOL LETT, V13, P413; Foix-L'Helias L, 2012, HUM REPROD, V27, P2186, DOI 10.1093/humrep/des149; Gierkowa A, 1976, Klin Oczna, V46, P1005; Grens KE, 2005, BRAIN BEHAV EVOLUT, V66, P1, DOI 10.1159/000085043; Harrison GS, 2004, ENDOCR-RELAT CANCER, V11, P725, DOI 10.1677/erc.1.00777; Hiroi N, 2001, INTERNAL MED, V40, P747, DOI 10.2169/internalmedicine.40.747; Hollborn M, 2011, MOL VIS, V17, P2738; Hollborn M, 2010, INVEST OPHTH VIS SCI, V51, P2721, DOI 10.1167/iovs.09-4661; Hope AJ, 1998, P ROY SOC B-BIOL SCI, V265, P869, DOI 10.1098/rspb.1998.0372; Iles RK, 2010, MOL CELL ENDOCRINOL, V329, P62, DOI 10.1016/j.mce.2010.07.014; Inoue T, 2007, GRAEF ARCH CLIN EXP, V245, P1049, DOI 10.1007/s00417-006-0491-3; Jennes L, 1997, RECENT PROG HORM RES, V52, P475; Jorsal T, 2012, ACTA ONCOL, V51, P3, DOI 10.3109/0284186X.2011.586000; Kallen B, 2010, PEDIATRICS, V126, pE270, DOI 10.1542/peds.2009-3225; Kars M, 2006, EUR J ENDOCRINOL, V155, P523, DOI 10.1530/eje.1.02268; KASS MA, 1977, SURV OPHTHALMOL, V22, P153, DOI 10.1016/0039-6257(77)90053-4; KAWAKAMI M, 1959, ENDOCRINOLOGY, V65, P631, DOI 10.1210/endo-65-4-631; Lei ZM, 2001, SEMIN REPROD MED, V19, P103, DOI 10.1055/s-2001-13917; LEI ZM, 1995, MOL CELL ENDOCRINOL, V109, P151, DOI 10.1016/0303-7207(95)03497-U; Licht P, 2001, SEMIN REPROD MED, V19, P37, DOI 10.1055/s-2001-13909; Lidegaard O, 2005, HUM REPROD, V20, P950, DOI 10.1093/humrep/deh714; LIU JHK, 1988, CURR EYE RES, V7, P1035, DOI 10.3109/02713688809015151; LIU JHK, 1988, CURR EYE RES, V7, P737, DOI 10.3109/02713688809033203; Lukacs H, 2001, SEMIN REPROD MED, V19, P111, DOI 10.1055/s-2001-13918; LUKACS H, 1995, HORM BEHAV, V29, P42, DOI 10.1006/hbeh.1995.1004; Lustbader JW, 1998, RECENT PROG HORM RES, V53, P395; Marees T, 2009, HUM REPROD, V24, P3220, DOI 10.1093/humrep/dep335; Maruska KP, 2007, BRAIN BEHAV EVOLUT, V70, P40, DOI 10.1159/000101068; MASAGO A, 1995, SURG NEUROL, V43, P158, DOI 10.1016/0090-3019(95)80128-4; MASSON EA, 1993, CLIN ENDOCRINOL, V38, P109, DOI 10.1111/j.1365-2265.1993.tb00980.x; MCFARLAND KC, 1989, SCIENCE, V245, P494, DOI 10.1126/science.2502842; Mendez-Hernandez C, 2012, CLIN OPHTHALMOL, V6, P1629, DOI 10.2147/OPTH.S36712; Moll AC, 2003, LANCET, V361, P309, DOI 10.1016/S0140-6736(03)12332-X; Pakarainen T, 2007, MOL CELL ENDOCRINOL, V269, P9, DOI 10.1016/j.mce.2006.10.019; PATIL AA, 1990, INT SURG, V75, P54; Putterman G J, 1986, J Ocul Pharmacol, V2, P121, DOI 10.1089/jop.1986.2.121; Sasaki K, 2011, CURR OPIN ENDOCRINOL, V18, P401, DOI 10.1097/MED.0b013e32834cd3b0; Schang AL, 2012, NEUROENDOCR IN PRESS; Talwar GP, 2011, AM J REPROD IMMUNOL, V66, P26, DOI 10.1111/j.1600-0897.2011.01002.x; TELEGDY G, 1971, ACTA PHYSIOL HUNG, V40, P209; Thomas D, 1996, MOL ENDOCRINOL, V10, P760, DOI 10.1210/me.10.6.760; Thompson DA, 1998, LIFE SCI, V63, P1057, DOI 10.1016/S0024-3205(98)00367-1; TOTH P, 1994, BRAIN RES, V654, P181, DOI 10.1016/0006-8993(94)90478-2; van Aerle R, 2008, PEPTIDES, V29, P57, DOI 10.1016/j.peptides.2007.10.018; VIRTANEN I, 1988, LAB INVEST, V59, P649; Wirsig-Wiechmann CR, 2002, BRAIN RES, V950, P210, DOI 10.1016/S0006-8993(02)03039-1; Xu XLL, 2009, CELL, V137, P1018, DOI 10.1016/j.cell.2009.03.051; Zhang W, 1999, LIFE SCI, V65, P2083, DOI 10.1016/S0024-3205(99)00474-9; ZIAI N, 1994, ARCH OPHTHALMOL-CHIC, V112, P801, DOI 10.1001/archopht.1994.01090180099043	72	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e52567	10.1371/journal.pone.0052567	http://dx.doi.org/10.1371/journal.pone.0052567			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23285091	Green Published, Green Submitted, gold			2022-12-27	WOS:000312694300091
J	Rocha, MR; Vasseur, DA; Gaedke, U				Rocha, Marcia R.; Vasseur, David A.; Gaedke, Ursula			Seasonal Variations Alter the Impact of Functional Traits on Plankton Dynamics	PLOS ONE			English	Article							COMPENSATORY DYNAMICS; CLEAR-WATER; PHYTOPLANKTON; PATTERNS; LIGHT; TEMPERATURE; SIMILARITY; DIVERSITY	Gaining understanding of food-web processes often requires a simplified representation of natural diversity. One such simplification can be based on functional traits, as functionally similar species may provide a similar contribution to ecosystem level-processes. However, understanding how similarity in functional traits actually translates into similar contributions to ecosystem-level properties remains a challenge due to the complex ways in which traits can influence species' dynamics. Moreover, in many communities, seasonality alters the abiotic and biotic forcing regime, causing ongoing changes to patterns of species' dominance; groups of species do not stay intact but are rather continuously subjected to changes throughout the year. Using long-term high frequency measurements of phytoplankton in Lake Constance, we investigated the effect of seasonal changes on the relationship between functional similarity and temporal dynamics similarity of 36 morphotypes, and the relative contribution of different functional traits during the different parts of the year. Our results revealed seasonal differences in the overall degree of synchronization of morphotypes' temporal dynamics and how combinations of functional traits influence the relationship between functional trait similarity and temporal dynamics similarity, showing that different forcing regimes change how species cope with their environment based on their functional traits. Moreover, we show that the individual functional traits matter at different periods of the year indicating that species which are dynamically similar at certain parts of the year may not be at others. The differential strength of the overall and individual impact of functional traits on species' temporal dynamics makes the cohesion of a pair of functionally similar species dependent on the different forcing. Hence, simplifying food webs based solely on functional traits may not provide consistent estimates of functional groups over all seasons.	[Rocha, Marcia R.; Gaedke, Ursula] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany; [Vasseur, David A.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA	University of Potsdam; Yale University	Gaedke, U (corresponding author), Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany.	gaedke@uni-potsdam.de		Vasseur, David/0000-0003-1706-9613	Univ. of Potsdam Graduate Initiative on Ecological Modeling UPGradE; Alexander von Humboldt Foundation; Deutsche Forschungsgemeinschaft (DFG)	Univ. of Potsdam Graduate Initiative on Ecological Modeling UPGradE; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	M.R. was partly funded by the Univ. of Potsdam Graduate Initiative on Ecological Modeling UPGradE. D.A.V. was supported by a fellowship from the Alexander von Humboldt Foundation. Data acquisition was performed by a large team of scientists within the Special Collaborative Program (SFB) 248 "Cycling of Matter in Lake Constance'' supported by Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves-de-Souza C, 2008, J PLANKTON RES, V30, P1233, DOI 10.1093/plankt/fbn079; BYRD RH, 1995, SIAM J SCI COMPUT, V16, P1190, DOI 10.1137/0916069; Gaedke U, 2004, AQUAT MICROB ECOL, V34, P247, DOI 10.3354/ame034247; Gaedke U., 1998, ARCH HYDROBIOL SPEC, V53, P119; Gaedke Ursula, 1998, Advances in Limnology, V53, P565; GASOL JM, 1995, J PLANKTON RES, V17, P1879, DOI 10.1093/plankt/17.10.1879; GOWER JC, 1971, BIOMETRICS, V27, P857, DOI 10.2307/2528823; Hase C., 1998, ARCH HYDROBIOL SPEC, V53, P159; HAWES I, 1990, J PLANKTON RES, V12, P513, DOI 10.1093/plankt/12.3.513; Hendriks AJ, 2007, ECOL MODEL, V205, P196, DOI 10.1016/j.ecolmodel.2007.02.029; Houlahan JE, 2007, P NATL ACAD SCI USA, V104, P3273, DOI 10.1073/pnas.0603798104; Huber V, 2006, OIKOS, V114, P265, DOI 10.1111/j.2006.0030-1299.14753.x; Huisman J, 1999, ECOLOGY, V80, P211, DOI 10.1890/0012-9658(1999)080[0211:CFLBPS]2.0.CO;2; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; LAMPERT W, 1978, ARCH HYDROBIOL, V82, P364; Lavorel S, 1997, TRENDS ECOL EVOL, V12, P474, DOI 10.1016/S0169-5347(97)01219-6; Lee RE, 1999, PHYCOLOGY; Litchman E, 2008, ANNU REV ECOL EVOL S, V39, P615, DOI 10.1146/annurev.ecolsys.39.110707.173549; Luczkovich JJ, 2003, J THEOR BIOL, V220, P303, DOI 10.1006/jtbi.2003.3147; Mouillot D, 2005, OECOLOGIA, V142, P353, DOI 10.1007/s00442-004-1744-7; PASCIAK WJ, 1974, LIMNOL OCEANOGR, V19, P881, DOI 10.4319/lo.1974.19.6.0881; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; PIMM SL, 1991, NATURE, V350, P669, DOI 10.1038/350669a0; R Development Core Team, 2007, R LANG ENV STAT COMP; Reynolds C.S., 1997, VEGETATION PROCESSES, V9, DOI 10.1017/S0025315400036432; Rocha MR, 2011, J ECOL, V99, P1453, DOI 10.1111/j.1365-2745.2011.01893.x; Rocha MR, 2011, OIKOS, V120, P17, DOI 10.1111/j.1600-0706.2010.18786.x; SOMMER U, 1986, ARCH HYDROBIOL, V106, P433; Stuber K, 1998, THESIS U KONSTANZ GE; TILZER MM, 1986, POLAR BIOL, V5, P105, DOI 10.1007/BF00443382; Tirok K, 2006, J PLANKTON RES, V28, P361, DOI 10.1093/plankt/fbi121; Vasseur DA, 2005, OIKOS, V110, P507, DOI 10.1111/j.0030-1299.2005.14006.x; Violle C, 2007, OIKOS, V116, P882, DOI 10.1111/j.2007.0030-1299.15559.x; Weithoff G, 2003, FRESHWATER BIOL, V48, P1669, DOI 10.1046/j.1365-2427.2003.01116.x; Yodzis P, 1999, OIKOS, V87, P327, DOI 10.2307/3546748	35	9	9	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51257	10.1371/journal.pone.0051257	http://dx.doi.org/10.1371/journal.pone.0051257			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23300539	Green Submitted, Green Published, gold			2022-12-27	WOS:000313236200077
J	Geissler, S; Textor, M; Kuhnisch, J; Konnig, D; Klein, O; Ode, A; Pfitzner, T; Adjaye, J; Kasper, G; Duda, GN				Geissler, Sven; Textor, Martin; Kuehnisch, Jirko; Koennig, Delia; Klein, Oliver; Ode, Andrea; Pfitzner, Tilman; Adjaye, James; Kasper, Grit; Duda, Georg N.			Functional Comparison of Chronological and In Vitro Aging: Differential Role of the Cytoskeleton and Mitochondria in Mesenchymal Stromal Cells	PLOS ONE			English	Article							STEM-CELLS; BETA-CATENIN; RAT-HEART; BONE; SENESCENCE; OSTEOBLAST; EXPRESSION; STRESS; LINES; INVOLVEMENT	Mesenchymal stromal cells (MSCs) are of high relevance for the regeneration of mesenchymal tissues such as bone and cartilage. The promising role of MSCs in cell-based therapies and tissue engineering appears to be limited due to a decline of their regenerative potential with increasing donor age, their limited availability in human tissues and the need of in vitro expansion prior to treatment. We therefore aimed to determine to which degree in vitro aging and chronological aging may be similar processes or if in vitro culture-related changes at the cellular and molecular level are at least altered as a function of donor age. For that purpose we established MSCs cultures from young (yMSCs) and aged (aMSCs) rats that were cultured for more than 100 passages. These long-term MSCs cultures were non-tumorigenic and exhibited similar surface marker patterns as primary MSCs of passage 2. During in vitro expansion, but not during chronological aging, MSCs progressively lose their progenitor characteristics, e.g., complete loss of osteogenic differentiation potential, diminished adipogenic differentiation, altered cell morphology and increased susceptibility towards senescence. Transcriptome analysis revealed that long-term in vitro MSCs cultivation leads to down-regulation of genes involved in cell differentiation, focal adhesion organization, cytoskeleton turnover and mitochondria function. Accordingly, functional analysis demonstrated altered mitochondrial morphology, decreased antioxidant capacities and elevated ROS levels in long-term cultivated yMSCs as well as aMSCs. Notably, only the MSC migration potential and their antioxidative capacity were altered by in vitro as well as chronological aging. Based on specific differences observed between the impact of chronological and in vitro MSC aging we conclude that both are distinct processes.	[Geissler, Sven; Textor, Martin; Koennig, Delia; Ode, Andrea; Pfitzner, Tilman; Kasper, Grit; Duda, Georg N.] Charite, Julius Wolff Inst, D-13353 Berlin, Germany; [Geissler, Sven; Textor, Martin; Klein, Oliver; Ode, Andrea; Kasper, Grit; Duda, Georg N.] Charite, Berlin Brandenburg Ctr Regenerat Therapies, D-13353 Berlin, Germany; [Kuehnisch, Jirko; Klein, Oliver] Charite, Inst Med & Human Genet, D-13353 Berlin, Germany; [Koennig, Delia; Adjaye, James] Max Planck Inst Mol Genet, Dept Vertebrate Genom, Mol Embryol & Aging Grp, D-14195 Berlin, Germany; [Adjaye, James] Univ Dusseldorf, Inst Stem Cell Res & Regenerat Med, D-40225 Dusseldorf, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; Heinrich Heine University Dusseldorf	Geissler, S (corresponding author), Charite, Julius Wolff Inst, D-13353 Berlin, Germany.	Sven.Geissler@charite.de	Duda, Georg N/H-2085-2016; Kühnisch, Jirko/M-3744-2019; Ode, Andrea/B-6805-2015; Geißler, Sven/J-7275-2013; Kühnisch, Jirko/L-7761-2013	Duda, Georg N/0000-0001-7605-3908; Kühnisch, Jirko/0000-0003-4744-5421; Geißler, Sven/0000-0002-8750-6324; Textor, Martin/0000-0001-8162-930X; klein, oliver/0000-0001-7984-7607	Federal Ministry of Education and Research (BMBF) through the BCRT; German Research Foundation (DFG) [GE2512/1-1]	Federal Ministry of Education and Research (BMBF) through the BCRT(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG))	This study was supported by the Federal Ministry of Education and Research (BMBF) by funding through the BCRT and by the German Research Foundation (DFG) grant GE2512/1-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artandi SE, 2005, BIOCHEM BIOPH RES CO, V331, P881, DOI 10.1016/j.bbrc.2005.03.211; Baxter MA, 2004, STEM CELLS, V22, P675, DOI 10.1634/stemcells.22-5-675; Berger JP, 2005, INT J OBESITY, V29, pS3, DOI 10.1038/sj.ijo.0802904; Beyer Nardi N, 2006, HANDB EXP PHARM, V174, P249; Bonab MM, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-14; Chanda D, 2010, J CELL BIOCHEM, V111, P249, DOI 10.1002/jcb.22701; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Duda GN, 2008, HARRISONS INNERE MED; Estrada JC, 2012, CELL DEATH DIFFER, V19, P743, DOI 10.1038/cdd.2011.172; Fehrer C, 2006, ANN NY ACAD SCI, V1067, P235, DOI 10.1196/annals.1354.030; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Gazzerro E, 2005, ENDOCRINOLOGY, V146, P655, DOI 10.1210/en.2004-0766; Gorbunova V, 2002, J BIOL CHEM, V277, P38540, DOI 10.1074/jbc.M202671200; Gruber R, 2006, EXP GERONTOL, V41, P1080, DOI 10.1016/j.exger.2006.09.008; Hansford RG, 1997, J BIOENERG BIOMEMBR, V29, P89, DOI 10.1023/A:1022420007908; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Hilton MJ, 2008, NAT MED, V14, P306, DOI 10.1038/nm1716; Izadpanah R, 2008, CANCER RES, V68, P4229, DOI 10.1158/0008-5472.CAN-07-5272; Kasper G, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-12; Kasper G, 2007, STEM CELLS, V25, P1985, DOI 10.1634/stemcells.2006-0676; Kasper G, 2007, STEM CELLS, V25, P903, DOI 10.1634/stemcells.2006-0432; Kasper G, 2010, STEM CELLS, V28, P633, DOI 10.1002/stem.305; Kasper G, 2009, STEM CELLS, V27, P1288, DOI 10.1002/stem.49; Khosla S, 2010, STEM CELLS, V28, P2124, DOI 10.1002/stem.546; Kitaori T, 2009, ARTHRITIS RHEUM-US, V60, P813, DOI 10.1002/art.24330; Krampera M, 2006, BONE, V39, P678, DOI 10.1016/j.bone.2006.04.020; Kuhn NZ, 2010, J CELL PHYSIOL, V222, P268, DOI 10.1002/jcp.21940; Larsen M, 2003, NAT REV MOL CELL BIO, V4, P700, DOI 10.1038/nrm1199; Le Blanc K, 2005, CYTOTHERAPY, V7, P36, DOI 10.1080/14653240510018118; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Liu B, 2007, DEV BIOL, V301, P298, DOI 10.1016/j.ydbio.2006.10.018; Marcellini S, 2012, BIOESSAYS; Mbalaviele G, 2005, J CELL BIOCHEM, V94, P403, DOI 10.1002/jcb.20253; Miura M, 2006, STEM CELLS, V24, P1095, DOI 10.1634/stemcells.2005-0403; Muller M, 2009, ANTIOXID REDOX SIGN, V11, P59, DOI 10.1089/ars.2008.2104; Noer A, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-18; Ode A, 2011, EUR CELLS MATER, V22, P26, DOI 10.22203/eCM.v022a03; Ogrunc M, 2011, EUR J CANCER, V47, P1616, DOI 10.1016/j.ejca.2011.04.003; Paradies G, 2010, FREE RADICAL BIO MED, V48, P1286, DOI 10.1016/j.freeradbiomed.2010.02.020; Passos JF, 2007, PLOS BIOL, V5, P1138, DOI 10.1371/journal.pbio.0050110; Prigione A, 2010, STEM CELLS, V28, P721, DOI 10.1002/stem.404; Quarto R, 2001, NEW ENGL J MED, V344, P385, DOI 10.1056/NEJM200102013440516; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Rosland GV, 2009, CANCER RES, V69, P5331, DOI 10.1158/0008-5472.CAN-08-4630; Salem HK, 2010, STEM CELLS, V28, P585, DOI 10.1002/stem.269; Savitha S, 2006, MECH AGEING DEV, V127, P349, DOI 10.1016/j.mad.2005.12.004; Sethe S, 2006, AGEING RES REV, V5, P91, DOI 10.1016/j.arr.2005.10.001; Sharpless NE, 2002, CELL, V110, P9, DOI 10.1016/S0092-8674(02)00818-8; Shiraha H, 2000, J BIOL CHEM, V275, P19343, DOI 10.1074/jbc.M000008200; Strube P, 2008, BONE, V42, P758, DOI 10.1016/S0021-9290(08)70350-6; Tarte K, 2010, BLOOD, V115, P1549, DOI 10.1182/blood-2009-05-219907; Wagner DO, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3107mr1; Wagner W, 2010, TISSUE ENG PART B-RE, V16, P445, DOI [10.1089/ten.teb.2009.0825, 10.1089/ten.TEB.2009.0825]; Wagner W, 2010, AGING-US, V2, P224, DOI 10.18632/aging.100136; Wagner W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005846; Xiao YT, 2007, BIOCHEM BIOPH RES CO, V362, P550, DOI 10.1016/j.bbrc.2007.08.045; Xie XY, 2011, STEM CELLS DEV, V20, P127, DOI 10.1089/scd.2009.0475; Yan Y, 2009, J CELL SCI, V122, P3566, DOI 10.1242/jcs.051904; Zhang DL, 2001, CELL BIOL INT, V25, P997, DOI 10.1006/cbir.2001.0745	60	117	120	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52700	10.1371/journal.pone.0052700	http://dx.doi.org/10.1371/journal.pone.0052700			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285157	Green Submitted, Green Published, gold			2022-12-27	WOS:000313051500049
J	Husse, J; Hintze, SC; Eichele, G; Lehnert, H; Oster, H				Husse, Jana; Hintze, Sophie Charlotte; Eichele, Gregor; Lehnert, Hendrik; Oster, Henrik			Circadian Clock Genes Per1 and Per2 Regulate the Response of Metabolism-Associated Transcripts to Sleep Disruption	PLOS ONE			English	Article							SHIFT WORK; ADIPOSE-TISSUE; PLASMA LEPTIN; FOOD-INTAKE; NIGHT-WORK; DEPRIVATION; OBESITY; RATS; EXPRESSION; DURATION	Human and animal studies demonstrate that short sleep or poor sleep quality, e.g. in night shift workers, promote the development of obesity and diabetes. Effects of sleep disruption on glucose homeostasis and liver physiology are well documented. However, changes in adipokine levels after sleep disruption suggest that adipocytes might be another important peripheral target of sleep. Circadian clocks regulate metabolic homeostasis and clock disruption can result in obesity and the metabolic syndrome. The finding that sleep and clock disruption have very similar metabolic effects prompted us to ask whether the circadian clock machinery may mediate the metabolic consequences of sleep disruption. To test this we analyzed energy homeostasis and adipocyte transcriptome regulation in a mouse model of shift work, in which we prevented mice from sleeping during the first six hours of their normal inactive phase for five consecutive days (timed sleep restriction - TSR). We compared the effects of TSR between wild-type and Per1/2 double mutant mice with the prediction that the absence of a circadian clock in Per1/2 mutants would result in a blunted metabolic response to TSR. In wild-types, TSR induces significant transcriptional reprogramming of white adipose tissue, suggestive of increased lipogenesis, together with increased secretion of the adipokine leptin and increased food intake, hallmarks of obesity and associated leptin resistance. Some of these changes persist for at least one week after the end of TSR, indicating that even short episodes of sleep disruption can induce prolonged physiological impairments. In contrast, Per1/2 deficient mice show blunted effects of TSR on food intake, leptin levels and adipose transcription. We conclude that the absence of a functional clock in Per1/2 double mutants protects these mice from TSR-induced metabolic reprogramming, suggesting a role of the circadian timing system in regulating the physiological effects of sleep disruption.	[Husse, Jana; Eichele, Gregor; Oster, Henrik] Max Planck Inst Biophys Chem, Gottingen, Germany; [Hintze, Sophie Charlotte; Lehnert, Hendrik; Oster, Henrik] Med Univ Lubeck, Dept Med 1, D-23538 Lubeck, Germany	Max Planck Society; University of Lubeck	Oster, H (corresponding author), Max Planck Inst Biophys Chem, Gottingen, Germany.	henrik.oster@uksh.de	Oster, Henrik/D-2335-2013; Oster, Henrik/O-4426-2019	Oster, Henrik/0000-0002-1414-7068; Oster, Henrik/0000-0002-1414-7068	German Research Foundation (DFG) [SFB 654]; Max Planck Society	German Research Foundation (DFG)(German Research Foundation (DFG)); Max Planck Society(Max Planck Society)	This work was supported by a grant from the German Research Foundation (DFG; SFB 654) to HO and HL. JH is supported by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahren B, 1997, AM J PHYSIOL-REG I, V273, pR113, DOI 10.1152/ajpregu.1997.273.1.R113; Antunes LC, 2010, NUTR RES REV, V23, P155, DOI 10.1017/S0954422410000016; Barclay JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037150; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Biggi N, 2008, CHRONOBIOL INT, V25, P443, DOI 10.1080/07420520802114193; Boivin DB, 2007, SLEEP MED, V8, P578, DOI 10.1016/j.sleep.2007.03.015; Brondel L, 2010, AM J CLIN NUTR, V91, P1550, DOI 10.3945/ajcn.2009.28523; Broussard J, 2010, BEST PRACT RES CL EN, V24, P763, DOI 10.1016/j.beem.2010.08.007; CDC, 2012, MORBIDITY MORTALITY; Challet E, 2000, BRAIN RES, V859, P398, DOI 10.1016/S0006-8993(00)02040-0; Crispim CA, 2011, METABOLISM, V60, P1726, DOI 10.1016/j.metabol.2011.04.014; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Donga E, 2010, J CLIN ENDOCR METAB, V95, P2963, DOI 10.1210/jc.2009-2430; Dufour CR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002143; Dumont, 1997, Int J Occup Environ Health, V3, pS10; Esquirol Y, 2011, ARCH CARDIOVASC DIS, V104, P636, DOI 10.1016/j.acvd.2011.09.004; Everson CA, 2004, AM J PHYSIOL-ENDOC M, V286, pE1060, DOI 10.1152/ajpendo.00553.2003; EVERSON CA, 1989, SLEEP, V12, P13, DOI 10.1093/sleep/12.1.13; Fonken LK, 2010, P NATL ACAD SCI USA, V107, P18664, DOI 10.1073/pnas.1008734107; FRANKEN P, 1993, PHYSIOL BEHAV, V54, P885, DOI 10.1016/0031-9384(93)90297-S; Franken P, 2001, J NEUROSCI, V21, P2610, DOI 10.1523/JNEUROSCI.21-08-02610.2001; Franken P, 1999, SLEEP, V22, P155; Fu LN, 2005, CELL, V122, P803, DOI 10.1016/j.cell.2005.06.028; *GALL ORG, 1995, SLEEP AM; Gluckman PD, 2012, NAT REV ENDOCRINOL, V8, P74, DOI 10.1038/nrendo.2011.226; Hairston KG, 2010, SLEEP, V33, P289, DOI 10.1093/sleep/33.3.289; Hasler G, 2004, SLEEP, V27, P661, DOI 10.1093/sleep/27.4.661; Hayes AL, 2011, SLEEP, V34, P147, DOI 10.1093/sleep/34.2.147; Karatsoreos IN, 2011, P NATL ACAD SCI USA, V108, P1657, DOI 10.1073/pnas.1018375108; Karlsson B, 2001, OCCUP ENVIRON MED, V58, P747, DOI 10.1136/oem.58.11.747; Karlsson BH, 2003, INT ARCH OCC ENV HEA, V76, P424, DOI 10.1007/s00420-003-0440-y; Katada S, 2012, CELL, V148, P24, DOI 10.1016/j.cell.2012.01.001; Knutson KL, 2008, ANN NY ACAD SCI, V1129, P287, DOI 10.1196/annals.1417.033; Knutson KL, 2007, SLEEP MED REV, V11, P163, DOI 10.1016/j.smrv.2007.01.002; Koban M, 2006, ENDOCRINOLOGY, V147, P421, DOI 10.1210/en.2005-0695; Koban M, 2005, AM J PHYSIOL-ENDOC M, V289, pE68, DOI 10.1152/ajpendo.00543.2004; Koban M, 2008, SLEEP, V31, P927; Kovac J, 2009, MOL CELLS, V28, P75, DOI 10.1007/s10059-009-0113-0; KRIPKE DF, 1979, ARCH GEN PSYCHIAT, V36, P103; Laposky A, 2005, SLEEP, V28, P395, DOI 10.1093/sleep/28.4.395; Laposky AD, 2008, FEBS LETT, V582, P142, DOI 10.1016/j.febslet.2007.06.079; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Maret S, 2007, P NATL ACAD SCI USA, V104, P20090, DOI 10.1073/pnas.0710131104; Miller BH, 2007, P NATL ACAD SCI USA, V104, P3342, DOI 10.1073/pnas.0611724104; Mongrain V, 2010, SLEEP, V33, P1147, DOI 10.1093/sleep/33.9.1147; Mullington JM, 2003, J NEUROENDOCRINOL, V15, P851, DOI 10.1046/j.1365-2826.2003.01069.x; Naylor E, 2000, J NEUROSCI, V20, P8138; Oster H, 2006, CELL METAB, V4, P163, DOI 10.1016/j.cmet.2006.07.002; Puttonen S, 2012, SCAND J WORK ENV HEA, V38, P343, DOI 10.5271/sjweh.3267; Rasouli N, 2008, J CLIN ENDOCR METAB, V93, pS64, DOI 10.1210/jc.2008-1613; Ripperger JA, 2011, FEBS LETT, V585, P1406, DOI 10.1016/j.febslet.2011.04.047; Neto JCR, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-125; Salgado-Delgado R, 2008, NEUROSCIENCE, V154, P922, DOI 10.1016/j.neuroscience.2008.03.066; Salgado-Delgado R, 2010, ENDOCRINOLOGY, V151, P1019, DOI 10.1210/en.2009-0864; Savoye M, 2002, INT J OBESITY, V26, P942, DOI 10.1038/sj.ijo.0802018; Shea SA, 2005, J CLIN ENDOCR METAB, V90, P2537, DOI 10.1210/jc.2004-2232; Simon C, 1998, J CLIN ENDOCR METAB, V83, P1893, DOI 10.1210/jc.83.6.1893; Simpson NS, 2010, BIOL RES NURS, V12, P47, DOI 10.1177/1099800410366301; Spiegel K, 2004, ANN INTERN MED, V141, P846, DOI 10.7326/0003-4819-141-11-200412070-00008; Spiegel K, 2004, J CLIN ENDOCR METAB, V89, P5762, DOI 10.1210/jc.2004-1003; Szosland D, 2010, INT J OCCUP MED ENV, V23, P287, DOI 10.2478/v10001-010-0032-5; Taheri S, 2004, PLOS MED, V1, P210, DOI 10.1371/journal.pmed.0010062; Van Cauter E, 2008, EUR J ENDOCRINOL, V159, pS59, DOI 10.1530/EJE-08-0298; World Health Organization, 2012, WORLD HLTH STAT, P109; Zhao I, 2012, J OCCUP ENVIRON MED, V54, P525, DOI 10.1097/JOM.0b013e31824e1073; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118; Zhong Sheng, 2004, Appl Bioinformatics, V3, P261, DOI 10.2165/00822942-200403040-00009; Zhu Y, 2011, CHRONOBIOL INT, V28, P852, DOI 10.3109/07420528.2011.618896; Zvonic S, 2006, DIABETES, V55, P962, DOI 10.2337/diabetes.55.04.06.db05-0873	72	56	58	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52983	10.1371/journal.pone.0052983	http://dx.doi.org/10.1371/journal.pone.0052983			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285241	Green Submitted, Green Published, gold			2022-12-27	WOS:000313051500093
J	Kelley, CF; Rosenberg, ES; O'Hara, BM; Frew, PM; Sanchez, T; Peterson, JL; del Rio, C; Sullivan, PS				Kelley, Colleen F.; Rosenberg, Eli S.; O'Hara, Brandon M.; Frew, Paula M.; Sanchez, Travis; Peterson, John L.; del Rio, Carlos; Sullivan, Patrick S.			Measuring Population Transmission Risk for HIV: An Alternative Metric of Exposure Risk in Men Who Have Sex with Men (MSM) in the US	PLOS ONE			English	Article							VIRAL LOAD; WHITE MEN; PREVENTION; INFECTION; BLACK; DISPARITIES; CARE	Background: Various metrics for HIV burden and treatment success [e.g. HIV prevalence, community viral load (CVL), population viral load (PVL), percent of HIV-positive persons with undetectable viral load] have important public health limitations for understanding disparities. Methods and Findings: Using data from an ongoing HIV incidence cohort of black and white men who have sex with men (MSM), we propose a new metric to measure the prevalence of those at risk of transmitting HIV and illustrate its value. MSM with plasma VL>400 copies/mL were defined as having 'transmission risk'. We calculated HIV prevalence, CVL, PVL, percent of HIV-positive with undetectable viral loads, and prevalence of plasma VL>400 copies/ml (%VL400) for black and white MSM. We used Monte Carlo simulation incorporating data on sexual mixing by race to estimate exposure of black and white HIV-negative MSM to a partner with transmission risk via unprotected anal intercourse (UAI). Of 709 MSM recruited, 42% (168/399) black and 14% (44/310) white MSM tested HIV-positive (p <.0001). No significant differences were seen in CVL, PVL, or percent of HIV positive with undetectable viral loads. The %VL400 was 25% (98/393) for black vs. 8% (25/310) for white MSM (p <.0001). Black MSM with 2 UAI partners were estimated to have 40% probability (95% CI: 35%, 45%) of having >= 1 UAI partner with transmission risk vs. 20% for white MSM (CI: 15%, 24%). Discussion: Despite similarities in other metrics, black MSM in our cohort are three times as likely as white MSM to have HIV transmission risk. With comparable risk behaviors, HIV-negative black MSM have a substantially higher likelihood of encountering a UAI partner at risk of transmitting HIV. Our results support increasing HIV testing, linkage to care, and antiretroviral treatment of HIV-positive MSM to reduce prevalence of those with transmission risk, particularly for black MSM.	[Kelley, Colleen F.; Frew, Paula M.; del Rio, Carlos] Emory Univ, Dept Med, Atlanta, GA 30322 USA; [Kelley, Colleen F.; Rosenberg, Eli S.; O'Hara, Brandon M.; Sanchez, Travis; Sullivan, Patrick S.] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA; [Frew, Paula M.] Emory Univ, Dept Behav Sci & Hlth Educ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Peterson, John L.] Georgia State Univ, Dept Psychol, Atlanta, GA 30303 USA; [del Rio, Carlos] Emory Univ, Hubert Dept Global Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	Emory University; Emory University; Rollins School Public Health; Emory University; Rollins School Public Health; University System of Georgia; Georgia State University; Emory University; Rollins School Public Health	Kelley, CF (corresponding author), Emory Univ, Dept Med, Atlanta, GA 30322 USA.	colleen.kelley@emory.edu	Kelley, Colleen F/O-4819-2016; del Rio, Carlos/B-3763-2012; Frew, Paula/B-4774-2012	Kelley, Colleen F/0000-0001-5611-0119; del Rio, Carlos/0000-0002-0153-3517; Sullivan, Patrick Sean/0000-0002-7728-0587; sanchez, travis/0000-0003-1133-4762; Frew, Paula/0000-0002-3078-9124	National Institutes of Health [R01-MH085600, R01-HD067111, KL2 RR025009]; Emory Center for AIDS Research [P30 AI050409]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD067111] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454, KL2TR000455] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025008, KL2RR025009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085600] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory Center for AIDS Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The study was supported by the National Institutes of Health R01-MH085600 and R01-HD067111 to PSS, KL2 RR025009 to CFK, and the Emory Center for AIDS Research P30 AI050409. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, NATL HIV AIDS STRATE; [Anonymous], 2008, MMWR MORB MORTAL WKL, V60, P694; [Anonymous], 2012, USING VIRAL LOAD DAT; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Beyrer C, 2012, LANCET, V380, P424, DOI 10.1016/S0140-6736(12)61022-8; BUCKLAND ST, 1984, BIOMETRICS, V40, P811, DOI 10.2307/2530926; Castel AD, 2012, AIDS, V26, P345, DOI 10.1097/QAD.0b013e32834de5fe; Christopoulos KA, 2011, CLIN INFECT DIS, V52, pS214, DOI 10.1093/cid/ciq045; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cohen MS, 2011, NEW ENGL J MED, V364, P1943, DOI 10.1056/NEJMra1011874; Cohen Stacy M., 2011, Morbidity and Mortality Weekly Report, V60, P1618; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; Eaton LA, 2010, AM J PUBLIC HEALTH, V100, P503, DOI 10.2105/AJPH.2008.155903; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Golden MR, 2008, JAIDS-J ACQ IMM DEF, V49, P212, DOI 10.1097/QAI.0b013e31818455e8; Goodreau SM, 2012, AIDS BEHAV, V16, P312, DOI 10.1007/s10461-010-9858-x; Hladik F, 2008, NAT REV IMMUNOL, V8, P447, DOI 10.1038/nri2302; Hollander M., 2014, NONPARAMETRIC STAT M, V3rd ed.; Johnson WD, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001230.pub2; Kilmarx PH, 2012, JAIDS-J ACQ IMM DEF, V60, P219, DOI 10.1097/QAI.0b013e3182531ba2; Marks G, 2010, SEX TRANSM DIS, V37, P325, DOI 10.1097/OLQ.0b013e3181c95dac; McQuillan GM, 2009, J ACQUIR IMMUNE DEFI; Millett GA, 2007, AIDS, V21, P2083, DOI 10.1097/QAD.0b013e3282e9a64b; Millett GA, 2012, LANCET, V380, P341, DOI 10.1016/S0140-6736(12)60899-X; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Oster AM, 2011, AIDS, V25, P1103, DOI 10.1097/QAD.0b013e3283471efa; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rosenberg ES, 2011, 6 IAS C HIV PATH TRE; Sanchez T.H., 2012, AIDS 2012 C WASH DC; Smith A., 2010, Morbidity and Mortality Weekly Report, V59, P1201; Sullivan PS, 2012, LANCET, V380, P388, DOI 10.1016/S0140-6736(12)60955-6; Sullivan PS, 2009, AIDS, V23, P1153, DOI 10.1097/QAD.0b013e32832baa34; Winter AK, 2012, JAIDS IN PRESS	34	55	55	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53284	10.1371/journal.pone.0053284	http://dx.doi.org/10.1371/journal.pone.0053284			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285274	gold, Green Published, Green Submitted			2022-12-27	WOS:000313051500128
J	Roderick, H; Mbiru, E; Coyne, D; Tripathi, L; Atkinson, HJ				Roderick, Hugh; Mbiru, Elvis; Coyne, Danny; Tripathi, Leena; Atkinson, Howard J.			Quantitative Digital Imaging of Banana Growth Suppression by Plant Parasitic Nematodes	PLOS ONE			English	Article							LEAF-AREA INDEX; RADOPHOLUS-SIMILIS; HELICOTYLENCHUS-MULTICINCTUS; MUSA SPP.; PRATYLENCHUS-GOODEYI; YIELD; AAA; RESISTANCE; DYNAMICS; COFFEAE	A digital camera fitted with a hemispherical lens was used to generate canopy leaf area index (LAI) values for a banana (Musa spp.) field trial with the aim of establishing a method for monitoring stresses on tall crop plants. The trial in Uganda consisted of two cultivars susceptible to nematodes, a plantain, Gonja manjaya and an East African Highland banana, Mbwazirume, plus a nematode resistant dessert banana, Yangambi km5. A comparative approach included adding a mixed population of Radopholus similis, Helicotylenchus multicinctus and Meloidogyne spp. to the soil around half the plants of each cultivar prior to field planting. Measurements of LAI were made fortnightly from 106 days post-planting over two successive cropping cycles. The highest mean LAI during the first cycle for Gonja manjaya was suppressed to 74.8 +/- 3.5% by the addition of nematodes, while for Mbwazirume the values were reduced to 71.1 +/- 1.9%. During the second cycle these values were 69.2 +/- 2.2% and 72.2 +/- 2.7%, respectively. Reductions in LAI values were validated as due to the biotic stress by assessing nematode numbers in roots and the necrosis they caused at each of two harvests and the relationship is described. Yield losses, including a component due to toppled plants, were 35.3% and 55.3% for Gonja manjaya and 31.4% and 55.8% for Mbwazirume, at first and second harvests respectively. Yangambi km5 showed no decrease in LAI and yield in the presence of nematodes at both harvests. LAI estimated by hemispherical photography provided a rapid basis for detecting biotic growth checks by nematodes on bananas, and demonstrated the potential of the approach for studies of growth checks to other tall crop plants caused by biotic or abiotic stresses.	[Roderick, Hugh; Atkinson, Howard J.] Univ Leeds, Ctr Plant Sci, Leeds, W Yorkshire, England; [Mbiru, Elvis; Coyne, Danny; Tripathi, Leena] Int Inst Trop Agr, Kampala, Uganda	University of Leeds	Atkinson, HJ (corresponding author), Univ Leeds, Ctr Plant Sci, Leeds, W Yorkshire, England.	h.j.atkinson@leeds.ac.uk		Mbiru, Dr James Elvis/0000-0003-3323-9467; Roderick, Hugh/0000-0002-8250-5023	BBSRC [BB/F004001/1]; IITA; Biotechnology and Biological Sciences Research Council [BB/F004001/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); IITA; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by funding from the BBSRC (grant number BB/F004001/1; http://www.bbsrc.ac.uk/home/home.aspx) and IITA (http://www.iita.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson H.J., 2003, GENETIC TRANSFORMATI, P74; BARKER KR, 1976, ANNU REV PHYTOPATHOL, V14, P327, DOI 10.1146/annurev.py.14.090176.001551; Breda NJJ, 2003, J EXP BOT, V54, P2403, DOI 10.1093/jxb/erg263; Brentu CF, 2004, NEMATOLOGY, V6, P455, DOI 10.1023/B:NEMT.0000046915.35372.0a; BRIDGE J, 1995, FUND APPL NEMATOL, V18, P251; Bridge J., 1993, Biological and integrated control of Highland banana and plantain pests and diseases: Proceedings of a Research Coordination Meeting, Cotonou, Benin 12-14 November 1991., P147; Chen JM, 1997, J GEOPHYS RES-ATMOS, V102, P29429, DOI 10.1029/97JD01107; Coyne D. L., 2007, Practical plant nematology: a field and laboratory guide; Coyne D, 2010, CROP PROT, V29, P1478, DOI 10.1016/j.cropro.2010.08.008; Fogain R, 2000, NEMATOLOGY, V2, P129, DOI 10.1163/156854100509015; Fogain R, 1998, FUND APPL NEMATOL, V21, P75; Gaidashova SV, 2010, SCI HORTIC-AMSTERDAM, V125, P316, DOI 10.1016/j.scienta.2010.04.010; Gowen Simon R., 2005, P611, DOI 10.1079/9780851997278.0611; Guan J, 2002, COMPUT ELECTRON AGR, V37, P97, DOI 10.1016/S0168-1699(02)00113-8; Hartman JB, 2010, EUPHYTICA, V172, P139, DOI 10.1007/s10681-009-0104-4; Kashaija I. N., 1994, AFRICAN J CROP SCI, V2, P99; Kreye C, 2009, FIELD CROP RES, V111, P197, DOI 10.1016/j.fcr.2008.12.007; LEBLANC S. G., 2002, P IGARSS 2002 TOR CA; Little T, 1978, AGR EXPT DESIGN ANAL; Moens T, 2006, NEMATOLOGY, V8, P45, DOI 10.1163/156854106776179999; Moens TAS, 2001, NEMATROPICA, V31, P55; Nyombi K, 2009, ANN APPL BIOL, V155, P403, DOI 10.1111/j.1744-7348.2009.00353.x; Pattison AB, 2002, INT J PEST MANAGE, V48, P107, DOI 10.1080/09670870110095737; Peper P. J., 1998, Journal of Arboriculture, V24, P98; PROT JC, 1993, J NEMATOL, V25, P277; Rich P.M., 1996, USER MANUSAL HEMI VI; Roderick H, 2012, MOL PLANT PATHOL, V13, P842, DOI 10.1111/j.1364-3703.2012.00792.x; Sarah J. L., 1996, Musa Pest Fact Sheet; SEINHORST J. W., 1965, NEMATOLOGICA, V11, P137; Snedecor G.W., 1989, AMES IOWA STATE U PR; Speijer P.R., 1997, SCREENING MUSA GERMP, VVolume 1; Tixier P, 2008, CROP PROT, V27, P1427, DOI 10.1016/j.cropro.2008.06.004; Turner DW, 1997, ACTA HORTIC, V490, P211; White MA, 2000, REMOTE SENS ENVIRON, V74, P45, DOI 10.1016/S0034-4257(00)00119-X	34	9	10	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53355	10.1371/journal.pone.0053355	http://dx.doi.org/10.1371/journal.pone.0053355			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285286	Green Published, gold			2022-12-27	WOS:000313051500141
J	Wang, T; Xu, C; Liu, YL; Fan, K; Li, ZH; Sun, X; Ouyang, H; Zhang, XC; Zhang, JH; Li, YJ; MacKenzie, F; Min, JR; Tu, XM				Wang, Tao; Xu, Chao; Liu, Yanli; Fan, Kai; Li, Zhihong; Sun, Xing; Ouyang, Hui; Zhang, Xuecheng; Zhang, Jiahai; Li, Yanjun; MacKenzie, Farrell; Min, Jinrong; Tu, Xiaoming			Crystal Structure of the Human SUV39H1 Chromodomain and Its Recognition of Histone H3K9me2/3	PLOS ONE			English	Article							METHYLTRANSFERASE SUV39H1; H3; COMPLEX; BINDING; METHYLATION; SPECIFICITY; PROTEINS; RECRUITMENT; REFINEMENT; MARKS	SUV39H1, the first identified histone lysine methyltransferase in human, is involved in chromatin modification and gene regulation. SUV39H1 contains a chromodomain in its N-terminus, which potentially plays a role in methyl-lysine recognition and SUV39H1 targeting. In this study, the structure of the chromodomain of human SUV39H1 was determined by X-ray crystallography. The SUV39H1 chromodomain displays a generally conserved structure fold compared with other solved chromodomains. However, different from other chromodomains, the SUV39H1 chromodomain possesses a much longer helix at its C-terminus. Furthermore, the SUV39H1 chromodomain was shown to recognize histone H3K9me2/3 specifically.	[Xu, Chao; Liu, Yanli; Li, Zhihong; Sun, Xing; Ouyang, Hui; Li, Yanjun; MacKenzie, Farrell; Min, Jinrong] Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada; [Xu, Chao; Liu, Yanli; Li, Zhihong; Sun, Xing; Ouyang, Hui; Li, Yanjun; MacKenzie, Farrell; Min, Jinrong] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Wang, Tao; Fan, Kai; Zhang, Jiahai; Tu, Xiaoming] Univ Sci & Technol China, Sch Life Sci, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; [Liu, Yanli; Min, Jinrong] Huazhong Normal Univ, Coll Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan, Peoples R China; [Zhang, Xuecheng] Anhui Univ, Sch Life Sci, Hefei 230039, Anhui, Peoples R China	University of Toronto; Structural Genomics Consortium; University of Toronto; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Central China Normal University; Anhui University	Min, JR (corresponding author), Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada.	jr.min@utoronto.ca; xmtu@ustc.edu.cn	Liu, Yanli/AAA-3283-2019; Xu, Chao/G-3885-2010; Tu, Xiaoming/G-5090-2018; Min, Jinrong/G-3449-2011	Liu, Yanli/0000-0003-0197-7617; Xu, Chao/0000-0003-0444-7080; Min, Jinrong/0000-0001-5210-3130; Poh, Yukkee/0000-0001-6925-8614	National Basic Research Program of China (973 Program) [2009CB918804]; Knowledge Innovation Program of the Chinese Academy of Science [KSCX2-EW-Q-4]; Chinese National Natural Science Foundations [31270780]; Structural Genomics Consortium [1097737]; Canadian Institutes for Health Research; Canadian Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institute; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Knowledge Innovation Program of the Chinese Academy of Science(Knowledge Innovation Program of the Chinese Academy of Sciences); Chinese National Natural Science Foundations(National Natural Science Foundation of China (NSFC)); Structural Genomics Consortium(University of Toronto); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institute(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the National Basic Research Program of China (973 Program), grant number 2009CB918804, the Knowledge Innovation Program of the Chinese Academy of Science, grant number KSCX2-EW-Q-4, and the Chinese National Natural Science Foundations, grant number 31270780. This work was also supported by the Structural Genomics Consortium, a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institute, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research and the Wellcome Trust to JM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors declare that they received funding from commercial sources - GlaxoSmithKline and Merck & Co., Inc. However, this does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Aagaard L, 1999, EMBO J, V18, P1923, DOI 10.1093/emboj/18.7.1923; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adams-Cioaba MA, 2009, BIOCHEM CELL BIOL, V87, P93, DOI 10.1139/O08-129; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bernstein E, 2006, MOL CELL BIOL, V26, P2560, DOI 10.1128/MCB.26.7.2560-2569.2006; Bian CB, 2011, EMBO J, V30, P2829, DOI 10.1038/emboj.2011.193; Brehm A, 2004, BIOESSAYS, V26, P133, DOI 10.1002/bies.10392; Carbone R, 2006, MOL CELL BIOL, V26, P1288, DOI 10.1128/MCB.26.4.1288-1296.2006; Chakraborty S, 2003, ONCOGENE, V22, P5229, DOI 10.1038/sj.onc.1206600; Chin HG, 2006, BIOCHEMISTRY-US, V45, P3272, DOI 10.1021/bi051997r; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Fischle W, 2008, J BIOL CHEM, V283, P19626, DOI 10.1074/jbc.M802655200; Guo YH, 2009, NUCLEIC ACIDS RES, V37, P2204, DOI 10.1093/nar/gkp086; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Kaustov L, 2011, J BIOL CHEM, V286, P521, DOI 10.1074/jbc.M110.191411; Kim D, 2010, NAT STRUCT MOL BIOL, V17, P1027, DOI 10.1038/nsmb.1856; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kuriyan J, 1997, ANNU REV BIOPH BIOM, V26, P259, DOI 10.1146/annurev.biophys.26.1.259; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Li J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025104; Liu K, 2010, P NATL ACAD SCI USA, V107, P18398, DOI 10.1073/pnas.1013106107; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Melcher M, 2000, MOL CELL BIOL, V20, P3728, DOI 10.1128/MCB.20.10.3728-3741.2000; Min JR, 2007, NAT STRUCT MOL BIOL, V14, P1229, DOI 10.1038/nsmb1340; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nayak V., 2011, NUCLEUS, V2; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Volkel P, 2007, BIOCHIMIE, V89, P1, DOI 10.1016/j.biochi.2006.07.009; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Xu C, 2008, STRUCTURE, V16, P1740, DOI 10.1016/j.str.2008.08.008; Xu C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1237; Xu C, 2010, P NATL ACAD SCI USA, V107, P19266, DOI 10.1073/pnas.1008937107; Zhang K, 2008, NAT STRUCT MOL BIOL, V15, P381, DOI 10.1038/nsmb.1406	38	56	57	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52977	10.1371/journal.pone.0052977	http://dx.doi.org/10.1371/journal.pone.0052977			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285239	gold, Green Published, Green Submitted			2022-12-27	WOS:000313051500092
J	Zhang, J; Xv, ZW; Wu, XF; Li, K				Zhang, Jun; Xv, Zhiwei; Wu, Xuefeng; Li, Ke			Potential Diagnostic Value of Serum p53 Antibody for Detecting Esophageal Cancer: A Meta-Analysis	PLOS ONE			English	Article							TRANSITIONAL-CELL CARCINOMA; ANTI-P53 ANTIBODIES; SYSTEMATIC REVIEWS; PROGNOSTIC-SIGNIFICANCE; NECK-CANCER; PROTEIN; HEAD; AUTOANTIBODIES; MARKERS; HETEROGENEITY	Background: Mutant p53 protein overexpression has been reported to induce serum antibodies against p53. Various studies assessing the diagnostic value of serum p53 antibody in patients with esophageal cancer remain controversial. This study aims to comprehensively and quantitatively summarize the potential diagnostic value of serum p53 antibody in esophageal cancer. Methods: We systematically searched PubMed and Embase until 31st May 2012, without language restriction. Studies were assessed for quality using QUADAS (quality assessment of studies of diagnostic accuracy). Positive likelihood ratio (PLR) and negative likelihood ratio (NLR) were pooled separately and compared with overall accuracy measures diagnostic odds ratio (DOR) and symmetric summary receiver operating characteristic (sROC). The PLR and NLR and their 95% confidence interval (CI) were calculated using a fixed effects model according to the Mantel-Haensed method and random effects model based on the work of Der Simonian and laird, respectively. Results: Fifteen studies (cases = 1079, controls = 2260) met the inclusion criteria for the meta-analysis. Approximately 53.33% (8/15) of the included studies were of high quality (QUADAS score >= 8), which were retrospective case-control studies. The summary estimates for quantitative analysis of serum p53 antibody in the diagnosis of esophageal cancer were PLR 6.95 (95% CI: 4.77-9.51), NLR 0.75 (95% CI: 0.72-0.78) and DOR 9.65 (95% CI: 7.04-13.22). However, we found significant heterogeneity between NLRs. Conclusions: The current evidence suggests serum p53 antibody has a potential diagnostic value for esophageal cancer. However, its discrimination power is not perfect because of low sensitivity. Impact: These results suggest that s-p53-antibody may be useful for monitoring residual tumor cells and for aiding in the selection of candidates for less invasive treatment procedures because of the high specificity of s-p53-antibody. Further studies may need to identify patterns of multiple biomarkers to further increase the power of EC detection.	[Zhang, Jun; Xv, Zhiwei; Wu, Xuefeng; Li, Ke] Shantou Univ, Coll Med, Dept Prevent Med, Shantou, Guangdong, Peoples R China	Shantou University	Zhang, J (corresponding author), Shantou Univ, Coll Med, Dept Prevent Med, Shantou, Guangdong, Peoples R China.	xzwhello@hotmail.com; kli@stu.edu.cn	xiaoxiao, zhang/HHN-4916-2022					Akere A., 2007, SMJ Singapore Medical Journal, V48, P41; Al Kassam D, 2007, MED CLIN-BARCELONA, V129, P761, DOI 10.1157/13113764; Angelopoulou K, 1998, CANCER, V78, P2146; Atta MM, 2008, CLIN BIOCHEM, V41, P1131, DOI 10.1016/j.clinbiochem.2008.06.006; Attallah AM, 2009, CLIN BIOCHEM, V42, P455, DOI 10.1016/j.clinbiochem.2008.11.004; Cai HY, 2008, WORLD J GASTROENTERO, V14, P4082, DOI 10.3748/wjg.14.4082; Cawley HM, 1998, GASTROENTEROLOGY, V115, P19, DOI 10.1016/S0016-5085(98)70360-9; Chen W, 2004, ANTICANCER RES, V24, P3245; Chow V, 2001, HEAD NECK-J SCI SPEC, V23, P286, DOI 10.1002/hed.1032; Clarke M, 2003, COCHRANE REV HDB 4 2; de Sousa MR, 2009, ARQ BRAS CARDIOL, V92, P241, DOI 10.1590/S0066-782X2009000300013; Deeks JJ, 2005, J CLIN EPIDEMIOL, V58, P882, DOI 10.1016/j.jclinepi.2005.01.016; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Deville Walter L, 2002, BMC Med Res Methodol, V2, P9, DOI 10.1186/1471-2288-2-9; DICKERSIN K, 1994, BMJ-BRIT MED J, V309, P1286, DOI 10.1136/bmj.309.6964.1286; Dinnes J, 2005, HEALTH TECHNOL ASSES, V9, P1, DOI 10.3310/hta9120; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gadelhak NA, 2009, HEPATO-GASTROENTEROL, V56, P1417; Gallagher EJ, 1998, ANN EMERG MED, V31, P391, DOI 10.1016/S0196-0644(98)70352-X; Glas AS, 2003, J CLIN EPIDEMIOL, V56, P1129, DOI 10.1016/S0895-4356(03)00177-X; Gu P, 2007, J CLIN LAB ANAL, V21, P398, DOI 10.1002/jcla.20208; Hagiwara Nobutoshi, 2000, Journal of Nippon Medical School, V67, P110, DOI 10.1272/jnms.67.110; Hammel P, 1999, INT J CANCER, V81, P712, DOI 10.1002/(SICI)1097-0215(19990531)81:5<712::AID-IJC7>3.0.CO;2-0; Hammel P, 1997, GUT, V40, P356, DOI 10.1136/gut.40.3.356; Himoto T, 2005, INT J ONCOL, V27, P1079; Honest H, 2002, BMC HEALTH SERV RES, V2, DOI 10.1186/1472-6963-2-4; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jones CM, 2005, ANN THORAC SURG, V79, P16, DOI 10.1016/j.athoracsur.2004.09.040; Kato H, 2005, ANTICANCER RES, V25, P3231; Kaur J, 1997, INT J CANCER, V74, P609, DOI 10.1002/(SICI)1097-0215(19971219)74:6<609::AID-IJC9>3.0.CO;2-Y; Khan K.S., 2001, UNDERTAKING SYSTEMAT; Kozlowski M, 2001, FOLIA HISTOCHEM CYTO, V39, P173; LAURENTPUIG P, 1995, GUT, V36, P455, DOI 10.1136/gut.36.3.455; LEVINE AJ, 1991, NATURE, V351, P453, DOI 10.1038/351453a0; Lijmer JG, 2002, STAT MED, V21, P1525, DOI 10.1002/sim.1185; Looi K, 2006, ONCOL REP, V16, P1105; LUBIN R, 1995, NAT MED, V1, P701, DOI 10.1038/nm0795-701; Maass JD, 1997, ANTICANCER RES, V17, P2873; Maehara Y, 1999, CANCER, V85, P302, DOI 10.1002/(SICI)1097-0142(19990115)85:2<302::AID-CNCR6>3.0.CO;2-6; Martin J, 2006, SYSTEMATIC REV EVALU; MARXSEN J, 1994, BRIT J CANCER, V70, P1031, DOI 10.1038/bjc.1994.443; Megliorino R, 2005, CANCER DETECT PREV, V29, P241, DOI 10.1016/j.cdp.2005.03.002; Muller M, 2006, INT J ONCOL, V29, P973; Ohshio G, 2002, J GASTROINTEST CANC, V31, P129, DOI 10.1385/IJGC:31:1-3:129; Parashar K, 1998, MUTAT RES-FUND MOL M, V422, P271, DOI 10.1016/S0027-5107(98)00207-3; Polge A, 1998, DIGEST DIS SCI, V43, P1434, DOI 10.1023/A:1018890126260; Raedle J, 1996, PANCREAS, V13, P241, DOI 10.1097/00006676-199610000-00005; Ralhan R, 2000, INT J CANCER, V85, P791, DOI 10.1002/(SICI)1097-0215(20000315)85:6&lt;791::AID-IJC9&gt;3.0.CO;2-K; Sanchez-Carbayo M, 1999, ANTICANCER RES, V19, P3531; Shimada H, 2000, CANCER-AM CANCER SOC, V89, P1677, DOI 10.1002/1097-0142(20001015)89:8<1677::AID-CNCR5>3.0.CO;2-9; Shimada H, 2003, CANCER-AM CANCER SOC, V97, P682, DOI 10.1002/cncr.11092; Shimada H, 2002, SURGERY, V132, P41, DOI 10.1067/msy.2002.125307; Shimada H, 2000, EXISTENCE SERUM P53; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Smidt N, 2011, COCHRANE HDB SYSTEMA; Soussi T, 2006, INT J CANCER, V57, P1; TRIVERS GE, 1995, J NATL CANCER I, V87, P1400, DOI 10.1093/jnci/87.18.1400; Walter SD, 2002, STAT MED, V21, P1237, DOI 10.1002/sim.1099; Wang Ming-Hui, 2004, Ai Zheng, V23, P467; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Wollenberg B, 1997, ANTICANCER RES, V17, P413; Wu M, 2010, MOL BIOL REP, V37, P339, DOI 10.1007/s11033-009-9744-7; Wunderlich H, 2000, UROL INT, V64, P13, DOI 10.1159/000030475; Zamora Javier, 2006, BMC Med Res Methodol, V6, P31, DOI 10.1186/1471-2288-6-31; Zhang JY, 2007, J HEPATOL, V46, P107, DOI 10.1016/j.jhep.2006.08.010; Zhou SL, 2010, WORLD J GASTROENTERO, V16, P2348, DOI 10.3748/wjg.v16.i19.2348	66	11	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52896	10.1371/journal.pone.0052896	http://dx.doi.org/10.1371/journal.pone.0052896			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285221	Green Published, Green Submitted, gold			2022-12-27	WOS:000313051500078
J	Lutermann, H; Bodenstein, C; Bennett, NC				Lutermann, Heike; Bodenstein, Chimone; Bennett, Nigel C.			Natural Parasite Infection Affects the Tolerance but Not the Response to a Simulated Secondary Parasite Infection	PLOS ONE			English	Article							IMMUNOCOMPETENCE HANDICAP HYPOTHESIS; HOTTENTOTUS-PRETORIAE RODENTIA; HIGHVELD MOLE-RAT; HELMINTH-PARASITES; STRESS HORMONES; HOST MORPHOLOGY; ENERGETIC COSTS; IMMUNE FUNCTION; TESTOSTERONE; MALARIA	Parasites deplete the resources of their host and can consequently affect the investment in competing traits (e. g. reproduction and immune defence). The immunocompetence handicap hypothesis posits that testosterone (T) mediates trade-offs between parasite defence and reproductive investment by suppressing immune function in male vertebrates while more recently a role for glucocorticoids (e. g. cortisol (C)) in resource allocation has been suggested. These hypotheses however, have not always found support in wild animals, possibly because most studies focus on a single parasite species, whereas infections with multiple parasites are the rule in nature. We measured body mass, T-and C-levels of wild male highveld mole-rats (Cryptomys hottentotus pretoriae) naturally uninfected or infected with a cestode (Mathevotaenia sp.) right after capture. Subsequently, we injected animals subcutaneously with a lipopolysaccharide (LPS) to simulate a bacterial infection and recorded changes in body mass, food intake, haematological parameters and hormone levels. As a control, animals were injected with saline. Natural infection neither affected initial body mass nor C-levels, whereas infected males had significantly reduced T-levels. We observed significant reductions in food intake, body mass and T in response to LPS but not saline while C increased. However, this response did not vary with infection status. In contrast, final body mass and some haematological parameters were significantly lowered in infected males. Our results suggest that naturally infected males are able to compensate for resource depletion by physiological adjustments. However, this leaves them less tolerant to the challenges of a secondary infection.	[Lutermann, Heike; Bodenstein, Chimone; Bennett, Nigel C.] Univ Pretoria, Dept Zool & Entomol, Hatfield, South Africa	University of Pretoria	Lutermann, H (corresponding author), Univ Pretoria, Dept Zool & Entomol, Private Bag X20, Hatfield, South Africa.	hlutermann@Zool.up.ac.za	Lutermann, Heike/A-4692-2008; Bennett, Nigel/E-4238-2010	Lutermann, Heike/0000-0002-7521-2302; Bennett, Nigel/0000-0001-9748-2947	Department of Science and Technology/National Research Foundation South African Research Chair for Behavioural Ecology and Physiology; University of Pretoria	Department of Science and Technology/National Research Foundation South African Research Chair for Behavioural Ecology and Physiology; University of Pretoria	This project was funded by the Department of Science and Technology/National Research Foundation South African Research Chair for Behavioural Ecology and Physiology to NCB. In addition, HL acknowledges funding through a Research Fellowship by the University of Pretoria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Raddad LJ, 2006, SCIENCE, V314, P1603, DOI 10.1126/science.1132338; Adelman JS, 2009, INTEGR COMP BIOL, V49, P202, DOI 10.1093/icb/icp028; Barthelemy M, 2004, PARASITOL RES, V93, P475, DOI 10.1007/s00436-004-1160-2; Beldomenico PM, 2008, J ANIM ECOL, V77, P984, DOI 10.1111/j.1365-2656.2008.01413.x; Blatteis CM, 2006, PHARMACOL THERAPEUT, V111, P194, DOI 10.1016/j.pharmthera.2005.10.013; Bordes F, 2009, PARASITOL RES, V106, P33, DOI 10.1007/s00436-009-1623-6; Canale CI, 2011, FUNCT ECOL, V25, P557, DOI 10.1111/j.1365-2435.2010.01815.x; Candolin U, 2001, PARASITOLOGY, V122, P457, DOI 10.1017/S0031182001007600; Christe P, 1996, ANIM BEHAV, V52, P1087, DOI 10.1006/anbe.1996.0256; CONN CA, 1995, J APPL PHYSIOL, V78, P466, DOI 10.1152/jappl.1995.78.2.466; Davis AK, 2008, FUNCT ECOL, V22, P760, DOI 10.1111/j.1365-2435.2008.01467.x; DELAHAY RJ, 1995, PARASITOLOGY, V110, P473, DOI 10.1017/S0031182000064817; Demas GE, 2011, FUNCT ECOL, V25, P29, DOI 10.1111/j.1365-2435.2010.01738.x; Dhabhar FS, 2009, NEUROIMMUNOMODULAT, V16, P300, DOI 10.1159/000216188; Dhabhar FS, 2002, BRAIN BEHAV IMMUN, V16, P785, DOI 10.1016/S0889-1591(02)00036-3; Elias D, 2006, TROP MED INT HEALTH, V11, P551, DOI 10.1111/j.1365-3156.2006.01578.x; Elsheikha HM, 2011, ESSENTIALS OF VETERINARY PARASITOLOGY, P1; Engeland CG, 2003, PSYCHONEUROENDOCRINO, V28, P970, DOI 10.1016/S0306-4530(02)00118-X; Evans MR, 2000, BEHAV ECOL SOCIOBIOL, V47, P156, DOI 10.1007/s002650050006; Ezenwa VO, 2012, FUNCT ECOL, V26, P123, DOI 10.1111/j.1365-2435.2011.01919.x; Ezenwa VO, 2010, AM NAT, V176, P613, DOI 10.1086/656496; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; French SS, 2007, J EXP BIOL, V210, P2859, DOI 10.1242/jeb.005348; Fuxjager MJ, 2011, FUNCT ECOL, V25, P132, DOI 10.1111/j.1365-2435.2010.01784.x; Goymann W, 2004, ANIM BEHAV, V67, P591, DOI 10.1016/j.anbehav.2003.08.007; Grech K, 2006, J EVOLUTION BIOL, V19, P1620, DOI 10.1111/j.1420-9101.2006.01116.x; Johnson RW, 1996, AM J PHYSIOL-REG I, V270, pR192, DOI 10.1152/ajpregu.1996.270.1.R192; Khokhlova IS, 2002, J ZOOL, V258, P349, DOI 10.1017/S0952836902001498; Knowles SCL, 2011, INT J PARASITOL, V41, P1041, DOI 10.1016/j.ijpara.2011.05.009; Kristan DM, 2000, J EXP BIOL, V203, P3495; Kristan DM, 2006, J COMP PHYSIOL B, V176, P139, DOI 10.1007/s00360-005-0036-9; Kristan DM, 2002, J EXP BIOL, V205, P3955; Lennie TA, 2001, PHYSIOL BEHAV, V73, P517, DOI 10.1016/S0031-9384(01)00480-2; Macnab V, 2011, HORM BEHAV, V60, P371, DOI 10.1016/j.yhbeh.2011.07.005; Maizels RM, 2004, IMMUNOL REV, V201, P89, DOI 10.1111/j.0105-2896.2004.00191.x; Maizels RM, 2003, NAT REV IMMUNOL, V3, P733, DOI 10.1038/nri1183; Malherbe GP, 2004, J ZOOL, V263, P159, DOI 10.1017/S0952836904004996; Martin LB, 2009, GEN COMP ENDOCR, V163, P70, DOI 10.1016/j.ygcen.2009.03.008; McEwen BS, 2003, HORM BEHAV, V43, P2, DOI 10.1016/S0018-506X(02)00024-7; Mills SC, 2009, AM NAT, V173, P475, DOI 10.1086/597222; MOLLER AP, 1995, TRENDS ECOL EVOL, V10, P121, DOI 10.1016/S0169-5347(00)89008-4; Nilsson JA, 2003, BEHAV ECOL, V14, P175, DOI 10.1093/beheco/14.2.175; Oppliger A, 1998, ECOL LETT, V1, P129; Owen-Ashley NT, 2004, AM NAT, V164, P490, DOI 10.1086/423714; Pedersen AB, 2007, TRENDS ECOL EVOL, V22, P133, DOI 10.1016/j.tree.2006.11.005; Pedersen AB, 2011, MOL ECOL, V20, P872, DOI 10.1111/j.1365-294X.2010.04938.x; Petney TN, 1998, INT J PARASITOL, V28, P377, DOI 10.1016/S0020-7519(97)00189-6; Poiani A, 2000, BEHAV ECOL SOCIOBIOL, V47, P230, DOI 10.1007/s002650050660; Roberts ML, 2004, ANIM BEHAV, V68, P227, DOI 10.1016/j.anbehav.2004.05.001; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Scantlebury M, 2007, P ROY SOC B-BIOL SCI, V274, P2169, DOI 10.1098/rspb.2007.0690; Schwanz LE, 2006, J EXP BIOL, V209, P5029, DOI 10.1242/jeb.02601; Smith FV, 1996, ANIM BEHAV, V52, P141, DOI 10.1006/anbe.1996.0160; Stearns SC, 1992, EVOLUTION LIFE HIST; Stockham SL., 2008, FUNDAMENTALS VET CLI, V2nd; Tizard I.R., 2004, VET IMMUNOLOGY INTRO, P67; van Rensburg LJ, 2003, J ZOOL, V260, P73, DOI 10.1017/S0952836903003443; van Rensburg LJ, 2002, CAN J ZOOL, V80, P810, DOI 10.1139/Z02-051; Viljoen H, 2011, J ZOOL, V285, P222, DOI 10.1111/j.1469-7998.2011.00833.x; Viljoen H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027003; Zala SM, 2004, BEHAV ECOL, V15, P338, DOI 10.1093/beheco/arh022	62	13	13	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52077	10.1371/journal.pone.0052077	http://dx.doi.org/10.1371/journal.pone.0052077			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300593	Green Published, gold, Green Submitted			2022-12-27	WOS:000312829100018
J	Manohar, A; Flint, RD; Knudsen, E; Moxon, KA				Manohar, Anitha; Flint, Robert D.; Knudsen, Eric; Moxon, Karen A.			Decoding Hindlimb Movement for a Brain Machine Interface after a Complete Spinal Transection	PLOS ONE			English	Article							PYRAMIDAL TRACT ACTIVITY; MOTOR CORTEX; ENSEMBLE ACTIVITY; MUSCULAR-ACTIVITY; CORTICAL-NEURONS; NEURAL ACTIVITY; PLASTICITY; LOCOMOTION; RESTORATION; RESPONSES	Stereotypical locomotor movements can be made without input from the brain after a complete spinal transection. However, the restoration of functional gait requires descending modulation of spinal circuits to independently control the movement of each limb. To evaluate whether a brain-machine interface (BMI) could be used to regain conscious control over the hindlimb, rats were trained to press a pedal and the encoding of hindlimb movement was assessed using a BMI paradigm. Off-line, information encoded by neurons in the hindlimb sensorimotor cortex was assessed. Next neural population functions, or weighted representations of the neuronal activity, were used to replace the hindlimb movement as a trigger for reward in real-time (on-line decoding) in three conditions: while the animal could still press the pedal, after the pedal was removed and after a complete spinal transection. A novel representation of the motor program was learned when the animals used neural control to achieve water reward (e.g. more information was conveyed faster). After complete spinal transection, the ability of these neurons to convey information was reduced by more than 40%. However, this BMI representation was relearned over time despite a persistent reduction in the neuronal firing rate during the task. Therefore, neural control is a general feature of the motor cortex, not restricted to forelimb movements, and can be regained after spinal injury.	[Manohar, Anitha; Flint, Robert D.; Knudsen, Eric; Moxon, Karen A.] Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA; [Moxon, Karen A.] Drexel Univ, Dept Neurobiol & Anat, Coll Med, Philadelphia, PA 19104 USA	Drexel University; Drexel University	Moxon, KA (corresponding author), Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA.	km57@drexel.edu	Moxon, Karen/K-7407-2012; Manohar, Anitha/AAU-4257-2020	Moxon, Karen/0000-0002-5790-097X; Manohar, Anitha/0000-0002-3011-2623	National Institutes of Health [NS057419]; Shriners Hospital for Children [89500]; Internationale Stiftung fur Forschung in Paraplegie [P113]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shriners Hospital for Children; Internationale Stiftung fur Forschung in Paraplegie	This work was supported by grant NS057419 from the National Institutes of Health, grant 89500 from Shriners Hospital for Children, and grant P113 from the Internationale Stiftung fur Forschung in Paraplegie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar J, 2010, J NEUROSCI, V30, P7528, DOI 10.1523/JNEUROSCI.0379-10.2010; Belanger M, 1996, J NEUROPHYSIOL, V76, P471, DOI 10.1152/jn.1996.76.1.471; Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; Chapin JK, 1999, J NEUROSCI METH, V94, P121, DOI 10.1016/S0165-0270(99)00130-2; Chapin JK, 1999, NAT NEUROSCI, V2, P664, DOI 10.1038/10223; Drew T, 1996, EXP BRAIN RES, V111, P153; Drew T, 1996, CAN J PHYSIOL PHARM, V74, P426, DOI 10.1139/cjpp-74-4-426; Drew T, 2008, J PHYSIOL-LONDON, V586, P1239, DOI 10.1113/jphysiol.2007.146605; Drew T, 2008, BRAIN RES REV, V57, P199, DOI 10.1016/j.brainresrev.2007.07.017; Ethier C, 2012, NATURE, V485, P368, DOI 10.1038/nature10987; EVARTS EV, 1966, J NEUROPHYSIOL, V29, P1011, DOI 10.1152/jn.1966.29.6.1011; EVARTS EV, 1976, J NEUROPHYSIOL, V39, P1069, DOI 10.1152/jn.1976.39.5.1069; EVARTS EV, 1968, J NEUROPHYSIOL, V31, P14, DOI 10.1152/jn.1968.31.1.14; EVARTS EV, 1969, J NEUROPHYSIOL, V32, P375, DOI 10.1152/jn.1969.32.3.375; Fagg AH, 2009, IEEE T NEUR SYS REH, V17, P487, DOI 10.1109/TNSRE.2009.2029313; FETZ EB, 1971, SCIENCE, V174, P431, DOI 10.1126/science.174.4007.431; Fetz EE, 2007, J PHYSIOL-LONDON, V579, P571, DOI 10.1113/jphysiol.2006.127142; FETZ EE, 1969, SCIENCE, V163, P955, DOI 10.1126/science.163.3870.955; Fitzsimmons NA, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.003.2009; Francis JT, 2006, IEEE T NEUR SYS REH, V14, P172, DOI 10.1109/TNSRE.2006.875553; Ganguly K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000153; Hermer-Vazquez L, 2004, BEHAV BRAIN RES, V150, P93, DOI 10.1016/S0166-4328(03)00226-2; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Hyland B, 1998, BEHAV BRAIN RES, V94, P255, DOI 10.1016/S0166-4328(97)00157-5; Jarosiewicz B, 2008, P NATL ACAD SCI USA, V105, P19486, DOI 10.1073/pnas.0808113105; Jones TA, 1999, J NEUROSCI, V19, P10153; Kao TSJ, 2011, J NEUROPHYSIOLOGY; Kennedy PR, 2000, IEEE T REHABIL ENG, V8, P198, DOI 10.1109/86.847815; Kennedy PR, 1998, NEUROREPORT, V9, P1707, DOI 10.1097/00001756-199806010-00007; Kleim JA, 2002, NEUROBIOL LEARN MEM, V77, P63, DOI 10.1006/nlme.2000.4004; Kleim JA, 1998, J NEUROPHYSIOL, V80, P3321, DOI 10.1152/jn.1998.80.6.3321; Kleim JA, 1998, NEUROBIOL LEARN MEM, V69, P274, DOI 10.1006/nlme.1998.3827; Laubach M, 1999, J NEUROSCI METH, V94, P141, DOI 10.1016/S0165-0270(99)00131-4; Lebedev MA, 2008, J NEUROPHYSIOL, V99, P166, DOI 10.1152/jn.00734.2007; Lebedev MA, 2006, TRENDS NEUROSCI, V29, P536, DOI 10.1016/j.tins.2006.07.004; Leergaard TB, 2004, J COMP NEUROL, V478, P306, DOI 10.1002/cne.20289; Magri C, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-81; Monfils MH, 2005, NEUROSCIENTIST, V11, P471, DOI 10.1177/1073858405278015; Moritz CT, 2008, NATURE, V456, P639, DOI 10.1038/nature07418; Moxon KA, 2008, NEUROSCIENCE, V156, P1083, DOI 10.1016/j.neuroscience.2008.08.009; Nicolelis MAL, 2001, NATURE, V409, P403, DOI 10.1038/35053191; Nudo RJ, 2001, MUSCLE NERVE, V24, P1000, DOI 10.1002/mus.1104; Nudo RJ, 1996, J NEUROSCI, V16, P785; Pohlmeyer EA, 2007, J NEURAL ENG, V4, P369, DOI 10.1088/1741-2560/4/4/003; Schwartz AB, 2006, NEURON, V52, P205, DOI 10.1016/j.neuron.2006.09.019; Serruya M, 2003, BIOL CYBERN, V88, P219, DOI 10.1007/s00422-002-0374-6; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; Song WG, 2011, J NEUROSCI, V31, P3110, DOI 10.1523/JNEUROSCI.2335-10.2011; Song WG, 2009, IEEE T BIO-MED ENG, V56, P2712, DOI 10.1109/TBME.2009.2026284; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; THACH WT, 1978, J NEUROPHYSIOL, V41, P654, DOI 10.1152/jn.1978.41.3.654; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582; WIDAJEWICZ W, 1994, J NEUROPHYSIOL, V72, P2070, DOI 10.1152/jn.1994.72.5.2070; Zacksenhouse M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000619; Zhang H, 2010, IEEE ENG MED BIO, P4124, DOI 10.1109/IEMBS.2010.5627320	56	24	24	7	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52173	10.1371/journal.pone.0052173	http://dx.doi.org/10.1371/journal.pone.0052173			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300606	Green Submitted, Green Published, gold			2022-12-27	WOS:000312829100026
J	Traynham, CJ; Roof, SR; Wang, HL; Prosak, RA; Tang, LF; Viatchenko-Karpinski, S; Ho, HT; Racoma, IO; Catalano, DJ; Huang, X; Han, YB; Kim, SU; Gyorke, S; Billman, GE; Villamena, FA; Ziolo, MT				Traynham, Christopher J.; Roof, Steve R.; Wang, Honglan; Prosak, Robert A.; Tang, Lifei; Viatchenko-Karpinski, Serge; Ho, Hsiang-Ting; Racoma, Ira O.; Catalano, Dominic J.; Huang, Xin; Han, Yongbin; Kim, Shang-U; Gyorke, Sandor; Billman, George E.; Villamena, Frederick A.; Ziolo, Mark T.			Diesterified Nitrone Rescues Nitroso-Redox Levels and Increases Myocyte Contraction Via Increased SR Ca2+ Handling	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; RADICAL-ANION ADDUCT; MITOCHONDRIAL ELECTRON-TRANSPORT; SUDDEN CARDIAC DEATH; OXYGEN-FREE RADICALS; HEART-FAILURE; XANTHINE-OXIDASE; VENTRICULAR MYOCYTES; PHOSPHOLAMBAN PHOSPHORYLATION; UNIMOLECULAR DECOMPOSITION	Nitric oxide (NO) and superoxide (O-2(-)) are important cardiac signaling molecules that regulate myocyte contraction. For appropriate regulation, NO and O-2(center dot-) must exist at defined levels. Unfortunately, the NO and O-2(center dot-) levels are altered in many cardiomyopathies (heart failure, ischemia, hypertrophy, etc.) leading to contractile dysfunction and adverse remodeling. Hence, rescuing the nitroso-redox levels is a potential therapeutic strategy. Nitrone spin traps have been shown to scavenge O-2(center dot-) while releasing NO as a reaction byproduct; and we synthesized a novel, cell permeable nitrone, 2-2-3,4-dihydro-2H-pyrrole 1-oxide (EMEPO). We hypothesized that EMEPO would improve contractile function in myocytes with altered nitroso-redox levels. Ventricular myocytes were isolated from wildtype (C57Bl/6) and NOS1 knockout (NOS1(-/-)) mice, a known model of NO/O-2(center dot-) imbalance, and incubated with EMEPO. EMEPO significantly reduced O-2(center dot-) (lucigenin-enhanced chemiluminescence) and elevated NO (DAF-FM diacetate) levels in NOS1(-/-) myocytes. Furthermore, EMEPO increased NOS1(-/-) myocyte basal contraction (Ca2+ transients, Fluo-4AM; shortening, video-edge detection), the force-frequency response and the contractile response to beta-adrenergic stimulation. EMEPO had no effect in wildtype myocytes. EMEPO also increased ryanodine receptor activity (sarcoplasmic reticulum Ca2+ leak/load relationship) and phospholamban Serine16 phosphorylation (Western blot). We also repeated our functional experiments in a canine post-myocardial infarction model and observed similar results to those seen in NOS1(-/-) myocytes. In conclusion, EMEPO improved contractile function in myocytes experiencing an imbalance of their nitroso-redox levels. The concurrent restoration of NO and O-2(center dot-) levels may have therapeutic potential in the treatment of various cardiomyopathies.	[Traynham, Christopher J.; Roof, Steve R.; Wang, Honglan; Tang, Lifei; Viatchenko-Karpinski, Serge; Catalano, Dominic J.; Huang, Xin; Gyorke, Sandor; Billman, George E.; Ziolo, Mark T.] Ohio State Univ, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Prosak, Robert A.; Ho, Hsiang-Ting; Racoma, Ira O.; Han, Yongbin; Kim, Shang-U; Villamena, Frederick A.] Ohio State Univ, Dept Pharmacol, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Ziolo, MT (corresponding author), Ohio State Univ, Dept Physiol & Cell Biol, Columbus, OH 43210 USA.	ziolo.1@osu.edu	Ziolo, Mark/E-4371-2011; Villamena, Frederick/E-4248-2011; Billman, George E/E-2758-2011	Villamena, Frederick/0000-0002-7330-8431; Catalano, Dominic/0000-0002-5736-7888	National Institutes of Health [R01-HL079283, K02-HL094692, R01-HL81248, F31 HL096435]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079283, F31HL096435, K02HL094692, R01HL081248] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by the National Institutes of Health (R01-HL079283, K02-HL094692, MTZ; R01-HL81248, FAV; F31 HL096435 CJT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBROSIO G, 1993, J BIOL CHEM, V268, P18532; Barouch LA, 2002, NATURE, V416, P337, DOI 10.1038/416337a; Belevych AE, 2009, CARDIOVASC RES, V84, P387, DOI 10.1093/cvr/cvp246; Billman GE, 2006, PHARMACOL THERAPEUT, V111, P808, DOI 10.1016/j.pharmthera.2006.01.002; Campbell DL, 1996, J GEN PHYSIOL, V108, P277, DOI 10.1085/jgp.108.4.277; Cappola TP, 2001, CIRCULATION, V104, P2407, DOI 10.1161/hc4501.098928; Damy T, 2004, LANCET, V363, P1365, DOI 10.1016/S0140-6736(04)16048-0; Dawson D, 2005, CIRCULATION, V112, P3729, DOI 10.1161/CIRCULATIONAHA.105.539437; Floyd RA, 2000, ANN NY ACAD SCI, V899, P222; Gonzalez DR, 2007, P NATL ACAD SCI USA, V104, P20612, DOI 10.1073/pnas.0706796104; Gonzalez DR, 2010, J BIOL CHEM, V285, P28938, DOI 10.1074/jbc.M110.154948; Hare JM, 2005, J CLIN INVEST, V115, P509, DOI 10.1172/JCI200524459; Hare JM, 2004, NEW ENGL J MED, V351, P2112, DOI 10.1056/NEJMe048269; Hare JM, 2008, J AM COLL CARDIOL, V51, P2301, DOI 10.1016/j.jacc.2008.01.068; Heymes C, 2003, J AM COLL CARDIOL, V41, P2164, DOI 10.1016/S0735-1097(03)00471-6; HUANG PL, 1993, CELL, V75, P1273, DOI 10.1016/0092-8674(93)90615-W; Ide T, 1999, CIRC RES, V85, P357, DOI 10.1161/01.RES.85.4.357; INANAMI O, 1995, FREE RADICAL RES, V23, P33, DOI 10.3109/10715769509064017; Khan SA, 2004, P NATL ACAD SCI USA, V101, P15944, DOI 10.1073/pnas.0404136101; Khan SA, 2003, CIRC RES, V92, P1322, DOI 10.1161/01.RES.0000078171.52542.9E; Kinugawa S, 2005, CIRC RES, V96, P355, DOI 10.1161/01.RES.0000155331.09458.A7; Kogler H, 2003, CARDIOVASC RES, V59, P582, DOI 10.1016/S0008-6363(03)00512-1; Kohr Mark J, 2010, Front Biosci (Elite Ed), V2, P614, DOI 10.2741/e118; Kohr MJ, 2010, J MOL CELL CARDIOL, V48, P645, DOI 10.1016/j.yjmcc.2010.01.007; Kuster GM, 2010, FREE RADICAL BIO MED, V48, P1182, DOI 10.1016/j.freeradbiomed.2010.01.038; Layland J, 2002, J PHYSIOL-LONDON, V540, P457, DOI 10.1113/jphysiol.2001.014126; Liu Y, 2010, MOL CELL BIOCHEM, V343, P143, DOI 10.1007/s11010-010-0508-4; Locigno EJ, 2005, ORG BIOMOL CHEM, V3, P3220, DOI 10.1039/b507530k; Nediani C, 2011, ANTIOXID REDOX SIGN, V14, P289, DOI 10.1089/ars.2010.3198; Roof SR, 2012, NITRIC OXID IN PRESS; Roof SR, 2011, AM J PHYSIOL-HEART C, V301, pH1570, DOI 10.1152/ajpheart.00402.2011; Saavedra WF, 2002, CIRC RES, V90, P297, DOI 10.1161/hh0302.104531; Sam F, 2005, J CARD FAIL, V11, P473, DOI 10.1016/j.cardfail.2005.01.007; Saraiva RM, 2005, CIRCULATION, V112, P3415, DOI 10.1161/CIRCULATIONAHA.105.557892; Sears CE, 2003, CIRC RES, V92, pE52, DOI 10.1161/01.RES.0000064585.95749.6D; Takimoto E, 2005, J CLIN INVEST, V115, P1221, DOI 10.1172/JCI200521968; Taylor AL, 2004, NEW ENGL J MED, V351, P2049, DOI 10.1056/NEJMoa042934; Villamena FA, 2005, J PHYS CHEM A, V109, P1662, DOI 10.1021/jp0451492; Villamena FA, 2010, J PHYS CHEM A, V114, P1153, DOI 10.1021/jp909614u; Villamena FA, 2009, J PHYS CHEM A, V113, P6398, DOI 10.1021/jp902269t; Wang H, 2008, AM J PHYSIOL-CELL PH, V294, pC1566, DOI 10.1152/ajpcell.00367.2007; Wang HL, 2010, J PHYSIOL-LONDON, V588, P2905, DOI 10.1113/jphysiol.2010.192617; Wildhirt SM, 1999, CARDIOVASC RES, V43, P698, DOI 10.1016/S0008-6363(99)00080-2; Xie H, 2006, BIOPHYS J, V91, P2882, DOI 10.1529/biophysj.106.087338; Zhang GX, 2005, CARDIOVASC RES, V65, P230, DOI 10.1016/j.cardiores.2004.08.013; Zhang YH, 2008, CIRC RES, V102, P242, DOI 10.1161/CIRCRESAHA.107.164798; Zhang YH, 2009, BBA-BIOENERGETICS, V1787, P811, DOI 10.1016/j.bbabio.2009.03.020; Zima AV, 2006, CARDIOVASC RES, V71, P310, DOI 10.1016/j.cardiores.2006.02.019; Ziolo MT, 2004, CIRCULATION, V109, P1886, DOI 10.1161/01.CIR.0000124231.98250.A8; Zuo L, 2009, J PHARMACOL EXP THER, V329, P515, DOI 10.1124/jpet.108.143479	50	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52005	10.1371/journal.pone.0052005	http://dx.doi.org/10.1371/journal.pone.0052005			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300588	Green Published, gold, Green Submitted			2022-12-27	WOS:000312829100017
J	Zeng, WB; Chen, YC; Bai, Y; Trang, P; Vu, GP; Lu, SW; Wu, JG; Liu, FY				Zeng, Wenbo; Chen, Yuan-Chuan; Bai, Yong; Phong Trang; Gia-Phong Vu; Lu, Sangwei; Wu, Jianguo; Liu, Fenyong			Effective Inhibition of Human Immunodeficiency Virus 1 Replication by Engineered RNase P Ribozyme	PLOS ONE			English	Article							EXTERNAL GUIDE SEQUENCES; IN-VITRO SELECTION; HIV-1 REPLICATION; ESCHERICHIA-COLI; MESSENGER-RNA; CATALYTIC SUBUNIT; CURRENT PROGRESS; GENE-EXPRESSION; RIBONUCLEASE-P; ENZYME	Using an in vitro selection procedure, we have previously isolated RNase P ribozyme variants that efficiently cleave an mRNA sequence in vitro. In this study, a variant was used to target the HIV RNA sequence in the tat region. The variant cleaved the tat RNA sequence in vitro about 20 times more efficiently than the wild type ribozyme. Our results provide the first direct evidence that combined mutations at nucleotide 83 and 340 of RNase P catalytic RNA from Escherichia coli (G(83) - > U-83 and G(340) -> A(340)) increase the overall efficiency of the ribozyme in cleaving an HIV RNA sequence. Moreover, the variant is more effective in reducing HIV-1 p24 expression and intracellular viral RNA level in cells than the wild type ribozyme. A reduction of about 90% in viral RNA level and a reduction of 150 fold in viral growth were observed in cells that expressed the variant, while a reduction of less than 10% was observed in cells that either did not express the ribozyme or produced a catalytically inactive ribozyme mutant. Thus, engineered ribozyme variants are effective in inhibiting HIV infection. These results also demonstrate the potential of engineering RNase P ribozymes for anti-HIV application.	[Zeng, Wenbo; Wu, Jianguo; Liu, Fenyong] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China; [Chen, Yuan-Chuan; Gia-Phong Vu; Lu, Sangwei; Liu, Fenyong] Univ Calif Berkeley, Program Comparat Biochem, Berkeley, CA 94720 USA; [Bai, Yong; Phong Trang; Lu, Sangwei; Liu, Fenyong] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA	Wuhan University; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Lu, SW (corresponding author), Univ Calif Berkeley, Program Comparat Biochem, Berkeley, CA 94720 USA.	sangwei@berkeley.edu; jwu@whu.edu.cn; liu_fy@berkeley.edu	Vu, Gia-Phong/HCH-7906-2022; Zeng, Wen/GPS-8058-2022	Wu, Jianguo/0000-0002-8326-2895	Block Grant Predoctoral Fellowship (UC-Berkeley); National Basic Research Program of China (973 Program) [2011CB504800, 2012CB518900]; National Natural Science Foundation of China [31100128, 81030031, 81171525]; National Mega Project on Major Infectious Disease Prevention of China [2012ZX10002006-003, 2012ZX10004-207]; National Mega Project on Major Drug Development of China [2011ZX09401-302]; NIH [AI041927, AI091536, DE014842]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041927, R56AI091536, R01AI091536] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014842] Funding Source: NIH RePORTER	Block Grant Predoctoral Fellowship (UC-Berkeley); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Mega Project on Major Infectious Disease Prevention of China; National Mega Project on Major Drug Development of China; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Y. C. and G. V. were partially supported by a Block Grant Predoctoral Fellowship (UC-Berkeley). This research has been supported by grants from National Basic Research Program of China (973 Program, No. 2011CB504800 and 2012CB518900), National Natural Science Foundation of China (No. 31100128, 81030031, and 81171525), National Mega Project on Major Infectious Disease Prevention of China (2012ZX10002006-003 and 2012ZX10004-207), National Mega Project on Major Drug Development of China (2011ZX09401-302), and NIH (AI041927, AI091536, and DE014842). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Altman S., 1999, RNA WORLD, P351; Anderson J, 2003, AIDS RES HUM RETROV, V19, P699, DOI 10.1089/088922203322280928; Autran B, 1997, SCIENCE, V277, P112, DOI 10.1126/science.277.5322.112; Bertrand E, 1997, RNA, V3, P75; BERZALHERRANZ A, 1992, GENE DEV, V6, P129, DOI 10.1101/gad.6.1.129; Chung J, 2011, FUTURE VIROL, V6, P1319, DOI 10.2217/FVL.11.113; Cobaleda C, 2000, BLOOD, V95, P731, DOI 10.1182/blood.V95.3.731.003k28_731_737; Daftarian PM, 1996, J IMMUNOL, V157, P12; Ditzler MA, 2011, NUCLEIC ACIDS RES, V39, P8237, DOI 10.1093/nar/gkr381; Evans D, 2006, TRENDS BIOCHEM SCI, V31, P333, DOI 10.1016/j.tibs.2006.04.007; FORSTER AC, 1990, SCIENCE, V249, P783, DOI 10.1126/science.1697102; FRANK DN, 1994, BIOCHEMISTRY-US, V33, P10800, DOI 10.1021/bi00201a030; Freed E., 2007, FIELDS VIROLOGY, P2108; GOLD L, 1995, ANNU REV BIOCHEM, V64, P763, DOI 10.1146/annurev.bi.64.070195.003555; GOPALAN V, 2006, RNA WORLD; GREEN R, 1990, NATURE, V347, P406, DOI 10.1038/347406a0; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; Guo HT, 2000, SCIENCE, V289, P452, DOI 10.1126/science.289.5478.452; Held DM, 2006, FRONT BIOSCI-LANDMRK, V11, P89, DOI 10.2741/1782; Ikeda M, 2006, NUCLEOS NUCLEOT NUCL, V25, P427, DOI 10.1080/01457630600684120; Jacque JM, 2002, NATURE, V418, P435, DOI 10.1038/nature00896; JOYCE GF, 1992, SCI AM, V267, P90, DOI 10.1038/scientificamerican1292-90; Kilani AF, 2000, J BIOL CHEM, V275, P10611, DOI 10.1074/jbc.275.14.10611; Kim JJ, 1997, RNA, V3, P613; Kraus G, 2002, P NATL ACAD SCI USA, V99, P3406, DOI 10.1073/pnas.052651199; Kurtizkes D., 2007, FIELDS VIROLOGY, P2188; Lan N, 1998, SCIENCE, V280, P1593, DOI 10.1126/science.280.5369.1593; Lewis W, 2003, NAT REV DRUG DISCOV, V2, P812, DOI 10.1038/nrd1201; LIU FY, 1995, GENE DEV, V9, P471, DOI 10.1101/gad.9.4.471; Mann H, 2003, MOL CELL, V12, P925, DOI 10.1016/S1097-2765(03)00357-5; Marvin MC, 2009, J CELL BIOCHEM, V108, P1244, DOI 10.1002/jcb.22367; MILLER AD, 1989, BIOTECHNIQUES, V7, P980; Novina CD, 2004, NATURE, V430, P161, DOI 10.1038/430161a; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; PYLE AM, 1990, P NATL ACAD SCI USA, V87, P8187, DOI 10.1073/pnas.87.21.8187; ROBERTSON DL, 1990, NATURE, V344, P467, DOI 10.1038/344467a0; SARVER N, 1990, SCIENCE, V247, P1222, DOI 10.1126/science.2107573; Scherer LJ, 2003, NAT BIOTECHNOL, V21, P1457, DOI 10.1038/nbt915; SZOSTAK JW, 1992, TRENDS BIOCHEM SCI, V17, P89, DOI 10.1016/0968-0004(92)90242-2; Tang J, 1997, RNA, V3, P914; Trang P, 2000, P NATL ACAD SCI USA, V97, P5812, DOI 10.1073/pnas.100101797; Trang P, 2000, J MOL BIOL, V301, P817, DOI 10.1006/jmbi.2000.4022; Unwalla HJ, 2004, NAT BIOTECHNOL, V22, P1573, DOI 10.1038/nbt1040; Wiebusch L, 2004, J GEN VIROL, V85, P179, DOI 10.1099/vir.0.19453-0; Wong-Staal F, 1998, HUM GENE THER, V9, P2407, DOI 10.1089/hum.1998.9.16-2407; Yeni P, 2006, J HEPATOL, V44, pS100, DOI 10.1016/j.jhep.2005.11.021; YU M, 1993, P NATL ACAD SCI USA, V90, P6340, DOI 10.1073/pnas.90.13.6340; YUAN Y, 1992, P NATL ACAD SCI USA, V89, P8006, DOI 10.1073/pnas.89.17.8006; ZAUG AJ, 1995, RNA, V1, P363; ZHOU C, 1994, GENE, V149, P33; Zhou J, 2011, GENE THER, V18, P1134, DOI 10.1038/gt.2011.149	52	10	10	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e51855	10.1371/journal.pone.0051855	http://dx.doi.org/10.1371/journal.pone.0051855			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300569	Green Published, Green Submitted, gold			2022-12-27	WOS:000313618800031
J	Kraaijeveld, AR; Layen, SJ; Futerman, PH; Godfray, HCJ				Kraaijeveld, Alex R.; Layen, Sophie J.; Futerman, Peter H.; Godfray, H. Charles J.			Lack of Phenotypic and Evolutionary Cross-Resistance against Parasitoids and Pathogens in Drosophila melanogaster	PLOS ONE			English	Article							IMMUNE-RESPONSE; GLYPTAPANTELES-LIPARIDIS; GEOGRAPHICAL VARIATION; HEMOCYTE CHANGES; ASOBARA-TABIDA; HOST-DEFENSE; TRADE-OFFS; LARVAE; INFECTION; ENCAPSULATION	Background: When organisms are attacked by multiple natural enemies, the evolution of a resistance mechanism to one natural enemy will be influenced by the degree of cross-resistance to another natural enemy. Cross-resistance can be positive, when a resistance mechanism against one natural enemy also offers resistance to another; or negative, in the form of a trade-off, when an increase in resistance against one natural enemy results in a decrease in resistance against another. Using Drosophila melanogaster, an important model system for the evolution of invertebrate immunity, we test for the existence of cross-resistance against parasites and pathogens, at both a phenotypic and evolutionary level. Methods: We used a field strain of D. melanogaster to test whether surviving parasitism by the parasitoid Asobara tabida has an effect on the resistance against Beauveria bassiana, an entomopathogenic fungus; and whether infection with the microsporidian Tubulinosema kingi has an effect on the resistance against A. tabida. We used lines selected for increased resistance to A. tabida to test whether increased parasitoid resistance has an effect on resistance against B. bassiana and T. kingi. We used lines selected for increased tolerance against B. bassiana to test whether increased fungal resistance has an effect on resistance against A. tabida. Results/Conclusions: We found no positive cross-resistance or trade-offs in the resistance to parasites and pathogens. This is an important finding, given the use of D. melanogaster as a model system for the evolution of invertebrate immunity. The lack of any cross-resistance to parasites and pathogens, at both the phenotypic and the evolutionary level, suggests that evolution of resistance against one class of natural enemies is largely independent of evolution of resistance against the other.	[Kraaijeveld, Alex R.; Layen, Sophie J.; Futerman, Peter H.; Godfray, H. Charles J.] Univ London Imperial Coll Sci Technol & Med, NERC Ctr Populat Biol, London, England	Imperial College London; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC)	Kraaijeveld, AR (corresponding author), Univ Southampton, Ctr Biol Sci, Highfield Campus, Southampton, Hants, England.	arkraa@soton.ac.uk			NERC	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The research described in this manuscript was not funded by a specific grant, but via a general recurrent budget from the institution where the work took place. The institution itself was funded by NERC (http://www.nerc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaisse H, 2003, DEV CELL, V5, P441, DOI 10.1016/S1534-5807(03)00244-2; Becnel James J., 1999, P447; BOULETREAU M, 1986, ENTOMOL EXP APPL, V41, P107, DOI 10.1007/BF00195565; Carton Y., 1986, P347; Cotter SC, 2004, J EVOLUTION BIOL, V17, P421, DOI 10.1046/j.1420-9101.2003.00655.x; DAVID L, 1994, J INVERTEBR PATHOL, V63, P212, DOI 10.1006/jipa.1994.1039; Delpuech JM, 1994, CAN J ZOOL, V71, P584; Eslin P, 1996, CAN J ZOOL, V74, P2193, DOI 10.1139/z96-248; Fellowes MDE, 1999, EVOLUTION, V53, P966, DOI 10.2307/2640737; Fellowes MDE, 1998, ECOL ENTOMOL, V23, P281, DOI 10.1046/j.1365-2311.1998.00137.x; Ferrari J, 2001, EVOLUTION, V55, P1805, DOI 10.1111/j.0014-3820.2001.tb00829.x; FRAENKEL G, 1947, PROC R SOC SER B-BIO, V134, P111, DOI 10.1098/rspb.1947.0006; Futerman PH, 2006, PARASITOLOGY, V132, P479, DOI 10.1017/S0031182005009339; Fuxa J. R., 1993, PARASITES PATHOGENS, V2, P197; Fytrou A, 2006, P R SOC B, V273, P791, DOI 10.1098/rspb.2005.3383; He WJ, 2008, CELL HOST MICROBE, V4, P52, DOI 10.1016/j.chom.2008.06.002; Hoch G, 2004, ENTOMOL EXP APPL, V113, P77, DOI 10.1111/j.0013-8703.2004.00203.x; Hoch G, 2000, J INVERTEBR PATHOL, V75, P59, DOI 10.1006/jipa.1999.4894; Hoch G, 2001, J INVERTEBR PATHOL, V77, P37, DOI 10.1006/jipa.2000.4987; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; HUNTER GW, 1961, EXP PARASITOL, V11, P133, DOI 10.1016/0014-4894(61)90018-2; Irving P, 2005, CELL MICROBIOL, V7, P335, DOI 10.1111/j.1462-5822.2004.00462.x; Kraaijeveld AR, 2008, HEREDITY, V100, P400, DOI 10.1038/sj.hdy.6801092; Kraaijeveld Alex R., 2009, P187; Kraaijeveld AR, 2009, ADV PARASIT, V70, P257, DOI 10.1016/S0065-308X(09)70010-7; KRAAIJEVELD AR, 1995, EVOL ECOL, V9, P10, DOI 10.1007/BF01237692; KRAAIJEVELD AR, 1994, PHYSIOL ENTOMOL, V19, P9, DOI 10.1111/j.1365-3032.1994.tb01068.x; Kraaijeveld AR, 1997, NATURE, V389, P278, DOI 10.1038/38483; Kraaijeveld AR, 2002, PARASITOLOGY, V125, pS71, DOI 10.1017/S0031182002001750; KRAAIJEVELD AR, 1994, ECOL ENTOMOL, V19, P221, DOI 10.1111/j.1365-2311.1994.tb00413.x; Kurtz J, 2000, J INVERTEBR PATHOL, V75, P237, DOI 10.1006/jipa.1999.4909; Kurtz J, 2003, NATURE, V425, P37, DOI 10.1038/425037a; Labrosse C, 2005, J INSECT PHYSIOL, V51, P161, DOI 10.1016/j.jinsphys.2004.10.004; Labrosse C, 2003, J INSECT PHYSIOL, V49, P513, DOI 10.1016/S0022-1910(03)00054-4; Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614; LEVIN DA, 1976, ANNU REV ECOL SYST, V7, P121, DOI 10.1146/annurev.es.07.110176.001005; Little TJ, 2003, CURR BIOL, V13, P489, DOI 10.1016/S0960-9822(03)00163-5; Maleck K, 1999, TRENDS PLANT SCI, V4, P215, DOI 10.1016/S1360-1385(99)01415-6; Meister M, 2003, CELL MICROBIOL, V5, P573, DOI 10.1046/j.1462-5822.2003.00302.x; Moret Y, 2001, NATURE, V414, P506, DOI 10.1038/35107138; Moret Y, 2003, P ROY SOC LOND B BIO, V270, P2475; NAPPI AJ, 1981, PARASITOLOGY, V83, P319, DOI 10.1017/S0031182000085322; Poitrineau K, 2003, J EVOLUTION BIOL, V16, P1319, DOI 10.1046/j.1420-9101.2003.00585.x; Rigby MC, 2000, P ROY SOC B-BIOL SCI, V267, P171, DOI 10.1098/rspb.2000.0983; Rizki T.M., 1984, P579; RIZKI TM, 1994, ANN NY ACAD SCI, V712, P178, DOI 10.1111/j.1749-6632.1994.tb33572.x; RIZKI TM, 1980, ROUX ARCH DEV BIOL, V188, P91, DOI 10.1007/BF00848799; Russo J, 2001, J INSECT PHYSIOL, V47, P167, DOI 10.1016/S0022-1910(00)00102-5; Sadd BM, 2005, BIOL LETTERS, V1, P386, DOI 10.1098/rsbl.2005.0369; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; Tinsley MC, 2006, PARASITOLOGY, V132, P767, DOI 10.1017/S0031182006009929; Tzou P, 2002, CURR OPIN MICROBIOL, V5, P102, DOI 10.1016/S1369-5274(02)00294-1; Vijendravarma RK, 2009, EVOLUTION, V63, P104, DOI 10.1111/j.1558-5646.2008.00516.x; Wang LH, 2006, IMMUNOBIOLOGY, V211, P251, DOI 10.1016/j.imbio.2006.01.001; Wertheim B, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r94	55	16	16	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e53002	10.1371/journal.pone.0053002	http://dx.doi.org/10.1371/journal.pone.0053002			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285247	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000313158800111
J	Altshuler, I; Vaillant, JJ; Xu, S; Cristescu, ME				Altshuler, Ianina; Vaillant, James J.; Xu, Sen; Cristescu, Melania E.			The Evolutionary History of Sarco(endo)plasmic Calcium ATPase (SERCA)	PLOS ONE			English	Article							RETICULUM CA2+-ATPASE SERCA; FUNCTIONAL COMPARISONS; EXPRESSION; ISOFORMS; PUMPS; FAMILIES; BIOLOGY; CLONING	Investigating the phylogenetic relationships within physiologically essential gene families across a broad range of taxa can reveal the key gene duplication events underlying their family expansion and is thus important to functional genomics studies. P-Type II ATPases represent a large family of ATP powered transporters that move ions across cellular membranes and includes Na+/K+ transporters, H+/K+ transporters, and plasma membrane Ca2+ pumps. Here, we examine the evolutionary history of one such transporter, the Sarco(endo)plasmic reticulum calcium ATPase (SERCA), which maintains calcium homeostasis in the cell by actively pumping Ca2+ into the sarco(endo)plasmic reticulum. Our protein-based phylogenetic analyses across Eukaryotes revealed two monophyletic clades of SERCA proteins, one containing animals, fungi, and plants, and the other consisting of plants and protists. Our analyses suggest that the three known SERCA proteins in vertebrates arose through two major gene duplication events after the divergence from tunicates, but before the separation of fishes and tetrapods. In plants, we recovered two SERCA clades, one being the sister group to Metazoa and the other to Apicomplexa clade, suggesting an ancient duplication in an early eukaryotic ancestor, followed by subsequent loss of one copy in Opisthokonta, the other in protists, and retention of both in plants. We also report relatively recent and independent gene duplication events within invertebrate taxa including tunicates and the leech Helobdella robusta. Thus, it appears that both ancient and recent gene duplication events have played an important role in the evolution of this ubiquitous gene family across the eukaryotic domain.	[Altshuler, Ianina; Vaillant, James J.; Xu, Sen; Cristescu, Melania E.] Univ Windsor, Great Lakes Inst Environm Res, Windsor, ON N9B 3P4, Canada; [Xu, Sen] Indiana Univ, Dept Biol, Bloomington, IN USA; [Cristescu, Melania E.] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	University of Windsor; Indiana University System; Indiana University Bloomington; McGill University	Altshuler, I (corresponding author), Univ Windsor, Great Lakes Inst Environm Res, Windsor, ON N9B 3P4, Canada.	altshuli@uwindsor.ca	Altshuler, Ianina/O-3206-2019	Xu, Sen/0000-0002-1304-9968; Altshuler, Ianina/0000-0003-2235-1664; Cristescu, Melania/0000-0002-0854-4040	Natural Sciences and Engineering Council (NSERC) of Canada	Natural Sciences and Engineering Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was funded by the Natural Sciences and Engineering Council (NSERC) of Canada grant to Melania E. Cristescu. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson JO, 2005, CELL MOL LIFE SCI, V62, P1182, DOI 10.1007/s00018-005-4539-z; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Baldauf SL, 2000, SCIENCE, V290, P972, DOI 10.1126/science.290.5493.972; Baxter I, 2003, PLANT PHYSIOL, V132, P618, DOI 10.1104/pp.103.021923; Benito B, 2004, EUKARYOT CELL, V3, P359, DOI 10.1128/EC.3.2.359-368.2004; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; BRANDL CJ, 1987, J BIOL CHEM, V262, P3768; CAMPBELL AM, 1991, J BIOL CHEM, V266, P16050; Cho SJ, 2010, MOL BIOL EVOL, V27, P1645, DOI 10.1093/molbev/msq052; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; Conde A, 2011, PLANT CELL PHYSIOL, V52, P1583, DOI 10.1093/pcp/pcr107; Corradi N, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-21; Cristescu ME, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-268; East JM, 2000, MOL MEMBR BIOL, V17, P189, DOI 10.1080/09687680010009646; Edgecombe GD, 2010, ARTHROPOD STRUCT DEV, V39, P74, DOI 10.1016/j.asd.2009.10.002; ESCALANTE R, 1993, J BIOL CHEM, V268, P14090; Fan WM, 2007, ACTA BIOCH BIOPH SIN, V39, P722, DOI 10.1111/j.1745-7270.2007.00330.x; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Harzsch S, 2002, J COMP NEUROL, V453, P10, DOI 10.1002/cne.10375; Hovnanian A., 2007, V45, P337; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; Jenner RA, 2010, ARTHROPOD STRUCT DEV, V39, P143, DOI 10.1016/j.asd.2009.11.001; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kabala K, 2005, ACTA PHYSIOL PLANT, V27, P559, DOI 10.1007/s11738-005-0062-y; Keeling PJ, 2005, TRENDS ECOL EVOL, V20, P670, DOI 10.1016/j.tree.2005.09.005; Kondrashov FA, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-2-research0008; Kourakis MJ, 2001, EVOL DEV, V3, P145, DOI 10.1046/j.1525-142x.2001.003003145.x; Kudla J, 2010, PLANT CELL, V22, P541, DOI 10.1105/tpc.109.072686; Kuhlbrandt W, 2004, NAT REV MOL CELL BIO, V5, P282, DOI 10.1038/nrm1354; LINGREL JB, 1992, J BIOENERG BIOMEMBR, V24, P263; LYTTON J, 1992, J BIOL CHEM, V267, P14483; Mallatt J, 2006, MOL PHYLOGENET EVOL, V40, P772, DOI 10.1016/j.ympev.2006.04.021; Mandal A, 2009, J COMP PHYSIOL B, V179, P205, DOI 10.1007/s00360-008-0303-7; Martin V, 2002, J BIOL CHEM, V277, P24442, DOI 10.1074/jbc.M202011200; Maser P, 2001, PLANT PHYSIOL, V126, P1646, DOI 10.1104/pp.126.4.1646; Mills RF, 2008, PLANT PHYSIOL, V146, P116, DOI 10.1104/pp.107.110817; Pedersen CNS, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00031; Qi HY, 2007, P NATL ACAD SCI USA, V104, P1219, DOI 10.1073/pnas.0610286104; Reddy ASN, 2011, PLANT CELL, V23, P2010, DOI 10.1105/tpc.111.084988; Regier JC, 2005, P ROY SOC B-BIOL SCI, V272, P395, DOI 10.1098/rspb.2004.2917; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ronquist F., 2005, MRBAYES 3 1 MANUAL; Sanders D, 2002, PLANT CELL, V14, pS401, DOI 10.1105/tpc.002899; Sinakevitch I, 2003, J COMP NEUROL, V467, P150, DOI 10.1002/cne.10925; Talla E, 1998, J BIOL CHEM, V273, P27831, DOI 10.1074/jbc.273.43.27831; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VERBOOMEN H, 1992, BIOCHEM J, V286, P591, DOI 10.1042/bj2860591; von Reumont BM, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-119; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Wuytack F, 2002, CELL CALCIUM, V32, P279, DOI 10.1016/S0143416002001847	52	31	31	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52617	10.1371/journal.pone.0052617	http://dx.doi.org/10.1371/journal.pone.0052617			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285113	Green Submitted, Green Published, gold			2022-12-27	WOS:000312794500210
J	Hussey, GS; Link, LA; Brown, AS; Howley, BV; Chaudhury, A; Howe, PH				Hussey, George S.; Link, Laura A.; Brown, Andrew S.; Howley, Breege V.; Chaudhury, Arindam; Howe, Philip H.			Establishment of a TGF beta-Induced Post-Transcriptional EMT Gene Signature	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; MESSENGER-RNAS; CANCER PROGRESSION; BREAST-CANCER; HNRNP E1; EXPRESSION; METASTASIS; CELLS; IDENTIFICATION; TRANSLATION	A major challenge in the clinical management of human cancers is to accurately stratify patients according to risk and likelihood of a favorable response. Stratification is confounded by significant phenotypic heterogeneity in some tumor types, often without obvious criteria for subdivision. Despite intensive transcriptional array analyses, the identity and validation of cancer specific 'signature genes' remains elusive, partially because the transcriptome does not mirror the proteome. The simplification associated with transcriptomic profiling does not take into consideration changes in the relative expression among transcripts that arise due to post-transcriptional regulatory events. We have previously shown that TGF beta post-transcriptionally regulates epithelial-mesenchymal transition (EMT) by causing increased expression of two transcripts, Dab2 and ILEI, by modulating hnRNP E1 phosphorylation. Using a genome-wide combinatorial approach involving expression profiling and RIP-Chip analysis, we have identified a cohort of translationally regulated mRNAs that are induced during TGF beta-mediated EMT. Coordinated translational regulation by hnRNP E1 constitutes a post-transcriptional regulon inhibiting the expression of related EMT-facilitating genes, thus enabling the cell to rapidly and coordinately regulate multiple EMT-facilitating genes. Citation: Hussey GS, Link LA, Brown AS, Howley BV, Chaudhury A, et al. (2012) Establishment of a TGF beta-Induced Post-Transcriptional EMT Gene Signature. PLoS ONE 7(12): e52624. doi:10.1371/journal.pone.0052624	[Hussey, George S.; Link, Laura A.; Brown, Andrew S.; Howley, Breege V.; Howe, Philip H.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Hussey, George S.; Link, Laura A.; Brown, Andrew S.; Howley, Breege V.; Howe, Philip H.] Med Univ S Carolina, Hollings Canc Ctr, Charleston, SC USA; [Hussey, George S.] Cleveland State Univ, Dept Biol Geol & Environm Sci, Cleveland, OH 44115 USA; [Link, Laura A.; Brown, Andrew S.] Kent State Univ, Dept Biomed Sci, Kent, OH 44242 USA; [Chaudhury, Arindam] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA	Medical University of South Carolina; Medical University of South Carolina; University System of Ohio; Cleveland State University; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; Baylor College of Medicine	Howe, PH (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA.	howep@musc.edu		Chaudhury, Arindam/0000-0001-5916-4534; CHAUDHURY, ARINDAM/0000-0002-5625-5278	National Cancer Institute [CA55536, CA154663]; American Heart Association [10PRE3870024]; NATIONAL CANCER INSTITUTE [R01CA055536, R29CA055536, R01CA154663] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants CA55536 and CA154663 from the National Cancer Institute (to Philip H. Howe) (http://www.cancer.gov/). George S. Hussey was supported by an American Heart Association (Great Rivers Affiliate) Pre-doctoral Fellowship 10PRE3870024 (http://www.heart.org/HEARTORG/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnoy S, 2000, BIOCHEM J, V351, P413, DOI 10.1042/0264-6021:3510413; Beilharz Traude H., 2004, Briefings in Functional Genomics & Proteomics, V3, P103, DOI 10.1093/bfgp/3.2.103; Beyer A, 2004, MOL CELL PROTEOMICS, V3, P1083, DOI 10.1074/mcp.M400099-MCP200; Bierie B, 2006, CYTOKINE GROWTH F R, V17, P29, DOI 10.1016/j.cytogfr.2005.09.006; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Chaudhury A, 2010, NAT CELL BIOL, V12, P286, DOI 10.1038/ncb2029; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Evdokimova V, 2012, SEMIN CANCER BIOL, V22, P437, DOI 10.1016/j.semcancer.2012.04.007; Garcia-Martinez J, 2004, MOL CELL, V15, P303, DOI 10.1016/j.molcel.2004.06.004; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Hieronymus H, 2004, GENE DEV, V18, P2845, DOI 10.1101/gad.1256904; Hussey GS, 2011, MOL CELL, V41, P419, DOI 10.1016/j.molcel.2011.02.003; Janda E, 2002, J CELL BIOL, V156, P299, DOI 10.1083/jcb.200109037; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Keene JD, 2005, CHROMOSOME RES, V13, P327, DOI 10.1007/s10577-005-0848-1; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo HW, 2007, CANCER RES, V67, P9066, DOI 10.1158/0008-5472.CAN-07-0575; Macke TJ, 2001, NUCLEIC ACIDS RES, V29, P4724, DOI 10.1093/nar/29.22.4724; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mazumder B, 1999, MOL CELL BIOL, V19, P6898; Merrick W C, 2001, Curr Protoc Cell Biol, VChapter 11, DOI 10.1002/0471143030.cb1109s08; Merritt C, 2008, CURR BIOL, V18, P1476, DOI 10.1016/j.cub.2008.08.013; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Oft M, 1996, GENE DEV, V10, P2462, DOI 10.1101/gad.10.19.2462; Penalva Luiz O F, 2004, Methods Mol Biol, V257, P125, DOI 10.1385/1-59259-750-5:125; Pradet-Balade B, 2001, TRENDS BIOCHEM SCI, V26, P225, DOI 10.1016/S0968-0004(00)01776-X; Prunier C, 2005, J BIOL CHEM, V280, P17540, DOI 10.1074/jbc.M500974200; REICHMANN E, 1992, CELL, V71, P1103, DOI 10.1016/S0092-8674(05)80060-1; Reimann I, 2002, J MOL BIOL, V315, P965, DOI 10.1006/jmbi.2001.5315; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Van Der Kelen K, 2009, CRIT REV BIOCHEM MOL, V44, P143, DOI 10.1080/10409230902882090; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vyas K, 2009, MOL CELL BIOL, V29, P458, DOI 10.1128/MCB.00824-08; Waerner T, 2006, CANCER CELL, V10, P227, DOI 10.1016/j.ccr.2006.07.020; Waggoner SA, 2003, MOL CELL BIOL, V23, P7055, DOI 10.1128/MCB.23.19.7055-7067.2003; Wang CC, 2012, HISTOPATHOLOGY, V61, P78, DOI 10.1111/j.1365-2559.2012.04204.x; Wang HH, 2010, CANCER CELL, V18, P52, DOI 10.1016/j.ccr.2010.04.028; Wendt MK, 2010, ONCOGENE, V29, P6485, DOI 10.1038/onc.2010.377; Yoshinaga K, 2004, CLIN CANCER RES, V10, P5702, DOI 10.1158/1078-0432.CCR-03-0262; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zhu W, 2012, GUT, V61, P562, DOI 10.1136/gutjnl-2011-300207; Zong Q, 1999, P NATL ACAD SCI USA, V96, P10632, DOI 10.1073/pnas.96.19.10632	43	37	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52624	10.1371/journal.pone.0052624	http://dx.doi.org/10.1371/journal.pone.0052624			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285117	Green Published, Green Submitted, gold			2022-12-27	WOS:000312794500212
J	Leibly, DJ; Nguyen, TN; Kao, LT; Hewitt, SN; Barrett, LK; Van Voorhis, WC				Leibly, David J.; Trang Nhu Nguyen; Kao, Louis T.; Hewitt, Stephen N.; Barrett, Lynn K.; Van Voorhis, Wesley C.			Stabilizing Additives Added during Cell Lysis Aid in the Solubilization of Recombinant Proteins	PLOS ONE			English	Article							STRUCTURAL GENOMICS CENTER; MALTOSE-BINDING PROTEIN; THERMAL-STABILITY; MOLECULAR-MECHANISM; ESCHERICHIA-COLI; GLYCINE BETAINE; FUSION PROTEINS; AGGREGATION; TREHALOSE; ARGININE	Insoluble recombinant proteins are a major issue for both structural genomics and enzymology research. Greater than 30% of recombinant proteins expressed in Escherichia coli (E. coli) appear to be insoluble. The prevailing view is that insolubly expressed proteins cannot be easily solubilized, and are usually sequestered into inclusion bodies. However, we hypothesize that small molecules added during the cell lysis stage can yield soluble protein from insoluble protein previously screened without additives or ligands. We present a novel screening method that utilized 144 additive conditions to increase the solubility of recombinant proteins expressed in E. coli. These selected additives are natural ligands, detergents, salts, buffers, and chemicals that have been shown to increase the stability of proteins in vivo. We present the methods used for this additive solubility screen and detailed results for 41 potential drug target recombinant proteins from infectious organisms. Increased solubility was observed for 80% of the recombinant proteins during the primary and secondary screening of lysis with the additives; that is 33 of 41 target proteins had increased solubility compared with no additive controls. Eleven additives (trehalose, glycine betaine, mannitol, L-Arginine, potassium citrate, CuCl2, proline, xylitol, NDSB 201, CTAB and K2PO4) solubilized more than one of the 41 proteins; these additives can be easily screened to increase protein solubility. Large-scale purifications were attempted for 15 of the proteins using the additives identified and eight (40%) were prepared for crystallization trials during the first purification attempt. Thus, this protocol allowed us to recover about a third of seemingly insoluble proteins for crystallography and structure determination. If recombinant proteins are required in smaller quantities or less purity, the final success rate may be even higher.	[Leibly, David J.; Trang Nhu Nguyen; Kao, Louis T.; Hewitt, Stephen N.; Barrett, Lynn K.; Van Voorhis, Wesley C.] Univ Washington, Sch Med, Dept Allergy & Infect Dis, Seattle, WA 98195 USA; [Leibly, David J.; Trang Nhu Nguyen; Kao, Louis T.; Hewitt, Stephen N.; Barrett, Lynn K.; Van Voorhis, Wesley C.] Seattle Struct Genom Ctr Infect Dis SSGCID, Seattle, WA USA	University of Washington; University of Washington Seattle	Van Voorhis, WC (corresponding author), Univ Washington, Sch Med, Dept Allergy & Infect Dis, Seattle, WA 98195 USA.	wesley@uw.edu			National Institute of Allergy and Infectious Diseases, National Institute of Health, Department of Health and Human Services [HHSN272200700057C]	National Institute of Allergy and Infectious Diseases, National Institute of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded under Federal Contract No. HHSN272200700057C from the National Institute of Allergy and Infectious Diseases, National Institute of Health, Department of Health and Human Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACK JF, 1979, BIOCHEMISTRY-US, V18, P5191, DOI 10.1021/bi00590a025; Bandyopadhyay A, 2012, NAT CHEM BIOL, V8, P238, DOI [10.1038/NCHEMBIO.768, 10.1038/nchembio.768]; Beranger F, 2008, BIOCHEM BIOPH RES CO, V374, P44, DOI 10.1016/j.bbrc.2008.06.094; Bondos SE, 2003, ANAL BIOCHEM, V316, P223, DOI 10.1016/S0003-2697(03)00059-9; Bryan CM, 2011, ACTA CRYSTALLOGR F, V67, P1010, DOI 10.1107/S1744309111018367; BUCHNER J, 1992, ANAL BIOCHEM, V205, P263, DOI 10.1016/0003-2697(92)90433-8; Choi R, 2011, ACTA CRYSTALLOGR F, V67, P998, DOI 10.1107/S1744309111017374; Collins T, 2006, ANAL BIOCHEM, V352, P299, DOI 10.1016/j.ab.2006.01.035; Courtenay ES, 2000, BIOCHEMISTRY-US, V39, P4455, DOI 10.1021/bi992887l; de Lencastre Novaes L. C., 2010, BIOTECHNOL PROGR, V27, P269; Derewenda ZS, 2004, METHODS, V34, P354, DOI 10.1016/j.ymeth.2004.03.024; Dokmanic I, 2008, ACTA CRYSTALLOGR D, V64, P257, DOI 10.1107/S090744490706595X; Expert-Bezancon N, 2003, BIOPHYS CHEM, V100, P469, DOI 10.1016/S0301-4622(02)00299-5; Fisher MT, 2006, P NATL ACAD SCI USA, V103, P13265, DOI 10.1073/pnas.0606106103; Ghosh R, 2009, BIOCHEMISTRY-US, V48, P1135, DOI 10.1021/bi802065j; Golovanov AP, 2004, J AM CHEM SOC, V126, P8933, DOI 10.1021/ja049297h; Graslund S, 2008, PROTEIN EXPRES PURIF, V58, P210, DOI 10.1016/j.pep.2007.11.008; Hammarstrom M, 2002, PROTEIN SCI, V11, P313, DOI 10.1110/ps.22102; Hewitt SN, 2011, ACTA CRYSTALLOGR F, V67, P1006, DOI 10.1107/S1744309111022159; Hu CY, 2010, PROTEINS, V78, P695, DOI 10.1002/prot.22598; Ignatova Z, 2006, P NATL ACAD SCI USA, V103, P13357, DOI 10.1073/pnas.0603772103; Jain N. K., 2010, CURR PROTOC PROTEIN, V59, DOI [DOI 10.1002/0471140864.PS0409S59, 10.1002/0471140864.ps0409s59]; Jain NK, 2009, PROTEIN SCI, V18, P24, DOI 10.1002/pro.3; Jensen WA, 1996, BBA-PROTEIN STRUCT M, V1296, P23, DOI 10.1016/0167-4838(96)00049-0; Kapust RB, 1999, PROTEIN SCI, V8, P1668, DOI 10.1110/ps.8.8.1668; Kaushik JK, 1998, J PHYS CHEM B, V102, P7058, DOI 10.1021/jp981119l; Kaushik JK, 2003, J BIOL CHEM, V278, P26458, DOI 10.1074/jbc.M300815200; Lawal OS, 2006, FOOD CHEM, V95, P101, DOI 10.1016/j.foodchem.2004.12.041; Lindner AB, 2008, P NATL ACAD SCI USA, V105, P3076, DOI 10.1073/pnas.0708931105; Liu R, 2005, NEUROBIOL DIS, V20, P74, DOI 10.1016/j.nbd.2005.02.003; Mehlin C, 2006, MOL BIOCHEM PARASIT, V148, P144, DOI 10.1016/j.molbiopara.2006.03.011; Mello CC, 2003, PROTEIN SCI, V12, P1522, DOI 10.1110/ps.0372903; Merchant SS, 2006, BBA-MOL CELL RES, V1763, P578, DOI 10.1016/j.bbamcr.2006.04.007; Miller L K, 1988, Biotechnology, V10, P457; Myler P. J., 2009, Infectious Disorders - Drug Targets, V9, P493; PALEG LG, 1984, PLANT PHYSIOL, V75, P974, DOI 10.1104/pp.75.4.974; Prajapati RS, 2007, PROTEINS, V66, P480, DOI 10.1002/prot.21215; Qing GL, 2004, NAT BIOTECHNOL, V22, P877, DOI 10.1038/nbt984; Remmele RL, 1998, PHARMACEUT RES, V15, P200; Rishi V, 1998, BIOCHEM J, V329, P137, DOI 10.1042/bj3290137; Savchenko A, 2003, PROTEINS, V50, P392, DOI 10.1002/prot.10282; Schlieker C, 2002, J BIOTECHNOL, V96, P13, DOI 10.1016/S0168-1656(02)00033-0; Schneider CP, 2011, J PHYS CHEM B, V115, P7447, DOI 10.1021/jp111920y; Singh LR, 2009, BBA-PROTEINS PROTEOM, V1794, P929, DOI 10.1016/j.bbapap.2009.02.005; Singh SM, 2005, J BIOSCI BIOENG, V99, P303, DOI 10.1263/jbb.99.303; SPIRIN AS, 1988, SCIENCE, V242, P1162, DOI 10.1126/science.3055301; Street TO, 2006, P NATL ACAD SCI USA, V103, P13997, DOI 10.1073/pnas.0606236103; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tiwari A, 2006, BIOPHYS CHEM, V124, P90, DOI 10.1016/j.bpc.2006.06.003; WILLIAMS DC, 1982, SCIENCE, V215, P687, DOI 10.1126/science.7036343; Won CM, 1998, INT J PHARM, V167, P25; Yee A, 2003, ACCOUNTS CHEM RES, V36, P183, DOI 10.1021/ar010126g; Zhao DX, 2007, CHINESE CHEM LETT, V18, P355, DOI 10.1016/j.cclet.2007.01.017; Zou Q, 2002, J AM CHEM SOC, V124, P1192, DOI 10.1021/ja004206b	54	62	69	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52482	10.1371/journal.pone.0052482	http://dx.doi.org/10.1371/journal.pone.0052482			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285060	gold, Green Published, Green Submitted			2022-12-27	WOS:000312794500180
J	Lindstrom, MS				Lindstrom, Mikael S.			Elucidation of Motifs in Ribosomal Protein S9 That Mediate Its Nucleolar Localization and Binding to NPM1/Nucleophosmin	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; NUCLEAR IMPORT; MESSENGER-RNA; GRANULAR COMPONENT; B23; BIOGENESIS; ARF; NUCLEOPHOSMIN; REVEALS; IDENTIFICATION	Biogenesis of eukaryotic ribosomes occurs mainly in a specific subnuclear compartment, the nucleolus, and involves the coordinated assembly of ribosomal RNA and ribosomal proteins. Identification of amino acid sequences mediating nucleolar localization of ribosomal proteins may provide important clues to understand the early steps in ribosome biogenesis. Human ribosomal protein S9 (RPS9), known in prokaryotes as RPS4, plays a critical role in ribosome biogenesis and directly binds to ribosomal RNA. RPS9 is targeted to the nucleolus but the regions in the protein that determine its localization remains unknown. Cellular expression of RPS9 deletion mutants revealed that it has three regions capable of driving nuclear localization of a fused enhanced green fluorescent protein (EGFP). The first region was mapped to the RPS9 N-terminus while the second one was located in the proteins C-terminus. The central and third region in RPS9 also behaved as a strong nucleolar localization signal and was hence sufficient to cause accumulation of EGFP in the nucleolus. RPS9 was previously shown to interact with the abundant nucleolar chaperone NPM1 (nucleophosmin). Evaluating different RPS9 fragments for their ability to bind NPM1 indicated that there are two binding sites for NPM1 on RPS9. Enforced expression of NPM1 resulted in nucleolar accumulation of a predominantly nucleoplasmic RPS9 mutant. Moreover, it was found that expression of a subset of RPS9 deletion mutants resulted in altered nucleolar morphology as evidenced by changes in the localization patterns of NPM1, fibrillarin and the silver stained nucleolar organizer regions. In conclusion, RPS9 has three regions that each are competent for nuclear localization, but only the central region acted as a potent nucleolar localization signal. Interestingly, the RPS9 nucleolar localization signal is residing in a highly conserved domain corresponding to a ribosomal RNA binding site.	Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden	Karolinska Institutet	Lindstrom, MS (corresponding author), Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden.	mikael.lindstrom@ki.se	Lindström, Mikael S/AAA-1451-2019	Lindström, Mikael S/0000-0003-1148-8497	Eke Wiberg foundation; Karolinska Institutet funds; Magnus Bergvall's foundation; Swedish Cancer Society (Cancerfonden); Swedish research council VR-MH project [K2012-99X-21969-01-3]	Eke Wiberg foundation; Karolinska Institutet funds; Magnus Bergvall's foundation; Swedish Cancer Society (Cancerfonden)(Swedish Cancer Society); Swedish research council VR-MH project	This study was made possible with financial support to M. L. from the Eke Wiberg foundation, Karolinska Institutet funds, and Magnus Bergvall's foundation. M. L. was a recipient of a fellowship award from the Swedish Cancer Society (Cancerfonden) 2007-2010, and is presently supported by the Swedish research council VR-MH project grant number K2012-99X-21969-01-3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad Y, 2009, NUCLEIC ACIDS RES, V37, pD181, DOI 10.1093/nar/gkn804; Amin MA, 2008, BIOCHEM J, V415, P345, DOI 10.1042/BJ20081411; Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Andersen JS, 2002, CURR BIOL, V12, P1, DOI 10.1016/S0960-9822(01)00650-9; Audas TE, 2012, MOL CELL, V45, P147, DOI 10.1016/j.molcel.2011.12.012; BAKER AM, 1995, J BIOL CHEM, V270, P22939, DOI 10.1074/jbc.270.39.22939; Ben-Shem A, 2010, SCIENCE, V330, P1203, DOI 10.1126/science.1194294; Bernstein KA, 2004, EUKARYOT CELL, V3, P1619, DOI 10.1128/EC.3.6.1619-1626.2004; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; Chan HJ, 2005, BIOCHEM BIOPH RES CO, V333, P396, DOI 10.1016/j.bbrc.2005.04.176; Chang SN, 2000, FEBS LETT, V484, P22, DOI 10.1016/S0014-5793(00)02118-9; Chen DY, 2001, J CELL BIOL, V153, P169, DOI 10.1083/jcb.153.1.169; Davies C, 1998, EMBO J, V17, P4545, DOI 10.1093/emboj/17.16.4545; Deisenroth C, 2010, ONCOGENE, V29, P4253, DOI 10.1038/onc.2010.189; DERENZINI M, 1992, HISTOCHEM J, V24, P951, DOI 10.1007/BF01046500; Eirin-Lopez JM, 2006, GENETICS, V173, P1835, DOI 10.1534/genetics.106.058990; Emmott E, 2009, EMBO REP, V10, P231, DOI 10.1038/embor.2009.14; Enomoto T, 2006, J BIOL CHEM, V281, P18463, DOI 10.1074/jbc.M602788200; Falini B, 2006, BLOOD, V107, P4514, DOI 10.1182/blood-2005-11-4745; FANKHAUSER C, 1991, MOL CELL BIOL, V11, P2567, DOI 10.1128/MCB.11.5.2567; Ferreira-Cerca S, 2005, MOL CELL, V20, P263, DOI 10.1016/j.molcel.2005.09.005; Ferreira-Cerca S, 2007, MOL CELL, V28, P446, DOI 10.1016/j.molcel.2007.09.029; Gadal O, 2002, J CELL BIOL, V157, P941, DOI 10.1083/jcb.200111039; Gallo S, 2011, IN VITRO CELL DEV-AN, V47, P132, DOI 10.1007/s11626-010-9370-7; Gorlich D, 1997, CURR OPIN CELL BIOL, V9, P412, DOI 10.1016/S0955-0674(97)80015-4; Goyal P, 2006, J BIOL CHEM, V281, P25223, DOI 10.1074/jbc.M603399200; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Hernandez-Verdun D, 2006, HISTOCHEM CELL BIOL, V125, P127, DOI 10.1007/s00418-005-0046-4; Hingorani K, 2000, J BIOL CHEM, V275, P24451, DOI 10.1074/jbc.M003278200; HUGLE B, 1985, J CELL BIOL, V100, P873, DOI 10.1083/jcb.100.3.873; Itahana K, 2003, MOL CELL, V12, P1151, DOI 10.1016/S1097-2765(03)00431-3; Jakel S, 1998, EMBO J, V17, P4491, DOI 10.1093/emboj/17.15.4491; Korgaonkar C, 2005, MOL CELL BIOL, V25, P1258, DOI 10.1128/MCB.25.4.1258-1271.2005; Kruger T, 2007, J CELL BIOL, V177, P573, DOI 10.1083/jcb.200612048; Kubota S, 1999, ONCOGENE, V18, P1503, DOI 10.1038/sj.onc.1202429; Kundu-Michalik S, 2008, MOL BIOL EVOL, V25, P580, DOI 10.1093/molbev/msn002; Lam YW, 2007, CURR BIOL, V17, P749, DOI 10.1016/j.cub.2007.03.064; Latonen L, 2011, ONCOGENE, V30, P790, DOI 10.1038/onc.2010.469; Lechertier T, 2007, J CELL SCI, V120, P265, DOI 10.1242/jcs.03345; Lindstrom MS, 2008, J BIOL CHEM, V283, P15568, DOI 10.1074/jbc.M801151200; Lindstrom MS, 2006, CELL BIOCHEM BIOPHYS, V46, P79, DOI 10.1385/CBB:46:1:79; Lindstrom MS, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/195209; Lindstrom MS, 2010, SILENCING RIBOSOMAL; Lohrum MAE, 2000, NAT CELL BIOL, V2, P179, DOI 10.1038/35004057; Markus MA, 1998, EMBO J, V17, P4559, DOI 10.1093/emboj/17.16.4559; Mekhail K, 2004, NAT CELL BIOL, V6, P642, DOI 10.1038/ncb1144; Mekhail K, 2007, MOL BIOL CELL, V18, P3966, DOI 10.1091/mbc.E07-03-0295; Michael WM, 1996, J BIOL CHEM, V271, P11571, DOI 10.1074/jbc.271.19.11571; Milkereit P, 2001, CELL, V105, P499, DOI 10.1016/S0092-8674(01)00358-0; Narla A, 2010, BLOOD, V115, P3196, DOI 10.1182/blood-2009-10-178129; Nishimura Y, 2002, BIOSCI BIOTECH BIOCH, V66, P2239, DOI 10.1271/bbb.66.2239; O'Donohue MF, 2010, J CELL BIOL, V190, P853, DOI 10.1083/jcb.201005117; Ochs RL, 1998, METHOD CELL BIOL, V53, P303; Okuwaki M, 2008, J BIOCHEM, V143, P441, DOI 10.1093/jb/mvm222; Pederson T, 1998, NUCLEIC ACIDS RES, V26, P3871, DOI 10.1093/nar/26.17.3871; Perera Y, 2009, MOL CANCER THER, V5, P5; PERRY RP, 1968, J CELL PHYSIOL, V72, P235, DOI 10.1002/jcp.1040720311; Pestov DG, 2001, MOL CELL BIOL, V21, P4246, DOI 10.1128/MCB.21.13.4246-4255.2001; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Pnueli L, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-285; Raska I, 2006, INT REV CYTOL, V255, P177, DOI 10.1016/S0074-7696(06)55004-1; Rosorius O, 2000, J BIOL CHEM, V275, P12061, DOI 10.1074/jbc.275.16.12061; Rout MP, 1997, CELL, V89, P715, DOI 10.1016/S0092-8674(00)80254-8; Scherl A, 2002, MOL BIOL CELL, V13, P4100, DOI 10.1091/mbc.E02-05-0271; SCHMIDT C, 1995, MOL BIOL CELL, V6, P1875, DOI 10.1091/mbc.6.12.1875; Scott MS, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-317; Scott MS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-74; Scott MS, 2010, NUCLEIC ACIDS RES, V38, P7388, DOI 10.1093/nar/gkq653; Staker BL, 2000, EMBO J, V19, P749, DOI 10.1093/emboj/19.4.749; Sundqvist A, 2009, EMBO REP, V10, P1132, DOI 10.1038/embor.2009.178; Szebeni A, 1997, BIOCHEMISTRY-US, V36, P3941, DOI 10.1021/bi9627931; SZEBENI A, 1995, BIOCHEMISTRY-US, V34, P8037, DOI 10.1021/bi00025a009; Takyar S, 2005, CELL, V120, P49, DOI 10.1016/j.cell.2004.11.042; Timmers ACJ, 1999, FEBS LETT, V452, P335, DOI 10.1016/S0014-5793(99)00669-9; TSAY YF, 1994, J BIOL CHEM, V269, P7579; VALDEZ BC, 1994, J BIOL CHEM, V269, P23776; VINCENT A, 1992, GENETICS, V132, P375; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Yusupova GZ, 2001, CELL, V106, P233, DOI 10.1016/S0092-8674(01)00435-4; Zhang YP, 2009, CANCER CELL, V16, P369, DOI 10.1016/j.ccr.2009.09.024; Zhang YP, 1999, MOL CELL, V3, P579, DOI 10.1016/S1097-2765(00)80351-2; Zhu Y, 2009, MOL CELL, V35, P316, DOI 10.1016/j.molcel.2009.07.014	83	19	19	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52476	10.1371/journal.pone.0052476	http://dx.doi.org/10.1371/journal.pone.0052476			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285058	Green Submitted, gold, Green Published			2022-12-27	WOS:000312794500179
J	Law, LNC; Zentner, M				Law, Lily N. C.; Zentner, Marcel			Assessing Musical Abilities Objectively: Construction and Validation of the Profile of Music Perception Skills	PLOS ONE			English	Article							TEMPORAL RESOLUTION; RECOGNITION; LEVEL; CHILDREN; MEMORY; PITCH; TIME; NEGATIVITY; SEQUENCES; EMOTIONS	A common approach for determining musical competence is to rely on information about individuals' extent of musical training, but relying on musicianship status fails to identify musically untrained individuals with musical skill, as well as those who, despite extensive musical training, may not be as skilled. To counteract this limitation, we developed a new test battery (Profile of Music Perception Skills; PROMS) that measures perceptual musical skills across multiple domains: tonal (melody, pitch), qualitative (timbre, tuning), temporal (rhythm, rhythm-to-melody, accent, tempo), and dynamic (loudness). The PROMS has satisfactory psychometric properties for the composite score (internal consistency and test-retest r>.85) and fair to good coefficients for the individual subtests (.56 to.85). Convergent validity was established with the relevant dimensions of Gordon's Advanced Measures of Music Audiation and Musical Aptitude Profile (melody, rhythm, tempo), the Musical Ear Test (rhythm), and sample instrumental sounds (timbre). Criterion validity was evidenced by consistently sizeable and significant relationships between test performance and external musical proficiency indicators in all three studies (.38 to.62, p<.05 to p<.01). An absence of correlations between test scores and a nonmusical auditory discrimination task supports the battery's discriminant validity (-.05, ns). The interrelationships among the various subtests could be accounted for by two higher order factors, sequential and sensory music processing. A brief version of the full PROMS is introduced as a time-efficient approximation of the full version of the battery.	[Law, Lily N. C.; Zentner, Marcel] Univ York, Dept Psychol, York YO10 5DD, N Yorkshire, England	University of York - UK	Zentner, M (corresponding author), Univ York, Dept Psychol, York YO10 5DD, N Yorkshire, England.	m.zentner@psych.york.ac.uk	Zentner, Marcel/C-7106-2011		Holbeck Foundation, York	Holbeck Foundation, York	This research was supported in part by a grant from the Holbeck Foundation, York. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1966, MUSICAL ABILITY CHIL; [Anonymous], 2011, LOG PRO 9 LOG STUD C; Bertoli S, 2002, CLIN NEUROPHYSIOL, V113, P396, DOI 10.1016/S1388-2457(02)00013-5; British Society of Audiology, 2004, PUR TON AIR BON COND; Brown S, PSYCHOL MUS IN PRESS; Carson AD, 1998, J CAREER ASSESSMENT, V6, P311, DOI 10.1177/106907279800600303; Cook ND, 2009, MUSIC PERCEPT, V27, P25, DOI 10.1525/MP.2009.27.1.25; Coutinho E, 2011, EMOTION, V11, P921, DOI 10.1037/a0024700; Cross I., 2007, OXFORD HDB EVOLUTION, P649, DOI DOI 10.1093/OXFORDHB/9780198568308.013.0045; Dahl S., 2003, P STOCKH MUS AC C SM, V2, P595; DOWLING WJ, 1995, PERCEPT PSYCHOPHYS, V57, P136, DOI 10.3758/BF03206500; Dreyer AA, 2008, J ACOUST SOC AM, V123, pEL1, DOI 10.1121/1.2820442; Ericsson KA, 2005, J EDUC GIFTED, V28, P287, DOI 10.4219/jeg-2005-335; Fabiani M, 2011, J ACOUST SOC AM, V130, pEL193, DOI 10.1121/1.3633687; Frey MC, 2004, PSYCHOL SCI, V15, P373, DOI 10.1111/j.0956-7976.2004.00687.x; Gabrielsson A, 1996, PSYCHOL MUSIC, V24, P69; Gagne F., 1999, PSYCHOL MUSIC, V27, P38, DOI [10.1177/0305735699271004, DOI 10.1177/0305735699271004]; Gaser C, 2003, J NEUROSCI, V23, P9240; Geringer JM, 2007, J RES MUSIC EDUC, V55, P289, DOI 10.1177/0022429408317366; Gibson C, 2009, BRAIN COGNITION, V69, P162, DOI 10.1016/j.bandc.2008.07.009; GLASBERG BR, 1992, HEARING RES, V64, P81, DOI 10.1016/0378-5955(92)90170-R; GLASBERG BR, 1989, SCAND AUDIOL, P1; Gordon E., 1965, B COUNC RES MUSIC ED, V6, P12; Gordon Edwin, 1990, PREDICTIVE VALIDITY; Gordon EE, 1995, MANUAL MUSICAL APTIT; Hailstone JC, 2009, Q J EXP PSYCHOL, V62, P2141, DOI 10.1080/17470210902765957; HALL JW, 1994, J ACOUST SOC AM, V96, P150, DOI 10.1121/1.410474; Haynes S.N., 2000, APPL CLIN P; Helmbold N., 2005, J INDIVID DIFFER, V26, P74, DOI [10.1027/1614-0001.26.2.74, DOI 10.1027/1614-0001.26.2.74]; Horwitz AR, 2011, J ACOUST SOC AM, V130, P2928, DOI 10.1121/1.3643829; HURFORD DP, 1990, J LEARN DISABIL, V23, P564, DOI 10.1177/002221949002300906; Jensen AR, 1998, EDUC PSYCHO, P111; Jones MR, 2010, SPRINGER HANDB AUDIT, V36, P1, DOI 10.1007/978-1-4419-6114-3_1; Kang R, 2009, EAR HEARING, V30, P411, DOI 10.1097/AUD.0b013e3181a61bc0; Karma K, 1973, RES B, V1; Karma K., 2007, PSYCHOMUSICOLOGY, V19, P79, DOI [10.1037/h0094033, DOI 10.1037/H0094033]; Keating P., 2005, D PRIME SIGNAL DETEC; Kidd GR, 2007, J ACOUST SOC AM, V122, P418, DOI 10.1121/1.2743154; Kirby JR, 2003, J EDUC PSYCHOL, V80, P437; Lee CY, 2008, J ACOUST SOC AM, V124, P3235, DOI 10.1121/1.2990713; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; LICKLIDER JCR, 1954, J ACOUST SOC AM, V26, P945, DOI 10.1121/1.1928005; Lima CF, 2011, EMOTION, V11, P1021, DOI 10.1037/a0024521; Macmillan NA, 2005, DETECTION THEORY USE; McDermott H, 2012, SPRINGER HDB AUDITOR, V39, P305; Meister I, 2005, HUM BRAIN MAPP, V25, P345, DOI 10.1002/hbm.20112; Micheyl C, 2008, PSYCHOL REV, V115, P1069, DOI 10.1037/a0013572; Moelants D, 2002, P 7 INT C MUSIC PERC, P1, DOI DOI 10.1044/1059-0889(2002/ER01); Mullensiefen D, 2012, 12 INT C MUS PERC CO; Muluk NB, 2011, AURIS NASUS LARYNX, V38, P6, DOI 10.1016/j.anl.2010.05.007; Murphy C., 1999, BRIT J MUSICAL ED, V16, P39, DOI DOI 10.1017/S0265051799000133; Muter V, 2004, DEV PSYCHOL, V40, P665, DOI 10.1037/0012-1649.40.5.665; Nettl Bruno, 2005, STUDY ETHNOMUSICOLOG; Patel A. D., 2008, MUSIC LANGUAGE BRAIN; Peretz I, 2003, ANN NY ACAD SCI, V999, P58, DOI 10.1196/annals.1284.006; Peretz I, 2003, NAT NEUROSCI, V6, P688, DOI 10.1038/nn1083; Prince JB, 2009, J EXP PSYCHOL HUMAN, V35, P1598, DOI 10.1037/a0016456; Rammsayer T. H., 2003, PSYCHOL MUSIC, V31, P123, DOI [DOI 10.1177/0305735603031002290, 10.1177/0305735603031002290]; RATCLIFF R, 1994, J EXP PSYCHOL LEARN, V20, P763, DOI 10.1037/0278-7393.20.4.763; Revelle W, 2009, PSYCHOMETRIKA, V74, P145, DOI 10.1007/s11336-008-9102-z; Schulze K, 2012, MUSIC PERCEPT, V29, P255, DOI 10.1525/MP.2012.29.3.255; Seashore C. E., 1960, 2 REVISION MANUAL IN; Shuter-Dyson Rosamund., 1999, PSYCHOL MUSIC, V2nd ed., P627; Sijtsma K, 2009, PSYCHOMETRIKA, V74, P107, DOI 10.1007/s11336-008-9101-0; Sloboda J. A., 2000, MUSIC MIND SCI, P220; Sloboda J.A., 1991, PSYCHOL MUSIC, V19, P3, DOI [DOI 10.1177/0305735691191001, 10.1177/0305735691191001]; Thomson JM, 2008, J PHYSIOL-PARIS, V102, P120, DOI 10.1016/j.jphysparis.2008.03.007; Wallentin M, 2010, LEARN INDIVID DIFFER, V20, P188, DOI 10.1016/j.lindif.2010.02.004; Watt Roger J., 1998, MUSIC SCI, V2, P33, DOI [10.1177/102986499800200103, DOI 10.1177/102986499800200103]; Weise A, 2012, BRAIN RES, V1439, P73, DOI 10.1016/j.brainres.2011.12.044; WIGHTMAN F, 1989, CHILD DEV, V60, P611, DOI 10.1111/j.1467-8624.1989.tb02742.x; Williamson VJ, 2010, MEM COGNITION, V38, P163, DOI 10.3758/MC.38.2.163; Wing H., 1948, TESTS MUSICAL ABILIT; Wing H.D., 1968, TESTS MUSICAL ABILIT, V2nd ed.; Wong PCM, 2007, NAT NEUROSCI, V10, P420, DOI 10.1038/nn1872; Zendel BR, 2009, J COGNITIVE NEUROSCI, V21, P1488, DOI 10.1162/jocn.2009.21140; Zeng FG, 2005, J NEUROPHYSIOL, V93, P3050, DOI 10.1152/jn.00985.2004; Zentner M, 2010, P NATL ACAD SCI USA, V107, P5768, DOI 10.1073/pnas.1000121107; Zentner MR, 1996, NATURE, V383, P29, DOI 10.1038/383029a0	79	115	118	4	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52508	10.1371/journal.pone.0052508	http://dx.doi.org/10.1371/journal.pone.0052508			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	064DQ	23285071	Green Submitted, Green Published, gold			2022-12-27	WOS:000313051500032
J	Lima, MR; Macedo, RHF; Martins, TLF; Schrey, AW; Martin, LB; Bensch, S				Lima, Marcos R.; Macedo, Regina H. F.; Martins, Thais L. F.; Schrey, Aaron W.; Martin, Lynn B.; Bensch, Staffan			Genetic and Morphometric Divergence of an Invasive Bird: The Introduced House Sparrow (Passer domesticus) in Brazil	PLOS ONE			English	Article							STARLING STURNUS-VULGARIS; NEW-ZEALAND POPULATIONS; FOUNDER EVENTS; DIFFERENTIATION; EVOLUTION; NORTH; DIVERSITY; SOFTWARE; BIOLOGY; SIZE	Introduced species are interesting systems for the study of contemporary evolution in new environments because of their spatial and temporal scales. For this study we had three aims: (i) to determine how genetic diversity and genetic differentiation of introduced populations of the house sparrow (Passer domesticus) in Brazil varies with range expansion, (ii) to determine how genetic diversity and differentiation in Brazil compares to ancestral European populations; and (iii) to determine whether selection or genetic drift has been more influential on phenotypic divergence. We used six microsatellite markers to genotype six populations from Brazil and four populations from Europe. We found slightly reduced levels of genetic diversity in Brazilian compared to native European populations. However, among introduced populations of Brazil, we found no association between genetic diversity and time since introduction. Moreover, overall genetic differentiation among introduced populations was low indicating that the expansion took place from large populations in which genetic drift effects would likely have been weak. We found significant phenotypic divergence among sites in Brazil. Given the absence of a spatial genetic pattern, divergent selection and not genetic drift seems to be the main force behind most of the phenotypic divergence encountered. Unravelling whether microevolution (e.g., allele frequency change), phenotypic plasticity, or both mediated phenotypic divergence is challenging and will require experimental work (e.g., common garden experiments or breeding programs).	[Bensch, Staffan] Lund Univ, Dept Biol, Lund, Sweden; [Lima, Marcos R.] Univ Brasilia, Dept Ecol IB, Brasilia, DF, Brazil; [Macedo, Regina H. F.] Univ Brasilia, Dept Zool IB, Brasilia, DF, Brazil; [Martins, Thais L. F.] Univ Exeter, Ctr Ecol & Conservat, Penryn, Cornwall, England; [Schrey, Aaron W.; Martin, Lynn B.] Univ S Florida, Dept Integrat Biol, Tampa, FL USA	Lund University; Universidade de Brasilia; Universidade de Brasilia; University of Exeter; State University System of Florida; University of South Florida	Bensch, S (corresponding author), Lund Univ, Dept Biol, Lund, Sweden.	Staffan.Bensch@biol.lu.se	Macedo, Regina/GSE-3916-2022; Lima, Marcos/A-4931-2013; Macedo, Regina H. F./C-1411-2013; Lima, Marcos Robalinho/R-8966-2019; Martin, Lynn/C-2037-2009	Lima, Marcos/0000-0002-5901-0911; Macedo, Regina H. F./0000-0003-3510-9172; Lima, Marcos Robalinho/0000-0002-5901-0911; Martin, Lynn/0000-0002-5887-4937; Schrey, Aaron/0000-0002-2165-7349	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [BEX 5066/10-7]; The British Ecological Society; National Science Foundation [0920475]; Swedish Research Council [621-2010-5277]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); The British Ecological Society; National Science Foundation(National Science Foundation (NSF)); Swedish Research Council(Swedish Research CouncilEuropean Commission)	Funding provided by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior awarded MRL a sandwich scholarship (Proc No: BEX 5066/10-7), The British Ecological Society to TLFM funded parts of the field work, National Science Foundation (No: 0920475) to LBM and the Swedish Research Council to SB funded parts of the laboratory work (No: 621-2010-5277). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf FW, 2003, CONSERV BIOL, V17, P24, DOI 10.1046/j.1523-1739.2003.02365.x; Anderson TR., 2006, BIOL UBIQUITOUS HOUS; BAKER AJ, 1987, EVOLUTION, V41, P525, DOI 10.1111/j.1558-5646.1987.tb05823.x; BAKER AJ, 1980, EVOLUTION, V34, P638, DOI 10.1111/j.1558-5646.1980.tb04003.x; BAKER AJ, 1992, EVOLUTION, V46, P1784, DOI 10.1111/j.1558-5646.1992.tb01169.x; Blackburn TM, 2009, OXFORD AVIAN BIOL, P1; Borges Sergio Henrique, 1996, Ararajuba, V4, P116; Bossdorf O, 2005, OECOLOGIA, V144, P1, DOI 10.1007/s00442-005-0070-z; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Brommer JE, 2011, J EVOLUTION BIOL, V24, P1160, DOI 10.1111/j.1420-9101.2011.02268.x; Cabe PR, 1998, HEREDITY, V80, P519, DOI 10.1038/sj.hdy.6882960; Clegg SM, 2002, P NATL ACAD SCI USA, V99, P8127, DOI 10.1073/pnas.102583399; Cornuet JM, 1996, GENETICS, V144, P2001; Crawford NG, 2010, MOL ECOL RESOUR, V10, P556, DOI 10.1111/j.1755-0998.2009.02801.x; DASILVA JMC, 1990, WILSON BULL, V102, P309; Dawson D, 2006, MOL ECOL, V15; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Duncan RP, 2003, ANNU REV ECOL EVOL S, V34, P71, DOI 10.1146/annurev.ecolsys.34.011802.132353; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Filzmoser P, 2011, MVOUTLIER MULTIVARIA; Goodman SJ, 1997, MOL ECOL, V6, P881, DOI 10.1046/j.1365-294X.1997.00260.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Griffith SC, 1999, BIOL J LINN SOC, V68, P303, DOI 10.1111/j.1095-8312.1999.tb01171.x; Hawley DM, 2006, MOL ECOL, V15, P263, DOI 10.1111/j.1365-294X.2005.02767.x; Holt RD, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P259; Huey RB, 2000, SCIENCE, V287, P308, DOI 10.1126/science.287.5451.308; Huey RB, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P139; Hutchison DW, 1999, EVOLUTION, V53, P1898, DOI 10.1111/j.1558-5646.1999.tb04571.x; Jensen H, 2003, J EVOLUTION BIOL, V16, P1296, DOI 10.1046/j.1420-9101.2003.00614.x; JOHNSTON RE, 1971, EVOLUTION, V25, P1, DOI 10.1111/j.1558-5646.1971.tb01855.x; JOHNSTON RF, 1973, AM NAT, V107, P373, DOI 10.1086/282841; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kalinowski ST, 2004, CONSERV GENET, V5, P539, DOI 10.1023/B:COGE.0000041021.91777.1a; Kekkonen J, 2011, HEREDITY, V106, P183, DOI 10.1038/hdy.2010.32; Kekkonen J, 2012, IBIS, V154, P846, DOI 10.1111/j.1474-919X.2012.01252.x; Keller SR, 2008, ECOL LETT, V11, P852, DOI 10.1111/j.1461-0248.2008.01188.x; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Leinonen T, 2008, J EVOLUTION BIOL, V21, P1, DOI 10.1111/j.1420-9101.2007.01445.x; Loiseau C, 2009, MOL ECOL, V18, P1331, DOI 10.1111/j.1365-294X.2009.04105.x; Long JL, 1981, INTRO BIRDS WORLD; Marzal A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021905; Mathys BA, 2011, P ROY SOC B-BIOL SCI, V278, P2392, DOI 10.1098/rspb.2010.2302; Merila J, 2001, J EVOLUTION BIOL, V14, P892, DOI 10.1046/j.1420-9101.2001.00348.x; Merila J, 1996, HEREDITY, V77, P410, DOI 10.1038/hdy.1996.161; Moulton MP, 2010, BIOL INVASIONS, V12, P2955, DOI 10.1007/s10530-010-9692-0; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Neumann K, 1996, MOL ECOL, V5, P307; Oksanen J, 2011, VEGAN COMMUNITY ECOL, P20; PARKIN DT, 1985, HEREDITY, V54, P15, DOI 10.1038/hdy.1985.4; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pujol B, 2008, MOL ECOL, V17, P4782, DOI 10.1111/j.1365-294X.2008.03958.x; Ramakrishnan AP, 2010, MOL ECOL, V19, P1134, DOI 10.1111/j.1365-294X.2010.04543.x; ROSS HA, 1983, J ZOOL, V201, P351; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Sambrook J., 2001, MOL CLONING LAB MANU; Sax DF, 2007, TRENDS ECOL EVOL, V22, P465, DOI 10.1016/j.tree.2007.06.009; Schrey AW, 2011, MOL ECOL, V20, P1133, DOI 10.1111/j.1365-294X.2011.05001.x; Sick H, 2001, ORNITOLOGIA BRASILEI; SICK HELMUT, 1959, BOL MUS NAC RIO DE JANEIRO ZOOL, V207, P1; Simberloff D, 2009, ANNU REV ECOL EVOL S, V40, P81, DOI 10.1146/annurev.ecolsys.110308.120304; SLATKIN M, 1995, GENETICS, V139, P457; SMITH NJH, 1980, CONDOR, V82, P109, DOI 10.2307/1366801; SMITH NJH, 1973, CONDOR, V75, P242, DOI 10.2307/1365873; SPITZE K, 1993, GENETICS, V135, P367; STLOUIS VL, 1988, EVOLUTION, V42, P266, DOI 10.1111/j.1558-5646.1988.tb04131.x; Suarez AV, 2008, MOL ECOL, V17, P351, DOI 10.1111/j.1365-294X.2007.03456.x; Taylor DR, 2007, EVOLUTION, V61, P334, DOI 10.1111/j.1558-5646.2007.00037.x; Uller T, 2011, GLOBAL CHANGE BIOL, V17, P3478, DOI 10.1111/j.1365-2486.2011.02509.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Wares JP, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P229; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Whitlock MC, 2008, MOL ECOL, V17, P1885, DOI 10.1111/j.1365-294X.2008.03712.x	75	13	14	0	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53332	10.1371/journal.pone.0053332	http://dx.doi.org/10.1371/journal.pone.0053332			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285283	Green Published, Green Submitted, gold			2022-12-27	WOS:000313051500137
J	Takahata, K; Takahashi, H; Maeda, T; Umeda, S; Suhara, T; Mimura, M; Kato, M				Takahata, Keisuke; Takahashi, Hidehiko; Maeda, Takaki; Umeda, Satoshi; Suhara, Tetsuya; Mimura, Masaru; Kato, Motoichiro			It's Not My Fault: Postdictive Modulation of Intentional Binding by Monetary Gains and Losses	PLOS ONE			English	Article							CAUSAL ATTRIBUTIONS; FREE WILL; EXPERIENCE; AWARENESS; SCHIZOPHRENIA; DEPRESSION; SUCCESS; AGENCY; SENSE; FACT	Sense of agency refers to the feeling that one's voluntary actions caused external events. Past studies have shown that compression of the subjective temporal interval between actions and external events, called intentional binding, is closely linked to the experience of agency. Current theories postulate that the experience of agency is constructed via predictive and postdictive pathways. One remaining problem is the source of human causality bias; people often make misjudgments on the causality of voluntary actions and external events depending on their rewarding or punishing outcomes. Although human causality bias implies that sense of agency can be modified by post-action information, convincing empirical findings for this issue are lacking. Here, we hypothesized that sense of agency would be modified by affective valences of action outcomes. To examine this issue, we investigated how rewarding and punishing outcomes following voluntary action modulate behavioral measures of agency using intentional binding paradigm and classical conditioning procedures. In the acquisition phase, auditory stimuli were paired with positive, neutral or negative monetary outcomes. Tone-reward associations were evaluated using reaction times and preference ratings. In the experimental session, participants performed a variant of intentional binding task, where participants made timing judgments for onsets of actions and sensory outcomes while playing simple slot games. Our results showed that temporal binding was modified by affective valences of action outcomes. Specifically, intentional binding was attenuated when negative outcome occurred, consistent with self-serving bias. Our study not only provides evidence for postdictive modification of agency, but also proposes a possible mechanism of human causality bias.	[Takahashi, Hidehiko] Kyoto Univ, Dept Psychiat, Grad Sch Med, Sakyo Ku, Kyoto, Japan; [Takahata, Keisuke; Maeda, Takaki; Mimura, Masaru; Kato, Motoichiro] Keio Univ, Sch Med, Dept Neuropsychiat, Shinjuku Ku, Tokyo, Japan; [Takahata, Keisuke; Suhara, Tetsuya] Natl Inst Radiol Sci, Clin Neuroimaging Team, Mol Neuroimaging Program, Mol Imaging Ctr,Inage ku, Chiba 260, Japan; [Takahashi, Hidehiko] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama, Japan; [Umeda, Satoshi] Keio Univ, Dept Psychol, Minato Ku, Tokyo, Japan	Kyoto University; Keio University; National Institutes for Quantum Science & Technology; Japan Science & Technology Agency (JST); Keio University	Takahashi, H (corresponding author), Kyoto Univ, Dept Psychiat, Grad Sch Med, Sakyo Ku, Kyoto, Japan.	hidehiko@kuhp.kyoto-u.ac.jp		Takahashi, Hidehiko/0000-0002-5102-1982; Takahata, Keisuke/0000-0002-0884-4924	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [23120009]; MEXT [23680045]; Brain Science Foundation; Takeda Science Foundation; Casio Science Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Brain Science Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Casio Science Foundation	Funding was provided by a Grant-in-Aid for Scientific Research on Innovative Areas: Prediction and Decision Making (23120009) from Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT), a Grant-in-Aid for Young Scientist A (23680045) from (MEXT), a grant for 'Integrated research on neuropsychiatric disorders' carried out under the Strategic Research Program for Brain Sciences, a research grant from Brain Science Foundation, a research grant from Takeda Science Foundation, and a research grant from Casio Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts H, 2011, SOC NEUROSCI, P1; Aarts H, 2011, PSYCHOL SCI, V22, P532, DOI 10.1177/0956797611399294; ALLOY LB, 1979, J EXP PSYCHOL GEN, V108, P441, DOI 10.1037/0096-3445.108.4.441; Bray S, 2007, J NEUROPHYSIOL, V97, P3036, DOI 10.1152/jn.01211.2006; Buehner MJ, 2010, PSYCHOL SCI, V21, P44, DOI 10.1177/0956797609354735; Buehner MJ, 2009, PSYCHOL SCI, V20, P1221, DOI 10.1111/j.1467-9280.2009.02435.x; Buehner MJ, 2012, PSYCHOL SCI IN PRESS; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Choi H, 2006, PERCEPTION, V35, P385, DOI 10.1068/p5462; Cravo AM, 2009, EXP BRAIN RES, V199, P95, DOI 10.1007/s00221-009-1969-0; Dogge M, 2012, CONSCIOUS COGN, V21, P501, DOI 10.1016/j.concog.2011.10.014; Eagleman DM, 2000, SCIENCE, V287, P2036, DOI 10.1126/science.287.5460.2036; Engbert K, 2007, CONSCIOUS COGN, V16, P255, DOI 10.1016/j.concog.2006.09.010; Gallagher S, 2000, TRENDS COGN SCI, V4, P14, DOI 10.1016/S1364-6613(99)01417-5; Haggard P, 2003, CONSCIOUS COGN, V12, P695, DOI 10.1016/S1053-8100(03)00052-7; Haggard P, 2003, NEUROREPORT, V14, P1081, DOI 10.1097/01.wnr.0000073684.00308.c0; Haggard P, 2002, NAT NEUROSCI, V5, P382, DOI 10.1038/nn827; Hauser M, 2011, SCHIZOPHR RES, V126, P20, DOI 10.1016/j.schres.2010.10.031; Johansson P, 2005, SCIENCE, V310, P116, DOI 10.1126/science.1111709; Kim H, 2006, PLOS BIOL, V4, P1453, DOI 10.1371/journal.pbio.0040233; KUIPER NA, 1978, J PERS SOC PSYCHOL, V36, P236, DOI 10.1037/0022-3514.36.3.236; LIBET B, 1983, BRAIN, V106, P623, DOI 10.1093/brain/106.3.623; Maeda T, 2012, PSYCHIAT RES, V198, P1, DOI 10.1016/j.psychres.2011.10.021; MCFARLAND C, 1982, J PERS SOC PSYCHOL, V43, P937, DOI 10.1037/0022-3514.43.5.937; Mezulis AH, 2004, PSYCHOL BULL, V130, P711, DOI 10.1037/0033-2909.130.5.711; Moore JW, 2010, P ROY SOC B-BIOL SCI, V277, P2503, DOI 10.1098/rspb.2010.0404; Moore JW, 2010, NEUROPSYCHOLOGIA, V48, P1125, DOI 10.1016/j.neuropsychologia.2009.12.014; Moore JW, 2009, CONSCIOUS COGN, V18, P1056, DOI 10.1016/j.concog.2009.05.004; Moore JW, 2012, CONSCIOUS COGN, P1; Moretto G, 2011, CONSCIOUS COGN, V20, P1847, DOI 10.1016/j.concog.2011.08.014; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; Obhi S, 2011, EXP BRAIN RES, V211, P663, DOI 10.1007/s00221-011-2662-7; Pronin E, 2010, P NATL ACAD SCI USA, V107, P22469, DOI 10.1073/pnas.1012046108; Seymour B, 2005, NAT NEUROSCI, V8, P1234, DOI 10.1038/nn1527; SWEENEY PD, 1986, J PERS SOC PSYCHOL, V50, P974, DOI 10.1037/0022-3514.50.5.974; Synofzik M, 2010, BRAIN, V133, P262, DOI 10.1093/brain/awp291; TAYLOR SE, 1994, PSYCHOL BULL, V116, P21, DOI 10.1037/0033-2909.116.1.21; Tipples J, 2008, EMOTION, V8, P127, DOI 10.1037/1528-3542.8.1.127; Tsakiris M, 2003, EXP BRAIN RES, V149, P439, DOI 10.1007/s00221-003-1386-8; Voss M, 2010, BRAIN, V133, P3104, DOI 10.1093/brain/awq152; Wegner D., 2002, ILLUSION CONSCIOUS W; Wegner DM, 1999, AM PSYCHOL, V54, P480, DOI 10.1037/0003-066X.54.7.480; Wegner DM, 2003, TRENDS COGN SCI, V7, P65, DOI 10.1016/S1364-6613(03)00002-0; Yamada Y, 2011, CONSCIOUS COGN, V20, P1835, DOI 10.1016/j.concog.2011.06.016	44	76	76	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53421	10.1371/journal.pone.0053421	http://dx.doi.org/10.1371/journal.pone.0053421			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	064DQ	23285293	Green Published, Green Submitted, gold			2022-12-27	WOS:000313051500148
J	Trejo-Becerril, C; Perez-Cardenas, E; Taja-Chayeb, L; Anker, P; Herrera-Goepfert, R; Medina-Velazquez, LA; Hidalgo-Miranda, A; Perez-Montiel, D; Chavez-Blanco, A; Cruz-Velazquez, J; Diaz-Chavez, J; Gaxiola, M; Duenas-Gonzalez, A				Trejo-Becerril, Catalina; Perez-Cardenas, Enrique; Taja-Chayeb, Lucia; Anker, Philippe; Herrera-Goepfert, Roberto; Medina-Velazquez, Luis A.; Hidalgo-Miranda, Alfredo; Perez-Montiel, Delia; Chavez-Blanco, Alma; Cruz-Velazquez, Judith; Diaz-Chavez, Jose; Gaxiola, Miguel; Duenas-Gonzalez, Alfonso			Cancer Progression Mediated by Horizontal Gene Transfer in an In Vivo Model	PLOS ONE			English	Article							FREE NUCLEIC-ACIDS; DIRECT DNA UPTAKE; ENZYME THERAPY; TRANSFORMATION; PLASMA; ORIGIN; CELLS; INFORMATION; LYMPHOCYTES; DROSOPHILA	It is known that cancer progresses by vertical gene transfer, but this paradigm ignores that DNA circulates in higher organisms and that it is biologically active upon its uptake by recipient cells. Here we confirm previous observations on the ability of cell-free DNA to induce in vitro cell transformation and tumorigenesis by treating NIH3T3 recipient murine cells with serum of colon cancer patients and supernatant of SW480 human cancer cells. Cell transformation and tumorigenesis of recipient cells did not occur if serum and supernatants were depleted of DNA. It is also demonstrated that horizontal cancer progression mediated by circulating DNA occurs via its uptake by recipient cells in an in vivo model where immunocompetent rats subjected to colon carcinogenesis with 1,2-dimethylhydrazine had increased rate of colonic tumors when injected in the dorsum with human SW480 colon carcinoma cells as a source of circulating oncogenic DNA, which could be offset by treating these animals with DNAse I and proteases. Though the contribution of biologically active molecules other than DNA for this phenomenon to occur cannot be ruled out, our results support the fact that cancer cells emit into the circulation biologically active DNA to foster tumor progression. Further exploration of the horizontal tumor progression phenomenon mediated by circulating DNA is clearly needed to determine whether its manipulation could have a role in cancer therapy.	[Duenas-Gonzalez, Alfonso] Univ Nacl Autonoma Mexico, Inst Nacl Cancerol, Inst Invest Biomed, Mexico City 04510, DF, Mexico; [Trejo-Becerril, Catalina; Perez-Cardenas, Enrique; Taja-Chayeb, Lucia; Chavez-Blanco, Alma; Diaz-Chavez, Jose] Inst Nacl Cancerol, Basic Res Div, Mexico City, DF, Mexico; [Anker, Philippe] OncoXL, Geneva, Switzerland; [Herrera-Goepfert, Roberto; Perez-Montiel, Delia] Inst Nacl Cancerol, Dept Pathol, Mexico City, DF, Mexico; [Medina-Velazquez, Luis A.] Univ Nacl Autonoma Mexico, Inst Nacl Cancerol, Inst Fis, Mexico City 04510, DF, Mexico; [Hidalgo-Miranda, Alfredo] Inst Nacl Med Genom, Canc Genom Lab, Mexico City, DF, Mexico; [Cruz-Velazquez, Judith] Inst Nacl Cancerol, Dept Cytogenet, Mexico City, DF, Mexico; [Gaxiola, Miguel] Inst Nacl Enfermedades Resp, Unidad Invest, Mexico City, DF, Mexico	Instituto Nacional de Cancerologia (INCAN); Universidad Nacional Autonoma de Mexico; Instituto Nacional de Cancerologia (INCAN); Instituto Nacional de Cancerologia (INCAN); Instituto Nacional de Cancerologia (INCAN); Universidad Nacional Autonoma de Mexico; Instituto Nacional de Medicina Genomica; Instituto Nacional de Cancerologia (INCAN)	Duenas-Gonzalez, A (corresponding author), Univ Nacl Autonoma Mexico, Inst Nacl Cancerol, Inst Invest Biomed, Mexico City 04510, DF, Mexico.	alfonso_duenasg@yahoo.com	Díaz-Chávez, José/HGU-7481-2022; Hidalgo-Miranda, Alfredo/B-2123-2010	Hidalgo-Miranda, Alfredo/0000-0003-2315-3977; Herrera-Goepfert, Roberto/0000-0001-7901-2378; Diaz-Chavez, Jose/0000-0001-9583-3790; PEREZ MONTIEL, MARIA DELIA/0000-0002-9338-2284	CONACyT [34649-M, 50699]; PAPIIT UNAM [IN214902]	CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); PAPIIT UNAM(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico)	This work was supported by CONACyT grants 34649-M, 50699 and from PAPIIT UNAM IN214902. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS DH, 1985, INT J BIOCHEM, V17, P1133, DOI 10.1016/0020-711X(85)90001-1; ANKER P, 1975, CANCER RES, V35, P2375; ANKER P, 1980, J IMMUNOGENET, V7, P475; ANKER P, 1984, CELL BIOCHEM FUNCT, V2, P33, DOI 10.1002/cbf.290020110; ANKER P, 1994, CR ACAD SCI III-VIE, V317, P869; ANKER P, 1968, NATURE, V219, P932, DOI 10.1038/219932a0; BENOIT J, 1960, BIOCHEM PHARMACOL, V4, P181, DOI 10.1016/0006-2952(60)90056-3; Bergsmedh A, 2001, P NATL ACAD SCI USA, V98, P6407, DOI 10.1073/pnas.101129998; Beuth J, 2008, INTEGR CANCER THER, V7, P311, DOI 10.1177/1534735408327251; BURKI E, 1948, OPHTHALMOLOGICA, V115, P241; DELAMIRANDE G, 1961, NATURE, V192, P52, DOI 10.1038/192052a0; FAHMY OG, 1961, NATURE, V191, P776, DOI 10.1038/191776a0; FOX AS, 1970, P NATL ACAD SCI USA, V67, P1608, DOI 10.1073/pnas.67.3.1608; GAHAN P. B., 1965, INT REV CYTOL, V18, P223, DOI 10.1016/S0074-7696(08)60555-0; GAHAN PB, 1962, NATURE, V195, P1115, DOI 10.1038/1951115a0; GAHAN PB, 1973, ANN BOT-LONDON, V37, P681, DOI 10.1093/oxfordjournals.aob.a084735; Gahan PB, 2003, CELL BIOCHEM FUNCT, V21, P11, DOI 10.1002/cbf.986; Gahan PB, 2010, CELL BIOCHEM FUNCT, V28, P529, DOI 10.1002/cbf.1690; Gaiffe E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036766; Garcia-Olmo DC, 2010, CANCER RES, V70, P560, DOI 10.1158/0008-5472.CAN-09-3513; HESS D, 1969, Z PFLANZENPHYSIOL, V61, P286; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Lee TH, 2011, SEMIN IMMUNOPATHOL, V33, P455, DOI 10.1007/s00281-011-0250-3; Leipner J, 2000, DRUGS, V59, P769, DOI 10.2165/00003495-200059040-00004; McAllister SS, 2008, CELL, V133, P994, DOI 10.1016/j.cell.2008.04.045; NAWA S, 1968, GENETICS, V58, P573; Patutina O, 2011, BIOCHIMIE, V93, P689, DOI 10.1016/j.biochi.2010.12.011; PELC SR, 1968, NATURE, V219, P162, DOI 10.1038/219162a0; Perse M, 2005, RADIOL ONCOL, V39, P61; Puszyk WM, 2009, CLIN BIOCHEM, V42, P736, DOI 10.1016/j.clinbiochem.2008.11.006; Raptis L, 2001, METH MOL B, V165, P151; Record M, 2011, BIOCHEM PHARMACOL, V81, P1171, DOI 10.1016/j.bcp.2011.02.011; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; SENARATNA T, 1991, PLANT SCI, V79, P223, DOI 10.1016/0168-9452(91)90109-L; Shklyaeva OA, 2008, DOKL BIOCHEM BIOPHYS, V420, P108, DOI 10.1134/S1607672908030034; Sleator RD, 2011, ARCH MICROBIOL, V193, P235, DOI 10.1007/s00203-011-0677-x; SLOTOVA J, 1968, BIOL PLANTARUM, V10, P190, DOI 10.1007/BF02921036; SLOTOVA J, 1969, BIOL PLANTARUM, V11, P216, DOI 10.1007/BF02920800; SOARES MB, 1985, J MOL EVOL, V22, P117, DOI 10.1007/BF02101690; STROUN M, 1967, NATURE, V215, P975, DOI 10.1038/215975b0; STROUN M, 1989, ONCOLOGY, V46, P318; STROUN M, 1970, NATURE, V227, P607, DOI 10.1038/227607a0; Stroun M, 1972, BIOCHEM J, V128, p00P; Szeles A, 1996, CHROMOSOME RES, V4, P310, DOI 10.1007/BF02263683; Taback B, 2004, CURR OPIN MOL THER, V6, P273; van der Vaart M, 2009, CLIN CHIM ACTA, V409, P21, DOI 10.1016/j.cca.2009.08.011; Wald M, 1998, LIFE SCI, V63, pPL237, DOI 10.1016/S0024-3205(98)00425-1; Walker JA, 2003, ANAL BIOCHEM, V315, P122, DOI 10.1016/S0003-2697(03)00081-2	48	70	73	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52754	10.1371/journal.pone.0052754	http://dx.doi.org/10.1371/journal.pone.0052754			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285175	Green Published, gold, Green Submitted			2022-12-27	WOS:000313051500055
J	van Engelen, K; Mommersteeg, MTM; Baars, MJH; Lam, J; Ilgun, A; van Trotsenburg, ASP; Smets, AMJB; Christoffels, VM; Mulder, BJM; Postma, AV				van Engelen, Klaartje; Mommersteeg, Mathilda T. M.; Baars, Marieke J. H.; Lam, Jan; Ilgun, Aho; van Trotsenburg, A. S. Paul; Smets, Anne M. J. B.; Christoffels, Vincent M.; Mulder, Barbara J. M.; Postma, Alex V.			The Ambiguous Role of NKX2-5 Mutations in Thyroid Dysgenesis	PLOS ONE			English	Article							CONGENITAL HEART-DISEASE; NON-AUTOIMMUNE HYPOTHYROIDISM; TRANSCRIPTION FACTOR NKX2-5; MOLECULAR ANALYSIS; GENE NKX2-5; PAX8; CELLS; THYROTROPIN; EXPRESSION; REGISTRY	NKX2-5 is a homeodomain-containing transcription factor implied in both heart and thyroid development. Numerous mutations in NKX2-5 have been reported in individuals with congenital heart disease (CHD), but recently a select few have been associated with thyroid dysgenesis, among which the p.A119S variation. We sequenced NKX2-5 in 303 sporadic CHD patients and 38 families with at least two individuals with CHD. The p.A119S variation was identified in two unrelated patients: one was found in the proband of a family with four affected individuals with CHD and the other in a sporadic CHD patient. Clinical evaluation of heart and thyroid showed that the mutation did not segregate with CHD in the familial case, nor did any of the seven mutation carriers have thyroid abnormalities. We tested the functional consequences of the p.A119S variation in a cellular context by performing transactivation assays with promoters relevant for both heart and thyroid development in rat heart derived H10 cells and HELA cells. There was no difference between wildtype NKX2-5 and p.A119S NKX2-5 in activation of the investigated promoters in both cell lines. Additionally, we reviewed the current literature on the topic, showing that there is no clear evidence for a major pathogenic role of NKX2-5 mutations in thyroid dysgenesis. In conclusion, our study demonstrates that p.A119S does not cause CHD or TD and that it is a rare variation that behaves equal to wildtype NKX2-5. Furthermore, given the wealth of published evidence, we suggest that NKX2-5 mutations do not play a major pathogenic role in thyroid dysgenesis, and that genetic testing of NKX2-5 in TD is not warranted.	[van Engelen, Klaartje; Mulder, Barbara J. M.] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1105 AZ Amsterdam, Netherlands; [van Engelen, Klaartje; Baars, Marieke J. H.] Univ Amsterdam, Acad Med Ctr, Dept Clin Genet, NL-1105 AZ Amsterdam, Netherlands; [van Engelen, Klaartje; Mulder, Barbara J. M.] Interuniv Cardiol Inst Netherlands ICIN, Utrecht, Netherlands; [Mommersteeg, Mathilda T. M.; Ilgun, Aho; Christoffels, Vincent M.; Postma, Alex V.] Univ Amsterdam, Acad Med Ctr, Dept Anat & Embryol, Heart Failure Res Ctr, NL-1105 AZ Amsterdam, Netherlands; [Lam, Jan] Univ Amsterdam, Acad Med Ctr, Dept Pediat Cardiol, NL-1105 AZ Amsterdam, Netherlands; [van Trotsenburg, A. S. Paul] Univ Amsterdam, Acad Med Ctr, Dept Pediat Endocrinol, NL-1105 AZ Amsterdam, Netherlands; [Smets, Anne M. J. B.] Univ Amsterdam, Acad Med Ctr, Dept Radiol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	van Engelen, K (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Cardiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	k.vanengelen@amc.uva.nl	van Trotsenburg, Paul/ABC-2379-2020; Postma, Alex V/H-4806-2019	van Trotsenburg, Paul/0000-0002-9677-7441; Postma, Alex V/0000-0003-4874-2487; Mommersteeg, Mathilda/0000-0001-6624-3038	Academic Medical Center (government funding)	Academic Medical Center (government funding)	This study was funded by the Academic Medical Center (government funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Taji E, 2007, EUR J ENDOCRINOL, V156, P521, DOI 10.1530/EJE-06-0709; Bartlett H, 2010, PEDIATR CARDIOL, V31, P335, DOI 10.1007/s00246-009-9605-0; Beffagna G, 2012, J CARDIOVASC MED HAG; Benson DW, 1999, J CLIN INVEST, V104, P1567, DOI 10.1172/JCI8154; Biben C, 2000, CIRC RES, V87, P888, DOI 10.1161/01.RES.87.10.888; Brust ES, 2012, ARQ BRAS ENDOCRINOL, V56, P173, DOI 10.1590/S0004-27302012000300004; Cangul H, 2010, CLIN ENDOCRINOL, V73, P671, DOI 10.1111/j.1365-2265.2010.03849.x; Castanet M, 2001, J CLIN ENDOCR METAB, V86, P2009, DOI 10.1210/jc.86.5.2009; Clifton-Bligh RJ, 1998, NAT GENET, V19, P399, DOI 10.1038/1294; Dean DS, 2008, BEST PRACT RES CL EN, V22, P901, DOI 10.1016/j.beem.2008.09.019; Dentice M, 2006, J CLIN ENDOCR METAB, V91, P1428, DOI 10.1210/jc.2005-1350; Fagman H, 2011, J MOL ENDOCRINOL, V46, pR33, DOI 10.1677/JME-10-0084; GEY GO, 1952, CANCER RES, V12, P264; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; Habets PEMH, 2002, GENE DEV, V16, P1234, DOI 10.1101/gad.222902; Hermanns P, 2011, J CLIN ENDOCR METAB, V96, pE977, DOI 10.1210/jc.2010-2341; Jahn L, 1996, J CELL SCI, V109, P397; Kasahara H, 2000, J CLIN INVEST, V106, P299, DOI 10.1172/JCI9860; Kempers MJE, 2006, J CLIN ENDOCR METAB, V91, P3370, DOI 10.1210/jc.2006-0058; Krude H, 2002, J CLIN INVEST, V109, P475, DOI 10.1172/JC1200214341; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; LINTS TJ, 1993, DEVELOPMENT, V119, P419; LYONS I, 1995, GENE DEV, V9, P1654, DOI 10.1101/gad.9.13.1654; Macchia PE, 1998, NAT GENET, V19, P83, DOI 10.1038/ng0598-83; Narumi S, 2010, J CLIN ENDOCR METAB, V95, P1981, DOI 10.1210/jc.2009-2373; Olivieri A, 2002, J CLIN ENDOCR METAB, V87, P557, DOI 10.1210/jc.87.2.557; Passeri E, 2011, J CLIN ENDOCR METAB, V96, pE1115, DOI 10.1210/jc.2011-0057; Postma AV, 2008, CIRC RES, V102, P1433, DOI 10.1161/CIRCRESAHA.107.168294; Ramos HE, 2009, THYROID, V19, P61, DOI 10.1089/thy.2008.0116; Reamon-Buettner SM, 2010, HUM MUTAT, V31, P1185, DOI 10.1002/humu.21345; Ruijter JM, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-2; Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108; Spencer CA, 2007, J CLIN ENDOCR METAB, V92, P4236, DOI 10.1210/jc.2007-0287; SUNTHORNTHEPVARAKUL T, 1995, NEW ENGL J MED, V332, P155, DOI 10.1056/NEJM199501193320305; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Van der Velde ET, 2005, EUR J EPIDEMIOL, V20, P549, DOI 10.1007/s10654-005-4264-9; Van Vliet G, 2003, CLIN GENET, V63, P445	37	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52685	10.1371/journal.pone.0052685	http://dx.doi.org/10.1371/journal.pone.0052685			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285148	Green Published, gold, Green Submitted			2022-12-27	WOS:000313051500048
J	Wootton, JT; Pfister, CA				Wootton, J. Timothy; Pfister, Catherine A.			Carbon System Measurements and Potential Climatic Drivers at a Site of Rapidly Declining Ocean pH	PLOS ONE			English	Article							DISSOLVED ORGANIC-CARBON; ACIDIFICATION; DIOXIDE; CO2; IMPACT; WATER; TRENDS; EXPORT	We explored changes in ocean pH in coastal Washington state, USA, by extending a decadal-scale pH data series, by reporting independent measures of dissolved inorganic carbon (DIC), spectrophotometric pH, and total alkalinity (TA), by exploring pH patterns over larger spatial scales, and by probing for long-term trends in environmental variables reflecting potentially important drivers of pH. We found that pH continued to decline in this area at a rapid rate, that pH exhibited high natural variability within years, that our measurements of pH corresponded well to spectrophotometric pH measures and expected pH calculated from DIC/TA, and that TA estimates based on salinity predicted well actual alkalinity. Multiple datasets reflecting upwelling, including water temperature, nutrient levels, phytoplankton abundance, the NOAA upwelling index, and data on local wind patterns showed no consistent trends over the period of our study. Multiple datasets reflecting precipitation change and freshwater runoff, including precipitation records, local and regional river discharge, salinity, nitrate and sulfate in rainwater, and dissolved organic carbon (DOC) in rivers also showed no consistent trends over time. Dissolved oxygen did not decline over time, indicating that long-term changes did not result from shifts in contributions of respiration to pH levels. These tests of multiple potential drivers of the observed rapid rate of pH decline indicate a primary role for inorganic carbon and suggest that geochemical models of coastal ocean carbon fluxes need increased investigation.	[Wootton, J. Timothy; Pfister, Catherine A.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA	University of Chicago	Wootton, JT (corresponding author), Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA.	twootton@uchicago.edu	Wootton, J. Timothy/F-3191-2015	Wootton, J. Timothy/0000-0002-7715-0344	Andrew W. Mellon Foundation; Olympic Natural Resources Center; SeaDoc Society through the Wildlife Health Center, School of Veterinary Medicine, University of California, Davis; National Science Foundation [OCE 97-11802, OCE 01-17801, OCE 04-52678, OCE 09-28232, DEB 09-19420]; Direct For Biological Sciences [0919420] Funding Source: National Science Foundation; Division Of Ocean Sciences [0928232] Funding Source: National Science Foundation	Andrew W. Mellon Foundation; Olympic Natural Resources Center; SeaDoc Society through the Wildlife Health Center, School of Veterinary Medicine, University of California, Davis(University of California System); National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Funding was provided in part by the Andrew W. Mellon Foundation; the Olympic Natural Resources Center; the SeaDoc Society through the Wildlife Health Center, School of Veterinary Medicine, University of California, Davis; and the National Science Foundation (OCE 97-11802, OCE 01-17801, OCE 04-52678, OCE 09-28232, DEB 09-19420). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS PA, 1994, EVOL ECOL, V8, P150, DOI 10.1007/BF01238247; Antonov J. I., 2006, WORLD OCEAN ATLAS 20; Barton A, 2012, LIMNOL OCEANOGR, V57, P698, DOI 10.4319/lo.2012.57.3.0698; Bates NR, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003759; Beaufort L, 2011, NATURE, V476, P80, DOI 10.1038/nature10295; Boyce DG, 2010, NATURE, V466, P591, DOI 10.1038/nature09268; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Chan F, 2008, SCIENCE, V319, P920, DOI 10.1126/science.1149016; Chesson P, 1990, ANNU REV ECOL SYST, V31, P343; Connolly TP, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005283; Cowles H.C., 1899, BOT GAZ, V27, P95, DOI [DOI 10.1086/327796, 10.1086/327796]; Dickson A.G., 2007, GUIDE BEST PRACTICES; DICKSON AG, 1984, GEOCHIM COSMOCHIM AC, V48, P2299, DOI 10.1016/0016-7037(84)90225-4; DICKSON AG, 1993, MAR CHEM, V44, P131, DOI 10.1016/0304-4203(93)90198-W; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Dore JE, 2009, P NATL ACAD SCI USA, V106, P12235, DOI 10.1073/pnas.0906044106; Evans W, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006625; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Feely RA, 2008, SCIENCE, V320, P1490, DOI 10.1126/science.1155676; Feely RA, 2010, ESTUAR COAST SHELF S, V88, P442, DOI 10.1016/j.ecss.2010.05.004; Freeman C, 2004, NATURE, V430, P195, DOI 10.1038/nature02707; Gaylord B, 2011, J EXP BIOL, V214, P2586, DOI 10.1242/jeb.055939; Gazeau F, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028554; Gazeau F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023010; Gonzalez-Davila M, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001993; Hall-Spencer JM, 2008, NATURE, V454, P96, DOI 10.1038/nature07051; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Knap A., 1996, 19 JGOFS UNESCO; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Lee K, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027207; LIKENS GE, 1970, ECOL MONOGR, V40, P23, DOI 10.2307/1942440; Monteith DT, 2007, NATURE, V450, P537, DOI 10.1038/nature06316; Nevison CD, 2008, BIOGEOSCIENCES, V5, P875, DOI 10.5194/bg-5-875-2008; Nienhuis S, 2010, P ROY SOC B-BIOL SCI, V277, P2553, DOI 10.1098/rspb.2010.0206; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Paine Robert T., 2010, P229; PAINE RT, 1994, EXCELLENCE ECOLOGY, V4; Pfister CA, 2007, LIMNOL OCEANOGR, V52, P1767, DOI 10.4319/lo.2007.52.5.1767; Pfister CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025766; Pierrot D., 2006, ORNLCDIAC105A US DEP, DOI [10.3334/CDIAC/otg.CO2SYS_XLS_CDIAC105a, DOI 10.3334/CDIAC/OTG.CO2SYS_XLS_CDIAC105A]; Provoost P, 2010, BIOGEOSCIENCES, V7, P3869, DOI 10.5194/bg-7-3869-2010; Raven J., 2005, OCEAN ACIDIFICATION; Salisbury J., 2008, EOS T AM GEOPHYS UN, V89, P513, DOI [10.1029/2008EO500001, DOI 10.1029/2008EO500001]; Santana-Casiano JM, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002788; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Striegl RG, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024413; Williams B, 2011, BIOGEOSCIENCES, V8, P165, DOI 10.5194/bg-8-165-2011; Wootton JT, 2008, P NATL ACAD SCI USA, V105, P18848, DOI 10.1073/pnas.0810079105; Worrall F, 2004, BIOGEOCHEMISTRY, V70, P369, DOI 10.1007/s10533-004-8131-7	49	52	54	2	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53396	10.1371/journal.pone.0053396	http://dx.doi.org/10.1371/journal.pone.0053396			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285290	Green Published, Green Submitted, gold			2022-12-27	WOS:000313051500145
J	Zhang, L; Dong, XW; Wang, JN; Tang, JM; Yang, JY; Guo, LY; Zheng, F; Kong, X; Huang, YZ; Chen, SY				Zhang, Lei; Dong, Xiao-Wei; Wang, Jia-Ning; Tang, Jun-Ming; Yang, Jian-Ye; Guo, Ling-Yun; Zheng, Fei; Kong, Xia; Huang, Yong-Zhang; Chen, Shi-You			PEP-1-CAT-Transduced Mesenchymal Stem Cells Acquire an Enhanced Viability and Promote Ischemia-Induced Angiogenesis	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; STROMAL CELLS; HEART; SURVIVAL; THERAPY; MECHANISMS; APOPTOSIS; STRESS; DEATH	Objective: Poor survival of mesenchymal stem cells (MSC) compromised the efficacy of stem cell therapy for ischemic diseases. The aim of this study is to investigate the role of PEP-1-CAT transduction in MSC survival and its effect on ischemia-induced angiogenesis. Methods: MSC apoptosis was evaluated by DAPI staining and quantified by Annexin V and PI double staining and Flow Cytometry. Malondialdehyde (MDA) content, lactate dehydrogenase (LDH) release, and Superoxide Dismutase (SOD) activities were simultaneously measured. MSC mitochondrial membrane potential was analyzed with JC-1 staining. MSC survival in rat muscles with gender-mismatched transplantation of the MSC after lower limb ischemia was assessed by detecting SRY expression. MSC apoptosis in ischemic area was determined by TUNEL assay. The effect of PEP-1-CAT-transduced MSC on angiogenesis in vivo was determined in the lower limb ischemia model. Results: PEP-1-CAT transduction decreased MSC apoptosis rate while down-regulating MDA content and blocking LDH release as compared to the treatment with H2O2 or CAT. However, SOD activity was up-regulated in PEP-1-CAT-transduced cells. Consistent with its effect on MSC apoptosis, PEP-1-CAT restored H2O2-attenuated mitochondrial membrane potential. Mechanistically, PEP-1-CAT blocked H2O2-induced down-regulation of PI3K/Akt activity, an essential signaling pathway regulating MSC apoptosis. In vivo, the viability of MSC implanted into ischemic area in lower limb ischemia rat model was increased by four-fold when transduced with PEP-1-CAT. Importantly, PEP-1-CAT-transduced MSC significantly enhanced ischemia-induced angiogenesis by up-regulating VEGF expression. Conclusions: PEP-1-CAT-transduction was able to increase MSC viability by regulating PI3K/Akt activity, which stimulated ischemia-induced angiogenesis.	[Zhang, Lei; Dong, Xiao-Wei; Wang, Jia-Ning; Tang, Jun-Ming; Yang, Jian-Ye; Guo, Ling-Yun; Zheng, Fei; Kong, Xia; Huang, Yong-Zhang] Hubei Univ Med, Inst Clin Med, Shiyan, Hubei, Peoples R China; [Zhang, Lei; Dong, Xiao-Wei; Wang, Jia-Ning; Tang, Jun-Ming; Yang, Jian-Ye; Guo, Ling-Yun; Zheng, Fei; Kong, Xia; Huang, Yong-Zhang] Hubei Univ Med, Renmin Hosp, Dept Cardiol, Shiyan, Hubei, Peoples R China; [Zhang, Lei; Dong, Xiao-Wei; Wang, Jia-Ning; Tang, Jun-Ming; Yang, Jian-Ye; Guo, Ling-Yun; Zheng, Fei; Kong, Xia; Huang, Yong-Zhang] Hubei Univ Med, Key Lab Human Embryon Stem Cell Hubei Prov, Shiyan, Hubei, Peoples R China; [Tang, Jun-Ming] Hubei Univ Med, Dept Physiol, Shiyan, Hubei, Peoples R China; [Chen, Shi-You] Univ Georgia, Dept Physiol & Pharmacol, Athens, GA USA	Hubei University of Medicine; Hubei University of Medicine; Hubei University of Medicine; Hubei University of Medicine; University System of Georgia; University of Georgia	Wang, JN (corresponding author), Hubei Univ Med, Inst Clin Med, Shiyan, Hubei, Peoples R China.	rywjn@vip.163.com			National Natural Science Foundation of China [81170095]; Hubei Health Department Science Foundation [JX5B24]; Hubei Education Department Science Foundation [T201112]; National Institutes of Health [HL093429, HL107526]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107526, R01HL093429] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hubei Health Department Science Foundation; Hubei Education Department Science Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by grants from National Natural Science Foundation of China (81170095),http://www.nsfc.gov.cn/Portal0/default152.htm; Hubei Health Department Science Foundation (JX5B24),http://www.hbws.gov.cn/; Hubei Education Department Science Foundation (T201112),http://www.hbe.gov.cn/.China; and National Institutes of Health (HL093429 and HL107526),http://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao CY, 2010, BIOCHEM CELL BIOL, V88, P629, DOI 10.1139/O10-018; Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Dong Xiao, 2007, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V29, P93; Foster KA, 2006, PROG NEUROBIOL, V79, P136, DOI 10.1016/j.pneurobio.2006.07.001; Geng YJ, 2003, ANN NY ACAD SCI, V1010, P687, DOI 10.1196/annals.1299.126; Huang GQ, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-73; Iwase T, 2005, CARDIOVASC RES, V66, P543, DOI 10.1016/j.cardiores.2005.02.006; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Mangi AA, 2003, NAT MED, V9, P1195, DOI 10.1038/nm912; Mishra V, 2005, ANN CLIN BIOCHEM, V42, P269, DOI 10.1258/0004563054255461; Perin EC, 2006, TEX HEART I J, V33, P204; Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Reinlib L, 2000, CIRCULATION, V101, pE182; Tang YL, 2005, J AM COLL CARDIOL, V46, P1339, DOI 10.1016/j.jacc.2005.05.079; Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442; Tsai RYL, 2002, DEV CELL, V2, P707, DOI 10.1016/S1534-5807(02)00195-8; Wei H, 2010, J CELL BIOCHEM, V111, P967, DOI 10.1002/jcb.22785; Zhang M, 2001, J MOL CELL CARDIOL, V33, P907, DOI 10.1006/jmcc.2001.1367; Zhang YE, 2011, RESUSCITATION, V82, P1081, DOI 10.1016/j.resuscitation.2011.01.034	23	8	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52537	10.1371/journal.pone.0052537	http://dx.doi.org/10.1371/journal.pone.0052537			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285080	Green Published, gold, Green Submitted			2022-12-27	WOS:000313051500033
J	Daud-Gallotti, RM; Costa, SF; Guimaraes, T; Padilha, KG; Inoue, EN; Vasconcelos, TN; Rodrigues, FDC; Barbosa, EV; Figueiredo, WB; Levin, AS				Daud-Gallotti, Renata M.; Costa, Silvia F.; Guimaraes, Thais; Padilha, Katia Grillo; Inoue, Evelize Naomi; Vasconcelos, Tiago Nery; Cunha Rodrigues, Fernanda da Silva; Barbosa, Edizangela Vasconcelos; Figueiredo, Walquiria Barcelos; Levin, Anna S.			Nursing Workload as a Risk Factor for Healthcare Associated Infections in ICU: A Prospective Study	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; SCORE; MANAGEMENT; OUTCOMES; ERROR	Introduction: Nurse understaffing is frequently hypothesized as a potential risk factor for healthcare-associated infections (HAI). This study aimed to evaluate the role of nursing workload in the occurrence of HAI, using Nursing Activities Score (NAS). Methods: This prospective cohort study enrolled all patients admitted to 3 Medical ICUs and one step-down unit during 3 months (2009). Patients were followed-up until HAI, discharge or death. Information was obtained from direct daily observation of medical and nursing rounds, chart review and monitoring of laboratory system. Nursing workload was determined using NAS. Non-compliance to the nurses' patient care plans (NPC) was identified. Demographic data, clinical severity, invasive procedures, hospital interventions, and the occurrence of other adverse events were also recorded. Patients who developed HAI were compared with those who did not. Results: 195 patients were included and 43 (22%) developed HAI: 16 pneumonia, 12 urinary-tract, 8 bloodstream, 2 surgical site, 2 other respiratory infections and 3 other. Average NAS and average proportion of non compliance with NPC were significantly higher in HAI patients. They were also more likely to suffer other adverse events. Only excessive nursing workload (OR: 11.41; p: 0.019) and severity of patient's clinical condition (OR: 1.13; p: 0.015) remained as risk factors to HAI. Conclusions: Excessive nursing workload was the main risk factor for HAI, when evaluated together with other invasive devices except mechanical ventilation. To our knowledge, this study is the first to evaluate prospectively the nursing workload as a potential risk factor for HAI, using NAS.	[Costa, Silvia F.; Levin, Anna S.] Univ Sao Paulo, Dept Infect Dis, Sao Paulo, Brazil; [Costa, Silvia F.; Levin, Anna S.] Univ Sao Paulo, Fac Med, LIM 54, Sao Paulo, Brazil; [Daud-Gallotti, Renata M.] Univ Nove Julho, Fac Med, Sao Paulo, Brazil; [Daud-Gallotti, Renata M.] Univ Sao Paulo, Humanizat Tech Div, Hosp Clin, Sao Paulo, Brazil; [Guimaraes, Thais; Levin, Anna S.] Univ Sao Paulo, Dept Infect Control, Hosp Clin, Fac Med, Sao Paulo, Brazil; [Padilha, Katia Grillo] Univ Sao Paulo, Sch Nursing, Sao Paulo, Brazil; [Barbosa, Edizangela Vasconcelos; Figueiredo, Walquiria Barcelos] Univ Sao Paulo, Nursing Div, Fac Med, Hosp Clin, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Nove de Julho; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Levin, AS (corresponding author), Univ Sao Paulo, Dept Infect Dis, Sao Paulo, Brazil.	gcih.adm@hc.fm.usp.br	Costa, Silvia F/K-4768-2012; Levin, Anna S./AAJ-1712-2021; Figueiredo Costa, silvia/ABC-7704-2021; Guimarães, Thais/C-7134-2014; Padilha, Katia/J-6798-2012; Levin, Anna S/C-8831-2012	Costa, Silvia F/0000-0003-1087-752X; Levin, Anna S./0000-0003-2427-8368; Figueiredo Costa, silvia/0000-0003-1087-752X; Guimarães, Thais/0000-0002-7282-5453; Padilha, Katia/0000-0002-6440-4667; Levin, Anna S/0000-0003-2427-8368; Reis Barbosa, Egberto/0000-0002-6996-9130	Foundation for Research of the State of Sao Paulo (FAPESP- Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [2008/00955-2]	Foundation for Research of the State of Sao Paulo (FAPESP- Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)	This study was funded by the Foundation for Research of the State of Sao Paulo (FAPESP- Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)-grant number 2008/00955-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson Shoana, 2012, Morbidity and Mortality Weekly Report, V61, P501; [Anonymous], 2008, SUMM EV PAT SAF IMPL; Anthony T, 2011, ARCH SURG-CHICAGO, V146, P263, DOI 10.1001/archsurg.2010.249; Blatnik J, 2006, J HOSP INFECT, V63, P162, DOI 10.1016/j.jhin.2005.11.013; Centers for Disease Control and Prevention, PROT PAT PREV HARM I; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cimiotti JP, 2012, AM J INFECT CONTROL, V40, P486, DOI 10.1016/j.ajic.2012.02.029; Coffin SE, 2008, INFECT CONT HOSP EP, V29, pS31, DOI 10.1086/591062; Cullen D J, 1974, Crit Care Med, V2, P57, DOI 10.1097/00003246-197403000-00001; Daud-Gallotti R, 2005, EUR J EMERG MED, V12, P63, DOI 10.1097/00063110-200504000-00005; HIATT HH, 1989, NEW ENGL J MED, V321, P480, DOI 10.1056/NEJM198908173210725; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; KHON LT, 1999, ERR HUMAN BUILDING S; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Lewin DI, 2005, ADV PATIENT SAFETY R, V2; Librero J, 1999, J CLIN EPIDEMIOL, V52, P171, DOI 10.1016/S0895-4356(98)00160-7; Lobo RD, 2010, AM J INFECT CONTROL, V38, P440, DOI 10.1016/j.ajic.2009.09.013; Manchikanti L, 2011, PAIN PHYSICIAN, V14, P425; Marschall J, 2008, INFECT CONT HOSP EP, V29, pS22, DOI 10.1086/591059; Michel P, 2004, BRIT MED J, V328, P199, DOI 10.1136/bmj.328.7433.199; Miranda DR, 2003, CRIT CARE MED, V31, P374, DOI 10.1097/01.CCM.0000045567.78801.CC; Penoyer DA, 2010, CRIT CARE MED, V38, P1521, DOI 10.1097/CCM.0b013e3181e47888; Reason J, 2000, BMJ-BRIT MED J, V320, P768, DOI 10.1136/bmj.320.7237.768; Stone PW, 2008, CLIN INFECT DIS, V47, P937, DOI 10.1086/591696; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Weingart SN, 2000, BRIT MED J, V320, P774, DOI 10.1136/bmj.320.7237.774; World Health Organization, 2008, 2 GLOB PAT SAF CHALL; World Health Organization, 2009, CONCEPTUAL FRAMEWORK	29	68	74	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52342	10.1371/journal.pone.0052342	http://dx.doi.org/10.1371/journal.pone.0052342			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300645	Green Published, gold			2022-12-27	WOS:000312829100042
J	Di, Z; Herpers, B; Fredriksson, L; Yan, K; van de Water, B; Verbeek, FJ; Meerman, JHN				Di, Zi; Herpers, Bram; Fredriksson, Lisa; Yan, Kuan; van de Water, Bob; Verbeek, Fons J.; Meerman, John H. N.			Automated Analysis of NF-kappa B Nuclear Translocation Kinetics in High-Throughput Screening	PLOS ONE			English	Article							ACTIVATION; DYNAMICS; ALPHA; DETERMINES; PATHWAYS; P65	Nuclear entry and exit of the NF-kappa B family of dimeric transcription factors plays an essential role in regulating cellular responses to inflammatory stress. The dynamics of this nuclear translocation can vary significantly within a cell population and may dramatically change e.g. upon drug exposure. Furthermore, there is significant heterogeneity in individual cell response upon stress signaling. In order to systematically determine factors that define NF-kappa B translocation dynamics, high-throughput screens that enable the analysis of dynamic NF-kappa B responses in individual cells in real time are essential. Thus far, only NF-kappa B downstream signaling responses of whole cell populations at the transcriptional level are in high-throughput mode. In this study, we developed a fully automated image analysis method to determine the time-course of NF-kappa B translocation in individual cells, suitable for high-throughput screenings in the context of compound screening and functional genomics. Two novel segmentation methods were used for defining the individual nuclear and cytoplasmic regions: watershed masked clustering (WMC) and best-fit ellipse of Voronoi cell (BEVC). The dynamic NF kappa B oscillatory response at the single cell and population level was coupled to automated extraction of 26 analogue translocation parameters including number of peaks, time to reach each peak, and amplitude of each peak. Our automated image analysis method was validated through a series of statistical tests demonstrating computational efficient and accurate NF-kappa B translocation dynamics quantification of our algorithm. Both pharmacological inhibition of NF-kappa B and short interfering RNAs targeting the inhibitor of NF kappa B, I kappa B alpha, demonstrated the ability of our method to identify compounds and genetic players that interfere with the nuclear transition of NF-kappa B.	[Di, Zi; Herpers, Bram; Fredriksson, Lisa; van de Water, Bob; Meerman, John H. N.] Leiden Univ, Div Toxicol, Leiden Amsterdam Ctr Drug Res, Leiden, Netherlands; [Yan, Kuan; Verbeek, Fons J.] Leiden Univ, Leiden Inst Adv Comp Sci, Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC	Meerman, JHN (corresponding author), Leiden Univ, Div Toxicol, Leiden Amsterdam Ctr Drug Res, Leiden, Netherlands.	meerman@lacdr.leidenuniv.nl	Herpers, Bram/P-1272-2014	Yan, Kuan/0000-0003-4143-3569	Netherlands Toxicogenomics Centre; TI Pharma [D3-201]	Netherlands Toxicogenomics Centre; TI Pharma	This work was supported by grants of the Netherlands Toxicogenomics Centre (http://toxicogenomics.nl) and TI Pharma http://www.tipharma.com), Project no. D3-201. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashall L, 2009, SCIENCE, V324, P242, DOI 10.1126/science.1164860; Brasier AR, 2006, CARDIOVASC TOXICOL, V6, P111, DOI 10.1385/CT:6:2:111; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Fisher RA, 1936, ANN EUGENIC, V7, P179, DOI 10.1111/j.1469-1809.1936.tb02137.x; Fredriksson L, 2011, HEPATOLOGY, V53, P2027, DOI 10.1002/hep.24314; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Gilmore TD, 1999, ONCOGENE, V18, P6842, DOI 10.1038/sj.onc.1203237; HADDAD RA, 1991, IEEE T SIGNAL PROCES, V39, P723, DOI 10.1109/78.80892; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Jiang X, 2003, J BIOL CHEM, V278, P919, DOI 10.1074/jbc.M208696200; Kalita MK, 2011, J BIOL CHEM, V286, P37741, DOI 10.1074/jbc.M111.280925; Kuan Yan, 2012, Leveraging Applications of Formal Methods, Verification and Validation. Applications and Case Studies. Proceedings of the 5th International Symposium, ISoLA 2012, P25, DOI 10.1007/978-3-642-34032-1_4; Kummel A, 2010, J BIOMOL SCREEN, V15, P95, DOI 10.1177/1087057109351311; Le Devedec SE, 2010, CELL MOL LIFE SCI, V67, P3219, DOI 10.1007/s00018-010-0419-2; Lee TK, 2010, CURR OPIN GENET DEV, V20, P677, DOI 10.1016/j.gde.2010.08.005; Lee TK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000599; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; McLachlan G.J., 2004, DISCRIMINANT ANAL ST, VVolume 544; Mount E, 2005, SCI TECH NEWS, V59, P53; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Paszek P, 2010, P NATL ACAD SCI USA, V107, P11644, DOI 10.1073/pnas.0913798107; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; STERNBERG SR, 1983, COMPUTER, V16, P22, DOI 10.1109/MC.1983.1654163; Stevens J, 1996, APPL MULTIVARIATE ST, V3rd ed.; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Tang C, 2005, P WORKSH DIG IM COMP, P61; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; Tian B, 2003, RECENT PROG HORM RES, V58, P95, DOI 10.1210/rp.58.1.95; Turner DA, 2010, J CELL SCI, V123, P2834, DOI 10.1242/jcs.069641; Verbeek F. J., 2003, Proceedings of the SPIE - The International Society for Optical Engineering, V5304, P13, DOI 10.1117/12.527049; Verbeek FJ, 1995, THESIS DELFT U TECHN; Verbeek FJ, 2000, IMAGE PROCESSING PRA, P153; Voronoi G., 1907, J REINE ANGEW MATH, V133, P97, DOI DOI 10.1515/CRLL.1908.133.97; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	36	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52337	10.1371/journal.pone.0052337	http://dx.doi.org/10.1371/journal.pone.0052337			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300644	Green Published, Green Submitted, gold			2022-12-27	WOS:000312829100041
J	Grothusen, C; Schuett, H; Hillmer, A; Lumpe, S; Grote, K; Ballmaier, M; Bleich, A; Glage, S; Tietge, UJF; Luchtefeld, M; Schieffer, B				Grothusen, Christina; Schuett, Harald; Hillmer, Anja; Lumpe, Stefan; Grote, Karsten; Ballmaier, Matthias; Bleich, Andre; Glage, Silke; Tietge, Uwe J. F.; Luchtefeld, Maren; Schieffer, Bernhard			Role of Suppressor of Cytokine Signaling-1 In Murine Atherosclerosis	PLOS ONE			English	Article							DEFICIENCY; MONOCYTES; SOCS1; HYPERLIPIDEMIA; LIPOPROTEINS; MACROPHAGES; EXPRESSION; MICE	Background: While the impact of inflammation as the substantial driving force of atherosclerosis has been investigated in detail throughout the years, the influence of negative regulators of pro-atherogenic pathways on plaque development has remained largely unknown. Suppressor of cytokine signaling (SOCS)-1 potently restricts transduction of various inflammatory signals and, thereby modulates T-cell development, macrophage activation and dendritic cell maturation. Its role in atherogenesis, however has not been elucidated so far. Methods and Results: Loss of SOCS-1 in the low-density lipoprotein receptor deficient murine model of atherosclerosis resulted in a complex, systemic and ultimately lethal inflammation with increased generation of Ly-6C(hi) monocytes and activated macrophages. Even short-term exposure of these mice to high-cholesterol dieting caused enhanced atherosclerotic plaque development with accumulation of M1 macrophages, Ly-6C positive cells and neutrophils. Conclusion: Our data not only imply that SOCS-1 is athero-protective but also emphasize the fundamental, regulatory importance of SOCS-1 in inflammation-prone organisms.	[Grothusen, Christina; Schuett, Harald; Hillmer, Anja; Lumpe, Stefan; Grote, Karsten; Luchtefeld, Maren; Schieffer, Bernhard] Hannover Med Sch, Dept Cardiol & Angiol, D-3000 Hannover, Germany; [Ballmaier, Matthias] Hannover Med Sch, Dept Pediat Haematol & Oncol, D-3000 Hannover, Germany; [Bleich, Andre; Glage, Silke] Hannover Med Sch, Inst Lab Anim Sci, D-3000 Hannover, Germany; [Tietge, Uwe J. F.] Univ Groningen, Univ Med Ctr Groningen, Ctr Liver Digest & Metab Dis, Dept Pediat, NL-9700 AB Groningen, Netherlands	Hannover Medical School; Hannover Medical School; Hannover Medical School; University of Groningen	Schieffer, B (corresponding author), Hannover Med Sch, Dept Cardiol & Angiol, D-3000 Hannover, Germany.	Schieffer.Bernhard@mh-hannover.de	Ballmaier, Matthias/J-4175-2014	Ballmaier, Matthias/0000-0002-1352-5995; Grote, Karsten/0000-0001-7914-3159	German Heart Research Foundation [F23/2004]; german research foundation [SFB566]	German Heart Research Foundation; german research foundation(German Research Foundation (DFG))	This work was supported by a grant of the German Heart Research Foundation (F23/2004) and the german research foundation grant (SFB566/project B9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chinen T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1181; Croker BA, 2003, NAT IMMUNOL, V4, P540, DOI 10.1038/ni931; Daugherty A, 1997, J CLIN INVEST, V100, P1575, DOI 10.1172/JCI119681; Drechsler M, 2010, CIRCULATION, V122, P1837, DOI 10.1161/CIRCULATIONAHA.110.961714; Drevets DA, 2010, J IMMUNOL, V185, P2432, DOI 10.4049/jimmunol.1000486; ESTERBAUER H, 1989, FREE RADICAL RES COM, V6, P67, DOI 10.3109/10715768909073429; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gonzalez-Leon MC, 2006, J ENDOTOXIN RES, V12, P296, DOI 10.1179/096805106X118843; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Jagavelu K, 2007, CIRC RES, V101, P1104, DOI 10.1161/CIRCRESAHA.107.156075; Luchtefeld M, 2010, CIRCULATION, V122, P1621, DOI 10.1161/CIRCULATIONAHA.110.956730; Mantovani A, 2009, ARTERIOSCL THROM VAS, V29, P1419, DOI 10.1161/ATVBAHA.108.180497; Marine JC, 1999, CELL, V98, P609, DOI 10.1016/S0092-8674(00)80048-3; Metcalf D, 1999, LEUKEMIA, V13, P926, DOI 10.1038/sj.leu.2401440; Ortiz-Munoz G, 2009, ARTERIOSCL THROM VAS, V29, P525, DOI 10.1161/ATVBAHA.108.173781; Qin HW, 2006, FASEB J, V20, P985, DOI 10.1096/fj.05-5493fje; Reardon CA, 2001, ARTERIOSCL THROM VAS, V21, P1011, DOI 10.1161/01.ATV.21.6.1011; ROSS R, 1976, SCIENCE, V193, P1094, DOI 10.1126/science.822515; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sachithanandan N, 2011, DIABETES, V60, P2023, DOI 10.2337/db11-0259; Salagianni M, 2012, CIRCULATION, V126, P952, DOI 10.1161/CIRCULATIONAHA.111.067678; Schieffer B, 2004, CIRCULATION, V110, P3493, DOI 10.1161/01.CIR.0000148135.08582.97; Schuett H, 2012, ARTERIOSCL THROM VAS, V32, P281, DOI 10.1161/ATVBAHA.111.229435; Starr R, 1998, P NATL ACAD SCI USA, V95, P14395, DOI 10.1073/pnas.95.24.14395; STARY HC, 1995, ARTERIOSCL THROM VAS, V15, P1512, DOI 10.1161/01.ATV.15.9.1512; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Swirski FK, 2009, ARTERIOSCL THROM VAS, V29, P1424, DOI 10.1161/ATVBAHA.108.180521; Taleb S, 2009, J EXP MED, V206, P2067, DOI 10.1084/jem.20090545; Tietge UJF, 2000, J BIOL CHEM, V275, P10077, DOI 10.1074/jbc.275.14.10077; Whyte CS, 2011, J LEUKOCYTE BIOL, V90, P845, DOI 10.1189/jlb.1110644; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zhang Y, 2011, J IMMUNOL, V186, P3093, DOI 10.4049/jimmunol.1002006	32	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e51608	10.1371/journal.pone.0051608	http://dx.doi.org/10.1371/journal.pone.0051608			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300554	gold, Green Published, Green Submitted			2022-12-27	WOS:000312829100010
J	Zhao, JJ; Eisenberg, JE; Spicknall, IH; Li, S; Koopman, JS				Zhao, Jijun; Eisenberg, Joseph E.; Spicknall, Ian H.; Li, Sheng; Koopman, James S.			Model Analysis of Fomite Mediated Influenza Transmission	PLOS ONE			English	Article							INFECTION RISK; A VIRUS; ENVIRONMENT; DYNAMICS; SURFACES; AEROSOL; HAND	Fomites involved in influenza transmission are either hand- or droplet-contaminated. We evaluated the interactions of fomite characteristics and human behaviors affecting these routes using an Environmental Infection Transmission System (EITS) model by comparing the basic reproduction numbers (R-0) for different fomite mediated transmission pathways. Fomites classified as large versus small surface sizes (reflecting high versus low droplet contamination levels) and high versus low touching frequency have important differences. For example, 1) the highly touched large surface fomite (public tables) has the highest transmission potential and generally strongest control measure effects; 2) transmission from droplet-contaminated routes exceed those from hand-contaminated routes except for highly touched small surface fomites such as door knob handles; and 3) covering a cough using the upper arm or using tissues effectively removes virus from the system and thus decreases total fomite transmission. Because covering a cough by hands diverts pathogens from the droplet-fomite route to the hand-fomite route, this has the potential to increase total fomite transmission for highly touched small surface fomites. An improved understanding and more refined data related to fomite mediated transmission routes will help inform intervention strategies for influenza and other pathogens that are mediated through the environment.	[Zhao, Jijun] Qingdao Univ, Inst Complex Sci, Qingdao 266071, Peoples R China; [Zhao, Jijun; Eisenberg, Joseph E.; Spicknall, Ian H.; Li, Sheng; Koopman, James S.] Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Eisenberg, Joseph E.; Li, Sheng; Koopman, James S.] Univ Michigan, Ctr Study Complex Syst, Ann Arbor, MI 48109 USA	Qingdao University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Zhao, JJ (corresponding author), Qingdao Univ, Inst Complex Sci, Qingdao 266071, Peoples R China.	jjzhao@umich.edu			US Environmental Protection Agency Science to Achieve Results (STAR) Program; US Department of Homeland Security University Programs [R83236201]	US Environmental Protection Agency Science to Achieve Results (STAR) Program(United States Environmental Protection Agency); US Department of Homeland Security University Programs(United States Department of Homeland Security (DHS))	This work was funded by the US Environmental Protection Agency Science to Achieve Results (STAR) Program and by US Department of Homeland Security University Programs grant R83236201 to JK and JE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson MP, 2008, B MATH BIOL, V70, P820, DOI 10.1007/s11538-007-9281-2; BEAN B, 1982, J INFECT DIS, V146, P47, DOI 10.1093/infdis/146.1.47; Boone SA, 2005, J INFECTION, V51, P103, DOI 10.1016/j.jinf.2004.09.011; Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4; Bridges CB, 2003, CLIN INFECT DIS, V37, P1094, DOI 10.1086/378292; Han K, 2009, EMERG INFECT DIS, V15, P1578, DOI 10.3201/eid1510.091013; Li S, 2009, AM J EPIDEMIOL, V170, P257, DOI 10.1093/aje/kwp116; Lowen AC, 2008, J VIROL, V82, P5650, DOI 10.1128/JVI.00325-08; McDevitt J, 2010, APPL ENVIRON MICROB, V76, P3943, DOI 10.1128/AEM.02674-09; Mubareka S, 2009, J INFECT DIS, V199, P858, DOI 10.1086/597073; Nicas M, 2005, J OCCUP ENVIRON HYG, V2, P143, DOI 10.1080/15459620590918466; Nicas M, 2008, J OCCUP ENVIRON HYG, V5, P347, DOI 10.1080/15459620802003896; Nicas M, 2006, RISK ANAL, V26, P1085, DOI 10.1111/j.1539-6924.2006.00802.x; Nicas M, 2009, RISK ANAL, V29, P1292, DOI 10.1111/j.1539-6924.2009.01253.x; Noakes CJ, 2006, EPIDEMIOL INFECT, V134, P1082, DOI 10.1017/S0950268806005875; Rusin P, 2002, J APPL MICROBIOL, V93, P585, DOI 10.1046/j.1365-2672.2002.01734.x; Snider DE, 2010, M SUMM WORKSH HELD N; Spicknall IH, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000969; Stilianakis NI, 2010, J R SOC INTERFACE, V7, P1355, DOI 10.1098/rsif.2010.0026; Tellier R, 2006, EMERG INFECT DIS, V12, P1657, DOI 10.3201/eid1211.060426	20	29	30	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e51984	10.1371/journal.pone.0051984	http://dx.doi.org/10.1371/journal.pone.0051984			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300585	Green Submitted, Green Published, gold			2022-12-27	WOS:000312829100016
J	Kumari, P; Sahal, D; Jain, SK; Chauhan, VS				Kumari, Pinky; Sahal, Dinkar; Jain, S. K.; Chauhan, Virander S.			Bioactivity Guided Fractionation of Leaves Extract of Nyctanthes arbor tristis (Harshringar) against P falciparum	PLOS ONE			English	Article							ANTIMALARIAL ACTIVITY; MEDICINAL-PLANTS; IN-VITRO	Background: Nyctanthes arbor-tristis (Harshringar, Night Jasmine) has been traditionally used in Ayurveda, Unani and other systems of medicine in India. The juice of its leaves has been used by various tribal populations of India in treatment of fevers resembling malaria. Aim of the study: This work reports the antiplasmodial activity guided fractionation of Harshringar leaves extract. Methodology: Crude ethanolic Harshringar leaves extract and its RPHPLC purified fractions were studied for antiplasmodial potency against 3D7 (CQ sensitive) and Dd2 (CQ resistant) strains of P. falciparum and subsequently subjected to bioassay guided fractionation using reverse phase chromatography to pursue the isolation of active fractions. Principal Findings: Harshringar crude leaves extract and some of its RPHPLC purified fractions exhibited promising antiplasmodial potency against 3D7 and Dd2 strains of P. falciparum. Conclusions: The present study has provided scientific validity to the traditional use of leaves extract of Harshringar against malaria leading to the conclusion that this plant holds promise with respect to antimalarial phytotherapy. This is the first scientific report of antiplasmodial activity of RPHPLC fractions of Harshringar leaves extract against P. falciparum strains.	[Kumari, Pinky; Sahal, Dinkar; Chauhan, Virander S.] Int Ctr Genet Engn & Biotechnol, Malaria Res Lab, New Delhi, India; [Jain, S. K.] Jamia Hamdard, Dept Biotechnol, New Delhi, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Jamia Hamdard University	Chauhan, VS (corresponding author), Int Ctr Genet Engn & Biotechnol, Malaria Res Lab, Aruna Asaf Ali Marg, New Delhi, India.	virander@icgeb.res.in	SAHAL, DINKAR/GYD-7570-2022; Chauhan, Virander S./K-5276-2019		Malaria Core Fund, ICGEB, New Delhi; University Grants Commission, New Delhi, India in the form of "CSIR-UGC Research Fellowship" [10-2(5)/2005(i)-E.U.II]	Malaria Core Fund, ICGEB, New Delhi; University Grants Commission, New Delhi, India in the form of "CSIR-UGC Research Fellowship"	This study was supported by Malaria Core Fund, ICGEB, New Delhi. All studies were conducted at ICGEB, New Delhi. Pinky Kumari got financial assistance from University Grants Commission, New Delhi, India in the form of "CSIR-UGC Research Fellowship, Award No - F.No. 10-2(5)/2005(i)-E.U.II". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asase A, 2005, J ETHNOPHARMACOL, V99, P273, DOI 10.1016/j.jep.2005.02.020; BADAM L, 1988, INDIAN J MED RES, V87, P379; Bhattacharya S, 2009, INT J AESTHETIC ANTI, p[2, 1]; Bombardelli E, 1989, FITOTERAPIA, V60, P1; Charak S, 1949, SHRI GULABKUNVERBA A, VV, P23; CHITRAVANSHI V C, 1992, International Journal of Pharmacognosy, V30, P71; Chopra RN., 1958, INDIGENOUS DRUGS IND, P408; Eberle C, 2011, CHEMMEDCHEM, V6, P292, DOI 10.1002/cmdc.201000420; Ekland EH, 2008, INT J PARASITOL, V38, P743, DOI 10.1016/j.ijpara.2008.03.004; Gilberger TW, 1997, J BIOL CHEM, V272, P29584, DOI 10.1074/jbc.272.47.29584; Ginsburg H, 2011, MALARIA J, V10; Jonville MC, 2008, J ETHNOPHARMACOL, V120, P382, DOI 10.1016/j.jep.2008.09.005; Karnik SR, 2008, INDIAN J TRADIT KNOW, V7, P330; Kirtikar K. R., 1935, INDIAN MED PLANT, V2nd, P1526; LAL J, 1976, Indian Journal of Physiology and Pharmacology, V20, P64; Lusakibanza M, 2010, J ETHNOPHARMACOL, V129, P398, DOI 10.1016/j.jep.2010.04.007; MISRA P, 1991, International Journal of Pharmacognosy, V29, P19; Nadkarni K. M., 1976, INDIAN MAT MED, V1, P857; Pink R, 2005, NAT REV DRUG DISCOV, V4, P727, DOI 10.1038/nrd1824; Ramalhete C, 2008, WORKSHOP PLANTAS MED; RATHORE A, 1990, PHYTOCHEMISTRY, V29, P1917, DOI 10.1016/0031-9422(90)85040-M; Saxena RS, 2002, J ETHNOPHARMACOL, V81, P321, DOI 10.1016/S0378-8741(02)00088-0; SAXENA RS, 1987, J ETHNOPHARMACOL, V19, P193, DOI 10.1016/0378-8741(87)90041-9; Shandhar HK., 2011, J INT PHARMACEUTICA, V1, P77; Shukla AK, 2011, J ETHNOPHARMACOL, V134, P996, DOI 10.1016/j.jep.2011.01.044; Singha U. K., 1992, International Journal of Pharmacognosy, V30, P289; Smilkstein M, 2004, ANTIMICROB AGENTS CH, V48, P1803, DOI 10.1128/AAC.48.5.1803-1806.2004; TANDON JS, 1991, J NAT PROD, V54, P1102, DOI 10.1021/np50076a030; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Willcox ML, 2000, PARASITOL TODAY, V16, P220, DOI 10.1016/S0169-4758(00)01678-1	31	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e51714	10.1371/journal.pone.0051714	http://dx.doi.org/10.1371/journal.pone.0051714			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300557	Green Published, Green Submitted, gold			2022-12-27	WOS:000313618800023
J	Ohta, K; Kawano, R; Ito, N				Ohta, Kunimasa; Kawano, Rie; Ito, Naofumi			Lactic Acid Bacteria Convert Human Fibroblasts to Multipotent Cells	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; NANOG; HOST	The human gastrointestinal tract is colonized by a vast community of symbionts and commensals. Lactic acid bacteria (LAB) form a group of related, low-GC-content, gram-positive bacteria that are considered to offer a number of probiotic benefits to general health. While the role of LAB in gastrointestinal microecology has been the subject of extensive study, little is known about how commensal prokaryotic organisms directly influence eukaryotic cells. Here, we demonstrate the generation of multipotential cells from adult human dermal fibroblast cells by incorporating LAB. LAB-incorporated cell clusters are similar to embryoid bodies derived from embryonic stem cells and can differentiate into endodermal, mesodermal, and ectodermal cells in vivo and in vitro. LAB-incorporated cell clusters express a set of genes associated with multipotency, and microarray analysis indicates a remarkable increase of NANOG, a multipotency marker, and a notable decrease in HOX gene expression in LAB-incorporated cells. During the cell culture, the LAB-incorporated cell clusters stop cell division and start to express early senescence markers without cell death. Thus, LAB-incorporated cell clusters have potentially wide-ranging implications for cell generation, reprogramming, and cell-based therapy.	[Ohta, Kunimasa; Kawano, Rie; Ito, Naofumi] Kumamoto Univ, Grad Sch Life Sci, Dept Dev Neurobiol, Kumamoto, Japan	Kumamoto University	Ohta, K (corresponding author), Kumamoto Univ, Grad Sch Life Sci, Dept Dev Neurobiol, Kumamoto, Japan.	ohta9203@gpo.kumamoto-u.ac.jp	Ohta, Kunimasa/AAW-6993-2020	Ohta, Kunimasa/0000-0002-4564-9757; Ito, Naofumi/0000-0002-2334-0513	Precursory Research for Embryonic Science and Technology program of the Japan Science and Technology Agency; Ministry of Education Culture, Sports, Science, and Technology of Japan	Precursory Research for Embryonic Science and Technology program of the Japan Science and Technology Agency; Ministry of Education Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Precursory Research for Embryonic Science and Technology program of the Japan Science and Technology Agency and Grants-in-Aid for Scientific Research on Molecular Brain Science from the Ministry of Education Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen A, 2000, METH MOL B, V125, P57; ALLEN A, 1993, PHYSIOL REV, V73, P823, DOI 10.1152/physrev.1993.73.4.823; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Forstner Janet F., 1994, P1255; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Isberg RR, 2002, CELL, V110, P1, DOI 10.1016/S0092-8674(02)00821-8; Kuroda Y, 2010, P NATL ACAD SCI USA, V107, P8639, DOI 10.1073/pnas.0911647107; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Madsen K, 2001, GASTROENTEROLOGY, V121, P580, DOI 10.1053/gast.2001.27224; MARGULIS I, 1970, J THEOR BIOL, V26, P337, DOI 10.1016/S0022-5193(70)80023-6; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; Meijerink J, 2001, J MOL DIAGN, V3, P55, DOI 10.1016/S1525-1578(10)60652-6; Mennigen R, 2009, ANN NY ACAD SCI, V1165, P183, DOI 10.1111/j.1749-6632.2009.04059.x; METCHNIKOFF II, 1907, PROLONGATION LIFE; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wakao S, 2011, P NATL ACAD SCI USA, V108, P9875, DOI 10.1073/pnas.1100816108; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; Yamaguchi S, 2005, GENE EXPR PATTERNS, V5, P639, DOI 10.1016/j.modgep.2005.03.001; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	23	25	27	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e51866	10.1371/journal.pone.0051866	http://dx.doi.org/10.1371/journal.pone.0051866			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300571	Green Published, Green Submitted, gold			2022-12-27	WOS:000313618800032
J	Rygula, R; Pluta, H; Popik, P				Rygula, Rafal; Pluta, Helena; Popik, Piotr			Laughing Rats Are Optimistic	PLOS ONE			English	Article							FREQUENCY ULTRASONIC VOCALIZATIONS; ORBITOFRONTAL CORTEX; COGNITIVE BIAS; DEPRESSION; BEHAVIOR; REWARD; NEUROBIOLOGY; ANTICIPATION; LAUGHTER; EXHIBIT	Emotions can bias human decisions-for example depressed or anxious people tend to make pessimistic judgements while those in positive affective states are often more optimistic. Several studies have reported that affect contingent judgement biases can also be produced in animals. The animals, however, cannot self-report; therefore, the valence of their emotions, to date, could only be assumed. Here we present the results of an experiment where the affect-contingent judgement bias has been produced by objectively measured positive emotions. We trained rats in operant Skinner boxes to press one lever in response to one tone to receive a food reward and to press another lever in response to a different tone to avoid punishment by electric foot shock. After attaining a stable level of discrimination performance, the animals were subjected to either handling or playful, experimenter-administered manual stimulation - tickling. This procedure has been confirmed to induce a positive affective state in rats, and the 50-kHz ultrasonic vocalisations (rat laughter) emitted by animals in response to tickling have been postulated to index positive emotions akin to human joy. During the tickling and handling sessions, the numbers of emitted high-frequency 50-kHz calls were scored. Immediately after tickling or handling, the animals were tested for their responses to a tone of intermediate frequency, and the pattern of their responses to this ambiguous cue was taken as an indicator of the animals' optimism. Our findings indicate that tickling induced positive emotions which are directly indexed in rats by laughter, can make animals more optimistic. We demonstrate for the first time a link between the directly measured positive affective state and decision making under uncertainty in an animal model. We also introduce innovative tandem-approach for studying emotional-cognitive interplay in animals, which may be of great value for understanding the emotional-cognitive changes associated with mood disorders.	[Rygula, Rafal; Pluta, Helena; Popik, Piotr] Polish Acad Sci, Maj Inst Pharmacol, Dept Behav Neurosci & Drug Dev, Krakow, Poland; [Popik, Piotr] Jagiellonian Univ, Coll Med, Fac Hlth Sci, Krakow, Poland	Polish Academy of Sciences; Maj Institute of Pharmacology of the Polish Academy of Sciences; Jagiellonian University; Collegium Medicum Jagiellonian University	Rygula, R (corresponding author), Polish Acad Sci, Maj Inst Pharmacol, Dept Behav Neurosci & Drug Dev, Krakow, Poland.	rygula@gmail.com	Popik, Piotr/R-5383-2016; Rygula, Rafal/AAI-4914-2020	Popik, Piotr/0000-0003-0722-1263; Rygula, Rafal/0000-0002-3662-5833	Foundation for Polish Science "Homing Plus" Programme; European Regional Development Fund (Innovative Economy Operational Programme); Iuventus Plus Programme of the Polish Ministry of Science and Higher Education [IP2011047271]; statutory funds of the Institute of Pharmacology Polish Academy of Sciences	Foundation for Polish Science "Homing Plus" Programme; European Regional Development Fund (Innovative Economy Operational Programme); Iuventus Plus Programme of the Polish Ministry of Science and Higher Education; statutory funds of the Institute of Pharmacology Polish Academy of Sciences	This work was supported by the Foundation for Polish Science "Homing Plus" Programme co-financed by the European Regional Development Fund (Innovative Economy Operational Programme 2007-2013), by the Iuventus Plus Programme of the Polish Ministry of Science and Higher Education (grant IP2011047271 to RR) and the statutory funds of the Institute of Pharmacology Polish Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach DR, 2009, J NEUROSCI, V29, P1648, DOI 10.1523/JNEUROSCI.4578-08.2009; BARFIELD RJ, 1986, ANN NY ACAD SCI, V474, P33, DOI 10.1111/j.1749-6632.1986.tb27996.x; Bateson M, 2011, CURR BIOL, V21, P1070, DOI 10.1016/j.cub.2011.05.017; Bethell EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044387; Brilot BO, 2010, ANIM COGN, V13, P721, DOI 10.1007/s10071-010-0323-z; BRITTLEBANK AD, 1993, BRIT J PSYCHIAT, V162, P118, DOI 10.1192/bjp.162.1.118; Burgdorf J, 2006, NEUROSCI BIOBEHAV R, V30, P173, DOI 10.1016/j.neubiorev.2005.06.001; Burgdorf J, 2000, BEHAV NEUROSCI, V114, P320, DOI 10.1037//0735-7044.114.2.320; Burgdorf J, 2005, BEHAV GENET, V35, P67, DOI 10.1007/s10519-004-0856-5; Burgdorf J, 2001, PHYSIOL BEHAV, V72, P167, DOI 10.1016/S0031-9384(00)00411-X; Burgdorf J, 2001, BEHAV NEUROSCI, V115, P940, DOI 10.1037/0735-7044.115.4.940; Burgdorf J, 2001, PSYCHOPHARMACOLOGY, V155, P35, DOI 10.1007/s002130100685; Burgdorf J, 2008, J COMP PSYCHOL, V122, P357, DOI 10.1037/a0012889; Burgdorf J, 2007, BEHAV BRAIN RES, V182, P274, DOI 10.1016/j.bbr.2007.03.010; Darwin C., 1872, P374; Doyle RE, 2011, PHYSIOL BEHAV, V102, P503, DOI 10.1016/j.physbeh.2011.01.001; Elliott R, 1999, NEUROPSYCHOLOGIA, V37, P403, DOI 10.1016/S0028-3932(98)00107-9; Enkel T, 2010, NEUROPSYCHOPHARMACOL, V35, P1008, DOI 10.1038/npp.2009.204; Harding EJ, 2004, NATURE, V427, P312, DOI 10.1038/427312a; Howell DC., 1997, STAT METHODS PSYCHOL, V4th ed; Knutson B, 1998, J COMP PSYCHOL, V112, P65, DOI 10.1037/0735-7036.112.1.65; Knutson B, 2002, PSYCHOL BULL, V128, P961, DOI 10.1037//0033-2909.128.6.961; Mallo T, 2007, BEHAV BRAIN RES, V184, P57, DOI 10.1016/j.bbr.2007.06.015; Mendl M, 2010, CURR BIOL, V20, pR839, DOI 10.1016/j.cub.2010.08.030; Murphy FC, 1999, PSYCHOL MED, V29, P1307, DOI 10.1017/S0033291799001233; Nygren TE, 1996, ORGAN BEHAV HUM DEC, V66, P59, DOI 10.1006/obhd.1996.0038; Panksepp J, 2005, SCIENCE, V308, P62, DOI 10.1126/science.1112066; Panksepp J, 2003, PHYSIOL BEHAV, V79, P533, DOI 10.1016/S0031-9384(03)00159-8; Panksepp J, 2000, BEHAV BRAIN RES, V115, P25, DOI 10.1016/S0166-4328(00)00238-2; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; Popik P, 2012, BEHAV BRAIN RES, V234, P223, DOI 10.1016/j.bbr.2012.06.028; Provine R, 2001, LAUGHTER SCI INVESTI; Rosen JB, 2006, BIOL PSYCHOL, V73, P49, DOI 10.1016/j.biopsycho.2006.01.007; Salmeto AL, 2011, BRAIN RES, V1373, P124, DOI 10.1016/j.brainres.2010.12.007; Schoenbaum G, 2005, NEURON, V47, P633, DOI 10.1016/j.neuron.2005.07.018; Schoenbaum G, 1998, NAT NEUROSCI, V1, P155, DOI 10.1038/407	36	96	96	2	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e51959	10.1371/journal.pone.0051959	http://dx.doi.org/10.1371/journal.pone.0051959			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300582	Green Published, Green Submitted, gold			2022-12-27	WOS:000313618800040
J	Stoeckel, MC; Morgenroth, F; Buetefisch, CM; Seitz, RJ				Stoeckel, M. Cornelia; Morgenroth, Farina; Buetefisch, Cathrin M.; Seitz, Ruediger J.			Differential Grey Matter Changes in Sensorimotor Cortex Related to Exceptional Fine Motor Skills	PLOS ONE			English	Article							INTERINDIVIDUAL VARIABILITY; SOMATOSENSORY CORTEX; BRAIN IMAGES; CHRONIC PAIN; MR-IMAGES; HAND AREA; REGISTRATION; PLASTICITY; ROBUST; MAP	Functional changes in sensorimotor representation occur in response to use and lesion throughout life. Emerging evidence suggests that functional changes are paralleled by respective macroscopic structural changes. In the present study we used voxel-based morphometry to investigate sensorimotor cortex in subjects with congenitally malformed upper extremities. We expected increased or decreased grey matter to parallel the enlarged or reduced functional representations we reported previously. More specifically, we expected decreased grey matter values in lateral sensorimotor cortex related to compromised hand function and increased grey matter values in medial sensorimotor cortex due to compensatory foot use. We found a medial cluster of grey matter increase in subjects with frequent, hand-like compensatory foot use. This increase was predominantly seen for lateral premotor, supplementary motor, and motor areas and only marginally involved somatosensory cortex. Contrary to our expectation, subjects with a reduced number of fingers, who had shown shrinkage of the functional hand representation previously, did not show decreased grey matter values within lateral sensorimotor cortex. Our data suggest that functional plastic changes in sensorimotor cortex can be associated with increases in grey matter but may also occur in otherwise macroscopically normal appearing grey matter volumes. Furthermore, macroscopic structural changes in motor and premotor areas may be observed without respective changes in somatosensory cortex.	[Stoeckel, M. Cornelia] Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, Hamburg, Germany; [Morgenroth, Farina; Seitz, Ruediger J.] Univ Hosp Dusseldorf, Dept Neurol, Dusseldorf, Germany; [Buetefisch, Cathrin M.] Emory Univ, Dept Neurol, Atlanta, GA 30322 USA; [Buetefisch, Cathrin M.] Emory Univ, Dept Rehabil Med, Atlanta, GA 30322 USA; [Seitz, Ruediger J.] Univ Dusseldorf, Biomed Res Ctr, D-40225 Dusseldorf, Germany; [Seitz, Ruediger J.] Brain Imaging Ctr W, Julich, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Emory University; Emory University; Heinrich Heine University Dusseldorf	Stoeckel, MC (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, Hamburg, Germany.	c.stoeckel@uke.de			Research Foundation of the Medical Faculty of the Heinrich-Heine-University Dusseldorf	Research Foundation of the Medical Faculty of the Heinrich-Heine-University Dusseldorf	MC Stoeckel was supported by the Research Foundation of the Medical Faculty of the Heinrich-Heine-University Dusseldorf. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson J.L.R., 2007, TR07JA1 FMRIB; Andersson J.L.R, 2007, TR07JA2 FMRIB; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Buetefisch CM, 2011, J NEUROPHYSIOL, V106, P1614, DOI 10.1152/jn.00048.2011; Cauda F, 2011, HUM BRAIN MAPP, V32, P1566, DOI 10.1002/hbm.21132; Chen R, 1997, CAN J NEUROL SCI, V24, P284, DOI 10.1017/S0317167100032947; DaSilva AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003396; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Feldman DE, 2005, SCIENCE, V310, P810, DOI 10.1126/science.1115807; Gaser C, 2003, J NEUROSCI, V23, P9240; Geyer S, 1999, NEUROIMAGE, V10, P63, DOI 10.1006/nimg.1999.0440; Geyer S, 1996, NATURE, V382, P805, DOI 10.1038/382805a0; Geyer S., 2003, MICROSTRUCTURAL BORD; Goldman A S, 1980, Prog Clin Biol Res, V36, P9; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Grefkes C, 2001, NEUROIMAGE, V14, P617, DOI 10.1006/nimg.2001.0858; HENKEL L, 1969, Journal of Bone and Joint Surgery British Volume, V51-B, P399; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; May A, 2007, CEREB CORTEX, V17, P205, DOI 10.1093/cercor/bhj138; May A, 2008, PAIN, V137, P7, DOI 10.1016/j.pain.2008.02.034; Merzenich M M, 1993, J Hand Ther, V6, P89; MERZENICH MM, 1984, J COMP NEUROL, V224, P591, DOI 10.1002/cne.902240408; Nudo RJ, 1996, J NEUROSCI, V16, P785; Rodriguez-Raecke R, 2009, J NEUROSCI, V29, P13746, DOI 10.1523/JNEUROSCI.3687-09.2009; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Sanes JN, 2000, ANNU REV NEUROSCI, V23, P393, DOI 10.1146/annurev.neuro.23.1.393; Schaechter JD, 2008, CEREB CORTEX, V18, P638, DOI 10.1093/cercor/bhm096; Scholz J, 2009, NAT NEUROSCI, V12, P1370, DOI 10.1038/nn.2412; Sievert G, 1965, Prax Kinderpsychol Kinderpsychiatr, V14, P193; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Stoeckel MC, 2009, P NATL ACAD SCI USA, V106, P2395, DOI 10.1073/pnas.0803733106; Stoeckel MC, 2005, EUR J NEUROSCI, V21, P556, DOI 10.1111/j.1460-9568.2005.03866.x; Stoeckel MC, 2005, J NEUROPHYSIOL, V93, P813, DOI 10.1152/jn.00749.2004; Stoeckel MC, 2004, EXP BRAIN RES, V156, P333, DOI 10.1007/s00221-003-1794-9; Yousry TA, 1997, BRAIN, V120, P141, DOI 10.1093/brain/120.1.141; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	41	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e51900	10.1371/journal.pone.0051900	http://dx.doi.org/10.1371/journal.pone.0051900			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300575	Green Published, Green Submitted, gold			2022-12-27	WOS:000313618800034
J	Barreto-Valer, K; Lopez-Bellido, R; Sanchez-Simon, FM; Rodriguez, RE				Barreto-Valer, Katherine; Lopez-Bellido, Roger; Macho Sanchez-Simon, Fatima; Rodriguez, Raquel E.			Modulation by Cocaine of Dopamine Receptors through miRNA-133b in Zebrafish Embryos	PLOS ONE			English	Article							LONG-TERM POTENTIATION; DELTA-OPIOID RECEPTOR; VIVO DRUG DISCOVERY; PRENATAL COCAINE; HUMAN-DISEASE; EXPRESSION; EXPOSURE; PITX3; GENES; DIFFERENTIATION	The use of cocaine during pregnancy can affect the mother and indirectly might alter the development of the embryo/foetus. Accordingly, in the present work our aim was to study in vivo (in zebrafish embryos) the effects of cocaine on the expression of dopamine receptors and on miR-133b. These embryos were exposed to cocaine hydrochloride (HCl) at 5 hours post-fertilization (hpf) and were then collected at 8, 16, 24, 48 and 72 hpf to study the expression of dopamine receptors, drd1, drd2a, drd2b and drd3, by quantitative real time PCR (qPCR) and in situ hybridization (ISH, only at 24 hpf). Our results indicate that cocaine alters the expression of the genes studied, depending on the stage of the developing embryo and the type of dopamine receptor. We found that cocaine reduced the expression of miR-133b at 24 and 48 hpf in the central nervous system (CNS) and at the periphery by qPCR and also that the spatial distribution of miR-133b was mainly seen in somites, a finding that suggests the involvement of miR-133b in the development of the skeletal muscle. In contrast, at the level of the CNS miR-133b had a weak and moderate expression at 24 and 48 hpf. We also analysed the interaction of miR-133b with the Pitx3 and Pitx3 target genes drd2a and drd2b, tyrosine hydroxylase (th) and dopamine transporter (dat) by microinjection of the Pitx3-3'UTR sequence. Microinjection of Pitx3-3'UTR affected the expression of pitx3, drd2a, drd2b, th and dat. In conclusion, in the present work we describe a possible mechanism to account for cocaine activity by controlling miR-133b transcription in zebrafish. Via miR-133b cocaine would modulate the expression of pitx3 and subsequently of dopamine receptors, dat and th. These results indicate that miRNAs can play an important role during embryogenesis and in drug addiction.	[Barreto-Valer, Katherine; Lopez-Bellido, Roger; Macho Sanchez-Simon, Fatima; Rodriguez, Raquel E.] Univ Salamanca, Dept Biochem & Mol Biol, Inst Neurosci Castilla & Leon, E-37008 Salamanca, Spain	University of Salamanca	Rodriguez, RE (corresponding author), Univ Salamanca, Dept Biochem & Mol Biol, Inst Neurosci Castilla & Leon, E-37008 Salamanca, Spain.	requelmi@usal.es		Rodriguez Rodriguez, Raquel/0000-0003-1805-3066; Barreto Valer, Katherine/0000-0002-7709-3896	Spanish Ministry of Education and Science [SAF2010-18597]; Regional Government of Castilla y Leo'n [B1039/SA25/10]	Spanish Ministry of Education and Science(Spanish Government); Regional Government of Castilla y Leo'n	This work was supported by the Spanish Ministry of Education and Science (grant SAF2010-18597) and the Regional Government of Castilla y Leo'n (grant B1039/SA25/10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KA, 2000, DEVELOPMENT, V127, P1857; Argilli E, 2008, J NEUROSCI, V28, P9092, DOI 10.1523/JNEUROSCI.1001-08.2008; Barrallo A, 1998, BIOCHEM BIOPH RES CO, V245, P544, DOI 10.1006/bbrc.1998.8496; Boehmler W, 2007, GENES BRAIN BEHAV, V6, P155, DOI 10.1111/j.1601-183X.2006.00243.x; Boehmler W, 2004, DEV DYNAM, V230, P481, DOI 10.1002/dvdy.20075; Breving K, 2010, INT J BIOCHEM CELL B, V42, P1316, DOI 10.1016/j.biocel.2009.09.016; Caine SB, 2002, J NEUROSCI, V22, P2977, DOI 10.1523/JNEUROSCI.22-07-02977.2002; Callier S, 2003, BIOL CELL, V95, P489, DOI 10.1016/S0248-4900(03)00089-3; Chakraborty C, 2009, CURR DRUG METAB, V10, P116, DOI 10.2174/138920009787522197; Chandrasekar V, 2009, MOL CELL NEUROSCI, V42, P350, DOI 10.1016/j.mcn.2009.08.009; Choi SJ, 1998, ANN NY ACAD SCI, V844, P293, DOI 10.1111/j.1749-6632.1998.tb08243.x; Coulon V, 2007, J BIOL CHEM, V282, P33192, DOI 10.1074/jbc.M706119200; Dalley JW, 2009, SEMIN CELL DEV BIOL, V20, P403, DOI 10.1016/j.semcdb.2009.01.002; Darland T, 2001, P NATL ACAD SCI USA, V98, P11691, DOI 10.1073/pnas.191380698; DelaneyBlack V, 1996, PEDIATRICS, V98, P735; Dempsey D, 1999, J ANAL TOXICOL, V23, P24, DOI 10.1093/jat/23.1.24; Dienes-Nagy A, 1999, J CHROMATOGR A, V854, P109, DOI 10.1016/S0021-9673(99)00750-5; Dreyer JL, 2010, GENOME MED, V2, DOI 10.1186/gm213; Dutta S, 2005, DEVELOPMENT, V132, P1579, DOI 10.1242/dev.01723; Eipper-Mains JE, 2011, RNA, V17, P1529, DOI 10.1261/rna.2775511; Eyler FD, 2009, DEV NEUROSCI-BASEL, V31, P121, DOI 10.1159/000207500; Fang YA, 1999, J NEUROSCI, V19, P8966, DOI 10.1523/JNEUROSCI.19-20-08966.1999; Feng QP, 2005, BRIT J PHARMACOL, V144, P887, DOI 10.1038/sj.bjp.0706130; Filippi A, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-135; Frederick AL, 2009, DEV NEUROSCI-BASEL, V31, P7, DOI 10.1159/000207490; Guo S, 1999, DEV BIOL, V208, P473, DOI 10.1006/dbio.1999.9204; Harvey JA, 2004, NEUROSCI BIOBEHAV R, V27, P751, DOI 10.1016/j.neubiorev.2003.11.006; He Y, 2010, J NEUROSCI, V30, P10251, DOI 10.1523/JNEUROSCI.2419-10.2010; Hollander JA, 2010, NATURE, V466, P197, DOI 10.1038/nature09202; Holzschuh J, 2001, MECH DEVELOP, V101, P237, DOI 10.1016/S0925-4773(01)00287-8; Huang CC, 2011, INT J NEUROPSYCHOPH, V14, P431, DOI 10.1017/S1461145710000258; Huang XQ, 2009, J PHYS CHEM B, V113, P15057, DOI 10.1021/jp900963n; Hummel M, 2002, J CELL PHYSIOL, V191, P17, DOI 10.1002/jcp.10078; Hwang DY, 2009, J NEUROCHEM, V111, P1202, DOI 10.1111/j.1471-4159.2009.06404.x; Irons TD, 2010, NEUROTOXICOL TERATOL, V32, P84, DOI 10.1016/j.ntt.2009.04.066; Jacobs FMJ, 2009, DEVELOPMENT, V136, P531, DOI 10.1242/dev.029769; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jones LB, 2000, J NEUROSCI, V20, P4606, DOI 10.1523/JNEUROSCI.20-12-04606.2000; Kari G, 2007, CLIN PHARMACOL THER, V82, P70, DOI 10.1038/sj.clpt.6100223; Kesrouani A, 2001, EARLY HUM DEV, V63, P79, DOI 10.1016/S0378-3782(01)00123-2; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kleinjan DA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040029; Koutsoulidou A, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-34; Kubrusly RCC, 2010, NEUROPHARMACOLOGY, V58, P436, DOI 10.1016/j.neuropharm.2009.09.007; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Li P, 2007, DEV DYNAM, V236, P1339, DOI 10.1002/dvdy.21130; Lidow MS, 2001, DEV BRAIN RES, V128, P45, DOI 10.1016/S0165-3806(01)00139-0; Little KY, 2009, PSYCHIAT RES, V168, P173, DOI 10.1016/j.psychres.2008.10.034; Liu QS, 2005, NATURE, V437, P1027, DOI 10.1038/nature04050; Lohi O, 2012, ACTA PAEDIAT; Lopez-Patino MA, 2008, PHYSIOL BEHAV, V93, P160, DOI 10.1016/j.physbeh.2007.08.013; Sanchez-Simon FM, 2010, MOL PHARMACOL, V78, P935, DOI 10.1124/mol.110.066837; Mameli M, 2011, NEUROPHARMACOLOGY, V61, P1052, DOI 10.1016/j.neuropharm.2011.01.036; Masserano JM, 1996, NEUROSCI LETT, V217, P73, DOI 10.1016/S0304-3940(96)13047-0; McCurley AT, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-102; Messiah SE, 2011, PROG PEDIATR CARDIOL, V31, P59, DOI 10.1016/j.ppedcard.2010.11.010; MEYER JS, 1993, BRAIN RES, V608, P129, DOI 10.1016/0006-8993(93)90783-J; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Morrow BA, 2001, SYNAPSE, V41, P337, DOI 10.1002/syn.1090; Nunes I, 2003, P NATL ACAD SCI USA, V100, P4245, DOI 10.1073/pnas.0230529100; Pinal-Seoane N, 2006, J MOL ENDOCRINOL, V37, P391, DOI 10.1677/jme.1.02136; Plessinger MA, 1998, OBSTET GYN CLIN N AM, V25, P99, DOI 10.1016/S0889-8545(05)70360-0; Postlethwait JH, 2007, J EXP ZOOL PART B, V308B, P563, DOI 10.1002/jez.b.21137; Rand TA, 2005, CELL, V123, P621, DOI 10.1016/j.cell.2005.10.020; Ryu S, 2007, CURR BIOL, V17, P873, DOI 10.1016/j.cub.2007.04.003; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salvatore MF, 2004, NEUROSCIENCE, V123, P481, DOI 10.1016/j.neuroscience.2003.10.002; Sanchez-Simon FM, 2008, NEUROSCIENCE, V151, P129, DOI 10.1016/j.neuroscience.2007.09.086; Santoriello C, 2012, J CLIN INVEST, V122, P2337, DOI 10.1172/JCI60434; SCHENKER S, 1993, CLIN PHARMACOL THER, V53, P329, DOI 10.1038/clpt.1993.29; Serafini G, 2012, NEUROSCI RES, V73, P179, DOI 10.1016/j.neures.2012.04.001; Shang EH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000587; Smidt MP, 2000, NAT NEUROSCI, V3, P337, DOI 10.1038/73902; Stanwood GD, 2003, NEUROSCIENCE, V122, P579, DOI 10.1016/j.neuroscience.2003.08.029; Stanwood GD, 2007, J NEUROSCI, V27, P152, DOI 10.1523/JNEUROSCI.4591-06.2007; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Ursitti F, 2001, THER DRUG MONIT, V23, P347, DOI 10.1097/00007691-200108000-00005; van den Munckhof P, 2003, DEVELOPMENT, V130, P2535, DOI 10.1242/dev.00464; Volkow ND, 2011, P NATL ACAD SCI USA, V108, P15037, DOI 10.1073/pnas.1010654108; Wallen A, 2003, ANN NY ACAD SCI, V991, P48; Zeng Y, 2009, MOL PHARMACOL, V75, P259, DOI 10.1124/mol.108.052118; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	84	21	25	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52701	10.1371/journal.pone.0052701	http://dx.doi.org/10.1371/journal.pone.0052701			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285158	Green Published, gold, Green Submitted			2022-12-27	WOS:000313158800090
J	Mellert, K; Lamla, M; Scheffzek, K; Wittig, R; Kaufmann, D				Mellert, Kevin; Lamla, Markus; Scheffzek, Klaus; Wittig, Rainer; Kaufmann, Dieter			Enhancing Endosomal Escape of Transduced Proteins by Photochemical Internalisation	PLOS ONE			English	Article							CELL-PENETRATING PEPTIDES; MACROMOLECULES; TRANSFECTION; DELIVERY; FUSION	Induced internalisation of functional proteins into cultured cells has become an important aspect in a rising number of in vitro and in vivo assays. The endo-lysosomal entrapment of the transduced proteins remains the major problem in all transduction protocols. In this study we compared the efficiency, cytotoxicity and protein targeting of different commercially available transduction reagents by transducing a well-studied fluorescently labelled protein (Atto488-bovine serum albumin) into cultured human sarcoma cells. The amount of internalised protein and toxicity differed between the different reagents, but the percentage of transduced cells was consistently high. Furthermore, in all protocols the signals of the transduced Atto488-BSA were predominantly punctual consistent with an endosomal localisation. To overcome the endosomal entrapment, the transduction protocols were combined with a photochemical internalisation (PCI) treatment. Using this combination revealed that an endosomal disruption is highly effective in cell penetrating peptide (CPP) mediated transduction, whereas lipid-mediated transductions lead to a lower signal spreading throughout the cytosol. No change in the signal distribution could be achieved in treatments using non-lipid polymers as a transduction reagent. Therefore, the combination of protein transduction protocols based on CPPs with the endosomolytic treatment PCI can facilitate protein transduction experiments in vitro.	[Mellert, Kevin; Kaufmann, Dieter] Univ Ulm, Inst Human Genet, D-89069 Ulm, Germany; [Lamla, Markus] Univ Ulm, Inst Organ Chem Macromol Chem 3, D-89069 Ulm, Germany; [Scheffzek, Klaus] Med Univ Innsbruck, Bioctr, Div Biol Chem, A-6020 Innsbruck, Austria; [Wittig, Rainer] Univ Ulm, Inst Lasertechnologien Med & Messtech ILM, D-89069 Ulm, Germany	Ulm University; Ulm University; Medical University of Innsbruck; Ulm University	Mellert, K (corresponding author), Univ Ulm, Inst Human Genet, D-89069 Ulm, Germany.	kevin.mellert@uni-ulm.de	Wittig, Rainer/AAT-5361-2021	Wittig, Rainer/0000-0002-3735-9370	Bundesministerium fur Bildung und Forschung (BMBF DLR G, Netzwerk Neurofibromatosis) [Verbundvorhaben 01GM0905]	Bundesministerium fur Bildung und Forschung (BMBF DLR G, Netzwerk Neurofibromatosis)	The financial support for this study was provided by the Bundesministerium fur Bildung und Forschung (BMBF DLR G, Verbundvorhaben 01GM0905 Netzwerk Neurofibromatosis, Teilprojekt 3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg K, 1999, CANCER RES, V59, P1180; Ciftci K, 2001, INT J PHARM, V218, P81, DOI 10.1016/S0378-5173(01)00623-8; El-Sayed A, 2009, AAPS J, V11, P13, DOI 10.1208/s12248-008-9071-2; Gillmeister MP, 2011, BIOCONJUGATE CHEM, V22, P556, DOI 10.1021/bc900445g; Mellert K, 2011, GENES-BASEL, V2, P562, DOI 10.3390/genes2030562; Nakase I, 2004, MOL THER, V10, P1011, DOI 10.1016/j.ymthe.2004.08.010; Neundorf I, 2009, PHARMACEUTICALS, V2, P49, DOI 10.3390/ph2020049; Norum OJ, 2009, PHOTOCH PHOTOBIO SCI, V8, P758, DOI 10.1039/b821129a; Oba M, 2012, BIOL PHARM BULL, V35, P1064, DOI 10.1248/bpb.b12-00001; Pan CY, 2010, MOL BIOL REP, V37, P2117, DOI 10.1007/s11033-009-9680-6; RAAB GH, 1990, ARCH GYNECOL OBSTET, V248, P13, DOI 10.1007/BF02389584; SEGLEN PO, 1979, EUR J BIOCHEM, V95, P215, DOI 10.1111/j.1432-1033.1979.tb12956.x; Selbo PK, 2001, INT J CANCER, V92, P761, DOI 10.1002/1097-0215(20010601)92:5<761::AID-IJC1238>3.0.CO;2-4; Sugita T, 2008, BRIT J PHARMACOL, V153, P1143, DOI 10.1038/sj.bjp.0707678; Ter-Avetisyan G, 2009, J BIOL CHEM, V284, P3370, DOI 10.1074/jbc.M805550200; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; Wang JTW, 2012, J CONTROL RELEASE, V157, P305, DOI 10.1016/j.jconrel.2011.08.025; Weyergang A, 2011, LASER SURG MED, V43, P721, DOI 10.1002/lsm.21084; Yamaguchi K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/872065; Zhang H, 2012, BIOMATERIALS, V33, P5047, DOI 10.1016/j.biomaterials.2012.03.061	20	31	33	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52473	10.1371/journal.pone.0052473	http://dx.doi.org/10.1371/journal.pone.0052473			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285056	Green Published, gold, Green Submitted			2022-12-27	WOS:000313158800068
J	Zhou, LC; Yang, H; Lin, XH; Okoro, EU; Guo, ZM				Zhou, Lichun; Yang, Hong; Lin, Xinghua; Okoro, Emmanuel U.; Guo, Zhongmao			Cholecystokinin Elevates Mouse Plasma Lipids	PLOS ONE			English	Article							CHOLESTEROL ABSORPTION; DIETARY-CHOLESTEROL; LDL RECEPTOR; MICE; CHYLOMICRONS; SUSCEPTIBILITY; GALLBLADDER; PROTEIN; RISK; CCK	Cholecystokinin (CCK) is a peptide hormone that induces bile release into the intestinal lumen which in turn aids in fat digestion and absorption in the intestine. While excretion of bile acids and cholesterol into the feces eliminates cholesterol from the body, this report examined the effect of CCK on increasing plasma cholesterol and triglycerides in mice. Our data demonstrated that intravenous injection of [Thr28, Nle31]-CCK at a dose of 50 ng/kg significantly increased plasma triglyceride and cholesterol levels by 22 and 31%, respectively, in fasting low-density lipoprotein receptor knockout (LDLR-/-) mice. The same dose of [Thr28, Nle31]-CCK induced 6 and 13% increases in plasma triglyceride and cholesterol, respectively, in wild-type mice. However, these particular before and after CCK treatment values did not achieve statistical significance. Oral feeding of olive oil further elevated plasma triglycerides, but did not alter plasma cholesterol levels in CCK-treated mice. The increased plasma cholesterol in CCK-treated mice was distributed in very-low, low and high density lipoproteins (VLDL, LDL and HDL) with less of an increase in HDL. Correspondingly, the plasma apolipoprotein (apo) B48, B100, apoE and apoAI levels were significantly higher in the CCK-treated mice than in untreated control mice. Ligation of the bile duct, blocking CCK receptors with proglumide or inhibition of Niemann-Pick C1 Like 1 transporter with ezetimibe reduced the hypercholesterolemic effect of [Thr28, Nle31]-CCK in LDLR-/- mice. These findings suggest that CCK-increased plasma cholesterol and triglycerides as a result of the reabsorption of biliary lipids from the intestine.	[Zhou, Lichun; Yang, Hong; Lin, Xinghua; Okoro, Emmanuel U.; Guo, Zhongmao] Meharry Med Coll, Dept Physiol, Nashville, TN 37208 USA	Meharry Medical College	Guo, ZM (corresponding author), Meharry Med Coll, Dept Physiol, Nashville, TN 37208 USA.	zguo@mmc.edu			National Institutes of Health [R01ES014471, R01HL089382, SC1HL101431]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [SC1HL101431, R01HL089382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014472] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by National Institutes of Health grants R01ES014471 and R01HL089382 (ZG), and SC1HL101431 (HY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ables GP, 2012, J LIPID RES; AHO HJ, 1989, INT J PANCREATOL, V5, P123; Berge KE, 2000, SCIENCE, V290, P1771, DOI 10.1126/science.290.5497.1771; Berna MJ, 2007, CURR TOP MED CHEM, V7, P1211; Blacklow SC, 2007, CURR OPIN STRUC BIOL, V17, P419, DOI 10.1016/j.sbi.2007.08.017; Calandra S, 2011, J LIPID RES, V52, P1885, DOI 10.1194/jlr.R017855; Cartwright IJ, 2000, J LIPID RES, V41, P1728; Flint A, 2002, NEUROPSYCHOPHARMACOL, V27, P663; GARDINER BN, 1976, GASTROENTEROLOGY, V70, P403; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; Havel RJ, 2004, ARTERIOSCL THROM VAS, V24, P213, DOI 10.1161/01.ATV.0000115382.53810.24; HIGUCHI K, 1992, J LIPID RES, V33, P1753; Hussain MM, 2000, ATHEROSCLEROSIS, V148, P1; Iqbal J, 2005, J LIPID RES, V46, P1491, DOI 10.1194/jlr.M500023-JLR200; ISHIBASHI S, 1994, J CLIN INVEST, V93, P1885, DOI 10.1172/JCI117179; JAZRAWI RP, 1986, GUT, V27, P355, DOI 10.1136/gut.27.4.355; KAPLITA PV, 1984, ARCH INT PHARMACOD T, V269, P271; Lin XH, 2011, FREE RADICAL BIO MED, V51, P97, DOI 10.1016/j.freeradbiomed.2011.04.020; MacIntosh CG, 2001, J CLIN ENDOCR METAB, V86, P5830, DOI 10.1210/jc.86.12.5830; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; Miyasaka K, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-14; Mulligan JD, 2003, J BIOL CHEM, V278, P13356, DOI 10.1074/jbc.M212377200; Nakajima K, 2011, CLIN CHIM ACTA, V412, P1306, DOI 10.1016/j.cca.2011.04.018; Narisawa S, 2003, MOL CELL BIOL, V23, P7525, DOI 10.1128/MCB.23.21.7525-7530.2003; Repa JJ, 2000, ANNU REV CELL DEV BI, V16, P459, DOI 10.1146/annurev.cellbio.16.1.459; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Tomkin GH, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/784536; Uchinami H, 2006, HEPATOLOGY, V44, P420, DOI 10.1002/hep.21268; Wang DQH, 2004, J CLIN INVEST, V114, P521, DOI 10.1172/JCI200416801; Wang DQH, 2002, J LIPID RES, V43, P1950, DOI 10.1194/jlr.M200078-JLR200; Wu DF, 2005, J LIPID RES, V46, P1380, DOI 10.1194/jlr.M400430-JLR200	31	5	5	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e51011	10.1371/journal.pone.0051011	http://dx.doi.org/10.1371/journal.pone.0051011			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23300532	Green Published, gold, Green Submitted			2022-12-27	WOS:000313158800006
J	Mohan, R; Jensen, KB; Petkova, VI; Dey, A; Barnsley, N; Ingvar, M; McAuley, JH; Moseley, GL; Ehrsson, HH				Mohan, Rahul; Jensen, Karin B.; Petkova, Valeria I.; Dey, Abishikta; Barnsley, Nadia; Ingvar, Martin; McAuley, James H.; Moseley, G. Lorimer; Ehrsson, Henrik H.			No Pain Relief with the Rubber Hand Illusion	PLOS ONE			English	Article							GRADED MOTOR IMAGERY; BODY; TOUCH; LIMB; OWNERSHIP; FEEL; PART	The sense of body ownership can be easily disrupted during illusions and the most common illusion is the rubber hand illusion. An idea that is rapidly gaining popularity in clinical pain medicine is that body ownership illusions can be used to modify pathological pain sensations and induce analgesia. However, this idea has not been empirically evaluated. Two separate research laboratories undertook independent randomized repeated measures experiments, both designed to detect an effect of the rubber hand illusion on experimentally induced hand pain. In Experiment 1, 16 healthy volunteers rated the pain evoked by noxious heat stimuli (5 s duration; interstimulus interval 25 s) of set temperatures (47 degrees, 48 degrees and 49 degrees C) during the rubber hand illusion or during a control condition. There was a main effect of stimulus temperature on pain ratings, but no main effect of condition (p = 0.32), nor a condition x temperature interaction (p = 0.31). In Experiment 2, 20 healthy volunteers underwent quantitative sensory testing to determine heat and cold pain thresholds during the rubber hand illusion or during a control condition. Secondary analyses involved heat and cold detection thresholds and paradoxical heat sensations. Again, there was no main effect of condition on heat pain threshold (p = 0.17), nor on cold pain threshold (p = 0.65), nor on any of the secondary measures (p<0.56 for all). We conclude that the rubber hand illusion does not induce analgesia.	[Mohan, Rahul; Dey, Abishikta; Barnsley, Nadia; McAuley, James H.; Moseley, G. Lorimer] Neurosci Res Australia, Sydney, NSW, Australia; [Jensen, Karin B.; Petkova, Valeria I.; Ingvar, Martin; Ehrsson, Henrik H.] Karolinska Inst, Dept Neurosci, Brain Body & Self Lab, Stockholm, Sweden; [Jensen, Karin B.; Petkova, Valeria I.; Ingvar, Martin; Ehrsson, Henrik H.] Karolinska Inst, Dept Clin Neurosci, Stockholm Brain Inst, Osher Ctr Integrat Med, Stockholm, Sweden; [Moseley, G. Lorimer] Univ S Australia, Sansom Inst Hlth Res, Adelaide, SA 5001, Australia	Neuroscience Research Australia; Karolinska Institutet; Karolinska Institutet; University of South Australia	Moseley, GL (corresponding author), Neurosci Res Australia, Sydney, NSW, Australia.	lorimer.moseley@gmail.com; Henrik.Ehrsson@ki.se	McAuley, James Henry/HHC-3949-2022; Moseley, Lorimer/A-7095-2009	McAuley, James Henry/0000-0002-0550-828X; Moseley, Lorimer/0000-0002-3750-4945; Jensen, Karin/0000-0003-2521-3160; Ingvar, Martin/0000-0002-9041-5714	National Health & Medical Research Council of Australia [571090]	National Health & Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	GLM is supported by the National Health & Medical Research Council of Australia ID 571090. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avillac M, 2005, NAT NEUROSCI, V8, P941, DOI 10.1038/nn1480; Azanon E, 2010, CURR BIOL, V20, P1304, DOI 10.1016/j.cub.2010.05.063; Barnsley N, 2011, CURR BIOL, V21, pR945, DOI 10.1016/j.cub.2011.10.039; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Capelari EDP, 2009, PERCEPTION, V38, P92, DOI 10.1068/p5892; Daly AE, 2009, EUR J PAIN, V13, P339, DOI 10.1016/j.ejpain.2008.05.003; Ehrsson HH, 2007, SCIENCE, V317, P1048, DOI 10.1126/science.1142175; Ehrsson HH, 2007, P NATL ACAD SCI USA, V104, P9828, DOI 10.1073/pnas.0610011104; Folegatti A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006920; Gallace A, 2011, PAIN, V152, P1418, DOI 10.1016/j.pain.2011.02.029; Guterstam A, 2012, CONSCIOUS COGN, V21, P1037, DOI 10.1016/j.concog.2012.01.018; Hansel A, 2011, EUR J PAIN, V15, P874, DOI 10.1016/j.ejpain.2011.03.013; Iriki A, 1996, NEUROREPORT, V7, P2325; Kelly AM, 2001, EMERG MED J, V18, P205, DOI 10.1136/emj.18.3.205; Kovacs FM, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-43; Lenggenhager B, 2007, SCIENCE, V317, P1096, DOI 10.1126/science.1143439; Lloyd DM, 2007, BRAIN COGNITION, V64, P104, DOI 10.1016/j.bandc.2006.09.013; Makin TR, 2008, BEHAV BRAIN RES, V191, P1, DOI 10.1016/j.bbr.2008.02.041; Moseley GL, 2008, P NATL ACAD SCI USA, V105, P13169, DOI 10.1073/pnas.0803768105; Moseley GL, 2006, NEUROLOGY, V67, P2129, DOI 10.1212/01.wnl.0000249112.56935.32; Moseley GL, 2012, NEUROREHAB NEURAL RE, V26, P646, DOI 10.1177/1545968311433209; Moseley GL, 2012, NEUROSCI BIOBEHAV R, V36, P34, DOI 10.1016/j.neubiorev.2011.03.013; Moseley GL, 2008, CURR BIOL, V18, pR1047, DOI 10.1016/j.cub.2008.09.031; Moseley GL, 2005, PAIN, V114, P54, DOI 10.1016/j.pain.2004.11.024; Moseley GL, 2004, PAIN, V108, P192, DOI 10.1016/j.pain.2004.01.006; Newport R, 2011, CURR BIOL, V21, pR804, DOI 10.1016/j.cub.2011.08.044; Petkova VI, 2011, CURR BIOL, V21, P1118, DOI 10.1016/j.cub.2011.05.022; Petkova VI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003832; Walsh LD, 2011, J PHYSIOL-LONDON, V589, P3009, DOI 10.1113/jphysiol.2011.204941	29	73	73	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52400	10.1371/journal.pone.0052400	http://dx.doi.org/10.1371/journal.pone.0052400			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285026	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000312794500158
J	Moore, MM; Oteng-Pabi, SK; Pandelieva, AT; Mayo, SL; Chica, RA				Moore, Matthew M.; Oteng-Pabi, Samuel K.; Pandelieva, Antonia T.; Mayo, Stephen L.; Chica, Roberto A.			Recovery of Red Fluorescent Protein Chromophore Maturation Deficiency through Rational Design	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; STRUCTURAL BASIS; VARIANTS; MECHANISM; EMISSION; CORAL; CHROMOPROTEINS; MUTAGENESIS; MUTANTS; PATHWAY	Red fluorescent proteins (RFPs) derived from organisms in the class Anthozoa have found widespread application as imaging tools in biological research. For most imaging experiments, RFPs that mature quickly to the red chromophore and produce little or no green chromophore are most useful. In this study, we used rational design to convert a yellow fluorescent mPlum mutant to a red-emitting RFP without reverting any of the mutations causing the maturation deficiency and without altering the red chromophore's covalent structure. We also created an optimized mPlum mutant (mPlum-E16P) that matures almost exclusively to the red chromophore. Analysis of the structure/function relationships in these proteins revealed two structural characteristics that are important for efficient red chromophore maturation in DsRed-derived RFPs. The first is the presence of a lysine residue at position 70 that is able to interact directly with the chromophore. The second is an absence of non-bonding interactions limiting the conformational flexibility at the peptide backbone that is oxidized during red chromophore formation. Satisfying or improving these structural features in other maturation-deficient RFPs may result in RFPs with faster and more complete maturation to the red chromophore.	[Oteng-Pabi, Samuel K.; Pandelieva, Antonia T.; Chica, Roberto A.] Univ Ottawa, Dept Chem, Ottawa, ON, Canada; [Moore, Matthew M.; Mayo, Stephen L.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Mayo, Stephen L.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Chica, Roberto A.] Univ Ottawa, Ctr Catalysis Res & Innovat, Ottawa, ON, Canada	University of Ottawa; California Institute of Technology; California Institute of Technology; University of Ottawa	Chica, RA (corresponding author), Univ Ottawa, Dept Chem, Ottawa, ON, Canada.	rchica@uottawa.ca			Natural Sciences and Engineering Research Council of Canada; University of Ottawa; Defense Advanced Research Projects Agency Protein Design Processes; Gordon and Betty Moore Foundation; Department of Energy; National Institutes of Health	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Ottawa; Defense Advanced Research Projects Agency Protein Design Processes; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Department of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca), the University of Ottawa (http://www.uottawa.ca), and the Defense Advanced Research Projects Agency Protein Design Processes (http://www.darpa.mil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Marie L. Ary for help with the manuscript. We would like to acknowledge the Gordon and Betty Moore Foundation for support of the Molecular Observatory at Caltech, and the Department of Energy and National Institutes of Health for supporting the Stanford Synchrotron Radiation Lightsource.	Abbyad P, 2007, P NATL ACAD SCI USA, V104, P20189, DOI 10.1073/pnas.0706185104; Afonine P., 2005, CCP4 NEWSLETTER, V42; Baird GS, 2000, P NATL ACAD SCI USA, V97, P11984, DOI 10.1073/pnas.97.22.11984; Bevis BJ, 2002, NAT BIOTECHNOL, V20, P83, DOI 10.1038/nbt0102-83; Bravaya KB, 2012, J AM CHEM SOC, V134, P2807, DOI 10.1021/ja2114568; Chica RA, 2010, P NATL ACAD SCI USA, V107, P20257, DOI 10.1073/pnas.1013910107; Chudakov DM, 2010, PHYSIOL REV, V90, P1103, DOI 10.1152/physrev.00038.2009; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Gross LA, 2000, P NATL ACAD SCI USA, V97, P11990, DOI 10.1073/pnas.97.22.11990; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mishin AS, 2008, BIOCHEMISTRY-US, V47, P4666, DOI 10.1021/bi702130s; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Pouwels LJ, 2008, BIOCHEMISTRY-US, V47, P10111, DOI 10.1021/bi8007164; Rosenow MA, 2004, BIOCHEMISTRY-US, V43, P4464, DOI 10.1021/bi0361315; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shcherbo D, 2009, BIOCHEM J, V418, P567, DOI 10.1042/BJ20081949; Shu XK, 2006, BIOCHEMISTRY-US, V45, P9639, DOI 10.1021/bi060773l; Shu XK, 2009, PROTEIN SCI, V18, P460, DOI 10.1002/pro.66; Sniegowski JA, 2005, J BIOL CHEM, V280, P26248, DOI 10.1074/jbc.M412327200; Strack RL, 2008, NAT METHODS, V5, P955, DOI 10.1038/nmeth.1264; Strack RL, 2010, J AM CHEM SOC, V132, P8496, DOI 10.1021/ja1030084; Strongin DE, 2007, PROTEIN ENG DES SEL, V20, P525, DOI 10.1093/protein/gzm046; Subach OM, 2010, CHEM BIOL, V17, P333, DOI 10.1016/j.chembiol.2010.03.005; Terskikh AV, 2002, J BIOL CHEM, V277, P7633, DOI 10.1074/jbc.C100694200; Tubbs JL, 2005, BIOCHEMISTRY-US, V44, P9833, DOI 10.1021/bi0472907; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Verkhusha VV, 2004, CHEM BIOL, V11, P845, DOI 10.1016/j.chembiol.2004.04.007; Verkhusha VV, 2004, NAT BIOTECHNOL, V22, P289, DOI 10.1038/nbt943; Wachter RM, 2010, BIOCHEMISTRY-US, V49, P7417, DOI 10.1021/bi100901h; Wachter RM, 1998, STRUCTURE, V6, P1267, DOI 10.1016/S0969-2126(98)00127-0; Wall MA, 2000, NAT STRUCT BIOL, V7, P1133; Wang L, 2004, P NATL ACAD SCI USA, V101, P16745, DOI 10.1073/pnas.0407752101; Wiehler J, 2001, FEBS LETT, V487, P384, DOI 10.1016/S0014-5793(00)02365-6; Wilmann PG, 2005, J MOL BIOL, V349, P223, DOI 10.1016/j.jmb.2005.03.020; Yarbrough D, 2001, P NATL ACAD SCI USA, V98, P462, DOI 10.1073/pnas.98.2.462	42	14	16	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52463	10.1371/journal.pone.0052463	http://dx.doi.org/10.1371/journal.pone.0052463			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285050	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000312794500174
J	Yin, DZ; Song, F; Xu, DR; Peterson, BS; Sun, LM; Men, WW; Yan, X; Fan, MX				Yin, Dazhi; Song, Fan; Xu, Dongrong; Peterson, Bradley S.; Sun, Limin; Men, Weiwei; Yan, Xu; Fan, Mingxia			Patterns in Cortical Connectivity for Determining Outcomes in Hand Function after Subcortical Stroke	PLOS ONE			English	Article							SENSORIMOTOR CORTEX ACTIVATION; MOTOR RECOVERY; RESTING-STATE; LONGITUDINAL FMRI; BRAIN ACTIVATION; MRI; NETWORK; REORGANIZATION; EXECUTION; IMAGERY	Background and Purpose: Previous studies have noted changes in resting-state functional connectivity during motor recovery following stroke. However, these studies always uncover various patterns of motor recovery. Moreover, subgroups of stroke patients with different outcomes in hand function have rarely been studied. Materials and Methods: We selected 24 patients who had a subcortical stroke in the left motor pathway and displayed only motor deficits. The patients were divided into two subgroups: completely paralyzed hands (CPH) ( 12 patients) and partially paralyzed hands (PPH) (12 patients). Twenty-four healthy controls (HC) were also recruited. We performed functional connectivity analysis in both the ipsilesional and contralesional primary motor cortex (M1) to explore the differences in the patterns between each pair of the three diagnostic groups. Results: Compared with the HC, the PPH group displays reduced connectivity of both the ipsilesional and contralesional M1 with bilateral prefrontal gyrus and contralesional cerebellum posterior lobe. The connectivity of both the ipsilesional and contralesional M1 with contralateral primary sensorimotor cortex was reduced in the CPH group. Additionally, the connectivity of the ipsilesional M1 with contralesional postcentral gyrus, superior parietal lobule and ipsilesional inferior parietal lobule was reduced in the CPH group compared with the PPH group. Moreover, the connectivity of these regions was positively correlated with the Fugl-Meyer Assessment scores (hand+wrist) across all stroke patients. Conclusions: Patterns in cortical connectivity may serve as a potential biomarker for the neural substratum associated with outcomes in hand function after subcortical stroke. Citation: Yin D, Song F, Xu D, Peterson BS, Sun L, et al. (2012) Patterns in Cortical Connectivity for Determining Outcomes in Hand Function after Subcortical Stroke. PLoS ONE 7(12): e52727. doi:10.1371/journal.pone.0052727	[Xu, Dongrong; Peterson, Bradley S.] New York State Psychiat Inst & Hosp, Dept Psychiat, MRI Unit, New York, NY 10032 USA; [Xu, Dongrong; Peterson, Bradley S.] Columbia Univ, New York, NY USA; [Yin, Dazhi; Men, Weiwei; Yan, Xu; Fan, Mingxia] E China Normal Univ, Key Lab Brain Funct Genom, Shanghai Key Lab Magnet Resonance, Shanghai 200062, Peoples R China; [Song, Fan; Sun, Limin] Fudan Univ, Huashan Hosp, Dept Rehabil Med, Shanghai 200433, Peoples R China	New York State Psychiatry Institute; Columbia University; East China Normal University; Fudan University	Xu, DR (corresponding author), New York State Psychiat Inst & Hosp, Dept Psychiat, MRI Unit, New York, NY 10032 USA.	xud@nyspi.columbia.edu; mxfan@phy.ecnu.edu.cn			Excellent Young Teachers Program of Shanghai Medical College of Fudan University [124]; Shanghai Commission of Science and Technology [10440710200]	Excellent Young Teachers Program of Shanghai Medical College of Fudan University; Shanghai Commission of Science and Technology(Shanghai Science & Technology Committee)	This work was supported by the Excellent Young Teachers Program of Shanghai Medical College of Fudan University (Grant No. 124) and a grant from the Shanghai Commission of Science and Technology (Grant No. 10440710200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Bianciardi M, 2009, NEUROIMAGE, V45, P160, DOI 10.1016/j.neuroimage.2008.10.034; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Calautti C, 2001, STROKE, V32, P2534, DOI 10.1161/hs1101.097401; Calautti C, 2003, STROKE, V34, P1553, DOI 10.1161/01.STR.0000071761.36075.A6; Calautti C, 2003, NEUROIMAGE, V19, P1650, DOI 10.1016/S1053-8119(03)00205-2; Cao XH, 2009, BRAIN RES, V1303, P195, DOI 10.1016/j.brainres.2009.08.029; Cao Y, 1998, STROKE, V29, P112, DOI 10.1161/01.STR.29.1.112; Carter AR, 2010, ANN NEUROL, V67, P365, DOI 10.1002/ana.21905; CHOLLET F, 1991, ANN NEUROL, V29, P63, DOI 10.1002/ana.410290112; Cramer SC, 1997, STROKE, V28, P2518, DOI 10.1161/01.STR.28.12.2518; Cramer SC, 2000, STROKE, V31, P668, DOI 10.1161/01.STR.31.3.668; DUNCAN PW, 1992, STROKE, V23, P1084, DOI 10.1161/01.STR.23.8.1084; Feydy A, 2002, STROKE, V33, P1610, DOI 10.1161/01.STR.0000017100.68294.52; Goldman RI, 2002, NEUROREPORT, V13, P2487, DOI 10.1097/00001756-200212200-00022; Grefkes C, 2008, ANN NEUROL, V63, P236, DOI 10.1002/ana.21228; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Hampson M, 2002, HUM BRAIN MAPP, V15, P247, DOI 10.1002/hbm.10022; Hanakawa T, 2008, CEREB CORTEX, V18, P2775, DOI 10.1093/cercor/bhn036; Lacourse MG, 2005, NEUROIMAGE, V27, P505, DOI 10.1016/j.neuroimage.2005.04.025; Leiguarda RC, 2000, BRAIN, V123, P860, DOI 10.1093/brain/123.5.860; Lewis GN, 2004, J MOTOR BEHAV, V36, P174, DOI 10.3200/JMBR.36.2.174-188; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Loubinoux I, 2003, NEUROIMAGE, V20, P2166, DOI 10.1016/j.neuroimage.2003.08.017; Loubinoux I, 2007, CEREB CORTEX, V17, P2980, DOI 10.1093/cercor/bhm023; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Lu H, 2007, P NATL ACAD SCI USA, V104, P18265, DOI 10.1073/pnas.0705791104; Mannell MV, 2010, HUM BRAIN MAPP, V31, P424, DOI 10.1002/hbm.20876; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Marshall RS, 2000, STROKE, V31, P656, DOI 10.1161/01.STR.31.3.656; Netz J, 1997, BRAIN, V120, P1579, DOI 10.1093/brain/120.9.1579; Park CH, 2011, STROKE, V42, P1357, DOI 10.1161/STROKEAHA.110.596155; Pineiro R, 2001, STROKE, V32, P1134, DOI 10.1161/01.STR.32.5.1134; Rose DK, 2005, CLIN REHABIL, V19, P452, DOI 10.1191/0269215505cr806oa; Sharma N, 2009, ANN NEUROL, V66, P604, DOI 10.1002/ana.21810; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Tombari D, 2004, NEUROIMAGE, V23, P827, DOI 10.1016/j.neuroimage.2004.07.058; Wang L, 2010, BRAIN, V133, P1224, DOI 10.1093/brain/awq043; Ward NS, 2003, BRAIN, V126, P1430, DOI 10.1093/brain/awg145; Ward NS, 2003, BRAIN, V126, P2476, DOI 10.1093/brain/awg245; WASSERMANN EM, 1991, NEUROLOGY, V41, P1795, DOI 10.1212/WNL.41.11.1795; WEILLER C, 1993, ANN NEUROL, V33, P181; Zhang HY, 2010, RADIOLOGY, V256, P598, DOI 10.1148/radiol.10091701	45	50	53	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52727	10.1371/journal.pone.0052727	http://dx.doi.org/10.1371/journal.pone.0052727			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285171	gold, Green Published, Green Submitted			2022-12-27	WOS:000312794500242
J	Bertran-Gonzalez, J; Chieng, BC; Laurent, V; Valjent, E; Balleine, BW				Bertran-Gonzalez, Jesus; Chieng, Billy C.; Laurent, Vincent; Valjent, Emmanuel; Balleine, Bernard W.			Striatal Cholinergic Interneurons Display Activity-Related Phosphorylation of Ribosomal Protein S6	PLOS ONE			English	Article							SYNAPTIC PLASTICITY; CELL-SIZE; RAT NEOSTRIATUM; NEURONS; KINASE; DOPAMINE; BRAIN; IDENTIFICATION; TRANSLATION; ACTIVATION	Cholinergic interneurons (CINs) provide the main source of acetylcholine to all striatal regions, and strongly modulate dopaminergic actions through complex regulation of pre- and post-synaptic acetylcholine receptors. Although striatal CINs have a well-defined electrophysiological profile, their biochemical properties are poorly understood, likely due to their low proportion within the striatum (2-3%). We report a strong and sustained phosphorylation of ribosomal protein S6 on its serine 240 and 244 residues (p-Ser(240-244)-S6rp), a protein integrant of the ribosomal machinery related to the mammalian target of the rapamycin complex 1 (mTORC1) pathway, which we found to be principally expressed in striatal CINs in basal conditions. We explored the functional relevance of this cellular event by pharmacologically inducing various sustained physiological activity states in CINs and assessing the effect on the levels of S6rp phosphorylation. Cell-attached electrophysiological recordings from CINs in a striatal slice preparation showed an inhibitory effect of tetrodotoxin (TTX) on action potential firing paralleled by a decrease in the p-Ser(240-244)-S6rp signal as detected by immunofluorescence after prolonged incubation. On the other hand, elevation in extracellular potassium concentration and the addition of apamin generated an increased firing rate and a burst-firing activity in CINs, respectively, and both stimulatory conditions significantly increased Ser(240-244)-S6rp phosphorylation above basal levels when incubated for one hour. Apamin generated a particularly large increase in phosphorylation that was sensitive to rapamycin. Taken together, our results demonstrate for the first time a link between the state of neuronal activity and a biochemical signaling event in striatal CINs, and suggest that immunofluorescence can be used to estimate the cellular activity of CINs under different pharmacological and/or behavioral conditions.	[Bertran-Gonzalez, Jesus; Chieng, Billy C.; Laurent, Vincent; Balleine, Bernard W.] Univ Sydney, Brain & Mind Res Inst, Behav Neurosci Lab, Sydney, NSW 2006, Australia; [Valjent, Emmanuel] CNRS UMR 5203, Inserm U661, Inst Genom Fonct, Montpellier, France	University of Sydney; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Balleine, BW (corresponding author), Univ Sydney, Brain & Mind Res Inst, Behav Neurosci Lab, Sydney, NSW 2006, Australia.	bernard.balleine@sydney.edu.au	Bertran-Gonzalez, J/L-1410-2017; Laurent, Vincent/I-3975-2019; Laurent, Vincent/H-5737-2013	Bertran-Gonzalez, J/0000-0002-3794-1782; Laurent, Vincent/0000-0003-2333-8437; Valjent, Emmanuel/0000-0002-1034-606X; Chieng, Billy/0000-0003-0222-8001; Balleine, Bernard/0000-0001-8618-7950	Australian Research Council (ARC) [FL0992409]; National Health and Medical Research Council (NHMRC) [633267]	Australian Research Council (ARC)(Australian Research Council); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This research was supported by grants from the Australian Research Council (ARC #FL0992409; http://www.arc.gov.au), and the National Health and Medical Research Council (NHMRC #633267; http://www.nhmrc.gov.au) to Bernard Balleine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Antion MD, 2008, LEARN MEMORY, V15, P29, DOI 10.1101/lm.661908; Bennett BD, 1999, J NEUROSCI, V19, P5586; Bennett BD, 2000, J NEUROSCI, V20, P8493, DOI 10.1523/JNEUROSCI.20-22-08493.2000; Berlanga ML, 2003, NEUROSCIENCE, V120, P1149, DOI 10.1016/S0306-4522(03)00378-6; BOLAM JP, 1984, CIBA F SYMP, V107, P30; Bolam JP, 1995, MOL CELLULAR MECH NE, P1; Bonsi P, 2004, LEARN MEMORY, V11, P755, DOI 10.1101/lm.82104; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Daigle TL, 2012, J NEUROSCI, V32, P11461, DOI 10.1523/JNEUROSCI.2234-12.2012; Ding JB, 2010, NEURON, V67, P294, DOI 10.1016/j.neuron.2010.06.017; English DF, 2012, NAT NEUROSCI, V15, P123, DOI 10.1038/nn.2984; Fino E, 2008, J PHYSIOL-LONDON, V586, P265, DOI 10.1113/jphysiol.2007.144501; Fino E, 2011, NEUROPHARMACOLOGY, V60, P780, DOI 10.1016/j.neuropharm.2011.01.023; FLOTOW H, 1992, J BIOL CHEM, V267, P3074; Gangarossa G, 2012, NEUROPHARMACOLOGY, P1; Gangarossa G, 2012, BRAIN STRUCTURE FUNC; Gerfen CR, 2011, ANNU REV NEUROSCI, V34, P441, DOI 10.1146/annurev-neuro-061010-113641; Goldberg JA, 2011, NEUROSCIENCE, V198, P27, DOI 10.1016/j.neuroscience.2011.08.067; KAWAGUCHI Y, 1995, TRENDS NEUROSCI, V18, P527, DOI 10.1016/0166-2236(95)98374-8; KAWAGUCHI Y, 1993, J NEUROSCI, V13, P4908; KIMURA H, 1980, SCIENCE, V208, P1057, DOI 10.1126/science.6990490; Knight ZA, 2012, CELL, V151, P1126, DOI 10.1016/j.cell.2012.10.039; Matamales M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004770; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; Moore CEJ, 2009, J MOL BIOL, V389, P480, DOI 10.1016/j.jmb.2009.04.020; NYGARD O, 1990, EUR J BIOCHEM, V191, P1, DOI 10.1111/j.1432-1033.1990.tb19087.x; PARKER PJ, 1985, EUR J BIOCHEM, V148, P579, DOI 10.1111/j.1432-1033.1985.tb08879.x; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Ruvinsky I, 2005, GENE DEV, V19, P2199, DOI 10.1101/gad.351605; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Santini E, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000308; Schulz JM, 2011, J NEUROSCI, V31, P11133, DOI 10.1523/JNEUROSCI.0661-11.2011; SORIMACHI M, 1975, BRAIN RES, V94, P325, DOI 10.1016/0006-8993(75)90065-7; Sullivan MA, 2008, J NEUROSCI, V28, P8682, DOI 10.1523/JNEUROSCI.2411-08.2008; Suzuki T, 2001, J NEUROSCI, V21, P6492, DOI 10.1523/JNEUROSCI.21-17-06492.2001; Tepper JM, 2004, CURR OPIN NEUROBIOL, V14, P685, DOI 10.1016/j.conb.2004.10.003; Threlfell S, 2012, NEURON, V75, P58, DOI 10.1016/j.neuron.2012.04.038; Threlfell S, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00011; Valjent E, 2011, NEUROPSYCHOPHARMACOL, V36, P2561, DOI 10.1038/npp.2011.144; Warner-Schmidt JL, 2012, P NATL ACAD SCI US; WILSON CJ, 1990, J NEUROSCI, V10, P508	44	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53195	10.1371/journal.pone.0053195	http://dx.doi.org/10.1371/journal.pone.0053195			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285266	Green Submitted, Green Published, gold			2022-12-27	WOS:000313051500120
J	Huntjens, B; Charman, WN; Workman, H; Hosking, SL; O'Donnell, C				Huntjens, Byki; Charman, W. Neil; Workman, Helena; Hosking, Sarah L.; O'Donnell, Clare			Short-Term Stability in Refractive Status Despite Large Fluctuations in Glucose Levels in Diabetes Mellitus Type 1 and 2	PLOS ONE			English	Article							POLYOL PATHWAY; GLYCEMIC CONTROL; REPEATABILITY; THICKNESS; HYPERGLYCEMIA; SOMATOSTATIN; HYPEROPIA; AGREEMENT; ONSET; SHAPE	Purpose: This work investigates how short-term changes in blood glucose concentration affect the refractive components of the diabetic eye in patients with long-term Type 1 and Type 2 diabetes. Methods: Blood glucose concentration, refractive error components (mean spherical equivalent MSE, J0, J45), central corneal thickness (CCT), anterior chamber depth (ACD), crystalline lens thickness (LT), axial length (AL) and ocular aberrations were monitored at two-hourly intervals over a 12-hour period in: 20 T1DM patients (mean age +/- SD) 38 +/- 14 years, baseline HbA1c 8.6 +/- 1.9%; 21 T2DM patients (mean age +/- SD) 56 +/- 11 years, HbA1c 7.5 +/- 1.8%; and in 20 control subjects (mean age +/- SD) 49 +/- 23 years, HbA1c 5.5 +/- 0.5%. The refractive and biometric results were compared with the corresponding changes in blood glucose concentration. Results: Blood glucose concentration at different times was found to vary significantly within (p<0.0005) and between groups (p<0.0005). However, the refractive error components and ocular aberrations were not found to alter significantly over the day in either the diabetic patients or the control subjects (p>0.05). Minor changes of marginal statistical or optical significance were observed in some biometric parameters. Similarly there were some marginally significant differences between the baseline biometric parameters of well-controlled and poorly-controlled diabetic subjects. Conclusion: This work suggests that normal, short-term fluctuations (of up to about 6 mM/l on a timescale of a few hours) in the blood glucose levels of diabetics are not usually associated with acute changes in refractive error or ocular wavefront aberrations. It is therefore possible that factors other than refractive error fluctuations are sometimes responsible for the transient visual problems often reported by diabetic patients.	[Charman, W. Neil; O'Donnell, Clare] Univ Manchester, Fac Life Sci, London WC2N 6EZ, England; [Huntjens, Byki; Hosking, Sarah L.] City Univ London, Div Optometry & Visual Sci, London EC1V 0HB, England; [Workman, Helena; O'Donnell, Clare] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England; [Hosking, Sarah L.] Univ Melbourne, Dept Ophthalmol, Melbourne, Vic, Australia; [O'Donnell, Clare] Optegra Eye Sci, Manchester, Lancs, England	University of Manchester; City University London; Aston University; University of Melbourne	O'Donnell, C (corresponding author), Univ Manchester, Fac Life Sci, 8 John Adam St, London WC2N 6EZ, England.	clare.odonnell@optegra.com		Huntjens, Byki/0000-0002-4864-0723	Lein Applied Diagnostics, United Kingdom; Lein Applied Diagnostics	Lein Applied Diagnostics, United Kingdom; Lein Applied Diagnostics	This work was supported by a PhD Research Scholarship from Lein Applied Diagnostics, United Kingdom (http://www.lein-ad.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr Byki Huntjens received funding for her PhD studies from Lein Applied Diagnostics. The data presented here were collected during her PhD studentship, hence the acknowledgement. However, this does not affect the authors' adherence to the PLOS ONE policies on sharing data and materials. We declare there are no competing interests in this regard.	Agardh E, 2011, ACTA OPHTHALMOL, V89, P107, DOI 10.1111/j.1755-3768.2009.01664.x; [Anonymous], 1991, OPHTHALMOLOGY, V98, P786; Bennett R. R, 1998, CLIN VISUAL OPTICS; Bourne W M, 1998, Trans Am Ophthalmol Soc, V96, P229; BOURNE WM, 1998, T AM OPHTHAL SOC, V96, P239; Chan B, 2006, CLIN EXP OPTOM, V89, P160, DOI 10.1111/j.1444-0938.2006.00029.x; Chung SSM, 2003, J AM SOC NEPHROL, V14, pS233, DOI 10.1097/01.ASN.0000077408.15865.06; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035; du Toit R, 2003, CORNEA, V22, P205, DOI 10.1097/00003226-200304000-00004; Elliott M, 1997, OPTOMETRY VISION SCI, V74, P434, DOI 10.1097/00006324-199706000-00028; EVA PR, 1982, BRIT J OPHTHALMOL, V66, P500, DOI 10.1136/bjo.66.8.500; FLEDELIUS HC, 1987, ACTA OPHTHALMOL, V65, P53; Furushima M, 1999, JPN J OPHTHALMOL, V43, P398, DOI 10.1016/S0021-5155(99)00098-2; Giusti C, 2003, SWISS MED WKLY, V133, P200; GONZALEZ RG, 1984, DIABETES, V33, P196, DOI 10.2337/diabetes.33.2.196; GWINUP G, 1976, DIABETES, V25, P29, DOI 10.2337/diabetes.25.1.29; Harper CL, 1996, BRIT J OPHTHALMOL, V80, P1068, DOI 10.1136/bjo.80.12.1068; Kato S, 2001, AM J OPHTHALMOL, V131, P301, DOI 10.1016/S0002-9394(00)00804-7; Kubo E, 2004, BIOCHEM BIOPH RES CO, V314, P1050, DOI 10.1016/j.bbrc.2004.01.002; Lane JT, 2001, AM J OPHTHALMOL, V132, P321, DOI 10.1016/S0002-9394(01)01048-0; LARSSON L, 1995, AM J OPHTHALMOL, V120, P362, DOI 10.1016/S0002-9394(14)72166-X; Lee JS, 2006, EYE, V20, P315, DOI 10.1038/sj.eye.6701868; MANDELL RB, 1965, NATURE, V208, P292, DOI 10.1038/208292a0; McNamara NA, 1998, INVEST OPHTH VIS SCI, V39, P3; National Toxicology Program, 2010, Natl Toxicol Program Tech Rep Ser, P1; O'Donnell C, 2005, CORNEA, V24, P920, DOI 10.1097/01.ico.0000157422.01146.e9; Okamoto F, 2000, BRIT J OPHTHALMOL, V84, P1097, DOI 10.1136/bjo.84.10.1097; Olansky Leann, 2004, MedGenMed, V6, P14; PATERSON CA, 1972, DOC OPHTHALMOL, V31, P1; Pierro L, 1996, ACTA OPHTHALMOL SCAN, V74, P539; PLANTEN JT, 1979, DOC OPHTHALMOL, V46, P237, DOI 10.1007/BF00142613; Ramana KV, 2003, FASEB J, V17, P417, DOI 10.1096/fj.02-0722com; Rubin A, 2004, S AFR OPTOM, V63, P65; SAITO Y, 1993, BRIT J OPHTHALMOL, V77, P145, DOI 10.1136/bjo.77.3.145; Sonmez B, 2005, CORNEA, V24, P531, DOI 10.1097/01.ico.0000151545.00489.12; Steffes P G, 1999, Diabetes Technol Ther, V1, P129, DOI 10.1089/152091599317332; Stone RA, 2004, INVEST OPHTH VIS SCI, V45, P63, DOI 10.1167/iovs.03-0294; Taylor AW, 2003, INVEST OPHTH VIS SCI, V44, P2644, DOI 10.1167/iovs.02-1216; Thibos LN, 1997, OPTOMETRY VISION SCI, V74, P367, DOI 10.1097/00006324-199706000-00019; WALDHAUSL W, 1977, J CLIN ENDOCR METAB, V44, P876, DOI 10.1210/jcem-44-5-876; WESTON BC, 1995, INVEST OPHTH VIS SCI, V36, P586; Wiemer NGM, 2008, OPHTHALMOLOGY, V115, P1679, DOI 10.1016/j.ophtha.2008.03.019; Wiemer NGM, 2008, GRAEF ARCH CLIN EXP, V246, P993, DOI 10.1007/s00417-008-0810-y; Wiemer NGM, 2007, CORNEA, V26, P1165, DOI 10.1097/ICO.0b013e31814fa82f; Wiemer NGM, 2009, ACTA OPHTHALMOL, V87, P176, DOI 10.1111/j.1755-3768.2008.01212.x; ZADNIK K, 1992, INVEST OPHTH VIS SCI, V33, P2325	46	6	6	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52947	10.1371/journal.pone.0052947	http://dx.doi.org/10.1371/journal.pone.0052947			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285232	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000313051500087
J	Zhao, K; Chen, G; Shi, XM; Gao, TT; Li, W; Zhao, Y; Zhang, FQ; Wu, J; Cui, XL; Wang, YF				Zhao, Kai; Chen, Gang; Shi, Xing-ming; Gao, Ting-ting; Li, Wei; Zhao, Yan; Zhang, Feng-qiang; Wu, Jin; Cui, Xianlan; Wang, Yun-feng			Preparation and Efficacy of a Live Newcastle Disease Virus Vaccine Encapsulated in Chitosan Nanoparticles	PLOS ONE			English	Article							INTRANASAL VACCINATION; DRUG-DELIVERY; IN-VITRO; PROTECTIVE IMMUNITY; NASAL DELIVERY; CHICKENS; DNA; MICROSPHERES; ANTIGEN; PROTEIN	Background: Newcastle disease (ND) is a highly contagious viral disease of poultry caused by pathogenic strains of the Newcastle disease virus (NDV). Live NDV vaccines are administered by drinking water, eyedrops or coarse aerosol spray. To further enhance mucosal immune responses, chitosan nanoparticles were developed for the mucosal delivery of a live NDV vaccine. Methodology/Principal Findings: A lentogenic live-virus vaccine (strain LaSota) against NDV encapsulated in chitosan nanoparticles were developed using an ionic crosslinking method. Chitosan nanoparticles containing the lentogenic live-virus vaccine against NDV (NDV-CS-NPs) were produced with good morphology, high stability, a mean diameter of 371.1 nm, an encapsulation rate of 77% and a zeta potential of +2.84 mV. The Western blotting analysis showed that NDV structural proteins were detected in NDV-CS-NPs. The virus release assay results of NDV-CS-NPs indicated that NDV was released from NDV-CS-NPs. Chickens immunized orally or intranasally with NDV-CS-NPs were fully protected whereas one out of five chickens immunized with the LaSota live NDV vaccine and three out of five chickens immunized with the inactivated NDV vaccine were dead after challenge with the highly virulent NDV strain F48E9. Conclusions/Significance: NDV-CS-NPs induced better protection of immunized specific pathogen free chickens compared to the live NDV vaccine strain LaSota and the inactivated NDV vaccine. This study lays a foundation for the further development of mucosal vaccines and drugs encapsulated in chitosan nanoparticles.	[Zhao, Kai; Chen, Gang; Gao, Ting-ting; Li, Wei; Zhang, Feng-qiang; Wu, Jin] Heilongjiang Univ, Coll Life Sci, Microbiol Lab, Harbin, Peoples R China; [Zhao, Kai; Shi, Xing-ming; Li, Wei; Zhao, Yan; Wang, Yun-feng] CAAS, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Div Avian Infect Dis, Harbin, Peoples R China	Heilongjiang University; Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS	Zhao, K (corresponding author), Heilongjiang Univ, Coll Life Sci, Microbiol Lab, Harbin, Peoples R China.	zk395@yahoo.com.cn; xianlan.cui@dpipwe.tas.gov.au; yfwang@hvri.ac.cn	Cui, Xianlan/N-1734-2017	Cui, Xianlan/0000-0002-5029-1286; Zhao, Kai/0000-0001-6139-1912	National Natural Science Foundation of China [31072119]; Funds for International Cooperation and Exchange of the National Natural Science Foundation of China [31110103064]; Program for New Century Excellent Talents in Heilongjiang Provincial University [1251-NCET-005]; Key Scientific and Technological Planning Project of Harbin [2009AA6CN125]; Innovation Foundation of Harbin [2010RFQXN091, 2011RFQXN039]; Education Committee Science and Technology Research General Projects of Heilongjiang Province [11541267]; High-level Talents (innovation team) Project of Heilongjiang University [Hdtd2010-17]; Heilongjiang Postdoctoral Foundation [LBH-Q07109]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Funds for International Cooperation and Exchange of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in Heilongjiang Provincial University(Program for New Century Excellent Talents in University (NCET)); Key Scientific and Technological Planning Project of Harbin; Innovation Foundation of Harbin; Education Committee Science and Technology Research General Projects of Heilongjiang Province; High-level Talents (innovation team) Project of Heilongjiang University; Heilongjiang Postdoctoral Foundation	This work was supported in part by National Natural Science Foundation of China (31072119), The Funds for International Cooperation and Exchange of the National Natural Science Foundation of China (31110103064), Program for New Century Excellent Talents in Heilongjiang Provincial University (1251-NCET-005), Key Scientific and Technological Planning Project of Harbin (2009AA6CN125), Innovation Foundation of Harbin (2010RFQXN091 and 2011RFQXN039), Education Committee Science and Technology Research General Projects of Heilongjiang Province (11541267), High-level Talents (innovation team) Project of Heilongjiang University (Hdtd2010-17) and Heilongjiang Postdoctoral Foundation (LBH-Q07109). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksungur P, 2004, J CONTROL RELEASE, V98, P269, DOI 10.1016/j.jconrel.2004.05.002; Alexander DJ, 2008, POULTRY DIS, P75; Amidi M, 2007, VACCINE, V25, P144, DOI 10.1016/j.vaccine.2006.06.086; Amidi M, 2010, ADV DRUG DELIVER REV, V62, P59, DOI 10.1016/j.addr.2009.11.009; Arifin MA, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/586363; Aspden TJ, 1997, J PHARM SCI, V86, P509, DOI 10.1021/js960182o; Boyoglu S, 2009, NANOMED-NANOTECHNOL, V5, P463, DOI 10.1016/j.nano.2009.02.004; Bwala D. G., 2011, International Journal of Poultry Science, V10, P98; [陈英杰 CHEN Yingjie], 2007, [中国药科大学学报, Journal of China Pharmaceutical University], V38, P186; CORIA MF, 1972, APPL MICROBIOL, V23, P281, DOI 10.1128/AEM.23.2.281-284.1972; Davis SS, 2001, ADV DRUG DELIVER REV, V51, P21, DOI 10.1016/S0169-409X(01)00162-4; de Moura MR, 2008, J COLLOID INTERF SCI, V321, P477, DOI 10.1016/j.jcis.2008.02.006; Echeonwu GON, 2008, AFR J MICROBIOL RES, V2, P120; EWERT DL, 1977, INFECT IMMUN, V18, P146, DOI 10.1128/IAI.18.1.146-150.1977; Fan HR, 1999, NAT BIOTECHNOL, V17, P870, DOI 10.1038/12856; Fan M, 2009, CARBOHYD POLYM, V78, P66, DOI 10.1016/j.carbpol.2009.03.031; Gavini E, 2006, INT J PHARMACEUT, V307, P9, DOI 10.1016/j.ijpharm.2005.09.013; GHUMMAN JS, 1976, AVIAN DIS, V20, P18, DOI 10.2307/1589470; Henderson A, 2011, VACCINE, V29, P5304, DOI 10.1016/j.vaccine.2011.05.009; JAYAWARDANE GWL, 1995, VET MICROBIOL, V46, P69, DOI 10.1016/0378-1135(95)00073-J; Jeon WJ, 2008, J VET SCI, V9, P295, DOI 10.4142/jvs.2008.9.3.295; Jin HL, 2004, VACCINE, V22, P2925, DOI 10.1016/j.vaccine.2003.12.026; Kang ML, 2008, J MICROBIOL BIOTECHN, V18, P1179; Kapczynski DR, 2005, VACCINE, V23, P3424, DOI 10.1016/j.vaccine.2005.01.140; Kasturi SP, 2005, BIOMATERIALS, V26, P6375, DOI 10.1016/j.biomaterials.2005.03.043; Kavanagh OV, 2003, VACCINE, V21, P4472, DOI 10.1016/S0264-410X(03)00432-8; Liu HL, 2008, RES VET SCI, V85, P612, DOI 10.1016/j.rvsc.2008.02.013; Liu SW, 1998, CHIN J ANIMAL POULT, V20, P140; Malhotra M, 2011, INT J NANOMED, V6, P485, DOI 10.2147/IJN.S17190; MARINO OC, 1987, AVIAN DIS, V31, P293, DOI 10.2307/1590875; Merz D.C., 1981, VIROLOGY, V28, P208; Mok HJ, 2008, EUR J PHARM BIOPHARM, V68, P105, DOI 10.1016/j.ejpb.2007.04.022; Newman KD, 2002, J BIOMED MATER RES, V60, P480, DOI 10.1002/jbm.10019; Partidos, 2000, Pharm Sci Technol Today, V3, P273, DOI 10.1016/S1461-5347(00)00281-9; Reynolds DL, 2000, AVIAN DIS, V44, P145, DOI 10.2307/1592518; Reynolds DL, 2000, AVIAN DIS, V44, P138, DOI 10.2307/1592517; Rouse JJ, 2007, INT J PHARMACEUT, V339, P112, DOI 10.1016/j.ijpharm.2007.02.026; Ruberti M, 2004, J DRUG TARGET, V12, P195, DOI 10.1080/10611860410001723126; Russell PH, 1997, VET IMMUNOL IMMUNOP, V60, P171, DOI 10.1016/S0165-2427(97)00094-9; RUSSELL PH, 1995, VACCINE, V13, P61, DOI 10.1016/0264-410X(95)80012-3; Senel S, 2000, BIOMATERIALS, V21, P2067, DOI 10.1016/S0142-9612(00)00134-4; Sonia TA, 2011, CARBOHYD POLYM, V84, P103, DOI 10.1016/j.carbpol.2010.10.070; SPRADBROW PB, 1992, NEWCASTLE DIS VILLAG; Takada A, 1996, VET MICROBIOL, V50, P17, DOI 10.1016/0378-1135(96)00004-1; Tseng LP, 2009, J BIOMED MATER RES B, V91B, P621, DOI 10.1002/jbm.b.31437; Turker S, 2004, PHARM WORLD SCI, V26, P137, DOI 10.1023/B:PHAR.0000026823.82950.ff; Ugwoke MI, 2005, ADV DRUG DELIVER REV, V57, P1640, DOI 10.1016/j.addr.2005.07.009; van Boven M, 2008, AVIAN PATHOL, V37, P1, DOI 10.1080/03079450701772391; Varshosaz J, 2004, J MICROENCAPSUL, V21, P761, DOI 10.1080/02652040400015403; Wang JJ, 2011, INT J NANOMED, V6, P765, DOI 10.2147/IJN.S17296; World Organisation for Animal Health (OIE), 2012, TERR MAN 2012; Xu JH, 2011, CLIN VACCINE IMMUNOL, V18, P75, DOI 10.1128/CVI.00263-10; Xu YM, 2003, BIOMATERIALS, V24, P5015, DOI 10.1016/S0142-9612(03)00408-3; Yan ZG, 2011, PAK VET J, V31, P280; Yu W, 2012, J NANOMATER, V2012, DOI 10.1155/2012/435873; Zhao FJ, 2012, CAN J MICROBIOL, V58, P117, DOI [10.1139/W11-115, 10.1139/w11-115]; Zhao K, 2011, VACCINE, V29, P8549, DOI 10.1016/j.vaccine.2011.09.029; Zoth SC, 2008, BRAZ J MED BIOL RES, V41, P318, DOI 10.1590/S0100-879X2008000400010	58	68	72	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53314	10.1371/journal.pone.0053314	http://dx.doi.org/10.1371/journal.pone.0053314			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285276	Green Submitted, Green Published, gold			2022-12-27	WOS:000313051500130
J	Binder, NK; Hannan, NJ; Gardner, DK				Binder, Natalie K.; Hannan, Natalie J.; Gardner, David K.			Paternal Diet-Induced Obesity Retards Early Mouse Embryo Development, Mitochondrial Activity and Pregnancy Health	PLOS ONE			English	Article							BODY-MASS INDEX; SEMEN QUALITY; REPRODUCTIVE HORMONES; PYRUVATE; PLACENTA; FAT; DYSFUNCTION; ASSOCIATION; BLASTOCYSTS; OOCYTES	Worldwide, 48% of adult males are overweight or obese. An association between infertility and excessive body weight is now accepted, although focus remains primarily on females. It has been shown that parental obesity results in compromised embryo development, disproportionate changes in embryo metabolism and reduced blastocyst cell number. The aim of this study was to determine whether paternal obesity has negative effects on the resultant embryo. Specifically, using in vitro fertilisation (IVF), we wanted to isolate the functional effects of obesity on sperm by examining the subsequent embryo both pre- and post-implantation. Epididymal sperm was collected from age matched normal and obese C57BL/6 mice and cryopreserved for subsequent IVF with oocytes collected from Swiss females (normal diet/weight). Obesity was induced in male mice by feeding a high fat diet of 22% fat for 10 weeks. Resultant embryos were cultured individually and development monitored using time-lapse microscopy. Paternal obesity resulted in a significant delay in preimplantation embryo development as early as syngamy (P<0.05). Metabolic parameters were measured across key developmental stages, demonstrating significant reduction in mitochondrial membrane potential (P<0.01). Blastocysts were stained to determine trophectoderm (TE) and inner cell mass (ICM) cell numbers, revealing significant differences in the ratio of cell allocation to TE and ICM lineages (P<0.01). Functional studies examining blastocyst attachment, growth and implantation demonstrated that blastocysts derived from sperm of obese males displayed significantly reduced outgrowth on fibronectin in vitro (P<0.05) and retarded fetal development in vivo following embryo transfer (P<0.05). Taken together, these data clearly demonstrate that paternal obesity has significant negative effects on the embryo at a variety of key early developmental stages, resulting in delayed development, reduced placental size and smaller offspring.	[Binder, Natalie K.; Hannan, Natalie J.; Gardner, David K.] Univ Melbourne, Dept Zool, Parkville, Vic 3052, Australia	University of Melbourne	Gardner, DK (corresponding author), Univ Melbourne, Dept Zool, Parkville, Vic 3052, Australia.	david.gardner@unimelb.edu.au		Hannan, Natalie/0000-0001-8446-2250; Binder, Natalie K/0000-0002-8943-2269; Gardner, David/0000-0003-3138-8274	Australian Postgraduate Award; NHMRC [628927]	Australian Postgraduate Award(Australian Government); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	NKB was supported by an Australian Postgraduate Award, and NJH was supported by NHMRC post-doctoral training fellowship # 628927. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggerholm AS, 2008, FERTIL STERIL, V90, P619, DOI 10.1016/j.fertnstert.2007.07.1292; ANDRAE U, 1985, TOXICOL LETT, V28, P93, DOI 10.1016/0378-4274(85)90015-3; ANSELL JD, 1975, J EMBRYOL EXP MORPH, V33, P177; Attaman JA, 2012, HUM REPROD, V27, P1466, DOI 10.1093/humrep/des065; Bakos HW, 2011, INT J ANDROL, V34, P402, DOI 10.1111/j.1365-2605.2010.01092.x; Bakos HW, 2011, FERTIL STERIL, V95, P1700, DOI 10.1016/j.fertnstert.2010.11.044; Barker DJP, 2004, J AM COLL NUTR, V23, p588S, DOI 10.1080/07315724.2004.10719428; Bassenge E, 2000, AM J PHYSIOL-HEART C, V279, pH2431, DOI 10.1152/ajpheart.2000.279.5.H2431; Binder NK, 2012, REPROD FERT DEVELOP, V24, P804, DOI 10.1071/RD11256; Chavarro JE, 2010, FERTIL STERIL, V93, P2222, DOI 10.1016/j.fertnstert.2009.01.100; Coan PM, 2005, PLACENTA, V26, pS10, DOI 10.1016/j.placenta.2004.12.009; Coupe B, 2010, ENDOCRINOLOGY, V151, P702, DOI 10.1210/en.2009-0893; Delahaye F, 2008, ENDOCRINOLOGY, V149, P470, DOI 10.1210/en.2007-1263; Dufourc Erick J, 2008, J Chem Biol, V1, P63, DOI 10.1007/s12154-008-0010-6; Fariello RM, 2012, BJU INT, V110, P863, DOI 10.1111/j.1464-410X.2011.10813.x; Fejes I, 2005, ANDROLOGIA, V37, P155, DOI 10.1111/j.1439-0272.2005.00671.x; GARDNER DK, 1990, J REPROD FERTIL, V88, P361, DOI 10.1530/jrf.0.0880361; Gardner DK, 2004, LAB GUIDE MAMMALIAN, P41; Giraud MN, 2000, HUM REPROD, V15, P2160, DOI 10.1093/humrep/15.10.2160; Godfrey KM, 2002, PLACENTA, V23, pS20, DOI 10.1053/plac.2002.0773; Hafner E, 2003, PLACENTA, V24, P336, DOI 10.1053/plac.2002.0918; Hammoud AO, 2012, ASIAN J ANDROL, V14, P77, DOI 10.1038/aja.2011.64; Hammoud AO, 2008, FERTIL STERIL, V90, P2222, DOI 10.1016/j.fertnstert.2007.10.011; Hannan NJ, 2011, ENDOCRINOLOGY, V152, P4948, DOI 10.1210/en.2011-1248; HARDY K, 1989, DEVELOPMENT, V107, P597; Herz H, 1997, FREE RADICAL RES, V26, P19, DOI 10.3109/10715769709097781; International Federation of Red Cross and Red Crescent Societies, 2011, WORLD DIS REP 2011 F; JANSSON T, 1986, BIOL NEONATE, V49, P172; Jansson T, 2007, CLIN SCI, V113, P1, DOI 10.1042/CS20060339; Jensen TK, 2004, FERTIL STERIL, V82, P863, DOI 10.1016/j.fertnstert.2004.03.056; Kort HI, 2006, J ANDROL, V27, P450, DOI 10.2164/jandrol.05124; LANE M, 1994, J REPROD FERTIL, V102, P305, DOI 10.1530/jrf.0.1020305; Lane M, 1996, HUM REPROD, V11, P1975; Lane M, 2004, LAB GUIDE MAMMALIAN, P24; Leahey TM, 2011, OBESITY, V19, P1157, DOI 10.1038/oby.2010.301; LEESE HJ, 1984, J REPROD FERTIL, V72, P9, DOI 10.1530/jrf.0.0720009; Lyle R, 1997, J ENDOCRINOL, V155, P1, DOI 10.1677/joe.0.1550001; Magnusdottir EV, 2005, HUM REPROD, V20, P208, DOI 10.1093/humrep/deh569; Metzger BE, 2010, BJOG-INT J OBSTET GY, V117, P575, DOI 10.1111/j.1471-0528.2009.02486.x; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Mitchell M, 2011, FERTIL STERIL, V95, P1349, DOI 10.1016/j.fertnstert.2010.09.038; Mitchell M, 2009, BIOL REPROD, V80, P622, DOI 10.1095/biolreprod.108.072595; National Center forHealth Statistics, 2011, HLTH US 2010 SPEC FE; O'Fallon J. V., 1995, Theriogenology, V43, P288, DOI 10.1016/0093-691X(95)92442-C; ono t, 2005, WHO GLOBAL COMPARABL; Ostermeier GC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002792; Palmer NO, 2012, AM J PHYSIOL-ENDOC M, V302, pE768, DOI 10.1152/ajpendo.00401.2011; Pauli EM, 2008, FERTIL STERIL, V90, P346, DOI 10.1016/j.fertnstert.2007.06.046; PIKO L, 1987, DEV BIOL, V123, P364, DOI 10.1016/0012-1606(87)90395-2; Qin DD, 2007, ASIAN J ANDROL, V9, P827, DOI 10.1111/j.1745-7262.2007.00268.x; Roland MCP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039324; Rulicke T, 2006, REPROD FERT DEVELOP, V18, P885, DOI 10.1071/RD06054; Lancellotti TES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013457; Thouas GA, 2004, BIOL REPROD, V71, P1936, DOI 10.1095/biolreprod.104.033589; Van Blerkom J, 2002, HUM REPROD, V17, P393, DOI 10.1093/humrep/17.2.393; WAHLSTEN D, 1977, J EMBRYOL EXP MORPH, V42, P79; Wakefield SL, 2011, BIOL REPROD, V84, P572, DOI 10.1095/biolreprod.110.087262; Wale PL, 2010, REPROD BIOMED ONLINE, V21, P402, DOI 10.1016/j.rbmo.2010.04.028	58	96	98	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52304	10.1371/journal.pone.0052304	http://dx.doi.org/10.1371/journal.pone.0052304			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300638	Green Published, Green Submitted, gold			2022-12-27	WOS:000312829100039
J	Durkin, K; Conti-Ramsden, G				Durkin, Kevin; Conti-Ramsden, Gina			Frequency of Educational Computer Use as a Longitudinal Predictor of Educational Outcome in Young People with Specific Language Impairment	PLOS ONE			English	Article							SELF-EFFICACY; FOLLOW-UP; ACADEMIC-PERFORMANCE; VIDEO GAMES; SCHOOL; HOME; INTERNET; ADOLESCENTS; STUDENTS; CHILDRENS	Computer use draws on linguistic abilities. Using this medium thus presents challenges for young people with Specific Language Impairment (SLI) and raises questions of whether computer-based tasks are appropriate for them. We consider theoretical arguments predicting impaired performance and negative outcomes relative to peers without SLI versus the possibility of positive gains. We examine the relationship between frequency of computer use (for leisure and educational purposes) and educational achievement; in particular examination performance at the end of compulsory education and level of educational progress two years later. Participants were 49 young people with SLI and 56 typically developing (TD) young people. At around age 17, the two groups did not differ in frequency of educational computer use or leisure computer use. There were no associations between computer use and educational outcomes in the TD group. In the SLI group, after PIQ was controlled for, educational computer use at around 17 years of age contributed substantially to the prediction of educational progress at 19 years. The findings suggest that educational uses of computers are conducive to educational progress in young people with SLI.	[Durkin, Kevin] Univ Strathclyde, Sch Psychol Sci & Hlth, Glasgow, Lanark, Scotland; [Conti-Ramsden, Gina] Univ Manchester, Sch Psychol Sci, Manchester, Lancs, England	University of Strathclyde; University of Manchester	Durkin, K (corresponding author), Univ Strathclyde, Sch Psychol Sci & Hlth, Glasgow, Lanark, Scotland.	kevin.durkin@strath.ac.uk			Economic and Social Research Council [RES-062-23-2745]; Nuffield Foundation [EDU/8366]; Economic and Social Research Council [ES/I00064X/1] Funding Source: researchfish; ESRC [ES/I00064X/1] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Nuffield Foundation; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The sources of funding that have supported the work are the Economic and Social Research Council (http://www.esrc.ac.uk) grant no. RES-062-23-2745 and the Nuffield Foundation (http://www.nuffieldfoundation.org) grant no. EDU/8366. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera M. D., 2003, COMPUTERS ENTERTAINM, V1, P10, DOI DOI 10.1145/950566.950583; Aslanidou S, 2008, COMPUT EDUC, V51, P1375, DOI 10.1016/j.compedu.2007.12.003; Bishop DVM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015112; Bishop DVM, 2004, PSYCHOL BULL, V130, P858, DOI 10.1037/0033-2909.130.6.858; BISHOP DVM, 1997, UNCOMMON UNDERSTANDI; Botting N, 2005, J CHILD PSYCHOL PSYC, V46, P317, DOI 10.1111/j.1469-7610.2004.00355.x; Brinton B., 2002, BLACKWELL HDB CHILDH, P588; Conti-Ramsden G, 1999, INT J LANG COMM DIS, V34, P359; Conti-Ramsden G., 2000, SPEECH LANGUAGE IMPA, P211; Conti-Ramsden G, 2012, J SPEECH LANG HEAR R, V55, P1716, DOI 10.1044/1092-4388(2012/10-0182); Conti-Ramsden G, 2011, CHILD PSYCHOLOGY AND PSYCHIATRY: FRAMEWORKS FOR PRACTICE, 2ND EDITION, P180; Conti-Ramsden G, 2010, COMPUT EDUC, V54, P136, DOI 10.1016/j.compedu.2009.07.015; Conti-Ramsden G, 2009, INT J LANG COMM DIS, V44, P15, DOI 10.1080/13682820801921601; ContiRamsden G, 1997, J SPEECH LANG HEAR R, V40, P765, DOI 10.1044/jslhr.4004.765; Dockrell J., 2007, RAISING ACHIEVEMENTS; Durkin K, 2011, J COMPUT ASSIST LEAR, V27, P49, DOI 10.1111/j.1365-2729.2010.00397.x; Durkin K, 2002, J APPL DEV PSYCHOL, V23, P373, DOI 10.1016/S0193-3973(02)00124-7; Durkin K, 2007, CHILD DEV, V78, P1441, DOI 10.1111/j.1467-8624.2007.01076.x; Durkin K, 2010, COMPUT HUM BEHAV, V26, P176, DOI 10.1016/j.chb.2009.10.007; Durkin K, 2009, INT J LANG COMM DIS, V44, P36, DOI 10.1080/13682820801921510; Durkin K, 2009, BRIT J DEV PSYCHOL, V27, P197, DOI 10.1348/026151008X383553; Durndell A, 2002, COMPUT HUM BEHAV, V18, P521, DOI 10.1016/S0747-5632(02)00006-7; Ferguson CJ, 2010, REV GEN PSYCHOL, V14, P68, DOI 10.1037/a0018941; Hetzroni OE, 2004, J LEARN DISABIL-US, V37, P143, DOI 10.1177/00222194040370020501; Hofferth SL, 2012, J RES ADOLESCENCE, V22, P215, DOI 10.1111/j.1532-7795.2011.00770.x; Igbaria M, 1995, OMEGA-INT J MANAGE S, V23, P587, DOI 10.1016/0305-0483(95)00035-6; Jackson LA, 2006, DEV PSYCHOL, V42, P429, DOI 10.1037/0012-1649.42.3.429; Johnson CJ, 2010, AM J SPEECH-LANG PAT, V19, P51, DOI 10.1044/1058-0360(2009/08-0083); Kay RH, 2008, COMPUT EDUC, V50, P1269, DOI 10.1016/j.compedu.2006.12.002; Keates A, 2002, DYSLEXIA INFORM COMM; Keates Simeon, 2007, Universal Access in the Information Society, V5, P329, DOI 10.1007/s10209-006-0058-4; Kemp N, 2011, J COMPUT ASSIST LEAR, V27, P18, DOI 10.1111/j.1365-2729.2010.00400.x; Kent N, 2004, J COMPUT ASSIST LEAR, V20, P440, DOI 10.1111/j.1365-2729.2004.00102.x; Kirkorian H. L., 2009, HDB CHILDREN MEDIA D, P188, DOI DOI 10.1002/9781444302752.CH9; Kuhlemeier H, 2007, COMPUT EDUC, V49, P460, DOI 10.1016/j.compedu.2005.10.004; Leitao S, 2004, INT J LANG COMM DIS, V39, P245, DOI 10.1080/13682820310001619478; Leonard L.B., 1998, CHILDREN SPECIFIC LA; Macgill A.R., 2008, WRITING TECHNOLOGY T; Miller CA, 2006, J SPEECH LANG HEAR R, V49, P712, DOI 10.1044/1092-4388(2006/052); Naevdal F, 2007, COMPUT EDUC, V49, P1112, DOI 10.1016/j.compedu.2006.01.003; Nippold MA, 2009, AM J SPEECH-LANG PAT, V18, P241, DOI 10.1044/1058-0360(2008/08-0022); Ohannessian CM, 2009, J CHILD FAM STUD, V18, P582, DOI 10.1007/s10826-009-9261-2; Olson CK, 2010, REV GEN PSYCHOL, V14, P180, DOI 10.1037/a0018984; Plester B, 2009, BRIT J DEV PSYCHOL, V27, P145, DOI 10.1348/026151008X320507; Roschelle JM, 2000, FUTURE CHILD, V10, P76, DOI 10.2307/1602690; Saade RG, 2009, J INF TECHNOL EDUC-R, V8, P177; Schmidt ME, 2008, FUTURE CHILD, V18, P63; Selwyn N, 2000, COMPUT EDUC, V34, P93, DOI 10.1016/S0360-1315(00)00006-3; Selwyn N, 1998, COMPUT EDUC, V31, P211, DOI 10.1016/S0360-1315(98)00033-5; Semel E., 2003, CLIN EVALUATION LANG, V4th Edn; Simkin Z., 2006, CHILD LANG TEACH THE, V22, P315, DOI DOI 10.1191/0265659006CT310XX; Snowling MJ, 2001, INT J LANG COMM DIS, V36, P173, DOI 10.1080/13682820010019892; Spence I, 2010, REV GEN PSYCHOL, V14, P92, DOI 10.1037/a0019491; St Clair MC, 2010, BRIT J DEV PSYCHOL, V28, P109, DOI 10.1348/026151009X480158; Stothard SE, 1998, J SPEECH LANG HEAR R, V41, P407, DOI 10.1044/jslhr.4102.407; Subrahmanyam K, 2001, J APPL DEV PSYCHOL, V22, P7, DOI 10.1016/S0193-3973(00)00063-0; Tomblin JB, 1997, J SPEECH LANG HEAR R, V40, P1245, DOI 10.1044/jslhr.4006.1245; Tsai MJ, 2003, INNOV EDUC TEACH INT, V40, P43, DOI 10.1080/1355800032000038822; Turow J., 1999, ANN PUBL POL CTR C F; Valentine G, 2005, 672 BMRB U LEEDS; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Whitehouse AJO, 2009, INT J LANG COMM DIS, V44, P489, DOI 10.1080/13682820802708080; Wittwer J, 2008, COMPUT EDUC, V50, P1558, DOI 10.1016/j.compedu.2007.03.001; Zhu YQ, 2011, COMPUT EDUC, V57, P2476, DOI 10.1016/j.compedu.2011.07.006; ZIMMERMAN BJ, 1992, AM EDUC RES J, V29, P663, DOI 10.3102/00028312029003663	65	4	4	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52194	10.1371/journal.pone.0052194	http://dx.doi.org/10.1371/journal.pone.0052194			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	061EA	23300610	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000312829100027
J	Gorostidi, A; Bergareche, A; Ruiz-Martinez, J; Marti-Masso, JF; Cruz, M; Varghese, S; Qureshi, MM; Alzahmi, F; Al-Hayani, A; de Munain, AL; El-Agnaf, OMA				Gorostidi, Ana; Bergareche, Alberto; Ruiz-Martinez, Javier; Marti-Masso, Jose F.; Cruz, Maria; Varghese, Shiji; Qureshi, Mohamed M.; Alzahmi, Fatimah; Al-Hayani, Abdulmonem; Lopez de Munain, Adolfo; El-Agnaf, Omar M. A.			alpha-Synuclein Levels in Blood Plasma from LRRK2 Mutation Carriers	PLOS ONE			English	Article							AUTOSOMAL-DOMINANT PARKINSONISM; CEREBROSPINAL-FLUID; SOLUBLE OLIGOMERS; SPANISH PATIENTS; ELEVATED LEVELS; DISEASE; BIOMARKER; G2019S; COMMON; NEUROPATHOLOGY	The diagnosis of Parkinson's disease (PD) remains primarily a clinical issue, based mainly on phenotypic patterns. The identification of biomarkers capable of permitting the preclinical detection of PD is critically needed. alpha-Synuclein is a key protein in PD, with missense and multiplication mutations in the gene encoding alpha-synuclein (SNCA) having been reported in familial cases of PD, and accumulation of the protein identified in Lewy bodies (LBs) and Lewy neurites (LNs) in affected brain regions. With the objective of validating the use of alpha-synuclein as a clinical or progressive biomarker in an accessible tissue, we used an enzyme-linked immunosorbent assay (ELISA) to measure alpha-synuclein levels in the peripheral blood plasma of idiopathic PD and LRRK2 mutation carrier patients and compared our findings with healthy control subjects. Compared to healthy controls, we found a significant decrease in plasma total alpha-synuclein levels in idiopathic PD (iPD) patients (n = 134, p = 0.010). However, the reduction was less significant in patients who were LRRK2 mutation carriers (n = 32, p = 0.133). This lack of significance could be due to the small number of individuals employed in this group. No predictive value of total alpha-synuclein in the diagnosis of PD was found in a receiver operating characteristic (ROC) curve analysis. Although this is a pilot study requiring corroboration on a larger cohort of patients, our results highlight the possible use of plasma alpha-synuclein as a biomarker for PD.	[Varghese, Shiji; Qureshi, Mohamed M.; Alzahmi, Fatimah; El-Agnaf, Omar M. A.] United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Biochem, Al Ain, U Arab Emirates; [Al-Hayani, Abdulmonem] King Abdulaziz Univ, Fac Med, Dept Anat, Jeddah 21413, Saudi Arabia; [Cruz, Maria] Ikerbasque Basque Fdn Sci, Bilbao, Bizkaia, Spain; [Gorostidi, Ana; Bergareche, Alberto; Ruiz-Martinez, Javier; Marti-Masso, Jose F.; Cruz, Maria; Lopez de Munain, Adolfo] Carlos III Hlth Inst, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [Gorostidi, Ana; Bergareche, Alberto; Ruiz-Martinez, Javier; Marti-Masso, Jose F.; Cruz, Maria; Lopez de Munain, Adolfo] Hosp Donostia, Dept Neurol, Movement Disorders Unit, Donostia San Sebastian, Gipuzkoa, Spain; [Gorostidi, Ana; Bergareche, Alberto; Ruiz-Martinez, Javier; Marti-Masso, Jose F.; Cruz, Maria; Lopez de Munain, Adolfo] Biodonostia Res Inst, Neurosci Area, Donostia San Sebastian, Gipuzkoa, Spain	United Arab Emirates University; King Abdulaziz University; Basque Foundation for Science; CIBERNED; University Hospital Donostia	El-Agnaf, OMA (corresponding author), United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Biochem, Al Ain, U Arab Emirates.	o.elagnaf@uaeu.ac.ae	Rodriguez-Oroz, Maria Cruz/D-1490-2018; DE MUNAIN, ADOLFO LOPEZ/AAB-1824-2020	Rodriguez-Oroz, Maria Cruz/0000-0001-5962-772X; Bergareche, Alberto/0000-0002-3904-7821; /0000-0002-9509-4032; Gorostidi, Ana/0000-0002-5494-4512	Michael J. Fox Foundation for Parkinson's Research (NY)	Michael J. Fox Foundation for Parkinson's Research (NY)	This work was supported by a grant from Michael J. Fox Foundation for Parkinson's Research (NY) to O.M.E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer DAM, 2006, EXP BRAIN RES, V173, P223, DOI 10.1007/s00221-006-0539-y; Barbour R, 2008, NEURODEGENER DIS, V5, P55, DOI 10.1159/000112832; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Borghi R, 2000, NEUROSCI LETT, V287, P65, DOI 10.1016/S0304-3940(00)01153-8; Duran R, 2010, MOVEMENT DISORD, V25, P489, DOI 10.1002/mds.22928; El-Agnaf OMA, 2003, FASEB J, V17, P1945, DOI 10.1096/fj.03-0098fje; El-Agnaf OMA, 2003, LANCET NEUROL, V2, P461, DOI 10.1016/S1474-4422(03)00481-2; El-Agnaf OMA, 1998, FEBS LETT, V440, P71, DOI 10.1016/S0014-5793(98)01418-5; El-Agnaf OMA, 2006, FASEB J, V20, P419, DOI 10.1096/fj.03-1449com; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; Foulds PG, 2011, FASEB J, V25, P4127, DOI 10.1096/fj.10-179192; Funayama M, 2002, ANN NEUROL, V51, P296, DOI 10.1002/ana.10113; Gaig C, 2006, ARCH NEUROL-CHICAGO, V63, P377, DOI 10.1001/archneur.63.3.377; Gaig C, 2007, J NEUROL NEUROSUR PS, V78, P626, DOI 10.1136/jnnp.2006.107904; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; Giasson BI, 2006, ANN NEUROL, V59, P315, DOI 10.1002/ana.20791; Gilks WP, 2005, LANCET, V365, P415, DOI 10.1016/S0140-6736(05)17830-1; Giordana MT, 2007, MOVEMENT DISORD, V22, P275, DOI 10.1002/mds.21281; Goldwurm S, 2005, J MED GENET, V42, DOI 10.1136/jmg.2005.035568; Gonzalez-Fernandez MC, 2007, PARKINSONISM RELAT D, V13, P509, DOI 10.1016/j.parkreldis.2007.04.003; Gorostidi A, 2009, NEUROGENETICS, V10, P157, DOI 10.1007/s10048-008-0162-0; Healy DG, 2008, LANCET NEUROL, V7, P583, DOI 10.1016/S1474-4422(08)70117-0; Hong Z, 2010, BRAIN, V133, P713, DOI 10.1093/brain/awq008; Infante J, 2006, NEUROSCI LETT, V395, P224, DOI 10.1016/j.neulet.2005.10.083; Khan NL, 2005, BRAIN, V128, P2786, DOI 10.1093/brain/awh667; Lee PH, 2006, J NEURAL TRANSM, V113, P1435, DOI 10.1007/s00702-005-0427-9; Marti-Masso JF, 2009, MOVEMENT DISORD, V24, P1998, DOI 10.1002/mds.22677; Mata IF, 2010, ARCH NEUROL-CHICAGO, V67, P1350, DOI 10.1001/archneurol.2010.279; Mehta PD, 2000, ARCH NEUROL-CHICAGO, V57, P100, DOI 10.1001/archneur.57.1.100; Mollenhauer B, 2010, BIOMARK MED, V4, P683, DOI 10.2217/BMM.10.90; Paleologou KE, 2009, BRAIN, V132, P1093, DOI 10.1093/brain/awn349; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Ross OA, 2006, ANN NEUROL, V59, P388, DOI 10.1002/ana.20731; Ross OA, 2011, LANCET NEUROL, V10, P898, DOI 10.1016/S1474-4422(11)70175-2; Schlossmacher MG, 2010, BIOMARK MED, V4, P647, DOI 10.2217/BMM.10.93; Sharon R, 2003, NEURON, V37, P583, DOI 10.1016/S0896-6273(03)00024-2; Sierks MR, 2011, INTEGR BIOL-UK, V3, P1188, DOI 10.1039/c1ib00018g; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tinsley RB, 2010, J NEUROSCI RES, V88, P2693, DOI 10.1002/jnr.22417; Tofaris GK, 2005, MOVEMENT DISORD, V20, pS37, DOI 10.1002/mds.20538; Tokuda T, 2010, NEUROLOGY, V75, P1766, DOI 10.1212/WNL.0b013e3181fd613b; Tokuda T, 2006, BIOCHEM BIOPH RES CO, V349, P162, DOI 10.1016/j.bbrc.2006.08.024; Wang W, 2011, P NATL ACAD SCI USA, V108, P17797, DOI 10.1073/pnas.1113260108; Wszolek Z K, 1997, Parkinsonism Relat Disord, V3, P125, DOI 10.1016/S1353-8020(97)00013-8; Wszolek ZK, 2004, NEUROLOGY, V62, P1619, DOI 10.1212/01.WNL.0000125015.06989.DB; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	47	31	33	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52312	10.1371/journal.pone.0052312	http://dx.doi.org/10.1371/journal.pone.0052312			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300640	Green Published, gold, Green Submitted			2022-12-27	WOS:000312829100040
J	Bender, TJ; Wise, ME; Utah, O; Moorman, AC; Sharapov, U; Drobeniuc, J; Khudyakov, Y; Fricchione, M; White-Comstock, MB; Thompson, ND; Patel, PR				Bender, Thomas John; Wise, Matthew E.; Utah, Okey; Moorman, Anne C.; Sharapov, Umid; Drobeniuc, Jan; Khudyakov, Yury; Fricchione, Marielle; White-Comstock, Mary Beth; Thompson, Nicola D.; Patel, Priti R.			Outbreak of Hepatitis B Virus Infections Associated with Assisted Monitoring of Blood Glucose in an Assisted Living Facility-Virginia, 2010	PLOS ONE			English	Article							VIRAL-HEPATITIS; UNITED-STATES; TRANSMISSION; RECOMMENDATIONS	Introduction: In January 2010, the Virginia Department of Health received reports of 2 hepatitis B virus (HBV) infections (1 acute, 1 chronic) among residents of a single assisted living facility (ALF). Both infected residents had diabetes and received assisted monitoring of blood glucose (AMBG) at the facility. An investigation was initiated in response. Objective: To determine the extent and mechanism of HBV transmission among ALF residents. Design: Retrospective cohort study. Setting: An ALF that primarily housed residents with neuropsychiatric disorders in 2 adjacent buildings in Virginia. Participants: Residents of the facility as of March 2010. Measurements: HBV serologic testing, relevant medical history, and HBV genome sequences. Risk ratios (RR) and 95% confidence intervals (CIs) were used to identify risk factors for HBV infection. Results: HBV serologic status was determined for 126 (91%) of 139 residents. Among 88 susceptible residents, 14 became acutely infected (attack rate, 16%), and 74 remained uninfected. Acute HBV infection developed among 12 (92%) of 13 residents who received AMBG, compared with 2 (3%) of 75 residents who did not (RR = 35; 95% CI, 8.7, 137). Identified infection control breaches during AMBG included shared use of fingerstick devices for multiple residents. HBV genome sequencing demonstrated 2 building-specific phylogenetic infection clusters, each having 99.8-100% sequence identity. Limitations: Transfer of residents out of the facility prior to our investigation might have contributed to an underestimate of cases. Resident interviews provided insufficient information to fully assess behavioral risk factors for HBV infection. Conclusions: Failure to adhere to safe practices during AMBG resulted in a large HBV outbreak. Protection of a growing and vulnerable ALF population requires improved training of staff and routine facility licensing inspections that scrutinize infection control practices.	[Bender, Thomas John; Utah, Okey; White-Comstock, Mary Beth] Virginia Dept Hlth, Richmond, VA USA; [Bender, Thomas John; Wise, Matthew E.] CDC, Epidem Intelligence Serv Program, Off Surveillance Epidemiol & Lab Serv, Atlanta, GA 30333 USA; [Wise, Matthew E.; Thompson, Nicola D.; Patel, Priti R.] CDC, Div Healthcare Qual Promot, Atlanta, GA 30333 USA; [Moorman, Anne C.; Sharapov, Umid; Drobeniuc, Jan; Khudyakov, Yury] CDC, Div Viral Hepatitis, Atlanta, GA 30333 USA; [Fricchione, Marielle] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Drexel University	Bender, TJ (corresponding author), Virginia Dept Hlth, Richmond, VA USA.	thomas.john.bender@dm.duke.edu		Moorman, Anne/0000-0003-2411-2798				[Anonymous], 2009, WECT NEWS 6, V6; BOND WW, 1981, LANCET, V1, P550; BRUNETTO MR, 1991, P NATL ACAD SCI USA, V88, P4186, DOI 10.1073/pnas.88.10.4186; Carder PC, 2002, J AGING STUD, V16, P1, DOI 10.1016/S0890-4065(01)00031-7; Centers for Disease Control and Prevention, 2002, INT HEP B SER TEST R; Centers for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET; Centers for Disease Control and Prevention, 2011, INF PREV BLOOD GLUC; Centers for Disease Control and Prevention, 2012, HEALTHC ASS HEP B C; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P217; Centers for Disease Control and Prevention (CDC), 2011, MMWR Morb Mortal Wkly Rep, V60, P1709; Centers for Disease Control and Prevention (CDC), 2011, MMWR Morb Mortal Wkly Rep, V60, P182; Centers for Disease Control (CDC), 1990, MMWR Morb Mortal Wkly Rep, V39, P610; Centers for Medicaid and Medicare Services, 2010, POINT CAR DEV INF CO; Chu CJ, 2002, HEPATOLOGY, V36, P1408, DOI 10.1053/jhep.2002.36949; Counard CA, 2010, J AM GERIATR SOC, V58, P306, DOI 10.1111/j.1532-5415.2009.02669.x; Daniels Danni, 2009, Morbidity and Mortality Weekly Report, V58, P1; Eckert J.K., 2009, INSIDE ASSISTED LIVI; FATTOVICH G, 1991, GUT, V32, P294, DOI 10.1136/gut.32.3.294; Food and Drug Administration, 1990, SAF AL HEP B TRANSM; Forbi JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011615; Klonoff David C, 2010, J Diabetes Sci Technol, V4, P1027; Louie RF, 2005, POINT CARE, V4, P158, DOI 10.1097/01.poc.0000189933.35225.77; McIntosh Yeatoe G., 2012, Morbidity and Mortality Weekly Report, V61, P339; Park NS, 2006, GERONTOLOGIST, V46, P238, DOI 10.1093/geront/46.2.238; Patel AS, 2009, INFECT CONT HOSP EP, V30, P209, DOI 10.1086/595693; Perz Joseph F, 2010, Clin Liver Dis, V14, P137, DOI 10.1016/j.cld.2009.11.004; POLISH LB, 1992, NEW ENGL J MED, V326, P721, DOI 10.1056/NEJM199203123261101; Quale JM, 1998, AM J MED, V105, P296, DOI 10.1016/S0002-9343(98)00256-3; Ramachandran S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025232; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schaefer MK, 2010, JAMA-J AM MED ASSOC, V303, P2273, DOI 10.1001/jama.2010.744; Schaffzin JK, 2012, AM J INFECT CONTROL, V40, P726, DOI 10.1016/j.ajic.2011.11.002; Sikorska-Simmons E, 2005, GERONTOLOGIST, V45, P196, DOI 10.1093/geront/45.2.196; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson Nicola D, 2009, J Diabetes Sci Technol, V3, P283; Thompson ND, 2010, J AM GERIATR SOC, V58, P914, DOI 10.1111/j.1532-5415.2010.02802.x; Thompson ND, 2009, ANN INTERN MED, V150, P33, DOI 10.7326/0003-4819-150-1-200901060-00007; U.S. Census Bureau, 2001, POP PROJ US AG SEX R; Webb R., 2005, Morbidity and Mortality Weekly Report, V54, P220; Weinbaum Cindy M., 2008, Morbidity and Mortality Weekly Report, V57, P1, DOI 10.1002/hep.22882; Williams IT, 2004, CLIN INFECT DIS, V38, P1592, DOI 10.1086/420935	41	12	13	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e50012	10.1371/journal.pone.0050012	http://dx.doi.org/10.1371/journal.pone.0050012			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300520	Green Published, gold, Green Submitted			2022-12-27	WOS:000313618800005
J	Johnstone, DB; Shegokar, V; Nihalani, D; Rathore, YS; Mallik, L; Ashish; Zare, V; Ikizler, HO; Powar, R; Holzman, LB				Johnstone, Duncan B.; Shegokar, Vijay; Nihalani, Deepak; Rathore, Yogendra Singh; Mallik, Leena; Ashish; Zare, Vasant; Ikizler, H. Omer; Powar, Rajaram; Holzman, Lawrence B.			APOL1 Null Alleles from a Rural Village in India Do Not Correlate with Glomerulosclerosis	PLOS ONE			English	Article							APOLIPOPROTEIN-L-I; FOCAL SEGMENTAL GLOMERULOSCLEROSIS; STAGE KIDNEY-DISEASE; AFRICAN-AMERICANS; TRYPANOSOMA-EVANSI; HISPANIC AMERICANS; ALLOGRAFT SURVIVAL; FECHTNER SYNDROMES; RENAL-DISEASE; HUMAN SERUM	Background: Among African-Americans, genome wide association revealed a strong correlation between the G1 and G2 alleles of APOL1 (apolipoproteinL1, also called trypanolytic factor) and kidney diseases including focal and segmental glomerulosclerosis, HIV-associated nephropathy and hypertensive nephrosclerosis. In the prevailing hypothesis, heterozygous APOL1 G1 and G2 alleles increase resistance against Trypanosoma that cause African sleeping sickness, resulting in positive selection of these alleles, but when homozygous the G1 and G2 alleles predispose to glomerulosclerosis. While efforts are underway to screen patients for G1 and G2 alleles and to better understand "APOL1 glomerulopathy," no data prove that these APOL1 sequence variants cause glomerulosclerosis. G1 and G2 correlate best with glomerulosclerosis as recessive alleles, which suggests a loss of function mutation for which proof of causality is commonly tested with homozygous null alleles. This test cannot be performed in rodents as the APOL gene cluster evolved only in primates. However, there is a homozygous APOL1 null human being who lives in a village in rural India. This individual and his family offer a unique opportunity to test causality between APOL1 null alleles and glomerulosclerosis. Methods and Findings: We obtained clinical data, blood and urine from this APOL1 null patient and 50 related villagers. Based on measurements of blood pressure, BUN, creatinine, albuminuria, genotyping and immunoblotting, this APOL1 null individual does not have glomerulosclerosis, nor do his relatives who carry APOL1 null alleles. Conclusions: This small study cannot provide definitive conclusions but the absence of glomerulosclerosis in this unique population is consistent with the possibility that African-American glomerulosclerosis is caused, not by loss of APOL1 function, but by other mechanisms including a subtle gain of function or by the "genetic hitchhiking" of deleterious mutations in a gene linked to APOL1 G1 and G2.	[Johnstone, Duncan B.; Nihalani, Deepak; Ikizler, H. Omer] Univ Penn, Renal Electrolyte & Hypertens Div, Philadelphia, PA 19104 USA; [Shegokar, Vijay; Powar, Rajaram; Holzman, Lawrence B.] Govt Med Hosp, Dept Microbiol, Nagpur, Maharashtra, India; [Rathore, Yogendra Singh; Mallik, Leena; Ashish] CSIR Inst Microbial Technol, Chandigarh, India; [Zare, Vasant] Publ Hlth Inst Nagpur, Nagpur, Maharashtra, India	University of Pennsylvania; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Johnstone, DB (corresponding author), Temple Univ, Sch Med, Div Nephrol, Philadelphia, PA 19122 USA.	Duncan.Johnstone@tuhs.temple.edu	nihalani, deepak/AAK-9453-2020; Mallik, Leena/AAM-4619-2020	Holzman, Lawrence/0000-0002-8961-234X	NIH/NIDDK [K08-DK081626]; CSIR/UGC India; NIH [RO1 1R01DK087956];  [OLP-0056]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087956] Funding Source: NIH RePORTER	NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); CSIR/UGC India(Council of Scientific & Industrial Research (CSIR) - IndiaUniversity Grants Commission, India); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by NIH/NIDDK (K08-DK081626) to DBJ. YSR and LM were supported by a Senior Research Fellowship from CSIR/UGC India. Work at CSIR-IMTECH was supported by funds from OLP-0056 to A. DN was supported by NIH RO1 1R01DK087956. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ailion M, 2003, GENETICS, V165, P127; Arrondel C, 2002, J AM SOC NEPHROL, V13, P65, DOI 10.1681/ASN.V13165; Ashley-Koch AE, 2011, BRIT J HAEMATOL, V155, P386, DOI 10.1111/j.1365-2141.2011.08832.x; Beales PL, 2003, AM J HUM GENET, V72, P1187, DOI 10.1086/375178; Behar DM, 2010, HUM MOL GENET, V19, P1816, DOI 10.1093/hmg/ddq040; Bostrom MA, 2010, NEPHROL DIAL TRANSPL, V25, P3348, DOI 10.1093/ndt/gfq214; Bostrom MA, 2010, CLIN J AM SOC NEPHRO, V5, P1107, DOI 10.2215/CJN.08721209; Chaudhary S, 2012, NAT PROTOC, V7, P453, DOI 10.1038/nprot.2011.453; Chun S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002240; Cohen DM, 2011, TRANSPLANTATION, V92, P722, DOI 10.1097/TP.0b013e31822eec39; Duchateau PN, 2001, J LIPID RES, V42, P620; Freedman BI, 2012, NEPHROL DIAL TRANSPL, V27, P1288, DOI 10.1093/ndt/gfr812; Freedman BI, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002150; Freedman BI, 2009, NEPHROL DIAL TRANSPL, V24, P3366, DOI 10.1093/ndt/gfp316; Friedman DJ, 2011, J CLIN INVEST, V121, P3367, DOI 10.1172/JCI46263; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; GREENWALD IS, 1982, GENETICS, V101, P211; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hoefele J, 2007, J AM SOC NEPHROL, V18, P2789, DOI 10.1681/ASN.2007020243; Huff CD, 2012, MOL BIOL EVOL, V29, P101, DOI 10.1093/molbev/msr151; Johnstone DB, 2011, AM J TRANSPLANT, V11, P2258, DOI 10.1111/j.1600-6143.2011.03673.x; Johnstone DB, 2011, MOL CELL BIOL, V31, P2162, DOI 10.1128/MCB.05234-11; Joshi PP, 2005, AM J TROP MED HYG, V73, P491, DOI 10.4269/ajtmh.2005.73.491; Kanji Z, 2011, J AM SOC NEPHROL, V22, P2091, DOI 10.1681/ASN.2010121234; Kao WHL, 2008, NAT GENET, V40, P1185, DOI 10.1038/ng.232; Kopp JB, 2008, NAT GENET, V40, P1175, DOI 10.1038/ng.226; Kopp JB, 2011, J AM SOC NEPHROL, V22, P2129, DOI 10.1681/ASN.2011040388; Lecordier L, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000685; Lugli EB, 2004, MOL BIOCHEM PARASIT, V138, P9, DOI 10.1016/j.molbiopara.2004.07.004; Madhavan SM, 2011, J AM SOC NEPHROL, V22, P2119, DOI 10.1681/ASN.2011010069; Merino D, 2009, J CELL BIOL, V186, P355, DOI 10.1083/jcb.200905153; National Institutes of Health NIoDaDaKD Bethesda MD, 2011, U S RENAL DATA SYSTE; Nelson GW, 2010, HUM MOL GENET, V19, P1805, DOI 10.1093/hmg/ddq039; Oleksyk TK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011474; Page NM, 2001, GENOMICS, V74, P71, DOI 10.1006/geno.2001.6534; Papeta N, 2011, J AM SOC NEPHROL, V22, P1991, DOI 10.1681/ASN.2011040434; Pays E, 2009, CURR OPIN IMMUNOL, V21, P493, DOI 10.1016/j.coi.2009.05.024; Perez-Morga D, 2005, SCIENCE, V309, P469, DOI 10.1126/science.1114566; Poelvoorde P, 2004, MOL BIOCHEM PARASIT, V134, P155, DOI 10.1016/j.molbiopara.2003.11.006; Reeves-Daniel AM, 2011, AM J TRANSPLANT, V11, P1025, DOI 10.1111/j.1600-6143.2011.03513.x; Sekine T, 2010, KIDNEY INT, V78, P207, DOI 10.1038/ki.2010.21; Seri M, 2003, MEDICINE, V82, P203, DOI 10.1097/00005792-200305000-00006; Smith EE, 2009, GENOME RES, V19, P850, DOI 10.1101/gr.085647.108; Tzur S, 2012, NEPHROL DIAL TRANSPL, V27, P1498, DOI 10.1093/ndt/gfr796; Tzur S, 2010, HUM GENET, V128, P345, DOI 10.1007/s00439-010-0861-0; Vanhamme L, 2003, NATURE, V422, P83, DOI 10.1038/nature01461; Vanhollebeke B, 2006, NEW ENGL J MED, V355, P2752, DOI 10.1056/NEJMoa063265; Vanhollebeke B, 2010, MOL MICROBIOL, V76, P806, DOI 10.1111/j.1365-2958.2010.07156.x; Wan GH, 2008, J BIOL CHEM, V283, P21540, DOI 10.1074/jbc.M800214200; Weigel D, 2008, CSH PROTOCOLS, V2008; Wheeler RJ, 2010, TRENDS PARASITOL, V26, P457, DOI 10.1016/j.pt.2010.05.005; WILKIE AOM, 1994, J MED GENET, V31, P89, DOI 10.1136/jmg.31.2.89	52	58	58	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e51546	10.1371/journal.pone.0051546	http://dx.doi.org/10.1371/journal.pone.0051546			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300552	gold, Green Published, Green Submitted			2022-12-27	WOS:000313618800020
J	Malla, B; Stucki, D; Borrell, S; Feldmann, J; Maharjan, B; Shrestha, B; Fenner, L; Gagneux, S				Malla, Bijaya; Stucki, David; Borrell, Sonia; Feldmann, Julia; Maharjan, Bhagwan; Shrestha, Bhawana; Fenner, Lukas; Gagneux, Sebastien			First Insights into the Phylogenetic Diversity of Mycobacterium tuberculosis in Nepal	PLOS ONE			English	Article							MULTIDRUG-RESISTANT TUBERCULOSIS; BEIJING GENOTYPE; DRUG-RESISTANCE; NUCLEOTIDE POLYMORPHISMS; GENETIC DIVERSITY; SEX-DIFFERENCES; STRAINS; EPIDEMIOLOGY; ASSOCIATION; EVOLUTION	Background: Tuberculosis (TB) is a major public health problem in Nepal. Strain variation in Mycobacterium tuberculosis may influence the outcome of TB infection and disease. To date, the phylogenetic diversity of M. tuberculosis in Nepal is unknown. Methods and Findings: We analyzed 261 M. tuberculosis isolates recovered from pulmonary TB patients recruited between August 2009 and August 2010 in Nepal. M. tuberculosis lineages were determined by single nucleotide polymorphisms (SNP) typing and spoligotyping. Drug resistance was determined by sequencing the hot spot regions of the relevant target genes. Overall, 164 (62.8%) TB patients were new, and 97 (37.2%) were previously treated. Any drug resistance was detected in 50 (19.2%) isolates, and 16 (6.1%) were multidrug-resistant. The most frequent M. tuberculosis lineage was Lineage 3 (CAS/Delhi) with 106 isolates (40.6%), followed by Lineage 2 (East-Asian lineage, includes Beijing genotype) with 84 isolates (32.2%), Lineage 4 (Euro-American lineage) with 41 (15.7%) isolates, and Lineage 1 (Indo-Oceanic lineage) with 30 isolates (11.5%). Based on spoligotyping, we found 45 different spoligotyping patterns that were previously described. The Beijing (83 isolates, 31.8%) and CAS spoligotype (52, 19.9%) were the dominant spoligotypes. A total of 36 (13.8%) isolates could not be assigned to any known spoligotyping pattern. Lineage 2 was associated with female sex (adjusted odds ratio [aOR] 2.58, 95% confidence interval [95% CI] 1.42-4.67, p = 0.002), and any drug resistance (aOR 2.79; 95% CI 1.43-5.45; p = 0.002). We found no evidence for an association of Lineage 2 with age or BCG vaccination status. Conclusions: We found a large genetic diversity of M. tuberculosis in Nepal with representation of all four major lineages. Lineages 3 and 2 were dominating. Lineage 2 was associated with clinical characteristics. This study fills an important gap on the map of the M. tuberculosis genetic diversity in the Asian region.	[Malla, Bijaya; Stucki, David; Borrell, Sonia; Feldmann, Julia; Gagneux, Sebastien] Swiss Trop & Publ Hlth Inst Swiss TPH, Basel, Switzerland; [Malla, Bijaya; Stucki, David; Borrell, Sonia; Feldmann, Julia; Gagneux, Sebastien] Univ Basel, Basel, Switzerland; [Maharjan, Bhagwan; Shrestha, Bhawana] German Nepal TB Project, Kathmandu, Nepal; [Fenner, Lukas] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of Bern	Fenner, L (corresponding author), Univ Bern, Inst Social & Prevent Med, Bern, Switzerland.	lfenner@ispm.unibe.ch; Sebastien.Gagneux@unibas.ch	Gagneux, Sebastien/ABE-7909-2020	Stucki, David/0000-0003-0131-9980; Fenner, Lukas/0000-0003-3309-4835; Gagneux, Sebastien/0000-0001-7783-9048	Swiss National Science Foundation [PP0033-119205]; National Institutes of Health [AI090928, HHSN266200700022C, U01 AI069924-06]; "Amt fur Ausbildungsbeitrage'', Canton of Basel, Switzerland; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069924, R01AI090928] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); "Amt fur Ausbildungsbeitrage'', Canton of Basel, Switzerland; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Swiss National Science Foundation (grant number PP0033-119205), and the National Institutes of Health (grant no. AI090928 and HHSN266200700022C). BIM was supported by the "Amt fur Ausbildungsbeitrage'', Canton of Basel, Switzerland, and LF by the National Institutes of Health (U01 AI069924-06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker L, 2004, EMERG INFECT DIS, V10, P1568, DOI 10.3201/eid1009.040046; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; Borgdorff MW, 2000, INT J TUBERC LUNG D, V4, P123; Borrell S, 2011, CLIN MICROBIOL INFEC, V17, P815, DOI 10.1111/j.1469-0691.2011.03556.x; Borrell S, 2009, INT J TUBERC LUNG D, V13, P1456; Brossier F, 2010, J CLIN MICROBIOL, V48, P1683, DOI 10.1128/JCM.01947-09; Brudey K, 2006, J CLIN MICROBIOL, V44, P183, DOI 10.1128/JCM.44.1.183-191.2006; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Buu TN, 2009, INT J TUBERC LUNG D, V13, P900; Buu TN, 2009, EMERG INFECT DIS, V15, P1570, DOI 10.3201/eid1510.090170; Caws M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000034; Click ES, 2012, CLIN INFECT DIS, V54, P211, DOI 10.1093/cid/cir788; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Connolly Maire, 1996, World Health Statistics Quarterly, V49, P115; Coscolla Mireilla, 2010, Drug Discov Today Dis Mech, V7, pe43, DOI 10.1016/j.ddmec.2010.09.004; Tho DQ, 2012, ANTIMICROB AGENTS CH, V56, P3074, DOI 10.1128/AAC.00319-12; de Jong BC, 2008, J INFECT DIS, V198, P1037, DOI 10.1086/591504; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Dong HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033904; Dou HY, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-170; Drobniewski FA, 2005, EUR RESPIR J, V26, P298, DOI 10.1183/09031936.05.00136004; Fenner L, 2012, ANTIMICROB AGENTS CH, V56, P3047, DOI 10.1128/AAC.06460-11; Fenner L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024737; Feuerriegel S, 2009, ANTIMICROB AGENTS CH, V53, P3353, DOI 10.1128/AAC.00050-09; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Getahun H, 2010, CLIN INFECT DIS, V50, pS201, DOI 10.1086/651492; Glynn JR, 2006, EMERG INFECT DIS, V12, P736, DOI 10.3201/eid1205.050400; Guo YL, 2011, INT J TUBERC LUNG D, V15, P789, DOI 10.5588/ijtld.10.0403; Gutacker MM, 2002, GENETICS, V162, P1533; Han H, 2007, J MED MICROBIOL, V56, P1219, DOI 10.1099/jmm.0.47005-0; Hanekom M, 2011, TUBERCULOSIS, V91, P510, DOI 10.1016/j.tube.2011.07.005; Hirsh AE, 2004, P NATL ACAD SCI USA, V101, P4871, DOI 10.1073/pnas.0305627101; Holmes CB, 1998, INT J TUBERC LUNG D, V2, P96; Hu Yi, 2009, Zhonghua Jie He He Hu Xi Za Zhi, V32, P576; Iwamoto T, 2008, ANTIMICROB AGENTS CH, V52, P3805, DOI 10.1128/AAC.00579-08; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Lari N, 2009, CLIN MICROBIOL INFEC, V15, P538, DOI 10.1111/j.1469-0691.2009.02712.x; Lasunskaia E, 2010, MICROBES INFECT, V12, P467, DOI 10.1016/j.micinf.2010.02.008; Lillebaek T, 2003, EMERG INFECT DIS, V9, P1553, DOI 10.3201/eid0912.030276; Liu Rui-xi, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P593; Malik AN, 2005, LANCET INFECT DIS, V5, P174, DOI 10.1016/S1473-3099(05)01310-1; Narayanan S, 2008, INFECT GENET EVOL, V8, P474, DOI 10.1016/j.meegid.2007.09.007; National Tuberculosis Program, 2010, NTP ANN REP 2009 201; Neyrolles O, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000199; Niemann S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007407; Pang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032976; Parwati I, 2010, LANCET INFECT DIS, V10, P103, DOI 10.1016/S1473-3099(09)70330-5; Rajapaksa US, 2011, INDIAN J MICROBIOL, V51, P410, DOI 10.1007/s12088-011-0150-1; Sandgren A, 2009, PLOS MED, V6, P132, DOI 10.1371/journal.pmed.1000002; Singh UB, 2004, EMERG INFECT DIS, V10, P1138, DOI 10.3201/eid1006.030575; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Staden R, 2000, Methods Mol Biol, V132, P115; Stucki D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041253; Sun JR, 2011, APMIS, V119, P581, DOI 10.1111/j.1600-0463.2011.02790.x; Sun YJ, 2006, EPIDEMIOL INFECT, V134, P329, DOI 10.1017/S095026880500525X; Supply P, 2003, MOL MICROBIOL, V47, P529, DOI 10.1046/j.1365-2958.2003.03315.x; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Svensson E, 2011, CLIN MICROBIOL INFEC, V17, P881, DOI 10.1111/j.1469-0691.2010.03358.x; Thwaites G, 2008, J CLIN MICROBIOL, V46, P1363, DOI 10.1128/JCM.02180-07; Uwizeye CB, 2011, INT J TUBERC LUNG D, V15, P776, DOI 10.5588/ijtld.10.0454; Victor T. C., 1999, Tubercle and Lung Disease, V79, P343, DOI 10.1054/tuld.1999.0222; WHO, 2009, WHOHTMTB2009422; WHO, 2011, WHO GLOBAL TUBERCULO; World Health Organization, 2011, NAT IMM PROGR; World Health Organization, 2010, GLOBALPLAN STOP TB 2; World Health Organization, 2010, 2010 GLOB REP SURV R	67	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52297	10.1371/journal.pone.0052297	http://dx.doi.org/10.1371/journal.pone.0052297			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300635	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000313618800066
J	Omurtag, A; Fenton, AA				Omurtag, Ahmet; Fenton, Andre A.			Assessing Diagnostic Tests: How to Correct for the Combined Effects of Interpretation and Reference Standard	PLOS ONE			English	Article							GOLD STANDARD; INTEROBSERVER AGREEMENT; INTERRATER RELIABILITY; ACUTE STROKE; SENSITIVITY; SPECIFICITY; ACCURACY; METHODOLOGY; FIBROSIS; ABSENCE	We describe a general solution to the problem of determining diagnostic accuracy without the use of a perfect reference standard and in the presence of interpreter variability. The accuracy of a diagnostic test is typically determined by comparing its outcomes with those of an established reference standard. But the accuracy of the standard itself and those of the interpreters strongly influence such assessments. We use our solution to examine the effects of the properties of the standard, the reliability of the interpreters, and the prevalence of abnormality on the measured sensitivity and specificity. Our results provide a method of systematically adjusting the measured sensitivity and specificity in order to estimate their true values. The results are validated by simulations and their detailed application to specific cases are described.	[Omurtag, Ahmet] Biosignal Grp, Brooklyn, NY USA; [Fenton, Andre A.] NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University	Omurtag, A (corresponding author), Biosignal Grp, Brooklyn, NY USA.	aomurtag@biosignalgroup.com		OMURTAG, AHMET/0000-0002-3773-8506; Fenton, Andre/0000-0002-5063-1156	NIH grant [1RC3NS070658]; SUNY Downstate Medical Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC3NS070658] Funding Source: NIH RePORTER	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SUNY Downstate Medical Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by NIH grant 1RC3NS070658 to Bio-Signal Group, with a subcontract to SUNY Downstate Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following interests: This work was partly supported by NIH grant 1RC3NS070658 to Bio-Signal Group. Ahmet Omurtag is the Director of Research and Engineering at Bio-Signal Group. Andre Fenton is the President of Bio-Signal Group and Professor at the Center for Neural Science at New York University. Bio-Signal Group is the developer of microEEG, a miniature portable EEG device approved by the FDA for marketing in the U.S. Andre Fenton and Ahmet Omurtag are co-inventors in the patent applications "EEG Kit" (US 2012/0143020 A1) and "Inter-rater and Intra-rater Reliability of Physiological Scan Interpretation" (PCT/US12/62214). This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Ahovuo JA, 2002, MAGN RESON IMAGING, V20, P401, DOI 10.1016/S0730-725X(02)00514-3; Alonzo TA, 1999, STAT MED, V18, P2987, DOI 10.1002/(SICI)1097-0258(19991130)18:22<2987::AID-SIM205>3.3.CO;2-2; AMENDT LE, 1990, PHYS THER, V70, P108, DOI 10.1093/ptj/70.2.108; Bronsvoort BMD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008628; Byrom J, 2006, INT J GYNECOL CANCER, V16, P253, DOI 10.1111/j.1525-1438.2006.00344.x; Gallaher MP, 2004, 041 NAT I STAND TECH; GART JJ, 1966, AM J EPIDEMIOL, V83, P593, DOI 10.1093/oxfordjournals.aje.a120610; HUI SL, 1980, BIOMETRICS, V36, P167, DOI 10.2307/2530508; Hunninghake GW, 2001, AM J RESP CRIT CARE, V164, P193, DOI 10.1164/ajrccm.164.2.2101090; Johnson WO, 2001, AM J EPIDEMIOL, V153, P921, DOI 10.1093/aje/153.9.921; Kalafut MA, 2000, STROKE, V31, P1667, DOI 10.1161/01.STR.31.7.1667; Kraemer HC, 2002, STAT MED, V21, P2109, DOI 10.1002/sim.1180; Lynch T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011989; Lytwyn A, 2005, CANCER-AM CANCER SOC, V103, P1447, DOI 10.1002/cncr.20927; Mathews WC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012284; Nedelec B, 2008, J BURN CARE RES, V29, P489, DOI 10.1097/BCR.0b013e3181710869; Ochola LB, 2006, LANCET INFECT DIS, V6, P582, DOI 10.1016/S1473-3099(06)70579-5; Poynard T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003857; Qu YS, 1996, BIOMETRICS, V52, P797, DOI 10.2307/2533043; Rutjes A, 2007, HLTH TECHNOLOGY ASSE, V11; Saur D, 2003, AM J NEURORADIOL, V24, P878; Scharf J, 2006, J COMPUT ASSIST TOMO, V30, P105, DOI 10.1097/01.rct.0000187417.15321.ca; STAQUET M, 1981, J CHRON DIS, V34, P599, DOI 10.1016/0021-9681(81)90059-X; To T, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-29; Toft N, 2005, PREV VET MED, V68, P19, DOI 10.1016/j.prevetmed.2005.01.006	25	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52221	10.1371/journal.pone.0052221	http://dx.doi.org/10.1371/journal.pone.0052221			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300619	Green Published, Green Submitted, gold			2022-12-27	WOS:000313618800059
J	Murayama, A; Sugiyama, N; Yoshimura, S; Ishihara-Sugano, M; Masaki, T; Kim, S; Wakita, T; Mishiro, S; Kato, T				Murayama, Asako; Sugiyama, Nao; Yoshimura, Seiko; Ishihara-Sugano, Mitsuko; Masaki, Takahiro; Kim, Sulyi; Wakita, Takaji; Mishiro, Shunji; Kato, Takanobu			A Subclone of HuH-7 with Enhanced Intracellular Hepatitis C Virus Production and Evasion of Virus Related-Cell Cycle Arrest	PLOS ONE			English	Article							DOWN-REGULATION; S-PHASE; NON-A; INFECTION; PROGRESSION; CULTURE; LINES; REPLICATION; INTERFERON; EXPRESSION	Hepatitis C virus (HCV) cell culture system with JFH-1 strain and HuH-7 cells enabled us to produce infectious HCV particles in vitro, and such system is useful to explore the anti-HCV compounds and to develop the vaccine against HCV. In the present study, we describe the derivation of a cell line that permits improved production of HCV particles. Specifically, we characterized several subclones that were isolated from the original HuH-7 cell line by limiting dilution. These HuH-7 subclones displayed a notable range of HCV production levels following transfection by full-genome JFH-1 RNA. Among these subclones, HuH-7T1 produced HCV more efficiently than other subclones and Huh-7.5.1 that is known to be highly permissive for HCV replication. Upon transfection with full-genome RNA, HCV production was increased ten-fold in HuH-7T1 compared to Huh-7.5.1. This increase in viral production correlated with increased efficiency of intracellular infectious virus production. Furthermore, HCV replication did not induce cell cycle arrest in HuH-7T1, whereas it did in Huh-7.5.1. Consequently, the use of HuH-7T1 as host cells could provide increased population of HCV-positive cells and elevated viral titer. In conclusion, we isolated a HuH-7 subclone, HuH-7T1, that supports efficient HCV production. High efficiency of intracellular infectious virus production and evasion of cell cycle arrest were important for this phenotype. We expect that the use of this cell line will facilitate analysis of the underlying mechanisms for HCV particle assembly and the cell cycle arrest caused by HCV.	[Murayama, Asako; Sugiyama, Nao; Masaki, Takahiro; Kim, Sulyi; Wakita, Takaji; Kato, Takanobu] Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan; [Yoshimura, Seiko; Ishihara-Sugano, Mitsuko] Toshiba Co Ltd, Corp Res & Dev Ctr, Yokohama, Kanagawa, Japan; [Mishiro, Shunji] Toshiba Gen Hosp, Dept Med Sci, Tokyo, Japan	National Institute of Infectious Diseases (NIID); Toshiba Corporation; Toshiba Corporation	Kato, T (corresponding author), Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan.	takato@nih.go.jp		Mishiro, Shunji/0000-0001-9618-6468	Japan Society for the Promotion of Science; Ministry of Health, Labour and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology; Grants-in-Aid for Scientific Research [23790513] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science, from the Ministry of Health, Labour and Welfare of Japan, and from the Ministry of Education, Culture, Sports, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akazawa D, 2007, J VIROL, V81, P5036, DOI 10.1128/JVI.01573-06; Alisi A, 2005, J CELL PHYSIOL, V205, P25, DOI 10.1002/jcp.20363; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Feld JJ, 2006, HEPATOLOGY, V43, pS194, DOI 10.1002/hep.21065; Friebe P, 2005, J VIROL, V79, P380, DOI 10.1128/JVI.79.1.380-392.2005; Gu BH, 2003, J VIROL, V77, P5352, DOI 10.1128/JVI.77.9.5352-5359.2003; Ikeda M, 2005, BIOCHEM BIOPH RES CO, V329, P1350, DOI 10.1016/j.bbrc.2005.02.138; Kannan RP, 2011, J VIROL, V85, P7989, DOI 10.1128/JVI.00280-11; Kato T, 2005, J CLIN MICROBIOL, V43, P5679, DOI 10.1128/JCM.43.11.5679-5684.2005; Kato T, 2006, NAT PROTOC, V1, P2334, DOI 10.1038/nprot.2006.395; KIYOSAWA K, 1990, HEPATOLOGY, V12, P671, DOI 10.1002/hep.1840120409; Koutsoudakis G, 2007, J VIROL, V81, P588, DOI 10.1128/JVI.01534-06; Liang T. Jake, 2000, Annals of Internal Medicine, V132, P296; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Munakata T, 2005, P NATL ACAD SCI USA, V102, P18159, DOI 10.1073/pnas.0505605102; Murayama A, 2012, J VIROL, V86, P2143, DOI 10.1128/JVI.05386-11; Murayama A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000885; Naka K, 2006, VIROLOGY, V346, P348, DOI 10.1016/j.virol.2005.10.023; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Robinson M, 2010, ANTIMICROB AGENTS CH, V54, P3099, DOI 10.1128/AAC.00289-10; Saeed M, 2011, HEPATOLOGY, V54, P425, DOI 10.1002/hep.24399; Sainz B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006561; Shimakami T, 2011, GASTROENTEROLOGY, V140, P667, DOI 10.1053/j.gastro.2010.10.056; Spaziani A, 2006, J BIOL CHEM, V281, P10983, DOI 10.1074/jbc.M512536200; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Takeda M, 2012, J GEN VIROL; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Walters KA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000269; Wang YH, 2011, J BIOL CHEM, V286, P26603, DOI 10.1074/jbc.M111.225672; Yang XJ, 2006, VIRUS RES, V121, P134, DOI 10.1016/j.virusres.2006.02.004; Yao ZQ, 2003, VIROLOGY, V314, P271, DOI 10.1016/S0042-6822(03)00419-7; Yi M, 2006, P NATL ACAD SCI USA, V103, P2310, DOI 10.1073/pnas.0510727103; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	34	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52697	10.1371/journal.pone.0052697	http://dx.doi.org/10.1371/journal.pone.0052697			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285155	Green Submitted, Green Published, gold			2022-12-27	WOS:000312794500234
J	Poortvliet, RKE; Ford, I; Lloyd, SM; Sattar, N; Mooijaart, SP; de Craen, AJM; Westendorp, RGJ; Jukema, JW; Packard, CJ; Gussekloo, J; de Ruijter, W; Stott, DJ				Poortvliet, Rosalinde K. E.; Ford, Ian; Lloyd, Suzanne M.; Sattar, Naveed; Mooijaart, Simon P.; de Craen, Anton J. M.; Westendorp, Rudi G. J.; Jukema, J. Wouter; Packard, Christopher J.; Gussekloo, Jacobijn; de Ruijter, Wouter; Stott, David J.			Blood Pressure Variability and Cardiovascular Risk in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)	PLOS ONE			English	Article							SOCIETY-OF-HYPERTENSION; PROGNOSTIC-SIGNIFICANCE; GUIDELINES; INFARCTION; PREDICTOR; MORTALITY; STROKE	Variability in blood pressure predicts cardiovascular disease in young-and middle-aged subjects, but relevant data for older individuals are sparse. We analysed data from the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER) study of 5804 participants aged 70-82 years with a history of, or risk factors for cardiovascular disease. Visit-to-visit variability in blood pressure (standard deviation) was determined using a minimum of five measurements over 1 year; an inception cohort of 4819 subjects had subsequent in-trial 3 years follow-up; longer-term follow-up (mean 7.1 years) was available for 1808 subjects. Higher systolic blood pressure variability independently predicted long-term follow-up vascular and total mortality (hazard ratio per 5 mmHg increase in standard deviation of systolic blood pressure = 1.2, 95% confidence interval 1.1-1.4; hazard ratio 1.1, 95% confidence interval 1.1-1.2, respectively). Variability in diastolic blood pressure associated with increased risk for coronary events (hazard ratio 1.5, 95% confidence interval 1.2-1.8 for each 5 mmHg increase), heart failure hospitalisation (hazard ratio 1.4, 95% confidence interval 1.1-1.8) and vascular (hazard ratio 1.4, 95% confidence interval 1.1-1.7) and total mortality (hazard ratio 1.3, 95% confidence interval 1.1-1.5), all in long-term follow-up. Pulse pressure variability was associated with increased stroke risk (hazard ratio 1.2, 95% confidence interval 1.0-1.4 for each 5 mmHg increase), vascular mortality (hazard ratio 1.2, 95% confidence interval 1.0-1.3) and total mortality (hazard ratio 1.1, 95% confidence interval 1.0-1.2), all in long-term follow-up. All associations were independent of respective mean blood pressure levels, age, gender, in-trial treatment group (pravastatin or placebo) and prior vascular disease and cardiovascular disease risk factors. Our observations suggest variability in diastolic blood pressure is more strongly associated with vascular or total mortality than is systolic pressure variability in older high-risk subjects.	[Poortvliet, Rosalinde K. E.; Gussekloo, Jacobijn; de Ruijter, Wouter] Leiden Univ, Med Ctr, Dept Publ Hlth & Primary Care, Leiden, Netherlands; [Ford, Ian; Lloyd, Suzanne M.] Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark, Scotland; [Sattar, Naveed] Univ Glasgow, Dept Vasc Biochem, Glasgow, Lanark, Scotland; [Mooijaart, Simon P.; de Craen, Anton J. M.; Westendorp, Rudi G. J.] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands; [Mooijaart, Simon P.] Inst Evidence Based Med Old Age, Leiden, Netherlands; [Westendorp, Rudi G. J.] Netherlands Consortium Healthy Ageing, Leiden, Netherlands; [Jukema, J. Wouter] Leiden Univ, Dept Cardiol, Med Ctr, Leiden, Netherlands; [Packard, Christopher J.; Stott, David J.] Univ Glasgow, Glasgow Royal Infirm, Fac Med, Acad Sect Geriatr Med, Glasgow G31 2ER, Lanark, Scotland	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Glasgow; University of Glasgow; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Glasgow	Poortvliet, RKE (corresponding author), Leiden Univ, Med Ctr, Dept Publ Hlth & Primary Care, Leiden, Netherlands.	r.k.e.poortvliet@lumc.nl	Mooijaart, Simon P./A-5306-2008; Ford, Ian/ABE-6145-2020; de Ruijter, Wouter/GRF-3867-2022; Gussekloo, Jacobijn/ABE-3879-2021; Lloyd, Suzanne/H-7424-2013; Poortvliet, Rosalinde/AAR-1982-2020; Jukema, J. Wouter/ABD-6503-2021	Mooijaart, Simon P./0000-0003-3106-3568; Gussekloo, Jacobijn/0000-0001-7186-8278; Jukema, J. Wouter/0000-0002-3246-8359	Bristol-Myers Squibb, United States of America; Wellcome Trust; Chief Scientist Office (CSO), Scotland, Government Health Directorates [CZH/4/637parh]; SBOH; Dutch Ministry of Health, Welfare and Sports; Chief Scientist Office [CZH/4/637] Funding Source: researchfish	Bristol-Myers Squibb, United States of America(Bristol-Myers Squibb); Wellcome Trust(Wellcome TrustEuropean Commission); Chief Scientist Office (CSO), Scotland, Government Health Directorates; SBOH; Dutch Ministry of Health, Welfare and Sports; Chief Scientist Office	The in-trial work in PROSPER was supported by an unrestricted investigator-initiated grant from Bristol-Myers Squibb, United States of America. The record linkage work in Scotland was supported by a grant from the Wellcome Trust for the Scottish Health Informatics Programme. The management and analysis of data was supported by an unrestricted project grant from the Chief Scientist Office (CSO), Scotland, reference number CZH/4/637parh Government Health Directorates. The first author received an unrestricted grant from the SBOH, employer of general practitioner trainees, a foundation funded by the Dutch Ministry of Health, Welfare and Sports (2010-2013). The commercial funder Bristol-Myers Squibb, United States of America provided an unrestricted investigator-initiated grant. There were no (non-)financial, competing interests regarding this commercial funder. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials. Role of the Sponsors: All funding sources were independent The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Cuffe RL, 2006, STROKE, V37, P2776, DOI 10.1161/01.STR.0000244761.62073.05; Ford I, 2002, CURR CONTR TRIALS C, V3, DOI 10.1186/1468-6708-3-8; FRATTOLA A, 1993, J HYPERTENS, V11, P1133, DOI 10.1097/00004872-199310000-00019; Geeganage C, 2011, STROKE, V42, P491, DOI 10.1161/STROKEAHA.110.596163; Grove JS, 1997, AM J EPIDEMIOL, V145, P771, DOI 10.1093/oxfordjournals.aje.a009169; Hata Y, 2002, J HUM HYPERTENS, V16, P141, DOI 10.1038/sj.jhh.1001301; Hata Y, 2000, HYPERTENS RES, V23, P553, DOI 10.1291/hypres.23.553; Havlik RJ, 2002, STROKE, V33, P26, DOI 10.1161/hs0102.101890; Howard SC, 2003, J CLIN EPIDEMIOL, V56, P1084, DOI 10.1016/S0895-4356(03)00267-1; Keenan K, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1492; Kikuya M, 2000, HYPERTENSION, V36, P901, DOI 10.1161/01.HYP.36.5.901; Klungel OH, 2000, J CLIN EPIDEMIOL, V53, P1158, DOI 10.1016/S0895-4356(00)00228-6; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f; Marshall T, 2004, BMJ-BRIT MED J, V328, P933, DOI 10.1136/bmj.328.7445.933; Muntner P, 2011, HYPERTENSION, V57, P160, DOI 10.1161/HYPERTENSIONAHA.110.162255; O'Brien E, 2005, J HYPERTENS, V23, P697, DOI 10.1097/01.hjh.0000163132.84890.c4; PARATI G, 1987, J HYPERTENS, V5, P93, DOI 10.1097/00004872-198702000-00013; Parati G, 2008, J HYPERTENS, V26, P1505, DOI 10.1097/HJH.0b013e328308da66; Pickering TG, 2005, CIRCULATION, V111, P697, DOI 10.1161/01.CIR.0000154900.76284.F6; Pringle E, 2003, J HYPERTENS, V21, P2251, DOI 10.1097/00004872-200312000-00012; Rothwell PM, 2010, LANCET, V375, P938, DOI 10.1016/S0140-6736(10)60309-1; Rothwell PM, 2010, LANCET, V375, P895, DOI 10.1016/S0140-6736(10)60308-X; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; Shepherd J, 1999, AM J CARDIOL, V84, P1192, DOI 10.1016/S0002-9149(99)00533-0; Tozawa M, 1999, NEPHROL DIAL TRANSPL, V14, P1976, DOI 10.1093/ndt/14.8.1976; Webb AJS, 2010, LANCET, V375, P906, DOI 10.1016/S0140-6736(10)60235-8	28	57	64	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52438	10.1371/journal.pone.0052438	http://dx.doi.org/10.1371/journal.pone.0052438			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285043	gold, Green Accepted, Green Published			2022-12-27	WOS:000312794500169
J	Keh, CE; Jha, AR; Nzarubara, B; Lanar, DE; Dutta, S; Theisen, M; Rosenthal, PJ; Dorsey, G; Nixon, DF; Greenhouse, B				Keh, Chris E.; Jha, Aashish R.; Nzarubara, Bridget; Lanar, David E.; Dutta, Sheetij; Theisen, Michael; Rosenthal, Philip J.; Dorsey, Grant; Nixon, Douglas F.; Greenhouse, Bryan			Associations between Antibodies to a Panel of Plasmodium falciparum Specific Antigens and Response to Sub-Optimal Antimalarial Therapy in Kampala, Uganda	PLOS ONE			English	Article							MEROZOITE SURFACE PROTEIN-1; GLUTAMATE-RICH PROTEIN; CLINICAL MALARIA; ESCHERICHIA-COLI; HOST IMMUNITY; CHILDREN; PROTECTION; TRANSMISSION; EFFICACY; IMMUNOGENICITY	Background: Antibodies are important in the control of blood stage Plasmodium falciparum infection. It is unclear which antibody responses are responsible for, or even associated with protection, partly due to confounding by heterogeneous exposure. Assessment of response to partially effective antimalarial therapy, which requires the host to assist in clearing parasites, offers an opportunity to measure protection independent of exposure. Methods: A cohort of children aged 1-10 years in Kampala, Uganda were treated with amodiaquine+sulfadoxine-pyrimethamine for uncomplicated malaria. Serum samples from the time of malaria diagnosis and 14 days later were analyzed for total IgG to 8 P. falciparum antigens using a quantitative indirect ELISA. Associations between antibody levels and risk of treatment failure were estimated using Cox proportional hazard regression. Results: Higher levels of antibodies to apical membrane antigen 1 (AMA-1), but to none of the other 7 antigens were significantly associated with protection against treatment failure (HR 0.57 per 10-fold increase in antibody level, CI 0.41-0.79, p = 0.001). Protection increased consistently across the entire range of antibody levels. Conclusions: Measurement of antibody levels to AMA-1 at the time of malaria may offer a quantitative biomarker of blood stage immunity to P. falciparum, a tool which is currently lacking.	[Keh, Chris E.; Jha, Aashish R.; Rosenthal, Philip J.; Dorsey, Grant; Nixon, Douglas F.; Greenhouse, Bryan] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Nzarubara, Bridget] Infect Dis Res Collaborat, Kampala, Uganda; [Lanar, David E.; Dutta, Sheetij] Walter Reed Army Inst Res, Div Malaria Vaccine Dev, Silver Spring, MD USA; [Theisen, Michael] Statens Serum Inst, Dept Clin Biochem & Immunol, DK-2300 Copenhagen, Denmark	University of California System; University of California San Francisco; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Statens Serum Institut	Greenhouse, B (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	bgreenhouse@medsfgh.ucsf.edu	Nixon, Douglas/AAU-5734-2020	Nixon, Douglas/0000-0002-2801-1786; Jha, Aashish/0000-0003-3227-1086; Greenhouse, Bryan/0000-0003-0287-9111	National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) [AI060530, AI076614]; International Centers of Excellence in Malaria Research [AI089674]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089674, P30AI027763, T32AI060530, K23AI076614] Funding Source: NIH RePORTER	National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); International Centers of Excellence in Malaria Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in part, by the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID): T32 Training in HIV Translational Research [PI: Diane Havlir, grant number AI060530 to CEK]; K23 [PI: Bryan Greenhouse, grant number AI076614 to BG]; and International Centers of Excellence in Malaria Research U19 [PI: Grant Dorsey, grant number AI089674 to GD, BG]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALYAMAN F, 1994, AM J TROP MED HYG, V51, P593, DOI 10.4269/ajtmh.1994.51.593; [Anonymous], 2000, T R SOC TROP MED S1, V94, pS1; Aubouy A, 2007, INFECT GENET EVOL, V7, P147, DOI 10.1016/j.meegid.2006.07.001; Bejon P, 2009, INFECT IMMUN, V77, P1917, DOI 10.1128/IAI.01358-08; Carvalho LJM, 2004, SCAND J IMMUNOL, V59, P363, DOI 10.1111/j.0300-9475.2004.01409.x; Clark TD, 2008, J INFECT DIS, V198, P393, DOI 10.1086/589778; Clark TD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011759; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Crompton PD, 2010, P NATL ACAD SCI USA, V107, P6958, DOI 10.1073/pnas.1001323107; Diarra A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-79; Djimde AA, 2003, AM J TROP MED HYG, V69, P558, DOI 10.4269/ajtmh.2003.69.558; Dorsey G, 2007, JAMA-J AM MED ASSOC, V297, P2210, DOI 10.1001/jama.297.20.2210; Dutta S, 2002, INFECT IMMUN, V70, P3101, DOI 10.1128/IAI.70.6.3101-3110.2002; Egan AF, 1996, J INFECT DIS, V173, P765, DOI 10.1093/infdis/173.3.765; Enevold A, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-153; Feng GQ, 2009, J INFECT DIS, V200, P299, DOI 10.1086/599841; Fowkes FJI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000218; Greenhouse B, 2007, ANTIMICROB AGENTS CH, V51, P3096, DOI 10.1128/AAC.00159-07; Greenhouse B, 2011, J INFECT DIS, V204, P19, DOI 10.1093/infdis/jir223; Greenhouse B, 2009, J INFECT DIS, V199, P758, DOI 10.1086/596741; John CC, 2008, J INFECT DIS, V197, P519, DOI 10.1086/526787; KASLOW DC, 1994, MOL BIOCHEM PARASIT, V63, P283, DOI 10.1016/0166-6851(94)90064-7; Kinyanjui SM, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-242; Mawili-Mboumba DP, 2003, J INFECT DIS, V187, P1137, DOI 10.1086/368414; Mayxay M, 2001, AM J TROP MED HYG, V65, P918, DOI 10.4269/ajtmh.2001.65.918; McGREGOR I. A., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P170, DOI 10.1016/0035-9203(63)90058-0; Nebie I, 2008, INFECT IMMUN, V76, P759, DOI 10.1128/IAI.01147-07; Nwuba RI, 2002, INFECT IMMUN, V70, P5328, DOI 10.1128/IAI.70.9.5328-5331.2002; Osier FHA, 2008, INFECT IMMUN, V76, P2240, DOI 10.1128/IAI.01585-07; Pinder M, 2006, INFECT IMMUN, V74, P2887, DOI 10.1128/IAI.74.5.2887-2893.2006; Polley SD, 2004, VACCINE, V23, P718, DOI 10.1016/j.vaccine.2004.05.031; R Core Team, 2020, R LANG ENV STAT COMP; Robert V, 2000, PARASITE IMMUNOL, V22, P589, DOI 10.1046/j.1365-3024.2000.00340.x; Rogerson SJ, 2010, LANCET INFECT DIS, V10, P51, DOI 10.1016/S1473-3099(09)70322-6; THEISEN M, 1995, CLIN DIAGN LAB IMMUN, V2, P30, DOI 10.1128/CDLI.2.1.30-34.1995; Thera MA, 2011, NEW ENGL J MED, V365, P1004, DOI 10.1056/NEJMoa1008115; Uthaipibull C, 2001, J MOL BIOL, V307, P1381, DOI 10.1006/jmbi.2001.4574; Van Geertruyden JP, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-258; Verret WJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-77; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 2020, REP ANT DRUG EFF RES	41	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e52571	10.1371/journal.pone.0052571	http://dx.doi.org/10.1371/journal.pone.0052571			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23285095	gold, Green Published, Green Submitted			2022-12-27	WOS:000312694300092
J	Buck, JR; St Clair, SB				Buck, Joshua R.; St Clair, Samuel B.			Aspen Increase Soil Moisture, Nutrients, Organic Matter and Respiration in Rocky Mountain Forest Communities	PLOS ONE			English	Article							NET ECOSYSTEM PRODUCTIVITY; CONIFER FORESTS; LITTER QUALITY; QUAKING ASPEN; CO2 EFFLUX; PURE ASPEN; DYNAMICS; BOREAL; SUCCESSION; PATTERNS	Development and change in forest communities are strongly influenced by plant-soil interactions. The primary objective of this paper was to identify how forest soil characteristics vary along gradients of forest community composition in aspen-conifer forests to better understand the relationship between forest vegetation characteristics and soil processes. The study was conducted on the Fishlake National Forest, Utah, USA. Soil measurements were collected in adjacent forest stands that were characterized as aspen dominated, mixed, conifer dominated or open meadow, which includes the range of vegetation conditions that exist in seral aspen forests. Soil chemistry, moisture content, respiration, and temperature were measured. There was a consistent trend in which aspen stands demonstrated higher mean soil nutrient concentrations than mixed and conifer dominated stands and meadows. Specifically, total N, NO3 and NH4 were nearly two-fold higher in soil underneath aspen dominated stands. Soil moisture was significantly higher in aspen stands and meadows in early summer but converged to similar levels as those found in mixed and conifer dominated stands in late summer. Soil respiration was significantly higher in aspen stands than conifer stands or meadows throughout the summer. These results suggest that changes in disturbance regimes or climate scenarios that favor conifer expansion or loss of aspen will decrease soil resource availability, which is likely to have important feedbacks on plant community development.	[Buck, Joshua R.; St Clair, Samuel B.] Brigham Young Univ, Dept Plant & Wildlife Sci, Provo, UT 84602 USA	Brigham Young University	St Clair, SB (corresponding author), Brigham Young Univ, Dept Plant & Wildlife Sci, Provo, UT 84602 USA.	stclair@byu.edu	St.Clair, Sam/GZA-4592-2022		Charles Redd Foundation	Charles Redd Foundation	The Charles Redd Foundation provided funding for this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAATH E, 1995, SOIL BIOL BIOCHEM, V27, P229, DOI 10.1016/0038-0717(94)00140-V; BARTOS DL, 1981, FOREST SCI, V27, P381; BATES PC, 1992, SOIL SCI SOC AM J, V56, P295, DOI 10.2136/sssaj1992.03615995005600010047x; Beaty RM, 2008, FOREST ECOL MANAG, V255, P707, DOI 10.1016/j.foreco.2007.09.044; Bever JD, 1997, J ECOL, V85, P561, DOI 10.2307/2960528; Calder WJ, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00119.1; Calder WJ, 2011, TREE PHYSIOL, V31, P582, DOI 10.1093/treephys/tpr041; Clark AL, 2011, FOREST ECOL MANAG, V262, P203, DOI 10.1016/j.foreco.2011.03.024; Coleman MD, 2000, PLANT SOIL, V225, P129, DOI 10.1023/A:1026564228951; CONNELL JH, 1977, AM NAT, V111, P1119, DOI 10.1086/283241; Day P.R., 1965, METHODS SOIL ANAL PA, V9, P545, DOI [10.2134/agronmonogr9.1.c43, DOI 10.2134/AGRONMONOGR9.1.C43]; Doerr SH, 2009, J HYDROL, V371, P12, DOI 10.1016/j.jhydrol.2009.03.011; Fang C, 1998, PLANT SOIL, V205, P135, DOI 10.1023/A:1004304309827; Gallant AL, 2003, ECOL APPL, V13, P385, DOI 10.1890/1051-0761(2003)013[0385:VDUFEA]2.0.CO;2; GRANT RF, 1994, SOIL SCI SOC AM J, V58, P1681, DOI 10.2136/sssaj1994.03615995005800060015x; Grayston SJ, 1997, APPL SOIL ECOL, V5, P29, DOI 10.1016/S0929-1393(96)00126-6; Hannam KD, 2007, APPL SOIL ECOL, V35, P635, DOI 10.1016/j.apsoil.2006.09.005; Hansen AJ, 2000, LANDSCAPE ECOL, V15, P505, DOI 10.1023/A:1008127228878; Huang Y, 2005, COMMUN SOIL SCI PLAN, V36, P1385, DOI 10.1081/CSS-200058468; Jassal RS, 2008, GLOBAL CHANGE BIOL, V14, P1305, DOI 10.1111/j.1365-2486.2008.01573.x; Johnson DW, 2001, FOREST ECOL MANAG, V140, P227, DOI 10.1016/S0378-1127(00)00282-6; Kljun N, 2006, ECOSYSTEMS, V9, P1128, DOI 10.1007/s10021-005-0082-x; Kraus TEC, 2003, PLANT SOIL, V256, P41, DOI 10.1023/A:1026206511084; Krishnan P, 2006, AGR FOREST METEOROL, V139, P208, DOI 10.1016/j.agrformet.2006.07.002; Kuhn TJ, 2011, PLANT ECOL, V212, P1451, DOI 10.1007/s11258-011-9920-4; Kurzel BP, 2007, FOREST ECOL MANAG, V252, P176, DOI 10.1016/j.foreco.2007.06.027; Laganiere J, 2009, APPL SOIL ECOL, V41, P19, DOI 10.1016/j.apsoil.2008.08.005; Laganiere J, 2012, SOIL BIOL BIOCHEM, V53, P18, DOI 10.1016/j.soilbio.2012.04.024; Laganiere J, 2011, SOIL SCI SOC AM J, V75, P1125, DOI 10.2136/sssaj2010.0275; LaMalfa EM, 2008, ECOSYSTEMS, V11, P569, DOI 10.1007/s10021-008-9143-2; Legare S, 2005, PLANT SOIL, V275, P207, DOI 10.1007/s11104-005-1482-6; Leroy CJ, 2006, FRESHWATER BIOL, V51, P605, DOI 10.1111/j.1365-2427.2006.01512.x; LINDSAY WL, 1978, SOIL SCI SOC AM J, V42, P421, DOI 10.2136/sssaj1978.03615995004200030009x; Mallik AU, 2003, CRIT REV PLANT SCI, V22, P341, DOI 10.1080/713610860; Mueggler W. F., 1985, ASPEN ECOLOGY MANAGE, P45; Myers RT, 2001, SOIL SCI SOC AM J, V65, P359, DOI 10.2136/sssaj2001.652359x; NIHLGARD B, 1971, OIKOS, V22, P302, DOI 10.2307/3543854; Normandin V, 1998, COMMUN SOIL SCI PLAN, V29, P1785, DOI 10.1080/00103629809370069; Ollinger SV, 2002, ECOLOGY, V83, P339, DOI 10.1890/0012-9658(2002)083[0339:RVIFCA]2.0.CO;2; OLSEN STERLING R., 1954, U S DEPT AGRIC CIRC, V939, P1; POLLARD JH, 1971, BIOMETRICS, V27, P991, DOI 10.2307/2528833; POPENOE JH, 1992, SOIL SCI SOC AM J, V56, P1951, DOI 10.2136/sssaj1992.03615995005600060050x; Pregitzer CC, 2010, EVOL ECOL, V24, P1045, DOI 10.1007/s10682-010-9363-8; Preston CM, 2009, ECOSYSTEMS, V12, P1053, DOI 10.1007/s10021-009-9266-0; Reich PB, 2001, ECOLOGY, V82, P2731, DOI 10.1890/0012-9658(2001)082[2731:IOLFAF]2.0.CO;2; Smith AE, 2005, FOREST ECOL MANAG, V213, P338, DOI 10.1016/j.foreco.2005.03.018; Smith EA, 2011, FOREST ECOL MANAG, V262, P325, DOI 10.1016/j.foreco.2011.03.038; St Clair SB, 2005, TREE PHYSIOL, V25, P85, DOI 10.1093/treephys/25.1.85; Ste-Marie C, 1999, SOIL BIOL BIOCHEM, V31, P1579, DOI 10.1016/S0038-0717(99)00086-3; Strand EK, 2009, ECOL MODEL, V220, P175, DOI 10.1016/j.ecolmodel.2008.09.010; STUMP LM, 1993, CAN J FOREST RES, V23, P492, DOI 10.1139/x93-067; Tobon C, 2004, BIOGEOCHEMISTRY, V69, P315, DOI 10.1023/B:BIOG.0000031051.29323.27; Uddling J, 2008, TREE PHYSIOL, V28, P1231, DOI 10.1093/treephys/28.8.1231; Wadleigh L, 1996, GREAT BASIN NAT, V56, P28; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003; Yarie J, 2008, FOREST ECOL MANAG, V256, P1055, DOI 10.1016/j.foreco.2008.06.022; Yuste JC, 2007, GLOBAL CHANGE BIOL, V13, P2018, DOI 10.1111/j.1365-2486.2007.01415.x	57	26	26	1	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e52369	10.1371/journal.pone.0052369	http://dx.doi.org/10.1371/journal.pone.0052369			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23285012	Green Published, gold, Green Submitted			2022-12-27	WOS:000312435900092
J	Briones, JC; Tsai, CH; Nakazawa, T; Sakai, Y; Papa, RDS; Hsieh, CH; Okuda, N				Briones, Jonathan Carlo; Tsai, Cheng-Han; Nakazawa, Takefumi; Sakai, Yoichiro; Papa, Rey Donne S.; Hsieh, Chih-Hao; Okuda, Noboru			Long-Term Changes in the Diet of Gymnogobius isaza from Lake Biwa, Japan: Effects of Body Size and Environmental Prey Availability	PLOS ONE			English	Article							PELAGIC FOOD WEBS; JESOGAMMARUS-ANNANDALEI; SALVELINUS-ALPINUS; PREDATOR; ISOTOPE; FISHES; EUTROPHICATION; COMMUNITY; SHIFTS; ZOOPLANKTON	Body size and environmental prey availability are both key factors determining feeding habits of gape-limited fish predators. However, our understanding of their interactive or relative effects is still limited. In this study, we performed quantitative dietary analysis of different body sizes of goby (Gymnogobius isaza) specimens collected from Lake Biwa between 1962 and 2004. First, we report that the diet was composed mainly of zooplankton (cladocerans and copepods) before the 1980s, and thereafter, shifted to zoobenthos (gammarids). This foraging shift coincided with, and thus can be linked to, known historical events in the lake at that time: decrease in zooplankton abundance with the alleviation of eutrophication, increase in fish body size resulting from fish population collapse, and increase in gammarid abundance due to reduced fish predation pressure. Supporting this view, our data analyses revealed how the long-term changes in the diet composition would be co-mediated by changes in fish body size and environmental prey availability. Specifically, while zoobenthos abundance strongly affected the fish diet composition, larger (smaller) fish preferred zoobenthos (zooplankton). Furthermore, the body size effects were stronger than those of prey availability. These results provide the best long-term evidence that fish feeding habits vary over decades with its body size and prey community due to anthropogenic disturbances.	[Tsai, Cheng-Han; Nakazawa, Takefumi; Hsieh, Chih-Hao] Natl Taiwan Univ, Inst Oceanog, Taipei 10764, Taiwan; [Briones, Jonathan Carlo] Univ Santo Tomas, Grad Sch, Manila, Philippines; [Hsieh, Chih-Hao] Natl Taiwan Univ, Inst Ecol & Evolutionary Biol, Taipei 10764, Taiwan; [Nakazawa, Takefumi; Sakai, Yoichiro; Okuda, Noboru] Kyoto Univ, Ctr Ecol Res, Otsu, Shiga, Japan; [Papa, Rey Donne S.] Univ Santo Tomas, Dept Biol Sci, Manila, Philippines; [Papa, Rey Donne S.] Univ Santo Tomas, Res Ctr Nat & Appl Sci, Manila, Philippines	National Taiwan University; University of Santo Tomas; National Taiwan University; Kyoto University; University of Santo Tomas; University of Santo Tomas	Nakazawa, T (corresponding author), Natl Taiwan Univ, Inst Oceanog, Taipei 10764, Taiwan.	take.nkzw@gmail.com	Hsieh, Chih-hao/B-3797-2008	Hsieh, Chih-hao/0000-0001-5935-7272; Papa, Rey Donne/0000-0003-0146-2525	Institute of Oceanography, National Taiwan University; Research Center for the Natural and Applied Sciences, University of Santo Tomas; Japan Society for the Promotion of Science Research Fellowship for Young Scientists [2103033]; Kurita Water and Environment Foundation [23299]; Frontier and Innovative Research of National Taiwan University; National Science Council of Taiwan; Environment Research and Technology Development Fund of the Ministry of the Environment of Japan [S-9-4]; Grants-in-Aid for Scientific Research [23657019] Funding Source: KAKEN	Institute of Oceanography, National Taiwan University; Research Center for the Natural and Applied Sciences, University of Santo Tomas; Japan Society for the Promotion of Science Research Fellowship for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kurita Water and Environment Foundation(Kurita Water and Environment Foundation); Frontier and Innovative Research of National Taiwan University(National Taiwan University); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Environment Research and Technology Development Fund of the Ministry of the Environment of Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by a joint program between the Institute of Oceanography, National Taiwan University and the Research Center for the Natural and Applied Sciences, University of Santo Tomas. TN was supported by the Japan Society for the Promotion of Science Research Fellowship for Young Scientists (2103033) and Kurita Water and Environment Foundation (23299). CH was supported by a grant for Frontier and Innovative Research of National Taiwan University and National Science Council of Taiwan. NO was supported by the Environment Research and Technology Development Fund (S-9-4) of the Ministry of the Environment of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes C, 2010, ECOLOGY, V91, P222, DOI 10.1890/08-2061.1; Braga RR, 2012, REV FISH BI IN PRESS; Bronmark C., 2005, BIOL LAKES PONDS; Cade BS, 2003, FRONT ECOL ENVIRON, V1, P412, DOI 10.1890/1540-9295(2003)001[0412:AGITQR]2.0.CO;2; Carpenter S.R., 1993, TROPHIC CASCADE LAKE; CHARNOV EL, 1976, AM NAT, V110, P141, DOI 10.1086/283054; Corrigan LJ, 2011, ECOL FRESHW FISH, V20, P5, DOI 10.1111/j.1600-0633.2010.00446.x; Cortes E, 1997, CAN J FISH AQUAT SCI, V54, P726, DOI 10.1139/cjfas-54-3-726; Davis AM, 2012, FRESHWATER BIOL, V57, P2156, DOI 10.1111/j.1365-2427.2012.02858.x; DIEHL S, 1992, ECOLOGY, V73, P1646, DOI 10.2307/1940017; Gerking SD., 2014, FEEDING ECOLOGY FISH; Gregersen F, 2006, FISHERIES MANAG ECOL, V13, P243, DOI 10.1111/j.1365-2400.2006.00500.x; Hsieh CH, 2011, BIOGEOSCIENCES, V8, P1383, DOI 10.5194/bg-8-1383-2011; Hsieh CH, 2010, AQUAT SCI, V72, P467, DOI 10.1007/s00027-010-0149-4; HYSLOP EJ, 1980, J FISH BIOL, V17, P411, DOI 10.1111/j.1095-8649.1980.tb02775.x; Ishikawa T, 2004, LIMNOL OCEANOGR, V49, P1840, DOI 10.4319/lo.2004.49.5.1840; Ishikawa T, 2002, FRESHWATER BIOL, V47, P1935, DOI 10.1046/j.1365-2427.2002.00942.x; Islam MS, 2006, ESTUAR COAST, V29, P519; Jacob U, 2011, ADV ECOL RES, V45, P181, DOI 10.1016/B978-0-12-386475-8.00005-8; Jeppesen E, 2003, ECOSYSTEMS, V6, P313, DOI 10.1007/PL00021503; Kawabata K, 1998, FRESHWATER BIOL, V39, P199, DOI 10.1046/j.1365-2427.1998.00267.x; Koenker R., 2010, ECONOMETRIC SOC MONO, V2005, P295; KOHLER CC, 1982, ENVIRON BIOL FISH, V7, P363, DOI 10.1007/BF00005571; Legendre P., 2012, NUMERICAL ECOLOGY; Lewis-Beck MS, 1980, APPL REGRESSION INTR; Manly B.F.J., 2006, RANDOMIZATION BOOTST, V3rd, DOI DOI 10.1201/9781315273075; Nagoshi M., 1966, RES POPUL ECOL, V8, P20, DOI [10.1007/BF02524743, DOI 10.1007/BF02524743]; Nakai Katsuki, 1999, P227; NAKANISHI N, 1984, Japanese Journal of Limnology, V45, P279; Nakazawa T, 2007, ECOL FRESHW FISH, V16, P362, DOI 10.1111/j.1600-0633.2007.00234.x; Nakazawa T, 2011, ADV ECOL RES, V45, P269, DOI 10.1016/B978-0-12-386475-8.00007-1; Nakazawa T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009120; Ogawa NO, 2001, LIMNOL OCEANOGR, V46, P1228, DOI 10.4319/lo.2001.46.5.1228; Okuda N, 2012, LAKE BIWA INTERACTIO, P205; Olden JD, 2010, DIVERS DISTRIB, V16, P496, DOI 10.1111/j.1472-4642.2010.00655.x; Papa RDS, 2008, ZOOL STUD, V47, P535; Persson L, 1996, ECOLOGY, V77, P900, DOI 10.2307/2265510; Pinnegar JK, 2003, J FISH BIOL, V63, P197, DOI 10.1111/j.1095-8649.2003.00204.x; Post DM, 2000, ECOLOGY, V81, P8, DOI 10.2307/177129; Post DM, 2003, ECOLOGY, V84, P1298, DOI 10.1890/0012-9658(2003)084[1298:IVITTO]2.0.CO;2; Renones O, 2002, J FISH BIOL, V61, P122, DOI [10.1006/jfbi.2002.2024, 10.1111/j.1095-8649.2002.tb01741.x]; Rooney N, 2006, NATURE, V442, P265, DOI 10.1038/nature04887; Schindler DE, 2002, OIKOS, V98, P177, DOI 10.1034/j.1600-0706.2002.980201.x; Shiga Statistics and Information Office, 1962, ANN REP AGR FOR FISH; Stephens D.W., 1986, pi; Tsugeki N, 2003, LIMNOLOGY, V4, P101, DOI 10.1007/s10201-003-0097-y; Vadeboncoeur Y, 2003, LIMNOL OCEANOGR, V48, P1408, DOI 10.4319/lo.2003.48.4.1408; Vadeboncoeur Y, 2005, ECOSYSTEMS, V8, P682, DOI 10.1007/s10021-003-0149-5; Vander Zanden MJ, 2011, ECOSYSTEMS, V14, P894, DOI 10.1007/s10021-011-9454-6; Vander Zanden MJ, 2002, ECOLOGY, V83, P2152, DOI 10.1890/0012-9658(2002)083[2152:FAIOBA]2.0.CO;2; Winfield IJ, 2012, FRESHWATER BIOL, V57, P373, DOI 10.1111/j.1365-2427.2011.02607.x; Wootton R.J., 1990, ECOLOGY TELEOST FISH; Xu J, 2007, ECOSCIENCE, V14, P170, DOI 10.2980/1195-6860(2007)14[170:SSIROB]2.0.CO;2; Yamada Yoshihiro, 1998, Japanese Journal of Limnology, V59, P409	54	15	16	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53167	10.1371/journal.pone.0053167	http://dx.doi.org/10.1371/journal.pone.0053167			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285262	Green Published, gold			2022-12-27	WOS:000313051500115
J	Casabonne, D; Almeida, J; Nieto, WG; Romero, A; Fernandez-Navarro, P; Rodriguez-Caballero, A; Munoz-Criado, S; Diaz, MG; Benavente, Y; de Sanjose, S; Orfao, A				Casabonne, Delphine; Almeida, Julia; Nieto, Wendy G.; Romero, Alfonso; Fernandez-Navarro, Paulino; Rodriguez-Caballero, Arancha; Munoz-Criado, Santiago; Gonzalez Diaz, Marcos; Benavente, Yolanda; de Sanjose, Silvia; Orfao, Alberto		Primary Hlth Care Grp Salamanca	Common Infectious Agents and Monoclonal B-Cell Lymphocytosis: A Cross-Sectional Epidemiological Study among Healthy Adults	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; SUBSEQUENT RISK; LEUKEMIA; PREVALENCE; NUMBERS; CLONES; MBL	Background: Risk factors associated with monoclonal B-cell lymphocytosis (MBL), a potential precursor of chronic lymphocytic leukaemia (CLL), remain unknown. Methods: Using a cross-sectional study design, we investigated demographic, medical and behavioural risk factors associated with MBL. "Low-count" MBL (cases) were defined as individuals with very low median absolute count of clonal B-cells, identified from screening of healthy individuals and the remainder classified as controls. 452 individuals completed a questionnaire with their general practitioner, both blind to the MBL status of the subject. Odds ratios (OR) and 95% confidence interval (CI) for MBL were estimated by means of unconditional logistic regression adjusted for confounding factors. Results: MBL were detected in 72/452 subjects (16%). Increasing age was strongly associated with MBL (P-trend<0.001). MBL was significantly less common among individuals vaccinated against pneumococcal or influenza (OR 0.49, 95% confidence interval (CI): 0.25 to 0.95; P-value = 0.03 and OR: 0.52, 95% CI: 0.29 to 0.93, P-value = 0.03, respectively). Albeit based on small numbers, cases were more likely to report infectious diseases among their children, respiratory disease among their siblings and personal history of pneumonia and meningitis. No other distinguishing epidemiological features were identified except for family history of cancer and an inverse relationship with diabetes treatment. All associations described above were retained after restricting the analysis to CLL-like MBL. Conclusion: Overall, these findings suggest that exposure to infectious agents leading to serious clinical manifestations in the patient or its surroundings may trigger immune events leading to MBL. This exploratory study provides initial insights and directions for future research related to MBL, a potential precursor of chronic lymphocytic leukaemia. Further work is warranted to confirm these findings.	[Casabonne, Delphine; Benavente, Yolanda; de Sanjose, Silvia] Inst Catala Oncol, IDIBELL, Unit Infect & Canc UNIC, Barcelona, Spain; [Casabonne, Delphine; Benavente, Yolanda; de Sanjose, Silvia] CIBERESP, Barcelona, Spain; [Almeida, Julia; Nieto, Wendy G.; Rodriguez-Caballero, Arancha; Orfao, Alberto] Univ Salamanca, Dept Med & Cytometry Serv, IBSAL,IBMCC,CSIC, Inst Biol Mol & Celular Canc,Ctr Invest Canc,USAL, E-37008 Salamanca, Spain; [Romero, Alfonso] Sanidad Castilla Y Leon SACYL, Ctr Atenc Primaria Salud Miguel Armijo Salmanca, Castilla Y Leon, Spain; [Fernandez-Navarro, Paulino] Sanidad Castilla Y Leon SACYL, Ctr Atenc Primaria Salud Ledesma, Castilla Y Leon, Spain; [Munoz-Criado, Santiago] Univ Hosp Salamanca, Microbiol Serv, Salamanca, Spain; [Gonzalez Diaz, Marcos] Univ Salamanca, Dept Med, E-37008 Salamanca, Spain; [Gonzalez Diaz, Marcos] Univ Hosp Salamanca, IBMCC, IBSAL, Serv Hematol, Salamanca, Spain	Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; University of Salamanca; University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC)	Casabonne, D (corresponding author), Inst Catala Oncol, IDIBELL, Unit Infect & Canc UNIC, Barcelona, Spain.	dcasabonne@iconcologia.net	de Sanjosé Llongueras, Silvia/H-6339-2014; Casabonne, Delphine/H-6425-2014; Orfao, Alberto/B-5801-2017; Benavente, Yolanda/H-9810-2014		Red Tematica de Investigacion Cooperativa en Cancer del Instituto de Salud Carlos III - FONDOS FEDER [RD06/0020/0035, 2006-RET2039-O, CIBERESP 06/02/0073]; Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Ministerio de Economia y Competitividad, Madrid, Spain [FIS PI06/0824-FEDER, PS09/02430-FEDER, PI11/01810-FEDER]; Gerencia Regional de Salud de Castilla y Leo n and Ayuda al Grupo GR37 de Excelencia de Castilla y Leon, Consejeria de Educacion [GRS206/A/08]; Consejeria de Sanidad, Junta de Castilla y Leon, Valladolid, Spain; Agencia de Gestio d'Ajuts Universitaris i de Recerca Generalitat de Catalunya [AGAUR 2009SGR1465]; Fundacion Cientifica de la Asociacion Espanola contra el Cancer;  [SAN/1778/2009]	Red Tematica de Investigacion Cooperativa en Cancer del Instituto de Salud Carlos III - FONDOS FEDER; Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Ministerio de Economia y Competitividad, Madrid, Spain; Gerencia Regional de Salud de Castilla y Leo n and Ayuda al Grupo GR37 de Excelencia de Castilla y Leon, Consejeria de Educacion; Consejeria de Sanidad, Junta de Castilla y Leon, Valladolid, Spain(Junta de Castilla y Leon); Agencia de Gestio d'Ajuts Universitaris i de Recerca Generalitat de Catalunya(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya); Fundacion Cientifica de la Asociacion Espanola contra el Cancer; 	This work was financially supported by the following grants: Red Tematica de Investigacion Cooperativa en Cancer del Instituto de Salud Carlos III - FONDOS FEDER (RD06/0020/0035, 2006-RET2039-O, CIBERESP 06/02/0073); FIS PI06/0824-FEDER, PS09/02430-FEDER and PI11/01810-FEDER, from the Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Ministerio de Economia y Competitividad, Madrid, Spain; GRS206/A/08 from the Gerencia Regional de Salud de Castilla y Leo n and Ayuda al Grupo GR37 de Excelencia de Castilla y Leon, Consejeria de Educacion, and SAN/1778/2009, Consejeria de Sanidad, Junta de Castilla y Leon, Valladolid, Spain; and Agencia de Gestio d'Ajuts Universitaris i de Recerca Generalitat de Catalunya (AGAUR 2009SGR1465). AR-C is supported by a grant from Fundacion Cientifica de la Asociacion Espanola contra el Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida J, 2011, LEUKEMIA, V25, P718, DOI 10.1038/leu.2010.305; Anderson LA, 2009, BRIT J HAEMATOL, V147, P444, DOI 10.1111/j.1365-2141.2009.07849.x; Clarke CA, 2011, CANCER EPIDEM BIOMAR, V20, P1064, DOI 10.1158/1055-9965.EPI-11-0038; D'Arena G, 2011, INT J IMMUNOPATH PH, V24, P915, DOI 10.1177/039463201102400410; Dagklis A, 2009, BLOOD, V114, P26, DOI 10.1182/blood-2008-09-176933; Fazi C, 2011, BLOOD, V118, P6618, DOI 10.1182/blood-2011-05-357251; Fazi C, 2010, CYTOM PART B-CLIN CY, V78B, pS61, DOI 10.1002/cyto.b.20545; Fortuny J, 2005, EUR J CANCER, V41, P1782, DOI 10.1016/j.ejca.2005.04.032; Ghia P, 2008, J INTERN MED, V264, P549, DOI 10.1111/j.1365-2796.2008.02030.x; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Hauswirth AW, 2012, AM J HEMATOL, V87, P721, DOI 10.1002/ajh.23214; La Vecchia C, 2011, METABOLISM, V60, P1357, DOI 10.1016/j.metabol.2011.03.011; Landgren O, 2007, BRIT J HAEMATOL, V139, P791, DOI 10.1111/j.1365-2141.2007.06859.x; Landgren O, 2007, BLOOD, V109, P2198, DOI 10.1182/blood-2006-08-044008; Landgren O, 2009, NEW ENGL J MED, V360, P659, DOI 10.1056/NEJMoa0806122; Marti GE, 2005, BRIT J HAEMATOL, V130, P325, DOI 10.1111/j.1365-2141.2005.05550.x; Marti G, 2007, BRIT J HAEMATOL, V139, P701, DOI 10.1111/j.1365-2141.2007.06865.x; Marwick Charles, 2003, BMJ, V326, P242; Matos DM, 2009, BRIT J HAEMATOL, V147, P339, DOI 10.1111/j.1365-2141.2009.07861.x; Moreira J, 2012, LEUKEMIA, DOI 0.1038/leu.2012.187; Nieto WG, 2009, BLOOD, V114, P33, DOI 10.1182/blood-2009-01-197368; Rawstron AC, 2004, J BIOL REG HOMEOS AG, V18, P155; Rawstron AC, 2008, NEW ENGL J MED, V359, P575, DOI 10.1056/NEJMoa075290; Scarfo L, 2010, SEMIN CANCER BIOL, V20, P384, DOI 10.1016/j.semcancer.2010.08.005; Shim YK, 2007, CYTOM PART B-CLIN CY, V72B, P344, DOI 10.1002/cyto.b.20174; Slager SL, 2011, BLOOD, V117, P1911, DOI 10.1182/blood-2010-09-308205; Smedby KE, 2008, BLOOD, V111, P4029, DOI 10.1182/blood-2007-10-119974; Wu SJ, 2010, BLOOD, V116, P4430, DOI 10.1182/blood-2010-05-285221	28	28	29	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52808	10.1371/journal.pone.0052808	http://dx.doi.org/10.1371/journal.pone.0052808			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285188	Green Published, gold, Green Submitted			2022-12-27	WOS:000313051500064
J	Gotoh, K; Inoue, M; Shiraishi, K; Masaki, T; Chiba, S; Mitsutomi, K; Shimasaki, T; Ando, H; Fujiwara, K; Katsuragi, I; Kakuma, T; Seike, M; Sakata, T; Yoshimatsu, H				Gotoh, Koro; Inoue, Megumi; Shiraishi, Kentaro; Masaki, Takayuki; Chiba, Seiichi; Mitsutomi, Kimihiko; Shimasaki, Takanobu; Ando, Hisae; Fujiwara, Kansuke; Katsuragi, Isao; Kakuma, Tetsuya; Seike, Masataka; Sakata, Toshiie; Yoshimatsu, Hironobu			Spleen-Derived Interleukin-10 Downregulates the Severity of High-Fat Diet-Induced Non-Alcoholic Fatty Pancreas Disease	PLOS ONE			English	Article							ANTIINFLAMMATORY ROLE; METABOLIC SYNDROME; IMMUNE FUNCTION; ADIPOSE-TISSUE; STELLATE CELLS; INFLAMMATION; OBESITY; ACTIVATION; EXPRESSION; GHRELIN	Obesity is associated with systemic low-grade inflammation and is a risk factor for non-alcoholic fatty pancreas disease (NAFPD), but the molecular mechanisms of these associations are not clear. Interleukin (IL)-10, a potent anti-inflammatory cytokine, is released during acute pancreatitis and is known to limit inflammatory responses by downregulating the release of proinflammatory mediators. The origin of IL-10 that suppresses pancreatitis has not been investigated. Since obesity is known to reduce expression of proinflammatory cytokines in the spleen, we examined whether spleen-derived IL-10 regulates NAFPD caused by high-fat (HF) diet-induced obesity. The following investigations were performed: 1) IL-10 induction from spleen was examined in male mice fed a HF diet; 2) triglyceride content, expression of pro- and anti-inflammatory cytokines and infiltration of M1 and M2 macrophages were determined to evaluate ectopic fat accumulation and inflammatory responses in the pancreas of splenectomy (SPX)-treated mice fed HF diet; 3) exogenous IL-10 was systemically administered to SPX-treated obese mice and the resulting pathogenesis caused by SPX was assessed; and 4) IL-10 knockout (IL-10KO) mice were treated with SPX and ectopic fat deposition and inflammatory conditions in the pancreas were investigated. Obesity impaired the ability of the spleen to synthesize cytokines, including IL-10. SPX aggravated fat accumulation and inflammatory responses in the pancreas of HF diet-induced obese mice and these effects were inhibited by systemic administration of IL-10. Moreover, SPX had little effect on fat deposition and inflammatory responses in the pancreas of IL-10KO mice. Our findings indicate that obesity reduces IL-10 production by the spleen and that spleen-derived IL-10 may protect against the development of NAFPD.	[Gotoh, Koro; Inoue, Megumi; Shiraishi, Kentaro; Masaki, Takayuki; Chiba, Seiichi; Mitsutomi, Kimihiko; Shimasaki, Takanobu; Ando, Hisae; Fujiwara, Kansuke; Katsuragi, Isao; Kakuma, Tetsuya; Seike, Masataka; Sakata, Toshiie; Yoshimatsu, Hironobu] Oita Univ, Fac Med, Dept Internal Med 1, Yufu City, Oita, Japan	Oita University	Gotoh, K (corresponding author), Oita Univ, Fac Med, Dept Internal Med 1, Yufu City, Oita, Japan.	gotokoro@oita-u.ac.jp		Masaki, Takayuki/0000-0002-2378-849X	Research on Measures for Intractable Diseases from Japan's Ministry of Health, Labor, and Welfare	Research on Measures for Intractable Diseases from Japan's Ministry of Health, Labor, and Welfare	This work was supported by a grant for the Research on Measures for Intractable Diseases from Japan's Ministry of Health, Labor, and Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagiri S, 2008, J CLIN BIOCHEM NUTR, V42, P150, DOI 10.3164/jcbn.2008022; Andres-Hernando A, 2011, AM J PHYSIOL-RENAL, V301, pF907, DOI 10.1152/ajprenal.00107.2011; Bachem MG, 1998, GASTROENTEROLOGY, V115, P421, DOI 10.1016/S0016-5085(98)70209-4; Balasa B, 2000, CELL IMMUNOL, V202, P97, DOI 10.1006/cimm.2000.1658; Blewett HJ, 2009, BRIT J NUTR, V102, P526, DOI 10.1017/S0007114509231722; Bock T, 2003, DIABETES, V52, P1716, DOI 10.2337/diabetes.52.7.1716; Brock P, 2006, J CELL MOL MED, V10, P884, DOI 10.1111/j.1582-4934.2006.tb00532.x; Chowdhury P, 2000, P SOC EXP BIOL MED, V223, P310, DOI 10.1046/j.1525-1373.2000.22344.x; Esposito K, 2003, J CLIN ENDOCR METAB, V88, P1055, DOI 10.1210/jc.2002-021437; Girndt M, 2001, KIDNEY INT, V60, P2385, DOI 10.1046/j.1523-1755.2001.00062.x; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gotoh K, 2012, DIABETES, V61, P1994, DOI 10.2337/db11-1688; Gotoh K, 2012, J NEUROCHEM, V120, P752, DOI 10.1111/j.1471-4159.2011.07617.x; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Jiang Joy, 2008, Metabolic Syndrome and Related Disorders, V6, P1, DOI 10.1089/met.2007.0026; Karmiris K, 2006, INFLAMM BOWEL DIS, V12, P100, DOI 10.1097/01.MIB.0000200345.38837.46; Kerem M, 2007, DIGEST DIS SCI, V52, P950, DOI 10.1007/s10620-006-9150-0; KLOPPEL G, 1992, VIRCHOWS ARCH A, V420, P1, DOI 10.1007/BF01605976; Lamas O, 2004, J PHYSIOL BIOCHEM, V60, P279, DOI 10.1007/BF03167074; Ludwig DS, 2001, J CLIN INVEST, V107, P379, DOI 10.1172/JCI10660; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mathur Abhishek, 2007, HPB (Oxford), V9, P312, DOI 10.1080/13651820701504157; MOORE KW, 1993, ANNU REV IMMUNOL, V11, P165, DOI 10.1146/annurev.iy.11.040193.001121; Navina S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002573; Ostrowski SE, 2004, J VIROL, V78, P8229, DOI 10.1128/JVI.78.15.8229-8237.2004; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; REITAMO S, 1994, J CLIN INVEST, V94, P2489, DOI 10.1172/JCI117618; Rongione AJ, 1997, GASTROENTEROLOGY, V112, P960, DOI 10.1053/gast.1997.v112.pm9041259; Sato-Mito N, 2009, J NUTR HEALTH AGING, V13, P602, DOI 10.1007/s12603-009-0170-2; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Tsukamoto H, 1998, HEPATOLOGY, V28, P1707, DOI 10.1002/hep.510280635; Waters KA, 2007, J SLEEP RES, V16, P388, DOI 10.1111/j.1365-2869.2007.00614.x; Zhang XL, 2008, PANCREAS, V37, pE31, DOI 10.1097/MPA.0b013e3181744b50	37	31	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53154	10.1371/journal.pone.0053154	http://dx.doi.org/10.1371/journal.pone.0053154			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285260	gold, Green Published, Green Submitted			2022-12-27	WOS:000313051500112
J	Leelatanawit, R; Klanchui, A; Uawisetwathana, U; Karoonuthaisiri, N				Leelatanawit, Rungnapa; Klanchui, Amornpan; Uawisetwathana, Umaporn; Karoonuthaisiri, Nitsara			Validation of Reference Genes for Real-Time PCR of Reproductive System in the Black Tiger Shrimp	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; HOUSEKEEPING GENES; BETA-ACTIN; INTERNAL CONTROL; RT-PCR; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; MOLECULAR-CLONING; ATLANTIC SALMON; DIFFERENTIAL EXPRESSION; TESTICULAR DEVELOPMENT	Gene expression of reproductive system of the black tiger shrimp (Peneaus monodon) has been widely studied to address poor maturation problem in captivity. However, a systematic evaluation of reference genes in quantitative real-time PCR (qPCR) for P. monodon reproductive organs is lacking. In this study, the stability of four potential reference genes (18s rRNA, GAPDH, beta-actin, and EF1-alpha) was examined in the reproductive tissues in various conditions using bioinformatic tools: NormFinder and geNorm. For NormFinder, EF1-alpha and GAPDH ranked first and second as the most stable genes in testis groups whereas GAPDH and EF1-alpha were for ovaries from wild-caught broodstock and domesticated groups. EF1-alpha and beta-actin ranked first and second for the eyestalk ablated ovaries. For geNorm, EF1-alpha and GAPDH had the best stability in all testis and ovaries from domesticated groups whereas EF1-alpha and beta-actin were the best for ovaries from wild-caught and eyestalk ablated groups. Moreover, the expression levels of two well-known reproductive genes, Dmc1 and Vitellogenin, were used to validate these reference genes. When normalized to EF1-alpha, the expected expression patterns were obtained in all cases. Therefore, this work suggests that EF1-alpha is more versatile as reference genes in qPCR analysis for reproductive system in P. monodon.	[Leelatanawit, Rungnapa; Klanchui, Amornpan; Uawisetwathana, Umaporn; Karoonuthaisiri, Nitsara] Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol, Microarray Lab, Klongluang, Pathumthani, Thailand	National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC)	Karoonuthaisiri, N (corresponding author), Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol, Microarray Lab, Klongluang, Pathumthani, Thailand.	nitsara.kar@biotec.or.th	Uawisetwathana, Umaporn/E-8974-2011		National Center for Genetic Engineering and Biotechnology (BIOTEC, Thailand); Cluster and Program Management Office of the National Science and Technology Development Agency, Thailand [P10-10467]	National Center for Genetic Engineering and Biotechnology (BIOTEC, Thailand); Cluster and Program Management Office of the National Science and Technology Development Agency, Thailand	This research is supported by the National Center for Genetic Engineering and Biotechnology (BIOTEC, Thailand) and Cluster and Program Management Office of the National Science and Technology Development Agency, Thailand (Grant number: P10-10467 and URL:http://www.nstda.or.th/scholarship). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Antony SP, 2011, IMMUNOBIOLOGY, V216, P184, DOI 10.1016/j.imbio.2010.05.030; Arts JAJ, 2007, FISH SHELLFISH IMMUN, V23, P504, DOI 10.1016/j.fsi.2006.08.018; Baillet A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026950; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Buaklin A, 2011, IDENTIFICATION EXPRE; Cale JM, 1997, J SOC GYNECOL INVEST, V4, P284, DOI 10.1016/S1071-5576(97)00067-1; Calvo EL, 1997, BIOCHEM BIOPH RES CO, V235, P636, DOI 10.1006/bbrc.1997.6716; Carlyle WC, 1996, J MOL CELL CARDIOL, V28, P53, DOI 10.1006/jmcc.1996.0006; Carrillo-Casas EM, 2008, CURR MICROBIOL, V56, P539, DOI 10.1007/s00284-008-9096-x; CHU KH, 1993, FISH RES, V18, P187, DOI 10.1016/0165-7836(93)90152-W; Deindl E, 2002, MOL CELL BIOCHEM, V236, P139, DOI 10.1023/A:1016166127465; Dhar AK, 2009, MOL IMMUNOL, V46, P1688, DOI 10.1016/j.molimm.2009.02.020; Ding ZJ, 2001, SEX PLANT REPROD, V13, P285, DOI 10.1007/s004970100065; DIRNHOFER S, 1995, TRENDS GENET, V11, P380, DOI 10.1016/S0168-9525(00)89115-5; Doutriaux MP, 1998, MOL GEN GENET, V257, P283, DOI 10.1007/s004380050649; Filby AL, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-10; Foldager CB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-94; Foss DL, 1998, ANIM BIOTECHNOL, V9, P67, DOI 10.1080/10495399809525893; Goidin D, 2001, ANAL BIOCHEM, V295, P17, DOI 10.1006/abio.2001.5171; Habu T, 1996, NUCLEIC ACIDS RES, V24, P470, DOI 10.1093/nar/24.3.470; He JQ, 2008, EUR RESPIR J, V32, P755, DOI 10.1183/09031936.00129107; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Infante C, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-28; Infante C, 2008, BMC MOL BIOL, V9, DOI [10.1186/1471-2199-9-19, 10.1186/1471-2199-9-28]; Ingerslev HC, 2006, MOL IMMUNOL, V43, P1194, DOI 10.1016/j.molimm.2005.07.009; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Jemiolo B, 2004, BIOCHEM BIOPH RES CO, V320, P1043, DOI 10.1016/j.bbrc.2004.05.223; Jian B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-59; Kajiura-Kobayashi H, 2005, DEV DYNAM, V232, P1115, DOI 10.1002/dvdy.20289; Khanlou KM, 2012, PLANTA, V236, P1381, DOI 10.1007/s00425-012-1682-2; Kim YK, 2005, ZOOL SCI, V22, P675, DOI 10.2108/zsj.22.675; Kortner TM, 2011, AQUACULTURE, V318, P355, DOI 10.1016/j.aquaculture.2011.05.038; Krussel JS, 1998, J CLIN ENDOCR METAB, V83, P953, DOI 10.1210/jc.83.3.953; Leelatanawit R, 2009, COMP BIOCHEM PHYS A, V152, P66, DOI 10.1016/j.cbpa.2008.09.004; Leelatanawit R, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-15; Leelatanawit R, 2008, BMB REP, V41, P796, DOI 10.5483/BMBRep.2008.41.11.796; Luo T, 2007, MOL IMMUNOL, V44, P1516, DOI 10.1016/j.molimm.2006.09.015; MANSUR NR, 1993, NUCLEIC ACIDS RES, V21, P993, DOI 10.1093/nar/21.4.993; McCurley AT, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-102; Okutsu T, 2010, FISHERIES SCI, V76, P961, DOI 10.1007/s12562-010-0295-6; Olsvik PA, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-21; Ozaki Y, 2006, COMP BIOCHEM PHYS B, V143, P309, DOI 10.1016/j.cbpb.2005.12.008; Pfennig F, 2012, REPRODUCTION, V143, P71, DOI 10.1530/REP-11-0292; Phiriyangkul P, 2007, MOL REPROD DEV, V74, P1198, DOI 10.1002/mrd.20629; Pongsomboon S, 2008, DIFFERENTIALLY EXPRE; PUISSANT C, 1994, EUR J ENDOCRINOL, V130, P522, DOI 10.1530/eje.0.1300522; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Sellars MJ, 2007, J BIOTECHNOL, V129, P391, DOI 10.1016/j.jbiotec.2007.01.029; Somboonwiwat K, 2006, DIFFERENTIALLY EXPRE; SPANAKIS E, 1993, NUCLEIC ACIDS RES, V21, P3809, DOI 10.1093/nar/21.16.3809; Stielow B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001203; Takanami T, 1998, DNA Res, V5, P373, DOI 10.1093/dnares/5.6.373; TANFERMIN JD, 1989, AQUACULTURE, V77, P229, DOI 10.1016/0044-8486(89)90205-6; Tharntada S, 2009, J GEN VIROL, V90, P1491, DOI 10.1099/vir.0.009621-0; Tsutsui N, 2000, ZOOL SCI, V17, P651, DOI 10.2108/zsj.15.651; Uawisetwathana U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024427; Underwood DJ, 2010, AQUACULTURE, V308, P82, DOI 10.1016/j.aquaculture.2010.08.027; Van Hiel MB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-56; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wongsurawat T, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-55; Yang YF, 2005, J APPL PHYSIOL, V98, P1745, DOI 10.1152/japplphysiol.01185.2004; Yoshida K, 1998, MOL CELL, V1, P707, DOI 10.1016/S1097-2765(00)80070-2; Zhang W, 2011, GENET MOL BIOL, V34, P136, DOI 10.1590/S1415-47572010005000099; Zhang ZB, 2007, TOXICOL SCI, V95, P356, DOI 10.1093/toxsci/kfl161; Zhou FL, 2011, MOL BIOL REP, V38, P1921, DOI 10.1007/s11033-010-0312-y	67	30	31	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52677	10.1371/journal.pone.0052677	http://dx.doi.org/10.1371/journal.pone.0052677			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285145	Green Published, Green Submitted, gold			2022-12-27	WOS:000313051500045
J	Perrin, S; Cremer, J; Faucher, O; Reynes, J; Dellamonica, P; Micallef, J; Solas, C; Lacarelle, B; Stretti, C; Kaspi, E; Robaglia-Schlupp, A; Tamalet, CNBC; Levy, N; Poizot-Martin, I; Cau, P; Roll, P				Perrin, Sophie; Cremer, Jonathan; Faucher, Olivia; Reynes, Jacques; Dellamonica, Pierre; Micallef, Joelle; Solas, Caroline; Lacarelle, Bruno; Stretti, Charlotte; Kaspi, Elise; Robaglia-Schlupp, Andree; Tamalet, Corine Nicolino-Brunet Catherine; Levy, Nicolas; Poizot-Martin, Isabelle; Cau, Pierre; Roll, Patrice			HIV Protease Inhibitors Do Not Cause the Accumulation of Prelamin A in PBMCs from Patients Receiving First Line Therapy: The ANRS EP45 "Aging" Study	PLOS ONE			English	Article							ENCODING LAMIN A/C; SIMULTANEOUS QUANTITATIVE-DETERMINATION; PERFORMANCE LIQUID-CHROMATOGRAPHY; A-TYPE LAMINS; NUCLEAR LAMINS; ADIPOCYTE DIFFERENTIATION; STRUCTURAL ORGANIZATION; RESTRICTIVE DERMOPATHY; INFECTED PATIENTS; LMNA MUTATIONS	Background: The ANRS EP45 "Aging" study investigates the cellular mechanisms involved in the accelerated aging of HIV-1 infected and treated patients. The present report focuses on lamin A processing, a pathway known to be altered in systemic genetic progeroid syndromes. Methods: 35 HIV-1 infected patients being treated with first line antiretroviral therapy (ART, mean duration at inclusion: 2.7 +/- 1.3 years) containing boosted protease inhibitors (PI/r) (comprising lopinavir/ritonavir in 65% of patients) were recruited together with 49 seronegative age- and sex-matched control subjects (http://clinicaltrials.gov/, NCT01038999). In more than 88% of patients, the viral load was <40 copies/ml and the CD4+ cell count was >500/mm(3). Prelamin A processing in peripheral blood mononuclear cells (PBMCs) from patients and controls was analysed by western blotting at inclusion. PBMCs from patients were also investigated at 12 and 24 months after enrolment in the study. PBMCs from healthy controls were also incubated with boosted lopinavir in culture medium containing various concentrations of proteins (4 to 80 g/L). Results: Lamin A precursor was not observed in cohort patient PBMC regardless of the PI/r used, the dose and the plasma concentration. Prelamin A was detected in PBMC incubated in culture medium containing a low protein concentration (4 g/L) but not in plasma (60-80 g/L) or in medium supplemented with BSA (40 g/L), both of which contain a high protein concentration. Conclusions: Prelamin A processing abnormalities were not observed in PBMCs from patients under the PI/r first line regimen. Therefore, PI/r do not appear to contribute to lamin A-related aging in PBMCs. In cultured PBMCs from healthy donors, prelamin A processing abnormalities were only observed when the protein concentration in the culture medium was low, thus increasing the amount of PI available to enter cells. ClinicalTrials.gov NCT01038999 http://clinicaltrials.gov/ ct2/show/NCT01038999.	[Perrin, Sophie; Cremer, Jonathan; Stretti, Charlotte; Kaspi, Elise; Robaglia-Schlupp, Andree; Levy, Nicolas; Cau, Pierre; Roll, Patrice] Aix Marseille Univ, UMR S 910, INSERM, Marseille, France; [Perrin, Sophie; Cremer, Jonathan; Stretti, Charlotte; Kaspi, Elise; Robaglia-Schlupp, Andree; Cau, Pierre; Roll, Patrice] CHU La Timone, APHM, Biol Cellulaire Lab, Marseille, France; [Faucher, Olivia] CHU St Marguerite, APHM, Serv Immunohematol Clin, Marseille, France; [Reynes, Jacques; Poizot-Martin, Isabelle] CHRU, Dept Malad Infect & Tropicales, Montpellier, France; [Dellamonica, Pierre] Sophia Antipolis Univ, CHU LArchet, Serv Infectiol, Nice, France; [Micallef, Joelle] CHU La Timone, APHM, CIC UPCET, Marseille, France; [Solas, Caroline; Lacarelle, Bruno] CHU La Timone, APHM, Lab Pharmacocinet & Toxicol, Marseille, France; [Solas, Caroline; Lacarelle, Bruno] Aix Marseille Univ, UMR S 911, INSERM, Marseille, France; CHU La Conception, APHM, Hematol Lab, Marseille, France; CHU La Timone, APHM, Federat Microbiol Clin, Marseille, France; [Tamalet, Corine Nicolino-Brunet Catherine] Aix Marseille Univ, CNRS, IRD, UM 63, Marseille, France; [Levy, Nicolas] CHU La Timone, APHM, Lab Genet Mol, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite de Montpellier; CHU de Montpellier; CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Roll, P (corresponding author), Aix Marseille Univ, UMR S 910, INSERM, Marseille, France.	patrice.roll@univ-amu.fr	Kaspi, Elise/I-4936-2016; LEVY, Nicolas/J-1632-2014; Joëlle, Micallef/P-6977-2016; ROLL, Patrice/GLS-4467-2022; lacarelle, bruno/C-5585-2015; ROLL, Patrice/I-4355-2016; Cau, Pierre/M-3541-2016	Kaspi, Elise/0000-0003-0458-5109; LEVY, Nicolas/0000-0001-5171-6365; ROLL, Patrice/0000-0002-0045-5641; lacarelle, bruno/0000-0002-7122-5851; ROLL, Patrice/0000-0002-0045-5641; Perrin, Sophie/0000-0003-4950-283X	French National Agency for Research on AIDS and Viral Hepatitis (ANRS) [ANRS EP45]; ANRS; Sidaction [B/22-2-02032]; ADEREM (Biological and medical research supportive association for Marseille hospital centres); Boehringer Mannheim	French National Agency for Research on AIDS and Viral Hepatitis (ANRS)(ANRSFrench National Research Agency (ANR)); ANRS(ANRSFrench National Research Agency (ANR)); Sidaction; ADEREM (Biological and medical research supportive association for Marseille hospital centres); Boehringer Mannheim	This work was supported by the French National Agency for Research on AIDS and Viral Hepatitis (ANRS, http://www.anrs.fr/) [ANRS EP45 "Aging" to PC]. SP was a recipient of a 3-year PhD grant from ANRS [ANRS EP45 "Aging" to PC] and an additional one-year PhD grant from Sidaction (http://www.sidaction.org/) [B/22-2-02032 to SP]. SP received a 3-month transition grant from ADEREM (Biological and medical research supportive association for Marseille hospital centres, http://aderem.fr/index.htm). JC was a recipient of a grant from Sidaction [A/19-3-01487 to PC]. PC was a recipient of grants from GlaxoSmithKline and from Boehringer Mannheim. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres V, 2009, J CELL BIOL, V187, P945, DOI 10.1083/jcb.200904124; Arab-Alameddine M, 2011, EXPERT OPIN DRUG MET; Bastard JP, 2002, LANCET, V359, P1026, DOI 10.1016/S0140-6736(02)08094-7; Bazzoli C, 2010, CLIN PHARMACOKINET, V49, P17, DOI 10.2165/11318110-000000000-00000; Bereziat V, 2011, AM J PATHOL, V179, P2443, DOI 10.1016/j.ajpath.2011.07.049; Bergo MO, 2002, P NATL ACAD SCI USA, V99, P13049, DOI 10.1073/pnas.192460799; Boffito M, 2003, AIDS RES HUM RETROV, V19, P825, DOI 10.1089/088922203769232629; Boguslavsky RL, 2006, HUM MOL GENET, V15, P653, DOI 10.1093/hmg/ddi480; Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799; Broers JLV, 2006, PHYSIOL REV, V86, P967, DOI 10.1152/physrev.00047.2005; Caron M, 2007, CELL DEATH DIFFER, V14, P1759, DOI 10.1038/sj.cdd.4402197; Caron M, 2003, AIDS, V17, P2437, DOI 10.1097/00002030-200311210-00005; Caron M, 2001, DIABETES, V50, P1378, DOI 10.2337/diabetes.50.6.1378; Coffinier C, 2008, J BIOL CHEM, V283, P9797, DOI 10.1074/jbc.M709629200; Coffinier C, 2007, P NATL ACAD SCI USA, V104, P13432, DOI 10.1073/pnas.0704212104; Cohen J, 2011, SCIENCE, V334, P1614, DOI 10.1126/science.334.6063.1614; Colombo S, 2004, J CHROMATOGR B, V810, P25, DOI 10.1016/j.jchromb.2004.07.008; Corrigan DP, 2005, BIOCHEM J, V387, P129, DOI 10.1042/BJ20041359; de Noronha CMC, 2001, SCIENCE, V294, P1105, DOI 10.1126/science.1063957; De Sandre-Giovannoli A, 2002, AM J HUM GENET, V70, P726, DOI 10.1086/339274; Decaudain A, 2007, J CLIN ENDOCR METAB, V92, P4835, DOI 10.1210/jc.2007-0654; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; Deeks SG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3172; Di Mascio M, 2009, ANTIMICROB AGENTS CH, V53, P4086, DOI 10.1128/AAC.00419-09; Dutour A, 2011, HUM MOL GENET, V20, P3779, DOI 10.1093/hmg/ddr294; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Fatkin D, 1999, NEW ENGL J MED, V341, P1715, DOI 10.1056/NEJM199912023412302; Ford J, 2004, J ANTIMICROB CHEMOTH, V54, P982, DOI 10.1093/jac/dkh487; Garg A, 2011, J CLIN ENDOCR METAB, V96, P3313, DOI 10.1210/jc.2011-1159; Ghosh AK, 2008, ACCOUNTS CHEM RES, V41, P78, DOI 10.1021/ar7001232; Guaraldi G, 2011, CLIN INFECT DIS, V53, P1120, DOI 10.1093/cid/cir627; Hartkoorn RC, 2010, PHARMACOGENET GENOM, V20, P112, DOI 10.1097/FPC.0b013e328335b02d; Hennekam RCM, 2006, AM J MED GENET A, V140A, P2603, DOI 10.1002/ajmg.a.31346; Hudon SE, 2008, BIOCHEM BIOPH RES CO, V374, P365, DOI 10.1016/j.bbrc.2008.07.033; Janneh O, 2008, BRIT J PHARMACOL, V155, P875, DOI 10.1038/bjp.2008.320; Justesen US, 2003, J CHROMATOGR B, V783, P491, DOI 10.1016/S1570-0232(02)00728-6; Kudlow BA, 2005, AIDS, V19, P1565, DOI 10.1097/01.aids.0000186827.91408.90; Lafeuillade Alain, 2002, HIV Clin Trials, V3, P27; Lefevre C, 2010, ARTERIOSCL THROM VAS, V30, P2611, DOI 10.1161/ATVBAHA.110.213603; LIN F, 1993, J BIOL CHEM, V268, P16321; Liu Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010874; LUTZ RJ, 1992, P NATL ACAD SCI USA, V89, P3000, DOI 10.1073/pnas.89.7.3000; Marsh KC, 1997, J CHROMATOGR B, V704, P307, DOI 10.1016/S0378-4347(97)00454-4; Marzolini C, 2002, J CHROMATOGR B, V774, P127, DOI 10.1016/S1570-0232(02)00169-1; Miranda M, 2007, JAIDS-J ACQ IMM DEF, V46, P384, DOI 10.1097/QAI.0b013e31815aba1b; Muchir A, 2000, HUM MOL GENET, V9, P1453, DOI 10.1093/hmg/9.9.1453; Mukhopadhyay A, 2002, MITOCHONDRION, V1, P511, DOI 10.1016/S1567-7249(02)00042-9; Muranyi W, 2002, SCIENCE, V297, P854, DOI 10.1126/science.1071506; Navarro CL, 2004, HUM MOL GENET, V13, P2493, DOI 10.1093/hmg/ddh265; Navarro CL, 2005, HUM MOL GENET, V14, P1503, DOI 10.1093/hmg/ddi159; Navarro CL, 2006, HUM MOL GENET, V15, pR151, DOI 10.1093/hmg/ddl214; Oldfield V, 2006, DRUGS, V66, P1275, DOI 10.2165/00003495-200666090-00012; Patterson KB, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003174; Pendas AM, 2002, NAT GENET, V31, P94, DOI 10.1038/ng871; Perrin S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041129; Prokocimer M, 2009, J CELL MOL MED, V13, P1059, DOI [10.1111/j.1582-4934.2009.00676.x, 10.1111/j.1582-4934.2008.00676.x]; Prot M, 2006, ANTIMICROB AGENTS CH, V50, P3998, DOI 10.1128/AAC.00625-06; Quaranta S, 2009, THER DRUG MONIT, V31, P695, DOI 10.1097/FTD.0b013e3181c05adf; Ragnauth CD, 2010, CIRCULATION, V121, P2200, DOI 10.1161/CIRCULATIONAHA.109.902056; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Scott ES, 2001, J VIROL, V75, P8818, DOI 10.1128/JVI.75.18.8818-8830.2001; Shackleton S, 2000, NAT GENET, V24, P153, DOI 10.1038/72807; Turriziani O, 2008, J MED VIROL, V80, P766, DOI 10.1002/jmv.21152; van Heeswijk RPG, 1998, J CHROMATOGR B, V719, P159, DOI 10.1016/S0378-4347(98)00392-2; Varela I, 2008, NAT MED, V14, P767, DOI 10.1038/nm1786; Yeni, 2010, PRISE CHARGE MED PER	67	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53035	10.1371/journal.pone.0053035	http://dx.doi.org/10.1371/journal.pone.0053035			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285253	gold, Green Published			2022-12-27	WOS:000313051500104
J	Qu, ZW; Miao, WY; Hu, SQ; Li, C; Zhuo, XL; Zong, YY; Wu, YP; Zhang, GY				Qu, Zhong-Wei; Miao, Wan-Ying; Hu, Shu-Qun; Li, Chong; Zhuo, Xing-Li; Zong, Yan-Yan; Wu, Yong-Ping; Zhang, Guang-Yi			N-Methyl-D-Aspartate Receptor-Dependent Denitrosylation of Neuronal Nitric Oxide Synthase Increase the Enzyme Activity	PLOS ONE			English	Article							PROTEIN-KINASE-II; S-NITROSYLATION; SER(847) PHOSPHORYLATION; THIOREDOXIN REDUCTASE; SIGNALING PATHWAY; NOS ACTIVITY; ISCHEMIA; BRAIN; EXPRESSION; HIPPOCAMPUS	Our laboratory once reported that neuronal nitric oxide synthase (nNOS) S-nitrosylation was decreased in rat hippocampus during cerebral ischemia-reperfusion, but the underlying mechanism was unclear. In this study, we show that nNOS activity is dynamically regulated by S-nitrosylation. We found that overexpressed nNOS in HEK293 (human embryonic kidney) cells could be S-nitrosylated by exogenous NO donor GSNO and which is associated with the enzyme activity decrease. Cys(331), one of the zinc-tetrathiolate cysteines, was identified as the key site of nNOS S-nitrosylation. In addition, we also found that nNOS is highly S-nitrosylated in resting rat hippocampal neurons and the enzyme undergos denitrosylation during the process of rat brain ischemia/reperfusion. Intrestingly, the process of nNOS denitrosylation is coupling with the decrease of nNOS phosphorylation at Ser(847), a site associated with nNOS activation. Further more, we document that nNOS denitrosylation could be suppressed by pretreatment of neurons with MK801, an antagonist of NMDAR, GSNO, EGTA, BAPTA, W-7, an inhibitor of calmodulin as well as TrxR1 antisense oligonucleotide (AS-ODN) respectively. Taken together, our data demonstrate that the denitrosylation of nNOS induced by calcium ion influx is a NMDAR-dependent process during the early stage of ischemia/reperfusion, which is majorly mediated by thioredoxin-1 (Trx1) system. nNOS dephosphorylation may be induced by the enzyme denitrosylation, which suggest that S-nitrosylation/denitrosylation of nNOS may be an important mechanism in regulating the enzyme activity.	[Qu, Zhong-Wei; Miao, Wan-Ying; Hu, Shu-Qun; Li, Chong; Zhuo, Xing-Li; Zong, Yan-Yan; Zhang, Guang-Yi] Xuzhou Med Coll, Jiangsu Key Lab Brain Dis Bioinformat, Res Ctr Biochem & Mol Biol, Xuzhou, Jiangsu, Peoples R China; [Wu, Yong-Ping] Xuzhou Med Coll, Jiangsu Key Lab Anesthesiol, Xuzhou, Jiangsu, Peoples R China	Xuzhou Medical University; Xuzhou Medical University	Zhang, GY (corresponding author), Xuzhou Med Coll, Jiangsu Key Lab Brain Dis Bioinformat, Res Ctr Biochem & Mol Biol, Xuzhou, Jiangsu, Peoples R China.	gyzhang@xzmc.edu.cn		Miao, Wanying/0000-0003-3972-2572; Zhongwei, Qu/0000-0002-6994-0530	National Natural Science Foudation of China [81271267, 31000360]; Education Departmental Nature Science Funds of Jiangsu Province [10KJA310053]; Science and Technology Bureau of Xuzhou [XF10C077]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Qing Lan Project; "Six Talent Peaks Program'' of Jiangsu Province	National Natural Science Foudation of China(National Natural Science Foundation of China (NSFC)); Education Departmental Nature Science Funds of Jiangsu Province; Science and Technology Bureau of Xuzhou; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Qing Lan Project(Jiangsu Polytech Institute); "Six Talent Peaks Program'' of Jiangsu Province	This work was supported by grants from the National Natural Science Foudation of China (81271267; 31000360;), the Education Departmental Nature Science Funds of Jiangsu Province (10KJA310053), the Science and Technology Bureau of Xuzhou (XF10C077), the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), the Qing Lan Project. Dr. Chong Li was supported by "Six Talent Peaks Program'' of Jiangsu Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuSoud HM, 1996, J BIOL CHEM, V271, P32515, DOI 10.1074/jbc.271.51.32515; Andrew PJ, 1999, CARDIOVASC RES, V43, P521, DOI 10.1016/S0008-6363(99)00115-7; Anema SM, 1999, BIOCHEM J, V342, P111, DOI 10.1042/0264-6021:3420111; Benhar M, 2009, NAT REV MOL CELL BIO, V10, P721, DOI 10.1038/nrm2764; Black SM, 1999, AM J PHYSIOL-HEART C, V277, pH1849, DOI 10.1152/ajpheart.1999.277.5.H1849; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; CHEN PF, 1995, BIOCHEM BIOPH RES CO, V215, P1119, DOI 10.1006/bbrc.1995.2579; Chvanov M, 2006, EMBO J, V25, P3024, DOI 10.1038/sj.emboj.7601207; Crane MS, 2009, BBA-GEN SUBJECTS, V1790, P1191, DOI 10.1016/j.bbagen.2009.07.001; Davis SM, 2000, STROKE, V31, P347, DOI 10.1161/01.STR.31.2.347; DAWSON VL, 1991, P NATL ACAD SCI USA, V88, P6368, DOI 10.1073/pnas.88.14.6368; Erwin PA, 2005, J BIOL CHEM, V280, P19888, DOI 10.1074/jbc.M413058200; FIX AS, 1993, EXP NEUROL, V123, P204, DOI 10.1006/exnr.1993.1153; Gu ZZ, 2002, SCIENCE, V297, P1186, DOI 10.1126/science.1073634; Hayashi Y, 1999, J BIOL CHEM, V274, P20597, DOI 10.1074/jbc.274.29.20597; Hemmens B, 2000, J BIOL CHEM, V275, P35786, DOI 10.1074/jbc.M005976200; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Holmgren A, 2010, BIOCHEM BIOPH RES CO, V396, P120, DOI 10.1016/j.bbrc.2010.03.083; HURSHMAN AR, 1995, BIOCHEMISTRY-US, V34, P5627, DOI 10.1021/bi00016a038; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; Jaffrey SR, 2005, METHOD ENZYMOL, V396, P105, DOI 10.1016/S0076-6879(05)96011-4; Kalinina EV, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1493, DOI 10.1134/S0006297908130099; KENNEDY MB, 1995, TRENDS BIOCHEM SCI, V20, P350, DOI 10.1016/S0968-0004(00)89074-X; Keynes RG, 2004, CURR MOL MED, V4, P179, DOI 10.2174/1566524043479176; Kolodziejski PJ, 2003, P NATL ACAD SCI USA, V100, P14263, DOI 10.1073/pnas.2435290100; Komeima K, 2000, J BIOL CHEM, V275, P28139; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; Lipton SA, 2002, TRENDS NEUROSCI, V25, P474, DOI 10.1016/S0166-2236(02)02245-2; Lopez-Sanchez LM, 2008, METHOD ENZYMOL, V440, P273, DOI [10.1016/S0076-6879(07)00877-8, 10.1016/S0076-6879(07)00817-8]; Ma KW, 2006, J BIOL CHEM, V281, P21250, DOI 10.1074/jbc.M600521200; Martasek P, 1998, J BIOL CHEM, V273, P34799, DOI 10.1074/jbc.273.52.34799; Morris GF, 1999, J NEUROSURG, V91, P737, DOI 10.3171/jns.1999.91.5.0737; Osuka K, 2002, J CEREBR BLOOD F MET, V22, P1098, DOI 10.1097/00004647-200209000-00007; Otani H, 2004, J PHARMACOL SCI, V96, P188, DOI 10.1254/jphs.FP0040385; Pei DS, 2008, J NEUROCHEM, V106, P1952, DOI 10.1111/j.1471-4159.2008.05531.x; Pei DS, 2009, NEUROCHEM RES, V34, P1507, DOI 10.1007/s11064-009-9938-3; PULSINELLI WA, 1979, STROKE, V10, P267, DOI 10.1161/01.STR.10.3.267; Raman CS, 1998, CELL, V95, P939, DOI 10.1016/S0092-8674(00)81718-3; Rameau GA, 2004, J BIOL CHEM, V279, P14307, DOI 10.1074/jbc.M311103200; Rameau GA, 2000, NEUROPHARMACOLOGY, V39, P2255, DOI 10.1016/S0028-3908(00)00066-6; Ravi K, 2004, P NATL ACAD SCI USA, V101, P2619, DOI 10.1073/pnas.0300464101; Samdani AF, 1997, STROKE, V28, P1283, DOI 10.1161/01.STR.28.6.1283; Sheehy AM, 1998, AM J PHYSIOL-LUNG C, V274, pL833, DOI 10.1152/ajplung.1998.274.5.L833; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P444, DOI 10.1073/pnas.89.1.444; Stuart-Smith K, 2002, J CLIN PATHOL-MOL PA, V55, P360, DOI 10.1136/mp.55.6.360; Trujillo M, 1998, J BIOL CHEM, V273, P7828, DOI 10.1074/jbc.273.14.7828; Watanabe Y, 2003, BIOCHEM J, V372, P465, DOI 10.1042/BJ20030380; Yan XB, 2004, ACTA PHARMACOL SIN, V25, P617; Yu HM, 2008, NEUROSCIENCE, V155, P1120, DOI 10.1016/j.neuroscience.2008.03.061; Yuan GJ, 2006, WORLD J GASTROENTERO, V12, P2375, DOI 10.3748/wjg.v12.i15.2375; Zai A, 1999, J CLIN INVEST, V103, P393, DOI 10.1172/JCI4890; Zhang J, 2011, J BIOL CHEM, V286, P7669, DOI 10.1074/jbc.M110.156299; Zheng Y, 2005, J CELL PHYSIOL, V205, P97, DOI 10.1002/jcp.20378	54	27	27	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52788	10.1371/journal.pone.0052788	http://dx.doi.org/10.1371/journal.pone.0052788			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285183	Green Submitted, gold, Green Published			2022-12-27	WOS:000313051500062
J	Shi, HT; Wang, YP; Cheng, ZM; Ye, TT; Chan, ZL				Shi, Haitao; Wang, Yanping; Cheng, Zhangmin; Ye, Tiantian; Chan, Zhulong			Analysis of Natural Variation in Bermudagrass (Cynodon dactylon) Reveals Physiological Responses Underlying Drought Tolerance	PLOS ONE			English	Article							WARM-SEASON TURFGRASSES; ARABIDOPSIS-THALIANA; RESISTANCE MECHANISMS; OXIDATIVE STRESS; SALT; PROTEINS; SURFACE; GENE; TRANSVAALENSIS; IDENTIFICATION	Bermudagrass (Cynodon dactylon) is a widely used warm-season turfgrass and one of the most drought tolerant species. Dissecting the natural variation in drought tolerance and physiological responses will bring us powerful basis and novel insight for plant breeding. In the present study, we evaluated the natural variation of drought tolerance among nine bermudagrass varieties by measuring physiological responses after drought stress treatment through withholding water. Three groups differing in drought tolerance were identified, including two tolerant, five moderately tolerant and two susceptible varieties. Under drought stress condition, drought sensitive variety (Yukon) showed relative higher water loss, more severe cell membrane damage (EL), and more accumulation of hydrogen peroxide (H2O2) and malondialdehyde (MDA), while drought tolerant variety (Tifgreen) exhibited significantly higher antioxidant enzymes activities. Further results indicated that drought induced cell injury in different varieties (Yukon, SR9554 and Tifgreen) exhibited liner correlation with leaf water content (LWC), H2O2 content, MDA content and antioxidant enzyme activities. Additionally, Tifgreen plants had significantly higher levels of osmolytes (proline level and soluble sugars) when compared with Yukon and SR9554 under drought stress condition. Taken together, our results indicated that natural variation of drought stress tolerance in bermudagrass varieties might be largely related to the induced changes of water status, osmolyte accumulation and antioxidant defense system.	[Shi, Haitao; Wang, Yanping; Cheng, Zhangmin; Ye, Tiantian; Chan, Zhulong] Chinese Acad Sci, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan Bot Garden, Wuhan, Peoples R China; [Cheng, Zhangmin; Ye, Tiantian] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Chan, ZL (corresponding author), Chinese Acad Sci, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan Bot Garden, Wuhan, Peoples R China.	zhulongch@wbgcas.cn	Chan, Zhulong/AAM-5018-2020	Chan, Zhulong/0000-0002-1933-6837; Wang, Yanping/0000-0003-4391-0883	Hundred Talents Program; Knowledge Innovative Key Program of Chinese Academy of Sciences [54Y154761O01076]	Hundred Talents Program(Chinese Academy of Sciences); Knowledge Innovative Key Program of Chinese Academy of Sciences	This research was supported by "the Hundred Talents Program'', the Knowledge Innovative Key Program of Chinese Academy of Sciences (Grant No. 54Y154761O01076) to Z. Chan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Blanco C, 2009, PLANT CELL, V21, P1877, DOI 10.1105/tpc.109.068114; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Bechtold U, 2010, PLANT CELL ENVIRON, V33, P1959, DOI 10.1111/j.1365-3040.2010.02198.x; Benfey PN, 2008, SCIENCE, V320, P495, DOI 10.1126/science.1153716; Bian SM, 2009, SCI HORTIC-AMSTERDAM, V120, P264, DOI 10.1016/j.scienta.2008.10.014; Bouchabke O, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001705; Campbell SA, 1997, NEW PHYTOL, V137, P61, DOI 10.1046/j.1469-8137.1997.00831.x; Carmo-Silva AE, 2008, PHOTOSYNTH RES, V97, P223, DOI 10.1007/s11120-008-9329-7; Carmo-Silva AE, 2009, PHYTOCHEMISTRY, V70, P664, DOI 10.1016/j.phytochem.2009.03.001; CARROW RN, 1995, CROP SCI, V35, P1685, DOI 10.2135/cropsci1995.0011183X003500060029x; Carrow RN, 1996, CROP SCI, V36, P687, DOI 10.2135/cropsci1996.0011183X003600020026x; Chan ZL, 2012, PLANT BIOTECHNOL J, V10, P284, DOI 10.1111/j.1467-7652.2011.00661.x; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; He ZY, 2008, CELL BIOL INT, V32, P367, DOI 10.1016/j.cellbi.2007.12.003; Hu LX, 2012, J PLANT PHYSIOL, V169, P146, DOI 10.1016/j.jplph.2011.08.020; Hu LX, 2010, PHYSIOL PLANTARUM, V139, P93, DOI 10.1111/j.1399-3054.2010.01350.x; Hu LX, 2010, J PLANT PHYSIOL, V167, P103, DOI 10.1016/j.jplph.2009.07.008; Huang B, 1997, CROP SCI, V37, P1858, DOI 10.2135/cropsci1997.0011183X003700060032x; Huang B, 1997, CROP SCI, V37, P1863, DOI 10.2135/cropsci1997.0011183X003700060033x; Kim C, 2009, PLANT MOL BIOL, V70, P1, DOI 10.1007/s11103-009-9453-6; Lindermayr C, 2005, PLANT PHYSIOL, V137, P921, DOI 10.1104/pp.104.058719; Lu SY, 2007, PLANT CELL REP, V26, P1413, DOI 10.1007/s00299-007-0339-2; Lu SY, 2009, PLANT CELL REP, V28, P517, DOI 10.1007/s00299-008-0649-z; Luo N, 2011, PHYSIOL PLANTARUM, V141, P19, DOI 10.1111/j.1399-3054.2010.01413.x; Luo Y, 2008, ENVIRON EXP BOT, V63, P378, DOI 10.1016/j.envexpbot.2007.11.016; MAEHLY AC, 1954, METHOD BIOCHEM ANAL, V1, P357; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Peskin AV, 2000, CLIN CHIM ACTA, V293, P157, DOI 10.1016/S0009-8981(99)00246-6; Qian Y, 1997, CROP SCI, V47, P2162, DOI DOI 10.2135/CROPSCI1997.0011183X003700030034X; Shi HT, 2012, PLANT CELL PHYSIOL, V53, P344, DOI 10.1093/pcp/pcr181; Shukla N, 2012, PLANT PHYSIOL BIOCH, V54, P78, DOI 10.1016/j.plaphy.2012.02.001; Thamsen M, 2011, CURR OPIN CHEM BIOL, V15, P113, DOI 10.1016/j.cbpa.2010.11.013; Wang XL, 2010, BIOCHEMISTRY-MOSCOW+, V75, P201, DOI 10.1134/S0006297910020100; Xu CP, 2010, J PLANT PHYSIOL, V167, P1477, DOI 10.1016/j.jplph.2010.05.006; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Zhao Y, 2011, PHYSIOL PLANTARUM, V141, P40, DOI 10.1111/j.1399-3054.2010.01419.x; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	38	91	102	3	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53422	10.1371/journal.pone.0053422	http://dx.doi.org/10.1371/journal.pone.0053422			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285294	Green Published, gold, Green Submitted			2022-12-27	WOS:000313051500149
J	Chen, YQ; Yang, Y; Xing, YF; Jiang, S; Sun, XW				Chen, Yan-Qing; Yang, Yang; Xing, Yan-Fen; Jiang, Sen; Sun, Xi-Wen			Detection of Rib Metastases in Patients with Lung Cancer: A Comparative Study of MRI, CT and Bone Scintigraphy	PLOS ONE			English	Article							SKELETAL METASTASES; PET/CT	We retrospectively investigated the imaging findings of bone scintigraphy, chest CT and chest MRI in 55 cases of lung cancer. The sensitivity, specificity and accuracy of the detection of rib metastases were compared between imaging modalities on both a per-lesion and a per-patient basis. On a per-lesion basis, MRI sensitivity and accuracy were significantly higher than that of bone scintigraphy and CT (P<0.05). The sensitivities, specificities, and accuracy levels between CT and bone scintigraphy did not differ on either a per-lesion or per-patient basis (P>0.05). MRI appears to be superior for the detection of ribs metastases in lung cancer.	[Chen, Yan-Qing; Yang, Yang; Xing, Yan-Fen; Jiang, Sen; Sun, Xi-Wen] Tongji Univ, Dept Radiol, Shanghai Pulm Hosp, Sch Med, Shanghai 200092, Peoples R China; [Chen, Yan-Qing; Yang, Yang; Xing, Yan-Fen] Soochow Univ, Sch Med, Suzhou, Jiangsu, Peoples R China	Tongji University; Soochow University - China	Sun, XW (corresponding author), Tongji Univ, Dept Radiol, Shanghai Pulm Hosp, Sch Med, Shanghai 200092, Peoples R China.	xwsun@citiz.net						Baur-Melnyk A, 2009, SEMIN MUSCULOSKEL R, V13, P111, DOI 10.1055/s-0029-1220882; Fischer BM, 2007, ANN ONCOL, V18, P338, DOI 10.1093/annonc/mdl374; Ghanem N, 2005, EUR J RADIOL, V55, P41, DOI 10.1016/j.ejrad.2005.01.016; Groves AM, 2006, EUR RADIOL, V16, P1066, DOI 10.1007/s00330-005-0042-z; Hirano Yasumitsu, 2005, Ann Thorac Cardiovasc Surg, V11, P401; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kagohashi K, 2003, INT J CLIN PRACT, V57, P184; Lane J M, 1997, Instr Course Lect, V46, P445; Paget S, 1989, LANCET, V8, P98, DOI [DOI 10.1016/S0140-6736(00)49915-0, 10.1016/S0140-6736(00)49915-0]; ROLAND SI, 1958, J UROLOGY, V79, P339, DOI 10.1016/S0022-5347(17)66278-5; Schmidt GP, 2009, EUR J RADIOL, V70, P393, DOI 10.1016/j.ejrad.2009.03.045; Sone S, 2007, CANCER METAST REV, V26, P685, DOI 10.1007/s10555-007-9081-z; Takenaka D, 2009, J MAGN RESON IMAGING, V30, P298, DOI 10.1002/jmri.21858; Thomas BG, 2000, PROSTATE CANCER P D, V3, P283, DOI 10.1038/sj.pcan.4500482; Tsuya A, 2007, LUNG CANCER, V57, P229, DOI 10.1016/j.lungcan.2007.03.013; Venkitaraman R, 2009, J MED IMAG RADIAT ON, V53, P241, DOI 10.1111/j.1754-9485.2009.02070.x; Xu Dong-Liang, 2005, Ai Zheng, V24, P1404; Yamaguchi T, 2001, Semin Musculoskelet Radiol, V5, P171, DOI 10.1055/s-2001-15676	19	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52213	10.1371/journal.pone.0052213	http://dx.doi.org/10.1371/journal.pone.0052213			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300617	Green Published, gold, Green Submitted			2022-12-27	WOS:000312829100029
J	Dai, FJ; Chen, YH; Song, YJ; Huang, L; Zhai, D; Dong, YM; Lai, L; Zhang, T; Li, DL; Pang, XF; Liu, MY; Yi, ZF				Dai, Fujun; Chen, Yihua; Song, Yajuan; Huang, Li; Zhai, Dong; Dong, Yanmin; Lai, Li; Zhang, Tao; Li, Dali; Pang, Xiufeng; Liu, Mingyao; Yi, Zhengfang			A Natural Small Molecule Harmine Inhibits Angiogenesis and Suppresses Tumour Growth through Activation of p53 in Endothelial Cells	PLOS ONE			English	Article							P53-MDM2 INTERACTION; DNA-DAMAGE; APOPTOSIS; PROTEIN; VEGF; PHOSPHORYLATION; RESTORATION; REPRESSION; EXPRESSION; COMPOUND	Activation of p53 effectively inhibits tumor angiogenesis that is necessary for tumor growth and metastasis. Reactivation of the p53 by small molecules has emerged as a promising new strategy for cancer therapy. Several classes of small-molecules that activate the p53 pathway have been discovered using various approaches. Here, we identified harmine (beta-carboline alkaloid) as a novel activator of p53 signaling involved in inhibition of angiogenesis and tumor growth. Harmine induced p53 phosphorylation and disrupted the p53-MDM2 interaction. Harmine also prevented p53 degradation in the presence of cycloheximide and activated nuclear accumulation of p53 followed by increasing its transcriptional activity in endothelial cells. Moreover, harmine not only induced endothelial cell cycle arrest and apoptosis, but also suppressed endothelial cell migration and tube formation as well as induction of neovascularity in a mouse corneal micropocket assay. Finally, harmine inhibited tumor growth by reducing tumor angiogenesis, as demonstrated by a xenograft tumor model. Our results suggested a novel mechanism and bioactivity of harmine, which inhibited tumor growth by activating the p53 signaling pathway and blocking angiogenesis in endothelial cells.	[Dai, Fujun; Chen, Yihua; Song, Yajuan; Huang, Li; Zhai, Dong; Dong, Yanmin; Lai, Li; Zhang, Tao; Li, Dali; Pang, Xiufeng; Liu, Mingyao; Yi, Zhengfang] E China Normal Univ, Shanghai Key Lab Regulatory Biol, Inst Biomed Sci, Shanghai 200062, Peoples R China; [Dai, Fujun; Chen, Yihua; Song, Yajuan; Huang, Li; Zhai, Dong; Dong, Yanmin; Lai, Li; Zhang, Tao; Li, Dali; Pang, Xiufeng; Liu, Mingyao; Yi, Zhengfang] E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China; [Liu, Mingyao] Texas A&M Univ Hlth Sci Ctr, Ctr Canc & Stem Cell Biol, Inst Biosci & Technol, Houston, TX USA; [Liu, Mingyao] Texas A&M Univ Hlth Sci Ctr, Dept Mol & Cellular Med, Houston, TX USA	East China Normal University; East China Normal University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Chen, YH (corresponding author), E China Normal Univ, Shanghai Key Lab Regulatory Biol, Inst Biomed Sci, Shanghai 200062, Peoples R China.	yhchen79@gmail.com; ibms.ecnu@gmail.com; yizhengfang@gmail.com	Chen, Yihua/A-4323-2013; Chen, Yihua/O-2743-2019	Chen, Yihua/0000-0003-1733-7980; Chen, Yihua/0000-0003-1733-7980; Liu, Mingyao/0000-0001-7339-5048	Major State Basic Research Development Program of China [2012CB910400, 2009CB918402]; National Natural Science Foundation of China [30930055, 30971523, 81071807]; Science and Technology Commission of Shanghai Municipality [11DZ2260300]	Major State Basic Research Development Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This study was partially sponsored by the Major State Basic Research Development Program of China (2012CB910400) (http://www.most.gov.cn), (2009CB918402) (http://www.973.gov.cn), National Natural Science Foundation of China (30930055, 30971523 and 81071807) (http://www.nsfc.gov.cn) and the Science and Technology Commission of Shanghai Municipality (11DZ2260300) (http://www.stcsm.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bravman T, 2006, ANAL BIOCHEM, V358, P281, DOI 10.1016/j.ab.2006.08.005; Bykov VJN, 2002, NAT MED, V8, P282, DOI 10.1038/nm0302-282; Cao MR, 2011, HEPATOB PANCREAT DIS, V10, P599, DOI 10.1016/S1499-3872(11)60102-1; Chen D, 2007, ONCOGENE, V26, P5029, DOI 10.1038/sj.onc.1210327; Chene P, 2003, NAT REV CANCER, V3, P102, DOI 10.1038/nrc991; Cho SG, 2009, CANCER RES, V69, P7062, DOI 10.1158/0008-5472.CAN-09-0476; DAMERON KM, 1994, SCIENCE, V265, P1582, DOI 10.1126/science.7521539; Dong YM, 2010, CARCINOGENESIS, V31, P2097, DOI 10.1093/carcin/bgq167; Duda DG, 2002, BRIT J CANCER, V86, P490, DOI 10.1038/sj.bjc.6600067; Frost D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019264; Gockler N, 2009, FEBS J, V276, P6324, DOI 10.1111/j.1742-4658.2009.07346.x; Hamsa TP, 2010, EUR J PHARMACOL, V649, P64, DOI 10.1016/j.ejphar.2010.09.010; Hamsa TP, 2010, EUR J PHARM; Ho TC, 2008, J BIOL CHEM, V283, P30273, DOI 10.1074/jbc.M804196200; Hoffman WH, 2002, J BIOL CHEM, V277, P3247, DOI 10.1074/jbc.M106643200; HUDSON JB, 1986, PHOTOCHEM PHOTOBIOL, V43, P21, DOI 10.1111/j.1751-1097.1986.tb05586.x; Jiang JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034283; Kapoor M, 2000, ONCOGENE, V19, P358, DOI 10.1038/sj.onc.1203300; Klein C, 2004, BRIT J CANCER, V91, P1415, DOI 10.1038/sj.bjc.6602164; Kok T. W., 2005, Angiogenesis, V8, P3, DOI 10.1007/s10456-005-2892-z; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Kumari SR, 1998, CANCER RES, V58, P5075; Lai L, 2012, BRIT J PHARMACOL, V165, P1084, DOI 10.1111/j.1476-5381.2011.01532.x; Lala S, 2004, J DRUG TARGET, V12, P165, DOI 10.1080/10611860410001712696; LEESMILLER SP, 1992, MOL CELL BIOL, V12, P5041, DOI 10.1128/MCB.12.11.5041; Li H, 2012, ONCOIMMUNOLOGY, V1, DOI 10.4161/onci.19409; Miyachi M, 2009, CLIN CANCER RES, V15, P4077, DOI 10.1158/1078-0432.CCR-08-2955; Moll UM, 2003, MOL CANCER RES, V1, P1001; Montero E, 2008, J CANCER RES CLIN, V134, P193, DOI 10.1007/s00432-007-0270-5; Murray-Zmijewski F, 2008, NAT REV MOL CELL BIO, V9, P702, DOI 10.1038/nrm2451; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Phan J, 2010, J BIOL CHEM, V285, P2174, DOI 10.1074/jbc.M109.073056; Raj D, 2008, CARCINOGENESIS, V29, P194, DOI 10.1093/carcin/bgm219; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Scovassi AI, 2004, BIOCHEM PHARMACOL, V68, P1041, DOI 10.1016/j.bcp.2004.04.023; Shangary S, 2009, ANNU REV PHARMACOL, V49, P223, DOI 10.1146/annurev.pharmtox.48.113006.094723; Sionov RV, 2001, MOL CELL BIOL, V21, P5869; Song SY, 2000, NEOPLASIA, V2, P261, DOI 10.1038/sj.neo.7900088; Song Y, ANGIOGENESIS, V15, P421; Teodoro JG, 2007, J MOL MED-JMM, V85, P1175, DOI 10.1007/s00109-007-0221-2; Villalonga-Planells R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018588; Wang L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001161; Xie SQ, 2001, J BIOL CHEM, V276, P36194, DOI 10.1074/jbc.M104157200; Yi ZF, 2009, INT J CANCER, V124, P843, DOI 10.1002/ijc.24027; Zaslavsky A, 2010, BLOOD, V115, P4605, DOI 10.1182/blood-2009-09-242065; Zhang L, 2009, ANTI-CANCER DRUG, V20, P416, DOI 10.1097/CAD.0b013e32832aa7b0; Zhang Q, 2012, EMBO MOL MED, V4, P298, DOI 10.1002/emmm.201100211; Zhang XL, 2011, INT J CANCER, V129, P2502, DOI 10.1002/ijc.25909	49	63	69	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52162	10.1371/journal.pone.0052162	http://dx.doi.org/10.1371/journal.pone.0052162			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300602	Green Submitted, gold, Green Published			2022-12-27	WOS:000312829100024
J	Salker, MS; Nautiyal, J; Steel, JH; Webster, Z; Sucurovic, S; Nicou, M; Singh, Y; Lucas, ES; Murakami, K; Chan, YW; James, S; Abdallah, Y; Christian, M; Croy, BA; Mulac-Jericevic, B; Quenby, S; Brosens, JJ				Salker, Madhuri S.; Nautiyal, Jaya; Steel, Jennifer H.; Webster, Zoe; Sucurovic, Sandra; Nicou, Marilena; Singh, Yogesh; Lucas, Emma S.; Murakami, Keisuke; Chan, Yi-Wah; James, Sean; Abdallah, Yazan; Christian, Mark; Croy, B. Anne; Mulac-Jericevic, Biserka; Quenby, Siobhan; Brosens, Jan J.			Disordered IL-33/ST2 Activation in Decidualizing Stromal Cells Prolongs Uterine Receptivity in Women with Recurrent Pregnancy Loss	PLOS ONE			English	Article							SOLUBLE ST2; ENDOMETRIAL RECEPTIVITY; INDIAN HEDGEHOG; CROSS-TALK; PROGESTERONE; RECEPTOR; IMPLANTATION; INTERLEUKIN-33; EMBRYO; GENE	Decidualization renders the endometrium transiently receptive to an implanting blastocyst although the underlying mechanisms remain incompletely understood. Here we show that human endometrial stromal cells (HESCs) rapidly release IL-33, a key regulator of innate immune responses, upon decidualization. In parallel, differentiating HESCs upregulate the IL-33 transmembrane receptor ST2L and other pro-inflammatory mediators before mounting a profound anti-inflammatory response that includes downregulation of ST2L and increased expression of the soluble decoy receptor sST2. We demonstrate that HESCs secrete factors permissive of embryo implantation in mice only during the pro-inflammatory phase of the decidual process. IL-33 knockdown in undifferentiated HESCs was sufficient to abrogate this pro-inflammatory decidual response. Further, sequential activation of the IL-33/ST2L/sST2 axis was disordered in decidualizing HESCs from women with recurrent pregnancy loss. Signals from these cultures prolonged the implantation window but also caused subsequent pregnancy failure in mice. Thus, Il-33/ST2 activation in HESCS drives an autoinflammatory response that controls the temporal expression of receptivity genes. Failure to constrain this response predisposes to miscarriage by allowing out-of-phase implantation in an unsupportive uterine environment.	[Salker, Madhuri S.; Sucurovic, Sandra; Lucas, Emma S.; Murakami, Keisuke; Chan, Yi-Wah; James, Sean; Abdallah, Yazan; Quenby, Siobhan; Brosens, Jan J.] Univ Hosp, Clin Sci Res Labs, Warwick Med Sch, Div Reprod Hlth, Coventry, W Midlands, England; [Salker, Madhuri S.; Nautiyal, Jaya; Steel, Jennifer H.; Nicou, Marilena; Christian, Mark] Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, London, England; [Webster, Zoe] Univ London Imperial Coll Sci Technol & Med, Embryon Stem Cell Facil, MRC, Ctr Clin Sci, London, England; [Sucurovic, Sandra; Mulac-Jericevic, Biserka] Univ Rijeka, Dept Physiol & Immunol, Sch Med, Rijeka, Croatia; [Singh, Yogesh] Univ London Royal Vet Coll, Dept Infect & Immun, London, England; [Croy, B. Anne] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada	University of Warwick; Imperial College London; Imperial College London; University of Rijeka; University of London; University of London Royal Veterinary College; Queens University - Canada	Brosens, JJ (corresponding author), Univ Hosp, Clin Sci Res Labs, Warwick Med Sch, Div Reprod Hlth, Coventry, W Midlands, England.	J.J.Brosens@warwick.ac.uk	Murakami, Keisuke/Q-1257-2019; Šućurović, Sandra/P-7405-2018; Singh, Yogesh/T-8230-2017; Mulac-Jericevic, Biserka/S-6034-2018; Lucas, Emma S/I-2719-2013; Steel, Jennifer/B-4737-2013	Šućurović, Sandra/0000-0002-1509-3452; Singh, Yogesh/0000-0001-6919-6273; Mulac-Jericevic, Biserka/0000-0001-8418-0712; Lucas, Emma S/0000-0002-8571-8921; Steel, Jennifer/0000-0003-4439-0090; Brosens, Jan/0000-0003-0116-9329; Christian, Mark/0000-0002-1616-4179; Salker, Madhuri Sonal/0000-0002-7939-289X; Quenby, Siobhan/0000-0003-3221-5471	Biomedical Research Unit in Reproductive Health; University Hospitals Coventry; Warwickshire National Health Service Trust; Warwick Medical School; Genesis Research Trust	Biomedical Research Unit in Reproductive Health; University Hospitals Coventry; Warwickshire National Health Service Trust; Warwick Medical School; Genesis Research Trust	This work was supported the Biomedical Research Unit in Reproductive Health, a joint initiative between the University Hospitals Coventry and Warwickshire National Health Service Trust and Warwick Medical School, and the Genesis Research Trust (MSS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achache H, 2006, HUM REPROD UPDATE, V12, P731, DOI 10.1093/humupd/dml004; Aghajanova L, 2008, SEMIN CELL DEV BIOL, V19, P204, DOI 10.1016/j.semcdb.2007.10.008; Al-Sabbagh M, 2011, ENDOCRINOLOGY, V152, P730, DOI 10.1210/en.2010-0899; Bazer FW, 2009, REPRODUCTION, V138, P195, DOI 10.1530/REP-09-0158; Beltran CJ, 2010, INFLAMM BOWEL DIS, V16, P1097, DOI 10.1002/ibd.21175; Brosens JJ, 2006, J MOL ENDOCRINOL, V36, P389, DOI 10.1677/jme.1.02060; Brosens JJ, 1999, ENDOCRINOLOGY, V140, P4809, DOI 10.1210/en.140.10.4809; Carriere V, 2007, P NATL ACAD SCI USA, V104, P282, DOI 10.1073/pnas.0606854104; Chaouat G, 1997, AM J REPROD IMMUNOL, V37, P427; Chapuis J, 2009, MOL PSYCHIATR, V14, P1004, DOI 10.1038/mp.2009.10; Cloke B, 2008, ENDOCRINOLOGY, V149, P4462, DOI 10.1210/en.2008-0356; Dey SK, 2004, ENDOCR REV, V25, P341, DOI 10.1210/er.2003-0020; Diedrich K, 2007, HUM REPROD UPDATE, V13, P365, DOI 10.1093/humupd/dmm011; Evers JLH, 2002, LANCET, V360, P151, DOI 10.1016/S0140-6736(02)09417-5; Gargett CE, 2012, FERTIL STERIL, V98, DOI 10.1016/j.fertnstert.2012.05.004; Gellersen B, 2003, J ENDOCRINOL, V178, P357, DOI 10.1677/joe.0.1780357; Gellersen B, 2007, SEMIN REPROD MED, V25, P445, DOI 10.1055/s-2007-991042; Granne I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024463; Grimaldi G, 2012, MOL HUMAN REPROD; Guzelogiu-Kayisli Z, 2009, SEMIN REPROD MED, V27, P62, DOI 10.1055/s-0028-1108011; Haraldsen G, 2009, TRENDS IMMUNOL, V30, P227, DOI 10.1016/j.it.2009.03.003; HARPER MJK, 1992, BAILLIERE CLIN OB GY, V6, P351, DOI 10.1016/S0950-3552(05)80092-6; Hoshino K, 1999, J EXP MED, V190, P1541, DOI 10.1084/jem.190.10.1541; Humphreys NE, 2008, J IMMUNOL, V180, P2443, DOI 10.4049/jimmunol.180.4.2443; Jones MC, 2006, P NATL ACAD SCI USA, V103, P16272, DOI 10.1073/pnas.0603002103; Kaitu'u-Lino TJ, 2012, J REPROD IMMUNOL, V95, P46, DOI 10.1016/j.jri.2012.06.003; Kakkar R, 2008, NAT REV DRUG DISCOV, V7, P827, DOI 10.1038/nrd2660; Kakkar R, 2012, J BIOL CHEM, V287, P6941, DOI 10.1074/jbc.M111.298703; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Koot YE, 2012, BIOCH BIOPHYSICA ACT; Kunes P, 2010, THORAC CARDIOV SURG, V58, P443, DOI 10.1055/s-0030-1250436; Laskarin G, 2005, CHEM IMMUNOL ALLERGY, V89, P10, DOI 10.1159/000087906; Li QX, 2011, SCIENCE, V331, P912, DOI 10.1126/science.1197454; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; Matsumoto H, 2002, DEV BIOL, V245, P280, DOI 10.1006/dbio.2002.0645; Miller AM, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-22; Miller AM, 2011, PHARMACOL THERAPEUT, V131, P179, DOI 10.1016/j.pharmthera.2011.02.005; Miller AM, 2010, CIRC RES, V107, P650, DOI 10.1161/CIRCRESAHA.110.218867; Mok MY, 2010, RHEUMATOLOGY, V49, P520, DOI 10.1093/rheumatology/kep402; Nallasamy S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002500; Nancy P, 2012, SCIENCE, V336, P1317, DOI 10.1126/science.1220030; Palmer G, 2008, CYTOKINE, V42, P358, DOI 10.1016/j.cyto.2008.03.008; Palmer G, 2011, NAT REV RHEUMATOL, V7, P321, DOI 10.1038/nrrheum.2011.53; Quenby S, 2002, HUM REPROD, V17, P1959, DOI 10.1093/humrep/17.8.1959; Rai R, 2006, LANCET, V368, P601, DOI 10.1016/S0140-6736(06)69204-0; Salker M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010287; Salker MS, 2011, NATURE MED; Sherwin JRA, 2007, ENDOCRINOLOGY, V148, P618, DOI 10.1210/en.2006-0832; Singh M, 2011, J ENDOCRINOL, V210, P5, DOI 10.1530/JOE-10-0461; Takamoto N, 2002, MOL ENDOCRINOL, V16, P2338, DOI 10.1210/me.2001-0154; Takano M, 2007, MOL ENDOCRINOL, V21, P2334, DOI 10.1210/me.2007-0058; Teklenburg G, 2010, MOL HUM REPROD, V16, P886, DOI 10.1093/molehr/gaq079; Wang CL, 2003, MICROSC RES TECHNIQ, V60, P420, DOI 10.1002/jemt.10280; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; WEGMANN TG, 1993, IMMUNOL TODAY, V14, P353, DOI 10.1016/0167-5699(93)90235-D; Wilcox AJ, 1999, NEW ENGL J MED, V340, P1796, DOI 10.1056/NEJM199906103402304; Wilczynski JR, 2005, EUR J OBSTET GYN R B, V122, P136, DOI 10.1016/j.ejogrb.2005.03.008; Yagami A, 2010, J IMMUNOL, V185, P5743, DOI 10.4049/jimmunol.0903818; Zhang JH, 2011, CELL MOL IMMUNOL, V8, P1, DOI 10.1038/cmi.2010.38; Zhao WH, 2010, CELL MOL IMMUNOL, V7, P260, DOI 10.1038/cmi.2010.3	60	132	139	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52252	10.1371/journal.pone.0052252	http://dx.doi.org/10.1371/journal.pone.0052252			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300625	Green Published, Green Submitted, gold			2022-12-27	WOS:000312829100035
J	Pai, S; Aliyu, SH; Enoch, DA; Karas, JA				Pai, Sumita; Aliyu, Sani Hussaini; Enoch, David Andrew; Karas, Johannis Andreas			Five Years Experience of Clostridium difficile Infection in Children at a UK Tertiary Hospital: Proposed Criteria for Diagnosis and Management	PLOS ONE			English	Article							ONCOLOGY PATIENTS; DISEASE; DIARRHEA; GASTROENTERITIS; ENTEROCOLITIS; COLONIZATION; SURVEILLANCE; COHORT; TOXIN; UNIT	Background: Clostridium difficile infection (CDI) is associated with significant morbidity and mortality in adults. There is increasing evidence of the pathogenic role of C. difficile in the paediatric population. We sought to ascertain the clinical presentation and severity of CDI in children at our institution and develop criteria to aid management. Methods: Clinical data was retrospectively collected from all children (0-16 yrs) with a positive C. difficile toxin result over a 5-year period. National adult guidelines were used to assess the severity and management of CDI. Results: Seventy-five patients were included with a mean age of 2.97 years. Forty-nine were hospital onset, 22 community onset and 4 healthcare-associated. The most common co-morbidity among the hospital onset infections was malignancy. Gastrointestinal conditions were most common among community onset infections. Fifty-five cases (73.3%) had received antibiotics in the preceding month, 7 (9.3%) had cow's milk intolerance and 9 (12%) had co-infection with another gut pathogen. According to national adult guidelines 57 cases (76%) were categorised as severe. Thirty cases received oral metronidazole, two patients required intensive care and one patient had a sub-total colectomy for pseudomembranous colitis. No mortality was observed. Discussion: We confirm the association of paediatric CDI with co-morbidities such as haematological and solid organ malignancies, recent antibiotic use and hospitalisation. We observed an association between cows milk protein intolerance and C. difficile. The use of adult criteria overestimated severity of disease in this cohort, as most cases experienced a mild course of illness with low morbidity and no mortality. This indicates that adult scoring criteria are not useful in guiding management and we propose specific criteria for children.	[Pai, Sumita; Aliyu, Sani Hussaini; Karas, Johannis Andreas] Addenbrookes Hosp, Clin Microbiol & Publ Hlth Lab, Hlth Protect Agcy, Cambridge, England; [Enoch, David Andrew] Peterborough & Stamford Hosp NHS Fdn Trust, Peterborough City Hosp, Peterborough, Cambs, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; Health Protection Agency; University of Cambridge	Karas, JA (corresponding author), Addenbrookes Hosp, Clin Microbiol & Publ Hlth Lab, Hlth Protect Agcy, Cambridge, England.	karasja@gmail.com			Cambridge University Hospitals NHS Foundation Trust	Cambridge University Hospitals NHS Foundation Trust	This work was part of an official hospital audit and was supported by Cambridge University Hospitals NHS Foundation Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRUNETTO AL, 1988, ARCH DIS CHILD, V63, P979, DOI 10.1136/adc.63.8.979; BURGNER DP, 1993, ARCH DIS CHILD, V69, P239, DOI 10.1136/adc.69.2.239; Castagnola E, 2009, SUPPORT CARE CANCER, V17, P321, DOI 10.1007/s00520-008-0507-0; [Department of Health Health Protection Agency], 2008, CLOSTR DIFF DEAL PRO; El-Mahallawy HA, 2004, PEDIATR BLOOD CANCER, V42, P338, DOI 10.1002/pbc.10394; ELLIS ME, 1984, BRIT MED J, V288, P524, DOI 10.1136/bmj.288.6416.524; Enoch DA, 2011, J INFECTION, V63, P105, DOI 10.1016/j.jinf.2011.05.016; Karas JA, 2010, J INFECTION, V61, P1, DOI 10.1016/j.jinf.2010.03.025; Kim J, 2008, PEDIATRICS, V122, P1266, DOI 10.1542/peds.2008-0469; Klein EJ, 2006, CLIN INFECT DIS, V43, P807, DOI 10.1086/507335; Lewis SJ, 1997, SCAND J GASTROENTERO, V32, P920, DOI 10.3109/00365529709011203; Lukkarinen H, 2009, PEDIATR INFECT DIS J, V28, P847, DOI 10.1097/INF.0b013e31819d1cd9; Morinville V, 2005, CAN J GASTROENTEROL, V19, P497, DOI 10.1155/2005/326296; MURRELL WG, 1993, J MED MICROBIOL, V39, P114, DOI 10.1099/00222615-39-2-114; Oguz F, 2001, SCAND J INFECT DIS, V33, P731, DOI 10.1080/003655401317074509; Penders J, 2007, GUT, V56, P661, DOI 10.1136/gut.2006.100164; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; SCHULLER I, 1995, ARCH DIS CHILD, V72, P219, DOI 10.1136/adc.72.3.219; Simon A, 2000, INFECT CONT HOSP EP, V21, P592, DOI 10.1086/501809; Simon A, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-70; Spivack JG, 2003, CLIN PEDIATR, V42, P347, DOI 10.1177/000992280304200407; THOMAS DFM, 1986, J PEDIATR SURG, V21, P22, DOI 10.1016/S0022-3468(86)80644-3; VISCIDI R, 1983, J INFECT DIS, V148, P93, DOI 10.1093/infdis/148.1.93; Wilcox MH, 2008, J ANTIMICROB CHEMOTH, V62, P388, DOI 10.1093/jac/dkn163; WOLFHAGEN MJHM, 1994, GUT, V35, P1608, DOI 10.1136/gut.35.11.1608; Wultanska D, 2010, EUR J CLIN MICROBIOL, V29, P1265, DOI 10.1007/s10096-010-0997-9; ZWIENER RJ, 1989, PEDIATR INFECT DIS J, V8, P876, DOI 10.1097/00006454-198912000-00010	27	42	47	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e51728	10.1371/journal.pone.0051728	http://dx.doi.org/10.1371/journal.pone.0051728			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300561	Green Submitted, Green Published, gold			2022-12-27	WOS:000313618800025
J	Mlambo, G; Coppens, I; Kumar, N				Mlambo, Godfree; Coppens, Isabelle; Kumar, Nirbhay			Aberrant Sporogonic Development of Dmc1 (a Meiotic Recombinase) Deficient Plasmodium berghei Parasites	PLOS ONE			English	Article							ANTIGENIC VARIATION; ALLELIC RECOMBINATION; CHROMOSOME SYNAPSIS; STRAND EXCHANGE; PHASE-I; DNA; FALCIPARUM; PROTEIN; AGENT; VIVAX	Background: In Plasmodium, meiosis occurs in diploid zygotes as they develop into haploid motile ookinetes inside the mosquito. Further sporogonic development involves transformation of ookinetes into oocysts and formation of infective sporozoites. Methodology/Principal Findings: Reverse genetics was employed to examine the role of the meiotic specific recombinase Dmc1, a bacterial RecA homolog during sporogony in Plasmodium berghei. PbDmc1 knockout (KO) parasites showed normal asexual growth kinetics compared to WT parasites; however oocyst formation in mosquitoes was reduced by 50 to 80%. Moreover, the majority of oocysts were retarded in their growth and were smaller in size compared to WT parasites. Only a few Dmc1 KO parasites completed maturation resulting in formation of fewer sporozoites which were incapable of infecting naive mice or hepatocytes in vitro. PbDmc1 KO parasites were shown to be approximately 18 times more sensitive to Bizelesin, a DNA alkylating drug compared to WT parasites as reflected by impairment of oocyst formation and sporogonic development in the mosquito vector. Conclusions/Significance: Our findings suggest that PbDmc1 plays a critical role in malaria transmission biology.	[Mlambo, Godfree; Coppens, Isabelle; Kumar, Nirbhay] Johns Hopkins Univ, Dept Mol Microbiol & Immunol, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA; [Kumar, Nirbhay] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Trop Med, New Orleans, LA USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Tulane University	Kumar, N (corresponding author), Johns Hopkins Univ, Dept Mol Microbiol & Immunol, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA.	nkumar@tulane.edu			National Institutes of Health [R01 AI068052]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI068052] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	These studies were supported by a National Institutes of Health grant R01 AI068052. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharyya MK, 2003, INT J PARASITOL, V33, P1385, DOI 10.1016/S0020-7519(03)00212-1; Bhattacharyya MK, 2004, INFECT GENET EVOL, V4, P91, DOI 10.1016/j.meegid.2004.01.008; BISHOP DK, 1994, CELL, V79, P1081, DOI 10.1016/0092-8674(94)90038-8; Bishop DK, 2004, CELL, V117, P9, DOI 10.1016/S0092-8674(04)00297-1; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Cox MM, 2003, ANNU REV MICROBIOL, V57, P551, DOI 10.1146/annurev.micro.57.030502.090953; Deitsch KW, 2009, NAT REV MICROBIOL, V7, P493, DOI 10.1038/nrmicro2145; Deitsch KW, 1999, MOL BIOCHEM PARASIT, V101, P107, DOI 10.1016/S0166-6851(99)00062-6; DING ZM, 1991, ANTI-CANCER DRUG DES, V6, P427; Dzikowski R, 2009, CURR GENET, V55, P103, DOI 10.1007/s00294-009-0233-2; Figtree M, 2000, MOL BIOCHEM PARASIT, V108, P53, DOI 10.1016/S0166-6851(00)00204-8; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; LEE CS, 1991, CANCER RES, V51, P6586; Liu J, 2005, J BIOL CHEM, V280, P1432, DOI 10.1074/jbc.M409740200; Lobo CA, 1999, MOL CELL, V3, P793, DOI 10.1016/S1097-2765(01)80011-3; Mambo G, 2008, INFECT IMMUN, V76, P2018, DOI 10.1128/IAI.01409-07; Neale MJ, 2006, NATURE, V442, P153, DOI 10.1038/nature04885; Pan J, 2007, PLOS BIOL, V5, P2774, DOI 10.1371/journal.pbio.0050333; Pitot HC, 2002, CLIN CANCER RES, V8, P712; Pittman DL, 1998, MOL CELL, V1, P697, DOI 10.1016/S1097-2765(00)80069-6; Proudfoot C, 2006, MOL BIOCHEM PARASIT, V145, P245, DOI 10.1016/j.molbiopara.2005.10.007; Putaporntip C, 1997, MOL BIOCHEM PARASIT, V84, P49, DOI 10.1016/S0166-6851(96)02786-7; Putaporntip C, 2002, P NATL ACAD SCI USA, V99, P16348, DOI 10.1073/pnas.252348999; RANFORDCARTWRIGHT LC, 1991, MOL BIOCHEM PARASIT, V49, P239, DOI 10.1016/0166-6851(91)90067-G; Sakihama N, 1999, GENE, V230, P47, DOI 10.1016/S0378-1119(99)00069-4; Schwacha A, 1997, CELL, V90, P1123, DOI 10.1016/S0092-8674(00)80378-5; Schwartz GH, 2003, ANN ONCOL, V14, P775, DOI 10.1093/annonc/mdg215; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; SINDEN RE, 1985, J PROTOZOOL, V32, P742, DOI 10.1111/j.1550-7408.1985.tb03113.x; Sinden RE, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P139; Sultan AA, 1997, CELL, V90, P511, DOI 10.1016/S0092-8674(00)80511-5; Taylor HM, 2000, MOL BIOCHEM PARASIT, V110, P391, DOI 10.1016/S0166-6851(00)00286-3; Yanow SK, 2008, J INFECT DIS, V197, P527, DOI 10.1086/526788	33	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52480	10.1371/journal.pone.0052480	http://dx.doi.org/10.1371/journal.pone.0052480			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285059	Green Submitted, Green Published, gold			2022-12-27	WOS:000313158800070
J	Kapralov, MV; Smith, JAC; Filatov, DA				Kapralov, Maxim V.; Smith, J. Andrew C.; Filatov, Dmitry A.			Rubisco Evolution in C-4 Eudicots: An Analysis of Amaranthaceae Sensu Lato	PLOS ONE			English	Article							RIBULOSE 1,5-BISPHOSPHATE CARBOXYLASE; CODON-SUBSTITUTION MODELS; AMINO-ACID SITES; MOLECULAR ADAPTATION; CHENOPODIACEAE IMPLICATIONS; PHYLOGENETIC ANALYSIS; S.L. CHENOPODIACEAE; POSITIVE SELECTION; ADAPTIVE EVOLUTION; KINETIC-PROPERTIES	Background: Rubisco (ribulose-1,5-bisphosphate carboxylase/oxygenase) catalyses the key reaction in the photosynthetic assimilation of CO2. In C-4 plants CO2 is supplied to Rubisco by an auxiliary CO2-concentrating pathway that helps to maximize the carboxylase activity of the enzyme while suppressing its oxygenase activity. As a consequence, C-4 Rubisco exhibits a higher maximum velocity but lower substrate specificity compared with the C-3 enzyme. Specific amino-acids in Rubisco are associated with C-4 photosynthesis in monocots, but it is not known whether selection has acted on Rubisco in a similar way in eudicots. Methodology/Principal Findings: We investigated Rubisco evolution in Amaranthaceae sensu lato (including Chenopodiaceae), the third-largest family of C-4 plants, using phylogeny-based maximum likelihood and Bayesian methods to detect Darwinian selection on the chloroplast rbcL gene in a sample of 179 species. Two Rubisco residues, 281 and 309, were found to be under positive selection in C-4 Amaranthaceae with multiple parallel replacements of alanine by serine at position 281 and methionine by isoleucine at position 309. Remarkably, both amino-acids have been detected in other C-4 plant groups, such as C-4 monocots, illustrating a striking parallelism in molecular evolution. Conclusions/Significance: Our findings illustrate how simple genetic changes can contribute to the evolution of photosynthesis and strengthen the hypothesis that parallel amino-acid replacements are associated with adaptive changes in Rubisco. Citation: Kapralov MV, Smith JAC, Filatov DA (2012) Rubisco Evolution in C-4 Eudicots: An Analysis of Amaranthaceae Sensu Lato. PLoS ONE 7(12): e52974. doi:10.1371/journal.pone.0052974	[Kapralov, Maxim V.; Smith, J. Andrew C.; Filatov, Dmitry A.] Univ Oxford, Dept Plant Sci, Oxford, England	University of Oxford	Kapralov, MV (corresponding author), Univ Oxford, Dept Plant Sci, S Parks Rd, Oxford, England.	maxim.kapralov@plants.ox.ac.uk	Smith, J.A.C./M-3338-2014	Smith, J.A.C./0000-0001-9188-0258; Kapralov, Maxim/0000-0001-7966-0295; Filatov, Dmitry/0000-0001-8077-5452	NERC [NE/H007741/1]; Natural Environment Research Council [NE/H007741/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was funded by NERC (http://www.nerc.ac.uk/; grant number NE/H007741/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhani H, 2007, INT J PLANT SCI, V168, P931, DOI 10.1086/518263; Bremer K, 1998, ANN MO BOT GARD, V85, P531, DOI 10.2307/2992015; Christin PA, 2008, MOL BIOL EVOL, V25, P2361, DOI 10.1093/molbev/msn178; Christin PA, 2010, TRENDS ECOL EVOL, V25, P403, DOI 10.1016/j.tree.2010.04.007; Edwards GE, 2004, ANNU REV PLANT BIOL, V55, P173, DOI 10.1146/annurev.arplant.55.031903.141725; ELLIS RJ, 1979, TRENDS BIOCHEM SCI, V4, P241, DOI 10.1016/0968-0004(79)90212-3; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Galmes J, 2005, PLANT CELL ENVIRON, V28, P571, DOI 10.1111/j.1365-3040.2005.01300.x; Genkov T, 2010, J BIOL CHEM, V285, P19833, DOI 10.1074/jbc.M110.124230; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; HUDSON GS, 1990, J BIOL CHEM, V265, P808; Iida S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004633; Ishikawa C, 2011, PLANT PHYSIOL, V156, P1603, DOI 10.1104/pp.111.177030; JORDAN DB, 1983, ARCH BIOCHEM BIOPHYS, V227, P425, DOI 10.1016/0003-9861(83)90472-1; JORDAN DB, 1981, NATURE, V291, P513, DOI 10.1038/291513a0; Kadereit G, 2003, INT J PLANT SCI, V164, P959, DOI 10.1086/378649; Kadereit G, 2012, P ROY SOC B-BIOL SCI, V279, P3304, DOI 10.1098/rspb.2012.0440; Kadereit G, 2011, TAXON, V60, P51, DOI 10.1002/tax.601006; Kadereit G, 2010, AM J BOT, V97, P1664, DOI 10.3732/ajb.1000169; Kapralov MV, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000008; Kapralov MV, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-73; Kapralov MV, 2006, SYST BOT, V31, P571, DOI 10.1600/036364406778388674; Kapralov MV, 2011, MOL BIOL EVOL, V28, P1491, DOI 10.1093/molbev/msq335; Kato S, 2011, J PHYCOL, V47, P999, DOI 10.1111/j.1529-8817.2011.01037.x; KNIGHT S, 1990, J MOL BIOL, V215, P113, DOI 10.1016/S0022-2836(05)80100-7; Kubien DS, 2008, J EXP BOT, V59, P1767, DOI 10.1093/jxb/erm283; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; LLOYD J, 1994, OECOLOGIA, V99, P201, DOI 10.1007/BF00627732; Maddison W.P., 2010, MESQUITE MODULAR SYS; Massingham T, 2005, GENETICS, V169, P1753, DOI 10.1534/genetics.104.032144; Miwa H, 2009, GENE, V441, P169, DOI 10.1016/j.gene.2008.11.020; Monson R.K., 1999, C4 PLANT BIOL, P215, DOI DOI 10.1016/B978-012614440-6/50008-2; Muller K, 2005, ANN MO BOT GARD, V92, P66; Nelson D.L., 2005, LEHNINGER PRINCIPLES, DOI DOI 10.1002/BMB.2005.494033010419; PAGEL M, 1994, P ROY SOC B-BIOL SCI, V255, P37, DOI 10.1098/rspb.1994.0006; Parthiban V, 2006, NUCLEIC ACIDS RES, V34, pW239, DOI 10.1093/nar/gkl190; Pyankov VI, 2010, BOT J LINN SOC, V163, P283, DOI 10.1111/j.1095-8339.2010.01062.x; Sage RF, 2004, NEW PHYTOL, V161, P341, DOI 10.1111/j.1469-8137.2004.00974.x; Sage RF, 2002, J EXP BOT, V53, P609, DOI 10.1093/jexbot/53.369.609; Sage RF, 2011, J EXP BOT, V62, P3155, DOI 10.1093/jxb/err048; Sen L, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-29; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Smith ME, 2009, FUNCT PLANT BIOL, V36, P770, DOI 10.1071/FP09120; Spreitzer RJ, 2002, ANNU REV PLANT BIOL, V53, P449, DOI 10.1146/annurev.arplant.53.100301.135233; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Still CJ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001807; Taylor TC, 1996, J BIOL CHEM, V271, P32894, DOI 10.1074/jbc.271.51.32894; Tcherkez GGB, 2006, P NATL ACAD SCI USA, V103, P7246, DOI 10.1073/pnas.0600605103; von Caemmerer S, 2003, PHOTOSYNTH RES, V77, P191, DOI 10.1023/A:1025830019591; Voznesenskaya EV, 2001, NATURE, V414, P543, DOI 10.1038/35107073; Wang MC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-266; Wen ZB, 2010, PLANT SYST EVOL, V288, P25, DOI 10.1007/s00606-010-0310-5; Whitney SM, 2011, P NATL ACAD SCI USA, V108, P14688, DOI 10.1073/pnas.1109503108; Whitney SM, 2011, PLANT PHYSIOL, V155, P27, DOI 10.1104/pp.110.164814; Witzel F, 2010, FEBS J, V277, P931, DOI 10.1111/j.1742-4658.2009.07541.x; Yang Z., 2006, COMPUTATIONAL MOL EV, DOI DOI 10.1093/ACPROF:OSO/9780198567028.001.0001; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2002, MOL BIOL EVOL, V19, P49, DOI 10.1093/oxfordjournals.molbev.a003981; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yang ZH, 2011, MOL BIOL EVOL, V28, P1217, DOI 10.1093/molbev/msq303; YEOH HH, 1981, PLANT PHYSIOL, V67, P1151, DOI 10.1104/pp.67.6.1151; Young JN, 2012, PHILOS T R SOC B, V367, P483, DOI 10.1098/rstb.2011.0145; Zamyatnin A A, 1972, Prog Biophys Mol Biol, V24, P107, DOI 10.1016/0079-6107(72)90005-3	67	40	44	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52974	10.1371/journal.pone.0052974	http://dx.doi.org/10.1371/journal.pone.0052974			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285238	Green Published, gold			2022-12-27	WOS:000312794500258
J	Miller-Sims, VC; Bottjer, SW				Miller-Sims, Vanessa C.; Bottjer, Sarah W.			Development of Auditory-Vocal Perceptual Skills in Songbirds	PLOS ONE			English	Article							SPEECH-PERCEPTION; ZEBRA FINCHES; POECILE-ATRICAPILLUS; INDIVIDUAL IDENTITY; PHONETIC PERCEPTION; SENSITIVE PERIOD; NEURAL CIRCUITS; LEARNED CALLS; BEGGING CALLS; BRAIN-STEM	Songbirds are one of the few groups of animals that learn the sounds used for vocal communication during development. Like humans, songbirds memorize vocal sounds based on auditory experience with vocalizations of adult "tutors", and then use auditory feedback of self-produced vocalizations to gradually match their motor output to the memory of tutor sounds. In humans, investigations of early vocal learning have focused mainly on perceptual skills of infants, whereas studies of songbirds have focused on measures of vocal production. In order to fully exploit songbirds as a model for human speech, understand the neural basis of learned vocal behavior, and investigate links between vocal perception and production, studies of songbirds must examine both behavioral measures of perception and neural measures of discrimination during development. Here we used behavioral and electrophysiological assays of the ability of songbirds to distinguish vocal calls of varying frequencies at different stages of vocal learning. The results show that neural tuning in auditory cortex mirrors behavioral improvements in the ability to make perceptual distinctions of vocal calls as birds are engaged in vocal learning. Thus, separate measures of neural discrimination and behavioral perception yielded highly similar trends during the course of vocal development. The timing of this improvement in the ability to distinguish vocal sounds correlates with our previous work showing substantial refinement of axonal connectivity in cortico-basal ganglia pathways necessary for vocal learning.	[Miller-Sims, Vanessa C.; Bottjer, Sarah W.] Univ So Calif, Neurobiol Sect, Los Angeles, CA 90089 USA	University of Southern California	Bottjer, SW (corresponding author), Univ So Calif, Neurobiol Sect, Los Angeles, CA 90089 USA.	bottjer@usc.edu			National Institute of Neurological Disorders and Stroke (NINDS) [NS 037547]; National Institute on Deafness and Other Communication Disorders (NIDCD) [DC 009975]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC012396, T32DC009975] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Deafness and Other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institute of Neurological Disorders and Stroke (NINDS) grant NS 037547 and National Institute on Deafness and Other Communication Disorders (NIDCD) Training Fellowship DC 009975. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin N, 2007, J NEUROPHYSIOL, V97, P3517, DOI 10.1152/jn.01066.2006; ASLIN RN, 1981, CHILD DEV, V52, P1135, DOI 10.2307/1129499; Barkat TR, 2011, NAT NEUROSCI, V14, P1189, DOI 10.1038/nn.2882; Bolhuis JJ, 2006, NAT REV NEUROSCI, V7, P347, DOI 10.1038/nrn1904; Bottjer SW, 1997, ANNU REV NEUROSCI, V20, P459, DOI 10.1146/annurev.neuro.20.1.459; Braaten RF, 2006, J COMP PSYCHOL, V120, P79, DOI 10.1037/0735-7036.120.2.79; Charrier I, 2005, J COMP PSYCHOL, V119, P371, DOI 10.1037/0735-7036.119.4.371; CHEW SJ, 1995, P NATL ACAD SCI USA, V92, P3406, DOI 10.1073/pnas.92.8.3406; Chew SJ, 1996, P NATL ACAD SCI USA, V93, P1950, DOI 10.1073/pnas.93.5.1950; D'Ausillo A, 2009, CURR BIOL, V19, P381, DOI 10.1016/j.cub.2009.01.017; Dave AS, 2000, SCIENCE, V290, P812, DOI 10.1126/science.290.5492.812; de Villers-Sidani E, 2011, PROG BRAIN RES, V191, P119, DOI 10.1016/B978-0-444-53752-2.00009-6; Dhanjal NS, 2008, J NEUROSCI, V28, P9969, DOI 10.1523/JNEUROSCI.2607-08.2008; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; EIMAS PD, 1971, SCIENCE, V171, P303, DOI 10.1126/science.171.3968.303; Fadiga L, 2002, EUR J NEUROSCI, V15, P399, DOI 10.1046/j.0953-816x.2001.01874.x; Gobes SMH, 2007, CURR BIOL, V17, P789, DOI 10.1016/j.cub.2007.03.059; Gobes SMH, 2009, J COMP NEUROL, V516, P312, DOI 10.1002/cne.22113; Guillette LM, 2010, J ACOUST SOC AM, V127, P1116, DOI 10.1121/1.3277247; Iyengar S, 2002, J NEUROSCI, V22, P946, DOI 10.1523/JNEUROSCI.22-03-00946.2002; Iyengar S, 1999, J NEUROSCI, V19, P6037, DOI 10.1523/JNEUROSCI.19-14-06037.1999; Kandler K, 2009, NAT NEUROSCI, V12, P711, DOI 10.1038/nn.2332; Keuroghlian AS, 2007, PROG NEUROBIOL, V82, P109, DOI 10.1016/j.pneurobio.2007.03.005; Konishi M., 1965, Zeitschrift fuer Tierpsychologie, V22, P770; Kuhl PK, 2008, PHILOS T R SOC B, V363, P979, DOI 10.1098/rstb.2007.2154; Kuhl PK, 2010, NEURON, V67, P713, DOI 10.1016/j.neuron.2010.08.038; KUHL PK, 1992, SCIENCE, V255, P606, DOI 10.1126/science.1736364; Kuhl PK, 2004, NAT REV NEUROSCI, V5, P831, DOI 10.1038/nrn1533; Kuhl PK, 2006, DEVELOPMENTAL SCI, V9, pF13, DOI 10.1111/j.1467-7687.2006.00468.x; Levrero F, 2009, CR BIOL, V332, P579, DOI 10.1016/j.crvi.2009.02.006; Liu WC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005929; London SE, 2008, NAT NEUROSCI, V11, P579, DOI 10.1038/nn.2103; MARLER P, 1981, TRENDS NEUROSCI, V4, P88, DOI 10.1016/0166-2236(81)90029-1; Mello CV, 1998, J COMP NEUROL, V395, P137; Miller-Sims VC, 2012, J NEUROPHYSIOL, V107, P1142, DOI 10.1152/jn.00614.2011; Nottebohm F, 1970, ONTOGENY BIRD SONG S, V167, P950; Phan ML, 2006, P NATL ACAD SCI USA, V103, P1088, DOI 10.1073/pnas.0510136103; Pienkowski M, 2011, NEUROSCI BIOBEHAV R, V35, P2117, DOI 10.1016/j.neubiorev.2011.02.002; Prather JF, 2008, NATURE, V451, P305, DOI 10.1038/nature06492; Riede T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011368; Rivera-Gaxiola M, 2005, DEVELOPMENTAL SCI, V8, P162, DOI 10.1111/j.1467-7687.2005.00403.x; Roberts TF, 2008, J NEUROSCI, V28, P3479, DOI 10.1523/JNEUROSCI.0177-08.2008; RUBEL EW, 1975, J EXP PSYCHOL ANIM B, V1, P287; Saffran J. R., 2006, HDB CHILD PSYCHOL, P58, DOI DOI 10.1002/9780470147658.CHPSY0202; Sanes DH, 2011, NEURON, V72, P912, DOI 10.1016/j.neuron.2011.12.005; Sarro EC, 2010, DEV NEUROBIOL, V70, P636, DOI 10.1002/dneu.20801; Schneider D, 2012, COSYNE 9 ANN M, P85; SIMPSON HB, 1990, J NEUROSCI, V10, P1541; Solis MM, 1997, J NEUROSCI, V17, P6447; Stripling R, 2003, NEUROBIOL LEARN MEM, V79, P41, DOI 10.1016/S1074-7427(02)00005-9; Terleph TA, 2006, J NEUROBIOL, V66, P281, DOI 10.1002/neu.20219; Tsao FM, 2004, CHILD DEV, V75, P1067, DOI 10.1111/j.1467-8624.2004.00726.x; Vates GE, 1996, J COMP NEUROL, V366, P613, DOI 10.1002/(SICI)1096-9861(19960318)366:4<613::AID-CNE5>3.0.CO;2-7; Vicario DS, 2004, ANN NY ACAD SCI, V1016, P246, DOI 10.1196/annals.1298.040; Vicario DS, 2002, J COMP PHYSIOL A, V188, P897, DOI 10.1007/s00359-002-0354-2; Vicario DS, 2001, ANIM BEHAV, V61, P805, DOI 10.1006/anbe.2000.1651; Vicario DS, 2001, J NEUROBIOL, V47, P109, DOI 10.1002/neu.1020; Vignal C, 2008, BEHAV PROCESS, V77, P191, DOI 10.1016/j.beproc.2007.09.003; Vignal C, 2011, J COMP PSYCHOL, V125, P150, DOI 10.1037/a0020865; Watkins K, 2004, J COGNITIVE NEUROSCI, V16, P978, DOI 10.1162/0898929041502616; WERKER JF, 1988, DEV PSYCHOL, V24, P672, DOI 10.1037/0012-1649.24.5.672; Werker JF, 2005, DEV PSYCHOBIOL, V46, P233, DOI 10.1002/dev.20060; Wilson SM, 2004, NAT NEUROSCI, V7, P701, DOI 10.1038/nn1263; Woolley SMN, 2012, DEV PSYCHOBIOL, V54, P612, DOI 10.1002/dev.21014; ZANN R, 1990, ANIM BEHAV, V40, P811, DOI 10.1016/S0003-3472(05)80982-0; ZANN R, 1984, Z TIERPSYCHOL, V66, P328; Zann RA., 1996, ZEBRA FINCH SYNTHESI; Zhang Y, 2005, NEUROIMAGE, V26, P703, DOI 10.1016/j.neuroimage.2005.02.040; Zhang Y, 2009, NEUROIMAGE, V46, P226, DOI 10.1016/j.neuroimage.2009.01.028	69	3	4	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52365	10.1371/journal.pone.0052365	http://dx.doi.org/10.1371/journal.pone.0052365			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285011	Green Submitted, gold, Green Published			2022-12-27	WOS:000312794500154
J	Soler, MA; Faisca, PFN				Soler, Miguel A.; Faisca, Patricia F. N.			How Difficult Is It to Fold a Knotted Protein? In Silico Insights from Surface-Tethered Folding Experiments	PLOS ONE			English	Article							SINGLE-DOMAIN PROTEINS; NONNATIVE INTERACTIONS; TRANSITION-STATE; MODEL PROTEINS; CONTACT ORDER; KINETICS; THERMODYNAMICS; SIMULATIONS; PERSPECTIVE; LANDSCAPE	We explore the effect of surface tethering on the folding process of a lattice protein that contains a trefoil knot in its native structure via Monte Carlo simulations. We show that the outcome of the tethering experiment depends critically on which terminus is used to link the protein to a chemically inert plane. In particular, if surface tethering occurs at the bead that is closer to the knotted core the folding rate becomes exceedingly slow and the protein is not able to find the native structure in all the attempted folding trajectories. Such low folding efficiency is also apparent from the analysis of the probability of knot formation, p(knot), as a function of nativeness. Indeed, p(knot) increases abruptly from similar to 0 to similar to 1 only when the protein has more than 80% of its native contacts formed, showing that a highly compact conformation must undergo substantial structural re-arrangement in order to get effectively knotted. When the protein is surface tethered by the bead that is placed more far away from the knotted core pknot is higher than in the other folding setups (including folding in the bulk), especially if conformations are highly native-like. These results show that the mobility of the terminus closest to the knotted core is critical for successful folding of trefoil proteins, which, in turn, highlights the importance of a knotting mechanism that is based on a threading movement of this terminus through a knotting loop. The results reported here predict that if this movement is blocked, knotting occurs via an alternative mechanism, the so-called spindle mechanism, which is prone to misfolding. Our simulations show that in the three considered folding setups the formation of the knot is typically a late event in the folding process. We discuss the implications of our findings for co-translational folding of knotted trefoils.	[Soler, Miguel A.; Faisca, Patricia F. N.] Univ Lisbon, Ctr Fis Mat Condensada, P-1699 Lisbon, Portugal; [Soler, Miguel A.; Faisca, Patricia F. N.] Univ Lisbon, Dept Fis, P-1699 Lisbon, Portugal	Universidade de Lisboa; Universidade de Lisboa	Soler, MA (corresponding author), Univ Lisbon, Ctr Fis Mat Condensada, P-1699 Lisbon, Portugal.	migsoler@cii.fc.ul.pt; patricia.fn.faisca@gmail.com	SOLER, MIGUEL/J-2389-2013; Faisca, Patricia/E-9758-2010	SOLER, MIGUEL/0000-0002-5780-9949; Faisca, Patricia/0000-0002-2493-2748	Fundacao para a Ciencia e a Tecnologia [PTDC/QUIQUI/112358/2009]	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by Fundacao para a Ciencia e a Tecnologia(PTDC/QUIQUI/112358/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABKEVICH VI, 1994, BIOCHEMISTRY-US, V33, P10026, DOI 10.1021/bi00199a029; Andersson FI, 2009, FEBS J, V276, P2625, DOI 10.1111/j.1742-4658.2009.06990.x; Bhattacherjee A, 2012, BIOPHYS J, V102, P569, DOI 10.1016/j.bpj.2011.12.008; Bolinger D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000731; CAMACHO CJ, 1993, P NATL ACAD SCI USA, V90, P6369, DOI 10.1073/pnas.90.13.6369; Chan HS, 1998, PROTEINS, V30, P2, DOI 10.1002/(SICI)1097-0134(19980101)30:1<2::AID-PROT2>3.0.CO;2-R; Chodera JD, 2007, J CHEM THEORY COMPUT, V3, P26, DOI 10.1021/ct0502864; DILL KA, 1995, PROTEIN SCI, V4, P561; Faisca PFN, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2973624; Faisca PFN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035599; Faisca PFN, 2010, PROTEIN SCI, V19, P2196, DOI 10.1002/pro.498; Faisca PFN, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/1/016009; Faisca PFN, 2005, BIOPHYS CHEM, V115, P169, DOI 10.1016/j.bpc.2004.12.022; Faisca PFN, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.051917; Faisca PFN, 2005, PROTEINS, V60, P712, DOI 10.1002/prot.20521; Faisca PFN, 2002, J CHEM PHYS, V116, P7231, DOI 10.1063/1.1466833; Feig M, 2004, J MOL GRAPH MODEL, V22, P377, DOI 10.1016/j.jmgm.2003.12.005; Finkelstein A. V., 2002, PROTEIN PHYS; Gutin AM, 1996, PHYS REV LETT, V77, P5433, DOI 10.1103/PhysRevLett.77.5433; Kaya H, 2003, PROTEINS, V52, P524, DOI 10.1002/prot.10478; King NP, 2010, P NATL ACAD SCI USA, V107, P20732, DOI 10.1073/pnas.1007602107; King NP, 2007, J MOL BIOL, V373, P153, DOI 10.1016/j.jmb.2007.07.042; Klimov DK, 1998, J MOL BIOL, V282, P471, DOI 10.1006/jmbi.1998.1997; Lai YL, 2012, NUCLEIC ACIDS RES, V40, pW228, DOI 10.1093/nar/gks592; Li L, 2000, NAT STRUCT BIOL, V7, P336; Li MS, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.218101; Mallam AL, 2008, MOL CELL, V30, P642, DOI 10.1016/j.molcel.2008.03.019; Mallam AL, 2007, J MOL BIOL, V366, P650, DOI 10.1016/j.jmb.2006.11.014; Mallam AL, 2006, J MOL BIOL, V359, P1420, DOI 10.1016/j.jmb.2006.04.032; Mallam AL, 2012, NAT CHEM BIOL, V8, P147, DOI 10.1038/nchembio.742; Mallam AL, 2010, P NATL ACAD SCI USA, V107, P8189, DOI 10.1073/pnas.0912161107; Mallam AL, 2008, P NATL ACAD SCI USA, V105, P18740, DOI 10.1073/pnas.0806697105; MANSFIELD ML, 1994, NAT STRUCT BIOL, V1, P213, DOI 10.1038/nsb0494-213; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Noel JK, 2010, P NATL ACAD SCI USA, V107, P15403, DOI 10.1073/pnas.1009522107; O'Brien EP, 2012, J AM CHEM SOC, V134, P10920, DOI 10.1021/ja302305u; O'Brien EP, 2011, J AM CHEM SOC, V133, P513, DOI 10.1021/ja107863z; O'Brien EP, 2010, J AM CHEM SOC, V132, P16928, DOI 10.1021/ja106530y; Plaxco KW, 1998, J MOL BIOL, V277, P985, DOI 10.1006/jmbi.1998.1645; QUAKE SR, 1995, PHYS REV E, V52, P1176, DOI 10.1103/PhysRevE.52.1176; Sayre TC, 2011, PROTEIN ENG DES SEL, V24, P627, DOI 10.1093/protein/gzr024; SHAKHNOVICH EI, 1993, P NATL ACAD SCI USA, V90, P7195, DOI 10.1073/pnas.90.15.7195; Skrbic T, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002504; Sulkowska JI, 2012, P NATL ACAD SCI USA, V109, P17783, DOI 10.1073/pnas.1201804109; Sulkowska JI, 2012, P NATL ACAD SCI USA, V109, pE1715, DOI 10.1073/pnas.1205918109; Sulkowska JI, 2010, J AM CHEM SOC, V132, P13954, DOI 10.1021/ja102441z; Sulkowska JI, 2009, P NATL ACAD SCI USA, V106, P3119, DOI 10.1073/pnas.0811147106; Sulkowska JI, 2008, P NATL ACAD SCI USA, V105, P19714, DOI 10.1073/pnas.0805468105; TAKETOMI H, 1975, INT J PEPT PROT RES, V7, P445; Taylor WR, 2000, NATURE, V406, P916, DOI 10.1038/35022623; Virnau P, 2006, PLOS COMPUT BIOL, V2, P1074, DOI 10.1371/journal.pcbi.0020122; Wallin S, 2007, J MOL BIOL, V368, P884, DOI 10.1016/j.jmb.2007.02.035; Wang PY, 2008, PROTEINS, V70, P925, DOI 10.1002/prot.21547; Yeates T, 2007, CURR OPIN CHEM BIOL, V11, P595, DOI 10.1016/j.cbpa.2007.10.002	54	19	19	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52343	10.1371/journal.pone.0052343	http://dx.doi.org/10.1371/journal.pone.0052343			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284997	Green Submitted, Green Published, gold			2022-12-27	WOS:000312794500148
J	Svingen, T; Francois, M; Wilhelm, D; Koopman, P				Svingen, Terje; Francois, Mathias; Wilhelm, Dagmar; Koopman, Peter			Three-Dimensional Imaging of Prox1-EGFP Transgenic Mouse Gonads Reveals Divergent Modes of Lymphangiogenesis in the Testis and Ovary	PLOS ONE			English	Article							LYMPHATIC VASCULATURE; INTERSTITIAL-TISSUE; CORPUS-LUTEUM; EXPRESSION; MICE; SYSTEM; RAT; CAPILLARIES; MAINTENANCE; VESSELS	The lymphatic vasculature forms a specialized part of the circulatory system, being essential for maintaining tissue fluid homeostasis and for transport of hormones, macromolecules, and immune cells. Although lymphatic vessels are assumed to play an important role in most tissues, their morphogenesis and function in the gonads remains poorly understood. Here we have exploited a lymphatic-specific Prox1-EGFP reporter mouse model and optical projection tomography technology to characterize both the temporal and spatial development of the lymphatic vessel network in mouse testes and ovaries. We find that lymphangiogenesis in the testis is initiated during late gestation, but in contrast to other organs, lymphatic vessels remain confined to the testis cap and, unlike blood vessels, do not infiltrate the entire organ. Conversely, lymphatic vessels invade the ovarian tissue, beginning postnatally, and sprouting from preexisting lymphatic vessels at the extraovarian rete. The ovary develops a rich network of lymphatic vessels, extending from the medulla into the surrounding cortex adjacent to developing follicles. This study reveals distinct patterns of lymphangiogenesis in the testes and ovaries and will serve as the basis for the identification of the divergent molecular pathways that control morphogenesis and the function of the lymphatic vasculature in these two organs. Citation: Svingen T, Francois M, Wilhelm D, Koopman P (2012) Three-Dimensional Imaging of Prox1-EGFP Transgenic Mouse Gonads Reveals Divergent Modes of Lymphangiogenesis in the Testis and Ovary. PLoS ONE 7(12): e52620. doi:10.1371/journal.pone.0052620	[Svingen, Terje; Francois, Mathias; Wilhelm, Dagmar; Koopman, Peter] Univ Queensland, Inst Mol Biosci, Div Mol Genet & Dev, Brisbane, Qld, Australia	University of Queensland	Koopman, P (corresponding author), Univ Queensland, Inst Mol Biosci, Div Mol Genet & Dev, Brisbane, Qld, Australia.	p.koopman@imb.uq.edu.au	francois, mathias/A-9604-2014; Koopman, Peter A/C-9416-2009; Wilhelm, Dagmar/B-6915-2009; Svingen, Terje/A-5283-2010	francois, mathias/0000-0002-9846-6882; Koopman, Peter A/0000-0001-6939-0914; Wilhelm, Dagmar/0000-0002-7757-4075; Svingen, Terje/0000-0003-4650-7651	Australian Research Council (ARC) [FF0776096]	Australian Research Council (ARC)(Australian Research Council)	This work was supported by a research grant from the Australian Research Council (ARC grant FF0776096). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazigou E, 2011, J CLIN INVEST, V121, P2984, DOI 10.1172/JCI58050; Bott RC, 2008, REPROD DOMEST ANIM, V43, P310, DOI 10.1111/j.1439-0531.2008.01179.x; Bott RC, 2010, CELL TISSUE RES, V342, P117, DOI 10.1007/s00441-010-1038-9; Brennan J, 2002, DEV BIOL, V244, P418, DOI 10.1006/dbio.2002.0578; Brown HM, 2010, ENDOCRINOLOGY, V151, P5446, DOI 10.1210/en.2010-0629; Choi I, 2011, BLOOD, V117, P362, DOI 10.1182/blood-2010-07-298562; CLARK RV, 1976, ANAT RECORD, V184, P203, DOI 10.1002/ar.1091840207; Cool J, 2011, P NATL ACAD SCI USA, V108, P167, DOI 10.1073/pnas.1010299108; Coveney D, 2008, P NATL ACAD SCI USA, V105, P7212, DOI 10.1073/pnas.0707674105; Davis J.R., 1970, TESTICULAR CAPSULE T, P281; FAWCETT DW, 1973, BIOL REPROD, V9, P500, DOI 10.1093/biolreprod/9.5.500; FAWCETT DW, 1969, J REPROD FERTIL, V19, P109, DOI 10.1530/jrf.0.0190109; Francois M, 2008, NATURE, V456, P643, DOI 10.1038/nature07391; Francois M, 2012, DEV BIOL, V364, P89, DOI 10.1016/j.ydbio.2011.12.032; Gordon EJ, 2008, DEV DYNAM, V237, P1901, DOI 10.1002/dvdy.21605; Hamasaki M, 1994, Kaibogaku Zasshi, V69, P669; Hirai S, 2012, J ANDROL, V33, P745, DOI 10.2164/jandrol.111.015156; Hirai S, 2010, MED MOL MORPHOL, V43, P37, DOI 10.1007/s00795-009-0473-8; ICHIKAWA S, 1987, LYMPHOLOGY, V20, P73; Itoh M, 1998, J ANDROL, V19, P466; JAPON MA, 1994, J HISTOCHEM CYTOCHEM, V42, P1117, DOI 10.1177/42.8.8027530; Johnson NC, 2008, GENE DEV, V22, P3282, DOI 10.1101/gad.1727208; KAZEEM A, 1986, LYMPHOLOGY, V19, P172; KAZEEM AA, 1991, LYMPHOLOGY, V24, P140; LORENCE MC, 1991, MOL CELL ENDOCRINOL, V80, P21, DOI 10.1016/0303-7207(91)90139-J; MCCULLOUGH DL, 1975, INVEST UROL, V13, P211; O'Shaughnessy PJ, 1998, ENDOCRINOLOGY, V139, P1141, DOI 10.1210/en.139.3.1141; Oliver G, 2004, NAT REV IMMUNOL, V4, P35, DOI 10.1038/nri1258; Olszewski Waldemar L, 2003, Lymphat Res Biol, V1, P11, DOI 10.1089/15396850360495655; OTSUKI Y, 1987, LYMPHOLOGY, V20, P64; Polanco JC, 2010, HUM MOL GENET, V19, P506, DOI 10.1093/hmg/ddp520; ROBAIRE B, 1989, ANN NY ACAD SCI, V564, P250, DOI 10.1111/j.1749-6632.1989.tb25902.x; Sapoznik S, 2009, CANCER RES, V69, P9306, DOI 10.1158/0008-5472.CAN-09-1213; Schacht V, 2005, AM J PATHOL, V166, P913, DOI 10.1016/S0002-9440(10)62311-5; Schulte-Merker S, 2011, J CELL BIOL, V193, P607, DOI 10.1083/jcb.201012094; Setchell BP, 1970, TESTIS, V1, P165; Shayan R, 2006, CARCINOGENESIS, V27, P1729, DOI 10.1093/carcin/bgl031; Sleeman J, 2009, SEMIN CANCER BIOL, V19, P285, DOI 10.1016/j.semcancer.2009.05.005; Srinivasan RS, 2007, GENE DEV, V21, P2422, DOI 10.1101/gad.1588407; Srinivasan RS, 2010, GENE DEV, V24, P696, DOI 10.1101/gad.1859310; Stefanczyk-Krzymowska S, 2002, EXP PHYSIOL, V87, P361, DOI 10.1113/eph8702338; Stefanczyk-Krzymowska Stanislawa, 2002, Reprod Biol, V2, P115; Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1; Wilhelm D, 2005, DEV BIOL, V287, P111, DOI 10.1016/j.ydbio.2005.08.039; Wrobel T, 2005, LYMPHOLOGY, V38, P107; Xu Fuhua, 2009, Lymphatic Research and Biology, V7, P159, DOI 10.1089/lrb.2009.0009; Yuan L, 2002, DEVELOPMENT, V129, P4797	47	29	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52620	10.1371/journal.pone.0052620	http://dx.doi.org/10.1371/journal.pone.0052620			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285114	Green Published, gold			2022-12-27	WOS:000312794500211
J	Zhu, H; Yang, W; He, LJ; Ding, WJ; Zheng, L; Liao, SD; Huang, P; Lu, W; He, QJ; Yang, B				Zhu, Hong; Yang, Wei; He, Ling-juan; Ding, Wan-jing; Zheng, Lin; Liao, Si-da; Huang, Ping; Lu, Wei; He, Qiao-jun; Yang, Bo			Upregulating Noxa by ER Stress, Celastrol Exerts Synergistic Anti-Cancer Activity in Combination with ABT-737 in Human Hepatocellular Carcinoma Cells	PLOS ONE			English	Article							COLORECTAL-CANCER CELLS; IN-VITRO; MELANOMA-CELLS; INHIBITOR; MCL-1; PROTEASOME; APOPTOSIS; BCL-2; VIVO; DEGRADATION	The human hepatocellular carcinoma (HCC) represents biologically aggressive and chemo-resistant cancers. Owing to the low affinity with the apoptotic factor Mcl-1, the BH3 mimetic drug ABT-737 failed to exert potent cancer-killing activities in variety of cancer models including HCC. The current study demonstrated that combining ABT-737 and Celastrol synergistically suppressed HCC cell proliferation, and induced apoptosis which was accompanied with the activation of caspase cascade and release of cytochrome c from mitochondria. Further study revealed that the enhanced Noxa caused by Celastrol was the key factor for the synergy, since small interfering RNA-mediated knockdown of Noxa expression in HCC cells resulted in decreased apoptosis and attenuated anti-proliferative effects of the combination. In addition, our study unraveled that, upon Celastrol exposure, the activation of endoplasmic reticulum (ER) stress, specifically, the eIF2 alpha-ATF4 pathway played indispensable roles in the activation of Noxa, which was validated by the observation that depletion of ATF4 significantly abrogated the Noxa elevation by Celastrol. Our findings highlight a novel signaling pathway through which Celastrol increase Noxa expression, and suggest the potential use of ATF4-mediated regulation of Noxa as a promising strategy to improve the anti-cancer activities of ABT-737.	[Zhu, Hong; Yang, Wei; He, Ling-juan; Ding, Wan-jing; Zheng, Lin; Liao, Si-da; He, Qiao-jun; Yang, Bo] Zhejiang Univ, Inst Pharmacol & Toxicol, Coll Pharmaceut Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Huang, Ping] Zhejiang Acad Tradit Chinese Med, Tongde Hosp Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China; [Lu, Wei] E China Normal Univ, Dept Chem, Inst Med Chem, Shanghai 200062, Peoples R China	Zhejiang University; East China Normal University	He, QJ (corresponding author), Zhejiang Univ, Inst Pharmacol & Toxicol, Coll Pharmaceut Sci, Hangzhou 310003, Zhejiang, Peoples R China.	qiaojunhe@zju.edu.cn; yang924@zju.edu.cn	Lu, Wei/P-6066-2014; Liao, Sida/AAI-8514-2021	Lu, Wei/0000-0003-3041-9200; Zhu, Hong/0000-0002-2575-4031; Liao, Sida/0000-0002-6233-0203	Fundamental Research Funds for the Central Universities [2011FZA7008]; Zhejiang Provincial Natural Science Foundation of China [Y2110933]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	The authors gratefully acknowledge financial support from the Fundamental Research Funds for the Central Universities (No. 2011FZA7008) and Zhejiang Provincial Natural Science Foundation of China (No. Y2110933). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Armstrong JL, 2010, J BIOL CHEM, V285, P6091, DOI 10.1074/jbc.M109.014092; Averous J, 2004, J BIOL CHEM, V279, P5288, DOI 10.1074/jbc.M311862200; Chen S, 2007, CANCER RES, V67, P782, DOI 10.1158/0008-5472.CAN-06-3964; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Czabotar PE, 2007, P NATL ACAD SCI USA, V104, P6217, DOI 10.1073/pnas.0701297104; Dai Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014153; Fernandez Y, 2005, CANCER RES, V65, P6294, DOI 10.1158/0008-5472.CAN-05-0686; Fleischer B, 2006, INT J ONCOL, V28, P25; Hann CL, 2008, CANCER RES, V68, P2321, DOI 10.1158/0008-5472.CAN-07-5031; Hieronymus H, 2006, CANCER CELL, V10, P321, DOI 10.1016/j.ccr.2006.09.005; Hikita H, 2010, HEPATOLOGY, V52, P1310, DOI 10.1002/hep.23836; Ishitsuka K, 2012, CANCER LETT, V317, P218, DOI 10.1016/j.canlet.2011.11.030; Jayanthan A, 2011, PEDIATR BLOOD CANCER, V56, P353, DOI 10.1002/pbc.22760; Kang MH, 2009, CLIN CANCER RES, V15, P1126, DOI 10.1158/1078-0432.CCR-08-0144; Lucas KM, 2012, CLIN CANCER RES, V18, P783, DOI 10.1158/1078-0432.CCR-11-1166; Meynet O, 2012, LEUKEMIA, V26, P1145, DOI 10.1038/leu.2011.327; Mologni L, 2009, INT J CANCER, V124, P1990, DOI 10.1002/ijc.24158; Nikiforov MA, 2007, P NATL ACAD SCI USA, V104, P19488, DOI 10.1073/pnas.0708380104; Okumura K, 2008, CLIN CANCER RES, V14, P8132, DOI 10.1158/1078-0432.CCR-08-1665; Patterson J, 2008, CANCER CHEMOTH PHARM, V61, P923, DOI 10.1007/s00280-007-0546-0; Peng B, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-79; Qin JZ, 2005, CANCER RES, V65, P6282, DOI 10.1158/0008-5472.CAN-05-0676; Raats DAE, 2011, CELL ONCOL, V34, P307, DOI 10.1007/s13402-011-0026-8; Rosen A, 1997, J CELL BIOCHEM, V64, P50, DOI 10.1002/(SICI)1097-4644(199701)64:1<50::AID-JCB8>3.0.CO;2-Z; Shinoura N, 1999, ONCOGENE, V18, P5703, DOI 10.1038/sj.onc.1202966; Sreeramulu S, 2009, ANGEW CHEM INT EDIT, V48, P5853, DOI 10.1002/anie.200900929; Taiyab A, 2009, BIOCHEM PHARMACOL, V78, P142, DOI 10.1016/j.bcp.2009.04.001; Tromp JM, 2012, CLIN CANCER RES, V18, P487, DOI 10.1158/1078-0432.CCR-11-1440; Wang Q, 2009, P NATL ACAD SCI USA, V106, P2200, DOI 10.1073/pnas.0807611106; Wang WB, 2012, J CELL PHYSIOL, V227, P2196, DOI 10.1002/jcp.22956; Yang HJ, 2006, CANCER RES, V66, P4758, DOI 10.1158/0008-5472.CAN-05-4529; Zhang C, 2011, MOL CANCER THER, V10, P1264, DOI 10.1158/1535-7163.MCT-10-1091; Zhang J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013910; Zhang R, 2005, ONCOGENE, V24, P3954, DOI 10.1038/sj.onc.1208548; Zhang T, 2009, J BIOL CHEM, V284, P35381, DOI 10.1074/jbc.M109.051532; Zheng L, 2011, CANCER LETT, V309, P27, DOI 10.1016/j.canlet.2011.05.011; Zhu H, 2010, CANCER INVEST, V28, P23, DOI 10.3109/07357900903095664	38	36	39	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52333	10.1371/journal.pone.0052333	http://dx.doi.org/10.1371/journal.pone.0052333			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284992	gold, Green Published, Green Submitted			2022-12-27	WOS:000312794500146
J	Chen, Q; Cao, H; Zhang, GC; Chen, LW; Chen, DZ; Li, QZ; Qiu, ZH				Chen, Qiang; Cao, Hua; Zhang, Gui-Can; Chen, Liang-Wan; Chen, Dao-Zhong; Li, Qian-Zhen; Qiu, Zhi-Huang			Atrioventricular Block Subsequent to Intraoperative Device Closure Atrial Septal Defect with Transthoracic Minimal Invasion; A Rare and Serious Complication	PLOS ONE			English	Article							CONGENITAL HEART-DISEASE; TRANSCATHETER CLOSURE; AMPLATZER DEVICE; CHILDREN; OCCLUDER; SAFETY; ADULTS; EXPERIENCE; EFFICACY	Objectives: Atrioventricular block (AVB) is a infrequent and serious complication after percutaneous ASD closure. In this study, we report on the incidence of AVB associated with intraoperative device closure of the ASD with transthoracic minimal invasion, and the outcomes of this complication in our center. Methods: Between May 2006 and January 2011, a total of 213 secundum-type ASD patients were accepted in our hospital for intraoperative and transthoracic device closure with a domestic occluder. All patients were assessed by real-time transthoracic echocardiography (TTE) and electrocardiograph (ECG). Results: All patients were occluded successfully under this approach. Immediate postprocedure third-degree AVB was observed in two patients. Since heart rates were in the range of about 50 to 55 beats per minute, no intervention was needed except for close observation for one patient. Another patient who recovered sinus rhythm intermittently during the operation was fitted with a temporary pacemaker. Approximately one week following glucocorticoid treatment, the AVB resolved spontaneously in these two patients. Mobitz type II AVB occurred in three patients during the procedure. Two patients developed post-operative cardiac arrest and were rescued successfully with cardiopulmonary resuscitation. One other patient changed to Mobitz type I AVB after three days. During the follow-up period, which ranged from six months to five years, no further occurrence of AVB was found. Conclusions: Intraoperative and transthoracic device closure of secundum ASDs with domestic occluder resulted in excellent closure rate. AVB is an infrequent but serious complication during and after device closure of a secundum ASD. AVB is a complication that warrants greater attention and long-term follow-up.	[Chen, Qiang; Cao, Hua; Zhang, Gui-Can; Chen, Liang-Wan; Chen, Dao-Zhong; Li, Qian-Zhen; Qiu, Zhi-Huang] Fujian Med Univ, Union Hosp, Dept Cardiovasc Surg, Fuzhou, Peoples R China	Fujian Medical University	Chen, Q (corresponding author), Fujian Med Univ, Union Hosp, Dept Cardiovasc Surg, Fuzhou, Peoples R China.	chenqiang2228@hotmail.com		Qiu, ZhiHuang/0000-0002-5917-8968				Al-Anani SJ, 2010, CATHETER CARDIO INTE, V75, P767, DOI 10.1002/ccd.22359; Bialkowski J, 2004, TEX HEART I J, V31, P220; Chen Q, 2012, EUR J CARDIO-THORAC, V41, P121, DOI 10.1016/j.ejcts.2011.04.001; Chen QA, 2011, J THORAC CARDIOV SUR, V141, P631, DOI 10.1016/j.jtcvs.2010.07.077; DICKINSON DF, 1981, BRIT HEART J, V46, P55; Formigari R, 2001, J AM COLL CARDIOL, V37, P1707, DOI 10.1016/S0735-1097(01)01213-X; Hannoush H, 2004, CLIN CARDIOL, V27, P236, DOI 10.1002/clc.4960270413; Hughes ML, 2002, HEART, V88, P67, DOI 10.1136/heart.88.1.67; Johnson JN, 2011, CATHETER CARDIO INTE, V78, P254, DOI 10.1002/ccd.23028; Li GS, 2009, ULTRASOUND MED BIOL, V35, P58, DOI 10.1016/j.ultrasmedbio.2008.06.008; Lin SM, 2007, J FORMOS MED ASSOC, V106, P1052, DOI 10.1016/S0929-6646(08)60083-2; Luermans JGLM, 2010, EUROINTERVENTION, V6, P604, DOI 10.4244/EIJV6I5A101; Majunke N, 2009, AM J CARDIOL, V103, P550, DOI 10.1016/j.amjcard.2008.10.018; Nehgme RA, 2009, PEDIATR CARDIOL, V30, P367, DOI 10.1007/s00246-008-9322-0; Pedra, 2000, Curr Interv Cardiol Rep, V2, P274; Rossi RI, 2008, CATHETER CARDIO INTE, V71, P231, DOI 10.1002/ccd.21361; Ryan WH, 2003, ANN THORAC SURG, V75, P1532, DOI 10.1016/S0003-4975(02)04720-3; Spence MS, 2005, HEART, V91, P1512, DOI 10.1136/hrt.2004.057562; Spies C, 2007, CLIN RES CARDIOL, V96, P340, DOI 10.1007/s00392-007-0502-3; Suda K, 2004, J AM COLL CARDIOL, V43, P1677, DOI 10.1016/j.jacc.2003.12.042; Zhang H, 2011, J CARDIOTHORAC SURG, V6, DOI 10.1186/1749-8090-6-123	21	5	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52726	10.1371/journal.pone.0052726	http://dx.doi.org/10.1371/journal.pone.0052726			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285170	Green Submitted, Green Published, gold			2022-12-27	WOS:000313051500053
J	Grauffel, C; Abboud, A; Liszczak, G; Marmorstein, R; Arnesen, T; Reuter, N				Grauffel, Cedric; Abboud, Angele; Liszczak, Glen; Marmorstein, Ronen; Arnesen, Thomas; Reuter, Nathalie			Specificity and Versatility of Substrate Binding Sites in Four Catalytic Domains of Human N-Terminal Acetyltransferases	PLOS ONE			English	Article							FREE-ENERGY DECOMPOSITION; MOLECULAR-MECHANICS; ACETYLATION; DYNAMICS; PROTEINS; COMPLEX; ELECTROSTATICS; SIMULATIONS	Nt-acetylation is among the most common protein modifications in eukaryotes. Although thought for a long time to protect proteins from degradation, the role of Nt-acetylation is still debated. It is catalyzed by enzymes called N-terminal acetyltransferases (NATs). In eukaryotes, several NATs, composed of at least one catalytic domain, target different substrates based on their N-terminal sequences. In order to better understand the substrate specificity of human NATs, we investigated in silico the enzyme-substrate interactions in four catalytic subunits of human NATs (Naa10p, Naa20p, Naa30p and Naa50p). To date hNaa50p is the only human subunit for which X-ray structures are available. We used the structure of the ternary hNaa50p/AcCoA/MLG complex and a structural model of hNaa10p as a starting point for multiple molecular dynamics simulations of hNaa50p/AcCoA/substrate (substrate = MLG, EEE, MKG), hNaa10p/AcCoA/substrate (substrate = MLG, EEE). Nine alanine point-mutants of the hNaa50p/AcCoA/MLG complex were also simulated. Homology models of hNaa20p and hNaa30p were built and compared to hNaa50p and hNaa10p. The simulations of hNaa50p/AcCoA/MLG reproduce the interactions revealed by the X-ray data. We observed strong hydrogen bonds between MLG and tyrosines 31, 138 and 139. Yet the tyrosines interacting with the substrate's backbone suggest that their role in specificity is limited. This is confirmed by the simulations of hNaa50p/AcCoA/EEE and hNaa10p/AcCoA/MLG, where these hydrogen bonds are still observed. Moreover these tyrosines are all conserved in hNaa20p and hNaa30p. Other amino acids tune the specificity of the S1' sites that is different for hNaa10p (acidic), hNaa20p (hydrophobic/basic), hNaa30p (basic) and hNaa50p (hydrophobic). We also observe dynamic correlation between the ligand binding site and helix alpha(2) that tightens under substrate binding. Finally, by comparing the four structures we propose maps of the peptide-enzyme interactions that should help rationalizing substrate-specificity and lay the ground for inhibitor design.	[Grauffel, Cedric; Arnesen, Thomas; Reuter, Nathalie] Univ Bergen, Dept Mol Biol, Bergen, Norway; [Grauffel, Cedric; Abboud, Angele; Reuter, Nathalie] Uni Res AS, Computat Biol Unit, Uni Comp, Bergen, Norway; [Liszczak, Glen; Marmorstein, Ronen] Univ Penn, Wistar Inst, Philadelphia, PA USA; [Liszczak, Glen; Marmorstein, Ronen] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Arnesen, Thomas] Univ Bergen, Dept Surg Sci, Bergen, Norway	University of Bergen; University of Bergen; The Wistar Institute; University of Pennsylvania; University of Pennsylvania; University of Bergen	Reuter, N (corresponding author), Univ Bergen, Dept Mol Biol, Bergen, Norway.	Nathalie.Reuter@mbi.uib.no	Arnesen, Thomas/Q-8117-2019; Reuter, Nathalie/G-2037-2012; Arnesen, Thomas/J-7139-2017	Arnesen, Thomas/0000-0002-3005-147X; Reuter, Nathalie/0000-0002-3649-7675; Arnesen, Thomas/0000-0002-3005-147X	Bergen Research Foundation; Research Council of Norway [197136]; Norwegian Cancer Society [PR-2009-0222]; NIH [GM060293, GM071339]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060293, T32GM071339] Funding Source: NIH RePORTER	Bergen Research Foundation; Research Council of Norway(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Bergen Research Foundation (N.R., C.G. and T.A.), the Research Council of Norway (Project 197136 to T.A.), and the Norwegian Cancer Society (Project PR-2009-0222 to T.A.). URLs : http://www.bfstiftelse.no, http://www.forskningsradet.no, http://www.kreftforeningen.no/. Part of this work was supported by NIH (http://www.nih.gov) grant GM060293 awarded to R.M. and NIH training grant GM071339 awarded to G.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnesen T, 2009, P NATL ACAD SCI USA, V106, P8157, DOI 10.1073/pnas.0901931106; Behnia R, 2004, NAT CELL BIOL, V6, P405, DOI 10.1038/ncb1120; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BRUNGER AT, 1988, PROTEINS, V4, P148, DOI 10.1002/prot.340040208; Caves LSD, 1998, PROTEIN SCI, V7, P649, DOI 10.1002/pro.5560070314; Ciechanover A, 2004, TRENDS CELL BIOL, V14, P103, DOI 10.1016/j.tcb.2004.01.004; DAVIS ME, 1991, COMPUT PHYS COMMUN, V62, P187, DOI 10.1016/0010-4655(91)90094-2; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Evjenth R, 2009, J BIOL CHEM, V284, P31122, DOI 10.1074/jbc.M109.001347; Hodawadekar SC, 2007, ONCOGENE, V26, P5528, DOI 10.1038/sj.onc.1210619; Hole K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024713; Hwang CS, 2010, SCIENCE, V327, P973, DOI 10.1126/science.1183147; JORNVALL H, 1975, J THEOR BIOL, V55, P1, DOI 10.1016/S0022-5193(75)80105-6; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Lafont V, 2007, PROTEINS, V67, P418, DOI 10.1002/prot.21259; Liszczak G, 2011, J BIOL CHEM; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Plasman K, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003301; Polevoda B, 2003, J MOL BIOL, V325, P595, DOI 10.1016/S0022-2836(02)01269-X; Polevoda Bogdan, 2009, BMC Proc, V3 Suppl 6, pS2, DOI 10.1186/1753-6561-3-S6-S2; Rostkowski M, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-6; Scott DC, 2011, SCIENCE, V334, P674, DOI 10.1126/science.1209307; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Siehl DL, 2007, J BIOL CHEM, V282, P11446, DOI 10.1074/jbc.M610267200; Starheim KK, 2008, BIOCHEM J, V415, P325, DOI 10.1042/BJ20080658; Starheim KK, 2012, TRENDS BIOCHEM SCI, V37, P152, DOI 10.1016/j.tibs.2012.02.003; Starheim KK, 2009, MOL CELL BIOL, V29, P3569, DOI 10.1128/MCB.01909-08; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Van Damme P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002169; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Zoete V, 2003, J COMPUT AID MOL DES, V17, P861, DOI 10.1023/B:JCAM.0000021882.99270.4c; Zoete V, 2007, PROTEINS, V67, P1026, DOI 10.1002/prot.21395	34	4	4	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52642	10.1371/journal.pone.0052642	http://dx.doi.org/10.1371/journal.pone.0052642			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285125	Green Published, Green Submitted, gold			2022-12-27	WOS:000313051500042
J	Muller, HP; Vernikouskaya, I; Ludolph, AC; Kassubek, J; Rasche, V				Mueller, Hans-Peter; Vernikouskaya, Ina; Ludolph, Albert C.; Kassubek, Jan; Rasche, Volker			Fast Diffusion Tensor Magnetic Resonance Imaging of the Mouse Brain at Ultrahigh-Field: Aiming at Cohort Studies	PLOS ONE			English	Article							FIBER TRACKING; ATLAS; MRI; MODEL	Introduction: In-vivo high resolution diffusion tensor imaging (DTI) of the mouse brain is often limited by the low signal to noise ratio (SNR) resulting from the required small voxel sizes. Recently, cryogenically cooled resonators (CCR) have demonstrated significant increase of the effective SNR. It is the objective of this study to enable fast DTI of the mouse brain. In this context, CCRs appear attractive for SNR improvement. Methods: Three mice underwent a DTI examination at 156(2) x 250 mu m(3) spatial resolution with a CCR at ultrahigh field (11.7T). Diffusion images were acquired along 30 gradient directions plus 5 references without diffusion encoding, resulting in a total acquisition time of 35 minutes. For comparison, mice additionally underwent a standardized 110 minutes acquisition protocol published earlier. Fractional anisotropy (FA) and fiber tracking (FT) results including quantitative tractwise fractional anisotropy statistics (TFAS) were qualitatively and quantitatively compared. Results: Qualitative and quantitative assessment of the calculated fractional anisotropy maps and fibre tracking results showed coinciding outcome comparing 35 minute scans to the standardized 110 minute scan. Coefficients of variation for ROI-based FA-comparison as well as for TFAS revealed comparable results for the different scanning protocols. Conclusion: Mouse DTI at 11.7 T was performed with an acquisition time of approximately 30 minutes, which is considered feasible for cohort studies. The rapid acquisition protocol reveals reliable and reproducible FA-values and FT reconstructions, thus allowing an experimental setup for in-vivo large scale whole brain murine DTI cohort studies.	[Mueller, Hans-Peter; Ludolph, Albert C.; Kassubek, Jan] Univ Ulm, Dept Neurol, D-7900 Ulm, Germany; [Vernikouskaya, Ina; Rasche, Volker] Univ Ulm, Core Facil Small Anim MRI, Ulm, Germany	Ulm University; Ulm University	Muller, HP (corresponding author), Univ Ulm, Dept Neurol, D-7900 Ulm, Germany.	hans-peter.mueller@uni-ulm.de	Kassubek, Jan/GPX-0910-2022; Rasche, Volker/P-6523-2016; Kassubek, Jan/F-2774-2015; Kassubek, Jan/O-1740-2019; Vernikouskaya, Ina/AAU-5675-2021	Kassubek, Jan/0000-0002-7106-9270; Rasche, Volker/0000-0001-8844-3583; Kassubek, Jan/0000-0002-7106-9270; Kassubek, Jan/0000-0002-7106-9270; 				Aggarwal M, 2009, NEUROSCIENCE, V162, P1339, DOI 10.1016/j.neuroscience.2009.05.070; Aggarwal M, 2010, MAGN RESON MED, V64, P249, DOI 10.1002/mrm.22426; Baltes C, 2009, NMR BIOMED, V22, P834, DOI 10.1002/nbm.1396; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Boretius S, 2007, J NEUROSCI METH, V161, P112, DOI 10.1016/j.jneumeth.2006.10.019; Chuang N, 2011, NEUROIMAGE, V54, P80, DOI 10.1016/j.neuroimage.2010.07.043; Guilfoyle DN, 2011, J NEUROSCI METH, V199, P10, DOI 10.1016/j.jneumeth.2011.04.011; Gutman DA, 2012, NEUROIMAGE, V63, P800, DOI 10.1016/j.neuroimage.2012.07.014; Harsan LA, 2010, NMR BIOMED, V23, P884, DOI 10.1002/nbm.1496; Jiang Y, 2011, NEUROIMAGE, V56, P1235, DOI 10.1016/j.neuroimage.2011.03.031; Kumar M, 2012, BRAIN RES, V1455, P56, DOI 10.1016/j.brainres.2012.03.041; Kunimatsu Akira, 2004, Magn Reson Med Sci, V3, P11, DOI 10.2463/mrms.3.11; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Muller HP, 2007, PHYS MED BIOL, V52, pN99, DOI 10.1088/0031-9155/52/6/N01; Mueller HP, 2007, BIOMED ENG ONLINE, V6, DOI 10.1186/1475-925X-6-42; Pathak AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022643; Ratering D, 2008, MAGN RESON MED, V59, P1440, DOI 10.1002/mrm.21629; Ruest T, 2011, NMR BIOMED, V24, P1369, DOI 10.1002/nbm.1700; Unrath A, 2010, HUM BRAIN MAPP, V31, P1727, DOI 10.1002/hbm.20971; Vollmar C, 2010, NEUROIMAGE, V51, P1384, DOI 10.1016/j.neuroimage.2010.03.046	21	14	14	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53389	10.1371/journal.pone.0053389	http://dx.doi.org/10.1371/journal.pone.0053389			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285289	Green Published, gold			2022-12-27	WOS:000313051500144
J	Orr, CH; Leifert, C; Cummings, SP; Cooper, JM				Orr, Caroline H.; Leifert, Carlo; Cummings, Stephen P.; Cooper, Julia M.			Impacts of Organic and Conventional Crop Management on Diversity and Activity of Free-Living Nitrogen Fixing Bacteria and Total Bacteria Are Subsidiary to Temporal Effects	PLOS ONE			English	Article							SOIL MICROBIAL BIOMASS; ARBUSCULAR MYCORRHIZAL FUNGI; NIFH GENE POOLS; COMMUNITY STRUCTURE; GROWTH; FERTILIZATION; PESTICIDES; FIXATION; RESPONSES; SYSTEMS	A three year field study (2007-2009) of the diversity and numbers of the total and metabolically active free-living diazotophic bacteria and total bacterial communities in organic and conventionally managed agricultural soil was conducted using the Nafferton Factorial Systems Comparison (NFSC) study, in northeast England. Fertility management appeared to have little impact on both diazotrophic and total bacterial communities. However, copy numbers of the nifH gene did appear to be negatively impacted by conventional crop protection measures across all years suggesting diazotrophs may be particularly sensitive to pesticides. Impacts of crop management were greatly overshadowed by the influence of temporal effects with diazotrophic communities changing on a year by year basis and from season to season. Quantitative analyses using qPCR of each community indicated that metabolically active diazotrophs were highest in year 1 but the population significantly declined in year 2 before recovering somewhat in the final year. The total bacterial population in contrast increased significantly each year. It appeared that the dominant drivers of qualitative and quantitative changes in both communities were annual and seasonal effects. Moreover, regression analyses showed activity of both communities was significantly affected by soil temperature and climatic conditions.	[Orr, Caroline H.; Cummings, Stephen P.] Northumbria Univ, Fac Hlth & Life Sci, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England; [Leifert, Carlo; Cooper, Julia M.] Newcastle Univ, Nafferton Ecol Farming Grp, Stocksfield, Northd, England	Northumbria University; Newcastle University - UK	Cummings, SP (corresponding author), Northumbria Univ, Fac Hlth & Life Sci, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England.	stephen.cummings@unn.ac.uk	Cummings, Stephen P/S-8336-2018	Cummings, Stephen P/0000-0001-5298-2075; Leifert, Carlo/0000-0002-2974-3612; Orr, Caroline Hayley/0000-0001-7140-4393	European Community under the Seventh Framework Programme for Research, Technological Development and Demonstration Activities, for the Integrated Project [NUE CROPS EU-FP7 222-645]; The Yorkshire Agricultural Society [NPD/JMD/08/72]; Nafferton Ecological Farming Group; Northumbria University Research Development Fund	European Community under the Seventh Framework Programme for Research, Technological Development and Demonstration Activities, for the Integrated Project; The Yorkshire Agricultural Society; Nafferton Ecological Farming Group; Northumbria University Research Development Fund	This work was funded by the following: European Community financial participation under the Seventh Framework Programme for Research, Technological Development and Demonstration Activities, for the Integrated Project NUE CROPS EU-FP7 222-645. The Yorkshire Agricultural Society. www.yas.co.uk. Grant NPD/JMD/08/72. Nafferton Ecological Farming Group. http://research.ncl.ac.uk/nefg. Institutional funding was provided by Northumbria University Research Development Fund. http://www.northumbria.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, TECHNOMETRICS; Baxter J, 2008, J APPL MICROBIOL, V104, P1605, DOI 10.1111/j.1365-2672.2007.03709.x; Beauchamp CJ, 2006, BIORESOURCE TECHNOL, V97, P1002, DOI 10.1016/j.biortech.2005.04.041; Bending GD, 2007, CHEMOSPHERE, V69, P82, DOI 10.1016/j.chemosphere.2007.04.042; Birkhofer K, 2008, SOIL BIOL BIOCHEM, V40, P2297, DOI 10.1016/j.soilbio.2008.05.007; Bohm GMB, 2009, SOIL BIOL BIOCHEM, V41, P420, DOI 10.1016/j.soilbio.2008.11.002; Bossio DA, 1998, MICROBIAL ECOL, V36, P1, DOI 10.1007/s002489900087; Burgmann H, 2005, ENVIRON MICROBIOL, V7, P1711, DOI 10.1111/j.1462-2920.2005.00818.x; Campbell BJ, 2010, ENVIRON MICROBIOL, V12, P1842, DOI 10.1111/j.1462-2920.2010.02189.x; CHAPIN DM, 1991, CAN J BOT, V69, P2744, DOI 10.1139/b91-345; Coelho MRR, 2009, APPL SOIL ECOL, V42, P48, DOI 10.1016/j.apsoil.2009.01.010; Coelho MRR, 2008, FEMS MICROBIOL LETT, V279, P15, DOI 10.1111/j.1574-6968.2007.00975.x; Cooper J, 2007, HDB ORGANIC FOOD SAF; Cummings SP, 2009, ENVIRON MICROBIOL, V11, P2510, DOI 10.1111/j.1462-2920.2009.01975.x; Cycon M, 2007, POL J ECOL, V55, P207; Cycon M, 2009, ECOTOXICOLOGY, V18, P632, DOI 10.1007/s10646-009-0321-6; DeLuca TH, 1996, BIOL FERT SOILS, V23, P140; Diallo S, 2011, FEMS MICROBIOL ECOL, V75, P351, DOI 10.1111/j.1574-6941.2010.01023.x; DONECHE B, 1983, SOIL SCI, V135, P361, DOI 10.1097/00010694-198306000-00004; Drenovsky RE, 2004, MICROB ECOL, V48, P424, DOI 10.1007/s00248-003-1063-2; Eckford R, 2002, APPL ENVIRON MICROB, V68, P5181, DOI 10.1128/AEM.68.10.5181-5185.2002; Esperschuetz J, 2007, FEMS MICROBIOL ECOL, V61, P26, DOI 10.1111/j.1574-6941.2007.00318.x; Fernandez-Calvino D, 2010, FEMS MICROBIOL ECOL, V73, P149, DOI 10.1111/j.1574-6941.2010.00873.x; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fox JE, 2004, ENVIRON HEALTH PERSP, V112, P672, DOI 10.1289/ehp.6456; Fox JE, 2007, P NATL ACAD SCI USA, V104, P10282, DOI 10.1073/pnas.0611710104; Gamble MD, 2010, MICROB ECOL, V59, P253, DOI 10.1007/s00248-009-9558-0; Griffiths BS, 2006, J ENVIRON QUAL, V35, P734, DOI 10.2134/jeq2005.0344; Hallin S, 2009, ISME J, V3, P597, DOI 10.1038/ismej.2008.128; Hartley AE, 2002, J ARID ENVIRON, V52, P293, DOI 10.1006/jare.2002.1007; Hartmann M, 2006, FEMS MICROBIOL ECOL, V57, P378, DOI 10.1111/j.1574-6941.2006.00132.x; Hauggaard-Nielsen H, 2009, NUTR CYCL AGROECOSYS, V84, P281, DOI 10.1007/s10705-008-9242-7; Hayden HL, 2010, SOIL BIOL BIOCHEM, V42, P1774, DOI 10.1016/j.soilbio.2010.06.015; Hsu SF, 2009, ISME J, V3, P124, DOI 10.1038/ismej.2008.82; Hussain S, 2009, ADV AGRON, V102, P159, DOI 10.1016/S0065-2113(09)01005-0; Jangid K, 2008, SOIL BIOL BIOCHEM, V40, P2843, DOI 10.1016/j.soilbio.2008.07.030; Kandeler E, 2006, APPL ENVIRON MICROB, V72, P5957, DOI 10.1128/AEM.00439-06; Karlen Y, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-131; Keeling AA, 1998, BIORESOURCE TECHNOL, V66, P89, DOI 10.1016/S0960-8524(98)00055-8; Kibblewhite MG, 2008, PHILOS T R SOC B, V363, P685, DOI 10.1098/rstb.2007.2178; KITOH S, 1991, SOIL SCI PLANT NUTR, V37, P419, DOI 10.1080/00380768.1991.10415054; Knauth S, 2005, ENVIRON MICROBIOL, V7, P1725, DOI 10.1111/j.1462-2920.2005.00841.x; KNOWLES R, 1974, SOIL BIOL BIOCHEM, V6, P353, DOI 10.1016/0038-0717(74)90043-1; Lejon DPH, 2005, MICROB ECOL, V50, P614, DOI 10.1007/s00248-005-5130-8; Lindstrom ES, 2005, AQUAT SCI, V67, P210, DOI 10.1007/s00027-005-0769-2; Mader P, 2002, SCIENCE, V296, P1694, DOI 10.1126/science.1071148; Milosevic NA, 2002, ZB MATICE SRP PRIR N, V102, P5, DOI [10.2298/ZMSPN0201005M, DOI 10.2298/ZMSPN0201005M]; Minitab, 2006, MIN STAT SOFTW REL 1; Morales SE, 2010, ISME J, V4, P799, DOI 10.1038/ismej.2010.8; Moreno B, 2009, AGR ECOSYST ENVIRON, V131, P333, DOI 10.1016/j.agee.2009.02.011; Ngosong C, 2010, APPL SOIL ECOL, V46, P134, DOI 10.1016/j.apsoil.2010.07.004; Ogilvie LA, 2008, MICROB ECOL, V56, P525, DOI 10.1007/s00248-008-9372-0; OMAR SA, 1992, WORLD J MICROB BIOT, V8, P326, DOI 10.1007/BF01201891; Orr CH, 2011, APPL ENVIRON MICROB, V77, P911, DOI 10.1128/AEM.01250-10; Pimentel D, 2005, BIOSCIENCE, V55, P573, DOI 10.1641/0006-3568(2005)055[0573:EEAECO]2.0.CO;2; Poly F, 2001, RES MICROBIOL, V152, P95, DOI 10.1016/S0923-2508(00)01172-4; Postma J, 2008, SOIL BIOL BIOCHEM, V40, P2394, DOI 10.1016/j.soilbio.2008.05.023; Prosser JI, 2010, ENVIRON MICROBIOL, V12, P1806, DOI 10.1111/j.1462-2920.2010.02201.x; R Development Core Team, 2006, R LANG ENV STAT COMP; Reddy KN, 2003, WEED SCI, V51, P496, DOI 10.1614/0043-1745(2003)051[0496:GSRTVS]2.0.CO;2; Reed SC, 2007, APPL SOIL ECOL, V36, P238, DOI 10.1016/j.apsoil.2007.02.002; ROPER MM, 1994, SOIL BIOL BIOCHEM, V26, P1087, DOI 10.1016/0038-0717(94)90125-2; Soil Association, 2005, SOIL ASS ORG STAND; Spyrou IM, 2009, MICROB ECOL, V58, P715, DOI 10.1007/s00248-009-9522-z; Sturz AV, 1999, PLANT PATHOL, V48, P26, DOI 10.1046/j.1365-3059.1999.00305.x; Tamm L, 2010, EUR J PLANT PATHOL, V127, P465, DOI 10.1007/s10658-010-9612-2; Toljander JF, 2008, FEMS MICROBIOL ECOL, V65, P323, DOI 10.1111/j.1574-6941.2008.00512.x; van Diepeningen AD, 2006, APPL SOIL ECOL, V31, P120, DOI 10.1016/j.apsoil.2005.03.003; van Overbeek L, 2008, FEMS MICROBIOL ECOL, V64, P283, DOI 10.1111/j.1574-6941.2008.00469.x; Vieira RF, 2007, PLANT SOIL, V300, P95, DOI 10.1007/s11104-007-9392-4; Wartiainen I, 2008, APPL SOIL ECOL, V39, P65, DOI 10.1016/j.apsoil.2007.11.008; Wessen E, 2010, SOIL BIOL BIOCHEM, V42, P1759, DOI 10.1016/j.soilbio.2010.06.013; Widmer F, 2006, APPL SOIL ECOL, V33, P294, DOI 10.1016/j.apsoil.2005.09.007; Zablotowicz RM, 2007, CROP PROT, V26, P370, DOI 10.1016/j.cropro.2005.05.013	74	49	58	2	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52891	10.1371/journal.pone.0052891	http://dx.doi.org/10.1371/journal.pone.0052891			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285218	Green Accepted, Green Published, gold			2022-12-27	WOS:000313051500077
J	Zhou, YH; Cahan, SH				Zhou, Yihong; Cahan, Sara Helms			A Novel Family of Terminal-Repeat Retrotransposon in Miniature (TRIM) in the Genome of the Red Harvester Ant, Pogonomyrmex barbatus	PLOS ONE			English	Article							TRANSPOSABLE ELEMENTS; DNA; EVOLUTION; GENE; DIVERSIFICATION; SPECIFICITY; SEQUENCE; ABUNDANT; CASTE	We report the first described non-plant family of TRIMs (terminal-repeat retrotransposons in miniature), which are small nonautonomous LTR retrotransposons, from the whole-genome sequence of the red harvester ant, Pogonomyrmex barbatus (Hymenoptera: Myrmicinae). Members of this retrotransposon family, named PbTRIM, have typical features of plant TRIMs in length and structure, although they share no overall sequence similarity. PbTRIM elements and their solo-LTRs are abundant in the host genome and exhibit an uneven distribution pattern. Elements are preferentially inserted into TA-rich regions with ATAT as the most common pattern of target site duplication (TSD). PbTRIM is most likely mobile as indicated by the young age of many complete elements, the high degree of sequence similarity among elements at different genomic locations, the abundance of elements in the host genome, and the presence of 4-bp target site duplications (TSDs) flanking the elements and solo-LTRs. Many PbTRIM elements and their solo-LTRs are located within or near genes, suggesting their potential roles in restructuring the host genes and genome. Database search, PCR and sequencing analysis revealed the presence of homologous PbTRIM elements in other ant species. The high sequence similarity between elements from distantly related ant species, the incongruence between the phylogenies of PbTRIM and its hosts, and the patchy distribution of the retroelement within the Myrmicinae subfamily indicate possible horizontal transfer events of the retroelement.	[Zhou, Yihong; Cahan, Sara Helms] Univ Vermont, Dept Biol, Burlington, VT 05405 USA	University of Vermont	Cahan, SH (corresponding author), Univ Vermont, Dept Biol, Burlington, VT 05405 USA.	scahan@uvm.edu			National Science Foundation grant [DEB-0919052]	National Science Foundation grant(National Science Foundation (NSF))	This research was funded by National Science Foundation grant DEB-0919052 to Sara Helms Cahan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENDER J, 1992, P NATL ACAD SCI USA, V89, P7996, DOI 10.1073/pnas.89.17.7996; Bennetzen JL, 1997, PLANT CELL, V9, P1509, DOI 10.1105/tpc.9.9.1509; Bennetzen JL, 2000, PLANT MOL BIOL, V42, P251, DOI 10.1023/A:1006344508454; Bowen NJ, 2003, GENOME RES, V13, P1984, DOI 10.1101/gr.1191603; Brady SG, 2006, P NATL ACAD SCI USA, V103, P18172, DOI 10.1073/pnas.0605858103; Cahan SH, 2006, ECOLOGY, V87, P2160, DOI 10.1890/0012-9658(2006)87[2160:RIBPRA]2.0.CO;2; Cahan SH, 2002, P ROY SOC B-BIOL SCI, V269, P1871, DOI 10.1098/rspb.2002.2061; CHALKER DL, 1992, GENE DEV, V6, P117, DOI 10.1101/gad.6.1.117; CHARLESWORTH B, 1994, NATURE, V371, P215, DOI 10.1038/371215a0; Gadau J, 2012, TRENDS GENET, V28, P14, DOI 10.1016/j.tig.2011.08.005; Gao DY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032010; Julian GE, 2002, P NATL ACAD SCI USA, V99, P8157, DOI 10.1073/pnas.112222099; Kalendar R, 2004, GENETICS, V166, P1437, DOI 10.1534/genetics.166.3.1437; Kalendar R, 2008, P NATL ACAD SCI USA, V105, P5833, DOI 10.1073/pnas.0709698105; Kalendar R, 2010, THEOR APPL GENET, V121, P1419, DOI 10.1007/s00122-010-1398-2; KAMINKER JS, 2002, GENOME BIOL, V0003; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Kumar A, 1999, ANNU REV GENET, V33, P479, DOI 10.1146/annurev.genet.33.1.479; Kwon SJ, 2007, MOL GENET GENOMICS, V278, P361, DOI 10.1007/s00438-007-0249-6; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Le Grice SFJ, 2003, BIOCHEMISTRY-US, V42, P14349, DOI 10.1021/bi030201q; Levin HL, 2011, NAT REV GENET, V12, P615, DOI 10.1038/nrg3030; Li W. H, 1997, MOL EVOLUTION; LIM JK, 1994, BIOESSAYS, V16, P269, DOI 10.1002/bies.950160410; Linheiro RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030008; Loreto ELS, 2008, HEREDITY, V100, P545, DOI 10.1038/sj.hdy.6801094; Maddison D. R., 2003, MACCLADE 4 ANAL PHYL; Majumdar A, 2011, J VIROL, V85, P519, DOI 10.1128/JVI.01719-10; McCollum AM, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-5; Moreau CS, 2006, SCIENCE, V312, P101, DOI 10.1126/science.1124891; Munoz-Torres MC, 2011, NUCLEIC ACIDS RES, V39, pD658, DOI 10.1093/nar/gkq1145; Nakatsuka T, 2006, MOL GENET GENOMICS, V275, P231, DOI 10.1007/s00438-005-0083-7; Nefedova LN, 2011, VIRUS GENES, V42, P297, DOI 10.1007/s11262-010-0566-4; Neumann P, 2003, PLANT MOL BIOL, V53, P399, DOI 10.1023/B:PLAN.0000006945.77043.ce; SanMiguel P, 1996, SCIENCE, V274, P765, DOI 10.1126/science.274.5288.765; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Smith CR, 2011, P NATL ACAD SCI USA, V108, P5667, DOI 10.1073/pnas.1007901108; Taber S. W., 1998, WORLD HARVESTER ANTS; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TEMIN HM, 1981, CELL, V27, P1, DOI 10.1016/0092-8674(81)90353-6; Vigdal TJ, 2002, J MOL BIOL, V323, P441, DOI 10.1016/S0022-2836(02)00991-9; Wessler SR, 2006, P NATL ACAD SCI USA, V103, P17600, DOI 10.1073/pnas.0607612103; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; WILLIAMSON VM, 1983, INT REV CYTOL, V83, P1, DOI 10.1016/S0074-7696(08)61684-8; Witte CP, 2001, P NATL ACAD SCI USA, V98, P13778, DOI 10.1073/pnas.241341898; Wurm Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-5; Xu Z, 2007, NUCLEIC ACIDS RES, V35, pW265, DOI 10.1093/nar/gkm286; Yang TJ, 2007, THEOR APPL GENET, V114, P627, DOI 10.1007/s00122-006-0463-3; Zhu YX, 2003, P NATL ACAD SCI USA, V100, P5891, DOI 10.1073/pnas.1036705100	49	20	21	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53401	10.1371/journal.pone.0053401	http://dx.doi.org/10.1371/journal.pone.0053401			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285291	Green Published, gold, Green Submitted			2022-12-27	WOS:000313051500146
J	Fernandez, I; Fridley, KM; Arasappan, D; Ambler, RV; Tucker, PW; Roy, K				Fernandez, Irina; Fridley, Krista M.; Arasappan, Dhivya; Ambler, Rosalind V.; Tucker, Philip W.; Roy, Krishnendu			Gene Expression Profile and Functionality of ESC-Derived Lin-ckit+Sca-1+Cells Are Distinct from Lin-ckit+Sca-1+Cells Isolated from Fetal Liver or Bone Marrow	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; DEFINITIVE HEMATOPOIESIS; DIFFERENTIATION; PROGENITORS; CULTURE; IDENTIFICATION; PURIFICATION; EXPANSION; SCAFFOLD; ORIGINS	In vitro bioreactor-based cultures are being extensively investigated for large-scale production of differentiated cells from embryonic stem cells (ESCs). However, it is unclear whether in vitro ESC-derived progenitors have similar gene expression profiles and functionalities as their in vivo counterparts. This is crucial in establishing the validity of ESC-derived cells as replacements for adult-isolated cells for clinical therapies. In this study, we compared the gene expression profiles of Lin-ckit+Sca-1+ (LKS) cells generated in vitro from mouse ESCs using either static or bioreactor-based cultures, with that of native LKS cells isolated from mouse fetal liver (FL) or bone marrow (BM). We found that in vitro-generated LKS cells were more similar to FL-than to BM LKS cells in gene expression. Further, when compared to cells derived from bioreactor cultures, static culture-derived LKS cells showed fewer differentially expressed genes relative to both in vivo LKS populations. Overall, the expression of hematopoietic genes was lower in ESC-derived LKS cells compared to cells from BM and FL, while the levels of non-hematopoietic genes were up-regulated. In order to determine if these molecular profiles correlated with functionality, we evaluated ESC-derived LKS cells for in vitro hematopoietic-differentiation and colony formation (CFU assay). Although static culture-generated cells failed to form any colonies, they did differentiate into CD11c+ and B220+ cells indicating some hematopoietic potential. In contrast, bioreactor-derived LKS cells, when differentiated under the same conditions failed to produce any B220+ or CD11c+ cells and did not form colonies, indicating that these cells are not hematopoietic progenitors. We conclude that in vitro culture conditions significantly affect the transcriptome and functionality of ESC-derived LKS cells and although in vitro differentiated LKS cells were lineage negative and expressed both ckit and Sca-1, these cells, especially those obtained from dynamic cultures, are significantly different from native cells of the same phenotype.	[Fernandez, Irina; Fridley, Krista M.; Ambler, Rosalind V.; Roy, Krishnendu] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA; [Tucker, Philip W.] Univ Texas Austin, Dept Mol Genet & Microbiol, Austin, TX 78712 USA; [Tucker, Philip W.; Roy, Krishnendu] Univ Texas Austin, Inst Cell & Mol Biol, Austin, TX 78712 USA; [Arasappan, Dhivya] Univ Texas Austin, Genome Sequencing & Anal Facil, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Roy, K (corresponding author), Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA.	kroy@mail.utexas.edu			National Institutes of Health [EB005026]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005026] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was partially supported through National Institutes of Health grant number EB005026 to KR and PWT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bryder D, 2006, AM J PATHOL, V169, P338, DOI 10.2353/ajpath.2006.060312; Cameron CM, 2006, BIOTECHNOL BIOENG, V94, P938, DOI 10.1002/bit.20919; Chambers Stuart M, 2007, Cell Stem Cell, V1, P578, DOI 10.1016/j.stem.2007.10.003; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Czechowicz A, 2010, IMMUNOLOGY ALLERGY C, V30; Dang SM, 2004, STEM CELLS, V22, P275, DOI 10.1634/stemcells.22-3-275; Dowdy CR, 2010, HUM MOL GENET, V19, P1048, DOI 10.1093/hmg/ddp568; Fok EYL, 2005, STEM CELLS, V23, P1333, DOI 10.1634/stemcells.2005-0112; Fridley K., 2012, STEM CELL R IN PRESS; Fridley KM, 2010, TISSUE ENG PT A, V16, P3285, DOI [10.1089/ten.tea.2010.0166, 10.1089/ten.TEA.2010.0166]; Fukui A, 2009, BIOCHEM BIOPH RES CO, V385, P330, DOI 10.1016/j.bbrc.2009.05.052; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; KALLIANPUR AR, 1994, BLOOD, V83, P1200; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kitagawa M, 2010, INT J HEMATOL, V91, P373, DOI 10.1007/s12185-010-0518-8; Lin J, 2011, STEM CELL REV REP, V7, P736, DOI 10.1007/s12015-010-9215-5; Liu H, 2005, TISSUE ENG, V11, P319, DOI 10.1089/ten.2005.11.319; Liu H, 2006, BIOMATERIALS, V27, P5978, DOI 10.1016/j.biomaterials.2006.05.053; Mikkola HKA, 2003, BLOOD, V101, P508, DOI 10.1182/blood-2002-06-1699; Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Morrison SJ, 1997, DEVELOPMENT, V124, P1929; MORRISON SJ, 1995, P NATL ACAD SCI USA, V92, P10302, DOI 10.1073/pnas.92.22.10302; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; OKADA S, 1991, BLOOD, V78, P1706; OKADA S, 1992, BLOOD, V80, P3044; Oliveros J.C., 2007, VENNY INTERACTIVE TO; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Papathanasiou P, 2009, STEM CELLS, V27, P2498, DOI 10.1002/stem.170; Park IK, 2002, BLOOD, V99, P488, DOI 10.1182/blood.V99.2.488; Paz H, 2010, BLOOD, V116, P1254, DOI 10.1182/blood-2009-11-254383; Phillips RL, 2000, SCIENCE, V288, P1635, DOI 10.1126/science.288.5471.1635; Potocnik AJ, 2000, IMMUNITY, V12, P653, DOI 10.1016/S1074-7613(00)80216-2; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Rao RR, 2004, BIOL REPROD, V71, P1772, DOI 10.1095/biolreprod.104.030395; Schiedlmeier B, 2007, P NATL ACAD SCI USA, V104, P16952, DOI 10.1073/pnas.0703082104; Sharova LV, 2007, DEV BIOL, V307, P446, DOI 10.1016/j.ydbio.2007.05.004; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Taiani JT, 2010, STEM CELLS DEV, V19, P989, DOI 10.1089/scd.2009.0297; Taqvi S, 2006, BIOMATERIALS, V27, P6024, DOI 10.1016/j.biomaterials.2006.05.052; Terskikh AV, 2003, BLOOD, V102, P94, DOI 10.1182/blood-2002-08-2509; Weissman IL, 2008, BLOOD, V112, P3543, DOI 10.1182/blood-2008-08-078220	45	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e51944	10.1371/journal.pone.0051944	http://dx.doi.org/10.1371/journal.pone.0051944			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300581	Green Published, gold, Green Submitted			2022-12-27	WOS:000312829100014
J	Ishteiwy, RA; Ward, TM; Dykxhoorn, DM; Burnstein, KL				Ishteiwy, Reema A.; Ward, Toby M.; Dykxhoorn, Derek M.; Burnstein, Kerry L.			The microRNA-23b/-27b Cluster Suppresses the Metastatic Phenotype of Castration-Resistant Prostate Cancer Cells	PLOS ONE			English	Article							E-CADHERIN REPRESSORS; MICRORNA EXPRESSION; RHO-GTPASES; HEPATOCELLULAR-CARCINOMA; PROGNOSTIC RELEVANCE; PROGRESSION; MIR-27B; ACTIVATION; PROTEIN; GROWTH	MicroRNAs (miRs) are small, endogenous, non-coding RNAs that regulate the stability and/or translation of complementary mRNA targets. MiRs have emerged not only as critical modulators of normal physiologic processes, but their deregulation may significantly impact prostate and other cancers. The expression of miR-23b and miR-27b, which are encoded by the same miR cluster (miR-23b/-27b), are downregulated in metastatic, castration-resistant tumors compared to primary prostate cancer and benign tissue; however, their possible role in prostate cancer progression is unknown. We found that ectopic expression of miR-23b/-27b in two independent castration-resistant prostate cancer cell lines resulted in suppression of invasion and migration, as well as reduced survival in soft agar (a measure of anoikis). However, there was no effect of miR-23b/-27b on cell proliferation suggesting that these miRs function as metastasis (but not growth) suppressors in prostate cancer. Conversely, inhibition of miR-23b/-27b in the less aggressive androgen-dependent LNCaP prostate cancer cell line resulted in enhanced invasion and migration also without affecting proliferation. Mechanistically, we found that introduction of miR-23b/-27b in metastatic, castration-resistant prostate cancer cell lines resulted in a significant attenuation of Rac1 activity without affecting total Rac1 levels and caused increased levels of the tumor suppressor E-cadherin. Inhibition of these miRs had the opposite effect in androgen-dependent LNCaP cells. These results suggest that miR-23b/-27b are metastasis suppressors that might serve as novel biomarkers and therapeutic agents for castration-resistant disease.	[Ishteiwy, Reema A.; Ward, Toby M.; Burnstein, Kerry L.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA; [Dykxhoorn, Derek M.] Univ Miami, Miller Sch Med, John P Hussman Inst Human Genom,Dept Human Genet, John T Macdonald Fdn,Dept Microbiol & Immunol, Miami, FL 33136 USA	University of Miami; University of Miami	Burnstein, KL (corresponding author), Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA.	kburnstein@med.miami.edu	Dykxhoorn, Derek M/D-1357-2015		National Institutes of Health Grant [CA132200]; DOD Pre-doctoral training grant [w81xwh-11-1-0314]; NATIONAL CANCER INSTITUTE [R01CA132200] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD Pre-doctoral training grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant CA132200 (to KLB) and DOD Pre-doctoral training grant w81xwh-11-1-0314 (to RAI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar N, 2010, ARTHRITIS RHEUM-US, V62, P1361, DOI 10.1002/art.27329; Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Bader AG, 2010, CANCER RES, V70, P7027, DOI 10.1158/0008-5472.CAN-10-2010; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Benitah SA, 2004, BBA-REV CANCER, V1705, P121, DOI 10.1016/j.bbcan.2004.10.002; Chen LC, 2011, ONCOL REP, V26, P1617, DOI 10.3892/or.2011.1458; Chunthapong J, 2004, J CELL BIOCHEM, V91, P649, DOI 10.1002/jcb.20032; Dalmay T, 2006, ONCOGENE, V25, P6170, DOI 10.1038/sj.onc.1209911; Dykxhoorn DM, 2010, CANCER RES, V70, P6401, DOI 10.1158/0008-5472.CAN-10-1346; Engers R, 2007, ENDOCR-RELAT CANCER, V14, P245, DOI 10.1677/ERC-06-0036; Engers R, 2006, BRIT J CANCER, V95, P1081, DOI 10.1038/sj.bjc.6603385; Frisch SM, 2001, ADV CANCER RES, V80, P39, DOI 10.1016/S0065-230X(01)80011-7; Fuse M, 2012, J HUMAN GENETICS; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Huang YS, 2008, J GASTROEN HEPATOL, V23, P87, DOI 10.1111/j.1440-1746.2007.05223.x; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Knight-Krajewski S, 2004, ONCOGENE, V23, P5513, DOI 10.1038/sj.onc.1207708; Kobayashi T, 2010, MOL ENDOCRINOL, V24, P722, DOI 10.1210/me.2009-0326; Lee JJ, 2012, ONCOGENE, V31, P3818, DOI 10.1038/onc.2011.543; Lin KT, 2012, CANCER RES, V72, P3000, DOI 10.1158/0008-5472.CAN-11-2502; LOOP SM, 1993, PROSTATE, V22, P93, DOI 10.1002/pros.2990220202; Luo Jan, 1997, Pathol Oncol Res, V3, P264; Lyons LS, 2008, MOL ENDOCRINOL, V22, P597, DOI 10.1210/me.2007-0158; Lyons LS, 2006, MOL ENDOCRINOL, V20, P1061, DOI 10.1210/me.2005-0346; Ma L, 2008, CELL CYCLE, V7, P570, DOI 10.4161/cc.7.5.5547; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Martens-Uzunova ES, 2012, ONCOGENE, V31, P978, DOI 10.1038/onc.2011.304; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Noren NK, 2000, J CELL BIOL, V150, P567, DOI 10.1083/jcb.150.3.567; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Saito T, 2000, UROL INT, V65, P140, DOI 10.1159/000064859; Salvi A, 2009, FEBS J, V276, P2966, DOI 10.1111/j.1742-4658.2009.07014.x; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Steeg Patricia S, 2003, Clin Breast Cancer, V4, P51, DOI 10.3816/CBC.2003.n.012; Sun T, 2012, PROSTATE, V72, P1093, DOI 10.1002/pros.22456; Sun T, 2009, CANCER RES, V69, P3356, DOI 10.1158/0008-5472.CAN-08-4112; Treiber T, 2012, THROMB HAEMOSTASIS, V107, P605, DOI 10.1160/TH11-12-0836; Tsuchiya Y, 2006, CANCER RES, V66, P9090, DOI 10.1158/0008-5472.CAN-06-1403; UMBAS R, 1994, CANCER RES, V54, P3929; WANG M, 1991, DIFFERENTIATION, V48, P115, DOI 10.1111/j.1432-0436.1991.tb00250.x; Wang YF, 2009, J BIOL CHEM, V284, P23094, DOI 10.1074/jbc.M109.012617; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yoshida J, 2009, MED MOL MORPHOL, V42, P82, DOI 10.1007/s00795-008-0436-5; Zhang HS, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1555	49	73	77	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52106	10.1371/journal.pone.0052106	http://dx.doi.org/10.1371/journal.pone.0052106			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300597	Green Published, Green Submitted, gold			2022-12-27	WOS:000313618800048
J	Norgan, AP; Lee, JRE; Oestreich, AJ; Payne, JA; Krueger, EW; Katzmann, DJ				Norgan, Andrew P.; Lee, Jacqueline R. E.; Oestreich, Andrea J.; Payne, Johanna A.; Krueger, Eugene W.; Katzmann, David J.			ESCRT-Independent Budding of HIV-1 Gag Virus-Like Particles from Saccharomyces cerevisiae Spheroplasts	PLOS ONE			English	Article							ROUS-SARCOMA-VIRUS; UBIQUITIN LIGASE; LEUKEMIA-VIRUS; L-DOMAINS; PROTEIN; REPLICATION; EXPRESSION; YEAST; MOTIF; POLYPROTEIN	Heterologous expression of HIV-1 Gag in a variety of host cells results in its packaging into virus-like particles (VLPs) that are subsequently released into the extracellular milieu. This phenomenon represents a useful tool for probing cellular factors required for viral budding and has contributed to the discovery of roles for ubiquitin ligases and the endosomal sorting complexes required for transport (ESCRTs) in viral budding. These factors are highly conserved throughout eukaryotes and have been studied extensively in the yeast Saccharomyces cerevisiae, a model eukaryote previously utilized as a host for the production of VLPs. We used heterologous expression of HIV Gag in yeast spheroplasts to examine the role of ESCRTs and associated factors (Rsp5, a HECT ubiquitin ligase of the Nedd4 family; Bro1, a homolog of Alix; and Vps4, the AAA-ATPase required for ESCRT function in all contexts/organisms investigated) in the generation of VLPs. Our data reveal: 1) characterized Gag-ESCRT interaction motifs (late domains) are not required for VLP budding, 2) loss of function alleles of the essential HECT ubiquitin ligase Rsp5 do not display defects in VLP formation, and 3) ESCRT function is not required for VLP formation from spheroplasts. These results suggest that the egress of HIV Gag from yeast cells is distinct from the most commonly described mode of exit from mammalian cells, instead mimicking ESCRT-independent VLP formation observed in a subset of mammalian cells. As such, budding of Gag from yeast cells appears to represent ESCRT-independent budding relevant to viral replication in at least some situations. Thus the myriad of genetic and biochemical tools available in the yeast system may be of utility in the study of this aspect of viral budding.	[Norgan, Andrew P.; Lee, Jacqueline R. E.; Oestreich, Andrea J.; Payne, Johanna A.; Katzmann, David J.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Krueger, Eugene W.] Mayo Clin, Ctr Cell Signaling Gastroenterol, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Katzmann, DJ (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA.	Katzmann.David@mayo.edu		Eve, Jacqueline/0000-0002-3159-5620	American Heart Association Predoctoral Fellowship [09PRE2220147]; NIH [1F30DA26762]; University of Minnesota-Rochester Bioinformatics and Computational Biology Seed Grant; National Institute of General Medical Sciences [5R01GM073024]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F30DA026762] Funding Source: NIH RePORTER	American Heart Association Predoctoral Fellowship(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Minnesota-Rochester Bioinformatics and Computational Biology Seed Grant; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by an American Heart Association Predoctoral Fellowship 09PRE2220147 (APN), NIH Predoctoral Fellowship 1F30DA26762 (APN), University of Minnesota-Rochester Bioinformatics and Computational Biology Seed Grant (DJK), and National Institute of General Medical Sciences grant 5R01GM073024 (DJK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accola MA, 2000, J VIROL, V74, P5395, DOI 10.1128/JVI.74.12.5395-5402.2000; Babst M, 2002, DEV CELL, V3, P283, DOI 10.1016/S1534-5807(02)00219-8; Babst M, 2005, TRAFFIC, V6, P2, DOI 10.1111/j.1600-0854.2004.00246.x; Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Babst M, 2000, TRAFFIC, V1, P248, DOI 10.1034/j.1600-0854.2000.010307.x; Babst M, 1997, EMBO J, V16, P1820, DOI 10.1093/emboj/16.8.1820; Barajas D, 2010, VIROLOGY, V397, P358, DOI 10.1016/j.virol.2009.11.010; Barajas D, 2009, J VIROL, V83, P11751, DOI 10.1128/JVI.00789-09; BATHURST IC, 1989, J VIROL, V63, P3176, DOI 10.1128/JVI.63.7.3176-3179.1989; Bello NF, 2012, J VIROL, V86, P4182, DOI 10.1128/JVI.07105-11; Bieniasz PD, 2006, VIROLOGY, V344, P55, DOI 10.1016/j.virol.2005.09.044; BONNET D, 1990, J VIROL, V64, P5628, DOI 10.1128/JVI.64.11.5628-5632.1990; Chung HY, 2008, J VIROL, V82, P4884, DOI 10.1128/JVI.02667-07; Demirov DG, 2002, J VIROL, V76, P105, DOI 10.1128/JVI.76.1.105-117.2002; Dunn R, 2001, J BIOL CHEM, V276, P25974, DOI 10.1074/jbc.M104113200; Duran JM, 2010, J CELL BIOL, V188, P527, DOI 10.1083/jcb.200911154; Dussupt V, 2011, J VIROL, V85, P2304, DOI 10.1128/JVI.01562-10; Fabrikant G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000575; Fujii K, 2009, VIROLOGY, V391, P284, DOI 10.1016/j.virol.2009.06.016; Gan X, 2011, MOL BIOL CELL, V22, P817, DOI 10.1091/mbc.E10-07-0625; Garoff H, 1998, MICROBIOL MOL BIOL R, V62, P1171, DOI 10.1128/MMBR.62.4.1171-1190.1998; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; GOTTLINGER HG, 1991, P NATL ACAD SCI USA, V88, P3195, DOI 10.1073/pnas.88.8.3195; Gottwein E, 2003, J VIROL, V77, P9474, DOI 10.1128/JVI.77.17.9474-9485.2003; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Harty RN, 2000, P NATL ACAD SCI USA, V97, P13871, DOI 10.1073/pnas.250277297; HUANG MJ, 1995, J VIROL, V69, P6810, DOI 10.1128/JVI.69.11.6810-6818.1995; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; Hurley JH, 2010, CELL, V143, P875, DOI 10.1016/j.cell.2010.11.030; Hurley JH, 2010, CRIT REV BIOCHEM MOL, V45, P463, DOI 10.3109/10409238.2010.502516; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; JACOBS E, 1989, GENE, V79, P71, DOI 10.1016/0378-1119(89)90093-0; Jadwin JA, 2010, J VIROL, V84, P704, DOI 10.1128/JVI.01319-09; JANDA M, 1993, CELL, V72, P961, DOI 10.1016/0092-8674(93)90584-D; KARACOSTAS V, 1989, P NATL ACAD SCI USA, V86, P8964, DOI 10.1073/pnas.86.22.8964; Katzmann DJ, 2004, MOL BIOL CELL, V15, P468, DOI 10.1091/mbc.E03-07-0473; Katzmann DJ, 2003, J CELL BIOL, V162, P413, DOI 10.1083/jcb.200302136; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Le Blanc I, 2002, J VIROL, V76, P10024, DOI 10.1128/JVI.76.19.10024-10029.2002; Lee JRE, 2009, J BIOL CHEM, V284, P32126, DOI 10.1074/jbc.M109.048629; MAKAROW M, 1985, EMBO J, V4, P1855, DOI 10.1002/j.1460-2075.1985.tb03860.x; Martin-Serrano J, 2004, J VIROL, V78, P5554, DOI 10.1128/JVI.78.11.5554-5563.2004; Martin-Serrano J, 2001, NAT MED, V7, P1313, DOI 10.1038/nm1201-1313; Medina G, 2005, TRAFFIC, V6, P880, DOI 10.1111/j.1600-0854.2005.00323.x; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Morita E, 2011, CELL HOST MICROBE, V9, P235, DOI 10.1016/j.chom.2011.02.004; Odorizzi G, 1998, CELL, V95, P847, DOI 10.1016/S0092-8674(00)81707-9; Odorizzi G, 2003, J CELL SCI, V116, P1893, DOI 10.1242/jcs.00395; Oestreich AJ, 2007, MOL BIOL CELL, V18, P707, DOI 10.1091/mbc.E06-08-0680; PARENT LJ, 1995, J VIROL, V69, P5455, DOI 10.1128/JVI.69.9.5455-5460.1995; Perez M, 2003, P NATL ACAD SCI USA, V100, P12978, DOI 10.1073/pnas.2133782100; Piper RC, 2007, ANNU REV CELL DEV BI, V23, P519, DOI 10.1146/annurev.cellbio.23.090506.123319; Popova E, 2010, J VIROL, V84, P6590, DOI 10.1128/JVI.00035-10; Price BD, 1996, P NATL ACAD SCI USA, V93, P9465, DOI 10.1073/pnas.93.18.9465; Puffer BA, 1997, J VIROL, V71, P6541, DOI 10.1128/JVI.71.9.6541-6546.1997; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Rotin D, 2000, J MEMBRANE BIOL, V176, P1; ROYER M, 1991, VIROLOGY, V184, P417, DOI 10.1016/0042-6822(91)90861-5; Sabo Y, 2008, J VIROL, V82, P9770, DOI 10.1128/JVI.00741-08; Sakuragi S, 2002, P NATL ACAD SCI USA, V99, P7956, DOI 10.1073/pnas.082281199; Sakuragi S, 2006, MICROBES INFECT, V8, P1875, DOI 10.1016/j.micinf.2006.02.027; Shen BY, 2011, J BIOL CHEM, V286, P14383, DOI 10.1074/jbc.M110.208660; Shih SC, 2002, NAT CELL BIOL, V4, P389, DOI 10.1038/ncb790; SHIODA T, 1990, VIROLOGY, V175, P139, DOI 10.1016/0042-6822(90)90194-V; SMITH AJ, 1990, J VIROL, V64, P2743, DOI 10.1128/JVI.64.6.2743-2750.1990; Strack B, 2000, P NATL ACAD SCI USA, V97, P13063, DOI 10.1073/pnas.97.24.13063; Strecker T, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-93; Taylor GM, 2007, J VIROL, V81, P13631, DOI 10.1128/JVI.01688-07; Tsunetsugu-Yokota Y, 2003, J VIROL, V77, P10250, DOI 10.1128/JVI.77.19.10250-10259.2003; Usami Y, 2008, J VIROL, V82, P4898, DOI 10.1128/JVI.02675-07; VALENZUELA P, 1982, NATURE, V298, P347, DOI 10.1038/298347a0; Wang HT, 2002, J VIROL, V76, P8485, DOI 10.1128/JVI.76.16.8485-8493.2002; Weiss ER, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001107; Weissenhorn W, 2011, CELL HOST MICROBE, V9, P172, DOI 10.1016/j.chom.2011.03.005; Yasuda J, 1998, J VIROL, V72, P4095, DOI 10.1128/JVI.72.5.4095-4103.1998	77	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52603	10.1371/journal.pone.0052603	http://dx.doi.org/10.1371/journal.pone.0052603			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285107	Green Published, Green Submitted, gold			2022-12-27	WOS:000313158800080
J	Xiao, S; Nayak, B; Samuel, A; Paldurai, A; Kanabagattebasavarajappa, M; Prajitno, TY; Bharoto, EE; Collins, PL; Samal, SK				Xiao, Sa; Nayak, Baibaswata; Samuel, Arthur; Paldurai, Anandan; Kanabagattebasavarajappa, Mallikarjuna; Prajitno, Teguh Y.; Bharoto, Eny E.; Collins, Peter L.; Samal, Siba K.			Generation by Reverse Genetics of an Effective, Stable, Live-Attenuated Newcastle Disease Virus Vaccine Based on a Currently Circulating, Highly Virulent Indonesian Strain	PLOS ONE			English	Article							PROTEIN CLEAVAGE SITE; SHEDDING FOLLOWING VACCINATION; FUSION PROTEIN; CHICKENS; IMMUNIZATION; DIVERSITY; CANDIDATE; SEQUENCES; WATERFOWL; OUTBREAKS	Newcastle disease virus (NDV) can cause severe disease in chickens. Although NDV vaccines exist, there are frequent reports of outbreaks in vaccinated chickens. During 2009-2010, despite intense vaccination, NDV caused major outbreaks among commercial poultry farms in Indonesia. These outbreaks raised concern regarding the protective immunity of current vaccines against circulating virulent strains in Indonesia. In this study, we investigated whether a recombinant attenuated Indonesian NDV strain could provide better protection against prevalent Indonesian viruses. A reverse genetics system for the highly virulent NDV strain Banjarmasin/010/10 (Ban/010) isolated in Indonesia in 2010 was constructed. The Ban/010 virus is classified in genotype VII of class II NDV, which is genetically distinct from the commercial vaccine strains B1 and LaSota, which belong to genotype II, and shares only 89 and 87% amino acid identity for the protective antigens F and HN, respectively. A mutant virus, named Ban/AF, was developed in which the virulent F protein cleavage site motif "RRQKR down arrow F" was modified to an avirulent motif "(G) under bar RQ (G) under barR down arrow(L) under bar" by three amino acid substitutions (underlined). The Ban/AF vaccine virus did not produce syncytia or plaques in cell culture, even in the presence of added protease. Pathogenicity tests showed that Ban/AF was completely avirulent. Ban/AF replicated efficiently during 10 consecutive passages in chickens and remained genetically stable. Serological analysis showed that Ban/AF induced higher neutralization and hemagglutination inhibition antibody titers against the prevalent viruses than the commercial vaccines B1 or LaSota. Both Ban/AF and commercial vaccines provided protection against clinical disease and mortality after challenge with virulent NDV strain Ban/010 (genotype VII) or GB Texas (genotype II). However, Ban/AF significantly reduced challenge virus shedding from the vaccinated birds compared to B1 vaccine. These results suggest that Ban/AF can provide better protection than commercial vaccines and is a promising vaccine candidate against NDV strains circulating in Indonesia.	[Xiao, Sa; Nayak, Baibaswata; Samuel, Arthur; Paldurai, Anandan; Kanabagattebasavarajappa, Mallikarjuna; Samal, Siba K.] Univ Maryland, Virginia Maryland Reg Coll Vet Med, College Pk, MD 20742 USA; [Prajitno, Teguh Y.] Japfa Comfeed Indonesia, Jakarta, Indonesia; [Bharoto, Eny E.] Vaksindo Satwa Nusantara, Jakarta, Indonesia; [Collins, Peter L.] NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA	University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Samal, SK (corresponding author), Univ Maryland, Virginia Maryland Reg Coll Vet Med, College Pk, MD 20742 USA.	ssamal@umd.edu	Nayak, Baibaswata/L-6156-2016		National Institute of Allergy and Infectious Diseases (NIAID) [N01A060009]; NIAID, National Institutes of Health (NIH) Intramural Research Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000938] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID, National Institutes of Health (NIH) Intramural Research Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by National Institute of Allergy and Infectious Diseases (NIAID) contract no. N01A060009 (85% support) and NIAID, National Institutes of Health (NIH) Intramural Research Program (15% support). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander D, 2003, PARAMYXOVIRIDAE; Alexander D.J., 1997, DIS POULTRY, P541; Biacchesi S, 2003, VIROLOGY, V315, P1, DOI 10.1016/S0042-6822(03)00528-2; COLLINS MS, 1993, ARCH VIROL, V128, P363, DOI 10.1007/BF01309446; Czegledi A, 2006, VIRUS RES, V120, P36, DOI 10.1016/j.virusres.2005.11.009; de Leeuw OS, 2003, J GEN VIROL, V84, P475, DOI 10.1099/vir.0.18714-0; Gould AR, 2001, VIRUS RES, V77, P51, DOI 10.1016/S0168-1702(01)00265-9; Hu SL, 2009, VACCINE, V27, P904, DOI 10.1016/j.vaccine.2008.11.091; Hu ZL, 2011, AVIAN DIS, V55, P391, DOI 10.1637/9633-122410-Reg.1; Huang ZH, 2003, J VIROL, V77, P8676, DOI 10.1128/JVI.77.16.8676-8685.2003; Jeon WJ, 2008, J VET SCI, V9, P295, DOI 10.4142/jvs.2008.9.3.295; JOHNSON PR, 1987, J VIROL, V61, P3163, DOI 10.1128/JVI.61.10.3163-3166.1987; Kapczynski DR, 2005, VACCINE, V23, P3424, DOI 10.1016/j.vaccine.2005.01.140; Khattar SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016776; Kim LM, 2007, J VIROL, V81, P12641, DOI 10.1128/JVI.00843-07; Liu XF, 2003, ARCH VIROL, V148, P1387, DOI 10.1007/s00705-003-0014-z; Lyles D. S., 2007, FIELDS VIROLOGY, V1, P1364; Miller PJ, 2007, VACCINE, V25, P7238, DOI 10.1016/j.vaccine.2007.07.017; Miller PJ, 2010, INFECT GENET EVOL, V10, P26, DOI 10.1016/j.meegid.2009.09.012; Miller PJ, 2009, AVIAN DIS, V53, P39, DOI 10.1637/8407-071208-Reg.1; MORRISON T, 1993, VIROLOGY, V193, P997, DOI 10.1006/viro.1993.1214; Panda A, 2004, MICROB PATHOGENESIS, V36, P1, DOI 10.1016/j.micpath.2003.07.003; Peeters BPH, 1999, J VIROL, V73, P5001, DOI 10.1128/JVI.73.6.5001-5009.1999; REED L. J., 1938, AMER JOUR HYG, V27, P493; SCHLOER GM, 1968, J VIROL, V2, P40, DOI 10.1128/JVI.2.1.40-47.1968; Shengqing Y, 2002, VIROLOGY, V301, P206, DOI 10.1006/viro.2002.1539; WINTERFIELD RW, 1957, POULTRY SCI, V36, P1076, DOI 10.3382/ps.0361076; Xiao S, 2012, J VIROL, V86, P5969, DOI 10.1128/JVI.00546-12; Xiao S, 2012, J VIROL, V86, P3828, DOI 10.1128/JVI.06765-11; Xiao S, 2011, VACCINE, V29, P5294, DOI 10.1016/j.vaccine.2011.05.010	30	60	68	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52751	10.1371/journal.pone.0052751	http://dx.doi.org/10.1371/journal.pone.0052751			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285174	gold, Green Submitted, Green Published			2022-12-27	WOS:000313158800094
J	Hof, AR; Jansson, R; Nilsson, C				Hof, Anouschka R.; Jansson, Roland; Nilsson, Christer			Future Climate Change Will Favour Non-Specialist Mammals in the (Sub)Arctics	PLOS ONE			English	Article							BIOTIC INTERACTIONS; SPECIES DISTRIBUTIONS; DIVERSITY; RESPONSES; BIODIVERSITY; BUTTERFLIES; EXTINCTION; PATTERNS; RECOVERY; IMPACTS	Arctic and subarctic (i.e., [sub] arctic) ecosystems are predicted to be particularly susceptible to climate change. The area of tundra is expected to decrease and temperate climates will extend further north, affecting species inhabiting northern environments. Consequently, species at high latitudes should be especially susceptible to climate change, likely experiencing significant range contractions. Contrary to these expectations, our modelling of species distributions suggests that predicted climate change up to 2080 will favour most mammals presently inhabiting (sub) arctic Europe. Assuming full dispersal ability, most species will benefit from climate change, except for a few cold-climate specialists. However, most resident species will contract their ranges if they are not able to track their climatic niches, but no species is predicted to go extinct. If climate would change far beyond current predictions, however, species might disappear. The reason for the relative stability of mammalian presence might be that arctic regions have experienced large climatic shifts in the past, filtering out sensitive and range-restricted taxa. We also provide evidence that for most (sub) arctic mammals it is not climate change per se that will threaten them, but possible constraints on their dispersal ability and changes in community composition. Such impacts of future changes in species communities should receive more attention in literature.	[Hof, Anouschka R.; Jansson, Roland; Nilsson, Christer] Umea Univ, Landscape Ecol Grp, Dept Ecol & Environm Sci, Umea, Sweden; [Hof, Anouschka R.] Swedish Univ Agr Sci SLU, Dept Wildlife Fish & Environm Studies, Umea, Sweden	Umea University; Swedish University of Agricultural Sciences	Hof, AR (corresponding author), Umea Univ, Landscape Ecol Grp, Dept Ecol & Environm Sci, Umea, Sweden.	Anouschka.Hof@emg.umu.se	Nilsson, Christer/AAI-1354-2019; Jansson, Roland/B-7972-2013; Hof, Anouschka R/V-5994-2019; Nilsson, Christer/I-9407-2012	Jansson, Roland/0000-0003-1767-7010; Hof, Anouschka R/0000-0001-6743-0089; Nilsson, Christer/0000-0003-1186-8115	Nordic Council of Ministers [91228]	Nordic Council of Ministers	This project was funded by the Nordic Council of Ministers (http://www.norden.org/en/nordic-council-of-ministers), Project number: 91228. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 2010, DIVERS DISTRIB, V16, P476, DOI 10.1111/j.1472-4642.2010.00654.x; Angerbjorn A, 2005, SAVING ENDANGERED FE; [Anonymous], 2005, ARCTIC CLIMATE IMPAC; Araujo MB, 2007, GLOBAL ECOL BIOGEOGR, V16, P743, DOI 10.1111/j.1466-8238.2007.00359.x; Araujo MB, 2011, ECOL LETT, V14, P484, DOI 10.1111/j.1461-0248.2011.01610.x; Bright PW, 1998, ANIM BEHAV, V56, P1485, DOI 10.1006/anbe.1998.0921; Callaghan TV, 2004, AMBIO, V33, P404, DOI 10.1639/0044-7447(2004)033[0404:BDAAOA]2.0.CO;2; Cantor SB, 1999, J CLIN EPIDEMIOL, V52, P885, DOI 10.1016/S0895-4356(99)00075-X; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Flojgaard C, 2009, IOP C SER EARTH ENV, V8, DOI 10.1088/1755-1315/8/1/012016; Fuglei E, 1999, J COMP PHYSIOL B, V169, P361, DOI 10.1007/s003600050232; Gaston KJ, 2000, J APPL ECOL, V37, P39, DOI 10.1046/j.1365-2664.2000.00485.x; Hastie T., 2009, UNSUPERVISED LEARNIN; Hill JK, 2002, P ROY SOC B-BIOL SCI, V269, P2163, DOI 10.1098/rspb.2002.2134; Hof AR, 2012, DIVERS DISTRIB, V18, P554, DOI 10.1111/j.1472-4642.2011.00876.x; Huntley Brian, 2005, P109; Jansson R, 2003, P ROY SOC B-BIOL SCI, V270, P583, DOI 10.1098/rspb.2002.2283; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Johnson CN, 2007, P R SOC B, V274, P341, DOI 10.1098/rspb.2006.3711; Kojola I, 2004, J ZOOL, V263, P229, DOI 10.1017/S0952836904005084; Levinsky I, 2007, BIODIVERS CONSERV, V16, P3803, DOI 10.1007/s10531-007-9181-7; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; Morueta-Holme N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010360; Nilsson C, 2010, AMBIO, V39, P81, DOI 10.1007/s13280-009-0010-y; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Roderfeld H, 2008, CLIMATIC CHANGE, V87, P283, DOI 10.1007/s10584-007-9350-4; Rodriguez-Castaneda G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044402; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Swenson JE, 1995, WILDLIFE BIOL, V1, P11, DOI 10.2981/wlb.1995.005; Thomas CD, 2006, TRENDS ECOL EVOL, V21, P415, DOI 10.1016/j.tree.2006.05.012; Thulin CG, 2003, MAMMAL REV, V33, P29, DOI 10.1046/j.1365-2907.2003.00008.x; Van der Putten WH, 2010, PHILOS T R SOC B, V365, P2025, DOI 10.1098/rstb.2010.0037; Virkkala R, 2008, BIOL CONSERV, V141, P1343, DOI 10.1016/j.biocon.2008.03.007; Wabakken P, 2001, CAN J ZOOL, V79, P710, DOI 10.1139/cjz-79-4-710; Warren MS, 2001, NATURE, V414, P65, DOI 10.1038/35102054; Wolf A, 2008, CLIMATIC CHANGE, V87, P91, DOI 10.1007/s10584-007-9340-6	40	44	44	0	121	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52574	10.1371/journal.pone.0052574	http://dx.doi.org/10.1371/journal.pone.0052574			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285098	Green Published, gold, Green Submitted			2022-12-27	WOS:000312794500202
J	Huang, HB; Liu, NN; Yang, CS; Liao, SY; Guo, HP; Zhao, K; Li, XF; Liu, ST; Guan, LX; Liu, CJ; Xu, L; Zhang, CG; Song, WB; Li, B; Tang, P; Dou, QP; Liu, JB				Huang, Hongbiao; Liu, Ningning; Yang, Changshan; Liao, Siyan; Guo, Haiping; Zhao, Kai; Li, Xiaofen; Liu, Shouting; Guan, Lixia; Liu, Chunjiao; Xu, Li; Zhang, Change; Song, Wenbin; Li, Bing; Tang, Ping; Dou, Q. Ping; Liu, Jinbao			HDAC Inhibitor L-Carnitine and Proteasome Inhibitor Bortezomib Synergistically Exert Anti-Tumor Activity In Vitro and In Vivo	PLOS ONE			English	Article							MULTIPLE-MYELOMA CELLS; 20 S PROTEASOME; HISTONE DEACETYLASE; PHASE-I; CANCER; APOPTOSIS; ACID; COMBINATION; THERAPY; PROTEIN	Combinations of proteasome inhibitors and histone deacetylases (HDAC) inhibitors appear to be the most potent to produce synergistic cytotoxicity in preclinical trials. We have recently confirmed that L-carnitine (LC) is an endogenous HDAC inhibitor. In the current study, the anti-tumor effect of LC plus proteasome inhibitor bortezomib (velcade, Vel) was investigated both in cultured hepatoma cancer cells and in Balb/c mice bearing HepG2 tumor. Cell death and cell viability were assayed by flow cytometry and MTS, respectively. Gene, mRNA expression and protein levels were detected by gene microarray, quantitative real-time PCR and Western blot, respectively. The effect of Vel on the acetylation of histone H3 associated with the p21(cip1) gene promoter was examined by using ChIP assay and proteasome peptidase activity was detected by cell-based chymotrypsin-like (CT-like) activity assay. Here we report that (i) the combination of LC and Vel synergistically induces cytotoxicity in vitro; (ii) the combination also synergistically inhibits tumor growth in vivo; (iii) two major pathways are involved in the synergistical effects of the combinational treatment: increased p21(cip1) expression and histone acetylation in vitro and in vivo and enhanced Vel-induced proteasome inhibition by LC. The synergistic effect of LC and Vel in cancer therapy should have great potential in the future clinical trials.	[Huang, Hongbiao; Liu, Ningning; Yang, Changshan; Liao, Siyan; Guo, Haiping; Zhao, Kai; Li, Xiaofen; Liu, Shouting; Guan, Lixia; Liu, Chunjiao; Xu, Li; Zhang, Change; Song, Wenbin; Tang, Ping; Dou, Q. Ping; Liu, Jinbao] Guangzhou Med Univ, Dept Pathophysiol, Prot Modificat & Degradat Lab, Guangzhou, Guangdong, Peoples R China; [Xu, Li] Peoples Hosp Guangxi Autonomous Reg, Dept Hematol, Nanning, Guangxi, Peoples R China; [Li, Bing] Guangzhou Med Univ, Expt Med Res Ctr, Guangzhou, Guangdong, Peoples R China; [Tang, Ping] Guangzhou Med Univ, Affiliated Guangzhou Municipal Peoples Hosp 1, Dept Hematol, Guangzhou, Guangdong, Peoples R China; [Dou, Q. Ping] Wayne State Univ, Sch Med, Mol Therapeut Program, Barbara Ann Karmanos Canc Inst, Detroit, MI USA; [Dou, Q. Ping] Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI USA; [Dou, Q. Ping] Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA; [Dou, Q. Ping] Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48201 USA	Guangzhou Medical University; Guangzhou Medical University; Guangzhou Medical University; Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University; Wayne State University; Wayne State University	Dou, QP (corresponding author), Guangzhou Med Univ, Dept Pathophysiol, Prot Modificat & Degradat Lab, Guangzhou, Guangdong, Peoples R China.	doup@karmanos.org; Liujinbao1@yahoo.com.cn		Liu, Ningning/0000-0002-9587-2332; Dou, Qingping/0000-0002-6465-1473	National High Technology Research and Development Program of China [2006AA02Z4B5]; National Natural Science Foundation of China [81070033, 30770835, 81170608, 81072091]; Guangdong Province Natural Science Foundation [9251018201002, 94510018201003604]; Foundation for Distinguished Young Talents in Higher Education of Guangdong; Foundation of Guangzhou Medical College for Doctor Scientists [2011C24]; Guangzhou Municipal Education Commission [10A057S, 08A108]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Foundation for Distinguished Young Talents in Higher Education of Guangdong; Foundation of Guangzhou Medical College for Doctor Scientists; Guangzhou Municipal Education Commission	This work was supported by the National High Technology Research and Development Program of China (Project 2006AA02Z4B5), National Natural Science Foundation of China (Project 81070033, 30770835, 81170608, 81072091) (to JL, PT, and CZ); Projects (9251018201002, 94510018201003604) of Guangdong Province Natural Science Foundation; Projects from Foundation for Distinguished Young Talents in Higher Education of Guangdong and the Foundation of Guangzhou Medical College for Doctor Scientists (2011C24), and projects from Guangzhou Municipal Education Commission (10A057S, 08A108) (to JL, HH and CZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arendt CS, 1999, EMBO J, V18, P3575, DOI 10.1093/emboj/18.13.3575; Badros A, 2009, CLIN CANCER RES, V15, P5250, DOI 10.1158/1078-0432.CCR-08-2850; Baiz D, 2009, BIOCHIMIE, V91, P373, DOI 10.1016/j.biochi.2008.10.015; Butler LM, 2000, CANCER RES, V60, P5165; Calvaruso G, 2007, ONCOL REP, V18, P447; Carew Jennifer S, 2002, Mol Cancer, V1, P9, DOI 10.1186/1476-4598-1-9; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Das Undurti N., 2006, Biotechnology Journal, V1, P420, DOI 10.1002/biot.200600012; Fine-Schi S, 2008, AM J RESP CELL MOL, V39, P458, DOI 10.1165/rcmb.2007-0320OC; Gareau C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020254; Groll M, 2006, STRUCTURE, V14, P451, DOI 10.1016/j.str.2005.11.019; Heider U, 2008, EUR J HAEMATOL, V80, P133, DOI 10.1111/j.1600-0609.2007.00995.x; Huang HB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049062; Huang Hongbiao, 2011, Front Biosci (Elite Ed), V3, P1315; Huang HB, 2011, CANCER LETT, V301, P221, DOI 10.1016/j.canlet.2010.12.015; Huang HB, 2010, CELL RES, V20, P1372, DOI 10.1038/cr.2010.123; Huber JM, 2009, AM J PHYSIOL-RENAL, V297, pF451, DOI 10.1152/ajprenal.90576.2008; Kane RC, 2006, CLIN CANCER RES, V12, P2955, DOI 10.1158/1078-0432.CCR-06-0170; Kikuchi J, 2010, BLOOD, V116, P406, DOI 10.1182/blood-2009-07-235663; Kim J, 2010, MOL CANCER THER, V9, P1977, DOI 10.1158/1535-7163.MCT-10-0141; Kimura Y, 2000, J BIOL CHEM, V275, P4635, DOI 10.1074/jbc.275.7.4635; Kubicek GJ, 2009, INT J RADIAT ONCOL, V74, P433, DOI 10.1016/j.ijrobp.2008.08.050; Lancet JE, 2011, CLIN CANCER RES, V17, P1140, DOI 10.1158/1078-0432.CCR-10-1878; Lauricella M, 2006, APOPTOSIS, V11, P607, DOI 10.1007/s10495-006-4689-y; Li BY, 2000, P NATL ACAD SCI USA, V97, P3850, DOI 10.1073/pnas.070047997; Li J, 2011, J CLIN INVEST, V121, P3689, DOI 10.1172/JCI45709; Lin ZH, 2009, CLIN CANCER RES, V15, P570, DOI 10.1158/1078-0432.CCR-08-1813; Lopez-Lazaro M, 2008, ANTI-CANCER AGENT ME, V8, P305, DOI 10.2174/187152008783961932; Mackay H, 2005, CLIN CANCER RES, V11, P5526, DOI 10.1158/1078-0432.CCR-05-0081; Mani A, 2005, J CLIN ONCOL, V23, P4776, DOI 10.1200/JCO.2005.05.081; McConkey D, 2010, BLOOD, V116, P308, DOI 10.1182/blood-2010-04-278507; Millward M, 2012, INVEST NEW DRUGS; Nalepa G, 2006, NAT REV DRUG DISCOV, V5, P596, DOI 10.1038/nrd2056; O'Connor OA, 2009, CLIN CANCER RES, V15, P7085, DOI 10.1158/1078-0432.CCR-09-0822; Oakervee HE, 2005, BRIT J HAEMATOL, V129, P755, DOI 10.1111/j.1365-2141.2005.05519.x; Obeng EA, 2006, BLOOD, V107, P4907, DOI 10.1182/blood-2005-08-3531; Oerlemans R, 2008, BLOOD, V112, P2489, DOI 10.1182/blood-2007-08-104950; Orlowski M, 2000, ARCH BIOCHEM BIOPHYS, V383, P1, DOI 10.1006/abbi.2000.2036; Pei XY, 2004, CLIN CANCER RES, V10, P3839, DOI 10.1158/1078-0432.CCR-03-0561; Qureshi N, 2005, IMMUNOL RES, V31, P243, DOI 10.1385/IR:31:3:243; RAMSAY RR, 1975, FEBS LETT, V54, P21, DOI 10.1016/0014-5793(75)81059-3; Richardson PG, 2005, NEW ENGL J MED, V352, P2487, DOI 10.1056/NEJMoa043445; Richon VM, 2000, P NATL ACAD SCI USA, V97, P10014, DOI 10.1073/pnas.180316197; Sahlin K, 2010, J PHYSL, V589, P1509; Sakairi T, 2011, NEPHROLOGY, V16, P76, DOI 10.1111/j.1440-1797.2010.01367.x; Smith AJ, 2011, J BIOL CHEM, V286, P17682, DOI 10.1074/jbc.M110.189092; Steiber Alison, 2004, Molecular Aspects of Medicine, V25, P455, DOI 10.1016/j.mam.2004.06.006; Su YJ, 2010, CLIN CANCER RES, V16, P348, DOI 10.1158/1078-0432.CCR-09-2087; Voorhees PM, 2003, CLIN CANCER RES, V9, P6316; Wang G, 2005, MOL CELL, V17, P683, DOI 10.1016/j.molcel.2005.02.010; Yin D, 2005, ONCOGENE, V24, P344, DOI 10.1038/sj.onc.1208225	51	16	17	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52576	10.1371/journal.pone.0052576	http://dx.doi.org/10.1371/journal.pone.0052576			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285100	Green Published, gold, Green Submitted			2022-12-27	WOS:000312794500204
J	Robert-Paganin, J; Nonin-Lecomte, S; Rety, S				Robert-Paganin, Julien; Nonin-Lecomte, Sylvie; Rety, Stephane			Crystal Structure of an EAL Domain in Complex with Reaction Product 5 '-pGpG	PLOS ONE			English	Article							CYCLIC DI-GMP; ACETOBACTER-XYLINUM; CATALYTIC MECHANISM; SIGNAL-TRANSDUCTION; CELLULOSE SYNTHESIS; TWITCHING MOTILITY; PHOSPHODIESTERASE; FIMX; HYDROLYSIS; SYSTEM	FimX is a large multidomain protein containing an EAL domain and involved in twitching motility in Pseudomonas aeruginosa. We present here two crystallographic structures of the EAL domain of FimX (residues 438-686): one of the apo form and the other of a complex with 5'-pGpG, the reaction product of the hydrolysis of c-di-GMP. In both crystal forms, the EAL domains form a dimer delimiting a large cavity encompassing the catalytic pockets. The ligand is trapped in this cavity by its sugar phosphate moiety. We confirmed by NMR that the guanine bases are not involved in the interaction in solution. We solved here the first structure of an EAL domain bound to the reaction product 5'-pGpG. Though isolated FimX EAL domain has a very low catalytic activity, which would not be significant compared to other catalytic EAL domains, the structure with the product of the reaction can provides some hints in the mechanism of hydrolysis of the c-di-GMP by EAL domains.	[Robert-Paganin, Julien; Nonin-Lecomte, Sylvie; Rety, Stephane] UMR 8015 Cente Natl Rech Sci, Lab Cristallog & RMN Biol, Paris, France; [Robert-Paganin, Julien; Nonin-Lecomte, Sylvie; Rety, Stephane] Univ Paris 05, Fac Pharm, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Rety, S (corresponding author), UMR 8015 Cente Natl Rech Sci, Lab Cristallog & RMN Biol, Paris, France.	stephane.rety@parisdescartes.fr	Rety, Stephane/L-9870-2019	Rety, Stephane/0000-0002-2089-6727; Nonin-Lecomte, Sylvie/0000-0001-5155-8088	CNRS; Institut Universitaire de France	CNRS(Centre National de la Recherche Scientifique (CNRS)); Institut Universitaire de France	This work was funded by CNRS. Publication costs were supported by the Institut Universitaire de France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Barends TRM, 2009, NATURE, V459, P1015, DOI 10.1038/nature07966; Benach J, 2007, EMBO J, V26, P5153, DOI 10.1038/sj.emboj.7601918; Bobrov AG, 2005, FEMS MICROBIOL LETT, V247, P123, DOI 10.1016/j.femsle.2005.04.036; Chen AD, 2000, J AM CHEM SOC, V122, P414, DOI 10.1021/ja992588j; Christen B, 2006, J BIOL CHEM, V281, P32015, DOI 10.1074/jbc.M603589200; D'Argenio DA, 2004, MICROBIOL-SGM, V150, P2497, DOI 10.1099/mic.0.27099-0; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Galperin MY, 2001, FEMS MICROBIOL LETT, V203, P11, DOI 10.1111/j.1574-6968.2001.tb10814.x; Guzzo CR, 2009, J MOL BIOL, V393, P848, DOI 10.1016/j.jmb.2009.07.065; Hanes CS, 1932, BIOCHEM J, V26, P1406, DOI 10.1042/bj0261406; Huang BX, 2003, J BACTERIOL, V185, P7068, DOI 10.1128/JB.185.24.7068-7076.2003; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kazmierczak BI, 2006, MOL MICROBIOL, V60, P1026, DOI 10.1111/j.1365-2958.2006.05156.x; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kulesekara H, 2006, P NATL ACAD SCI USA, V103, P2839, DOI 10.1073/pnas.0511090103; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Minasov G, 2009, J BIOL CHEM, V284, P13174, DOI 10.1074/jbc.M808221200; Navarro MVAS, 2009, STRUCTURE, V17, P1104, DOI 10.1016/j.str.2009.06.010; Qi YN, 2011, J BIOL CHEM, V286, P2910, DOI 10.1074/jbc.M110.196220; Rao F, 2008, J BACTERIOL, V190, P3622, DOI 10.1128/JB.00165-08; Rao F, 2009, J BACTERIOL, V191, P4722, DOI 10.1128/JB.00327-09; Romling U, 2011, ENV MICROBIOL; ROSS P, 1987, NATURE, V325, P279, DOI 10.1038/325279a0; ROSS P, 1990, J BIOL CHEM, V265, P18933; Schmidt AJ, 2005, J BACTERIOL, V187, P4774, DOI 10.1128/JB.187.14.4774-4781.2005; Schrodinger L., 2020, PYMOL; Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x; Srivastava D, 2011, J BACTERIOL, V193, P6331, DOI 10.1128/JB.05167-11; Sudarsan N, 2008, SCIENCE, V321, P411, DOI 10.1126/science.1159519; Tamayo R, 2005, J BIOL CHEM, V280, P33324, DOI 10.1074/jbc.M506500200; Tchigvintsev A, 2010, J MOL BIOL, V402, P524, DOI 10.1016/j.jmb.2010.07.050; Trimble MJ, 2011, P NATL ACAD SCI USA, V108, P18079, DOI 10.1073/pnas.1113790108	33	13	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52424	10.1371/journal.pone.0052424	http://dx.doi.org/10.1371/journal.pone.0052424			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285035	Green Published, gold, Green Submitted			2022-12-27	WOS:000312794500163
J	Yao, J; Hong, WF; Huang, JJ; Zhan, K; Huang, H; Hong, M				Yao, Juan; Hong, Weifang; Huang, Jiujiu; Zhan, Kai; Huang, Hong; Hong, Mei			N-glycosylation Dictates Proper Processing of Organic Anion Transporting Polypeptide 1B1	PLOS ONE			English	Article							OATP TRANSPORTERS; DRUG; MEMBRANE; POLYMORPHISMS; DISPOSITION; KIDNEY; IMPACT; CELLS	Organic anion transporting polypeptides (OATPs) have been extensively recognized as key determinants of absorption, distribution, metabolism and excretion (ADME) of various drugs, xenobiotics and toxins. Putative N-glycosylation sites located in the extracellular loops 2 and 5 is considered a common feature of all OATPs and some members have been demonstrated to be glycosylated proteins. However, experimental evidence is still lacking on how such a post-translational modification affect the transport activity of OATPs and which of the putative glycosylation sites are utilized in these transporter proteins. In the present study, we substituted asparagine residues that are possibly involved in N-glycosylation with glutamine residues and identified three glycosylation sites (Asn134, Asn503 and Asn516) within the structure of OATP1B1, an OATP member that is mainly expressed in the human liver. Our results showed that Asn134 and Asn516 are used for glycosylation under normal conditions; however, when Asn134 was mutagenized, an additional asparagine at position 503 is involved in the glycosylation process. Simultaneously replacement of all three asparagines with glutamines led to significantly reduced protein level as well as loss of transport activity. Further studies revealed that glycosylation affected stability of the transporter protein and the unglycosylated mutant was retained within endoplasmic reticulum.	[Yao, Juan; Hong, Weifang; Huang, Jiujiu; Zhan, Kai; Hong, Mei] S China Agr Univ, Coll Life Sci, Guangzhou, Guangdong, Peoples R China; [Huang, Hong] Univ S Florida, Sch Informat, Tampa, FL USA	South China Agricultural University; State University System of Florida; University of South Florida	Hong, M (corresponding author), S China Agr Univ, Coll Life Sci, Guangzhou, Guangdong, Peoples R China.	mh2788@scau.edu.cn	Huang, Hong/G-5957-2016	Huang, Hong/0000-0002-8957-4881; Hong, Mei/0000-0001-9219-2844	Chinese Ministry of Human Resources and Social Security; National Natural Science Foundation of China [81141115]	Chinese Ministry of Human Resources and Social Security; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Returned high-level talents from abroad grant of the Chinese Ministry of Human Resources and Social Security and National Natural Science Foundation of China grant (81141115) to MH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Hagenbuch B, 2008, XENOBIOTICA, V38, P778, DOI [10.1080/00498250801986951, 10.1080/00498250801986951 ]; Hagenbuch B, 2003, BBA-BIOMEMBRANES, V1609, P1, DOI 10.1016/S0005-2736(02)00633-8; Ho RH, 2006, GASTROENTEROLOGY, V130, P1793, DOI 10.1053/j.gastro.2006.02.034; Kalliokoski A, 2009, BRIT J PHARMACOL, V158, P693, DOI 10.1111/j.1476-5381.2009.00430.x; Konig J, 2006, N-S ARCH PHARMACOL, V372, P432, DOI 10.1007/s00210-006-0040-y; Konig J, 2000, AM J PHYSIOL-GASTR L, V278, pG156, DOI 10.1152/ajpgi.2000.278.1.G156; Lee W, 2005, J BIOL CHEM, V280, P9610, DOI 10.1074/jbc.M411092200; Li N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036647; Lodish H, 2000, MOL CELL BIOL; Mikkaichi Tsuyoshi, 2004, Drug Metab Pharmacokinet, V19, P171, DOI 10.2133/dmpk.19.171; Mochizuki K, 2007, AM J PHYSIOL-GASTR L, V292, pG818, DOI 10.1152/ajpgi.00415.2006; Nakanishi T, 2012, DRUG METAB PHARMACOK, V27, P106, DOI 10.2133/dmpk.DMPK-11-RV-099; OTT RJ, 1992, J BIOL CHEM, V267, P133; Poirier A, 2007, CURR OPIN DRUG DISC, V10, P74; Russell D, 2009, CARBOHYD RES, V344, P1508, DOI 10.1016/j.carres.2009.06.033; Sharon N, 1993, FEBS, V218, P1; Shitara Y, 2005, ANNU REV PHARMACOL, V45, P689, DOI 10.1146/annurev.pharmtox.44.101802.121444; Tanaka K, 2004, J BIOL CHEM, V279, P14961, DOI 10.1074/jbc.M400197200; van Montfoort JE, 2003, CURR DRUG METAB, V4, P185, DOI 10.2174/1389200033489460; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Wang PJ, 2008, AM J PHYSIOL-GASTR L, V294, pG1052, DOI 10.1152/ajpgi.00584.2007	21	32	33	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52563	10.1371/journal.pone.0052563	http://dx.doi.org/10.1371/journal.pone.0052563			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285087	Green Published, gold, Green Submitted			2022-12-27	WOS:000312794500195
J	Zhou, SY; Hu, W; Deng, XM; Ma, ZB; Chen, LH; Huang, C; Wang, C; Wang, J; He, YZ; Yang, GX; He, GY				Zhou, Shiyi; Hu, Wei; Deng, Xiaomin; Ma, Zhanbing; Chen, Lihong; Huang, Chao; Wang, Chen; Wang, Jie; He, Yanzhen; Yang, Guangxiao; He, Guangyuan			Overexpression of the Wheat Aquaporin Gene, TaAQP7, Enhances Drought Tolerance in Transgenic Tobacco	PLOS ONE			English	Article							MEMBRANE INTRINSIC PROTEINS; ROOT WATER TRANSPORT; ABSCISIC-ACID; HYDRAULIC CONDUCTIVITY; HYDROGEN-PEROXIDE; ANTIOXIDANT DEFENSE; FUNCTIONAL-ANALYSIS; EXPRESSION ANALYSIS; SIGNALING MOLECULE; STRESS	Aquaporin (AQP) proteins have been shown to transport water and other small molecules through biological membranes, which is crucial for plants to combat stress caused by drought. However, the precise role of AQPs in drought stress response is not completely understood in plants. In this study, a PIP2 subgroup gene AQP, designated as TaAQP7, was cloned and characterized from wheat. Expression of TaAQP7-GFP fusion protein revealed its localization in the plasma membrane. TaAQP7 exhibited high water channel activity in Xenopus laevis oocytes and TaAQP7 transcript was induced by dehydration, and treatments with polyethylene glycol (PEG), abscisic acid (ABA) and H2O2. Further, TaAQP7 was upregulated after PEG treatment and was blocked by inhibitors of ABA biosynthesis, implying that ABA signaling was involved in the upregulation of TaAQP7 after PEG treatment. Overexpression of TaAQP7 increased drought tolerance in tobacco. The transgenic tobacco lines had lower levels of malondialdehyde (MDA) and H2O2, and less ion leakage (IL), but higher relative water content (RWC) and superoxide dismutase (SOD) and catalase (CAT) activities when compared with the wild type (WT) under drought stress. Taken together, our results show that TaAQP7 confers drought stress tolerance in transgenic tobacco by increasing the ability to retain water, reduce ROS accumulation and membrane damage, and enhance the activities of antioxidants.	[Zhou, Shiyi; Hu, Wei; Deng, Xiaomin; Ma, Zhanbing; Chen, Lihong; Huang, Chao; Wang, Chen; Wang, Jie; He, Yanzhen; Yang, Guangxiao; He, Guangyuan] Huazhong Univ Sci & Technol HUST, Chinese Natl Ctr Plant Gene Res Wuhan HUST Part, Genet Engn Int Cooperat Base Chinese Minist Sci &, Key Lab Mol Biophys,Chinese Minist Educ,Coll Life, Wuhan, Peoples R China	Huazhong University of Science & Technology	Yang, GX (corresponding author), Huazhong Univ Sci & Technol HUST, Chinese Natl Ctr Plant Gene Res Wuhan HUST Part, Genet Engn Int Cooperat Base Chinese Minist Sci &, Key Lab Mol Biophys,Chinese Minist Educ,Coll Life, Wuhan, Peoples R China.	ygx@mail.hust.edu.cn; hegy@mail.hust.edu.cn			International S & T Cooperation Key Projects of MoST [2009DFB30340]; National Genetically Modified New Varieties of Major Projects of China [2011ZX08002-004, 2011ZX08010-004]; Key Projects of S & T Research of MoE of China [109105]; Wuhan Municipal S & T research project [201120922286]	International S & T Cooperation Key Projects of MoST; National Genetically Modified New Varieties of Major Projects of China; Key Projects of S & T Research of MoE of China; Wuhan Municipal S & T research project	This work was supported by International S & T Cooperation Key Projects of MoST (Grant No. 2009DFB30340) (http://www.cistc.gov.cn/); National Genetically Modified New Varieties of Major Projects of China (2011ZX08002-004, 2011ZX08010-004) (http://www.nmp.gov.cn/); Key Projects of S & T Research of MoE of China (Grant No. 109105) (http://www.moe.edu.cn/); and Wuhan Municipal S & T research project (Grant No. 201120922286) (http://www.whst.gov.cn/whst_Index.chtml). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharon R, 2003, PLANT CELL, V15, P439, DOI 10.1105/tpc.009225; Alexandersson E, 2005, PLANT MOL BIOL, V59, P469, DOI 10.1007/s11103-005-0352-1; Aroca R, 2005, PLANT PHYSIOL, V137, P341, DOI 10.1104/pp.104.051045; Ayadi M, 2011, PLANT PHYSIOL BIOCH, V49, P1029, DOI 10.1016/j.plaphy.2011.06.002; BARRS HD, 1962, AUST J BIOL SCI, V15, P413, DOI 10.1071/BI9620413; Benabdellah K, 2009, PLANT MOL BIOL, V70, P647, DOI 10.1007/s11103-009-9497-7; Bienert GP, 2006, BBA-BIOMEMBRANES, V1758, P994, DOI 10.1016/j.bbamem.2006.02.015; Boursiac Y, 2008, PLANT J, V56, P207, DOI 10.1111/j.1365-313X.2008.03594.x; Boursiac Y, 2008, PLANT SIGNAL BEHAV, V3, P1096, DOI 10.4161/psb.3.12.7002; Chaumont F, 2001, PLANT PHYSIOL, V125, P1206, DOI 10.1104/pp.125.3.1206; Choudhary SP, 2012, TRENDS PLANT SCI, V17, P594, DOI 10.1016/j.tplants.2012.05.012; Cui XH, 2008, J PLANT RES, V121, P207, DOI 10.1007/s10265-007-0130-z; Daniels MJ, 1996, PLANT CELL, V8, P587, DOI 10.1105/tpc.8.4.587; Dynowski M, 2008, BIOCHEM J, V414, P53, DOI 10.1042/BJ20080287; Ehlert C, 2009, PLANT PHYSIOL, V150, P1093, DOI 10.1104/pp.108.131458; FLOWER DJ, 1986, PLANT CELL ENVIRON, V9, P33, DOI 10.1111/j.1365-3040.1986.tb01720.x; Forrest KL, 2008, FUNCT INTEGR GENOMIC, V8, P115, DOI 10.1007/s10142-007-0065-4; Gao ZX, 2010, PLANT CELL PHYSIOL, V51, P767, DOI 10.1093/pcp/pcq036; Guan LQM, 2000, PLANT J, V22, P87, DOI 10.1046/j.1365-313x.2000.00723.x; Guo L, 2006, CELL RES, V16, P277, DOI 10.1038/sj.cr.7310035; Hanba YT, 2004, PLANT CELL PHYSIOL, V45, P521, DOI 10.1093/pcp/pch070; Hanson MR, 2001, J EXP BOT, V52, P529, DOI 10.1093/jexbot/52.356.529; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Heinen RB, 2009, J EXP BOT, V60, P2971, DOI 10.1093/jxb/erp171; Horie T, 2011, PLANT CELL PHYSIOL, V52, P663, DOI 10.1093/pcp/pcr027; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Hose E, 2000, PLANTA, V211, P874, DOI 10.1007/s004250000412; Hu XL, 2005, PLANTA, V223, P57, DOI 10.1007/s00425-005-0068-0; Huang XS, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-230; Hung KT, 2004, J PLANT PHYSIOL, V161, P1347, DOI 10.1016/j.jplph.2004.05.011; Jaleel CA, 2009, ACTA PHYSIOL PLANT, V31, P427, DOI 10.1007/s11738-009-0275-6; Jang JY, 2004, PLANT MOL BIOL, V54, P713, DOI 10.1023/B:PLAN.0000040900.61345.a6; Jiang MY, 2002, J EXP BOT, V53, P2401, DOI 10.1093/jxb/erf090; Jiang MY, 2001, PLANT CELL PHYSIOL, V42, P1265, DOI 10.1093/pcp/pce162; Johanson U, 2001, PLANT PHYSIOL, V126, P1358, DOI 10.1104/pp.126.4.1358; Johansson I, 2000, BBA-BIOMEMBRANES, V1465, P324, DOI 10.1016/S0005-2736(00)00147-4; KALDENHOFF R, 1993, PLANT MOL BIOL, V23, P1187, DOI 10.1007/BF00042352; Kim YX, 2009, J EXP BOT, V60, P547, DOI 10.1093/jxb/ern299; Kourie JI, 1998, AM J PHYSIOL-CELL PH, V275, pC1, DOI 10.1152/ajpcell.1998.275.1.C1; Kwak JM, 2003, EMBO J, V22, P2623, DOI 10.1093/emboj/cdg277; Laloi C, 2004, PLANT PHYSIOL, V134, P1006, DOI 10.1104/pp.103.035782; Lee SH, 2004, J EXP BOT, V55, P1733, DOI 10.1093/jxb/erh189; Li DD, 2009, PLANT CELL REP, V28, P291, DOI 10.1007/s00299-008-0626-6; Li GW, 2008, PLANT CELL PHYSIOL, V49, P1851, DOI 10.1093/pcp/pcn166; Lian HL, 2004, PLANT CELL PHYSIOL, V45, P481, DOI 10.1093/pcp/pch058; Lian HL, 2006, CELL RES, V16, P651, DOI 10.1038/sj.cr.7310068; Lin CC, 2001, PLANT SCI, V160, P323, DOI 10.1016/S0168-9452(00)00396-4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahdieh M, 2008, PLANT CELL PHYSIOL, V49, P801, DOI 10.1093/pcp/pcn054; Mariaux JB, 1998, PLANT MOL BIOL, V38, P1089, DOI 10.1023/A:1006013130681; Maurel C, 1997, ANNU REV PLANT PHYS, V48, P399, DOI 10.1146/annurev.arplant.48.1.399; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Mittler R, 1999, P NATL ACAD SCI USA, V96, P14165, DOI 10.1073/pnas.96.24.14165; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Moore K, 1998, FREE RADICAL RES, V28, P659, DOI 10.3109/10715769809065821; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; North GB, 2000, ANN BOT-LONDON, V85, P247, DOI 10.1006/anbo.1999.1026; Pan JW, 2012, PLANTA, V235, P661, DOI 10.1007/s00425-011-1510-0; Pei ZM, 2000, NATURE, V406, P731, DOI 10.1038/35021067; Peng YH, 2008, PLANT CELL ENVIRON, V31, P1275, DOI 10.1111/j.1365-3040.2008.01840.x; Polle A, 2001, PLANT PHYSIOL, V126, P445, DOI 10.1104/pp.126.1.445; POLLE A, 1994, PLANT PHYSIOL, V106, P53, DOI 10.1104/pp.106.1.53; Quintero JM, 1999, J EXP BOT, V50, P1607, DOI 10.1093/jexbot/50.339.1607; Rampino P, 2006, PLANT CELL ENVIRON, V29, P2143, DOI 10.1111/j.1365-3040.2006.01588.x; Sade N, 2010, PLANT PHYSIOL, V152, P245, DOI 10.1104/pp.109.145854; Sakurai J, 2005, PLANT CELL PHYSIOL, V46, P1568, DOI 10.1093/pcp/pci172; Siefritz F, 2001, J EXP BOT, V52, P1953, DOI 10.1093/jexbot/52.363.1953; Suga S, 2002, PLANT CELL PHYSIOL, V43, P1229, DOI 10.1093/pcp/pcf148; Vera-Estrella R, 2004, PLANT PHYSIOL, V135, P2318, DOI 10.1104/pp.104.044891; Wan XC, 2004, J EXP BOT, V55, P411, DOI 10.1093/jxb/erh051; Wei H, 2006, PLANT CELL ENVIRON, V29, P558, DOI 10.1111/j.1365-3040.2005.01432.x; Weig A, 1997, PLANT PHYSIOL, V114, P1347, DOI 10.1104/pp.114.4.1347; Ye Q, 2008, PLANTA, V227, P1311, DOI 10.1007/s00425-008-0703-7; Yu X, 2006, CELL RES, V16, P599, DOI 10.1038/sj.cr.7310077; Zhang AY, 2006, PLANT PHYSIOL, V141, P475, DOI 10.1104/pp.105.075416; Zhang JF, 2008, PLANT MOL BIOL REP, V26, P32, DOI 10.1007/s11105-008-0020-0; ZHANG R, 1991, AM J PHYSIOL, V260, pC26, DOI 10.1152/ajpcell.1991.260.1.C26; Zhang YX, 2008, MOL BIOTECHNOL, V40, P280, DOI 10.1007/s12033-008-9084-1; Zhao CX, 2008, COLLOID SURFACE B, V62, P163, DOI 10.1016/j.colsurfb.2007.10.015	79	138	163	0	123	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52439	10.1371/journal.pone.0052439	http://dx.doi.org/10.1371/journal.pone.0052439			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285044	Green Published, Green Submitted, gold			2022-12-27	WOS:000312794500170
J	Forestier, A; Sarrazy, F; Caillat, S; Vandenbrouck, Y; Sauvaigo, S				Forestier, Anne; Sarrazy, Fanny; Caillat, Sylvain; Vandenbrouck, Yves; Sauvaigo, Sylvie			Functional DNA Repair Signature of Cancer Cell Lines Exposed to a Set of Cytotoxic Anticancer Drugs Using a Multiplexed Enzymatic Repair Assay on Biochip	PLOS ONE			English	Article							BASE EXCISION-REPAIR; DAMAGE RESPONSE; MISMATCH REPAIR; ADJUVANT CHEMOTHERAPY; CROSS-LINKS; PROTEIN; 5-FLUOROURACIL; RECOMBINATION; IMPROVEMENT; MECHANISMS	The development of resistances to conventional anticancer drugs compromises the efficacy of cancer treatments. In the case of DNA-targeting chemotherapeutic agents, cancer cells may display tolerance to the drug-induced DNA lesions and/or enhanced DNA repair. However, the role of DNA damage response (DDR) and DNA repair in this chemoresistance has yet to be defined. To provide insights in this challenging area, we analyzed the DNA repair signature of 7 cancer cell lines treated by 5 cytotoxic drugs using a recently developed multiplexed functional DNA repair assay. This comprehensive approach considered the complexity and redundancy of the different DNA repair pathways. Data was analyzed using clustering methods and statistical tests. This DNA repair profiling method defined relevant groups based on similarities between different drugs, thus providing information relating to their dominant mechanism of action at the DNA level. Similarly, similarities between different cell lines presumably identified identical functional DDR despite a high level of genetic heterogeneity between cell lines. Our strategy has shed new light on the contribution of specific repair sub-pathways to drug-induced cytotoxicity. Although further molecular characterisations are needed to fully unravel the mechanisms underlying our findings, our approach proved to be very promising to interrogate the complexity of the DNA repair response. Indeed, it could be used to predict the efficacy of a given drug and the chemosensitivity of individual patients, and thus to choose the right treatment for individualised cancer care.	[Forestier, Anne; Sarrazy, Fanny; Caillat, Sylvain; Sauvaigo, Sylvie] UJF Grenoble 1, Lab Lesions Acides Nucl, CEA, DSM,INAC,SCIB,UMR E3, Grenoble, France; [Vandenbrouck, Yves] UJF Grenoble 1, Lab Biol Grande Echelle, CEA, DSV,IRTSV,U1038,INSERM, Grenoble, France	CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Sauvaigo, S (corresponding author), UJF Grenoble 1, Lab Lesions Acides Nucl, CEA, DSM,INAC,SCIB,UMR E3, Grenoble, France.	sylvie.sauvaigo@cea.fr	VANDENBROUCK, Yves/Q-2675-2017	VANDENBROUCK, Yves/0000-0002-1292-373X	transversal CEA program Technologies for Health; GRAVIT; European Commission [LSHB-CT-2006-037575]	transversal CEA program Technologies for Health; GRAVIT; European Commission(European CommissionEuropean Commission Joint Research Centre)	The authors thank the transversal CEA program Technologies for Health for support as well as GRAVIT for its financial accompaniment. This work was also partially supported by the European Commission (Contract LSHB-CT-2006-037575) - project 'Comet assay and cell array for fast and efficient genotoxicity testing' (COMICS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida KH, 2007, DNA REPAIR, V6, P695, DOI 10.1016/j.dnarep.2007.01.009; Bohanes P, 2011, CLIN COLORECTAL CANC, V10, P157, DOI 10.1016/j.clcc.2011.03.024; Branham WS, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-8; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Couve S, 2009, J BIOL CHEM, V284, P11963, DOI 10.1074/jbc.M900746200; Darzynkiewicz Z, 2009, EUR J PHARMACOL, V625, P143, DOI 10.1016/j.ejphar.2009.05.032; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Drablos F, 2004, DNA REPAIR, V3, P1389, DOI 10.1016/j.dnarep.2004.05.004; du Puch CBM, 2011, ARCH BIOCHEM BIOPHYS, V507, P296, DOI 10.1016/j.abb.2010.12.021; Fojo T, 2001, J NATL CANCER I, V93, P1434, DOI 10.1093/jnci/93.19.1434; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Helleday T, 2010, CARCINOGENESIS, V31, P955, DOI 10.1093/carcin/bgq064; Ischenko AA, 2002, NATURE, V415, P183, DOI 10.1038/415183a; Johnson SW, 1997, CANCER RES, V57, P850; Jover R, 2009, EUR J CANCER, V45, P365, DOI 10.1016/j.ejca.2008.07.016; Jung HJ, 2007, ONCOGENE, V26, P7517, DOI 10.1038/sj.onc.1210557; Klungland A, 1999, MOL CELL, V3, P33, DOI 10.1016/S1097-2765(00)80172-0; Krokan HE, 2000, FEBS LETT, V476, P73, DOI 10.1016/S0014-5793(00)01674-4; Lange SS, 2009, MOL CARCINOGEN, V48, P571, DOI 10.1002/mc.20544; Li LS, 2009, BRIT J PHARMACOL, V158, P679, DOI 10.1111/j.1476-5381.2009.00423.x; Liscovitch M, 2007, CANCER LETT, V245, P350, DOI 10.1016/j.canlet.2006.01.013; Ljungman M, 2009, CHEM REV, V109, P2929, DOI 10.1021/cr900047g; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; McDermott U, 2011, NEW ENGL J MED, V364, P340, DOI 10.1056/NEJMra0907178; Middleton MR, 2003, LANCET ONCOL, V4, P37, DOI 10.1016/S1470-2045(03)00959-8; Millau JF, 2008, LAB CHIP, V8, P1713, DOI 10.1039/b806634e; Mohammed MZ, 2011, BRIT J CANCER, V104, P653, DOI 10.1038/sj.bjc.6606058; Morris JR, 2010, CANCER RES, V70, P3861, DOI 10.1158/0008-5472.CAN-10-0468; Nouspikel T, 2009, CELL MOL LIFE SCI, V66, P994, DOI 10.1007/s00018-009-8737-y; Paz-Elizur T, 2008, CANCER LETT, V266, P60, DOI 10.1016/j.canlet.2008.02.032; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Pons B, 2010, MECH AGEING DEV, V131, P661, DOI 10.1016/j.mad.2010.09.002; Prunier C, 2012, MUTAT RES-FUND MOL M, V736, P48, DOI 10.1016/j.mrfmmm.2011.05.005; Reardon JT, 1997, P NATL ACAD SCI USA, V94, P9463, DOI 10.1073/pnas.94.17.9463; Robert J, 2004, CRIT REV ONCOL HEMAT, V51, P205, DOI 10.1016/S1040-8428(04)00111-8; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Sander M, 2006, DNA REPAIR, V5, P523, DOI 10.1016/j.dnarep.2005.11.003; Sauvaigo S, 2010, J INVEST DERMATOL, V130, P1739, DOI 10.1038/jid.2010.10; Scherf U, 2000, NAT GENET, V24, P236, DOI 10.1038/73439; Sengupta S, 2005, NAT REV MOL CELL BIO, V6, P44, DOI 10.1038/nrm1546; Sinicrope FA, 2010, NAT REV CLIN ONCOL, V7, P174, DOI 10.1038/nrclinonc.2009.235; Stracker TH, 2009, DNA REPAIR, V8, P1047, DOI 10.1016/j.dnarep.2009.04.012; Swanton C, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2159; Swift LP, 2006, CANCER RES, V66, P4863, DOI 10.1158/0008-5472.CAN-05-3410; Vekris A, 2004, CANCER RES, V64, P356, DOI 10.1158/0008-5472.CAN-03-2258; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Wang X, 2001, MOL CELL BIOL, V21, P713, DOI 10.1128/MCB.21.3.713-720.2001; Wood RD, 1997, J BIOL CHEM, V272, P23465, DOI 10.1074/jbc.272.38.23465; Wyatt MD, 2009, CELL MOL LIFE SCI, V66, P788, DOI 10.1007/s00018-008-8557-5; Zheng HY, 2006, DNA REPAIR, V5, P566, DOI 10.1016/j.dnarep.2006.01.010; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	51	11	11	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e51754	10.1371/journal.pone.0051754	http://dx.doi.org/10.1371/journal.pone.0051754			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300565	Green Published, gold			2022-12-27	WOS:000313872600007
J	Bucci, M; Papapetropoulos, A; Vellecco, V; Zhou, ZM; Zaid, A; Giannogonas, P; Cantalupo, A; Dhayade, S; Karalis, KP; Wang, R; Feil, R; Cirino, G				Bucci, Mariarosaria; Papapetropoulos, Andreas; Vellecco, Valentina; Zhou, Zongmin; Zaid, Altaany; Giannogonas, Panagiotis; Cantalupo, Anna; Dhayade, Sandeep; Karalis, Katia P.; Wang, Rui; Feil, Robert; Cirino, Giuseppe			cGMP-Dependent Protein Kinase Contributes to Hydrogen Sulfide-Stimulated Vasorelaxation	PLOS ONE			English	Article							NITRIC-OXIDE; INDUCED RELAXATION; CARBON-MONOXIDE; IN-VITRO; H2S; ENDOTHELIUM; ACTIVATION; INHIBITOR; RATS; ANGIOGENESIS	A growing body of evidence suggests that hydrogen sulfide (H2S) is a signaling molecule in mammalian cells. In the cardiovascular system, H2S enhances vasodilation and angiogenesis. H2S-induced vasodilation is hypothesized to occur through ATP-sensitive potassium channels (K-ATP); however, we recently demonstrated that it also increases cGMP levels in tissues. Herein, we studied the involvement of cGMP-dependent protein kinase-I in H2S-induced vasorelaxation. The effect of H2S on vessel tone was studied in phenylephrine-contracted aortic rings with or without endothelium. cGMP levels were determined in cultured cells or isolated vessel by enzyme immunoassay. Pretreatment of aortic rings with sildenafil attenuated NaHS-induced relaxation, confirming previous findings that H2S is a phosphodiesterase inhibitor. In addition, vascular tissue levels of cGMP in cystathionine gamma lyase knockouts were lower than those in wild-type control mice. Treatment of aortic rings with NaHS, a fast releasing H2S donor, enhanced phosphorylation of vasodilator-stimulated phosphoprotein in a time-dependent manner, suggesting that cGMP-dependent protein kinase (PKG) is activated after exposure to H2S. Incubation of aortic rings with a PKG-I inhibitor (DT-2) attenuated NaHS-stimulated relaxation. Interestingly, vasodilatory responses to a slowly releasing H2S donor (GYY 4137) were unaffected by DT-2, suggesting that this donor dilates mouse aorta through PKG-independent pathways. Dilatory responses to NaHS and L-cysteine (a substrate for H2S production) were reduced in vessels of PKG-I knockout mice (PKG-I-/-). Moreover, glibenclamide inhibited NaHS-induced vasorelaxation in vessels from wild-type animals, but not PKG-I-/-, suggesting that there is a cross-talk between K-ATP and PKG. Our results confirm the role of cGMP in the vascular responses to NaHS and demonstrate that genetic deletion of PKG-I attenuates NaHS and L-cysteine-stimulated vasodilation.	[Bucci, Mariarosaria; Vellecco, Valentina; Cantalupo, Anna; Cirino, Giuseppe] Univ Naples Federico II, Dept Expt Pharmacol, Fac Pharm, Naples, Italy; [Papapetropoulos, Andreas] Univ Patras, Dept Pharm, Mol Pharmacol Lab, Patras, Greece; [Papapetropoulos, Andreas; Giannogonas, Panagiotis; Karalis, Katia P.] Acad Athens, Dev Biol Sect, Ctr Basic Res, Biomed Res Fdn, Athens, Greece; [Zhou, Zongmin] Univ Athens, Sch Med, GP Livanos Lab, Dept Crit Care & Pulm Serv 1, GR-11527 Athens, Greece; [Zaid, Altaany; Wang, Rui] Lakehead Univ, Dept Biol, Thunder Bay, ON P7B 5E1, Canada; [Dhayade, Sandeep; Feil, Robert] Univ Tubingen, Interfak Inst Biochem, Tubingen, Germany	University of Naples Federico II; University of Patras; Academy of Athens; Athens Medical School; National & Kapodistrian University of Athens; Lakehead University; Eberhard Karls University of Tubingen	Papapetropoulos, A (corresponding author), Univ Naples Federico II, Dept Expt Pharmacol, Fac Pharm, Naples, Italy.	apapapet@upatras.gr	Feil, Robert/B-8918-2014; Andreas, Papapetropoulos/AAJ-3089-2020; Wang, Rui/C-7824-2012	Feil, Robert/0000-0002-7335-4841; Wang, Rui/0000-0003-3825-3620; Vellecco, Valentina/0000-0002-5674-9112; Altaany, Zaid/0000-0002-3260-9078; Dhayade, Sandeep/0000-0002-1681-8216; Papapetropoulos, Andreas/0000-0002-4253-5930; Cirino, Giuseppe/0000-0003-3954-4083	Fondazione per la Ricerca Scientifica Termale FoRST (Rome, Italy); European Union (European Social Fund - ESF); Operational Program "Education and Lifelong Learning'' of the National Strategic Reference Framework (NSRF) - Research Funding Program: Thalis; European Social Fund; Aristeia [1436]; EU FP7 REGPOT [CT-2011-285950]; COST Action (ENOG: European network on gasotransmitters) [BM1005]; Discovery grant from the Natural Sciences and Engineering Research Council of Canada; Heart and Stroke Foundation Canada	Fondazione per la Ricerca Scientifica Termale FoRST (Rome, Italy); European Union (European Social Fund - ESF)(European Social Fund (ESF)); Operational Program "Education and Lifelong Learning'' of the National Strategic Reference Framework (NSRF) - Research Funding Program: Thalis; European Social Fund(European Social Fund (ESF)); Aristeia; EU FP7 REGPOT; COST Action (ENOG: European network on gasotransmitters); Discovery grant from the Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Heart and Stroke Foundation Canada(Heart & Stroke Foundation of Canada)	This work has been funded by Fondazione per la Ricerca Scientifica Termale FoRST (Rome, Italy (to GC) and co-financed by the European Union (European Social Fund - ESF) and Greek national funds through the Operational Program "Education and Lifelong Learning'' of the National Strategic Reference Framework (NSRF) - Research Funding Program: Thalis; Investing in knowledge society through the European Social Fund and Aristeia 2011 (1436) to AP, by EU FP7 REGPOT CT-2011-285950 - "SEE-DRUG" and by the COST Action BM1005 (ENOG: European network on gasotransmitters). This work has also been partially supported by a Discovery grant from the Natural Sciences and Engineering Research Council of Canada and the Heart and Stroke Foundation Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brancaleone V, 2008, BRIT J PHARMACOL, V155, P673, DOI 10.1038/bjp.2008.296; Bucci M, 2010, ARTERIOSCL THROM VAS, V30, P1998, DOI 10.1161/ATVBAHA.110.209783; Calvert JW, 2010, ANTIOXID REDOX SIGN, V12, P1203, DOI 10.1089/ars.2009.2882; Chai YP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018191; Cheang WS, 2010, VASC PHARMACOL, V53, P94, DOI 10.1016/j.vph.2010.04.004; Cheng YQ, 2004, AM J PHYSIOL-HEART C, V287, pH2316, DOI 10.1152/ajpheart.00331.2004; Coletta C, 2012, P NATL ACAD SCI USA, V109, P9161, DOI 10.1073/pnas.1202916109; Costa ADT, 2005, CIRC RES, V97, P329, DOI 10.1161/01.RES.0000178451.08719.5b; Dang VC, 2006, AM J PHYSIOL-HEART C, V290, pH1808, DOI 10.1152/ajpheart.00772.2005; Dhaese I, 2009, EUR J PHARMACOL, V606, P180, DOI 10.1016/j.ejphar.2009.01.011; Dostmann WRG, 2000, P NATL ACAD SCI USA, V97, P14772, DOI 10.1073/pnas.97.26.14772; Gambaryan S, 2012, BRIT J PHARMACOL, V167, P826, DOI 10.1111/j.1476-5381.2012.02044.x; Han J, 2002, AM J PHYSIOL-HEART C, V283, pH1545, DOI 10.1152/ajpheart.01052.2001; Hofmann F, 2005, J BIOL CHEM, V280, P1, DOI 10.1074/jbc.R400035200; Hu LF, 2011, J PHARMACOL EXP THER, V339, P726, DOI 10.1124/jpet.111.184754; Ibarra-Alvarado C, 2002, MOL PHARMACOL, V61, P312, DOI 10.1124/mol.61.2.312; Jiang B, 2010, ANTIOXID REDOX SIGN, V12, P1167, DOI 10.1089/ars.2009.2894; Kimura H, 2010, ANTIOXID REDOX SIGN, V12, P1111, DOI 10.1089/ars.2009.2919; Kubo S, 2007, TOXICOLOGY, V232, P138, DOI 10.1016/j.tox.2006.12.023; Lavu M, 2011, CLIN SCI, V120, P219, DOI 10.1042/CS20100462; Li L, 2011, ANN REV PHARM TOXICO, V51; Li L, 2008, CIRCULATION, V117, P2351, DOI 10.1161/CIRCULATIONAHA.107.753467; Li L, 2009, PHARMACOL THERAPEUT, V123, P386, DOI 10.1016/j.pharmthera.2009.05.005; LIU YH, 2011, J CARDIOVASC PHARM; Motterlini R, 2010, NAT REV DRUG DISCOV, V9, P728, DOI 10.1038/nrd3228; Mustafa AK, 2011, CIRC RES, V109, P1259, DOI 10.1161/CIRCRESAHA.111.240242; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.268re2; PAPAPETROPOULOS A, 1994, HYPERTENSION, V23, P476, DOI 10.1161/01.HYP.23.4.476; Papapetropoulos A, 2009, P NATL ACAD SCI USA, V106, P21972, DOI 10.1073/pnas.0908047106; Roy A, 2012, AM J HYPERTENS, V25, P74, DOI 10.1038/ajh.2011.149; Sessa WC, 2004, J CELL SCI, V117, P2427, DOI 10.1242/jcs.01165; Shibuya N, 2009, J BIOCHEM, V146, P623, DOI 10.1093/jb/mvp111; Suzuki K, 2011, P NATL ACAD SCI USA, V108, P13829, DOI 10.1073/pnas.1105121108; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425; Teixeira CE, 2006, J PHARMACOL EXP THER, V316, P654, DOI 10.1124/jpet.105.092544; Valtcheva N, 2009, J BIOL CHEM, V284, P556, DOI 10.1074/jbc.M806161200; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; Wang R, 2011, CURR OPIN NEPHROL HY, V20, P107, DOI 10.1097/MNH.0b013e3283430651; Wang R, 2009, KIDNEY INT, V76, P700, DOI 10.1038/ki.2009.221; Wegener JW, 2002, CIRC RES, V90, P18, DOI 10.1161/hh0102.103222; Whiteman Matthew, 2011, Expert Rev Clin Pharmacol, V4, P13, DOI 10.1586/ecp.10.134; Yan H, 2004, BIOCHEM BIOPH RES CO, V313, P22, DOI 10.1016/j.bbrc.2003.11.081; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Zhao W., 2002, AM J PHYSL HEART CIR, V283, pH474; Zhao WM, 2003, CAN J PHYSIOL PHARM, V81, P848, DOI 10.1139/Y03-077; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008; Zhao YD, 2000, BIOCHEMISTRY-US, V39, P10848, DOI 10.1021/bi9929296; Zhou ZM, 2012, BIOORGAN MED CHEM, V20, P2675, DOI 10.1016/j.bmc.2012.02.028	48	111	114	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53319	10.1371/journal.pone.0053319	http://dx.doi.org/10.1371/journal.pone.0053319			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285278	gold, Green Submitted, Green Published			2022-12-27	WOS:000313051500132
J	Linnebank, M; Moskau, S; Semmler, A; Hoefgen, B; Bopp, G; Kallweit, U; Maier, W; Schutz, CG; Wullner, U				Linnebank, Michael; Moskau, Susanna; Semmler, Alexander; Hoefgen, Barbara; Bopp, Gisela; Kallweit, Ulf; Maier, Wolfgang; Schuetz, Christian G.; Wuellner, Ullrich			A Possible Genetic Link between MTHFR Genotype and Smoking Behavior	PLOS ONE			English	Article							METHYLENETETRAHYDROFOLATE REDUCTASE MTHFR; HOMOCYSTEINE; POLYMORPHISMS	Background: Hyperhomocysteinemia is an independent risk factor for stroke and other vascular events. The variant methylenetetrahydrofolate reductase (MTHFR) C677T is associated with elevated homocysteine levels, cardiovascular disease and stroke, which supports a causal relationship between hyperhomocysteinemia and vascular disease. However, MTHFR variants have also been reported to be associated with smoking behavior, which could be an important confounder. Methodology/Principal Findings: We analyzed the MTHFR variants C677T and A1298C in two independent samples of 525 and 535 individuals, respectively. 21% of the non-smokers, but only 12% of the smokers were homozygous carriers of both MTHFR wildtype alleles, i.e. 677CC and 1298AA (Chi(2) = 15.8; p<0.001; binary regression). Plasma homocysteine levels were higher in smokers (13.9 +/- 4.1 mu mol/L) than in non-smokers (12.6 +/- 4.0 mu mol/L; F = 11.4; p = 0.001; ANOVA). Smoking MTHFR 677TT individuals had the highest plasma homocysteine levels (16.2 +/- 5.2 mu mol/L), non-smoking 677CC individuals had the lowest (12.2 +/- 13.6 mu mol/L). Conclusions/Significance: In our study samples, MTHFR variants and smoking behaviour were associated with homocysteine plasma levels. In addition, the MTHFR variants were associated with smoking behaviour. Such an association may be a relevant confounder between MTHFR variants, homocysteine plasma levels and vascular diseases.	[Linnebank, Michael; Moskau, Susanna; Semmler, Alexander; Wuellner, Ullrich] Univ Hosp Bonn, Dept Neurol, Bonn, Germany; [Hoefgen, Barbara; Bopp, Gisela; Maier, Wolfgang; Schuetz, Christian G.] Univ Hosp Bonn, Dept Psychiat, Bonn, Germany; [Linnebank, Michael; Semmler, Alexander; Kallweit, Ulf] Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland; [Schuetz, Christian G.] Univ British Columbia, Inst Mental Hlth, Vancouver, BC V5Z 1M9, Canada	University of Bonn; University of Bonn; University of Zurich; University Zurich Hospital; University of British Columbia	Linnebank, M (corresponding author), Univ Hosp Bonn, Dept Neurol, Bonn, Germany.	michael.linnebank@usz.ch	Kallweit, Ulf/AAM-3989-2021; Wüllner, Ullrich/R-6790-2019					Brown KS, 2004, ATHEROSCLEROSIS, V174, P315, DOI 10.1016/j.atherosclerosis.2004.01.023; Goyette P, 1998, MAMM GENOME, V9, P652, DOI 10.1007/s003359900838; Hankey GJ, 2005, LANCET, V365, P194; Husemoen LLN, 2004, EUR J CLIN NUTR, V58, P1142, DOI 10.1038/sj.ejcn.1601942; Imyanitov EN, 2004, CANCER LETT, V204, P3, DOI 10.1016/j.canlet.2003.09.026; Johnson WG, 2001, AM J MED GENET, V98, P361, DOI 10.1002/1096-8628(20010201)98:4<361::AID-AJMG1111>3.0.CO;2-F; Linnebank M, 2000, EUR J PEDIATR, V159, P472, DOI 10.1007/s004310051311; Liu Chiu-Shong, 2009, Cancer Genomics & Proteomics, V6, P325; Mudd S. H, 2001, DISORDERS TRANSSULFU, P2007	9	6	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53322	10.1371/journal.pone.0053322	http://dx.doi.org/10.1371/journal.pone.0053322			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285280	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000313051500134
J	Hill, DL; Eriksson, EM; Carmagnac, AB; Wilson, DW; Cowman, AF; Hansen, DS; Schofield, L				Hill, Danika L.; Eriksson, Emily M.; Carmagnac, Amandine B.; Wilson, Danny W.; Cowman, Alan F.; Hansen, Diana S.; Schofield, Louis			Efficient Measurement of Opsonising Antibodies to Plasmodium falciparum Merozoites	PLOS ONE			English	Article							INVASION-INHIBITORY ANTIBODIES; GROWTH IN-VITRO; FC-GAMMA-RII; INFECTED ERYTHROCYTES; SURFACE PROTEIN-1; PARASITE GROWTH; IMMUNE-RESPONSES; MALARIAL PIGMENT; BLOOD MONOCYTES; FLOW-CYTOMETRY	Background: Antibodies targeting merozoites are important in protection from malaria. Therefore, merozoite surface proteins are attractive vaccine candidates. There is a need for robust functional assays to investigate mechanisms of acquired immunity and vaccine efficacy. To date, the study of merozoite phagocytosis has been confounded by the complexity and variability of in vitro assays. Methodology/Principal findings: We have developed a new flow cytometry-based merozoite phagocytosis assay. An optimized merozoite preparation technique produced high yields of merozoites separated from haemozoin. Phagocytosis by the undifferentiated THP-1 monocytic cell line was mediated only by Fc Receptors, and was therefore ideal for studying opsonising antibody responses. The assay showed robust phagocytosis with highly diluted immune sera and strong inter-assay correlation. The assay effectively measured differences in opsonisation-dependent phagocytosis among individuals. Conclusions/Significance: This highly reproducible assay has potential applications in assessing the role of opsonic phagocytosis in naturally acquired immunity and vaccine trials.	[Hill, Danika L.; Eriksson, Emily M.; Carmagnac, Amandine B.; Wilson, Danny W.; Cowman, Alan F.; Hansen, Diana S.; Schofield, Louis] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Hill, Danika L.; Eriksson, Emily M.; Wilson, Danny W.; Cowman, Alan F.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia	Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne	Schofield, L (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia.	schofield@wehi.edu.au	Cowman, Alan F/C-7642-2013; Wilson, Danny W/E-6186-2019; Hill, Danika/ADA-4249-2022	Cowman, Alan F/0000-0001-5145-9004; Wilson, Danny W/0000-0002-5073-1405; Hill, Danika/0000-0001-6284-7061; Eriksson, Emily/0000-0002-7851-973X	Australian National Health and Medical Research Council [1031212]; United States National Institutes of Health [AI089686]; NHMRC [APP1035715]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089686] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was made possible through Victorian State Government Operational Infrastructure Support and Australian Government NHMRC IRIISS. This work was supported by Australian National Health and Medical Research Council grant 1031212 and United States National Institutes of Health AI089686. AFC and LS are fellows of the NHMRC. DWW is supported by a Peter Doherty Australian Biomedical Fellowship from the NHMRC (APP1035715). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ataide R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022491; Ataide R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010807; Aucan C, 2000, INFECT IMMUN, V68, P1252, DOI 10.1128/IAI.68.3.1252-1258.2000; Bang G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028165; Barfod L, 2011, P NATL ACAD SCI USA, V108, P12485, DOI 10.1073/pnas.1103708108; Barrera V, 2011, BLOOD, V117, P5674, DOI 10.1182/blood-2010-10-312413; BOUHAROUNTAYOUN H, 1990, J EXP MED, V172, P1633, DOI 10.1084/jem.172.6.1633; BOUHAROUNTAYOUN H, 1995, J EXP MED, V182, P409, DOI 10.1084/jem.182.2.409; BOUHAROUNTAYOUN H, 1992, INFECT IMMUN, V60, P1473, DOI 10.1128/IAI.60.4.1473-1481.1992; Boyle MJ, 2010, P NATL ACAD SCI USA, V107, P14378, DOI 10.1073/pnas.1009198107; CALLE JMC, 1992, J IMMUNOL, V149, P2695; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Demanga CG, 2010, INFECT IMMUN, V78, P486, DOI 10.1128/IAI.01359-08; DRUILHE P, 1987, INFECT IMMUN, V55, P888, DOI 10.1128/IAI.55.4.888-891.1987; Egan AF, 1999, PARASITE IMMUNOL, V21, P133, DOI 10.1046/j.1365-3024.1999.00209.x; Esen M, 2009, VACCINE, V27, P6862, DOI 10.1016/j.vaccine.2009.09.011; Evans KJ, 2006, BLOOD, V107, P1192, DOI 10.1182/blood-2005-08-3460; Feng GQ, 2009, J INFECT DIS, V200, P299, DOI 10.1086/599841; FLEIT HB, 1991, J LEUKOCYTE BIOL, V49, P556, DOI 10.1002/jlb.49.6.556; Fowkes FJI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000218; Gilson PR, 2008, MOL MICROBIOL, V68, P124, DOI 10.1111/j.1365-2958.2008.06140.x; Healey G, 2007, J IMMUNOL METHODS, V322, P50, DOI 10.1016/j.jim.2007.01.024; Hodder AN, 2001, INFECT IMMUN, V69, P3286, DOI 10.1128/IAI.69.5.3286-3294.2001; Jafarshad A, 2007, J IMMUNOL, V178, P3099, DOI 10.4049/jimmunol.178.5.3099; Jaramillo M, 2005, J IMMUNOL, V174, P475, DOI 10.4049/jimmunol.174.1.475; Jaworowski A, 2009, CLIN VACCINE IMMUNOL, V16, P312, DOI 10.1128/CVI.00356-08; John CC, 2004, J IMMUNOL, V173, P666, DOI 10.4049/jimmunol.173.1.666; Joos C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009871; KHUSMITH S, 1983, B SOC PATHOL EXOT, V76, P137; KHUSMITH S, 1983, PARASITE IMMUNOL, V5, P357, DOI 10.1111/j.1365-3024.1983.tb00751.x; KHUSMITH S, 1982, INFECT IMMUN, V35, P874, DOI 10.1128/IAI.35.3.874-879.1982; Kumaratilake LM, 2000, CLIN DIAGN LAB IMMUN, V7, P9, DOI 10.1128/CDLI.7.1.9-13.2000; Marsh K, 2006, PARASITE IMMUNOL, V28, P51, DOI 10.1111/j.1365-3024.2006.00808.x; MARSH K, 1989, T ROY SOC TROP MED H, V83, P293, DOI 10.1016/0035-9203(89)90478-1; McCarthy JS, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0024413, 10.1371/journal.pone.0021914]; McGilvray ID, 2000, BLOOD, V96, P3231, DOI 10.1182/blood.V96.9.3231; MCGREGOR IA, 1964, AM J TROP MED HYG, V13, P237, DOI 10.4269/ajtmh.1964.13.237; McIntosh RS, 2007, PLOS PATHOG, V3, P647, DOI 10.1371/journal.ppat.0030072; MENDIS KN, 1990, INT J PARASITOL, V20, P497, DOI 10.1016/0020-7519(90)90197-U; Millington OR, 2006, J BIOL-LONDON, V5, P5; Mlambo G, 2007, EXP PARASITOL, V115, P211, DOI 10.1016/j.exppara.2006.08.003; Mosiman VL, 1997, CYTOMETRY, V30, P151; Nebl T, 2005, PARASITOLOGY, V130, pS45, DOI 10.1017/S0031182005008152; Nuutila J, 2005, CYTOM PART A, V65A, P93, DOI 10.1002/cyto.a.20139; OEUVRAY C, 1994, BLOOD, V84, P1594; Perraut R, 2005, J INFECT DIS, V191, P264, DOI 10.1086/426398; Persson KEM, 2006, J CLIN MICROBIOL, V44, P1665, DOI 10.1128/JCM.44.5.1665-1673.2006; Richards JS, 2009, IMMUNOL CELL BIOL, V87, P377, DOI 10.1038/icb.2009.27; Riglar DT, 2011, CELL HOST MICROBE, V9, P9, DOI 10.1016/j.chom.2010.12.003; Rono J, 2012, INFECT IMMUN, V80, P1900, DOI 10.1128/IAI.06190-11; RZEPCZYK CM, 1988, INT J PARASITOL, V18, P401, DOI 10.1016/0020-7519(88)90151-8; Salmon BL, 2001, P NATL ACAD SCI USA, V98, P271, DOI 10.1073/pnas.011413198; Schofield L, 1996, IMMUNOL CELL BIOL, V74, P555, DOI 10.1038/icb.1996.89; SCHWARZER E, 1992, J EXP MED, V176, P1033, DOI 10.1084/jem.176.4.1033; Shi YP, 1999, AM J TROP MED HYG, V60, P135, DOI 10.4269/ajtmh.1999.60.135; Singh S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005410; Sirima SB, 2011, NEW ENGL J MED, V365, P1062, DOI 10.1056/NEJMc1100670; Sirima SB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007549; Skorokhod OA, 2004, J IMMUNOL, V173, P4066, DOI 10.4049/jimmunol.173.6.4066; Strom TS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026657; Taborda CP, 2003, J IMMUNOL, V170, P3621, DOI 10.4049/jimmunol.170.7.3621; Tebo AE, 2002, CLIN EXP IMMUNOL, V130, P300, DOI 10.1046/j.1365-2249.2002.01972.x; Theisen M, 1998, INFECT IMMUN, V66, P11, DOI 10.1128/IAI.66.1.11-17.1998; Tippett E, 2007, J IMMUNOL METHODS, V325, P42, DOI 10.1016/j.jim.2007.05.012; Wilson DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027705; Wilson DW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-152	67	28	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e51692	10.1371/journal.pone.0051692	http://dx.doi.org/10.1371/journal.pone.0051692			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300556	Green Published, Green Accepted, gold			2022-12-27	WOS:000313618800022
J	Wachstein, J; Tischer, S; Figueiredo, C; Limbourg, A; Falk, C; Immenschuh, S; Blasczyk, R; Eiz-Vesper, B				Wachstein, Julian; Tischer, Sabine; Figueiredo, Constanca; Limbourg, Anne; Falk, Christine; Immenschuh, Stephan; Blasczyk, Rainer; Eiz-Vesper, Britta			HSP70 Enhances Immunosuppressive Function of CD4(+)CD25(+)FoxP3(+) T Regulatory Cells and Cytotoxicity in CD4(+)CD25(-) T Cells	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; IMMUNOLOGICAL-TOLERANCE; MEDIATED SUPPRESSION; MOLECULAR CHAPERONES; ADAPTIVE IMMUNITY; PERIPHERAL-BLOOD; GRANZYME-B; IN-VIVO; ACTIVATION; INNATE	Human CD4(+)CD25(+)FoxP3(+) T regulatory cells (Tregs) control effector T cells and play a central role in peripheral tolerance and immune homeostasis. Heat shock protein 70 (HSP70) is a major immunomodulatory molecule, but its effect on the functions of Tregs is not well understood. To investigate target-dependent and -independent Treg functions, we studied cytokine expression, regulation of proliferation and cytotoxicity after exposure of Tregs to HSP70. HSP70-treated Tregs significantly inhibited proliferation of CD4(+)CD25(-) target cells and downregulated the secretion of the proinflammatory cytokines IFN-gamma and TNF-alpha. By contrast, HSP70 increased the secretion of Treg suppressor cytokines IL-10 and TGF-beta. Treatment with HSP70 enhanced the cytotoxic properties of Tregs only to a minor extent (4-fold), but led to stronger responses in CD4(+)CD25(-) cells (42-fold). HSP70-induced modulation of T-cell responses was further enhanced by combined treatment with HSP70 plus IL-2. Treatment of Tregs with HSP70 led to phosphorylation of PI3K/AKT and the MAPKs JNK and p38, but not that of ERK1/2. Exposure of Tregs to specific inhibitors of PI3K/AKT and the MAPKs JNK and p38 reduced the immunosuppressive function of HSP70-treated Tregs as indicated by the modified secretion of specific target cell (IFN-gamma, TNF-alpha) and suppressor cytokines (IL-10, TGF-beta). Taken together, the data show that HSP70 enhances the suppressive capacity of Tregs to neutralize target immune cells. Thus HSP70-enhanced suppression of Tregs may prevent exaggerated immune responses and may play a major role in maintaining immune homeostasis.	[Wachstein, Julian; Tischer, Sabine; Figueiredo, Constanca; Immenschuh, Stephan; Blasczyk, Rainer; Eiz-Vesper, Britta] Hannover Med Sch, Inst Transfus Med, Hannover, Germany; [Figueiredo, Constanca; Limbourg, Anne; Falk, Christine; Blasczyk, Rainer; Eiz-Vesper, Britta] Hannover Med Sch, Integrated Res & Treatment Ctr IFB Tx, Hannover, Germany; [Limbourg, Anne] Hannover Med Sch, Dept Plast Hand & Reconstruct Surg, Hannover, Germany; [Falk, Christine] Hannover Med Sch, Inst Transplant Immunol, Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School; Hannover Medical School	Eiz-Vesper, B (corresponding author), Hannover Med Sch, Inst Transfus Med, Hannover, Germany.	eiz-vesper.britta@mh-hannover.de	Falk, Christine/Q-4143-2016; Immenschuh, Stephan/AAM-9181-2020	Falk, Christine/0000-0003-1376-7318; Immenschuh, Stephan/0000-0003-3722-5791; Blasczyk, Rainer/0000-0003-3875-3190	German Federal Ministry of Education and Research [01EO0802]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This study was supported in part by the German Federal Ministry of Education and Research (reference number: 01EO0802). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Asea A, 2002, J BIOL CHEM, V277, P15028, DOI 10.1074/jbc.M200497200; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Baecher-Allan C, 2001, J IMMUNOL, V167, P1245, DOI 10.4049/jimmunol.167.3.1245; Bajor A, 2011, CLIN EXP IMMUNOL; Beere HM, 2005, J CLIN INVEST, V115, P2633, DOI 10.1172/JCI26471; Borges TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014264; Bour-Jordan H, 2009, IMMUNOL REV, V229, P41, DOI 10.1111/j.1600-065X.2009.00775.x; Chen TY, 2010, EUR J IMMUNOL, V40, P1541, DOI 10.1002/eji.201040616; Crellin NK, 2007, BLOOD, V109, P2014, DOI 10.1182/blood-2006-07-035279; Dai J, 2009, INT IMMUNOPHARMACOL, V9, P528, DOI 10.1016/j.intimp.2009.01.027; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Figueiredo C, 2009, BLOOD, V113, P3008, DOI 10.1182/blood-2008-06-162727; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Friedline RH, 2009, J EXP MED, V206, P421, DOI 10.1084/jem.20081811; Geiger TL, 2012, HUM IMMUNOL, V73, P232, DOI 10.1016/j.humimm.2011.12.012; GERDES J, 1984, J IMMUNOL, V133, P1710; Golovina TN, 2008, J IMMUNOL, V181, P2855, DOI 10.4049/jimmunol.181.4.2855; Gondek DC, 2005, J IMMUNOL, V174, P1783, DOI 10.4049/jimmunol.174.4.1783; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Henderson B, 2010, CELL STRESS CHAPERON, V15, P123, DOI 10.1007/s12192-009-0137-6; Herbelin A, 1998, J IMMUNOL, V161, P2620; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Jonuleit H, 2001, J EXP MED, V193, P1285, DOI 10.1084/jem.193.11.1285; Kane LP, 2001, NAT IMMUNOL, V2, P37, DOI 10.1038/83144; Le Bras S, 2006, J CLIN INVEST, V116, P1473, DOI 10.1172/JCI28880; Li LQ, 2005, BLOOD, V106, P3068, DOI 10.1182/blood-2005-04-1531; Lindley S, 2005, DIABETES, V54, P92, DOI 10.2337/diabetes.54.1.92; Lord SJ, 2003, IMMUNOL REV, V193, P31, DOI 10.1034/j.1600-065X.2003.00044.x; Mahajan Supriya D., 2003, Biological Procedures Online, V5, P182, DOI 10.1251/bpo60; McHugh RS, 2002, IMMUNITY, V16, P311, DOI 10.1016/S1074-7613(02)00280-7; Multhoff G, 2001, CELL STRESS CHAPERON, V6, P337, DOI 10.1379/1466-1268(2001)006<0337:AMHPSN>2.0.CO;2; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; Nikolova M, 2009, BLOOD, V113, P4556, DOI 10.1182/blood-2008-04-151407; Nishimura E, 2004, INT IMMUNOL, V16, P1189, DOI 10.1093/intimm/dxh122; Papiernik M, 1998, INT IMMUNOL, V10, P371, DOI 10.1093/intimm/10.4.371; Sakaguchi S, 2001, IMMUNOL REV, V182, P18, DOI 10.1034/j.1600-065X.2001.1820102.x; Schorr N, 2011, HANDCHIR MIKROCHIR P, V43, P325, DOI 10.1055/s-0030-1267966; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Shevach EM, 2001, IMMUNOL REV, V182, P58, DOI 10.1034/j.1600-065X.2001.1820104.x; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Soares A, 2010, J IMMUNOL METHODS, V362, P43, DOI 10.1016/j.jim.2010.08.007; Srivastava P, 2002, NAT REV IMMUNOL, V2, P185, DOI 10.1038/nri749; Suri-Payer E, 2001, J AUTOIMMUN, V16, P115, DOI 10.1006/jaut.2000.0473; Sutmuller RPM, 2006, J CLIN INVEST, V116, P485, DOI 10.1172/JCI25439; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; Tamura Y, 1997, SCIENCE, V278, P117, DOI 10.1126/science.278.5335.117; Tang QZ, 2004, EUR J IMMUNOL, V34, P2996, DOI 10.1002/eji.200425143; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; Tsan MF, 2009, J LEUKOCYTE BIOL, V85, P905, DOI 10.1189/jlb.0109005; Vabulas RM, 2002, J BIOL CHEM, V277, P20847, DOI 10.1074/jbc.M200425200; van Eden W, 2005, NAT REV IMMUNOL, V5, P318, DOI 10.1038/nri1593; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Vukmanovic-Stejic M, 2008, J CLIN INVEST, V118, P3639, DOI 10.1172/JCI35834; Zanin-Zhorov A, 2005, J IMMUNOL, V174, P3227, DOI 10.4049/jimmunol.174.6.3227; Zanin-Zhorov A, 2003, FASEB J, V17, P1567, DOI 10.1096/fj.02-1139fje; Zanin-Zhorov A, 2006, J CLIN INVEST, V116, P2022, DOI 10.1172/JCI28423; Zheng LM, 2004, J IMMUNOL, V173, P6319, DOI 10.4049/jimmunol.173.10.6319	59	60	64	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e51747	10.1371/journal.pone.0051747	http://dx.doi.org/10.1371/journal.pone.0051747			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300563	Green Published, Green Submitted, gold			2022-12-27	WOS:000313618800027
J	You, YY; Gupta, VK; Graham, SL; Klistorner, A				You, Yuyi; Gupta, Vivek K.; Graham, Stuart L.; Klistorner, Alexander			Anterograde Degeneration along the Visual Pathway after Optic Nerve Injury	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; TRANSNEURONAL RETROGRADE DEGENERATION; LATERAL GENICULATE-NUCLEUS; TRANSSYNAPTIC DEGENERATION; SIGNALING PATHWAYS; DISEASE PATHOLOGY; INSULIN-RECEPTOR; BRAIN-DAMAGE; NEURONS; MODEL	Purpose: To investigate anterograde degenerative changes along the visual pathway in a rat model of optic nerve axotomy. Methods: Optic nerve transection was performed in adult Sprague-Dawley rats. Animals were sacrificed at regular time intervals and tissues harvested. Immunoblotting followed by densitometric analysis was used to determine the phosphorylation profile of Akt in the dorsal lateral geniculate nucleus (dLGN) and the primary visual cortex (V1). The neuronal cell size and cell density were measured in the dLGN and the V1 using Nissl staining. The prevalence of apoptosis was characterized by terminal deoxynucleotidyl-transferase-mediated biotin-dUTP nick end labelling (TUNEL) histochemistry. Caspase-3 antibodies were also used to identify apoptotic cells. Neurons and astrocytes were detected using NeuN and glial fibrillary acidic protein (GFAP), respectively. Results: An early and sustained loss of Akt phosphorylation was observed after optic nerve transection in both dLGN and V1. At week one, a decrease in the neuronal cell size (50.5 +/- 4.9 vs 60.3 +/- 5.0 mu m(2), P = 0.042) and an increase of TUNEL positive cells (7.9 +/- 0.6 vs 1.4 +/- 0.56 x 10(2) cells/mm(2), P<0.001) were evident in the dLGN but not in V1. A significant decline in neuronal cell number (14.5 +/- 0.1 vs 17.4 +/- 1.3 x 10(2) cells/mm(2), P = 0.048), cell size (42.5 +/- 4.3 vs 62.1 +/- 4.7 mu m(2), P = 0.001) and an increase in apoptotic cells (5.6 +/- 0.5 vs 2.0 +/- 0.4 x 10(2) cells/mm(2), P<0.001) appeared in V1 initially at one month post-transection. The changes in the visual pathway continued through two months. Both neuronal cells and GFAP-positive glial cells were affected in this anterograde degeneration along the visual pathway. Conclusions: Anterograde degeneration along the visual pathway takes place in target relay (LGN) and visual cortex following the optic nerve injury. Apoptosis was observed in both neural and adjacent glial cells. Reduction of Akt phosphorylation preceded cellular and apoptotic changes.	[You, Yuyi; Gupta, Vivek K.; Graham, Stuart L.; Klistorner, Alexander] Macquarie Univ, Australian Sch Adv Med, Dept Ophthalmol, Sydney, NSW 2109, Australia; [Graham, Stuart L.; Klistorner, Alexander] Univ Sydney, Save Sight Inst, Sydney, NSW 2006, Australia	Macquarie University; University of Sydney	Gupta, VK (corresponding author), Macquarie Univ, Australian Sch Adv Med, Dept Ophthalmol, Sydney, NSW 2109, Australia.	vivek.gupta@mq.edu.au	Gupta, Vivek Kumar/AAB-8940-2022	Klistorner, Alexander/0000-0003-0361-6399; , Yuyi/0000-0002-0175-3018; Gupta, Vivek/0000-0002-0202-7843; Graham, Stuart/0000-0001-7519-969X	Ophthalmic Research Institute Australia (ORIA); National Multiple Sclerosis Society (NMSS); Multiple Sclerosis Research Australia (MSRA Incubator Grant) [10-057]; Macquarie University New Staff (MQNS) Grant; Sydney Foundation for Medical Research; Allergan Australia; Novartis Pharmaceuticals Australia	Ophthalmic Research Institute Australia (ORIA); National Multiple Sclerosis Society (NMSS)(National Multiple Sclerosis Society); Multiple Sclerosis Research Australia (MSRA Incubator Grant); Macquarie University New Staff (MQNS) Grant; Sydney Foundation for Medical Research; Allergan Australia(AbbVieAllergan); Novartis Pharmaceuticals Australia	Supported by Ophthalmic Research Institute Australia (ORIA), National Multiple Sclerosis Society (NMSS), Multiple Sclerosis Research Australia (MSRA Incubator Grant, 10-057), and Macquarie University New Staff (MQNS) Grant. AK was supported by the Sydney Foundation for Medical Research. VG was supported by an educational grant from Allergan Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study is supported by research funding from Allergan Australia and Novartis Pharmaceuticals Australia (competing interests: Allergan Australia, Novartis Pharmaceuticals Australia). This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Barber AJ, 2001, J BIOL CHEM, V276, P32814, DOI 10.1074/jbc.M104738200; Beier KT, 2011, P NATL ACAD SCI USA, V108, P15414, DOI 10.1073/pnas.1110854108; Boucard CC, 2009, BRAIN, V132, P1898, DOI 10.1093/brain/awp119; Bridge H, 2011, INVEST OPHTH VIS SCI, V52, P382, DOI 10.1167/iovs.10-5708; Brundin P, 2008, NAT REV NEUROSCI, V9, P741, DOI 10.1038/nrn2477; Canudas AM, 2005, MOL BRAIN RES, V134, P147, DOI 10.1016/j.molbrainres.2004.11.012; Cheng HC, 2011, J NEUROSCI, V31, P2125, DOI 10.1523/JNEUROSCI.5519-10.2011; Chiu SL, 2008, NEURON, V58, P708, DOI 10.1016/j.neuron.2008.04.014; Conti AC, 1998, J NEUROSCI, V18, P5663; Cowey A, 2011, BRAIN, V134, P2149, DOI 10.1093/brain/awr125; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Duarte AI, 2008, BBA-MOL CELL RES, V1783, P994, DOI 10.1016/j.bbamcr.2008.02.016; EIDELBERG E, 1989, BRAIN RES BULL, V22, P39, DOI 10.1016/0361-9230(89)90125-1; Flammer J, 2007, SURV OPHTHALMOL, V52, pS162, DOI 10.1016/j.survophthal.2007.08.012; Ginsberg SD, 2002, J NEUROTRAUM, V19, P99, DOI 10.1089/089771502753460277; GOBEL S, 1984, J NEUROSCI, V4, P2281; Gupta N, 2007, CURR OPIN OPHTHALMOL, V18, P110, DOI 10.1097/ICU.0b013e3280895aea; Gupta VK, 2009, J HAZARD MATER, V163, P396, DOI 10.1016/j.jhazmat.2008.06.104; Gupta VK, 2012, BBA-MOL BASIS DIS, V1822, P1643, DOI 10.1016/j.bbadis.2012.07.016; Hardy J, 2012, NEW ENGL J MED, V366, P2126, DOI 10.1056/NEJMcibr1202401; HASELTINE EC, 1979, BRAIN RES, V176, P153, DOI 10.1016/0006-8993(79)90878-3; Ito Y, 2010, CNS NEUROSCI THER, V16, pe169, DOI 10.1111/j.1755-5949.2010.00176.x; Jindahra P, 2009, BRAIN, V132, P628, DOI 10.1093/brain/awp001; Johnson H, 2000, EXP BRAIN RES, V132, P269, DOI 10.1007/s002210000384; Kermer P, 2000, J NEUROSCI, V20, P722, DOI 10.1523/JNEUROSCI.20-02-00722.2000; KIERNAN JA, 1991, BRAIN, V114, P843, DOI 10.1093/brain/114.2.843; Kovac AD, 2004, BRAIN PATHOL, V14, P249; Lam DY, 2003, INVEST OPHTH VIS SCI, V44, P2573, DOI 10.1167/iovs.02-0779; Lau C, 2011, NEUROIMAGE, V58, P878, DOI 10.1016/j.neuroimage.2011.06.055; Leamey CA, 2008, EYE RETINA VISUAL SY, P35; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; Ly T, 2011, VISION RES, V51, P243, DOI 10.1016/j.visres.2010.08.003; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Ramu J, 2008, EXP NEUROL, V212, P100, DOI 10.1016/j.expneurol.2008.03.018; SCHALLERT T, 1990, CAN J PSYCHOL, V44, P276, DOI 10.1037/h0084244; Schubert M, 2004, P NATL ACAD SCI USA, V101, P3100, DOI 10.1073/pnas.0308724101; Su JH, 1997, NEUROBIOL DIS, V4, P365, DOI 10.1006/nbdi.1997.0164; Theoret H, 1997, BRAIN RES, V775, P203, DOI 10.1016/S0006-8993(97)00949-9; Vickers JC, 1997, AUST NZ J OPHTHALMOL, V25, P239, DOI 10.1111/j.1442-9071.1997.tb01400.x; Weber AJ, 2000, INVEST OPHTH VIS SCI, V41, P1370; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147; You YY, 2011, INVEST OPHTH VIS SCI, V52, P6911, DOI 10.1167/iovs.11-7434; Yucel YH, 2003, PROG RETIN EYE RES, V22, P465, DOI 10.1016/S1350-9462(03)00026-0; Yucel Y, 2008, PROG BRAIN RES, V173, P465, DOI 10.1016/S0079-6123(08)01132-1; Zacharaki T, 2010, BRAIN RES, V1344, P62, DOI 10.1016/j.brainres.2010.05.021; Zeng GY, 2000, CIRCULATION, V101, P1539, DOI 10.1161/01.CIR.101.13.1539; Zhang SD, 2009, BRAIN RES, V1303, P131, DOI 10.1016/j.brainres.2009.09.029	49	42	43	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52061	10.1371/journal.pone.0052061	http://dx.doi.org/10.1371/journal.pone.0052061			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300590	Green Published, Green Submitted			2022-12-27	WOS:000313618800044
J	Markaki, A; Kyriazis, J; Stylianou, K; Fragkiadakis, GA; Perakis, K; Margioris, AN; Ganotakis, ES; Daphnis, E				Markaki, Anastasia; Kyriazis, John; Stylianou, Kostas; Fragkiadakis, George A.; Perakis, Kostas; Margioris, Andrew N.; Ganotakis, Emmanuel S.; Daphnis, Eugene			The Role of Serum Magnesium and Calcium on the Association between Adiponectin Levels and All-Cause Mortality in End-Stage Renal Disease Patients	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; MAINTENANCE HEMODIALYSIS-PATIENTS; CORONARY-HEART-DISEASE; PLASMA ADIPONECTIN; CARDIOVASCULAR-DISEASE; PRIMARY HYPERPARATHYROIDISM; INSULIN-RESISTANCE; MYOCARDIAL-INFARCTION; MINERAL METABOLISM; RISK-FACTORS	Background: Adiponectin (ADPN) is the most abundant adipocyte-specific cytokine that plays an important role in energy homeostasis by regulating lipid and glucose metabolism. Studies of the impact of ADPN on clinical outcomes have yielded contradictory results so far. Here, we examined the association of ADPN with serum magnesium (s-Mg) and calcium (s-Ca) levels and explored the possibility whether these two factors could modify the relationship between ADPN and all-cause mortality in patients with end-stage renal disease. Methodology/Principal Findings: After baseline assessment, 47 hemodialysis and 27 peritoneal dialysis patients were followed-up for a median period of 50 months. S-Mg and s-Ca levels emerged as positive and negative predictors of ADPN levels, respectively. During the follow-up period 18 deaths occurred. There was a significant 4% increased risk for all-cause mortality for each 1-mu g/ml increment of ADPN (crude HR, 1.04; 95% CI, 1.01-1.07), even after adjustment for s-Mg and s-Ca levels, dialysis mode, age, albumin and C-reactive protein. Cox analysis stratified by s-Mg levels (below and above the median value of 2.45 mg/dl) and s-Ca levels (below and above the median value of 9.3 mg/dl), revealed ADPN as an independent predictor of total mortality only in the low s-Mg and high s-Ca groups. Furthermore, low s-Mg and high s-Ca levels were independently associated with malnutrition, inflammation, arterial stiffening and risk of death. Conclusions/Significance: The predictive value of ADPN in all-cause mortality in end-stage renal disease patients appears to be critically dependent on s-Mg and s-Ca levels. Conversely, s-Mg and s-Ca may impact on clinical outcomes by directly modifying the ADPN's bioactivity.	[Kyriazis, John] Gen Hosp Chios, Dept Nephrol, Chios, Greece; [Markaki, Anastasia; Fragkiadakis, George A.] Technol Educ Inst Crete, Dept Nutr & Dietet, Iraklion, Greece; [Stylianou, Kostas; Perakis, Kostas; Daphnis, Eugene] Univ Hosp Heraklion, Dept Nephrol, Iraklion, Crete, Greece; [Ganotakis, Emmanuel S.] Univ Hosp Heraklion, Dept Internal Med, Iraklion, Crete, Greece; [Margioris, Andrew N.] Univ Crete, Dept Clin Chem, Sch Med, Iraklion, Crete, Greece	Hellenic Mediterranean University; University Hospital of Heraklion; University Hospital of Heraklion; University of Crete	Kyriazis, J (corresponding author), Gen Hosp Chios, Dept Nephrol, Chios, Greece.	jks@otenet.gr	Markaki, Anastasia/D-3492-2013; Stylianou, Konstantinos/C-5868-2009; Stylianou, Konstantinos/H-2806-2019; Markaki, Anastasia/ABG-5865-2020	Stylianou, Konstantinos/0000-0003-3678-9421; Stylianou, Konstantinos/0000-0003-3678-9421; Fragkiadakis, Georgios A./0000-0002-7596-7676; GANOTAKIS, EMMANUEL/0000-0001-8093-7562				[Anonymous], 2011, KIDNEY INT S113, V76, pS50; Banga Anannya, 2008, Metabolic Syndrome and Related Disorders, V6, P103, DOI 10.1089/met.2007.0033; Becker B, 2005, J AM SOC NEPHROL, V16, P1091, DOI 10.1681/ASN.2004090742; Bollerslev J, 2009, J CLIN ENDOCR METAB, V94, P2255, DOI 10.1210/jc.2008-2742; Bosticardo G, 2012, NEPHROL DIAL TRANSPL, V27, P2489, DOI 10.1093/ndt/gfr733; Cassidy A, 2009, J NUTR, V139, P353, DOI 10.3945/jn.108.098681; Cavusoglu E, 2006, EUR HEART J, V27, P2300, DOI 10.1093/eurheartj/ehl153; Chandran M, 2003, DIABETES CARE, V26, P2442, DOI 10.2337/diacare.26.8.2442; Chudek J, 2003, TRANSPL P, V35, P2186, DOI 10.1016/j.transproceed.2003.08.001; Cunningham J, 2012, CLIN KIDNEY J, V5, P39, DOI 10.1093/ndtplus/sfr166; Dekker JM, 2008, J CLIN ENDOCR METAB, V93, P1489, DOI 10.1210/jc.2007-1436; Delfini E, 2007, METABOLISM, V56, P30, DOI 10.1016/j.metabol.2006.08.019; Diez JJ, 2009, AM J NEPHROL, V30, P244, DOI 10.1159/000221147; Guessous I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018865; Hsu CW, 2010, NEPHROLOGY, V15, P313, DOI 10.1111/j.1440-1797.2009.01202.x; Ignacy W, 2005, NEPHRON CLIN PRACT, V101, pC18, DOI 10.1159/000085707; Ishimura E, 2007, MAGNESIUM RES, V20, P237, DOI 10.1684/mrh.2007.0116; Iwashima Y, 2006, AM J CARDIOL, V98, P1603, DOI 10.1016/j.amjcard.2006.07.039; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Kistorp C, 2005, CIRCULATION, V112, P1756, DOI 10.1161/CIRCULATIONAHA.104.530972; Kollerits B, 2007, KIDNEY INT, V71, P1279, DOI 10.1038/sj.ki.5002191; Kotani K, 2009, ASIAN PAC J CANCER P, V10, P87; Kyriazis J, 2004, KIDNEY INT, V66, P1221, DOI 10.1111/j.1523-1755.2004.00875.x; Kyriazis J, 2002, KIDNEY INT, V61, P276, DOI 10.1046/j.1523-1755.2002.00100.x; Laughlin GA, 2007, AM J EPIDEMIOL, V165, P164, DOI 10.1093/aje/kwk001; Lo MM, 2011, PEDIATR NEPHROL, V26, P2009, DOI 10.1007/s00467-011-1906-x; Mallamaci F, 2002, J NEPHROL, V15, P507; Mantzoros CS, 2005, J CLIN ENDOCR METAB, V90, P4542, DOI 10.1210/jc.2005-0372; Massy ZA, 2012, CLIN KIDNEY J, V5, P52, DOI 10.1093/ndtplus/sfr167; Menon V, 2006, J AM SOC NEPHROL, V17, P2599, DOI 10.1681/ASN.2006040331; Nishimura M, 2006, NEPHROL DIAL TRANSPL, V21, P1640, DOI 10.1093/ndt/gfk088; Ohashi N, 2008, INTERNAL MED, V47, P485, DOI 10.2169/internalmedicine.47.0614; Park SH, 2009, CLIN NEPHROL, V72, P87; Pham PCT, 2007, CLIN J AM SOC NEPHRO, V2, P366, DOI 10.2215/CJN.02960906; Pills S, 2006, J CLIN ENDOCR METAB, V91, P4277; Pischon T, 2003, CLIN CHEM, V49, P650, DOI 10.1373/49.4.650; Pischon T, 2004, JAMA-J AM MED ASSOC, V291, P1730, DOI 10.1001/jama.291.14.1730; Qi L, 2005, DIABETES CARE, V28, P1022, DOI 10.2337/diacare.28.5.1022; Qi Y, 2004, NAT MED, V10, P524, DOI 10.1038/nm1029; Rabin KR, 2005, EXPERT REV CARDIOVAS, V3, P465, DOI 10.1586/14779072.3.3.465; RESNICK LM, 1989, AM J MED, V87, pS17, DOI 10.1016/0002-9343(89)90490-7; Rizza S, 2010, J AM GERIATR SOC, V58, P702, DOI 10.1111/j.1532-5415.2010.02773.x; Salem S, 2012, AM J NEPHROL, V35, P31, DOI 10.1159/000334742; Saris NEL, 2000, CLIN CHIM ACTA, V294, P1, DOI 10.1016/S0009-8981(99)00258-2; Sattar N, 2006, CIRCULATION, V114, P623, DOI 10.1161/CIRCULATIONAHA.106.618918; Shen YY, 2007, NEPHROL DIAL TRANSPL, V22, P171, DOI 10.1093/ndt/gfl552; Stenvinkel P, 2004, KIDNEY INT, V65, P274, DOI 10.1111/j.1523-1755.2004.00370.x; Sun G, 2005, DIABETES, V54, P3336, DOI 10.2337/diabetes.54.11.3336; Takaya J, 2007, PEDIATR RES, V62, P700, DOI 10.1203/PDR.0b013e318157d219; Tetta C, 2002, INT J ARTIF ORGANS, V25, P18, DOI 10.1177/039139880202500104; Tzanakis I, 2004, MAGNESIUM RES, V17, P102; Wannamethee SG, 2007, ARCH INTERN MED, V167, P1510, DOI 10.1001/archinte.167.14.1510; Yang WS, 2001, J CLIN ENDOCR METAB, V86, P3815, DOI 10.1210/jc.86.8.3815; Ybarra J, 2007, NURS CLIN N AM, V42, P79, DOI 10.1016/j.cnur.2006.11.010; Young EW, 2007, ADV CHRONIC KIDNEY D, V14, P13, DOI 10.1053/j.ackd.2006.10.003; Young EW, 2005, KIDNEY INT, V67, P1179, DOI 10.1111/j.1523-1755.2005.00185.x; Zoccali C, 2011, J INTERN MED, V269, P172, DOI 10.1111/j.1365-2796.2010.02288.x; Zoccali C, 2002, J AM SOC NEPHROL, V13, P134, DOI 10.1681/ASN.V131134	58	26	27	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52350	10.1371/journal.pone.0052350	http://dx.doi.org/10.1371/journal.pone.0052350			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285003	Green Published, gold, Green Submitted			2022-12-27	WOS:000312794500150
J	Casanova, JC; Badia-Careaga, C; Uribe, V; Sanz-Ezquerro, JJ				Casanova, Jesus C.; Badia-Careaga, Claudio; Uribe, Veronica; Jose Sanz-Ezquerro, Juan			Bambi and Sp8 Expression Mark Digit Tips and Their Absence Shows That Chick Wing Digits 2 and 3 Are Truncated	PLOS ONE			English	Article							LIMB DEVELOPMENT; MORPHOGENESIS; REGENERATION; OUTGROWTH; PATHWAYS; IDENTITY; BIRDS; MICE; BUD	An often overlooked aspect of digit development is the special nature of the terminal phalanx, a specialized structure with characteristics distinct from other phalanges, for example the presence of ectodermal derivatives such as nails and claws. Here, we describe the unique ossification pattern of distal phalanges and characteristic gene expression in the digit tips of chick and duck embryos. Our results show that the distal phalanx of chick wing digit 1 is a genuine tip with a characteristic ossification pattern and expression of Bambi and Sp8; however, the terminal phalanx of digits 2* and 3 is not a genuine tip, and these are therefore truncated digits. Bambi and Sp8 expression in the chick wing provides a direct molecular assessment of digit identity changes after experimental manipulations of digit primordia. In contrast, digits 1 and 2 of the duck wing both possess true tips. Although chick wing-tip development was not rescued by application of Fgf8, this treatment induced the development of extra phalanges. Grafting experiments show that competence for tip formation, including nails, is latent in the interdigital tissue. Our results deepen understanding of the mechanisms of digit tip formation, highlighting its developmental autonomy and modular nature, with implications for digit reduction or loss during evolution. * Numbering of wing digits is 1, 2, 3 from anterior to posterior.	[Casanova, Jesus C.; Badia-Careaga, Claudio; Uribe, Veronica; Jose Sanz-Ezquerro, Juan] CNIC, Dept Cardiovasc Dev & Repair, Madrid, Spain; [Casanova, Jesus C.; Jose Sanz-Ezquerro, Juan] CSIC, Ctr Nacl Biotecnol, Dept Immunol & Oncol, Madrid, Spain; [Jose Sanz-Ezquerro, Juan] CSIC, Ctr Nacl Biotecnol, Dept Mol & Cellular Biol, Madrid, Spain	Centro Nacional de Investigaciones Cardiovasculares (CNIC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Sanz-Ezquerro, JJ (corresponding author), CNIC, Dept Cardiovasc Dev & Repair, Madrid, Spain.	jjsanz@cnb.csic.es	Ezquerro, Juan Jose Sanz/I-7905-2014	Ezquerro, Juan Jose Sanz/0000-0002-9084-6354	Spanish Ministerio de Ciencia y Tecnologia [BFU2003-06100, BFU2006-12859]; Fundacio La Marato TV3 [MTV082031]; Ramon y Cajal contract; FPU fellowship from the Spanish Ministerio de Ciencia y Tecnologia	Spanish Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacio La Marato TV3; Ramon y Cajal contract(Spanish Government); FPU fellowship from the Spanish Ministerio de Ciencia y Tecnologia	This work was supported by grants BFU2003-06100 and BFU2006-12859 from the Spanish Ministerio de Ciencia y Tecnologia and grant MTV082031 from Fundacio La Marato TV3 to JJSE. JJSE was the recipient of a Ramon y Cajal contract and JCC of a FPU fellowship from the Spanish Ministerio de Ciencia y Tecnologia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell SM, 2003, P NATL ACAD SCI USA, V100, P12195, DOI 10.1073/pnas.2134310100; Boardman PE, 2002, CURR BIOL, V12, P1965, DOI 10.1016/S0960-9822(02)01296-4; BORGENS RB, 1982, SCIENCE, V217, P747, DOI 10.1126/science.7100922; Casanova JC, 2007, DEV GROWTH DIFFER, V49, P479, DOI 10.1111/j.1440-169x.2007.00951.x; Casanova JC, 2011, DEVELOPMENT, V138, P1195, DOI 10.1242/dev.057570; Chen JQ, 2007, GENESIS, V45, P482, DOI 10.1002/dvg.20320; Dahn RD, 2000, SCIENCE, V289, P438, DOI 10.1126/science.289.5478.438; Fernandez-Teran M, 2008, INT J DEV BIOL, V52, P857, DOI 10.1387/ijdb.072416mf; FISHER HARVEY I., 1940, AMER MIDLAND NAT, V23, P234, DOI 10.2307/2485270; Grotewold L, 2001, MECH DEVELOP, V100, P327, DOI 10.1016/S0925-4773(00)00524-4; Hamburger H, 1951, J MORPHOL, V88, P49; Harman MT, 1938, AM NAT, V72, P59, DOI 10.1086/280765; HOLDER N, 1978, J EMBRYOL EXP MORPH, V44, P15; Kaltofen RS, 1971, EMBRYONIC DEV EGGS P; Kaufman M.H., 1992, ATLAS MOUSE DEV; Kawakami Y, 2004, DEVELOPMENT, V131, P4763, DOI 10.1242/dev.01331; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lehoczky JA, 2011, P NATL ACAD SCI USA, V108, P20609, DOI 10.1073/pnas.1118017108; Merino R, 1998, DEV BIOL, V200, P35, DOI 10.1006/dbio.1998.8946; NIETO A, 1996, METHOD CELL BIOL, P219; Onichtchouk D, 1999, NATURE, V401, P480, DOI 10.1038/46794; Rinkevich Y, 2011, NATURE, V476, P409, DOI 10.1038/nature10346; Sanz-Ezquerro JJ, 2000, DEVELOPMENT, V127, P4811; Sanz-Ezquerro JJ, 2003, CURR BIOL, V13, P1830, DOI 10.1016/j.cub.2003.09.040; Sanz-Ezquerro JJ, 2003, J ANAT, V202, P51, DOI 10.1046/j.1469-7580.2003.00134.x; Stricker S, 2011, DEV DYNAM, V240, P990, DOI 10.1002/dvdy.22565; Suzuki T, 2008, P NATL ACAD SCI USA, V105, P4185, DOI 10.1073/pnas.0707899105; Tamura K, 2011, SCIENCE, V331, P753, DOI 10.1126/science.1198229; Tickle C, 2004, MECH DEVELOP, V121, P1019, DOI 10.1016/j.mod.2004.05.015; Towers M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1437; Treichel D, 2003, GENE DEV, V17, P2630, DOI 10.1101/gad.274103; Uejima A, 2010, DEV GROWTH DIFFER, V52, P223, DOI 10.1111/j.1440-169X.2009.01161.x; Wang Z, 2011, NATURE, V477, P583, DOI 10.1038/nature10391; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; Yu L, 2010, DEVELOPMENT, V137, P551, DOI 10.1242/dev.042424; Zeller R, 2009, NAT REV GENET, V10, P845, DOI 10.1038/nrg2681; Zhou J, 2007, BIOCHEM BIOPH RES CO, V363, P513, DOI 10.1016/j.bbrc.2007.08.198; Zhu JJ, 2008, DEV CELL, V14, P624, DOI 10.1016/j.devcel.2008.01.008; Zuzarte-Luis V, 2004, DEV BIOL, V272, P39, DOI 10.1016/j.ydbio.2004.04.015	39	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52781	10.1371/journal.pone.0052781	http://dx.doi.org/10.1371/journal.pone.0052781			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285181	Green Submitted, Green Published, gold			2022-12-27	WOS:000313051500060
J	Rinkevich, FD; Hedtke, SM; Leichter, CA; Harris, SA; Su, C; Brady, SG; Taskin, V; Qiu, XH; Scott, JG				Rinkevich, Frank D.; Hedtke, Shannon M.; Leichter, Cheryl A.; Harris, Sarah A.; Su, Cathy; Brady, Sean G.; Taskin, Vatan; Qiu, Xinghui; Scott, Jeffrey G.			Multiple Origins of kdr-type Resistance in the House Fly, Musca domestica	PLOS ONE			English	Article							SODIUM-CHANNEL GENE; APHID MYZUS-PERSICAE; IN-FIELD POPULATIONS; PEACH-POTATO APHIDS; INSECTICIDE RESISTANCE; PYRETHROID RESISTANCE; MOLECULAR ANALYSIS; BEMISIA-TABACI; MUTATIONS; FREQUENCIES	Insecticide resistance is a model phenotype that can be used to investigate evolutionary processes underlying the spread of alleles across a global landscape, while offering valuable insights into solving the problems that resistant pests present to human health and agriculture. Pyrethroids are one of the most widely used classes of insecticides world-wide and they exert their toxic effects through interactions with the voltage-sensitive sodium channel (Vssc). Specific mutations in Vssc (kdr, kdr-his and super-kdr) are known to cause resistance to pyrethroid insecticides in house flies. In order to determine the number of evolutionary origins of kdr, kdr-his and super-kdr, we sequenced a region of Vssc from house flies collected in the USA, Turkey and China. Our phylogenetic analysis of Vssc unequivocally supports the hypothesis of multiple independent origins of kdr, super-kdr and kdr-his on an unprecedented geographic scale. The implications of these evolutionary processes on pest management are discussed.	[Rinkevich, Frank D.; Hedtke, Shannon M.; Leichter, Cheryl A.; Harris, Sarah A.; Su, Cathy; Scott, Jeffrey G.] Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA; [Brady, Sean G.] Smithsonian Inst, Natl Museum Nat Hist, Dept Entomol, Washington, DC 20560 USA; [Taskin, Vatan] Mugla Sitki Kocman Univ, Fac Sci, Dept Biol, Mugla, Turkey; [Qiu, Xinghui] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China	Cornell University; Smithsonian Institution; Smithsonian National Museum of Natural History; Mugla Sitki Kocman University; Chinese Academy of Sciences; Institute of Zoology, CAS	Scott, JG (corresponding author), Cornell Univ, Dept Entomol, Comstock Hall, Ithaca, NY 14853 USA.	JGS5@cornell.edu		Hedtke, Shannon/0000-0002-7499-7662	Hatch project [139 7416]	Hatch project(United States Department of Agriculture (USDA))	This work was supported by Hatch project 139 7416. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon M, 2006, INSECT BIOCHEM MOLEC, V36, P71, DOI 10.1016/j.ibmb.2005.10.007; Andreev D, 1999, J MOL EVOL, V48, P615, DOI 10.1007/PL00006504; [Anonymous], 2012, EVOL BIOINFORM, V8, P1, DOI 10.4137/EBO.S8532; Anstead JA, 2005, INSECT BIOCHEM MOLEC, V35, P249, DOI 10.1016/j.ibmb.2004.12.004; ANTHONY NM, 1995, PESTIC BIOCHEM PHYS, V51, P220, DOI 10.1006/pest.1995.1022; Berticat C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-104; CAPRIO MA, 1992, J ECON ENTOMOL, V85, P611, DOI 10.1093/jee/85.3.611; Daborn PJ, 2002, SCIENCE, V297, P2253, DOI 10.1126/science.1074170; Dong K, 1998, PESTIC BIOCHEM PHYS, V60, P195, DOI 10.1006/pest.1998.2339; Dong K, 1997, INSECT BIOCHEM MOLEC, V27, P93, DOI 10.1016/S0965-1748(96)00082-3; Dong Ke, 2007, Invertebrate Neuroscience, V7, P17, DOI 10.1007/s10158-006-0036-9; FARNHAM AW, 1987, PESTIC SCI, V19, P209, DOI 10.1002/ps.2780190306; ffrench-Constant RH, 2004, TRENDS GENET, V20, P163, DOI 10.1016/j.tig.2004.01.003; ffrenchConstant RH, 1996, ACS SYM SER, V645, P106; FFRENCHCONSTANT RH, 1993, NATURE, V363, P449, DOI 10.1038/363449a0; Field Linda M., 1994, Insect Molecular Biology, V3, P143, DOI 10.1111/j.1365-2583.1994.tb00161.x; Foster SP, 2003, HEREDITY, V91, P98, DOI 10.1038/sj.hdy.6800285; Foster SP, 1999, B ENTOMOL RES, V89, P133, DOI 10.1017/S0007485399000218; GEORGHIOU GP, 1977, J ECON ENTOMOL, V70, P319, DOI 10.1093/jee/70.3.319; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hillis David M., 1996, P321; Keiding J, 1986, VECTOR BIOL CONTROL, V86, P937; KNIPPLE DC, 1994, P NATL ACAD SCI USA, V91, P2483, DOI 10.1073/pnas.91.7.2483; Krafsur ES, 2005, J HERED, V96, P502, DOI 10.1093/jhered/esi093; Maddison W.P., MESQUITE MODULAR SYS; Marquez JG, 2002, J HERED, V93, P254, DOI 10.1093/jhered/93.4.254; Marshall KL, 2012, J PESTIC SCI, V37, P169, DOI 10.1584/jpestics.D11-017; Milani R., 1957, Rivista di Parassitologia Roma, V18, P199; Newcomb RD, 2005, J MOL EVOL, V60, P207, DOI 10.1007/s00239-004-0104-x; Nyoni BN, 2011, PEST MANAG SCI, V67, P891, DOI 10.1002/ps.2145; Park Y, 1997, INSECT BIOCHEM MOLEC, V27, P9, DOI 10.1016/S0965-1748(96)00077-X; Pinto J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001243; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Qiu XH, 2007, PESTIC BIOCHEM PHYS, V89, P146, DOI 10.1016/j.pestbp.2007.05.003; RAYMOND M, 1991, NATURE, V350, P151, DOI 10.1038/350151a0; Rinkevich FD, 2006, INSECT MOL BIOL, V15, P157, DOI 10.1111/j.1365-2583.2006.00620.x; Rinkevich FD, 2007, INSECT BIOCHEM MOLEC, V37, P550, DOI 10.1016/j.ibmb.2007.02.013; SCHOOF HERBERT F., 1959, PEST CONTROL, V27, P16; Seifert J, 2002, PESTIC BIOCHEM PHYS, V72, P40, DOI 10.1006/pest.2001.2577; Tan JG, 2005, MOL PHARMACOL, V67, P513, DOI 10.1124/mol.104.006205; Taskin V, 2011, J VECTOR ECOL, V36, P239, DOI 10.1111/j.1948-7134.2011.00164.x; Wang QM, 2012, PESTIC BIOCHEM PHYS, V102, P153, DOI 10.1016/j.pestbp.2011.12.007; Whitten MJ, 1981, P 3 AUST C GRASSL IN; WILLIAMSON MS, 1993, MOL GEN GENET, V240, P17, DOI 10.1007/BF00276878; Williamson MS, 1996, MOL GEN GENET, V252, P51, DOI 10.1007/BF02173204; Zwickl DJ., 2006, THESIS	46	40	41	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52761	10.1371/journal.pone.0052761	http://dx.doi.org/10.1371/journal.pone.0052761			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285178	Green Submitted, gold, Green Published			2022-12-27	WOS:000313051500058
J	Rodrigues, F; Sousa, MJ; Ludovico, P; Santos, H; Corte-Real, M; Leao, C				Rodrigues, Fernando; Sousa, Maria Joao; Ludovico, Paula; Santos, Helena; Corte-Real, Manuela; Leao, Cecilia			The Fate of Acetic Acid during Glucose Co-Metabolism by the Spoilage Yeast Zygosaccharomyces bailii	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; C-13-NMR SPECTROSCOPY; MATHEMATICAL-MODEL; CARBOXYLIC-ACIDS; TRANSPORT; FERMENTATION; CYCLE; INHIBITION; ETHANOL; CELLS	Zygosaccharomyces bailii is one of the most widely represented spoilage yeast species, being able to metabolise acetic acid in the presence of glucose. To clarify whether simultaneous utilisation of the two substrates affects growth efficiency, we examined growth in single- and mixed-substrate cultures with glucose and acetic acid. Our findings indicate that the biomass yield in the first phase of growth is the result of the weighted sum of the respective biomass yields on single-substrate medium, supporting the conclusion that biomass yield on each substrate is not affected by the presence of the other at pH 3.0 and 5.0, at least for the substrate concentrations examined. In vivo C-13-NMR spectroscopy studies showed that the gluconeogenic pathway is not operational and that [2-C-13] acetate is metabolised via the Krebs cycle leading to the production of glutamate labelled on C-2, C-3 and C-4. The incorporation of [U-C-14] acetate in the cellular constituents resulted mainly in the labelling of the protein and lipid pools 51.5% and 31.5%, respectively. Overall, our data establish that glucose is metabolised primarily through the glycolytic pathway, and acetic acid is used as an additional source of acetyl-CoA both for lipid synthesis and the Krebs cycle. This study provides useful clues for the design of new strategies aimed at overcoming yeast spoilage in acidic, sugar-containing food environments. Moreover, the elucidation of the molecular basis underlying the resistance phenotype of Z. bailii to acetic acid will have a potential impact on the improvement of the performance of S. cerevisiae industrial strains often exposed to acetic acid stress conditions, such as in wine and bioethanol production.	[Sousa, Maria Joao; Corte-Real, Manuela] Univ Minho, Dept Biol, Ctr Mol & Environm Biol CBMA, Braga, Portugal; [Rodrigues, Fernando; Ludovico, Paula; Leao, Cecilia] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal; [Rodrigues, Fernando; Ludovico, Paula; Leao, Cecilia] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal; [Santos, Helena] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal	Universidade do Minho; Universidade do Minho; Universidade Nova de Lisboa	Corte-Real, M (corresponding author), Univ Minho, Dept Biol, Ctr Mol & Environm Biol CBMA, Braga, Portugal.	mcortereal@bio.uminho.pt	Corte-Real, Manuela/B-6328-2013; Rodrigues, Fernando/T-5299-2018; Santos, Helena/B-9141-2011; Rodrigues, Fernando/A-3123-2011; Sousa, Maria/HCI-9642-2022; Ludovico, Paula/B-4338-2011; Leao, Cecília/B-5051-2013; Sousa, Maria João/H-8775-2013	Corte-Real, Manuela/0000-0002-1423-1331; Rodrigues, Fernando/0000-0001-8436-9398; Santos, Helena/0000-0002-8050-9485; Ludovico, Paula/0000-0003-4130-7167; Sousa, Maria João/0000-0001-9424-4150; Leao, Cecilia/0000-0003-1311-7884	Fundacao para a Ciencia e Tecnologia (FCT), Portugal [PTDC/AGR-ALI/102608/2008]; FEDER through POFC - COMPETE; FCT [PEst-C/BIA/UI4050/2011];  [FCOMP-01-0124-FEDER- 007047]; Fundação para a Ciência e a Tecnologia [PTDC/AGR-ALI/102608/2008] Funding Source: FCT	Fundacao para a Ciencia e Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology); FEDER through POFC - COMPETE; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); ; Fundação para a Ciência e a Tecnologia	This work was supported by Fundacao para a Ciencia e Tecnologia (FCT), Portugal Grant PTDC/AGR-ALI/102608/2008 and by project FCOMP-01-0124-FEDER- 007047 and by FEDER through POFC - COMPETE and national funds from FCT - project PEst-C/BIA/UI4050/2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arneborg N, 2000, ARCH MICROBIOL, V174, P125, DOI 10.1007/s002030000185; CASAL M, 1995, BBA-MOL CELL RES, V1267, P122, DOI 10.1016/0167-4889(95)00067-3; CASSIO F, 1993, YEAST, V9, P743, DOI 10.1002/yea.320090708; CASSIO F, 1987, APPL ENVIRON MICROB, V53, P509; Dang TDT, 2009, FOOD MICROBIOL, V26, P320, DOI 10.1016/j.fm.2008.12.002; De VC, 1992, YEAST, V8, P1043; DEJONGGUBBELS P, 1995, YEAST, V11, P407, DOI 10.1002/yea.320110503; dos Santos MM, 2003, EUKARYOT CELL, V2, P599, DOI 10.1128/EC.2.3.599-608.2003; Fernandes L, 1997, LETT APPL MICROBIOL, V25, P249, DOI 10.1046/j.1472-765X.1997.00214.x; Fernandes L, 1999, LETT APPL MICROBIOL, V28, P345, DOI 10.1046/j.1365-2672.1999.00551.x; FIECHTER A, 1981, ADV MICROB PHYSIOL, V22, P123, DOI 10.1016/S0065-2911(08)60327-6; Geros H, 2000, J FOOD PROTECT, V63, P96, DOI 10.4315/0362-028X-63.1.96; Guerreiro JF, 2012, PROTEOMICS, V12, P2303, DOI 10.1002/pmic.201100457; JONES JG, 1993, BIOCHEMISTRY-US, V32, P12240, DOI 10.1021/bi00096a037; LEE YY, 1999, ADV BIOCHEM ENG BIOT, V65, P93, DOI DOI 10.1007/3-540-49194-5_5; Ludovico P, 2003, FEMS YEAST RES, V3, P449, DOI 10.1016/S1567-1356(03)00107-7; MAIORELLA B, 1983, BIOTECHNOL BIOENG, V25, P103, DOI 10.1002/bit.260250109; Palmqvist E, 2000, BIORESOURCE TECHNOL, V74, P17, DOI 10.1016/S0960-8524(99)00160-1; PRONK JT, 1994, MICROBIOL-SGM, V140, P601, DOI 10.1099/00221287-140-3-601; Prudencio C, 1998, CYTOMETRY, V31, P307, DOI 10.1002/(SICI)1097-0320(19980401)31:4<307::AID-CYTO11>3.0.CO;2-U; Rodrigues F, 2004, YEAST, V21, P325, DOI 10.1002/yea.1081; RONNE H, 1995, TRENDS GENET, V11, P12, DOI 10.1016/S0168-9525(00)88980-5; SANTOS H, 1986, J MAGN RESON, V68, P345, DOI 10.1016/0022-2364(86)90251-9; Sousa MJ, 1998, MICROBIOL-UK, V144, P665, DOI 10.1099/00221287-144-3-665; Sousa MJ, 1996, APPL ENVIRON MICROB, V62, P3152, DOI 10.1128/AEM.62.9.3152-3157.1996; Sousa MJ, 2012, CELL METABOLISM CELL; SUMEGI B, 1992, BIOCHEMISTRY-US, V31, P8720, DOI 10.1021/bi00152a006; TranDinh S, 1996, EUR J BIOCHEM, V242, P220, DOI 10.1111/j.1432-1033.1996.0220r.x; TranDinh S, 1997, EUR J BIOCHEM, V245, P497, DOI 10.1111/j.1432-1033.1997.t01-2-00497.x; TRANDINH S, 1991, EUR J BIOCHEM, V201, P715, DOI 10.1111/j.1432-1033.1991.tb16333.x; TSAI CS, 1989, BIOCHEM CELL BIOL, V67, P464, DOI 10.1139/o89-073; VANDENBERG MA, 1995, EUR J BIOCHEM, V231, P704; VANUDEN N, 1967, ARCH MIKROBIOL, V58, P155; Vilela-Moura A, 2008, APPL MICROBIOL BIOT, V80, P881, DOI 10.1007/s00253-008-1616-x	34	28	29	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52402	10.1371/journal.pone.0052402	http://dx.doi.org/10.1371/journal.pone.0052402			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285028	Green Submitted, Green Published, gold			2022-12-27	WOS:000313051500029
J	Epperlein, HH; Khattak, S; Knapp, D; Tanaka, EM; Malashichev, YB				Epperlein, Hans-Henning; Khattak, Shahryar; Knapp, Dunja; Tanaka, Elly M.; Malashichev, Yegor B.			Neural Crest Does Not Contribute to the Neck and Shoulder in the Axolotl (Ambystoma mexicanum)	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; CELL-MIGRATION; PLASTRON BONES; AVIAN SCAPULA; DUAL ORIGIN; EVOLUTION; REGENERATION; POPULATION; HOMOLOGIES; GIRDLE	Background: A major step during the evolution of tetrapods was their transition from water to land. This process involved the reduction or complete loss of the dermal bones that made up connections to the skull and a concomitant enlargement of the endochondral shoulder girdle. In the mouse the latter is derived from three separate embryonic sources: lateral plate mesoderm, somites, and neural crest. The neural crest was suggested to sustain the muscle attachments. How this complex composition of the endochondral shoulder girdle arose during evolution and whether it is shared by all tetrapods is unknown. Salamanders that lack dermal bone within their shoulder girdle were of special interest for a possible contribution of the neural crest to the endochondral elements and muscle attachment sites, and we therefore studied them in this context. Results: We grafted neural crest from GFP+ fluorescent transgenic axolotl (Ambystoma mexicanum) donor embryos into white (d/d) axolotl hosts and followed the presence of neural crest cells within the cartilage of the shoulder girdle and the connective tissue of muscle attachment sites of the neck-shoulder region. Strikingly, neural crest cells did not contribute to any part of the endochondral shoulder girdle or to the connective tissue at muscle attachment sites in axolotl. Conclusions: Our results in axolotl suggest that neural crest does not serve a general function in vertebrate shoulder muscle attachment sites as predicted by the "muscle scaffold theory," and that it is not necessary to maintain connectivity of the endochondral shoulder girdle to the skull. Our data support the possibility that the contribution of the neural crest to the endochondral shoulder girdle, which is observed in the mouse, arose de novo in mammals as a developmental basis for their skeletal synapomorphies. This further supports the hypothesis of an increased neural crest diversification during vertebrate evolution.	[Malashichev, Yegor B.] St Petersburg State Univ, Dept Embryol, Fac Biol & Soil Sci, St Petersburg, Russia; [Malashichev, Yegor B.] St Petersburg State Univ, Dept Vertebrate Zool, Fac Biol & Soil Sci, St Petersburg, Russia; [Epperlein, Hans-Henning; Khattak, Shahryar; Knapp, Dunja; Tanaka, Elly M.] Tech Univ Dresden, Ctr Regenerat Therapies, Dresden, Germany; [Epperlein, Hans-Henning] Tech Univ Dresden, Dept Anat, Dresden, Germany	Saint Petersburg State University; Saint Petersburg State University; Technische Universitat Dresden; Technische Universitat Dresden	Malashichev, YB (corresponding author), St Petersburg State Univ, Dept Embryol, Fac Biol & Soil Sci, St Petersburg, Russia.	malashichev@embryo.pu.ru	Malashichev, Yegor/D-3511-2013; Knapp, Dunja/N-2180-2017; Tanaka, Elly M/F-8572-2010	Malashichev, Yegor/0000-0003-3813-5712; Knapp, Dunja/0000-0002-7533-2208; Tanaka, Elly/0000-0003-4240-2158	A. von Humboldt Foundation [3.4-8151/07074]; Russian Foundation of Basic Research [10-04-01202-a]; Herbert Quandt Memorial Fund; Deutscher Akademischer Austausch Dienst	A. von Humboldt Foundation(Alexander von Humboldt Foundation); Russian Foundation of Basic Research(Russian Foundation for Basic Research (RFBR)); Herbert Quandt Memorial Fund; Deutscher Akademischer Austausch Dienst(Deutscher Akademischer Austausch Dienst (DAAD))	Supported by A. von Humboldt Foundation through equipment donation grant 3.4-8151/07074, Russian Foundation of Basic Research through grant 10-04-01202-a, and by Herbert Quandt Memorial Fund and Deutscher Akademischer Austausch Dienst through travel grants to YM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlberg PE, 2006, EVOL DEV, V8, P116, DOI 10.1111/j.1525-142X.2006.00082.x; Baleeva NV, 2009, AMPHIBIAN PECTORAL G; Bordzilovskaya N. P., 1989, DEV BIOL AXOLOTL, P201; Cebra-Thomas JA, 2007, EVOL DEV, V9, P267, DOI 10.1111/j.1525-142X.2007.00159.x; CHEVALLIER A, 1977, J EMBRYOL EXP MORPH, V42, P275; Clark K, 2001, GENESIS, V31, P111, DOI 10.1002/gene.10012; Donoghue PCJ, 2008, BIOESSAYS, V30, P530, DOI 10.1002/bies.20767; ERICKSON CA, 1995, DEVELOPMENT, V121, P915; Francis ETB, 1934, ANATOMY SALAMANDER; Grassme K, 2009, MECH DEVELOP, V126, pS292, DOI 10.1016/j.mod.2009.06.793; Gross JB, 2008, DEV BIOL, V317, P389, DOI 10.1016/j.ydbio.2008.02.046; Hall BK, 2001, J EXP ZOOL, V289, P153, DOI 10.1002/1097-010X(20010215)289:3<153::AID-JEZ1>3.0.CO;2-O; Hall BK, 1999, NEURAL CREST DEV EVO; Hu YM, 1997, NATURE, V390, P137, DOI 10.1038/36505; Huang RJ, 1999, ANAT EMBRYOL, V200, P137, DOI 10.1007/s004290050268; Huang RJ, 2000, DEVELOPMENT, V127, P3789; Kragl M, 2009, NATURE, V460, P60, DOI 10.1038/nature08152; LOFBERG J, 1989, DEV BIOL, V131, P168, DOI 10.1016/S0012-1606(89)80048-X; Matsuoka T, 2005, NATURE, V436, P347, DOI 10.1038/nature03837; McGonnell IM, 2001, J ANAT, V199, P189, DOI 10.1046/j.1469-7580.2001.19910189.x; McGonnell IM, 2001, DEV BIOL, V236, P354, DOI 10.1006/dbio.2001.0330; Nye HLD, 2003, DEV DYNAM, V226, P555, DOI 10.1002/dvdy.10237; Perris R, 2000, MECH DEVELOP, V95, P3, DOI 10.1016/S0925-4773(00)00365-8; Qiang J, 1999, NATURE, V398, P326, DOI [10.1038/18665, DOI 10.1038/18665]; Romer A.S, 1956, OSTEOLOGY REPTILIA; Sanchez-Villagra MR, 2006, EVOL DEV, V8, P113, DOI 10.1111/j.1525-142X.2006.00081.x; Sobkow L, 2006, DEV BIOL, V290, P386, DOI 10.1016/j.ydbio.2005.11.037; Steinberg M, 1957, CARNEGIE I WASHINGTO, V56, P347; STOCUM DL, 1982, J EMBRYOL EXP MORPH, V69, P7; Valasek P, 2010, J ANAT, V216, P482, DOI 10.1111/j.1469-7580.2009.01200.x; Vickaryous MK, 2006, BIOL REV, V81, P425, DOI 10.1017/S1464793106007068; WALMSLEY ME, 1991, J CELL BIOL, V114, P9, DOI 10.1083/jcb.114.1.9	32	21	22	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52244	10.1371/journal.pone.0052244	http://dx.doi.org/10.1371/journal.pone.0052244			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300623	gold, Green Published, Green Submitted			2022-12-27	WOS:000312829100033
J	Stander, BA; Joubert, F; Tu, CK; Sippel, KH; McKenna, R; Joubert, AM				Stander, Barend Andre; Joubert, Fourie; Tu, Chingkuang; Sippel, Katherine H.; McKenna, Robert; Joubert, Annie Margaretha			In Vitro Evaluation of ESE-15-ol, an Estradiol Analogue with Nanomolar Antimitotic and Carbonic Anhydrase Inhibitory Activity	PLOS ONE			English	Article							GENE LISTS; 2-METHOXYESTRADIOL; CONSEQUENCES; CHECKPOINT; DOCKING; CELLS; IX	Antimitotic compounds are still one of the most widely used chemotherapeutic anticancer drugs in the clinic today. Given their effectiveness against cancer it is beneficial to continue enhancing these drugs. One way is to improve the bioavailability and efficacy by synthesizing derivatives that reversibly bind to carbonic anhydrase II (CAII) in red blood cells followed by a slow release into the blood circulation system. In the present study we describe the in vitro biological activity of a reduced derivative of 2-ethyl-3-O-sulphamoyl-estradiol (2EE), 2-ethyl-3-O-sulphamoyl-estra-1,3,5(10),15-tetraen-17-ol (ESE-15-ol). ESE-15-ol is capable of inhibiting carbonic anhydrase activity in the nanomolar range and is selective towards a mimic of carbonic anhydrase IX when compared to the CAII isoform. Docking studies using Autodock Vina suggest that the dehydration of the D-ring plays a role towards the selectivity of ESE-15-ol to CAIX and that the binding mode of ESE-15-ol is substantially different when compared to 2EE. ESE-15-ol is able to reduce cell growth to 50% after 48 h at 50-75 nM in MCF-7, MDA-MB-231, and MCF-12A cells. The compound is the least potent against the non-tumorigenic MCF-12A cells. In vitro mechanistic studies demonstrate that the newly synthesized compound induces mitochondrial membrane depolarization, abrogates the phosphorylation status of Bcl-2 and affects gene expression of genes associated with cell death and mitosis.	[Stander, Barend Andre; Joubert, Annie Margaretha] Univ Pretoria, Dept Physiol, ZA-0002 Pretoria, Gauteng, South Africa; [Joubert, Fourie] Univ Pretoria, Dept Biochem, Bioinformat & Computat Biol Unit, ZA-0002 Pretoria, Gauteng, South Africa; [Tu, Chingkuang] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Sippel, Katherine H.] Baylor Coll Med, Houston, TX 77030 USA; [McKenna, Robert] Univ Florida, Dept Pharmacol & Therapeut, Gainesville, FL USA	University of Pretoria; University of Pretoria; State University System of Florida; University of Florida; Baylor College of Medicine; State University System of Florida; University of Florida	Stander, BA (corresponding author), Univ Pretoria, Dept Physiol, ZA-0002 Pretoria, Gauteng, South Africa.	standerandre@gmail.com	Joubert, Annie/AAU-4562-2021	Joubert, Annie/0000-0002-6931-7554; Joubert, Fourie/0000-0003-4998-7531	Medical Research Council of South Africa [AG374, AK076]; Cancer Association of South Africa [AK246]; National Research Foundation (NRF) [AL239]; Research Committee of the Faculty of Health Sciences (RESCOM) of University of Pretoria; Struwig-Germeshuysen Cancer Research Trust of South Africa [AJ038, AN074]	Medical Research Council of South Africa(South African Medical Research Council); Cancer Association of South Africa; National Research Foundation (NRF); Research Committee of the Faculty of Health Sciences (RESCOM) of University of Pretoria; Struwig-Germeshuysen Cancer Research Trust of South Africa	This research was supported by grants from the Medical Research Council of South Africa (AG374, AK076), the Cancer Association of South Africa (AK246), National Research Foundation (NRF) (AL239), the Research Committee of the Faculty of Health Sciences (RESCOM) of University of Pretoria, and the Struwig-Germeshuysen Cancer Research Trust of South Africa (AJ038, AN074). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amendola R, 2009, CURR CANCER DRUG TAR, V9, P118, DOI 10.2174/156800909787580935; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berry JM, 1996, CYTOTECHNOLOGY, V21, P73, DOI 10.1007/BF00364838; Elger W, 1995, J STEROID BIOCHEM, V55, P395, DOI 10.1016/0960-0760(95)00214-6; Fukumura D, 2007, J CELL BIOCHEM, V101, P937, DOI 10.1002/jcb.21187; Genis C, 2009, BIOCHEMISTRY-US, V48, P1322, DOI 10.1021/bi802035f; GILLIES RJ, 1986, ANAL BIOCHEM, V159, P109, DOI 10.1016/0003-2697(86)90314-3; GREVER MR, 1992, SEMIN ONCOL, V19, P622; Guthrie H. David, 2008, V477, P89, DOI 10.1007/978-1-60327-517-0_8; Ho YT, 2003, BIOCHEM BIOPH RES CO, V305, P909, DOI 10.1016/S0006-291X(03)00865-9; Hughes RA, 2002, MOL PHARMACOL, V61, P1053, DOI 10.1124/mol.61.5.1053; Jourdan F, 2010, J MED CHEM, V53, P2942, DOI 10.1021/jm9018806; KEYSE SM, 1989, P NATL ACAD SCI USA, V86, P99, DOI 10.1073/pnas.86.1.99; KUENG W, 1989, ANAL BIOCHEM, V182, P16, DOI 10.1016/0003-2697(89)90710-0; Kutuk O, 2008, CURR MOL MED, V8, P102; Li Y, 2009, CANCER INVEST, V27, P613, DOI 10.1080/07357900802653464; Luo J, 2009, MOL CELL BIOL, V30, P537; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pW317, DOI 10.1093/nar/gkp416; Pastorekova S, 2008, BJU INT, V101, P8, DOI 10.1111/j.1464-410X.2008.07642.x; Pedretti A, 2004, J COMPUT AID MOL DES, V18, P167, DOI 10.1023/B:JCAM.0000035186.90683.f2; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pirooznia M, 2007, BIOINFORMATION, V1, P420, DOI 10.6026/97320630001420; Rao PN, 2002, STEROIDS, V67, P1079, DOI 10.1016/S0039-128X(02)00066-1; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Rofstad EK, 2006, CANCER RES, V66, P6699, DOI 10.1158/0008-5472.CAN-06-0983; Rossio V, 2010, J CELL BIOL, V191, P981, DOI 10.1083/jcb.201007025; Segel IH, 1975, ENZYME KINETICS BEHA; SILVERMAN DN, 1982, METHOD ENZYMOL, V87, P732; Sippel KH, 2011, LETT DRUG DES DISCOV, V8, P678; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stander A, 2011, CHEM BIOL DRUG DES, V77, P173, DOI 10.1111/j.1747-0285.2010.01064.x; Stander BA, 2010, J STEROID BIOCHEM, V119, P149, DOI 10.1016/j.jsbmb.2010.02.019; Stanton RA, 2011, MED RES REV, V31, P443, DOI 10.1002/med.20242; Stubbs M, 2000, MOL MED TODAY, V6, P15, DOI 10.1016/S1357-4310(99)01615-9; Supuran CT, 2007, BIOORGAN MED CHEM, V15, P4336, DOI 10.1016/j.bmc.2007.04.020; Tinley TL, 2003, CANCER RES, V63, P1538; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wang YL, 2006, J BIOCHEM, V139, P17, DOI 10.1093/jb/mvj021; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Winum JY, 2005, MED RES REV, V25, P186, DOI 10.1002/med.20021; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401; Yao YX, 2012, FRONT BIOSCI-LANDMRK, V17, P976, DOI 10.2741/3968; Yu J, 2008, ONCOGENE, V27, pS71, DOI 10.1038/onc.2009.45	44	22	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52205	10.1371/journal.pone.0052205	http://dx.doi.org/10.1371/journal.pone.0052205			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300615	gold, Green Published, Green Submitted			2022-12-27	WOS:000312829100028
J	Alkhateeb, AA; Leitzel, K; Ali, SM; Campbell-Baird, C; Evans, M; Fuchs, EM; Kostler, WJ; Lipton, A; Connor, J				Alkhateeb, Ahmed A.; Leitzel, Kim; Ali, Suhail M.; Campbell-Baird, Cynthia; Evans, Matthew; Fuchs, Eva-Maria; Koestler, Wolfgang J.; Lipton, Allan; Connor, James			Elevation in Inflammatory Serum Biomarkers Predicts Response to Trastuzumab-Containing Therapy	PLOS ONE			English	Article							C-REACTIVE PROTEIN; METASTATIC BREAST-CANCER; ANTIINFLAMMATORY DRUG-USE; FERRITIN; IRON; ASSOCIATION; MACROPHAGES; SURVIVAL; CELLS; SECRETION	Approximately half of all HER2/neu-overexpressing breast cancer patients do not respond to trastuzumab-containing therapy. Therefore, there remains an urgent and unmet clinical need for the development of predictive biomarkers for trastuzumab response. Recently, several lines of evidence have demonstrated that the inflammatory tumor microenvironment is a major contributor to therapy resistance in breast cancer. In order to explore the predictive value of inflammation in breast cancer patients, we measured the inflammatory biomarkers serum ferritin and C-reactive protein (CRP) in 66 patients immediately before undergoing trastuzumab-containing therapy and evaluated their progression-free and overall survival. The elevation in pre-treatment serum ferritin (> 250 ng/ml) or CRP (> 7.25 mg/l) was a significant predictor of reduced progression-free survival and shorter overall survival. When patients were stratified based on their serum ferritin and CRP levels, patients with elevation in both inflammatory biomarkers had a markedly poorer response to trastuzumab-containing therapy. Therefore, the elevation in inflammatory serum biomarkers may reflect a pathological state that decreases the clinical efficacy of this therapy. Anti-inflammatory drugs and life-style changes to decrease inflammation in cancer patients should be explored as possible strategies to sensitize patients to anti-cancer therapeutics.	[Alkhateeb, Ahmed A.; Connor, James] Penn State Univ, Milton S Hershey Med Ctr, Dept Neurosurg, Hershey, PA 17033 USA; [Leitzel, Kim; Ali, Suhail M.; Campbell-Baird, Cynthia; Evans, Matthew; Lipton, Allan] Penn State Univ, Milton S Hershey Med Ctr, Div Hematol Med Oncol, Hershey, PA 17033 USA; [Ali, Suhail M.] Lebanon VA Med Ctr, Dept Med, Lebanon, PA USA; [Fuchs, Eva-Maria; Koestler, Wolfgang J.] Med Univ Vienna, Dept Med, Vienna, Austria	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Medical University of Vienna	Connor, J (corresponding author), Penn State Univ, Milton S Hershey Med Ctr, Dept Neurosurg, Hershey, PA 17033 USA.	jconnor@hmc.psu.edu						Allen KJ, 2008, NEW ENGL J MED, V358, P221, DOI 10.1056/NEJMoa073286; Allin KH, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2891; BROXMEYER HE, 1989, BLOOD, V73, P74; Coffman LG, 2009, P NATL ACAD SCI USA, V106, P570, DOI 10.1073/pnas.0812010106; Cohen LA, 2010, BLOOD, V116, P1574, DOI 10.1182/blood-2009-11-253815; Cotterchio M, 2001, CANCER EPIDEM BIOMAR, V10, P1213; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Crawford DC, 2006, CIRCULATION, V114, P2458, DOI 10.1161/CIRCULATIONAHA.106.615740; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; Ferring-Appel D, 2009, BLOOD, V113, P679, DOI 10.1182/blood-2008-05-155093; Ghosh S, 2004, BLOOD, V103, P2369, DOI 10.1182/blood-2003-09-3050; Heikkila K, 2007, J EPIDEMIOL COMMUN H, V61, P824, DOI 10.1136/jech.2006.051292; Holmes MD, 2010, J CLIN ONCOL, V28, P1467, DOI 10.1200/JCO.2009.22.7918; JACOBS A, 1976, BRIT J CANCER, V34, P286, DOI 10.1038/bjc.1976.164; Jehn M, 2004, DIABETES CARE, V27, P2422, DOI 10.2337/diacare.27.10.2422; Johnson TW, 2002, CANCER EPIDEM BIOMAR, V11, P1586; JONES BM, 1980, CLIN CHIM ACTA, V106, P203, DOI 10.1016/0009-8981(80)90173-4; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kostler WJ, 2004, CLIN CANCER RES, V10, P1618, DOI 10.1158/1078-0432.CCR-0385-3; Liu JM, 2003, AM J CLIN NUTR, V78, P1160, DOI 10.1093/ajcn/78.6.1160; Ma YS, 2006, AM J CLIN NUTR, V83, P760, DOI 10.1093/ajcn/83.4.760; Miller LD, 2011, CANCER RES, V71, P6728, DOI 10.1158/0008-5472.CAN-11-1870; Nakasone ES, 2012, CANCER CELL, V21, P488, DOI 10.1016/j.ccr.2012.02.017; O'Meara A, 2011, TRANSFUSION, V51, P2183, DOI 10.1111/j.1537-2995.2011.03148.x; Pierce BL, 2009, J CLIN ONCOL, V27, P3437, DOI 10.1200/JCO.2008.18.9068; Priceman SJ, 2010, BLOOD, V115, P1461, DOI 10.1182/blood-2009-08-237412; ROBERTSON JFR, 1991, CANCER IMMUNOL IMMUN, V33, P403, DOI 10.1007/BF01741602; Rolny C, 2011, CANCER CELL, V19, P31, DOI 10.1016/j.ccr.2010.11.009; Shree T, 2011, GENE DEV, V25, P2465, DOI 10.1101/gad.180331.111; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Streetz KL, 2001, CELL MOL BIOL, V47, P661; Tchernof A, 2002, CIRCULATION, V105, P564, DOI 10.1161/hc0502.103331; Todorich B, 2011, GLIA, V59, P927, DOI 10.1002/glia.21164; Tran TN, 1997, BLOOD, V90, P4979, DOI 10.1182/blood.V90.12.4979.4979_4979_4986; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.20.3.719; ZHANG DX, 1995, BIOCHEM J, V310, P143, DOI 10.1042/bj3100143; Zhang ZZ, 2011, BLOOD, V118, P1912, DOI 10.1182/blood-2011-01-330324	37	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e51379	10.1371/journal.pone.0051379	http://dx.doi.org/10.1371/journal.pone.0051379			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300545	Green Published, gold, Green Submitted			2022-12-27	WOS:000313618800017
J	Chotibut, T; Apple, DM; Jefferis, R; Salvatore, MF				Chotibut, Tanya; Apple, Deana M.; Jefferis, Rebecca; Salvatore, Michael F.			Dopamine Transporter Loss in 6-OHDA Parkinson's Model Is Unmet by Parallel Reduction in Dopamine Uptake	PLOS ONE			English	Article							ORGANIC CATION TRANSPORTER-3; MEDIAL PREFRONTAL CORTEX; EXTRACELLULAR DOPAMINE; IN-VIVO; SUBSTANTIA-NIGRA; NOREPINEPHRINE TRANSPORTER; MONOAMINE TRANSPORTER; NORADRENALINE CARRIER; CULTURED RAT; STRIATUM	The dopamine transporter (DAT) regulates synaptic dopamine (DA) in striatum and modulation of DAT can affect locomotor activity. Thus, in Parkinson's disease (PD), DAT loss could affect DA clearance and locomotor activity. The locomotor benefits of L-DOPA may be mediated by transport through monoamine transporters and conversion to DA. However, its impact upon DA reuptake is unknown and may modulate synaptic DA. Using the unilateral 6-OHDA rat PD model, we examined [H-3] DA uptake dynamics in relation to striatal DAT and tyrosine hydroxylase (TH) protein loss compared with contralateral intact striatum. Despite > 70% striatal DAT loss, DA uptake decreased only similar to 25% and increased as DAT loss approached 99%. As other monoamine transporters can transport DA, we determined if norepinephrine (NE) and serotonin (5-HT) differentially modulated DA uptake in lesioned striatum. Unlabeled DA, NE, and 5-HT were used, at a concentration that differentially inhibited DA uptake in intact striatum, to compete against [H-3]DA uptake. In 6-OHDA lesioned striatum, DA was less effective, whereas NE was more effective, at inhibiting [H-3]DA uptake. Furthermore, norepinephrine transporter (NET) protein levels increased and desipramine was, two-fold more effective at inhibiting NE uptake. Serotonin inhibited [H-3]DA uptake, but without significant difference between lesioned and contralateral striatum. L-DOPA inhibited [H-3]DA uptake two-fold more in lesioned striatum and inhibited NE uptake similar to five-fold more than DA uptake in naive striatum. Consequently, DA uptake may be mediated by NET when DAT loss is at PD levels. Increased inhibition of DA uptake by L-DOPA and its preferential inhibition of NE over DA uptake, indicates that NET-mediated DA uptake may be modulated by L-DOPA when DAT loss exceeds 70%. These results indicate a novel mechanism for DA uptake during PD progression and provide new insight into how L-DOPA affects DA uptake, revealing possible mechanisms of its therapeutic and side effect potential.	[Chotibut, Tanya; Apple, Deana M.; Jefferis, Rebecca; Salvatore, Michael F.] Louisiana State Univ, Dept Pharmacol Toxicol & Neurosci, Hlth Sci Ctr, Shreveport, LA 71105 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Salvatore, MF (corresponding author), Louisiana State Univ, Dept Pharmacol Toxicol & Neurosci, Hlth Sci Ctr, Shreveport, LA 71105 USA.	msalva@lsuhsc.edu	Salvatore, Michael/ABC-8926-2021		Edward P. Stiles Trust Fund-LSU Health Sciences Center-Shreveport; Biomedical Research Foundation of Northwest Louisiana; Parkinson's Disease Resource of NW Louisiana	Edward P. Stiles Trust Fund-LSU Health Sciences Center-Shreveport; Biomedical Research Foundation of Northwest Louisiana; Parkinson's Disease Resource of NW Louisiana	This work was funded in part by intramural grant awards to MFS from the Edward P. Stiles Trust Fund-LSU Health Sciences Center-Shreveport, The Biomedical Research Foundation of Northwest Louisiana, and the Parkinson's Disease Resource of NW Louisiana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams Jr, 2005, BRAIN, V128, P2777, DOI 10.1093/brain/awh607; Albin RL, 2008, J CEREBR BLOOD F MET, V28, P441, DOI 10.1038/sj.jcbfm.9600599; Arai A, 2008, SYNAPSE, V62, P632, DOI 10.1002/syn.20535; Bergstrom BP, 2011, NEUROSCIENCE, V193, P310, DOI 10.1016/j.neuroscience.2011.07.029; Bergstrom BP, 2003, J NEUROCHEM, V87, P1224, DOI 10.1046/j.1471-4159.2003.02104.x; BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5; Bezard E, 2001, J NEUROSCI, V21, P6853, DOI 10.1523/JNEUROSCI.21-17-06853.2001; Borgkvist A, 2012, INT J NEUROPSYCHOPH, V15, P531, DOI 10.1017/S1461145711000812; Buck K, 2009, NEUROSCIENCE, V159, P16, DOI 10.1016/j.neuroscience.2008.12.026; Carboni E, 2006, J NEUROCHEM, V96, P473, DOI 10.1111/j.1471-4159.2005.03556.x; CARBONI E, 1990, J NEUROCHEM, V55, P1067, DOI 10.1111/j.1471-4159.1990.tb04599.x; Carta M, 2006, J NEUROCHEM, V96, P1718, DOI 10.1111/j.1471-4159.2006.03696.x; CASS WA, 1995, J NEUROCHEM, V65, P201; Cenci MA, 2007, TRENDS NEUROSCI, V30, P236, DOI 10.1016/j.tins.2007.03.005; Chen BT, 2001, J NEUROSCI, V21, P7841, DOI 10.1523/JNEUROSCI.21-19-07841.2001; Cragg SJ, 2000, J NEUROSCI, V20, P8209; Cragg SJ, 1997, J NEUROPHYSIOL, V77, P863, DOI 10.1152/jn.1997.77.2.863; Cui M, 2009, P NATL ACAD SCI USA, V106, P8043, DOI 10.1073/pnas.0900358106; DICHIARA G, 1992, NEUROCHEM INT, V20, pS231; Engel K, 2005, MOL PHARMACOL, V68, P1397, DOI 10.1124/mol.105.016832; Engel K, 2004, J BIOL CHEM, V279, P50042, DOI 10.1074/jbc.M407913200; Eshleman AJ, 1999, J PHARMACOL EXP THER, V289, P877; Fisone G, 2011, INT REV NEUROBIOL, V98, P95, DOI 10.1016/B978-0-12-381328-2.00004-3; Garris PA, 1997, BRAIN RES, V753, P225, DOI 10.1016/S0006-8993(97)00003-6; Gasser PJ, 2006, J NEUROSCI, V26, P8758, DOI 10.1523/JNEUROSCI.0570-06.2006; GIROS B, 1994, J BIOL CHEM, V269, P15985; Goldberg NRS, 2012, NEUROBIOL DIS, V45, P1051, DOI 10.1016/j.nbd.2011.12.024; GRESCH PJ, 1995, J NEUROCHEM, V65, P111; Grundemann D, 1998, J BIOL CHEM, V273, P30915, DOI 10.1074/jbc.273.47.30915; GU H, 1994, J BIOL CHEM, V269, P7124; Hashimoto W, 2005, LIFE SCI, V76, P1603, DOI 10.1016/j.lfs.2004.08.029; Hebert MA, 1998, BRAIN RES, V797, P42, DOI 10.1016/S0006-8993(98)00370-9; Hoffman AF, 1998, J PHARMACOL EXP THER, V287, P487; Hornykiewicz O, 1986, ADV NEUROL, V45, P19; HUDSON JL, 1993, BRAIN RES, V626, P167, DOI 10.1016/0006-8993(93)90576-9; Inazu M, 2003, J NEUROCHEM, V84, P136, DOI 10.1046/j.1471-4159.2003.01514.x; Iravani MM, 2005, EUR J NEUROSCI, V21, P841, DOI 10.1111/j.1460-9568.2005.03915.x; Jaber M, 1999, EUR J NEUROSCI, V11, P3499, DOI 10.1046/j.1460-9568.1999.00764.x; Jones SR, 1998, P NATL ACAD SCI USA, V95, P4029, DOI 10.1073/pnas.95.7.4029; JUORIO AV, 1993, BRAIN RES, V626, P306, DOI 10.1016/0006-8993(93)90592-B; Kannari K, 2006, NEUROSCI LETT, V402, P62, DOI 10.1016/j.neulet.2006.03.059; Keller CM, 2011, PSYCHOPHARMACOLOGY, V215, P513, DOI 10.1007/s00213-011-2301-9; Kerenyi L, 2003, ARCH NEUROL-CHICAGO, V60, P1223, DOI 10.1001/archneur.60.9.1223; Khakimova G. R., 2010, Doklady Akademii Nauk, V435, P272; Koepsell H, 2007, PHARM RES-DORDR, V24, P1227, DOI 10.1007/s11095-007-9254-z; Larsen MB, 2011, J NEUROSCI, V31, P6605, DOI 10.1523/JNEUROSCI.0576-11.2011; Lee CS, 2000, ANN NEUROL, V47, P493, DOI 10.1002/1531-8249(200004)47:4<493::AID-ANA13>3.0.CO;2-4; Leng A, 2004, BEHAV BRAIN RES, V154, P375, DOI 10.1016/j.bbr.2004.03.004; LLOYD KG, 1975, J PHARMACOL EXP THER, V195, P453; Madras BK, 2006, J PHARMACOL EXP THER, V319, P570, DOI 10.1124/jpet.106.105312; Miller DW, 1999, J NEUROCHEM, V72, P1516, DOI 10.1046/j.1471-4159.1999.721516.x; Moron JA, 2002, J NEUROSCI, V22, P389, DOI 10.1523/JNEUROSCI.22-02-00389.2002; Mura A, 1995, BRAIN RES, V704, P51, DOI 10.1016/0006-8993(95)01104-8; Navailles S, 2010, NEUROBIOL DIS, V38, P136, DOI 10.1016/j.nbd.2010.01.012; Nutt JG, 2004, ANN NEUROL, V55, P766, DOI 10.1002/ana.20089; PACHOLCZYK T, 1991, NATURE, V350, P350, DOI 10.1038/350350a0; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Perez XA, 2008, J NEUROCHEM, V105, P1861, DOI 10.1111/j.1471-4159.2008.05268.x; Pirker W, 2003, MOVEMENT DISORD, V18, pS43, DOI 10.1002/mds.10579; Sabeti J, 2002, J PHARMACOL EXP THER, V302, P1201, DOI 10.1124/jpet.102.035816; Salvatore MF, 2005, MOL BRAIN RES, V139, P341, DOI 10.1016/j.molbrainres.2005.06.002; Salvatore MF, 2003, NEUROBIOL AGING, V24, P1147, DOI 10.1016/S0197-4580(03)00129-5; Salvatore MF, 2012, JOVE-J VIS EXP, DOI 10.3791/4171; SANDLER M, 1971, LANCET, V1, P784; Sarre S, 2004, J NEUROCHEM, V90, P29, DOI 10.1111/j.1471-4159.2004.02471.x; SNYDER GL, 1990, J PHARMACOL EXP THER, V253, P867; SNYDER SH, 1969, J PHARMACOL EXP THER, V165, P78; Sossi V, 2007, ANN NEUROL, V62, P468, DOI 10.1002/ana.21204; Sossi V, 2009, J NEUROCHEM, V109, P85, DOI 10.1111/j.1471-4159.2009.05904.x; Spielewoy C, 2000, BEHAV PHARMACOL, V11, P279, DOI 10.1097/00008877-200006000-00011; Swant J, 2011, J BIOL CHEM, V286, P43933, DOI 10.1074/jbc.M111.241232; Takeda H, 2002, N-S ARCH PHARMACOL, V366, P620, DOI 10.1007/s00210-002-0640-0; Tanaka H, 1999, NEUROREPORT, V10, P631, DOI 10.1097/00001756-199902250-00034; Tanda G, 1997, EUR J NEUROSCI, V9, P2077, DOI 10.1111/j.1460-9568.1997.tb01375.x; Teismann P, 2004, CELL TISSUE RES, V318, P149, DOI 10.1007/s00441-004-0944-0; Tsai MJ, 1996, J NEUROSCI RES, V43, P490, DOI 10.1002/(SICI)1097-4547(19960215)43:4<490::AID-JNR10>3.3.CO;2-K; Vizi ES, 2004, J NEUROSCI, V24, P7888, DOI 10.1523/JNEUROSCI.1506-04.2004; Wayment HK, 2001, J NEUROSCI, V21, P35, DOI 10.1523/JNEUROSCI.21-01-00035.2001; Yamamoto BK, 1998, J NEUROCHEM, V71, P274; Zhou MY, 2007, BIOCHEM PHARMACOL, V73, P147, DOI 10.1016/j.bcp.2006.09.008	80	45	47	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52322	10.1371/journal.pone.0052322	http://dx.doi.org/10.1371/journal.pone.0052322			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300642	Green Published, Green Submitted, gold			2022-12-27	WOS:000313618800069
J	Pante, E; Rohfritsch, A; Becquet, V; Belkhir, K; Bierne, N; Garcia, P				Pante, Eric; Rohfritsch, Audrey; Becquet, Vanessa; Belkhir, Khalid; Bierne, Nicolas; Garcia, Pascale			SNP Detection from De Novo Transcriptome Sequencing in the Bivalve Macoma balthica: Marker Development for Evolutionary Studies	PLOS ONE			English	Article							OYSTER CRASSOSTREA-GIGAS; MITOCHONDRIAL GENOME; NEXT-GENERATION; NUCLEOTIDE POLYMORPHISM; INTERTIDAL ECOSYSTEMS; NATURAL-POPULATION; SUMMER MORTALITY; LOCAL ADAPTATION; CLIMATE-CHANGE; HYBRID ZONES	Hybrid zones are noteworthy systems for the study of environmental adaptation to fast-changing environments, as they constitute reservoirs of polymorphism and are key to the maintenance of biodiversity. They can move in relation to climate fluctuations, as temperature can affect both selection and migration, or remain trapped by environmental and physical barriers. There is therefore a very strong incentive to study the dynamics of hybrid zones subjected to climate variations. The infaunal bivalve Macoma balthica emerges as a noteworthy model species, as divergent lineages hybridize, and its native NE Atlantic range is currently contracting to the North. To investigate the dynamics and functioning of hybrid zones in M. balthica, we developed new molecular markers by sequencing the collective transcriptome of 30 individuals. Ten individuals were pooled for each of the three populations sampled at the margins of two hybrid zones. A single 454 run generated 277 Mb from which 17K SNPs were detected. SNP density averaged 1 polymorphic site every 14 to 19 bases, for mitochondrial and nuclear loci, respectively. An FST scan detected high genetic divergence among several hundred SNPs, some of them involved in energetic metabolism, cellular respiration and physiological stress. The high population differentiation, recorded for nuclear-encoded ATP synthase and NADH dehydrogenase as well as most mitochondrial loci, suggests cytonuclear genetic incompatibilities. Results from this study will help pave the way to a high-resolution study of hybrid zone dynamics in M. balthica, and the relative importance of endogenous and exogenous barriers to gene flow in this system.	[Pante, Eric; Rohfritsch, Audrey; Becquet, Vanessa; Garcia, Pascale] Univ La Rochelle, Littoral Environm & Soc Joint Res Unit 7266, Ctr Natl Rech Sci, La Rochelle, France; [Belkhir, Khalid] Univ Montpellier 2, Joint Res Unit 5554, Inst Sci Entreprise & Management, Montpellier, France; [Bierne, Nicolas] Univ Montpellier 2, Joint Res Unit 5554A, Inst Sci Entreprise & Management, Stn Mediterraneenne Environm Littoral, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); La Rochelle Universite; Universite de Montpellier; Universite de Montpellier	Pante, E (corresponding author), Univ La Rochelle, Littoral Environm & Soc Joint Res Unit 7266, Ctr Natl Rech Sci, La Rochelle, France.	pante.eric@gmail.com	Pante, Eric/C-4230-2011	Pante, Eric/0000-0001-7680-2112; Garcia, Pascale/0000-0001-8488-6061; Bierne, Nicolas/0000-0003-1856-3197	European Union [31031-2008]; Agence Nationale de la Recherche (Hi-Flo project) [ANR-08-BLAN-0334-01]	European Union(European Commission); Agence Nationale de la Recherche (Hi-Flo project)(French National Research Agency (ANR))	The University of La Rochelle computing infrastructure \YMIR'' was partly funded by the European Union (contract 31031-2008, European Regional Development Fund). This work was funded by the Agence Nationale de la Recherche (Hi-Flo project ANR-08-BLAN-0334-01); salaries for AR and EP were covered by a grant to the Poitou-Charente region (Contrat de Projet Etat-Region 2007-2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOLD J, 1993, ANNU REV ECOL SYST, V24, P521, DOI 10.1146/annurev.es.24.110193.002513; ASMUSSEN MA, 1987, GENETICS, V115, P755; Barbazuk WB, 2007, PLANT J, V51, P910, DOI 10.1111/j.1365-313X.2007.03193.x; BARTON NH, 1979, HEREDITY, V43, P341, DOI 10.1038/hdy.1979.87; Bazin E, 2006, SCIENCE, V312, P570, DOI 10.1126/science.1122033; Beaumont MA, 2005, TRENDS ECOL EVOL, V20, P435, DOI 10.1016/j.tree.2005.05.017; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Becquet V, 2012, J EXP MAR BIOL ECOL, V432, P73, DOI 10.1016/j.jembe.2012.07.008; Becquet V, 2009, CONSERV GENET RESOUR, V1, P265, DOI 10.1007/s12686-009-9065-0; Bell G, 2008, EVOL APPL, V1, P3, DOI 10.1111/j.1752-4571.2007.00011.x; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Bierne N, 2011, MOL ECOL, V20, P2044, DOI 10.1111/j.1365-294X.2011.05080.x; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Blankenberg D, 2010, BIOINFORMATICS, V26, P1783, DOI 10.1093/bioinformatics/btq281; Boore JL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-182; Boutet I, 2004, GENE, V329, P147, DOI 10.1016/j.gene.2003.12.027; BREEUWER JAJ, 1995, EVOLUTION, V49, P705, DOI 10.1111/j.1558-5646.1995.tb02307.x; Bultelle F, 2002, MAR ENVIRON RES, V54, P385, DOI 10.1016/S0141-1136(02)00159-9; Burton RS, 2006, AM NAT, V168, pS14, DOI 10.1086/509046; Burton RS, 2012, MOL ECOL, V21, P4942, DOI 10.1111/mec.12006; BUTOW RA, 1989, GENOME, V31, P757, DOI 10.1139/g89-134; Cahais V, 2012, MOL ECOL RESOUR, V12, P834, DOI 10.1111/j.1755-0998.2012.03148.x; Charif D., 2007, SEQINR 10 2 CONTRIBU, P207, DOI [10.1007/978-3-540-35306-5_10, DOI 10.1007/978-3-540-35306-5_10]; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Cutter AD, 2006, GENETICS, V174, P901, DOI 10.1534/genetics.106.061879; Degremont L, 2007, AQUACULTURE, V262, P41, DOI 10.1016/j.aquaculture.2006.10.025; DeJong RJ, 2004, J PARASITOL, V90, P991, DOI 10.1645/GE-284R; EJDUNG G, 1992, MAR ECOL PROG SER, V88, P207, DOI 10.3354/meps088207; Ekblom R, 2011, HEREDITY, V107, P1, DOI 10.1038/hdy.2010.152; Ellison CK, 2006, EVOLUTION, V60, P1382, DOI 10.1111/j.0014-3820.2006.tb01217.x; Excoffier L, 2009, HEREDITY, V103, P285, DOI 10.1038/hdy.2009.74; Faure E, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-56; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Freamo H, 2011, MOL ECOL RESOUR, V11, P254, DOI 10.1111/j.1755-0998.2010.02952.x; Gagliardi D, 2004, TRENDS GENET, V20, P260, DOI 10.1016/j.tig.2004.04.006; Gagliardi D, 1999, EMBO J, V18, P3757, DOI 10.1093/emboj/18.13.3757; Gagnaire PA, 2012, MOL BIOL EVOL, V29, P2909, DOI 10.1093/molbev/mss076; Galindo, 2010, J EVOLUTION BIOL, V23, P2768, DOI 10.1111/j.1420-9101.2010.02173.x; Galindo J, 2010, J EVOLUTION BIOL, V23, P2004, DOI 10.1111/j.1420-9101.2010.02071.x; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Gilad Y, 2009, TRENDS GENET, V25, P463, DOI 10.1016/j.tig.2009.09.003; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gotz S, 2011, BIOINFORMATICS, V27, P919, DOI 10.1093/bioinformatics/btr059; Goikoetxea N, 2009, CONT SHELF RES, V29, P1060, DOI 10.1016/j.csr.2008.11.014; Gompert Z, 2009, MOL ECOL, V18, P1207, DOI 10.1111/j.1365-294X.2009.04098.x; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Harr B, 2006, GENOME RES, V16, P730, DOI 10.1101/gr.5045006; Helmuth B, 2006, ANNU REV ECOL EVOL S, V37, P373, DOI 10.1146/annurev.ecolsys.37.091305.110149; Hilbish TJ, 2012, J BIOGEOGR, V39, P676, DOI 10.1111/j.1365-2699.2011.02633.x; Hilbish TJ, 2010, J BIOGEOGR, V37, P423, DOI 10.1111/j.1365-2699.2009.02218.x; Hummel H, 2000, J EXP MAR BIOL ECOL, V251, P85, DOI 10.1016/S0022-0981(00)00208-2; Huvet A, 2004, GENE, V343, P211, DOI 10.1016/j.gene.2004.09.008; Jansen JM, 2007, J EXP MAR BIOL ECOL, V344, P161, DOI 10.1016/j.jembe.2006.12.014; Jeffreys H., 1948, INT SERIES MONOGRAPH, V2a; Jolly MT, 2006, MOL ECOL, V15, P1841, DOI 10.1111/j.1365-294X.2006.02910.x; Jolly MT, 2005, HEREDITY, V94, P23, DOI 10.1038/sj.hdy.6800543; Khachane AN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-435; Kofler R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015925; Kolaczkowski B, 2011, GENETICS, V187, P245, DOI 10.1534/genetics.110.123059; Latta RG, 2001, GENETICS, V158, P843; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Luttikhuizen PC, 2003, J EVOLUTION BIOL, V16, P260, DOI 10.1046/j.1420-9101.2003.00510.x; Luttikhuizen PC, 2003, MOL ECOL, V12, P2215, DOI 10.1046/j.1365-294X.2003.01872.x; Luttikhuizen PC, 2012, MOL ECOL, V21, P30; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mattila J, 1998, J EXP MAR BIOL ECOL, V227, P221, DOI 10.1016/S0022-0981(97)00272-4; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Mohanty BK, 2011, WIRES RNA, V2, P256, DOI 10.1002/wrna.51; Narum SR, 2011, MOL ECOL RESOUR, V11, P184, DOI 10.1111/j.1755-0998.2011.02987.x; NCBI, 2012, SEQ READ ARCH SRA; Nikula R, 2008, MOL ECOL, V17, P1505, DOI 10.1111/j.1365-294X.2007.03688.x; Nikula R, 2007, EVOLUTION, V61, P928, DOI 10.1111/j.1558-5646.2007.00066.x; Nosil P, 2009, MOL ECOL, V18, P375, DOI 10.1111/j.1365-294X.2008.03946.x; Oliveira DCSG, 2008, MOL BIOL EVOL, V25, P2167, DOI 10.1093/molbev/msn159; Orsini L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-309; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2004, TECHNICAL REPORT; Perez-Enciso M, 2010, ANIM GENET, V41, P561, DOI 10.1111/j.1365-2052.2010.02057.x; Philippart CJM, 2003, LIMNOL OCEANOGR, V48, P2171, DOI 10.4319/lo.2003.48.6.2171; PIERSMA T, 1993, NETH J SEA RES, V31, P299, DOI 10.1016/0077-7579(93)90047-V; Ponstingl H, 2012, SMALT; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; R Development Core Team, 2012, R LANG ENV STAT COMP; Riginos C, 2007, MOL ECOL, V16, P3971, DOI 10.1111/j.1365-294X.2007.03505.x; Sauvage C, 2007, GENE, V406, P13, DOI 10.1016/j.gene.2007.05.011; SeqClean, 2012, DFCI GEN IND SOFTW T; Shapiro JA, 2007, P NATL ACAD SCI USA, V104, P2271, DOI 10.1073/pnas.0610385104; Small KS, 2007, P NATL ACAD SCI USA, V104, P5698, DOI 10.1073/pnas.0700890104; Stapley J, 2010, TRENDS ECOL EVOL, V25, P705, DOI 10.1016/j.tree.2010.09.002; Strelkov P, 2007, MOL ECOL, V16, P4110, DOI 10.1111/j.1365-294X.2007.03463.x; Tatusov T, 2012, ORF FINDER OPEN READ; Turner TL, 2010, NAT GENET, V42, P260, DOI 10.1038/ng.515; VAINOLA R, 1989, OLSEN INT S, P309; Vainola R, 2003, MAR BIOL, V143, P935, DOI 10.1007/s00227-003-1137-1; Van Tassell CP, 2008, NAT METHODS, V5, P247, DOI 10.1038/NMETH.1185; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wolf JBW, 2010, PHILOS T R SOC B, V365, P1717, DOI 10.1098/rstb.2010.0023	102	16	17	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52302	10.1371/journal.pone.0052302	http://dx.doi.org/10.1371/journal.pone.0052302			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300636	Green Published, gold			2022-12-27	WOS:000313618800067
J	Corella, D; Ortega-Azorin, C; Sorli, JV; Covas, MI; Carrasco, P; Salas-Salvado, J; Martinez-Gonzalez, MA; Aros, F; Lapetra, J; Serra-Majem, L; Lamuela-Raventos, R; Gomez-Gracia, E; Fiol, M; Pinto, X; Ros, E; Marti, A; Coltell, O; Ordovas, JM; Estruch, R				Corella, Dolores; Ortega-Azorin, Carolina; Sorli, Jose V.; Isabel Covas, M.; Carrasco, Paula; Salas-Salvado, Jordi; Angel Martinez-Gonzalez, Miguel; Aros, Fernando; Lapetra, Jose; Serra-Majem, Lluis; Lamuela-Raventos, Rosa; Gomez-Gracia, Enrique; Fiol, Miquel; Pinto, Xavier; Ros, Emilio; Marti, Amelia; Coltell, Oscar; Ordovas, Jose M.; Estruch, Ramon			Statistical and Biological Gene-Lifestyle Interactions of MC4R and FTO with Diet and Physical Activity on Obesity: New Effects on Alcohol Consumption	PLOS ONE			English	Article							BODY-MASS INDEX; COMMON VARIANTS; FAT MASS; ETHANOL INTAKE; ENERGY-INTAKE; FOOD-INTAKE; RS9939609 POLYMORPHISM; ACTIVITY QUESTIONNAIRE; MELANOCORTIN RECEPTOR; ASSOCIATION	Background: Fat mass and obesity (FTO) and melanocortin-4 receptor (MC4R) and are relevant genes associated with obesity. This could be through food intake, but results are contradictory. Modulation by diet or other lifestyle factors is also not well understood. Objective: To investigate whether MC4R and FTO associations with body-weight are modulated by diet and physical activity (PA), and to study their association with alcohol and food intake. Methods: Adherence to Mediterranean diet (AdMedDiet) and physical activity (PA) were assessed by validated questionnaires in 7,052 high cardiovascular risk subjects. MC4R rs17782313 and FTO rs9939609 were determined. Independent and joint associations (aggregate genetic score) as well as statistical and biological gene-lifestyle interactions were analyzed. Results: FTO rs9939609 was associated with higher bodymass index (BMI), waist circumference (WC) and obesity (P < 0.05 for all). A similar, but not significant trend was found for MC4R rs17782313. Their additive effects (aggregate score) were significant and we observed a 7% per-allele increase of being obese (OR = 1.07; 95% CI 1.01-1.13). We found relevant statistical interactions (P, 0.05) with PA. So, in active individuals, the associations with higher BMI, WC or obesity were not detected. A biological (non-statistical) interaction between AdMedDiet and rs9939609 and the aggregate score was found. Greater AdMedDiet in individuals carrying 4 or 3-risk alleles counterbalanced their genetic predisposition, exhibiting similar BMI (P = 0.502) than individuals with no risk alleles and lower AdMedDiet. They also had lower BMI (P = 0.021) than their counterparts with low AdMedDiet. We did not find any consistent association with energy or macronutrients, but found a novel association between these polymorphisms and lower alcohol consumption in variant-allele carriers (B+/-SE: -0.57+/-0.16 g/d per-score-allele; P = 0.001). Conclusion: Statistical and biological interactions with PA and diet modulate the effects of FTO and MC4R polymorphisms on obesity. The novel association with alcohol consumption seems independent of their effects on BMI.	[Corella, Dolores; Ortega-Azorin, Carolina; Sorli, Jose V.; Carrasco, Paula; Estruch, Ramon] Univ Valencia, Sch Med, Dept Prevent Med & Publ Hlth, Valencia, Spain; [Corella, Dolores; Ortega-Azorin, Carolina; Sorli, Jose V.; Isabel Covas, M.; Carrasco, Paula; Salas-Salvado, Jordi; Lapetra, Jose; Fiol, Miquel; Ros, Emilio; Coltell, Oscar] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr, Madrid, Spain; [Isabel Covas, M.] Municipal Inst Med Res IMIM, Cardiovasc Epidemiol Unit, Barcelona, Spain; [Salas-Salvado, Jordi] Univ Rovira & Virgili, IISPV, Fac Med, Human Nutr Unit, E-43201 Reus, Spain; [Angel Martinez-Gonzalez, Miguel] Univ Navarra, Sch Clin Med, Dept Prevent Med & Publ Hlth, E-31080 Pamplona, Spain; [Aros, Fernando] Hosp Txagorritxu, Dept Cardiol, Vitoria, Spain; [Lapetra, Jose] San Pablo Hlth Ctr, Primary Care Div Sevilla, Dept Family Med, Seville, Spain; [Serra-Majem, Lluis] Univ Las Palmas Gran Canaria, Dept Clin Sci, Las Palmas Gran Canaria, Spain; [Lamuela-Raventos, Rosa] Univ Barcelona, Sch Pharm, Dept Nutr & Food Sci, Barcelona, Spain; [Gomez-Gracia, Enrique] Univ Malaga, Sch Med, Dept Epidemiol, Malaga, Spain; [Fiol, Miquel] Hosp Son Dureta, Univ Inst Hlth Sci Invest, Palma De Mallorca, Spain; [Pinto, Xavier] Hosp Llobregat, Hosp Univ Bellvitge, Lipids & Vasc Risk Unit, Barcelona, Spain; [Ros, Emilio] Hosp Clin Barcelona, Inst Invest Biomed August Pi Sunyer IDIBAPS, Endocrinol & Nutr Serv, Lipid Clin, Barcelona, Spain; [Marti, Amelia] Univ Navarra, Dept Nutr Food Sci Physiol & Toxicol, E-31080 Pamplona, Spain; [Coltell, Oscar] Univ Jaume 1, Dept Comp Languages & Syst, Castellon de La Plana, Spain; [Ordovas, Jose M.] Tufts Univ, JM USDA Human Nutr Res Ctr Aging, Nutr & Genom Lab, Boston, MA 02111 USA; [Ordovas, Jose M.] CNIC, Dept Cardiovasc Epidemiol & Populat Genet, Madrid, Spain; [Ordovas, Jose M.] IMDEA Alimentac, Madrid, Spain; [Estruch, Ramon] IDIBAPS, Hosp Clin, Dept Internal Med, Barcelona, Spain	University of Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); University of Navarra; University Hospital of Araba; Universidad de Las Palmas de Gran Canaria; University of Barcelona; Universidad de Malaga; Hospital Universitari Son Espases; Hospital Universitari Son Dureta; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Navarra; Universitat Jaume I; Tufts University; United States Department of Agriculture (USDA); Centro Nacional de Investigaciones Cardiovasculares (CNIC); University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Corella, D (corresponding author), Univ Valencia, Sch Med, Dept Prevent Med & Publ Hlth, Valencia, Spain.	dolores.corella@uv.es	Pintó, Xavier/AGI-4297-2022; IBIS, ATENCION PRIMARIA/I-3524-2016; Estruch, Ramon/AAZ-3723-2020; Serra-Majem, Lluis/I-6708-2019; Fiol, Miguel/F-6793-2016; Salas-Salvado, Jordi/C-7229-2017; Martinez-Gonzalez, Miguel A./AAE-7669-2019; Lapetra, Jose/F-2552-2015; Carrasco, Paula/D-7864-2019; Sorlí, José V/L-8758-2014; Marti, Amelia/M-2709-2019; Coltell, Oscar/AAA-9936-2019; Martí, Amelia/H-1192-2017; Lamuela-Raventos, Rosa M/F-3986-2016; Ordovas, Jose/B-8727-2013	Pintó, Xavier/0000-0002-2216-2444; Serra-Majem, Lluis/0000-0002-9658-9061; Fiol, Miguel/0000-0002-5370-1391; Salas-Salvado, Jordi/0000-0003-2700-7459; Carrasco, Paula/0000-0002-7170-4318; Sorlí, José V/0000-0002-0130-2006; Marti, Amelia/0000-0001-9832-7981; Coltell, Oscar/0000-0002-4518-8495; Martí, Amelia/0000-0001-9832-7981; Lamuela-Raventos, Rosa M/0000-0002-1287-4560; Ordovas, Jose/0000-0002-7581-5680; Ros, Emilio/0000-0002-2573-1294; Martinez-Gonzalez, Miguel A./0000-0002-3917-9808	Official funding agency for Biomedical Research of the Spanish Government; Instituto de Salud Carlos III (ISCIII); Fondo Europeo de Desarrollo Regional (FEDER) [RTIC G03/140, CIBERobn, RD 06/0045, PI04-2239, PI 05/2584, CP06/00100, PI07/0240, PI07/1138, PI07/0954, PI 07/0473, PI10/01407, PI11/02505 PI11/01647 CNIC-06, AGL2010-22319-C03-03]; Generalitat Valenciana [AP-042/11, BEST11-263]	Official funding agency for Biomedical Research of the Spanish Government; Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); Fondo Europeo de Desarrollo Regional (FEDER)(European CommissionSpanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission)	The Official funding agency for Biomedical Research of the Spanish Government, Instituto de Salud Carlos III (ISCIII) and Fondo Europeo de Desarrollo Regional (FEDER), provided the grants for his study: RTIC G03/140, CIBERobn, RD 06/0045, PI04-2239, PI 05/2584, CP06/00100, PI07/0240, PI07/1138, PI07/0954, PI 07/0473, PI10/01407, PI11/02505 PI11/01647 CNIC-06 and AGL2010-22319-C03-03. The Generalitat Valenciana provided grants AP-042/11 and BEST11-263. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlbom A, 2005, EUR J EPIDEMIOL, V20, P563, DOI 10.1007/s10654-005-4410-4; Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS55, DOI 10.2337/dc08-S055; Andreasen CH, 2008, DIABETES, V57, P95, DOI 10.2337/db07-0910; Martinez-Gonzalez MA, 2012, INT J EPIDEMIOL, V41, P377, DOI 10.1093/ije/dyq250; Baik I, 2012, NUTR RES PRACT, V6, P78, DOI 10.4162/nrp.2012.6.1.78; Cauchi S, 2009, J MOL MED, V87, P537, DOI 10.1007/s00109-009-0451-6; Cecil JE, 2008, NEW ENGL J MED, V359, P2558, DOI 10.1056/NEJMoa0803839; Church C, 2010, NAT GENET, V42, P1086, DOI 10.1038/ng.713; Cole SA, 2010, AM J CLIN NUTR, V91, P191, DOI 10.3945/ajcn.2009.28514; Corella D, 2012, NUTR METAB CARDIOVAS, V22, P651, DOI 10.1016/j.numecd.2010.10.006; Corella D, 2011, J NUTR, V141, P2219, DOI 10.3945/jn.111.143826; Corella D, 2009, CIRC-CARDIOVASC GENE, V2, P637, DOI 10.1161/CIRCGENETICS.109.891366; Dempfle A, 2008, EUR J HUM GENET, V16, P1164, DOI 10.1038/ejhg.2008.106; ELOSUA R, 1994, AM J EPIDEMIOL, V139, P1197, DOI 10.1093/oxfordjournals.aje.a116966; Elosua R, 2000, MED SCI SPORT EXER, V32, P1431, DOI 10.1097/00005768-200008000-00011; Estruch R, 2006, ANN INTERN MED, V145, P1, DOI 10.7326/0003-4819-145-1-200607040-00004; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; Fernandez-Ballarth JD, 2010, BRIT J NUTR, V103, P1808, DOI 10.1017/S0007114509993837; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gauderman WJ, 2006, QUANTO 1 1 COMPUTER; Grau K, 2009, INT J OBESITY, V33, P1227, DOI 10.1038/ijo.2009.159; Hakanen M, 2009, J CLIN ENDOCR METAB, V94, P1281, DOI 10.1210/jc.2008-1199; Hardy R, 2010, HUM MOL GENET, V19, P545, DOI 10.1093/hmg/ddp504; Hasselbalch AL, 2010, J NUTR, V140, P831, DOI 10.3945/jn.109.114439; Haupt A, 2009, EXP CLIN ENDOCR DIAB, V117, P194, DOI 10.1055/s-0028-1087176; Hertel JK, 2011, DIABETES, V60, P1637, DOI 10.2337/db10-1340; Huang W, 2011, ENDOCRINE, V39, P69, DOI 10.1007/s12020-010-9413-6; Kilpelainen TO, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001116; Lappalainen T, 2012, BR J NUTR, V23, P1, DOI DOI 10.1017/S0007114511007410; Li H, 2012, DIABETOLOGIA, V55, P981, DOI 10.1007/s00125-011-2370-7; Liem ET, 2010, AM J CLIN NUTR, V91, P321, DOI 10.3945/ajcn.2009.28186; Liu GF, 2011, EUR J EPIDEMIOL, V26, P463, DOI 10.1007/s10654-011-9583-4; Liu GF, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-57; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Loos RJF, 2011, EUR J PHARMACOL, V660, P156, DOI 10.1016/j.ejphar.2011.01.033; Luan JA, 2001, INT J EPIDEMIOL, V30, P1035, DOI 10.1093/ije/30.5.1035; Martinelli CE, 2011, J CLIN ENDOCR METAB, V96, pE181, DOI 10.1210/jc.2010-1369; Mataix J., 2003, TABLA COMPOSICION AL, V4th; Navarro M, 2005, ALCOHOL CLIN EXP RES, V29, P949, DOI 10.1097/01.ALC.0000167740.19702.8C; Navarro M, 2011, ALCOHOL CLIN EXP RES, V35, P1058, DOI 10.1111/j.1530-0277.2011.01438.x; Nordestgaard BG, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001212; Pearson TA, 1996, CIRCULATION, V94, P3023, DOI 10.1161/01.CIR.94.11.3023; Peng SH, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-71; Phillips CM, 2012, J NUTR, V142, P824, DOI 10.3945/jn.111.153460; Polidori C, 2006, PEPTIDES, V27, P144, DOI 10.1016/j.peptides.2005.07.008; Qi L, 2008, HUM MOL GENET, V17, P3502, DOI 10.1093/hmg/ddn242; Rampersaud E, 2008, ARCH INTERN MED, V168, P1791, DOI 10.1001/archinte.168.16.1791; Razquin C, 2010, INT J OBESITY, V34, P266, DOI 10.1038/ijo.2009.233; Rouskas K, 2012, OBESITY, V20, P389, DOI 10.1038/oby.2011.177; Santoro N, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-25; Schroder H, 2011, J NUTR, V141, P1140, DOI 10.3945/jn.110.135566; Sobczyk-Kopciol A, 2011, ADDICTION, V106, P739, DOI 10.1111/j.1360-0443.2010.03248.x; Sonestedt E, 2009, AM J CLIN NUTR, V90, P1418, DOI 10.3945/ajcn.2009.27958; Srisai D, 2011, ENDOCRINOLOGY, V152, P890, DOI 10.1210/en.2010-0716; Taylor AE, 2011, J OBES, V2011, DOI 10.1155/2011/307542; Tenesa A, 2009, INT J OBESITY, V33, P284, DOI 10.1038/ijo.2008.257; Thomsen M, 2012, J CLIN ENDOCR METAB, V97, pE1074, DOI 10.1210/jc.2011-3282; Timpson NJ, 2008, AM J CLIN NUTR, V88, P971, DOI 10.1093/ajcn/88.4.971; Tung YCL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008771; Vasan SK, 2012, OBESITY; Vimaleswaran KS, 2012, OBESITY, V20, P1669, DOI 10.1038/oby.2012.49; Wang XF, 2010, HUM HERED, V70, P269, DOI 10.1159/000321967; Wang XF, 2011, NAT REV GENET, V12, P74, DOI 10.1038/nrg2579-c2; Xi B, 2011, AM J EPIDEMIOL, V173, P1256, DOI 10.1093/aje/kwr008; York DA, 2011, PHARMACOL BIOCHEM BE, V98, P112, DOI 10.1016/j.pbb.2010.12.010	65	51	55	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52344	10.1371/journal.pone.0052344	http://dx.doi.org/10.1371/journal.pone.0052344			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284998	Green Published, Green Submitted, gold			2022-12-27	WOS:000313158800050
J	Lu, XH; An, SQ; Tang, DJ; McCarthy, Y; Tang, JL; Dow, JM; Ryan, RP				Lu, Xiu-Hong; An, Shi-Qi; Tang, Dong-Jie; McCarthy, Yvonne; Tang, Ji-Liang; Dow, John Maxwell; Ryan, Robert P.			RsmA Regulates Biofilm Formation in Xanthomonas campestris through a Regulatory Network Involving Cyclic di-GMP and the Clp Transcription Factor	PLOS ONE			English	Article							GYP DOMAIN PROTEIN; HD-GYP; PV. CAMPESTRIS; VIRULENCE; BINDING; PATHOGENICITY; EXPRESSION; BACTERIA	Biofilm formation and dispersal in the black rot pathogen Xanthomonas campestris pathovar campestris (Xcc) is influenced by a number of factors. The extracellular mannanase ManA has been implicated in biofilm dispersal whereas biofilm formation requires a putative glycosyl transferase encoded by the xag gene cluster. Previously we demonstrated that the post-transcriptional regulator RsmA exerts a negative regulatory influence on biofilm formation in Xcc. Here we address the mechanisms by which RsmA exerts this action. We show that RsmA binds to the transcripts of three genes encoding GGDEF domain diguanylate cyclases to influence their expression. Accordingly, mutation of rsmA leads to an increase in cellular levels of cyclic di-GMP. This effect is associated with a down-regulation of transcription of manA, but an upregulation of xag gene transcription. Mutation of clp, which encodes a cyclic di-GMP-responsive transcriptional regulator of the CRP-FNR family, has similar divergent effects on the expression of manA and xag. Nevertheless Clp binding to manA and xag promoters is inhibited by cyclic di-GMP. The data support the contention that, in common with other CRP-FNR family members, Clp can act as both an activator and repressor of transcription of different genes to influence biofilm formation as a response to cyclic di-GMP.	[Lu, Xiu-Hong; An, Shi-Qi; Tang, Dong-Jie; Tang, Ji-Liang] Guangxi Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning 530004, Peoples R China; [Lu, Xiu-Hong; An, Shi-Qi; Tang, Dong-Jie; Tang, Ji-Liang] Guangxi Univ, Coll Life Sci & Technol, Nanning 530004, Peoples R China; [An, Shi-Qi; McCarthy, Yvonne; Dow, John Maxwell; Ryan, Robert P.] Natl Univ Ireland Univ Coll Cork, Dept Microbiol, BioSci Inst, Cork, Ireland	Guangxi University; Guangxi University; University College Cork	Tang, JL (corresponding author), Guangxi Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning 530004, Peoples R China.	jltang@gxu.edu.cn; m.dow@ucc.ie		Dow, Max/0000-0001-8245-2294; Ryan, Rober/0000-0002-7353-0913; An, Shi-qi/0000-0002-2593-9642	Science Foundation Ireland [SFI 07/IN.1/B955, SFI 09/SIRG/B1654, 07/IN.1/B955/IRPs]; Royal Irish Academy fellowship; National Science Foundation of China [30810103912]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Royal Irish Academy fellowship; National Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work of the authors has been supported in part by grants awarded by the Science Foundation Ireland (SFI 07/IN.1/B955 to J.M.D. and SFI 09/SIRG/B1654 to R.P.R.), Royal Irish Academy fellowship (to R.R.P) and an International Research Partnership supported by Science Foundation Ireland (07/IN.1/B955/IRPs) and the National Science Foundation of China (30810103912). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber CE, 1997, MOL MICROBIOL, V24, P555, DOI 10.1046/j.1365-2958.1997.3721736.x; Chao NX, 2008, MOL PLANT MICROBE IN, V21, P411, DOI 10.1094/MPMI-21-4-0411; Chin KH, 2010, J MOL BIOL, V396, P646, DOI 10.1016/j.jmb.2009.11.076; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Dow JM, 2003, P NATL ACAD SCI USA, V100, P10995, DOI 10.1073/pnas.1833360100; Fazli M, 2011, MOL MICROBIOL, V82, P327, DOI 10.1111/j.1365-2958.2011.07814.x; Gomelsky M, 2009, J BACTERIOL, V191, P6785, DOI 10.1128/JB.01173-09; He YW, 2007, MOL MICROBIOL, V64, P281, DOI 10.1111/j.1365-2958.2007.05670.x; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Hsiao YM, 2010, J AGR FOOD CHEM, V58, P1653, DOI 10.1021/jf903637s; Hsiao YM, 2005, FEBS LETT, V579, P3525, DOI 10.1016/j.febslet.2005.05.023; Jonas K, 2008, MOL MICROBIOL, V70, P236, DOI 10.1111/j.1365-2958.2008.06411.x; Jonas K, 2010, ENVIRON MICROBIOL, V12, P524, DOI 10.1111/j.1462-2920.2009.02097.x; Leduc JL, 2009, J BACTERIOL, V191, P7121, DOI 10.1128/JB.00845-09; Mccarthy Y, 2008, MOL PLANT PATHOL, V9, P819, DOI [10.1111/j.1364-3703.2008.00495.x, 10.1111/J.1364-3703.2008.00495.X]; Milohanic E, 2003, MOL MICROBIOL, V47, P1613, DOI 10.1046/j.1365-2958.2003.03413.x; Monds RD, 2009, TRENDS MICROBIOL, V17, P73, DOI 10.1016/j.tim.2008.11.001; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Romeo T, 2013, ENVIRON MICROBIOL, V15, P313, DOI 10.1111/j.1462-2920.2012.02794.x; Romling U, 2012, ENVIRON MICROBIOL, V14, P1817, DOI 10.1111/j.1462-2920.2011.02617.x; Ryan RP, 2007, MOL MICROBIOL, V63, P429, DOI 10.1111/j.1365-2958.2006.05531.x; Ryan RP, 2012, TRENDS MICROBIOL, V20, P235, DOI 10.1016/j.tim.2012.02.008; Ryan RP, 2011, NAT REV MICROBIOL, V9, P344, DOI 10.1038/nrmicro2558; Ryan RP, 2010, P NATL ACAD SCI USA, V107, P5989, DOI 10.1073/pnas.0912839107; Ryan RP, 2009, ENVIRON MICROBIOL, V11, P1126, DOI 10.1111/j.1462-2920.2008.01842.x; Ryan RP, 2006, P NATL ACAD SCI USA, V103, P6712, DOI 10.1073/pnas.0600345103; Sambrook J, 1989, MOL CLONING LAB MANU; Slater H, 2000, MOL MICROBIOL, V38, P986, DOI 10.1046/j.1365-2958.2000.02196.x; Sondermann H, 2012, CURR OPIN MICROBIOL, V15, P140, DOI 10.1016/j.mib.2011.12.008; SPIRO S, 1990, FEMS MICROBIOL REV, V6, P399; Srivastava D, 2012, J BACTERIOL, V194, P4485, DOI 10.1128/JB.00379-12; Tao F, 2010, ENVIRON MICROBIOL, V12, P3159, DOI 10.1111/j.1462-2920.2010.02288.x; Yakhnin AV, 2000, J BIOL CHEM, V275, P4519, DOI 10.1074/jbc.275.6.4519	34	27	32	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52646	10.1371/journal.pone.0052646	http://dx.doi.org/10.1371/journal.pone.0052646			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285129	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000313158800085
J	Ochoa, MC; Fioravanti, J; Duitman, EH; Medina-Echeverz, J; Palazon, A; Arina, A; Dubrot, J; Alfaro, C; Morales-Kastresana, A; Murillo, O; Hervas-Stubbs, S; Prieto, J; Berraondo, P; Melero, I				Ochoa, Maria C.; Fioravanti, Jessica; Duitman, Erwin H.; Medina-Echeverz, Jose; Palazon, Asis; Arina, Ainhoa; Dubrot, Juan; Alfaro, Carlos; Morales-Kastresana, Aizea; Murillo, Oihana; Hervas-Stubbs, Sandra; Prieto, Jesus; Berraondo, Pedro; Melero, Ignacio			Liver Gene Transfer of Interkeukin-15 Constructs That Become Part of Circulating High Density Lipoproteins for Immunotherapy	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; DENDRITIC CELLS; ANTITUMOR-ACTIVITY; INTRATUMORAL INJECTION; MONOCLONAL-ANTIBODIES; MOUSE MODEL; T-CELLS; IL-15; INTERLEUKIN-15; NK	Apolipoprotein A-I (Apo A-I) is a major component of high density lipoproteins (HDL) that transport cholesterol in circulation. We have constructed an expression plasmid encoding a chimeric molecule encompassing interleukin-15 (IL-15) and Apo A-I (pApo-hIL15) that was tested by hydrodynamic injections into mice and was co-administered with a plasmid encoding the sushi domain of IL-15R alpha (pSushi) in order to enhance IL-15 trans-presentation and thereby bioactivity. The pharmacokinetics of the Apo A-I chimeric protein were much longer than non-stabilized IL-15 and its bioactivity was enhanced in combination with IL-15R alpha Sushi. Importantly, the APO-IL-15 fusion protein was incorporated in part into circulating HDL. Liver gene transfer of these constructs increased NK and memory-phenotype CD8 lymphocyte numbers in peripheral blood, spleen and liver as a result of proliferation documented by CFSE dilution and BrdU incorporation. Moreover, the gene transfer procedure partly rescued the NK and memory T-cell deficiency observed in IL-15R alpha(-/-) mice. pApo-hIL15+ pSushi gene transfer to the liver showed a modest therapeutic activity against subcutaneously transplanted MC38 colon carcinoma tumors, that was more evident when tumors were set up as liver metastases. The improved pharmacokinetic profile and the strong biological activity of APO-IL-15 fusion protein holds promise for further development in combination with other immunotherapies.	[Ochoa, Maria C.; Fioravanti, Jessica; Medina-Echeverz, Jose; Palazon, Asis; Dubrot, Juan; Alfaro, Carlos; Morales-Kastresana, Aizea; Hervas-Stubbs, Sandra; Prieto, Jesus; Berraondo, Pedro; Melero, Ignacio] Univ Navarra, Ctr Appl Med Res, E-31080 Pamplona, Spain; [Duitman, Erwin H.] Res Ctr Borstel, Dept Immunol & Cell Biol, Borstel, Germany; [Arina, Ainhoa] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Murillo, Oihana] Stanford Univ, Dept Otolaryngol, Stanford Canc Ctr, Stanford, CA 94305 USA; [Murillo, Oihana] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA	University of Navarra; Forschungszentrum Borstel; University of Chicago; Stanford Cancer Institute; Stanford University; Stanford University	Berraondo, P (corresponding author), Univ Navarra, Ctr Appl Med Res, E-31080 Pamplona, Spain.	pberraondol@unav.es; imelero@unav.es	Berraondo, Pedro/J-3154-2012; Palazon, Asis/ABI-1748-2020; Dubrot, Juan/ABI-1676-2020; Alfaro, Carlos/K-3566-2014; Fioravanti, Jessica/AAS-1245-2020; Murillo, Oihana/S-4162-2018; Melero, Ignacio/T-7600-2019; Ochoa, Maria C./K-4508-2017; Hervas-Stubbs, Sandra/C-9053-2018	Berraondo, Pedro/0000-0001-7410-1865; Palazon, Asis/0000-0002-7172-7229; Dubrot, Juan/0000-0002-8093-2208; Alfaro, Carlos/0000-0002-4812-7153; Fioravanti, Jessica/0000-0001-6263-4306; Murillo, Oihana/0000-0003-3963-7394; Melero, Ignacio/0000-0002-1360-348X; Ochoa, Maria C./0000-0001-9920-2144; Hervas-Stubbs, Sandra/0000-0003-3391-1516; Prieto, Jesus/0000-0002-1091-9593	Ministerio de Ciencia e Innovacion; Fundacion Cientifica of AECC; Ministerio de Educacion y Ciencia; Fondo de Investigacion Sanitaria (FIS); MEC/EI Ministerio de Ciencia e Innovacion [SAF2005-03131, SAF2008-03294]; RETIC [RD06/0020/0065]; European commission; Fundacion Mutua Madrilena; UTE for project FIMA;  [PI060932];  [FIS PI10/00264]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fundacion Cientifica of AECC; Ministerio de Educacion y Ciencia(Spanish Government); Fondo de Investigacion Sanitaria (FIS)(Instituto de Salud Carlos III); MEC/EI Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)); RETIC; European commission(European CommissionEuropean Commission Joint Research Centre); Fundacion Mutua Madrilena(Instituto de Salud Carlos III); UTE for project FIMA; ; 	MCO receives a Sara Borrell contract from Ministerio de Ciencia e Innovacion. CA is supported by Fundacion Cientifica of AECC. SH-S receives a Ramon y Cajal contract from Ministerio de Educacion y Ciencia, and AM-K a scholarship from Ministerio de Ciencia e Innovacion. PB a Miguel Servet contract from Fondo de Investigacion Sanitaria (FIS); AP, JF and JM a scholarship from FIS. Financial support was from MEC/EI Ministerio de Ciencia e Innovacion (SAF2005-03131 and SAF2008-03294), RETIC (RD06/0020/0065), (PI060932 and FIS PI10/00264), European commission 7th famework program and SUDOE-IMMUNONET, Fundacion Mutua Madrilena, and "UTE for project FIMA''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arina A, 2008, GENE THER, V15, P473, DOI 10.1038/gt.2008.4; Berger C, 2009, BLOOD, V114, P2417, DOI 10.1182/blood-2008-12-189266; Bonamassa B, 2010, PHARM RES; CARSON WE, 1994, J EXP MED, V180, P1395, DOI 10.1084/jem.180.4.1395; Chang CM, 2010, HUM GENE THER, V21, P611, DOI 10.1089/hum.2009.187; Cheever MA, 2009, CLIN CANCER RES, V15, P5323, DOI 10.1158/1078-0432.CCR-09-0737; Croce M, 2005, CLIN CANCER RES, V11, P735; Dubois S, 2002, IMMUNITY, V17, P537, DOI 10.1016/S1074-7613(02)00429-6; Dubois S, 2008, J IMMUNOL, V180, P2099, DOI 10.4049/jimmunol.180.4.2099; Dubrot J, 2010, CANCER IMMUNOL IMMUN, V59, P1621, DOI 10.1007/s00262-010-0888-z; Duitman EH, 2008, MOL CELL BIOL, V28, P4851, DOI 10.1128/MCB.02178-07; Fehniger TA, 2001, J EXP MED, V193, P219, DOI 10.1084/jem.193.2.219; Fioravanti J, 2011, HEPATOLOGY; Fioravanti J, 2011, HEPATOLOGY, V53, P1864, DOI 10.1002/hep.24306; Francis GA, 2010, BBA-MOL CELL BIOL L, V1801, P1286, DOI 10.1016/j.bbalip.2010.08.009; Goldrath AW, 2002, J EXP MED, V195, P1515, DOI 10.1084/jem.20020033; He YK, 2000, HUM GENE THER, V11, P547, DOI 10.1089/10430340050015734; Huntington ND, 2009, J EXP MED, V206, P25, DOI 10.1084/jem.20082013; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Klebanoff CA, 2004, P NATL ACAD SCI USA, V101, P1969, DOI 10.1073/pnas.0307298101; Kobayashi H, 2005, BLOOD, V105, P721, DOI 10.1182/blood-2003-12-4187; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Lorenzen I, 2006, J BIOL CHEM, V281, P6642, DOI 10.1074/jbc.M513118200; Lugli E, 2010, BLOOD, V116, P3238, DOI 10.1182/blood-2010-03-275438; Lund-Katz S, 2010, SUBCELL BIOCHEM, V51, P183, DOI 10.1007/978-90-481-8622-8_7; Martinez Forero Ivan, 2012, J Transl Med, V10, P108, DOI 10.1186/1479-5876-10-108; Meazza R, 2000, INT J CANCER, V87, P574, DOI 10.1002/1097-0215(20000815)87:4<574::AID-IJC18>3.3.CO;2-K; Melero I, 1999, GENE THER, V6, P1779, DOI 10.1038/sj.gt.3301010; Mignot G, 2008, J IMMUNOL, V180, P6477, DOI 10.4049/jimmunol.180.10.6477; Mortier E, 2006, J BIOL CHEM, V281, P1612, DOI 10.1074/jbc.M508624200; MUNGER W, 1995, CELL IMMUNOL, V165, P289, DOI 10.1006/cimm.1995.1216; Oh S, 2003, P NATL ACAD SCI USA, V100, P3392, DOI 10.1073/pnas.0630592100; Oh S, 2008, P NATL ACAD SCI USA, V105, P5201, DOI 10.1073/pnas.0801003105; Rodriguez-Sureda V, 2002, ANAL BIOCHEM, V303, P73, DOI 10.1006/abio.2001.5546; Rubinstein MP, 2006, P NATL ACAD SCI USA, V103, P9166, DOI 10.1073/pnas.0600240103; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; Sandau MM, 2004, J IMMUNOL, V173, P6537, DOI 10.4049/jimmunol.173.11.6537; Soman G, 2009, J IMMUNOL METHODS, V348, P83, DOI 10.1016/j.jim.2009.07.010; Steel JC, 2010, CANCER RES, V70, P1072, DOI 10.1158/0008-5472.CAN-09-1301; Stoklasek TA, 2006, J IMMUNOL, V177, P6072, DOI 10.4049/jimmunol.177.9.6072; Su F, 2010, P NATL ACAD SCI USA, V107, P19997, DOI 10.1073/pnas.1009010107; Suda T, 2007, MOL THER, V15, P2063, DOI 10.1038/sj.mt.6300314; Tirapu I, 2004, INT J CANCER, V110, P51, DOI 10.1002/ijc.20093; Vera M, 2005, MOL THER, V12, P950, DOI 10.1016/j.ymthe.2005.03.030; Waldmann TA, 1999, ANNU REV IMMUNOL, V17, P19, DOI 10.1146/annurev.immunol.17.1.19; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Wei XQ, 2001, J IMMUNOL, V167, P277, DOI 10.4049/jimmunol.167.1.277; Yu P, 2010, CLIN CANCER RES, V16, P6019, DOI 10.1158/1078-0432.CCR-10-1966; Zabala M, 2007, J HEPATOL, V47, P807, DOI 10.1016/j.jhep.2007.07.025	49	11	12	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52370	10.1371/journal.pone.0052370	http://dx.doi.org/10.1371/journal.pone.0052370			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285013	gold, Green Published, Green Submitted			2022-12-27	WOS:000313158800055
J	Sun, FJ; Gao, H; Zhang, YQ; Wang, L; Fang, N; Tan, YF; Guo, ZB; Xia, PY; Zhou, DS; Yang, RF				Sun, Fengjun; Gao, He; Zhang, Yiquan; Wang, Li; Fang, Nan; Tan, Yafang; Guo, Zhaobiao; Xia, Peiyuan; Zhou, Dongsheng; Yang, Ruifu			Fur Is a Repressor of Biofilm Formation in Yersinia pestis	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; DIGUANYLATE CYCLASE; RCS PHOSPHORELAY; FLEA VECTOR; PLAGUE; TRANSCRIPTION; EVOLUTION; INFECTION; VIRULENCE; BACTERIA	Background: Yersinia pestis synthesizes the attached biofilms in the flea proventriculus, which is important for the transmission of this pathogen by fleas. The hmsHFRS operons is responsible for the synthesis of exopolysaccharide (the major component of biofilm matrix), which is activated by the signaling molecule 39, 5'-cyclic diguanylic acid (c-di-GMP) synthesized by the only two diguanylate cyclases HmsT, and YPO0449 (located in a putative operonYPO0450-0448). Methodology/Principal Findings: The phenotypic assays indicated that the transcriptional regulator Fur inhibited the Y. pestis biofilm production in vitro and on nematode. Two distinct Fur box-like sequences were predicted within the promoter-proximal region of hmsT, suggesting that hmsT might be a direct Fur target. The subsequent primer extension, LacZ fusion, electrophoretic mobility shift, and DNase I footprinting assays disclosed that Fur specifically bound to the hmsT promoter-proximal region for repressing the hmsT transcription. In contrast, Fur had no regulatory effect on hmsHFRS and YPO0450-0448 at the transcriptional level. The detection of intracellular c-di-GMP levels revealed that Fur inhibited the c-di-GMP production. Conclusions/Significance: Y. pestis Fur inhibits the c-di-GMP production through directly repressing the transcription of hmsT, and thus it acts as a repressor of biofilm formation. Since the relevant genetic contents for fur, hmsT, hmsHFRS, and YPO0450-0448 are extremely conserved between Y. pestis and typical Y. pseudotuberculosis, the above regulatory mechanisms can be applied to Y. pseudotuberculosis.	[Sun, Fengjun; Gao, He; Zhang, Yiquan; Wang, Li; Fang, Nan; Tan, Yafang; Guo, Zhaobiao; Zhou, Dongsheng; Yang, Ruifu] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Sun, Fengjun; Xia, Peiyuan] Third Mil Med Univ, Southwest Hosp, Dept Pharm, Chongqing, Peoples R China; [Gao, He] Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Natl Inst Communicable Dis Control & Prevent, Beijing, Peoples R China	Beijing Institute of Microbiology & Epidemiology; Army Medical University; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Xia, PY (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Pharm, Chongqing, Peoples R China.	py_xia@yahoo.com.cn; dongshengzhou1977@gmail.com; ruifuyang@gmail.com	Zhang, Yiquan/AAP-3311-2021; Yang, Ruifu/A-2273-2011	Zhang, Yiquan/0000-0003-3935-4079; Yang, Ruifu/0000-0003-3219-7269; Zhou, Dongsheng/0000-0003-3827-5969	National Natural Science Foundation of China [30930001, 30900823]; National Basic Research Program of China [2009CB522600]; Beijing Nova Program [Z12111000250000]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Beijing Nova Program(Beijing Municipal Science & Technology Commission)	Financial support was provided by the National Natural Science Foundation of China (30930001, and 30900823), by the National Basic Research Program of China (2009CB522600), and by the Beijing Nova Program (Z12111000250000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; Ali A, 2002, APPL ENVIRON MICROB, V68, P5773, DOI 10.1128/AEM.68.11.5773-5778.2002; Bobrov AG, 2008, ENVIRON MICROBIOL, V10, P1419, DOI 10.1111/j.1462-2920.2007.01554.x; Bobrov AG, 2011, MOL MICROBIOL, V79, P533, DOI 10.1111/j.1365-2958.2010.07470.x; Chain PSG, 2004, P NATL ACAD SCI USA, V101, P13826, DOI 10.1073/pnas.0404012101; Chen YS, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-274; CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996, DOI 10.1128/JCM.22.6.996-1006.1985; Cotter PA, 2007, CURR OPIN MICROBIOL, V10, P17, DOI 10.1016/j.mib.2006.12.006; Darby C, 2002, NATURE, V417, P243, DOI 10.1038/417243a; Darby C, 2008, TRENDS MICROBIOL, V16, P158, DOI 10.1016/j.tim.2008.01.005; El-Robh MS, 2002, BIOCHEM J, V368, P835, DOI 10.1042/BJ20021003; Erickson DL, 2008, J BACTERIOL, V190, P8163, DOI 10.1128/JB.01181-08; Erickson DL, 2006, J BACTERIOL, V188, P1113, DOI 10.1128/JB.188.3.1113-1119.2006; Escolar L, 1999, J BACTERIOL, V181, P6223, DOI 10.1128/JB.181.20.6223-6229.1999; Forman S, 2006, MICROBIOL-SGM, V152, P3399, DOI 10.1099/mic.0.29224-0; Gao H, 2008, J BACTERIOL, V190, P3063, DOI 10.1128/JB.01910-07; Hinnebusch BJ, 2008, CURR TOP MICROBIOL, V322, P229; Hinnebusch BJ, 2002, SCIENCE, V296, P733, DOI 10.1126/science.1069972; Joshua GWP, 2003, MICROBIOL-SGM, V149, P3221, DOI 10.1099/mic.0.26475-0; Kirillina O, 2004, MOL MICROBIOL, V54, P75, DOI 10.1111/j.1365-2958.2004.04253.x; Majdalani N, 2005, ANNU REV MICROBIOL, V59, P379, DOI 10.1146/annurev.micro.59.050405.101230; Matthysse AG, 1996, FEMS MICROBIOL LETT, V145, P87, DOI 10.1016/0378-1097(96)00392-8; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Simm R, 2005, J BACTERIOL, V187, P6816, DOI 10.1128/JB.187.19.6816-6823.2005; Spangler C, 2010, J MICROBIOL METH, V81, P226, DOI 10.1016/j.mimet.2010.03.020; Sun YC, 2008, P NATL ACAD SCI USA, V105, P8097, DOI 10.1073/pnas.0803525105; Sun YC, 2012, J BACTERIOL, V194, P2020, DOI 10.1128/JB.06243-11; Sun YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019267; van Helden J, 2003, NUCLEIC ACIDS RES, V31, P3593, DOI 10.1093/nar/gkg567; Wehland M, 2000, J BIOL CHEM, V275, P7013, DOI 10.1074/jbc.275.10.7013; Zhang YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025484; Zhou DS, 2011, PROTEIN CELL, V2, P173, DOI 10.1007/s13238-011-1024-3; Zhou DS, 2006, FEMS MICROBIOL LETT, V258, P9, DOI 10.1111/j.1574-6968.2006.00208.x; Zhou DS, 2004, J BACTERIOL, V186, P5147, DOI 10.1128/jb.186.15.5147-5152.2004	34	33	38	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52392	10.1371/journal.pone.0052392	http://dx.doi.org/10.1371/journal.pone.0052392			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285021	Green Published, gold, Green Submitted			2022-12-27	WOS:000313158800060
J	Belle, L; Bruck, F; Foguenne, J; Gothot, A; Beguin, Y; Baron, F; Briquet, A				Belle, Ludovic; Bruck, France; Foguenne, Jacques; Gothot, Andre; Beguin, Yves; Baron, Frederic; Briquet, Alexandra			Imatinib and Nilotinib Inhibit Hematopoietic Progenitor Cell Growth, but Do Not Prevent Adhesion, Migration and Engraftment of Human Cord Blood CD34(+) Cells	PLOS ONE			English	Article							TYROSINE KINASE INHIBITOR; CHRONIC MYELOID-LEUKEMIA; CHRONIC MYELOGENOUS LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; BONE-MARROW; STEM-CELLS; IN-VITRO; BCR-ABL; SELECTIVE INHIBITOR; PERIPHERAL-BLOOD	Background: The availability of tyrosine kinase inhibitors (TKIs) has considerably changed the management of Philadelphia chromosome positive leukemia. The BCR-ABL inhibitor imatinib is also known to inhibit the tyrosine kinase of the stem cell factor receptor, c-Kit. Nilotinib is 30 times more potent than imatinib towards BCR-ABL in vitro. Studies in healthy volunteers and patients with chronic myelogenous leukemia or gastrointestinal stromal tumors have shown that therapeutic doses of nilotinib deliver drug levels similar to those of imatinib. The aim of this study was to compare the inhibitory effects of imatinib and nilotinib on proliferation, differentiation, adhesion, migration and engraftment capacities of human cord blood CD34(+) cells. Design and Methods: After a 48-hour cell culture with or without TKIs, CFC, LTC-IC, migration, adhesion and cell cycle analysis were performed. In a second time, the impact of these TKIs on engraftment was assessed in a xenotransplantation model using NOD/SCID/IL-2R gamma (null) mice. Results: TKIs did not affect LTC-IC frequencies despite in vitro inhibition of CFC formation due to inhibition of CD34(+) cell cycle entry. Adhesion of CD34(+) cells to retronectin was reduced in the presence of either imatinib or nilotinib but only at high concentrations. Migration through a SDF-1 alpha gradient was not changed by cell culture in the presence of TKIs. Finally, bone marrow cellularity and human chimerism were not affected by daily doses of imatinib and nilotinib in a xenogenic transplantation model. No significant difference was seen between TKIs given the equivalent affinity of imatinib and nilotinib for KIT. Conclusions: These data suggest that combining non-myeloablative conditioning regimen with TKIs starting the day of the transplantation could be safe.	[Belle, Ludovic; Bruck, France; Gothot, Andre; Beguin, Yves; Baron, Frederic; Briquet, Alexandra] Univ Liege, Hematol Res Unit, Giga I3, Liege, Belgium; [Foguenne, Jacques; Gothot, Andre] Ctr Hosp Univ Liege, Dept Lab Hematol & Immunohematol, Liege, Belgium; [Beguin, Yves; Baron, Frederic] Ctr Hosp Univ Liege, Div Hematol, Dept Med, Liege, Belgium	University of Liege; University of Liege; University of Liege	Belle, L (corresponding author), Univ Liege, Hematol Res Unit, Giga I3, Liege, Belgium.	lbelle@ulg.ac.be			Novartis Pharmaceuticals; National Fund for Scientific Research (FNRS)	Novartis Pharmaceuticals(Novartis); National Fund for Scientific Research (FNRS)(Fonds de la Recherche Scientifique - FNRS)	LB, F. Baron and YB have received travel grants from Novartis Pharmaceuticals. YB received unrestricted research grant from Novartis Pharmaceuticals. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. This study was supported by the National Fund for Scientific Research (FNRS; http://www1.frs-fnrs.be/). The travel grants and unrestricted research grants from Novartis Pharmaceuticals where not part of the funding for this study. The FNRS had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Similarly Novartis Pharmaceuticals had no role in study design, data collection and analysis or decision to publish. They did however receive the final draft of the publication prior to submission since they kindly provided the authors with imatinib and nilotinib, and suggested a number of minor edits to the manuscript.	Baron F, 2005, CURR OPIN HEMATOL, V12, P435, DOI 10.1097/01.moh.0000177830.63033.9d; Bartolovic K, 2004, BLOOD, V103, P523, DOI 10.1182/blood-2003-05-1535; Breccia M, 2010, LEUKEMIA RES, V34, P143, DOI 10.1016/j.leukres.2009.04.036; Brendel C, 2007, LEUKEMIA, V21, P1267, DOI 10.1038/sj.leu.2404638; Carpenter PA, 2007, BLOOD, V109, P2791, DOI 10.1182/blood-2006-04-019836; Druker BJ, 2000, J CLIN INVEST, V105, P3, DOI 10.1172/JCI9083; Gigant C, 2001, J HEMATOTH STEM CELL, V10, P807, DOI 10.1089/152581601317210908; HAYLOCK DN, 1992, BLOOD, V80, P1405; Heinrich MC, 2000, BLOOD, V96, P925, DOI 10.1182/blood.V96.3.925.015k50_925_932; Hoepfl J, 2002, LEUKEMIA, V16, P1584, DOI 10.1038/sj.leu.2402679; Holtz MS, 2002, BLOOD, V99, P3792, DOI 10.1182/blood.V99.10.3792; Holyoake TL, 1999, EXP HEMATOL, V27, P1418, DOI 10.1016/S0301-472X(99)00078-8; Huygen S, 2002, BLOOD, V100, P2744, DOI 10.1182/blood.V100.8.2744; Jabbour E, 2007, CANCER-AM CANCER SOC, V110, P340, DOI 10.1002/cncr.22778; Jorgensen HG, 2007, BLOOD, V109, P4016, DOI 10.1182/blood-2006-11-057521; Kim CH, 1998, BLOOD, V91, P100, DOI 10.1182/blood.V91.1.100.100_100_110; Kurzrock R, 2003, ANN INTERN MED, V138, P819, DOI 10.7326/0003-4819-138-10-200305200-00010; Lee SJ, 2008, BLOOD, V112, P3500, DOI 10.1182/blood-2008-02-141689; Levesque JP, 1999, EXP HEMATOL, V27, P579, DOI 10.1016/S0301-472X(98)00069-1; LEVESQUE JP, 1995, J EXP MED, V181, P1805, DOI 10.1084/jem.181.5.1805; Manley PW, 2010, BIOORGAN MED CHEM, V18, P6977, DOI 10.1016/j.bmc.2010.08.026; Mauro MJ, 2002, J CLIN ONCOL, V20, P325, DOI 10.1200/JCO.20.1.325; Miller CL, 1997, BLOOD, V89, P1214, DOI 10.1182/blood.V89.4.1214; Mohty M, 2008, HAEMATOLOGICA, V93, P303, DOI 10.3324/haematol.11960; O'Sullivan S, 2011, BONE, V49, P281, DOI 10.1016/j.bone.2011.04.014; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Pirson L, 2006, STEM CELLS, V24, P1814, DOI 10.1634/stemcells.2005-0290; Ram R, 2011, HAEMATOL-HEMATOL J, V96, P1113, DOI 10.3324/haematol.2011.040261; ROSTI V, 1995, BLOOD, V86, P3387, DOI 10.1182/blood.V86.9.3387.bloodjournal8693387; Vermeulen M, 1998, BLOOD, V92, P894, DOI 10.1182/blood.V92.3.894.415k22_894_900; von Bubnoff N, 2006, BLOOD, V108, P1328, DOI 10.1182/blood-2005-12-010132; Weisberg E, 2006, BRIT J CANCER, V94, P1765, DOI 10.1038/sj.bjc.6603170; Weisberg E, 2005, CANCER CELL, V7, P129, DOI 10.1016/j.ccr.2005.01.007; Weisberg E, 2007, BLOOD, V109, P2112, DOI 10.1182/BLOOD-2006-06-026377; YEE NS, 1994, J EXP MED, V179, P1777, DOI 10.1084/jem.179.6.1777; Yong KL, 2002, BRIT J HAEMATOL, V119, P500, DOI 10.1046/j.1365-2141.2002.03837.x; Zheng Yi-zhou, 2004, Zhonghua Xue Ye Xue Za Zhi, V25, P736	37	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52564	10.1371/journal.pone.0052564	http://dx.doi.org/10.1371/journal.pone.0052564			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285088	Green Submitted, Green Published, gold			2022-12-27	WOS:000312794500196
J	Matsha, TE; Masconi, K; Yako, YY; Hassan, MS; Macharia, M; Erasmus, RT; Kengne, AP				Matsha, Tandi Edith; Masconi, Katya; Yako, Yandiswa Yolanda; Hassan, Mogamat Shafick; Macharia, Muiriri; Erasmus, Rajiv Timothy; Kengne, Andre Pascal			Polymorphisms in the Non-Muscle Myosin Heavy Chain Gene (MYH9) Are Associated with Lower Glomerular Filtration Rate in Mixed Ancestry Diabetic Subjects from South Africa	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; STAGE RENAL-DISEASE; DISPARITIES; RISK; HIV; EPIDEMIOLOGY; ALBUMINURIA; NEPHROPATHY; MANAGEMENT; AMERICANS	Objective: Though single nucleotide polymorphisms (SNPs) in the non-muscle myosin gene (MYH9) have been reported to explain most of the excess risk of nondiabetic chronic kidney disease (CKD), in African-Americans, some studies have also shown associations with diabetic end-stage renal disease. We investigated the association of MYH9 SNPs with renal traits in a mixed-ancestry South African population prone to diabetes. Research Design and Methods: Three SNPs known to be associated with CKD (rs4821480, rs5756152 and rs12107) were genotyped using Taqman assay in 716 adults (198 with diabetes) from the Bellville-South community, Cape Town. Glomerular filtration rate was estimated (eGFR) and urinary albumin/creatinine ratio (ACR) assessed. Multivariable regressions were used to relate the SNPs with renal traits. Results: Mean age was 53.6 years, with the expected differences observed in characteristics by diabetic status. Significant associations were found between rs575152 and serum creatinine, and eGFR in the total population, and in diabetic participants (all p <= 0.003), but not in non-diabetics (all p >= 0.16), with significant interactions by diabetes status (interaction-p <= 0.009). The association with ACR was borderline in diabetic participants (p = 0.05) and non-significant in non-diabetics (p = 0.85), with significant interaction (interaction p = 0.02). rs12107 was associated with fasting-, 2-hour glucose and HbA1c in diabetic participants only (interaction-p <= 0.003), but not with renal traits. Conclusion: MYH9 SNPs were associated with renal traits only in diabetic participants in this population. Our findings and other studies suggest that MYH9 may have a broader genetic risk effect on kidney diseases.	[Kengne, Andre Pascal] S African MRC, NCRP Cardiovasc & Metab Dis, Cape Town, South Africa; [Kengne, Andre Pascal] Univ Cape Town, ZA-7925 Cape Town, South Africa; [Matsha, Tandi Edith] Cape Peninsula Univ Technol, Dept Biomed Sci, Fac Hlth & Wellness Sci, Cape Town, South Africa; [Masconi, Katya; Yako, Yandiswa Yolanda; Hassan, Mogamat Shafick; Macharia, Muiriri; Erasmus, Rajiv Timothy] Natl Hlth Lab Serv, Div Chem Pathol, Fac Hlth Sci, Cape Town, South Africa; [Masconi, Katya; Yako, Yandiswa Yolanda; Hassan, Mogamat Shafick; Macharia, Muiriri; Erasmus, Rajiv Timothy] Univ Stellenbosch, Cape Town, South Africa; [Hassan, Mogamat Shafick] Cape Peninsula Univ Technol, Dept Nursing & Radiog, Fac Hlth & Wellness Sci, Cape Town, South Africa	South African Medical Research Council; University of Cape Town; Cape Peninsula University of Technology; Stellenbosch University; Cape Peninsula University of Technology	Kengne, AP (corresponding author), S African MRC, NCRP Cardiovasc & Metab Dis, Cape Town, South Africa.	andre.kengne@mrc.ac.za	Lutermann, Heike/A-4692-2008; Kengne, Andre Pascal/ABB-3696-2020	Lutermann, Heike/0000-0002-7521-2302; Matsha, Tandi/0000-0001-5251-030X; Macharia, Muiruri/0000-0002-5508-274X; Kengne, Andre Pascal/0000-0002-5183-131X	Cape Peninsula University of Technology, South Africa	Cape Peninsula University of Technology, South Africa	This research was supported by a grant from the University Research Fund of the Cape Peninsula University of Technology, South Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrondel C, 2002, J AM SOC NEPHROL, V13, P65, DOI 10.1681/ASN.V13165; Behar DM, 2010, HUM MOL GENET, V19, P1816, DOI 10.1093/hmg/ddq040; Bostrom MA, 2010, CLIN J AM SOC NEPHRO, V5, P1107, DOI 10.2215/CJN.08721209; Chalmers J, 1999, CLIN EXP HYPERTENS, V21, P1009; Cooke JN, 2012, NEPHROL DIAL TRANSPL, V27, P1505, DOI 10.1093/ndt/gfr522; Cordonnier D, 1996, NEPHROL DIAL TRANSPL, V11, P936; COWIE CC, 1989, NEW ENGL J MED, V321, P1074, DOI 10.1056/NEJM198910193211603; de Wit E, 2010, HUM GENET, V128, P145, DOI 10.1007/s00439-010-0836-1; Fernandez M, 2007, ARTHRIT RHEUM-ARTHR, V57, P576, DOI 10.1002/art.22672; Freedman BI, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002150; Freedman BI, 2009, NEPHROL DIAL TRANSPL, V24, P3366, DOI 10.1093/ndt/gfp316; Freedman BI, 2009, AM J NEPHROL, V29, P626, DOI 10.1159/000194791; Hall V, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-564; Herrema H, 2006, MOL BIOL CELL, V17, P3291, DOI 10.1091/mbc.E06-01-0067; Igo RP, 2011, AM J NEPHROL, V33, P381, DOI 10.1159/000326763; Kao WHL, 2008, NAT GENET, V40, P1185, DOI 10.1038/ng.232; Kitiyakara C, 2004, AM J KIDNEY DIS, V44, P815, DOI 10.1016/S0272-6386(04)01081-9; Kopp JB, 2003, KIDNEY INT, V63, P43, DOI 10.1046/j.1523-1755.63.s83.39.x; Kopp JB, 2008, NAT GENET, V40, P1175, DOI 10.1038/ng.226; Kopp JB, 2010, KIDNEY INT, V78, P130, DOI 10.1038/ki.2010.82; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey Andrew S., 2000, Journal of the American Society of Nephrology, V11, p155A; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levitt NS, 2008, HEART, V94, P1376, DOI 10.1136/hrt.2008.147306; Levitt NS, 2006, DIABETIC MED, V23, P103, DOI 10.1111/j.1464-5491.2006.01768.x; Matsha TE, 2012, CARDIOVASC J AFR, V23, P5, DOI 10.5830/CVJA-2010-087; Mbanya JCN, 2010, LANCET, V375, P2254, DOI 10.1016/S0140-6736(10)60550-8; Medapalli RK, 2012, JAIDS-J ACQ IMM DEF, V60, P393, DOI 10.1097/QAI.0b013e31825b70d9; O'Seaghdha CM, 2011, HUM MOL GENET, V20, P2450, DOI 10.1093/hmg/ddr118; Oleksyk TK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011474; Perry J, 2006, J AM SOC NEPHROL, V17, P66, DOI 10.1681/ASN.2005060586; Saleem MA, 2008, AM J PHYSIOL-RENAL, V295, pF959, DOI 10.1152/ajprenal.00559.2007; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; Toto RD, 2004, KIDNEY INT, V66, pS102, DOI 10.1111/j.1523-1755.2004.09224.x; Tzur S, 2010, HUM GENET, V128, P345, DOI 10.1007/s00439-010-0861-0; WHO consultation, 1999, DEF DIAGN CLASS DI 1; Winkler C, 2010, MT SINAI J MED, V77, P149, DOI 10.1002/msj.20172; Young F, 2009, GLOBALIZATION HEALTH, V5, DOI 10.1186/1744-8603-5-9; Zemlin AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022558	39	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52529	10.1371/journal.pone.0052529	http://dx.doi.org/10.1371/journal.pone.0052529			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285077	Green Published, gold, Green Submitted			2022-12-27	WOS:000312794500190
J	Pelosi, A; Piedrafita, D; De Guzman, G; Shepherd, R; Hamill, JD; Meeusen, E; Walmsley, AM				Pelosi, Assunta; Piedrafita, David; De Guzman, Giorgio; Shepherd, Robert; Hamill, John D.; Meeusen, Els; Walmsley, Amanda M.			The Effect of Plant Tissue and Vaccine Formulation on the Oral Immunogenicity of a Model Plant-Made Antigen in Sheep	PLOS ONE			English	Article							HEAT-LABILE ENTEROTOXIN; IMMUNE-RESPONSES; B-SUBUNIT; HEMAGGLUTININ PROTEIN; MUCOSAL; TOXIN; IMMUNIZATION; VIRUS; CELLS; MICE	Antigen-specific antibody responses against a model antigen (the B subunit of the heat labile toxin of enterotoxigenic Escherichia coli, LTB) were studied in sheep following oral immunisation with plant-made and delivered vaccines. Delivery from a root-based vehicle resulted in antigen-specific immune responses in mucosal secretions of the abomasum and small intestine and mesenteric lymph nodes. Immune responses from the corresponding leaf-based vaccine were more robust and included stimulation of antigen-specific antibodies in mucosal secretions of the abomasum. These findings suggest that oral delivery of a plant bioencapsulated antigen can survive passage through the rumen to elicit mucosal and systemic immune responses in sheep. Moreover, the plant tissue used as the vaccine delivery vehicle affects the magnitude of these responses. Citation: Pelosi A, Piedrafita D, De Guzman G, Shepherd R, Hamill JD, et al. (2012) The Effect of Plant Tissue and Vaccine Formulation on the Oral Immunogenicity of a Model Plant-Made Antigen in Sheep. PLoS ONE 7(12): e52907. doi: 10.1371/journal.pone.0052907	[Pelosi, Assunta; De Guzman, Giorgio; Shepherd, Robert; Hamill, John D.; Walmsley, Amanda M.] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia; [Piedrafita, David; Meeusen, Els] Monash Univ, Dept Physiol, Clayton, Vic 3168, Australia	Monash University; Monash University	Walmsley, AM (corresponding author), Monash Univ, Sch Biol Sci, Clayton, Vic, Australia.	amanda.walmsley@monash.edu	De Guzman, Giorgio/B-9227-2013	piedrafita, david/0000-0001-8692-990X; Meeusen, Els/0000-0003-1239-6287; Shepherd, Robert/0000-0003-3152-3122	Dow AgroSciences, LLC; Australian Research Council; Linkage Grant Scheme [LP088231]; Dow AgroSciences through the ARC Linkage Grant mechanism; Monash University	Dow AgroSciences, LLC; Australian Research Council(Australian Research Council); Linkage Grant Scheme(Australian Research Council); Dow AgroSciences through the ARC Linkage Grant mechanism; Monash University(Monash University)	Dow AgroSciences, LLC; http://www.dowagro.com/; Australian Research Council; Linkage Grant Scheme; Grant Number LP088231; http://www.arc.gov.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The commercial partner Dow AgroSciences provided funds alone through the ARC Linkage Grant mechanism and therefore has no competing interest, provided no direct employment (other than personnel hired by Monash University to undertake the study using grant funds), provided no consultancy, filed no patent applications nor patents, has no related products in development or marketed related products and does not alter our adherence to all the PLOS ONE policies on sharing data and materials.	Chikwamba R, 2002, TRANSGENIC RES, V11, P479, DOI 10.1023/A:1020393426750; Chikwamba RK, 2003, P NATL ACAD SCI USA, V100, P11127, DOI 10.1073/pnas.1836901100; De Guzman G, 2011, BIOTECHNOL LETT, V33, P2495, DOI 10.1007/s10529-011-0710-9; De Haan L, 1998, IMMUNOLOGY, V94, P424, DOI 10.1046/j.1365-2567.1998.00535.x; HAQ TA, 1995, SCIENCE, V268, P714, DOI 10.1126/science.7732379; Holmgren J, 2003, VACCINE, V21, pS89, DOI 10.1016/S0264-410X(03)00206-8; HOLMGREN J, 1982, INFECT IMMUN, V38, P424, DOI 10.1128/IAI.38.2.424-433.1982; JEFFERSON RA, 1987, EMBO J, V6, P3901; Khandelwal A, 2003, VACCINE, V21, P3282, DOI 10.1016/S0264-410X(03)00192-0; Khandelwal A, 2011, VET IMMUNOL IMMUNOP, V140, P291, DOI 10.1016/j.vetimm.2010.12.007; Kirk DD, 2005, TRANSGENIC RES, V14, P449, DOI 10.1007/s11248-005-5697-3; Kirk DD, 2005, IMMUNOL CELL BIOL, V83, P248, DOI 10.1111/j.1440-1711.2005.01340.x; LOGAN AC, 1991, INFECT IMMUN, V59, P1024, DOI 10.1128/IAI.59.3.1024-1031.1991; Loza-Rubio E, 2012, VACCINE, V30, P5551, DOI 10.1016/j.vaccine.2012.06.039; Mason HS, 1998, VACCINE, V16, P1336, DOI 10.1016/S0264-410X(98)80020-0; McNeilly TN, 2008, SMALL RUMINANT RES, V76, P83, DOI 10.1016/j.smallrumres.2007.12.013; Meeusen EN, 2011, VACCINE, V29, P8506, DOI 10.1016/j.vaccine.2011.09.010; Pelosi A, 2011, CURR DRUG DELIV, V8, P612, DOI 10.2174/156720111797635513; POPPI DP, 1985, J AGR SCI, V105, P9, DOI 10.1017/S0021859600055623; Premier RR, 2004, VET IMMUNOL IMMUNOP, V98, P77, DOI 10.1016/j.vetimm.2003.10.005; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Reuter F, 2009, J CONTROL RELEASE, V137, P98, DOI 10.1016/j.jconrel.2009.03.015; Rigano MM, 2006, VACCINE, V24, P691, DOI 10.1016/j.vaccine.2005.08.009; RUDDOCK LW, 1995, J BIOL CHEM, V270, P29953; Sedgmen BJ, 2003, IMMUNOL CELL BIOL, V81, P305, DOI 10.1046/j.1440-1711.2003.t01-1-01173.x; Shewen PE, 2009, VET IMMUNOL IMMUNOP, V128, P192, DOI 10.1016/j.vetimm.2008.10.297; SIXMA TK, 1991, NATURE, V351, P371, DOI 10.1038/351371a0; SIXMA TK, 1993, J MOL BIOL, V230, P890, DOI 10.1006/jmbi.1993.1209; Swiatczak B, 2012, SEMIN IMMUNOL, V24, P43, DOI 10.1016/j.smim.2011.11.004; Tacket CO, 1998, NAT MED, V4, P607, DOI 10.1038/nm0598-607; Walmsley AM, 2003, PLANT CELL REP, V21, P1020, DOI 10.1007/s00299-003-0619-4; Webster DE, 2006, VACCINE, V24, P3538, DOI 10.1016/j.vaccine.2006.02.002; WESTON RH, 1968, AUST J AGR RES, V19, P261, DOI 10.1071/AR9680261; Yang WZ, 2002, J DAIRY SCI, V85, P1958, DOI 10.3168/jds.S0022-0302(02)74272-0; Young AR, 2009, GLYCOCONJUGATE J, V26, P423, DOI 10.1007/s10719-008-9190-0; ZEMELMAN BV, 1989, INFECT IMMUN, V57, P2947, DOI 10.1128/IAI.57.10.2947-2952.1989	36	13	13	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52907	10.1371/journal.pone.0052907	http://dx.doi.org/10.1371/journal.pone.0052907			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285224	Green Published, Green Submitted, gold			2022-12-27	WOS:000312794500257
J	Simcic, M; Sosic, I; Hodoscek, M; Barreteau, H; Blanot, D; Gobec, S; Grdadolnik, SG				Simcic, Mihael; Sosic, Izidor; Hodoscek, Milan; Barreteau, Helene; Blanot, Didier; Gobec, Stanislav; Grdadolnik, Simona Golic			The Binding Mode of Second-Generation Sulfonamide Inhibitors of MurD: Clues for Rational Design of Potent MurD Inhibitors	PLOS ONE			English	Article							D-GLUTAMIC ACID; MOLECULAR-DYNAMICS SIMULATIONS; TRANSFER DIFFERENCE NMR; PEPTIDOGLYCAN BIOSYNTHESIS; ADDING ENZYME; L-ALANINE; PHOSPHINATE INHIBITORS; ESCHERICHIA-COLI; LIGASE MURD; PROTEINS	A series of optimized sulfonamide derivatives was recently reported as novel inhibitors of UDP-N-acetylmuramoyl-L-alanine: D-glutamate ligase (MurD). These are based on naphthalene-N-sulfonyl-D-glutamic acid and have the D-glutamic acid replaced with rigidified mimetics. Here we have defined the binding site of these novel ligands to MurD using H-1/C-13 heteronuclear single quantum correlation. The MurD protein was selectively C-13-labeled on the methyl groups of Ile (delta 1 only), Leu and Val, and was isolated and purified. Crucial Ile, Leu and Val methyl groups in the vicinity of the ligand binding site were identified by comparison of chemical shift perturbation patterns among the ligands with various structural elements and known binding modes. The conformational and dynamic properties of the bound ligands and their binding interactions were examined using the transferred nuclear Overhauser effect and saturation transfer difference. In addition, the binding mode of these novel inhibitors was thoroughly examined using unrestrained molecular dynamics simulations. Our results reveal the complex dynamic behavior of ligand-MurD complexes and its influence on ligand-enzyme contacts. We further present important findings for the rational design of potent Mur ligase inhibitors. Citation: Simcic. M, Sosic. I, Hodoscek M, Barreteau H, Blanot D, et al. (2012) The Binding Mode of Second-Generation Sulfonamide Inhibitors of MurD: Clues for Rational Design of Potent MurD Inhibitors. PLoS ONE 7(12): e52817. doi:10.1371/journal.pone.0052817	[Simcic, Mihael; Grdadolnik, Simona Golic] EN FIST Ctr Excellence, Ljubljana, Slovenia; [Simcic, Mihael; Grdadolnik, Simona Golic] Natl Inst Chem, Lab Biomol Struct, Ljubljana, Slovenia; [Sosic, Izidor; Gobec, Stanislav] Univ Ljubljana, Fac Pharm, Ljubljana, Slovenia; [Hodoscek, Milan] Natl Inst Chem, Lab Mol Modeling, Ljubljana, Slovenia; [Barreteau, Helene; Blanot, Didier] Univ Paris 11, Lab Enveloppes Bacteriennes & Antibiot, Orsay, France; [Blanot, Didier] CNRS, F-91405 Orsay, France	National Institute of Chemistry - Slovenia; University of Ljubljana; National Institute of Chemistry - Slovenia; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS)	Grdadolnik, SG (corresponding author), EN FIST Ctr Excellence, Ljubljana, Slovenia.	simona.grdadolnik@ki.si		Sosic, Izidor/0000-0002-3370-4587; Golic Grdadolnik, Simona/0000-0002-0873-9593; Gobec, Stanislav/0000-0002-9678-3083	Slovenian Research Agency [J1-0317-0104-08, P1-0010]; EN-FIST Centre of Excellence; European Union [LSHM-CT-2004-512138]	Slovenian Research Agency(Slovenian Research Agency - Slovenia); EN-FIST Centre of Excellence; European Union(European Commission)	This work was supported by the Slovenian Research Agency (Project No. J1-0317-0104-08 and P1-0010), EN-FIST Centre of Excellence, and the European Union FP6 Integrated Project EUR-INTAFAR (Project No. LSHM-CT-2004-512138) under the thematic priority Life Sciences, Genomics and Biotechnology for Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreteau H, 2008, FEMS MICROBIOL REV, V32, P168, DOI 10.1111/j.1574-6976.2008.00104.x; Bertrand JA, 1999, J MOL BIOL, V289, P579, DOI 10.1006/jmbi.1999.2800; Bertrand JA, 2000, J MOL BIOL, V301, P1257, DOI 10.1006/jmbi.2000.3994; Bertrand JA, 1997, EMBO J, V16, P3416, DOI 10.1093/emboj/16.12.3416; Borstnik U, 2004, J CHEM INF COMP SCI, V44, P359, DOI 10.1021/ci034261e; Bouhss A, 1999, BIOCHEMISTRY-US, V38, P12240, DOI 10.1021/bi990517r; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P725, DOI 10.1016/B978-012164491-8/50011-7; Chopra I, 2008, LANCET INFECT DIS, V8, P133, DOI 10.1016/S1473-3099(08)70018-5; CLORE GM, 1983, J MAGN RESON, V53, P423, DOI 10.1016/0022-2364(83)90215-9; CLORE GM, 1982, J MAGN RESON, V48, P402, DOI 10.1016/0022-2364(82)90073-7; Dalvit C, 1998, J BIOMOL NMR, V11, P437, DOI 10.1023/A:1008272928075; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; El Zoeiby A, 2003, MOL MICROBIOL, V47, P1, DOI 10.1046/j.1365-2958.2003.03289.x; Gegnas LD, 1998, BIOORG MED CHEM LETT, V8, P1643, DOI 10.1016/S0960-894X(98)00285-6; Goddard D., 2008, SPARKY 3; Humljan J, 2008, J MED CHEM, V51, P7486, DOI 10.1021/jm800762u; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Keeler J., 2003, ANGEW CHEM, V115, P4068, DOI [10.1002/ange.200351947, DOI 10.1002/ANGE.200351947]; Kotnik M, 2007, J MOL BIOL, V370, P107, DOI 10.1016/j.jmb.2007.04.048; Kristan K, 2009, J BIOMOL SCREEN, V14, P412, DOI 10.1177/1087057109332597; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mayer M, 2001, J AM CHEM SOC, V123, P6108, DOI 10.1021/ja0100120; McCullough C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033958; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Petek M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-159; PRATVIELSOSA F, 1994, FEMS MICROBIOL LETT, V115, P223, DOI 10.1111/j.1574-6968.1994.tb06642.x; Simcic M, 2009, J MED CHEM, V52, P2899, DOI 10.1021/jm900117n; Sosic I, 2011, EUR J MED CHEM, V46, P2880, DOI 10.1016/j.ejmech.2011.04.011; Strancar K, 2006, BIOORG MED CHEM LETT, V16, P343, DOI 10.1016/j.bmcl.2005.09.086; Tanner ME, 1996, J ORG CHEM, V61, P1756, DOI 10.1021/jo951780a; Tomasic T, 2011, J MED CHEM, V54, P4600, DOI 10.1021/jm2002525; Tomasic T, 2010, CHEMMEDCHEM, V5, P286, DOI 10.1002/cmdc.200900449; Tugarinov V, 2006, NAT PROTOC, V1, P749, DOI 10.1038/nprot.2006.101; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Xu XP, 2001, J BIOMOL NMR, V21, P321, DOI 10.1023/A:1013324104681; Yan JL, 2003, J MAGN RESON, V163, P270, DOI 10.1016/S1090-7807(03)00106-X; Zidar N, 2010, J MED CHEM, V53, P6584, DOI 10.1021/jm100285g	42	10	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52817	10.1371/journal.pone.0052817	http://dx.doi.org/10.1371/journal.pone.0052817			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285193	Green Published, Green Submitted, gold			2022-12-27	WOS:000312794500249
J	Sugiura, M; Nakamura, M; Ogawa, K; Ikoma, Y; Yano, M				Sugiura, Minoru; Nakamura, Mieko; Ogawa, Kazunori; Ikoma, Yoshinori; Yano, Masamichi			High Serum Carotenoids Associated with Lower Risk for Bone Loss and Osteoporosis in Post-Menopausal Japanese Female Subjects: Prospective Cohort Study	PLOS ONE			English	Article							MINERAL DENSITY; BETA-CRYPTOXANTHIN; DIETARY PATTERNS; CIGARETTE-SMOKING; OXIDATIVE STRESS; FEMORAL TISSUES; FREE-RADICALS; HIP FRACTURE; IN-VITRO; RESORPTION	Introduction: Recent epidemiological studies show that high intakes of carotenoids might be useful to maintain bone health, but little is known about the association of serum carotenoids with change of bone mineral density (BMD). The objective of this study was to investigate longitudinally whether serum carotenoids are associated with bone loss. Methods: We conducted a follow-up on 146 male and 99 pre- and 212 post-menopausal female subjects from the Mikkabi study. Those who participated in previous BMD surveys and completed four years of follow-up were examined longitudinally. Results: During a 4-year follow-up, 15 of the post-menopausal female subjects developed new-onset osteoporosis. In contrast, none of the male and pre-menopausal female subjects did. In male and pre-menopausal female subjects, the six serum carotenoids at the baseline were not associated with bone loss. On the other hand, in post-menopausal female subjects, the 4-year bone loss of radius was inversely associated with the serum carotenoid concentrations, especially in beta-carotene. After adjustments for confounders, the odds ratios (OR) for osteoporosis in the highest tertiles of serum beta-carotene and beta-cryptoxanthin against the lowest tertiles were 0.24 (95% confidence interval 0.05-1.21) and 0.07 (CI: 0.01-0.88), respectively. Serum b-cryptoxanthin was also inversely associated with the risk for osteopenia and/or osteoporosis (P for trend, 0.037). In addition, our retrospective analysis revealed that subjects who developed osteoporosis and/or osteopenia during the survey period had significantly lower serum concentrations of beta-cryptoxanthin and beta-carotene at the baseline than those in the normal group. Conclusions: Antioxidant carotenoids, especially beta-cryptoxanthin and beta-carotene, are inversely associated with the change of radial BMD in post-menopausal female subjects.	[Sugiura, Minoru; Ogawa, Kazunori; Ikoma, Yoshinori; Yano, Masamichi] Natl Inst Fruit Tree Sci, Citrus Res Div, Shizuoka, Japan; [Nakamura, Mieko] Hamamatsu Univ Sch Med, Dept Community Hlth & Prevent Med, Hamamatsu, Shizuoka 4313192, Japan	National Agriculture & Food Research Organization - Japan; Hamamatsu University School of Medicine	Sugiura, M (corresponding author), Natl Inst Fruit Tree Sci, Citrus Res Div, Shizuoka, Japan.	msugiura@affrc.go.jp	Nakamura, Mieko/AFS-0483-2022	Nakamura, Mieko/0000-0002-9411-8784	Ministry of Agriculture, Forestry, and Fisheries (MAFF); Council for advancement of Fruit Tree Science	Ministry of Agriculture, Forestry, and Fisheries (MAFF)(Ministry of Agriculture Forestry & Fisheries - Japan); Council for advancement of Fruit Tree Science	This work was supported by a grant from the Ministry of Agriculture, Forestry, and Fisheries (MAFF) for a food research project titled "Integrated Research on Safety and Physiological Function of Food" and a grant from the Council for advancement of Fruit Tree Science. The funders had a role in data collection and analysis.	Almeida M, 2007, J BIOL CHEM, V282, P27298, DOI 10.1074/jbc.M702811200; Baeuerle PA, 1996, PATHOL BIOL, V44, P29; Basu S, 2001, BIOCHEM BIOPH RES CO, V288, P275, DOI 10.1006/bbrc.2001.5747; BAX BE, 1992, BIOCHEM BIOPH RES CO, V183, P1153, DOI 10.1016/S0006-291X(05)80311-0; Christodoulou C, 2003, POSTGRAD MED J, V79, P133, DOI 10.1136/pmj.79.929.133; Egami I, 1999, J Epidemiol, V9, P227; GARRETT IR, 1990, J CLIN INVEST, V85, P632, DOI 10.1172/JCI114485; Gennari C, 2001, Public Health Nutr, V4, P547; GUTTERIDGE JMC, 1994, CHEM-BIOL INTERACT, V91, P133, DOI 10.1016/0009-2797(94)90033-7; Iotsova V, 1997, NAT MED, V3, P1285, DOI 10.1038/nm1197-1285; Jilka RL, 2007, J BONE MINER RES, V22, P1492, DOI 10.1359/JBMR.070518; Law MR, 1997, BMJ-BRIT MED J, V315, P841, DOI 10.1136/bmj.315.7112.841; Macdonald HM, 2004, AM J CLIN NUTR, V79, P155; Maggio D, 2006, BONE, V38, P244, DOI 10.1016/j.bone.2005.08.003; Maggio D, 2003, J CLIN ENDOCR METAB, V88, P1523, DOI 10.1210/jc.2002-021496; McGartland CP, 2004, AM J CLIN NUTR, V80, P1019, DOI 10.1093/ajcn/80.4.1019; Melhus H, 1999, J BONE MINER RES, V14, P129, DOI 10.1359/jbmr.1999.14.1.129; *MIN HLTH LAB WELF, 2004, COMPR SURV LIV COND; New SA, 1997, AM J CLIN NUTR, V65, P1831, DOI 10.1093/ajcn/65.6.1831; Okubo H, 2006, AM J CLIN NUTR, V83, P1185, DOI 10.1093/ajcn/83.5.1185; Orimo H, 2001, J BONE MINER METAB, V19, P331, DOI 10.1007/s007740170001; Prentice A, 2004, PUBLIC HEALTH NUTR, V7, P227, DOI 10.1079/PHN2003590; Prynne CJ, 2006, AM J CLIN NUTR, V83, P1420, DOI 10.1093/ajcn/83.6.1420; Rock CL, 1996, J AM DIET ASSOC, V96, P693, DOI 10.1016/S0002-8223(96)00190-3; Sahni S, 2009, OSTEOPOROSIS INT, V20, P1853, DOI 10.1007/s00198-009-0897-y; Sahni S, 2009, AM J CLIN NUTR, V89, P416, DOI 10.3945/ajcn.2008.26388; *SCI TECHN AG, 1983, STAND TABL FOOD COMP; Science and Technology Agency, 1997, STAND TABL FOOD COMP; Sugiura M, 2008, OSTEOPOROSIS INT, V19, P211, DOI 10.1007/s00198-007-0457-2; Sugiura M, 2005, J EPIDEMIOL, V15, P180, DOI 10.2188/jea.15.180; Sugiura M, 2011, OSTEOPOROSIS INT, V22, P143, DOI 10.1007/s00198-010-1239-9; Sugiura M, 2009, BRIT J NUTR, V102, P1211, DOI 10.1017/S0007114509382124; Tucker KL, 2002, AM J CLIN NUTR, V76, P245, DOI 10.1093/ajcn/76.1.245; Uchiyama S, 2004, BIOL PHARM BULL, V27, P232, DOI 10.1248/bpb.27.232; Wakai K, 1999, J Epidemiol, V9, P216; Wattanapenpaiboon N, 2003, ASIA PAC J CLIN NUTR, V12, P467; Yalin S, 2005, CLIN EXP RHEUMATOL, V23, P689; Yamaguchi M, 2004, MOL CELL BIOCHEM, V258, P137, DOI 10.1023/B:MCBI.0000012848.50541.19; Yamaguchi M, 2003, BIOL PHARM BULL, V26, P1188, DOI 10.1248/bpb.26.1188; Yang ZF, 2008, INT J VITAM NUTR RES, V78, P105, DOI 10.1024/0300-9831.78.3.105	40	63	69	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52643	10.1371/journal.pone.0052643	http://dx.doi.org/10.1371/journal.pone.0052643			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285126	Green Published, Green Submitted, gold			2022-12-27	WOS:000312794500217
J	Parrish, DD; Blevins, M; Stinnette, SE; Rebeiro, PF; Shepherd, BE; Sterling, TR; McGowan, CC; Wester, CW				Parrish, Deidra D.; Blevins, Meridith; Stinnette, Samuel E.; Rebeiro, Peter F.; Shepherd, Bryan E.; Sterling, Timothy R.; McGowan, Catherine C.; Wester, C. William			Virologic, Immunologic and Clinical Responses in Foreign-Born versus US-Born HIV-1 Infected Adults Initiating Antiretroviral Therapy: An Observational Cohort Study	PLOS ONE			English	Article							1ST YEAR; MORTALITY; HIV	Introduction: Mortality rates within the first year of combination antiretroviral therapy (cART) initiation are several-fold higher in resource-limited countries than in resource-replete settings. However studies in western countries examining virologic, immunologic and clinical responses after cART initiation in indigenous versus non-indigenous populations have shown mixed results. This study aimed to determine whether there is a difference in these outcomes in a United States setting between foreign-born and US-born patients. Methods: This retrospective observational cohort study of HIV-1 infected adults in one urban clinic in the United States compared virologic suppression, immune recovery and rates of AIDS defining events (ADEs) within the first year of cART using linear mixed effect models, log rank tests and Cox proportional hazard models. Data were analyzed for 94 foreign-born and 1242 US-born patients. Results: Foreign-born patients were younger (31.7 years versus 38.5 years), more often female (38.3% versus 27.1%), less often injection drug users (3.2% versus 9.5%) or men who have sex with men (19.0% versus 54.5%), and had higher loss to follow-up rates (14.9% versus 6.2%). No significant differences were detected between the groups in suppression of plasma HIV-1 RNA, CD4+ cell recovery or development of ADEs. Conclusions: During the first year on cART, virologic suppression, immune recovery and development of ADEs were comparable between foreign-born and US-born patients in care in a US clinic. Differential rates of loss to follow-up warrant further investigation in the foreign-born population.	[Parrish, Deidra D.] Vanderbilt Univ, Inst Global Hlth, Nashville, TN 37203 USA; [Blevins, Meridith; Shepherd, Bryan E.] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA; [Stinnette, Samuel E.; Rebeiro, Peter F.; Sterling, Timothy R.; McGowan, Catherine C.; Wester, C. William] Vanderbilt Univ, Sch Med, Div Infect Dis, Nashville, TN 37212 USA; [McGowan, Catherine C.] Vanderbilt Comprehens Care Clin, Nashville, TN USA; [Wester, C. William] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Harvard University; Harvard T.H. Chan School of Public Health	Parrish, DD (corresponding author), Vanderbilt Univ, Inst Global Hlth, Nashville, TN 37203 USA.	d.parrish@vanderbilt.edu		Blevins, Meridith/0000-0002-3861-9859; Rebeiro, Peter/0000-0003-1951-9104	National Institutes of Health [T32A107474, P30AI54999, K24AI065298, K23AI073141, P30AI 060354]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI073141, K24AI065298, P30AI054999, P30AI060354] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the following research grants from the National Institutes of Health: T32A107474 (DDP), P30AI54999 to Vanderbilt-Meharry Center for AIDS Research (SES, BES, PFR, and TRS), K24AI065298 (SES, TRS), K23AI073141 (CWW) and P30AI 060354 to Harvard Center for AIDS Research (CWW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Carten ML, 2012, J IMMIGRANT MIN 0505; Crawford T, 2011, J IMMIGRANT MIN 0217; Etard JF, 2006, AIDS, V20, P1181, DOI 10.1097/01.aids.0000226959.87471.01; Frater AJ, 2002, AIDS, V16, P1139, DOI 10.1097/00002030-200205240-00007; Lawn SD, 2005, AIDS, V19, P2141, DOI 10.1097/01.aids.0000194802.89540.e1; Marazzi MC, 2008, AIDS RES HUM RETROV, V24, P555, DOI 10.1089/aid.2007.0217; Nellen JF, 2004, JAIDS-J ACQ IMM DEF, V36, P943, DOI 10.1097/00126334-200408010-00008; Perez-Molina JA, 2010, CURR HIV RES, V8, P521, DOI 10.2174/157016210793499178; Prosser AT, 2012, JAMA-J AM MED ASSOC, V308, P601, DOI 10.1001/jama.2012.9046; Staehelin C, 2003, AIDS, V17, P2237, DOI 10.1097/00002030-200310170-00012; Tuboi SH, 2009, JAIDS-J ACQ IMM DEF, V51, P615, DOI 10.1097/QAI.0b013e3181a44f0a; van den Berg JB, 2005, HIV MED, V6, P299, DOI 10.1111/j.1468-1293.2005.00304.x	13	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e52336	10.1371/journal.pone.0052336	http://dx.doi.org/10.1371/journal.pone.0052336			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284994	Green Published, gold			2022-12-27	WOS:000312694300087
J	Kumsa, B; Socolovschi, C; Parola, P; Rolain, JM; Raoult, D				Kumsa, Bersissa; Socolovschi, Cristina; Parola, Philippe; Rolain, Jean-Marc; Raoult, Didier			Molecular Detection of Acinetobacter Species in Lice and Keds of Domestic Animals in Oromia Regional State, Ethiopia	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; BACTERIAL DIVERSITY; RPOB GENE; BAUMANNII; IDENTIFICATION; SPP.; ECTOPARASITES; BARTONELLA; MICROBIOTA; HORSES	This study was conducted to determine the presence of Acinetobacter and Rickettsia species DNA in lice and Melophagus ovinus (sheep ked) of animals from Oromia Regional State in Ethiopia. From September through November 2011, a total of 207 cattle, 85 sheep, 47 dogs and 16 cats were examined for ectoparasites. Results of morphological identification revealed several species of ectoparasites: Linognathus vituli (L. vituli), Bovicola bovis (B. bovis) and Solenopotes capillatus (S. capillatus) on cattle; B. ovis and Melophagus ovinus (M. ovinus) on sheep; and Heterodoxus spiniger (H. spiniger) on dogs. There was a significantly (p <= 0.0001) higher prevalence of L. vituli observed in cattle than both S. capillatus and B. bovis. Molecular identification of lice using an 18S rRNA gene analysis confirms the identified lice species by morphological methods. We detected different Acinetobacter species among lice (11.1%) and keds (86.4%) including A. soli in L. vituli of cattle, A. lowffii in M. ovinus of sheep, A. pittii in H. spiniger of dogs, 1 new Acinetobacter spp. in M. ovinus and 2 new Acinetobacter spp. in H. spiniger of dogs using partial rpoB gene sequence analysis. There was a significantly higher prevalence of Acinetobacter spp. in keds than in lice (p <= 0.00001). Higher percentage of Acinetobacter spp. DNA was detected in H. spiniger than in both B. ovis and L. vituli (p <= 0.00001). Carbapenemase resistance encoding genes for blaOXA-23, blaOXA-24, blaOXA-58, blaNDM-1 and blaOXA-51 were not found in any lice and keds. These findings suggest that synanthropic animals and their ectoparasites might increase the risk of human exposure to zoonotic pathogens and could be a source for Acinetobacter spp. infections in humans. However, additional epidemiological data are required to determine whether ectoparasites of animals can act as environmental reservoirs and play a role in spreading these bacteria to both animal and human hosts.	[Kumsa, Bersissa; Socolovschi, Cristina; Parola, Philippe; Rolain, Jean-Marc; Raoult, Didier] Aix Marseille Univ, URMITE, UM63, CNRS 7278,IRD 198,Inserm 1095, Marseille, France; [Kumsa, Bersissa] Univ Addis Ababa, Coll Vet Med & Agr, Dept Parasitol, Bishoftu, Ethiopia	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); Addis Ababa University	Raoult, D (corresponding author), Aix Marseille Univ, URMITE, UM63, CNRS 7278,IRD 198,Inserm 1095, Marseille, France.	didier.raoult@gmail.com	Kumsa, Bersissa/I-3144-2019; RAOULT, Didier/A-8434-2008; Parola, Philippe/AAY-4346-2021; Rolain, Jean-Marc/Y-3788-2019	Kumsa, Bersissa/0000-0003-4737-3106; RAOULT, Didier/0000-0002-0633-5974; Parola, Philippe/0000-0002-1061-1927; Rolain, Jean-Marc/0000-0002-2402-4467				Abebayehu T, 2010, TROP ANIM HEALTH PRO, V42, P1719, DOI 10.1007/s11250-010-9625-z; Barker SC, 2003, ZOOL SCR, V32, P407, DOI 10.1046/j.1463-6409.2003.00120.x; Bouvresse S, 2011, COMP IMMUNOL MICROB, V34, P475, DOI 10.1016/j.cimid.2011.08.007; Central Statistical Agency, 2008, ETH AGR SAMPL SURV R, VII; Chanie M, 2010, TROP ANIM HEALTH PRO, V42, P1103, DOI 10.1007/s11250-010-9531-4; Choi JY, 2012, DIAGN MICR INFEC DIS, V74, P177, DOI 10.1016/j.diagmicrobio.2012.06.023; Debarry J, 2007, J ALLERGY CLIN IMMUN, V119, P1514, DOI 10.1016/j.jaci.2007.03.023; Djadid ND, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028484; Endimiani A, 2011, J ANTIMICROB CHEMOTH, V66, P2248, DOI 10.1093/jac/dkr289; Francey T, 2000, J VET INTERN MED, V14, P177, DOI 10.1892/0891-6640(2000)014&lt;0177:TROBAA&gt;2.3.CO;2; Geiger A, 2011, MICROB ECOL, V62, P632, DOI 10.1007/s00248-011-9830-y; Geiger A, 2009, INFECT GENET EVOL, V9, P1364, DOI 10.1016/j.meegid.2009.09.013; Gouveia C, 2008, NEOTROP ENTOMOL, V37, P597, DOI 10.1590/S1519-566X2008000500016; Gundi VAKB, 2009, MICROBIOL-SGM, V155, P2333, DOI 10.1099/mic.0.026054-0; Hamouda A, 2011, INT J ANTIMICROB AG, V38, P314, DOI 10.1016/j.ijantimicag.2011.06.007; Higgins PG, 2010, J ANTIMICROB CHEMOTH, V65, P233, DOI 10.1093/jac/dkp428; Hornok S, 2010, VET PARASITOL, V174, P355, DOI 10.1016/j.vetpar.2010.09.003; Hornok S, 2011, VECTOR-BORNE ZOONOT, V11, P1319, DOI 10.1089/vbz.2011.0649; Karah N, 2011, J ANTIMICROB CHEMOTH, V66, P738, DOI 10.1093/jac/dkq521; Kempf M, 2012, INT J INFECT DIS; Kempf M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039495; Kumsa B., 2008, Bulletin of Animal Health and Production in Africa, V56, P213; Kumsa B, 2011, ONDERSTEPOORT J VET, V78; Kumsa B, 2012, ONDERSTEPOORT J VET, V79, DOI 10.4102/ojvr.v79i1.442; Kusradze I, 2011, INT J ANTIMICROB AG, V38, P164, DOI 10.1016/j.ijantimicag.2011.03.021; La Scola B, 2004, EMERG INFECT DIS, V10, P1671, DOI 10.3201/eid1009.040242; La Scola B, 2006, J CLIN MICROBIOL, V44, P827, DOI 10.1128/JCM.44.3.827-832.2006; Light JE, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-292; Murrell A, 2003, PARASITOL RES, V89, P326, DOI 10.1007/s00436-002-0722-4; Nachappa P, 2011, CURR MICROBIOL, V62, P1510, DOI 10.1007/s00284-011-9885-5; Nakwan N, 2011, RES REPORTS NEONATAT; Narciso-da-Rocha C, 2012, APPL MICROBIOL BIOTE; Nemec A, 2011, RES MICROBIOL, V162, P393, DOI 10.1016/j.resmic.2011.02.006; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Pidiyar VJ, 2004, AM J TROP MED HYG, V70, P597, DOI 10.4269/ajtmh.2004.70.597; Pellegrino FLPC, 2011, J CLIN MICROBIOL, V49, P2283, DOI 10.1128/JCM.00326-11; Poirel L, 2012, EMERG INFECT DIS, V18, P523, DOI 10.3201/eid1803.111330; Reed DL, 2002, MICROB ECOL, V44, P78, DOI 10.1007/s00248-002-0009-4; Regalado NG, 2009, TRAVEL MED INFECT DI, V7, P316, DOI 10.1016/j.tmaid.2009.06.001; Reid NM, 2011, APPL ENVIRON MICROB, V77, P7000, DOI 10.1128/AEM.05609-11; Saisongkorh Watcharee, 2009, Journal of the Medical Association of Thailand, V92, P707; Sant'Anna MRV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042531; Sertse T, 2007, SMALL RUMINANT RES, V69, P55, DOI 10.1016/j.smallrumres.2005.12.011; Singh ST, 2012, INFECT GENET EVOL, V12, P411, DOI 10.1016/j.meegid.2012.01.015; Small RW, 2005, VET PARASITOL, V130, P141, DOI 10.1016/j.vetpar.2005.03.005; Smet A, 2012, J ANTIMICROB CHEMOTH, V67, P3009, DOI 10.1093/jac/dks311; Socolovschi C, 2010, EMERG INFECT DIS, V16, P1495, DOI 10.3201/eid1609.100258; Taylor M. A., 2007, VET PARASITOL, V3rd; Turton JF, 2010, J CLIN MICROBIOL, V48, P1445, DOI 10.1128/JCM.02467-09; Vaz-Moreira I, 2011, INT J SYST EVOL MICR, V61, P2837, DOI 10.1099/ijs.0.027045-0; Wall R, 1997, VET ENTOMOLOGY, V1; Walter G, 2012, AM J TROP MED HYG, V86, P1049, DOI 10.4269/ajtmh.2012.11-0794; Wisplinghoff H, 2012, J INFECTION, V64, P282, DOI 10.1016/j.jinf.2011.12.008; Yacob HT, 2008, ENTOM RES, V28, P26; Yong Z, 2003, CR BIOL, V326, P565, DOI 10.1016/S1631-0691(03)00153-7; Zordan S, 2011, EMERG INFECT DIS, V17, P1751, DOI 10.3201/eid1709.101931; Zouache K, 2011, FEMS MICROBIOL ECOL, V75, P377, DOI 10.1111/j.1574-6941.2010.01012.x	57	28	29	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e52377	10.1371/journal.pone.0052377	http://dx.doi.org/10.1371/journal.pone.0052377			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23285015	gold, Green Published, Green Submitted			2022-12-27	WOS:000312435900093
J	Puradiredja, DI; Coast, E				Puradiredja, Dewi Ismajani; Coast, Ernestina			Transactional Sex Risk across a Typology of Rural and Urban Female Sex Workers in Indonesia: A Mixed Methods Study	PLOS ONE			English	Article							CONDOM USE; EDUCATIONAL-ATTAINMENT; HIV PREVALENCE; DETERMINANTS; INFECTION; PARTNERS; BEHAVIOR; VIOLENCE; POVERTY; AFRICA	Context-specific typologies of female sex workers (FSWs) are essential for the design of HIV intervention programming. This study develops a novel FSW typology for the analysis of transactional sex risk in rural and urban settings in Indonesia. Mixed methods include a survey of rural and urban FSWs (n = 310), in-depth interviews (n = 11), key informant interviews (n = 5) and ethnographic assessments. Thematic analysis categorises FSWs into 5 distinct groups based on geographical location of their sex work settings, place of solicitation, and whether sex work is their primary occupation. Multiple regression analysis shows that the likelihood of consistent condom use was higher among urban venue-based FSWs for whom sex work is not the only source of income than for any of the other rural and urban FSW groups. This effect was explained by the significantly lower likelihood of consistent condom use by rural venue-based FSWs (adjusted OR: 0.34 95% CI 0.13-0.90, p = 0.029). The FSW typology and differences in organisational features and social dynamics are more closely related to the risk of unprotected transactional sex, than levels of condom awareness and availability. Interventions need context-specific strategies to reach the different FSWs identified by this study's typology.	[Puradiredja, Dewi Ismajani] London Sch Hyg & Trop Med, Dept Populat Hlth, London WC1, England; [Puradiredja, Dewi Ismajani; Coast, Ernestina] Univ London London Sch Econ & Polit Sci, Dept Social Policy, London WC2A 2AE, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School Economics & Political Science	Puradiredja, DI (corresponding author), London Sch Hyg & Trop Med, Dept Populat Hlth, London WC1, England.	jani.puradiredja@lshtm.ac.uk	Coast, Ernestina/C-7220-2012	Coast, Ernestina/0000-0002-8703-307X; Puradiredja, Dewi Ismajani/0000-0001-6390-9885	Economic and Social Science Research Council (ESRC) [ES.J004898.1]; Central Research Fund; ESRC [ES/J004898/1] Funding Source: UKRI; Economic and Social Research Council [ES/J004898/1] Funding Source: researchfish	Economic and Social Science Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Central Research Fund; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The work was supported by Economic and Social Science Research Council (ESRC) Grant ES.J004898.1 (http://www.esrc.ac.uk/); and Central Research Fund grants awarded in 2006 and 2007 respectively (http://www.london.ac.uk/awards_pg.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, BEH SURV SURV BSS DA; Blanchard JF, 2008, SEX TRANSM INFECT, V84, pII24, DOI 10.1136/sti.2008.033167; Bradley H, 2007, AIDS BEHAV, V11, P736, DOI 10.1007/s10461-006-9185-4; Buzdugan R, 2010, INT J EPIDEMIOL, V39, P439, DOI 10.1093/ije/dyp351; Choi SYP, 2007, CULT HEALTH SEX, V9, P489, DOI 10.1080/13691050701220446; Collumbien M, 2009, SEX TRANSM INFECT, V85, P3, DOI 10.1136/sti.2008.033571; Davidoff-Gore A, 2011, AIDS CARE, V23, P1282, DOI 10.1080/09540121.2011.555744; Deering KN, 2010, SEX TRANSM DIS, V37, P687, DOI 10.1097/OLQ.0b013e3181ecfeeb; Directorate of Communicable Disease Control and Environmental Health, 2008, MATH MOD HIV EP IND; Family Health International, 2007, BEH SURV SURV BSS DA; Fang XY, 2008, HEALTH CARE WOMEN IN, V29, P316, DOI 10.1080/07399330701738382; Gallo MF, 2011, J WOMENS HEALTH, V20, P733, DOI 10.1089/jwh.2010.2436; Geis S, 2011, JAIDS-J ACQ IMM DEF, V56, P453, DOI 10.1097/QAI.0b013e3182118fa3; Harcourt C, 2005, SEX TRANSM INFECT, V81, P201, DOI 10.1136/sti.2004.012468; Hargreaves JR, 2008, J EPIDEMIOL COMMUN H, V62, P113, DOI 10.1136/jech.2006.053827; Hargreaves JR, 2007, AIDS, V21, pS39, DOI 10.1097/01.aids.0000300534.97601.d6; Hargreaves JR, 2002, TROP MED INT HEALTH, V7, P489, DOI 10.1046/j.1365-3156.2002.00889.x; IndonesiaDHS, 2003, IND DEM HLTH SURV 20; IndonesiaDHS, 2007, IND DEM HLTH SURV 20; Kea Spratt, 2007, IMPLEMENTING 100 CON; Kusunoki Y, 2011, DEMOGRAPHY, V48, P1451, DOI 10.1007/s13524-011-0061-0; Li J, 2012, SEX TRANSM DIS, V39, P195, DOI 10.1097/OLQ.0b013e31823d2e2a; Li Q, 2010, SEX TRANSM DIS, V37, P700, DOI 10.1097/OLQ.0b013e3181e1a2b2; Liao SS, 2011, AIDS CARE, V23, P66, DOI 10.1080/09540121.2011.555742; Macaluso M, 2000, AIDS, V14, P537, DOI 10.1097/00002030-200003310-00009; Magnani R, 2005, AIDS, V19, pS67, DOI 10.1097/01.aids.0000172879.20628.e1; Medhi GK, 2012, AIDS CARE, V24, P369, DOI 10.1080/09540121.2011.608787; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; Ministry of Health Statistics Indonesia USAID FHI, 2007, INT BIOL BEH SURV MO; National AIDS Commission Republic of Indonesia, 2010, REP IND COUNTR REP F; Parks KA, 2011, AIDS BEHAV, V15, P1332, DOI 10.1007/s10461-010-9829-2; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Ramesh BA, 2008, AIDS, V22, pS35, DOI 10.1097/01.aids.0000343762.54831.5c; Shannon K, 2008, INT J DRUG POLICY, V19, P140, DOI 10.1016/j.drugpo.2007.11.024; Shannon K, 2008, SOC SCI MED, V66, P911, DOI 10.1016/j.socscimed.2007.11.008; Shannon K, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2939; Silverman D., 2006, INTERPRETING QUALITA, V3a; Smith J, 1999, INT J STD AIDS, V10, P452, DOI 10.1258/0956462991914456; Statistics Indonesia, 2005, BEH SURV SURV BSS RE; Strauss A., 1990, BASICS QUALITATIVE R; Stroeken K, 2012, AIDS CARE, V24, P186, DOI 10.1080/09540121.2011.596519; UN Joint Programme on HIV/AIDS, 2010, GLOB REP UNAIDS REP; van Lottum J, 2012, APPL ECON, V44, P4485, DOI 10.1080/00036846.2011.591735; Yang C, 2010, J URBAN HEALTH, V87, P292, DOI 10.1007/s11524-009-9431-y	44	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52858	10.1371/journal.pone.0052858	http://dx.doi.org/10.1371/journal.pone.0052858			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	064DQ	23285205	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000313051500071
J	Nolan-Stevaux, O; Zhong, WD; Culp, S; Shaffer, K; Hoover, J; Wickramasinghe, D; Ruefli-Brasse, A				Nolan-Stevaux, Olivier; Zhong, Wendy; Culp, Stacey; Shaffer, Kathy; Hoover, Joseph; Wickramasinghe, Dineli; Ruefli-Brasse, Astrid			Endoglin Requirement for BMP9 Signaling in Endothelial Cells Reveals New Mechanism of Action for Selective Anti-Endoglin Antibodies	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; RECEPTOR-LIKE KINASE-1; SMAD1/5 PHOSPHORYLATION; TUMOR-GROWTH; 1 ALK1; ANGIOGENESIS; EXPRESSION; VEGF; PROLIFERATION; PHASE	Endoglin (ENG), a co-receptor for several TGF beta-family cytokines, is expressed in dividing endothelial cells alongside ALK1, the ACVRL1 gene product. ENG and ACVRL1 are both required for angiogenesis and mutations in either gene are associated with Hereditary Hemorrhagic Telangectasia, a rare genetic vascular disorder. ENG and ALK1 function in the same genetic pathway but the relative contribution of TGF beta and BMP9 to SMAD1/5/8 activation and the requirement of ENG as a co-mediator of SMAD phosphorylation in endothelial cells remain debated. Here, we show that BMP9 and TGF beta 1 induce distinct SMAD phosphorylation responses in primary human endothelial cells and that, unlike BMP9, TGF beta only induces SMAD1/5/8 phosphorylation in a subset of immortalized mouse endothelial cell lines, but not in primary human endothelial cells. We also demonstrate, using siRNA depletion of ENG and novel anti-ENG antibodies, that ENG is required for BMP9/pSMAD1 signaling in all human and mouse endothelial cells tested. Finally, anti-ENG antibodies that interfere with BMP9/pSMAD1 signaling, but not with TGF beta 1/pSMAD3 signaling, also decrease in vitro HUVEC endothelial tube formation and inhibit BMP9 binding to recombinant ENG in vitro. Our data demonstrate that BMP9 signaling inhibition is a key and previously unreported mechanism of action of TRC105, an anti-angiogenic anti-Endoglin antibody currently evaluated in clinical trials.	[Nolan-Stevaux, Olivier; Zhong, Wendy; Wickramasinghe, Dineli; Ruefli-Brasse, Astrid] Amgen Inc, Oncol Res, San Francisco, CA USA; [Culp, Stacey; Shaffer, Kathy; Hoover, Joseph] Amgen Inc, Therapeut Discovery, Seattle, WA USA	Amgen; Amgen	Nolan-Stevaux, O (corresponding author), Amgen Inc, Oncol Res, San Francisco, CA USA.	oliviern@amgen.com		Nolan-Stevaux, Olivier/0000-0002-5934-4786	Amgen	Amgen(Amgen)	This work was performed at Amgen, solely supported by Amgen, and all authors are employed by Amgen. Monoclonal Rat anti-Human ENG Ab and monoclonal Rat anti-mouse Eng Ab (both developed at Amgen) were used in this study. The authors thank Dyke McEwen for running the first sets of HUVEC tube formation assays at Essen Bioscience. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Alt A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029948; Bailly S, 2008, BLOOD, V111, P478, DOI 10.1182/blood-2007-10-118042; Bernabeu C, 2009, BBA-MOL BASIS DIS, V1792, P954, DOI 10.1016/j.bbadis.2009.07.003; Bidart M, 2012, CELL MOL LIFE SCI, V69, P313, DOI 10.1007/s00018-011-0751-1; Bishop E T, 1999, Angiogenesis, V3, P335, DOI 10.1023/A:1026546219962; Blanco FJ, 2005, J CELL PHYSIOL, V204, P574, DOI 10.1002/jcp.20311; Bostrom K, 2004, J BIOL CHEM, V279, P52904, DOI 10.1074/jbc.M406868200; Bourdeau A, 1999, J CLIN INVEST, V104, P1343, DOI 10.1172/JCI8088; Brown MA, 2005, J BIOL CHEM, V280, P25111, DOI 10.1074/jbc.M503328200; Castonguay R, 2011, J BIOL CHEM, V286, P30034, DOI 10.1074/jbc.M111.260133; CHEIFETZ S, 1992, J BIOL CHEM, V267, P19027; Cunha SI, 2011, BLOOD, V117, P6999, DOI 10.1182/blood-2011-01-330142; Cunha SI, 2010, J EXP MED, V207, P85, DOI 10.1084/jem.20091309; Dallas NA, 2008, CLIN CANCER RES, V14, P1931, DOI 10.1158/1078-0432.CCR-07-4478; Daly AC, 2008, MOL CELL BIOL, V28, P6889, DOI 10.1128/MCB.01192-08; David L, 2008, CIRC RES, V102, P914, DOI 10.1161/CIRCRESAHA.107.165530; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; David L, 2009, CYTOKINE GROWTH F R, V20, P203, DOI 10.1016/j.cytogfr.2009.05.001; Duwel A, 2007, TUMOR BIOL, V28, P1, DOI 10.1159/000097040; Evensen L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005798; Fernandez-L A, 2005, CARDIOVASC RES, V68, P235, DOI 10.1016/j.cardiores.2005.06.009; Gazit-Bornstein G, 2010, ANTIBODIES DIRECTED; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Koleva RI, 2006, J BIOL CHEM, V281, P25110, DOI 10.1074/jbc.M601288200; Lamouille S, 2002, BLOOD, V100, P4495, DOI 10.1182/blood.V100.13.4495; Lebrin F, 2004, EMBO J, V23, P4018, DOI 10.1038/sj.emboj.7600386; Lebrin F, 2008, TRENDS CARDIOVAS MED, V18, P25, DOI 10.1016/j.tcm.2007.11.003; Li DY, 1999, SCIENCE, V284, P1534, DOI 10.1126/science.284.5419.1534; Liu IM, 2009, EMBO J, V28, P88, DOI 10.1038/emboj.2008.266; Llorca O, 2007, J MOL BIOL, V365, P694, DOI 10.1016/j.jmb.2006.10.015; Lopez-Novoa JM, 2010, AM J PHYSIOL-HEART C, V299, pH959, DOI 10.1152/ajpheart.01251.2009; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Mitchell D, 2010, MOL CANCER THER, V9, P379, DOI 10.1158/1535-7163.MCT-09-0650; Morris E, 2011, J CELL PHYSIOL, V226, P3340, DOI 10.1002/jcp.22690; Nolan-Stevaux O, 2012, TUMOR ANGIOGENESIS, P85; Pardali E, 2010, TRENDS CELL BIOL, V20, P556, DOI 10.1016/j.tcb.2010.06.006; Pece-Barbara N, 1999, HUM MOL GENET, V8, P2171, DOI 10.1093/hmg/8.12.2171; Rosen LS, 2012, CLIN CANCER RES, V18, P4820, DOI 10.1158/1078-0432.CCR-12-0098; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Seon BK, 2011, CURR DRUG DELIV, V8, P135; Shao ES, 2009, BLOOD, V114, P2197, DOI 10.1182/blood-2009-01-199166; She X, 2003, THESIS STATE U NEW Y; Sorensen LK, 2003, DEV BIOL, V261, P235, DOI 10.1016/S0012-1606(03)00158-1; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Tsujie M, 2008, INT J CANCER, V122, P2266, DOI 10.1002/ijc.23314; Upton PD, 2009, J BIOL CHEM, V284, P15794, DOI 10.1074/jbc.M109.002881; Urness LD, 2000, NAT GENET, V26, P328, DOI 10.1038/81634; van Meeteren LA, 2011, CELL TISSUE RES; van Meeteren LA, 2012, J BIOL CHEM, V287, P18551, DOI 10.1074/jbc.M111.338103; van Meeteren LA, 2011, CURR PHARM BIOTECHNO, V12, P2108; WAKEFIELD LM, 1995, CLIN CANCER RES, V1, P129; Wrighton KH, 2009, J BIOL CHEM, V284, P9755, DOI 10.1074/jbc.M809223200; YAMASHITA H, 1994, J BIOL CHEM, V269, P1995	53	71	91	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e50920	10.1371/journal.pone.0050920	http://dx.doi.org/10.1371/journal.pone.0050920			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300529	Green Published, gold, Green Submitted			2022-12-27	WOS:000312829100005
J	Russo, RR; Dasa, V; Duarte, R; Beakley, B; Mishra, M; Thompson, H				Russo, Russell R.; Dasa, Vinod; Duarte, Robert; Beakley, Burton; Mishra, Manish; Thompson, Hilary			Post-Operative Hypertension after Total Knee Arthroplasty and the Effects on Transfusion Rates	PLOS ONE			English	Article							BLOOD-TRANSFUSION; TOTAL HIP	Transfusions are a cause of significant patient morbidity as well as expense. Anesthesia literature has examined controlled intraoperative hypotension as a means for reducing blood loss and transfusions. Our hypothesis is that inversely increased blood pressure post-operatively would then lead to increased blood loss and transfusions. We examined 105 consecutive patients who underwent TKA. We found a significant odds ratio of 1.123 for pre-operative hematocrit. For post-operative blood pressure, we calculated an insignificant odds ratio of 1.007, proving no relationship between post-operative blood pressure and transfusions. This is the first study to examine increased post-operative blood pressure's contribution to transfusion rates. Although we confirmed that low pre-operative hematocrit contributes to increased transfusions, we did not find a relationship between post-operative blood pressure and transfusions.	[Russo, Russell R.; Dasa, Vinod; Duarte, Robert] Louisiana State Univ, Hlth Sci Ctr, Dept Orthoped Surg, New Orleans, LA USA; [Beakley, Burton] Louisiana State Univ, Sch Med, Hlth Sci Ctr, Shreveport, LA USA; [Mishra, Manish] Tulane Sch Med, New Orleans, LA USA; [Thompson, Hilary] Louisiana State Univ, Hlth Sci Ctr, Dept Biostat, New Orleans, LA USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Tulane University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Russo, RR (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Orthoped Surg, New Orleans, LA USA.	rrusso@lsuhsc.edu		dasa, vinod/0000-0001-5282-4026; Russo, Russell/0000-0002-6465-4746				Bong MR, 2004, J ARTHROPLASTY, V19, P281, DOI 10.1016/j.arth.2003.10.013; ETCHASON J, 1995, NEW ENGL J MED, V332, P719, DOI 10.1056/NEJM199503163321106; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Juelsgaard P, 2001, REGIONAL ANESTHESIA, V26, P2; Kourtzis N, 2004, AM J SURG, V187, P261, DOI 10.1016/j.amjsurg.2003.11.022; Kurtz S, 2005, J BONE JOINT SURG AM, V87A, P1487, DOI 10.2106/JBJS.D.02441; Lee GC, 2005, CLIN ORTHOP RELAT R, P170, DOI 10.1097/01.blo.0000187338.25250.6a; Levy O, 1999, J BONE JOINT SURG AM, V81A, P1580, DOI 10.2106/00004623-199911000-00010; Mesa-Ramos F, 2008, ACTA ORTHOP BELG, V74, P83; Shander A, 2010, TRANSFUSION, V50, P753, DOI 10.1111/j.1537-2995.2009.02518.x; SooHoo NF, 2006, J BONE JOINT SURG AM, V88A, P480, DOI 10.2106/JBJS.E.00629; THOMPSON GE, 1978, ANESTHESIOLOGY, V48, P91, DOI 10.1097/00000542-197802000-00003	12	1	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e50967	10.1371/journal.pone.0050967	http://dx.doi.org/10.1371/journal.pone.0050967			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300531	gold, Green Published, Green Submitted			2022-12-27	WOS:000313618800009
J	Hughes, CE; Radhakrishnan, UP; Lordkipanidze, M; Egginton, S; Dijkstra, JM; Jagadeeswaran, P; Watson, SP				Hughes, Craig E.; Radhakrishnan, Uvaraj P.; Lordkipanidze, Marie; Egginton, Stuart; Dijkstra, Johannes M.; Jagadeeswaran, Pudur; Watson, Stephen P.			G6f-Like Is an ITAM-Containing Collagen Receptor in Thrombocytes	PLOS ONE			English	Article							GLYCOPROTEIN-VI; VASCULAR OCCLUSION; THROMBUS FORMATION; GAMMA-CHAIN; CELL-LINES; IN-VIVO; ZEBRAFISH; PLATELETS; CLEC-2; HEMOSTASIS	Collagen activates mammalian platelets through a complex of the immunoglobulin (Ig) receptor GPVI and the Fc receptor gamma-chain, which has an immunoreceptor tyrosine-based activation motif (ITAM). Cross-linking of GPVI mediates activation through the sequential activation of Src and Syk family kinases and activation of PLC gamma 2. Nucleated thrombocytes in fish are activated by collagen but lack an ortholog of GPVI. In this study we show that collagen activates trout thrombocytes in whole blood and under flow conditions through a Src kinase driven pathway. We identify the Ig receptor G6f-like as a collagen receptor and demonstrate in a cell line assay that it signals through its cytoplasmic ITAM. Using a morpholino for in vivo knock-down of G6f-like levels in zebrafish, we observed a marked delay or absence of occlusion of the venous and arterial systems in response to laser injury. Thus, G6f-like is a physiologically relevant collagen receptor in fish thrombocytes which signals through the same ITAM-based signalling pathway as mammalian GPVI, providing a novel example of convergent evolution.	[Hughes, Craig E.; Lordkipanidze, Marie; Egginton, Stuart; Watson, Stephen P.] Univ Birmingham, Inst Biomed Res, Ctr Cardiovasc Sci, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Radhakrishnan, Uvaraj P.; Jagadeeswaran, Pudur] Univ N Texas, Dept Biol Sci, Denton, TX 76203 USA; [Dijkstra, Johannes M.] Fujita Hlth Univ, Inst Comprehens Med Sci, Toyoake, Aichi, Japan	University of Birmingham; University of North Texas System; University of North Texas Denton; Fujita Health University	Hughes, CE (corresponding author), Univ Birmingham, Inst Biomed Res, Ctr Cardiovasc Sci, Coll Med & Dent Sci, Birmingham, W Midlands, England.	c.e.hughes@bham.ac.uk	Lordkipanidzé, Marie/E-6222-2011; Watson, Stephen P/Q-6292-2016	Lordkipanidzé, Marie/0000-0001-7418-6766; Watson, Stephen P/0000-0002-7846-7423; Hughes, Craig/0000-0002-9790-5820; Egginton, Stuart/0000-0002-3084-9692	Wellcome Trust [073107, 088410]; British Heart Foundation [PG/07/116, PG/05/134]; National Institutes of Health [HL077910]; British Heart Foundation [PG/11/31/28835, RG/09/007/27917] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077910] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); British Heart Foundation(British Heart Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Wellcome Trust (073107 and 088410), the British Heart Foundation (PG/07/116 and PG/05/134), and the National Institutes of Health (HL077910). SPW holds a BHF Chair (CH/03/003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BABA TW, 1985, VIROLOGY, V144, P139, DOI 10.1016/0042-6822(85)90312-5; BorschHaubold AG, 1997, EUR J BIOCHEM, V245, P751, DOI 10.1111/j.1432-1033.1997.t01-1-00751.x; Dawood BB, 2007, PLATELETS, V18, P329, DOI 10.1080/09537100601024111; Fuller GLJ, 2007, J BIOL CHEM, V282, P12397, DOI 10.1074/jbc.M609558200; Garcia A, 2006, PROTEOMICS, V6, P5332, DOI 10.1002/pmic.200600299; Gibbins J, 1996, J BIOL CHEM, V271, P18095, DOI 10.1074/jbc.271.30.18095; Gregory M, 2002, BLOOD CELL MOL DIS, V29, P286, DOI 10.1006/bcmd.2002.0568; Guo P, 2009, NATURE, V459, P796, DOI 10.1038/nature08068; Hechler B, 2009, J THROMB HAEMOST; Hughes CE, 2008, J THROMB HAEMOST, V6, P2152, DOI 10.1111/j.1538-7836.2008.03166.x; Hughes CE, 2010, BLOOD, V115, P2947, DOI 10.1182/blood-2009-08-237834; Inoue O, 2003, J CELL BIOL, V160, P769, DOI 10.1083/jcb.200208043; Jagadeeswaran P, 2004, METHOD CELL BIOL, V76, P489; Jagadeeswaran P, 2005, J THROMB HAEMOST, V3, P46, DOI 10.1111/j.1538-7836.2004.00999.x; Jagadeeswaran P, 1999, BRIT J HAEMATOL, V107, P731, DOI 10.1046/j.1365-2141.1999.01763.x; Jagadeeswaran P, 2011, METHOD CELL BIOL, V101, P197, DOI 10.1016/B978-0-12-387036-0.00009-8; Kalia N, 2008, MICROCIRCULATION, V15, P325, DOI 10.1080/10739680701728822; Kim S, 2010, BLOOD CELL MOL DIS, V44, P169, DOI 10.1016/j.bcmd.2009.12.004; Kim S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008403; Kollner B, 2004, DEV COMP IMMUNOL, V28, P1049, DOI 10.1016/j.dci.2004.03.004; Mori J, 2008, J BIOL CHEM, V283, P35419, DOI 10.1074/jbc.M806895200; Munnix ICA, 2005, ARTERIOSCL THROM VAS, V25, P2673, DOI 10.1161/01.ATV.0000193568.71980.4a; Nash CA, 2010, J THROMB HAEMOST, V8, P2273, DOI 10.1111/j.1538-7836.2010.03992.x; Ohashi K, 2010, IMMUNOGENETICS, V62, P543, DOI 10.1007/s00251-010-0460-1; Smethurst PA, 2007, J BIOL CHEM, V282, P1296, DOI 10.1074/jbc.M606479200; Tomlinson MG, 2007, J THROMB HAEMOST, V5, P2274, DOI 10.1111/j.1538-7836.2007.02746.x; Tomlinson MG, 2004, MOL CELL BIOL, V24, P2455, DOI 10.1128/MCB.24.6.2455-2466.2004	27	4	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52622	10.1371/journal.pone.0052622	http://dx.doi.org/10.1371/journal.pone.0052622			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285115	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000313158800082
J	Chalencon, S; Busso, T; Lacour, JR; Garet, M; Pichot, V; Connes, P; Gabel, CP; Roche, F; Barthelemy, JC				Chalencon, Sebastien; Busso, Thierry; Lacour, Jean-Rene; Garet, Martin; Pichot, Vincent; Connes, Philippe; Gabel, Charles Philip; Roche, Frederic; Barthelemy, Jean Claude			A Model for the Training Effects in Swimming Demonstrates a Strong Relationship between Parasympathetic Activity, Performance and Index of Fatigue	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; SYSTEMS-MODEL; RESPONSES; EXERCISE; TAPER; FREQUENCY; DYNAMICS	Competitive swimming as a physical activity results in changes to the activity level of the autonomic nervous system (ANS). However, the precise relationship between ANS activity, fatigue and sports performance remains contentious. To address this problem and build a model to support a consistent relationship, data were gathered from national and regional swimmers during two 30 consecutive-week training periods. Nocturnal ANS activity was measured weekly and quantified through wavelet transform analysis of the recorded heart rate variability. Performance was then measured through a subsequent morning 400 meters freestyle time-trial. A model was proposed where indices of fatigue were computed using Banister's two antagonistic component model of fatigue and adaptation applied to both the ANS activity and the performance. This demonstrated that a logarithmic relationship existed between performance and ANS activity for each subject. There was a high degree of model fit between the measured and calculated performance (R-2 = 0.84 +/- 0.14, p<0.01) and the measured and calculated High Frequency (HF) power of the ANS activity (R-2 = 0.79 +/- 0.07, p<0.01). During the taper periods, improvements in measured performance and measured HF were strongly related. In the model, variations in performance were related to significant reductions in the level of 'Negative Influences' rather than increases in 'Positive Influences'. Furthermore, the delay needed to return to the initial performance level was highly correlated to the delay required to return to the initial HF power level (p<0.01). The delay required to reach peak performance was highly correlated to the delay required to reach the maximal level of HF power (p = 0.02). Building the ANS/performance identity of a subject, including the time to peak HF, may help predict the maximal performance that could be obtained at a given time. Citation: Chalencon S, Busso T, Lacour J-R, Garet M, Pichot V, et al. (2012) A Model for the Training Effects in Swimming Demonstrates a Strong Relationship between Parasympathetic Activity, Performance and Index of Fatigue. PLoS ONE 7(12): e52636. doi:10.1371/journal.pone. 0052636	[Chalencon, Sebastien; Lacour, Jean-Rene; Garet, Martin; Pichot, Vincent; Roche, Frederic; Barthelemy, Jean Claude] Univ St Etienne, PRES Lyon, SNA EPIS, Lab EA4607, St Etienne, France; [Busso, Thierry] Univ St Etienne, PRES Lyon, Exercise Physiol Lab, EA4338, St Etienne, France; [Connes, Philippe] Ricou Hosp, Acad Hosp Pointe A Pitre, UMR Inserm 665, Pointe A Pitre, Guadeloupe, France; [Gabel, Charles Philip] Univ Sunshine Coast, Sippy Downs, Qld, Australia	Universite Jean Monnet; Universite Jean Monnet; CHU Guadeloupe; Institut National de la Sante et de la Recherche Medicale (Inserm); University of the Sunshine Coast	Chalencon, S (corresponding author), Univ St Etienne, PRES Lyon, SNA EPIS, Lab EA4607, St Etienne, France.	seb.chalencon@gmail.com	Connes, Philippe/J-7835-2019; Busso, Thierry/AAG-1970-2019; Barthelemy, Jean-Claude/AAE-7180-2019	Connes, Philippe/0000-0002-9232-0268; Busso, Thierry/0000-0002-5042-4384; Philippe, Connes/0000-0001-8449-7998; Roche, Frederic/0000-0001-6115-7958; Gabel, Charles Philip/0000-0001-8354-4545				Banister E, 1982, PHYSL TESTING HIGH P; BANISTER EW, 1985, EUR J APPL PHYSIOL, V54, P16, DOI 10.1007/BF00426292; Banister EW, 1975, AUST J SPORTS MED, V7, P57; Bosquet L, 2007, MED SCI SPORT EXER, V39, P1358, DOI 10.1249/mss.0b013e31806010e0; Busso T, 2003, MED SCI SPORT EXER, V35, P1188, DOI 10.1249/01.MSS.0000074465.13621.37; BUSSO T, 1990, EUR J APPL PHYSIOL, V61, P48, DOI 10.1007/BF00236693; Busso T, 2002, J APPL PHYSIOL, V92, P572, DOI 10.1152/japplphysiol.00429.2001; BUSSO T, 1991, J APPL PHYSIOL, V71, P2044, DOI 10.1152/jappl.1991.71.5.2044; BUSSO T, 1992, EUR J APPL PHYSIOL, V64, P381, DOI 10.1007/BF00636228; CALVERT TW, 1976, IEEE T SYST MAN CYB, V6, P94, DOI 10.1109/TSMC.1976.5409179; Casey A, 2000, AM J PHYSIOL-ENDOC M, V278, pE65, DOI 10.1152/ajpendo.2000.278.1.E65; FITZCLARKE JR, 1991, J APPL PHYSIOL, V71, P1151, DOI 10.1152/jappl.1991.71.3.1151; FRY RW, 1992, CAN J SPORT SCI, V17, P241; FRY RW, 1992, EUR J APPL PHYSIOL O, V64, P335, DOI 10.1007/BF00636221; FURLAN R, 1993, CARDIOVASC RES, V27, P482, DOI 10.1093/cvr/27.3.482; Garet M, 2004, MED SCI SPORT EXER, V36, P2112, DOI 10.1249/01.MSS.0000147588.28955.48; Goldberger JJ, 2001, CIRCULATION, V103, P1977; Hautala AJ, 2003, AM J PHYSIOL-HEART C, V285, pH1747, DOI 10.1152/ajpheart.00202.2003; Hedelin R, 2001, MED SCI SPORT EXER, V33, P1394, DOI 10.1097/00005768-200108000-00023; JensenUrstad K, 1997, SCAND J MED SCI SPOR, V7, P274; Kenney WL., 1988, EXERCISE PHYSL CURRE, P59; Kiviniemi AM, 2007, EUR J APPL PHYSIOL, V101, P743, DOI 10.1007/s00421-007-0552-2; KUIPERS H, 1988, SPORTS MED, V6, P79, DOI 10.2165/00007256-198806020-00003; Mujika I, 1996, MED SCI SPORT EXER, V28, P251, DOI 10.1097/00005768-199602000-00015; Mujika I, 1998, INT J SPORTS MED, V19, P439, DOI 10.1055/s-2007-971942; Mujika I, 2003, MED SCI SPORT EXER, V35, P1182, DOI 10.1249/01.MSS.0000074448.73931.11; Pichot V, 1999, J APPL PHYSIOL, V86, P1081, DOI 10.1152/jappl.1999.86.3.1081; Pichot V, 2002, PFLUG ARCH EUR J PHY, V445, P267, DOI 10.1007/s00424-002-0917-7; Pichot V, 2000, MED SCI SPORT EXER, V32, P1729, DOI 10.1097/00005768-200010000-00011; Thomas L, 2005, MED SCI SPORT EXER, V37, P1615, DOI 10.1249/01.mss.0000177461.94156.4b; Thomas L, 2008, J SPORT SCI, V26, P643, DOI 10.1080/02640410701716782; Thomas L, 2009, J STRENGTH COND RES, V23, P1729, DOI 10.1519/JSC.0b013e3181b3dfa1; Tulppo MP, 1998, AM J PHYSIOL-HEART C, V274, pH810, DOI 10.1152/ajpheart.1998.274.3.H810; WENGER HA, 1986, SPORTS MED, V3, P346, DOI 10.2165/00007256-198603050-00004	34	36	37	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52636	10.1371/journal.pone.0052636	http://dx.doi.org/10.1371/journal.pone.0052636			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285121	gold, Green Submitted, Green Published			2022-12-27	WOS:000312794500215
J	Fatihah, HNN; Mat, N; Zaimah, ARN; Zuhailah, MN; Norhaslinda, H; Khairil, M; Ghani, AY; Ali, AM				Fatihah, Hasan N. N.; Mat, Nashriyah; Zaimah, Abdul R. N.; Zuhailah, Mazlan N.; Norhaslinda, Haron; Khairil, Mahmud; Ghani, Abdul Y.; Ali, Abdul M.			Morphological Phylogenetic Analysis of Seven Varieties of Ficus deltoidea Jack from the Malay Peninsula of Malaysia	PLOS ONE			English	Article							MORACEAE; EXTRACT	This study is the first report to suggest a morphological phylogenetic framework for the seven varieties of Ficus deltoidea Jack (Ficus: Moraceae) from the Malay Peninsula of Malaysia. Several molecular-based classifications on the genus Ficus had been proposed, but neither had discussed the relationship between seven varieties of F. deltoidea to its allies nor within the varieties. The relationship between seven varieties of F. deltoidea is still debated due to the extreme morphological variabilities and ambiguous boundaries between taxa. Thus, the correct identification of these varieties is important as several morphological characters are variety-specific. To test the monophyly and further resolved the relationship in F. deltoidea, a morphological phylogenetic analysis was conducted based on herbarium specimens representing the seven varieties of F. deltoidea that were collected from the Malay Peninsula of Malaysia, by using related species of the genus Ficus; F. grossularioides, F. ischnopoda and F. oleifolia as the outgroups. Parsimony and neighbour-joining analyses indicated that F. deltoidea is monophyletic, in that the seven varieties of F. deltoidea nested into two clades; clade subspecies deltoidea (var. deltoidea, var. bilobata, var. angustifolia, var. kunstleri and var. trengganuensis) and clade subspecies motleyana (var. intermedia and var. motleyana).	[Fatihah, Hasan N. N.; Mat, Nashriyah; Zaimah, Abdul R. N.; Zuhailah, Mazlan N.; Norhaslinda, Haron; Khairil, Mahmud; Ghani, Abdul Y.] Univ Sultan Zainal Abidin, Dept Agr Sci, Fac Agr & Biotechnol, Terengganu, Malaysia; [Ali, Abdul M.] Univ Sultan Zainal Abidin, Dept Biotechnol, Fac Agr & Biotechnol, Terengganu, Malaysia	Universiti Sultan Zainal Abidin; Universiti Sultan Zainal Abidin	Mat, N (corresponding author), Univ Sultan Zainal Abidin, Dept Agr Sci, Fac Agr & Biotechnol, Gong Badak Campus, Terengganu, Malaysia.	nashriyah@unisza.edu.my	Fatihah, Hasan Nudin Nur/G-1730-2013	Mahmud, Khairil/0000-0002-6758-2995; Nur Fatihah, Hasan Nudin/0000-0002-6721-0067	Universiti Sultan Zainal Abidin's grant [UDM/09/BR (0013)]	Universiti Sultan Zainal Abidin's grant	This study was supported by a Universiti Sultan Zainal Abidin's grant; with a reference number of UDM/09/BR (0013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam Z, 2011, SAINS MALAYS, V40, P489; Bailey LH, 1976, HORTUS; Berg CC, 2003, BLUMEA, V48, P529; Berg CC, 2005, FLORA MALESIANA 1, V17, P1702; Corner E.J.H., 1960, GARD B SINGAPORE, V17, P416; CORNER EJH, 1969, PHILOS T ROY SOC B, V256, P281, DOI 10.1098/rstb.1969.0043; Farsi E, 2011, AFR J BIOTECHNOL, V10, P15184, DOI 10.5897/AJB11.1365; Fatihah HNN, 2012, S AFR J BOT, V83, P78, DOI 10.1016/j.sajb.2012.07.010; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Hoberg EP, 1999, SYST PARASITOL, V42, P51, DOI 10.1023/A:1006100629059; KAMARUDIN MS, 2002, TUMBUHAN UBATAN MALA; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kochummen K. M., 1998, Gardens' Bulletin (Singapore), V50, P197; Kochummen KM, 1978, TREE FLORA MALAYA MA, V3, P119; Kress WJ, 2002, AM J BOT, V89, P1682, DOI 10.3732/ajb.89.10.1682; Mat N, 2012, SAINS MALAYS, V41, P527; Musa Y., 2005, B TEKNOL TANAM, V2, P35; Norhaniza Aminudin, 2007, Malaysian Journal of Science, V26, P73; Omar MH, 2011, J AGR FOOD CHEM, V59, P1363, DOI 10.1021/jf1032729; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pennington RT, 1996, SYST BIOL, V45, P496, DOI 10.2307/2413527; Ronsted N, 2008, SYMBIOSIS, V45, P45; Ronsted N, 2005, P ROY SOC B-BIOL SCI, V272, P2593, DOI 10.1098/rspb.2005.3249; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sata N., 1944, MONOGRAPHIC STUDY GE; Subhash JB, 2009, J FOR SCI, V25, P57; Swofford DL, 2002, PAUP PHYLOGENETIC AN; USDA, 2007, ARS NAT GEN RES PROG; WATROUS LE, 1981, SYST ZOOL, V30, P1, DOI 10.2307/2992297	30	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52441	10.1371/journal.pone.0052441	http://dx.doi.org/10.1371/journal.pone.0052441			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285045	Green Submitted, gold, Green Published			2022-12-27	WOS:000312794500171
J	Gao, XL; Gigoux, M; Yang, J; Leconte, J; Yang, X; Suh, WK				Gao, Xiaoling; Gigoux, Mathieu; Yang, Jie; Leconte, Julien; Yang, Xi; Suh, Woong-Kyung			Anti-Chlamydial Th17 Responses Are Controlled by the Inducible Costimulator Partially through Phosphoinositide 3-Kinase Signaling	PLOS ONE			English	Article							GENITAL-TRACT INFECTION; CELL-DEFICIENT MICE; CD4(+) T-CELLS; IMMUNE-RESPONSES; MOLECULE ICOS; IFN-GAMMA; PROTECTIVE IMMUNITY; DENDRITIC CELLS; TRACHOMATIS; MURIDARUM	We previously showed that mice deficient in the Inducible Costimulator ligand (ICOSL-KO) develop more severe disease and lung pathology with delayed bacterial clearance upon respiratory infection of Chlamydia muridarum. Importantly, the exacerbation of disease in ICOSL-KO mice was seen despite heightened IFN-gamma/Th1 responses, the major defense mechanisms against Chlamydia. To gain insight into the mechanism of ICOS function in this model, we presently analyzed anti-Chlamydia immune responses in mice lacking the entire ICOS (ICOS-KO) versus knock-in mice expressing a mutant ICOS (ICOS-Y181F) that has selectively lost the ability to activate phosphoinositide 3-kinase (PI3K). Like ICOSL-KO mice, ICOS-KO mice showed worse disease with elevated IFN-gamma/Th1 responses compared to wild-type (WT) mice. ICOS-Y181F mice developed much milder disease compared to ICOS-KO mice, yet they were still not fully protected to the WT level. This partial protection in ICOS-Y181F mice could not be explained by the magnitude of IFN-gamma/Th1 responses since these mice developed a similar level of IFN-gamma response compared to WT mice. It was rather IL-17/Th17 responses that reflected disease severity: IL-17/Th17 response was partially impaired in ICOS-Y181F mice compared to WT, but was substantially stronger than that of ICOS-KO mice. Consistently, we found that both polarization and expansion of Th17 cells were partially impaired in ICOS-Y181F CD4 T cells, and was further reduced in ICOS-KO CD4 T cells in vitro. Our results indicate that once the IFN-gamma/Th1 response is above a threshold level, the IL-17/Th17 response becomes a limiting factor in controlling Chlamydia lung infection, and that ICOS plays an important role in promoting Th17 responses in part through the activation of PI3K.	[Gao, Xiaoling; Yang, Jie; Yang, Xi] Univ Manitoba, Fac Med, Lab Infect & Immun, Dept Med Microbiol, Winnipeg, MB, Canada; [Gigoux, Mathieu; Leconte, Julien; Suh, Woong-Kyung] Inst Rech Clin Montreal, Immune Regulat Lab, Montreal, PQ H2W 1R7, Canada; [Gigoux, Mathieu; Suh, Woong-Kyung] McGill Univ, Fac Med, Dept Microbiol & Immunol, Montreal, PQ, Canada; [Leconte, Julien; Suh, Woong-Kyung] Univ Montreal, Dept Microbiol & Immunol, Montreal, PQ H3C 3J7, Canada; [Suh, Woong-Kyung] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada	University of Manitoba; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; McGill University; Universite de Montreal; Universite de Montreal	Yang, X (corresponding author), Univ Manitoba, Fac Med, Lab Infect & Immun, Dept Med Microbiol, Winnipeg, MB, Canada.	yangxi@cc.umanitoba.ca; woong-kyung.suh@ircm.qc.ca	Gao, xiao ling/GQI-2790-2022	Suh, Woong-Kyung/0000-0002-6420-3283; Yang, Xi/0000-0002-8831-7488; Gigoux, Mathieu/0000-0002-1831-7597	Canadian Institutes of Health Research (CIHR) [ROP100410, MOP84544]; Manitoba Health Research Council	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Manitoba Health Research Council	This work was supported by grants from Canadian Institutes of Health Research (CIHR)(http://www.cihr-irsc.gc.ca/) [ROP100410 (XY) and MOP84544 (WKS)] and Manitoba Health Research Council (XY). XY holds Canada Research Chair in Infection and Immunity and W-KS is a CIHR New Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai H, 2009, J IMMUNOL, V183, P5886, DOI 10.4049/jimmunol.0901584; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Bilenki L, 2006, J IMMUNOL, V177, P7067, DOI 10.4049/jimmunol.177.10.7067; Bonhagen K, 2003, EUR J IMMUNOL, V33, P392, DOI 10.1002/immu.200310013; Brunham RC, 2005, NAT REV IMMUNOL, V5, P149, DOI 10.1038/nri1551; BYRNE GI, 1987, J INFECT DIS, V156, P993, DOI 10.1093/infdis/156.6.993; Coyle AJ, 2000, IMMUNITY, V13, P95, DOI 10.1016/S1074-7613(00)00011-X; Darville T, 2003, J IMMUNOL, V171, P6187, DOI 10.4049/jimmunol.171.11.6187; Dong C, 2001, NATURE, V409, P97, DOI 10.1038/35051100; Farris CM, 2010, INFECT IMMUN, V78, P4374, DOI 10.1128/IAI.00622-10; Gigoux M, 2009, P NATL ACAD SCI USA, V106, P20371, DOI 10.1073/pnas.0911573106; Gondek DC, 2009, J IMMUNOL, V183, P1313, DOI 10.4049/jimmunol.0900295; Hamada S, 2008, J IMMUNOL, V181, P3456, DOI 10.4049/jimmunol.181.5.3456; Haylock-Jacobs S, 2011, J AUTOIMMUN, V36, P278, DOI 10.1016/j.jaut.2011.02.006; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; Jiao L, 2011, J IMMUNOL, V187, P401, DOI 10.4049/jimmunol.1002519; Johansson M, 1997, IMMUNOLOGY, V92, P422, DOI 10.1046/j.1365-2567.1997.00378.x; Kadkhoda K, 2010, J IMMUNOL, V184, P3780, DOI 10.4049/jimmunol.0901384; Khader SA, 2010, VIRULENCE, V1, P423, DOI 10.4161/viru.1.5.12862; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Li WD, 2008, J IMMUNOL, V180, P3375, DOI 10.4049/jimmunol.180.5.3375; Lin YY, 2009, IMMUNITY, V31, P799, DOI 10.1016/j.immuni.2009.08.025; Lu H, 2002, J IMMUNOL, V169, P6324, DOI 10.4049/jimmunol.169.11.6324; McAdam AJ, 2001, NATURE, V409, P102, DOI 10.1038/35051107; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Paulos CM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000448; Qiu HY, 2008, J IMMUNOL, V181, P2092, DOI 10.4049/jimmunol.181.3.2092; Rottman JB, 2001, NAT IMMUNOL, V2, P605, DOI 10.1038/89750; Schaefer JS, 2010, J LEUKOCYTE BIOL, V87, P301, DOI 10.1189/jlb.0409238; Schulz SM, 2008, INT IMMUNOL, V20, P1129, DOI 10.1093/intimm/dxn069; Scurlock AM, 2011, INFECT IMMUN, V79, P1349, DOI 10.1128/IAI.00984-10; Suh WK, 2004, J IMMUNOL, V172, P5917, DOI 10.4049/jimmunol.172.10.5917; Tafuri A, 2001, NATURE, V409, P105, DOI 10.1038/35051113; Umemura M, 2007, J IMMUNOL, V178, P3786, DOI 10.4049/jimmunol.178.6.3786; WILLIAMS DM, 1987, INFECT IMMUN, V55, P2387, DOI 10.1128/IAI.55.10.2387-2390.1987; WILLIAMS DM, 1988, INFECT IMMUN, V56, P3004, DOI 10.1128/IAI.56.11.3004-3006.1988; Yang X, 1996, J IMMUNOL, V156, P4338; Ye P, 2001, AM J RESP CELL MOL, V25, P335, DOI 10.1165/ajrcmb.25.3.4424; Zhang XY, 2009, J IMMUNOL, V183, P1291, DOI 10.4049/jimmunol.0803075; Zhang YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039214	40	22	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52657	10.1371/journal.pone.0052657	http://dx.doi.org/10.1371/journal.pone.0052657			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285133	Green Submitted, gold, Green Published			2022-12-27	WOS:000312794500222
J	Lyabin, DN; Eliseeva, IA; Ovchinnikov, LP				Lyabin, Dmitry N.; Eliseeva, Irina A.; Ovchinnikov, Lev P.			YB-1 Synthesis Is Regulated by mTOR Signaling Pathway	PLOS ONE			English	Article							Y-BOX PROTEIN-1; TRANSCRIPTION FACTOR YB-1; MESSENGER-RNA; IN-VITRO; EXPRESSION; TRANSLATION; PROMOTES; CANCER; DNA; INITIATION	YB-1 is a eukaryotic protein with numerous intra-and extracellular functions based on its ability to interact with RNA, DNA, and many proteins. In spite of achievements in studying its functions, regulation of YB-1 synthesis in the cell remains poorly understood. In the current study Western and Northern blotting were used to determine the amounts of YB-1 and YB-1 mRNA in rabbit organs and several cell lines. As found, in the majority of studied eukaryotic cells a considerable proportion of YB-1 mRNA was stored in free mRNPs, i.e., was poorly translated. Also, we demonstrated that YB-1 synthesis depended on conditions that determined the rate of cell division. Specific suppression of YB-1 synthesis resulted from inhibition of the mTOR signaling pathway with inhibitor PP242, but not rapamycin. Experiments on reporter constructs showed that dependence of YB-1 mRNA translation on activity of the mTOR signaling pathway was dictated by 59 untranslated regions of this mRNA, irrelatively of the TOP-like sequences at the beginning of 5' UTR.	[Lyabin, Dmitry N.; Eliseeva, Irina A.; Ovchinnikov, Lev P.] Russian Acad Sci, Inst Prot Res, Pushchino 142292, Moscow Region, Russia	Russian Academy of Sciences	Ovchinnikov, LP (corresponding author), Russian Acad Sci, Inst Prot Res, Pushchino 142292, Moscow Region, Russia.	ovchinn@vega.protres.ru	Ovchinnikov, Lev/L-2397-2015; Lyabin, Dmitry/K-3178-2013; Irina, Eliseeva/J-8175-2015		Russian Academy of Sciences; Russian Foundation for Basic Research [11-04-00267, 12-04-31018]	Russian Academy of Sciences(Russian Academy of Sciences); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This work was supported by Programs on "Molecular and Cellular Biology" and "Basic Sciences to Medicine" of the Russian Academy of Sciences and Russian Foundation for Basic Research (http://www.rfbr.ru/rffi/ru/), (#11-04-00267, #12-04-31018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader AG, 2005, MOL CELL BIOL, V25, P2095, DOI 10.1128/MCB.25.6.2095-2106.2005; Bargou RC, 1997, NAT MED, V3, P447, DOI 10.1038/nm0497-447; Basaki Y, 2010, EUR J CANCER, V46, P954, DOI 10.1016/j.ejca.2009.12.024; Bergmann S, 2005, CANCER RES, V65, P4078, DOI 10.1158/0008-5472.CAN-04-4056; Bianchini A, 2008, CARCINOGENESIS, V29, P2279, DOI 10.1093/carcin/bgn221; Chansky HA, 2001, CANCER RES, V61, P3586; Dmitriev SE, 2007, MOL CELL BIOL, V27, P4685, DOI 10.1128/MCB.02138-06; Eliseeva IA, 2011, BIOCHEMISTRY-MOSCOW+, V76, P1402, DOI 10.1134/S0006297911130049; Evdokimova V, 2001, EMBO J, V20, P5491, DOI 10.1093/emboj/20.19.5491; Evdokimova V, 2006, MOL CELL BIOL, V26, P277, DOI 10.1128/MCB.26.1.277-292.2006; Evdokimova V, 2009, CANCER CELL, V15, P402, DOI 10.1016/j.ccr.2009.03.017; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Feng QC, 2009, NEPHRON EXP NEPHROL, V113, pE16, DOI 10.1159/000228079; Frye BC, 2009, EMBO REP, V10, P783, DOI 10.1038/embor.2009.81; Gaudreault I, 2004, NUCLEIC ACIDS RES, V32, P316, DOI 10.1093/nar/gkh170; Gens G. P., 2010, Klinicheskaya Laboratornaya Diagnostika, P29; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Kato M, 2010, J BIOL CHEM, V285, P34004, DOI 10.1074/jbc.M110.165027; Knosel T, 2005, NEOPLASIA, V7, P741, DOI 10.1593/neo.05178; Kuwano M, 2004, MOL CANCER THER, V3, P1485; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Levenson VV, 2000, CANCER RES, V60, P5027; Lovett DH, 2010, BIOCHEM BIOPH RES CO, V398, P482, DOI 10.1016/j.bbrc.2010.06.104; Lyabin DN, 2011, RNA BIOL, V8, P883, DOI 10.4161/rna.8.5.16022; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Nekrasov MP, 2003, J BIOL CHEM, V278, P13936, DOI 10.1074/jbc.M209145200; Ohashi S, 2009, MOL CELL BIOCHEM, V327, P267, DOI 10.1007/s11010-009-0065-x; Ohga T, 1996, CANCER RES, V56, P4224; Pestryakov P, 2012, J MOL RECOGNIT, V25, P224, DOI 10.1002/jmr.2182; POKROVSKAYA ID, 1994, ANAL BIOCHEM, V220, P420, DOI 10.1006/abio.1994.1360; Raffetseder U, 2003, J BIOL CHEM, V278, P18241, DOI 10.1074/jbc.M212518200; Rauen T, 2009, J BIOL CHEM, V284, P26928, DOI 10.1074/jbc.M109.046599; Shiota M, 2008, CANCER RES, V68, P98, DOI 10.1158/0008-5472.CAN-07-2981; Shiota M, 2009, CANCER RES, V69, P3148, DOI 10.1158/0008-5472.CAN-08-2334; Skabkin MA, 2001, J BIOL CHEM, V276, P44841, DOI 10.1074/jbc.M107581200; Skabkina OV, 2005, MOL CELL BIOL, V25, P3317, DOI 10.1128/MCB.25.8.3317-3323.2005; Skabkina OV, 2003, J BIOL CHEM, V278, P18191, DOI 10.1074/jbc.M209073200; Stein U, 2001, J BIOL CHEM, V276, P28562, DOI 10.1074/jbc.M100311200; Svitkin YV, 2009, EMBO J, V28, P58, DOI 10.1038/emboj.2008.259; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Uramoto H, 2002, J BIOL CHEM, V277, P31694, DOI 10.1074/jbc.M200266200; Wakiyama M, 1997, BIOCHIMIE, V79, P781, DOI 10.1016/S0300-9084(97)86937-4; Wu Y, 2012, J SURG ONCOL, V105, P724, DOI 10.1002/jso.23030; Yokoyama H, 2003, BIOCHEM BIOPH RES CO, V303, P140, DOI 10.1016/S0006-291X(03)00296-1	44	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52527	10.1371/journal.pone.0052527	http://dx.doi.org/10.1371/journal.pone.0052527			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285076	Green Published, Green Submitted, gold			2022-12-27	WOS:000312794500189
J	Ambrose, KV; Belanger, FC				Ambrose, Karen V.; Belanger, Faith C.			SOLiD-SAGE of Endophyte-Infected Red Fescue Reveals Numerous Effects on Host Transcriptome and an Abundance of Highly Expressed Fungal Secreted Proteins	PLOS ONE			English	Article							CHITIN-TRIGGERED IMMUNITY; HORIZONTAL GENE-TRANSFER; LOLIUM-PERENNE; LARGE-SCALE; MEDIATED SUPPRESSION; EPICHLOE ENDOPHYTES; NEOTYPHODIUM-LOLII; MOLECULAR-CLONING; SERIAL ANALYSIS; TALL FESCUE	One of the most important plant-fungal symbiotic relationships is that of cool season grasses with endophytic fungi of the genera Epichloe and Neotyphodium. These associations often confer benefits, such as resistance to herbivores and improved drought tolerance, to the hosts. One benefit that appears to be unique to fine fescue grasses is disease resistance. As a first step towards understanding the basis of the endophyte-mediated disease resistance in Festuca rubra we carried out a SOLiD-SAGE quantitative transcriptome comparison of endophyte-free and Epichloe festucae-infected F. rubra. Over 200 plant genes involved in a wide variety of physiological processes were statistically significantly differentially expressed between the two samples. Many of the endophyte expressed genes were surprisingly abundant, with the most abundant fungal tag representing over 10% of the fungal mapped tags. Many of the abundant fungal tags were for secreted proteins. The second most abundantly expressed fungal gene was for a secreted antifungal protein and is of particular interest regarding the endophyte-mediated disease resistance. Similar genes in Penicillium and Aspergillus spp. have been demonstrated to have antifungal activity. Of the 10 epichloae whole genome sequences available, only one isolate of E. festucae and Neotyphodium gansuense var inebrians have an antifungal protein gene. The uniqueness of this gene in E. festucae from F. rubra, its transcript abundance, and the secreted nature of the protein, all suggest it may be involved in the disease resistance conferred to the host, which is a unique feature of the fine fescue-endophyte symbiosis.	[Ambrose, Karen V.; Belanger, Faith C.] Rutgers State Univ, Dept Plant Biol & Pathol, New Brunswick, NJ 08903 USA	Rutgers State University New Brunswick	Belanger, FC (corresponding author), Rutgers State Univ, Dept Plant Biol & Pathol, New Brunswick, NJ 08903 USA.	belanger@aesop.rutgers.edu			Rutgers Center for Turfgrass Science; NSF [EF-0523661]; USDA-NRI [2005-35319-16141]; National Institutes of Health [2 P20 RR-16481]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016481] Funding Source: NIH RePORTER	Rutgers Center for Turfgrass Science; NSF(National Science Foundation (NSF)); USDA-NRI(United States Department of Agriculture (USDA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported with funds provided by the Rutgers Center for Turfgrass Science. The genomic sequencing and genome annotation of Epichloe, Neotyphodium, Claviceps, Periglandula, and Aciculosporium (Genome Project at University of Kentucky, URL: http://www.endophyte.uky.edu/) were supported by grants to Dr. C. Schardl (NSF EF-0523661, USDA-NRI 2005-35319-16141, and National Institutes of Health 2 P20 RR-16481). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguileta G, 2008, SYST BIOL, V57, P613, DOI 10.1080/10635150802306527; Alabert C, 2012, NAT REV MOL CELL BIO, V13, P153, DOI 10.1038/nrm3288; Alves SL, 2008, APPL ENVIRON MICROB, V74, P1494, DOI 10.1128/AEM.02570-07; Torres MA, 2010, PHYSIOL PLANTARUM, V138, P414, DOI 10.1111/j.1399-3054.2009.01326.x; [Anonymous], 2008, NAT METHODS, V5, P15, DOI 10.1038/NMETH1155; [Anonymous], APPL TURFGRASS SCI; Auer PL, 2012, BRIEF FUNCT GENOMICS, V11, P57, DOI 10.1093/bfgp/elr041; Batista AS, 2004, J MOL MICROB BIOTECH, V8, P26, DOI 10.1159/000082078; Bausher M, 2003, PLANT SCI, V165, P415, DOI 10.1016/S0168-9452(03)00202-4; Bettiga M, 2008, BIOTECHNOL BIOFUELS, V1, DOI 10.1186/1754-6834-1-16; Binns D, 2009, BIOINFORMATICS, V25, P3045, DOI 10.1093/bioinformatics/btp536; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Brown DW, 2011, CURR GENET, V57, P51, DOI 10.1007/s00294-010-0326-y; Calsa T, 2007, PLANT MOL BIOL, V63, P745, DOI 10.1007/s11103-006-9121-z; Christensen MJ, 2008, FUNGAL GENET BIOL, V45, P84, DOI 10.1016/j.fgb.2007.07.013; Clarke BB, 2006, PLANT DIS, V90, P994, DOI 10.1094/PD-90-0994; Clay K, 2002, AM NAT, V160, pS99, DOI 10.1086/342161; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469; de Jonge R, 2010, SCIENCE, V329, P953, DOI 10.1126/science.1190859; de Vries RP, 2001, MICROBIOL MOL BIOL R, V65, P497, DOI 10.1128/MMBR.65.4.497-522.2001; Dinkins RD, 2010, J PLANT PHYSIOL, V167, P1197, DOI 10.1016/j.jplph.2010.04.002; Dodge AG, 2005, APPL ENVIRON MICROB, V71, P876, DOI 10.1128/AEM.71.2.876-882.2005; Doehlemann G, 2005, FUNGAL GENET BIOL, V42, P601, DOI 10.1016/j.fgb.2005.03.001; Eaton CJ, 2010, PLANT PHYSIOL, V153, P1780, DOI 10.1104/pp.110.158451; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Faghihi MA, 2009, NAT REV MOL CELL BIO, V10, P637, DOI 10.1038/nrm2738; Fernie AR, 2009, PHYTOCHEMISTRY, V70, P828, DOI 10.1016/j.phytochem.2009.04.023; Fitzpatrick DA, 2012, FEMS MICROBIOL LETT, V329, P1, DOI 10.1111/j.1574-6968.2011.02465.x; Fleetwood DJ, 2007, APPL ENVIRON MICROB, V73, P2571, DOI 10.1128/AEM.00257-07; GAFFNEY T, 1993, SCIENCE, V261, P754, DOI 10.1126/science.261.5122.754; Ge XJ, 2006, BIOINFORMATICS, V22, P2475, DOI 10.1093/bioinformatics/btl429; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Gibbings JG, 2003, PLANT BIOTECHNOL J, V1, P271, DOI 10.1046/j.1467-7652.2003.00026.x; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gotz S, 2011, BIOINFORMATICS, V27, P919, DOI 10.1093/bioinformatics/btr059; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grobler J, 1995, YEAST, V11, P1485, DOI 10.1002/yea.320111503; Hamilton CE, 2012, FUNGAL DIVERS, V54, P1, DOI 10.1007/s13225-012-0158-9; Heller J, 2011, ANNU REV PHYTOPATHOL, V49, P369, DOI 10.1146/annurev-phyto-072910-095355; Hibbett DS, 2007, MYCOL RES, V111, P509, DOI 10.1016/j.mycres.2007.03.004; HINTON DM, 1985, CAN J BOT, V63, P36, DOI 10.1139/b85-006; Hong LZ, 2011, GENOME RES, V21, P1905, DOI 10.1101/gr.122135.111; Jantasuriyarat C, 2005, PLANT PHYSIOL, V138, P105, DOI 10.1104/pp.104.055624; Johnson L, 2010, INOCULUM, V61, P58; Johnson LJ, 2003, PHYSIOL MOL PLANT P, V63, P305, DOI 10.1016/j.pmpp.2004.04.001; Johnson-Cicalese J, 2000, CROP SCI, V40, P1485, DOI 10.2135/cropsci2000.4051485x; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Kuldau G, 2008, BIOL CONTROL, V46, P57, DOI 10.1016/j.biocontrol.2008.01.023; Kutil BL, 2007, FUNGAL GENET BIOL, V44, P1002, DOI 10.1016/j.fgb.2007.04.003; LAM CK, 1994, MYCOLOGIA, V86, P408, DOI 10.2307/3760573; Leandro MJ, 2006, BIOCHEM J, V395, P543, DOI 10.1042/BJ20051465; Li CJ, 2008, MICROBIOL RES, V163, P431, DOI 10.1016/j.micres.2006.07.007; Liberator P, 1998, J BIOL CHEM, V273, P4237, DOI 10.1074/jbc.273.7.4237; Lingner U, 2011, J BIOL CHEM, V286, P20913, DOI 10.1074/jbc.M110.213678; Link T, 2005, BIOCHEM J, V389, P289, DOI 10.1042/BJ20050301; Lister R, 2009, CURR OPIN PLANT BIOL, V12, P107, DOI 10.1016/j.pbi.2008.11.004; Lutzoni F, 2004, AM J BOT, V91, P1446, DOI 10.3732/ajb.91.10.1446; Marshall E, 2011, J EXP BOT, V62, P1677, DOI 10.1093/jxb/err002; Marshall R, 2011, PLANT PHYSIOL, V156, P756, DOI 10.1104/pp.111.176347; Marx F, 2004, APPL MICROBIOL BIOT, V65, P133, DOI 10.1007/s00253-004-1600-z; Matsumura H, 2005, CELL MICROBIOL, V7, P11, DOI 10.1111/j.1462-5822.2004.00478.x; Matsumura H, 2003, P NATL ACAD SCI USA, V100, P15718, DOI 10.1073/pnas.2536670100; Matsumura H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012010; Mentlak TA, 2012, PLANT CELL, V24, P322, DOI 10.1105/tpc.111.092957; Meyer S, 2010, TRENDS PLANT SCI, V15, P40, DOI 10.1016/j.tplants.2009.10.002; Michel G, 2010, NEW PHYTOL, V188, P67, DOI 10.1111/j.1469-8137.2010.03345.x; Moon CD, 2007, MYCOLOGIA, V99, P895, DOI 10.3852/mycologia.99.6.895; Moy M, 2002, PLANT PHYSIOL, V130, P1298, DOI 10.1104/pp.010108; Pang TL, 2010, J CELL SCI, V123, P3745, DOI 10.1242/jcs.064709; Plett JM, 2012, EFFECTORS PLANT MICR, P295; Poole RL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-475; Pratt LH, 2005, PLANT PHYSIOL, V139, P869, DOI 10.1104/pp.105.066134; Quere R, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh161; Rasmussen S, 2008, PLANT PHYSIOL, V146, P1440, DOI 10.1104/pp.107.111898; Rasmussen S, 2012, NEW PHYTOL, V196, P7, DOI 10.1111/j.1469-8137.2012.04250.x; Rasmussen S, 2009, PHYTOCHEM REV, V8, P535, DOI 10.1007/s11101-009-9136-6; Reddy PV, 1996, PLANT PHYSIOL, V111, P1209, DOI 10.1104/pp.111.4.1209; Regenberg B, 1999, CURR GENET, V36, P317, DOI 10.1007/s002940050506; Ren QH, 2007, NUCLEIC ACIDS RES, V35, pD274, DOI 10.1093/nar/gkl925; Rep M, 2005, FEMS MICROBIOL LETT, V253, P19, DOI 10.1016/j.femsle.2005.09.014; RICHARDSON MD, 1992, CROP SCI, V32, P1060, DOI 10.2135/cropsci1992.0011183X003200040045x; Robinson SJ, 2004, PLANT PHYSIOL, V136, P3223, DOI 10.1104/pp.104.043406; Rodriguez RJ, 2009, NEW PHYTOL, V182, P314, DOI 10.1111/j.1469-8137.2009.02773.x; Rouxel T, 2012, EFFECTORS PLANT MICR, P195; Ruemmele BA, 2003, TURFGRASS BIOL GENET; Schardl C.L., 2009, PLANT RELATIONSHIPS, V5, P275, DOI [10.1007/978-3-540-87407-2_15, DOI 10.1007/978-3-540-87407-2_15]; Schardl CL, 2012, FUNGAL ECOL, V5, P331, DOI 10.1016/j.funeco.2011.04.005; Schardl CL, 2001, FUNGAL GENET BIOL, V33, P69, DOI 10.1006/fgbi.2001.1275; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Scott B, 2010, RECENT DEV MANAGEMEN, V1, P275; Scott B., 2012, TOPICS CURRENT GENET, P243, DOI DOI 10.1007/978-3-642-22916-9_12; Scott B, 2008, CURR OPIN MICROBIOL, V11, P488, DOI 10.1016/j.mib.2008.10.008; Siebert S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022953; Smarda P, 2008, ANN BOT-LONDON, V101, P421, DOI 10.1093/aob/mcm307; Soanes DM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002300; Solomon PS, 2007, TRENDS MICROBIOL, V15, P257, DOI 10.1016/j.tim.2007.04.002; Spiering MJ, 2006, ANN BOT-LONDON, V98, P379, DOI 10.1093/aob/mcl108; Sterck L, 2007, CURR OPIN PLANT BIOL, V10, P199, DOI 10.1016/j.pbi.2007.01.004; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Tadych M, 2012, FUNGAL DIVERS, V54, P117, DOI 10.1007/s13225-012-0170-0; Takemoto D, 2006, PLANT CELL, V18, P2807, DOI 10.1105/tpc.106.046169; Tanaka A, 2006, PLANT CELL, V18, P1052, DOI 10.1105/tpc.105.039263; Tanaka A, 2005, MOL MICROBIOL, V57, P1036, DOI 10.1111/j.1365-2958.2005.04747.x; Tanaka A, 2008, MOL MICROBIOL, V68, P1165, DOI 10.1111/j.1365-2958.2008.06217.x; Tanaka A, 2012, CURR OPIN PLANT BIOL, V15, P462, DOI 10.1016/j.pbi.2012.03.007; Teichert S, 2008, EUKARYOT CELL, V7, P187, DOI 10.1128/EC.00351-07; TEMPLETON MD, 1994, MOL PLANT MICROBE IN, V7, P320, DOI 10.1094/MPMI-7-0320; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vazquez-de-Aldana BR, 2013, PLANT SOIL, V362, P201, DOI 10.1007/s11104-012-1283-7; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Werner A, 2010, BIOCHEM SOC T, V38, P1144, DOI 10.1042/BST0381144; White JF, 2010, PHYSIOL PLANTARUM, V138, P440, DOI 10.1111/j.1399-3054.2009.01332.x; Wilkinson HH, 2000, MOL PLANT MICROBE IN, V13, P1027, DOI 10.1094/MPMI.2000.13.10.1027; Young CA, 2005, MOL GENET GENOMICS, V274, P13, DOI 10.1007/s00438-005-1130-0; Young CA, 2006, FUNGAL GENET BIOL, V43, P679, DOI 10.1016/j.fgb.2006.04.004; Yue Q, 2000, J CHEM ECOL, V26, P279, DOI 10.1023/A:1005410115940; Zhang DX, 2009, PLANT PHYSIOL, V150, P1072, DOI 10.1104/pp.109.138222; Zhang N, 2011, MOL PLANT MICROBE IN, V24, P984, DOI 10.1094/MPMI-02-11-0028	120	54	56	3	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53214	10.1371/journal.pone.0053214	http://dx.doi.org/10.1371/journal.pone.0053214			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285269	Green Submitted, Green Published, gold			2022-12-27	WOS:000313051500123
J	Buzdugan, R; Watadzaushe, C; Dirawo, J; Mundida, O; Langhaug, L; Willis, N; Hatzold, K; Ncube, G; Mugurungi, O; Benedikt, C; Copas, A; Cowan, FM				Buzdugan, Raluca; Watadzaushe, Constancia; Dirawo, Jeffrey; Mundida, Oscar; Langhaug, Lisa; Willis, Nicola; Hatzold, Karin; Ncube, Getrude; Mugurungi, Owen; Benedikt, Clemens; Copas, Andrew; Cowan, Frances M.			Positive Attitudes to Pediatric HIV Testing: Findings from a Nationally Representative Survey from Zimbabwe	PLOS ONE			English	Article							WESTERN KENYA; HEALTH-CARE; CHILDREN; ADOLESCENTS; INFECTION; AFRICA; ACCEPTABILITY; MORTALITY; INFANTS	Objective: Early HIV testing and diagnosis are paramount for increasing treatment initiation among children, necessary for their survival and improved health. However, uptake of pediatric HIV testing is low in high-prevalence areas. We present data on attitudes towards pediatric testing from a nationally representative survey in Zimbabwe. Methods: All 18-24 year olds and a proportion of 25-49 year olds living in randomly selected enumeration areas from all ten Zimbabwe provinces were invited to self-complete an anonymous questionnaire on a personal digital assistant, and 16,719 people agreed to participate (75% of eligibles). Results: Most people think children can benefit from HIV testing (91%), 81% of people who looked after children know how to access testing for their children and 92% would feel happier if their children were tested. Notably, 42% fear that, if tested, children may be discriminated against by some community members and 28% fear their children are HIV positive. People who fear discrimination against children who have tested for HIV are more likely than their counterparts to perceive their community as stigmatizing against HIV positive people (43% vs. 29%). They are also less likely to report positive attitudes to HIV themselves (49% vs. 74%). Only 28% think it is possible for children HIV-infected at birth to live into adolescence without treatment. Approximately 70% of people (irrespective of whether they are themselves parents) think HIV-infected children in their communities can access testing and treatment. Conclusions: Pediatric HIV testing is the essential gateway to prevention and care services. Our data indicate positive attitudes to testing children, suggesting a conducive environment for increasing uptake of pediatric testing in Zimbabwe. However, there is a need to better understand the barriers to pediatric testing, such as stigma and discrimination, and address the gaps in knowledge regarding HIV/AIDS in children.	[Buzdugan, Raluca; Copas, Andrew; Cowan, Frances M.] UCL, Res Dept Infect & Populat Hlth, London, England; [Buzdugan, Raluca] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Watadzaushe, Constancia; Dirawo, Jeffrey; Langhaug, Lisa; Cowan, Frances M.] Univ Zimbabwe, ZAPP UZ, Harare, Zimbabwe; [Mundida, Oscar] Natl AIDS Council, Harare, Zimbabwe; [Willis, Nicola] Africaid, Harare, Zimbabwe; [Hatzold, Karin] Populat Serv Int, Harare, Zimbabwe; [Ncube, Getrude; Mugurungi, Owen] Minist Hlth & Child Welf, Harare, Zimbabwe; [Benedikt, Clemens] UNFPA, Harare, Zimbabwe	University of London; University College London; University of California System; University of California Berkeley; University of Zimbabwe	Buzdugan, R (corresponding author), UCL, Res Dept Infect & Populat Hlth, London, England.	rbuzdugan@berkeley.edu		Langhaug, Lisa/0000-0002-9131-8158; Cowan, Frances/0000-0003-3087-4422; Copas, Andrew/0000-0001-8968-5963	UNPFA Zimbabwe Soul City	UNPFA Zimbabwe Soul City	Funders: UNPFA Zimbabwe & Soul City. Soul City had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Clemens Benedikt from UNFPA provided substantive inputs into the study design and contributed to this manuscript.	Bandason T, 2011, 18 C RETR OPP INF CR; Berendes S, 2011, J ASSOC NURSE AIDS C, V22, P215, DOI 10.1016/j.jana.2010.08.005; Braitstein P, 2011, JAIDS-J ACQ IMM DEF, V57, pE40, DOI 10.1097/QAI.0b013e3182167f0d; Chhagan MK, 2011, TROP MED INT HEALTH, V16, P1490, DOI 10.1111/j.1365-3156.2011.02872.x; Donahue MC, 2012, AIDS CARE; Ferrand RA, 2011, AM J PUBLIC HEALTH, V101, P2325, DOI 10.2105/AJPH.2011.300250; Ferrand RA, 2010, CLIN INFECT DIS, V51, P844, DOI 10.1086/656361; Ferrand RA, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000178; Ferrand RA, 2009, AIDS, V23, P2039, DOI 10.1097/QAD.0b013e32833016ce; Georgia, 2012, GLOBAL AIDS RESPONSE; Joint United Nations Programme on HIV/AIDS, 2012, TOG WE WILL END AIDS; Kankasa C, 2009, JAIDS-J ACQ IMM DEF, V51, P202, DOI 10.1097/QAI.0b013e31819c173f; McCollum ED, 2011, PEDIATR INFECT DIS J, V30, pE75, DOI 10.1097/INF.0b013e3182103f8a; Mutanga JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029656; Newell ML, 2004, AIDS, V18, pS27, DOI 10.1097/00002030-200406002-00004; Oga MA, 2011, JAIDS-J ACQ IMM DEF, V57, pS16, DOI 10.1097/QAI.0b013e31821fd487; Ostermann J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016488; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; Vreeman RC, 2010, JAIDS-J ACQ IMM DEF, V55, pE3, DOI 10.1097/QAI.0b013e3181f0758f; Wanyenze RK, 2010, TROP MED INT HEALTH, V15, P113, DOI 10.1111/j.1365-3156.2009.02417.x; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E; Yeap AD, 2010, AIDS CARE, V22, P1101, DOI 10.1080/09540121003602218	22	16	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53213	10.1371/journal.pone.0053213	http://dx.doi.org/10.1371/journal.pone.0053213			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	064DQ	23285268	gold, Green Published, Green Submitted			2022-12-27	WOS:000313051500122
J	Karakas, M; Baumert, J; Kleber, ME; Thorand, B; Dallmeier, D; Silbernagel, G; Grammer, TB; Rottbauer, W; Meisinger, C; Illig, T; Marz, W; Koenig, W				Karakas, Mahir; Baumert, Jens; Kleber, Marcus E.; Thorand, Barbara; Dallmeier, Dhayana; Silbernagel, Guenther; Grammer, Tanja B.; Rottbauer, Wolfgang; Meisinger, Christa; Illig, Thomas; Maerz, Winfried; Koenig, Wolfgang			A Variant In the Abo Gene Explains the Variation in Soluble E-Selectin Levels-Results from Dense Genotyping in Two Independent Populations	PLOS ONE			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; RISK; DISEASE; ASSOCIATION; HEART; LOCI; ATHEROSCLEROSIS	Background: Elevated soluble (s) E-selectin levels have been associated with various cardiovascular diseases. Recently, genetic variants in the ABO blood group have been related to E-selectin levels in a small cohort of patients with type 1 diabetes. We evaluated whether this association is reproducible in two large samples of Caucasians. Methodology/Principal Findings: Data of the present study was drawn from the population-based MONICA/KORA Augsburg study (n = 1,482) and the patients-based LURIC study (n = 1,546). A high-density genotyping array (50K IBC Chip) containing single-nucleotide polymorphisms (SNPs) from E-selectin candidate genes selected on known biology of E-selectin metabolism, mouse genetic studies, and human genetic association studies, was used for genotyping. Linear regression analyses with adjustment for age and sex (and survey in KORA) were applied to assess associations between gene variants and sE-selectin concentrations. A number of 12 SNPs (in KORA) and 13 SNPs (in LURIC), all from the ABO blood group gene, were significantly associated with the log-transformed concentration of E-selectin. The strongest association was observed for rs651007 with a change of log-transformed sE-selectin per one copy of the minor allele of -0.37 ng/ml (p = 1.87x10(-103)) in KORA and -0.35 ng/ml (p = 5.11x10(-84)) in LURIC. Inclusion of rs651007 increased the explained sE-selectin variance by 0.256 in KORA and 0.213 in LURIC. All SNPs had minor allele frequencies above 20% showing a substantial gene variation. Conclusions/Significance: Our findings in two independent samples indicate that the genetic variants at the ABO locus affect sE-selectin levels. Since distinct genome-wide association studies linked the ABO gene with myocardial infarction (MI) in the presence of coronary atherosclerosis and with coronary artery disease, these findings may not only enhance our understanding of adhesion molecule biology, but may also provide a focus for several novel research avenues.	[Karakas, Mahir; Kleber, Marcus E.; Dallmeier, Dhayana; Rottbauer, Wolfgang; Koenig, Wolfgang] Univ Ulm, Med Ctr, Dept Internal Med Cardiol 2, Ulm, Germany; [Baumert, Jens; Thorand, Barbara; Meisinger, Christa] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany; [Kleber, Marcus E.; Grammer, Tanja B.; Maerz, Winfried] Heidelberg Univ, Med Fac Mannheim, Mannheim Inst Publ Hlth Social & Prevent Med, D-6800 Mannheim, Germany; [Silbernagel, Guenther] Univ Tubingen, Dept Internal Med, Div Endocrinol Diabetol Nephrol Vasc Dis & Clin C, D-7400 Tubingen, Germany; [Illig, Thomas] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Res Unit Mol Epidemiol, Neuherberg, Germany; [Illig, Thomas] Hannover Med Sch, Hannover Unified Biobank, D-3000 Hannover, Germany; [Maerz, Winfried] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Graz, Austria; [Maerz, Winfried] Synlab Serv GmbH, Synlab Acad, Mannheim, Germany	Ulm University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Ruprecht Karls University Heidelberg; Eberhard Karls University of Tubingen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Hannover Medical School; Medical University of Graz; SYNLAB Group	Koenig, W (corresponding author), Univ Ulm, Med Ctr, Dept Internal Med Cardiol 2, Ulm, Germany.	wolfgang.koenig@uniklinik-ulm.de	Thorand, Barbara/B-5349-2014; Meisinger, Christine/B-5358-2014; Dallmeier, Dhayana/A-1169-2015	Thorand, Barbara/0000-0002-8416-6440; Dallmeier, Dhayana/0000-0003-3665-7023; Meisinger, Christa/0000-0002-9026-6544; Koenig, Wolfgang/0000-0002-2064-9603; Kleber, Marcus/0000-0003-0663-7275; Silbernagel, Guenther/0000-0001-9323-329X	Helmholtz Zentrum Munchen, German Research Center for Environmental Health, Neuherberg, Germany; German Federal Ministry of Education and Research (BMBF); German National Genome Research Network (NGFNPlus) [01GS0834]; German Research Foundation [TH-784/2-1, TH-784/2-2]; European Foundation; Helmholtz Zentrum Munchen; German Diabetes Center and the University of Ulm; Munich Center of Health Sciences (MC Health), Ludwig Maximilians University (LMU) innovative; European Union [201668, LSHM-CT-2004-503485]	Helmholtz Zentrum Munchen, German Research Center for Environmental Health, Neuherberg, Germany(Helmholtz Association); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German National Genome Research Network (NGFNPlus); German Research Foundation(German Research Foundation (DFG)); European Foundation(European Science Foundation (ESF)); Helmholtz Zentrum Munchen(Helmholtz Association); German Diabetes Center and the University of Ulm; Munich Center of Health Sciences (MC Health), Ludwig Maximilians University (LMU) innovative; European Union(European Commission)	The MONICA/KORA Augsburg studies were financed by the Helmholtz Zentrum Munchen, German Research Center for Environmental Health, Neuherberg, Germany and supported by grants from the German Federal Ministry of Education and Research (BMBF). Part of this work was financed by the German National Genome Research Network (NGFNPlus, project number 01GS0834), by the German Research Foundation (TH-784/2-1 and TH-784/2-2), by the European Foundation for the Study of Diabetes and through additional funds from the Helmholtz Zentrum Munchen, the German Diabetes Center and the University of Ulm. Furthermore, the research was supported within the Munich Center of Health Sciences (MC Health) as part of the Ludwig Maximilians University (LMU) innovative. LURIC received funding through the 6th Framework Programme (integrated project Bloodomics, grant LSHM-CT-2004-503485) and the 7th of Framework Programme (integrated project AtheroRemo, Grant Agreement number 201668) of the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbalic M, 2010, HUM MOL GENET, V19, P1863, DOI 10.1093/hmg/ddq061; Chasman DI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000730; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Herder C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019852; Ho M, 2000, J EXP MED, V192, P1205, DOI 10.1084/jem.192.8.1205; Hwang SJ, 1997, CIRCULATION, V96, P4219; Karakas M, 2012, J INTERN MED, V271, P43, DOI 10.1111/j.1365-2796.2011.02397.x; Kiechl S, 2011, CIRC-CARDIOVASC GENE, V4, P681, DOI 10.1161/CIRCGENETICS.111.960682; Koenig W, 2011, CLIN CHEM, V57, P1196, DOI 10.1373/clinchem.2011.165134; Lanktree MB, 2011, AM J HUM GENET, V88, P6, DOI 10.1016/j.ajhg.2010.11.007; LEEUWENBERG JFM, 1992, IMMUNOLOGY, V77, P543; Lowel H, 2005, GESUNDHEITSWESEN, V67, pS13, DOI 10.1055/s-2005-858234; Meigs JB, 2004, JAMA-J AM MED ASSOC, V291, P1978, DOI 10.1001/jama.291.16.1978; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qi L, 2010, HUM MOL GENET, V19, P1856, DOI 10.1093/hmg/ddq057; Reilly MP, 2011, LANCET, V377, P383, DOI 10.1016/S0140-6736(10)61996-4; Saxena R, 2012, AM J HUM GENET, V90, P410, DOI 10.1016/j.ajhg.2011.12.022; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Smith NL, 2010, CIRCULATION, V121, P1382, DOI 10.1161/CIRCULATIONAHA.109.869156; Thorand B, 2005, DIABETES, V54, P2932, DOI 10.2337/diabetes.54.10.2932; Tregouet DA, 2009, BLOOD, V113, P5298, DOI 10.1182/blood-2008-11-190389; Wu O, 2008, J THROMB HAEMOST, V6, P62; YAMAMOTO F, 1990, NATURE, V345, P229, DOI 10.1038/345229a0; YAMAMOTO F, 1992, BIOCHEM BIOPH RES CO, V187, P366, DOI 10.1016/S0006-291X(05)81502-5	24	30	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e51441	10.1371/journal.pone.0051441	http://dx.doi.org/10.1371/journal.pone.0051441			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23300549	Green Submitted, Green Published, gold			2022-12-27	WOS:000313051500011
J	Wang, ZW; Feng, AZ; Cui, MB; Liu, YX; Wang, LZ; Wang, QM				Wang, Ziwen; Feng, Anzheng; Cui, Mingbo; Liu, Yuxiu; Wang, Lizhong; Wang, Qingmin			First Discovery and Stucture-Activity Relationship Study of Phenanthroquinolizidines as Novel Antiviral Agents against Tobacco Mosaic Virus (TMV)	PLOS ONE			English	Article							INHIBITORY-ACTIVITY; ALKALOIDS; CRYPTOPLEURINE; IDENTIFICATION; ANALOGS	A series of phenanthroquinolizidine alkaloids 1-24 were prepared and first evaluated for their antiviral activity against tobacco mosaic virus (TMV). The bioassay results showed that most of these compounds exhibited good to excellent in vivo anti-TMV activity, of which compounds 1, 2, 15 and 16 displayed significantly higher activity than (R)-antofine and commercial Ningnanmycin at the same test condition. The substituents on the phenanthrene moiety play an important role for maintaining high in vivo antiviral activity. The introduction of 6-hydroxyl, which is proposed to interact with TMV RNA, did increased anti-TMV activity. The 14aR-configuration was confirmed to be the preferred antiviral configuration for phenanthroquinolizidine alkaloids. Introduction of hydroxy group at 15-position of phenanthroquinolizidine alkaloids increased activity for S-configuration but decreased activity for R-configuration. Present study provides fundamental support for development and optimization of phenanthroquinolizidine alkaloids as potential inhibitors of plant virus.	[Wang, Ziwen; Feng, Anzheng; Cui, Mingbo; Liu, Yuxiu; Wang, Lizhong; Wang, Qingmin] Nankai Univ, State Key Lab Elementoorgan Chem, Res Inst Elementoorgan Chem, Tianjin 300071, Peoples R China	Nankai University	Wang, QM (corresponding author), Nankai Univ, State Key Lab Elementoorgan Chem, Res Inst Elementoorgan Chem, Tianjin 300071, Peoples R China.	wang98h@263.net			National Key Project for Basic Research [2010CB126106]; National Natural Science Foundation of China [21132003, 21121002, 30890143]; Tianjin Natural Science Foundation [11JCZDJC20500]; National Key Technology Research and Development Program [2011BAE06B05]; China Postdoctoral Science Foundation [2011M500519, 2012T50207]	National Key Project for Basic Research(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Natural Science Foundation(Natural Science Foundation of Tianjin); National Key Technology Research and Development Program(National Key Technology R&D Program); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	The authors gratefully acknowledge assistance from the National Key Project for Basic Research (2010CB126106) and the National Natural Science Foundation of China (21132003, 21121002, 30890143) and the Tianjin Natural Science Foundation (11JCZDJC20500) and the National Key Technology Research and Development Program (2011BAE06B05) and the China Postdoctoral Science Foundation (2011M500519, 2012T50207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALSHAMMA A, 1982, PHYTOCHEMISTRY, V21, P485, DOI 10.1016/S0031-9422(00)95304-4; An TY, 2001, PHYTOCHEMISTRY, V58, P1267, DOI 10.1016/S0031-9422(01)00382-X; Bos L., 1982, Crop Protection, V1, P263, DOI 10.1016/0261-2194(82)90002-3; Chen J, 2009, J AGR FOOD CHEM, V57, P6590, DOI 10.1021/jf901632j; Chen MH, 2009, J AGR FOOD CHEM, V57, P1383, DOI 10.1021/jf803215t; Cui MB, 2009, EUR J ORG CHEM, V2009, P5445, DOI 10.1002/ejoc.200900834; DELALANDE IS, 1948, AUST J EXP BIOL MED, V26, P181, DOI 10.1038/icb.1948.18; FARNSWORTH NR, 1969, AUST J CHEM, V22, P1805, DOI 10.1071/CH9691805; Gao S, 2012, CHEMBIOCHEM, V13, P1622, DOI 10.1002/cbic.201200313; Gao W, 2008, BIOORG MED CHEM LETT, V18, P704, DOI 10.1016/j.bmcl.2007.11.054; Ge YH, 2012, J AGR FOOD CHEM, V60, P4289, DOI 10.1021/jf205362d; GELLERT E, 1956, AUST J CHEM, V9, P489, DOI 10.1071/CH9560489; HANSEN AJ, 1989, CRIT REV PLANT SCI, V8, P45, DOI 10.1080/07352688909382270; Jin HR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040355; KRMPOTIC E, 1972, J PHARM SCI-US, V61, P1508, DOI 10.1002/jps.2600610945; Luo YG, 2003, PLANTA MED, V69, P842, DOI 10.1055/s-2003-43215; Ouyang GP, 2008, J AGR FOOD CHEM, V56, P10160, DOI 10.1021/jf802489e; Ouyang MA, 2007, J AGR FOOD CHEM, V55, P6460, DOI 10.1021/jf0709808; Qian XH, 2010, J AGR FOOD CHEM, V58, P2613, DOI 10.1021/jf904098w; Seiber JN, 2011, J AGR FOOD CHEM, V59, P1, DOI 10.1021/jf1046078; SIDWELL RW, 1972, SCIENCE, V177, P705, DOI 10.1126/science.177.4050.705; Song BA., 2009, ENV FRIENDLY ANTIPLA, P1; Wang KL, 2010, J AGR FOOD CHEM, V58, P2703, DOI 10.1021/jf902543r; Wang ZW, 2012, EUR J MED CHEM, V51, P250, DOI 10.1016/j.ejmech.2012.02.048; Wang ZW, 2010, TETRAHEDRON LETT, V51, P1377, DOI 10.1016/j.tetlet.2009.12.135; Wu M, 2011, ORG BIOMOL CHEM, V9, P141, DOI 10.1039/c0ob00287a; Xie L, 2009, IEEE POW ENER SOC GE, P4557; Yang CW, 2010, ANTIVIR RES, V88, P160, DOI 10.1016/j.antiviral.2010.08.009; Yang JQ, 2010, J AGR FOOD CHEM, V58, P2730, DOI 10.1021/jf902861m; Yuan DK, 2011, CHINESE CHEM LETT, V22, P18, DOI 10.1016/j.cclet.2010.07.011	30	25	27	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52933	10.1371/journal.pone.0052933	http://dx.doi.org/10.1371/journal.pone.0052933			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285230	Green Published, Green Submitted, gold			2022-12-27	WOS:000313051500085
J	Ahmed, A; Al Tamimi, DM; Isab, AA; Alkhawajah, AMM; Shawarby, MA				Ahmed, Ayesha; Al Tamimi, Dalal M.; Isab, Anvarhusein A.; Alkhawajah, Abdulaziz M. Mansour; Shawarby, Mohamed A.			Histological Changes in Kidney and Liver of Rats Due to Gold (III) Compound [Au(en)Cl-2]Cl	PLOS ONE			English	Article							CISPLATIN NEPHROTOXICITY; COMPLEXES; DRUG; ETHYLENEDIAMINE; APOPTOSIS; NECROSIS	Introduction: Development of novel metallodrugs with enhanced anti-proliferative potential and reduced toxicity has become the prime focus of the evolving medicinal chemistry. In this regards, gold (III) complexes with various ligands are being extensively investigated. In the current study renal and hepatic toxicity of a newly developed gold (III) compound [Au(en)Cl-2]Cl was assessed by histopathological evaluation of liver and kidney specimens of rats exposed to the compound. Methods: Male rats (n = 42) weighing 200-250 gram were injected single, varying doses of gold (III) compound [(dichlorido(ethylenediamine) aurate((III)] chloride [Au(en)Cl-2]Cl in the acute toxicity component of the study. In the subacute toxicity part, a dose of 32.2 mg/kg (equivalent to 1/10 of LD50) was administered intraperitoneally for 14 consecutive days before sacrificing the animals. After autopsy, the renal and hepatic tissues were preserved in buffered formalin. Processing of the samples was followed by histopathological evaluation. The results were compared with the normal controls (n = 11). Results: A dose of 32.2 mg/kg (1/10 of LD50) revealed no renal tubular necrosis. The predominant histopathological finding was mild pyelitis, a prominence of eosinophils and mild congestion. The hepatic lesions comprised varying extents of ballooning degeneration with accompanying congestion and focal portal inflammation. Conclusion: Gold (III) compound [Au(en)Cl-2]Cl causes minimal histological changes in kidney and liver of rats, reflecting its relative safety as compared to other clinically established antineoplastic drugs.	[Ahmed, Ayesha; Al Tamimi, Dalal M.; Shawarby, Mohamed A.] Univ Dammam, Coll Med, Dept Pathol, Al Khobar, Saudi Arabia; [Ahmed, Ayesha; Al Tamimi, Dalal M.; Shawarby, Mohamed A.] Univ Al Khobar, King Fahd Hosp, Al Khobar, Saudi Arabia; [Isab, Anvarhusein A.] King Fahd Univ Petr & Minerals, Dept Chem, Dhahran 31261, Saudi Arabia; [Alkhawajah, Abdulaziz M. Mansour] Univ Dammam, Coll Med, Dept Pharmacol, Dammam, Saudi Arabia	Imam Abdulrahman Bin Faisal University; Imam Abdulrahman Bin Faisal University; King Fahd University of Petroleum & Minerals; Imam Abdulrahman Bin Faisal University	Ahmed, A (corresponding author), Univ Dammam, Coll Med, Dept Pathol, Al Khobar, Saudi Arabia.	ayesash@hotmail.com; aisab@kfupm.edu.sa	Ahmed, Ayesha/A-5195-2015	Ahmed, Ayesha/0000-0002-2036-7067	King Abdulaziz City for Science and Technology through the Science & Technology Unit at King Fahd University of Petroleum Minerals [08-BIO94-4]	King Abdulaziz City for Science and Technology through the Science & Technology Unit at King Fahd University of Petroleum Minerals	The funding agency is King Abdulaziz City for Science and Technology through the Science & Technology Unit at King Fahd University of Petroleum & Minerals through project No. 08-BIO94-4 as part of the National Science, Technology and Innovation Plan (Kingdom of Saudi Arabia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Maythalony BA, 2009, INORG CHIM ACTA, V362, P3109, DOI 10.1016/j.ica.2009.02.009; Arany I, 2003, SEMIN NEPHROL, V23, P460, DOI 10.1016/S0270-9295(03)00089-5; Atasayar S, 2009, EXP TOXICOL PATHOL, V61, P23, DOI 10.1016/j.etp.2008.04.016; Avci A, 2008, TURK J MED SCI, V38, P117; Basu A, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/201367; Bhattacharya R, 2008, ADV DRUG DELIVER REV, V60, P1289, DOI 10.1016/j.addr.2008.03.013; Bindoli A, 2009, COORDIN CHEM REV, V253, P1692, DOI 10.1016/j.ccr.2009.02.026; BROCK PR, 1991, J PEDIATR-US, V118, P531, DOI 10.1016/S0022-3476(05)83372-4; Cattaruzza L, 2011, INT J CANCER, V128, P206, DOI 10.1002/ijc.25311; Chao SY, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-23; Chow KHM, 2010, CANCER RES, V70, P329, DOI 10.1158/0008-5472.CAN-09-3324; Daniel MC, 2004, CHEM REV, V104, P293, DOI 10.1021/cr030698+; El-Sayyad HI, 2009, INT J BIOL SCI, V5, P466; FELSON DT, 1990, ARTHRITIS RHEUM, V33, P1449, DOI 10.1002/art.1780331001; Galanski M, 2005, CURR MED CHEM, V12, P2075, DOI 10.2174/0929867054637626; Gronroos M, 2006, PEDIATR BLOOD CANCER, V46, P624, DOI 10.1002/pbc.20471; Hanigan MH, 2001, AM J PATHOL, V159, P1889, DOI 10.1016/S0002-9440(10)63035-0; Healy E, 1998, KIDNEY INT, V54, P1955, DOI 10.1046/j.1523-1755.1998.00202.x; HOKE GD, 1989, TOXICOL APPL PHARM, V100, P293, DOI 10.1016/0041-008X(89)90315-3; Isab AA, 2011, SPECTROCHIM ACTA A, V79, P1196, DOI 10.1016/j.saa.2011.04.042; Kart A, 2010, EXP TOXICOL PATHOL, V62, P45, DOI 10.1016/j.etp.2009.02.066; Kean W F, 1987, Singapore Med J, V28, P117; KEAN WF, 1985, SEMIN ARTHRITIS RHEU, V14, P180, DOI 10.1016/0049-0172(85)90037-X; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Liu J, 1998, TOXICOL APPL PHARM, V149, P24, DOI 10.1006/taap.1997.8325; Magherini F, 2010, J BIOL INORG CHEM, V15, P573, DOI 10.1007/s00775-010-0624-3; MAHDIHASSAN S, 1985, AM J CHINESE MED, V13, P93, DOI 10.1142/S0192415X85000149; Martins NM, 2008, J APPL TOXICOL, V28, P337, DOI 10.1002/jat.1284; MEIJER S, 1982, CANCER CHEMOTH PHARM, V8, P27, DOI 10.1007/BF00292867; Milacic V, 2008, HISTOL HISTOPATHOL, V23, P101, DOI 10.14670/HH-23.101; Miller LC, 1944, P SOC EXP BIOL MED, V57, P261; Milovanovic M, 2010, J INORG BIOCHEM, V104, P944, DOI 10.1016/j.jinorgbio.2010.04.014; Oliver TG, 2010, GENE DEV, V24, P837, DOI 10.1101/gad.1897010; Ott I, 2007, ARCH PHARM, V340, P117, DOI 10.1002/ardp.200600151; Ott I, 2009, COORDIN CHEM REV, V253, P1670, DOI 10.1016/j.ccr.2009.02.019; Pacheco E. A., 2009, GOLD, P217; Panyala NR, 2009, J APPL BIOMED, V7, P75, DOI 10.32725/jab.2009.008; Ramachandran R, 2009, J CLIN PATHOL, V62, P481, DOI 10.1136/jcp.2008.058248; Ravindra P, 2010, J CELL ANIMAL BIOL, V4, P108; Rollino Cristiana, 2010, G Ital Nefrol, V27 Suppl 50, pS70; ROSENBERG B, 1969, NATURE, V222, P385, DOI 10.1038/222385a0; ROSENBERG B, 1965, NATURE, V205, P698, DOI 10.1038/205698a0; Schmidbauer H, 1999, GOLD PROGR CHEM BIOC; Shaw CF, 1999, CHEM REV, V99, P2589, DOI 10.1021/cr980431o; Tiekink ERT, 2002, CRIT REV ONCOL HEMAT, V42, P225, DOI 10.1016/S1040-8428(01)00216-5; Underwood JCE, 1985, HISTOCHEMISTRY THEOR, V2; Wu ML, 2001, J TOXICOL-CLIN TOXIC, V39, P739, DOI 10.1081/CLT-100108516; Yamashita T, 2010, OTOLARYNGOL HEAD NEC, V143, P54; Yan JJ, 2010, CHEM COMMUN, V46, P3893, DOI 10.1039/c001216e; Yao X, 2007, AM J MED SCI, V334, P115, DOI 10.1097/MAJ.0b013e31812dfe1e; Zhang J, 2008, TOXICOL PATHOL, V36, P397, DOI 10.1177/0192623308315832; Zhu SR, 2006, INORG CHEM, V45, P2688, DOI 10.1021/ic051411p	52	12	12	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e51889	10.1371/journal.pone.0051889	http://dx.doi.org/10.1371/journal.pone.0051889			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300573	Green Submitted, Green Published, gold			2022-12-27	WOS:000312829100013
J	Bottger, A; Doxey, AC; Hess, MW; Pfaller, K; Salvenmoser, W; Deutzmann, R; Geissner, A; Pauly, B; Altstatter, J; Munder, S; Heim, A; Gabius, HJ; McConkey, BJ; David, CN				Boettger, Angelika; Doxey, Andrew C.; Hess, Michael W.; Pfaller, Kristian; Salvenmoser, Willi; Deutzmann, Rainer; Geissner, Andreas; Pauly, Barbara; Altstaetter, Johannes; Muender, Sandra; Heim, Astrid; Gabius, Hans-Joachim; McConkey, Brendan J.; David, Charles N.			Horizontal Gene Transfer Contributed to the Evolution of Extracellular Surface Structures: The Freshwater Polyp Hydra Is Covered by a Complex Fibrous Cuticle Containing Glycosaminoglycans and Proteins of the PPOD and SWT (Sweet Tooth) Families	PLOS ONE			English	Article							EPITHELIUM CORYNE TUBULOSA; FIBROBLAST GROWTH-FACTORS; CYSTEINE-RICH DOMAIN; ELECTRON-MICROSCOPY; MANNOSE RECEPTOR; BINDING; LECTIN; CELL; CHONDROITIN; SULFATE	The single-cell layered ectoderm of the fresh water polyp Hydra fulfills the function of an epidermis by protecting the animals from the surrounding medium. Its outer surface is covered by a fibrous structure termed the cuticle layer, with similarity to the extracellular surface coats of mammalian epithelia. In this paper we have identified molecular components of the cuticle. We show that its outermost layer contains glycoproteins and glycosaminoglycans and we have identified chondroitin and chondroitin-6-sulfate chains. In a search for proteins that could be involved in organising this structure we found PPOD proteins and several members of a protein family containing only SWT (sweet tooth) domains. Structural analyses indicate that PPODs consist of two tandem beta-trefoil domains with similarity to carbohydrate-binding sites found in lectins. Experimental evidence confirmed that PPODs can bind sulfated glycans and are secreted into the cuticle layer from granules localized under the apical surface of the ectodermal epithelial cells. PPODs are taxon-specific proteins which appear to have entered the Hydra genome by horizontal gene transfer from bacteria. Their acquisition at the time Hydra evolved from a marine ancestor may have been critical for the transition to the freshwater environment.	[Boettger, Angelika; Pauly, Barbara; Altstaetter, Johannes; Muender, Sandra; Heim, Astrid; David, Charles N.] Univ Munich, Dept Biol 2, Munich, Germany; [Doxey, Andrew C.; McConkey, Brendan J.] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada; [Hess, Michael W.; Pfaller, Kristian] Innsbruck Med Univ, Div Histol & Embryol, Innsbruck, Austria; [Salvenmoser, Willi] Univ Innsbruck, Ctr Mol Biosci Innsbruck, A-6020 Innsbruck, Austria; [Salvenmoser, Willi] Univ Innsbruck, Inst Zool, A-6020 Innsbruck, Austria; [Deutzmann, Rainer; Geissner, Andreas] Univ Regensburg, Dept Biol, Regensburg, Germany; [Gabius, Hans-Joachim] Univ Munich, Fac Vet, Inst Physiol Chem, Munich, Germany	University of Munich; University of Waterloo; Medical University of Innsbruck; University of Innsbruck; University of Innsbruck; University of Regensburg; University of Munich	Bottger, A (corresponding author), Univ Munich, Dept Biol 2, Munich, Germany.	boettger@zi.biologie.uni-muenchen.de	Geissner, Andreas/C-5834-2014; Hess, Michael/AAE-1985-2019	Geissner, Andreas/0000-0002-6996-4671; Hess, Michael/0000-0002-5154-3553; Bottger, Angelika/0000-0003-3273-9558; Doxey, Andrew/0000-0003-2015-099X; Gabius, Hans-Joachim/0000-0003-3467-3900	German Research Foundation; FWF Austrian Science Foundation	German Research Foundation(German Research Foundation (DFG)); FWF Austrian Science Foundation(Austrian Science Fund (FWF))	Funding provided by the German Research Foundation (http://www.dfg.de/index.jsp) and the FWF Austrian Science Foundation (http://www.fwf.ac.at/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bottger A, 2006, EUR J CELL BIOL, V85, P1107, DOI 10.1016/j.ejcb.2006.05.007; Broom A, 2012, STRUCTURE, V20, P161, DOI 10.1016/j.str.2011.10.021; Chapman JA, 2010, NATURE, V464, P592, DOI 10.1038/nature08830; Collins AG, 2006, SYST BIOL, V55, P97, DOI 10.1080/10635150500433615; Deakin JA, 2008, GLYCOBIOLOGY, V18, P483, DOI 10.1093/glycob/cwn028; DEANGELIS PL, 1990, BIOCHIM BIOPHYS ACTA, V1037, P100, DOI 10.1016/0167-4838(90)90107-Q; DEANGELIS PL, 1987, J BIOL CHEM, V262, P13946; Doxey AC, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-23; DUTTA C, 1990, ANAL BIOCHEM, V184, P96, DOI 10.1016/0003-2697(90)90018-5; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fraune S, 2010, P NATL ACAD SCI USA, V107, P18067, DOI 10.1073/pnas.1008573107; Friden V, 2011, KIDNEY INT, V79, P1322, DOI 10.1038/ki.2011.58; Gabius HJ, 2011, TRENDS BIOCHEM SCI, V36, P298, DOI 10.1016/j.tibs.2011.01.005; GABIUS HJ, 1984, J NATL CANCER I, V73, P1349; GABIUS HJ, 2009, SUGAR CODE FUNDAMENT, P317; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hazes B, 1996, PROTEIN SCI, V5, P1490, DOI 10.1002/pro.5560050805; Heger A, 2000, PROTEINS, V41, P224, DOI 10.1002/1097-0134(20001101)41:2<224::AID-PROT70>3.0.CO;2-Z; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; HESS MW, 1995, HISTOCHEM CELL BIOL, V104, P443, DOI 10.1007/BF01464334; Hoffmeister-Ullerich SAH, 2002, EUR J BIOCHEM, V269, P4597, DOI 10.1046/j.1432-1033.2002.03159.x; Holstein TW, 2010, METHOD CELL BIOL, V96, P285, DOI 10.1016/S0091-679X(10)96013-5; Holtman M, 2001, J COMP NEUROL, V432, P550; Holtmann M, 2001, J COMP NEUROL, V432, P537, DOI 10.1002/cne.1118; Hroudova M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036420; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KOHNKEGODT B, 1989, BIOCHEMISTRY-US, V28, P6531, DOI 10.1021/bi00442a001; Kuznetsov SG, 2002, J EXP BIOL, V205, P3809; LENHOFF H M, 1970, Laboratory Animals (London), V4, P139, DOI 10.1258/002367770781036463; LENTZ T, 1966, CELL BIOL HYDRA; Leteux C, 2000, J EXP MED, V191, P1117, DOI 10.1084/jem.191.7.1117; Liu Y, 2000, J EXP MED, V191, P1105, DOI 10.1084/jem.191.7.1105; Lopez-Lucendo MF, 2004, J MOL BIOL, V343, P957, DOI 10.1016/j.jmb.2004.08.078; Loris R, 2002, BBA-GEN SUBJECTS, V1572, P198, DOI 10.1016/S0304-4165(02)00309-4; LUFT JH, 1971, ANAT REC, V171, P347, DOI 10.1002/ar.1091710302; McConkey BJ, 2002, BIOINFORMATICS, V18, P1365, DOI 10.1093/bioinformatics/18.10.1365; Monzavi-Karbassi B, 2007, INT J CANCER, V120, P1179, DOI 10.1002/ijc.22424; Moran Y, 2012, MOL BIOL EVOL; MURZIN AG, 1992, J MOL BIOL, V223, P531, DOI 10.1016/0022-2836(92)90668-A; Notenboom V, 2002, BIOCHEMISTRY-US, V41, P4246, DOI 10.1021/bi015865j; Reidling JC, 2000, J BIOL CHEM, V275, P10323, DOI 10.1074/jbc.275.14.10323; Sarras MP, 2001, BIOESSAYS, V23, P716, DOI 10.1002/bies.1101; Sedeh RS, 2010, J MOL BIOL, V400, P589, DOI 10.1016/j.jmb.2010.04.043; SHIGENAKA Y, 1971, J CELL SCI, V8, P127; THIERY JP, 1967, J MICROSC-PARIS, V6, P987; THOMAS MB, 1995, INVERTEBR BIOL, V114, P107, DOI 10.2307/3226883; Thomsen S, 2006, DEV GENES EVOL, V216, P57, DOI 10.1007/s00427-005-0032-9; Viola M, 2008, CONNECT TISSUE RES, V49, P111, DOI 10.1080/03008200802148405; Westheide W., 1996, SPECIAL ZOOLOGY 1; WINEERA JS, 1974, J MORPHOL, V144, P131, DOI 10.1002/jmor.1051440202; Wittlieb J, 2006, P NATL ACAD SCI USA, V103, P6208, DOI 10.1073/pnas.0510163103; Yamada S, 2007, GLYCOBIOLOGY, V17, P886, DOI 10.1093/glycob/cwm051	53	18	18	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52278	10.1371/journal.pone.0052278	http://dx.doi.org/10.1371/journal.pone.0052278			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300632	Green Published, Green Submitted, gold			2022-12-27	WOS:000312829100037
J	Moenke, G; Falcke, M; Thurley, K				Moenke, Gregor; Falcke, Martin; Thurley, Keven			Hierarchic Stochastic Modelling Applied to Intracellular Ca2+ Signals	PLOS ONE			English	Article							WAITING TIME DISTRIBUTIONS; GENE-EXPRESSION; CALCIUM; PUFFS; OSCILLATIONS; ROBUSTNESS; TRANSDUCTION; VARIABILITY; RECEPTORS; CLUSTERS	Important biological processes like cell signalling and gene expression have noisy components and are very complex at the same time. Mathematical analysis of such systems has often been limited to the study of isolated subsystems, or approximations are used that are difficult to justify. Here we extend a recently published method (Thurley and Falcke, PNAS 2011) which is formulated in observable system configurations instead of molecular transitions. This reduces the number of system states by several orders of magnitude and avoids fitting of kinetic parameters. The method is applied to Ca2+ signalling. Ca2+ is a ubiquitous second messenger transmitting information by stochastic sequences of concentration spikes, which arise by coupling of subcellular Ca2+ release events (puffs). We derive analytical expressions for a mechanistic Ca2+ model, based on recent data from live cell imaging, and calculate Ca2+ spike statistics in dependence on cellular parameters like stimulus strength or number of Ca2+ channels. The new approach substantiates a generic Ca2+ model, which is a very convenient way to simulate Ca2+ spike sequences with correct spiking statistics.	[Moenke, Gregor; Falcke, Martin; Thurley, Keven] Max Delbruck Ctr Mol Med, Berlin, Germany; [Thurley, Keven] Charite, Inst Theoret Biol, D-13353 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Thurley, K (corresponding author), Max Delbruck Ctr Mol Med, Berlin, Germany.	kevin.thurley@mdc-berlin.de	Falcke, Martin/I-2966-2012	Falcke, Martin/0000-0001-7137-1114; Monke, Gregor/0000-0002-3521-715X	German Research Foundation [GRK 1772]	German Research Foundation(German Research Foundation (DFG))	GM was supported by the German Research Foundation funded graduate school GRK 1772: http://www2.hu-berlin.de/biologie/theorybp/index.php?goto = PhD%20program%20CS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Altschuler SJ, 2010, CELL, V141, P559, DOI 10.1016/j.cell.2010.04.033; Balazsi G, 2011, CELL, V144, P910, DOI 10.1016/j.cell.2011.01.030; Barrio M, 2006, PLOS COMPUT BIOL, V2, P1017, DOI 10.1371/journal.pcbi.0020117; Bel G, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/1/016003; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; Blochl F, 2011, B MATH BIOL, V73, P706, DOI 10.1007/s11538-010-9604-6; Borisov NM, 2005, BIOPHYS J, V89, P951, DOI 10.1529/biophysj.105.060533; Bratsun D, 2005, P NATL ACAD SCI USA, V102, P14593, DOI 10.1073/pnas.0503858102; Cagatay T, 2009, CELL, V139, P512, DOI 10.1016/j.cell.2009.07.046; DELBRUCK M, 1945, J BACTERIOL, V50, P131; Delbruck M., 1940, J CHEM PHYS, V8, P120, DOI [10.1063/1.1750549, DOI 10.1063/1.1750549]; DEYOUNG GW, 1992, P NATL ACAD SCI USA, V89, P9895, DOI 10.1073/pnas.89.20.9895; Dickinson GD, 2012, BIOPHYS J, V102, P1826, DOI 10.1016/j.bpj.2012.03.029; Dupont G, 2000, BBA-MOL CELL RES, V1498, P134, DOI 10.1016/S0167-4889(00)00090-2; Dupont G, 2008, BIOPHYS J, V95, P2193, DOI 10.1529/biophysj.108.133777; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Falcke M, 2004, ADV PHYS, V53, P255, DOI 10.1080/00018730410001703159; Feinerman O, 2008, SCIENCE, V321, P1081, DOI 10.1126/science.1158013; Fritsche-Guenther R, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.27; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Gupta RD, 2007, J STAT PLANN INFEREN, P137; Harper CV, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000607; Higgins ER, 2009, J THEOR BIOL, V259, P338, DOI 10.1016/j.jtbi.2009.03.018; Josic K, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002264; Lade SJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002360; Laughlin RB, 2000, P NATL ACAD SCI USA, V97, P28, DOI 10.1073/pnas.97.1.28; Lu T, 2006, P NATL ACAD SCI USA, V103, P16752, DOI 10.1073/pnas.0607698103; Marchant J, 1999, EMBO J, V18, P5285, DOI 10.1093/emboj/18.19.5285; Marchant JS, 2001, EMBO J, V20, P65, DOI 10.1093/emboj/20.1.65; Mariani L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.13; McDonnell MD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000348; MEYER T, 1988, P NATL ACAD SCI USA, V85, P5051, DOI 10.1073/pnas.85.14.5051; Oancea E, 1998, CELL, V95, P307, DOI 10.1016/S0092-8674(00)81763-8; Penzlin H, 2009, NATURWISSENSCHAFTEN, V96, P1, DOI 10.1007/s00114-008-0422-8; Prager T, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.011118; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Schlicht R, 2008, J MATH BIOL, V57, P613, DOI 10.1007/s00285-008-0178-y; Schuster S, 2002, EUR J BIOCHEM, V269, P1333, DOI 10.1046/j.0014-2956.2001.02720.x; Skupin A, 2007, GENOME INFORM SER, V18, P44; Skupin A, 2008, BIOPHYS J, V94, P2404, DOI 10.1529/biophysj.107.119495; Skupin A, 2012, ADV EXP MED BIOL, V740, P531, DOI 10.1007/978-94-007-2888-2_24; Skupin A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000870; Skupin A, 2009, CHAOS, V19, DOI 10.1063/1.3184537; Smith IF, 2009, P NATL ACAD SCI USA, V106, P6404, DOI 10.1073/pnas.0810799106; Sneyd J, 2005, PROG BIOPHYS MOL BIO, V89, P207, DOI 10.1016/j.pbiomolbio.2004.11.001; Sneyd J, 2004, PROG BIOPHYS MOL BIO, V85, P121, DOI 10.1016/j.pbiomolbio.2004.01.013; Suter DM, 2011, SCIENCE, V332, P472, DOI 10.1126/science.1198817; Tanase-Nicola S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000125; TaufiqUrRahman, 2009, NATURE, V458, P655, DOI 10.1038/nature07763; Taylor CW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004010; Thul R, 2007, EPL-EUROPHYS LETT, V79, DOI 10.1209/0295-5075/79/38003; Thul R, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.188103; Thurley K, 2012, BBA-GEN SUBJECTS, V1820, P1185, DOI 10.1016/j.bbagen.2011.10.007; Thurley K, 2011, BIOPHYS J, V101, P2638, DOI 10.1016/j.bpj.2011.10.030; Thurley K, 2011, P NATL ACAD SCI USA, V108, P427, DOI 10.1073/pnas.1008435108; Ueda M, 2007, BIOPHYS J, V93, P11, DOI 10.1529/biophysj.106.100263; VANKAMPEN NG, 2002, STOCHASTIC PROCESSES; Zhou CS, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.098101	60	16	17	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e51178	10.1371/journal.pone.0051178	http://dx.doi.org/10.1371/journal.pone.0051178			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300536	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000312829100006
J	Zhu, J; Qiu, J; Magrane, G; Abedalthagafi, M; Zanko, A; Golabi, M; Chehab, FF				Zhu, Jun; Qiu, Jun; Magrane, Gregg; Abedalthagafi, Malak; Zanko, Andrea; Golabi, Mahin; Chehab, Farid F.			Duplication of C7orf58, WNT16 and FAM3C in an Obese Female with a t(7;22)(q32.1;q11.2) Chromosomal Translocation and Clinical Features Resembling Coffin-Siris Syndrome	PLOS ONE			English	Article							ACUTE LYMPHOBLASTOID LEUKEMIA; MENTAL-RETARDATION; SWI/SNF COMPLEX; CANCER; MUTATIONS; EXPRESSION; DISEASE; GENE; ONYCHODYSPLASIA; METABOLISM	We characterized the t(7;22)(q32;q11.2) chromosomal translocation in an obese female with coarse features, short stature, developmental delay and a hypoplastic fifth digit. While these clinical features suggest Coffin-Siris Syndrome (CSS), we excluded a CSS diagnosis by exome sequencing based on the absence of deleterious mutations in six chromatin-remodeling genes recently shown to cause CSS. Thus, molecular characterization of her translocation could delineate genes that underlie other syndromes resembling CSS. Comparative genomic hybridization microarrays revealed on chromosome 7 the duplication of a 434,682 bp region that included the tail end of an uncharacterized gene termed C7orf58 (also called CPED1) and spanned the entire WNT16 and FAM3C genes. Because the translocation breakpoint on chromosome 22 did not disrupt any apparent gene, her disorder was deemed to result from the rearrangement on chromosome 7. Mapping of yeast and bacterial artificial chromosome clones by fluorescent in situ hybridization on chromosome spreads from this patient showed that the duplicated region and all three genes within it were located on both derivative chromosomes 7 and 22. Furthermore, DNA sequencing of exons and splice junctional regions from C7orf58, WNT16 and FAM3C revealed the presence of potential splice site and promoter mutations, thereby augmenting the detrimental effect of the duplicated genes. Hence, dysregulation and/or disruptions of C7orf58, WNT16 and FAM3C underlie the phenotype of this patient, serve as candidate genes for other individuals with similar clinical features and could provide insights into the physiological role of the novel gene C7orf58.	[Zhu, Jun; Qiu, Jun; Magrane, Gregg; Chehab, Farid F.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Abedalthagafi, Malak] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Zanko, Andrea; Golabi, Mahin] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Chehab, FF (corresponding author), Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.	chehabf@labmed2.ucsf.edu	Abedalthagafi, Malak/Q-7434-2019	Abedalthagafi, Malak/0000-0003-1786-3366	National Institutes of Health [T32 DK07636]; University of California San Francisco/National Institutes of Health Diabetes Center [P30 DK063720]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720, T32DK007636] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California San Francisco/National Institutes of Health Diabetes Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health T32 DK07636 and by a pilot and feasibility grant from the University of California San Francisco/National Institutes of Health Diabetes Center Grant P30 DK063720. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASLAND R, 1995, TRENDS BIOCHEM SCI, V20, P56, DOI 10.1016/S0968-0004(00)88957-4; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bouffard GG, 1997, GENOME RES, V7, P673, DOI 10.1101/gr.7.7.673; Brautbar A, 2009, AM J MED GENET A, V149A, P559, DOI 10.1002/ajmg.a.32671; Brest P, 2011, NAT GENET, V43, P242, DOI 10.1038/ng.762; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; COFFIN GS, 1970, AM J DIS CHILD, V119, P433, DOI 10.1001/archpedi.1970.02100050435009; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Dauwerse JG, 2010, AM J MED GENET A, V152A, P427, DOI 10.1002/ajmg.a.33203; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Dogan RI, 2007, NUCLEIC ACIDS RES, V35, pW285, DOI 10.1093/nar/gkm407; Elliott AM, 2000, CLIN DYSMORPHOL, V9, P15, DOI 10.1097/00019605-200009010-00003; Farooqi IS, 2001, NATURE, V414, P34, DOI 10.1038/35102112; Fear MW, 2000, BIOCHEM BIOPH RES CO, V278, P814, DOI 10.1006/bbrc.2000.3852; Fleck BJ, 2001, AM J MED GENET, V99, P1, DOI 10.1002/1096-8628(20010215)99:1<1::AID-AJMG1127>3.0.CO;2-A; FRYNS JP, 1986, CLIN GENET, V29, P263; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Gunduz M, 2008, CANCER SCI, V99, P531, DOI 10.1111/j.1349-7006.2007.00708.x; Havel PJ, 1996, J CLIN ENDOCR METAB, V81, P4406, DOI 10.1210/jc.81.12.4406; KALLIONIEMI OP, 1992, P NATL ACAD SCI USA, V89, P5321, DOI 10.1073/pnas.89.12.5321; Kim HG, 2012, AM J HUM GENET, V91, P56, DOI 10.1016/j.ajhg.2012.05.005; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Mazieres J, 2005, ONCOGENE, V24, P5396, DOI 10.1038/sj.onc.1208568; McGhee EM, 2000, AM J MED GENET, V93, P241, DOI 10.1002/1096-8628(20000731)93:3<241::AID-AJMG16>3.0.CO;2-E; McWhirter JR, 1999, P NATL ACAD SCI USA, V96, P11464, DOI 10.1073/pnas.96.20.11464; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Musio A, 2006, NAT GENET, V38, P528, DOI 10.1038/ng1779; Perry GH, 2008, AM J HUM GENET, V82, P685, DOI 10.1016/j.ajhg.2007.12.010; Prestwich TC, 2007, CURR OPIN CELL BIOL, V19, P612, DOI 10.1016/j.ceb.2007.09.014; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; Santen GWE, 2012, NAT GENET, V44, P379, DOI 10.1038/ng.2217; Schrier SA, 2012, AM J MED GENET A, V158A, P1865, DOI 10.1002/ajmg.a.35415; Schug Jonathan, 2008, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0206s21; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; SENIOR B, 1971, AM J DIS CHILD, V122, P7, DOI 10.1001/archpedi.1971.02110010043002; Tsurusaki Y, 2012, NAT GENET, V44, P376, DOI 10.1038/ng.2219; TUNNESSEN WW, 1978, AM J DIS CHILD, V132, P393, DOI 10.1001/archpedi.1978.02120290065011; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Wright WS, 2007, DIABETES, V56, P295, DOI 10.2337/db06-1339; YUNIS JJ, 1976, SCIENCE, V191, P1268, DOI 10.1126/science.1257746; Zhu Y, 2002, GENOMICS, V80, P144, DOI 10.1006/geno.2002.6816	45	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52353	10.1371/journal.pone.0052353	http://dx.doi.org/10.1371/journal.pone.0052353			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300646	Green Published, gold			2022-12-27	WOS:000312829100043
J	Zhou, H; Gao, J; Zou, DW; Wu, WB; Li, ZS				Zhou, Hui; Gao, Jun; Zou, Duowu; Wu, Wenbin; Li, Zhaoshen			Effect of Octreotide on Enteric Motor Neurons in Experimental Acute Necrotizing Pancreatitis	PLOS ONE			English	Article							SMALL-BOWEL MOTILITY; INTERSTITIAL-CELLS; BACTERIAL OVERGROWTH; INFLAMMATORY RESPONSE; NERVOUS-SYSTEM; SOMATOSTATIN; RATS; DYSMOTILITY; MOUSE; MODEL	Background/Aims: Amelioration of intestinal dysmotility and stasis during the early period of acute necrotizing pancreatitis (ANP) appears to be important to reduce the risks of secondary pancreatic infection. We aimed to characterize the association between the neuropathy of the enteric nervous system and gut dysfunction and to examine the effect of octreotide on motor innervation in the early stage of ANP. Methodology/Principal Findings: The rats were randomly divided into eight groups: control+saline; control+octreotide; ANP+saline and ANP+octreotide (24 h, 48 h, 72 h). The spontaneous activity of ileal segments and the response to ACh, L-NNA were recorded. The alterations of myenteric neuronal nitric oxide synthase (nNOS), choline acetyltransferase (CHAT), PGP9.5 and somatostatin receptor 2 (SSTR2) immunoreactive cells were evaluated by immunofluorescence and the protein expression of nNOS and CHAT were evaluated by western blot. We found the amplitude of spontaneous contractions at 48 h and the response to ACh at 24 h declined in the ANP+saline rats. A higher contractile response to both ACh and to L-NNA was observed in the ANP+octreotide group, compared with the ANP+saline rats at 24 h. A significant reduction in the nNOS and cholinergic neurons was observed in ANP+saline rats at the three time points. However, this reduction was greatly ameliorated in the presence of octreotide at 24 h and 48 h. The protein expression of CHAT neurons at 24 h and the nNOS neurons at 48 h in the ANP+octreotide rats was much higher than the ANP+saline rats. Conclusion: The pathogenesis of ileus in the early stage of ANP may be related to the neuropathy of the enteric nervous system. Octreotide may reduce the severity of ileus by lessening the damage to enteric motor innervation.	[Zhou, Hui] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Dept Gastroenterol, Shanghai 200030, Peoples R China; [Zhou, Hui] Second Mil Med Univ, Changhai Hosp, Dept Internal Med, Div Gastroenterol, Shanghai, Peoples R China; [Wu, Wenbin] Second Mil Med Univ, Changhai Hosp, Dept Internal Med, Lab Stress Res, Shanghai, Peoples R China	Shanghai Jiao Tong University; Naval Medical University; Naval Medical University	Li, ZS (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Internal Med, Div Gastroenterol, Shanghai, Peoples R China.	zhsli@96590.net	Gao, Jun/C-1686-2008	Gao, Jun/0000-0003-4637-1918	National Nature Science Funds, China [81100257]	National Nature Science Funds, China	This work was supported by grants from the National Nature Science Funds, serial numbers: (81100257) to Zhou, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdu F, 2002, AM J PHYSIOL-GASTR L, V282, pG624, DOI 10.1152/ajpgi.00354.2001; Al Mofleh IA, 2008, WORLD J GASTROENTERO, V14, P675, DOI 10.3748/wjg.14.675; Barnett P, 2003, ENDOCRINE, V20, P255, DOI 10.1385/ENDO:20:3:255; BEGER HG, 1986, GASTROENTEROLOGY, V91, P433, DOI 10.1016/0016-5085(86)90579-2; BERG RD, 1979, INFECT IMMUN, V23, P403, DOI 10.1128/IAI.23.2.403-411.1979; Cescato R, 2006, J NUCL MED, V47, P502; Chandrasekharan B, 2007, NEUROGASTROENT MOTIL, V19, P951, DOI 10.1111/j.1365-2982.2007.01023.x; Chen Chun-Chia, 1999, Proceedings of the National Science Council Republic of China Part B Life Sciences, V23, P1; Corleto VD, 2006, NEUROGASTROENT MOTIL, V18, P217, DOI 10.1111/j.1365-2982.2005.00752.x; Corleto VD, 2010, CURR OPIN ENDOCRINOL, V17, P63, DOI 10.1097/MED.0b013e32833463ed; De Man JG, 2002, INT J PARASITOL, V32, P1309, DOI 10.1016/S0020-7519(02)00128-5; Demedts I, 2006, NEUROGASTROENT MOTIL, V18, P1102, DOI 10.1111/j.1365-2982.2006.00857.x; Dugernier T, 2005, PANCREAS, V31, P168, DOI 10.1097/01.mpa.0000170681.89652.95; FAUSSONEPELLEGRINI MS, 1985, ANAT EMBRYOL, V171, P163, DOI 10.1007/BF00341410; Fritz S, 2010, AM J SURG, V200, P111, DOI 10.1016/j.amjsurg.2009.08.019; Fritz S, 2008, CRIT CARE, V12, DOI 10.1186/cc7118; Grider JR, 2003, J PHARMACOL EXP THER, V307, P460, DOI 10.1124/jpet.103.053512; HARUMA K, 1994, GUT, V35, P1064, DOI 10.1136/gut.35.8.1064; JOHANSSON C, 1978, SCAND J GASTROENTERO, V13, P481, DOI 10.3109/00365527809181925; Li J, 2011, CURR PHARM DESIGN, V17, P1594, DOI 10.2174/138161211796196936; Linden DR, 2005, NEUROGASTROENT MOTIL, V17, P751, DOI 10.1111/j.1365-2982.2005.00703.x; MILENOV K, 1993, COMP BIOCHEM PHYS C, V106, P337, DOI 10.1016/0742-8413(93)90143-9; Nieuwenhuijs VB, 1998, ANN SURG, V228, P188, DOI 10.1097/00000658-199808000-00007; ODONNELL LJD, 1990, ALIMENT PHARM THERAP, V4, P177; Pawlikowski M., 2007, SOMATOSTATIN ANALOGS, DOI [10.1201/9781498713528, DOI 10.1201/9781498713528]; Rakonczay Z, 2008, CRIT CARE MED, V36, P2117, DOI 10.1097/CCM.0b013e31817d7f5c; Rickenbacher A, 2008, SURGERY, V143, P94, DOI 10.1016/j.surg.2007.06.034; RUNKEL NSF, 1991, J SURG RES, V51, P18, DOI 10.1016/0022-4804(91)90064-S; Sanovic S, 1999, AM J PATHOL, V155, P1051, DOI 10.1016/S0002-9440(10)65207-8; Shimojima N, 2006, J SURG RES, V135, P255, DOI 10.1016/j.jss.2006.04.022; SOUDAH HC, 1991, NEW ENGL J MED, V325, P1461, DOI 10.1056/NEJM199111213252102; Tang WF, 2007, J DIGEST DIS, V8, P96, DOI 10.1111/j.1443-9573.2007.00293.x; Van Felius ID, 2003, NEUROGASTROENT MOTIL, V15, P267, DOI 10.1046/j.1365-2982.2003.00410.x; Vasina V, 2006, AUTON NEUROSCI-BASIC, V126, P264, DOI 10.1016/j.autneu.2006.02.025; Wang XP, 2003, J GASTROEN HEPATOL, V18, P57, DOI 10.1046/j.1440-1746.2003.02898.x; Weber CK, 2001, PANCREATOLOGY, V1, P356, DOI 10.1159/000055834; Yamamoto T, 2008, J GASTROEN HEPATOL, V23, P660, DOI 10.1111/j.1440-1746.2008.05326.x; Zhang XP, 2009, HEPATOB PANCREAT DIS, V8, P85; Zhang XP, 2009, TURK J GASTROENTEROL, V20, P108; Zhou H, 2011, PANCREAS, V40, P1226, DOI 10.1097/MPA.0b013e318220afab; Zhou H, 2011, SURGERY, V149, P262, DOI 10.1016/j.surg.2010.04.023; Zhou MT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037347	42	6	7	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52163	10.1371/journal.pone.0052163	http://dx.doi.org/10.1371/journal.pone.0052163			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300603	Green Submitted, Green Published, gold			2022-12-27	WOS:000313618800050
J	Gomes, MVM; Toffoli, LV; Arruda, DW; Soldera, LM; Pelosi, GG; Neves-Souza, RD; Freitas, ER; Castro, DT; Marquez, AS				Gomes, Marcus V. M.; Toffoli, Leandro V.; Arruda, Douglas W.; Soldera, Larissa M.; Pelosi, Gislaine G.; Neves-Souza, Rejane D.; Freitas, Eliane R.; Castro, Denilson T.; Marquez, Audrey S.			Age-Related Changes in the Global DNA Methylation Profile of Leukocytes Are Linked to Nutrition but Are Not Associated with the MTHFR C677T Genotype or to Functional Capacities	PLOS ONE			English	Article							MINI-MENTAL-STATE; GASTRIC-CANCER RISK; EPIGENETIC REGULATION; GENOMIC METHYLATION; COLORECTAL ADENOMA; BLADDER-CANCER; BREAST-CANCER; FOLATE STATUS; GENE; HYPOMETHYLATION	Global DNA methylation of peripheral blood leukocytes has been recently proposed as a potential biomarker for disease risk. However, the amplitude of the changes in DNA methylation associated with normal aging and the impacts of environmental changes on this variation are still unclear. In this context, we evaluated the association of global DNA methylation with nutritional habits, tobacco smoking, body mass index (BMI), clinical laboratory parameters, polymorphism C677T MTHFR, functional cognition and the daily practice of physical activity in a cancer-free older population. Leukocyte global DNA methylation from 126 older individuals was quantified using a high-throughput ELISA-based method. Global DNA hypomethylation was observed in older individuals when compared to a younger population (p = 0.0469), confirming changes in DNA methylation in the aging process. Furthermore, the methylation profile of elders was correlated with the daily ingestion of carbohydrates (p = 0.0494), lipids (p = 0.0494), vitamin B6 (p = 0.0421), magnesium (p = 0.0302), and also to the serum levels of total protein (p = 0.0004), alpha 2 globulin (p = 0.0013) and albumin (p = 0.0015). No statistically significant difference was observed when global DNA methylation were stratified according to C677T MTHFR genotypes (p = 0.7200), BMI (p = 0.1170), smoking habit (p = 0.4382), physical activity in daily life (p = 0.8492), scored cognitive function (p = 0.7229) or depression state (p = 0.8301). Our data indicate that age-related variations in the global DNA methylation profile of leukocytes might be modulated by the daily intake of carbohydrates, lipids, vitamin B6, and magnesium and be associated with serum protein levels, however it is independent of C677T MTHFR genotype and not correlated with BMI, smoking habit, cognitive function or the routine physical activities.	[Gomes, Marcus V. M.; Toffoli, Leandro V.; Arruda, Douglas W.; Soldera, Larissa M.; Neves-Souza, Rejane D.; Freitas, Eliane R.; Castro, Denilson T.; Marquez, Audrey S.] Univ No Parana UNOPAR, Res Ctr Hlth Sci, Londrina, Parana, Brazil; [Pelosi, Gislaine G.] State Univ Londrina UEL, Dept Physiol Sci, Ctr Biol Sci, Londrina, Parana, Brazil	University Norte Parana; Universidade Estadual de Londrina	Gomes, MVM (corresponding author), Univ No Parana UNOPAR, Res Ctr Hlth Sci, Londrina, Parana, Brazil.	mvmgomes@gmail.com	Pelosi, Gislaine/AAF-8585-2021		National Foundation for Development of Private Education (Funadesp) [5300665]	National Foundation for Development of Private Education (Funadesp)	This work was supported by a grant from the National Foundation for Development of Private Education (Funadesp) (no.5300665). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avanutrionline, 2012, SOFTW WIND; Axume J, 2007, NUTR RES, V27, P13, DOI 10.1016/j.nutres.2006.12.006; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bell JT, 2012, PLOS GENET, V8, P189, DOI 10.1371/journal.pgen.1002629; BERDYSHEV G. D., 1967, BIOKHIMIYA, V32, P988; Bestor TH, 1998, CIBA F SYMP, V214, P187; Brucki SMD, 2003, ARQ NEURO-PSIQUIAT, V61, P777, DOI 10.1590/S0004-282X2003000500014; Calvanese V, 2009, AGEING RES REV, V8, P268, DOI 10.1016/j.arr.2009.03.004; Cash HL, 2012, INT J CANCER, V130, P1151, DOI 10.1002/ijc.26098; Choi JY, 2009, CARCINOGENESIS, V30, P1889, DOI 10.1093/carcin/bgp143; Chouliaras L, 2011, BRAIN BEHAV IMMUN, V25, P616, DOI 10.1016/j.bbi.2010.11.016; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Feil R, 2012, NAT REV GENET, V13, P97, DOI 10.1038/nrg3142; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fraga MF, 2009, CURR OPIN IMMUNOL, V21, P446, DOI 10.1016/j.coi.2009.04.003; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Friso S, 2002, P NATL ACAD SCI USA, V99, P5606, DOI 10.1073/pnas.062066299; Fuke C, 2004, ANN HUM GENET, V68, P196, DOI 10.1046/j.1529-8817.2004.00081.x; Gao Y, 2012, BRIT J CANCER, V106, P585, DOI 10.1038/bjc.2011.562; Graff J, 2009, EUR J NEUROSCI, V30, P1, DOI 10.1111/j.1460-9568.2009.06787.x; Guerrero-Preston R, 2010, EPIGENETICS-US, V5, DOI 10.4161/epi.5.6.12378; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Hou LF, 2010, INT J CANCER, V127, P1866, DOI 10.1002/ijc.25190; Hsiung DT, 2007, CANCER EPIDEM BIOMAR, V16, P108, DOI 10.1158/1055-9965.EPI-06-0636; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; Jung AY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024976; Kwabi-Addo B, 2007, CLIN CANCER RES, V13, P3796, DOI 10.1158/1078-0432.CCR-07-0085; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Li YY, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-98; Li YY, 2010, FASEB J, V24, P1442, DOI 10.1096/fj.09-149328; Liao LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027361; Lim U, 2008, GASTROENTEROLOGY, V134, P47, DOI 10.1053/j.gastro.2007.10.013; Moore LE, 2008, LANCET ONCOL, V9, P359, DOI 10.1016/S1470-2045(08)70038-X; MURDEN RA, 1991, J AM GERIATR SOC, V39, P149, DOI 10.1111/j.1532-5415.1991.tb01617.x; OLERUP O, 1992, TISSUE ANTIGENS, V39, P225, DOI 10.1111/j.1399-0039.1992.tb01940.x; Ono H, 2012, CANC SCI, V7; Pallavi R, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00318; Panning B, 1998, CELL, V93, P305, DOI 10.1016/S0092-8674(00)81155-1; Penner MR, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00009; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Pufulete M, 2003, GASTROENTEROLOGY, V124, P1240, DOI 10.1016/S0016-5085(03)00279-8; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Ronn T, 2008, DIABETOLOGIA, V51, P1159, DOI 10.1007/s00125-008-1018-8; Schiepers OJG, 2012, BRIT J NUTR, V107, P744, DOI 10.1017/S0007114511003576; Slimani N, 1999, COMPUT METH PROG BIO, V58, P251, DOI 10.1016/S0169-2607(98)00088-1; So K, 2006, PATHOL INT, V56, P571, DOI 10.1111/j.1440-1827.2006.02010.x; Spirduso WW, 1995, PHYS DIMENSIONS AGIN; Thompson RF, 2010, AGING CELL, V9, P506, DOI 10.1111/j.1474-9726.2010.00577.x; Tohgi H, 1999, MOL BRAIN RES, V70, P288, DOI 10.1016/S0169-328X(99)00163-1; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; VANYUSHI.BF, 1973, GERONTOLOGY, V19, P138, DOI 10.1159/000211967; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Wilhelm CS, 2010, CLIN CANCER RES, V16, P1682, DOI 10.1158/1078-0432.CCR-09-2983; WILSON VL, 1987, J BIOL CHEM, V262, P9948; Wong CCY, 2010, EPIGENETICS-US, V5, DOI 10.4161/epi.5.6.12226; Woo HD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034615; Wu HC, 2011, EPIGENETICS-US, V6, P29, DOI 10.4161/epi.6.1.13393; Zhang FF, 2011, EPIGENETICS-US, V6, P623, DOI 10.4161/epi.6.5.15335	60	46	47	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52570	10.1371/journal.pone.0052570	http://dx.doi.org/10.1371/journal.pone.0052570			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285094	Green Published, gold, Green Submitted			2022-12-27	WOS:000312794500200
J	Jung, S; Kim, S; Gale, M; Cherni, I; Fonseca, R; Carpten, J; Salhia, B				Jung, Sungwon; Kim, Seungchan; Gale, Molly; Cherni, Irene; Fonseca, Rafael; Carpten, John; Salhia, Bodour			DNA Methylation in Multiple Myeloma Is Weakly Associated with Gene Transcription	PLOS ONE			English	Article							FACTOR-I RECEPTOR; GROWTH-FACTOR; MONOCLONAL-ANTIBODY; CELL-PROLIFERATION; HIGH-FREQUENCY; HUMAN CANCER; INSULIN; GENOME; HYPERMETHYLATION; ISLANDS	Previous studies have now demonstrated that both genic and global hypomethylation characterizes the multiple myeloma (MM) epigenome. Whether these methylation changes are associated with global and corresponding increases (or decreases) in transcriptional activity are poorly understood. The purpose of our current study was to correlate DNA methylation levels in MM to gene expression. We analyzed matching datasets generated by the GoldenGate methylation BeadArray and Affymetrix gene expression platforms in 193 MM samples. We subsequently utilized two independent statistical approaches to identify methylation-expression correlations. In the first approach, we used a linear correlation parameter by computing a Pearson correlation coefficient. In the second approach, we discretized samples into low and high methylation groups and then compared the gene expression differences between the groups. Only methylation of 2.1% and 25.3% of CpG sites on the methylation array correlated to gene expression by Pearson correlation or the discretization method, respectively. Among the genes with methylation-expression correlations were IGF1R, DLC1, p16, and IL17RB. In conclusion, DNA methylation may directly regulate relatively few genes and suggests that additional studies are needed to determine the effects of genome-wide methylation changes in MM. Citation: Jung S, Kim S, Gale M, Cherni I, Fonseca R, et al. (2012) DNA Methylation in Multiple Myeloma Is Weakly Associated with Gene Transcription. PLoS ONE 7(12): e52626. doi:10.1371/journal.pone.0052626	[Jung, Sungwon; Kim, Seungchan; Gale, Molly; Cherni, Irene; Carpten, John; Salhia, Bodour] Translat Genom Res Inst, Integrated Canc Genom Div, Phoenix, AZ 85004 USA; [Fonseca, Rafael] Mayo Clin, Scottsdale, AZ USA	Translational Genomics Research Institute; Mayo Clinic; Mayo Clinic Phoenix	Salhia, B (corresponding author), Translat Genom Res Inst, Integrated Canc Genom Div, Phoenix, AZ 85004 USA.	bsalhia@tgen.org		Kim, Seungchan/0000-0003-4183-4338; Fonseca, Rafael/0000-0002-5938-3769	Multiple Myeloma Research Foundation	Multiple Myeloma Research Foundation	This research was supported in part by the Multiple Myeloma Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Avet-Loiseau H, 2011, J CLIN ONCOL, V29, P1893, DOI 10.1200/JCO.2010.32.8435; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Baumann P, 2009, ANTI-CANCER DRUG, V20, P259, DOI 10.1097/CAD.0b013e328328d18b; Bergsagel PL, 2005, J CLIN ONCOL, V23, P6333, DOI 10.1200/JCO.2005.05.021; Bergsagel PL, 2005, BLOOD, V106, P296, DOI 10.1182/blood-2005-01-0034; BIRD A, 1985, CELL, V40, P91, DOI 10.1016/0092-8674(85)90312-5; Cedar H, 2012, ANNU REV BIOCHEM, V81, P97, DOI 10.1146/annurev-biochem-052610-091920; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chen Wenming, 2002, Chinese Medical Sciences Journal, V17, P101; Cheng XD, 2010, BIOCHEMISTRY-US, V49, P2999, DOI 10.1021/bi100213t; Cheung HH, 2009, BIRTH DEFECTS RES C, V87, P335, DOI 10.1002/bdrc.20163; Chng WJ, 2006, LEUKEMIA, V20, P174, DOI 10.1038/sj.leu.2403997; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Descamps G, 2009, BRIT J CANCER, V100, P366, DOI 10.1038/sj.bjc.6604839; Dhodapkar KM, 2008, BLOOD, V112, P2878, DOI 10.1182/blood-2008-03-143222; Esteller M, 2003, ADV EXP MED BIOL, V532, P39; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Fonseca R, 2009, LEUKEMIA, V23, P2210, DOI 10.1038/leu.2009.174; Gonzalez-Paz N, 2007, BLOOD, V109, P1228, DOI 10.1182/blood-2006-05-024661; GOODMAN JI, 1993, ENVIRON HEALTH PERSP, V101, P169, DOI 10.2307/3431863; Guillerm GL, 2003, HAEMATOLOGICA, V88, P476; Han H, 2011, HUM MOL GENET, V20, P4299, DOI 10.1093/hmg/ddr356; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Mateos MV, 2002, BRIT J HAEMATOL, V118, P1034, DOI 10.1046/j.1365-2141.2002.03749.x; Menu Eline, 2009, Archives of Physiology and Biochemistry, V115, P49, DOI 10.1080/13813450902736583; Moreau P, 2011, LEUKEMIA, V25, P872, DOI 10.1038/leu.2011.4; Ogoshi K, 2011, GENOMICS, V98, P280, DOI 10.1016/j.ygeno.2011.07.003; Sabbatini P, 2009, CLIN CANCER RES, V15, P3058, DOI 10.1158/1078-0432.CCR-08-2530; Salhia B, 2010, CANCER RES, V70, P6934, DOI 10.1158/0008-5472.CAN-10-0282; Song YF, 2006, J CLIN PATHOL, V59, P947, DOI 10.1136/jcp.2005.031377; Sprynski AC, 2010, LEUKEMIA, V24, P1940, DOI 10.1038/leu.2010.192; Sprynski AC, 2009, BLOOD, V113, P4614, DOI 10.1182/blood-2008-07-170464; Stewart AK, 2007, LEUKEMIA, V21, P529, DOI 10.1038/sj.leu.2404516; Ullmannova-Benson V, 2009, LEUKEMIA, V23, P383, DOI 10.1038/leu.2008.285; Yuregir OO, 2009, INT J LAB HEMATOL	37	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52626	10.1371/journal.pone.0052626	http://dx.doi.org/10.1371/journal.pone.0052626			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285118	Green Submitted, Green Published, gold			2022-12-27	WOS:000312794500213
J	Oni, T; Tsekela, R; Kwaza, B; Manjezi, L; Bangani, N; Wilkinson, KA; Coetzee, D; Wilkinson, RJ				Oni, Tolu; Tsekela, Relebohile; Kwaza, Bekekile; Manjezi, Lulama; Bangani, Nonzwakazi; Wilkinson, Katalin A.; Coetzee, David; Wilkinson, Robert J.			A Recent HIV Diagnosis Is Associated with Non-Completion of Isoniazid Preventive Therapy in an HIV-Infected Cohort in Cape Town	PLOS ONE			English	Article							LATENT TUBERCULOSIS INFECTION; ADHERENCE; IMPLEMENTATION; BARRIERS; FAILURE; ADULTS	Introduction: Despite high rates of successful treatment TB incidence in South Africa remains high, suggesting ongoing transmission and a large reservoir of latently infected persons. Isoniazid preventive therapy (IPT) is recommended as preventive therapy in HIV-infected persons. However, implementation has been slow, impeded by barriers and challenges including the fear of non-adherence. Objective and Methods: The aim was to evaluate predictors of IPT non-completion. One hundred and sixty four antiretroviral therapy (ART)-naive HIV-infected patients with tuberculin skin test >= 5 mm were recruited from Khayelitsha day hospital and followed up monthly. A questionnaire was used to collect demographic information. Results: The overall completion rate was 69%. In multivariable analysis, there was a 29% decrease in risk of non-completion for every year after HIV diagnosis (OR 0.81; 95% C.I. 0.68-0.98). Self-reported alcohol drinkers (OR 4.05; 95% C.I. 1.89-9.06) also had a four-fold higher risk of non-completion, with a strong association between alcohol drinkers and smoking (chi(2) 27.08; p<0.001). Conclusion: We identify patients with a recent HIV diagnosis, in addition to self-reported drinkers and smokers as being at higher risk of non-completion of IPT. The period of time since HIV diagnosis should therefore be taken into account when initiating IPT. Our results also suggest that smokers and alcohol drinkers should be identified and targeted for adherence interventions when implementing IPT on a wider scale. Citation: Oni T, Tsekela R, Kwaza B, Manjezi L, Bangani N, et al. (2012) A Recent HIV Diagnosis Is Associated with Non-Completion of Isoniazid Preventive Therapy in an HIV-Infected Cohort in Cape Town. PLoS ONE 7(12): e52489. doi:10.1371/journal.pone.0052489	[Oni, Tolu; Tsekela, Relebohile; Kwaza, Bekekile; Bangani, Nonzwakazi; Wilkinson, Katalin A.; Wilkinson, Robert J.] Univ Cape Town, Fac Hlth Sci, Clin Infect Dis Res Initiat, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Oni, Tolu; Wilkinson, Robert J.] Univ London Imperial Coll Sci Technol & Med, Div Med, London, England; [Oni, Tolu; Coetzee, David] Univ Cape Town, Ctr Infect Dis & Epidemiol Res, Sch Publ Hlth, ZA-7925 Cape Town, South Africa; [Manjezi, Lulama] Khayelitsha Day Hosp, Cape Town, South Africa; [Wilkinson, Katalin A.; Wilkinson, Robert J.] Natl Inst Med Res, MRC, London NW7 1AA, England	University of Cape Town; Imperial College London; University of Cape Town; MRC National Institute for Medical Research	Oni, T (corresponding author), Univ Cape Town, Fac Hlth Sci, Clin Infect Dis Res Initiat, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa.	tolullahoni@doctors.org.uk	Wilkinson, Katalin/AAQ-7713-2021; Wilkinson, Katalin/AAF-6805-2020	Wilkinson, Katalin/0000-0002-9796-2040; Wilkinson, Robert/0000-0002-2753-1800; Oni, Tolu/0000-0003-4499-1910	Wellcome Trust [084323, 088316]; MRC [U1175.02.002.00014.01]; ILULU Consortium; European Union [Sante/2006/105-061]; EDCTP [IP.07.32080.002]	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ILULU Consortium; European Union(European Commission); EDCTP	RJW is funded by the Wellcome Trust (084323, 088316) and MRC (U1175.02.002.00014.01). This study was supported by the ILULU Consortium, which is funded by a grant from the European Union (Sante/2006/105-061) and EDCTP (IP.07.32080.002). The funders had no role in the design of the study or preparation of the manuscript.	Anibarro L, 2010, INT J TUBERC LUNG D, V14, P701; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Dye C, 2006, LANCET, V367, P938, DOI 10.1016/S0140-6736(06)68384-0; Getahun H, 2010, AIDS, V24, pS57, DOI 10.1097/01.aids.0000391023.03037.1f; Gust DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018435; Hirsch-Moverman Y, 2008, INT J TUBERC LUNG D, V12, P1235; Hirsch-Moverman Y, 2010, INT J TUBERC LUNG D, V14, P1104; Kwara A, 2008, CHEST, V133, P862, DOI 10.1378/chest.07-2024; Lavigne M, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-66; Lester R, 2010, AIDS, V24, pS45, DOI 10.1097/01.aids.0000391021.18284.12; Li JH, 2010, INT J INFECT DIS, V14, pE292, DOI 10.1016/j.ijid.2009.05.007; Machado A, 2009, INT J TUBERC LUNG D, V13, P719; Martinson NA, 2011, NEW ENGL J MED, V365, P11, DOI 10.1056/NEJMoa1005136; Medecins Sans Frontieres, 2012, SUMM KHAYEL ACT REP; Ngamvithayapong J, 1997, AIDS, V11, P107, DOI 10.1097/00002030-199701000-00016; Pennell WT, 2011, TECHNICAL CHALLENGES OF MULTIPOLLUTANT AIR QUALITY MANAGEMENT, P1, DOI 10.1007/978-94-007-0304-9_1; Rowe KA, 2005, INT J TUBERC LUNG D, V9, P263; Samandari T, 2011, LANCET, V377, P1588, DOI 10.1016/S0140-6736(11)60204-3; Thirumurthy H, 2012, B WORLD HEALTH ORGAN, V90, P390, DOI 10.2471/BLT.11.099317; Trajman A, 2010, INT J TUBERC LUNG D, V14, P551	20	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52489	10.1371/journal.pone.0052489	http://dx.doi.org/10.1371/journal.pone.0052489			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285064	Green Published, Green Submitted, gold			2022-12-27	WOS:000312794500183
J	Rua, O; Larrayoz, IM; Barajas, MT; Velilla, S; Martinez, A				Rua, Oscar; Larrayoz, Ignacio M.; Barajas, Maria T.; Velilla, Sara; Martinez, Alfredo			Oral Doxycycline Reduces Pterygium Lesions; Results from a Double Blind, Randomized, Placebo Controlled Clinical Trial	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; SUBCONJUNCTIVAL BEVACIZUMAB; RECURRENT PTERYGIUM; BASAL-CELLS; ANGIOGENESIS; CONJUNCTIVAL; PATHOGENESIS; EXPRESSION; EXCISION; EYE	Purpose: To determine whether oral doxycycline treatment reduces pterygium lesions. Design: Double blind, randomized, placebo controlled clinical trial. Participants: 98 adult patients with primary pterygium. Methods: Patients were randomly assigned to receive 100 mg oral doxycycline twice a day (49 subjects), or placebo (49 subjects), for 30 days. Photographs of the lesion were taken at the time of recruitment and at the end of the treatment. Follow-up sessions were performed 6 and 12 months post-treatment. Statistical analyses for both continuous and categorical variables were applied. p values of less than 0.05 were considered to indicate statistical significance. Main Outcome Measures: The primary endpoint was the change in lesion size after 30 days of treatment. Results: The primary endpoint was not met for the whole population but subgroup analysis showed that doxycycline was effective in patients of Caucasian origin while other ethnicities, mostly Hispanic, did not respond to the treatment. Moreover, there was a correlation between age and better response (p = 0.003). Adverse events were uncommon, mild, and in agreement with previous reports on short doxycycline treatments. Conclusions: Oral doxycycline was superior to placebo for the treatment of primary pterygia in older Caucasian patients. These findings support the use of doxycycline for pterygium treatment in particular populations. Trial Registration: European Union Clinical Trials Register EudraCT 2008-007178-39	[Larrayoz, Ignacio M.; Martinez, Alfredo] Ctr Biomed Res La Rioja CIBIR, Oncol Area, Logrono, Spain; [Rua, Oscar; Velilla, Sara] Hosp San Pedro, Ophthalmol Serv, Logrono, Spain		Martinez, A (corresponding author), Ctr Biomed Res La Rioja CIBIR, Oncol Area, Logrono, Spain.	amartinezr@riojasalud.es	Martinez, Alfredo/GQH-5998-2022; Larrayoz, Ignacio M/I-5613-2012	Martinez, Alfredo/0000-0003-4882-4044; Larrayoz, Ignacio M/0000-0003-1629-152X	Spain's Ministry of Health, Social Policy, and Equality [DIN-021]	Spain's Ministry of Health, Social Policy, and Equality	Supported by a Grant from Spain's Ministry of Health, Social Policy, and Equality, No. DIN-021. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang M, 2012, OPHTHALMOLOGY, V119, P1509, DOI 10.1016/j.ophtha.2012.02.009; Aspiotis M, 2007, EYE, V21, P1095, DOI 10.1038/sj.eye.6702495; Aydin E, 2008, CORNEA, V27, P446, DOI 10.1097/ICO.0b013e3181605ff9; Bahar I, 2008, CURR EYE RES, V33, P23, DOI 10.1080/02713680701799101; Chhipa RR, 2005, TOXICOL APPL PHARM, V202, P268, DOI 10.1016/j.taap.2004.06.025; Chui J, 2008, OCUL SURF, V6, P24, DOI 10.1016/S1542-0124(12)70103-9; Coroneo M, 2011, EYE CONTACT LENS, V37, P214, DOI 10.1097/ICL.0b013e318223394e; Cox CA, 2010, OPHTHALMOLOGY, V117, P1782, DOI 10.1016/j.ophtha.2010.01.037; Di Girolamo N, 2004, PROG RETIN EYE RES, V23, P195, DOI 10.1016/j.preteyeres.2004.02.002; Dushku N, 1997, CURR EYE RES, V16, P1179, DOI 10.1076/ceyr.16.12.1179.5036; Dushku N, 2001, ARCH OPHTHALMOL-CHIC, V119, P695, DOI 10.1001/archopht.119.5.695; Fallah MR, 2010, CURR EYE RES, V35, P17, DOI 10.3109/02713680903395273; Gilmour MA, 2005, VET OPHTHALMOL, V8, P331, DOI 10.1111/j.1463-5224.2005.00422.x; Golub L M, 1998, Adv Dent Res, V12, P12; Hanemaaijer R, 1997, J BIOL CHEM, V272, P31504, DOI 10.1074/jbc.272.50.31504; HAUSTEIN J, 1983, ANAT EMBRYOL, V168, P291, DOI 10.1007/BF00315823; Jaworski CJ, 2009, MOL VIS, V15, P2421; John-Aryankalayil M, 2006, MOL VIS, V12, P55; Kandavel R, 2010, CORNEA, V29, P141, DOI 10.1097/ICO.0b013e3181b11630; Khalfaoui T, 2011, PATHOL BIOL, V59, P137, DOI 10.1016/j.patbio.2009.04.006; Kobayashi H, 1997, NATURE, V387, P767, DOI 10.1038/42842; Landers J, 2011, CLIN EXP OPHTHALMOL, V39, P604, DOI 10.1111/j.1442-9071.2011.02532.x; Larrayoz IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039359; Lee CZ, 2004, STROKE, V35, P1715, DOI 10.1161/01.STR.0000129334.05181.b6; Liang D, 2008, CURR EYE RES, V33, P653, DOI 10.1080/02713680802245772; Nemesure B, 2008, OPHTHALMOLOGY, V115, P2153, DOI 10.1016/j.ophtha.2008.08.003; Papadia M, 2008, CURR EYE RES, V33, P429, DOI 10.1080/02713680802130354; Razeghinejad MR, 2010, OPHTHALMIC RES, V43, P134, DOI 10.1159/000252980; Shiroma H, 2009, AM J OPHTHALMOL, V148, P766, DOI 10.1016/j.ajo.2009.06.006; Smith GN, 1998, J RHEUMATOL, V25, P532; Smith VA, 2008, BRIT J OPHTHALMOL, V92, P856, DOI 10.1136/bjo.2007.125989; Stieger K, 2007, GENE THER, V14, P1668, DOI 10.1038/sj.gt.3303034; Tan DTH, 1997, ARCH OPHTHALMOL-CHIC, V115, P1235, DOI 10.1001/archopht.1997.01100160405001; Teng CC, 2009, CORNEA, V28, P468, DOI 10.1097/ICO.0b013e31818d382d; Verbraeken H, 1996, GRAEF ARCH CLIN EXP, V234, pS59, DOI 10.1007/BF02343049; Viso E, 2011, EYE, V25, P350, DOI 10.1038/eye.2010.204; Weinstein O, 2002, EYE, V16, P619, DOI 10.1038/sj.eye.6700150; Welch MN, 2011, NEPAL J OPHTHALMOL, V3, P9, DOI 10.3126/nepjoph.v3i1.4271	38	8	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e52696	10.1371/journal.pone.0052696	http://dx.doi.org/10.1371/journal.pone.0052696			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23285154	Green Submitted, Green Published, gold			2022-12-27	WOS:000312694300096
J	Bailey, JR; Bland, PW; Tarlton, JF; Peters, I; Moorghen, M; Sylvester, PA; Probert, CSJ; Whiting, CV				Bailey, Jennifer R.; Bland, Paul W.; Tarlton, John F.; Peters, Iain; Moorghen, Moganaden; Sylvester, Paul A.; Probert, Christopher S. J.; Whiting, Christine V.			IL-13 Promotes Collagen Accumulation in Crohn's Disease Fibrosis by Down-Regulation of Fibroblast MMP Synthesis: A Role for Innate Lymphoid Cells?	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; TISSUE INHIBITOR; GENE-EXPRESSION; LIVER FIBROSIS; INTERLEUKIN-13; PATHOGENESIS; INFLAMMATION; ACTIVATION; RECEPTORS; INDUCTION	Background: Fibrosis is a serious consequence of Crohn's disease (CD), often necessitating surgical resection. We examined the hypothesis that IL-13 may promote collagen accumulation within the CD muscle microenvironment. Methods: Factors potentially modulating collagen deposition were examined in intestinal tissue samples from fibrotic (f) CD and compared with cancer control (C), ulcerative colitis (UC) and uninvolved (u) CD. Mechanisms attributable to IL-13 were analysed using cell lines derived from uninvolved muscle tissue and tissue explants. Results: In fCD muscle extracts, collagen synthesis was significantly increased compared to other groups, but MMP-2 was not co-ordinately increased. IL-13 transcripts were highest in fCD muscle compared to muscle from other groups. IL-13 receptor (R) alpha 1 was expressed by intestinal muscle smooth muscle, nerve and KIR+ cells. Fibroblasts from intestinal muscle expressed R alpha 1, phosphorylated STAT6 in response to IL-13, and subsequently down-regulated MMP-2 and TNF-alpha-induced MMP-1 and MMP-9 synthesis. Cells with the phenotype KIR(+)CD45(+)CD56(+/-)CD3(-) were significantly increased in fCD muscle compared to all other groups, expressed Ra1 and membrane IL-13, and transcribed high levels of IL-13. In explanted CD muscle, these cells did not phosphorylate STAT6 in response to exogenous IL-13. Conclusions: The data indicate that in fibrotic intestinal muscle of Crohn's patients, the IL-13 pathway is stimulated, involving a novel population of infiltrating IL-13R alpha 1(+), KIR+ innate lymphoid cells, producing IL-13 which inhibits fibroblast MMP synthesis. Consequently, matrix degradation is down-regulated and this leads to excessive collagen deposition.	[Bailey, Jennifer R.; Bland, Paul W.; Tarlton, John F.; Whiting, Christine V.] Univ Bristol, Sch Vet Sci, Bristol BS18 7DU, Avon, England; [Bland, Paul W.] Univ Gothenburg, Dept Microbiol & Immunol, Mucosal Immunobiol & Vaccine Ctr MIVAC, Gothenburg, Sweden; [Peters, Iain] Univ Exeter, Innovat Ctr, Exeter, Devon, England; [Moorghen, Moganaden] St Marks Hosp, Dept Histopathol, Harrow, Middx, England; [Sylvester, Paul A.] Univ Bristol, Bristol Royal Infirm, Dept Surg, Bristol BS2 8HW, Avon, England; [Probert, Christopher S. J.] Univ Liverpool, Dept Gastroenterol, Liverpool L69 3BX, Merseyside, England	University of Bristol; University of Gothenburg; University of Exeter; Imperial College London; Bristol Royal Infirmary; University of Bristol; University of Liverpool	Tarlton, JF (corresponding author), Univ Bristol, Sch Vet Sci, Bristol BS18 7DU, Avon, England.	John.Tarlton@bris.ac.uk	Bailey, Jennifer/H-5856-2013	Tarlton, John/0000-0002-4886-6634; Probert, Christopher/0000-0003-4550-0239	Action Medical Research [SP4260]; National Association for Colitis and Crohn's disease [M/07/5]; Swedish Fund for Strategic Research; Edith Lidiard Private Bequest	Action Medical Research; National Association for Colitis and Crohn's disease; Swedish Fund for Strategic Research(Swedish Foundation for Strategic Research); Edith Lidiard Private Bequest	This work was supported by Action Medical Research, SP4260 (http://www.action.org.uk); National Association for Colitis and Crohn's disease, M/07/5 (http://www.nacc.org.uk); Swedish Fund for Strategic Research (http://www.stratresearch.se/en/), and Edith Lidiard Private Bequest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiho H, 2002, AM J PHYSIOL-GASTR L, V282, pG226, DOI 10.1152/ajpgi.2002.282.2.G226; Bishop JE, 1998, MOL MED TODAY, V4, P69, DOI 10.1016/S1357-4310(97)01193-3; Bosse Y, 2008, INT ARCH ALLERGY IMM, V146, P138, DOI 10.1159/000113517; Burke JP, 2007, AM J GASTROENTEROL, V102, P439, DOI 10.1111/j.1572-0241.2006.01010.x; Fichtner-Feigl S, 2006, NAT MED, V12, P99, DOI 10.1038/nm1332; Fichtner-Feigl S, 2007, J IMMUNOL, V178, P5859, DOI 10.4049/jimmunol.178.9.5859; Fichtner-Feigl S, 2008, GASTROENTEROLOGY, V135, P2003, DOI 10.1053/j.gastro.2008.08.055; Goffin L, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2991; Hershey GKK, 2003, J ALLERGY CLIN IMMUN, V111, P677, DOI 10.1067/mai.2003.1333; Inman CF, 2005, J IMMUNOL METHODS, V302, P156, DOI 10.1016/j.jim.2005.05.005; Inoue S, 1999, AM J GASTROENTEROL, V94, P2441; Jeong WI, 2011, HEPATOLOGY, V53, P1342, DOI 10.1002/hep.24190; Kadivar K, 2004, INFLAMM BOWEL DIS, V10, P593, DOI 10.1097/00054725-200409000-00014; Kawashima R, 2006, GASTROENTEROLOGY, V131, P130, DOI 10.1053/j.gastro.2006.04.022; Kim ES, 2007, CANCER LETT, V252, P147, DOI 10.1016/j.canlet.2006.12.016; Koukoulis G, 2001, ARCH PATHOL LAB MED, V125, P1331; Krantz SB, 2011, MOL CANCER RES, V9, P1294, DOI 10.1158/1541-7786.MCR-11-0023; Lee PJ, 2006, J CLIN INVEST, V116, P163, DOI 10.1172/JCI25711; Leonardi A, 2003, INVEST OPHTH VIS SCI, V44, P183, DOI 10.1167/iovs.02-0420; Morimoto M, 2006, J IMMUNOL, V176, P491, DOI 10.4049/jimmunol.176.1.491; Mourelle M, 1998, GASTROENTEROLOGY, V114, P519, DOI 10.1016/S0016-5085(98)70535-9; Notas G, 2009, CLIN IMMUNOL, V130, P16, DOI 10.1016/j.clim.2008.08.008; Oriente A, 2000, J PHARMACOL EXP THER, V292, P988; Qin HW, 1999, J BIOL CHEM, V274, P29130, DOI 10.1074/jbc.274.41.29130; Radaeva S, 2006, GASTROENTEROLOGY, V130, P435, DOI 10.1053/j.gastro.2005.10.055; Radbill BD, 2011, DIGEST DIS SCI, V56, P406, DOI 10.1007/s10620-010-1296-0; Rogler G, 2001, SCAND J GASTROENTERO, V36, P389, DOI 10.1080/003655201300051216; Rozen S, 2000, Methods Mol Biol, V132, P365; Scharl M, 2012, GUT; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Straub RH, 2008, GUT, V57, P911, DOI 10.1136/gut.2007.125401; Tarlton JF, 2000, AM J PATHOL, V157, P1927, DOI 10.1016/S0002-9440(10)64831-6; Vainer B, 2000, CYTOKINE, V12, P1531, DOI 10.1006/cyto.2000.0744; Vandesompele J, 2002, ANAL BIOCHEM, V303, P95, DOI 10.1006/abio.2001.5564; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Whiting CV, 2001, J HISTOCHEM CYTOCHEM, V49, P727, DOI 10.1177/002215540104900606; Wynn TA, 2003, ANNU REV IMMUNOL, V21, P425, DOI 10.1146/annurev.immunol.21.120601.141142; Zhao AP, 2003, J IMMUNOL, V171, P948, DOI 10.4049/jimmunol.171.2.948; Zhou XX, 2007, J ALLERGY CLIN IMMUN, V119, P1388, DOI 10.1016/j.jaci.2007.02.011; Zhou XX, 2005, AM J PHYSIOL-CELL PH, V288, pC435, DOI 10.1152/ajpcell.00035.2004	40	86	88	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e52332	10.1371/journal.pone.0052332	http://dx.doi.org/10.1371/journal.pone.0052332			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300643	Green Published, gold, Green Submitted			2022-12-27	WOS:000313872600014
J	Chan, T; Shimizu, Y; Pospisil, P; Nijo, N; Fujiwara, A; Taninaka, Y; Ishikawa, T; Hori, H; Nanba, D; Imai, A; Morita, N; Yoshioka-Nishimura, M; Izumi, Y; Yamamoto, Y; Kobayashi, H; Mizusawa, N; Wada, H; Yamamoto, Y				Chan, Tiffanie; Shimizu, Yurika; Pospisil, Pavel; Nijo, Nobuyoshi; Fujiwara, Anna; Taninaka, Yoshito; Ishikawa, Tomomi; Hori, Haruka; Nanba, Daisuke; Imai, Aya; Morita, Noriko; Yoshioka-Nishimura, Miho; Izumi, Yohei; Yamamoto, Yoko; Kobayashi, Hideki; Mizusawa, Naoki; Wada, Hajime; Yamamoto, Yasusi			Quality Control of Photosystem II: Lipid Peroxidation Accelerates Photoinhibition under Excessive Illumination	PLOS ONE			English	Article							SINGLET OXYGEN PRODUCTION; D1 PROTEIN; SIDE PHOTOINHIBITION; LIGHT; TURNOVER; THYLAKOIDS; STRESS; PLANTS; PHOTOPRODUCTION; MALONDIALDEHYDE	Environmental stresses lower the efficiency of photosynthesis and sometimes cause irreversible damage to plant functions. When spinach thylakoids and Photosystem II membranes were illuminated with excessive visible light (100- 1,000 mmol photons m(-1) s(-1)) for 10 min at either 20 degrees C or 30 degrees C, the optimum quantum yield of Photosystem II decreased as the light intensity and temperature increased. Reactive oxygen species and endogenous cationic radicals produced through a photochemical reaction at and/or near the reaction center have been implicated in the damage to the D1 protein. Here we present evidence that lipid peroxidation induced by the illumination is involved in the damage to the D1 protein and the subunits of the light-harvesting complex of Photosystem II. This is reasoned from the results that considerable lipid peroxidation occurred in the thylakoids in the light, and that lipoxygenase externally added in the dark induced inhibition of Photosystem II activity in the thylakoids, production of singlet oxygen, which was monitored by electron paramagnetic resonance spin trapping, and damage to the D1 protein, in parallel with lipid peroxidation. Modification of the subunits of the light-harvesting complex of Photosystem II by malondialdehyde as well as oxidation of the subunits was also observed. We suggest that mainly singlet oxygen formed through lipid peroxidation under light stress participates in damaging the Photosystem II subunits.	[Chan, Tiffanie; Shimizu, Yurika; Nijo, Nobuyoshi; Fujiwara, Anna; Taninaka, Yoshito; Ishikawa, Tomomi; Hori, Haruka; Nanba, Daisuke; Imai, Aya; Morita, Noriko; Yoshioka-Nishimura, Miho; Yamamoto, Yasusi] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama, Japan; [Pospisil, Pavel] Palacky Univ, Fac Sci, Ctr Reg Hana Biotechnol & Agr Res, Dept Biophys, CR-77147 Olomouc, Czech Republic; [Izumi, Yohei; Yamamoto, Yoko] Okayama Univ, Inst Plant Sci & Resources, Kurashiki, Okayama, Japan; [Kobayashi, Hideki] Okayama Univ, Ctr Fac Dev, Okayama, Japan; [Mizusawa, Naoki; Wada, Hajime] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo, Japan	Okayama University; Palacky University Olomouc; Okayama University; Okayama University; University of Tokyo	Yamamoto, Y (corresponding author), Okayama Univ, Grad Sch Nat Sci & Technol, Okayama, Japan.	yasusiya@cc.okayama-u.ac.jp	POSPÍŠIL, Pavel/AAH-4451-2019; Yamamoto, Yasusi/B-2637-2011; Yoshioka-Nishimura, Miho/C-2745-2015	POSPÍŠIL, Pavel/0000-0001-9126-2011; Ishikawa, Tomomi/0000-0002-7262-4870	Ministry of Education, Culture, Sports, Science and Technology of Japan [20570039]; Ministry of Education Youth and Sports, Czech Republic [ED0007/01/01, CZ.1.07/2.3.00/20.0057]; Grants-in-Aid for Scientific Research [22780046, 24570160] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education Youth and Sports, Czech Republic(Ministry of Education, Youth & Sports - Czech RepublicCzech Republic Government); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Scientific Research 20570039 from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Y. Y.) and by the grants no. ED0007/01/01 Centre of the Region Hana for Biotechnological and Agricultural Research and no. CZ.1.07/2.3.00/20.0057 Operational Programme Education for Competitiveness from the Ministry of Education Youth and Sports, Czech Republic (P. P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANANYEV G, 1994, PHOTOSYNTH RES, V41, P327, DOI 10.1007/BF00019410; ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; BARBER J, 1992, TRENDS BIOCHEM SCI, V17, P61, DOI 10.1016/0968-0004(92)90503-2; BLUBAUGH DJ, 1991, BIOCHEMISTRY-US, V30, P7586, DOI 10.1021/bi00244a030; Brash AR, 1999, J BIOL CHEM, V274, P23679, DOI 10.1074/jbc.274.34.23679; DORNE AJ, 1990, P NATL ACAD SCI USA, V87, P71, DOI 10.1073/pnas.87.1.71; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; FRANKEL E N, 1980, Progress in Lipid Research, V19, P1, DOI 10.1016/0163-7827(80)90006-5; Grechkin A, 1998, PROG LIPID RES, V37, P317, DOI 10.1016/S0163-7827(98)00014-9; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Halliwell B., 2007, FREE RADICALS BIOL M; Havaux M, 2003, TRENDS PLANT SCI, V8, P409, DOI 10.1016/S1360-1385(03)00185-7; Henmi T, 2003, PLANT CELL PHYSIOL, V44, P451, DOI 10.1093/pcp/pcg049; HIDEG E, 1994, PHOTOSYNTH RES, V39, P191, DOI 10.1007/BF00029386; Ishikawa Y, 1999, BBA-BIOENERGETICS, V1413, P147, DOI 10.1016/S0005-2728(99)00093-6; JEGERSCHOLD C, 1990, BIOCHEMISTRY-US, V29, P6179, DOI 10.1021/bi00478a010; KANERVO E, 1995, FEBS LETT, V364, P239, DOI 10.1016/0014-5793(95)00404-W; Khorobrykh SA, 2002, PHOTOSYNTH RES, V71, P209, DOI 10.1023/A:1015583502345; Khorobrykh SA, BIOCHEMISTRY, V50; KLIMOV V, 1993, PHOTOSYNTH RES, V38, P409, DOI 10.1007/BF00046768; Komayama K, 2007, BBA-BIOENERGETICS, V1767, P838, DOI 10.1016/j.bbabio.2007.05.001; Krieger-Liszkay A, 2008, PHOTOSYNTH RES, V98, P551, DOI 10.1007/s11120-008-9349-3; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; Loll B, 2007, BBA-BIOENERGETICS, V1767, P509, DOI 10.1016/j.bbabio.2006.12.009; MACPHERSON AN, 1993, BIOCHIM BIOPHYS ACTA, V1143, P301, DOI 10.1016/0005-2728(93)90201-P; Mano J, 2002, PLANT CELL PHYSIOL, V43, P1445, DOI 10.1093/pcp/pcf187; MARNETT LJ, 1979, ANAL BIOCHEM, V99, P458, DOI 10.1016/S0003-2697(79)80033-0; McGinley CM, 2003, CHEM COMMUN, P2843, DOI 10.1039/b311008g; MISHRA NP, 1994, BBA-BIOENERGETICS, V1186, P81, DOI 10.1016/0005-2728(94)90138-4; Mizusawa N, 2012, BBA-BIOENERGETICS, V1817, P194, DOI 10.1016/j.bbabio.2011.04.008; MOAN J, 1979, NATURE, V279, P450, DOI 10.1038/279450a0; Ohira S, 2005, PHOTOSYNTH RES, V84, P29, DOI 10.1007/s11120-004-7310-7; Pospisil P, 2004, BIOCHEMISTRY-US, V43, P6783, DOI 10.1021/bi036219i; Pospisil P, 2007, BBA-BIOENERGETICS, V1767, P854, DOI 10.1016/j.bbabio.2007.02.011; Pospisil P, 2012, BBA-BIOENERGETICS, V1817, P218, DOI 10.1016/j.bbabio.2011.05.017; Pospisil P, 2009, BBA-BIOENERGETICS, V1787, P1151, DOI 10.1016/j.bbabio.2009.05.005; Sakurai I, 2006, J BIOCHEM, V140, P201, DOI 10.1093/jb/mvj141; SOMERVILLE C, 2000, LIPIDS BIOCH MOL BIO, P456; Telfer A, 2005, PHOTOCH PHOTOBIO SCI, V4, P950, DOI 10.1039/b507888c; TELFER A, 1994, J BIOL CHEM, V269, P13244; Vass I, 2008, PHOTOINHIBITION PHOT; Wada H., 2010, LIPIDS PHOTOSYNTHESI; Yamamoto Y, 2004, METH MOL B, V274, P217; Yamamoto Y, 2001, PLANT CELL PHYSIOL, V42, P121, DOI 10.1093/pcp/pce022; YAMAMOTO Y, 1995, BIOCHEMISTRY-US, V34, P9038, DOI 10.1021/bi00028a012; Yamamoto Y, 2008, PHOTOSYNTH RES, V98, P589, DOI 10.1007/s11120-008-9372-4; Yamashita A, 2008, J BIOL CHEM, V283, P28380, DOI 10.1074/jbc.M710465200; Yamauchi Y, 2008, PLANT PHYSIOL BIOCH, V46, P786, DOI 10.1016/j.plaphy.2008.04.018; [No title captured]	49	40	41	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52100	10.1371/journal.pone.0052100	http://dx.doi.org/10.1371/journal.pone.0052100			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300595	Green Submitted, gold, Green Published			2022-12-27	WOS:000312829100019
J	Hatcher, AM; Tsai, AC; Kumbakumba, E; Dworkin, SL; Hunt, PW; Martin, JN; Clark, G; Bangsberg, DR; Weiser, SD				Hatcher, Abigail M.; Tsai, Alexander C.; Kumbakumba, Elias; Dworkin, Shari L.; Hunt, Peter W.; Martin, Jeffrey N.; Clark, Gina; Bangsberg, David R.; Weiser, Sheri D.			Sexual Relationship Power and Depression among HIV-Infected Women in Rural Uganda	PLOS ONE			English	Article							LEARNED HELPLESSNESS MODEL; INTIMATE PARTNER VIOLENCE; MENTAL-HEALTH-SERVICES; QUALITY-OF-LIFE; CD4 CELL COUNT; MEDICAL OUTCOMES; ANTIRETROVIRAL THERAPY; POSTTRAUMATIC-STRESS; GENDER-DIFFERENCES; DOMESTIC VIOLENCE	Background: Depression is associated with increased HIV transmission risk, increased morbidity, and higher risk of HIV-related death among HIV-infected women. Low sexual relationship power also contributes to HIV risk, but there is limited understanding of how it relates to mental health among HIV-infected women. Methods: Participants were 270 HIV-infected women from the Uganda AIDS Rural Treatment Outcomes study, a prospective cohort of individuals initiating antiretroviral therapy (ART) in Mbarara, Uganda. Our primary predictor was baseline sexual relationship power as measured by the Sexual Relationship Power Scale (SRPS). The primary outcome was depression severity, measured with the Hopkins Symptom Checklist (HSCL), and a secondary outcome was a functional scale for mental health status (MHS). Adjusted models controlled for socio-demographic factors, CD4 count, alcohol and tobacco use, baseline WHO stage 4 disease, social support, and duration of ART. Results: The mean HSCL score was 1.34 and 23.7% of participants had HSCL scores consistent with probable depression (HSCL > 1.75). Compared to participants with low SRPS scores, individuals with both moderate (coefficient b = -0.21; 95% CI, -0.36 to -0.07) and high power (b = -0.21; 95% CI, -0.36 to -0.06) reported decreased depressive symptomology. High SRPS scores halved the likelihood of women meeting criteria for probable depression (adjusted odds ratio = 0.44; 95% CI, 0.20 to 0.93). In lagged models, low SRPS predicted subsequent depression severity, but depression did not predict subsequent changes in SPRS. Results were similar for MHS, with lagged models showing SRPS predicts subsequent mental health, but not visa versa. Both Decision-Making Dominance and Relationship Control subscales of SRPS were associated with depression symptom severity. Conclusions: HIV-infected women with high sexual relationship power had lower depression and higher mental health status than women with low power. Interventions to improve equity in decision-making and control within dyadic partnerships are critical to prevent HIV transmission and to optimize mental health of HIV-infected women.	[Hatcher, Abigail M.; Hunt, Peter W.; Weiser, Sheri D.] Univ Calif San Francisco, Div HIV AIDS, Dept Med, San Francisco, CA 94143 USA; [Hatcher, Abigail M.] Univ Witwatersrand, Wits Reprod Hlth & HIV Inst, Johannesburg, South Africa; [Tsai, Alexander C.; Bangsberg, David R.] Massachusetts Gen Hosp, Ctr Global Hlth, Boston, MA 02114 USA; [Tsai, Alexander C.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Tsai, Alexander C.; Bangsberg, David R.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Kumbakumba, Elias; Bangsberg, David R.] Mbarara Univ Sci & Technol, Mbarara, Uganda; [Dworkin, Shari L.] Univ Calif San Francisco, Dept Social & Behav Sci, San Francisco, CA USA; [Martin, Jeffrey N.] Univ Calif San Francisco, Dept Epidemiol, San Francisco, CA 94143 USA; [Clark, Gina] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA	University of California System; University of California San Francisco; University of Witwatersrand; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Mbarara University of Science & Technology; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Hatcher, AM (corresponding author), Univ Calif San Francisco, Div HIV AIDS, Dept Med, San Francisco, CA 94143 USA.	hatchera@globalhealth.ucsf.edu	Hunt, Peter W./P-2976-2017; Tsai, Alexander C./F-4247-2015; Hatcher, Abigail M/G-9128-2011	Hunt, Peter W./0000-0002-4571-4870; Tsai, Alexander C./0000-0001-6397-7917; Hatcher, Abigail M/0000-0002-4150-1405	NIH [K23 MH-079713, MH-79713-03S1, R01 MH-54907, P30 AI27763, K24 MH-87227, K23 MH-096620]; Tim and Jane Meyer Family Foundation; Burke Family Foundation; Paiko Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354, P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH079713, K24MH087227, K23MH096620, R01MH054907, R25MH060482] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tim and Jane Meyer Family Foundation; Burke Family Foundation; Paiko Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The study was funded by NIH K23 MH-079713, MH-79713-03S1, NIH R01 MH-54907, NIH P30 AI27763, and the Tim and Jane Meyer Family Foundation. The authors acknowledge the following additional sources of salary support: the Burke Family Foundation, NIH K24 MH-87227, K23 MH-096620, and the Paiko Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMSON LY, 1978, J ABNORM PSYCHOL, V87, P49, DOI 10.1037/0021-843X.87.1.49; Amaro H, 2000, SEX ROLES, V42, P723, DOI 10.1023/A:1007059708789; Antelman G, 2007, JAIDS-J ACQ IMM DEF, V44, P470, DOI 10.1097/QAI.0b013e31802f1318; Babikako HM, 2010, HEALTH QUAL LIFE OUT, V8, P1, DOI 10.1186/1477-7525-8-93; Bolton P, 2004, SOC PSYCH PSYCH EPID, V39, P442, DOI 10.1007/s00127-004-0763-3; Bolton P, 2001, J NERV MENT DIS, V189, P238, DOI 10.1097/00005053-200104000-00005; Bougarel L, 2011, PSYCHOPHARMACOLOGY, V215, P595, DOI 10.1007/s00213-011-2218-3; Bradley KA, 2003, ARCH INTERN MED, V163, P821, DOI 10.1001/archinte.163.7.821; BUCHWALD AM, 1978, J ABNORM PSYCHOL, V87, P180; BURACK JH, 1993, JAMA-J AM MED ASSOC, V270, P2568, DOI 10.1001/jama.270.21.2568; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; CAMPBELL R, 1995, PSYCHOL WOMEN QUART, V19, P237, DOI 10.1111/j.1471-6402.1995.tb00290.x; Chisholm D, 2007, LANCET, V370, P1241, DOI 10.1016/S0140-6736(07)61242-2; Chonody JM, 2008, AFFILIA J WOM SOC WO, V23, P338, DOI 10.1177/0886109908323971; Ciesla JA, 2001, AM J PSYCHIAT, V158, P725, DOI 10.1176/appi.ajp.158.5.725; Cohen MH, 2009, J WOMENS HEALTH, V18, P1783, DOI 10.1089/jwh.2009.1367; CONNELL RW, 1985, SOCIOLOGY, V19, P260, DOI 10.1177/0038038585019002008; Cook JA, 2004, AM J PUBLIC HEALTH, V94, P1133, DOI 10.2105/AJPH.94.7.1133; Cook JA, 2002, J ACQ IMMUN DEF SYND, V30, P401, DOI [10.1097/00042560-200208010-00005, 10.1097/01.QAI.0000018280.16783.FE]; Derogatis L R, 1974, Mod Probl Pharmacopsychiatry, V7, P79; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; Eaton J, 2011, LANCET, V378, P1592, DOI 10.1016/S0140-6736(11)60891-X; Eller L S, 2001, Clin Nurs Res, V10, P401; Ellsberg M, 2008, LANCET, V371, P1165, DOI 10.1016/S0140-6736(08)60522-X; Epino HM, 2012, AIDS CARE; Evans DL, 2002, AM J PSYCHIAT, V159, P1752, DOI 10.1176/appi.ajp.159.10.1752; Farmer P, 1996, COMMON COURAGE PR; Filson J, 2010, J INTERPERS VIOLENCE, V25, P400, DOI 10.1177/0886260509334401; Gagnon AJ, 2010, HEALTH PLACE, V16, P10, DOI 10.1016/j.healthplace.2009.06.009; Geng EH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014098; Gielen A C, 2000, Matern Child Health J, V4, P111, DOI 10.1023/A:1009522321240; GOVE WR, 1983, J HEALTH SOC BEHAV, V24, P122, DOI 10.2307/2136639; GRANT RL, 1978, AM J PSYCHIAT, V135, P625; Hahm HC, 2011, AIDS BEHAV; Hahm HC, 2012, AIDS BEHAV, V16, P179, DOI 10.1007/s10461-011-9885-2; Hajszan T, 2009, BIOL PSYCHIAT, V65, P392, DOI 10.1016/j.biopsych.2008.09.031; Ickovics JR, 2001, JAMA-J AM MED ASSOC, V285, P1466, DOI 10.1001/jama.285.11.1466; James John S, 2004, AIDS Treat News, P2; Kaharuza FM, 2006, AIDS BEHAV, V10, pS105, DOI 10.1007/s10461-006-9142-2; Kawachi I, 2001, J URBAN HEALTH, V78, P458, DOI 10.1093/jurban/78.3.458; Ketchen B, 2009, WOMEN HEALTH, V49, P197, DOI 10.1080/03630240902963648; KIECOLTGLASER JK, 1987, PSYCHOSOM MED, V49, P13, DOI 10.1097/00006842-198701000-00002; Kim HK, 2002, J FAM ISSUES, V23, P885, DOI 10.1177/019251302237296; Kinyanda E, 2011, SOC PSYCH PSYCH EPID, V46, P35, DOI 10.1007/s00127-009-0164-8; Landstedt E, 2009, SOCIOL HEALTH ILL, V31, P962, DOI 10.1111/j.1467-9566.2009.01170.x; Li B, 2011, NATURE, V470, P535, DOI 10.1038/nature09742; Low-Beer S, 2000, J ACQ IMMUN DEF SYND, V23, P295; Lundberg P, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-125; Maier SF, 2001, BIOL PSYCHIAT, V49, P763, DOI 10.1016/S0006-3223(00)01095-7; Martinez P, 2008, AIDS BEHAV, V12, P605, DOI 10.1007/s10461-007-9312-x; Mello VA, 2010, ARCH WOMEN MENT HLTH, V13, P193, DOI 10.1007/s00737-009-0094-1; MILLER WR, 1975, J ABNORM PSYCHOL, V84, P228, DOI 10.1037/h0076720; Millikin CP, 2003, J CLIN EXP NEUROPSYC, V25, P201, DOI 10.1076/jcen.25.2.201.13644; Mirowsky J, 2017, SOCIAL CAUSES PSYCHO; Nduna M, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-44; Ovuga E, 2005, SOC PSYCH PSYCH EPID, V40, P439, DOI 10.1007/s00127-005-0915-0; Palar K, 2012, AIDS; Bermudez MP, 2010, CURR HIV RES, V8, P172, DOI 10.2174/157016210790442669; Pettifor AE, 2004, EMERG INFECT DIS, V10, P1996, DOI 10.3201/eid1011.040252; Petty F, 1997, ANN NY ACAD SCI, V821, P529, DOI 10.1111/j.1749-6632.1997.tb48322.x; Piccinelli M, 2000, BRIT J PSYCHIAT, V177, P486, DOI 10.1192/bjp.177.6.486; Prachakul W, 2007, J ASSOC NURSE AIDS C, V18, P67, DOI 10.1016/j.jana.2007.08.002; Pulerwitz J, 2002, AIDS CARE, V14, P789, DOI 10.1080/0954012021000031868; Pulerwitz J, 2000, SEX ROLES, V42, P637, DOI 10.1023/A:1007051506972; Rabkin JG, 2000, PSYCHOSOM MED, V62, P413, DOI 10.1097/00006842-200005000-00015; Revicki DA, 1998, MED CARE, V36, P126, DOI 10.1097/00005650-199802000-00003; ROSS CE, 1990, J MARRIAGE FAM, V52, P1059, DOI 10.2307/353319; Saraceno B, 2007, LANCET, V370, P1164, DOI 10.1016/S0140-6736(07)61263-X; Seligman M. E., 1974, DEPRESSION LEARNED H; Shahriar Jim, 2003, Health Qual Life Outcomes, V1, P25, DOI 10.1186/1477-7525-1-25; Shannon K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028739; Sherr L, 2011, PSYCHOL HEALTH MED, V16, P612, DOI 10.1080/13548506.2011.579991; Siedner MJ, 2012, AIDS BEHAV; Simbayi LC, 2007, SOC SCI MED, V64, P1823, DOI 10.1016/j.socscimed.2007.01.006; Smit J, 2006, PUBLIC HEALTH, V120, P534, DOI 10.1016/j.puhe.2006.01.009; Stein MD, 1997, J WOMENS HEALTH, V6, P569, DOI 10.1089/jwh.1997.6.569; Tomlinson M, 2009, B WORLD HEALTH ORGAN, V87, P438, DOI 10.2471/BLT.08.054353; Tsai AC, 2012, SOC SCI MED, V74, P2012, DOI 10.1016/j.socscimed.2012.02.033; Tsai AC, 2010, ARCH GEN PSYCHIAT, V67, P1282, DOI 10.1001/archgenpsychiatry.2010.160; Valente Sharon M, 2003, J Assoc Nurses AIDS Care, V14, P41, DOI 10.1177/1055329002250993; Valverde EE, 2007, JAIDS-J ACQ IMM DEF, V46, pS96, DOI 10.1097/QAI.0b013e318157683b; Weeks MR, 2010, AIDS PATIENT CARE ST, V24, P297, DOI 10.1089/apc.2009.0312; Weiser SD, 2010, 17 C RETR OPP INF SA; Wingood GM, 2000, HEALTH EDUC BEHAV, V27, P539, DOI 10.1177/109019810002700502; World Vision, 2017, INT LIV ASS TARG REF; Wu AW, 1997, QUAL LIFE RES, V6, P481, DOI 10.1023/A:1018451930750; WU AW, 1991, MED CARE, V29, P786, DOI 10.1097/00005650-199108000-00011; Wu DY, 2008, JAIDS-J ACQ IMM DEF, V48, P500, DOI 10.1097/QAI.0b013e31817dc3e9; Yang XS, 2011, AIDS CARE, V23, P75, DOI 10.1080/09540121.2010.525620	89	40	41	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e49821	10.1371/journal.pone.0049821	http://dx.doi.org/10.1371/journal.pone.0049821			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	071TV	23300519	Green Published, gold, Green Submitted			2022-12-27	WOS:000313618800004
J	Bhattacharya, A; Chen, CY; Ho, S; Mitchell, JA				Bhattacharya, Anandi; Chen, Chih-Yu; Ho, Sara; Mitchell, Jennifer A.			Upstream Distal Regulatory Elements Contact the Lmo2 Promoter in Mouse Erythroid Cells	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; GLOBIN LOCUS REQUIRES; LIM PROTEIN RBTN2; CHIP-SEQ; INTERGENIC TRANSCRIPTION; HYPERSENSITIVE SITES; GENE ACTIVATION; BETA; CHROMATIN; EXPRESSION	The Lim domain only 2 (Lmo2) gene encodes a transcriptional cofactor critical for the development of hematopoietic stem cells. Several distal regulatory elements have been identified upstream of the Lmo2 gene in the human and mouse genomes that are capable of enhancing reporter gene expression in erythroid cells and may be responsible for the high level transcription of Lmo2 in the erythroid lineage. In this study we investigate how these elements regulate transcription of Lmo2 and whether or not they function cooperatively in the endogenous context. Chromosome conformation capture (3C) experiments show that chromatin-chromatin interactions exist between upstream regulatory elements and the Lmo2 promoter in erythroid cells but that these interactions are absent from kidney where Lmo2 is transcribed at twelve fold lower levels. Specifically, long range chromatin-chromatin interactions occur between the Lmo2 proximal promoter and two broad regions, 3-31 and 66-105 kb upstream of Lmo2, which we term the proximal and distal control regions for Lmo2 (pCR and dCR respectively). Each of these regions is bound by several transcription factors suggesting that multiple regulatory elements cooperate in regulating high level transcription of Lmo2 in erythroid cells. Binding of CTCF and cohesin which support chromatin loops at other loci were also found within the dCR and at the Lmo2 proximal promoter. Intergenic transcription occurs throughout the dCR in erythroid cells but not in kidney suggesting a role for these intergenic transcripts in regulating Lmo2, similar to the broad domain of intergenic transcription observed at the human beta-globin locus control region. Our data supports a model in which the dCR functions through a chromatin looping mechanism to contact and enhance Lmo2 transcription specifically in erythroid cells. Furthermore, these chromatin loops are supported by the cohesin complex recruited to both CTCF and transcription factor bound regions.	[Bhattacharya, Anandi; Chen, Chih-Yu; Ho, Sara; Mitchell, Jennifer A.] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada	University of Toronto	Mitchell, JA (corresponding author), Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada.	ja.mitchell@utoronto.ca	Chen, Chih-yu/AAX-3735-2020; cheng, yong/I-4270-2012	Chen, Chih-yu/0000-0003-4790-0025; Mitchell, Jennifer/0000-0002-7147-4604	Natural Sciences and Engineering Research Council of Canada; Department of Cell and Systems Biology; Department of Economics, University of Toronto; Ontario Graduate Scholarship; National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Department of Cell and Systems Biology; Department of Economics, University of Toronto; Ontario Graduate Scholarship(Ontario Graduate Scholarship); National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This study was supported by the Natural Sciences and Engineering Research Council of Canada (Discovery Grant held by JAM). AB was funded by the Department of Cell and Systems Biology and the Department of Economics, University of Toronto. CYC was supported in part by an Ontario Graduate Scholarship. The ENCODE project is funded by the National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano T, 2009, DEV CELL, V16, P47, DOI 10.1016/j.devcel.2008.11.011; Anderson KP, 1998, J BIOL CHEM, V273, P14347, DOI 10.1074/jbc.273.23.14347; Anguita E, 2004, EMBO J, V23, P2841, DOI 10.1038/sj.emboj.7600274; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Blow MJ, 2010, NAT GENET, V42, P806, DOI 10.1038/ng.650; BOEHM T, 1991, P NATL ACAD SCI USA, V88, P4367, DOI 10.1073/pnas.88.10.4367; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; Chen CY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-152; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cheng Y, 2009, GENOME RES, V19, P2172, DOI 10.1101/gr.098921.109; Conaway RC, 2011, CURR OPIN GENET DEV, V21, P225, DOI 10.1016/j.gde.2011.01.013; Crable SC, 2003, BLOOD, V101, P4757, DOI 10.1182/blood-2002-09-2702; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; Cuylen S, 2010, CELL STEM CELL, V7, P424, DOI 10.1016/j.stem.2010.09.006; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; DICKERMAN HW, 1976, ARCH BIOCHEM BIOPHYS, V177, P1, DOI 10.1016/0003-9861(76)90408-2; Drissen R, 2004, GENE DEV, V18, P2485, DOI 10.1101/gad.317004; Faure AJ, 2012, GENOME RES; Ferraiuolo MA, 2010, NUCLEIC ACIDS RES, V38, P7472, DOI 10.1093/nar/gkq644; FISCH P, 1992, ONCOGENE, V7, P2389; FITZGERALD TJ, 1992, BLOOD, V80, P3189; FORONI L, 1992, J MOL BIOL, V226, P747, DOI 10.1016/0022-2836(92)90630-3; FORRESTER WC, 1986, P NATL ACAD SCI USA, V83, P1359, DOI 10.1073/pnas.83.5.1359; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; GARCIA IS, 1991, ONCOGENE, V6, P577; Gribnau J, 2000, MOL CELL, V5, P377, DOI 10.1016/S1097-2765(00)80432-3; Grill B, 2004, J IMMUNOL, V172, P2389, DOI 10.4049/jimmunol.172.4.2389; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hadjur S, 2009, NATURE, V460, P410, DOI 10.1038/nature08079; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hou CH, 2010, P NATL ACAD SCI USA, V107, P3651, DOI 10.1073/pnas.0912087107; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kooren J, 2007, J BIOL CHEM, V282, P16544, DOI 10.1074/jbc.M701159200; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; Landry JR, 2009, BLOOD, V113, P5783, DOI 10.1182/blood-2008-11-187757; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LARSON RC, 1994, ONCOGENE, V9, P3675; Lecuyer E, 2002, BLOOD, V100, P2430, DOI 10.1182/blood-2002-02-0568; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Miles J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000630; MOON AM, 1990, P NATL ACAD SCI USA, V87, P7693, DOI 10.1073/pnas.87.19.7693; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Nativio R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000739; Ono Y, 1998, MOL CELL BIOL, V18, P6939, DOI 10.1128/MCB.18.12.6939; Oram SH, 2010, ONCOGENE, V29, P5796, DOI 10.1038/onc.2010.320; OSADA H, 1995, P NATL ACAD SCI USA, V92, P9585, DOI 10.1073/pnas.92.21.9585; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Palstra RJ, 2003, NAT GENET, V35, P190, DOI 10.1038/ng1244; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Pilon AM, 2011, BLOOD; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; ROYERPOKORA B, 1995, ONCOGENE, V10, P1353; ROYERPOKORA B, 1991, ONCOGENE, V6, P1887; Soler E, 2010, GENE DEV, V24, P277, DOI 10.1101/gad.551810; Song SH, 2007, MOL CELL, V28, P810, DOI 10.1016/j.molcel.2007.09.025; Song SH, 2010, BLOOD, V116, P2356, DOI 10.1182/blood-2010-03-272252; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Tallack MR, 2010, GENOME RES, V20, P1052, DOI 10.1101/gr.106575.110; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; TUAN D, 1992, P NATL ACAD SCI USA, V89, P11219, DOI 10.1073/pnas.89.23.11219; TUAN D, 1985, P NATL ACAD SCI USA, V82, P6384, DOI 10.1073/pnas.82.19.6384; TUAN DYH, 1989, P NATL ACAD SCI USA, V86, P2554, DOI 10.1073/pnas.86.8.2554; Vakoc CR, 2005, MOL CELL, V17, P453, DOI 10.1016/j.molcel.2004.12.028; VALGEARCHER VE, 1994, P NATL ACAD SCI USA, V91, P8617, DOI 10.1073/pnas.91.18.8617; Vernimmen D, 2007, EMBO J, V26, P2041, DOI 10.1038/sj.emboj.7601654; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145; WARREN AJ, 1994, CELL, V78, P45, DOI 10.1016/0092-8674(94)90571-1; WIJGERDE M, 1995, NATURE, V377, P209, DOI 10.1038/377209a0; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; WU C, 1980, NATURE, V286, P854, DOI 10.1038/286854a0; Wurtele H, 2006, CHROMOSOME RES, V14, P477, DOI 10.1007/s10577-006-1075-0; Yu M, 2009, MOL CELL, V36, P682, DOI 10.1016/j.molcel.2009.11.002	78	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52880	10.1371/journal.pone.0052880	http://dx.doi.org/10.1371/journal.pone.0052880			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285212	Green Published, Green Submitted, gold			2022-12-27	WOS:000313158800103
J	Nakayama, T; Ishida, K; Archibald, JM				Nakayama, Takuro; Ishida, Ken-ichiro; Archibald, John M.			Broad Distribution of TPI-GAPDH Fusion Proteins among Eukaryotes: Evidence for Glycolytic Reactions in the Mitochondrion?	PLOS ONE			English	Article							GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; PHOSPHOGLYCERATE KINASE; PHYLOGENY; EVOLUTION; GENOME; ORIGIN; APICOMPLEXAN; METABOLISM; ENZYMES; SUPPORT	Glycolysis is a central metabolic pathway in eukaryotic and prokaryotic cells. In eukaryotes, the textbook view is that glycolysis occurs in the cytosol. However, fusion proteins comprised of two glycolytic enzymes, triosephosphate isomerase (TPI) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH), were found in members of the stramenopiles (diatoms and oomycetes) and shown to possess amino-terminal mitochondrial targeting signals. Here we show that mitochondrial TPI-GAPDH fusion protein genes are widely spread across the known diversity of stramenopiles, including non-photosynthetic species (Bicosoeca sp. and Blastocystis hominis). We also show that TPI-GAPDH fusion genes exist in three cercozoan taxa (Paulinella chromatophora, Thaumatomastix sp. and Mataza hastifera) and an apusozoan protist, Thecamonas trahens. Interestingly, subcellular localization predictions for other glycolytic enzymes in stramenopiles and a cercozoan show that a significant fraction of the glycolytic enzymes in these species have mitochondrial-targeted isoforms. These results suggest that part of the glycolytic pathway occurs inside mitochondria in these organisms, broadening our knowledge of the diversity of mitochondrial metabolism of protists.	[Nakayama, Takuro; Archibald, John M.] Dalhousie Univ, Canadian Inst Adv Res, Dept Biochem & Mol Biol, Program Integrated Microbial Biodivers, Halifax, NS, Canada; [Ishida, Ken-ichiro] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan	Canadian Institute for Advanced Research (CIFAR); Dalhousie University; University of Tsukuba	Archibald, JM (corresponding author), Dalhousie Univ, Canadian Inst Adv Res, Dept Biochem & Mol Biol, Program Integrated Microbial Biodivers, Halifax, NS, Canada.	jmarchib@dal.ca	NAKAYAMA, Takuro/AAT-9444-2020	NAKAYAMA, Takuro/0000-0001-5135-0156	Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]; NSERC; CIHR	Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR(Canadian Institutes of Health Research (CIHR))	The work conducted by the U.S. Department of Energy Joint Genome Institute is supported by the Office of Science of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. J.M.A. is supported by an NSERC Discovery Grant. J.M.A. is the holder of a CIHR New Investigator Award and is a Fellow of the Canadian Institute for Advanced Research, Program in Integrated Microbial Biodiversity. T.N. is a JSPS Postdoctoral Fellow for Research Abroad. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archibald JM, 2009, CURR BIOL, V19, pR81, DOI 10.1016/j.cub.2008.11.067; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Bannai H, 2002, BIOINFORMATICS, V18, P298, DOI 10.1093/bioinformatics/18.2.298; Banuls AL, 2007, ADV PARASIT, V64, P1, DOI 10.1016/S0065-308X(06)64001-3; Barrett MP, 2003, LANCET, V362, P1469, DOI 10.1016/S0140-6736(03)14694-6; Brandina I, 2006, BBA-BIOENERGETICS, V1757, P1217, DOI 10.1016/j.bbabio.2006.07.001; Branny P, 1998, MICROBIOL-SGM, V144, P905, DOI 10.1099/00221287-144-4-905; Burki F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000790; Burki F, 2012, P ROY SOC B-BIOL SCI, V279, P2246, DOI 10.1098/rspb.2011.2301; Burki F, 2009, GENOME BIOL EVOL, V1, P231, DOI 10.1093/gbe/evp022; Canback B, 2002, P NATL ACAD SCI USA, V99, P6097, DOI 10.1073/pnas.082112499; Cavalier-Smith T, 2003, PROTIST, V154, P341, DOI 10.1078/143446103322454112; Cavalier-Smith T, 2010, PROTIST, V161, P549, DOI 10.1016/j.protis.2010.04.002; Chevalier N, 2000, EUR J BIOCHEM, V267, P1464, DOI 10.1046/j.1432-1327.2000.01145.x; Cock JM, 2010, NATURE, V465, P617, DOI 10.1038/nature09016; Daubenberger CA, 2003, BIOL CHEM, V384, P1227, DOI 10.1515/BC.2003.135; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fitzpatrick DA, 2006, MOL BIOL EVOL, V23, P74, DOI 10.1093/molbev/msj009; GAVEL Y, 1990, PROTEIN ENG, V4, P33, DOI 10.1093/protein/4.1.33; Giege P, 2003, PLANT CELL, V15, P2140, DOI 10.1105/tpc.012500; Ginger ML, 2010, PHILOS T R SOC B, V365, P831, DOI 10.1098/rstb.2009.0259; Glucksman E, 2011, PROTIST, V162, P207, DOI 10.1016/j.protis.2010.06.004; Gobler CJ, 2011, P NATL ACAD SCI USA, V108, P4352, DOI 10.1073/pnas.1016106108; Graham JWA, 2007, PLANT CELL, V19, P3723, DOI 10.1105/tpc.107.053371; GRANA X, 1995, COMP BIOCHEM PHYS B, V112, P287, DOI 10.1016/0305-0491(95)00076-3; Gray MW, 1998, NATURE, V396, P109, DOI 10.1038/24030; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hackett JD, 2007, MOL BIOL EVOL, V24, P1702, DOI 10.1093/molbev/msm089; HART DT, 1984, MOL BIOCHEM PARASIT, V13, P159, DOI 10.1016/0166-6851(84)90110-5; Heazlewood JL, 2005, PLANT PHYSIOL, V139, P598, DOI 10.1104/pp.105.065532; Janouskovec J, 2010, P NATL ACAD SCI USA, V107, P10949, DOI 10.1073/pnas.1003335107; Jewett TJ, 2003, MOL CELL, V11, P885, DOI 10.1016/S1097-2765(03)00113-8; Kamikawa R, 2011, EUR J PROTISTOL, V47, P24, DOI 10.1016/j.ejop.2010.08.002; Kamoun S, 2003, EUKARYOT CELL, V2, P191, DOI 10.1128/EC.2.2.191-199.2003; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Kim JW, 2005, TRENDS BIOCHEM SCI, V30, P142, DOI 10.1016/j.tibs.2005.01.005; Kroth PG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001426; Liaud MF, 2000, MOL BIOL EVOL, V17, P213, DOI 10.1093/oxfordjournals.molbev.a026301; McFadden GI, 1996, NATURE, V381, P482, DOI 10.1038/381482a0; Michel G, 2010, NEW PHYTOL, V188, P67, DOI 10.1111/j.1469-8137.2010.03345.x; Michels PAM, 2006, BBA-MOL CELL RES, V1763, P1463, DOI 10.1016/j.bbamcr.2006.08.019; Moreira D, 2007, MOL PHYLOGENET EVOL, V44, P255, DOI 10.1016/j.ympev.2006.11.001; Nakayama T, 2009, CURR BIOL, V19, pR284, DOI 10.1016/j.cub.2009.02.043; Nowack ECM, 2011, MOL BIOL EVOL, V28, P407, DOI 10.1093/molbev/msq209; Petsalaki Evangelia I., 2006, Genomics Proteomics & Bioinformatics, V4, P48, DOI 10.1016/S1672-0229(06)60016-8; Philippe H, 2000, P ROY SOC B-BIOL SCI, V267, P1213, DOI 10.1098/rspb.2000.1130; Richly E, 2004, GENE, V329, P11, DOI 10.1016/j.gene.2004.01.008; Riisberg I, 2009, PROTIST, V160, P191, DOI 10.1016/j.protis.2008.11.004; Rogers MB, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-89; Saito T, 2008, J BIOL CHEM, V283, P14041, DOI 10.1074/jbc.M709015200; SCHURIG H, 1995, EMBO J, V14, P442, DOI 10.1002/j.1460-2075.1995.tb07020.x; Sirover MA, 2005, J CELL BIOCHEM, V95, P45, DOI 10.1002/jcb.20399; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Smith DGS, 2007, J MOL BIOL, V374, P837, DOI 10.1016/j.jmb.2007.09.051; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stechmann A, 2003, CURR BIOL, V13, pR665, DOI 10.1016/S0960-9822(03)00602-X; Stechmann A, 2002, SCIENCE, V297, P89, DOI 10.1126/science.1071196; Stechmann A, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-101; Takishita K, 2005, J EUKARYOT MICROBIOL, V52, P343, DOI 10.1111/j.1550-7408.2005.00042x; Tovy A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000775; Tsaousis AD, 2010, ANAEROBIC PARASITIC PROTOZOA: GENOMICS AND MOLECULAR BIOLOGY, P205; VISSER N, 1981, EUR J BIOCHEM, V118, P521, DOI 10.1111/j.1432-1033.1981.tb05550.x; VONHEIJNE G, 1986, EMBO J, V5, P1335, DOI 10.1002/j.1460-2075.1986.tb04364.x; Yabuki A, 2011, J EUKARYOT MICROBIOL, V58, P94, DOI 10.1111/j.1550-7408.2010.00524.x; YANG D, 1985, P NATL ACAD SCI USA, V82, P4443, DOI 10.1073/pnas.82.13.4443; Yoon HS, 2002, P NATL ACAD SCI USA, V99, P15507, DOI 10.1073/pnas.242379899	66	11	11	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52340	10.1371/journal.pone.0052340	http://dx.doi.org/10.1371/journal.pone.0052340			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284996	Green Published, gold, Green Submitted			2022-12-27	WOS:000312794500147
J	Yue, GH; Xia, JH; Liu, P; Liu, F; Sun, F; Lin, G				Yue, Gen Hua; Xia, Jun Hong; Liu, Peng; Liu, Feng; Sun, Fei; Lin, Grace			Tracing Asian Seabass Individuals to Single Fish Farms Using Microsatellites	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; LATES-CALCARIFER; POPULATION ASSIGNMENT; GENETIC ASSIGNMENT; COMPUTER-PROGRAM; DNA MARKERS; TRACEABILITY; ESCAPEES; LOCI; IDENTIFICATION	Traceability through physical labels is well established, but it is not highly reliable as physical labels can be easily changed or lost. Application of DNA markers to the traceability of food plays an increasingly important role for consumer protection and confidence building. In this study, we tested the efficiency of 16 polymorphic microsatellites and their combinations for tracing 368 fish to four populations where they originated. Using the maximum likelihood and Bayesian methods, three most efficient microsatellites were required to assign over 95% of fish to the correct populations. Selection of markers based on the assignment score estimated with the software WHICHLOCI was most effective in choosing markers for individual assignment, followed by the selection based on the allele number of individual markers. By combining rapid DNA extraction, and high-throughput genotyping of selected microsatellites, it is possible to conduct routine genetic traceability with high accuracy in Asian seabass. Citation: Yue GH, Xia JH, Liu P, Liu F, Sun F, et al. (2012) Tracing Asian Seabass Individuals to Single Fish Farms Using Microsatellites. PLoS ONE 7(12): e52721. doi:10.1371/journal.pone.0052721	[Yue, Gen Hua; Xia, Jun Hong; Liu, Peng; Liu, Feng; Sun, Fei; Lin, Grace] Natl Univ Singapore, Mol Populat Genet Grp, Temasek Life Sci Lab, Singapore 117548, Singapore	National University of Singapore	Yue, GH (corresponding author), Natl Univ Singapore, Mol Populat Genet Grp, Temasek Life Sci Lab, 1 Res Link, Singapore 117548, Singapore.	genhua@tll.org.sg	Yue, GH/F-4801-2015	Yue, GH/0000-0002-3537-2248	National Research Foundation (NRF), Singapore	National Research Foundation (NRF), Singapore(National Research Foundation, Singapore)	This study is supported by the National Research Foundation (NRF), Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banks MA, 2003, BIOINFORMATICS, V19, P1436, DOI 10.1093/bioinformatics/btg172; Banks MA, 2000, J HERED, V91, P87, DOI 10.1093/jhered/91.1.87; Cirillo A, 2009, EUR FOOD RES TECHNOL, V228, P875, DOI 10.1007/s00217-008-1000-1; Dalvit C, 2007, MEAT SCI, V77, P437, DOI 10.1016/j.meatsci.2007.05.027; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fan B, 2005, ASIAN AUSTRAL J ANIM, V18, P1529, DOI 10.5713/ajas.2005.1529; FAO Fisheries Department, 2010, STAT WORLD FISH AQ 2; Glover KA, 2008, ICES J MAR SCI, V65, P912, DOI 10.1093/icesjms/fsn056; Glover KA, 2010, AQUACULT ENV INTERAC, V1, P1, DOI 10.3354/aei00002; Glover KA, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-2; Glover KA, 2009, AQUACULTURE, V290, P37, DOI 10.1016/j.aquaculture.2009.01.034; Glover KA, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-87; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Guerard F, 2005, ADV BIOCHEM ENG BIOT, V96, P127, DOI 10.1007/b135783; Hansen MM, 2001, FISH FISH, V2, P93, DOI 10.1046/j.1467-2960.2001.00043.x; Hastein T, 2001, REV SCI TECH OIE, V20, P564, DOI 10.20506/rst.20.2.1300; Hayes B, 2005, AQUACULTURE, V250, P70, DOI 10.1016/j.aquaculture.2005.03.008; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Lewis PO, 2000, GENETIC DATA ANAL; Liu Z, 2011, NEXT GENRATION SEQUE; Liu ZJ, 2004, AQUACULTURE, V238, P1, DOI 10.1016/j.aquaculture.2004.05.027; Loftus R, 2005, REV SCI TECH OIE, V24, P231, DOI 10.20506/rst.24.1.1563; Maldini M, 2006, AQUACULTURE, V261, P487, DOI 10.1016/j.aquaculture.2006.07.010; Ogden R, 2008, FISH FISH, V9, P462, DOI 10.1111/j.1467-2979.2008.00305.x; Opara LU, 2003, J FOOD AGRIC ENVIRON, V1, P101; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Rodriguez-Ramirez R, 2011, ANAL CHIM ACTA, V685, P120, DOI 10.1016/j.aca.2010.11.021; Sargent J.R., 2001, FARMED FISH QUALITY, P3; SHEARER KD, 2001, FARMED FISH QUALITY, P31; Wang CM, 2011, MAR BIOTECHNOL, V13, P74, DOI 10.1007/s10126-010-9271-5; Wang CM, 2008, AQUAC RES, V39, P1612, DOI 10.1111/j.1365-2109.2008.02034.x; Wang CM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-274; Wang CM, 2007, GENETICS, V175, P907, DOI 10.1534/genetics.106.059972; WEBER JL, 1989, AM J HUM GENET, V44, P388; Yue G, 2001, MAR BIOTECHNOL, V3, P1, DOI 10.1007/s101260000043; Yue GH, 2009, AQUACULTURE, V293, P22, DOI 10.1016/j.aquaculture.2009.03.053; Yue GH, 2005, ELECTROPHORESIS, V26, P3081, DOI 10.1002/elps.200410411; Yue GH, 2002, MAR BIOTECHNOL, V4, P503, DOI 10.1007/s10126-002-0037-6; Yue GH, 1999, ELECTROPHORESIS, V20, P3358, DOI 10.1002/(SICI)1522-2683(19991101)20:17<3358::AID-ELPS3358>3.0.CO;2-B; Zhu ZY, 2006, GENOME, V49, P969, DOI 10.1139/G06-080; Zhu ZY, 2010, ANIM GENET, V41, P208, DOI 10.1111/j.1365-2052.2009.01973.x; Zhu ZY, 2006, AQUACULTURE, V256, P167, DOI 10.1016/j.aquaculture.2006.02.033	42	10	11	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52721	10.1371/journal.pone.0052721	http://dx.doi.org/10.1371/journal.pone.0052721			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285169	gold, Green Published, Green Submitted			2022-12-27	WOS:000312794500241
J	Barbati, E; Specchia, C; Villella, M; Rossi, ML; Barlera, S; Bottazzi, B; Crociati, L; d'Arienzo, C; Fanelli, R; Garlanda, C; Gori, F; Mango, R; Mantovani, A; Merla, G; Nicolis, EB; Pietri, S; Presbitero, P; Sudo, Y; Villella, A; Franzosi, MG				Barbati, Elisa; Specchia, Claudia; Villella, Massimo; Rossi, Marco Luciano; Barlera, Simona; Bottazzi, Barbara; Crociati, Luisa; d'Arienzo, Carmela; Fanelli, Raffaele; Garlanda, Cecilia; Gori, Francesca; Mango, Ruggiero; Mantovani, Alberto; Merla, Giuseppe; Nicolis, Enrico B.; Pietri, Silvia; Presbitero, Patrizia; Sudo, Yukio; Villella, Alessandro; Franzosi, Maria Grazia			Influence of Pentraxin 3 (PTX3) Genetic Variants on Myocardial Infarction Risk and PTX3 Plasma Levels	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CORONARY-HEART-DISEASE; TOLL-LIKE RECEPTOR-4; LONG PENTRAXIN; VASCULAR INFLAMMATION; INNATE IMMUNITY; UNSTABLE ANGINA; ATHEROSCLEROSIS; ASSOCIATION; MARKER	PTX3 is a long pentraxin of the innate immune system produced by different cell types (mononuclear phagocytes, dendritic cells, fibroblasts and endothelial cells) at the inflammatory site. It appears to have a cardiovascular protective function by acting on the immune-inflammatory balance in the cardiovascular system. PTX3 plasma concentration is an independent predictor of mortality in patients with acute myocardial infarction (AMI) but the influence of PTX3 genetic variants on PTX3 plasma concentration has been investigated very little and there is no information on the association between PTX3 variations and AMI. Subjects of European origin (3245, 1751 AMI survivors and 1494 controls) were genotyped for three common PTX3 polymorphisms (SNPs) (rs2305619, rs3816527, rs1840680). Genotype and allele frequencies of the three SNPs and the haplotype frequencies were compared for the two groups. None of the genotypes, alleles or haplotypes were significantly associated with the risk of AMI. However, analysis adjusted for age and sex indicated that the three PTX3 SNPs and the corresponding haplotypes were significantly associated with different PTX3 plasma levels. There was also a significant association between PTX3 plasma concentrations and the risk of all-cause mortality at three years in AMI patients (OR 1.10, 95% CI: 1.01-1.20, p = 0.02). Our study showed that PTX3 plasma levels are influenced by three PTX3 polymorphisms. Genetically determined high PTX3 levels do not influence the risk of AMI, suggesting that the PTX3 concentration itself is unlikely to be even a modest causal factor for AMI. Analysis also confirmed that PTX3 is a prognostic marker after AMI.	[Specchia, Claudia; Barlera, Simona; Crociati, Luisa; Gori, Francesca; Nicolis, Enrico B.; Pietri, Silvia; Franzosi, Maria Grazia] Ist Ric Farmacol Mario Negri, Dept Cardiovasc Res, Milan, Italy; [Barbati, Elisa; Bottazzi, Barbara; Garlanda, Cecilia; Mantovani, Alberto] Humanitas Clin & Res Ctr, Dept Inflammat & Immunol, Milan, Italy; [Barbati, Elisa; Mantovani, Alberto] Univ Milan, Dept Translat Med, Milan, Italy; [Specchia, Claudia] Univ Brescia, Dept Biomed Sci & Biotechnol, Brescia, Italy; [Villella, Massimo; d'Arienzo, Carmela; Fanelli, Raffaele] IRCCS Casa Sollievo Sofferenza, Dept Cardiol, San Giovanni Rotondo, Italy; [Rossi, Marco Luciano; Mango, Ruggiero; Presbitero, Patrizia] Humanitas Clin & Res Ctr, Dept Intervent Cardiol, Milan, Italy; [Merla, Giuseppe] IRCCS Casa Sollievo Sofferenza, Med Genet Unit, San Giovanni Rotondo, Italy; [Sudo, Yukio] Perseus Prote Inc, Tokyo, Japan; [Villella, Alessandro] F Lastaria Hosp, Dept Cardiol, Lucera, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Milan; University of Brescia; IRCCS Casa Sollievo Della Sofferenza; IRCCS Casa Sollievo Della Sofferenza	Franzosi, MG (corresponding author), Ist Ric Farmacol Mario Negri, Dept Cardiovasc Res, Milan, Italy.	mariagrazia.franzosi@marionegri.it	bottazzi, barbara/ABH-9274-2020; Garlanda, Cecilia/K-4601-2016; Mantovani, Alberto/HCI-7449-2022; Nicolis, Enrico Bjørn/ABG-8467-2020; merla, giuseppe/K-4627-2012	bottazzi, barbara/0000-0002-1930-9257; Garlanda, Cecilia/0000-0002-1510-7703; Mantovani, Alberto/0000-0001-5578-236X; Nicolis, Enrico Bjørn/0000-0001-9246-2533; merla, giuseppe/0000-0001-5078-928X	Italian Minister of Health (Ricerca Finalizzata IRCCS) [RF-OGR-2007-661844]; Ricerca Indipendente; Cariplo Foundation [2009/2582]; European Research Council (ERC-HIIS); Tolerage (TOLERAGE Health research grant) [HEALTH-F4-2008-202156]	Italian Minister of Health (Ricerca Finalizzata IRCCS); Ricerca Indipendente; Cariplo Foundation(Fondazione Cariplo); European Research Council (ERC-HIIS); Tolerage (TOLERAGE Health research grant)	This work has been supported by the Italian Minister of Health (Ricerca Finalizzata IRCCS no RF-OGR-2007-661844, to CS, MV, SB, LC, CdA, RF, FG, RM, GM, EN, SP, PP, AV, MGF); Ricerca Indipendente 2009 (to EB, MLR, CG, SB, LC, EN, SP, PP, MGF), Cariplo Foundation (2009/2582, to BB, AM), European Research Council (ERC-HIIS, to AM, CG) and Tolerage (TOLERAGE Health research grant; HEALTH-F4-2008-202156, to AM, BB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo-Espliguero R, 2004, HEART, V90, P983, DOI 10.1136/hrt.2002.001297; Bottazzi B, 2010, ANNU REV IMMUNOL, V28, P157, DOI 10.1146/annurev-immunol-030409-101305; Casas JP, 2008, J INTERN MED, V264, P295, DOI 10.1111/j.1365-2796.2008.02015.x; Chang MK, 2002, P NATL ACAD SCI USA, V99, P13043, DOI 10.1073/pnas.192399699; Chiarini M, 2010, GENES IMMUN, V11, P665, DOI 10.1038/gene.2010.41; Dahlof Bjorn, 2010, Am J Cardiol, V105, p3A, DOI 10.1016/j.amjcard.2009.10.007; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; Deban L, 2010, NAT IMMUNOL, V11, P328, DOI 10.1038/ni.1854; Diamond JM, 2012, AM J RESP CRIT CARE, V186, P546, DOI 10.1164/rccm.201204-0692OC; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; Garlanda C, 2002, NATURE, V420, P182, DOI 10.1038/nature01195; Garlanda C, 2005, ANNU REV IMMUNOL, V23, P337, DOI 10.1146/annurev.immunol.23.021704.115756; Gauderman WJ, 2006, QUANTO 1 1 COMPUTER; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Inforzato A, 2008, J BIOL CHEM, V283, P10147, DOI 10.1074/jbc.M708535200; Inoue K, 2007, ARTERIOSCL THROM VAS, V27, P161, DOI 10.1161/01.ATV.0000252126.48375.d5; Jenny NS, 2009, ARTERIOSCL THROM VAS, V29, P594, DOI 10.1161/ATVBAHA.108.178947; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Kotooka N, 2008, ATHEROSCLEROSIS, V197, P368, DOI 10.1016/j.atherosclerosis.2007.05.031; Latini R, 2004, CIRCULATION, V110, P2349, DOI 10.1161/01.CIR.0000145167.30987.2E; Lloyd-Jones DM, 2010, CIRCULATION, V121, P1768, DOI 10.1161/CIRCULATIONAHA.109.849166; Matsui S, 2010, ATHEROSCLEROSIS, V210, P220, DOI 10.1016/j.atherosclerosis.2009.10.033; May L, 2010, BIOL REPROD, V82, P299, DOI 10.1095/biolreprod.109.079111; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Norata GD, 2010, TRENDS CARDIOVAS MED, V20, P35, DOI 10.1016/j.tcm.2010.03.005; Norata GD, 2009, CIRCULATION, V120, P699, DOI 10.1161/CIRCULATIONAHA.108.806547; Olesen R, 2007, GENES IMMUN, V8, P456, DOI 10.1038/sj.gene.6364410; Pasterkamp G, 2004, EUR J CLIN INVEST, V34, P328, DOI 10.1111/j.1365-2362.2004.01338.x; Peri G, 2000, CIRCULATION, V102, P636, DOI 10.1161/01.CIR.102.6.636; Rolph MS, 2002, ARTERIOSCL THROM VAS, V22, pE10, DOI 10.1161/01.ATV.0000015595.95497.2F; Salio M, 2008, CIRCULATION, V117, P1055, DOI 10.1161/CIRCULATIONAHA.107.749234; Savchenko AS, 2008, J PATHOL, V215, P48, DOI 10.1002/path.2314; Suzuki S, 2008, AM HEART J, V155, P75, DOI 10.1016/j.ahj.2007.08.013; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; Verzilli C, 2008, AM J HUM GENET, V82, P859, DOI 10.1016/j.ajhg.2008.01.016; Wensley F, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d548; Zacho J, 2008, NEW ENGL J MED, V359, P1897, DOI 10.1056/NEJMoa0707402; Zhang YX, 1999, ATHEROSCLEROSIS, V145, P375, DOI 10.1016/S0021-9150(99)00105-7	39	48	48	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53030	10.1371/journal.pone.0053030	http://dx.doi.org/10.1371/journal.pone.0053030			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285251	Green Published, gold, Green Submitted			2022-12-27	WOS:000313051500102
J	Hu, QN; Zhu, H; Li, XB; Zhang, MM; Deng, Z; Yang, XY; Deng, ZX				Hu, Qian-Nan; Zhu, Hui; Li, Xiaobing; Zhang, Manman; Deng, Zhe; Yang, Xiaoyan; Deng, Zixin			Assignment of EC Numbers to Enzymatic Reactions with Reaction Difference Fingerprints	PLOS ONE			English	Article							CLASSIFICATION; PREDICTION; MECHANISM	The EC numbers represent enzymes and enzyme genes (genomic information), but they are also utilized as identifiers of enzymatic reactions (chemical information). In the present work (ECAssigner), our newly proposed reaction difference fingerprints (RDF) are applied to assign EC numbers to enzymatic reactions. The fingerprints of reactant molecules minus the fingerprints of product molecules will generate reaction difference fingerprints, which are then used to calculate reaction Euclidean distance, a reaction similarity measurement, of two reactions. The EC number of the most similar training reaction will be assigned to an input reaction. For 5120 balanced enzymatic reactions, the RDF with a fingerprint length at 3 obtained at the sub-subclass, subclass, and main class level with cross-validation accuracies of 83.1%, 86.7%, and 92.6% respectively. Compared with three published methods, ECAssigner is the first fully automatic server for EC number assignment. The EC assignment system (ECAssigner) is freely available via: http://cadd.whu.edu.cn/ecassigner/.	[Hu, Qian-Nan] Wuhan Univ, Key Lab Combinatorial Biosynth & Drug Discovery, Minist Educ, Wuhan 430072, Peoples R China; Wuhan Univ, Sch Pharmaceut Sci, Wuhan 430072, Peoples R China	Wuhan University; Wuhan University	Hu, QN (corresponding author), Wuhan Univ, Key Lab Combinatorial Biosynth & Drug Discovery, Minist Educ, Wuhan 430072, Peoples R China.	qnhu@whu.edu.cn	Zhu, Hui/N-3137-2019; Zhu, Hui/AAV-2711-2021; Hu, Qian/GWZ-7617-2022	Zhu, Hui/0000-0002-8601-669X; 	National Natural Science Foundation of China; Ministry of Science and Technology of China (973 Program); Ministry of Science and Technology of China (863 Program); National Mega Project on Major Drug Development	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China (973 Program)(Ministry of Science and Technology, ChinaNational Basic Research Program of China); Ministry of Science and Technology of China (863 Program)(Ministry of Science and Technology, ChinaNational High Technology Research and Development Program of China); National Mega Project on Major Drug Development	This study was supported by grants from the National Natural Science Foundation of China, the Ministry of Science and Technology of China (973 and 863 Programs) and the National Mega Project on Major Drug Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett AJ, 1992, ENZYME NOMENCLATURE; Egelhofer V, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000661; Faulon JL, 2008, BIOINFORMATICS, V24, P225, DOI 10.1093/bioinformatics/btm580; Hattori M, 2003, J AM CHEM SOC, V125, P11853, DOI 10.1021/ja036030u; Holliday GL, 2007, NUCLEIC ACIDS RES, V35, pD515, DOI 10.1093/nar/gkl774; Hu QN, 2011, BIOINFORMATICS, V27, P2465, DOI 10.1093/bioinformatics/btr413; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kotera M, 2004, J AM CHEM SOC, V126, P16487, DOI 10.1021/ja0466457; Latino DARS, 2008, BIOINFORMATICS, V24, P2236, DOI 10.1093/bioinformatics/btn405; Latino DARS, 2009, J CHEM INF MODEL, V49, P1839, DOI 10.1021/ci900104b; Leber M, 2009, BIOINFORMATICS, V25, P3135, DOI 10.1093/bioinformatics/btp549; O'Boyle NM, 2007, J MOL BIOL, V368, P1484, DOI 10.1016/j.jmb.2007.02.065; Oh M, 2007, J CHEM INF MODEL, V47, P1702, DOI 10.1021/ci700006f; Ridder L, 2008, CHEMMEDCHEM, V3, P821, DOI 10.1002/cmdc.200700312; Sacher O, 2009, J CHEM INF MODEL, V49, P1525, DOI 10.1021/ci800277f; Yamanishi Y, 2009, BIOINFORMATICS, V25, pI179, DOI 10.1093/bioinformatics/btp223; Zhang QY, 2005, J CHEM INF MODEL, V45, P1775, DOI 10.1021/ci0502707; Zitha-Bovens E, 2009, J BIOMOL SCREEN, V14, P557, DOI 10.1177/1087057109336953	18	17	18	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52901	10.1371/journal.pone.0052901	http://dx.doi.org/10.1371/journal.pone.0052901			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285222	gold, Green Submitted, Green Published			2022-12-27	WOS:000313051500079
J	Kao, HK; Chen, WF; Chen, CH; Shyu, VBH; Cheng, MH; Chang, KP				Kao, Huang-Kai; Chen, Wei F.; Chen, Chih-Hao; Shyu, Victor Bong-Hang; Cheng, Ming-Huei; Chang, Kai-Ping			The Roles of Albumin Levels in Head and Neck Cancer Patients with Liver Cirrhosis Undergoing Tumor Ablation and Microsurgical Free Tissue Transfer	PLOS ONE			English	Article							POSTOPERATIVE MORBIDITY; MALNUTRITION; MORTALITY; HYPOALBUMINEMIA; PREDICTOR; ADMISSION; LENGTH	Objective: To evaluate the changes of serum albumin levels during the peri-operative period, and correlate these changes to surgical outcomes, postoperative morbidity and mortality in head and neck cancer patients with cirrhosis. Methods: 57 patients with liver cirrhosis out of 3,022 patients who underwent immediate free flap reconstruction after surgical ablation of head and neck cancer performed over a 9-year period were included in the study. Two sets of groups were arranged based on the preoperative albumin (>3.5 g/dL vs. <= 3.5 g/dL) and POD1 albumin (>2.7 g/dL vs. <= 2.7 g/dL) levels and were compared with respect to patient-related variables, surgical outcomes, medical and surgical complications, and mortalities. Results: All patients had significant decreases in albumin levels postoperatively. Hypoalbuminemia, both preoperative and postoperative, was associated with the model for end-stage liver disease (MELD) score, the amount of blood loss, the duration of ICU stay and hospital stay, and postoperative medical and surgical complications. In particular, preoperative hypoalbuminemia (serum albumin <= 3.5 g/dL) was associated strongly with medical complications and mortality, while postoperative hypoalbuminemia (serum albumin <= 2.7 g/dL) with surgical complications. Conclusion: Our study demonstrated the prognostic values of albumin levels in head and neck cancer patient with liver cirrhosis. The perioperative albumin levels can be utilized for risk stratification to potentially improve surgical and postoperative management of these challenging patients.	[Chang, Kai-Ping] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Otolaryngol Head & Neck Surg, Tao Yuan, Taiwan; [Kao, Huang-Kai; Chen, Chih-Hao; Shyu, Victor Bong-Hang; Cheng, Ming-Huei] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Plast & Reconstruct Surg, Tao Yuan, Taiwan; [Chen, Wei F.] Univ Iowa Hosp & Clin, Dept Surg, Div Plast & Reconstruct Surg, Iowa City, IA 52242 USA	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; University of Iowa	Chang, KP (corresponding author), Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Otolaryngol Head & Neck Surg, Tao Yuan, Taiwan.	dr.kpchang@gmail.com	Cheng, Ming-Huei/AAD-8579-2019	Chen, Wei/0000-0002-4163-6641				Aguilar OG, 2001, INT SURG, V86, P42; Al-Shaiba R, 2004, BRIT J CANCER, V91, P205, DOI 10.1038/sj.bjc.6601886; ALBERTS WM, 1991, ARCH INTERN MED, V151, P2383, DOI 10.1001/archinte.151.12.2383; Fuhrman P, 2004, J AM DIET ASSOC, V104, P1258, DOI 10.1016/j.jada.2004.05.213; Garcia-Tsao G, 2008, HEPATOLOGY, V48, P2064, DOI 10.1002/hep.22605; Gibbs J, 1999, ARCH SURG-CHICAGO, V134, P36, DOI 10.1001/archsurg.134.1.36; HERRMANN FR, 1992, ARCH INTERN MED, V152, P125, DOI 10.1001/archinte.152.1.125; Hussain M, 1991, CANCER, V67, P717; IRVIN TT, 1974, ANN SURG, V180, P765, DOI 10.1097/00000658-197411000-00010; Kao HK, 2011, HEAD NECK-J SCI SPEC, V33, P529, DOI 10.1002/hed.21486; Kao HK, 2010, ANN SURG ONCOL, V17, P536, DOI 10.1245/s10434-009-0805-x; Kao HK, 2009, ORAL ONCOL, V45, P1058, DOI 10.1016/j.oraloncology.2009.07.010; Kuzu MA, 2006, WORLD J SURG, V30, P378, DOI 10.1007/s00268-005-0163-1; Marinella MA, 1998, SOUTHERN MED J, V91, P851, DOI 10.1097/00007611-199809000-00009; MATTHEWS TW, 1995, J OTOLARYNGOL, V24, P87; Rivadeneira DE, 2001, SURGERY, V129, P617, DOI 10.1067/msy.2001.112963; Schwartz SR, 2004, OTOLARYNG HEAD NECK, V131, P61, DOI 10.1016/j.otohns.2003.08.028; Sullivan DH, 2005, J AM GERIATR SOC, V53, P1222, DOI 10.1111/j.1532-5415.2005.53369.x; WARD MWN, 1982, BRIT J SURG, V69, P308, DOI 10.1002/bjs.1800690604	19	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52678	10.1371/journal.pone.0052678	http://dx.doi.org/10.1371/journal.pone.0052678			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285146	gold, Green Submitted, Green Published			2022-12-27	WOS:000313051500046
J	Caidi, H; Harcourt, JL; Tripp, RA; Anderson, LJ; Haynes, LM				Caidi, Hayat; Harcourt, Jennifer L.; Tripp, Ralph A.; Anderson, Larry J.; Haynes, Lia M.			Combination Therapy Using Monoclonal Antibodies against Respiratory Syncytial Virus (RSV) G Glycoprotein Protects from RSV Disease in BALB/c Mice	PLOS ONE			English	Article							SUBSTANCE-P; F-GLYCOPROTEIN; CX3C MOTIF; INFECTION; BRONCHIOLITIS; INFLAMMATION; NEUTRALIZATION; PATHOGENESIS; VACCINATION; EXPRESSION	Therapeutic options to control respiratory syncytial virus (RSV) are limited, thus development of new therapeutics is high priority. Previous studies with a monoclonal antibody (mAb) reactive to an epitope proximal to the central conserved region (CCR) of RSV G protein (mAb 131-2G) showed therapeutic efficacy for reducing pulmonary inflammation RSV infection in BALB/c mice. Here, we show a protective effect in RSV-infected mice therapeutically treated with a mAb (130-6D) reactive to an epitope within the CCR of G protein, while treatment with a mAb specific for a carboxyl G protein epitope had no effect. Combined treatment with mAbs 130-6D and 131-2G significantly decreased RSV-associated pulmonary inflammation compared to either antibody alone. The results suggest that anti-RSV G protein mAbs that react at or near the CCR and can block RSV G protein-mediated activities are effective at preventing RSV disease and may be an effective strategy for RSV therapeutic treatment.	[Caidi, Hayat; Harcourt, Jennifer L.; Haynes, Lia M.] Ctr Dis Control & Prevent CDC, Natl Ctr Immunizat & Resp Dis, Div Viral Dis, Gastroenteritis & Resp Viruses Lab Branch, Atlanta, GA USA; [Tripp, Ralph A.] Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA USA; [Anderson, Larry J.] Emory Childrens Ctr, Div Pediat Infect Dis, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; University System of Georgia; University of Georgia	Haynes, LM (corresponding author), Ctr Dis Control & Prevent CDC, Natl Ctr Immunizat & Resp Dis, Div Viral Dis, Gastroenteritis & Resp Viruses Lab Branch, Atlanta, GA USA.	loh5@cdc.gov		Tripp, Ralph/0000-0002-2924-9956	National Institutes of Health [5RO1AI06275-03]; Georgia Research Alliance; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI088744] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Research Alliance; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported in part by the National Institutes of Health (5RO1AI06275-03) and through the Georgia Research Alliance to R. T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanatidou V, 2006, PEDIATR INFECT DIS J, V25, P410, DOI 10.1097/01.inf.0000214998.16248.b7; ANDERSON LJ, 1988, J VIROL, V62, P4232, DOI 10.1128/JVI.62.11.4232-4238.1988; ANDERSON LJ, 1986, J CLIN MICROBIOL, V23, P475, DOI 10.1128/JCM.23.3.475-480.1986; ANDERSON LJ, 1985, J INFECT DIS, V151, P626, DOI 10.1093/infdis/151.4.626; Andersson C, 2000, FEMS IMMUNOL MED MIC, V29, P247, DOI 10.1111/j.1574-695X.2000.tb01530.x; Coffman S, 2009, MCN-AM J MATERN-CHIL, V34, P378, DOI 10.1097/01.NMC.0000363687.27939.e4; Collarini EJ, 2009, J IMMUNOL, V183, P6338, DOI 10.4049/jimmunol.0901373; Empey KM, 2010, CLIN INFECT DIS, V50, P1258, DOI 10.1086/651603; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Harcourt J, 2006, J IMMUNOL, V176, P1600, DOI 10.4049/jimmunol.176.3.1600; Harcourt JL, 2004, J INFECT DIS, V190, P1936, DOI 10.1086/425516; Haynes LM, 2009, J INFECT DIS, V200, P439, DOI 10.1086/600108; Haynes LM, 2003, J VIROL, V77, P9831, DOI 10.1128/JVI.77.18.9831-9844.2003; Haynes LM, 2002, J VIROL, V76, P6873, DOI 10.1128/JVI.76.14.6873-6881.2002; JOHNSON PR, 1987, J VIROL, V61, P3163, DOI 10.1128/JVI.61.10.3163-3166.1987; Kauvar LM, 2010, IMMUNOTHERAPY-UK, V2, P655, DOI [10.2217/imt.10.53, 10.2217/IMT.10.53]; Krilov LR, 2011, EXPERT REV ANTI-INFE, V9, P27, DOI 10.1586/ERI.10.140; Langeduk JP, 1997, J VIROL, V71, P4065; Mejias A, 2004, ANTIMICROB AGENTS CH, V48, P1811, DOI 10.1128/AAC.48.5.1811-1822.2004; Miao C, 2009, J GEN VIROL, V200, P1119; Murata Y, 2009, CLIN LAB MED, V29, P725, DOI 10.1016/j.cll.2009.07.004; Panitch HB, 2001, CURR OPIN PEDIATR, V13, P256, DOI 10.1097/00008480-200106000-00008; Radu GU, 2010, J VIROL, V84, P9632, DOI 10.1128/JVI.00451-10; Shay DK, 1999, JAMA-J AM MED ASSOC, V282, P1440, DOI 10.1001/jama.282.15.1440; SULLENDER W, 1995, VIROLOGY, V209, P70, DOI 10.1006/viro.1995.1231; Tripp RA, 2001, NAT IMMUNOL, V2, P732, DOI 10.1038/90675; Tripp RA, 2004, VIRAL IMMUNOL, V17, P165, DOI 10.1089/0882824041310513; Tripp RA, 2003, J VIROL, V77, P6580, DOI 10.1128/JVI.77.11.6580-6584.2003; Tripp RA, 2000, J VIROL, V74, P6227, DOI 10.1128/JVI.74.13.6227-6229.2000; Varga SM, 2002, VIROLOGY, V295, P203, DOI 10.1006/viro.2002.1382; Walsh EE, 1998, J GEN VIROL, V79, P479, DOI 10.1099/0022-1317-79-3-479; WIN N, 1992, CLIN LAB HAEMATOL, V14, P29	32	34	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e51485	10.1371/journal.pone.0051485	http://dx.doi.org/10.1371/journal.pone.0051485			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300550	gold, Green Published, Green Submitted			2022-12-27	WOS:000312829100009
J	Hammond, E; Brandt, R; Dredge, K				Hammond, Edward; Brandt, Ralf; Dredge, Keith			PG545, a Heparan Sulfate Mimetic, Reduces Heparanase Expression In Vivo, Blocks Spontaneous Metastases and Enhances Overall Survival in the 4T1 Breast Carcinoma Model	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; ANTIANGIOGENIC THERAPY; CANCER METASTASIS; DISEASE PROGRESSION; LUNG-CANCER; TUMOR; ANGIOGENESIS; INHIBITOR; IMPACT; TARGET	PG545 is a clinically relevant heparan sulfate (HS) mimetic which, in addition to possessing anti-angiogenic properties, also acts as a heparanase inhibitor which may differentiate its mechanism(s) of action from approved angiogenesis inhibitors. The degradation of HS by heparanase has been strongly implicated in cell dissemination and the metastatic process. Thus, the anti-metastatic activity of PG545 has been linked to the enzymatic function of heparanase - the only endoglycosidase known to cleave HS, an important component of the extracellular matrix (ECM) which represents a potential avenue for therapeutic intervention for certain metastatic cancer indications. Recent concerns raised about the paucity of overall survival as an endpoint in mouse models of clinically relevant metastasis led us to examine the effect of PG545 on the progression of both primary tumor growth and the spontaneously metastasizing disease in the 4T1 syngeneic breast carcinoma model in a non-surgical and surgical (mastectomy) setting. PG545 significantly inhibited primary tumor growth but importantly also inhibited lung metastasis in treated mice, an effect not observed with the tyrosine kinase inhibitor sorafenib. Importantly, PG545 significantly enhanced overall survival compared to vehicle control and the sorafenib group, suggesting PG545's inhibitory effect on heparanase is indeed a critical attribute to induce anti-metastatic activity. In addition to blocking a common angiogenic signalling pathway in tumor cells, the expression of heparanase in the primary tumor and lung was also significantly reduced by PG545 treatment. These results support the ongoing development of PG545 and highlight the potential utility in metastatic disease settings.	[Hammond, Edward; Dredge, Keith] Progen Pharmaceut, Res & Dev, Darra, Qld, Australia; [Brandt, Ralf] vivoPharm, Bundoora, Vic, Australia	Progen Pharmaceuticals - Australia	Hammond, E (corresponding author), Progen Pharmaceut, Res & Dev, Darra, Qld, Australia.	edwardh@progen-pharma.com						Barash U, 2010, FEBS J, V277, P3890, DOI 10.1111/j.1742-4658.2010.07799.x; Ben-Zaken O, 2007, BIOCHEM BIOPH RES CO, V361, P829, DOI 10.1016/j.bbrc.2007.06.188; Borsig L, 2011, NEOPLASIA, V13, P445, DOI 10.1593/neo.101734; Cohen I, 2006, INT J CANCER, V118, P1609, DOI 10.1002/ijc.21552; Day CP, 2012, INT J CANCER, V130, P190, DOI 10.1002/ijc.25978; De Bock K, 2011, NAT REV CLIN ONCOL, V8, P393, DOI 10.1038/nrclinonc.2011.83; de Mestre AM, 2005, J BIOL CHEM, V280, P35136, DOI 10.1074/jbc.M503414200; de Mestre AM, 2003, J BIOL CHEM, V278, P50377, DOI 10.1074/jbc.M310154200; Dempsey LA, 2000, TRENDS BIOCHEM SCI, V25, P349, DOI 10.1016/S0968-0004(00)01619-4; Dredge K, 2011, BRIT J CANCER, V104, P635, DOI 10.1038/bjc.2011.11; Dredge K, 2010, INVEST NEW DRUG, V28, P276, DOI 10.1007/s10637-009-9245-5; Ebos JML, 2011, NAT REV CLIN ONCOL, V8, P210, DOI 10.1038/nrclinonc.2011.21; Ebos JML, 2009, CLIN CANCER RES, V15, P5020, DOI 10.1158/1078-0432.CCR-09-0095; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Elkin M, 2001, FASEB J, V15, P1661, DOI 10.1096/fj.00-0895fje; Gandhi NS, 2010, DRUG DISCOV TODAY, V15, P1058, DOI 10.1016/j.drudis.2010.10.009; Gotte M, 2006, CANCER RES, V66, P10233, DOI 10.1158/0008-5472.CAN-06-1464; Hammond E., 2006, NEW DEV THERAPEUTIC, P251; Hayat MJ, 2007, ONCOLOGIST, V12, P20, DOI 10.1634/theoncologist.12-1-20; Holland SJ, 2010, CANCER RES, V70, P1544, DOI 10.1158/0008-5472.CAN-09-2997; Hortobagyi G, 2010, CANC MED, P1449; Imada T, 2006, INT J MOL MED, V17, P221; Jones SE, 2008, CLIN BREAST CANCER, V8, P224, DOI 10.3816/CBC.2008.n.025; Korpal M, 2011, NAT MED, V17, P1101, DOI 10.1038/nm.2401; Le Devedec SE, 2009, CLIN EXP METASTAS, V26, P673, DOI 10.1007/s10585-009-9267-6; Lelekakis M, 1999, CLIN EXP METASTAS, V17, P163, DOI 10.1023/A:1006689719505; Li QN, 2009, ACTA PHARMACOL SIN, V30, P1033, DOI 10.1038/aps.2009.97; Liu CJ, 2009, J HEPATOL, V50, P958, DOI 10.1016/j.jhep.2008.12.023; Luan Q, 2011, CANCER LETT, V308, P100, DOI 10.1016/j.canlet.2011.04.019; Maxhimer JB, 2005, J AM COLL SURGEONS, V200, P328, DOI 10.1016/j.jamcollsurg.2004.10.034; Maxhimer JB, 2002, SURGERY, V132, P326, DOI 10.1067/msy.2002.125719; McKenzie EA, 2007, BRIT J PHARMACOL, V151, P1, DOI 10.1038/sj.bjp.0707182; Mina LA, 2011, NAT REV CLIN ONCOL, V8, P325, DOI 10.1038/nrclinonc.2011.59; O'Shaughnessy J, 2005, ONCOLOGIST, V10, P20, DOI 10.1634/theoncologist.10-90003-20; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Raman Karthik, 2010, Curr Chem Biol, V4, P20; Ritchie JP, 2011, CLIN CANCER RES, V17, P1382, DOI 10.1158/1078-0432.CCR-10-2476; Sargent DJ, 2008, J CLIN ONCOL, V26, P1922, DOI 10.1200/JCO.2007.14.8064; Sasaki M, 2001, MEDIAT INFLAMM, V10, P259, DOI 10.1080/09629350120093731; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Sleeman J, 2010, EUR J CANCER, V46, P1177, DOI 10.1016/j.ejca.2010.02.039; Steeg PS, 2009, CLIN CANCER RES, V15, P4529, DOI 10.1158/1078-0432.CCR-09-1363; Theodoro TR, 2007, NEOPLASIA, V9, P504, DOI 10.1593/neo.07241; Utsugi T, 1996, CANCER RES, V56, P2809; Verma S, 2011, ONCOLOGIST, V16, P25, DOI 10.1634/theoncologist.2010-0278; Vlodavsky I, 2006, PATHOPHYSIOL HAEMO T, V35, P116, DOI 10.1159/000093553; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Zetser A, 2006, CANCER RES, V66, P1455, DOI 10.1158/0008-5472.CAN-05-1811; Zhang LX, 2011, CANCER RES, V71, P645, DOI 10.1158/0008-5472.CAN-10-1910; Zhou H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021106	50	53	57	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52175	10.1371/journal.pone.0052175	http://dx.doi.org/10.1371/journal.pone.0052175			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300607	Green Published, Green Submitted, gold			2022-12-27	WOS:000313618800051
J	Bandelj, V; Solidoro, C; Curiel, D; Cossarini, G; Canu, DM; Rismondo, A				Bandelj, Vinko; Solidoro, Cosimo; Curiel, Daniele; Cossarini, Gianpiero; Canu, Donata Melaku; Rismondo, Andrea			Fuzziness and Heterogeneity of Benthic Metacommunities in a Complex Transitional System	PLOS ONE			English	Article							TRANSPORT TIME SCALES; LAGOON-OF-VENICE; ESTUARINE QUALITY; DRAINAGE-BASIN; HARD BOTTOMS; COMMUNITY; ASSEMBLAGES; VARIABILITY; CONTINUUM; PARADOX	We propose an extension to the metacommunity (MC) concept and a novel operational methodology that has the potential to refine the analysis of MC structure at different hierarchical levels. We show that assemblages of species can also be seen as assemblages of abstract subregional habitat-related metacommunities (habMCs). This intrinsically fuzzy concept recognizes the existence of habMCs that are typically associated with given habitats, while allowing for the mixing and superposition of different habMCs in all sites and for boundaries among subregions that are neither spatially sharp nor temporally constant. The combination of fuzzy clustering and direct gradient analysis permits us to 1) objectively identify the number of habMCs that are present in a region as well as their spatial distributions and relative weights at different sites; 2) associate different subregions with different biological communities; and 3) quantitatively assess the affinities between habMCs and physical, morphological, biogeochemical, and environmental properties, thereby enabling an analysis of the roles and relative importance of various environmental parameters in shaping the spatial structure of a metacommunity. This concept and methodology offer the possibility of integrating the continuum and community unit concepts and of developing the concept of a habMC ecological niche. This approach also facilitates the practical application of the MC concept, which are not currently in common use. Applying these methods to macrophytobenthic and macrozoobenthic hard-substrate assemblages in the Venetian Lagoon, we identified a hierarchical organization of macrobenthic communities that associated different habMCs with different habitats. Our results demonstrate that different reference terms should be applied to different subregions to assess the ecological status of a waterbody and show that a combination of several environmental parameters describes the spatial heterogeneity of benthic communities much better than any single property can. Our results also emphasize the importance of considering heterogeneity and fuzziness when working in natural systems.	[Bandelj, Vinko; Solidoro, Cosimo; Cossarini, Gianpiero; Canu, Donata Melaku] Ist Nazl Oceanog & Geofis Sperimentale, OGS, Sgonico, Italy; [Curiel, Daniele; Rismondo, Andrea] SELC, Venice, Italy	Istituto Nazionale di Oceanografia e di Geofisica Sperimentale	Solidoro, C (corresponding author), Ist Nazl Oceanog & Geofis Sperimentale, OGS, Sgonico, Italy.	csolidoro@inogs.it	Melaku Canu, Donata/O-9290-2015; Bandelj, Vinko/J-2129-2019; Cossarini, Gianpiero/AAV-5489-2020	Melaku Canu, Donata/0000-0002-1853-2115; Bandelj, Vinko/0000-0003-0455-1806; Cossarini, Gianpiero/0000-0001-7803-8568; solidoro, cosimo/0000-0003-2354-4302	Magistato alle Acque - Consorzio Venezia Nuova	Magistato alle Acque - Consorzio Venezia Nuova	The study was funded by Magistato alle Acque - Consorzio Venezia Nuova. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1958, LIMNOL OCEANOGR, V3, P346; ARIAS AM, 1994, MAR ECOL PROG SER, V115, P151, DOI 10.3354/meps115151; Bandelj V, 2008, MAR ECOL PROG SER, V368, P23, DOI 10.3354/meps07565; Bandelj V, 2009, ECOL MODEL, V220, P2838, DOI 10.1016/j.ecolmodel.2009.04.024; Bellucci LG, 2002, SCI TOTAL ENVIRON, V295, P35, DOI 10.1016/S0048-9697(02)00040-2; Bezdek J. C., 1981, Pattern recognition with fuzzy objective function algorithms; Bezdek JC, 1987, NATO ASI SERIES; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Borja A, 2010, MAR POLLUT BULL, V60, P2175, DOI 10.1016/j.marpolbul.2010.09.026; BOUDOURESQUE C-F, 1971, Tethys, V3, P79; Brown DG, 1998, PLANT ECOL, V134, P97, DOI 10.1023/A:1009796502293; Canu DM, 2012, MAR POLLUT BULL, V64, P2391, DOI 10.1016/j.marpolbul.2012.08.007; Clements FE, 1936, J ECOL, V24, P252, DOI 10.2307/2256278; Collavini F, 2005, ENVIRON INT, V31, P939, DOI 10.1016/j.envint.2005.05.003; COLLINS SL, 1993, J VEG SCI, V4, P149, DOI 10.2307/3236099; Corriero G, 2007, ITAL J ZOOL, V74, P21, DOI 10.1080/11250000601084100; Cossarini G, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005080; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; Cucco A, 2009, ECOL MODEL, V220, P913, DOI 10.1016/j.ecolmodel.2009.01.008; Dauvin JC, 2007, MAR POLLUT BULL, V55, P271, DOI 10.1016/j.marpolbul.2006.08.017; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Elliott M, 2007, MAR POLLUT BULL, V54, P640, DOI 10.1016/j.marpolbul.2007.02.003; Equihua M, 1990, J ECOL, V78, P19; Gacic M, 2005, FLOODING ENV CHALLEN, P431; Gilbert B, 2004, P NATL ACAD SCI USA, V101, P7651, DOI 10.1073/pnas.0400814101; Gilpin M.E., 1991, METAPOPULATION DYNAM; Gleason H.A., 1926, B TORREY BOT CLUB, V53, P7, DOI DOI 10.2307/2479933; GOODALL DW, 1963, VEGETATIO, V11, P297; Guelorget O., 1992, Vie et Milieu, V42, P215; GUERZONI S, 2006, ATLANTE LAGUNA VENEZ; Guisan A, 2002, ECOL MODEL, V157, P89, DOI 10.1016/S0304-3800(02)00204-1; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Leathwick JR, 2001, ECOLOGY, V82, P2560, DOI 10.1890/0012-9658(2001)082[2560:CIBTSI]2.0.CO;2; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Legendre P., 2012, NUMERICAL ECOLOGY; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Losso C, 2010, ENVIRON INT, V36, P92, DOI 10.1016/j.envint.2009.07.017; Marchini A, 2006, ECOL MODEL, V193, P105, DOI 10.1016/j.ecolmodel.2005.07.041; MILLET B, 1994, MAR ECOL PROG SER, V108, P161, DOI 10.3354/meps108161; Molinaroli E, 2007, J MARINE SYST, V68, P303, DOI 10.1016/j.jmarsys.2006.12.003; Occhipinti Ambrogi A, 1998, B MUS CIV ST NAT VEN, V49, P145; ODEH IOA, 1992, SOIL SCI SOC AM J, V56, P505, DOI 10.2136/sssaj1992.03615995005600020027x; Olano JM, 1998, PLANT ECOL, V134, P113, DOI 10.1023/A:1009767714612; Orfanidis S., 2007, Transitional Waters Bulletin, V1, P45; RAO CR, 1952, ADV STAT METHODS BIO; ROUBENS M, 1982, EUR J OPER RES, V10, P294, DOI 10.1016/0377-2217(82)90228-4; Sconfietti R, 2003, OCEANOL ACTA, V26, P47, DOI 10.1016/S0399-1784(02)01228-8; SHIPLEY B, 1987, VEGETATIO, V69, P47, DOI 10.1007/BF00038686; Silvert W, 2000, ECOL MODEL, V130, P111, DOI 10.1016/S0304-3800(00)00204-0; Solidoro C, 2004, J MARINE SYST, V51, P7, DOI 10.1016/j.jmarsys.2004.05.024; Solidoro C, 2004, J MARINE SYST, V51, P147, DOI 10.1016/j.jmarsys.2004.05.010; Solidoro C., 2010, COASTAL LAGOONS SYST, P483, DOI DOI 10.1201/EBK1420088304-C19; TAKEOKA H, 1984, CONT SHELF RES, V3, P311, DOI 10.1016/0278-4343(84)90014-1; ter Braak C.J.F., 2012, CANOCO REFERENCE MAN; TERBRAAK CJF, 1988, ADV ECOL RES, V18, P271; Umgiesser G, 2004, J MARINE SYST, V51, P123, DOI 10.1016/j.jmarsys.2004.05.009; VANDENWOLLENBERG AL, 1977, PSYCHOMETRIKA, V42, P207, DOI 10.1007/BF02294050; WHITTAKER RH, 1967, BIOL REV, V42, P207, DOI 10.1111/j.1469-185X.1967.tb01419.x; WHITTAKER RH, 1953, ECOL MONOGR, V23, P41, DOI 10.2307/1943519; ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X; Zuliani A, 2005, ENVIRON INT, V31, P929, DOI 10.1016/j.envint.2005.05.004	63	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52395	10.1371/journal.pone.0052395	http://dx.doi.org/10.1371/journal.pone.0052395			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285023	Green Published, gold, Green Submitted			2022-12-27	WOS:000313158800061
J	Nichele, I; Zamo, A; Bertolaso, A; Bifari, F; Tinelli, M; Franchini, M; Stradoni, R; Aprili, F; Pizzolo, G; Krampera, M				Nichele, Ilaria; Zamo, Alberto; Bertolaso, Anna; Bifari, Francesco; Tinelli, Martina; Franchini, Marta; Stradoni, Roberta; Aprili, Fiorenza; Pizzolo, Giovanni; Krampera, Mauro			VR09 Cell Line: An EBV-Positive Lymphoblastoid Cell Line with In Vivo Characteristics of Diffuse Large B Cell Lymphoma of Activated B-Cell Type	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; CHRONIC LYMPHOCYTIC-LEUKEMIA; WALDENSTROM MACROGLOBULINEMIA; LYMPHOPLASMACYTIC LYMPHOMA; MUTATIONS; PROTEIN; MICE	Background: small B-cell neoplasms can show plasmacytic differentiation and may potentially progress to aggressive lymphoma (DLBCL). Epstein-Barr virus (EBV) infection may cause the transformation of malignant cells in vitro. Design and Method: we established VR09 cell line with plasmacytic differentiation, obtained from a case of atypical, non-CLL B-cell chronic lymphoproliferative disease with plasmacytic features. We used flow cytometry, immunohistochemistry, polymerase chain reaction, cytogenetic analysis and florescence in situ hybridization in the attempt at thoroughly characterizing the cell line. We showed VR09 tumorigenic potential in vivo, leading to the development of activated DLBCL with plasmacytic features. Results: VR09 cells displayed plasmacytic appearance and grew as spherical tumors when inoculated subcutaneously into immunodeficient Rag2(-/-) c-chain(-/-) mice. VR09 cell line and tumors displayed the phenotype of activated stage of B cell maturation, with secretory differentiation (CD19+ CD20+ CD79a+ CD79b+/- CD138+ cyclin D1-Ki67 80% IgM+ IgD+ MUM1+ MNDA+ CD10-CD22+ CD23+ CD43+ K+, lambda-Bcl2+Bcl6-) and they presented episomal EBV genome, chromosome 12 trisomy, lack of c-MYC rearrangement and Myd88 gene mutation, presence of somatic hypermutation in the VH region, and wild-type p53. Conclusion: This new EBV-positive cell line may be useful to further characterize in vivo activated DLBCL with plasmacytic features.	[Nichele, Ilaria; Bifari, Francesco; Tinelli, Martina; Stradoni, Roberta; Pizzolo, Giovanni; Krampera, Mauro] Univ Verona, Dept Med, Sect Hematol, Stem Cell Res Lab, I-37100 Verona, Italy; [Zamo, Alberto; Bertolaso, Anna; Franchini, Marta] Univ Verona, Dept Pathol & Diagnost, Sect Pathol Anat, I-37100 Verona, Italy; [Aprili, Fiorenza] Azienda Osped Univ Integrata Verona, Dept Pathol & Diagnost, Lab Cytogenet, Verona, Italy	University of Verona; University of Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona	Krampera, M (corresponding author), Univ Verona, Dept Med, Sect Hematol, Stem Cell Res Lab, I-37100 Verona, Italy.	mauro.krampera@univr.it	KRAMPERA, MAURO/K-5596-2018; Bifari, Francesco/M-3430-2014; Zamò, Alberto/ABF-4436-2020	Bifari, Francesco/0000-0003-2028-3012; KRAMPERA, Mauro/0000-0002-7280-2040; Zamo, Alberto/0000-0001-6203-7966	Italian Ministry of University and Scientific Research; Fondazione CARIVERONA; Fondazione AIRC	Italian Ministry of University and Scientific Research(Ministry of Education, Universities and Research (MIUR)); Fondazione CARIVERONA(Fondazione Cariverona); Fondazione AIRC(Fondazione AIRC per la ricerca sul cancro)	This work was supported by Italian Ministry of University and Scientific Research (PRIN 2005, PRIN 2007), Fondazione CARIVERONA, (Bando 2003 and 2008) and Fondazione AIRC (MFAG 2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann M, 2005, PLOS BIOL, V3, P2148, DOI 10.1371/journal.pbio.0030404; Ansell SM, 1999, AM J HEMATOL, V60, P99, DOI 10.1002/(SICI)1096-8652(199902)60:2<99::AID-AJH3>3.0.CO;2-T; Brest P, 2011, NAT GENET, V43, P242, DOI 10.1038/ng.762; Brothman AR, 2009, CYTOGENET GENOME RES, V127, P1, DOI 10.1159/000279442; Brunelli M, 2008, MODERN PATHOL, V21, P1, DOI 10.1038/modpathol.3800967; Campo E, 2011, BLOOD, V117, P5019, DOI 10.1182/blood-2011-01-293050; Chen MR, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00005; Choi WWL, 2009, CLIN CANCER RES, V15, P5494, DOI 10.1158/1078-0432.CCR-09-0113; Drexler HG, 2000, LEUKEMIA RES, V24, P881, DOI 10.1016/S0145-2126(00)00070-9; Falini B, 2000, BLOOD, V95, P2084, DOI 10.1182/blood.V95.6.2084; Hjalmar V, 1998, HAEMATOLOGICA, V83, P602; Kanellis G, 2009, LEUKEMIA, V23, P1847, DOI 10.1038/leu.2009.108; Kojima M, 2010, PATHOBIOLOGY, V77, P218, DOI 10.1159/000301154; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Lin P, 2003, AM J CLIN PATHOL, V120, P246, DOI 10.1039/R01VXG46MFCDVNHL; Montes-Moreno S, 2010, HAEMATOL-HEMATOL J, V95, P1342, DOI 10.3324/haematol.2009.016113; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; Nilsson K, 1999, HUM CELL, V5, P25; Pangalis GA, 1999, SEMIN HEMATOL, V36, P104; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Ross D, 2009, HEMATOL ONCOL, V27, P1, DOI 10.1002/hon.880; Stacchini A, 1999, LEUKEMIA RES, V23, P127, DOI 10.1016/S0145-2126(98)00154-4; Stilgenbauer S, 1998, ANN HEMATOL, V76, P101, DOI 10.1007/s002770050373; Tarrand JJ, 2010, CANCER-AM CANCER SOC, V116, P880, DOI 10.1002/cncr.24839; Tsimberidou AM, 2005, CANCER-AM CANCER SOC, V103, P216, DOI 10.1002/cncr.20773; van Rijn RS, 2007, EXP HEMATOL, V35, P117, DOI 10.1016/j.exphem.2006.09.018; Varghese AM, 2008, LEUKEMIA LYMPHOMA, V49, P1618, DOI 10.1080/10428190802123481; Zamo A, 2006, HAEMATOLOGICA, V91, P40	29	3	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52811	10.1371/journal.pone.0052811	http://dx.doi.org/10.1371/journal.pone.0052811			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285191	gold, Green Published, Green Submitted			2022-12-27	WOS:000313158800096
J	Zhang, J; Huang, ZH; Qiu, XH; Yang, YM; Zhu, DY; Xu, W				Zhang, Jing; Huang, Zhi Hai; Qiu, Xiao Hui; Yang, Yi Ming; Zhu, Da Yuan; Xu, Wen			Neutral Fragment Filtering for Rapid Identification of New Diester-Diterpenoid Alkaloids in Roots of Aconitum carmichaeli by Ultra-High-Pressure Liquid Chromatography Coupled with Linear Ion Trap-Orbitrap Mass Spectrometry	PLOS ONE			English	Article							C-19-DITERPENOID ALKALOIDS; NORDITERPENOID ALKALOIDS; CHEMISTRY; TOXICITY; MODE; MSN	A rapid and effective method was developed for separation and identification of diester-diterpenoid alkaloids (DDA) in the roots of Aconitum carmichaeli by ultra-high-pressure liquid chromatography coupled with high resolution LTQ-Orbitrap tandem mass spectrometry (UHPLC-LTQ-Orbitrap-MSn). According to accurate mass measurement and the characteristic neutral loss filtering strategy, a total of 42 diester-diterpenoid alkaloids (DDA) were rapidly detected and characterized or tentatively identified. Meanwhile, the proposed fragmentation pathways and the major diagnostic fragment ions of aconitine, mesaconitine and hypaconitine were investigated to trace DDA derivatives in crude plant extracts. 23 potential new compounds were successfully screened and characterized in Aconitum carmichaeli, including 16 short chain fatty acyls DDA, 4 N-dealkyl DDA and several isomers of aconitine, mesaconitine and hypaconitine.	[Zhang, Jing; Qiu, Xiao Hui; Yang, Yi Ming; Zhu, Da Yuan; Xu, Wen] Guangzhou Univ Chinese Med, Clin Coll 2, Lab Chinese Mat Med Preparat, Guangzhou, Guangdong, Peoples R China; [Huang, Zhi Hai] Guangdong Prov Acad Chinese Med Sci, Guangzhou, Guangdong, Peoples R China	Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine	Xu, W (corresponding author), Guangzhou Univ Chinese Med, Clin Coll 2, Lab Chinese Mat Med Preparat, Guangzhou, Guangdong, Peoples R China.	freexuwen@163.com	Butane, Lynn/M-9514-2014; Xu, Wen/H-6226-2011	, Wen/0000-0002-3913-3607; Zhang, Jing/0000-0003-2411-4734				Ameri A, 1998, PROG NEUROBIOL, V56, P211, DOI 10.1016/S0301-0082(98)00037-9; Bello-Ramirez AM, 2004, FUND CLIN PHARMACOL, V18, P699, DOI 10.1111/j.1472-8206.2004.00280.x; BISSET NG, 1981, J ETHNOPHARMACOL, V4, P247, DOI 10.1016/0378-8741(81)90001-5; Chan TYK, 2009, HUM EXP TOXICOL, V28, P795, DOI 10.1177/0960327109353056; Chan TYK, 2009, CLIN TOXICOL, V47, P279, DOI 10.1080/15563650902904407; Chan TYK, 2002, DRUG SAFETY, V25, P823, DOI 10.2165/00002018-200225110-00006; Chen DL, 2003, ACTA CHIM SINICA, V61, P901; Chen LH, 2005, CHEM J CHINESE U, V26, P2340; DICKENS P, 1994, FORENSIC SCI INT, V67, P55, DOI 10.1016/0379-0738(94)90412-X; Dunn WB, 2008, J CHROMATOGR B, V871, P288, DOI 10.1016/j.jchromb.2008.03.021; Hu R, 2009, RAPID COMMUN MASS SP, V23, P1619, DOI 10.1002/rcm.4038; KONNO C, 1979, PLANTA MED, V35, P150, DOI 10.1055/s-0028-1097196; Li R, 2006, RAPID COMMUN MASS SP, V20, P157, DOI 10.1002/rcm.2283; Lim HK, 2007, RAPID COMMUN MASS SP, V21, P1821, DOI 10.1002/rcm.3024; Lin CC, 2004, ANN EMERG MED, V43, P574, DOI 10.1016/j.annemergmed.2003.10.046; Liu WL, 2010, J SEP SCI, V33, P2898, DOI 10.1002/jssc.201000285; Liu XX, 2012, CHEM PHARM BULL, V60, P144, DOI 10.1248/cpb.60.144; Malik AK, 2010, J CHROMATOGR A, V1217, P4018, DOI 10.1016/j.chroma.2010.03.015; Mitamura M, 2002, EUR J PHARMACOL, V436, P217, DOI 10.1016/S0014-2999(01)01623-5; MURAYAMA M, 1984, EUR J PHARMACOL, V101, P29, DOI 10.1016/0014-2999(84)90027-X; Shim SH, 2003, CHEM PHARM BULL, V51, P999; Sleno L, 2005, J AM SOC MASS SPECTR, V16, P183, DOI 10.1016/j.jasms.2004.10.001; TAI YT, 1992, LANCET, V340, P1254, DOI 10.1016/0140-6736(92)92951-B; Tan GG, 2011, BIOMED CHROMATOGR, V25, P1343, DOI 10.1002/bmc.1607; Turabekova MA, 2004, MOLECULES, V9, P1194, DOI 10.3390/91201194; Turabekova MA, 2008, ENVIRON TOXICOL PHAR, V25, P310, DOI 10.1016/j.etap.2007.10.035; Wang FP, 2010, NAT PROD REP, V27, P529, DOI 10.1039/b916679c; Wang Y, 2002, RAPID COMMUN MASS SP, V16, P2075, DOI 10.1002/rcm.828; Werner E, 2008, ANAL CHEM, V80, P4918, DOI 10.1021/ac800094p; Wu W, 2007, J MASS SPECTROM, V42, P58, DOI 10.1002/jms.1138; Xie GB, 2003, HETEROCYCLES, V60, P631; Xie Y, 2005, J CHROMATOGR A, V1093, P195, DOI 10.1016/j.chroma.2005.07.071; Yang JH, 1999, PHYTOCHEMISTRY, V50, P345, DOI 10.1016/S0031-9422(98)00387-2; Yue H, 2009, TALANTA, V77, P1800, DOI 10.1016/j.talanta.2008.10.022; Yue H, 2008, ACTA CHIM SINICA, V66, P211; Zhang F, 2005, CHINESE CHEM LETT, V16, P1043	36	18	20	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52352	10.1371/journal.pone.0052352	http://dx.doi.org/10.1371/journal.pone.0052352			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285005	gold, Green Submitted, Green Published			2022-12-27	WOS:000313158800053
J	Alexander, HM; Reed, AW; Kettle, WD; Slade, NA; Roels, SAB; Collins, CD; Salisbury, V				Alexander, Helen M.; Reed, Aaron W.; Kettle, W. Dean; Slade, Norman A.; Roels, Sarah A. Bodbyl; Collins, Cathy D.; Salisbury, Vaughn			Detection and Plant Monitoring Programs: Lessons from an Intensive Survey of Asclepias meadii with Five Observers	PLOS ONE			English	Article							MARK-RECAPTURE MODELS; DEMOGRAPHIC PARAMETERS; IMPERFECT DETECTION; DENSITY-ESTIMATION; POPULATION-SIZE; SURVIVAL; DORMANCY; ORCHID; CONSEQUENCES; CONSERVATION	Monitoring programs, where numbers of individuals are followed through time, are central to conservation. Although incomplete detection is expected with wildlife surveys, this topic is rarely considered with plants. However, if plants are missed in surveys, raw count data can lead to biased estimates of population abundance and vital rates. To illustrate, we had five independent observers survey patches of the rare plant Asclepias meadii at two prairie sites. We analyzed data with two mark-recapture approaches. Using the program CAPTURE, the estimated number of patches equaled the detected number for a burned site, but exceeded detected numbers by 28% for an unburned site. Analyses of detected patches using Huggins models revealed important effects of observer, patch state (flowering/nonflowering), and patch size (number of stems) on probabilities of detection. Although some results were expected (i.e. greater detection of flowering than nonflowering patches), the importance of our approach is the ability to quantify the magnitude of detection problems. We also evaluated the degree to which increased observer numbers improved detection: smaller groups (3-4 observers) generally found 90 - 99% of the patches found by all five people, but pairs of observers or single observers had high error and detection depended on which individuals were involved. We conclude that an intensive study at the start of a long-term monitoring study provides essential information about probabilities of detection and what factors cause plants to be missed. This information can guide development of monitoring programs. Citation: Alexander HM, Reed AW, Kettle WD, Slade NA, Bodbyl Roels SA, et al. (2012) Detection and Plant Monitoring Programs: Lessons from an Intensive Survey of Asclepias meadii with Five Observers. PLoS ONE 7(12): e52762. doi:10.1371/journal.pone.0052762	[Alexander, Helen M.; Slade, Norman A.; Roels, Sarah A. Bodbyl] Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; [Reed, Aaron W.] Univ Missouri, Sch Biol Sci, Kansas City, MO 64110 USA; [Kettle, W. Dean; Salisbury, Vaughn] Univ Kansas, Kansas Biol Survey, Lawrence, KS 66045 USA; [Slade, Norman A.] Univ Kansas, Museum Nat Hist, Biodivers Res Ctr, Lawrence, KS 66045 USA; [Collins, Cathy D.] Colby Coll, Dept Biol, Waterville, ME 04901 USA	University of Kansas; University of Missouri System; University of Missouri Kansas City; University of Kansas; University of Kansas; Colby College	Alexander, HM (corresponding author), Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA.	halexander@ku.edu	Roels, Sarah A Bodbyl/K-1221-2012	Bodbyl, Sarah/0000-0001-7590-677X	Kansas Biological Survey at the University of Kansas; University of Kansas Field Station (KUFS), a research unit of the Kansas Biological Survey; University of Kansas	Kansas Biological Survey at the University of Kansas; University of Kansas Field Station (KUFS), a research unit of the Kansas Biological Survey; University of Kansas	This work was supported by the Kansas Biological Survey at the University of Kansas. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was conducted at and supported by the University of Kansas Field Station (KUFS), a research unit of the Kansas Biological Survey and the University of Kansas. This is publication number 912.	Alexander HM, 2009, J ECOL, V97, P267, DOI 10.1111/j.1365-2745.2008.01468.x; Alexander HM, 1997, ECOLOGY, V78, P1230, DOI 10.2307/2265872; Amstrup S. C., 2003, HDB CAPTURE RECAPTUR; [Anonymous], 1991, USERS GUIDE INTERACT; [Anonymous], 1998, 17301 BLM; Betz, 1989, P 11 N AM PRAIR C, P13; Bouldin J, 2008, J BIOGEOGR, V35, P2000, DOI 10.1111/j.1365-2699.2008.01940.x; Bowles ML, 1998, ANN MO BOT GARD, V85, P110, DOI 10.2307/2992001; Buckland ST, 2007, BIOMETRICS, V63, P989, DOI 10.1111/j.1541-0420.2007.00798.x; Buckland S.T., 2001, pi; Burnham K. P., 1998, MODEL SELECTION INFE; Cahill JF, 2002, AM J BOT, V89, P1401, DOI 10.3732/ajb.89.9.1401; Chen GK, 2009, J ECOL, V97, P1383, DOI 10.1111/j.1365-2745.2009.01560.x; COLE DN, 1995, J APPL ECOL, V32, P215, DOI 10.2307/2404430; Dickinson JL, 2010, ANNU REV ECOL EVOL S, V41, P149, DOI 10.1146/annurev-ecolsys-102209-144636; Emry DJ, 2011, J APPL ECOL, V48, P1391, DOI 10.1111/j.1365-2664.2011.02050.x; Garrard GE, 2008, AUSTRAL ECOL, V33, P986, DOI 10.1111/j.1442-9993.2008.01869.x; Goodwin KM, 2010, INVAS PLANT SCI MANA, V3, P113, DOI 10.1614/IPSM-D-09-00025.1; HUGGINS RM, 1991, BIOMETRICS, V47, P725, DOI 10.2307/2532158; HUGGINS RM, 1989, BIOMETRIKA, V76, P133, DOI 10.1093/biomet/76.1.133; Kery M, 2003, J ECOL, V91, P265, DOI 10.1046/j.1365-2745.2003.00759.x; Kery M, 2005, OIKOS, V108, P307, DOI 10.1111/j.0030-1299.2005.13589.x; Kery M, 2004, J ECOL, V92, P686, DOI 10.1111/j.0022-0477.2004.00885.x; Kery M, 2004, CONSERV BIOL, V18, P570, DOI 10.1111/j.1523-1739.2004.00105.x; Kery M, 2008, COMMUNITY ECOL, V9, P207, DOI 10.1556/ComEc.9.2008.2.10; Kettle WD, 2000, AM MIDL NAT, V144, P66, DOI 10.1674/0003-0031(2000)144[0066:AYESOA]2.0.CO;2; Kissa DO, 2012, FOREST ECOL MANAG, V263, P114, DOI 10.1016/j.foreco.2011.09.020; Lahoreau G., 2004, Animal Biodiversity and Conservation, V27, P549; Lesica P, 2007, J ECOL, V95, P1360, DOI 10.1111/j.1365-2745.2007.01291.x; Moore CT, 2011, J FISH WILDL MANAG, V2, P247, DOI 10.3996/012011-JFWM-007; Moore JL, 2011, ECOL APPL, V21, P601, DOI 10.1890/10-0590.1; NICHOLS JD, 1992, BIOSCIENCE, V42, P94, DOI 10.2307/1311650; Philippi T, 2001, NAT AREA J, V21, P111; Powell LA, 2007, CONDOR, V109, P949, DOI 10.1650/0010-5422(2007)109[949:AVODPU]2.0.CO;2; Regan TJ, 2011, J APPL ECOL, V48, P76, DOI 10.1111/j.1365-2664.2010.01915.x; Ros M, 2004, COMMUN SOIL SCI PLAN, V35, P1591, DOI 10.1081/CSS-120038556; SAMSON F, 1994, BIOSCIENCE, V44, P418, DOI 10.2307/1312365; Sandercock BK, 2006, J WILDLIFE MANAGE, V70, P1504, DOI 10.2193/0022-541X(2006)70[1504:EODPFL]2.0.CO;2; Shefferson RP, 2001, ECOLOGY, V82, P145, DOI 10.2307/2680092; Shefferson RP, 2003, ECOLOGY, V84, P1199, DOI 10.1890/0012-9658(2003)084[1199:LHTIAR]2.0.CO;2; Slade NA, 2003, ECOLOGY, V84, P791, DOI 10.1890/0012-9658(2003)084[0791:EOPSAP]2.0.CO;2; Tecic DL, 1998, ANN MO BOT GARD, V85, P97, DOI 10.2307/2992000; U.S. Fish and WildlifeService, 2003, MEADS MILKW ASLC MEA; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; White GC, 1982, LA8787NERP LOS AL NA; Williams B. K., 2002, ANAL MANAGEMENT ANIM	46	16	16	2	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52762	10.1371/journal.pone.0052762	http://dx.doi.org/10.1371/journal.pone.0052762			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285179	Green Published, gold			2022-12-27	WOS:000312794500244
J	Duan, W; Ran, H; Zhou, ZJ; He, QF; Zheng, J				Duan, Wei; Ran, Hong; Zhou, Zhujuan; He, Qifen; Zheng, Jian			Adenosine A2A Receptor Deficiency Up-Regulates Cystatin F Expression in White Matter Lesions Induced by Chronic Cerebral Hypoperfusion	PLOS ONE			English	Article							A(2A) RECEPTORS; DENDRITIC CELLS; CYSTEINE CATHEPSINS; GENE-EXPRESSION; INNATE IMMUNITY; BRAIN-INJURY; ACTIVATION; MICROGLIA; STRIATUM; ISCHEMIA	In previous studies, we have shown that the inactivation of the adenosine A2A receptor exacerbates chronic cerebral hypoperfusion-induced white matter lesions (WMLs) by enhancing neuroinflammatory responses. However, the molecular mechanism underlying the effect of the adenosine A2A receptor remains unknown. Recent studies have demonstrated that cystatin F, a potent endogenous cysteine protease inhibitor, is selectively expressed in immune cells in association with inflammatory demyelination in central nervous system diseases. To understand the expression of cystatin F and its potential role in the effect of A2A receptor on WMLs induced through chronic cerebral hypoperfusion, we investigated cystatin F expression in the WMLs of A2A receptor gene knockout mice, the littermate wild-type mice and wild-type mice treated daily with the A2A receptor agonist CGS21680 or both CGS21680 and A2A receptor antagonist SCH58261 after chronic cerebral hypoperfusion. The results of quantitative-PCR and western blot analysis revealed that cystatin F mRNA and protein expression were significantly up-regulated in the WMLs after chronic cerebral hypoperfusion. In addition, cystatin F expression in the corpus callosum was significantly increased in A2A receptor gene knockout mice and markedly decreased in mice treated with CGS21680 on both the mRNA and protein levels. Additionally, SCH58261 counteracted the attenuation of cystatin F expression produced by CGS21680 after chronic cerebral hypoperfusion. Moreover, double immunofluorescence staining revealed that cystatin F was co-localized with the activated microglia marker CD11b. In conclusion, the cystatin F expression in the activated microglia is closely associated with the effect of the A2A receptors, which may be related to the neuroinflammatory responses occurring during the pathological process.	[Duan, Wei; Ran, Hong; Zhou, Zhujuan; He, Qifen; Zheng, Jian] Third Mil Med Univ, Xinqiao Hosp, Dept Neurol, Chongqing, Peoples R China	Army Medical University	Zheng, J (corresponding author), Third Mil Med Univ, Xinqiao Hosp, Dept Neurol, Chongqing, Peoples R China.	jzheng59@hotmail.com	zhou, zhou/HCH-1084-2022		National Natural Science Foundation of China [81100891, 81070933]; Youth Creation Foundation of Third Military Medical University [2010XQN29]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Creation Foundation of Third Military Medical University	This work was supported by grants from the National Natural Science Foundation of China (No. 81100891, No. 81070933) and the Youth Creation Foundation of Third Military Medical University (No.2010XQN29). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bangert C, 2003, J INVEST DERMATOL, V121, P1409, DOI 10.1111/j.1523-1747.2003.12623.x; Bird PI, 2009, NAT REV IMMUNOL, V9, P871, DOI 10.1038/nri2671; Chen JF, 1999, J NEUROSCI, V19, P9192, DOI 10.1523/jneurosci.19-21-09192.1999; Colbert JD, 2011, J BIOL CHEM, V286, P42082, DOI 10.1074/jbc.M111.253914; Colbert JD, 2009, TRAFFIC, V10, P425, DOI 10.1111/j.1600-0854.2009.00881.x; Day YJ, 2003, J CLIN INVEST, V112, P883, DOI 10.1172/JCI200315483; Deng YY, 2008, BRAIN PATHOL, V18, P387, DOI 10.1111/j.1750-3639.2008.00138.x; Duan W, 2009, J NEUROL SCI, V285, P39, DOI 10.1016/j.jns.2009.05.010; Farkas E, 2004, ACTA NEUROPATHOL, V108, P57, DOI 10.1007/s00401-004-0864-9; GEHRMANN J, 1995, BRAIN RES REV, V20, P269, DOI 10.1016/0165-0173(94)00015-H; Hamilton G, 2008, EMBO J, V27, P499, DOI 10.1038/sj.emboj.7601979; Hashimoto S, 2000, BLOOD, V96, P2206, DOI 10.1182/blood.V96.6.2206.h8002206_2206_2214; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Hof PR., 2000, COMP CYTOARCHITECTON; Itziou A, 2009, CHEMOSPHERE, V76, P1315, DOI 10.1016/j.chemosphere.2009.06.032; Izzotti A, 2009, BRAIN PATHOL, V19, P650, DOI 10.1111/j.1750-3639.2008.00229.x; Kopitar-Jerala N, 2006, FEBS LETT, V580, P6295, DOI 10.1016/j.febslet.2006.10.055; Kraft AD, 2011, INT J ENV RES PUB HE, V8, P2980, DOI 10.3390/ijerph8072980; Langerholc T, 2005, FEBS J, V272, P1535, DOI 10.1111/j.1742-4658.2005.04594.x; Lehnardt S, 2010, GLIA, V58, P253, DOI 10.1002/glia.20928; Ma JM, 2011, J NEUROSCI RES, V89, P639, DOI 10.1002/jnr.22567; Magister S, 2012, EUR J CELL BIOL, V91, P391, DOI 10.1016/j.ejcb.2012.01.001; Mayne M, 2001, ANN NEUROL, V49, P727, DOI 10.1002/ana.1010; Milne GR, 2011, THESCIENTIFICWORLDJO, V11, P320, DOI 10.1100/tsw.2011.22; Monopoli A, 1998, J PHARMACOL EXP THER, V285, P9; Moorhouse P, 2008, LANCET NEUROL, V7, P246, DOI 10.1016/S1474-4422(08)70040-1; Obata-Onai A, 2002, INT IMMUNOL, V14, P1085, DOI 10.1093/intimm/dxf086; Omori K, 2007, CELL TISSUE RES, V330, P75, DOI 10.1007/s00441-007-0457-8; Orru M, 2011, NEUROPHARMACOLOGY, V61, P967, DOI 10.1016/j.neuropharm.2011.06.025; Pintor A, 2001, EUR J PHARMACOL, V421, P177, DOI 10.1016/S0014-2999(01)01058-5; Popoli P, 2002, J NEUROSCI, V22, P1967, DOI 10.1523/JNEUROSCI.22-05-01967.2002; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Reece TB, 2004, J SURG RES, V121, P130, DOI 10.1016/j.jss.2004.04.006; Reiser J, 2010, J CLIN INVEST, V120, P3421, DOI 10.1172/JCI42918; Shibata M, 2004, STROKE, V35, P2598, DOI 10.1161/01.STR.0000143725.19053.60; Sitkovsky MV, 2004, ANNU REV IMMUNOL, V22, P657, DOI 10.1146/annurev.immunol.22.012703.104731; Sriram S, 2011, J NEUROIMMUNOL, V239, P13, DOI 10.1016/j.jneuroim.2011.08.012; Turk V, 2008, FRONT BIOSCI-LANDMRK, V13, P5406, DOI 10.2741/3089; Turk V, 2012, BBA-PROTEINS PROTEOM, V1824, P68, DOI 10.1016/j.bbapap.2011.10.002; Verdot L, 1999, EUR J BIOCHEM, V266, P1111, DOI 10.1046/j.1432-1327.1999.00964.x; Wakita H, 1999, NEUROREPORT, V10, P1461, DOI 10.1097/00001756-199905140-00013; Yu LQ, 2004, NAT MED, V10, P1081, DOI 10.1038/nm1103	42	17	17	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52566	10.1371/journal.pone.0052566	http://dx.doi.org/10.1371/journal.pone.0052566			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285090	Green Submitted, Green Published, gold			2022-12-27	WOS:000312794500197
J	Lin, SL; Tarrant, M; Hui, LL; Kwok, MK; Lam, TH; Leung, GM; Schooling, CM				Lin, Shi Lin; Tarrant, Marie; Hui, Lai Ling; Kwok, Man Ki; Lam, Tai Hing; Leung, Gabriel M.; Schooling, C. Mary			The Role of Dairy Products and Milk in Adolescent Obesity: Evidence from Hong Kong's "Children of 1997" Birth Cohort	PLOS ONE			English	Article							BODY-FAT; BEVERAGE CONSUMPTION; SOCIOECONOMIC-STATUS; MULTIPLE IMPUTATION; DIETARY CALCIUM; WEIGHT-GAIN; CHILDHOOD; ADIPOSITY; CHINESE; BONE	Background: Observational studies, mainly from Western populations, suggest dairy consumption is inversely associated with adiposity. However, in these populations the intake range is limited and both diet and obesity may share social patterning. Evidence from non-Western developed settings with different social patterning, is valuable in distinguishing whether observed associations are biologically mediated or socially confounded. Objective: To examine the associations of milk or other dairy product consumption with adolescent obesity. Methods: We used multivariable linear regression models to examine the associations of milk or other dairy product consumption, obtained from a food frequency questionnaire, at 11 years with body mass index (BMI) z-scores at 13 years and waist hip ratio (WHR) at 11 years, in 5,968 adolescents from a Chinese birth cohort, comprising 88% of births in April and May 1997. We used multiple imputation for missing exposures and confounders. Results: Only 65.7% regularly consumed milk and 72.4% other dairy products. Milk and other dairy product consumption was positively associated with socio-economic position but not with BMI z-score or WHR, with or without adjustment for sex, mother's birthplace, parental education, physical activity and other food consumption. Conclusions: The lack of association of milk and other dairy product consumption with adiposity in a non-Western setting was not consistent with the majority of evidence from Western settings. Observed anti-obesigenic effects in Western settings may be due to socially patterned confounding.	[Lin, Shi Lin; Hui, Lai Ling; Kwok, Man Ki; Lam, Tai Hing; Leung, Gabriel M.; Schooling, C. Mary] Univ Hong Kong, Li Ka Shing Fac Med, Lifestyle & Life Course Epidemiol Grp, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Tarrant, Marie] Univ Hong Kong, Li Ka Shing Fac Med, Sch Nursing, Hong Kong, Hong Kong, Peoples R China; [Schooling, C. Mary] CUNY Hunter Coll, Sch Publ Hlth, New York, NY 10021 USA	University of Hong Kong; University of Hong Kong; City University of New York (CUNY) System; Hunter College (CUNY)	Schooling, CM (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Lifestyle & Life Course Epidemiol Grp, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China.	cms1@hkucc.hku.hk	Hui, Lai Ling/C-4528-2009; Lam, Tai Hing/C-4317-2009	HUI, Lai Ling/0000-0003-0688-3329; Kwok, Man Ki/0000-0003-3777-4766; Leung, Gabriel/0000-0002-2503-6283; Lam, Tai Hing/0000-0002-2033-9971; Schooling, Mary/0000-0001-9933-5887	Health Care and Promotion Fund, Health and Welfare Bureau, Government of Hong Kong (HCPF) [216106]; Health and Health Services Research Fund (HHSRF) [03040771, 07080751, 08090761]; Research Fund for the Control of Infectious Diseases in Hong Kong (RFCID), Government of the Hong Kong SAR [04050172]; University Research Committee Strategic Research Theme (SRT) of Public Health Granted Research, The University of Hong Kong	Health Care and Promotion Fund, Health and Welfare Bureau, Government of Hong Kong (HCPF); Health and Health Services Research Fund (HHSRF); Research Fund for the Control of Infectious Diseases in Hong Kong (RFCID), Government of the Hong Kong SAR; University Research Committee Strategic Research Theme (SRT) of Public Health Granted Research, The University of Hong Kong	The initial "Infant health and lifestyle survey" was funded by the Health Care and Promotion Fund, Health and Welfare Bureau, Government of Hong Kong (HCPF Grant # 216106). Since 2005, the "Children of 1997" birth cohort has been funded by the Health and Health Services Research Fund (HHSRF Grants #03040771, #07080751, #08090761) and the Research Fund for the Control of Infectious Diseases in Hong Kong (RFCID Grant # 04050172), Government of the Hong Kong SAR. The "Children of 1997" birth cohort has also received funding from the University Research Committee Strategic Research Theme (SRT) of Public Health Granted Research, The University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIMA H, 1970, J ACM, V17, P589, DOI 10.1145/321607.321609; Barba G, 2005, BRIT J NUTR, V93, P15, DOI 10.1079/BJN20041300; Berkey CS, 2005, ARCH PEDIAT ADOL MED, V159, P543, DOI 10.1001/archpedi.159.6.543; Cadogan J, 1997, BMJ-BRIT MED J, V315, P1255, DOI 10.1136/bmj.315.7118.1255; Carruth BR, 2001, INT J OBESITY, V25, P559, DOI 10.1038/sj.ijo.0801562; Census and Statistics Department, 2007, HEALTH; Central Health Education Unit Centre for Health Protection, 2006, BAS ASS PROM HLTH EA; CHAN GM, 1995, J PEDIATR-US, V126, P551, DOI 10.1016/S0022-3476(95)70348-9; Development Core Team, 2005, R LANG ENV STAT COMP; Fiorito LM, 2009, AM J CLIN NUTR, V90, P935, DOI 10.3945/ajcn.2009.27623; Harrell, 2010, HMISC HARRELL MISCEL; Harrell FE, 2001, REGRESSION MODELING; Hoglund D, 1998, EUR J CLIN NUTR, V52, P784, DOI 10.1038/sj.ejcn.1600644; Huh SY, 2010, J AM DIET ASSOC, V110, P563, DOI 10.1016/j.jada.2009.12.025; Hui LL, 2003, INT J OBESITY, V27, P1411, DOI 10.1038/sj.ijo.0802423; Johnson L, 2007, NUTRITION, V23, P557, DOI 10.1016/j.nut.2007.05.005; Lam TH, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.6.e91; Lin SL, 2011, INT J EPIDEMIOL, V40, P1238, DOI 10.1093/ije/dyr086; Louie JCY, 2011, OBES REV, V12, pE582, DOI 10.1111/j.1467-789X.2011.00881.x; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Merrilees MJ, 2000, EUR J NUTR, V39, P256, DOI 10.1007/s003940070004; Moons KGM, 2006, J CLIN EPIDEMIOL, V59, P1092, DOI 10.1016/j.jclinepi.2006.01.009; Moore LL, 2006, OBESITY, V14, P1010, DOI 10.1038/oby.2006.116; NeumarkSztainer D, 1997, J NUTR EDUC, V29, P12, DOI 10.1016/S0022-3182(97)70141-9; Newby PK, 2004, J AM DIET ASSOC, V104, P1086, DOI 10.1016/j.jada.2004.04.020; Novotny R, 2004, J NUTR, V134, P1905, DOI 10.1093/jn/134.8.1905; Phillips SM, 2003, INT J OBESITY, V27, P1106, DOI 10.1038/sj.ijo.0802370; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Schooling CM, 2012, INT J EPIDEMIOL, V41, P611, DOI 10.1093/ije/dyq243; Schooling CM, 2010, ARCH DIS CHILD, V95, P437, DOI 10.1136/adc.2009.168542; Schooling CM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-49; Schooling CM, 2006, INT J EPIDEMIOL, V35, P418, DOI 10.1093/ije/dyi296; Seaman SR, 2012, BIOMETRICS, V68, P129, DOI 10.1111/j.1541-0420.2011.01666.x; Shrewsbury V, 2008, OBESITY, V16, P275, DOI 10.1038/oby.2007.35; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Striegel-Moore RH, 2006, J PEDIATR-US, V148, P183, DOI 10.1016/j.jpeds.2005.11.025; Tam CS, 2006, INT J OBESITY, V30, P1091, DOI 10.1038/sj.ijo.0803328; WHO, 2007, WHO GROWTH REF 5 19; Zemel MB, 2000, FASEB J, V14, P1132, DOI 10.1096/fasebj.14.9.1132; Zemel MB, 2005, INT J OBESITY, V29, P391, DOI 10.1038/sj.ijo.0802880; Zemel MB, 2004, OBES RES, V12, P582, DOI 10.1038/oby.2004.67	41	19	21	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52575	10.1371/journal.pone.0052575	http://dx.doi.org/10.1371/journal.pone.0052575			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285099	gold, Green Published			2022-12-27	WOS:000312794500203
J	Qiu, XJ; Ding, SS; Shi, TL				Qiu, Xiaojie; Ding, Shanshan; Shi, Tieliu			From Understanding the Development Landscape of the Canonical Fate-Switch Pair to Constructing a Dynamic Landscape for Two-Step Neural Differentiation	PLOS ONE			English	Article							POTENTIAL LANDSCAPE; IPS CELLS; FIBROBLASTS; IDENTIFICATION; TRANSCRIPTOME; EXPRESSION; EXISTENCE; EVOLUTION; GENES; NOISE	Recent progress in stem cell biology, notably cell fate conversion, calls for novel theoretical understanding for cell differentiation. The existing qualitative concept of Waddington's "epigenetic landscape" has attracted particular attention because it captures subsequent fate decision points, thus manifesting the hierarchical ("tree-like") nature of cell fate diversification. Here, we generalized a recent work and explored such a developmental landscape for a two-gene fate decision circuit by integrating the underlying probability landscapes with different parameters (corresponding to distinct developmental stages). The change of entropy production rate along the parameter changes indicates which parameter changes can represent a normal developmental process while other parameters' change can not. The transdifferentiation paths over the landscape under certain conditions reveal the possibility of a direct and reversible phenotypic conversion. As the intensity of noise increases, we found that the landscape becomes flatter and the dominant paths more straight, implying the importance of biological noise processing mechanism in development and reprogramming. We further extended the landscape of the one-step fate decision to that for two-step decisions in central nervous system (CNS) differentiation. A minimal network and dynamic model for CNS differentiation was firstly constructed where two three-gene motifs are coupled. We then implemented the SDEs (Stochastic Differentiation Equations) simulation for the validity of the network and model. By integrating the two landscapes for the two switch gene pairs, we constructed the two-step development landscape for CNS differentiation. Our work provides new insights into cellular differentiation and important clues for better reprogramming strategies.	[Shi, Tieliu] E China Normal Univ, Ctr Bioinformat & Computat Biol, Sch Life Sci, Shanghai 200062, Peoples R China; E China Normal Univ, Sch Life Sci, Inst Biomed Sci, Shanghai 200062, Peoples R China	East China Normal University; East China Normal University	Shi, TL (corresponding author), E China Normal Univ, Ctr Bioinformat & Computat Biol, Sch Life Sci, Shanghai 200062, Peoples R China.	tieliushi01@gmail.com			National 973 Key Basic Research Program [2010CB945401, 2012CB910400]; National Natural Science Foundation of China [31171264, 31071162, 31000590]; Science and Technology Commission of Shanghai Municipality [11DZ2260300]	National 973 Key Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by the National 973 Key Basic Research Program (2010CB945401, 2012CB910400); the National Natural Science Foundation of China (31171264, 31071162, 31000590); and the Science and Technology Commission of Shanghai Municipality (11DZ2260300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrecut M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019358; Ao P, 2005, PHYS LIFE REV, V2, P117, DOI 10.1016/j.plrev.2005.03.002; Ao P, 2004, J PHYS A-MATH GEN, V37, pL25, DOI 10.1088/0305-4470/37/3/L01; Ao P, 2007, COMPLEXITY, V12, P19, DOI 10.1002/cplx.20171; Ao P, 2009, J GENET GENOMICS, V36, P63, DOI 10.1016/S1673-8527(08)60093-4; Arias AM, 2006, NAT REV GENET, V7, P34, DOI 10.1038/nrg1750; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Bhattacharya S, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-85; Brock A, 2009, NAT REV GENET, V10, P336, DOI 10.1038/nrg2556; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Chickarmane V, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000268; Cotterell J, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.74; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Gonzalez F, 2011, NAT REV GENET, V12, P231, DOI 10.1038/nrg2937; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Hartl D, 2008, PROTEOMICS, V8, P1257, DOI 10.1002/pmic.200700724; Huang S, 2011, BIOESSAYS; Huang S, 2011, SEMINARS CANC BIOL; Huang S, 2007, DEV BIOL, V305, P695, DOI 10.1016/j.ydbio.2007.02.036; Huang S, 2009, BIOESSAYS, V31, P546, DOI 10.1002/bies.200800189; Jablonka E, 2002, ANN NY ACAD SCI, V981, P82; Jopling C, 2011, NAT REV MOL CELL BIO, V12, P79, DOI 10.1038/nrm3043; KAUFFMAN S, 1969, NATURE, V224, P177, DOI 10.1038/224177a0; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Kim J, 2011, P NATL ACAD SCI USA, V108, P7838, DOI 10.1073/pnas.1103113108; Krumsiek J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022649; Kwon C, 2005, P NATL ACAD SCI USA, V102, P13029, DOI 10.1073/pnas.0506347102; Liao J, 2008, CELL RES, V18, P600, DOI 10.1038/cr.2008.51; MacArthur BD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003086; Nielsen JA, 2006, J NEUROSCI, V26, P9881, DOI 10.1523/JNEUROSCI.2246-06.2006; Qiang M, 2011, SCI CHINA LIFE SCI, V54, P1156, DOI 10.1007/s11427-011-4261-z; Ruan WM, 2011, SCI CHINA LIFE SCI, V54, P553, DOI 10.1007/s11427-011-4179-5; Sanosaka T, 2008, NEUROSCIENCE, V155, P780, DOI 10.1016/j.neuroscience.2008.06.039; Sayers EW, 2011, NUCLEIC ACIDS RES, V39, pD38, DOI 10.1093/nar/gkq1172; SWENSON R, 1991, Ecological Psychology, V3, P317, DOI 10.1207/s15326969eco0304_2; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thom R, 1954, COMMENT MATH HELV, V28, P17, DOI DOI 10.1007/BF02566923; VanOoyen A, 2003, DEV COGN NEUROSCI, P1; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Waddington C., 1957, STRATEGY GENES; Wang J, 2008, P NATL ACAD SCI USA, V105, P12271, DOI 10.1073/pnas.0800579105; Wang Jin, 2008, PMC Biophys, V1, P7, DOI 10.1186/1757-5036-1-7; Wang J, 2011, P NATL ACAD SCI USA, V108, P8257, DOI 10.1073/pnas.1017017108; Wang J, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3478547; Wang J, 2010, BIOPHYS J, V99, P29, DOI 10.1016/j.bpj.2010.03.058; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Xing JH, 2010, J PHYS A-MATH THEOR, V43, DOI 10.1088/1751-8113/43/37/375003; Yin L, 2006, J PHYS A-MATH GEN, V39, P8593, DOI 10.1088/0305-4470/39/27/003; Zhou J, 2010, TRENDS GENETICS; Zhou JX, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019798, 10.1371/journal.pone.0014752, 10.1371/journal.pone.0024340]	51	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e49271	10.1371/journal.pone.0049271	http://dx.doi.org/10.1371/journal.pone.0049271			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051EQ	23300518	Green Published			2022-12-27	WOS:000312108500004
J	Delbin, MA; Davel, APC; Couto, GK; de Araujo, GG; Rossoni, LV; Antunes, E; Zanesco, A				Delbin, Maria A.; Davel, Ana Paula C.; Couto, Gisele Kruger; de Araujo, Gustavo G.; Rossoni, Luciana Venturini; Antunes, Edson; Zanesco, Angelina			Interaction between Advanced Glycation End Products Formation and Vascular Responses in Femoral and Coronary Arteries from Exercised Diabetic Rats	PLOS ONE			English	Article							ENDOTHELIUM-DEPENDENT RELAXATION; INSULIN-RESISTANCE; HYPERPOLARIZING FACTOR; OXIDANT STRESS; SMOOTH-MUSCLE; MOLECULAR-MECHANISMS; PHYSICAL-ACTIVITY; CAROTID ARTERIES; BLOOD-PRESSURE; UP-REGULATION	Background: The majority of studies have investigated the effect of exercise training (TR) on vascular responses in diabetic animals (DB), but none evaluated nitric oxide (NO) and advanced glycation end products (AGEs) formation associated with oxidant and antioxidant activities in femoral and coronary arteries from trained diabetic rats. Our hypothesis was that 8-week TR would alter AGEs levels in type 1 diabetic rats ameliorating vascular responsiveness. Methodology/Principal Findings: Male Wistar rats were divided into control sedentary (C/SD), sedentary diabetic (SD/DB), and trained diabetic (TR/DB). DB was induced by streptozotocin (i.p.: 60 mg/kg). TR was performed for 60 min per day, 5 days/week, during 8 weeks. Concentration-response curves to acetylcholine (ACh), sodium nitroprusside (SNP), phenylephrine (PHE) and tromboxane analog (U46619) were obtained. The protein expressions of eNOS, receptor for AGEs (RAGE), Cu/Zn-SOD and Mn-SOD were analyzed. Tissues NO production and reactive oxygen species (ROS) generation were evaluated. Plasma nitrate/nitrite (NOx-), superoxide dismutase (SOD), catalase (CAT), thiobarbituric acid reactive substances (TBARS) and N-epsilon-(carboxymethyl) lysine (CML, AGE biomarker). A rightward shift in the concentration-response curves to ACh was observed in femoral and coronary arteries from SD/DB that was accompanied by an increase in TBARS and CML levels. Decreased in the eNOS expression, tissues NO production and NOx- levels were associated with increased ROS generation. A positive interaction between the beneficial effect of TR on the relaxing responses to ACh and the reduction in TBARS and CML levels were observed without changing in antioxidant activities. The eNOS protein expression, tissues NO production and ROS generation were fully re-established in TR/DB, but plasma NOx- levels were partially restored. Conclusion: Shear stress induced by TR fully restores the eNOS/NO pathway in both preparations from non-treated diabetic rats, however, a massive production of AGEs still affecting relaxing responses possibly involving other endothelium-dependent vasodilator agents, mainly in coronary artery.	[Delbin, Maria A.; de Araujo, Gustavo G.; Zanesco, Angelina] Univ Sao Paulo State UNESP, Dept Phys Educ, Inst Biosci, Sao Paulo, Brazil; [Davel, Ana Paula C.] Univ Estadual Campinas, Dept Anat Cellular Biol Physiol & Biophys, Inst Biol, Sao Paulo, Brazil; [Couto, Gisele Kruger; Rossoni, Luciana Venturini] Univ Sao Paulo, Dept Physiol & Biophys, Inst Biomed Sci, Sao Paulo, Brazil; [Antunes, Edson] Univ Estadual Campinas, Dept Pharmacol, Fac Med Sci, Sao Paulo, Brazil	Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas	Zanesco, A (corresponding author), Univ Sao Paulo State UNESP, Dept Phys Educ, Inst Biosci, Sao Paulo, Brazil.	azanesco@rc.unesp.br	ANTUNES, EDSON/F-6731-2012; Zanesco, Angelina/V-6154-2019; Fisiologia comparada, Inct/I-2427-2013; Davel, Ana P/L-8801-2013; Zanesco, Angelina/N-3632-2013; Zanesco, Angelina/AAF-6370-2019; de Araujo, Gustavo Gomes/C-9172-2013; Rossoni, Luciana Venturini/C-7226-2012; Rossoni, Luciana Venturini/AFR-0021-2022; Delbin, Maria A/F-4233-2012	ANTUNES, EDSON/0000-0003-2201-8247; Zanesco, Angelina/0000-0002-2515-1871; Davel, Ana P/0000-0002-9862-4262; Rossoni, Luciana Venturini/0000-0002-0944-9483; Delbin, Maria/0000-0002-3537-055X	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was funded by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avogaro A, 2008, DIABETES RES CLIN PR, V82, pS94, DOI 10.1016/j.diabres.2008.09.021; Bavenholm PN, 2000, DIABETES, V49, P1078, DOI 10.2337/diabetes.49.7.1078; Belotto MF, 2010, CLIN EXP IMMUNOL, V162, P237, DOI 10.1111/j.1365-2249.2010.04240.x; BLONDEL O, 1989, DIABETES METAB, V15, P382; BONORA E, 1989, J CLIN ENDOCR METAB, V68, P374, DOI 10.1210/jcem-68-2-374; Brandes RP, 2000, P NATL ACAD SCI USA, V97, P9747, DOI 10.1073/pnas.97.17.9747; Busse R, 2002, TRENDS PHARMACOL SCI, V23, P374, DOI 10.1016/S0165-6147(02)02050-3; Cade WT, 2008, PHYS THER, V88, P1322, DOI 10.2522/ptj.20080008; Cao J, 2008, INT J MOL SCI, V9, P2388, DOI 10.3390/ijms9122388; Chakraphan D, 2005, CLIN HEMORHEOL MICRO, V32, P217; Chimen M, 2012, DIABETOLOGIA, V55, P542, DOI 10.1007/s00125-011-2403-2; Christopher MJ, 2003, J APPL PHYSIOL, V95, P1523, DOI 10.1152/japplphysiol.00199.2003; Claudino MA, 2011, LIFE SCI, V88, P272, DOI 10.1016/j.lfs.2010.11.018; Claudino MA, 2010, UROLOGY, V75, P961, DOI 10.1016/j.urology.2009.05.098; Colberg SR, 2007, CURR DIABETES REV, V3, P176; Colleran PN, 2010, J PHYSIOL-LONDON, V588, P1293, DOI 10.1113/jphysiol.2009.186247; Cong L, 2001, Wei Sheng Yan Jiu, V30, P158; Davel AP, 2012, TOXICOLOGY, V295, P39, DOI 10.1016/j.tox.2012.02.004; de Moraes C, 2008, BMC PHYSL, V29, P8; Delbin MA, 2011, INFLAMMATION, V34, P319, DOI 10.1007/s10753-010-9237-9; Di Pascoli M, 2006, BIOCHEM BIOPH RES CO, V340, P935, DOI 10.1016/j.bbrc.2005.12.082; Dong L, 2008, J CEREBR BLOOD F MET, V28, P377, DOI 10.1038/sj.jcbfm.9600536; Farmer DGS, 2009, PHARMACOL THERAPEUT, V124, P185, DOI 10.1016/j.pharmthera.2009.06.013; Fisher AB, 2001, AM J PHYSIOL-LUNG C, V281, pL529, DOI 10.1152/ajplung.2001.281.3.L529; Fuchsjager-Mayrl G, 2002, DIABETES CARE, V25, P1795, DOI 10.2337/diacare.25.10.1795; Fukao M, 1997, BRIT J PHARMACOL, V121, P1383, DOI 10.1038/sj.bjp.0701258; Goldin A, 2006, CIRCULATION, V114, P597, DOI 10.1161/CIRCULATIONAHA.106.621854; Grillo MA, 2008, AMINO ACIDS, V35, P29, DOI 10.1007/s00726-007-0606-0; GRYGLEWSKI RJ, 1986, NATURE, V320, P454, DOI 10.1038/320454a0; Gupte S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011800; Hadi HAR, 2007, VASC HEALTH RISK MAN, V3, P853; Harthmann AD, 2007, AUTON NEUROSCI-BASIC, V133, P115, DOI 10.1016/j.autneu.2006.10.004; HATTORI Y, 1991, AM J PHYSIOL, V261, pH1086, DOI 10.1152/ajpheart.1991.261.4.H1086; Janghorbani M, 2007, DIABETES CARE, V30, P1730, DOI 10.2337/dc06-2363; Kamata K, 2000, N-S ARCH PHARMACOL, V362, P52, DOI 10.1007/s002100000248; Kamper M, 2010, TRANSL RES, V156, P26, DOI 10.1016/j.trsl.2010.05.004; Kojda G, 2005, CARDIOVASC RES, V67, P187, DOI 10.1016/j.cardiores.2005.04.032; Koltai MZ, 1997, CARDIOVASC RES, V34, P157; Kuru O, 2009, J APPL PHYSIOL, V107, P896, DOI 10.1152/japplphysiol.91180.2008; Lu T, 2010, CIRC RES, V106, P1164, DOI 10.1161/CIRCRESAHA.109.209767; Lu X, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-48; Malakul W, 2008, CLIN EXP PHARMACOL P, V35, P192, DOI 10.1111/j.1440-1681.2007.04811.x; McAllister RM, 1996, J APPL PHYSIOL, V80, P216, DOI 10.1152/jappl.1996.80.1.216; Milstien S, 1999, BIOCHEM BIOPH RES CO, V263, P681, DOI 10.1006/bbrc.1999.1422; MULVANY MJ, 1977, CIRC RES, V41, P19, DOI 10.1161/01.RES.41.1.19; Nadeau KJ, 2010, J CLIN ENDOCR METAB, V95, P513, DOI 10.1210/jc.2009-1756; Nemoto S, 2012, PEPTIDES, V33, P109, DOI 10.1016/j.peptides.2011.11.018; Nin JW, 2011, DIABETES CARE, V34, P442, DOI 10.2337/dc10-1087; Okamoto MM, 2011, J ENDOCRINOL, V211, P55, DOI 10.1530/JOE-11-0105; Parker JL, 1997, J APPL PHYSIOL, V83, P434, DOI 10.1152/jappl.1997.83.2.434; Perseghin G, 2003, AM J PHYSIOL-ENDOC M, V285, pE1174, DOI 10.1152/ajpendo.00279.2003; Pieper GM, 1997, CARDIOVASC RES, V34, P145, DOI 10.1016/S0008-6363(96)00237-4; Pieper GM, 1999, DIABETOLOGIA, V42, P204, DOI 10.1007/s001250051140; Pieper GM, 1998, J CARDIOVASC PHARM, V32, P101, DOI 10.1097/00005344-199807000-00016; Ramalho AC, 2006, DIABETES RES CLIN PR, V72, P271, DOI 10.1016/j.diabres.2005.11.011; Ramasamy R, 2011, ANN NY ACAD SCI, V1243, P88, DOI 10.1111/j.1749-6632.2011.06320.x; Rojas A, 2000, CIRC RES, V86, pE50, DOI 10.1161/01.RES.86.3.e50; SCHMIDT AM, 1994, ARTERIOSCLER THROMB, V14, P1521, DOI 10.1161/01.ATV.14.10.1521; SCHMIDT AM, 1995, J CLIN INVEST, V96, P1395, DOI 10.1172/JCI118175; Schmidt AM, 1999, CIRC RES, V84, P489, DOI 10.1161/01.RES.84.5.489; Seeger JPH, 2011, DIABETES OBES METAB, V13, P382, DOI 10.1111/j.1463-1326.2011.01361.x; Shao CH, 2009, J APPL PHYSIOL, V106, P1280, DOI 10.1152/japplphysiol.91280.2008; Shi Y, 2008, BRIT J PHARMACOL, V154, P639, DOI 10.1038/bjp.2008.110; Shi Y, 2006, J PHARMACOL EXP THER, V318, P276, DOI 10.1124/jpet.105.099739; Sigal RJ, 2007, ANN INTERN MED, V147, P357, DOI 10.7326/0003-4819-147-6-200709180-00005; Sponton CHG, 2010, EUR J CARDIOV PREV R, V17, P676, DOI 10.1097/HJR.0b013e32833a1301; Traub O, 1998, ARTERIOSCL THROM VAS, V18, P677, DOI 10.1161/01.ATV.18.5.677; Wang RX, 2012, CHINESE MED J-PEKING, V125, P2548, DOI 10.3760/cma.j.issn.0366-6999.2012.14.028; Wautier MP, 2001, AM J PHYSIOL-ENDOC M, V280, pE685, DOI 10.1152/ajpendo.2001.280.5.E685; Wenzel P, 2008, FREE RADICAL BIO MED, V45, P619, DOI 10.1016/j.freeradbiomed.2008.05.009; Williams RS, 2005, PLOS MED, V2, P209, DOI 10.1371/journal.pmed.0020068; Wu Y, 2000, Zhonghua Yi Xue Za Zhi, V80, P172; Xu B, 2003, FASEB J, V17, P1289, DOI 10.1096/fj.02-0490fje; YAN SD, 1994, J BIOL CHEM, V269, P9889; YKIJARVINEN H, 1984, DIABETES CARE, V7, P520, DOI 10.2337/diacare.7.6.520; Zanesco A, 1997, J PHARMACOL EXP THER, V280, P677; Zanesco A, 2007, PHARMACOL THERAPEUT, V114, P307, DOI 10.1016/j.pharmthera.2007.03.010; Zaros P. R., 2009, BMC WOMENS HEALTH, V19, P9; Zhao ZW, 2011, ARZNEIMITTEL-FORSCH, V61, P239, DOI 10.1055/s-0031-1296194	79	38	41	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53318	10.1371/journal.pone.0053318	http://dx.doi.org/10.1371/journal.pone.0053318			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285277	gold, Green Published, Green Submitted			2022-12-27	WOS:000313051500131
J	Liu, JY; Ulloa, A; Perrone-Bizzozero, N; Yeo, R; Chen, JY; Calhoun, VD				Liu, Jingyu; Ulloa, Alvaro; Perrone-Bizzozero, Nora; Yeo, Ronald; Chen, Jiayu; Calhoun, Vince D.			A Pilot Study on Collective Effects of 22q13.31 Deletions on Gray Matter Concentration in Schizophrenia	PLOS ONE			English	Article							COPY-NUMBER VARIATION; INDEPENDENT COMPONENT ANALYSIS; FMRI DATA; GENES; GENOME; SUSCEPTIBILITY; METAANALYSIS; ASSOCIATION; VARIANTS; PATHWAYS	The association of copy number variation (CNV) with schizophrenia has been reported with evidence of increased frequency of both rare and large CNVs. Yet, little is known about the impact of CNVs in brain structure. In this pilot study, we explored collective effects of all CNVs in each cytogenetic band on the risk of schizophrenia and gray matter variation measured in structural magnetic resonance imaging. With 324 participants' CNV profiles (151 schizophrenia patients and 173 healthy controls), we first extracted specific CNV features that differ between patients and controls using a two sample t-test, and then tested their associations with gray matter concentration using a linear regression model in a subset of 301 participants. Our data first provided evidence of population structure in CNV features where elevated rare CNV burden in schizophrenia patients was confounded by the levels associated with African American subjects. We considered this ethnic group difference in the following cytoband analyses. Deletions in one cytoband 22q13.31 were observed significantly (p<0.05) more in patients than controls from all samples after controlling ethnicity, and the deletion load was also significantly (p = 1.44 x 10(-4)) associated with reduced gray matter concentration of a brain network mainly comprised of the cingulate gyrus and insula. Since 80% deletion carriers were patients, patients with deletions also showed reduced gray matter concentration compared with patients without deletions (p = 3.36 x 10(-4)). Our findings indicate that regional CNVs at 22q13.31, no matter the size, may influence the risk of schizophrenia with a remarkably increased mutation rate and with reduced gray matter concentration in the peri-limbic cortex. This proof-of-concept study suggests that the CNVs occurring at some 'hotspots' may in fact cause biological downstream effects and larger studies are important for confirming our initial results.	[Liu, Jingyu; Calhoun, Vince D.] Mind Res Network, Albuquerque, NM USA; [Liu, Jingyu; Ulloa, Alvaro; Chen, Jiayu; Calhoun, Vince D.] Univ New Mexico, Dept Elect & Comp Engn, Albuquerque, NM 87131 USA; [Perrone-Bizzozero, Nora; Calhoun, Vince D.] Univ New Mexico, Dept Neurosci, Albuquerque, NM 87131 USA; [Yeo, Ronald] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA	Lovelace Respiratory Research Institute; University of New Mexico; University of New Mexico; University of New Mexico	Liu, JY (corresponding author), Mind Res Network, Albuquerque, NM USA.	jliu@mrn.org	Chen, Jiayu/Q-9042-2017; Ulloa, Alvaro/ABD-3900-2021; Calhoun, Vince D./ACN-9399-2022	Calhoun, Vince D./0000-0001-9058-0747; Ulloa-Cerna, Alvaro/0000-0001-8899-0026; Liu, Jingyu/0000-0002-1724-7523	NIH, Centers of Biomedical Research Excellence [5P20 RR021938]; Department of Energy [DE-FG02-99ER62764]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021938] Funding Source: NIH RePORTER	NIH, Centers of Biomedical Research Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This project was funded by NIH, Centers of Biomedical Research Excellence; Contract grant number: 5P20 RR021938. The data collection was funded by the Department of Energy, grant DE-FG02-99ER62764. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Bassett AS, 2010, AM J PSYCHIAT, V167, P899, DOI 10.1176/appi.ajp.2009.09071016; Burbach JPH, 2009, TRENDS NEUROSCI, V32, P69, DOI 10.1016/j.tins.2008.11.002; Calhoun VD, 2006, IEEE ENG MED BIOL, V25, P79, DOI 10.1109/MEMB.2006.1607672; Calhoun VD, 2006, HUM BRAIN MAPP, V27, P598, DOI 10.1002/hbm.20204; Cardoso JF, 1997, IEEE SIGNAL PROC LET, V4, P112, DOI 10.1109/97.566704; Chen JY, 2011, IEEE ENG MED BIO, P6975, DOI 10.1109/IEMBS.2011.6091763; Chen JY, 2010, IEEE INT C BIO BIO W, P827, DOI 10.1109/BIBMW.2010.5703928; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Dauber A, 2011, AM J HUMAN GENETICS; Dhar SU, 2010, AM J MED GENET A, V152A, P573, DOI 10.1002/ajmg.a.33253; Diskin SJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn556; Fornito A, 2009, SCHIZOPHR RES, V108, P104, DOI 10.1016/j.schres.2008.12.011; Gardner DM, 2010, AM J PSYCHIAT, V167, P686, DOI 10.1176/appi.ajp.2009.09060802; Garrity AG, 2007, AM J PSYCHIAT, V164, P450, DOI 10.1176/appi.ajp.164.3.450; Glessner JT, 2010, P NATL ACAD SCI USA, V107, P10584, DOI 10.1073/pnas.1000274107; Goldmuntz E, 2005, CLIN PERINATOL, V32, P963, DOI 10.1016/j.clp.2005.09.006; Guilmatre A, 2009, ARCH GEN PSYCHIAT, V66, P947, DOI 10.1001/archgenpsychiatry.2009.80; Harbuz R, 2011, AM J HUM GENET, V88, P351, DOI 10.1016/j.ajhg.2011.02.007; Honea R, 2005, AM J PSYCHIAT, V162, P2233, DOI 10.1176/appi.ajp.162.12.2233; Kirov G, 2010, EXPERT REV NEUROTHER, V10, P25, DOI [10.1586/ern.09.133, 10.1586/ERN.09.133]; Kirov G, 2009, SCHIZOPHRENIA BULL, V35, P851, DOI 10.1093/schbul/sbp079; Kirov G, 2009, HUM MOL GENET, V18, P1497, DOI 10.1093/hmg/ddp043; Lachman HM, 2007, AM J MED GENET B, V144B, P259, DOI 10.1002/ajmg.b.30498; Lercher MJ, 2003, HUM MOL GENET, V12, P2411, DOI 10.1093/hmg/ddg251; Levinson DF, 2011, AM J PSYCHIAT, V168, P302, DOI 10.1176/appi.ajp.2010.10060876; Liu J, 2011, ADDICTION BIOL; Magri C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013422; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; McKinney C, 2008, ANN RHEUM DIS, V67, P409, DOI 10.1136/ard.2007.075028; Meda SA, 2008, SCHIZOPHR RES, V101, P95, DOI 10.1016/j.schres.2008.02.007; Meyer-Lindenberg Andreas, 2010, Dialogues Clin Neurosci, V12, P449; Momma K, 1999, PEDIATR CARDIOL, V20, P97, DOI 10.1007/s002469900414; Need AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000373; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Pearlson GD, 1999, BIOL PSYCHIAT, V46, P627, DOI 10.1016/S0006-3223(99)00071-2; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Segall JM, 2009, SCHIZOPHRENIA BULL, V35, P82, DOI 10.1093/schbul/sbn150; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Tam GWC, 2009, BIOL PSYCHIAT, V66, P1005, DOI 10.1016/j.biopsych.2009.07.027; van Haren NE, 2008, CURR OPIN PSYCHIATR, V21, P161, DOI 10.1097/YCO.0b013e3282f4f25b; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Wilson GM, 2006, HUM MOL GENET, V15, P743, DOI 10.1093/hmg/ddi489; Xu L, 2009, HUM BRAIN MAPP, V30, P711, DOI 10.1002/hbm.20540; Yang Y, 2007, AM J HUM GENET, V80, P1037, DOI 10.1086/518257; Yeo RA, 2011, BIOL PSYCHIAT; Yeo RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016339	55	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52865	10.1371/journal.pone.0052865	http://dx.doi.org/10.1371/journal.pone.0052865			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285208	Green Submitted, Green Published, gold			2022-12-27	WOS:000313051500073
J	Vigneswara, V; Berry, M; Logan, A; Ahmed, Z				Vigneswara, Vasanthy; Berry, Martin; Logan, Ann; Ahmed, Zubair			Pharmacological Inhibition of Caspase-2 Protects Axotomised Retinal Ganglion Cells from Apoptosis in Adult Rats	PLOS ONE			English	Article							OPTIC-NERVE LESION; CPP32-LIKE PROTEASES; DELAYED DEATH; CLEAVAGE; DEGENERATION; NEUROPROTECTION; REGENERATION; ACTIVATION; NEURONS; TARGET	Severing the axons of retinal ganglion cells (RGC) by crushing the optic nerve (ONC) causes the majority of RGC to degenerate and die, primarily by apoptosis. We showed recently that after ONC in adult rats, caspase-2 activation occurred specifically in RGC while no localisation of caspase-3 was observed in ganglion cells but in cells of the inner nuclear layer. We further showed that inhibition of caspase-2 using a single injection of stably modified siRNA to caspase-2 protected almost all RGC from death at 7 days, offering significant protection for up to 1 month after ONC. In the present study, we confirmed that cleaved caspase-2 was localised and activated in RGC (and occasional neurons in the inner nuclear layer), while TUNEL+ RGC were also observed after ONC. We then investigated if suppression of caspase-2 using serial intravitreal injections of the pharmacological inhibitor z-VDVAD-fmk (z-VDVAD) protected RGC from death for 15 days after ONC. Treatment of eyes with z-VDVAD suppressed cleaved caspase-2 activation by >85% at 3-4 days after ONC. Increasing concentrations of z-VDVAD protected greater numbers of RGC from death at 15 days after ONC, up to a maximum of 60% using 4000 ng/ml of z-VDVAD, compared to PBS treated controls. The 15-day treatment with 4000 ng/ml of z-VDVAD after ONC suppressed levels of cleaved caspase-2 but no significant changes in levels of cleaved caspase-3, -6, -7 or -8 were detected. Although suppression of caspase-2 protected 60% of RGC from death, RGC axon regeneration was not promoted. These results suggest that caspase-2 specifically mediates death of RGC after ONC and that suppression of caspase-2 may be a useful therapeutic strategy to enhance RGC survival not only after axotomy but also in diseases where RGC death occurs such as glaucoma and optic neuritis.	[Vigneswara, Vasanthy; Berry, Martin; Logan, Ann; Ahmed, Zubair] Univ Birmingham, Neurotrauma & Neurodegenerat Sect, Sch Clin & Expt Med, Coll Med & Dent Sci, Birmingham, W Midlands, England	University of Birmingham	Ahmed, Z (corresponding author), Univ Birmingham, Neurotrauma & Neurodegenerat Sect, Sch Clin & Expt Med, Coll Med & Dent Sci, Birmingham, W Midlands, England.	z.ahmed.1@bham.ac.uk	Ahmed, Zubair/AAN-1869-2021	Logan, Ann/0000-0003-3215-5042	Wellcome Trust [092539/Z/10/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by a grant from the Wellcome Trust, grant no: 092539/Z/10/Z to ZA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudo M, 2008, MOL VIS, V14, P1050; Ahmed Z, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.54; Ahmed Z, 2005, MOL CELL NEUROSCI, V28, P64, DOI 10.1016/j.mcn.2004.08.013; Ahmed Z, 2006, FASEB J, V20, P1939, DOI 10.1096/fj.05-5339fje; Ahmed Z, 2010, NEUROBIOL DIS, V37, P441, DOI 10.1016/j.nbd.2009.10.024; Akpan N, 2011, J NEUROSCI, V31, P8894, DOI 10.1523/JNEUROSCI.0698-11.2011; Baltmr A, 2010, EXP EYE RES, V91, P554, DOI 10.1016/j.exer.2010.08.009; Baumgartner R, 2009, BIOCHEM J, V423, P429, DOI 10.1042/BJ20090540; BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994; Bernstein SL, 2011, PROG RETIN EYE RES, V30, P167, DOI 10.1016/j.preteyeres.2011.02.003; Berry M, 1996, J NEUROCYTOL, V25, P147, DOI 10.1007/BF02284793; Berry M, 1999, J NEUROCYTOL, V28, P721, DOI 10.1023/A:1007086004022; Bokoch GM, 1998, CELL DEATH DIFFER, V5, P637, DOI 10.1038/sj.cdd.4400405; Bonfanti L, 1996, J NEUROSCI, V16, P4186; Boyce M, 2004, CELL DEATH DIFFER, V11, P29, DOI 10.1038/sj.cdd.4401339; CASCIOLAROSEN LA, 1994, J BIOL CHEM, V269, P30757; Chauvier D, 2007, CELL DEATH DIFFER, V14, P387, DOI 10.1038/sj.cdd.4402044; Chierzi S, 1998, VISION RES, V38, P1537, DOI 10.1016/S0042-6989(97)00332-5; Degterev A, 2003, ONCOGENE, V22, P8543, DOI 10.1038/sj.onc.1207107; Douglas MR, 2009, BRAIN, V132, P3102, DOI 10.1093/brain/awp240; Ehrenschwender M, 2010, CELL DEATH DIFFER, V17, P1435, DOI 10.1038/cdd.2010.36; Finn JT, 2000, J NEUROSCI, V20, P1333; Fischer U, 2006, ONCOGENE, V25, P152, DOI 10.1038/sj.onc.1209015; GARCIAVALENZUELA E, 1994, J NEUROBIOL, V25, P431, DOI 10.1002/neu.480250408; Guo HS, 2004, AM J PATHOL, V165, P523, DOI 10.1016/S0002-9440(10)63317-2; Ho LH, 2008, ONCOGENE, V27, P3393, DOI 10.1038/sj.onc.1211005; Inoue S, 2009, CELL DEATH DIFFER, V16, P1053, DOI 10.1038/cdd.2009.29; Isenmann S, 1997, EUR J NEUROSCI, V9, P1763, DOI 10.1111/j.1460-9568.1997.tb01534.x; Kermer P, 1999, FEBS LETT, V453, P361, DOI 10.1016/S0014-5793(99)00747-4; Kermer P, 1998, J NEUROSCI, V18, P4656; Kermer P, 1998, EUR J NEUROSCI, V10, P202; Koeberle PD, 2010, NEUROSCIENCE, V169, P495, DOI 10.1016/j.neuroscience.2010.04.079; Koeberle PD, 1998, VISION RES, V38, P1505, DOI 10.1016/S0042-6989(97)00364-7; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Kurokawa T, 1999, INVEST OPHTH VIS SCI, V40, P3006; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; Leist M, 1997, J EXP MED, V185, P1481, DOI 10.1084/jem.185.8.1481; Lucius R, 1997, MOL BRAIN RES, V48, P181, DOI 10.1016/S0169-328X(97)00170-8; Monnier PP, 2011, J NEUROSCI, V31, P10494, DOI 10.1523/JNEUROSCI.0148-11.2011; Niizuma K, 2008, P NATL ACAD SCI USA, V105, P16368, DOI 10.1073/pnas.0806222105; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Park KJ, 2010, NAT NEUROSCI, V13, P559, DOI 10.1038/nn.2513; Porter AG, 1997, BIOESSAYS, V19, P501, DOI 10.1002/bies.950190609; RABACCHI SA, 1994, J NEUROSCI, V14, P5292; Ribe EM, 2012, BIOCHEM J, V444, P591, DOI 10.1042/BJ20111588; Sidi S, 2008, CELL, V133, P864, DOI 10.1016/j.cell.2008.03.037; Singh M, 2001, J NEUROCHEM, V77, P466, DOI 10.1046/j.1471-4159.2001.00258.x; Song QZ, 1996, EMBO J, V15, P3238, DOI 10.1002/j.1460-2075.1996.tb00688.x; Troy CM, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.138pe42; Troy CM, 2000, J NEUROSCI, V20, P1386; Tu S, 2006, NAT CELL BIOL, V8, P72, DOI 10.1038/ncb1340; Upton JP, 2008, MOL CELL BIOL, V28, P3943, DOI 10.1128/MCB.00013-08; VILLEGASPEREZ MP, 1993, J NEUROBIOL, V24, P23, DOI 10.1002/neu.480240103; Weishaupt JH, 2003, NEUROBIOL DIS, V13, P124, DOI 10.1016/S0969-9961(03)00032-9; Werner AB, 2004, J BIOL CHEM, V279, P28771, DOI 10.1074/jbc.M400268200	55	37	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53473	10.1371/journal.pone.0053473	http://dx.doi.org/10.1371/journal.pone.0053473			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285297	Green Published, gold, Green Submitted			2022-12-27	WOS:000313051500152
J	Wang, CJ; Yang, W; Wang, C; Gu, C; Niu, DD; Liu, HX; Wang, YP; Guo, JH				Wang, Chun-Juan; Yang, Wei; Wang, Chao; Gu, Chun; Niu, Dong-Dong; Liu, Hong-Xia; Wang, Yun-Peng; Guo, Jian-Hua			Induction of Drought Tolerance in Cucumber Plants by a Consortium of Three Plant Growth-Promoting Rhizobacterium Strains	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; STRESS-INDUCED CHANGES; SUPEROXIDE-DISMUTASE; ACTIVE OXYGEN; RESISTANCE; EXPRESSION; L.; INOCULATION; ALLEVIATION; SUBSTANCES	Our previous work showed that a consortium of three plant growth-promoting rhizobacterium (PGPR) strains (Bacillus cereus AR156, Bacillus subtilis SM21, and Serratia sp. XY21), termed as BBS for short, was a promising biocontrol agent. The present study investigated its effect on drought tolerance in cucumber plants. After withholding watering for 13 days, BBS-treated cucumber plants had much darker green leaves and substantially lighter wilt symptoms than control plants. Compared to the control, the BBS treatment decreased the leaf monodehydroascorbate (MDA) content and relative electrical conductivity by 40% and 15%, respectively; increased the leaf proline content and the root recovery intension by 3.45-fold and 50%, respectively; and also maintained the leaf chlorophyll content in cucumber plants under drought stress. Besides, in relation to the control, the BBS treatment significantly enhanced the superoxide dismutase (SOD) activity and mitigated the drought-triggered down-regulation of the expression of the genes cAPX, rbcL, and rbcS encoding cytosolic ascorbate peroxidase, and ribulose-1,5-bisphosphate carboxy/oxygenase (Rubisco) large and small subunits, respectively, in cucumber leaves. However, 1-aminocyclopropane-1-carboxylate (ACC) deaminase activity was undetected in none of the culture solutions of three BBS constituent strains. These results indicated that BBS conferred induced systemic tolerance to drought stress in cucumber plants, by protecting plant cells, maintaining photosynthetic efficiency and root vigor and increasing some of antioxidase activities, without involving the action of ACC deaminase to lower plant ethylene levels.	[Wang, Chun-Juan; Yang, Wei; Wang, Chao; Niu, Dong-Dong; Liu, Hong-Xia; Wang, Yun-Peng; Guo, Jian-Hua] Nanjing Agr Univ, Coll Plant Protect, Dept Plant Pathol, Nanjing, Jiangsu, Peoples R China; [Wang, Chun-Juan; Yang, Wei; Wang, Chao; Niu, Dong-Dong; Liu, Hong-Xia; Wang, Yun-Peng; Guo, Jian-Hua] Nanjing Agr Univ, Key Lab Integrated Management Crop Dis & Pests, Minist Educ, Nanjing, Jiangsu, Peoples R China; [Gu, Chun; Guo, Jian-Hua] Anfeng Biogen Pesticide Engn Ctr Jiangsu Prov, Taicang, Peoples R China; [Yang, Wei] Huaiyin Normal Univ, Sch Life Sci, Jiangsu Key Lab Ecoagr Biotechnol Hongze Lake, Huaian, Peoples R China	Nanjing Agricultural University; Nanjing Agricultural University; Huaiyin Normal University	Wang, YP (corresponding author), Nanjing Agr Univ, Coll Plant Protect, Dept Plant Pathol, Nanjing, Jiangsu, Peoples R China.	ypwang@njau.edu.cn; jhguo@njau.edu.cn			National Natural Science Foundation of China [30971956, 31000876, 31171809]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20100097120012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the National Natural Science Foundation of China (30971956, 31000876, and 31171809) and the Specialized Research Fund for the Doctoral Program of Higher Education of China (20100097120012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abogadallah GM, 2011, PLANT SCI, V180, P540, DOI 10.1016/j.plantsci.2010.12.004; Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; Ashraf M, 2005, FLORA, V200, P535, DOI 10.1016/j.flora.2005.06.005; Asrar AWA, 2011, SAUDI J BIOL SCI, V18, P93, DOI 10.1016/j.sjbs.2010.06.007; Ben Romdhane S, 2009, SOIL BIOL BIOCHEM, V41, P2568, DOI 10.1016/j.soilbio.2009.09.020; Benabdellah K, 2011, EUR J SOIL BIOL, V47, P303, DOI 10.1016/j.ejsobi.2011.07.004; Borowicz VA, 2010, PEDOBIOLOGIA, V53, P265, DOI 10.1016/j.pedobi.2010.01.001; BOWLER C, 1992, ANNU REV PLANT PHYS, V43, P83, DOI 10.1146/annurev.pp.43.060192.000503; BOYER JS, 1982, SCIENCE, V218, P443, DOI 10.1126/science.218.4571.443; Chen Xing-du, 2008, ACTA BOTANICA BOREALI-OCCIDENTALIA SINICA, V28, P136; Cushman JC, 2000, CURR OPIN PLANT BIOL, V3, P117, DOI 10.1016/S1369-5266(99)00052-7; Dobra J, 2011, J PLANT PHYSIOL, V168, P1588, DOI 10.1016/j.jplph.2011.02.009; Figueiredo MVB, 2008, APPL SOIL ECOL, V40, P182, DOI 10.1016/j.apsoil.2008.04.005; Glick BR, 2007, CRIT REV PLANT SCI, V26, P227, DOI 10.1080/07352680701572966; Glombitza S, 2004, PLANT MOL BIOL, V54, P817, DOI 10.1007/s11103-004-0274-3; Guo JH, 2009, State Intellectual Property Office of the People's Republic of China. Patent, Patent No. [ZL 200810088388.X, 200810088388]; Guo JH, 2009, [Trademark Office of The State Administration For Industry & Commerce of the People'S Republic of China, Patent application number], Patent No. 7823197; Guo JH, 2011, State Intellectual Property Office of the People's Republic of China. Patent, Patent No. [200710130838.2, 2007101308382]; Hu HuiFang, 2008, Journal of Shenyang Agricultural University, V39, P83; Franzini VI, 2010, J PLANT PHYSIOL, V167, P614, DOI 10.1016/j.jplph.2009.11.010; Jaleel CA, 2007, COLLOID SURFACE B, V60, P201, DOI 10.1016/j.colsurfb.2007.06.010; Kane KH, 2011, ENVIRON EXP BOT, V71, P337, DOI 10.1016/j.envexpbot.2011.01.002; Kohler J, 2008, FUNCT PLANT BIOL, V35, P141, DOI 10.1071/FP07218; Li KR, 2008, NEW FOREST, V35, P255, DOI 10.1007/s11056-007-9075-2; Liu RX, 2008, AGR WATER MANAGE, V95, P1261, DOI 10.1016/j.agwat.2008.05.002; Liu Ruizhi, 2009, Journal of Ocean University of China, V8, P303, DOI 10.1007/s11802-009-0303-6; Lu SY, 2009, PLANT PHYSIOL BIOCH, V47, P132, DOI 10.1016/j.plaphy.2008.10.006; Mascher R, 2005, PLANT SCI, V168, P691, DOI 10.1016/j.plantsci.2004.09.036; Mayak S, 2004, PLANT SCI, V166, P525, DOI 10.1016/j.plantsci.2003.10.025; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Moore BD, 1999, PLANT CELL ENVIRON, V22, P567, DOI 10.1046/j.1365-3040.1999.00432.x; Garcia AN, 2011, MYCORRHIZA, V21, P53, DOI 10.1007/s00572-010-0310-x; Niu DD, 2012, BIOCONTROL SCI TECHN, V22, P991, DOI 10.1080/09583157.2012.706595; Niu DD, 2011, MOL PLANT MICROBE IN, V24, P533, DOI 10.1094/MPMI-09-10-0213; OSONUBI O, 1991, PLANT SOIL, V136, P131, DOI 10.1007/BF02465228; Patnaik D, 2001, ELECT J BIOTECH, V4, P74; Qiu ZB, 2007, J PHOTOCHEMISTRY PHO, V90, P17; Sharp RG, 2011, SCI HORTIC-AMSTERDAM, V129, P804, DOI 10.1016/j.scienta.2011.03.016; SMIRNOFF N, 1993, NEW PHYTOL, V125, P27, DOI 10.1111/j.1469-8137.1993.tb03863.x; Sun CA, 2010, J PLANT PHYSIOL, V167, P1009, DOI 10.1016/j.jplph.2010.02.013; TANAKA K, 1990, AGR BIOL CHEM TOKYO, V54, P2629, DOI 10.1080/00021369.1990.10870355; Timmusk S, 1999, MOL PLANT MICROBE IN, V12, P951, DOI 10.1094/MPMI.1999.12.11.951; Vazquez MM, 2001, PLANT SCI, V161, P347, DOI 10.1016/S0168-9452(01)00416-2; Wei LH, 2010, BIOCONTROL SCI TECHN, V20, P739, DOI 10.1080/09583151003714109; Wu QS, 2008, EUR J SOIL BIOL, V44, P122, DOI 10.1016/j.ejsobi.2007.10.001; Xia XJ, 2009, PLANT PHYSIOL, V150, P801, DOI 10.1104/pp.109.138230; Xu XF, 2009, NO HORTICULTURE, V2, P12; Xue Q.Y., 2008, STUDIES SCREENING ST; Yang J, 2009, TRENDS PLANT SCI, V14, P1, DOI 10.1016/j.tplants.2008.10.004; Yang S, 2011, J PLANT PHYSIOL, V168, P1804, DOI 10.1016/j.jplph.2011.05.017; Yuan GF, 2010, SCI HORTIC-AMSTERDAM, V126, P103, DOI 10.1016/j.scienta.2010.06.014; ZHANG JX, 1994, PLANT CELL PHYSIOL, V35, P785, DOI 10.1093/oxfordjournals.pcp.a078658; Zheng Y, 2010, EFFECTS BIOPESTICIDE; Zhou QJ, 2007, ACTA AGR BOREALI SIN, V22, P79; Zhuang ZG, 2010, EFFECTS BIOPESTICIDE, P372; 郑颖, 2011, [江苏农业科学, Jiangsu Agricultural Sciences], V39, P199	56	185	198	5	114	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52565	10.1371/journal.pone.0052565	http://dx.doi.org/10.1371/journal.pone.0052565			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285089	Green Published, gold, Green Submitted			2022-12-27	WOS:000313051500035
J	Calaminus, SDJ; Guitart, A; Sinclair, A; Schachtner, H; Watson, SP; Holyoake, TL; Kranc, KR; Machesky, LM				Calaminus, Simon D. J.; Guitart, Amelie; Sinclair, Amy; Schachtner, Hannah; Watson, Steve P.; Holyoake, Tessa L.; Kranc, Kamil R.; Machesky, Laura M.			Lineage Tracing of Pf4-Cre Marks Hematopoietic Stem Cells and Their Progeny	PLOS ONE			English	Article							PLATELET-FUNCTION; TRANSGENIC MICE; CRE; MEGAKARYOPOIESIS; MEGAKARYOCYTE; ACTIVATION; EXPRESSION; REGULATOR; KNOCKOUTS; TISSUES	The development of a megakaryocyte lineage specific Cre deleter, using the Pf4 (CXCL4) promoter (Pf4-Cre), was a significant step forward in the specific analysis of platelet and megakaryocyte cell biology. However, in the present study we have employed a sensitive reporter-based approach to demonstrate that Pf4-Cre also recombines in a significant proportion of both fetal liver and bone marrow hematopoietic stem cells (HSCs), including the most primitive fraction containing the long-term repopulating HSCs. Consequently, we demonstrate that Pf4-Cre activity is not megakaryocyte lineage-specific but extends to other myeloid and lymphoid lineages at significant levels between 15-60%. Finally, we show for the first time that Pf4 transcripts are present in adult HSCs and primitive hematopoietic progenitor cells. These results have fundamental implications for the use of the Pf4-Cre mouse model and for our understanding of a possible role for Pf4 in the development of the hematopoietic lineage.	[Guitart, Amelie; Sinclair, Amy; Holyoake, Tessa L.; Kranc, Kamil R.] Univ Glasgow, Inst Canc Sci, Paul OGorman Leukaemia Res Ctr, Glasgow, Lanark, Scotland; [Calaminus, Simon D. J.; Schachtner, Hannah; Machesky, Laura M.] Univ Glasgow, Beatson Inst Canc Res, Glasgow, Lanark, Scotland; [Watson, Steve P.] Univ Birmingham, Ctr Cardiovasc Sci, Inst Biomed Res, Birmingham, W Midlands, England	University of Glasgow; Beatson Institute; University of Glasgow; University of Birmingham	Kranc, KR (corresponding author), Univ Glasgow, Inst Canc Sci, Paul OGorman Leukaemia Res Ctr, Glasgow, Lanark, Scotland.	kamil.kranc@glasgow.ac.uk; l.machesky@beatson.gla.ac.uk	Holyoake, Tessa/M-3668-2015; Machesky, Laura/Z-4554-2019; Watson, Stephen P/Q-6292-2016	Holyoake, Tessa/0000-0002-0608-6066; Machesky, Laura/0000-0002-7592-9856; Watson, Stephen P/0000-0002-7846-7423; Guitart, Amelie/0000-0002-1451-8789	Leukemia & Lymphoma Research; Kay Kendal Leukemia Fund; Royal Society; Tenovus Scotland; Cancer Research UK; Biotechnology and Biological Sciences Research Council; BHF; British Heart Foundation [FS/09/034/27756] Funding Source: researchfish; Cancer Research UK [15673] Funding Source: researchfish	Leukemia & Lymphoma Research; Kay Kendal Leukemia Fund; Royal Society(Royal Society of London); Tenovus Scotland; Cancer Research UK(Cancer Research UK); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BHF(British Heart Foundation); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK)	The authors' laboratories are supported by grants from Leukemia & Lymphoma Research (K. R. K), Kay Kendal Leukemia Fund (K. R. K, A. G.), The Royal Society (K. R. K), Tenovus Scotland (K. R. K), and the Cancer Research UK (L. M, K. R. K and T. L. H). K. R. K is a Cancer Research UK Senior Cancer Research Fellow. S. P. W is a BHF chair. A. S is supported by a PhD Studentship from the Biotechnology and Biological Sciences Research Council. H. S. is supported by a Ph.D. studentship from the BHF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertozzi CC, 2010, BLOOD, V116, P661, DOI 10.1182/blood-2010-02-270876; Bockamp E, 2008, REGEN MED, V3, P217, DOI 10.2217/17460751.3.2.217; Chagraoui H, 2011, BLOOD, V118, P723, DOI 10.1182/blood-2011-01-328765; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Finney BA, 2012, BLOOD, V119, P1747, DOI 10.1182/blood-2011-09-380709; Halene S, 2010, BLOOD, V116, P1942, DOI 10.1182/blood-2010-01-261743; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hitchcock IS, 2008, BLOOD, V111, P596, DOI 10.1182/blood-2007-05-089680; Kent DG, 2009, BLOOD, V113, P6342, DOI 10.1182/blood-2008-12-192054; Kranc KR, 2009, CELL STEM CELL, V5, P659, DOI 10.1016/j.stem.2009.11.001; Luche H, 2007, EUR J IMMUNOL, V37, P43, DOI 10.1002/eji.200636745; Matthaei KI, 2007, J PHYSIOL-LONDON, V582, P481, DOI 10.1113/jphysiol.2007.134908; Mazharian A, 2011, BLOOD, V117, P5198, DOI 10.1182/blood-2010-12-326850; Morgan EA, 2010, FASEB J, V24, P1117, DOI 10.1096/fj.09-138420; Mortensen M, 2011, J EXP MED, V208, P455, DOI 10.1084/jem.20101145; Pearce AC, 2007, BIOCHEM J, V401, P753, DOI 10.1042/BJ20061508; Pina C, 2012, NAT CELL BIOL, V14, P287, DOI 10.1038/ncb2442; Schaffner A, 2005, J LEUKOCYTE BIOL, V78, P202, DOI 10.1189/jlb.0105024; Speck NA, 2009, BLOOD CELL MOL DIS, V43, P6, DOI 10.1016/j.bcmd.2009.01.010; Tiedt R, 2007, BLOOD, V109, P1503, DOI 10.1182/blood-2006-04-020362; Tonks ID, 2003, GENESIS, V37, P131, DOI 10.1002/gene.10242	21	56	56	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e51361	10.1371/journal.pone.0051361	http://dx.doi.org/10.1371/journal.pone.0051361			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300543	Green Published, gold, Green Accepted			2022-12-27	WOS:000312829100007
J	Cure, C; Antunes, R; Samarra, F; Alves, AC; Visser, F; Kvadsheim, PH; Miller, PJO				Cure, Charlotte; Antunes, Ricardo; Samarra, Filipa; Alves, Ana Catarina; Visser, Fleur; Kvadsheim, Petter H.; Miller, Patrick J. O.			Pilot Whales Attracted to Killer Whale Sounds: Acoustically-Mediated Interspecific Interactions in Cetaceans	PLOS ONE			English	Article							ORCINUS-ORCA; MEGAPTERA-NOVAEANGLIAE; HUMPBACK WHALES; PLAYBACK; BEHAVIOR; ECOLOGY; NORTH; WILD	In cetaceans' communities, interactions between individuals of different species are often observed in the wild. Yet, due to methodological and technical challenges very little is known about the mediation of these interactions and their effect on cetaceans' behavior. Killer whales (Orcinus orca) are a highly vocal species and can be both food competitors and potential predators of many other cetaceans. Thus, the interception of their vocalizations by unintended cetacean receivers may be particularly important in mediating interspecific interactions. To address this hypothesis, we conducted playbacks of killer whale vocalizations recorded during herring-feeding activity to free-ranging long-finned pilot whales (Globicephala melas). Using a multi-sensor tag, we were able to track the whales and to monitor changes of their movements and social behavior in response to the playbacks. We demonstrated that the playback of killer whale sounds to pilot whales induced a clear increase in group size and a strong attraction of the animals towards the sound source. These findings provide the first experimental evidence that the interception of heterospecific vocalizations can mediate interactions between different cetacean species in previously unrecognized ways.	[Cure, Charlotte; Antunes, Ricardo; Samarra, Filipa; Alves, Ana Catarina; Miller, Patrick J. O.] Univ St Andrews, Sea Mammal Res Unit, Sch Biol, St Andrews, Fife, Scotland; [Visser, Fleur] Netherlands Org Appl Sci Res TNO, The Hague, Netherlands; [Visser, Fleur] Kelp Marine Res, Hoorn, Netherlands; [Kvadsheim, Petter H.] Norwegian Def Res Estab FFI, Horten, Norway	University of St Andrews; Netherlands Organization Applied Science Research; Norwegian Defence Research Establishment	Cure, C (corresponding author), Univ St Andrews, Sea Mammal Res Unit, Sch Biol, St Andrews, Fife, Scotland.	cc201@st-andrews.ac.uk		Visser, Fleur/0000-0003-1024-3244; Samarra, Filipa/0000-0002-9909-0565; Antunes, Ricardo/0000-0001-6783-3523	US Office of Naval Research; Norwegian Ministry of Defense; Netherlands Ministry of Defense; WWF-Norway; TOTAL Foundation; Foundation Bleustein-Blanchet	US Office of Naval Research(Office of Naval Research); Norwegian Ministry of Defense; Netherlands Ministry of Defense; WWF-Norway; TOTAL Foundation(Total SA); Foundation Bleustein-Blanchet	This study was mainly funded by three naval organisations: the US Office of Naval Research, the Norwegian Ministry of Defense and the Netherlands Ministry of Defense. In addition, WWF-Norway, TOTAL Foundation and the Foundation Bleustein-Blanchet also contributed financially. Authors are employed by government (Norwegian Defense Research Establishment), independent no-profit (Netherlands Organization for Applied Scientific Research and Kelp Marine Research), or academic (University of St. Andrews) research organisations. No authors are employed by naval organisations. The funders had no role in study design, data analysis, or preparation of the manuscript.	Agrawal AA, 2007, FRONT ECOL ENVIRON, V5, P145, DOI 10.1890/1540-9295(2007)5[145:FKGIPA]2.0.CO;2; Bisther A, 2001, CULTURE MARINE ANIMA; Blanchet S, 2010, ANN NY ACAD SCI, V1195, P149, DOI 10.1111/j.1749-6632.2010.05477.x; CLARK CW, 1980, SCIENCE, V207, P663, DOI 10.1126/science.207.4431.663; CUMMINGS WC, 1971, FISH BULL NATL OC AT, V69, P525; de Stephanis R, 2005, 19 ANN C EUR CET SOC; Deecke VB, 2002, NATURE, V420, P171, DOI 10.1038/nature01030; Deecke VB, 2011, AQUAT BIOL, V13, P79, DOI 10.3354/ab00353; Deecke Volker B., 2006, Aquatic Mammals, V32, P461, DOI 10.1578/AM.32.4.2006.461; Desportes Genevieve, 1993, Reports of the International Whaling Commission Special Issue, V14, P305; Eskesen IG, 2011, J ACOUST SOC AM, V130, P9, DOI 10.1121/1.3583499; FISH JF, 1971, FISH BULL NATL OC AT, V69, P531; Foote AD, 2008, J ACOUST SOC AM, V123, P1747, DOI 10.1121/1.2836752; Foote AD, 2009, MOL ECOL, V18, P5207, DOI 10.1111/j.1365-294X.2009.04407.x; FORD JKB, 1989, CAN J ZOOL, V67, P727, DOI 10.1139/z89-105; Golubski AJ, 2011, J ANIM ECOL, V80, P1097, DOI 10.1111/j.1365-2656.2011.01852.x; Hardin JW, 2012, GEN ESTIMATING EQUAT; Ings TC, 2009, J ANIM ECOL, V78, P253, DOI 10.1111/j.1365-2656.2008.01460.x; JEFFERSON TA, 1991, MAMMAL REV, V21, P151, DOI 10.1111/j.1365-2907.1991.tb00291.x; Johnson MP, 2003, IEEE J OCEANIC ENG, V28, P3, DOI 10.1109/JOE.2002.808212; MCGREGOR PK, 1992, NATO ADV SCI I A-LIF, V228, P1; Miller PJO, 2006, J COMP PHYSIOL A, V192, P449, DOI 10.1007/s00359-005-0085-2; MOBLEY JR, 1988, BEHAV ECOL SOCIOBIOL, V23, P211, DOI 10.1007/BF00302944; Pacini AF, 2010, J EXP BIOL, V213, P3138, DOI 10.1242/jeb.044636; Parks SE, 2003, MAR MAMMAL SCI, V19, P563, DOI 10.1111/j.1748-7692.2003.tb01321.x; Peake Tom M., 2006, P13; Selling J, 2011, 25 ANN C EUR CET SOC; Simila T, 1996, CAN J FISH AQUAT SCI, V53, P769, DOI 10.1139/cjfas-53-4-769; Simon M, 2007, ACTA ETHOL, V10, P47, DOI 10.1007/s10211-007-0029-7; STENERSEN J., 2004, NORWEGIAN KILLER WHA; TYACK P, 1983, BEHAV ECOL SOCIOBIOL, V13, P49, DOI 10.1007/BF00295075; Tyack PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017009; Visser F, 2011, 201101289 FFI	33	37	38	2	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52201	10.1371/journal.pone.0052201	http://dx.doi.org/10.1371/journal.pone.0052201			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300613	Green Submitted, Green Published, gold			2022-12-27	WOS:000313618800056
J	Ng, TP; Niti, M; Yap, KB; Tan, WC				Ng, Tze Pin; Niti, Mathew; Yap, Keng Bee; Tan, Wan Cheng			Curcumins-Rich Curry Diet and Pulmonary Function in Asian Older Adults	PLOS ONE			English	Article							FRESH FRUIT CONSUMPTION; LUNG-FUNCTION DECLINE; 3RD NATIONAL-HEALTH; VITAMIN-E; VENTILATORY FUNCTION; SERUM CAROTENOIDS; NUTRITION; ANTIOXIDANTS; PHARMACOLOGY; SMOKING	Background: Research on the effects of dietary nutrients on respiratory health in human populations have not investigated curcumin, a potent anti-oxidant and anti-inflammatory compound present principally in turmeric used in large amounts in Asian curry meals. Objectives: To examine the association of curry intake with pulmonary function among smokers and non-smokers. Design: The frequency of curry intake, respiratory risk factors and spirometry were measured in a population-based study of 2,478 Chinese older adults aged 55 and above in the Singapore Longitudinal Ageing Studies. Results: Curry intake (at least once monthly) was significantly associated with better FEV1 (b = 0.045 +/- 0.018, p = 0.011) and FEV1/FVC (b = 1.14 +/- 0.52, p = 0.029) in multivariate analyses that controlled simultaneously for gender, age, height, height-squared, smoking, occupational exposure and asthma/COPD history and other dietary or supplementary intakes. Increasing levels of curry intake ('never or rarely', 'occasional', 'often', 'very often') were associated with higher mean adjusted FEV1 (p for linear trend = 0.001) and FEV1/FVC% (p for linear trend = 0.048). Significant effect modifications were observed for FEV1 (curry*smoking interaction, p = 0.028) and FEV1/FVC% (curry* smoking interaction, p = 0.05). There were significantly larger differences in FEV1 and FEV1/FVC% between curry intake and non-curry intake especially among current and past smokers. The mean adjusted FEV1 associated with curry intake was 9.2% higher among current smokers, 10.3% higher among past smokers, and 1.5% higher among non-smokers. Conclusion: The possible role of curcumins in protecting the pulmonary function of smokers should be investigated in further clinical studies.	[Ng, Tze Pin; Niti, Mathew; Yap, Keng Bee; Tan, Wan Cheng] Natl Univ Singapore, Yong Loo Lin Sch Med, Gerontol Res Programme, Singapore 117595, Singapore; [Ng, Tze Pin] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Psychol Med, Singapore 117595, Singapore; [Niti, Mathew] Minist Hlth, Singapore, Singapore; [Yap, Keng Bee] Alexandra Hosp, Singapore, Singapore; [Tan, Wan Cheng] Univ British Columbia, James Hogg Res Ctr, Heart Lung Inst, St Pauls Hosp, Vancouver, BC V5Z 1M9, Canada	National University of Singapore; National University of Singapore; Ministry of Health-Singapore; St. Paul's Hospital; University of British Columbia; University of Saskatchewan	Ng, TP (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Gerontol Res Programme, Singapore 117595, Singapore.	pcmngtp@nus.edu.sg			Biomedical Research Council, Agency for Science, Technology and Research in Singapore [03/1/21/17/214, 08/1/21/19/567]	Biomedical Research Council, Agency for Science, Technology and Research in Singapore(Agency for Science Technology & Research (A*STAR))	This work was funded by research grants (No. 03/1/21/17/214 and No. 08/1/21/19/567) from the Biomedical Research Council, Agency for Science, Technology and Research in Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2009, TRENDS PHARMACOL SCI, V30, P85, DOI 10.1016/j.tips.2008.11.002; AMMON HPT, 1993, J ETHNOPHARMACOL, V38, P113, DOI 10.1016/0378-8741(93)90005-P; AMMON HPT, 1991, PLANTA MED, V57, P1, DOI 10.1055/s-2006-960004; Black PN, 2005, CHEST, V128, P3792, DOI 10.1378/chest.128.6.3792; BRITTON JR, 1995, AM J RESP CRIT CARE, V151, P1383, DOI 10.1164/ajrccm.151.5.7735589; Butland BK, 2000, THORAX, V55, P102, DOI 10.1136/thorax.55.2.102; Carey IM, 1998, AM J RESP CRIT CARE, V158, P728, DOI 10.1164/ajrccm.158.3.9712065; Cook DG, 1997, THORAX, V52, P628, DOI 10.1136/thx.52.7.628; Dobak John, 1994, Journal of Dermatological Science, V8, P18, DOI 10.1016/0923-1811(94)90316-6; Grievink L, 2000, AM J RESP CRIT CARE, V161, P790, DOI 10.1164/ajrccm.161.3.9904040; Grievink L, 1998, THORAX, V53, P166, DOI 10.1136/thx.53.3.166; Guenegou A, 2006, THORAX, V61, P320, DOI 10.1136/thx.2005.047373; Hu GZ, 2000, AM J EPIDEMIOL, V151, P975, DOI 10.1093/oxfordjournals.aje.a010141; Kelly Y, 2003, EUR RESPIR J, V21, P664, DOI 10.1183/09031936.03.00055702; Koli K, 2000, CELL GROWTH DIFFER, V11, P221; McKeever TM, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-67; Pan MH, 2000, BIOCHEM PHARMACOL, V60, P1665, DOI 10.1016/S0006-2952(00)00489-5; Pearson P, 2005, EUR J CLIN NUTR, V59, P1043, DOI 10.1038/sj.ejcn.1602209; PRYOR WA, 1993, ANN NY ACAD SCI, V686, P12, DOI 10.1111/j.1749-6632.1993.tb39148.x; REDDY ACP, 1992, MOL CELL BIOCHEM, V111, P117; Romieu I, 2001, EPIDEMIOL REV, V23, P268, DOI 10.1093/oxfordjournals.epirev.a000806; Schunemann HJ, 2001, EPIDEMIOL REV, V23, P248, DOI 10.1093/oxfordjournals.epirev.a000805; Schunemann HJ, 2001, AM J RESP CRIT CARE, V163, P1246, DOI 10.1164/ajrccm.163.5.2007135; SCHWARTZ J, 1994, EUR RESPIR J, V7, P1821, DOI 10.1183/09031936.94.07101821; SHAHAR E, 1994, NEW ENGL J MED, V331, P228, DOI 10.1056/NEJM199407283310403; SHARMA OP, 1976, BIOCHEM PHARMACOL, V25, P1811, DOI 10.1016/0006-2952(76)90421-4; SHARP DS, 1994, AM J RESP CRIT CARE, V150, P983, DOI 10.1164/ajrccm.150.4.7921474; SREEJAYAN, 1994, J PHARM PHARMACOL, V46, P1013, DOI 10.1111/j.2042-7158.1994.tb03258.x; SRIMAL RC, 1973, J PHARM PHARMACOL, V25, P447, DOI 10.1111/j.2042-7158.1973.tb09131.x; STRACHAN DP, 1991, THORAX, V46, P624, DOI 10.1136/thx.46.9.624; Suzuki M, 2009, AM J PHYSIOL-LUNG C, V296, pL614, DOI 10.1152/ajplung.90443.2008; Tabak C, 1999, THORAX, V54, P1021, DOI 10.1136/thx.54.11.1021; TODA S, 1985, CHEM PHARM BULL, V33, P1725; Venkatesan N, 1999, LIFE SCI, V66, pPL21, DOI 10.1016/S0024-3205(99)00576-7; Xu YX, 1998, HEMATOPATHOL MOL HEM, V11, P49	35	16	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e51753	10.1371/journal.pone.0051753	http://dx.doi.org/10.1371/journal.pone.0051753			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300564	gold, Green Published			2022-12-27	WOS:000313618800028
J	Rokitta, SD; John, U; Rost, B				Rokitta, Sebastian D.; John, Uwe; Rost, Bjoern			Ocean Acidification Affects Redox-Balance and Ion-Homeostasis in the Life-Cycle Stages of Emiliania huxleyi	PLOS ONE			English	Article							PENTOSE-PHOSPHATE PATHWAY; INORGANIC CARBON; ELEVATED CO2; LIGHT; TEMPERATURE; TRANSCRIPTOMICS; PHOTOSYNTHESIS; CALCIFICATION; METABOLISM; PROTEOMICS	Ocean Acidification (OA) has been shown to affect photosynthesis and calcification in the coccolithophore Emiliania huxleyi, a cosmopolitan calcifier that significantly contributes to the regulation of the biological carbon pumps. Its non-calcifying, haploid life-cycle stage was found to be relatively unaffected by OA with respect to biomass production. Deeper insights into physiological key processes and their dependence on environmental factors are lacking, but are required to understand and possibly estimate the dynamics of carbon cycling in present and future oceans. Therefore, calcifying diploid and non-calcifying haploid cells were acclimated to present and future CO2 partial pressures (pCO(2); 38.5 Pa vs. 101.3 Pa CO2) under low and high light (50 vs. 300 mu mol photons m(-2) s(-1)). Comparative microarray-based transcriptome profiling was used to screen for the underlying cellular processes and allowed to follow up interpretations derived from physiological data. In the diplont, the observed increases in biomass production under OA are likely caused by stimulated production of glycoconjugates and lipids. The observed lowered calcification under OA can be attributed to impaired signal-transduction and ion-transport. The haplont utilizes distinct genes and metabolic pathways, reflecting the stage-specific usage of certain portions of the genome. With respect to functionality and energy-dependence, however, the transcriptomic OA-responses resemble those of the diplont. In both life-cycle stages, OA affects the cellular redox-state as a master regulator and thereby causes a metabolic shift from oxidative towards reductive pathways, which involves a reconstellation of carbon flux networks within and across compartments. Whereas signal transduction and ion-homeostasis appear equally OA-sensitive under both light intensities, the effects on carbon metabolism and light physiology are clearly modulated by light availability. These interactive effects can be attributed to the influence of OA and light on the redox equilibria of NAD and NADP, which function as major sensors for energization and stress. This generic mode of action of OA may therefore provoke similar cell-physiological responses in other protists.	[Rokitta, Sebastian D.; John, Uwe; Rost, Bjoern] Alfred Wegener Inst Polar & Marine Res, Bremerhaven, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Rokitta, SD (corresponding author), Alfred Wegener Inst Polar & Marine Res, Bremerhaven, Germany.	Sebastian.Rokitta@awi.de	john, uwe/S-3009-2016; Rokitta, Sebastian/ABC-6832-2020; Rost, Bjoern/B-4447-2015	john, uwe/0000-0002-1297-4086; Rokitta, Sebastian/0000-0002-7540-9033; Rost, Bjoern/0000-0001-5452-5505	European Research Council (ERC) under the European Community's Seventh Framework Programme (FP7) [205150]; European Project on Ocean Acidification (EPOCA) [211384]	European Research Council (ERC) under the European Community's Seventh Framework Programme (FP7)(European Research Council (ERC)); European Project on Ocean Acidification (EPOCA)	The work was funded by the European Research Council (ERC) under the European Community's Seventh Framework Programme (FP7 / 2007 - 2013), grant agreement #205150, and contributes to the European Project on Ocean Acidification (EPOCA), grant agreement 211384. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amtmann A, 2007, CELL RES, V17, P483, DOI 10.1038/cr.2007.49; Araujo WL, 2012, PLANT CELL ENVIRON, V35, P1, DOI 10.1111/j.1365-3040.2011.02332.x; Bach LT, 2011, LIMNOL OCEANOGR, V56, P2040, DOI 10.4319/lo.2011.56.6.2040; Badger MR, 1998, CAN J BOT, V76, P1052, DOI 10.1139/b98-074; Baginsky S, 2010, PLANT PHYSIOL, V152, P402, DOI 10.1104/pp.109.150433; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Borchard C, 2011, J EXP MAR BIOL ECOL, V410, P61, DOI 10.1016/j.jembe.2011.10.004; Bustos DM, 2002, FEBS LETT, V530, P169, DOI 10.1016/S0014-5793(02)03455-5; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cui LQ, 2010, J APPL PHYCOL, V22, P563, DOI 10.1007/s10811-009-9494-x; De Bodt C, 2010, BIOGEOSCIENCES, V7, P1401, DOI 10.5194/bg-7-1401-2010; DICKSON AG, 1990, J CHEM THERMODYN, V22, P113, DOI 10.1016/0021-9614(90)90074-Z; DICKSON AG, 1981, DEEP-SEA RES, V28, P609, DOI 10.1016/0198-0149(81)90121-7; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Eastmond PJ, 2003, CURR OPIN PLANT BIOL, V6, P231, DOI 10.1016/S1369-5266(03)00037-2; Eicks M, 2002, PLANT PHYSIOL, V128, P512, DOI 10.1104/pp.010576; Fabry VJ, 2008, SCIENCE, V320, P1020, DOI 10.1126/science.1157130; Feder ME, 2005, J EVOLUTION BIOL, V18, P901, DOI 10.1111/j.1420-9101.2005.00921.x; Feng Y, 2008, EUR J PHYCOL, V43, P87, DOI 10.1080/09670260701664674; Fernie AR, 2012, PLANT PHYSIOL, V158, P1139, DOI 10.1104/pp.112.193235; Fernie AR, 2001, PLANTA, V212, P250, DOI 10.1007/s004250000386; Fiorini S, 2011, AQUAT MICROB ECOL, V64, P221, DOI 10.3354/ame01520; Frada M, 2008, P NATL ACAD SCI USA, V105, P15944, DOI 10.1073/pnas.0807707105; Gao KS, 2012, NAT CLIM CHANGE, V2, P519, DOI 10.1038/NCLIMATE1507; Goss R, 2010, PHOTOSYNTH RES, V106, P103, DOI 10.1007/s11120-010-9536-x; Graham IA, 2002, PROG LIPID RES, V41, P156, DOI 10.1016/S0163-7827(01)00022-4; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Hallows WC, 2012, J BIOL CHEM, V287, P3850, DOI 10.1074/jbc.M111.317404; Hanning I, 1999, PLANT PHYSIOL, V119, P1025, DOI 10.1104/pp.119.3.1025; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hoppe CJM, 2011, J EXP MAR BIOL ECOL, V406, P54, DOI 10.1016/j.jembe.2011.06.008; Klaas C, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001765; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Kruger A, 2011, ANTIOXID REDOX SIGN, V15, P311, DOI 10.1089/ars.2010.3797; Kruger NJ, 2003, CURR OPIN PLANT BIOL, V6, P236, DOI 10.1016/S1369-5266(03)00039-6; Lam PJ, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2010GB003868; Langer G, 2009, BIOGEOSCIENCES, V6, P2637, DOI 10.5194/bg-6-2637-2009; Mackinder L, 2011, ENV MICROBIOL, P16; McCarthy A, 2012, J PHYCOL, V48, P635, DOI 10.1111/j.1529-8817.2012.01171.x; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Pollak N, 2007, BIOCHEM J, V402, P205, DOI 10.1042/BJ20061638; Raghavendra AS, 2003, TRENDS PLANT SCI, V8, P546, DOI 10.1016/j.tplants.2003.09.015; Richier S, 2011, MAR BIOL, V158, P551, DOI 10.1007/s00227-010-1580-8; Ridgwell A, 2007, BIOGEOSCIENCES, V4, P481, DOI 10.5194/bg-4-481-2007; Riebesell U., 2000, NATURE, V407, P634, DOI DOI 10.1038/35030078; Rokitta SD, 2012, LIMNOL OCEANOGR, V57, P607, DOI 10.4319/lo.2012.57.2.0607; Rokitta SD, 2011, J PHYCOL, V47, P829, DOI 10.1111/j.1529-8817.2011.01014.x; Rosen H, 2009, ANNU REV BIOCHEM, V78, P743, DOI 10.1146/annurev.biochem.78.072407.103733; Rost B, 2003, LIMNOL OCEANOGR, V48, P55, DOI 10.4319/lo.2003.48.1.0055; Rost B, 2004, COCCOLITHOPHORES: FROM MOLECULAR PROCESSES TO GLOBAL IMPACT, P99; Shi D, 2009, BIOGEOSCIENCES, V6, P1199, DOI 10.5194/bg-6-1199-2009; Staats N, 2000, MAR ECOL PROG SER, V193, P261, DOI 10.3354/meps193261; Stoll MHC, 2001, ANAL CHEM, V73, P4111, DOI 10.1021/ac010303r; Suffrian K, 2011, NEW PHYTOL, V190, P595, DOI 10.1111/j.1469-8137.2010.03633.x; Tamoi M, 2011, PHOTOSYNTH RES, V108, P15, DOI 10.1007/s11120-011-9645-1; Taylor AR, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001085; Trimborn S, 2007, LIMNOL OCEANOGR, V52, P2285, DOI 10.4319/lo.2007.52.5.2285; Tsuji Y, 2012, PLANT CELL PHYSIOL, V53, P1043, DOI 10.1093/pcp/pcs045; Vardi A, 2009, SCIENCE, V326, P861, DOI 10.1126/science.1177322; Volk T., 1985, GEOPHYS MONOGR SER, V32, P99, DOI DOI 10.1029/GM032P0099; von Dassow P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r114; Wallace D, 2006, MS EXCEL PROGRAM DEV; Weber APM, 2011, ANNU REV PLANT BIOL, V62, P53, DOI 10.1146/annurev-arplant-042110-103903; Xiong YQ, 2009, PLANT CELL PHYSIOL, V50, P1277, DOI 10.1093/pcp/pcp070; Zondervan I, 2007, DEEP-SEA RES PT II, V54, P521, DOI 10.1016/j.dsr2.2006.12.004	66	57	59	5	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52212	10.1371/journal.pone.0052212	http://dx.doi.org/10.1371/journal.pone.0052212			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300616	Green Published, Green Submitted, gold			2022-12-27	WOS:000313618800058
J	Zwaan, RA; Pecher, D				Zwaan, Rolf A.; Pecher, Diane			Revisiting Mental Simulation in Language Comprehension: Six Replication Attempts	PLOS ONE			English	Article							PERCEPTUAL SIMULATION; OBJECT COLOR; REPRESENTATION; ORIENTATION; ACTIVATION; IMAGERY; PIZZA; GREEN; COIN	The notion of language comprehension as mental simulation has become popular in cognitive science. We revisit some of the original empirical evidence for this. Specifically, we attempted to replicate the findings from earlier studies that examined the mental simulation of object orientation, shape, and color, respectively, in sentence-picture verification. For each of these sets of findings, we conducted two web-based replication attempts using Amazon's Mechanical Turk. Our results are mixed. Participants responded faster to pictures that matched the orientation or shape implied by the sentence, replicating the original findings. The effect was larger and stronger for shape than orientation. Participants also responded faster to pictures that matched the color implied by the sentence, whereas the original studies obtained mismatch advantages. We argue that these results support mental simulation theory, show the importance of replication studies, and show the viability of web-based data collection.	[Zwaan, Rolf A.; Pecher, Diane] Erasmus Univ, Dept Psychol, Rotterdam, Netherlands	Erasmus University Rotterdam	Zwaan, RA (corresponding author), Erasmus Univ, Dept Psychol, Rotterdam, Netherlands.	zwaan@fsw.eur.nl		Zwaan, Rolf/0000-0001-9967-7879; Pecher, Diane/0000-0003-0976-6080				Barsalou LW, 1999, BEHAV BRAIN SCI, V22, P577, DOI 10.1017/S0140525X99532147; Blajenkova O, 2006, APPL COGNITIVE PSYCH, V20, P239, DOI 10.1002/acp.1182; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Connell L., 2005, P 27 ANN C COGN SCI, P482; Connell L, 2007, COGNITION, V102, P476, DOI 10.1016/j.cognition.2006.02.009; Coppens LC, 2012, BRAIN LANG, V122, P64, DOI 10.1016/j.bandl.2012.04.006; Dijkstra K, 2004, PSYCHOL AGING, V19, P352, DOI 10.1037/0882-7974.19.2.352; Engelen JAA, 2011, J EXP CHILD PSYCHOL, V110, P659, DOI 10.1016/j.jecp.2011.06.009; Glenberg AM, 1997, BEHAV BRAIN SCI, V20, P1, DOI 10.1017/S0140525X97470012; GRAESSER AC, 1994, PSYCHOL REV, V101, P371, DOI 10.1037/0033-295X.101.3.371; HARNAD S, 1990, PHYSICA D, V42, P335, DOI 10.1016/0167-2789(90)90087-6; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; Hirschfeld G, 2011, BRAIN RES, V1377, P78, DOI 10.1016/j.brainres.2010.12.063; Holt LE, 2006, PSYCHON B REV, V13, P694, DOI 10.3758/BF03193983; Huettig F, 2008, MEM COGNITION, V36, P341, DOI 10.3758/MC.36.2.341; Huettig F, 2011, Q J EXP PSYCHOL, V64, P122, DOI 10.1080/17470218.2010.481474; Joseph JE, 1997, ACTA PSYCHOL, V97, P95, DOI 10.1016/S0001-6918(97)00026-7; Kaup B, 2007, Q J EXP PSYCHOL, V60, P976, DOI 10.1080/17470210600823512; Kozhevnikov M, 2005, MEM COGNITION, V33, P710, DOI 10.3758/BF03195337; Lincoln AE, 2007, NEUROPSYCHOLOGIA, V45, P397, DOI 10.1016/j.neuropsychologia.2006.06.010; Madden CJ, 2006, J EXP PSYCHOL LEARN, V32, P1291, DOI 10.1037/0278-7393.32.6.1291; MARKS DF, 1973, BRIT J PSYCHOL, V64, P17, DOI 10.1111/j.2044-8295.1973.tb01322.x; Masson MEJ, 2011, BEHAV RES METHODS, V43, P679, DOI 10.3758/s13428-010-0049-5; Mitterer H, 2008, PSYCHOL SCI, V19, P629, DOI 10.1111/j.1467-9280.2008.02133.x; Nosek BA, 2012, PERSPECT PSYCHOL SCI, V7, P615, DOI 10.1177/1745691612459058; Palmer S., 1999, VISION SCI PHOTONS P; Pashler H, 2012, PERSPECT PSYCHOL SCI, V7, P528, DOI 10.1177/1745691612465253; Pecher D, 1998, J MEM LANG, V38, P401, DOI 10.1006/jmla.1997.2557; Pecher D, 2009, PSYCHON B REV, V16, P914, DOI 10.3758/PBR.16.5.914; Pecher D, 2009, Q J EXP PSYCHOL, V62, P1108, DOI 10.1080/17470210802633255; RATCLIFF R, 1993, PSYCHOL BULL, V114, P510, DOI 10.1037/0033-2909.114.3.510; Richter T, 2009, MEM COGNITION, V37, P1187, DOI 10.3758/MC.37.8.1187; Rouder JN, 2009, PSYCHON B REV, V16, P225, DOI 10.3758/PBR.16.2.225; Rouw R, 1997, COGNITION, V63, P209, DOI 10.1016/S0010-0277(97)00006-1; Schank RC., 1977, SCRIPTS PLANS GOALS; Schmidt S, 2009, REV GEN PSYCHOL, V13, P90, DOI 10.1037/a0015108; Solomon KO, 2004, MEM COGNITION, V32, P244, DOI 10.3758/BF03196856; Stanfield RA, 2001, PSYCHOL SCI, V12, P153, DOI 10.1111/1467-9280.00326; Therriault DJ, 2009, COGN PROCESS, V10, P335, DOI 10.1007/s10339-009-0260-4; Wagenmakers EJ, 2007, PSYCHON B REV, V14, P779, DOI 10.3758/BF03194105; Wassenburg SI, 2010, Q J EXP PSYCHOL, V63, P1665, DOI 10.1080/17470218.2010.502579; Yee E, 2012, PSYCHOL SCI, V23, P364, DOI 10.1177/0956797611430691; Zwaan RA, 2002, PSYCHOL SCI, V13, P168, DOI 10.1111/1467-9280.00430; Zwaan RA, 1998, PSYCHOL BULL, V123, P162, DOI 10.1037/0033-2909.123.2.162	44	87	88	4	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e51382	10.1371/journal.pone.0051382	http://dx.doi.org/10.1371/journal.pone.0051382			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	071TV	23300547	Green Submitted, gold, Green Published			2022-12-27	WOS:000313618800019
J	Achille, C; Sundaresh, S; Chu, B; Hadjiargyrou, M				Achille, Clement; Sundaresh, Sowmya; Chu, Benjamin; Hadjiargyrou, Michael			Cdk2 Silencing via a DNA/PCL Electrospun Scaffold Suppresses Proliferation and Increases Death of Breast Cancer Cells	PLOS ONE			English	Article							NONVIRAL GENE DELIVERY; IN-VITRO; NANOFIBROUS SCAFFOLDS; RNA INTERFERENCE; SIRNA DELIVERY; NANOSTRUCTURED SCAFFOLDS; SUSTAINED DELIVERY; CONTROLLED-RELEASE; DRUG-DELIVERY; DNA	RNA interference (RNAi) is a promising approach for cancer treatment. Site specific and controlled delivery of RNAi could be beneficial to the patient, while at the same time reducing undesirable off-target side effects. We utilized electrospinning to generate a biodegradable scaffold capable of incorporating and delivering a bioactive plasmid encoding for short hairpin (sh) RNA against the cell cycle specific protein, Cdk2. Three electrospun scaffolds were constructed, one using polycaprolactone (PCL) alone (Control) and PCL with plasmid DNA encoding for either Cdk2 (Cdk2i) and EGFP (EGFPi, also served as a control) shRNA. Scaffold fiber diameters ranged from 1 to 20 mm (DNA containing) and 0.2-3 mu m (Control). While the electrospun fibers remained intact for more than two weeks in physiological buffer, degradation was visible during the third week of incubation. Approximately 20-60 ng/ml (similar to 2.5% cumulative release) of intact and bioactive plasmid DNA was released over 21 days. Further, Cdk2 mRNA expression in cells plated on the Cdk2i scaffold was decreased by similar to 51% and 30%, in comparison with that of cells plated on Control or EGFPi scaffold, respectively. This decrease in Cdk2 mRNA by the Cdk2i scaffold translated to a similar to 40% decrease in the proliferation of the breast cancer cell line, MCF-7, as well as the presence of increased number of dead cells. Taken together, these results represent the first successful demonstration of the delivery of bioactive RNAi-based plasmid DNA from an electrospun polymer scaffold, specifically, in disrupting cell cycle regulation and suppressing proliferation of cancer cells.	[Hadjiargyrou, Michael] New York Inst Technol, Dept Life Sci, Old Westbury, NY 11568 USA; [Achille, Clement] Univ Paris Est Creteil, Inst Super Biosci Paris, Creteil, France; [Sundaresh, Sowmya] SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA; [Chu, Benjamin] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA	New York Institute Technology; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Hadjiargyrou, M (corresponding author), New York Inst Technol, Dept Life Sci, Old Westbury, NY 11568 USA.	mhadji@nyit.edu	Hadjiargyrou, Michael/H-7191-2018	Hadjiargyrou, Michael/0000-0001-8927-2333				Andersen MO, 2010, MOL THER, V18, P2018, DOI 10.1038/mt.2010.166; Cao HQ, 2010, J CONTROL RELEASE, V144, P203, DOI 10.1016/j.jconrel.2010.02.003; Chiu JB, 2007, J BIOMED MATER RES A, V83A, P1117, DOI 10.1002/jbm.a.31279; Chiu JB, 2005, J BIOMED NANOTECHNOL, V1, P115, DOI 10.1166/jbn.2005.018; Chu B, 2006, J PHYS-CONDENS MAT, V18, pS2513, DOI 10.1088/0953-8984/18/36/S21; Dimitrova M, 2008, P NATL ACAD SCI USA, V105, P16320, DOI 10.1073/pnas.0800156105; Fan XY, 2010, PHARMAZIE, V65, P830, DOI 10.1691/ph.2010.0156; Gersch RP, 2009, BONE, V45, P330, DOI 10.1016/j.bone.2009.04.245; Hadjiargyrou M, 2008, EXPERT OPIN DRUG DEL, V5, P1093, DOI [10.1517/17425247.5.10.1093, 10.1517/17425247.5.10.1093 ]; Hadjiargyrou M, 2011, NANOFIBERS - PRODUCTION, PROPERTIES AND FUNCTIONAL APPLICATIONS, P383; Han HD, 2011, CANCER BIOL THER, V11, P839, DOI 10.4161/cbt.11.9.15185; Holladay C, 2009, J CONTROL RELEASE, V136, P220, DOI 10.1016/j.jconrel.2009.02.006; Hong JK, 2011, TISSUE ENG PART B-RE, V17, P125, DOI [10.1089/ten.teb.2010.0552, 10.1089/ten.TEB.2010.0552]; Kim HS, 2010, J CONTROL RELEASE, V145, P264, DOI 10.1016/j.jconrel.2010.03.006; Kim K, 2004, J CONTROL RELEASE, V98, P47, DOI 10.1016/j.jconrel.2004.04.009; Krebs MD, 2009, J AM CHEM SOC, V131, P9204, DOI 10.1021/ja9037615; Li J, 2010, NANOMEDICINE-UK, V5, P1483, DOI 10.2217/NNM.10.124; Liang DH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni171; Liu C, 2010, AM J PHYSIOL-CELL PH, V298, pC1100, DOI 10.1152/ajpcell.00553.2009; Long XE, 2010, BMB REP, V43, P291, DOI 10.5483/BMBRep.2010.43.4.291; Luu YK, 2003, J CONTROL RELEASE, V89, P341, DOI 10.1016/S0168-3659(03)00097-X; Martins A, 2007, NANOMEDICINE-UK, V2, P929, DOI 10.2217/17435889.2.6.929; Monaghan M, 2011, ADV DRUG DELIVER REV, V63, P197, DOI 10.1016/j.addr.2011.01.006; Nie HM, 2007, J CONTROL RELEASE, V120, P111, DOI 10.1016/j.jconrel.2007.03.018; Pecot CV, 2011, NAT REV CANCER, V11, P59, DOI 10.1038/nrc2966; Rahman MA, 2012, J CONTROL RELEASE, V159, P384, DOI 10.1016/j.jconrel.2012.01.045; Rujitanaroj PO, 2011, BIOMATERIALS, V32, P5915, DOI 10.1016/j.biomaterials.2011.04.065; Sakai S, 2009, J BIOMED MATER RES A, V88A, P281, DOI 10.1002/jbm.a.31870; San Juan A, 2009, BIOMACROMOLECULES, V10, P3074, DOI 10.1021/bm900740g; Saraf A, 2010, J CONTROL RELEASE, V143, P95, DOI 10.1016/j.jconrel.2009.12.009; Shen XX, 2011, INT J PHARMACEUT, V408, P200, DOI 10.1016/j.ijpharm.2011.01.058; Singh A, 2009, BIOMATERIALS, V30, P5187, DOI 10.1016/j.biomaterials.2009.06.001; Smith MH, 2012, ACCOUNTS CHEM RES, V45, P985, DOI 10.1021/ar200216f; Takahashi H, 2010, J CONTROL RELEASE, V147, P400, DOI 10.1016/j.jconrel.2010.08.019; Takanashi M, 2009, GENE THER, V16, P982, DOI 10.1038/gt.2009.66; Tzeng SY, 2011, INT J NANOMED, V6, P3309, DOI 10.2147/IJN.S27269; Vinas-Castells R, 2009, BIOCONJUGATE CHEM, V20, P2262, DOI 10.1021/bc900241w; Wu SY, 2009, AAPS J, V11, P639, DOI 10.1208/s12248-009-9140-1; Yang DJ, 2009, J BIOMAT SCI-POLYM E, V20, P1321, DOI 10.1163/156856209X453024; Yang Y, 2011, ACTA BIOMATER, V7, P2533, DOI 10.1016/j.actbio.2011.02.031; Zhang J, 2011, J BIOMED MATER RES A, V96A, P212, DOI 10.1002/jbm.a.32962; Zhang X, 2010, BIOMATERIALS, V31, P6013, DOI 10.1016/j.biomaterials.2010.04.024; Zhao X, 2011, J BIOMED NANOTECHNOL, V7, P823, DOI 10.1166/jbn.2011.1342	43	31	31	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52356	10.1371/journal.pone.0052356	http://dx.doi.org/10.1371/journal.pone.0052356			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285007	Green Published, gold, Green Submitted			2022-12-27	WOS:000312794500151
J	Elfawal, MA; Towler, MJ; Reich, NG; Golenbock, D; Weathers, PJ; Rich, SM				Elfawal, Mostafa A.; Towler, Melissa J.; Reich, Nicholas G.; Golenbock, Douglas; Weathers, Pamela J.; Rich, Stephen M.			Dried Whole Plant Artemisia annua as an Antimalarial Therapy	PLOS ONE			English	Article							IN-VITRO; THIOREDOXIN REDUCTASE; MALARIA; FLAVONOIDS; RESISTANCE; EFFICACY; DRUGS; HEMIN; L.	Drugs are primary weapons for reducing malaria in human populations. However emergence of resistant parasites has repeatedly curtailed the lifespan of each drug that is developed and deployed. Currently the most effective anti-malarial is artemisinin, which is extracted from the leaves of Artemisia annua. Due to poor pharmacokinetic properties and prudent efforts to curtail resistance to monotherapies, artemisinin is prescribed only in combination with other anti-malarials composing an Artemisinin Combination Therapy (ACT). Low yield in the plant, and the added cost of secondary anti-malarials in the ACT, make artemisinin costly for the developing world. As an alternative, we compared the efficacy of oral delivery of the dried leaves of whole plant (WP) A. annua to a comparable dose of pure artemisinin in a rodent malaria model (Plasmodium chabaudi). We found that a single dose of WP (containing 24 mg/kg artemisinin) reduces parasitemia more effectively than a comparable dose of purified drug. This increased efficacy may result from a documented 40-fold increase in the bioavailability of artemisinin in the blood of mice fed the whole plant, in comparison to those administered synthetic drug. Synergistic benefits may derive from the presence of other anti-malarial compounds in A. annua. If shown to be clinically efficacious, well-tolerated, and compatible with the public health imperative of forestalling evolution of drug resistance, inexpensive, locally grown and processed A. annua might prove to be an effective addition to the global effort to reduce malaria morbidity and mortality. Citation: Elfawal MA, Towler MJ, Reich NG, Golenbock D, Weathers PJ, et al. (2012) Dried Whole Plant Artemisia annua as an Antimalarial Therapy. PLoS ONE 7(12): e52746. doi:10.1371/journal.pone.0052746	[Elfawal, Mostafa A.; Rich, Stephen M.] Univ Massachusetts, Dept Microbiol, Lab Med Zool, Amherst, MA 01003 USA; [Towler, Melissa J.; Weathers, Pamela J.] Worcester Polytech Inst, Dept Biol & Biotechnol, Worcester, MA 01609 USA; [Reich, Nicholas G.] Univ Massachusetts, Div Biostat & Epidemiol, Sch Publ Hlth & Hlth Sci, Amherst, MA 01003 USA; [Golenbock, Douglas] Univ Massachusetts, Sch Med, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Amherst; Worcester Polytechnic Institute; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Worcester	Rich, SM (corresponding author), Univ Massachusetts, Dept Microbiol, Lab Med Zool, Amherst, MA 01003 USA.	smrich@psis.umass.edu	Rich, Stephen/AAX-6953-2020; Reich, Nicholas/L-1168-2019	Reich, Nicholas/0000-0003-3503-9899	UMass Medical School Center for Clinical and Translational Science [CCTS-20110001]; National Institutes of Health [R01-AI079293]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079293] Funding Source: NIH RePORTER	UMass Medical School Center for Clinical and Translational Science; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by UMass Medical School Center for Clinical and Translational Science (grant CCTS-20110001 and the National Institutes of Health (grant R01-AI079293). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALIN MH, 1994, AM J TROP MED HYG, V50, P771, DOI 10.4269/ajtmh.1994.50.771; Arsenault PR, 2008, CURR MED CHEM, V15, P2886, DOI 10.2174/092986708786242813; Atkinson B, 1991, BIOCH ENG BIOTECHNOL; Avery MA, 2003, J MED CHEM, V46, P4244, DOI 10.1021/jm030181q; Barbacka K, 2011, CURR PHARM BIOTECHNO, V12, P1743, DOI 10.2174/138920111798376923; Bilia AR, 2008, NAT PROD COMMUN, V3, P1999; Bilia AR, 2002, LIFE SCI, V70, P769, DOI 10.1016/S0024-3205(01)01447-3; Carlton JMR, 2001, TRENDS PARASITOL, V17, P236, DOI 10.1016/S1471-4922(01)01899-2; Cox F.E.G., 1978, P309; de Ridder S, 2008, J ETHNOPHARMACOL, V120, P302, DOI 10.1016/j.jep.2008.09.017; de Vries P, 1999, PRODUCTION APPL ARTE; Douglas Bates, 2011, LME4 LINEAR MIXED EF; Duke J.A, 2001, HDB PHYTOCHEMICAL CO, P70; Efferth T, 2009, HERBAL DRUGS ETHNOME, P179; ELFORD BC, 1987, T ROY SOC TROP MED H, V81, P434, DOI 10.1016/0035-9203(87)90161-1; Ferreira JFS, 2010, MOLECULES, V15, P3135, DOI 10.3390/molecules15053135; Firestone GL, 2009, MOL ENDOCRINOL, V23, P1940, DOI 10.1210/me.2009-0149; Gordi T, 2002, ANTIMICROB AGENTS CH, V46, P1026, DOI 10.1128/AAC.46.4.1026-1031.2002; Graham IA, 2010, SCIENCE, V327, P328, DOI 10.1126/science.1182612; Hsu E, 2006, T ROY SOC TROP MED H, V100, P505, DOI 10.1016/j.trstmh.2005.09.020; Kindermans JM, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-125; Kraft C, 2003, PHYTOTHER RES, V17, P123, DOI 10.1002/ptr.1066; Krnajski Z, 2002, J BIOL CHEM, V277, P25970, DOI 10.1074/jbc.M203539200; Kumar S, 2004, IND CROP PROD, V19, P77, DOI 10.1016/j.indcrop.2003.07.003; LIU KCSC, 1992, PLANT CELL REP, V11, P637, DOI 10.1007/BF00236389; Lu J, 2006, CANCER RES, V66, P4410, DOI 10.1158/0008-5472.CAN-05-3310; Meshnick SR, 2002, INT J PARASITOL, V32, P1655, DOI 10.1016/S0020-7519(02)00194-7; MESHNICK SR, 1991, MOL BIOCHEM PARASIT, V49, P181, DOI 10.1016/0166-6851(91)90062-B; Mishina YV, 2007, ANTIMICROB AGENTS CH, V51, P1852, DOI 10.1128/AAC.01544-06; OTT KJ, 1968, J PROTOZOOL, V15, P365, DOI 10.1111/j.1550-7408.1968.tb02138.x; Rasoanaivo P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-S1-S4; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Rodger WS, 2012, ORG PROCESS RES DEV, V16, P764; Sen R, 2007, J MED MICROBIOL, V56, P1213, DOI 10.1099/jmm.0.47364-0; Sharma V, 2009, BRIT J PHARMACOL, V157, P907, DOI 10.1111/j.1476-5381.2009.00267.x; Svensson USH, 1999, BRIT J CLIN PHARMACO, V48, P528, DOI 10.1046/j.1365-2125.1999.00044.x; Team RDC, 2012, R LANG ENV STAT COMP; Utzinger J, 2001, CURR MED CHEM, V8, P1841, DOI 10.2174/0929867013371581; van der Kooy F, 2011, PLANTA MED, V77, P1754, DOI 10.1055/s-0030-1271065; Weathers PJ, 2011, PHYTOCHEM REV, V10, P173, DOI 10.1007/s11101-010-9166-0; Weathers PJ, 2012, PLANTA MED; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2010, GUID TREATM MAL, V2nd; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Willcox M, 2009, J ALTERN COMPLEM MED, V15, P101, DOI 10.1089/acm.2008.0327; Zhu CY, 2012, J AM CHEM SOC, V134, P13577, DOI 10.1021/ja3061479	47	61	61	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52746	10.1371/journal.pone.0052746	http://dx.doi.org/10.1371/journal.pone.0052746			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23289055	Green Published, gold			2022-12-27	WOS:000312794500243
J	Mitchell, PL; Karakach, TK; Currie, DL; McLeod, RS				Mitchell, Patricia L.; Karakach, Tobias K.; Currie, Deborah L.; McLeod, Roger S.			t-10, c-12 CLA Dietary Supplementation Inhibits Atherosclerotic Lesion Development Despite Adverse Cardiovascular and Hepatic Metabolic Marker Profiles	PLOS ONE			English	Article							CONJUGATED LINOLEIC-ACID; PROLIFERATOR-ACTIVATED RECEPTOR; INSULIN-RESISTANCE; PEROXISOME PROLIFERATION; TRANS-10,CIS-12 ISOMER; GLUCOSE-TOLERANCE; DEFICIENCY LEADS; LIPID-METABOLISM; FATTY LIVER; OBESE MEN	Animal and human studies have indicated that fatty acids such as the conjugated linoleic acids (CLA) found in milk could potentially alter the risk of developing metabolic disorders including diabetes and cardiovascular disease (CVD). Using susceptible rodent models (apoE(-/-) and LDLr-/- mice) we investigated the interrelationship between mouse strain, dietary conjugated linoleic acids and metabolic markers of CVD. Despite an adverse metabolic risk profile, atherosclerosis (measured directly by lesion area), was significantly reduced with t-10, c-12 CLA and mixed isomer CLA (Mix) supplementation in both apoE(-/-) (p<0.05, n = 11) and LDLr-/- mice (p<0.01, n = 10). Principal component analysis was utilized to delineate the influence of multiple plasma and tissue metabolites on the development of atherosclerosis. Group clustering by dietary supplementation was evident, with the t-10, c-12 CLA supplemented animals having distinct patterns, suggestive of hepatic insulin resistance, regardless of mouse strain. The effect of CLA supplementation on hepatic lipid and fatty acid composition was explored in the LDLr-/- strain. Dietary supplementation with t-10, c-12 CLA significantly increased liver weight (p<0.05, n = 10), triglyceride (p<0.01, n = 10) and cholesterol ester content (p<0.01, n = 10). Furthermore, t-10, c-12 CLA also increased the ratio of 18:1 to 18:0 fatty acid in the liver suggesting an increase in the activity of stearoyl-CoA desaturase. Changes in plasma adiponectin and liver weight with t-10, c-12 CLA supplementation were evident within 3 weeks of initiation of the diet. These observations provide evidence that the individual CLA isomers have divergent mechanisms of action and that t-10, c-12 CLA rapidly changes plasma and liver markers of metabolic syndrome, despite evidence of reduction in atherosclerosis. Citation: Mitchell PL, Karakach TK, Currie DL, McLeod RS (2012) t-10, c-12 CLA Dietary Supplementation Inhibits Atherosclerotic Lesion Development Despite Adverse Cardiovascular and Hepatic Metabolic Marker Profiles. PLoS ONE 7(12): e52634. doi:10.1371/journal.pone.0052634	[Mitchell, Patricia L.; Karakach, Tobias K.; Currie, Deborah L.; McLeod, Roger S.] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada	Dalhousie University	McLeod, RS (corresponding author), Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada.	rmcleod2@dal.ca	Mitchell, Patricia/AAB-7801-2021; McLeod, Roger/F-8014-2015	Mitchell, Patricia/0000-0002-0773-1047; McLeod, Roger/0000-0002-6740-5569; Karakach, Tobias/0000-0003-2460-3781	Advanced Foods and Materials Network (AFMnet); Dairy Farmers of Canada	Advanced Foods and Materials Network (AFMnet); Dairy Farmers of Canada	The authors acknowledge the financial support of the Advanced Foods and Materials Network (AFMnet), and Dairy Farmers of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreoli MF, 2009, NUTRITION, V25, P445, DOI 10.1016/j.nut.2008.10.015; Arbones-Mainar JM, 2006, J NUTR, V136, P353, DOI 10.1093/jn/136.2.353; Arbones-Mainar JM, 2006, ATHEROSCLEROSIS, V189, P318, DOI 10.1016/j.atherosclerosis.2006.01.015; Biddinger SB, 2008, CELL METAB, V7, P125, DOI 10.1016/j.cmet.2007.11.013; Buettner R, 2007, OBESITY, V15, P798, DOI 10.1038/oby.2007.608; Choi YJ, 2000, J NUTR, V130, P1920, DOI 10.1093/jn/130.8.1920; Cimini AM, 2005, INT J CANCER, V117, P923, DOI 10.1002/ijc.21272; Clement L, 2002, J LIPID RES, V43, P1400, DOI 10.1194/jlr.M20008-JLR200; Cooper MH, 2008, ATHEROSCLEROSIS, V200, P294, DOI 10.1016/j.atherosclerosis.2007.12.040; Costet P, 1998, J BIOL CHEM, V273, P29577, DOI 10.1074/jbc.273.45.29577; de Deckere EAM, 1999, BRIT J NUTR, V82, P309, DOI 10.1017/S0007114599001518; de Roos B, 2005, FASEB J, V19, P813, DOI 10.1096/fj.04-2974fje; FOLCH J, 1957, J BIOL CHEM, V226, P497; Franczyk-Zarow M, 2008, BRIT J NUTR, V99, P49, DOI 10.1017/S0007114507793893; Griffin JL, 2004, NAT REV CANCER, V4, P551, DOI 10.1038/nrc1390; Haas JT, 2009, CURR OPIN LIPIDOL, V20, P206, DOI 10.1097/MOL.0b013e32832b2024; Houseknecht KL, 1998, BIOCHEM BIOPH RES CO, V244, P678, DOI 10.1006/bbrc.1998.8303; Joven J, 2007, ATHEROSCLEROSIS, V195, pE85, DOI 10.1016/j.atherosclerosis.2007.06.012; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Lee KN, 1998, BIOCHEM BIOPH RES CO, V248, P817, DOI 10.1006/bbrc.1998.8994; Lichtman AH, 1999, ARTERIOSCL THROM VAS, V19, P1938, DOI 10.1161/01.ATV.19.8.1938; LISSNER L, 1995, EUR J CLIN NUTR, V49, P79; Liu LF, 2007, AM J PHYSIOL-GASTR L, V292, P1671, DOI 10.1152/ajpgi.00523.2006; Macarulla MT, 2005, NUTRITION, V21, P512, DOI 10.1016/j.nut.2004.07.011; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Malinowski E. R., 1980, FACTOR ANAL CHEM; McGuinness OP, 2009, AM J PHYSIOL-ENDOC M, V297, pE849, DOI 10.1152/ajpendo.90996.2008; McLeod RS, 2004, AM J CLIN NUTR, V79, p1169S, DOI 10.1093/ajcn/79.6.1169S; Mitchell PL, 2008, BIOCHEM CELL BIOL, V86, P293, DOI [10.1139/O08-070, 10.1139/o08-070]; Mitchell PL, 2005, BBA-MOL CELL BIOL L, V1734, P269, DOI 10.1016/j.bbalip.2005.04.007; Moloney F, 2004, AM J CLIN NUTR, V80, P887; Moya-Camarena SY, 1999, BBA-MOL CELL BIOL L, V1436, P331, DOI 10.1016/S0005-2760(98)00121-0; Navarro Maria A, 2010, Front Biosci (Elite Ed), V2, P87, DOI 10.2741/e69; Nestel P, 2006, ATHEROSCLEROSIS, V189, P282, DOI 10.1016/j.atherosclerosis.2005.12.020; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; NICHOLSON JK, 1995, ANAL CHEM, V67, P793, DOI 10.1021/ac00101a004; Noone EJ, 2002, BRIT J NUTR, V88, P243, DOI 10.1079/BJN2002615; Oikawa D, 2009, BRIT J NUTR, V101, P1558, DOI 10.1017/S0007114508091253; Okamoto Y, 2006, CLIN SCI, V110, P267, DOI 10.1042/CS20050182; Park Y, 1999, LIPIDS, V34, P235, DOI 10.1007/s11745-999-0358-8; Parra Pilar, 2010, Nutr Metab (Lond), V7, P5, DOI 10.1186/1743-7075-7-5; Poirier H, 2005, DIABETOLOGIA, V48, P1059, DOI 10.1007/s00125-005-1765-8; Poirier H, 2005, BIOCHIMIE, V87, P73, DOI 10.1016/j.biochi.2004.11.006; Purushotham A, 2007, J LIPID RES, V48, P444, DOI 10.1194/jlr.M600393-JLR200; Ringseis R, 2006, BBA-GEN SUBJECTS, V1760, P290, DOI 10.1016/j.bbagen.2005.12.002; Riserus U, 2004, AM J CLIN NUTR, V80, P279; Riserus U, 2004, DIABETOLOGIA, V47, P1016, DOI 10.1007/s00125-004-1421-8; Riserus U, 2002, DIABETES CARE, V25, P1516, DOI 10.2337/diacare.25.9.1516; Roche HM, 2002, DIABETES, V51, P2037, DOI 10.2337/diabetes.51.7.2037; Ryder JW, 2001, DIABETES, V50, P1149, DOI 10.2337/diabetes.50.5.1149; Semenkovich CF, 2006, J CLIN INVEST, V116, P1813, DOI 10.1172/JCI29024; Sobel BE, 2007, AM J MED, V120, pS3, DOI 10.1016/j.amjmed.2007.07.002; Sugden MC, 2002, BIOCHEM J, V364, P361, DOI 10.1042/BJ20011699; Svenson KL, 2007, J APPL PHYSIOL, V102, P2369, DOI 10.1152/japplphysiol.01077.2006; Syvertsen C, 2007, INT J OBESITY, V31, P1148, DOI 10.1038/sj.ijo.0803482; Taylor CG, 2004, AM J CLIN NUTR, V79, p1164S, DOI 10.1093/ajcn/79.6.1164S; Terpstra AHM, 2002, J NUTR, V132, P940, DOI 10.1093/jn/132.5.940; Teupser D, 2003, ARTERIOSCL THROM VAS, V23, P1907, DOI 10.1161/01.ATV.0000090126.34881.B1; Toomey S, 2006, ATHEROSCLEROSIS, V187, P40, DOI 10.1016/j.atherosclerosis.2005.08.024; Tricon S, 2004, AM J CLIN NUTR, V80, P614; Tsuboyama-Kasaoka N, 2000, DIABETES, V49, P1534, DOI 10.2337/diabetes.49.9.1534; Valeille K, 2004, BRIT J NUTR, V91, P191, DOI 10.1079/BJN20031057; Wilson TA, 2006, LIPIDS, V41, P41, DOI 10.1007/s11745-006-5068-8; Wu L, 2006, J LIPID RES, V47, P2215, DOI 10.1194/jlr.M600146-JLR200; Yurawecz MP, 1999, ADVANCES IN CONJUGATED LINOLEIC ACID RESEARCH, VOL 1, P64; Zadelaar S, 2007, ARTERIOSCL THROM VAS, V27, P1706, DOI 10.1161/ATVBAHA.107.142570	66	13	13	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52634	10.1371/journal.pone.0052634	http://dx.doi.org/10.1371/journal.pone.0052634			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285120	Green Published, Green Submitted, gold			2022-12-27	WOS:000312794500214
J	Rottman, M; Goldberg, J; Hacking, SA				Rottman, Martin; Goldberg, Joel; Hacking, S. Adam			Titanium-Tethered Vancomycin Prevents Resistance to Rifampicin in Staphylococcus aureus in vitro	PLOS ONE			English	Article							BIOFILM FORMATION; SURFACE; ALLOY; INHIBITION; ATTACHMENT; REPLACEMENT; INFECTION; MODEL; HIP	Rifampicin is currently recognized as the most potent drug against Gram positive implant related infections. The use of rifampicin is limited by the emergence of bacterial resistance, which is often managed by coadministration of a second antibiotic. The purpose of this study was to determine the effectiveness of soluble rifampicin in combination with vancomycin tethered to titanium metal as a means to control bacterial growth and resistance in vitro. Bacterial growth was inhibited when the vancomycin-tethered titanium discs were treated with Staphylococcus aureus inocula of >= 2 x 10(6) CFU, however inocula greater than 2 x 10(6) CFU/disc adhered and survived. The combination of surface-tethered vancomycin with soluble rifampicin enhanced the inhibitory effect of rifampicin for an inoculum of 10(6) CFU/cm(2) by one dilution (combination MIC of 0.008 mg/L versus 0.015 mg/L for rifampicin alone). Moreover, surface tethered vancomycin prevented the emergence of a rifampicin resistant population in an inoculum of 2 x 10(8) CFU. Citation: Rottman M, Goldberg J, Hacking SA (2012) Titanium-Tethered Vancomycin Prevents Resistance to Rifampicin in Staphylococcus aureus in vitro. PLoS ONE 7(12): e52883. doi: 10.1371/journal.pone.0052883	[Rottman, Martin; Goldberg, Joel; Hacking, S. Adam] Harvard Univ, Sch Med, Lab Musculoskeletal Res & Innovat, Dept Orthopaed, Boston, MA 02114 USA; [Rottman, Martin; Goldberg, Joel; Hacking, S. Adam] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Rottman, Martin] Harvard Univ, Sch Med, Wyss Inst, Boston, MA USA; [Rottman, Martin] Univ Versailles St Quentin, EA Physiopathol & Diagnost Infect Microbiennes 36, Garches, France; [Rottman, Martin] Hop Raymond Poincare, AP HP, Microbiol Lab, Garches, France	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP	Hacking, SA (corresponding author), Harvard Univ, Sch Med, Lab Musculoskeletal Res & Innovat, Dept Orthopaed, Boston, MA 02114 USA.	ahacking@partners.org	Rottman, Martin/I-3005-2012; Rottman, Martin/AAD-9075-2021	Rottman, Martin/0000-0001-5953-3344; 				Antoci V, 2007, J ORTHOP RES, V25, P858, DOI 10.1002/jor.20348; Antoci V, 2008, BIOMATERIALS, V29, P4684, DOI 10.1016/j.biomaterials.2008.08.016; Aumsuwan N, 2008, BIOMACROMOLECULES, V9, P1712, DOI 10.1021/bm800176t; Baker P, 2012, KNEE SURG SPORT TR A; Byren I, 2012, ANTIMICROB AGENTS CH; Chen CP, 2010, BIOCONJUGATE CHEM, V21, P1978, DOI 10.1021/bc100136e; Courvalin P, 2006, CLIN INFECT DIS, V42, pS25, DOI 10.1086/491711; Edupuganti OP, 2007, BIOORG MED CHEM LETT, V17, P2692, DOI 10.1016/j.bmcl.2007.03.005; Fan XW, 2005, J AM CHEM SOC, V127, P15843, DOI 10.1021/ja0532638; Fitzgerald Steven J, 2011, Surg Technol Int, V21, P204; Forrest GN, 2010, CLIN MICROBIOL REV, V23, P14, DOI 10.1128/CMR.00034-09; Gawalt ES, 2003, LANGMUIR, V19, P200, DOI 10.1021/la0203436; Jose B, 2005, CHEM BIOL, V12, P1041, DOI 10.1016/j.chembiol.2005.06.013; Ketonis C, 2009, CLIN ORTHOP RELAT R, V467, P1678, DOI 10.1007/s11999-009-0828-4; Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222; Liu C, 2011, CLIN INFECT DIS, V53, P319, DOI [10.1093/cid/cir353, 10.1093/cid/ciq146]; Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4; MOORMAN DR, 1981, ANTIMICROB AGENTS CH, V20, P709, DOI 10.1128/AAC.20.6.709; Moyad TF, 2008, ORTHOPEDICS, V31, P581, DOI 10.3928/01477447-20080601-22; Murphy CK, 2006, ANTIMICROB AGENTS CH, V50, P827, DOI 10.1128/AAC.50.3.827-834.2006; Ong KL, 2009, J ARTHROPLASTY, V24, P105, DOI 10.1016/j.arth.2009.04.027; Parvizi J, 2004, CLIN ORTHOP RELAT R, P33, DOI 10.1097/01.blo.0000150116.65231.45; Pettit RK, 2005, ANTIMICROB AGENTS CH, V49, P2612, DOI 10.1128/AAC.49.7.2612-2617.2005; Poultsides Lazaros A, 2010, J Bone Joint Surg Am, V92, pe13, DOI 10.2106/JBJS.I.01131; Roux AL, 2011, CLIN MICROBIOL INFEC, V17, P447, DOI 10.1111/j.1469-0691.2010.03359.x; Shah AK, 1999, BIOL CELL, V91, P131, DOI 10.1016/S0248-4900(99)80037-9; Silverman BM, 2005, LANGMUIR, V21, P225, DOI 10.1021/la048227l; Stewart S, 2012, J BONE JOINT SURG AM, V94A, P1406, DOI 10.2106/JBJS.K.00886; Tote K, 2008, LETT APPL MICROBIOL, V46, P249, DOI 10.1111/j.1472-765X.2007.02298.x; Tote K, 2009, INT J ANTIMICROB AG, V33, P525, DOI 10.1016/j.ijantimicag.2008.11.004; Vanhegan IS, 2012, J BONE JOINT SURG BR, V94B, P875, DOI 10.1302/0301-620X.94B7.28710; Xiao SJ, 1997, J MATER SCI-MATER M, V8, P867, DOI 10.1023/A:1018501804943	32	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52883	10.1371/journal.pone.0052883	http://dx.doi.org/10.1371/journal.pone.0052883			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285213	Green Published, gold, Green Submitted			2022-12-27	WOS:000312794500253
J	Steel, R; Cross, RS; Ellis, SL; Anderson, RL				Steel, Rohan; Cross, Ryan S.; Ellis, Sarah L.; Anderson, Robin L.			Hsp70 Architecture: The Formation of Novel Polymeric Structures of Hsp70.1 and Hsc70 after Proteotoxic Stress	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; INDUCED APOPTOSIS; MOLECULAR CHAPERONES; INHIBITS APOPTOSIS; APAF-1 APOPTOSOME; MAMMALIAN-CELLS; HEAT-SHOCK-PROTEIN-70; MITOCHONDRIA; BINDING; ASSOCIATION	Heat induces Hsp70.1 (HSPA1) and Hsc70 (HSPA8) to form complex detergent insoluble cytoplasmic and nuclear structures that are distinct from the cytoskeleton and internal cell membranes. These novel structures have not been observed by earlier immunofluorescence studies as they are obscured by the abundance of soluble Hsp70.1/Hsc70 present in cells. While resistant to detergents, these Hsp70 structures display complex intracellular dynamics and are efficiently disaggregated by ATP, indicating that this pool of Hsp70.1/Hsc70 retains native function and regulation. Hsp70.1 promotes the repair of proteotoxic damage and cell survival after stress. In heated fibroblasts expressing Hsp70.1, Hsp70.1 and Hsc70 complexes are efficiently disaggregated before the cells undergo-heat induced apoptosis. In the absence of Hsp70.1, fibroblasts have increased rates of heat-induced apoptosis and maintain stable insoluble Hsc70 structures. The differences in the intracellular distribution of Hsp70.1 and Hsc70, combined with the ability of Hsp70.1, but not Hsc70, to promote the disaggregation of insoluble Hsp70.1/Hsc70 complexes, indicate that these two closely related proteins perform distinctly different cellular functions in heated cells.	[Steel, Rohan; Cross, Ryan S.; Ellis, Sarah L.; Anderson, Robin L.] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Ellis, Sarah L.; Anderson, Robin L.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3052, Australia	Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne	Anderson, RL (corresponding author), Peter MacCallum Canc Ctr, St Andrews Pl, Melbourne, Vic, Australia.	robin.anderson@petermac.org	Anderson, Robin/I-2306-2013; Anderson, Robin/K-6966-2019; Anderson, Robin/S-1005-2017	/0000-0002-0423-6120; Anderson, Robin/0000-0002-6841-7422; Ellis, Sarah/0000-0002-5772-6051; Cross, Ryan/0000-0002-8573-8551	National Institute of Health/National Cancer Institute [CA81421]; National Breast Cancer Foundation (NBCF Australia); NATIONAL CANCER INSTITUTE [R01CA081421] Funding Source: NIH RePORTER	National Institute of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Breast Cancer Foundation (NBCF Australia); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was supported by the National Institute of Health/National Cancer Institute Grant CA81421. RLA is supported by a fellowship from the National Breast Cancer Foundation (NBCF Australia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Anderson P, 2009, CURR BIOL, V19, pR397, DOI 10.1016/j.cub.2009.03.013; BECKMANN RP, 1990, SCIENCE, V248, P850, DOI 10.1126/science.2188360; Beere HM, 2000, NAT CELL BIOL, V2, P469, DOI 10.1038/35019501; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Buzzard KA, 1998, J BIOL CHEM, V273, P17147, DOI 10.1074/jbc.273.27.17147; CHAPPELL TG, 1986, CELL, V45, P3, DOI 10.1016/0092-8674(86)90532-5; Clemons NJ, 2005, J BIOL CHEM, V280, P9005, DOI 10.1074/jbc.M414165200; Dittmar KD, 1997, J BIOL CHEM, V272, P13047, DOI 10.1074/jbc.272.20.13047; Ellis S, 2000, J HISTOCHEM CYTOCHEM, V48, P321, DOI 10.1177/002215540004800302; Gabai VL, 1997, J BIOL CHEM, V272, P18033, DOI 10.1074/jbc.272.29.18033; Garcia-Mata R, 1999, J CELL BIOL, V146, P1239, DOI 10.1083/jcb.146.6.1239; Goloubinoff P, 1999, P NATL ACAD SCI USA, V96, P13732, DOI 10.1073/pnas.96.24.13732; Gotoh T, 2004, CELL DEATH DIFFER, V11, P390, DOI 10.1038/sj.cdd.4401369; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Irmer H, 1997, J BIOL CHEM, V272, P2230; JAATTELA M, 1992, EMBO J, V11, P3507, DOI 10.1002/j.1460-2075.1992.tb05433.x; KAMPINGA HH, 1993, INT J HYPERTHER, V9, P89, DOI 10.3109/02656739309061481; KIM DH, 1992, J CELL PHYSIOL, V153, P353, DOI 10.1002/jcp.1041530215; KING C, 1995, J BIOL CHEM, V270, P22535, DOI 10.1074/jbc.270.38.22535; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI LG, 1995, EXP CELL RES, V217, P460, DOI 10.1006/excr.1995.1110; Liang P, 1997, J CELL SCI, V110, P1431; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; MARGULIS BA, 1991, J BIOL CHEM, V266, P9295; MILARSKI KL, 1989, J CELL BIOL, V108, P413, DOI 10.1083/jcb.108.2.413; Minami Y, 1999, GENES CELLS, V4, P721, DOI 10.1046/j.1365-2443.1999.00299.x; Nollen EAA, 2001, P NATL ACAD SCI USA, V98, P12038, DOI 10.1073/pnas.201112398; Nylandsted J, 2004, J EXP MED, V200, P425, DOI 10.1084/jem.20040531; Oh WK, 2003, MOL CELLS, V16, P84; PALLEROS DR, 1991, P NATL ACAD SCI USA, V88, P5719, DOI 10.1073/pnas.88.13.5719; PELHAM H, 1984, PHILOS T ROY SOC B, V307, P301, DOI 10.1098/rstb.1984.0131; RAMSBY ML, 1994, ELECTROPHORESIS, V15, P265, DOI 10.1002/elps.1150150146; Raynes DA, 1998, J BIOL CHEM, V273, P32883, DOI 10.1074/jbc.273.49.32883; Saleh A, 2000, NAT CELL BIOL, V2, P476, DOI 10.1038/35019510; SIMON MM, 1995, J CLIN INVEST, V95, P926, DOI 10.1172/JCI117800; Stankiewicz AR, 2009, CELL DEATH DIFFER, V16, P638, DOI 10.1038/cdd.2008.189; Stankiewicz AR, 2005, J BIOL CHEM, V280, P38729, DOI 10.1074/jbc.M509497200; Steel R, 2004, J BIOL CHEM, V279, P51490, DOI 10.1074/jbc.M401314200; SUGITO K, 1995, FEBS LETT, V358, P161, DOI 10.1016/0014-5793(94)01417-Y; Takayama S, 1997, EMBO J, V16, P4887, DOI 10.1093/emboj/16.16.4887; YAMANE M, 1995, CELL STRUCT FUNCT, V20, P157, DOI 10.1247/csf.20.157; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3; Zeng XC, 2004, J CELL SCI, V117, P4991, DOI 10.1242/jcs.01373	44	8	11	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e52351	10.1371/journal.pone.0052351	http://dx.doi.org/10.1371/journal.pone.0052351			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23285004	Green Published, gold			2022-12-27	WOS:000312694300088
J	Hwang, I; Scott, JM; Kakarla, T; Duriancik, DM; Choi, S; Cho, C; Lee, T; Park, H; French, AR; Beli, E; Gardner, E; Kim, S				Hwang, Ilwoong; Scott, Jeannine M.; Kakarla, Tejaswi; Duriancik, David M.; Choi, Seohyun; Cho, Chunghwan; Lee, Taehyung; Park, Hyojin; French, Anthony R.; Beli, Eleni; Gardner, Elizabeth; Kim, Sungjin			Activation Mechanisms of Natural Killer Cells during Influenza Virus Infection	PLOS ONE			English	Article							IFN-GAMMA PRODUCTION; HUMAN NK CELLS; DENDRITIC CELLS; CUTTING EDGE; STAT4 ACTIVATION; IMMUNE-RESPONSES; MEDIATED CYTOTOXICITY; ANTIVIRAL DEFENSE; DISTINCT ROLES; ALPHA-BETA	During early viral infection, activation of natural killer (NK) cells elicits the effector functions of target cell lysis and cytokine production. However, the cellular and molecular mechanisms leading to NK cell activation during viral infections are incompletely understood. In this study, using a model of acute viral infection, we investigated the mechanisms controlling cytotoxic activity and cytokine production in response to influenza (flu) virus. Analysis of cytokine receptor deficient mice demonstrated that type I interferons (IFNs), but not IL-12 or IL-18, were critical for the NK cell expression of both IFN-gamma and granzyme B in response to flu infection. Further, adoptive transfer experiments revealed that NK cell activation was mediated by type I IFNs acting directly on NK cells. Analysis of signal transduction molecules showed that during flu infection, STAT1 activation in NK cells was completely dependent on direct type I IFN signaling, whereas STAT4 activation was only partially dependent. In addition, granzyme B induction in NK cells was mediated by signaling primarily through STAT1, but not STAT4, while IFN-gamma production was mediated by signaling through STAT4, but not STAT1. Therefore, our findings demonstrate the importance of direct action of type I IFNs on NK cells to mount effective NK cell responses in the context of flu infection and delineate NK cell signaling pathways responsible for controlling cytotoxic activity and cytokine production.	[Hwang, Ilwoong; Scott, Jeannine M.; Kakarla, Tejaswi; Choi, Seohyun; Cho, Chunghwan; Lee, Taehyung; Park, Hyojin; Kim, Sungjin] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Duriancik, David M.; Beli, Eleni; Gardner, Elizabeth] Michigan State Univ, Dept Food Sci & Human Nutr, E Lansing, MI 48824 USA; [French, Anthony R.] Washington Univ, Sch Med, Dept Pediat, Div Pediat Rheumatol, St Louis, MO 63110 USA	Michigan State University; Michigan State University; Washington University (WUSTL)	Kim, S (corresponding author), Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA.	kimsj@msu.edu	Beli, Eleni/AAL-7433-2020	Beli, Eleni/0000-0003-1889-640X	National Institute on Aging [5R01AG034949]; Korea Research Council of Fundamental Science & Technology in Republic of Korea; NATIONAL INSTITUTE ON AGING [R01AG034949] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Korea Research Council of Fundamental Science & Technology in Republic of Korea; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institute on Aging, 5R01AG034949 to EG and National Agenda Project grant from the Korea Research Council of Fundamental Science & Technology in Republic of Korea to SK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Careem MF, 2012, J INFECT DIS, V206, P167, DOI 10.1093/infdis/jis340; Alter G, 2009, J INTERN MED, V265, P29, DOI 10.1111/j.1365-2796.2008.02045.x; Andoniou CE, 2005, NAT IMMUNOL, V6, P1011, DOI 10.1038/ni1244; Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Barr DP, 2007, EUR J IMMUNOL, V37, P1334, DOI 10.1002/eji.200636362; Beli E, 2011, MECH AGEING DEV, V132, P503, DOI 10.1016/j.mad.2011.08.005; Bertoletti A, 2011, GUT; Beuneu H, 2011, J IMMUNOL, V187, P2084, DOI 10.4049/jimmunol.1004210; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; BIRON CA, 1989, NEW ENGL J MED, V320, P1731, DOI 10.1056/NEJM198906293202605; BIRON CA, 1984, J LEUKOCYTE BIOL, V35, P31, DOI 10.1002/jlb.35.1.31; BLOOMFIELD SE, 1980, OPHTHALMOLOGY, V87, P1226; BRUTKIEWICZ RR, 1992, NAT IMMUN, V11, P203; Chaix J, 2008, J IMMUNOL, V181, P1627, DOI 10.4049/jimmunol.181.3.1627; Chen Y, 2005, J VIRAL HEPATITIS, V12, P38, DOI 10.1111/j.1365-2893.2005.00543.x; Cheng VCC, 2012, CLIN MICROBIOL REV, V25, P223, DOI 10.1128/CMR.05012-11; Chew T, 2009, VIRUSES-BASEL, V1, P979, DOI 10.3390/v1030979; Cooper MA, 2002, BLOOD, V100, P3633, DOI 10.1182/blood-2001-12-0293; Denney L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010675; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Dokun AO, 2001, NAT IMMUNOL, V2, P951, DOI 10.1038/ni714; Farrell HE, 1999, IMMUNOL REV, V168, P187, DOI 10.1111/j.1600-065X.1999.tb01293.x; Fawaz LM, 1999, J IMMUNOL, V163, P4473; Fehniger TA, 2007, IMMUNITY, V26, P798, DOI 10.1016/j.immuni.2007.04.010; Ferlazzo G, 2004, P NATL ACAD SCI USA, V101, P16606, DOI 10.1073/pnas.0407522101; French AR, 2004, IMMUNITY, V20, P747, DOI 10.1016/j.immuni.2004.05.006; French AR, 2003, CURR OPIN IMMUNOL, V15, P45, DOI 10.1016/S095279150200002X; Freudenberg MA, 2002, J IMMUNOL, V169, P1665, DOI 10.4049/jimmunol.169.4.1665; Gazit R, 2006, NAT IMMUNOL, V7, P517, DOI 10.1038/ni1322; Geurs TL, 2009, J IMMUNOL, V183, P5830, DOI 10.4049/jimmunol.0901520; GIDLUND M, 1978, NATURE, V273, P759, DOI 10.1038/273759a0; Gu J, 2007, LANCET, V370, P1137, DOI 10.1016/S0140-6736(07)61515-3; Hansen ML, 2011, MOL IMMUNOL, V48, P2087, DOI 10.1016/j.molimm.2011.07.008; Ito T, 2006, BLOOD, V107, P2423, DOI 10.1182/blood-2005-07-2709; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Khakoo SI, 2004, SCIENCE, V305, P872, DOI 10.1126/science.1097670; Kida K, 2000, PEDIATR INT, V42, P631, DOI 10.1046/j.1442-200x.2000.01315.x; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Kim S, 2000, P NATL ACAD SCI USA, V97, P2731, DOI 10.1073/pnas.050588297; Koka R, 2004, J IMMUNOL, V173, P3594, DOI 10.4049/jimmunol.173.6.3594; Kreijtz JHCM, 2011, VIRUS RES, V162, P19, DOI 10.1016/j.virusres.2011.09.022; Kuijpers TW, 2008, BLOOD, V112, P914, DOI 10.1182/blood-2008-05-157354; KUNDER SC, 1993, ANN NY ACAD SCI, V685, P618, DOI 10.1111/j.1749-6632.1993.tb35926.x; Lanier LL, 2008, NAT REV IMMUNOL, V8, P259, DOI 10.1038/nri2276; Lee CK, 2000, J IMMUNOL, V165, P3571, DOI 10.4049/jimmunol.165.7.3571; Lee SH, 2007, TRENDS IMMUNOL, V28, P252, DOI 10.1016/j.it.2007.04.001; Lesinski GB, 2003, J CLIN INVEST, V112, P170, DOI 10.1172/JCI200316603; Liang SJ, 2003, CYTOKINE, V23, P190, DOI 10.1016/S1043-4666(03)00226-6; Liu BX, 2003, MICROB PATHOGENESIS, V34, P161, DOI 10.1016/S0882-4010(02)00191-2; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Lucas M, 2007, IMMUNITY, V26, P503, DOI 10.1016/j.immuni.2007.03.006; Mack EA, 2011, MBIO, V2, DOI 10.1128/mBio.00169-11; Martinez J, 2008, J IMMUNOL, V180, P1592, DOI 10.4049/jimmunol.180.3.1592; Matikainen S, 2001, EUR J IMMUNOL, V31, P2236, DOI 10.1002/1521-4141(200107)31:7<2236::AID-IMMU2236>3.0.CO;2-G; Miyagi T, 2007, J EXP MED, V204, P2383, DOI 10.1084/jem.20070401; Miyagi T, 2010, METHODS MOL BIOL, V612, P159, DOI 10.1007/978-1-60761-362-6_11; Mocarski ES, 2002, TRENDS MICROBIOL, V10, P332, DOI 10.1016/S0966-842X(02)02393-4; Narni-Mancinelli E, 2012, SCIENCE, V335, P344, DOI 10.1126/science.1215621; Nguyen KB, 2002, J IMMUNOL, V169, P4279, DOI 10.4049/jimmunol.169.8.4279; Nguyen KB, 2002, SCIENCE, V297, P2063, DOI 10.1126/science.1074900; Orange JS, 2002, MICROBES INFECT, V4, P1545, DOI 10.1016/S1286-4579(02)00038-2; Orange JS, 1996, J IMMUNOL, V156, P1138; Orange JS, 1996, J IMMUNOL, V156, P4746; Pien GC, 2000, J IMMUNOL, V165, P4787, DOI 10.4049/jimmunol.165.9.4787; Prlic M, 2003, J EXP MED, V197, P967, DOI 10.1084/jem.20021847; Reading PC, 2007, J IMMUNOL, V179, P3214, DOI 10.4049/jimmunol.179.5.3214; SANTOLI D, 1978, J IMMUNOL, V121, P532; SHRESTA S, 1995, P NATL ACAD SCI USA, V92, P5679, DOI 10.1073/pnas.92.12.5679; STEINSTREILEIN J, 1986, J IMMUNOL, V136, P1435; Strengell M, 2003, J IMMUNOL, V170, P5464, DOI 10.4049/jimmunol.170.11.5464; Swann JB, 2007, J IMMUNOL, V178, P7540, DOI 10.4049/jimmunol.178.12.7540; Thierfelder WE, 1996, NATURE, V382, P171, DOI 10.1038/382171a0; TRINCHIERI G, 1978, J IMMUNOL, V120, P1849; Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664; UNKELESS JC, 1979, J EXP MED, V150, P580, DOI 10.1084/jem.150.3.580; Vidal SM, 2011, CURR OPIN VIROL, V1, P497, DOI 10.1016/j.coviro.2011.10.017; Walzer T, 2005, BLOOD, V106, P2252, DOI 10.1182/blood-2005-03-1154; Wang KS, 1999, J IMMUNOL, V162, P299; Zhang C, 2008, CYTOKINE, V42, P128, DOI 10.1016/j.cyto.2008.01.003; Zhang ZF, 2009, HUM PATHOL, V40, P735, DOI 10.1016/j.humpath.2008.08.015	80	45	45	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e51858	10.1371/journal.pone.0051858	http://dx.doi.org/10.1371/journal.pone.0051858			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300570	gold, Green Submitted, Green Published			2022-12-27	WOS:000313872600009
J	Fryer, RM; Muthukumarana, A; Harrison, PC; Mazurek, SN; Chen, RR; Harrington, KE; Dinallo, RM; Horan, JC; Patnaude, L; Modis, LK; Reinhart, GA				Fryer, Ryan M.; Muthukumarana, Akalushi; Harrison, Paul C.; Mazurek, Suzanne Nodop; Chen, Rong Rhonda; Harrington, Kyle E.; Dinallo, Roger M.; Horan, Joshua C.; Patnaude, Lori; Modis, Louise K.; Reinhart, Glenn A.			The Clinically-tested S1P Receptor Agonists, FTY720 and BAF312, Demonstrate Subtype-Specific Bradycardia (S1P(1)) and Hypertension (S1P(3)) in Rat	PLOS ONE			English	Article							SPHINGOSINE 1-PHOSPHATE RECEPTORS; TYROSINE KINASE INHIBITOR; PIG ATRIAL MYOCYTES; MULTIPLE-SCLEROSIS; BLOOD-PRESSURE; FINGOLIMOD FTY720; ORAL FINGOLIMOD; SPHINGOSINE-1-PHOSPHATE; HEART; IMMUNOSUPPRESSANT	Sphingosine-1-phospate (S1P) and S1P receptor agonists elicit mechanism-based effects on cardiovascular function in vivo. Indeed, FTY720 (non-selective S1P(X) receptor agonist) produces modest hypertension in patients (2-3 mmHg in 1-yr trial) as well as acute bradycardia independent of changes in blood pressure. However, the precise receptor subtypes responsible is controversial, likely dependent upon the cardiovascular response in question (e.g. bradycardia, hypertension), and perhaps even species-dependent since functional differences in rodent, rabbit, and human have been suggested. Thus, we characterized the S1P receptor subtype specificity for each compound in vitro and, in vivo, the cardiovascular effects of FTY720 and the more selective S1P(1,5) agonist, BAF312, were tested during acute i.v. infusion in anesthetized rats and after oral administration for 10 days in telemetry-instrumented conscious rats. Acute i.v. infusion of FTY720 (0.1, 0.3, 1.0 mg/kg/20 min) or BAF312 (0.5, 1.5, 5.0 mg/kg/20 min) elicited acute bradycardia in anesthetized rats demonstrating an S1P(1) mediated mechanism-of-action. However, while FTY720 (0.5, 1.5, 5.0 mg/kg/d) elicited dose-dependent hypertension after multiple days of oral administration in rat at clinically relevant plasma concentrations (24-hr mean blood pressure = 8.4, 12.8, 16.2 mmHg above baseline vs. 3 mmHg in vehicle controls), BAF312 (0.3, 3.0, 30.0 mg/kg/d) had no significant effect on blood pressure at any dose tested suggesting that hypertension produced by FTY720 is mediated S1P(3) receptors. In summary, in vitro selectivity results in combination with studies performed in anesthetized and conscious rats administered two clinically tested S1P agonists, FTY720 or BAF312, suggest that S1P(1) receptors mediate bradycardia while hypertension is mediated by S1P(3) receptor activation.	[Fryer, Ryan M.; Muthukumarana, Akalushi; Harrison, Paul C.; Mazurek, Suzanne Nodop; Chen, Rong Rhonda; Reinhart, Glenn A.] Boehringer Ingelheim Pharmaceut Inc, Dept Cardiometab Dis Res, Ridgefield, CT 06877 USA; [Harrington, Kyle E.; Dinallo, Roger M.] Boehringer Ingelheim Pharmaceut Inc, Dept Drug Discovery Support, Ridgefield, CT 06877 USA; [Horan, Joshua C.] Boehringer Ingelheim Pharmaceut Inc, Dept Med Chem, Ridgefield, CT 06877 USA; [Patnaude, Lori; Modis, Louise K.] Boehringer Ingelheim Pharmaceut Inc, Dept Immunol & Inflammat, Ridgefield, CT 06877 USA	Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim	Fryer, RM (corresponding author), Boehringer Ingelheim Pharmaceut Inc, Dept Cardiometab Dis Res, 90 E Ridge POB 368, Ridgefield, CT 06877 USA.	ryan.fryer@boehringer-ingelheim.com						Banfor PN, 2009, J CARDIOVASC PHARM, V53, P173, DOI 10.1097/FJC.0b013e3181993493; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Brinkmann V, 2007, PHARMACOL THERAPEUT, V115, P84, DOI 10.1016/j.pharmthera.2007.04.006; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Bunemann M, 1995, J PHYSIOL-LONDON, V489, P701; Cohen JA, 2010, NEW ENGL J MED, V362, P402, DOI 10.1056/NEJMoa0907839; Demont EH, 2011, J MED CHEM, V54, P6724, DOI 10.1021/jm200609t; Durand P, 2000, SYNTHESIS-STUTTGART, P505; Forrest M, 2004, J PHARMACOL EXP THER, V309, P758, DOI 10.1124/jpet.103.062828; Forrest MJ, 2008, BRIT J PHARMACOL, V154, P1465, DOI 10.1038/bjp.2008.229; Franklin PH, 2009, J PHARMACOL EXP THER, V329, P928, DOI 10.1124/jpet.108.144816; Fryer RM, 2012, J CARDIOVASC PHARM, V59, P369, DOI 10.1097/FJC.0b013e31824485dd; Fujishiro J, 2006, TRANSPLANTATION, V82, P804, DOI 10.1097/01.tp.0000232687.78242.cd; Gergely P, 2012, BRIT J PHARMACOL, V167, P1035, DOI 10.1111/j.1476-5381.2012.02061.x; Gergely P, 25 C EUR COMM TREATM; Guo J, 1999, PFLUG ARCH EUR J PHY, V438, P642, DOI 10.1007/s004240051088; Hale JJ, 2004, BIOORG MED CHEM LETT, V14, P3501, DOI 10.1016/j.bmcl.2004.04.070; Himmel HM, 2000, MOL PHARMACOL, V58, P449, DOI 10.1124/mol.58.2.449; Igarashi J, 2008, BBA-MOL CELL BIOL L, V1781, P489, DOI 10.1016/j.bbalip.2008.06.008; Igarashi J, 2009, CARDIOVASC RES, V82, P212, DOI 10.1093/cvr/cvp064; Jo EJ, 2005, CHEM BIOL, V12, P703, DOI 10.1016/j.chembiol.2005.04.019; Jongsma M, 2009, BRIT J PHARMACOL, V156, P1305, DOI 10.1111/j.1476-5381.2009.00134.x; Kym PR, 2006, J MED CHEM, V49, P2339, DOI 10.1021/jm0512286; Lewis N, 2012, J IMMUNOLOGY; Liu Y., 2010, Patent No. [WO2010071794, 2010071794]; Means CK, 2009, CARDIOVASC RES, V82, P193, DOI 10.1093/cvr/cvp086; Means CK, 2008, J BIOL CHEM, V283, P11954, DOI 10.1074/jbc.M707422200; Mullershausen F, 2009, NAT CHEM BIOL, V5, P428, DOI 10.1038/nchembio.173; Murakami A, 2010, MOL PHARMACOL, V77, P704, DOI 10.1124/mol.109.061481; O'Connor P, 2009, NEUROLOGY, V72, P73, DOI 10.1212/01.wnl.0000338569.32367.3d; Ochi R, 2006, CARDIOVASC RES, V70, P88, DOI 10.1016/j.cardiores.2006.01.010; Ota Hiroki, 2011, Pulm Circ, V1, P399, DOI 10.4103/2045-8932.87309; Pan S., 2004, PCT Int. Appl, Patent No. [WO2004103306, 2004103306]; Saha AK, 2011, ACS MED CHEM LETT, V2, P97, DOI 10.1021/ml100227q; Schmouder R, 2006, J CLIN PHARMACOL, V46, P895, DOI 10.1177/0091270006289853; Schubert R, 2006, CARDIOVASC RES, V70, P9, DOI 10.1016/j.cardiores.2006.02.012; Segreti JA, 2008, J PHARMACOL EXP THER, V325, P331, DOI 10.1124/jpet.107.132530; Shimizu H, 2005, CIRCULATION, V111, P222, DOI 10.1161/01.CIR.0000152101.41037.AB; Sugiyama A, 2000, JPN J PHARMACOL, V82, P338, DOI 10.1254/jjp.82.338; Sugiyama A, 2000, CARDIOVASC RES, V46, P119, DOI 10.1016/S0008-6363(00)00013-4; Tao R, 2009, J CARDIOVASC PHARM, V53, P486, DOI 10.1097/FJC.0b013e3181a7b58a; Tawadrous MN, 2002, TRANSPLANTATION, V74, P602, DOI 10.1097/00007890-200209150-00004; Wallstrom E, 2010, AM AC NEUR 62 ANN M	43	68	76	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52985	10.1371/journal.pone.0052985	http://dx.doi.org/10.1371/journal.pone.0052985			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285242	Green Submitted, Green Published, gold			2022-12-27	WOS:000313051500094
J	Saba, GK; Schofield, O; Torres, JJ; Ombres, EH; Steinberg, DK				Saba, Grace K.; Schofield, Oscar; Torres, Joseph J.; Ombres, Erica H.; Steinberg, Deborah K.			Increased Feeding and Nutrient Excretion of Adult Antarctic Krill, Euphausia superba, Exposed to Enhanced Carbon Dioxide (CO2)	PLOS ONE			English	Article							DISSOLVED ORGANIC-CARBON; COPEPOD ACARTIA-TONSA; OCEAN ACIDIFICATION; SOUTHERN-OCEAN; AUSTRAL SUMMER; ELEMENTAL COMPOSITION; HYPERCAPNIC ACIDOSIS; NITROGEN-EXCRETION; METABOLIC-ACTIVITY; ATLANTIC SECTOR	Ocean acidification has a wide-ranging potential for impacting the physiology and metabolism of zooplankton. Sufficiently elevated CO2 concentrations can alter internal acid-base balance, compromising homeostatic regulation and disrupting internal systems ranging from oxygen transport to ion balance. We assessed feeding and nutrient excretion rates in natural populations of the keystone species Euphausia superba (Antarctic krill) by conducting a CO2 perturbation experiment at ambient and elevated atmospheric CO2 levels in January 2011 along the West Antarctic Peninsula (WAP). Under elevated CO2 conditions (similar to 672 ppm), ingestion rates of krill averaged 78 mu g C individual(-1) d(-1) and were 3.5 times higher than krill ingestion rates at ambient, present day CO2 concentrations. Additionally, rates of ammonium, phosphate, and dissolved organic carbon (DOC) excretion by krill were 1.5, 1.5, and 3.0 times higher, respectively, in the high CO2 treatment than at ambient CO2 concentrations. Excretion of urea, however, was similar to 17% lower in the high CO2 treatment, suggesting differences in catabolic processes of krill between treatments. Activities of key metabolic enzymes, malate dehydrogenase (MDH) and lactate dehydrogenase (LDH), were consistently higher in the high CO2 treatment. The observed shifts in metabolism are consistent with increased physiological costs associated with regulating internal acid-base equilibria. This represents an additional stress that may hamper growth and reproduction, which would negatively impact an already declining krill population along the WAP.	[Saba, Grace K.; Schofield, Oscar] Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08903 USA; [Torres, Joseph J.; Ombres, Erica H.] Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA; [Steinberg, Deborah K.] Coll William & Mary, Virginia Inst Marine Sci, Gloucester Point, VA USA	Rutgers State University New Brunswick; State University System of Florida; University of South Florida; William & Mary; Virginia Institute of Marine Science	Saba, GK (corresponding author), Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08903 USA.	saba@marine.rutgers.edu	Schofield, Oscar/H-4169-2018	Schofield, Oscar/0000-0003-2359-4131	LTER Program of the U. S. National Science Foundation [ANT-0823101]; Moore Foundation grant [1859]	LTER Program of the U. S. National Science Foundation(National Science Foundation (NSF)); Moore Foundation grant	The research was supported by the LTER Program of the U. S. National Science Foundation (ANT-0823101) and Moore Foundation grant #1859. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albessard E, 2001, COMP BIOCHEM PHYS A, V129, P373, DOI 10.1016/S1095-6433(00)00355-X; Andersson AJ, 2012, BIOGEOSCIENCES, V9, P893, DOI 10.5194/bg-9-893-2012; Atkinson A, 2004, NATURE, V432, P100, DOI 10.1038/nature02996; Barry J, 2011, GUIDE BEST PRACTICES, P53; Bechmann RK, 2011, J TOXICOL ENV HEAL A, V74, P424, DOI 10.1080/15287394.2011.550460; Bernard KS, 2012, DEEP-SEA RES PT I, V62, P111, DOI 10.1016/j.dsr.2011.12.015; Boyd CM, 1984, CRUST BIOL, V4; Brewer PG, 2009, P NATL ACAD SCI USA, V106, P12213, DOI 10.1073/pnas.0906815106; Bridges C., 1983, LIFE CHEM REP S, V1, P353; Burleson ML, 2000, COMP BIOCHEM PHYS A, V125, P403, DOI 10.1016/S1095-6433(00)00167-7; Christian J. R., 2007, PICES SPEC PUBL, V3, P1; CLARKE A, 1983, POLAR BIOL, V2, P69, DOI 10.1007/BF00303172; Conover R. J., 1956, Bulletin of the Bingham Oceanographic Collection, V15, P156; Cook AJ, 2005, SCIENCE, V308, P541, DOI 10.1126/science.1104235; CORNER EDS, 1976, J MAR BIOL ASSOC UK, V56, P345, DOI 10.1017/S0025315400018968; Cullen M, 2003, DEEP-SEA RES PT II, V50, P1787, DOI 10.1016/S0967-0645(03)00088-2; DICKSON AG, 1990, J CHEM THERMODYN, V22, P113, DOI 10.1016/0021-9614(90)90074-Z; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Donnelly J, 2004, DEEP-SEA RES PT II, V51, P2225, DOI 10.1016/j.dsr2.2004.07.003; DUCKLOW HW, 1993, DEEP-SEA RES PT II, V40, P245, DOI 10.1016/0967-0645(93)90016-G; Everson I, 2000, KRILL BIOL ECOLOGY F; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Froneman PW, 2000, DEEP-SEA RES PT I, V47, P1687, DOI 10.1016/S0967-0637(99)00121-1; FROST BW, 1972, LIMNOL OCEANOGR, V17, P805, DOI 10.4319/lo.1972.17.6.0805; Geiger SP, 2001, HYDROBIOLOGIA, V453, P79, DOI 10.1023/A:1013107715862; Godlewska Malgorzata, 1996, Polskie Archiwum Hydrobiologii, V43, P9; Grasshoff K, 1999, METHODS SEAWATER ANA; Gutowska MA, 2008, MAR ECOL PROG SER, V373, P303, DOI 10.3354/meps07782; Haberman KL, 2003, J EXP MAR BIOL ECOL, V283, P97, DOI 10.1016/S0022-0981(02)00467-7; Hasle G.R., 1978, PHYTOPLANKTON MANUAL, VVolume 6, P88; Hauton C, 2009, BIOGEOSCIENCES, V6, P1479, DOI 10.5194/bg-6-1479-2009; Hedges JI, 1984, LIMNOL OCEANOGR, V29, P20; HOLMHANSEN O, 1984, J CRUSTACEAN BIOL, V4, P156; HOPKINS TL, 1985, MAR BIOL, V89, P197, DOI 10.1007/BF00392890; Hosie GW, 2000, DEEP-SEA RES PT II, V47, P2437, DOI 10.1016/S0967-0645(00)00031-X; Houghton J. T., 1996, CLIMATE CHANGE SCI C; Hu MY, 2011, AM J PHYSIOL-REG I, V300, pR1100, DOI 10.1152/ajpregu.00653.2010; HUNTLEY ME, 1994, MAR ECOL PROG SER, V107, P23, DOI 10.3354/meps107023; IKEDA T, 1982, MAR BIOL, V71, P283, DOI 10.1007/BF00397045; IKEDA T, 1981, AUST J MAR FRESH RES, V32, P921; IKEDA T, 1985, MAR BIOL, V85, P1, DOI 10.1007/BF00396409; ISHII H, 1987, POLAR BIOL, V7, P379, DOI 10.1007/BF00293228; Jones RH, 2002, MAR ECOL PROG SER, V235, P147, DOI 10.3354/meps235147; Kato M, 1982, T TOKYO U FISH, V5, P167; Kawaguchi S, 2011, BIOL LETTERS, V7, P288, DOI 10.1098/rsbl.2010.0777; Kim HC, 2006, LIMNOL OCEANOGR, V51, P331, DOI 10.4319/lo.2006.51.1.0331; Kim HC, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040271; King R, 2003, MAR FRESHW BEHAV PHY, V36, P271, DOI 10.1080/10236240310001614457; KIORBOE T, 1985, MAR ECOL PROG SER, V26, P85, DOI 10.3354/meps026085; Koeve W, 2012, BIOGEOSCIENCES, V9, P3787, DOI 10.5194/bg-9-3787-2012; Lascara CM, 1999, DEEP-SEA RES PT I, V46, P951, DOI 10.1016/S0967-0637(98)00099-5; LAWS RM, 1985, AM SCI, V73, P26; Lehninger A L, 1982, PRINCIPLES BIOCH; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maas AE, 2011, MAR ECOL PROG SER, V441, P129, DOI 10.3354/meps09358; Mackey MD, 1996, MAR ECOL PROG SER, V144, P265, DOI 10.3354/meps144265; Martinson DG, 2008, DEEP-SEA RES PT II, V55, P1964, DOI 10.1016/j.dsr2.2008.04.038; Mauchline J., 1998, ADV MAR BIOL, V33, P1, DOI DOI 10.1163/156854008784513492; McKendry JE, 2001, J EXP BIOL, V204, P1519; McKenzie DJ, 2002, J COMP PHYSIOL B, V172, P339, DOI 10.1007/s00360-002-0260-5; McNeil BI, 2008, P NATL ACAD SCI USA, V105, P18860, DOI 10.1073/pnas.0806318105; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Meyer B, 2010, MAR ECOL PROG SER, V398, P1, DOI 10.3354/meps08371; MEYER MA, 1983, POLAR BIOL, V1, P193, DOI 10.1007/BF00443187; Michaelidis B, 2007, MAR BIOL, V150, P1417, DOI 10.1007/s00227-006-0436-8; Miller CA, 1998, J PLANKTON RES, V20, P1767, DOI 10.1093/plankt/20.9.1767; Moline MA, 2004, GLOBAL CHANGE BIOL, V10, P1973, DOI 10.1111/j.1365-2486.2004.00825.x; Montes-Hugo M, 2009, SCIENCE, V323, P1470, DOI 10.1126/science.1164533; MORRIS DJ, 1984, J CRUSTACEAN BIOL, V4, P185, DOI 10.1163/1937240X84X00589; Nicol S, 2006, BIOSCIENCE, V56, P111, DOI 10.1641/0006-3568(2006)056[0111:KCASIE]2.0.CO;2; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Pakhomov EA, 2004, DEEP-SEA RES PT II, V51, P2617, DOI 10.1016/j.dsr2.2000.11.002; Pakhomov EA, 1997, J PLANKTON RES, V19, P399, DOI 10.1093/plankt/19.4.399; Parsons T.R., 1984, MANUAL BIOL CHEM MET; Peltzer ET, 1996, MAR CHEM, V54, P85, DOI 10.1016/0304-4203(96)00023-0; Perissinotto R, 1997, MAR ECOL PROG SER, V160, P77, DOI 10.3354/meps160077; Perissinotto R, 2000, MAR BIOL, V136, P129, DOI 10.1007/s002270050015; Portner HO, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002561; Portner HO, 2004, J OCEANOGR, V60, P705, DOI 10.1007/s10872-004-5763-0; PORTNER HO, 1990, J EXP BIOL, V150, P407; PRICE HJ, 1988, MAR BIOL, V97, P67, DOI 10.1007/BF00391246; PRICE NM, 1987, MAR BIOL, V94, P307, DOI 10.1007/BF00392945; PUTT M, 1989, LIMNOL OCEANOGR, V34, P1097, DOI 10.4319/lo.1989.34.6.1097; Quetin L.B., 1985, P372; QUETIN LB, 1991, AM ZOOL, V31, P49; Quetin LB, 1987, EOS, V68, P109; Raven J, 2005, 1205 ROYAL SCI; REGNAULT M, 1987, BIOL REV, V62, P1, DOI 10.1111/j.1469-185X.1987.tb00623.x; Ridgwell A, 2010, NAT GEOSCI, V3, P196, DOI 10.1038/NGEO755; Riebesell U, 2004, J OCEANOGR, V60, P719, DOI 10.1007/s10872-004-5764-z; Robbins L.L., 2010, CO2CALC USER FRIENDL, DOI 10.3133/ofr20101280; Roger C., 1982, Oceanographie Tropicale, V17, P177; Rosa R, 2008, P NATL ACAD SCI USA, V105, P20776, DOI 10.1073/pnas.0806886105; ROSS RM, 1982, MAR BIOL, V68, P1, DOI 10.1007/BF00393135; Ruiz-Halpern S, 2011, LIMNOL OCEANOGR, V56, P521, DOI 10.4319/lo.2011.56.2.0521; Saage A, 2009, J SEA RES, V62, P16, DOI 10.1016/j.seares.2009.01.002; Saba GK, 2011, J EXP MAR BIOL ECOL, V404, P47, DOI 10.1016/j.jembe.2011.04.013; Saba GK, 2009, MAR ECOL PROG SER, V386, P147, DOI 10.3354/meps08070; Sabine CL, 2007, GREENHOUSE GAS SINKS, P31, DOI 10.1079/9781845931896.0031; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Schofield O, 2010, SCIENCE, V328, P1520, DOI 10.1126/science.1185779; Seibel BA, 2003, J EXP BIOL, V206, P641, DOI 10.1242/jeb.00141; Seibel BA, 2001, SCIENCE, V294, P319, DOI 10.1126/science.1065301; Seibel BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030464; Sharp JH, 2002, MAR CHEM, V77, P239, DOI 10.1016/S0304-4203(02)00002-6; Siegel V., 1988, P219; Skvarca P, 1999, ANN GLACIOL-SER, V29, P255, DOI 10.3189/172756499781821283; Smetacek V, 2004, ANTARCT SCI, V16, P541, DOI 10.1017/S0954102004002317; Solomon S., 2007, PHYS SCI BASIS WORKI; Somero G.N., 1985, P454; Stammerjohn SE, 2008, DEEP-SEA RES PT II, V55, P2041, DOI 10.1016/j.dsr2.2008.04.026; Steinberg DK, 2008, NITROGEN IN THE MARINE ENVIRONMENT, 2ND EDITION, P1135, DOI 10.1016/B978-0-12-372522-6.00026-8; Strickland J.D.H., 1968, B FISHERIES RES BOAR, V167; Tovar-Sanchez A, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL029096; Utermohl H., 1931, Verhandlungen der Internationalen Vereinigung fuer Theoretische Limnologie Stuttgart, V5, P567; Vaughan DG, 2003, CLIMATIC CHANGE, V60, P243, DOI 10.1023/A:1026021217991; WALSH PJ, 1989, B MAR SCI, V45, P68; Watanabe Y, 2006, J OCEANOGR, V62, P185, DOI 10.1007/s10872-006-0043-9; WEBER LH, 1985, ANTARCTIC NUTR CYCLE, P283; Whitehouse MJ, 2011, DEEP-SEA RES PT I, V58, P725, DOI 10.1016/j.dsr.2011.03.006; Wood HL, 2008, P ROY SOC B-BIOL SCI, V275, P1767, DOI 10.1098/rspb.2008.0343; WRIGHT SW, 1991, MAR ECOL PROG SER, V77, P183, DOI 10.3354/meps077183; Yen J, 2003, MAR FRESHW BEHAV PHY, V36, P307, DOI 10.1080/10236240310001614439	124	54	55	0	128	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52224	10.1371/journal.pone.0052224	http://dx.doi.org/10.1371/journal.pone.0052224			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300621	Green Published, gold			2022-12-27	WOS:000313618800060
J	Arruvito, L; Sabatte, J; Pandolfi, J; Baz, P; Billordo, LA; Lasala, MB; Salomon, H; Geffner, J; Fainboim, L				Arruvito, Lourdes; Sabatte, Juan; Pandolfi, Julieta; Baz, Placida; Billordo, Luis A.; Lasala, Maria B.; Salomon, Horacio; Geffner, Jorge; Fainboim, Leonardo			Analysis of Suppressor and Non-Suppressor FOXP3+T Cells in HIV-1-Infected Patients	PLOS ONE			English	Article							REGULATORY T-CELLS; HIV-INFECTION; ANTIRETROVIRAL THERAPY; IMMUNE ACTIVATION; EXPRESSION; CD4(+)CD25(+); PHENOTYPE; FREQUENCY; SUBSETS	Recently, it was shown that peripheral blood FOXP3+CD4+ T cells are composed of three phenotypic and functionally distinct subpopulations. Two of them having in vitro suppressive effects were characterized as resting Treg cells (rTregs) and activated Treg cells (aTregs). A third subset, identified as FOXP3+ non-Tregs, does not display any suppressor activity and produce high levels of Th1 and Th17 cytokines upon stimulation. In the present study we focus on the characteristics of these three subsets of FOXP3+CD4+ T cells in untreated HIV-1-infected patients. We found that the absolute counts of rTregs, aTregs and FOXP3+ non-Tregs were reduced in HIV-1 patients compared with healthy donors. The relative frequency of rTregs and aTregs was similar in HIV-1 patients and healthy donors, while the frequency of FOXP3+ non-Tregs was significantly higher in HIV-1 patients, reaching a maximum in those patients with the lower values of CD4 counts. Contrasting with the observations made in FOXP3-CD4+ T cells, we did not find a negative correlation between the number of rTregs, aTregs or FOXP3+ non-Tregs and virus load. Studies performed with either whole PBMCs or sorted aTregs and FOXP3+ non-Tregs cells showed that these two populations of FOXP3+ T cells were highly permissive to HIV-1 infection. Upon infection, FOXP3+ non-Tregs markedly down-regulates its capacity to produce Th1 and Th17 cytokines, however, they retain the ability to produce substantial amounts of Th2 cytokines. This suggests that FOXP3+ non-Tregs might contribute to the polarization of CD4+ T cells into a Th2 profile, predictive of a poor outcome of HIV-1-infected patients.	[Arruvito, Lourdes; Pandolfi, Julieta; Baz, Placida; Billordo, Luis A.; Fainboim, Leonardo] Univ Buenos Aires, Inst Immunol Genet & Metab INIGEM, Clin Hosp, Natl Council Sci & Technol Res, Buenos Aires, DF, Argentina; [Sabatte, Juan; Salomon, Horacio; Geffner, Jorge] Univ Buenos Aires, Sch Med, Dept Microbiol, Inst Biomed Res Retroviruses & AIDS, Buenos Aires, DF, Argentina; [Lasala, Maria B.] Univ Buenos Aires, Clin Hosp, Dept Infect Dis, Buenos Aires, DF, Argentina	University of Buenos Aires; University of Buenos Aires; University of Buenos Aires	Fainboim, L (corresponding author), Univ Buenos Aires, Inst Immunol Genet & Metab INIGEM, Clin Hosp, Natl Council Sci & Technol Res, Buenos Aires, DF, Argentina.	lfainboim@hospitaldeclinicas.uba.ar		Fainboim, Leonardo/0000-0002-8907-0341	CONICET - PMO BID - PICT, Argentina [2339- PAE 37011]	CONICET - PMO BID - PICT, Argentina	This work was supported by grants from CONICET - PMO BID - PICT No 2339- PAE 37011 -Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson J, 2005, J IMMUNOL, V174, P3143, DOI 10.4049/jimmunol.174.6.3143; Apoil PA, 2005, JAIDS-J ACQ IMM DEF, V39, P381, DOI 10.1097/01.qai.0000169662.30783.2d; Arruvito L, 2007, J IMMUNOL, V178, P2572, DOI 10.4049/jimmunol.178.4.2572; Baker CAR, 2007, CLIN EXP IMMUNOL, V147, P533, DOI 10.1111/j.1365-2249.2006.03319.x; Belkaid Y, 2009, ANNU REV IMMUNOL, V27, P551, DOI 10.1146/annurev.immunol.021908.132723; Bi X, 2009, EUR J IMMUNOL, V39, P301, DOI 10.1002/eji.200838667; Di Mitri D, 2011, J IMMUNOL, V187, P2093, DOI 10.4049/jimmunol.1100978; Douek DC, 2003, ANNU REV IMMUNOL, V21, P265, DOI 10.1146/annurev.immunol.21.120601.141053; Eggena MP, 2005, J IMMUNOL, V174, P4407, DOI 10.4049/jimmunol.174.7.4407; Epple HJ, 2006, BLOOD, V108, P3072, DOI 10.1182/blood-2006-04-016923; Fazekas de St Groth B, 2008, AIDS, V22, P671, DOI 10.1097/QAD.0b013e3282f466da; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Hammer SM, 2008, JAMA-J AM MED ASSOC, V300, P555, DOI 10.1001/jama.300.5.555; Hunt PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015924; Imami N, 2002, J VIROL, V76, P9011, DOI 10.1128/JVI.76.18.9011-9023.2002; Lim A, 2007, AIDS, V21, P1525, DOI 10.1097/QAD.0b013e32825eab8b; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Lundgren JD, 2008, HIV MED, V9, P72, DOI 10.1111/j.1468-1293.2007.00534.x; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Roncador G, 2005, EUR J IMMUNOL, V35, P1681, DOI 10.1002/eji.200526189; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Severe P, 2010, NEW ENGL J MED, V363, P257, DOI 10.1056/NEJMoa0910370; Simonetta F, 2012, J INFECT DIS, V205, P1510, DOI 10.1093/infdis/jis235; Sousa AE, 1999, J IMMUNOL, V162, P3718; Tenorio AR, 2008, JAIDS-J ACQ IMM DEF, V48, P577, DOI 10.1097/QAI.0b013e31817bbea5; Tsunemi S, 2005, AIDS, V19, P879, DOI 10.1097/01.aids.0000171401.23243.56; zur Wiesch JS, 2011, J VIROL, V85, P1287, DOI 10.1128/JVI.01758-10	29	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52580	10.1371/journal.pone.0052580	http://dx.doi.org/10.1371/journal.pone.0052580			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285102	Green Published, Green Submitted, gold			2022-12-27	WOS:000312794500206
J	Chang, ZL; Lu, ST; Chen, LH; Jin, Q; Yang, J				Chang, Zhili; Lu, Shuting; Chen, Lihong; Jin, Qi; Yang, Jian			Causative Species and Serotypes of Shigellosis in Mainland China: Systematic Review and Meta-Analysis	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; DISEASE BURDEN; FLEXNERI	Background: Shigella, the causative agent of shigellosis, is a major global public health concern, particularly in developing countries with poor sanitation. A comprehensive and current understanding of the prevalent species and serotypes of shigellosis is essential for both disease prevention and vaccine development. However, no current data are available on the causative species/serotypes of shigellosis in mainland China during the past decade. Methods and Findings: Relevant studies addressing the prevalent species of shigellosis in mainland China from January 2001 to December 2010 were identified from PubMed and the Chinese BioMedical Literature Database (in Chinese) until April 2012. A total of 131 eligible articles (136 studies) were included in this review. Meta-analyses showed that the prevalences of S. flexneri and S. sonnei were 76.2% (95% CI, 73.7%-78.5%) and 21.3% (95% CI, 19.0%-23.7%), respectively. Stratified analyses indicated a decrease in the prevalence of S. flexneri cases and an increase in the prevalence of S. sonnei cases concurrent with the rapid economic growth experienced by China in recent years. Moreover, significantly higher rates of S. sonnei were observed in the East, North and Northeast regions of China, as compared to the rest of the country. These phenomena imply the possible association between the prevalent species of Shigella and regional economic status; however, additional factors also exist and require further investigations. Moreover, the two major serotypes S. flexneri 2a and 4c accounted for 21.5% (95% CI, 16.7%-27.4%) and 12.9% (95% CI 9.8%-16.9%) of S. flexneri infections, respectively, in the past decade. However, these results were found to be frequently heterogeneous (p for Q tests <0.01). Conclusions: This study provides an updated review of the causative agents of shigellosis in mainland China and focuses on the importance of strengthening prevention and research efforts on S. sonnei and the newly emerged S. flexneri serotype 4c.	[Chang, Zhili; Chen, Lihong; Jin, Qi; Yang, Jian] Chinese Acad Med Sci, MOH Key Lab Syst Biol Pathogens, Inst Pathogen Biol, Beijing 100730, Peoples R China; [Chang, Zhili; Lu, Shuting; Chen, Lihong; Jin, Qi; Yang, Jian] Peking Union Med Coll, Beijing 100021, Peoples R China; [Lu, Shuting] Chinese Acad Med Sci, Inst Med Informat Med Lib, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Information - CAMS	Jin, Q (corresponding author), Chinese Acad Med Sci, MOH Key Lab Syst Biol Pathogens, Inst Pathogen Biol, Beijing 100730, Peoples R China.	zdsys@vip.sina.com; yangj@ipbcams.ac.cn	Yang, Jian/A-3031-2009	Yang, Jian/0000-0002-8826-5198	Ministry of Science and Technology of China [2009CB522603, 2011CB504904]; Beijing Nova Program [2009A67]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Beijing Nova Program(Beijing Municipal Science & Technology Commission)	This work was supported by the National Basic Research Program from the Ministry of Science and Technology of China grants 2009CB522603 and 2011CB504904 (to JY and QJ, respectively), and Beijing Nova Program grant 2009A67 (to JY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardhan P, 2010, EMERG INFECT DIS, V16, P1718, DOI 10.3201/eid1611.090934; DUPONT HL, 1989, J INFECT DIS, V159, P1126, DOI 10.1093/infdis/159.6.1126; HALE TL, 1991, MICROBIOL REV, V55, P206, DOI 10.1128/MMBR.55.2.206-224.1991; Jin Q, 2002, NUCLEIC ACIDS RES, V30, P4432, DOI 10.1093/nar/gkf566; Kaminski RW, 2009, EXPERT REV VACCINES, V8, P1693, DOI 10.1586/ERV.09.127; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; Kweon MN, 2008, CURR OPIN INFECT DIS, V21, P313, DOI 10.1097/QCO.0b013e3282f88b92; PRYAMUKHINA NS, 1988, J CLIN MICROBIOL, V26, P1147, DOI 10.1128/JCM.26.6.1147-1149.1988; Rui X, 1996, Chin J Biotechnol, V12, P89; Seol SY, 2006, J MED MICROBIOL, V55, P871, DOI 10.1099/jmm.0.46441-0; Sui JL, 2010, DIS SURVEILL, V25, P947, DOI DOI 10.3784/J.ISSN.1003-9961.2010.12.006; van Boven M, 2005, P ROY SOC B-BIOL SCI, V272, P1617, DOI 10.1098/rspb.2005.3108; von Seidlein L, 2006, PLOS MED, V3, P1556, DOI 10.1371/journal.pmed.0030353; Wang XY, 2006, B WORLD HEALTH ORGAN, V84, P561, DOI 10.2471/BLT.05.023853; Wei HL, 2007, DIAGN MICR INFEC DIS, V58, P469, DOI 10.1016/j.diagmicrobio.2007.03.006; Yang F, 2005, NUCLEIC ACIDS RES, V33, P6445, DOI 10.1093/nar/gki954	17	37	46	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52515	10.1371/journal.pone.0052515	http://dx.doi.org/10.1371/journal.pone.0052515			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285073	Green Submitted, gold, Green Published			2022-12-27	WOS:000312794500186
J	Farre, JC; Aknin, C; Araya, A; Castandet, B				Farre, Jean-Claude; Aknin, Cindy; Araya, Alejandro; Castandet, Benoit			RNA Editing in Mitochondrial Trans-Introns Is Required for Splicing	PLOS ONE			English	Article							GROUP-II INTRON; PLANT-MITOCHONDRIA; GENE-EXPRESSION; TRANSSPLICING MODEL; LARIAT FORMATION; BRANCH-SITE; WHEAT; TRANSCRIPTION; OENOTHERA; SEQUENCE	In plant mitochondria, gene expression of translatable mRNAs is a complex process with two critical steps, RNA editing and splicing. We studied the role of RNA editing on non-coding regions of the mat-r-nad1e-nad5c transcript from wheat mitochondria. This RNA contains two trans-introns, 3'-nad1-I4 and 3'-nad5-I2, involved in different trans-splicing events, ensuring the association of nad1d-nad1e and nad5b-nad5c exons from nad1 and nad5 mRNAs respectively. The C-to-U editing changes studied here affect homologous positions on 3'-nad1-I4 and 3'-nad5-I2. It is proposed that these base changes are necessary to place an Adenosine residue in a bulging conformation characteristic of domain VI (D6) from group II introns. In this work, we investigated the role of RNA editing events on 3'-nad1-I4 and 3'-nad5-I2 in the trans-splicing process using in vivo and in organello approaches. When the branched intermediates formed during the splicing process were analyzed, the C residues from D6 intron domains from 3'-nad1-I4 and 3'-nad5-I2 were found changed to U, suggesting that RNA editing of these residues could be mandatory for splicing. This assumption was tested by expressing recombinant mat-r-nad1e transgenes introduced into mitochondria by electroporation. Mutation of the editing target residue dramatically affected trans-splicing. Interestingly, the exon joining efficiency was not recovered by compensatory mutations, suggesting that the role of RNA editing is not confined to the restoration of the secondary structure of domain D6 of the intron. Our results strongly support the hypothesis that RNA editing in trans-introns precedes maturation, and is required for the splicing reaction. In addition, this is the first report using an in organello approach to study the trans-splicing process, opening the way to future studies of this peculiar mechanism.	[Farre, Jean-Claude; Aknin, Cindy; Araya, Alejandro; Castandet, Benoit] CNRS, Microbiol Fondamentale & Pathol UMR5234, Bordeaux, France; [Farre, Jean-Claude; Aknin, Cindy; Araya, Alejandro; Castandet, Benoit] Univ Bordeaux Segalen, Bordeaux, France; [Araya, Alejandro] Ctr INRA Bordeaux, Inst Biol Vegetale Mol, Biol Fruit & Pathol UMR1332, Vilenave Dornon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; INRAE; UDICE-French Research Universities; Universite de Bordeaux	Araya, A (corresponding author), CNRS, Microbiol Fondamentale & Pathol UMR5234, Bordeaux, France.	aaraya@reger.u-bordeaux2.fr			Centre National de la Recherche Scientifique; Universite Bordeaux Segalen, France; PICS-CNRS program [3641]	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite Bordeaux Segalen, France; PICS-CNRS program	This research was supported by the Centre National de la Recherche Scientifique, the Universite Bordeaux Segalen, France, and the PICS-CNRS program no 3641. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begu D, 1998, CURR GENET, V33, P420, DOI 10.1007/s002940050355; BEGU D, 1990, PLANT CELL, V2, P1283, DOI 10.1105/tpc.2.12.1283; Begu D, 2011, CURR GENET, V57, P317, DOI 10.1007/s00294-011-0349-z; BINDER S, 1992, J BIOL CHEM, V267, P7615; BLANC V, 1995, FEBS LETT, V373, P56, DOI 10.1016/0014-5793(95)00991-H; Bonen L, 2008, MITOCHONDRION, V8, P26, DOI 10.1016/j.mito.2007.09.005; BORNER GV, 1995, MOL GEN GENET, V246, P739, DOI 10.1007/BF00290721; Carrillo C, 1997, NUCLEIC ACIDS RES, V25, P403, DOI 10.1093/nar/25.2.403; Carrillo C, 2001, MOL GEN GENET, V264, P595, DOI 10.1007/s004380000345; Castandet B, 2011, BIOCHEMISTRY-MOSCOW+, V76, P924, DOI 10.1134/S0006297911080086; Castandet B, 2010, NUCLEIC ACIDS RES, V38, P7112, DOI 10.1093/nar/gkq591; Chanfreau G, 1996, EMBO J, V15, P3466, DOI 10.1002/j.1460-2075.1996.tb00713.x; CHAPDELAINE Y, 1991, CELL, V65, P465, DOI 10.1016/0092-8674(91)90464-A; Choury D, 2005, NUCLEIC ACIDS RES, V33, P7058, DOI 10.1093/nar/gki1017; Chu VT, 1998, RNA, V4, P1186, DOI 10.1017/S1355838298980724; Costa M, 1997, J MOL BIOL, V267, P520, DOI 10.1006/jmbi.1996.0882; COVELLO PS, 1990, FEBS LETT, V268, P5, DOI 10.1016/0014-5793(90)80958-L; Daniels DL, 1996, J MOL BIOL, V256, P31, DOI 10.1006/jmbi.1996.0066; de Longevialle AF, 2007, PLANT CELL, V19, P3256, DOI 10.1105/tpc.107.054841; de Longevialle AF, 2010, MOL PLANT, V3, P691, DOI 10.1093/mp/ssq025; DESOUZA AP, 1991, PLANT CELL, V3, P1363, DOI 10.1105/tpc.3.12.1363; Elina H, 2010, NUCLEIC ACIDS RES, V38, P996, DOI 10.1093/nar/gkp994; Farre JC, 2002, PLANT J, V29, P203, DOI 10.1046/j.1365-313x.2002.01207.x; Farre JC, 1999, PLANT MOL BIOL, V40, P959, DOI 10.1023/A:1006296422485; Farre JC, 2001, NUCLEIC ACIDS RES, V29, P2484, DOI 10.1093/nar/29.12.2484; Farre JC, 2007, METHOD ENZYMOL, V424, P483, DOI 10.1016/S0076-6879(07)24022-4; Finta C, 2002, J BIOL CHEM, V277, P5882, DOI 10.1074/jbc.M109175200; Granlund M, 2001, J BACTERIOL, V183, P2560, DOI 10.1128/JB.183.8.2560-2569.2001; Hamill S, 2006, MOL CELL, V23, P831, DOI 10.1016/j.molcel.2006.07.017; HERNOULD M, 1993, P NATL ACAD SCI USA, V90, P2370, DOI 10.1073/pnas.90.6.2370; JARRELL KA, 1988, MOL CELL BIOL, V8, P2361, DOI 10.1128/MCB.8.6.2361; Kuhn K, 2005, NUCLEIC ACIDS RES, V33, P337, DOI 10.1093/nar/gki179; Laurencikiene J, 2006, EMBO REP, V7, P303, DOI 10.1038/sj.embor.7400621; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Li CF, 2011, EMBO J, V30, P3040, DOI 10.1038/emboj.2011.214; Li CF, 2011, RNA, V17, P1321, DOI 10.1261/rna.2655911; Li-Pook-Than J, 2006, NUCLEIC ACIDS RES, V34, P2782, DOI 10.1093/nar/gkl328; Liere K, 2011, J PLANT PHYSIOL, V168, P1345, DOI 10.1016/j.jplph.2011.01.005; Martin W, 2006, NATURE, V440, P41, DOI 10.1038/nature04531; MICHEL F, 1995, ANNU REV BIOCHEM, V64, P435, DOI 10.1146/annurev.bi.64.070195.002251; Osenberg S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011173; Pyle AM, 2010, CRIT REV BIOCHEM MOL, V45, P215, DOI 10.3109/10409231003796523; Schlatterer JC, 2006, J AM CHEM SOC, V128, P3866, DOI 10.1021/ja0578754; SCHMELZER C, 1986, CELL, V46, P557, DOI 10.1016/0092-8674(86)90881-0; Schmitz-Linneweber C, 2006, PLANT CELL, V18, P2650, DOI 10.1105/tpc.106.046110; SHARP PA, 1991, SCIENCE, V254, P663, DOI 10.1126/science.1948046; Toor N, 2006, NUCLEIC ACIDS RES, V34, P6461, DOI 10.1093/nar/gkl820; VANDERVEEN R, 1987, EMBO J, V6, P3827, DOI 10.1002/j.1460-2075.1987.tb02719.x; Vogel J, 2002, EMBO J, V21, P3794, DOI 10.1093/emboj/cdf359; Waldsich C, 2007, NAT STRUCT MOL BIOL, V14, P37, DOI 10.1038/nsmb1181; WISSINGER B, 1991, CELL, V65, P473, DOI 10.1016/0092-8674(91)90465-B; Zabaleta E, 1996, P NATL ACAD SCI USA, V93, P11259, DOI 10.1073/pnas.93.20.11259; ZANLUNGO S, 1995, CURR GENET, V27, P565, DOI 10.1007/BF00314449	53	33	33	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52644	10.1371/journal.pone.0052644	http://dx.doi.org/10.1371/journal.pone.0052644			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285127	Green Published, Green Submitted, gold			2022-12-27	WOS:000312794500218
J	Leigh, R; Jen, SS; Varma, DD; Hillis, AE; Barker, PB				Leigh, Richard; Jen, Shyian S.; Varma, Daniel D.; Hillis, Argye E.; Barker, Peter B.			Arrival Time Correction for Dynamic Susceptibility Contrast MR Permeability Imaging in Stroke Patients	PLOS ONE			English	Article							BRAIN-BARRIER DISRUPTION; CEREBRAL BLOOD-VOLUME; ACUTE ISCHEMIC-STROKE; HEMORRHAGIC TRANSFORMATION; PARENCHYMAL ENHANCEMENT; PREDICTION; THERAPY; GRADE	Purpose: To determine if applying an arrival time correction (ATC) to dynamic susceptibility contrast (DSC) based permeability imaging will improve its ability to identify contrast leakage in stroke patients for whom the shape of the measured curve may be very different due to hypoperfusion. Materials and Methods: A technique described in brain tumor patients was adapted to incorporate a correction for delayed contrast delivery due to perfusion deficits. This technique was applied to the MRIs of 9 stroke patients known to have blood-brain barrier (BBB) disruption on T1 post contrast imaging. Regions of BBB damage were compared with normal tissue from the contralateral hemisphere. Receiver operating characteristic (ROC) analysis was performed to compare the detection of BBB damage before and after ATC. Results: ATC improved the area under the curve (AUC) of the ROC from 0.53 to 0.70. The sensitivity improved from 0.51 to 0.67 and the specificity improved from 0.57 to 0.66. Visual inspection of the ROC curve revealed that the performance of the uncorrected analysis was worse than random guess at some thresholds. Conclusions: The ability of DSC permeability imaging to identify contrast enhancing tissue in stroke patients improved considerably when an ATC was applied. Using DSC permeability imaging in stroke patients without an ATC may lead to false identification of BBB disruption.	[Leigh, Richard; Jen, Shyian S.; Hillis, Argye E.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Barker, Peter B.] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD USA; [Varma, Daniel D.] Flinders Comprehens Stroke Ctr, Bedford Pk, SA, Australia; [Barker, Peter B.] Kennedy Krieger Inst, FM Kirby Res Ctr Funct Brain Imaging, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Flinders University South Australia; Kennedy Krieger Institute	Leigh, R (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.	rleigh4@jhu.edu	Leigh, Richard/K-8401-2013	Leigh, Richard/0000-0002-8285-1815	NINDS NIH HHS [R01 NS047691] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047691] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bang OY, 2007, ANN NEUROL, V62, P170, DOI 10.1002/ana.21174; Bang OY, 2009, STROKE, V40, P454, DOI 10.1161/STROKEAHA.108.522847; Boxerman JL, 2006, AM J NEURORADIOL, V27, P859; Hjort N, 2008, STROKE, V39, P1025, DOI 10.1161/STROKEAHA.107.497719; Jiang Q, 2002, J CEREBR BLOOD F MET, V22, P559, DOI 10.1097/00004647-200205000-00007; Kim EY, 2005, AM J NEURORADIOL, V26, P1050; Knight RA, 1998, STROKE, V29, P144, DOI 10.1161/01.STR.29.1.144; Latour LL, 2004, ANN NEUROL, V56, P468, DOI 10.1002/ana.20199; Provenzale JM, 2002, AM J ROENTGENOL, V178, P711, DOI 10.2214/ajr.178.3.1780711; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; Warach S, 2004, STROKE, V35, P2659, DOI 10.1161/01.STR.0000144051.32131.09; Wintermark M, 2008, STROKE, V39, P1621, DOI 10.1161/STROKEAHA.107.512319; Wu SP, 2009, INVEST RADIOL, V44, P662, DOI 10.1097/RLI.0b013e3181ae9c40; Zaharchuk G, 2007, AM J NEURORADIOL, V28, P1850, DOI 10.3174/ajnr.A0831	14	24	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52656	10.1371/journal.pone.0052656	http://dx.doi.org/10.1371/journal.pone.0052656			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285132	Green Submitted, Green Published, gold			2022-12-27	WOS:000312794500221
J	Serva, A; Knapp, B; Tsai, YT; Claas, C; Lisauskas, T; Matula, P; Harder, N; Kaderali, L; Rohr, K; Erfle, H; Eils, R; Braga, V; Starkuviene, V				Serva, Andrius; Knapp, Bettina; Tsai, Yueh-Tso; Claas, Christoph; Lisauskas, Tautvydas; Matula, Petr; Harder, Nathalie; Kaderali, Lars; Rohr, Karl; Erfle, Holger; Eils, Roland; Braga, Vania; Starkuviene, Vytaute			miR-17-5p Regulates Endocytic Trafficking through Targeting TBC1D2/Armus	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; E-CADHERIN; BREAST-CANCER; DOWN-REGULATION; IMAGE-ANALYSIS; LUNG CANCERS; MICRORNA; CLUSTER; EXPRESSION; MEMBRANE	miRNA cluster miR-17-92 is known as oncomir-1 due to its potent oncogenic function. miR-17-92 is a polycistronic cluster that encodes 6 miRNAs, and can both facilitate and inhibit cell proliferation. Known targets of miRNAs encoded by this cluster are largely regulators of cell cycle progression and apoptosis. Here, we show that miRNAs encoded by this cluster and sharing the seed sequence of miR-17 exert their influence on one of the most essential cellular processes - endocytic trafficking. By mRNA expression analysis we identified that regulation of endocytic trafficking by miR-17 can potentially be achieved by targeting of a number of trafficking regulators. We have thoroughly validated TBC1D2/Armus, a GAP of Rab7 GTPase, as a novel target of miR-17. Our study reveals regulation of endocytic trafficking as a novel function of miR-17, which might act cooperatively with other functions of miR-17 and related miRNAs in health and disease.	[Lisauskas, Tautvydas; Harder, Nathalie; Rohr, Karl; Eils, Roland; Starkuviene, Vytaute] Heidelberg Univ, DKFZ, BioQuant, Heidelberg, Germany; [Knapp, Bettina; Kaderali, Lars] Tech Univ Dresden, Inst Med Informat & Biometry, Dresden, Germany; [Matula, Petr; Harder, Nathalie; Rohr, Karl; Eils, Roland] Heidelberg Univ, Inst Pharm & Mol Biotechnol, Heidelberg, Germany; [Matula, Petr] Masaryk Univ, Fac Informat, Ctr Biomed Image Anal, Brno, Czech Republic; [Braga, Vania] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Technische Universitat Dresden; Ruprecht Karls University Heidelberg; Masaryk University Brno; Imperial College London	Starkuviene, V (corresponding author), Heidelberg Univ, DKFZ, BioQuant, Heidelberg, Germany.	vytaute.starkuviene@bioquant.uni-heidelberg.de	Matula, Petr/L-2119-2013; Starkuviene, Vytaute/AAG-9378-2021; Braga, Vania MM/C-7345-2008; Eils, Roland/B-6121-2009	Matula, Petr/0000-0003-4125-1597; Eils, Roland/0000-0002-0034-4036; Harder, Nathalie/0000-0002-6171-6462; Kaderali, Lars/0000-0002-2359-2294; Lisauskas, Tautvydas/0000-0001-9954-0469; Braga, Vania/0000-0003-0546-7163	BMBF FORSYS ViroQuant [0313923]; BMBF SysTec [0315523A]; Baden Wurttemberg Stiftung [P-LS-Meth/ 11]; LGFG fellowship of Graduate Academy of Heidelberg University; Grant Agency of the Czech Republic [P302/12/G157]; MRC [G0600791] Funding Source: UKRI; Cancer Research UK [11980] Funding Source: researchfish; Medical Research Council [G0600791] Funding Source: researchfish	BMBF FORSYS ViroQuant(Federal Ministry of Education & Research (BMBF)); BMBF SysTec(Federal Ministry of Education & Research (BMBF)); Baden Wurttemberg Stiftung; LGFG fellowship of Graduate Academy of Heidelberg University; Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by BMBF FORSYS ViroQuant (#0313923), BMBF SysTec (0315523A) and Baden Wurttemberg Stiftung (P-LS-Meth/ 11). AS is supported by LGFG fellowship of Graduate Academy of Heidelberg University. PM is partially supported by the Grant Agency of the Czech Republic (P302/12/G157). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alto NM, 2002, J CELL BIOL, V158, P659, DOI 10.1083/jcb.200204081; Andreev J, 1999, MOL CELL BIOL, V19, P2338; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; BAKER ME, 1988, BIOCHEM J, V255, P1057, DOI 10.1042/bj2551057; Baum B, 2011, J CELL BIOL, V192, P907, DOI 10.1083/jcb.201009141; BIRCHMEIER C, 1993, ANNU REV CELL BIOL, V9, P511, DOI 10.1146/annurev.cb.09.110193.002455; Bonauer A, 2009, CELL CYCLE, V8, P3866, DOI 10.4161/cc.8.23.9994; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; CARPENTER G, 1976, J CELL BIOL, V71, P159, DOI 10.1083/jcb.71.1.159; Carraro G, 2009, DEV BIOL, V333, P238, DOI 10.1016/j.ydbio.2009.06.020; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chotard L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015662; Chotard L, 2010, MOL BIOL CELL, V21, P2285, DOI 10.1091/mbc.E09-11-0947; Cloonan N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r127; Elcheva I, 2009, MOL CELL, V35, P240, DOI 10.1016/j.molcel.2009.06.007; Engqvist-Goldstein AEY, 2004, MOL BIOL CELL, V15, P1666, DOI 10.1091/mbc.E03-09-0639; Fontana L, 2007, NAT CELL BIOL, V9, P775, DOI 10.1038/ncb1613; Fontana L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002236; Frasa MAM, 2010, CURR BIOL, V20, P198, DOI 10.1016/j.cub.2009.12.053; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; GHOSH RN, 1994, J CELL SCI, V107, P2177; Gilbert DF, 2009, J BIOMOL SCREEN, V14, P944, DOI 10.1177/1087057109339523; Grillari J, 2010, BIOGERONTOLOGY, V11, P501, DOI 10.1007/s10522-010-9272-9; Hackl M, 2010, AGING CELL, V9, P291, DOI 10.1111/j.1474-9726.2010.00549.x; Harder N, 2008, METHOD CELL BIOL, V85, P539, DOI 10.1016/S0091-679X(08)85023-6; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hirota Y, 2009, CELL MOL LIFE SCI, V66, P2913, DOI 10.1007/s00018-009-0080-9; HOPKINS CR, 1983, CELL, V35, P321, DOI 10.1016/0092-8674(83)90235-0; Hossain A, 2006, MOL CELL BIOL, V26, P8191, DOI 10.1128/MCB.00242-06; Jadhav V, 2012, BIOTECHNOL BIOENG, V109, P1376, DOI 10.1002/bit.24490; Kanzaki H, 2011, PROTEOMICS, V11, P3531, DOI 10.1002/pmic.201000501; Le TL, 1999, J CELL BIOL, V146, P219, DOI 10.1083/jcb.146.1.219; LEE I, 2009, GENOME RES; Leonard D, 2008, J CELL SCI, V121, P3445, DOI 10.1242/jcs.031484; Li CX, 2007, MOL BIOL CELL, V18, P3081, DOI 10.1091/mbc.E07-02-0172; Li WD, 2009, DEVELOPMENT, V136, P2445, DOI 10.1242/dev.035949; Li ZH, 2011, EMBO J, V30, P823, DOI 10.1038/emboj.2011.2; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loerke D, 2009, PLOS BIOL, V7, P628, DOI 10.1371/journal.pbio.1000057; Lu Y, 2007, DEV BIOL, V310, P442, DOI 10.1016/j.ydbio.2007.08.007; Manni I, 2009, FASEB J, V23, P3957, DOI 10.1096/fj.09-131847; Matsubara H, 2007, ONCOGENE, V26, P6099, DOI 10.1038/sj.onc.1210425; Matula P, 2009, CYTOM PART A, V75A, P309, DOI 10.1002/cyto.a.20662; MAYOR S, 1993, J CELL BIOL, V121, P1257, DOI 10.1083/jcb.121.6.1257; McCaffrey MW, 2001, FEBS LETT, V495, P21, DOI 10.1016/S0014-5793(01)02359-6; Mettlen M, 2010, J CELL BIOL, V188, P919, DOI 10.1083/jcb.200908078; Moretti F, 2010, RNA, V16, P2493, DOI 10.1261/rna.2384610; Mu P, 2009, GENE DEV, V23, P2806, DOI 10.1101/gad.1872909; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Olive V, 2009, GENE DEV, V23, P2839, DOI 10.1101/gad.1861409; Palacios F, 2005, MOL CELL BIOL, V25, P389, DOI 10.1128/MCB.25.1.389-402.2005; Patel N, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-10; Paterson AD, 2003, J BIOL CHEM, V278, P21050, DOI 10.1074/jbc.M300082200; Peralta ER, 2010, J BIOL CHEM, V285, P16814, DOI 10.1074/jbc.M110.111633; Pickering MT, 2009, ONCOGENE, V28, P140, DOI 10.1038/onc.2008.372; Pillai RS, 2005, RNA, V11, P1753, DOI 10.1261/rna.2248605; Rieber N, 2009, BIOINFORMATICS, V25, P678, DOI 10.1093/bioinformatics/btp014; Roepstorff K, 2008, HISTOCHEM CELL BIOL, V129, P563, DOI 10.1007/s00418-008-0401-3; Schaar DG, 2009, EXP HEMATOL, V37, P245, DOI 10.1016/j.exphem.2008.10.002; Scherr M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm971; Schmidt-Glenewinkel H, 2009, J BIOL CHEM, V284, P17243, DOI 10.1074/jbc.M809586200; SCHNEIDER WJ, 1989, BIOCHIM BIOPHYS ACTA, V988, P303, DOI 10.1016/0304-4157(89)90023-3; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Serva A, 2011, J NUCLEIC ACIDS, V2011, DOI 10.4061/2011/870903; Shan SW, 2009, NAT CELL BIOL, V11, P1031, DOI 10.1038/ncb1917; Smith-Vikos T, 2012, J CELL SCI, V125, P7, DOI 10.1242/jcs.099200; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; STEIN M, 1987, EMBO J, V6, P2677, DOI 10.1002/j.1460-2075.1987.tb02559.x; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Tanzer A, 2004, J MOL BIOL, V339, P327, DOI 10.1016/j.jmb.2004.03.065; Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Vitelli R, 1997, J BIOL CHEM, V272, P4391, DOI 10.1074/jbc.272.7.4391; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang XW, 2006, NUCLEIC ACIDS RES, V34, P1646, DOI 10.1093/nar/gkl068; Willnow TE, 1999, NAT CELL BIOL, V1, pE157, DOI 10.1038/14109; Yu ZR, 2008, J CELL BIOL, V182, P509, DOI 10.1083/jcb.200801079; Yu ZR, 2010, P NATL ACAD SCI USA, V107, P8231, DOI 10.1073/pnas.1002080107; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103	83	25	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52555	10.1371/journal.pone.0052555	http://dx.doi.org/10.1371/journal.pone.0052555			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285084	Green Published, Green Submitted, gold			2022-12-27	WOS:000312794500193
J	Zhang, XH; Zhang, J; Huang, HQ; Xue, RZ; Hu, XC; Li, MR; Zhong, Y; Yuan, LY				Zhang, Xiaohui; Zhang, Jing; Huang, Huaiqiu; Xue, Ruzeng; Hu, Xuchu; Li, Meirong; Zhong, Yi; Yuan, Liyan			Taenia taeniaeformis in Rat Favors Protracted Skin Lesions Caused by Sporothrix schenckii Infection: Dectin-1 and IL-17 Are Dispensable for Clearance of This Fungus	PLOS ONE			English	Article							RIO-DE-JANEIRO; CYTOKINE PRODUCTION; IMMUNE-RESPONSE; SPOROTRICHOSIS; CELLS; MACROPHAGES; EXPRESSION; RESISTANCE; ACTIVATION	We occasionally found that cestode Taenia taeniaeformis in rats favored Sporothrix schenckii infection and survival, causing protracted cutaneous lesions. In this study, we compared the pathology and cytokines profile of rats co-infected with the two pathogens and infected with S. schenckii alone to explore underlying mechanisms. In the co-infection group, there was high expression of beta-glucan receptor Dectin-1 in the cutaneous lesions and no multinucleated giant cells, but in the S. schenckii infection group the opposite was observed. Cytokines profiles demonstrated an expected finding that IL-4, commonly expressed in helminth and fungus infection, is undetectable in the two infection groups. In the single fungal infection group, cytokines IFN-gamma, IL-10 and IL-17 kept increasing in the first few weeks of infection to a peak which was followed by gradual decrease. This study showed that Dectin-1 and IL-17, which were believed to be the major anti-fungus mechanisms, are Th2 independent and dispensable for clearance of S. schenckii infection, suggesting that S. schenckii has a different molecular recognition pattern and evokes anti-infection mechanisms other than Dectin-1 and IL-17. Citation: Zhang X, Zhang J, Huang H, Xue R, Hu X, et al. (2012) Taenia taeniaeformis in Rat Favors Protracted Skin Lesions Caused by Sporothrix schenckii Infection: Dectin-1 and IL-17 Are Dispensable for Clearance of This Fungus. PLoS ONE 7(12): e52514. doi:10.1371/journal.pone.0052514	[Zhang, Xiaohui; Huang, Huaiqiu; Li, Meirong; Zhong, Yi; Yuan, Liyan] Sun Yat Sen Univ, Dept Dermatol & Venereol, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Xiaohui; Xue, Ruzeng] Guangdong Prov Ctr Skin Dis & STIs Control & Prev, Dept Dermatol, Guangzhou, Guangdong, Peoples R China; [Zhang, Jing] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Dermatol & Venereol, Guangzhou 510275, Guangdong, Peoples R China; [Hu, Xuchu] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Parasitol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Huang, HQ (corresponding author), Sun Yat Sen Univ, Dept Dermatol & Venereol, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China.	hhuaiqiu@medmail.com.cn; hnhxch@hotmail.com		huaiqiu, HUANG/0000-0002-6320-8031				Alonso-Trujillo J, 2007, PARASITOL RES, V100, P1341, DOI 10.1007/s00436-006-0424-4; Bhatia S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015943; Burns MJ, 2009, WEST J EMERG MED, V10, P204; Carlos IZ, 2009, MYCOPATHOLOGIA, V168, P1, DOI 10.1007/s11046-009-9190-z; de Miranda LHM, 2009, MYCOPATHOLOGIA, V168, P79, DOI 10.1007/s11046-009-9198-4; Dupasquier M, 2006, J LEUKOCYTE BIOL, V80, P838, DOI 10.1189/jlb.1005564; Fujimura T, 1996, ACTA DERM-VENEREOL, V76, P321; Gause WC, 2003, TRENDS IMMUNOL, V24, P269, DOI 10.1016/S1471-4906(03)00101-7; Guasconi L, 2011, IMMUNOLOGY, V133, P386, DOI 10.1111/j.1365-2567.2011.03449.x; Gutierrez-Galhardo MC, 2010, MYCOSES, V53, P78, DOI 10.1111/j.1439-0507.2008.01655.x; Guzman-Beltran S, 2012, MICROBES INFECT, V14, P1093, DOI 10.1016/j.micinf.2012.06.001; Koga T, 2002, MED MYCOL, V40, P111, DOI 10.1080/mmy.40.2.111.114; KOGA T, 1994, ACTA DERM-VENEREOL, V74, P328; Kumar JM, 2006, VET PARASITOL, V141, P362, DOI 10.1016/j.vetpar.2006.05.029; Lopes-Bezerra LM, 2006, AN ACAD BRAS CIENC, V78, P293, DOI 10.1590/S0001-37652006000200009; Maizels RM, 2004, IMMUNOL REV, V201, P89, DOI 10.1111/j.0105-2896.2004.00191.x; Osorio F, 2008, EUR J IMMUNOL, V38, P3274, DOI 10.1002/eji.200838950; Pappas PW, 1999, EXP PARASITOL, V91, P315, DOI 10.1006/expr.1998.4392; Ramos-e-Silva M, 2007, CLIN DERMATOL, V25, P181, DOI 10.1016/j.clindermatol.2006.05.006; Rice PJ, 2005, J PHARMACOL EXP THER, V314, P1079, DOI 10.1124/jpet.105.085415; Schubach TMP, 2002, MYCOPATHOLOGIA, V153, P83, DOI 10.1023/A:1014449621732; Tachibana T, 1999, MED MYCOL, V37, P397, DOI 10.1046/j.1365-280X.1999.00239.x; Uenotsuchi T, 2006, INT IMMUNOL, V18, P1637, DOI 10.1093/intimm/dxl097; van de Veerdonk FL, 2009, CELL HOST MICROBE, V5, P329, DOI 10.1016/j.chom.2009.02.006; Willment JA, 2003, J IMMUNOL, V171, P4569, DOI 10.4049/jimmunol.171.9.4569; Xie Z, 2010, MED MYCOL, V48, P201, DOI 10.3109/13693780902785320; Xu SL, 2009, J BIOL CHEM, V284, P22005, DOI 10.1074/jbc.M109.009076; Yang Z, 2009, IMMUNOBIOLOGY, V214, P321, DOI 10.1016/j.imbio.2008.09.002	28	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52514	10.1371/journal.pone.0052514	http://dx.doi.org/10.1371/journal.pone.0052514			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285072	gold, Green Submitted, Green Published			2022-12-27	WOS:000312794500185
J	Brandt, G; Merico, A; Vollan, B; Schluter, A				Brandt, Gunnar; Merico, Agostino; Vollan, Bjoern; Schlueter, Achim			Human Adaptive Behavior in Common Pool Resource Systems	PLOS ONE			English	Article							HOMO-ECONOMICUS; COOPERATION; SUSTAINABILITY; UNCERTAINTY; COLLAPSE; SHIFTS; RISK; TIME	Overexploitation of common-pool resources, resulting from uncooperative harvest behavior, is a major problem in many social-ecological systems. Feedbacks between user behavior and resource productivity induce non-linear dynamics in the harvest and the resource stock that complicate the understanding and the prediction of the co-evolutionary system. With an adaptive model constrained by data from a behavioral economic experiment, we show that users' expectations of future pay-offs vary as a result of the previous harvest experience, the time-horizon, and the ability to communicate. In our model, harvest behavior is a trait that adjusts to continuously changing potential returns according to a trade-off between the users' current harvest and the discounted future productivity of the resource. Given a maximum discount factor, which quantifies the users' perception of future pay-offs, the temporal dynamics of harvest behavior and ecological resource can be predicted. Our results reveal a non-linear relation between the previous harvest and current discount rates, which is most sensitive around a reference harvest level. While higher than expected returns resulting from cooperative harvesting in the past increase the importance of future resource productivity and foster sustainability, harvests below the reference level lead to a downward spiral of increasing overexploitation and disappointing returns.	[Brandt, Gunnar; Merico, Agostino; Vollan, Bjoern; Schlueter, Achim] Leibniz Ctr Trop Marine Ecol, Bremen, Germany; [Merico, Agostino] Jacobs Univ, Sch Sci & Engn, Bremen, Germany; [Vollan, Bjoern] Univ Innsbruck, Inst Publ Finance, A-6020 Innsbruck, Austria; [Schlueter, Achim] Jacobs Univ, Sch Humanities & Social Sci, Bremen, Germany	Leibniz Zentrum fur Marine Tropenforschung (ZMT); Jacobs University; University of Innsbruck; Jacobs University	Brandt, G (corresponding author), Leibniz Ctr Trop Marine Ecol, Bremen, Germany.	gunnar.brandt@zmt-bremen.de	Vollan, Björn/AAN-9265-2020; Merico, Agostino/C-1103-2013	Vollan, Björn/0000-0002-5592-4185; Merico, Agostino/0000-0001-8095-8056	Leibniz Center for Tropical Marine Ecology	Leibniz Center for Tropical Marine Ecology	This research was fully funded by the Leibniz Center for Tropical Marine Ecology (www.zmt-bremen.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS PA, 1993, EVOL ECOL, V7, P465, DOI 10.1007/BF01237642; Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; An L, 2012, ECOL MODEL, V229, P25, DOI 10.1016/j.ecolmodel.2011.07.010; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; CLARK CW, 1973, SCIENCE, V181, P630, DOI 10.1126/science.181.4100.630; Clark CW., 1976, MATH BIOECONOMICS; Dal Bo P, 2005, AM ECON REV, V95, P1591; Dal Bo P, 2011, AM ECON REV, V101, P411, DOI 10.1257/aer.101.1.411; Dietz T, 2003, SCIENCE, V302, P1907, DOI 10.1126/science.1091015; Dolsak N., 2003, COMMONS NEW MILLENNI; Dreber A, 2008, NATURE, V452, P348, DOI 10.1038/nature06723; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Frederick S, 2002, J ECON LIT, V40, P351, DOI 10.1257/002205102320161311; Gachter S, 2009, PHILOS T R SOC B, V364, P791, DOI 10.1098/rstb.2008.0275; Gintis H, 2000, ECOL ECON, V35, P311, DOI 10.1016/S0921-8009(00)00216-0; Gneezy U, 2000, J LEGAL STUD, V29, P1, DOI 10.1086/468061; Grafton RQ, 2007, SCIENCE, V318, P1601, DOI 10.1126/science.1146017; Gutierrez NL, 2011, NATURE, V470, P386, DOI 10.1038/nature09689; Hayo B, 2012, J ECON BEHAV ORGAN, V81, P9, DOI 10.1016/j.jebo.2011.09.002; Henrich J, 2004, J ECON BEHAV ORGAN, V53, P3, DOI 10.1016/S0167-2681(03)00094-5; Henrich J, 2001, AM ECON REV, V91, P73, DOI 10.1257/aer.91.2.73; Herrmann B, 2008, SCIENCE, V319, P1362, DOI 10.1126/science.1153808; Holt CA, 2002, AM ECON REV, V92, P1644, DOI 10.1257/000282802762024700; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Janssen MA, 2007, INT J COMMONS, V1, P43, DOI DOI 10.18352/IJC.12; Janssen MA, 2010, SCIENCE, V328, P613, DOI 10.1126/science.1183532; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kenward RE, 2011, P NATL ACAD SCI USA, V108, P5308, DOI 10.1073/pnas.1007933108; Kortenkamp KV, 2006, PERS SOC PSYCHOL B, V32, P603, DOI 10.1177/0146167205284006; Lamba S, 2011, P NATL ACAD SCI USA, V2011, P1; LANDE R, 1994, NATURE, V372, P88, DOI 10.1038/372088a0; Lees K, 2006, FISH FISH, V7, P104, DOI 10.1111/j.1467-2979.2006.00215.x; Levin S, 2010, PHILOS T R SOC B, V365, P13, DOI 10.1098/rstb.2009.0197; Levin SA, 2006, ECOL RES, V21, P328, DOI 10.1007/s11284-006-0162-1; Liu JG, 2007, SCIENCE, V317, P1513, DOI 10.1126/science.1144004; Merico A, 2009, ECOL MODEL, V220, P3001, DOI 10.1016/j.ecolmodel.2009.05.005; Norberg J, 2001, P NATL ACAD SCI USA, V98, P11376, DOI 10.1073/pnas.171315998; Ostrom, 1990, GOVERNING COMMONS; Ostrom E, 2007, P NATL ACAD SCI USA, V104, P15181, DOI 10.1073/pnas.0702288104; Ostrom E, 2009, SCIENCE, V325, P419, DOI 10.1126/science.1172133; Pandolfi JM, 2005, SCIENCE, V307, P1725, DOI 10.1126/science.1104258; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Pinsky ML, 2011, P NATL ACAD SCI USA, V108, P8317, DOI 10.1073/pnas.1015313108; Rand DG, 2009, SCIENCE, V325, P1272, DOI 10.1126/science.1177418; Rustagi D, 2010, SCIENCE, V330, P961, DOI 10.1126/science.1193649; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Wada Y, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044571; Wirtz KW, 1996, ECOL MODEL, V92, P33, DOI 10.1016/0304-3800(95)00196-4	50	11	11	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52763	10.1371/journal.pone.0052763	http://dx.doi.org/10.1371/journal.pone.0052763			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	064DQ	23285180	Green Submitted, Green Published, gold			2022-12-27	WOS:000313051500059
J	Chowdhary, A; Kathuria, S; Xu, JP; Sharma, C; Sundar, G; Singh, PK; Gaur, SN; Hagen, F; Klaassen, CH; Meis, JF				Chowdhary, Anuradha; Kathuria, Shallu; Xu, Jianping; Sharma, Cheshta; Sundar, Gandhi; Singh, Pradeep Kumar; Gaur, Shailendra N.; Hagen, Ferry; Klaassen, Corne H.; Meis, Jacques F.			Clonal Expansion and Emergence of Environmental Multiple-Triazole-Resistant Aspergillus fumigatus Strains Carrying the TR34/L98H Mutations in the cyp51A Gene in India	PLOS ONE			English	Article							AZOLE RESISTANCE; INVASIVE ASPERGILLOSIS; CROSS-RESISTANCE; TR/L98H MUTATION; THERAPY; DRUGS; PLANT; RECOMBINATION; ITRACONAZOLE; POSACONAZOLE	Azole resistance is an emerging problem in Aspergillus which impacts the management of aspergillosis. Here in we report the emergence and clonal spread of resistance to triazoles in environmental Aspergillus fumigatus isolates in India. A total of 44 (7%) A. fumigatus isolates from 24 environmental samples were found to be triazole resistant. The isolation rate of resistant A. fumigatus was highest (33%) from soil of tea gardens followed by soil from flower pots of the hospital garden (20%), soil beneath cotton trees (20%), rice paddy fields (12.3%), air samples of hospital wards (7.6%) and from soil admixed with bird droppings (3.8%). These strains showed cross-resistance to voriconazole, posaconazole, itraconazole and to six triazole fungicides used extensively in agriculture. Our analyses identified that all triazole-resistant strains from India shared the same TR34/L98H mutation in the cyp51 gene. In contrast to the genetic uniformity of azole-resistant strains the azole-susceptible isolates from patients and environments in India were genetically very diverse. All nine loci were highly polymorphic in populations of azole-susceptible isolates from both clinical and environmental samples. Furthermore, all Indian environmental and clinical azole resistant isolates shared the same multilocus microsatellite genotype not found in any other analyzed samples, either from within India or from the Netherlands, France, Germany or China. Our population genetic analyses suggest that the Indian azole-resistant A. fumigatus genotype was likely an extremely adaptive recombinant progeny derived from a cross between an azole-resistant strain migrated from outside of India and a native azole-susceptible strain from within India, followed by mutation and then rapid dispersal through many parts of India. Our results are consistent with the hypothesis that exposure of A. fumigatus to azole fungicides in the environment causes cross-resistance to medical triazoles. The study emphasises the need of continued surveillance of resistance in environmental and clinical A. fumigatus strains.	[Chowdhary, Anuradha; Kathuria, Shallu; Sharma, Cheshta; Sundar, Gandhi; Singh, Pradeep Kumar] Univ Delhi, Vallabhbhai Patel Chest Inst, Dept Med Mycol, Delhi 110007, India; [Xu, Jianping] McMaster Univ, Dept Biol, Hamilton, ON, Canada; [Gaur, Shailendra N.] Univ Delhi, Vallabhbhai Patel Chest Inst, Dept Pulm Med, Delhi 110007, India; [Hagen, Ferry; Klaassen, Corne H.; Meis, Jacques F.] Canisius Wilhelmina Hosp, Dept Med Microbiol & Infect Dis, Nijmegen, Netherlands; [Meis, Jacques F.] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands	University of Delhi; McMaster University; University of Delhi; Canisius-Wilhelmina Hospital; Radboud University Nijmegen	Chowdhary, A (corresponding author), Univ Delhi, Vallabhbhai Patel Chest Inst, Dept Med Mycol, Delhi 110007, India.	dranuradha@hotmail.com	Meis, Jacques F/A-9241-2010; Hagen, Ferry/B-9044-2009; Sharma, Cheshta/J-7966-2019; Kathuria, Shallu/AAN-5835-2020; Chowdhary, Anuradha/ABF-1252-2020	Meis, Jacques F/0000-0003-3253-6080; Hagen, Ferry/0000-0002-5622-1916; Chowdhary, Anuradha/0000-0002-2028-7462; Singh, Pradeep Kumar/0000-0003-1492-598X; Sharma, Cheshta/0000-0003-3216-263X	Department of Biotechnology New Delhi, India [BT/39/NE/TBP/2010]; Astellas; Merck; Schering Plough; Gilead; Janssen Pharmaceuticals; Pfizer; NSERC of Canada	Department of Biotechnology New Delhi, India(Department of Biotechnology (DBT) India); Astellas(Astellas Pharmaceuticals); Merck(Merck & Company); Schering Plough(Merck & CompanySchering Plough Corporation); Gilead(Gilead Sciences); Janssen Pharmaceuticals(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Pfizer(Pfizer); NSERC of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported with a grant from the Department of Biotechnology (Grant Reference Number: BT/39/NE/TBP/2010), New Delhi, India. J.F. Meis received grants from Astellas, Merck, Schering Plough, Gilead and Janssen Pharmaceuticals. C.H. Klaassen received a grant from Pfizer. J.P. Xu received grants from NSERC of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; J.F. Meis received grants from Astellas, Merck, Schering-Plough, Gilead and Janssen Pharmaceuticals, is a consultant to Basilea and Merck and received speaker's fees from Merck, Schering-Plough, Gilead and Janssen Pharmaceutica. C.H. Klaassen received a grant from Pfizer. J.P. Xu received grants from NSERC of Canada. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Agapow PM, 2001, MOL ECOL NOTES, V1, P101, DOI 10.1046/j.1471-8278.2000.00014.x; Arendrup MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010080; Burgel PR, 2012, ANTIMICROB AGENTS CH, V56, P869, DOI 10.1128/AAC.05077-11; Camps SMT, 2012, ANTIMICROB AGENTS CH, V56, P10, DOI 10.1128/AAC.05088-11; Chakrabarti A, 2011, MED MYCOL, V49, pS35, DOI 10.3109/13693786.2010.505206; Chowdhary A, 2012, J ANTIMICROB CHEMOTH, V67, P362, DOI 10.1093/jac/dkr443; CLSI, 2008, REFERENCE METHOD BRO, P2; Cornely OA, 2007, NEW ENGL J MED, V356, P348, DOI 10.1056/NEJMoa061094; de Valk HA, 2005, J CLIN MICROBIOL, V43, P4112, DOI 10.1128/JCM.43.8.4112-4120.2005; Denning DW, 2011, FUTURE MICROBIOL, V6, P1229, DOI [10.2217/FMB.11.118, 10.2217/fmb.11.118]; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Fisher MC, 2012, MOL ECOL, V21, P1305, DOI 10.1111/j.1365-294X.2012.05506.x; GLASS NL, 1995, APPL ENVIRON MICROB, V61, P1323, DOI 10.1128/AEM.61.4.1323-1330.1995; Herbrecht R, 2002, NEW ENGL J MED, V347, P408, DOI 10.1056/NEJMoa020191; Hof H, 2001, ANTIMICROB AGENTS CH, V45, P2987, DOI 10.1128/AAC.45.11.2987-2990.2001; Hong SB, 2006, INT J SYST EVOL MICR, V56, P477, DOI 10.1099/ijs.0.63980-0; Howard SJ, 2010, CLIN MICROBIOL INFEC, V16, P683, DOI 10.1111/j.1469-0691.2009.02911.x; Howard SJ, 2009, EMERG INFECT DIS, V15, P1068, DOI 10.3201/eid1507.090043; Howard SJ, 2011, MED MYCOL, V49, pS90, DOI 10.3109/13693786.2010.508469; Klaassen CHW, 2012, MOL ECOL, V21, P57, DOI 10.1111/j.1365-294X.2011.05364.x; Klaassen CHW, 2010, J ANTIMICROB CHEMOTH, V65, P901, DOI 10.1093/jac/dkq041; Kuipers S, 2011, ANTIMICROB AGENTS CH, V55, P3564, DOI 10.1128/AAC.01544-10; Lockhart SR, 2011, ANTIMICROB AGENTS CH, V55, P4465, DOI 10.1128/AAC.00185-11; Rodriguez-Tudela JL, 2008, ANTIMICROB AGENTS CH, V52, P2468, DOI 10.1128/AAC.00156-08; Mortensen KL, 2010, ANTIMICROB AGENTS CH, V54, P4545, DOI 10.1128/AAC.00692-10; Muller FMC, 2007, ANTIMICROB AGENTS CH, V51, P3014, DOI 10.1128/AAC.00459-07; NETHMAP, 2012, CONS ANT AG ANT RES; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Rath PM, 2012, ANTIMICROB AGENTS CH, V56, P6060, DOI 10.1128/AAC.01017-12; Serfling A, 2007, ANTIMICROB AGENTS CH, V51, P3672, DOI 10.1128/AAC.00654-07; Singh N, 2000, J ENVIRON SCI HEAL B, V35, P549, DOI 10.1080/03601230009373291; Snelders E, 2008, PLOS MED, V5, P1629, DOI 10.1371/journal.pmed.0050219; Snelders E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031801; Snelders E, 2011, FUTURE MICROBIOL, V6, P335, DOI [10.2217/FMB.11.4, 10.2217/fmb.11.4]; Snelders E, 2009, APPL ENVIRON MICROB, V75, P4053, DOI 10.1128/AEM.00231-09; Stensvold CR, 2012, CURR FUNGAL INFECT R, V6, P178, DOI 10.1007/s12281-012-0097-7; Thind TS, 2007, INDIAN PHYTOPATHOL, V60, P421; van der Linden JWM, 2011, EMERG INFECT DIS, V17, P1846, DOI 10.3201/eid1710.110226; Verweij PE, 2009, DRUG RESIST UPDATE, V12, P141, DOI 10.1016/j.drup.2009.09.002; Verweij PE, 2009, LANCET INFECT DIS, V9, P789, DOI 10.1016/S1473-3099(09)70265-8; Verweij PE, 1997, INT J INFECT DIS, V2, P61; zur Wiesch PA, 2011, LANCET INFECT DIS, V11, P236, DOI 10.1016/S1473-3099(10)70264-4	42	146	149	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52871	10.1371/journal.pone.0052871	http://dx.doi.org/10.1371/journal.pone.0052871			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285210	Green Published, Green Submitted, gold			2022-12-27	WOS:000313051500074
J	Liu, FC; Yu, HP; Hwang, TL; Tsai, YF				Liu, Fu-Chao; Yu, Huang-Ping; Hwang, Tsong-Long; Tsai, Yung-Fong			Protective Effect of Tropisetron on Rodent Hepatic Injury after Trauma-Hemorrhagic Shock through P38 MAPK-Dependent Hemeoxygenase-1 Expression	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; INFLAMMATORY CYTOKINE PRODUCTION; CHEMOTHERAPY-INDUCED NAUSEA; 5-HT3 RECEPTOR ANTAGONISTS; HEME OXYGENASE-1; UP-REGULATION; MEDIATED CARDIOPROTECTION; MECHANISM; LUNG; AKT	Tropisetron can decrease inflammatory cell responses and alleviate organ damage caused by trauma-hemorrhage, but the mechanism of these effects remains unknown. The p38 mitogen-activated protein kinase/hemeoxygenase-1 (p38 MAPK/HO-1) pathway exerts anti-inflammatory effects on different tissues. The aim of this study was to investigate whether p38 MAPK/HO-1 plays any role in the tropisetron-mediated attenuation of hepatic injury after trauma-hemorrhage. Male Sprague-Dawley rats underwent trauma-hemorrhage (mean blood pressure maintained at approximately 35-40 mmHg for 90 min), followed by fluid resuscitation. During resuscitation, several treatment regimens were administered: four doses of tropisetron alone (0.1, 0.3, 1, 3 mg/kg body weight), or a single dose of tropisetron (1 mg/kg body weight) with and without a p38 MAPK inhibitor (SB-203580, 2 mg/kg body weight) or HO antagonist (chromium-mesoporphyrin, 2.5 mg/kg body weight). Various parameters were measured, and the animals were sacrificed at 24 h post-resuscitation. The results showed that trauma-hemorrhage increased the following parameters: plasma concentrations of aspartate (AST) and alanine aminotransferases (ALT), hepatic myeloperoxidase (MPO) activity, and levels of cytokine-induced neutrophil chemoattractant-1 and -3 (CINC-1 and CINC-3), intercellular adhesion molecule-1 (ICAM-1), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), and macrophage inflammatory protein-1 alpha (MIP-1 alpha). These parameters were significantly improved in the tropisetron-treated rats subjected to trauma-hemorrhage. Tropisetron treatment also increased hepatic p38 MAPK and HO-1 expression compared with vehicle-treated trauma-hemorrhaged rats. Co-administration of SB-203580 or chromium-mesoporphyrin with tropisetron abolished the tropisetron-induced beneficial effects on the above parameters and hepatic injury. These results suggest that the protective effect of tropisetron administration on alleviation of hepatic injury after trauma-hemorrhage is likely mediated through p38 MAPK-dependent HO-1 expression.	[Liu, Fu-Chao; Yu, Huang-Ping; Tsai, Yung-Fong] Chang Gung Mem Hosp, Dept Anesthesiol, Tao Yuan, Taiwan; [Liu, Fu-Chao; Yu, Huang-Ping; Tsai, Yung-Fong] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan; [Hwang, Tsong-Long] Chang Gung Univ, Grad Inst Nat Prod, Tao Yuan, Taiwan; [Tsai, Yung-Fong] Chang Gung Univ, Grad Inst Clin Med Sci, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung University	Yu, HP (corresponding author), Chang Gung Mem Hosp, Dept Anesthesiol, Tao Yuan, Taiwan.	yuhp2001@adm.cgmh.org.tw	Liu, Fu-Chao/AAB-3780-2021; Hwang, Tsong-Long/AAE-6944-2020	Hwang, Tsong-Long/0000-0002-5780-3977; Liu, F-C/0000-0003-1712-4053	National Science Council [NSC98-2314-B-182A-034-MY3, NSC 101-2314-B-182 -082]; Chang Gung Memorial Hospital [CMRPG381073, CMRPG 392122]	National Science Council(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was supported in part by grants from the National Science Council (NSC98-2314-B-182A-034-MY3) and Chang Gung Memorial Hospital (CMRPG381073) to HPY and from the National Science Council (NSC 101-2314-B-182 -082) and Chang Gung Memorial Hospital (CMRPG 392122) to FCL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Nasim, 2011, J Emerg Trauma Shock, V4, P114, DOI 10.4103/0974-2700.76846; Alten JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001605; An L, 2012, EUR J PHARMACOL, V677, P1, DOI 10.1016/j.ejphar.2011.12.010; Aoudjit L, 2003, AM J PHYSIOL-RENAL, V285, pF765, DOI 10.1152/ajprenal.00100.2003; Dorman Robert B, 2004, Comp Hepatol, V3 Suppl 1, pS42, DOI 10.1186/1476-5926-2-S1-S42; Douzinas EE, 2012, CRIT CARE MED, V40, P1348, DOI 10.1097/CCM.0b013e31823e9501; Drechsler Y, 2006, J IMMUNOL, V177, P2592, DOI 10.4049/jimmunol.177.4.2592; Faerber L, 2007, EUR J PHARMACOL, V560, P1, DOI 10.1016/j.ejphar.2007.01.028; Fiebich BL, 2004, SCAND J RHEUMATOL, V33, P28, DOI 10.1080/03009740410006998; Grochot-Przeczek A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005803; Haines DD, 2012, ACTA PHYSIOL, V204, P487, DOI 10.1111/j.1748-1716.2011.02387.x; Hesketh PJ, 2000, CANCER INVEST, V18, P163, DOI 10.3109/07357900009038248; Hsu JT, 2008, SHOCK, V30, P372, DOI 10.1097/SHK.0b013e318164f25c; Hsu JT, 2008, AM J PHYSIOL-REG I, V294, pR1825, DOI 10.1152/ajpregu.00112.2008; Hsu JT, 2007, AM J PHYSIOL-HEART C, V292, pH2982, DOI 10.1152/ajpheart.01303.2006; Kan WH, 2008, AM J PHYSIOL-HEART C, V294, pH2627, DOI 10.1152/ajpheart.91444.2007; Li J, 2011, J TRAUMA, V71, P1262, DOI 10.1097/TA.0b013e31821280c5; Liu FC, 2008, ACTA ANAESTH SCAND, V52, P635, DOI 10.1111/j.1399-6576.2008.01592.x; Liu FC, 2012, SHOCK, V38, P76, DOI 10.1097/SHK.0b013e318259ad51; Liu FC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025907; Liu FC, 2011, RESUSCITATION, V82, P335, DOI 10.1016/j.resuscitation.2010.11.007; Liu FC, 2009, ANESTH ANALG, V108, P1855, DOI 10.1213/ane.0b013e3181a1a194; Lv KY, 2012, J SURG RES, V178, P827, DOI 10.1016/j.jss.2012.04.006; MENEGAUX F, 1993, J TRAUMA, V35, P865, DOI 10.1097/00005373-199312000-00011; Okamoto K, 2006, NEUROSCIENCE, V143, P597, DOI 10.1016/j.neuroscience.2006.08.009; Rahimian R, 2011, BRAIN RES, V1392, P101, DOI 10.1016/j.brainres.2011.03.053; Sato H, 2005, SHOCK, V24, P488, DOI 10.1097/01.shk.0000176594.64626.7f; Sato H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030124; Shen XD, 2005, AM J TRANSPLANT, V5, P1793, DOI 10.1111/j.1600-6143.2005.00932.x; Shifflett DE, 2004, AM J PHYSIOL-GASTR L, V286, pG906, DOI 10.1152/ajpgi.00478.2003; Shimizu T, 2007, ANN SURG, V245, P297, DOI 10.1097/01.sla.0000232523.88621.17; Simpson K, 2000, DRUGS, V59, P1297, DOI 10.2165/00003495-200059060-00008; Suda K, 2010, SHOCK, V33, P526, DOI 10.1097/SHK.0b013e3181cc064b; Tsai YF, 2012, J SURG RES, V176, P171, DOI 10.1016/j.jss.2011.05.039; Yu HP, 2008, SHOCK, V30, P324, DOI 10.1097/SHK.0b013e318164f013; Yu HP, 2011, SHOCK, V35, P517, DOI 10.1097/SHK.0b013e318209e931; Yu HP, 2006, J LEUKOCYTE BIOL, V79, P277, DOI 10.1189/jlb.0705363; Yu HP, 2006, J LEUKOCYTE BIOL, V79, P963, DOI 10.1189/jlb.1005596; Zeng Z, 2010, WORLD J GASTROENTERO, V16, P1285, DOI 10.3748/wjg.v16.i10.1285; Zhu ZW, 2008, HEPATOLOGY, V48, P1430, DOI 10.1002/hep.22491	40	27	30	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53203	10.1371/journal.pone.0053203	http://dx.doi.org/10.1371/journal.pone.0053203			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285267	Green Published, gold, Green Submitted			2022-12-27	WOS:000313051500121
J	Yuan, PY; Shen, XQ; Liu, J; Hou, YR; Zhu, MQ; Huang, JS; Xu, PP				Yuan, Peiyan; Shen, Xiaoqing; Liu, Jing; Hou, Yarong; Zhu, Manqun; Huang, Jiansheng; Xu, Pingping			Effects of Dentifrice Containing Hydroxyapatite on Dentinal Tubule Occlusion and Aqueous Hexavalent Chromium Cations Sorption: A Preliminary Study	PLOS ONE			English	Article							HYDRAULIC CONDUCTANCE; DESENSITIZING AGENTS; CONTAMINATED SOILS; SENSITIVE TEETH; METAL; WATER; LEAD; DESORPTION; RETENTION; INGESTION	In order to endow environmental protection features to dentifrice, hydroxyapatite (HA) was added to ordinary dentifrice. The effects on dentinal tubule occlusion and surface mineralization were compared after brushing dentine discs with dentifrice with or without HA. The two types of dentifrice were then added to 100 mu g/ml of hexavalent chromium cation (Cr6+) solution in order to evaluate their capacities of adsorbing Cr6+ from water. Our results showed that the dentifrice containing HA was significantly better than the ordinary dentifrice in occluding the dentinal tubules with a plugging rate greater than 90%. Moreover, the effect of the HA dentifrice was persistent and energy-dispersive spectrometer (EDS) revealed that the atomic percentages of calcium and phosphorus on the surface of dentine discs increased significantly. Adding HA to ordinary dentifrice significantly enhanced the ability of dentifrice to adsorb Cr6+ from water with the removal rate up to 52.36%. In addition, the sorption was stable. Our study suggests that HA can be added to ordinary dentifrice to obtain dentifrice that has both relieving dentin hypersensitivity benefits and also helps to control environmental pollution.	[Yuan, Peiyan; Liu, Jing; Hou, Yarong; Zhu, Manqun; Huang, Jiansheng; Xu, Pingping] So Med Univ, Guangdong Prov Stomatol Hosp, Lab Oral Dis, Guangzhou, Guangdong, Peoples R China; [Shen, Xiaoqing] So Med Univ, Zhujiang Hosp, Dept Stomatol, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China	Xu, PP (corresponding author), So Med Univ, Guangdong Prov Stomatol Hosp, Lab Oral Dis, Guangzhou, Guangdong, Peoples R China.	sci8620@gmail.com			Guangdong Provincial Science and Technology Projects [2011B080701099]	Guangdong Provincial Science and Technology Projects	The study was supported by the Guangdong Provincial Science and Technology Projects (No. 2011B080701099) (http://pro.gdstc.gov.cn/stms/main.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed TR, 2005, J ORAL REHABIL, V32, P589, DOI 10.1111/j.1365-2842.2005.01473.x; Arrais César Augusto Galvão, 2004, J. Appl. Oral Sci., V12, P144, DOI 10.1590/S1678-77572004000200012; Arrais UAG, 2003, J DENT, V31, P577, DOI 10.1016/S0300-5712(03)00115-5; Bradberry SM, 1999, J TOXICOL-CLIN TOXIC, V37, P195, DOI 10.1081/CLT-100102419; BRANNSTROM M, 1963, J AM DENT ASSOC, V66, P366; Cao XD, 2004, ENVIRON POLLUT, V131, P435, DOI 10.1016/j.envpol.2004.03.003; Chaturvedi PK, 2006, CHEMOSPHERE, V64, P1109, DOI 10.1016/j.chemosphere.2005.11.077; Chen JH, 2010, ENVIRON PROG SUSTAIN, V29, P233, DOI 10.1002/ep.10371; 김민수, 2008, Journal of Periodontal & Implant Science, V38, P1; Corami A, 2007, J HAZARD MATER, V146, P164, DOI 10.1016/j.jhazmat.2006.12.003; Costa M, 2006, CRIT REV TOXICOL, V36, P155, DOI 10.1080/10408440500534032; Cummins D, 2010, AM J DENT, V23, p3A; del Rio JAG, 2004, J ENVIRON MANAGE, V71, P169, DOI 10.1016/j.jenvman.2004.02.004; Driessens F C, 1982, Monogr Oral Sci, V10, P1; Felter SP, 1997, REGUL TOXICOL PHARM, V25, P43, DOI 10.1006/rtph.1996.1073; Gillam D G, 1997, Adv Dent Res, V11, P487; Gillam DG, 2001, J ORAL REHABIL, V28, P1037, DOI 10.1046/j.1365-2842.2001.00775.x; Giovanna GM, 2008, J DENT, V36, P565, DOI 10.1016/j.jdent.2008.03.012; GREENHILL JD, 1981, J DENT RES, V60, P686, DOI 10.1177/00220345810600030401; 강소진, 2009, Journal of Periodontal & Implant Science, V39, P9; Huang SB, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/3/034104; ISO TR 10271, 1993, 10271 ISO TR; Itthagarun A, 2010, HONG KONG DENT J, V7, P61; Izzotti A, 2002, MOL CARCINOGEN, V35, P75, DOI 10.1002/mc.10077; Kim BI, 2006, KEY ENG MATER, V309-311, P541, DOI 10.4028/www.scientific.net/KEM.309-311.541; Kim Su-Hwan, 2009, Journal of Periodontal & Implant Science, V39, P87; Kodaka T, 1999, J ELECTRON MICROSC, V48, P167, DOI 10.1093/oxfordjournals.jmicro.a023663; Kodaka T, 2001, J ELECTRON MICROSC, V50, P57, DOI 10.1093/jmicro/50.1.57; Kolker Justine L, 2002, J Adhes Dent, V4, P211; Lavender SA, 2010, AM J DENT, V23, p14A; Lee SY, 2008, J ORAL REHABIL, V35, P847, DOI 10.1111/j.1365-2842.2008.01876.x; LeGeros R Z, 1991, Monogr Oral Sci, V15, P1; Linos A, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-50; MA QY, 1995, ENVIRON SCI TECHNOL, V29, P1118, DOI 10.1021/es00004a034; Markowitz K, 2008, J ORAL REHABIL, V35, P300, DOI 10.1111/j.1365-2842.2007.01798.x; Markowitz K, 2007, J DENT RES, V86, P292, DOI 10.1177/154405910708600401; Mobasherpour I, 2011, DESALINATION, V266, P142, DOI 10.1016/j.desal.2010.08.016; Mojiri A, 2012, AFR J MICROBIOL RES, V6, P643, DOI 10.5897/AJMR-11-1492; Mordan NJ, 1997, J ORAL REHABIL, V24, P148, DOI 10.1046/j.1365-2842.1997.d01-260.x; Orchardson R, 2006, J AM DENT ASSOC, V137, P990, DOI 10.14219/jada.archive.2006.0321; Pan HB, 2007, ARCH ORAL BIOL, V52, P618, DOI 10.1016/j.archoralbio.2006.12.007; Parolia Abhishek, 2011, J Calif Dent Assoc, V39, P167; Peld M, 2004, ENVIRON SCI TECHNOL, V38, P5626, DOI 10.1021/es049831l; Pereira JC, 2005, DENT MATER, V21, P129, DOI 10.1016/j.dental.2004.02.007; Phuengprasop T, 2011, J HAZARD MATER, V186, P502, DOI 10.1016/j.jhazmat.2010.11.065; Rafael AL, 2007, TOXICOL APPL PHARM, V224, P163, DOI 10.1016/j.taap.2007.07.004; Raicevic S, 2005, J HAZARD MATER, V117, P41, DOI 10.1016/j.jhazmat.2004.07.024; Sandrine B, 2007, J HAZARD MATER, V139, P443, DOI 10.1016/j.jhazmat.2006.02.039; Schiff Thomas, 2009, Am J Dent, V22 Spec No A, p8A; SENA FJ, 1990, DENT CLIN N AM, V34, P475; Tirapelli Camila, 2010, Braz. oral res., V24, P381, DOI 10.1590/S1806-83242010000400002; Vanoirbeek JAJ, 2003, J TOXICOL ENV HEAL A, V66, P393, DOI 10.1080/15287390306366; Younger PL, 2002, ENVIRON POLLUT, V5; Zeidler-Erdely PC, 2011, J TOXICOL ENV HEAL A, V74, P728, DOI 10.1080/15287394.2011.556063	54	22	25	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e45283	10.1371/journal.pone.0045283	http://dx.doi.org/10.1371/journal.pone.0045283			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23300511	Green Published, Green Submitted, gold			2022-12-27	WOS:000313051500001
J	Zhang, F; Guo, X; Wu, SX; Han, J; Liu, YJ; Shen, H; Deng, HW				Zhang, Feng; Guo, Xiong; Wu, Shixun; Han, Jing; Liu, Yongjun; Shen, Hui; Deng, Hong-Wen			Genome-Wide Pathway Association Studies of Multiple Correlated Quantitative Phenotypes Using Principle Component Analyses	PLOS ONE			English	Article							SET ENRICHMENT ANALYSIS; GENETIC ASSOCIATION; BONE MASS; DISEASE; TRAITS; POLYMORPHISM; OBESITY; TESTS; BMD	Genome-wide pathway association studies provide novel insight into the biological mechanism underlying complex diseases. Current pathway association studies primarily focus on single important disease phenotype, which is sometimes insufficient to characterize the clinical manifestations of complex diseases. We present a multi-phenotypes pathway association study(MPPAS) approach using principle component analysis(PCA). In our approach, PCA is first applied to multiple correlated quantitative phenotypes for extracting a set of orthogonal phenotypic components. The extracted phenotypic components are then used for pathway association analysis instead of original quantitative phenotypes. Four statistics were proposed for PCA-based MPPAS in this study. Simulations using the real data from the HapMap project were conducted to evaluate the power and type I error rates of PCA-based MPPAS under various scenarios considering sample sizes, additive and interactive genetic effects. A real genome-wide association study data set of bone mineral density (BMD) at hip and spine were also analyzed by PCA-based MPPAS. Simulation studies illustrated the performance of PCA-based MPPAS for identifying the causal pathways underlying complex diseases. Genome-wide MPPAS of BMD detected associations between BMD and KENNY_CTNNB1_TARGETS_UP as well as LONGEVITYPATHWAY pathways in this study. We aim to provide a applicable MPPAS approach, which may help to gain deep understanding the potential biological mechanism of association results for complex diseases.	[Zhang, Feng; Guo, Xiong; Wu, Shixun; Han, Jing] Xi An Jiao Tong Univ, Key Lab Environm & Gene Related Dis, Minist Educ, Fac Publ Hlth,Coll Med, Xian 710049, Shaanxi, Peoples R China; [Liu, Yongjun; Shen, Hui; Deng, Hong-Wen] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Biostat, New Orleans, LA USA	Xi'an Jiaotong University; Tulane University	Zhang, F (corresponding author), Xi An Jiao Tong Univ, Key Lab Environm & Gene Related Dis, Minist Educ, Fac Publ Hlth,Coll Med, Xian 710049, Shaanxi, Peoples R China.	fzhxjtu@gmail.com	Liu, Yong/GWQ-6163-2022	Deng, Hong-Wen/0000-0002-0387-8818	National Natural Scientific Foundation of China [81102086]; Doctoral fund of Ministry of Education of China [20110201120057]; Fundamental Research Funds for the Central Universities of China; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050496, R01AR057049] Funding Source: NIH RePORTER	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral fund of Ministry of Education of China(Ministry of Education, China); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The study was supported by National Natural Scientific Foundation of China (81102086), the Doctoral fund of Ministry of Education of China (20110201120057) and the Fundamental Research Funds for the Central Universities of China.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askland K, 2009, HUM GENET, V125, P63, DOI 10.1007/s00439-008-0600-y; Barabasi AL, 2007, NEW ENGL J MED, V357, P404, DOI 10.1056/NEJMe078114; Chen L, 2009, BIOINFORMATICS, V25, P237, DOI 10.1093/bioinformatics/btn613; de Las Fuentes L, 2012, EUR J HUM GENET; Deng HW, 2001, GENETICS, V159, P1319; Dennison EM, 2009, J RHEUMATOL, V36, P1520, DOI 10.3899/jrheum.081061; Dennison EM, 2004, J CLIN ENDOCR METAB, V89, P4898, DOI 10.1210/jc.2004-0151; Holmans P, 2009, AM J HUM GENET, V85, P13, DOI 10.1016/j.ajhg.2009.05.011; Lakatos PL, 2004, EUR J GASTROEN HEPAT, V16, P753, DOI 10.1097/01.meg.0000108364.41221.d0; Lesnick TG, 2007, PLOS GENET, V3, P984, DOI 10.1371/journal.pgen.0030098; Liu XG, 2009, AM J HUM GENET, V84, P418, DOI 10.1016/j.ajhg.2009.02.004; Liu YJ, 2010, OBESITY, V18, P2339, DOI 10.1038/oby.2010.83; Luo L, 2010, EUR J HUM GENET, V18, P1045, DOI 10.1038/ejhg.2010.62; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Mei H, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-100; O'Dushlaine C, 2009, BIOINFORMATICS, V25, P2762, DOI 10.1093/bioinformatics/btp448; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Development Core Team, 2007, R LANG ENV STAT COMP; Rawadi G, 2005, EXPERT OPIN THER TAR, V9, P1063, DOI 10.1517/14728222.9.5.1063; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Sims AM, 2008, J BONE MINER RES, V23, P499, DOI 10.1359/JBMR.071113; Spencer CCA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000477; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Ulici V, 2009, BONE, V45, P1133, DOI 10.1016/j.bone.2009.08.003; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Yang QO, 2010, GENET EPIDEMIOL, V34, P444, DOI 10.1002/gepi.20497; Yu K, 2009, GENET EPIDEMIOL, V33, P700, DOI 10.1002/gepi.20422; Zhang KL, 2010, NUCLEIC ACIDS RES, V38, pW90, DOI 10.1093/nar/gkq324; Zhang LS, 2010, J BONE MINER RES, V25, P1572, DOI 10.1002/jbmr.36	34	23	25	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53320	10.1371/journal.pone.0053320	http://dx.doi.org/10.1371/journal.pone.0053320			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285279	Green Submitted, gold, Green Published			2022-12-27	WOS:000313051500133
J	Knudsen, L; Hansen, BF; Jensen, P; Pedersen, TA; Vestergaard, K; Schaffer, L; Blagoev, B; Oleksiewicz, MB; Kiselyov, VV; De Meyts, P				Knudsen, Louise; Hansen, Bo Falck; Jensen, Pia; Pedersen, Thomas Askov; Vestergaard, Kirsten; Schaffer, Lauge; Blagoev, Blagoy; Oleksiewicz, Martin B.; Kiselyov, Vladislav V.; De Meyts, Pierre			Agonism and Antagonism at the Insulin Receptor	PLOS ONE			English	Article							LIGAND-INDUCED ACTIVATION; GROWTH-FACTOR RECEPTOR; NEGATIVE COOPERATIVITY; MONOCLONAL-ANTIBODIES; SIGNALING PATHWAYS; STRUCTURAL BASIS; BINDING; HORMONE; PEPTIDE; KINASE	Insulin can trigger metabolic as well as mitogenic effects, the latter being pharmaceutically undesirable. An understanding of the structure/function relationships between insulin receptor (IR) binding and mitogenic/metabolic signalling would greatly facilitate the preclinical development of new insulin analogues. The occurrence of ligand agonism and antagonism is well described for G protein-coupled receptors (GPCRs) and other receptors but in general, with the exception of antibodies, not for receptor tyrosine kinases (RTKs). In the case of the IR, no natural ligand or insulin analogue has been shown to exhibit antagonistic properties, with the exception of a crosslinked insulin dimer (B29-B'29). However, synthetic monomeric or dimeric peptides targeting sites 1 or 2 of the IR were shown to be either agonists or antagonists. We found here that the S961 peptide, previously described to be an IR antagonist, exhibited partial agonistic effects in the 1-10 nM range, showing altogether a bell-shaped dose-response curve. Intriguingly, the agonistic effects of S961 were seen only on mitogenic endpoints (H-3-thymidine incorporation), and not on metabolic endpoints (C-14-glucose incorporation in adipocytes and muscle cells). The agonistic effects of S961 were observed in 3 independent cell lines, with complete concordance between mitogenicity (H-3-thymidine incorporation) and phosphorylation of the IR and Akt. Together with the B29-B'29 crosslinked dimer, S961 is a rare example of a mixed agonist/antagonist for the human IR. A plausible mechanistic explanation based on the bivalent crosslinking model of IR activation is proposed.	[Knudsen, Louise; Kiselyov, Vladislav V.; De Meyts, Pierre] Hagedorn Res Inst, Receptor Syst Biol Lab, Gentofte, Denmark; [Knudsen, Louise; Schaffer, Lauge; Kiselyov, Vladislav V.; De Meyts, Pierre] Hagedorn Res Inst, Dept Insulin & Incretin Biol, Gentofte, Denmark; [Hansen, Bo Falck; Jensen, Pia; Pedersen, Thomas Askov; Vestergaard, Kirsten] Novo Nordisk AS, Insulin Biol, Malov, Denmark; [Knudsen, Louise; Blagoev, Blagoy] Univ So Denmark, Odense M, Denmark; [Oleksiewicz, Martin B.] Arsanis Biosci, Vienna, Austria	Novo Nordisk; Hagedorn Research Institute; Novo Nordisk; Hagedorn Research Institute; Novo Nordisk; University of Southern Denmark	Knudsen, L (corresponding author), Hagedorn Res Inst, Receptor Syst Biol Lab, Gentofte, Denmark.	lsek@novonordisk.com		De Meyts, Pierre/0000-0001-6214-0824; Blagoev, Blagoy/0000-0002-3596-0066	Danish Ministry of Science, Technology and Innovation; Corporate Research Affairs (CORA) within Novo Nordisk A/S; Novo Nordisk [S661, S961]	Danish Ministry of Science, Technology and Innovation; Corporate Research Affairs (CORA) within Novo Nordisk A/S; Novo Nordisk(Novo Nordisk)	L. Knudsen is supported by an Industrial PhD scholarship from the Danish Ministry of Science, Technology and Innovation as well as by Corporate Research Affairs (CORA) within Novo Nordisk A/S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: Thomas Askov Pedersen, Kirsten Vestergaard, Pierre De Meyts, Vladislav V. Kiselyov, Bo Falck Hansen, Pia Jensen, and Lauge Schaffer were employees of Novo Nordisk A/S. Pierre De Meyts, Bo Falck Hansen, Pia Jensen, Lauge Schaffer Louise Knudsen, Kirsten Vestergaard and Thomas Askov Pedersen own Novo Nordisk stocks. Novo Nordisk were a funder for this study and provided the S661 and S961 for the study. Martin B. Oleksiewicz was employed by Arsanis Biosciences at the time of the study. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Baker JG, 2007, TRENDS PHARMACOL SCI, V28, P374, DOI 10.1016/j.tips.2007.06.011; Benyoucef S, 2007, BIOCHEM J, V403, P603, DOI 10.1042/BJ20061709; Blagoev B, 2002, J BIOL CHEM, V277, P42011, DOI 10.1074/jbc.M206975200; Bonnesen C, 2010, CELL BIOL TOXICOL, V26, P293, DOI 10.1007/s10565-009-9142-x; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; DEMEYTS P, 1978, NATURE, V273, P504; DEMEYTS P, 1994, DIABETOLOGIA, V37, pS135, DOI 10.1007/BF00400837; DEMEYTS P, 1973, BIOCHEM BIOPH RES CO, V55, P154, DOI 10.1016/S0006-291X(73)80072-5; DIACONESCU C, 1982, H-S Z PHYSIOL CHEM, V363, P187, DOI 10.1515/bchm2.1982.363.1.187; EBINA Y, 1985, CELL, V40, P747, DOI 10.1016/0092-8674(85)90334-4; FIGLEWICZ DP, 1983, AM J PHYSIOL, V245, pE483, DOI 10.1152/ajpendo.1983.245.5.E483; FUH G, 1992, SCIENCE, V256, P1677, DOI 10.1126/science.256.5064.1677; GU JL, 1988, BIOCHEM BIOPH RES CO, V150, P694, DOI 10.1016/0006-291X(88)90447-0; Hansen BF, 1996, BIOCHEM J, V315, P271; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; ILONDO MM, 1994, ENDOCRINOLOGY, V134, P2397, DOI 10.1210/en.134.6.2397; Jensen M, 2007, J BIOL CHEM, V282, P35179, DOI 10.1074/jbc.M704599200; KASUGA M, 1982, SCIENCE, V215, P185, DOI 10.1126/science.7031900; KEEFER LM, 1981, BIOCHEM BIOPH RES CO, V100, P1229, DOI 10.1016/0006-291X(81)91955-0; Kiselyov VV, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.78; Knudsen L, 2011, BIOCHEM J, V440, P397, DOI 10.1042/BJ20110550; KOBAYASHI M, 1982, BIOCHEM J, V206, P597, DOI 10.1042/bj2060597; Leahy DJ, 2008, CANCER CELL, V13, P291, DOI 10.1016/j.ccr.2008.03.010; Levitzki A, 2006, ANNU REV BIOCHEM, V75, P93, DOI 10.1146/annurev.biochem.75.103004.142657; Listov-Saabye N, 2009, J APPL TOXICOL, V29, P470, DOI 10.1002/jat.1428; McKern NM, 2006, NATURE, V443, P218, DOI 10.1038/nature05106; Menting JG, 2009, BIOCHEMISTRY-US, V48, P5492, DOI 10.1021/bi900261q; OLEFSKY JM, 1980, J BIOL CHEM, V255, P6098; Oleksiewicz MB, 2011, J APPL TOXICOL, V31, P329, DOI 10.1002/jat.1590; PETRUZZELLI LM, 1982, P NATL ACAD SCI-BIOL, V79, P6792, DOI 10.1073/pnas.79.22.6792; Pillutla RC, 2002, J BIOL CHEM, V277, P22590, DOI 10.1074/jbc.M202119200; Schaffer L, 2003, P NATL ACAD SCI USA, V100, P4435, DOI 10.1073/pnas.0830026100; SCHAFFER L, 1994, EUR J BIOCHEM, V221, P1127, DOI 10.1111/j.1432-1033.1994.tb18833.x; Schaffer L, 2008, BIOCHEM BIOPH RES CO, V376, P380, DOI 10.1016/j.bbrc.2008.08.151; Smith BJ, 2010, P NATL ACAD SCI USA, V107, P6771, DOI 10.1073/pnas.1001813107; SOOS MA, 1992, J BIOL CHEM, V267, P12955; SOOS MA, 1986, BIOCHEM J, V235, P199, DOI 10.1042/bj2350199; TAGER H, 1980, P NATL ACAD SCI-BIOL, V77, P3181, DOI 10.1073/pnas.77.6.3181; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; ULLRICH A, 1986, EMBO J, V5, P2503, DOI 10.1002/j.1460-2075.1986.tb04528.x; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; VERSPOHL EJ, 1988, J CLIN ENDOCR METAB, V67, P169, DOI 10.1210/jcem-67-1-169; Vikram A, 2011, STEROIDS, V76, P416, DOI 10.1016/j.steroids.2010.12.014; Vikram A, 2010, BIOCHEM BIOPH RES CO, V398, P260, DOI 10.1016/j.bbrc.2010.06.070; Ward CW, 2012, CURR OPIN STRUC BIOL, V22, P360, DOI 10.1016/j.sbi.2012.03.014; Ward CW, 2009, BIOESSAYS, V31, P422, DOI 10.1002/bies.200800210; WEILAND M, 1990, P NATL ACAD SCI USA, V87, P1154, DOI 10.1073/pnas.87.3.1154; WHITESELL RR, 1979, J BIOL CHEM, V254, P5276; WHITTAKER J, 1987, P NATL ACAD SCI USA, V84, P5237, DOI 10.1073/pnas.84.15.5237; Whittaker J, 2012, P NATL ACAD SCI USA, V109, P11166, DOI 10.1073/pnas.1205681109	50	33	34	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e51972	10.1371/journal.pone.0051972	http://dx.doi.org/10.1371/journal.pone.0051972			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300584	Green Published, Green Submitted, gold			2022-12-27	WOS:000312829100015
J	Lohela, TJ; Campbell, OMR; Gabrysch, S				Lohela, Terhi J.; Campbell, Oona M. R.; Gabrysch, Sabine			Distance to Care, Facility Delivery and Early Neonatal Mortality in Malawi and Zambia	PLOS ONE			English	Article							CHILD-MORTALITY; HEALTH-CARE; STILLBIRTHS; SURVIVAL; PROGRESS; DEATHS; ACCESS	Background: Globally, approximately 3 million babies die annually within their first month. Access to adequate care at birth is needed to reduce newborn as well as maternal deaths. We explore the influence of distance to delivery care and of level of care on early neonatal mortality in rural Zambia and Malawi, the influence of distance (and level of care) on facility delivery, and the influence of facility delivery on early neonatal mortality. Methods and Findings: National Health Facility Censuses were used to classify the level of obstetric care for 1131 Zambian and 446 Malawian delivery facilities. Straight-line distances to facilities were calculated for 3771 newborns in the 2007 Zambia DHS and 8842 newborns in the 2004 Malawi DHS. There was no association between distance to care and early neonatal mortality in Malawi (OR 0.97, 95% CI 0.58-1.60), while in Zambia, further distance (per 10 km) was associated with lower mortality (OR 0.55, 95% CI 0.35-0.87). The level of care provided in the closest facility showed no association with early neonatal mortality in either Malawi (OR 1.02, 95% CI 0.90-1.16) or Zambia (OR 1.02, 95% CI 0.82-1.26). In both countries, distance to care was strongly associated with facility use for delivery (Malawi: OR 0.35 per 10km, 95% CI 0.26-0.46). All results are adjusted for available confounders. Early neonatal mortality did not differ by frequency of facility delivery in the community. Conclusions: While better geographic access and higher level of care were associated with more frequent facility delivery, there was no association with lower early neonatal mortality. This could be due to low quality of care for newborns at health facilities, but differential underreporting of early neonatal deaths in the DHS is an alternative explanation. Improved data sources are needed to monitor progress in the provision of obstetric and newborn care and its impact on mortality.	[Lohela, Terhi J.; Gabrysch, Sabine] Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany; [Lohela, Terhi J.] Helsinki Univ Hosp, Jorvi Hosp, Dept Anaesthesiol & Intens Care Med, Espoo, Finland; [Campbell, Oona M. R.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England	Ruprecht Karls University Heidelberg; University of Helsinki; Helsinki University Central Hospital; University of London; London School of Hygiene & Tropical Medicine	Gabrysch, S (corresponding author), Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany.	sabine.gabrysch@uni-heidelberg.de	Gabrysch, Sabine/A-3503-2013	Gabrysch, Sabine/0000-0002-7081-0506; Campbell, Oona/0000-0002-9311-0115; Lohela, Terhi/0000-0002-6596-1780	University of Heidelberg through a Margarete von Wrangell Fellowship; European Social Fund; Ministry of Science, Research and the Arts Baden-Wurttemberg; Medical Faculty's Rahel Goitein-Straus Programme; London School of Hygiene and Tropical Medicine	University of Heidelberg through a Margarete von Wrangell Fellowship; European Social Fund(European Social Fund (ESF)); Ministry of Science, Research and the Arts Baden-Wurttemberg; Medical Faculty's Rahel Goitein-Straus Programme; London School of Hygiene and Tropical Medicine	SG is paid by the University of Heidelberg through a Margarete von Wrangell Fellowship supported by the European Social Fund and by the Ministry of Science, Research and the Arts Baden-Wurttemberg, and has received salary support from the Medical Faculty's Rahel Goitein-Straus Programme. TJL did this work as part of her MSc thesis and was subsequently employed by SG through Heidelberg University funds. OMRC is supported by the London School of Hygiene and Tropical Medicine. No funders had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adisasmita Asri, 2008, BMC Pregnancy Childbirth, V8, P10, DOI 10.1186/1471-2393-8-10; [Anonymous], LEV TRENDS CHILD MOR; Bell JS., 2003, TRENDS DELIVERY CARE; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Brocklehurst P, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7400; Central Statistical Office Ministry of Health Tropical Diseases Research Centre Inc University of Zambia Macro International Inc, 2009, ZAMB DEM HLTH SURV 2; Curtis S, 1995, OCCASIONAL PAPERS MA; Filippi V, 2005, ACTA OBSTET GYN SCAN, V84, P11, DOI 10.1111/j.0001-6349.2005.00636.x; Gabrysch S, 2012, PLOS MED IN PRESS; Gabrysch S, 2012, TROP MED INT HEALTH, V17, P2, DOI 10.1111/j.1365-3156.2011.02851.x; Gabrysch S, 2011, INT J GYNECOL OBSTET, V114, P174, DOI 10.1016/j.ijgo.2011.05.007; Gabrysch S, 2011, TROP MED INT HEALTH, V16, P627, DOI 10.1111/j.1365-3156.2011.02741.x; Gabrysch S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000394; Glei DA, 2003, SOC SCI MED, V57, P2447, DOI 10.1016/S0277-9536(03)00140-0; *HLTH FAC ASS TECH, 2005, PROF HLTH FAC ASS ME; Johnson K., 2009, FIELDWORK RELATED FA; Lawn J, 2005, B WORLD HEALTH ORGAN, V83, P409; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lawn JE, 2009, INT J GYNECOL OBSTET, V107, pS123, DOI 10.1016/j.ijgo.2009.07.021; Lawn JE, 2009, INT J GYNECOL OBSTET, V107, pS5, DOI 10.1016/j.ijgo.2009.07.016; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Malqvist M, 2008, ANN TROP PAEDIATR, V28, P191, DOI 10.1179/146532808X335633; Malqvist M, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-762; MEASURE DHS What We Do. Geographic Information Systems (GIS), MEASURE DHS WHAT WE; Nathan R, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-18; Neal S., 2012, 25 ESRC CTR POP CHAN; NSO ICF, 2005, MAL DEM HLTH SURV 20; Okwaraji YB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033564; Pullum TW, 2008, ASSESSMENT QUALITY D; Ronsmans C, 2010, B WORLD HEALTH ORGAN, V88, P289, DOI 10.2471/BLT.09.069385; Rutherford ME, 2009, B WORLD HEALTH ORGAN, V87, P216, DOI 10.2471/BLT.08.052175; Rutstein SO, 2006, GUIDE DHS STAT; Schoeps A, 2011, AM J EPIDEMIOL, V173, P492, DOI 10.1093/aje/kwq386; Titaley CR, 2011, HLTH POLICY PLAN; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1	35	86	87	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52110	10.1371/journal.pone.0052110	http://dx.doi.org/10.1371/journal.pone.0052110			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300599	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000312829100021
J	Skrovseth, SO; Bellika, JG; Godtliebsen, F				Skrovseth, Stein Olav; Bellika, Johan Gustav; Godtliebsen, Fred			Causality in Scale Space as an Approach to Change Detection	PLOS ONE			English	Article							CHANGE-POINT DETECTION; BAYESIAN-ANALYSIS; INFERENCE; QUALITY; KERNEL; MODELS; TOOL	Kernel density estimation and kernel regression are useful ways to visualize and assess the structure of data. Using these techniques we define a temporal scale space as the vector space spanned by bandwidth and a temporal variable. In this space significance regions that reflect a significant derivative in the kernel smooth similar to those of SiZer (Significant Zero-crossings of derivatives) are indicated. Significance regions are established by hypothesis tests for significant gradient at every point in scale space. Causality is imposed onto the space by restricting to kernels with left-bounded or finite support and shifting kernels forward. We show that these adjustments to the methodology enable early detection of changes in time series constituting live surveillance systems of either count data or unevenly sampled measurements. Warning delays are comparable to standard techniques though comparison shows that other techniques may be better suited for single-scale problems. Our method reliably detects change points even with little to no knowledge about the relevant scale of the problem. Hence the technique will be applicable for a large variety of sources without tailoring. Furthermore this technique enables us to obtain a retrospective reliable interval estimate of the time of a change point rather than a point estimate. We apply the technique to disease outbreak detection based on laboratory confirmed cases for pertussis and influenza as well as blood glucose concentration obtained from patients with diabetes type 1.	[Skrovseth, Stein Olav; Bellika, Johan Gustav] Univ Hosp N Norway, Norwegian Ctr Integrated Care & Telemed, Tromso, Norway; [Bellika, Johan Gustav] Univ Tromso, Dept Comp Sci, Tromso, Norway; [Godtliebsen, Fred] Univ Tromso, Dept Math & Stat, Tromso, Norway	UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso	Skrovseth, SO (corresponding author), Univ Hosp N Norway, Norwegian Ctr Integrated Care & Telemed, Tromso, Norway.	stein.olav.skrovseth@telemed.no		Skrovseth, Stein Olav/0000-0003-3568-867X	Norwegian Research Council [174934]; regional health authority of North Norway [ID3919/HST952-10]	Norwegian Research Council(Research Council of NorwayEuropean Commission); regional health authority of North Norway	The research is performed as part of Troms Telemedicine Laboratory in part funded by the Norwegian Research Council under grant no 174934. The Diabetes data is gathered and analyzed under project ID3919/HST952-10 funded by the regional health authority of North Norway. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An MY, 1998, J ECON THEORY, V80, P350, DOI 10.1006/jeth.1998.2400; BABAUD J, 1986, IEEE T PATTERN ANAL, V8, P26, DOI 10.1109/TPAMI.1986.4767749; BARRY D, 1993, J AM STAT ASSOC, V88, P309, DOI 10.1080/01621459.1993.10594323; Beaulieu C, 2012, PHILOS T R SOC A, V370, P1228, DOI 10.1098/rsta.2011.0383; Belik V, 2011, PHYS REV X, V1, DOI 10.1103/PhysRevX.1.011001; Bellika JG, 2007, INT J MED INFORM, V76, P313, DOI 10.1016/j.ijmedinf.2006.02.007; Chaudhuri P, 2000, ANN STAT, V28, P408, DOI 10.1214/aos/1016218224; Chaudhuri P, 1999, J AM STAT ASSOC, V94, P807, DOI 10.2307/2669996; Cule M, 2010, J R STAT SOC B, V72, P545, DOI 10.1111/j.1467-9868.2010.00753.x; Diggle P, 2005, ENVIRONMETRICS, V16, P423, DOI 10.1002/env.712; Edlund S, 2011, EPIDEMICS-NETH, V3, P135, DOI 10.1016/j.epidem.2011.04.002; Erdman C, 2007, J STAT SOFTW, V23, P1; Fearnhead P, 2007, J ROY STAT SOC B, V69, P589, DOI 10.1111/j.1467-9868.2007.00601.x; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Gradsteyn I S, 2000, TABLE INTEGRALS SERI; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Hannig J, 2006, J AM STAT ASSOC, V101, P484, DOI 10.1198/016214505000001294; Hastie T, 2009, ELEMENTS STAT LEARNI, P33, DOI 10.1007/978-0-387-84858-7; HINKLEY DV, 1970, BIOMETRIKA, V57, P1; Killick R, 2012, CHANGEPOINT; LAI TL, 1995, J R STAT SOC B, V57, P613, DOI 10.1111/j.2517-6161.1995.tb02052.x; McCulloch DK, 2011, BLOOD GLUCOSE SELF M; Mei YJ, 2006, ANN STAT, V34, P92, DOI 10.1214/009053605000000859; Neill DB, 2012, J R STAT SOC B, P74; PAGE ES, 1954, BIOMETRIKA, V41, P100, DOI 10.1093/biomet/41.1-2.100; Pearl Judea, 2009, CAUSALITY, P2; R Core Team, 2016, R FDN STAT COMP; Roehr B, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4627; Schrodle B, 2011, ENVIRONMETRICS, V22, P725, DOI 10.1002/env.1065; SHEATHER SJ, 1991, J ROY STAT SOC B MET, V53, P683; Shewhart WA, 1925, J AM STAT ASSOC, V20, P546, DOI 10.2307/2277170; Skrovseth SO, 2012, DIABETES TECHNOL THE, V14, P1098, DOI 10.1089/dia.2012.0160; Tartakovsky AG, 2006, IEEE T SIGNAL PROCES, V54, P3372, DOI 10.1109/TSP.2006.879308; van Rossum MCW, 2001, NEURAL COMPUT, V13, P751, DOI 10.1162/089976601300014321; Wand MP., 1994, KERNEL SMOOTHING	35	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2012	7	12							e52253	10.1371/journal.pone.0052253	http://dx.doi.org/10.1371/journal.pone.0052253			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061EA	23300626	Green Published, Green Submitted, gold			2022-12-27	WOS:000312829100036
J	Ganzenmuller, GC; Hiermaier, S; Steinhauser, MO				Ganzenmueller, Georg C.; Hiermaier, Stefan; Steinhauser, Martin O.			Consistent Temperature Coupling with Thermal Fluctuations of Smooth Particle Hydrodynamics and Molecular Dynamics	PLOS ONE			English	Article							VELOCITY IMPACT COMPUTATIONS; FRACTURE INSTABILITIES; ENERGY-CONSERVATION; LIPID-BILAYERS; SHOCK-WAVES; SIMULATIONS; WATER; DEFORMATION; MODEL; SPH	We propose a thermodynamically consistent and energy-conserving temperature coupling scheme between the atomistic and the continuum domain. The coupling scheme links the two domains using the DPDE (Dissipative Particle Dynamics at constant Energy) thermostat and is designed to handle strong temperature gradients across the atomistic/continuum domain interface. The fundamentally different definitions of temperature in the continuum and atomistic domain - internal energy and heat capacity versus particle velocity - are accounted for in a straightforward and conceptually intuitive way by the DPDE thermostat. We verify the here-proposed scheme using a fluid, which is simultaneously represented as a continuum using Smooth Particle Hydrodynamics, and as an atomistically resolved liquid using Molecular Dynamics. In the case of equilibrium contact between both domains, we show that the correct microscopic equilibrium properties of the atomistic fluid are obtained. As an example of a strong non-equilibrium situation, we consider the propagation of a steady shock-wave from the continuum domain into the atomistic domain, and show that the coupling scheme conserves both energy and shock-wave dynamics. To demonstrate the applicability of our scheme to real systems, we consider shock loading of a phospholipid bilayer immersed in water in a multi-scale simulation, an interesting topic of biological relevance.	[Ganzenmueller, Georg C.; Hiermaier, Stefan; Steinhauser, Martin O.] Ernst Mach Inst, Fraunhofer Inst High Speed Dynam, Freiburg, Germany	Fraunhofer Gesellschaft	Ganzenmuller, GC (corresponding author), Ernst Mach Inst, Fraunhofer Inst High Speed Dynam, Freiburg, Germany.	georg.ganzenmueller@emi.fraunhofer.de		Ganzenmueller, Georg/0000-0001-5741-8844; Steinhauser, Martin Oliver/0000-0002-8639-4252	Fraunhofer-Gesellschaft, Germany [600016]	Fraunhofer-Gesellschaft, Germany	This work was carried out with financial support from the Fraunhofer-Gesellschaft, Germany, grant number 600016 (Vintage Class). http://www.fraunhofer.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham FF, 2000, PHYS REV LETT, V84, P3113, DOI 10.1103/PhysRevLett.84.3113; Allen M., 2017, COMPUTER SIMULATIONS, V2nd; Avalos JB, 1997, EUROPHYS LETT, V40, P141, DOI 10.1209/epl/i1997-00436-6; Buehler MJ, 2006, NATURE, V439, P307, DOI 10.1038/nature04408; Cleary PW, 1999, J COMPUT PHYS, V148, P227, DOI 10.1006/jcph.1998.6118; COOKE CH, 1992, COMMUN APPL NUMER M, V8, P219, DOI 10.1002/cnm.1630080403; de la Rubia TD, 2000, NATURE, V406, P871, DOI 10.1038/35022544; Diestler DJ, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.184104; Espanol P, 1997, EUROPHYS LETT, V40, P631, DOI 10.1209/epl/i1997-00515-8; Espanol P, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026705; Fago M, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.100102; Ganzenmuller GC, 2011, SOFT MATTER, V7, P4307, DOI 10.1039/c0sm01296c; GINGOLD RA, 1977, MON NOT R ASTRON SOC, V181, P375, DOI 10.1093/mnras/181.3.375; Gonzalez LM, 2009, PROCEEDINGS OF THE 4; Gravouil A, 2001, INT J NUMER METH ENG, V50, P199, DOI 10.1002/1097-0207(20010110)50:1<199::AID-NME132>3.0.CO;2-A; Gu YT, 2006, MULTISCALE MODEL SIM, V5, P1128, DOI 10.1137/060654232; HOOGERBRUGGE PJ, 1992, EUROPHYS LETT, V19, P155, DOI 10.1209/0295-5075/19/3/001; Hoover WilliamGraham., 2006, SMOOTH PARTICLE APPL, DOI 10.1142/6218; JOHNSON GR, 1994, NUCL ENG DES, V150, P265, DOI 10.1016/0029-5493(94)90143-0; Johnson GR, 1996, COMPUT METHOD APPL M, V139, P347, DOI 10.1016/S0045-7825(96)01089-4; Kermode JR, 2008, NATURE, V455, P1224, DOI 10.1038/nature07297; Kodama T, 2002, BBA-MOL CELL RES, V1542, P186, DOI 10.1016/S0167-4889(01)00177-X; Koshiyama K, 2008, BBA-BIOMEMBRANES, V1778, P1423, DOI 10.1016/j.bbamem.2008.03.010; Koshiyama K, 2006, BIOPHYS J, V91, P2198, DOI 10.1529/biophysj.105.077677; Kwon Y. W., 2008, MULTISCALE MODELLING; Lu G, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.024108; Lucy L, 1977, ASTRON J, V82; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Marrink SJ, 2009, BBA-BIOMEMBRANES, V1788, P149, DOI 10.1016/j.bbamem.2008.10.006; Nagayama K, 2002, J APPL PHYS, V91, P476, DOI 10.1063/1.1421630; PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039; REE FH, 1980, J CHEM PHYS, V73, P5401, DOI 10.1063/1.439940; Shenoy VB, 1998, PHYS REV LETT, V80, P742, DOI 10.1103/PhysRevLett.80.742; Smith GS, 2000, PHYS REV LETT, V84, P1260, DOI 10.1103/PhysRevLett.84.1260; Steinhauser M.O., 2008, COMPUTATIONAL MULTIS; Steinhauser MO, 2006, EUROPHYS LETT, V73, P62, DOI 10.1209/epl/i2005-10353-2; Stoltz G, 2006, EUROPHYS LETT, V76, P849, DOI 10.1209/epl/i2006-10350-y; Warner DH, 2006, INT J PLASTICITY, V22, P754, DOI 10.1016/j.ijplas.2005.04.014; Xiao SP, 2004, COMPUT METHOD APPL M, V193, P1645, DOI 10.1016/j.cma.2003.12.053	40	10	10	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e51989	10.1371/journal.pone.0051989	http://dx.doi.org/10.1371/journal.pone.0051989			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300586	gold, Green Published, Green Submitted			2022-12-27	WOS:000313618800042
J	Lockyer, AE; Emery, AM; Kane, RA; Walker, AJ; Mayer, CD; Mitta, G; Coustau, C; Adema, CM; Hanelt, B; Rollinson, D; Noble, LR; Jones, CS				Lockyer, Anne E.; Emery, Aidan M.; Kane, Richard A.; Walker, Anthony J.; Mayer, Claus D.; Mitta, Guillaume; Coustau, Christine; Adema, Coen M.; Hanelt, Ben; Rollinson, David; Noble, Leslie R.; Jones, Catherine S.			Early Differential Gene Expression in Haemocytes from Resistant and Susceptible Biomphalaria glabrata Strains in Response to Schistosoma mansoni	PLOS ONE			English	Article							INTERMEDIATE SNAIL HOST; ECHINOSTOMA-PARAENSEI; DEFENSE CELLS; SUPEROXIDE-DISMUTASE; PRIMARY SPOROCYSTS; MICROARRAY DATA; INFECTION; COMPATIBILITY; DISCOVERY; SYSTEM	The outcome of infection in the host snail Biomphalaria glabrata with the digenean parasite Schistosoma mansoni is determined by the initial molecular interplay occurring between them. The mechanisms by which schistosomes evade snail immune recognition to ensure survival are not fully understood, but one possibility is that the snail internal defence system is manipulated by the schistosome enabling the parasite to establish infection. This study provides novel insights into the nature of schistosome resistance and susceptibility in B. glabrata at the transcriptomic level by simultaneously comparing gene expression in haemocytes from parasite-exposed and control groups of both schistosome-resistant and schistosome-susceptible strains, 2 h post exposure to S. mansoni miracidia, using an novel 5 K cDNA microarray. Differences in gene expression, including those for immune/stress response, signal transduction and matrix/adhesion genes were identified between the two snail strains and tests for asymmetric distributions of gene function also identified immune-related gene expression in resistant snails, but not in susceptible. Gene set enrichment analysis revealed that genes involved in mitochondrial electron transport, ubiquinone biosynthesis and electron carrier activity were consistently up-regulated in resistant snails but down-regulated in susceptible. This supports the hypothesis that schistosome-resistant snails recognize schistosomes and mount an appropriate defence response, while in schistosome-susceptible snails the parasite suppresses this defence response, early in infection.	[Lockyer, Anne E.; Emery, Aidan M.; Kane, Richard A.; Rollinson, David] Nat Hist Museum, Dept Life Sci, Wolfson Wellcome Biomed Labs, London SW7 5BD, England; [Walker, Anthony J.] Univ Kingston, Sch Life Sci, Kingston Upon Thames KT1 2EE, Surrey, England; [Mayer, Claus D.] Univ Aberdeen, Rowett Inst Nutr & Hlth, BioSS Biomath & Stat Scotland Off, Aberdeen, Scotland; [Mitta, Guillaume] Univ Perpignan, CNRS, F-66025 Perpignan, France; [Coustau, Christine] INRA CNRS UNS, Sophia Agrobiotech Inst, F-06903 Sophia Antipolis, France; [Adema, Coen M.; Hanelt, Ben] Univ New Mexico, CETI, Albuquerque, NM 87131 USA; [Noble, Leslie R.; Jones, Catherine S.] Univ Aberdeen, Sch Biol Sci, Aberdeen, Scotland	Natural History Museum London; Kingston University; James Hutton Institute; University of Aberdeen; Centre National de la Recherche Scientifique (CNRS); Universite Perpignan Via Domitia; INRAE; University of New Mexico; University of Aberdeen	Jones, CS (corresponding author), Univ Aberdeen, Sch Biol Sci, Aberdeen, Scotland.	c.s.jones@abdn.ac.uk	Rollinson, David/C-7406-2009; Lockyer, Anne/AAO-4327-2021; Mayer, Claus-Dieter/L-9353-2013	Hanelt, Ben/0000-0001-9298-7356; mitta, guillaume/0000-0003-1188-1467; Lockyer, Anne/0000-0002-3498-2423; Emery, Aidan/0000-0001-9028-8586; Noble, leslie/0000-0003-3076-0759; COUSTAU, Christine/0000-0001-7524-0947; Mayer, Claus-Dieter/0000-0001-8788-3149	Wellcome Trust [068589/Z/02/Z]; United States National Institutes of Health (NIH), USA [R01AI052363, COBRE 1P20RR018754 IdEA]; NCRR; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052363] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); United States National Institutes of Health (NIH), USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was carried out with funding from the Wellcome Trust (068589/Z/02/Z). CMA and BH acknowledge support from the United States National Institutes of Health (NIH), USA R01AI052363 (CMA) and COBRE 1P20RR018754 IdEA, NCRR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adema C.M., 1997, ADV TREMATODE BIOL, P230; Adema CM, 2006, MEM I OSWALDO CRUZ, V101, P167, DOI 10.1590/S0074-02762006000900027; Adema CM, 2010, MOL IMMUNOL, V47, P849, DOI 10.1016/j.molimm.2009.10.019; Bayne CJ, 2009, MOL BIOCHEM PARASIT, V165, P8, DOI 10.1016/j.molbiopara.2009.01.005; Bayne CJ, 2001, PARASITOLOGY, V123, pS159; Bender RC, 2007, DEV COMP IMMUNOL, V31, P874, DOI 10.1016/j.dci.2006.12.005; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BOSWELL CA, 1985, EXP PARASITOL, V60, P133, DOI 10.1016/S0014-4894(85)80030-8; Bouchut A, 2006, INT J PARASITOL, V36, P175, DOI 10.1016/j.ijpara.2005.09.009; Chitsulo L, 2004, NAT REV MICROBIOL, V2, P12, DOI 10.1038/nrmicro801; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Davids BJ, 1998, DEV COMP IMMUNOL, V22, P39, DOI 10.1016/S0145-305X(97)00039-6; Davids BJ, 1999, GENE, V228, P213, DOI 10.1016/S0378-1119(99)00008-6; Deleury E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032512; El-Ansary A, 2006, MED SCI MONITOR, V12, pRA282; Goodall CP, 2006, MOL BIOCHEM PARASIT, V147, P207, DOI 10.1016/j.molbiopara.2006.02.009; Hanelt B, 2008, J INVERTEBR PATHOL, V99, P192, DOI 10.1016/j.jip.2008.06.002; Hanington PC, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001591; Hanington PC, 2010, P NATL ACAD SCI USA, V107, P21087, DOI 10.1073/pnas.1011242107; Hanington PC, 2011, J INNATE IMMUN, V3, P17, DOI 10.1159/000321882; Hanington PC, 2010, INT J PARASITOL, V40, P819, DOI 10.1016/j.ijpara.2009.12.005; Hertel LA, 2005, DEV COMP IMMUNOL, V29, P295, DOI 10.1016/j.dci.2004.08.003; Humphries JE, 2008, DEV COMP IMMUNOL, V32, P554, DOI 10.1016/j.dci.2007.09.001; Ittiprasert W, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002677; Ittiprasert W, 2009, EXP PARASITOL, V123, P203, DOI 10.1016/j.exppara.2009.07.015; Jones CS, 2001, PARASITOLOGY, V123, pS181; Jung Y, 2005, J INVERTEBR PATHOL, V90, P59, DOI 10.1016/j.jip.2005.06.014; Kerr M K, 2001, Biostatistics, V2, P183, DOI 10.1093/biostatistics/2.2.183; Lafferty KD, 2009, TRENDS PARASITOL, V25, P564, DOI 10.1016/j.pt.2009.09.003; LEWIS FA, 1986, J PARASITOL, V72, P813, DOI 10.2307/3281829; LIE KJ, 1976, J PARASITOL, V62, P608, DOI 10.2307/3279428; Lieb B, 2006, P NATL ACAD SCI USA, V103, P12011, DOI 10.1073/pnas.0601861103; Lockhart DJ, 2000, NATURE, V405, P827, DOI 10.1038/35015701; Lockyer AE, 2000, PARASITOLOGY, V120, P399, DOI 10.1017/S0031182099005624; Lockyer AE, 2004, EXP PARASITOL, V107, P97, DOI 10.1016/j.exppara.2004.04.004; Lockyer AE, 2004, CAN J ZOOL, V82, P251, DOI [10.1139/z03-215, 10.1139/Z03-215]; Lockyer AE, 2007, DEV COMP IMMUNOL, V31, P763, DOI 10.1016/j.dci.2006.11.004; Lockyer AE, 2007, MOL BIOCHEM PARASIT, V151, P18, DOI 10.1016/j.molbiopara.2006.09.009; Lockyer AE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-634; Loker ES, 2010, ADV EXP MED BIOL, V708, P17; LOKER ES, 1992, J PARASITOL, V78, P104, DOI 10.2307/3283696; Medina I, 2010, NUCLEIC ACIDS RES, V38, pW210, DOI 10.1093/nar/gkq388; Mitta G, 2005, DEV COMP IMMUNOL, V29, P393, DOI 10.1016/j.dci.2004.10.002; Mitta G, 2012, DEV COMP IMMUNOL, V37, P1, DOI 10.1016/j.dci.2011.09.002; Mone Y, 2011, INT J PARASITOL, V41, P721, DOI 10.1016/j.ijpara.2011.01.007; Mourao MD, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000550; NEWTON WL, 1953, EXP PARASITOL, V2, P242, DOI 10.1016/0014-4894(53)90036-8; Pan SCT, 1996, JPN J MED SCI BIOL, V49, P129, DOI 10.7883/yoken1952.49.129; PARAENSE W. L., 1963, REV INST MED TROP SAO PAULO, V5, P15; Petalidis L, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng142; Plows LD, 2005, INT J PARASITOL, V35, P293, DOI 10.1016/j.ijpara.2004.11.012; Plows LD, 2006, BBA-MOL CELL RES, V1763, P779, DOI 10.1016/j.bbamcr.2006.04.008; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tanguy A, 2004, GENE, V338, P121, DOI 10.1016/j.gene.2004.05.019; Theron A, 2005, J HELMINTHOL, V79, P187, DOI 10.1079/JOH2005299; Walker AJ, 2006, TRENDS PARASITOL, V22, P154, DOI 10.1016/j.pt.2006.02.003; Walker AJ, 2010, CELL TISSUE RES, V341, P131, DOI 10.1007/s00441-010-0986-4; Walker AJ, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-203; Webster JP, 2001, PARASITOLOGY, V123, pS41, DOI 10.1017/S0031182001008071; Webster JP, 1999, P ROY SOC B-BIOL SCI, V266, P391, DOI 10.1098/rspb.1999.0650; Yoshino TP, 2008, GENE, V411, P46, DOI 10.1016/j.gene.2008.01.003; YOSHINO TP, 1983, PARASITE IMMUNOL, V5, P317, DOI 10.1111/j.1365-3024.1983.tb00747.x; Zahoor Z, 2008, DEV COMP IMMUNOL, V32, P1561, DOI 10.1016/j.dci.2008.05.014; Zahoor Z, 2010, CELL STRESS CHAPERON, V15, P639, DOI 10.1007/s12192-010-0176-z; Zahoor Z, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-18; Zhang SM, 2004, SCIENCE, V305, P251, DOI 10.1126/science.1088069	69	44	47	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e511020	10.1371/journal.pone.0051102	http://dx.doi.org/10.1371/journal.pone.0051102			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300533	Green Published, Green Accepted, gold			2022-12-27	WOS:000313618800010
J	Xu, GQ; Zou, W; Chen, XL; Xu, N; Liu, LM; Chen, J				Xu, Guoqiang; Zou, Wei; Chen, Xiulai; Xu, Nan; Liu, Liming; Chen, Jian			Fumaric Acid Production in Saccharomyces cerevisiae by In Silico Aided Metabolic Engineering	PLOS ONE			English	Article							ESCHERICHIA-COLI; YEAST; RECONSTRUCTION; EXPRESSION; MODELS; GROWTH	Fumaric acid (FA) is a promising biomass-derived building-block chemical. Bio-based FA production from renewable feedstock is a promising and sustainable alternative to petroleum-based chemical synthesis. Here we report on FA production by direct fermentation using metabolically engineered Saccharomyces cerevisiae with the aid of in silico analysis of a genome-scale metabolic model. First, FUM1 was selected as the target gene on the basis of extensive literature mining. Flux balance analysis (FBA) revealed that FUM1 deletion can lead to FA production and slightly lower growth of S. cerevisiae. The engineered S. cerevisiae strain obtained by deleting FUM1 can produce FA up to a concentration of 610 +/- 31 mg L-1 without any apparent change in growth in fed-batch culture. FT-IR and H-1 and C-13 NMR spectra confirmed that FA was synthesized by the engineered S. cerevisiae strain. FBA identified pyruvate carboxylase as one of the factors limiting higher FA production. When the RoPYC gene was introduced, S. cerevisiae produced 1134 +/- 48 mg L-1 FA. Furthermore, the final engineered S. cerevisiae strain was able to produce 1675 +/- 52 mg L-1 FA in batch culture when the SFC1 gene encoding a succinate-fumarate transporter was introduced. These results demonstrate that the model shows great predictive capability for metabolic engineering. Moreover, FA production in S. cerevisiae can be efficiently developed with the aid of in silico metabolic engineering.	[Xu, Guoqiang; Zou, Wei; Chen, Xiulai; Xu, Nan; Liu, Liming; Chen, Jian] Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Peoples R China; [Xu, Guoqiang; Zou, Wei; Chen, Xiulai; Xu, Nan; Liu, Liming; Chen, Jian] Jiangnan Univ, Key Lab Ind Biotechnol, Minist Educ, Sch Biotechnol, Wuxi, Peoples R China; [Xu, Guoqiang; Zou, Wei; Liu, Liming; Chen, Jian] Jiangnan Univ, Key Lab Carbohydrate Chem & Biotechnol, Minist Educ, Sch Biotechnol, Wuxi, Peoples R China	Jiangnan University; Jiangnan University; Jiangnan University	Liu, LM (corresponding author), Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Peoples R China.	mingll@jiangnan.edu.cn; jchen@jiangnan.edu.cn	Chen, Xiulai/AAB-8395-2020; Liu, Liming/B-1972-2009	Chen, Xiulai/0000-0002-5154-3860; Liu, Liming/0000-0003-3022-936X; Xu, Nan/0000-0002-2510-3394	Key Program of National Natural Science Foundation of China [20836003]; National Outstanding Doctorate Paper Author Special Fund [200962]; Program for New Century Excellent Talents in University [NCET-10-0456]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Doctor Candidate Foundation of Jiangnan University [JUDCF09015]	Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Outstanding Doctorate Paper Author Special Fund; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Priority Academic Program Development of Jiangsu Higher Education Institutions; Doctor Candidate Foundation of Jiangnan University	This work was supported by grants from the Key Program of National Natural Science Foundation of China (No. 20836003), the National Outstanding Doctorate Paper Author Special Fund (No. 200962), Program for New Century Excellent Talents in University (NCET-10-0456), the Priority Academic Program Development of Jiangsu Higher Education Institutions, and Doctor Candidate Foundation of Jiangnan University (JUDCF09015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DA, 2009, FEMS YEAST RES, V9, P1123, DOI 10.1111/j.1567-1364.2009.00537.x; Arikawa Y, 1999, J BIOSCI BIOENG, V87, P28, DOI 10.1016/S1389-1723(99)80004-8; Bojunga N, 1998, MOL GEN GENET, V260, P453, DOI 10.1007/s004380050916; Bro C, 2006, METAB ENG, V8, P102, DOI 10.1016/j.ymben.2005.09.007; Brochado AR, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-84; Cao NJ, 1996, APPL ENVIRON MICROB, V62, P2926, DOI 10.1128/AEM.62.8.2926-2931.1996; Duarte NC, 2004, GENOME RES, V14, P1298, DOI 10.1101/gr.2250904; Durot M, 2009, FEMS MICROBIOL REV, V33, P164, DOI 10.1111/j.1574-6976.2008.00146.x; Edwards JS, 2000, BIOTECHNOL PROGR, V16, P927, DOI 10.1021/bp0000712; Frick O, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-30; Goldberg I, 2006, J CHEM TECHNOL BIOT, V81, P1601, DOI 10.1002/jctb.1590; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; KACLIKOVA E, 1992, FEMS MICROBIOL LETT, V91, P101; KENEALY W, 1986, APPL ENVIRON MICROB, V52, P128, DOI 10.1128/AEM.52.1.128-133.1986; Kim TY, 2011, CURR OPIN BIOTECHNOL; Lee JW, 2011, TRENDS BIOTECHNOL, V29, P370, DOI 10.1016/j.tibtech.2011.04.001; Lee KH, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100196; Liu LM, 2010, FEBS LETT, V584, P2556, DOI 10.1016/j.febslet.2010.04.052; Nevoigt E, 2008, MICROBIOL MOL BIOL R, V72, P379, DOI 10.1128/MMBR.00025-07; Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Osterlund T, 2011, BIOTECHNOL ADV; Palmieri L, 1997, FEBS LETT, V417, P114, DOI 10.1016/S0014-5793(97)01269-6; Park JH, 2007, P NATL ACAD SCI USA, V104, P7797, DOI 10.1073/pnas.0702609104; Raab AM, 2011, APPL ENVIRON MICROB, V77, P1981, DOI 10.1128/AEM.02219-10; Raman K, 2009, BRIEF BIOINFORM, V10, P435, DOI 10.1093/bib/bbp011; Redruello B, 1999, FEBS LETT, V445, P246, DOI 10.1016/S0014-5793(99)00120-9; Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308; Tokuhiro K, 2009, APPL MICROBIOL BIOT, V82, P883, DOI 10.1007/s00253-008-1831-5; Xu GQ, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-24; Zelle RM, 2008, APPL ENVIRON MICROB, V74, P2766, DOI 10.1128/AEM.02591-07; Zelle RM, 2010, APPL ENVIRON MICROB, V76, P744, DOI 10.1128/AEM.02396-09	33	36	42	3	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52086	10.1371/journal.pone.0052086	http://dx.doi.org/10.1371/journal.pone.0052086			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300594	Green Submitted, Green Published, gold			2022-12-27	WOS:000313618800047
J	Fang, GZ; Yang, P; Cui, JG; Yao, DZ; Brauth, SE; Tang, YZ				Fang, Guangzhan; Yang, Ping; Cui, Jianguo; Yao, Dezhong; Brauth, Steven E.; Tang, Yezhong			Mating Signals Indicating Sexual Receptiveness Induce Unique Spatio-Temporal EEG Theta Patterns in an Anuran Species	PLOS ONE			English	Article							SELF-ORGANIZED CRITICALITY; EARLY GENE-EXPRESSION; FEMALE TUNGARA FROGS; MATE CHOICE; WORKING-MEMORY; COGNITIVE-PROCESSES; BRAIN OSCILLATIONS; ALZHEIMERS-DISEASE; CEREBRAL ASYMMETRY; AUDITORY MIDBRAIN	Female mate choice is of importance for individual fitness as well as a determining factor in genetic diversity and speciation. Nevertheless relatively little is known about how females process information acquired from males during mate selection. In the Emei music frog, Babina daunchina, males normally call from hidden burrows and females in the reproductive stage prefer male calls produced from inside burrows compared with ones from outside burrows. The present study evaluated changes in electroencephalogram (EEG) power output in four frequency bands induced by male courtship vocalizations on both sides of the telencephalon and mesencephalon in females. The results show that (1) both the values of left hemispheric theta relative power and global lateralization in the theta band are modulated by the sexual attractiveness of the acoustic stimulus in the reproductive stage, suggesting the theta oscillation is closely correlated with processing information associated with mate choice; (2) mean relative power in the beta band is significantly greater in the mesencephalon than the left telencephalon, regardless of reproductive status or the biological significance of signals, indicating it is associated with processing acoustic features and (3) relative power in the delta and alpha bands are not affected by reproductive status or acoustic stimuli. The results imply that EEG power in the theta and beta bands reflect different information processing mechanisms related to vocal recognition and auditory perception in anurans.	[Fang, Guangzhan; Yang, Ping; Cui, Jianguo; Tang, Yezhong] Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Sichuan, Peoples R China; [Yao, Dezhong] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Key Lab Neuroinformat, Minist Educ, Chengdu 610054, Peoples R China; [Brauth, Steven E.] Univ Maryland, Dept Psychol, College Pk, MD 20742 USA	Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; University of Electronic Science & Technology of China; University System of Maryland; University of Maryland College Park	Tang, YZ (corresponding author), Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Sichuan, Peoples R China.	tangyz@cib.ac.cn	fang, guangzhan/AAH-1098-2020	Fang, Guangzhan/0000-0003-1803-6610	National Natural Science Foundation of China [31270042, 2011CB707803]; Ministry of Education of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China)	This work was supported by the National Natural Science Foundation of China (31270042 to Jianguo Cui, 2011CB707803 to Dezhong Yao), and the Ministry of Education of China (the "111" Project) to Dezhong Yao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addante RJ, 2011, P NATL ACAD SCI USA, V108, P10702, DOI 10.1073/pnas.1014528108; Akre KL, 2010, CURR BIOL, V20, P502, DOI 10.1016/j.cub.2010.01.021; Alexander Richard D., 1997, P4, DOI 10.1017/CBO9780511721946.002; Baijal S, 2010, COGN PROCESS, V11, P31, DOI 10.1007/s10339-009-0272-0; BAK P, 1988, PHYS REV A, V38, P364, DOI 10.1103/PhysRevA.38.364; BAK P, 1987, PHYS REV LETT, V59, P381, DOI 10.1103/PhysRevLett.59.381; Basar E, 2000, INT J PSYCHOPHYSIOL, V35, P95, DOI 10.1016/S0167-8760(99)00047-1; Basar E, 2001, INT J PSYCHOPHYSIOL, V39, P241, DOI 10.1016/S0167-8760(00)00145-8; Bateson M, 2005, TRENDS ECOL EVOL, V20, P659, DOI 10.1016/j.tree.2005.08.013; Bisazza A, 1998, NEUROSCI BIOBEHAV R, V22, P411, DOI 10.1016/S0149-7634(97)00050-X; Brismar T, 2007, PHYSIOL BEHAV, V92, P141, DOI 10.1016/j.physbeh.2007.05.047; Burmeister SS, 2008, BRAIN RES, V1190, P105, DOI 10.1016/j.brainres.2007.11.008; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Cui JG, 2012, BIOL LETTERS, V8, P337, DOI 10.1098/rsbl.2011.1091; Cui JG, 2010, ANIM BEHAV, V80, P181, DOI 10.1016/j.anbehav.2010.05.012; Davidson R.J., 1984, EMOTIONS COGNITION B, P320; Davidson R.J., 1984, APPROACHES EMOTION, P39; DAVIDSON RJ, 1990, J PERS SOC PSYCHOL, V58, P330, DOI 10.1037/0022-3514.58.2.330; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Edwards CJ, 2002, NAT NEUROSCI, V5, P934, DOI 10.1038/nn916; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Fang GZ, 2012, J COMP PHYSIOL A, V198, P119, DOI 10.1007/s00359-011-0693-y; FENG AS, 1990, PROG NEUROBIOL, V34, P313, DOI 10.1016/0301-0082(90)90008-5; FENG AS, 1981, HEARING RES, V5, P201, DOI 10.1016/0378-5955(81)90046-0; FERNANDEZ T, 1995, ELECTROEN CLIN NEURO, V94, P175, DOI 10.1016/0013-4694(94)00262-J; Gibson RM, 1996, TRENDS ECOL EVOL, V11, P468, DOI 10.1016/0169-5347(96)10050-1; HOBSON JA, 1968, NATURE, V220, P386, DOI 10.1038/220386a0; Huang C, 2000, CLIN NEUROPHYSIOL, V111, P1961, DOI 10.1016/S1388-2457(00)00454-5; Jacobs J, 2006, NEUROIMAGE, V32, P978, DOI 10.1016/j.neuroimage.2006.02.018; JANETOS AC, 1980, BEHAV ECOL SOCIOBIOL, V7, P107, DOI 10.1007/BF00299515; JOHN ER, 1980, SCIENCE, V210, P1255, DOI 10.1126/science.7434026; Kirkpatrick M, 2006, ANIM BEHAV, V71, P1215, DOI 10.1016/j.anbehav.2005.11.010; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Knyazev GG, 2007, NEUROSCI BIOBEHAV R, V31, P377, DOI 10.1016/j.neubiorev.2006.10.004; Kopell N, 2000, P NATL ACAD SCI USA, V97, P1867, DOI 10.1073/pnas.97.4.1867; KOSTOWSKI WOJCIECH, 1967, BRAIN RES, V6, P783, DOI 10.1016/0006-8993(67)90137-0; LAMING PR, 1982, BEHAV NEURAL BIOL, V34, P296, DOI 10.1016/S0163-1047(82)91678-8; Lee H, 2005, NEURON, V45, P147, DOI 10.1016/j.neuron.2004.12.025; Leonard AS, 2009, BEHAV ECOL, V20, P1175, DOI 10.1093/beheco/arp115; Lynch KS, 2006, HORM BEHAV, V49, P450, DOI 10.1016/j.yhbeh.2005.10.001; Mangiamele LA, 2008, BRAIN BEHAV EVOLUT, V72, P239, DOI 10.1159/000171481; Montgomery SM, 2009, J NEUROSCI, V29, P1381, DOI 10.1523/JNEUROSCI.4339-08.2009; MOORE AJ, 1988, EVOLUTION, V42, P387, DOI [10.2307/2409241, 10.1111/j.1558-5646.1988.tb04141.x]; Moretti DV, 2004, CLIN NEUROPHYSIOL, V115, P299, DOI 10.1016/S1388-2457(03)00345-6; Neary T.J., 1990, Cerebral Cortex, V8A, P107; NEWBERRY RC, 1995, APPL ANIM BEHAV SCI, V44, P229, DOI 10.1016/0168-1591(95)00616-Z; ONO K, 1980, INT J NEUROSCI, V11, P9, DOI 10.3109/00207458009147573; Parker G.A., 1983, P141; Pfurtscheller G, 1996, ELECTROEN CLIN NEURO, V98, P281, DOI 10.1016/0013-4694(95)00258-8; Phelps SM, 2006, AM NAT, V167, P28, DOI 10.1086/498538; Philiastides MG, 2007, J NEUROSCI, V27, P13082, DOI 10.1523/JNEUROSCI.3540-07.2007; RAY WJ, 1985, SCIENCE, V228, P750, DOI 10.1126/science.3992243; Rickard Nikki S, 2005, Behav Cogn Neurosci Rev, V4, P235, DOI 10.1177/1534582305285869; Sauseng P, 2008, NEUROIMAGE, V40, P308, DOI 10.1016/j.neuroimage.2007.11.032; Sauseng P, 2010, NEUROSCI BIOBEHAV R, V34, P1015, DOI 10.1016/j.neubiorev.2009.12.006; SERVIT Z, 1965, ELECTROEN CLIN NEURO, V19, P162, DOI 10.1016/0013-4694(65)90226-9; Sutton SK, 1997, PSYCHOL SCI, V8, P204, DOI 10.1111/j.1467-9280.1997.tb00413.x; Thut G, 2009, TRENDS COGN SCI, V13, P182, DOI 10.1016/j.tics.2009.01.004; Utts JM, 2006, STAT IDEAS METHODS, P361; WALKER SF, 1980, BRIT J PSYCHOL, V71, P329, DOI 10.1111/j.2044-8295.1980.tb01750.x; Westhoff G, 2002, J COMP NEUROL, V445, P97, DOI 10.1002/cne.10136; Wilczynski W., 2006, HEARING SOUND COMMUN, P221; Wittenberger J.F., 1983, P435	66	15	18	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52364	10.1371/journal.pone.0052364	http://dx.doi.org/10.1371/journal.pone.0052364			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285010	gold, Green Published			2022-12-27	WOS:000313158800054
J	Castellano-Pozo, M; Garcia-Muse, T; Aguilera, A				Castellano-Pozo, Maikel; Garcia-Muse, Tatiana; Aguilera, Andres			The Caenorhabditis elegans THO Complex Is Required for the Mitotic Cell Cycle and Development	PLOS ONE			English	Article							DAMAGE-INDUCED APOPTOSIS; C-ELEGANS; TRANSCRIPTION ELONGATION; GENOME INSTABILITY; MESSENGER-RNA; R-LOOPS; RECOMBINATION; REPLICATION; PATHWAY; PROTEIN	THO is a conserved eukaryotic complex involved in mRNP biogenesis and RNA export that plays an important role in preventing transcription- and RNA-mediated genome instability in mitosis and meiosis. In mammals THO is essential for embryogenesis, which limits our capacity to analyze the physiological relevance of THO during development and in adult organisms. Using Caenorhabditis elegans as a model system we show that the THO complex is essential for mitotic genome integrity and the developmentally regulated mitotic cell cycles occurring during late postembryonic stages.	[Castellano-Pozo, Maikel; Garcia-Muse, Tatiana; Aguilera, Andres] Univ Seville, Dept Mol Biol, Ctr Andaluz Biol Mol & Med Regenerat, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER)	Garcia-Muse, T (corresponding author), Univ Seville, Dept Mol Biol, Ctr Andaluz Biol Mol & Med Regenerat, Seville, Spain.	tatiana.muse@cabimer.es	Aguilera, Andres/L-1825-2014; Castellano-Pozo, Maikel/AAV-5232-2020; Garcia-Muse, Tatiana/F-1339-2016; Castellano, Maikel/AAX-8510-2020	Aguilera, Andres/0000-0003-4782-1714; Garcia-Muse, Tatiana/0000-0002-3195-2261; Castellano, Maikel/0000-0003-4134-9025	Spanish Ministry of Science and Innovation [BFU2010-16372, CSD2007-0015]; European Union (FEDER); Junta de Andalucia [CVI4567]; Spanish National Institute of Health Carlos III	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Union (FEDER)(European Commission); Junta de Andalucia(Junta de Andalucia); Spanish National Institute of Health Carlos III(Instituto de Salud Carlos III)	This work was supported by grants from the Spanish Ministry of Science and Innovation (BFU2010-16372 and Consolider Ingenio 2010 CSD2007-0015), the European Union (FEDER) and the Junta de Andalucia (CVI4567). MCP was the recipient of a predoctoral training fellowship from the Spanish National Institute of Health Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Aguilera A, 2012, MOL CELL, V46, P115, DOI 10.1016/j.molcel.2012.04.009; Ahmed S, 2001, CURR BIOL, V11, P1934, DOI 10.1016/S0960-9822(01)00604-2; BRENNER S, 1974, GENETICS, V77, P71; Castellano-Pozo M, 2012, EMBO REP, V13, P923, DOI 10.1038/embor.2012.119; Chavez S, 2000, EMBO J, V19, P5824, DOI 10.1093/emboj/19.21.5824; Dominguez-Sanchez MS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002386; Garcia-Muse T, 2005, EMBO J, V24, P4345, DOI 10.1038/sj.emboj.7600896; Garcia-Muse T, 2007, CHROMOSOME RES, V15, P607, DOI 10.1007/s10577-007-1146-x; Gartner A, 2000, MOL CELL, V5, P435, DOI 10.1016/S1097-2765(00)80438-4; Gomez-Gonzalez B, 2009, MOL CELL BIOL, V29, P5203, DOI 10.1128/MCB.00402-09; Gomez-Gonzalez B, 2009, NUCLEIC ACIDS RES, V37, P4315, DOI 10.1093/nar/gkp385; Grigsby IF, 2009, DEV BIOL, V329, P64, DOI 10.1016/j.ydbio.2009.02.015; Huertas P, 2003, MOL CELL, V12, P711, DOI 10.1016/j.molcel.2003.08.010; Jaramillo-Lambert A, 2007, DEV BIOL, V308, P206, DOI 10.1016/j.ydbio.2007.05.019; Jeong J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001348; Jimeno S, 2002, EMBO J, V21, P3526, DOI 10.1093/emboj/cdf335; Kawasaki I, 1998, CELL, V94, P635, DOI 10.1016/S0092-8674(00)81605-0; Kawasaki L, 2004, GENETICS, V167, P645, DOI 10.1534/genetics.103.023093; Kim KW, 2009, DEV CELL, V16, P723, DOI 10.1016/j.devcel.2009.04.002; Kimble Judith, 2005, WormBook, P1; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; Kuersten S, 2004, MOL CELL, V14, P599, DOI 10.1016/j.molcel.2004.05.004; L'Hernault Steven W, 2006, WormBook, P1; Lee Min-Ho, 2006, WormBook, P1; Luna R, 2005, MOL CELL, V18, P711, DOI 10.1016/j.molcel.2005.05.001; Luna R, 2012, BBA-GENE REGUL MECH, V1819, P514, DOI 10.1016/j.bbagrm.2011.11.012; Martin JS, 2005, MOL CELL BIOL, V25, P3127, DOI 10.1128/MCB.25.8.3127-3139.2005; McLellan J, 2009, MOL BIOL CELL, V20, P5306, DOI 10.1091/mbc.E09-08-0699; O'Connell KF, 1998, GENETICS, V149, P1303; Okkema P, 2005, WORMBOOK, DOI [10.1895/worm-book.1.45.1, DOI 10.1895/WORMBOOK.1.45.1, 10.1895/wormbook.1.45.1]; Pena A, 2012, EMBO J, V31, P1605, DOI 10.1038/emboj.2012.10; Polanowska J, 2006, EMBO J, V25, P2178, DOI 10.1038/sj.emboj.7601102; Schumacher B, 2005, CELL, V120, P357, DOI 10.1016/j.cell.2004.12.009; Shaye DD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020085; Sternberg Paul W, 2005, WormBook, P1, DOI 10.1895/wormbook.1.6.1; Suh N, 2009, GENETICS, V181, P1249, DOI 10.1534/genetics.108.099440; Tsuzuki T, 1996, P NATL ACAD SCI USA, V93, P6236, DOI 10.1073/pnas.93.13.6236; Wang XL, 2006, MOL CELL BIOL, V26, P4362, DOI 10.1128/MCB.02163-05; WARD S, 1986, J CELL BIOL, V102, P1778, DOI 10.1083/jcb.102.5.1778; Weidhaas JB, 2006, P NATL ACAD SCI USA, V103, P9946, DOI 10.1073/pnas.0603791103	41	12	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52447	10.1371/journal.pone.0052447	http://dx.doi.org/10.1371/journal.pone.0052447			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285047	Green Published, Green Submitted, gold			2022-12-27	WOS:000312794500172
J	Hirose, M; Takeishi, Y; Nakada, T; Shimojo, H; Kashihara, T; Nishio, A; Suzuki, S; Mende, U; Matsumoto, K; Matsushita, N; Taira, E; Sato, F; Yamada, M				Hirose, Masamichi; Takeishi, Yasuchika; Nakada, Tsutomu; Shimojo, Hisashi; Kashihara, Toshihide; Nishio, Ayako; Suzuki, Satoshi; Mende, Ulrike; Matsumoto, Kiyoshi; Matsushita, Naoko; Taira, Eiichi; Sato, Fumika; Yamada, Mitsuhiko			Nicorandil Prevents G alpha(q)-Induced Progressive Heart Failure and Ventricular Arrhythmias in Transgenic Mice	PLOS ONE			English	Article							SENSITIVE POTASSIUM CHANNELS; DILATED CARDIOMYOPATHY; CARDIAC DYSFUNCTION; INDUCED APOPTOSIS; FLOW RESERVE; HYPERTROPHY; RAT; MODEL; ACTIVATION; MECHANISMS	Background: Beneficial effects of nicorandil on the treatment of hypertensive heart failure (HF) and ischemic heart disease have been suggested. However, whether nicorandil has inhibitory effects on HF and ventricular arrhythmias caused by the activation of G protein alpha q (G alpha(q)) -coupled receptor (GPCR) signaling still remains unknown. We investigated these inhibitory effects of nicorandil in transgenic mice with transient cardiac expression of activated G alpha(q) (G alpha(q)-TG). Methodology/Principal Findings: Nicorandil (6 mg/kg/day) or vehicle was chronically administered to G alpha(q)-TG from 8 to 32 weeks of age, and all experiments were performed in mice at the age of 32 weeks. Chronic nicorandil administration prevented the severe reduction of left ventricular fractional shortening and inhibited ventricular interstitial fibrosis in G alpha(q)-TG. SUR-2B and SERCA2 gene expression was decreased in vehicle-treated G alpha(q)-TG but not in nicorandil-treated G alpha(q)-TG. eNOS gene expression was also increased in nicorandil-treated G alpha(q)-TG compared with vehicle-treated G alpha(q)-TG. Electrocardiogram demonstrated that premature ventricular contraction (PVC) was frequently (more than 20 beats/min) observed in 7 of 10 vehicle-treated G alpha(q)-TG but in none of 10 nicorandil-treated G alpha(q)-TG. The QT interval was significantly shorter in nicorandil-treated G alpha(q)-TG than vehicle-treated G alpha(q)-TG. Acute nicorandil administration shortened ventricular monophasic action potential duration and reduced the number of PVCs in Langendorff-perfused G alpha(q)-TG mouse hearts. Moreover, HMR1098, a blocker of cardiac sarcolemmal K-ATP channels, significantly attenuated the shortening of MAP duration induced by nicorandil in the G alpha(q)-TG heart. Conclusions/Significance: These findings suggest that nicorandil can prevent the development of HF and ventricular arrhythmia caused by the activation of GPCR signaling through the shortening of the QT interval, action potential duration, the normalization of SERCA2 gene expression. Nicorandil may also improve the impaired coronary circulation during HF.	[Hirose, Masamichi; Sato, Fumika] Iwate Med Univ, Dept Mol & Cellular Pharmacol, Sch Pharmaceut Sci, Shiwa, Iwate, Japan; [Takeishi, Yasuchika; Suzuki, Satoshi] Fukushima Med Univ, Dept Cardiol & Hematol, Fukushima, Japan; [Nakada, Tsutomu; Kashihara, Toshihide; Yamada, Mitsuhiko] Shinshu Univ, Sch Med, Dept Mol Pharmacol, Matsumoto, Nagano 390, Japan; [Shimojo, Hisashi] Shinshu Univ, Sch Med, Dept Pathol, Matsumoto, Nagano 390, Japan; [Nishio, Ayako; Matsumoto, Kiyoshi] Shinshu Univ, Res Ctr Human & Environm Sci, Matsumoto, Nagano 390, Japan; [Mende, Ulrike] Brown Univ, Rhode Isl Hosp, Cardiovasc Res Ctr, Div Cardiol, Providence, RI 02903 USA; [Mende, Ulrike] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA; [Matsushita, Naoko; Taira, Eiichi] Iwate Med Univ, Dept Pharmacol, Sch Med, Shiwa, Iwate, Japan	Iwate Medical University; Fukushima Medical University; Shinshu University; Shinshu University; Shinshu University; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Iwate Medical University	Hirose, M (corresponding author), Iwate Med Univ, Dept Mol & Cellular Pharmacol, Sch Pharmaceut Sci, Shiwa, Iwate, Japan.	mhirose@iwate-med.ac.jp	yamada, Mitsuhiko/V-1269-2019	yamada, Mitsuhiko/0000-0002-7515-3824; Kashihara, Toshihide/0000-0001-8787-5376	Ministry of Education, Culture, Sports, Science and Technology, Japan [21590276]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by a Grant-in-Aid for Scientific Research from Ministry of Education, Culture, Sports, Science and Technology, Japan (No. 21590276) (to MH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Bogoyevitch MA, 1996, INT J BIOCHEM CELL B, V28, P1, DOI 10.1016/1357-2725(95)00142-5; Canetti M, 2003, AM J CARDIOL, V92, P1246, DOI 10.1016/j.amjcard.2003.08.002; Coma-Canella I, 2003, REV ESP CARDIOL, V56, P354, DOI 10.1157/13045650; Date T, 2005, J CARDIOVASC PHARM, V46, P721, DOI 10.1097/01.fjc.0000184466.37951.76; Hirose M, 2008, BASIC CLIN PHARMACOL, V102, P504, DOI 10.1111/j.1742-7843.2008.00242.x; Hirose M, 2011, CIRC J, V75, P2333, DOI 10.1253/circj.CJ-10-1213; Hirose M, 2009, HEART RHYTHM, V6, P78, DOI 10.1016/j.hrthm.2008.10.018; HOLZMANN S, 1983, J CARDIOVASC PHARM, V5, P364, DOI 10.1097/00005344-198305000-00004; Hongo M, 2005, J CARDIOVASC PHARM, V46, P452, DOI 10.1097/01.fjc.0000176728.74690.09; Horinaka S, 2001, J CARDIOVASC PHARM, V38, P200, DOI 10.1097/00005344-200108000-00005; Hunter JJ, 1999, NEW ENGL J MED, V341, P1276, DOI 10.1056/NEJM199910213411706; Hwang GS, 2006, EUR J PHARMACOL, V540, P131, DOI 10.1016/j.ejphar.2006.04.031; Izawa H, 2003, EUR HEART J, V24, P1340, DOI 10.1016/S0195-668X(03)00236-7; Kaab S, 1996, CIRC RES, V78, P262, DOI 10.1161/01.RES.78.2.262; Kamiyoshi Y, 2005, J MOL CELL CARDIOL, V39, P467, DOI 10.1016/j.yjmcc.2005.04.004; Koitabashi N, 2005, BIOCHEM BIOPH RES CO, V328, P116, DOI 10.1016/j.bbrc.2004.12.139; Lee TM, 2008, J AM COLL CARDIOL, V51, P1309, DOI 10.1016/j.jacc.2007.11.067; LEFER DJ, 1988, LIFE SCI, V42, P1907, DOI 10.1016/0024-3205(88)90031-8; Liou JY, 2011, PHARMACOLOGY, V87, P144, DOI 10.1159/000323555; Mende U, 1998, P NATL ACAD SCI USA, V95, P13893, DOI 10.1073/pnas.95.23.13893; Niizeki T, 2008, AM J PHYSIOL-HEART C, V295, pH245, DOI 10.1152/ajpheart.00066.2008; Niizeki T, 2008, CIRC J, V72, P309, DOI 10.1253/circj.72.309; Noguchi K, 1998, FUNDAM CLIN PHARM, V12, P270, DOI 10.1111/j.1472-8206.1998.tb00954.x; Onohara N, 2006, EMBO J, V25, P5305, DOI 10.1038/sj.emboj.7601417; Seino S, 1999, ANNU REV PHYSIOL, V61, P337, DOI 10.1146/annurev.physiol.61.1.337; Takeishi Y, 1999, CIRC RES, V85, P264, DOI 10.1161/01.RES.85.3.264; Teshima Y, 2003, BRAIN RES, V990, P45, DOI 10.1016/S0006-8993(03)03383-3; TREASURE CB, 1990, CIRCULATION, V81, P772, DOI 10.1161/01.CIR.81.3.772; Xu JL, 2005, HYPERTENSION, V46, P719, DOI 10.1161/01.HYP.0000185189.46698.15; Yamada M, 2004, MOL PHARMACOL, V65, P1198, DOI 10.1124/mol.65.5.1198; Zhao X, 2002, AM J PHYSIOL-HEART C, V283, pH2371, DOI 10.1152/ajpheart.00383.2002; Zhou M, 2007, J HISTOCHEM CYTOCHEM, V55, P795, DOI 10.1369/jhc.6A7104.2007	32	8	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52667	10.1371/journal.pone.0052667	http://dx.doi.org/10.1371/journal.pone.0052667			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285142	Green Submitted, gold, Green Published			2022-12-27	WOS:000312794500227
J	Koch, G; Bozzali, M; Bonni, S; Giacobbe, V; Caltagirone, C; Cercignani, M				Koch, Giacomo; Bozzali, Marco; Bonni, Sonia; Giacobbe, Viola; Caltagirone, Carlo; Cercignani, Mara			fMRI Resting Slow Fluctuations Correlate with the Activity of Fast Cortico-Cortical Physiological Connections	PLOS ONE			English	Article							STATE FUNCTIONAL CONNECTIVITY; IPSILATERAL MOTOR CORTEX; HUMAN BRAIN; MAGNETIC STIMULATION; POSTERIOR PARIETAL; COMPONENT ANALYSIS; NETWORKS; SPACE; VARIABILITY; SIGNALS	Recording of slow spontaneous fluctuations at rest using functional magnetic resonance imaging (fMRI) allows distinct long-range cortical networks to be identified. The neuronal basis of connectivity as assessed by resting-state fMRI still needs to be fully clarified, considering that these signals are an indirect measure of neuronal activity, reflecting slow local variations in de-oxyhaemoglobin concentration. Here, we combined fMRI with multifocal transcranial magnetic stimulation (TMS), a technique that allows the investigation of the causal neurophysiological interactions occurring in specific cortico-cortical connections. We investigated whether the physiological properties of parieto-frontal circuits mapped with short-latency multifocal TMS at rest may have some relationship with the resting-state fMRI measures of specific resting-state functional networks (RSNs). Results showed that the activity of fast cortico-cortical physiological interactions occurring in the millisecond range correlated selectively with the coupling of fMRI slow oscillations within the same cortical areas that form part of the dorsal attention network, i.e., the attention system believed to be involved in reorientation of attention. We conclude that resting-state fMRI ongoing slow fluctuations likely reflect the interaction of underlying physiological cortico-cortical connections.	[Bozzali, Marco; Cercignani, Mara] Santa Lucia Fdn IRCCS, Neuroimaging Lab, Rome, Italy; [Koch, Giacomo; Bonni, Sonia; Giacobbe, Viola; Caltagirone, Carlo] Santa Lucia Fdn IRCCS, Lab Clin & Behav Neurol, Rome, Italy; [Koch, Giacomo; Caltagirone, Carlo] Univ Roma Tor Vergata, Dept Neurosci, Rome, Italy; [Cercignani, Mara] Univ Sussex, Clin Imaging Sci Ctr, Brighton & Sussex Med Sch, Falmer, England	IRCCS Santa Lucia; IRCCS Santa Lucia; University of Rome Tor Vergata; University of Brighton; University of Sussex	Cercignani, M (corresponding author), Santa Lucia Fdn IRCCS, Neuroimaging Lab, Rome, Italy.	m.cercignani@bsms.ac.uk	Bozzali, Marco/AAC-1031-2022; Caltagirone, Carlo/B-4930-2013; Koch, Giacomo/G-3155-2012	KOch, Giacomo/0000-0001-6155-9439; Bozzali, Marco/0000-0002-0568-2026; Cercignani, Mara/0000-0002-4550-2456	Italian Ministry of Health [RF 08.18, GR 08.22]	Italian Ministry of Health(Ministry of Health, Italy)	This work has been funded by grants from the Italian Ministry of Health to GK (RF 08.18) and MB (GR 08.22). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianciardi M, 2009, MAGN RESON IMAGING, V27, P1019, DOI 10.1016/j.mri.2009.02.004; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 1997, NMR BIOMED, V10, P165, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<165::AID-NBM454>3.0.CO;2-7; Caspers S, 2008, BRAIN STRUCT FUNCT, V212, P481, DOI 10.1007/s00429-008-0195-z; Corbetta M, 1998, P NATL ACAD SCI USA, V95, P831, DOI 10.1073/pnas.95.3.831; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; FERBERT A, 1992, J PHYSIOL-LONDON, V453, P525, DOI 10.1113/jphysiol.1992.sp019243; Fox MD, 2006, NAT NEUROSCI, V9, P23, DOI 10.1038/nn1616; Fox MD, 2007, NEURON, V56, P171, DOI 10.1016/j.neuron.2007.08.023; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius M, 2008, CURR OPIN NEUROL, V21, P424, DOI 10.1097/WCO.0b013e328306f2c5; He BYJ, 2008, P NATL ACAD SCI USA, V105, P16039, DOI 10.1073/pnas.0807010105; Jann K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012945; Koch G, 2008, J NEUROSCI, V28, P5944, DOI 10.1523/JNEUROSCI.0957-08.2008; Koch G, 2007, J NEUROSCI, V27, P6815, DOI 10.1523/JNEUROSCI.0598-07.2007; Koch G, 2006, J NEUROSCI, V26, P7452, DOI 10.1523/JNEUROSCI.1158-06.2006; Koch G, 2011, J NEUROSCI, V31, P8967, DOI 10.1523/JNEUROSCI.6567-10.2011; Koch G, 2010, NEUROIMAGE, V51, P300, DOI 10.1016/j.neuroimage.2010.02.022; Koch G, 2008, BRAIN, V131, P3147, DOI 10.1093/brain/awn273; LEHMANN D, 1987, ELECTROEN CLIN NEURO, V67, P271, DOI 10.1016/0013-4694(87)90025-3; Lowe MJ, 2000, NEUROIMAGE, V12, P582, DOI 10.1006/nimg.2000.0654; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Mars RB, 2011, J NEUROSCI, V31, P4087, DOI 10.1523/JNEUROSCI.5102-10.2011; Mennes M, 2010, NEUROIMAGE, V50, P1690, DOI 10.1016/j.neuroimage.2010.01.002; Musso F, 2010, NEUROIMAGE, V52, P1149, DOI 10.1016/j.neuroimage.2010.01.093; Nir Y, 2008, NAT NEUROSCI, V11, P1100, DOI 10.1038/nn.2177; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ozaki TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020079; Rosazza C, 2012, AM J NEURORADIOL, V33, P180, DOI 10.3174/ajnr.A2733; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Scholvinck ML, 2010, P NATL ACAD SCI USA, V107, P10238, DOI 10.1073/pnas.0913110107; Shmuel A, 2008, HUM BRAIN MAPP, V29, P751, DOI 10.1002/hbm.20580; Van de Ville D, 2010, P NATL ACAD SCI USA, V107, P18179, DOI 10.1073/pnas.1007841107	37	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52660	10.1371/journal.pone.0052660	http://dx.doi.org/10.1371/journal.pone.0052660			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285136	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000312794500223
J	Potthoff, E; Guillaume-Gentil, O; Ossola, D; Polesel-Maris, J; LeibundGut-Landmann, S; Zambelli, T; Vorholt, JA				Potthoff, Eva; Guillaume-Gentil, Orane; Ossola, Dario; Polesel-Maris, Jerome; LeibundGut-Landmann, Salome; Zambelli, Tomaso; Vorholt, Julia A.			Rapid and Serial Quantification of Adhesion Forces of Yeast and Mammalian Cells	PLOS ONE			English	Article							SURFACES; MICROSCOPY; STRENGTH; MANIPULATION; EXPRESSION; PROTEINS; GROWTH	Cell adhesion to surfaces represents the basis for niche colonization and survival. Here we establish serial quantification of adhesion forces of different cell types using a single probe. The pace of single-cell force-spectroscopy was accelerated to up to 200 yeast and 20 mammalian cells per probe when replacing the conventional cell trapping cantilever chemistry of atomic force microscopy by underpressure immobilization with fluidic force microscopy (FluidFM). In consequence, statistically relevant data could be recorded in a rapid manner, the spectrum of examinable cells was enlarged, and the cell physiology preserved until approached for force spectroscopy. Adhesion forces of Candida albicans increased from below 4 up to 16 nN at 37 degrees C on hydrophobic surfaces, whereas a Delta hgc1-mutant showed forces consistently below 4 nN. Monitoring adhesion of mammalian cells revealed mean adhesion forces of 600 nN of HeLa cells on fibronectin and were one order of magnitude higher than those observed for HEK cells.	[Ossola, Dario; Zambelli, Tomaso] ETH, Inst Biomed Engn, Zurich, Switzerland; [Potthoff, Eva; Guillaume-Gentil, Orane; LeibundGut-Landmann, Salome; Vorholt, Julia A.] ETH, Inst Microbiol, CH-8092 Zurich, Switzerland; [Polesel-Maris, Jerome] CEA Saclay Commissariat Energie Atom, SPCSI, Gif Sur Yvette, France	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; CEA; UDICE-French Research Universities; Universite Paris Saclay	Zambelli, T (corresponding author), ETH, Inst Biomed Engn, Zurich, Switzerland.	zambelli@biomed.ee.ethz.ch; vorholt@micro.biol.ethz.ch	Guillaume-Gentil, Orane/B-2570-2015; Polesel, Jerome/AFT-7323-2022; Vorholt, Julia/K-3514-2016	Guillaume-Gentil, Orane/0000-0002-5987-3709; Polesel, Jerome/0000-0003-0457-619X; Vorholt, Julia/0000-0002-6011-4910; Dague, Etienne/0000-0003-3290-9166; LeibundGut-Landmann, Salome/0000-0002-5724-4837	Swiss innovation promotion agency KTI-CTI [11722.1 PFNM-NM]; Swiss National Science Foundation (SNSF)	Swiss innovation promotion agency KTI-CTI; Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF))	This study was supported by the Swiss innovation promotion agency KTI-CTI (11722.1 PFNM-NM) (to TZ and JAV) and a grant from the Swiss National Science Foundation (SNSF) (to TZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An YH, 1997, J MICROBIOL METH, V30, P141, DOI 10.1016/S0167-7012(97)00058-4; ASHKIN A, 1987, SCIENCE, V235, P1517, DOI 10.1126/science.3547653; Banerjee I, 2011, ADV MATER, V23, P690, DOI 10.1002/adma.201001215; Barelle CJ, 2004, YEAST, V21, P333, DOI 10.1002/yea.1099; BAROR Y, 1990, EXPERIENTIA, V46, P823, DOI 10.1007/BF01935532; Benoit M, 2000, NAT CELL BIOL, V2, P313, DOI 10.1038/35014000; Benoit M, 2002, CELLS TISSUES ORGANS, V172, P174, DOI 10.1159/000066964; Berne BJ, 2009, ANNU REV PHYS CHEM, V60, P85, DOI 10.1146/annurev.physchem.58.032806.104445; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; Bowen WR, 2002, BIOTECHNOL BIOENG, V79, P170, DOI 10.1002/bit.10321; Bowen WR, 2001, J COLLOID INTERF SCI, V237, P54, DOI 10.1006/jcis.2001.7437; Chandler D, 2005, NATURE, V437, P640, DOI 10.1038/nature04162; Charnley M, 2011, REACT FUNCT POLYM, V71, P329, DOI 10.1016/j.reactfunctpolym.2010.10.013; Dorig P, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3462979; Emerson RJ, 2006, LANGMUIR, V22, P11311, DOI 10.1021/la061984u; Eun CS, 2011, J PHYS CHEM A, V115, P6059, DOI 10.1021/jp110608p; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Finkel JS, 2011, NAT REV MICROBIOL, V9, P109, DOI 10.1038/nrmicro2475; FRANCIS GW, 1987, J CELL SCI, V87, P519; Friedrichs J, 2010, PROTEOMICS, V10, P1455, DOI 10.1002/pmic.200900724; Gigler A, 2007, J PHYS CONF SER, V61, P780, DOI 10.1088/1742-6596/61/1/156; GLEE PM, 1995, INFECT IMMUN, V63, P1373, DOI 10.1128/IAI.63.4.1373-1379.1995; Graziano G, 2009, J PHYS CHEM B, V113, P11232, DOI 10.1021/jp9025738; HAZEN BW, 1988, INFECT IMMUN, V56, P2521, DOI 10.1128/IAI.56.9.2521-2525.1988; Helenius J, 2008, J CELL SCI, V121, P1785, DOI 10.1242/jcs.030999; Hosseini BH, 2009, P NATL ACAD SCI USA, V106, P17852, DOI 10.1073/pnas.0905384106; Huang NP, 2001, LANGMUIR, V17, P489, DOI 10.1021/la000736+; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; KLEBE RJ, 1974, NATURE, V250, P248, DOI 10.1038/250248a0; Meister A, 2009, NANO LETT, V9, P2501, DOI 10.1021/nl901384x; Pelling AE, 2004, SCIENCE, V305, P1147, DOI 10.1126/science.1097640; Prechtel K, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.028101; Puech PH, 2006, ULTRAMICROSCOPY, V106, P637, DOI 10.1016/j.ultramic.2005.08.003; Sader JE, 1999, REV SCI INSTRUM, V70, P3967, DOI 10.1063/1.1150021; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; Shao JY, 2004, FRONT BIOSCI-LANDMRK, V9, P2183, DOI 10.2741/1386; Taubenberger A, 2011, LIFE AT THE NANOSCALE: ATOMIC FORCE MICROSCOPY OF LIVE CELLS, P209; Tosatti S, 2002, LANGMUIR, V18, P3537, DOI 10.1021/la011459p; Touhami A, 2003, LANGMUIR, V19, P4539, DOI 10.1021/la034136x; Tsang PH, 2006, P NATL ACAD SCI USA, V103, P5764, DOI 10.1073/pnas.0601705103; Walter N, 2006, NANO LETT, V6, P398, DOI 10.1021/nl052168u; Weder G, 2010, BIOMATERIALS, V31, P6436, DOI 10.1016/j.biomaterials.2010.04.068; Weder G, 2010, LANGMUIR, V26, P8180, DOI 10.1021/la904526u; Whiteway M, 2007, ANNU REV MICROBIOL, V61, P529, DOI 10.1146/annurev.micro.61.080706.093341; Wojcikiewicz Ewa P., 2004, Biol Proced Online, V6, P1, DOI 10.1251/bpo67; Zheng XD, 2004, EMBO J, V23, P1845, DOI 10.1038/sj.emboj.7600195	48	87	89	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52712	10.1371/journal.pone.0052712	http://dx.doi.org/10.1371/journal.pone.0052712			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285166	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000312794500239
J	Skaaby, T; Husemoen, LLN; Pisinger, C; Jorgensen, T; Thuesen, BH; Fenger, M; Linneberg, A				Skaaby, Tea; Husemoen, Lise Lotte Nystrup; Pisinger, Charlotta; Jorgensen, Torben; Thuesen, Betina Heinsbaek; Fenger, Mogens; Linneberg, Allan			Vitamin D Status and Cause-Specific Mortality: A General Population Study	PLOS ONE			English	Article							SERUM 25-HYDROXYVITAMIN D; CARDIOVASCULAR-DISEASE MORTALITY; NUTRITION EXAMINATION SURVEY; 3RD NATIONAL-HEALTH; ALL-CAUSE MORTALITY; BREAST-CANCER RISK; LIVER-DISEASE; D DEFICIENCY; D SUPPLEMENTATION; D LEVEL	Background: Vitamin D deficiency is associated with an increased risk of all-cause mortality in observational studies. The specific causes of death underlying this association lack clarity. We investigated the association between vitamin D status and cause-specific mortality. Methods: We included a total of 9,146 individuals from the two population-based studies, Monica10 and Inter99, conducted in 1993-94 and 1999-2001, respectively. Vitamin D status was assessed as serum 25-hydroxyvitamin D. Information on causes of death was obtained from The Danish Register of Causes of Death until 31 December 2009. There were a total of 832 deaths (median follow-up 10.3 years). Results: Multivariable Cox regression analyses with age as underlying time axis and vitamin D quartiles showed significant associations between vitamin D status and death caused by diseases of the respiratory system, the digestive system, and endocrine, nutritional and metabolic diseases with hazard ratios (HRs) 0.26 (p(trend) = 0.0042), 0.28 (p(trend) = 0.0040), and 0.21 (p(trend) = 0.035), respectively, for the fourth vitamin D quartile compared to the first. We found non-significantly lower HRs for death caused by mental and behavioural diseases and diseases of the nervous system, but no association between vitamin D status and death caused by neoplasms or diseases of the circulatory system. Conclusion: The associations of vitamin D status and cause-specific mortality suggest that we also look elsewhere (than to cardiovascular disease and cancer) to explain the inverse association between vitamin D status and mortality.	[Skaaby, Tea; Husemoen, Lise Lotte Nystrup; Pisinger, Charlotta; Jorgensen, Torben; Thuesen, Betina Heinsbaek; Linneberg, Allan] Glostrup Cty Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Jorgensen, Torben] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark; [Jorgensen, Torben] Aalborg Univ, Fac Med, Aalborg, Denmark; [Fenger, Mogens] Univ Copenhagen, Hvidovre Hosp, Dept Clin Biochem, DK-2650 Hvidovre, Denmark	University of Copenhagen; University of Copenhagen; Aalborg University; University of Copenhagen	Skaaby, T (corresponding author), Glostrup Cty Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark.	tea.skaaby.01@regionh.dk	Jørgensen, Torben/Z-1335-2018	Jorgensen, Torben/0000-0001-9453-2830; Pisinger, Charlotta/0000-0002-7970-3168; Skaaby, Tea/0000-0003-0031-5726; Linneberg, Allan/0000-0002-0994-0184; Thuesen, Betina/0000-0001-9772-4344	Health Insurance Foundation [2010 B 131]	Health Insurance Foundation	The present study was supported by The Health Insurance Foundation (grant number 2010 B 131). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas S, 2009, INT J CANCER, V124, P250, DOI 10.1002/ijc.23904; Adams JS, 2008, NAT CLIN PRACT ENDOC, V4, P80, DOI 10.1038/ncpendmet0716; Alvarez JA, 2010, INT J ENDOCRINOL, V2010, DOI 10.1155/2010/351385; Anderson JL, 2010, AM J CARDIOL, V106, P963, DOI 10.1016/j.amjcard.2010.05.027; Annweiler C, 2012, J GERONTOL A; Annweiler C, 2011, NEUROEPIDEMIOLOGY, V37, P249, DOI 10.1159/000334177; Arteh J, 2010, DIGEST DIS SCI, V55, P2624, DOI 10.1007/s10620-009-1069-9; Autier P, 2007, ARCH INTERN MED, V167, P1730, DOI 10.1001/archinte.167.16.1730; Barchetta I, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-85; Bikle DD, 2007, J BONE MINER RES, V22, pV50, DOI 10.1359/JBMR.07S208; Black PN, 2005, CHEST, V128, P3792, DOI 10.1378/chest.128.6.3792; Bouillon R, 2008, ENDOCR REV, V29, P726, DOI 10.1210/er.2008-0004; Carter GD, 2004, CLIN CHEM, V50, P2195, DOI 10.1373/clinchem.2004.040683; Dobak John, 1994, Journal of Dermatological Science, V8, P18, DOI 10.1016/0923-1811(94)90316-6; Forouhi NG, 2008, DIABETES, V57, P2619, DOI 10.2337/db08-0593; Freedman DM, 2010, CANCER RES, V70, P8587, DOI 10.1158/0008-5472.CAN-10-1420; Ginde AA, 2009, J AM GERIATR SOC, V57, P1595, DOI 10.1111/j.1532-5415.2009.02359.x; Ginde AA, 2009, ARCH INTERN MED, V169, P384, DOI 10.1001/archinternmed.2008.560; Grant WB, 2011, DERM-ENDOCRINOL, V3, P199, DOI [10.4161/derm.3.3.15364, 10.4161/derm.15364]; Hagenau T, 2009, OSTEOPOROSIS INT, V20, P133, DOI 10.1007/s00198-008-0626-y; Hogberg G, 2012, ACTA PAEDIAT; Holick MF, 2005, J NUTR, V135, p2739S, DOI 10.1093/jn/135.11.2739S; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hsia J, 2007, CIRCULATION, V115, P846, DOI 10.1161/CIRCULATIONAHA.106.673491; Hutchinson MS, 2010, EUR J ENDOCRINOL, V162, P935, DOI 10.1530/EJE-09-1041; Hypponen E, 2006, DIABETES CARE, V29, P2244, DOI 10.2337/dc06-0946; [IARC WHO], 2008, VIT D CANC; Jakobsen J, 2009, SCAND J CLIN LAB INV, V69, P190, DOI 10.1080/00365510802471570; Jorde R, 2010, AM J EPIDEMIOL, V171, P903, DOI 10.1093/aje/kwq005; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Juel K, 1999, DAN MED BULL, V46, P354; Kilkkinen A, 2008, CANCER EPIDEM BIOMAR, V17, P3274, DOI 10.1158/1055-9965.EPI-08-0199; Landbo C, 1999, AM J RESP CRIT CARE, V160, P1856, DOI 10.1164/ajrccm.160.6.9902115; Llewellyn DJ, 2010, ARCH INTERN MED, V170, P1135, DOI 10.1001/archinternmed.2010.173; Ma YL, 2011, J CLIN ONCOL, V29, P3775, DOI 10.1200/JCO.2011.35.7566; Malham M, 2011, WORLD J GASTROENTERO, V17, P922, DOI 10.3748/wjg.v17.i7.922; Melamed ML, 2008, ARCH INTERN MED, V168, P1629, DOI 10.1001/archinte.168.15.1629; Olsen MH, 2007, EUR HEART J, V28, P1374, DOI 10.1093/eurheartj/ehl448; Pappa HM, 2008, CURR OPIN GASTROEN, V24, P176, DOI 10.1097/MOG.0b013e3282f4d2f3; Petta S, 2010, HEPATOLOGY, V51, P1158, DOI 10.1002/hep.23489; Pilz S, 2009, CLIN ENDOCRINOL, V71, P666, DOI 10.1111/j.1365-2265.2009.03548.x; Pittas AG, 2010, DIABETES CARE, V33, P2021, DOI 10.2337/dc10-0790; Putz-Bankuti C, 2012, LIVER INT, V32, P845, DOI 10.1111/j.1478-3231.2011.02735.x; Rejnmark L, 2012, J CLIN ENDOCR METAB, V97, P2670, DOI 10.1210/jc.2011-3328; Romme EA, 2012, ANN MED; Semba RD, 2010, EUR J CLIN NUTR, V64, P203, DOI 10.1038/ejcn.2009.140; Thomas GN, 2012, DIABETES CARE, V35, P1158, DOI 10.2337/dc11-1714; Thuesen B, 2012, BONE, V50, P605, DOI 10.1016/j.bone.2011.12.016; Thyssen JP, 2012, J ALLERGY CLIN IMMUN; Trivedi DP, 2003, BMJ-BRIT MED J, V326, P469, DOI 10.1136/bmj.326.7387.469; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; World Health Organization, 2000, WHO TECH REP SER, V894, pi; Yin L, 2010, EUR J CANCER, V46, P2196, DOI 10.1016/j.ejca.2010.03.037	53	28	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52423	10.1371/journal.pone.0052423	http://dx.doi.org/10.1371/journal.pone.0052423			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285034	Green Published, gold, Green Submitted			2022-12-27	WOS:000312794500162
J	Zuccotti, P; Cartelli, D; Stroppi, M; Pandini, V; Venturin, M; Aliverti, A; Battaglioli, E; Cappelletti, G; Riva, P				Zuccotti, Paola; Cartelli, Daniele; Stroppi, Michela; Pandini, Vittorio; Venturin, Marco; Aliverti, Alessandro; Battaglioli, Elena; Cappelletti, Graziella; Riva, Paola			Centaurin-alpha(2) Interacts with beta-Tubulin and Stabilizes Microtubules	PLOS ONE			English	Article							NF1 MICRODELETION INTERVAL; GTPASE-ACTIVATING PROTEIN; SUBCELLULAR-LOCALIZATION; EXPRESSION ANALYSIS; CANDIDATE GENES; BRAIN; P42(IP4); RANBPM; P42(IP4)/CENTAURIN-ALPHA-1; IDENTIFICATION	Centaurin-alpha(2) is a GTPase-activating protein for ARF (ARFGAP) showing a diffuse cytoplasmic localization capable to translocate to membrane, where it binds phosphatidylinositols. Taking into account that Centaurin-alpha(2) can localize in cytoplasm and that its cytoplasmatic function is not well defined, we searched for further interactors by yeast two-hybrid assay to investigate its biological function. We identified a further Centaurin-alpha(2) interacting protein, beta-Tubulin, by yeast two-hybrid assay. The interaction, involving the C-terminal region of beta-Tubulin, has been confirmed by coimmunoprecipitation experiments. After Centaurin-alpha(2) overexpression in HeLa cells and extraction of soluble (alpha beta dimers) and insoluble (microtubules) fractions of Tubulin, we observed that Centaurin-alpha(2) mainly interacts with the polymerized Tubulin fraction, besides colocalizing with microtubules (MTs) in cytoplasm accordingly. Even following the depolimerizing Tubulin treatments Centaurin-alpha(2) remains mainly associated to nocodazole-and cold-resistant MTs. We found an increase of MT stability in transfected HeLa cells, evaluating as marker of stability the level of MT acetylation. In vitro assays using purified Centaurin-alpha(2) and tubulin confirmed that Centaurin-alpha(2) promotes tubulin assembly and increases microtubule stability. The biological effect of Centaurin-alpha(2) overexpression, assessed through the detection of an increased number of mitotic HeLa cells with bipolar spindles and with the correct number of centrosomes in both dividing and not dividing cells, is consistent with the Centaurin-alpha(2) role on MT stabilization. Centaurin-alpha(2) interacts with beta-Tubulin and it mainly associates to MTs, resistant to destabilizing agents, in vitro and in cell. We propose Centaurin-alpha(2) as a new microtubule-associated protein (MAP) increasing MT stability. Citation: Zuccotti P, Cartelli D, Stroppi M, Pandini V, Venturin M, et al. (2012) Centaurin-alpha(2) Interacts with beta-Tubulin and Stabilizes Microtubules. PLoS ONE 7(12): e52867. doi:10.1371/journal.pone.0052867	[Cartelli, Daniele; Pandini, Vittorio; Aliverti, Alessandro; Cappelletti, Graziella] Univ Milan, Dipartimento Biosci, Milan, Italy; [Zuccotti, Paola; Stroppi, Michela; Venturin, Marco; Battaglioli, Elena; Riva, Paola] Univ Milan, Dipartimento Biotecnol Med & Med Traslaz, Milan, Italy	University of Milan; University of Milan	Cappelletti, G (corresponding author), Univ Milan, Dipartimento Biosci, Milan, Italy.	graziella.cappelletti@unimi.it; paola.riva@unimi.it	Cartelli, Daniele/AAI-3424-2021; Cappelletti, Graziella/AAS-7780-2021; Venturin, Marco/J-8735-2017; Cartelli, Daniele/K-5110-2018; Riva, Paola/K-7871-2016; battaglioli, elena/H-9350-2017; Aliverti, Alessandro/B-7875-2017	Cartelli, Daniele/0000-0002-7069-420X; Venturin, Marco/0000-0002-5871-9689; Cartelli, Daniele/0000-0002-7069-420X; Riva, Paola/0000-0001-6481-8467; Aliverti, Alessandro/0000-0002-1226-3655; Cappelletti, Graziella/0000-0003-0903-5392; Battaglioli, Elena/0000-0001-9168-7212	academic grant (PUR); "Dote ricerca", FSE, Regione Lombardia	academic grant (PUR); "Dote ricerca", FSE, Regione Lombardia(Regione Lombardia)	This work was supported by an academic grant (PUR 2008) to PR and "Dote ricerca", FSE, Regione Lombardia to DC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Bassam J, 2002, J CELL BIOL, V157, P1187, DOI 10.1083/jcb.200201048; Bartelt-Kirbach B, 2009, NEUROGENETICS, V10, P79, DOI 10.1007/s10048-008-0154-0; Basu R, 2007, CURR OPIN CELL BIOL, V19, P88, DOI 10.1016/j.ceb.2006.12.012; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Brinkley BR, 2001, TRENDS CELL BIOL, V11, P18, DOI 10.1016/S0962-8924(00)01872-9; Cartelli D, 2010, J NEUROCHEM, V115, P247, DOI 10.1111/j.1471-4159.2010.06924.x; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; Chang JS, 2005, J BIOL CHEM, V280, P6897, DOI 10.1074/jbc.M406350200; Cho HP, 2005, MOL CELL BIOL, V25, P4541, DOI 10.1128/MCB.25.11.4541-4551.2005; CUKIERMAN E, 1995, SCIENCE, V270, P1999, DOI 10.1126/science.270.5244.1999; Denti S, 2004, J BIOL CHEM, V279, P13027, DOI 10.1074/jbc.M313515200; Eot-Houllier G, 2010, J BIOL CHEM, V285, P29556, DOI 10.1074/jbc.M110.144220; Fukasawa K, 2007, NAT REV CANCER, V7, P911, DOI 10.1038/nrc2249; Geyp M, 1996, CANCER GENET CYTOGEN, V87, P117, DOI 10.1016/0165-4608(95)00235-9; Ghadimi BM, 2000, GENE CHROMOSOME CANC, V27, P183, DOI 10.1002/(SICI)1098-2264(200002)27:2<183::AID-GCC10>3.0.CO;2-P; Haase A, 2008, J NEUROCHEM, V105, P2237, DOI 10.1111/j.1471-4159.2008.05308.x; Hanck T, 2004, J NEUROCHEM, V88, P326, DOI 10.1046/j.1471-4159.2003.02143.x; Hinchcliffe EH, 2001, CURR BIOL, V11, pR698, DOI 10.1016/S0960-9822(01)00412-2; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Janke C, 2011, NAT REV MOL CELL BIO, V12, P773, DOI 10.1038/nrm3227; Krauss SW, 2008, MOL CELL BIOL, V28, P2283, DOI 10.1128/MCB.02021-07; Lee J, 2010, J BIOL CHEM, V285, P24576; Lemmon MA, 1996, CELL, V85, P621, DOI 10.1016/S0092-8674(00)81022-3; Lingle WL, 1998, P NATL ACAD SCI USA, V95, P2950, DOI 10.1073/pnas.95.6.2950; Moncini S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020038; Nakamura M, 1998, J CELL BIOL, V143, P1041, DOI 10.1083/jcb.143.4.1041; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Palazzo A, 2003, NATURE, V421, P230, DOI 10.1038/421230a; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Sedehizade F, 2002, MOL BRAIN RES, V99, P1, DOI 10.1016/S0169-328X(01)00335-7; Smith E, 2011, EMBO J, V30, P2233, DOI 10.1038/emboj.2011.120; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Stricker R, 2006, J NEUROCHEM, V98, P343, DOI 10.1111/j.1471-4159.2006.03869.x; SULLIVAN KF, 1986, P NATL ACAD SCI USA, V83, P4327, DOI 10.1073/pnas.83.12.4327; Venkateswarlu K, 2005, J CELL SCI, V118, P2471, DOI 10.1242/jcs.02369; Venkateswarlu K, 2004, J BIOL CHEM, V279, P6205, DOI 10.1074/jbc.C300482200; Venkateswarlu K, 2007, J CELL SCI, V120, P792, DOI 10.1242/jcs.03373; Venturin M, 2005, ANN HUM GENET, V69, P508, DOI 10.1111/j.1529-8817.2005.00203.x; Venturin M, 2004, J MED GENET, V41, P35, DOI 10.1136/jmg.2003.014761; Wade RH, 2009, MOL BIOTECHNOL, V43, P177, DOI 10.1007/s12033-009-9193-5; Yang MJ, 2006, MOL CELL, V23, P377, DOI 10.1016/j.molcel.2006.07.012	41	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52867	10.1371/journal.pone.0052867	http://dx.doi.org/10.1371/journal.pone.0052867			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285209	gold, Green Published			2022-12-27	WOS:000312794500252
J	Palomares, F; Roques, S; Chavez, C; Silveira, L; Keller, C; Sollmann, R; do Prado, DM; Torres, PC; Adrados, B; Godoy, JA; Jacomo, ATDA; Torres, NM; Furtado, MM; Lopez-Bao, JV				Palomares, Francisco; Roques, Severine; Chavez, Cuauhtemoc; Silveira, Leandro; Keller, Claudia; Sollmann, Rahel; do Prado, Denise Mello; Torres, Patricia Carignano; Adrados, Begona; Godoy, Jose Antonio; de Almeida Jacomo, Anah Tereza; Torres, Natalia Mundim; Furtado, Mariana Malzoni; Lopez-Bao, Jose Vicente			High Proportion of Male Faeces in Jaguar Populations	PLOS ONE			English	Article							PUMAS PUMA-CONCOLOR; PANTHERA-ONCA; CENTRAL BRAZIL; ATLANTIC FOREST; HABITAT USE; SYMPATRIC JAGUARS; SCENT MARKING; NATIONAL-PARK; MELES-MELES; DENSITY	Faeces provide relevant biological information which includes, with the application of genetic techniques, the sex and identity of individuals that defecated, thus providing potentially useful data on the behaviour and ecology of individuals, as well as the dynamics and structure of populations. This paper presents estimates of the sex ratio of different felid species (jaguar, Panthera onca; puma, Puma concolor; and ocelot/margay, Leopardus pardalis/Leopardus wiedi) as observed in field collected faeces, and proposes several hypotheses that could explain the strikingly high proportion of faeces from male jaguars. The proportion of male and female faeces was estimated using a non-invasive faecal sampling method in 14 study areas in Mexico and Brazil. Faecal samples were genetically analysed to identify the species, the sex and the individual (the latter only for samples identified as belonging to jaguars). Considering the three species, 72.6% of faeces (n = 493) were from males; however, there were significant differences among them, with the proportion from males being higher for jaguars than for pumas and ocelots/margays. A male-bias was consistently observed in all study areas for jaguar faeces, but not for the other species. For jaguars the trend was the same when considering the number of individuals identified (n = 68), with an average of 4.2 +/- 0.56 faeces per male and 2.0 +/- 0.36 per female. The observed faecal marking patterns might be related to the behaviour of female jaguars directed toward protecting litters from males, and in both male and female pumas, to prevent interspecific aggressions from male jaguars. The hypothesis that there are effectively more males than females in jaguar populations cannot be discarded, which could be due to the fact that females are territorial and males are not, or a tendency for males to disperse into suboptimal areas for the species.	[Palomares, Francisco; Roques, Severine; Adrados, Begona; Lopez-Bao, Jose Vicente] CSIC, Dept Conservat Biol, Estn Biol Donana, E-41080 Seville, Spain; [Chavez, Cuauhtemoc] Univ Autonoma Metropolitana, Unidad Lerma, Mexico City, DF, Mexico; [Silveira, Leandro; de Almeida Jacomo, Anah Tereza; Torres, Natalia Mundim] Jaguar Conservat Fund, Mineiros, Go, Brazil; [Keller, Claudia; do Prado, Denise Mello; Torres, Patricia Carignano] INPA, Manaus, Amazonas, Brazil; [Sollmann, Rahel] N Carolina State Univ, Dept Forestry & Environm Resources, Raleigh, NC 27695 USA; [Godoy, Jose Antonio] CSIC, Estn Biol Donana, Dept Integrat Ecol, E-41080 Seville, Spain; [Furtado, Mariana Malzoni] Univ Sao Paulo, Fac Med Vet & Zootecnia, Dept Prevent Vet Med & Anim Hlth, Sao Paulo, Brazil	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Universidad Autonoma Metropolitana - Mexico; Institute Nacional de Pesquisas da Amazonia; University of North Carolina; North Carolina State University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Universidade de Sao Paulo	Palomares, F (corresponding author), CSIC, Dept Conservat Biol, Estn Biol Donana, E-41080 Seville, Spain.	ffpaloma@ebd.csic.es	Carignano Torres, Patricia/F-2794-2016; CHAVEZ, CUAUHTÉMOC/C-5754-2019; Keller, Claudia/C-2493-2012; Furtado, Mariana/ABH-2648-2021; Palomares, Francisco/F-5327-2016; Godoy, José Antonio/B-9288-2008	Carignano Torres, Patricia/0000-0003-0426-8277; CHAVEZ, CUAUHTÉMOC/0000-0003-2201-4748; Palomares, Francisco/0000-0002-4655-7205; Godoy, José Antonio/0000-0001-7502-9471; Roques, Severine/0000-0002-9029-7789; Lopez-Bao, Jose Vicente/0000-0001-9213-998X; Torres, Natalia Mundim/0000-0001-7123-5112; Furtado, Mariana Malzoni/0000-0001-5147-7202	Fundacion BBVA [BIOCON 05 - 100/06]; Spanish Ministry of Science and Innovation [CGL2010-16902]; Memphis Zoo; Earthwatch Institute	Fundacion BBVA(BBVA Foundation); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Memphis Zoo; Earthwatch Institute	The research was carried out under projects BIOCON 05 - 100/06 of Fundacion BBVA and CGL2010-16902 of the Spanish Ministry of Science and Innovation, the Memphis Zoo and Earthwatch Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Brashares JS, 1999, ANIM BEHAV, V57, P11, DOI 10.1006/anbe.1998.0942; de Azevedo FCC, 2008, BIOTROPICA, V40, P494, DOI 10.1111/j.1744-7429.2008.00404.x; de Azevedo FCC, 2007, BIOL CONSERV, V137, P391, DOI 10.1016/j.biocon.2007.02.022; Cavalcanti SMC, 2009, J MAMMAL, V90, P935, DOI 10.1644/08-MAMM-A-188.1; Chavez C, 2010, THESIS U GRANADA SPA; Chavez C, 2006, THESIS U NACL AUTONO; Conde DA, 2010, BIOL CONSERV, V143, P1980, DOI 10.1016/j.biocon.2010.04.049; CRAWSHAW PG, 1991, J ZOOL, V223, P357, DOI 10.1111/j.1469-7998.1991.tb04770.x; De Angelo C, 2011, DIVERS DISTRIB, V17, P422, DOI 10.1111/j.1472-4642.2011.00746.x; Di Bitetti MS, 2006, J ZOOL, V270, P153, DOI 10.1111/j.1469-7998.2006.00102.x; Dillon A, 2008, J ZOOL, V275, P391, DOI 10.1111/j.1469-7998.2008.00452.x; Foster RJ, 2010, BIOTROPICA, V42, P724, DOI 10.1111/j.1744-7429.2010.00641.x; Frantz AC, 2003, MOL ECOL, V12, P1649, DOI 10.1046/j.1365-294X.2003.01848.x; Goulart FVB, 2009, MAMM BIOL, V74, P182, DOI 10.1016/j.mambio.2009.02.006; Green Rosemary, 2000, IUCN Otter Specialist Group Bulletin, V17, P20; Haines Aaron M., 2006, Acta Zoologica Sinica, V52, P1142; Harmsen BJ, 2010, J MAMMAL, V91, P1225, DOI 10.1644/09-MAMM-A-416.1; Harmsen BJ, 2010, BIOTROPICA, V42, P126, DOI 10.1111/j.1744-7429.2009.00544.x; Harmsen BJ, 2009, J MAMMAL, V90, P612, DOI 10.1644/08-MAMM-A-140R.1; HOSS M, 1993, NUCLEIC ACIDS RES, V21, P3913, DOI 10.1093/nar/21.16.3913; Janecka JE, 2007, WILDLIFE BIOL, V13, P38, DOI 10.2981/0909-6396(2007)13[38:EFMDIB]2.0.CO;2; Kohn MH, 1997, TRENDS ECOL EVOL, V12, P223, DOI 10.1016/S0169-5347(97)01050-1; Kruuk H., 1995, WILD OTTERS PREDATIO; Logan Kenneth A., 2010, P105; Long RA, 2007, J WILDLIFE MANAGE, V71, P2007, DOI 10.2193/2006-230; MACDONALD DW, 1980, S ZOOL SOC LONDON, V45, P107; Maffei L, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P119, DOI 10.1007/978-4-431-99495-4_8; Menotti-Raymond M, 1999, GENOMICS, V57, P9, DOI 10.1006/geno.1999.5743; Negroes N, 2010, J WILDLIFE MANAGE, V74, P1195, DOI 10.2193/2009-256; Nunez R, 2006, THESIS U NACL AUTONO; Oliveira de TG, 2010, BIOL CONSERVATION WI; Pickett EJ, 2012, WILDLIFE RES, V39, P350, DOI 10.1071/WR11193; Pilgrim KL, 2005, MOL ECOL NOTES, V5, P60, DOI 10.1111/j.1471-8286.2004.00831.x; PUTMAN RJ, 1984, MAMMAL REV, V14, P79, DOI 10.1111/j.1365-2907.1984.tb00341.x; RABINOWITZ AR, 1986, J ZOOL, V210, P149, DOI 10.1111/j.1469-7998.1986.tb03627.x; ROBINSON IH, 1988, J ZOOL, V216, P577, DOI 10.1111/j.1469-7998.1988.tb02453.x; Romero-Munoz A, 2010, J TROP ECOL, V26, P303, DOI 10.1017/S0266467410000052; ROPER TJ, 1993, BEHAVIOUR, V127, P289, DOI 10.1163/156853993X00074; Roques S, 2011, MOL ECOL RESOUR, V11, P171, DOI 10.1111/j.1755-0998.2010.02878.x; Roques S., ORYX IN PRESS; Salom-Perez R, 2007, ORYX, V41, P51, DOI 10.1017/S0030605307001615; SCHALLER GB, 1980, BIOTROPICA, V12, P161, DOI 10.2307/2387967; Scognamillo D, 2003, J ZOOL, V259, P269, DOI 10.1017/S0952836902003230; Silveira L., 2004, THESIS U BRASILIA BR; Smith DA, 2001, SCIENCE, V291, P435, DOI 10.1126/science.291.5503.435B; SMITH JLD, 1989, ANIM BEHAV, V37, P1; Soares TN, 2006, GENET MOL BIOL, V29, P735, DOI 10.1590/S1415-47572006000400025; Sollmann R, 2012, MAMM BIOL, V77, P41, DOI 10.1016/j.mambio.2011.06.011; Sollmann R, 2011, BIOL CONSERV, V144, P1017, DOI 10.1016/j.biocon.2010.12.011; Sunquist ME., 1981, SMITHSON CONTRIB ZOO, DOI DOI 10.5479/SI.00810282.336; Trolle M, 2003, J MAMMAL, V84, P607, DOI 10.1644/1545-1542(2003)084<0607:EOODIT>2.0.CO;2	52	17	18	0	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52923	10.1371/journal.pone.0052923	http://dx.doi.org/10.1371/journal.pone.0052923			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285226	Green Published, gold			2022-12-27	WOS:000313051500081
J	Buss, H; Handschick, K; Jurrmann, N; Pekkonen, P; Beuerlein, K; Muller, H; Wait, R; Saklatvala, J; Ojala, PM; Schmitz, ML; Naumann, M; Kracht, M				Buss, Holger; Handschick, Katja; Jurrmann, Nadine; Pekkonen, Pirita; Beuerlein, Knut; Mueller, Helmut; Wait, Robin; Saklatvala, Jeremy; Ojala, Paivi M.; Schmitz, M. Lienhard; Naumann, Michael; Kracht, Michael			Cyclin-Dependent Kinase 6 Phosphorylates NF-kappa B P65 at Serine 536 and Contributes to the Regulation of Inflammatory Gene Expression	PLOS ONE			English	Article							CELL-CYCLE; TRANSACTIVATION DOMAIN; THYMOCYTE DEVELOPMENT; HERPESVIRUS CYCLIN; STATISTICAL-MODEL; VIRAL CYCLIN; IKK-EPSILON; IN-VIVO; CDK6; CANCER	Nuclear factor kappa-B (NF-kappa B) activates multiple genes with overlapping roles in cell proliferation, inflammation and cancer. Using an unbiased approach we identified human CDK6 as a novel kinase phosphorylating NF-kappa B p65 at serine 536. Purified and reconstituted CDK6/cyclin complexes phosphorylated p65 in vitro and in transfected cells. The physiological role of CDK6 for basal as well as cytokine-induced p65 phosphorylation or NF-kappa B activation was revealed upon RNAi-mediated suppression of CDK6. Inhibition of CDK6 catalytic activity by PD332991 suppressed activation of NF-kappa B and TNF-induced gene expression. In complex with a constitutively active viral cyclin CDK6 stimulated NF-kappa B p65-mediated transcription in a target gene specific manner and this effect was partially dependent on its ability to phosphorylate p65 at serine 536. Tumor formation in thymi and spleens of v-cyclin transgenic mice correlated with increased levels of p65 Ser536 phosphorylation, increased expression of CDK6 and upregulaton of the NF-kappa B target cyclin D3. These results suggest that aberrant CDK6 expression or activation that is frequently observed in human tumors can contribute through NF-kappa B to chronic inflammation and neoplasia.	[Buss, Holger] Hannover Med Sch, Inst Pharmacol, Hannover, Germany; [Jurrmann, Nadine; Naumann, Michael] Otto Von Guericke Univ, Inst Expt Internal Med, Magdeburg, Germany; [Pekkonen, Pirita; Ojala, Paivi M.] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Pekkonen, Pirita; Ojala, Paivi M.] Univ Helsinki, Res Programs Unit, Biomedicum Helsinki, Helsinki, Finland; [Beuerlein, Knut; Mueller, Helmut; Kracht, Michael] Univ Giessen, Rudolf Buchheim Inst Pharmacol, D-35390 Giessen, Germany; [Wait, Robin; Saklatvala, Jeremy] Univ London Imperial Coll Sci Technol & Med, Kennedy Inst, Div Rheumatol, London, England; [Ojala, Paivi M.] Univ Helsinki, Fdn Finnish Canc Inst, Biomedicum Helsinki, Helsinki, Finland; [Schmitz, M. Lienhard] Univ Giessen, Inst Biochem, D-35390 Giessen, Germany	Hannover Medical School; Otto von Guericke University; University of Helsinki; University of Helsinki; Justus Liebig University Giessen; Imperial College London; University of Oxford; University of Helsinki; Justus Liebig University Giessen	Naumann, M (corresponding author), Otto Von Guericke Univ, Inst Expt Internal Med, Magdeburg, Germany.	Naumann@med.ovgu.de; Michael.Kracht@pharma.med.uni-giessen.de	Schmitz, M. Lienhard/D-9328-2017; Ojala, Paivi M/J-3266-2014; Naumann, Michael/B-5285-2011	Schmitz, M. Lienhard/0000-0002-6984-7192; Naumann, Michael/0000-0002-8060-2313; Kracht, Michael/0000-0002-8501-043X; Ojala, Paivi/0000-0001-9065-1832	Deutsche Forschungsgemeinschaft [Kr1143/7-1, TRR81 (B2), Na292/9-1, SFB854 (TP4)]; Cancer Foundation Finland sr [110105] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cancer Foundation Finland sr	This work was supported by grants from the Deutsche Forschungsgemeinschaft Kr1143/7-1, TRR81 (B2), Na292/9-1, SFB854 (TP4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adli M, 2006, J BIOL CHEM, V281, P26976, DOI 10.1074/jbc.M603133200; Anders L, 2011, CANCER CELL, V20, P620, DOI 10.1016/j.ccr.2011.10.001; Arvanitakis L, 1996, BLOOD, V88, P2648, DOI 10.1182/blood.V88.7.2648.bloodjournal8872648; Barre B, 2007, EMBO J, V26, P4841, DOI 10.1038/sj.emboj.7601899; Bockstaele L, 2009, MOL CELL BIOL, V29, P4188, DOI 10.1128/MCB.01823-08; Buss H, 2004, J BIOL CHEM, V279, P55633, DOI 10.1074/jbc.M409825200; Buss H, 2004, J BIOL CHEM, V279, P49571, DOI 10.1074/jbc.C400442200; Chang Y, 1996, NATURE, V382, P410, DOI 10.1038/382410a0; Cheung PCF, 2003, EMBO J, V22, P5793, DOI 10.1093/emboj/cdg552; Dong J, 2008, GENE DEV, V22, P1159, DOI 10.1101/gad.1657408; Errico A, 2010, ADV ENZYME REGUL, V50, P375, DOI 10.1016/j.advenzreg.2009.12.001; Fry DW, 2004, MOL CANCER THER, V3, P1427; Geng H, 2009, EMBO REP, V10, P381, DOI 10.1038/embor.2009.10; Grossel MJ, 2006, J CELL BIOCHEM, V97, P485, DOI 10.1002/jcb.20712; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hinz M, 1999, MOL CELL BIOL, V19, P2690; Hoberg JE, 2006, MOL CELL BIOL, V26, P457, DOI 10.1128/MCB.26.2.457-471.2006; Holtmann H, 1999, MOL CELL BIOL, V19, P6742; Hu MG, 2011, BLOOD, V117, P6120, DOI 10.1182/blood-2010-08-300517; Hu MG, 2009, CANCER RES, V69, P810, DOI 10.1158/0008-5472.CAN-08-2473; Jones R, 2007, CANCER RES, V67, P9134, DOI 10.1158/0008-5472.CAN-07-1528; JUNG JU, 1994, MOL CELL BIOL, V14, P7235, DOI 10.1128/MCB.14.11.7235; Kaldis P, 2001, MOL BIOL CELL, V12, P3987, DOI 10.1091/mbc.12.12.3987; Kaltschmidt B, 1999, ONCOGENE, V18, P3213, DOI 10.1038/sj.onc.1202657; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Keller SA, 2006, BLOOD, V107, P3295, DOI 10.1182/blood-2005-07-2730; Koopal S, 2007, PLOS PATHOG, V3, P1348, DOI 10.1371/journal.ppat.0030140; Kress E, 2011, NAT CELL BIOL, V13, P638, DOI 10.1038/ncb2276; Lapenna S, 2009, NAT REV DRUG DISCOV, V8, P547, DOI 10.1038/nrd2907; Latres E, 2000, EMBO J, V19, P3496, DOI 10.1093/emboj/19.13.3496; Malumbres M, 2004, CELL, V118, P493, DOI 10.1016/j.cell.2004.08.002; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Mattioli I, 2004, J IMMUNOL, V172, P6336, DOI 10.4049/jimmunol.172.10.6336; MEYERSON M, 1991, COLD SPRING HARB SYM, V56, P177; MEYERSON M, 1994, MOL CELL BIOL, V14, P2077, DOI 10.1128/MCB.14.3.2077; Moreno R, 2010, NUCLEIC ACIDS RES, V38, P6029, DOI 10.1093/nar/gkq439; Nagel S, 2008, LEUKEMIA, V22, P387, DOI 10.1038/sj.leu.2405028; Natoli G, 2005, NAT IMMUNOL, V6, P439, DOI 10.1038/ni1196; Naugler WE, 2008, CURR OPIN GENET DEV, V18, P19, DOI 10.1016/j.gde.2008.01.020; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nowak DE, 2008, MOL CELL BIOL, V28, P3623, DOI 10.1128/MCB.01152-07; O'Shea JM, 2008, BIOCHEM SOC T, V36, P603, DOI 10.1042/BST0360603; O'Shea JM, 2010, BIOCHEM J, V426, P345, DOI 10.1042/BJ20091630; Ojala PM, 2000, NAT CELL BIOL, V2, P819, DOI 10.1038/35041064; Okazaki T, 2003, BIOCHEM BIOPH RES CO, V300, P807, DOI 10.1016/S0006-291X(02)02932-7; Ortega S, 2002, BBA-REV CANCER, V1602, P73, DOI 10.1016/S0304-419X(02)00037-9; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Phelps DE, 1997, METHOD ENZYMOL, V283, P194; Rivadeneira DB, 2010, GASTROENTEROLOGY, V138, P1920, DOI 10.1053/j.gastro.2010.01.007; Ruas M, 2007, MOL CELL BIOL, V27, P4273, DOI 10.1128/MCB.02286-06; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Santamaria D, 2007, NATURE, V448, P811, DOI 10.1038/nature06046; Sarek G, 2006, BLOOD, V107, P725, DOI 10.1182/blood-2005-06-2534; Sarek G, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000818; Schmitz ML, 2004, CHEMBIOCHEM, V5, P1348, DOI 10.1002/cbic.200400144; SCHMITZ ML, 1994, J BIOL CHEM, V269, P25613; Schneider G, 2006, EMBO J, V25, P3801, DOI 10.1038/sj.emboj.7601259; Schweitzer K, 2007, EMBO J, V26, P1532, DOI 10.1038/sj.emboj.7601600; Swanton C, 1997, NATURE, V390, P184, DOI 10.1038/36606; Tanaka T, 2007, NAT IMMUNOL, V8, P584, DOI 10.1038/ni1464; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Verschuren EW, 2004, J GEN VIROL, V85, P1347, DOI 10.1099/vir.0.79812-0; Verschuren EW, 2004, CANCER RES, V64, P581, DOI 10.1158/0008-5472.CAN-03-1863; Verschuren EW, 2002, CANCER CELL, V2, P229, DOI 10.1016/S1535-6108(02)00123-X; Wiedemeyer WR, 2010, P NATL ACAD SCI USA, V107, P11501, DOI 10.1073/pnas.1001613107; Wietek C, 2007, TRENDS BIOCHEM SCI, V32, P311, DOI 10.1016/j.tibs.2007.05.003; Wolff B, 1999, ONCOGENE, V18, P2663, DOI 10.1038/sj.onc.1202617; Zhang LS, 2008, BLOOD, V111, P1193, DOI 10.1182/blood-2007-08-109702	71	58	63	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e51847	10.1371/journal.pone.0051847	http://dx.doi.org/10.1371/journal.pone.0051847			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300567	Green Published, Green Submitted, gold			2022-12-27	WOS:000313618800029
J	Lomanowska, AM; Guitton, MJ				Lomanowska, Anna M.; Guitton, Matthieu J.			Virtually Naked: Virtual Environment Reveals Sex-Dependent Nature of Skin Disclosure	PLOS ONE			English	Article							WAIST-TO-HIP; GENDER-DIFFERENCES; BEAUTY; WORLD; WOMEN; TOUCH; SHOULDER; AVATARS; RATIOS	The human tendency to reveal or cover naked skin reflects a competition between the individual propensity for social interactions related to sexual appeal and interpersonal touch versus climatic, environmental, physical, and cultural constraints. However, due to the ubiquitous nature of these constraints, isolating on a large scale the spontaneous human tendency to reveal naked skin has remained impossible. Using the online 3-dimensional virtual world of Second Life, we examined spontaneous human skin-covering behavior unhindered by real-world climatic, environmental, and physical variables. Analysis of hundreds of avatars revealed that virtual females disclose substantially more naked skin than virtual males. This phenomenon was not related to avatar hypersexualization as evaluated by measurement of sexually dimorphic body proportions. Furthermore, analysis of skin-covering behavior of a population of culturally homogeneous avatars indicated that the propensity of female avatars to reveal naked skin persisted despite explicit cultural norms promoting less revealing attire. These findings have implications for further understanding how sex-specific aspects of skin disclosure influence human social interactions in both virtual and real settings.	[Lomanowska, Anna M.; Guitton, Matthieu J.] Inst Univ Sante Mentale Quebec, Quebec City, PQ, Canada; [Lomanowska, Anna M.; Guitton, Matthieu J.] Univ Laval, Fac Med, Quebec City, PQ G1K 7P4, Canada	Laval University; Laval University	Guitton, MJ (corresponding author), Inst Univ Sante Mentale Quebec, Quebec City, PQ, Canada.	matthieu.guitton@fmed.ulaval.ca			Natural Sciences and Engineering Research Council of Canada [371644]; "Fonds de la Recherche en Sante du Quebec" (FRSQ); FRSQ	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); "Fonds de la Recherche en Sante du Quebec" (FRSQ)(Fonds de la Recherche en Sante du Quebec); FRSQ(Fonds de la Recherche en Sante du Quebec)	This work was supported by a grant from the Natural Sciences and Engineering Research Council of Canada (grant number 371644). MJG holds a Career Grant from the "Fonds de la Recherche en Sante du Quebec" (FRSQ) and AML is supported by a postdoctoral fellowship from FRSQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBEY A, 1987, J APPL SOC PSYCHOL, V17, P108, DOI 10.1111/j.1559-1816.1987.tb00304.x; [Anonymous], P 27 INT C HUM FACT; Bainbridge WS, 2007, SCIENCE, V317, P472, DOI 10.1126/science.1146930; Blascovich J., 2011, INFINITE REALITY AVA, DOI DOI 10.1162/PRES_R_00068; Braun MF, 2006, J SOC PERS RELAT, V23, P805, DOI 10.1177/0265407506068264; BUSS DM, 1993, PSYCHOL REV, V100, P204, DOI 10.1037/0033-295X.100.2.204; Downs E, 2010, SEX ROLES, V62, P721, DOI 10.1007/s11199-009-9637-1; Gallace A, 2010, NEUROSCI BIOBEHAV R, V34, P246, DOI 10.1016/j.neubiorev.2008.10.004; Ghazanfar AA, 2004, NAT REV NEUROSCI, V5, P603, DOI 10.1038/nrn1473; Giard F, 2010, COMPUT HUM BEHAV, V26, P1748, DOI 10.1016/j.chb.2010.07.001; Gottschalk S, 2010, SYMB INTERACT, V33, P501, DOI 10.1525/si.2010.33.4.501; Grammer K, 2004, J SEX RES, V41, P66, DOI 10.1080/00224490409552214; Grammer K, 2003, BIOL REV, V78, P385, DOI 10.1017/S1464793102006085; Guitton M.J., 2011, DESIGN PRINCIPLES PR, V5, P209, DOI [10.18848/1833-1874/cgp/v05i01/38012, DOI 10.18848/1833-1874/CGP/V05I01/38012]; Guitton MJ, 2012, COMPUT HUM BEHAV, V28, P1681, DOI 10.1016/j.chb.2012.04.006; Guitton MJ, 2012, COMPUT HUM BEHAV, V28, P450, DOI 10.1016/j.chb.2011.10.016; Guitton MJ, 2010, COMPUT HUM BEHAV, V26, P1772, DOI 10.1016/j.chb.2010.07.004; Hansen KT, 2004, ANNU REV ANTHROPOL, V33, P369, DOI 10.1146/annurev.anthro.33.070203.143805; HARVEY JS, 1984, SOUTH MED J, V77, P204, DOI 10.1097/00007611-198402000-00019; Hertenstein MJ, 2011, SEX ROLES, V64, P70, DOI 10.1007/s11199-010-9842-y; Hietanen JK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024408; Hill EM, 1987, ETHOL SOCIOBIOL, V8, P143, DOI DOI 10.1016/0162-3095(87)90037-9; Hughes SM, 2003, EVOL HUM BEHAV, V24, P173, DOI 10.1016/S1090-5138(02)00149-6; Jablonski N. G., 2006, SKIN NATURAL HIST; Jasienska G, 2004, P ROY SOC B-BIOL SCI, V271, P1213, DOI 10.1098/rspb.2004.2712; Jones, 1986, W J SPEECH COMMUNICA, V50, P227, DOI [10.1080/10570318609374230, DOI 10.1080/10570318609374230]; Kasten Kevin R, 2011, J Intensive Care Med, V26, P223, DOI 10.1177/0885066610390869; Langlois JH, 2000, PSYCHOL BULL, V126, P390, DOI 10.1037/0033-2909.126.3.390; Lomanowska AM, 2012, COMPUT HUM BEHAV, V28, P318, DOI 10.1016/j.chb.2011.09.015; Maisey DS, 1999, LANCET, V353, P1500, DOI 10.1016/S0140-6736(99)00438-9; Miller MK, 2007, SEX ROLES, V57, P733, DOI 10.1007/s11199-007-9307-0; Morris D., 1967, NAKED APE ZOOLOGISTS; NGUYEN T, 1975, J COMMUN, V25, P92, DOI 10.1111/j.1460-2466.1975.tb00610.x; Nummenmaa L, 2012, ARCH SEX BEHAV; Rantala MJ, 2007, J ZOOL, V273, P1, DOI 10.1111/j.1469-7998.2007.00295.x; Shelton AK, 2010, COMPUT HUM BEHAV, V26, P1223, DOI 10.1016/j.chb.2010.03.019; STIER DS, 1984, J PERS SOC PSYCHOL, V47, P440, DOI 10.1037/0022-3514.47.2.440; Wachtel TL, 2000, BURNS, V26, P156, DOI 10.1016/S0305-4179(99)00047-9	38	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e51921	10.1371/journal.pone.0051921	http://dx.doi.org/10.1371/journal.pone.0051921			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	071TV	23300580	Green Submitted, gold, Green Published			2022-12-27	WOS:000313618800039
J	Chen, X; Li, M; Chen, DH; Gao, WT; Guan, JL; Komatsu, M; Yin, XM				Chen, Xi; Li, Min; Chen, Daohong; Gao, Wentao; Guan, Jun-Lin; Komatsu, Massaki; Yin, Xiao-Ming			Autophagy Induced by Calcium Phosphate Precipitates Involves Endoplasmic Reticulum Membranes in Autophagosome Biogenesis	PLOS ONE			English	Article							REGULATES ATG9; MACROAUTOPHAGY; PROTEINS; TRAFFICKING; COMPLEX; STRESS; GOLGI; MITOCHONDRIA; COMPARTMENTS; INDUCTION	Calcium can play an important role in the regulation of autophagy. We previously reported that exogenously introduced calcium in the form of calcium phosphate precipitates (CPP) induces autophagy. Here we showed that CPP-induced autophagy required the classical autophagic machinery, including the autophagosome initiating molecules FIP200 and Beclin 1, as well as molecules involved in the autophagosome membrane extension, Atg4, Atg5 and Atg3. On the other hand, Atg9 seemed to place a restriction on CPP-induced autophagy. Loss of Atg9 led to enhanced LC3 punctation and enhanced p62 degradation. CPP-induced autophagy was independent of mTOR and reactive oxygen species. It also did not affect MAP kinase activation and ER stress. DFCP1 is an ER-resident molecule that binds to phosphatidylinositol 3-phosphate. CPP activated DFCP1 punctation in a class III phosphatidylinositol-3-kinase and calcium dependent manner, and caused the association of DFCP1 puncta with the autophagosomes. Consistently, ER membranes, but not Golgi or mitochondrial membranes, colocalized with CPP-induced LC3 positive autophagosomes. These data suggest that CPP-induced autophagosome formation involves the interaction with the ER membrane.	[Chen, Xi; Li, Min; Chen, Daohong; Yin, Xiao-Ming] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN USA; [Chen, Xi] Zhejiang Univ, Sch Med, Childrens Hosp, Hangzhou 310003, Zhejiang, Peoples R China; [Gao, Wentao] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA USA; [Guan, Jun-Lin] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA; [Komatsu, Massaki] Tokyo Metropolitan Inst Med Sci, Tokyo 113, Japan	Indiana University System; Indiana University Bloomington; Zhejiang University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Michigan System; University of Michigan; Tokyo Metropolitan Institute of Medical Science	Yin, XM (corresponding author), Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN USA.	xmyin@iupui.edu	Komatsu, Masaaki/B-8321-2011; Li, Min/B-1281-2011	Komatsu, Masaaki/0000-0001-7672-7722; 	National Institutes of Health [CA111456]; NATIONAL CANCER INSTITUTE [R01CA111456] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by a grant from the National Institutes of Health (CA111456) to XMY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Cardenas C, 2010, CELL, V142, P270, DOI 10.1016/j.cell.2010.06.007; Decuypere JP, 2011, CELL CALCIUM, V50, P242, DOI 10.1016/j.ceca.2011.04.001; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; Ding WX, 2007, J BIOL CHEM, V282, P4702, DOI 10.1074/jbc.M609267200; Ding WX, 2010, GASTROENTEROLOGY, V139, P1740, DOI 10.1053/j.gastro.2010.07.041; Ding WX, 2010, J BIOL CHEM, V285, P27879, DOI 10.1074/jbc.M110.119537; Fujita N, 2008, MOL BIOL CELL, V19, P4651, DOI 10.1091/mbc.E08-03-0312; Gao WT, 2008, AUTOPHAGY, V4, P754, DOI 10.4161/auto.6360; Gao WT, 2010, J BIOL CHEM, V285, P1371, DOI 10.1074/jbc.M109.054197; Geng JF, 2010, AUTOPHAGY, V6, P950, DOI 10.4161/auto.6.7.13009; GORDON PB, 1993, J BIOL CHEM, V268, P26107; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009; Hayashi-Nishino M, 2009, NAT CELL BIOL, V11, P1433, DOI 10.1038/ncb1991; He CC, 2009, AUTOPHAGY, V5, P385, DOI 10.4161/auto.5.3.7699; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; Itakura E, 2010, AUTOPHAGY, V6, P764, DOI 10.4161/auto.6.6.12709; Jaboin JJ, 2007, TECHNOL CANCER RES T, V6, P443, DOI 10.1177/153303460700600510; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kageyama S, 2011, MOL BIOL CELL, V22, P2290, DOI 10.1091/mbc.E10-11-0893; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Longatti A, 2009, CELL DEATH DIFFER, V16, P956, DOI 10.1038/cdd.2009.39; Mari M, 2010, J CELL BIOL, V190, P1005, DOI 10.1083/jcb.200912089; Matsunaga K, 2010, J CELL BIOL, V190, P511, DOI 10.1083/jcb.200911141; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Nair U, 2011, CELL, V146, P290, DOI 10.1016/j.cell.2011.06.022; Ni HM, 2011, AUTOPHAGY, V7, P188, DOI 10.4161/auto.7.2.14181; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Ravikumar B, 2003, HUM MOL GENET, V12, P985, DOI 10.1093/hmg/ddg109; Ravikumar B, 2010, NAT CELL BIOL, V12, P747, DOI 10.1038/ncb2078; Reggiori F, 2004, DEV CELL, V6, P79, DOI 10.1016/S1534-5807(03)00402-7; Ridley SH, 2001, J CELL SCI, V114, P3991; Rubinsztein DC, 2012, CURR BIOL, V22, pR29, DOI 10.1016/j.cub.2011.11.034; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Sarkar S, 2009, AUTOPHAGY, V5, P307, DOI 10.4161/auto.5.3.7664; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Takahashi Y, 2011, AUTOPHAGY, V7, P61, DOI 10.4161/auto.7.1.14015; Tang HW, 2011, EMBO J, V30, P636, DOI 10.1038/emboj.2010.338; Webber JL, 2010, AUTOPHAGY, V6, P292, DOI 10.4161/auto.6.2.11128; Webber JL, 2010, FEBS LETT, V584, P1319, DOI 10.1016/j.febslet.2010.01.020; Williams A, 2008, NAT CHEM BIOL, V4, P295, DOI 10.1038/nchembio.79; Yla-Anttila P, 2009, AUTOPHAGY, V5, P1180; Yorimitsu T, 2006, J BIOL CHEM, V281, P30299, DOI 10.1074/jbc.M607007200; Young AJ, 2006, MED SCI SPORT EXER, V38, P1, DOI 10.1249/01.mss.0000196708.08925.8b; Yue Z, 2007, AUTOPHAGY, V3, P139, DOI 10.4161/auto.3602; Zeng XH, 2006, J CELL SCI, V119, P259, DOI 10.1242/jcs.02735	49	29	36	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52347	10.1371/journal.pone.0052347	http://dx.doi.org/10.1371/journal.pone.0052347			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285000	Green Published, Green Submitted, gold			2022-12-27	WOS:000313158800051
J	Cristina, ML; Spagnolo, AM; Sartini, M; Panatto, D; Gasparini, R; Orlando, P; Ottria, G; Perdelli, F				Cristina, Maria Luisa; Spagnolo, Anna Maria; Sartini, Marina; Panatto, Donatella; Gasparini, Roberto; Orlando, Paolo; Ottria, Gianluca; Perdelli, Fernanda			Can Particulate Air Sampling Predict Microbial Load in Operating Theatres for Arthroplasty?	PLOS ONE			English	Article							SURGERY; QUALITY; ROOM; FLOW	Several studies have proposed that the microbiological quality of the air in operating theatres be indirectly evaluated by means of particle counting, a technique derived from industrial clean-room technology standards, using airborne particle concentration as an index of microbial contamination. However, the relationship between particle counting and microbiological sampling has rarely been evaluated and demonstrated in operating theatres. The aim of the present study was to determine whether particle counting could predict microbiological contamination of the air in an operating theatre during 95 surgical arthroplasty procedures. This investigation was carried out over a period of three months in 2010 in an orthopedic operating theatre devoted exclusively to prosthetic surgery. During each procedure, the bacterial contamination of the air was determined by means of active sampling; at the same time, airborne particulate contamination was assessed throughout the entire procedure. On considering the total number of surgical operations, the mean value of the total bacterial load in the center of the operating theatre proved to be 35 CFU/m(3); the mean particle count was 4,194,569 no./m(3) for particles of diameter >= 0.5 mu m and 13,519 no./m(3) for particles of diameter >= 5 mu m. No significant differences emerged between the median values of the airborne microbial load recorded during the two types of procedure monitored. Particulates with a diameter of >= 0.5 mm were detected in statistically higher concentrations (p<0.001) during knee-replacement procedures. By contrast, particulates with a diameter of >= 5 mu m displayed a statistically higher concentration during hip-replacement procedures (p<0.05). The results did not reveal any statistically significant correlation between microbial loads and particle counts for either of the particle diameters considered (>= 0.5 mu m and >= 5 mu m). Consequently, microbiological monitoring remains the most suitable method of evaluating the quality of air in operating theatres.	[Cristina, Maria Luisa; Spagnolo, Anna Maria; Sartini, Marina; Panatto, Donatella; Gasparini, Roberto; Orlando, Paolo; Ottria, Gianluca; Perdelli, Fernanda] Univ Genoa, Dept Hlth Sci, Genoa, Italy	University of Genoa	Cristina, ML (corresponding author), Univ Genoa, Dept Hlth Sci, Genoa, Italy.	cristinaml@unige.it	Sartini, Marina/I-2950-2012; Bragazzi, Nicola Luigi/G-1672-2011	Bragazzi, Nicola Luigi/0000-0001-8409-868X; CRISTINA, Maria Luisa/0000-0002-7926-7108; Gasparini, Roberto/0000-0002-1012-6913; Panatto, Donatella/0000-0002-2677-0551; Spagnolo, Anna Maria/0000-0001-6559-3626; Orlando, Paolo/0000-0002-6576-9860; Sartini, Marina/0000-0002-7127-2893				Al-Waked R, 2010, ENG APPL COMP FLUID, V4, P1; Andersson AE, 2012, AM J INFECT CONTROL, V40, P750, DOI 10.1016/j.ajic.2011.09.015; [Anonymous], 1999, 146441 EB ISO TECHN; [Anonymous], 2003, S90351 NF AFNOR; Bruske-Hohlfeld Irene, 2008, J Occup Med Toxicol, V3, P31, DOI 10.1186/1745-6673-3-31; Cristina ML, 2012, ADV MED BIOL, V34, P63; Dharan S, 2002, J HOSP INFECT, V51, P79, DOI 10.1053/jhin.2002.1217; Diab-Elschahawi M, 2011, AM J INFECT CONTROL, V39, pE25, DOI 10.1016/j.ajic.2010.10.035; Gould D, 2001, Nurs Stand, V15, P45; Istituto Superiore per la Prevenzione e Sicurezza sul Lavoro (ISPESL), 2010, LIN GUID STAND SIC I; Landrin A, 2005, J HOSP INFECT, V61, P27, DOI 10.1016/j.jhin.2005.03.002; Orlando P., 1999, Igiene Moderna, V112, P1253; Sartini M, 2006, J Prev Med Hyg, V47, P155; Scaltriti S, 2007, J HOSP INFECT, V66, P320, DOI 10.1016/j.jhin.2007.05.019; SEAL DV, 1990, J APPL BACTERIOL, V68, P225, DOI 10.1111/j.1365-2672.1990.tb02568.x; Stocks GW, 2010, AM J INFECT CONTROL, V38, P199, DOI 10.1016/j.ajic.2009.07.006; Wan GH, 2011, AM J INFECT CONTROL, V39, P302, DOI 10.1016/j.ajic.2010.07.006; Weaving Paul, 2008, J Perioper Pract, V18, P199	18	35	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52809	10.1371/journal.pone.0052809	http://dx.doi.org/10.1371/journal.pone.0052809			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285189	Green Published, Green Submitted, gold			2022-12-27	WOS:000313158800095
J	Kowall, B; Ebert, N; Then, C; Thiery, J; Koenig, W; Meisinger, C; Rathmann, W; Seissler, J				Kowall, Bernd; Ebert, Nina; Then, Cornelia; Thiery, Joachim; Koenig, Wolfgang; Meisinger, Christa; Rathmann, Wolfgang; Seissler, Jochen			Associations between Blood Glucose and Carotid Intima-Media Thickness Disappear after Adjustment for Shared Risk Factors: The KORA F4 Study	PLOS ONE			English	Article							POSTCHALLENGE PLASMA-GLUCOSE; IMPAIRED FASTING GLUCOSE; TYPE-2 DIABETIC-PATIENTS; CARDIOVASCULAR-DISEASE; ATHEROSCLEROSIS RISK; SUBCLINICAL ATHEROSCLEROSIS; NONDIABETIC INDIVIDUALS; ARTERY ATHEROSCLEROSIS; GLYCATED HEMOGLOBIN; WALL THICKNESS	Objective: The association between blood glucose and carotid intima-media thickness (CIMT) is considered to be established knowledge. We aimed to assess whether associations between different measures of glycaemia and CIMT are actually independent of anthropometric variables and metabolic risk factors. Moreover, we checked published studies for the adjustment for shared risk factors of blood glucose and CIMT. Methods: Fasting glucose, 2-hour glucose, HbA1c, and CIMT were measured in 31-81-years-old participants of the population-based Cooperative Health Research in the Region of Augsburg (KORA) F4 study in Southern Germany (n = 2,663). CIMT was assessed according to the Rotterdam protocol. Linear and logistic regression models with adjustment for age, sex, anthropometric measures, hypertension, and dyslipidaemia were fitted to assess the association between continuous measures of glycaemia, and categories of glucose regulation, respectively, with CIMT. Results: We found a 0.10 mm increase (95%-confidence interval: 0.08-0.12) in CIMT in subjects with compared to subjects without diabetes in crude analysis. This increase was not significant in age-sex adjusted models (p = 0.17). Likewise, neither impaired fasting glucose (p = 0.22) nor impaired glucose tolerance (p = 0.93) were associated with CIMT after adjustment for age, sex, and waist circumference. In multivariable adjusted models, age, sex, hypertension, waist circumference, HDL and LDL cholesterol, but neither fasting glucose nor 2-hour glucose nor HbA1c were associated with elevated CIMT. Literature findings are inconclusive regarding an independent association of glucose levels and CIMT. Conclusion: CIMT is highly dependent on traditional cardiovascular risk factors, but no relationships between blood glucose and CIMT were found after adjustment for age, sex, and anthropometric variables.	[Kowall, Bernd; Ebert, Nina; Rathmann, Wolfgang] Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Biometr & Epidemiol, D-40225 Dusseldorf, Germany; [Then, Cornelia; Seissler, Jochen] Klinikum Ludwig Maximilians Univ, Diabet Zentrum, Med Klin & Poliklin 4, Munich, Germany; [Thiery, Joachim] Univ Leipzig, Inst Lab Med Clin Chem & Mol Diagnost, D-04109 Leipzig, Germany; [Koenig, Wolfgang] Univ Ulm, Med Ctr, Dept Internal Med Cardiol 2, D-89069 Ulm, Germany; [Meisinger, Christa] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol 2, Neuherberg, Germany; [Seissler, Jochen] Univ Munich, Clin Cooperat Grp Diabet, Munich, Germany	Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; University of Munich; Leipzig University; Ulm University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich	Kowall, B (corresponding author), Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Biometr & Epidemiol, D-40225 Dusseldorf, Germany.	bernd.kowall@ddz.uni-duesseldorf.de	Meisinger, Christine/B-5358-2014	Meisinger, Christa/0000-0002-9026-6544; Koenig, Wolfgang/0000-0002-2064-9603	German Research Foundation (DFG) [RA 459/2-1]; German Federal Ministry of Health; Ministry of School, Science and Research of the State of North-Rhine-Westfalia; Helmholtz Zentrum Munchen; German Research Center for Environmental Health; German Federal Ministry of Education, Science, Research and Technology; State of Bavaria; project Greifswald Approach to Individualized Medicine (GANI_MED); Federal Ministry of Education and Research; Ministry of Cultural Affairs of the Federal State of Mecklenburg-West Pomerania [03IS2061D]; NATIONAL INSTITUTE ON AGING [P30AG013846] Funding Source: NIH RePORTER	German Research Foundation (DFG)(German Research Foundation (DFG)); German Federal Ministry of Health; Ministry of School, Science and Research of the State of North-Rhine-Westfalia; Helmholtz Zentrum Munchen(Helmholtz Association); German Research Center for Environmental Health; German Federal Ministry of Education, Science, Research and Technology; State of Bavaria; project Greifswald Approach to Individualized Medicine (GANI_MED); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Ministry of Cultural Affairs of the Federal State of Mecklenburg-West Pomerania; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Diabetes Cohort Study was funded by a German Research Foundation project grant to WR (DFG; RA 459/2-1). The German Diabetes Center is funded by the German Federal Ministry of Health, and the Ministry of School, Science and Research of the State of North-Rhine-Westfalia. The KORA research platform and the KORA Augsburg studies are financed by the Helmholtz Zentrum Munchen, German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education, Science, Research and Technology and by the State of Bavaria. This work is also funded by the project Greifswald Approach to Individualized Medicine (GANI_MED). The GANI_MED consortium is funded by the Federal Ministry of Education and Research and the Ministry of Cultural Affairs of the Federal State of Mecklenburg-West Pomerania (support codes: 03IS2061D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronson D, 2008, ADV CARDIOL, V45, P1, DOI 10.1159/000115118; Barr ELM, 2007, CIRCULATION, V116, P151, DOI 10.1161/CIRCULATIONAHA.106.685628; Bobbert T, 2010, DIABETES CARE, V33, P203, DOI 10.2337/dc09-1009; Bonora E, 2000, DIABETOLOGIA, V43, P156, DOI 10.1007/s001250050024; BOTS ML, 1994, J CLIN EPIDEMIOL, V47, P921, DOI 10.1016/0895-4356(94)90196-1; Brohall G, 2006, DIABETIC MED, V23, P609, DOI 10.1111/j.1464-5491.2005.01725.x; Brohall G, 2009, NUTR METAB CARDIOVAS, V19, P327, DOI 10.1016/j.numecd.2008.02.002; Chamnan P, 2011, DIABETOLOGIA, V54, P291, DOI 10.1007/s00125-010-1914-6; Choi SW, 2011, J DIABETES COMPLICAT, V25, P7, DOI 10.1016/j.jdiacomp.2009.12.001; de Kreutzenberg SV, 2009, NUTR METAB CARDIOVAS, V19, P667, DOI 10.1016/j.numecd.2009.03.014; Einarson TR, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-37; Faeh D, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-32; Fitch KV, 2011, ATHEROSCLEROSIS, V217, P437, DOI 10.1016/j.atherosclerosis.2011.04.009; FOLSOM AR, 1994, STROKE, V25, P66, DOI 10.1161/01.STR.25.1.66; Ford ES, 2010, J AM COLL CARDIOL, V55, P1310, DOI 10.1016/j.jacc.2009.10.060; Fox CS, 2007, CIRCULATION, V115, P1544, DOI 10.1161/CIRCULATIONAHA.106.658948; Goya K, 2003, METABOLISM, V52, P1302, DOI 10.1016/S0026-0495(03)00197-5; Hanefeld M, 1999, DIABETIC MED, V16, P212, DOI 10.1046/j.1464-5491.1999.00072.x; Hanefeld M, 1999, ATHEROSCLEROSIS, V144, P229, DOI 10.1016/S0021-9150(99)00059-3; Hu YM, 2010, ATHEROSCLEROSIS, V210, P302, DOI 10.1016/j.atherosclerosis.2009.11.015; Huang Y, 2011, J CLIN ENDOCR METAB, V96; Ishizaka N, 2009, ATHEROSCLEROSIS, V204, P619, DOI 10.1016/j.atherosclerosis.2008.10.022; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Meigs JB, 2002, DIABETES CARE, V25, P1845, DOI 10.2337/diacare.25.10.1845; O'Leary DH, 2002, AM J CARDIOL, V90, p18L, DOI 10.1016/S0002-9149(02)02957-0; Okada M, 2000, INTERNAL MED, V39, P362, DOI 10.2169/internalmedicine.39.362; Polak JF, 2011, NEW ENGL J MED, V365, P213, DOI 10.1056/NEJMoa1012592; Rajala U, 2003, J HUM HYPERTENS, V17, P705, DOI 10.1038/sj.jhh.1001594; Rasmussen-Torvik LJ, 2011, DIABETES, V60, P331, DOI 10.2337/db10-0839; Rathmann W, 2003, DIABETOLOGIA, V46, P182, DOI 10.1007/s00125-002-1025-0; Selvin E, 2005, DIABETES CARE, V28, P1965, DOI 10.2337/diacare.28.8.1965; Selvin E, 2010, NEW ENGL J MED, V362, P800, DOI 10.1056/NEJMoa0908359; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Stern MP, 2002, DIABETES CARE, V25, P1851, DOI 10.2337/diacare.25.10.1851; Su TC, 2012, J ATHEROSCLER THROMB, V19, P872, DOI 10.5551/jat.10728; Temelkova-Kurktschiev T, 1998, DIABETOLOGIA, V41, P706, DOI 10.1007/s001250050972; Temelkova-Kurktschiev TS, 2000, DIABETES CARE, V23, P1830, DOI 10.2337/diacare.23.12.1830; W.H. Organization, 1999, DEFINITION DIAGNOSIS; Zhang YF, 2006, CLIN ENDOCRINOL, V64, P153, DOI 10.1111/j.1365-2265.2005.02440.x; Zhu W, 2010, CLIN CARDIOL, V33, P542, DOI 10.1002/clc.20788	40	28	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52590	10.1371/journal.pone.0052590	http://dx.doi.org/10.1371/journal.pone.0052590			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285104	Green Published, Green Submitted, gold			2022-12-27	WOS:000313158800079
J	Weis, T; Puschmann, S; Brechmann, A; Thiel, CM				Weis, Tina; Puschmann, Sebastian; Brechmann, Andre; Thiel, Christiane M.			Effects of L-dopa during Auditory Instrumental Learning in Humans	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; ANTERIOR CINGULATE CORTEX; ADULT CORTICAL PLASTICITY; VENTRAL TEGMENTAL AREA; EVENT-RELATED FMRI; PARKINSONS-DISEASE; PREDICTION ERRORS; RECEPTIVE-FIELDS; MAP PLASTICITY; MEMORY CONSOLIDATION	The dopaminergic neurotransmitter system is critically involved in promoting plasticity in auditory cortex. We combined functional magnetic resonance imaging (fMRI) and a pharmacological manipulation to investigate dopaminergic modulation of neural activity in auditory cortex during instrumental learning. Volunteers either received 100 mg L-dopa (Madopar) or placebo in an appetitive, differential instrumental conditioning paradigm, which involved learning that a specific category of frequency modulated tones predicts a monetary reward when fast responses were made in a subsequent reaction time task. The other category of frequency modulated tones was not related to a reward. Our behavioral data provides evidence that dopaminergic stimulation differentially impacts on the speed of instrumental responding in rewarded and unrewarded trials. L-dopa increased neural BOLD activity in left auditory cortex to tones in rewarded and unrewarded trials. This increase was related to plasma L-dopa levels and learning rate. Our data thus provides evidence for dopaminergic modulation of neural activity in auditory cortex, which occurs for both auditory stimuli related to a later reward and those not related to a reward.	[Weis, Tina; Puschmann, Sebastian; Thiel, Christiane M.] Carl von Ossietzky Univ Oldenburg, Dept Psychol, D-26111 Oldenburg, Germany; [Brechmann, Andre] Leibniz Inst Neurobiol, Special Lab Noninvas Brain Imaging, Magdeburg, Germany; [Thiel, Christiane M.] Carl von Ossietzky Univ Oldenburg, Res Ctr Neurosensory Sci, D-26111 Oldenburg, Germany	Carl von Ossietzky Universitat Oldenburg; Leibniz Institut fur Neurobiologie (LIN); Carl von Ossietzky Universitat Oldenburg	Weis, T (corresponding author), Carl von Ossietzky Univ Oldenburg, Dept Psychol, D-26111 Oldenburg, Germany.	tina.weis@uni-oldenburg.de		Puschmann, Sebastian/0000-0002-8552-5353; , Christiane/0000-0003-4788-4301; Brechmann, Andre/0000-0003-3903-0840	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) [SFB/TRR31]; Neurosenses	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG)); Neurosenses	This work was supported by the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG, SFB/TRR31). Sebastian Puschmann was supported by Neurosenses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiez C, 2006, CEREB CORTEX, V16, P1040, DOI 10.1093/cercor/bhj046; Bakin JS, 1996, BEHAV NEUROSCI, V110, P905, DOI 10.1037/0735-7044.110.5.905; Bao SW, 2001, NATURE, V412, P79, DOI 10.1038/35083586; Beitel RE, 2003, P NATL ACAD SCI USA, V100, P11070, DOI 10.1073/pnas.1334187100; Blake DT, 2006, NEURON, V52, P371, DOI 10.1016/j.neuron.2006.08.009; BOND A, 1974, BRIT J MED PSYCHOL, V47, P211, DOI 10.1111/j.2044-8341.1974.tb02285.x; Brechmann A, 2005, CEREB CORTEX, V15, P578, DOI 10.1093/cercor/bhh159; Brockelmann AK, 2011, J NEUROSCI, V31, P7801, DOI 10.1523/JNEUROSCI.6236-10.2011; Brosch M, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00005; Budinger E, 2008, BRAIN RES, V1220, P2, DOI 10.1016/j.brainres.2007.07.084; CONDON CD, 1991, BEHAV NEUROSCI, V105, P416, DOI 10.1037/0735-7044.105.3.416; Contin M, 1999, CLIN NEUROPHARMACOL, V22, P351; Contin M, 2010, J NEUROL, V257, pS253, DOI 10.1007/s00415-010-5728-8; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Daniel R, 2012, NEUROIMAGE, V59, P3457, DOI 10.1016/j.neuroimage.2011.11.058; de la Fuente-Fernandez R, 2004, BRAIN, V127, P2747, DOI 10.1093/brain/awh290; DINGEMANSE J, 1995, BRIT J CLIN PHARMACO, V40, P253, DOI 10.1111/j.1365-2125.1995.tb05781.x; EDELINE JM, 1991, BEHAV NEUROSCI, V105, P618, DOI 10.1037/0735-7044.105.5.618; Engineer ND, 2012, NEUROSCIENCE, V205, P81, DOI 10.1016/j.neuroscience.2011.12.056; Feldman DE, 2005, SCIENCE, V310, P810, DOI 10.1126/science.1115807; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; Froemke RC, 2011, NEUROSCI BIOBEHAV R, V35, P2105, DOI 10.1016/j.neubiorev.2011.02.006; Gallistel CR, 2004, P NATL ACAD SCI USA, V101, P13124, DOI 10.1073/pnas.0404965101; Gilbert CD, 2009, J PHYSIOL-LONDON, V587, P2743, DOI 10.1113/jphysiol.2009.171488; Gollub RL, 1998, J CEREBR BLOOD F MET, V18, P724, DOI 10.1097/00004647-199807000-00003; Guitart-Masip M, 2012, P NATL ACAD SCI USA, V109, P7511, DOI 10.1073/pnas.1202229109; Hickey C, 2010, J NEUROSCI, V30, P11096, DOI 10.1523/JNEUROSCI.1026-10.2010; Holroyd CB, 2012, TRENDS COGN SCI, V16, P122, DOI 10.1016/j.tics.2011.12.008; Hui GK, 2009, NEUROBIOL LEARN MEM, V92, P27, DOI 10.1016/j.nlm.2009.02.008; Ilango A, 2011, BEHAV BRAIN RES, V225, P515, DOI 10.1016/j.bbr.2011.08.014; Kennerley SW, 2006, NAT NEUROSCI, V9, P940, DOI 10.1038/nn1724; Kirsch P, 2003, NEUROIMAGE, V20, P1086, DOI 10.1016/S1053-8119(03)00381-1; Kisley MA, 2001, EUR J NEUROSCI, V13, P1993, DOI 10.1046/j.0953-816x.2001.01568.x; Knecht S, 2004, ANN NEUROL, V56, P20, DOI 10.1002/ana.20125; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; Koelsch S, 2006, HUM BRAIN MAPP, V27, P239, DOI 10.1002/hbm.20180; LEENDERS KL, 1985, BRAIN, V108, P171, DOI 10.1093/brain/108.1.171; Leyton M, 2007, J PSYCHIATR NEUROSCI, V32, P129; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; Meyer M, 2004, BRAIN LANG, V89, P277, DOI 10.1016/S0093-934X(03)00350-X; MONTASTRUC JL, 1987, MOVEMENT DISORD, V2, P279, DOI 10.1002/mds.870020405; Monte-Silva K, 2010, J PHYSIOL-LONDON, V588, P3415, DOI 10.1113/jphysiol.2010.190181; Muhlack S, 2007, MOVEMENT DISORD, V22, P427, DOI 10.1002/mds.21346; Muller RA, 2001, BRAIN LANG, V76, P70, DOI 10.1006/brln.2000.2398; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; Ohl FW, 2005, CURR OPIN NEUROBIOL, V15, P470, DOI 10.1016/j.conb.2005.07.002; Ohl FW, 2001, NATURE, V412, P733, DOI 10.1038/35089076; Ohlin KE, 2012, NEUROIMAGE, V61, P228, DOI 10.1016/j.neuroimage.2012.02.066; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Onur OA, 2011, J COGNITIVE NEUROSCI, V23, P2797, DOI 10.1162/jocn.2011.21603; Op de Beeck HP, 2010, TRENDS COGN SCI, V14, P22, DOI 10.1016/j.tics.2009.11.002; Pappata S, 2002, NEUROIMAGE, V16, P1015, DOI 10.1006/nimg.2002.1121; Pessiglione M, 2006, NATURE, V442, P1042, DOI 10.1038/nature05051; Polley DB, 2004, P NATL ACAD SCI USA, V101, P16351, DOI 10.1073/pnas.0407586101; Puschmann S, 2012, HUMAN BRAIN MAPPING; Rao SM, 2000, AM J PSYCHIAT, V157, P1697, DOI 10.1176/appi.ajp.157.10.1697; Reed A, 2011, NEURON, V70, P121, DOI 10.1016/j.neuron.2011.02.038; Salamone JD, 2012, J EXP ANAL BEHAV, V97, P125, DOI 10.1901/jeab.2012.97-125; Samson RD, 2010, COGN NEURODYNAMICS, V4, P91, DOI 10.1007/s11571-010-9109-x; Scheidtmann K, 2004, RESTOR NEUROL NEUROS, V22, P393; Schicknick H, 2008, CEREB CORTEX, V18, P2646, DOI 10.1093/cercor/bhn026; Schicknick H, 2012, EUR J NEUROSCI, V35, P763, DOI 10.1111/j.1460-9568.2012.07994.x; Schott BH, 2004, LEARN MEMORY, V11, P383, DOI 10.1101/lm.75004; Schott BH, 2008, J NEUROSCI, V28, P14311, DOI 10.1523/JNEUROSCI.2058-08.2008; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Shumake J, 2010, J NEUROSCI, V30, P5876, DOI 10.1523/JNEUROSCI.3604-09.2010; Stark H, 1997, J NEUROCHEM, V68, P691; Stark H, 2004, NEUROSCIENCE, V126, P21, DOI 10.1016/j.neuroscience.2004.02.026; Takahashi H, 2011, NEUROSCIENCE, V199, P243, DOI 10.1016/j.neuroscience.2011.09.046; Takahashi H, 2010, BIOSYSTEMS, V101, P37, DOI 10.1016/j.biosystems.2010.04.003; Thiel CM, 2002, EUR J NEUROSCI, V16, P2199, DOI 10.1046/j.1460-9568.2002.02272.x; Thiel CM, 2002, NEURON, V35, P567, DOI 10.1016/S0896-6273(02)00801-2; Thirugnanasambandam N, 2011, J NEUROSCI, V31, P5294, DOI 10.1523/JNEUROSCI.6258-10.2011; Tobey EA, 2005, EAR HEARING, V26, p45S, DOI 10.1097/00003446-200508001-00007; Wallis JD, 2010, CURR OPIN NEUROBIOL, V20, P191, DOI 10.1016/j.conb.2010.02.009; Wilke M, 2007, J NEUROSCI METH, V163, P128, DOI 10.1016/j.jneumeth.2007.01.026; Wilke M, 2006, NEUROIMAGE, V33, P522, DOI 10.1016/j.neuroimage.2006.07.010; Wittmann BC, 2005, NEURON, V45, P459, DOI 10.1016/j.neuron.2005.01.010; World Medical Association, 2008, WORLD MED ASS DECL H; Wunderlich K, 2012, NEURON, V75, P418, DOI 10.1016/j.neuron.2012.03.042	84	13	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52504	10.1371/journal.pone.0052504	http://dx.doi.org/10.1371/journal.pone.0052504			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285070	Green Published, Green Submitted, gold			2022-12-27	WOS:000313158800075
J	Agarwal, D; Dange, RB; Vila, J; Otamendi, AJ; Francis, J				Agarwal, Deepmala; Dange, Rahul B.; Vila, Jorge; Otamendi, Arturo J.; Francis, Joseph			Detraining Differentially Preserved Beneficial Effects of Exercise on Hypertension: Effects on Blood Pressure, Cardiac Function, Brain Inflammatory Cytokines and Oxidative Stress	PLOS ONE			English	Article							II-INDUCED HYPERTENSION; CENTRAL-NERVOUS-SYSTEM; FACTOR-KAPPA-B; ANGIOTENSIN-II; PARAVENTRICULAR NUCLEUS; HEART-FAILURE; SUPEROXIDE-DISMUTASE; NAD(P)H OXIDASE; NADPH OXIDASE; ORGAN DAMAGE	Aims: This study sought to investigate the effects of physical detraining on blood pressure (BP) and cardiac morphology and function in hypertension, and on pro-and anti-inflammatory cytokines (PICs and AIC) and oxidative stress within the brain of hypertensive rats. Methods and Results: Hypertension was induced in male Sprague-Dawley rats by delivering AngiotensinII for 42 days using implanted osmotic minipumps. Rats were randomized into sedentary, trained, and detrained groups. Trained rats underwent moderate-intensity exercise (ExT) for 42 days, whereas, detrained groups underwent 28 days of exercise followed by 14 days of detraining. BP and cardiac function were evaluated by radio-telemetry and echocardiography, respectively. At the end, the paraventricular nucleus (PVN) was analyzed by Real-time RT-PCR and Western blot. ExT in AngII-infused rats caused delayed progression of hypertension, reduced cardiac hypertrophy, and improved diastolic function. These results were associated with significantly reduced PICs, increased AIC (interleukin (IL)-10), and attenuated oxidative stress in the PVN. Detraining did not abolish the exercise-induced attenuation in MAP in hypertensive rats; however, detraining failed to completely preserve exercise-mediated improvement in cardiac hypertrophy and function. Additionally, detraining did not reverse exercise-induced improvement in PICs in the PVN of hypertensive rats; however, the improvements in IL-10 were abolished. Conclusion: These results indicate that although 2 weeks of detraining is not long enough to completely abolish the beneficial effects of regular exercise, continuing cessation of exercise may lead to detrimental effects.	[Agarwal, Deepmala; Dange, Rahul B.; Vila, Jorge; Otamendi, Arturo J.; Francis, Joseph] Louisiana State Univ, Sch Vet Med, Baton Rouge, LA 70803 USA	Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University	Francis, J (corresponding author), Louisiana State Univ, Sch Vet Med, Baton Rouge, LA 70803 USA.	jfrancis@lsu.edu			National Heart, Lung, and Blood Institute [HL-80544]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080544] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Heart, Lung, and Blood Institute (Grant number HL-80544 to Joseph Francis). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal D, 2011, BASIC RES CARDIOL, V106, P1069, DOI 10.1007/s00395-011-0231-7; Agarwal D, 2012, ANTIOXID REDOX SIGN, V16, P139, DOI 10.1089/ars.2011.3967; Agarwal D, 2009, HYPERTENSION, V54, P1393, DOI 10.1161/HYPERTENSIONAHA.109.135459; Ahmed Nazir, 2008, J Ayub Med Coll Abbottabad, V20, P66; Allen AM, 2000, AM J HYPERTENS, V13, p31S, DOI 10.1016/S0895-7061(99)00249-6; Badoer E, 2010, AM J PHYSIOL-RENAL, V298, pF839, DOI 10.1152/ajprenal.00734.2009; Bai Y, 2009, AM J NEPHROL, V29, DOI 10.1159/000178817; Bocalini DS, 2010, EUR J APPL PHYSIOL, V109, P909, DOI 10.1007/s00421-010-1406-x; Boissiere J, 2008, J APPL PHYSIOL, V104, P321, DOI 10.1152/japplphysiol.00442.2007; Campos RR, 2009, HYPERTENS RES, V32, P1047, DOI 10.1038/hr.2009.180; Cardinale JP, 2012, HYPERTENSION, V59, P113, DOI 10.1161/HYPERTENSIONAHA.111.182154; Chicco AJ, 2008, HYPERTENSION, V51, P1096, DOI 10.1161/HYPERTENSIONAHA.107.107078; Coote JH, 2005, EXP PHYSIOL, V90, P169, DOI 10.1113/expphysiol.2004.029041; Dorffel Y, 1999, HYPERTENSION, V34, P113, DOI 10.1161/01.HYP.34.1.113; Fujita M, 2007, HYPERTENSION, V50, P360, DOI 10.1161/HYPERTENSIONAHA.107.091009; Gao L, 2005, CIRCULATION, V112, P1763, DOI 10.1161/CIRCULATIONAHA.105.552174; Graham DA, 2004, J APPL PHYSIOL, V96, P2088, DOI 10.1152/japplphysiol.01252.2003; Jennings JR, 2009, NEUROIMAGE, V47, P914, DOI 10.1016/j.neuroimage.2009.04.072; Kang YM, 2009, CARDIOVASC RES, V82, P503, DOI 10.1093/cvr/cvp073; Kannan H, 1996, AM J PHYSIOL-REG I, V270, pR479, DOI 10.1152/ajpregu.1996.270.2.R479; Kar S, 2010, J APPL PHYSIOL, V108, P923, DOI 10.1152/japplphysiol.00840.2009; KIMURA T, 1993, ANN NY ACAD SCI, V689, P330, DOI 10.1111/j.1749-6632.1993.tb55558.x; Kobayashi Seiichi, 2002, J Atheroscler Thromb, V9, P184; Kohno H, 2002, JPN HEART J, V43, P25, DOI 10.1536/jhj.43.25; Kump DS, 2005, J PHYSIOL-LONDON, V562, P829, DOI 10.1113/jphysiol.2004.073593; Law M, 2003, Health Technol Assess, V7, P1; Lehnen AM, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-67; Lu Y, 2009, NEUROL RES, V31, P420, DOI 10.1179/174313208X353677; Mayorov DN, 2004, HYPERTENSION, V44, P101, DOI 10.1161/01.HYP.0000131290.12255.04; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Mostarda C, 2009, AUTON NEUROSCI-BASIC, V145, P11, DOI 10.1016/j.autneu.2008.10.010; Murdoch CE, 2011, BASIC RES CARDIOL, V106, P527, DOI 10.1007/s00395-011-0179-7; Murray PJ, 2005, P NATL ACAD SCI USA, V102, P8686, DOI 10.1073/pnas.0500419102; NEUFER PD, 1992, CAN J PHYSIOL PHARM, V70, P1286, DOI 10.1139/y92-178; Nomoto T, 2009, GENE THER, V16, P383, DOI 10.1038/gt.2008.151; Nonaka-Sarukawa M, 2008, J GENE MED, V10, P368, DOI 10.1002/jgm.1166; PAVLIK G, 1985, ACTA PHYSIOL HUNG, V66, P27; Peeters ACTM, 2001, EUR J CLIN INVEST, V31, P31, DOI 10.1046/j.1365-2362.2001.00743.x; Pellett AA, 2004, ECHOCARDIOGR-J CARD, V21, P669, DOI 10.1111/j.0742-2822.2004.04052.x; Qi J, 2012, CARDIOVASC TOXICOL; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Shi P, 2010, CLIN EXP PHARMACOL P, V37, pE52, DOI 10.1111/j.1440-1681.2009.05234.x; Sirker A, 2011, BASIC RES CARDIOL, V106, P735, DOI 10.1007/s00395-011-0190-z; Sriramula S, 2011, CARDIOVASC RES, V92, P401, DOI 10.1093/cvr/cvr242; Sun CW, 2005, CIRC RES, V96, P659, DOI 10.1161/01.RES.0000161257.02571.4b; Sun MW, 2008, HYPERTENS RES, V31, P543, DOI 10.1291/hypres.31.543; Vaziri ND, 2003, KIDNEY INT, V63, P186, DOI 10.1046/j.1523-1755.2003.00711.x; Veras-Silva AS, 1997, AM J PHYSIOL-HEART C, V273, pH2627, DOI 10.1152/ajpheart.1997.273.6.H2627; Xia HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022682; Zimmerman MC, 2004, CIRC RES, V95, P210, DOI 10.1161/01.RES.0000135483.12297.e4; Zimmerman MC, 2002, CIRC RES, V91, P1038, DOI 10.1161/01.RES.0000043501.47934.FA	51	25	25	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52569	10.1371/journal.pone.0052569	http://dx.doi.org/10.1371/journal.pone.0052569			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285093	Green Published, gold, Green Submitted			2022-12-27	WOS:000312794500199
J	Oshima, K; Sugimoto, Y; Irving, TC; Wakabayashi, K				Oshima, Kanji; Sugimoto, Yasunobu; Irving, Thomas C.; Wakabayashi, Katsuzo			Head-Head Interactions of Resting Myosin Crossbridges in Intact Frog Skeletal Muscles, Revealed by Synchrotron X-Ray Fiber Diffraction	PLOS ONE			English	Article							BINDING-PROTEIN-C; FISH MUSCLE; A-BAND; 3-DIMENSIONAL STRUCTURE; 3D STRUCTURE; MYBP-C; VERTEBRATE MUSCLE; STRIATED-MUSCLE; FINE-STRUCTURE; ATP TURNOVER	The intensities of the myosin-based layer lines in the x-ray diffraction patterns from live resting frog skeletal muscles with full thick-thin filament overlap from which partial lattice sampling effects had been removed were analyzed to elucidate the configurations of myosin crossbridges around the thick filament backbone to nanometer resolution. The repeat of myosin binding protein C (C-protein) molecules on the thick filaments was determined to be 45.33 nm, slightly longer than that of myosin crossbridges. With the inclusion of structural information for C-proteins and a pre-powerstroke head shape, modeling in terms of a mixed population of regular and perturbed regions of myosin crown repeats along the filament revealed that the myosin filament had azimuthal perturbations of crossbridges in addition to axial perturbations in the perturbed region, producing pseudo-six-fold rotational symmetry in the structure projected down the filament axis. Myosin crossbridges had a different organization about the filament axis in each of the regular and perturbed regions. In the regular region that lacks C-proteins, there were inter-molecular interactions between the myosin heads in axially adjacent crown levels. In the perturbed region that contains C-proteins, in addition to inter-molecular interactions between the myosin heads in the closest adjacent crown levels, there were also intra-molecular interactions between the paired heads on the same crown level. Common features of the interactions in both regions were interactions between a portion of the 50-kDa-domain and part of the converter domain of the myosin heads, similar to those found in the phosphorylation-regulated invertebrate myosin. These interactions are primarily electrostatic and the converter domain is responsible for the head-head interactions. Thus multiple head-head interactions of myosin crossbridges also characterize the switched-off state and have an important role in the regulation or other functions of myosin in thin filament-regulated muscles as well as in the thick filament-regulated muscles.	[Sugimoto, Yasunobu; Wakabayashi, Katsuzo] Osaka Univ, Grad Sch Engn Sci, Div Biophys Engn, Toyonaka, Osaka 560, Japan; [Oshima, Kanji] Osaka Univ, Inst Prot Res, Suita, Osaka 565, Japan; [Irving, Thomas C.] IIT, Dept Biol & Chem Sci, Chicago, IL 60616 USA	Osaka University; Osaka University; Illinois Institute of Technology	Wakabayashi, K (corresponding author), Osaka Univ, Grad Sch Engn Sci, Div Biophys Engn, Toyonaka, Osaka 560, Japan.	waka@bpe.es.osaka-u.ac.jp			Special Coordination Funds from the Ministry of Education, Science, Sports and Culture of Japan; National Center for Research Resource from the National Institute of Health [2P41RR008630-17]; National Institute of General Medical Sciences from the National Institute of Health [9P41GM103622-17]; U.S. DOE [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR008630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103622] Funding Source: NIH RePORTER	Special Coordination Funds from the Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Center for Research Resource from the National Institute of Health; National Institute of General Medical Sciences from the National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. DOE(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the Special Coordination Funds from the Ministry of Education, Science, Sports and Culture of Japan. This project was also supported by grants from the National Center for Research Resource (2P41RR008630-17) and the National Institute of General Medical Sciences (9P41GM103622-17) from the National Institute of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Drs Y. Takezawa, T. Kobayashi, H. Tanaka and D. B. Gore for their kind help with physiological and x-ray experiments at the Photon Factory and the Advanced Photon Source, Dr T. Arata for invaluable discussions and Prof H. Nakamura for stimulating suggestions and support. This work was approved by the Photon Factory Advisory Committee. Use of the Advanced Photon Source was supported by the U.S. DOE under Contract No. DE-AC02-06CH11357.	Al-Khayat HA, 2004, J MUSCLE RES CELL M, V25, P635, DOI 10.1007/s10974-004-5333-5; AL-Khayat HA, 2003, BIOPHYS J, V85, P1063, DOI 10.1016/S0006-3495(03)74545-7; Al-Khayat HA, 2008, J STRUCT BIOL, V163, P117, DOI 10.1016/j.jsb.2008.03.011; Al-Khayat HA, 2006, J STRUCT BIOL, V155, P202, DOI 10.1016/j.jsb.2006.01.014; Al-Khayat HA, 2006, J STRUCT BIOL, V155, P218, DOI 10.1016/j.jsb.2006.03.029; Al-Khayat HA, 2009, J STRUCT BIOL, V166, P183, DOI 10.1016/j.jsb.2009.02.006; Alamo L, 2008, J MOL BIOL, V384, P780, DOI 10.1016/j.jmb.2008.10.013; AMEMIYA Y, 1987, SCIENCE, V237, P164, DOI 10.1126/science.3496662; Amemiya Y., 1998, PHOTON FACTORY NEWS, V16, P9; BAGSHAW CR, 1974, BIOCHEM J, V141, P331, DOI 10.1042/bj1410331; Craig R, 2006, CURR OPIN STRUC BIOL, V16, P204, DOI 10.1016/j.sbi.2006.03.006; CRAIG R, 1977, J MOL BIOL, V109, P69, DOI 10.1016/S0022-2836(77)80046-6; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; Fischetti R, 2004, J SYNCHROTRON RADIAT, V11, P399, DOI 10.1107/S0909049504016760; Fujiwara S, 2009, J STRUCT BIOL, V167, P25, DOI 10.1016/j.jsb.2009.03.018; Fukunishi Y, 2003, J PHYS CHEM B, V107, P13201, DOI 10.1021/jp035478e; HARFORD J, 1994, J MOL BIOL, V239, P500, DOI 10.1006/jmbi.1994.1391; Haselgrove J C, 1980, J Muscle Res Cell Motil, V1, P177, DOI 10.1007/BF00711798; Higo J, 2001, J COMPUT CHEM, V22, P1983, DOI 10.1002/jcc.1147; Hudson L, 1997, J MOL BIOL, V273, P440, DOI 10.1006/jmbi.1997.1321; HUXLEY HE, 1982, J MOL BIOL, V158, P637, DOI 10.1016/0022-2836(82)90253-4; IRVING TC, 1989, J MUSCLE RES CELL M, V10, P385, DOI 10.1007/BF01758435; Juanhuix J, 2001, BIOPHYS J, V80, P1429, DOI 10.1016/S0006-3495(01)76115-2; Jung HS, 2008, MOL BIOL CELL, V19, P3234, DOI 10.1091/mbc.E08-02-0206; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Luther PK, 1996, J MORPHOL, V229, P325, DOI 10.1002/(SICI)1097-4687(199609)229:3<325::AID-JMOR7>3.0.CO;2-X; LUTHER PK, 1980, J MOL BIOL, V141, P409, DOI 10.1016/0022-2836(80)90254-5; Luther PK, 2008, J MOL BIOL, V384, P60, DOI 10.1016/j.jmb.2008.09.013; Luther PK, 2011, P NATL ACAD SCI USA, V108, P11423, DOI 10.1073/pnas.1103216108; MALINCHIK SB, 1992, J MUSCLE RES CELL M, V13, P406, DOI 10.1007/BF01738036; Matsuo Tatsuhito, 2010, Biophysics (Nagoya-shi), V6, P13, DOI 10.2142/biophysics.6.13; Naber N, 2011, J MOL BIOL, V411, P943, DOI 10.1016/j.jmb.2011.06.051; NAMBA K, 1980, J MOL BIOL, V138, P1, DOI 10.1016/S0022-2836(80)80002-7; Oshima K, 2007, J MOL BIOL, V367, P275, DOI 10.1016/j.jmb.2006.12.036; Oshima K, 2011, J APPL CRYSTALLOGR, V44, P398, DOI 10.1107/S0021889811006455; Phillips WC, 2002, J SYNCHROTRON RADIAT, V9, P36; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; ROME E, 1973, NATURE-NEW BIOL, V244, P152, DOI 10.1038/newbio244152a0; Rotkiewicz P, 2008, J COMPUT CHEM, V29, P1460, DOI 10.1002/jcc.20906; SJOSTROM M, 1977, J MOL BIOL, V109, P49, DOI 10.1016/S0022-2836(77)80045-4; Squire JM, 2005, ADV PROTEIN CHEM, V71, P17, DOI 10.1016/S0065-3233(04)71002-5; Squire JM, 2004, J MOL BIOL, V343, P1345, DOI 10.1016/j.jmb.2004.08.084; Squire JM, 2003, J MOL BIOL, V331, P713, DOI 10.1016/S0022-2836(03)00781-2; SQUIRE JM, 1982, J MOL BIOL, V155, P467, DOI 10.1016/0022-2836(82)90482-X; Squire JM, 1981, STRUCTURAL BASIS MUS, P330; Standley DM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-116; Stewart MA, 2010, P NATL ACAD SCI USA, V107, P430, DOI 10.1073/pnas.0909468107; SUGIMOTO Y, 1995, BIOPHYS J, V68, pS29; Swank DM, 2002, NAT CELL BIOL, V4, P312, DOI 10.1038/ncb776; WAKABAYASHI K, 1994, BIOPHYS J, V67, P2422, DOI 10.1016/S0006-3495(94)80729-5; WAKABAYASHI K, 1991, HDB SYNCHROTRON RAD, V4, P597; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Wendt T, 2001, P NATL ACAD SCI USA, V98, P4361, DOI 10.1073/pnas.071051098; Woodhead JL, 2005, NATURE, V436, P1195, DOI 10.1038/nature03920; YU LC, 1989, BIOPHYS J, V55, P433, DOI 10.1016/S0006-3495(89)82837-1; Zhao FQ, 2008, BIOPHYS J, V95, P3322, DOI 10.1529/biophysj.108.137067; Zhao FQ, 2009, J MOL BIOL, V385, P423, DOI 10.1016/j.jmb.2008.10.038; Zoghbi ME, 2008, P NATL ACAD SCI USA, V105, P2386, DOI 10.1073/pnas.0708912105	60	8	8	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52421	10.1371/journal.pone.0052421	http://dx.doi.org/10.1371/journal.pone.0052421			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285033	Green Submitted, Green Published, gold			2022-12-27	WOS:000312794500161
J	Thomson, SR; Nahon, JE; Mutsaers, CA; Thomson, D; Hamilton, G; Parson, SH; Gillingwater, TH				Thomson, Sophie R.; Nahon, Joya E.; Mutsaers, Chantal A.; Thomson, Derek; Hamilton, Gillian; Parson, Simon H.; Gillingwater, Thomas H.			Morphological Characteristics of Motor Neurons Do Not Determine Their Relative Susceptibility to Degeneration in a Mouse Model of Severe Spinal Muscular Atrophy	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; PLURIPOTENT STEM-CELLS; SELECTIVE VULNERABILITY; SKELETAL-MUSCLE; NEUROMUSCULAR-JUNCTIONS; SYNAPSE ELIMINATION; IN-VIVO; MICE; PATHOLOGY; GENE	Spinal muscular atrophy (SMA) is a leading genetic cause of infant mortality, resulting primarily from the degeneration and loss of lower motor neurons. Studies using mouse models of SMA have revealed widespread heterogeneity in the susceptibility of individual motor neurons to neurodegeneration, but the underlying reasons remain unclear. Data from related motor neuron diseases, such as amyotrophic lateral sclerosis (ALS), suggest that morphological properties of motor neurons may regulate susceptibility: in ALS larger motor units innervating fast-twitch muscles degenerate first. We therefore set out to determine whether intrinsic morphological characteristics of motor neurons influenced their relative vulnerability to SMA. Motor neuron vulnerability was mapped across 10 muscle groups in SMA mice. Neither the position of the muscle in the body, nor the fibre type of the muscle innervated, influenced susceptibility. Morphological properties of vulnerable and disease-resistant motor neurons were then determined from single motor units reconstructed in Thy. 1-YFP-H mice. None of the parameters we investigated in healthy young adult mice - including motor unit size, motor unit arbor length, branching patterns, motor endplate size, developmental pruning and numbers of terminal Schwann cells at neuromuscular junctions - correlated with vulnerability. We conclude that morphological characteristics of motor neurons are not a major determinant of disease-susceptibility in SMA, in stark contrast to related forms of motor neuron disease such as ALS. This suggests that subtle molecular differences between motor neurons, or extrinsic factors arising from other cell types, are more likely to determine relative susceptibility in SMA.	[Thomson, Sophie R.; Nahon, Joya E.; Mutsaers, Chantal A.; Thomson, Derek; Hamilton, Gillian; Parson, Simon H.; Gillingwater, Thomas H.] Univ Edinburgh, Euan MacDonald Ctr Motor Neurone Dis Res, Edinburgh, Midlothian, Scotland; [Thomson, Sophie R.; Nahon, Joya E.; Mutsaers, Chantal A.; Hamilton, Gillian; Parson, Simon H.; Gillingwater, Thomas H.] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Gillingwater, TH (corresponding author), Univ Edinburgh, Euan MacDonald Ctr Motor Neurone Dis Res, Edinburgh, Midlothian, Scotland.	T.Gillingwater@ed.ac.uk	Hunter, Gillian/A-1952-2015	Gillingwater, Thomas/0000-0002-0306-5577; Parson, Simon/0000-0002-8848-8738	Wellcome Trust; SMA Trust; Muscular Dystrophy Campaign; Motor Neuron Disease Scotland; Euan MacDonald Centre for Motor Neuron Disease	Wellcome Trust(Wellcome TrustEuropean Commission); SMA Trust; Muscular Dystrophy Campaign(Muscular Dystrophy AssociationEuropean Commission); Motor Neuron Disease Scotland; Euan MacDonald Centre for Motor Neuron Disease	This work was funded by grants from the Wellcome Trust, SMA Trust, the Muscular Dystrophy Campaign, Motor Neuron Disease Scotland, and the Euan MacDonald Centre for Motor Neuron Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGAUTPETIT D, 1987, NEUROSCI LETT, V82, P83, DOI 10.1016/0304-3940(87)90175-3; BRADLEY WG, 1983, ANN NEUROL, V14, P267, DOI 10.1002/ana.410140304; BROWN MC, 1976, J PHYSIOL-LONDON, V261, P387, DOI 10.1113/jphysiol.1976.sp011565; Cifuentes-Diaz C, 2002, HUM MOL GENET, V11, P1439, DOI 10.1093/hmg/11.12.1439; DENGLER R, 1990, MUSCLE NERVE, V13, P545, DOI 10.1002/mus.880130612; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Feng Z, 2008, ANN NY ACAD SCI, V1132, P19, DOI 10.1196/annals.1405.016; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Gillingwater TH, 2003, J NEUROCYTOL, V32, P863, DOI 10.1023/B:NEUR.0000020629.51673.f5; Hegedus J, 2007, NEUROBIOL DIS, V28, P154, DOI 10.1016/j.nbd.2007.07.003; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Kariya S, 2008, HUM MOL GENET, V17, P2552, DOI 10.1093/hmg/ddn156; Kariya S, 2012, HUM MOL GENET, V21, P3421, DOI 10.1093/hmg/dds174; Kong LL, 2009, J NEUROSCI, V29, P842, DOI 10.1523/JNEUROSCI.4434-08.2009; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Ling KKY, 2012, HUM MOL GENET, V21, P185, DOI 10.1093/hmg/ddr453; Ling KKY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015457; Lionikas A, 2005, PHYSIOL GENOMICS, V21, P184, DOI 10.1152/physiolgenomics.00209.2004; Lobsiger CS, 2009, P NATL ACAD SCI USA, V106, P4465, DOI 10.1073/pnas.0813339106; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Lunn MR, 2008, LANCET, V371, P2120, DOI 10.1016/S0140-6736(08)60921-6; McCann CM, 2007, J NEUROSCI, V27, P6064, DOI 10.1523/JNEUROSCI.0627-07.2007; Mentis GZ, 2011, NEURON, V69, P453, DOI 10.1016/j.neuron.2010.12.032; Monani UR, 2000, HUM MOL GENET, V9, P333, DOI 10.1093/hmg/9.3.333; Murray LM, 2010, NEUROMUSCULAR DISORD, V20, P740, DOI 10.1016/j.nmd.2010.06.013; Murray LM, 2008, HUM MOL GENET, V17, P949, DOI 10.1093/hmg/ddm367; Murray LM, 2010, HUM MOL GENET, V19, P420, DOI 10.1093/hmg/ddp506; Mutsaers CA, 2011, HUM MOL GENET, V20, P4334, DOI 10.1093/hmg/ddr360; PEARN J, 1978, J MED GENET, V15, P409, DOI 10.1136/jmg.15.6.409; Pun S, 2006, NAT NEUROSCI, V9, P408, DOI 10.1038/nn1653; Ruggiu M, 2012, MOL CELL BIOL, V32, P126, DOI 10.1128/MCB.06077-11; Saxena S, 2009, NAT NEUROSCI, V12, P627, DOI 10.1038/nn.2297; Sleigh JN, 2011, DIS MODEL MECH, V4, P457, DOI 10.1242/dmm.007245; Talbot K, 2001, SEMIN NEUROL, V21, P189, DOI 10.1055/s-2001-15264; Thomson SR, 2012, J ANAT, V220, P122, DOI 10.1111/j.1469-7580.2011.01459.x; Turner BJ, 2009, NEUROBIOL DIS, V34, P511, DOI 10.1016/j.nbd.2009.03.005; Valdez G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034640; Vrbova G, 2012, NEUROMUSCULAR DISORD, V22, P381, DOI 10.1016/j.nmd.2011.12.002; Wirth B, 1999, AM J HUM GENET, V64, P1340, DOI 10.1086/302369; Yamazaki T, 2012, CELL REP, V2, P799, DOI 10.1016/j.celrep.2012.08.025	41	33	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52605	10.1371/journal.pone.0052605	http://dx.doi.org/10.1371/journal.pone.0052605			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285108	Green Published, gold, Green Submitted			2022-12-27	WOS:000312794500208
J	Winter, C; Payet, JP; Suttle, CA				Winter, Christian; Payet, Jerome P.; Suttle, Curtis A.			Modeling the Winter-to-Summer Transition of Prokaryotic and Viral Abundance in the Arctic Ocean	PLOS ONE			English	Article							ARTIFICIAL NEURAL-NETWORKS; NUCLEIC-ACID CONTENT; NATURAL PLANKTONIC BACTERIA; FLOW-CYTOMETRY; BEAUFORT SEA; AQUATIC SYSTEMS; CANADIAN SHELF; ALGAL BLOOM; VIRUSES; BACTERIOPLANKTON	One of the challenges in oceanography is to understand the influence of environmental factors on the abundances of prokaryotes and viruses. Generally, conventional statistical methods resolve trends well, but more complex relationships are difficult to explore. In such cases, Artificial Neural Networks (ANNs) offer an alternative way for data analysis. Here, we developed ANN-based models of prokaryotic and viral abundances in the Arctic Ocean. The models were used to identify the best predictors for prokaryotic and viral abundances including cytometrically-distinguishable populations of prokaryotes (high and low nucleic acid cells) and viruses (high-and low-fluorescent viruses) among salinity, temperature, depth, day length, and the concentration of Chlorophyll-a. The best performing ANNs to model the abundances of high and low nucleic acid cells used temperature and Chl-a as input parameters, while the abundances of high-and low-fluorescent viruses used depth, Chl-a, and day length as input parameters. Decreasing viral abundance with increasing depth and decreasing system productivity was captured well by the ANNs. Despite identifying the same predictors for the two populations of prokaryotes and viruses, respectively, the structure of the best performing ANNs differed between high and low nucleic acid cells and between high-and low-fluorescent viruses. Also, the two prokaryotic and viral groups responded differently to changes in the predictor parameters; hence, the cytometric distinction between these populations is ecologically relevant. The models imply that temperature is the main factor explaining most of the variation in the abundances of high nucleic acid cells and total prokaryotes and that the mechanisms governing the reaction to changes in the environment are distinctly different among the prokaryotic and viral populations. Citation: Winter C, Payet JP, Suttle CA (2012) Modeling the Winter-to-Summer Transition of Prokaryotic and Viral Abundance in the Arctic Ocean. PLoS ONE 7(12): e52794. doi:10.1371/journal.pone.0052794	[Winter, Christian] Univ Vienna, Dept Marine Biol, Vienna, Austria; [Payet, Jerome P.] Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA; [Suttle, Curtis A.] Univ British Columbia, Dept Earth Ocean & Atmospher Sci, Vancouver, BC V5Z 1M9, Canada; [Suttle, Curtis A.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada; [Suttle, Curtis A.] Univ British Columbia, Dept Bot, Vancouver, BC, Canada; [Suttle, Curtis A.] Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V5Z 1M9, Canada	University of Vienna; Oregon State University; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Winter, C (corresponding author), Univ Vienna, Dept Marine Biol, Vienna, Austria.	christian.winter@univie.ac.at	suttle, c/N-1144-2019; Suttle, Curtis A/C-3150-2008	suttle, c/0000-0002-0372-0033; Suttle, Curtis A/0000-0002-0372-0033; Winter, Christian/0000-0001-6327-0209	NSERC through the Canadian Arctic Shelf Exchange Study (CASES); Discovery Grant; TULA foundation; University of Vienna	NSERC through the Canadian Arctic Shelf Exchange Study (CASES); Discovery Grant; TULA foundation; University of Vienna	Field sampling was funded by NSERC through the Canadian Arctic Shelf Exchange Study (CASES) and a Discovery Grant to C. A. Suttle. C. Winter was financially supported by a grant to the Centre for Microbial Diversity and Evolution (CMDE) at the University of British Columbia from the TULA foundation. Additional financial support was provided by the University of Vienna. The funders had no role in study design, data collection and analysis, decision to publish, or presentation of the manuscript.	Basheer IA, 2000, J MICROBIOL METH, V43, P3, DOI 10.1016/S0167-7012(00)00201-3; Baudoux AC, 2007, LIMNOL OCEANOGR, V52, P2519, DOI 10.4319/lo.2007.52.6.2519; Belgrano A, 2001, J PLANKTON RES, V23, P651, DOI 10.1093/plankt/23.6.651; Bouvier T, 2007, ENVIRON MICROBIOL, V9, P287, DOI 10.1111/j.1462-2920.2006.01137.x; Brussaard CPD, 2004, APPL ENVIRON MICROB, V70, P1506, DOI 10.1128/AEM.70.3.1506-1513.2004; Brussaard CPD, 2000, J VIROL METHODS, V85, P175, DOI 10.1016/S0166-0934(99)00167-6; Carmack EC, 2002, ARCTIC, V55, P29; Carmack EC, 2004, MAR ECOL PROG SER, V277, P37, DOI 10.3354/meps277037; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; Gasol JM, 1999, APPL ENVIRON MICROB, V65, P4475; Gasol JM, 2000, SCI MAR, V64, P197, DOI 10.3989/scimar.2000.64n2197; HAYKIN S, 1999, NEURAL NETWORKS; Hodges LR, 2005, AQUAT MICROB ECOL, V40, P217, DOI 10.3354/ame040217; Jochem FJ, 2004, MAR BIOL, V145, P1213, DOI 10.1007/s00227-004-1406-7; Kirchman DL, 2009, NAT REV MICROBIOL, V7, P451, DOI 10.1038/nrmicro2115; Lebaron P, 2001, APPL ENVIRON MICROB, V67, P1775, DOI 10.1128/AEM.67.4.1775-1782.2001; Lebaron P, 2002, AQUAT MICROB ECOL, V28, P131, DOI 10.3354/ame028131; Li WKW, 2009, SCIENCE, V326, P539, DOI 10.1126/science.1179798; Li WKW, 2001, CYTOMETRY, V44, P236, DOI 10.1002/1097-0320(20010701)44:3<236::AID-CYTO1116>3.0.CO;2-5; Longnecker K, 2005, APPL ENVIRON MICROB, V71, P7737, DOI 10.1128/AEM.71.12.7737-7749.2005; MARANGER R, 1994, MAR ECOL PROG SER, V111, P121, DOI 10.3354/meps111121; Marie D, 1996, APPL ENVIRON MICROB, V62, P1649, DOI 10.1128/AEM.62.5.1649-1655.1996; Marie D, 1999, CURRENT PROTOCOLS CY; Marquardt D., 1963, INT J COMPUT VISION, V11, P431, DOI DOI 10.1137/0111030; Middelboe M, 2002, DEEP-SEA RES PT II, V49, P5063, DOI 10.1016/S0967-0645(02)00178-9; MURRAY AG, 1992, MAR ECOL PROG SER, V89, P103, DOI 10.3354/meps089103; Payet J. P., 2010, MAN AQUAT VIRAL ECOL, P102, DOI [10.4319/mave.2010.978-0-9845591-0-7.102, DOI 10.4319/MAVE.2010.978-0-9845591-0-7.102]; Payet JP, 2008, J MARINE SYST, V74, P933, DOI 10.1016/j.jmarsys.2007.11.002; Peterson BJ, 2006, SCIENCE, V313, P1061, DOI 10.1126/science.1122593; Rodriguez-Valera F, 2009, NAT REV MICROBIOL, V7, P828, DOI 10.1038/nrmicro2235; Scardi M, 1996, MAR ECOL PROG SER, V139, P289, DOI 10.3354/meps139289; Scharek R, 2007, AQUAT MICROB ECOL, V46, P153, DOI 10.3354/ame046153; Shimada K, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025624; Smetacek V, 2005, NATURE, V437, P362, DOI 10.1038/nature04161; Steele M, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031651; Stein R., 2004, ORGANIC CARBON CYCLE; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; Thingstad TF, 2000, LIMNOL OCEANOGR, V45, P1320, DOI 10.4319/lo.2000.45.6.1320; Vila-Costa M, 2012, ENVIRON MICROBIOL, V14, P1390, DOI 10.1111/j.1462-2920.2012.02720.x; Wang YY, 2009, ISME J, V3, P889, DOI 10.1038/ismej.2009.46; Weinbauer MG, 2004, FEMS MICROBIOL REV, V28, P127, DOI 10.1016/j.femsre.2003.08.001; Wells LE, 2006, AQUAT MICROB ECOL, V43, P209, DOI 10.3354/ame043209; Wilhelm SW, 1999, BIOSCIENCE, V49, P781, DOI 10.2307/1313569; Winter C, 2005, ENVIRON MICROBIOL, V7, P881, DOI 10.1111/j.1462-2920.2005.00768.x; Winter C, 2010, MICROBIOL MOL BIOL R, V74, P42, DOI 10.1128/MMBR.00034-09; Winter C, 2009, DEEP-SEA RES PT I, V56, P1972, DOI 10.1016/j.dsr.2009.07.003; Woodd-Walker RS, 2001, J PLANKTON RES, V23, P875, DOI 10.1093/plankt/23.8.875; Yager PL, 2001, LIMNOL OCEANOGR, V46, P790, DOI 10.4319/lo.2001.46.4.0790; Yamamoto-Kawai M, 2006, NATURE, V443, P43, DOI 10.1038/443043a; Zubkov MV, 2001, APPL ENVIRON MICROB, V67, P5210, DOI 10.1128/AEM.67.11.5210-5218.2001	50	9	9	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52794	10.1371/journal.pone.0052794	http://dx.doi.org/10.1371/journal.pone.0052794			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285186	Green Published, Green Submitted, gold			2022-12-27	WOS:000312794500246
J	Son, DS; Kabir, SM; Dong, YL; Lee, E; Adunyah, SE				Son, Deok-Soo; Kabir, Syder M.; Dong, Yuan-Lin; Lee, Eunsook; Adunyah, Samuel E.			Inhibitory Effect of Tumor Suppressor p53 on Proinflammatory Chemokine Expression in Ovarian Cancer Cells by Reducing Proteasomal Degradation of I kappa B	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; WILD-TYPE P53; EPITHELIAL CANCER; ASCITIC FLUID; CROSS-TALK; ALPHA; GROWTH; ACTIVATION; RESISTANCE; PHOSPHORYLATION	Ovarian cancer, one of inflammation-associated cancers, is the fifth leading cause of cancer deaths among women. Inflammation in the tumor microenvironment is associated with peritoneal tumor dissemination and massive ascites, which contribute to high mortality in ovarian cancer. Tumor suppressor p53 is frequently deleted or mutated in aggressive and high-grade ovarian cancer, probably aggravating cancer progression and increasing mortality. We therefore investigated the influence of p53 on proinflammatory chemokines in ovarian cancer cells. A PCR array of the chemokine network revealed that ovarian cancer cells with low or mutated p53 expression expressed high levels of proinflammatory chemokines such as CXCL1, 2, 3 and 8. Transient transfection of p53 into p53-null ovarian cancer cells downregulated proinflammatory chemokines induced by tumor necrosis factor-alpha (TNF), a proinflammatory cytokine abundantly expressed in ovarian cancer. Furthermore, p53 restoration or stabilization blocked TNF-induced NF-kappa B promoter activity and reduced TNF-activated I kappa B. Restoration of p53 increased ubiquitination of I kappa B, resulting from concurrently reduced proteasome activity followed by stability of I kappa B. A ubiquitination PCR array on restoration of p53 did not reveal any significant change in expression except for Mdm2, indicating that the balance between p53 and Mdm2 is more important in regulating NF-kappa B signaling rather than the direct effect of p53 on ubiquitin-related genes or I kappa B kinases. In addition, nutlin-3, a specific inducer of p53 stabilization, inhibited proinflammatory chemokines by reducing TNF-activated I kappa B through p53 stabilization. Taken together, these results suggest that p53 inhibits proinflammatory chemokines in ovarian cancer cells by reducing proteasomal degradation of I kappa B. Thus, frequent loss or mutation of p53 may promote tumor progression by enhancing inflammation in the tumor microenvironment.	[Son, Deok-Soo; Kabir, Syder M.; Dong, Yuan-Lin; Adunyah, Samuel E.] Meharry Med Coll, Dept Biochem & Canc Biol, Nashville, TN 37208 USA; [Lee, Eunsook] Meharry Med Coll, Dept Physiol, Nashville, TN 37208 USA	Meharry Medical College; Meharry Medical College	Son, DS (corresponding author), Meharry Med Coll, Dept Biochem & Canc Biol, Nashville, TN 37208 USA.	dson@mmc.edu			National Institutes of Health NIAID [SC1AI089073]; NIGMS [SC1 089630]; NCI [U54CA163069-02]; NIMHD from the National Institutes of Health [U54MD007593-04]; NATIONAL CANCER INSTITUTE [U54CA163069] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR026140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [SC1AI089073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC1GM089630] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD007593] Funding Source: NIH RePORTER	National Institutes of Health NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIMHD from the National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by National Institutes of Health NIAID SC1AI089073 (DS), NIGMS SC1 089630 (EL), NCI U54CA163069-02 and NIMHD U54MD007593-04 (SA) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohuslav J, 2004, J BIOL CHEM, V279, P26115, DOI 10.1074/jbc.M313509200; Chobanian N, 2008, SURG CLIN N AM, V88, P285, DOI 10.1016/j.suc.2007.12.002; Dreyfus DH, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-12; Duan ZF, 1999, CLIN CANCER RES, V5, P3445; Endo S, 2011, CANCER SCI, V102, P605, DOI 10.1111/j.1349-7006.2010.01821.x; Fleming JS, 2006, MOL CELL ENDOCRINOL, V247, P4, DOI 10.1016/j.mce.2005.09.014; Gu LB, 2004, J BIOL CHEM, V279, P52141, DOI 10.1074/jbc.M407915200; Gu LB, 2002, BLOOD, V99, P3367, DOI 10.1182/blood.V99.9.3367; Huang WC, 2007, MOL CELL, V26, P75, DOI 10.1016/j.molcel.2007.02.019; Hwang IY, 2010, CANCER LETT, V294, P82, DOI 10.1016/j.canlet.2010.01.025; Ikeda A, 2000, BIOCHEM BIOPH RES CO, V272, P375, DOI 10.1006/bbrc.2000.2786; Ivarsson K, 1998, GYNECOL ONCOL, V71, P420, DOI 10.1006/gyno.1998.5198; Ivarsson K, 2000, ACTA OBSTET GYN SCAN, V79, P777, DOI 10.1034/j.1600-0412.2000.079009777.x; Jin X, 2002, ANTICANCER RES, V22, P659; Kagami S, 2006, EXP DERMATOL, V15, P95, DOI 10.1111/j.1600-0625.2005.00390.x; Kawauchi K, 2008, BIOCHEM BIOPH RES CO, V372, P137, DOI 10.1016/j.bbrc.2008.05.021; Kawauchi K, 2009, P NATL ACAD SCI USA, V106, P3431, DOI 10.1073/pnas.0813210106; Khabele D, 2007, CANCER BIOL THER, V6, P795, DOI 10.4161/cbt.6.5.4007; Landen CN, 2008, J CLIN ONCOL, V26, P995, DOI 10.1200/JCO.2006.07.9970; Lee Z, 2006, CANCER RES, V66, P2740, DOI 10.1158/0008-5472.CAN-05-2947; Liu G, 2009, J IMMUNOL, V182, P5063, DOI 10.4049/jimmunol.0803526; Marine JC, 2010, CELL DEATH DIFFER, V17, P93, DOI 10.1038/cdd.2009.68; MORADI MM, 1993, CANCER, V72, P2433, DOI 10.1002/1097-0142(19931015)72:8<2433::AID-CNCR2820720822>3.0.CO;2-L; Ness RB, 1999, JNCI-J NATL CANCER I, V91, P1459, DOI 10.1093/jnci/91.17.1459; Ogawa H, 2004, AM J PHYSIOL-GASTR L, V287, pG1062, DOI 10.1152/ajpgi.00162.2004; Rasmussen MK, 2008, INFLAMM RES, V57, P329, DOI 10.1007/s00011-007-7220-1; Ravi R, 1998, CANCER RES, V58, P4531; Roby KF, 2000, CARCINOGENESIS, V21, P585, DOI 10.1093/carcin/21.4.585; Salminen A, 2010, J CELL PHYSIOL, V224, P1, DOI 10.1002/jcp.22119; Schneider G, 2010, ONCOGENE, V29, P2795, DOI 10.1038/onc.2010.46; Schutyser E, 2002, J BIOL CHEM, V277, P24584, DOI 10.1074/jbc.M112275200; Son DS, 2007, CANCER BIOL THER, V6, P1302; Suzuki K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/978312; Tanaka K, 2001, BIOCHIMIE, V83, P351, DOI 10.1016/S0300-9084(01)01237-8; Van Maerken T, 2009, JNCI-J NATL CANCER I, V101, P1562, DOI 10.1093/jnci/djp355; Wade M, 2010, TRENDS CELL BIOL, V20, P299, DOI 10.1016/j.tcb.2010.01.009; Webster GA, 1999, MOL CELL BIOL, V19, P3485; Wilson AJ, 2011, CANCER BIOL THER, V12, P484, DOI 10.4161/cbt.12.6.15956; YAGINUMA Y, 1992, CANCER RES, V52, P4196; Yang G, 2006, P NATL ACAD SCI USA, V103, P16472, DOI 10.1073/pnas.0605752103; Zhou MX, 2003, ONCOGENE, V22, P8137, DOI 10.1038/sj.onc.1206911	41	44	45	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2012	7	12							e51116	10.1371/journal.pone.0051116	http://dx.doi.org/10.1371/journal.pone.0051116			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GO	23300534	Green Published, gold, Green Submitted			2022-12-27	WOS:000313872600004
J	Laigle, C; Confort-Gouny, S; Le Fur, Y; Cozzone, PJ; Viola, A				Laigle, Christophe; Confort-Gouny, Sylviane; Le Fur, Yann; Cozzone, Patrick J.; Viola, Angele			Deletion of TRAAK Potassium Channel Affects Brain Metabolism and Protects against Ischemia	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; FOCAL CEREBRAL-ISCHEMIA; CELL-VOLUME REGULATION; DOMAIN K+ CHANNELS; APPARENT DIFFUSION-COEFFICIENT; COTRANSPORTER MESSENGER-RNA; MAGNETIC-RESONANCE; RAT-BRAIN; IN-VIVO; FUNCTIONAL-SIGNIFICANCE	Cerebral stroke is a worldwide leading cause of disability. The two-pore domain K+ channels identified as background channels are involved in many functions in brain under physiological and pathological conditions. We addressed the hypothesis that TRAAK, a mechano-gated and lipid-sensitive two-pore domain K+ channel, is involved in the pathophysiology of brain ischemia. We studied the effects of TRAAK deletion on brain morphology and metabolism under physiological conditions, and during temporary focal cerebral ischemia in Traak(-/-) mice using a combination of in vivo magnetic resonance imaging (MRI) techniques and multinuclear magnetic resonance spectroscopy (MRS) methods. We provide the first in vivo evidence establishing a link between TRAAK and neurometabolism. Under physiological conditions, Traak(-/-) mice showed a particular metabolic phenotype characterized by higher levels of taurine and myo-inositol than Traak(+/+) mice. Upon ischemia, Traak(-/-) mice had a smaller infarcted volume, with lower contribution of cellular edema than Traak(+/+) mice. Moreover, brain microcirculation was less damaged, and brain metabolism and pH were preserved. Our results show that expression of TRAAK strongly influences tissue levels of organic osmolytes. Traak(-/-) mice resilience to cellular edema under ischemia appears related to their physiologically high levels of myo-inositol and of taurine, an aminoacid involved in the modulation of mitochondrial activity and cell death. The beneficial effects of TRAAK deletion designate this channel as a promising pharmacological target for the treatment against stroke.	[Laigle, Christophe; Confort-Gouny, Sylviane; Le Fur, Yann; Cozzone, Patrick J.; Viola, Angele] Aix Marseille Univ, Natl Ctr Sci Res CNRS, CRMBM, Joint Res Unit 7339,UMR 7339, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Aix-Marseille Universite	Viola, A (corresponding author), Aix Marseille Univ, Natl Ctr Sci Res CNRS, CRMBM, Joint Res Unit 7339,UMR 7339, Marseille, France.	angele.viola@univ-amu.fr			National Center for Scientific Research (CNRS); Aix-Marseille University	National Center for Scientific Research (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Aix-Marseille University	This work was supported by the National Center for Scientific Research (CNRS) and Aix-Marseille University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HS, 2005, NEUROSCIENCE, V133, P1007, DOI 10.1016/j.neuroscience.2005.03.041; ANDREWS RJ, 1991, STROKE, V22, P943, DOI 10.1161/01.STR.22.7.943; Ay H, 1999, NEUROLOGY, V52, P1784, DOI 10.1212/WNL.52.9.1784; Beetsch JW, 1998, AM J PHYSIOL-CELL PH, V274, pC866, DOI 10.1152/ajpcell.1998.274.4.C866; Berthet C, 2011, STROKE, V42, P799, DOI 10.1161/STROKEAHA.110.603647; Bitoun M, 2000, GLIA, V32, P165, DOI 10.1002/1098-1136(200011)32:2<165::AID-GLIA60>3.0.CO;2-2; BRAND A, 1993, DEV NEUROSCI-BASEL, V15, P289, DOI 10.1159/000111347; Brand A, 1997, CELL MOL BIOL, V43, P645; Brand A, 1998, J NEUROCHEM, V71, P827; Bryan RM, 2006, AM J PHYSL HEART CIR; Bulley S, 2012, J PHYSL; Butcher K, 2008, STROKE, V39, P75, DOI 10.1161/STROKEAHA.107.490524; Cardin V, 1999, J NEUROSCI RES, V56, P659; Cho TH, 2009, STROKE, V40, P3400, DOI 10.1161/STROKEAHA.109.563064; Chvatal A, 2007, J ANAT, V210, P671, DOI 10.1111/j.1469-7580.2007.00724.x; Ding D, 2000, EXP NEUROL, V162, P1, DOI 10.1006/exnr.2000.7226; Doubal FN, 2011, J NEUROL NEUROSUR PS, V82, P540, DOI 10.1136/jnnp.2009.190298; Fink M, 1998, EMBO J, V17, P3297, DOI 10.1093/emboj/17.12.3297; Fisher SK, 2002, J NEUROCHEM, V82, P736, DOI 10.1046/j.1471-4159.2002.01041.x; Franks NP, 2004, TRENDS PHARMACOL SCI, V25, P601, DOI 10.1016/j.tips.2004.09.003; Hayward NMEA, 2011, J CEREBR BLOOD F MET, V31, P1119, DOI 10.1038/jcbfm.2010.202; Heurteaux C, 2004, EMBO J, V23, P2684, DOI 10.1038/sj.emboj.7600234; Heurteaux C, 2006, NEUROSCIENCE, V137, P241, DOI 10.1016/j.neuroscience.2005.08.083; Hoehn M, 2001, J MAGN RESON IMAGING, V14, P491, DOI 10.1002/jmri.1213; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Huang CS, 1997, J PHARMACOL EXP THER, V282, P1280; Inoue K, 1996, NEUROREPORT, V7, P1195, DOI 10.1097/00001756-199604260-00020; Judge Susan I V, 2007, Recent Pat CNS Drug Discov, V2, P200, DOI 10.2174/157488907782411765; Kang JX, 1996, P NATL ACAD SCI USA, V93, P3542, DOI 10.1073/pnas.93.8.3542; Kim Y, 2001, PFLUG ARCH EUR J PHY, V442, P64, DOI 10.1007/s004240000496; Kimelberg HK, 2005, GLIA, V50, P389, DOI 10.1002/glia.20174; Lambert IH, 2008, ACTA PHYSIOL, V194, P255, DOI 10.1111/j.1748-1716.2008.01910.x; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; Lauritzen I, 2000, EMBO J, V19, P1784, DOI 10.1093/emboj/19.8.1784; Leon R, 2009, J NEUROSCI RES, V87, P1185, DOI 10.1002/jnr.21926; Lesage F, 2000, AM J PHYSIOL-RENAL, V279, pF793, DOI 10.1152/ajprenal.2000.279.5.F793; Lesage F, 2000, FEBS LETT, V471, P137, DOI 10.1016/S0014-5793(00)01388-0; Lesage F, 2003, NEUROPHARMACOLOGY, V44, P1, DOI 10.1016/S0028-3908(02)00339-8; Liu KF, 2001, STROKE, V32, P1897, DOI 10.1161/01.STR.32.8.1897; Lopes CMB, 2005, J PHYSIOL-LONDON, V564, P117, DOI 10.1113/jphysiol.2004.081935; Maingret F, 2000, J BIOL CHEM, V275, P10128, DOI 10.1074/jbc.275.14.10128; Maingret F, 1999, J BIOL CHEM, V274, P1381, DOI 10.1074/jbc.274.3.1381; Mathie A, 2007, CURR OPIN INVEST DR, V8, P555; Mathie A, 2007, J PHYSIOL-LONDON, V578, P377, DOI 10.1113/jphysiol.2006.121582; McNaughton NCL, 2000, NEUROPHARMACOLOGY, V39, P1247, DOI 10.1016/S0028-3908(99)00201-4; Meadows HJ, 2001, BRAIN RES, V892, P94, DOI 10.1016/S0006-8993(00)03239-X; Medhurst AD, 2001, MOL BRAIN RES, V86, P101, DOI 10.1016/S0169-328X(00)00263-1; Moffett JR, 2007, PROG NEUROBIOL, V81, P89, DOI 10.1016/j.pneurobio.2006.12.003; Molchanova SM, 2006, BRAIN RES, V1099, P64, DOI 10.1016/j.brainres.2006.04.105; MORAN J, 1994, NEUROCHEM RES, V19, P415, DOI 10.1007/BF00967318; Nicoli F, 2003, STROKE, V34, pE82, DOI 10.1161/01.STR.0000078659.43423.0A; Noel J, 2009, EMBO J, V28, P1308, DOI 10.1038/emboj.2009.57; Olson JE, 2006, J NEUROCHEM, V96, P1375, DOI 10.1111/j.1471-4159.2006.03652.x; Pasler D, 2007, BRAIN RES, V1173, P14, DOI 10.1016/j.brainres.2007.07.013; Parsons MW, 2000, NEUROLOGY, V55, P498, DOI 10.1212/WNL.55.4.498; Patel AJ, 2001, TRENDS NEUROSCI, V24, P339, DOI 10.1016/S0166-2236(00)01810-5; Penet MF, 2006, BEHAV GENET, V36, P732, DOI 10.1007/s10519-006-9077-4; Penet MF, 2005, J NEUROSCI, V25, P7352, DOI 10.1523/JNEUROSCI.1002-05.2005; Pow DV, 2002, GLIA, V37, P153, DOI 10.1002/glia.10026; Ren L, 2010, NEUROL RES, V32, P763, DOI 10.1179/016164109X12445616596481; Reyes R, 2000, NEUROSCIENCE, V95, P893; Rossi DJ, 2007, NAT NEUROSCI, V10, P1377, DOI 10.1038/nn2004; Rumpel H, 2003, J MAGN RESON IMAGING, V17, P11, DOI 10.1002/jmri.10233; Sabbadini M, 2009, J MOL BIOL, V385, P1331, DOI 10.1016/j.jmb.2008.11.048; Saransaari P, 1999, NEUROSCIENCE, V94, P949, DOI 10.1016/S0306-4522(99)00384-X; Saransaari P, 2008, AMINO ACIDS, V34, P429, DOI 10.1007/s00726-007-0553-9; Saransaari P, 2000, AMINO ACIDS, V19, P509, DOI 10.1007/s007260070003; SAUNDERS DE, 1995, STROKE, V26, P1007, DOI 10.1161/01.STR.26.6.1007; Schaffer S, 2000, AMINO ACIDS, V19, P527, DOI 10.1007/s007260070004; SCHURR A, 1987, LIFE SCI, V40, P2059, DOI 10.1016/0024-3205(87)90098-1; Sims NR, 2002, NEUROCHEM INT, V40, P511, DOI 10.1016/S0197-0186(01)00122-X; SMITH SE, 1993, NEUROREPORT, V4, P1339, DOI 10.1097/00001756-199309150-00013; Stefani A, 1997, EXP NEUROL, V147, P115, DOI 10.1006/exnr.1997.6554; Strange K, 2004, ADV PHYSIOL EDUC, V28, P155, DOI 10.1152/advan.00034.2004; Sun M, 2008, CELL MOL NEUROBIOL, V28, P71, DOI 10.1007/s10571-007-9250-1; Sun M, 2011, AMINO ACIDS, V40, P1419, DOI 10.1007/s00726-010-0751-8; Talley EM, 2001, J NEUROSCI, V21, P7491, DOI 10.1523/JNEUROSCI.21-19-07491.2001; Taranukhin AG, 2008, AMINO ACIDS, V34, P169, DOI 10.1007/s00726-006-0405-z; Tkac I, 1999, MAGNET RESON MED, V41, P649, DOI 10.1002/(SICI)1522-2594(199904)41:4<649::AID-MRM2>3.0.CO;2-G; Urbani A, 2000, EUR J NEUROSCI, V12, P3567, DOI 10.1046/j.1460-9568.2000.00242.x; URENJAK J, 1993, J NEUROSCI, V13, P981, DOI 10.1523/jneurosci.13-03-00981.1993; Viola A, 2011, AM J NEURORADIOL, V32, P1451, DOI 10.3174/ajnr.A2555; Viola A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000157; Vitvitsky V, 2011, J BIOL CHEM, V286, P32002, DOI 10.1074/jbc.M111.253344; Wang GH, 2007, NEUROPHARMACOLOGY, V52, P1199, DOI 10.1016/j.neuropharm.2006.10.022; Won SJ, 2002, J BIOCHEM MOL BIOL, V35, P67, DOI 10.5483/BMBRep.2002.35.1.067; Yamashita T, 1996, J CEREBR BLOOD F MET, V16, P1203, DOI 10.1097/00004647-199611000-00014; Yancey PH, 2005, J EXP BIOL, V208, P2819, DOI 10.1242/jeb.01730; Zhou F, 2006, ADV EXP MED BIOL, V583, P353	89	20	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53266	10.1371/journal.pone.0053266	http://dx.doi.org/10.1371/journal.pone.0053266			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285272	Green Submitted, Green Published, gold			2022-12-27	WOS:000313051500126
J	Liu, C; Xu, DW; Han, HY; Fan, YD; Schain, F; Xu, ZH; Claesson, HE; Bjorkholm, M; Sjoberg, J				Liu, Cheng; Xu, Dawei; Han, Hongya; Fan, Yidong; Schain, Frida; Xu, Zhonghua; Claesson, Hans-Erik; Bjorkholm, Magnus; Sjoberg, Jan			Transcriptional Regulation of 15-Lipoxygenase Expression by Histone H3 Lysine 4 Methylation/Demethylation	PLOS ONE			English	Article							LINKED MENTAL-RETARDATION; METHYLTRANSFERASE SMYD3; HODGKIN LYMPHOMA; PROSTATE-CANCER; UP-REGULATION; TUMOR-GROWTH; GENE; METHYLATION; BINDING; CELLS	15-Lipoxygenase-1 (15-LOX-1) oxidizes polyunsaturated fatty acids to a rich spectrum of biologically active metabolites and is implicated in physiological membrane remodelling, inflammation and apoptosis. Its deregulation is involved in the pathogenesis of diverse cancer and immune diseases. Recent experimental evidence reveals that dynamic histone methylation/demethylation mediated by histone methyltransferases and demethylases plays a critical role in regulation of chromatin remodelling and gene expression. In the present study, we compared the histone 3 lysine 4 (H3-K4) methylation status of the 15-LOX-1 promoter region of the two Hodgkin lymphoma (HL) cell lines L1236 and L428 with abundant and undetectable 15-LOX-1 expression, respectively. We identified a potential role of H3-K4 methylation in positive regulation of 15-LOX-1 transcription. Furthermore, we found that histone methyltransferase SMYD3 inhibition reduced 15-LOX-1 expression by decreasing promoter activity in L1236 cells. SMYD3 knock down in these cells abolished di-/trimethylation of H3-K4, attenuated the occupancy by the transactivator STAT6, and led to diminished histone H3 acetylation at the 15-LOX-1 promoter. In contrast, inhibition of SMCX, a JmjC-domain-containing H3-K4 tri-demethylase, upregulated 15-LOX-1 expression through induction of H3-K4 trimethylation, histone acetylation and STAT6 recruitment at the 15-LOX-1 promoter in L428 cells. In addition, we observed strong SMYD3 expression in the prostate cancer cell line LNCaP and its inhibition led to decreased 15-LOX-1 expression. Taken together, our data suggest that regulation of histone methylation/demethylation at the 15-LOX-1 promoter is important in 15-LOX-1 expression.	[Liu, Cheng; Xu, Dawei; Han, Hongya; Schain, Frida; Claesson, Hans-Erik; Bjorkholm, Magnus; Sjoberg, Jan] Karolinska Univ, Hosp Solna, Dept Med, Div Hematol, Stockholm, Sweden; [Liu, Cheng; Xu, Dawei; Han, Hongya; Schain, Frida; Claesson, Hans-Erik; Bjorkholm, Magnus; Sjoberg, Jan] Karolinska Inst, Stockholm, Sweden; [Liu, Cheng; Fan, Yidong; Xu, Zhonghua] Shandong Univ, Qilu Hosp, Dept Urol, Jinan 250100, Peoples R China	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Shandong University	Liu, C (corresponding author), Karolinska Univ, Hosp Solna, Dept Med, Div Hematol, Stockholm, Sweden.	Cheng.Liu@ki.se		Claesson, Hans-Erik/0000-0002-1960-6542; Xu, Dawei/0000-0003-3141-4524	Swedish Cancer Society; Stockholm County Council; Karolinska Institutet; Biolipox AB; National Natural Science Foundationg of China [30901497]; Shandong Province Natural Science Foundation [Y2003C08]; Promotive research fund for excellent young and middle-aged scientists of Shandong Province [BS2010YY027]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry	Swedish Cancer Society(Swedish Cancer Society); Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Biolipox AB; National Natural Science Foundationg of China; Shandong Province Natural Science Foundation(Natural Science Foundation of Shandong Province); Promotive research fund for excellent young and middle-aged scientists of Shandong Province; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	The study was supported by grants from the Swedish Cancer Society, Stockholm County Council, Karolinska Institutet, an unrestricted grant from Biolipox AB, National Natural Science Foundationg of China (30901497); the Shandong Province Natural Science Foundation (Y2003C08); Promotive research fund for excellent young and middle-aged scientists of Shandong Province (BS2010YY027); the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson E, 2006, BBA-MOL CELL BIOL L, V1761, P1498, DOI 10.1016/j.bbalip.2006.09.007; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Chen BL, 2006, J BIOL CHEM, V281, P18296, DOI 10.1074/jbc.M603484200; Claesson HE, 2009, PROSTAG OTH LIPID M, V89, P120, DOI 10.1016/j.prostaglandins.2008.12.003; Cock-Rada AM, 2012, CANCER RES, V72, P810, DOI 10.1158/0008-5472.CAN-11-1052; Conrad DJ, 2000, AM J RESP CELL MOL, V22, P226, DOI 10.1165/ajrcmb.22.2.3786; Das S, 2007, PROSTATE, V67, P1550, DOI 10.1002/pros.20640; Dobrian AD, 2011, PROG LIPID RES, V50, P115, DOI 10.1016/j.plipres.2010.10.005; Eissenberg JC, 2010, DEV BIOL, V339, P240, DOI 10.1016/j.ydbio.2009.08.017; Ezaki J, 2011, IUBMB LIFE, V63, P1001, DOI 10.1002/iub.537; Ge Z, 2006, MOL CELL BIOL, V26, P230, DOI 10.1128/MCB.26.1.230-237.2006; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; Jensen LR, 2005, AM J HUM GENET, V76, P227, DOI 10.1086/427563; Kamitani H, 2001, CARCINOGENESIS, V22, P187, DOI 10.1093/carcin/22.1.187; Kelavkar U, 1998, MOL BIOL REP, V25, P173, DOI 10.1023/A:1006813009006; Kelavkar UP, 2007, PROSTAG OTH LIPID M, V82, P185, DOI 10.1016/j.prostaglandins.2006.05.015; Kelavkar Uddhav, 2006, J Carcinog, V5, P9, DOI 10.1186/1477-3163-5-9; Kelavkar UP, 2009, NEOPLASIA, V11, P692, DOI 10.1593/neo.09334; Kim H, 2009, J BIOL CHEM, V284, P19867, DOI 10.1074/jbc.M109.021485; Kuhn H, 2006, PROG LIPID RES, V45, P334, DOI 10.1016/j.plipres.2006.02.003; Liu C, 2004, EXP CELL RES, V297, P61, DOI 10.1016/j.yexcr.2004.02.014; Liu C, 2007, CANCER RES, V67, P2626, DOI 10.1158/0008-5472.CAN-06-4126; Liu C, 2012, EXP CELL RES, V318, P169, DOI 10.1016/j.yexcr.2011.10.017; Marafioti T, 2000, BLOOD, V95, P1443, DOI 10.1182/blood.V95.4.1443.004k55_1443_1450; Niu X, 2012, ONCOGENE, V31, P776, DOI 10.1038/onc.2011.266; Ordovas JM, 2010, NAT REV CARDIOL, V7, P510, DOI 10.1038/nrcardio.2010.104; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Quina AS, 2006, BIOCHEM PHARMACOL, V72, P1563, DOI 10.1016/j.bcp.2006.06.016; Rong SX, 2012, J LIPID RES, V53, P686, DOI 10.1194/jlr.M022723; Schewe T, 2002, BIOL CHEM, V383, P365, DOI 10.1515/BC.2002.041; Shankaranarayanan P, 2001, J BIOL CHEM, V276, P42753, DOI 10.1074/jbc.M102626200; Silva FP, 2007, ONCOGENE; Tahiliani M, 2007, NATURE, V447, P601, DOI 10.1038/nature05823; van Leyen K, 1998, NATURE, V395, P392, DOI 10.1038/26500; Wittwer J, 2006, HUM MUTAT, V27, P78, DOI 10.1002/humu.20273; Wu SH, 2009, AM J PATHOL, V174, P115, DOI 10.2353/ajpath.2009.080671; Xu DW, 1998, BRIT J HAEMATOL, V102, P1367, DOI 10.1046/j.1365-2141.1998.00969.x; Zhao JM, 2011, P NATL ACAD SCI USA, V108, P14246, DOI 10.1073/pnas.1018075108; Zuo X, 2008, FASEB J; Zuo XS, 2008, J BIOL CHEM, V283, P31341, DOI 10.1074/jbc.M803729200; Zuo XS, 2012, J NATL CANCER I, V104, P709, DOI 10.1093/jnci/djs187	41	22	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52703	10.1371/journal.pone.0052703	http://dx.doi.org/10.1371/journal.pone.0052703			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285160	Green Published, gold, Green Submitted			2022-12-27	WOS:000313051500050
J	Peng, ZH; Yang, HT; Norris, J; Chen, X; Huan, XP; Yu, RB; Wang, N; Shen, HB; Chen, F				Peng, Zhihang; Yang, Haitao; Norris, Jessie; Chen, Xin; Huan, Xiping; Yu, Rongbin; Wang, Ning; Shen, Hongbing; Chen, Feng			HIV Incidence and Predictors Associated with Retention in a Cohort of Men Who have Sex with Men in Yangzhou, Jiangsu Province, China	PLOS ONE			English	Article							HEPATITIS-B; UNITED-STATES; POSITIVE MEN; SYPHILIS; INFECTIONS; PREVALENCE; RISK; HIV/AIDS; EPIDEMIC; BEHAVIOR	Background: The study was to investigate the incidence of HIV-1 and related factors, as well as predictors associated with retention in a cohort study among men who have sex with men (MSM) in Yangzhou, Jiangsu Province, China. A carefully designed 12-month prospective cohort study was conducted. Methodology/Principal Findings: A total of 278 sero-negative MSM were recruited and followed up for 12 months starting from May, 2008. Participants were tested for HIV-1 at baseline, 6-month, and 12-month follow-up visits. Questionnaire interviews were conducted to collect information. The retention rate and HIV incidence were analyzed as functions of demographic and behavioral variables. Risk factors were identified by estimating the relative risks (RR) and respective 95% confidence intervals (CI) using a Poisson regression model, univariate and multivariate analyses and risk factors analyses. 71 (25.5%) and 45 (16.2%) of the 278 participants were retained at the 6-month and 12-month follow-up visits respectively. The incidence rates of HIV-1 were 5.65 and 6.67 per 100 person years (PY) respectively. Both having received condoms and having received lubricant were negatively associated with HIV sero-conversion at the 12 months' follow-up. Predictors associated with 12-month retention rate include Yangzhou residency (RR = 0.471, 95% CI: 0.275 similar to 0.807, P = 0.006), having received condoms (RR = 0.065, 95% CI: 0.007 similar to 0.572, P = 0.014), and having received VCTs (RR = 0.093, 95% CI: 0.010 similar to 0.818, P = 0.032). Conclusions/Significance: The incidence of HIV-1 among MSM in Yangzhou is relatively high and effective interventions are needed urgently. More attention should be focused on maintaining a higher retention rate.	[Peng, Zhihang; Chen, Xin; Yu, Rongbin; Shen, Hongbing; Chen, Feng] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China; [Yang, Haitao; Huan, Xiping] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Norris, Jessie; Wang, Ning] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China	Nanjing Medical University; Jiangsu Provincial Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention	Chen, F (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China.	fengchen@njmu.edu.cn		Chen, Feng/0000-0002-2699-7190	National S&T Major Project Foundation of China [2012ZX10001-001, 2011ZX10004-90]; National Natural Science Foundation of China [81001288]	National S&T Major Project Foundation of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by National S&T Major Project Foundation of China (No. 2012ZX10001-001 and No. 2011ZX10004-902); National Natural Science Foundation of China (81001288). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao Yu-gang, 2009, Zhonghua Yu Fang Yi Xue Za Zhi, V43, P981; Beyrer C, 2010, EPIDEMIOL REV, V32, P137, DOI 10.1093/epirev/mxq011; Bezemer D, 2010, AIDS, V24, P271, DOI 10.1097/QAD.0b013e328333ddee; Buchbinder SP, 2005, JAIDS-J ACQ IMM DEF, V39, P82, DOI 10.1097/01.qai.0000134740.41585.f4; *CDCP, 2008, HIV AIDS SURV REP CA; Centers for Disease Control and Prevention (CDC), 1989, MMWR-MORBID MORTAL W, V30, P250; Choi KH, 2003, LANCET, V361, P2125, DOI 10.1016/S0140-6736(03)13690-2; Feng YJ, 2010, JAIDS-J ACQ IMM DEF, V53, pS74, DOI 10.1097/QAI.0b013e3181c7dd16; Guo HX, 2009, SEX TRANSM DIS, V36, P120, DOI 10.1097/OLQ.0b013e31818d3fa0; Hao C, 2011, SEX TRANSM INFECT, V87, P199, DOI 10.1136/sti.2010.042903; Li A, 2009, AIDS BEHAV, V13, P318, DOI 10.1007/s10461-008-9448-3; Li Dong-Liang, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P663; Li DL, 2010, AIDS PATIENT CARE ST, V24, P595, DOI 10.1089/apc.2010.0083; Li SW, 2008, CHINESE MED J-PEKING, V121, P1105, DOI 10.1097/00029330-200806020-00013; Li Shu-ming, 2011, Zhonghua Yu Fang Yi Xue Za Zhi, V45, P118; Li Xinxu, 2008, Southeast Asian Journal of Tropical Medicine and Public Health, V39, P99; Liu HJ, 2009, AIDS BEHAV, V13, P652, DOI 10.1007/s10461-008-9475-0; Lu L, 2008, NATURE, V455, P609, DOI 10.1038/455609a; Ma XY, 2007, JAIDS-J ACQ IMM DEF, V45, P581, DOI 10.1097/QAI.0b013e31811eadbc; Magnus M, 2010, JAIDS-J ACQ IMM DEF, V53, P529, DOI 10.1097/QAI.0b013e3181b56404; Qian ZH, 2005, SEX TRANSM INFECT, V81, P442, DOI 10.1136/sti.2004.014258; Ruan SM, 2009, AIDS BEHAV, V13, P671, DOI 10.1007/s10461-009-9567-5; Ruan YH, 2009, JAIDS-J ACQ IMM DEF, V52, P604, DOI 10.1097/QAI.0b013e3181b31f5c; Ruan YH, 2009, AIDS BEHAV, V13, P663, DOI 10.1007/s10461-008-9503-0; Smith A., 2010, Morbidity and Mortality Weekly Report, V59, P1201; Smith AD, 2009, LANCET, V374, P416, DOI 10.1016/S0140-6736(09)61118-1; State Council AIDS Working Committee Office and UN Theme Group on HIV/AIDS in China, 2005, JOINT ASS HIV AIDS P; State Council AIDS Working Committee Office and Un Theme Group on HIV/AIDS in China, 2008, JOINT ASS HIV AIDS P; The Ministry of Health of the People's Republic of China Joint United Nations Programme on HIV/AIDS and World Health Organization, 2008, 2005 UPD HIV AIDS EP; UNAIDS, 2010, UNAIDS REP GLOB AIDS; van Griensven F, 2010, AIDS, V24, pS30, DOI 10.1097/01.aids.0000390087.22565.b4; van Griensven F, 2009, CURR OPIN HIV AIDS, V4, P300, DOI 10.1097/COH.0b013e32832c3bb3; van Kesteren NMC, 2007, ARCH SEX BEHAV, V36, P437, DOI 10.1007/s10508-006-9125-4; Wang Yi, 2010, Zhonghua Yu Fang Yi Xue Za Zhi, V44, P636; Wong WCW, 2007, AIDS CARE, V19, P850, DOI 10.1080/09540120601086808; Wu ZY, 2007, LANCET, V369, P679, DOI 10.1016/S0140-6736(07)60315-8; Xu JJ, 2010, SEX TRANSM DIS, V37, P432, DOI 10.1097/OLQ.0b013e3181d13eed; Yang HT, 2010, SEX TRANSM DIS, V37, P208, DOI 10.1097/OLQ.0b013e3181d13c59; Zhang Bei-chuan, 2007, Zhonghua Liu Xing Bing Xue Za Zhi, V28, P32	39	14	16	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52731	10.1371/journal.pone.0052731	http://dx.doi.org/10.1371/journal.pone.0052731			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	064DQ	23285172	gold, Green Published, Green Submitted			2022-12-27	WOS:000313051500054
J	Sun, J; Zhang, X; Deng, SR; Zhang, CL; Wang, MJ; Ding, MQ; Zhao, R; Shen, X; Zhou, XY; Lu, CF; Chen, SL				Sun, Jian; Zhang, Xuan; Deng, Shurong; Zhang, Chunlan; Wang, Meijuan; Ding, Mingquan; Zhao, Rui; Shen, Xin; Zhou, Xiaoyang; Lu, Cunfu; Chen, Shaoliang			Extracellular ATP Signaling Is Mediated by H2O2 and Cytosolic Ca2+ in the Salt Response of Populus euphratica Cells	PLOS ONE			English	Article							NITRIC-OXIDE PRODUCTION; ARABIDOPSIS-THALIANA; K+/NA+ HOMEOSTASIS; NA+/H+ ANTIPORTER; NUCLEOTIDES; TRANSPORT; STRESS; TOLERANCE; SALINITY; PROTEIN	Extracellular ATP (eATP) has been implicated in mediating plant growth and antioxidant defense; however, it is largely unknown whether eATP might mediate salinity tolerance. We used confocal microscopy, a non-invasive vibrating ion-selective microelectrode, and quantitative real time PCR analysis to evaluate the physiological significance of eATP in the salt resistance of cell cultures derived from a salt-tolerant woody species, Populus euphratica. Application of NaCl (200 mM) shock induced a transient elevation in [eATP]. We investigated the effects of eATP by blocking P2 receptors with suramin and PPADS and applying an ATP trap system of hexokinase-glucose. We found that eATP regulated a wide range of cellular processes required for salt adaptation, including vacuolar Na+ compartmentation, Na+/H+ exchange across the plasma membrane (PM), K+ homeostasis, reactive oxygen species regulation, and salt-responsive expression of genes related to K+/Na+ homeostasis and PM repair. Furthermore, we found that the eATP signaling was mediated by H2O2 and cytosolic Ca2+ released in response to high salt in P. euphratica cells. We concluded that salt-induced eATP was sensed by purinoceptors in the PM, and this led to the induction of downstream signals, like H2O2 and cytosolic Ca2+, which are required for the upregulation of genes linked to K+/Na+ homeostasis and PM repair. Consequently, the viability of P. euphratica cells was maintained during a prolonged period of salt stress.	[Sun, Jian; Zhang, Xuan; Deng, Shurong; Zhang, Chunlan; Wang, Meijuan; Ding, Mingquan; Zhao, Rui; Shen, Xin; Zhou, Xiaoyang; Lu, Cunfu; Chen, Shaoliang] Beijing Forestry Univ, Coll Biol Sci & Technol, Beijing, Peoples R China; [Sun, Jian] Jiangsu Normal Univ, Coll Life Sci, Xuzhou, Peoples R China	Beijing Forestry University; Jiangsu Normal University	Chen, SL (corresponding author), Beijing Forestry Univ, Coll Biol Sci & Technol, Beijing, Peoples R China.	Lschen@bjfu.edu.cn			Fundamental Research Funds for the Central Universities [JC2011-2, BLYJ200903]; Beijing Natural Science Foundation [6112017]; National Natural Science Foundation of China [31170570]; Foundation for the Supervisors of Beijing Excellent Doctoral Dissertations [YB20081002201]; Scientific Research Support Project for Teachers with Doctor's Degrees, Jiangsu Normal University, China [11XLR23]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for the Supervisors of Beijing Excellent Doctoral Dissertations; Scientific Research Support Project for Teachers with Doctor's Degrees, Jiangsu Normal University, China	This work was supported by the Fundamental Research Funds for the Central Universities (JC2011-2, BLYJ200903), Beijing Natural Science Foundation (6112017), National Natural Science Foundation of China (31170570), Foundation for the Supervisors of Beijing Excellent Doctoral Dissertations (YB20081002201), and the Scientific Research Support Project for Teachers with Doctor's Degrees, Jiangsu Normal University, China (No.11XLR23). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batelli G, 2007, MOL CELL BIOL, V27, P7781, DOI 10.1128/MCB.00430-07; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen ZH, 2007, PLANT PHYSIOL, V145, P1714, DOI 10.1104/pp.107.110262; Chivasa S, 2005, PLANT CELL, V17, P3019, DOI 10.1105/tpc.105.036806; Chivasa S, 2009, PLANT J, V60, P436, DOI 10.1111/j.1365-313X.2009.03968.x; Chung JS, 2008, PLANT J, V53, P554, DOI 10.1111/j.1365-313X.2007.03364.x; Clark G, 2011, PLANT PHYSIOL, V156, P1740, DOI 10.1104/pp.111.174466; Clark G, 2010, PLANT PHYSIOL, V152, P1073, DOI 10.1104/pp.109.147637; Clark G, 2009, PLANT SCI, V177, P239, DOI 10.1016/j.plantsci.2009.05.004; Demidchik V, 2003, PLANT PHYSIOL, V133, P456, DOI 10.1104/pp.103.024091; Demidchik V, 2007, PLANT J, V49, P377, DOI 10.1111/j.1365-313X.2006.02971.x; Demidchik V, 2009, PLANT J, V58, P903, DOI 10.1111/j.1365-313X.2009.03830.x; Desikan R, 2001, PLANT PHYSIOL, V127, P159, DOI 10.1104/pp.127.1.159; Foresi NP, 2007, PLANT PHYSIOL, V145, P589, DOI 10.1104/pp.107.106518; Fraile-Escanciano A, 2010, NEW PHYTOL, V188, P750, DOI 10.1111/j.1469-8137.2010.03405.x; Hao LH, 2012, MOL PLANT, V5, P852, DOI 10.1093/mp/ssr095; Jeter CR, 2004, PLANT CELL, V16, P2652, DOI 10.1105/tpc.104.023945; Jiang MY, 2002, J EXP BOT, V53, P2401, DOI 10.1093/jxb/erf090; Kim SH, 2009, BIOSCI BIOTECH BIOCH, V73, P1252, DOI 10.1271/bbb.80660; Kim SY, 2006, PLANT PHYSIOL, V142, P984, DOI 10.1104/pp.106.085670; Konrad KR, 2008, PLANT J, V55, P161, DOI 10.1111/j.1365-313X.2008.03498.x; Lew RR, 2000, PLANT SCI, V153, P1, DOI 10.1016/S0168-9452(99)00242-3; Martinez-Atienza J, 2007, PLANT PHYSIOL, V143, P1001, DOI 10.1104/pp.106.092635; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Oh DH, 2009, PLANT PHYSIOL, V151, P210, DOI 10.1104/pp.109.137802; Pottosin I, 2009, FEBS LETT, V583, P921, DOI 10.1016/j.febslet.2009.02.009; Qiu QS, 2004, J BIOL CHEM, V279, P207, DOI 10.1074/jbc.M307982200; Reichler SA, 2009, J EXP BOT, V60, P2129, DOI 10.1093/jxb/erp091; Roux SJ, 2007, TRENDS PLANT SCI, V12, P522, DOI 10.1016/j.tplants.2007.09.003; Schapire AL, 2008, PLANT CELL, V20, P3374, DOI 10.1105/tpc.108.063859; Shabala S, 2000, ANN BOT-LONDON, V85, P681, DOI 10.1006/anbo.2000.1131; Shabala S, 2008, PHYSIOL PLANTARUM, V133, P651, DOI 10.1111/j.1399-3054.2007.01008.x; Shi HZ, 2000, P NATL ACAD SCI USA, V97, P6896, DOI 10.1073/pnas.120170197; Shi HZ, 2002, PLANT CELL, V14, P465, DOI 10.1105/tpc.010371; Silva P, 2010, J PLANT GROWTH REGUL, V29, P23, DOI 10.1007/s00344-009-9110-y; Song CJ, 2006, PLANT PHYSIOL, V140, P1222, DOI 10.1104/pp.105.073072; Sueldo DJ, 2010, NEW PHYTOL, V185, P909, DOI 10.1111/j.1469-8137.2009.03165.x; Sun J, 2012, PLANT CELL ENVIRON, V35, P893, DOI 10.1111/j.1365-3040.2011.02461.x; Sun JA, 2010, PLANT CELL TISS ORG, V103, P205, DOI 10.1007/s11240-010-9768-7; Sun J, 2010, PLANT CELL ENVIRON, V33, P943, DOI 10.1111/j.1365-3040.2010.02118.x; Sun J, 2009, TREE PHYSIOL, V29, P1175, DOI 10.1093/treephys/tpp048; Sun J, 2009, PLANT PHYSIOL, V149, P1141, DOI 10.1104/pp.108.129494; Tanaka K, 2010, TRENDS CELL BIOL, V20, P601, DOI 10.1016/j.tcb.2010.07.005; Tanaka K, 2010, PLANT PHYSIOL, V154, P705, DOI 10.1104/pp.110.162503; Tang RJ, 2010, PLANT MOL BIOL, V74, P367, DOI 10.1007/s11103-010-9680-x; Tang WQ, 2003, PLANT PHYSIOL, V131, P147, DOI 10.1104/pp.013672; Tracy FE, 2008, PLANT CELL ENVIRON, V31, P1063, DOI 10.1111/j.1365-3040.2008.01817.x; Vranova E, 2002, J EXP BOT, V53, P1227, DOI 10.1093/jexbot/53.372.1227; Wang RG, 2008, TREE PHYSIOL, V28, P947, DOI 10.1093/treephys/28.6.947; Wang RG, 2007, TREES-STRUCT FUNCT, V21, P581, DOI 10.1007/s00468-007-0154-y; Wu YX, 2007, PLANT MOL BIOL, V65, P1, DOI 10.1007/s11103-007-9170-y; Yamazaki T, 2008, PLANT CELL, V20, P3389, DOI 10.1105/tpc.108.062679; Yu LJ, 2010, NEW PHYTOL, V188, P762, DOI 10.1111/j.1469-8137.2010.03422.x; Zhang AY, 2006, PLANT PHYSIOL, V141, P475, DOI 10.1104/pp.105.075416; Zhang F, 2007, PLANT CELL ENVIRON, V30, P775, DOI 10.1111/j.1365-3040.2007.01667.x; Zhu JK, 2003, CURR OPIN PLANT BIOL, V6, P441, DOI 10.1016/S1369-5266(03)00085-2; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	57	22	36	3	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53136	10.1371/journal.pone.0053136	http://dx.doi.org/10.1371/journal.pone.0053136			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285259	Green Published, gold, Green Submitted			2022-12-27	WOS:000313051500111
J	Xue, T; Yuan, K; Zhao, L; Yu, DH; Zhao, LM; Dong, T; Cheng, P; von Deneen, KM; Qin, W; Tian, J				Xue, Ting; Yuan, Kai; Zhao, Ling; Yu, Dahua; Zhao, Limei; Dong, Tao; Cheng, Ping; von Deneen, Karen M.; Qin, Wei; Tian, Jie			Intrinsic Brain Network Abnormalities in Migraines without Aura Revealed in Resting-State fMRI	PLOS ONE			English	Article							QUALITY-OF-LIFE; FUNCTIONAL CONNECTIVITY; DEFAULT-MODE; PAIN-MATRIX; BASE-LINE; CORTEX; PERCEPTION; POPULATION; FIBROMYALGIA; DISTURBANCES	Background: Previous studies have defined low-frequency, spatially consistent intrinsic connectivity networks (ICN) in resting functional magnetic resonance imaging (fMRI) data which reflect functional interactions among distinct brain areas. We sought to explore whether and how repeated migraine attacks influence intrinsic brain connectivity, as well as how activity in these networks correlates with clinical indicators of migraine. Methods/Principal Findings: Resting-state fMRI data in twenty-three patients with migraines without aura (MwoA) and 23 age- and gender-matched healthy controls (HC) were analyzed using independent component analysis (ICA), in combination with a "dual-regression'' technique to identify the group differences of three important pain-related networks [default mode network (DMN), bilateral central executive network (CEN), salience network (SN)] between the MwoA patients and HC. Compared with the HC, MwoA patients showed aberrant intrinsic connectivity within the bilateral CEN and SN, and greater connectivity between both the DMN and right CEN (rCEN) and the insula cortex - a critical region involving in pain processing. Furthermore, greater connectivity between both the DMN and rCEN and the insula correlated with duration of migraine. Conclusions: Our findings may provide new insights into the characterization of migraine as a condition affecting brain activity in intrinsic connectivity networks. Moreover, the abnormalities may be the consequence of a persistent central neural system dysfunction, reflecting cumulative brain insults due to frequent ongoing migraine attacks.	[Xue, Ting; Yuan, Kai; Yu, Dahua; Zhao, Limei; Dong, Tao; Cheng, Ping; von Deneen, Karen M.; Qin, Wei; Tian, Jie] Xidian Univ, Sch Life Sci & Technol, Life Sci Res Ctr, Xian, Shaanxi, Peoples R China; [Zhao, Ling] Chengdu Univ Tradit Chinese Med, Teaching Hosp 3, Chengdu, Sichuan, Peoples R China; [Yu, Dahua] Inner Mongolia Univ Sci & Technol, Sch Informat Engn, Informat Proc Lab, Baotou, Inner Mongolia, Peoples R China; [Tian, Jie] Chinese Acad Sci, Intelligent Med Res Ctr, Inst Automat, Beijing, Peoples R China	Xidian University; Chengdu University of Traditional Chinese Medicine; Inner Mongolia University of Science & Technology; Chinese Academy of Sciences; Institute of Automation, CAS	Qin, W (corresponding author), Xidian Univ, Sch Life Sci & Technol, Life Sci Res Ctr, Xian, Shaanxi, Peoples R China.	wqin@xidian.edu.cn; tian@ieee.org	Life, PAM/M-9552-2013; Yuan, Kai/M-9403-2013; tian, jie/M-6336-2013; Tian, Jie/H-1190-2011; Yu, Dahua/N-7242-2013; 秦, 伟/J-9770-2016; Yuan, Kai/I-4150-2016	Tian, Jie/0000-0003-0498-0432; Yu, Dahua/0000-0001-7850-7512; 秦, 伟/0000-0003-4583-0406; Yuan, Kai/0000-0002-3098-1124	Project for the National Key Basic Research and Development Program (973) [2011CB707702, 2012CB518501]; National Natural Science Foundation of China [30930112, 30970774, 60901064, 30873462, 81000640, 81000641, 81071217, 81101036, 81101108, 31150110171, 30901900]; Fundamental Research Funds for the Central Universities; Natural Science Foundation of Inner Mongolia [2012MS0908]; Innovation Fund Project of Inner Mongolia University of Science and Technology [2010NC030, 2010NC037]	Project for the National Key Basic Research and Development Program (973)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Natural Science Foundation of Inner Mongolia; Innovation Fund Project of Inner Mongolia University of Science and Technology	This paper is supported by the Project for the National Key Basic Research and Development Program (973) under Grant Nos. 2011CB707702, 2012CB518501, the National Natural Science Foundation of China under Grant Nos. 30930112, 30970774, 60901064, 30873462, 81000640, 81000641, 81071217, 81101036, 81101108, 31150110171, 30901900, the Fundamental Research Funds for the Central Universities, the Natural Science Foundation of Inner Mongolia under Grant No. 2012MS0908 and the Innovation Fund Project of Inner Mongolia University of Science and Technology Nos. 2010NC030, 2010NC037. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Aurora SK, 2007, CEPHALALGIA, V27, P1442, DOI 10.1111/j.1468-2982.2007.01502.x; Beckmann C., 2009, NEUROIMAGE, V47, pS148, DOI [10.1016/S1053-8119(09)71511-3, DOI 10.1016/S1053-8119(09)71511-3, 10.1016/s1053-8119(09)71511-3]; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Boly M, 2007, P NATL ACAD SCI USA, V104, P12187, DOI 10.1073/pnas.0611404104; Bornhovd K, 2002, BRAIN, V125, P1326, DOI 10.1093/brain/awf137; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; Calandre EP, 2002, CEPHALALGIA, V22, P291, DOI 10.1046/j.1468-2982.2002.00370.x; Cauda F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041929; Cauda F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004542; Chiapparini L, 2010, NEUROL SCI, V31, P19, DOI 10.1007/s10072-010-0266-9; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Cordes D, 2000, AM J NEURORADIOL, V21, P1636; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Critchley HD, 2004, P NATL ACAD SCI USA, V101, P6333, DOI 10.1073/pnas.0401510101; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Dick B, 2002, ARTHRIT RHEUM-ARTHR, V47, P639, DOI 10.1002/art.10800; Eccleston C, 1999, PSYCHOL BULL, V125, P356, DOI 10.1037/0033-2909.125.3.356; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; Fox MD, 2006, NAT NEUROSCI, V9, P23, DOI 10.1038/nn1616; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NEURON, V56, P171, DOI 10.1016/j.neuron.2007.08.023; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius M, 2008, CURR OPIN NEUROL, V21, P424, DOI 10.1097/WCO.0b013e328306f2c5; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Iannetti GD, 2010, EXP BRAIN RES, V205, P1, DOI 10.1007/s00221-010-2340-1; Jin C, 2012, NMR BIOMEDI IN PRESS; Kurth F, 2010, BRAIN STRUCT FUNCT, V214, P519, DOI 10.1007/s00429-010-0255-z; Launer LJ, 1999, NEUROLOGY, V53, P537, DOI 10.1212/WNL.53.3.537; Le Pira F, 2000, CEPHALALGIA, V20, P475, DOI 10.1046/j.1468-2982.2000.00074.x; Legrain V, 2011, PROG NEUROBIOL, V93, P111, DOI 10.1016/j.pneurobio.2010.10.005; Lipton RB, 2000, NEUROLOGY, V55, P629, DOI 10.1212/WNL.55.5.629; Lorenz J, 1997, PAIN, V73, P369, DOI 10.1016/S0304-3959(97)00123-1; Ma N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016560; Mainero C, 2011, ANN NEUROL, V70, P838, DOI 10.1002/ana.22537; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Meyer JS, 2000, ANN NEUROL, V48, P430; Moulton EA, 2011, CEREB CORTEX, V21, P435, DOI 10.1093/cercor/bhq109; Mouraux A, 2009, J NEUROPHYSIOL, V101, P3258, DOI 10.1152/jn.91181.2008; Mouraux A, 2011, NEUROIMAGE, V54, P2237, DOI 10.1016/j.neuroimage.2010.09.084; Napadow V, 2010, ARTHRITIS RHEUM-US, V62, P2545, DOI 10.1002/art.27497; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Otti A, 2010, NEUROSCIENCE, V169, P143, DOI 10.1016/j.neuroscience.2010.04.072; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Palaniyappan L, 2012, J PSYCHIATR NEUROSCI, V37, P17, DOI 10.1503/jpn.100176; Ploner M, 2010, P NATL ACAD SCI USA, V107, P355, DOI 10.1073/pnas.0906186106; Qi RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037400; Raichle ME, 2005, J COMP NEUROL, V493, P167, DOI 10.1002/cne.20752; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rocca MA, 2010, CEPHALALGIA, V30, P1383, DOI 10.1177/0333102410365164; Roosendaal SD, 2010, BRAIN, V133, P1612, DOI 10.1093/brain/awq058; Russo A, 2012, J NEUROL, V259, P1903, DOI 10.1007/s00415-012-6438-1; Schwedt TJ, 2009, LANCET NEUROL, V8, P560, DOI 10.1016/S1474-4422(09)70107-3; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Seifert F, 2012, HUMAN BRAIN MAPPING; Seminowicz DA, 2007, J NEUROPHYSIOL, V97, P3651, DOI 10.1152/jn.01210.2006; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Terwindt GM, 2000, NEUROLOGY, V55, P624, DOI 10.1212/WNL.55.5.624; Tracey I, 2005, CURR OPIN NEUROBIOL, V15, P478, DOI 10.1016/j.conb.2005.06.010; Treede RD, 1999, PAIN, V79, P105, DOI 10.1016/S0304-3959(98)00184-5; Uddin L. Q., 2010, FRONTIERS SYSTEMS NE, V4; Uddin LQ, 2011, J NEUROSCI, V31, P18578, DOI 10.1523/JNEUROSCI.4465-11.2011; Van Damme S, 2010, NEUROSCI BIOBEHAV R, V34, P204, DOI 10.1016/j.neubiorev.2009.01.005; Veldhuijzen DS, 2006, PAIN, V121, P60, DOI 10.1016/j.pain.2005.12.004; Wager TD, 2009, NEUROIMAGE, V45, pS210, DOI 10.1016/j.neuroimage.2008.10.061; Wu QZ, 2011, HUM BRAIN MAPP, V32, P1290, DOI 10.1002/hbm.21108; Yarkoni T, 2011, NAT METHODS, V8, P665, DOI [10.1038/NMETH.1635, 10.1038/nmeth.1635]; Yu DH, 2012, NMR BIOMED, V25, P806, DOI 10.1002/nbm.1796; Yuan K, 2010, NEUROSCI LETT, V475, P20, DOI 10.1016/j.neulet.2010.03.033	79	125	129	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52927	10.1371/journal.pone.0052927	http://dx.doi.org/10.1371/journal.pone.0052927			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285228	Green Submitted, Green Published, gold			2022-12-27	WOS:000313051500083
J	Zhang, HN; Wu, SW; Yang, YH; Tabashnik, BE; Wu, YD				Zhang, Haonan; Wu, Shuwen; Yang, Yihua; Tabashnik, Bruce E.; Wu, Yidong			Non-Recessive Bt Toxin Resistance Conferred by an Intracellular Cadherin Mutation in Field-Selected Populations of Cotton Bollworm	PLOS ONE			English	Article							BACILLUS-THURINGIENSIS TOXINS; HELICOVERPA-ARMIGERA HUBNER; CRY1AC DELTA-ENDOTOXIN; INSECT RESISTANCE; DIAMONDBACK MOTH; PINK-BOLLWORM; HELIOTHIS-VIRESCENS; PECTINOPHORA-GOSSYPIELLA; EVOLVED RESISTANCE; BOMBYX-MORI	Transgenic crops producing Bacillus thuringiensis (Bt) toxins have been planted widely to control insect pests, yet evolution of resistance by the pests can reduce the benefits of this approach. Recessive mutations in the extracellular domain of toxin-binding cadherin proteins that confer resistance to Bt toxin Cry1Ac by disrupting toxin binding have been reported previously in three major lepidopteran pests, including the cotton bollworm, Helicoverpa armigera. Here we report a novel allele from cotton bollworm with a deletion in the intracellular domain of cadherin that is genetically linked with non-recessive resistance to Cry1Ac. We discovered this allele in each of three field-selected populations we screened from northern China where Bt cotton producing Cry1Ac has been grown intensively. We expressed four types of cadherin alleles in heterologous cell cultures: susceptible, resistant with the intracellular domain mutation, and two complementary chimeric alleles with and without the mutation. Cells transfected with each of the four cadherin alleles bound Cry1Ac and were killed by Cry1Ac. However, relative to cells transfected with either the susceptible allele or the chimeric allele lacking the intracellular domain mutation, cells transfected with the resistant allele or the chimeric allele containing the intracellular domain mutation were less susceptible to Cry1Ac. These results suggest that the intracellular domain of cadherin is involved in post-binding events that affect toxicity of Cry1Ac. This evidence is consistent with the vital role of the intracellular region of cadherin proposed by the cell signaling model of the mode of action of Bt toxins. Considered together with previously reported data, the results suggest that both pore formation and cell signaling pathways contribute to the efficacy of Bt toxins.	[Zhang, Haonan; Wu, Shuwen; Yang, Yihua; Wu, Yidong] Nanjing Agr Univ, Key Lab Integrated Management Crop Dis & Pests, Minist Educ, Coll Plant Protect, Nanjing, Jiangsu, Peoples R China; [Tabashnik, Bruce E.] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA	Nanjing Agricultural University; University of Arizona	Wu, YD (corresponding author), Nanjing Agr Univ, Key Lab Integrated Management Crop Dis & Pests, Minist Educ, Coll Plant Protect, Nanjing, Jiangsu, Peoples R China.	wyd@njau.edu.cn	ZHANG, HAONAN/N-6395-2018; Wu, Yidong/E-9720-2012; Zhang, Haonan/J-2245-2019	ZHANG, HAONAN/0000-0003-1196-2750; Wu, Yidong/0000-0003-3456-3373; Zhang, Haonan/0000-0003-1196-2750	Ministry of Agriculture of China [2011ZX08012-004]; National Natural Science Foundation of China [31272382]; 111 program [B07030]; U.S. Department of Agriculture-Agriculture and Food Research Initiative [2008-35302-0390]	Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 program(Ministry of Education, China - 111 Project); U.S. Department of Agriculture-Agriculture and Food Research Initiative	This work was funded by research grants from the Ministry of Agriculture of China (2011ZX08012-004), the National Natural Science Foundation of China (31272382), the 111 program (B07030), and the U.S. Department of Agriculture-Agriculture and Food Research Initiative (2008-35302-0390). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhurst RJ, 2003, J ECON ENTOMOL, V96, P1290, DOI 10.1603/0022-0493-96.4.1290; Atsumi S, 2012, P NATL ACAD SCI USA, V109, pE1591, DOI 10.1073/pnas.1120698109; Baxter SW, 2011, GENETICS, V189, P675, DOI 10.1534/genetics.111.130971; Bravo A, 2011, INSECT BIOCHEM MOLEC, V41, P423, DOI 10.1016/j.ibmb.2011.02.006; Carriere Y, 2010, EVOL APPL, V3, P561, DOI 10.1111/j.1752-4571.2010.00129.x; Dhurua S, 2011, PEST MANAG SCI, V67, P898, DOI 10.1002/ps.2127; Downes S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012567; Fabrick JA, 2007, INSECT BIOCHEM MOLEC, V37, P97, DOI 10.1016/j.ibmb.2006.10.010; Ferre J, 2002, ANNU REV ENTOMOL, V47, P501, DOI 10.1146/annurev.ento.47.091201.145234; Gahan LJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001248; Gahan LJ, 2001, SCIENCE, V293, P857, DOI 10.1126/science.1060949; Gassmann AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022629; Gonzalez-Cabrera J, 2003, INSECT BIOCHEM MOLEC, V33, P929, DOI 10.1016/S0965-1748(03)00099-7; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; Heckel DG, 1999, P NATL ACAD SCI USA, V96, P8373, DOI 10.1073/pnas.96.15.8373; Janmaat AF, 2003, P ROY SOC B-BIOL SCI, V270, P2263, DOI 10.1098/rspb.2003.2497; Jurat-Fuentes JL, 2004, BIOCHEMISTRY-US, V43, P14299, DOI 10.1021/bi048500i; Jurat-Fuentes JL, 2006, J INVERTEBR PATHOL, V92, P166, DOI 10.1016/j.jip.2006.01.010; Jurat-Fuentes JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017606; Kranthi KR, 2006, CROP PROT, V25, P119, DOI 10.1016/j.cropro.2005.03.011; Liang GM, 2008, J INVERTEBR PATHOL, V97, P142, DOI 10.1016/j.jip.2007.09.007; Liu CX, 2010, J INSECT PHYSIOL, V56, P718, DOI 10.1016/j.jinsphys.2009.12.012; Liu YB, 1997, APPL ENVIRON MICROB, V63, P2218, DOI 10.1128/AEM.63.6.2218-2223.1997; Mendelsohn M, 2003, NAT BIOTECHNOL, V21, P1003, DOI 10.1038/nbt0903-1003; Morin S, 2003, P NATL ACAD SCI USA, V100, P5004, DOI 10.1073/pnas.0831036100; Nagamatsu Y, 1998, BIOSCI BIOTECH BIOCH, V62, P718, DOI 10.1271/bbb.62.718; Pigott CR, 2007, MICROBIOL MOL BIOL R, V71, P255, DOI 10.1128/MMBR.00034-06; Sanahuja G, 2011, PLANT BIOTECHNOL J, V9, P283, DOI 10.1111/j.1467-7652.2011.00595.x; STONE BF, 1968, B WORLD HEALTH ORGAN, V38, P325; Storer NP, 2010, J ECON ENTOMOL, V103, P1031, DOI 10.1603/EC10040; TABASHNIK BE, 1994, ANNU REV ENTOMOL, V39, P47, DOI 10.1146/annurev.en.39.010194.000403; Tabashnik BE, 1997, P NATL ACAD SCI USA, V94, P1640, DOI 10.1073/pnas.94.5.1640; TABASHNIK BE, 1994, P NATL ACAD SCI USA, V91, P4120, DOI 10.1073/pnas.91.10.4120; TABASHNIK BE, 1990, J ECON ENTOMOL, V83, P1671, DOI 10.1093/jee/83.5.1671; Tabashnik BE, 1998, PHILOS T R SOC B, V353, P1751, DOI 10.1098/rstb.1998.0327; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P199, DOI 10.1038/nbt1382; Tabashnik BE, 2012, J ECON ENTOMOL, V105, P767, DOI 10.1603/EC12080; Tabashnik BE, 2009, J ECON ENTOMOL, V102, P2011, DOI 10.1603/029.102.0601; Tang Q., 2007, DPS DATA PROCESSING; Tiewsiri K, 2011, P NATL ACAD SCI USA, V108, P14037, DOI 10.1073/pnas.1102555108; Vachon V, 2012, J INVERTEBR PATHOL, V111, P1, DOI 10.1016/j.jip.2012.05.001; van Rensburg J. B. J., 2007, South African Journal of Plant and Soil, V24, P147; Wan P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029975; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; Wu Y, 2009, J APPL ENTOMOL, V133, P375, DOI 10.1111/j.1439-0418.2008.01368.x; Xu XJ, 2008, J INVERTEBR PATHOL, V97, P27, DOI 10.1016/j.jip.2007.04.009; Xu XJ, 2005, APPL ENVIRON MICROB, V71, P948, DOI 10.1128/AEM.71.2.948-954.2005; Yang YH, 2009, B ENTOMOL RES, V99, P175, DOI 10.1017/S0007485308006226; Yang YJ, 2007, APPL ENVIRON MICROB, V73, P6939, DOI 10.1128/AEM.01703-07; Yang YJ, 2006, INSECT BIOCHEM MOLEC, V36, P735, DOI 10.1016/j.ibmb.2006.06.003; Zhang HN, 2012, P NATL ACAD SCI USA, V109, P10275, DOI 10.1073/pnas.1200156109; Zhang HN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022874; Zhang XB, 2006, P NATL ACAD SCI USA, V103, P9897, DOI 10.1073/pnas.0604017103; Zhao J, 2010, INSECT BIOCHEM MOLEC, V40, P113, DOI 10.1016/j.ibmb.2010.01.001	54	50	53	3	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53418	10.1371/journal.pone.0053418	http://dx.doi.org/10.1371/journal.pone.0053418			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285292	gold, Green Published, Green Submitted			2022-12-27	WOS:000313051500147
J	Abdelhadi, J; Wefstaedt, P; Nolte, I; Schilling, N				Abdelhadi, Jalal; Wefstaedt, Patrick; Nolte, Ingo; Schilling, Nadja			Fore-Aft Ground Force Adaptations to Induced Forelimb Lameness in Walking and Trotting Dogs	PLOS ONE			English	Article							TOTAL-ELBOW ARTHROPLASTY; LABRADOR RETRIEVERS; EPAXIAL MUSCLES; PLATE ANALYSES; GAIT ANALYSIS; HIND-LIMB; JOINT; TREADMILL; REDISTRIBUTION; ACCELERATION	Animals alter their locomotor mechanics to adapt to a loss of limb function. To better understand their compensatory mechanisms, this study evaluated the changes in the fore-aft ground forces to forelimb lameness and tested the hypothesis that dogs unload the affected limb by producing a nose-up pitching moment via the exertion of a net-propulsive force when the lame limb is on the ground. Seven healthy Beagles walked and trotted at steady speed on an instrumented treadmill while horizontal force data were collected before and after a moderate lameness was induced. Peak, mean and summed braking and propulsive forces as well as the duration each force was exerted and the time to reach maximum force were evaluated for both the sound and the lame condition. Compared with the sound condition, a net-propulsive force was produced by the lame diagonal limbs due to a reduced braking force in the affected forelimb and an increased propulsive force in the contralateral hindlimb when the dogs walked and trotted. To regain pitch stability and ensure steady speed for a given locomotor cycle, the dogs produced a net-braking force when the sound diagonal limbs were on the ground by exerting greater braking forces in both limbs during walking and additionally reducing the propulsive force in the hindlimb during trotting. Consistent with the proposed mechanism, dogs maximize their double support phases when walking. Likely associated with the fore-aft force adaptations to lameness are changes in muscle recruitment that potentially result in short- and long-term effects on the limb and trunk muscles.	[Abdelhadi, Jalal; Wefstaedt, Patrick; Nolte, Ingo; Schilling, Nadja] Univ Vet Med Hannover, Small Anim Clin, Hannover, Germany; [Abdelhadi, Jalal] Univ Tripoli, Fac Vet Med, Dept Surg & Reprod, Tripoli, Libya; [Schilling, Nadja] Univ Jena, Inst Systemat Zool & Evolutionary Biol, Jena, Germany	University of Veterinary Medicine Hannover, Foundation; Friedrich Schiller University of Jena	Schilling, N (corresponding author), Univ Vet Med Hannover, Small Anim Clin, Hannover, Germany.	nadja.schilling@tiho-hannover.de	Schilling, Nadja/F-9627-2013		Lybian government; Center of Interdisciplinary Prevention of Diseases related to Professional Activities (KIP); Berufsgenossenschaft Nahrungsmittel und Gastgewerbe, Erfurt; Friedrich-Schiller-University Jena	Lybian government; Center of Interdisciplinary Prevention of Diseases related to Professional Activities (KIP); Berufsgenossenschaft Nahrungsmittel und Gastgewerbe, Erfurt; Friedrich-Schiller-University Jena	This study was supported by Lybian government (scholarship to JA) and the Center of Interdisciplinary Prevention of Diseases related to Professional Activities (KIP) funded by the Berufsgenossenschaft Nahrungsmittel und Gastgewerbe, Erfurt and the Friedrich-Schiller-University Jena (to NS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhadi J, 2012, AM J VET RE IN PRESS; Bertram JEA, 2000, AM J VET RES, V61, P832, DOI 10.2460/ajvr.2000.61.832; Bertram JEA, 1997, VET COMP ORTHOPAED, V10, P160; Bockstahler BA, 2009, VET J, V180, P202, DOI 10.1016/j.tvjl.2007.12.025; BRYANT JD, 1987, J ZOOL, V213, P193, DOI 10.1111/j.1469-7998.1987.tb03693.x; Bubenik LJ, 2002, VET SURG, V31, P23, DOI 10.1053/jvet.2002.29460; BUDSBERG SC, 1987, AM J VET RES, V48, P915; BUDSBERG SC, 1993, AM J VET RES, V54, P1569; BUDSBERG SC, 1988, AM J VET RES, V49, P1522; Budsberg SC, 1999, VET COMP ORTHOPAED, V12, P15; Burton NJ, 2008, VET COMP ORTHOPAED, V21, P110, DOI 10.3415/VCOT-07-04-0038; Carrier DR, 2008, J EXP BIOL, V211, P150, DOI 10.1242/jeb.010678; CAVAGNA GA, 1977, AM J PHYSIOL, V233, pR243, DOI 10.1152/ajpregu.1977.233.5.R243; Conzemius MG, 2003, VET SURG, V32, P545, DOI 10.1111/j.1532-950X.2003.00545.x; Conzemius MG, 2001, VET SURG, V30, P11, DOI 10.1053/jvet.2001.20325; Deban SM, 2012, J EXP BIOL, V215, P287, DOI 10.1242/jeb.063230; DeCamp CE, 1997, VET CLIN N AM-SMALL, V27, P825, DOI 10.1016/S0195-5616(97)50082-9; Druen S, 2010, BERL MUNCH TIERARZTL, V123, P339, DOI 10.2376/0005-9366-123-339; Fanchon L, 2006, VET COMP ORTHOPAED, V19, P81; FARLEY CT, 1993, J EXP BIOL, V185, P71; Griffin TM, 2004, J EXP BIOL, V207, P3545, DOI 10.1242/jeb.01177; GRIFFON DJ, 1994, VET COMP ORTHOPAED, V7, P154; HERZOG W, 1989, MED SCI SPORT EXER, V21, P110, DOI 10.1249/00005768-198902000-00020; Hildebrand M., 1966, Folia Biotheoretica, VNo. 6, P9; Kapatkin AS, 2006, JAVMA-J AM VET MED A, V228, P1350, DOI 10.2460/javma.228.9.1350; Kirpensteijn J, 2000, VET REC, V146, P155, DOI 10.1136/vr.146.6.155; Lee DV, 2004, J EXP BIOL, V207, P1715, DOI 10.1242/jeb.00947; Lee DV, 1999, J EXP BIOL, V202, P3565; MCLAUGHLIN R, 1995, VET SURG, V24, P207, DOI 10.1111/j.1532-950X.1995.tb01320.x; MCLAUGHLIN R, 1995, AM J VET RES, V56, P159; Ragetly CA, 2012, AM J VET RES, V73, P1171, DOI 10.2460/ajvr.73.8.1171; Ragetly CA, 2010, VET SURG, V39, P513, DOI 10.1111/j.1532-950X.2010.00680.x; RIGGS CM, 1993, AM J VET RES, V54, P1523; RUMPH PF, 1994, AM J VET RES, V55, P756; Schilling N, 2010, J EXP BIOL, V213, P1490, DOI 10.1242/jeb.039487; Schilling N, 2009, J EXP BIOL, V212, P1053, DOI 10.1242/jeb.020248; Schilling N, 2009, J EXP BIOL, V212, P1036, DOI 10.1242/jeb.020255; Theyse LFH, 2000, VET COMP ORTHOPAED, V13, P135; Walter RM, 2007, J EXP BIOL, V210, P208, DOI 10.1242/jeb.02645; WENTINK GH, 1977, ANAT EMBRYOL, V151, P171, DOI 10.1007/BF00297479; [No title captured]	41	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e52202	10.1371/journal.pone.0052202	http://dx.doi.org/10.1371/journal.pone.0052202			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300614	gold, Green Published, Green Submitted			2022-12-27	WOS:000313618800057
J	Chopra, K; Chadha, VK; Ramachandra, J; Aggarwal, N				Chopra, Kamal; Chadha, Vineet K.; Ramachandra, Jitendra; Aggarwal, Nishi			Trend in Annual Risk of Tuberculous Infection in North India	PLOS ONE			English	Article								Setting: Six selected districts in Northern India. Objectives: To find out the trend in Annual risk of tuberculous infection (ARTI) in north India. Study Design: Two rounds of community level surveys were conducted during 2000-2001 and 2009-10 respectively. Representative samples of children 1-9 years of age were tuberculin tested and maximum transverse diameter of induration was recorded in mm at about 72 hours. ARTI was computed from the estimated Prevalence of infection using mirror-image technique and anti-mode method. Results: ARTI was found to decline from 1.9% (confidence interval: 1.7-2.1) at round I to 1.1% (confidence interval: 0.8-1.3) at round II at the rate of 8% per year during the intervening period. Conclusion: A significant reduction in the risk of tuberculous infection among children was observed between two rounds of surveys carried out at an interval of about 9 years.	[Chopra, Kamal] New Delhi TB Ctr, Directors Off, New Delhi, India; [Chadha, Vineet K.] Natl TB Inst, Epidemiol & Res Div, Bangalore, Karnataka, India; [Ramachandra, Jitendra] Natl TB Inst, HRD Div, Bangalore, Karnataka, India; [Aggarwal, Nishi] New Delhi TB Ctr, Dept Stat, New Delhi, India		Chopra, K (corresponding author), New Delhi TB Ctr, Directors Off, New Delhi, India.	chopra_drkk@yahoo.co.in			Ministry of Health and Family welfare, Government of India	Ministry of Health and Family welfare, Government of India	Authors are grateful to all the field staff and district health authorities for support. Funds were provided by the Ministry of Health and Family welfare, Government of India. Best regards will remain due to Dr V K Dhingra (late), the then Director of New Delhi TB Centre.	Bleiker M A, 1989, Bull Int Union Tuberc Lung Dis, V64, P7; Cauthen GM, 2002, B WORLD HEALTH ORGAN, V80, P503; Central TB Division Directorate General Health Services Ministry of Health and Family Welfare Government of India, 2010, TB INDIA 2010 REVISE; Chadha VK, 2008, INT J TUBERC LUNG D, V12, P1116; Chadha VK, 2005, INT J TUBERC LUNG D, V9, P569; Chadha VK, 2004, INT J TUBERC LUNG D, V8, P1437; Chadha VK, 2003, B WORLD HEALTH ORGAN, V81, P573; Chadha VK, 2003, INT J TUBERC LUNG D, V7, P172; Chadha VK, 2011, TEXT BOOK OF PULMONA, P489; Channabasavaiah R, 1993, INDIAN J TUBERCULOSI, V40, P137; Gopi PG, 2006, INT J TUBERC LUNG D, V10, P345; HONG YP, 1993, TUBERCLE LUNG DIS, V74, P323, DOI 10.1016/0962-8479(93)90107-9; Indian Council of Medical Research, 1959, SPECIAL REPORT SERIE, V34; Neuenschwander BE, 2010, BAYESIAN MIXTURE ANA; Rieder HL, 2011, INT J TUBERC LUNG D, V15, pS1; Styblo K, 1991, EPIDEMIOLOGY OF TUBE, V24	16	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2012	7	12							e51854	10.1371/journal.pone.0051854	http://dx.doi.org/10.1371/journal.pone.0051854			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TV	23300568	Green Published, gold, Green Submitted			2022-12-27	WOS:000313618800030
J	Bogdanov, AM; Kudryavtseva, EI; Lukyanov, KA				Bogdanov, Alexey M.; Kudryavtseva, Elena I.; Lukyanov, Konstantin A.			Anti-Fading Media for Live Cell GFP Imaging	PLOS ONE			English	Article							FLUORESCENT PROTEINS; LIVING CELLS	Photostability is one of the most important characteristic of a dye for fluorescence microscopy. Recently we demonstrated that vitamins present in imaging media dramatically accelerate photobleaching of Enhanced Green Fluorescent Protein (EGFP) and many other green fluorescent and photoactivatable proteins. Here we tested all vitamins of commonly used media (such as Dulbecco's Modified Eagle Medium, DMEM) one-by-one and found that only two vitamins, riboflavin and pyridoxal, decrease photostability of EGFP. Thus, DMEM without riboflavin and pyridoxal can be used as an imaging medium, which ensures high photostability of GFPs at the expense of minimal biochemical disturbance. Then, we tested some antioxidants and found that a plant flavonoid rutin greatly enhances photostability of EGFP during live cell microscopy. In complete DMEM, rutin increased EGFP photostability up to the level of vitamin-depleted DMEM. Moreover, being added to vitamin-depleted DMEM, rutin was able to further suppress EGFP photobleaching. Potentially, new medium formulations can be widely used for fluorescence microscopy of GFP-expressing cells and model multicellular organisms in a variety of imaging applications, where photostability represents a challenge.	[Bogdanov, Alexey M.; Kudryavtseva, Elena I.; Lukyanov, Konstantin A.] Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Lukyanov, KA (corresponding author), Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia.	kluk@ibch.ru	Bogdanov, Alexey/Q-7926-2019; Lukyanov, Konstantin A/D-4030-2013; Bogdanov, Alexey M/S-2759-2018	Bogdanov, Alexey/0000-0002-5346-789X; Lukyanov, Konstantin A/0000-0001-9845-2088; Bogdanov, Alexey M/0000-0002-5346-789X	Dinasty Foundation; Russian Foundation for Basic Research [11-04-01861a]	Dinasty Foundation; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This work was supported by the Dinasty Foundation and Russian Foundation for Basic Research grant 11-04-01861a. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Bhandary B, 2012, ARCH PHARM RES, V35, P1091, DOI 10.1007/s12272-012-0617-6; Bogdanov AM, 2009, NAT METHODS, V6, P859, DOI 10.1038/nmeth1209-859; Bogdanov AM, 2009, NAT CHEM BIOL, V5, P459, DOI 10.1038/nchembio.174; Chudakov DM, 2010, PHYSIOL REV, V90, P1103, DOI 10.1152/physrev.00038.2009; Fernandez-Suarez M, 2008, NAT REV MOL CELL BIO, V9, P929, DOI 10.1038/nrm2531; HANASAKI Y, 1994, FREE RADICAL BIO MED, V16, P845, DOI 10.1016/0891-5849(94)90202-X; Huvaere K, 2012, J AGR FOOD CHEM, V60, P9261, DOI 10.1021/jf301823h; Kohl T, 2005, ADV BIOCHEM ENG BIOT, V95, P107; LONGIN A, 1993, J HISTOCHEM CYTOCHEM, V41, P1833, DOI 10.1177/41.12.8245431; MIKHAILOV AV, 1995, CELL MOTIL CYTOSKEL, V32, P173, DOI 10.1002/cm.970320303	11	36	38	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e53004	10.1371/journal.pone.0053004	http://dx.doi.org/10.1371/journal.pone.0053004			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285248	Green Submitted, gold, Green Published			2022-12-27	WOS:000313158800112
J	Mamber, C; Kamphuis, W; Haring, NL; Peprah, N; Middeldorp, J; Hol, EM				Mamber, Carlyn; Kamphuis, Willem; Haring, Nina L.; Peprah, Nuzrat; Middeldorp, Jinte; Hol, Elly M.			GFAP delta Expression in Glia of the Developmental and Adolescent Mouse Brain	PLOS ONE			English	Article							FIBRILLARY ACIDIC PROTEIN; CENTRAL-NERVOUS-SYSTEM; SUBVENTRICULAR ZONE; MESSENGER-RNA; PROGENITOR CELLS; GENE-EXPRESSION; CEREBRAL-CORTEX; RADIAL GLIA; STEM-CELLS; RAT-BRAIN	Glial fibrillary acidic protein (GFAP) is the major intermediate filament (IF) protein in astrocytes. In the human brain, GFAP isoforms have unique expression patterns, which indicate that they play distinct functional roles. One isoform, GFAP delta, is expressed by proliferative radial glia in the developing human brain. In the adult human, GFAP delta is a marker for neural stem cells. However, it is unknown whether GFAP delta marks the same population of radial glia and astrocytes in the developing mouse brain as it does in the developing human brain. This study characterizes the expression pattern of GFAP delta throughout mouse embryogenesis and into adolescence. GFAP delta transcripts are expressed from E12, but immunohistochemistry shows GFAP delta staining only from E18. This finding suggests a translational uncoupling. GFAP delta expression increases from E18 to P5 and then decreases until its expression plateaus around P25. During development, GFAP delta is expressed by radial glia, as denoted by the co-expression of markers like vimentin and nestin. GFAP delta is also expressed in other astrocytic populations during development. A similar pattern is observed in the adolescent mouse, where GFAP delta marks both neural stem cells and mature astrocytes. Interestingly, the GFAP delta/Gfap alpha transcript ratio remains stable throughout development as well as in primary astrocyte and neurosphere cultures. These data suggest that all astroglia cells in the developing and adolescent mouse brain express GFAP delta, regardless of their neurogenic capabilities. GFAP delta may be an integral component of all mouse astrocytes, but it is not a specific neural stem cell marker in mice as it is in humans.	[Mamber, Carlyn; Kamphuis, Willem; Haring, Nina L.; Peprah, Nuzrat; Middeldorp, Jinte; Hol, Elly M.] Inst Royal Netherlands Acad Arts & Sci KNAW, Dept Astrocyte Biol & Neurodegenerat, Netherlands Inst Neurosci, Amsterdam, Netherlands; [Middeldorp, Jinte] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Hol, Elly M.] Univ Amsterdam, Swammerdam Inst Life Sci, Ctr Neurosci, Amsterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Stanford University; University of Amsterdam	Hol, EM (corresponding author), Inst Royal Netherlands Acad Arts & Sci KNAW, Dept Astrocyte Biol & Neurodegenerat, Netherlands Inst Neurosci, Amsterdam, Netherlands.	e.hol@nin.knaw.nl	Hol, Elly/J-2025-2019; , Jinte/AHA-6575-2022; Hol, Elly M/F-1891-2013; Middeldorp, Jinte/M-2352-2016	Hol, Elly/0000-0001-5604-2603; , Jinte/0000-0002-9198-8020; Hol, Elly M/0000-0001-5604-2603; Middeldorp, Jinte/0000-0002-9198-8020	Netherlands Organization for Scientific Research (NWO) [865.09.003]; NANONET COST [BM1002]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NANONET COST(European Cooperation in Science and Technology (COST))	This project is funded by the Netherlands Organization for Scientific Research (NWO; VICI grant to E.M.H. [865.09.003]; URL: http://www.nwo.nl/) and NANONET COST [BM1002]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 1912, J COMP NEUROL, V22, P547; ALTMAN J, 1966, J COMP NEUROL, V126, P337, DOI 10.1002/cne.901260302; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Andrae J, 2001, MECH DEVELOP, V107, P181, DOI 10.1016/S0925-4773(01)00460-9; Baba H, 1997, DEV NEUROSCI-BASEL, V19, P49, DOI 10.1159/000111185; Barry G, 2008, J NEUROSCI, V28, P12328, DOI 10.1523/JNEUROSCI.4000-08.2008; BIGNAMI A, 1989, INT J DEV NEUROSCI, V7, P343, DOI 10.1016/0736-5748(89)90056-7; Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; BRENNER M, 1994, J NEUROSCI, V14, P1030, DOI 10.1523/JNEUROSCI.14-03-01030.1994; Bruni JE, 1998, AID JEMT2 3 0 CO 2 Z; Burns KA, 2009, GLIA, V57, P1115, DOI 10.1002/glia.20835; Clancy B, 2001, NEUROSCIENCE, V105, P7, DOI 10.1016/S0306-4522(01)00171-3; Condorelli DF, 1999, NEUROCHEM RES, V24, P709, DOI 10.1023/A:1021016828704; Dijk F, 2004, INVEST OPHTH VIS SCI, V45, P330, DOI 10.1167/iovs.03-0285; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; DUPREY P, 1995, INT J DEV BIOL, V39, P443; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Fox IJ, 2004, DEV BRAIN RES, V153, P121, DOI 10.1016/j.devbrainres.2004.07.011; Gage FH, 1998, J NEUROBIOL, V36, P249, DOI 10.1002/(SICI)1097-4695(199808)36:2<249::AID-NEU11>3.0.CO;2-9; Ge WP, 2012, NATURE, V484, P376, DOI 10.1038/nature10959; Gotz M, 2005, NEURON, V46, P369, DOI 10.1016/j.neuron.2005.04.012; Imura T, 2003, J NEUROSCI, V23, P2824; Kamphuis W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042823; Kamphuis W, 2012, GLIA, V60, P615, DOI 10.1002/glia.22295; Kim JS, 2011, J VET SCI, V12, P1, DOI 10.4142/jvs.2011.12.1.1; Kimelberg HK, 2004, NEUROCHEM INT, V45, P191, DOI 10.1016/j.neuint.2003.08.015; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; Leonard BW, 2009, J COMP NEUROL, V515, P269, DOI 10.1002/cne.22040; Lepekhin EA, 2001, J NEUROCHEM, V79, P617, DOI 10.1046/j.1471-4159.2001.00595.x; Leprince P, 2001, Prog Brain Res, V132, P13; LEVITT P, 1980, J COMP NEUROL, V193, P815, DOI 10.1002/cne.901930316; Lindwall C, 2007, CURR OPIN NEUROBIOL, V17, P3, DOI 10.1016/j.conb.2007.01.008; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Malatesta P, 2000, DEVELOPMENT, V127, P5253; Maslov AY, 2004, J NEUROSCI, V24, P1726, DOI 10.1523/JNEUROSCI.4608-03.2004; Mellodew K, 2004, DEV BRAIN RES, V151, P13, DOI 10.1016/j.devbrainres.2004.03.018; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Middeldorp J, 2010, DEVELOPMENT, V137, P313, DOI 10.1242/dev.041632; MISSON JP, 1988, DEV BRAIN RES, V44, P95, DOI 10.1016/0165-3806(88)90121-6; Nielsen AL, 2002, J BIOL CHEM, V277, P29983, DOI 10.1074/jbc.M112121200; Oland LA, 2011, GLIA, V59, P1273, DOI 10.1002/glia.21096; Pallari Hanna-Mari, 2006, Sci STKE, V2006, ppe53, DOI 10.1126/stke.3662006pe53; Perng MD, 2008, MOL BIOL CELL, V19, P4521, DOI 10.1091/mbc.E08-03-0284; Pinto L, 2007, PROG NEUROBIOL, V83, P2, DOI 10.1016/j.pneurobio.2007.02.010; Pontious A, 2008, DEV NEUROSCI-BASEL, V30, P24, DOI 10.1159/000109848; Roelofs RF, 2005, GLIA, V52, P289, DOI 10.1002/glia.20243; ROLLAND B, 1990, DEV BRAIN RES, V56, P144, DOI 10.1016/0165-3806(90)90175-X; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; SANCHOTELLO M, 1995, GLIA, V15, P157, DOI 10.1002/glia.440150208; Sarnat HB, 1998, AID JEMT3 3 0 CO 2 U; SCHNITZER J, 1981, J CELL BIOL, V90, P435, DOI 10.1083/jcb.90.2.435; Singh R, 2003, GENOMICS, V82, P185, DOI 10.1016/S0888-7543(03)00106-X; SORIANO E, 1994, J COMP NEUROL, V342, P571, DOI 10.1002/cne.903420406; Takemura M, 2002, J NEUROSCI, V22, P6972; Valles S, 2002, J NEUROCHEM, V69, P2484, DOI [10.1046/j.1471-4159.1997.69062484.x, DOI 10.1046/J.1471-4159.1997.69062484.X]; van den Berge SA, 2010, AGING CELL, V9, P313, DOI 10.1111/j.1474-9726.2010.00556.x; van Strien ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025037; von Bohlen und Halbach O, 2011, CELL TISSUE RES, V345, P1, DOI 10.1007/s00441-011-1196-4; WOODHAMS PL, 1981, ANAT EMBRYOL, V163, P331, DOI 10.1007/BF00315709; Zhou M, 2000, MOL BRAIN RES, V76, P121, DOI 10.1016/S0169-328X(99)00341-1	61	39	39	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52659	10.1371/journal.pone.0052659	http://dx.doi.org/10.1371/journal.pone.0052659			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285135	Green Published, Green Submitted, gold			2022-12-27	WOS:000313158800086
J	Zhang, ZH; Wang, K; Guo, L; Zhu, YJ; Fan, YY; Cheng, SH; Zhuang, JY				Zhang, Zhen-Hua; Wang, Kai; Guo, Liang; Zhu, Yu-Jun; Fan, Ye-Yang; Cheng, Shi-Hua; Zhuang, Jie-Yun			Pleiotropism of the Photoperiod-Insensitive Allele of Hd1 on Heading Date, Plant Height and Yield Traits in Rice	PLOS ONE			English	Article							NATURAL VARIATION; SHORT ARM; GENE; HD3A; CHROMOSOME-6; EXPRESSION; REGULATOR; SIGNAL; EHD1	Five populations segregated in isogenic backgrounds and three sets of near isogenic lines (NILs) overlapping in a 362.3-kb region covering heading date gene Hd1 were developed from the indica rice cross Zhenshan97 (ZS97)/Milyang 46 (MY46). They were used to analyze the effects of Hd1 on heading date, plant height and yield traits. In a background of the parental mixtures, the photoperiod-sensitive allele derived from ZS97 functioned in promoting and delaying flowering in the natural short-day and long-day conditions, respectively. In the background of ZS97, no response to the photoperiod was observed, whereas the photoperiod-insensitive allele derived from MY46 functioned in delaying flowering, increasing plant height, and enhancing grain productivity. The additive effects estimated in two NIL sets were 6.14 and 6.14 d for heading date, 4.46 and 5.55 cm for plant height, 10.82 and 11.54 for the number of spikelets per panicle, 6.82 and 8.00 for the number of grains per panicle, and 2.16 and 2.23 g for grain yield per plant, which explained 94.1% and 96.3%, 70.5% and 84.8%, 52.4% and 55.2%, 28.9% and 39.2%, and 36.5% and 26.9% of the phenotypic variances, respectively. Since the photoperiod-insensitive allele of Hd1 confers a long vegetative phase, it is a good candidate for breeding rice varieties with high yielding potential for low latitudes.	[Zhang, Zhen-Hua; Wang, Kai; Guo, Liang; Zhu, Yu-Jun; Fan, Ye-Yang; Cheng, Shi-Hua; Zhuang, Jie-Yun] China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou, Zhejiang, Peoples R China; [Zhang, Zhen-Hua; Wang, Kai; Guo, Liang; Zhu, Yu-Jun; Fan, Ye-Yang; Cheng, Shi-Hua; Zhuang, Jie-Yun] China Natl Rice Res Inst, Chinese Natl Ctr Rice Improvement, Hangzhou, Zhejiang, Peoples R China	Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS; Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS	Cheng, SH (corresponding author), China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou, Zhejiang, Peoples R China.	shcheng@mail.hz.zj.cn; jz1803@hzcnc.com	Zhuang, Jie-Yun/B-4131-2012; Zhu, Yujun/GYU-5471-2022	Zhuang, Jie-Yun/0000-0002-1439-5061; Zhu, Yujun/0000-0001-6409-1990; Zhang, Zhen-Hua/0000-0003-0711-7466	Chinese 863 Program [2012AA101102-2]; Chinese High-yielding Transgenic Program [2011ZX08001-004]; China National Rice Research Institute [2012RG002-3]	Chinese 863 Program(National High Technology Research and Development Program of China); Chinese High-yielding Transgenic Program; China National Rice Research Institute	This work was funded by the Chinese 863 Program (No. 2012AA101102-2), the Chinese High-yielding Transgenic Program (No. 2011ZX08001-004), and research funding from the China National Rice Research Institute (No. 2012RG002-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bian XF, 2011, PLANT CELL REP, V30, P2243, DOI 10.1007/s00299-011-1129-4; Chen X, 1997, THEOR APPL GENET, V95, P553, DOI 10.1007/s001220050596; Dai WM, 2008, EUPHYTICA, V160, P317, DOI 10.1007/s10681-007-9501-8; Doi K, 2004, GENE DEV, V18, P926, DOI 10.1101/gad.1189604; Gong JY, 2010, AGR SCI CHINA, V9, P1085, DOI 10.1016/S1671-2927(09)60194-2; Guo L, 2012, RICE SCI IN PRESS; Ishikawa R, 2011, MOL GENET GENOMICS, V285, P461, DOI 10.1007/s00438-011-0621-4; Itoh H, 2010, NAT GENET, V42, P635, DOI 10.1038/ng.606; Izawa T, 2002, GENE DEV, V16, P2006, DOI 10.1101/gad.999202; Kojima S, 2002, PLANT CELL PHYSIOL, V43, P1096, DOI 10.1093/pcp/pcf156; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Matsubara K, 2012, PLANT CELL PHYSIOL, V53, P709, DOI 10.1093/pcp/pcs028; Nishida H, 2002, CROP SCI, V42, P348, DOI 10.2135/cropsci2002.0348; Ogiso E, 2010, PLANT PHYSIOL, V152, P808, DOI 10.1104/pp.109.148908; Rychlik W., 2008, OLIGO PRIMER ANAL SO; SAS Institute Inc, 1999, SAS STAT US GUID; Tamaki S, 2007, SCIENCE, V316, P1033, DOI 10.1126/science.1141753; Tsuji H, 2011, CURR OPIN PLANT BIOL, V14, P45, DOI 10.1016/j.pbi.2010.08.016; Wang S., 2011, WINDOWS QTL CARTOGRA; Wei XiangJin, 2012, Acta Agronomica Sinica, V38, P10; Wei XJ, 2010, PLANT PHYSIOL, V153, P1747, DOI 10.1104/pp.110.156943; Wei XJ, 2010, MOL BREEDING, V25, P287, DOI 10.1007/s11032-009-9332-5; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yan WH, 2011, MOL PLANT, V4, P319, DOI 10.1093/mp/ssq070; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Yuan QB, 2009, THEOR APPL GENET, V119, P675, DOI 10.1007/s00122-009-1078-2; Zheng KL, 1995, IRRI DISCUSSION PAPE, V12	27	43	47	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52538	10.1371/journal.pone.0052538	http://dx.doi.org/10.1371/journal.pone.0052538			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285081	Green Published, Green Submitted, gold			2022-12-27	WOS:000312794500192
J	Fang, L; Hemion, C; Goldblum, D; Meyer, P; Orgul, S; Frank, S; Flammer, J; Neutzner, A				Fang, Lei; Hemion, Charles; Goldblum, David; Meyer, Peter; Orguel, Selim; Frank, Stephan; Flammer, Josef; Neutzner, Albert			Inactivation of MARCH5 Prevents Mitochondrial Fragmentation and Interferes with Cell Death in a Neuronal Cell Model	PLOS ONE			English	Article							DYNAMIN-RELATED PROTEIN; PEROXISOMAL FISSION; OPTIC ATROPHY; APOPTOSIS; NEURODEGENERATION; FUSION; LINE; DRP1; MAINTENANCE; OPA1	Purpose: To study the impact of the mitochondrial ubiquitin ligase MARCH5 on mitochondrial morphology and induction of apoptosis using an in vitro model of neuronal precursor cells exposed to glaucoma-relevant stress conditions. Methods: RGC5 cells transfected with expression constructs for MARCH5, MARCH5(H43W), Dpr1(K38A) or vector control were exposed to either elevated pressure of 30 mmHg, oxidative stress caused by mitochondrial electron transport chain (ETC) inhibition, or hypoxia-reoxygenation conditions. Mitochondrial morphology of RGC5 cells was analyzed following staining of the mitochondrial marker cytochrome c and photoactivatable GFP (PAGFP) diffusion assay. Induction of apoptotic cell death in these cells was determined by analyzing the release of cytochrome c from mitochondria into the cytosol and flow cytometry. Results: Exposure of RGC5 cells to oxidative stress conditions as well as to elevated pressure resulted in the fragmentation of the mitochondrial network in control cells as well as in cells expressing MARCH5. In cells expressing inactive MARCH5(H43W) or inactive Drp(K38A), mitochondrial fragmentation was significantly blocked and mitochondrial morphology was comparable to that of control cells under normal conditions. Exposure of RGC5 cells to elevated pressure or oxidative stress conditions induced apoptotic cell death as assessed by cytochrome c release and DNA staining, while expression of dominant-negative MARCH5(H43W) or Drp1(K38A) did significantly delay cell death. Conclusion: Preventing mitochondrial fragmentation through interference with the mitochondrial fission machinery protects neuronal cells from programmed cell death following exposure to stressors physiologically relevant to the pathogenesis of glaucoma.	[Fang, Lei; Hemion, Charles; Meyer, Peter; Neutzner, Albert] Univ Basel, Dept Biomed, Basel, Switzerland; [Goldblum, David; Meyer, Peter; Orguel, Selim; Flammer, Josef; Neutzner, Albert] Univ Basel, Dept Ophthalmol, Basel, Switzerland; [Frank, Stephan] Univ Basel, Inst Pathol, Div Neuropathol, Basel, Switzerland	University of Basel; University of Basel; University of Basel	Neutzner, A (corresponding author), Univ Basel, Dept Biomed, Basel, Switzerland.	albert.neutzner@unibas.ch	Neutzner, Albert/ABC-4368-2020; Goldblum, David/G-8559-2014	Goldblum, David/0000-0002-2119-1710; Neutzner, Albert/0000-0001-9254-5558	China Scholarship Council (CSC); Swiss National Foundation [31003A_129798]; Gottfried and Julia Bangerter-Rhyner foundation	China Scholarship Council (CSC)(China Scholarship Council); Swiss National Foundation(Swiss National Science Foundation (SNSF)); Gottfried and Julia Bangerter-Rhyner foundation	This work was supported by a grant of the China Scholarship Council (CSC) to LF and a grant from the Swiss National Foundation (31003A_129798) and the Gottfried and Julia Bangerter-Rhyner foundation to AN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker M.J., 2011, COLD SPRING HARB PER, V3; Carelli V, 2009, BBA-BIOENERGETICS, V1787, P518, DOI 10.1016/j.bbabio.2009.02.024; Chang CR, 2010, ANN NY ACAD SCI, V1201, P34, DOI 10.1111/j.1749-6632.2010.05629.x; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Flammer J, 2008, CAN J OPHTHALMOL, V43, P317, DOI 10.3129/i08-056; Frank S, 2003, BIOCHEM BIOPH RES CO, V304, P481, DOI 10.1016/S0006-291X(03)00620-X; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Gandre-Babbe S, 2008, MOL BIOL CELL, V19, P2402, DOI 10.1091/mbc.E07-12-1287; Grohm J, 2012, CELL DEATH DIFFER; Ju WK, 2010, MOL VIS, V16, P1331; Karbowski M, 2007, J CELL BIOL, V178, P71, DOI 10.1083/jcb.200611064; Karbowski M, 2012, ACTA NEUROPATHOL, V123, P157, DOI 10.1007/s00401-011-0921-0; Krishnamoorthy RR, 2001, MOL BRAIN RES, V86, P1, DOI 10.1016/S0169-328X(00)00224-2; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; Nakamura N, 2006, EMBO REP, V7, P1019, DOI 10.1038/sj.embor.7400790; Neuspiel M, 2008, CURR BIOL, V18, P102, DOI 10.1016/j.cub.2007.12.038; Neutzner A, 2008, ANN NY ACAD SCI, V1147, P242, DOI 10.1196/annals.1427.012; Nickells RW, 2012, ANN REV NEUROSCI; Palmer CS, 2011, EMBO REP, V12, P565, DOI 10.1038/embor.2011.54; Schnichels S, 2012, NEUROCHEM INT, V60, P581, DOI 10.1016/j.neuint.2012.02.017; Sugiura A, 2011, MITOCHONDRION, V11, P139, DOI 10.1016/j.mito.2010.09.001; Tang F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024367; Van Bergen NJ, 2009, INVEST OPHTH VIS SCI, V50, P4267, DOI 10.1167/iovs.09-3484; Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Xin XR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020142; Yonashiro R, 2006, EMBO J, V25, P3618, DOI 10.1038/sj.emboj.7601249; Yonashiro R, 2012, P NATL ACAD SCI USA, V109, P2382, DOI 10.1073/pnas.1114985109; Yonashiro R, 2009, MOL BIOL CELL, V20, P4524, DOI 10.1091/mbc.E09-02-0112	32	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e52637	10.1371/journal.pone.0052637	http://dx.doi.org/10.1371/journal.pone.0052637			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23285122	Green Submitted, gold, Green Published			2022-12-27	WOS:000312694300095
J	Cao, WQ; Ma, ZF; Rasenick, MM; Yeh, SY; Yu, JZ				Cao, WenQing; Ma, ZhiFan; Rasenick, Mark M.; Yeh, ShuYan; Yu, JiangZhou			N-3 Poly-Unsaturated Fatty Acids Shift Estrogen Signaling to Inhibit Human Breast Cancer Cell Growth	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; LIPID RAFTS; INDUCED APOPTOSIS; ADENYLYL-CYCLASE; GENE-EXPRESSION; GPR30; PROLIFERATION; PATHWAY; ALPHA; CAMP	Although evidence has shown the regulating effect of n-3 poly-unsaturated fatty acid (n-3 PUFA) on cell signaling transduction, it remains unknown whether n-3 PUFA treatment modulates estrogen signaling. The current study showed that docosahexaenoic acid (DHA, C22:6), eicosapentaenoic acid (EPA, C20:5) shifted the pro-survival and proliferative effect of estrogen to a pro-apoptotic effect in human breast cancer (BCa) MCF-7 and T47D cells. 17 beta-estradiol (E2) enhanced the inhibitory effect of n-3 PUFAs on BCa cell growth. The IC50 of DHA or EPA in MCF-7 cells decreased when combined with E2 (10 nM) treatment (from 173 mu M for DHA only to 113 mu M for DHA+E2, and from 187 mu m for EPA only to 130 mu m for EPA+E2). E2 also augmented apoptosis in n-3 PUFA-treated BCa cells. In contrast, in cells treated with stearic acid (SA, C18:0) as well as cells not treated with fatty acid, E2 promoted breast cancer cell growth. Classical (nuclear) estrogen receptors may not be involved in the pro-apoptotic effects of E2 on the n-3 PUFA-treated BCa cells because ER alpha agonist failed to elicit, and ER alpha knockdown failed to block E2 pro-apoptotic effects. Subsequent studies reveal that G protein coupled estrogen receptor 1 (GPER1) may mediate the pro-apoptotic effect of estrogen. N-3 PUFA treatment initiated the pro-apoptotic signaling of estrogen by increasing GPER1-cAMP-PKA signaling response, and blunting EGFR, Erk 1/2, and AKT activity. These findings may not only provide the evidence to link n-3 PUFAs biologic effects and the pro- apoptotic signaling of estrogen in breast cancer cells, but also shed new insight into the potential application of n-3 PUFAs in BCa treatment.	[Cao, WenQing; Ma, ZhiFan; Yeh, ShuYan; Yu, JiangZhou] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, George Whipple Lab Canc Res, Rochester, NY 14642 USA; [Rasenick, Mark M.] Univ Illinois, Coll Med, Dept Physiol & Biophys, Chicago, IL USA; [Rasenick, Mark M.] Univ Illinois, Coll Med, Dept Psychiat, Chicago, IL USA; [Rasenick, Mark M.] Jesse Brown VA Med Ctr, Chicago, IL USA; [Yeh, ShuYan] Univ Rochester, Med Ctr, Dept Urol, George Whipple Lab Canc Res, Rochester, NY 14642 USA; [Ma, ZhiFan] Shanxi Med Univ, Hosp 1, Dept Urol, Taiyuan, Shanxi, Peoples R China	University of Rochester; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; University of Rochester; Shanxi Medical University	Yu, JZ (corresponding author), Univ Rochester, Med Ctr, Dept Pathol & Lab Med, George Whipple Lab Canc Res, Rochester, NY 14642 USA.	jiangzhou_yu@urmc.rochester.edu	Cao, Wenqing/GPF-9107-2022	Cao, Wenqing/0000-0002-2761-3355	Department of Pathology and Lab Medicine, University of Rochester Medical Center, Rochester, NY, USA	Department of Pathology and Lab Medicine, University of Rochester Medical Center, Rochester, NY, USA	Funding for this project was provided by Department of Pathology and Lab Medicine, University of Rochester Medical Center, Rochester, NY, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaogi K, 2009, ONCOGENE, V28, P2894, DOI 10.1038/onc.2009.151; Allen JA, 2005, MOL PHARMACOL, V67, P1493, DOI 10.1124/mol.104.008342; Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Allen JA, 2009, MOL PHARMACOL, V76, P1082, DOI 10.1124/mol.109.060160; Altenburg JD, 2009, MOL CANCER RES, V7, P1013, DOI 10.1158/1541-7786.MCR-08-0385; Ariazi EA, 2011, P NATL ACAD SCI USA, V108, P18879, DOI 10.1073/pnas.1115188108; Ariazi EA, 2010, CANCER RES, V70, P1184, DOI 10.1158/0008-5472.CAN-09-3068; ARONICA SM, 1994, P NATL ACAD SCI USA, V91, P8517, DOI 10.1073/pnas.91.18.8517; BOE R, 1995, BRIT J CANCER, V72, P1151, DOI 10.1038/bjc.1995.479; Castoria G, 2008, FRONT BIOSCI-LANDMRK, V13, P1318, DOI 10.2741/2764; Chen JH, 1998, P NATL ACAD SCI USA, V95, P2648, DOI 10.1073/pnas.95.5.2648; Chen M, 2009, CARCINOGENESIS, V30, P841, DOI 10.1093/carcin/bgn288; Chow SKY, 2004, J ENDOCRINOL, V182, P325, DOI 10.1677/joe.0.1820325; Corsetto PA, 2012, CELL BIOCHEM BIOPHYS, V64, P45, DOI 10.1007/s12013-012-9365-y; Corsetto PA, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-73; Dimri M, 2010, CARCINOGENESIS, V31, P489, DOI 10.1093/carcin/bgp305; Evinger AJ, 2005, STEROIDS, V70, P361, DOI 10.1016/j.steroids.2005.02.015; Filardo EJ, 2005, TRENDS ENDOCRIN MET, V16, P362, DOI 10.1016/j.tem.2005.08.005; Filardo EJ, 2000, MOL ENDOCRINOL, V14, P1649, DOI 10.1210/me.14.10.1649; Filardo EJ, 2002, J STEROID BIOCHEM, V80, P231, DOI 10.1016/S0960-0760(01)00190-X; Filardo EJ, 2002, MOL ENDOCRINOL, V16, P70, DOI 10.1210/me.16.1.70; Files J A, 2012, Minerva Ginecol, V64, P223; Jordan VC, 2005, BREAST, V14, P624, DOI 10.1016/j.breast.2005.08.022; Kang KS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010296; Kastrati I, 2010, ENDOCRINOLOGY, V151, P5602, DOI 10.1210/en.2010-0378; KATO JY, 1994, CELL, V79, P487, DOI 10.1016/0092-8674(94)90257-7; Kelly MJ, 2001, TRENDS ENDOCRIN MET, V12, P152, DOI 10.1016/S1043-2760(01)00377-0; Kelly MJ, 1999, TRENDS ENDOCRIN MET, V10, P369, DOI 10.1016/S1043-2760(99)00190-3; KENNEDY BJ, 1962, CANCER, V15, P641, DOI 10.1002/1097-0142(196205/06)15:3<641::AID-CNCR2820150330>3.0.CO;2-9; KENNEDY BJ, 1962, CANCER CHEMOTH REP, P283; Kim SN, 2001, INT J CANCER, V93, P33, DOI 10.1002/ijc.1308; Lewis JS, 2005, JNCI-J NATL CANCER I, V97, P1746, DOI 10.1093/jnci/dji400; Ligumsky H, 2012, BREAST CANCER RES TR, V132, P449, DOI 10.1007/s10549-011-1585-0; Madak-Erdogan Z, 2011, MOL CELL BIOL, V31, P226, DOI 10.1128/MCB.00821-10; Maggiolini M, 2004, J BIOL CHEM, V279, P27008, DOI 10.1074/jbc.M403588200; Notas G, 2012, STEROIDS, V77, P943, DOI 10.1016/j.steroids.2011.11.005; Pandey DP, 2009, EMBO J, V28, P523, DOI 10.1038/emboj.2008.304; Pedram A, 2006, MOL ENDOCRINOL, V20, P1996, DOI 10.1210/me.2005-0525; Prossnitz ER, 2008, J STEROID BIOCHEM, V109, P350, DOI 10.1016/j.jsbmb.2008.03.006; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Rogers KR, 2010, CARCINOGENESIS, V31, P1523, DOI 10.1093/carcin/bgq111; Santen RJ, 2009, STEROIDS, V74, P586, DOI 10.1016/j.steroids.2008.11.020; Schley PD, 2007, J NUTR, V137, P548, DOI 10.1093/jn/137.3.548; Schley PD, 2005, BREAST CANCER RES TR, V92, P187, DOI 10.1007/s10549-005-2415-z; Shyr CR, 2010, PROSTATE, V70, P190, DOI 10.1002/pros.21052; Signori C, 2011, CANCER RES, V71, P6091, DOI 10.1158/0008-5472.CAN-11-0977; Song RXD, 2003, APOPTOSIS, V8, P55, DOI 10.1023/A:1021649019025; Song RXD, 2001, J NATL CANCER I, V93, P1714, DOI 10.1093/jnci/93.22.1714; Stillwell W, 2005, REPROD NUTR DEV, V45, P559, DOI 10.1051/rnd:2005046; Stoica GE, 2003, MOL ENDOCRINOL, V17, P818, DOI 10.1210/me.2002-0330; Sun HG, 2011, CARCINOGENESIS, V32, P1518, DOI 10.1093/carcin/bgr132; Thangavel M, 2009, CELL SIGNAL, V21, P301, DOI 10.1016/j.cellsig.2008.10.017; Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064; Williams JA, 2012, BIOPHYS J, V103, P228, DOI 10.1016/j.bpj.2012.06.016; Wu M, 2005, INT J CANCER, V117, P340, DOI 10.1002/ijc.21238; Yu JZ, 2009, J BIOL CHEM, V284, P10462, DOI 10.1074/jbc.M809166200; Zambon AC, 2011, J BIOL CHEM, V286, P33260, DOI 10.1074/jbc.M111.268979; Zhang DX, 2011, J BIOL CHEM, V286, P17746, DOI 10.1074/jbc.M110.206029; Zivadinovic D, 2005, BREAST CANCER RES, V7, pR101, DOI 10.1186/bcr958	59	60	61	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52838	10.1371/journal.pone.0052838	http://dx.doi.org/10.1371/journal.pone.0052838			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23145098	Green Published, Green Submitted, gold			2022-12-27	WOS:000313051500068
J	Lin, YW; Lin, HY; Tsou, YL; Chitra, E; Hsiao, KN; Shao, HY; Liu, CC; Sia, C; Chong, P; Chow, YH				Lin, Yi-Wen; Lin, Hsiang-Yin; Tsou, Yueh-Liang; Chitra, Ebenezer; Hsiao, Kuang-Nan; Shao, Hsiao-Yun; Liu, Chia-Chyi; Sia, Charles; Chong, Pele; Chow, Yen-Hung			Human SCARB2-Mediated Entry and Endocytosis of EV71	PLOS ONE			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; RESPIRATORY SYNCYTIAL VIRUS; SELECTIN GLYCOPROTEIN LIGAND-1; NEUROGENIC PULMONARY-EDEMA; ENTEROVIRUS 71; CELLULAR RECEPTOR; P-SELECTIN; DEPENDENT ENDOCYTOSIS; MOUTH-DISEASE; PUBLIC-HEALTH	Enterovirus (EV) 71 infection is known to cause hand-foot-and-mouth disease (HFMD) and in severe cases, induces neurological disorders culminating in fatality. An outbreak of EV71 in South East Asia in 1997 affected over 120,000 people and caused neurological disorders in a few individuals. The control of EV71 infection through public health interventions remains minimal and treatments are only symptomatic. Recently, human scavenger receptor class B, member 2 (SCARB2) has been reported to be a cellular receptor of EV71. We expressed human SCARB2 gene in NIH3T3 cells (3T3-SCARB2) to study the mechanisms of EV71 entry and infection. We demonstrated that human SCARB2 serves as a cellular receptor for EV71 entry. Disruption of expression of SCARB2 using siRNAs can interfere EV71 infection and subsequent inhibit the expression of viral capsid proteins in RD and 3T3-SCARB2 but not Vero cells. SiRNAs specific to clathrin or dynamin or chemical inhibitor of clathrin-mediated endocytosis were all capable of interfering with the entry of EV71 into 3T3-SCARB2 cells. On the other hand, caveolin specific siRNA or inhibitors of caveolae-mediated endocytosis had no effect, confirming that only clathrin-mediated pathway was involved in EV71 infection. Endocytosis of EV71 was also found to be pH-dependent requiring endosomal acidification and also required intact membrane cholesterol. In summary, the mechanism of EV71 entry through SCARB2 as the receptor for attachment, and its cellular entry is through a clathrin-mediated and pHdependent endocytic pathway. This study on the receptor and endocytic mechanisms of EV71 infection is useful for the development of effective medications and prophylactic treatment against the enterovirus.	[Lin, Yi-Wen; Lin, Hsiang-Yin; Tsou, Yueh-Liang; Chitra, Ebenezer; Hsiao, Kuang-Nan; Shao, Hsiao-Yun; Liu, Chia-Chyi; Sia, Charles; Chong, Pele; Chow, Yen-Hung] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Taipei, Taiwan; [Lin, Yi-Wen] Natl Tsing Hua Univ, Inst Mol Med, Grad Program Biotechnol Med, Hsinchu, Taiwan; [Tsou, Yueh-Liang] Natl Def Med Ctr, Grad Sch Life Sci, Taipei, Taiwan; [Sia, Charles; Chong, Pele] China Med Univ, Grad Inst Immunol, Taichung, Taiwan	National Health Research Institutes - Taiwan; National Tsing Hua University; National Defense Medical Center; China Medical University Taiwan	Lin, YW (corresponding author), Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Taipei, Taiwan.	pelechong@nhri.org.tw; choeyenh@nhri.org.tw	Liu, Chia-Chyi/A-8215-2012; Sia, Dwo-Yuan/E-3860-2010; Chong, Pele/E-3855-2010; Chitra, Ebenezer/F-5984-2019; Chow, Yen-Hung/E-3863-2010	Liu, Chia-Chyi/0000-0002-6257-0389; Chitra, Ebenezer/0000-0002-5818-6587; 	National Health Research Institutes [99A1-VCPP08-014]; National Science Council (NSC) of Taiwan [99-2323-B-400-014-]	National Health Research Institutes(National Health Research Institutes, Japan); National Science Council (NSC) of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the National Health Research Institutes' intramural grant (99A1-VCPP08-014) (www.nhri.org.tw) and a grant (99-2323-B-400-014-) from the National Science Council (NSC) (http://web1.nsc.gov.tw) of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuBakar S, 1999, VIRUS RES, V61, P1, DOI 10.1016/S0168-1702(99)00019-2; ALEXANDER JP, 1994, J INFECT DIS, V169, P905, DOI 10.1093/infdis/169.4.905; Altschuler Y, 1998, J CELL BIOL, V143, P1871, DOI 10.1083/jcb.143.7.1871; Aoki T, 1999, EXP CELL RES, V253, P629, DOI 10.1006/excr.1999.4652; Baba T, 1995, COLD SPRING HARB SYM, V60, P235, DOI 10.1101/SQB.1995.060.01.027; Bayer N, 1998, J VIROL, V72, P9645, DOI 10.1128/JVI.72.12.9645-9655.1998; Bayer N, 2001, J BIOL CHEM, V276, P3952, DOI 10.1074/jbc.M004722200; Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06; BROWN MS, 1980, J LIPID RES, V21, P505; Chang JY, 1998, BIOCHEM BIOPH RES CO, V249, P817, DOI 10.1006/bbrc.1998.9237; Chang LY, 1998, LANCET, V352, P367, DOI 10.1016/S0140-6736(98)24031-1; CHUMAKOV M, 1979, ARCH VIROL, V60, P329, DOI 10.1007/BF01317504; Chung YC, 2008, VACCINE, V26, P1855, DOI 10.1016/j.vaccine.2008.01.058; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Damm EM, 2005, J CELL BIOL, V168, P477, DOI 10.1083/jcb.200407113; Danthi P, 2004, J VIROL, V78, P33, DOI 10.1128/JVI.78.1.33-41.2004; De Tulleo L, 1998, EMBO J, V17, P4585, DOI 10.1093/emboj/17.16.4585; Eash S, 2004, J VIROL, V78, P11583, DOI 10.1128/JVI.78.21.11583-11590.2004; Eckhardt ERM, 2006, J BIOL CHEM, V281, P4348, DOI 10.1074/jbc.M513154200; Empig CJ, 2002, J VIROL, V76, P5266, DOI 10.1128/JVI.76.10.5266-5270.2002; Eskelinen EL, 2003, TRENDS CELL BIOL, V13, P137, DOI 10.1016/S0962-8924(03)00005-9; Gianni T, 2004, J VIROL, V78, P12268, DOI 10.1128/JVI.78.22.12268-12276.2004; Grove J, 2007, J VIROL, V81, P3162, DOI 10.1128/JVI.02356-06; Guang D, 2007, VIRUS RES, V125, P61, DOI 10.1016/j.virusres.2006.12.005; Hailstones D, 1998, J LIPID RES, V39, P369; He YN, 2000, P NATL ACAD SCI USA, V97, P79, DOI 10.1073/pnas.97.1.79; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Hussain KM, 2011, J BIOL CHEM, V286, P309, DOI 10.1074/jbc.M110.168468; Inoue Y, 2007, J VIROL, V81, P8722, DOI 10.1128/JVI.00253-07; Kolokoltsov AA, 2007, J VIROL, V81, P7786, DOI 10.1128/JVI.02780-06; Kuronita T, 2002, J CELL SCI, V115, P4117, DOI 10.1242/jcs.00075; Laszik Z, 1996, BLOOD, V88, P3010, DOI 10.1182/blood.V88.8.3010.bloodjournal8883010; Lee DW, 2006, J CELL SCI, V119, P3502, DOI 10.1242/jcs.03092; Lee MS, 2010, EXPERT REV VACCINES, V9, P149, DOI [10.1586/erv.09.152, 10.1586/ERV.09.152]; Lin KH, 2006, J MED VIROL, V78, P254, DOI 10.1002/jmv.20534; Lin YC, 2002, VACCINE, V20, P2485, DOI 10.1016/S0264-410X(02)00182-2; Liu CC, 2011, VACCINE, V29, P4362, DOI 10.1016/j.vaccine.2011.04.010; Liu PS, 1999, BIOCHEM BIOPH RES CO, V261, P695, DOI 10.1006/bbrc.1999.1082; LONBERGHOLM K, 1972, J VIROL, V9, P29, DOI 10.1128/JVI.9.1.29-40.1972; Lu CH, 2008, PROTEINS, V72, P625, DOI 10.1002/prot.21954; Lum LCS, 1998, LANCET, V352, P1391, DOI 10.1016/S0140-6736(05)60789-1; Marjomaki V, 2002, J VIROL, V76, P1856, DOI 10.1128/JVI.76.4.1856-1865.2002; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; McMinn PC, 2003, NEUROL J SE ASIA, V8, P57; Melnick J L, 1980, Intervirology, V12, P297; MENDELSOHN CL, 1989, CELL, V56, P855, DOI 10.1016/0092-8674(89)90690-9; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Nabi IR, 2003, J CELL BIOL, V161, P673, DOI 10.1083/jcb.200302028; NAGY G, 1982, ARCH VIROL, V71, P217, DOI 10.1007/BF01314873; Nawa M, 2003, J GEN VIROL, V84, P1737, DOI 10.1099/vir.0.18883-0; Nichols BJ, 2001, TRENDS CELL BIOL, V11, P406, DOI 10.1016/S0962-8924(01)02107-9; Nishimura Y, 2009, NAT MED, V15, P794, DOI 10.1038/nm.1961; Orlandi PA, 1998, J CELL BIOL, V141, P905, DOI 10.1083/jcb.141.4.905; Parton RG, 1999, IMMUNOL REV, V168, P23, DOI 10.1111/j.1600-065X.1999.tb01280.x; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Pelkmans L, 2003, CURR OPIN CELL BIOL, V15, P414, DOI 10.1016/S0955-0674(03)00081-4; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Qiu J, 2008, LANCET NEUROL, V7, P868, DOI 10.1016/S1474-4422(08)70207-2; Richterova Z, 2001, J VIROL, V75, P10880, DOI 10.1128/JVI.75.22.10880-10891.2001; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; ROTHBERG KG, 1990, J CELL BIOL, V111, P2931, DOI 10.1083/jcb.111.6.2931; Rust MJ, 2004, NAT STRUCT MOL BIOL, V11, P567, DOI 10.1038/nsmb769; SAKO D, 1993, CELL, V75, P1179, DOI 10.1016/0092-8674(93)90327-M; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304; SCHNITZER JE, 1994, J CELL BIOL, V127, P1217, DOI 10.1083/jcb.127.5.1217; Shu LM, 2000, ARCH BIOCHEM BIOPHYS, V373, P83, DOI 10.1006/abbi.1999.1553; Sieczkarski SB, 2003, TRAFFIC, V4, P333, DOI 10.1034/j.1600-0854.2003.00090.x; Sieczkarski SB, 2002, J VIROL, V76, P10455, DOI 10.1128/JVI.76.20.10455-10464.2002; Smaby JM, 1996, BIOPHYS J, V70, P868, DOI 10.1016/S0006-3495(96)79629-7; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; Soulet F, 2005, MOL BIOL CELL, V16, P2058, DOI 10.1091/mbc.E04-11-1016; SRINIVASAKUMAR N, 1991, J VIROL, V65, P4063, DOI 10.1128/JVI.65.8.4063-4069.1991; Sun XJ, 2005, VIROLOGY, V338, P53, DOI 10.1016/j.virol.2005.05.006; Tung Wong Siew, 2007, Genet Vaccines Ther, V5, P6, DOI 10.1186/1479-0556-5-6; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; Werling D, 1999, J LEUKOCYTE BIOL, V66, P50, DOI 10.1002/jlb.66.1.50; Wu TN, 1999, EMERG INFECT DIS, V5, P458, DOI 10.3201/eid0503.990321; Xing L, 2000, EMBO J, V19, P1207, DOI 10.1093/emboj/19.6.1207; Yamayoshi S, 2011, J VIROL, V85, P4937, DOI 10.1128/JVI.02358-10; Yamayoshi S, 2009, NAT MED, V15, P798, DOI 10.1038/nm.1992	83	76	89	5	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30507	10.1371/journal.pone.0030507	http://dx.doi.org/10.1371/journal.pone.0030507			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272359	gold, Green Published, Green Submitted			2022-12-27	WOS:000301454400137
J	Li, JL; Qin, HR; Wu, J; Sadd, BM; Wang, XH; Evans, JD; Peng, WJ; Chen, YP				Li, Jilian; Qin, Haoran; Wu, Jie; Sadd, Ben M.; Wang, Xiuhong; Evans, Jay D.; Peng, Wenjun; Chen, Yanping			The Prevalence of Parasites and Pathogens in Asian Honeybees Apis cerana in China	PLOS ONE			English	Article							DEFORMED-WING-VIRUS; BEE COLONY COLLAPSE; NOSEMA-CERANAE; GUT BACTERIA; MELLIFERA L.; MOLECULAR DIAGNOSIS; BOMBUS-TERRESTRIS; VARROA-JACOBSONI; PARALYSIS VIRUS; BUMBLE BEES	Pathogens and parasites represent significant threats to the health and well-being of honeybee species that are key pollinators of agricultural crops and flowers worldwide. We conducted a nationwide survey to determine the occurrence and prevalence of pathogens and parasites in Asian honeybees, Apis cerana, in China. Our study provides evidence of infections of A. cerana by pathogenic Deformed wing virus (DWV), Black queen cell virus (BQCV), Nosema ceranae, and C. bombi species that have been linked to population declines of European honeybees, A. mellifera, and bumble bees. However, the prevalence of DWV, a virus that causes widespread infection in A. mellifera, was low, arguably a result of the greater ability of A. cerana to resist the ectoprasitic mite Varroa destructor, an efficient vector of DWV. Analyses of microbial communities from the A. cerana digestive tract showed that Nosema infection could have detrimental effects on the gut microbiota. Workers infected by N. ceranae tended to have lower bacterial quantities, with these differences being significant for the Bifidobacterium and Pasteurellaceae bacteria groups. The results of this nationwide screen show that parasites and pathogens that have caused serious problems in European honeybees can be found in native honeybee species kept in Asia. Environmental changes due to new agricultural practices and globalization may facilitate the spread of pathogens into new geographic areas. The foraging behavior of pollinators that are in close geographic proximity likely have played an important role in spreading of parasites and pathogens over to new hosts. Phylogenetic analyses provide insights into the movement and population structure of these parasites, suggesting a bidirectional flow of parasites among pollinators. The presence of these parasites and pathogens may have considerable implications for an observed population decline of Asian honeybees.	[Li, Jilian; Qin, Haoran; Wu, Jie; Wang, Xiuhong; Peng, Wenjun] Chinese Acad Agr Sci, Inst Apicultural Res, Minist Agr, Key Lab Pollinating Insect Biol, Beijing 100193, Peoples R China; [Evans, Jay D.; Chen, Yanping] ARS, USDA, Bee Res Lab, Beltsville, MD USA; [Sadd, Ben M.] Eth Zurich Univ Str, Inst Integrat Biol, Zurich, Switzerland	Chinese Academy of Agricultural Sciences; Institute of Apicultural Research, CAAS; Ministry of Agriculture & Rural Affairs; United States Department of Agriculture (USDA)	Peng, WJ (corresponding author), Chinese Acad Agr Sci, Inst Apicultural Res, Minist Agr, Key Lab Pollinating Insect Biol, Beijing 100193, Peoples R China.	bumblebeeljl@hotmail.com; judy.chen@ars.usda.gov	Evans, Jay D/C-8408-2012	Evans, Jay D/0000-0002-0036-4651; Chen, Chen/0000-0001-6741-7036; Sadd, Ben/0000-0003-3136-5144	Chinese Academy of Agricultural Sciences (CAAS), Beijing, China; Eidgenosische Technische Hochschule (ETH), Zurich, Switzerland [2009DFA32600]; Beijing Natural Science Foundation [6122032]; Chinese National Natural Science Foundation [30700606, 30972149]; China Agriculture Research System (CARS-45) [201203080-4]; Special Fund for Agricultural Research in the Public Interest [201203080-4]	Chinese Academy of Agricultural Sciences (CAAS), Beijing, China; Eidgenosische Technische Hochschule (ETH), Zurich, Switzerland; Beijing Natural Science Foundation(Beijing Natural Science Foundation); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); China Agriculture Research System (CARS-45); Special Fund for Agricultural Research in the Public Interest	Funding was provided by an international joint research project between the Chinese Academy of Agricultural Sciences (CAAS), Beijing, China and Eidgenosische Technische Hochschule (ETH), Zurich, Switzerland (No. 2009DFA32600), Beijing Natural Science Foundation (No. 6122032), Chinese National Natural Science Foundation (No. 30700606, 30972149), the China Agriculture Research System (CARS-45) (201203080-4), the Special Fund for Agricultural Research in the Public Interest (201203080-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai HX, 2012, J INVERTEBR PATHOL, V109, P160, DOI 10.1016/j.jip.2011.10.006; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson DL, 2000, EXP APPL ACAROL, V24, P165, DOI 10.1023/A:1006456720416; Baker A, 2008, J INVERTEBR PATHOL, V98, P239, DOI 10.1016/j.jip.2008.02.010; Benjeddou M, 2001, APPL ENVIRON MICROB, V67, P2384, DOI 10.1128/AEM.67.5.2384-2387.2001; Berenyi O, 2006, APPL ENVIRON MICROB, V72, P2414, DOI 10.1128/AEM.72.4.2414-2420.2006; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; BREZNAK JA, 1994, ANNU REV ENTOMOL, V39, P453, DOI 10.1146/annurev.en.39.010194.002321; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Carreck NL, 2010, J APICULT RES, V49, P93, DOI 10.3896/IBRA.1.49.1.13; Chaimanee V, 2011, J INVERTEBR PATHOL, V107, P229, DOI 10.1016/j.jip.2011.05.012; Chen YP, 2010, APIDOLOGIE, V41, P364, DOI 10.1051/apido/2010021; Chen Y, 2008, J INVERTEBR PATHOL, V97, P186, DOI 10.1016/j.jip.2007.07.010; Chen YP, 2009, J INVERTEBR PATHOL, V101, P204, DOI 10.1016/j.jip.2009.05.012; Chen YP, 2004, J INVERTEBR PATHOL, V87, P84, DOI 10.1016/j.jip.2004.07.005; Chen YP, 2004, AM BEE J, V144, P557; Choe SE, 2012, J INVERTEBR PATHOL, V109, P330, DOI 10.1016/j.jip.2012.01.003; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Dillon RJ, 2005, ECOL LETT, V8, P1291, DOI 10.1111/j.1461-0248.2005.00828.x; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Fraune S, 2010, BIOESSAYS, V32, P571, DOI 10.1002/bies.200900192; Fries I, 2010, J INVERTEBR PATHOL, V103, pS73, DOI 10.1016/j.jip.2009.06.017; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Gegear RJ, 2006, P ROY SOC B-BIOL SCI, V273, P1073, DOI 10.1098/rspb.2005.3423; Genersch E, 2006, J INVERTEBR PATHOL, V91, P61, DOI 10.1016/j.jip.2005.10.002; Ghazoul J, 2005, TRENDS ECOL EVOL, V20, P367, DOI 10.1016/j.tree.2005.04.026; GILLIAM M, 1988, MICROBIOS, V55, P95; Gisder S, 2009, J GEN VIROL, V90, P463, DOI 10.1099/vir.0.005579-0; Gisder S, 2010, APPL ENVIRON MICROB, V76, P3032, DOI 10.1128/AEM.03097-09; Goulson D, 2008, ANNU REV ENTOMOL, V53, P191, DOI 10.1146/annurev.ento.53.103106.093454; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; He X., 2011, APICULTURE CHINA, V62, P21; Higes M, 2008, ENVIRON MICROBIOL, V10, P2659, DOI 10.1111/j.1462-2920.2008.01687.x; Higes M, 2009, ENV MICROBIOL REP, V1, P110, DOI 10.1111/j.1758-2229.2009.00014.x; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Huang WF, 2008, J INVERTEBR PATHOL, V97, P9, DOI 10.1016/j.jip.2007.07.001; Inglis GD, 1998, APIDOLOGIE, V29, P327, DOI 10.1051/apido:19980403; Janson EM, 2008, EVOLUTION, V62, P997, DOI 10.1111/j.1558-5646.2008.00348.x; [季荣 Ji Rong], 2003, [生态学杂志, Chinese Journal of Ecology], V22, P70; Klee J, 2007, J INVERTEBR PATHOL, V96, P1, DOI 10.1016/j.jip.2007.02.014; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Koch H, 2011, P NATL ACAD SCI USA, V108, P19288, DOI 10.1073/pnas.1110474108; Koch H, 2011, MICROB ECOL, V62, P121, DOI 10.1007/s00248-011-9854-3; Li JL, 2011, J ECON ENTOMOL, V104, P732, DOI 10.1603/EC10355; Martin-Hernandez R, 2007, APPL ENVIRON MICROB, V73, P6331, DOI 10.1128/AEM.00270-07; Martinson VG, 2011, MOL ECOL, V20, P619, DOI 10.1111/j.1365-294X.2010.04959.x; Mohr KI, 2007, APPL MICROBIOL BIOT, V75, P573, DOI 10.1007/s00253-007-0846-7; Moran NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036393; Oldroyd BP, 1999, TRENDS ECOL EVOL, V14, P312, DOI 10.1016/S0169-5347(99)01613-4; Pedersen AB, 2005, INT J PARASITOL, V35, P647, DOI 10.1016/j.ijpara.2005.01.005; Peng WJ, 2011, APIDOLOGIE, V42, P650, DOI 10.1007/s13592-011-0061-5; Pettis JS, 2010, APIDOLOGIE, V41, P256, DOI 10.1051/apido/2010013; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Ratnieks FLW, 2010, SCIENCE, V327, P152, DOI 10.1126/science.1185563; Ribiere M, 2002, APIDOLOGIE, V33, P339, DOI 10.1051/apido:2002020; Sabree ZL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041250; Singh R, 2010, PLOS ONE, V5, P1, DOI DOI 10.1371/J0URNAL.P0NE.0014357; Stoltz D, 1995, J APICULT RES, V34, P153, DOI 10.1080/00218839.1995.11100900; Tentcheva D, 2004, APPL ENVIRON MICROB, V70, P7185, DOI 10.1128/AEM.70.12.7185-7191.2004; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vanengelsdorp D, 2007, AM BEE J, V147, P599; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Vorburger C, 2010, BIOL LETTERS, V6, P109, DOI 10.1098/rsbl.2009.0642; Woolhouse MEJ, 2001, SCIENCE, V292, P1109, DOI 10.1126/science.1059026; Wu J, 2006, AM BEE J, V146, P153; Yang Guan-Huang, 2005, Acta Entomologica Sinica, V48, P401; Yoshiyama M, 2009, J INVERTEBR PATHOL, V102, P91, DOI 10.1016/j.jip.2009.07.005; Yourth CP, 2008, INSECT SOC, V55, P86, DOI 10.1007/s00040-007-0974-1	70	67	88	1	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e47955	10.1371/journal.pone.0047955	http://dx.doi.org/10.1371/journal.pone.0047955			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144838	Green Published, Green Submitted, gold			2022-12-27	WOS:000311935800030
J	Pratheeshkumar, P; Budhraja, A; Son, YO; Wang, X; Zhang, Z; Ding, SZ; Wang, L; Hitron, A; Lee, JC; Xu, M; Chen, G; Luo, J; Shi, XL				Pratheeshkumar, Poyil; Budhraja, Amit; Son, Young-Ok; Wang, Xin; Zhang, Zhuo; Ding, Songze; Wang, Lei; Hitron, Andrew; Lee, Jeong-Chae; Xu, Mei; Chen, Gang; Luo, Jia; Shi, Xianglin			Quercetin Inhibits Angiogenesis Mediated Human Prostate Tumor Growth by Targeting VEGFR-2 Regulated AKT/mTOR/P70S6K Signaling Pathways	PLOS ONE			English	Article							CANCER PREVENTION; ACTIVATION; APOPTOSIS; INVASION; BIOLOGY; CELLS; MTOR	Angiogenesis is a crucial step in the growth and metastasis of cancers, since it enables the growing tumor to receive oxygen and nutrients. Cancer prevention using natural products has become an integral part of cancer control. We studied the antiangiogenic activity of quercetin using ex vivo, in vivo and in vitro models. Rat aortic ring assay showed that quercetin at non-toxic concentrations significantly inhibited microvessel sprouting and exhibited a significant inhibition in the proliferation, migration, invasion and tube formation of endothelial cells, which are key events in the process of angiogenesis. Most importantly, quercetin treatment inhibited ex vivo angiogenesis as revealed by chicken egg chorioallantoic membrane assay (CAM) and matrigel plug assay. Western blot analysis showed that quercetin suppressed VEGF induced phosphorylation of VEGF receptor 2 and their downstream protein kinases AKT, mTOR, and ribosomal protein S6 kinase in HUVECs. Quercetin (20 mg/kg/d) significantly reduced the volume and the weight of solid tumors in prostate xenograft mouse model, indicating that quercetin inhibited tumorigenesis by targeting angiogenesis. Furthermore, quercetin reduced the cell viability and induced apoptosis in prostate cancer cells, which were correlated with the downregulation of AKT, mTOR and P70S6K expressions. Collectively the findings in the present study suggest that quercetin inhibits tumor growth and angiogenesis by targeting VEGF-R2 regulated AKT/mTOR/P70S6K signaling pathway, and could be used as a potential drug candidate for cancer therapy.	[Pratheeshkumar, Poyil; Budhraja, Amit; Son, Young-Ok; Wang, Xin; Zhang, Zhuo; Ding, Songze; Wang, Lei; Hitron, Andrew; Lee, Jeong-Chae; Shi, Xianglin] Univ Kentucky, Coll Med, Grad Ctr Toxicol, Lexington, KY 40536 USA; [Xu, Mei; Chen, Gang; Luo, Jia] Univ Kentucky, Coll Med, Dept Internal Med, Lexington, KY USA	University of Kentucky; University of Kentucky	Shi, XL (corresponding author), Univ Kentucky, Coll Med, Grad Ctr Toxicol, Lexington, KY 40536 USA.	xshi5@email.uky.edu	Luo, Jia/E-4674-2012; Wang, Lei/E-3063-2012; Son, Youngok/AAB-1380-2021; Zhang, Zhuo/B-8601-2012; Son, Young-Ok/P-3675-2015	Luo, Jia/0000-0002-6968-3618; Budhraja, Amit/0000-0002-4216-8608; Son, Youngok/0000-0003-0154-4061	National Institutes of Health [1R01ES020870, 5R21ES019249]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020870, R21ES019249] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health grants: 1R01ES020870 (Shi), and 5R21ES019249 (Shi and Zhang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGER NA, 1985, BIOCHEMISTRY-US, V24, P4352, DOI 10.1021/bi00337a015; Berger NA, 2010, POLY ADP RIBOSE CELL; Bhat TA, 2008, FOOD CHEM TOXICOL, V46, P1334, DOI 10.1016/j.fct.2007.08.032; Bischoff SC, 2008, CURR OPIN CLIN NUTR, V11, P733, DOI 10.1097/MCO.0b013e32831394b8; Budhraja A, 2012, MOL CANCER THER, V11, P132, DOI 10.1158/1535-7163.MCT-11-0343; Cao YH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.259re1; Chen J, 2002, BIOCHEM PHARMACOL, V64, P1071, DOI 10.1016/S0006-2952(02)01263-7; Dvorak HF, 2005, J THROMB HAEMOST, V3, P1835, DOI 10.1111/j.1538-7836.2005.01361.x; Fasolo A, 2008, MTOR INHIBITORS TREA; Ferrara N, 2001, ACTA HAEMATOL-BASEL, V106, P148, DOI 10.1159/000046610; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; FOLKMAN J, 1992, J BIOL CHEM, V267, P10931; Formica JV, 1995, FOOD CHEM TOXICOL, V33, P1061, DOI 10.1016/0278-6915(95)00077-1; KAUFMANN SH, 1993, CANCER RES, V53, P3976; KECK PJ, 1989, SCIENCE, V246, P1309, DOI 10.1126/science.2479987; Kuttan G, 2011, PHARM BIOL, V49, P995, DOI 10.3109/13880209.2011.559476; Li W, 2008, ONCOL REP, V20, P713, DOI 10.3892/or_00000064; Liu LZ, 2008, CANCER RES, V68, P8183, DOI 10.1158/0008-5472.CAN-08-0819; Liu LZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020858; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; McMahon G, 2000, Oncologist, V5 Suppl 1, P3; Murakami A, 2008, CANCER LETT, V269, P315, DOI 10.1016/j.canlet.2008.03.046; Nicholson DW, 1995, IDENTIFICATION INHIB; Pang XF, 2009, CANCER RES, V69, P5893, DOI 10.1158/0008-5472.CAN-09-0755; Patan S, 2004, CANC TREAT, V117, P3; Pratheeshkumar P, 2011, J ENVIRON PATHOL TOX, V30, P33, DOI 10.1615/JEnvironPatholToxicolOncol.v30.i1.40; Pratheeshkumar P, 2012, ANTICANCER AGENTS ME; Pratheeshkumar P, 2011, EUROPEAN J PHARM; Pratheeshkumar P, 2011, DRUG CHEM TOXICOL, V34, P261, DOI 10.3109/01480545.2010.520017; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Roberts WG, 1997, CANCER RES, V57, P765; Seeliger H, 2007, CANCER METAST REV, V26, P611, DOI 10.1007/s10555-007-9077-8; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; Tie Jeanne, 2012, Critical Reviews in Oncogenesis, V17, P51; Tufan AC, 2005, CURR CANCER DRUG TAR, V5, P249, DOI 10.2174/1568009054064624; Wang SP, 2011, BOUND VALUE PROBL, DOI 10.1155/2011/901796; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Yao H, 2011, J ENVIRON SCI HEAL C, V29, P1, DOI 10.1080/10590501.2011.551317; Yap TA, 2008, CURR OPIN PHARMACOL, V8, P393, DOI 10.1016/j.coph.2008.08.004; Yi TF, 2008, MOL CANCER THER, V7, P1789, DOI 10.1158/1535-7163.MCT-08-0124	40	186	200	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2012	7	10							e47516	10.1371/journal.pone.0047516	http://dx.doi.org/10.1371/journal.pone.0047516			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZN	23300633	Green Published, Green Submitted, gold			2022-12-27	WOS:000312384500013
J	Liang, S; Hu, JS; Cao, WJ; Cai, SJ				Liang, Shuo; Hu, Jingsong; Cao, Weijun; Cai, Sanjun			Meta-Analysis of Cytochrome P-450 2C9 Polymorphism and Colorectal Cancer Risk	PLOS ONE			English	Article							XENOBIOTIC-METABOLIZING ENZYMES; GENE POLYMORPHISMS; CIGARETTE-SMOKING; CYP2C9 GENOTYPES; IN-VITRO; ASSOCIATION; CARCINOMA; CELECOXIB; P4502C9; OXIDOREDUCTASE	Background: CYP2C9 encodes a member of the cytochrome P450 superfamily of enzymes which play a central role in activating and detoxifying many carcinogens and endogenous compounds thought to be involved in the development of colorectal cancer (CRC). In the past decade, the relationship between CYP2C9 common polymorphisms (R144C and 1359L) and CRC has been reported in various ethnic groups; however, these studies have yielded contradictory results. To investigate this inconsistency, we performed this meta-analysis. Methods: Databases including Pubmed, EMBASE, Web of Science and China National Knowledge Infrastructure (CNKI) were searched to find relevant studies. Odds ratios (ORs) with 95% confidence intervals (CIs) were used to assess the strength of association. Results: A total of 13 articles involving 9,463 cases and 11,416 controls were included. Overall, the summary odds ratio of CRC was 0.98 (95% CI: 0.89-1.06) and 0.99 (95% CI: 0.87-1.14) for CYP2C9 144C and 359L alleles, respectively. No significant results were observed using dominant or recessive genetic model for these polymorphisms. In the stratified analyses according to ethnicity and sex, no evidence of any gene-disease association was obtained. Conclusions: This meta-analysis suggests that the CYP2C9 may not be associated with colorectal cancer development.	[Liang, Shuo; Cao, Weijun] Tongji Univ, Sch Med, Dept Resp, Pulm Hosp Shanghai, Shanghai 200092, Peoples R China; [Hu, Jingsong; Cai, Sanjun] Fudan Univ, Sch Med, Dept Colorectal Canc, Shanghai Canc Ctr, Shanghai 200433, Peoples R China	Tongji University; Fudan University	Cao, WJ (corresponding author), Tongji Univ, Sch Med, Dept Resp, Pulm Hosp Shanghai, Shanghai 200092, Peoples R China.	Weijun_Cao@163.com; Sanjun_Cai@163.com	Cao, Wenqing/GPF-9107-2022	Cao, Wenqing/0000-0002-2761-3355	Natural Science Foundation of Shanghai [10ZR1425000]; Doctoral Fund of Ministry of Education of China [20100072120060]; key projects of Shanghai Municipal Health Bureau [2010006]; Science and Technology Commission of Shanghai Municipality [0852nm05600, 09411951500]; National Science Foundation of China [30971323]; Shanghai Subject Chief Scientist [08XD14034]	Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Doctoral Fund of Ministry of Education of China(Ministry of Education, China); key projects of Shanghai Municipal Health Bureau; Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Subject Chief Scientist	This work was supported by the Natural Science Foundation of Shanghai (10ZR1425000), Doctoral Fund of Ministry of Education of China (20100072120060), key projects of Shanghai Municipal Health Bureau (2010006), the Science and Technology Commission of Shanghai Municipality (0852nm05600, 09411951500), National Science Foundation of China (30971323) and Shanghai Subject Chief Scientist (08XD14034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Buyukdogan M, 2009, UHOD-ULUSLAR HEMATOL, V19, P134; Center MM, 2009, CA-CANCER J CLIN, V59, P366, DOI 10.3322/caac.20038; Chan AT, 2004, CLIN GASTROENTEROL H, V2, P704, DOI 10.1016/S1542-3565(04)00294-0; Cleary SP, 2010, AM J EPIDEMIOL, V172, P1000, DOI 10.1093/aje/kwq245; Cotterchio M, 2008, CANCER EPIDEM BIOMAR, V17, P3098, DOI 10.1158/1055-9965.EPI-08-0341; Crespi CL, 1997, PHARMACOGENETICS, V7, P203, DOI 10.1097/00008571-199706000-00005; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gertig DM, 1998, SEMIN CANCER BIOL, V8, P285, DOI 10.1006/scbi.1998.0078; GOLDSTEIN JA, 1994, PHARMACOGENETICS, V4, P285, DOI 10.1097/00008571-199412000-00001; ILETT KF, 1994, BIOCHEM PHARMACOL, V47, P914, DOI 10.1016/0006-2952(94)90493-6; Inoue K, 1997, PHARMACOGENETICS, V7, P103, DOI 10.1097/00008571-199704000-00003; Kury S, 2007, CANCER EPIDEM BIOMAR, V16, P1460, DOI 10.1158/1055-9965.EPI-07-0236; Lafuente MJ, 2000, CARCINOGENESIS, V21, P1813, DOI 10.1093/carcin/21.10.1813; Landi S, 2005, PHARMACOGENET GENOM, V15, P535, DOI 10.1097/01.fpc.0000165904.48994.3d; Liao LH, 2007, CLIN CHIM ACTA, V380, P191, DOI 10.1016/j.cca.2007.02.033; Marchand Loic Le, 1999, Journal of the National Cancer Institute Monographs, P101; Martinez C, 2001, CARCINOGENESIS, V22, P1323, DOI 10.1093/carcin/22.8.1323; McGreavey LE, 2005, PHARMACOGENET GENOM, V15, P713, DOI 10.1097/01.fpc.0000174786.85238.63; Northwood EL, 2010, PHARMACOGENET GENOM, V20, P315, DOI 10.1097/FPC.0b013e3283395c6a; Sainz J, 2011, ENDOCR-RELAT CANCER, V18, P265, DOI 10.1530/ERC-10-0264; Samowitz WS, 2006, CLIN GASTROENTEROL H, V4, P894, DOI 10.1016/j.cgh.2006.04.021; Sandberg M, 2002, BRIT J CLIN PHARMACO, V54, P423, DOI 10.1046/j.1365-2125.2002.01660.x; Takahashi H, 1998, PHARMACOGENETICS, V8, P365, DOI 10.1097/00008571-199810000-00001; Takanashi K, 2000, PHARMACOGENETICS, V10, P95, DOI 10.1097/00008571-200003000-00001; Tang CY, 2000, J PHARMACOL EXP THER, V293, P453; Tang CY, 2000, DRUG METAB DISPOS, V28, P567; Tang CY, 2001, PHARMACOGENETICS, V11, P223, DOI 10.1097/00008571-200104000-00006; Tranah GJ, 2005, MOL CARCINOGEN, V44, P21, DOI 10.1002/mc.20112; Windmill KF, 1997, MUTAT RES-FUND MOL M, V376, P153, DOI 10.1016/S0027-5107(97)00038-9; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x; Xiong YY, 2011, GENOMICS, V97, P277, DOI 10.1016/j.ygeno.2010.11.004; Zhou SF, 2009, CURR MED CHEM, V16, P3480, DOI 10.2174/092986709789057635	34	60	61	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49134	10.1371/journal.pone.0049134	http://dx.doi.org/10.1371/journal.pone.0049134			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145098	Green Published, Green Submitted, gold			2022-12-27	WOS:000311935800217
J	Wang, W; Ao, L; Rayburn, ER; Xu, HX; Zhang, XR; Zhang, X; Nag, SA; Wu, XM; Wang, MH; Wang, H; Van Meir, EG; Zhang, R				Wang, Wei; Ao, Lin; Rayburn, Elizabeth R.; Xu, Hongxia; Zhang, Xiangrong; Zhang, Xu; Nag, Subhasree Ashok; Wu, Xuming; Wang, Ming-Hai; Wang, Hui; Van Meir, Erwin G.; Zhang, Ruiwen			KCN1, a Novel Synthetic Sulfonamide Anticancer Agent: In Vitro and In Vivo Anti-Pancreatic Cancer Activities and Preclinical Pharmacology	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR; PRIVILEGED STRUCTURES; HIF-1 INHIBITORS; TUMOR HYPOXIA; HIF-1-ALPHA; PATHWAY; BIOLOGY; IDENTIFICATION; ANGIOGENESIS; CHECKPOINTS	The purpose of the present study was to determine the in vitro and in vivo anti-cancer activity and pharmacological properties of 3,4-dimethoxy-N-[(2,2-dimethyl-2H-chromen-6-yl)methyl]-N-phenylbenzenesulfonamide, KCN1. In the present study, we investigated the in vitro activity of KCN1 on cell proliferation and cell cycle distribution of pancreatic cancer cells, using the MTT and BrdUrd assays, and flow cytometry. The in vivo anti-cancer effects of KCN1 were evaluated in two distinct xenograft models of pancreatic cancer. We also developed an HPLC method for the quantitation of the compound, and examined its stability in mouse plasma, plasma protein binding, and degradation by mouse S9 microsomal enzymes. Furthermore, we examined the pharmacokinetics of KCN1 following intravenous or intraperitoneal injection in mice. Results showed that, in a dose-dependent manner, KCN1 inhibited cell growth and induced cell cycle arrest in human pancreatic cancer cells in vitro, and showed in vivo anticancer efficacy in mice bearing Panc-1 or Mia Paca-2 tumor xenografts. The HPLC method provided linear detection of KCN1 in all of the matrices in the range from 0.1 to 100 mu M, and had a lower limit of detection of 0.085 mu M in mouse plasma. KCN1 was very stable in mouse plasma, extensively plasma bound, and metabolized by S9 microsomal enzymes. The pharmacokinetic studies indicated that KCN1 could be detected in all of the tissues examined, most for at least 24 h. In conclusion, our preclinical data indicate that KCN1 is a potential therapeutic agent for pancreatic cancer, providing a basis for its future development.	[Wang, Wei; Ao, Lin; Xu, Hongxia; Zhang, Xiangrong; Zhang, Xu; Nag, Subhasree Ashok; Wu, Xuming; Zhang, Ruiwen] Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Dept Pharmaceut Sci, Amarillo, TX USA; [Wang, Wei; Wang, Ming-Hai; Zhang, Ruiwen] Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Canc Biol Ctr, Amarillo, TX USA; [Wang, Wei; Ao, Lin; Rayburn, Elizabeth R.; Xu, Hongxia; Zhang, Xiangrong; Zhang, Xu; Zhang, Ruiwen] Univ Alabama Birmingham, Dept Pharmacol & Toxicol, Div Clin Pharmacol, Birmingham, AL USA; [Wu, Xuming] Nantong Univ, Nantong Canc Hosp, Nantong, Peoples R China; [Wang, Ming-Hai] Texas Tech Univ, Hlth Sci Ctr, Dept Biomed Sci, Amarillo, TX USA; [Wang, Hui] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai, Peoples R China; [Van Meir, Erwin G.] Emory Univ, Sch Med, Dept Neurosurg, Atlanta, GA USA; [Van Meir, Erwin G.] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA USA; [Van Meir, Erwin G.] Emory Univ, Winship Canc Ctr, Atlanta, GA 30322 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; University of Alabama System; University of Alabama Birmingham; Nantong University; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Emory University; Emory University; Emory University	Wang, W (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Dept Pharmaceut Sci, Amarillo, TX USA.	evanmei@emory.edu; ruiwen.zhang@ttuhsc.edu	Nag, subhasree/T-1505-2019; Xu, Hongxia/AAN-8608-2021	Nag, subhasree/0000-0001-6933-4349; xu, hongxia/0000-0001-5215-734X; Van Meir, Erwin G./0000-0003-2444-7707	National Institutes of Health grant [R01 CA116804, R01 CA91980]; National Institutes of Health [R01 CA112029, R01 CA121211]; EmTechBio; University Research Committee of Emory University; Brain Tumor Foundation for Children; V Foundation for Cancer Research; One Hundred Talents Program, Chinese Academy of Sciences; National Nature Science Foundation [30870513, 31070680, 91029715, 81025017]; Ministry of Science and Technology of China [2007CB947100]; National Science and Technology Major Project Key New Drug Creation and Manufacturing Program [2009ZX09102-114, 2009ZX09301-011]; NATIONAL CANCER INSTITUTE [R01CA112029, R01CA091980, R01CA116804, R01CA121211] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EmTechBio; University Research Committee of Emory University; Brain Tumor Foundation for Children; V Foundation for Cancer Research; One Hundred Talents Program, Chinese Academy of Sciences; National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Science and Technology Major Project Key New Drug Creation and Manufacturing Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a National Institutes of Health grant R01 CA116804 (to EGVM). RZ was also supported by National Institutes of Health grants R01 CA112029 and R01 CA121211. EGVM was also supported by EmTechBio, the University Research Committee of Emory University, the Brain Tumor Foundation for Children, and the V Foundation for Cancer Research. HW was supported by the One Hundred Talents Program, Chinese Academy of Sciences, grants from National Nature Science Foundation (30870513, 31070680, 91029715 and 81025017) and Ministry of Science and Technology of China (2007CB947100), National Science and Technology Major Project Key New Drug Creation and Manufacturing Program 2009ZX09102-114, 2009ZX09301-011). MW was supported by National Institutes of Health grant R01 CA91980. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 1998, J DRUG TARGET, V5, P303, DOI 10.3109/10611869808995883; Bacon AL, 2004, ANN MED, V36, P530, DOI 10.1080/07853890410018231; Bartek J, 2001, FEBS LETT, V490, P117, DOI 10.1016/S0014-5793(01)02114-7; Bayraktar S, 2010, WORLD J GASTROENTERO, V16, P673, DOI 10.3748/wjg.v16.i6.673; Belozerov VE, 2005, ANTI-CANCER DRUG, V16, P901, DOI 10.1097/01.cad.0000180116.85912.69; Belozerov VE, 2006, CURR OPIN INVEST DR, V7, P1067; BOWERS VD, 1991, TRANSPLANTATION, V51, P847, DOI 10.1097/00007890-199104000-00021; Brat DJ, 2002, ADV ANAT PATHOL, V9, P24, DOI 10.1097/00125480-200201000-00004; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Dorr R T, 1994, Ann Pharmacother, V28, pS11; Gelderblom H, 2001, EUR J CANCER, V37, P1590, DOI 10.1016/S0959-8049(01)00171-X; Goda N, 2003, MOL CELL BIOL, V23, P359, DOI 10.1128/MCB.23.1.359-369.2003; Janssen A, 2011, ONCOGENE, V30, P2799, DOI 10.1038/onc.2011.30; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jensen RL, 2009, J NEURO-ONCOL, V92, P317, DOI 10.1007/s11060-009-9827-2; Kaelin WG, 2011, COLD SH Q B, V76, P335, DOI 10.1101/sqb.2011.76.010975; Kaur B, 2004, J NEURO-ONCOL, V70, P229, DOI 10.1007/s11060-004-2752-5; Knisely JPS, 2002, NEUROIMAG CLIN N AM, V12, P525, DOI 10.1016/S1052-5149(02)00032-1; Koh MY, 2010, RECENT RESULTS CANC, V180, P15, DOI 10.1007/978-3-540-78281-0_3; Lukas J, 2004, DNA REPAIR, V3, P997, DOI 10.1016/j.dnarep.2004.03.006; Mooring SR, 2011, J MED CHEM, V54, P8471, DOI 10.1021/jm201018g; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mun J, 2012, J MED CHEM, V55, P6738, DOI 10.1021/jm300752n; Mun JY, 2012, BIOORGAN MED CHEM, V20, P4590, DOI 10.1016/j.bmc.2012.04.064; Narita T, 2009, CLIN CANCER RES, V15, P6128, DOI 10.1158/1078-0432.CCR-08-3180; Nicolaou KC, 2000, J AM CHEM SOC, V122, P9939, DOI 10.1021/ja002033k; Nicolaou KC, 2000, J AM CHEM SOC, V122, P9954, DOI 10.1021/ja002034c; Nojima Hiroshi, 2004, Methods Mol Biol, V280, P3; Onnis B, 2009, J CELL MOL MED, V13, P2780, DOI 10.1111/j.1582-4934.2009.00876.x; Pancreatic Cancer. National Cancer Institute, PANCR CANC; Poon E, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001173; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Semenza GL, 2009, CURR PHARM DESIGN, V15, P3839, DOI 10.2174/138161209789649402; Shi Q, 2012, ACS MED CHEM LETT, V3, P620, DOI 10.1021/ml300042k; Tan C, 2005, CANCER RES, V65, P605; Tan C, 2011, BIOORG MED CHEM LETT, V21, P5528, DOI 10.1016/j.bmcl.2011.06.099; Tohma Y, 1998, J NEUROPATH EXP NEUR, V57, P239, DOI 10.1097/00005072-199803000-00005; Tsaioun K, 2009, ATLA-ALTERN LAB ANIM, V37, P47, DOI 10.1177/026119290903701S10; van der Groep P, 2008, BREAST CANCER RES TR, V111, P475, DOI 10.1007/s10549-007-9817-z; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; Wang JL, 2009, CURR PHARM DESIGN, V15, P2195, DOI 10.2174/138161209788682514; Wang W, 2009, CANCER LETT, V278, P241, DOI 10.1016/j.canlet.2009.01.005; Weinmann M, 2004, ONKOLOGIE, V27, P83, DOI 10.1159/000075611; Wilson GD, 2007, FRONT BIOSCI-LANDMRK, V12, P3502, DOI 10.2741/2330; Yin S, 2012, CLIN CANC R IN PRESS; Zhang XR, 2012, MAR DRUGS, V10, P1138, DOI 10.3390/md10051138	46	50	53	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44883	10.1371/journal.pone.0044883	http://dx.doi.org/10.1371/journal.pone.0044883			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028659	Green Published, gold, Green Submitted			2022-12-27	WOS:000308788700049
J	Wang, XM; Zhu, CF; Bao, WG; Zhao, K; Niu, JQ; Yu, XF; Zhang, WY				Wang, Xiaomei; Zhu, Chunfeng; Bao, Wanguo; Zhao, Ke; Niu, Junqi; Yu, Xiao-Fang; Zhang, Wenyan			Characterization of Full-Length Enterovirus 71 Strains from Severe and Mild Disease Patients in Northeastern China	PLOS ONE			English	Article							MOUTH-DISEASE; MOLECULAR EPIDEMIOLOGY; FOOT; HAND; TAIWAN; RECOMBINATION; INFECTION; EVOLUTION; OUTBREAK	Human enterovirus 71 (EV71)-associated hand, foot, and mouth disease (HFMD) has been a leading cause of childhood infection in China since 2008. Epidemic and molecular characteristics of HFMD have been examined in many areas of China, including the central and southern regions. However, clinical and genetic characterization of EV71 in the northeastern region of China is scarce. In this study, a series of analyses were performed on seven full-length EV71 sequences from HFMD patients who had either severe or mild disease. We have determined that these seven circulating EV71 viruses from Changchun, China are actually complex recombinant viruses involving multiple type A human enterovirus (HEV). Classified as EV71 subtype C4 (EV71 C4), these Changchun EV71 viruses contain genetic recombination events between the CA4, CA5, EV71B4 and EV71C1 strains. Most of the structural protein region (P1) of these viruses resembled that of the prototype EV71 C1 strains. The non-structural protein domains (P2 and P3) showed a high degree of similarity with CA4, CA5 and EV71 B4 in different regions. The 5'UTR had unclassified recombination, while partial 3D region of these viruses showed a high degree of similarity to CA16. Phylogenetic analysis of full-length or partial sequences of isolates from severe or mild disease patients in Changchun always formed a single cluster in various phylogenetic analyses of different genomic regions, suggesting that all seven strains originated from one single common ancestor. There was no correlation between viral genomic sequence and virulence. Thus, we found that circulating recombinant forms of EV71 are prevalent among HFMD patients in Northeastern China. The existence of a unique cluster of EV71 related viruses in Northeast China has important implications for vaccine development that would address the increasing prevalence of HFMD.	[Wang, Xiaomei; Zhu, Chunfeng; Zhao, Ke; Yu, Xiao-Fang; Zhang, Wenyan] Jilin Univ, Hosp 1, Inst Virol & AIDS Res, Changchun, Jilin Province, Peoples R China; [Wang, Xiaomei; Niu, Junqi] Jilin Univ, Hosp 1, Dept Hepatol, Changchun, Jilin Province, Peoples R China; [Bao, Wanguo] Jilin Univ, Hosp 1, Dept Infect Dis, Changchun, Jilin Province, Peoples R China	Jilin University; Jilin University; Jilin University	Wang, XM (corresponding author), Jilin Univ, Hosp 1, Inst Virol & AIDS Res, Changchun, Jilin Province, Peoples R China.	junqiniu@yahoo.com.cn; xfyu@jhsph.edu; zhangwenyan@jlu.edu.cn	Li, Yang/GWM-7879-2022; Wang, Xiaohui/B-8126-2011; Li, Yuan/GXV-1310-2022; YIN, HANG/O-2097-2014; Smith, Christina/GXG-6941-2022; Tetens, Jens/H-5344-2012; Wang, Xugao/B-1111-2015; Pausch, Hubert/U-5934-2019; Pausch, Hubert/B-7637-2018; li, yong/HDN-3885-2022	Wang, Xiaohui/0000-0002-3415-5612; YIN, HANG/0000-0002-9762-4818; Wang, Xugao/0000-0003-1207-8852; Pausch, Hubert/0000-0002-0501-6760; Wang, Jing/0000-0002-2806-6517; Boville (Smith), Christina/0000-0002-2577-9343; Li, Jing/0000-0003-2504-1629; Comita, Liza/0000-0002-9169-1331; Fiorini, Zeno/0000-0001-5218-2502; wang, yizhen/0000-0002-3908-7102	Specialized Research Fund for the Doctoral Program of Higher Education; Jilin University [200903258]; Key Laboratory of Molecular Virology, Jilin Province, China [20102209]; Direct For Mathematical & Physical Scien [0954819] Funding Source: National Science Foundation	Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Jilin University(Jilin University); Key Laboratory of Molecular Virology, Jilin Province, China; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported in part by funding from the Specialized Research Fund for the Doctoral Program of Higher Education and Jilin University (No200903258) to Wenyan Zhang, and a grant from the Key Laboratory of Molecular Virology, Jilin Province (20102209), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown BA, 1999, J VIROL, V73, P9969, DOI 10.1128/JVI.73.12.9969-9975.1999; Chan KP, 2003, EMERG INFECT DIS, V9, P78; Chan YF, 2004, EMERG INFECT DIS, V10, P1468; Chan YF, 2010, INFECT GENET EVOL, V10, P404, DOI 10.1016/j.meegid.2009.05.010; Chang GH, 2010, VIRUS RES, V151, P66, DOI 10.1016/j.virusres.2010.04.001; Chen KT, 2007, PEDIATRICS, V120, pE244, DOI 10.1542/peds.2006-3331; CHUMAKOV M, 1979, ARCH VIROL, V60, P329, DOI 10.1007/BF01317504; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Huang SW, 2009, J CLIN MICROBIOL, V47, P3653, DOI 10.1128/JCM.00630-09; Huang SC, 2008, VIRUS RES, V131, P250, DOI 10.1016/j.virusres.2007.10.002; Li LL, 2005, J CLIN MICROBIOL, V43, P3835, DOI 10.1128/JCM.43.8.3835-3839.2005; Li RQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026237; Mao LX, 2010, J CLIN VIROL, V49, P100, DOI 10.1016/j.jcv.2010.07.009; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304; Shi XD, 2011, CENT EUR J MED, V6, P220, DOI 10.2478/s11536-010-0075-9; Shimizu H, 2004, PEDIATR INT, V46, P231, DOI 10.1046/j.1442-200x.2004.01868.x; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Tan XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025662; Yoke-Fun C, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-74; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002; Zhu Z, 2007, BIOMED ENVIRON SCI, V20, P321	22	319	351	22	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e32405	10.1371/journal.pone.0050575	http://dx.doi.org/10.1371/journal.pone.0050575			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22558416	gold, Green Submitted, Green Published			2022-12-27	WOS:000304523400005
J	Wang, XX; Huang, M; Wang, YZ				Wang, Xinxia; Huang, Ming; Wang, Yizhen			The Effect of Insulin, TNF alpha and DHA on the Proliferation, Differentiation and Lipolysis of Preadipocytes Isolated from Large Yellow Croaker (Pseudosciaena Crocea R.)	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; TROUT ONCORHYNCHUS-MYKISS; FATTY-ACID SYNTHASE; INHIBITS ADIPOCYTE DIFFERENTIATION; ADIPOSE TRIGLYCERIDE LIPASE; ACTIVATED RECEPTORS ALPHA; SIGNAL-RELATED KINASE; LPL GENE-EXPRESSION; RAINBOW-TROUT; LIPOPROTEIN-LIPASE	Fish final product can be affected by excessive lipid accumulation. Therefore, it is important to develop strategies to control obesity in cultivated fish to strengthen the sustainability of the aquaculture industry. As in mammals, the development of adiposity in fish depends on hormonal, cytokine and dietary factors. In this study, we investigated the proliferation and differentiation of preadipocytes isolated from the large yellow croaker and examined the effects of critical factors such as insulin, TNF alpha and DHA on the proliferation, differentiation and lipolysis of adipocytes. Preadipocytes were isolated by collagenase digestion, after which their proliferation was evaluated. The differentiation process was optimized by assaying glycerol-3-phosphate dehydrogenase (GPDH) activity. Oil red O staining and electron microscopy were performed to visualize the accumulated triacylglycerol. Gene transcript levels were measured using SYBR green quantitative real-time PCR. Insulin promoted preadipocytes proliferation, stimulated cell differentiation and decreased lipolysis of mature adipocytes. TNF alpha and DHA inhibited cell proliferation and differentiation. While TNF alpha stimulated mature adipocyte lipolysis, DHA showed no lipolytic effect on adipocytes. The expressions of adipose triglyceride lipase (ATGL), fatty acid synthase (FAS), lipoprotein lipase (LPL) and peroxisome proliferator-activated receptor alpha, gamma (PPAR alpha, PPAR gamma) were quantified during preadipocytes differentiation and adipocytes lipolysis to partly explain the regulation mechanisms. In summary, the results of this study indicated that although preadipocytes proliferation and the differentiation process in large yellow croaker are similar to these processes in mammals, the effects of critical factors such as insulin, TNF alpha and DHA on fish adipocytes development are not exactly the same. Our findings fill in the gaps in the basic data regarding the effects of critical factors on adiposity development in fish and will facilitate the further study of molecular mechanism by which these factors act in fish and the application of this knowledge to eventually control obesity in cultured species.	[Wang, Xinxia; Huang, Ming; Wang, Yizhen] Zhejiang Univ, Inst Feed Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Wang, YZ (corresponding author), Zhejiang Univ, Inst Feed Sci, Hangzhou 310003, Zhejiang, Peoples R China.	yzwang@zju.edu.cn	Li, Yang/GWM-7879-2022; Wang, Xiaohui/B-8126-2011; Li, Yuan/GXV-1310-2022; YIN, HANG/O-2097-2014; Smith, Christina/GXG-6941-2022; Tetens, Jens/H-5344-2012; Wang, Xugao/B-1111-2015; Pausch, Hubert/U-5934-2019; Pausch, Hubert/B-7637-2018; li, yong/HDN-3885-2022	Wang, Xiaohui/0000-0002-3415-5612; YIN, HANG/0000-0002-9762-4818; Wang, Xugao/0000-0003-1207-8852; Pausch, Hubert/0000-0002-0501-6760; Wang, Jing/0000-0002-2806-6517; Boville (Smith), Christina/0000-0002-2577-9343; Li, Jing/0000-0003-2504-1629; Comita, Liza/0000-0002-9169-1331; Fiorini, Zeno/0000-0001-5218-2502; wang, yizhen/0000-0002-3908-7102	NSFC (National Natural Science Foundation of China) [30901104]; China Postdoctoral Science Foundation [2009046138]; Direct For Mathematical & Physical Scien [0954819] Funding Source: National Science Foundation	NSFC (National Natural Science Foundation of China)(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by grants from the NSFC (National Natural Science Foundation of China, grant # 30901104), and the China Postdoctoral Science Foundation (grant # 2009046138). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albalat A, 2007, COMP BIOCHEM PHYS B, V148, P151, DOI 10.1016/j.cbpb.2007.05.004; Albalat A, 2005, COMP BIOCHEM PHYS A, V142, P347, DOI 10.1016/j.cbpa.2005.08.006; Albalat A, 2005, AM J PHYSIOL-REG I, V289, pR259, DOI 10.1152/ajpregu.00574.2004; Albalat A, 2005, J ENDOCRINOL, V184, P527, DOI 10.1677/joe.1.05940; Albalat A, 2006, GEN COMP ENDOCR, V146, P226, DOI 10.1016/j.ygcen.2005.11.011; [Anonymous], 2011, CHIN FISH STAT YB; Awad AB, 2000, J NUTR BIOCHEM, V11, P153, DOI 10.1016/S0955-2863(99)00087-X; Boney CM, 2000, MOL ENDOCRINOL, V14, P805, DOI 10.1210/me.14.6.805; Boone C, 2000, REPROD NUTR DEV, V40, P325, DOI 10.1051/rnd:2000103; Bouraoui L, 2008, J ENDOCRINOL, V198, P459, DOI 10.1677/JOE-08-0264; Bouraoui L, 2012, COMP BIOCHEM PHYS A, V161, P83, DOI 10.1016/j.cbpa.2011.09.008; Bouraoui L, 2010, AM J PHYSIOL-REG I, V299, pR33, DOI 10.1152/ajpregu.00457.2009; Calviello G, 1999, LIPIDS, V34, P599, DOI 10.1007/s11745-999-0404-6; Capilla E, 2011, GEN COMP ENDOCR, V172, P107, DOI 10.1016/j.ygcen.2011.03.020; Cawthorn WP, 2008, FEBS LETT, V582, P117, DOI 10.1016/j.febslet.2007.11.051; Cersosimo E, 2012, AM J PHYSIOL-CELL PH, V302, pC652, DOI 10.1152/ajpcell.00022.2011; CHAJES V, 1995, BREAST CANCER RES TR, V34, P199, DOI 10.1007/BF00689711; Chamras H, 2002, J NUTR BIOCHEM, V13, P711, DOI 10.1016/S0955-2863(02)00230-9; CHEATHAM B, 1995, ENDOCR REV, V16, P117, DOI 10.1210/er.16.2.117; Choi SM, 2010, MOL CELL BIOL, V30, P5009, DOI 10.1128/MCB.00797-10; Claycombe KJ, 1998, AM J PHYSIOL-REG I, V274, pR1253, DOI 10.1152/ajpregu.1998.274.5.R1253; CORNELIUS P, 1990, J BIOL CHEM, V265, P20506; DANI C, 1990, J CELL BIOCHEM, V43, P103, DOI 10.1002/jcb.240430202; Degerman E, 1998, METHODS, V14, P43, DOI 10.1006/meth.1997.0564; Deiuliis JA, 2008, LIPIDS, V43, P215, DOI 10.1007/s11745-007-3146-1; DOERRLER W, 1994, CYTOKINE, V6, P478, DOI 10.1016/1043-4666(94)90074-4; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; FRANSEN L, 1986, CELL IMMUNOL, V100, P260, DOI 10.1016/0008-8749(86)90025-0; Garcia-Castillo J, 2004, CELL MOL LIFE SCI, V61, P1331, DOI 10.1007/s00018-004-4068-1; Gasic S, 1999, J BIOL CHEM, V274, P6770, DOI 10.1074/jbc.274.10.6770; Glosli H, 2005, BBA-MOL CELL BIOL L, V1734, P235, DOI 10.1016/j.bbalip.2005.02.011; Goldberg IJ, 1996, J LIPID RES, V37, P693; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Grohmann M, 2005, J LIPID RES, V46, P93, DOI 10.1194/jlr.M400295-JLR200; GRUNFELD C, 1988, J LIPID RES, V29, P1327; Hansen JO, 2008, AQUACULTURE, V284, P159, DOI 10.1016/j.aquaculture.2008.07.043; HARMON JS, 1992, GEN COMP ENDOCR, V87, P214, DOI 10.1016/0016-6480(92)90025-F; Hensler M, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-128; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Khan S, 2002, J LIPID RES, V43, P979; Kim HK, 2006, J NUTR, V136, P409, DOI 10.1093/jn/136.2.409; Kim HK, 2006, J NUTR, V136, P2965, DOI 10.1093/jn/136.12.2965; Kim JY, 2006, AM J PHYSIOL-ENDOC M, V291, pE115, DOI 10.1152/ajpendo.00317.2005; Kitamura T, 1999, MOL CELL BIOL, V19, P6286; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Kralisch S, 2005, MOL CELL ENDOCRINOL, V240, P43, DOI 10.1016/j.mce.2005.06.002; Kras KM, 2000, OBES RES, V8, P186, DOI 10.1038/oby.2000.20; Li XF, 2012, FISH PHYSIOL BIOCHEM, V38, P529, DOI 10.1007/s10695-011-9533-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LopezSoriano J, 1997, MOL CELL ENDOCRINOL, V132, P93, DOI 10.1016/S0303-7207(97)00125-1; Madsen L, 2005, BBA-MOL BASIS DIS, V1740, P266, DOI 10.1016/j.bbadis.2005.03.001; Montserrat N, 2007, GEN COMP ENDOCR, V150, P462, DOI 10.1016/j.ygcen.2006.11.009; Morrison RF, 1999, J BIOL CHEM, V274, P17088, DOI 10.1074/jbc.274.24.17088; Niemela SM, 2007, J CRANIOFAC SURG, V18, P325, DOI 10.1097/scs.0b013e3180333b6a; Oku H, 2006, COMP BIOCHEM PHYS B, V144, P326, DOI 10.1016/j.cbpb.2006.03.008; Okuno M, 1997, J NUTR, V127, P1752, DOI 10.1093/jn/127.9.1752; PALOMBELLA VJ, 1989, J BIOL CHEM, V264, P18128; PAULAUSKIS JD, 1989, J BIOL CHEM, V264, P574; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Radenne A, 2008, AM J PHYSIOL-ENDOC M, V295, pE884, DOI 10.1152/ajpendo.90438.2008; RAMIREZZACARIAS JL, 1992, HISTOCHEMISTRY, V97, P493, DOI 10.1007/BF00316069; Ramsay TG, 2003, COMP BIOCHEM PHYS B, V136, P245, DOI 10.1016/S1096-4959(02)00261-0; Rieusset J, 1999, DIABETES, V48, P699, DOI 10.2337/diabetes.48.4.699; Ruan H, 2003, J BIOL CHEM, V278, P28181, DOI 10.1074/jbc.M303141200; Ruan H, 2002, DIABETES, V51, P3176, DOI 10.2337/diabetes.51.11.3176; Ryden M, 2007, J INTERN MED, V262, P431, DOI 10.1111/j.1365-2796.2007.01854.x; Sakaguchi Y, 2004, BLOOD, V104, P2728, DOI 10.1182/blood-2003-12-4452; Shalev A, 1996, ENDOCRINOLOGY, V137, P4499, DOI 10.1210/en.137.10.4499; SMITH RA, 1986, J BIOL CHEM, V261, P4871; Sottile V, 2001, ANAL BIOCHEM, V293, P124, DOI 10.1006/abio.2001.5121; Souza SC, 2003, J CELL BIOCHEM, V89, P1077, DOI 10.1002/jcb.10565; Sun C, 2011, MOL BIOL REP, V38, P731, DOI 10.1007/s11033-010-0160-9; Suryawan A, 1997, J ANIM SCI, V75, P105; Todorcevic M, 2008, BBA-MOL CELL BIOL L, V1781, P326, DOI 10.1016/j.bbalip.2008.04.014; van Harmelen V, 2004, METABOLISM, V53, P632, DOI 10.1016/j.metabol.2003.11.012; Vegusdal A, 2003, LIPIDS, V38, P289, DOI 10.1007/s11745-003-1063-3; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Wang D, 1998, J BIOL CHEM, V273, P25420, DOI 10.1074/jbc.273.39.25420; Wang XX, 2012, AQUAC RES, V43, P281, DOI 10.1111/j.1365-2109.2011.02826.x; Xing H, 1997, ENDOCRINOLOGY, V138, P2776, DOI 10.1210/en.138.7.2776; Xu HY, 1999, J BIOL CHEM, V274, P26287, DOI 10.1074/jbc.274.37.26287; Yoon M, 2009, PHARMACOL RES, V60, P151, DOI 10.1016/j.phrs.2009.02.004; Zhang F, 2004, DRUG NEWS PERSPECT, V17, P661, DOI 10.1358/dnp.2004.17.10.873918; Zhang HH, 2002, DIABETES, V51, P2929, DOI 10.2337/diabetes.51.10.2929; Zhao ZY, 2008, J FOOD LIPIDS, V15, P534, DOI 10.1111/j.1745-4522.2008.00138.x; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	87	319	351	22	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e48069	10.1371/journal.pone.0048069	http://dx.doi.org/10.1371/journal.pone.0048069			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	22558416	Green Published, gold, Green Submitted			2022-12-27	WOS:000310262500033
J	Wang, XG; Comita, LS; Hao, ZQ; Davies, SJ; Ye, J; Lin, F; Yuan, ZQ				Wang, Xugao; Comita, Liza S.; Hao, Zhanqing; Davies, Stuart J.; Ye, Ji; Lin, Fei; Yuan, Zuoqiang			Local-Scale Drivers of Tree Survival in a Temperate Forest	PLOS ONE			English	Article							TROPICAL TREE; DENSITY-DEPENDENCE; HABITAT ASSOCIATIONS; SHADE TOLERANCE; SPATIAL DISTRIBUTIONS; SIZE DISTRIBUTIONS; SOIL INTERACTIONS; INDIVIDUAL TREES; LONG-TERM; GROWTH	Tree survival plays a central role in forest ecosystems. Although many factors such as tree size, abiotic and biotic neighborhoods have been proposed as being important in explaining patterns of tree survival, their contributions are still subject to debate. We used generalized linear mixed models to examine the relative importance of tree size, local abiotic conditions and the density and identity of neighbors on tree survival in an old-growth temperate forest in northeastern China at three levels (community, guild and species). Tree size and both abiotic and biotic neighborhood variables influenced tree survival under current forest conditions, but their relative importance varied dramatically within and among the community, guild and species levels. Of the variables tested, tree size was typically the most important predictor of tree survival, followed by biotic and then abiotic variables. The effect of tree size on survival varied from strongly positive for small trees (1-20 cm dbh) and medium trees (20-40 cm dbh), to slightly negative for large trees (>40 cm dbh). Among the biotic factors, we found strong evidence for negative density and frequency dependence in this temperate forest, as indicated by negative effects of both total basal area of neighbors and the frequency of conspecific neighbors. Among the abiotic factors tested, soil nutrients tended to be more important in affecting tree survival than topographic variables. Abiotic factors generally influenced survival for species with relatively high abundance, for individuals in smaller size classes and for shade-tolerant species. Our study demonstrates that the relative importance of variables driving patterns of tree survival differs greatly among size classes, species guilds and abundance classes in temperate forest, which can further understanding of forest dynamics and offer important insights into forest management.	[Wang, Xugao; Hao, Zhanqing; Ye, Ji; Lin, Fei; Yuan, Zuoqiang] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang, Liaoning Provin, Peoples R China; [Comita, Liza S.] Ohio State Univ, Dept Ecol Evolut & Organismal Biol, Columbus, OH 43210 USA; [Comita, Liza S.] Smithsonian Trop Res Inst, Balboa Ancon, Panama; [Davies, Stuart J.] Harvard Univ, Ctr Trop Forest Sci, Boston, MA 02115 USA; [Davies, Stuart J.] Smithsonian Trop Res Inst, Boston, MA USA	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; University System of Ohio; Ohio State University; Smithsonian Institution; Smithsonian Tropical Research Institute; Harvard University; Smithsonian Institution; Smithsonian Tropical Research Institute	Wang, XG (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang, Liaoning Provin, Peoples R China.	hzq@iae.ac.cn	Li, Yang/GWM-7879-2022; Wang, Xiaohui/B-8126-2011; Li, Yuan/GXV-1310-2022; YIN, HANG/O-2097-2014; Smith, Christina/GXG-6941-2022; Tetens, Jens/H-5344-2012; Wang, Xugao/B-1111-2015; Pausch, Hubert/U-5934-2019; Pausch, Hubert/B-7637-2018; li, yong/HDN-3885-2022	Wang, Xiaohui/0000-0002-3415-5612; YIN, HANG/0000-0002-9762-4818; Wang, Xugao/0000-0003-1207-8852; Pausch, Hubert/0000-0002-0501-6760; Wang, Jing/0000-0002-2806-6517; Boville (Smith), Christina/0000-0002-2577-9343; Li, Jing/0000-0003-2504-1629; Comita, Liza/0000-0002-9169-1331; Fiorini, Zeno/0000-0001-5218-2502; wang, yizhen/0000-0002-3908-7102	Chinese Academy of Sciences [KSCX2-EW-Z-5, KZCX2-YW-QN402]; National Natural Science Foundation of China [40971286, 31011120470, 31061160188]; Center for Tropical Forest Science of the Smithsonian Tropical Research Institute; HSBC Climate Partnership; National Center for Ecological Analysis and Synthesis; NSF [EF-0553768]; University of California, Santa Barbara; State of California; Direct For Mathematical & Physical Scien [0954819] Funding Source: National Science Foundation	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Center for Tropical Forest Science of the Smithsonian Tropical Research Institute; HSBC Climate Partnership; National Center for Ecological Analysis and Synthesis; NSF(National Science Foundation (NSF)); University of California, Santa Barbara(University of California System); State of California; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This study was supported by the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-Z-5 and KZCX2-YW-QN402) and the National Natural Science Foundation of China (40971286, 31011120470 and 31061160188). XW acknowledges the support of a fellowship from the Center for Tropical Forest Science of the Smithsonian Tropical Research Institute and the HSBC Climate Partnership. LSC acknowledges the support of a fellowship from the National Center for Ecological Analysis and Synthesis, a center funded by NSF (Grant #EF-0553768), the University of California, Santa Barbara, and the State of California. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates D., 2009, LME4 LINEAR MIXED EF; Blundell AG, 2001, J ECOL, V89, P608, DOI 10.1046/j.0022-0477.2001.00581.x; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Canham CD, 2006, ECOL APPL, V16, P540, DOI 10.1890/1051-0761(2006)016[0540:NAOCTC]2.0.CO;2; Castagneri D, 2010, ANN FOREST SCI, V67, DOI 10.1051/forest/2009111; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; CLARK DA, 1992, ECOL MONOGR, V62, P315, DOI 10.2307/2937114; COLEY PD, 1980, NATURE, V284, P545, DOI 10.1038/284545a0; Comita LS, 2007, J ECOL, V95, P482, DOI 10.1111/j.1365-2745.2007.01229.x; Comita LS, 2010, SCIENCE, V329, P330, DOI 10.1126/science.1190772; Comita LS, 2009, J ECOL, V97, P1346, DOI 10.1111/j.1365-2745.2009.01551.x; Comita LS, 2009, ECOLOGY, V90, P2755, DOI 10.1890/08-1482.1; Comita LS, 2009, ECOLOGY, V90, P328, DOI 10.1890/08-0451.1; CONDIT R, 1994, ECOLOGY, V75, P671, DOI 10.2307/1941725; Condit R., 1998, Tropical forest census plots: methods and results from Barro Colorado Island, Panama and a comparison with other plots.; CONNELL J H, 1971, P298; Coomes DA, 2007, J ECOL, V95, P27, DOI 10.1111/j.1365-2745.2006.01179.x; Coomes DA, 2006, TRENDS ECOL EVOL, V21, P593, DOI 10.1016/j.tree.2006.09.002; Das A, 2008, ECOLOGY, V89, P1744, DOI 10.1890/07-0524.1; Davies SJ, 2001, ECOLOGY, V82, P920, DOI 10.1890/0012-9658(2001)082[0920:TMAGIS]2.0.CO;2; Ehrenfeld JG, 2005, ANNU REV ENV RESOUR, V30, P75, DOI 10.1146/annurev.energy.30.050504.144212; FILIP GM, 1982, PLANT DIS, V66, P240, DOI 10.1094/PD-66-240; Finzi AC, 1998, ECOL APPL, V8, P447, DOI 10.2307/2641084; Finzi AC, 1998, ECOL APPL, V8, P440, DOI 10.2307/2641083; FRANKLIN JF, 1987, BIOSCIENCE, V37, P550, DOI 10.2307/1310665; Gelman A, DATA ANAL USING REGR; [郝占庆 HAO ZhanQing], 2008, [植物生态学报, Acta Phytoecologica Sinica], V32, P238; Harms KE, 2001, J ECOL, V89, P947, DOI 10.1111/j.1365-2745.2001.00615.x; Harrell FE, 2001, REGRESSION MODELING; He FL, 2000, J ECOL, V88, P676, DOI 10.1046/j.1365-2745.2000.00482.x; HIBBS DE, 1983, ECOLOGY, V64, P1394, DOI 10.2307/1937493; HilleRisLambers J, 2002, NATURE, V417, P732, DOI 10.1038/nature00809; Hubbell SP, 2001, ECOL RES, V16, P859, DOI 10.1046/j.1440-1703.2001.00445.x; Imaji A, 2010, OECOLOGIA, V162, P273, DOI 10.1007/s00442-009-1453-3; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; John R, 2007, P NATL ACAD SCI USA, V104, P864, DOI 10.1073/pnas.0604666104; Keane RE, 2001, CLIMATIC CHANGE, V51, P509, DOI 10.1023/A:1012539409854; KENKEL NC, 1988, ECOLOGY, V69, P1017, DOI 10.2307/1941257; Kunstler G, 2009, J ECOL, V97, P685, DOI 10.1111/j.1365-2745.2009.01482.x; Lines ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013212; LOEHLE C, 1988, CAN J FOREST RES, V18, P209, DOI 10.1139/x88-032; Lorimer CG, 2001, J ECOL, V89, P960, DOI 10.1111/j.1365-2745.2001.00619.x; Lu R.Q, 1999, SOIL AGRO CHEM ANAL; Lutz JA, 2006, ECOL MONOGR, V76, P257, DOI 10.1890/0012-9615(2006)076[0257:TMDEFD]2.0.CO;2; Maloney PE, 2008, CAN J FOREST RES, V38, P3011, DOI 10.1139/X08-141; Mangan SA, 2010, NATURE, V466, P752, DOI 10.1038/nature09273; McCarthy-Neumann S, 2008, ECOLOGY, V89, P1883, DOI 10.1890/07-0211.1; McCarthy-Neumann S, 2010, J ECOL, V98, P408, DOI 10.1111/j.1365-2745.2009.01620.x; Mordecai EA, 2011, ECOL MONOGR, V81, P429, DOI 10.1890/10-2241.1; Muller-Landau HC, 2006, ECOL LETT, V9, P575, DOI 10.1111/j.1461-0248.2006.00904.x; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Nakashizuka T, 2001, TRENDS ECOL EVOL, V16, P205, DOI 10.1016/S0169-5347(01)02117-6; NORBERG RA, 1988, AM NAT, V131, P220, DOI 10.1086/284787; Packer A, 2000, NATURE, V404, P278, DOI 10.1038/35005072; Packer A, 2003, ECOLOGY, V84, P108, DOI 10.1890/0012-9658(2003)084[0108:SPAPSS]2.0.CO;2; Peters HA, 2003, ECOL LETT, V6, P757, DOI 10.1046/j.1461-0248.2003.00492.x; Queenborough SA, 2007, ECOLOGY, V88, P2248, DOI 10.1890/06-0737.1; Queenborough SA, 2009, P ROY SOC B-BIOL SCI, V276, P4197, DOI 10.1098/rspb.2009.0921; R Core Team, 2020, R LANG ENV STAT COMP; Reinhart KO, 2009, ECOLOGY, V90, P2984, DOI 10.1890/08-1380.1; Runkle JR, 2000, ECOLOGY, V81, P554, DOI 10.1890/0012-9658(2000)081[0554:CTTIOG]2.0.CO;2; Russo SE, 2005, J ECOL, V93, P879, DOI 10.1111/j.1365-2745.2005.01030.x; Shibata M, 2010, ECOSCIENCE, V17, P137, DOI 10.2980/17-2-3163; Slik JW, 2001, OECOLOGIA, V141, P114; SOMERS RH, 1962, AM SOCIOL REV, V27, P799, DOI 10.2307/2090408; STERNER RW, 1986, J ECOL, V74, P621, DOI 10.2307/2260386; Uriarte M, 2004, ECOL MONOGR, V74, P591, DOI 10.1890/03-4031; Volkov I, 2005, NATURE, V438, P658, DOI 10.1038/nature04030; Wang LiWei, 2011, Biodiversity Science, V19, P260, DOI 10.3724/SP.J.1003.2011.11279; Wang XG, 2008, ACTA OECOL, V33, P345, DOI 10.1016/j.actao.2008.01.005; Wang XG, 2010, CAN J FOREST RES, V40, P1011, DOI 10.1139/X10-056; Wang XG, 2010, J ECOL, V98, P674, DOI 10.1111/j.1365-2745.2010.01644.x; Wang XG, 2009, OIKOS, V118, P25, DOI 10.1111/j.0030-1299.2008.16598.x; WEINER J, 1990, TRENDS ECOL EVOL, V5, P360, DOI 10.1016/0169-5347(90)90095-U; WHITE J, 1970, J ECOL, V58, P467, DOI 10.2307/2258284; Woods KD, 2000, ECOLOGY, V81, P110, DOI 10.2307/177138; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809; Yao XH, 2001, CAN J FOREST RES, V31, P283, DOI 10.1139/cjfr-31-2-283; Zhang J, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest/2008086; Zhao DH, 2006, ECOL MODEL, V196, P90, DOI 10.1016/j.ecolmodel.2006.02.002; Zuur Alain F., 2009, P1	83	319	351	22	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e29469	10.1371/journal.pone.0029469	http://dx.doi.org/10.1371/journal.pone.0029469			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22558416	gold, Green Published, Green Submitted			2022-12-27	WOS:000302733900002
J	Wang, XM; Yang, R; Feng, SF; Hou, XQ; Zhang, YQ; Li, Y; Ren, Y				Wang, Xumei; Yang, Rui; Feng, Shifang; Hou, Xiaoqi; Zhang, Yuqu; Li, Yan; Ren, Yi			Genetic Variation in Rheum palmatum and Rheum tanguticum (Polygonaceae), Two Medicinally and Endemic Species in China Using ISSR Markers	PLOS ONE			English	Article							CHLOROPLAST DNA; DIVERSITY; SEQUENCE; EVOLUTION; RHUBARB; DIFFERENTIATION; POPULATIONS; RADIATION; PLATEAU; NUMBER	Aims: Both Rheum palmatum and R. tanguticum are important but endangered medicinal plants endemic to China. In this study, we aimed to (i) investigate the level and pattern of genetic variability within/among populations of those species; (ii) evaluate genetic differentiation between both species and its relationships and ascertain whether both species are consistent with their current taxonomical treatment as separate species; and (iii) discuss the implications for the effective conservation of two species. Methods: Total 574 individuals from 30 populations of R. palmatum and R. tanguticum were collected, covering the entire distribution range of two species in China. The genetic variation within and among 30 populations was evaluated using inter-simple sequence repeat (ISSR) markers. Important Findings: Twelve selected ISSR primers generated a total of 175 fragments, 173 (98.86%) of which were polymorphic. The Nei's gene diversity (H) and Shannon's index (I) of both species were high at species level (H = 0.3107, I = 0.4677 for R. palmatum; H = 0.2848, I = 0.4333 for R. tanguticum). But for both species, the genetic diversity was low at population level, and average within-population diversity of R. palmatum was H = 0.1438, I = 0.2151, and that of R. tanguticum was H = 0.1415, I = 0.2126. The hierarchical AMOVA revealed high levels of among-population genetic differentiation in both species, in line with the gene differentiation coefficient and the limited among-population gene flow (R. palmatum: Phi(st) = 0.592, G(st) = 0.537, N-m = 0.432; R. tanguticum: Phi(st) = 0.567, G(st) = 0.497, N-m = 0.507). By contrast, only 6.52% of the total genetic variance was partitioned between R. palmatum and R. tanguticum. Bayesian analysis, UPGMA cluster analysis, and PCoA analysis all demonstrated the similar results. A significant isolation-by-distance pattern was revealed in R. palmatum (r = 0.547, P = 0.010), but not in R. tanguticum (r = 0.241, P = 0.100). Based on these results, effective conservation strategies were proposed for these two species. The small molecular variance between R. palmatum and R. tanguticum revealed that they had a common ancestor, and we considered that these two species might not be good species.	[Wang, Xumei; Yang, Rui; Li, Yan] Xi An Jiao Tong Univ, Coll Med, Xian 710049, Peoples R China; [Feng, Shifang; Hou, Xiaoqi; Zhang, Yuqu; Ren, Yi] Shaanxi Normal Univ, Coll Life Sci, Xian, Peoples R China	Xi'an Jiaotong University; Shaanxi Normal University	Wang, XM (corresponding author), Xi An Jiao Tong Univ, Coll Med, Xian 710049, Peoples R China.	wangxumei@mail.xjtu.edu.cn	Li, Yang/GWM-7879-2022; Wang, Xiaohui/B-8126-2011; Li, Yuan/GXV-1310-2022; YIN, HANG/O-2097-2014; Smith, Christina/GXG-6941-2022; Tetens, Jens/H-5344-2012; Wang, Xugao/B-1111-2015; Pausch, Hubert/U-5934-2019; Pausch, Hubert/B-7637-2018; li, yong/HDN-3885-2022	Wang, Xiaohui/0000-0002-3415-5612; YIN, HANG/0000-0002-9762-4818; Wang, Xugao/0000-0003-1207-8852; Pausch, Hubert/0000-0002-0501-6760; Wang, Jing/0000-0002-2806-6517; Boville (Smith), Christina/0000-0002-2577-9343; Li, Jing/0000-0003-2504-1629; Comita, Liza/0000-0002-9169-1331; Fiorini, Zeno/0000-0001-5218-2502; wang, yizhen/0000-0002-3908-7102	National Nature Science Foundation of China [81001602]; Direct For Mathematical & Physical Scien [0954819] Funding Source: National Science Foundation	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by National Nature Science Foundation of China (No. 81001602). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amel SH, 2004, GENET RESOUR CROP EV, V51, P269, DOI 10.1023/B:GRES.0000024012.59828.6b; [Anonymous], 1984, GARTENFLORA, V23, P305; Bao BJ., 2003, FLORA CHINA, V5, P341; BARRETT SCH, 1991, GENETICS AND CONSERVATION OF RARE PLANTS, P3; Chen Da-Xia, 2008, Zhongguo Zhong Yao Za Zhi, V33, P2309; Chen FJ, 2009, BIOCHEM SYST ECOL, V37, P613, DOI 10.1016/j.bse.2009.08.004; Chennaoui-Kourda H, 2007, BIOCHEM SYST ECOL, V35, P682, DOI 10.1016/j.bse.2007.05.005; Chinese Pharmacopoeia Committee, 2010, PHARM PEOPL REP CHIN, P22; Dodd SC, 2002, AM J BOT, V89, P613, DOI 10.3732/ajb.89.4.613; Doyle J. J., 1987, PHYTOCHEM B, P11; Esselman EJ, 1999, MOL ECOL, V8, P443, DOI 10.1046/j.1365-294X.1999.00585.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Freeland J. R., 2011, MOL ECOLOGY; Ge XJ, 2005, BIODIVERS CONSERV, V14, P849, DOI 10.1007/s10531-004-0655-6; Ge XJ, 1999, MOL ECOL, V8, P2061, DOI 10.1046/j.1365-294x.1999.00821.x; Goropashnaya AV, 2001, MOL ECOL, V10, P2807, DOI 10.1046/j.1365-294X.2001.t01-1-01410.x; Hamrick J. L., 1990, Plant population genetics, breeding, and genetic resources., P43; Hamrick J. L., 1992, New Forests, V6, P95, DOI 10.1007/BF00120641; Hamrick J. L., 1996, P281; Hamrick JL, 1996, PHILOS T ROY SOC B, V351, P1291, DOI 10.1098/rstb.1996.0112; Hogbin PM, 1999, CONSERV BIOL, V13, P514, DOI 10.1046/j.1523-1739.1999.98182.x; Hu YP, 2010, BIOCHEM SYST ECOL, V38, P264, DOI 10.1016/j.bse.2010.01.006; KARRON JD, 1991, GENETICS AND CONSERVATION OF RARE PLANTS, P87; Knuth P, 1906, HDB FLOWER POLLINATI, V3; Lewontin R.C., 1972, EVOL BIOL, P381, DOI [10.1007/978-1-4684-9063-3_14, DOI 10.1007/978-1-4684-9063-3_14]; Li EX, 2008, MOL PHYLOGENET EVOL, V49, P702, DOI 10.1016/j.ympev.2008.09.012; Li JM, 2007, PLANT SCI, V172, P1048, DOI 10.1016/j.plantsci.2007.02.009; Li PQ, 2010, LIAONING J TRAD CHIN, V37, P136; Lu Jian-ying, 2008, Xibei Shifan Daxue Xuebao (Ziran Kexue Ban), V44, P66; MCDERMOTT JM, 1993, ANNU REV PHYTOPATHOL, V31, P353, DOI 10.1146/annurev.py.31.090193.002033; Miller MP, 1997, TOOLS POPULATION GEN; Moreira RG, 2010, CONSERV GENET, V11, P1247, DOI 10.1007/s10592-009-9953-6; Moreno S, 1998, EUPHYTICA, V101, P117, DOI 10.1023/A:1018379805873; MULLER J, 1981, BOT REV, V47, P1, DOI 10.1007/BF02860537; NEI M, 1974, GENETICS, V76, P379; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pritchard JK, 2000, GENETICS, V155, P945; Rajesh PN, 2003, EUPHYTICA, V129, P15, DOI 10.1023/A:1021567821141; Reddy MP, 2002, EUPHYTICA, V128, P9, DOI 10.1023/A:1020691618797; Song ZQ, 2010, GENETICA, V138, P241, DOI 10.1007/s10709-009-9416-5; Sun YS, 2012, MOL PHYLOGENET EVOL, V63, P150, DOI 10.1016/j.ympev.2012.01.002; Suo FengMei, 2010, Zhongcaoyao = Chinese Traditional and Herbal Drugs, V41, P292; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wang A. T., 2009, THESIS LANZHOU U; Wang AL, 2005, ANN BOT-LONDON, V96, P489, DOI 10.1093/aob/mci201; Wang XM, 2012, INT J MOL SCI, V13, P3900, DOI 10.3390/ijms13033900; Wang XM, 2010, J MED PLANTS RES, V4, P1865; Wang XM, 2010, J MED PLANTS RES, V4, P904; Wright S, 1931, GENETICS, V16, P0097; Wu JK, 1992, ACTA BOT BOREALI-OCC, V12, P309; Xia T, 2005, BIOCHEM GENET, V43, P87, DOI 10.1007/s10528-005-1502-5; Xiao Su-ping, 2007, Zhongguo Zhong Yao Za Zhi, V32, P195; Yang DY, 2004, BIOL PHARM BULL, V27, P375, DOI 10.1248/bpb.27.375; Yeh F.C., 1997, POPGENE VERSION 1 31	55	319	351	22	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e51667	10.1371/journal.pone.0051667	http://dx.doi.org/10.1371/journal.pone.0051667			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	22558416	Green Published, Green Submitted, gold			2022-12-27	WOS:000312483300022
J	Wang, XH; Fiorini, Z; Smith, C; Zhang, YN; Li, J; Watkins, LR; Yin, H				Wang, Xiaohui; Fiorini, Zeno; Smith, Christina; Zhang, Yingning; Li, Jing; Watkins, Linda R.; Yin, Hang			Repositioning Antimicrobial Agent Pentamidine as a Disruptor of the Lateral Interactions of Transmembrane Domain 5 of EBV Latent Membrane Protein 1	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; HUMAN CYCLIN A(2); ENDOTHELIAL-CELLS; P-GLYCOPROTEIN; EXPRESSION; BRAIN; ACTIVATION; RESISTANCE; STABILITY; APOPTOSIS	The lateral transmembrane protein-protein interactions (PPI) have been regarded as "undruggable" despite their importance in many essential biological processes. The homo-trimerization of transmembrane domain 5 (TMD-5) of latent membrane protein 1 (LMP-1) is critical for the constitutive oncogenic activation of the Epstein-Barr virus (EBV). Herein we repurpose the antimicrobial agent pentamidine as a regulator of LMP-1 TMD-5 lateral interactions. The results of ToxR assay, tryptophan fluorescence assay, courmarin fluorescence dequenching assay, and Bis-Tris sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) consistently show pentamidine disrupts LMP-1 TMD-5 lateral interactions. Furthermore, pentamidine inhibits LMP-1 signaling, inducing cellular apoptosis and suppressing cell proliferation in the EBV infected B cells. In contrast, EBV negative cells are less susceptible to pentamidine. This study provides a novel non-peptide small molecule agent for regulating LMP-1 TMD-5 lateral interactions.	[Li, Jing] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Rheumatol, Beijing 100730, Peoples R China; [Wang, Xiaohui; Fiorini, Zeno; Smith, Christina; Yin, Hang] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Wang, Xiaohui; Fiorini, Zeno; Smith, Christina; Yin, Hang] Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA; [Wang, Xiaohui; Zhang, Yingning; Watkins, Linda R.] Univ Colorado, Dept Psychol, Boulder, CO 80309 USA; [Wang, Xiaohui; Zhang, Yingning; Watkins, Linda R.] Univ Colorado, Ctr Neurosci, Boulder, CO 80309 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Li, J (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Rheumatol, Beijing 100730, Peoples R China.	lijing6515@pumch.cn; hubert.yin@colorado.edu	Li, Yang/GWM-7879-2022; Wang, Xiaohui/B-8126-2011; Li, Yuan/GXV-1310-2022; YIN, HANG/O-2097-2014; Smith, Christina/GXG-6941-2022; Tetens, Jens/H-5344-2012; Wang, Xugao/B-1111-2015; Pausch, Hubert/U-5934-2019; Pausch, Hubert/B-7637-2018; li, yong/HDN-3885-2022	Wang, Xiaohui/0000-0002-3415-5612; YIN, HANG/0000-0002-9762-4818; Wang, Xugao/0000-0003-1207-8852; Pausch, Hubert/0000-0002-0501-6760; Wang, Jing/0000-0002-2806-6517; Boville (Smith), Christina/0000-0002-2577-9343; Li, Jing/0000-0003-2504-1629; Comita, Liza/0000-0002-9169-1331; Fiorini, Zeno/0000-0001-5218-2502; wang, yizhen/0000-0002-3908-7102	National Institutes of Health [R21CA138373, DA024044]; Cancer League of Colorado; American Association of Cancer Research; Sidney Kimmel Foundation for Cancer Research [SKF-08-101]; Stand Up to Cancer Innovative Research Award [SU2C]; Direct For Mathematical & Physical Scien [0954819] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer League of Colorado; American Association of Cancer Research; Sidney Kimmel Foundation for Cancer Research; Stand Up to Cancer Innovative Research Award; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The authors thank the National Institutes of Health (R21CA138373, DA024044), Cancer League of Colorado for financial supports of this work. H.Y. is also grateful for the 2009 Elion Award from the American Association of Cancer Research, a Kimmel Scholar Award from the Sidney Kimmel Foundation for Cancer Research (SKF-08-101) and a Stand Up to Cancer (SU2C) Innovative Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEY MC, 1988, CANCER RES, V48, P589; Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Beaulieu E, 1997, BIOCHEM J, V326, P539, DOI 10.1042/bj3260539; Bray PG, 2003, TRENDS PARASITOL, V19, P232, DOI 10.1016/S1471-4922(03)00069-2; CORDONCARDO C, 1989, P NATL ACAD SCI USA, V86, P695, DOI 10.1073/pnas.86.2.695; Grigoriev MY, 2002, CELL CYCLE, V1, P337, DOI 10.4161/cc.1.5.152; Jenssen Havard, 2008, V494, P177, DOI 10.1007/978-1-59745-419-3_10; Joce C, 2011, JOVE-J VIS EXP, DOI 10.3791/2721; Joce C, 2011, BBA-BIOMEMBRANES, V1808, P2948, DOI 10.1016/j.bbamem.2011.07.008; KAVATHAS P, 1980, P NATL ACAD SCI-BIOL, V77, P4251, DOI 10.1073/pnas.77.7.4251; Kaykas A, 2001, EMBO J, V20, P2641, DOI 10.1093/emboj/20.11.2641; Long HM, 2011, CURR OPIN IMMUNOL, V23, P258, DOI 10.1016/j.coi.2010.12.014; Maeda E, 2009, JPN J RADIOL, V27, P4, DOI 10.1007/s11604-008-0291-2; Perriere N, 2005, J NEUROCHEM, V93, P279, DOI 10.1111/j.1471-4159.2004.03020.x; Quintana FJ, 2007, BIOCHEMISTRY-US, V46, P2317, DOI 10.1021/bi061849g; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Richter L, 2010, P NATL ACAD SCI USA, V107, P14597, DOI 10.1073/pnas.1003026107; Russ WP, 1999, P NATL ACAD SCI USA, V96, P863, DOI 10.1073/pnas.96.3.863; Sackett DL, 2009, NAT CHEM, V1, P596, DOI 10.1038/nchem.427; Sammond DW, 2011, BIOPOLYMERS, V95, P772, DOI 10.1002/bip.21672; Sheikh MS, 2003, CELL CYCLE, V2, P550, DOI 10.4161/cc.2.6.566; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Sun BH, 2000, WORLD J GASTROENTERO, V6, P356; Toussirot E, 2008, BEST PRACT RES CL RH, V22, P883, DOI 10.1016/j.berh.2008.09.007; Vereide D, 2009, SEMIN CANCER BIOL, V19, P389, DOI 10.1016/j.semcancer.2009.07.006; Verma S, 2006, BRAIN BEHAV IMMUN, V20, P449, DOI 10.1016/j.bbi.2005.10.005; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wang XH, 2008, J PHYS CHEM B, V112, P8346, DOI 10.1021/jp712026m; Wang X, 2007, PROTEIN EXPRES PURIF, V56, P27, DOI 10.1016/j.pep.2007.05.011; Wang XH, 2012, BBA-BIOMEMBRANES, V1818, P2282, DOI 10.1016/j.bbamem.2012.05.013; Wang XH, 2012, P NATL ACAD SCI USA, V109, P6325, DOI 10.1073/pnas.1200130109; Wang XH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006665; Wilson AJ, 2009, CHEM SOC REV, V38, P3289, DOI 10.1039/b807197g; Yin H, 2008, ANGEW CHEM INT EDIT, V47, P2744, DOI 10.1002/anie.200704780; Yin H, 2006, J BIOL CHEM, V281, P36732, DOI 10.1074/jbc.M605877200; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Zhang BC, 2012, CELL, V148, P739, DOI 10.1016/j.cell.2011.12.031; Zhao TX, 2010, CURR PHARM DESIGN, V16, P1055, DOI 10.2174/138161210790963878	38	319	351	22	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47703	10.1371/journal.pone.0047703	http://dx.doi.org/10.1371/journal.pone.0047703			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	22558416	Green Submitted, gold, Green Published			2022-12-27	WOS:000310050200040
J	Wang, XM; Mao, XO; Xie, L; Sun, F; Greenberg, DA; Jin, KL				Wang, Xiaomei; Mao, XiaoOu; Xie, Lin; Sun, Fen; Greenberg, David A.; Jin, Kunlin			Conditional Depletion of Neurogenesis Inhibits Long-Term Recovery after Experimental Stroke in Mice	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; SUBVENTRICULAR ZONE; FOREBRAIN NEUROGENESIS; BRAIN; CELLS; REPLACEMENT; PRECURSORS; MIGRATION; NEURONS	We reported previously that ablation of doublecortin (DCX)-immunopositive newborn neurons in mice worsens anatomical and functional outcome measured 1 day after experimental stroke, but whether this effect persists is unknown. We generated transgenic mice that express herpes simplex virus thymidine kinase under control of the DCX promoter (DCX-TK transgenic mice). DCX-expressing and recently divided cells in the rostral subventricular zone (SVZ) and hippocampus of DCX-TK transgenic mice, but not wild-type mice, were specifically depleted after ganciclovir (GCV) treatment for 14 days. Focal cerebral ischemia was induced by permanent distal middle cerebral artery occlusion (MCAO) on day 14 of vehicle or GCV treatment, and mice were killed 12 weeks after MCAO. Infarct volume was significantly increased and neurologic deficits were more severe in GCV- compared to vehicle-treated DCX-TK transgenic mice at first 8 weeks, after depletion of DCX- and bromodeoxyuridine-immunoreactive cells in the SVZ and dentate gyrus following focal ischemia. Our results indicate that endogenous neurogenesis in a critical period following experimental stroke influences the course of long-term recovery.	[Wang, Xiaomei; Mao, XiaoOu; Xie, Lin; Sun, Fen; Greenberg, David A.; Jin, Kunlin] Buck Inst Res Aging, Novato, CA USA; [Jin, Kunlin] Univ N Texas Hlth Sci Ctr Ft Worth, Dept Pharmacol & Neurosci, Ft Worth, TX USA; [Jin, Kunlin] Univ N Texas Hlth Sci Ctr Ft Worth, Inst Aging & Alzheimers Dis Res, Ft Worth, TX USA	Buck Institute for Research on Aging; University of North Texas System; University of North Texas Health Science Center; University of North Texas System; University of North Texas Health Science Center	Wang, XM (corresponding author), Buck Inst Res Aging, Novato, CA USA.	kunlin.jin@unthsc.edu	Pausch, Hubert/U-5934-2019; Sun, Fen/I-8516-2016; Zeng, Maomao/M-1422-2013; Lizier, Joseph/B-8093-2008; Wang, Xuelong/GQB-3574-2022; Prokopenko, Mikhail/A-3995-2008; Wang, X. Rosalind/B-7097-2008	Pausch, Hubert/0000-0002-0501-6760; Yan, Jizhou/0000-0001-7482-7842; Zeng, Maomao/0000-0001-9259-1992; Lizier, Joseph/0000-0002-9910-8972; Tetens, Jens/0000-0001-5352-464X; Tang, Hailiang/0000-0003-1852-3128; SUN, FEN/0000-0003-2094-9494; Wurmser, Christine/0000-0003-0649-6206; Yu, Zhuowei/0000-0002-9152-6491; Wang, Xuelong/0000-0003-4616-1531; Kou, Xiaoxing/0000-0001-9680-0077; Prokopenko, Mikhail/0000-0002-4215-0344; Miller, Jennifer/0000-0003-2110-3693; Wang, X. Rosalind/0000-0001-5454-6197; Fries, Ruedi/0000-0002-4657-1787; Mao, Ying/0000-0001-8055-115X	United States Public Health Service Grant [NS57186, AG21980, NS44921, NS62414]	United States Public Health Service Grant(United States Department of Health & Human ServicesUnited States Public Health Service)	This work was supported by United States Public Health Service Grants NS57186 and AG21980 (to KJ) and NS44921 and NS62414 (to DAG). The URL of any funder's website is www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameh EA, 2009, SURG INFECT, V10, P105, DOI 10.1089/sur.2007.082; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Encarnacion A, 2011, J NEUROSCI METH, V196, P247, DOI 10.1016/j.jneumeth.2011.01.010; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Gu WG, 2000, J CEREBR BLOOD F MET, V20, P1166, DOI 10.1097/00004647-200008000-00002; Jin K, 2003, MOL CELL NEUROSCI, V24, P171, DOI 10.1016/S1044-7431(03)00159-3; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Jin KL, 2010, AGING CELL, V9, P1076, DOI 10.1111/j.1474-9726.2010.00638.x; Jin KL, 2010, P NATL ACAD SCI USA, V107, P7993, DOI 10.1073/pnas.1000154107; Jorgensen H S, 1999, Phys Med Rehabil Clin N Am, V10, P887; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Lai B, 2008, NEUROSCI LETT, V442, P305, DOI 10.1016/j.neulet.2008.07.032; Liu JL, 1998, J NEUROSCI, V18, P7768; Mayo NE, 1999, DISABIL REHABIL, V21, P258; MCDERMOTT KW, 1991, J ANAT, V178, P45; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; OHLSSON AL, 1995, STROKE, V26, P644, DOI 10.1161/01.STR.26.4.644; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Raber J, 2004, ANN NEUROL, V55, P381, DOI 10.1002/ana.10853; REARDON JE, 1989, J BIOL CHEM, V264, P19039; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Yoshimura S, 2001, P NATL ACAD SCI USA, V98, P5874, DOI 10.1073/pnas.101034998; Zhang L, 2002, J NEUROSCI METH, V117, P207, DOI 10.1016/S0165-0270(02)00114-0; Zhang RL, 2004, J CEREBR BLOOD F MET, V24, P441, DOI 10.1097/00004647-200404000-00009; Zhu CL, 2009, J NEUROCHEM, V111, P1447, DOI 10.1111/j.1471-4159.2009.06413.x	26	658	680	34	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38932	10.1371/journal.pone.0038932	http://dx.doi.org/10.1371/journal.pone.0038932			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22808095	Green Submitted, gold, Green Published			2022-12-27	WOS:000305652700041
J	Wang, XJ; Wei, DL; Song, ZG; Jiao, HC; Lin, H				Wang, Xiao Juan; Wei, Dai Lin; Song, Zhi Gang; Jiao, Hong Chao; Lin, Hai			Effects of Fatty Acid Treatments on the Dexamethasone-Induced Intramuscular Lipid Accumulation in Chickens	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SKELETAL-MUSCLE CELLS; INDUCED INSULIN-RESISTANCE; MAMMALIAN TARGET; GENE-EXPRESSION; DOWN-REGULATION; PPAR-ALPHA; RAT; RECEPTOR; LIVER	Background: Glucocorticoid has an important effect on lipid metabolism in muscles, and the type of fatty acid likely affects mitochondrial utilization. Therefore, we hypothesize that the different fatty acid types treatment may affect the glucocorticoid induction of intramuscular lipid accumulation. Methodology/Principal Findings: The effect of dexamethasone (DEX) on fatty acid metabolism and storage in skeletal muscle of broiler chickens (Gallus gallus domesticus) was investigated with and without fatty acid treatments. Male Arbor Acres chickens (31 d old) were treated with either palmitic acid (PA) or oleic acid (OA) for 7 days, followed by DEX administration for 3 days (35-37 d old). The DEX-induced lipid uptake and oxidation imbalance, which was estimated by increased fatty acid transport protein 1 (FATP1) expression and decreased carnitine palmitoyl transferase 1 activity, contributed to skeletal muscle lipid accumulation. More sensitive than glycolytic muscle, the oxidative muscle in DEX-treated chickens showed a decrease in the AMP to ATP ratio, a decrease in AMP-activated protein kinase (AMPK) alpha phosphorylation and its activity, as well as an increase in the phosphorylation of mammalian target of rapamycin (mTOR) and ribosomal p70S6 kinase, without Akt activation. DEX-stimulated lipid deposition was augmented by PA, but alleviated by OA, in response to pathways that were regulated differently, including AMPK, mTOR and FATP1. Conclusions: DEX-induced intramuscular lipid accumulation was aggravated by SFA but alleviated by unsaturated fatty acid. The suppressed AMPK and augmented mTOR signaling pathways were involved in glucocortcoid-mediated enhanced intramuscular fat accumulation.	[Wang, Xiao Juan; Song, Zhi Gang; Jiao, Hong Chao; Lin, Hai] Shandong Agr Univ, Dept Anim Sci, Tai An, Shandong, Peoples R China; [Wei, Dai Lin] Taian Cent Hosp, Dept Endocrine, Tai An, Shandong, Peoples R China	Shandong Agricultural University	Wang, XJ (corresponding author), Shandong Agr Univ, Dept Anim Sci, Tai An, Shandong, Peoples R China.	hailin@sdau.edu.cn	Pausch, Hubert/U-5934-2019; Sun, Fen/I-8516-2016; Zeng, Maomao/M-1422-2013; Lizier, Joseph/B-8093-2008; Wang, Xuelong/GQB-3574-2022; Prokopenko, Mikhail/A-3995-2008; Wang, X. Rosalind/B-7097-2008	Pausch, Hubert/0000-0002-0501-6760; Yan, Jizhou/0000-0001-7482-7842; Zeng, Maomao/0000-0001-9259-1992; Lizier, Joseph/0000-0002-9910-8972; Tetens, Jens/0000-0001-5352-464X; Tang, Hailiang/0000-0003-1852-3128; SUN, FEN/0000-0003-2094-9494; Wurmser, Christine/0000-0003-0649-6206; Yu, Zhuowei/0000-0002-9152-6491; Wang, Xuelong/0000-0003-4616-1531; Kou, Xiaoxing/0000-0001-9680-0077; Prokopenko, Mikhail/0000-0002-4215-0344; Miller, Jennifer/0000-0003-2110-3693; Wang, X. Rosalind/0000-0001-5454-6197; Fries, Ruedi/0000-0002-4657-1787; Mao, Ying/0000-0001-8055-115X	Shandong Science Fund for Distinguished Youth Scholars; National Basic Research Program of China [2004CB117507]; National Natural Science Foundation of China [30771573]; Research Fund for the Doctoral Program of Higher Education of China	Shandong Science Fund for Distinguished Youth Scholars; National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by grants from the Shandong Science Fund for Distinguished Youth Scholars, the National Basic Research Program of China (2004CB117507), the National Natural Science Foundation of China (No.30771573), and Research Fund for the Doctoral Program of Higher Education of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The contents of this article are solely the responsibility of the authors and do not necessarily represent the official views of the sponsoring agencies.	Andrews RC, 1999, CLIN SCI, V96, P513, DOI 10.1042/cs0960513; Aoki M, 2001, P NATL ACAD SCI USA, V98, P136, DOI 10.1073/pnas.011528498; Berthiaume M, 2007, AM J PHYSIOL-ENDOC M, V293, pE1045, DOI 10.1152/ajpendo.00276.2007; BIEBER LL, 1972, ANAL BIOCHEM, V50, P509, DOI 10.1016/0003-2697(72)90061-9; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Bowes SB, 1996, J ENDOCRINOL, V148, P501, DOI 10.1677/joe.0.1480501; Braun EJ, 2008, COMP BIOCHEM PHYS B, V151, P1, DOI 10.1016/j.cbpb.2008.05.007; Cai YL, 2009, COMP BIOCHEM PHYS C, V150, P164, DOI 10.1016/j.cbpc.2009.04.005; Caton PW, 2011, BIOCHEM J, V437, P521, DOI 10.1042/BJ20110702; Christ-Crain M, 2008, FASEB J, V22, P1672, DOI 10.1096/fj.07-094144; Chuang JC, 2010, J LIPID RES, V51, P1344, DOI 10.1194/jlr.M002196; Clark H, 2004, EUR J BIOCHEM, V271, P2215, DOI 10.1111/j.1432-1033.2004.04151.x; Close B, 1997, LAB ANIM-UK, V31, P1, DOI 10.1258/002367797780600297; Coll T, 2006, DIABETES, V55, P2779, DOI 10.2337/db05-1494; Cota D, 2009, OBESITY, V17, P1641, DOI 10.1038/oby.2009.84; DAVIES SP, 1989, EUR J BIOCHEM, V186, P123, DOI 10.1111/j.1432-1033.1989.tb15185.x; de Oliveira C, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-11; Duchene S, 2008, DOMEST ANIM ENDOCRIN, V34, P1, DOI 10.1016/j.domaniend.2006.09.002; Dupont J, 1999, J ENDOCRINOL, V162, P67, DOI 10.1677/joe.0.1620067; Dupont JL, 2004, DOMEST ANIM ENDOCRIN, V26, P127, DOI 10.1016/j.domaniend.2003.09.004; Dupont J, 2008, J ENDOCRINOL, V197, P531, DOI 10.1677/JOE-08-0055; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Foucaud L, 1998, BBA-LIPID LIPID MET, V1391, P204, DOI 10.1016/S0005-2760(97)00213-0; Gao D, 2009, BRIT J NUTR, V102, P1557, DOI 10.1017/S0007114509990948; Gaster M, 2005, DIABETES, V54, P648, DOI 10.2337/diabetes.54.3.648; GRIFFIN HD, 1982, BRIT POULTRY SCI, V23, P307, DOI 10.1080/00071688208447962; Halevy O, 2000, J NUTR, V130, P858, DOI 10.1093/jn/130.4.858; Hardie DG, 2007, ANNU REV PHARMACOL, V47, P185, DOI 10.1146/annurev.pharmtox.47.120505.105304; Hayat MA, 1973, PRINCIPLES TECHNIQUE, V3, P237; Hickson-Bick DLM, 2000, J MOL CELL CARDIOL, V32, P511, DOI 10.1006/jmcc.1999.1098; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Hu ZY, 2009, J CLIN INVEST, V119, P3059, DOI 10.1172/JCI38770; HUNNICUTT JW, 1994, DIABETES, V43, P540, DOI 10.2337/diabetes.43.4.540; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Kamara K, 1998, PHYSIOL BEHAV, V64, P1, DOI 10.1016/S0031-9384(97)00534-9; Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921; Koh EH, 2003, DIABETES, V52, P2331, DOI 10.2337/diabetes.52.9.2331; Korach-Andre M, 2005, AM J PHYSIOL-ENDOC M, V288, pE106, DOI 10.1152/ajpendo.00089.2004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee WJ, 2006, BIOCHEM BIOPH RES CO, V340, P291, DOI 10.1016/j.bbrc.2005.12.011; Lillie RD, 1976, HISTOPATHOLOGIC TECH, Vfourth, P559; Lin H, 2004, COMP BIOCHEM PHYS B, V139, P737, DOI 10.1016/j.cbpc.2004.09.013; Liu ZQ, 2004, AM J PHYSIOL-ENDOC M, V287, pE275, DOI 10.1152/ajpendo.00457.2003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mordier S, 2007, BIOCHEM BIOPH RES CO, V362, P206, DOI 10.1016/j.bbrc.2007.08.004; Nader N, 2010, MOL ENDOCRINOL, V24, P1748, DOI 10.1210/me.2010-0192; Nakken GN, 2010, J APPL PHYSIOL, V108, P298, DOI 10.1152/japplphysiol.00906.2009; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Prasad SSSV, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-111; Proszkowiec-Weglarz M, 2006, COMP BIOCHEM PHYS B, V143, P92, DOI 10.1016/j.cbpb.2005.10.009; Qi D, 2004, DIABETES, V53, P1790, DOI 10.2337/diabetes.53.7.1790; Qi D, 2006, AM J PHYSIOL-ENDOC M, V291, P420; Rivas DA, 2009, J ENDOCRINOL, V202, P441, DOI 10.1677/JOE-09-0202; Ruddock MW, 2008, J BIOCHEM, V144, P599, DOI 10.1093/jb/mvn105; Ruderman NB, 2006, OBESITY, V14, p25S, DOI 10.1038/oby.2006.279; Rutter GA, 2003, BIOCHEM J, V375, P1, DOI 10.1042/BJ20030048; RYDER JM, 1985, J AGR FOOD CHEM, V33, P678, DOI 10.1021/jf00064a027; Saha AK, 2003, MOL CELL BIOCHEM, V253, P65, DOI 10.1023/A:1026053302036; Schwartz GJ, 2008, CELL METAB, V8, P281, DOI 10.1016/j.cmet.2008.08.005; Sekulic A, 2000, CANCER RES, V60, P3504; Shah OJ, 2000, AM J PHYSIOL, V279, P74; SIMON J, 1974, ENDOCRINOLOGY, V95, P1439, DOI 10.1210/endo-95-5-1439; Sipula IJ, 2006, METABOLISM, V55, P1637, DOI 10.1016/j.metabol.2006.08.002; SMOLENSKI RT, 1993, BIOMED CHROMATOGR, V7, P189, DOI 10.1002/bmc.1130070404; Staiger H, 2005, DIABETOLOGIA, V48, P2115, DOI 10.1007/s00125-005-1895-z; Stuart M, 2010, END ABSTR, V21, P180; Tremblay F, 2007, P NATL ACAD SCI USA, V104, P14056, DOI 10.1073/pnas.0706517104; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Wang XJ, 2012, STRESS, V15, P443, DOI 10.3109/10253890.2011.639413; Wang XJ, 2010, COMP BIOCHEM PHYS C, V151, P447, DOI 10.1016/j.cbpc.2010.01.010; Watt MJ, 2006, J PHYSIOL-LONDON, V574, P139, DOI 10.1113/jphysiol.2006.107318; Winder WW, 1996, AM J PHYSIOL-ENDOC M, V270, pE299, DOI 10.1152/ajpendo.1996.270.2.E299; Wu QW, 2006, MOL CELL BIOL, V26, P3455, DOI 10.1128/MCB.26.9.3455-3467.2006; Zhang JL, 2004, AM J PHYSIOL-ENDOC M, V286, pE168, DOI 10.1152/ajpendo.00232.2003; Zhao JP, 2009, COMP BIOCHEM PHYS C, V149, P448, DOI 10.1016/j.cbpc.2008.10.106	75	658	680	34	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36663	10.1371/journal.pone.0036663	http://dx.doi.org/10.1371/journal.pone.0036663			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22808095	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343500022
J	Wang, XL; Wurmser, C; Pausch, H; Jung, S; Reinhardt, F; Tetens, J; Thaller, G; Fries, R				Wang, Xiaolong; Wurmser, Christine; Pausch, Hubert; Jung, Simone; Reinhardt, Friedrich; Tetens, Jens; Thaller, Georg; Fries, Ruedi			Identification and Dissection of Four Major QTL Affecting Milk Fat Content in the German Holstein-Friesian Population	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; GROWTH-HORMONE RECEPTOR; MISSENSE MUTATION; GENE; DGAT1; AGPAT6; YIELD; TRANSCRIPTION; EXPRESSION; TISSUE	Milk composition traits exhibit a complex genetic architecture with a small number of major quantitative trait loci (QTL) explaining a large fraction of the genetic variation and numerous QTL with minor effects. In order to identify QTL for milk fat percentage (FP) in the German Holstein-Friesian (HF) population, a genome-wide association study (GWAS) was performed. The study population consisted of 2327 progeny-tested bulls. Genotypes were available for 44,280 SNPs. Phenotypes in the form of estimated breeding values (EBVs) for FP were used as highly heritable traits. A variance components-based approach was used to account for population stratification. The GWAS identified four major QTL regions explaining 46.18% of the FP EBV variance. Besides two previously known FP QTL on BTA14 (P = 8.91x10-(198)) and BTA20 (P = 7.03x10(-12)) within DGAT1 and GHR, respectively, we uncovered two additional QTL regions on BTA5 (P = 2.00x10(-13)) and BTA27 (P = 9.83x10(-5)) encompassing EPS8 and GPAT4, respectively. EPS8 and GPAT4 are involved in lipid metabolism in mammals. Re-sequencing of EPS8 and GPAT4 revealed 50 polymorphisms. Genotypes for five of them were inferred for the entire study population. Two polymorphisms affecting potential transcription factor binding sites of EPS8 (P = 1.40x10(-12)) and GPAT4 (P = 5.18x10(-5)), respectively, were highly significantly associated with the FP EBV. Our results provide evidence that alteration of regulatory sites is an important aspect of genetic variation of complex traits in cattle.	[Wang, Xiaolong; Wurmser, Christine; Pausch, Hubert; Jung, Simone; Fries, Ruedi] Tech Univ Muenchen, Chair Anim Breeding, Freising Weihenstephan, Germany; [Reinhardt, Friedrich] Vereinigte Informat Syst Tierhaltung wV, Verden, Germany; [Tetens, Jens; Thaller, Georg] Univ Kiel, Inst Anim Breeding & Husb, Kiel, Germany	Technical University of Munich; University of Kiel	Wang, XL (corresponding author), Tech Univ Muenchen, Chair Anim Breeding, Freising Weihenstephan, Germany.	xiaolong.wang@tierzucht.tum.de	Pausch, Hubert/U-5934-2019; Sun, Fen/I-8516-2016; Zeng, Maomao/M-1422-2013; Lizier, Joseph/B-8093-2008; Wang, Xuelong/GQB-3574-2022; Prokopenko, Mikhail/A-3995-2008; Wang, X. Rosalind/B-7097-2008	Pausch, Hubert/0000-0002-0501-6760; Yan, Jizhou/0000-0001-7482-7842; Zeng, Maomao/0000-0001-9259-1992; Lizier, Joseph/0000-0002-9910-8972; Tetens, Jens/0000-0001-5352-464X; Tang, Hailiang/0000-0003-1852-3128; SUN, FEN/0000-0003-2094-9494; Wurmser, Christine/0000-0003-0649-6206; Yu, Zhuowei/0000-0002-9152-6491; Wang, Xuelong/0000-0003-4616-1531; Kou, Xiaoxing/0000-0001-9680-0077; Prokopenko, Mikhail/0000-0002-4215-0344; Miller, Jennifer/0000-0003-2110-3693; Wang, X. Rosalind/0000-0001-5454-6197; Fries, Ruedi/0000-0002-4657-1787; Mao, Ying/0000-0001-8055-115X	German Ministry of Education and Research, BMBF [0315134A, 0315134D, 0315131A]; Forderverein Biotechnologieforschung e.V. (FBF), Bonn; Lohmann Tierzucht GmbH, Cuxhaven; China Scholarship Council (CSC)	German Ministry of Education and Research, BMBF(Federal Ministry of Education & Research (BMBF)); Forderverein Biotechnologieforschung e.V. (FBF), Bonn; Lohmann Tierzucht GmbH, Cuxhaven; China Scholarship Council (CSC)(China Scholarship Council)	This study is part of the projects FUGATO-plus GenoTrack and FUGATO-plus MeGA-M and was financially supported by the German Ministry of Education and Research, BMBF (grants 0315134A, 0315134D and 0315131A), the Forderverein Biotechnologieforschung e.V. (FBF), Bonn, and Lohmann Tierzucht GmbH, Cuxhaven. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge the vit w.V. Verden for providing phenotype data and the China Scholarship Council (CSC) for supporting X. Wang by a grant.	Beigneux AP, 2006, J LIPID RES, V47, P734, DOI 10.1194/jlr.M500556-JLR200; Bionaz M, 2008, J NUTR, V138, P1019, DOI 10.1093/jn/138.6.1019; Blott S, 2003, GENETICS, V163, P253; Bouwman AC, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-43; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Buttchereit N, 2010, J DAIRY SCI, V93, P1702, DOI 10.3168/jds.2009-2198; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chakravarty K, 2005, CRIT REV BIOCHEM MOL, V40, P129, DOI 10.1080/10409230590935479; Chatterjee S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005197; Cohen-Zinder M, 2005, GENOME RES, V15, P936, DOI 10.1101/gr.3806705; Ed L, 2009, BIOINFORMATICS, V25, P1836, DOI 10.1093/bioinformatics/btp314; FAZIOLI F, 1993, EMBO J, V12, P3799, DOI 10.1002/j.1460-2075.1993.tb06058.x; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gremme G, 2005, INFORM SOFTWARE TECH, V47, P965, DOI 10.1016/j.infsof.2005.09.005; Grisart B, 2002, GENOME RES, V12, P222, DOI 10.1101/gr.224202; Guo DL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000446; Hamza MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004907; Hayes BJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001139; Jiang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013661; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Loor JJ, 2005, PHYSIOL GENOMICS, V23, P217, DOI 10.1152/physiolgenomics.00132.2005; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Portales-Casamar E, 2009, JASPAR 2010 GREATLY; Quackenbush J, 2001, NUCLEIC ACIDS RES, V29, P159, DOI 10.1093/nar/29.1.159; Schennink A, 2007, ANIM GENET, V38, P467, DOI 10.1111/j.1365-2052.2007.01635.x; Schennink A, 2009, ANIM GENET, V40, P909, DOI 10.1111/j.1365-2052.2009.01940.x; Schug Jonathan, 2008, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0206s21; Signorelli F, 2009, LIVEST SCI, V125, P74, DOI 10.1016/j.livsci.2009.02.014; Thaller G, 2003, J ANIM SCI, V81, P1911; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Vergnes L, 2006, J LIPID RES, V47, P745, DOI 10.1194/jlr.M500553-JLR200; Viitala S, 2006, GENETICS, V173, P2151, DOI 10.1534/genetics.105.046730; Winter A, 2002, P NATL ACAD SCI USA, V99, P9300, DOI 10.1073/pnas.142293799; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	35	658	680	34	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40711	10.1371/journal.pone.0040711	http://dx.doi.org/10.1371/journal.pone.0040711			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808095	gold, Green Submitted, Green Published			2022-12-27	WOS:000306362400093
